id|nct_id|mesh_term|downcase_mesh_term|mesh_type
57139181|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
57139260|NCT04616534|Gemcitabine|gemcitabine|mesh-list
57139783|NCT03166527|Antibodies|antibodies|mesh-list
57139903|NCT05740371|Argatroban|argatroban|mesh-list
57139927|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140150|NCT05746065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57140449|NCT00054158|Doxorubicin|doxorubicin|mesh-list
57140524|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57140823|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140974|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
57141128|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141205|NCT02264041|Itraconazole|itraconazole|mesh-list
57141277|NCT02262169|Omeprazole|omeprazole|mesh-list
57141579|NCT01379209|Sirolimus|sirolimus|mesh-list
57141737|NCT02266303|Insulin|insulin|mesh-list
57141871|NCT02269735|MK-2640|mk-2640|mesh-list
57142174|NCT04506554|Nivolumab|nivolumab|mesh-list
57142775|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
57143155|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57143536|NCT04681105|Antibodies|antibodies|mesh-list
57143923|NCT03134443|Analgesics|analgesics|mesh-ancestor
57144064|NCT05630859|Vaccines|vaccines|mesh-list
57144514|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
57144659|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144732|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57144884|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145035|NCT00459745|Pravastatin|pravastatin|mesh-list
57145262|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57145414|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57145491|NCT02279953|Vortioxetine|vortioxetine|mesh-list
57145562|NCT03537287|Progesterone|progesterone|mesh-list
57145636|NCT02177357|Protective Agents|protective agents|mesh-ancestor
57145856|NCT00546793|Veltuzumab|veltuzumab|mesh-list
57146154|NCT03133897|Prednisone|prednisone|mesh-list
57146313|NCT02190695|Carboplatin|carboplatin|mesh-list
57146756|NCT00319969|Topotecan|topotecan|mesh-list
57146906|NCT00028639|Bortezomib|bortezomib|mesh-list
57147055|NCT00004231|Teniposide|teniposide|mesh-list
57147129|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147587|NCT02198417|Metformin|metformin|mesh-list
57147736|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57147821|NCT02367807|Tenofovir|tenofovir|mesh-list
57147888|NCT02363985|Vitamin A|vitamin a|mesh-list
57148567|NCT05594043|Pembrolizumab|pembrolizumab|mesh-list
57148867|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57148951|NCT05286827|Olaparib|olaparib|mesh-list
57149018|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149243|NCT04919629|Antibodies|antibodies|mesh-list
57149325|NCT04868409|Rocuronium|rocuronium|mesh-list
57149525|NCT04530565|Mesna|mesna|mesh-list
57149550|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
57149701|NCT04310007|Gemcitabine|gemcitabine|mesh-list
57149863|NCT04147546|Artenimol|artenimol|mesh-list
57150162|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150316|NCT03496766|Tipifarnib|tipifarnib|mesh-list
57150393|NCT03300557|Exemestane|exemestane|mesh-list
57151227|NCT00024622|Dopamine Agents|dopamine agents|mesh-ancestor
57151228|NCT00024622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57151229|NCT00024622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151230|NCT00024622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151231|NCT00018057|Fluoxetine|fluoxetine|mesh-list
57151232|NCT00018057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57151233|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57151234|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57151235|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151236|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57151237|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
57151238|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151239|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57151240|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
57151241|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57151242|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57139182|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
57139183|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
57139184|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139185|NCT02226757|Paclitaxel|paclitaxel|mesh-list
57139186|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57139187|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139188|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
57139189|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
57139190|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
57139191|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139192|NCT04616924|Clarithromycin|clarithromycin|mesh-list
57139193|NCT04616924|Rifabutin|rifabutin|mesh-list
57139194|NCT04616924|Clofazimine|clofazimine|mesh-list
57139195|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57139196|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139197|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57139198|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139199|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139200|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57139201|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57139202|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57139203|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
57139204|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139205|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
57139206|NCT02226913|Lidocaine|lidocaine|mesh-list
57139207|NCT02226913|Epinephrine|epinephrine|mesh-list
57139208|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
57139209|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
57139210|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139211|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139212|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
57139213|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139214|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57139215|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57139216|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57139217|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139218|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139219|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57139220|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57139221|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
57139222|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139223|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57139224|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57139225|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
57139226|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57139227|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
57139228|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
57139229|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
57139230|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57139231|NCT05491616|Nivolumab|nivolumab|mesh-list
57139232|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57139233|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139234|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57139235|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139236|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
57139237|NCT02254655|Puerarin|puerarin|mesh-list
57139238|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
57139239|NCT02226991|Ritonavir|ritonavir|mesh-list
57139240|NCT02226991|Tipranavir|tipranavir|mesh-list
57139241|NCT02226991|Efavirenz|efavirenz|mesh-list
57139242|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57139243|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57139244|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
57139245|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139246|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139247|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57139248|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57139249|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
57139250|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139251|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57139252|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57139253|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57139254|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57139255|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57139256|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57139257|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57139258|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57139259|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57139261|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57139262|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
57139263|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139264|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139265|NCT04616534|Antiviral Agents|antiviral agents|mesh-ancestor
57139266|NCT04616534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139267|NCT04616534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139268|NCT04616534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57139269|NCT04616534|Immunologic Factors|immunologic factors|mesh-ancestor
57139270|NCT04616534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139271|NCT05042791|Capecitabine|capecitabine|mesh-list
57139272|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57139273|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
57139274|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139275|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139276|NCT00705783|Aripiprazole|aripiprazole|mesh-list
57139277|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
57139278|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57139279|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57139280|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57139281|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139282|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139283|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
57139284|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
57139285|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139286|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139287|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57139288|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57139289|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
57139290|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57139291|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57139292|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57139293|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57139294|NCT03719768|Avelumab|avelumab|mesh-list
57139295|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57139296|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139297|NCT02145611|Vildagliptin|vildagliptin|mesh-list
57139298|NCT02145611|Glyburide|glyburide|mesh-list
57139299|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57139300|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139301|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57139302|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
57139303|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139304|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139305|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
57139306|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57139307|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139308|NCT03543683|Aspirin|aspirin|mesh-list
57139309|NCT03543683|Osimertinib|osimertinib|mesh-list
57139310|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57139311|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57139312|NCT03543683|Analgesics|analgesics|mesh-ancestor
57139313|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
57139314|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139315|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139316|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139317|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139318|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57139319|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57139320|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139321|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57139322|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57139323|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139324|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
57139325|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139326|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57139327|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
57139328|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57139329|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56990927|NCT03620825|Analgesics|analgesics|mesh-ancestor
57139330|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57139331|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139332|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139333|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
57139334|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139335|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139336|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57139337|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139338|NCT02396979|Methadone|methadone|mesh-list
57139339|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57139340|NCT02396979|Narcotics|narcotics|mesh-ancestor
57139341|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139342|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139343|NCT02396979|Analgesics|analgesics|mesh-ancestor
57139344|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
57139345|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139346|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
57139347|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
57139348|NCT02145767|Progesterone|progesterone|mesh-list
57139349|NCT02145767|Progestins|progestins|mesh-ancestor
57139350|NCT02145767|Hormones|hormones|mesh-ancestor
57139351|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139352|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139353|NCT02031523|Analgesics|analgesics|mesh-list
57139354|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
57139355|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139356|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139357|NCT02397213|Cyclosporine|cyclosporine|mesh-list
57139358|NCT02397213|Cyclosporins|cyclosporins|mesh-list
57139359|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139360|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139361|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57139362|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
57139363|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139364|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
57139365|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139366|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
57139367|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139368|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57139369|NCT04480281|Lidocaine|lidocaine|mesh-list
57139370|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
57139371|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
57139372|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139373|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139374|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
57139375|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139376|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57139377|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57139378|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57139379|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139380|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139381|NCT03544775|Anesthetics|anesthetics|mesh-list
57139382|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139383|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139384|NCT02258815|Dinutuximab|dinutuximab|mesh-list
57139385|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139386|NCT02149433|Prednisone|prednisone|mesh-list
57139387|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139388|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
57139389|NCT02149433|Hormones|hormones|mesh-ancestor
57139390|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139391|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139392|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57139393|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139394|NCT02228005|Sertraline|sertraline|mesh-list
57139395|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
57139396|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57139397|NCT02228005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57139398|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57139399|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139400|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139401|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139402|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
55730340|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57139403|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139404|NCT02228083|Lidocaine|lidocaine|mesh-list
57139405|NCT02228083|Epinephrine|epinephrine|mesh-list
57139406|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
57139407|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
57139408|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139409|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139410|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
57139411|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139412|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57139413|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57139414|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57139415|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139416|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139417|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57139418|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57139419|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
57139420|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139421|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57139422|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57139423|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
57139424|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57139425|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
57139426|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
57139427|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
57139428|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57139429|NCT02394483|Olorofim|olorofim|mesh-list
57139430|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
57139431|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139432|NCT02142335|Rituximab|rituximab|mesh-list
57139433|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57139434|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139435|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
57139436|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139437|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139438|NCT02228239|Mirtazapine|mirtazapine|mesh-list
57139439|NCT02228239|Esketamine|esketamine|mesh-list
57139440|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
57139441|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57139442|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57139443|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
57139444|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
57139445|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139446|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139447|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139448|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57139449|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57139450|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139451|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57139452|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57139453|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57139454|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
57139455|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57139456|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57139457|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
57139458|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57139459|NCT03167385|Apatinib|apatinib|mesh-list
57139460|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139461|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57139462|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139463|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139464|NCT02142569|Tocotrienols|tocotrienols|mesh-list
57139465|NCT02142569|Vitamin E|vitamin e|mesh-list
57139466|NCT02142569|Tocopherols|tocopherols|mesh-list
57139467|NCT02142569|Red yeast rice|red yeast rice|mesh-list
57139468|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
57139469|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139470|NCT02142569|Protective Agents|protective agents|mesh-ancestor
57139471|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139472|NCT02142569|Vitamins|vitamins|mesh-ancestor
57139473|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
57139474|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57139475|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57139476|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57139477|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
57139478|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139479|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57139480|NCT02228473|Atropine|atropine|mesh-list
57139481|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
57139482|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57139483|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57139484|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57139485|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
57139486|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139487|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139488|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57139489|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
57139490|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
57139491|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
57139492|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57139493|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57139494|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
57139495|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139496|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139497|NCT02394015|Doxorubicin|doxorubicin|mesh-list
57139498|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57139499|NCT02394015|Trabectedin|trabectedin|mesh-list
57139500|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57139501|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139502|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57139503|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57139504|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139505|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139506|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57139507|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
57139508|NCT02394093|Aspirin|aspirin|mesh-list
57139509|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57139510|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57139511|NCT02394093|Analgesics|analgesics|mesh-ancestor
57139512|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
57139513|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139514|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139515|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139516|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139517|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57139518|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57139519|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139520|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57139521|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57139522|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139523|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
57139524|NCT02146391|Enclomiphene|enclomiphene|mesh-list
57139525|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57139526|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
57139527|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139528|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139529|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57139530|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
57139531|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57139532|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57139533|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57139534|NCT04225273|Lidocaine|lidocaine|mesh-list
57139535|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
57139536|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
57139537|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139538|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139539|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
57139540|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139541|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57139542|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57139543|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57139544|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139545|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139546|NCT02146547|Aripiprazole|aripiprazole|mesh-list
57139547|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
57139548|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
57139549|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57139550|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57139551|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57139552|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139553|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139554|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
57139555|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
57139556|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139557|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139558|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57139559|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57139560|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
57139561|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57139562|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57139563|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57139564|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57139565|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
57139566|NCT02146703|Gemcitabine|gemcitabine|mesh-list
57139567|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57139568|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
57139569|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139570|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139571|NCT02146703|Antiviral Agents|antiviral agents|mesh-ancestor
57139572|NCT02146703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139573|NCT02146703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139574|NCT02146703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57139575|NCT02146703|Immunologic Factors|immunologic factors|mesh-ancestor
57139576|NCT02146703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139577|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57139578|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57139579|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57139580|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139581|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139582|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57139583|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139584|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139585|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
57139586|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139587|NCT02782169|Pregabalin|pregabalin|mesh-list
57139588|NCT02782169|Analgesics|analgesics|mesh-ancestor
57139589|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
57139590|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139591|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139592|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
57139593|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57139594|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139595|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139596|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57139597|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57139598|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57139599|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139600|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57139601|NCT04163185|Meloxicam|meloxicam|mesh-list
57139602|NCT04163185|Rizatriptan|rizatriptan|mesh-list
57139603|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57139604|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57139605|NCT04163185|Analgesics|analgesics|mesh-ancestor
57139606|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
57139607|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139608|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139609|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139610|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139611|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57139612|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57139613|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139614|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139615|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57139616|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
57139617|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139618|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
57139619|NCT02149901|Ephedrine|ephedrine|mesh-list
57139620|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57139621|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
57139622|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139623|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139624|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57139625|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
57139626|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
57139627|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57139628|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57139629|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
57139630|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
57139631|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139632|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139633|NCT04440267|Dexamethasone|dexamethasone|mesh-list
57139634|NCT04440267|Prednisone|prednisone|mesh-list
57139635|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
57139636|NCT04440267|Methotrexate|methotrexate|mesh-list
57139637|NCT04440267|Vincristine|vincristine|mesh-list
57139638|NCT04440267|Daunorubicin|daunorubicin|mesh-list
57139639|NCT04440267|Asparaginase|asparaginase|mesh-list
57139640|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
57139641|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57139642|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
57139643|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139644|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139645|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57139646|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
57139647|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139648|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139649|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57139650|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139651|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
57139652|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
57139653|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139654|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57139655|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
57139656|NCT04440267|Hormones|hormones|mesh-ancestor
57139657|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139658|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57139659|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57139660|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
57139661|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57139662|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57139663|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
57139664|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
57139665|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139666|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57139667|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57139668|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57139669|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
57139670|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
57139671|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
57139672|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57139673|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57139674|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57139675|NCT02043847|Melphalan|melphalan|mesh-list
57139676|NCT02043847|Lenograstim|lenograstim|mesh-list
57139677|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57139678|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
57139679|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139680|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57139681|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
57139682|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139683|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139684|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57139685|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57139686|NCT02146937|Bicalutamide|bicalutamide|mesh-list
57139687|NCT02146937|Finasteride|finasteride|mesh-list
57139688|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
57139689|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
57139690|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139691|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139692|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139693|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57139694|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57139695|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139696|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139697|NCT02146937|Urological Agents|urological agents|mesh-ancestor
57139698|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57139699|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
56833573|NCT02296918|Rituximab|rituximab|mesh-list
57139700|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
57139701|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
57139702|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
57139703|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139704|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139705|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
57139706|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
57139707|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139708|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139709|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57139710|NCT02147015|Hormones|hormones|mesh-ancestor
57139711|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139712|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57139713|NCT02147015|Protective Agents|protective agents|mesh-ancestor
57139714|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139715|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139716|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57139717|NCT02229175|Bevacizumab|bevacizumab|mesh-list
57139718|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57139719|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139720|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57139721|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57139722|NCT02229175|Growth Substances|growth substances|mesh-ancestor
57139723|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139724|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
57139725|NCT05744739|Azacitidine|azacitidine|mesh-list
57139726|NCT05744739|Venetoclax|venetoclax|mesh-list
57139727|NCT05744739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57139728|NCT05744739|Antimetabolites|antimetabolites|mesh-ancestor
57139729|NCT05744739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139730|NCT05744739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139731|NCT05744739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139732|NCT04947007|Bupivacaine|bupivacaine|mesh-list
57139733|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
57139734|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
57139735|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139736|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139737|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
57139738|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139739|NCT04104685|Minocycline|minocycline|mesh-list
57139740|NCT04104685|Adapalene|adapalene|mesh-list
57139741|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57139742|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139743|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57139744|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57139745|NCT04104685|Analgesics|analgesics|mesh-ancestor
57139746|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
57139747|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139748|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139749|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139750|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139751|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
57139752|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57139753|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139754|NCT02392845|Docetaxel|docetaxel|mesh-list
57139755|NCT02392845|Epirubicin|epirubicin|mesh-list
57139756|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139757|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
57139758|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
57139759|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
57139760|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139761|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57139762|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57139763|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57139764|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139765|NCT04093765|Antimalarials|antimalarials|mesh-list
57139766|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57139767|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57139768|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139769|NCT03166605|Simethicone|simethicone|mesh-list
57139770|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
57139771|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139772|NCT03166605|Emollients|emollients|mesh-ancestor
57139773|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
57139774|NCT03699956|Carboplatin|carboplatin|mesh-list
57139775|NCT03699956|Etoposide|etoposide|mesh-list
57139776|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139777|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57139778|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57139779|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57139780|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139781|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139782|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
57139784|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
57139785|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57139786|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57139787|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
57139788|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139789|NCT02695719|Lubiprostone|lubiprostone|mesh-list
57139790|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57139791|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139792|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139793|NCT05498012|Cannabidiol|cannabidiol|mesh-list
57139794|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
57139795|NCT02150291|Folic Acid|folic acid|mesh-list
57139796|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
57139797|NCT02150291|Hematinics|hematinics|mesh-ancestor
57139798|NCT02150291|Vitamins|vitamins|mesh-ancestor
57139799|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
57139800|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139801|NCT04907071|Coal Tar|coal tar|mesh-list
57139802|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
57139803|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
57139804|NCT02155517|Propofol|propofol|mesh-list
57139805|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57139806|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139807|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139808|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57139809|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
57139810|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
57139811|NCT05497934|Glycerol|glycerol|mesh-list
57139812|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57139813|NCT05497934|Protective Agents|protective agents|mesh-ancestor
57139814|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139815|NCT02229721|Oxytocin|oxytocin|mesh-list
57139816|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
57139817|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57139818|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139819|NCT05497700|Norepinephrine|norepinephrine|mesh-list
57139820|NCT05497700|Ephedrine|ephedrine|mesh-list
57139821|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57139822|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57139823|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
57139824|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139825|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139826|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139827|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
57139828|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
57139829|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139830|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57139831|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57139832|NCT03106389|Misoprostol|misoprostol|mesh-list
57139833|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57139834|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
57139835|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57139836|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139837|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57139838|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57139839|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
57139840|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57139841|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57139842|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139843|NCT02255045|Diclofenac|diclofenac|mesh-list
57139844|NCT02255045|Meloxicam|meloxicam|mesh-list
57139845|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57139846|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57139847|NCT02255045|Analgesics|analgesics|mesh-ancestor
57139848|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
57139849|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139850|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139851|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139852|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139853|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57139854|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139855|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139856|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57139857|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57139858|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57139859|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57139860|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139861|NCT02150447|Lansoprazole|lansoprazole|mesh-list
57139862|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57139863|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57139864|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57139865|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139866|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139867|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57139868|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139869|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139870|NCT05741229|Nitroglycerin|nitroglycerin|mesh-list
57139871|NCT05741229|Vasodilator Agents|vasodilator agents|mesh-ancestor
57139872|NCT02229955|Cyclosporine|cyclosporine|mesh-list
57139873|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57139874|NCT02229955|Cyclosporins|cyclosporins|mesh-list
57139875|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139876|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139877|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57139878|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
57139879|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139880|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
57139881|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139882|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
57139883|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139884|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57139885|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57139886|NCT02230033|Itraconazole|itraconazole|mesh-list
57139887|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
57139888|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
57139889|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139890|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57139891|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57139892|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139893|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139894|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57139895|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
57139896|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139897|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139898|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57139899|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57139900|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
57139901|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57139902|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57139904|NCT05740371|Antithrombins|antithrombins|mesh-ancestor
57139905|NCT05740371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57139906|NCT05740371|Protease Inhibitors|protease inhibitors|mesh-ancestor
57139907|NCT05740371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139908|NCT05740371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139909|NCT05740371|Anticoagulants|anticoagulants|mesh-ancestor
57139910|NCT05740371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57139911|NCT02223949|Alprostadil|alprostadil|mesh-list
57139912|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57139913|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
57139914|NCT02223949|Urological Agents|urological agents|mesh-ancestor
57139915|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57139916|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57139917|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57139918|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139919|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139920|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57139921|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139922|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139923|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
57139924|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139925|NCT02691507|Decanoic acid|decanoic acid|mesh-list
57139926|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
57139928|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
57139929|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57139930|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57139931|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139932|NCT02151695|Aflibercept|aflibercept|mesh-list
57139933|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57139934|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57139935|NCT02151695|Growth Substances|growth substances|mesh-ancestor
57139936|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139937|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
57139938|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139939|NCT02151929|Everolimus|everolimus|mesh-list
57139940|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139941|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57139942|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
57139943|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139944|NCT03542357|Calcitonin|calcitonin|mesh-list
57139945|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
57139946|NCT03542357|Sumatriptan|sumatriptan|mesh-list
57139947|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
57139948|NCT03542357|Katacalcin|katacalcin|mesh-list
57139949|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57139950|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57139951|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57139952|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
57139953|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139954|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139955|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139956|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57139957|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57139958|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
57139959|NCT04811001|Osimertinib|osimertinib|mesh-list
57139960|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139961|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57139962|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139963|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139964|NCT02150993|Ritonavir|ritonavir|mesh-list
57139965|NCT02150993|Lopinavir|lopinavir|mesh-list
57139966|NCT02150993|Tenofovir|tenofovir|mesh-list
57139967|NCT02150993|Lamivudine|lamivudine|mesh-list
57139968|NCT02150993|Zidovudine|zidovudine|mesh-list
57139969|NCT02150993|Emtricitabine|emtricitabine|mesh-list
57139970|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
57139971|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
57139972|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57139973|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57139974|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
57139975|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139976|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139977|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57139978|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57139979|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
57139980|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139981|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57139982|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57139983|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57139984|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57139985|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
57139986|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57139987|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57139988|NCT02690727|Tenalisib|tenalisib|mesh-list
57139989|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
57139990|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139991|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139992|NCT02224105|Prednisolone|prednisolone|mesh-list
57139993|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57139994|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
57139995|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57139996|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
57139997|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57139998|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
57139999|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140000|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
57140001|NCT02224105|Hormones|hormones|mesh-ancestor
57140002|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140003|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140004|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57140005|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140006|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
57140007|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
57140008|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140009|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140010|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57140011|NCT02224105|Protective Agents|protective agents|mesh-ancestor
57140012|NCT02156375|Ustekinumab|ustekinumab|mesh-list
57140013|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
57140014|NCT04057131|Icatibant|icatibant|mesh-list
57140015|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57140016|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57140017|NCT04057131|Analgesics|analgesics|mesh-ancestor
57140018|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
57140019|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140020|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140021|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140022|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57140023|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
57140024|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
57140025|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140026|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57140027|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140028|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
57140029|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
57140030|NCT03542279|Hormones|hormones|mesh-ancestor
57140031|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140032|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140033|NCT02230735|Epinephrine|epinephrine|mesh-list
57140034|NCT02230735|Racepinephrine|racepinephrine|mesh-list
57140035|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
57140036|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57140037|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57140038|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
57140039|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140040|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140041|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140042|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57140043|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57140044|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
57140045|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140046|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57140047|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
57140048|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
57140049|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
57140050|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57140051|NCT02258581|Tenofovir|tenofovir|mesh-list
57140052|NCT02258581|Vesatolimod|vesatolimod|mesh-list
57140053|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
57140054|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140055|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57140056|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57140057|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140058|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140059|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57140060|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57140061|NCT05746377|Metoclopramide|metoclopramide|mesh-list
57140062|NCT05746377|Antiemetics|antiemetics|mesh-ancestor
57140063|NCT05746377|Autonomic Agents|autonomic agents|mesh-ancestor
57140064|NCT05746377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140065|NCT05746377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140066|NCT05746377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140067|NCT05746377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57140068|NCT05746377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57140069|NCT05746377|Dopamine Agents|dopamine agents|mesh-ancestor
57140070|NCT05746377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140071|NCT05746377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140072|NCT03165825|Dexamethasone|dexamethasone|mesh-list
57140073|NCT03165825|Betamethasone|betamethasone|mesh-list
57140074|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140075|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
57140076|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
57140077|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140078|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140079|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140080|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
57140081|NCT03165825|Hormones|hormones|mesh-ancestor
57140082|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140083|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57140084|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140085|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57140086|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
57140087|NCT03167853|Antibodies|antibodies|mesh-list
57140088|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57140089|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
57140090|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140091|NCT05704647|Nivolumab|nivolumab|mesh-list
57140092|NCT05704647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57140093|NCT05704647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140094|NCT05704647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57140095|NCT05704647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140096|NCT05746143|Zolpidem|zolpidem|mesh-list
57140097|NCT05746143|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57140098|NCT05746143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57140099|NCT05746143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57140100|NCT05746143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140101|NCT05746143|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57140102|NCT05746143|GABA Agonists|gaba agonists|mesh-ancestor
57140103|NCT05746143|GABA Agents|gaba agents|mesh-ancestor
57140104|NCT05746143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140105|NCT05746143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140106|NCT03165591|Vaccines|vaccines|mesh-list
57140107|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
57140108|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140109|NCT03114813|Carvedilol|carvedilol|mesh-list
57140110|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57140111|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57140112|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
57140113|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140114|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140115|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140116|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57140117|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
57140118|NCT03114813|Protective Agents|protective agents|mesh-ancestor
57140119|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57140120|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57140121|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57140122|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
57140123|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57140124|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57140125|NCT01358864|Interferons|interferons|mesh-list
57140126|NCT01358864|Ribavirin|ribavirin|mesh-list
57140127|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
57140128|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140129|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
57140130|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140131|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
57140132|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140133|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
57140134|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140135|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
57140136|NCT02750761|Tedizolid|tedizolid|mesh-list
57140137|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
57140138|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57140139|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140140|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57140141|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140142|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140143|NCT05746065|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57140144|NCT05746065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57140145|NCT05746065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57140146|NCT05746065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140147|NCT05746065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140148|NCT05746065|Antiviral Agents|antiviral agents|mesh-ancestor
57140149|NCT05746065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140151|NCT05746065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57140152|NCT02814019|Idebenone|idebenone|mesh-list
57140153|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
57140154|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140155|NCT02814019|Protective Agents|protective agents|mesh-ancestor
57140156|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140157|NCT05745987|Vaccines|vaccines|mesh-list
57140158|NCT05745987|Immunologic Factors|immunologic factors|mesh-ancestor
57140159|NCT05745987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140160|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
57140161|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
57140162|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57140163|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57140164|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140165|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140166|NCT03364244|Urological Agents|urological agents|mesh-ancestor
57140167|NCT03165123|Azithromycin|azithromycin|mesh-list
57140168|NCT03165123|Dexamethasone|dexamethasone|mesh-list
57140169|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140170|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
57140171|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
57140172|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140173|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140174|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140175|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
57140176|NCT03165123|Hormones|hormones|mesh-ancestor
57140177|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140178|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57140179|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140180|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57140181|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140182|NCT01131169|Vidarabine|vidarabine|mesh-list
57140183|NCT01131169|Fludarabine|fludarabine|mesh-list
57140184|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
57140185|NCT01131169|Melphalan|melphalan|mesh-list
57140186|NCT01131169|Busulfan|busulfan|mesh-list
57140187|NCT01131169|Lenograstim|lenograstim|mesh-list
57140188|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140189|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57140190|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
57140191|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140192|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140193|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
57140194|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140195|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
57140196|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140197|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57140198|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
57140199|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57140200|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57140201|NCT02688933|Insulin|insulin|mesh-list
57140202|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57140203|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
57140204|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57140205|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140206|NCT04372628|Ritonavir|ritonavir|mesh-list
57140207|NCT04372628|Lopinavir|lopinavir|mesh-list
57140208|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57140209|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57140210|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
57140211|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140212|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140213|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57140214|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57140215|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
57140216|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140217|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57140218|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57140219|NCT03626545|Docetaxel|docetaxel|mesh-list
57140220|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140221|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
57140222|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
57140223|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
57140224|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140225|NCT04230980|Gabapentin|gabapentin|mesh-list
57140226|NCT04230980|Analgesics|analgesics|mesh-ancestor
57140227|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
57140228|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140229|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140230|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
57140231|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57140232|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57140233|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57140234|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57140235|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57140236|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57140237|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140238|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140239|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
57140240|NCT00882505|Vitamin D|vitamin d|mesh-list
57140241|NCT00882505|Vitamins|vitamins|mesh-ancestor
57140242|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
57140243|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140244|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57140245|NCT03015740|Nivolumab|nivolumab|mesh-list
57140246|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57140247|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140248|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57140249|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140250|NCT04480359|Meloxicam|meloxicam|mesh-list
57140251|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57140252|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57140253|NCT04480359|Analgesics|analgesics|mesh-ancestor
57140254|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
57140255|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140256|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140257|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140258|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57140259|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57140260|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57140261|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140262|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140263|NCT03724825|Testosterone|testosterone|mesh-list
57140264|NCT03724825|Androgens|androgens|mesh-ancestor
57140265|NCT03724825|Hormones|hormones|mesh-ancestor
57140266|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140267|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140268|NCT04227704|Ketamine|ketamine|mesh-list
57140269|NCT04227704|Analgesics|analgesics|mesh-ancestor
57140270|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
57140271|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140272|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140273|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57140274|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57140275|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
57140276|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
57140277|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57140278|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57140279|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57140280|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140281|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140282|NCT03720613|Naloxegol|naloxegol|mesh-list
57140283|NCT03720613|Lubiprostone|lubiprostone|mesh-list
57140284|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57140285|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57140286|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140287|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57140288|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140289|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
57140290|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140291|NCT02709512|Cisplatin|cisplatin|mesh-list
57140292|NCT02709512|Pemetrexed|pemetrexed|mesh-list
57140293|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140294|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140295|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140296|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57140297|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57140298|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
57140299|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140300|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
57140301|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140302|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57140303|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57140304|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
57140305|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140306|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140307|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57140308|NCT03659929|Amphetamine|amphetamine|mesh-list
57140309|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57140310|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140311|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
57140312|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
57140313|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140314|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
57140315|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140316|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140317|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
57140318|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57140319|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57140320|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57140321|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57140322|NCT02811679|Blinatumomab|blinatumomab|mesh-list
57140323|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140324|NCT03448081|Calcipotriene|calcipotriene|mesh-list
57140325|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
57140326|NCT04721977|Capecitabine|capecitabine|mesh-list
57140327|NCT04721977|Trastuzumab|trastuzumab|mesh-list
57140328|NCT04721977|Tucatinib|tucatinib|mesh-list
57140329|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57140330|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
57140331|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140332|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140333|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57140334|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57140335|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140336|NCT02232607|Lacidipine|lacidipine|mesh-list
57140337|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57140338|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57140339|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57140340|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140341|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57140342|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140343|NCT02232685|Choline|choline|mesh-list
57140344|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
57140345|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57140346|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
57140347|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140348|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140349|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57140350|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
57140351|NCT02232763|Losartan|losartan|mesh-list
57140352|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57140353|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57140354|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57140355|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57140356|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140357|NCT04294784|Paclitaxel|paclitaxel|mesh-list
57140358|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57140359|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57140360|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57140361|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140362|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
57140363|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
57140364|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
57140365|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140366|NCT02262559|Telmisartan|telmisartan|mesh-list
57140367|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57140368|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57140369|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57140370|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140371|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
57140372|NCT05491460|Apixaban|apixaban|mesh-list
57140373|NCT05491460|Edoxaban|edoxaban|mesh-list
57140374|NCT05491460|Dabigatran|dabigatran|mesh-list
57140375|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57140376|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
57140377|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57140378|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
57140379|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140380|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140381|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
57140382|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
57140383|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57140384|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57140385|NCT02762929|Bupivacaine|bupivacaine|mesh-list
57140386|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
57140387|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
57140388|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57140389|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140390|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
57140391|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140392|NCT02262637|Telmisartan|telmisartan|mesh-list
57140393|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
57140394|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57140395|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57140396|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57140397|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140398|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57140399|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57140400|NCT02262637|Diuretics|diuretics|mesh-ancestor
57140401|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
57140402|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140403|NCT03301051|Vaccines|vaccines|mesh-list
57140404|NCT03301051|Immunologic Factors|immunologic factors|mesh-ancestor
57140405|NCT03301051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140406|NCT02606305|Bevacizumab|bevacizumab|mesh-list
57140407|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
57140408|NCT02606305|Carboplatin|carboplatin|mesh-list
57140409|NCT02606305|Doxorubicin|doxorubicin|mesh-list
57140410|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57140411|NCT02606305|Maytansine|maytansine|mesh-list
57140412|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57140413|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140414|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57140415|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57140416|NCT02606305|Growth Substances|growth substances|mesh-ancestor
57140417|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140418|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
57140419|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57140420|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57140421|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57140422|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140423|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140424|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57140425|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
57140426|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
57140427|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
57140428|NCT01662986|Bromides|bromides|mesh-list
57140429|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
57140430|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57140431|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
57140432|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140433|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140434|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57140435|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
57140436|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
57140437|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57140438|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
57140439|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140440|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140441|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
57140442|NCT05497232|Pancrelipase|pancrelipase|mesh-list
57140443|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140444|NCT04205630|Trastuzumab|trastuzumab|mesh-list
57140445|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57140446|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140447|NCT00054158|Thalidomide|thalidomide|mesh-list
57140448|NCT00054158|Dexamethasone|dexamethasone|mesh-list
57140450|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57140451|NCT00054158|Vincristine|vincristine|mesh-list
55730494|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
57140452|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140453|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
57140454|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
57140455|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140456|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140457|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140458|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
57140459|NCT00054158|Hormones|hormones|mesh-ancestor
57140460|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140461|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57140462|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140463|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57140464|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57140465|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57140466|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140467|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140468|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57140469|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
57140470|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
57140471|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
57140472|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140473|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
57140474|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
57140475|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57140476|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140477|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57140478|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57140479|NCT00054158|Growth Substances|growth substances|mesh-ancestor
57140480|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
57140481|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57140482|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
57140483|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140484|NCT05496764|Dexamethasone|dexamethasone|mesh-list
57140485|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140486|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
57140487|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
57140488|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140489|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140490|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140491|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
57140492|NCT05496764|Hormones|hormones|mesh-ancestor
57140493|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140494|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57140495|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140496|NCT05496530|Triamcinolone|triamcinolone|mesh-list
57140497|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57140498|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57140499|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57140500|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140501|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
57140502|NCT05496530|Hormones|hormones|mesh-ancestor
57140503|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140504|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140505|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140506|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
57140507|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140508|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140509|NCT02744833|Enoxaparin|enoxaparin|mesh-list
57140510|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
57140511|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
57140512|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57140513|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57140514|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140515|NCT02234869|Interferons|interferons|mesh-list
57140516|NCT02234869|Interferon-beta|interferon-beta|mesh-list
57140517|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
57140518|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
57140519|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140520|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
57140521|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140522|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
57140523|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140525|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
57140526|NCT05499026|Cathartics|cathartics|mesh-ancestor
57140527|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140528|NCT05498714|Lactulose|lactulose|mesh-list
57140529|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140530|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
57140531|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
57140532|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
57140533|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
57140534|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140535|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
57140536|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140537|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140538|NCT01338025|Lamivudine|lamivudine|mesh-list
57140539|NCT01338025|Emtricitabine|emtricitabine|mesh-list
57140540|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57140541|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57140542|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140543|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140544|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
57140545|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140546|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57140547|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57140548|NCT05498636|Prednisone|prednisone|mesh-list
57140549|NCT05498636|Etoposide|etoposide|mesh-list
57140550|NCT05498636|Lenalidomide|lenalidomide|mesh-list
57140551|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140552|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
57140553|NCT05498636|Hormones|hormones|mesh-ancestor
57140554|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140555|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140556|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57140557|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140558|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57140559|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57140560|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57140561|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140562|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140563|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
57140564|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57140565|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57140566|NCT05498636|Growth Substances|growth substances|mesh-ancestor
57140567|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
57140568|NCT02262715|Oseltamivir|oseltamivir|mesh-list
57140569|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
57140570|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140571|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140572|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140573|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
57140574|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57140575|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57140576|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57140577|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57140578|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140579|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
57140580|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140581|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140582|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57140583|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140584|NCT02588677|Riluzole|riluzole|mesh-list
57140585|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
57140586|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57140587|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57140588|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140589|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140590|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140591|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57140592|NCT02588677|Protective Agents|protective agents|mesh-ancestor
57140593|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
57140594|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
57140595|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57140596|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56822364|NCT01565837|Ipilimumab|ipilimumab|mesh-list
57140597|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140598|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140599|NCT05490680|Urological Agents|urological agents|mesh-ancestor
57140600|NCT04424420|Acetaminophen|acetaminophen|mesh-list
57140601|NCT04424420|Ibuprofen|ibuprofen|mesh-list
57140602|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57140603|NCT04424420|Analgesics|analgesics|mesh-ancestor
57140604|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
57140605|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140606|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140607|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
57140608|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57140609|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140610|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57140611|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57140612|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140613|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140614|NCT05495750|Bupivacaine|bupivacaine|mesh-list
57140615|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
57140616|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
57140617|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57140618|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140619|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
57140620|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140621|NCT02233075|Interferons|interferons|mesh-list
57140622|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
57140623|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
57140624|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57140625|NCT02233075|REP 2139|rep 2139|mesh-list
57140626|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140627|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
57140628|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140629|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
57140630|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140631|NCT04300244|Nivolumab|nivolumab|mesh-list
57140632|NCT04300244|Ipilimumab|ipilimumab|mesh-list
57140633|NCT04300244|Sargramostim|sargramostim|mesh-list
57140634|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57140635|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140636|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57140637|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140638|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
57140639|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140640|NCT02578771|Methylene Blue|methylene blue|mesh-list
57140641|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140642|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140643|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
57140644|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57140645|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
57140646|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
57140647|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140648|NCT02259595|Expectorants|expectorants|mesh-ancestor
57140649|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
57140650|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57140651|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
57140652|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140653|NCT02259595|Protective Agents|protective agents|mesh-ancestor
57140654|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140655|NCT02259595|Antidotes|antidotes|mesh-ancestor
57140656|NCT02804035|Furosemide|furosemide|mesh-list
57140657|NCT02804035|Diuretics|diuretics|mesh-ancestor
57140658|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
57140659|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140660|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57140661|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57140662|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140663|NCT02262793|Telmisartan|telmisartan|mesh-list
57140664|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57140665|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57140666|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57140667|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140668|NCT02559206|Linaclotide|linaclotide|mesh-list
57140669|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57140670|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
57140671|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140672|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140673|NCT05485766|Paclitaxel|paclitaxel|mesh-list
57140674|NCT05485766|Carboplatin|carboplatin|mesh-list
57140675|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
57140676|NCT05485766|Olaparib|olaparib|mesh-list
57140677|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57140678|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140679|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
57140680|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
57140681|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
57140682|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140683|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57140684|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57140685|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140686|NCT04402723|Cytarabine|cytarabine|mesh-list
57140687|NCT04402723|Daunorubicin|daunorubicin|mesh-list
57140688|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57140689|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
57140690|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140691|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140692|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
57140693|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140694|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140695|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
57140696|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140697|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57140698|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57140699|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57140700|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140701|NCT02235337|Riboflavin|riboflavin|mesh-list
57140702|NCT02235337|Vitamins|vitamins|mesh-ancestor
57140703|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
57140704|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140705|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
57140706|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57140707|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
57140708|NCT02233231|Varenicline|varenicline|mesh-list
57140709|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57140710|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57140711|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
57140712|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140713|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140714|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140715|NCT02263027|Vaccines|vaccines|mesh-list
57140716|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
57140717|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140718|NCT02263105|Temozolomide|temozolomide|mesh-list
57140719|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57140720|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
57140721|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140722|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140723|NCT05485064|Fentanyl|fentanyl|mesh-list
57140724|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57140725|NCT05485064|Narcotics|narcotics|mesh-ancestor
57140726|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57140727|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140728|NCT05485064|Analgesics|analgesics|mesh-ancestor
57140729|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
57140730|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140731|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57140732|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57140733|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
57140734|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
57140735|NCT05626153|Anesthetics|anesthetics|mesh-list
57140736|NCT05626153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57140737|NCT05626153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140738|NCT02553343|Vaccines|vaccines|mesh-list
57140739|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
57140740|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140741|NCT02235415|Lacidipine|lacidipine|mesh-list
57140742|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57140743|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57140744|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57140745|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140746|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57140747|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140748|NCT03995017|Nivolumab|nivolumab|mesh-list
57140749|NCT03995017|Ramucirumab|ramucirumab|mesh-list
57140750|NCT03995017|Rucaparib|rucaparib|mesh-list
57140751|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57140752|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140753|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57140754|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140755|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57140756|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140757|NCT02558894|Durvalumab|durvalumab|mesh-list
57140758|NCT02558894|Tremelimumab|tremelimumab|mesh-list
57140759|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57140760|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57140761|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140762|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
57140763|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140764|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57140765|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140766|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140767|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140768|NCT02233387|Imidazole|imidazole|mesh-list
57140769|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140770|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140771|NCT02521285|Aspirin|aspirin|mesh-list
57140772|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57140773|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57140774|NCT02521285|Analgesics|analgesics|mesh-ancestor
57140775|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
57140776|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140777|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140778|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140779|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57140780|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57140781|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57140782|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140783|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57140784|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57140785|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140786|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
57140787|NCT02510599|Solithromycin|solithromycin|mesh-list
57140788|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57140789|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140790|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
57140791|NCT02235805|Cathartics|cathartics|mesh-ancestor
57140792|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57140793|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57140794|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57140795|NCT02688387|Ambrisentan|ambrisentan|mesh-list
57140796|NCT02688387|Tadalafil|tadalafil|mesh-list
57140797|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
57140798|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57140799|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57140800|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140801|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140802|NCT02688387|Urological Agents|urological agents|mesh-ancestor
57140803|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57140804|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
57140805|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57140806|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57140807|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140808|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57140809|NCT05489900|Analgesics|analgesics|mesh-ancestor
57140810|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
57140811|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140812|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57140813|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57140814|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57140815|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
57140816|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140817|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140818|NCT05542849|Acarbose|acarbose|mesh-list
57140819|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57140820|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140821|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140822|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57140824|NCT05489666|Vitamin D|vitamin d|mesh-list
57140825|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
57140826|NCT05489666|Vitamins|vitamins|mesh-ancestor
57140827|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
57140828|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140829|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57140830|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57140831|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57140832|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140833|NCT05483894|Atorvastatin|atorvastatin|mesh-list
57140834|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57140835|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57140836|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
57140837|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140838|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57140839|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57140840|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140841|NCT01621243|Gemcitabine|gemcitabine|mesh-list
57140842|NCT01621243|Paclitaxel|paclitaxel|mesh-list
57140843|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57140844|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57140845|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140846|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
57140847|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
57140848|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
57140849|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140850|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57140851|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
57140852|NCT01621243|Antiviral Agents|antiviral agents|mesh-ancestor
57140853|NCT01621243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140854|NCT01621243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140855|NCT01621243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140856|NCT01621243|Immunologic Factors|immunologic factors|mesh-ancestor
57140857|NCT01621243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140858|NCT04076761|Trifluridine|trifluridine|mesh-list
57140859|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
57140860|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140861|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
57140862|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140863|NCT04046887|Gemcitabine|gemcitabine|mesh-list
57140864|NCT04046887|Paclitaxel|paclitaxel|mesh-list
57140865|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57140866|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140867|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
57140868|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
57140869|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
57140870|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140871|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57140872|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
57140873|NCT04046887|Antiviral Agents|antiviral agents|mesh-ancestor
57140874|NCT04046887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140875|NCT04046887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140876|NCT04046887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140877|NCT04046887|Immunologic Factors|immunologic factors|mesh-ancestor
57140878|NCT04046887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140879|NCT02235961|Liraglutide|liraglutide|mesh-list
57140880|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57140881|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140882|NCT02235961|Incretins|incretins|mesh-ancestor
57140883|NCT02235961|Hormones|hormones|mesh-ancestor
57140884|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140885|NCT01610245|Oseltamivir|oseltamivir|mesh-list
57140886|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
57140887|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
57140888|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140889|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140890|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140891|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57140892|NCT04138628|Atezolizumab|atezolizumab|mesh-list
57140893|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140894|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
57140895|NCT04138394|Vitamins|vitamins|mesh-ancestor
57140896|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
57140897|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140898|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
57140899|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140900|NCT04138394|Protective Agents|protective agents|mesh-ancestor
57140901|NCT02741791|Bupropion|bupropion|mesh-list
57140902|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57140903|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
57140904|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57140905|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57140906|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57140907|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57140908|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140909|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
57140910|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57140911|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140912|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57140913|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57140914|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140915|NCT05436535|Triamcinolone|triamcinolone|mesh-list
57140916|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57140917|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57140918|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57140919|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57140920|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
57140921|NCT05436535|Hormones|hormones|mesh-ancestor
57140922|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57140923|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140924|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140925|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
57140926|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140927|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140928|NCT04275518|Cytarabine|cytarabine|mesh-list
57140929|NCT04275518|Azacitidine|azacitidine|mesh-list
57140930|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57140931|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
57140932|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140933|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140934|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
57140935|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140936|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140937|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
57140938|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140939|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140940|NCT02263495|Gemcitabine|gemcitabine|mesh-list
57140941|NCT02263495|Paclitaxel|paclitaxel|mesh-list
57140942|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57140943|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140944|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
57140945|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
57140946|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
57140947|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140948|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57140949|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
57140950|NCT02263495|Antiviral Agents|antiviral agents|mesh-ancestor
57140951|NCT02263495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140952|NCT02263495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140953|NCT02263495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140954|NCT02263495|Immunologic Factors|immunologic factors|mesh-ancestor
57140955|NCT02263495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140956|NCT02687451|Oxymorphone|oxymorphone|mesh-list
57140957|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57140958|NCT02687451|Narcotics|narcotics|mesh-ancestor
57140959|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57140960|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140961|NCT02687451|Analgesics|analgesics|mesh-ancestor
57140962|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
57140963|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57140964|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57140965|NCT02557646|Ribavirin|ribavirin|mesh-list
57140966|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57140967|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
57140968|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140969|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
57140970|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140971|NCT03859687|Vitamins|vitamins|mesh-list
57140972|NCT03859687|Vitamin A|vitamin a|mesh-list
57140973|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
57140975|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57140976|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
57140977|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140978|NCT03859687|Protective Agents|protective agents|mesh-ancestor
57140979|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57140980|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140981|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
57140982|NCT02679573|Linezolid|linezolid|mesh-list
57140983|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57140984|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57140985|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57140986|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57140987|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57140988|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140989|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140990|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57140991|NCT05493332|Leucovorin|leucovorin|mesh-list
57140992|NCT05493332|Fluorouracil|fluorouracil|mesh-list
57140993|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
57140994|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
57140995|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57140996|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57140997|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57140998|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57140999|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
57141000|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141001|NCT05493332|Antidotes|antidotes|mesh-ancestor
57141002|NCT05493332|Protective Agents|protective agents|mesh-ancestor
57141003|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
57141004|NCT05493332|Vitamins|vitamins|mesh-ancestor
57141005|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
57141006|NCT01591447|Solithromycin|solithromycin|mesh-list
57141007|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141008|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141009|NCT01578655|Prednisone|prednisone|mesh-list
57141010|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141011|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
57141012|NCT01578655|Hormones|hormones|mesh-ancestor
57141013|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141014|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141015|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57141016|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141017|NCT03965234|Cisplatin|cisplatin|mesh-list
57141018|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141019|NCT05361447|Diazepam|diazepam|mesh-list
57141020|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57141021|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
57141022|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
57141023|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
57141024|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141025|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141026|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141027|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57141028|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57141029|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57141030|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57141031|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57141032|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57141033|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57141034|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57141035|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
57141036|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
57141037|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
57141038|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
57141039|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141040|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141041|NCT01577173|Cetuximab|cetuximab|mesh-list
57141042|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57141043|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141044|NCT01573351|Interferons|interferons|mesh-list
57141045|NCT01573351|Ribavirin|ribavirin|mesh-list
57141046|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
57141047|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
57141048|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57141049|NCT01573351|Asunaprevir|asunaprevir|mesh-list
57141050|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141051|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
57141052|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141053|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
57141054|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141055|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
57141056|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141057|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
57141058|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141059|NCT02685033|Dalbavancin|dalbavancin|mesh-list
57141060|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141061|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141062|NCT05579223|Hydromorphone|hydromorphone|mesh-list
57141063|NCT05579223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57141064|NCT05579223|Narcotics|narcotics|mesh-ancestor
57141065|NCT05579223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57141066|NCT05579223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141067|NCT05579223|Analgesics|analgesics|mesh-ancestor
57141068|NCT05579223|Sensory System Agents|sensory system agents|mesh-ancestor
57141069|NCT05579223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141070|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
57141071|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
57141072|NCT00258427|Busulfan|busulfan|mesh-list
57141073|NCT00258427|Fludarabine|fludarabine|mesh-list
57141074|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
57141075|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57141076|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141077|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
57141078|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141079|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141080|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57141081|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
57141082|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141083|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141084|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57141085|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57141086|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
57141087|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141088|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
57141089|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
57141090|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141091|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141092|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
57141093|NCT00258427|Hormones|hormones|mesh-ancestor
57141094|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141095|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57141096|NCT00258427|Protective Agents|protective agents|mesh-ancestor
57141097|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
57141098|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57141099|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57141100|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141101|NCT05215951|Osimertinib|osimertinib|mesh-list
57141102|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141103|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57141104|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141105|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141106|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57141107|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57141108|NCT02233621|Estradiol|estradiol|mesh-list
57141109|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57141110|NCT02233621|Estrogens|estrogens|mesh-ancestor
57141111|NCT02233621|Hormones|hormones|mesh-ancestor
57141112|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141113|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141114|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57141115|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
57141116|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57141117|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57141118|NCT02557100|Adalimumab|adalimumab|mesh-list
57141119|NCT02557100|Methotrexate|methotrexate|mesh-list
57141120|NCT02557100|Abatacept|abatacept|mesh-list
57141121|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57141122|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
57141123|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57141124|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141125|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57141126|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
57141127|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141129|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
57141130|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141131|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57141132|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141133|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
57141134|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141135|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57141136|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141137|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57141138|NCT02233777|Pregabalin|pregabalin|mesh-list
57141139|NCT02233777|Analgesics|analgesics|mesh-ancestor
57141140|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
57141141|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141142|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141143|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
57141144|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57141145|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57141146|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141147|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57141148|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57141149|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57141150|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57141151|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57141152|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57141153|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57141154|NCT01520545|Baclofen|baclofen|mesh-list
57141155|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57141156|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141157|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57141158|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141159|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57141160|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
57141161|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
57141162|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141163|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141164|NCT05488106|Riboflavin|riboflavin|mesh-list
57141165|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
57141166|NCT05488106|Vitamins|vitamins|mesh-ancestor
57141167|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
57141168|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141169|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57141170|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
57141171|NCT05492318|Clarithromycin|clarithromycin|mesh-list
57141172|NCT05492318|Midazolam|midazolam|mesh-list
57141173|NCT05492318|Dabigatran|dabigatran|mesh-list
57141174|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
57141175|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57141176|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57141177|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57141178|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141179|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57141180|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57141181|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57141182|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57141183|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
57141184|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
57141185|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
57141186|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
57141187|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141188|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141189|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141190|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141191|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57141192|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141193|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57141194|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57141195|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
57141196|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57141197|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
57141198|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
57141199|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57141200|NCT01337635|Vitamin D|vitamin d|mesh-list
57141201|NCT01337635|Vitamins|vitamins|mesh-ancestor
57141202|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
57141203|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141204|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57141206|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
57141207|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141208|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57141209|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57141210|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141211|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141212|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57141213|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
57141214|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141215|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141216|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57141217|NCT02261779|Tretinoin|tretinoin|mesh-list
57141218|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
57141219|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141220|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
57141221|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
57141222|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
57141223|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57141224|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57141225|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141226|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141227|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57141228|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57141229|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57141230|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141231|NCT05157685|Azithromycin|azithromycin|mesh-list
57141232|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141233|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141234|NCT02556632|Curcumin|curcumin|mesh-list
57141235|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57141236|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57141237|NCT02556632|Analgesics|analgesics|mesh-ancestor
57141238|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
57141239|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141240|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141241|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141242|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141243|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141244|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141245|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141246|NCT05491928|Tempol|tempol|mesh-list
57141247|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
57141248|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141249|NCT05491928|Protective Agents|protective agents|mesh-ancestor
57141250|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141251|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57141252|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141253|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57141254|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57141255|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
57141256|NCT05487794|Testosterone|testosterone|mesh-list
57141257|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
57141258|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
57141259|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57141260|NCT05487794|Androgens|androgens|mesh-ancestor
57141261|NCT05487794|Hormones|hormones|mesh-ancestor
57141262|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141263|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141264|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57141265|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141266|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
57141267|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
57141268|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141269|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141270|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57141271|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57141272|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141273|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141274|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141275|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56823039|NCT00222729|Bevacizumab|bevacizumab|mesh-list
57141276|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57141278|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57141279|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141280|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57141281|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141282|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141283|NCT05491694|Paclitaxel|paclitaxel|mesh-list
57141284|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
57141285|NCT05491694|Carboplatin|carboplatin|mesh-list
57141286|NCT05491694|Epirubicin|epirubicin|mesh-list
57141287|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57141288|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141289|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
57141290|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
57141291|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
57141292|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141293|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141294|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
57141295|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141296|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141297|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57141298|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
57141299|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57141300|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57141301|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57141302|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57141303|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141304|NCT05105035|Meropenem|meropenem|mesh-list
57141305|NCT05105035|Ceftazidime|ceftazidime|mesh-list
57141306|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141307|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141308|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
57141309|NCT01501513|Laxatives|laxatives|mesh-ancestor
57141310|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141311|NCT05480072|Palmidrol|palmidrol|mesh-list
57141312|NCT05480072|Analgesics|analgesics|mesh-ancestor
57141313|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
57141314|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141315|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141316|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57141317|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57141318|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141319|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141320|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
57141321|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141322|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57141323|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57141324|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141325|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141326|NCT05480072|Hormones|hormones|mesh-ancestor
57141327|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141328|NCT01499563|Risperidone|risperidone|mesh-list
57141329|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57141330|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
57141331|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141332|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141333|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141334|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57141335|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57141336|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57141337|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57141338|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57141339|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
57141340|NCT05479916|Caseins|caseins|mesh-list
57141341|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
57141342|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
57141343|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141344|NCT03922880|Nivolumab|nivolumab|mesh-list
57141345|NCT03922880|Ipilimumab|ipilimumab|mesh-list
57141346|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57141347|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141348|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57141349|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141350|NCT02264119|Pantoprazole|pantoprazole|mesh-list
57141351|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57141352|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141353|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57141354|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141355|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141356|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
57141357|NCT02262481|Progestins|progestins|mesh-ancestor
57141358|NCT02262481|Hormones|hormones|mesh-ancestor
55730798|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
57141359|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141360|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141361|NCT01435369|Pidilizumab|pidilizumab|mesh-list
57141362|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57141363|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141364|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57141365|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57141366|NCT01252693|Goserelin|goserelin|mesh-list
57141367|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57141368|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141369|NCT03980509|Curcumin|curcumin|mesh-list
57141370|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57141371|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57141372|NCT03980509|Analgesics|analgesics|mesh-ancestor
57141373|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
57141374|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141375|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141376|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141377|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141378|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141379|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141380|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141381|NCT01486849|Riluzole|riluzole|mesh-list
57141382|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
57141383|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57141384|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57141385|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141386|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141387|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141388|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57141389|NCT01486849|Protective Agents|protective agents|mesh-ancestor
57141390|NCT01484119|Cetirizine|cetirizine|mesh-list
57141391|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57141392|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57141393|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57141394|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
57141395|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
57141396|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141397|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141398|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141399|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57141400|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
57141401|NCT01482403|Ribavirin|ribavirin|mesh-list
57141402|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
57141403|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141404|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
57141405|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141406|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
57141407|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141408|NCT01481077|Latanoprost|latanoprost|mesh-list
57141409|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57141410|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57141411|NCT02268409|Luspatercept|luspatercept|mesh-list
57141412|NCT02268409|Hematinics|hematinics|mesh-ancestor
57141413|NCT02268487|Sertraline|sertraline|mesh-list
57141414|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
57141415|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57141416|NCT02268487|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57141417|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57141418|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57141419|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141420|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141421|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
57141422|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141423|NCT02265289|Clopidogrel|clopidogrel|mesh-list
57141424|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56823181|NCT00266630|Carbamazepine|carbamazepine|mesh-list
57141425|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57141426|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57141427|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57141428|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
57141429|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141430|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730799|NCT03783091|Vitamins|vitamins|mesh-ancestor
57141431|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141432|NCT02265445|beta-Lactams|beta-lactams|mesh-list
57141433|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141434|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141435|NCT04476121|Aspirin|aspirin|mesh-list
57141436|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57141437|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57141438|NCT04476121|Analgesics|analgesics|mesh-ancestor
57141439|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
57141440|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141441|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141442|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141443|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141444|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57141445|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57141446|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141447|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57141448|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57141449|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141450|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
57141451|NCT01234519|Doxorubicin|doxorubicin|mesh-list
57141452|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57141453|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141454|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57141455|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57141456|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141457|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141458|NCT01474135|Travoprost|travoprost|mesh-list
57141459|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57141460|NCT02268565|Aspirin|aspirin|mesh-list
57141461|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
57141462|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57141463|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57141464|NCT02268565|Analgesics|analgesics|mesh-ancestor
57141465|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
57141466|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141467|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141468|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141469|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57141470|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57141471|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141472|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57141473|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57141474|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141475|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
57141476|NCT05479448|Prednisone|prednisone|mesh-list
57141477|NCT05479448|Hormones|hormones|mesh-list
57141478|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141479|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
57141480|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141481|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141482|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57141483|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141484|NCT02264587|Domperidone|domperidone|mesh-list
57141485|NCT02264587|Mosapride|mosapride|mesh-list
57141486|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
57141487|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
57141488|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141489|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141490|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141491|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57141492|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
57141493|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141494|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141495|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57141496|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
57141497|NCT05475080|Anticoagulants|anticoagulants|mesh-list
57141498|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
57141499|NCT02264665|Everolimus|everolimus|mesh-list
57141500|NCT02264665|Sunitinib|sunitinib|mesh-list
57141501|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141502|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141503|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
57141504|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141505|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55730800|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
57141506|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57141507|NCT02264665|Growth Substances|growth substances|mesh-ancestor
57141508|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
57141509|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57141510|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141511|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141512|NCT02683941|Lanreotide|lanreotide|mesh-list
57141513|NCT02683941|Somatostatin|somatostatin|mesh-list
57141514|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141515|NCT02683941|Hormones|hormones|mesh-ancestor
57141516|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141517|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141518|NCT05232123|Cannabidiol|cannabidiol|mesh-list
57141519|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
57141520|NCT01225393|Adalimumab|adalimumab|mesh-list
57141521|NCT01225393|Methotrexate|methotrexate|mesh-list
57141522|NCT01225393|Leflunomide|leflunomide|mesh-list
57141523|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57141524|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
57141525|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57141526|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141527|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57141528|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
57141529|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141530|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141531|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
57141532|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141533|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57141534|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141535|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
57141536|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141537|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57141538|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141539|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57141540|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57141541|NCT02264743|Estradiol|estradiol|mesh-list
57141542|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57141543|NCT02264743|Estrogens|estrogens|mesh-ancestor
57141544|NCT02264743|Hormones|hormones|mesh-ancestor
57141545|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141546|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141547|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57141548|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
57141549|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57141550|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57141551|NCT01220947|Ritonavir|ritonavir|mesh-list
57141552|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57141553|NCT01220947|Lactams|lactams|mesh-list
57141554|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57141555|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57141556|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
57141557|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141558|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141559|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57141560|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57141561|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
57141562|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141563|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57141564|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57141565|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141566|NCT03953833|Antibodies|antibodies|mesh-list
57141567|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57141568|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
57141569|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141570|NCT01393639|Prednisone|prednisone|mesh-list
57141571|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141572|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
57141573|NCT01393639|Hormones|hormones|mesh-ancestor
57141574|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141575|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141576|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57141577|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141578|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
57141580|NCT01379209|Methotrexate|methotrexate|mesh-list
57141581|NCT01379209|KRN 7000|krn 7000|mesh-list
57141582|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
57141583|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57141584|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
57141585|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57141586|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141587|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57141588|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
57141589|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141590|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141591|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
57141592|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141593|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57141594|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141595|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
57141596|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141597|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57141598|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57141599|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57141600|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
57141601|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141602|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141603|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
57141604|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57141605|NCT02913482|Risdiplam|risdiplam|mesh-list
57141606|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57141607|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141608|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141609|NCT01204099|Docetaxel|docetaxel|mesh-list
57141610|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141611|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
57141612|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
57141613|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
57141614|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141615|NCT02853500|Doxorubicin|doxorubicin|mesh-list
57141616|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57141617|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141618|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57141619|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57141620|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141621|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141622|NCT01188187|Dexamethasone|dexamethasone|mesh-list
57141623|NCT01188187|Prednisone|prednisone|mesh-list
57141624|NCT01188187|Docetaxel|docetaxel|mesh-list
57141625|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141626|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
57141627|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
57141628|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141629|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141630|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141631|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
57141632|NCT01188187|Hormones|hormones|mesh-ancestor
57141633|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141634|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57141635|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141636|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
57141637|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
57141638|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
57141639|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141640|NCT05478356|Atropine|atropine|mesh-list
57141641|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57141642|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57141643|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57141644|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57141645|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57141646|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
57141647|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823407|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141648|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141649|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57141650|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
57141651|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
57141652|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
57141653|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57141654|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57141655|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
57141656|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141657|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141658|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57141659|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141660|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57141661|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141662|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141663|NCT01175785|Cyclosporine|cyclosporine|mesh-list
57141664|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
57141665|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
57141666|NCT01175785|Fludarabine|fludarabine|mesh-list
57141667|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
57141668|NCT01175785|Cyclosporins|cyclosporins|mesh-list
57141669|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141670|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
57141671|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141672|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141673|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57141674|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
57141675|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141676|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141677|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57141678|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57141679|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
57141680|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141681|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
57141682|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141683|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
57141684|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57141685|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57141686|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57141687|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
57141688|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141689|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
57141690|NCT05478044|Vitamins|vitamins|mesh-ancestor
57141691|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
57141692|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141693|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
57141694|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141695|NCT05478044|Protective Agents|protective agents|mesh-ancestor
57141696|NCT05472506|Nivolumab|nivolumab|mesh-list
57141697|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57141698|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141699|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57141700|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141701|NCT01445899|Ranibizumab|ranibizumab|mesh-list
57141702|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57141703|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57141704|NCT01445899|Growth Substances|growth substances|mesh-ancestor
57141705|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141706|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
57141707|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141708|NCT04475029|Morphine|morphine|mesh-list
57141709|NCT04475029|Methadone|methadone|mesh-list
57141710|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57141711|NCT04475029|Narcotics|narcotics|mesh-ancestor
57141712|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57141713|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141714|NCT04475029|Analgesics|analgesics|mesh-ancestor
57141715|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
57141716|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141717|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
57141718|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
57141719|NCT03649724|Leuprolide|leuprolide|mesh-list
57141720|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57141721|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
57141722|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57141723|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823484|NCT00203294|Hormones|hormones|mesh-ancestor
57141724|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57141725|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141726|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
57141727|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57141728|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57141729|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57141730|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57141731|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141732|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
57141733|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141734|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141735|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57141736|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141738|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57141739|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141740|NCT02551874|Metformin|metformin|mesh-list
57141741|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
57141742|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
57141743|NCT02551874|Saxagliptin|saxagliptin|mesh-list
57141744|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57141745|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141746|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57141747|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141748|NCT02551874|Incretins|incretins|mesh-ancestor
57141749|NCT02551874|Hormones|hormones|mesh-ancestor
57141750|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141751|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57141752|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
57141753|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141754|NCT03646604|Upadacitinib|upadacitinib|mesh-list
57141755|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57141756|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57141757|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141758|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141759|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141760|NCT01354717|Fluorouracil|fluorouracil|mesh-list
57141761|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
57141762|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141763|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57141764|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141765|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141766|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
57141767|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141768|NCT01072981|Gemcitabine|gemcitabine|mesh-list
57141769|NCT01072981|Fluorouracil|fluorouracil|mesh-list
57141770|NCT01072981|Pancrelipase|pancrelipase|mesh-list
57141771|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
57141772|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57141773|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
57141774|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141775|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141776|NCT01072981|Antiviral Agents|antiviral agents|mesh-ancestor
57141777|NCT01072981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141778|NCT01072981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141779|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141780|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141781|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141782|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57141783|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
57141784|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57141785|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
57141786|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141787|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
57141788|NCT03347708|Protective Agents|protective agents|mesh-ancestor
57141789|NCT01159249|Vildagliptin|vildagliptin|mesh-list
57141790|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57141791|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141792|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57141793|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
57141794|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141795|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141796|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
57141797|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57141798|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141799|NCT01345045|Pregabalin|pregabalin|mesh-list
57141800|NCT01345045|Analgesics|analgesics|mesh-ancestor
57141801|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
57141802|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141803|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141804|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
57141805|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55731184|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141806|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57141807|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141808|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57141809|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57141810|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57141811|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57141812|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57141813|NCT01344187|Riboflavin|riboflavin|mesh-list
57141814|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57141815|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
57141816|NCT01344187|Vitamins|vitamins|mesh-ancestor
57141817|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
57141818|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141819|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57141820|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
57141821|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57141822|NCT01338883|Efavirenz|efavirenz|mesh-list
57141823|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
57141824|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57141825|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57141826|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141827|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141828|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
57141829|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141830|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57141831|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57141832|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57141833|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57141834|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57141835|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57141836|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57141837|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57141838|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57141839|NCT05625919|Sirolimus|sirolimus|mesh-list
57141840|NCT05625919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141841|NCT05625919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141842|NCT05625919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57141843|NCT05625919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141844|NCT05625919|Antifungal Agents|antifungal agents|mesh-ancestor
57141845|NCT05625919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141846|NCT05625919|Immunologic Factors|immunologic factors|mesh-ancestor
57141847|NCT05625919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141848|NCT02682927|Fenfluramine|fenfluramine|mesh-list
57141849|NCT02682927|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57141850|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57141851|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57141852|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141853|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141854|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
57141855|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141856|NCT02266537|Doxazosin|doxazosin|mesh-list
57141857|NCT02266537|Tamsulosin|tamsulosin|mesh-list
57141858|NCT02266537|Alfuzosin|alfuzosin|mesh-list
57141859|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57141860|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57141861|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57141862|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
57141863|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141864|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141865|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141866|NCT02266537|Urological Agents|urological agents|mesh-ancestor
57141867|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57141868|NCT02269735|Insulin|insulin|mesh-list
57141869|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57141870|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
56823639|NCT01097278|Vitamin D|vitamin d|mesh-list
57141872|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57141873|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141874|NCT05625373|Vancomycin|vancomycin|mesh-list
57141875|NCT05625373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57141876|NCT05625373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141877|NCT01038739|Mesalamine|mesalamine|mesh-list
57141878|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57141879|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57141880|NCT01038739|Analgesics|analgesics|mesh-ancestor
57141881|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
57141882|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141883|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141884|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141885|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141886|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
57141887|NCT05478837|Fludarabine|fludarabine|mesh-list
57141888|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141889|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
57141890|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141891|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141892|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57141893|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
57141894|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141895|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141896|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57141897|NCT01336465|Etrolizumab|etrolizumab|mesh-list
57141898|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141899|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
57141900|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141901|NCT03315026|Siltuximab|siltuximab|mesh-list
57141902|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141903|NCT02769065|Donepezil|donepezil|mesh-list
57141904|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57141905|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57141906|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141907|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
57141908|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57141909|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141910|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
57141911|NCT02540954|Aflibercept|aflibercept|mesh-list
57141912|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57141913|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57141914|NCT02540954|Growth Substances|growth substances|mesh-ancestor
57141915|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141916|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
57141917|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141918|NCT05265975|Rituximab|rituximab|mesh-list
57141919|NCT05265975|Lenalidomide|lenalidomide|mesh-list
57141920|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57141921|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141922|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
57141923|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141924|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141925|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57141926|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57141927|NCT05265975|Growth Substances|growth substances|mesh-ancestor
57141928|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
57141929|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
57141930|NCT05451849|Fludarabine|fludarabine|mesh-list
57141931|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57141932|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
57141933|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141934|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57141935|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57141936|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
57141937|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141938|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141939|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57141940|NCT02151305|Remifentanil|remifentanil|mesh-list
57141941|NCT02151305|Propofol|propofol|mesh-list
57141942|NCT02151305|Sevoflurane|sevoflurane|mesh-list
57141943|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57141944|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57141945|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141946|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57141947|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
57141948|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
57141949|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57141950|NCT02151305|Narcotics|narcotics|mesh-ancestor
57141951|NCT02151305|Analgesics|analgesics|mesh-ancestor
57141952|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
57141953|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141954|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57141955|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57141956|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
57141957|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57141958|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
57141959|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57141960|NCT03164421|Expectorants|expectorants|mesh-ancestor
57141961|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
57141962|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57141963|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
57141964|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57141965|NCT03164421|Protective Agents|protective agents|mesh-ancestor
57141966|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141967|NCT03164421|Antidotes|antidotes|mesh-ancestor
57141968|NCT05476952|Rocuronium|rocuronium|mesh-list
57141969|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57141970|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57141971|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57141972|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141973|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141974|NCT05228613|Vaccines|vaccines|mesh-list
57141975|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
57141976|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141977|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57141978|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57141979|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141980|NCT02628704|Dexamethasone|dexamethasone|mesh-list
57141981|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57141982|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
57141983|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
57141984|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141985|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141986|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57141987|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
57141988|NCT02628704|Hormones|hormones|mesh-ancestor
57141989|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57141990|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57141991|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57141992|NCT02152475|Curcumin|curcumin|mesh-list
57141993|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57141994|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57141995|NCT02152475|Analgesics|analgesics|mesh-ancestor
57141996|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
57141997|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57141998|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57141999|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142000|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57142001|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142002|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142003|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142004|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
57142005|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57142006|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142007|NCT03161457|Rituximab|rituximab|mesh-list
57142008|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57142009|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142010|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
57142011|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142012|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57142013|NCT02576912|Dronabinol|dronabinol|mesh-list
57142014|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
57142015|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142016|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57142017|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57142018|NCT02576912|Analgesics|analgesics|mesh-ancestor
57142019|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
57142020|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142021|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57142022|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57142023|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142024|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142025|NCT02576912|Hormones|hormones|mesh-ancestor
57142026|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142027|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57142028|NCT02159573|Natalizumab|natalizumab|mesh-list
57142029|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
57142030|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142031|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
57142032|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57142033|NCT02152709|Vaccines|vaccines|mesh-list
57142034|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
57142035|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142036|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
57142037|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
57142038|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57142039|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142040|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57142041|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57142042|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142043|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142044|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142045|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142046|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
57142047|NCT03164109|Protective Agents|protective agents|mesh-ancestor
57142048|NCT02152787|Propofol|propofol|mesh-list
57142049|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57142050|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57142051|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142052|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57142053|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
57142054|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
57142055|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
57142056|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
57142057|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142058|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57142059|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142060|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142061|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
57142062|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57142063|NCT02765399|Liraglutide|liraglutide|mesh-list
57142064|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57142065|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142066|NCT02765399|Incretins|incretins|mesh-ancestor
57142067|NCT02765399|Hormones|hormones|mesh-ancestor
57142068|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142069|NCT03970304|Vaccines|vaccines|mesh-list
57142070|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
57142071|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142072|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
57142073|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57142074|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57142075|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57142076|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57142077|NCT01037179|Analgesics|analgesics|mesh-ancestor
57142078|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
57142079|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142080|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142081|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142082|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57142083|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57142084|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57142085|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57142086|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
57142087|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
57142088|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142089|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142090|NCT02269969|Tobramycin|tobramycin|mesh-list
57142091|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57142092|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142093|NCT03555578|Leuprolide|leuprolide|mesh-list
57142094|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57142095|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
57142096|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142097|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142098|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57142099|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142100|NCT03232424|Temozolomide|temozolomide|mesh-list
57142101|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57142102|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
57142103|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142104|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142105|NCT02484404|Durvalumab|durvalumab|mesh-list
57142106|NCT02484404|Olaparib|olaparib|mesh-list
57142107|NCT02484404|Cediranib|cediranib|mesh-list
57142108|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57142109|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142110|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57142111|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142112|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142113|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57142114|NCT03163407|Norepinephrine|norepinephrine|mesh-list
57142115|NCT03163407|Ephedrine|ephedrine|mesh-list
57142116|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57142117|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57142118|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
57142119|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142120|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142121|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142122|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
57142123|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
57142124|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142125|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57142126|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57142127|NCT02547974|Vaccines|vaccines|mesh-list
57142128|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
57142129|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142130|NCT00154297|Everolimus|everolimus|mesh-list
57142131|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142132|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57142133|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
57142134|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142135|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
57142136|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57142137|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57142138|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142139|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57142140|NCT02270281|Analgesics|analgesics|mesh-ancestor
57142141|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
57142142|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142143|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57142144|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57142145|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57142146|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
57142147|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142148|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142149|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57142150|NCT01033123|Iniparib|iniparib|mesh-list
57142151|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142152|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142153|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142154|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
57142155|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
57142156|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142157|NCT03163173|Protective Agents|protective agents|mesh-ancestor
57142158|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142159|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
57142160|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57142161|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57142162|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142163|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57142164|NCT03162861|Anesthetics|anesthetics|mesh-list
57142165|NCT03162861|Propofol|propofol|mesh-list
57142166|NCT03162861|Sevoflurane|sevoflurane|mesh-list
57142167|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57142168|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142169|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57142170|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57142171|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
57142172|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57142173|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57142175|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57142176|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142177|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57142178|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142179|NCT05476172|Dienogest|dienogest|mesh-list
57142180|NCT05476172|Norethindrone|norethindrone|mesh-list
57142181|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
57142182|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57142183|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57142184|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57142185|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
57142186|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142187|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142188|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57142189|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57142190|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57142191|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
57142192|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142193|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57142194|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142195|NCT02765165|Lomustine|lomustine|mesh-list
57142196|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57142197|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
57142198|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142199|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142200|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
57142201|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
57142202|NCT02156843|Vitamins|vitamins|mesh-ancestor
57142203|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
57142204|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142205|NCT02675907|Meloxicam|meloxicam|mesh-list
57142206|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57142207|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57142208|NCT02675907|Analgesics|analgesics|mesh-ancestor
57142209|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
57142210|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142211|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142212|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142213|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57142214|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57142215|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57142216|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142217|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142218|NCT02152865|Lupeol|lupeol|mesh-list
57142219|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142220|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57142221|NCT02152943|Trastuzumab|trastuzumab|mesh-list
57142222|NCT02152943|Everolimus|everolimus|mesh-list
57142223|NCT02152943|Letrozole|letrozole|mesh-list
57142224|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
57142225|NCT02152943|Antibodies|antibodies|mesh-list
57142226|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
57142227|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57142228|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
57142229|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142230|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142231|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57142232|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57142233|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57142234|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142235|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142236|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57142237|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
57142238|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142239|NCT02156999|Vitamin D|vitamin d|mesh-list
57142240|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
57142241|NCT02156999|Vitamins|vitamins|mesh-ancestor
57142242|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
57142243|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142244|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57142245|NCT05014581|Norepinephrine|norepinephrine|mesh-list
56824064|NCT00435461|Xhance|xhance|mesh-list
57142246|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57142247|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57142248|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
57142249|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142250|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142251|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142252|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
57142253|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
57142254|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836124|NCT00255008|Ribavirin|ribavirin|mesh-list
57142255|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57142256|NCT04719273|Anastrozole|anastrozole|mesh-list
57142257|NCT04719273|Onapristone|onapristone|mesh-list
57142258|NCT04719273|Progesterone|progesterone|mesh-list
57142259|NCT04719273|Estrogens|estrogens|mesh-list
57142260|NCT04719273|Progestins|progestins|mesh-ancestor
57142261|NCT04719273|Hormones|hormones|mesh-ancestor
57142262|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142263|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142264|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57142265|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142266|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57142267|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57142268|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142269|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142270|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57142271|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
57142272|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57142273|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
57142274|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142275|NCT02159651|Tacrolimus|tacrolimus|mesh-list
57142276|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57142277|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
57142278|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142279|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57142280|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142281|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142282|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57142283|NCT02774681|Trastuzumab|trastuzumab|mesh-list
57142284|NCT02774681|Palbociclib|palbociclib|mesh-list
57142285|NCT02774681|Antibodies|antibodies|mesh-list
57142286|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
57142287|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57142288|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
57142289|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142290|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142291|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57142292|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142293|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142294|NCT02157311|Tenofovir|tenofovir|mesh-list
57142295|NCT02157311|Lamivudine|lamivudine|mesh-list
57142296|NCT02157311|Emtricitabine|emtricitabine|mesh-list
57142297|NCT02157311|Efavirenz|efavirenz|mesh-list
57142298|NCT02157311|Lopinavir|lopinavir|mesh-list
57142299|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57142300|NCT02157311|Darunavir|darunavir|mesh-list
57142301|NCT02157311|Abacavir|abacavir|mesh-list
57142302|NCT02157311|Rilpivirine|rilpivirine|mesh-list
57142303|NCT02157311|Etravirine|etravirine|mesh-list
57142304|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
57142305|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142306|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57142307|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57142308|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142309|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142310|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57142311|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57142312|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57142313|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57142314|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57142315|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57142316|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57142317|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57142318|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57142319|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57142320|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
57142321|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57142322|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
57142323|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57142324|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57142325|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142326|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
57142327|NCT04784039|Coagulants|coagulants|mesh-ancestor
57142328|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
57142329|NCT02157467|BMS-955176|bms-955176|mesh-list
57142330|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57142331|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57142332|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142333|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57142334|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57142335|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142336|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142337|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142338|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57142339|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
57142340|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142341|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142342|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57142343|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57142344|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57142345|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57142346|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57142347|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
57142348|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57142349|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
57142350|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57142351|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
57142352|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142353|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142354|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57142355|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57142356|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142357|NCT00152971|Enoxaparin|enoxaparin|mesh-list
57142358|NCT00152971|Dabigatran|dabigatran|mesh-list
57142359|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
57142360|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57142361|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57142362|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142363|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
57142364|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57142365|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
57142366|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142367|NCT04675827|Trastuzumab|trastuzumab|mesh-list
57142368|NCT04675827|Pertuzumab|pertuzumab|mesh-list
57142369|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
57142370|NCT04675827|Maytansine|maytansine|mesh-list
57142371|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57142372|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142373|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57142374|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
57142375|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
57142376|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
57142377|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142378|NCT02538614|Idelalisib|idelalisib|mesh-list
57142379|NCT02538614|BI 836826|bi 836826|mesh-list
57142380|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142381|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142382|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142383|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57142384|NCT03504644|Vincristine|vincristine|mesh-list
57142385|NCT03504644|Venetoclax|venetoclax|mesh-list
57142386|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57142387|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142388|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
57142389|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
57142390|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
57142391|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142392|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57142393|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57142394|NCT02160275|Insulin|insulin|mesh-list
57142395|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57142396|NCT02160275|Pancrelipase|pancrelipase|mesh-list
57142397|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57142398|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142399|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57142400|NCT03126968|Epinephrine|epinephrine|mesh-list
57142401|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57142402|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57142403|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
57142404|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142405|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142406|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142407|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57142408|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57142409|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
57142410|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142411|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57142412|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
57142413|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
57142414|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
57142415|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57142416|NCT02266849|Loperamide|loperamide|mesh-list
57142417|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
57142418|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57142419|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57142420|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57142421|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57142422|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57142423|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142424|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142425|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142426|NCT01309945|Analgesics|analgesics|mesh-ancestor
57142427|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
57142428|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142429|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
57142430|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57142431|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
57142432|NCT02160353|Prednisolone|prednisolone|mesh-list
57142433|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
57142434|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142435|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
57142436|NCT02160353|Hormones|hormones|mesh-ancestor
57142437|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142438|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142439|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57142440|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142441|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57142442|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142443|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142444|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
57142445|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57142446|NCT02153567|Citalopram|citalopram|mesh-list
57142447|NCT02153567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57142448|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57142449|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57142450|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142451|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142452|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
57142453|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142454|NCT02153567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57142455|NCT02153567|Antidepressive Agents|antidepressive agents|mesh-ancestor
57142456|NCT02153567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57142457|NCT02441660|Capsaicin|capsaicin|mesh-list
57142458|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
57142459|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
57142460|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
57142461|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142462|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142463|NCT01303783|Candesartan|candesartan|mesh-list
57142464|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
57142465|NCT01303783|Nifedipine|nifedipine|mesh-list
57142466|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57142467|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57142468|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57142469|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142470|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57142471|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57142472|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57142473|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142474|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
57142475|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
57142476|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142477|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
57142478|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57142479|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57142480|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142481|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
57142482|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
57142483|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
57142484|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57142485|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
57142486|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142487|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57142488|NCT02153879|Niacin|niacin|mesh-list
57142489|NCT02153879|Fenofibrate|fenofibrate|mesh-list
57142490|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57142491|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
57142492|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142493|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57142494|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
57142495|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
57142496|NCT02153879|Vitamins|vitamins|mesh-ancestor
57142497|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
57142498|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142499|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
57142500|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57142501|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57142502|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142503|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57142504|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57142505|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142506|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142507|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142508|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57142509|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
57142510|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142511|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142512|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57142513|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57142514|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57142515|NCT02160743|Metformin|metformin|mesh-list
57142516|NCT02160743|Atorvastatin|atorvastatin|mesh-list
57142517|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57142518|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142519|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57142520|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57142521|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
57142522|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142523|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57142524|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57142525|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142526|NCT02158013|Diltiazem|diltiazem|mesh-list
57142527|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57142528|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57142529|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57142530|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142531|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57142532|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142533|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
57142534|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
57142535|NCT01023295|Combretastatin|combretastatin|mesh-list
57142536|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57142537|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142538|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
57142539|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
57142540|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
57142541|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142542|NCT05468138|Antibodies|antibodies|mesh-list
57142543|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
57142544|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142545|NCT05675787|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57142546|NCT05675787|Atorvastatin|atorvastatin|mesh-list
57142547|NCT05675787|Medroxyprogesterone|medroxyprogesterone|mesh-list
57142548|NCT05675787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57142549|NCT05675787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57142550|NCT05675787|Antimetabolites|antimetabolites|mesh-ancestor
57142551|NCT05675787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836414|NCT01306006|Vaccines|vaccines|mesh-list
57142552|NCT05675787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57142553|NCT05675787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57142554|NCT05675787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142555|NCT05675787|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57142556|NCT05675787|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57142557|NCT05675787|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57142558|NCT05675787|Contraceptive Agents|contraceptive agents|mesh-ancestor
57142559|NCT05675787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142560|NCT05675787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142561|NCT05675787|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57142562|NCT05675787|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57142563|NCT05675787|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57142564|NCT05675787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57142565|NCT05675787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142566|NCT01140217|Norethindrone|norethindrone|mesh-list
57142567|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
57142568|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57142569|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57142570|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57142571|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
57142572|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142573|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142574|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57142575|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57142576|NCT05676645|Lumefantrine|lumefantrine|mesh-list
57142577|NCT05676645|Artemether|artemether|mesh-list
57142578|NCT05676645|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57142579|NCT05676645|Antimalarials|antimalarials|mesh-ancestor
57142580|NCT05676645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57142581|NCT05676645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57142582|NCT05676645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142583|NCT01297543|Lenograstim|lenograstim|mesh-list
57142584|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57142585|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
57142586|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142587|NCT03541265|Bupivacaine|bupivacaine|mesh-list
57142588|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
57142589|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
57142590|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57142591|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142592|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
57142593|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142594|NCT02547038|Amoxicillin|amoxicillin|mesh-list
57142595|NCT02547038|Metronidazole|metronidazole|mesh-list
57142596|NCT02547038|Clarithromycin|clarithromycin|mesh-list
57142597|NCT02547038|Tetracycline|tetracycline|mesh-list
57142598|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
57142599|NCT02547038|Pantoprazole|pantoprazole|mesh-list
57142600|NCT02547038|Bismuth|bismuth|mesh-list
57142601|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57142602|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142603|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57142604|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57142605|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57142606|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142607|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142608|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57142609|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57142610|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57142611|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57142612|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57142613|NCT02547038|Antacids|antacids|mesh-ancestor
57142614|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57142615|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57142616|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57142617|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142618|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142619|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57142620|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57142621|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142622|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
57142623|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142624|NCT02161055|Insulin|insulin|mesh-list
57142625|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57142626|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57142627|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142628|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
57142629|NCT04483544|Olaparib|olaparib|mesh-list
57142630|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57142631|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142632|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57142633|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142634|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142635|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57142636|NCT02764697|Hormones|hormones|mesh-ancestor
57142637|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142638|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142639|NCT04822337|Dexamethasone|dexamethasone|mesh-list
57142640|NCT04822337|Lenalidomide|lenalidomide|mesh-list
57142641|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142642|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
57142643|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
57142644|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142645|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142646|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57142647|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
57142648|NCT04822337|Hormones|hormones|mesh-ancestor
57142649|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142650|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57142651|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142652|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
57142653|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57142654|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57142655|NCT04822337|Growth Substances|growth substances|mesh-ancestor
57142656|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
57142657|NCT02266927|Fluticasone|fluticasone|mesh-list
57142658|NCT02266927|Xhance|xhance|mesh-list
57142659|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142660|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57142661|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
57142662|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142663|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142664|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57142665|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
57142666|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
57142667|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57142668|NCT02158481|Carotenoids|carotenoids|mesh-list
57142669|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
57142670|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142671|NCT02158481|Protective Agents|protective agents|mesh-ancestor
57142672|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142673|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57142674|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142675|NCT05466734|Cilostazol|cilostazol|mesh-list
57142676|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57142677|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
57142678|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142679|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142680|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57142681|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
57142682|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57142683|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57142684|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142685|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57142686|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
57142687|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57142688|NCT05466734|Protective Agents|protective agents|mesh-ancestor
57142689|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57142690|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57142691|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142692|NCT01020565|Entecavir|entecavir|mesh-list
57142693|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
57142694|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142695|NCT04965597|Methotrexate|methotrexate|mesh-list
57142696|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
57142697|NCT04965597|Fludarabine|fludarabine|mesh-list
57142698|NCT04965597|Treosulfan|treosulfan|mesh-list
57142699|NCT04965597|Busulfan|busulfan|mesh-list
57142700|NCT04965597|Tacrolimus|tacrolimus|mesh-list
57142701|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
57142702|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57142703|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
57142704|NCT04965597|Antibodies|antibodies|mesh-list
57142705|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
57142706|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57142707|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57142708|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57142709|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
57142710|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57142711|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142712|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57142713|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
57142714|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142715|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142716|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
57142717|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142718|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57142719|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57142720|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
57142721|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57142722|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57142723|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57142724|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57142725|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
57142726|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57142727|NCT01020097|Fluorides|fluorides|mesh-list
57142728|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
57142729|NCT01020097|Protective Agents|protective agents|mesh-ancestor
57142730|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142731|NCT02154269|Lenograstim|lenograstim|mesh-list
57142732|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57142733|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
57142734|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142735|NCT04914741|Prednisolone|prednisolone|mesh-list
57142736|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
57142737|NCT04914741|Rituximab|rituximab|mesh-list
57142738|NCT04914741|Doxorubicin|doxorubicin|mesh-list
57142739|NCT04914741|Vincristine|vincristine|mesh-list
57142740|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57142741|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
57142742|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142743|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57142744|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57142745|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
57142746|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142747|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142748|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57142749|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57142750|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57142751|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57142752|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57142753|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142754|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57142755|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
57142756|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
57142757|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
57142758|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142759|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
57142760|NCT04914741|Hormones|hormones|mesh-ancestor
57142761|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142762|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57142763|NCT03738683|Tazobactam|tazobactam|mesh-list
57142764|NCT03738683|Piperacillin|piperacillin|mesh-list
57142765|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57142766|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57142767|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142768|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57142769|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142770|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142771|NCT04475887|Iron|iron|mesh-list
57142772|NCT04475887|Trace Elements|trace elements|mesh-ancestor
57142773|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
57142774|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142776|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57142777|NCT02267239|Listerine|listerine|mesh-list
57142778|NCT02267239|Hexetidine|hexetidine|mesh-list
57142779|NCT02267239|Menthol|menthol|mesh-list
57142780|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
57142781|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57142782|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142783|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
57142784|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
57142785|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
57142786|NCT02267239|Protective Agents|protective agents|mesh-ancestor
57142787|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142788|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
57142789|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
57142790|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
57142791|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
57142792|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57142793|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
57142794|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142795|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142796|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142797|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57142798|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142799|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
57142800|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142801|NCT02766023|Metronidazole|metronidazole|mesh-list
57142802|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142803|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57142804|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57142805|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57142806|NCT05466500|Dexamethasone|dexamethasone|mesh-list
57142807|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
57142808|NCT05466500|Bupivacaine|bupivacaine|mesh-list
57142809|NCT05466500|BB 1101|bb 1101|mesh-list
57142810|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142811|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
57142812|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
57142813|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142814|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142815|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57142816|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
57142817|NCT05466500|Hormones|hormones|mesh-ancestor
57142818|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57142819|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57142820|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142821|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
57142822|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142823|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142824|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
57142825|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
57142826|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57142827|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
57142828|NCT04475107|Artesunate|artesunate|mesh-list
57142829|NCT04475107|Pyronaridine|pyronaridine|mesh-list
57142830|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
57142831|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57142832|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57142833|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142834|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142835|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
57142836|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
57142837|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57142838|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
57142839|NCT02254967|Vancomycin|vancomycin|mesh-list
57142840|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
57142841|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57142842|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142843|NCT05444036|Ketamine|ketamine|mesh-list
57142844|NCT05444036|Analgesics|analgesics|mesh-ancestor
57142845|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
57142846|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142847|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142848|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57142849|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57142850|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
57142851|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
57142852|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57142853|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57142854|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57142855|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142856|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142857|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
57142858|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57142859|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57142860|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142861|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
57142862|NCT03923959|Coagulants|coagulants|mesh-ancestor
57142863|NCT02161367|Simethicone|simethicone|mesh-list
57142864|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
57142865|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142866|NCT02161367|Emollients|emollients|mesh-ancestor
57142867|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
57142868|NCT03542825|Iron|iron|mesh-list
57142869|NCT03542825|Lactoferrin|lactoferrin|mesh-list
57142870|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
57142871|NCT03542825|Trace Elements|trace elements|mesh-ancestor
57142872|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
57142873|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142874|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142875|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
57142876|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
57142877|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142878|NCT01001923|Fasinumab|fasinumab|mesh-list
57142879|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57142880|NCT01001923|Analgesics|analgesics|mesh-ancestor
57142881|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
57142882|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142883|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142884|NCT05627947|Cyclosporine|cyclosporine|mesh-list
57142885|NCT05627947|Mitomycins|mitomycins|mesh-list
57142886|NCT05627947|Mitomycin|mitomycin|mesh-list
57142887|NCT05627947|Cyclosporins|cyclosporins|mesh-list
57142888|NCT05627947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142889|NCT05627947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142890|NCT05627947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57142891|NCT05627947|Immunologic Factors|immunologic factors|mesh-ancestor
57142892|NCT05627947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142893|NCT05627947|Antifungal Agents|antifungal agents|mesh-ancestor
57142894|NCT05627947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142895|NCT05627947|Dermatologic Agents|dermatologic agents|mesh-ancestor
57142896|NCT05627947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57142897|NCT05627947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57142898|NCT05627947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57142899|NCT05627947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142900|NCT05627947|Alkylating Agents|alkylating agents|mesh-ancestor
57142901|NCT05627947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57142902|NCT02154503|Minoxidil|minoxidil|mesh-list
57142903|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57142904|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
57142905|NCT02536976|Mirabegron|mirabegron|mesh-list
57142906|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57142907|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57142908|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57142909|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
57142910|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142911|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142912|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142913|NCT02536976|Urological Agents|urological agents|mesh-ancestor
57142914|NCT04310397|Trametinib|trametinib|mesh-list
57142915|NCT04310397|Dabrafenib|dabrafenib|mesh-list
57142916|NCT04310397|Spartalizumab|spartalizumab|mesh-list
57142917|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142918|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57142919|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142920|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142921|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57142922|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
57142923|NCT00992563|Ranibizumab|ranibizumab|mesh-list
57142924|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57142925|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57142926|NCT00992563|Growth Substances|growth substances|mesh-ancestor
57142927|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142928|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
57142929|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142930|NCT02267707|Gemcitabine|gemcitabine|mesh-list
57142931|NCT02267707|Paclitaxel|paclitaxel|mesh-list
57142932|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57142933|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142934|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
57142935|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
57142936|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
57142937|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142938|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57142939|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
57142940|NCT02267707|Antiviral Agents|antiviral agents|mesh-ancestor
57142941|NCT02267707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142942|NCT02267707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142943|NCT02267707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57142944|NCT02267707|Immunologic Factors|immunologic factors|mesh-ancestor
57142945|NCT02267707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142946|NCT01373229|Plerixafor|plerixafor|mesh-list
57142947|NCT01373229|Rituximab|rituximab|mesh-list
57142948|NCT01373229|Lenalidomide|lenalidomide|mesh-list
57142949|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57142950|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142951|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
57142952|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142953|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57142954|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57142955|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57142956|NCT01373229|Growth Substances|growth substances|mesh-ancestor
57142957|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
57142958|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57142959|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57142960|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
57142961|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57142962|NCT02671461|Aspirin|aspirin|mesh-list
57142963|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57142964|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57142965|NCT02671461|Analgesics|analgesics|mesh-ancestor
57142966|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
57142967|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57142968|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142969|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57142970|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57142971|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57142972|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57142973|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142974|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57142975|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57142976|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57142977|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
57142978|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57142979|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
57142980|NCT05467033|Coagulants|coagulants|mesh-ancestor
57142981|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57142982|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
57142983|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142984|NCT04196283|Paclitaxel|paclitaxel|mesh-list
57142985|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57142986|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57142987|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
57142988|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
57142989|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
57142990|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142991|NCT02268019|Epinephrine|epinephrine|mesh-list
57142992|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57142993|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57142994|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
57142995|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57142996|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57142997|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57142998|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57142999|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57143000|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
57143001|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143002|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57143003|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
57143004|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
57143005|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
57143006|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57143007|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57143008|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57143009|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
57143010|NCT01110889|S 20098|s 20098|mesh-list
57143011|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57143012|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143013|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143014|NCT01106989|Lidocaine|lidocaine|mesh-list
57143015|NCT01106989|Tetracaine|tetracaine|mesh-list
57143016|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
57143017|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
57143018|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143019|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143020|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
57143021|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143022|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57143023|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57143024|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57143025|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57143026|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143027|NCT00975091|Entecavir|entecavir|mesh-list
57143028|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
57143029|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143030|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
57143031|NCT02535416|Promethazine|promethazine|mesh-list
57143032|NCT02535416|Cetirizine|cetirizine|mesh-list
57143033|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57143034|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57143035|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143036|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143037|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
57143038|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
57143039|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
57143040|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143041|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
57143042|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
57143043|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57143044|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57143045|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
57143046|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
57143047|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57143048|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143049|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57143050|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
57143051|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
57143052|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57143053|NCT00911443|Interferons|interferons|mesh-list
57143054|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
57143055|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
57143056|NCT00911443|Dacarbazine|dacarbazine|mesh-list
57143057|NCT00911443|Thymalfasin|thymalfasin|mesh-list
57143058|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143059|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
57143060|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143061|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
57143062|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143063|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57143064|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
57143065|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143066|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57143067|NCT03949478|Ibuprofen|ibuprofen|mesh-list
57143068|NCT03949478|Nifedipine|nifedipine|mesh-list
57143069|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57143070|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57143071|NCT03949478|Analgesics|analgesics|mesh-ancestor
57143072|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
57143073|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143074|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143075|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143076|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143077|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57143078|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824859|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
57143079|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143080|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57143081|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57143082|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57143083|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
57143084|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
57143085|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57143086|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
57143087|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
57143088|NCT00909649|Coagulants|coagulants|mesh-ancestor
57143089|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57143090|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
57143091|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143092|NCT04310059|Folic Acid|folic acid|mesh-list
57143093|NCT04310059|Hematinics|hematinics|mesh-ancestor
57143094|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
57143095|NCT04310059|Vitamins|vitamins|mesh-ancestor
57143096|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
57143097|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143098|NCT04787965|Opicapone|opicapone|mesh-list
57143099|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
57143100|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143101|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143102|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57143103|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57143104|NCT02670915|Insulin|insulin|mesh-list
57143105|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57143106|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
57143107|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
57143108|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
57143109|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57143110|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143111|NCT02545868|Vaccines|vaccines|mesh-list
57143112|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
57143113|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143114|NCT00821977|Vildagliptin|vildagliptin|mesh-list
57143115|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57143116|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143117|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57143118|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
57143119|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143120|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143121|NCT04474327|Montelukast|montelukast|mesh-list
57143122|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57143123|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
57143124|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57143125|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
57143126|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143127|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143128|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57143129|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57143130|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143131|NCT04745949|Prednisone|prednisone|mesh-list
57143132|NCT04745949|Cortisone|cortisone|mesh-list
57143133|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
57143134|NCT04745949|Rituximab|rituximab|mesh-list
57143135|NCT04745949|Doxorubicin|doxorubicin|mesh-list
57143136|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57143137|NCT04745949|Nivolumab|nivolumab|mesh-list
57143138|NCT04745949|Daunorubicin|daunorubicin|mesh-list
57143139|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57143140|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57143141|NCT04745949|Antibodies|antibodies|mesh-list
57143142|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
57143143|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57143144|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
57143145|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57143146|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
57143147|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143148|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143149|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57143150|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
57143151|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143152|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143153|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57143154|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57143156|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57143157|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143158|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143159|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
57143160|NCT04745949|Hormones|hormones|mesh-ancestor
57143161|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731255|NCT05350917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143162|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57143163|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57143164|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
57143165|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
57143166|NCT00961675|Dexamethasone|dexamethasone|mesh-list
57143167|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
57143168|NCT00961675|Povidone|povidone|mesh-list
57143169|NCT00961675|BB 1101|bb 1101|mesh-list
57143170|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143171|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
57143172|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
57143173|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143174|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143175|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57143176|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
57143177|NCT00961675|Hormones|hormones|mesh-ancestor
57143178|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143179|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57143180|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143181|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
57143182|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143183|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143184|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57143185|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143186|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57143187|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57143188|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57143189|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57143190|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
57143191|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
57143192|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57143193|NCT00819169|Conatumumab|conatumumab|mesh-list
57143194|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57143195|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143196|NCT02161679|Carboplatin|carboplatin|mesh-list
57143197|NCT02161679|Camptothecin|camptothecin|mesh-list
57143198|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
57143199|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143200|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57143201|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57143202|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57143203|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143204|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143205|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
57143206|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143207|NCT04729725|Cemiplimab|cemiplimab|mesh-list
57143208|NCT04729725|Antibodies|antibodies|mesh-list
57143209|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57143210|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
57143211|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143212|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57143213|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143214|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
57143215|NCT04262492|Apixaban|apixaban|mesh-list
57143216|NCT04262492|Edoxaban|edoxaban|mesh-list
57143217|NCT04262492|Dabigatran|dabigatran|mesh-list
57143218|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57143219|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
57143220|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57143221|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
57143222|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143223|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143224|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
57143225|NCT00955981|Lesinurad|lesinurad|mesh-list
57143226|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
57143227|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143228|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
57143229|NCT00955981|Renal Agents|renal agents|mesh-ancestor
57143230|NCT03541031|Micronutrients|micronutrients|mesh-list
57143231|NCT03541031|Trace Elements|trace elements|mesh-list
57143232|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143233|NCT05454709|Glucagon|glucagon|mesh-list
57143234|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57143235|NCT05454709|Hormones|hormones|mesh-ancestor
57143236|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143237|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143238|NCT05675319|Dexamethasone|dexamethasone|mesh-list
57143239|NCT05675319|Dexamethasone acetate|dexamethasone acetate|mesh-list
57143240|NCT05675319|Lenalidomide|lenalidomide|mesh-list
57143241|NCT05675319|Bortezomib|bortezomib|mesh-list
57143242|NCT05675319|Daratumumab|daratumumab|mesh-list
57143243|NCT05675319|Pomalidomide|pomalidomide|mesh-list
57143244|NCT05675319|Ixazomib|ixazomib|mesh-list
57143245|NCT05675319|Elotuzumab|elotuzumab|mesh-list
57143246|NCT05675319|BB 1101|bb 1101|mesh-list
57143247|NCT05675319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57143248|NCT05675319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143249|NCT05675319|Antiemetics|antiemetics|mesh-ancestor
57143250|NCT05675319|Autonomic Agents|autonomic agents|mesh-ancestor
57143251|NCT05675319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143252|NCT05675319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143253|NCT05675319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57143254|NCT05675319|Glucocorticoids|glucocorticoids|mesh-ancestor
57143255|NCT05675319|Hormones|hormones|mesh-ancestor
57143256|NCT05675319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143257|NCT05675319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57143258|NCT05675319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143259|NCT05675319|Protease Inhibitors|protease inhibitors|mesh-ancestor
57143260|NCT05675319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143261|NCT05675319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143262|NCT05675319|Immunologic Factors|immunologic factors|mesh-ancestor
57143263|NCT05675319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57143264|NCT05675319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57143265|NCT05675319|Growth Substances|growth substances|mesh-ancestor
57143266|NCT05675319|Growth Inhibitors|growth inhibitors|mesh-ancestor
57143267|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57143268|NCT03290937|Cetuximab|cetuximab|mesh-list
57143269|NCT03290937|Irinotecan|irinotecan|mesh-list
57143270|NCT03290937|Camptothecin|camptothecin|mesh-list
57143271|NCT03290937|Antibodies|antibodies|mesh-list
57143272|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
57143273|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57143274|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
57143275|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
57143276|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143277|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143278|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57143279|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57143280|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143281|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143282|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57143283|NCT02154737|Gemcitabine|gemcitabine|mesh-list
57143284|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57143285|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57143286|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
57143287|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143288|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143289|NCT02154737|Antiviral Agents|antiviral agents|mesh-ancestor
57143290|NCT02154737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143291|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143292|NCT02154737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57143293|NCT02154737|Immunologic Factors|immunologic factors|mesh-ancestor
57143294|NCT02154737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143295|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57143296|NCT00813163|Irinotecan|irinotecan|mesh-list
57143297|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57143298|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57143299|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143300|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143301|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143302|NCT04030455|Cisplatin|cisplatin|mesh-list
57143303|NCT04030455|Carboplatin|carboplatin|mesh-list
57143304|NCT04030455|Docetaxel|docetaxel|mesh-list
57143305|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
57143306|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143307|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
57143308|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
57143309|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
57143310|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143311|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57143312|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57143313|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143314|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143315|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57143316|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57143317|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
57143318|NCT04474093|Methamphetamine|methamphetamine|mesh-list
57143319|NCT04474093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57143320|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143321|NCT04474093|Sympathomimetics|sympathomimetics|mesh-ancestor
57143322|NCT04474093|Autonomic Agents|autonomic agents|mesh-ancestor
57143323|NCT04474093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143324|NCT04474093|Dopamine Agents|dopamine agents|mesh-ancestor
57143325|NCT04474093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57143326|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143327|NCT04474093|Adrenergic Agents|adrenergic agents|mesh-ancestor
57143328|NCT04474093|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57143329|NCT04474093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57143330|NCT04474093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57143331|NCT04474093|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57143332|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
57143333|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57143334|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143335|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
57143336|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57143337|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143338|NCT02159027|Maraviroc|maraviroc|mesh-list
57143339|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57143340|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57143341|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143342|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57143343|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57143344|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
57143345|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143346|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57143347|NCT02161991|Aprepitant|aprepitant|mesh-list
57143348|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
57143349|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
57143350|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143351|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143352|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57143353|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57143354|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57143355|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143356|NCT05439356|Colchicine|colchicine|mesh-list
57143357|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
57143358|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143359|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
57143360|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
57143361|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
57143362|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143363|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143364|NCT00948961|Poly I-C|poly i-c|mesh-list
57143365|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57143366|NCT00948961|Poly ICLC|poly iclc|mesh-list
57143367|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
57143368|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
57143369|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143370|NCT00948961|Laxatives|laxatives|mesh-ancestor
57143371|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57143372|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
57143373|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143374|NCT02159105|Chrysarobin|chrysarobin|mesh-list
57143375|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57143376|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57143377|NCT02159105|Analgesics|analgesics|mesh-ancestor
57143378|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
57143379|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143380|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143381|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143382|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825149|NCT00231842|Ifosfamide|ifosfamide|mesh-list
57143383|NCT00890305|Pidilizumab|pidilizumab|mesh-list
57143384|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57143385|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143386|NCT01661972|Capecitabine|capecitabine|mesh-list
57143387|NCT01661972|Aflibercept|aflibercept|mesh-list
57143388|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57143389|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
57143390|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143391|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143392|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57143393|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57143394|NCT01661972|Growth Substances|growth substances|mesh-ancestor
57143395|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143396|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
57143397|NCT00890149|Ondansetron|ondansetron|mesh-list
57143398|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
57143399|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
57143400|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143401|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143402|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57143403|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
57143404|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
57143405|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57143406|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
57143407|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57143408|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143409|NCT00890149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57143410|NCT00890149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57143411|NCT00890149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143412|NCT00890149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57143413|NCT00890149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57143414|NCT02155049|Bimatoprost|bimatoprost|mesh-list
57143415|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57143416|NCT03540953|Mitomycins|mitomycins|mesh-list
57143417|NCT03540953|Mitomycin|mitomycin|mesh-list
57143418|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57143419|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143420|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
57143421|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143422|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57143423|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143424|NCT00888355|Losartan|losartan|mesh-list
57143425|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57143426|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57143427|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57143428|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57143429|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143430|NCT00794677|Ezetimibe|ezetimibe|mesh-list
57143431|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57143432|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57143433|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
57143434|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143435|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57143436|NCT00792727|Ketoprofen|ketoprofen|mesh-list
57143437|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57143438|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57143439|NCT00792727|Analgesics|analgesics|mesh-ancestor
57143440|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
57143441|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143442|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143443|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143444|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143445|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57143446|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143447|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143448|NCT00945763|Ibuprofen|ibuprofen|mesh-list
57143449|NCT00945763|Meloxicam|meloxicam|mesh-list
57143450|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57143451|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57143452|NCT00945763|Analgesics|analgesics|mesh-ancestor
57143453|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
57143454|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143455|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143456|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143457|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143458|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57143459|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143460|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143461|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57143462|NCT02770391|Leuprolide|leuprolide|mesh-list
57143463|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57143464|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
57143465|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57143466|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143467|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57143468|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143469|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
57143470|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57143471|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143472|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57143473|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57143474|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143475|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143476|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143477|NCT00938587|Prednisone|prednisone|mesh-list
57143478|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143479|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
57143480|NCT00938587|Hormones|hormones|mesh-ancestor
57143481|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143482|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143483|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57143484|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143485|NCT02536664|Rituximab|rituximab|mesh-list
57143486|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57143487|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143488|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
57143489|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143490|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143491|NCT02162303|Colchicine|colchicine|mesh-list
57143492|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
57143493|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143494|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
57143495|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
57143496|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
57143497|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143498|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143499|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
57143500|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
57143501|NCT05430308|Povidone|povidone|mesh-list
57143502|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57143503|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143504|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
57143505|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
57143506|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
57143507|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
57143508|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143509|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
57143510|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143511|NCT04729387|Paclitaxel|paclitaxel|mesh-list
57143512|NCT04729387|Doxorubicin|doxorubicin|mesh-list
57143513|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57143514|NCT04729387|Olaparib|olaparib|mesh-list
57143515|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57143516|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143517|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
57143518|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
57143519|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
57143520|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143521|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57143522|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57143523|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57143524|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143525|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57143526|NCT04707703|Isavuconazole|isavuconazole|mesh-list
57143527|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
57143528|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143529|NCT04681105|Acetaminophen|acetaminophen|mesh-list
57143530|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
57143531|NCT04681105|Promethazine|promethazine|mesh-list
56825299|NCT00181844|Lamotrigine|lamotrigine|mesh-list
57143532|NCT04681105|Dexamethasone|dexamethasone|mesh-list
57143533|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
57143534|NCT04681105|Ibuprofen|ibuprofen|mesh-list
57143535|NCT04681105|Ranitidine|ranitidine|mesh-list
57143537|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
57143538|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57143539|NCT04681105|BB 1101|bb 1101|mesh-list
57143540|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
57143541|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143542|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143543|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
57143544|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
56837397|NCT01567540|Hormones|hormones|mesh-ancestor
57143545|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143546|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57143547|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
57143548|NCT04681105|Hormones|hormones|mesh-ancestor
57143549|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143550|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57143551|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143552|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
57143553|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143554|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143555|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57143556|NCT04681105|Analgesics|analgesics|mesh-ancestor
57143557|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
57143558|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
57143559|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57143560|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143561|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57143562|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57143563|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57143564|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143565|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
57143566|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
57143567|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57143568|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
57143569|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
57143570|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57143571|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57143572|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
57143573|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
57143574|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57143575|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57143576|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
57143577|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57143578|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143579|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57143580|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57143581|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143582|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143583|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143584|NCT00934921|Ondansetron|ondansetron|mesh-list
57143585|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
57143586|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
57143587|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143588|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143589|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57143590|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
57143591|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
57143592|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57143593|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
57143594|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57143595|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143596|NCT00934921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57143597|NCT00934921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57143598|NCT00934921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143599|NCT00934921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57143600|NCT00934921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57143601|NCT05429450|Triamcinolone|triamcinolone|mesh-list
57143602|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57143603|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57143604|NCT05429450|Methotrexate|methotrexate|mesh-list
57143605|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57143606|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57143607|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
57143608|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57143609|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143610|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57143611|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
57143612|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143613|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143614|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
57143615|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143616|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57143617|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57143618|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
57143619|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143620|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57143621|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143622|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
57143623|NCT05429450|Hormones|hormones|mesh-ancestor
57143624|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143625|NCT00103259|Irinotecan|irinotecan|mesh-list
57143626|NCT00103259|Bortezomib|bortezomib|mesh-list
57143627|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57143628|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57143629|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143630|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143631|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143632|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
57143633|NCT05400109|Fludarabine|fludarabine|mesh-list
57143634|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
57143635|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57143636|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
57143637|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143638|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143639|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57143640|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
57143641|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143642|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143643|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57143644|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57143645|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
57143646|NCT02162381|Methylphenidate|methylphenidate|mesh-list
57143647|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57143648|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143649|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57143650|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57143651|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57143652|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143653|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
57143654|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57143655|NCT00782431|Vaccines|vaccines|mesh-list
57143656|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
57143657|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143658|NCT02155439|Triamcinolone|triamcinolone|mesh-list
57143659|NCT02155439|Fluorouracil|fluorouracil|mesh-list
57143660|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
57143661|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143662|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57143663|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143664|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57143665|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
57143666|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143667|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143668|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
57143669|NCT02155439|Hormones|hormones|mesh-ancestor
57143670|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143671|NCT04627285|Lacosamide|lacosamide|mesh-list
57143672|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
57143673|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57143674|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57143675|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57143676|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143677|NCT02544152|Lubiprostone|lubiprostone|mesh-list
57143678|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57143679|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57143680|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143681|NCT02162537|Bevacizumab|bevacizumab|mesh-list
57143682|NCT02162537|Pemetrexed|pemetrexed|mesh-list
57143683|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825450|NCT00203502|Growth Substances|growth substances|mesh-ancestor
57143684|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143685|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57143686|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57143687|NCT02162537|Growth Substances|growth substances|mesh-ancestor
57143688|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143689|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
57143690|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143691|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143692|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57143693|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57143694|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57143695|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57143696|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143697|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
57143698|NCT00864175|Docetaxel|docetaxel|mesh-list
57143699|NCT00864175|Trastuzumab|trastuzumab|mesh-list
57143700|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143701|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
57143702|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
57143703|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
57143704|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143705|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57143706|NCT02166593|Atorvastatin|atorvastatin|mesh-list
57143707|NCT02166593|Pravastatin|pravastatin|mesh-list
57143708|NCT02166593|Fenofibrate|fenofibrate|mesh-list
57143709|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57143710|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57143711|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
57143712|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143713|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57143714|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57143715|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143716|NCT00858871|Sorafenib|sorafenib|mesh-list
57143717|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143718|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57143719|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143720|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143721|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
57143722|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57143723|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
57143724|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143725|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
57143726|NCT02162693|Protective Agents|protective agents|mesh-ancestor
57143727|NCT02163161|Abrocitinib|abrocitinib|mesh-list
57143728|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57143729|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143730|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143731|NCT00917293|Pyridoxal|pyridoxal|mesh-list
57143732|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
57143733|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
57143734|NCT00917293|Vitamins|vitamins|mesh-ancestor
57143735|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
57143736|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143737|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
57143738|NCT00845299|Latanoprost|latanoprost|mesh-list
57143739|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
57143740|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57143741|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57143742|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57143743|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143744|NCT02255591|Lidocaine|lidocaine|mesh-list
57143745|NCT02255591|Epinephrine|epinephrine|mesh-list
57143746|NCT02255591|Racepinephrine|racepinephrine|mesh-list
57143747|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
57143748|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
57143749|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
57143750|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143751|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143752|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
57143753|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143754|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57143755|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57143756|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57143757|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57143758|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143759|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57143760|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57143761|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
57143762|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57143763|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57143764|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57143765|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
57143766|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57143767|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
57143768|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
57143769|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
57143770|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57143771|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57143772|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
57143773|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143774|NCT02167061|Metformin|metformin|mesh-list
57143775|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57143776|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143777|NCT03715465|Melatonin|melatonin|mesh-list
57143778|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
57143779|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143780|NCT03715465|Protective Agents|protective agents|mesh-ancestor
57143781|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143782|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143783|NCT04706741|Prednisone|prednisone|mesh-list
57143784|NCT04706741|Prednisolone|prednisolone|mesh-list
57143785|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143786|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
57143787|NCT04706741|Hormones|hormones|mesh-ancestor
57143788|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143789|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143790|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57143791|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143792|NCT02171039|Dabigatran|dabigatran|mesh-list
57143793|NCT02171039|Atorvastatin|atorvastatin|mesh-list
57143794|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57143795|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57143796|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
57143797|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143798|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57143799|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57143800|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143801|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
57143802|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57143803|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
57143804|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
57143805|NCT00840073|Trandolapril|trandolapril|mesh-list
57143806|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57143807|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
57143808|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143809|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143810|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57143811|NCT02261207|Axitinib|axitinib|mesh-list
57143812|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143813|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57143814|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143815|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143816|NCT00838279|Lamotrigine|lamotrigine|mesh-list
57143817|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
57143818|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57143819|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57143820|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143821|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57143822|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143823|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57143824|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57143825|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143826|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57143827|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57143828|NCT02163707|Psilocybin|psilocybin|mesh-list
57143829|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
57143830|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143831|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57143832|NCT00769795|Goserelin|goserelin|mesh-list
57143833|NCT00769795|Bicalutamide|bicalutamide|mesh-list
56825597|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
57143834|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57143835|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143836|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
57143837|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
57143838|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143839|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143840|NCT03134677|Bupivacaine|bupivacaine|mesh-list
57143841|NCT03134677|Sevoflurane|sevoflurane|mesh-list
57143842|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
57143843|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
57143844|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143845|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143846|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
57143847|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143848|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57143849|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57143850|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
57143851|NCT00722917|Pioglitazone|pioglitazone|mesh-list
57143852|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57143853|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143854|NCT02164097|Heparin|heparin|mesh-list
57143855|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
57143856|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57143857|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57143858|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143859|NCT00717457|Exenatide|exenatide|mesh-list
57143860|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57143861|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57143862|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143863|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57143864|NCT00717457|Incretins|incretins|mesh-ancestor
57143865|NCT00717457|Hormones|hormones|mesh-ancestor
57143866|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143867|NCT02171507|Diclofenac|diclofenac|mesh-list
57143868|NCT02171507|Dabigatran|dabigatran|mesh-list
57143869|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57143870|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57143871|NCT02171507|Analgesics|analgesics|mesh-ancestor
57143872|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
57143873|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143874|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143875|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143876|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143877|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57143878|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143879|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143880|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
57143881|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57143882|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
57143883|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
57143884|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57143885|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57143886|NCT00758953|Danazol|danazol|mesh-list
57143887|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57143888|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
57143889|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143890|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143891|NCT02167685|Brincidofovir|brincidofovir|mesh-list
57143892|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
57143893|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143894|NCT00758563|Triclosan|triclosan|mesh-list
57143895|NCT00758563|Fluorides|fluorides|mesh-list
57143896|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
57143897|NCT00758563|Protective Agents|protective agents|mesh-ancestor
57143898|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143899|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57143900|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143901|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57143902|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57143903|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
57143904|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143905|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57143906|NCT02171585|Clarithromycin|clarithromycin|mesh-list
57143907|NCT02171585|Dabigatran|dabigatran|mesh-list
57143908|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57143909|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143910|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57143911|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143912|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143913|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57143914|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57143915|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
57143916|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57143917|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
57143918|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
57143919|NCT03134443|Andrographolide|andrographolide|mesh-list
57143920|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57143921|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57143922|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57143924|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
57143925|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57143926|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143927|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57143928|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57143929|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57143930|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143931|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
57143932|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57143933|NCT02171663|Afatinib|afatinib|mesh-list
57143934|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143935|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57143936|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143937|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143938|NCT02171741|Docetaxel|docetaxel|mesh-list
57143939|NCT02171741|Afatinib|afatinib|mesh-list
57143940|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57143941|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
57143942|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
57143943|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
57143944|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143945|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57143946|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143947|NCT00835705|Amoxicillin|amoxicillin|mesh-list
57143948|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57143949|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
57143950|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
57143951|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57143952|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143953|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57143954|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143955|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143956|NCT02938520|Rilpivirine|rilpivirine|mesh-list
57143957|NCT02938520|Cabotegravir|cabotegravir|mesh-list
57143958|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57143959|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57143960|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57143961|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143962|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
57143963|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143964|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57143965|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57143966|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57143967|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57143968|NCT00713401|Esmolol|esmolol|mesh-list
57143969|NCT00713401|Tecadenoson|tecadenoson|mesh-list
57143970|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57143971|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57143972|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57143973|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
57143974|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57143975|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143976|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143977|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57143978|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
57143979|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
57143980|NCT02171975|Anesthetics|anesthetics|mesh-list
57143981|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57143982|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143983|NCT00835549|Cefdinir|cefdinir|mesh-list
57143984|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57143985|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57143986|NCT02164253|Deferiprone|deferiprone|mesh-list
57143987|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57143988|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
57143989|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
57143990|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57143991|NCT00755287|Metformin|metformin|mesh-list
57143992|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
57143993|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57143994|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57143995|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57143996|NCT00755287|Incretins|incretins|mesh-ancestor
57143997|NCT00755287|Hormones|hormones|mesh-ancestor
57143998|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57143999|NCT02168075|Mannitol|mannitol|mesh-list
57144000|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57144001|NCT02168075|Diuretics|diuretics|mesh-ancestor
57144002|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
57144003|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144004|NCT00712699|Adderall|adderall|mesh-list
57144005|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57144006|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144007|NCT03945825|Vaccines|vaccines|mesh-list
57144008|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
57144009|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144010|NCT03819517|Resveratrol|resveratrol|mesh-list
57144011|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
57144012|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144013|NCT03819517|Protective Agents|protective agents|mesh-ancestor
57144014|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144015|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144016|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57144017|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
57144018|NCT02759315|Ruzasvir|ruzasvir|mesh-list
57144019|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
57144020|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144021|NCT04265534|Folic Acid|folic acid|mesh-list
57144022|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
57144023|NCT04265534|Dexamethasone|dexamethasone|mesh-list
57144024|NCT04265534|Carboplatin|carboplatin|mesh-list
57144025|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
57144026|NCT04265534|Pemetrexed|pemetrexed|mesh-list
57144027|NCT04265534|Vitamins|vitamins|mesh-ancestor
57144028|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
57144029|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144030|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57144031|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
57144032|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
57144033|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144034|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57144035|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
57144036|NCT04265534|Hormones|hormones|mesh-ancestor
57144037|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144038|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57144039|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144040|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57144041|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144042|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144043|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57144044|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57144045|NCT04265534|Hematinics|hematinics|mesh-ancestor
57144046|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
57144047|NCT00697099|Enoxaparin|enoxaparin|mesh-list
57144048|NCT00697099|Semuloparin|semuloparin|mesh-list
57144049|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
57144050|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
57144051|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57144052|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57144053|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144054|NCT02172131|Olodaterol|olodaterol|mesh-list
57144055|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57144056|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
57144057|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825823|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
57144058|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144059|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57144060|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
57144061|NCT05435768|Denosumab|denosumab|mesh-list
57144062|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57144063|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144065|NCT05630859|Immunologic Factors|immunologic factors|mesh-ancestor
57144066|NCT05630859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144067|NCT00835081|Cefadroxil|cefadroxil|mesh-list
57144068|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57144069|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144070|NCT02543918|Ixekizumab|ixekizumab|mesh-list
57144071|NCT02543918|Vaccines|vaccines|mesh-list
57144072|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57144073|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
57144074|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144075|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
57144076|NCT03539003|Remifentanil|remifentanil|mesh-list
57144077|NCT03539003|Propofol|propofol|mesh-list
57144078|NCT03539003|Sevoflurane|sevoflurane|mesh-list
57144079|NCT03539003|Desflurane|desflurane|mesh-list
57144080|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57144081|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144082|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144083|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57144084|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
57144085|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
57144086|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57144087|NCT03539003|Narcotics|narcotics|mesh-ancestor
57144088|NCT03539003|Analgesics|analgesics|mesh-ancestor
57144089|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
57144090|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144091|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57144092|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57144093|NCT00751231|Clopidogrel|clopidogrel|mesh-list
57144094|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57144095|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57144096|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57144097|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57144098|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
57144099|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144100|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144101|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144102|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
57144103|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57144104|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57144105|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144106|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
57144107|NCT02164565|Coagulants|coagulants|mesh-ancestor
57144108|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
57144109|NCT00750295|Hematinics|hematinics|mesh-ancestor
57144110|NCT02172209|Empagliflozin|empagliflozin|mesh-list
57144111|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57144112|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144113|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57144114|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144115|NCT02168543|Alendronate|alendronate|mesh-list
57144116|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57144117|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144118|NCT01372995|Vitamin D|vitamin d|mesh-list
57144119|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
57144120|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
57144121|NCT01372995|Vitamins|vitamins|mesh-list
57144122|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
57144123|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144124|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57144125|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57144126|NCT04239859|Cyclosporine|cyclosporine|mesh-list
57144127|NCT04239859|Methotrexate|methotrexate|mesh-list
57144128|NCT04239859|Acitretin|acitretin|mesh-list
57144129|NCT04239859|Cyclosporins|cyclosporins|mesh-list
57144130|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57144131|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
57144132|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57144133|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144134|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57144135|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
57144136|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144137|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144138|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
57144139|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144140|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57144141|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57144142|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
57144143|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57144144|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57144145|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
57144146|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144147|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56837999|NCT03759262|Vitamins|vitamins|mesh-ancestor
57144148|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
57144149|NCT02938923|Testosterone|testosterone|mesh-list
57144150|NCT02938923|Androgens|androgens|mesh-ancestor
57144151|NCT02938923|Hormones|hormones|mesh-ancestor
57144152|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144153|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144154|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
57144155|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57144156|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
57144157|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
57144158|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144159|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144160|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57144161|NCT02757521|Analgesics|analgesics|mesh-ancestor
57144162|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
57144163|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144164|NCT00744367|Metformin|metformin|mesh-list
57144165|NCT00744367|Pioglitazone|pioglitazone|mesh-list
57144166|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57144167|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57144168|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144169|NCT00744367|Incretins|incretins|mesh-ancestor
57144170|NCT00744367|Hormones|hormones|mesh-ancestor
57144171|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144172|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
57144173|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57144174|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57144175|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
57144176|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144177|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144178|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57144179|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
57144180|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
57144181|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57144182|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
57144183|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144184|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144185|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57144186|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57144187|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57144188|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
57144189|NCT02261129|Telmisartan|telmisartan|mesh-list
57144190|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57144191|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57144192|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57144193|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144194|NCT00694135|Dexamethasone|dexamethasone|mesh-list
57144195|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
57144196|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57144197|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57144198|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57144199|NCT00694135|BB 1101|bb 1101|mesh-list
57144200|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57144201|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
57144202|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
57144203|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144204|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144205|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57144206|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
57144207|NCT00694135|Hormones|hormones|mesh-ancestor
57144208|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144209|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57144210|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144211|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
56825973|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
57144212|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144213|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144214|NCT03540095|Bupivacaine|bupivacaine|mesh-list
57144215|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
57144216|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
57144217|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144218|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144219|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
57144220|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144221|NCT03071185|Dexmedetomidine|dexmedetomidine|mesh-list
57144222|NCT03071185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57144223|NCT03071185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144224|NCT03071185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144225|NCT03071185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57144226|NCT03071185|Analgesics|analgesics|mesh-ancestor
57144227|NCT03071185|Sensory System Agents|sensory system agents|mesh-ancestor
57144228|NCT03071185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144229|NCT03071185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57144230|NCT03071185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57144231|NCT03071185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57144232|NCT03071185|Adrenergic Agents|adrenergic agents|mesh-ancestor
57144233|NCT03071185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144234|NCT03071185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144235|NCT00741715|Atorvastatin|atorvastatin|mesh-list
57144236|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57144237|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57144238|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
57144239|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144240|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57144241|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57144242|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144243|NCT02169167|Octenidine|octenidine|mesh-list
57144244|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144245|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57144246|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
57144247|NCT02172443|Ipratropium|ipratropium|mesh-list
57144248|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57144249|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
57144250|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144251|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144252|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57144253|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
57144254|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
57144255|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57144256|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
57144257|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144258|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144259|NCT00834613|Metformin|metformin|mesh-list
57144260|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57144261|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144262|NCT02172521|Bromides|bromides|mesh-list
57144263|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
57144264|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57144265|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
57144266|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144267|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144268|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57144269|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
57144270|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
57144271|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57144272|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
57144273|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144274|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144275|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
57144276|NCT00834535|Cefdinir|cefdinir|mesh-list
57144277|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57144278|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144279|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
57144280|NCT00691717|Anecortave|anecortave|mesh-list
57144281|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57144282|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57144283|NCT00691717|Growth Substances|growth substances|mesh-ancestor
57144284|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144285|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
57144286|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826060|NCT01114282|Bortezomib|bortezomib|mesh-list
57144287|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57144288|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57144289|NCT00834067|Moexipril|moexipril|mesh-list
57144290|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57144291|NCT00834067|Diuretics|diuretics|mesh-ancestor
57144292|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
57144293|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144294|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57144295|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57144296|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144297|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57144298|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
57144299|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144300|NCT00682981|Carboplatin|carboplatin|mesh-list
57144301|NCT00682981|Etoposide|etoposide|mesh-list
57144302|NCT00682981|Obatoclax|obatoclax|mesh-list
57144303|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144304|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57144305|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57144306|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57144307|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144308|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144309|NCT00833521|Zolpidem|zolpidem|mesh-list
57144310|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57144311|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57144312|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144313|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144314|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57144315|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
57144316|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
57144317|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144318|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144319|NCT00832507|Cicletanine|cicletanine|mesh-list
57144320|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57144321|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57144322|NCT00832507|Diuretics|diuretics|mesh-ancestor
57144323|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
57144324|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144325|NCT04862143|Fulvestrant|fulvestrant|mesh-list
57144326|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57144327|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144328|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57144329|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57144330|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
57144331|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144332|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144333|NCT02721459|Vemurafenib|vemurafenib|mesh-list
57144334|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144335|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57144336|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144337|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144338|NCT02802943|Imiquimod|imiquimod|mesh-list
57144339|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57144340|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
57144341|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144342|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144343|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
57144344|NCT02165033|Budesonide|budesonide|mesh-list
57144345|NCT02165033|Procaterol|procaterol|mesh-list
57144346|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57144347|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57144348|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
57144349|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144350|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144351|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57144352|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
57144353|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
57144354|NCT02165033|Hormones|hormones|mesh-ancestor
57144355|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144356|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
57144357|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57144358|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57144359|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57144360|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
57144361|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144362|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144363|NCT00734461|Naltrexone|naltrexone|mesh-list
57144364|NCT00734461|Oxycodone|oxycodone|mesh-list
57144365|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57144366|NCT00734461|Narcotics|narcotics|mesh-ancestor
57144367|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144368|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144369|NCT00734461|Analgesics|analgesics|mesh-ancestor
57144370|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
57144371|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144372|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57144373|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57144374|NCT02169713|Tamsulosin|tamsulosin|mesh-list
57144375|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
57144376|NCT02169713|Mirabegron|mirabegron|mesh-list
57144377|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57144378|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57144379|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57144380|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
57144381|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144382|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144383|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144384|NCT02169713|Urological Agents|urological agents|mesh-ancestor
57144385|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57144386|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57144387|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
57144388|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57144389|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57144390|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57144391|NCT03980041|Nivolumab|nivolumab|mesh-list
57144392|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57144393|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144394|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57144395|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144396|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
57144397|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57144398|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57144399|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144400|NCT00829309|Pravastatin|pravastatin|mesh-list
57144401|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57144402|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57144403|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
57144404|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144405|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57144406|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57144407|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144408|NCT02165189|Ribavirin|ribavirin|mesh-list
57144409|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
57144410|NCT02165189|Simeprevir|simeprevir|mesh-list
57144411|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
57144412|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144413|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
57144414|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144415|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
57144416|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144417|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
57144418|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
57144419|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144420|NCT00725881|Protective Agents|protective agents|mesh-ancestor
57144421|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144422|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57144423|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144424|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
57144425|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57144426|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144427|NCT02403505|Myeloma Proteins|myeloma proteins|mesh-list
57144428|NCT02403505|Paraproteins|paraproteins|mesh-list
57144429|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
57144430|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
57144431|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144432|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57144433|NCT03947827|Minocycline|minocycline|mesh-list
57144434|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56826202|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
57144435|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144436|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
57144437|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57144438|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
57144439|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57144440|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
57144441|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144442|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144443|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
57144444|NCT01950403|Linaclotide|linaclotide|mesh-list
57144445|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57144446|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
57144447|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144448|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57144449|NCT03607539|Pemetrexed|pemetrexed|mesh-list
57144450|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144451|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144452|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144453|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57144454|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57144455|NCT00629941|Azithromycin|azithromycin|mesh-list
57144456|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57144457|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144458|NCT02404779|Cisatracurium|cisatracurium|mesh-list
57144459|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57144460|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57144461|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144462|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144463|NCT00629551|Paroxetine|paroxetine|mesh-list
57144464|NCT00629551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57144465|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57144466|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57144467|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144468|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144469|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
57144470|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144471|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57144472|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
57144473|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57144474|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57144475|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57144476|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144477|NCT00625651|Bevacizumab|bevacizumab|mesh-list
57144478|NCT00625651|Conatumumab|conatumumab|mesh-list
57144479|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57144480|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144481|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57144482|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57144483|NCT00625651|Growth Substances|growth substances|mesh-ancestor
57144484|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144485|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
57144486|NCT00672997|Timolol|timolol|mesh-list
57144487|NCT00672997|Travoprost|travoprost|mesh-list
57144488|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57144489|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57144490|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57144491|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57144492|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
57144493|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144494|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144495|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144496|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57144497|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57144498|NCT02130453|Regadenoson|regadenoson|mesh-list
57144499|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
57144500|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57144501|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
57144502|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
57144503|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144504|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144505|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144506|NCT02669043|Ketamine|ketamine|mesh-list
57144507|NCT02669043|Analgesics|analgesics|mesh-ancestor
57144508|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
57144509|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144510|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144511|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57144512|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57144513|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
57144515|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144516|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57144517|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57144518|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144519|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144520|NCT02760407|Adalimumab|adalimumab|mesh-list
57144521|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57144522|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57144523|NCT05209555|Pilocarpine|pilocarpine|mesh-list
57144524|NCT05209555|Miotics|miotics|mesh-ancestor
57144525|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
57144526|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144527|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144528|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57144529|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57144530|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
57144531|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144532|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144533|NCT02020707|Paclitaxel|paclitaxel|mesh-list
57144534|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57144535|NCT02020707|Bevacizumab|bevacizumab|mesh-list
57144536|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57144537|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
57144538|NCT02020707|Antibodies|antibodies|mesh-list
57144539|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
57144540|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57144541|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
57144542|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57144543|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144544|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
57144545|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
57144546|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
57144547|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144548|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57144549|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57144550|NCT02020707|Growth Substances|growth substances|mesh-ancestor
57144551|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144552|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
57144553|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
57144554|NCT02281045|Citric Acid|citric acid|mesh-list
57144555|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
57144556|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
57144557|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57144558|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
57144559|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
57144560|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144561|NCT04472689|Lidocaine|lidocaine|mesh-list
57144562|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
57144563|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
57144564|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144565|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144566|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
57144567|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144568|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57144569|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57144570|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57144571|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57144572|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144573|NCT02405013|Ribavirin|ribavirin|mesh-list
57144574|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
57144575|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
57144576|NCT02405013|Ledipasvir|ledipasvir|mesh-list
57144577|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
57144578|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144579|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
57144580|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144581|NCT02173145|Azithromycin|azithromycin|mesh-list
57144582|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57144583|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144584|NCT00670033|Travoprost|travoprost|mesh-list
57144585|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57144586|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57144587|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57144588|NCT02283775|Dexamethasone|dexamethasone|mesh-list
57144589|NCT02283775|Pomalidomide|pomalidomide|mesh-list
57144590|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57144591|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
57144592|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
57144593|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144594|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144595|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57144596|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
57144597|NCT02283775|Hormones|hormones|mesh-ancestor
57144598|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144599|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57144600|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144601|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
57144602|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57144603|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57144604|NCT02283775|Growth Substances|growth substances|mesh-ancestor
57144605|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
57144606|NCT04479891|Itraconazole|itraconazole|mesh-list
57144607|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
57144608|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144609|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57144610|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57144611|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144612|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144613|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57144614|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
57144615|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144616|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144617|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57144618|NCT02281201|Thrombin|thrombin|mesh-list
57144619|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
57144620|NCT02281201|Coagulants|coagulants|mesh-ancestor
57144621|NCT02281279|Rituximab|rituximab|mesh-list
57144622|NCT02281279|Lenalidomide|lenalidomide|mesh-list
57144623|NCT02281279|Romidepsin|romidepsin|mesh-list
57144624|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57144625|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144626|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
57144627|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144628|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57144629|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57144630|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57144631|NCT02281279|Growth Substances|growth substances|mesh-ancestor
57144632|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
57144633|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57144634|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57144635|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57144636|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144637|NCT02173457|Incretins|incretins|mesh-ancestor
57144638|NCT02173457|Hormones|hormones|mesh-ancestor
57144639|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144640|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57144641|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
57144642|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144643|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144644|NCT04626635|Cemiplimab|cemiplimab|mesh-list
57144645|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57144646|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144647|NCT00805129|Everolimus|everolimus|mesh-list
57144648|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144649|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57144650|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
57144651|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144652|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
57144653|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57144654|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144655|NCT00501709|Abatacept|abatacept|mesh-list
57144656|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56826427|NCT01211314|Enalapril|enalapril|mesh-list
57144657|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57144658|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144660|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
57144661|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144662|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57144663|NCT02273635|Andrographolide|andrographolide|mesh-list
57144664|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57144665|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57144666|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57144667|NCT02273635|Analgesics|analgesics|mesh-ancestor
57144668|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
57144669|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144670|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144671|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57144672|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57144673|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57144674|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144675|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
57144676|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57144677|NCT02170415|Pregabalin|pregabalin|mesh-list
57144678|NCT02170415|Anesthetics|anesthetics|mesh-list
57144679|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
57144680|NCT02170415|Analgesics|analgesics|mesh-ancestor
57144681|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
57144682|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144683|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144684|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
57144685|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57144686|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57144687|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144688|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57144689|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57144690|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57144691|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144692|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57144693|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
57144694|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144695|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57144696|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57144697|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144698|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144699|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
57144700|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
57144701|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57144702|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57144703|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
57144704|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144705|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144706|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57144707|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
57144708|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
57144709|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57144710|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
57144711|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144712|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144713|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57144714|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57144715|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57144716|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
57144717|NCT02274259|Ranibizumab|ranibizumab|mesh-list
57144718|NCT02274259|Aflibercept|aflibercept|mesh-list
57144719|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57144720|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57144721|NCT02274259|Growth Substances|growth substances|mesh-ancestor
57144722|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144723|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
57144724|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144725|NCT05571111|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57144726|NCT05571111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57144727|NCT05571111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144728|NCT02404623|Vitamin D|vitamin d|mesh-list
57144729|NCT02404623|Vitamins|vitamins|mesh-ancestor
57144730|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
57144731|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144733|NCT02170571|Dabigatran|dabigatran|mesh-list
57144734|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
57144735|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57144736|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
57144737|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144738|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144739|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
57144740|NCT04481841|Vitamins|vitamins|mesh-list
57144741|NCT04481841|Vitamin E|vitamin e|mesh-list
57144742|NCT04481841|Riboflavin|riboflavin|mesh-list
57144743|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
57144744|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144745|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
57144746|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
57144747|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144748|NCT04481841|Protective Agents|protective agents|mesh-ancestor
57144749|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57144750|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
57144751|NCT02388477|Doxycycline|doxycycline|mesh-list
57144752|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57144753|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144754|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
57144755|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57144756|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57144757|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57144758|NCT02166359|Icodextrin|icodextrin|mesh-list
57144759|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
57144760|NCT00488839|Baclofen|baclofen|mesh-list
57144761|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57144762|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144763|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57144764|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144765|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57144766|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
57144767|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
57144768|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144769|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144770|NCT02255747|Lactulose|lactulose|mesh-list
57144771|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57144772|NCT01654731|Bezafibrate|bezafibrate|mesh-list
57144773|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57144774|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
57144775|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144776|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57144777|NCT00485563|Folic Acid|folic acid|mesh-list
57144778|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
57144779|NCT00485563|Interferons|interferons|mesh-list
57144780|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
57144781|NCT00485563|Interleukin-2|interleukin-2|mesh-list
57144782|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
57144783|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144784|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
57144785|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144786|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
57144787|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144788|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57144789|NCT00485563|Analgesics|analgesics|mesh-ancestor
57144790|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
57144791|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144792|NCT00485563|Hematinics|hematinics|mesh-ancestor
57144793|NCT00485563|Vitamins|vitamins|mesh-ancestor
57144794|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
57144795|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57144796|NCT02170805|Pantoprazole|pantoprazole|mesh-list
57144797|NCT02170805|Dabigatran|dabigatran|mesh-list
57144798|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57144799|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57144800|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57144801|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144802|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144803|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
57144804|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57144805|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
57144806|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
57144807|NCT00606697|Vofopitant|vofopitant|mesh-list
57144808|NCT00606697|Vestipitant|vestipitant|mesh-list
57144809|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57144810|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144811|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144812|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144813|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
57144814|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
57144815|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144816|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57144817|NCT02404077|Clonidine|clonidine|mesh-list
57144818|NCT02404077|Analgesics|analgesics|mesh-ancestor
57144819|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
57144820|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144821|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144822|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57144823|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
57144824|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
57144825|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57144826|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57144827|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57144828|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
57144829|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144830|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144831|NCT02174939|Cilostazol|cilostazol|mesh-list
57144832|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57144833|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
57144834|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144835|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144836|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57144837|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
57144838|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57144839|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57144840|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144841|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57144842|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
57144843|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57144844|NCT02174939|Protective Agents|protective agents|mesh-ancestor
57144845|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57144846|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57144847|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144848|NCT02404233|Darunavir|darunavir|mesh-list
57144849|NCT02404233|Cobicistat|cobicistat|mesh-list
57144850|NCT02404233|Rilpivirine|rilpivirine|mesh-list
57144851|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
57144852|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57144853|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57144854|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
57144855|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144856|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144857|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57144858|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57144859|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
57144860|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144861|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57144862|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57144863|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57144864|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57144865|NCT00603577|Xaliproden|xaliproden|mesh-list
57144866|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57144867|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57144868|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
57144869|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144870|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144871|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144872|NCT02178293|Ketoprofen|ketoprofen|mesh-list
57144873|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
57144874|NCT02178293|Benzydamine|benzydamine|mesh-list
57144875|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57144876|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57144877|NCT02178293|Analgesics|analgesics|mesh-ancestor
57144878|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
57144879|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144880|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144881|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57144882|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57144883|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56826649|NCT01219036|Hormones|hormones|mesh-ancestor
57144885|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144886|NCT03170895|Sorafenib|sorafenib|mesh-list
57144887|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
57144888|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144889|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57144890|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144891|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144892|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57144893|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57144894|NCT02277847|Cytarabine|cytarabine|mesh-list
57144895|NCT02277847|Idarubicin|idarubicin|mesh-list
57144896|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57144897|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
57144898|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144899|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144900|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
57144901|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144902|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57144903|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
57144904|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144905|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57144906|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57144907|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57144908|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144909|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
57144910|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57144911|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
57144912|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144913|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144914|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57144915|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
57144916|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57144917|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
57144918|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144919|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57144920|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57144921|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
57144922|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
57144923|NCT01457781|Protective Agents|protective agents|mesh-ancestor
57144924|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
57144925|NCT00468403|Abatacept|abatacept|mesh-list
57144926|NCT00468403|Tacrolimus|tacrolimus|mesh-list
57144927|NCT00468403|Basiliximab|basiliximab|mesh-list
57144928|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57144929|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
57144930|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144931|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57144932|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144933|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144934|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57144935|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144936|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57144937|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
57144938|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57144939|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144940|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57144941|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57144942|NCT02175017|Nivolumab|nivolumab|mesh-list
57144943|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57144944|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144945|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57144946|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144947|NCT02178449|Dexamethasone|dexamethasone|mesh-list
57144948|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
57144949|NCT02178449|Ropivacaine|ropivacaine|mesh-list
57144950|NCT02178449|BB 1101|bb 1101|mesh-list
57144951|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57144952|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
57144953|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
57144954|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57144955|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144956|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57144957|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
57144958|NCT02178449|Hormones|hormones|mesh-ancestor
57144959|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57144960|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57144961|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57144962|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
57144963|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
57144964|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57144965|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
57144966|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
57144967|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144968|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144969|NCT02387931|Vitamin D|vitamin d|mesh-list
57144970|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
57144971|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
57144972|NCT02387931|Vitamins|vitamins|mesh-list
57144973|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
57144974|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144975|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57144976|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57144977|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
57144978|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57144979|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57144980|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144981|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
57144982|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57144983|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
57144984|NCT00829023|Povidone-Iodine|povidone-iodine|mesh-list
57144985|NCT00829023|Povidone|povidone|mesh-list
57144986|NCT00829023|Plasma Substitutes|plasma substitutes|mesh-ancestor
57144987|NCT00829023|Blood Substitutes|blood substitutes|mesh-ancestor
57144988|NCT00829023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57144989|NCT00829023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57144990|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
57144991|NCT02178683|Tacrolimus|tacrolimus|mesh-list
57144992|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57144993|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
57144994|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57144995|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57144996|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57144997|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57144998|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57144999|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145000|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57145001|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
57145002|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57145003|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145004|NCT03170739|Dopamine|dopamine|mesh-list
57145005|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
57145006|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57145007|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57145008|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145009|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57145010|NCT03170739|Analgesics|analgesics|mesh-ancestor
57145011|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
57145012|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145013|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57145014|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57145015|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57145016|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
57145017|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145018|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145019|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57145020|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
57145021|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
57145022|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
57145023|NCT03170739|Protective Agents|protective agents|mesh-ancestor
57145024|NCT03133975|Vitamin D|vitamin d|mesh-list
57145025|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
57145026|NCT03133975|Vitamins|vitamins|mesh-ancestor
57145027|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
57145028|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145029|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57145030|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57145031|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
57145032|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57145033|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145034|NCT00459745|Fenofibrate|fenofibrate|mesh-list
57145036|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57145037|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
57145038|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145039|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57145040|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57145041|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57145042|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145043|NCT02178761|Chromium|chromium|mesh-list
57145044|NCT02178761|Everolimus|everolimus|mesh-list
57145045|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145046|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57145047|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
57145048|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145049|NCT02178761|Trace Elements|trace elements|mesh-ancestor
57145050|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
57145051|NCT00492999|Leucovorin|leucovorin|mesh-list
57145052|NCT00492999|Dexamethasone|dexamethasone|mesh-list
57145053|NCT00492999|Fluorouracil|fluorouracil|mesh-list
57145054|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
57145055|NCT00492999|Irinotecan|irinotecan|mesh-list
57145056|NCT00492999|Floxuridine|floxuridine|mesh-list
57145057|NCT00492999|Calcium|calcium|mesh-list
57145058|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
57145059|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145060|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
57145061|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
57145062|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145063|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145064|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57145065|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
57145066|NCT00492999|Hormones|hormones|mesh-ancestor
57145067|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145068|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57145069|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145070|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57145071|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
57145072|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145073|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57145074|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57145075|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
57145076|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57145077|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57145078|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145079|NCT00492999|Antidotes|antidotes|mesh-ancestor
57145080|NCT00492999|Protective Agents|protective agents|mesh-ancestor
57145081|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
57145082|NCT00492999|Vitamins|vitamins|mesh-ancestor
57145083|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
57145084|NCT02742181|Alvimopan|alvimopan|mesh-list
57145085|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57145086|NCT02175407|Itraconazole|itraconazole|mesh-list
57145087|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
57145088|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145089|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57145090|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57145091|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145092|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145093|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57145094|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
57145095|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145096|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145097|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57145098|NCT02182193|Nintedanib|nintedanib|mesh-list
57145099|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145100|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57145101|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145102|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145103|NCT02175485|Fexofenadine|fexofenadine|mesh-list
57145104|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57145105|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57145106|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57145107|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
57145108|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
57145109|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826874|NCT01215136|Paclitaxel|paclitaxel|mesh-list
57145110|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145111|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145112|NCT04575779|Cyclosporine|cyclosporine|mesh-list
57145113|NCT04575779|Cyclosporins|cyclosporins|mesh-list
57145114|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145115|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145116|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57145117|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
57145118|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145119|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
57145120|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145121|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
57145122|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145123|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57145124|NCT02741713|Lidocaine|lidocaine|mesh-list
57145125|NCT02741713|Clonidine|clonidine|mesh-list
57145126|NCT02741713|Epinephrine|epinephrine|mesh-list
57145127|NCT02741713|Racepinephrine|racepinephrine|mesh-list
57145128|NCT02741713|Bupivacaine|bupivacaine|mesh-list
57145129|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57145130|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
57145131|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
57145132|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
57145133|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57145134|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145135|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
57145136|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145137|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57145138|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57145139|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57145140|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57145141|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145142|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57145143|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57145144|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
57145145|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145146|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57145147|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57145148|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
57145149|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57145150|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
57145151|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
57145152|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
57145153|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57145154|NCT02741713|Analgesics|analgesics|mesh-ancestor
57145155|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57145156|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
57145157|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57145158|NCT00459277|Fentanyl|fentanyl|mesh-list
57145159|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57145160|NCT00459277|Narcotics|narcotics|mesh-ancestor
57145161|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57145162|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145163|NCT00459277|Analgesics|analgesics|mesh-ancestor
57145164|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
57145165|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145166|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57145167|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57145168|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
57145169|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
57145170|NCT00602329|Leucovorin|leucovorin|mesh-list
57145171|NCT00602329|Bevacizumab|bevacizumab|mesh-list
57145172|NCT00602329|Fluorouracil|fluorouracil|mesh-list
57145173|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
57145174|NCT00602329|Calcium|calcium|mesh-list
57145175|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
57145176|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57145177|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145178|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57145179|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57145180|NCT00602329|Growth Substances|growth substances|mesh-ancestor
57145181|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145182|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
57145183|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57145184|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
57145185|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145186|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57145187|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57145188|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
57145189|NCT00602329|Antidotes|antidotes|mesh-ancestor
57145190|NCT00602329|Protective Agents|protective agents|mesh-ancestor
57145191|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
57145192|NCT00602329|Vitamins|vitamins|mesh-ancestor
57145193|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
57145194|NCT02182505|Fenoterol|fenoterol|mesh-list
57145195|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57145196|NCT02182505|Ipratropium|ipratropium|mesh-list
57145197|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57145198|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
57145199|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145200|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145201|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57145202|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
57145203|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
57145204|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
57145205|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57145206|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57145207|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57145208|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57145209|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
57145210|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145211|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145212|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57145213|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
57145214|NCT02387619|Amlodipine|amlodipine|mesh-list
57145215|NCT02387619|Telmisartan|telmisartan|mesh-list
57145216|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
57145217|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57145218|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57145219|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57145220|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57145221|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145222|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57145223|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145224|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
57145225|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57145226|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57145227|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
57145228|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57145229|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57145230|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145231|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57145232|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57145233|NCT03537443|Vitamin D|vitamin d|mesh-list
57145234|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
57145235|NCT03537443|Vitamins|vitamins|mesh-ancestor
57145236|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
57145237|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145238|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57145239|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57145240|NCT00595699|Citalopram|citalopram|mesh-list
57145241|NCT00595699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57145242|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57145243|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57145244|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145245|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145246|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
57145247|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145248|NCT00595699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57145249|NCT00595699|Antidepressive Agents|antidepressive agents|mesh-ancestor
57145250|NCT00595699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57145251|NCT02256215|Vitamin D|vitamin d|mesh-list
57145252|NCT02256215|Vitamins|vitamins|mesh-ancestor
57145253|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
57145254|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145255|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57145256|NCT02182583|Oxitropium|oxitropium|mesh-list
57145257|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
57145258|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
57145259|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145260|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145261|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57145263|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145264|NCT02182661|Oxitropium|oxitropium|mesh-list
57145265|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
57145266|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
57145267|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145268|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145269|NCT02663271|Bevacizumab|bevacizumab|mesh-list
57145270|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57145271|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145272|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57145273|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57145274|NCT02663271|Growth Substances|growth substances|mesh-ancestor
57145275|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145276|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
57145277|NCT00659191|Cabotegravir|cabotegravir|mesh-list
57145278|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57145279|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57145280|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145281|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145282|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57145283|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57145284|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
57145285|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145286|NCT02182739|Meloxicam|meloxicam|mesh-list
57145287|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57145288|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57145289|NCT02182739|Analgesics|analgesics|mesh-ancestor
57145290|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
57145291|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145292|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145293|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145294|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145295|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57145296|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57145297|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145298|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145299|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
57145300|NCT00583609|Laxatives|laxatives|mesh-ancestor
57145301|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57145302|NCT03170115|Aspirin|aspirin|mesh-list
57145303|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57145304|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57145305|NCT03170115|Analgesics|analgesics|mesh-ancestor
57145306|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
57145307|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145308|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145309|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145310|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145311|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57145312|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57145313|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145314|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57145315|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57145316|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145317|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
57145318|NCT03169959|Metformin|metformin|mesh-list
57145319|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
57145320|NCT03169959|Saxagliptin|saxagliptin|mesh-list
57145321|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57145322|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145323|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57145324|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145325|NCT03169959|Incretins|incretins|mesh-ancestor
57145326|NCT03169959|Hormones|hormones|mesh-ancestor
57145327|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145328|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57145329|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
57145330|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145331|NCT02176187|Fenoterol|fenoterol|mesh-list
57145332|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57145333|NCT02176187|Ipratropium|ipratropium|mesh-list
57145334|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57145335|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
57145336|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145337|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145338|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57145339|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
57145340|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
57145341|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
57145342|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57145343|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57145344|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57145345|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57145346|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
57145347|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145348|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145349|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57145350|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
57145351|NCT02176499|Telmisartan|telmisartan|mesh-list
57145352|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57145353|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57145354|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57145355|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145356|NCT02176733|Cyclosporine|cyclosporine|mesh-list
57145357|NCT02176733|Cyclosporins|cyclosporins|mesh-list
57145358|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145359|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145360|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57145361|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
57145362|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145363|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
57145364|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145365|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
57145366|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145367|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57145368|NCT03536741|Anesthetics|anesthetics|mesh-list
57145369|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
57145370|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57145371|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145372|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
57145373|NCT02403687|Topiramate|topiramate|mesh-list
57145374|NCT02403687|Diclofenac|diclofenac|mesh-list
57145375|NCT02403687|Meloxicam|meloxicam|mesh-list
57145376|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
57145377|NCT02403687|Lidocaine|lidocaine|mesh-list
57145378|NCT02403687|Clonidine|clonidine|mesh-list
57145379|NCT02403687|Sumatriptan|sumatriptan|mesh-list
57145380|NCT02403687|Ketamine|ketamine|mesh-list
57145381|NCT02403687|Gabapentin|gabapentin|mesh-list
57145382|NCT02403687|Amitriptyline|amitriptyline|mesh-list
57145383|NCT02403687|Tizanidine|tizanidine|mesh-list
57145384|NCT02403687|Bupivacaine|bupivacaine|mesh-list
57145385|NCT02403687|Prilocaine|prilocaine|mesh-list
57145386|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
57145387|NCT02403687|Baclofen|baclofen|mesh-list
57145388|NCT02403687|Capsaicin|capsaicin|mesh-list
57145389|NCT02403687|Menthol|menthol|mesh-list
57145390|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
57145391|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
57145392|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57145393|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145394|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
57145395|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145396|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57145397|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57145398|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57145399|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57145400|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145401|NCT02403687|Analgesics|analgesics|mesh-ancestor
57145402|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57145403|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57145404|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
57145405|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57145406|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57145407|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145408|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
57145409|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57145410|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57145411|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57145412|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
57145413|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57145415|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145416|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145417|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57145418|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145419|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57145420|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
57145421|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
57145422|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57145423|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57145424|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57145425|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
57145426|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
57145427|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57145428|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57145429|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57145430|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
57145431|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57145432|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57145433|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
57145434|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57145435|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57145436|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
57145437|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
57145438|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
57145439|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57145440|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57145441|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57145442|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57145443|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
57145444|NCT02742649|Timolol|timolol|mesh-list
57145445|NCT02742649|Bimatoprost|bimatoprost|mesh-list
57145446|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57145447|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57145448|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
57145449|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145450|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145451|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145452|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57145453|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57145454|NCT02183051|Ibuprofen|ibuprofen|mesh-list
57145455|NCT02183051|Meloxicam|meloxicam|mesh-list
57145456|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57145457|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57145458|NCT02183051|Analgesics|analgesics|mesh-ancestor
57145459|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
57145460|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145461|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145462|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145463|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145464|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57145465|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145466|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145467|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57145468|NCT03169725|Vaccines|vaccines|mesh-list
57145469|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
57145470|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145471|NCT02403531|Docetaxel|docetaxel|mesh-list
57145472|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145473|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
57145474|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
57145475|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
57145476|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145477|NCT02183129|Diclofenac|diclofenac|mesh-list
57145478|NCT02183129|Meloxicam|meloxicam|mesh-list
57145479|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57145480|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57145481|NCT02183129|Analgesics|analgesics|mesh-ancestor
57145482|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
57145483|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145484|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145485|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145486|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145487|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57145488|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145489|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145490|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57145492|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
57145493|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57145494|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57145495|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57145496|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57145497|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145498|NCT02279953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57145499|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57145500|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57145501|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145502|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145503|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
57145504|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57145505|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55731333|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57145506|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57145507|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57145508|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
57145509|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57145510|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57145511|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145512|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57145513|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57145514|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145515|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145516|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145517|NCT02387307|Interferons|interferons|mesh-list
57145518|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145519|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
57145520|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145521|NCT02183363|Linagliptin|linagliptin|mesh-list
57145522|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57145523|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145524|NCT02183363|Incretins|incretins|mesh-ancestor
57145525|NCT02183363|Hormones|hormones|mesh-ancestor
57145526|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145527|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57145528|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
57145529|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145530|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145531|NCT02183441|Linagliptin|linagliptin|mesh-list
57145532|NCT02183441|Ritonavir|ritonavir|mesh-list
57145533|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57145534|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57145535|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
57145536|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145537|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145538|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57145539|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57145540|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
57145541|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145542|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57145543|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57145544|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57145545|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145546|NCT02183441|Incretins|incretins|mesh-ancestor
57145547|NCT02183441|Hormones|hormones|mesh-ancestor
57145548|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145549|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57145550|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57145551|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
57145552|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57145553|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57145554|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57145555|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57145556|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145557|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
57145558|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145559|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145560|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57145561|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145563|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
57145564|NCT03537287|Progestins|progestins|mesh-ancestor
57145565|NCT03537287|Hormones|hormones|mesh-ancestor
57145566|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145567|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145568|NCT02280031|Aspirin|aspirin|mesh-list
57145569|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57145570|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57145571|NCT02280031|Analgesics|analgesics|mesh-ancestor
57145572|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
57145573|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145574|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145575|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145576|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145577|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57145578|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57145579|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145580|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57145581|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57145582|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145583|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
57145584|NCT00449605|Metformin|metformin|mesh-list
57145585|NCT00449605|Glimepiride|glimepiride|mesh-list
57145586|NCT00449605|Rimonabant|rimonabant|mesh-list
57145587|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57145588|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145589|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57145590|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57145591|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
57145592|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57145593|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
57145594|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57145595|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145596|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145597|NCT00449605|Hormones|hormones|mesh-ancestor
57145598|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145599|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
57145600|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57145601|NCT02774239|Antibodies|antibodies|mesh-list
57145602|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
57145603|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
57145604|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145605|NCT02280109|Tenofovir|tenofovir|mesh-list
57145606|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
57145607|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145608|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57145609|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57145610|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145611|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145612|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57145613|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57145614|NCT00576667|Rimonabant|rimonabant|mesh-list
57145615|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57145616|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
57145617|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57145618|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145619|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145620|NCT00576667|Hormones|hormones|mesh-ancestor
57145621|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145622|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145623|NCT02403063|Neostigmine|neostigmine|mesh-list
57145624|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57145625|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145626|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145627|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
57145628|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145629|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145630|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57145631|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
57145632|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145633|NCT02177357|Pramipexole|pramipexole|mesh-list
57145634|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
57145635|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145637|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145638|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57145639|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57145640|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
57145641|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
57145642|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145643|NCT02386449|Mannitol|mannitol|mesh-list
57145644|NCT02386449|Bisacodyl|bisacodyl|mesh-list
57145645|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
57145646|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
57145647|NCT02386449|Citric Acid|citric acid|mesh-list
57145648|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
57145649|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57145650|NCT02386449|Diuretics|diuretics|mesh-ancestor
57145651|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
57145652|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145653|NCT02386449|Cathartics|cathartics|mesh-ancestor
57145654|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57145655|NCT02386449|Laxatives|laxatives|mesh-ancestor
57145656|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
57145657|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57145658|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
57145659|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
57145660|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145661|NCT02386449|Antacids|antacids|mesh-ancestor
57145662|NCT00656539|Azithromycin|azithromycin|mesh-list
57145663|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57145664|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145665|NCT02179775|Propranolol|propranolol|mesh-list
57145666|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57145667|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57145668|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
57145669|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145670|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145671|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145672|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57145673|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57145674|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
57145675|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57145676|NCT02177435|Telmisartan|telmisartan|mesh-list
57145677|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
57145678|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57145679|NCT02177435|Diuretics|diuretics|mesh-ancestor
57145680|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
57145681|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145682|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57145683|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57145684|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145685|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57145686|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57145687|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57145688|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57145689|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57145690|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
57145691|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145692|NCT02280265|Factor VIII|factor viii|mesh-list
57145693|NCT02280265|Coagulants|coagulants|mesh-ancestor
57145694|NCT02179931|Flupenthixol|flupenthixol|mesh-list
57145695|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
57145696|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57145697|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57145698|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57145699|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145700|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57145701|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57145702|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
57145703|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145704|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145705|NCT02184065|Meloxicam|meloxicam|mesh-list
57145706|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57145707|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57145708|NCT02184065|Analgesics|analgesics|mesh-ancestor
57145709|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
57145710|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145711|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145712|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145713|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145714|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57145715|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57145716|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145717|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145718|NCT00564421|Epinastine|epinastine|mesh-list
57145719|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57145720|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
57145721|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
57145722|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145723|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145724|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145725|NCT02665689|Ranibizumab|ranibizumab|mesh-list
57145726|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57145727|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57145728|NCT02665689|Growth Substances|growth substances|mesh-ancestor
57145729|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145730|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
57145731|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145732|NCT02386293|Irbesartan|irbesartan|mesh-list
57145733|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57145734|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57145735|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57145736|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145737|NCT00563563|Naltrexone|naltrexone|mesh-list
57145738|NCT00563563|Bupropion|bupropion|mesh-list
57145739|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57145740|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57145741|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145742|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
57145743|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145744|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57145745|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
57145746|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57145747|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57145748|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57145749|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57145750|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145751|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
57145752|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145753|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57145754|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57145755|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145756|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57145757|NCT05149365|Cyclosporine|cyclosporine|mesh-list
57145758|NCT05149365|Methotrexate|methotrexate|mesh-list
57145759|NCT05149365|Cyclosporins|cyclosporins|mesh-list
57145760|NCT05149365|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57145761|NCT05149365|Abortifacient Agents|abortifacient agents|mesh-ancestor
57145762|NCT05149365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57145763|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145764|NCT05149365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57145765|NCT05149365|Antimetabolites|antimetabolites|mesh-ancestor
57145766|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145767|NCT05149365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145768|NCT05149365|Dermatologic Agents|dermatologic agents|mesh-ancestor
57145769|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145770|NCT05149365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57145771|NCT05149365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57145772|NCT05149365|Immunologic Factors|immunologic factors|mesh-ancestor
57145773|NCT05149365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145774|NCT05149365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57145775|NCT05149365|Antifungal Agents|antifungal agents|mesh-ancestor
57145776|NCT05149365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145777|NCT05149365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57145778|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57145779|NCT05149365|Incretins|incretins|mesh-ancestor
57145780|NCT05149365|Hormones|hormones|mesh-ancestor
57145781|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145782|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57145783|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
57145784|NCT02180087|Ketoprofen|ketoprofen|mesh-list
57145785|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57145786|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57145787|NCT02180087|Analgesics|analgesics|mesh-ancestor
57145788|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
57145789|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145790|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145791|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145792|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145793|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57145794|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145795|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145796|NCT02184299|Nevirapine|nevirapine|mesh-list
57145797|NCT02184299|Prednisone|prednisone|mesh-list
57145798|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145799|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
57145800|NCT02184299|Hormones|hormones|mesh-ancestor
57145801|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145802|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839660|NCT04060654|Buprenorphine|buprenorphine|mesh-list
57145803|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57145804|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145805|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57145806|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57145807|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145808|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145809|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
57145810|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145811|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57145812|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57145813|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57145814|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57145815|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
57145816|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57145817|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57145818|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145819|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145820|NCT02282371|Cetuximab|cetuximab|mesh-list
57145821|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57145822|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145823|NCT02402595|Itraconazole|itraconazole|mesh-list
57145824|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
57145825|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145826|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57145827|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57145828|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145829|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145830|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57145831|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
57145832|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145833|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145834|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57145835|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
57145836|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57145837|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
57145838|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145839|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57145840|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145841|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57145842|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145843|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
57145844|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57145845|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57145846|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145847|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
57145848|NCT02180321|Coagulants|coagulants|mesh-ancestor
57145849|NCT00547651|Topotecan|topotecan|mesh-list
57145850|NCT00547651|Amrubicin|amrubicin|mesh-list
57145851|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57145852|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57145853|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145854|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145855|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145857|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145858|NCT02402283|Metronidazole|metronidazole|mesh-list
57145859|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145860|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57145861|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57145862|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57145863|NCT02184533|Selenious Acid|selenious acid|mesh-list
57145864|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
57145865|NCT02184533|Trace Elements|trace elements|mesh-ancestor
57145866|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
57145867|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145868|NCT02386059|Dexamethasone|dexamethasone|mesh-list
57145869|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
57145870|NCT02386059|Ondansetron|ondansetron|mesh-list
57145871|NCT02386059|BB 1101|bb 1101|mesh-list
57145872|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145873|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
57145874|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
57145875|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145876|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145877|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57145878|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
57145879|NCT02386059|Hormones|hormones|mesh-ancestor
57145880|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145881|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57145882|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145883|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
57145884|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145885|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145886|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
57145887|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
57145888|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57145889|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
57145890|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145891|NCT02386059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57145892|NCT02386059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57145893|NCT02386059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57145894|NCT02386059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57145895|NCT02386059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57145896|NCT00443287|Cilostazol|cilostazol|mesh-list
57145897|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
57145898|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57145899|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
57145900|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145901|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145902|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57145903|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
57145904|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57145905|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57145906|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145907|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57145908|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
57145909|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57145910|NCT00443287|Protective Agents|protective agents|mesh-ancestor
57145911|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57145912|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57145913|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145914|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
57145915|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
57145916|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
57145917|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57145918|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145919|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145920|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
57145921|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57145922|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57145923|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145924|NCT02390739|Aldesleukin|aldesleukin|mesh-list
57145925|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
57145926|NCT02390739|Fludarabine|fludarabine|mesh-list
57145927|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57145928|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
57145929|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145930|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57145931|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57145932|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
57145933|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145934|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145935|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57145936|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57145937|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57145938|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
57145939|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57145940|NCT02385825|Vaccines|vaccines|mesh-list
57145941|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
57145942|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145943|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
57145944|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145945|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57145946|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145947|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145948|NCT02390817|Neostigmine|neostigmine|mesh-list
57145949|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57145950|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57145951|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145952|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
57145953|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145954|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145955|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57145956|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
57145957|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57145958|NCT00537043|Carvedilol|carvedilol|mesh-list
57145959|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57145960|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57145961|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
57145962|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145963|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145964|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145965|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57145966|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
57145967|NCT00537043|Protective Agents|protective agents|mesh-ancestor
57145968|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57145969|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57145970|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57145971|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
57145972|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57145973|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57145974|NCT05041101|Halichondrin B|halichondrin b|mesh-list
57145975|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
57145976|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
57145977|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
57145978|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145979|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145980|NCT00387907|Trastuzumab|trastuzumab|mesh-list
57145981|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57145982|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57145983|NCT02180789|Tamsulosin|tamsulosin|mesh-list
57145984|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57145985|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57145986|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57145987|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
57145988|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57145989|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57145990|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145991|NCT02180789|Urological Agents|urological agents|mesh-ancestor
57145992|NCT02282683|Prednisone|prednisone|mesh-list
57145993|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57145994|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
57145995|NCT02282683|Hormones|hormones|mesh-ancestor
57145996|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57145997|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57145998|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57145999|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146000|NCT00375193|Amrubicin|amrubicin|mesh-list
57146001|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146002|NCT00151411|Metformin|metformin|mesh-list
57146003|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146004|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146005|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
57146006|NCT04471441|Everolimus|everolimus|mesh-list
57146007|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146008|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57146009|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
57146010|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146011|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57146012|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57146013|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
57146014|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57146015|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146016|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146017|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146018|NCT02662569|Atorvastatin|atorvastatin|mesh-list
57146019|NCT02662569|Evolocumab|evolocumab|mesh-list
57146020|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57146021|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57146022|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
57146023|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146024|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57146025|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57146026|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146027|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
57146028|NCT02178137|Astringents|astringents|mesh-ancestor
57146029|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146030|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
57146031|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
57146032|NCT02181023|Bromides|bromides|mesh-list
57146033|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
57146034|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57146035|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57146036|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57146037|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
57146038|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146039|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146040|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146041|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
57146042|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57146043|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57146044|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146045|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
57146046|NCT02286973|Coagulants|coagulants|mesh-ancestor
57146047|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
57146048|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57146049|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146050|NCT05015439|Cannabidiol|cannabidiol|mesh-list
57146051|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
57146052|NCT02287129|Paclitaxel|paclitaxel|mesh-list
57146053|NCT02287129|Carboplatin|carboplatin|mesh-list
57146054|NCT02287129|Capecitabine|capecitabine|mesh-list
57146055|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
57146056|NCT02287129|Epirubicin|epirubicin|mesh-list
57146057|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57146058|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146059|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
57146060|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
57146061|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
57146062|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146063|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57146064|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
57146065|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57146066|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57146067|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57146068|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146069|NCT02256683|Dabigatran|dabigatran|mesh-list
57146070|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
57146071|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
57146072|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57146073|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
57146074|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146075|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146076|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
57146077|NCT00411385|Interferons|interferons|mesh-list
57146078|NCT00411385|Ribavirin|ribavirin|mesh-list
56827851|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
57146079|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
57146080|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
57146081|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57146082|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146083|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
57146084|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146085|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
57146086|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146087|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
57146088|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146089|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57146090|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
57146091|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146092|NCT02185547|Sertraline|sertraline|mesh-list
57146093|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
57146094|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57146095|NCT02185547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57146096|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57146097|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56990928|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
57146098|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146099|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146100|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
57146101|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146102|NCT02030483|Dexamethasone|dexamethasone|mesh-list
57146103|NCT02030483|Lenalidomide|lenalidomide|mesh-list
57146104|NCT02030483|Palbociclib|palbociclib|mesh-list
57146105|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146106|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
57146107|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
57146108|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146109|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146110|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57146111|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
57146112|NCT02030483|Hormones|hormones|mesh-ancestor
57146113|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146114|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57146115|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146116|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
57146117|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57146118|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57146119|NCT02030483|Growth Substances|growth substances|mesh-ancestor
57146120|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
57146121|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57146122|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146123|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146124|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57146125|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57146126|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57146127|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57146128|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146129|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
57146130|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146131|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146132|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
57146133|NCT02385435|Bupivacaine|bupivacaine|mesh-list
57146134|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
57146135|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
57146136|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146137|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146138|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
57146139|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146140|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57146141|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57146142|NCT02385435|Analgesics|analgesics|mesh-ancestor
57146143|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57146144|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57146145|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57146146|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
57146147|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146148|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146149|NCT02753075|Fluorides|fluorides|mesh-list
57146150|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
57146151|NCT02753075|Protective Agents|protective agents|mesh-ancestor
57146152|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146153|NCT03133897|Dexamethasone|dexamethasone|mesh-list
57146155|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146156|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
57146157|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
57146158|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146159|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146160|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57146161|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
57146162|NCT03133897|Hormones|hormones|mesh-ancestor
57146163|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146164|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57146165|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146166|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
57146167|NCT05443425|Leflunomide|leflunomide|mesh-list
57146168|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146169|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146170|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57146171|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
57146172|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146173|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57146174|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57146175|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
57146176|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57146177|NCT02190149|Factor VIII|factor viii|mesh-list
57146178|NCT02190149|Coagulants|coagulants|mesh-ancestor
57146179|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
57146180|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146181|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
57146182|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146183|NCT02185859|Lidocaine|lidocaine|mesh-list
57146184|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
57146185|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
57146186|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
57146187|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146188|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146189|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
57146190|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146191|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57146192|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57146193|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57146194|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57146195|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146196|NCT02185859|Analgesics|analgesics|mesh-ancestor
57146197|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
57146198|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57146199|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57146200|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
57146201|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57146202|NCT02332720|Ribavirin|ribavirin|mesh-list
57146203|NCT02332720|Grazoprevir|grazoprevir|mesh-list
57146204|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
57146205|NCT02332720|Ruzasvir|ruzasvir|mesh-list
57146206|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
57146207|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146208|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
57146209|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146210|NCT05089175|Aspirin|aspirin|mesh-list
57146211|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57146212|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57146213|NCT05089175|Analgesics|analgesics|mesh-ancestor
57146214|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
57146215|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146216|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146217|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146218|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57146219|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57146220|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57146221|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146222|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57146223|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57146224|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146225|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
57146226|NCT02181335|Budesonide|budesonide|mesh-list
57146227|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146228|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57146229|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
57146230|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146231|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146232|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57146233|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
57146234|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
57146235|NCT02181335|Hormones|hormones|mesh-ancestor
57146236|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146237|NCT00517153|Miglustat|miglustat|mesh-list
57146238|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146239|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146240|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57146241|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57146242|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
57146243|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146244|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57146245|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146246|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146247|NCT02285101|BCT-100|bct-100|mesh-list
57146248|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146249|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
57146250|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
57146251|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146252|NCT00359437|Satavaptan|satavaptan|mesh-list
57146253|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57146254|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146255|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
57146256|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146257|NCT05064449|Itraconazole|itraconazole|mesh-list
57146258|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
57146259|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
57146260|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146261|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57146262|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57146263|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146264|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146265|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57146266|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
57146267|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146268|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146269|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57146270|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57146271|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57146272|NCT05064449|Analgesics|analgesics|mesh-ancestor
57146273|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
57146274|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146275|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146276|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57146277|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57146278|NCT00401011|Dexamethasone|dexamethasone|mesh-list
57146279|NCT00401011|Bortezomib|bortezomib|mesh-list
57146280|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146281|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
57146282|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
57146283|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146284|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146285|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57146286|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
57146287|NCT00401011|Hormones|hormones|mesh-ancestor
57146288|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146289|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57146290|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146291|NCT01645930|Dexamethasone|dexamethasone|mesh-list
57146292|NCT01645930|Lenalidomide|lenalidomide|mesh-list
57146293|NCT01645930|Ixazomib|ixazomib|mesh-list
57146294|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146295|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
57146296|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
57146297|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146298|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146299|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57146300|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
57146301|NCT01645930|Hormones|hormones|mesh-ancestor
57146302|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146303|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57146304|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146305|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
57146306|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57146307|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57146308|NCT01645930|Growth Substances|growth substances|mesh-ancestor
57146309|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
57146310|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
57146311|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146312|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146314|NCT02190695|Decitabine|decitabine|mesh-list
57146315|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
57146316|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146317|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57146318|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
57146319|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146320|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146321|NCT00514267|Prednisone|prednisone|mesh-list
57146322|NCT00514267|Docetaxel|docetaxel|mesh-list
57146323|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146324|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
57146325|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
57146326|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
57146327|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146328|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146329|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
57146330|NCT00514267|Hormones|hormones|mesh-ancestor
57146331|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146332|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146333|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57146334|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
57146335|NCT04199104|Lenvatinib|lenvatinib|mesh-list
57146336|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57146337|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146338|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57146339|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146340|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146341|NCT02384967|Darunavir|darunavir|mesh-list
57146342|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57146343|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57146344|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
57146345|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146346|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146347|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57146348|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57146349|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
57146350|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146351|NCT02186249|Nivolumab|nivolumab|mesh-list
57146352|NCT02186249|Ipilimumab|ipilimumab|mesh-list
57146353|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57146354|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146355|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57146356|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146357|NCT00511459|Paclitaxel|paclitaxel|mesh-list
57146358|NCT00511459|Bevacizumab|bevacizumab|mesh-list
57146359|NCT00511459|Trebananib|trebananib|mesh-list
57146360|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57146361|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146362|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
57146363|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
57146364|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
57146365|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146366|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57146367|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57146368|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57146369|NCT00511459|Growth Substances|growth substances|mesh-ancestor
57146370|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146371|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
57146372|NCT02384889|Eflornithine|eflornithine|mesh-list
57146373|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146374|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57146375|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57146376|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57146377|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146378|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
57146379|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146380|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146381|NCT02299336|Aflibercept|aflibercept|mesh-list
57146382|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57146383|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57146384|NCT02299336|Growth Substances|growth substances|mesh-ancestor
57146385|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146386|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
57146387|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146388|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
57146389|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146390|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146391|NCT02186483|Metformin|metformin|mesh-list
57146392|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57146393|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146394|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146395|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57146396|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57146397|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
57146398|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146399|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57146400|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57146401|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146402|NCT02256605|Vitamin D|vitamin d|mesh-list
57146403|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
57146404|NCT02256605|Vitamins|vitamins|mesh-ancestor
57146405|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
57146406|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146407|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57146408|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57146409|NCT00393991|Fluticasone|fluticasone|mesh-list
57146410|NCT00393991|Xhance|xhance|mesh-list
57146411|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
57146412|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146413|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57146414|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
57146415|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146416|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146417|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57146418|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
57146419|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
57146420|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57146421|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57146422|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57146423|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57146424|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
57146425|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146426|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146427|NCT02664441|Exenatide|exenatide|mesh-list
57146428|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146429|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146430|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57146431|NCT02664441|Incretins|incretins|mesh-ancestor
57146432|NCT02664441|Hormones|hormones|mesh-ancestor
57146433|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146434|NCT02191007|Calcitriol|calcitriol|mesh-list
57146435|NCT02191007|Betamethasone|betamethasone|mesh-list
57146436|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
57146437|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57146438|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
57146439|NCT02191007|Calcipotriene|calcipotriene|mesh-list
57146440|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57146441|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146442|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
57146443|NCT02191007|Hormones|hormones|mesh-ancestor
57146444|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146445|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146446|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57146447|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
57146448|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
57146449|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57146450|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57146451|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57146452|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146453|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57146454|NCT02191007|Vitamins|vitamins|mesh-ancestor
57146455|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
57146456|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57146457|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
57146458|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57146459|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
57146460|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146461|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57146462|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57146463|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
57146464|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146465|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146466|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57146467|NCT04470115|Anesthetics|anesthetics|mesh-list
57146468|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146469|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146470|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
57146471|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57146472|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731880|NCT03499223|Ranibizumab|ranibizumab|mesh-list
57146473|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146474|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57146475|NCT02384343|Analgesics|analgesics|mesh-ancestor
57146476|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
57146477|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146478|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57146479|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57146480|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57146481|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
57146482|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146483|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146484|NCT05033639|Melatonin|melatonin|mesh-list
57146485|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
57146486|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146487|NCT05033639|Protective Agents|protective agents|mesh-ancestor
57146488|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146489|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146490|NCT02328040|Insulin|insulin|mesh-list
57146491|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57146492|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57146493|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
57146494|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146495|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146496|NCT02328040|Incretins|incretins|mesh-ancestor
57146497|NCT02328040|Hormones|hormones|mesh-ancestor
57146498|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146499|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57146500|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
57146501|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146502|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146503|NCT00355849|Insulin|insulin|mesh-list
57146504|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57146505|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
57146506|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146507|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146508|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
57146509|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
57146510|NCT02384499|Coagulants|coagulants|mesh-ancestor
57146511|NCT02186951|Amoxicillin|amoxicillin|mesh-list
57146512|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
57146513|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
57146514|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57146515|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146516|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146517|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146518|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57146519|NCT02285413|Cisplatin|cisplatin|mesh-list
57146520|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146521|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57146522|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
57146523|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146524|NCT02187107|Darunavir|darunavir|mesh-list
57146525|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57146526|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57146527|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
57146528|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828304|NCT01236586|Hormones|hormones|mesh-ancestor
57146529|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146530|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57146531|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57146532|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
57146533|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146534|NCT02285491|Bupivacaine|bupivacaine|mesh-list
57146535|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
57146536|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
57146537|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146538|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146539|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
57146540|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146541|NCT02298868|Baclofen|baclofen|mesh-list
57146542|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57146543|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146544|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57146545|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146546|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57146547|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
57146548|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
57146549|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146550|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146551|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
57146552|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57146553|NCT04881682|Antibodies|antibodies|mesh-list
57146554|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
57146555|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146556|NCT02389179|Vitamin D|vitamin d|mesh-list
57146557|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
57146558|NCT02389179|Vitamins|vitamins|mesh-ancestor
57146559|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
57146560|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146561|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57146562|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57146563|NCT02285647|Rolapitant|rolapitant|mesh-list
57146564|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57146565|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146566|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146567|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146568|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
57146569|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146570|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146571|NCT02187497|Telmisartan|telmisartan|mesh-list
57146572|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57146573|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57146574|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57146575|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146576|NCT04195750|Everolimus|everolimus|mesh-list
57146577|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146578|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57146579|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
57146580|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146581|NCT00099853|Pioglitazone|pioglitazone|mesh-list
57146582|NCT00099853|Vildagliptin|vildagliptin|mesh-list
57146583|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146584|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146585|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57146586|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
57146587|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146588|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146589|NCT02381145|Resveratrol|resveratrol|mesh-list
57146590|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
57146591|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146592|NCT02381145|Protective Agents|protective agents|mesh-ancestor
57146593|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146594|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146595|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57146596|NCT00097357|Enoxaparin|enoxaparin|mesh-list
57146597|NCT00097357|Warfarin|warfarin|mesh-list
57146598|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
57146599|NCT00097357|Apixaban|apixaban|mesh-list
57146600|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
57146601|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57146602|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57146603|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146604|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57146605|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
57146606|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57146607|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
57146608|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146609|NCT02296840|Acetaminophen|acetaminophen|mesh-list
57146610|NCT02296840|Ibuprofen|ibuprofen|mesh-list
57146611|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
57146612|NCT02296840|Hydrocodone|hydrocodone|mesh-list
57146613|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57146614|NCT02296840|Analgesics|analgesics|mesh-ancestor
57146615|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
57146616|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146617|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146618|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
57146619|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57146620|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146621|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57146622|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57146623|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146624|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146625|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57146626|NCT02296840|Narcotics|narcotics|mesh-ancestor
57146627|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146628|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
57146629|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
57146630|NCT02191319|Nevirapine|nevirapine|mesh-list
57146631|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57146632|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57146633|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146634|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146635|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
57146636|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146637|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57146638|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57146639|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57146640|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57146641|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57146642|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57146643|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146644|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57146645|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146646|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146647|NCT05363319|Cemiplimab|cemiplimab|mesh-list
57146648|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57146649|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146650|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
57146651|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
57146652|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
57146653|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57146654|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57146655|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146656|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146657|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146658|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
57146659|NCT00326287|Linezolid|linezolid|mesh-list
57146660|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
57146661|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
57146662|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57146663|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146664|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57146665|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146666|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146667|NCT02191943|Fluorides|fluorides|mesh-list
57146668|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
57146669|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
57146670|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
57146671|NCT02191943|Protective Agents|protective agents|mesh-ancestor
57146672|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146673|NCT02663895|Treprostinil|treprostinil|mesh-list
57146674|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57146675|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
57146676|NCT00320203|Anecortave|anecortave|mesh-list
57146677|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57146678|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57146679|NCT00320203|Growth Substances|growth substances|mesh-ancestor
57146680|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146681|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
57146682|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146683|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146684|NCT00071461|Bosentan|bosentan|mesh-list
57146685|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57146686|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57146687|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146688|NCT00069745|Prednisone|prednisone|mesh-list
57146689|NCT00069745|Satraplatin|satraplatin|mesh-list
57146690|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146691|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
57146692|NCT00069745|Hormones|hormones|mesh-ancestor
57146693|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146694|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146695|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57146696|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146697|NCT02192411|Lidocaine|lidocaine|mesh-list
57146698|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
57146699|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
57146700|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146701|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146702|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
57146703|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146704|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57146705|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57146706|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57146707|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57146708|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146709|NCT02193893|Coal Tar|coal tar|mesh-list
57146710|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
57146711|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
57146712|NCT02384187|Gabapentin|gabapentin|mesh-list
57146713|NCT02384187|Analgesics|analgesics|mesh-ancestor
57146714|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
57146715|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146716|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146717|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
57146718|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57146719|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57146720|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146721|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57146722|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57146723|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57146724|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146725|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146726|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
57146727|NCT02192723|Olanzapine|olanzapine|mesh-list
57146728|NCT02192723|Risperidone|risperidone|mesh-list
57146729|NCT02192723|Aripiprazole|aripiprazole|mesh-list
57146730|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57146731|NCT02192723|Ziprasidone|ziprasidone|mesh-list
57146732|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
57146733|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57146734|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
57146735|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146736|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146737|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146738|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57146739|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146740|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57146741|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57146742|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
57146743|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
57146744|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
57146745|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146746|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57146747|NCT02192723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57146748|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57146749|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57146750|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
57146751|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
57146752|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57146753|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57146754|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57146755|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57146757|NCT00319969|Amrubicin|amrubicin|mesh-list
57146758|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57146759|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57146760|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146761|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146762|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146763|NCT00317395|Heparin|heparin|mesh-list
57146764|NCT00317395|Calcium heparin|calcium heparin|mesh-list
57146765|NCT00317395|Otamixaban|otamixaban|mesh-list
57146766|NCT00317395|Eptifibatide|eptifibatide|mesh-list
57146767|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
57146768|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57146769|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57146770|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146771|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57146772|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57146773|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
57146774|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57146775|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
57146776|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146777|NCT02383563|Metformin|metformin|mesh-list
57146778|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146779|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146780|NCT03535961|Etoposide|etoposide|mesh-list
57146781|NCT03535961|Apatinib|apatinib|mesh-list
57146782|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57146783|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146784|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57146785|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57146786|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146787|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146788|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57146789|NCT02380755|Clomiphene|clomiphene|mesh-list
57146790|NCT02380755|Enclomiphene|enclomiphene|mesh-list
57146791|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
57146792|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57146793|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
57146794|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146795|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146796|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57146797|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
57146798|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57146799|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57146800|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57146801|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
57146802|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57146803|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57146804|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57146805|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57146806|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57146807|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146808|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
57146809|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146810|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146811|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57146812|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146813|NCT02380521|Exenatide|exenatide|mesh-list
57146814|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57146815|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146816|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57146817|NCT02380521|Incretins|incretins|mesh-ancestor
57146818|NCT02380521|Hormones|hormones|mesh-ancestor
57146819|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146820|NCT00315757|Bortezomib|bortezomib|mesh-list
57146821|NCT00315757|Mapatumumab|mapatumumab|mesh-list
57146822|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57146823|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146824|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
57146825|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146826|NCT02377401|Zanamivir|zanamivir|mesh-list
57146827|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
57146828|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146829|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146830|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146831|NCT00312091|Lamivudine|lamivudine|mesh-list
57146832|NCT00312091|Nevirapine|nevirapine|mesh-list
57146833|NCT00312091|Stavudine|stavudine|mesh-list
57146834|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57146835|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57146836|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146837|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146838|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
57146839|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146840|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57146841|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57146842|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57146843|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57146844|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
57146845|NCT00389779|Guanfacine|guanfacine|mesh-list
57146846|NCT00389779|Darusentan|darusentan|mesh-list
57146847|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57146848|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57146849|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57146850|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57146851|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
57146852|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146853|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146854|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146855|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57146856|NCT00389155|Gemcitabine|gemcitabine|mesh-list
57146857|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57146858|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
57146859|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146860|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146861|NCT00389155|Antiviral Agents|antiviral agents|mesh-ancestor
57146862|NCT00389155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146863|NCT00389155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146864|NCT00389155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57146865|NCT00389155|Immunologic Factors|immunologic factors|mesh-ancestor
57146866|NCT00389155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146867|NCT02188511|Nicotine|nicotine|mesh-list
57146868|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57146869|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
57146870|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146871|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146872|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57146873|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57146874|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
57146875|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146876|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146877|NCT02380131|Capecitabine|capecitabine|mesh-list
57146878|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
57146879|NCT02380131|Trastuzumab|trastuzumab|mesh-list
57146880|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57146881|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
57146882|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146883|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146884|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57146885|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57146886|NCT03535103|Hormones|hormones|mesh-ancestor
57146887|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146888|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146889|NCT04360941|Palbociclib|palbociclib|mesh-list
57146890|NCT04360941|Avelumab|avelumab|mesh-list
57146891|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146892|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57146893|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146894|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146895|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57146896|NCT04551365|Chitosan|chitosan|mesh-list
57146897|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57146898|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57146899|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
57146900|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146901|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57146902|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
57146903|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
57146904|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
57146905|NCT04551365|Coagulants|coagulants|mesh-ancestor
57146907|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146908|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
57146909|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
57146910|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
57146911|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146912|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57146913|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57146914|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
57146915|NCT00298987|Dasatinib|dasatinib|mesh-list
57146916|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146917|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57146918|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146919|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146920|NCT02380053|Celiprolol|celiprolol|mesh-list
57146921|NCT02380053|Bisoprolol|bisoprolol|mesh-list
57146922|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57146923|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
57146924|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
56840795|NCT00390221|Daclizumab|daclizumab|mesh-list
57146925|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146926|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146927|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57146928|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57146929|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57146930|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
57146931|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146932|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146933|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57146934|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
57146935|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
57146936|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57146937|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57146938|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
57146939|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57146940|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
57146941|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146942|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146943|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57146944|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57146945|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57146946|NCT03535415|Hormones|hormones|mesh-list
57146947|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57146948|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146949|NCT02030717|Clonidine|clonidine|mesh-list
57146950|NCT02030717|Anesthetics|anesthetics|mesh-list
57146951|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57146952|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146953|NCT02030717|Analgesics|analgesics|mesh-ancestor
57146954|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
57146955|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57146956|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57146957|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
57146958|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
57146959|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57146960|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57146961|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57146962|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
57146963|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146964|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146965|NCT02371473|Acetazolamide|acetazolamide|mesh-list
57146966|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
57146967|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57146968|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146969|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146970|NCT02371473|Diuretics|diuretics|mesh-ancestor
57146971|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
57146972|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146973|NCT04301661|Tenofovir|tenofovir|mesh-list
57146974|NCT04301661|Lamivudine|lamivudine|mesh-list
56828761|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57146975|NCT04301661|Emtricitabine|emtricitabine|mesh-list
57146976|NCT04301661|Abacavir|abacavir|mesh-list
57146977|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
57146978|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57146979|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57146980|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57146981|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57146982|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146983|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57146984|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57146985|NCT05721235|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
57146986|NCT05721235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57146987|NCT05721235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57146988|NCT05721235|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57146989|NCT05721235|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57146990|NCT05721235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57146991|NCT05721235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57146992|NCT05721235|Dopamine Agents|dopamine agents|mesh-ancestor
57146993|NCT05721235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57146994|NCT02194049|Etoposide|etoposide|mesh-list
57146995|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
57146996|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57146997|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57146998|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57146999|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57147000|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147001|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147002|NCT02379663|Enoxaparin|enoxaparin|mesh-list
57147003|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
57147004|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57147005|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
57147006|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57147007|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
57147008|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147009|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147010|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
57147011|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57147012|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57147013|NCT02030639|ON 01910|on 01910|mesh-list
57147014|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147015|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57147016|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147017|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147018|NCT00004897|Leucovorin|leucovorin|mesh-list
57147019|NCT00004897|Interferons|interferons|mesh-list
57147020|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
57147021|NCT00004897|Fluorouracil|fluorouracil|mesh-list
57147022|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
57147023|NCT00004897|Calcium|calcium|mesh-list
57147024|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
57147025|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147026|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57147027|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147028|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
57147029|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147030|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57147031|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57147032|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
57147033|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
57147034|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147035|NCT00004897|Antidotes|antidotes|mesh-ancestor
57147036|NCT00004897|Protective Agents|protective agents|mesh-ancestor
57147037|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
57147038|NCT00004897|Vitamins|vitamins|mesh-ancestor
57147039|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
57147040|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
57147041|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147042|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57147043|NCT00004231|Leucovorin|leucovorin|mesh-list
57147044|NCT00004231|Interferons|interferons|mesh-list
57147045|NCT00004231|Cytarabine|cytarabine|mesh-list
57147046|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
57147047|NCT00004231|Aldesleukin|aldesleukin|mesh-list
57147048|NCT00004231|Prednisone|prednisone|mesh-list
57147049|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
57147050|NCT00004231|Busulfan|busulfan|mesh-list
57147051|NCT00004231|Doxorubicin|doxorubicin|mesh-list
57147052|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56828836|NCT00424775|Vorinostat|vorinostat|mesh-list
57147053|NCT00004231|Methotrexate|methotrexate|mesh-list
57147054|NCT00004231|Vincristine|vincristine|mesh-list
57147056|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
57147057|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57147058|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
57147059|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147060|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57147061|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57147062|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
57147063|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147064|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147065|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57147066|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57147067|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57147068|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57147069|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147070|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57147071|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
57147072|NCT00004231|Hormones|hormones|mesh-ancestor
57147073|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57147074|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57147075|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57147076|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
57147077|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57147078|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57147079|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
57147080|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
57147081|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57147082|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57147083|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
57147084|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147085|NCT00004231|Antidotes|antidotes|mesh-ancestor
57147086|NCT00004231|Protective Agents|protective agents|mesh-ancestor
57147087|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
57147088|NCT00004231|Vitamins|vitamins|mesh-ancestor
57147089|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
57147090|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57147091|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
57147092|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
57147093|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
57147094|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57147095|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57147096|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57147097|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147098|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147099|NCT03535259|Sorafenib|sorafenib|mesh-list
57147100|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147101|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57147102|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147103|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147104|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
57147105|NCT00004171|Busulfan|busulfan|mesh-list
57147106|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57147107|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
57147108|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147109|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57147110|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57147111|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
57147112|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147113|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147114|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57147115|NCT00004165|Melphalan|melphalan|mesh-list
57147116|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
57147117|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147118|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57147119|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
57147120|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147121|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147122|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57147123|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57147124|NCT00004093|Gemcitabine|gemcitabine|mesh-list
57147125|NCT00004093|Paclitaxel|paclitaxel|mesh-list
57147126|NCT00004093|Vinorelbine|vinorelbine|mesh-list
57147127|NCT00004093|Carboplatin|carboplatin|mesh-list
57147128|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56828910|NCT01141894|Dobutamine|dobutamine|mesh-list
57147130|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
57147131|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
57147132|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
57147133|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147134|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57147135|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
57147136|NCT00004093|Antiviral Agents|antiviral agents|mesh-ancestor
57147137|NCT00004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147138|NCT00004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147139|NCT00004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57147140|NCT00004093|Immunologic Factors|immunologic factors|mesh-ancestor
57147141|NCT00004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147142|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57147143|NCT02193269|Minocycline|minocycline|mesh-list
57147144|NCT02193269|Tetracycline|tetracycline|mesh-list
57147145|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147146|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57147147|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147148|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147149|NCT00002479|Tretinoin|tretinoin|mesh-list
57147150|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147151|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
57147152|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
57147153|NCT00002371|Lamivudine|lamivudine|mesh-list
57147154|NCT00002371|Zidovudine|zidovudine|mesh-list
57147155|NCT00002371|Stavudine|stavudine|mesh-list
57147156|NCT00002371|Indinavir|indinavir|mesh-list
57147157|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57147158|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57147159|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147160|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147161|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
57147162|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147163|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57147164|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57147165|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
57147166|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57147167|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57147168|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
57147169|NCT02189681|Anesthetics|anesthetics|mesh-list
57147170|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147171|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147172|NCT05715385|Bromfenac|bromfenac|mesh-list
57147173|NCT05715385|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57147174|NCT05715385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57147175|NCT05715385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57147176|NCT05715385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57147177|NCT05715385|Analgesics|analgesics|mesh-ancestor
57147178|NCT05715385|Sensory System Agents|sensory system agents|mesh-ancestor
57147179|NCT05715385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147180|NCT05715385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147181|NCT05715385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57147182|NCT05715385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57147183|NCT04182633|Vancomycin|vancomycin|mesh-list
57147184|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
57147185|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57147186|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147187|NCT04182633|Laxatives|laxatives|mesh-ancestor
57147188|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57147189|NCT02194283|Ambroxol|ambroxol|mesh-list
57147190|NCT02194283|Expectorants|expectorants|mesh-ancestor
57147191|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
57147192|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
57147193|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57147194|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57147195|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147196|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57147197|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57147198|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57147199|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57147200|NCT00263341|Estrogens|estrogens|mesh-ancestor
57147201|NCT00263341|Hormones|hormones|mesh-ancestor
57147202|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828989|NCT01145404|Lapatinib|lapatinib|mesh-list
57147203|NCT03534869|Analgesics|analgesics|mesh-list
57147204|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
57147205|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147206|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147207|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
57147208|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147209|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57147210|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
57147211|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
57147212|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57147213|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57147214|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147215|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147216|NCT02378649|Urological Agents|urological agents|mesh-ancestor
57147217|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
57147218|NCT02197169|Interferons|interferons|mesh-list
57147219|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
57147220|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147221|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
57147222|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147223|NCT02376309|Nandrolone|nandrolone|mesh-list
57147224|NCT02376309|Androgens|androgens|mesh-ancestor
57147225|NCT02376309|Hormones|hormones|mesh-ancestor
57147226|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732099|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
57147227|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147228|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
57147229|NCT00232141|Pregabalin|pregabalin|mesh-list
57147230|NCT00232141|Analgesics|analgesics|mesh-ancestor
57147231|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
57147232|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147233|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147234|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
57147235|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57147236|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57147237|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147238|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57147239|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57147240|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57147241|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147242|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57147243|NCT02378415|Ketamine|ketamine|mesh-list
57147244|NCT02378415|Analgesics|analgesics|mesh-ancestor
57147245|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
57147246|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147247|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147248|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57147249|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57147250|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
57147251|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
57147252|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147253|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57147254|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57147255|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147256|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147257|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
57147258|NCT02197403|Propofol|propofol|mesh-list
57147259|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57147260|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147261|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147262|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57147263|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
57147264|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
57147265|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57147266|NCT02197403|Analgesics|analgesics|mesh-ancestor
57147267|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
57147268|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147269|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57147270|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57147271|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57147272|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
57147273|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147274|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147275|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57147276|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
57147277|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147278|NCT02194829|Gemcitabine|gemcitabine|mesh-list
57147279|NCT02194829|Paclitaxel|paclitaxel|mesh-list
57147280|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57147281|NCT02194829|Adavosertib|adavosertib|mesh-list
57147282|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57147283|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147284|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
57147285|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
57147286|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
57147287|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147288|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57147289|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
57147290|NCT02194829|Antiviral Agents|antiviral agents|mesh-ancestor
57147291|NCT02194829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147292|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147293|NCT02194829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57147294|NCT02194829|Immunologic Factors|immunologic factors|mesh-ancestor
57147295|NCT02194829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147296|NCT05708521|Hydromorphone|hydromorphone|mesh-list
57147297|NCT05708521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57147298|NCT05708521|Narcotics|narcotics|mesh-ancestor
57147299|NCT05708521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147300|NCT05708521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147301|NCT05708521|Analgesics|analgesics|mesh-ancestor
57147302|NCT05708521|Sensory System Agents|sensory system agents|mesh-ancestor
57147303|NCT05708521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147304|NCT03534713|Paclitaxel|paclitaxel|mesh-list
57147305|NCT03534713|Carboplatin|carboplatin|mesh-list
57147306|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57147307|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147308|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
57147309|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
57147310|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
57147311|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147312|NCT02376075|Linagliptin|linagliptin|mesh-list
57147313|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57147314|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147315|NCT02376075|Incretins|incretins|mesh-ancestor
57147316|NCT02376075|Hormones|hormones|mesh-ancestor
57147317|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57147318|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57147319|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
57147320|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147321|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147322|NCT02197637|Vinorelbine|vinorelbine|mesh-list
57147323|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57147324|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147325|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
57147326|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
57147327|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
57147328|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147329|NCT04469413|Acetaminophen|acetaminophen|mesh-list
57147330|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57147331|NCT04469413|Analgesics|analgesics|mesh-ancestor
57147332|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
57147333|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147334|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147335|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
57147336|NCT03532087|Denosumab|denosumab|mesh-list
57147337|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57147338|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147339|NCT02369523|Bupivacaine|bupivacaine|mesh-list
57147340|NCT02369523|Ropivacaine|ropivacaine|mesh-list
57147341|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
57147342|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
57147343|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147344|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147345|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
57147346|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147347|NCT05690503|Ketamine|ketamine|mesh-list
57147348|NCT05690503|Analgesics|analgesics|mesh-ancestor
57147349|NCT05690503|Sensory System Agents|sensory system agents|mesh-ancestor
57147350|NCT05690503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147351|NCT05690503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147352|NCT05690503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57147353|NCT05690503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57147354|NCT05690503|Anesthetics, General|anesthetics, general|mesh-ancestor
57147355|NCT05690503|Anesthetics|anesthetics|mesh-ancestor
57147356|NCT05690503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147357|NCT05690503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57147358|NCT05690503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57147359|NCT05690503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147360|NCT05690503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147361|NCT02288923|Acetaminophen|acetaminophen|mesh-list
57147362|NCT02288923|Ibuprofen|ibuprofen|mesh-list
57147363|NCT02288923|Morphine|morphine|mesh-list
57147364|NCT02288923|Antiemetics|antiemetics|mesh-list
57147365|NCT02288923|Anesthetics|anesthetics|mesh-list
57147366|NCT02288923|Emetics|emetics|mesh-list
57147367|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147368|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147369|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57147370|NCT02288923|Narcotics|narcotics|mesh-ancestor
57147371|NCT02288923|Analgesics|analgesics|mesh-ancestor
57147372|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
57147373|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147374|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57147375|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57147376|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57147377|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57147378|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57147379|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147380|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147381|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
57147382|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
57147383|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57147384|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57147385|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57147386|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
57147387|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147388|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147389|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57147390|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
57147391|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
57147392|NCT02195375|Hormones|hormones|mesh-ancestor
57147393|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57147394|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
57147395|NCT03531931|Apatinib|apatinib|mesh-list
57147396|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147397|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57147398|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147399|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147400|NCT05726383|Viscum album peptide|viscum album peptide|mesh-list
57147401|NCT05726383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147402|NCT05726383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57147403|NCT05726383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57147404|NCT05726383|Antiviral Agents|antiviral agents|mesh-ancestor
57147405|NCT05726383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147406|NCT03601455|Durvalumab|durvalumab|mesh-list
57147407|NCT03601455|Ipilimumab|ipilimumab|mesh-list
57147408|NCT03601455|Tremelimumab|tremelimumab|mesh-list
57147409|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
57147410|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57147411|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
57147412|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57147413|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147414|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
57147415|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147416|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57147417|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147418|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
57147419|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57147420|NCT02369133|Acetaminophen|acetaminophen|mesh-list
57147421|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57147422|NCT02369133|Analgesics|analgesics|mesh-ancestor
57147423|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
57147424|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147425|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147426|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
57147427|NCT02377635|Selenious Acid|selenious acid|mesh-list
57147428|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
57147429|NCT02377635|Trace Elements|trace elements|mesh-ancestor
57147430|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
57147431|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147432|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
57147433|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
57147434|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147435|NCT02198027|Bupivacaine|bupivacaine|mesh-list
57147436|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
57147437|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
57147438|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147439|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147440|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
57147441|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147442|NCT02257463|Theophylline|theophylline|mesh-list
57147443|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
57147444|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
57147445|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147446|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147447|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57147448|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
57147449|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147450|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147451|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57147452|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147453|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
57147454|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57147455|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57147456|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
57147457|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
57147458|NCT04109885|Promethazine|promethazine|mesh-list
57147459|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
57147460|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57147461|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57147462|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147463|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147464|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
57147465|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
57147466|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
57147467|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147468|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
57147469|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
57147470|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57147471|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57147472|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
57147473|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
57147474|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147475|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147476|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57147477|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
57147478|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
57147479|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57147480|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57147481|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57147482|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57147483|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
57147484|NCT02198261|Minoxidil|minoxidil|mesh-list
57147485|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57147486|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
57147487|NCT03533699|Propranolol|propranolol|mesh-list
57147488|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57147489|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57147490|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
57147491|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147492|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147493|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147494|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57147495|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57147496|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
57147497|NCT00135421|Citalopram|citalopram|mesh-list
57147498|NCT00135421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57147499|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57147500|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57147501|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147502|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147503|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
57147504|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147505|NCT00135421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57147506|NCT00135421|Antidepressive Agents|antidepressive agents|mesh-ancestor
57147507|NCT00135421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57147508|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
57147509|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57147510|NCT02200991|Lixisenatide|lixisenatide|mesh-list
57147511|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57147512|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147513|NCT02200991|Incretins|incretins|mesh-ancestor
57147514|NCT02200991|Hormones|hormones|mesh-ancestor
57147515|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57147516|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57147517|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
57147518|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147519|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147520|NCT01979367|Analgesics|analgesics|mesh-list
57147521|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
57147522|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147523|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147524|NCT02368743|Mesalamine|mesalamine|mesh-list
57147525|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57147526|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57147527|NCT02368743|Analgesics|analgesics|mesh-ancestor
57147528|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
57147529|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147530|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147531|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57147532|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57147533|NCT00135343|Ritonavir|ritonavir|mesh-list
57147534|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57147535|NCT00135343|Efavirenz|efavirenz|mesh-list
57147536|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57147537|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57147538|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
57147539|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147540|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147541|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57147542|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57147543|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
57147544|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147545|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57147546|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57147547|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57147548|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57147549|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57147550|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57147551|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57147552|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57147553|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57147554|NCT02201225|Micronutrients|micronutrients|mesh-list
57147555|NCT02201225|Trace Elements|trace elements|mesh-list
57147556|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147557|NCT02365155|Vitamin D|vitamin d|mesh-list
57147558|NCT02365155|Vitamins|vitamins|mesh-list
57147559|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
57147560|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147561|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57147562|NCT05724745|Albuterol|albuterol|mesh-list
57147563|NCT05724745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57147564|NCT05724745|Autonomic Agents|autonomic agents|mesh-ancestor
57147565|NCT05724745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147566|NCT05724745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147567|NCT05724745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57147568|NCT05724745|Respiratory System Agents|respiratory system agents|mesh-ancestor
57147569|NCT05724745|Tocolytic Agents|tocolytic agents|mesh-ancestor
57147570|NCT05724745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57147571|NCT05724745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57147572|NCT05724745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57147573|NCT05724745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57147574|NCT05724745|Adrenergic Agents|adrenergic agents|mesh-ancestor
57147575|NCT05724745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147576|NCT05724745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147577|NCT04597671|Durvalumab|durvalumab|mesh-list
57147578|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57147579|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147580|NCT02198807|Piperaquine|piperaquine|mesh-list
56829361|NCT04982146|Antidotes|antidotes|mesh-ancestor
57147581|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
57147582|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
57147583|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57147584|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57147585|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147586|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57147588|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57147589|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147590|NCT02201459|Interferons|interferons|mesh-list
57147591|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
57147592|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
57147593|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57147594|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147595|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
57147596|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147597|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
57147598|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147599|NCT02368665|Amlodipine|amlodipine|mesh-list
57147600|NCT02368665|Candesartan|candesartan|mesh-list
57147601|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
57147602|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57147603|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55732178|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
57147604|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57147605|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147606|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57147607|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147608|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
57147609|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57147610|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57147611|NCT05724589|Mitogens|mitogens|mesh-list
57147612|NCT05724589|Mitosis Modulators|mitosis modulators|mesh-ancestor
57147613|NCT05724589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147614|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57147615|NCT02198495|Hematinics|hematinics|mesh-ancestor
57147616|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57147617|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
57147618|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57147619|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
57147620|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147621|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
57147622|NCT02375217|Neostigmine|neostigmine|mesh-list
57147623|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57147624|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147625|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147626|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
57147627|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147628|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147629|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57147630|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
57147631|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147632|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57147633|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57147634|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57147635|NCT02206295|Selexipag|selexipag|mesh-list
57147636|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57147637|NCT02375139|Metformin|metformin|mesh-list
57147638|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57147639|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147640|NCT02202005|Nevirapine|nevirapine|mesh-list
57147641|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57147642|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57147643|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147644|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147645|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
57147646|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147647|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57147648|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57147649|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57147650|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57147651|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57147652|NCT02741245|Ezetimibe|ezetimibe|mesh-list
57147653|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57147654|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57147655|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
57147656|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147657|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57147658|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57147659|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147660|NCT02202239|Fentanyl|fentanyl|mesh-list
57147661|NCT02202239|Midazolam|midazolam|mesh-list
57147662|NCT02202239|Remifentanil|remifentanil|mesh-list
57147663|NCT02202239|Propofol|propofol|mesh-list
57147664|NCT02202239|Etomidate|etomidate|mesh-list
57147665|NCT02202239|Sevoflurane|sevoflurane|mesh-list
57147666|NCT02202239|Cisatracurium|cisatracurium|mesh-list
57147667|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57147668|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147669|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147670|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57147671|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
57147672|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
57147673|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57147674|NCT02202239|Narcotics|narcotics|mesh-ancestor
57147675|NCT02202239|Analgesics|analgesics|mesh-ancestor
57147676|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
57147677|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147678|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57147679|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57147680|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57147681|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57147682|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
57147683|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
57147684|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147685|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147686|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57147687|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57147688|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57147689|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57147690|NCT02368197|Paclitaxel|paclitaxel|mesh-list
57147691|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57147692|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147693|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
57147694|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
57147695|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
57147696|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147697|NCT02364765|Remifentanil|remifentanil|mesh-list
57147698|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57147699|NCT02364765|Narcotics|narcotics|mesh-ancestor
57147700|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147701|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147702|NCT02364765|Analgesics|analgesics|mesh-ancestor
57147703|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
57147704|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147705|NCT03529201|Fentanyl|fentanyl|mesh-list
57147706|NCT03529201|Oxycodone|oxycodone|mesh-list
57147707|NCT03529201|Sevoflurane|sevoflurane|mesh-list
57147708|NCT03529201|Rocuronium|rocuronium|mesh-list
57147709|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57147710|NCT03529201|Narcotics|narcotics|mesh-ancestor
57147711|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147712|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147713|NCT03529201|Analgesics|analgesics|mesh-ancestor
57147714|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
57147715|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147716|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57147717|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57147718|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
57147719|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
57147720|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57147721|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57147722|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57147723|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57147724|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57147725|NCT04547049|Cytarabine|cytarabine|mesh-list
57147726|NCT04547049|Cyclosporine|cyclosporine|mesh-list
57147727|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
57147728|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
57147729|NCT04547049|Busulfan|busulfan|mesh-list
56829510|NCT00421343|Calcium|calcium|mesh-list
57147730|NCT04547049|Cyclosporins|cyclosporins|mesh-list
57147731|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57147732|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
57147733|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57147734|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
57147735|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147737|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57147738|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
57147739|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147740|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147741|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57147742|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57147743|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
57147744|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
57147745|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147746|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147747|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
57147748|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
57147749|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57147750|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57147751|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57147752|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
57147753|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57147754|NCT05647291|Methylprednisolone|methylprednisolone|mesh-list
57147755|NCT05647291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57147756|NCT05647291|Antiemetics|antiemetics|mesh-ancestor
57147757|NCT05647291|Autonomic Agents|autonomic agents|mesh-ancestor
57147758|NCT05647291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147759|NCT05647291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147760|NCT05647291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57147761|NCT05647291|Glucocorticoids|glucocorticoids|mesh-ancestor
57147762|NCT05647291|Hormones|hormones|mesh-ancestor
57147763|NCT05647291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57147764|NCT05647291|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57147765|NCT05647291|Protective Agents|protective agents|mesh-ancestor
57147766|NCT03105765|Ketamine|ketamine|mesh-list
57147767|NCT03105765|Analgesics|analgesics|mesh-ancestor
57147768|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
57147769|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147770|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147771|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57147772|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57147773|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
57147774|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
57147775|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147776|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57147777|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57147778|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147779|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147780|NCT02202473|Lamivudine|lamivudine|mesh-list
57147781|NCT02202473|Oxymatrine|oxymatrine|mesh-list
57147782|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57147783|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57147784|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147785|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147786|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
57147787|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147788|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57147789|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57147790|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57147791|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
57147792|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147793|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57147794|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147795|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147796|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
57147797|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57147798|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147799|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57147800|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57147801|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
57147802|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147803|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57147804|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147805|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147806|NCT02202707|Gabapentin|gabapentin|mesh-list
57147807|NCT02202707|Analgesics|analgesics|mesh-ancestor
57147808|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
57147809|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147810|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147811|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
57147812|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57147813|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57147814|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147815|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57147816|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57147817|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57147818|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147819|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147820|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
57147822|NCT02367807|Emtricitabine|emtricitabine|mesh-list
57147823|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
57147824|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147825|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57147826|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57147827|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147828|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147829|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57147830|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57147831|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
57147832|NCT02364609|Afatinib|afatinib|mesh-list
57147833|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57147834|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147835|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57147836|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147837|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147838|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
57147839|NCT02364453|Growth Substances|growth substances|mesh-ancestor
57147840|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147841|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
57147842|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147843|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147844|NCT02258009|Ranibizumab|ranibizumab|mesh-list
57147845|NCT02258009|Aflibercept|aflibercept|mesh-list
57147846|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57147847|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57147848|NCT02258009|Growth Substances|growth substances|mesh-ancestor
57147849|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147850|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
57147851|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147852|NCT02203097|Propofol|propofol|mesh-list
57147853|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57147854|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147855|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147856|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57147857|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
57147858|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
57147859|NCT04439487|Anesthetics|anesthetics|mesh-list
57147860|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147861|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147862|NCT03528967|Aspirin|aspirin|mesh-list
57147863|NCT03528967|Enoxaparin|enoxaparin|mesh-list
57147864|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57147865|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57147866|NCT03528967|Analgesics|analgesics|mesh-ancestor
57147867|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
57147868|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147869|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147870|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57147871|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57147872|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57147873|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57147874|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147875|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57147876|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57147877|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147878|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
57147879|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
57147880|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
57147881|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
57147882|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57147883|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57147884|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147885|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147886|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147887|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57147889|NCT02363985|Vitamins|vitamins|mesh-ancestor
57147890|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
57147891|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147892|NCT05723731|Laxatives|laxatives|mesh-list
57147893|NCT05723731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57147894|NCT02363829|Nelfinavir|nelfinavir|mesh-list
57147895|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57147896|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57147897|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
57147898|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147899|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147900|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57147901|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57147902|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
57147903|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147904|NCT03113019|Vaccines|vaccines|mesh-list
57147905|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
57147906|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147907|NCT02363751|Bevacizumab|bevacizumab|mesh-list
57147908|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57147909|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147910|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57147911|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57147912|NCT02363751|Growth Substances|growth substances|mesh-ancestor
57147913|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147914|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
57147915|NCT03279471|Sertraline|sertraline|mesh-list
57147916|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
57147917|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57147918|NCT03279471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57147919|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57147920|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57147921|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147922|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57147923|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
57147924|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147925|NCT03240861|Aldesleukin|aldesleukin|mesh-list
57147926|NCT03240861|Plerixafor|plerixafor|mesh-list
57147927|NCT03240861|Fludarabine|fludarabine|mesh-list
57147928|NCT03240861|Busulfan|busulfan|mesh-list
57147929|NCT03240861|Interleukin-2|interleukin-2|mesh-list
57147930|NCT03240861|Lenograstim|lenograstim|mesh-list
57147931|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147932|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147933|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57147934|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
57147935|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147936|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57147937|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
57147938|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57147939|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57147940|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57147941|NCT03240861|Analgesics|analgesics|mesh-ancestor
57147942|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
57147943|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147944|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57147945|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57147946|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
57147947|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147948|NCT03527251|Ipilimumab|ipilimumab|mesh-list
57147949|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57147950|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147951|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57147952|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147953|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
57147954|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
57147955|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147956|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
57147957|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
57147958|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
57147959|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57147960|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57147961|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
57147962|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57147963|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
57147964|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147965|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57147966|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147967|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147968|NCT04594915|Edoxaban|edoxaban|mesh-list
57147969|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57147970|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
57147971|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57147972|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
57147973|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147974|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147975|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
57147976|NCT04546633|Lumefantrine|lumefantrine|mesh-list
57147977|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
57147978|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57147979|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57147980|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57147981|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
57147982|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57147983|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147984|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
57147985|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57147986|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
57147987|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57147988|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
57147989|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147990|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147991|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
57147992|NCT04462471|Vemurafenib|vemurafenib|mesh-list
57147993|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57147994|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57147995|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57147996|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57147997|NCT03043599|Nivolumab|nivolumab|mesh-list
57147998|NCT03043599|Ipilimumab|ipilimumab|mesh-list
57147999|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148000|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148001|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57148002|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148003|NCT02366949|Paclitaxel|paclitaxel|mesh-list
57148004|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57148005|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148006|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148007|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148008|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148009|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148010|NCT03532919|Cystatins|cystatins|mesh-list
57148011|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
57148012|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
57148013|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148014|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148015|NCT05503225|Colchicine|colchicine|mesh-list
57148016|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
57148017|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57148018|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148019|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148020|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148021|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148022|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148023|NCT02203175|Fentanyl|fentanyl|mesh-list
57148024|NCT02203175|Propofol|propofol|mesh-list
57148025|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57148026|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148027|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148028|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57148029|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
57148030|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
57148031|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57148032|NCT02203175|Narcotics|narcotics|mesh-ancestor
57148033|NCT02203175|Analgesics|analgesics|mesh-ancestor
57148034|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
57148035|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148036|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57148037|NCT05791799|Etonogestrel|etonogestrel|mesh-list
57148038|NCT05791799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57148039|NCT05791799|Contraceptive Agents|contraceptive agents|mesh-ancestor
57148040|NCT05791799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57148041|NCT05791799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148042|NCT05791799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57148043|NCT05791721|Dexamethasone|dexamethasone|mesh-list
57148044|NCT05791721|Etoricoxib|etoricoxib|mesh-list
57148045|NCT05791721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148046|NCT05791721|Antiemetics|antiemetics|mesh-ancestor
57148047|NCT05791721|Autonomic Agents|autonomic agents|mesh-ancestor
57148048|NCT05791721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148049|NCT05791721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148050|NCT05791721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57148051|NCT05791721|Glucocorticoids|glucocorticoids|mesh-ancestor
57148052|NCT05791721|Hormones|hormones|mesh-ancestor
57148053|NCT05791721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148054|NCT05791721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148055|NCT05791721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148056|NCT05791721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57148057|NCT05791721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57148058|NCT05791721|Analgesics|analgesics|mesh-ancestor
57148059|NCT05791721|Sensory System Agents|sensory system agents|mesh-ancestor
57148060|NCT05791721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57148061|NCT05791721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57148062|NCT05791721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57148063|NCT05791721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148064|NCT05791721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148065|NCT05791669|Listerine|listerine|mesh-list
57148066|NCT05791669|Fluorides|fluorides|mesh-list
57148067|NCT05791669|Sodium Fluoride|sodium fluoride|mesh-list
57148068|NCT05791669|Fluorides, Topical|fluorides, topical|mesh-list
57148069|NCT05791669|Cariostatic Agents|cariostatic agents|mesh-ancestor
57148070|NCT05791669|Protective Agents|protective agents|mesh-ancestor
57148071|NCT05791669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148072|NCT05791669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57148073|NCT05791669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148074|NCT05791617|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
57148075|NCT05791617|Natriuretic Agents|natriuretic agents|mesh-ancestor
57148076|NCT05791617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148077|NCT05791565|Norflurane|norflurane|mesh-list
57148078|NCT05791565|Albuterol|albuterol|mesh-list
57148079|NCT05791565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57148080|NCT05791565|Autonomic Agents|autonomic agents|mesh-ancestor
57148081|NCT05791565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148082|NCT05791565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148083|NCT05791565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57148084|NCT05791565|Respiratory System Agents|respiratory system agents|mesh-ancestor
57148085|NCT05791565|Tocolytic Agents|tocolytic agents|mesh-ancestor
57148086|NCT05791565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57148087|NCT05791565|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57148088|NCT05791565|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57148089|NCT05791565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57148090|NCT05791565|Adrenergic Agents|adrenergic agents|mesh-ancestor
57148091|NCT05791565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148092|NCT05791565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148093|NCT05791565|Anesthetics|anesthetics|mesh-ancestor
57148094|NCT05791565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148095|NCT05791487|Budesonide|budesonide|mesh-list
57148096|NCT05791487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148097|NCT05791487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57148098|NCT05791487|Autonomic Agents|autonomic agents|mesh-ancestor
57148099|NCT05791487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148100|NCT05791487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148101|NCT05791487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57148102|NCT05791487|Respiratory System Agents|respiratory system agents|mesh-ancestor
57148103|NCT05791487|Glucocorticoids|glucocorticoids|mesh-ancestor
57148104|NCT05791487|Hormones|hormones|mesh-ancestor
57148105|NCT05791487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148106|NCT05791474|Denosumab|denosumab|mesh-list
57148107|NCT05791474|Diphosphonates|diphosphonates|mesh-list
57148108|NCT05791474|Capecitabine|capecitabine|mesh-list
57148109|NCT05791474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57148110|NCT05791474|Antimetabolites|antimetabolites|mesh-ancestor
57148111|NCT05791474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148112|NCT05791474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148113|NCT05791474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57148114|NCT05791474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148115|NCT05791409|Venetoclax|venetoclax|mesh-list
57148116|NCT05791409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148117|NCT05791331|Pulmonary Surfactants|pulmonary surfactants|mesh-list
57148118|NCT05791331|Respiratory System Agents|respiratory system agents|mesh-ancestor
57148119|NCT05791097|Paclitaxel|paclitaxel|mesh-list
57148120|NCT05791097|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57148121|NCT05791097|Carboplatin|carboplatin|mesh-list
57148122|NCT05791097|Pembrolizumab|pembrolizumab|mesh-list
57148123|NCT05791097|Pemetrexed|pemetrexed|mesh-list
57148124|NCT05791097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57148125|NCT05791097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148126|NCT05791097|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148127|NCT05791097|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148128|NCT05791097|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148129|NCT05791097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148130|NCT05791097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148131|NCT05791097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148132|NCT05791097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57148133|NCT05791097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57148134|NCT05791058|Anesthetics|anesthetics|mesh-list
57148135|NCT05791058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148136|NCT05791058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148137|NCT05790941|Minoxidil|minoxidil|mesh-list
57148138|NCT05790941|Latanoprost|latanoprost|mesh-list
57148139|NCT05790941|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57148140|NCT05790941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57148141|NCT05790941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57148142|NCT05790941|Vasodilator Agents|vasodilator agents|mesh-ancestor
57148143|NCT05790902|Tamsulosin|tamsulosin|mesh-list
57148144|NCT05790902|Silodosin|silodosin|mesh-list
57148145|NCT05790902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57148146|NCT05790902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57148147|NCT05790902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57148148|NCT05790902|Adrenergic Agents|adrenergic agents|mesh-ancestor
57148149|NCT05790902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148150|NCT05790902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148151|NCT05790902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148152|NCT05790902|Urological Agents|urological agents|mesh-ancestor
57148153|NCT05790720|Propofol|propofol|mesh-list
57148154|NCT05790720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57148155|NCT05790720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148156|NCT05790720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148157|NCT05790720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57148158|NCT05790720|Anesthetics, General|anesthetics, general|mesh-ancestor
57148159|NCT05790720|Anesthetics|anesthetics|mesh-ancestor
57148160|NCT05790707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
57148161|NCT05790681|Insulin|insulin|mesh-list
57148162|NCT05790681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57148163|NCT05790681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148164|NCT05790629|Calcium, Dietary|calcium, dietary|mesh-list
57148165|NCT05790629|Calcium|calcium|mesh-list
57148166|NCT05790629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57148167|NCT05790629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148168|NCT05790629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57148169|NCT05790603|Hemostatics|hemostatics|mesh-list
57148170|NCT05790603|Coagulants|coagulants|mesh-ancestor
57148171|NCT05790577|Niacinamide|niacinamide|mesh-list
57148172|NCT05790577|Niacin|niacin|mesh-list
57148173|NCT05790577|Nicotinic Acids|nicotinic acids|mesh-list
57148174|NCT05790577|Metformin|metformin|mesh-list
57148175|NCT05790577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57148176|NCT05790577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148177|NCT05790577|Vitamin B Complex|vitamin b complex|mesh-ancestor
57148178|NCT05790577|Vitamins|vitamins|mesh-ancestor
57148179|NCT05790577|Micronutrients|micronutrients|mesh-ancestor
57148180|NCT05790577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57148181|NCT05790577|Antimetabolites|antimetabolites|mesh-ancestor
57148182|NCT05790577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148183|NCT05790577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57148184|NCT05790577|Vasodilator Agents|vasodilator agents|mesh-ancestor
57148185|NCT05790525|Bismuth|bismuth|mesh-list
57148186|NCT05790525|Antacids|antacids|mesh-ancestor
57148187|NCT05790525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148188|NCT05790525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57148189|NCT05790499|Atorvastatin|atorvastatin|mesh-list
57148190|NCT05790499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57148191|NCT05790499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57148192|NCT05790499|Antimetabolites|antimetabolites|mesh-ancestor
57148193|NCT05790499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148194|NCT05790499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57148195|NCT05790499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57148196|NCT05790499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148197|NCT05790486|Nicotine|nicotine|mesh-list
57148198|NCT05790486|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57148199|NCT05790486|Autonomic Agents|autonomic agents|mesh-ancestor
57148200|NCT05790486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148201|NCT05790486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148202|NCT05790486|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57148203|NCT05790486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57148204|NCT05790486|Cholinergic Agents|cholinergic agents|mesh-ancestor
57148205|NCT05790486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148206|NCT05790486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148207|NCT05790447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57148208|NCT05790447|Thymalfasin|thymalfasin|mesh-list
57148209|NCT05790447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57148210|NCT05790447|Immunologic Factors|immunologic factors|mesh-ancestor
55768646|NCT03605901|Analgesics|analgesics|mesh-ancestor
57148211|NCT05790447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148212|NCT05790447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148213|NCT05790447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148214|NCT05790330|Methotrexate|methotrexate|mesh-list
57148215|NCT05790330|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57148216|NCT05790330|Abortifacient Agents|abortifacient agents|mesh-ancestor
57148217|NCT05790330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57148218|NCT05790330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148219|NCT05790330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57148220|NCT05790330|Antimetabolites|antimetabolites|mesh-ancestor
57148221|NCT05790330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148222|NCT05790330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148223|NCT05790330|Dermatologic Agents|dermatologic agents|mesh-ancestor
57148224|NCT05790330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148225|NCT05790330|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57148226|NCT05790330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57148227|NCT05790330|Immunologic Factors|immunologic factors|mesh-ancestor
57148228|NCT05790330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57148229|NCT05790330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57148230|NCT05790252|Buprenorphine|buprenorphine|mesh-list
57148231|NCT05790252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57148232|NCT05790252|Narcotics|narcotics|mesh-ancestor
57148233|NCT05790252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148234|NCT05790252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148235|NCT05790252|Analgesics|analgesics|mesh-ancestor
57148236|NCT05790252|Sensory System Agents|sensory system agents|mesh-ancestor
57148237|NCT05790252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148238|NCT05790252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57148239|NCT05790239|Amphetamine|amphetamine|mesh-list
57148240|NCT05790239|Dextroamphetamine|dextroamphetamine|mesh-list
57148241|NCT05790239|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
57148242|NCT05790239|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57148243|NCT05790239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148244|NCT05790239|Sympathomimetics|sympathomimetics|mesh-ancestor
57148245|NCT05790239|Autonomic Agents|autonomic agents|mesh-ancestor
57148246|NCT05790239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148247|NCT05790239|Dopamine Agents|dopamine agents|mesh-ancestor
57148248|NCT05790239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148249|NCT05790239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148250|NCT05790239|Adrenergic Agents|adrenergic agents|mesh-ancestor
57148251|NCT05790239|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57148252|NCT05790239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57148253|NCT05790239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57148254|NCT05790239|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57148255|NCT05790239|Hallucinogens|hallucinogens|mesh-ancestor
57148256|NCT05790239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57148257|NCT05790239|Serotonin Agents|serotonin agents|mesh-ancestor
57148258|NCT05790213|Androgens|androgens|mesh-list
57148259|NCT05790213|Hormones|hormones|mesh-ancestor
57148260|NCT05790213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148261|NCT05790213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830041|NCT01150318|Iodine|iodine|mesh-list
57148262|NCT05790161|Caffeine|caffeine|mesh-list
57148263|NCT05790161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57148264|NCT05790161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148265|NCT05790161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57148266|NCT05790161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148267|NCT05790161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148268|NCT05790161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57148269|NCT05790161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57148270|NCT05790161|Purinergic Agents|purinergic agents|mesh-ancestor
57148271|NCT05790161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148272|NCT05789732|Tadalafil|tadalafil|mesh-list
57148273|NCT05789732|Silodosin|silodosin|mesh-list
57148274|NCT05789732|Vasodilator Agents|vasodilator agents|mesh-ancestor
57148275|NCT05789732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57148276|NCT05789732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57148277|NCT05789732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148278|NCT05789732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148279|NCT05789732|Urological Agents|urological agents|mesh-ancestor
57148280|NCT05789732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57148281|NCT05789732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56842153|NCT03605212|Febuxostat|febuxostat|mesh-list
57148282|NCT05789732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57148283|NCT05789732|Adrenergic Agents|adrenergic agents|mesh-ancestor
57148284|NCT05789732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148285|NCT05789732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148286|NCT05789173|Efavirenz|efavirenz|mesh-list
57148287|NCT05789173|Clonidine|clonidine|mesh-list
57148288|NCT05789173|Methadone|methadone|mesh-list
57148289|NCT05789173|Tizanidine|tizanidine|mesh-list
57148290|NCT05789173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57148291|NCT05789173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57148292|NCT05789173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148293|NCT05789173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148294|NCT05789173|Antiviral Agents|antiviral agents|mesh-ancestor
57148295|NCT05789173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148296|NCT05789173|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57148297|NCT05789173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57148298|NCT05789173|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57148299|NCT05789173|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57148300|NCT05789173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57148301|NCT05789173|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57148302|NCT05789173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57148303|NCT05789173|Narcotics|narcotics|mesh-ancestor
57148304|NCT05789173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148305|NCT05789173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148306|NCT05789173|Analgesics|analgesics|mesh-ancestor
57148307|NCT05789173|Sensory System Agents|sensory system agents|mesh-ancestor
57148308|NCT05789173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148309|NCT05789173|Antitussive Agents|antitussive agents|mesh-ancestor
57148310|NCT05789173|Respiratory System Agents|respiratory system agents|mesh-ancestor
57148311|NCT05789173|Anticonvulsants|anticonvulsants|mesh-ancestor
57148312|NCT05789173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57148313|NCT05789173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57148314|NCT05789173|Parasympatholytics|parasympatholytics|mesh-ancestor
57148315|NCT05789173|Autonomic Agents|autonomic agents|mesh-ancestor
57148316|NCT05789173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57148317|NCT05789173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57148318|NCT05789173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57148319|NCT05789173|Adrenergic Agents|adrenergic agents|mesh-ancestor
57148320|NCT05789173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148321|NCT05789173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57148322|NCT05789173|Sympatholytics|sympatholytics|mesh-ancestor
57148323|NCT05786716|Trastuzumab|trastuzumab|mesh-list
57148324|NCT05786716|Pertuzumab|pertuzumab|mesh-list
57148325|NCT05786716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148326|NCT05786716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148327|NCT05786599|Methadone|methadone|mesh-list
57148328|NCT05786599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57148329|NCT05786599|Narcotics|narcotics|mesh-ancestor
57148330|NCT05786599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148331|NCT05786599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148332|NCT05786599|Analgesics|analgesics|mesh-ancestor
57148333|NCT05786599|Sensory System Agents|sensory system agents|mesh-ancestor
57148334|NCT05786599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148335|NCT05786599|Antitussive Agents|antitussive agents|mesh-ancestor
57148336|NCT05786599|Respiratory System Agents|respiratory system agents|mesh-ancestor
57148337|NCT05785767|Cemiplimab|cemiplimab|mesh-list
57148338|NCT05785767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148339|NCT05785767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148340|NCT05782361|Pembrolizumab|pembrolizumab|mesh-list
57148341|NCT05782361|Tepotinib|tepotinib|mesh-list
57148342|NCT05782361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148343|NCT05782361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148344|NCT05777603|Vancomycin|vancomycin|mesh-list
57148345|NCT05777603|Aztreonam|aztreonam|mesh-list
57148346|NCT05777603|Pembrolizumab|pembrolizumab|mesh-list
57148347|NCT05777603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148348|NCT05777603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148349|NCT05777603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57148350|NCT05777603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148351|NCT05770180|Vaccines|vaccines|mesh-list
57148352|NCT05770180|Immunologic Factors|immunologic factors|mesh-ancestor
57148353|NCT05770180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148354|NCT05768178|Vemurafenib|vemurafenib|mesh-list
57148355|NCT05768178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148356|NCT05768178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57148357|NCT05768178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148358|NCT05768178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148359|NCT05752201|Vaccines|vaccines|mesh-list
57148360|NCT05752201|Immunologic Factors|immunologic factors|mesh-ancestor
57148361|NCT05752201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148362|NCT05746481|Carboplatin|carboplatin|mesh-list
57148363|NCT05746481|Pemetrexed|pemetrexed|mesh-list
57148364|NCT05746481|Atezolizumab|atezolizumab|mesh-list
57148365|NCT05746481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148366|NCT05746481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148367|NCT05746481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148368|NCT05746481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57148369|NCT05746481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57148370|NCT05729139|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57148371|NCT05729139|Interferon alpha-2|interferon alpha-2|mesh-list
57148372|NCT05729139|Cemiplimab|cemiplimab|mesh-list
57148373|NCT05729139|Antiviral Agents|antiviral agents|mesh-ancestor
57148374|NCT05729139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148375|NCT05729139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148376|NCT05729139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148377|NCT05713799|Thioctic Acid|thioctic acid|mesh-list
57148378|NCT05713799|Mirabegron|mirabegron|mesh-list
57148379|NCT05713799|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57148380|NCT05713799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57148381|NCT05713799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57148382|NCT05713799|Adrenergic Agents|adrenergic agents|mesh-ancestor
57148383|NCT05713799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148384|NCT05713799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148385|NCT05713799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148386|NCT05713799|Urological Agents|urological agents|mesh-ancestor
57148387|NCT05713799|Antioxidants|antioxidants|mesh-ancestor
57148388|NCT05713799|Protective Agents|protective agents|mesh-ancestor
57148389|NCT05713799|Vitamin B Complex|vitamin b complex|mesh-ancestor
57148390|NCT05713799|Vitamins|vitamins|mesh-ancestor
57148391|NCT05713799|Micronutrients|micronutrients|mesh-ancestor
57148392|NCT05707208|Lidocaine|lidocaine|mesh-list
57148393|NCT05707208|Anesthetics, Local|anesthetics, local|mesh-ancestor
57148394|NCT05707208|Anesthetics|anesthetics|mesh-ancestor
57148395|NCT05707208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148396|NCT05707208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148397|NCT05707208|Sensory System Agents|sensory system agents|mesh-ancestor
57148398|NCT05707208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148399|NCT05707208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57148400|NCT05707208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57148401|NCT05707208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57148402|NCT05707208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57148403|NCT05707208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148404|NCT05704725|Aflibercept|aflibercept|mesh-list
57148405|NCT05704725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57148406|NCT05704725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57148407|NCT05704725|Growth Substances|growth substances|mesh-ancestor
57148408|NCT05704725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148409|NCT05704725|Growth Inhibitors|growth inhibitors|mesh-ancestor
57148410|NCT05704725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148411|NCT05704036|Estradiol|estradiol|mesh-list
57148412|NCT05704036|Estrogens|estrogens|mesh-list
57148413|NCT05704036|Progesterone|progesterone|mesh-list
57148414|NCT05704036|Hormones|hormones|mesh-ancestor
57148415|NCT05704036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148416|NCT05704036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148417|NCT05704036|Progestins|progestins|mesh-ancestor
57148418|NCT05694013|Atezolizumab|atezolizumab|mesh-list
57148419|NCT05694013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148420|NCT05684276|Paclitaxel|paclitaxel|mesh-list
57148421|NCT05684276|Carboplatin|carboplatin|mesh-list
57148422|NCT05684276|Nivolumab|nivolumab|mesh-list
57148423|NCT05684276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57148424|NCT05684276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148425|NCT05684276|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148426|NCT05684276|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148427|NCT05684276|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148428|NCT05684276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148429|NCT05684276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148430|NCT05684276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57148431|NCT05683444|Octreotide|octreotide|mesh-list
57148432|NCT05683444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57148433|NCT05683444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148434|NCT05683444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148435|NCT05681195|Pemetrexed|pemetrexed|mesh-list
57148436|NCT05681195|Zanubrutinib|zanubrutinib|mesh-list
57148437|NCT05681195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148438|NCT05681195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148439|NCT05681195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148440|NCT05681195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57148441|NCT05681195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57148442|NCT05681195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57148443|NCT05669482|Gemcitabine|gemcitabine|mesh-list
57148444|NCT05669482|Paclitaxel|paclitaxel|mesh-list
57148445|NCT05669482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57148446|NCT05669482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148447|NCT05669482|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148448|NCT05669482|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148449|NCT05669482|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148450|NCT05669482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148451|NCT05669482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57148452|NCT05669482|Antimetabolites|antimetabolites|mesh-ancestor
57148453|NCT05669482|Antiviral Agents|antiviral agents|mesh-ancestor
57148454|NCT05669482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148455|NCT05669482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148456|NCT05669482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57148457|NCT05669482|Immunologic Factors|immunologic factors|mesh-ancestor
57148458|NCT05669482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148459|NCT05669274|Caseins|caseins|mesh-list
57148460|NCT05669274|Chelating Agents|chelating agents|mesh-ancestor
57148461|NCT05669274|Sequestering Agents|sequestering agents|mesh-ancestor
57148462|NCT05669274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148463|NCT05667090|Vitamin D|vitamin d|mesh-list
57148464|NCT05667090|Vitamins|vitamins|mesh-ancestor
57148465|NCT05667090|Micronutrients|micronutrients|mesh-ancestor
57148466|NCT05667090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148467|NCT05667090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57148468|NCT05660681|Glycerol|glycerol|mesh-list
57148469|NCT05660681|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57148470|NCT05660681|Protective Agents|protective agents|mesh-ancestor
57148471|NCT05660681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148472|NCT05652478|Tenofovir|tenofovir|mesh-list
57148473|NCT05652478|Dolutegravir|dolutegravir|mesh-list
57148474|NCT05652478|Antiviral Agents|antiviral agents|mesh-ancestor
57148475|NCT05652478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148476|NCT05652478|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57148477|NCT05652478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57148478|NCT05652478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148479|NCT05652478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148480|NCT05652478|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57148481|NCT05652478|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57148482|NCT05652478|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57148483|NCT05652478|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57148484|NCT05650164|Avelumab|avelumab|mesh-list
57148485|NCT05650164|Axitinib|axitinib|mesh-list
57148486|NCT05650164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148487|NCT05650164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148488|NCT05650164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57148489|NCT05650164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148490|NCT05650164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148491|NCT05647343|Ciclopirox|ciclopirox|mesh-list
57148492|NCT05647343|Antifungal Agents|antifungal agents|mesh-ancestor
57148493|NCT05647343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148494|NCT05644561|Ravulizumab|ravulizumab|mesh-list
57148495|NCT05644561|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57148496|NCT05644561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57148497|NCT05644561|Immunologic Factors|immunologic factors|mesh-ancestor
57148498|NCT05644561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148499|NCT05643170|Xanomeline|xanomeline|mesh-list
57148500|NCT05643170|Trospium chloride|trospium chloride|mesh-list
57148501|NCT05643170|Parasympatholytics|parasympatholytics|mesh-ancestor
57148502|NCT05643170|Autonomic Agents|autonomic agents|mesh-ancestor
57148503|NCT05643170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148504|NCT05643170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148505|NCT05643170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57148506|NCT05643170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57148507|NCT05643170|Cholinergic Agents|cholinergic agents|mesh-ancestor
57148508|NCT05643170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148509|NCT05643170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148510|NCT05643170|Urological Agents|urological agents|mesh-ancestor
57148511|NCT05643170|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57148512|NCT05643170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57148513|NCT05643170|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57148514|NCT05643170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57148515|NCT05642195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
57148516|NCT05642195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57148517|NCT05642195|Immunologic Factors|immunologic factors|mesh-ancestor
57148518|NCT05642195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148519|NCT05630781|Suvorexant|suvorexant|mesh-list
57148520|NCT05630781|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57148521|NCT05630781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57148522|NCT05630781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148523|NCT05630781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148524|NCT05630781|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57148525|NCT05630781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148526|NCT05630781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148527|NCT05625932|Tinzaparin|tinzaparin|mesh-list
57148528|NCT05625932|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57148529|NCT05625932|Dalteparin|dalteparin|mesh-list
57148530|NCT05625932|Anticoagulants|anticoagulants|mesh-ancestor
57148531|NCT05625932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57148532|NCT05625932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57148533|NCT05625932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148534|NCT05618301|Natalizumab|natalizumab|mesh-list
57148535|NCT05618301|Immunologic Factors|immunologic factors|mesh-ancestor
57148536|NCT05618301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148537|NCT05617625|Fludarabine|fludarabine|mesh-list
57148538|NCT05617625|Melphalan|melphalan|mesh-list
57148539|NCT05617625|Busulfan|busulfan|mesh-list
57148540|NCT05617625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148541|NCT05617625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148542|NCT05617625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57148543|NCT05617625|Immunologic Factors|immunologic factors|mesh-ancestor
57148544|NCT05617625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148545|NCT05617625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57148546|NCT05617625|Alkylating Agents|alkylating agents|mesh-ancestor
57148547|NCT05617625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57148548|NCT05605964|Leuprolide|leuprolide|mesh-list
57148549|NCT05605964|Relugolix|relugolix|mesh-list
57148550|NCT05605964|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57148551|NCT05605964|Fertility Agents|fertility agents|mesh-ancestor
57148552|NCT05605964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57148553|NCT05605964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148554|NCT05605964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148555|NCT05605964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148556|NCT05605964|Androgen Antagonists|androgen antagonists|mesh-ancestor
57148557|NCT05605964|Hormone Antagonists|hormone antagonists|mesh-ancestor
57148558|NCT05605964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148559|NCT05603754|Lorecivivint|lorecivivint|mesh-list
57148560|NCT05603754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148561|NCT05601882|Upadacitinib|upadacitinib|mesh-list
57148562|NCT05601882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57148563|NCT05601882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57148564|NCT05601882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148565|NCT05601882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148566|NCT05601882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57148568|NCT05594043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148569|NCT05594043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148570|NCT05582694|UB-421|ub-421|mesh-list
57148571|NCT05582694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57148572|NCT05582694|Antiviral Agents|antiviral agents|mesh-ancestor
57148573|NCT05582694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148574|NCT05578976|Prednisone|prednisone|mesh-list
57148575|NCT05578976|Cyclophosphamide|cyclophosphamide|mesh-list
57148576|NCT05578976|Rituximab|rituximab|mesh-list
57148577|NCT05578976|Doxorubicin|doxorubicin|mesh-list
57148578|NCT05578976|Vincristine|vincristine|mesh-list
57148579|NCT05578976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57148580|NCT05578976|Immunologic Factors|immunologic factors|mesh-ancestor
57148581|NCT05578976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148582|NCT05578976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57148583|NCT05578976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57148584|NCT05578976|Alkylating Agents|alkylating agents|mesh-ancestor
57148585|NCT05578976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148586|NCT05578976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148587|NCT05578976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57148588|NCT05578976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148589|NCT05578976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57148590|NCT05578976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57148591|NCT05578976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57148592|NCT05578976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148593|NCT05578976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148594|NCT05578976|Glucocorticoids|glucocorticoids|mesh-ancestor
57148595|NCT05578976|Hormones|hormones|mesh-ancestor
57148596|NCT05578976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148597|NCT05578976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148598|NCT05578976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57148599|NCT05578976|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148600|NCT05578976|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148601|NCT05578976|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148602|NCT05568888|Thrombin|thrombin|mesh-list
57148603|NCT05568888|Hemostatics|hemostatics|mesh-ancestor
57148604|NCT05568888|Coagulants|coagulants|mesh-ancestor
57148605|NCT05553392|Petrolatum|petrolatum|mesh-list
57148606|NCT05553392|Emollients|emollients|mesh-ancestor
57148607|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
57148608|NCT05552976|Dexamethasone|dexamethasone|mesh-list
57148609|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148610|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
57148611|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
57148612|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148613|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148614|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57148615|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
57148616|NCT05552976|Hormones|hormones|mesh-ancestor
57148617|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148618|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148619|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148620|NCT05538910|Nicotine|nicotine|mesh-list
57148621|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57148622|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
57148623|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148624|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148625|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57148626|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57148627|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
57148628|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148629|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148630|NCT05530421|Dexamethasone|dexamethasone|mesh-list
57148631|NCT05530421|Venetoclax|venetoclax|mesh-list
57148632|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148633|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
57148634|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
57148635|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148636|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148637|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57148638|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
57148639|NCT05530421|Hormones|hormones|mesh-ancestor
57148640|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148641|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148642|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148643|NCT05526755|Osimertinib|osimertinib|mesh-list
57148644|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148645|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57148646|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148647|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148648|NCT05523596|Benzonidazole|benzonidazole|mesh-list
57148649|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57148650|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
57148651|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148652|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57148653|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57148654|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57148655|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148656|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57148657|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148658|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148659|NCT05518734|Itraconazole|itraconazole|mesh-list
57148660|NCT05518734|Midazolam|midazolam|mesh-list
57148661|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57148662|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57148663|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148664|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148665|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57148666|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57148667|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57148668|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57148669|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
57148670|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
57148671|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
57148672|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
57148673|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148674|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148675|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
57148676|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148677|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57148678|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57148679|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148680|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57148681|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
57148682|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148683|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57148684|NCT05513365|Goserelin|goserelin|mesh-list
57148685|NCT05513365|Bicalutamide|bicalutamide|mesh-list
57148686|NCT05513365|Dutasteride|dutasteride|mesh-list
57148687|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148688|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148689|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
57148690|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
57148691|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148692|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148693|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57148694|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57148695|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148696|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148697|NCT05490134|Naloxone|naloxone|mesh-list
57148698|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57148699|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148700|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
57148701|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148702|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
57148703|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148704|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148705|NCT05478174|Propofol|propofol|mesh-list
57148706|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57148707|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148708|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148709|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57148710|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
57148711|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
57148712|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
57148713|NCT05470283|Fludarabine|fludarabine|mesh-list
57148714|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
57148715|NCT05470283|Furosemide|furosemide|mesh-list
57148716|NCT05470283|Acetazolamide|acetazolamide|mesh-list
57148717|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830483|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57148718|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
57148719|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148720|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57148721|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57148722|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
57148723|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148724|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148725|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57148726|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57148727|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
57148728|NCT05470283|Diuretics|diuretics|mesh-ancestor
57148729|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
57148730|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57148731|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57148732|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
57148733|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57148734|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148735|NCT05467176|Relugolix|relugolix|mesh-list
57148736|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
57148737|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
56990929|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148738|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148739|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148740|NCT05457257|Prednisone|prednisone|mesh-list
57148741|NCT05457257|Olaparib|olaparib|mesh-list
57148742|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
57148743|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148744|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
57148745|NCT05457257|Hormones|hormones|mesh-ancestor
57148746|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148747|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148748|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148749|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148750|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57148751|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148752|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148753|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57148754|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
57148755|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57148756|NCT05456685|Carboplatin|carboplatin|mesh-list
57148757|NCT05456685|Maytansine|maytansine|mesh-list
57148758|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148759|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57148760|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148761|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148762|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148763|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148764|NCT05442749|Niraparib|niraparib|mesh-list
57148765|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57148766|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148767|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148768|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148769|NCT05438602|Ritonavir|ritonavir|mesh-list
57148770|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57148771|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57148772|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
57148773|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148774|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148775|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57148776|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57148777|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
57148778|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148779|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57148780|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57148781|NCT05419011|Vaccines|vaccines|mesh-list
57148782|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
57148783|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148784|NCT05413304|Temozolomide|temozolomide|mesh-list
57148785|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
57148786|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57148787|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
57148788|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148789|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148790|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57148791|NCT05411081|Atezolizumab|atezolizumab|mesh-list
57148792|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57148793|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148794|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
57148795|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148796|NCT05389930|Ethanol|ethanol|mesh-list
57148797|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57148798|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148799|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148800|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148801|NCT05389423|Prednisone|prednisone|mesh-list
57148802|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
57148803|NCT05389423|Rituximab|rituximab|mesh-list
57148804|NCT05389423|Doxorubicin|doxorubicin|mesh-list
57148805|NCT05389423|Etoposide|etoposide|mesh-list
57148806|NCT05389423|Vincristine|vincristine|mesh-list
57148807|NCT05389423|Pomalidomide|pomalidomide|mesh-list
57148808|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57148809|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
57148810|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148811|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842678|NCT01082198|Vaccines|vaccines|mesh-list
57148812|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57148813|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
57148814|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148815|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148816|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57148817|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148818|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57148819|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57148820|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57148821|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148822|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148823|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
57148824|NCT05389423|Hormones|hormones|mesh-ancestor
57148825|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148826|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148827|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57148828|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148829|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148830|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148831|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57148832|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57148833|NCT05389423|Growth Substances|growth substances|mesh-ancestor
57148834|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
57148835|NCT05371054|Prednisone|prednisone|mesh-list
57148836|NCT05371054|Venetoclax|venetoclax|mesh-list
57148837|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148838|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
57148839|NCT05371054|Hormones|hormones|mesh-ancestor
57148840|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148841|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148842|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148843|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148844|NCT05370911|Psilocybin|psilocybin|mesh-list
57148845|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
57148846|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148847|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57148848|NCT05361655|Palbociclib|palbociclib|mesh-list
57148849|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57148850|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148851|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57148852|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148853|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148854|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57148855|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57148856|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
57148857|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148858|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148859|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
57148860|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57148861|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148862|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
57148863|NCT05350774|Methylprednisolone|methylprednisolone|mesh-list
57148864|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
57148865|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57148866|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
57148868|NCT05350774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148869|NCT05350774|Antiemetics|antiemetics|mesh-ancestor
57148870|NCT05350774|Autonomic Agents|autonomic agents|mesh-ancestor
57148871|NCT05350774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148872|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148873|NCT05350774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57148874|NCT05350774|Glucocorticoids|glucocorticoids|mesh-ancestor
57148875|NCT05350774|Hormones|hormones|mesh-ancestor
57148876|NCT05350774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148877|NCT05350774|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57148878|NCT05350774|Protective Agents|protective agents|mesh-ancestor
57148879|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
57148880|NCT05342636|Paclitaxel|paclitaxel|mesh-list
57148881|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
57148882|NCT05342636|Irinotecan|irinotecan|mesh-list
57148883|NCT05342636|Lenvatinib|lenvatinib|mesh-list
57148884|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
57148885|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57148886|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148887|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148888|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148889|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148890|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148891|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148892|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57148893|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57148894|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148895|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
57148896|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148897|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57148898|NCT05328908|Trifluridine|trifluridine|mesh-list
57148899|NCT05328908|Nivolumab|nivolumab|mesh-list
57148900|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148901|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148902|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57148903|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148904|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
57148905|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
57148906|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148907|NCT05320887|Nicotine|nicotine|mesh-list
57148908|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57148909|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
57148910|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148911|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148912|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57148913|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57148914|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
57148915|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57148916|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148917|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57148918|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
57148919|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148920|NCT05308056|Anesthetics|anesthetics|mesh-list
57148921|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57148922|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148923|NCT05306340|Tamoxifen|tamoxifen|mesh-list
57148924|NCT05306340|Dexamethasone|dexamethasone|mesh-list
57148925|NCT05306340|Fulvestrant|fulvestrant|mesh-list
57148926|NCT05306340|Everolimus|everolimus|mesh-list
57148927|NCT05306340|Exemestane|exemestane|mesh-list
57148928|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57148929|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
57148930|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
57148931|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57148932|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148933|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57148934|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
57148935|NCT05306340|Hormones|hormones|mesh-ancestor
57148936|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57148937|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57148938|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148939|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57148940|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
57148941|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57148942|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
57148943|NCT05306340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57148944|NCT05306340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57148945|NCT05306340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57148946|NCT05306340|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57148947|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57148948|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57148949|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148950|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148952|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57148953|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148954|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148955|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148956|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
57148957|NCT05286801|Atezolizumab|atezolizumab|mesh-list
57148958|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57148959|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57148960|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148961|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
57148962|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148963|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57148964|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148965|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
57148966|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
57148967|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57148968|NCT05276284|Atezolizumab|atezolizumab|mesh-list
57148969|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
57148970|NCT05276284|Thioguanine|thioguanine|mesh-list
57148971|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148972|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
57148973|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148974|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57148975|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57148976|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
57148977|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57148978|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57148979|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57148980|NCT05256290|Temozolomide|temozolomide|mesh-list
57148981|NCT05256290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57148982|NCT05256290|Alkylating Agents|alkylating agents|mesh-ancestor
57148983|NCT05256290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148984|NCT05256290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148985|NCT05256225|Paclitaxel|paclitaxel|mesh-list
57148986|NCT05256225|Carboplatin|carboplatin|mesh-list
57148987|NCT05256225|Trastuzumab|trastuzumab|mesh-list
57148988|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57148989|NCT05256225|Pertuzumab|pertuzumab|mesh-list
57148990|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57148991|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57148992|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
57148993|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
57148994|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
57148995|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57148996|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57148997|NCT05244226|Fentanyl|fentanyl|mesh-list
57148998|NCT05244226|Methadone|methadone|mesh-list
57148999|NCT05244226|Hydromorphone|hydromorphone|mesh-list
57149000|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57149001|NCT05244226|Narcotics|narcotics|mesh-ancestor
57149002|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57149003|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149004|NCT05244226|Analgesics|analgesics|mesh-ancestor
57149005|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
57149006|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149007|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57149008|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57149009|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
57149010|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
57149011|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
57149012|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
57149013|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
57149014|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149015|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149016|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
57149017|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149019|NCT05237960|Metformin|metformin|mesh-list
57149020|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57149021|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149022|NCT05231122|Bevacizumab|bevacizumab|mesh-list
57149023|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57149024|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
57149025|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
57149026|NCT05231122|Antibodies|antibodies|mesh-list
57149027|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
57149028|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149029|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
57149030|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149031|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57149032|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57149033|NCT05231122|Growth Substances|growth substances|mesh-ancestor
57149034|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149035|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
57149036|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
57149037|NCT05221840|Durvalumab|durvalumab|mesh-list
57149038|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149039|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149040|NCT05204862|Antibodies|antibodies|mesh-list
57149041|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
57149042|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149043|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
57149044|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57149045|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149046|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57149047|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149048|NCT05173987|Paclitaxel|paclitaxel|mesh-list
57149049|NCT05173987|Docetaxel|docetaxel|mesh-list
57149050|NCT05173987|Carboplatin|carboplatin|mesh-list
57149051|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
57149052|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149053|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149054|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149055|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149056|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149057|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149058|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149059|NCT05171647|Gemcitabine|gemcitabine|mesh-list
57149060|NCT05171647|Rituximab|rituximab|mesh-list
57149061|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
57149062|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149063|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149064|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
57149065|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149066|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57149067|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149068|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
57149069|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149070|NCT05171647|Antiviral Agents|antiviral agents|mesh-ancestor
57149071|NCT05171647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149072|NCT05171647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149073|NCT05171647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149074|NCT05144698|Sirolimus|sirolimus|mesh-list
57149075|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57149076|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149077|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149078|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149079|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
57149080|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149081|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
57149082|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149083|NCT05139017|Gemcitabine|gemcitabine|mesh-list
57149084|NCT05139017|Rituximab|rituximab|mesh-list
57149085|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
57149086|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57149087|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149088|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149089|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
57149090|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149091|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57149092|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56830859|NCT01156246|Metformin|metformin|mesh-list
57149093|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
57149094|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149095|NCT05139017|Antiviral Agents|antiviral agents|mesh-ancestor
57149096|NCT05139017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149097|NCT05139017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149098|NCT05139017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149099|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149100|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
57149101|NCT05130268|Dronedarone|dronedarone|mesh-list
57149102|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57149103|NCT05122182|Proxigermanium|proxigermanium|mesh-list
57149104|NCT05122182|Candesartan|candesartan|mesh-list
57149105|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
57149106|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57149107|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57149108|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57149109|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149110|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149111|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
57149112|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
57149113|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149114|NCT05116189|Paclitaxel|paclitaxel|mesh-list
57149115|NCT05116189|Docetaxel|docetaxel|mesh-list
57149116|NCT05116189|Bevacizumab|bevacizumab|mesh-list
57149117|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
57149118|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149119|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149120|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149121|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149122|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149123|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149124|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149125|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57149126|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57149127|NCT05116189|Growth Substances|growth substances|mesh-ancestor
57149128|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149129|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
57149130|NCT05092360|Gemcitabine|gemcitabine|mesh-list
57149131|NCT05092360|Paclitaxel|paclitaxel|mesh-list
57149132|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57149133|NCT05092360|Doxorubicin|doxorubicin|mesh-list
57149134|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57149135|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
57149136|NCT05092360|Topotecan|topotecan|mesh-list
57149137|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149138|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149139|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149140|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149141|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149142|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149143|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149144|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
57149145|NCT05092360|Antiviral Agents|antiviral agents|mesh-ancestor
57149146|NCT05092360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149147|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149148|NCT05092360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149149|NCT05092360|Immunologic Factors|immunologic factors|mesh-ancestor
57149150|NCT05092360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149151|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149152|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57149153|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57149154|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149155|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57149156|NCT05065801|Folfirinox|folfirinox|mesh-list
57149157|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149158|NCT05045066|Vitamin D|vitamin d|mesh-list
57149159|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
57149160|NCT05045066|Vitamins|vitamins|mesh-ancestor
57149161|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
57149162|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149163|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57149164|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57149165|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57149166|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57149167|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149168|NCT04980222|Prednisone|prednisone|mesh-list
57149169|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
57149170|NCT04980222|Rituximab|rituximab|mesh-list
57149171|NCT04980222|Doxorubicin|doxorubicin|mesh-list
57149172|NCT04980222|Vincristine|vincristine|mesh-list
57149173|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149174|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
57149175|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149176|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57149177|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149178|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
57149179|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149180|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149181|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57149182|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149183|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149184|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57149185|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57149186|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149187|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57149188|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
57149189|NCT04980222|Hormones|hormones|mesh-ancestor
57149190|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57149191|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57149192|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149193|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149194|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149195|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149196|NCT04979442|Trabectedin|trabectedin|mesh-list
57149197|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149198|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
57149199|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149200|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149201|NCT04971785|Firsocostat|firsocostat|mesh-list
57149202|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149203|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149204|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
57149205|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
57149206|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
57149207|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57149208|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149209|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
57149210|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149211|NCT04933539|Dexamethasone|dexamethasone|mesh-list
57149212|NCT04933539|Daratumumab|daratumumab|mesh-list
57149213|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57149214|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
57149215|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
57149216|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149217|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149218|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57149219|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
57149220|NCT04933539|Hormones|hormones|mesh-ancestor
57149221|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57149222|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57149223|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149224|NCT04928846|Docetaxel|docetaxel|mesh-list
57149225|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149226|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149227|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149228|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149229|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149230|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57149231|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57149232|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57149233|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149234|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149235|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
57149236|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149237|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57149238|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57149239|NCT04919629|Bevacizumab|bevacizumab|mesh-list
57149240|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57149241|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
56831007|NCT01263652|Narcotics|narcotics|mesh-ancestor
57149242|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
57149244|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
57149245|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149246|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
57149247|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149248|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57149249|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57149250|NCT04919629|Growth Substances|growth substances|mesh-ancestor
57149251|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149252|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
57149253|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
57149254|NCT04915183|Atorvastatin|atorvastatin|mesh-list
57149255|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57149256|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57149257|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
57149258|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149259|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57149260|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57149261|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149262|NCT04910061|Niacinamide|niacinamide|mesh-list
57149263|NCT04910061|Niacin|niacin|mesh-list
57149264|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
57149265|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
57149266|NCT04910061|Vitamins|vitamins|mesh-ancestor
57149267|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
55732560|NCT03490487|Hormones|hormones|mesh-ancestor
57149268|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149269|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57149270|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
57149271|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149272|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57149273|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
57149274|NCT04908956|Osimertinib|osimertinib|mesh-list
57149275|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149276|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57149277|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149278|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149279|NCT04892264|Dexamethasone|dexamethasone|mesh-list
57149280|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
57149281|NCT04892264|Lenalidomide|lenalidomide|mesh-list
57149282|NCT04892264|Daratumumab|daratumumab|mesh-list
57149283|NCT04892264|Ichthammol|ichthammol|mesh-list
57149284|NCT04892264|BB 1101|bb 1101|mesh-list
57149285|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57149286|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
57149287|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
57149288|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149289|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149290|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57149291|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
57149292|NCT04892264|Hormones|hormones|mesh-ancestor
57149293|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57149294|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57149295|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149296|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
57149297|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149298|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149299|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
57149300|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57149301|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57149302|NCT04892264|Growth Substances|growth substances|mesh-ancestor
57149303|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
57149304|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
57149305|NCT04890093|Vincristine|vincristine|mesh-list
57149306|NCT04890093|Temozolomide|temozolomide|mesh-list
57149307|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149308|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149309|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149310|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149311|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149312|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149313|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149314|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
57149315|NCT04887467|Apomorphine|apomorphine|mesh-list
57149316|NCT04887467|Emetics|emetics|mesh-ancestor
57149317|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149318|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
57149319|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149320|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57149321|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
57149322|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
57149323|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57149324|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149326|NCT04868409|Succinylcholine|succinylcholine|mesh-list
57149327|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57149328|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57149329|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57149330|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149331|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149332|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
57149333|NCT04861064|Sirolimus|sirolimus|mesh-list
57149334|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57149335|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149336|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149337|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149338|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
57149339|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149340|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
57149341|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149342|NCT04846335|Doxycycline|doxycycline|mesh-list
57149343|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57149344|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149345|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
57149346|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57149347|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57149348|NCT04821310|Pantoprazole|pantoprazole|mesh-list
57149349|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57149350|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57149351|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57149352|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149353|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149354|NCT04817241|Cytarabine|cytarabine|mesh-list
57149355|NCT04817241|Decitabine|decitabine|mesh-list
57149356|NCT04817241|Daunorubicin|daunorubicin|mesh-list
57149357|NCT04817241|Venetoclax|venetoclax|mesh-list
57149358|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149359|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
57149360|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149361|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149362|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
57149363|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149364|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149365|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
57149366|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149367|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149368|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57149369|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57149370|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149371|NCT04799275|Prednisone|prednisone|mesh-list
57149372|NCT04799275|Cortisone|cortisone|mesh-list
57149373|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
57149374|NCT04799275|Rituximab|rituximab|mesh-list
57149375|NCT04799275|Doxorubicin|doxorubicin|mesh-list
57149376|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57149377|NCT04799275|Vincristine|vincristine|mesh-list
57149378|NCT04799275|Azacitidine|azacitidine|mesh-list
57149379|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57149380|NCT04799275|Antibodies|antibodies|mesh-list
57149381|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
57149382|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149383|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149384|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
57149385|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149386|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57149387|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149388|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
57149389|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149390|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149391|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57149392|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149393|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57149394|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57149395|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149396|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57149397|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
57149398|NCT04799275|Hormones|hormones|mesh-ancestor
57149399|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57149400|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57149401|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149402|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149403|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149404|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149405|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149406|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
57149407|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
57149408|NCT04798339|Hematinics|hematinics|mesh-ancestor
57149409|NCT04796220|Gemcitabine|gemcitabine|mesh-list
57149410|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149411|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
57149412|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149413|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149414|NCT04796220|Antiviral Agents|antiviral agents|mesh-ancestor
57149415|NCT04796220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149416|NCT04796220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149417|NCT04796220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149418|NCT04796220|Immunologic Factors|immunologic factors|mesh-ancestor
57149419|NCT04796220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149420|NCT04777045|Diltiazem|diltiazem|mesh-list
57149421|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57149422|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57149423|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57149424|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149425|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57149426|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149427|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
57149428|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
57149429|NCT04736706|Lenvatinib|lenvatinib|mesh-list
57149430|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149431|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149432|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57149433|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149434|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149435|NCT04700124|Gemcitabine|gemcitabine|mesh-list
57149436|NCT04700124|Cisplatin|cisplatin|mesh-list
57149437|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
57149438|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149439|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149440|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
57149441|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149442|NCT04700124|Antiviral Agents|antiviral agents|mesh-ancestor
57149443|NCT04700124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149444|NCT04700124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149445|NCT04700124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149446|NCT04700124|Immunologic Factors|immunologic factors|mesh-ancestor
57149447|NCT04700124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149448|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149449|NCT04665739|Everolimus|everolimus|mesh-list
57149450|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
57149451|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149452|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149453|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
57149454|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149455|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149456|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57149457|NCT04632238|Metronidazole|metronidazole|mesh-list
57149458|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149459|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57149460|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57149461|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57149462|NCT04597190|Norepinephrine|norepinephrine|mesh-list
57149463|NCT04597190|Serotonin|serotonin|mesh-list
57149464|NCT04597190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
57149465|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57149466|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57149467|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
57149468|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57149469|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149470|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149471|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
57149472|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
57149473|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149474|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57149475|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57149476|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
57149477|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57149478|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57149479|NCT04586231|Lenvatinib|lenvatinib|mesh-list
57149480|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149481|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57149482|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149483|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149484|NCT04577755|Pomalidomide|pomalidomide|mesh-list
57149485|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
57149486|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149487|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57149488|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57149489|NCT04577755|Growth Substances|growth substances|mesh-ancestor
57149490|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
57149491|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149492|NCT04577638|Nivolumab|nivolumab|mesh-list
57149493|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149494|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149495|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57149496|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149497|NCT04549168|Lemborexant|lemborexant|mesh-list
57149498|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57149499|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57149500|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149501|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57149502|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57149503|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57149504|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149505|NCT04530565|Cytarabine|cytarabine|mesh-list
57149506|NCT04530565|Dexamethasone|dexamethasone|mesh-list
57149507|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
57149508|NCT04530565|Prednisone|prednisone|mesh-list
57149509|NCT04530565|Cortisone|cortisone|mesh-list
57149510|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
57149511|NCT04530565|Doxorubicin|doxorubicin|mesh-list
57149512|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57149513|NCT04530565|Methotrexate|methotrexate|mesh-list
57149514|NCT04530565|Vincristine|vincristine|mesh-list
57149515|NCT04530565|Dasatinib|dasatinib|mesh-list
57149516|NCT04530565|Blinatumomab|blinatumomab|mesh-list
57149517|NCT04530565|Ponatinib|ponatinib|mesh-list
57149518|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57149519|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
57149520|NCT04530565|Antibodies|antibodies|mesh-list
57149521|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
57149522|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149523|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57149524|NCT04530565|BB 1101|bb 1101|mesh-list
57149526|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149527|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
57149528|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149529|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57149530|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149531|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
57149532|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149533|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149534|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57149535|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57149536|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
57149537|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
57149538|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149539|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57149540|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
57149541|NCT04530565|Hormones|hormones|mesh-ancestor
57149542|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57149543|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57149544|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
57149545|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149546|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149547|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57149548|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57149549|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57149551|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57149552|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149553|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
57149554|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
57149555|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57149556|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57149557|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
57149558|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149559|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149560|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149561|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149562|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149563|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57149564|NCT04530565|Protective Agents|protective agents|mesh-ancestor
57149565|NCT04529772|Prednisone|prednisone|mesh-list
57149566|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
57149567|NCT04529772|Rituximab|rituximab|mesh-list
57149568|NCT04529772|Doxorubicin|doxorubicin|mesh-list
57149569|NCT04529772|Vincristine|vincristine|mesh-list
57149570|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
57149571|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149572|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
57149573|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149574|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57149575|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149576|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
57149577|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149578|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149579|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57149580|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149581|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149582|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57149583|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57149584|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149585|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57149586|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
57149587|NCT04529772|Hormones|hormones|mesh-ancestor
57149588|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57149589|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57149590|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149591|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149592|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149593|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149594|NCT04517799|Cannabidiol|cannabidiol|mesh-list
57149595|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
57149596|NCT04495296|Gemcitabine|gemcitabine|mesh-list
57149597|NCT04495296|Paclitaxel|paclitaxel|mesh-list
57149598|NCT04495296|Capecitabine|capecitabine|mesh-list
57149599|NCT04495296|Oxaliplatin|oxaliplatin|mesh-list
57149600|NCT04495296|Nivolumab|nivolumab|mesh-list
57149601|NCT04495296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149602|NCT04495296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149603|NCT04495296|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149604|NCT04495296|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149605|NCT04495296|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149606|NCT04495296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149607|NCT04495296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149608|NCT04495296|Antimetabolites|antimetabolites|mesh-ancestor
57149609|NCT04495296|Antiviral Agents|antiviral agents|mesh-ancestor
57149610|NCT04495296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149611|NCT04495296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149612|NCT04495296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149613|NCT04495296|Immunologic Factors|immunologic factors|mesh-ancestor
57149614|NCT04495296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149615|NCT04495296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149616|NCT04495296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57149617|NCT04421963|Olaparib|olaparib|mesh-list
57149618|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57149619|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149620|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149621|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149622|NCT04408638|Gemcitabine|gemcitabine|mesh-list
57149623|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
57149624|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
57149625|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149626|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
57149627|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149628|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149629|NCT04408638|Antiviral Agents|antiviral agents|mesh-ancestor
57149630|NCT04408638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149631|NCT04408638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149632|NCT04408638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149633|NCT04408638|Immunologic Factors|immunologic factors|mesh-ancestor
57149634|NCT04408638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149635|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149636|NCT04404062|Antibodies|antibodies|mesh-list
57149637|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
57149638|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
57149639|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149640|NCT04402788|Atezolizumab|atezolizumab|mesh-list
57149641|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149642|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149643|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
57149644|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149645|NCT04396860|Nivolumab|nivolumab|mesh-list
57149646|NCT04396860|Ipilimumab|ipilimumab|mesh-list
57149647|NCT04396860|Temozolomide|temozolomide|mesh-list
57149648|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149649|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149650|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57149651|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149652|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149653|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
57149654|NCT04370795|Sirolimus|sirolimus|mesh-list
57149655|NCT04370795|Busulfan|busulfan|mesh-list
57149656|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57149657|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149658|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149659|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149660|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
57149661|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149662|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
57149663|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149664|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
57149665|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149666|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149667|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57149668|NCT04352777|Fulvestrant|fulvestrant|mesh-list
57149669|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57149670|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57149671|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149672|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57149673|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57149674|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
57149675|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57149676|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149677|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57149678|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149679|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149680|NCT04339751|Vorinostat|vorinostat|mesh-list
57149681|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149682|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57149683|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149684|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149685|NCT04339738|Paclitaxel|paclitaxel|mesh-list
57149686|NCT04339738|Nivolumab|nivolumab|mesh-list
57149687|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57149688|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149689|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149690|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149691|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149692|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149693|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149694|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149695|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57149696|NCT04310020|Atezolizumab|atezolizumab|mesh-list
57149697|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149698|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149699|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
57149700|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149702|NCT04310007|Paclitaxel|paclitaxel|mesh-list
57149703|NCT04310007|Docetaxel|docetaxel|mesh-list
57149704|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57149705|NCT04310007|Nivolumab|nivolumab|mesh-list
57149706|NCT04310007|Ramucirumab|ramucirumab|mesh-list
57149707|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57149708|NCT04310007|Antibodies|antibodies|mesh-list
57149709|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
57149710|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149711|NCT04310007|Lexatumumab|lexatumumab|mesh-list
57149712|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149713|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149714|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149715|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149716|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149717|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149718|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
57149719|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149720|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149721|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
57149722|NCT04310007|Antiviral Agents|antiviral agents|mesh-ancestor
57149723|NCT04310007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149724|NCT04310007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149725|NCT04310007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149726|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57149727|NCT04276363|Nicotine|nicotine|mesh-list
57149728|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57149729|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
57149730|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149731|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149732|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57149733|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57149734|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
57149735|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57149736|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149737|NCT04267848|Gemcitabine|gemcitabine|mesh-list
57149738|NCT04267848|Paclitaxel|paclitaxel|mesh-list
57149739|NCT04267848|Cisplatin|cisplatin|mesh-list
57149740|NCT04267848|Carboplatin|carboplatin|mesh-list
57149741|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
57149742|NCT04267848|Pemetrexed|pemetrexed|mesh-list
57149743|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57149744|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149745|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149746|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149747|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149748|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149749|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149750|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149751|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
57149752|NCT04267848|Antiviral Agents|antiviral agents|mesh-ancestor
57149753|NCT04267848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149754|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149755|NCT04267848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149756|NCT04267848|Immunologic Factors|immunologic factors|mesh-ancestor
57149757|NCT04267848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149758|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149759|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57149760|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57149761|NCT04260854|Bupivacaine|bupivacaine|mesh-list
57149762|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
57149763|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
57149764|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57149765|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149766|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
57149767|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57149768|NCT04216290|Gemcitabine|gemcitabine|mesh-list
57149769|NCT04216290|Cisplatin|cisplatin|mesh-list
57149770|NCT04216290|Fluorouracil|fluorouracil|mesh-list
57149771|NCT04216290|Durvalumab|durvalumab|mesh-list
57149772|NCT04216290|Mitomycins|mitomycins|mesh-list
57149773|NCT04216290|Mitomycin|mitomycin|mesh-list
57149774|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
57149775|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149776|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
57149777|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149778|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149779|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
57149780|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149781|NCT04216290|Antiviral Agents|antiviral agents|mesh-ancestor
57149782|NCT04216290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149783|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149784|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149785|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
57149786|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149787|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149788|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57149789|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
57149790|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57149791|NCT04214262|Atezolizumab|atezolizumab|mesh-list
57149792|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149793|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149794|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
57149795|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149796|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
57149797|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149798|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149799|NCT04181060|Bevacizumab|bevacizumab|mesh-list
57149800|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57149801|NCT04181060|Osimertinib|osimertinib|mesh-list
57149802|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
57149803|NCT04181060|Antibodies|antibodies|mesh-list
57149804|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
57149805|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149806|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
57149807|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149808|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57149809|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57149810|NCT04181060|Growth Substances|growth substances|mesh-ancestor
57149811|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149812|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
57149813|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
57149814|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149815|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57149816|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149817|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
57149818|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57149819|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149820|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149821|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149822|NCT04175912|Paclitaxel|paclitaxel|mesh-list
57149823|NCT04175912|Carboplatin|carboplatin|mesh-list
57149824|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57149825|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
57149826|NCT04175912|Pevonedistat|pevonedistat|mesh-list
57149827|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149828|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149829|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149830|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149831|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149832|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149833|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
57149834|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149835|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149836|NCT04165070|Paclitaxel|paclitaxel|mesh-list
57149837|NCT04165070|Carboplatin|carboplatin|mesh-list
57149838|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
57149839|NCT04165070|Pemetrexed|pemetrexed|mesh-list
57149840|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149841|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149842|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149843|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149844|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149845|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149846|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149847|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149848|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57149849|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57149850|NCT04164082|Gemcitabine|gemcitabine|mesh-list
57149851|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
57149852|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149853|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
57149854|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149855|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149856|NCT04164082|Antiviral Agents|antiviral agents|mesh-ancestor
57149857|NCT04164082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149858|NCT04164082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149859|NCT04164082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149860|NCT04164082|Immunologic Factors|immunologic factors|mesh-ancestor
57149861|NCT04164082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149862|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149864|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
57149865|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57149866|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57149867|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149868|NCT04141579|Evolocumab|evolocumab|mesh-list
57149869|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57149870|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57149871|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
57149872|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149873|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57149874|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
57149875|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149876|NCT04102436|Aldesleukin|aldesleukin|mesh-list
57149877|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
57149878|NCT04102436|Fludarabine|fludarabine|mesh-list
57149879|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149880|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
57149881|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149882|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57149883|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57149884|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
57149885|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149886|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149887|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57149888|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57149889|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57149890|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
57149891|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57149892|NCT04100018|Prednisone|prednisone|mesh-list
57149893|NCT04100018|Docetaxel|docetaxel|mesh-list
57149894|NCT04100018|Nivolumab|nivolumab|mesh-list
57149895|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149896|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149897|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149898|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149899|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149900|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57149901|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
57149902|NCT04100018|Hormones|hormones|mesh-ancestor
57149903|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57149904|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149905|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57149906|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149907|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57149908|NCT04097561|Belimumab|belimumab|mesh-list
57149909|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149910|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
57149911|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149912|NCT04095689|Docetaxel|docetaxel|mesh-list
57149913|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
57149914|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149915|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149916|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149917|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149918|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149919|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149920|NCT04092283|Paclitaxel|paclitaxel|mesh-list
57149921|NCT04092283|Etoposide|etoposide|mesh-list
57149922|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
57149923|NCT04092283|Cisplatin|cisplatin|mesh-list
57149924|NCT04092283|Carboplatin|carboplatin|mesh-list
57149925|NCT04092283|Pemetrexed|pemetrexed|mesh-list
57149926|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57149927|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
57149928|NCT04092283|Durvalumab|durvalumab|mesh-list
57149929|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
57149930|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57149931|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
57149932|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57149933|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149934|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
57149935|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
57149936|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
57149937|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149938|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57149939|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57149940|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149941|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57149942|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57149943|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149944|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
57149945|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149946|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
57149947|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
57149948|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
57149949|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149950|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149951|NCT04059484|Tamoxifen|tamoxifen|mesh-list
57149952|NCT04059484|Letrozole|letrozole|mesh-list
57149953|NCT04059484|Fulvestrant|fulvestrant|mesh-list
57149954|NCT04059484|Anastrozole|anastrozole|mesh-list
57149955|NCT04059484|Exemestane|exemestane|mesh-list
57149956|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149957|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57149958|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57149959|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149960|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149961|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57149962|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
57149963|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57149964|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149965|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57149966|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57149967|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57149968|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57149969|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57149970|NCT04054752|Vaccines|vaccines|mesh-list
57149971|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
57149972|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149973|NCT04038502|Carboplatin|carboplatin|mesh-list
57149974|NCT04038502|Olaparib|olaparib|mesh-list
57149975|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149976|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57149977|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57149978|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149979|NCT04008030|Leucovorin|leucovorin|mesh-list
57149980|NCT04008030|Bevacizumab|bevacizumab|mesh-list
57149981|NCT04008030|Nivolumab|nivolumab|mesh-list
57149982|NCT04008030|Cetuximab|cetuximab|mesh-list
57149983|NCT04008030|Ipilimumab|ipilimumab|mesh-list
57149984|NCT04008030|Fluorouracil|fluorouracil|mesh-list
57149985|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
57149986|NCT04008030|Irinotecan|irinotecan|mesh-list
57149987|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57149988|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57149989|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57149990|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57149991|NCT04008030|Growth Substances|growth substances|mesh-ancestor
57149992|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57149993|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
57149994|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
57149995|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57149996|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57149997|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57149998|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
57149999|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150000|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57150001|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57150002|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150003|NCT04008030|Antidotes|antidotes|mesh-ancestor
57150004|NCT04008030|Protective Agents|protective agents|mesh-ancestor
57150005|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
57150006|NCT04008030|Vitamins|vitamins|mesh-ancestor
57150007|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
57150008|NCT03984448|Prednisone|prednisone|mesh-list
57150009|NCT03984448|Cortisone|cortisone|mesh-list
57150010|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
57150011|NCT03984448|Rituximab|rituximab|mesh-list
57150012|NCT03984448|Doxorubicin|doxorubicin|mesh-list
57150013|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57150014|NCT03984448|Etoposide|etoposide|mesh-list
57150015|NCT03984448|Vincristine|vincristine|mesh-list
57150016|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
57150017|NCT03984448|Venetoclax|venetoclax|mesh-list
57150018|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
57150019|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57150020|NCT03984448|Antibodies|antibodies|mesh-list
57150021|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
57150022|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150023|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150024|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
57150025|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150026|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57150027|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57150028|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
57150029|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150030|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150031|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57150032|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150033|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57150034|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57150035|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150036|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57150037|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
57150038|NCT03984448|Hormones|hormones|mesh-ancestor
57150039|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57150040|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57150041|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150042|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150043|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150044|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150045|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
57150046|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
57150047|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57150048|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57150049|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57150050|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150051|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57150052|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57150053|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150054|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
57150055|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57150056|NCT03972657|Cemiplimab|cemiplimab|mesh-list
57150057|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150058|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150059|NCT03952585|Cisplatin|cisplatin|mesh-list
57150060|NCT03952585|Nivolumab|nivolumab|mesh-list
57150061|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150062|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150063|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150064|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150065|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
57150066|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150067|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150068|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57150069|NCT03907488|Nivolumab|nivolumab|mesh-list
57150070|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57150071|NCT03907488|Doxorubicin|doxorubicin|mesh-list
57150072|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57150073|NCT03907488|Dacarbazine|dacarbazine|mesh-list
57150074|NCT03907488|Vinblastine|vinblastine|mesh-list
57150075|NCT03907488|Antibodies|antibodies|mesh-list
57150076|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
57150077|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150078|NCT03907488|Lenograstim|lenograstim|mesh-list
57150079|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
57150080|NCT03907488|Imidazole|imidazole|mesh-list
57150081|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
57150082|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150083|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150084|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150085|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57150086|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57150087|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150088|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150089|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150090|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57150091|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57150092|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
57150093|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150094|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150095|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150096|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150097|NCT03871257|Carboplatin|carboplatin|mesh-list
57150098|NCT03871257|Vincristine|vincristine|mesh-list
57150099|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150100|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150101|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150102|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150103|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150104|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150105|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
57150106|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150107|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150108|NCT03866382|Nivolumab|nivolumab|mesh-list
57150109|NCT03866382|Ipilimumab|ipilimumab|mesh-list
57150110|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150111|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150112|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150113|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150114|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57150115|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
57150116|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150117|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
57150118|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150119|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150120|NCT03841617|Hormones|hormones|mesh-list
57150121|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57150122|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150123|NCT03816397|Adalimumab|adalimumab|mesh-list
57150124|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57150125|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57150126|NCT03816332|Prednisone|prednisone|mesh-list
57150127|NCT03816332|Cortisone|cortisone|mesh-list
57150128|NCT03816332|Nivolumab|nivolumab|mesh-list
57150129|NCT03816332|Ipilimumab|ipilimumab|mesh-list
57150130|NCT03816332|Tacrolimus|tacrolimus|mesh-list
57150131|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57150132|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
57150133|NCT03816332|Hormones|hormones|mesh-ancestor
57150134|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57150135|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150136|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57150137|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150138|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150139|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150140|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150141|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150142|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
57150143|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57150144|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150145|NCT03811015|Cisplatin|cisplatin|mesh-list
57150146|NCT03811015|Nivolumab|nivolumab|mesh-list
57150147|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150148|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150149|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150150|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150151|NCT03811002|Cisplatin|cisplatin|mesh-list
57150152|NCT03811002|Carboplatin|carboplatin|mesh-list
57150153|NCT03811002|Etoposide|etoposide|mesh-list
57150154|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
57150155|NCT03811002|Atezolizumab|atezolizumab|mesh-list
57150156|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
57150157|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150158|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150159|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150160|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57150161|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57150163|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150164|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
57150165|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150166|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
57150167|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
57150168|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150169|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150170|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150171|NCT03805607|Ketorolac|ketorolac|mesh-list
57150172|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57150173|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57150174|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57150175|NCT03805607|Analgesics|analgesics|mesh-ancestor
57150176|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
57150177|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57150178|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150179|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57150180|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57150181|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57150182|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150183|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150184|NCT03793179|Carboplatin|carboplatin|mesh-list
57150185|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
57150186|NCT03793179|Pemetrexed|pemetrexed|mesh-list
57150187|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150188|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844030|NCT05001880|Pemetrexed|pemetrexed|mesh-list
57150189|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150190|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150191|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57150192|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57150193|NCT03793166|Nivolumab|nivolumab|mesh-list
57150194|NCT03793166|Ipilimumab|ipilimumab|mesh-list
57150195|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150196|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150197|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150198|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150199|NCT03775265|Gemcitabine|gemcitabine|mesh-list
57150200|NCT03775265|Cisplatin|cisplatin|mesh-list
57150201|NCT03775265|Fluorouracil|fluorouracil|mesh-list
57150202|NCT03775265|Atezolizumab|atezolizumab|mesh-list
57150203|NCT03775265|Mitomycins|mitomycins|mesh-list
57150204|NCT03775265|Mitomycin|mitomycin|mesh-list
57150205|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150206|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150207|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150208|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
57150209|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150210|NCT03775265|Antiviral Agents|antiviral agents|mesh-ancestor
57150211|NCT03775265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150212|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150213|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150214|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
57150215|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150216|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150217|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
57150218|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57150219|NCT03733067|Abatacept|abatacept|mesh-list
57150220|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150221|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150222|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150223|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150224|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
57150225|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150226|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57150227|NCT03718767|Nivolumab|nivolumab|mesh-list
57150228|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150229|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150230|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150231|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150232|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
57150233|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150234|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150235|NCT03701282|Venetoclax|venetoclax|mesh-list
57150236|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
57150237|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150238|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150239|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150240|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
57150241|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150242|NCT03671018|Rituximab|rituximab|mesh-list
57150243|NCT03671018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150244|NCT03671018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150245|NCT03671018|Immunologic Factors|immunologic factors|mesh-ancestor
57150246|NCT03671018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150247|NCT03671018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57150248|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
57150249|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
57150250|NCT03670966|Fludarabine|fludarabine|mesh-list
57150251|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
57150252|NCT03670966|Tacrolimus|tacrolimus|mesh-list
57150253|NCT03670966|Antibodies|antibodies|mesh-list
57150254|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150255|NCT03670966|Lenograstim|lenograstim|mesh-list
57150256|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150257|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
57150258|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150259|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57150260|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57150261|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
57150262|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150263|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150264|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57150265|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150266|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
57150267|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150268|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57150269|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150270|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150271|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57150272|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
57150273|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57150274|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57150275|NCT03660826|Durvalumab|durvalumab|mesh-list
57150276|NCT03660826|Olaparib|olaparib|mesh-list
57150277|NCT03660826|Cediranib|cediranib|mesh-list
57150278|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57150279|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
57150280|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150281|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
57150282|NCT03660826|Maleic acid|maleic acid|mesh-list
57150283|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150284|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150285|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
57150286|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150287|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150288|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150289|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57150290|NCT03648905|Dopamine|dopamine|mesh-list
57150291|NCT03648905|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57150292|NCT03648905|Sympathomimetics|sympathomimetics|mesh-ancestor
57150293|NCT03648905|Autonomic Agents|autonomic agents|mesh-ancestor
57150294|NCT03648905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57150295|NCT03648905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150296|NCT03648905|Dopamine Agents|dopamine agents|mesh-ancestor
57150297|NCT03648905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57150298|NCT03648905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150299|NCT03648905|Protective Agents|protective agents|mesh-ancestor
57150300|NCT03604991|Paclitaxel|paclitaxel|mesh-list
57150301|NCT03604991|Carboplatin|carboplatin|mesh-list
57150302|NCT03604991|Nivolumab|nivolumab|mesh-list
57150303|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57150304|NCT03604991|Ipilimumab|ipilimumab|mesh-list
57150305|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150306|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150307|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150308|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150309|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150310|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150311|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150312|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56832058|NCT00252564|Antidotes|antidotes|mesh-ancestor
57150313|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57150314|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150315|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150317|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150318|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
57150319|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150320|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150321|NCT03484819|Nivolumab|nivolumab|mesh-list
57150322|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150323|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150324|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150325|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150326|NCT03467789|Vitamin D|vitamin d|mesh-list
57150327|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
57150328|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
57150329|NCT03467789|Vitamins|vitamins|mesh-list
57150330|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
57150331|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150332|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57150333|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57150334|NCT03436745|Zolpidem|zolpidem|mesh-list
57150335|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57150336|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57150337|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57150338|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150339|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57150340|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
57150341|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
57150342|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57150343|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150344|NCT03407144|Prednisone|prednisone|mesh-list
57150345|NCT03407144|Prednisolone|prednisolone|mesh-list
57150346|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
57150347|NCT03407144|Dacarbazine|dacarbazine|mesh-list
57150348|NCT03407144|Doxorubicin|doxorubicin|mesh-list
57150349|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
57150350|NCT03407144|Etoposide|etoposide|mesh-list
57150351|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
57150352|NCT03407144|Vincristine|vincristine|mesh-list
57150353|NCT03407144|Bleomycin|bleomycin|mesh-list
57150354|NCT03407144|Vinblastine|vinblastine|mesh-list
57150355|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150356|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
57150357|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150358|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57150359|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57150360|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
57150361|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150362|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150363|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57150364|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150365|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57150366|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57150367|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150368|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150369|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57150370|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
57150371|NCT03407144|Hormones|hormones|mesh-ancestor
57150372|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57150373|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57150374|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150375|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150376|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150377|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150378|NCT03406715|Nivolumab|nivolumab|mesh-list
57150379|NCT03406715|Ipilimumab|ipilimumab|mesh-list
57150380|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150381|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150382|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150383|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150384|NCT03363763|Sirolimus|sirolimus|mesh-list
57150385|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57150386|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150387|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56832133|NCT01164046|Vitamin K|vitamin k|mesh-list
57150388|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150389|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
57150390|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150391|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
57150392|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150394|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150395|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57150396|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57150397|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150398|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150399|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57150400|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
57150401|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57150402|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150403|NCT03294460|Ethanol|ethanol|mesh-list
57150404|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57150405|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150406|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57150407|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150408|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
57150409|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150410|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150411|NCT03224507|Dexamethasone|dexamethasone|mesh-list
57150412|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
57150413|NCT03224507|Lenalidomide|lenalidomide|mesh-list
57150414|NCT03224507|Daratumumab|daratumumab|mesh-list
57150415|NCT03224507|BB 1101|bb 1101|mesh-list
57150416|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150417|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57150418|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
57150419|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
57150420|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57150421|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150422|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57150423|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
57150424|NCT03224507|Hormones|hormones|mesh-ancestor
57150425|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57150426|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57150427|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150428|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
57150429|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150430|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150431|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
57150432|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57150433|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57150434|NCT03224507|Growth Substances|growth substances|mesh-ancestor
57150435|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
57150436|NCT03218826|Docetaxel|docetaxel|mesh-list
57150437|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150438|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150439|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150440|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150441|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150442|NCT03199885|Paclitaxel|paclitaxel|mesh-list
57150443|NCT03199885|Docetaxel|docetaxel|mesh-list
57150444|NCT03199885|Trastuzumab|trastuzumab|mesh-list
57150445|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57150446|NCT03199885|Atezolizumab|atezolizumab|mesh-list
57150447|NCT03199885|Pertuzumab|pertuzumab|mesh-list
57150448|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
57150449|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57150450|NCT03199885|Antibodies|antibodies|mesh-list
57150451|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
57150452|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150453|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150454|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150455|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150456|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150457|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150458|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150459|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
57150460|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150461|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
57150462|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57150463|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57150464|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150465|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
57150466|NCT03182751|Coagulants|coagulants|mesh-ancestor
57150467|NCT03178552|Gemcitabine|gemcitabine|mesh-list
57150468|NCT03178552|Bevacizumab|bevacizumab|mesh-list
57150469|NCT03178552|Carboplatin|carboplatin|mesh-list
57150470|NCT03178552|Docetaxel|docetaxel|mesh-list
57150471|NCT03178552|Pemetrexed|pemetrexed|mesh-list
57150472|NCT03178552|Atezolizumab|atezolizumab|mesh-list
57150473|NCT03178552|Vemurafenib|vemurafenib|mesh-list
57150474|NCT03178552|Entrectinib|entrectinib|mesh-list
57150475|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150476|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150477|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57150478|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57150479|NCT03178552|Growth Substances|growth substances|mesh-ancestor
57150480|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150481|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
57150482|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150483|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
57150484|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150485|NCT03178552|Antiviral Agents|antiviral agents|mesh-ancestor
57150486|NCT03178552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150487|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150488|NCT03178552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150489|NCT03178552|Immunologic Factors|immunologic factors|mesh-ancestor
57150490|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150491|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150492|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150493|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57150494|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57150495|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57150496|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57150497|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57150498|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150499|NCT03105245|Thiopental|thiopental|mesh-list
57150500|NCT03105245|Anesthetics|anesthetics|mesh-list
57150501|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57150502|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150503|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
57150504|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57150505|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57150506|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
57150507|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
57150508|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
57150509|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57150510|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150511|NCT03092674|Cytarabine|cytarabine|mesh-list
57150512|NCT03092674|Nivolumab|nivolumab|mesh-list
57150513|NCT03092674|Azacitidine|azacitidine|mesh-list
57150514|NCT03092674|Decitabine|decitabine|mesh-list
57150515|NCT03092674|Midostaurin|midostaurin|mesh-list
57150516|NCT03092674|Staurosporine|staurosporine|mesh-list
57150517|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150518|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150519|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150520|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150521|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150522|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
57150523|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
57150524|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150525|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150526|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
57150527|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150528|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150529|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57150530|NCT03076554|Avelumab|avelumab|mesh-list
57150531|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150532|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150533|NCT03057106|Durvalumab|durvalumab|mesh-list
57150534|NCT03057106|Tremelimumab|tremelimumab|mesh-list
57150535|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150536|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150537|NCT03027388|LB100|lb100|mesh-list
57150538|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150539|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150540|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150541|NCT03020199|Betamethasone|betamethasone|mesh-list
57150542|NCT03020199|Calcipotriene|calcipotriene|mesh-list
57150543|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150544|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57150545|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
57150546|NCT03020199|Hormones|hormones|mesh-ancestor
57150547|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57150548|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150549|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57150550|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
57150551|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
57150552|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
57150553|NCT03019588|Paclitaxel|paclitaxel|mesh-list
57150554|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
57150555|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150556|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150557|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150558|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150559|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150560|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150561|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150562|NCT02979873|Sirolimus|sirolimus|mesh-list
57150563|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57150564|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150565|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150566|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150567|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
57150568|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150569|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
57150570|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150571|NCT02975882|Sirolimus|sirolimus|mesh-list
57150572|NCT02975882|Irinotecan|irinotecan|mesh-list
57150573|NCT02975882|Camptothecin|camptothecin|mesh-list
57150574|NCT02975882|Temozolomide|temozolomide|mesh-list
57150575|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57150576|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57150577|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150578|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150579|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150580|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57150581|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
57150582|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57150583|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150584|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150585|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
57150586|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150587|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
57150588|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150589|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150590|NCT02959944|Prednisone|prednisone|mesh-list
57150591|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57150592|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
57150593|NCT02959944|Hormones|hormones|mesh-ancestor
57150594|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57150595|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150596|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57150597|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150598|NCT02955394|Fulvestrant|fulvestrant|mesh-list
57150599|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57150600|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150601|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57150602|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57150603|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
57150604|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57150605|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150606|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
57150607|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150608|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150609|NCT02891824|Bevacizumab|bevacizumab|mesh-list
57150610|NCT02891824|Atezolizumab|atezolizumab|mesh-list
57150611|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150612|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150613|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57150614|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57150615|NCT02891824|Growth Substances|growth substances|mesh-ancestor
56832358|NCT01164826|Nabumetone|nabumetone|mesh-list
57150616|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150617|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
57150618|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
57150619|NCT02890355|Leucovorin|leucovorin|mesh-list
57150620|NCT02890355|Folic Acid|folic acid|mesh-list
57150621|NCT02890355|Fluorouracil|fluorouracil|mesh-list
57150622|NCT02890355|Irinotecan|irinotecan|mesh-list
57150623|NCT02890355|Veliparib|veliparib|mesh-list
57150624|NCT02890355|Camptothecin|camptothecin|mesh-list
57150625|NCT02890355|Calcium|calcium|mesh-list
57150626|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
57150627|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57150628|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150629|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57150630|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
57150631|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150632|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150633|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150634|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150635|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
57150636|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57150637|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57150638|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150639|NCT02890355|Antidotes|antidotes|mesh-ancestor
57150640|NCT02890355|Protective Agents|protective agents|mesh-ancestor
57150641|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
57150642|NCT02890355|Vitamins|vitamins|mesh-ancestor
57150643|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
57150644|NCT02890355|Hematinics|hematinics|mesh-ancestor
57150645|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57150646|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150647|NCT02872116|Leucovorin|leucovorin|mesh-list
57150648|NCT02872116|Fluorouracil|fluorouracil|mesh-list
57150649|NCT02872116|Capecitabine|capecitabine|mesh-list
57150650|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
57150651|NCT02872116|Nivolumab|nivolumab|mesh-list
57150652|NCT02872116|Ipilimumab|ipilimumab|mesh-list
57150653|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
57150654|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150655|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150656|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150657|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150658|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
57150659|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150660|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150661|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150662|NCT02872116|Antidotes|antidotes|mesh-ancestor
57150663|NCT02872116|Protective Agents|protective agents|mesh-ancestor
57150664|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
57150665|NCT02872116|Vitamins|vitamins|mesh-ancestor
57150666|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
57150667|NCT02866747|Durvalumab|durvalumab|mesh-list
57150668|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150669|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150670|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
57150671|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57150672|NCT02841280|Diuretics|diuretics|mesh-ancestor
57150673|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
57150674|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150675|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57150676|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57150677|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150678|NCT02834013|Nivolumab|nivolumab|mesh-list
57150679|NCT02834013|Ipilimumab|ipilimumab|mesh-list
57150680|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150681|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150682|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150683|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150684|NCT02823002|Lidocaine|lidocaine|mesh-list
57150685|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
57150686|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
57150687|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57150688|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150689|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
57150690|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57150691|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56832438|NCT01177852|Ephedrine|ephedrine|mesh-list
57150692|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57150693|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57150694|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57150695|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150696|NCT02806687|Gemcitabine|gemcitabine|mesh-list
57150697|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150698|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
57150699|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150700|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150701|NCT02806687|Antiviral Agents|antiviral agents|mesh-ancestor
57150702|NCT02806687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150703|NCT02806687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150704|NCT02806687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150705|NCT02806687|Immunologic Factors|immunologic factors|mesh-ancestor
57150706|NCT02806687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150707|NCT02723331|Gemcitabine|gemcitabine|mesh-list
57150708|NCT02723331|Paclitaxel|paclitaxel|mesh-list
57150709|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57150710|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150711|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150712|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150713|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150714|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150715|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150716|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150717|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
57150718|NCT02723331|Antiviral Agents|antiviral agents|mesh-ancestor
57150719|NCT02723331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150720|NCT02723331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150721|NCT02723331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150722|NCT02723331|Immunologic Factors|immunologic factors|mesh-ancestor
57150723|NCT02723331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150724|NCT02631733|Irinotecan|irinotecan|mesh-list
57150725|NCT02631733|Veliparib|veliparib|mesh-list
57150726|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57150727|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57150728|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57150729|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150730|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150731|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150732|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57150733|NCT02631733|Hematinics|hematinics|mesh-ancestor
57150734|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57150735|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57150736|NCT02581137|Metformin|metformin|mesh-list
57150737|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57150738|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150739|NCT02559180|Aflibercept|aflibercept|mesh-list
57150740|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57150741|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57150742|NCT02559180|Growth Substances|growth substances|mesh-ancestor
57150743|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150744|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
57150745|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150746|NCT02539966|Sirolimus|sirolimus|mesh-list
57150747|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57150748|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150749|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150750|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150751|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
57150752|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150753|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
57150754|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150755|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57150756|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57150757|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150758|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57150759|NCT02511028|Hematinics|hematinics|mesh-ancestor
57150760|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57150761|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57150762|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57150763|NCT02465060|Nivolumab|nivolumab|mesh-list
57150764|NCT02465060|Trastuzumab|trastuzumab|mesh-list
57150765|NCT02465060|Pertuzumab|pertuzumab|mesh-list
57150766|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
57150767|NCT02465060|Sunitinib|sunitinib|mesh-list
57150768|NCT02465060|Dasatinib|dasatinib|mesh-list
57150769|NCT02465060|Palbociclib|palbociclib|mesh-list
57150770|NCT02465060|Trametinib|trametinib|mesh-list
57150771|NCT02465060|Osimertinib|osimertinib|mesh-list
57150772|NCT02465060|Afatinib|afatinib|mesh-list
57150773|NCT02465060|Dabrafenib|dabrafenib|mesh-list
57150774|NCT02465060|Crizotinib|crizotinib|mesh-list
57150775|NCT02465060|Maytansine|maytansine|mesh-list
57150776|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
57150777|NCT02465060|GSK2636771|gsk2636771|mesh-list
57150778|NCT02465060|Antibodies|antibodies|mesh-list
57150779|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
57150780|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150781|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
57150782|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
57150783|NCT02465060|Adavosertib|adavosertib|mesh-list
57150784|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
57150785|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150786|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150787|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150788|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150789|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57150790|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57150791|NCT02465060|Growth Substances|growth substances|mesh-ancestor
57150792|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
57150793|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57150794|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150795|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150796|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150797|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150798|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150799|NCT02455557|Temozolomide|temozolomide|mesh-list
57150800|NCT02455557|Sargramostim|sargramostim|mesh-list
57150801|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
57150802|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57150803|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
57150804|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150805|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150806|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
57150807|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150808|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57150809|NCT02401139|Ketamine|ketamine|mesh-list
57150810|NCT02401139|Analgesics|analgesics|mesh-ancestor
57150811|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
57150812|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57150813|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150814|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57150815|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57150816|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
57150817|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
57150818|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57150819|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57150820|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57150821|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57150822|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150823|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
57150824|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57150825|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57150826|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150827|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
57150828|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
57150829|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150830|NCT02379416|Paclitaxel|paclitaxel|mesh-list
57150831|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150832|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150833|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150834|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150835|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150836|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150837|NCT02369458|Mitomycins|mitomycins|mesh-list
57150838|NCT02369458|Mitomycin|mitomycin|mesh-list
57150839|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150840|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150841|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
57150842|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150843|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57150844|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150845|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
56832583|NCT01178710|Simvastatin|simvastatin|mesh-list
57150846|NCT02367846|NuvaRing|nuvaring|mesh-list
57150847|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
57150848|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
57150849|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57150850|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150851|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57150852|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57150853|NCT02203526|Cytarabine|cytarabine|mesh-list
57150854|NCT02203526|Isavuconazole|isavuconazole|mesh-list
57150855|NCT02203526|Rituximab|rituximab|mesh-list
57150856|NCT02203526|Methotrexate|methotrexate|mesh-list
57150857|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150858|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150859|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
57150860|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150861|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57150862|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57150863|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
57150864|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57150865|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150866|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
57150867|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150868|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
57150869|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150870|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57150871|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150872|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57150873|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
57150874|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150875|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
57150876|NCT02196181|Trametinib|trametinib|mesh-list
57150877|NCT02196181|Dabrafenib|dabrafenib|mesh-list
57150878|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
57150879|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150880|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57150881|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150882|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150883|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57150884|NCT02196181|Protective Agents|protective agents|mesh-ancestor
57150885|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150886|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57150887|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
57150888|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
57150889|NCT02195895|Vitamin D|vitamin d|mesh-list
57150890|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
57150891|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
57150892|NCT02195895|Alendronate|alendronate|mesh-list
57150893|NCT02195895|Vitamins|vitamins|mesh-list
57150894|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
57150895|NCT02195895|Antacids|antacids|mesh-list
57150896|NCT02195895|Calcium|calcium|mesh-list
57150897|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
57150898|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150899|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57150900|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57150901|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150902|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57150903|NCT02194738|Gemcitabine|gemcitabine|mesh-list
57150904|NCT02194738|Paclitaxel|paclitaxel|mesh-list
57150905|NCT02194738|Cisplatin|cisplatin|mesh-list
57150906|NCT02194738|Carboplatin|carboplatin|mesh-list
57150907|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
57150908|NCT02194738|Nivolumab|nivolumab|mesh-list
57150909|NCT02194738|Pemetrexed|pemetrexed|mesh-list
57150910|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57150911|NCT02194738|Crizotinib|crizotinib|mesh-list
57150912|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150913|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150914|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150915|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150916|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150917|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832659|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57150918|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150919|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
57150920|NCT02194738|Antiviral Agents|antiviral agents|mesh-ancestor
57150921|NCT02194738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150922|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150923|NCT02194738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150924|NCT02194738|Immunologic Factors|immunologic factors|mesh-ancestor
57150925|NCT02194738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150926|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57150927|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150928|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57150929|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57150930|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57150931|NCT02015013|Plerixafor|plerixafor|mesh-list
57150932|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57150933|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57150934|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
57150935|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150936|NCT01970722|Gemcitabine|gemcitabine|mesh-list
57150937|NCT01970722|Paclitaxel|paclitaxel|mesh-list
57150938|NCT01970722|Cisplatin|cisplatin|mesh-list
57150939|NCT01970722|Carboplatin|carboplatin|mesh-list
57150940|NCT01970722|Doxorubicin|doxorubicin|mesh-list
57150941|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57150942|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57150943|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57150944|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150945|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
57150946|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
57150947|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
57150948|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150949|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150950|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
57150951|NCT01970722|Antiviral Agents|antiviral agents|mesh-ancestor
57150952|NCT01970722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57150953|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150954|NCT01970722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150955|NCT01970722|Immunologic Factors|immunologic factors|mesh-ancestor
57150956|NCT01970722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150957|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57150958|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57150959|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57150960|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
57150961|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57150962|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
57150963|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57150964|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150965|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57150966|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57150967|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57150968|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
57150969|NCT01953900|Fludarabine|fludarabine|mesh-list
57150970|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57150971|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
57150972|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150973|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57150974|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57150975|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
57150976|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150977|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150978|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57150979|NCT01913951|Azacitidine|azacitidine|mesh-list
57150980|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57150981|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
57150982|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150983|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150984|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57150985|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57150986|NCT01896999|Nivolumab|nivolumab|mesh-list
57150987|NCT01896999|Ipilimumab|ipilimumab|mesh-list
57150988|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57150989|NCT01896999|Antibodies|antibodies|mesh-list
57150990|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
57150991|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57150992|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
57150993|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
57150994|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57150995|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57150996|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57150997|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57150998|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
56832733|NCT03862768|Sunitinib|sunitinib|mesh-list
57150999|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57151000|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57151001|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
57151002|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57151003|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57151004|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57151005|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151006|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151007|NCT01842386|Rituximab|rituximab|mesh-list
57151008|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57151009|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151010|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
57151011|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151012|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57151013|NCT01712620|Spironolactone|spironolactone|mesh-list
57151014|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57151015|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
57151016|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57151017|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151018|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57151019|NCT01712620|Diuretics|diuretics|mesh-ancestor
57151020|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
57151021|NCT01709136|Sirolimus|sirolimus|mesh-list
57151022|NCT01709136|Tacrolimus|tacrolimus|mesh-list
57151023|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57151024|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
57151025|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151026|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57151027|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151028|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151029|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57151030|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57151031|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57151032|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151033|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
57151034|NCT01570868|Ponatinib|ponatinib|mesh-list
57151035|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151036|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57151037|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151038|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151039|NCT01565499|Paclitaxel|paclitaxel|mesh-list
57151040|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57151041|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151042|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
57151043|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
57151044|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
57151045|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151046|NCT01553214|Dexamethasone|dexamethasone|mesh-list
57151047|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57151048|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
57151049|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
57151050|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57151051|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151052|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57151053|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
57151054|NCT01553214|Hormones|hormones|mesh-ancestor
57151055|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57151056|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57151057|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151058|NCT01391962|Sunitinib|sunitinib|mesh-list
57151059|NCT01391962|Cediranib|cediranib|mesh-list
57151060|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151061|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57151062|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57151063|NCT01391962|Growth Substances|growth substances|mesh-ancestor
57151064|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151065|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
57151066|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57151067|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151068|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151069|NCT01371630|Cytarabine|cytarabine|mesh-list
57151070|NCT01371630|Dexamethasone|dexamethasone|mesh-list
57151071|NCT01371630|Prednisone|prednisone|mesh-list
57151072|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
57151073|NCT01371630|Rituximab|rituximab|mesh-list
57151074|NCT01371630|Methotrexate|methotrexate|mesh-list
57151075|NCT01371630|Vincristine|vincristine|mesh-list
57151076|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
57151077|NCT01371630|Blinatumomab|blinatumomab|mesh-list
57151078|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
57151079|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57151080|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
57151081|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151082|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57151083|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57151084|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
57151085|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151086|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151087|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57151088|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57151089|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57151090|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
57151091|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
57151092|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57151093|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57151094|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
57151095|NCT01371630|Hormones|hormones|mesh-ancestor
57151096|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57151097|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57151098|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57151099|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
57151100|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57151101|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57151102|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
57151103|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
57151104|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151105|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57151106|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57151107|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
57151108|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57151109|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57151110|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
57151111|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
57151112|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
57151113|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57151114|NCT01319565|Aldesleukin|aldesleukin|mesh-list
57151115|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
57151116|NCT01319565|Fludarabine|fludarabine|mesh-list
57151117|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57151118|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
57151119|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151120|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57151121|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57151122|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
57151123|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151124|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151125|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57151126|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57151127|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57151128|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
57151129|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57151130|NCT01306942|Paclitaxel|paclitaxel|mesh-list
57151131|NCT01306942|Trastuzumab|trastuzumab|mesh-list
57151132|NCT01306942|Dasatinib|dasatinib|mesh-list
57151133|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57151134|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151135|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
57151136|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
57151137|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
57151138|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151139|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57151140|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57151141|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151142|NCT01036087|Paclitaxel|paclitaxel|mesh-list
57151143|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57151144|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
57151145|NCT01036087|Carboplatin|carboplatin|mesh-list
57151146|NCT01036087|Fluorouracil|fluorouracil|mesh-list
57151147|NCT01036087|Epirubicin|epirubicin|mesh-list
56832890|NCT01287130|Cetuximab|cetuximab|mesh-list
57151148|NCT01036087|Panitumumab|panitumumab|mesh-list
57151149|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57151150|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151151|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
57151152|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
57151153|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
57151154|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151155|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57151156|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
57151157|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151158|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57151159|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57151160|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
57151161|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57151162|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
57151163|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57151164|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57151165|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57151166|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57151167|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151168|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57151169|NCT00967785|Plerixafor|plerixafor|mesh-list
57151170|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57151171|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57151172|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
57151173|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57151174|NCT00783367|Dexamethasone|dexamethasone|mesh-list
57151175|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
57151176|NCT00783367|Rituximab|rituximab|mesh-list
57151177|NCT00783367|Lenalidomide|lenalidomide|mesh-list
57151178|NCT00783367|BB 1101|bb 1101|mesh-list
57151179|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57151180|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151181|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
57151182|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151183|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57151184|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57151185|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
57151186|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
57151187|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57151188|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57151189|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
57151190|NCT00783367|Hormones|hormones|mesh-ancestor
57151191|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57151192|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57151193|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
57151194|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151195|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151196|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57151197|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57151198|NCT00783367|Growth Substances|growth substances|mesh-ancestor
57151199|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
57151200|NCT00572156|Mecasermin|mecasermin|mesh-list
57151201|NCT00572156|Growth Substances|growth substances|mesh-ancestor
57151202|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151203|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
57151204|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57151205|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57151206|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57151207|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57151208|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151209|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
57151210|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57151211|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151212|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57151213|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57151214|NCT00255216|Policosanol|policosanol|mesh-list
57151215|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57151216|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57151217|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
57151218|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151219|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57151220|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57151221|NCT00079066|Cetuximab|cetuximab|mesh-list
57151222|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57151223|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151224|NCT00024622|Levodopa|levodopa|mesh-list
57151225|NCT00024622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57151226|NCT00024622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57151243|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57151244|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151245|NCT00018044|Clofazimine|clofazimine|mesh-list
57151246|NCT00018044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57151247|NCT00018044|Leprostatic Agents|leprostatic agents|mesh-ancestor
57151248|NCT00018044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57151249|NCT00018044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57151250|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
57151251|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
57151252|NCT00001521|Letrozole|letrozole|mesh-list
57151253|NCT00001521|Flutamide|flutamide|mesh-list
57151254|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151255|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57151256|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57151257|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151258|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57151259|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57151260|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
57151261|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57151262|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151263|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57151264|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
57151265|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57151266|NCT00001379|Interferons|interferons|mesh-list
57151267|NCT00001379|Rituximab|rituximab|mesh-list
57151268|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57151269|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
57151270|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57151271|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57151272|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
57151273|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57151274|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57151275|NCT00001230|Diethylcarbamazine|diethylcarbamazine|mesh-list
57151276|NCT00001230|Filaricides|filaricides|mesh-ancestor
57151277|NCT00001230|Antinematodal Agents|antinematodal agents|mesh-ancestor
57151278|NCT00001230|Anthelmintics|anthelmintics|mesh-ancestor
57151279|NCT00001230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57151280|NCT00001230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57151281|NCT00001230|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
57151282|NCT00001230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57151283|NCT00001230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833867|NCT01189864|Analgesics|analgesics|mesh-ancestor
56834114|NCT01199458|Alfentanil|alfentanil|mesh-list
56834184|NCT03844984|Lidocaine|lidocaine|mesh-list
56834239|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
56834596|NCT01204216|Biotin|biotin|mesh-list
56834616|NCT01204450|Sirolimus|sirolimus|mesh-list
56835596|NCT01567384|Pemetrexed|pemetrexed|mesh-list
56835980|NCT01304212|Ketorolac|ketorolac|mesh-list
56836345|NCT01304836|Tacrolimus|tacrolimus|mesh-list
56836569|NCT01308346|Everolimus|everolimus|mesh-list
56836944|NCT03776500|Macozinone|macozinone|mesh-list
56838461|NCT05024734|Gemcitabine|gemcitabine|mesh-list
56839286|NCT04358068|Azithromycin|azithromycin|mesh-list
56839885|NCT04195828|Paclitaxel|paclitaxel|mesh-list
56842231|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
56842752|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56843200|NCT05781854|Bupivacaine|bupivacaine|mesh-list
56843280|NCT05781308|Paclitaxel|paclitaxel|mesh-list
56843506|NCT05554354|Fulvestrant|fulvestrant|mesh-list
56844858|NCT03914443|Nivolumab|nivolumab|mesh-list
56924232|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56924233|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924234|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
56924235|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924236|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
56924237|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924238|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
56924239|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56924240|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
56924241|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56924242|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924243|NCT03721328|Vancomycin|vancomycin|mesh-list
56924244|NCT03721328|Tobramycin|tobramycin|mesh-list
56924245|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56924246|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924247|NCT01220791|Progesterone|progesterone|mesh-list
56924248|NCT01220791|Progestins|progestins|mesh-ancestor
56924249|NCT01220791|Hormones|hormones|mesh-ancestor
56924250|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924251|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924252|NCT01353482|Pemetrexed|pemetrexed|mesh-list
56924253|NCT01353482|Vorinostat|vorinostat|mesh-list
56924254|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924255|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924256|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924257|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56924258|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56924259|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56924260|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
56924261|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56924262|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
56924263|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56924264|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924265|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56924266|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
56924267|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56924268|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56924269|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56924270|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924271|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924272|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
56924273|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924274|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924275|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56924276|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924277|NCT01353716|Dolutegravir|dolutegravir|mesh-list
56924278|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56924279|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56924280|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924281|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924282|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56924283|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56924284|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
56924285|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924286|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
56924287|NCT04481672|Analgesics|analgesics|mesh-ancestor
56924288|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
56924289|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924290|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924291|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
56924292|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924293|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56924294|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
56924295|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56924296|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924297|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924298|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56924299|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
56924300|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56924301|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56924302|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
56924303|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56924304|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56924305|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56924306|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924307|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924308|NCT04465942|Paclitaxel|paclitaxel|mesh-list
56924309|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
56924310|NCT04465942|Nivolumab|nivolumab|mesh-list
56924311|NCT04465942|Pemetrexed|pemetrexed|mesh-list
56924312|NCT04465942|Atezolizumab|atezolizumab|mesh-list
56924313|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56924314|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924315|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
56924316|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
56924317|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
56924318|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924319|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924320|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56924321|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924322|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56924323|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56924324|NCT01126645|Sorafenib|sorafenib|mesh-list
56924325|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924326|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56924327|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924328|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924329|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56924330|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
56924331|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
56924332|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924333|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
56924334|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924335|NCT01329289|Dexamethasone|dexamethasone|mesh-list
56924336|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
56924337|NCT01329289|Bortezomib|bortezomib|mesh-list
56924338|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56924339|NCT01329289|Pasireotide|pasireotide|mesh-list
56924340|NCT01329289|BB 1101|bb 1101|mesh-list
56924341|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924342|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
56924343|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
56924344|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924345|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924346|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56924347|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
56924348|NCT01329289|Hormones|hormones|mesh-ancestor
56924349|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924350|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56924351|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924352|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
56924353|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924354|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924355|NCT02291536|Dronabinol|dronabinol|mesh-list
56924356|NCT02291536|Cannabidiol|cannabidiol|mesh-list
56924357|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
56924358|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
56924359|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924360|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56924361|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56924362|NCT02291536|Analgesics|analgesics|mesh-ancestor
56924363|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
56924364|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924365|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56924366|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56924367|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924368|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924369|NCT02291536|Hormones|hormones|mesh-ancestor
56924370|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924371|NCT01317992|Ibudilast|ibudilast|mesh-list
56924372|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56924373|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
56924374|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924375|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924376|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56924377|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
56924378|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56911718|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
56924379|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924380|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924381|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56924382|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
56924383|NCT03635788|Rilpivirine|rilpivirine|mesh-list
56924384|NCT03635788|Cabotegravir|cabotegravir|mesh-list
56924385|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56924386|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56924387|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924388|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924389|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
56924390|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924391|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56924392|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56924393|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56924394|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56924395|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
56924396|NCT01348412|Raltitrexed|raltitrexed|mesh-list
56924397|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924398|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56924399|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
56924400|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924401|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56924402|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924403|NCT01353794|Sorafenib|sorafenib|mesh-list
56924404|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924405|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56924406|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924407|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924408|NCT01224301|Vaccines|vaccines|mesh-list
56924409|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
56924410|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924411|NCT01221025|Parecoxib|parecoxib|mesh-list
56924412|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56924413|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56924414|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924415|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924416|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56924417|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56924418|NCT01221025|Analgesics|analgesics|mesh-ancestor
56924419|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
56924420|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924421|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924422|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924423|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56924424|NCT03523390|Avelumab|avelumab|mesh-list
56924425|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924426|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924427|NCT01221103|Dexamethasone|dexamethasone|mesh-list
56924428|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56924429|NCT01221103|Ofatumumab|ofatumumab|mesh-list
56924430|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56924431|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924432|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
56924433|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
56924434|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924435|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924436|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56924437|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
56924438|NCT01221103|Hormones|hormones|mesh-ancestor
56924439|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924440|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56924441|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924442|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56924443|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
56924444|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924445|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
56924446|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
56924447|NCT03706898|Dolutegravir|dolutegravir|mesh-list
56924448|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
56924449|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
56924450|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924451|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56924452|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56924453|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924454|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924455|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56924456|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56924457|NCT03927313|Aspirin|aspirin|mesh-list
56924458|NCT03927313|Rifampin|rifampin|mesh-list
56924459|NCT03927313|Linezolid|linezolid|mesh-list
56924460|NCT03927313|Dexamethasone|dexamethasone|mesh-list
56924461|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924462|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
56924463|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
56924464|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924465|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924466|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56924467|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
56924468|NCT03927313|Hormones|hormones|mesh-ancestor
56924469|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924470|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56924471|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924472|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56924473|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56924474|NCT03927313|Analgesics|analgesics|mesh-ancestor
56924475|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
56924476|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56924477|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56924478|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56924479|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924480|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56924481|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56924482|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924483|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
56924484|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56924485|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
56924486|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56924487|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924488|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
56924489|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56924490|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56924491|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56924492|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56924493|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56924494|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56924495|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56924496|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56924497|NCT01224457|Phenobarbital|phenobarbital|mesh-list
56924498|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
56924499|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56924500|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924501|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924502|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56845486|NCT01583036|Digoxin|digoxin|mesh-list
56924503|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56924504|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924505|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924506|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
56924507|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
56924508|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56924509|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56924510|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56924511|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
56924512|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56924513|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
56924514|NCT03133312|Povidone|povidone|mesh-list
56924515|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56924516|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924517|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
56924518|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56924519|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
56924520|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
56924521|NCT01318148|Caspofungin|caspofungin|mesh-list
56924522|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
56924523|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924524|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924525|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924526|NCT01354262|Vitamin D|vitamin d|mesh-list
56924527|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
56924528|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
56924529|NCT01354262|Vitamins|vitamins|mesh-list
56924530|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
56924531|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924532|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56924533|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56924534|NCT01343498|Dactolisib|dactolisib|mesh-list
56924535|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924536|NCT01221337|Heparin|heparin|mesh-list
56924537|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
56924538|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56924539|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56924540|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924541|NCT01354418|Phenylephrine|phenylephrine|mesh-list
56924542|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
56924543|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56924544|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
56924545|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
56924546|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924547|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924548|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
56924549|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56924550|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
56924551|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
56924552|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56924553|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56924554|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56924555|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
56924556|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924557|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924558|NCT01354418|Protective Agents|protective agents|mesh-ancestor
56924559|NCT02818868|Apixaban|apixaban|mesh-list
56924560|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56924561|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
56924562|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56924563|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
56924564|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924565|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924566|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
56924567|NCT01224535|Micronutrients|micronutrients|mesh-list
56924568|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924569|NCT02289274|Aceclofenac|aceclofenac|mesh-list
56924570|NCT02289274|Eperisone|eperisone|mesh-list
56924571|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56924572|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56924573|NCT02289274|Analgesics|analgesics|mesh-ancestor
56924574|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
56924575|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924576|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924577|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924578|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56924579|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
56924580|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56924581|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924582|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924583|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56924584|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56924585|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56924586|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
56924587|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
56924588|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
56924589|NCT01224613|Vaccines|vaccines|mesh-list
56924590|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
56924591|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924592|NCT03930433|Nebivolol|nebivolol|mesh-list
56924593|NCT03930433|Diltiazem|diltiazem|mesh-list
56924594|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56924595|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
56924596|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56924597|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56924598|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56924599|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
56924600|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924601|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924602|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924603|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56924604|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924605|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56924606|NCT01224769|Rituximab|rituximab|mesh-list
56924607|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56924608|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924609|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924610|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
56924611|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924612|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56924613|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56924614|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
56924615|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924616|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56924617|NCT02289430|Ezetimibe|ezetimibe|mesh-list
56924618|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56924619|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56924620|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
56924621|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924622|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56924623|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56924624|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924625|NCT01224847|Lidocaine|lidocaine|mesh-list
56924626|NCT01224847|Cocaine|cocaine|mesh-list
56924627|NCT01224847|Tetracaine|tetracaine|mesh-list
56924628|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
56924629|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
56924630|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924631|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924632|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
56924633|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924634|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56924635|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56924636|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56924637|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924638|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924639|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56924640|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56924641|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56924642|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
56924643|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924644|NCT02289586|Fentanyl|fentanyl|mesh-list
56924645|NCT02289586|Midazolam|midazolam|mesh-list
56924646|NCT02289586|Remifentanil|remifentanil|mesh-list
56924647|NCT02289586|Dezocine|dezocine|mesh-list
56924648|NCT02289586|Propofol|propofol|mesh-list
56924649|NCT02289586|Rocuronium|rocuronium|mesh-list
56924650|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
56924651|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924652|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924653|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56924654|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56924655|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
56924656|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56924657|NCT02289586|Narcotics|narcotics|mesh-ancestor
56924658|NCT02289586|Analgesics|analgesics|mesh-ancestor
56924659|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
56924660|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924661|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56924662|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56924663|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56924664|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56924665|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
56924666|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
56924667|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924668|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924669|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56924670|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56924671|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56924672|NCT03740581|Insulin|insulin|mesh-list
56924673|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56924674|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924675|NCT03874897|Antibodies|antibodies|mesh-list
56924676|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56924677|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
56924678|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924679|NCT02294266|Ethanol|ethanol|mesh-list
56924680|NCT02294266|Methamphetamine|methamphetamine|mesh-list
56924681|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56912022|NCT03535558|Azithromycin|azithromycin|mesh-list
56924682|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924683|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924684|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924685|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56924686|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
56924687|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
56924688|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924689|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
56924690|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924691|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924692|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
56924693|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56924694|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56924695|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924696|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56924697|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
56924698|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56924699|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
56924700|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924701|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56924702|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56924703|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
56924704|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924705|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924706|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56924707|NCT01130311|Vitamin D|vitamin d|mesh-list
56924708|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
56924709|NCT01130311|Vitamins|vitamins|mesh-ancestor
56924710|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
56924711|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924712|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56924713|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56924714|NCT03926377|Clobetasol|clobetasol|mesh-list
56924715|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924716|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
56924717|NCT03926377|Hormones|hormones|mesh-ancestor
56924718|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924719|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924720|NCT03132688|Propofol|propofol|mesh-list
56924721|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56924722|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924723|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924724|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56924725|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
56924726|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
56924727|NCT01227811|Darifenacin|darifenacin|mesh-list
56924728|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56845686|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
56924729|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
56924730|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56924731|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924732|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924733|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924734|NCT01227811|Urological Agents|urological agents|mesh-ancestor
56924735|NCT01225081|Pioglitazone|pioglitazone|mesh-list
56924736|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
56924737|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56924738|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924739|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56924740|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924741|NCT02298166|Cytarabine|cytarabine|mesh-list
56924742|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
56924743|NCT02298166|Crenolanib|crenolanib|mesh-list
56924744|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56924745|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
56924746|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924747|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924748|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
56924749|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924750|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56924751|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
56924752|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924753|NCT02298166|Analgesics|analgesics|mesh-ancestor
56924754|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
56924755|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924756|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56924757|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56924758|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924759|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
56924760|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56924761|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924762|NCT01221883|Diazepam|diazepam|mesh-list
56924763|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56924764|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
56924765|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
56924766|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
56924767|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924768|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924769|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56924770|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56924771|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924772|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56924773|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56924774|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56924775|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56924776|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56924777|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56924778|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
56924779|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
56924780|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
56924781|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
56924782|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924783|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924784|NCT02294656|Triamcinolone|triamcinolone|mesh-list
56924785|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56924786|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56924787|NCT02294656|Ranibizumab|ranibizumab|mesh-list
56924788|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56924789|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56924790|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56924791|NCT02294656|Growth Substances|growth substances|mesh-ancestor
56924792|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924793|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
56924794|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924795|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924796|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
56924797|NCT02294656|Hormones|hormones|mesh-ancestor
56924798|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924799|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56924800|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
56924801|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924802|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924803|NCT02785952|Nivolumab|nivolumab|mesh-list
56924804|NCT02785952|Ipilimumab|ipilimumab|mesh-list
56924805|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924806|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924807|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56924808|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924809|NCT01225237|Ramosetron|ramosetron|mesh-list
56924810|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
56924811|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
56924812|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924813|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924814|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56924815|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56924816|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
56924817|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924818|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924819|NCT03517930|Loratadine|loratadine|mesh-list
56924820|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
56924821|NCT03517930|Ephedrine|ephedrine|mesh-list
56924822|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
56924823|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
56924824|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56924825|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56924826|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56924827|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
56924828|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
56924829|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924830|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924831|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924832|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56924833|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
56924834|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924835|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56924836|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
56924837|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
56924838|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56924839|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56924840|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
56924841|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
56924842|NCT01130467|Methylphenidate|methylphenidate|mesh-list
56924843|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56924844|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56924845|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924846|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56924847|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56924848|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924849|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924850|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
56924851|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924852|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56924853|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
56924854|NCT02295046|Amlodipine|amlodipine|mesh-list
56924855|NCT02295046|Atorvastatin|atorvastatin|mesh-list
56924856|NCT02295046|Calcium|calcium|mesh-list
56924857|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56924858|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924859|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56924860|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56924861|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
56924862|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924863|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56924864|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56924865|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924866|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56924867|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56924868|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924869|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
56924870|NCT03517618|Leucovorin|leucovorin|mesh-list
56924871|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924872|NCT03517618|Antidotes|antidotes|mesh-ancestor
56924873|NCT03517618|Protective Agents|protective agents|mesh-ancestor
56924874|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
56924875|NCT03517618|Vitamins|vitamins|mesh-ancestor
56924876|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
56924877|NCT02295124|Oxycodone|oxycodone|mesh-list
56924878|NCT02295124|Hydromorphone|hydromorphone|mesh-list
56924879|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56924880|NCT02295124|Narcotics|narcotics|mesh-ancestor
56924881|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924882|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924883|NCT02295124|Analgesics|analgesics|mesh-ancestor
56924884|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
56924885|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924886|NCT03925051|Denosumab|denosumab|mesh-list
56924887|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56924888|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924889|NCT03514576|Pasireotide|pasireotide|mesh-list
56924890|NCT03514576|Hormones|hormones|mesh-ancestor
56924891|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924892|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924893|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
56924894|NCT02299024|Narcotics|narcotics|mesh-ancestor
56924895|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924896|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924897|NCT02299024|Analgesics|analgesics|mesh-ancestor
56924898|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
56924899|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924900|NCT03929419|Insulin|insulin|mesh-list
56924901|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56924902|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924903|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56924904|NCT01228279|Icodextrin|icodextrin|mesh-list
56924905|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
56924906|NCT03514342|Ropivacaine|ropivacaine|mesh-list
56924907|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
56924908|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
56924909|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924910|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924911|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
56924912|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924913|NCT01228045|Trastuzumab|trastuzumab|mesh-list
56924914|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924915|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924916|NCT03514030|Antibodies|antibodies|mesh-list
56924917|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
56924918|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924919|NCT03517462|Ivermectin|ivermectin|mesh-list
56924920|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56924921|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924922|NCT03929575|Calcium|calcium|mesh-list
56924923|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56924924|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924925|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
56924926|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56924927|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56924928|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56924929|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924930|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924931|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
56924932|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924933|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924934|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56924935|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924936|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56924937|NCT01131247|Ofatumumab|ofatumumab|mesh-list
56924938|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56924939|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56924940|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
56924941|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924942|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924943|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
56924944|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924945|NCT03513874|Metformin|metformin|mesh-list
56924946|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56924947|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924948|NCT01228357|Milnacipran|milnacipran|mesh-list
56924949|NCT01228357|Mirtazapine|mirtazapine|mesh-list
56924950|NCT01228357|Sertraline|sertraline|mesh-list
56924951|NCT01228357|Fluoxetine|fluoxetine|mesh-list
56924952|NCT01228357|Paroxetine|paroxetine|mesh-list
56924953|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56924954|NCT01228357|Nortriptyline|nortriptyline|mesh-list
56924955|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
56924956|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56924957|NCT01228357|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56924958|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56924959|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56924960|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924961|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56924962|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
56924963|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924964|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56924965|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56924966|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56924967|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924968|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56924969|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56924970|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
56924971|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
56924972|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56924973|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56924974|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924975|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56924976|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56924977|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56924978|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
56924979|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56924980|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56912327|NCT02208778|Remifentanil|remifentanil|mesh-list
56924981|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56924982|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56924983|NCT01228357|Analgesics|analgesics|mesh-ancestor
56924984|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
56924985|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924986|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56924987|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56924988|NCT01130701|Capecitabine|capecitabine|mesh-list
56924989|NCT01130701|Panitumumab|panitumumab|mesh-list
56924990|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56924991|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
56924992|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924993|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924994|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924995|NCT02292550|Ceritinib|ceritinib|mesh-list
56924996|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924997|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56924998|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924999|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925000|NCT03925285|Bevacizumab|bevacizumab|mesh-list
56925001|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56925002|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925003|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56925004|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56925005|NCT03925285|Growth Substances|growth substances|mesh-ancestor
56925006|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925007|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
56925008|NCT04464694|Ranibizumab|ranibizumab|mesh-list
56925009|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56925010|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56925011|NCT04464694|Growth Substances|growth substances|mesh-ancestor
56925012|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925013|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
56925014|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925015|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56925016|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925017|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56925018|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925019|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925020|NCT03513484|Azacitidine|azacitidine|mesh-list
56925021|NCT03513484|Nintedanib|nintedanib|mesh-list
56925022|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56925023|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
56925024|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925025|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925026|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925027|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56925028|NCT03519724|Neostigmine|neostigmine|mesh-list
56925029|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56925030|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925031|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925032|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
56925033|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925034|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925035|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56925036|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
56925037|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925038|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
56925039|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56925040|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56925041|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925042|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
56925043|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925044|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925045|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
56925046|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56925047|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925048|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56925049|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
56925050|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56925051|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925052|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925053|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925054|NCT01132027|Tacrolimus|tacrolimus|mesh-list
56925055|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925056|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
56925057|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925058|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56925059|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925060|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925061|NCT03136484|Canagliflozin|canagliflozin|mesh-list
56925062|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56925063|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925064|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56925065|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925066|NCT01132183|Valproic Acid|valproic acid|mesh-list
56925067|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
56925068|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925069|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925070|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
56925071|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925072|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925073|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
56925074|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56925075|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925076|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56925077|NCT03923881|Cetuximab|cetuximab|mesh-list
56925078|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56925079|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925080|NCT02295748|Deflazacort|deflazacort|mesh-list
56925081|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925082|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925083|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
56925084|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925085|NCT03923803|Calcitonin|calcitonin|mesh-list
56925086|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
56925087|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56925088|NCT03923803|Katacalcin|katacalcin|mesh-list
56925089|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56925090|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925091|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56925092|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
56925093|NCT02295826|Aspirin|aspirin|mesh-list
56925094|NCT02295826|Dabigatran|dabigatran|mesh-list
56925095|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56925096|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56925097|NCT02295826|Analgesics|analgesics|mesh-ancestor
56925098|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
56925099|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925100|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925101|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925102|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925103|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56925104|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56925105|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925106|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56925107|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56925108|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925109|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
56925110|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
56925111|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56925112|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
56925113|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
56925114|NCT01348724|Naloxegol|naloxegol|mesh-list
56925115|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56925116|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925117|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
56925118|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925119|NCT03519022|Cocaine|cocaine|mesh-list
56925120|NCT03519022|Methylphenidate|methylphenidate|mesh-list
56925121|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56925122|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925123|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56925124|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56925125|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56925126|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925127|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
56925128|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925129|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
56925130|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
56925131|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925132|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
56925133|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925134|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56925135|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56925136|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56925137|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925138|NCT03516526|Natalizumab|natalizumab|mesh-list
56925139|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
56925140|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925141|NCT02730416|Paclitaxel|paclitaxel|mesh-list
56925142|NCT02730416|Carboplatin|carboplatin|mesh-list
56925143|NCT02730416|Nintedanib|nintedanib|mesh-list
56925144|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56925145|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925146|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
56925147|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
56925148|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
56925149|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925150|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56925151|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925152|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
56925153|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
56925154|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
56925155|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925156|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925157|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
56925158|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925159|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56925160|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
56925161|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56925162|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56925163|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925164|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925165|NCT01348880|Urological Agents|urological agents|mesh-ancestor
56925166|NCT03923179|Etoposide|etoposide|mesh-list
56925167|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56925168|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925169|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56925170|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56925171|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925172|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925173|NCT01318460|Simendan|simendan|mesh-list
56925174|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56925175|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
56925176|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56925177|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56925178|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925179|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925180|NCT01318460|Protective Agents|protective agents|mesh-ancestor
56925181|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925182|NCT02299726|Spironolactone|spironolactone|mesh-list
56925183|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56925184|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
56925185|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925186|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925187|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56925188|NCT02299726|Diuretics|diuretics|mesh-ancestor
56925189|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
56925190|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
56925191|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56925192|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56925193|NCT03647852|Prednisolone|prednisolone|mesh-list
56925194|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
56925195|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56925196|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
56925197|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925198|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
56925199|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
56925200|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925201|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925202|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56925203|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
56925204|NCT03647852|Hormones|hormones|mesh-ancestor
56925205|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925206|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56925207|NCT03647852|Protective Agents|protective agents|mesh-ancestor
56925208|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56925209|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925210|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56925211|NCT01354886|Hormones|hormones|mesh-ancestor
56925212|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925213|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925214|NCT02299882|Vancomycin|vancomycin|mesh-list
56925215|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56925216|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925217|NCT01355120|Ipilimumab|ipilimumab|mesh-list
56925218|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56925219|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925220|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56925221|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925222|NCT02300038|Lidocaine|lidocaine|mesh-list
56925223|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
56925224|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
56925225|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925226|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925227|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
56925228|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925229|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56925230|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56925231|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56925232|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56925233|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925234|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
56925235|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56925236|NCT01355198|Glycine|glycine|mesh-list
56925237|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
56925238|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925239|NCT01355198|Expectorants|expectorants|mesh-ancestor
56925240|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
56925241|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56925242|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
56925243|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925244|NCT01355198|Protective Agents|protective agents|mesh-ancestor
56925245|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925246|NCT01355198|Antidotes|antidotes|mesh-ancestor
56925247|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
56925248|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925249|NCT01355276|Domperidone|domperidone|mesh-list
56925250|NCT01355276|Cinitapride|cinitapride|mesh-list
56925251|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
56925252|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
56925253|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925254|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925255|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56925256|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56925257|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
56925258|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925259|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925260|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56925261|NCT02589860|Melphalan|melphalan|mesh-list
56925262|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56925263|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
56925264|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925265|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925266|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56925267|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925268|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
56925269|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925270|NCT01355354|Digoxin|digoxin|mesh-list
56925271|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56925272|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56925273|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925274|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925275|NCT01355354|Protective Agents|protective agents|mesh-ancestor
56912631|NCT02205892|Lupeol|lupeol|mesh-list
56925276|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925277|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56925278|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56925279|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56925280|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56925281|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56925282|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
56925283|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925284|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925285|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925286|NCT01349270|Prednisone|prednisone|mesh-list
56925287|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
56925288|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56925289|NCT01349270|Antibodies|antibodies|mesh-list
56925290|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925291|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
56925292|NCT01349270|Hormones|hormones|mesh-ancestor
56925293|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925294|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925295|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56925296|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925297|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
56925298|NCT01132417|Tigecycline|tigecycline|mesh-list
56925299|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56925300|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925301|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56925302|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925303|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925304|NCT02300194|Morphine|morphine|mesh-list
56925305|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56925306|NCT02300194|Narcotics|narcotics|mesh-ancestor
56925307|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925308|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925309|NCT02300194|Analgesics|analgesics|mesh-ancestor
56925310|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
56925311|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925312|NCT01225705|Ritonavir|ritonavir|mesh-list
56925313|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56925314|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
56925315|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56925316|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56925317|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
56925318|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925319|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925320|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56925321|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56925322|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
56925323|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925324|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56925325|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56925326|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56925327|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56925328|NCT01665794|Dexamethasone|dexamethasone|mesh-list
56925329|NCT01665794|Daratumumab|daratumumab|mesh-list
56925330|NCT01665794|Pomalidomide|pomalidomide|mesh-list
56925331|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925332|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
56925333|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
56925334|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925335|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925336|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56925337|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
56925338|NCT01665794|Hormones|hormones|mesh-ancestor
56925339|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925340|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56925341|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925342|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
56925343|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56925344|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56925345|NCT01665794|Growth Substances|growth substances|mesh-ancestor
56925346|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
56925347|NCT01128985|Canagliflozin|canagliflozin|mesh-list
56925348|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56925349|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925350|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56925351|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925352|NCT03512860|Valproic Acid|valproic acid|mesh-list
56925353|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
56925354|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925355|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925356|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
56925357|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925358|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925359|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
56925360|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56925361|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925362|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56925363|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
56925364|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56925365|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925367|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56925368|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925369|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56925370|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925371|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
56925372|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925373|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
56925374|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925375|NCT01132573|Clofarabine|clofarabine|mesh-list
56925376|NCT01132573|Entinostat|entinostat|mesh-list
56925377|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56925378|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56925379|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
56925380|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925381|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925382|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925383|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56925384|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56925385|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925386|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56925387|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56925388|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56925389|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925390|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
56925391|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925392|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
56925393|NCT02333162|Fludarabine|fludarabine|mesh-list
56925394|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
56925395|NCT02333162|Melphalan|melphalan|mesh-list
56925396|NCT02333162|Tacrolimus|tacrolimus|mesh-list
56925397|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925398|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56925399|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
56925400|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925401|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925402|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
56925403|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925404|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56925405|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925406|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56925407|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56925408|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
56925409|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56925410|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925411|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56925412|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
56925413|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56925414|NCT03518320|Gemcitabine|gemcitabine|mesh-list
56925415|NCT03518320|Nivolumab|nivolumab|mesh-list
56925416|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56925417|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
56925418|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925419|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925420|NCT03518320|Antiviral Agents|antiviral agents|mesh-ancestor
56925421|NCT03518320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925422|NCT03518320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925423|NCT03518320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925424|NCT03518320|Immunologic Factors|immunologic factors|mesh-ancestor
56925425|NCT03518320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912773|NCT00094835|Paclitaxel|paclitaxel|mesh-list
56925426|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56925427|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56925428|NCT01134289|Bupivacaine|bupivacaine|mesh-list
56925429|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
56925430|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
56925431|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
56925432|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925433|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925434|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
56925435|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925436|NCT02318342|Warfarin|warfarin|mesh-list
56925437|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
56925438|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56925439|NCT02300350|Digoxin|digoxin|mesh-list
56925440|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56925441|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56925442|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925443|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925444|NCT02300350|Protective Agents|protective agents|mesh-ancestor
56925445|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925446|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56925447|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56925448|NCT01349348|Tolvaptan|tolvaptan|mesh-list
56925449|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56925450|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925451|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
56925452|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925453|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
56925454|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
56925455|NCT02300428|Trace Elements|trace elements|mesh-ancestor
56925456|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
56925457|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925458|NCT02300428|Hematinics|hematinics|mesh-ancestor
56925459|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56925460|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56925461|NCT02296996|Trametinib|trametinib|mesh-list
56925462|NCT02296996|Dabrafenib|dabrafenib|mesh-list
56925463|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925464|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56925465|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925466|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925467|NCT01132729|Valacyclovir|valacyclovir|mesh-list
56925468|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
56925469|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925470|NCT02294110|Anesthetics|anesthetics|mesh-list
56925471|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925472|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925473|NCT03512548|Itraconazole|itraconazole|mesh-list
56925474|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
56925475|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925476|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56925477|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56925478|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925479|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925480|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56925481|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
56925482|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925483|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925484|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56925485|NCT03515668|Methylphenidate|methylphenidate|mesh-list
56925486|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56925487|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925488|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56925489|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56925490|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56925491|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925492|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
56925493|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925494|NCT01356212|Ketorolac|ketorolac|mesh-list
56925495|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56925496|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56925497|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56925498|NCT01356212|Analgesics|analgesics|mesh-ancestor
56925499|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
56925500|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925501|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925502|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925503|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925504|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56925505|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925506|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925507|NCT02302378|Bupivacaine|bupivacaine|mesh-list
56925508|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
56925509|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
56925510|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925511|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925512|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
56925513|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925514|NCT01356368|Docetaxel|docetaxel|mesh-list
56925515|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925516|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56925517|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56925518|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56925519|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925520|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
56925521|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56925522|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56925523|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925524|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
56925525|NCT02302456|Coagulants|coagulants|mesh-ancestor
56925526|NCT01356524|Progesterone|progesterone|mesh-list
56925527|NCT01356524|Progestins|progestins|mesh-ancestor
56925528|NCT01356524|Hormones|hormones|mesh-ancestor
56925529|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925530|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925531|NCT01232023|Indobufen|indobufen|mesh-list
56925532|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56925533|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56925534|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925535|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925536|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56925537|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56925538|NCT01232023|Analgesics|analgesics|mesh-ancestor
56925539|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
56925540|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925541|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925542|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925543|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925544|NCT02300740|Niacinamide|niacinamide|mesh-list
56925545|NCT02300740|Niacin|niacin|mesh-list
56925546|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
56925547|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
56925548|NCT02300740|Vitamins|vitamins|mesh-ancestor
56925549|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
56925550|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925551|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56925552|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
56925553|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925554|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56925555|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
56925556|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56925557|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56925558|NCT02297386|Testosterone|testosterone|mesh-list
56925559|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
56925560|NCT02297386|Androgens|androgens|mesh-ancestor
56925561|NCT02297386|Hormones|hormones|mesh-ancestor
56925562|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925563|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925564|NCT04464616|Anesthetics|anesthetics|mesh-list
56925565|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925566|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925567|NCT01356680|Prednisone|prednisone|mesh-list
56925568|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
56925569|NCT01356680|Dacarbazine|dacarbazine|mesh-list
56925570|NCT01356680|Etoposide|etoposide|mesh-list
56925571|NCT01356680|Vincristine|vincristine|mesh-list
56925572|NCT01356680|Doxorubicin|doxorubicin|mesh-list
56925573|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56925574|NCT01356680|Bleomycin|bleomycin|mesh-list
56925576|NCT01356680|Procarbazine|procarbazine|mesh-list
56925577|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925578|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
56925579|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925580|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925581|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56925582|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
56925583|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925584|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925585|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56925586|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925587|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
56925588|NCT01356680|Hormones|hormones|mesh-ancestor
56925589|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925590|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56925591|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56925592|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56925593|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56925594|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925595|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
56925596|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
56925597|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
56925598|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56925599|NCT04464850|Iron|iron|mesh-list
56925600|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
56925601|NCT04464850|Folic Acid|folic acid|mesh-list
56925602|NCT04464850|Trace Elements|trace elements|mesh-ancestor
56925603|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
56925604|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925605|NCT04464850|Hematinics|hematinics|mesh-ancestor
56925606|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
56925607|NCT04464850|Vitamins|vitamins|mesh-ancestor
56925608|NCT01356758|Adalimumab|adalimumab|mesh-list
56925609|NCT01356758|Etanercept|etanercept|mesh-list
56925610|NCT01356758|Infliximab|infliximab|mesh-list
56925611|NCT01356758|Ustekinumab|ustekinumab|mesh-list
56925612|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925613|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925614|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
56925615|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56925616|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56925617|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56925618|NCT01356758|Analgesics|analgesics|mesh-ancestor
56925619|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
56925620|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925621|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925622|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925623|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
56925624|NCT01134523|Paclitaxel|paclitaxel|mesh-list
56925625|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56925626|NCT01134523|Epirubicin|epirubicin|mesh-list
56925627|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56925628|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925629|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
56925630|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
56925631|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
56925632|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925633|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56925634|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56925635|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56925636|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925637|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56925638|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
56925639|NCT01349738|Levofloxacin|levofloxacin|mesh-list
56925640|NCT01349738|Ofloxacin|ofloxacin|mesh-list
56925641|NCT01349738|Gentamicins|gentamicins|mesh-list
56925642|NCT01349738|Cefazolin|cefazolin|mesh-list
56925643|NCT01349738|Tobramycin|tobramycin|mesh-list
56925644|NCT01349738|Ampicillin|ampicillin|mesh-list
56925645|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56925646|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
56925647|NCT01349738|Sulbactam|sulbactam|mesh-list
56925648|NCT01349738|Trimethoprim|trimethoprim|mesh-list
56925649|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
56925650|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925651|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56925652|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56925653|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925654|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925655|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925656|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56925657|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56925658|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56925659|NCT01349738|Renal Agents|renal agents|mesh-ancestor
56925660|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56925661|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
56925662|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56925663|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56925664|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56925665|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56925666|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56925667|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56925668|NCT02302768|Selenium|selenium|mesh-list
56925669|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
56925670|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925671|NCT02302768|Protective Agents|protective agents|mesh-ancestor
56925672|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925673|NCT02302768|Trace Elements|trace elements|mesh-ancestor
56925674|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
56925675|NCT03921775|Propofol|propofol|mesh-list
56925676|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56925677|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925678|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925679|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56925680|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
56925681|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
56925682|NCT01356992|Enoxaparin|enoxaparin|mesh-list
56925683|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
56925684|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56925685|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56925686|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925687|NCT01350050|Carticaine|carticaine|mesh-list
56925688|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
56925689|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
56925690|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925691|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925692|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
56925693|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925694|NCT03918889|Midazolam|midazolam|mesh-list
56925695|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
56925696|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56925697|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925698|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925699|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56925700|NCT03918889|Analgesics|analgesics|mesh-ancestor
56925701|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
56925702|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925703|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56925704|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56925705|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56925706|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
56925707|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925708|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925709|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56925710|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56925711|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56925712|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56925713|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56925714|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
56925715|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
56925716|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
56925717|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
56925718|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
56925719|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56925720|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925721|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56925722|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925723|NCT03739801|Irinotecan|irinotecan|mesh-list
56925724|NCT03739801|Ramucirumab|ramucirumab|mesh-list
56925725|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56925726|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56925727|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925728|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925729|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925730|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
56925731|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56925732|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925733|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
56925734|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56925735|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56925736|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56925737|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56925738|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925739|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
56925740|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925741|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925742|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56925743|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925744|NCT02297854|Valganciclovir|valganciclovir|mesh-list
56925745|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
56925746|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925747|NCT03511768|Octreotide|octreotide|mesh-list
56925748|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
56925749|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56925750|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56925751|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925752|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56925753|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925754|NCT01134991|Minocycline|minocycline|mesh-list
56925755|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56925756|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925757|NCT03515200|Cytarabine|cytarabine|mesh-list
56925758|NCT03515200|Dexamethasone|dexamethasone|mesh-list
56925759|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
56925760|NCT03515200|Doxorubicin|doxorubicin|mesh-list
56925761|NCT03515200|Methotrexate|methotrexate|mesh-list
56925762|NCT03515200|Bortezomib|bortezomib|mesh-list
56925763|NCT03515200|Dasatinib|dasatinib|mesh-list
56925764|NCT03515200|Palbociclib|palbociclib|mesh-list
56925765|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925766|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
56925767|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
56925768|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925769|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925770|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56925771|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
56925772|NCT03515200|Hormones|hormones|mesh-ancestor
56925773|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925774|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56925775|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925776|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56925777|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56925778|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56925779|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990930|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925780|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925781|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56925782|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
56925783|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56925784|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56925785|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
56925786|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
56925787|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56925788|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925789|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
56925790|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925791|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56925792|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
56925793|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925794|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56925795|NCT03918265|Tacrolimus|tacrolimus|mesh-list
56925796|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925797|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
56925798|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925799|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56925800|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925801|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925802|NCT03920839|Gemcitabine|gemcitabine|mesh-list
56925803|NCT03920839|Paclitaxel|paclitaxel|mesh-list
56925804|NCT03920839|Carboplatin|carboplatin|mesh-list
56925805|NCT03920839|Pemetrexed|pemetrexed|mesh-list
56925806|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56925807|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925808|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
56925809|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
56925810|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
56925811|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925812|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56925813|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
56925814|NCT03920839|Antiviral Agents|antiviral agents|mesh-ancestor
56925815|NCT03920839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925816|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925817|NCT03920839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925818|NCT03920839|Immunologic Factors|immunologic factors|mesh-ancestor
56925819|NCT03920839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925820|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56925821|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56925822|NCT02301130|Durvalumab|durvalumab|mesh-list
56925823|NCT02301130|Tremelimumab|tremelimumab|mesh-list
56925824|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
56925825|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56925826|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56925827|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925828|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
56925829|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925830|NCT03920605|Tenofovir|tenofovir|mesh-list
56925831|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56925832|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56925833|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
56925834|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925835|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56925836|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56925837|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925838|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925839|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56925840|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56925841|NCT02301208|Nedaplatin|nedaplatin|mesh-list
56925842|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925843|NCT02298010|Capecitabine|capecitabine|mesh-list
56925844|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
56925845|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56925846|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
56925847|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925848|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925849|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
56925850|NCT01229605|Docetaxel|docetaxel|mesh-list
56925851|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56925852|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
56925853|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925854|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925855|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56925856|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
56925857|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925858|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925859|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56925860|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
56925861|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
56925862|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
56925863|NCT01319006|Glycine|glycine|mesh-list
56925864|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
56925865|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925866|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925867|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925868|NCT01358240|Econazole|econazole|mesh-list
56925869|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
56925870|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925871|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56925872|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56925873|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925874|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925875|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56925876|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
56925877|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56925878|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925879|NCT01131949|Lamotrigine|lamotrigine|mesh-list
56925880|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
56925881|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56925882|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56925883|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925884|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56925885|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925886|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56925887|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56925888|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925889|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56925890|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56925891|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
56925892|NCT03511222|Nivolumab|nivolumab|mesh-list
56925893|NCT03511222|Vorolanib|vorolanib|mesh-list
56925894|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56925895|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56925896|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56925897|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925898|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56925899|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925900|NCT01230463|Ketorolac|ketorolac|mesh-list
56925901|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56925902|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56925903|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56925904|NCT01230463|Analgesics|analgesics|mesh-ancestor
56925905|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
56925906|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925907|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925908|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925909|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925910|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56925911|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925912|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925913|NCT01358396|Chrysarobin|chrysarobin|mesh-list
56925914|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56925915|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56925916|NCT01358396|Analgesics|analgesics|mesh-ancestor
56925917|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
56925918|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925919|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925920|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925921|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925922|NCT01135615|Calcium|calcium|mesh-list
56925923|NCT01135615|Sevelamer|sevelamer|mesh-list
56925924|NCT01135615|Calcium acetate|calcium acetate|mesh-list
56925925|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56925926|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925927|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
56925928|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
56846908|NCT00399893|Octreotide|octreotide|mesh-list
56925929|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925930|NCT01361516|Anesthetics|anesthetics|mesh-list
56925931|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925932|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925933|NCT03920137|Nicotine|nicotine|mesh-list
56925934|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56925935|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
56925936|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925937|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925938|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56925939|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56925940|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
56925941|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925942|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925943|NCT03132610|Andrographolide|andrographolide|mesh-list
56925944|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56925945|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56925946|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56925947|NCT03132610|Analgesics|analgesics|mesh-ancestor
56925948|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
56925949|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925950|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925951|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56925952|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56925953|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56925954|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925956|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56925957|NCT02298088|Clopidogrel|clopidogrel|mesh-list
56925958|NCT02298088|Ticagrelor|ticagrelor|mesh-list
56925959|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56925960|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56925961|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56925962|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56925963|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
56925964|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56925965|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925966|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925967|NCT01133119|Bupivacaine|bupivacaine|mesh-list
56925968|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
56925969|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
56925970|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56925971|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56925972|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
56925973|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56925974|NCT01230541|Udenafil|udenafil|mesh-list
56925975|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56925976|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56925977|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925978|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925979|NCT01229761|Trimethoprim|trimethoprim|mesh-list
56925980|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56925981|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
56925982|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56925983|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56925984|NCT01229761|Renal Agents|renal agents|mesh-ancestor
56925985|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
56925986|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56925987|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56925988|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56925989|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56925990|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56925991|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56925992|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56925993|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56925994|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56925995|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
56925996|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
56925997|NCT03514810|Ketoprofen|ketoprofen|mesh-list
56925998|NCT03514810|Sertraline|sertraline|mesh-list
56925999|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
56926000|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56926001|NCT03514810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56926002|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56926003|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56926004|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926005|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926006|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
56926007|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926008|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56926009|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926010|NCT03514810|Analgesics|analgesics|mesh-ancestor
56926011|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
56926012|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926013|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926014|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926015|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56926016|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926017|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
56926018|NCT02301676|Propofol|propofol|mesh-list
56926019|NCT02301676|Sevoflurane|sevoflurane|mesh-list
56926020|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56926021|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926022|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926023|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56926024|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
56926025|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
56926026|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926027|NCT02301676|Analgesics|analgesics|mesh-ancestor
56926028|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
56926029|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926030|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56926031|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56926032|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56926033|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
56926034|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926035|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926036|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56926037|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56926038|NCT01135771|Insulin|insulin|mesh-list
56926039|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56926040|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926041|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
56926042|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56926043|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56926044|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56926045|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926046|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
56926047|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926048|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926049|NCT01135927|Insulin|insulin|mesh-list
56926050|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56926051|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
56926052|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56926053|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926054|NCT02301910|Tenecteplase|tenecteplase|mesh-list
56926055|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56926056|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56926057|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926058|NCT01585753|Maraviroc|maraviroc|mesh-list
56926059|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56926060|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56926061|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926062|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56926063|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56926064|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
56926065|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926066|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56926067|NCT01136005|Provitamins|provitamins|mesh-list
56926068|NCT01136005|Vitamins|vitamins|mesh-ancestor
56926069|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
56926070|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926071|NCT03509740|Acetaminophen|acetaminophen|mesh-list
56926072|NCT03509740|Tramadol|tramadol|mesh-list
56926073|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926074|NCT03509740|Analgesics|analgesics|mesh-ancestor
56926075|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
56926076|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926077|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926078|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
56926079|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56926080|NCT03509740|Narcotics|narcotics|mesh-ancestor
56926081|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926082|NCT03918187|Midazolam|midazolam|mesh-list
56926083|NCT03918187|Nalbuphine|nalbuphine|mesh-list
56926084|NCT03918187|Bupivacaine|bupivacaine|mesh-list
56926085|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
56926086|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
56926087|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926088|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926089|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
56926090|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926091|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56926092|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56926093|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56926094|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56926095|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56926096|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56926097|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
56926098|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
56926099|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
56926100|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926101|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926102|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56926103|NCT03918187|Narcotics|narcotics|mesh-ancestor
56913455|NCT01090661|Mipomersen|mipomersen|mesh-list
56926104|NCT03918187|Analgesics|analgesics|mesh-ancestor
56926106|NCT03507634|Fentanyl|fentanyl|mesh-list
56926107|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
56926108|NCT03507634|Remifentanil|remifentanil|mesh-list
56926109|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
56926110|NCT03507634|Anesthetics|anesthetics|mesh-list
56926111|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
56926112|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926113|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926114|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
56926115|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926116|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56926117|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56926118|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56926119|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56926120|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926121|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56926122|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926123|NCT03507634|Analgesics|analgesics|mesh-ancestor
56926124|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56926125|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56926126|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56926127|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56926128|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926129|NCT03507634|Narcotics|narcotics|mesh-ancestor
56926130|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56926131|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56926132|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
56926133|NCT03507556|Metronidazole|metronidazole|mesh-list
56926134|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
56926135|NCT03507556|Minocycline|minocycline|mesh-list
56926136|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
56926137|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926138|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56926139|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56926140|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56926141|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56926142|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56926143|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926144|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926145|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926146|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56926147|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56926148|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56926149|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
56926150|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56926151|NCT03507556|Protective Agents|protective agents|mesh-ancestor
56926152|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926153|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
56926154|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56926155|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
56926156|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926157|NCT01232257|Expectorants|expectorants|mesh-ancestor
56926158|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
56926159|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56926160|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
56926161|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926162|NCT01232257|Protective Agents|protective agents|mesh-ancestor
56926163|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926164|NCT01232257|Antidotes|antidotes|mesh-ancestor
56926165|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
56926166|NCT03509662|Thiamine|thiamine|mesh-list
56926167|NCT03509662|Vitamins|vitamins|mesh-ancestor
56926168|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
56926169|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926170|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
56926171|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926172|NCT03509662|Protective Agents|protective agents|mesh-ancestor
56926173|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
56926174|NCT05461573|Drospirenone|drospirenone|mesh-list
56926175|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56926176|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
56926177|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56926178|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926179|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56926180|NCT05461573|Diuretics|diuretics|mesh-ancestor
56926181|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
56926182|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
56926183|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56926184|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926185|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56926186|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56926187|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926188|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926189|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926190|NCT01133431|Glimepiride|glimepiride|mesh-list
56926191|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56926192|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56926193|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926194|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56926195|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
56926196|NCT05610007|Prilocaine|prilocaine|mesh-list
56926197|NCT05610007|Anesthetics, Local|anesthetics, local|mesh-ancestor
56926198|NCT05610007|Anesthetics|anesthetics|mesh-ancestor
56926199|NCT05610007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926200|NCT05610007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926201|NCT05610007|Sensory System Agents|sensory system agents|mesh-ancestor
56926202|NCT05610007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926203|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
56926204|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
56926205|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56926206|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926207|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56926208|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56926209|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926210|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926211|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926212|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926213|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56926214|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56926215|NCT02303782|Azacitidine|azacitidine|mesh-list
56926216|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56926217|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
56926218|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926219|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926220|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926221|NCT01233505|Capecitabine|capecitabine|mesh-list
56926222|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
56926223|NCT01233505|Veliparib|veliparib|mesh-list
56926224|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56926225|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
56926226|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926227|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926228|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56926229|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926230|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
56926231|NCT04925180|Cyproterone|cyproterone|mesh-list
56926232|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
56926233|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
56926234|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56926235|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926236|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926237|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56926238|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
56926239|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56926240|NCT01133509|Vaccines|vaccines|mesh-list
56926241|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
56926242|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926243|NCT02306902|Fenofibrate|fenofibrate|mesh-list
56926244|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56926245|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
56926246|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926247|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56926248|NCT01230697|Sorafenib|sorafenib|mesh-list
56926249|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926250|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56926251|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926252|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926253|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56926254|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
56926255|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56926256|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
56926257|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926258|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926259|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56926260|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
56926261|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56926262|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56926263|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56926264|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
56926265|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926266|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926267|NCT01230775|Anagrelide|anagrelide|mesh-list
56926268|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56926269|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56926270|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926271|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56926272|NCT01136317|Omeprazole|omeprazole|mesh-list
56926273|NCT01136317|Rabeprazole|rabeprazole|mesh-list
56926274|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56926275|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926276|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56926277|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926278|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926279|NCT03507244|Dexamethasone|dexamethasone|mesh-list
56926280|NCT03507244|Pemetrexed|pemetrexed|mesh-list
56926281|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926282|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
56926283|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
56926284|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926285|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926286|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926287|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
56926288|NCT03507244|Hormones|hormones|mesh-ancestor
56926289|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56926290|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56926291|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926292|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926293|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926294|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56926295|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56926296|NCT01136395|Rituximab|rituximab|mesh-list
56926297|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56926298|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926299|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
56926300|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926301|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926302|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
56926303|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56926304|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56926305|NCT02304094|Prednisolone|prednisolone|mesh-list
56926306|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
56926307|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56926308|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
56926309|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926310|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
56926311|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
56926312|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926313|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926314|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926315|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
56926316|NCT02304094|Hormones|hormones|mesh-ancestor
56926317|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56926318|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56926319|NCT02304094|Protective Agents|protective agents|mesh-ancestor
56926320|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56926321|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926322|NCT03507166|Trastuzumab|trastuzumab|mesh-list
56926323|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56926324|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926325|NCT01233583|Adalimumab|adalimumab|mesh-list
56926326|NCT01233583|Etanercept|etanercept|mesh-list
56926327|NCT01233583|Infliximab|infliximab|mesh-list
56926328|NCT01233583|Acitretin|acitretin|mesh-list
56926329|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926330|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926331|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56926332|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926333|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56926334|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926335|NCT01233583|Analgesics|analgesics|mesh-ancestor
56926336|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
56926337|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926338|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926339|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56926340|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
56926341|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
56926342|NCT02304250|Dexamethasone|dexamethasone|mesh-list
56926343|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926344|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
56926345|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
56926346|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926347|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926348|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926349|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
56926350|NCT02304250|Hormones|hormones|mesh-ancestor
56926351|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56926352|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56926353|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926354|NCT01136551|Huperzine A|huperzine a|mesh-list
56926355|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56926356|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926357|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926358|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
56926359|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926360|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926361|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56926362|NCT01136551|Protective Agents|protective agents|mesh-ancestor
56926363|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
56926364|NCT03132142|Capsaicin|capsaicin|mesh-list
56926365|NCT03132142|Menthol|menthol|mesh-list
56926366|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
56926367|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56926368|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
56926369|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926370|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926371|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56926372|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926373|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56926374|NCT03132142|Protective Agents|protective agents|mesh-ancestor
56926375|NCT01232647|Vitamins|vitamins|mesh-list
56926376|NCT01232647|Vitamin K|vitamin k|mesh-list
56926377|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
56926378|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
56926379|NCT01232647|Menatetrenone|menatetrenone|mesh-list
56926380|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
56926381|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926382|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56926383|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56926384|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926385|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
56926386|NCT01232647|Coagulants|coagulants|mesh-ancestor
56926387|NCT03917095|Mesalamine|mesalamine|mesh-list
56926388|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56926389|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926390|NCT03917095|Analgesics|analgesics|mesh-ancestor
56926391|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
56926392|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926393|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926394|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926395|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926396|NCT01133743|Thalidomide|thalidomide|mesh-list
56926397|NCT01133743|Dexamethasone|dexamethasone|mesh-list
56926398|NCT01133743|Lenalidomide|lenalidomide|mesh-list
56926399|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926400|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
56926401|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
56926402|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926403|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926404|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926405|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
56926406|NCT01133743|Hormones|hormones|mesh-ancestor
56926407|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56926408|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56926409|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926410|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
56926411|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56926412|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56926413|NCT01133743|Growth Substances|growth substances|mesh-ancestor
56926414|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
56926415|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56926416|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
56926417|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56926418|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926419|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56926420|NCT01138423|Moxonidine|moxonidine|mesh-list
56926421|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56926422|NCT01138423|Diuretics|diuretics|mesh-ancestor
56926423|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
56926424|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926425|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56926426|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56926427|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926428|NCT01136863|Felodipine|felodipine|mesh-list
56926429|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56926430|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56926431|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56926432|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56926433|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926434|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56926435|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926436|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
56926437|NCT03961516|Pancrelipase|pancrelipase|mesh-list
56926438|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926439|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
56926440|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56926441|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56926442|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56926443|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56926444|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926445|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
56926446|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926447|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926448|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56926449|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926450|NCT05553145|Antibodies|antibodies|mesh-list
56926451|NCT05553145|Autoantibodies|autoantibodies|mesh-list
56926452|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
56926453|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926454|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
56926455|NCT03504280|Vitamin D|vitamin d|mesh-list
56926456|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56847424|NCT01347580|Ticagrelor|ticagrelor|mesh-list
56926457|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926458|NCT03504280|Vitamins|vitamins|mesh-ancestor
56926459|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
56926460|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56926461|NCT03504202|Trimetazidine|trimetazidine|mesh-list
56926462|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
56926463|NCT01136941|Zileuton|zileuton|mesh-list
56926464|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56926465|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926466|NCT01136941|Analgesics|analgesics|mesh-ancestor
56926467|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
56926468|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926469|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926470|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926471|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926472|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56926473|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926474|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926475|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56926476|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
56926477|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56926478|NCT01232803|Tenofovir|tenofovir|mesh-list
56926479|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
56926480|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926481|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56926482|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56926483|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926484|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926485|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56926486|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56926487|NCT03504046|Pancrelipase|pancrelipase|mesh-list
56926488|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926489|NCT01139203|Lamivudine|lamivudine|mesh-list
56926490|NCT01139203|Adefovir|adefovir|mesh-list
56926491|NCT01139203|Entecavir|entecavir|mesh-list
56926492|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56926493|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56926494|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926495|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926496|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
56926497|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926498|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56926499|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56926500|NCT05187715|Simvastatin|simvastatin|mesh-list
56926501|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56926502|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56926503|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
56926504|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926505|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56926506|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56926507|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926508|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
56926509|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56926510|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56926511|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926512|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
56926513|NCT02312440|Coagulants|coagulants|mesh-ancestor
56926514|NCT01137019|Everolimus|everolimus|mesh-list
56926515|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926516|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56926517|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
56926518|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926519|NCT02308072|Olaparib|olaparib|mesh-list
56926520|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926521|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56926522|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926523|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926524|NCT03508804|Lidocaine|lidocaine|mesh-list
56926525|NCT03508804|Prilocaine|prilocaine|mesh-list
56926526|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56926527|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
56926528|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
56926529|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926530|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926531|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
56926532|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926533|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56926534|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56926535|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56926536|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56926537|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926538|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56926539|NCT01231165|Aspirin|aspirin|mesh-list
56926540|NCT01231165|Amiloride|amiloride|mesh-list
56926541|NCT01231165|Clopidogrel|clopidogrel|mesh-list
56926542|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56926543|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56926544|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926545|NCT01231165|Analgesics|analgesics|mesh-ancestor
56926546|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
56926547|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926548|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926549|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926550|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926551|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56926552|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56926553|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926554|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56926555|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56926556|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926557|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
56926558|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56926559|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56926560|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56926561|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
56926562|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926563|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56926564|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56926565|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
56926566|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56926567|NCT01231165|Diuretics|diuretics|mesh-ancestor
56926568|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
56926569|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56926570|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56926571|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56926572|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56926573|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56926574|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56926575|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56926576|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926577|NCT01233895|Bortezomib|bortezomib|mesh-list
56926578|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926579|NCT05221645|Rituximab|rituximab|mesh-list
56926580|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
56926581|NCT05221645|Carboplatin|carboplatin|mesh-list
56926582|NCT05221645|Etoposide|etoposide|mesh-list
56926583|NCT05221645|Ifosfamide|ifosfamide|mesh-list
56926584|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56926585|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926586|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
56926587|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926588|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926589|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56926590|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56926591|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56926592|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926593|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926594|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56926595|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
56926596|NCT05219929|Tetracycline|tetracycline|mesh-list
56926597|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56926598|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926599|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56926600|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926601|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926602|NCT03506620|Ropivacaine|ropivacaine|mesh-list
56926603|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
56926604|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
56847568|NCT00363311|Dutasteride|dutasteride|mesh-list
56926605|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926606|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926607|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
56926608|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926609|NCT02305030|Opicapone|opicapone|mesh-list
56926610|NCT02305030|Warfarin|warfarin|mesh-list
56926611|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
56926612|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56926613|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926614|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926615|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56926616|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56926617|NCT01139437|Vaccines|vaccines|mesh-list
56926618|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
56926619|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926620|NCT01137253|Trimethaphan|trimethaphan|mesh-list
56926621|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
56926622|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56926623|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56926624|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56926625|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
56926626|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926627|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926628|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56926629|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56926630|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
56926631|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926632|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926633|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
56926634|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56926635|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56926636|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926637|NCT03506542|Mitomycins|mitomycins|mesh-list
56926638|NCT03506542|Mitomycin|mitomycin|mesh-list
56926639|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56926640|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926641|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
56926642|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926643|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56926644|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926645|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
56926646|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56926647|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926648|NCT02312908|Clonazepam|clonazepam|mesh-list
56926649|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
56926650|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
56926651|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
56926652|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926653|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926654|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926655|NCT02308930|Vitamin D|vitamin d|mesh-list
56926656|NCT02308930|Vitamins|vitamins|mesh-list
56926657|NCT02308930|Vitamin A|vitamin a|mesh-list
56926658|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
56926659|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
56926660|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926661|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
56926662|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926663|NCT02308930|Protective Agents|protective agents|mesh-ancestor
56926664|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56926665|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926666|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56926667|NCT01139671|Remifentanil|remifentanil|mesh-list
56926668|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56926669|NCT01139671|Narcotics|narcotics|mesh-ancestor
56926670|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926671|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926672|NCT01139671|Analgesics|analgesics|mesh-ancestor
56926673|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
56926674|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926675|NCT02313064|CXA-10|cxa-10|mesh-list
56926676|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926677|NCT05088889|Nivolumab|nivolumab|mesh-list
56926678|NCT05088889|Ipilimumab|ipilimumab|mesh-list
56926679|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56926680|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926681|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56926682|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926683|NCT01234051|Docetaxel|docetaxel|mesh-list
56926684|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
56926685|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926686|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
56926687|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
56926688|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
56926689|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926690|NCT03341962|Calcium|calcium|mesh-list
56926691|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56926692|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926693|NCT01234597|Insulin|insulin|mesh-list
56926694|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56926695|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
56926696|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
56926697|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56926698|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926699|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
56926700|NCT02313220|Exenatide|exenatide|mesh-list
56926701|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56926702|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926703|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56926704|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926705|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56926706|NCT02313220|Incretins|incretins|mesh-ancestor
56926707|NCT02313220|Hormones|hormones|mesh-ancestor
56926708|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56926709|NCT05177731|Cytarabine|cytarabine|mesh-list
56926711|NCT05177731|Venetoclax|venetoclax|mesh-list
56926712|NCT05177731|Idarubicin|idarubicin|mesh-list
56926713|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56926714|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
56926715|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926716|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926717|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
56926718|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926719|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56926720|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
56926721|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926722|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926723|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56926724|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56926725|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56926726|NCT02309320|Gontivimab|gontivimab|mesh-list
56926727|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
56926728|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926729|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
56926730|NCT01139749|Ciclopirox|ciclopirox|mesh-list
56926731|NCT01139749|Salicylates|salicylates|mesh-list
56926732|NCT01139749|Isotretinoin|isotretinoin|mesh-list
56926733|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
56926734|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926735|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
56926736|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
56926737|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56926738|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926739|NCT01139749|Analgesics|analgesics|mesh-ancestor
56926740|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
56926741|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926742|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926743|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926744|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926745|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56926746|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926747|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926748|NCT04748419|Durvalumab|durvalumab|mesh-list
56926749|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56926750|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926751|NCT02305810|Everolimus|everolimus|mesh-list
56926752|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926753|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56926754|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
56926755|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926756|NCT01142869|Cetuximab|cetuximab|mesh-list
56926757|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56926758|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926759|NCT01139905|Ritonavir|ritonavir|mesh-list
56926760|NCT01139905|Lopinavir|lopinavir|mesh-list
56926761|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56926762|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56926763|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
56926764|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926765|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926766|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56926767|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56926768|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
56926769|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926770|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56926771|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56926772|NCT05044429|Lidocaine|lidocaine|mesh-list
56926773|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
56926774|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
56926775|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926776|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926777|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
56926778|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926779|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56926780|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56926781|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56926782|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56926783|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926784|NCT02309554|Nonoxynol|nonoxynol|mesh-list
56926785|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56926786|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56926787|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926788|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56926789|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
56926790|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56926791|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56926792|NCT01143025|Ropivacaine|ropivacaine|mesh-list
56926793|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
56926794|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
56926795|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926796|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926797|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
56926798|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926800|NCT03502642|Ropivacaine|ropivacaine|mesh-list
56926801|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
56926802|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926803|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926804|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56926805|NCT03502642|Narcotics|narcotics|mesh-ancestor
56926806|NCT03502642|Analgesics|analgesics|mesh-ancestor
56926807|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
56926808|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926809|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
56926810|NCT02306278|Gabapentin|gabapentin|mesh-list
56926811|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926812|NCT02306278|Analgesics|analgesics|mesh-ancestor
56926813|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
56926814|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926815|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
56926816|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56926817|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56926818|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926819|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56926820|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56926821|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56926822|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926823|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926824|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
56926825|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
56926826|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56926827|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926828|NCT02313922|Etanercept|etanercept|mesh-list
56926829|NCT02313922|Methotrexate|methotrexate|mesh-list
56926830|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56926831|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
56926832|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56926833|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847788|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
56926834|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56926835|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
56926836|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926837|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926838|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
56926839|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926840|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56926841|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56926842|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
56926843|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926844|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56926845|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56926846|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926847|NCT02313922|Analgesics|analgesics|mesh-ancestor
56926848|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
56926849|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926850|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926851|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926852|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56926853|NCT04629781|Docetaxel|docetaxel|mesh-list
56926854|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926855|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
56926856|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
56926857|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
56926858|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926859|NCT03508102|Remifentanil|remifentanil|mesh-list
56926860|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56926862|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926863|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926864|NCT03508102|Analgesics|analgesics|mesh-ancestor
56926865|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
56926866|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926867|NCT03505528|Paclitaxel|paclitaxel|mesh-list
56926868|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56926869|NCT03505528|Phenelzine|phenelzine|mesh-list
56926870|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56926871|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926872|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
56926873|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
56926874|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
56926875|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926876|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
56926877|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56926878|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56926879|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926880|NCT01234285|Heparin|heparin|mesh-list
56926881|NCT01234285|Calcium heparin|calcium heparin|mesh-list
56926882|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
56926883|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56926884|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56926885|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926886|NCT02314312|Cyclosporine|cyclosporine|mesh-list
56926887|NCT02314312|Prednisolone|prednisolone|mesh-list
56926888|NCT02314312|Everolimus|everolimus|mesh-list
56926889|NCT02314312|Cyclosporins|cyclosporins|mesh-list
56926890|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926891|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926892|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56926893|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
56926894|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926895|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
56926896|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926897|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56926898|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926899|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56926900|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926901|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926902|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
56926903|NCT02314312|Hormones|hormones|mesh-ancestor
56926904|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56926905|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56926906|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
56926907|NCT02316340|Vorinostat|vorinostat|mesh-list
56926908|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
56847868|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
56926909|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56926910|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56926911|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926912|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926913|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926914|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926915|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926916|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56926917|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56926918|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56926919|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
56926920|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56926921|NCT03396445|Paclitaxel|paclitaxel|mesh-list
56926922|NCT03396445|Carboplatin|carboplatin|mesh-list
56926923|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
56926924|NCT03396445|Pemetrexed|pemetrexed|mesh-list
56926925|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56926926|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926927|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
56926928|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
56926929|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
56926930|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926931|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56926932|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926933|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56926934|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56926935|NCT02310490|Mannitol|mannitol|mesh-list
56926936|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56926937|NCT02310490|Diuretics|diuretics|mesh-ancestor
56926938|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
56926939|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926940|NCT02316496|Irinotecan|irinotecan|mesh-list
56926941|NCT02316496|Cetuximab|cetuximab|mesh-list
56926942|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56926943|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56926944|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926945|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926946|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56926947|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56926948|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
56926949|NCT01140529|Haloperidol|haloperidol|mesh-list
56926950|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
56926951|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56926952|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56926953|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926954|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926955|NCT01140529|Analgesics|analgesics|mesh-ancestor
56926956|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
56926957|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926958|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56926959|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56926960|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56926961|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
56926962|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926963|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926964|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
56926965|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
56926966|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56926967|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56926968|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56926969|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56926970|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56926971|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
56926972|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56926973|NCT01141153|Aspirin|aspirin|mesh-list
56926974|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
56926975|NCT01141153|Clopidogrel|clopidogrel|mesh-list
56926976|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56926977|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56926978|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56926979|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56926980|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
56926981|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56926982|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56926983|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56926984|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56926985|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56926986|NCT01141153|Analgesics|analgesics|mesh-ancestor
56926987|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
56926988|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56926989|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56926990|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56926991|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56926992|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56926993|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56926994|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56926995|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
56926996|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
56926997|NCT01235143|Sevoflurane|sevoflurane|mesh-list
56926998|NCT01235143|Desflurane|desflurane|mesh-list
56926999|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56927000|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56927001|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
56927002|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
56927003|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927004|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927005|NCT01238029|Capecitabine|capecitabine|mesh-list
56927006|NCT01238029|Vinorelbine|vinorelbine|mesh-list
56927007|NCT01238029|Lapatinib|lapatinib|mesh-list
56927008|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56927009|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
56927010|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927011|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927012|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56914355|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
56927013|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
56927014|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
56927015|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
56927016|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56927017|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927018|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
56927019|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56927020|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56927021|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927022|NCT03139604|Prednisone|prednisone|mesh-list
56927023|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
56927024|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56927025|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56927026|NCT03139604|Prednisolone|prednisolone|mesh-list
56927027|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
56927028|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56927029|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
56927030|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927031|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
56927032|NCT03139604|Hormones|hormones|mesh-ancestor
56927033|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927034|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927035|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56927036|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927037|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
56927038|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
56927039|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927040|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56927041|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56927042|NCT03139604|Protective Agents|protective agents|mesh-ancestor
56927043|NCT01350596|Ibuprofen|ibuprofen|mesh-list
56927044|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56927045|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56927046|NCT01350596|Analgesics|analgesics|mesh-ancestor
56927047|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
56927048|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927049|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927050|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927051|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56927052|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56927053|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927054|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927055|NCT04462588|Metronidazole|metronidazole|mesh-list
56927056|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927057|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56927058|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56927059|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56927060|NCT04462822|Fluticasone|fluticasone|mesh-list
56927061|NCT04462822|Xhance|xhance|mesh-list
56927062|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56927063|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56927064|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927065|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56927066|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
56927067|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927068|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927069|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56927070|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
56927071|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
56927072|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56927073|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56927074|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56927075|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56927076|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
56927077|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927078|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927079|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
56927080|NCT04462822|Hormones|hormones|mesh-ancestor
56927081|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927082|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
56927083|NCT01362218|Aspirin|aspirin|mesh-list
56927084|NCT01362218|Ramipril|ramipril|mesh-list
56927085|NCT01362218|Simvastatin|simvastatin|mesh-list
56927086|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56927087|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56927088|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
56927089|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927090|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56927091|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56927092|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927093|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56927094|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56927095|NCT01362218|Analgesics|analgesics|mesh-ancestor
56927096|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
56927097|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927098|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927099|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927100|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56927101|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56927102|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56927103|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56927104|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56927105|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
56927106|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56927107|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
56927108|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56927109|NCT02316964|Aldesleukin|aldesleukin|mesh-list
56927110|NCT02316964|Decitabine|decitabine|mesh-list
56927111|NCT02316964|Azacitidine|azacitidine|mesh-list
56927112|NCT02316964|Interleukin-2|interleukin-2|mesh-list
56927113|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56927114|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
56927115|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927116|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927117|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927118|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56927119|NCT02316964|Analgesics|analgesics|mesh-ancestor
56927120|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
56927121|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927122|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927123|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56927124|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56927125|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
56927126|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927127|NCT02875340|Risperidone|risperidone|mesh-list
56927128|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56927129|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
56927130|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927131|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927132|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927133|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56927134|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56927135|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927136|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56927137|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56927138|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
56927139|NCT03236857|Venetoclax|venetoclax|mesh-list
56927140|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927141|NCT04462666|Etoricoxib|etoricoxib|mesh-list
56927142|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56927143|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56927144|NCT04462666|Analgesics|analgesics|mesh-ancestor
56927145|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
56927146|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927147|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927148|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927149|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56927150|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56927151|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56927152|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927153|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927154|NCT01359020|Acetaminophen|acetaminophen|mesh-list
56927155|NCT01359020|Dipyrone|dipyrone|mesh-list
56927156|NCT01359020|Ibuprofen|ibuprofen|mesh-list
56927157|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56927158|NCT01359020|Analgesics|analgesics|mesh-ancestor
56927159|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
56927160|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927161|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927162|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
56927163|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56927164|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927165|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56927166|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56927167|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927168|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927169|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
56927170|NCT01359098|Dexamethasone|dexamethasone|mesh-list
56927171|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927172|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
56927173|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
56927174|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927175|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927176|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56927177|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
56927178|NCT01359098|Hormones|hormones|mesh-ancestor
56927179|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927180|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56927181|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927182|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927183|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927184|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56927185|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927186|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56927187|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56927188|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56927189|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56927190|NCT05382871|Vaccines|vaccines|mesh-list
56927191|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
56927192|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927193|NCT01319240|Insulin|insulin|mesh-list
56927194|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56927195|NCT01319240|Liraglutide|liraglutide|mesh-list
56927196|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
56927197|NCT01319240|Xultophy|xultophy|mesh-list
56927198|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56927199|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927200|NCT01319240|Incretins|incretins|mesh-ancestor
56927201|NCT01319240|Hormones|hormones|mesh-ancestor
56927202|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927203|NCT04463056|Eculizumab|eculizumab|mesh-list
56927204|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56927205|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56927206|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
56927207|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927208|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
56927209|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56848167|NCT00040664|Ritonavir|ritonavir|mesh-list
56927210|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56927211|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927212|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
56927213|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927214|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927215|NCT03319316|Durvalumab|durvalumab|mesh-list
56927216|NCT03319316|Tremelimumab|tremelimumab|mesh-list
56927217|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56927218|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927219|NCT02316028|Decitabine|decitabine|mesh-list
56927220|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56927221|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
56927222|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927223|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927224|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927225|NCT01359488|Hormones|hormones|mesh-list
56927226|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56927227|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927228|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927229|NCT01141465|Fluticasone|fluticasone|mesh-list
56927230|NCT01141465|Xhance|xhance|mesh-list
56927231|NCT01141465|Budesonide|budesonide|mesh-list
56927232|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
56927233|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56927234|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56927235|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56927236|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927237|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56927238|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
56927239|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927240|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927241|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56927242|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
56927243|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
56927244|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56927245|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
56927246|NCT01141465|Hormones|hormones|mesh-ancestor
56927247|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927248|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56927249|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56927250|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56927251|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
56927252|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927253|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927254|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
56927255|NCT01141543|Plerixafor|plerixafor|mesh-list
56927256|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56927257|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56927258|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
56927259|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927260|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56927261|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56927262|NCT03300518|Estradiol|estradiol|mesh-list
56927263|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56927264|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56927265|NCT03300518|Ganirelix|ganirelix|mesh-list
56927266|NCT03300518|Estrogens|estrogens|mesh-ancestor
56927267|NCT03300518|Hormones|hormones|mesh-ancestor
56927268|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927269|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927270|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56927271|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
56927272|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56927273|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56927274|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
56927275|NCT02317198|Clopidogrel|clopidogrel|mesh-list
56927276|NCT02317198|Ticagrelor|ticagrelor|mesh-list
56927277|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56927278|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56927279|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56927280|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56927281|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56927282|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
56848238|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
56927283|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927284|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927285|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927286|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
56927287|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56927288|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
56927289|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927290|NCT01359722|Expectorants|expectorants|mesh-ancestor
56927291|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
56927292|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56927293|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
56927294|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927295|NCT01359722|Protective Agents|protective agents|mesh-ancestor
56927296|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927297|NCT01359722|Antidotes|antidotes|mesh-ancestor
56927298|NCT01238185|Aspirin|aspirin|mesh-list
56927299|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56927300|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56927301|NCT01238185|Analgesics|analgesics|mesh-ancestor
56927302|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
56927303|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927304|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927305|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927306|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56927307|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56927308|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56927309|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927310|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56927311|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56927312|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927313|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
56927314|NCT01143805|Tofacitinib|tofacitinib|mesh-list
56927315|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56927316|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927317|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927318|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
56927319|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927320|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56927321|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927322|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927323|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
56927324|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927325|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927326|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56927327|NCT03498118|Bupivacaine|bupivacaine|mesh-list
56927328|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
56927329|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
56927330|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927331|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927332|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
56927333|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927334|NCT05188742|Mirabegron|mirabegron|mesh-list
56927335|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56927336|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56927337|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56927338|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
56927339|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927340|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927341|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927342|NCT05188742|Urological Agents|urological agents|mesh-ancestor
56927343|NCT02324452|Fluorouracil|fluorouracil|mesh-list
56927344|NCT02324452|Capecitabine|capecitabine|mesh-list
56927345|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
56927346|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927347|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56927348|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927349|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56927350|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
56927351|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927352|NCT02321176|Resveratrol|resveratrol|mesh-list
56927353|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
56848314|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
56927354|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927355|NCT02321176|Protective Agents|protective agents|mesh-ancestor
56927356|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927357|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927358|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56927359|NCT01351298|Lidocaine|lidocaine|mesh-list
56927360|NCT01351298|Xylometazoline|xylometazoline|mesh-list
56927361|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
56927362|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
56927363|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927364|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927365|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
56927366|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927367|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56927368|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56927369|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56927370|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56927371|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927372|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
56927373|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56927374|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
56927375|NCT02324686|Vitamin K|vitamin k|mesh-list
56927376|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
56927377|NCT02324686|Vitamins|vitamins|mesh-ancestor
56927378|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
56927379|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927380|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56927381|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56927382|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927383|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
56927384|NCT02324686|Coagulants|coagulants|mesh-ancestor
56927385|NCT01360034|Indomethacin|indomethacin|mesh-list
56927386|NCT01360034|Nifedipine|nifedipine|mesh-list
56927387|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56927388|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56927389|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927390|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56927391|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927392|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
56927393|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
56927394|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56927395|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56927396|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56927397|NCT01360034|Analgesics|analgesics|mesh-ancestor
56927398|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
56927399|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927400|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927401|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56927402|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
56927403|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56927404|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927405|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56927406|NCT01363310|Citalopram|citalopram|mesh-list
56927407|NCT01363310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56927408|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56927409|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56927410|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927411|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927412|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
56927413|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927414|NCT01363310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56927415|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
56927416|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56927417|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56927418|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56927419|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927420|NCT01363544|Methylphenidate|methylphenidate|mesh-list
56927421|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56927422|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927423|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56927424|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56927425|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56927426|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927427|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
56927428|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927429|NCT03257618|Temozolomide|temozolomide|mesh-list
56927430|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56927431|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
56927432|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927433|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927434|NCT04175834|Cetirizine|cetirizine|mesh-list
56927435|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
56927436|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56927437|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56927438|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56927439|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
56927440|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927441|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927442|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927443|NCT02324998|Olaparib|olaparib|mesh-list
56927444|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56927445|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927446|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927447|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927448|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
56927449|NCT03500848|Sirolimus|sirolimus|mesh-list
56927450|NCT03500848|Tacrolimus|tacrolimus|mesh-list
56927451|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56927452|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
56927453|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927454|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56927455|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927456|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927457|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56927458|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927459|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56927461|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56927462|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927463|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
56927464|NCT01360190|Fluoxetine|fluoxetine|mesh-list
56927465|NCT01360190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56927466|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56927467|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56927468|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927469|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927470|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
56927471|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927472|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56927473|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
56927474|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56927475|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56927476|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56927477|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927478|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
56927479|NCT01363934|Hematinics|hematinics|mesh-ancestor
56927480|NCT03132376|Caseins|caseins|mesh-list
56927481|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
56927482|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
56927483|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927484|NCT01364012|Paclitaxel|paclitaxel|mesh-list
56927485|NCT01364012|Bevacizumab|bevacizumab|mesh-list
56927486|NCT01364012|Carboplatin|carboplatin|mesh-list
56927487|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56927488|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927489|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56927490|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56927491|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56927492|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927493|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56927494|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56927495|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56927496|NCT01364012|Growth Substances|growth substances|mesh-ancestor
56927497|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927498|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
56927499|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56927500|NCT02318056|Bacitracin|bacitracin|mesh-list
56927501|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56927502|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927503|NCT02318056|Laxatives|laxatives|mesh-ancestor
56927504|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56927505|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56927506|NCT05188118|Nivolumab|nivolumab|mesh-list
56927507|NCT05188118|Ipilimumab|ipilimumab|mesh-list
56927508|NCT05188118|Everolimus|everolimus|mesh-list
56927509|NCT05188118|Lenvatinib|lenvatinib|mesh-list
56927510|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56927511|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927512|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56927513|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927514|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56927515|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
56927516|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927517|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56927518|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927519|NCT01360424|Teriparatide|teriparatide|mesh-list
56927520|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56927521|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927522|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56927523|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
56927524|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56927525|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927526|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
56927527|NCT01364402|Hematinics|hematinics|mesh-ancestor
56927528|NCT03552380|Nivolumab|nivolumab|mesh-list
56927529|NCT03552380|Ipilimumab|ipilimumab|mesh-list
56927530|NCT03552380|Entinostat|entinostat|mesh-list
56927531|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56927532|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927533|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56927534|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927535|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56927536|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927537|NCT02318290|Analgesics|analgesics|mesh-list
56927538|NCT02318290|Narcotics|narcotics|mesh-list
56927539|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
56927540|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927541|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927542|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927543|NCT03467360|Etoposide|etoposide|mesh-list
56927544|NCT03467360|Acetazolamide|acetazolamide|mesh-list
56927545|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56927546|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927547|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56927548|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56927549|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927550|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927551|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
56927552|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56927553|NCT03467360|Diuretics|diuretics|mesh-ancestor
56927554|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
56927555|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927556|NCT03452072|Timolol|timolol|mesh-list
56927557|NCT03452072|Petrolatum|petrolatum|mesh-list
56927558|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56927559|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56927560|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
56927561|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927562|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927563|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927564|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56927565|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56927566|NCT03452072|Emollients|emollients|mesh-ancestor
56927567|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
56927568|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56927569|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56927570|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56927571|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
56927572|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927573|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927574|NCT03433040|Progestins|progestins|mesh-ancestor
56927575|NCT03433040|Hormones|hormones|mesh-ancestor
56927576|NCT02318446|Folic Acid|folic acid|mesh-list
56927577|NCT02318446|Hematinics|hematinics|mesh-ancestor
56927578|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
56927579|NCT02318446|Vitamins|vitamins|mesh-ancestor
56927580|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
56927581|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927582|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56927583|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56927584|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56927585|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
56927586|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927587|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
56927588|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56927589|NCT01360658|Antibodies|antibodies|mesh-list
56927590|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
56927591|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56927592|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
56927593|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927594|NCT02318758|Ethanol|ethanol|mesh-list
56927595|NCT02318758|Treprostinil|treprostinil|mesh-list
56927596|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56927597|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927598|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927599|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927600|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56927601|NCT02441686|Dexamethasone|dexamethasone|mesh-list
56927602|NCT02441686|Lenalidomide|lenalidomide|mesh-list
56927603|NCT02441686|Bortezomib|bortezomib|mesh-list
56927604|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927605|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
56927606|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
56927607|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927608|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927609|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56927610|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
56927611|NCT02441686|Hormones|hormones|mesh-ancestor
56927612|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927613|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56927614|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927615|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
56927616|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56927617|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56927618|NCT02441686|Growth Substances|growth substances|mesh-ancestor
56927619|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
56927620|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56927621|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
56927622|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927623|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927624|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927625|NCT01352234|Aspirin|aspirin|mesh-list
56927626|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56927627|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56927628|NCT01352234|Analgesics|analgesics|mesh-ancestor
56927629|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
56927630|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927631|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927632|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927633|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56927634|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56927635|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56927636|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927637|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56927638|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56927639|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927640|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
56927641|NCT01364792|Valacyclovir|valacyclovir|mesh-list
56927642|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
56927643|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927644|NCT02318836|Lofexidine|lofexidine|mesh-list
56927645|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56927646|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56927647|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927648|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
56927649|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927650|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56927651|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56927652|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56927653|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
56927654|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927655|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927656|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56927657|NCT01352312|Ofatumumab|ofatumumab|mesh-list
56927658|NCT01352312|Pentostatin|pentostatin|mesh-list
56927659|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56927660|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
56927661|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927662|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927663|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56927664|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927665|NCT02939209|Hydromorphone|hydromorphone|mesh-list
56927666|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56927667|NCT02939209|Narcotics|narcotics|mesh-ancestor
56927668|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927669|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927670|NCT02939209|Analgesics|analgesics|mesh-ancestor
56927671|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
56927672|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927673|NCT01141855|Varenicline|varenicline|mesh-list
56927674|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56927675|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56927676|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
56927677|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927678|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927679|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927680|NCT01236859|Gabapentin|gabapentin|mesh-list
56927681|NCT01236859|Analgesics|analgesics|mesh-ancestor
56927682|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
56927683|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927684|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927685|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
56927686|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56927687|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56927688|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927689|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56927690|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56927691|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56927692|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927693|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927694|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
56927695|NCT01145365|Anesthetics|anesthetics|mesh-list
56927696|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927697|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927698|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
56927699|NCT01365104|Deferoxamine|deferoxamine|mesh-list
56927700|NCT01365104|Siderophores|siderophores|mesh-ancestor
56927701|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56927702|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
56927703|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
56927704|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927705|NCT03492970|Melatonin|melatonin|mesh-list
56927706|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
56927707|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927708|NCT03492970|Protective Agents|protective agents|mesh-ancestor
56927709|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927710|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927711|NCT01362374|Leucovorin|leucovorin|mesh-list
56927712|NCT01362374|Paclitaxel|paclitaxel|mesh-list
56927713|NCT01362374|Docetaxel|docetaxel|mesh-list
56927714|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
56927715|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56927716|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927717|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
56927718|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
56927719|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
56927720|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927721|NCT01362374|Antidotes|antidotes|mesh-ancestor
56927722|NCT01362374|Protective Agents|protective agents|mesh-ancestor
56927723|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927724|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
56927725|NCT01362374|Vitamins|vitamins|mesh-ancestor
56927726|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
56848692|NCT05497726|Bevacizumab|bevacizumab|mesh-list
56927727|NCT01142011|Belimumab|belimumab|mesh-list
56927728|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56927729|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
56927730|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927731|NCT02319460|Thrombin|thrombin|mesh-list
56927732|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
56927733|NCT02319460|Coagulants|coagulants|mesh-ancestor
56927734|NCT04722952|Cytarabine|cytarabine|mesh-list
56927735|NCT04722952|Azacitidine|azacitidine|mesh-list
56927736|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
56927737|NCT04722952|Visilizumab|visilizumab|mesh-list
56927738|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56927739|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
56927740|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927741|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927742|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
56927743|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927744|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56927745|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
56927746|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927747|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927748|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56927749|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56927750|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
56927751|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56927752|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
56927753|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927754|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
56927755|NCT01365260|Protective Agents|protective agents|mesh-ancestor
56927756|NCT01235455|Interferons|interferons|mesh-list
56927757|NCT01235455|Interferon-beta|interferon-beta|mesh-list
56927758|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
56927759|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927760|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
56927761|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927762|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
56927763|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927764|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56927765|NCT01145677|Topiramate|topiramate|mesh-list
56927766|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
56927767|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56927768|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927769|NCT03499444|Rucaparib|rucaparib|mesh-list
56927770|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56927771|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927772|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927773|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927774|NCT02319616|Clobetasol|clobetasol|mesh-list
56927775|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927776|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
56927777|NCT02319616|Hormones|hormones|mesh-ancestor
56927778|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927779|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927780|NCT01142245|Esomeprazole|esomeprazole|mesh-list
56927781|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56927782|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56927783|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56927784|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927785|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927786|NCT02319772|Galidesivir|galidesivir|mesh-list
56927787|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
56927788|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927789|NCT03959527|Azithromycin|azithromycin|mesh-list
56927790|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
56927791|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56927792|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927793|NCT03499132|Anesthetics|anesthetics|mesh-list
56927794|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927795|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927796|NCT01142401|Bortezomib|bortezomib|mesh-list
56927797|NCT01142401|Fulvestrant|fulvestrant|mesh-list
56927798|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927799|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56927800|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56927801|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56927802|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
55732687|NCT03491969|Protective Agents|protective agents|mesh-ancestor
56927803|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927804|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927805|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
56927806|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927807|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927808|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927809|NCT03498820|Remifentanil|remifentanil|mesh-list
56927810|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56927811|NCT03498820|Narcotics|narcotics|mesh-ancestor
56927812|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927813|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927814|NCT03498820|Analgesics|analgesics|mesh-ancestor
56927815|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
56927816|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927817|NCT05158309|Capsaicin|capsaicin|mesh-list
56927818|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
56927819|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
56927820|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
56927821|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927822|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927823|NCT02320084|Nitisinone|nitisinone|mesh-list
56927824|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927825|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927826|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56927827|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
56927828|NCT02320240|Citalopram|citalopram|mesh-list
56927829|NCT02320240|Fluoxetine|fluoxetine|mesh-list
56927830|NCT02320240|Paroxetine|paroxetine|mesh-list
56927831|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56927832|NCT02320240|Sertraline|sertraline|mesh-list
56927833|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56927834|NCT02320240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56927835|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56927836|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56927837|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927838|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927839|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
56927840|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927841|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56927842|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
56927843|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56927844|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927845|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56927846|NCT02320240|Analgesics|analgesics|mesh-ancestor
56927847|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
56927848|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
56927849|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56927850|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56927851|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927852|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56927853|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56927854|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927855|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56927856|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56927857|NCT03492736|Melatonin|melatonin|mesh-list
56927858|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
56927859|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927860|NCT03492736|Protective Agents|protective agents|mesh-ancestor
56927861|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927862|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56927863|NCT02320474|Aflibercept|aflibercept|mesh-list
56927864|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56927865|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56927866|NCT02320474|Growth Substances|growth substances|mesh-ancestor
56927867|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927868|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
56927869|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927870|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
56927871|NCT03492580|Empagliflozin|empagliflozin|mesh-list
56927872|NCT03492580|Canagliflozin|canagliflozin|mesh-list
56927873|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56927874|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56927875|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56927876|NCT03492580|Glucagon|glucagon|mesh-list
56848836|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
56927877|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56927878|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927879|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56927880|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927881|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56927882|NCT03492580|Hormones|hormones|mesh-ancestor
56927883|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927884|NCT03492580|Incretins|incretins|mesh-ancestor
56927885|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
56927886|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927887|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
56927888|NCT01238965|Leucovorin|leucovorin|mesh-list
56927889|NCT01238965|Fluorouracil|fluorouracil|mesh-list
56927890|NCT01238965|Panobinostat|panobinostat|mesh-list
56927891|NCT01238965|Calcium|calcium|mesh-list
56927892|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
56927893|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56927894|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56927895|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927896|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56927897|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
56927898|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927899|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56927900|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927901|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56927902|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
56927903|NCT01238965|Antidotes|antidotes|mesh-ancestor
56927904|NCT01238965|Protective Agents|protective agents|mesh-ancestor
56927905|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
56927906|NCT01238965|Vitamins|vitamins|mesh-ancestor
56927907|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
56927908|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56927909|NCT01142557|Interferons|interferons|mesh-list
56927910|NCT01142557|Interferon-beta|interferon-beta|mesh-list
56927911|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
56927912|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927913|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
56927914|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927915|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
56927916|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927917|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56927919|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56927920|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
56927921|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56927922|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927923|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56927924|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56927925|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
56927926|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
56927927|NCT01144117|Hematinics|hematinics|mesh-ancestor
56927928|NCT04987294|Rasburicase|rasburicase|mesh-list
56927929|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
56927930|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56927931|NCT04371640|Sirolimus|sirolimus|mesh-list
56927932|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56927933|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927934|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56927935|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927936|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
56927937|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56927938|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
56927939|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927940|NCT04356196|Verapamil|verapamil|mesh-list
56927941|NCT04356196|Bisoprolol|bisoprolol|mesh-list
56927942|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56927943|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56927944|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56927945|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927946|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56927947|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927948|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
56927949|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56927950|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
56927951|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
56927952|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927953|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56927954|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56927955|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56927956|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
56927957|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56927958|NCT02115139|Ipilimumab|ipilimumab|mesh-list
56927959|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56927960|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927961|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56927962|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56927963|NCT02047981|Azithromycin|azithromycin|mesh-list
56927964|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56927965|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56927966|NCT04802356|Dexamethasone|dexamethasone|mesh-list
56927967|NCT04802356|Lenalidomide|lenalidomide|mesh-list
56927968|NCT04802356|Bortezomib|bortezomib|mesh-list
56927969|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56927970|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
56927971|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
56927972|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927973|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927974|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56927975|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
56927976|NCT04802356|Hormones|hormones|mesh-ancestor
56927977|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56927978|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56927979|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927980|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
56927981|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56927982|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56927983|NCT04802356|Growth Substances|growth substances|mesh-ancestor
56927984|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
56927985|NCT01142635|Bromides|bromides|mesh-list
56927986|NCT01142635|Rocuronium|rocuronium|mesh-list
56927987|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
56927988|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56927989|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56927990|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56927991|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56927992|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56927993|NCT01144195|Panitumumab|panitumumab|mesh-list
56927994|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56927995|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56927996|NCT05631769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56927997|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56927998|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56927999|NCT02528383|Estradiol|estradiol|mesh-list
56928000|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56928001|NCT02528383|Estrogens|estrogens|mesh-ancestor
56928002|NCT02528383|Hormones|hormones|mesh-ancestor
56928003|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928004|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928005|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56928006|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
56928007|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56928008|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56928009|NCT01146067|Rivastigmine|rivastigmine|mesh-list
56928010|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56928011|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928012|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928013|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
56928014|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928015|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928016|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56928017|NCT01146067|Protective Agents|protective agents|mesh-ancestor
56928018|NCT01237249|Dexamethasone|dexamethasone|mesh-list
56928019|NCT01237249|Prednisone|prednisone|mesh-list
56928020|NCT01237249|Melphalan|melphalan|mesh-list
56928021|NCT01237249|Lenalidomide|lenalidomide|mesh-list
56928022|NCT01237249|Bortezomib|bortezomib|mesh-list
56928023|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56928024|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
56928025|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
56928026|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928027|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928028|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928029|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
56928030|NCT01237249|Hormones|hormones|mesh-ancestor
56928031|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928032|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56928033|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928034|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56928035|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
56928036|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928037|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56928038|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928039|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
56928040|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56928041|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56928042|NCT01237249|Growth Substances|growth substances|mesh-ancestor
56928043|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
56928044|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
56928045|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56928046|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
56928047|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928048|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928049|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56928050|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
56928051|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56928052|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56928053|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56928054|NCT01244347|Folic Acid|folic acid|mesh-list
56928055|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
56928056|NCT01244347|Hematinics|hematinics|mesh-ancestor
56928057|NCT01244347|Vitamins|vitamins|mesh-ancestor
56928058|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
56928059|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928060|NCT05000047|Silicon|silicon|mesh-list
56928061|NCT05000047|Trace Elements|trace elements|mesh-ancestor
56928062|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
56928063|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928064|NCT01763827|Ezetimibe|ezetimibe|mesh-list
56928065|NCT01763827|Evolocumab|evolocumab|mesh-list
56928066|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56928067|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56928068|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56928069|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
56928070|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928071|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56928072|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
56928073|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928075|NCT01146145|Morphine|morphine|mesh-list
56928076|NCT01146145|Analgesics|analgesics|mesh-ancestor
56928077|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
56928078|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928079|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928080|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56928081|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56928082|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
56928083|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
56928084|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928085|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56928086|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56928087|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928088|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928089|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56928090|NCT01146145|Narcotics|narcotics|mesh-ancestor
56928091|NCT01146535|Interferons|interferons|mesh-list
56928092|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
56928093|NCT01146535|Oseltamivir|oseltamivir|mesh-list
56928094|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928095|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
56928096|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56928097|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
56928098|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928099|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928100|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928101|NCT01732783|Panitumumab|panitumumab|mesh-list
56928102|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56928103|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928104|NCT04355728|Heparin|heparin|mesh-list
56928105|NCT04355728|Calcium heparin|calcium heparin|mesh-list
56928106|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
56928107|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56928108|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56928109|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928110|NCT01693783|Ipilimumab|ipilimumab|mesh-list
56928111|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56928112|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928113|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56928114|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928115|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
56928116|NCT02528461|Liver Extracts|liver extracts|mesh-list
56928117|NCT02528461|Hematinics|hematinics|mesh-ancestor
56928118|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
56928119|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56928120|NCT02649790|Dexamethasone|dexamethasone|mesh-list
56928121|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56928122|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
56928123|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
56928124|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928125|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928126|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928127|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
56928128|NCT02649790|Hormones|hormones|mesh-ancestor
56928129|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928130|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56928131|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928132|NCT01237483|Cetuximab|cetuximab|mesh-list
56928133|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56928134|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928135|NCT01240213|Vitamin D|vitamin d|mesh-list
56928136|NCT01240213|Vitamins|vitamins|mesh-ancestor
56928137|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
56928138|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928139|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56928140|NCT01375777|Ezetimibe|ezetimibe|mesh-list
56928141|NCT01375777|Evolocumab|evolocumab|mesh-list
56928142|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56928143|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56928144|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56928145|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
56928146|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928147|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56928148|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
56928149|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928150|NCT02431702|Haloperidol|haloperidol|mesh-list
56928151|NCT02431702|Olanzapine|olanzapine|mesh-list
56928152|NCT02431702|Risperidone|risperidone|mesh-list
56928153|NCT02431702|Aripiprazole|aripiprazole|mesh-list
56928154|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56928155|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56928156|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
56928157|NCT02431702|Perphenazine|perphenazine|mesh-list
56928158|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56928159|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
56928160|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928161|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928162|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928163|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56928164|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56928165|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928166|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56928167|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56928168|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
56928169|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
56928170|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
56928171|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928172|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928173|NCT02431702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56928174|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56928175|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928176|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
56928177|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
56928178|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56928179|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56928180|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56928181|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56928182|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56928183|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
56928184|NCT01145209|Fludarabine|fludarabine|mesh-list
56928185|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
56928186|NCT01145209|Ofatumumab|ofatumumab|mesh-list
56928187|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928188|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
56928189|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928190|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928191|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56928192|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
56928193|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928194|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928195|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56928196|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56928197|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
56928198|NCT02086552|Lenalidomide|lenalidomide|mesh-list
56928199|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
56928200|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928201|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56928202|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56928203|NCT02086552|Growth Substances|growth substances|mesh-ancestor
56928204|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
56928205|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928206|NCT02321878|Liraglutide|liraglutide|mesh-list
56928207|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56928208|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928209|NCT02321878|Incretins|incretins|mesh-ancestor
56928210|NCT02321878|Hormones|hormones|mesh-ancestor
56928211|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928212|NCT03625141|Atezolizumab|atezolizumab|mesh-list
56928213|NCT03625141|Vemurafenib|vemurafenib|mesh-list
56928214|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928215|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56928216|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928217|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928218|NCT03491410|Aspirin|aspirin|mesh-list
56928219|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56928220|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56915561|NCT01088165|Adalimumab|adalimumab|mesh-list
56928222|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
56928223|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928224|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928225|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56928226|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928227|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56928228|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56928229|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928230|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56928231|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56928232|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928233|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
56928234|NCT00876031|Etoposide|etoposide|mesh-list
56928235|NCT00876031|Idarubicin|idarubicin|mesh-list
56928236|NCT00876031|Trofosfamide|trofosfamide|mesh-list
56928237|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56928238|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928239|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56928240|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56928241|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928242|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928243|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56928244|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928245|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
56928246|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928247|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56928248|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
56928249|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
56928250|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
56928251|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
56928252|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928253|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928254|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
56928255|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928256|NCT01146301|Clopidogrel|clopidogrel|mesh-list
56928257|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56849162|NCT01115972|Valsartan|valsartan|mesh-list
56928258|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56928259|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56928260|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56928261|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
56928262|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928263|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928264|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928265|NCT00807859|Paclitaxel|paclitaxel|mesh-list
56928266|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56928267|NCT00807859|Capecitabine|capecitabine|mesh-list
56928268|NCT00807859|Trastuzumab|trastuzumab|mesh-list
56928269|NCT00807859|Lapatinib|lapatinib|mesh-list
56928270|NCT00807859|Trebananib|trebananib|mesh-list
56928271|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56928272|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928273|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
56928274|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
56928275|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
56928276|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928277|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56928278|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
56928279|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56928280|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56928281|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928282|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56928283|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56928284|NCT00807859|Growth Substances|growth substances|mesh-ancestor
56928285|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928286|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
56928287|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56928288|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56928289|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56928290|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928291|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
56928292|NCT03491098|Prednisolone|prednisolone|mesh-list
56928293|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56928294|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
56928295|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56928296|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
56928297|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56928298|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
56928299|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56928300|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
56928301|NCT03491098|Hormones|hormones|mesh-ancestor
56928302|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928303|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928304|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56928305|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928306|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
56928307|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
56928308|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928309|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928310|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56928311|NCT03491098|Protective Agents|protective agents|mesh-ancestor
56928312|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
56928313|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56928314|NCT02322502|Propofol|propofol|mesh-list
56928315|NCT02322502|Sevoflurane|sevoflurane|mesh-list
56928316|NCT02322502|Desflurane|desflurane|mesh-list
56928317|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56928318|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928319|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928320|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56928321|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
56928322|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
56928323|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56928324|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56928325|NCT02322580|Etanercept|etanercept|mesh-list
56928326|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56928327|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56928328|NCT02322580|Analgesics|analgesics|mesh-ancestor
56928329|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
56928330|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928331|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928332|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56928333|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928334|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928335|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928336|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
56928337|NCT03190174|Sirolimus|sirolimus|mesh-list
56928338|NCT03190174|Nivolumab|nivolumab|mesh-list
56928339|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56928340|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928341|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56928342|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928343|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56928344|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56928345|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56928346|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
56928347|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928348|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
56928349|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928350|NCT03490708|Tranilast|tranilast|mesh-list
56928351|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56928352|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56928353|NCT03490708|Analgesics|analgesics|mesh-ancestor
56928354|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
56928355|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928356|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928357|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56928358|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928359|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56928360|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928361|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928362|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56928363|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56928364|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
56928365|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
56928366|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928367|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56928368|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56928369|NCT00924326|Vidarabine|vidarabine|mesh-list
56928370|NCT00924326|Aldesleukin|aldesleukin|mesh-list
56928371|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
56928372|NCT00924326|Fludarabine|fludarabine|mesh-list
56928373|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
56928374|NCT00924326|Interleukin-2|interleukin-2|mesh-list
56928375|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928376|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
56928377|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928378|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928379|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56928380|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
56928381|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928382|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928383|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56928384|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56928385|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
56928386|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
56928387|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56928388|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56928389|NCT00924326|Analgesics|analgesics|mesh-ancestor
56928390|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
56928391|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928392|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56928393|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56928394|NCT03496870|Levodopa|levodopa|mesh-list
56928395|NCT03496870|Carbidopa|carbidopa|mesh-list
56928396|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56928397|NCT03496870|Opicapone|opicapone|mesh-list
56928398|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56928399|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56928400|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
56928401|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928402|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928403|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928404|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56928405|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928406|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56928407|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
56928408|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
56928409|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56928410|NCT01370096|Epoprostenol|epoprostenol|mesh-list
56928411|NCT01370096|Vasopressins|vasopressins|mesh-list
56928412|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
56928413|NCT01370096|Tezosentan|tezosentan|mesh-list
56928414|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
56928415|NCT01370096|Coagulants|coagulants|mesh-ancestor
56928416|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56928417|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56928418|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
56928419|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928420|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56928421|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56928422|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
56928423|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56928424|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
56928425|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928426|NCT05160896|Bevacizumab|bevacizumab|mesh-list
56928427|NCT05160896|Cetuximab|cetuximab|mesh-list
56928428|NCT05160896|Irinotecan|irinotecan|mesh-list
56928429|NCT05160896|Raltitrexed|raltitrexed|mesh-list
56928430|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56928431|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928432|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56928433|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56928434|NCT05160896|Growth Substances|growth substances|mesh-ancestor
56928435|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928436|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56928437|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56928438|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56928439|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928440|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928441|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56928442|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
56928443|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56928444|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
56928445|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928446|NCT04297592|Doxycycline|doxycycline|mesh-list
56928447|NCT04297592|Cephalexin|cephalexin|mesh-list
56928448|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56928449|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56928450|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
56928451|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56928452|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56928453|NCT03845114|Insulin|insulin|mesh-list
56928454|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56928455|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56928456|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928457|NCT02875028|Vorapaxar|vorapaxar|mesh-list
56928458|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56928459|NCT01371344|Tacrolimus|tacrolimus|mesh-list
56928460|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928461|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
56928462|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928463|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56928464|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928465|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928466|NCT03631004|Olanzapine|olanzapine|mesh-list
56928467|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
56928468|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
56928469|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928470|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928471|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928472|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56928473|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56928474|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928475|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56928476|NCT03631004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56928477|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56928478|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928479|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928480|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928481|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
56928482|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
56928483|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928484|NCT00943618|Bupropion|bupropion|mesh-list
56849383|NCT01116128|Prednisone|prednisone|mesh-list
56928485|NCT00943618|Varenicline|varenicline|mesh-list
56928486|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56928487|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
56928488|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56928489|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56928490|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56928491|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928492|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928493|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
56928494|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928495|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928496|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56928497|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56928498|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928499|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56928500|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56928501|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
56928502|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
56928503|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
56928504|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56928505|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56928506|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
56928507|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
56928508|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928509|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928510|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928511|NCT02322658|Eszopiclone|eszopiclone|mesh-list
56928512|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56928513|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928514|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928515|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
56928516|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56928517|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
56928518|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56928519|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
56928520|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928521|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915858|NCT00869128|Melatonin|melatonin|mesh-list
56928522|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
56928523|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
56928524|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56928525|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928526|NCT02710084|Oxytocin|oxytocin|mesh-list
56928527|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
56928528|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56928529|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928530|NCT02849990|Prednisone|prednisone|mesh-list
56928531|NCT02849990|Cortisone|cortisone|mesh-list
56928532|NCT02849990|Indomethacin|indomethacin|mesh-list
56928533|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
56928534|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56928535|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
56928536|NCT02849990|Hormones|hormones|mesh-ancestor
56928537|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928538|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928539|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56928540|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928541|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56928542|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928543|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928544|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
56928545|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56928546|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56928547|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56928548|NCT02849990|Analgesics|analgesics|mesh-ancestor
56928549|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
56928550|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928551|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928552|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
56928553|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
56928554|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56928555|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56928556|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
56928557|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56928558|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928559|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
56928560|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928561|NCT03490396|Povidone|povidone|mesh-list
56928562|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
56928563|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56928564|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
56928565|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928566|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
56928567|NCT03490396|Protective Agents|protective agents|mesh-ancestor
56928568|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
56928569|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
56928570|NCT05136040|Bupivacaine|bupivacaine|mesh-list
56928571|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
56928572|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
56928573|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928574|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928575|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
56928576|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928577|NCT03496246|Vitamin D|vitamin d|mesh-list
56928578|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56928579|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
56928580|NCT03496246|Calcifediol|calcifediol|mesh-list
56928581|NCT03496246|Calcium|calcium|mesh-list
56928582|NCT03496246|Vitamins|vitamins|mesh-ancestor
56928583|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
56928584|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928585|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56928586|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56928587|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
56928588|NCT02017964|Carboplatin|carboplatin|mesh-list
56928589|NCT02017964|Methotrexate|methotrexate|mesh-list
56928590|NCT02017964|Etoposide|etoposide|mesh-list
56928591|NCT02017964|Vincristine|vincristine|mesh-list
56928592|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
56915932|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56928593|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
56928594|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928595|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
56928596|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928597|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928598|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56928599|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
56928600|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928601|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928602|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56928603|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56928604|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
56928605|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56928606|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56928607|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
56928608|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
56928609|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928610|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56928611|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56928612|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56928613|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56928614|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56928615|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
56928616|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
56928617|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
56928618|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
56928619|NCT05121298|Upadacitinib|upadacitinib|mesh-list
56928620|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56928621|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56928622|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928623|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928624|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928625|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56928626|NCT01956110|Hormones|hormones|mesh-ancestor
56928627|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928628|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928629|NCT03489928|Misoprostol|misoprostol|mesh-list
56928630|NCT03489928|Dinoprostone|dinoprostone|mesh-list
56928631|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56928632|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
56928633|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56928634|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928635|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56928636|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928637|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
56928638|NCT02323282|Ropivacaine|ropivacaine|mesh-list
56928639|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
56928640|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
56928641|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928642|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928643|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
56928644|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928645|NCT01802086|Lidocaine|lidocaine|mesh-list
56928646|NCT01802086|Prilocaine|prilocaine|mesh-list
56928647|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56928648|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
56928649|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
56928650|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928651|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928652|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
56928653|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928654|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56928655|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56928656|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56928657|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928658|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928659|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56928660|NCT05347316|Colchicine|colchicine|mesh-list
56928661|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
56928662|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928663|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
56928664|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
56928665|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
56928666|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928667|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928668|NCT03495466|Anesthetics|anesthetics|mesh-list
56928669|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928670|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928671|NCT01372826|Naloxegol|naloxegol|mesh-list
56928672|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56928673|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928674|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
56928675|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928676|NCT01371968|Alfentanil|alfentanil|mesh-list
56928677|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56928678|NCT01371968|Narcotics|narcotics|mesh-ancestor
56928679|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928680|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928681|NCT01371968|Analgesics|analgesics|mesh-ancestor
56928682|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
56928683|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928684|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56928685|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
56928686|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
56928687|NCT04989322|Carboplatin|carboplatin|mesh-list
56928688|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
56928689|NCT04989322|Pemetrexed|pemetrexed|mesh-list
56928690|NCT04989322|Lenvatinib|lenvatinib|mesh-list
56928691|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928692|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56928693|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928694|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928695|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56928696|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56928697|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56928698|NCT01367054|Metformin|metformin|mesh-list
56928699|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56928700|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928701|NCT03634514|Hormones|hormones|mesh-list
56928702|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928703|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928704|NCT02323438|Menthol|menthol|mesh-list
56928705|NCT02323438|Nicotine|nicotine|mesh-list
56928706|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56928707|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
56928708|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928709|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928710|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56928711|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56928712|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
56928713|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928714|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928715|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
56928716|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
56928717|NCT01372904|Dexamethasone|dexamethasone|mesh-list
56928718|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
56928719|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56928720|NCT01372904|BB 1101|bb 1101|mesh-list
56928721|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56928722|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
56928723|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
56928724|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928725|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928726|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928727|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
56928728|NCT01372904|Hormones|hormones|mesh-ancestor
56928729|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928730|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56928731|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928732|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
56928733|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928734|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928735|NCT01372982|Letrozole|letrozole|mesh-list
56928736|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928737|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56928738|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56928739|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928740|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928741|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56928742|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
56928743|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928744|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928745|NCT02323516|Aspirin|aspirin|mesh-list
56928746|NCT02323516|Loperamide|loperamide|mesh-list
56928747|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
56928748|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56928749|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56928750|NCT02323516|Analgesics|analgesics|mesh-ancestor
56928751|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
56928752|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928753|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928754|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56928755|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928756|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56928757|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56928758|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928759|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56928760|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56928761|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928762|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
56928763|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928764|NCT01367210|Maraviroc|maraviroc|mesh-list
56928765|NCT01367210|Darunavir|darunavir|mesh-list
56928766|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56928767|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56928768|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56928769|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928770|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56928771|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
56928772|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56928773|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56928774|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56928775|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56928776|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
56928777|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928778|NCT02323594|Asunaprevir|asunaprevir|mesh-list
56928779|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
56928780|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928781|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928782|NCT01372280|Galantamine|galantamine|mesh-list
56928783|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56928784|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928785|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928786|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
56928787|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928788|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928789|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56928790|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
56928791|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928792|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
56928793|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
56928794|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56928795|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928796|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56928797|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928798|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
56928799|NCT04742140|Analgesics|analgesics|mesh-ancestor
56928800|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
56928801|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928802|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928803|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
56928804|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928805|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56928806|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
56928807|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56928808|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928809|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928810|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56928811|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
56928812|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56928813|NCT04580992|Ajmaline|ajmaline|mesh-list
56928814|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56928815|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56928816|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56928817|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928818|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928819|NCT04590274|Azithromycin|azithromycin|mesh-list
56928820|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
56928821|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56928822|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56928823|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
56928824|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56928825|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56928826|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928827|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928828|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928829|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
56928830|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56928831|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928832|NCT04455178|Indapamide|indapamide|mesh-list
56928833|NCT04455178|Spironolactone|spironolactone|mesh-list
56928834|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56928835|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
56928836|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928837|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928838|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56928839|NCT04455178|Diuretics|diuretics|mesh-ancestor
56928840|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
56928841|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56928842|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56928843|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928844|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928845|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
56928846|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56928847|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928848|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
56928849|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928850|NCT02446834|Metformin|metformin|mesh-list
56928851|NCT02446834|Acarbose|acarbose|mesh-list
56928852|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56928853|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928854|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56928855|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928856|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928857|NCT03489616|Pemetrexed|pemetrexed|mesh-list
56928858|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928859|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928860|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928861|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56928862|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56928863|NCT02859896|Calcitriol|calcitriol|mesh-list
56928864|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56928865|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56928866|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928867|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56928868|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928869|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928870|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56928871|NCT02859896|Vitamins|vitamins|mesh-ancestor
56928872|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
56928873|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56928874|NCT02323906|Sorafenib|sorafenib|mesh-list
56928875|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928876|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56928877|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928878|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928879|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56928880|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
56928881|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56928882|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56928883|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928884|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928885|NCT01319942|Sorafenib|sorafenib|mesh-list
56928886|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928887|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56928888|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928889|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928890|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
56928891|NCT01373138|Ephedrine|ephedrine|mesh-list
56928892|NCT01373138|Desloratadine|desloratadine|mesh-list
56928893|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56928894|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
56928895|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928896|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928897|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928898|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56928899|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56928900|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
56928901|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
56928902|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56928903|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
56928904|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928905|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56928906|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
56928907|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
56928908|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56928909|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56928910|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
56928911|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
56928912|NCT01373216|Exenatide|exenatide|mesh-list
56928913|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56928914|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928915|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56928916|NCT01373216|Incretins|incretins|mesh-ancestor
56928917|NCT01373216|Hormones|hormones|mesh-ancestor
56928918|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928919|NCT03487354|Misoprostol|misoprostol|mesh-list
56928920|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56928921|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
56928922|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56928923|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928924|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56928925|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56928926|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
56928927|NCT04461340|Sirolimus|sirolimus|mesh-list
56928928|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56928929|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849832|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
56928930|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56928931|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928932|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
56928933|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928934|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
56928935|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928936|NCT05154968|Mannitol|mannitol|mesh-list
56928937|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56928938|NCT05154968|Diuretics|diuretics|mesh-ancestor
56928939|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
56928940|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928941|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
56928942|NCT01373372|Hormones|hormones|mesh-ancestor
56928943|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56928944|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928945|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56928946|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56928947|NCT02324296|Cisplatin|cisplatin|mesh-list
56928948|NCT02324296|Etoposide|etoposide|mesh-list
56928949|NCT02324296|Ifosfamide|ifosfamide|mesh-list
56928950|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56928951|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56928952|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56928953|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56928954|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56928955|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928956|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56928957|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
56928958|NCT03494686|Anesthetics|anesthetics|mesh-list
56928959|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56928960|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928961|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
56928962|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
56928963|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56928964|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928965|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928966|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
56928967|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
56928968|NCT02565914|Ivacaftor|ivacaftor|mesh-list
56928969|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56928970|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56928971|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56928972|NCT03881020|Fluorides|fluorides|mesh-list
56928973|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
56928974|NCT03881020|Protective Agents|protective agents|mesh-ancestor
56928975|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928976|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
56928977|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56928978|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928979|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
56928980|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56928981|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
56928982|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56928983|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56928984|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
56928985|NCT03487042|Bimatoprost|bimatoprost|mesh-list
56928986|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56928987|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56928988|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56928989|NCT02513186|Dexamethasone|dexamethasone|mesh-list
56928990|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
56928991|NCT02513186|Lenalidomide|lenalidomide|mesh-list
56928992|NCT02513186|Bortezomib|bortezomib|mesh-list
56928993|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56928994|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
56928995|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56928996|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56928997|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56928998|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
56928999|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929000|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929001|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56929002|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929003|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
56849907|NCT01124630|Leucovorin|leucovorin|mesh-list
56929004|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
56929005|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929006|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56929007|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
56929008|NCT02513186|Hormones|hormones|mesh-ancestor
56929009|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929010|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56929011|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56929012|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56929013|NCT02513186|Growth Substances|growth substances|mesh-ancestor
56929014|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
56929015|NCT03115294|Theophylline|theophylline|mesh-list
56929016|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56929017|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
56929018|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929019|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929020|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56929021|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
56929022|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56929023|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929024|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929025|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
56929026|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56929027|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56929028|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
56929029|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929030|NCT01367756|Citalopram|citalopram|mesh-list
56929031|NCT01367756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56929032|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56929033|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56929034|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929035|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929036|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
56929037|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929038|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56929039|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
56929040|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56929041|NCT04624958|Rituximab|rituximab|mesh-list
56929042|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
56929043|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56929044|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916376|NCT04718740|Vitamin K|vitamin k|mesh-list
56929045|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
56929046|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929047|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929048|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56929049|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929050|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929051|NCT01453088|Bortezomib|bortezomib|mesh-list
56929052|NCT01453088|Melphalan|melphalan|mesh-list
56929053|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929054|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56929055|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
56929056|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929057|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56929058|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56929059|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
56929060|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929061|NCT03485482|Bisoprolol|bisoprolol|mesh-list
56929062|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56929063|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
56929064|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
56929065|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929066|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929067|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56929068|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56929069|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56929070|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
56929071|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929072|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929073|NCT02946424|Simvastatin|simvastatin|mesh-list
56929074|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56929075|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56929076|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
56929077|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929078|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56929079|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56929080|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929081|NCT00783536|Etanercept|etanercept|mesh-list
56929082|NCT00783536|Methotrexate|methotrexate|mesh-list
56929083|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56929084|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
56929085|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56929086|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929087|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56929088|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
56929089|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929090|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929091|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56929092|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929093|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56929094|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56929095|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
56929096|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929097|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56929098|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56929099|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56929100|NCT00783536|Analgesics|analgesics|mesh-ancestor
56929101|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
56929102|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929103|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929104|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56929105|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56929106|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56929107|NCT01367912|Estradiol|estradiol|mesh-list
56929108|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56929109|NCT01367912|Estrogens|estrogens|mesh-ancestor
56929110|NCT01367912|Hormones|hormones|mesh-ancestor
56929111|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929112|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929113|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56929114|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
56929115|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56929116|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56929117|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56929118|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
56929119|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56929120|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929121|NCT03115112|Incretins|incretins|mesh-ancestor
56929122|NCT03115112|Hormones|hormones|mesh-ancestor
56929123|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929124|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56929125|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
56929126|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929127|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929128|NCT01373528|Budesonide|budesonide|mesh-list
56929129|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929130|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56929131|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
56929132|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929133|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929134|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56929135|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
56929136|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
56929137|NCT01373528|Hormones|hormones|mesh-ancestor
56929138|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929139|NCT03634202|Capecitabine|capecitabine|mesh-list
56929140|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56929141|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
56929142|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929143|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929144|NCT05019560|Sevoflurane|sevoflurane|mesh-list
56929145|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56929146|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56929147|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
56929148|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
56929149|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929150|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929151|NCT01373606|Terlipressin|terlipressin|mesh-list
56929152|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56929153|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56929154|NCT01367990|Norepinephrine|norepinephrine|mesh-list
56929155|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56929156|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56929157|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
56929158|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929159|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929160|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929161|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
56929162|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
56929163|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929164|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56929165|NCT03556358|Paclitaxel|paclitaxel|mesh-list
56929166|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
56929167|NCT03556358|Trastuzumab|trastuzumab|mesh-list
56929168|NCT03556358|Epirubicin|epirubicin|mesh-list
56929169|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56929170|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929171|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56929172|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56929173|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56929174|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929175|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56929176|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
56929177|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929178|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929179|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56929180|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
56929181|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56929182|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56929183|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56929184|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56929185|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56929186|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929187|NCT01374308|Interferons|interferons|mesh-list
56929188|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
56929189|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
56929190|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56929191|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929192|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
56929193|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929194|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
56929195|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929196|NCT01368068|Tibolone|tibolone|mesh-list
56929197|NCT01368068|Citalopram|citalopram|mesh-list
56929198|NCT01368068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56929199|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56929200|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56929201|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929202|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929203|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
56929204|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929205|NCT01368068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56929206|NCT01368068|Antidepressive Agents|antidepressive agents|mesh-ancestor
56929207|NCT01368068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56929208|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
56929209|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
56929210|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929211|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56929212|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56929213|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929214|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56929215|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
56929216|NCT01368068|Hormones|hormones|mesh-ancestor
56929217|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56929218|NCT03228680|Hormones|hormones|mesh-ancestor
56929219|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929220|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929221|NCT01373684|Tenofovir|tenofovir|mesh-list
56929222|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56929223|NCT01373684|Entecavir|entecavir|mesh-list
56929224|NCT01373684|Adefovir|adefovir|mesh-list
56929225|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
56929226|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929227|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56929228|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56929229|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929230|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929231|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56929232|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56929233|NCT04490018|Vaccines|vaccines|mesh-list
56929234|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
56929235|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929236|NCT02891798|Dexamethasone|dexamethasone|mesh-list
56929237|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
56929238|NCT02891798|Clonidine|clonidine|mesh-list
56929239|NCT02891798|Buprenorphine|buprenorphine|mesh-list
56929240|NCT02891798|Bupivacaine|bupivacaine|mesh-list
56929241|NCT02891798|BB 1101|bb 1101|mesh-list
56929242|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929243|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
56929244|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
56929245|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929246|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929247|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56929248|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
56929249|NCT02891798|Hormones|hormones|mesh-ancestor
56929250|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929251|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56929252|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929253|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
56929254|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929255|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929256|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
56929257|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
56929258|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929259|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
56929260|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56929261|NCT02891798|Narcotics|narcotics|mesh-ancestor
56929262|NCT02891798|Analgesics|analgesics|mesh-ancestor
56929263|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56929264|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56929265|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
56929266|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56929267|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56929268|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56929269|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
56929270|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929271|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
56929272|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
56929273|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
56929274|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929275|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929276|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
56929277|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929278|NCT01374620|Paclitaxel|paclitaxel|mesh-list
56929279|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56929280|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
56929281|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56929282|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929283|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
56929284|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
56929285|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
56929286|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929287|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56929288|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
56929289|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929290|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929291|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56929292|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
56929293|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56929294|NCT01374698|Aspirin|aspirin|mesh-list
56929295|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56929296|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56929297|NCT01374698|Analgesics|analgesics|mesh-ancestor
56929298|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
56929299|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733440|NCT03473093|Morphine|morphine|mesh-list
56929300|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929301|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929302|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929303|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56929304|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56929305|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929306|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56929307|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56929308|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929309|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
56929310|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
56929311|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56929312|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929313|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929314|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56929315|NCT05197088|Tamsulosin|tamsulosin|mesh-list
56929316|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56929317|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56929318|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56929319|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
56929320|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929321|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929322|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929323|NCT05197088|Urological Agents|urological agents|mesh-ancestor
56929324|NCT01375088|Propolis|propolis|mesh-list
56929325|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929326|NCT01368848|Bevacizumab|bevacizumab|mesh-list
56929327|NCT01368848|Docetaxel|docetaxel|mesh-list
56929328|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56929329|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929330|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56929331|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56929332|NCT01368848|Growth Substances|growth substances|mesh-ancestor
56929333|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929334|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
56929335|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
56929336|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
56929337|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
56929338|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929339|NCT03604874|Oxytocin|oxytocin|mesh-list
56929340|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
56929341|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56929342|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929343|NCT01369082|Cyclosporine|cyclosporine|mesh-list
56929344|NCT01369082|Sirolimus|sirolimus|mesh-list
56929345|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
56929346|NCT01369082|Tacrolimus|tacrolimus|mesh-list
56929347|NCT01369082|Cyclosporins|cyclosporins|mesh-list
56929348|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56929349|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
56929350|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929351|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56929352|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929353|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929354|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
56929355|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929356|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
56929357|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929358|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56929359|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929360|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56929361|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
56929362|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56929363|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
56929364|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56929365|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56929366|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929367|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
56929368|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
56929369|NCT03135262|Rituximab|rituximab|mesh-list
56929370|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
56929371|NCT03135262|Venetoclax|venetoclax|mesh-list
56929372|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56929373|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929374|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
56929375|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850278|NCT03710044|Cyclosporine|cyclosporine|mesh-list
56929376|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929377|NCT01375244|Lisinopril|lisinopril|mesh-list
56929378|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56929379|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
56929380|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929381|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929382|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56929383|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56929384|NCT01375244|Protective Agents|protective agents|mesh-ancestor
56929385|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929386|NCT01375322|Amlodipine|amlodipine|mesh-list
56929387|NCT01375322|Valsartan|valsartan|mesh-list
56929388|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56929389|NCT01375322|Benazepril|benazepril|mesh-list
56929390|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56929391|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56929392|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56929393|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929394|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56929395|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929396|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
56929397|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56929398|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56929399|NCT01375322|Diuretics|diuretics|mesh-ancestor
56929400|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
56929401|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56929402|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56929403|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
56929404|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929405|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
56929406|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56929407|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56929408|NCT01369238|Analgesics|analgesics|mesh-ancestor
56929409|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
56929410|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929411|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929412|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929413|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929414|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
56929415|NCT03485404|Vitamins|vitamins|mesh-list
56929416|NCT03485404|Folic Acid|folic acid|mesh-list
56929417|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
56929418|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
56929419|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
56929420|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929421|NCT03485404|Hematinics|hematinics|mesh-ancestor
56929423|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929424|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56929425|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929426|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929427|NCT03072628|Nicotine|nicotine|mesh-list
56929428|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56929429|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
56929430|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929431|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929432|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56929433|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56929434|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
56929435|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929436|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929437|NCT03535194|Mirikizumab|mirikizumab|mesh-list
56929438|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56929439|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56929440|NCT03535194|Analgesics|analgesics|mesh-ancestor
56929441|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
56929442|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929443|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929444|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929445|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929446|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56929447|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56929448|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56929449|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56929450|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
56929451|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929452|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929453|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929454|NCT05194904|Ketorolac|ketorolac|mesh-list
56929455|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
56929456|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56929457|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929458|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929459|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56929460|NCT05194904|Analgesics|analgesics|mesh-ancestor
56929461|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
56929462|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929463|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56929464|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56929465|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56929466|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
56929467|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929468|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929469|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56929470|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929471|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929472|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56929473|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929474|NCT01375400|Aspirin|aspirin|mesh-list
56929475|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56929476|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56929477|NCT01375400|Analgesics|analgesics|mesh-ancestor
56929478|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
56929479|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929480|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929481|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929482|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929483|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56929484|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56929485|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929486|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56929487|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56929488|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929489|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
56929490|NCT01319864|Plerixafor|plerixafor|mesh-list
56929491|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56929492|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56929493|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
56916831|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56929495|NCT05194046|Amoxicillin|amoxicillin|mesh-list
56929496|NCT05194046|Clarithromycin|clarithromycin|mesh-list
56929497|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56929498|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929499|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56929500|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929501|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929502|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56929503|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56929504|NCT01369472|Carvedilol|carvedilol|mesh-list
56929505|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56929506|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56929507|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
56929508|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929509|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929510|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929511|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56929512|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
56929513|NCT01369472|Protective Agents|protective agents|mesh-ancestor
56929514|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56929515|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56929516|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56929517|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
56929518|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56929519|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56929520|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
56929521|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56929522|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
56929523|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
56929524|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
56929525|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929526|NCT03720522|Adenosine|adenosine|mesh-list
56929527|NCT03720522|Analgesics|analgesics|mesh-ancestor
56929528|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
56929529|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929530|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929531|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56929532|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
56929533|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56929534|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
56929535|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
56929536|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929537|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929538|NCT01375556|Ethanol|ethanol|mesh-list
56929539|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56929540|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929541|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929542|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929543|NCT03486496|Gefitinib|gefitinib|mesh-list
56929544|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929545|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56929546|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929547|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929548|NCT02091934|Dipivefrin|dipivefrin|mesh-list
56929549|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56929550|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
56929551|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929552|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929553|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929554|NCT01375634|Midazolam|midazolam|mesh-list
56929555|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56929556|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56929557|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929558|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929559|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56929560|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56929561|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56929562|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56929563|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
56929564|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
56929565|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
56929566|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
56929567|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929568|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929569|NCT05388448|Amoxicillin|amoxicillin|mesh-list
56929570|NCT05388448|Rifampin|rifampin|mesh-list
56929571|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
56929572|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
56929573|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56929574|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929575|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56929576|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
56929577|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
56929578|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56929579|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929580|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929581|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56929582|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56929583|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56929584|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56929585|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56929586|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56929587|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56929588|NCT05108740|Everolimus|everolimus|mesh-list
56929589|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929590|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56929591|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
56929592|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929593|NCT05105750|Aspirin|aspirin|mesh-list
56929594|NCT05105750|Indobufen|indobufen|mesh-list
56929595|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56929596|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56929597|NCT05105750|Analgesics|analgesics|mesh-ancestor
56929598|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
56929599|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929600|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929601|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929602|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929603|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56929604|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56929605|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929606|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56929607|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56929608|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929609|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
56929610|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56929611|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56929612|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929613|NCT05152264|Analgesics|analgesics|mesh-list
56929614|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
56929615|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929616|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929617|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
56929618|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929619|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
56929620|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929621|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929622|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56929623|NCT05152186|Disinfectants|disinfectants|mesh-list
56929624|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929625|NCT03485092|Empagliflozin|empagliflozin|mesh-list
56929626|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56929627|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929628|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56929629|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929630|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
56929631|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
56929632|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
56929633|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56929634|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929635|NCT05064800|Ritonavir|ritonavir|mesh-list
56929636|NCT05064800|Dabigatran|dabigatran|mesh-list
56929637|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56929638|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56929639|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
56929640|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916989|NCT01100125|Insulin|insulin|mesh-list
56929641|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929642|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56929643|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56929644|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
56929645|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929646|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56929647|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56929648|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
56929649|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56929650|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
56929651|NCT01376180|Lamotrigine|lamotrigine|mesh-list
56929652|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
56929653|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56929654|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56929655|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929656|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56929657|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929658|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56929659|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56929660|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929661|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56929662|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56929663|NCT03633734|Folfirinox|folfirinox|mesh-list
56929664|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929665|NCT01376258|Finasteride|finasteride|mesh-list
56929666|NCT01376258|Dutasteride|dutasteride|mesh-list
56929667|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56929668|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56929669|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929670|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929671|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
56929672|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929673|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929674|NCT01376258|Urological Agents|urological agents|mesh-ancestor
56929675|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56929676|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56929677|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56929678|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56929679|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929680|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
56929681|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929682|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929683|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56929684|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929685|NCT03531840|Olaparib|olaparib|mesh-list
56929686|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56929687|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929688|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929689|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929690|NCT05151796|Aspirin|aspirin|mesh-list
56929691|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56929692|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56929693|NCT05151796|Analgesics|analgesics|mesh-ancestor
56929694|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
56929695|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929696|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929697|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929698|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929699|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56929700|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56929701|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929702|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56929703|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56929704|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929705|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
56929706|NCT04460092|Insulin|insulin|mesh-list
56929707|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56929708|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56929709|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929710|NCT03110900|Lorazepam|lorazepam|mesh-list
56929711|NCT03110900|Haloperidol|haloperidol|mesh-list
56929712|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
56917060|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929713|NCT03110900|Loxapine|loxapine|mesh-list
56929714|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
56929715|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
56929716|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929717|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929718|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56929719|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56929720|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56929721|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929722|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56929723|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56929724|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
56929725|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929726|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929727|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56929728|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
56929729|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56929730|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56929731|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
56929732|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
56929733|NCT03486184|Cystatins|cystatins|mesh-list
56929734|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56929735|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
56929736|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929737|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929738|NCT03486106|Propofol|propofol|mesh-list
56929739|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56929740|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929741|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929742|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56929743|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
56929744|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
56929745|NCT03109756|Gaboxadol|gaboxadol|mesh-list
56929746|NCT03109756|Analgesics|analgesics|mesh-ancestor
56929747|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
56929748|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929749|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929750|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
56929751|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
56929752|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
56929753|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929754|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929755|NCT03867734|Aztreonam|aztreonam|mesh-list
56929756|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56929757|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929758|NCT05759546|Fulvestrant|fulvestrant|mesh-list
56929759|NCT05759546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56929760|NCT05759546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929761|NCT05759546|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56929762|NCT05759546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56929763|NCT05759546|Hormone Antagonists|hormone antagonists|mesh-ancestor
56929764|NCT05759546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929765|NCT05759546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929766|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56929767|NCT05151016|Mifepristone|mifepristone|mesh-list
56929768|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56929769|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
56929770|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56929771|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929772|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56929773|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56929774|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56929775|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
56929776|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56929777|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56929778|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
56929779|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929780|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
56929781|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56929782|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56929783|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56929784|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929785|NCT04459312|Antibodies|antibodies|mesh-list
56929786|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
56929787|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929788|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56929789|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929790|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56929791|NCT04871360|Laxatives|laxatives|mesh-ancestor
56929792|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56929793|NCT05153200|Adalimumab|adalimumab|mesh-list
56929794|NCT05153200|Upadacitinib|upadacitinib|mesh-list
56929795|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929796|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929797|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56929798|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56929799|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929800|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929801|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
56929802|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929803|NCT03477136|Vitamin D|vitamin d|mesh-list
56929804|NCT03477136|Vitamins|vitamins|mesh-ancestor
56929805|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
56929806|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929807|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56929808|NCT03552068|Clonidine|clonidine|mesh-list
56929809|NCT03552068|Analgesics|analgesics|mesh-ancestor
56929810|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
56929811|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929812|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929813|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56929814|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
56929815|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
56929816|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56929817|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56929818|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56929819|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
56929820|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56929821|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929822|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56929823|NCT00702988|Hormones|hormones|mesh-ancestor
56929824|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929825|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929826|NCT05759312|Metformin|metformin|mesh-list
56929827|NCT05759312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56929828|NCT05759312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929829|NCT03446456|Vasopressins|vasopressins|mesh-list
56929830|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
56929831|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
56929832|NCT03446456|Coagulants|coagulants|mesh-ancestor
56929833|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56929834|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56929835|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
56929836|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929837|NCT03396692|Morphine|morphine|mesh-list
56929838|NCT03396692|Ropivacaine|ropivacaine|mesh-list
56929839|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56929840|NCT03396692|Narcotics|narcotics|mesh-ancestor
56929841|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929842|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929843|NCT03396692|Analgesics|analgesics|mesh-ancestor
56929844|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
56929845|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929846|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
56929847|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
56929848|NCT04796948|Leucovorin|leucovorin|mesh-list
56929849|NCT04796948|Fluorouracil|fluorouracil|mesh-list
56929850|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
56929851|NCT04796948|Irinotecan|irinotecan|mesh-list
56929852|NCT04796948|Calcium|calcium|mesh-list
56929853|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
56929854|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56929855|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929856|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
56929857|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929858|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56929859|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929860|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56929861|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
56929862|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56929863|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56929864|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929865|NCT04796948|Antidotes|antidotes|mesh-ancestor
56917230|NCT01104883|Iodine|iodine|mesh-list
56929866|NCT04796948|Protective Agents|protective agents|mesh-ancestor
56929867|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
56929868|NCT04796948|Vitamins|vitamins|mesh-ancestor
56929869|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
56929870|NCT03480958|Morphine|morphine|mesh-list
56929871|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56929872|NCT03480958|Narcotics|narcotics|mesh-ancestor
56929873|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929874|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929875|NCT03480958|Analgesics|analgesics|mesh-ancestor
56929876|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
56929877|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929878|NCT03495102|Dulaglutide|dulaglutide|mesh-list
56929879|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56929880|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929881|NCT05759156|Tranexamic Acid|tranexamic acid|mesh-list
56929882|NCT05759156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56929883|NCT05759156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56929884|NCT05759156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929885|NCT05759156|Hemostatics|hemostatics|mesh-ancestor
56929886|NCT05759156|Coagulants|coagulants|mesh-ancestor
56929887|NCT04859608|Eculizumab|eculizumab|mesh-list
56929888|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56929889|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56929890|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
56929891|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929892|NCT04754386|Antibodies|antibodies|mesh-list
56929893|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
56929894|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929895|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56929896|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56929897|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56929898|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929899|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
56929900|NCT03253172|Diuretics|diuretics|mesh-ancestor
56929901|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
56929902|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929903|NCT03253172|Expectorants|expectorants|mesh-ancestor
56929904|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
56929905|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
56929906|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56929907|NCT03480646|Prednisone|prednisone|mesh-list
56929908|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
56929909|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56929910|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
56929911|NCT03480646|Hormones|hormones|mesh-ancestor
56929912|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56929913|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929914|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56929915|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929916|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929917|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929918|NCT03483142|Misoprostol|misoprostol|mesh-list
56929919|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56929920|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
56929921|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56929922|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929923|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56929924|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56929925|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
56929926|NCT03726372|Bromides|bromides|mesh-list
56929927|NCT03726372|Rocuronium|rocuronium|mesh-list
56929928|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
56929929|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56929930|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56929931|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56929932|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929933|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929934|NCT03104816|Acetaminophen|acetaminophen|mesh-list
56929935|NCT03104816|Hydromorphone|hydromorphone|mesh-list
56929936|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56929937|NCT03104816|Analgesics|analgesics|mesh-ancestor
56929938|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
56929939|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56929940|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929941|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
56929942|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56929943|NCT03104816|Narcotics|narcotics|mesh-ancestor
56929944|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56929945|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
56929946|NCT04720976|Osimertinib|osimertinib|mesh-list
56929947|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56929948|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929949|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56929950|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929951|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929952|NCT03480568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56929953|NCT03480568|Immunologic Factors|immunologic factors|mesh-ancestor
56929954|NCT03480568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929955|NCT04707326|Lamivudine|lamivudine|mesh-list
56929956|NCT04707326|Dolutegravir|dolutegravir|mesh-list
56929957|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56929958|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56929959|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56929960|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929961|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
56929962|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929963|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56929964|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56929965|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56929966|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56929967|NCT03559062|Ivacaftor|ivacaftor|mesh-list
56929968|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56929969|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56929970|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929971|NCT05759000|Dapagliflozin|dapagliflozin|mesh-list
55733441|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56929972|NCT05759000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56929973|NCT05759000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929974|NCT05759000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56929975|NCT05759000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929976|NCT03726216|Dalbavancin|dalbavancin|mesh-list
56929977|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56929978|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56929979|NCT00089791|Denosumab|denosumab|mesh-list
56929980|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56929981|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929982|NCT02876510|Aldesleukin|aldesleukin|mesh-list
56929983|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
56929984|NCT02876510|Fludarabine|fludarabine|mesh-list
56929985|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
56929986|NCT02876510|Atezolizumab|atezolizumab|mesh-list
56929987|NCT02876510|Interleukin-2|interleukin-2|mesh-list
56929988|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56929989|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
56929990|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56929991|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56929992|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56929993|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
56929994|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56929995|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56929996|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56929997|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56929998|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
56929999|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
56930000|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930001|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930002|NCT02876510|Analgesics|analgesics|mesh-ancestor
56930003|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
56930004|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930005|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56930006|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56930007|NCT03477175|Sorafenib|sorafenib|mesh-list
56930008|NCT03477175|Lenvatinib|lenvatinib|mesh-list
56930009|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930010|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56930011|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930012|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930013|NCT03380455|Cimetidine|cimetidine|mesh-list
56930014|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56930015|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56930016|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56930017|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
56930018|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
56930019|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930020|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930021|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930022|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56930023|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56930024|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930025|NCT02815280|Minocycline|minocycline|mesh-list
56930026|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56930027|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930028|NCT03482752|Molgramostim|molgramostim|mesh-list
56930029|NCT03482752|Sargramostim|sargramostim|mesh-list
56930030|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930031|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
56930032|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930033|NCT04729543|Azacitidine|azacitidine|mesh-list
56930034|NCT04729543|Interleukin-2|interleukin-2|mesh-list
56930035|NCT04729543|Valproic Acid|valproic acid|mesh-list
56930036|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56930037|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
56930038|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930039|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930040|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930041|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930042|NCT04729543|Analgesics|analgesics|mesh-ancestor
56930043|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
56930044|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930045|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930046|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
56930047|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
56850946|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
56930048|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930049|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
56930050|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56930051|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930052|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56930053|NCT01310712|Oxybutynin|oxybutynin|mesh-list
56930054|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
56930055|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
56930056|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930057|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930058|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56930059|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56930060|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
56930061|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930062|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930063|NCT01310712|Urological Agents|urological agents|mesh-ancestor
56930064|NCT02737930|Fluoxetine|fluoxetine|mesh-list
56930065|NCT02737930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56930066|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56930067|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930068|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930069|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930070|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
56930071|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930072|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56930073|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
56930074|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56930075|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56930076|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56930077|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930078|NCT04707391|Vaccines|vaccines|mesh-list
56930079|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
56930080|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930081|NCT01242787|Entecavir|entecavir|mesh-list
56930082|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
56930083|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930084|NCT03476356|Clomiphene|clomiphene|mesh-list
56930085|NCT03476356|Enclomiphene|enclomiphene|mesh-list
56930086|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
56930087|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56930088|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
56930089|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930090|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930091|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56930093|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56930094|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56930095|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56930096|NCT03723096|Pomalidomide|pomalidomide|mesh-list
56930097|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
56930098|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930099|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56930100|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56930101|NCT03723096|Growth Substances|growth substances|mesh-ancestor
56930102|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
56930103|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930104|NCT02534012|Anesthetics|anesthetics|mesh-list
56930105|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930106|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930107|NCT05626387|Mycophenolic Acid|mycophenolic acid|mesh-list
56930108|NCT05626387|Prednisolone|prednisolone|mesh-list
56930109|NCT05626387|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56930110|NCT05626387|Methylprednisolone|methylprednisolone|mesh-list
56930111|NCT05626387|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56930112|NCT05626387|Prednisolone acetate|prednisolone acetate|mesh-list
56930113|NCT05626387|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56930114|NCT05626387|Prednisolone phosphate|prednisolone phosphate|mesh-list
56930115|NCT05626387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56930116|NCT05626387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930117|NCT05626387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56930118|NCT05626387|Antitubercular Agents|antitubercular agents|mesh-ancestor
56930119|NCT05626387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56930120|NCT05626387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930121|NCT05626387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851023|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
56930122|NCT05626387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930123|NCT05626387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930124|NCT05626387|Glucocorticoids|glucocorticoids|mesh-ancestor
56930125|NCT05626387|Hormones|hormones|mesh-ancestor
56930126|NCT05626387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930127|NCT05626387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930128|NCT05626387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56930129|NCT05626387|Antiemetics|antiemetics|mesh-ancestor
56930130|NCT05626387|Autonomic Agents|autonomic agents|mesh-ancestor
56930131|NCT05626387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930132|NCT05626387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56930133|NCT05626387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56930134|NCT05626387|Protective Agents|protective agents|mesh-ancestor
56930135|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
56930136|NCT03722940|Analgesics|analgesics|mesh-ancestor
56930137|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
56930138|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930139|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930140|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
56930141|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930142|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56930143|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
56930144|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56930145|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930146|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930147|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56930148|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
56930149|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56930150|NCT01146925|Deferiprone|deferiprone|mesh-list
56930151|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56930152|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
56930153|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
56930154|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930155|NCT04635254|Histamine|histamine|mesh-list
56930156|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
56930157|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
56930158|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930159|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930160|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930161|NCT03476044|Selenium|selenium|mesh-list
56930162|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
56930163|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930164|NCT03476044|Protective Agents|protective agents|mesh-ancestor
56917518|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
56930165|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930166|NCT03476044|Trace Elements|trace elements|mesh-ancestor
56930167|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
56930168|NCT01250821|Menotropins|menotropins|mesh-list
56930169|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56930170|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
56930171|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56930172|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930173|NCT03493698|Midazolam|midazolam|mesh-list
56930174|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56930175|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56930176|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930177|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930178|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56930179|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56930180|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56930181|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56930182|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
56930183|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
56930184|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
56930185|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
56930186|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930187|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930188|NCT01148173|Ifosfamide|ifosfamide|mesh-list
56930189|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56930190|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
56930191|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930192|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930193|NCT01898312|Mifepristone|mifepristone|mesh-list
56930194|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56930195|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
56930196|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56930197|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930198|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56930199|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56930200|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56930201|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
56930202|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56930203|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56930204|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
56930205|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930206|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
56930207|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56930208|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56930209|NCT03528174|Pancrelipase|pancrelipase|mesh-list
56930210|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56930211|NCT05756660|Sodium thiosulfate|sodium thiosulfate|mesh-list
56930212|NCT05756660|Cisplatin|cisplatin|mesh-list
56930213|NCT05756660|Vorinostat|vorinostat|mesh-list
56930214|NCT05756660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930215|NCT05756660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56930216|NCT05756660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930217|NCT05756660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930218|NCT05756660|Antidotes|antidotes|mesh-ancestor
56930219|NCT05756660|Protective Agents|protective agents|mesh-ancestor
56930220|NCT05756660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930221|NCT05756660|Antioxidants|antioxidants|mesh-ancestor
56930222|NCT05756660|Antitubercular Agents|antitubercular agents|mesh-ancestor
56930223|NCT05756660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56930224|NCT05756660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930225|NCT05756660|Chelating Agents|chelating agents|mesh-ancestor
56930226|NCT05756660|Sequestering Agents|sequestering agents|mesh-ancestor
56930227|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56930228|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56930229|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930230|NCT03482440|Analgesics|analgesics|mesh-ancestor
56930231|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
56930232|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930233|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930234|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930235|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930236|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
56930237|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
56930238|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930239|NCT01253473|Budesonide|budesonide|mesh-list
56917583|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
56930240|NCT01253473|Albuterol|albuterol|mesh-list
56930241|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
56930242|NCT01253473|Ipratropium|ipratropium|mesh-list
56930243|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930244|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56930245|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
56930246|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930247|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930248|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56930249|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
56930250|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
56930251|NCT01253473|Hormones|hormones|mesh-ancestor
56930252|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930253|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56930254|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56930255|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56930256|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
56930257|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930258|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930259|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
56930260|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56930261|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56930262|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
56930263|NCT01883804|Methyldopa|methyldopa|mesh-list
56930264|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56930265|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
56930266|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
56930267|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930268|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930269|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56930270|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56930271|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56930272|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
56930273|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930274|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930275|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56930276|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930277|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930278|NCT03475810|Midazolam|midazolam|mesh-list
56930279|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56930280|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56930281|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930282|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930283|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56930284|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56930285|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56930286|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56930287|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
56930288|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
56930289|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
56930290|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
56930291|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930292|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930293|NCT03480100|Xylometazoline|xylometazoline|mesh-list
56930294|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
56930295|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56930296|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
56930297|NCT02348203|Aspirin|aspirin|mesh-list
56930298|NCT02348203|Zileuton|zileuton|mesh-list
56930299|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56930300|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930301|NCT02348203|Analgesics|analgesics|mesh-ancestor
56930302|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
56930303|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930304|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930305|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930306|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930307|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56930308|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56930309|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930310|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56930311|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56930312|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930313|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
56930314|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56930315|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56930316|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
56930317|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930318|NCT03493542|Vaccines|vaccines|mesh-list
56930319|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
56930320|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930321|NCT04365088|Deflazacort|deflazacort|mesh-list
56930322|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930323|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56930324|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
56930325|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930326|NCT03482362|Vinorelbine|vinorelbine|mesh-list
56930327|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56930328|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930329|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
56930330|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
56930331|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
56930332|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930333|NCT04500470|Ketoprofen|ketoprofen|mesh-list
56930334|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56930335|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930336|NCT04500470|Analgesics|analgesics|mesh-ancestor
56930337|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
56930338|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930339|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930340|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930341|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851246|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
56930342|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56930343|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930344|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930345|NCT03493386|Glycine|glycine|mesh-list
56930346|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
56930347|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930348|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930349|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930350|NCT04937816|Empagliflozin|empagliflozin|mesh-list
56930351|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56930352|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930353|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56930354|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930355|NCT01366898|Methotrexate|methotrexate|mesh-list
56930356|NCT01366898|Idarubicin|idarubicin|mesh-list
56930357|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56930358|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
56930359|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56930360|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930361|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56930362|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
56930363|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930364|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930365|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
56930366|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930367|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56930368|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56930369|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
56930370|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930371|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56930372|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56930373|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56930374|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56930375|NCT01248871|Sufentanil|sufentanil|mesh-list
56930376|NCT01248871|Remifentanil|remifentanil|mesh-list
56930377|NCT01248871|Dsuvia|dsuvia|mesh-list
56930378|NCT01248871|Propofol|propofol|mesh-list
56930379|NCT01248871|Sevoflurane|sevoflurane|mesh-list
56930380|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56930381|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930382|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930383|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56930384|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
56930385|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
56930386|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56930387|NCT01248871|Narcotics|narcotics|mesh-ancestor
56930388|NCT01248871|Analgesics|analgesics|mesh-ancestor
56930389|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
56930390|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930391|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56930392|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56930393|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56930394|NCT01251133|Vaccines|vaccines|mesh-list
56930395|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
56930396|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930397|NCT03720288|Acetazolamide|acetazolamide|mesh-list
56930398|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
56930399|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56930400|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930401|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930402|NCT03720288|Diuretics|diuretics|mesh-ancestor
56930403|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
56930404|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930405|NCT03907813|Bupivacaine|bupivacaine|mesh-list
56930406|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
56930407|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
56930408|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930409|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930410|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
56930411|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930412|NCT00938912|Lacosamide|lacosamide|mesh-list
56930413|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
56930414|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56930415|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56930416|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930417|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930418|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
56930419|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56930420|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56930421|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56930422|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930423|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930424|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
56930425|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930426|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930427|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56930428|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930429|NCT03473340|Pirfenidone|pirfenidone|mesh-list
56930430|NCT03473340|Analgesics|analgesics|mesh-ancestor
56930431|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
56930432|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930433|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930434|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56930435|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930436|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930437|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930438|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930439|NCT01147705|Allopurinol|allopurinol|mesh-list
56930440|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
56930441|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930442|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930443|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
56930444|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930445|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56930446|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
56930447|NCT01147705|Protective Agents|protective agents|mesh-ancestor
56930448|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930449|NCT03907111|Chitosan|chitosan|mesh-list
56930450|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56930451|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56930452|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
56930453|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930454|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56930455|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
56930456|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
56930457|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
56930458|NCT03907111|Coagulants|coagulants|mesh-ancestor
56930459|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
56930460|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
56917818|NCT03946657|Anesthetics|anesthetics|mesh-list
56930461|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930462|NCT03912727|Protective Agents|protective agents|mesh-ancestor
56930463|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930464|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
56930465|NCT03912727|Vitamins|vitamins|mesh-ancestor
56930466|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
56930467|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
56930468|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56930469|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56930470|NCT03661567|Prednisolone|prednisolone|mesh-list
56930471|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
56930472|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56930473|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
56930474|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930475|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
56930476|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
56930477|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930478|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930479|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56930480|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
56930481|NCT03661567|Hormones|hormones|mesh-ancestor
56930482|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930483|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56930484|NCT03661567|Protective Agents|protective agents|mesh-ancestor
56930485|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56930486|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930487|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
56930488|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56930489|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930490|NCT03472326|GS-9131|gs-9131|mesh-list
56930491|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930492|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930493|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56930494|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56930495|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
56930496|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930497|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56930498|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56930499|NCT04182100|Aspirin|aspirin|mesh-list
56930500|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56930501|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930502|NCT04182100|Analgesics|analgesics|mesh-ancestor
56930503|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
56930504|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930505|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930506|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930507|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930508|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56930509|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56930510|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930511|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56930512|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56930513|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930514|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
56930515|NCT03479320|Lidocaine|lidocaine|mesh-list
56930516|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
56930517|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
56930518|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930519|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930520|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
56930521|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930522|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56930523|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56930524|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56930525|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930526|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930527|NCT03912415|Paclitaxel|paclitaxel|mesh-list
56930528|NCT03912415|Bevacizumab|bevacizumab|mesh-list
56930529|NCT03912415|Carboplatin|carboplatin|mesh-list
56930530|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56930531|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930532|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
56930533|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
56930534|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
56930535|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930536|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56930537|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56917936|NCT02743780|MGV354|mgv354|mesh-list
56930538|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56930539|NCT03912415|Growth Substances|growth substances|mesh-ancestor
56930540|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930541|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
56930543|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930544|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56930545|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
56930546|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930547|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
56930548|NCT00925652|Bevacizumab|bevacizumab|mesh-list
56930549|NCT00925652|Methotrexate|methotrexate|mesh-list
56930550|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56930551|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
56930552|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930553|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930554|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56930555|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
56930556|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930557|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930558|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56930559|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56930560|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56930561|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56930562|NCT00925652|Growth Substances|growth substances|mesh-ancestor
56930563|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
55733442|NCT03473093|Narcotics|narcotics|mesh-ancestor
56851484|NCT01131806|Hormones|hormones|mesh-ancestor
56930564|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56930565|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
56930566|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56930567|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56930568|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
56930569|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
56930570|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930571|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56930572|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56930573|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
56930574|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56930575|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930576|NCT03954106|Defibrotide|defibrotide|mesh-list
56930577|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56930578|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56930579|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930580|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56930581|NCT03525444|Ivacaftor|ivacaftor|mesh-list
56930582|NCT03525444|Elexacaftor|elexacaftor|mesh-list
56930583|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56930584|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930585|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930586|NCT05656352|Chrysarobin|chrysarobin|mesh-list
56930587|NCT05656352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56930588|NCT05656352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930589|NCT05656352|Analgesics|analgesics|mesh-ancestor
56930590|NCT05656352|Sensory System Agents|sensory system agents|mesh-ancestor
56930591|NCT05656352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930592|NCT05656352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930593|NCT05656352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930594|NCT05656352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930595|NCT01251835|Rifampin|rifampin|mesh-list
56930596|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
56930597|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56930598|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
56930599|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56930600|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930601|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
56930602|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56930603|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930604|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930605|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56930606|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56930607|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56930608|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56930609|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56930610|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56930611|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56930613|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
56930614|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
56930615|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930616|NCT03632876|Protective Agents|protective agents|mesh-ancestor
56930617|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930618|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56930619|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930620|NCT03632876|Vitamins|vitamins|mesh-ancestor
56930621|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
56930622|NCT03914755|Tucatinib|tucatinib|mesh-list
56930623|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930624|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56930625|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930626|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930627|NCT03905317|Bevacizumab|bevacizumab|mesh-list
56930628|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56930629|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930630|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56930631|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56930632|NCT03905317|Growth Substances|growth substances|mesh-ancestor
56930633|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930634|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
56930635|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56851547|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56930636|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
56930637|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930638|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
56930639|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
56930640|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930641|NCT01251991|Psyllium|psyllium|mesh-list
56930642|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
56930643|NCT01251991|Cathartics|cathartics|mesh-ancestor
56930644|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56930645|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
56930646|NCT04458454|Methocarbamol|methocarbamol|mesh-list
56930647|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56930648|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930649|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56930650|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930651|NCT03914677|Mecamylamine|mecamylamine|mesh-list
56930652|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56930653|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56930654|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
56930655|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930656|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930657|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56930658|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56930659|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
56930660|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930661|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930662|NCT03479086|Topiramate|topiramate|mesh-list
56930663|NCT03479086|Naltrexone|naltrexone|mesh-list
56930664|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56930665|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56930666|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930667|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
56930668|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930669|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
56930670|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56930671|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
56930672|NCT01252069|Progestins|progestins|mesh-list
56930673|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56930674|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
56930675|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56930676|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930677|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56930678|NCT01252069|Hormones|hormones|mesh-ancestor
56930679|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930680|NCT01252225|Lidocaine|lidocaine|mesh-list
56930681|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
56930682|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
56930683|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930684|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930685|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
56930686|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930687|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56930688|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56930689|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56930690|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930691|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930692|NCT04459702|Ritonavir|ritonavir|mesh-list
56930693|NCT04459702|Lopinavir|lopinavir|mesh-list
56930694|NCT04459702|Azithromycin|azithromycin|mesh-list
56930695|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
56930696|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56930697|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56930698|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
56930699|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930700|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930701|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56930702|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56930703|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
56930704|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930705|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56930706|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56930707|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56930708|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
56930709|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56930710|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56930711|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930712|NCT03574792|Oxycodone|oxycodone|mesh-list
56930713|NCT03574792|Methadone|methadone|mesh-list
56930714|NCT03574792|Gabapentin|gabapentin|mesh-list
56930715|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56930716|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56930717|NCT03574792|Narcotics|narcotics|mesh-ancestor
56930718|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930719|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930720|NCT03574792|Analgesics|analgesics|mesh-ancestor
56930721|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
56930722|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930723|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
56930724|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56930725|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56930726|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56930727|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56930728|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56930729|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930730|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930731|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
56930732|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
56930733|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
56930734|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56930735|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56930736|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930737|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56930738|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
56930739|NCT03904849|Cannabidiol|cannabidiol|mesh-list
56930740|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
56930741|NCT01250743|Vitamins|vitamins|mesh-list
56930742|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
56930743|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
56930744|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930745|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
56930746|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930747|NCT01250743|Protective Agents|protective agents|mesh-ancestor
56930748|NCT01254175|Vaccines|vaccines|mesh-list
56930749|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
56930750|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930751|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56930752|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56930753|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930754|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930755|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56930756|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
56930757|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930758|NCT03903367|Fentanyl|fentanyl|mesh-list
56930759|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56930760|NCT03903367|Narcotics|narcotics|mesh-ancestor
56918112|NCT02283424|Carboplatin|carboplatin|mesh-list
56930761|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930762|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930764|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
56930765|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930766|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56930767|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56930768|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
56930769|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
56930770|NCT03486834|Vaccines|vaccines|mesh-list
56930771|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
56930772|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930773|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
56930774|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930775|NCT03177460|Daratumumab|daratumumab|mesh-list
56930776|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930777|NCT05649722|Treprostinil|treprostinil|mesh-list
56930778|NCT05649722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56930779|NCT03717168|Hormones|hormones|mesh-list
56930780|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930781|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930782|NCT05553301|Vaccines|vaccines|mesh-list
56930783|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
56930784|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930785|NCT00708448|Bevacizumab|bevacizumab|mesh-list
56930786|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56930787|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56930788|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930789|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56930790|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56930791|NCT00708448|Growth Substances|growth substances|mesh-ancestor
56930792|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930793|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
56930794|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56930795|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930796|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930797|NCT02892604|Insulin|insulin|mesh-list
56930798|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56930799|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930800|NCT03478306|Melatonin|melatonin|mesh-list
56930801|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
56930802|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930803|NCT03478306|Protective Agents|protective agents|mesh-ancestor
56930804|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930805|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930806|NCT03103100|Lidocaine|lidocaine|mesh-list
56930807|NCT03103100|Bupivacaine|bupivacaine|mesh-list
56930808|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
56930809|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
56930810|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56930811|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930812|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
56930813|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930814|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56930815|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56930816|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56930817|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930818|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930819|NCT02940496|Ribavirin|ribavirin|mesh-list
56930820|NCT02940496|Grazoprevir|grazoprevir|mesh-list
56930821|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56930822|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
56930823|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56930824|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930825|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
56930826|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930827|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
56930828|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930829|NCT03639168|Cisplatin|cisplatin|mesh-list
56930830|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930831|NCT03131050|Scopolamine|scopolamine|mesh-list
56930832|NCT03131050|Citalopram|citalopram|mesh-list
56930833|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56930834|NCT03131050|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56930835|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56930836|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930837|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930838|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930839|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
56930840|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930841|NCT03131050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56930842|NCT03131050|Antidepressive Agents|antidepressive agents|mesh-ancestor
56930843|NCT03131050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56930844|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
56930845|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
56930846|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930847|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56930848|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56930849|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
56930850|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56930851|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
56930852|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56930853|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
56930854|NCT03719820|Clopidogrel|clopidogrel|mesh-list
56930855|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56930856|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930857|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930858|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56930859|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930860|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56930861|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56930862|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56930863|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
56930864|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56930865|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56930866|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56930867|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
56930868|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56930869|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56930870|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56930871|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56930872|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56930873|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56930874|NCT03903133|Vitamin E|vitamin e|mesh-list
56930875|NCT03903133|Antioxidants|antioxidants|mesh-list
56930876|NCT03903133|Vitamins|vitamins|mesh-ancestor
56930877|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
56930878|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930879|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930880|NCT03903133|Protective Agents|protective agents|mesh-ancestor
56930881|NCT01254799|Doxycycline|doxycycline|mesh-list
56930882|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56930883|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930884|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
56930885|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56930886|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56930887|NCT05553938|Empagliflozin|empagliflozin|mesh-list
56930888|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56930889|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930890|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56930891|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930892|NCT03718884|Mirikizumab|mirikizumab|mesh-list
56930893|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56930894|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930895|NCT03718884|Analgesics|analgesics|mesh-ancestor
56930896|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
56930897|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930898|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930899|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56930900|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930901|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56930902|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56930903|NCT05760248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56930904|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
56930905|NCT03716856|Fludarabine|fludarabine|mesh-list
56930906|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56930907|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
56930908|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930909|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56930910|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56930911|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
56930912|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930913|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930914|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56930915|NCT03910543|Tofacitinib|tofacitinib|mesh-list
56930916|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56930917|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930918|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930919|NCT03101462|Vaccines|vaccines|mesh-list
56930920|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
56930921|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930922|NCT03904537|Antibodies|antibodies|mesh-list
56930923|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
56930924|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930925|NCT05416580|Metformin|metformin|mesh-list
56930926|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56930927|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56930928|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930929|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56930930|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56930931|NCT03904225|Tegafur|tegafur|mesh-list
56930932|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56930933|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
56930934|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930935|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930936|NCT03910231|Tolvaptan|tolvaptan|mesh-list
56851850|NCT04973254|Rilpivirine|rilpivirine|mesh-list
56930937|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56930938|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930939|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
56930940|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930941|NCT01149109|Temozolomide|temozolomide|mesh-list
56930942|NCT01149109|Lomustine|lomustine|mesh-list
56930943|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56930944|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
56930945|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930946|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930947|NCT05667415|Cisplatin|cisplatin|mesh-list
56930948|NCT05667415|Disulfiram|disulfiram|mesh-list
56930949|NCT05667415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930950|NCT05667415|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56930951|NCT05667415|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56930952|NCT05667415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930953|NCT05667415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930954|NCT01586143|Acetaminophen|acetaminophen|mesh-list
56930955|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56930956|NCT01586143|Analgesics|analgesics|mesh-ancestor
56930957|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
56930958|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56930959|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930960|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
56930961|NCT01256359|Docetaxel|docetaxel|mesh-list
56930962|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56930963|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
56930964|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
56930965|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
56930966|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930967|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56930968|NCT02527993|Liraglutide|liraglutide|mesh-list
56930969|NCT02527993|Acarbose|acarbose|mesh-list
56930970|NCT02527993|Verapamil|verapamil|mesh-list
56930971|NCT02527993|Pasireotide|pasireotide|mesh-list
56930972|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56930973|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930974|NCT02527993|Incretins|incretins|mesh-ancestor
56930975|NCT02527993|Hormones|hormones|mesh-ancestor
56930976|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930977|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56930978|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
56930979|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930980|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56930981|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56930982|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56930983|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56930984|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56930985|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56918336|NCT03635684|Acetaminophen|acetaminophen|mesh-list
56931009|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56931010|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56931011|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931012|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931014|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
56931015|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931016|NCT03900871|Aspirin|aspirin|mesh-list
56931017|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931018|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931019|NCT03900871|Analgesics|analgesics|mesh-ancestor
56931020|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
56931021|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931022|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931023|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931024|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931025|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56931026|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56931027|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931028|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56931029|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56931030|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931031|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
56931058|NCT01149577|Olanzapine|olanzapine|mesh-list
56931059|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
56931060|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
56931061|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931062|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931063|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56931064|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56931065|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56931066|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56931067|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56931068|NCT01149577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56931069|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56931070|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931071|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931072|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931073|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
56931074|NCT05480306|Bevacizumab|bevacizumab|mesh-list
56931075|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56931076|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931077|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56931078|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56931079|NCT05480306|Growth Substances|growth substances|mesh-ancestor
56931080|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931081|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
56931082|NCT03894007|Maytansine|maytansine|mesh-list
56931083|NCT03894007|Docetaxel|docetaxel|mesh-list
56931084|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56931085|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
56931086|NCT03894007|Carboplatin|carboplatin|mesh-list
56931087|NCT03894007|Trastuzumab|trastuzumab|mesh-list
56931088|NCT03894007|Atezolizumab|atezolizumab|mesh-list
56931089|NCT03894007|Epirubicin|epirubicin|mesh-list
56931090|NCT03894007|Pertuzumab|pertuzumab|mesh-list
56931091|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56931092|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931093|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
56931094|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
56931095|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
56931096|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931097|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56931098|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
56931099|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931100|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931101|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56931102|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
56931103|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56931104|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56931105|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56931106|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56931107|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56931108|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931109|NCT01150747|Azithromycin|azithromycin|mesh-list
56931110|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
56931111|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56931112|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931113|NCT03893695|Nivolumab|nivolumab|mesh-list
56931114|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56931115|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931116|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56931117|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931118|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56931119|NCT01258309|Ketorolac|ketorolac|mesh-list
56931120|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56931121|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56931122|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56931123|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931124|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931125|NCT01258309|Analgesics|analgesics|mesh-ancestor
56931126|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
56931127|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931128|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931129|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931130|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931131|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56931132|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990931|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56852002|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
56931133|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931134|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56931135|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56931136|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56931137|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
56931138|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
56931139|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931140|NCT01256905|Modafinil|modafinil|mesh-list
56931141|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56931142|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931143|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56931144|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56931145|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56931146|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931147|NCT01586299|Acetaminophen|acetaminophen|mesh-list
56931148|NCT01586299|Ibuprofen|ibuprofen|mesh-list
56931149|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931150|NCT01586299|Analgesics|analgesics|mesh-ancestor
56931151|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
56931152|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931153|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931154|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
56931155|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931156|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931157|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931158|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56931159|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931160|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931161|NCT02874794|Valsartan|valsartan|mesh-list
56931162|NCT02874794|Enalapril|enalapril|mesh-list
56931163|NCT02874794|Enalaprilat|enalaprilat|mesh-list
56931164|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56931165|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56931166|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56931167|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56931168|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931169|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56931170|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
56931171|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931172|NCT03102710|Lidocaine|lidocaine|mesh-list
56931173|NCT03102710|Capsaicin|capsaicin|mesh-list
56931174|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
56931175|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
56931176|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56931177|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931178|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
56931179|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931180|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56931181|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56931182|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56931183|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931184|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931185|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
56931186|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931187|NCT01149967|Dexetimide|dexetimide|mesh-list
56931188|NCT01149967|Citalopram|citalopram|mesh-list
56931189|NCT01149967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56931190|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56931191|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931192|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931193|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931194|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
56931195|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931196|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56931197|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
56931198|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56931199|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56931200|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56931201|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
56931202|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
56990932|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56852078|NCT01231490|Naproxen|naproxen|mesh-list
56931203|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931204|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56931205|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56931206|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
56931207|NCT05505409|Pirfenidone|pirfenidone|mesh-list
56931208|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
56931209|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56931210|NCT05505409|Hormones|hormones|mesh-ancestor
56931211|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56931212|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931213|NCT05505409|Analgesics|analgesics|mesh-ancestor
56931214|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
56931215|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931216|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931217|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931218|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931219|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931220|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931221|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
56931222|NCT01257139|Docetaxel|docetaxel|mesh-list
56931223|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931224|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
56931225|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
56931226|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
56931227|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931228|NCT04770740|Vitamin K|vitamin k|mesh-list
56931229|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
56931230|NCT04770740|Vitamin MK 7|vitamin mk 7|mesh-list
56931231|NCT04770740|Vitamins|vitamins|mesh-ancestor
56931232|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
56931233|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931234|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56931235|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56931236|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931237|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
56931238|NCT04770740|Coagulants|coagulants|mesh-ancestor
56931239|NCT03896971|Cyclosporine|cyclosporine|mesh-list
56931240|NCT03896971|Cyclosporins|cyclosporins|mesh-list
56931241|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931242|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931243|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56931244|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
56931245|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931246|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
56931247|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931248|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931249|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931250|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56931251|NCT01258777|Golimumab|golimumab|mesh-list
56931252|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56931253|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56931254|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931255|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56931256|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
56931257|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931258|NCT05301842|Durvalumab|durvalumab|mesh-list
56931259|NCT05301842|Lenvatinib|lenvatinib|mesh-list
56931260|NCT05301842|Tremelimumab|tremelimumab|mesh-list
56931261|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56931262|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931263|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56931264|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931265|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931266|NCT03896893|Emollients|emollients|mesh-list
56931267|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931268|NCT01257373|Cobalt|cobalt|mesh-list
56931269|NCT01257373|Chromium|chromium|mesh-list
56931270|NCT01257373|Sirolimus|sirolimus|mesh-list
56931271|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56931272|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931273|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56931274|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931275|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
56931276|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56931277|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
56931278|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931279|NCT01257373|Trace Elements|trace elements|mesh-ancestor
56852152|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
56931280|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
56931281|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
56931282|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56931283|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56931284|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931285|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
56931286|NCT03899233|Coagulants|coagulants|mesh-ancestor
56931287|NCT03101150|Vitamin D|vitamin d|mesh-list
56931288|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
56931289|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
56931290|NCT03101150|Vitamins|vitamins|mesh-list
56931291|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
56931292|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931293|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56931294|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56931295|NCT03899077|Goserelin|goserelin|mesh-list
56931296|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56931297|NCT03899077|Leuprolide|leuprolide|mesh-list
56931298|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56931299|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931300|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
56931301|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56931302|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
56931303|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56931304|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931305|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56931306|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56931307|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
56931308|NCT01255579|Fluticasone|fluticasone|mesh-list
56931309|NCT01255579|Beclomethasone|beclomethasone|mesh-list
56931310|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
56931311|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56931312|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56931313|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931314|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56931315|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
56931316|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931317|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931318|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56931319|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
56931320|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931321|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56931322|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56931323|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56931324|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56931325|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
56931326|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931327|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931328|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
56931329|NCT01255579|Hormones|hormones|mesh-ancestor
56931330|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56931331|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
56931332|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56931333|NCT03101930|Liraglutide|liraglutide|mesh-list
56931334|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56931335|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931336|NCT03101930|Incretins|incretins|mesh-ancestor
56931337|NCT03101930|Hormones|hormones|mesh-ancestor
56931338|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56931339|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56931340|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
56931341|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931342|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931343|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56931344|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56931345|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56931346|NCT05415254|Calcitriol|calcitriol|mesh-list
56931347|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56931348|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931349|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56931350|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931351|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931352|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56852226|NCT02945410|Vitamin D|vitamin d|mesh-list
56931353|NCT05415254|Vitamins|vitamins|mesh-ancestor
56931354|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
56931355|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56931356|NCT01150201|Losartan|losartan|mesh-list
56931357|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56931358|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56931359|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56931360|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56931361|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931362|NCT03464136|Adalimumab|adalimumab|mesh-list
56931363|NCT03464136|Ustekinumab|ustekinumab|mesh-list
56931364|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931365|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931366|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931367|NCT01257451|Vildagliptin|vildagliptin|mesh-list
56931368|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56931369|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931370|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56931371|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
56931372|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931373|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931374|NCT01257529|Pregabalin|pregabalin|mesh-list
56931375|NCT01257529|Analgesics|analgesics|mesh-ancestor
56931376|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
56931377|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931378|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931379|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
56931380|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56931381|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931382|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931383|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56931384|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56931385|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56931386|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56931387|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56931388|NCT03896113|Celecoxib|celecoxib|mesh-list
56931389|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931390|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931391|NCT03896113|Analgesics|analgesics|mesh-ancestor
56931392|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
56931393|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931394|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931395|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931396|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931397|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56931398|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56931399|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931400|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931401|NCT03100838|Nifedipine|nifedipine|mesh-list
56931402|NCT03100838|Omeprazole|omeprazole|mesh-list
56931403|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56931404|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56931405|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56931406|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56931407|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931408|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931409|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56931410|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931411|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56931412|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931413|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
56931414|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
56931415|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56931416|NCT01260025|Endostatins|endostatins|mesh-list
56931417|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931418|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56931419|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56931420|NCT01260025|Growth Substances|growth substances|mesh-ancestor
56931421|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931422|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
56931423|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
56931424|NCT03984578|Capecitabine|capecitabine|mesh-list
56990933|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
56931425|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56931426|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931427|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56931428|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
56931429|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931430|NCT03892525|Atezolizumab|atezolizumab|mesh-list
56931431|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931432|NCT05418452|Metformin|metformin|mesh-list
56931433|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56931434|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931435|NCT01260103|Temozolomide|temozolomide|mesh-list
56931436|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56931437|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
56931438|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931439|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931440|NCT03480750|Carboplatin|carboplatin|mesh-list
56931441|NCT03480750|Doxorubicin|doxorubicin|mesh-list
56931442|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56931443|NCT03480750|Trientine|trientine|mesh-list
56931444|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931445|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56931446|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56931447|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56931448|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931449|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931450|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
56931451|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
56931452|NCT03892447|Ferulic acid|ferulic acid|mesh-list
56931453|NCT03892447|Dopamine|dopamine|mesh-list
56931454|NCT03892447|Alprostadil|alprostadil|mesh-list
56931455|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56931456|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
56931457|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
56931458|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931459|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931460|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
56931461|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931462|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931463|NCT03892447|Protective Agents|protective agents|mesh-ancestor
56931464|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56931465|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
56931466|NCT03892447|Urological Agents|urological agents|mesh-ancestor
56931467|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931468|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931469|NCT03892447|Analgesics|analgesics|mesh-ancestor
56931470|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
56931471|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931472|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931473|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
56931474|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56931475|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56931476|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56931477|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56931478|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
56931479|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
56931480|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
56931481|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56931482|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56931483|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
56931484|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931485|NCT05250596|Colchicine|colchicine|mesh-list
56931486|NCT05250596|Atorvastatin|atorvastatin|mesh-list
56931487|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56931488|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56931489|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
56931490|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931491|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56931492|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56931493|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931494|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
56931495|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931496|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
56931497|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
56931498|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
56931499|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931500|NCT04788914|Charcoal|charcoal|mesh-list
56931501|NCT04788914|Antidotes|antidotes|mesh-ancestor
56852378|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931502|NCT04788914|Protective Agents|protective agents|mesh-ancestor
56931503|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931504|NCT03716622|Clarithromycin|clarithromycin|mesh-list
56931505|NCT03716622|Furazolidone|furazolidone|mesh-list
56931506|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56931507|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931508|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56931509|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931510|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931511|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56931512|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56931513|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56931514|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56931515|NCT03716622|Renal Agents|renal agents|mesh-ancestor
56931516|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56931517|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56931518|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56931519|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56931520|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56931521|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
56931522|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931523|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56931524|NCT03892213|Benzonidazole|benzonidazole|mesh-list
56931525|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56931526|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
56931527|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931528|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56931529|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56931530|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56931531|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931532|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
56931533|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56931534|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931535|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
56931536|NCT01257919|Azelaic acid|azelaic acid|mesh-list
56931537|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931538|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931539|NCT04881032|Temozolomide|temozolomide|mesh-list
56931540|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56931541|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
56931542|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931543|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931544|NCT03891979|Metronidazole|metronidazole|mesh-list
56931545|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
56931546|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
56931547|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56931548|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931549|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931550|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56931551|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56931552|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56931553|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56931554|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56931555|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931556|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931557|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56931558|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56931559|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
56931560|NCT01260415|Panitumumab|panitumumab|mesh-list
56931561|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931562|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56931563|NCT04608344|Atorvastatin|atorvastatin|mesh-list
56931564|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56931565|NCT04608344|Pravastatin|pravastatin|mesh-list
56931566|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56931567|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56931568|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
56931569|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931570|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56931571|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56931572|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931573|NCT03891433|Meropenem|meropenem|mesh-list
56931574|NCT03891433|Tazobactam|tazobactam|mesh-list
56931575|NCT03891433|Piperacillin|piperacillin|mesh-list
56931576|NCT03891433|Ertapenem|ertapenem|mesh-list
56931577|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56931578|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931579|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56931580|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931581|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931582|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56931583|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931584|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56931585|NCT03895411|Sotalol|sotalol|mesh-list
56931586|NCT03895411|Propafenone|propafenone|mesh-list
56931587|NCT03895411|Metoprolol|metoprolol|mesh-list
56931588|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56931589|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56931590|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
56931591|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931592|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931593|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931594|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56931595|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
56931596|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
56931597|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931598|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56931599|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56931600|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931601|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56931602|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56931603|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56931604|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
56931605|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931606|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
56931607|NCT03891277|Hematinics|hematinics|mesh-ancestor
56931608|NCT03888157|Liraglutide|liraglutide|mesh-list
56931609|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56931610|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931611|NCT03888157|Incretins|incretins|mesh-ancestor
56931612|NCT03888157|Hormones|hormones|mesh-ancestor
56931613|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56931614|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
56931615|NCT01154491|Hematinics|hematinics|mesh-ancestor
56931616|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56931617|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931618|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56931619|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56931620|NCT02527603|Analgesics|analgesics|mesh-ancestor
56931621|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
56931622|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931623|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931624|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931625|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931626|NCT01259479|Satraplatin|satraplatin|mesh-list
56931627|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931628|NCT01260727|Vaccines|vaccines|mesh-list
56931629|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
56931630|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931631|NCT03890809|BMS-986165|bms-986165|mesh-list
56931632|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931633|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56931634|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931635|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931636|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
56931637|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56931638|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56931639|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56931640|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931641|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931642|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
56931643|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931644|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931645|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56931646|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931647|NCT01154569|Azithromycin|azithromycin|mesh-list
56931648|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56931649|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931650|NCT03891043|Selenium|selenium|mesh-list
56852530|NCT04939636|Vitamin D|vitamin d|mesh-list
56931651|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
56931652|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931653|NCT03891043|Protective Agents|protective agents|mesh-ancestor
56931654|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931655|NCT03891043|Trace Elements|trace elements|mesh-ancestor
56931656|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
56931657|NCT03890341|Drospirenone|drospirenone|mesh-list
56931658|NCT03890341|Midazolam|midazolam|mesh-list
56931659|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56931660|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56931661|NCT03890341|Betadex|betadex|mesh-list
56931662|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56919014|NCT00313222|Bosentan|bosentan|mesh-list
56931663|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56931664|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56931665|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931666|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56931667|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56931668|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56931669|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56931670|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
56931671|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
56931672|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
56931673|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
56931674|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931675|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931676|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56931677|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56931678|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56931679|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
56931680|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56931681|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56931682|NCT03890341|Estrogens|estrogens|mesh-ancestor
56931683|NCT03890341|Hormones|hormones|mesh-ancestor
56931684|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56931685|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56931686|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
56931687|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56931688|NCT03890341|Diuretics|diuretics|mesh-ancestor
56931689|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
56931690|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
56931691|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
56931692|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56931693|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56931694|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56931695|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931696|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931697|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
56931698|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931699|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931700|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56931701|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931702|NCT03894085|Paroxetine|paroxetine|mesh-list
56931703|NCT03894085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56931704|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56931705|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931706|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931707|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931708|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
56931709|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931710|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56931711|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
56931712|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56931713|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56931714|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56931715|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931716|NCT01152931|Vitamins|vitamins|mesh-list
56931717|NCT01152931|Vitamin E|vitamin e|mesh-list
56931718|NCT01152931|Tocopherols|tocopherols|mesh-list
56931719|NCT01152931|Tocotrienols|tocotrienols|mesh-list
56931720|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
56931721|NCT01152931|Vitamin A|vitamin a|mesh-list
56931722|NCT01152931|Zinc|zinc|mesh-list
56931723|NCT01152931|Selenium|selenium|mesh-list
56931724|NCT01152931|Artesunate|artesunate|mesh-list
56931725|NCT01152931|Lumefantrine|lumefantrine|mesh-list
56931726|NCT01152931|Artemether|artemether|mesh-list
56931727|NCT01152931|Amodiaquine|amodiaquine|mesh-list
56931728|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
56931729|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
56931730|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931731|NCT01152931|Trace Elements|trace elements|mesh-ancestor
56931732|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
56931733|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931734|NCT01152931|Protective Agents|protective agents|mesh-ancestor
56931735|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
56931736|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56931737|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56931738|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931739|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931740|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
56931741|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
56931742|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56931743|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
56931744|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56931745|NCT01261117|Ibuprofen|ibuprofen|mesh-list
56931746|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931747|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931748|NCT01261117|Analgesics|analgesics|mesh-ancestor
56931749|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
56931750|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931751|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931752|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931753|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931754|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56931755|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931756|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931757|NCT03889717|Vitamin D|vitamin d|mesh-list
56931758|NCT03889717|Vitamins|vitamins|mesh-ancestor
56931759|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
56931760|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931761|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56931762|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
56931763|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56931764|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56931765|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931766|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
56931767|NCT03885895|Coagulants|coagulants|mesh-ancestor
56931768|NCT01154647|Citalopram|citalopram|mesh-list
56931769|NCT01154647|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56931770|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56931771|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931772|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931773|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931774|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
56931775|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931776|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56931777|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
56931778|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56931779|NCT01153165|Citalopram|citalopram|mesh-list
56931780|NCT01153165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56931781|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56931782|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931783|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931784|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931785|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
56931786|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931787|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56931788|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
56931789|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56931790|NCT01155505|Lenalidomide|lenalidomide|mesh-list
56931791|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
56931792|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931793|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56931794|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56931795|NCT01155505|Growth Substances|growth substances|mesh-ancestor
56931796|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
56931797|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931798|NCT01153243|Vitamin D|vitamin d|mesh-list
56931799|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
56931800|NCT01153243|Vitamins|vitamins|mesh-ancestor
56931801|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
56931802|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931803|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56931804|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56931805|NCT03432858|Vancomycin|vancomycin|mesh-list
56931806|NCT03432858|Cefazolin|cefazolin|mesh-list
56931807|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56931808|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931809|NCT05659914|Durvalumab|durvalumab|mesh-list
56931810|NCT05659914|Olaparib|olaparib|mesh-list
56931811|NCT05659914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56931812|NCT05659914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931813|NCT05659914|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56931814|NCT05659914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931815|NCT05659914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919156|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
56931816|NCT01154803|Micronutrients|micronutrients|mesh-list
56931817|NCT01154803|Trace Elements|trace elements|mesh-list
56931818|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931819|NCT03885427|Ketamine|ketamine|mesh-list
56931820|NCT03885427|Analgesics|analgesics|mesh-ancestor
56931821|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
56931822|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931823|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931824|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56931825|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56931826|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
56931827|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
56931828|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56931829|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56931830|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56931831|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931832|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931833|NCT03456960|Aspirin|aspirin|mesh-list
56931834|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931835|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931836|NCT03456960|Analgesics|analgesics|mesh-ancestor
56931837|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
56931838|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931839|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931840|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931841|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931842|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56931843|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56931844|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931845|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56931846|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56931847|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931848|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
56931849|NCT03716388|Mesalamine|mesalamine|mesh-list
56931850|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931851|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931852|NCT03716388|Analgesics|analgesics|mesh-ancestor
56931853|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
56931854|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931855|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931856|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931857|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931858|NCT01311336|Loratadine|loratadine|mesh-list
56931859|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
56931860|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931861|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56931862|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56931863|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56931864|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
56931865|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
56931866|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931867|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931868|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931869|NCT03430986|Lidocaine|lidocaine|mesh-list
56931870|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
56931871|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
56931872|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56931873|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931874|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
56931875|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931876|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56931877|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56931878|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56931879|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56931880|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931881|NCT01261741|Memantine|memantine|mesh-list
56931882|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56931883|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56931884|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
56931885|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931886|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931887|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931888|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56931889|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56931890|NCT05645718|Cytarabine|cytarabine|mesh-list
56931891|NCT05645718|Dexamethasone|dexamethasone|mesh-list
56931892|NCT05645718|Prednisone|prednisone|mesh-list
56931893|NCT05645718|Cyclophosphamide|cyclophosphamide|mesh-list
56931894|NCT05645718|Rituximab|rituximab|mesh-list
56931895|NCT05645718|Methotrexate|methotrexate|mesh-list
56931896|NCT05645718|Vincristine|vincristine|mesh-list
56931897|NCT05645718|Mercaptopurine|mercaptopurine|mesh-list
56931898|NCT05645718|Blinatumomab|blinatumomab|mesh-list
56931899|NCT05645718|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56931900|NCT05645718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56931901|NCT05645718|Immunologic Factors|immunologic factors|mesh-ancestor
56931902|NCT05645718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931903|NCT05645718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931904|NCT05645718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56931905|NCT05645718|Alkylating Agents|alkylating agents|mesh-ancestor
56931906|NCT05645718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931907|NCT05645718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931908|NCT05645718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56931909|NCT05645718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56931910|NCT05645718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931911|NCT05645718|Antiemetics|antiemetics|mesh-ancestor
56931912|NCT05645718|Autonomic Agents|autonomic agents|mesh-ancestor
56931913|NCT05645718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931914|NCT05645718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56931915|NCT05645718|Glucocorticoids|glucocorticoids|mesh-ancestor
56931916|NCT05645718|Hormones|hormones|mesh-ancestor
56931917|NCT05645718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56931918|NCT05645718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56931919|NCT05645718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56931920|NCT05645718|Abortifacient Agents|abortifacient agents|mesh-ancestor
56931921|NCT05645718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56931922|NCT05645718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56931923|NCT05645718|Antimetabolites|antimetabolites|mesh-ancestor
56931924|NCT05645718|Dermatologic Agents|dermatologic agents|mesh-ancestor
56931925|NCT05645718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931926|NCT05645718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56931927|NCT05645718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56931928|NCT05645718|Antiviral Agents|antiviral agents|mesh-ancestor
56931929|NCT05645718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931930|NCT05645718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56931931|NCT05645718|Tubulin Modulators|tubulin modulators|mesh-ancestor
56931932|NCT05645718|Antimitotic Agents|antimitotic agents|mesh-ancestor
56931933|NCT05645718|Mitosis Modulators|mitosis modulators|mesh-ancestor
56931934|NCT05645718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56931935|NCT01157455|Aspirin|aspirin|mesh-list
56931936|NCT01157455|Everolimus|everolimus|mesh-list
56931937|NCT01157455|Heparin|heparin|mesh-list
56931938|NCT01157455|Bivalirudin|bivalirudin|mesh-list
56931939|NCT01157455|Clopidogrel|clopidogrel|mesh-list
56931940|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56931941|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56931942|NCT01157455|Analgesics|analgesics|mesh-ancestor
56931943|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
56931944|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931945|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931946|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931947|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56931948|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56931949|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56931950|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931951|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56931952|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56931953|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931954|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
56931955|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56931956|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56931957|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
56931958|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56931959|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56931960|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56931961|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
56931962|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56931963|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
56931964|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
56919304|NCT00065728|Anecortave|anecortave|mesh-list
56931965|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56931966|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
56931967|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56931968|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931969|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931971|NCT03884881|Imipenem|imipenem|mesh-list
56931972|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56931973|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931974|NCT01154881|Insulin|insulin|mesh-list
56931975|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56931976|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931977|NCT03886441|Beclomethasone|beclomethasone|mesh-list
56931978|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56931979|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
56931980|NCT03886441|Hormones|hormones|mesh-ancestor
56931981|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56931982|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931983|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56931984|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
56931985|NCT03713346|Caseins|caseins|mesh-list
56931986|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
56931987|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
56931988|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931989|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
56931990|NCT01154959|Rifampin|rifampin|mesh-list
56931991|NCT01154959|Isoniazid|isoniazid|mesh-list
56931992|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
56931993|NCT01154959|Ethambutol|ethambutol|mesh-list
56931994|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56931995|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56931996|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56931997|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56931998|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56931999|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932000|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932001|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56932002|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
56932003|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
56932004|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56932005|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56932006|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56932007|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56932008|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56932009|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56932010|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56932011|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56932012|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56932013|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
56932014|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56932015|NCT03881293|Lidocaine|lidocaine|mesh-list
56932016|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
56932017|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
56932018|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932019|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932020|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
56932021|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932022|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56932023|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56932024|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56932025|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56932026|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932027|NCT01155037|Vaccines|vaccines|mesh-list
56932028|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
56932029|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932030|NCT01261897|Ropivacaine|ropivacaine|mesh-list
56932031|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
56932032|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
56932033|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932034|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932035|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
56932036|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932037|NCT03448536|Acetaminophen|acetaminophen|mesh-list
56932038|NCT03448536|Naproxen|naproxen|mesh-list
56932039|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56932040|NCT03448536|Analgesics|analgesics|mesh-ancestor
56932041|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
56932042|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932043|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932044|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
56932045|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56932046|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932047|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56932048|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
56932049|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56932050|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932051|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932052|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
56932053|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56932054|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
56932055|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932056|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932057|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56932058|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
56932059|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56932060|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
56932061|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932062|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932063|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56932064|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
56932065|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
56932066|NCT01155115|Protective Agents|protective agents|mesh-ancestor
56932067|NCT03713190|Empagliflozin|empagliflozin|mesh-list
56932068|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56932069|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932070|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56932071|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932072|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
56932073|NCT03718182|Vitamin D|vitamin d|mesh-list
56932074|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56932075|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932076|NCT03718182|Vitamins|vitamins|mesh-ancestor
56932077|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
56932078|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56932079|NCT03881449|Aripiprazole|aripiprazole|mesh-list
56932080|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
56932081|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56932082|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56932083|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56932084|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932085|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932086|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
56932087|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
56932088|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932089|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932090|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56932091|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56932092|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
56932093|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56932094|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56932095|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56932096|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56932097|NCT03884491|Vortioxetine|vortioxetine|mesh-list
56932098|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
56932099|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56932100|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56932101|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56932102|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932103|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932104|NCT03884491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56932105|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56932106|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56932107|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932108|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932109|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
56932110|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56932111|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56932112|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56932113|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56932114|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56932115|NCT03712956|Doxorubicin|doxorubicin|mesh-list
56932116|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56932117|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932118|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56932119|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56932120|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932121|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932122|NCT03880981|Acetaminophen|acetaminophen|mesh-list
56932124|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56932125|NCT03880981|Analgesics|analgesics|mesh-ancestor
56932126|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
56932127|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932128|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932129|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
56932130|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56932131|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932132|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56932133|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56932134|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932135|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932136|NCT03424044|Glucagon|glucagon|mesh-list
56932137|NCT03424044|Pancrelipase|pancrelipase|mesh-list
56932138|NCT03424044|Pancreatin|pancreatin|mesh-list
56932139|NCT03424044|Hormones|hormones|mesh-list
56932140|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932141|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932142|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56932143|NCT03880903|Albuterol|albuterol|mesh-list
56932144|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56932145|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
56932146|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932147|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932148|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56932149|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
56932150|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
56932151|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56932152|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56932153|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56932154|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56932155|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
56932156|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932157|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932158|NCT01155895|Amlodipine|amlodipine|mesh-list
56932159|NCT01155895|Benazepril|benazepril|mesh-list
56932160|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56932161|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56932162|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56932163|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932164|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56932165|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932166|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
56932167|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56932168|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
56932169|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932170|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
56932171|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56932172|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932173|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56932174|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56932175|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932176|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932177|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932178|NCT01589809|Niacinamide|niacinamide|mesh-list
56932179|NCT01589809|Niacin|niacin|mesh-list
56932180|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
56932181|NCT01589809|Vitamins|vitamins|mesh-ancestor
56932182|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
56932183|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932184|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
56932185|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56932186|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
56932187|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919526|NCT03147248|Infliximab|infliximab|mesh-list
56932188|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56932189|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
56932190|NCT01264237|Etoricoxib|etoricoxib|mesh-list
56932191|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56932192|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56932193|NCT01264237|Analgesics|analgesics|mesh-ancestor
56932194|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
56932195|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932196|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932197|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932198|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56932199|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56932200|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56932201|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932202|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932203|NCT03880825|Metformin|metformin|mesh-list
56932204|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56932205|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932206|NCT01159639|Clopidogrel|clopidogrel|mesh-list
56932207|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56932208|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56932209|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56932210|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56932211|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
56932212|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932213|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932214|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932215|NCT03880357|Betamethasone|betamethasone|mesh-list
56932216|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
56932217|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56932218|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
56932219|NCT03880357|Calcipotriene|calcipotriene|mesh-list
56932220|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56932221|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932222|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
56932223|NCT03880357|Hormones|hormones|mesh-ancestor
56932224|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932225|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932226|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56932227|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
56932228|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
56932229|NCT01264315|Lenalidomide|lenalidomide|mesh-list
56932230|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
56932231|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932232|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56932233|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56932234|NCT01264315|Growth Substances|growth substances|mesh-ancestor
56932235|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
56932236|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932237|NCT01266031|Bevacizumab|bevacizumab|mesh-list
56932238|NCT01266031|Vorinostat|vorinostat|mesh-list
56932239|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56932240|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932241|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56932242|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56932243|NCT01266031|Growth Substances|growth substances|mesh-ancestor
56932244|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932245|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
56932246|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56932247|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932248|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932249|NCT03880045|Vasopressins|vasopressins|mesh-list
56932250|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
56932251|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
56932252|NCT03880045|Coagulants|coagulants|mesh-ancestor
56932253|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56932254|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56932255|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
56932256|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932257|NCT03879889|Nicotine|nicotine|mesh-list
56932258|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56932259|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
56932260|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919604|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
56932261|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932262|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56932263|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56932264|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
56932265|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932266|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932268|NCT01266187|Cetuximab|cetuximab|mesh-list
56932269|NCT01266187|Fluorouracil|fluorouracil|mesh-list
56932270|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
56932271|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56932272|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932273|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
56932274|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932275|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56932276|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56932277|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
56932278|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932279|NCT01266187|Antidotes|antidotes|mesh-ancestor
56932280|NCT01266187|Protective Agents|protective agents|mesh-ancestor
56932281|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
56932282|NCT01266187|Vitamins|vitamins|mesh-ancestor
56932283|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
56932284|NCT01586533|Mesalamine|mesalamine|mesh-list
56932285|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56932286|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56932287|NCT01586533|Analgesics|analgesics|mesh-ancestor
56932288|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
56932289|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932290|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932291|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932292|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56932293|NCT03880123|Ixazomib|ixazomib|mesh-list
56932294|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932295|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
56932296|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932297|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932298|NCT01266499|Colistin|colistin|mesh-list
56932299|NCT01266499|Polymyxins|polymyxins|mesh-list
56932300|NCT01266499|Gentamicins|gentamicins|mesh-list
56932301|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56932302|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932303|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56932304|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932305|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932306|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
56932307|NCT00075725|Leucovorin|leucovorin|mesh-list
56932308|NCT00075725|Folic Acid|folic acid|mesh-list
56932309|NCT00075725|Cytarabine|cytarabine|mesh-list
56932310|NCT00075725|Dexamethasone|dexamethasone|mesh-list
56932311|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
56932312|NCT00075725|Prednisone|prednisone|mesh-list
56932313|NCT00075725|Cortisone|cortisone|mesh-list
56932314|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
56932315|NCT00075725|Doxorubicin|doxorubicin|mesh-list
56932316|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56932317|NCT00075725|Methotrexate|methotrexate|mesh-list
56932318|NCT00075725|Vincristine|vincristine|mesh-list
56932319|NCT00075725|Daunorubicin|daunorubicin|mesh-list
56932320|NCT00075725|Asparaginase|asparaginase|mesh-list
56932321|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
56932322|NCT00075725|Pegaspargase|pegaspargase|mesh-list
56932323|NCT00075725|Thioguanine|thioguanine|mesh-list
56932324|NCT00075725|BB 1101|bb 1101|mesh-list
56932325|NCT00075725|Calcium|calcium|mesh-list
56932326|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
56932327|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
56932328|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56932329|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
56932330|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932331|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56932332|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56932333|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
56932334|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932335|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919678|NCT03531970|Hormones|hormones|mesh-ancestor
56932336|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56932337|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932338|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
56932339|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
56932340|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932341|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56932342|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
56932344|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932345|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56932346|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
56932347|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932348|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56932349|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56932350|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56932351|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56932352|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56932353|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56932354|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
56932355|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56932356|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56932357|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
56932358|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
56932359|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56932360|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56932361|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
56932362|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932363|NCT00075725|Antidotes|antidotes|mesh-ancestor
56932364|NCT00075725|Protective Agents|protective agents|mesh-ancestor
56932365|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
56932366|NCT00075725|Vitamins|vitamins|mesh-ancestor
56932367|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
56932368|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56932369|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
56932370|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
56932371|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
56932372|NCT00075725|Hematinics|hematinics|mesh-ancestor
56932373|NCT02953782|Cetuximab|cetuximab|mesh-list
56932374|NCT02953782|Magrolimab|magrolimab|mesh-list
56932375|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56932376|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932377|NCT01264783|RNS60|rns60|mesh-list
56932378|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56932379|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56932380|NCT01264783|Analgesics|analgesics|mesh-ancestor
56932381|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
56932382|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932383|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932384|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932385|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56932386|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56932387|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56932388|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
56932389|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56932390|NCT01160029|Nateglinide|nateglinide|mesh-list
56932391|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56932392|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932393|NCT00057863|Paclitaxel|paclitaxel|mesh-list
56932394|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
56932395|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56932396|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932397|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
56932398|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
56932399|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
56932400|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932401|NCT01266655|Baclofen|baclofen|mesh-list
56932402|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56932403|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932404|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56932405|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853275|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56932406|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56932407|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
56932408|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
56932409|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932410|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932411|NCT00075023|Thalidomide|thalidomide|mesh-list
56932412|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56932413|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
56932414|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932415|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
56932416|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56932417|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932418|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56932419|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56932420|NCT00075023|Growth Substances|growth substances|mesh-ancestor
56932421|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
56932422|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932423|NCT01100801|Cisplatin|cisplatin|mesh-list
56932424|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
56932425|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932426|NCT01263145|Paclitaxel|paclitaxel|mesh-list
56932427|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56932428|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932429|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
56932430|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
56932431|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
56932432|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932433|NCT03717558|Ivermectin|ivermectin|mesh-list
56932434|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56932435|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932436|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
56932437|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
56932438|NCT00074711|Calcium|calcium|mesh-list
56932439|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56932440|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932441|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56932442|NCT00074711|Antacids|antacids|mesh-ancestor
56932443|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932444|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56932445|NCT03960905|Meropenem|meropenem|mesh-list
56932446|NCT03960905|Ceftazidime|ceftazidime|mesh-list
56932447|NCT03960905|Cefepime|cefepime|mesh-list
56932448|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
56932449|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56932450|NCT05619120|Mexiletine|mexiletine|mesh-list
56932451|NCT05619120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56932452|NCT05619120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56932453|NCT05619120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56932454|NCT05619120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56932455|NCT05619120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932456|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
56932457|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56932458|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56932459|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56932460|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56932461|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56932462|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56932463|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
56932464|NCT01265017|Estradiol|estradiol|mesh-list
56932465|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56932466|NCT01265017|Hormones|hormones|mesh-ancestor
56932467|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932468|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932469|NCT01265017|Estrogens|estrogens|mesh-ancestor
56932470|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56932471|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
56932472|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56932473|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56932474|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932475|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56932476|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56932477|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56932478|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56932479|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56932480|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932481|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56932482|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
56932483|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932484|NCT05036317|Empagliflozin|empagliflozin|mesh-list
56932485|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56932486|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932487|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56932488|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932489|NCT03879811|Nivolumab|nivolumab|mesh-list
56932490|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56932491|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932492|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56932493|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932494|NCT01158859|Pregabalin|pregabalin|mesh-list
56932495|NCT01158859|Analgesics|analgesics|mesh-ancestor
56932496|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
56932497|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932498|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932499|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
56932500|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56932501|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56932502|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932503|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56932504|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56932505|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56932506|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932507|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56932508|NCT01100021|Doxazosin|doxazosin|mesh-list
56932509|NCT01100021|Tamsulosin|tamsulosin|mesh-list
56932510|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56932511|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56932512|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56932513|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
56932514|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932515|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932516|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932517|NCT01100021|Urological Agents|urological agents|mesh-ancestor
56932518|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56932519|NCT03407430|Pregabalin|pregabalin|mesh-list
56932520|NCT03407430|Analgesics|analgesics|mesh-ancestor
56932521|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
56932522|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932523|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932524|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
56932525|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56932526|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56932527|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932528|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56932529|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56932530|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56932531|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932532|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56932533|NCT01266811|Dexamethasone|dexamethasone|mesh-list
56932534|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
56932535|NCT01266811|Bortezomib|bortezomib|mesh-list
56932536|NCT01266811|Siltuximab|siltuximab|mesh-list
56932537|NCT01266811|BB 1101|bb 1101|mesh-list
56932538|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932539|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
56932540|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
56932541|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932542|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932543|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56932544|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
56932545|NCT01266811|Hormones|hormones|mesh-ancestor
56932546|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932547|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56932548|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932549|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
56932550|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932551|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932552|NCT01158937|Meropenem|meropenem|mesh-list
56932553|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56932554|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932555|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
56932556|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56932557|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932558|NCT01100177|Sunitinib|sunitinib|mesh-list
56932559|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932560|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56932561|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56932562|NCT01100177|Growth Substances|growth substances|mesh-ancestor
56932563|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932564|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
56932565|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56932566|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630640|NCT02743572|Iron|iron|mesh-list
56932567|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932568|NCT01100333|Hormones|hormones|mesh-list
56932569|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56932570|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932571|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932572|NCT01327235|Cisplatin|cisplatin|mesh-list
56932573|NCT01327235|Endostar protein|endostar protein|mesh-list
56932574|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932575|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56932576|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56932577|NCT01327235|Growth Substances|growth substances|mesh-ancestor
56932578|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932579|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
56932580|NCT03406260|Lasmiditan|lasmiditan|mesh-list
56932581|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56932582|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
56932583|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932584|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932585|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932586|NCT01089179|Metformin|metformin|mesh-list
56932587|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56932588|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932589|NCT01160185|Paclitaxel|paclitaxel|mesh-list
56932590|NCT01160185|Topotecan|topotecan|mesh-list
56932591|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56932592|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932593|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
56932594|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
56932595|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
56932596|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932597|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56932598|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56932599|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932600|NCT03419364|Niacinamide|niacinamide|mesh-list
56932601|NCT03419364|Niacin|niacin|mesh-list
56932602|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
56932603|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
56932604|NCT03419364|Vitamins|vitamins|mesh-ancestor
56932605|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
56932606|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932607|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56932608|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
56932609|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932610|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56932611|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
56932612|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
56932613|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
56932614|NCT01265173|Cefotaxime|cefotaxime|mesh-list
56932615|NCT01265173|Cefoxitin|cefoxitin|mesh-list
56932616|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56932617|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932618|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56932619|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56932620|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932621|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932622|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932623|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56932624|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56932625|NCT01159327|Sorafenib|sorafenib|mesh-list
56932626|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932627|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56932628|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990934|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
56932629|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932630|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
56932631|NCT01160341|Testosterone|testosterone|mesh-list
56932632|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
56932633|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
56932634|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56932635|NCT01160341|Androgens|androgens|mesh-ancestor
56932636|NCT01160341|Hormones|hormones|mesh-ancestor
56932637|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932638|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932639|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56932640|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932641|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
56932642|NCT03882775|Heparin|heparin|mesh-list
56932644|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
56932645|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56932646|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56932647|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932648|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
56932649|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56932650|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
56932651|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932652|NCT03877705|Listerine|listerine|mesh-list
56932653|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
56932654|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56932655|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932656|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
56932657|NCT03877705|Protective Agents|protective agents|mesh-ancestor
56932658|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932659|NCT01160419|Leucovorin|leucovorin|mesh-list
56932660|NCT01160419|Folic Acid|folic acid|mesh-list
56932661|NCT01160419|Docetaxel|docetaxel|mesh-list
56932662|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
56932663|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
56932664|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932665|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
56932666|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
56932667|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
56932668|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932669|NCT01160419|Antidotes|antidotes|mesh-ancestor
56932670|NCT01160419|Protective Agents|protective agents|mesh-ancestor
56932671|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932672|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
56932673|NCT01160419|Vitamins|vitamins|mesh-ancestor
56932674|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
56932675|NCT01160419|Hematinics|hematinics|mesh-ancestor
56932676|NCT02954172|Paclitaxel|paclitaxel|mesh-list
56932677|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56932678|NCT02954172|Bevacizumab|bevacizumab|mesh-list
56932679|NCT02954172|Carboplatin|carboplatin|mesh-list
56932680|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56932681|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932682|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
56932683|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
56932684|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
56932685|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932686|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56932687|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56932688|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56932689|NCT02954172|Growth Substances|growth substances|mesh-ancestor
56932690|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932691|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
56932692|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
56932693|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932694|NCT02953938|Ranibizumab|ranibizumab|mesh-list
56932695|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56932696|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56932697|NCT02953938|Growth Substances|growth substances|mesh-ancestor
56932698|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932699|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
56932700|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932701|NCT01161667|Naratriptan|naratriptan|mesh-list
56932702|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56932703|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56932704|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56932705|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
56932706|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990935|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56932707|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932708|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932709|NCT02526979|Mirabegron|mirabegron|mesh-list
56932710|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56932711|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56932712|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56932713|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
56932714|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932715|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932716|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932717|NCT02526979|Urological Agents|urological agents|mesh-ancestor
56932718|NCT03882541|Midazolam|midazolam|mesh-list
56932719|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56932720|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56932721|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932722|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932723|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56932724|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56932725|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56932726|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56932727|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
56932728|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
56932729|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
56932730|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
56932731|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932732|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932733|NCT01267903|Vaccines|vaccines|mesh-list
56932734|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
56932735|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932736|NCT03576313|Ivermectin|ivermectin|mesh-list
56932737|NCT03576313|Piperaquine|piperaquine|mesh-list
56932738|NCT03576313|Artenimol|artenimol|mesh-list
56932739|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56932740|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932741|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
56932742|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56932743|NCT01161979|Zonisamide|zonisamide|mesh-list
56932744|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
56932745|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56932746|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56932747|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932748|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56932749|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932750|NCT01160731|Etoposide|etoposide|mesh-list
56932751|NCT01160731|Panobinostat|panobinostat|mesh-list
56932752|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
56932753|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932754|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56932755|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56932756|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56932757|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932758|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932759|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56932760|NCT01160965|Ropivacaine|ropivacaine|mesh-list
56932761|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
56932762|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
56932763|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
56932764|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932765|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932766|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
56932767|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932768|NCT01156909|Rituximab|rituximab|mesh-list
56932769|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56932770|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932771|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
56932772|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932773|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56932774|NCT01162603|Latanoprost|latanoprost|mesh-list
56932775|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56932776|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56932777|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
56932778|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56932779|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932780|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
56932781|NCT02527213|Antidotes|antidotes|mesh-ancestor
56932782|NCT02527213|Protective Agents|protective agents|mesh-ancestor
56932783|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932784|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
56932785|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932786|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
56932787|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56932788|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932789|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
56932790|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
56932791|NCT01161277|Haloperidol|haloperidol|mesh-list
56932792|NCT01161277|Aripiprazole|aripiprazole|mesh-list
56920223|NCT01115725|Hormones|hormones|mesh-ancestor
56932793|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
56932794|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
56932795|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56932796|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56932798|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932799|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932800|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
56932801|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
56932802|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932803|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932804|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56932805|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56932806|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
56932807|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56932808|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56932809|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56932810|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56932811|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
56932812|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
56932813|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932814|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56932815|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56932816|NCT01268215|Budesonide|budesonide|mesh-list
56932817|NCT01268215|Calfactant|calfactant|mesh-list
56932818|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932819|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56932820|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
56932821|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932822|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932823|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56932824|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
56932825|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
56932826|NCT01268215|Hormones|hormones|mesh-ancestor
56932827|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932828|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56932829|NCT01269307|Ketamine|ketamine|mesh-list
56932830|NCT01269307|Propofol|propofol|mesh-list
56932831|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56932832|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932833|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932834|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56932835|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
56932836|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
56932837|NCT01269307|Analgesics|analgesics|mesh-ancestor
56932838|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
56932839|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932840|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56932841|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56932842|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56932843|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932844|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932845|NCT03874585|Nicotine|nicotine|mesh-list
56932846|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56932847|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
56932848|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932849|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932850|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56932851|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56932852|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
56932853|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932854|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932855|NCT01268371|Everolimus|everolimus|mesh-list
56932856|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932857|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56932858|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
56932859|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932860|NCT01267669|Somatostatin|somatostatin|mesh-list
56932861|NCT01267669|Hormones|hormones|mesh-ancestor
56932862|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932863|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932864|NCT05666869|Esketamine|esketamine|mesh-list
56932865|NCT05666869|Antidepressive Agents|antidepressive agents|mesh-ancestor
56932866|NCT05666869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56932867|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56932868|NCT01164943|Hormones|hormones|mesh-ancestor
56932869|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920265|NCT01216579|Mannitol|mannitol|mesh-list
56932870|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932871|NCT01269541|Rifampin|rifampin|mesh-list
56932872|NCT01269541|Mupirocin|mupirocin|mesh-list
56932873|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56932874|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
56932875|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56932876|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932877|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
56932878|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56932879|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932880|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932881|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56932882|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56932883|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56932884|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56932885|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56932886|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56932887|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56932888|NCT03877003|Choline|choline|mesh-list
56932889|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
56932890|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56932891|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
56932892|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932893|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56932894|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56932895|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
56932896|NCT01280149|Substance P|substance p|mesh-list
56932897|NCT01280149|Neurokinin A|neurokinin a|mesh-list
56932898|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932899|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932900|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932901|NCT01165255|Bupropion|bupropion|mesh-list
56932902|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
56932903|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56932904|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56932905|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56932906|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56932907|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56932908|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932909|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
56932910|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932911|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932912|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56932913|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56932914|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932915|NCT01167049|Capecitabine|capecitabine|mesh-list
56932916|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56932917|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
56932918|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932919|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932920|NCT01311414|Urapidil|urapidil|mesh-list
56932921|NCT01311414|Cafedrine|cafedrine|mesh-list
56932922|NCT01311414|Theodrenaline|theodrenaline|mesh-list
56932923|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56932924|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
56932925|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56932926|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
56932927|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56932928|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932929|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853810|NCT03897452|Fentanyl|fentanyl|mesh-list
56932930|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56932931|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56932932|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56932933|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
56932934|NCT03715296|Lenalidomide|lenalidomide|mesh-list
56932935|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
56932936|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932937|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56932938|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56932939|NCT03715296|Growth Substances|growth substances|mesh-ancestor
56932940|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
56932941|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932942|NCT01347762|Nabilone|nabilone|mesh-list
56932943|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
56932944|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
56932945|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932946|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932947|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56932948|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56932949|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56932950|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932951|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56932952|NCT03874273|Crizotinib|crizotinib|mesh-list
56932953|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932954|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56932955|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56932956|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932957|NCT05657652|Cytarabine|cytarabine|mesh-list
56932958|NCT05657652|Venetoclax|venetoclax|mesh-list
56932959|NCT05657652|Cladribine|cladribine|mesh-list
56932960|NCT05657652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56932961|NCT05657652|Antimetabolites|antimetabolites|mesh-ancestor
56932962|NCT05657652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932963|NCT05657652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56932964|NCT05657652|Antiviral Agents|antiviral agents|mesh-ancestor
56932965|NCT05657652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56932966|NCT05657652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56932967|NCT05657652|Immunologic Factors|immunologic factors|mesh-ancestor
56932968|NCT05657652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932969|NCT01167127|Oxycodone|oxycodone|mesh-list
56932970|NCT01167127|Naloxone|naloxone|mesh-list
56932971|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56932972|NCT01167127|Narcotics|narcotics|mesh-ancestor
56932973|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56932974|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932975|NCT01167127|Analgesics|analgesics|mesh-ancestor
56932976|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
56932977|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56932978|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56932979|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56932980|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56932981|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
56932982|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56932983|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932984|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56932985|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56932986|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56932987|NCT03872011|Vitamins|vitamins|mesh-list
56932988|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
56932989|NCT03872011|Thiamine|thiamine|mesh-list
56932990|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
56932991|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
56932992|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56932993|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56932994|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
56932995|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56932996|NCT03872011|Protective Agents|protective agents|mesh-ancestor
56932997|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
56932998|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
56932999|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56933000|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933001|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
56933002|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56933003|NCT01163929|Paclitaxel|paclitaxel|mesh-list
56933004|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56933005|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933006|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
56933007|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
56933008|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
56933009|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933010|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
56933011|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56933012|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933013|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
56933014|NCT00073307|Sorafenib|sorafenib|mesh-list
56933015|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933016|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56933017|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933018|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933019|NCT01270789|Liraglutide|liraglutide|mesh-list
56933020|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56933021|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933022|NCT01270789|Incretins|incretins|mesh-ancestor
56933023|NCT01270789|Hormones|hormones|mesh-ancestor
56933024|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933025|NCT01164085|Ketorolac|ketorolac|mesh-list
56933026|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56933027|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56933028|NCT01164085|Analgesics|analgesics|mesh-ancestor
56933029|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
56933030|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933031|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933032|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933033|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56933034|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56933035|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933036|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933037|NCT01271179|Insulin|insulin|mesh-list
56933038|NCT01271179|Allopurinol|allopurinol|mesh-list
56933039|NCT01271179|Adenosine|adenosine|mesh-list
56933040|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56933041|NCT01271179|Analgesics|analgesics|mesh-ancestor
56933042|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
56933043|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933044|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933045|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56933046|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
56933047|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56933048|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
56933049|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
56933050|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933051|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933052|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
56933053|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933054|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
56933055|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56933056|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56933057|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
56933058|NCT01271179|Protective Agents|protective agents|mesh-ancestor
56933059|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56933060|NCT03388164|Dexetimide|dexetimide|mesh-list
56933061|NCT03388164|Citalopram|citalopram|mesh-list
56933062|NCT03388164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56933063|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56933064|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56933065|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933066|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933067|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
56933068|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933069|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56933070|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
56933071|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56933072|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56933073|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56933074|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
56933075|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
56933076|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933077|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56933078|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56933079|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
56933080|NCT01268761|Cetrorelix|cetrorelix|mesh-list
56933081|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56933082|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
56933083|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56933084|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933085|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
56933086|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933087|NCT01268839|Efavirenz|efavirenz|mesh-list
56933088|NCT01268839|Rilpivirine|rilpivirine|mesh-list
56933089|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56933090|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56933091|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933092|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933093|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
56933094|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933095|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56933096|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56933097|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56933098|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56933099|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56933100|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56933101|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56933102|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56933103|NCT03403374|Evolocumab|evolocumab|mesh-list
56933104|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56933105|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56933106|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
56933107|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933108|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56933109|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
56933110|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56933111|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56933112|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933113|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56933114|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56933115|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
56933116|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933117|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933118|NCT03387462|Tenofovir|tenofovir|mesh-list
56933119|NCT03387462|Emtricitabine|emtricitabine|mesh-list
56933120|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
56933121|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933122|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56933123|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56933124|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933125|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933126|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56933127|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56933128|NCT03756883|Fluticasone|fluticasone|mesh-list
56933129|NCT03756883|Xhance|xhance|mesh-list
56933130|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56933131|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56933132|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933133|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56933134|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
56933135|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933136|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933137|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56933138|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
56933139|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
56933140|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56933141|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56933142|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56933143|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56933144|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
56933145|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933146|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933147|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
56933148|NCT03756883|Hormones|hormones|mesh-ancestor
56933149|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933150|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
56933151|NCT01586611|Leucovorin|leucovorin|mesh-list
56933152|NCT01586611|Gemcitabine|gemcitabine|mesh-list
56933153|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
56933154|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56933155|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
56933156|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933157|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933158|NCT01586611|Antiviral Agents|antiviral agents|mesh-ancestor
56933159|NCT01586611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933160|NCT01586611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933161|NCT01586611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56933162|NCT01586611|Immunologic Factors|immunologic factors|mesh-ancestor
56933163|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933164|NCT01586611|Antidotes|antidotes|mesh-ancestor
56933165|NCT01586611|Protective Agents|protective agents|mesh-ancestor
56933166|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
56933167|NCT01586611|Vitamins|vitamins|mesh-ancestor
56933168|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
56933169|NCT03386448|Scopolamine|scopolamine|mesh-list
56933170|NCT03386448|Naltrexone|naltrexone|mesh-list
56933171|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56933173|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56933174|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933175|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
56933176|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933177|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56933178|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
56933179|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
56933180|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933181|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
56933182|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56933183|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
56933184|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933185|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933186|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56933187|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
56933188|NCT01280929|Ranibizumab|ranibizumab|mesh-list
56933189|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56933190|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56933191|NCT01280929|Growth Substances|growth substances|mesh-ancestor
56933192|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933193|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
56933194|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933195|NCT01268917|Aspirin|aspirin|mesh-list
56933196|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56933197|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56933198|NCT01268917|Analgesics|analgesics|mesh-ancestor
56933199|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
56933200|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933201|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933202|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933203|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56933204|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56933205|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56933206|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933207|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56933208|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56933209|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933210|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
56933211|NCT01281163|Lapatinib|lapatinib|mesh-list
56933212|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933213|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56933214|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933215|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933216|NCT01268995|Cyclosporine|cyclosporine|mesh-list
56933217|NCT01268995|Tacrolimus|tacrolimus|mesh-list
56933218|NCT01268995|Cyclosporins|cyclosporins|mesh-list
56933219|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56933220|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
56933221|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933222|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56933223|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933224|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933225|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
56933226|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933227|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
56933228|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56933229|NCT00009737|Leucovorin|leucovorin|mesh-list
56933230|NCT00009737|Fluorouracil|fluorouracil|mesh-list
56933231|NCT00009737|Capecitabine|capecitabine|mesh-list
56933232|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
56933233|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933234|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56933235|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933236|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56933237|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
56933238|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933239|NCT00009737|Antidotes|antidotes|mesh-ancestor
56933240|NCT00009737|Protective Agents|protective agents|mesh-ancestor
56933241|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
56933242|NCT00009737|Vitamins|vitamins|mesh-ancestor
56933243|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
56933244|NCT03711240|Leucovorin|leucovorin|mesh-list
56933245|NCT03711240|Bevacizumab|bevacizumab|mesh-list
56933246|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
56933247|NCT03711240|Irinotecan|irinotecan|mesh-list
56933248|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56933249|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933250|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56933251|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56933252|NCT03711240|Growth Substances|growth substances|mesh-ancestor
56933253|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933254|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
56933255|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56933256|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56933257|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933258|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933259|NCT03711240|Antidotes|antidotes|mesh-ancestor
56933260|NCT03711240|Protective Agents|protective agents|mesh-ancestor
56933261|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
56933262|NCT03711240|Vitamins|vitamins|mesh-ancestor
56933263|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
56933264|NCT01271881|Heparin|heparin|mesh-list
56933265|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
56933266|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56933267|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56933268|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933269|NCT05459844|Octreotide|octreotide|mesh-list
56933270|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56933271|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933272|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56933273|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933274|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56933275|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933276|NCT03874975|Vitamin D|vitamin d|mesh-list
56933277|NCT03874975|Vitamins|vitamins|mesh-ancestor
56933278|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
56933279|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933280|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56933281|NCT01164709|Nelfinavir|nelfinavir|mesh-list
56933282|NCT01164709|Bortezomib|bortezomib|mesh-list
56933283|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933284|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56933285|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56933286|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
56933287|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933288|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933289|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56933290|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56933291|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
56933292|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933293|NCT03960671|Midazolam|midazolam|mesh-list
56933294|NCT03960671|Diazepam|diazepam|mesh-list
56933295|NCT03960671|Propofol|propofol|mesh-list
56933296|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56933297|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933298|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933299|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56933300|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
56933301|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
56933302|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56933303|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56933304|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56933305|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56933306|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
56933307|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
56933308|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933309|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933310|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
56933311|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
56933312|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
56933313|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933314|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933315|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56933316|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56933317|NCT01281553|Cisapride|cisapride|mesh-list
56933318|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56933319|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933320|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56933321|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
56933322|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933323|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933324|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933326|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56933327|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
56933328|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933329|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933330|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56933331|NCT01269151|Ranibizumab|ranibizumab|mesh-list
56933332|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56933333|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56933334|NCT01269151|Growth Substances|growth substances|mesh-ancestor
56933335|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933336|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
56933337|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933338|NCT00028769|Paclitaxel|paclitaxel|mesh-list
56933339|NCT00028769|Etoposide|etoposide|mesh-list
56933340|NCT00028769|Leuprolide|leuprolide|mesh-list
56933341|NCT00028769|Goserelin|goserelin|mesh-list
56933342|NCT00028769|Bicalutamide|bicalutamide|mesh-list
56933343|NCT00028769|Flutamide|flutamide|mesh-list
56933344|NCT00028769|Estramustine|estramustine|mesh-list
56933345|NCT00028769|Nilutamide|nilutamide|mesh-list
56933346|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56933347|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933348|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
56933349|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
56933350|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
56933351|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933352|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56933353|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56933354|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933355|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56933356|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
56933357|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56933358|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933359|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56933360|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
56933361|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
56933362|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933363|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56933364|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
56933365|NCT01281787|Losartan|losartan|mesh-list
56933366|NCT01281787|Metoprolol|metoprolol|mesh-list
56933367|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56933368|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56933369|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56933370|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56933371|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933372|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
56933373|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
56933374|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933375|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933376|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56933377|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56933378|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56933379|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
56933380|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933381|NCT02953314|Ivacaftor|ivacaftor|mesh-list
56933382|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56933383|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56933384|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933385|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
56933386|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56933387|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
56933388|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933389|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56933390|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56933391|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
56933392|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933393|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933394|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56933395|NCT01273441|Amoxicillin|amoxicillin|mesh-list
56933396|NCT01273441|Metronidazole|metronidazole|mesh-list
56933397|NCT01273441|Clarithromycin|clarithromycin|mesh-list
56933398|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56920812|NCT01212913|Insulin|insulin|mesh-list
56933399|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933400|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56933401|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56933402|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56933403|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933404|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933405|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56933406|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56933407|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
56933408|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56933409|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56933410|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933411|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
56933412|NCT03714360|Coagulants|coagulants|mesh-ancestor
56933413|NCT01169857|Bortezomib|bortezomib|mesh-list
56933414|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56933415|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933416|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
56933417|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933418|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933419|NCT01169935|Dextrans|dextrans|mesh-list
56933420|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
56933421|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
56933422|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
56933423|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56933424|NCT01168063|Amoxicillin|amoxicillin|mesh-list
56933425|NCT01168063|Metronidazole|metronidazole|mesh-list
56933426|NCT01168063|Clarithromycin|clarithromycin|mesh-list
56933427|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56933428|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933429|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
56933430|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56933431|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56933432|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56933433|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933434|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933435|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56933436|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56933437|NCT01166035|Lenalidomide|lenalidomide|mesh-list
56933438|NCT01166035|Cetuximab|cetuximab|mesh-list
56933439|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
56933440|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933441|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56933442|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56933443|NCT01166035|Growth Substances|growth substances|mesh-ancestor
56933444|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
56933445|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933446|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56933447|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56933448|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56933449|NCT03869281|Pancrelipase|pancrelipase|mesh-list
56933450|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933451|NCT01281943|Sirolimus|sirolimus|mesh-list
56933452|NCT01281943|Doxorubicin|doxorubicin|mesh-list
56933453|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56933454|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56933455|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933456|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56933457|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56933458|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933459|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933460|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56933461|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933462|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
56933463|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56933464|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
56933465|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933466|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
56933467|NCT03869047|Bupivacaine|bupivacaine|mesh-list
56933468|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
56933469|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
56933470|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933471|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933472|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
56933473|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933474|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56933475|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56933476|NCT03869047|Analgesics|analgesics|mesh-ancestor
56933477|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56933478|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56933479|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56933480|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
56933481|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933482|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933483|NCT01168531|Dexamethasone|dexamethasone|mesh-list
56933484|NCT01168531|Pregabalin|pregabalin|mesh-list
56933485|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933486|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
56933487|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
56933488|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933489|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933490|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933491|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
56933492|NCT01168531|Hormones|hormones|mesh-ancestor
56933493|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933494|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56933495|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933496|NCT01168531|Analgesics|analgesics|mesh-ancestor
56933497|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
56933498|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
56933499|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56933500|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56933501|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933502|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56933503|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56933504|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56933505|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933506|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56933507|NCT01170169|Omeprazole|omeprazole|mesh-list
56933508|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56933509|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933510|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56933511|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933512|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933513|NCT01587313|Hydralazine|hydralazine|mesh-list
56933514|NCT01587313|Isosorbide|isosorbide|mesh-list
56933515|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56933516|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56933517|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56933518|NCT01587313|Diuretics|diuretics|mesh-ancestor
56933519|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
56933520|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933521|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
56933522|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56933523|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933524|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56933525|NCT01282333|Gemcitabine|gemcitabine|mesh-list
56933526|NCT01282333|Veliparib|veliparib|mesh-list
56933527|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933528|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56933529|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
56933530|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933531|NCT01282333|Antiviral Agents|antiviral agents|mesh-ancestor
56933532|NCT01282333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933533|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933534|NCT01282333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56933535|NCT01282333|Immunologic Factors|immunologic factors|mesh-ancestor
56933536|NCT01282333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733520|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
56933537|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56933538|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
56933539|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
56933540|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56933541|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933542|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933543|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
56933544|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56933545|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933546|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933547|NCT03868969|Fosfomycin|fosfomycin|mesh-list
56933548|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56933549|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933550|NCT01311570|Buprenorphine|buprenorphine|mesh-list
56933551|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56933552|NCT01311570|Narcotics|narcotics|mesh-ancestor
56933553|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933554|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933555|NCT01311570|Analgesics|analgesics|mesh-ancestor
56933556|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
56933557|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933558|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56933559|NCT01170325|Valproic Acid|valproic acid|mesh-list
56933560|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
56933561|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933562|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933563|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
56933564|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933565|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933566|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
56933567|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56933568|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933569|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56933570|NCT05542446|Colistin|colistin|mesh-list
56933571|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56933572|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933573|NCT03355326|Glycerol|glycerol|mesh-list
56933574|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56933575|NCT03355326|Protective Agents|protective agents|mesh-ancestor
56933576|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933577|NCT01170637|Ibuprofen|ibuprofen|mesh-list
56933578|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
56933579|NCT01170637|Ephedrine|ephedrine|mesh-list
56933580|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56933581|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56933582|NCT01170637|Analgesics|analgesics|mesh-ancestor
56933583|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
56933584|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933585|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933586|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933587|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56933588|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56933589|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933590|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933591|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56933592|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
56933593|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56933594|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
56933595|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
56933596|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56933597|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56933598|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
56933599|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
56933600|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933601|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
56933602|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56933603|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933604|NCT02526745|Vaccines|vaccines|mesh-list
56933605|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
56933606|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933607|NCT01169389|Bupivacaine|bupivacaine|mesh-list
56933608|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
56933609|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
56933610|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933611|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933612|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
56933613|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933614|NCT01170871|Pemetrexed|pemetrexed|mesh-list
56933615|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933616|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933617|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933618|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56933619|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56933620|NCT03868111|Sufentanil|sufentanil|mesh-list
56933621|NCT03868111|Remifentanil|remifentanil|mesh-list
56933622|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56933623|NCT03868111|Narcotics|narcotics|mesh-ancestor
56933624|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933625|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933626|NCT03868111|Analgesics|analgesics|mesh-ancestor
56933627|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
56933628|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933629|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56933630|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56933631|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
56933633|NCT01282879|Itraconazole|itraconazole|mesh-list
56933634|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
56933635|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933636|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56933637|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56933638|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933639|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933640|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56933641|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
56933642|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933643|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933644|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56933645|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
56933646|NCT03868033|Denosumab|denosumab|mesh-list
56933647|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56933648|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933649|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
56933650|NCT01166815|Astringents|astringents|mesh-ancestor
56933651|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933652|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56933653|NCT03751657|Insulin|insulin|mesh-list
56933654|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56933655|NCT03751657|Metformin|metformin|mesh-list
56933656|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
56933657|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56933658|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56933659|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933660|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
56933661|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933662|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933663|NCT03873415|BMS-986165|bms-986165|mesh-list
56933664|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
56933665|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56933666|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933667|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933668|NCT00025259|Cytarabine|cytarabine|mesh-list
56933669|NCT00025259|Dexamethasone|dexamethasone|mesh-list
56933670|NCT00025259|Prednisone|prednisone|mesh-list
56933671|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
56933672|NCT00025259|Cortisone|cortisone|mesh-list
56933673|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
56933674|NCT00025259|Cisplatin|cisplatin|mesh-list
56933675|NCT00025259|Doxorubicin|doxorubicin|mesh-list
56933676|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56933677|NCT00025259|Etoposide|etoposide|mesh-list
56933678|NCT00025259|Vincristine|vincristine|mesh-list
56933679|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
56933680|NCT00025259|Bleomycin|bleomycin|mesh-list
56933681|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
56933682|NCT00025259|Lenograstim|lenograstim|mesh-list
56933683|NCT00025259|BB 1101|bb 1101|mesh-list
56933684|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56933685|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
56933686|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933687|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56933688|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56933689|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
56933690|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933691|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854560|NCT03880916|Analgesics|analgesics|mesh-ancestor
56933692|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56933693|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933694|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
56933695|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
56933696|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933697|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933698|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
56933699|NCT00025259|Hormones|hormones|mesh-ancestor
56933700|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933701|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56933702|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56933703|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56933704|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56933705|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933706|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56933707|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56933708|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
56933709|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
56933710|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933711|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56933712|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
56933713|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
56933714|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
56933715|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
56933716|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
56933717|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
56933718|NCT01171651|Sorafenib|sorafenib|mesh-list
56933719|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933720|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56933721|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933722|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933723|NCT03866629|Lifitegrast|lifitegrast|mesh-list
56933724|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56933725|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56933726|NCT01280071|Aminophylline|aminophylline|mesh-list
56933727|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56933728|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
56933729|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933730|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933731|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56933732|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
56933733|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56933734|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56933735|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933736|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933737|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56933738|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56933739|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
56933740|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933741|NCT01280071|Protective Agents|protective agents|mesh-ancestor
56933742|NCT02526199|Dexamethasone|dexamethasone|mesh-list
56933743|NCT02526199|Epinephrine|epinephrine|mesh-list
56933744|NCT02526199|Bupivacaine|bupivacaine|mesh-list
56933745|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933746|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
56933747|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
56933748|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933749|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933750|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933751|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
56933752|NCT02526199|Hormones|hormones|mesh-ancestor
56933753|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933754|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56933755|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933756|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
56933757|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
56933758|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933759|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
56933760|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56933761|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56933762|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
56933763|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933764|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933765|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56933766|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56933767|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56933768|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
56933769|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
56933770|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
56933771|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56933772|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56933773|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56933774|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56933775|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56933776|NCT03863977|Dexamethasone|dexamethasone|mesh-list
56933777|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
56921166|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56933778|NCT03863977|Bupivacaine|bupivacaine|mesh-list
56933780|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933781|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
56933782|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
56933783|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933784|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933785|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933786|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
56933787|NCT03863977|Hormones|hormones|mesh-ancestor
56933788|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933789|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56933790|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933791|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
56933792|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933793|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933794|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
56933795|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
56933796|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933797|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
56933798|NCT01171807|Dexamethasone|dexamethasone|mesh-list
56933799|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56933800|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933801|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
56933802|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
56933803|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933804|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933805|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933806|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
56933807|NCT01171807|Hormones|hormones|mesh-ancestor
56933808|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933809|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56933810|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933811|NCT01171885|Ropivacaine|ropivacaine|mesh-list
56933812|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
56933813|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
56933814|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56933815|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933816|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
56933817|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933818|NCT01286233|Metformin|metformin|mesh-list
56933819|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56933820|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933821|NCT01175161|Copper|copper|mesh-list
56933822|NCT01175161|Trace Elements|trace elements|mesh-ancestor
56933823|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
56933824|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933825|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56933826|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56933827|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933828|NCT01284907|Vitamin D|vitamin d|mesh-list
56933829|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
56933830|NCT01284907|Vitamins|vitamins|mesh-ancestor
56933831|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
56933832|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933833|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56933834|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56933835|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
56933836|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56933837|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
56933838|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933839|NCT00024167|Ketoconazole|ketoconazole|mesh-list
56933840|NCT00024167|Dexamethasone|dexamethasone|mesh-list
56933841|NCT00024167|Prednisone|prednisone|mesh-list
56933842|NCT00024167|Estramustine|estramustine|mesh-list
56933843|NCT00024167|Docetaxel|docetaxel|mesh-list
56933844|NCT00024167|Doxorubicin|doxorubicin|mesh-list
56933845|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56933846|NCT00024167|Vinblastine|vinblastine|mesh-list
56933847|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933848|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
56933849|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
56933850|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933851|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933852|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933853|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
56933854|NCT00024167|Hormones|hormones|mesh-ancestor
56933855|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933856|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56933857|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933858|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
56933859|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
56933860|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
56933861|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933862|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56933863|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56933864|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56933865|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933866|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
56933867|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933868|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56933869|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56933870|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56933871|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
56933872|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56933873|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56933874|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56933875|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
56933877|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56933878|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
56933879|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
56933880|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56933881|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56933882|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933883|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56933884|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56933885|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
56933886|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933887|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
56933888|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56933889|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
56933890|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933891|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56933892|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933893|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
56933894|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56933895|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
56933896|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56933897|NCT01285141|Protective Agents|protective agents|mesh-ancestor
56933898|NCT01285219|Lenograstim|lenograstim|mesh-list
56933899|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56933900|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
56933901|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933902|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
56933903|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56933904|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
56933905|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933906|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
56933907|NCT01284439|Protective Agents|protective agents|mesh-ancestor
56933908|NCT00071981|Molgramostim|molgramostim|mesh-list
56933909|NCT00071981|Vaccines|vaccines|mesh-list
56933910|NCT00071981|Sargramostim|sargramostim|mesh-list
56933911|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
56933912|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
56933913|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933914|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933915|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56933916|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56933917|NCT01172431|Indapamide|indapamide|mesh-list
56933918|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56933919|NCT01172431|Diuretics|diuretics|mesh-ancestor
56933920|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
56933921|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933922|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56933923|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56933924|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933925|NCT01172509|Baclofen|baclofen|mesh-list
56933926|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56933927|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933928|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56933929|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921311|NCT02457442|Remifentanil|remifentanil|mesh-list
56933930|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56933931|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
56933932|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
56933933|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56933934|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933935|NCT01089959|Esomeprazole|esomeprazole|mesh-list
56933936|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56933937|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56933938|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56933939|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933940|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933941|NCT01090037|Epoprostenol|epoprostenol|mesh-list
56933942|NCT01090037|Beraprost|beraprost|mesh-list
56933943|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56933944|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
56933945|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56933946|NCT01285375|Curcumin|curcumin|mesh-list
56933947|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56933948|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56933949|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56933950|NCT01285375|Analgesics|analgesics|mesh-ancestor
56933951|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
56933952|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56933953|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933954|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56933955|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56933956|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933957|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933958|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933959|NCT05625893|Bevacizumab|bevacizumab|mesh-list
56933960|NCT05625893|Atezolizumab|atezolizumab|mesh-list
56933961|NCT05625893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56933962|NCT05625893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933963|NCT05625893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56933964|NCT05625893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56933965|NCT05625893|Growth Substances|growth substances|mesh-ancestor
56933966|NCT05625893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933967|NCT05625893|Growth Inhibitors|growth inhibitors|mesh-ancestor
56933968|NCT01178047|Rasagiline|rasagiline|mesh-list
56933969|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56933970|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56933971|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933972|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56933973|NCT01178047|Protective Agents|protective agents|mesh-ancestor
56933974|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933975|NCT01101113|Cinacalcet|cinacalcet|mesh-list
56933976|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56933977|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933978|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56933979|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
56933980|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56933981|NCT01288261|Paclitaxel|paclitaxel|mesh-list
56933982|NCT01288261|Bavituximab|bavituximab|mesh-list
56933983|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56933984|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56933985|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
56933986|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
56933987|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
56933988|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56933989|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56933990|NCT01174303|Insulin|insulin|mesh-list
56933991|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56933992|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
56933993|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
56933994|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56933995|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
56933996|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56933997|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56933998|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56933999|NCT01285453|Vadimezan|vadimezan|mesh-list
56934000|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934001|NCT01288339|Leucovorin|leucovorin|mesh-list
56934002|NCT01288339|Fluorouracil|fluorouracil|mesh-list
56934003|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
56921389|NCT01347944|Growth Substances|growth substances|mesh-ancestor
56934005|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
56934006|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934007|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56934008|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934009|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934010|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
56934011|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934012|NCT01288339|Antidotes|antidotes|mesh-ancestor
56934013|NCT01288339|Protective Agents|protective agents|mesh-ancestor
56934014|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
56934015|NCT01288339|Vitamins|vitamins|mesh-ancestor
56934016|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
56934017|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56934018|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
56934019|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934020|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56934021|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
56934022|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934023|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
56934024|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56934025|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56934026|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56934027|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56934028|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934029|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934030|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
56934031|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934032|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934033|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56934034|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934035|NCT01105481|Amisulpride|amisulpride|mesh-list
56934036|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56934037|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56934038|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934039|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934040|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56934041|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56934042|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
56934043|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934044|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934045|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56934046|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
56934047|NCT01178203|Naproxen|naproxen|mesh-list
56934048|NCT01178203|Tramadol|tramadol|mesh-list
56934049|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56934050|NCT01178203|Narcotics|narcotics|mesh-ancestor
56934051|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934052|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934053|NCT01178203|Analgesics|analgesics|mesh-ancestor
56934054|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
56934055|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934056|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56934057|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56934058|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56934059|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934060|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
56934061|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56934062|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934063|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934064|NCT01286701|Terbinafine|terbinafine|mesh-list
56934065|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
56934066|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934067|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990936|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56934068|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934069|NCT00006305|Biguanides|biguanides|mesh-list
56934070|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56934071|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
56934072|NCT00006305|Calcium|calcium|mesh-list
56934073|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56934074|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56934075|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56934076|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56934077|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934078|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56934079|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56934080|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
56934081|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934082|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934083|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
56934084|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934085|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934087|NCT01286857|Trace Elements|trace elements|mesh-ancestor
56934088|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
56934089|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934090|NCT01101269|Lisinopril|lisinopril|mesh-list
56934091|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56934092|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
56934093|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934094|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934095|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56934096|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56934097|NCT01101269|Protective Agents|protective agents|mesh-ancestor
56934098|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934099|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56934100|NCT01103375|Isotretinoin|isotretinoin|mesh-list
56934101|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934102|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56934103|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934104|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934105|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
56934106|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56934107|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
56934108|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
56934109|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56934110|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56934111|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
56934112|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934113|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56934114|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56934115|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934116|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934117|NCT01285765|Rituximab|rituximab|mesh-list
56934118|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56934119|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934120|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
56934121|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934122|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934123|NCT03864913|Testosterone|testosterone|mesh-list
56934124|NCT03864913|Androgens|androgens|mesh-ancestor
56934125|NCT03864913|Hormones|hormones|mesh-ancestor
56934126|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56934127|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934128|NCT03865147|Acetaminophen|acetaminophen|mesh-list
56934129|NCT03865147|Cetrimonium|cetrimonium|mesh-list
56934130|NCT03865147|Ibuprofen|ibuprofen|mesh-list
56934131|NCT03865147|Lidocaine|lidocaine|mesh-list
56934132|NCT03865147|Epinephrine|epinephrine|mesh-list
56934133|NCT03865147|Racepinephrine|racepinephrine|mesh-list
56934134|NCT03865147|Bupivacaine|bupivacaine|mesh-list
56934135|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56934136|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
56934137|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
56934138|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
56934139|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934140|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934141|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
56934142|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934143|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56990937|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934144|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56934145|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56934146|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934147|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934148|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56934149|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56934150|NCT03865147|Analgesics|analgesics|mesh-ancestor
56934151|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56934152|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934153|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56934154|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934155|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
56934156|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56934157|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56934158|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
56934159|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934160|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56934161|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56934162|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
56934163|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56934164|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
56934165|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
56934166|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
56934167|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56934168|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56934169|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56934170|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934171|NCT03722823|Tucatinib|tucatinib|mesh-list
56934172|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934173|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56934174|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934175|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934176|NCT03862651|Cangrelor|cangrelor|mesh-list
56934177|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56934178|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56934179|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56934180|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56934181|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
56934182|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934183|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934184|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934185|NCT03349710|Nivolumab|nivolumab|mesh-list
56934186|NCT03349710|Cetuximab|cetuximab|mesh-list
56934187|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934188|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56934189|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56934190|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934191|NCT01288495|Psyllium|psyllium|mesh-list
56934192|NCT01288495|Cathartics|cathartics|mesh-ancestor
56934193|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56934194|NCT01105793|Danazol|danazol|mesh-list
56934195|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56934196|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
56934197|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56934198|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934199|NCT04934579|Rituximab|rituximab|mesh-list
56934200|NCT04934579|Methotrexate|methotrexate|mesh-list
56934201|NCT04934579|Lenalidomide|lenalidomide|mesh-list
56934202|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56934203|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934204|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
56934205|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934206|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934207|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56934208|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
56934209|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56934210|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56934211|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
56934212|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934213|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
56934214|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934215|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56934216|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934217|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56855102|NCT01160432|Methadone|methadone|mesh-list
56934218|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56934219|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56934220|NCT04934579|Growth Substances|growth substances|mesh-ancestor
56934221|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
56934222|NCT03134131|TIC10 compound|tic10 compound|mesh-list
56934223|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934224|NCT01103609|Warfarin|warfarin|mesh-list
56934225|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
56934226|NCT03528369|Capsaicin|capsaicin|mesh-list
56934227|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
56934228|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
56934229|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
56934230|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934231|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934233|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56934234|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56934235|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
56934236|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934237|NCT01174693|Clopidogrel|clopidogrel|mesh-list
56934238|NCT01174693|Triflusal|triflusal|mesh-list
56934239|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56934240|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56934241|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56934242|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56934243|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
56934244|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934245|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934246|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934247|NCT00006011|Paclitaxel|paclitaxel|mesh-list
56934248|NCT00006011|Doxorubicin|doxorubicin|mesh-list
56934249|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56934250|NCT00006011|Lenograstim|lenograstim|mesh-list
56934251|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56934252|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934253|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
56934254|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
56934255|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
56934256|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934257|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56934258|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56934259|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56934260|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934261|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56934262|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
56934263|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934264|NCT01105871|Naloxone|naloxone|mesh-list
56934265|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56934266|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934267|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
56934268|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934269|NCT03377556|Talazoparib|talazoparib|mesh-list
56934270|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56934271|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934272|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934273|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934274|NCT05625581|Cyclophosphamide|cyclophosphamide|mesh-list
56934275|NCT05625581|Tofacitinib|tofacitinib|mesh-list
56934276|NCT05625581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934277|NCT05625581|Immunologic Factors|immunologic factors|mesh-ancestor
56934278|NCT05625581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934279|NCT05625581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934280|NCT05625581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56934281|NCT05625581|Alkylating Agents|alkylating agents|mesh-ancestor
56934282|NCT05625581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934283|NCT05625581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934284|NCT05625581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56934285|NCT05625581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56934286|NCT05625581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934287|NCT05625503|Verapamil|verapamil|mesh-list
56934288|NCT05625503|Nicardipine|nicardipine|mesh-list
56934289|NCT05625503|Calcium Channel Blockers|calcium channel blockers|mesh-list
56934290|NCT05625503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56934291|NCT05625503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934292|NCT05625503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56855178|NCT03882008|Abatacept|abatacept|mesh-list
56934293|NCT05625503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934294|NCT05625503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934295|NCT05625503|Vasodilator Agents|vasodilator agents|mesh-ancestor
56934296|NCT05625503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56934297|NCT01176175|Progesterone|progesterone|mesh-list
56934298|NCT01176175|Progestins|progestins|mesh-ancestor
56934299|NCT01176175|Hormones|hormones|mesh-ancestor
56934300|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56934301|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934302|NCT05624099|Paclitaxel|paclitaxel|mesh-list
56934303|NCT05624099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56934304|NCT05624099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934305|NCT05624099|Tubulin Modulators|tubulin modulators|mesh-ancestor
56934306|NCT05624099|Antimitotic Agents|antimitotic agents|mesh-ancestor
56934307|NCT05624099|Mitosis Modulators|mitosis modulators|mesh-ancestor
56934308|NCT05624099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934309|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
56934310|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
56934311|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934312|NCT03864523|Pioglitazone|pioglitazone|mesh-list
56934313|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56934314|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934315|NCT03527745|Albendazole|albendazole|mesh-list
56934316|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
56934317|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56934318|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934319|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
56934320|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56934321|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56934322|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
56934323|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
56934324|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
56934325|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934326|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934327|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56934328|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
56934329|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934330|NCT03583359|Lidocaine|lidocaine|mesh-list
56934331|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
56934332|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
56934333|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934334|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934335|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
56934336|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934337|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56934338|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56934339|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56934340|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934341|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934342|NCT05619887|Fentanyl|fentanyl|mesh-list
56934343|NCT05619887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56934344|NCT05619887|Narcotics|narcotics|mesh-ancestor
56934345|NCT05619887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934346|NCT05619887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934347|NCT05619887|Analgesics|analgesics|mesh-ancestor
56934348|NCT05619887|Sensory System Agents|sensory system agents|mesh-ancestor
56934349|NCT05619887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934350|NCT05619887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56934351|NCT05619887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56934352|NCT05619887|Anesthetics, General|anesthetics, general|mesh-ancestor
56934353|NCT05619887|Anesthetics|anesthetics|mesh-ancestor
56934354|NCT01174927|Heroin|heroin|mesh-list
56934355|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56934356|NCT01174927|Narcotics|narcotics|mesh-ancestor
56934357|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934358|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934359|NCT01174927|Analgesics|analgesics|mesh-ancestor
56934360|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
56934361|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934362|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
56934363|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56934364|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934365|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56934366|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56855239|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
56934367|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934368|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934369|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934370|NCT03948737|Tocopherols|tocopherols|mesh-list
56934371|NCT03948737|Vitamin E|vitamin e|mesh-list
56934372|NCT03948737|Tocotrienols|tocotrienols|mesh-list
56934373|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
56934374|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
56934375|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934376|NCT03948737|Protective Agents|protective agents|mesh-ancestor
56921765|NCT05789017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934377|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934378|NCT03948737|Vitamins|vitamins|mesh-ancestor
56934379|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
56934380|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
56934381|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56934382|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56934383|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934384|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934385|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
56934386|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934387|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934388|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56934389|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934390|NCT01327859|Donepezil|donepezil|mesh-list
56934391|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56934392|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934393|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934394|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
56934395|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934396|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934397|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
56934398|NCT01176409|Valacyclovir|valacyclovir|mesh-list
56934399|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
56934400|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934401|NCT03480009|Oxycodone|oxycodone|mesh-list
56934402|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
56934403|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56934404|NCT03480009|Narcotics|narcotics|mesh-ancestor
56934405|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934406|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934407|NCT03480009|Analgesics|analgesics|mesh-ancestor
56934408|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
56934409|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934410|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
56934411|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
56934412|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56934413|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56934414|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934415|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934416|NCT03859375|Disinfectants|disinfectants|mesh-list
56934417|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934418|NCT01310751|Iloprost|iloprost|mesh-list
56934419|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56934420|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
56934421|NCT01180933|Folic Acid|folic acid|mesh-list
56934422|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
56934423|NCT01180933|Hematinics|hematinics|mesh-ancestor
56934424|NCT01180933|Vitamins|vitamins|mesh-ancestor
56934425|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
56934426|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934427|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
56934428|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56934429|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56934430|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934431|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
56934432|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
56934433|NCT03859141|Vaccines|vaccines|mesh-list
56934434|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
56934435|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934436|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
56934437|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934438|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
56934439|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934440|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
56934441|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56934442|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56934443|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
56934444|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934445|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56934446|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56934447|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934448|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934449|NCT03711708|Sertraline|sertraline|mesh-list
56934450|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
56934451|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56934452|NCT03711708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56934453|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56934454|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934455|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934456|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934457|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
56934458|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934459|NCT01179529|Omalizumab|omalizumab|mesh-list
56934460|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56934461|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56934462|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
56934463|NCT00004859|Thalidomide|thalidomide|mesh-list
56934464|NCT00004859|Paclitaxel|paclitaxel|mesh-list
56934465|NCT00004859|Carboplatin|carboplatin|mesh-list
56934466|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56934467|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934468|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
56934469|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
56934470|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
56934471|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934472|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934473|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
56934474|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934475|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
56934476|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56934477|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934478|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56934479|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56934480|NCT00004859|Growth Substances|growth substances|mesh-ancestor
56934481|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
56934482|NCT03348930|Tolcapone|tolcapone|mesh-list
56934483|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56934484|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56934485|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56934486|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934487|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934488|NCT03500211|Lidocaine|lidocaine|mesh-list
56934489|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
56934490|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
56934491|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934492|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934493|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
56934494|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934495|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56934496|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56934497|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56934498|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934499|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934500|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
56934501|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56934502|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934503|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56934504|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934505|NCT04760717|Spironolactone|spironolactone|mesh-list
56934506|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56934507|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
56934508|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56934509|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934510|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56934511|NCT04760717|Diuretics|diuretics|mesh-ancestor
56934512|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
56934513|NCT03478683|Budesonide|budesonide|mesh-list
56934514|NCT03478683|Albuterol|albuterol|mesh-list
56934515|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
56934516|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
56934517|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56934518|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56934519|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56934520|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
56934521|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934522|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934523|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56934524|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
56934525|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
56934526|NCT03478683|Hormones|hormones|mesh-ancestor
56934527|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56934528|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56934529|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56934530|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56934531|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
56934532|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934533|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934534|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
56934535|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56934536|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
56934537|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
56934538|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56934539|NCT04744883|Naloxone|naloxone|mesh-list
56934540|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56934541|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934542|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
56934543|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934544|NCT01288963|Aldesleukin|aldesleukin|mesh-list
56934545|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934546|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56934547|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56934548|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
56934549|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934550|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
56934551|NCT01176799|Doxorubicin|doxorubicin|mesh-list
56934552|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56934553|NCT01176799|Sunitinib|sunitinib|mesh-list
56934554|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934555|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
56934556|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934557|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934558|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56934559|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
56934560|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934561|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934562|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56934563|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56934564|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56934565|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56934566|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934567|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56934568|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56934569|NCT01176799|Growth Substances|growth substances|mesh-ancestor
56934570|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
56934571|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56934572|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
56934573|NCT03861403|Avelumab|avelumab|mesh-list
56934574|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934575|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
56934576|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934577|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934578|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56934579|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
56934580|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934581|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934582|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56934583|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56934584|NCT03477903|Metoclopramide|metoclopramide|mesh-list
56934585|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
56934586|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
56934587|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934588|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934589|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56934590|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56934591|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56934592|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
56934593|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934594|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934595|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
56934596|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56934597|NCT04728425|Antibodies|antibodies|mesh-list
56934598|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
56934599|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56934600|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
56934601|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
56934602|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934603|NCT01181401|Cisplatin|cisplatin|mesh-list
56934605|NCT01181401|Cetuximab|cetuximab|mesh-list
56934606|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934607|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
56934608|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
56934609|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
56934610|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934611|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56934612|NCT01287715|Etanercept|etanercept|mesh-list
56934613|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56934614|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56934615|NCT01287715|Analgesics|analgesics|mesh-ancestor
56934616|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
56934617|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934618|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934619|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56934620|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934621|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56934622|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934623|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
56934624|NCT03474081|Albuterol|albuterol|mesh-list
56934625|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
56934626|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56934627|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
56934628|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934629|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934630|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56934631|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
56934632|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
56934633|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56934634|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
56934635|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934636|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934637|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
56934638|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56934639|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56934640|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56934641|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56934642|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
56934643|NCT03393000|Vitamin A|vitamin a|mesh-list
56934644|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
56934645|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
56934646|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934647|NCT03393000|Protective Agents|protective agents|mesh-ancestor
56934648|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934649|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56934650|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934651|NCT03393000|Vitamins|vitamins|mesh-ancestor
56934652|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
56934653|NCT01311804|Parecoxib|parecoxib|mesh-list
56934654|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56934655|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56934656|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934657|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934658|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56934659|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56934660|NCT01311804|Analgesics|analgesics|mesh-ancestor
56934661|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
56934662|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934663|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934664|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56934665|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934666|NCT03370770|Osimertinib|osimertinib|mesh-list
56934667|NCT03370770|Afatinib|afatinib|mesh-list
56934668|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934669|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56934670|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934671|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934672|NCT01180075|Ritonavir|ritonavir|mesh-list
56934673|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56934674|NCT01180075|Tenofovir|tenofovir|mesh-list
56934675|NCT01180075|Emtricitabine|emtricitabine|mesh-list
56934676|NCT01180075|Efavirenz|efavirenz|mesh-list
56934677|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56934678|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56934679|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
56934680|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934681|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934682|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56934683|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56934684|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
56934685|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934686|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56934687|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56934688|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56934689|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56934690|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56934691|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56934692|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56934693|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56934694|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56934695|NCT01311882|Zopiclone|zopiclone|mesh-list
56934696|NCT01311882|Suvorexant|suvorexant|mesh-list
56934697|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56934698|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934699|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934700|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56934701|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56934702|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934703|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934704|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
56934705|NCT01287793|Tigecycline|tigecycline|mesh-list
56934706|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56934707|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934708|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56934709|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56934710|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934711|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934712|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934713|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56934714|NCT03391284|Acetaminophen|acetaminophen|mesh-list
56934715|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56934716|NCT03391284|Analgesics|analgesics|mesh-ancestor
56934717|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
56934718|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934719|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934720|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
56934721|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
56934722|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934723|NCT03719625|Norepinephrine|norepinephrine|mesh-list
56934724|NCT03719625|Ephedrine|ephedrine|mesh-list
56934725|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56934726|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56934727|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
56934728|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934729|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934730|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934731|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
56934732|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
56934733|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934734|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56934735|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56934736|NCT01289743|Etanercept|etanercept|mesh-list
56934737|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56934738|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56934739|NCT01289743|Analgesics|analgesics|mesh-ancestor
56934740|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
56934741|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934742|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934743|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56934744|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934745|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56934746|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934747|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
56934748|NCT03390426|Anesthetics|anesthetics|mesh-list
56934749|NCT03390426|Mepivacaine|mepivacaine|mesh-list
56934750|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
56934751|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934752|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934753|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
56934755|NCT03472521|Gabapentin|gabapentin|mesh-list
56934756|NCT03472521|Analgesics|analgesics|mesh-ancestor
56934757|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
56934758|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934759|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934760|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
56934761|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56934762|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56934763|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934764|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56934765|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56934766|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56934767|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934768|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934769|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
56934770|NCT01177423|Anesthetics|anesthetics|mesh-list
56934771|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934772|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934773|NCT01180231|Moxonidine|moxonidine|mesh-list
56934774|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56934775|NCT01177501|Topotecan|topotecan|mesh-list
56934776|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56934777|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56934778|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934779|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934780|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934781|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
56934782|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
56934783|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
56934784|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56934785|NCT03478150|Protective Agents|protective agents|mesh-ancestor
56934786|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934787|NCT03499353|Talazoparib|talazoparib|mesh-list
56934788|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56934789|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934790|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934791|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934792|NCT03368664|Interferons|interferons|mesh-list
56934793|NCT03368664|Acyclovir|acyclovir|mesh-list
56934794|NCT03368664|Interferon-beta|interferon-beta|mesh-list
56934795|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
56934796|NCT03368664|Prednisolone|prednisolone|mesh-list
56934797|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
56934798|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
56934799|NCT03368664|Ranitidine|ranitidine|mesh-list
56934800|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
56934801|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56934802|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934803|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
56934804|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934805|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56934806|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
56934807|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
56934808|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934809|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934810|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56934811|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
56934812|NCT03368664|Hormones|hormones|mesh-ancestor
56934813|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56934814|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56934815|NCT03368664|Protective Agents|protective agents|mesh-ancestor
56934816|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56934817|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56934818|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56934819|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
56934820|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934821|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934822|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56934823|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56934824|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
56934825|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
56934826|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934827|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934828|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56934829|NCT00004259|Carmustine|carmustine|mesh-list
56934830|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56934831|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
56934832|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934833|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934834|NCT01177579|Copper|copper|mesh-list
56934835|NCT01177579|Trace Elements|trace elements|mesh-ancestor
56934836|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
56934837|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934838|NCT03722355|Carmustine|carmustine|mesh-list
56934839|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56934840|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
56934841|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934842|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934843|NCT03857815|Antibodies|antibodies|mesh-list
56934844|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
56934845|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934846|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56934847|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56934848|NCT04682405|Melphalan|melphalan|mesh-list
56934849|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56934850|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
56934851|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934852|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934853|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56934854|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934855|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
56934856|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934857|NCT03477994|Clonidine|clonidine|mesh-list
56934858|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
56934859|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56934860|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934861|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934862|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56934863|NCT03477994|Analgesics|analgesics|mesh-ancestor
56934864|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
56934865|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934866|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56934867|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56934868|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56934869|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
56934870|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934871|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934872|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56934873|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
56934874|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
56934875|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56934876|NCT04668131|Lubricant Eye Drops|lubricant eye drops|mesh-list
56934877|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
56934878|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56934879|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56934880|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
56934881|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934882|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
56934883|NCT04668131|Protective Agents|protective agents|mesh-ancestor
56934884|NCT03857581|Olanzapine|olanzapine|mesh-list
56934885|NCT03857581|Clozapine|clozapine|mesh-list
56934886|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
56934887|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
56934888|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934889|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934890|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56934891|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56934892|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56934893|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934894|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56934895|NCT03857581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56855749|NCT01274780|Emtricitabine|emtricitabine|mesh-list
56934896|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56934897|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934898|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934899|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934900|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
56934901|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56934902|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
56934903|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
56934904|NCT01103843|Clopidogrel|clopidogrel|mesh-list
56934905|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56934906|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56934907|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56934908|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56934909|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56934910|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
56934911|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934912|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934913|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934914|NCT03738865|Glucagon|glucagon|mesh-list
56934915|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56934916|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56934917|NCT03738865|Hormones|hormones|mesh-ancestor
56934918|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56934919|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934920|NCT03738865|Incretins|incretins|mesh-ancestor
56934921|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56934922|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56934923|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
56934924|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56934925|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
56934926|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934927|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
56934928|NCT03524157|Protective Agents|protective agents|mesh-ancestor
56934929|NCT03719391|Nicotine|nicotine|mesh-list
56934930|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56934931|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
56934932|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934933|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934934|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56934935|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56934936|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
56934937|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934938|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934939|NCT03468543|Memantine|memantine|mesh-list
56934940|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56934941|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56934942|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
56934943|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934944|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934945|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934946|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56934947|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56934948|NCT03467763|Metformin|metformin|mesh-list
56934949|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56934950|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934951|NCT00004031|Prednisone|prednisone|mesh-list
56934952|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
56934953|NCT00004031|Carmustine|carmustine|mesh-list
56934954|NCT00004031|Rituximab|rituximab|mesh-list
56934955|NCT00004031|Doxorubicin|doxorubicin|mesh-list
56934956|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56934957|NCT00004031|Etoposide|etoposide|mesh-list
56934958|NCT00004031|Vincristine|vincristine|mesh-list
56934959|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56934960|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
56934961|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934962|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56934963|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56934964|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
56934965|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934966|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56934967|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56934968|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56934969|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56934970|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56934971|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56934972|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56934973|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56934974|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
56934975|NCT00004031|Hormones|hormones|mesh-ancestor
56934976|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56934977|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56934978|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56934979|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
56934980|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
56934981|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
56934982|NCT01184443|Olanzapine|olanzapine|mesh-list
56934983|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
56934984|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
56934985|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56934986|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56934987|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56934988|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56934989|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56934990|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56934991|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56934992|NCT01184443|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56934993|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56934994|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56934995|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56934996|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56934997|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
56934998|NCT01180621|Vaccines|vaccines|mesh-list
56934999|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
56935000|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935001|NCT01290133|Vestipitant|vestipitant|mesh-list
56935002|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56935003|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935004|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935005|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935006|NCT03467217|Losartan|losartan|mesh-list
56935007|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56935008|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56935009|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56935010|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56935011|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935012|NCT00003875|Aldesleukin|aldesleukin|mesh-list
56935013|NCT00003875|Etoposide|etoposide|mesh-list
56935014|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
56935015|NCT00003875|Busulfan|busulfan|mesh-list
56935016|NCT00003875|Interleukin-2|interleukin-2|mesh-list
56935017|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56935018|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935019|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56935020|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56935021|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935022|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935023|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
56935024|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935025|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
56935026|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935027|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56935028|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56935029|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56935030|NCT00003875|Analgesics|analgesics|mesh-ancestor
56935031|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
56935032|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935033|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56935034|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56935035|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
56935036|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935037|NCT01327625|Azithromycin|azithromycin|mesh-list
56935038|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56935039|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935040|NCT01290211|Ritonavir|ritonavir|mesh-list
56935041|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
56935042|NCT01290211|Maraviroc|maraviroc|mesh-list
56935043|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56935044|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56935045|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
56935046|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935047|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935048|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56935049|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56935050|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
56935051|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935052|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56935053|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56935054|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56935055|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56935056|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56935057|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56935058|NCT03720873|Gefitinib|gefitinib|mesh-list
56935059|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935060|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56935061|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935062|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935063|NCT04633889|Deferoxamine|deferoxamine|mesh-list
56935064|NCT04633889|Siderophores|siderophores|mesh-ancestor
56935065|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56935066|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
56935067|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
56935068|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935069|NCT01311960|Bevacizumab|bevacizumab|mesh-list
56935070|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56935071|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56935072|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935073|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56935074|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56935075|NCT01311960|Growth Substances|growth substances|mesh-ancestor
56935076|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935077|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
56935078|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56935079|NCT03709056|Propofol|propofol|mesh-list
56935080|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56935081|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935082|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935083|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56935084|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
56935085|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
56935086|NCT05663307|Aspirin|aspirin|mesh-list
56935087|NCT05663307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56935088|NCT05663307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56935089|NCT05663307|Analgesics|analgesics|mesh-ancestor
56935090|NCT05663307|Sensory System Agents|sensory system agents|mesh-ancestor
56935091|NCT05663307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935092|NCT05663307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935093|NCT05663307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56935094|NCT05663307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56935095|NCT05663307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56935096|NCT05663307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56935097|NCT05663307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935098|NCT05663307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56935099|NCT05663307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56935100|NCT05663307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935101|NCT05663307|Antipyretics|antipyretics|mesh-ancestor
56935102|NCT01106495|Simvastatin|simvastatin|mesh-list
56935103|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56935104|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56935105|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
56935106|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935107|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56935108|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56935109|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935110|NCT01184833|Interferons|interferons|mesh-list
56935111|NCT01184833|Interferon-beta|interferon-beta|mesh-list
56935112|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
56935113|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935114|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
56935115|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935116|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
56935117|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935118|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56935119|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
56855975|NCT03349268|Xenon|xenon|mesh-list
56935120|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
56935121|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56935122|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
56935123|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56935124|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56935125|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935126|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56935127|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935128|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935129|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56935130|NCT01184911|Renal Agents|renal agents|mesh-ancestor
56935131|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
56935132|NCT01185067|Resveratrol|resveratrol|mesh-list
56935133|NCT01185067|Antioxidants|antioxidants|mesh-list
56935134|NCT01185067|Quercetin|quercetin|mesh-list
56935135|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935136|NCT01185067|Protective Agents|protective agents|mesh-ancestor
56935137|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935138|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935139|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56935140|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56935141|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935142|NCT03364686|Biotin|biotin|mesh-list
56935143|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
56935144|NCT03364686|Vitamins|vitamins|mesh-ancestor
56935145|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
56935146|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935147|NCT03437577|Tacrolimus|tacrolimus|mesh-list
56935148|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935149|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
56935150|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935151|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56935152|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935153|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935154|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
56935155|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
56935156|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56935157|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935158|NCT03364608|Albuterol|albuterol|mesh-list
56935159|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56935160|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
56935161|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935162|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935163|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56935164|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
56935165|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
56935166|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56935167|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56935168|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56935169|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56935170|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
56935171|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935172|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935173|NCT03719157|Anesthetics|anesthetics|mesh-list
56935174|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
56935175|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935176|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935177|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
56935178|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935179|NCT01185223|Valganciclovir|valganciclovir|mesh-list
56935180|NCT01185223|Ganciclovir|ganciclovir|mesh-list
56935181|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56935182|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
56935183|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935184|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56935185|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935186|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935187|NCT03852979|Paclitaxel|paclitaxel|mesh-list
56935188|NCT03852979|Carboplatin|carboplatin|mesh-list
56935189|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56935190|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935191|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56935192|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56935193|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56052584|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56935194|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935195|NCT01188031|Alprazolam|alprazolam|mesh-list
56935196|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56935197|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935198|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935199|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56935200|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56935201|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56935202|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
56935203|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
56935204|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935205|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935206|NCT01182883|Sirolimus|sirolimus|mesh-list
56935207|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56935208|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935209|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56935210|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935211|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
56935212|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935213|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
56935214|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935215|NCT01188265|Valproic Acid|valproic acid|mesh-list
56935216|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
56935217|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
56935218|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
56935219|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56935220|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56935221|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935222|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935223|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935224|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
56935225|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935226|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
56935227|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
56935228|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56935229|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935230|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56935231|NCT01291069|Tadalafil|tadalafil|mesh-list
56935232|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935233|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
56935234|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56935235|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56935236|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935237|NCT01291069|Urological Agents|urological agents|mesh-ancestor
56935238|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
56935239|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935240|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56935241|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56935242|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935243|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56935244|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935245|NCT01588639|Insulin|insulin|mesh-list
56935246|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56935247|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56935248|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935249|NCT02524639|Sirolimus|sirolimus|mesh-list
56935250|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56935251|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935252|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56935253|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935254|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
56935255|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935256|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
56935257|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935258|NCT01185535|Anesthetics|anesthetics|mesh-list
56935259|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935260|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935261|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
56935262|NCT00003659|Rituximab|rituximab|mesh-list
56935263|NCT00003659|Fludarabine|fludarabine|mesh-list
56935264|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
56935265|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935266|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
56935267|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935268|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56935269|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56935270|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
56935271|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935272|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935273|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56935274|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56935275|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56935276|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
56935277|NCT01101581|Epratuzumab|epratuzumab|mesh-list
56935278|NCT01101581|Veltuzumab|veltuzumab|mesh-list
56935279|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56935280|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56935281|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935283|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
56935284|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935285|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56935286|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56935287|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56935288|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
56935289|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935290|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56935291|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56935292|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935293|NCT03494985|Muramidase|muramidase|mesh-list
56935294|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935295|NCT01185769|Tocotrienols|tocotrienols|mesh-list
56935296|NCT01185769|Vitamin E|vitamin e|mesh-list
56935297|NCT01185769|Tocopherols|tocopherols|mesh-list
56935298|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
56935299|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935300|NCT01185769|Protective Agents|protective agents|mesh-ancestor
56935301|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935302|NCT01185769|Vitamins|vitamins|mesh-ancestor
56935303|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
56935304|NCT01185847|Gemcitabine|gemcitabine|mesh-list
56935305|NCT01185847|Pemetrexed|pemetrexed|mesh-list
56935306|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935307|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56935308|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
56935309|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935310|NCT01185847|Antiviral Agents|antiviral agents|mesh-ancestor
56935311|NCT01185847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935312|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935313|NCT01185847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935314|NCT01185847|Immunologic Factors|immunologic factors|mesh-ancestor
56935315|NCT01185847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935316|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56935317|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56935318|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
56935319|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56935320|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
56935321|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935322|NCT03720483|Expectorants|expectorants|mesh-ancestor
56935323|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
56935324|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56935325|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
56935326|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935327|NCT03720483|Protective Agents|protective agents|mesh-ancestor
56935328|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935329|NCT03720483|Antidotes|antidotes|mesh-ancestor
56935330|NCT01183663|Leucovorin|leucovorin|mesh-list
56935331|NCT01183663|Sirolimus|sirolimus|mesh-list
56935332|NCT01183663|Bevacizumab|bevacizumab|mesh-list
56935333|NCT01183663|Lenalidomide|lenalidomide|mesh-list
56935334|NCT01183663|Fluorouracil|fluorouracil|mesh-list
56935335|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
56935336|NCT01183663|Sorafenib|sorafenib|mesh-list
56935337|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56935338|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935339|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56935340|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56935341|NCT01183663|Growth Substances|growth substances|mesh-ancestor
56935342|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935343|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
56935344|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
56935345|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935346|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56935347|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935348|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
56935349|NCT01183663|Antidotes|antidotes|mesh-ancestor
56935350|NCT01183663|Protective Agents|protective agents|mesh-ancestor
56935351|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
56935352|NCT01183663|Vitamins|vitamins|mesh-ancestor
56935353|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
56935354|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56935355|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935356|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56935357|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935358|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56935359|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
56935361|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56935362|NCT03344172|Gemcitabine|gemcitabine|mesh-list
56935363|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
56935364|NCT03344172|Paclitaxel|paclitaxel|mesh-list
56935365|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56935366|NCT03344172|Avelumab|avelumab|mesh-list
56935367|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56935368|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935369|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
56935370|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
56935371|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
56935372|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935373|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56935374|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
56935375|NCT03344172|Antiviral Agents|antiviral agents|mesh-ancestor
56935376|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935377|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935378|NCT03344172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935379|NCT03344172|Immunologic Factors|immunologic factors|mesh-ancestor
56935380|NCT03344172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935381|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
56935382|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56935383|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56935384|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56935385|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56935386|NCT01188733|Octreotide|octreotide|mesh-list
56935387|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56935388|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56935389|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935390|NCT01101659|Ketamine|ketamine|mesh-list
56935391|NCT01101659|Analgesics|analgesics|mesh-ancestor
56935392|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
56935393|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935394|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935395|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56935396|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56935397|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
56935398|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
56935399|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935400|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56935401|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56935402|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935403|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935404|NCT03855865|Vortioxetine|vortioxetine|mesh-list
56935405|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
56935406|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56935407|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56935408|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56935409|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935410|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935411|NCT03855865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56935412|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56935413|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56935414|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935415|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935416|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
56935417|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56935418|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56935419|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56935420|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56935421|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
56935422|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56935423|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
56935424|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935425|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
56935426|NCT01290367|Protective Agents|protective agents|mesh-ancestor
56935427|NCT03465891|Atezolizumab|atezolizumab|mesh-list
56935428|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935429|NCT03363906|Dulaglutide|dulaglutide|mesh-list
56935430|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56935431|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56935432|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935433|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
56935434|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
56935435|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
56935436|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56935437|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56935439|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
56935440|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56935441|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
56935442|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
56935443|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56935444|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
56935445|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
56935446|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935447|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935448|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56935449|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
56935450|NCT03948191|Hormones|hormones|mesh-ancestor
56935451|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935452|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56935453|NCT03948191|Protective Agents|protective agents|mesh-ancestor
56935454|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56935455|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935456|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56935457|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56935458|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935459|NCT01292083|Azacitidine|azacitidine|mesh-list
56935460|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56935461|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
56935462|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935463|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935464|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935465|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
56935466|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56935467|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56935468|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935469|NCT01292161|Silymarin|silymarin|mesh-list
56935470|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
56935471|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935472|NCT01292161|Protective Agents|protective agents|mesh-ancestor
56935473|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935474|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
56935475|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
56935476|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56935477|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56935478|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935479|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935480|NCT01185925|Urological Agents|urological agents|mesh-ancestor
56935481|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
56935482|NCT01188889|Everolimus|everolimus|mesh-list
56935483|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935484|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56935485|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935486|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935487|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935488|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
56935489|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935490|NCT01184287|Ranpirnase|ranpirnase|mesh-list
56935491|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935492|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56935493|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935494|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935495|NCT01107431|Chromium|chromium|mesh-list
56935496|NCT01107431|Trace Elements|trace elements|mesh-ancestor
56935497|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
56935498|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935499|NCT01186159|Parecoxib|parecoxib|mesh-list
56935500|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56935501|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56935502|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935503|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935504|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56935505|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56935506|NCT01186159|Analgesics|analgesics|mesh-ancestor
56935507|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
56935508|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935509|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935510|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56935511|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56935512|NCT01107509|Everolimus|everolimus|mesh-list
56935513|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935514|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935515|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
56935516|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935517|NCT01101815|Naltrexone|naltrexone|mesh-list
56935518|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56935519|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56935520|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935521|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
56935522|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935523|NCT01104935|Trastuzumab|trastuzumab|mesh-list
56935524|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56935525|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935526|NCT01293643|Clindamycin|clindamycin|mesh-list
56935527|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
56935528|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
56935529|NCT01293643|Amphotericin B|amphotericin b|mesh-list
56935530|NCT01293643|Tetracycline|tetracycline|mesh-list
56935531|NCT01293643|Ketoconazole|ketoconazole|mesh-list
56935532|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56935533|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56935534|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935535|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56935536|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935537|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935538|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
56935539|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56935540|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56935541|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56935542|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
56935543|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935544|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935545|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56935546|NCT01293643|Amebicides|amebicides|mesh-ancestor
56935547|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56935548|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56935549|NCT01105013|Clotrimazole|clotrimazole|mesh-list
56935550|NCT01105013|Miconazole|miconazole|mesh-list
56935551|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56935552|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935553|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
56935554|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56935555|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56935556|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935557|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935558|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56935559|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
56935560|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935561|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935562|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56935563|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56935564|NCT03851731|Naltrexone|naltrexone|mesh-list
56935565|NCT03851731|Naloxone|naloxone|mesh-list
56935566|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56935567|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56935568|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935569|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
56935570|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935571|NCT03707652|Vitamins|vitamins|mesh-list
56935572|NCT03707652|Niacinamide|niacinamide|mesh-list
56935573|NCT03707652|Niacin|niacin|mesh-list
56935574|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
56935575|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
56935576|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
56935577|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935578|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56935579|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
56935580|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935581|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56935582|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
56935584|NCT01588093|Growth Substances|growth substances|mesh-ancestor
56935585|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935586|NCT01186471|Nicotine|nicotine|mesh-list
56935587|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56935588|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
56935589|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935590|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935591|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56935592|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56935593|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
56935594|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935595|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935596|NCT01292551|Bosentan|bosentan|mesh-list
56935597|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56935598|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56935599|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935600|NCT03854383|Isosorbide|isosorbide|mesh-list
56935601|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56935602|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56935603|NCT03854383|Misoprostol|misoprostol|mesh-list
56935604|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56935605|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
56935606|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56935607|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935608|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56935609|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56935610|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
56935611|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56935612|NCT03854383|Diuretics|diuretics|mesh-ancestor
56935613|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
56935614|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
56935615|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56935616|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935617|NCT03854617|Vinorelbine|vinorelbine|mesh-list
56935618|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56935619|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935620|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
56935621|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
56935622|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
56935623|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935624|NCT01186549|Lidocaine|lidocaine|mesh-list
56935625|NCT01186549|Ephedrine|ephedrine|mesh-list
56935626|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
56935627|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
56935628|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
56935629|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935630|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935631|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
56935632|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935633|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56935634|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56935635|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56935636|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56935637|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935638|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56935639|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
56935640|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
56935641|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56935642|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
56935643|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935644|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56935645|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56935646|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
56935647|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
56935648|NCT03851341|Metformin|metformin|mesh-list
56935649|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56935650|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56935651|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935652|NCT03851341|Incretins|incretins|mesh-ancestor
56935653|NCT03851341|Hormones|hormones|mesh-ancestor
56935654|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935655|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56935656|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
56935657|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935658|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935659|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
56935660|NCT04788108|Progestins|progestins|mesh-ancestor
56935661|NCT04788108|Hormones|hormones|mesh-ancestor
56935662|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935663|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935664|NCT00003389|Prednisone|prednisone|mesh-list
56935665|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
56935666|NCT00003389|Dacarbazine|dacarbazine|mesh-list
56935667|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
56935668|NCT00003389|Doxorubicin|doxorubicin|mesh-list
56935669|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56935670|NCT00003389|Etoposide|etoposide|mesh-list
56935671|NCT00003389|Vincristine|vincristine|mesh-list
56935672|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
56935673|NCT00003389|Bleomycin|bleomycin|mesh-list
56935674|NCT00003389|Vinblastine|vinblastine|mesh-list
56935675|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
56935676|NCT00003389|Imidazole|imidazole|mesh-list
56935677|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935678|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
56935679|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935680|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56935681|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56935682|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
56935683|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935684|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935685|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56935686|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56935687|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56935688|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56935689|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935690|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56935691|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
56935692|NCT00003389|Hormones|hormones|mesh-ancestor
56935693|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935694|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56935695|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56935696|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
56935697|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
56935698|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
56935699|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
56935700|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
56935701|NCT03362190|Ranibizumab|ranibizumab|mesh-list
56935702|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56935703|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56935704|NCT03362190|Growth Substances|growth substances|mesh-ancestor
56935705|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935706|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
56935707|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935708|NCT01292785|Hormones|hormones|mesh-list
56935709|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935710|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935711|NCT02323126|Nivolumab|nivolumab|mesh-list
56935712|NCT02323126|Nazartinib|nazartinib|mesh-list
56935713|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56935714|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935715|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56935716|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935717|NCT01291459|Tenofovir|tenofovir|mesh-list
56935718|NCT01291459|Emtricitabine|emtricitabine|mesh-list
56935719|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
56935720|NCT01291459|Maraviroc|maraviroc|mesh-list
56935721|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
56935722|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935723|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56935724|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56856574|NCT01179308|Anesthetics|anesthetics|mesh-list
56935725|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935726|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935727|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56935728|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56935729|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56935730|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56935731|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56923136|NCT04522284|Capecitabine|capecitabine|mesh-list
56935732|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56935733|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56935734|NCT00003377|Paclitaxel|paclitaxel|mesh-list
56935735|NCT00003377|Cisplatin|cisplatin|mesh-list
56935736|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56935737|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935738|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
56935739|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
56935740|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
56935741|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935742|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56935743|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56935744|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
56935745|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935746|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56935747|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56935748|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
56935749|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
56935750|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935751|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935752|NCT01328015|Oxybutynin|oxybutynin|mesh-list
56935753|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56935754|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
56935755|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
56935756|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935757|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935758|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56935759|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
56935760|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935761|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935762|NCT01328015|Urological Agents|urological agents|mesh-ancestor
56935763|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
56935764|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56935765|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56935766|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
56935767|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935768|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56935769|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56935770|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935771|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935772|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56935773|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
56935774|NCT00002651|Goserelin|goserelin|mesh-list
56935775|NCT00002651|Bicalutamide|bicalutamide|mesh-list
56935776|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56935777|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935778|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
56935779|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
56935780|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935781|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935782|NCT03853993|Vaccines|vaccines|mesh-list
56935783|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
56935784|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935785|NCT03473626|Alicaforsen|alicaforsen|mesh-list
56935786|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56935787|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935788|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
56935789|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935790|NCT05154682|Acetaminophen|acetaminophen|mesh-list
56935791|NCT05154682|Naproxen|naproxen|mesh-list
56935792|NCT05154682|Oxycodone|oxycodone|mesh-list
56935793|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56935794|NCT05154682|Analgesics|analgesics|mesh-ancestor
56935795|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
56935796|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935797|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856658|NCT01176344|Vitamin D|vitamin d|mesh-list
56935798|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
56935799|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56935800|NCT05154682|Narcotics|narcotics|mesh-ancestor
56935801|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935802|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56935803|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56935804|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56935805|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
56935806|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56935807|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935808|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935810|NCT04312841|Letermovir|letermovir|mesh-list
56935811|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56935812|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935813|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935814|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935815|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935816|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56935817|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
56935818|NCT01294735|Temozolomide|temozolomide|mesh-list
56935819|NCT01294735|Niraparib|niraparib|mesh-list
56935820|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56935821|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
56935822|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935823|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935824|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56935825|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935826|NCT03851263|Evolocumab|evolocumab|mesh-list
56935827|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56935828|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56935829|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
56935830|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935831|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56935832|NCT03849235|Glucagon|glucagon|mesh-list
56935833|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56935834|NCT03849235|Hormones|hormones|mesh-ancestor
56935835|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935836|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935837|NCT03477448|Bleomycin|bleomycin|mesh-list
56935838|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56935839|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935840|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
56935841|NCT01187485|Testosterone|testosterone|mesh-list
56935842|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
56935843|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
56935844|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56935845|NCT01187485|Androgens|androgens|mesh-ancestor
56935846|NCT01187485|Hormones|hormones|mesh-ancestor
56935847|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935848|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935849|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56935850|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935851|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
56935852|NCT00002597|Leuprolide|leuprolide|mesh-list
56935853|NCT00002597|Goserelin|goserelin|mesh-list
56935854|NCT00002597|Flutamide|flutamide|mesh-list
56935855|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56935856|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
56935857|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56935858|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935859|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56935860|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935861|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
56935862|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
56935863|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56935864|NCT03853525|Petrolatum|petrolatum|mesh-list
56935865|NCT03853525|Emollients|emollients|mesh-ancestor
56935866|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
56935867|NCT03716583|Melatonin|melatonin|mesh-list
56935868|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56935869|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
56935870|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935871|NCT03716583|Protective Agents|protective agents|mesh-ancestor
56935872|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935873|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56935874|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56935875|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56935876|NCT02738008|Tenofovir|tenofovir|mesh-list
56935877|NCT02738008|Entecavir|entecavir|mesh-list
56935878|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
56935879|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56935880|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
56935881|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935882|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56935883|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56935884|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56935885|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935886|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56935887|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56935888|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
56935889|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935890|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935891|NCT03720249|Vitamins|vitamins|mesh-list
56935892|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
56935893|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
56935894|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
56935895|NCT03720249|Betaine|betaine|mesh-list
56935896|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
56935897|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935898|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56935899|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
56935900|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56935901|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
56935902|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935903|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56935904|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56935905|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56935906|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56935907|NCT01294969|Analgesics|analgesics|mesh-ancestor
56935908|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
56935909|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935910|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935911|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56935912|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56935913|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56935914|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56935915|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56935916|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
56935917|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
56935918|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935919|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935920|NCT03850561|Ubiquinone|ubiquinone|mesh-list
56935921|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
56935922|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
56935923|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935924|NCT03850561|Vitamins|vitamins|mesh-ancestor
56935925|NCT00002525|Leucovorin|leucovorin|mesh-list
56935926|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
56935927|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56935928|NCT00002525|Fluorouracil|fluorouracil|mesh-list
56935929|NCT00002525|Calcium|calcium|mesh-list
56935930|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
56935931|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56935932|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935933|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
56935934|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935935|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56935936|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935937|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935938|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
56935939|NCT00002525|Antidotes|antidotes|mesh-ancestor
56935940|NCT00002525|Protective Agents|protective agents|mesh-ancestor
56935941|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
56935942|NCT00002525|Vitamins|vitamins|mesh-ancestor
56935943|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
56935944|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
56935945|NCT01190137|Vitamin D|vitamin d|mesh-list
56935946|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
56935947|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56935948|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935949|NCT01190137|Vitamins|vitamins|mesh-ancestor
56935950|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
56935951|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56935952|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
56935953|NCT02529839|Fludarabine|fludarabine|mesh-list
56935954|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
56935955|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56935956|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
56935957|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935958|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56935959|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56935960|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
56935961|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935962|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935963|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56935964|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56935966|NCT05039801|Bevacizumab|bevacizumab|mesh-list
56935967|NCT05039801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56935968|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56935969|NCT05039801|Tubulin Modulators|tubulin modulators|mesh-ancestor
56935970|NCT05039801|Antimitotic Agents|antimitotic agents|mesh-ancestor
56935971|NCT05039801|Mitosis Modulators|mitosis modulators|mesh-ancestor
56935972|NCT05039801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935973|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56935974|NCT05039801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56935975|NCT05039801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56935976|NCT05039801|Growth Substances|growth substances|mesh-ancestor
56935977|NCT05039801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935978|NCT05039801|Growth Inhibitors|growth inhibitors|mesh-ancestor
56935979|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
56935980|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56935981|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
56935982|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935983|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56935984|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56935985|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
56935986|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56935987|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
56935988|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56935989|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56935990|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56935991|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
56935992|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
56935993|NCT03473314|Protective Agents|protective agents|mesh-ancestor
56935994|NCT03945539|Itraconazole|itraconazole|mesh-list
56935995|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
56935996|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
56935997|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56935998|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56935999|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56936000|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936001|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936002|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56936003|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
56936004|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56936005|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936006|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56936007|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
56936008|NCT01190293|Efavirenz|efavirenz|mesh-list
56936009|NCT01190293|Maraviroc|maraviroc|mesh-list
56936010|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56936011|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56936012|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936013|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936014|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
56936015|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936016|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56936017|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56936018|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56936019|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56936020|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56936021|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56936022|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56936023|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56856880|NCT01180322|Cytarabine|cytarabine|mesh-list
56936024|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56936025|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56936026|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56936027|NCT03945227|Spartalizumab|spartalizumab|mesh-list
56936028|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56936029|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936030|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936031|NCT01108133|Dexamethasone|dexamethasone|mesh-list
56936032|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56936033|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
56936034|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
56936035|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936036|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936037|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56936039|NCT01108133|Hormones|hormones|mesh-ancestor
56936040|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56936041|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56936042|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936043|NCT01108289|Oxytocin|oxytocin|mesh-list
56936044|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
56936045|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56936046|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936047|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
56936048|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56936049|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56936050|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936051|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56936052|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56936053|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
56936054|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936055|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936056|NCT03947411|Oseltamivir|oseltamivir|mesh-list
56936057|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
56936058|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936059|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936060|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936061|NCT03257254|Polidocanol|polidocanol|mesh-list
56936062|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56936063|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56936064|NCT01327469|Albendazole|albendazole|mesh-list
56936065|NCT01327469|Mebendazole|mebendazole|mesh-list
56936066|NCT01327469|Piperazine|piperazine|mesh-list
56936067|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
56936068|NCT01327469|Pyrantel|pyrantel|mesh-list
56936069|NCT01327469|Oxantel|oxantel|mesh-list
56936070|NCT01327469|DMP 777|dmp 777|mesh-list
56936071|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
56936072|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56936073|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936074|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
56936075|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56936076|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56936077|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
56936078|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
56936079|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
56936080|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936081|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936082|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
56936083|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936084|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56936085|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56936086|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56936087|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936088|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936089|NCT03950141|Apatinib|apatinib|mesh-list
56936090|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936091|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56936092|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936093|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936094|NCT01328171|Folic Acid|folic acid|mesh-list
56936095|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
56936096|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
56936097|NCT01328171|Irinotecan|irinotecan|mesh-list
56936098|NCT01328171|Panitumumab|panitumumab|mesh-list
56936099|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936100|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56936101|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56936102|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936103|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936104|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936105|NCT01328171|Hematinics|hematinics|mesh-ancestor
56936106|NCT01328171|Vitamins|vitamins|mesh-ancestor
56936107|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
56936108|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56936109|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
56936110|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56936111|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936112|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56936113|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56936114|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936115|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936116|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936117|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56936118|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56936119|NCT03084718|Beclomethasone|beclomethasone|mesh-list
56936120|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56936121|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
56936122|NCT03084718|Hormones|hormones|mesh-ancestor
56936123|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56936124|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936125|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56936126|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
56936127|NCT03638999|Ketorolac|ketorolac|mesh-list
56936128|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56936129|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56936130|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56936131|NCT03638999|Analgesics|analgesics|mesh-ancestor
56936132|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
56936133|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936134|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936135|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56936136|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56936137|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56936138|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936139|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936140|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
56936141|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56936142|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936143|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
56936144|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56936145|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936146|NCT03944291|Bupivacaine|bupivacaine|mesh-list
56936147|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
56936148|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
56936149|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936150|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936151|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
56936152|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936153|NCT03067571|Daratumumab|daratumumab|mesh-list
56936154|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936155|NCT01102439|Aspirin|aspirin|mesh-list
56936156|NCT01102439|Clopidogrel|clopidogrel|mesh-list
56936157|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56936158|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56936159|NCT01102439|Analgesics|analgesics|mesh-ancestor
56936160|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
56936161|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936162|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936163|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56936164|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56936165|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56936166|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56936167|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936168|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56936169|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56936170|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936171|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
56936172|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56936173|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56936174|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56936175|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
56936176|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936177|NCT03949985|Hemostatics|hemostatics|mesh-list
56936178|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
56936179|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56936180|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936181|NCT03949985|Coagulants|coagulants|mesh-ancestor
56936182|NCT01584791|Aspirin|aspirin|mesh-list
56936183|NCT01584791|Clopidogrel|clopidogrel|mesh-list
56936184|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56936185|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56936186|NCT01584791|Analgesics|analgesics|mesh-ancestor
56936187|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
56936188|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936189|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936190|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56936191|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56936192|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56936193|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56936194|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936195|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56936196|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56936197|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936198|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
56936199|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56936200|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56936201|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56936202|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
56936203|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936204|NCT04285684|Ketamine|ketamine|mesh-list
56936205|NCT04285684|Analgesics|analgesics|mesh-ancestor
56936206|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
56936207|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936208|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936209|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56936210|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56936211|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
56936212|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
56936213|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936214|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56936215|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56936216|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936217|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936218|NCT01310985|Capecitabine|capecitabine|mesh-list
56936219|NCT01310985|Cetuximab|cetuximab|mesh-list
56936220|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56936221|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
56936222|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936223|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936224|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56936225|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
56936226|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56936227|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936228|NCT02492711|Trastuzumab|trastuzumab|mesh-list
56936229|NCT02492711|Margetuximab|margetuximab|mesh-list
56936230|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56936231|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936232|NCT03716427|Tolbutamide|tolbutamide|mesh-list
56936233|NCT03716427|Midazolam|midazolam|mesh-list
56936234|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
56936235|NCT03716427|Omeprazole|omeprazole|mesh-list
56936236|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56936237|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56936238|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936239|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936240|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56936241|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56936242|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56936243|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56936244|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
56936245|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
56936246|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
56936247|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
56936248|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936249|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936250|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56857101|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936251|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56936252|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56936253|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936254|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
56936255|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
56936256|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56936257|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56936258|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56936259|NCT01147822|Sunitinib|sunitinib|mesh-list
56936260|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531961|NCT04999215|Choline|choline|mesh-list
56936261|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56936262|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56936263|NCT01147822|Growth Substances|growth substances|mesh-ancestor
56936264|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936265|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
56936266|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56936267|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936268|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936269|NCT03431337|Amoxicillin|amoxicillin|mesh-list
56936270|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56936271|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936272|NCT01293097|Atorvastatin|atorvastatin|mesh-list
56936273|NCT01293097|Pravastatin|pravastatin|mesh-list
56936274|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56936275|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56936276|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
56936277|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936278|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56936279|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56936280|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936281|NCT03516292|Mitogens|mitogens|mesh-list
56936282|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
56936283|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936284|NCT01291615|Gemcitabine|gemcitabine|mesh-list
56936285|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56936286|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
56936287|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936288|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936289|NCT01291615|Antiviral Agents|antiviral agents|mesh-ancestor
56936290|NCT01291615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936291|NCT01291615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936292|NCT01291615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56936293|NCT01291615|Immunologic Factors|immunologic factors|mesh-ancestor
56936294|NCT01291615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936295|NCT01295047|Atenolol|atenolol|mesh-list
56936296|NCT01295047|Verapamil|verapamil|mesh-list
56936297|NCT01295047|Perindopril|perindopril|mesh-list
56936298|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56936299|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56936300|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
56936301|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
56936302|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936303|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936304|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56936305|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56936306|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56936307|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
56936308|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936309|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936310|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56936311|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936312|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56936313|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
56936314|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56936315|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
56936316|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936317|NCT03472846|Teriparatide|teriparatide|mesh-list
56936318|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56936319|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936320|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56936321|NCT01190371|Artesunate|artesunate|mesh-list
56936322|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
56936323|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56936324|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56936325|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936326|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936327|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
56936328|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
56936329|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56936330|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
56936331|NCT05158426|Propofol|propofol|mesh-list
56936332|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56936333|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936334|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532037|NCT02878161|Analgesics|analgesics|mesh-ancestor
56936335|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56936336|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
56936337|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
56936338|NCT03853369|Nifekalant|nifekalant|mesh-list
56936339|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56936340|NCT05158348|Lidocaine|lidocaine|mesh-list
56936341|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
56936342|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
56936343|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
56936344|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936345|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936346|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
56936347|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936348|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56936349|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56936350|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56936351|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936352|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936353|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56936354|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56936355|NCT05158348|Analgesics|analgesics|mesh-ancestor
56936356|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56936357|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56936358|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56936359|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
56936360|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936361|NCT01187719|Phenytoin|phenytoin|mesh-list
56936362|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
56936363|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56936364|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56936365|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936366|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936367|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56936368|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56936369|NCT01102595|Bevacizumab|bevacizumab|mesh-list
56936370|NCT01102595|Temozolomide|temozolomide|mesh-list
56936371|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56936372|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936373|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56936374|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56936375|NCT01102595|Growth Substances|growth substances|mesh-ancestor
56936376|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936377|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
56936378|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56936379|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
56936380|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936381|NCT03949517|Piperidine|piperidine|mesh-list
56936382|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56936383|NCT03949517|Bombesin|bombesin|mesh-list
56936384|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936385|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56936386|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936387|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936388|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56936389|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936390|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56936391|NCT03848611|Vorolanib|vorolanib|mesh-list
56936392|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56936393|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936394|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936395|NCT01584947|Bupivacaine|bupivacaine|mesh-list
56936396|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
56936397|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
56936398|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936399|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936400|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
56936401|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936402|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
56936403|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56936404|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936405|NCT01109615|Gemcitabine|gemcitabine|mesh-list
56936406|NCT01109615|Pemetrexed|pemetrexed|mesh-list
56936407|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56936408|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
56936409|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936410|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936411|NCT01109615|Antiviral Agents|antiviral agents|mesh-ancestor
56936412|NCT01109615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936413|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936414|NCT01109615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56936415|NCT01109615|Immunologic Factors|immunologic factors|mesh-ancestor
56936416|NCT01109615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936417|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56936418|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56936419|NCT01209065|Ritonavir|ritonavir|mesh-list
56936420|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
56936421|NCT01209065|Dolutegravir|dolutegravir|mesh-list
56936422|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56936423|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56936424|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
56936425|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936426|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936427|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56936428|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56936429|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
56936430|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936431|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56936432|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56936433|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56936434|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56936435|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
56936436|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56936437|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936438|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936439|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
56936440|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936441|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936442|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
56936443|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936444|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936445|NCT03481725|Coal Tar|coal tar|mesh-list
56936446|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
56936447|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
56936448|NCT03472456|Eugenol|eugenol|mesh-list
56936449|NCT03472456|Carticaine|carticaine|mesh-list
56936450|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
56936451|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
56936452|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936453|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936454|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
56936455|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936456|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936457|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56936458|NCT01193881|R04929097|r04929097|mesh-list
56936459|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936460|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56936461|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936462|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936463|NCT01194037|Interferons|interferons|mesh-list
56936464|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
56936465|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
56936466|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56936467|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936468|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
56936469|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936470|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
56936471|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936472|NCT03480243|Erythromycin|erythromycin|mesh-list
56936473|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
56936474|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56936475|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
56936476|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56936477|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936478|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56936479|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56936480|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936481|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936482|NCT01109693|Mirtazapine|mirtazapine|mesh-list
56936484|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
56936485|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56936486|NCT01109693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56936487|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56936488|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936489|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936490|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936491|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
56936492|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936493|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56936494|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
56936495|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
56936496|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56936497|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56936498|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936499|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56936500|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56936501|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56936502|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
56936503|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56936504|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56936505|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56936506|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
56936507|NCT01190683|Vitamin D|vitamin d|mesh-list
56936508|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
56936509|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
56936510|NCT01190683|Vitamins|vitamins|mesh-list
56936511|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
56936512|NCT01190683|Calcium|calcium|mesh-list
56936513|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
56936514|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936515|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56936516|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56936517|NCT01190683|Antacids|antacids|mesh-ancestor
56936518|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936519|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56936520|NCT01190761|Galantamine|galantamine|mesh-list
56936521|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56936522|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936523|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936524|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
56936525|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936526|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936527|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56936528|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
56936529|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936530|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
56936531|NCT01209455|Acetaminophen|acetaminophen|mesh-list
56936532|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
56936533|NCT01209455|Ranitidine|ranitidine|mesh-list
56936534|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56936535|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56936536|NCT01209455|Analgesics|analgesics|mesh-ancestor
56936537|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
56936538|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936539|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936540|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
56936541|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56936542|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56936543|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56936544|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
56936545|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
56936546|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052585|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
56936547|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936548|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
56936549|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
56936550|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56936551|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56936552|NCT01194115|Metronidazole|metronidazole|mesh-list
56936553|NCT01194115|Cephalexin|cephalexin|mesh-list
56936554|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936555|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56936556|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56936557|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56936558|NCT01209533|Iloprost|iloprost|mesh-list
56936559|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56936561|NCT03847363|Anesthetics|anesthetics|mesh-list
56936562|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936563|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936564|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
56936565|NCT01207739|Doxycycline|doxycycline|mesh-list
56936566|NCT01207739|Clarithromycin|clarithromycin|mesh-list
56936567|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
56936568|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56936569|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56936570|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936571|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936572|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936573|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56936574|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56936575|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56936576|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56936577|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56936578|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
56936579|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56936580|NCT03847207|Pasireotide|pasireotide|mesh-list
56936581|NCT03847207|Hormones|hormones|mesh-ancestor
56936582|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56936583|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936584|NCT01192087|Cetuximab|cetuximab|mesh-list
56936585|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56936586|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936587|NCT03942029|Fluconazole|fluconazole|mesh-list
56936588|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
56936589|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936590|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56936591|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56936592|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936593|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936594|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56936595|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
56936596|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56936597|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936598|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56936599|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56936600|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56936601|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56936602|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
56936603|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936604|NCT01192165|Paclitaxel|paclitaxel|mesh-list
56936605|NCT01192165|Docetaxel|docetaxel|mesh-list
56936606|NCT01192165|Carboplatin|carboplatin|mesh-list
56936607|NCT01192165|Pemetrexed|pemetrexed|mesh-list
56936608|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56936609|NCT01192165|Trametinib|trametinib|mesh-list
56936610|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56936611|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936612|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
56936613|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
56936614|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
56936615|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936616|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936617|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56936618|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56936619|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56936620|NCT01192243|Carboplatin|carboplatin|mesh-list
56936621|NCT01192243|Pemetrexed|pemetrexed|mesh-list
56936622|NCT01192243|Gefitinib|gefitinib|mesh-list
56936623|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857481|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
56936624|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936625|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936626|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56936627|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56936628|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56936629|NCT01209845|Ketamine|ketamine|mesh-list
56936630|NCT01209845|Analgesics|analgesics|mesh-ancestor
56936631|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
56936632|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936633|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936634|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56936635|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56936636|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
56936638|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936639|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56936640|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56936641|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936642|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936643|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
56936644|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
56936645|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56936646|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936647|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936648|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
56936649|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56936650|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936651|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936652|NCT01196767|Ropivacaine|ropivacaine|mesh-list
56936653|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
56936654|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
56936655|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936656|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936657|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
56936658|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936659|NCT01211795|Ketoprofen|ketoprofen|mesh-list
56936660|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56936661|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56936662|NCT01211795|Analgesics|analgesics|mesh-ancestor
56936663|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
56936664|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936665|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936666|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56936667|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56936668|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56936669|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936670|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936671|NCT03451773|Gemcitabine|gemcitabine|mesh-list
56936672|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56936673|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
56936674|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936675|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936676|NCT03451773|Antiviral Agents|antiviral agents|mesh-ancestor
56936677|NCT03451773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936678|NCT03451773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936679|NCT03451773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56936680|NCT03451773|Immunologic Factors|immunologic factors|mesh-ancestor
56936681|NCT03451773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936682|NCT01112891|Vitamin D|vitamin d|mesh-list
56936683|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
56936684|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
56936685|NCT01112891|Vitamins|vitamins|mesh-list
56936686|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
56936687|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936688|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56936689|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56936690|NCT03847441|Vitamin D|vitamin d|mesh-list
56936691|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
56936692|NCT03847441|Calcipotriene|calcipotriene|mesh-list
56936693|NCT03847441|Vitamins|vitamins|mesh-ancestor
56936694|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
56936695|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936696|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56936697|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56936698|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
56936699|NCT02529683|NuvaRing|nuvaring|mesh-list
56936700|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56936701|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
56936702|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56936703|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936704|NCT05406895|Lidocaine|lidocaine|mesh-list
56936705|NCT05406895|Epinephrine|epinephrine|mesh-list
56936706|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
56936707|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
56936708|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936709|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936710|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
56936711|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936712|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56936713|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56936714|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56936715|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936716|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936717|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56936718|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56936719|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
56936720|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936721|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56936722|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56936723|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
56936724|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56936725|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
56936726|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
56936727|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
56936728|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56936729|NCT03425253|Lidocaine|lidocaine|mesh-list
56936730|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
56936731|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
56936732|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936733|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936734|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
56936735|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936736|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56936737|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56936738|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56936739|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936740|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936741|NCT03941561|Tegafur|tegafur|mesh-list
56936742|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56936743|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
56936744|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936745|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936746|NCT05403229|Topiramate|topiramate|mesh-list
56936747|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
56936748|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56936749|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936750|NCT03424239|Vitamin D|vitamin d|mesh-list
56936751|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
56936752|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
56936753|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
56936754|NCT03424239|Vitamins|vitamins|mesh-list
56936755|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
56936756|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936757|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56936758|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56936759|NCT03941795|Axitinib|axitinib|mesh-list
56936760|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936761|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56936762|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936763|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936764|NCT01197001|Losartan|losartan|mesh-list
56936765|NCT01197001|Amlodipine|amlodipine|mesh-list
56936766|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56936767|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56936768|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936769|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936770|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56857635|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
56936771|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936772|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
56936773|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56936774|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56936775|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56936776|NCT01113047|Amlodipine|amlodipine|mesh-list
56936777|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56936778|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56936779|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936780|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936781|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56936782|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936783|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
56936784|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
56936785|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56936786|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936787|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56936788|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936789|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936790|NCT01210391|Caseins|caseins|mesh-list
56936791|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
56936792|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
56936793|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936794|NCT03846739|Oxytocin|oxytocin|mesh-list
56936795|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
56936796|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56936797|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936798|NCT03716115|Budesonide|budesonide|mesh-list
56936799|NCT03716115|Teduglutide|teduglutide|mesh-list
56936800|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56936801|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56936802|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
56936803|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936804|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936805|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56936806|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
56936807|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
56936808|NCT03716115|Hormones|hormones|mesh-ancestor
56936809|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56936810|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56936811|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56936812|NCT03716115|Protective Agents|protective agents|mesh-ancestor
56936813|NCT01113281|Vaccines|vaccines|mesh-list
56936814|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
56936815|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936816|NCT01295593|Cladribine|cladribine|mesh-list
56936817|NCT01295593|Valproic Acid|valproic acid|mesh-list
56936818|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
56936819|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936820|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936821|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
56936822|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936823|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936824|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
56936825|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56936826|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936827|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56936828|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936829|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56936830|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
56936831|NCT03845881|Oxycodone|oxycodone|mesh-list
56936832|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56936833|NCT03845881|Narcotics|narcotics|mesh-ancestor
56936834|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936835|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936836|NCT03845881|Analgesics|analgesics|mesh-ancestor
56936837|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
56936838|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936839|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
56936840|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56936841|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936842|NCT01296997|Calcium|calcium|mesh-list
56936843|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56936844|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936845|NCT01114841|Tazarotene|tazarotene|mesh-list
56936846|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
56936847|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
56936848|NCT01113437|Omalizumab|omalizumab|mesh-list
56936849|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56936850|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56936851|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
56936852|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
56936853|NCT01197235|Hematinics|hematinics|mesh-ancestor
56936854|NCT01192789|Amoxicillin|amoxicillin|mesh-list
56532556|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
56936855|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56936856|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936857|NCT01211171|Telmisartan|telmisartan|mesh-list
56936858|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56936859|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56936860|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56936861|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936862|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
56936863|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56936864|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56936865|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936866|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
56936867|NCT03846973|Coagulants|coagulants|mesh-ancestor
56936868|NCT01113515|Esmolol|esmolol|mesh-list
56936869|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56936870|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56936871|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56936872|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
56936873|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936874|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936875|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936876|NCT01211327|Cyclosporine|cyclosporine|mesh-list
56936877|NCT01211327|Dexamethasone|dexamethasone|mesh-list
56936878|NCT01211327|Cyclosporins|cyclosporins|mesh-list
56936879|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56936880|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
56936881|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
56936882|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56936883|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936884|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56936885|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
56936886|NCT01211327|Hormones|hormones|mesh-ancestor
56936887|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56936888|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56936889|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936890|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936891|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936892|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56936893|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
56936894|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
56936895|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936896|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
56936897|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56936898|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56936899|NCT05601895|Sorafenib|sorafenib|mesh-list
56936900|NCT05601895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936901|NCT05601895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56936902|NCT05601895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936903|NCT05601895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936904|NCT01113671|Vitamin E|vitamin e|mesh-list
56936905|NCT01113671|Tocopherols|tocopherols|mesh-list
56936906|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
56936907|NCT01113671|Vitamins|vitamins|mesh-ancestor
56936908|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
56936909|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936910|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
56936911|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936912|NCT01113671|Protective Agents|protective agents|mesh-ancestor
56936913|NCT03943043|Gemcitabine|gemcitabine|mesh-list
56936914|NCT03943043|Paclitaxel|paclitaxel|mesh-list
56936915|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
56936916|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56936917|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936918|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
56936919|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
56936920|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
56936921|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936922|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56936923|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
56936924|NCT03943043|Antiviral Agents|antiviral agents|mesh-ancestor
56936925|NCT03943043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936926|NCT03943043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936927|NCT03943043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56936928|NCT03943043|Immunologic Factors|immunologic factors|mesh-ancestor
56936929|NCT03943043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936930|NCT01109927|Insulin|insulin|mesh-list
56936931|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56936932|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936933|NCT03940235|Androgens|androgens|mesh-list
56936934|NCT03940235|Hormones|hormones|mesh-ancestor
56936935|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56936936|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936937|NCT03848533|Metformin|metformin|mesh-list
56936938|NCT03848533|Melatonin|melatonin|mesh-list
56936939|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56936940|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936941|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
56936942|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936943|NCT03848533|Protective Agents|protective agents|mesh-ancestor
56936944|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936945|NCT01193491|Geldanamycin|geldanamycin|mesh-list
56936946|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56936947|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936948|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
56936949|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56936950|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936951|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936952|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56936953|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
56936954|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56936955|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56936956|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56936957|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936958|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936959|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56936960|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56936961|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56936962|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
56936963|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56936964|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936965|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56936966|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56936967|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
56936968|NCT01208285|Ivacaftor|ivacaftor|mesh-list
56936969|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56936970|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56936971|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936972|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
56936973|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56936974|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
56936975|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
56936976|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936977|NCT01208441|Letrozole|letrozole|mesh-list
56936978|NCT01208441|R04929097|r04929097|mesh-list
56936979|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56936980|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56936981|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56936982|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936983|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936984|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56936985|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
56936986|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56936987|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936988|NCT03718377|Anesthetics|anesthetics|mesh-list
56936989|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56936990|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56936991|NCT01197469|Tadalafil|tadalafil|mesh-list
56936992|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
56936993|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56936994|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56936995|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56936996|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56936997|NCT01197469|Urological Agents|urological agents|mesh-ancestor
56936998|NCT01211561|Selenium|selenium|mesh-list
56936999|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
56937000|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937001|NCT01211561|Protective Agents|protective agents|mesh-ancestor
56937002|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937003|NCT01211561|Trace Elements|trace elements|mesh-ancestor
56937004|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
56937005|NCT05358535|Propofol|propofol|mesh-list
56937006|NCT05358535|Etomidate|etomidate|mesh-list
56937007|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56937008|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937009|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937010|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56937011|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
56937012|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
56937013|NCT01213355|Scopolamine|scopolamine|mesh-list
56937014|NCT01213355|Donepezil|donepezil|mesh-list
56937015|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56937016|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56937017|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937018|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937019|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
56937020|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937021|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937022|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
56937023|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56937024|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
56937025|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
56937026|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937027|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56937028|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
56937029|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56937030|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56937031|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
56937032|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
56937033|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56937034|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56937035|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937036|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
56937037|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937038|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937039|NCT03848065|Vaccines|vaccines|mesh-list
56937040|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
56937041|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937042|NCT01110473|Azacitidine|azacitidine|mesh-list
56937043|NCT01110473|Ilorasertib|ilorasertib|mesh-list
56937044|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56937045|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
56937046|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937047|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937048|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937049|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56937050|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
56937051|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56937052|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937053|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937054|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56937055|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56937056|NCT05558761|Protective Agents|protective agents|mesh-ancestor
56937057|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937058|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
56937059|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56937060|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
56937061|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
56937062|NCT03940391|Midazolam|midazolam|mesh-list
56937063|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56937064|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56937065|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937066|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937067|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56937068|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56937069|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56937070|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56937071|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
56937072|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
56937073|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
56937074|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
56937075|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937076|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937077|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
56937078|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
56937079|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56937080|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
56937081|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
56937082|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56937083|NCT03715881|Prednisolone|prednisolone|mesh-list
56937084|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
56937085|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937086|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
56937087|NCT03715881|Hormones|hormones|mesh-ancestor
56937088|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937089|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937090|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56937091|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937092|NCT03715881|Hematinics|hematinics|mesh-ancestor
56937093|NCT01197781|Verapamil|verapamil|mesh-list
56937094|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56937095|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56937096|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56937097|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937098|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56937099|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937100|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
56937101|NCT01110551|Vaccines|vaccines|mesh-list
56937102|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
56937103|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937104|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56937105|NCT01296139|Hematinics|hematinics|mesh-ancestor
56937106|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56937107|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56937108|NCT03940469|Dexamethasone|dexamethasone|mesh-list
56937109|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
56937110|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
56937111|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937112|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
56937113|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
56937114|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937115|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937116|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56937117|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
56937118|NCT03940469|Hormones|hormones|mesh-ancestor
56937119|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937120|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56937121|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937122|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56937123|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937124|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56937125|NCT03940469|Analgesics|analgesics|mesh-ancestor
56937126|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
56937127|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56937128|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56937129|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56937130|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
56937131|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937132|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937133|NCT01110785|Panitumumab|panitumumab|mesh-list
56937134|NCT01110785|Simvastatin|simvastatin|mesh-list
56937135|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56937136|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56937137|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
56937138|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937139|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56937140|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56937141|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937142|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56937143|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937144|NCT03846271|Oxytocin|oxytocin|mesh-list
56937145|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
56052586|NCT02271698|Hormones|hormones|mesh-ancestor
56937146|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56937147|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937148|NCT01110941|Leucovorin|leucovorin|mesh-list
56937149|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
56937150|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937151|NCT01110941|Antidotes|antidotes|mesh-ancestor
56937152|NCT01110941|Protective Agents|protective agents|mesh-ancestor
56937153|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937154|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
56937155|NCT01110941|Vitamins|vitamins|mesh-ancestor
56937156|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
56937157|NCT03448419|Empagliflozin|empagliflozin|mesh-list
56937158|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56532862|NCT05331781|Narcotics|narcotics|mesh-ancestor
56937159|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937161|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937162|NCT01118039|Sunitinib|sunitinib|mesh-list
56937163|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937164|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56937165|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56937166|NCT01118039|Growth Substances|growth substances|mesh-ancestor
56937167|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937168|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
56937169|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56937170|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937171|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937172|NCT01213433|Artesunate|artesunate|mesh-list
56937173|NCT01213433|Amodiaquine|amodiaquine|mesh-list
56937174|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
56937175|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56937176|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56937177|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937178|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937179|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
56937180|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
56937181|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56937182|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
56937183|NCT01111253|Amoxicillin|amoxicillin|mesh-list
56937184|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
56937185|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
56937186|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56937187|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56937188|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937189|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56937190|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937191|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937192|NCT01213667|Ranibizumab|ranibizumab|mesh-list
56937193|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56937194|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56937195|NCT01213667|Growth Substances|growth substances|mesh-ancestor
56937196|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937197|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
56937198|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937199|NCT01196065|Memantine|memantine|mesh-list
56937200|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56937201|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56937202|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
56937203|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937204|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937205|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937206|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56937207|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56937208|NCT05258773|Azasetron|azasetron|mesh-list
56937209|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
56937210|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
56937211|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937212|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937213|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56937214|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56937215|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
56937216|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937217|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937218|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56937219|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56937220|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56937221|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937222|NCT03845179|Incretins|incretins|mesh-ancestor
56937223|NCT03845179|Hormones|hormones|mesh-ancestor
56937224|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937225|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
56937226|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937227|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937228|NCT03936023|Saxagliptin|saxagliptin|mesh-list
56937229|NCT03936023|Incretins|incretins|mesh-ancestor
56937230|NCT03936023|Hormones|hormones|mesh-ancestor
56937231|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937232|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937233|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56937234|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
56937235|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937236|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937237|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56937238|NCT01121705|Interferons|interferons|mesh-list
56937239|NCT01121705|Ribavirin|ribavirin|mesh-list
56937240|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
56937241|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
56937242|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56937243|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937244|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
56937245|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937246|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
56937247|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937248|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
56937249|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937250|NCT01196455|Capecitabine|capecitabine|mesh-list
56937251|NCT01196455|Mitomycins|mitomycins|mesh-list
56937252|NCT01196455|Mitomycin|mitomycin|mesh-list
56937253|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56937254|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
56937255|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937256|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937257|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56937258|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
56937259|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56937260|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937261|NCT03846583|Trastuzumab|trastuzumab|mesh-list
56937262|NCT03846583|Tucatinib|tucatinib|mesh-list
56937263|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56937264|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56937265|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937266|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56937267|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937268|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937269|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56937270|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
56937271|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937272|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937273|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56937274|NCT01115543|Calcitriol|calcitriol|mesh-list
56937275|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
56937276|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56937277|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56937278|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937279|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56937280|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56937281|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937282|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56937283|NCT01115543|Vitamins|vitamins|mesh-ancestor
56937284|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
56937285|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56937286|NCT01118429|Oxybutynin|oxybutynin|mesh-list
56937287|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
56937288|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
56937289|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937290|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937291|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56937292|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56937293|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
56937294|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937295|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937296|NCT01118429|Urological Agents|urological agents|mesh-ancestor
56937297|NCT01216007|Propofol|propofol|mesh-list
56937298|NCT01216007|Sevoflurane|sevoflurane|mesh-list
56937299|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56937300|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937301|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937302|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56937303|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
56937304|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
56937305|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56937306|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56937307|NCT01198249|Losartan|losartan|mesh-list
56937308|NCT01198249|Amlodipine|amlodipine|mesh-list
56937309|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56937310|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56937311|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56937312|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56937313|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937314|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56937315|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937316|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
56937317|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56937318|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56937319|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56937320|NCT01198249|Diuretics|diuretics|mesh-ancestor
56937321|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
56937322|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56937323|NCT02529761|Sorafenib|sorafenib|mesh-list
56937324|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937325|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56937326|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937327|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937328|NCT03844243|Mitogens|mitogens|mesh-list
56937329|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
56937330|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937331|NCT05479591|Xultophy|xultophy|mesh-list
56937332|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56937333|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937334|NCT05479591|Incretins|incretins|mesh-ancestor
56937335|NCT05479591|Hormones|hormones|mesh-ancestor
56937336|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937337|NCT01119209|Ropivacaine|ropivacaine|mesh-list
56937338|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
56937339|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
56937340|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937341|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937342|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
56937343|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937344|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
56937345|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56937346|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937347|NCT01116167|Letrozole|letrozole|mesh-list
56937348|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937349|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56937350|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56937351|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937352|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937353|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56937354|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
56937355|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937356|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937357|NCT01119521|Isoniazid|isoniazid|mesh-list
56937358|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
56937359|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56937360|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937361|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56937362|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56937363|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
56937364|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937365|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56937366|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
56937367|NCT03939923|Rocuronium|rocuronium|mesh-list
56937368|NCT03939923|Neostigmine|neostigmine|mesh-list
56937369|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56937370|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56937371|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56937372|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937373|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937374|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56937375|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937376|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937377|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
56937378|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937379|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56937380|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
56533091|NCT04413253|Hormones|hormones|mesh-ancestor
56937381|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56937382|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56937383|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56937384|NCT01119599|Temozolomide|temozolomide|mesh-list
56937385|NCT01119599|R04929097|r04929097|mesh-list
56937386|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56937387|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
56937388|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937389|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937390|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937391|NCT03419403|Temozolomide|temozolomide|mesh-list
56937392|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56937393|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56937394|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56937395|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
56937396|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937397|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937398|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56937399|NCT05156437|Amoxicillin|amoxicillin|mesh-list
56937400|NCT05156437|Vancomycin|vancomycin|mesh-list
56937401|NCT05156437|Levofloxacin|levofloxacin|mesh-list
56937402|NCT05156437|Rifampin|rifampin|mesh-list
56937403|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
56937404|NCT05156437|Linezolid|linezolid|mesh-list
56937405|NCT05156437|Daptomycin|daptomycin|mesh-list
56937406|NCT05156437|Cephalexin|cephalexin|mesh-list
56937407|NCT05156437|Ampicillin|ampicillin|mesh-list
56937408|NCT05156437|Cefepime|cefepime|mesh-list
56937409|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56937410|NCT05156437|Oxacillin|oxacillin|mesh-list
56937411|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
56937412|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56937413|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937414|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56937415|NCT05156437|Renal Agents|renal agents|mesh-ancestor
56937416|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56937417|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56937418|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937419|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937420|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937421|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56937422|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56937423|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56937424|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
56937425|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
56937426|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56937427|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56937428|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56937429|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56937430|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56937431|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56937432|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56937433|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56937434|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
56937435|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56937436|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
56937437|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937438|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937439|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
56937440|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937441|NCT03715725|Warfarin|warfarin|mesh-list
56937442|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
56937443|NCT03715725|Dabigatran|dabigatran|mesh-list
56937444|NCT03715725|Apixaban|apixaban|mesh-list
56937445|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
56937446|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56937447|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
56937448|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56937449|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
56937450|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937451|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937452|NCT01212653|Golimumab|golimumab|mesh-list
56937453|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56937454|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937455|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56937456|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
56937457|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937458|NCT01213979|Iron|iron|mesh-list
56937459|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56937460|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
56937461|NCT01213979|Trace Elements|trace elements|mesh-ancestor
56937462|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
56937463|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937464|NCT01213979|Hematinics|hematinics|mesh-ancestor
56937465|NCT05282719|Azacitidine|azacitidine|mesh-list
56937466|NCT05282719|Venetoclax|venetoclax|mesh-list
56937467|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56937468|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
56937469|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937470|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937471|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937472|NCT03447249|Ivacaftor|ivacaftor|mesh-list
56937473|NCT03447249|VX-659|vx-659|mesh-list
56937474|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56937475|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56937476|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937477|NCT04156555|Amoxicillin|amoxicillin|mesh-list
56937478|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
56937479|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
56937480|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56937481|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56937482|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937483|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56937484|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937485|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937486|NCT01200121|Bevacizumab|bevacizumab|mesh-list
56937487|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56937488|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937489|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56937490|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56937491|NCT01200121|Growth Substances|growth substances|mesh-ancestor
56937492|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937493|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
56937494|NCT01214291|Toremifene|toremifene|mesh-list
56937495|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56937496|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937497|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56937498|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56937499|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
56937500|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937501|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937502|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56937503|NCT01116635|Doxorubicin|doxorubicin|mesh-list
56937504|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56937505|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937506|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56937507|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56937508|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937509|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937510|NCT01566799|Metformin|metformin|mesh-list
56937511|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56937512|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937513|NCT04642807|Calpastatin|calpastatin|mesh-list
56937514|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56937515|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
56937516|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937517|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937518|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
56937519|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937520|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56937521|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937522|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937523|NCT01198639|Remifentanil|remifentanil|mesh-list
56937524|NCT01198639|Propofol|propofol|mesh-list
56937525|NCT01198639|Anesthetics|anesthetics|mesh-list
56937526|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56937527|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937528|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937529|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56937530|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
56937531|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56533234|NCT02962063|Paclitaxel|paclitaxel|mesh-list
56937532|NCT01198639|Narcotics|narcotics|mesh-ancestor
56937534|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
56937535|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937536|NCT01116713|Dexamethasone|dexamethasone|mesh-list
56937537|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937538|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
56937539|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
56937540|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937541|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937542|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56937543|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
56937544|NCT01116713|Hormones|hormones|mesh-ancestor
56937545|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937546|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56937547|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937548|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
56937549|NCT01202149|Emollients|emollients|mesh-list
56937550|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56937551|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56937552|NCT01202149|Analgesics|analgesics|mesh-ancestor
56937553|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
56937554|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937555|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937556|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937557|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56937558|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
56937559|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56937560|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
56937561|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56937562|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937563|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937564|NCT01116791|Cisplatin|cisplatin|mesh-list
56937565|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937566|NCT03717909|Valproic Acid|valproic acid|mesh-list
56937567|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
56937568|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937569|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937570|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
56937571|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937572|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937573|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
56937574|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56937575|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937576|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56937577|NCT03940001|Paclitaxel|paclitaxel|mesh-list
56937578|NCT03940001|Carboplatin|carboplatin|mesh-list
56937579|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56937580|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937581|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
56937582|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
56937583|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
56937584|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937585|NCT01120769|Acetaminophen|acetaminophen|mesh-list
56937586|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56937587|NCT01120769|Analgesics|analgesics|mesh-ancestor
56937588|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
56937589|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937590|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937591|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
56937592|NCT03715413|Tamoxifen|tamoxifen|mesh-list
56937593|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56937594|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
56937595|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937596|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937597|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56937598|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937599|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56937600|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56937601|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56937602|NCT01122251|Valsartan|valsartan|mesh-list
56937603|NCT01122251|Lercanidipine|lercanidipine|mesh-list
56533306|NCT00626769|Genistein|genistein|mesh-list
56937604|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56937605|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56937606|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56937607|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937608|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56937609|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56937610|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56937611|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937612|NCT04600999|Favipiravir|favipiravir|mesh-list
56937613|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
56937614|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937615|NCT01199029|Prednisone|prednisone|mesh-list
56937616|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937617|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
56937618|NCT01199029|Hormones|hormones|mesh-ancestor
56937619|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937620|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937621|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56937622|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937623|NCT01200745|Capsaicin|capsaicin|mesh-list
56937624|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
56937625|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
56937626|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
56937627|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937628|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937629|NCT01585415|Aldesleukin|aldesleukin|mesh-list
56937630|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
56937631|NCT01585415|Fludarabine|fludarabine|mesh-list
56937632|NCT01585415|Vemurafenib|vemurafenib|mesh-list
56937633|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56937634|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
56937635|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937636|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56937637|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56937638|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
56937639|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937640|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937641|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56937642|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56937643|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56937644|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
56937645|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937646|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56937647|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937648|NCT01566643|Metronidazole|metronidazole|mesh-list
56937649|NCT01566643|Rabeprazole|rabeprazole|mesh-list
56937650|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937651|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56937652|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56937653|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56937654|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56937655|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56937656|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56937657|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937658|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937659|NCT03841747|Paclitaxel|paclitaxel|mesh-list
56937660|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
56937661|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56937662|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937663|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
56937664|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
56937665|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
56937666|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937667|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56937668|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
56937669|NCT01121237|Hematinics|hematinics|mesh-ancestor
56937670|NCT03841591|Metformin|metformin|mesh-list
56937671|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56937672|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858540|NCT01190462|Cetuximab|cetuximab|mesh-list
56937673|NCT05667727|Epinephrine|epinephrine|mesh-list
56937674|NCT05667727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56937675|NCT05667727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56937676|NCT05667727|Adrenergic Agents|adrenergic agents|mesh-ancestor
56937677|NCT05667727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937678|NCT05667727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937679|NCT05667727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937680|NCT05667727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56937681|NCT05667727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56533400|NCT00975130|Golimumab|golimumab|mesh-list
56937683|NCT05667727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937684|NCT05667727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56937685|NCT05667727|Respiratory System Agents|respiratory system agents|mesh-ancestor
56937686|NCT05667727|Mydriatics|mydriatics|mesh-ancestor
56937687|NCT05667727|Sympathomimetics|sympathomimetics|mesh-ancestor
56937688|NCT05667727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56937689|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56937690|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
56937691|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56937692|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56937693|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56937694|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937695|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937696|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
56937697|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56937698|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
56937699|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937700|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
56937701|NCT01212809|Protective Agents|protective agents|mesh-ancestor
56937702|NCT01214993|Dolutegravir|dolutegravir|mesh-list
56937703|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56937704|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56937705|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937706|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937707|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56937708|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56937709|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
56937710|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937711|NCT03843229|Bufanolides|bufanolides|mesh-list
56937712|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56937713|NCT03843229|Protective Agents|protective agents|mesh-ancestor
56937714|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937715|NCT04042753|Nivolumab|nivolumab|mesh-list
56937716|NCT04042753|Ipilimumab|ipilimumab|mesh-list
56937717|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56937718|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937719|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56937720|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937721|NCT01212887|Aldesleukin|aldesleukin|mesh-list
56937722|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
56937723|NCT01212887|Fludarabine|fludarabine|mesh-list
56937724|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
56937725|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56937726|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
56937727|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937728|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56937729|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56937730|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
56937731|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937732|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937733|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56937734|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56937735|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
56937736|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56937737|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56937738|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
56937739|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937740|NCT01215149|Vaccines|vaccines|mesh-list
56937741|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
56937742|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937743|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
56937744|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937745|NCT04961281|Triamcinolone|triamcinolone|mesh-list
56937746|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
56937747|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56937748|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937749|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937750|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56937751|NCT04961281|Analgesics|analgesics|mesh-ancestor
56937752|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
56937753|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937754|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56937755|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56937756|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56937757|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
56937758|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937759|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937760|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937761|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
56937762|NCT04961281|Hormones|hormones|mesh-ancestor
56937763|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56937764|NCT01212965|Selenium|selenium|mesh-list
56937765|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
56937766|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937767|NCT01212965|Protective Agents|protective agents|mesh-ancestor
56937768|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937769|NCT01212965|Trace Elements|trace elements|mesh-ancestor
56937770|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
56937771|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
56937772|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56937773|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937774|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56937775|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937776|NCT01216709|Iron|iron|mesh-list
56937777|NCT01216709|Trace Elements|trace elements|mesh-ancestor
56937778|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
56937779|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937780|NCT01216787|R04929097|r04929097|mesh-list
56937781|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937782|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937783|NCT05282251|Bupivacaine|bupivacaine|mesh-list
56937784|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
56937785|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
56937786|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937787|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937788|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
56937789|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937790|NCT04485559|Everolimus|everolimus|mesh-list
56937791|NCT04485559|Trametinib|trametinib|mesh-list
56937792|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937793|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56937794|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
56937795|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937796|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56937797|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937798|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937799|NCT01199341|Warfarin|warfarin|mesh-list
56937800|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
56937801|NCT01215539|Panitumumab|panitumumab|mesh-list
56937802|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56937803|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937804|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
56937805|NCT01203709|Tacrolimus|tacrolimus|mesh-list
56937806|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56937807|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
56937808|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937809|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56937810|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937811|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937812|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56937813|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937814|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56937815|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
56937816|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56937817|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937818|NCT01122407|Trimethaphan|trimethaphan|mesh-list
56937819|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
56937820|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937821|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55733599|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
56937822|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56937823|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56937824|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
56937825|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937826|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937827|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56937828|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56937829|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
56937830|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937831|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
56937832|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56937833|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
56937835|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56937836|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56937837|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937838|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937839|NCT01124435|Celecoxib|celecoxib|mesh-list
56937840|NCT01124435|Carboplatin|carboplatin|mesh-list
56937841|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937842|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56937843|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56937844|NCT01124435|Analgesics|analgesics|mesh-ancestor
56937845|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
56937846|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937847|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937848|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937849|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56937850|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56937851|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56937852|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937853|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937854|NCT03294304|Gemcitabine|gemcitabine|mesh-list
56937855|NCT03294304|Nivolumab|nivolumab|mesh-list
56937856|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937857|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56937858|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
56937859|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937860|NCT03294304|Antiviral Agents|antiviral agents|mesh-ancestor
56937861|NCT03294304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937862|NCT03294304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937863|NCT03294304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56937864|NCT03294304|Immunologic Factors|immunologic factors|mesh-ancestor
56937865|NCT03294304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937866|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56937867|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56937868|NCT01201213|Anesthetics|anesthetics|mesh-list
56937869|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
56937870|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937871|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937872|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
56937873|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937874|NCT03472378|Celecoxib|celecoxib|mesh-list
56937875|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56937876|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56937877|NCT03472378|Analgesics|analgesics|mesh-ancestor
56937878|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
56937879|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937880|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937881|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937882|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56937883|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56937884|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56937885|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937886|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937887|NCT03408873|Aripiprazole|aripiprazole|mesh-list
56937888|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
56937889|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56937890|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56937891|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56937892|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937893|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937894|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
56937895|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
56937896|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937897|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937898|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56937899|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56937900|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
56937901|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56937902|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56937903|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56937904|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56937905|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56937906|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56937907|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56937908|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
56937909|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937910|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56937911|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56937912|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937913|NCT03780959|Etanercept|etanercept|mesh-list
56937914|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56937915|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56937916|NCT03780959|Analgesics|analgesics|mesh-ancestor
56937917|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
56937918|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937919|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937920|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56937921|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56937922|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56937923|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56937924|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
56937925|NCT03838783|Insulin|insulin|mesh-list
56937926|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56937927|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937928|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
56937929|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
56937930|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
56937931|NCT03408639|Vitamins|vitamins|mesh-ancestor
56937932|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
56937933|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937934|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
56937935|NCT03408639|Hematinics|hematinics|mesh-ancestor
56937936|NCT01219205|Bevacizumab|bevacizumab|mesh-list
56937937|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56937938|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56937939|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56937940|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56937941|NCT01219205|Growth Substances|growth substances|mesh-ancestor
56937942|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937943|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
56937944|NCT03810235|Lidocaine|lidocaine|mesh-list
56937945|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
56937946|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
56937947|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937948|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937949|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
56937950|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937951|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56937952|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56937953|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56937954|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56937955|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937956|NCT03408483|Epinephrine|epinephrine|mesh-list
56937957|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
56937958|NCT03408483|Bupivacaine|bupivacaine|mesh-list
56937959|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
56937960|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
56937961|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56937962|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937963|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
56937964|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937965|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56937966|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56937967|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
56937968|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56937969|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937970|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56937971|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56937972|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
56937973|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56937974|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
56937975|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
56937976|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
56937977|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56937978|NCT03408483|Narcotics|narcotics|mesh-ancestor
56937979|NCT03408483|Analgesics|analgesics|mesh-ancestor
56937980|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
56937981|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56937982|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
56937983|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937984|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
56937985|NCT03777917|Protective Agents|protective agents|mesh-ancestor
56937986|NCT03715023|PC-786|pc-786|mesh-list
56937987|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
56937988|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56937989|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56937990|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56937991|NCT03714867|Pregabalin|pregabalin|mesh-list
56937992|NCT03714867|Analgesics|analgesics|mesh-ancestor
56937993|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
56937994|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56937995|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56937996|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
56937997|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56937998|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56937999|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938000|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56938001|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56938002|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56938003|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938004|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56938005|NCT01204177|Sorafenib|sorafenib|mesh-list
56938006|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938007|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56938008|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938009|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938010|NCT01217099|Azithromycin|azithromycin|mesh-list
56938011|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
56938012|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56938013|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56938014|NCT01217099|Prednisolone|prednisolone|mesh-list
56938015|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
56938016|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56938017|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
56938018|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56938019|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
56938020|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
56938021|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938022|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938023|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56938024|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
56938025|NCT01217099|Hormones|hormones|mesh-ancestor
56938026|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938027|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56938028|NCT01217099|Protective Agents|protective agents|mesh-ancestor
56938029|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56938030|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938031|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56938032|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938033|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
56938034|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56938035|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
56938036|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938037|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938038|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56938039|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
56938040|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56938041|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
56938042|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938043|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938044|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56938045|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
56938046|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
56938047|NCT04305457|Protective Agents|protective agents|mesh-ancestor
56938048|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
56938049|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56938050|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56938051|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
56938052|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938053|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938054|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938055|NCT01122563|Urological Agents|urological agents|mesh-ancestor
56938056|NCT01217177|Everolimus|everolimus|mesh-list
56938057|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938058|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938059|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
56938060|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938061|NCT01204333|Heparin|heparin|mesh-list
56938062|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
56938063|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56938064|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56938065|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938066|NCT02529059|Tenofovir|tenofovir|mesh-list
56938067|NCT02529059|Emtricitabine|emtricitabine|mesh-list
56938068|NCT02529059|Rilpivirine|rilpivirine|mesh-list
56938069|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
56938070|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938071|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56938072|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56938073|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938074|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938075|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56938076|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56938077|NCT03100058|Licogliflozin|licogliflozin|mesh-list
56938078|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56938079|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938080|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56938081|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938082|NCT03932123|Vancomycin|vancomycin|mesh-list
56938083|NCT03932123|Meropenem|meropenem|mesh-list
56938084|NCT03932123|Tazobactam|tazobactam|mesh-list
56938085|NCT03932123|Piperacillin|piperacillin|mesh-list
56938086|NCT03932123|Cefotaxime|cefotaxime|mesh-list
56938087|NCT03932123|Cefoxitin|cefoxitin|mesh-list
56938088|NCT03932123|Azlocillin|azlocillin|mesh-list
56938089|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56938090|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938091|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56938092|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938093|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938094|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
56938095|NCT02866279|Etonogestrel|etonogestrel|mesh-list
56938096|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56938097|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938098|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56938099|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56938100|NCT01222169|Propofol|propofol|mesh-list
56938101|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56938102|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938103|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938104|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56938105|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
56938106|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
56938107|NCT02871778|Ivacaftor|ivacaftor|mesh-list
56938108|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56938109|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56938110|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938111|NCT04947592|Fluconazole|fluconazole|mesh-list
56938112|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
56938113|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938114|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56938115|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56938116|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938117|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938118|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56938119|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
56938120|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938121|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938122|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56938123|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56938124|NCT02735473|Choline|choline|mesh-list
56938125|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
56938126|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56938127|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
56938128|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938129|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56938130|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56533833|NCT02845843|Ritonavir|ritonavir|mesh-list
56938131|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
56938132|NCT05156788|Lenvatinib|lenvatinib|mesh-list
56938133|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938134|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56938135|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938136|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938137|NCT04199767|Insulin|insulin|mesh-list
56938138|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56938139|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
56938140|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56938141|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938142|NCT01125059|Methadone|methadone|mesh-list
56938143|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56938144|NCT01125059|Narcotics|narcotics|mesh-ancestor
56938145|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938146|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938147|NCT01125059|Analgesics|analgesics|mesh-ancestor
56938148|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
56938149|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938150|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
56938151|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
56938152|NCT01204411|Artesunate|artesunate|mesh-list
56938153|NCT01204411|Amodiaquine|amodiaquine|mesh-list
56938154|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
56938155|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56938156|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56938157|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938158|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938159|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
56938160|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
56938161|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56938162|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
56938163|NCT01471444|Methotrexate|methotrexate|mesh-list
56938164|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
56938165|NCT01471444|Clofarabine|clofarabine|mesh-list
56938166|NCT01471444|Fludarabine|fludarabine|mesh-list
56938167|NCT01471444|Busulfan|busulfan|mesh-list
56938168|NCT01471444|Tacrolimus|tacrolimus|mesh-list
56938169|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
56938170|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56938171|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56938172|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
56938173|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56938174|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938175|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56938176|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
56938177|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938178|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938179|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
56938180|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938181|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56938182|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938183|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
56938184|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56938185|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56938186|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56938187|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
56938188|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56938189|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56938190|NCT05282407|Tenofovir|tenofovir|mesh-list
56938191|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
56938192|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938193|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56938194|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56938195|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938196|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938197|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56938198|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56938199|NCT04209686|Paclitaxel|paclitaxel|mesh-list
56938200|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
56938201|NCT04209686|Olaparib|olaparib|mesh-list
56938202|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56938203|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938204|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
56938205|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
56938206|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
56938207|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938208|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56938209|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56938210|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938211|NCT01125215|Capsaicin|capsaicin|mesh-list
56938212|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
56938213|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
56938214|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
56938215|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938216|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938217|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
56938218|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56938219|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
56938220|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938221|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938222|NCT05162872|Niraparib|niraparib|mesh-list
56938223|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56938224|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938225|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938226|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938227|NCT01567111|Metomidate|metomidate|mesh-list
56938228|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56938229|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938230|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938231|NCT03955211|Acetaminophen|acetaminophen|mesh-list
56938232|NCT03955211|Ibuprofen|ibuprofen|mesh-list
56938233|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56938234|NCT03955211|Analgesics|analgesics|mesh-ancestor
56938235|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
56938236|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938237|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938238|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
56938239|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56938240|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56938241|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56938242|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56938243|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938244|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938245|NCT03933605|Midazolam|midazolam|mesh-list
56938246|NCT03933605|Palonosetron|palonosetron|mesh-list
56938247|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56938248|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56938249|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938250|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938251|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56938252|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56938253|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56938254|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56938255|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
56938256|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
56938257|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
56938258|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
56938259|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938260|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938261|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
56938262|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
56938263|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938264|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56938265|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56938266|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56938267|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
56938268|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
56938269|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56938270|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56938271|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
56938272|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
56938273|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
56938274|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
56938275|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56938276|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938277|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938278|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
56938279|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56938280|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938281|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938282|NCT01311141|Doripenem|doripenem|mesh-list
56938283|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56938284|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938285|NCT01122641|Vildagliptin|vildagliptin|mesh-list
56938286|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56938287|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938288|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56938289|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
56938290|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938291|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938292|NCT03423979|Paclitaxel|paclitaxel|mesh-list
56938293|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56938294|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938295|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56938296|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56938297|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56938298|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938299|NCT03714555|Copper|copper|mesh-list
56938300|NCT03714555|Gemcitabine|gemcitabine|mesh-list
56938301|NCT03714555|Paclitaxel|paclitaxel|mesh-list
56938302|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56938303|NCT03714555|Folfirinox|folfirinox|mesh-list
56938304|NCT03714555|Disulfiram|disulfiram|mesh-list
56938305|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56938306|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938307|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
56938308|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
56938309|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
56938310|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938311|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56938312|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
56938313|NCT03714555|Antiviral Agents|antiviral agents|mesh-ancestor
56938314|NCT03714555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938315|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938316|NCT03714555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938317|NCT03714555|Immunologic Factors|immunologic factors|mesh-ancestor
56938318|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938319|NCT03714555|Trace Elements|trace elements|mesh-ancestor
56938320|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
56938321|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56938322|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56938323|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
56938324|NCT01125449|Vitamins|vitamins|mesh-ancestor
56938325|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
56938326|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938327|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
56938328|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938329|NCT01125449|Protective Agents|protective agents|mesh-ancestor
56938330|NCT01206049|Gemcitabine|gemcitabine|mesh-list
56938331|NCT01206049|Bevacizumab|bevacizumab|mesh-list
56938332|NCT01206049|Panitumumab|panitumumab|mesh-list
56938333|NCT01206049|Capecitabine|capecitabine|mesh-list
56938334|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
56938335|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56938336|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938337|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56938338|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56938339|NCT01206049|Growth Substances|growth substances|mesh-ancestor
56938340|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938341|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
56938342|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56938343|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
56938344|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938345|NCT01206049|Antiviral Agents|antiviral agents|mesh-ancestor
56938346|NCT01206049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938347|NCT01206049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938348|NCT01206049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938349|NCT01206049|Immunologic Factors|immunologic factors|mesh-ancestor
56938350|NCT03931889|Vitamin D|vitamin d|mesh-list
56938351|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
56859221|NCT00306527|Vaccines|vaccines|mesh-list
56938352|NCT03931889|Vitamins|vitamins|mesh-ancestor
56938353|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
56938354|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938355|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56938356|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56938357|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56938358|NCT02953821|Hormones|hormones|mesh-ancestor
56938359|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938360|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938361|NCT01206205|Lenalidomide|lenalidomide|mesh-list
56938362|NCT01206205|Bortezomib|bortezomib|mesh-list
56938363|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
56938364|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938365|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56938366|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56938367|NCT01206205|Growth Substances|growth substances|mesh-ancestor
56938368|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
56938369|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938370|NCT03783923|Deflazacort|deflazacort|mesh-list
56938371|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56938372|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938373|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
56938374|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938375|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56938376|NCT03472144|Levofloxacin|levofloxacin|mesh-list
56938377|NCT03472144|Ofloxacin|ofloxacin|mesh-list
56938378|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56938379|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938380|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
56938381|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56938382|NCT03472144|Renal Agents|renal agents|mesh-ancestor
56938383|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56938384|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56938385|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938386|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938387|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938388|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56938389|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56938390|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
56938391|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
56938392|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938393|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56938394|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938395|NCT01219751|Sunitinib|sunitinib|mesh-list
56938396|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938397|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56938398|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56938399|NCT01219751|Growth Substances|growth substances|mesh-ancestor
56938400|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938401|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
56938402|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56938403|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938404|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938405|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
56938406|NCT04823091|Fludarabine|fludarabine|mesh-list
56938407|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938408|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
56938409|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938410|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56938411|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56938412|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
56938413|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938414|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938415|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56938416|NCT01125527|Vaccines|vaccines|mesh-list
56938417|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
56938418|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938419|NCT01298401|Gemcitabine|gemcitabine|mesh-list
56938420|NCT01298401|Capecitabine|capecitabine|mesh-list
56938421|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56938422|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
56938423|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938424|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938425|NCT01298401|Antiviral Agents|antiviral agents|mesh-ancestor
56938426|NCT01298401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938427|NCT01298401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938428|NCT01298401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938429|NCT01298401|Immunologic Factors|immunologic factors|mesh-ancestor
56938430|NCT01298401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938431|NCT03931343|Epinephrine|epinephrine|mesh-list
56938432|NCT03931343|Racepinephrine|racepinephrine|mesh-list
56938433|NCT03931343|Bupivacaine|bupivacaine|mesh-list
56938434|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
56938435|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
56938436|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
56534131|NCT00899431|Rituximab|rituximab|mesh-list
56938437|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938438|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938439|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
56938440|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938441|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56938442|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56938443|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
56938444|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938445|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938446|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56938447|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56938448|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
56938449|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56938450|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
56938451|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
56938452|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
56938453|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56938454|NCT04046614|Nivolumab|nivolumab|mesh-list
56938455|NCT04046614|Nintedanib|nintedanib|mesh-list
56938456|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56938457|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938458|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56938459|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938460|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56938461|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938462|NCT04867798|Tenofovir|tenofovir|mesh-list
56938463|NCT04867798|Lamivudine|lamivudine|mesh-list
56938464|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
56938465|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938466|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56938467|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56938468|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938469|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938470|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56938471|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56938472|NCT01122953|Phenytoin|phenytoin|mesh-list
56938473|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
56938474|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56938475|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56938476|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56938477|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938478|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56938479|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56938480|NCT01125683|Donepezil|donepezil|mesh-list
56938481|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56938482|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938483|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938484|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
56938485|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938486|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938487|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
56938488|NCT01127555|Leucovorin|leucovorin|mesh-list
56938489|NCT01127555|Fluorouracil|fluorouracil|mesh-list
56938490|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
56938491|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
56938492|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938493|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56938494|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938495|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938496|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
56938497|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938498|NCT01127555|Antidotes|antidotes|mesh-ancestor
56938499|NCT01127555|Protective Agents|protective agents|mesh-ancestor
56859369|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
56938500|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
56938501|NCT01127555|Vitamins|vitamins|mesh-ancestor
56938502|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
56938503|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
56938504|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938505|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
56938506|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938507|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56938508|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56938509|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
56938510|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534205|NCT01228175|Vitamins|vitamins|mesh-ancestor
56938511|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938512|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56938513|NCT03471988|Voriconazole|voriconazole|mesh-list
56938514|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
56938515|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938516|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56938517|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56938518|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938519|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938520|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56938521|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
56938522|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938523|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938524|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56938525|NCT03724981|Dulaglutide|dulaglutide|mesh-list
56938526|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56938527|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938528|NCT03442569|Nivolumab|nivolumab|mesh-list
56938529|NCT03442569|Ipilimumab|ipilimumab|mesh-list
56938530|NCT03442569|Panitumumab|panitumumab|mesh-list
56938531|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56938532|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938533|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56938534|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938535|NCT01123031|Esomeprazole|esomeprazole|mesh-list
56938536|NCT01123031|Lansoprazole|lansoprazole|mesh-list
56938537|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
56938538|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56938539|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56938540|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56938541|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938542|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938543|NCT01220063|Irinotecan|irinotecan|mesh-list
56938544|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56938545|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56938546|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938547|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938548|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938549|NCT01298713|Tamoxifen|tamoxifen|mesh-list
56938550|NCT01298713|Everolimus|everolimus|mesh-list
56938551|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938552|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938553|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
56938554|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938555|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56938556|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
56938557|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938558|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56938559|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56938560|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56938561|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56938562|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
56938563|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56938564|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938565|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56938566|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938567|NCT04496596|Suramin|suramin|mesh-list
56938568|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
56938569|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
56938570|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56938571|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938572|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938573|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56938574|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56938575|NCT01217879|Telmisartan|telmisartan|mesh-list
56938576|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56938577|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56938578|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56938579|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938580|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
56938581|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56938582|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534279|NCT00895843|Analgesics|analgesics|mesh-ancestor
56938583|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
56938584|NCT04249310|Olodaterol|olodaterol|mesh-list
56938585|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56938586|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
56938587|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938588|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938589|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56938590|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
56938591|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
56938592|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56938593|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
56938594|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938595|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938596|NCT05665075|Cytarabine|cytarabine|mesh-list
56938597|NCT05665075|Cyclophosphamide|cyclophosphamide|mesh-list
56938598|NCT05665075|Fludarabine|fludarabine|mesh-list
56938599|NCT05665075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938600|NCT05665075|Immunologic Factors|immunologic factors|mesh-ancestor
56938601|NCT05665075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938602|NCT05665075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56938603|NCT05665075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56938604|NCT05665075|Alkylating Agents|alkylating agents|mesh-ancestor
56938605|NCT05665075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938606|NCT05665075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938607|NCT05665075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56938608|NCT05665075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56938609|NCT05665075|Antimetabolites|antimetabolites|mesh-ancestor
56938610|NCT05665075|Antiviral Agents|antiviral agents|mesh-ancestor
56938611|NCT05665075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938612|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56938613|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
56938614|NCT03714165|Defensins|defensins|mesh-list
56938615|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938616|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
56938617|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56938618|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938619|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938620|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56938621|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
56938622|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56938623|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
56938624|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
56938625|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938626|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938627|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56938628|NCT03932825|Analgesics|analgesics|mesh-ancestor
56938629|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
56938630|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938631|NCT03932981|Temozolomide|temozolomide|mesh-list
56938632|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56938633|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
56938634|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938635|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938636|NCT01220219|Pregabalin|pregabalin|mesh-list
56938637|NCT01220219|Analgesics|analgesics|mesh-ancestor
56938638|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
56938639|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938640|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938641|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
56938642|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56938643|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56938644|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938645|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56938646|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56938647|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56938648|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938649|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56938650|NCT03441789|Betamethasone|betamethasone|mesh-list
56938651|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
56938652|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56938653|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
56938654|NCT03441789|Calcipotriene|calcipotriene|mesh-list
56938655|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56938656|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56938657|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
56938658|NCT03441789|Hormones|hormones|mesh-ancestor
56938659|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938660|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938661|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56938662|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
56938663|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
56938664|NCT03359005|Vincristine|vincristine|mesh-list
56938665|NCT03359005|Temozolomide|temozolomide|mesh-list
56938666|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56938667|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938668|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56938669|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56938670|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
56938671|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938672|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56938673|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
56938674|NCT04321174|Ritonavir|ritonavir|mesh-list
56938675|NCT04321174|Lopinavir|lopinavir|mesh-list
56938676|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56938677|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56938678|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
56938679|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938680|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938681|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56938682|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56938683|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
56938684|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938685|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56938686|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56938687|NCT01123265|Methotrexate|methotrexate|mesh-list
56938688|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56938689|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
56938690|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56938691|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938692|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56938693|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
56938694|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938695|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938696|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
56938697|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938698|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56938699|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938700|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
56938701|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56938702|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56938703|NCT01204723|Aprepitant|aprepitant|mesh-list
56938704|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
56938705|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
56938706|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
56938707|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938708|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938709|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56938710|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56938711|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938712|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938713|NCT05572515|Dexamethasone|dexamethasone|mesh-list
56938714|NCT05572515|Bortezomib|bortezomib|mesh-list
56938715|NCT05572515|Pomalidomide|pomalidomide|mesh-list
56938716|NCT05572515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56938717|NCT05572515|Antiemetics|antiemetics|mesh-ancestor
56938718|NCT05572515|Autonomic Agents|autonomic agents|mesh-ancestor
56938719|NCT05572515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859595|NCT03209518|Leuprolide|leuprolide|mesh-list
56938720|NCT05572515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938721|NCT05572515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56938722|NCT05572515|Glucocorticoids|glucocorticoids|mesh-ancestor
56938723|NCT05572515|Hormones|hormones|mesh-ancestor
56938724|NCT05572515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938725|NCT05572515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56938726|NCT05572515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938727|NCT05572515|Immunologic Factors|immunologic factors|mesh-ancestor
56938728|NCT05572515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56938729|NCT05572515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56938730|NCT05572515|Growth Substances|growth substances|mesh-ancestor
56938731|NCT05572515|Growth Inhibitors|growth inhibitors|mesh-ancestor
56938732|NCT01204801|Doxorubicin|doxorubicin|mesh-list
56938733|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56938734|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56938735|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938736|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56938737|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56938738|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938739|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938740|NCT04194814|Betamethasone|betamethasone|mesh-list
56938741|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
56938742|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56938743|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
56938744|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56938745|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56938746|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
56938747|NCT04194814|Hormones|hormones|mesh-ancestor
56938748|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938749|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938750|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56938751|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
56938752|NCT03832621|Nivolumab|nivolumab|mesh-list
56938753|NCT03832621|Ipilimumab|ipilimumab|mesh-list
56938754|NCT03832621|Temozolomide|temozolomide|mesh-list
56938755|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56938756|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938757|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56938758|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938759|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56938760|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
56938761|NCT01220375|Plerixafor|plerixafor|mesh-list
56938762|NCT01220375|Vinorelbine|vinorelbine|mesh-list
56938763|NCT01220375|Lenograstim|lenograstim|mesh-list
56938764|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56938765|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
56938766|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938767|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56938768|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938769|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
56938770|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
56938771|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
56938772|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938773|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56938774|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56938775|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
56938776|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938777|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
56938778|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
56938779|NCT01223729|Vitamins|vitamins|mesh-ancestor
56938780|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
56938781|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938782|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
56938783|NCT01126073|Niacin|niacin|mesh-list
56938784|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56938785|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
56938786|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938787|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56938788|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
56938789|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
56938790|NCT01126073|Vitamins|vitamins|mesh-ancestor
56938791|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
56938792|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938793|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
56938794|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859674|NCT00332189|Verapamil|verapamil|mesh-list
56938795|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938796|NCT05470881|Atropine|atropine|mesh-list
56938797|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56938798|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56938799|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56938800|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
56938801|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938802|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938803|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56938804|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
56938805|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
56938806|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
56938807|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56938808|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56938809|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
56938810|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938811|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938812|NCT03130504|Progesterone|progesterone|mesh-list
56938813|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56938814|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56938815|NCT03130504|Progestins|progestins|mesh-ancestor
56938816|NCT03130504|Hormones|hormones|mesh-ancestor
56938817|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938818|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938819|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56938820|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
56938821|NCT03819127|Metformin|metformin|mesh-list
56938822|NCT03819127|Vildagliptin|vildagliptin|mesh-list
56938823|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56938824|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938825|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56938826|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
56938827|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938828|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938829|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
56938830|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56938831|NCT05607550|Aflutinib|aflutinib|mesh-list
56938832|NCT05607550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56938833|NCT05607550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938834|NCT05607550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938835|NCT01299181|Atorvastatin|atorvastatin|mesh-list
56938836|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56938837|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56938838|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
56938839|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938840|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56938841|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56938842|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938843|NCT04075292|Rituximab|rituximab|mesh-list
56938844|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
56938845|NCT04075292|Chlorambucil|chlorambucil|mesh-list
56938846|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56938847|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938848|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
56938849|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938850|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56938851|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56938852|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
56938853|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938854|NCT03930875|Aspirin|aspirin|mesh-list
56938855|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56938856|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56938857|NCT03930875|Analgesics|analgesics|mesh-ancestor
56938858|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
56938859|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938860|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938861|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56938862|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56938863|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56938864|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56938865|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938866|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56938867|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56938868|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938869|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
56938870|NCT01206907|Oxymorphone|oxymorphone|mesh-list
56938871|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56938872|NCT01206907|Narcotics|narcotics|mesh-ancestor
56938873|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56938874|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938875|NCT01206907|Analgesics|analgesics|mesh-ancestor
56938876|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
56938877|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938878|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56938879|NCT03925246|Nivolumab|nivolumab|mesh-list
56938880|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56938881|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938882|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56938883|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534577|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
56938884|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56938885|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56938886|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56938887|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
56938888|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938889|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56938890|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56938891|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938892|NCT04071236|Avelumab|avelumab|mesh-list
56938893|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56938894|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56938895|NCT04071236|Peposertib|peposertib|mesh-list
56938896|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56938897|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938898|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
56938899|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938900|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56938901|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938902|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938903|NCT01126229|Resveratrol|resveratrol|mesh-list
56938904|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
56938905|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938906|NCT01126229|Protective Agents|protective agents|mesh-ancestor
56938907|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938908|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938909|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56938910|NCT03474640|Antibodies|antibodies|mesh-list
56938911|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56938912|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
56938913|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938914|NCT01126307|Verapamil|verapamil|mesh-list
56938915|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56938916|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56938917|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56938918|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938919|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56938920|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938921|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
56938922|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
56938923|NCT03439137|Hematinics|hematinics|mesh-ancestor
56938924|NCT04173338|Pemetrexed|pemetrexed|mesh-list
56938925|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938926|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938927|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938928|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56938929|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56938930|NCT03936491|Methylphenidate|methylphenidate|mesh-list
56938931|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56938932|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56938933|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938934|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56938935|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56938936|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56938937|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938938|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
56938939|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938940|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56938941|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
56938942|NCT00890617|Prednisone|prednisone|mesh-list
56938943|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56938944|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
56938945|NCT00890617|Hormones|hormones|mesh-ancestor
56938946|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56938947|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938948|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56938949|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56938950|NCT00610051|Alprostadil|alprostadil|mesh-list
56938951|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56938952|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
56938953|NCT00610051|Urological Agents|urological agents|mesh-ancestor
56938954|NCT03468946|Caffeine|caffeine|mesh-list
56938955|NCT03468946|Citric Acid|citric acid|mesh-list
56938956|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56534659|NCT00966940|Travoprost|travoprost|mesh-list
56938957|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938958|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56938959|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938960|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938961|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56938962|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56938963|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
56938964|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938965|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
56938966|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56938967|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
56938968|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
56938969|NCT01218425|Levodopa|levodopa|mesh-list
56938970|NCT01218425|Carbidopa|carbidopa|mesh-list
56938971|NCT01218425|Domperidone|domperidone|mesh-list
56938972|NCT01218425|Methylphenidate|methylphenidate|mesh-list
56938973|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56938974|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938975|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56938976|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56938977|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56938978|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56938979|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
56938980|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56938981|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56938982|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56938983|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56938984|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56938985|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
56938986|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
56938987|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56938988|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56938989|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56938990|NCT05621005|Rifaximin|rifaximin|mesh-list
56938991|NCT05621005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56938992|NCT05621005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56938993|NCT05621005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56938994|NCT01224041|Tacrolimus|tacrolimus|mesh-list
56938995|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56938996|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
56938997|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56938998|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56938999|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939000|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939001|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
56939002|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939003|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939004|NCT05081492|Antibodies|antibodies|mesh-list
56939005|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
56939006|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
56939007|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939008|NCT01123811|Cetuximab|cetuximab|mesh-list
56939009|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56939010|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939011|NCT01128101|Spironolactone|spironolactone|mesh-list
56939012|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56939013|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
55733695|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
56939014|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939015|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939016|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56939017|NCT01128101|Diuretics|diuretics|mesh-ancestor
56939018|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
56939019|NCT01299415|Vadimezan|vadimezan|mesh-list
56939020|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939021|NCT01123967|Nicotine|nicotine|mesh-list
56939022|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56939023|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
56939024|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939025|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939026|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56939027|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56939028|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
56939029|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939030|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939031|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
56939032|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939033|NCT01126697|Ubiquinone|ubiquinone|mesh-list
56939034|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
56939035|NCT01126697|Lisinopril|lisinopril|mesh-list
56939036|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56939037|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
56939038|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939039|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939040|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56939041|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56939042|NCT01126697|Protective Agents|protective agents|mesh-ancestor
56939043|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939044|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
56939045|NCT01126697|Vitamins|vitamins|mesh-ancestor
56939046|NCT01220843|Sevelamer|sevelamer|mesh-list
56939047|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
56939048|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
56939049|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939050|NCT02804932|Methamphetamine|methamphetamine|mesh-list
56939051|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56939052|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939053|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
56939054|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
56939055|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939056|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
56939057|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939058|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939059|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
56939060|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56939061|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56939062|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56939063|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56939064|NCT03468790|Fluticasone|fluticasone|mesh-list
56939065|NCT03468790|Xhance|xhance|mesh-list
56939066|NCT03468790|Budesonide|budesonide|mesh-list
56939067|NCT03468790|Albuterol|albuterol|mesh-list
56939068|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
56939069|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56939070|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56939071|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56939072|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56939073|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56939074|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
56939075|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939076|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939077|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56939078|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56939079|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
56939080|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56939081|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
56939082|NCT03468790|Hormones|hormones|mesh-ancestor
56939083|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939084|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56939085|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56939086|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56939087|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
56939088|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939089|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939090|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
56939091|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56939092|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
56939093|NCT01224197|Simeprevir|simeprevir|mesh-list
56939094|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
56939095|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939096|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
56939097|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939098|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939099|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
56939100|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
56939101|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939102|NCT01224353|Protective Agents|protective agents|mesh-ancestor
56939103|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939104|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
56939105|NCT01224353|Vitamins|vitamins|mesh-ancestor
56939106|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
56534802|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
56939108|NCT01218581|Goserelin|goserelin|mesh-list
56939109|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939110|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56939111|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56939112|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939113|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939114|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56939115|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
56939116|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939117|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939118|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56939119|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
56939120|NCT01207297|Tacrolimus|tacrolimus|mesh-list
56939121|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56939122|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
56939123|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939124|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56939125|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56939126|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
56939127|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939128|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939129|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56939130|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56939131|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939132|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
56939133|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56939134|NCT03720847|Estradiol|estradiol|mesh-list
56939135|NCT03720847|Progesterone|progesterone|mesh-list
56939136|NCT03720847|Estrogens|estrogens|mesh-ancestor
56939137|NCT03720847|Hormones|hormones|mesh-ancestor
56939138|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939139|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939140|NCT03720847|Progestins|progestins|mesh-ancestor
56939141|NCT01128257|Alendronate|alendronate|mesh-list
56939142|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
56939143|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56939144|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939145|NCT01205347|Simvastatin|simvastatin|mesh-list
56939146|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56939147|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56939148|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
56939149|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939150|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56939151|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56939152|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939153|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
56939154|NCT01218737|Prednisolone|prednisolone|mesh-list
56939155|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56939156|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
56939157|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56939158|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
56939159|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56939160|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
56939161|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56939162|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
56939163|NCT01218737|Hormones|hormones|mesh-ancestor
56939164|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939165|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939166|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56939167|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939168|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
56939169|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
56939170|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939171|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56939172|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56939173|NCT01218737|Protective Agents|protective agents|mesh-ancestor
56939174|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56939175|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939176|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56939177|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56939178|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56939179|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56939180|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534878|NCT01226459|Minoxidil|minoxidil|mesh-list
56939181|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939182|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
56939183|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56939184|NCT01224509|Mifepristone|mifepristone|mesh-list
56939185|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56939186|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
56939187|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56939188|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939189|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56939190|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56939191|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56939192|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
56939193|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56939194|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56939195|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
56939196|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939197|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
56939198|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56939199|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56939200|NCT01301053|Insulin|insulin|mesh-list
56939201|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56939202|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56939203|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939204|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
56939205|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56939206|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
56939207|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939208|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
56939209|NCT03825133|Protective Agents|protective agents|mesh-ancestor
56939210|NCT03817567|Antibodies|antibodies|mesh-list
56939211|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56939212|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
56939213|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939214|NCT01127009|Cytarabine|cytarabine|mesh-list
56939215|NCT01127009|Etoposide|etoposide|mesh-list
56939216|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
56939217|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
56939218|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
56939219|NCT01127009|Bortezomib|bortezomib|mesh-list
56939220|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56939221|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939222|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56939223|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56939224|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939225|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939226|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56939227|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
56939228|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
56939229|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939230|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56939231|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
56939232|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939233|NCT01127009|Analgesics|analgesics|mesh-ancestor
56939234|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
56939235|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939236|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
56939237|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
56939238|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
56939239|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
56939240|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
56939241|NCT03817411|Capecitabine|capecitabine|mesh-list
56939242|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
56939243|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56939244|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
56939245|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939246|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939247|NCT01205737|Rituximab|rituximab|mesh-list
56939248|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56939249|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939250|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
56939251|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939252|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56939253|NCT01218893|Chloroquine|chloroquine|mesh-list
56939254|NCT01218893|Proguanil|proguanil|mesh-list
56534960|NCT02861482|Oxytocin|oxytocin|mesh-list
56939255|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56939256|NCT01218893|Amebicides|amebicides|mesh-ancestor
56939257|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56939258|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56939259|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939260|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
56939261|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56939262|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
56939263|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939264|NCT03824119|Ibuprofen|ibuprofen|mesh-list
56939265|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56939266|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56939267|NCT03824119|Analgesics|analgesics|mesh-ancestor
56939268|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
56939269|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939270|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939271|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56939272|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56939273|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56939274|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939275|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939276|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
56939277|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56939278|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56939279|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939280|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
56939281|NCT03823417|Coagulants|coagulants|mesh-ancestor
56939282|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
56939283|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939284|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56939285|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939286|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939287|NCT01225913|Fluticasone|fluticasone|mesh-list
56939288|NCT01225913|Xhance|xhance|mesh-list
56939289|NCT01225913|Budesonide|budesonide|mesh-list
56939290|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
56939291|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56939292|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56939293|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56939294|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56939295|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56939296|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
56939297|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939298|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939299|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56939300|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
56939301|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
56939302|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56939303|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
56939304|NCT01225913|Hormones|hormones|mesh-ancestor
56939305|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939306|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56939307|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56939308|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56939309|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
56939310|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939311|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939312|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
56939313|NCT01224977|Azithromycin|azithromycin|mesh-list
56939314|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56860191|NCT00301067|Calcitriol|calcitriol|mesh-list
56939315|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939316|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
56939317|NCT01226069|Glycerol|glycerol|mesh-list
56939318|NCT01226069|Analgesics|analgesics|mesh-ancestor
56939319|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
56939320|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939321|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939322|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
56939323|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939324|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56939325|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
56939326|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56939327|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56939328|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939329|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56939330|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
56535029|NCT00892099|Vitamin D|vitamin d|mesh-list
56939332|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56939333|NCT01226069|Protective Agents|protective agents|mesh-ancestor
56939334|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
56939335|NCT03928691|Analgesics|analgesics|mesh-ancestor
56939336|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
56939337|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939338|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939339|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
56939340|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939341|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56939342|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
56939343|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56939344|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56939345|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939346|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56939347|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
56939348|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56939349|NCT01297855|Rifampin|rifampin|mesh-list
56939350|NCT01297855|Colistin|colistin|mesh-list
56939351|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56939352|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
56939353|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56939354|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939355|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
56939356|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56939357|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939358|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939359|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56939360|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56939361|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56939362|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56939363|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56939364|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56939365|NCT02631070|Luspatercept|luspatercept|mesh-list
56939366|NCT02631070|Hematinics|hematinics|mesh-ancestor
56939367|NCT01298011|Gemcitabine|gemcitabine|mesh-list
56939368|NCT01298011|Paclitaxel|paclitaxel|mesh-list
56939369|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56939370|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56939371|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939372|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
56939373|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
56939374|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
56939375|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939376|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56939377|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
56939378|NCT01298011|Antiviral Agents|antiviral agents|mesh-ancestor
56939379|NCT01298011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939380|NCT01298011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939381|NCT01298011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56939382|NCT01298011|Immunologic Factors|immunologic factors|mesh-ancestor
56939383|NCT01298011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939384|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56939385|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
56939386|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56535101|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
56535102|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
56535103|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
56535104|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535105|NCT02860234|Capecitabine|capecitabine|mesh-list
56535106|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
56535107|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56535108|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
56535109|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535110|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535111|NCT00630370|ATI 7505|ati 7505|mesh-list
56535112|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56535113|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56535114|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
56535115|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535117|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939387|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56939388|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939389|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939390|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939391|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
56939392|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56939393|NCT05137678|Glyburide|glyburide|mesh-list
56939394|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56939395|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939396|NCT01226303|Tretinoin|tretinoin|mesh-list
56939397|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939398|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
56939399|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
56939400|NCT03814759|Cisplatin|cisplatin|mesh-list
56939401|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939402|NCT05101018|Denosumab|denosumab|mesh-list
56939403|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56939404|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939405|NCT03929861|Fluconazole|fluconazole|mesh-list
56939406|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
56939407|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939408|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56939409|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56939410|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939411|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939412|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56939413|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
56939414|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939415|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939416|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56939417|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56939418|NCT03821623|Niacinamide|niacinamide|mesh-list
56939419|NCT03821623|Niacin|niacin|mesh-list
56939420|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
56939421|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
56939422|NCT03821623|Vitamins|vitamins|mesh-ancestor
56939423|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
56939424|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939425|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56939426|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
56939427|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939428|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56939429|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
56939430|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56939431|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
56939432|NCT03928145|Amiloride|amiloride|mesh-list
56939433|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56939434|NCT03928145|Diuretics|diuretics|mesh-ancestor
56939435|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
56939436|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939437|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56939438|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56939439|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939440|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56939441|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56939442|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56939443|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56939444|NCT01129271|Clopidogrel|clopidogrel|mesh-list
56860342|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56939445|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56939446|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56939447|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56939448|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56939449|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
56939450|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939451|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939452|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939453|NCT03816553|Apatinib|apatinib|mesh-list
56939454|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939455|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56939456|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939457|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939458|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
56939459|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535177|NCT02830789|Calcium|calcium|mesh-list
56939460|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56939461|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939462|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939463|NCT00741988|Bevacizumab|bevacizumab|mesh-list
56939464|NCT00741988|Carboplatin|carboplatin|mesh-list
56939465|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56939466|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939467|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56939468|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56939469|NCT00741988|Growth Substances|growth substances|mesh-ancestor
56939470|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939471|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
56939472|NCT01131377|Acetazolamide|acetazolamide|mesh-list
56939473|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
56939474|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56939475|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939476|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939477|NCT01131377|Diuretics|diuretics|mesh-ancestor
56939478|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
56939479|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939480|NCT04457050|Ribavirin|ribavirin|mesh-list
56939481|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
56939482|NCT04457050|Ledipasvir|ledipasvir|mesh-list
56939483|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
56939484|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939485|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
56939486|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939487|NCT01228409|Acitretin|acitretin|mesh-list
56939488|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
56939489|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56939490|NCT03470350|Capecitabine|capecitabine|mesh-list
56939491|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56939492|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
56939493|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939494|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939495|NCT04565392|Famotidine|famotidine|mesh-list
56939496|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56939497|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56939498|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56939499|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
56939500|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
56939501|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939502|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939503|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939504|NCT05654233|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56939505|NCT05654233|Anticoagulants|anticoagulants|mesh-ancestor
56939506|NCT05654233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56939507|NCT05654233|Antimetabolites|antimetabolites|mesh-ancestor
56939508|NCT05654233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939509|NCT05654233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56939510|NCT05654233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56939511|NCT05654233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56939512|NCT05654233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56939513|NCT05654233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939514|NCT01226771|Ribavirin|ribavirin|mesh-list
56939515|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
56939516|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860413|NCT01065701|Analgesics|analgesics|mesh-ancestor
56939517|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
56939518|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939519|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
56939520|NCT03814447|Fludarabine|fludarabine|mesh-list
56939521|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56939522|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
56939523|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939524|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56939525|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56939526|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
56939527|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939528|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939529|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56939530|NCT01129427|Pantoprazole|pantoprazole|mesh-list
56939531|NCT01129427|Clopidogrel|clopidogrel|mesh-list
56939532|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56939533|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56939534|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56939536|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
56939537|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939538|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939539|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939540|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56939541|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56939542|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56939543|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939544|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56939545|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
56939546|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939547|NCT03354429|Ticagrelor|ticagrelor|mesh-list
56939548|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56939549|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56939550|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56939551|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56939552|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
56939553|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939554|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939555|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939556|NCT05160298|Ropivacaine|ropivacaine|mesh-list
56939557|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
56939558|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
56939559|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939560|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939561|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
56939562|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939563|NCT05164198|Adalimumab|adalimumab|mesh-list
56939564|NCT05164198|Etanercept|etanercept|mesh-list
56939565|NCT05164198|Golimumab|golimumab|mesh-list
56939566|NCT05164198|Infliximab|infliximab|mesh-list
56939567|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56939568|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56939569|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
56939570|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56939571|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56939572|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56939573|NCT05164198|Analgesics|analgesics|mesh-ancestor
56939574|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
56939575|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939576|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939577|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56939578|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
56939579|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56939580|NCT03740399|Anesthetics|anesthetics|mesh-list
56939581|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939582|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939583|NCT05160220|Psilocybin|psilocybin|mesh-list
56939584|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
56939585|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939586|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56939587|NCT03924245|Olaparib|olaparib|mesh-list
56939588|NCT03924245|Entinostat|entinostat|mesh-list
56939589|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56939590|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733696|NCT03668639|Hormones|hormones|mesh-ancestor
56939591|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939592|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939593|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56939594|NCT05647447|SR 142801|sr 142801|mesh-list
56939595|NCT05647447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56939596|NCT05647447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56939597|NCT05647447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939598|NCT05647447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939599|NCT05647447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56939600|NCT01225445|Ramipril|ramipril|mesh-list
56939601|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56939602|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
56939603|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939604|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939605|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56939606|NCT05623111|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56939607|NCT05623111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56939608|NCT05623111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939609|NCT05623111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939610|NCT05623111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56939611|NCT05623111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56939612|NCT05623111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939613|NCT05623111|Cholinergic Agents|cholinergic agents|mesh-ancestor
56939614|NCT05623111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939615|NCT05555329|Thalidomide|thalidomide|mesh-list
56939616|NCT05555329|Pomalidomide|pomalidomide|mesh-list
56939617|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
56939618|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939619|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56939620|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56939621|NCT05555329|Growth Substances|growth substances|mesh-ancestor
56939622|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
56939623|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939624|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56939625|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
56939626|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56939627|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939628|NCT05390710|Paclitaxel|paclitaxel|mesh-list
56939629|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56939630|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56939631|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939632|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
56939633|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
56939634|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
56939635|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939636|NCT01228565|Cetuximab|cetuximab|mesh-list
56939637|NCT01228565|OTD70DERM|otd70derm|mesh-list
56939638|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56939639|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939640|NCT01228565|Protective Agents|protective agents|mesh-ancestor
56939641|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939642|NCT01226849|Rituximab|rituximab|mesh-list
56939643|NCT01226849|Carboplatin|carboplatin|mesh-list
56939644|NCT01226849|Etoposide|etoposide|mesh-list
56939645|NCT01226849|Bortezomib|bortezomib|mesh-list
56939646|NCT01226849|Ifosfamide|ifosfamide|mesh-list
56939647|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56939648|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939649|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
56939650|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939651|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56939652|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56939653|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56939654|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56939655|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939656|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939657|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56939658|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
56939659|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
56939660|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939661|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939662|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56939663|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56939664|NCT05159674|Analgesics|analgesics|mesh-ancestor
56939665|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
56939666|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939667|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56939668|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56939669|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56939670|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
56939671|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939672|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939673|NCT03813979|Dolutegravir|dolutegravir|mesh-list
56939674|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56939675|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56939676|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939677|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939678|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56939679|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56939680|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
56939681|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535403|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56939682|NCT05555121|Progesterone|progesterone|mesh-list
56939683|NCT05555121|Progestins|progestins|mesh-ancestor
56939684|NCT05555121|Hormones|hormones|mesh-ancestor
56939685|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939686|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939687|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
56939688|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939689|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56939690|NCT05553613|Clopidogrel|clopidogrel|mesh-list
56939691|NCT05553613|Ticagrelor|ticagrelor|mesh-list
56939692|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56939693|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56939694|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56939695|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56939696|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
56939697|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939698|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939699|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939700|NCT03901144|Glycerol|glycerol|mesh-list
56939701|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56939702|NCT03901144|Protective Agents|protective agents|mesh-ancestor
56939703|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939704|NCT01129739|Cyclosporine|cyclosporine|mesh-list
56939705|NCT01129739|Cyclosporins|cyclosporins|mesh-list
56939706|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939707|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939708|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56939709|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
56939710|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939711|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
56939712|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939713|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
56939714|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56939715|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56939716|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56939717|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
56939718|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56939719|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
56939720|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939721|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939722|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939723|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56939724|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939725|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
56939726|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939727|NCT03384693|Defibrotide|defibrotide|mesh-list
56939728|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56939729|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56939730|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939731|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56939732|NCT05533281|Dexamethasone|dexamethasone|mesh-list
56939733|NCT05533281|Metoclopramide|metoclopramide|mesh-list
56939734|NCT05533281|Tropisetron|tropisetron|mesh-list
56939735|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56939736|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
56939737|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
56939738|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939739|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939740|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56939741|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
56939742|NCT05533281|Hormones|hormones|mesh-ancestor
56939743|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56939744|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56939745|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939746|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56939747|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56939748|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
56939749|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939750|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939751|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56939752|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56939753|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
56939754|NCT04455802|Morphine|morphine|mesh-list
56939755|NCT04455802|Buprenorphine|buprenorphine|mesh-list
56535479|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
56939756|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56939757|NCT04455802|Narcotics|narcotics|mesh-ancestor
56939758|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939759|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939760|NCT04455802|Analgesics|analgesics|mesh-ancestor
56939761|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
56939762|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939763|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56939764|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
56939765|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56939766|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939767|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939768|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56939769|NCT03923075|Analgesics|analgesics|mesh-ancestor
56939770|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
56939771|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939772|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56939773|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56939774|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56939775|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
56939776|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939777|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939778|NCT03923231|Ritonavir|ritonavir|mesh-list
56939779|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56939780|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56939781|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56939782|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
56939783|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939784|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939785|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56939786|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56939787|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
56939788|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939789|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56939790|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56939791|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
56939792|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939793|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
56939794|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56939795|NCT02618980|Hemostatics|hemostatics|mesh-list
56939796|NCT02618980|Coagulants|coagulants|mesh-ancestor
56939797|NCT02613598|Bortezomib|bortezomib|mesh-list
56939798|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939799|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
56939800|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56939801|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
56939802|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56939803|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
56939804|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939805|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939806|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
56939807|NCT01225523|Paclitaxel|paclitaxel|mesh-list
56939808|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56939809|NCT01225523|Cisplatin|cisplatin|mesh-list
56939810|NCT01225523|Fluorouracil|fluorouracil|mesh-list
56939811|NCT01225523|Capecitabine|capecitabine|mesh-list
56939812|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56939813|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939814|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
56939815|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
56939816|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
56939817|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939818|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
56939819|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56939820|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56939821|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
56939822|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939823|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
56939824|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56535549|NCT00633685|Fluoxetine|fluoxetine|mesh-list
56939825|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
56939826|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939827|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
56939828|NCT03815539|Protective Agents|protective agents|mesh-ancestor
56939829|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
56939830|NCT03922919|Cefotaxime|cefotaxime|mesh-list
56939831|NCT03922919|Cefoxitin|cefoxitin|mesh-list
56939832|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56939833|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939834|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
56939835|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56939836|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939837|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939838|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56939839|NCT03813277|Analgesics|analgesics|mesh-ancestor
56939840|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
56939841|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939842|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56939843|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56939844|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56939845|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
56939846|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939847|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939848|NCT03815461|Paclitaxel|paclitaxel|mesh-list
56939849|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56939850|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939851|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
56939852|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
56939853|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
56939854|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939855|NCT01285102|Irinotecan|irinotecan|mesh-list
56939856|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56939857|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56939858|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56939859|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939860|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939861|NCT03740243|Buprenorphine|buprenorphine|mesh-list
56939862|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56939863|NCT03740243|Naloxone|naloxone|mesh-list
56939864|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56939865|NCT03740243|Narcotics|narcotics|mesh-ancestor
56939866|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939867|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939868|NCT03740243|Analgesics|analgesics|mesh-ancestor
56939869|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
56939870|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939871|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56939872|NCT03813043|Midazolam|midazolam|mesh-list
56939873|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56939874|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56939875|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939876|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939877|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56939878|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56939879|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56939880|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56939881|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
56939882|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
56939883|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
56939884|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
56939885|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939886|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939887|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
56939888|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56939889|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56939890|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56939891|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56939892|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939893|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
56939894|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939895|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939896|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56939897|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939898|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
56939899|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56939900|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939901|NCT03815305|Petrolatum|petrolatum|mesh-list
56939902|NCT03815305|Emollients|emollients|mesh-ancestor
56939903|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
56939904|NCT01560013|Naltrexone|naltrexone|mesh-list
56939905|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56939906|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56939907|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939908|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
56939909|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939910|NCT01302145|Metformin|metformin|mesh-list
56939911|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
56939912|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56939913|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939914|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56939915|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939916|NCT01560091|Tamsulosin|tamsulosin|mesh-list
56939917|NCT01560091|Silodosin|silodosin|mesh-list
56939918|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56939919|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56939920|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56939921|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
56939922|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939923|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939924|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939925|NCT01560091|Urological Agents|urological agents|mesh-ancestor
56939926|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
56939927|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56939928|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56939929|NCT03807271|Anesthetics|anesthetics|mesh-list
56939930|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939931|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939932|NCT03812731|Fentanyl|fentanyl|mesh-list
56939933|NCT03812731|Ropivacaine|ropivacaine|mesh-list
56939934|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
56939935|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
56939936|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939937|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939938|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
56939939|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939940|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56939941|NCT03812731|Narcotics|narcotics|mesh-ancestor
56939942|NCT03812731|Analgesics|analgesics|mesh-ancestor
56939943|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56939944|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56939945|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
56939946|NCT03351231|Nivolumab|nivolumab|mesh-list
56939947|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56939948|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939949|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56939950|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939951|NCT03922373|Benzonatate|benzonatate|mesh-list
56939952|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
56939953|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
56939954|NCT03709719|Blinatumomab|blinatumomab|mesh-list
56939955|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939956|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
56939957|NCT03926663|Bupivacaine|bupivacaine|mesh-list
56939958|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
56939959|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
56939960|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939961|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939962|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
56939963|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56939964|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56939965|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56860858|NCT03201562|Aceclidine|aceclidine|mesh-list
56939966|NCT03926663|Analgesics|analgesics|mesh-ancestor
56939967|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56939968|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56939969|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56939970|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
56939971|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939972|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939973|NCT05165914|Midazolam|midazolam|mesh-list
56939974|NCT05165914|Anesthetics|anesthetics|mesh-list
56939975|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939976|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939977|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56939978|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56939979|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56939980|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56939981|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56939982|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56939983|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
56939985|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
56939986|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56939987|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939988|NCT04420975|Nivolumab|nivolumab|mesh-list
56939989|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56939990|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56939991|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56939992|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56939993|NCT01132157|Propofol|propofol|mesh-list
56939994|NCT01132157|Desflurane|desflurane|mesh-list
56939995|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56939996|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56939997|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56939998|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56939999|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
56940000|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
56940001|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56940002|NCT05389150|Pregabalin|pregabalin|mesh-list
56940003|NCT05389150|Tramadol|tramadol|mesh-list
56940004|NCT05389150|Analgesics|analgesics|mesh-ancestor
56940005|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
56940006|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940007|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940008|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
56940009|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56940010|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56940011|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940012|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56940013|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56940014|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56940015|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940016|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56940017|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56940018|NCT05389150|Narcotics|narcotics|mesh-ancestor
56940019|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56940020|NCT03806101|Abrocitinib|abrocitinib|mesh-list
56940021|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56940022|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56940023|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
56940024|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940025|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56940026|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56940027|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940028|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940029|NCT03812419|Esomeprazole|esomeprazole|mesh-list
56940030|NCT03812419|Pantoprazole|pantoprazole|mesh-list
56940031|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56940032|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56940033|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56940034|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940035|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940036|NCT01132235|Etanercept|etanercept|mesh-list
56940037|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56940038|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56940039|NCT01132235|Analgesics|analgesics|mesh-ancestor
56940040|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
56940041|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940042|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940043|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56940044|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940045|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56940046|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940047|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
56940048|NCT04388839|Dactinomycin|dactinomycin|mesh-list
56940049|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
56940050|NCT04388839|Vincristine|vincristine|mesh-list
56940051|NCT04388839|Vinorelbine|vinorelbine|mesh-list
56940052|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940053|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
56940054|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940055|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940056|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56940057|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
56535774|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56940058|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940059|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940060|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56940061|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56940062|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
56940063|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
56940064|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
56940065|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56940066|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940067|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56940068|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56940069|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940070|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56940071|NCT01131689|Sorafenib|sorafenib|mesh-list
56940072|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940073|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940074|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940075|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940076|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
56940077|NCT03401229|Benralizumab|benralizumab|mesh-list
56940078|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56940079|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
56940080|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56940081|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56940082|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
56940083|NCT05435053|Nivolumab|nivolumab|mesh-list
56940084|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940085|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940086|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56940087|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940088|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
56940089|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
56940090|NCT05281081|Morphine|morphine|mesh-list
56940091|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
56940092|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56940093|NCT05281081|Narcotics|narcotics|mesh-ancestor
56940094|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940095|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940096|NCT05281081|Analgesics|analgesics|mesh-ancestor
56940097|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
56940098|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940099|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
56940100|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
56940101|NCT01303237|Cetuximab|cetuximab|mesh-list
56940102|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940103|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940104|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
56940105|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56940106|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940107|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56940108|NCT01227941|Doxorubicin|doxorubicin|mesh-list
56940109|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56940110|NCT01227941|Niraparib|niraparib|mesh-list
56940111|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56940112|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940113|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56940114|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56940115|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861014|NCT05441410|Artesunate|artesunate|mesh-list
56940116|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940117|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56940118|NCT03919565|Tenofovir|tenofovir|mesh-list
56940119|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56940120|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56940121|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
56940122|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940123|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56940124|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56940125|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940126|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940127|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56940128|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56940129|NCT03380091|Vitamin D|vitamin d|mesh-list
56940130|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
56940131|NCT03380091|Metformin|metformin|mesh-list
56940132|NCT03380091|Vitamins|vitamins|mesh-ancestor
56940133|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
56940134|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940135|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940136|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56940137|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56940138|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
56940139|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940140|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940141|NCT03919253|Paclitaxel|paclitaxel|mesh-list
56940142|NCT03919253|Maleic acid|maleic acid|mesh-list
56940143|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56940144|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940145|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
56940146|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
56940147|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
56940148|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940149|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940150|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56940151|NCT05165290|Latanoprost|latanoprost|mesh-list
56940152|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56940153|NCT01132703|Glyburide|glyburide|mesh-list
56940154|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940155|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940156|NCT01377922|Amifampridine|amifampridine|mesh-list
56940157|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56940158|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940159|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940160|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56940161|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56940162|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940163|NCT03919175|Rituximab|rituximab|mesh-list
56940164|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940165|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940166|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
56940167|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940168|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940169|NCT01303471|Remifentanil|remifentanil|mesh-list
56940170|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56940171|NCT01303471|Narcotics|narcotics|mesh-ancestor
56940172|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940173|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940174|NCT01303471|Analgesics|analgesics|mesh-ancestor
56940175|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
56940176|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940177|NCT03804541|Ensartinib|ensartinib|mesh-list
56940178|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940179|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940180|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940181|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940182|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
56940183|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940184|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940185|NCT03710811|Insulin|insulin|mesh-list
56940186|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940187|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940188|NCT01303549|Amphotericin B|amphotericin b|mesh-list
56940189|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56940190|NCT01303549|Anidulafungin|anidulafungin|mesh-list
56940191|NCT01303549|Amebicides|amebicides|mesh-ancestor
56940192|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56940193|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56940194|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940195|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56940196|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
56940197|NCT03796975|Metformin|metformin|mesh-list
56940198|NCT03796975|Pioglitazone|pioglitazone|mesh-list
56940199|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940200|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940201|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56940202|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940203|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940204|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940205|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940206|NCT05400070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56940207|NCT05400070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940208|NCT05400070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535929|NCT01238588|Sevelamer|sevelamer|mesh-list
56940210|NCT01302613|Capecitabine|capecitabine|mesh-list
56940211|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
56940212|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56940213|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
56940214|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940215|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940216|NCT01302613|Antidotes|antidotes|mesh-ancestor
56940217|NCT01302613|Protective Agents|protective agents|mesh-ancestor
56940218|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940219|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
56940220|NCT01302613|Vitamins|vitamins|mesh-ancestor
56940221|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
56940222|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
56940223|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56940224|NCT03803371|Acetaminophen|acetaminophen|mesh-list
56940225|NCT03803371|Tramadol|tramadol|mesh-list
56940226|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56940227|NCT03803371|Analgesics|analgesics|mesh-ancestor
56940228|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
56940229|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940230|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940231|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
56940232|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56940233|NCT03803371|Narcotics|narcotics|mesh-ancestor
56940234|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940235|NCT01130909|Ketamine|ketamine|mesh-list
56940236|NCT01130909|Analgesics|analgesics|mesh-ancestor
56940237|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
56940238|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940239|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940240|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56940241|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56940242|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
56940243|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
56940244|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940245|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56940246|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56940247|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940248|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940249|NCT03918551|Febuxostat|febuxostat|mesh-list
56940250|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
56940251|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940252|NCT04453930|Irinotecan|irinotecan|mesh-list
56940253|NCT04453930|Apatinib|apatinib|mesh-list
56940254|NCT04453930|Antibodies|antibodies|mesh-list
56940255|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
56940256|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940257|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56940258|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56940259|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940260|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940261|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940262|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940263|NCT03796507|Temozolomide|temozolomide|mesh-list
56940264|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56940265|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
56940266|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940267|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940268|NCT04586062|Plasminogen|plasminogen|mesh-list
56940269|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56940270|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56940271|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940272|NCT01132781|Theophylline|theophylline|mesh-list
56940273|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56940274|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
56940275|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940276|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940277|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56940278|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
56940279|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56940280|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940281|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940282|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
56940283|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56536001|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
56940284|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56940285|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
56940286|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940287|NCT03497767|Osimertinib|osimertinib|mesh-list
56940288|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940289|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940290|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940291|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940292|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
56940293|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56940294|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56940295|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940296|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
56940297|NCT05397652|Coagulants|coagulants|mesh-ancestor
56940298|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
56940299|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940300|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
56940301|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940302|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940303|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56940304|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
56940305|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940306|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940307|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56940308|NCT01134341|Vitamins|vitamins|mesh-list
56940309|NCT01134341|Folic Acid|folic acid|mesh-list
56940310|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
56940311|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
56940312|NCT01134341|Bexarotene|bexarotene|mesh-list
56940313|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
56940314|NCT01134341|Aminopterin|aminopterin|mesh-list
56940315|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
56940316|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940317|NCT01134341|Hematinics|hematinics|mesh-ancestor
56940318|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940319|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56940320|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940321|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940322|NCT04308304|Donepezil|donepezil|mesh-list
56940323|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56940324|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940325|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940326|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
56940327|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940328|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940329|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
56940330|NCT05397262|Fluorouracil|fluorouracil|mesh-list
56940331|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940332|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
56940333|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940334|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56940335|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940336|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
56940337|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940338|NCT01230359|Pyridoxine|pyridoxine|mesh-list
56940339|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
56940340|NCT01230359|Vitamins|vitamins|mesh-ancestor
56940341|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
56940342|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861234|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
56940343|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
56940344|NCT04218409|Oxycodone|oxycodone|mesh-list
56940345|NCT04218409|Oxytocin|oxytocin|mesh-list
56940346|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
56940347|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56940348|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940349|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56940350|NCT04218409|Narcotics|narcotics|mesh-ancestor
56940351|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940352|NCT04218409|Analgesics|analgesics|mesh-ancestor
56940353|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
56940354|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940355|NCT05591677|Cycloserine|cycloserine|mesh-list
56940356|NCT05591677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56940357|NCT05591677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940358|NCT05591677|Renal Agents|renal agents|mesh-ancestor
56940359|NCT05591677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56940360|NCT05591677|Antitubercular Agents|antitubercular agents|mesh-ancestor
56940361|NCT05591677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56940362|NCT05591677|Antimetabolites|antimetabolites|mesh-ancestor
56940363|NCT05591677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940364|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
56940365|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940366|NCT03795571|Gemcitabine|gemcitabine|mesh-list
56940367|NCT03795571|Dexamethasone|dexamethasone|mesh-list
56940368|NCT03795571|Rituximab|rituximab|mesh-list
56940369|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
56940370|NCT03795571|Lenalidomide|lenalidomide|mesh-list
56940371|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940372|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940373|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
56940374|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940375|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940376|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56940377|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
56940378|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
56940379|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940380|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56940381|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
56940382|NCT03795571|Hormones|hormones|mesh-ancestor
56940383|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56940384|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56940385|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56940386|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
56940387|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940388|NCT03795571|Antiviral Agents|antiviral agents|mesh-ancestor
56940389|NCT03795571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940390|NCT03795571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940391|NCT03795571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940392|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56940393|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56940394|NCT03795571|Growth Substances|growth substances|mesh-ancestor
56940395|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
56940396|NCT04280848|Temozolomide|temozolomide|mesh-list
56940397|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56940398|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
56940399|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940400|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940401|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
56940402|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56940403|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56940404|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940405|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
56940406|NCT03795649|Coagulants|coagulants|mesh-ancestor
56940407|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
56940408|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56940409|NCT04211272|Macitentan|macitentan|mesh-list
56940410|NCT04211272|Riociguat|riociguat|mesh-list
56940411|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56940412|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56940413|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
56940414|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940415|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56940416|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56940417|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861322|NCT01340248|Carvedilol|carvedilol|mesh-list
56940418|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
56940419|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56940420|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56940421|NCT04211272|Urological Agents|urological agents|mesh-ancestor
56940422|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56940423|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56940424|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56940425|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
56940426|NCT05402189|Fentanyl|fentanyl|mesh-list
56940427|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56940428|NCT05402189|Narcotics|narcotics|mesh-ancestor
56940429|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940430|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940431|NCT05402189|Analgesics|analgesics|mesh-ancestor
56940432|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
56940433|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940434|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56940435|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56536157|NCT01233050|Ethanol|ethanol|mesh-list
56940436|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
56940437|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
56940438|NCT01304563|Vaccines|vaccines|mesh-list
56940439|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
56940440|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940441|NCT01231997|Udenafil|udenafil|mesh-list
56940442|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56940443|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56940444|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940445|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940446|NCT03795805|Lidocaine|lidocaine|mesh-list
56940447|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
56940448|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
56940449|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940450|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940451|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
56940452|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940453|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56940454|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56940455|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56940456|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56940457|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940458|NCT04072042|Apatinib|apatinib|mesh-list
56940459|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940460|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940461|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940462|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940463|NCT03799315|Nicotine|nicotine|mesh-list
56940464|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56940465|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
56940466|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940467|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940468|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56940469|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56940470|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
56940471|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940472|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940473|NCT05387200|Alendronate|alendronate|mesh-list
56940474|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56940475|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940476|NCT05386810|Vaccines|vaccines|mesh-list
56940477|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
56940478|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940479|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
56940480|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56940481|NCT04910269|Antibodies|antibodies|mesh-list
56940482|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
56940483|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940484|NCT03442972|Teduglutide|teduglutide|mesh-list
56940485|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56940486|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56940487|NCT03442972|Protective Agents|protective agents|mesh-ancestor
56940488|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940489|NCT03921671|Paclitaxel|paclitaxel|mesh-list
56940490|NCT03921671|Carboplatin|carboplatin|mesh-list
56940491|NCT03921671|Ramucirumab|ramucirumab|mesh-list
56940492|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56940493|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940494|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
56940495|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
56940496|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
56940497|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940498|NCT05374954|Vaccines|vaccines|mesh-list
56940499|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
56940500|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940501|NCT03921593|Pancrelipase|pancrelipase|mesh-list
56940502|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56940503|NCT03369951|Minocycline|minocycline|mesh-list
56940504|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56940505|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940506|NCT01131767|Naproxen|naproxen|mesh-list
56940507|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
56940508|NCT01131767|Ephedrine|ephedrine|mesh-list
56940509|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56940510|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56940511|NCT01131767|Analgesics|analgesics|mesh-ancestor
56940512|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
56536223|NCT02888054|Allopurinol|allopurinol|mesh-list
56940513|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940514|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940515|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56940516|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940517|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
56940518|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56940519|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940520|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940521|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56940522|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
56940523|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56940524|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
56940525|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
56940526|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56940527|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56940528|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
56940529|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
56940530|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940531|NCT03795259|Rocuronium|rocuronium|mesh-list
56940532|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56940533|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56940534|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56940535|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940536|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940537|NCT01229189|Vitamin D|vitamin d|mesh-list
56940538|NCT01229189|Vitamins|vitamins|mesh-ancestor
56940539|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
56940540|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940541|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56940542|NCT05481489|Atropine|atropine|mesh-list
56940543|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56940544|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56940545|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56940546|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
56940547|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940548|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940549|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56940550|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
56940551|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
56940552|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
56940553|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56940554|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56940555|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
56940556|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940557|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940558|NCT05341180|Lactulose|lactulose|mesh-list
56940559|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56940560|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56940561|NCT01133483|Fexofenadine|fexofenadine|mesh-list
56940562|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
56940563|NCT01133483|Ephedrine|ephedrine|mesh-list
56940564|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56940565|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
56940566|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940567|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940568|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56940569|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
56940570|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
56940571|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56940572|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56940573|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
56940574|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
56940575|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940576|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940577|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56940578|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56940579|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56940580|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
56940581|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
56940582|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
56940583|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
56940584|NCT05401721|Coagulants|coagulants|mesh-ancestor
56940585|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56940586|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56940587|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
56940588|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940589|NCT01560481|Metformin|metformin|mesh-list
56940590|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940591|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940592|NCT04795531|Insulin|insulin|mesh-list
56940593|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56940594|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
56940595|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940596|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940597|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56940598|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56940599|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56940600|NCT03229408|Analgesics|analgesics|mesh-ancestor
56940601|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
56940602|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940603|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940604|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56940605|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940606|NCT05238844|Tenofovir|tenofovir|mesh-list
56940607|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
56940608|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940609|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56940610|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56940611|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940612|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940613|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56940614|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56940615|NCT04785625|Bupivacaine|bupivacaine|mesh-list
56940616|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
56940617|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
56940618|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940619|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940620|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
56940621|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940622|NCT03368859|Leucovorin|leucovorin|mesh-list
56940623|NCT03368859|Bevacizumab|bevacizumab|mesh-list
56940624|NCT03368859|Fluorouracil|fluorouracil|mesh-list
56940625|NCT03368859|Irinotecan|irinotecan|mesh-list
56940626|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940627|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940628|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56940629|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56940630|NCT03368859|Growth Substances|growth substances|mesh-ancestor
56940631|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940632|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
56940633|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
56940634|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940635|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56940636|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940637|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
56940638|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56940639|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56940640|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940641|NCT03368859|Antidotes|antidotes|mesh-ancestor
56940642|NCT03368859|Protective Agents|protective agents|mesh-ancestor
56940643|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
56940644|NCT03368859|Vitamins|vitamins|mesh-ancestor
56940645|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
56940646|NCT01134965|Digoxin|digoxin|mesh-list
56940647|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56940648|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56940649|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940650|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940651|NCT01134965|Protective Agents|protective agents|mesh-ancestor
56940652|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940653|NCT03810547|Ketamine|ketamine|mesh-list
56940654|NCT03810547|Propofol|propofol|mesh-list
56940655|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56940656|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940657|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940658|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56940659|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
56940660|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
56940661|NCT03810547|Analgesics|analgesics|mesh-ancestor
56940662|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
56536375|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
56940663|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940664|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56940665|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56940666|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56940667|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940668|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940669|NCT03096314|Vitamin D|vitamin d|mesh-list
56940670|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
56940671|NCT03096314|Vitamins|vitamins|mesh-ancestor
56940672|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
56940673|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940674|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56940675|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56940676|NCT03917459|Enalapril|enalapril|mesh-list
56940677|NCT03917459|Enalaprilat|enalaprilat|mesh-list
56940678|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56940679|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56940680|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
56940681|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940682|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940683|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56940684|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56940685|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56940686|NCT05421741|Vancomycin|vancomycin|mesh-list
56940687|NCT05421741|Gentamicins|gentamicins|mesh-list
56940688|NCT05421741|Tobramycin|tobramycin|mesh-list
56940689|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940690|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56940691|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940692|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940693|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
56940694|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
56940695|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940696|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56940697|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940698|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940699|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
56940700|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940701|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56940702|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940703|NCT03129646|Paromomycin|paromomycin|mesh-list
56940704|NCT03129646|Miltefosine|miltefosine|mesh-list
56940705|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56940706|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56940707|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940708|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56940709|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56940710|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
56940711|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940712|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
56940713|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56940714|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
56940715|NCT03710655|Histamine|histamine|mesh-list
56940716|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
56940717|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
56940718|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940719|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940720|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940721|NCT01135199|Pomalidomide|pomalidomide|mesh-list
56940722|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
56940723|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940724|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56940725|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56940726|NCT01135199|Growth Substances|growth substances|mesh-ancestor
56940727|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
56940728|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940729|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
56940730|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940731|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940732|NCT03917537|Nivolumab|nivolumab|mesh-list
56940733|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940734|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940735|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56940736|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940737|NCT03335163|Topiramate|topiramate|mesh-list
56940738|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
56940739|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940740|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940741|NCT03982030|Dalbavancin|dalbavancin|mesh-list
56940742|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56940743|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940744|NCT03176953|Topiramate|topiramate|mesh-list
56940745|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
56940746|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56940747|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940748|NCT04749602|Nivolumab|nivolumab|mesh-list
56940749|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940750|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940751|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56940752|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940753|NCT03461302|Coal Tar|coal tar|mesh-list
56940754|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
56940755|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
56940756|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
56940757|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
56940758|NCT03128359|Melphalan|melphalan|mesh-list
56940759|NCT03128359|Busulfan|busulfan|mesh-list
56940760|NCT03128359|Fludarabine|fludarabine|mesh-list
56940761|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
56940762|NCT03128359|Tacrolimus|tacrolimus|mesh-list
56940763|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940764|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
56940765|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940766|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940767|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56940768|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
56940769|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940770|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940771|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56940772|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56940773|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
56940774|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56940775|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940776|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56940777|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56940778|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
56940779|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56940780|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940781|NCT01232075|Letrozole|letrozole|mesh-list
56940782|NCT01232075|Citric Acid|citric acid|mesh-list
56940783|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
56940784|NCT01232075|Clomiphene|clomiphene|mesh-list
56940785|NCT01232075|Enclomiphene|enclomiphene|mesh-list
56940786|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
56940787|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
56940788|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56940789|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
56940790|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
56940791|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940792|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940793|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56940794|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56940795|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940796|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56940797|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
56940798|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56940799|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940800|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56940801|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
56940802|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56940803|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56940804|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56940805|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
56940806|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56940807|NCT01131845|Treprostinil|treprostinil|mesh-list
56940808|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56940809|NCT03711422|Afatinib|afatinib|mesh-list
56940810|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940811|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940812|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940813|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940814|NCT03460678|Pemetrexed|pemetrexed|mesh-list
56940815|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56940816|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940817|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940818|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940819|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56940820|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56940821|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940823|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56940824|NCT03810391|Narcotics|narcotics|mesh-ancestor
56940825|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940826|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940827|NCT03810391|Analgesics|analgesics|mesh-ancestor
56940828|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
56940829|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940830|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
56940831|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
56940832|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56940833|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
56940834|NCT01229579|Astringents|astringents|mesh-ancestor
56940835|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940836|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
56940837|NCT01131923|Amlodipine|amlodipine|mesh-list
56940838|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56940839|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56940840|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56940841|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940842|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56940843|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940844|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
56940845|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
56940846|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
56940847|NCT01230983|Leucovorin|leucovorin|mesh-list
56940848|NCT01230983|Cytarabine|cytarabine|mesh-list
56940849|NCT01230983|Prednisone|prednisone|mesh-list
56940850|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
56940851|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56940852|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56940853|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56940854|NCT01230983|Doxorubicin|doxorubicin|mesh-list
56940855|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56940856|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
56940857|NCT01230983|Methotrexate|methotrexate|mesh-list
56940858|NCT01230983|Vincristine|vincristine|mesh-list
56940859|NCT01230983|Asparaginase|asparaginase|mesh-list
56940860|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
56940861|NCT01230983|Razoxane|razoxane|mesh-list
56940862|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
56940863|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56940864|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940865|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56940866|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56940867|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940868|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940869|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940870|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56940871|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
56940872|NCT01230983|Hormones|hormones|mesh-ancestor
56940873|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56940874|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56940875|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56940876|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
56940877|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56940878|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56940879|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
56940880|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
56940881|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56940882|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940883|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
56940884|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940885|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56940886|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
56940887|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940888|NCT01230983|Antidotes|antidotes|mesh-ancestor
56940889|NCT01230983|Protective Agents|protective agents|mesh-ancestor
56940890|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
56940891|NCT01230983|Vitamins|vitamins|mesh-ancestor
56940892|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
56940893|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56940894|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
56940895|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
56940896|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
56940897|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56940898|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
56940899|NCT01304797|Trastuzumab|trastuzumab|mesh-list
56940900|NCT01304797|Doxorubicin|doxorubicin|mesh-list
56940901|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
56940902|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56940903|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
56940904|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940905|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940906|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56940907|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
56940908|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940909|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940910|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56940911|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940912|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56940913|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56940914|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56940915|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940916|NCT03707535|Infliximab|infliximab|mesh-list
56940917|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
56940918|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56940919|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940920|NCT01133795|Midodrine|midodrine|mesh-list
56940921|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
56940922|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
56940923|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940924|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940925|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56940926|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56940927|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56940928|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56940929|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
56940930|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940931|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940932|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
56940933|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
56940934|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56940935|NCT01133873|Narcotics|narcotics|mesh-ancestor
56940936|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940937|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940938|NCT01133873|Analgesics|analgesics|mesh-ancestor
56940939|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
56940940|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940941|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
56940942|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
56940943|NCT01229813|Bevacizumab|bevacizumab|mesh-list
56940944|NCT01229813|Capecitabine|capecitabine|mesh-list
56940945|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56940946|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940947|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940948|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56940949|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56940950|NCT01229813|Growth Substances|growth substances|mesh-ancestor
56940951|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940952|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
56940953|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56940954|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
56940955|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940956|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56940957|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940958|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
56940959|NCT01649947|Paclitaxel|paclitaxel|mesh-list
56940960|NCT01649947|Bevacizumab|bevacizumab|mesh-list
56940961|NCT01649947|Carboplatin|carboplatin|mesh-list
56940962|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56940963|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56940964|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
56940965|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
56940966|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
56940967|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940968|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56940969|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56940970|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56940971|NCT01649947|Growth Substances|growth substances|mesh-ancestor
56940972|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940973|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
56940974|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
56940975|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56940976|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56940977|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56940978|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56940979|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56940980|NCT03793075|Ketamine|ketamine|mesh-list
56940981|NCT03793075|Propofol|propofol|mesh-list
56940982|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56940983|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56940984|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56940985|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56940986|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
56940987|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
56940988|NCT03793075|Analgesics|analgesics|mesh-ancestor
56940989|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
56940990|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56940991|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56940992|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56940993|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56940994|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56940995|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56940996|NCT01233167|Clopidogrel|clopidogrel|mesh-list
56940997|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56940998|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56940999|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56941000|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56941001|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
56941002|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941003|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941004|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941005|NCT01304095|Ranolazine|ranolazine|mesh-list
56941006|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56941007|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56941008|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941009|NCT03707457|Nivolumab|nivolumab|mesh-list
56941010|NCT03707457|Ipilimumab|ipilimumab|mesh-list
56941011|NCT03707457|Antibodies|antibodies|mesh-list
56941012|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56941013|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
56941014|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941015|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56941016|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941017|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56941018|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941019|NCT01568294|Pomalidomide|pomalidomide|mesh-list
56941020|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
56941021|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941022|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56941023|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56941024|NCT01568294|Growth Substances|growth substances|mesh-ancestor
56941025|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
56941026|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941027|NCT03422666|Teduglutide|teduglutide|mesh-list
56941028|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56941029|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56941030|NCT03422666|Protective Agents|protective agents|mesh-ancestor
56941031|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941032|NCT03453190|Apremilast|apremilast|mesh-list
56941033|NCT03453190|Clobetasol|clobetasol|mesh-list
56941034|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56941035|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56941036|NCT03453190|Analgesics|analgesics|mesh-ancestor
56941037|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
56941038|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941039|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941040|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941041|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56941042|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56941043|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56941044|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941045|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941046|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
56941047|NCT03453190|Hormones|hormones|mesh-ancestor
56941048|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941049|NCT01231139|Acetaminophen|acetaminophen|mesh-list
56941050|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56941051|NCT01231139|Analgesics|analgesics|mesh-ancestor
56941052|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
56941053|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941054|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941055|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
56941056|NCT03382574|Denosumab|denosumab|mesh-list
56941057|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56941058|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941059|NCT01137695|Pramlintide|pramlintide|mesh-list
56941060|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
56941061|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56941062|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941063|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
56941064|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56941065|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
56941066|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941067|NCT03451396|Lifitegrast|lifitegrast|mesh-list
56941068|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56941069|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56941070|NCT02528825|Remifentanil|remifentanil|mesh-list
56941071|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56941072|NCT02528825|Narcotics|narcotics|mesh-ancestor
56941073|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941074|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941075|NCT02528825|Analgesics|analgesics|mesh-ancestor
56941076|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
56941077|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941078|NCT01233245|Interferons|interferons|mesh-list
56941079|NCT01233245|Interferon-beta|interferon-beta|mesh-list
56941080|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
56941081|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941082|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
56941083|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941084|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
56941085|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941086|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56941087|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
56941088|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56941089|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941090|NCT03776812|Paclitaxel|paclitaxel|mesh-list
56941091|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56941092|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56941093|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941094|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56941095|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56941096|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56941097|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941098|NCT03361605|Propofol|propofol|mesh-list
56861986|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
56941099|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56941100|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941101|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941102|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56941103|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
56941104|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
56941105|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
56941106|NCT03794167|Melphalan|melphalan|mesh-list
56941107|NCT03794167|Busulfan|busulfan|mesh-list
56941108|NCT03794167|Etoposide|etoposide|mesh-list
56941109|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941110|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
56941111|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941112|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56941113|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56941114|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
56941115|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941116|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941117|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56941118|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56941119|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56941120|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56941121|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941122|NCT05332821|Bevacizumab|bevacizumab|mesh-list
56941123|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56941124|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56941125|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941126|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56941127|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56941128|NCT05332821|Growth Substances|growth substances|mesh-ancestor
56941129|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941130|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
56941131|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941132|NCT03842228|Durvalumab|durvalumab|mesh-list
56941133|NCT03842228|Olaparib|olaparib|mesh-list
56941134|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56941135|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
56941136|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56941137|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
56941138|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56941139|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941140|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
56941141|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941142|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941143|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941144|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
56941145|NCT05331651|Tropisetron|tropisetron|mesh-list
56941146|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56941147|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56941148|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56941149|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
56941150|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941151|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941152|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941153|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
56941154|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
56941155|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941156|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56941157|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56941158|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56941159|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
56941160|NCT01134185|Prucalopride|prucalopride|mesh-list
56941161|NCT01134185|Laxatives|laxatives|mesh-ancestor
56941162|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56941163|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56941164|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56941165|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
56941166|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941167|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941168|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941169|NCT03829046|Evolocumab|evolocumab|mesh-list
56941170|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56941171|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56941172|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
56941173|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941174|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56941175|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
56941176|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56941177|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941178|NCT01231529|Dolutegravir|dolutegravir|mesh-list
56941179|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56941180|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56941181|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941182|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941183|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56941184|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56941185|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
56941186|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941187|NCT03836209|Cytarabine|cytarabine|mesh-list
56941188|NCT03836209|Daunorubicin|daunorubicin|mesh-list
56941189|NCT03836209|Midostaurin|midostaurin|mesh-list
56941190|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56941191|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
56941192|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941193|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941194|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
56941195|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941196|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941197|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
56941198|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941199|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56941200|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56941201|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56941202|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941203|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56941205|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
56941206|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56941207|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
56941208|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56941209|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941210|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
56941211|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941212|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56941213|NCT05306704|Calcifediol|calcifediol|mesh-list
56941214|NCT05306704|Vitamins|vitamins|mesh-ancestor
56941215|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
56941216|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941217|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56941218|NCT01231685|Ritonavir|ritonavir|mesh-list
56941219|NCT01231685|Lopinavir|lopinavir|mesh-list
56941220|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56941221|NCT01231685|Darunavir|darunavir|mesh-list
56941222|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56941223|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
56941224|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
56941225|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56941226|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941227|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941228|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56941229|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56941230|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
56941231|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941232|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56941233|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56941234|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56941235|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56941236|NCT05402735|Uric Acid|uric acid|mesh-list
56941237|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
56941238|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941239|NCT05402735|Protective Agents|protective agents|mesh-ancestor
56941240|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941241|NCT03785678|Tenecteplase|tenecteplase|mesh-list
56941242|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56941243|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56941244|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941245|NCT01138085|Trametinib|trametinib|mesh-list
56941246|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941247|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56941248|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733776|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56941249|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941250|NCT05278858|Triamcinolone|triamcinolone|mesh-list
56941251|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941252|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
56941253|NCT05278858|Hormones|hormones|mesh-ancestor
56941254|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941255|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941256|NCT05260528|Cytarabine|cytarabine|mesh-list
56941257|NCT05260528|Idarubicin|idarubicin|mesh-list
56941258|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56941259|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
56941260|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941261|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941262|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
56941263|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941264|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941265|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
56941266|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941267|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56941268|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56941269|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56941270|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536973|NCT02802163|Hormones|hormones|mesh-ancestor
56941271|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56941273|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
56941274|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941275|NCT03359811|Bupivacaine|bupivacaine|mesh-list
56941276|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
56941277|NCT03359811|Anesthetics|anesthetics|mesh-list
56941278|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941279|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941280|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
56941281|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941282|NCT03728426|Letermovir|letermovir|mesh-list
56941283|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56941284|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941285|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941286|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941287|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
56941288|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941289|NCT01140581|Dronedarone|dronedarone|mesh-list
56941290|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56941291|NCT03792139|Itraconazole|itraconazole|mesh-list
56941292|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
56941293|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941294|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56941295|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56941296|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941297|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941298|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56941299|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
56941300|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941301|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941302|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56941303|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56941304|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
56941305|NCT04664738|Coagulants|coagulants|mesh-ancestor
56941306|NCT03792295|Acetaminophen|acetaminophen|mesh-list
56941307|NCT03792295|Ibuprofen|ibuprofen|mesh-list
56941308|NCT03792295|Oxycodone|oxycodone|mesh-list
56941309|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56941310|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56941311|NCT03792295|Analgesics|analgesics|mesh-ancestor
56941312|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
56941313|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941314|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941315|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941316|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56941317|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56941318|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941319|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941320|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56941321|NCT03792295|Narcotics|narcotics|mesh-ancestor
56941322|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941323|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
56941324|NCT02473042|Promethazine|promethazine|mesh-list
56941325|NCT02473042|Dexamethasone|dexamethasone|mesh-list
56941326|NCT02473042|Ondansetron|ondansetron|mesh-list
56941327|NCT02473042|Famotidine|famotidine|mesh-list
56941328|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941329|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
56941330|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
56941331|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941332|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941333|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56941334|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
56941335|NCT02473042|Hormones|hormones|mesh-ancestor
56941336|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941337|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56941338|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941339|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
56941340|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
56941341|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56941342|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
56941343|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941344|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941345|NCT02473042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56537047|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
56941346|NCT02473042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56941347|NCT02473042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941348|NCT02473042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56941349|NCT02473042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56941350|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56941351|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56941352|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
56941353|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
56941354|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56941355|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56941356|NCT03449056|Albuterol|albuterol|mesh-list
56941357|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56941358|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
56941359|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941360|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941361|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56941362|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
56941363|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
56941364|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56941365|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56941366|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56941367|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56941368|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
56941369|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941370|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941371|NCT01135433|Metformin|metformin|mesh-list
56941372|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
56941373|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56941374|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941375|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56941376|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941377|NCT04745273|Ondansetron|ondansetron|mesh-list
56941378|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
56941379|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
56941380|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941381|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941382|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56941383|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
56941384|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
56941385|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56941386|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
56941387|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941388|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941389|NCT04745273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56941390|NCT04745273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56941391|NCT04745273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941392|NCT04745273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56941393|NCT04745273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56941394|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
56941395|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56941396|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
56941397|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941398|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
56941399|NCT01305187|Protective Agents|protective agents|mesh-ancestor
56941400|NCT01138397|Vaccines|vaccines|mesh-list
56941401|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
56941402|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941403|NCT03448744|Entecavir|entecavir|mesh-list
56941404|NCT03448744|Thymalfasin|thymalfasin|mesh-list
56941405|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
56941406|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941407|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56941408|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
56941409|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941410|NCT03448588|Selenium|selenium|mesh-list
56941411|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
56941412|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941413|NCT03448588|Protective Agents|protective agents|mesh-ancestor
56941414|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941415|NCT03448588|Trace Elements|trace elements|mesh-ancestor
56941416|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
56941417|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
56941418|NCT03797443|Gemcitabine|gemcitabine|mesh-list
56941419|NCT03797443|Paclitaxel|paclitaxel|mesh-list
56941420|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56941421|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941422|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
56941423|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
56941424|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
56941425|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941426|NCT03797443|Vitamins|vitamins|mesh-ancestor
56941427|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
56941428|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941429|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56941430|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
56941431|NCT03797443|Antiviral Agents|antiviral agents|mesh-ancestor
56941432|NCT03797443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941433|NCT03797443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941434|NCT03797443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941435|NCT03797443|Immunologic Factors|immunologic factors|mesh-ancestor
56941436|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
56941437|NCT03797443|Protective Agents|protective agents|mesh-ancestor
56941438|NCT01135589|Micafungin|micafungin|mesh-list
56941439|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
56941440|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941441|NCT01915810|Nicotine|nicotine|mesh-list
56941442|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56941443|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
56941444|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941445|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941446|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56941447|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56941448|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
56941449|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941450|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941451|NCT01140737|Axitinib|axitinib|mesh-list
56941452|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941453|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56941454|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941455|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941456|NCT05594095|Everolimus|everolimus|mesh-list
56941457|NCT05594095|Fulvestrant|fulvestrant|mesh-list
56941458|NCT05594095|Goserelin|goserelin|mesh-list
56941459|NCT05594095|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56941460|NCT05594095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941461|NCT05594095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941462|NCT05594095|Immunologic Factors|immunologic factors|mesh-ancestor
56941463|NCT05594095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941464|NCT05594095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56941465|NCT05594095|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56941466|NCT05594095|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56941467|NCT05594095|Hormone Antagonists|hormone antagonists|mesh-ancestor
56941468|NCT05594095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941469|NCT05594095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56941470|NCT05594095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941471|NCT05594095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941472|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
56941473|NCT03129490|Apixaban|apixaban|mesh-list
56941474|NCT03129490|Edoxaban|edoxaban|mesh-list
56941475|NCT03129490|Dabigatran|dabigatran|mesh-list
56941476|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56941477|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
56862364|NCT05624996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56941478|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56941479|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
56941480|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941481|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941482|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
56941483|NCT05624671|Fentanyl|fentanyl|mesh-list
56941484|NCT05624671|Bupivacaine|bupivacaine|mesh-list
56941485|NCT05624671|Anesthetics, Local|anesthetics, local|mesh-ancestor
56941486|NCT05624671|Anesthetics|anesthetics|mesh-ancestor
56941487|NCT05624671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941488|NCT05624671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941489|NCT05624671|Sensory System Agents|sensory system agents|mesh-ancestor
56941490|NCT05624671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941491|NCT05624671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56941492|NCT05624671|Narcotics|narcotics|mesh-ancestor
56941493|NCT05624671|Analgesics|analgesics|mesh-ancestor
56941494|NCT05624671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56941495|NCT05624671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56941496|NCT05624671|Anesthetics, General|anesthetics, general|mesh-ancestor
56941497|NCT03578965|Cefazolin|cefazolin|mesh-list
56941498|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56941499|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941500|NCT03791905|Leucovorin|leucovorin|mesh-list
56941502|NCT03791905|Fluorouracil|fluorouracil|mesh-list
56941503|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
56941504|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56941505|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941506|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
56941507|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
56941508|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
56941509|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941510|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
56941511|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56941512|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941513|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
56941514|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941515|NCT03791905|Antidotes|antidotes|mesh-ancestor
56941516|NCT03791905|Protective Agents|protective agents|mesh-ancestor
56941517|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
56941518|NCT03791905|Vitamins|vitamins|mesh-ancestor
56941519|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
56941520|NCT01138553|Mifepristone|mifepristone|mesh-list
56941521|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56941522|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
56941523|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56941524|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941525|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56941526|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56941527|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56941528|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
56941529|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56941530|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56941531|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
56941532|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941533|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
56941534|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56941535|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56941536|NCT05171374|Trametinib|trametinib|mesh-list
56941537|NCT05171374|Dabrafenib|dabrafenib|mesh-list
56941538|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941539|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56941540|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941541|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941542|NCT03447184|Androgens|androgens|mesh-list
56941543|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56941544|NCT03447184|Hormones|hormones|mesh-ancestor
56941545|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941546|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941547|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56941548|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941549|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941550|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56941551|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
56941552|NCT03739541|Benzonidazole|benzonidazole|mesh-list
56862450|NCT05624528|Tolcapone|tolcapone|mesh-list
56941553|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941554|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
56941555|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941556|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56941557|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56941558|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56941559|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941560|NCT01135667|Clopidogrel|clopidogrel|mesh-list
56941561|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56941562|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56941563|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56941564|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56941565|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56941566|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
56941567|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941568|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941569|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941570|NCT03446872|Leucovorin|leucovorin|mesh-list
56941571|NCT03446872|Fluorouracil|fluorouracil|mesh-list
56941572|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
56941573|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537276|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941574|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56941575|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941576|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941577|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
56941578|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941579|NCT03446872|Antidotes|antidotes|mesh-ancestor
56941580|NCT03446872|Protective Agents|protective agents|mesh-ancestor
56941581|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
56941582|NCT03446872|Vitamins|vitamins|mesh-ancestor
56941583|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
56941584|NCT03446638|Cytarabine|cytarabine|mesh-list
56941585|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56941586|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
56941587|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941588|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941589|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
56941590|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941591|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941592|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
56941593|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941594|NCT05401019|Pramipexole|pramipexole|mesh-list
56941595|NCT05401019|Risperidone|risperidone|mesh-list
56941596|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56941597|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
56941598|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941599|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941600|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941601|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56941602|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56941603|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941604|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56941605|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56941606|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
56941607|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
56941608|NCT05401019|Protective Agents|protective agents|mesh-ancestor
56941609|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56941610|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56941611|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
56941612|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
56941613|NCT03788863|Diflucortolone|diflucortolone|mesh-list
56941614|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941615|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
56941616|NCT03788863|Hormones|hormones|mesh-ancestor
56941617|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941618|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941619|NCT04659161|Xanomeline|xanomeline|mesh-list
56941620|NCT04659161|Trospium chloride|trospium chloride|mesh-list
56941621|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
56941622|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
56941623|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941624|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941625|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56941626|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56941627|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
56941628|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941629|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941630|NCT04659161|Urological Agents|urological agents|mesh-ancestor
56941631|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56941632|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56941633|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56941634|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56941635|NCT03129256|Apatinib|apatinib|mesh-list
56941636|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941637|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56941638|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941639|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941640|NCT05193851|Ricolinostat|ricolinostat|mesh-list
56941641|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941642|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56941643|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941644|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941645|NCT05682807|Caffeine|caffeine|mesh-list
56941646|NCT05682807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56941647|NCT05682807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941648|NCT05682807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56941649|NCT05682807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941650|NCT05682807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941651|NCT05682807|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56941652|NCT05682807|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56941653|NCT05682807|Purinergic Agents|purinergic agents|mesh-ancestor
56941654|NCT05682807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941655|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
56941656|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
56941657|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
56941658|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941659|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941660|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
56941661|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941662|NCT05364099|Triamcinolone|triamcinolone|mesh-list
56941664|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
56941665|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
56941666|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941667|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941668|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
56941669|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941670|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56941671|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56941672|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56941673|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56941674|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941675|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941676|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
56941677|NCT05364099|Hormones|hormones|mesh-ancestor
56941678|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941679|NCT03445702|Metformin|metformin|mesh-list
56941680|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56941681|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941682|NCT03445624|Infliximab|infliximab|mesh-list
56941683|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
56941684|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56941685|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56941686|NCT01312077|Morphine|morphine|mesh-list
56941687|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
56941688|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56941689|NCT01312077|Narcotics|narcotics|mesh-ancestor
56941690|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941691|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941692|NCT01312077|Analgesics|analgesics|mesh-ancestor
56941693|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
56941694|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941695|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
56941696|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
56941697|NCT03793309|Vitamin D|vitamin d|mesh-list
56941698|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
56941699|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
56941700|NCT03793309|Vitamins|vitamins|mesh-list
56941701|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
56941702|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941703|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56941704|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56941705|NCT01140893|Exenatide|exenatide|mesh-list
56941706|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56941707|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941708|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56941709|NCT01140893|Incretins|incretins|mesh-ancestor
56941710|NCT01140893|Hormones|hormones|mesh-ancestor
56941711|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941712|NCT03445468|Vaccines|vaccines|mesh-list
56941713|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
56941714|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941715|NCT03791827|Cyclosporine|cyclosporine|mesh-list
56941716|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
56941717|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
56941718|NCT03791827|Prednisone|prednisone|mesh-list
56941719|NCT03791827|Prednisolone|prednisolone|mesh-list
56941720|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
56941721|NCT03791827|Rituximab|rituximab|mesh-list
56941722|NCT03791827|Azathioprine|azathioprine|mesh-list
56941723|NCT03791827|Tacrolimus|tacrolimus|mesh-list
56941724|NCT03791827|Cyclosporins|cyclosporins|mesh-list
56941725|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941726|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
56941727|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941728|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56941729|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56941730|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
56941731|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941732|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941733|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56941734|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56941735|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941736|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
56941737|NCT03791827|Hormones|hormones|mesh-ancestor
56941738|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941739|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56941740|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56941741|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941742|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
56941743|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941744|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
56941745|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56941746|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56941747|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
56941748|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56941749|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
56941750|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56941751|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56941752|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
56941753|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56941754|NCT03708861|Ritonavir|ritonavir|mesh-list
56941755|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56941756|NCT03708861|Maraviroc|maraviroc|mesh-list
56941757|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56941758|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56941759|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
56941760|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941761|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941762|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56941763|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56941764|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
56941765|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941766|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56941767|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56941768|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56941769|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56941770|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56941771|NCT04798755|Adalimumab|adalimumab|mesh-list
56941772|NCT04798755|Methotrexate|methotrexate|mesh-list
56941773|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56941774|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
56941775|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56941776|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941777|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56941778|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
56052672|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941779|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941780|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941781|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
56941782|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941783|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56941784|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941785|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
56941786|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56941787|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56941788|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941789|NCT01308229|Paclitaxel|paclitaxel|mesh-list
56941790|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56941791|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941792|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
56941793|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
56941794|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
56941795|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941796|NCT03445078|Selenium|selenium|mesh-list
56941797|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
56941798|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941799|NCT03445078|Protective Agents|protective agents|mesh-ancestor
56941800|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941801|NCT03445078|Trace Elements|trace elements|mesh-ancestor
56285759|NCT00389311|Nonoxynol|nonoxynol|mesh-list
56941802|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
56941803|NCT05252585|Everolimus|everolimus|mesh-list
56941804|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941805|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56941806|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
56941807|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941808|NCT01233791|Diazepam|diazepam|mesh-list
56941809|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56941810|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
56941811|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
56941812|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
56941813|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941814|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941815|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56941816|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56941817|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941818|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56941819|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56941820|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56941821|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56941822|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56941823|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56941824|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
56941825|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
56941826|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
56941827|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
56941828|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941829|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941830|NCT01140971|Misoprostol|misoprostol|mesh-list
56941831|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56941832|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
56941833|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56941834|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941835|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56941836|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56941837|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
56941838|NCT01306357|Hormones|hormones|mesh-list
56941839|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941840|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941841|NCT03129022|Anesthetics|anesthetics|mesh-list
56941842|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941843|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941844|NCT03342963|Aripiprazole|aripiprazole|mesh-list
56941845|NCT03342963|Sertraline|sertraline|mesh-list
56941846|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
56941847|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56941848|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56941849|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56941850|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941851|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941852|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
56941853|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
56941854|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941855|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941856|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56941857|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56941858|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
56941859|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56941860|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56941861|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56941862|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56941863|NCT03342963|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56941864|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56941865|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56941866|NCT03706755|Norepinephrine|norepinephrine|mesh-list
56941867|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56941868|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56941869|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
56941870|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941871|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941872|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941873|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
56941874|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
56941875|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56285827|NCT00001378|Fenretinide|fenretinide|mesh-list
56941876|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56941877|NCT03791515|Calcitonin|calcitonin|mesh-list
56941878|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
56941879|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56941880|NCT03791515|Katacalcin|katacalcin|mesh-list
56941881|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56941882|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941883|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56941884|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
56941885|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
56941886|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
56941887|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941888|NCT04595591|Remifentanil|remifentanil|mesh-list
56941889|NCT04595591|Rocuronium|rocuronium|mesh-list
56941890|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56941891|NCT04595591|Narcotics|narcotics|mesh-ancestor
56941892|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941893|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941894|NCT04595591|Analgesics|analgesics|mesh-ancestor
56941895|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
56941896|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941897|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56941898|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56941899|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56941900|NCT03709953|Apatinib|apatinib|mesh-list
56941901|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56941902|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56941903|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941904|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941905|NCT03444142|Exenatide|exenatide|mesh-list
56941906|NCT03444142|Dulaglutide|dulaglutide|mesh-list
56941907|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56941908|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941909|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56941910|NCT03444142|Incretins|incretins|mesh-ancestor
56941911|NCT03444142|Hormones|hormones|mesh-ancestor
56941912|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56941913|NCT01305733|Ketorolac|ketorolac|mesh-list
56941914|NCT01305733|Epinephrine|epinephrine|mesh-list
56941915|NCT01305733|Racepinephrine|racepinephrine|mesh-list
56941916|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
56941917|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
56941918|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56941919|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56941920|NCT01305733|Analgesics|analgesics|mesh-ancestor
56941921|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
56941922|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56941923|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941924|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941925|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56941926|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56941927|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733777|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
56941928|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941929|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
56941930|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
56941931|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56941932|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56941933|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56941934|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
56941935|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941936|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56941937|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56941938|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
56941939|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56941940|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
56941941|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
56941942|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
56941943|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56941944|NCT05210153|Sertraline|sertraline|mesh-list
56941945|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
56941946|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56941947|NCT05210153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56941948|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56941949|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56941950|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941951|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941952|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
56941953|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941955|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
56941956|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56941957|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56941958|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941959|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56941960|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
56941961|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56941962|NCT04749459|Protective Agents|protective agents|mesh-ancestor
56941963|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941964|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
56941965|NCT04585295|Betaine|betaine|mesh-list
56941966|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56941967|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
56941968|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56941969|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
56941970|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941971|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56941972|NCT05693545|Penicillins|penicillins|mesh-list
56941973|NCT05693545|Penicillin G|penicillin g|mesh-list
56941974|NCT05693545|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56941975|NCT05693545|Penicillin G Procaine|penicillin g procaine|mesh-list
56941976|NCT05693545|Penicillin V|penicillin v|mesh-list
56941977|NCT05693545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56941978|NCT05693545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56941979|NCT01136213|Fluoxetine|fluoxetine|mesh-list
56941980|NCT01136213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56941981|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56941982|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56941983|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56941984|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56941985|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
56941986|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56941987|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56941988|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
56941989|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56941990|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56941991|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56941992|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56941993|NCT03361176|Triamcinolone|triamcinolone|mesh-list
56941994|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56941995|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56941996|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
56941997|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56941998|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56941999|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
56942000|NCT03361176|Hormones|hormones|mesh-ancestor
56942001|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942002|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862910|NCT01335334|Omeprazole|omeprazole|mesh-list
56942003|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942004|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
56942005|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942006|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942007|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56942008|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942009|NCT03438214|Vancomycin|vancomycin|mesh-list
56942010|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56942011|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942012|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
56942013|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56942014|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56942015|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942016|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
56942017|NCT01141127|Coagulants|coagulants|mesh-ancestor
56942018|NCT05693467|Dexamethasone|dexamethasone|mesh-list
56942019|NCT05693467|Ropivacaine|ropivacaine|mesh-list
56942020|NCT05693467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56942021|NCT05693467|Antiemetics|antiemetics|mesh-ancestor
56942022|NCT05693467|Autonomic Agents|autonomic agents|mesh-ancestor
56942023|NCT05693467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942024|NCT05693467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942025|NCT05693467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942026|NCT05693467|Glucocorticoids|glucocorticoids|mesh-ancestor
56942027|NCT05693467|Hormones|hormones|mesh-ancestor
56942028|NCT05693467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942029|NCT05693467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56942030|NCT05693467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942031|NCT05693467|Anesthetics, Local|anesthetics, local|mesh-ancestor
56942032|NCT05693467|Anesthetics|anesthetics|mesh-ancestor
56942033|NCT05693467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942034|NCT05693467|Sensory System Agents|sensory system agents|mesh-ancestor
56942035|NCT04613206|Vaccines|vaccines|mesh-list
56942036|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
56942037|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942038|NCT03708822|Docetaxel|docetaxel|mesh-list
56942039|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
56942040|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942041|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
56942042|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
56942043|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
56942044|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942045|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942046|NCT05280444|Idarubicin|idarubicin|mesh-list
56942047|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56942048|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942049|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56942050|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56942051|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942052|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942053|NCT01308541|Propofol|propofol|mesh-list
56942054|NCT01308541|Fospropofol|fospropofol|mesh-list
56942055|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56942056|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942057|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942058|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56942059|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
56942060|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
56942061|NCT05679765|Dexamethasone|dexamethasone|mesh-list
56942062|NCT05679765|Dexamethasone acetate|dexamethasone acetate|mesh-list
56942063|NCT05679765|Lidocaine|lidocaine|mesh-list
56942064|NCT05679765|BB 1101|bb 1101|mesh-list
56942065|NCT05679765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56942066|NCT05679765|Antiemetics|antiemetics|mesh-ancestor
56942067|NCT05679765|Autonomic Agents|autonomic agents|mesh-ancestor
56942068|NCT05679765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942069|NCT05679765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942070|NCT05679765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942071|NCT05679765|Glucocorticoids|glucocorticoids|mesh-ancestor
56942072|NCT05679765|Hormones|hormones|mesh-ancestor
56942073|NCT05679765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942074|NCT05679765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56942075|NCT05679765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942076|NCT05679765|Protease Inhibitors|protease inhibitors|mesh-ancestor
56942077|NCT05679765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942078|NCT05679765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942079|NCT05679765|Anesthetics, Local|anesthetics, local|mesh-ancestor
56942080|NCT05679765|Anesthetics|anesthetics|mesh-ancestor
56942081|NCT05679765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942082|NCT05679765|Sensory System Agents|sensory system agents|mesh-ancestor
56942083|NCT05679765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56942084|NCT05679765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56942085|NCT05679765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56942086|NCT05679765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56942087|NCT03437980|Propofol|propofol|mesh-list
56942088|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56942089|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942090|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942091|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56942092|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
56942093|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
56942094|NCT05176119|Ketamine|ketamine|mesh-list
56942095|NCT05176119|Nalbuphine|nalbuphine|mesh-list
56942096|NCT05176119|Analgesics|analgesics|mesh-ancestor
56942097|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
56942098|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942099|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942100|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56942101|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56942102|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
56942103|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
56942104|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942105|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56942106|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56942107|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942108|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942110|NCT05176119|Narcotics|narcotics|mesh-ancestor
56942111|NCT03437902|Vitamins|vitamins|mesh-list
56942112|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
56942113|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
56942114|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942115|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
56942116|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942117|NCT03437902|Protective Agents|protective agents|mesh-ancestor
56942118|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
56942119|NCT05283499|Analgesics|analgesics|mesh-list
56942120|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56942121|NCT05283499|Narcotics|narcotics|mesh-ancestor
56942122|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942123|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942124|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
56942125|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942126|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
56942127|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
56942128|NCT03437824|Vitamins|vitamins|mesh-ancestor
56942129|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
56942130|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942131|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
56942132|NCT03437824|Hematinics|hematinics|mesh-ancestor
56942133|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
56942134|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
56942135|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56942136|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56942137|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
56942138|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942139|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942140|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942141|NCT01136525|Valacyclovir|valacyclovir|mesh-list
56942142|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
56942143|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942144|NCT05632445|Apixaban|apixaban|mesh-list
56942145|NCT05632445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56942146|NCT05632445|Antithrombins|antithrombins|mesh-ancestor
56942147|NCT05632445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56942148|NCT05632445|Protease Inhibitors|protease inhibitors|mesh-ancestor
56942149|NCT05632445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942150|NCT05632445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942151|NCT05632445|Anticoagulants|anticoagulants|mesh-ancestor
56942152|NCT04422652|Bupropion|bupropion|mesh-list
56942153|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56942154|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
56942155|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56942156|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56942157|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56942158|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56942159|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942160|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
56942161|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942162|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942163|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56942164|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56942165|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942166|NCT01235117|Azacitidine|azacitidine|mesh-list
56942167|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56942168|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
56942169|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942170|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942171|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942172|NCT01306591|Bevacizumab|bevacizumab|mesh-list
56942173|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942174|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942175|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56942176|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56942177|NCT01306591|Growth Substances|growth substances|mesh-ancestor
56942178|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942179|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
56942180|NCT03098030|Irinotecan|irinotecan|mesh-list
56942181|NCT03098030|Topotecan|topotecan|mesh-list
56942182|NCT03098030|Dinutuximab|dinutuximab|mesh-list
56942183|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56942184|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56942185|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942186|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942187|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942188|NCT01233947|Fulvestrant|fulvestrant|mesh-list
56942189|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56942190|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942191|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56942192|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56942193|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
56942194|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942195|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942196|NCT01139645|Esomeprazole|esomeprazole|mesh-list
56942197|NCT01139645|Rabeprazole|rabeprazole|mesh-list
56942198|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56942199|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942200|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56942201|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942202|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942203|NCT03706287|Cisplatin|cisplatin|mesh-list
56942204|NCT03706287|Carboplatin|carboplatin|mesh-list
56942205|NCT03706287|Pemetrexed|pemetrexed|mesh-list
56942206|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942207|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942208|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942209|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56942210|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56942211|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
56942212|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56942213|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
56942214|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942215|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942216|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56942217|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
56942218|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56942219|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
56942220|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942221|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942222|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56942223|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
56942224|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
56942225|NCT05109611|Protective Agents|protective agents|mesh-ancestor
56942226|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56942227|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942228|NCT05107193|Afatinib|afatinib|mesh-list
56942229|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942230|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56942231|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942232|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942233|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56942234|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56942235|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
56942236|NCT02522650|Amiloride|amiloride|mesh-list
56942237|NCT02522650|Triamterene|triamterene|mesh-list
56942238|NCT02522650|Diuretics|diuretics|mesh-ancestor
56942239|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
56942240|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942241|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56942242|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56942243|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56942244|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942245|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56942246|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56942247|NCT05681871|Folic Acid|folic acid|mesh-list
56942248|NCT05681871|Ferrous fumarate|ferrous fumarate|mesh-list
56942249|NCT05681871|Ferrous gluconate|ferrous gluconate|mesh-list
56942250|NCT05681871|Hematinics|hematinics|mesh-ancestor
56942251|NCT05681871|Vitamin B Complex|vitamin b complex|mesh-ancestor
56942252|NCT05681871|Vitamins|vitamins|mesh-ancestor
56942253|NCT05681871|Micronutrients|micronutrients|mesh-ancestor
56942254|NCT05681871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942255|NCT05681871|Trace Elements|trace elements|mesh-ancestor
56942256|NCT05681715|Rozanolixizumab|rozanolixizumab|mesh-list
56942257|NCT05681715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942258|NCT05681715|Immunologic Factors|immunologic factors|mesh-ancestor
56942259|NCT05681715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942260|NCT04455958|Ritonavir|ritonavir|mesh-list
56942261|NCT04455958|Lopinavir|lopinavir|mesh-list
56942262|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56942263|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56942264|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
56942265|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942266|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942267|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56942268|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56942269|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
56942270|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942271|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56942272|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56942273|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56942274|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942275|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
56942276|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942277|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942278|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942279|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56942280|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
56942281|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56942282|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56942283|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56942284|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56942285|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942286|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
56942287|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942288|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942289|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56942290|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942291|NCT01378858|Varenicline|varenicline|mesh-list
56942292|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56942293|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56942294|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
56942295|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942296|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942297|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942298|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
56942299|NCT02891850|Tadalafil|tadalafil|mesh-list
56942300|NCT02891850|Riociguat|riociguat|mesh-list
56942301|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
56942302|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55734236|NCT05322265|Racepinephrine|racepinephrine|mesh-list
56942303|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56942304|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942305|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942306|NCT02891850|Urological Agents|urological agents|mesh-ancestor
56942307|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
56942308|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
56942309|NCT05175027|Povidone|povidone|mesh-list
56942310|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
56942311|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
56942312|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56942313|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942314|NCT05089630|Vaccines|vaccines|mesh-list
56942315|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
56942316|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942317|NCT03707418|Heparin|heparin|mesh-list
56942318|NCT03707418|Calcium heparin|calcium heparin|mesh-list
56942319|NCT03707418|Bivalirudin|bivalirudin|mesh-list
56942320|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
56942321|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56942322|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56942323|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942324|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
56942325|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56942326|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
56942327|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942328|NCT05681481|Prednisone|prednisone|mesh-list
56942329|NCT05681481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56942330|NCT05681481|Glucocorticoids|glucocorticoids|mesh-ancestor
56942331|NCT05681481|Hormones|hormones|mesh-ancestor
56942332|NCT05681481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942333|NCT05681481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942334|NCT05681481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56942335|NCT05681481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942336|NCT03785041|Tramadol|tramadol|mesh-list
56942337|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
56942338|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56942339|NCT03785041|Narcotics|narcotics|mesh-ancestor
56942340|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942341|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942342|NCT03785041|Analgesics|analgesics|mesh-ancestor
56942343|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
56942344|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942345|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
56942346|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
56942347|NCT03710304|Misoprostol|misoprostol|mesh-list
56942348|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
56942349|NCT03710304|Oxytocin|oxytocin|mesh-list
56942350|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
56942351|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56942352|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942353|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56942354|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56942355|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942356|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
56942357|NCT03710304|Coagulants|coagulants|mesh-ancestor
56942358|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56942359|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
56942360|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56942361|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942362|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
56942363|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942364|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942365|NCT05605639|Bupivacaine|bupivacaine|mesh-list
56942366|NCT05605639|Anesthetics, Local|anesthetics, local|mesh-ancestor
56942367|NCT05605639|Anesthetics|anesthetics|mesh-ancestor
56942368|NCT05605639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942369|NCT05605639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942370|NCT05605639|Sensory System Agents|sensory system agents|mesh-ancestor
56942371|NCT05605639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942372|NCT04853446|Dexamethasone|dexamethasone|mesh-list
56942373|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
56942374|NCT04853446|BB 1101|bb 1101|mesh-list
56942375|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56942376|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
56942377|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
56942378|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942379|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942380|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56863266|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
56942381|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
56942382|NCT04853446|Hormones|hormones|mesh-ancestor
56942383|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942384|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56942385|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942386|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
56942387|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942388|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942389|NCT03790345|Vitamins|vitamins|mesh-list
56942390|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
56942391|NCT03790345|Pyridoxine|pyridoxine|mesh-list
56942392|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
56942393|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
56942394|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
56942395|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942396|NCT05416190|Anticoagulants|anticoagulants|mesh-list
56942397|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
56942398|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
56942399|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942400|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56942401|NCT04454788|Tenecteplase|tenecteplase|mesh-list
56942402|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56942403|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56942404|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942405|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56942407|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942408|NCT04862650|Paclitaxel|paclitaxel|mesh-list
56942409|NCT04862650|Carboplatin|carboplatin|mesh-list
56942410|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56942411|NCT04862650|Cemiplimab|cemiplimab|mesh-list
56942412|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56942413|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942414|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
56942415|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
56942416|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
56942417|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942418|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942419|NCT05163561|Vaccines|vaccines|mesh-list
56942420|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
56942421|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942422|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
56942423|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
56942424|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942425|NCT05681403|Cytarabine|cytarabine|mesh-list
56942426|NCT05681403|Carmustine|carmustine|mesh-list
56942427|NCT05681403|Melphalan|melphalan|mesh-list
56942428|NCT05681403|Etoposide|etoposide|mesh-list
56942429|NCT05681403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56942430|NCT05681403|Alkylating Agents|alkylating agents|mesh-ancestor
56942431|NCT05681403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942432|NCT05681403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942433|NCT05681403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56942434|NCT05681403|Antimetabolites|antimetabolites|mesh-ancestor
56942435|NCT05681403|Antiviral Agents|antiviral agents|mesh-ancestor
56942436|NCT05681403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942437|NCT05681403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942438|NCT05681403|Immunologic Factors|immunologic factors|mesh-ancestor
56942439|NCT05681403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942440|NCT05681403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56942441|NCT05681403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56942442|NCT05681403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56942443|NCT05681403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942444|NCT05681403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56942445|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56942446|NCT01309009|MEN 11420|men 11420|mesh-list
56942447|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56942448|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
56942449|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942450|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942451|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56942452|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
56942453|NCT03339453|Glucagon|glucagon|mesh-list
56942454|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56942455|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942456|NCT03339453|Hormones|hormones|mesh-ancestor
56942457|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942458|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942459|NCT03339453|Incretins|incretins|mesh-ancestor
56942460|NCT05418686|Colchicine|colchicine|mesh-list
56942461|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
56942462|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56942463|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
56942464|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
56942465|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
56942466|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942467|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942468|NCT01306981|Ranibizumab|ranibizumab|mesh-list
56942469|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56942470|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56942471|NCT01306981|Growth Substances|growth substances|mesh-ancestor
56942472|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942473|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
56942474|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942475|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56942476|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
56942477|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942478|NCT05076799|Lactulose|lactulose|mesh-list
56942479|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942480|NCT03784495|Melatonin|melatonin|mesh-list
56942481|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
56942482|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942483|NCT03784495|Protective Agents|protective agents|mesh-ancestor
56942484|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942485|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942486|NCT04120246|Acetic Acid|acetic acid|mesh-list
56942487|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56942488|NCT04120246|Trastuzumab|trastuzumab|mesh-list
56942489|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56942490|NCT04120246|Antibodies|antibodies|mesh-list
56942491|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
56942492|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56942493|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
56942494|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942495|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942496|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56942497|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942498|NCT05659147|Secretin|secretin|mesh-list
56942499|NCT05659147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942500|NCT05659147|Hormones|hormones|mesh-ancestor
56942501|NCT05659147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942502|NCT05659147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942503|NCT05234697|Remifentanil|remifentanil|mesh-list
56942504|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56942505|NCT05234697|Narcotics|narcotics|mesh-ancestor
56942506|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942507|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942508|NCT05234697|Analgesics|analgesics|mesh-ancestor
56942509|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
56942510|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942511|NCT03490760|Durvalumab|durvalumab|mesh-list
56942512|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942513|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942514|NCT02133404|Cinacalcet|cinacalcet|mesh-list
56942515|NCT02133404|ASP7991|asp7991|mesh-list
56942516|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56942517|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942518|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56942519|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
56942520|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942521|NCT01307215|Ropivacaine|ropivacaine|mesh-list
56942522|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
56942523|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
56942524|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942525|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942526|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
56942527|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942528|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
56942529|NCT03761056|Fludarabine|fludarabine|mesh-list
56942530|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942531|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
56942532|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942533|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56942534|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56942535|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
56942536|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942537|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942538|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56942539|NCT05177601|Cycloserine|cycloserine|mesh-list
56942540|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56942541|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942542|NCT05177601|Renal Agents|renal agents|mesh-ancestor
56942543|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56942544|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
56942545|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56942546|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
56942547|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942548|NCT03420794|Analgesics|analgesics|mesh-list
56942549|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56942550|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
56942551|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942552|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942553|NCT01568450|Oxycodone|oxycodone|mesh-list
56942554|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56942555|NCT01568450|Narcotics|narcotics|mesh-ancestor
56942556|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942557|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942558|NCT01568450|Analgesics|analgesics|mesh-ancestor
56942559|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
56942560|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942561|NCT05410496|Tenofovir|tenofovir|mesh-list
56942562|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
56942563|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942564|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56942565|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56942566|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942567|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942568|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56942569|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56942570|NCT03784105|Codeine|codeine|mesh-list
56942571|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56942572|NCT03784105|Narcotics|narcotics|mesh-ancestor
56942573|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942574|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942575|NCT03784105|Analgesics|analgesics|mesh-ancestor
56942576|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
56942577|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942578|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
56942579|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
56942580|NCT03366142|Ustekinumab|ustekinumab|mesh-list
56942581|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56942582|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56942583|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56942584|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942585|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942586|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
56942587|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942588|NCT03784261|Abatacept|abatacept|mesh-list
56942589|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56942590|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942591|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942592|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942593|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
56942594|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942595|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56942596|NCT02989402|Rivastigmine|rivastigmine|mesh-list
56942597|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56942598|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942599|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942600|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
56942601|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942602|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942603|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56942604|NCT02989402|Protective Agents|protective agents|mesh-ancestor
56942605|NCT03783949|Gemcitabine|gemcitabine|mesh-list
56942606|NCT03783949|Paclitaxel|paclitaxel|mesh-list
56942607|NCT03783949|Carboplatin|carboplatin|mesh-list
56942608|NCT03783949|Niraparib|niraparib|mesh-list
56942609|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56942610|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942611|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
56942612|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
56942613|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
56942614|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942615|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56942616|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
56942617|NCT03783949|Antiviral Agents|antiviral agents|mesh-ancestor
56942618|NCT03783949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942619|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942620|NCT03783949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942621|NCT03783949|Immunologic Factors|immunologic factors|mesh-ancestor
56942622|NCT03783949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942623|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56942624|NCT02861950|Bupivacaine|bupivacaine|mesh-list
56942625|NCT02861950|Ropivacaine|ropivacaine|mesh-list
56942626|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
56942627|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
56942628|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942629|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942630|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
56942631|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538323|NCT02762851|Vaccines|vaccines|mesh-list
56942633|NCT05681247|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56942634|NCT05681247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56942635|NCT05681247|Antimetabolites|antimetabolites|mesh-ancestor
56942636|NCT05681247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942637|NCT05681247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56942638|NCT03787927|Aspirin|aspirin|mesh-list
56942639|NCT03787927|Clopidogrel|clopidogrel|mesh-list
56942640|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56942641|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56942642|NCT03787927|Analgesics|analgesics|mesh-ancestor
56942643|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
56942644|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942645|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942646|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56942647|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56942648|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56942649|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56942650|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942651|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56942652|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56942653|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942654|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
56942655|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56942656|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56942657|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56942658|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
56942659|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942660|NCT00602576|Temozolomide|temozolomide|mesh-list
56942661|NCT00602576|Sorafenib|sorafenib|mesh-list
56942662|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56942663|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
56942664|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942665|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942666|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56942667|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942668|NCT04807972|Folfirinox|folfirinox|mesh-list
56942669|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942670|NCT05694871|Palbociclib|palbociclib|mesh-list
56942671|NCT05694871|Cemiplimab|cemiplimab|mesh-list
56942672|NCT05694871|Immunoglobulins|immunoglobulins|mesh-list
56942673|NCT05694871|Immunoglobulin G|immunoglobulin g|mesh-list
56942674|NCT05694871|Immunologic Factors|immunologic factors|mesh-ancestor
56942675|NCT05694871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942676|NCT05694871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942677|NCT05694871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56942678|NCT05694871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942679|NCT05694871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942680|NCT05694871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942681|NCT03359850|Niraparib|niraparib|mesh-list
56942682|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56942683|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942684|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942685|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942686|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
56942687|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
56942688|NCT01306123|Vitamins|vitamins|mesh-ancestor
56942689|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
56942690|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942691|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
56942692|NCT01306123|Hematinics|hematinics|mesh-ancestor
56942693|NCT04557956|Trametinib|trametinib|mesh-list
56942694|NCT04557956|Dabrafenib|dabrafenib|mesh-list
56942695|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56942696|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942697|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56942698|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942699|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942700|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56942701|NCT04557956|Protective Agents|protective agents|mesh-ancestor
56942702|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942703|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56942704|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
56942705|NCT04803994|Bevacizumab|bevacizumab|mesh-list
56942706|NCT04803994|Atezolizumab|atezolizumab|mesh-list
56942707|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942708|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942709|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56942710|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56942711|NCT04803994|Growth Substances|growth substances|mesh-ancestor
56942712|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942713|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
56942714|NCT03130426|Insulin|insulin|mesh-list
56942715|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56942716|NCT03130426|Metformin|metformin|mesh-list
56942717|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
56942718|NCT03130426|Lixisenatide|lixisenatide|mesh-list
56942719|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56942720|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942721|NCT00114140|Temozolomide|temozolomide|mesh-list
56942722|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56942723|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
56942724|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942725|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942726|NCT03342690|Eplerenone|eplerenone|mesh-list
56942727|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56942728|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
56942729|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942730|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942731|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56942732|NCT03342690|Diuretics|diuretics|mesh-ancestor
56942733|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
56942734|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56942735|NCT03130582|Etoposide|etoposide|mesh-list
56942736|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56942737|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942738|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56942739|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56942740|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942741|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942742|NCT04752540|Olorofim|olorofim|mesh-list
56942743|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
56942744|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942745|NCT03712345|Vilobelimab|vilobelimab|mesh-list
56942746|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56942747|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942748|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
56942749|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942750|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56942751|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56942752|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942753|NCT03130348|Dexamethasone|dexamethasone|mesh-list
56942754|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
56942755|NCT03130348|Bortezomib|bortezomib|mesh-list
56942756|NCT03130348|Ichthammol|ichthammol|mesh-list
56942757|NCT03130348|BB 1101|bb 1101|mesh-list
56942758|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56942759|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
56942760|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
56942761|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942762|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942763|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942764|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
56942765|NCT03130348|Hormones|hormones|mesh-ancestor
56942766|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942767|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56942768|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942769|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
56942770|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942771|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942772|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
56942773|NCT01307527|Riboflavin|riboflavin|mesh-list
56942774|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
56942775|NCT01307527|Vitamins|vitamins|mesh-ancestor
56942776|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
56942777|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942778|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56942779|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
56942780|NCT05070403|Afatinib|afatinib|mesh-list
56942781|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538471|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942782|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56942783|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942784|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942785|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
56942786|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
56942787|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56942788|NCT03789799|Protective Agents|protective agents|mesh-ancestor
56942789|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942790|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
56942791|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56942792|NCT05439772|Ondansetron|ondansetron|mesh-list
56942793|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
56942794|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
56942795|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942796|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942797|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942798|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
56942799|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
56942800|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56942801|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
56942802|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942803|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942804|NCT05439772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56942805|NCT05439772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56942806|NCT05439772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942807|NCT05439772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56942808|NCT05439772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56942809|NCT05694715|Irinotecan|irinotecan|mesh-list
56942810|NCT05694715|Niraparib|niraparib|mesh-list
56942811|NCT05694715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56942812|NCT05694715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56942813|NCT05694715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942814|NCT05694715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942815|NCT05694715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942816|NCT05694715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56942817|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
56942818|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942819|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942820|NCT01309399|Teriparatide|teriparatide|mesh-list
56942821|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56942822|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942823|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56942824|NCT03311828|Daratumumab|daratumumab|mesh-list
56942825|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942826|NCT01309477|Tacrolimus|tacrolimus|mesh-list
56942827|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942828|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
56942829|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942830|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56942831|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942832|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942833|NCT03709992|Tamsulosin|tamsulosin|mesh-list
56942834|NCT03709992|Trospium chloride|trospium chloride|mesh-list
56942835|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56942836|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56942837|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56942838|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
56942839|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942840|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942841|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942842|NCT03709992|Urological Agents|urological agents|mesh-ancestor
56942843|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
56942844|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
56942845|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942846|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56942847|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56942848|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
56942849|NCT05438992|Bupivacaine|bupivacaine|mesh-list
56942850|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
56942851|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
56942852|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942853|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942854|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
56942855|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942856|NCT05361486|Primaquine|primaquine|mesh-list
56942857|NCT05361486|Tafenoquine|tafenoquine|mesh-list
56538547|NCT02764723|Bupivacaine|bupivacaine|mesh-list
56942858|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
56942859|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56942860|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56942861|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942862|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
56942863|NCT03089216|Calcium|calcium|mesh-list
56942864|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56942865|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942866|NCT03089216|Antacids|antacids|mesh-ancestor
56942867|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942868|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942869|NCT03339726|Phenylephrine|phenylephrine|mesh-list
56942870|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
56942871|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56942872|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
56942873|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
56942874|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942875|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942876|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
56942877|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56942878|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
56942879|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
56942880|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56942881|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56942882|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56942883|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
56942884|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942885|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942886|NCT03339726|Protective Agents|protective agents|mesh-ancestor
56942887|NCT03339297|Defibrotide|defibrotide|mesh-list
56942888|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56942889|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56942890|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942891|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56942892|NCT05434624|Midazolam|midazolam|mesh-list
56942893|NCT05434624|Propofol|propofol|mesh-list
56942894|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56942895|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56942896|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942897|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56942898|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
56942899|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
56942900|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56942901|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56942902|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56942903|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56942904|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
56942905|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
56942906|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56942907|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942908|NCT01309633|Gemcitabine|gemcitabine|mesh-list
56942909|NCT01309633|Bevacizumab|bevacizumab|mesh-list
56942910|NCT01309633|Sunitinib|sunitinib|mesh-list
56942911|NCT01309633|Cisplatin|cisplatin|mesh-list
56863792|NCT01347268|Hormones|hormones|mesh-ancestor
56942912|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942913|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942914|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56942915|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56942916|NCT01309633|Growth Substances|growth substances|mesh-ancestor
56942917|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942918|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
56942919|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56942920|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
56942921|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942922|NCT01309633|Antiviral Agents|antiviral agents|mesh-ancestor
56942923|NCT01309633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942924|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942925|NCT01309633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942926|NCT01309633|Immunologic Factors|immunologic factors|mesh-ancestor
56942927|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56942928|NCT04538378|Durvalumab|durvalumab|mesh-list
56942929|NCT04538378|Olaparib|olaparib|mesh-list
56942930|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56942931|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538624|NCT02767999|Fluoxetine|fluoxetine|mesh-list
56942932|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56942933|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942934|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942935|NCT05215431|Antioxidants|antioxidants|mesh-list
56942936|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942937|NCT05215431|Protective Agents|protective agents|mesh-ancestor
56942938|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942939|NCT04681417|Carboplatin|carboplatin|mesh-list
56942940|NCT04681417|Etoposide|etoposide|mesh-list
56942941|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
56942942|NCT04681417|Vincristine|vincristine|mesh-list
56942943|NCT04681417|Melphalan|melphalan|mesh-list
56942944|NCT04681417|Topotecan|topotecan|mesh-list
56942945|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942946|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56942947|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56942948|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56942949|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942950|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56942951|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
56942952|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
56942953|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
56942954|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56942955|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
56942956|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56942957|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942958|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
56942959|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942960|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56942961|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
56942962|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56942963|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56942964|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
56942965|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56942966|NCT01310647|Estradiol|estradiol|mesh-list
56942967|NCT01310647|Testosterone|testosterone|mesh-list
56942968|NCT01310647|Estrogens|estrogens|mesh-ancestor
56942969|NCT01310647|Hormones|hormones|mesh-ancestor
56942970|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942971|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942972|NCT01310647|Androgens|androgens|mesh-ancestor
56942973|NCT05560399|Dexamethasone|dexamethasone|mesh-list
56942974|NCT05560399|Elotuzumab|elotuzumab|mesh-list
56942975|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56942976|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
56942977|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
56942978|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56942979|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942980|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56942981|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
56942982|NCT05560399|Hormones|hormones|mesh-ancestor
56942983|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942984|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56942985|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56942986|NCT02949024|Triamcinolone|triamcinolone|mesh-list
56942987|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56942988|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56942989|NCT02949024|Aflibercept|aflibercept|mesh-list
56942990|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56942991|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56942992|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
56942993|NCT02949024|Hormones|hormones|mesh-ancestor
56942994|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56942995|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56942996|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56942997|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
56942998|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56942999|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943000|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56943001|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56943002|NCT02949024|Growth Substances|growth substances|mesh-ancestor
56943003|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
56943004|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943005|NCT04394481|Dexamethasone|dexamethasone|mesh-list
56943006|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
56943007|NCT04394481|Ropivacaine|ropivacaine|mesh-list
56943008|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56943009|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
56538695|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56943010|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
56943011|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943012|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943013|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943014|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
56943015|NCT04394481|Hormones|hormones|mesh-ancestor
56943016|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943017|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56943018|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943019|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56943020|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943021|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56943022|NCT04394481|Analgesics|analgesics|mesh-ancestor
56943023|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
56943024|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56943025|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56943026|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56943027|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
56943028|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943029|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943030|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
56943031|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
56943032|NCT03782935|Choline|choline|mesh-list
56943033|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
56943034|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56943035|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
56943036|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943037|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943038|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56943039|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
56943040|NCT04370847|Ephedrine|ephedrine|mesh-list
56943041|NCT04370847|Fentanyl|fentanyl|mesh-list
56943042|NCT04370847|Bupivacaine|bupivacaine|mesh-list
56943043|NCT04370847|Oxytocin|oxytocin|mesh-list
56943044|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
56943045|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
56943046|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943047|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943048|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
56943049|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943050|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56943051|NCT04370847|Narcotics|narcotics|mesh-ancestor
56943052|NCT04370847|Analgesics|analgesics|mesh-ancestor
56943053|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56943054|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56943055|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
56943056|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
56943057|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56943058|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56943059|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
56943060|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
56943061|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56863938|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943062|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
56943063|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943064|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943065|NCT03708120|Insect Repellents|insect repellents|mesh-list
56943066|NCT03708120|Protective Agents|protective agents|mesh-ancestor
56943067|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943068|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
56943069|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943070|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943071|NCT01309789|Prednisone|prednisone|mesh-list
56943072|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
56943073|NCT01309789|Doxorubicin|doxorubicin|mesh-list
56943074|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56943075|NCT01309789|Vincristine|vincristine|mesh-list
56943076|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56943077|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56943078|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56943079|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
56943080|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943081|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56943082|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56943083|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
56943084|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943085|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943086|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56943087|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56943088|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56943089|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56943090|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943091|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56943092|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
56943093|NCT01309789|Hormones|hormones|mesh-ancestor
56943094|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943095|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56943096|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56943097|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
56943098|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
56943099|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
56943100|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943101|NCT04532528|Dabigatran|dabigatran|mesh-list
56943102|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
56943103|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56943104|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
56943105|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943106|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943107|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
56943108|NCT03707847|Etoposide|etoposide|mesh-list
56943109|NCT03707847|Crizotinib|crizotinib|mesh-list
56943110|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56943111|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943112|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56943113|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56943114|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943115|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943116|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56943117|NCT03338400|Dexamethasone|dexamethasone|mesh-list
56943118|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56943119|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
56943120|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
56943121|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943122|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943123|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943124|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
56943125|NCT03338400|Hormones|hormones|mesh-ancestor
56943126|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943127|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56943128|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943129|NCT04511702|Methotrexate|methotrexate|mesh-list
56943130|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56943131|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
56943132|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56943133|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943134|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56943135|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
56943136|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943137|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943138|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
56943139|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943140|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56943141|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56943142|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
56943143|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56943144|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56943145|NCT03787147|Lidocaine|lidocaine|mesh-list
56943146|NCT03787147|Bupivacaine|bupivacaine|mesh-list
56943147|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
56943148|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
56943149|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943150|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943151|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
56943152|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943153|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56943154|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56943155|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56943156|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56943157|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943158|NCT02620306|Losartan|losartan|mesh-list
56943159|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56943160|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56943161|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56943162|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56943163|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943164|NCT03781843|Lidocaine|lidocaine|mesh-list
56943165|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
56943166|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
56943167|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943168|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943169|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
56943170|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943171|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56943172|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56943173|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56943174|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56943175|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943176|NCT05205447|Itraconazole|itraconazole|mesh-list
56943177|NCT05205447|Carbamazepine|carbamazepine|mesh-list
56943178|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
56943179|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943180|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56943181|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56943182|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943183|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943184|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56943185|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
56943186|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943187|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943188|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56943189|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
56943190|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
56943191|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56943192|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943193|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56943194|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56943195|NCT05205447|Analgesics|analgesics|mesh-ancestor
56943196|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
56943197|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943198|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56943199|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56943200|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56943201|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56943202|NCT03781687|Morphine|morphine|mesh-list
56943203|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56943204|NCT03781687|Narcotics|narcotics|mesh-ancestor
56943205|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943206|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943207|NCT03781687|Analgesics|analgesics|mesh-ancestor
56943208|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
56943209|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943210|NCT03092726|ASP8062|asp8062|mesh-list
56943211|NCT03092726|Analgesics|analgesics|mesh-ancestor
56943212|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
56943213|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943214|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943215|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
56943216|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
56943217|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943218|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943219|NCT05328154|Diphosphonates|diphosphonates|mesh-list
56943220|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56943221|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943222|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
56943223|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56943224|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
56943225|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56943226|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
56943227|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943228|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943229|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
56943230|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56943231|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56943232|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
56287176|NCT04169347|Vitamins|vitamins|mesh-ancestor
56943233|NCT05126511|Hormones|hormones|mesh-ancestor
56943234|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943235|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943236|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943237|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943238|NCT05598242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56943239|NCT05598242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56943240|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
56943241|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56943242|NCT05598164|Botulinum Toxins|botulinum toxins|mesh-list
56943243|NCT05598164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56943244|NCT05598164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56943245|NCT05598164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56943246|NCT05598164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56943247|NCT05598164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943248|NCT05598164|Cholinergic Agents|cholinergic agents|mesh-ancestor
56943249|NCT05598164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943250|NCT05598164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943251|NCT05598164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56943252|NCT05598164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943253|NCT03787069|Lidocaine|lidocaine|mesh-list
56943254|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
56943255|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
56943256|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943257|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943258|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
56943259|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943260|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56943261|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56943262|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56943263|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56943264|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943265|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56943266|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943267|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943268|NCT05251090|Factor VIII|factor viii|mesh-list
56943269|NCT05251090|Coagulants|coagulants|mesh-ancestor
56943270|NCT05207709|Paclitaxel|paclitaxel|mesh-list
56943271|NCT05207709|Letrozole|letrozole|mesh-list
56943272|NCT05207709|Fulvestrant|fulvestrant|mesh-list
56943273|NCT05207709|Palbociclib|palbociclib|mesh-list
56943274|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56943275|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943276|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
56943277|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
56943278|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
56052706|NCT05747768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56864229|NCT04737278|Niacin|niacin|mesh-list
56943279|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943280|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56943281|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56943282|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943283|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56943284|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
56943285|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943286|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943287|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56943288|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56943289|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56943290|NCT04447118|Docetaxel|docetaxel|mesh-list
56943291|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943292|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56943293|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56943294|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56943295|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943296|NCT05532319|Lenvatinib|lenvatinib|mesh-list
56943297|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943298|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56943299|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943300|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943301|NCT01553032|Cetuximab|cetuximab|mesh-list
56943302|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943303|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943304|NCT05181124|Naproxen|naproxen|mesh-list
56943305|NCT05181124|Meloxicam|meloxicam|mesh-list
56539003|NCT04268524|Miltefosine|miltefosine|mesh-list
56539074|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943306|NCT05181124|Aceclofenac|aceclofenac|mesh-list
56943307|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56943308|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56943309|NCT05181124|Analgesics|analgesics|mesh-ancestor
56943310|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
56943311|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943312|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943313|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56943314|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56943315|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
56943316|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56943317|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943318|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943319|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56943320|NCT02897648|Lactams|lactams|mesh-list
56943321|NCT02897648|beta-Lactams|beta-lactams|mesh-list
56943322|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56943323|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943324|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
56943325|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56943326|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943327|NCT04424966|Infigratinib|infigratinib|mesh-list
56943328|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943329|NCT04959591|Acetaminophen|acetaminophen|mesh-list
56943330|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56943331|NCT04959591|Analgesics|analgesics|mesh-ancestor
56943332|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
56943333|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943334|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943335|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
56943336|NCT05598086|Tranexamic Acid|tranexamic acid|mesh-list
56943337|NCT05598086|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56943338|NCT05598086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56943339|NCT05598086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943340|NCT05598086|Hemostatics|hemostatics|mesh-ancestor
56943341|NCT05598086|Coagulants|coagulants|mesh-ancestor
56943342|NCT00753532|Vitamin E|vitamin e|mesh-list
56943343|NCT00753532|Tocopherols|tocopherols|mesh-list
56943344|NCT00753532|Tocotrienols|tocotrienols|mesh-list
56943345|NCT00753532|Tocovid|tocovid|mesh-list
56943346|NCT00753532|Vitamins|vitamins|mesh-ancestor
56943347|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
56943348|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943349|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
56943350|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943351|NCT00753532|Protective Agents|protective agents|mesh-ancestor
56943352|NCT03632408|Zopiclone|zopiclone|mesh-list
56943353|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56943354|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943355|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943356|NCT01307839|Lidocaine|lidocaine|mesh-list
56943357|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
56943358|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
56943359|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943360|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943361|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
56943362|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943363|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56943364|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56943365|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56943366|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56943367|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943368|NCT05018091|Dexamethasone|dexamethasone|mesh-list
56943369|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
56943370|NCT05018091|BB 1101|bb 1101|mesh-list
56943371|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56943372|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
56943373|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
56943374|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943375|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943376|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943377|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
56943378|NCT05018091|Hormones|hormones|mesh-ancestor
56943379|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943380|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56943381|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943382|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
56943383|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943384|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943386|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943387|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943388|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
56943389|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943390|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56943391|NCT01328548|Vaccines|vaccines|mesh-list
56943392|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
56943393|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943394|NCT04453306|Topiramate|topiramate|mesh-list
56943395|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
56943396|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56943397|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943398|NCT03777163|Vaccines|vaccines|mesh-list
56943399|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
56943400|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943401|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
56943402|NCT03468478|Sirolimus|sirolimus|mesh-list
56943403|NCT03468478|Everolimus|everolimus|mesh-list
56943404|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943405|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56943406|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
56943407|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943408|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56943409|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56943410|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
56943411|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56943412|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943413|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943414|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943415|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
56943416|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
56943417|NCT03786289|Hematinics|hematinics|mesh-ancestor
56943418|NCT05597540|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56943419|NCT05597540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56943420|NCT05597540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943421|NCT05597540|Antitubercular Agents|antitubercular agents|mesh-ancestor
56943422|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
56943423|NCT03776851|Hematinics|hematinics|mesh-ancestor
56943424|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56943425|NCT03337308|Ezetimibe|ezetimibe|mesh-list
56943426|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56943427|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56943428|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
56052707|NCT05747768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943429|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943430|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56943431|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943432|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56943433|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943434|NCT03631862|Apatinib|apatinib|mesh-list
56943435|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943436|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56943437|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943438|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943439|NCT02761070|Bevacizumab|bevacizumab|mesh-list
56943440|NCT02761070|Temozolomide|temozolomide|mesh-list
56943441|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943442|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943443|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56943444|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56943445|NCT02761070|Growth Substances|growth substances|mesh-ancestor
56943446|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943447|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
56943448|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56943449|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
56943450|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943451|NCT03468010|Paclitaxel|paclitaxel|mesh-list
56943452|NCT03468010|Cisplatin|cisplatin|mesh-list
56943453|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56943454|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943455|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
56943456|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
56539153|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
56943457|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
56943458|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943460|NCT03780673|Simvastatin|simvastatin|mesh-list
56943461|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56943462|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56943463|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
56943464|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943465|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56943466|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56943467|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943468|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56943469|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943470|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943471|NCT03337152|Chloroquine|chloroquine|mesh-list
56943472|NCT03337152|Primaquine|primaquine|mesh-list
56943473|NCT03337152|Amebicides|amebicides|mesh-ancestor
56943474|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56943475|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56943476|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943477|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
56943478|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56943479|NCT03467620|Cannabidiol|cannabidiol|mesh-list
56943480|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
56943481|NCT03780205|Methamphetamine|methamphetamine|mesh-list
56943482|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56943483|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943484|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
56943485|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
56943486|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943487|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
56943488|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943489|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943490|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
56943491|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56943492|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56943493|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56943494|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56943495|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56943496|NCT04751500|Metronidazole|metronidazole|mesh-list
56943497|NCT04751500|Clindamycin|clindamycin|mesh-list
56943498|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56943499|NCT04751500|Misoprostol|misoprostol|mesh-list
56943500|NCT04751500|Mifepristone|mifepristone|mesh-list
56943501|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943502|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56943503|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56943504|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56943505|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
56943506|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56943507|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943508|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56943509|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943510|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
56943511|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56943512|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943513|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943514|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56943515|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56943516|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56943517|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56943518|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
56943519|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56943520|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56943521|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
56943522|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943523|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
56943524|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56943525|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56943526|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56943527|NCT04305249|Nivolumab|nivolumab|mesh-list
56943528|NCT04305249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943529|NCT04305249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943530|NCT04305249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56943531|NCT04305249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943532|NCT03710161|Vitamin D|vitamin d|mesh-list
56943533|NCT03710161|Vitamins|vitamins|mesh-ancestor
56943534|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
56943535|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943536|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56943537|NCT02719574|Cytarabine|cytarabine|mesh-list
56943538|NCT02719574|Azacitidine|azacitidine|mesh-list
56943539|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56943540|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
56943541|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943542|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943543|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
56943544|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943545|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56943546|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
56943547|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943548|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943549|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
56943550|NCT04947501|Ifosfamide|ifosfamide|mesh-list
56943551|NCT04947501|Carboplatin|carboplatin|mesh-list
56943552|NCT04947501|Doxorubicin|doxorubicin|mesh-list
56943553|NCT04947501|Etoposide|etoposide|mesh-list
56943554|NCT04947501|Vincristine|vincristine|mesh-list
56943555|NCT04947501|Topotecan|topotecan|mesh-list
56943556|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56943557|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
56943558|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943559|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56943560|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56943561|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
56943562|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943563|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943564|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56943565|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56943566|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56943567|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56943568|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943569|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56943570|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
56943571|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
56943572|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
56943573|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56943574|NCT03707808|Nivolumab|nivolumab|mesh-list
56943575|NCT03707808|Ipilimumab|ipilimumab|mesh-list
56943576|NCT03707808|Avelumab|avelumab|mesh-list
56943577|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943578|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943579|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56943580|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943581|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56943582|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56943583|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56943584|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56943585|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943586|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
56943587|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943588|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943589|NCT05638620|Bupivacaine|bupivacaine|mesh-list
56943590|NCT05638620|Anesthetics, Local|anesthetics, local|mesh-ancestor
56943591|NCT05638620|Anesthetics|anesthetics|mesh-ancestor
56943592|NCT05638620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943593|NCT05638620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943594|NCT05638620|Sensory System Agents|sensory system agents|mesh-ancestor
56943595|NCT05638620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943596|NCT03632330|Midazolam|midazolam|mesh-list
56943597|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
56943598|NCT03632330|Propofol|propofol|mesh-list
56943599|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56943600|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943601|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539301|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56943602|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56943603|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
56943604|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
56943605|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56943606|NCT03632330|Analgesics|analgesics|mesh-ancestor
56943607|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
56943608|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943609|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56943610|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56943611|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56943612|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
56943613|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943614|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943615|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56943616|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56943617|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56943618|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56943619|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
56943620|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
56943621|NCT04673422|Montelukast|montelukast|mesh-list
56943622|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56943623|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56943624|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56943625|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
56943626|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943627|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943628|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56943629|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56943630|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943631|NCT03090152|Bupivacaine|bupivacaine|mesh-list
56943632|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
56943633|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
56943634|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943635|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943636|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
56943637|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943638|NCT03466528|Thiamine|thiamine|mesh-list
56943639|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
56943640|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
56943641|NCT03466528|Vitamins|vitamins|mesh-ancestor
56943642|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
56943643|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943644|NCT03466528|Analgesics|analgesics|mesh-ancestor
56943645|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
56943646|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943647|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
56943648|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943649|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56943650|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
56943651|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56864538|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
56943652|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56943653|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943654|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56943655|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
56943656|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56943657|NCT05090280|Nafamostat|nafamostat|mesh-list
56943658|NCT05090280|Naltrexone|naltrexone|mesh-list
56943659|NCT05090280|Oxycodone|oxycodone|mesh-list
56943660|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56943661|NCT05090280|Narcotics|narcotics|mesh-ancestor
56943662|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943663|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943664|NCT05090280|Analgesics|analgesics|mesh-ancestor
56943665|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
56943666|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943667|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56943668|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56943669|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56943670|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56943671|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56943672|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56943673|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
56943674|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
56943675|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943676|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943677|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56943678|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56943679|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56539373|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56943680|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56943681|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
56943682|NCT03466216|Octreotide|octreotide|mesh-list
56943683|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943684|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56943685|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943686|NCT03098654|Metformin|metformin|mesh-list
56943687|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56943688|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943689|NCT05175066|Bisoprolol|bisoprolol|mesh-list
56943690|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56943691|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
56943692|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
56943693|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943694|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943695|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56943696|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56943697|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56943698|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
56943699|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943700|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943701|NCT03130114|Azithromycin|azithromycin|mesh-list
56943702|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56943703|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943704|NCT05294341|Norethindrone|norethindrone|mesh-list
56943705|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
56943706|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56943707|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56943708|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56943709|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
56943710|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56943711|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943712|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56943713|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56943714|NCT03130270|Apatinib|apatinib|mesh-list
56943715|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943716|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56943717|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943718|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943719|NCT03780361|Aflibercept|aflibercept|mesh-list
56943720|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56943721|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56943722|NCT03780361|Growth Substances|growth substances|mesh-ancestor
56943723|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864618|NCT01096212|Sevoflurane|sevoflurane|mesh-list
56943724|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
56943725|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943726|NCT05183646|Proxigermanium|proxigermanium|mesh-list
56943727|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943728|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
56943729|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
56943730|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943731|NCT04943445|Paclitaxel|paclitaxel|mesh-list
56943732|NCT04943445|Carboplatin|carboplatin|mesh-list
56943733|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
56943734|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
56943735|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56943736|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943737|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
56943738|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
56943739|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
56943740|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943741|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943742|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943743|NCT02522572|Plerixafor|plerixafor|mesh-list
56943744|NCT02522572|Bortezomib|bortezomib|mesh-list
56943745|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943746|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56943747|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56943748|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
56943749|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943750|NCT04602507|Ivermectin|ivermectin|mesh-list
56943751|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56943752|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943753|NCT04657666|Nabiximols|nabiximols|mesh-list
56943754|NCT04657666|Analgesics|analgesics|mesh-ancestor
56943755|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
56943756|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539526|NCT04269928|Epinephrine|epinephrine|mesh-list
56943757|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943758|NCT04645966|Acetaminophen|acetaminophen|mesh-list
56943759|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56943760|NCT04645966|Analgesics|analgesics|mesh-ancestor
56943761|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
56943762|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943763|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943764|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
56943765|NCT03773809|Vitamin D|vitamin d|mesh-list
56943766|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
56943767|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
56943768|NCT03773809|Vitamins|vitamins|mesh-list
56943769|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
56943770|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943771|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56943772|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56943773|NCT01313611|Rituximab|rituximab|mesh-list
56943774|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56943775|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943776|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943777|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
56943778|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943779|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56943780|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56943781|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
56943782|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943783|NCT04998786|Dexamethasone|dexamethasone|mesh-list
56943784|NCT04998786|Ixazomib|ixazomib|mesh-list
56943785|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56943786|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
56943787|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
56943788|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943789|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943790|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943791|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
56943792|NCT04998786|Hormones|hormones|mesh-ancestor
56943793|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943794|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56943795|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943796|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
56943797|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943798|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943799|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56943800|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943801|NCT04534582|Denosumab|denosumab|mesh-list
56943802|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56943803|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943804|NCT03780049|Leucovorin|leucovorin|mesh-list
56943805|NCT03780049|Fluorouracil|fluorouracil|mesh-list
56943806|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
56943807|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
56943808|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943809|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56943810|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943811|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56943812|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
56943813|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943814|NCT03780049|Antidotes|antidotes|mesh-ancestor
56943815|NCT03780049|Protective Agents|protective agents|mesh-ancestor
56943816|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
56943817|NCT03780049|Vitamins|vitamins|mesh-ancestor
56943818|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
56943819|NCT04252287|Canagliflozin|canagliflozin|mesh-list
56943820|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56943821|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943822|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56943823|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943824|NCT05681754|Calcium, Dietary|calcium, dietary|mesh-list
56943825|NCT05681754|Calcium|calcium|mesh-list
56943826|NCT05681754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56943827|NCT05681754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943828|NCT05681754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56943829|NCT03465202|Capecitabine|capecitabine|mesh-list
56943830|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56943831|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
56943832|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943833|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943834|NCT04195958|Omalizumab|omalizumab|mesh-list
56943835|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56943836|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56943837|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
56943838|NCT05540262|Edaravone|edaravone|mesh-list
56943839|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56943840|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
56943841|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943842|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56943843|NCT05540262|Protective Agents|protective agents|mesh-ancestor
56943844|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943845|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
56943846|NCT04245423|Narcotics|narcotics|mesh-ancestor
56943847|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943848|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943849|NCT04245423|Analgesics|analgesics|mesh-ancestor
56943850|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
56943851|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943852|NCT02735200|Vitamin D|vitamin d|mesh-list
56943853|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
56943854|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
56943855|NCT02735200|Vitamins|vitamins|mesh-list
56943856|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
56943857|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943858|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56943859|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56943860|NCT01312311|Docetaxel|docetaxel|mesh-list
56943861|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943862|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
56943863|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
56943864|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
56943865|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943866|NCT03464968|Leucovorin|leucovorin|mesh-list
56943867|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
56943868|NCT03464968|Irinotecan|irinotecan|mesh-list
56943869|NCT03464968|Fluorouracil|fluorouracil|mesh-list
56943870|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
56943871|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943872|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56943873|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56943874|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943875|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864761|NCT03950700|Epinephrine|epinephrine|mesh-list
56943876|NCT03464968|Antidotes|antidotes|mesh-ancestor
56943877|NCT03464968|Protective Agents|protective agents|mesh-ancestor
56943878|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943879|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
56943880|NCT03464968|Vitamins|vitamins|mesh-ancestor
56943881|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
56943882|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
56943883|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56943884|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56943885|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
56943886|NCT05073744|Morphine|morphine|mesh-list
56943887|NCT05073744|Nalbuphine|nalbuphine|mesh-list
56943888|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56943889|NCT05073744|Narcotics|narcotics|mesh-ancestor
56943890|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943891|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943892|NCT05073744|Analgesics|analgesics|mesh-ancestor
56943893|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
56943894|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943895|NCT05681598|Hydroxyurea|hydroxyurea|mesh-list
56943896|NCT05681598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943897|NCT05681598|Antisickling Agents|antisickling agents|mesh-ancestor
56943898|NCT05681598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56943899|NCT05681598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943900|NCT05681598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56943901|NCT01312350|Docetaxel|docetaxel|mesh-list
56943902|NCT01312350|Fluorouracil|fluorouracil|mesh-list
56943903|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943904|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
56943905|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
56943906|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
56943907|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943908|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
56943909|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56943910|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56943911|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
56943912|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943913|NCT03464656|Antioxidants|antioxidants|mesh-list
56943914|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943915|NCT03464656|Protective Agents|protective agents|mesh-ancestor
56943916|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943917|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
56943918|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56943919|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943920|NCT03705858|Lintuzumab|lintuzumab|mesh-list
56943921|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56943922|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943923|NCT05156658|Etonogestrel|etonogestrel|mesh-list
56943924|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56943925|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
56943926|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56943927|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943928|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56943929|NCT03463642|Vitamin D|vitamin d|mesh-list
56943930|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
56943931|NCT03463642|Mineral Oil|mineral oil|mesh-list
56943932|NCT03463642|Vitamins|vitamins|mesh-ancestor
56943933|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
56943934|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943935|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56943936|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56943937|NCT03463642|Emollients|emollients|mesh-ancestor
56943938|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
56943939|NCT03463564|Insulin|insulin|mesh-list
56943940|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56943941|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56943942|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943943|NCT05092386|Vaccines|vaccines|mesh-list
56943944|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
56943945|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943946|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56943947|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
56943948|NCT03463252|Progesterone|progesterone|mesh-list
56943949|NCT03463252|Progestins|progestins|mesh-ancestor
56943950|NCT03463252|Hormones|hormones|mesh-ancestor
56943951|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56943952|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943953|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56943954|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56943955|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56943956|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
56943957|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56943958|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56943959|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56943960|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56943961|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56943962|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56943963|NCT05309538|Betahistine|betahistine|mesh-list
56943964|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
56943965|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
56943966|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
56943967|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56943968|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943969|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943970|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56943971|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
56943972|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56943973|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56943974|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943975|NCT03011450|Fenofibrate|fenofibrate|mesh-list
56943976|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56943977|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
56943978|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56943979|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56943980|NCT03638856|Misoprostol|misoprostol|mesh-list
56943981|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56943982|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
56943983|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56943984|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943985|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56943986|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56943988|NCT03705780|Fentanyl|fentanyl|mesh-list
56943989|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56943990|NCT03705780|Narcotics|narcotics|mesh-ancestor
56943991|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56943992|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56943993|NCT03705780|Analgesics|analgesics|mesh-ancestor
56943994|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
56943995|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56943996|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56943997|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56943998|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
56943999|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
56944000|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
56944001|NCT04976790|Analgesics|analgesics|mesh-ancestor
56944002|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
56944003|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944004|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944005|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56944006|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56944007|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56944008|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56944009|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56944010|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944011|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944012|NCT04973670|Sivelestat|sivelestat|mesh-list
56944013|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56944014|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
56944015|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944016|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944017|NCT03678688|Bedaquiline|bedaquiline|mesh-list
56944018|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
56944019|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
56944020|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56944021|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944022|NCT04452838|Fesoterodine|fesoterodine|mesh-list
56944023|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56944024|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56944025|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
56944026|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944027|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944028|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944029|NCT04452838|Urological Agents|urological agents|mesh-ancestor
56944030|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
56944031|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56944032|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944033|NCT04188860|Paclitaxel|paclitaxel|mesh-list
56944034|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56944035|NCT04188860|Antibodies|antibodies|mesh-list
56944036|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56944037|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944038|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
56944039|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
56944040|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
56944041|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944042|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
56944043|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944044|NCT05425862|Talazoparib|talazoparib|mesh-list
56944045|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56944046|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944047|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944048|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944049|NCT01383668|Sirolimus|sirolimus|mesh-list
56944050|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
56944051|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56944052|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944053|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56944054|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944055|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
56944056|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944057|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
56944058|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944059|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56944060|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
56944061|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56944062|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944063|NCT01381796|Sumatriptan|sumatriptan|mesh-list
56944064|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56944065|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56944066|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56944067|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
56944068|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944069|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944070|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944071|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56944072|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944073|NCT04375228|Rituximab|rituximab|mesh-list
56944074|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944075|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944076|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
56944077|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944078|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56944079|NCT02521714|Lenalidomide|lenalidomide|mesh-list
56944080|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
56944081|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944082|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56944083|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56944084|NCT02521714|Growth Substances|growth substances|mesh-ancestor
56944085|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
56944086|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944087|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
56944088|NCT02096588|Doxorubicin|doxorubicin|mesh-list
56944089|NCT02096588|Simvastatin|simvastatin|mesh-list
56944090|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944091|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
56944092|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944093|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56944094|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56944095|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
56944096|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944097|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944098|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56944099|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56944100|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56944101|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56944102|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944103|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56944104|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56944105|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
56944106|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56944107|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56944108|NCT03768089|Ivacaftor|ivacaftor|mesh-list
56944109|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56944110|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56944111|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944112|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56944113|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56944114|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944115|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944116|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56944117|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56944118|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944119|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
56944120|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944121|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
56944122|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
56944123|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944124|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944125|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944126|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
56944127|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
56944128|NCT01381640|Acetaminophen|acetaminophen|mesh-list
56944129|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56944130|NCT01381640|Analgesics|analgesics|mesh-ancestor
56944131|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
56944132|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944133|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944134|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
56944135|NCT04483973|Ebselen|ebselen|mesh-list
56944136|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56944137|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56944138|NCT04483973|Analgesics|analgesics|mesh-ancestor
56944139|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
56944140|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944141|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944142|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56944143|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56944144|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56944145|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56944146|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
56944147|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944148|NCT04483973|Protective Agents|protective agents|mesh-ancestor
56944149|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56944150|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944151|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56944152|NCT04283890|Nivolumab|nivolumab|mesh-list
56944153|NCT04283890|Ipilimumab|ipilimumab|mesh-list
56944154|NCT04283890|Melphalan|melphalan|mesh-list
56944155|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944156|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944157|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56944158|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944159|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56944160|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
56944161|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56944162|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944163|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
56944164|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944165|NCT01139723|Bevacizumab|bevacizumab|mesh-list
56944166|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944167|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944168|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56944169|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56944170|NCT01139723|Growth Substances|growth substances|mesh-ancestor
56944171|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944172|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
56944173|NCT05068037|Antiemetics|antiemetics|mesh-list
56944174|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
56944175|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944176|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944177|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56944178|NCT01136759|Tenofovir|tenofovir|mesh-list
56944179|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
56944180|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944181|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56944182|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56944183|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944184|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944185|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56944186|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56944187|NCT03436654|Prednisone|prednisone|mesh-list
56944188|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
56944189|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56944190|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
56944191|NCT03436654|Hormones|hormones|mesh-ancestor
56944192|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944193|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944194|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56944195|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944196|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56944197|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944198|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944199|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
56944200|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56944201|NCT01141439|Fluticasone|fluticasone|mesh-list
56944202|NCT01141439|Xhance|xhance|mesh-list
56944203|NCT01141439|Beclomethasone|beclomethasone|mesh-list
56944204|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56944205|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56944206|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
56944207|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944208|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944209|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56944210|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
56944212|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56944213|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
56944214|NCT01141439|Hormones|hormones|mesh-ancestor
56944215|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944216|NCT05549531|Itraconazole|itraconazole|mesh-list
56944217|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
56944218|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944219|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56944220|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56944221|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944222|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944223|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56944224|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
56944225|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944226|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944227|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56944228|NCT02953834|Insulin|insulin|mesh-list
56944229|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56944230|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944231|NCT04452370|Etoposide|etoposide|mesh-list
56944232|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56944233|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944234|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56944235|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56944236|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944237|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944238|NCT03819088|Zinc|zinc|mesh-list
56944239|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
56944240|NCT03819088|Trace Elements|trace elements|mesh-ancestor
56944241|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
56944242|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944243|NCT03819088|Astringents|astringents|mesh-ancestor
56944244|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
56944245|NCT01232777|Bevacizumab|bevacizumab|mesh-list
56944246|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944247|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944248|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56944249|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56944250|NCT01232777|Growth Substances|growth substances|mesh-ancestor
56944251|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944252|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
56944253|NCT03634228|Cytarabine|cytarabine|mesh-list
56944254|NCT03634228|Venetoclax|venetoclax|mesh-list
56944255|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56944256|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
56944257|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944258|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944259|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
56944260|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944261|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944262|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
56944263|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944264|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
56944265|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56944266|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944267|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
56944268|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56944269|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944270|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56944271|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944272|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56944273|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56944274|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944275|NCT03119584|Linaclotide|linaclotide|mesh-list
56944276|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56944277|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
56944278|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944279|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56944280|NCT03129867|Ticagrelor|ticagrelor|mesh-list
56944281|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56944282|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56944290|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944292|NCT01140035|Insulin|insulin|mesh-list
56944293|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56944294|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944304|NCT02525692|TIC10 compound|tic10 compound|mesh-list
56944305|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944306|NCT02366494|Docetaxel|docetaxel|mesh-list
56944307|NCT02366494|Leuprolide|leuprolide|mesh-list
56944308|NCT02366494|Goserelin|goserelin|mesh-list
56944309|NCT02366494|Bicalutamide|bicalutamide|mesh-list
56944310|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56944311|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944312|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
56944313|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
56944314|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
56944315|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944316|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56944317|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
56944318|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56944319|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944320|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56944321|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
56944322|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
56944323|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944324|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
56944325|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56944326|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
56944327|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56944328|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
56944329|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56944330|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56944331|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
56944332|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944333|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944334|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
56944335|NCT02168140|Protective Agents|protective agents|mesh-ancestor
56944336|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944337|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
56944338|NCT02168140|Vitamins|vitamins|mesh-ancestor
56944339|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
56944340|NCT00872950|Amifampridine|amifampridine|mesh-list
56944341|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56944342|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944343|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944344|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56944345|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56944346|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944347|NCT03233217|Vaccines|vaccines|mesh-list
56944348|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
56944349|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944350|NCT01568996|Sulforaphane|sulforaphane|mesh-list
56944351|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56944352|NCT01568996|Protective Agents|protective agents|mesh-ancestor
56944353|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944354|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944355|NCT02943993|Edoxaban|edoxaban|mesh-list
56944356|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56944357|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
56944358|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56944359|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
56944360|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944361|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944362|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
56944363|NCT02620150|Citalopram|citalopram|mesh-list
56944364|NCT02620150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56944365|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56944366|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56944367|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944368|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944369|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
56944370|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944371|NCT02620150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56944372|NCT02620150|Antidepressive Agents|antidepressive agents|mesh-ancestor
56944373|NCT02620150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56944374|NCT04098302|Dutasteride|dutasteride|mesh-list
56944375|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56944376|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56944377|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944378|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944379|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
56944380|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944381|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944382|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56944383|NCT04761159|Ketamine|ketamine|mesh-list
56944384|NCT04761159|Analgesics|analgesics|mesh-ancestor
56944385|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
56944386|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944387|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944388|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56944389|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56944390|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
56944391|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
56944392|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56944393|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56944394|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56944395|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944396|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944397|NCT05488613|Midostaurin|midostaurin|mesh-list
56944398|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944399|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56944400|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944401|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944402|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56944403|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944404|NCT01137383|Interferons|interferons|mesh-list
56944405|NCT01137383|Ribavirin|ribavirin|mesh-list
56944406|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
56944407|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
56944408|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56944409|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944410|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
56944411|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944412|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
56944413|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944414|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
56944415|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944416|NCT03449836|Fluticasone|fluticasone|mesh-list
56944417|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
56944418|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56944419|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56944420|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
56944421|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944422|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944423|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56944424|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
56944425|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
56944426|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56944428|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56944429|NCT03961256|Exenatide|exenatide|mesh-list
56944430|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56944431|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944432|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56944433|NCT03961256|Incretins|incretins|mesh-ancestor
56944434|NCT03961256|Hormones|hormones|mesh-ancestor
56944435|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944436|NCT03443518|Remifentanil|remifentanil|mesh-list
56944437|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56944438|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944439|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56944440|NCT03443518|Narcotics|narcotics|mesh-ancestor
56944441|NCT03443518|Analgesics|analgesics|mesh-ancestor
56944442|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
56944443|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944444|NCT01142843|Propolis|propolis|mesh-list
56944445|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944446|NCT04985500|Bupivacaine|bupivacaine|mesh-list
56944447|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
56944448|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
56944449|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56944450|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944451|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
56944452|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944453|NCT04330625|Volagidemab|volagidemab|mesh-list
56944454|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56944455|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944456|NCT03747497|Linezolid|linezolid|mesh-list
56944457|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56944458|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944459|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56944460|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944461|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944462|NCT03109600|Vaccines|vaccines|mesh-list
56944463|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56944464|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
56944465|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944466|NCT03679013|Acetaminophen|acetaminophen|mesh-list
56944467|NCT03679013|Gabapentin|gabapentin|mesh-list
56944468|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56944469|NCT03679013|Analgesics|analgesics|mesh-ancestor
56944470|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
56944471|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944472|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944473|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
56944474|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
56944475|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56944476|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56944477|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56944478|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56944479|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56944480|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56944481|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944482|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944483|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
56944484|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
56944485|NCT01140425|PF 232798|pf 232798|mesh-list
56944486|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56944487|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944488|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56944489|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56944490|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944491|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944492|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944493|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56944494|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56865371|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
56944495|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56944496|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
56944497|NCT04884412|Anesthetics|anesthetics|mesh-list
56944498|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56944499|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944500|NCT03991013|Dolutegravir|dolutegravir|mesh-list
56944501|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56944502|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56540218|NCT02749747|Sulpiride|sulpiride|mesh-list
56944503|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944504|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944505|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56944506|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56944507|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
56944508|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944509|NCT03441412|Metoprolol|metoprolol|mesh-list
56944510|NCT03441412|Epinephrine|epinephrine|mesh-list
56944511|NCT03441412|Ticagrelor|ticagrelor|mesh-list
56944512|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56944513|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56944514|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
56944515|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944516|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944517|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944518|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56944519|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56944520|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
56944521|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944522|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56944523|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
56944524|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
56944525|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
56944526|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56944527|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56944528|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56944529|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56944530|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56944531|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
56944532|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56944533|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56944534|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
56944535|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56944536|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56944537|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56944538|NCT01235819|Insulin|insulin|mesh-list
56944539|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56944540|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56944541|NCT01235819|Exenatide|exenatide|mesh-list
56944542|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56944543|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56944544|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944545|NCT01235819|Incretins|incretins|mesh-ancestor
56944546|NCT01235819|Hormones|hormones|mesh-ancestor
56944547|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944548|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
56944549|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944550|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944551|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56944552|NCT05275569|Antiemetics|antiemetics|mesh-list
56944553|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
56944554|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944555|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944556|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56944557|NCT04599933|Pilocarpine|pilocarpine|mesh-list
56944558|NCT04599933|Miotics|miotics|mesh-ancestor
56944559|NCT04599933|Autonomic Agents|autonomic agents|mesh-ancestor
56944560|NCT04599933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944561|NCT04599933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944562|NCT04599933|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56944563|NCT04599933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56944564|NCT04599933|Cholinergic Agents|cholinergic agents|mesh-ancestor
56944565|NCT04599933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944566|NCT04599933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944567|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56944568|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944569|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944570|NCT03859973|BI 425809|bi 425809|mesh-list
56944571|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
56944572|NCT02824575|Paclitaxel|paclitaxel|mesh-list
56944573|NCT02824575|Rebastinib|rebastinib|mesh-list
56944574|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56944575|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944576|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
56944577|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
56944578|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
56944579|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944580|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540281|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
56944581|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944582|NCT03780608|Durvalumab|durvalumab|mesh-list
56944583|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944584|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944585|NCT02807181|Gemcitabine|gemcitabine|mesh-list
56944586|NCT02807181|Cisplatin|cisplatin|mesh-list
56944587|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944588|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56944589|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
56944590|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944591|NCT02807181|Antiviral Agents|antiviral agents|mesh-ancestor
56944592|NCT02807181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944593|NCT02807181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944594|NCT02807181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944595|NCT02807181|Immunologic Factors|immunologic factors|mesh-ancestor
56944596|NCT02807181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944597|NCT03631316|Valganciclovir|valganciclovir|mesh-list
56944598|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
56944599|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944600|NCT03608865|Durvalumab|durvalumab|mesh-list
56944601|NCT03608865|Tremelimumab|tremelimumab|mesh-list
56944602|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944603|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944604|NCT03532451|Nivolumab|nivolumab|mesh-list
56944605|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944606|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944607|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56944608|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944609|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
56944610|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56944611|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
56944612|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944613|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
56944614|NCT04704531|Protective Agents|protective agents|mesh-ancestor
56944615|NCT02637531|Nivolumab|nivolumab|mesh-list
56944616|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944617|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944618|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56944619|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944620|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
56944621|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56944622|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56944623|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
56944624|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
56944625|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944626|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944627|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944628|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
56944629|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
56944630|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56944631|NCT03654716|Cytarabine|cytarabine|mesh-list
56944632|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56944633|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
56944634|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944635|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944636|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
56944637|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944638|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944639|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
56944640|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944642|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56944643|NCT01380548|Trace Elements|trace elements|mesh-ancestor
56865516|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
56944644|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
56944645|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944646|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56944647|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
56944648|NCT01313247|Acetaminophen|acetaminophen|mesh-list
56944649|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56944650|NCT01313247|Analgesics|analgesics|mesh-ancestor
56944651|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
56944652|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944653|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944654|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
56944655|NCT01142453|Interferons|interferons|mesh-list
56944656|NCT01142453|Interferon-beta|interferon-beta|mesh-list
56944657|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
56944658|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944659|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
56944660|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944661|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
56944662|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944663|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56944665|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56944666|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944667|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
56944668|NCT03560193|Ethanol|ethanol|mesh-list
56944669|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
56944670|NCT03560193|Povidone|povidone|mesh-list
56944671|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56944672|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944673|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
56944674|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56944675|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944676|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
56944677|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
56944678|NCT04451200|Busulfan|busulfan|mesh-list
56944679|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
56944680|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944681|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944682|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
56944683|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944684|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56944685|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944686|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56944687|NCT04678479|Ganaxolone|ganaxolone|mesh-list
56944688|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
56944689|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944690|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944691|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944692|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
56944693|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
56944694|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
56944695|NCT03431831|Naltrexone|naltrexone|mesh-list
56944696|NCT03431831|Bupropion|bupropion|mesh-list
56944697|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56944698|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56944699|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56944700|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944701|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
56944702|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944703|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56944704|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
56944705|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56944706|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56944707|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56944708|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56944709|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944710|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
56944711|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944712|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56944713|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56944714|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944715|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56944716|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56944717|NCT03442556|Carboplatin|carboplatin|mesh-list
56944718|NCT03442556|Docetaxel|docetaxel|mesh-list
56944719|NCT03442556|Rucaparib|rucaparib|mesh-list
56944720|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944721|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56944722|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56944723|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56944724|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944725|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56944726|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944727|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
56944728|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
56944729|NCT02251821|Melphalan|melphalan|mesh-list
56944730|NCT02251821|Busulfan|busulfan|mesh-list
56944731|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
56944732|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56540431|NCT02281981|Curcumin|curcumin|mesh-list
56944733|NCT02251821|Methotrexate|methotrexate|mesh-list
56944734|NCT02251821|Fludarabine|fludarabine|mesh-list
56944735|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
56944736|NCT02251821|Tacrolimus|tacrolimus|mesh-list
56944737|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944738|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
56944739|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944740|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56944741|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56944742|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
56944743|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944744|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944745|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56944746|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56944747|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
56944748|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56944749|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56944750|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
56944751|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
56944752|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944753|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56944754|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56944755|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56944756|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56944757|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56944758|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
56944759|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56944760|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944761|NCT03784781|Dimercaprol|dimercaprol|mesh-list
56944762|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
56944763|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
56944764|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944765|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56944766|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56944767|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56944768|NCT03425201|Niraparib|niraparib|mesh-list
56944769|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56944770|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944771|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944772|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944773|NCT03438604|Donepezil|donepezil|mesh-list
56944774|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56944775|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944776|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944777|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
56944778|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944779|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944780|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
56944781|NCT03433378|Tretinoin|tretinoin|mesh-list
56944782|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944783|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
56944784|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
56944785|NCT03433222|Coal Tar|coal tar|mesh-list
56944786|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
56944787|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56944788|NCT05016076|Dexamethasone|dexamethasone|mesh-list
56944789|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56944790|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
56944791|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
56944792|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944793|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944794|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56944795|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
56944796|NCT05016076|Hormones|hormones|mesh-ancestor
56944797|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944798|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56944799|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944800|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
56944801|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56944802|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56944803|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944804|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56944805|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
56944806|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56944807|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56944808|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944809|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
56944810|NCT03433144|Coagulants|coagulants|mesh-ancestor
56944811|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
56944812|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56944813|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56944814|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56944815|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56944816|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944817|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
56944818|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944819|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944820|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56944821|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944822|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56944824|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56944825|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
56944826|NCT02927834|Hormones|hormones|mesh-ancestor
56944827|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944828|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944829|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56944830|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944831|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56944832|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944833|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56944834|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944835|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944836|NCT03170180|Sunitinib|sunitinib|mesh-list
56944837|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
56944838|NCT03170180|Gefitinib|gefitinib|mesh-list
56944839|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944840|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56944841|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56944842|NCT03170180|Growth Substances|growth substances|mesh-ancestor
56944843|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944844|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
56944845|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56944846|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944847|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944848|NCT03319667|Dexamethasone|dexamethasone|mesh-list
56944849|NCT03319667|Lenalidomide|lenalidomide|mesh-list
56944850|NCT03319667|Bortezomib|bortezomib|mesh-list
56944851|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56944852|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
56944853|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
56944854|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944855|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944856|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56944857|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
56944858|NCT03319667|Hormones|hormones|mesh-ancestor
56944859|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56944860|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56944861|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944862|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
56944863|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56944864|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56944865|NCT03319667|Growth Substances|growth substances|mesh-ancestor
56944866|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
56944867|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
56944868|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944869|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944870|NCT03432598|Gemcitabine|gemcitabine|mesh-list
56944871|NCT03432598|Paclitaxel|paclitaxel|mesh-list
56944872|NCT03432598|Etoposide|etoposide|mesh-list
56944873|NCT03432598|Carboplatin|carboplatin|mesh-list
56944874|NCT03432598|Pemetrexed|pemetrexed|mesh-list
56944875|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56944876|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944877|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
56944878|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
56944879|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
56944880|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944881|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56944882|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
56944883|NCT03432598|Antiviral Agents|antiviral agents|mesh-ancestor
56944884|NCT03432598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944885|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944886|NCT03432598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944887|NCT03432598|Immunologic Factors|immunologic factors|mesh-ancestor
56944888|NCT03432598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944889|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56944890|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56944891|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56944892|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56944893|NCT03432442|Ivermectin|ivermectin|mesh-list
56944894|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56944895|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944896|NCT01964547|Nabiximols|nabiximols|mesh-list
56944897|NCT01964547|Analgesics|analgesics|mesh-ancestor
56944898|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
56944899|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944900|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944901|NCT01380314|Miltefosine|miltefosine|mesh-list
56944902|NCT01380314|Imiquimod|imiquimod|mesh-list
56944903|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56944904|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
56944905|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944906|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944907|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
56944908|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
56944909|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56944910|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56944911|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56944912|NCT03110510|Leucovorin|leucovorin|mesh-list
56944913|NCT03110510|Fluorouracil|fluorouracil|mesh-list
56944914|NCT03110510|Irinotecan|irinotecan|mesh-list
56944915|NCT03110510|Calcium|calcium|mesh-list
56944916|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
56944917|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56944918|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944919|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
56944920|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944921|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56944922|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944923|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56944924|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
56944925|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56944926|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56944927|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944928|NCT03110510|Antidotes|antidotes|mesh-ancestor
56944929|NCT03110510|Protective Agents|protective agents|mesh-ancestor
56944930|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
56944931|NCT03110510|Vitamins|vitamins|mesh-ancestor
56944932|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
56944933|NCT01238237|Cetuximab|cetuximab|mesh-list
56944934|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944935|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944936|NCT03431974|Aminopterin|aminopterin|mesh-list
56944937|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56944938|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56944939|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944940|NCT03319719|Lidocaine|lidocaine|mesh-list
56944941|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
56944942|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
56944943|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
56944944|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56944945|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944946|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
56944947|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944948|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56865819|NCT00321100|Cetuximab|cetuximab|mesh-list
56944949|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56944950|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56944951|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56944952|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944953|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56944954|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
56944955|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
56944956|NCT03319719|Protective Agents|protective agents|mesh-ancestor
56944957|NCT03128242|Oxytocin|oxytocin|mesh-list
56944958|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
56944959|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56540656|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56944960|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944961|NCT01313689|Ofatumumab|ofatumumab|mesh-list
56944962|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944963|NCT04564157|Paclitaxel|paclitaxel|mesh-list
56944964|NCT04564157|Carboplatin|carboplatin|mesh-list
56944965|NCT04564157|Nivolumab|nivolumab|mesh-list
56944966|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56944967|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56944968|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
56944969|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
56944970|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
56944971|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944972|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56944973|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56944974|NCT03431272|Lifitegrast|lifitegrast|mesh-list
56944975|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56944976|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56944977|NCT02528513|Fentanyl|fentanyl|mesh-list
56944978|NCT02528513|Midazolam|midazolam|mesh-list
56944979|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
56944980|NCT02528513|Propofol|propofol|mesh-list
56944981|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56944982|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56944983|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944984|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56944985|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
56944986|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
56944987|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56944988|NCT02528513|Analgesics|analgesics|mesh-ancestor
56944989|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
56944990|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56944991|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56944992|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56944993|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56944994|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
56944995|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944996|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944997|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56944998|NCT02528513|Narcotics|narcotics|mesh-ancestor
56944999|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56945000|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56945001|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56945002|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56945003|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
56945004|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
56945005|NCT01320007|Furosemide|furosemide|mesh-list
56945006|NCT01320007|Diuretics|diuretics|mesh-ancestor
56945007|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
56945008|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945009|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56945010|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56945011|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945012|NCT03318315|Vaccines|vaccines|mesh-list
56945013|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
56945014|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945015|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
56945016|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56945017|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
56945018|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945019|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945020|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56945021|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
56945022|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56945023|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
56945024|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945025|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945026|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56945027|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
56945028|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
56945029|NCT04460183|Protective Agents|protective agents|mesh-ancestor
56945030|NCT01243697|Desogestrel|desogestrel|mesh-list
56945031|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56945032|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56945033|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56540729|NCT05629429|Olaparib|olaparib|mesh-list
56945034|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
56945035|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56945036|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945037|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56945038|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56945040|NCT01243697|Hormones|hormones|mesh-ancestor
56945041|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945042|NCT04703101|Leucovorin|leucovorin|mesh-list
56945043|NCT04703101|Fluorouracil|fluorouracil|mesh-list
56945044|NCT04703101|Capecitabine|capecitabine|mesh-list
56945045|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
56945046|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
56945047|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945048|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56945049|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945050|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945051|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
56945052|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945053|NCT04703101|Antidotes|antidotes|mesh-ancestor
56945054|NCT04703101|Protective Agents|protective agents|mesh-ancestor
56945055|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
56945056|NCT04703101|Vitamins|vitamins|mesh-ancestor
56945057|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
56945058|NCT01145573|Calcium|calcium|mesh-list
56945059|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56945060|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945061|NCT01320709|Piroxicam|piroxicam|mesh-list
56945062|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56945063|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56945064|NCT01320709|Analgesics|analgesics|mesh-ancestor
56945065|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
56945066|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945067|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945068|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56945069|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945070|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56945071|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945072|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945073|NCT01238393|Ranibizumab|ranibizumab|mesh-list
56945074|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56945075|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56945076|NCT01238393|Growth Substances|growth substances|mesh-ancestor
56945077|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945078|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
56945079|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945080|NCT01244399|Inositol|inositol|mesh-list
56945081|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
56945082|NCT01244399|Vitamins|vitamins|mesh-ancestor
56945083|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
56945084|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945085|NCT03776305|Imipenem|imipenem|mesh-list
56945086|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56945087|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945088|NCT01146509|Donepezil|donepezil|mesh-list
56945089|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56945090|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945091|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945092|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
56945093|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945094|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945095|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
56945096|NCT03775993|Hormones|hormones|mesh-list
56945097|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945098|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945099|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
56945100|NCT03316131|Febuxostat|febuxostat|mesh-list
56945101|NCT03316131|Verinurad|verinurad|mesh-list
56945102|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56945103|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945104|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56945105|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945106|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
56945107|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945108|NCT03779659|Anesthetics|anesthetics|mesh-list
56945109|NCT03779659|Benzocaine|benzocaine|mesh-list
56945110|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
56945111|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945112|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945113|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
56945114|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945115|NCT01145807|Terbinafine|terbinafine|mesh-list
56945116|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
56945117|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945118|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945119|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945120|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56945121|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56945122|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945123|NCT03898895|Antibodies|antibodies|mesh-list
56945124|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
56945125|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945126|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56945127|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56945128|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
56945129|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945130|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945131|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56945132|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
56945133|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
56945134|NCT01245569|Hormones|hormones|mesh-ancestor
56945135|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945136|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
56945137|NCT01314859|Nifedipine|nifedipine|mesh-list
56945138|NCT01314859|Atosiban|atosiban|mesh-list
56945139|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56945140|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56945141|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945142|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56945143|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945144|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
56945145|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
56945146|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56945147|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
56945148|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945149|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56945150|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
56945151|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56945152|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56945153|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945154|NCT01238627|Nicotine|nicotine|mesh-list
56945155|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56945156|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
56945157|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945158|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945159|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56945160|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56945161|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
56945162|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945163|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945164|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
56945165|NCT03733145|Giapreza|giapreza|mesh-list
56945166|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
56945167|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56945168|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56945169|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
56945170|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945171|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945172|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
56945173|NCT01321021|Promethazine|promethazine|mesh-list
56945174|NCT01321021|Losartan|losartan|mesh-list
56945175|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56945176|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56945177|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56945178|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56945179|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945180|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56945181|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56945182|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945183|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945184|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
56945185|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
56945186|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
56945187|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945188|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
56945189|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
56945190|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56945191|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56945192|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
56945193|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
56945194|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945195|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56945196|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
56945197|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
56945198|NCT01238705|Metoprolol|metoprolol|mesh-list
56945199|NCT01238705|Felodipine|felodipine|mesh-list
56945200|NCT01238705|Irbesartan|irbesartan|mesh-list
56945201|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56945202|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56945203|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
56945204|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
56945205|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945206|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945207|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56945208|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56945209|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56945210|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
56945211|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945212|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945213|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56945214|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56945215|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56945216|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56945217|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56945218|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
56945219|NCT03779347|Praziquantel|praziquantel|mesh-list
56945220|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
56945221|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56945222|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945223|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
56945224|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945225|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56945226|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
56945227|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
56945228|NCT01245725|Tirofiban|tirofiban|mesh-list
56945229|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56945230|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56945231|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945232|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56945233|NCT01143545|Celecoxib|celecoxib|mesh-list
56945234|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
56945235|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945236|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
56945237|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945238|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945239|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56945240|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
56945241|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945242|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945243|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56945244|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56945245|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56945246|NCT01143545|Analgesics|analgesics|mesh-ancestor
56945247|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
56945248|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945249|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56945250|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56945251|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56945252|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945253|NCT03779035|Gemcitabine|gemcitabine|mesh-list
56945254|NCT03779035|Capecitabine|capecitabine|mesh-list
56945255|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56945256|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
56945257|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945258|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540957|NCT02727205|Rotigotine|rotigotine|mesh-list
56945259|NCT03779035|Antiviral Agents|antiviral agents|mesh-ancestor
56945261|NCT03779035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945262|NCT03779035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945263|NCT03779035|Immunologic Factors|immunologic factors|mesh-ancestor
56945264|NCT03779035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945265|NCT01586117|Amifostine|amifostine|mesh-list
56945266|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56945267|NCT01586117|Protective Agents|protective agents|mesh-ancestor
56945268|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945269|NCT03779191|Bevacizumab|bevacizumab|mesh-list
56945270|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945271|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945272|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56945273|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56945274|NCT03779191|Growth Substances|growth substances|mesh-ancestor
56945275|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945276|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
56945277|NCT03301415|Valganciclovir|valganciclovir|mesh-list
56945278|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
56945279|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945280|NCT05449015|Atropine|atropine|mesh-list
56945281|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56945282|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56945283|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56945284|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
56945285|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945286|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945287|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56945288|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
56945289|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
56945290|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
56945291|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56945292|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56945293|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
56945294|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945295|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945296|NCT01239017|Fasinumab|fasinumab|mesh-list
56945297|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56945298|NCT01239017|Analgesics|analgesics|mesh-ancestor
56945299|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
56945300|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945301|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945302|NCT02732938|Gemcitabine|gemcitabine|mesh-list
56945303|NCT02732938|Paclitaxel|paclitaxel|mesh-list
56945304|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56945305|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945306|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
56945307|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
56945308|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
56945309|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945310|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56945311|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
56945312|NCT02732938|Antiviral Agents|antiviral agents|mesh-ancestor
56945313|NCT02732938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945314|NCT02732938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945315|NCT02732938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945316|NCT02732938|Immunologic Factors|immunologic factors|mesh-ancestor
56945317|NCT02732938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945318|NCT03778723|Fentanyl|fentanyl|mesh-list
56945319|NCT03778723|Anesthetics|anesthetics|mesh-list
56945320|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945321|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945322|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56945323|NCT03778723|Narcotics|narcotics|mesh-ancestor
56945324|NCT03778723|Analgesics|analgesics|mesh-ancestor
56945325|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
56945326|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945327|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56945328|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56945329|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
56945330|NCT01245959|Cisplatin|cisplatin|mesh-list
56945331|NCT01245959|Docetaxel|docetaxel|mesh-list
56945332|NCT01245959|Fluorouracil|fluorouracil|mesh-list
56945333|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945334|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
56945335|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
56945336|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
56945337|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945338|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
56945339|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56945340|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945341|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
56945342|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945343|NCT04327024|Allopurinol|allopurinol|mesh-list
56945345|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
56945346|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945347|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945348|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
56945349|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945350|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56945351|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
56945352|NCT04327024|Protective Agents|protective agents|mesh-ancestor
56945353|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945354|NCT03778645|Epinephrine|epinephrine|mesh-list
56945355|NCT03778645|Racepinephrine|racepinephrine|mesh-list
56945356|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
56945357|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56945358|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56945359|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
56945360|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945361|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945362|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945363|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56945364|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56945365|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
56945366|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945367|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56945368|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
56945369|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
56945370|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
56945371|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56945372|NCT04326478|Azithromycin|azithromycin|mesh-list
56945373|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56945374|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945375|NCT01239173|Propranolol|propranolol|mesh-list
56945376|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56945377|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56945378|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
56945379|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945380|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945381|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945382|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56945383|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56945384|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
56945385|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
56945386|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945387|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56945388|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
56945389|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
56945390|NCT04647721|Protective Agents|protective agents|mesh-ancestor
56945391|NCT03470038|Mitogens|mitogens|mesh-list
56945392|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56945393|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945394|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
56945395|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945396|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
56945397|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945398|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945399|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56945400|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
56945401|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945402|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945403|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56945404|NCT03778567|Lamivudine|lamivudine|mesh-list
56945405|NCT03778567|Telbivudine|telbivudine|mesh-list
56945406|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56945407|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56945408|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945409|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945410|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
56945411|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541177|NCT02716129|Narcotics|narcotics|mesh-ancestor
56945412|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56945413|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56945414|NCT03784066|Durvalumab|durvalumab|mesh-list
56945415|NCT03784066|Tremelimumab|tremelimumab|mesh-list
56945416|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56945417|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945418|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945419|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
56945420|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945421|NCT03774901|Avelumab|avelumab|mesh-list
56945422|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945423|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945424|NCT05168683|Rasburicase|rasburicase|mesh-list
56945425|NCT05168683|Uric Acid|uric acid|mesh-list
56945426|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
56945427|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945428|NCT05168683|Protective Agents|protective agents|mesh-ancestor
56945429|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945430|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
56945431|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945432|NCT03113123|Tenofovir|tenofovir|mesh-list
56945433|NCT03113123|Emtricitabine|emtricitabine|mesh-list
56945434|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56945435|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
56945436|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945437|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56945438|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56945439|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945440|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945441|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56945442|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56945443|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
56945444|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56945445|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945446|NCT01143857|Varenicline|varenicline|mesh-list
56945447|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56945448|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56945449|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
56945450|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945451|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945452|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945453|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
56945454|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
56945455|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
56945456|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56945457|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56945458|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
56945459|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945460|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
56945461|NCT05159284|Protective Agents|protective agents|mesh-ancestor
56945462|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56945463|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56945464|NCT03063203|Decitabine|decitabine|mesh-list
56945465|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56945466|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
56945467|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945468|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945469|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945470|NCT03435094|Alendronate|alendronate|mesh-list
56945471|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56945472|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945473|NCT03772483|Anesthetics|anesthetics|mesh-list
56945474|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945475|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945476|NCT01236911|Calcium|calcium|mesh-list
56945477|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56945478|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945479|NCT03772561|Durvalumab|durvalumab|mesh-list
56945480|NCT03772561|Olaparib|olaparib|mesh-list
56945481|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945482|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945483|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56945484|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945485|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945486|NCT01239485|Irinotecan|irinotecan|mesh-list
56945487|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56945488|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56945489|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945490|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945491|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945493|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56945494|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945495|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945496|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
56945497|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945498|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945499|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56945500|NCT01146041|Protective Agents|protective agents|mesh-ancestor
56945501|NCT04450576|Chrysarobin|chrysarobin|mesh-list
56945502|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56945503|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56945504|NCT04450576|Analgesics|analgesics|mesh-ancestor
56945505|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
56945506|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945507|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945508|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56945509|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945510|NCT03430180|Naloxone|naloxone|mesh-list
56945511|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56945512|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945513|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
56945514|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945515|NCT03777787|Denatonium|denatonium|mesh-list
56945516|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
56945517|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945518|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
56945519|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945520|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
56945521|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945522|NCT03395314|Midazolam|midazolam|mesh-list
56945523|NCT03395314|Ketamine|ketamine|mesh-list
56945524|NCT03395314|Analgesics|analgesics|mesh-ancestor
56945525|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
56945526|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945527|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945528|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56945529|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56945530|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
56945531|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
56945532|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945533|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56945534|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56945535|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945536|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945537|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56945538|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56945539|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56945540|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56945541|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56945542|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
56945543|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
56945544|NCT03430024|Estrogens|estrogens|mesh-list
56945545|NCT03430024|Hormones|hormones|mesh-ancestor
56945546|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945547|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945548|NCT03434782|Listerine|listerine|mesh-list
56945549|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56945550|NCT03434782|Fluorides|fluorides|mesh-list
56945551|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
56945552|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
56945553|NCT03434782|Protective Agents|protective agents|mesh-ancestor
56945554|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945555|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56945556|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945557|NCT01320397|Losartan|losartan|mesh-list
56945558|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56541231|NCT02724163|Analgesics|analgesics|mesh-ancestor
56945559|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56945560|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56945561|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56945562|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945563|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
56945564|NCT03434704|Clotrimazole|clotrimazole|mesh-list
56945565|NCT03434704|Miconazole|miconazole|mesh-list
56945566|NCT03434704|Fludarabine|fludarabine|mesh-list
56945567|NCT03434704|Thiotepa|thiotepa|mesh-list
56945568|NCT03434704|Treosulfan|treosulfan|mesh-list
56945569|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945570|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945571|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945572|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
56945573|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945574|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56945575|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
56945576|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56945577|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945578|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56945579|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56945580|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56945581|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945582|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56945583|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
56945584|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945585|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56945586|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56945587|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56945588|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945589|NCT04779151|Niraparib|niraparib|mesh-list
56945590|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56945591|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945592|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945593|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945594|NCT02891226|Mirikizumab|mirikizumab|mesh-list
56945595|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56945596|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56945597|NCT02891226|Analgesics|analgesics|mesh-ancestor
56945598|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
56945599|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945600|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945601|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56945602|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945603|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56945604|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56945605|NCT03654274|Norethindrone|norethindrone|mesh-list
56945606|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
56945607|NCT03654274|Estradiol|estradiol|mesh-list
56945608|NCT03654274|Relugolix|relugolix|mesh-list
56945609|NCT03654274|Estrogens|estrogens|mesh-ancestor
56945610|NCT03654274|Hormones|hormones|mesh-ancestor
56945611|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945612|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945613|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56945614|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
56945615|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56945616|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56945617|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56945618|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56945619|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56945620|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
56945621|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
56945622|NCT03771781|Empagliflozin|empagliflozin|mesh-list
56945623|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56945624|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945625|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56945626|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945627|NCT04140721|Moxonidine|moxonidine|mesh-list
56945628|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56945629|NCT03224104|Temozolomide|temozolomide|mesh-list
56945630|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56945631|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
56945632|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945633|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945634|NCT01320475|Sufentanil|sufentanil|mesh-list
56945635|NCT01320475|Ketamine|ketamine|mesh-list
56945636|NCT01320475|Analgesics|analgesics|mesh-ancestor
56945637|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
56945638|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945639|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945640|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56945641|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56945642|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
56945643|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
56945644|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945645|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56945646|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56945647|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945648|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945649|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56945650|NCT01320475|Narcotics|narcotics|mesh-ancestor
56945651|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56945652|NCT05177406|Erenumab|erenumab|mesh-list
56945653|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56945654|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945655|NCT05177406|Analgesics|analgesics|mesh-ancestor
56945656|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
56945657|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945658|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945659|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
56945660|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56945661|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56945662|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56945663|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56945664|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945665|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56945666|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56945667|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945668|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945669|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945670|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56945671|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
56945672|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56945673|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945674|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56945675|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56945676|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56945677|NCT02521246|Losartan|losartan|mesh-list
56945678|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56945679|NCT02521246|Candesartan|candesartan|mesh-list
56945680|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
56945681|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
56945682|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56945683|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56945684|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56945685|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56945686|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945687|NCT02521246|Diuretics|diuretics|mesh-ancestor
56945688|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
56945689|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945690|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56945691|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56945692|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
56945693|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56945694|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
56945695|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945696|NCT05309070|Expectorants|expectorants|mesh-ancestor
56945697|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
56945698|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56945699|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
56945700|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945701|NCT05309070|Protective Agents|protective agents|mesh-ancestor
56945702|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945703|NCT05309070|Antidotes|antidotes|mesh-ancestor
56945704|NCT04735549|Hormones|hormones|mesh-list
56945705|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945706|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945707|NCT04763928|Decitabine|decitabine|mesh-list
56945708|NCT04763928|Venetoclax|venetoclax|mesh-list
56945709|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56945710|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
56945711|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945712|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945713|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945714|NCT01567501|Cetirizine|cetirizine|mesh-list
56945715|NCT01567501|Levocetirizine|levocetirizine|mesh-list
56945716|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56945717|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56945718|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
56945719|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
56945720|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945721|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945722|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945723|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56945724|NCT01321957|Bevacizumab|bevacizumab|mesh-list
56945725|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
56945726|NCT01321957|Irinotecan|irinotecan|mesh-list
56945727|NCT01321957|Fluorouracil|fluorouracil|mesh-list
56945728|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945729|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945730|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56945731|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56945732|NCT01321957|Growth Substances|growth substances|mesh-ancestor
56945733|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945734|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
56945735|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56945736|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56945737|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945738|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945739|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
56945740|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56945741|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945742|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
56945743|NCT01321255|Aspirin|aspirin|mesh-list
56945744|NCT01321255|Ramipril|ramipril|mesh-list
56945745|NCT01321255|Simvastatin|simvastatin|mesh-list
56945746|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56945747|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56945748|NCT01321255|Analgesics|analgesics|mesh-ancestor
56945749|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
56945750|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945751|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945752|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56945753|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945754|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56945755|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56945756|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945757|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56945758|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56945759|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945760|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
56945761|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56945762|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56945763|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
56945764|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56945765|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56945766|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56945767|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
56945768|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56945769|NCT05363592|Metformin|metformin|mesh-list
56945770|NCT05363592|Alogliptin|alogliptin|mesh-list
56945771|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56945772|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945773|NCT05363592|Incretins|incretins|mesh-ancestor
56945774|NCT05363592|Hormones|hormones|mesh-ancestor
55734237|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
56866658|NCT01328106|Trametinib|trametinib|mesh-list
56945775|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945776|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56945777|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
56945778|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945779|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945780|NCT03708211|Esomeprazole|esomeprazole|mesh-list
56945781|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56945782|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56945783|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56945784|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945785|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945787|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56945788|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
56945789|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56945790|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
56945791|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945792|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945793|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56945794|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56945795|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945796|NCT03433534|Nivolumab|nivolumab|mesh-list
56945797|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945798|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945799|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56945800|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945801|NCT05445895|Clopidogrel|clopidogrel|mesh-list
56945802|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56945803|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56945804|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56945805|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56945806|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
56945807|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945808|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945809|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945810|NCT03367299|Blinatumomab|blinatumomab|mesh-list
56945811|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945812|NCT04449952|Listerine|listerine|mesh-list
56945813|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
56945814|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
56945815|NCT04449952|Protective Agents|protective agents|mesh-ancestor
56945816|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945817|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56945818|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945819|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
56945820|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56945821|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
56945822|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56945823|NCT04449718|Vitamin D|vitamin d|mesh-list
56945824|NCT04449718|Vitamins|vitamins|mesh-ancestor
56945825|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
56945826|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945827|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56945828|NCT03763279|Triclosan|triclosan|mesh-list
56945829|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56945830|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945831|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56945832|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56945833|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
56945834|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945835|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56945836|NCT03638037|Vitamin D|vitamin d|mesh-list
56945837|NCT03638037|Vitamins|vitamins|mesh-ancestor
56945838|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
56945839|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945840|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56945841|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
56945842|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
56945843|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56945844|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945845|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945846|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56945847|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
56945848|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945849|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945850|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
56945851|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
56945852|NCT03763123|Paclitaxel|paclitaxel|mesh-list
56945853|NCT03763123|Topotecan|topotecan|mesh-list
56945854|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56945855|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945856|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
56945857|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
56945858|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
56945859|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945860|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56945861|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56945862|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945863|NCT03429400|Morphine|morphine|mesh-list
56945864|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56945865|NCT03429400|Narcotics|narcotics|mesh-ancestor
56945866|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945867|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945868|NCT03429400|Analgesics|analgesics|mesh-ancestor
56945869|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
56945870|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945871|NCT03429010|Anesthetics|anesthetics|mesh-list
56945872|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945873|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945874|NCT02944656|Gabapentin|gabapentin|mesh-list
56945875|NCT02944656|Analgesics|analgesics|mesh-ancestor
56945876|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
56945877|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945878|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945879|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
56945880|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56945881|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56945882|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945883|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56945884|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56945885|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56945886|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56945887|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945888|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
56945889|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
56945890|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945891|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945892|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
56945893|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
56945894|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56945895|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56945896|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945897|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945898|NCT03763045|Urological Agents|urological agents|mesh-ancestor
56945899|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
56945900|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945901|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
56945902|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56945903|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56945904|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945905|NCT01321489|Urological Agents|urological agents|mesh-ancestor
56945906|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
56945907|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56945908|NCT04800627|Pevonedistat|pevonedistat|mesh-list
56945909|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945910|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945911|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945912|NCT05308602|Vaccines|vaccines|mesh-list
56945913|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
56945914|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945915|NCT03768037|Pemetrexed|pemetrexed|mesh-list
56945916|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945917|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945918|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945919|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56945920|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56945921|NCT01146977|Cytarabine|cytarabine|mesh-list
56945922|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56945923|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
56945924|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945925|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945926|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
56945927|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945928|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945929|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
56945930|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945931|NCT03762967|Hormones|hormones|mesh-list
56945932|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56945933|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945934|NCT02664935|Docetaxel|docetaxel|mesh-list
56945935|NCT02664935|Durvalumab|durvalumab|mesh-list
56945936|NCT02664935|Palbociclib|palbociclib|mesh-list
56945937|NCT02664935|Osimertinib|osimertinib|mesh-list
56945938|NCT02664935|Crizotinib|crizotinib|mesh-list
56945939|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945940|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
56945941|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
56945942|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
56945943|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945944|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945945|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56945946|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56945947|NCT03762889|Anesthetics|anesthetics|mesh-list
56945948|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56945949|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945950|NCT03746041|Abaloparatide|abaloparatide|mesh-list
56945951|NCT03746041|Bevacizumab|bevacizumab|mesh-list
56945952|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56945953|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945954|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56945955|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56945956|NCT03746041|Growth Substances|growth substances|mesh-ancestor
56945957|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945958|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
56945959|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56945960|NCT01236989|Liver Extracts|liver extracts|mesh-list
56945961|NCT01236989|Hematinics|hematinics|mesh-ancestor
56945962|NCT03423472|Vitamin A|vitamin a|mesh-list
56945963|NCT03423472|Vitamins|vitamins|mesh-ancestor
56945964|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
56945965|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945966|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
56945967|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56945968|NCT01239563|Basiliximab|basiliximab|mesh-list
56945969|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
56945970|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945971|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945972|NCT01883297|Aldesleukin|aldesleukin|mesh-list
56945973|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
56945974|NCT01883297|Interleukin-2|interleukin-2|mesh-list
56945975|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56945976|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
56945977|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945978|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56945979|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56945980|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
56945981|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56945982|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56945983|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56945984|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56945985|NCT01883297|Analgesics|analgesics|mesh-ancestor
56945986|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
56945987|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56945988|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56945989|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56945990|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
56945991|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945992|NCT04546581|Remdesivir|remdesivir|mesh-list
56945993|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
56945994|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56945995|NCT04546581|Antibodies|antibodies|mesh-list
56945996|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
56945997|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56945998|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
55734387|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56945999|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946000|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
56946001|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946002|NCT02204254|Doxycycline|doxycycline|mesh-list
56946003|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56946004|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946005|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
56946006|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56946007|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56946008|NCT01321567|Rabeprazole|rabeprazole|mesh-list
56946009|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56946010|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56946011|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56946012|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946013|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946014|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
56946015|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56946016|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946017|NCT05294172|Gemcitabine|gemcitabine|mesh-list
56946018|NCT05294172|Cisplatin|cisplatin|mesh-list
56946019|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946020|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56946021|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
56946022|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946023|NCT05294172|Antiviral Agents|antiviral agents|mesh-ancestor
56946024|NCT05294172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946025|NCT05294172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946026|NCT05294172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946027|NCT05294172|Immunologic Factors|immunologic factors|mesh-ancestor
56946028|NCT05294172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946029|NCT03164655|Leucovorin|leucovorin|mesh-list
56946030|NCT03164655|Bevacizumab|bevacizumab|mesh-list
56946031|NCT03164655|Cetuximab|cetuximab|mesh-list
56946032|NCT03164655|Panitumumab|panitumumab|mesh-list
56946033|NCT03164655|Fluorouracil|fluorouracil|mesh-list
56946034|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
56946035|NCT03164655|Irinotecan|irinotecan|mesh-list
56946036|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56946037|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946038|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56946039|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56946040|NCT03164655|Growth Substances|growth substances|mesh-ancestor
56946041|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946042|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
56946043|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
56946044|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946045|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56946046|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946047|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
56946048|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56946049|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56946050|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946051|NCT03164655|Antidotes|antidotes|mesh-ancestor
56946052|NCT03164655|Protective Agents|protective agents|mesh-ancestor
56946053|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
56946054|NCT03164655|Vitamins|vitamins|mesh-ancestor
56946055|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
56946056|NCT02561273|Prednisone|prednisone|mesh-list
56946057|NCT02561273|Cortisone|cortisone|mesh-list
56946058|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
56946059|NCT02561273|Doxorubicin|doxorubicin|mesh-list
56946060|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56946061|NCT02561273|Etoposide|etoposide|mesh-list
56946062|NCT02561273|Vincristine|vincristine|mesh-list
56946063|NCT02561273|Lenalidomide|lenalidomide|mesh-list
56946064|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
56946065|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
56946066|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946067|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
56946068|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946069|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946070|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56946071|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
56946072|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946073|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946074|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56946075|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56946076|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56946077|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56866941|NCT03634852|Triamcinolone|triamcinolone|mesh-list
56946078|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946079|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56946080|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
56946081|NCT02561273|Hormones|hormones|mesh-ancestor
56946082|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946083|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56946084|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56946085|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
56946086|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
56946087|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
56946088|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56946089|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56946090|NCT02561273|Growth Substances|growth substances|mesh-ancestor
56946091|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
56946092|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
56946093|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
56946094|NCT02521012|Vitamin D|vitamin d|mesh-list
56946095|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
56946096|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
56946097|NCT02521012|Vitamins|vitamins|mesh-list
56946098|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
56946099|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946100|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56946101|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56946102|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
56946103|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56946104|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56946105|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946106|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
56946107|NCT05302986|Coagulants|coagulants|mesh-ancestor
56946108|NCT04756128|Colchicine|colchicine|mesh-list
56946109|NCT04756128|Naltrexone|naltrexone|mesh-list
56946110|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56946111|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56946112|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946113|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
56946114|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946115|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
56946116|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946117|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
56946118|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
56946119|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
56946120|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946121|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946122|NCT03427216|Diazepam|diazepam|mesh-list
56946123|NCT03427216|Baclofen|baclofen|mesh-list
56946124|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56946125|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946126|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56946127|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946128|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56946129|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
56946130|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
56946131|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946132|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946133|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56946134|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
56946135|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
56946136|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
56946137|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56946138|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56946139|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946140|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56946141|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56946142|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56946143|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56946144|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
56946145|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
56946146|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
56946147|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
56946148|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56946149|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946150|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946151|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56946152|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56946153|NCT01144091|Protective Agents|protective agents|mesh-ancestor
56946154|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946155|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
56946156|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56946157|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
56946158|NCT02392559|Evolocumab|evolocumab|mesh-list
56946159|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56541829|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
56946160|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56946161|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
56946162|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946163|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56946164|NCT04301778|Durvalumab|durvalumab|mesh-list
56946165|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56946166|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946167|NCT03332589|Dabrafenib|dabrafenib|mesh-list
56946168|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946169|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56946170|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946171|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946172|NCT03767569|Folic Acid|folic acid|mesh-list
56946173|NCT03767569|Inositol|inositol|mesh-list
56946174|NCT03767569|Hematinics|hematinics|mesh-ancestor
56946175|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
56946176|NCT03767569|Vitamins|vitamins|mesh-ancestor
56946177|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
56946178|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946179|NCT03620916|Morphine|morphine|mesh-list
56946180|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56946181|NCT03620916|Narcotics|narcotics|mesh-ancestor
56946182|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946183|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946184|NCT03620916|Analgesics|analgesics|mesh-ancestor
56946185|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
56946186|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946187|NCT01237067|Carboplatin|carboplatin|mesh-list
56946188|NCT01237067|Olaparib|olaparib|mesh-list
56946189|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946190|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56946191|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946192|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946193|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
56946194|NCT01864109|Temozolomide|temozolomide|mesh-list
56946195|NCT01864109|Ifosfamide|ifosfamide|mesh-list
56946196|NCT01864109|Doxorubicin|doxorubicin|mesh-list
56946197|NCT01864109|Irinotecan|irinotecan|mesh-list
56946198|NCT01864109|Etoposide|etoposide|mesh-list
56946199|NCT01864109|Vincristine|vincristine|mesh-list
56946200|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
56946201|NCT01864109|Razoxane|razoxane|mesh-list
56946202|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946203|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
56946204|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946205|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946206|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56946207|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
56946208|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946209|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946210|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56946211|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56946212|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56946213|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56946214|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946215|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56946216|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56946217|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
56946218|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
56946219|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
56946220|NCT01864109|Protective Agents|protective agents|mesh-ancestor
56946221|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56946222|NCT03767335|Trastuzumab|trastuzumab|mesh-list
56946223|NCT03767335|Fulvestrant|fulvestrant|mesh-list
56946224|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56946225|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946226|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56946227|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56946228|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56946229|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
55734529|NCT04923659|Carbamazepine|carbamazepine|mesh-list
56867096|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
56946230|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946231|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946232|NCT03426982|Heparin|heparin|mesh-list
56946233|NCT03426982|Calcium heparin|calcium heparin|mesh-list
56946234|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
56946235|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56946236|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56946237|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946238|NCT01862315|Gemcitabine|gemcitabine|mesh-list
56946239|NCT01862315|Dexamethasone|dexamethasone|mesh-list
56946240|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
56946241|NCT01862315|Floxuridine|floxuridine|mesh-list
56946242|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56946243|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
56946244|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
56946245|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946246|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946247|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56946248|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
56946249|NCT01862315|Hormones|hormones|mesh-ancestor
56946250|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946251|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56946252|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946253|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56946254|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
56946255|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946256|NCT01862315|Antiviral Agents|antiviral agents|mesh-ancestor
56946257|NCT01862315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946258|NCT01862315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946259|NCT01862315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946260|NCT01862315|Immunologic Factors|immunologic factors|mesh-ancestor
56946261|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
56946262|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56946263|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946264|NCT01546948|Methadone|methadone|mesh-list
56946265|NCT01546948|Hydromorphone|hydromorphone|mesh-list
56946266|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56946267|NCT01546948|Narcotics|narcotics|mesh-ancestor
56946268|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946269|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946270|NCT01546948|Analgesics|analgesics|mesh-ancestor
56946271|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
56946272|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946273|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
56946274|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
56946275|NCT00458003|Phenylephrine|phenylephrine|mesh-list
56946276|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
56946277|NCT00458003|Ephedrine|ephedrine|mesh-list
56946278|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56946279|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
56946280|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
56946281|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946282|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946283|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
56946284|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56946285|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
56946286|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
56946287|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56946288|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56946289|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56946290|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
56946291|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946292|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946293|NCT00458003|Protective Agents|protective agents|mesh-ancestor
56946294|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56946295|NCT04599972|Pilocarpine|pilocarpine|mesh-list
56946296|NCT04599972|Miotics|miotics|mesh-ancestor
56946297|NCT04599972|Autonomic Agents|autonomic agents|mesh-ancestor
56946298|NCT04599972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946299|NCT04599972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946300|NCT04599972|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56946301|NCT04599972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56946302|NCT04599972|Cholinergic Agents|cholinergic agents|mesh-ancestor
56946303|NCT04599972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052719|NCT05747768|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56946304|NCT04599972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946305|NCT03008616|Digoxin|digoxin|mesh-list
56946306|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56946307|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56946308|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946309|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946310|NCT03008616|Protective Agents|protective agents|mesh-ancestor
56946311|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946312|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
56946313|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56946314|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946315|NCT03426592|Vitamin D|vitamin d|mesh-list
56946316|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
56946317|NCT03426592|Vitamins|vitamins|mesh-ancestor
56946318|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
56946319|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946320|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56946321|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56946323|NCT01567657|Meperidine|meperidine|mesh-list
56946324|NCT01567657|Propofol|propofol|mesh-list
56946325|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56946326|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946327|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946328|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56946329|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
56946330|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
56946331|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56946332|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56946333|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56946334|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56946335|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
56946336|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
56946337|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946338|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946339|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56946340|NCT01567657|Narcotics|narcotics|mesh-ancestor
56946341|NCT01567657|Analgesics|analgesics|mesh-ancestor
56946342|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
56946343|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946344|NCT03416062|Niacinamide|niacinamide|mesh-list
56946345|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
56946346|NCT03416062|Vitamins|vitamins|mesh-ancestor
56946347|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
56946348|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946349|NCT03761485|Fluorides|fluorides|mesh-list
56946350|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
56946351|NCT03761485|Protective Agents|protective agents|mesh-ancestor
56946352|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946353|NCT03766867|Vortioxetine|vortioxetine|mesh-list
56946354|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
56946355|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56946356|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56946357|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56946358|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946359|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946360|NCT03766867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56946361|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56946362|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56946363|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946364|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946365|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
56946366|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56946367|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56946368|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56946369|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56946370|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
56946371|NCT02061293|Promethazine|promethazine|mesh-list
56946372|NCT02061293|Psilocybin|psilocybin|mesh-list
56946373|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56946374|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56946375|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946376|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946377|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
56946378|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
56946379|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
56946380|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946381|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
56946382|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
56946383|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56946384|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56946385|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
56946386|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
56946387|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946388|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946389|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56946390|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
56946391|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
56946392|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
56946393|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56946394|NCT03761329|Lidocaine|lidocaine|mesh-list
56946395|NCT03761329|Anesthetics|anesthetics|mesh-list
56542052|NCT00604006|Diuretics|diuretics|mesh-ancestor
56946396|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
56946397|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946398|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946399|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
56946400|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946401|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56946402|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56946403|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56946404|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56946405|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946406|NCT03415906|Valsartan|valsartan|mesh-list
56946407|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56946408|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56946409|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56946410|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56946411|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946412|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
56946413|NCT03415750|Everolimus|everolimus|mesh-list
56946414|NCT03415750|Tacrolimus|tacrolimus|mesh-list
56946415|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946416|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
56946417|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946418|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56946419|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946420|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946421|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946422|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56946423|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56946424|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
56946425|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56946426|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946427|NCT01239719|Clemastine|clemastine|mesh-list
56946428|NCT01239719|Dexamethasone|dexamethasone|mesh-list
56946429|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
56946430|NCT01239719|BB 1101|bb 1101|mesh-list
56946431|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56946432|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
56946433|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
56946434|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946435|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946436|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56946437|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
56946438|NCT01239719|Hormones|hormones|mesh-ancestor
56946439|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946440|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56946441|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946442|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
56946443|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946444|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946445|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
56946446|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
56946447|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56946448|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
56946449|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
56946450|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946451|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56946452|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
56946453|NCT03916679|Fludarabine|fludarabine|mesh-list
56946454|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946455|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
56946456|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946457|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946458|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56946459|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
56946460|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946461|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946462|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56946463|NCT03421990|Anesthetics|anesthetics|mesh-list
56946464|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946465|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946466|NCT02913612|Timolol|timolol|mesh-list
56946467|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56946468|NCT02913612|Maleic acid|maleic acid|mesh-list
56542129|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
56946469|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946470|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946471|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56946472|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56946473|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
56946474|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946475|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946476|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56946477|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56946479|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56946480|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946481|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56946482|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56946483|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56946484|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946485|NCT01248299|Cisplatin|cisplatin|mesh-list
56946486|NCT01248299|Docetaxel|docetaxel|mesh-list
56946487|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
56946488|NCT01248299|Fluorouracil|fluorouracil|mesh-list
56946489|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946490|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
56946491|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
56946492|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
56946493|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946494|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
56946495|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56946496|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946497|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
56946498|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946499|NCT01239875|Vaccines|vaccines|mesh-list
56946500|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56946501|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
56946502|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946503|NCT03415594|Glucagon|glucagon|mesh-list
56946504|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56946505|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56946506|NCT03415594|Hormones|hormones|mesh-ancestor
56946507|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946508|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946509|NCT03415594|Incretins|incretins|mesh-ancestor
56946510|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
56946511|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56946512|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946513|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
56946514|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
56946515|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56946516|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56946517|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946518|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946519|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946520|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946521|NCT02709954|Ethanol|ethanol|mesh-list
56946522|NCT02709954|Dronabinol|dronabinol|mesh-list
56946523|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56946524|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946525|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946526|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946527|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
56946528|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56946529|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56946530|NCT02709954|Analgesics|analgesics|mesh-ancestor
56946531|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
56946532|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946533|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56946534|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56946535|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946536|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946537|NCT02709954|Hormones|hormones|mesh-ancestor
56946538|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946539|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
56946540|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
56946541|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56542206|NCT00930046|Ropivacaine|ropivacaine|mesh-list
56946542|NCT03620838|Progesterone|progesterone|mesh-list
56946543|NCT03620838|Progestins|progestins|mesh-ancestor
56946544|NCT03620838|Hormones|hormones|mesh-ancestor
56946545|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946546|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946547|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56946548|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56946549|NCT01239953|Paclitaxel|paclitaxel|mesh-list
56946550|NCT01239953|Everolimus|everolimus|mesh-list
56946551|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56946552|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946553|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56946554|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56946555|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56946556|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946557|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946558|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
56946559|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946560|NCT01322191|Morphine|morphine|mesh-list
56946561|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56946562|NCT01322191|Narcotics|narcotics|mesh-ancestor
56946563|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946564|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946565|NCT01322191|Analgesics|analgesics|mesh-ancestor
56946566|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
56946567|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946568|NCT03620760|Aspirin|aspirin|mesh-list
56946569|NCT03620760|Ticagrelor|ticagrelor|mesh-list
56946570|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56946571|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56946572|NCT03620760|Analgesics|analgesics|mesh-ancestor
56946573|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
56946574|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946575|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946576|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56946577|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946578|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56946579|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56946580|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946581|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56946582|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56946583|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946584|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
56946585|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56946586|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56946587|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56946588|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
56946589|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946590|NCT03765931|Amoxicillin|amoxicillin|mesh-list
56946591|NCT03765931|Doxycycline|doxycycline|mesh-list
56946592|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56946593|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946594|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
56946595|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56946596|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56946597|NCT01240265|Vitamin D|vitamin d|mesh-list
56946598|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
56946599|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
56946600|NCT01240265|Vitamins|vitamins|mesh-list
56946601|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
56946602|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946603|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56946604|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56946605|NCT02327455|Dobutamine|dobutamine|mesh-list
56946606|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56946607|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
56946608|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
56946609|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946610|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946611|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56946612|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56946613|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56946614|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
56946615|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946616|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946617|NCT02327455|Protective Agents|protective agents|mesh-ancestor
56946618|NCT03638076|Ritonavir|ritonavir|mesh-list
56946619|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56946620|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56946621|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
56946622|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946623|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946624|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56946625|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56946626|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
56946627|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946628|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56946629|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56946630|NCT01329731|Olaflur|olaflur|mesh-list
56946631|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
56946632|NCT01329731|Protective Agents|protective agents|mesh-ancestor
56946633|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946634|NCT03765697|Lidocaine|lidocaine|mesh-list
56946635|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
56946636|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
56946637|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946638|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946639|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
56946640|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946641|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56946642|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56946643|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56946644|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56946645|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946646|NCT03311841|Rifampin|rifampin|mesh-list
56946647|NCT03311841|Midazolam|midazolam|mesh-list
56946648|NCT03311841|Dabigatran|dabigatran|mesh-list
56946649|NCT03311841|Atorvastatin|atorvastatin|mesh-list
56946650|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56946651|NCT03311841|Pitavastatin|pitavastatin|mesh-list
56946652|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56946653|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56946654|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56946655|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946656|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946657|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56946658|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56946659|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56946660|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56946661|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
56946662|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
56946663|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
56946664|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
56946665|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946666|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946667|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56946668|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56946669|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
56946670|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56946671|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56946672|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946673|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
56946674|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56946675|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
56946676|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
56946677|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56946678|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
56946679|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56946680|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867546|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
56946681|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
56946682|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56946683|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56946684|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56946685|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56946686|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56946687|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56946688|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56946689|NCT02115295|Cytarabine|cytarabine|mesh-list
56946690|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56946691|NCT02115295|Venetoclax|venetoclax|mesh-list
56542354|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946692|NCT02115295|Idarubicin|idarubicin|mesh-list
56946693|NCT02115295|Cladribine|cladribine|mesh-list
56946694|NCT02115295|Midostaurin|midostaurin|mesh-list
56946695|NCT02115295|Staurosporine|staurosporine|mesh-list
56946696|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56946697|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
56946698|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946699|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946700|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
56946701|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946702|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946703|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
56946704|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946705|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56946706|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56946707|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56946708|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946709|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56946710|NCT01249937|Triamcinolone|triamcinolone|mesh-list
56946711|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56946712|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56946713|NCT01249937|Ranibizumab|ranibizumab|mesh-list
56946714|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56946715|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56946716|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56946717|NCT01249937|Growth Substances|growth substances|mesh-ancestor
56946718|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946719|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
56946720|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946721|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56946722|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
56946723|NCT01249937|Hormones|hormones|mesh-ancestor
56946724|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946725|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946726|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
56946727|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946728|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946729|NCT02528201|Celecoxib|celecoxib|mesh-list
56946730|NCT02528201|Diclofenac|diclofenac|mesh-list
56946731|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56946732|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56946733|NCT02528201|Analgesics|analgesics|mesh-ancestor
56946734|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
56946735|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946736|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946737|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56946738|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946739|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56946740|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56946741|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946742|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946743|NCT03758677|Gemcitabine|gemcitabine|mesh-list
56946744|NCT03758677|Docetaxel|docetaxel|mesh-list
56946745|NCT03758677|Pemetrexed|pemetrexed|mesh-list
56946746|NCT03758677|Apatinib|apatinib|mesh-list
56946747|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56946748|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
56946749|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946750|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946751|NCT03758677|Antiviral Agents|antiviral agents|mesh-ancestor
56946752|NCT03758677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946753|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946754|NCT03758677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946755|NCT03758677|Immunologic Factors|immunologic factors|mesh-ancestor
56946756|NCT03758677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946757|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
56946758|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
56946759|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
56946760|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56946761|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56946762|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56946763|NCT03764683|Suvorexant|suvorexant|mesh-list
56946764|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56946765|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56946766|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946767|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542430|NCT01009983|Paclitaxel|paclitaxel|mesh-list
56946768|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56946769|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946770|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946772|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
56946773|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946774|NCT01242605|Gemcitabine|gemcitabine|mesh-list
56946775|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946776|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56946777|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
56946778|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946779|NCT01242605|Antiviral Agents|antiviral agents|mesh-ancestor
56946780|NCT01242605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946781|NCT01242605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946782|NCT01242605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946783|NCT01242605|Immunologic Factors|immunologic factors|mesh-ancestor
56946784|NCT01242605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946785|NCT03414814|Osimertinib|osimertinib|mesh-list
56946786|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946787|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56946788|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946789|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946790|NCT03421366|Posaconazole|posaconazole|mesh-list
56946791|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
56946792|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946793|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56946794|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56946795|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56946796|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56946797|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56946798|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946799|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946800|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56946801|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
56946802|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946803|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946804|NCT03764605|Metformin|metformin|mesh-list
56946805|NCT03764605|Tolvaptan|tolvaptan|mesh-list
56946806|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56946807|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946808|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56946809|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946810|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
56946811|NCT03764527|Artesunate|artesunate|mesh-list
56946812|NCT03764527|Lumefantrine|lumefantrine|mesh-list
56946813|NCT03764527|Artemether|artemether|mesh-list
56946814|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56946815|NCT03764527|Amodiaquine|amodiaquine|mesh-list
56946816|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
56946817|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56946818|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56946819|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946820|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946821|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
56946822|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
56946823|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56946824|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
56946825|NCT01321801|Pregabalin|pregabalin|mesh-list
56946826|NCT01321801|Analgesics|analgesics|mesh-ancestor
56946827|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
56946828|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946829|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946830|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
56946831|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56946832|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56946833|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946834|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56946835|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56946836|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56946837|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946838|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56946839|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
56946840|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56946841|NCT01155375|Hematinics|hematinics|mesh-ancestor
56946842|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56946843|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56946844|NCT01155375|Trace Elements|trace elements|mesh-ancestor
56946845|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
56946846|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946847|NCT03759301|Cetrorelix|cetrorelix|mesh-list
56946848|NCT03759301|Hormones|hormones|mesh-list
56946849|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946850|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946851|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56946852|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
56946853|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56946854|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
56946855|NCT02913313|Nivolumab|nivolumab|mesh-list
56946856|NCT02913313|Ipilimumab|ipilimumab|mesh-list
56946857|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56946858|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946859|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56946860|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946861|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
56946862|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56946863|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946864|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
56946865|NCT02260102|Temocillin|temocillin|mesh-list
56946866|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56946867|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56946868|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
56946869|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56946870|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946871|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946872|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56946873|NCT03425734|Analgesics|analgesics|mesh-ancestor
56946874|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
56946875|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946876|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56946877|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56946878|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56946879|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
56946880|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946881|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946882|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
56946883|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56946884|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
56946885|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
56946886|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56946887|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946888|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56946889|NCT03420586|Analgesics|analgesics|mesh-ancestor
56946890|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
56946891|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946892|NCT03759067|Clopidogrel|clopidogrel|mesh-list
56946893|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56946894|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56946895|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56946896|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56946897|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
56946898|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946899|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946900|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946901|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
56946902|NCT03425656|Docetaxel|docetaxel|mesh-list
56946903|NCT03425656|Doxorubicin|doxorubicin|mesh-list
56946904|NCT03425656|Trastuzumab|trastuzumab|mesh-list
56946905|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946906|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
56946907|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946908|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946909|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56946910|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
56946911|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946912|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946913|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56946914|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
56946915|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
56542580|NCT03651271|Nivolumab|nivolumab|mesh-list
56946916|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
56946917|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56946918|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56946919|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56946920|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946921|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56946922|NCT03413722|Everolimus|everolimus|mesh-list
56946923|NCT03413722|Tacrolimus|tacrolimus|mesh-list
56946924|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946925|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
56946926|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946927|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56946928|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946929|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946930|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946931|NCT04843462|Esketamine|esketamine|mesh-list
56946932|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
56946933|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56946934|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
56946935|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56946936|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946937|NCT03413410|Metoprolol|metoprolol|mesh-list
56946938|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56946939|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56946940|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
56946941|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
56946942|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946943|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946944|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56946945|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56946946|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56946947|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
56946948|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946949|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946950|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56946951|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56946952|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
56946953|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946954|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56946955|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56946956|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
56946957|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
56946958|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56946959|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946960|NCT03424876|Sunitinib|sunitinib|mesh-list
56946961|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
56946962|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946963|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56946964|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56946965|NCT03424876|Growth Substances|growth substances|mesh-ancestor
56946966|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946967|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
56946968|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56946969|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946970|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946971|NCT03476577|Ibuprofen|ibuprofen|mesh-list
56946972|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56946973|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56946974|NCT03476577|Analgesics|analgesics|mesh-ancestor
56946975|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
56946976|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56946977|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946978|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56946979|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946980|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56946981|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56946982|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946983|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56946984|NCT03419650|Hormones|hormones|mesh-ancestor
56946985|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56946986|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946987|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
56946988|NCT04893915|Fludarabine|fludarabine|mesh-list
56946989|NCT04893915|Interleukin-2|interleukin-2|mesh-list
56946990|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56946991|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
56946992|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56946993|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56946994|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56946995|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
56946996|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56946997|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56946998|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56946999|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947000|NCT04893915|Analgesics|analgesics|mesh-ancestor
56947001|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
56947002|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947003|NCT03419494|Doxorubicin|doxorubicin|mesh-list
56947004|NCT03419494|Daunorubicin|daunorubicin|mesh-list
56947005|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56947006|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56947007|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947008|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56947009|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56947010|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947011|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947012|NCT03413020|Amoxicillin|amoxicillin|mesh-list
56947013|NCT03413020|Metronidazole|metronidazole|mesh-list
56947014|NCT03413020|Clarithromycin|clarithromycin|mesh-list
56947015|NCT03413020|Levofloxacin|levofloxacin|mesh-list
56947016|NCT03413020|Ofloxacin|ofloxacin|mesh-list
56947017|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
56947018|NCT03413020|Esomeprazole|esomeprazole|mesh-list
56947019|NCT03413020|Bismuth|bismuth|mesh-list
56947020|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947021|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56947022|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947023|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56947024|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56947025|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56947026|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56947027|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56947028|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947029|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56947030|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56947031|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56947032|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56947033|NCT03413020|Renal Agents|renal agents|mesh-ancestor
56947034|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56947035|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56947036|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947037|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56947038|NCT03413020|Antacids|antacids|mesh-ancestor
56947039|NCT03413020|Diuretics|diuretics|mesh-ancestor
56947040|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
56947041|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947042|NCT03413020|Expectorants|expectorants|mesh-ancestor
56947043|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
56947044|NCT03424408|Aspirin|aspirin|mesh-list
56947045|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56947046|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947047|NCT03424408|Analgesics|analgesics|mesh-ancestor
56947048|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
56947049|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947050|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947051|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947052|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947053|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56947054|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56947055|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947056|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56947057|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56947058|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947059|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
56947060|NCT02807805|Niclosamide|niclosamide|mesh-list
56542732|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947061|NCT02807805|Prednisone|prednisone|mesh-list
56947062|NCT02807805|Cortisone|cortisone|mesh-list
56947063|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
56947064|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947065|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
56947066|NCT02807805|Hormones|hormones|mesh-ancestor
56947067|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56947068|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947069|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56947070|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947071|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56947072|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947073|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947074|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
56947075|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56947076|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
56947077|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56947078|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
56947079|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56947080|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947081|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
56947082|NCT03305055|Fentanyl|fentanyl|mesh-list
56947083|NCT03305055|Ketamine|ketamine|mesh-list
56947084|NCT03305055|Analgesics|analgesics|mesh-ancestor
56947085|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
56947086|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947087|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947088|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56947089|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56947090|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
56947091|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
56947092|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947093|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56947094|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56947095|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947096|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947097|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56947098|NCT03305055|Narcotics|narcotics|mesh-ancestor
56947099|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56947100|NCT04547985|Naltrexone|naltrexone|mesh-list
56947101|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56947102|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56947103|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947104|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
56947105|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947106|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
56947107|NCT03412552|Analgesics|analgesics|mesh-ancestor
56947108|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
56947109|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947110|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947111|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
56947112|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947113|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56947114|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
56947115|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56947116|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56947117|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947118|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56947119|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
56947120|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56947121|NCT03412474|Acetaminophen|acetaminophen|mesh-list
56947122|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
56947123|NCT03412474|Bupivacaine|bupivacaine|mesh-list
56947124|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
56947125|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
56947126|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56868005|NCT05169424|Xhance|xhance|mesh-list
56947127|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947128|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
56947129|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947130|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56947131|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947132|NCT03412474|Analgesics|analgesics|mesh-ancestor
56947133|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56947134|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56947135|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56947136|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
56947137|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947138|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947139|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
56947141|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
56947142|NCT04527003|Cannabidiol|cannabidiol|mesh-list
56947143|NCT04527003|Norethindrone|norethindrone|mesh-list
56947144|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
56947145|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
56947146|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56947147|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56947148|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56947149|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
56947150|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56947151|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947152|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56947153|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56947154|NCT04447612|Gemcitabine|gemcitabine|mesh-list
56947155|NCT04447612|Durvalumab|durvalumab|mesh-list
56947156|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947157|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56947158|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
56947159|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947160|NCT04447612|Antiviral Agents|antiviral agents|mesh-ancestor
56947161|NCT04447612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947162|NCT04447612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947163|NCT04447612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56947164|NCT04447612|Immunologic Factors|immunologic factors|mesh-ancestor
56947165|NCT04447612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947166|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947167|NCT03418558|Trastuzumab|trastuzumab|mesh-list
56947168|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56947169|NCT03418558|Maytansine|maytansine|mesh-list
56947170|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947171|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947172|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56947173|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
56947174|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
56947175|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
56947176|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947177|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
56947178|NCT05170828|Sirolimus|sirolimus|mesh-list
56947179|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
56947180|NCT05170828|Busulfan|busulfan|mesh-list
56947181|NCT05170828|Fludarabine|fludarabine|mesh-list
56947182|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56947183|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
56947184|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947185|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947186|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56947187|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
56947188|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947189|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947190|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56947191|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56947192|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56947193|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
56947194|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56947195|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947196|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947197|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
56947198|NCT03412006|Fulacimstat|fulacimstat|mesh-list
56947199|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947200|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947201|NCT03418246|Calcium|calcium|mesh-list
56868067|NCT01124058|Heparin|heparin|mesh-list
56947202|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56947203|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947204|NCT03411850|Abatacept|abatacept|mesh-list
56947205|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56947206|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947207|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947208|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56947209|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
56947210|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947211|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947212|NCT05170594|Bevacizumab|bevacizumab|mesh-list
56947213|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56947214|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947215|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947216|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56947217|NCT05170594|Growth Substances|growth substances|mesh-ancestor
56947218|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947219|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56947220|NCT03410836|Lidocaine|lidocaine|mesh-list
56947221|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
56947222|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
56947223|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947224|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947225|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
56947226|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947227|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56947228|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56947229|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56947230|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56947231|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947232|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
56947233|NCT03273153|Atezolizumab|atezolizumab|mesh-list
56947234|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947235|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947236|NCT03418090|Xenon|xenon|mesh-list
56947237|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56947238|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
56947239|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
56947240|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947241|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947242|NCT03323034|Irinotecan|irinotecan|mesh-list
56947243|NCT03323034|Temozolomide|temozolomide|mesh-list
56947244|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56947245|NCT03323034|Pevonedistat|pevonedistat|mesh-list
56947246|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56947247|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56947248|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947249|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947250|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56947251|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
56947252|NCT02520934|Miglustat|miglustat|mesh-list
56947253|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947254|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947255|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56947256|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56947257|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
56947258|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947259|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56947260|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56947261|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947262|NCT02749968|Bupivacaine|bupivacaine|mesh-list
56947263|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
56947264|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
56947265|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947266|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947267|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
56947268|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947269|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56947270|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56947271|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947272|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
56947273|NCT03417700|Vitamin D|vitamin d|mesh-list
56947274|NCT03417700|Vitamins|vitamins|mesh-ancestor
56947275|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
56947276|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947277|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56947278|NCT03410524|Simethicone|simethicone|mesh-list
56947279|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
56947280|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947281|NCT03410524|Emollients|emollients|mesh-ancestor
56947282|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
56947283|NCT02713776|Pasireotide|pasireotide|mesh-list
56947284|NCT02713776|Somatostatin|somatostatin|mesh-list
56947285|NCT02713776|Hormones|hormones|mesh-ancestor
56947286|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56947287|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947288|NCT05215990|Metformin|metformin|mesh-list
56947289|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56542954|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
56543029|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56947290|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947291|NCT03268941|Metoclopramide|metoclopramide|mesh-list
56947292|NCT03268941|Maleic acid|maleic acid|mesh-list
56947293|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947294|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947295|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
56947296|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
56947297|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947298|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947299|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56947300|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56947301|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56947302|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
56947303|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947304|NCT05215834|Remifentanil|remifentanil|mesh-list
56947305|NCT05215834|Propofol|propofol|mesh-list
56947306|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56947307|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947308|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947309|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56947310|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
56947311|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
56947312|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56947313|NCT05215834|Narcotics|narcotics|mesh-ancestor
56947314|NCT05215834|Analgesics|analgesics|mesh-ancestor
56947315|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
56947316|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947317|NCT03394144|Durvalumab|durvalumab|mesh-list
56947318|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947319|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947320|NCT05011149|Ibuprofen|ibuprofen|mesh-list
56947321|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56947322|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947323|NCT05011149|Analgesics|analgesics|mesh-ancestor
56947324|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
56947325|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947326|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947327|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947328|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947329|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56947330|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947331|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947332|NCT03393988|Fentanyl|fentanyl|mesh-list
56947333|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
56947334|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
56947335|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56947336|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947337|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947338|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947339|NCT03393988|Analgesics|analgesics|mesh-ancestor
56947340|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
56947341|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947342|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56947343|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56947344|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56947345|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
56947346|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947347|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947348|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56947349|NCT03393988|Narcotics|narcotics|mesh-ancestor
56947350|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56947351|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56947352|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
56947353|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
56947354|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
56947355|NCT03410212|Ketorolac|ketorolac|mesh-list
56947356|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56947357|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56947358|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947359|NCT03410212|Analgesics|analgesics|mesh-ancestor
56947360|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
56947361|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947362|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947363|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947364|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56543103|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56947365|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56947366|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947367|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947368|NCT03397264|Aflibercept|aflibercept|mesh-list
56947369|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56947370|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56947371|NCT03397264|Growth Substances|growth substances|mesh-ancestor
56947372|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947373|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
56947374|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947375|NCT03397186|Trabectedin|trabectedin|mesh-list
56947376|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56947377|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
56947378|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947379|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947380|NCT03393364|Ketorolac|ketorolac|mesh-list
56947381|NCT03393364|Oxycodone|oxycodone|mesh-list
56947382|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56947383|NCT03393364|Narcotics|narcotics|mesh-ancestor
56947384|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947385|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947386|NCT03393364|Analgesics|analgesics|mesh-ancestor
56947387|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
56947388|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947389|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56947390|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947391|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947392|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947393|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56947394|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947395|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947396|NCT04632706|Ivermectin|ivermectin|mesh-list
56947397|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56947398|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947399|NCT03405454|Durvalumab|durvalumab|mesh-list
56947400|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947401|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947402|NCT05168176|Dolutegravir|dolutegravir|mesh-list
56947403|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56947404|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56947405|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947406|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947407|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56947408|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56947409|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
56947410|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947411|NCT04539730|Bupivacaine|bupivacaine|mesh-list
56947412|NCT04539730|Ropivacaine|ropivacaine|mesh-list
56947413|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
56947414|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
56947415|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947416|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947417|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
56947418|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947419|NCT03396484|Methyldopa|methyldopa|mesh-list
56947420|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56947421|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
56947422|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
56947423|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947424|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947425|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56947426|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56947427|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56947428|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
56947429|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947430|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947431|NCT02388906|Nivolumab|nivolumab|mesh-list
56947432|NCT02388906|Ipilimumab|ipilimumab|mesh-list
56947433|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947434|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947435|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56947436|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947437|NCT03321396|Calcium|calcium|mesh-list
56947438|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56947439|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947440|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
56947441|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
56947442|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56947443|NCT03321006|Citalopram|citalopram|mesh-list
56947444|NCT03321006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56947445|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56947446|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56947447|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947448|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947449|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
56947450|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947451|NCT03321006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56947452|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
56947453|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56947454|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947455|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56947456|NCT03321006|Analgesics|analgesics|mesh-ancestor
56947457|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
56947458|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
56947459|NCT04760626|Insulin|insulin|mesh-list
56947460|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56947461|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
56947462|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56947463|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947464|NCT01974609|Acetaminophen|acetaminophen|mesh-list
56947465|NCT01974609|Ibuprofen|ibuprofen|mesh-list
56947466|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56947467|NCT01974609|Hydrocodone|hydrocodone|mesh-list
56947468|NCT01974609|Narcotics|narcotics|mesh-list
56947469|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947470|NCT01974609|Analgesics|analgesics|mesh-ancestor
56947471|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
56947472|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947473|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947474|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
56947475|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56947476|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947477|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947478|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56947479|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947480|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947481|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56947482|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947483|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
56947484|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
56947485|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
56947486|NCT02593123|Molgramostim|molgramostim|mesh-list
56947487|NCT02593123|Lenograstim|lenograstim|mesh-list
56947488|NCT02593123|Sargramostim|sargramostim|mesh-list
56947489|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56947490|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
56947491|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947492|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56947493|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947494|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56947495|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
56947496|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56947497|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947498|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868362|NCT03740568|Hormones|hormones|mesh-ancestor
56947499|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947500|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
56947501|NCT03396250|Promethazine|promethazine|mesh-list
56947502|NCT03396250|Naproxen|naproxen|mesh-list
56947503|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56947504|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947505|NCT03396250|Analgesics|analgesics|mesh-ancestor
56947506|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
56947507|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947508|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947509|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947510|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947511|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
56947512|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56947513|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947514|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947515|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56947516|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56947517|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947518|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
56947519|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
56947520|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
56947521|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
56947522|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56947523|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56947524|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
56947525|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
56947526|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947527|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56947528|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
56947529|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56947530|NCT03302559|Vitamin A|vitamin a|mesh-list
56947531|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
56947532|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
56947533|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56947534|NCT03302559|Protective Agents|protective agents|mesh-ancestor
56947535|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947536|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
56947537|NCT03302559|Vitamins|vitamins|mesh-ancestor
56947538|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
56947539|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
56947540|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947541|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56947542|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947543|NCT03763669|Folic Acid|folic acid|mesh-list
56947544|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
56947545|NCT03763669|Inositol|inositol|mesh-list
56947546|NCT03763669|Hematinics|hematinics|mesh-ancestor
56947547|NCT03763669|Vitamins|vitamins|mesh-ancestor
56947548|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
56947549|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947550|NCT03302247|Gemcitabine|gemcitabine|mesh-list
56947551|NCT03302247|Nivolumab|nivolumab|mesh-list
56947552|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56947553|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
56947554|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947555|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947556|NCT03302247|Antiviral Agents|antiviral agents|mesh-ancestor
56947557|NCT03302247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947558|NCT03302247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947559|NCT03302247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56947560|NCT03302247|Immunologic Factors|immunologic factors|mesh-ancestor
56947561|NCT03302247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947562|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947563|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56947564|NCT01758081|Vitamin D|vitamin d|mesh-list
56947565|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
56947566|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
56947567|NCT01758081|Vitamins|vitamins|mesh-list
56947568|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
56947569|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947570|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56947571|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56947572|NCT04363840|Aspirin|aspirin|mesh-list
56947573|NCT04363840|Vitamin D|vitamin d|mesh-list
56947574|NCT04363840|Vitamins|vitamins|mesh-ancestor
56947575|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
56947576|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947577|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56947578|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56947579|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947580|NCT04363840|Analgesics|analgesics|mesh-ancestor
56947581|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
56947582|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947583|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947584|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947585|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56947586|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56947587|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947588|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56947589|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56947590|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947591|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
56947596|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947597|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56947598|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56947599|NCT03392740|Protective Agents|protective agents|mesh-ancestor
56947600|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947602|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947603|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
56947604|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
56947605|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947606|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947607|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56947608|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
56947609|NCT04919317|Hormones|hormones|mesh-ancestor
56947610|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56947611|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56947612|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947613|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
56947614|NCT02818023|Vemurafenib|vemurafenib|mesh-list
56947615|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947616|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947617|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56947618|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947619|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947620|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56947621|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56947622|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947623|NCT04631536|Folic Acid|folic acid|mesh-list
56947624|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
56947625|NCT04631536|Nicorandil|nicorandil|mesh-list
56947626|NCT04631536|Nebivolol|nebivolol|mesh-list
56947627|NCT04631536|Atorvastatin|atorvastatin|mesh-list
56947628|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56947629|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56947630|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
56947631|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947632|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56947633|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56947634|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947635|NCT04631536|Hematinics|hematinics|mesh-ancestor
56947636|NCT04631536|Vitamins|vitamins|mesh-ancestor
56947637|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
56947638|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947639|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56947640|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
56947641|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56947642|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56947643|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56947644|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
56947645|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947646|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56947647|NCT03262233|Nicotine|nicotine|mesh-list
56947648|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56947649|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
56947650|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947651|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947652|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56947653|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56947654|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
56947655|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947656|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947662|NCT05166538|Clopidogrel|clopidogrel|mesh-list
56947663|NCT05166538|Ticagrelor|ticagrelor|mesh-list
56947664|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56947665|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56947666|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56947667|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56947668|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
56947669|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947670|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947671|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947672|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56947673|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56947674|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947675|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56947676|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56947677|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56947678|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947679|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
56947680|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947681|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
56947682|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56947683|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56947684|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56947685|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56947686|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947687|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
56947688|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947689|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947690|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56947691|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947692|NCT04447378|PENTA|penta|mesh-list
56947693|NCT04447378|Fondaparinux|fondaparinux|mesh-list
56947694|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56947695|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
56947696|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56947697|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
56947698|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947699|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947700|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
56947701|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56947702|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56947703|NCT04150887|Azacitidine|azacitidine|mesh-list
56947704|NCT04150887|Venetoclax|venetoclax|mesh-list
56947705|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56947706|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
56947707|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947708|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947709|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947710|NCT03125980|Capecitabine|capecitabine|mesh-list
56947711|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
56947712|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56947713|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
56947714|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947715|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947716|NCT03399604|Treprostinil|treprostinil|mesh-list
56947717|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56947718|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
56947719|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56947720|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
56947721|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947722|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
56947723|NCT04697823|Protective Agents|protective agents|mesh-ancestor
56947724|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56947725|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947726|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56947727|NCT03399526|Calcitriol|calcitriol|mesh-list
56947728|NCT03399526|Betamethasone|betamethasone|mesh-list
56947729|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
56947730|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56947731|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
56947732|NCT03399526|Clobetasol|clobetasol|mesh-list
56947733|NCT03399526|Prednicarbate|prednicarbate|mesh-list
56947734|NCT03399526|Calcipotriene|calcipotriene|mesh-list
56052720|NCT05747768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56868587|NCT03924492|Brexanolone|brexanolone|mesh-list
56947735|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56947736|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543400|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56947737|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
56947738|NCT03399526|Hormones|hormones|mesh-ancestor
56947739|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56947740|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947741|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56947742|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
56947743|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
56947744|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56947745|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56947746|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56947747|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947748|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56947750|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
56947751|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56947752|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56947753|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
56947754|NCT03392272|Coagulants|coagulants|mesh-ancestor
56947755|NCT03905902|Vaccines|vaccines|mesh-list
56947756|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
56947757|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947758|NCT03638310|Gentamicins|gentamicins|mesh-list
56947759|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56947760|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947761|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56947762|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947763|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947764|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
56947765|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
56947766|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947767|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
56947768|NCT03399448|Fludarabine|fludarabine|mesh-list
56947769|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56947770|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
56947771|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947772|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947773|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56947774|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
56947775|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947776|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947777|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56947778|NCT03755947|Venetoclax|venetoclax|mesh-list
56947779|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
56947780|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947781|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947782|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56947783|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56947784|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56947785|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
56947786|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947787|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56947788|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56947789|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947790|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
56947791|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
56947792|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947793|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947794|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947795|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
56947796|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
56947797|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
56947798|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56947799|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
56947800|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56947801|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56947802|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947803|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56947804|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947805|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56947806|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947807|NCT01610700|Nabiximols|nabiximols|mesh-list
56947808|NCT01610700|Analgesics|analgesics|mesh-ancestor
56947809|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
56947810|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947811|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947812|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
56947813|NCT04632459|Ramucirumab|ramucirumab|mesh-list
56947814|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947815|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543474|NCT02691871|Docetaxel|docetaxel|mesh-list
56947824|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947825|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947827|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
56947828|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
56947829|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56947830|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56947831|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56947832|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56947833|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
56947834|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947835|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947836|NCT04623684|Phenylephrine|phenylephrine|mesh-list
56947837|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
56947838|NCT04623684|Tropicamide|tropicamide|mesh-list
56947839|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56947840|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
56947841|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
56947842|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947843|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947844|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
56947845|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56947846|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
56947847|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
56947848|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56947849|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56947850|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56947851|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
56947852|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947853|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947854|NCT04623684|Protective Agents|protective agents|mesh-ancestor
56947855|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56947856|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56947857|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
56947858|NCT03297021|Ondansetron|ondansetron|mesh-list
56947859|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
56947860|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
56947861|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947862|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947863|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56947864|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
56947865|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
56947866|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56947867|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
56947868|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947869|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947870|NCT03297021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56947871|NCT03297021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56947872|NCT03297021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56947873|NCT03297021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56947874|NCT03297021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56947883|NCT03752749|Prednisolone|prednisolone|mesh-list
56947884|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947885|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
56947886|NCT03752749|Hormones|hormones|mesh-ancestor
56947887|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56947888|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947889|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56947890|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947894|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56947895|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56947897|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947898|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56947899|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56947900|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947901|NCT00536172|Citalopram|citalopram|mesh-list
56947902|NCT00536172|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56868735|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
56947903|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56947904|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56947905|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947906|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947907|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
56947908|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947909|NCT00536172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56947910|NCT00536172|Antidepressive Agents|antidepressive agents|mesh-ancestor
56947911|NCT00536172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56947912|NCT03755557|Budesonide|budesonide|mesh-list
56947913|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947914|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56947915|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
56947916|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947917|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947918|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56947919|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
56947920|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
56947921|NCT03755557|Hormones|hormones|mesh-ancestor
56947922|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56947923|NCT03511599|Cycloserine|cycloserine|mesh-list
56947924|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56947925|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56947926|NCT03511599|Renal Agents|renal agents|mesh-ancestor
56947927|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56947928|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
56947929|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56947930|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
56947931|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947932|NCT01140867|Zonisamide|zonisamide|mesh-list
56947933|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
56947934|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56947935|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56947936|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947937|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56947938|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947939|NCT04572997|Apremilast|apremilast|mesh-list
56947940|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56947941|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947942|NCT04572997|Analgesics|analgesics|mesh-ancestor
56947943|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
56947944|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947945|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947946|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947947|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947948|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56947949|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56947950|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947951|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947952|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56947953|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56947954|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947955|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56947956|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947957|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56947958|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
56947959|NCT02891070|Coagulants|coagulants|mesh-ancestor
56947960|NCT00381381|Donepezil|donepezil|mesh-list
56947961|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56947962|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947963|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947964|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
56947965|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56947966|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947967|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
56947968|NCT03637335|Carboplatin|carboplatin|mesh-list
56947969|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947970|NCT02939937|Phenytoin|phenytoin|mesh-list
56947971|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
56052721|NCT05747768|Antimetabolites|antimetabolites|mesh-ancestor
56868813|NCT01131546|Amlodipine|amlodipine|mesh-list
56947972|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56947973|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56947974|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56947975|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947976|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56947977|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56947978|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56947979|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56947980|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56947981|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56947982|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
56947983|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947984|NCT02774265|Aspirin|aspirin|mesh-list
56947985|NCT02774265|Heparin|heparin|mesh-list
56947986|NCT02774265|Enoxaparin|enoxaparin|mesh-list
56947987|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56947988|NCT02774265|Tinzaparin|tinzaparin|mesh-list
56947989|NCT02774265|Dalteparin|dalteparin|mesh-list
56947990|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56947991|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56947992|NCT02774265|Analgesics|analgesics|mesh-ancestor
56947993|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
56947994|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56947995|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56947996|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56947997|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56947998|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56947999|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56948000|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948001|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56948002|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56948003|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948004|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
56948005|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
56948006|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56948007|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56948008|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56948009|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948010|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948011|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56948012|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56948013|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948014|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
56948015|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948016|NCT03755479|Insulin|insulin|mesh-list
56948017|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56948018|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948019|NCT05239390|Dronabinol|dronabinol|mesh-list
56948020|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
56948021|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948022|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56948023|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56948024|NCT05239390|Analgesics|analgesics|mesh-ancestor
56948025|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
56948026|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948027|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56948028|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56948029|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948030|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948031|NCT05239390|Hormones|hormones|mesh-ancestor
56948032|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948033|NCT03752437|Heparin|heparin|mesh-list
56948034|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
56948035|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56948036|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56948037|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948038|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
56948039|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56948040|NCT04748341|Benzocaine|benzocaine|mesh-list
56948041|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
56948042|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
56948043|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948044|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948045|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
56948046|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948047|NCT01328002|Milnacipran|milnacipran|mesh-list
56948048|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
56948049|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56948050|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56948051|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56948052|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948053|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948054|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948055|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56948056|NCT01328002|Analgesics|analgesics|mesh-ancestor
56948057|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
56948058|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948059|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
56948060|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56948061|NCT05239078|Anesthetics|anesthetics|mesh-list
56948062|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
56948063|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948064|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948065|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
56948066|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948067|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56948068|NCT02579265|SMOFlipid|smoflipid|mesh-list
56948069|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
56948070|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56948071|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56948072|NCT05238220|Valganciclovir|valganciclovir|mesh-list
56948073|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
56948074|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948075|NCT04446598|Tadalafil|tadalafil|mesh-list
56948076|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
56948077|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56948078|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56948079|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948080|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948081|NCT04446598|Urological Agents|urological agents|mesh-ancestor
56948082|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
56948083|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56948084|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948085|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948086|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56948087|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56948088|NCT03391570|Analgesics|analgesics|mesh-ancestor
56948089|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
56948090|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948091|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948092|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56948093|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56948094|NCT03755089|Lidocaine|lidocaine|mesh-list
56948095|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
56948096|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
56948097|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948098|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948099|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
56948100|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948101|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56948102|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56948103|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56948104|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56948105|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948106|NCT03757117|Hormones|hormones|mesh-list
56948107|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948108|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948109|NCT03752125|Caffeine|caffeine|mesh-list
56948110|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56948111|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948112|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56948113|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948114|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734530|NCT04923659|Lorazepam|lorazepam|mesh-list
56948115|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56948116|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56948117|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
56948118|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948119|NCT03289533|Avelumab|avelumab|mesh-list
56948120|NCT03289533|Axitinib|axitinib|mesh-list
56948121|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56948122|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948123|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56948124|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948125|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948126|NCT03395002|Fluticasone|fluticasone|mesh-list
56948127|NCT03395002|Xhance|xhance|mesh-list
56948128|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
56948129|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56948130|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56948131|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56948132|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
56948133|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948134|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948135|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56948136|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
56948137|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
56948138|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56948139|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
56948140|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56948141|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
56948142|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948143|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948144|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56948145|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56948146|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56948147|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
56948148|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
56948149|NCT05238064|Doxorubicin|doxorubicin|mesh-list
56948150|NCT05238064|Vincristine|vincristine|mesh-list
56948151|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56948152|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
56948153|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948154|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56948155|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56948156|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
56948157|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948158|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948159|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56948160|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56948161|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56948162|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56948163|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948164|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56948165|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
56948166|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
56948167|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
56948168|NCT03390790|Lidocaine|lidocaine|mesh-list
56948169|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
56948170|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
56948171|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948172|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948173|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
56948174|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948175|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56948176|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56948177|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56948178|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56948179|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948180|NCT03697993|Levofloxacin|levofloxacin|mesh-list
56948181|NCT03697993|Ofloxacin|ofloxacin|mesh-list
56948182|NCT03697993|Fosfomycin|fosfomycin|mesh-list
56948183|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56948184|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948186|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56948187|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56948188|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56948189|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948190|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948191|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948192|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56948193|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56948194|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
56948195|NCT05393245|Olodaterol|olodaterol|mesh-list
56948196|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
56948197|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56948198|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56948199|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
56948200|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948201|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948202|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56948203|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
56948204|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
56948205|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56948206|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948207|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948208|NCT04544995|Niraparib|niraparib|mesh-list
56948209|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56948210|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948211|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948212|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948213|NCT03390712|Risperidone|risperidone|mesh-list
56948214|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56948215|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
56948216|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56948217|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
56948218|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948219|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948220|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948221|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56948222|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948223|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56948224|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56948225|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
56948226|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56948227|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56948228|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
56948229|NCT03756727|Vitamins|vitamins|mesh-ancestor
56948230|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
56948231|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948232|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
56948233|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948234|NCT03756727|Protective Agents|protective agents|mesh-ancestor
56948235|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56948236|NCT03398434|Apixaban|apixaban|mesh-list
56948237|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56948238|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
56948239|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56948240|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
56948241|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948242|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948243|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
56948244|NCT03398122|Apatinib|apatinib|mesh-list
56948245|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948246|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56948247|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948248|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948249|NCT05459857|Menthol|menthol|mesh-list
56948250|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
56948251|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
56948252|NCT03394222|Budesonide|budesonide|mesh-list
56948253|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56948254|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56948255|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
56543924|NCT00618241|Lamotrigine|lamotrigine|mesh-list
56948256|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948257|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948258|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56948259|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
56948260|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
56948261|NCT03394222|Hormones|hormones|mesh-ancestor
56948262|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948263|NCT03398044|Dexamethasone|dexamethasone|mesh-list
56948264|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56948265|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
56948266|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
56948267|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948268|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948269|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56948270|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
56948271|NCT03398044|Hormones|hormones|mesh-ancestor
56948272|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948273|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56948274|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948275|NCT03389776|Anesthetics|anesthetics|mesh-list
56948276|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948277|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948278|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
56948279|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56948280|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56948281|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
56948282|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948283|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948284|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56948285|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
56948286|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
56948287|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56948288|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
56948289|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948290|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948291|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
56948292|NCT02813200|Hormones|hormones|mesh-ancestor
56948293|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948294|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
56948295|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56948296|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56948297|NCT03750721|Rifampin|rifampin|mesh-list
56948298|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56948299|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
56948300|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56948301|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948302|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
56948303|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56948304|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948305|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948306|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56948307|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56948308|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56948309|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56948310|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56948311|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56948312|NCT01481272|Leucovorin|leucovorin|mesh-list
56948313|NCT01481272|Cytarabine|cytarabine|mesh-list
56948314|NCT01481272|Methotrexate|methotrexate|mesh-list
56948315|NCT01481272|Etoposide|etoposide|mesh-list
56948316|NCT01481272|Ofatumumab|ofatumumab|mesh-list
56948317|NCT01481272|Lenograstim|lenograstim|mesh-list
56948318|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56948319|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
56948320|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56948321|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948322|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56948323|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
56948324|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948325|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948326|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
56948327|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948328|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56948329|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56948330|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
56948331|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56948332|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56948333|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56948334|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56948335|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56948336|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
56948337|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948339|NCT01481272|Protective Agents|protective agents|mesh-ancestor
56948340|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
56869184|NCT01135056|Sorafenib|sorafenib|mesh-list
56948341|NCT01481272|Vitamins|vitamins|mesh-ancestor
56948342|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
56948343|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56948344|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
56948345|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56948346|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948347|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
56948348|NCT02687386|Analgesics|analgesics|mesh-ancestor
56948349|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
56948350|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948351|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948352|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948353|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56948354|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56948355|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948356|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948357|NCT04531813|Butenafine|butenafine|mesh-list
56948358|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
56948359|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948360|NCT01380028|Prednisone|prednisone|mesh-list
56948361|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56948362|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
56948363|NCT01380028|Hormones|hormones|mesh-ancestor
56948364|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948365|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948366|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56948367|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948368|NCT01305460|Azacitidine|azacitidine|mesh-list
56948369|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56948370|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
56948371|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948372|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948373|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948374|NCT04943341|Triamcinolone|triamcinolone|mesh-list
56948375|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56948376|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56948377|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56948378|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56948379|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
56948380|NCT04943341|Hormones|hormones|mesh-ancestor
56948381|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948382|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948383|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56948384|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
56948385|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948386|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948387|NCT03754543|Iron|iron|mesh-list
56948388|NCT03754543|Trace Elements|trace elements|mesh-ancestor
56948389|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
56948390|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948391|NCT01199302|Brodalumab|brodalumab|mesh-list
56948392|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
56948393|NCT03754387|Ceftazidime|ceftazidime|mesh-list
56948394|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56948395|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948396|NCT04918147|Acetaminophen|acetaminophen|mesh-list
56948397|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
56948398|NCT04918147|Promethazine|promethazine|mesh-list
56948399|NCT04918147|Prednisone|prednisone|mesh-list
56948400|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
56948401|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56948402|NCT04918147|Elotuzumab|elotuzumab|mesh-list
56948403|NCT04918147|Famotidine|famotidine|mesh-list
56948404|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56948405|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
56948406|NCT04918147|Hormones|hormones|mesh-ancestor
56948407|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948408|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948409|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56948410|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948411|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56948412|NCT04918147|Analgesics|analgesics|mesh-ancestor
56948413|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
56948414|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948415|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
56948416|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
56869261|NCT05401032|Tamsulosin|tamsulosin|mesh-list
56948417|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
56948418|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56948419|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56948420|NCT04918147|Protective Agents|protective agents|mesh-ancestor
56948421|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56948422|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56948423|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948424|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
56948425|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
56948426|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56948427|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
56948428|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
56948429|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948430|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948431|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56948432|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
56948433|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
56948434|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56948435|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56948436|NCT03171480|Isosorbide|isosorbide|mesh-list
56948437|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56948438|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56948439|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56948440|NCT03171480|Diuretics|diuretics|mesh-ancestor
56948441|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
56948442|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948443|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
56948444|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56948445|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948446|NCT04465357|Erenumab|erenumab|mesh-list
56948447|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56948448|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948449|NCT04465357|Analgesics|analgesics|mesh-ancestor
56948450|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
56948451|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948452|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948453|NCT02761694|Paclitaxel|paclitaxel|mesh-list
56948454|NCT02761694|Fulvestrant|fulvestrant|mesh-list
56948455|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56948456|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948457|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
56948458|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
56948459|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
56948460|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948461|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56948462|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56948463|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56948464|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
56948465|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948466|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948467|NCT05396690|Sevoflurane|sevoflurane|mesh-list
56948468|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56948469|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56948470|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
56948471|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
56948472|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948473|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948474|NCT01384058|Simvastatin|simvastatin|mesh-list
56948475|NCT01384058|Ezetimibe|ezetimibe|mesh-list
56948476|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56948477|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56948478|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
56948479|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948480|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56948481|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56948482|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948483|NCT04401384|Pyridoxine|pyridoxine|mesh-list
56948484|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
56948485|NCT04401384|Doxylamine|doxylamine|mesh-list
56948486|NCT04401384|Dicyclomine|dicyclomine|mesh-list
56948487|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
56948488|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
56948489|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948490|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948491|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56948492|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56948493|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
56948494|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
56948495|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948496|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948497|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
56948498|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56948499|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56948500|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
56948501|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
56948502|NCT04401384|Vitamins|vitamins|mesh-ancestor
56948503|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
56948504|NCT03312114|Avelumab|avelumab|mesh-list
56948505|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56948506|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948507|NCT04239222|Ibuprofen|ibuprofen|mesh-list
56948508|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56948509|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56948510|NCT04239222|Analgesics|analgesics|mesh-ancestor
56948511|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
56948512|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948513|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948514|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56948515|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56948516|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56948517|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948518|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948519|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
56948520|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
56948521|NCT02566304|Fludarabine|fludarabine|mesh-list
56948522|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
56948523|NCT02566304|Tacrolimus|tacrolimus|mesh-list
56948524|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56948525|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
56948526|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948527|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56948528|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56948529|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
56948530|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948531|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948532|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56948533|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56948534|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
56948535|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948536|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56948537|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948538|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56948539|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56948540|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
56948541|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56948542|NCT04732260|Letermovir|letermovir|mesh-list
56948543|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56948544|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948545|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948546|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948547|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
56948548|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948549|NCT04407247|Infliximab|infliximab|mesh-list
56948550|NCT04407247|Vedolizumab|vedolizumab|mesh-list
56948551|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
56948552|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
56948553|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
56948554|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948555|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
56948556|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56948557|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56948558|NCT03084536|Acetaminophen|acetaminophen|mesh-list
56948559|NCT03084536|Celecoxib|celecoxib|mesh-list
56948560|NCT03084536|Fentanyl|fentanyl|mesh-list
56948561|NCT03084536|Midazolam|midazolam|mesh-list
56948562|NCT03084536|Gabapentin|gabapentin|mesh-list
56948563|NCT03084536|Bupivacaine|bupivacaine|mesh-list
56948564|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
56948565|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
56948566|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734531|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
56948567|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948568|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
56948569|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948570|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56948571|NCT03084536|Narcotics|narcotics|mesh-ancestor
56948572|NCT03084536|Analgesics|analgesics|mesh-ancestor
56948573|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56948574|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56948575|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
56948576|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56948577|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56948578|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56948579|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56948580|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
56948581|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
56948582|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948583|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948584|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56948585|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
56948586|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56948587|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56948588|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56948589|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56948590|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56948591|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948592|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
56948593|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56948594|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56948595|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
56948596|NCT03311724|Tirzepatide|tirzepatide|mesh-list
56948597|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56948598|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948599|NCT03311724|Incretins|incretins|mesh-ancestor
56948600|NCT03311724|Hormones|hormones|mesh-ancestor
56948601|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56948602|NCT05213312|Paclitaxel|paclitaxel|mesh-list
56948603|NCT05213312|Fluorouracil|fluorouracil|mesh-list
56948604|NCT05213312|Nivolumab|nivolumab|mesh-list
56948605|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56948606|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948607|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
56948608|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
56948609|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
56948610|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948611|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
56948612|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56948613|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56948614|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
56948615|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948616|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56948617|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56948618|NCT04080804|Nivolumab|nivolumab|mesh-list
56948619|NCT04080804|Ipilimumab|ipilimumab|mesh-list
56948620|NCT04080804|Antibodies|antibodies|mesh-list
56948621|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
56948622|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
56948623|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948624|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56948625|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948626|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56948627|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948628|NCT03311646|Nicotine|nicotine|mesh-list
56948629|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56948630|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
56948631|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948632|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948633|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56948634|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56948635|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
56948636|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948637|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948638|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
56948640|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
56948641|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948642|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
56948643|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948644|NCT03680274|Protective Agents|protective agents|mesh-ancestor
56948645|NCT03288987|Leucovorin|leucovorin|mesh-list
56948646|NCT03288987|Bevacizumab|bevacizumab|mesh-list
56948647|NCT03288987|Fluorouracil|fluorouracil|mesh-list
56948648|NCT03288987|Irinotecan|irinotecan|mesh-list
56948649|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56948650|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948651|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56948652|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56948653|NCT03288987|Growth Substances|growth substances|mesh-ancestor
56948654|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948655|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
56948656|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
56948657|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948658|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56948659|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56948660|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
56948661|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56948662|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56948663|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948664|NCT03288987|Antidotes|antidotes|mesh-ancestor
56948665|NCT03288987|Protective Agents|protective agents|mesh-ancestor
56948666|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
56948667|NCT03288987|Vitamins|vitamins|mesh-ancestor
56948668|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
56948669|NCT01379846|Vaccines|vaccines|mesh-list
56948670|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
56948671|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948672|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
56948673|NCT01379300|Dabigatran|dabigatran|mesh-list
56948674|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56948675|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
56948676|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56948677|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
56948678|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948679|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948680|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
56948681|NCT03682224|Epinephrine|epinephrine|mesh-list
56948682|NCT03682224|Bupivacaine|bupivacaine|mesh-list
56948683|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
56948684|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
56948685|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948686|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948687|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
56948688|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948689|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56948690|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56948691|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
56948692|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948693|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948694|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56948695|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56948696|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
56948697|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56948698|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
56948699|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
56948700|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
56948701|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56948702|NCT01383044|Carvedilol|carvedilol|mesh-list
56948703|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56948704|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56948705|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
56948706|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948707|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948708|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948709|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56948710|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
56948711|NCT01383044|Protective Agents|protective agents|mesh-ancestor
56948712|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56948713|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56948714|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56948715|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
56948716|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56948717|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56948718|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
56948719|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56948720|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
56948721|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948722|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948723|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56948724|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
56948725|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56948726|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56948727|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56948728|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
56948729|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948730|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948731|NCT03083990|Bevacizumab|bevacizumab|mesh-list
56948732|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56948733|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948734|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56948735|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56948736|NCT03083990|Growth Substances|growth substances|mesh-ancestor
56948737|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948738|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
56948739|NCT03252015|Lasmiditan|lasmiditan|mesh-list
56948740|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56948741|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
56948742|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948743|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948744|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948745|NCT01314027|Gemcitabine|gemcitabine|mesh-list
56948746|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
56948747|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56948748|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
56948749|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948750|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948751|NCT01314027|Antiviral Agents|antiviral agents|mesh-ancestor
56948752|NCT01314027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948753|NCT01314027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948754|NCT01314027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56948755|NCT01314027|Immunologic Factors|immunologic factors|mesh-ancestor
56948756|NCT01314027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948757|NCT03708003|Venetoclax|venetoclax|mesh-list
56948758|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948759|NCT03083132|Modafinil|modafinil|mesh-list
56948760|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56948761|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948762|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56948763|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56948764|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56948765|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948766|NCT04121468|Metformin|metformin|mesh-list
56948767|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56948768|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948769|NCT03354728|Vaccines|vaccines|mesh-list
56948770|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
56948771|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948772|NCT03341936|Nivolumab|nivolumab|mesh-list
56948773|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56948774|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948775|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56948776|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948777|NCT03648489|Paclitaxel|paclitaxel|mesh-list
56948778|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56948779|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948780|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56948781|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56948782|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56948783|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948784|NCT01382888|Heparin|heparin|mesh-list
56948785|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
56948786|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56948787|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56292718|NCT00275938|Interferons|interferons|mesh-list
56948788|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948789|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56948791|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56948792|NCT04809116|Pimavanserin|pimavanserin|mesh-list
56948793|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56948794|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56948795|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56948796|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56948797|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948798|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948799|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56948800|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56948801|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56948802|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
56948803|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948804|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948805|NCT02199236|Capecitabine|capecitabine|mesh-list
56948806|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56948807|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
56948808|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948809|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948810|NCT03077438|Vaccines|vaccines|mesh-list
56948811|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
56948812|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948813|NCT01382732|Oxytocin|oxytocin|mesh-list
56948814|NCT01382732|Carbetocin|carbetocin|mesh-list
56948815|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
56948816|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56948817|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948818|NCT02183870|Crizotinib|crizotinib|mesh-list
56948819|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948820|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56948821|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948822|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948823|NCT03076970|Sumatriptan|sumatriptan|mesh-list
56948824|NCT03076970|Lasmiditan|lasmiditan|mesh-list
56948825|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56948826|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56948827|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56948828|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
56948829|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948830|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948831|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948832|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
56948833|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
56948834|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56948835|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56948836|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948837|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948838|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948839|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56948840|NCT04897880|Panobinostat|panobinostat|mesh-list
56948841|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948842|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56948843|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948844|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948845|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
56948846|NCT02890992|Niacin|niacin|mesh-list
56948847|NCT02890992|Niacinamide|niacinamide|mesh-list
56948848|NCT02890992|Ezetimibe|ezetimibe|mesh-list
56948849|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
56948850|NCT02890992|Fenofibrate|fenofibrate|mesh-list
56948851|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56948852|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56948853|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
56948854|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948855|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56948856|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
56948857|NCT02890992|Vitamins|vitamins|mesh-ancestor
56948858|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
56948859|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948860|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
56948861|NCT03603912|Metformin|metformin|mesh-list
56948862|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56948863|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948864|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56948865|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56948866|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56948867|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948868|NCT05274984|Lidocaine|lidocaine|mesh-list
56948869|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
56948870|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
55734532|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
56948871|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948872|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948873|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
56948874|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948875|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56948876|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56948877|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56948878|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56948879|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948880|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
56948881|NCT05274672|Cephalexin|cephalexin|mesh-list
56948882|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56948883|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
56948884|NCT05274672|Trimethoprim|trimethoprim|mesh-list
56948885|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
56948886|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56948887|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56948888|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56948889|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56948890|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948891|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948892|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948893|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56948894|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56948895|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56948896|NCT05274672|Renal Agents|renal agents|mesh-ancestor
56948897|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
56948898|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56948899|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56948900|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56948901|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56948902|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56948903|NCT01379144|Latanoprost|latanoprost|mesh-list
56948904|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56948905|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56948906|NCT04179890|Afatinib|afatinib|mesh-list
56948907|NCT04179890|Mitogens|mitogens|mesh-list
56948908|NCT04179890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56948909|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948910|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56948911|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56948912|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948913|NCT01376882|Caffeine|caffeine|mesh-list
56948914|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56948915|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948916|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56948917|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948918|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948919|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56948920|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56948921|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
56948922|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948923|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
56948924|NCT03329196|Hematinics|hematinics|mesh-ancestor
56948925|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
56948926|NCT01382498|Calcium|calcium|mesh-list
56948927|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56948928|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948929|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
56948930|NCT01382498|Coagulants|coagulants|mesh-ancestor
56948931|NCT05322902|Propofol|propofol|mesh-list
56948932|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56948933|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948934|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948935|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56948936|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
56948937|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
56948938|NCT03476538|Gabapentin|gabapentin|mesh-list
56948939|NCT03476538|Analgesics|analgesics|mesh-ancestor
56948940|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
56948941|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948942|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948943|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
56948944|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56948945|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56948946|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56948947|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56948948|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56948949|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56948950|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948951|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948952|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
56948953|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
56948954|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56948955|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56948956|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56948957|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56948958|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948959|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
56948960|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948961|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948962|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56948963|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948964|NCT04592744|Vasopressins|vasopressins|mesh-list
56948965|NCT04592744|Epinephrine|epinephrine|mesh-list
56948966|NCT04592744|Norepinephrine|norepinephrine|mesh-list
56948967|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
56948968|NCT04592744|Giapreza|giapreza|mesh-list
56948969|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
56948970|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56948971|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56948972|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
56948973|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56948974|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56948975|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948976|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56948977|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56948978|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
56948979|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56948980|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56948981|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
56948982|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
56948983|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
56948984|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56948985|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
56948986|NCT04592744|Coagulants|coagulants|mesh-ancestor
56948987|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56948988|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
56948989|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56948990|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
56948991|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56948992|NCT00000116|Vitamin A|vitamin a|mesh-list
56948993|NCT00000116|Vitamins|vitamins|mesh-ancestor
56948994|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
56948995|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56948996|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56948997|NCT05232396|Antibodies|antibodies|mesh-list
56948998|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
56948999|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56949000|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
56949001|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949002|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949003|NCT05222724|Ibuprofen|ibuprofen|mesh-list
56949004|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56949005|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56949006|NCT05222724|Analgesics|analgesics|mesh-ancestor
56949007|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
56949008|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949009|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949010|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949011|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949012|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56949013|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949014|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949015|NCT01382342|Rasagiline|rasagiline|mesh-list
56949016|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56949017|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949018|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949019|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56949020|NCT01382342|Protective Agents|protective agents|mesh-ancestor
56949021|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949022|NCT03471728|Linaclotide|linaclotide|mesh-list
56949023|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56949024|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
56949025|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949026|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949027|NCT03630614|Nicotine|nicotine|mesh-list
56949028|NCT03630614|Varenicline|varenicline|mesh-list
56949029|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56949030|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
56949031|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949032|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949033|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56949034|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56949035|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
56949036|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949037|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949038|NCT05463224|Lazertinib|lazertinib|mesh-list
56949039|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56949040|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949041|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949042|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56949043|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949044|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
56949045|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56949046|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949047|NCT01378754|Fospropofol|fospropofol|mesh-list
56949048|NCT01378754|Propofol|propofol|mesh-list
56949049|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56949050|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949051|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949052|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56949053|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
56949054|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
56949055|NCT05764304|Sinomenine|sinomenine|mesh-list
56949056|NCT05764304|Glucocorticoids|glucocorticoids|mesh-list
56949057|NCT05764304|Hormones|hormones|mesh-ancestor
56949058|NCT05764304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949059|NCT05764304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949060|NCT05764304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949061|NCT03075410|GSK656|gsk656|mesh-list
56949062|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56949063|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949064|NCT05764226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56949065|NCT02826512|Niraparib|niraparib|mesh-list
56949066|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56949067|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949068|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949069|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949070|NCT05391230|Permethrin|permethrin|mesh-list
56949071|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949072|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949073|NCT02731352|Apatinib|apatinib|mesh-list
56949074|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949075|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56949076|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949077|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949078|NCT05132660|Levodopa|levodopa|mesh-list
56949079|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56949080|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56949081|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56949082|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
56949083|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949084|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949085|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949086|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56949087|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
56949088|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
56544751|NCT00640003|Baclofen|baclofen|mesh-list
56949090|NCT05762744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56949091|NCT05762744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949092|NCT05762744|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56949093|NCT05762744|Incretins|incretins|mesh-ancestor
56949094|NCT05762744|Hormones|hormones|mesh-ancestor
56949095|NCT05762744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949096|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
56949097|NCT02257424|Trametinib|trametinib|mesh-list
56949098|NCT02257424|Dabrafenib|dabrafenib|mesh-list
56949099|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
56949100|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56949101|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56949102|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949103|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949104|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949105|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949106|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949107|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56949108|NCT01858922|Cytarabine|cytarabine|mesh-list
56949109|NCT01858922|Dexamethasone|dexamethasone|mesh-list
56949110|NCT01858922|Prednisone|prednisone|mesh-list
56949111|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
56949112|NCT01858922|Cisplatin|cisplatin|mesh-list
56949113|NCT01858922|Doxorubicin|doxorubicin|mesh-list
56949114|NCT01858922|Etoposide|etoposide|mesh-list
56949115|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
56949116|NCT01858922|Vincristine|vincristine|mesh-list
56949117|NCT01858922|Bleomycin|bleomycin|mesh-list
56949118|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949119|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
56949120|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949121|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949122|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56949123|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
56949124|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949125|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949126|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56949127|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949128|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
56949129|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
56949130|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949131|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949132|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
56949133|NCT01858922|Hormones|hormones|mesh-ancestor
56949134|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949135|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56949136|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949137|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56949138|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56949139|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56949140|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56949141|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56949142|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
56949143|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
56949144|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949145|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
56949146|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
56949147|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
56949148|NCT01378286|Artesunate|artesunate|mesh-list
56949149|NCT01378286|Chloroquine|chloroquine|mesh-list
56949150|NCT01378286|Amodiaquine|amodiaquine|mesh-list
56949151|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
56949152|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56949153|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56949154|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949155|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949156|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
56949157|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
56949158|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56949159|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
56949160|NCT01378286|Amebicides|amebicides|mesh-ancestor
56949161|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949162|NCT01377974|Miltefosine|miltefosine|mesh-list
56949163|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56544828|NCT04318067|Melatonin|melatonin|mesh-list
56949164|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
56949165|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949166|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949167|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56949168|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56949169|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56949170|NCT04929080|Antibodies|antibodies|mesh-list
56949171|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
56949172|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56949173|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
56949174|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
56949175|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949176|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949177|NCT03071276|Cytarabine|cytarabine|mesh-list
56949178|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
56949179|NCT03071276|Methotrexate|methotrexate|mesh-list
56949180|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
56949181|NCT03071276|Fludarabine|fludarabine|mesh-list
56949182|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56949183|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
56949184|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56949185|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949186|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56949187|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
56949188|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949189|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949190|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
56949191|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949192|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56949193|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949194|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
56949195|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949196|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56949197|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
56949198|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949199|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949200|NCT03629600|Indomethacin|indomethacin|mesh-list
56949201|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56949202|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56949203|NCT03629600|Analgesics|analgesics|mesh-ancestor
56949204|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
56949205|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949206|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949207|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949208|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949209|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
56949210|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
56949211|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56949212|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56949213|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949214|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949215|NCT03074162|Diclofenac|diclofenac|mesh-list
56949216|NCT03074162|Capsaicin|capsaicin|mesh-list
56949217|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56949218|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56949219|NCT03074162|Analgesics|analgesics|mesh-ancestor
56949220|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
56949221|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949222|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949223|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949224|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949225|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56949226|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949227|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949228|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
56949229|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
56949230|NCT05069012|Morphine|morphine|mesh-list
56949231|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56949232|NCT05069012|Narcotics|narcotics|mesh-ancestor
56949233|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949234|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949235|NCT05069012|Analgesics|analgesics|mesh-ancestor
56949236|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
56949237|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949238|NCT04065074|FX006|fx006|mesh-list
56949239|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949240|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
56949241|NCT04065074|Hormones|hormones|mesh-ancestor
56949242|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949243|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949244|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949245|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
56949246|NCT03947216|Pimavanserin|pimavanserin|mesh-list
56949247|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56949248|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56949249|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56949250|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56949251|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949252|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949253|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56949254|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56949255|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56949256|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
56949257|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949258|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949259|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
56949260|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56949261|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949262|NCT02888106|Tenofovir|tenofovir|mesh-list
56949263|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56949264|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
56949265|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
56949266|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949267|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56949268|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56949269|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949270|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949271|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56949272|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56949273|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949274|NCT03793010|FX006|fx006|mesh-list
56949275|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949276|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
56949277|NCT03793010|Hormones|hormones|mesh-ancestor
56949278|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949279|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949280|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949281|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
56949282|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
56949283|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56949284|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
56949285|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56949286|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
56949287|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949288|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949289|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
56949290|NCT03304626|Prednisone|prednisone|mesh-list
56949291|NCT03304626|Budesonide|budesonide|mesh-list
56949292|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949293|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
56949294|NCT03304626|Hormones|hormones|mesh-ancestor
56949295|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949296|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949297|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56949298|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949299|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56949300|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
56949301|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949302|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56949303|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
56949304|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
56949305|NCT05121714|Caffeine|caffeine|mesh-list
56949306|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56949307|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949308|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56949309|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949310|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949311|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56949312|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56949313|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
56949314|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949315|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56949316|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56949317|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949318|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56949319|NCT05121714|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56949320|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56949321|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56949322|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
56949323|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56949324|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
56949325|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56949326|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56949327|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56949328|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
56949329|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56949330|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949331|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949332|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56949333|NCT02958150|Analgesics|analgesics|mesh-ancestor
56949334|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
56949335|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949336|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56949337|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56949338|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56949339|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
56949340|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949341|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949342|NCT04250142|Methamphetamine|methamphetamine|mesh-list
56949343|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56949344|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949345|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
56949346|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
56949347|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949348|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
56949349|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949350|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949351|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
56949352|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56949353|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56949354|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56949355|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56949356|NCT02714322|Adalimumab|adalimumab|mesh-list
56949357|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949358|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949359|NCT03267576|Metformin|metformin|mesh-list
56949360|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56949361|NCT03267576|Canagliflozin|canagliflozin|mesh-list
56949362|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56949363|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949364|NCT03267576|Incretins|incretins|mesh-ancestor
56949365|NCT03267576|Hormones|hormones|mesh-ancestor
56949366|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949367|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56949368|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
56949369|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949370|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949371|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56949372|NCT02472912|Adalimumab|adalimumab|mesh-list
56949373|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949374|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949375|NCT02356458|Bortezomib|bortezomib|mesh-list
56949376|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949377|NCT03243630|Menthol|menthol|mesh-list
56949378|NCT03243630|Nicotine|nicotine|mesh-list
56949379|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56949380|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
56949381|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949382|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949383|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56949384|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56949385|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
56949386|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949387|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949388|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
56949389|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
56949390|NCT05376319|Rituximab|rituximab|mesh-list
56949391|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
56949392|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56949393|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949394|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
56949395|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949396|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949397|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
56949398|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56949399|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949400|NCT03753685|Ensartinib|ensartinib|mesh-list
56949401|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949402|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56949403|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949404|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949405|NCT04573946|Vitamin D|vitamin d|mesh-list
56949406|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
56949407|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
56949408|NCT04573946|Vitamins|vitamins|mesh-list
56949409|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
56949410|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949411|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56949412|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56949413|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56949414|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56949415|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
56949416|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949417|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949418|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56949419|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56949420|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56949421|NCT02787044|Vaccines|vaccines|mesh-list
56949422|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
56949423|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949424|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
56949425|NCT01345019|Denosumab|denosumab|mesh-list
56949426|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56949427|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949428|NCT03629522|Ondansetron|ondansetron|mesh-list
56949429|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
56949430|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
56949431|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949432|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949433|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949434|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
56949435|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
56949436|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56949437|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
56949438|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949439|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949440|NCT03629522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56949441|NCT03629522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56949442|NCT03629522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949443|NCT03629522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56949444|NCT03629522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56949445|NCT03751111|Naloxone|naloxone|mesh-list
56949446|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56949447|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949448|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
56949449|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949450|NCT05167370|Amifostine|amifostine|mesh-list
56949451|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56949452|NCT05167370|Protective Agents|protective agents|mesh-ancestor
56949453|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949454|NCT01265537|Tacrolimus|tacrolimus|mesh-list
56949455|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949456|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
56949457|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949458|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56949459|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949460|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949461|NCT05763836|Ibuprofen|ibuprofen|mesh-list
56949462|NCT05763836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56949463|NCT05763836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56949464|NCT05763836|Analgesics|analgesics|mesh-ancestor
56949465|NCT05763836|Sensory System Agents|sensory system agents|mesh-ancestor
56949466|NCT05763836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949467|NCT05763836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949468|NCT05763836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949469|NCT05763836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949470|NCT05763836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56949471|NCT05763836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949472|NCT05763836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949473|NCT01237535|Progesterone|progesterone|mesh-list
56949474|NCT01237535|Estrogens|estrogens|mesh-list
56949475|NCT01237535|Progestins|progestins|mesh-ancestor
56949476|NCT01237535|Hormones|hormones|mesh-ancestor
56949477|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949478|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949479|NCT04396639|Factor VIII|factor viii|mesh-list
56949480|NCT04396639|Coagulants|coagulants|mesh-ancestor
56949481|NCT01146431|Anesthetics|anesthetics|mesh-list
56949482|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949483|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949484|NCT01250249|Vaccines|vaccines|mesh-list
56949485|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
56949486|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
56949487|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949488|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56949489|NCT03747679|Mannitol|mannitol|mesh-list
56949490|NCT03747679|Sorbitol|sorbitol|mesh-list
56949491|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56949492|NCT03747679|Diuretics|diuretics|mesh-ancestor
56949493|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
56949494|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949495|NCT03747679|Cathartics|cathartics|mesh-ancestor
56949496|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949497|NCT04669457|Midazolam|midazolam|mesh-list
56949498|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
56949499|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56949500|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949501|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949502|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56949503|NCT04669457|Analgesics|analgesics|mesh-ancestor
56949504|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
56949505|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949506|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56949507|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56949508|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56949509|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
56949510|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949511|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949512|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56949513|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56949514|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56949515|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56949516|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56949517|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
56949518|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
56949519|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
56949520|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
56949521|NCT01243385|Metformin|metformin|mesh-list
56949522|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56949523|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949524|NCT01147133|Clopidogrel|clopidogrel|mesh-list
56949525|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56949526|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56949527|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56949528|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56949529|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
56949530|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949531|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949532|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949533|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
56949534|NCT02162420|Fludarabine|fludarabine|mesh-list
56949535|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
56949536|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56949537|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949538|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
56949539|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949540|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949541|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56949542|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
56949543|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949544|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949545|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56949546|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56949547|NCT04167085|Doxycycline|doxycycline|mesh-list
56949548|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56949549|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949550|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
56949551|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56949552|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56949553|NCT01147289|Meloxicam|meloxicam|mesh-list
56870384|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
56949554|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56949555|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56949556|NCT01147289|Analgesics|analgesics|mesh-ancestor
56949557|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
56949558|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949559|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949560|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949561|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949562|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56949563|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56949564|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949565|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949566|NCT01237769|Vitamin D|vitamin d|mesh-list
56949567|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
56949568|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
56949569|NCT01237769|Vitamins|vitamins|mesh-list
56949570|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
56949571|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949572|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56949573|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56949574|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56949575|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
56949576|NCT03914963|Coagulants|coagulants|mesh-ancestor
56949577|NCT04162795|Loratadine|loratadine|mesh-list
56949578|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
56949579|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
56949580|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56949581|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56949582|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56949583|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
56949584|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
56949585|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949586|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949587|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949588|NCT01250951|Deferasirox|deferasirox|mesh-list
56949589|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56949590|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
56949591|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
56949592|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949593|NCT03069482|Nicotine|nicotine|mesh-list
56949594|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56949595|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
56949596|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949597|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949598|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56949599|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56949600|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
56949601|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949602|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949603|NCT01250405|Cinacalcet|cinacalcet|mesh-list
56949604|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56949605|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949606|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56949607|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
56949608|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949609|NCT05083910|Misoprostol|misoprostol|mesh-list
56949610|NCT05083910|Oxytocin|oxytocin|mesh-list
56949611|NCT05083910|Carbetocin|carbetocin|mesh-list
56949612|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
56949613|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56949614|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949615|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56949616|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
56949617|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56949618|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949619|NCT01250561|Valacyclovir|valacyclovir|mesh-list
56949620|NCT01250561|Gabapentin|gabapentin|mesh-list
56949621|NCT01250561|Analgesics|analgesics|mesh-ancestor
56949622|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
56949623|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949624|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949625|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
56949626|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56949627|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56949628|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949629|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56949630|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56949631|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56949632|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949633|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949634|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
56949635|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
56949636|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949637|NCT05055908|Atezolizumab|atezolizumab|mesh-list
56949638|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949639|NCT01147523|Vitamin E|vitamin e|mesh-list
56949640|NCT01147523|Spironolactone|spironolactone|mesh-list
56949641|NCT01147523|Vitamins|vitamins|mesh-ancestor
56949642|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
56949643|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949644|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
56949645|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949646|NCT01147523|Protective Agents|protective agents|mesh-ancestor
56949647|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56949648|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
56949649|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949650|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56949651|NCT01147523|Diuretics|diuretics|mesh-ancestor
56949652|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
56949653|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
56949654|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56949655|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
56949656|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949657|NCT01251029|Expectorants|expectorants|mesh-ancestor
56949658|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
56949659|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56949660|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
56949661|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949662|NCT01251029|Protective Agents|protective agents|mesh-ancestor
56949663|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949664|NCT01251029|Antidotes|antidotes|mesh-ancestor
56949665|NCT01251107|Prednisone|prednisone|mesh-list
56949666|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
56949667|NCT01251107|Dacarbazine|dacarbazine|mesh-list
56949668|NCT01251107|Doxorubicin|doxorubicin|mesh-list
56949669|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56949670|NCT01251107|Etoposide|etoposide|mesh-list
56949671|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
56949672|NCT01251107|Vincristine|vincristine|mesh-list
56949673|NCT01251107|Bleomycin|bleomycin|mesh-list
56949674|NCT01251107|Vinblastine|vinblastine|mesh-list
56949675|NCT01251107|Procarbazine|procarbazine|mesh-list
56949676|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949677|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
56949678|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949679|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949680|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56949681|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
56949682|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949683|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949684|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56949685|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56949686|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56949687|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56949688|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949689|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949690|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
56949691|NCT01251107|Hormones|hormones|mesh-ancestor
56949692|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949693|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56949694|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56949695|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56949696|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56545353|NCT00642577|Vitamins|vitamins|mesh-ancestor
56949697|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56949698|NCT01125176|Thalidomide|thalidomide|mesh-list
56949699|NCT01125176|Rituximab|rituximab|mesh-list
56949700|NCT01125176|Lenalidomide|lenalidomide|mesh-list
56949701|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56949702|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949703|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
55734688|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56949704|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949705|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949706|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56949707|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56949708|NCT01125176|Growth Substances|growth substances|mesh-ancestor
56949709|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
56949710|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949711|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
56949712|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56949713|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949714|NCT04412096|Timolol|timolol|mesh-list
56949715|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56949716|NCT04412096|Latanoprost|latanoprost|mesh-list
56949717|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56949718|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56949719|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56949720|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
56949721|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949722|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949723|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949724|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56949725|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56949726|NCT00882050|Exenatide|exenatide|mesh-list
56949727|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56949728|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949729|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56949730|NCT00882050|Incretins|incretins|mesh-ancestor
56949731|NCT00882050|Hormones|hormones|mesh-ancestor
56949732|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949733|NCT03912857|Apatinib|apatinib|mesh-list
56949734|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949735|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56949736|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949737|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949738|NCT04316390|Vitamins|vitamins|mesh-list
56949739|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
56949740|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
56949741|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949742|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
56949743|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949744|NCT04316390|Protective Agents|protective agents|mesh-ancestor
56949745|NCT04892420|Dexamethasone|dexamethasone|mesh-list
56949746|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
56949747|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
56949748|NCT04892420|Bupivacaine|bupivacaine|mesh-list
56949749|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949750|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
56949751|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
56949752|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949753|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949754|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949755|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
56949756|NCT04892420|Hormones|hormones|mesh-ancestor
56949757|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949758|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56949759|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949760|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
56949761|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
56949762|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949763|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
56949764|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56949765|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56949766|NCT04892420|Analgesics|analgesics|mesh-ancestor
56949767|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56949768|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56949769|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56949770|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
56949771|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949772|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949773|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56949774|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
56949775|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56949776|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56949777|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56949778|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
56949779|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56870608|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
56949780|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56949781|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56949782|NCT01251263|Estradiol|estradiol|mesh-list
56949783|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56949784|NCT01251263|Estrogens|estrogens|mesh-ancestor
56949785|NCT01251263|Hormones|hormones|mesh-ancestor
56949786|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949787|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949788|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56949789|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
56949790|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56949791|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56949792|NCT04707534|Dexamethasone|dexamethasone|mesh-list
56949793|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949794|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
56949795|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
56949796|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949797|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949798|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949799|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
56949800|NCT04707534|Hormones|hormones|mesh-ancestor
56949801|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949802|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56949803|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949804|NCT05761730|Dexamethasone|dexamethasone|mesh-list
56949805|NCT05761730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949806|NCT05761730|Antiemetics|antiemetics|mesh-ancestor
56949807|NCT05761730|Autonomic Agents|autonomic agents|mesh-ancestor
56949808|NCT05761730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949809|NCT05761730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949810|NCT05761730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949811|NCT05761730|Glucocorticoids|glucocorticoids|mesh-ancestor
56949812|NCT05761730|Hormones|hormones|mesh-ancestor
56949813|NCT05761730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949814|NCT05761730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56949815|NCT05761730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949816|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56949817|NCT04257500|Etonogestrel|etonogestrel|mesh-list
56949818|NCT04257500|NuvaRing|nuvaring|mesh-list
56949819|NCT04257500|Estradiol|estradiol|mesh-list
56949820|NCT04257500|Estrogens|estrogens|mesh-ancestor
56949821|NCT04257500|Hormones|hormones|mesh-ancestor
56949822|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949823|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949824|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56949825|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
56949826|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56949827|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56949828|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56949829|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56949830|NCT04353817|Ivacaftor|ivacaftor|mesh-list
56949831|NCT04353817|Elexacaftor|elexacaftor|mesh-list
56949832|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56949833|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56949834|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949835|NCT05206682|Goserelin|goserelin|mesh-list
56949836|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56949837|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949838|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
56949839|NCT00159588|Gabapentin|gabapentin|mesh-list
56949840|NCT00159588|Valproic Acid|valproic acid|mesh-list
56949841|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
56949842|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
56949843|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56949844|NCT00159588|Analgesics|analgesics|mesh-ancestor
56949845|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
56949846|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949847|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949848|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
56949849|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56545503|NCT01194869|Paclitaxel|paclitaxel|mesh-list
56949850|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56949851|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949852|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55734689|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
56949853|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56949854|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56949855|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949856|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949857|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
56949858|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949859|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
56949860|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56949861|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56949862|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
56949863|NCT04166942|Belumosudil|belumosudil|mesh-list
56949864|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56949865|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949866|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949867|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
56949868|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56949869|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56949870|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56949871|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56949872|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949873|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
56949874|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949875|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949876|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56949877|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949878|NCT04349917|Methylphenidate|methylphenidate|mesh-list
56949879|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56949880|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949881|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56949882|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56949883|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56949884|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949885|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
56949886|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949887|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56949888|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56949889|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56949890|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
56949891|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949892|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56949893|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56949894|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949895|NCT04691856|Acetaminophen|acetaminophen|mesh-list
56949897|NCT04691856|Morphine|morphine|mesh-list
56949898|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56949899|NCT04691856|Narcotics|narcotics|mesh-ancestor
56949900|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949901|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949902|NCT04691856|Analgesics|analgesics|mesh-ancestor
56949903|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
56949904|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949905|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56949906|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56949907|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949908|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949909|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56949910|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949911|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949912|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
56949913|NCT03924986|Gemcitabine|gemcitabine|mesh-list
56949914|NCT03924986|Cisplatin|cisplatin|mesh-list
56949915|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949916|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56949917|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
56949918|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949919|NCT03924986|Antiviral Agents|antiviral agents|mesh-ancestor
56949920|NCT03924986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949921|NCT03924986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949922|NCT03924986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949923|NCT03924986|Immunologic Factors|immunologic factors|mesh-ancestor
56949924|NCT03924986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949925|NCT01254929|Frovatriptan|frovatriptan|mesh-list
56949926|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56870759|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
56949927|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
56949928|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949929|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949930|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949931|NCT03300570|Dolcanatide|dolcanatide|mesh-list
56949932|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56949933|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
56949934|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949935|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949936|NCT03853694|Morphine|morphine|mesh-list
56949937|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56949938|NCT03853694|Narcotics|narcotics|mesh-ancestor
56949939|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56949940|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949941|NCT03853694|Analgesics|analgesics|mesh-ancestor
56949942|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
56949943|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949944|NCT04154293|Isotretinoin|isotretinoin|mesh-list
56949945|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
56949946|NCT01148147|Adenosine|adenosine|mesh-list
56949947|NCT01148147|Analgesics|analgesics|mesh-ancestor
56949948|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
56949949|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949950|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949951|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56949952|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
56949953|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56949954|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
56949955|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
56949956|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56949957|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949958|NCT03902249|Dexamethasone|dexamethasone|mesh-list
56949959|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56949960|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
56949961|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
56949962|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56949963|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949964|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56949965|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
56949966|NCT03902249|Hormones|hormones|mesh-ancestor
56949967|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56949968|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56949969|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949970|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
56949971|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
56949972|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949973|NCT03908489|Protective Agents|protective agents|mesh-ancestor
56949974|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949975|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56949976|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949977|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56949978|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56949979|NCT04342897|Zansecimab|zansecimab|mesh-list
56949980|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
56949981|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56949982|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
56949983|NCT03263767|Fludarabine|fludarabine|mesh-list
56949984|NCT03263767|Clofarabine|clofarabine|mesh-list
56949985|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
56949986|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56949987|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
56949988|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56949989|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949990|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56949991|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
56949992|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56949993|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56949994|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56949995|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56949996|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
56949997|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56949998|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56949999|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
56950000|NCT03908333|Gemcitabine|gemcitabine|mesh-list
56870836|NCT02780310|Lenvatinib|lenvatinib|mesh-list
56950002|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56950003|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56950004|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950005|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
56950006|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
56950007|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
56950008|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950009|NCT03908333|Vitamins|vitamins|mesh-ancestor
56950010|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
56950011|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950012|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56950013|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
56950014|NCT03908333|Antiviral Agents|antiviral agents|mesh-ancestor
56950015|NCT03908333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950016|NCT03908333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950017|NCT03908333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56950018|NCT03908333|Immunologic Factors|immunologic factors|mesh-ancestor
56950019|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
56950020|NCT03908333|Protective Agents|protective agents|mesh-ancestor
56950021|NCT04340557|Losartan|losartan|mesh-list
56950022|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56950023|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56950024|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56950025|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56950026|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950027|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
56950028|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
56950029|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56950030|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56950031|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
56950032|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950033|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
56950034|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
56950035|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56950036|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950037|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56950038|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
56950039|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950040|NCT04549376|Iodine|iodine|mesh-list
56950041|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
56950042|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
56950043|NCT04549376|Povidone|povidone|mesh-list
56950044|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56950045|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950046|NCT04549376|Trace Elements|trace elements|mesh-ancestor
56950047|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
56950048|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950049|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
56950050|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
56950051|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
56950052|NCT01149395|Lansoprazole|lansoprazole|mesh-list
56950053|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56950054|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950055|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56950056|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950057|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950058|NCT02527733|Ranibizumab|ranibizumab|mesh-list
56950059|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56950060|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56950061|NCT02527733|Growth Substances|growth substances|mesh-ancestor
56950062|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950063|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
56950064|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950065|NCT04135495|Ivacaftor|ivacaftor|mesh-list
56950066|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56950067|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56950068|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950069|NCT01148303|Etoricoxib|etoricoxib|mesh-list
56950070|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56950071|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56950072|NCT01148303|Analgesics|analgesics|mesh-ancestor
56950073|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
56950074|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950075|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950076|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950078|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56950079|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56950080|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950081|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950082|NCT03066830|Metformin|metformin|mesh-list
56950083|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56950084|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56950085|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950086|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56950087|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950088|NCT03900377|Rituximab|rituximab|mesh-list
56950089|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56950090|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950091|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
56950092|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950093|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950094|NCT05205200|Paclitaxel|paclitaxel|mesh-list
56950095|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56950096|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950097|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56950098|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56950099|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56950100|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950101|NCT01149629|Droxidopa|droxidopa|mesh-list
56950102|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56950103|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56950104|NCT05205122|Mitomycins|mitomycins|mesh-list
56950105|NCT05205122|Mitomycin|mitomycin|mesh-list
56950106|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56950107|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950108|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
56950109|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950110|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56950111|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950112|NCT03907163|Dronabinol|dronabinol|mesh-list
56950113|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
56950114|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950115|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56950116|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56950117|NCT03907163|Analgesics|analgesics|mesh-ancestor
56950118|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
56950119|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950120|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56950121|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56950122|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950123|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950124|NCT03907163|Hormones|hormones|mesh-ancestor
56950125|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950126|NCT01253681|Paclitaxel|paclitaxel|mesh-list
56950127|NCT01253681|Carboplatin|carboplatin|mesh-list
56950128|NCT01253681|Trebananib|trebananib|mesh-list
56950129|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56950130|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950131|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
56950132|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
56950133|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
56950134|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950135|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56950136|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56950137|NCT01253681|Growth Substances|growth substances|mesh-ancestor
56950138|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950139|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
56950140|NCT01149941|Ibuprofen|ibuprofen|mesh-list
56950141|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56950142|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56950143|NCT01149941|Analgesics|analgesics|mesh-ancestor
56950144|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
56950145|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950146|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950148|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950149|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56950150|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734763|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870984|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
56950151|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950152|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
56950153|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950154|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
56950155|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
56950156|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950157|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950158|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950159|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
56950160|NCT01589549|Hormones|hormones|mesh-ancestor
56950161|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950162|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56950163|NCT01589549|Protective Agents|protective agents|mesh-ancestor
56950164|NCT03899675|Caffeine|caffeine|mesh-list
56950165|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56950166|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950167|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56950168|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950169|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950170|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56950171|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56950172|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
56950173|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950174|NCT01562197|Axitinib|axitinib|mesh-list
56950175|NCT01562197|Lomustine|lomustine|mesh-list
56950176|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950177|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56950178|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950179|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950180|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56950181|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
56950182|NCT03905837|Lidocaine|lidocaine|mesh-list
56950183|NCT03905837|Piperidine|piperidine|mesh-list
56950184|NCT03905837|Remifentanil|remifentanil|mesh-list
56950185|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
56950186|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
56950187|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56950188|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950189|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
56950190|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950191|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56950192|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56950193|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56950194|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56950195|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950196|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56950197|NCT03905837|Narcotics|narcotics|mesh-ancestor
56950198|NCT03905837|Analgesics|analgesics|mesh-ancestor
56950199|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56950200|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56950201|NCT03063632|Interferons|interferons|mesh-list
56950202|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
56950203|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
56950204|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56950205|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950206|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
56950207|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950208|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
56950209|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
56950210|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56950211|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56950212|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950213|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950214|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950215|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950216|NCT01148615|Docetaxel|docetaxel|mesh-list
56950217|NCT01148615|Aflibercept|aflibercept|mesh-list
56950218|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950219|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
56950220|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
56950221|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
56950222|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950223|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56950224|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56950225|NCT01148615|Growth Substances|growth substances|mesh-ancestor
56950226|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950227|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
56950228|NCT04161248|Gemcitabine|gemcitabine|mesh-list
56950229|NCT04161248|Dexamethasone|dexamethasone|mesh-list
56950230|NCT04161248|Rituximab|rituximab|mesh-list
56950231|NCT04161248|Venetoclax|venetoclax|mesh-list
56950232|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56950233|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950234|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
56950235|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950236|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950237|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950238|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
56950239|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
56950240|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950241|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950242|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
56950243|NCT04161248|Hormones|hormones|mesh-ancestor
56950244|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950245|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56950246|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56950247|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
56950248|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950249|NCT04161248|Antiviral Agents|antiviral agents|mesh-ancestor
56950250|NCT04161248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950251|NCT04161248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950252|NCT04161248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56950253|NCT03905759|Colchicine|colchicine|mesh-list
56950254|NCT03905759|Amiodarone|amiodarone|mesh-list
56950255|NCT03905759|Dronedarone|dronedarone|mesh-list
56950256|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
56950257|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950258|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
56950259|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
56950260|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
56950261|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950262|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950263|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56950264|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
56950265|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56950266|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56950267|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56950268|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56950269|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56950270|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950271|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56950272|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56950273|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56950274|NCT01255475|Amlodipine|amlodipine|mesh-list
56950275|NCT01255475|Hydralazine|hydralazine|mesh-list
56950276|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56950277|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56950278|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56950279|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950280|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56950281|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950282|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
56950283|NCT05208398|Warfarin|warfarin|mesh-list
56950284|NCT05208398|Apixaban|apixaban|mesh-list
56950285|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
56950286|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56950287|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
56950288|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56950289|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
56950290|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950291|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950292|NCT05593601|Neomycin|neomycin|mesh-list
56950293|NCT05593601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56950294|NCT05593601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950295|NCT05593601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56950296|NCT05593601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950297|NCT05593601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950298|NCT03629210|Dexamethasone|dexamethasone|mesh-list
56950299|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950300|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
56950301|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
56950302|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950303|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950304|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950305|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
56950307|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950308|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56950309|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950310|NCT05569811|Letrozole|letrozole|mesh-list
56950311|NCT05569811|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
56950312|NCT05569811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950313|NCT05569811|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56950314|NCT05569811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56950315|NCT05569811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950316|NCT05569811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950317|NCT05569811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56950318|NCT05569811|Hormone Antagonists|hormone antagonists|mesh-ancestor
56950319|NCT05569811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950320|NCT05569811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950321|NCT05569811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56950322|NCT03899285|Citalopram|citalopram|mesh-list
56950323|NCT03899285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56950324|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56950325|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56950326|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950327|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950328|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
56950329|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950330|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56950331|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
56950332|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56950333|NCT01254071|Tamsulosin|tamsulosin|mesh-list
56950334|NCT01254071|Dutasteride|dutasteride|mesh-list
56950335|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56950336|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56950337|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56950338|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
56950339|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950340|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950341|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950342|NCT01254071|Urological Agents|urological agents|mesh-ancestor
56950343|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56950344|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56950345|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950346|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
56950347|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950348|NCT05761418|Misoprostol|misoprostol|mesh-list
56950349|NCT05761418|Dinoprostone|dinoprostone|mesh-list
56950350|NCT05761418|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56950351|NCT05761418|Abortifacient Agents|abortifacient agents|mesh-ancestor
56950352|NCT05761418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56950353|NCT05761418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950354|NCT05761418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56950355|NCT05761418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950356|NCT05761418|Oxytocics|oxytocics|mesh-ancestor
56950357|NCT05207774|Oxytocin|oxytocin|mesh-list
56950358|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
56950359|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56950360|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950361|NCT02528123|Tobramycin|tobramycin|mesh-list
56950362|NCT02528123|Ofloxacin|ofloxacin|mesh-list
56950363|NCT02528123|Dexamethasone|dexamethasone|mesh-list
56950364|NCT02528123|Benoxinate|benoxinate|mesh-list
56950365|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
56950366|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950367|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
56950368|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
56950369|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950370|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950372|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
56950373|NCT02528123|Hormones|hormones|mesh-ancestor
56950374|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871214|NCT01148628|Everolimus|everolimus|mesh-list
56950375|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56950376|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950377|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56950378|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950379|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56950380|NCT02528123|Renal Agents|renal agents|mesh-ancestor
56950381|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56950382|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56950383|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950384|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950385|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56950386|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56950387|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
56950388|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
56950389|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56950390|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
56950391|NCT02527811|Urinastatin|urinastatin|mesh-list
56950392|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
56950393|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56950394|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
56950395|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950396|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950397|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56950398|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56950399|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950400|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
56950401|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
56950402|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56950403|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56950404|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950405|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950406|NCT01254383|Urological Agents|urological agents|mesh-ancestor
56950407|NCT03700970|Bupivacaine|bupivacaine|mesh-list
56950408|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
56950409|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
56950410|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56950411|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950412|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
56950413|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950414|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
56950415|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56950416|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56950417|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56950418|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56950419|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950420|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
56950421|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950422|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950423|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56950424|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950425|NCT04320745|Testosterone|testosterone|mesh-list
56950426|NCT04320745|Androgens|androgens|mesh-ancestor
56950427|NCT04320745|Hormones|hormones|mesh-ancestor
56950428|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950429|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950430|NCT05741060|Equol|equol|mesh-list
56950431|NCT05741060|Phytoestrogens|phytoestrogens|mesh-ancestor
56950432|NCT05741060|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56950433|NCT05741060|Estrogens|estrogens|mesh-ancestor
56950434|NCT05741060|Hormones|hormones|mesh-ancestor
56950435|NCT05741060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950436|NCT05741060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950437|NCT01254461|Pravastatin|pravastatin|mesh-list
56950438|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56950439|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56950440|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
56950441|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950442|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56546105|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950443|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56950444|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950446|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
56950447|NCT03747523|Vitamins|vitamins|mesh-ancestor
56950448|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
56950449|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950450|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56950451|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56950452|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
56950453|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56950454|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950455|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56950456|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56950457|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950458|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950459|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950460|NCT03063086|Fluticasone|fluticasone|mesh-list
56950461|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56950462|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950463|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56950464|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
56950465|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950466|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950467|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56950468|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
56950469|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
56950470|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56950471|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56950472|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56950473|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56950474|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
56950475|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950476|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950477|NCT03904745|Atosiban|atosiban|mesh-list
56950478|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
56950479|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950480|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950481|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
56950482|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56950483|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
56950484|NCT05187338|Ipilimumab|ipilimumab|mesh-list
56950485|NCT05187338|Durvalumab|durvalumab|mesh-list
56950486|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56950487|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950488|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56950489|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950490|NCT03898583|Calcitriol|calcitriol|mesh-list
56950491|NCT03898583|Betamethasone|betamethasone|mesh-list
56950492|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
56950493|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56950494|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
56950495|NCT03898583|Calcipotriene|calcipotriene|mesh-list
56950496|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56950497|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950498|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
56950499|NCT03898583|Hormones|hormones|mesh-ancestor
56950500|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950501|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950502|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56950503|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
56950504|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56950505|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56950506|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56950507|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56950508|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950509|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56950510|NCT03898583|Vitamins|vitamins|mesh-ancestor
56950511|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
56950512|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56950513|NCT03898193|Montelukast|montelukast|mesh-list
56950514|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56950515|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
56546179|NCT05663515|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56950516|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56950517|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
56950518|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950519|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871357|NCT01149330|Analgesics|analgesics|mesh-ancestor
56950520|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56950521|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56950522|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950523|NCT03321188|Paclitaxel|paclitaxel|mesh-list
56950524|NCT03321188|Carboplatin|carboplatin|mesh-list
56950525|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56950526|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950527|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56950528|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56950529|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56950530|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950531|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56950532|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56950533|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950534|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56950535|NCT01254617|Cetuximab|cetuximab|mesh-list
56950536|NCT01254617|Lenalidomide|lenalidomide|mesh-list
56950537|NCT01254617|Antibodies|antibodies|mesh-list
56950538|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
56950539|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56950540|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
56950541|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950542|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950543|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56950544|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56950545|NCT01254617|Growth Substances|growth substances|mesh-ancestor
56950546|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
56950547|NCT01150331|Levetiracetam|levetiracetam|mesh-list
56950548|NCT01150331|Clonazepam|clonazepam|mesh-list
56950549|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
56950550|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
56950551|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
56950552|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
56950553|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950554|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950555|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950556|NCT03191084|Dronabinol|dronabinol|mesh-list
56950557|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
56950558|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950559|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56950560|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56950561|NCT03191084|Analgesics|analgesics|mesh-ancestor
56950562|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
56950563|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950564|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56950565|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56950566|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950567|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950568|NCT03191084|Hormones|hormones|mesh-ancestor
56950569|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950570|NCT01256489|Infliximab|infliximab|mesh-list
56950571|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
56950572|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950573|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950574|NCT03746119|Nicotine|nicotine|mesh-list
56950575|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56950576|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
56950577|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950578|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950579|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56950580|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56950581|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
56950582|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950583|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950584|NCT01149005|Insulin|insulin|mesh-list
56950585|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56950586|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
56950587|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
56950588|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
56950589|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56950590|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546257|NCT01134042|Fluticasone|fluticasone|mesh-list
56950592|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
56950593|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950594|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56871432|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950595|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56950596|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950597|NCT05122130|Melatonin|melatonin|mesh-list
56950598|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
56950599|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950600|NCT05122130|Protective Agents|protective agents|mesh-ancestor
56950601|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950602|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56950603|NCT02898506|Liraglutide|liraglutide|mesh-list
56950604|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56950605|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950606|NCT02898506|Incretins|incretins|mesh-ancestor
56950607|NCT02898506|Hormones|hormones|mesh-ancestor
56950608|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950609|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
56950610|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56950611|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
56950612|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950613|NCT04123405|Expectorants|expectorants|mesh-ancestor
56950614|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
56950615|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56950616|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
56950617|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950618|NCT04123405|Protective Agents|protective agents|mesh-ancestor
56950619|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950620|NCT04123405|Antidotes|antidotes|mesh-ancestor
56950621|NCT02611232|Liraglutide|liraglutide|mesh-list
56950622|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56950623|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950624|NCT02611232|Incretins|incretins|mesh-ancestor
56950625|NCT02611232|Hormones|hormones|mesh-ancestor
56950626|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950627|NCT01150877|Vitamin D|vitamin d|mesh-list
56950628|NCT01150877|Vitamins|vitamins|mesh-ancestor
56950629|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
56950630|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950631|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56950632|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56950633|NCT03893591|Dalteparin|dalteparin|mesh-list
56950634|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
56950635|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56950636|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56950637|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950638|NCT01256801|Interleukin-2|interleukin-2|mesh-list
56950639|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950640|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56950641|NCT01256801|Analgesics|analgesics|mesh-ancestor
56950642|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
56950643|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950644|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950645|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
56950646|NCT02519738|Triamcinolone|triamcinolone|mesh-list
56950647|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56950648|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950649|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
56950650|NCT02519738|Hormones|hormones|mesh-ancestor
56950651|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950652|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950653|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56950654|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
56950655|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56950656|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950657|NCT03893747|Vaccines|vaccines|mesh-list
56950658|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
56950659|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950660|NCT02343224|Interferons|interferons|mesh-list
56950661|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
56950662|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
56950663|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56950664|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546327|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950665|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
56950666|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950667|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
56950668|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871507|NCT03904056|Ranibizumab|ranibizumab|mesh-list
56950669|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56950670|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56950671|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950673|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
56950674|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56950675|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950676|NCT05737862|Folic Acid|folic acid|mesh-list
56950677|NCT05737862|Hematinics|hematinics|mesh-ancestor
56950678|NCT05737862|Vitamin B Complex|vitamin b complex|mesh-ancestor
56950679|NCT05737862|Vitamins|vitamins|mesh-ancestor
56950680|NCT05737862|Micronutrients|micronutrients|mesh-ancestor
56950681|NCT05737862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950682|NCT02097680|Letrozole|letrozole|mesh-list
56950683|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950684|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56950685|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56950686|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950687|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950688|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56950689|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
56950690|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950691|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950692|NCT01150955|Resveratrol|resveratrol|mesh-list
56950693|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
56950694|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950695|NCT01150955|Protective Agents|protective agents|mesh-ancestor
56950696|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950697|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950698|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56950699|NCT03897413|Antacids|antacids|mesh-list
56950700|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
56950701|NCT03897413|Calcium|calcium|mesh-list
56950702|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56950703|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950704|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950705|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950706|NCT01258439|Ritonavir|ritonavir|mesh-list
56950707|NCT01258439|Darunavir|darunavir|mesh-list
56950708|NCT01258439|Tenofovir|tenofovir|mesh-list
56950709|NCT01258439|Emtricitabine|emtricitabine|mesh-list
56950710|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
56950711|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56950712|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56950713|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56950714|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
56950715|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950716|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950717|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56950718|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56950719|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
56950720|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950721|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56950722|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56950723|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56950724|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56950725|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56950726|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56950727|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56950728|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56950729|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950730|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950731|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950732|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56950733|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56950734|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56950735|NCT03893045|Hematinics|hematinics|mesh-ancestor
56950736|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56950737|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56950738|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
56950739|NCT01560572|Prednisolone|prednisolone|mesh-list
56950740|NCT01560572|Tacrolimus|tacrolimus|mesh-list
56950741|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56950743|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950744|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56871581|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950745|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950746|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950747|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950748|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
56950749|NCT01560572|Hormones|hormones|mesh-ancestor
56950750|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950751|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56950752|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950753|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56950754|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56950755|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
56950756|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56950757|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950758|NCT05209256|Pemetrexed|pemetrexed|mesh-list
56950759|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950760|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950761|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950762|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56950763|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56950764|NCT03896321|Anticoagulants|anticoagulants|mesh-list
56950765|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56950766|NCT05211050|Cromakalim|cromakalim|mesh-list
56950767|NCT05211050|Sumatriptan|sumatriptan|mesh-list
56950768|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56950769|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56950770|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56950771|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
56950772|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950773|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950774|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950775|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56950776|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56950777|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
56950778|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950779|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56950780|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56950781|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
56950782|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
56950783|NCT03892499|Itraconazole|itraconazole|mesh-list
56950784|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
56950785|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950786|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56950787|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56950788|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950789|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950790|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56950791|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
56950792|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950793|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950794|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56950795|NCT01152047|Oxytocin|oxytocin|mesh-list
56950796|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
56950797|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56950798|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950799|NCT01151267|Anesthetics|anesthetics|mesh-list
56950800|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56950801|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950802|NCT01259141|Azithromycin|azithromycin|mesh-list
56950803|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
56950804|NCT01259141|Cephalosporins|cephalosporins|mesh-list
56950805|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56950806|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950807|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56950808|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56950809|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950810|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950811|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950812|NCT05210192|Lidocaine|lidocaine|mesh-list
56950813|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
56950814|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
56950815|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56950816|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950817|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
56950818|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950819|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56950820|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56950821|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56950822|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56950823|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950824|NCT01152203|Bevacizumab|bevacizumab|mesh-list
56950825|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56950826|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56950827|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950828|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56950829|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56950830|NCT01152203|Growth Substances|growth substances|mesh-ancestor
56950831|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950832|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
56950833|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56950834|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
56950835|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950836|NCT01257815|Ranibizumab|ranibizumab|mesh-list
56950837|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56950838|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56950839|NCT01257815|Growth Substances|growth substances|mesh-ancestor
56950840|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950841|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
56950842|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950843|NCT03892421|Cytarabine|cytarabine|mesh-list
56950844|NCT03892421|Dexamethasone|dexamethasone|mesh-list
56950845|NCT03892421|Rituximab|rituximab|mesh-list
56950846|NCT03892421|Carboplatin|carboplatin|mesh-list
56950847|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56950848|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950849|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
56950850|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950851|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950852|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950853|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
56950854|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
56950855|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950856|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950857|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
56950858|NCT03892421|Hormones|hormones|mesh-ancestor
56950859|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950860|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56950861|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56950862|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
56950863|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950864|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
56950865|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950866|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56950867|NCT05546567|Niacinamide|niacinamide|mesh-list
56950868|NCT05546567|Niacin|niacin|mesh-list
56950869|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
56950870|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
56950871|NCT05546567|Vitamins|vitamins|mesh-ancestor
56950872|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
56950873|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950874|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56950875|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
56950876|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950877|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56950878|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
56950879|NCT03895229|Empagliflozin|empagliflozin|mesh-list
56950880|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56950881|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950882|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56950883|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950884|NCT01257893|Aspirin|aspirin|mesh-list
56950885|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56950886|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56950887|NCT01257893|Analgesics|analgesics|mesh-ancestor
56950888|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
56950889|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871727|NCT02527668|Vitamins|vitamins|mesh-ancestor
56950890|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950891|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950892|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950893|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56950894|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56950895|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950896|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56950897|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56950898|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950899|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
56950900|NCT01152593|Mupirocin|mupirocin|mesh-list
56950901|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56950902|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950903|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56950904|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950905|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950906|NCT01259219|Rifabutin|rifabutin|mesh-list
56950907|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56950908|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950909|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56950910|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
56950911|NCT03891095|Oxytocin|oxytocin|mesh-list
56950912|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
56950913|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56950914|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950915|NCT05102591|Ketorolac|ketorolac|mesh-list
56950916|NCT05102591|Metoclopramide|metoclopramide|mesh-list
56950917|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56950918|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56950919|NCT05102591|Analgesics|analgesics|mesh-ancestor
56950920|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
56950921|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950922|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950923|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950924|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950925|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56950926|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950927|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950928|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
56950929|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
56950930|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950931|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56950932|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56950933|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
56950934|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950935|NCT05667077|Amantadine|amantadine|mesh-list
56950936|NCT05667077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56950937|NCT05667077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56950938|NCT05667077|Antiviral Agents|antiviral agents|mesh-ancestor
56950939|NCT05667077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950940|NCT05667077|Dopamine Agents|dopamine agents|mesh-ancestor
56950941|NCT05667077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950942|NCT05667077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950943|NCT05667077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950944|NCT05667077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56950945|NCT05667077|Analgesics|analgesics|mesh-ancestor
56950946|NCT05667077|Sensory System Agents|sensory system agents|mesh-ancestor
56950947|NCT05667077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950948|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
56950949|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56950950|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56950951|NCT03894839|Glutaral|glutaral|mesh-list
56950952|NCT03894839|Eusol|eusol|mesh-list
56950953|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56950954|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56950955|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
56950956|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
56950957|NCT01152749|Nicotine|nicotine|mesh-list
56950958|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56950959|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
56950960|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56950961|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950962|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56950963|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56950964|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
56950965|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950966|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950967|NCT03894683|Melatonin|melatonin|mesh-list
56950968|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
56950969|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950970|NCT03894683|Protective Agents|protective agents|mesh-ancestor
56950971|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950972|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56950973|NCT01259531|Silodosin|silodosin|mesh-list
56950974|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56950975|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56950976|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56950977|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
56950978|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56950979|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950980|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950981|NCT01259531|Urological Agents|urological agents|mesh-ancestor
56950982|NCT01151735|Complement C1s|complement c1s|mesh-list
56950983|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
56950984|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950985|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56950986|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56950987|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56950988|NCT03061214|Incretins|incretins|mesh-ancestor
56950989|NCT03061214|Hormones|hormones|mesh-ancestor
56950990|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56950991|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56950992|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
56950993|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56950994|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56950995|NCT01152827|Everolimus|everolimus|mesh-list
56950996|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56950997|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56950998|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
56950999|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951000|NCT01153373|Ethanol|ethanol|mesh-list
56951001|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56951002|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951003|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951004|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951005|NCT03889145|Amlodipine|amlodipine|mesh-list
56951006|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56951007|NCT03889145|Telmisartan|telmisartan|mesh-list
56951008|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56951009|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56951010|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56951011|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951012|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56951013|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951014|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
56951015|NCT03889145|Diuretics|diuretics|mesh-ancestor
56951016|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
56951017|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56951018|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56951019|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56951020|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
56951021|NCT03888677|Epirubicin|epirubicin|mesh-list
56951022|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56951023|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
56951024|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951025|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56951026|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56951027|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
56951028|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951029|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951030|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56951031|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56951032|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56951033|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56951034|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951035|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
56951036|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951037|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951038|NCT01260233|Nicotine|nicotine|mesh-list
56871887|NCT01255878|Gabapentin|gabapentin|mesh-list
56951039|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56951040|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
56951041|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951042|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951043|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56951044|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56951045|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
56951046|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951047|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951048|NCT01153919|Interferons|interferons|mesh-list
56951049|NCT01153919|Ribavirin|ribavirin|mesh-list
56951050|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
56951051|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
56951052|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56951053|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951054|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
56951055|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951056|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
56951057|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951058|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
56951059|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951060|NCT03912389|Carboplatin|carboplatin|mesh-list
56951061|NCT03912389|Pemetrexed|pemetrexed|mesh-list
56951062|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951063|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951064|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951065|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56951066|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56951067|NCT01147757|Remifentanil|remifentanil|mesh-list
56951068|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56951069|NCT01147757|Narcotics|narcotics|mesh-ancestor
56951070|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951071|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951072|NCT01147757|Analgesics|analgesics|mesh-ancestor
56951073|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
56951074|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951075|NCT01251809|Pegaspargase|pegaspargase|mesh-list
56951076|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951077|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
56951078|NCT01154387|Tacrolimus|tacrolimus|mesh-list
56951079|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
56951080|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56951081|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56951082|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
56951083|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951084|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56951085|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951086|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951087|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56951088|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951089|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56951090|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
56951091|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56951092|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951093|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
56951094|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56951095|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951096|NCT01260623|Prednisone|prednisone|mesh-list
56951097|NCT01260623|Prednisolone|prednisolone|mesh-list
56951098|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951099|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
56951100|NCT01260623|Hormones|hormones|mesh-ancestor
56951101|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951102|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951103|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951104|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951105|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56951106|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
56951107|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56951108|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
56951109|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56951110|NCT01260857|Diuretics|diuretics|mesh-ancestor
56951111|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
56951112|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951113|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56951114|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56951115|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951116|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
56951117|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951118|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951119|NCT01153217|Tenofovir|tenofovir|mesh-list
56951120|NCT01153217|Abacavir|abacavir|mesh-list
56951121|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
56951122|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951123|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56951124|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56951125|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951126|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951127|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56951128|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56951129|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
56951130|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56951131|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951132|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56951133|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
56951134|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56951135|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951136|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951137|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951138|NCT03889379|Albuterol|albuterol|mesh-list
56951139|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56951140|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
56951141|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951142|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951143|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56951144|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
56951145|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
56951146|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56951147|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56951148|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56951149|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56951150|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
56951151|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951152|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951153|NCT01586507|Tramadol|tramadol|mesh-list
56951154|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56951155|NCT01586507|Narcotics|narcotics|mesh-ancestor
56951156|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951157|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951158|NCT01586507|Analgesics|analgesics|mesh-ancestor
56951159|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
56951160|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951161|NCT03910361|Pioglitazone|pioglitazone|mesh-list
56951162|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951163|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951164|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56951165|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
56951166|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56951167|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56951168|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56951169|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
56951170|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56951171|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951172|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56951173|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56951174|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56951175|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951176|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951177|NCT03885947|Fludarabine|fludarabine|mesh-list
56951178|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
56951179|NCT03885947|Thiotepa|thiotepa|mesh-list
56951180|NCT03885947|Valproic Acid|valproic acid|mesh-list
56951181|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951182|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951183|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56951184|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
56951185|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951186|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56951187|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56872029|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
56951188|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
56951189|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56951191|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951192|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
56951193|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951194|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
56951195|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56951196|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951197|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56951198|NCT01261481|Tolvaptan|tolvaptan|mesh-list
56951199|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56951200|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951201|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
56951202|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951203|NCT01261637|Ropivacaine|ropivacaine|mesh-list
56951204|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
56951205|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
56951206|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951207|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951208|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
56951209|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951210|NCT01262183|Panitumumab|panitumumab|mesh-list
56951211|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56951212|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951213|NCT01154933|Exenatide|exenatide|mesh-list
56951214|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951215|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951216|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56951217|NCT01154933|Incretins|incretins|mesh-ancestor
56951218|NCT01154933|Hormones|hormones|mesh-ancestor
56951219|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951220|NCT01155635|Carvedilol|carvedilol|mesh-list
56951221|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56951222|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56951223|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
56951224|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951225|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951226|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951227|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56951228|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
56951229|NCT01155635|Protective Agents|protective agents|mesh-ancestor
56951230|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56951231|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56951232|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56951233|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
56951234|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56951235|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56951236|NCT01155089|Anastrozole|anastrozole|mesh-list
56951237|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951238|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951239|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56951240|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56951241|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951242|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951243|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56951244|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
56951245|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951246|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951247|NCT01155245|Teriparatide|teriparatide|mesh-list
56951248|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56951249|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951250|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56951251|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
56951252|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56951253|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
56951254|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951255|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
56951256|NCT01262417|Protective Agents|protective agents|mesh-ancestor
56951257|NCT01155791|Prednisone|prednisone|mesh-list
56951258|NCT01155791|Docetaxel|docetaxel|mesh-list
56951259|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951260|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
56951261|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
56951262|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
56951263|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951264|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951265|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
56951266|NCT01155791|Hormones|hormones|mesh-ancestor
56951267|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951268|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951269|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951270|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56951271|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56951272|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56951273|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951274|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951275|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56951276|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56951277|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951278|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
56951279|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951280|NCT03881423|Bromides|bromides|mesh-list
56951281|NCT03881423|Rocuronium|rocuronium|mesh-list
56951282|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
56951283|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
56951284|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56951285|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56951286|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951287|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951288|NCT03884465|Treprostinil|treprostinil|mesh-list
56951289|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56951290|NCT01155947|Anastrozole|anastrozole|mesh-list
56951291|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951292|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951293|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56951294|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56951295|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951296|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951297|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56951298|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
56951299|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951300|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951301|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56951302|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56951303|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56951304|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951305|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951306|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56951307|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56951308|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56951309|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
56951310|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951311|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951312|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56951313|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56951314|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
56951315|NCT01264133|Adefovir|adefovir|mesh-list
56951316|NCT01264133|Clevudine|clevudine|mesh-list
56951317|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
56951318|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951319|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56951320|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56951321|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951322|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951323|NCT02527577|Ropivacaine|ropivacaine|mesh-list
56951324|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
56951325|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
56951326|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951327|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951328|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
56951329|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951330|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56951331|NCT03883841|Hematinics|hematinics|mesh-ancestor
56951332|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
56951333|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951334|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56547008|NCT00642733|Gemcitabine|gemcitabine|mesh-list
56951335|NCT01264211|Diacetylrhein|diacetylrhein|mesh-list
56951336|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951337|NCT03880877|Leucovorin|leucovorin|mesh-list
56951338|NCT03880877|Antidotes|antidotes|mesh-ancestor
56951339|NCT03880877|Protective Agents|protective agents|mesh-ancestor
56951340|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951341|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
56951342|NCT03880877|Vitamins|vitamins|mesh-ancestor
56951343|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
56951344|NCT05666999|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56951345|NCT05666999|Laxatives|laxatives|mesh-ancestor
56951346|NCT05666999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56951347|NCT01262729|Xenon|xenon|mesh-list
56951348|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56951349|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
56951350|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
56951351|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951352|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951353|NCT01264289|Finasteride|finasteride|mesh-list
56951354|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56951355|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56951356|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951357|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951358|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
56951359|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951360|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951361|NCT01264289|Urological Agents|urological agents|mesh-ancestor
56951362|NCT03880487|Oxycodone|oxycodone|mesh-list
56951363|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56951364|NCT03880487|Narcotics|narcotics|mesh-ancestor
56951365|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951366|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951367|NCT03880487|Analgesics|analgesics|mesh-ancestor
56951368|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
56951369|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951370|NCT03880409|Lidocaine|lidocaine|mesh-list
56951371|NCT03880409|Epinephrine|epinephrine|mesh-list
56951372|NCT03880409|Racepinephrine|racepinephrine|mesh-list
56951373|NCT03880409|Carticaine|carticaine|mesh-list
56951374|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
56951375|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
56951376|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
56951377|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951378|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951379|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
56951380|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951381|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56951382|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56951383|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56951384|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56951385|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951386|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56951387|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56951388|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
56951389|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951390|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56951391|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56951392|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
56951393|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56951394|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
56951395|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
56951396|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
56951397|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56951398|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
56951399|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56951400|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951401|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56951402|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56951403|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951404|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951405|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951406|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56951407|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56951408|NCT01264367|Interferons|interferons|mesh-list
56547084|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
56951409|NCT01264367|Clevudine|clevudine|mesh-list
56951410|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951411|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
56951412|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951413|NCT05097716|Tolbutamide|tolbutamide|mesh-list
56951414|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951415|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951416|NCT01262963|Dabrafenib|dabrafenib|mesh-list
56951417|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951418|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56951419|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951420|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951421|NCT01264445|Vaccines|vaccines|mesh-list
56951422|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
56951423|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951424|NCT01157975|Pioglitazone|pioglitazone|mesh-list
56951425|NCT01157975|Prednisone|prednisone|mesh-list
56951426|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951427|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
56951428|NCT01157975|Hormones|hormones|mesh-ancestor
56951429|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951430|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951431|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951432|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951433|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951434|NCT03060512|Naloxegol|naloxegol|mesh-list
56951435|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56951436|NCT03060512|Laxatives|laxatives|mesh-ancestor
56951437|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56951438|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56951439|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951440|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
56951441|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951442|NCT01263353|Everolimus|everolimus|mesh-list
56951443|NCT01263353|Pasireotide|pasireotide|mesh-list
56951444|NCT01263353|Somatostatin|somatostatin|mesh-list
56951445|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951446|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56951447|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
56951448|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951449|NCT01263353|Hormones|hormones|mesh-ancestor
56951450|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951451|NCT01158287|Sorafenib|sorafenib|mesh-list
56951452|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951453|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56951454|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951455|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951456|NCT01158365|Glycerol|glycerol|mesh-list
56951457|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56951458|NCT01158365|Protective Agents|protective agents|mesh-ancestor
56951459|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951460|NCT01156649|Acetaminophen|acetaminophen|mesh-list
56951461|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56951462|NCT01156649|Analgesics|analgesics|mesh-ancestor
56951463|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
56951464|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951465|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951466|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
56951467|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
56951468|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56951469|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951470|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56951471|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56951472|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951473|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951474|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951475|NCT03879707|Melatonin|melatonin|mesh-list
56951476|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
56951477|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951478|NCT03879707|Protective Agents|protective agents|mesh-ancestor
56951479|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951480|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951481|NCT01265147|Nedaplatin|nedaplatin|mesh-list
56951482|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951483|NCT01159145|Omeprazole|omeprazole|mesh-list
56951484|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55734936|NCT03237611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56872341|NCT01263366|Norepinephrine|norepinephrine|mesh-list
56951485|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56547157|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56951486|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56951487|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951488|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951490|NCT01156883|Dexamethasone|dexamethasone|mesh-list
56951491|NCT01156883|Prednisone|prednisone|mesh-list
56951492|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
56951493|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
56951494|NCT01156883|Ifosfamide|ifosfamide|mesh-list
56951495|NCT01156883|Doxorubicin|doxorubicin|mesh-list
56951496|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56951497|NCT01156883|Methotrexate|methotrexate|mesh-list
56951498|NCT01156883|Vincristine|vincristine|mesh-list
56951499|NCT01156883|Daunorubicin|daunorubicin|mesh-list
56951500|NCT01156883|Asparaginase|asparaginase|mesh-list
56951501|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
56951502|NCT01156883|Thioguanine|thioguanine|mesh-list
56951503|NCT01156883|Vindesine|vindesine|mesh-list
56951504|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56951505|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
56951506|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951507|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56951508|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56951509|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
56951510|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951511|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951512|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56951513|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951514|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
56951515|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
56951516|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951517|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56951518|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
56951519|NCT01156883|Hormones|hormones|mesh-ancestor
56951520|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951521|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951522|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56951523|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56951524|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56951525|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951526|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56951527|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
56951528|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56951529|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56951530|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
56951531|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
56951532|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56951533|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56951534|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
56951535|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951536|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56951537|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
56951538|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
56951539|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
56951540|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56951541|NCT01156883|Protective Agents|protective agents|mesh-ancestor
56951542|NCT01156961|Paclitaxel|paclitaxel|mesh-list
56951543|NCT01156961|Bevacizumab|bevacizumab|mesh-list
56951544|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56951545|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951546|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
56951547|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
56951548|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
56951549|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951550|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56951551|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56951552|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56951553|NCT01156961|Growth Substances|growth substances|mesh-ancestor
56951554|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951555|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
56951556|NCT01159301|Sorafenib|sorafenib|mesh-list
56951557|NCT01159301|Entinostat|entinostat|mesh-list
56951558|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56951559|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951560|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56951561|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951562|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951563|NCT01159379|Ertapenem|ertapenem|mesh-list
56951564|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56951565|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951566|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56951567|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951568|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951569|NCT01159847|Incretins|incretins|mesh-ancestor
56951570|NCT01159847|Hormones|hormones|mesh-ancestor
56951571|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951572|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56951573|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
56951574|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951575|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951576|NCT02539160|Ticagrelor|ticagrelor|mesh-list
56951577|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56951578|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56951579|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56951580|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56951581|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
56951582|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951583|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951584|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951585|NCT01265927|Trastuzumab|trastuzumab|mesh-list
56951586|NCT01265927|Imetelstat|imetelstat|mesh-list
56951587|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56951588|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951589|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951590|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951591|NCT01266005|Entecavir|entecavir|mesh-list
56951592|NCT01266005|Clevudine|clevudine|mesh-list
56951593|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
56951594|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951595|NCT04292899|Remdesivir|remdesivir|mesh-list
56951596|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
56951597|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951598|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
56951599|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951600|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
56951601|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56951602|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56951603|NCT03876899|Analgesics|analgesics|mesh-ancestor
56951604|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
56951605|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951606|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951607|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951608|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56951609|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56951610|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
56951611|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951612|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56951613|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
56951614|NCT03241173|Nivolumab|nivolumab|mesh-list
56951615|NCT03241173|Ipilimumab|ipilimumab|mesh-list
56951616|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56951617|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951618|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56951619|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951620|NCT03264066|Atezolizumab|atezolizumab|mesh-list
56951621|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56951622|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951623|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
56951624|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951625|NCT03759041|Vancomycin|vancomycin|mesh-list
56951626|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56951627|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951628|NCT04110145|Linaclotide|linaclotide|mesh-list
56951629|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56951630|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
56951631|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951632|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56951633|NCT02477618|Brexanolone|brexanolone|mesh-list
56951634|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
56951635|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872484|NCT01161654|Naratriptan|naratriptan|mesh-list
56951636|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951637|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951638|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
56951639|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
56951640|NCT01268033|Rituximab|rituximab|mesh-list
56951641|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56951642|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951643|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
56951644|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951645|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56951646|NCT01162031|Bortezomib|bortezomib|mesh-list
56951647|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951648|NCT02879162|Durvalumab|durvalumab|mesh-list
56951649|NCT02879162|Tremelimumab|tremelimumab|mesh-list
56951650|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56951651|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951652|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
56951653|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951654|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951655|NCT02285504|Brexanolone|brexanolone|mesh-list
56951656|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
56951657|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951658|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951659|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951660|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
56951661|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
56951662|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
56951663|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951664|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56951665|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951666|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951667|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56951668|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56951669|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
56951670|NCT05158491|Irinotecan|irinotecan|mesh-list
56951671|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56951672|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56951673|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951674|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951675|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951676|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
56951677|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951678|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951679|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56951680|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56951681|NCT03240081|Estradiol|estradiol|mesh-list
56951682|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56951683|NCT03240081|Estrogens|estrogens|mesh-ancestor
56951684|NCT03240081|Hormones|hormones|mesh-ancestor
56951685|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951686|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951687|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56951688|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
56951689|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56951690|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56951691|NCT03876587|Docetaxel|docetaxel|mesh-list
56951692|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951693|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56951694|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56951695|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
56951696|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951697|NCT05571267|Bevacizumab|bevacizumab|mesh-list
56951698|NCT05571267|Ranibizumab|ranibizumab|mesh-list
56951699|NCT05571267|Aflibercept|aflibercept|mesh-list
56951700|NCT05571267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56951701|NCT05571267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951702|NCT05571267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56951703|NCT05571267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56951704|NCT05571267|Growth Substances|growth substances|mesh-ancestor
56951705|NCT05571267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951706|NCT05571267|Growth Inhibitors|growth inhibitors|mesh-ancestor
56951707|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56951708|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
55735242|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56951709|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951710|NCT04635423|Vaccines|vaccines|mesh-list
56951711|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
56951712|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951713|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
56951714|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951715|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56951716|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
56951717|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
56951718|NCT03282357|Protective Agents|protective agents|mesh-ancestor
56951719|NCT01162967|Posaconazole|posaconazole|mesh-list
56951720|NCT01162967|Benzonidazole|benzonidazole|mesh-list
56951721|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
56951722|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951723|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56951724|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56951725|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56951726|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56951727|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56951728|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951729|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951730|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56951731|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
56951732|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951733|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951734|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56951735|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
56951736|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56951737|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
56951738|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951739|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56951740|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
56951741|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951742|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951743|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56951744|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56951745|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56951746|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
56951747|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56951748|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
56951749|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56951750|NCT04272775|Dexamethasone|dexamethasone|mesh-list
56951751|NCT04272775|Lenalidomide|lenalidomide|mesh-list
56951752|NCT04272775|Ixazomib|ixazomib|mesh-list
56951753|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951754|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
56951755|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
56951756|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951757|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951758|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56951759|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
56951760|NCT04272775|Hormones|hormones|mesh-ancestor
56951761|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951762|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951763|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951764|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
56951765|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56951766|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56951767|NCT04272775|Growth Substances|growth substances|mesh-ancestor
56951768|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
56951769|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
56951770|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951771|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951772|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
56951773|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951774|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951775|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
56951776|NCT01163201|Fludarabine|fludarabine|mesh-list
56951777|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56951778|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
56951779|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951780|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56951781|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56951782|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
56052722|NCT05747768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56951783|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951784|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951785|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56951786|NCT03876041|Dexamethasone|dexamethasone|mesh-list
56951787|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
56547461|NCT04177303|Metformin|metformin|mesh-list
56951789|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56951790|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56951791|NCT03876041|BB 1101|bb 1101|mesh-list
56951792|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951793|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
56951794|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
56951795|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951796|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951797|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56951798|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
56951799|NCT03876041|Hormones|hormones|mesh-ancestor
56951800|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951801|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951802|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951803|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
56951804|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951805|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951806|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56951807|NCT03876041|Protective Agents|protective agents|mesh-ancestor
56951808|NCT04102345|Zolpidem|zolpidem|mesh-list
56951809|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56951810|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56951811|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951812|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951813|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56951814|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
56951815|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
56951816|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951817|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951818|NCT01163435|Clarithromycin|clarithromycin|mesh-list
56951819|NCT01163435|Levofloxacin|levofloxacin|mesh-list
56951820|NCT01163435|Ofloxacin|ofloxacin|mesh-list
56951821|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56951822|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951823|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56951824|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951825|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951826|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56951827|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56951828|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56951829|NCT01163435|Renal Agents|renal agents|mesh-ancestor
56951830|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56951831|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56951832|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951833|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56951834|NCT03299244|Cinacalcet|cinacalcet|mesh-list
56951835|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56951836|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951837|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56951838|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
56951839|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951840|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56951841|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951842|NCT03757715|Dexamethasone|dexamethasone|mesh-list
56951843|NCT03757715|Bupivacaine|bupivacaine|mesh-list
56951844|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951845|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
56951846|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
56951847|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951848|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951849|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56951850|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
56951851|NCT03757715|Hormones|hormones|mesh-ancestor
56951852|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951853|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56951854|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951855|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
56951856|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
56872704|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
56951857|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951858|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
56951859|NCT01163825|Mitogens|mitogens|mesh-list
56951860|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56295798|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
56951861|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951862|NCT01163903|Doxorubicin|doxorubicin|mesh-list
56951863|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56951864|NCT01163903|Pantoprazole|pantoprazole|mesh-list
56951865|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56951866|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951867|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56951868|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56951869|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951870|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951871|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56951872|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56951873|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56951874|NCT03759587|Niraparib|niraparib|mesh-list
56951875|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56951876|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951877|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951878|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951879|NCT03745807|Nivolumab|nivolumab|mesh-list
56951880|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56951881|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951882|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56951883|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951884|NCT01164059|Haloperidol|haloperidol|mesh-list
56951885|NCT01164059|Olanzapine|olanzapine|mesh-list
56951886|NCT01164059|Aripiprazole|aripiprazole|mesh-list
56951887|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56951888|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
56951889|NCT01164059|Flupenthixol|flupenthixol|mesh-list
56951890|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
56951891|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
56951892|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
56951893|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951894|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951895|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56951896|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56951897|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56951898|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951899|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56951900|NCT01164059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56951901|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56951902|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56951903|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951904|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951905|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
56951906|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
56951907|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
56951908|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
56951909|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56951910|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56951911|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56951912|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56951913|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56951914|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56951915|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56951916|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
56951917|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56951918|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951919|NCT03878771|Clobetasol|clobetasol|mesh-list
56951920|NCT03878771|Benzocaine|benzocaine|mesh-list
56951921|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56951922|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
56951923|NCT03878771|Hormones|hormones|mesh-ancestor
56951924|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56951925|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951926|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
56951927|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
56872770|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56951928|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56951929|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
56951930|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951931|NCT02959918|Sirolimus|sirolimus|mesh-list
56951932|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56951933|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56951934|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56951935|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951936|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
56951937|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56951938|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
56951939|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951940|NCT04256317|Azacitidine|azacitidine|mesh-list
56951941|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56951942|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
56951943|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951944|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951945|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951946|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56951947|NCT01266707|Vaccines|vaccines|mesh-list
56951948|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
56951949|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951950|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56951951|NCT01266707|Growth Substances|growth substances|mesh-ancestor
56951952|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
56951953|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951954|NCT03263442|Thiamine|thiamine|mesh-list
56951955|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
56951956|NCT03263442|Vitamins|vitamins|mesh-ancestor
56951957|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
56951958|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951959|NCT01164215|Leucovorin|leucovorin|mesh-list
56951960|NCT01164215|Fluorouracil|fluorouracil|mesh-list
56951961|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
56951962|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
56951963|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951964|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
56951965|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951966|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56951967|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56951968|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56951969|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
56951970|NCT01164215|Antidotes|antidotes|mesh-ancestor
56951971|NCT01164215|Protective Agents|protective agents|mesh-ancestor
56951972|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
56951973|NCT01164215|Vitamins|vitamins|mesh-ancestor
56951974|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
56951975|NCT04245709|Clenbuterol|clenbuterol|mesh-list
56951976|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56951977|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56951978|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
56951979|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56951980|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951981|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951982|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56951983|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
56951984|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56951985|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56951986|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
56951987|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
56951988|NCT03878693|Fomepizole|fomepizole|mesh-list
56951989|NCT03878693|Antidotes|antidotes|mesh-ancestor
56951990|NCT03878693|Protective Agents|protective agents|mesh-ancestor
56951991|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951992|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56951993|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951994|NCT05305495|Empagliflozin|empagliflozin|mesh-list
56951995|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56951996|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56951997|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56951998|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56951999|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
56952000|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56952001|NCT02527109|Nifedipine|nifedipine|mesh-list
56952002|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56952003|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56952004|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952005|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56952006|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952007|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
56952008|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
56952009|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56952010|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56952011|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56952012|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56952013|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
56952014|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952015|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952016|NCT02940522|Progestins|progestins|mesh-ancestor
56952017|NCT02940522|Hormones|hormones|mesh-ancestor
56952018|NCT01266785|Infliximab|infliximab|mesh-list
56952019|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56952020|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56952021|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56952022|NCT03262038|Ondansetron|ondansetron|mesh-list
56952023|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
56952024|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
56952025|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952026|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952027|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56952028|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
56952029|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
56952030|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56952031|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
56952032|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952033|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952034|NCT03262038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56952035|NCT03262038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56952036|NCT03262038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952037|NCT03262038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56952038|NCT03262038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56952039|NCT03746821|Biotin|biotin|mesh-list
56952040|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
56952041|NCT03746821|Vitamins|vitamins|mesh-ancestor
56952042|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
56952043|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952044|NCT02785224|Vasopressins|vasopressins|mesh-list
56952045|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
56952046|NCT02785224|Epinephrine|epinephrine|mesh-list
56952047|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56952048|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56952049|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
56952050|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952051|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952052|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952053|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56952054|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56952055|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
56952056|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952057|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56952058|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
56952059|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
56952060|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
56952061|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56952062|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
56952063|NCT02785224|Coagulants|coagulants|mesh-ancestor
56952064|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56952065|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
56952066|NCT02472964|Paclitaxel|paclitaxel|mesh-list
56952067|NCT02472964|Docetaxel|docetaxel|mesh-list
56952068|NCT02472964|Trastuzumab|trastuzumab|mesh-list
56952069|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56952070|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952071|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
56952072|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
56952073|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
56952074|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952075|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952076|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56952077|NCT01160315|Norethindrone|norethindrone|mesh-list
56952078|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
56952079|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
56952080|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56952081|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
56952082|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56952083|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952084|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56952085|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56952086|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952087|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56952088|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56952089|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56952090|NCT04223791|Islatravir|islatravir|mesh-list
56952091|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
56952092|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952093|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952094|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952095|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56952096|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56952097|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56952098|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
56952099|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
56952100|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952101|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
56952102|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952103|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952104|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
56952105|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56952106|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56952107|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
56952108|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952109|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56952110|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56952111|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952112|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952113|NCT04003285|Pregnanolone|pregnanolone|mesh-list
56952114|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
56952115|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952116|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952117|NCT03380728|Ibogaine|ibogaine|mesh-list
56952118|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
56952119|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952120|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56952121|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56952122|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56952123|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952124|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952125|NCT01104922|Cetuximab|cetuximab|mesh-list
56952126|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952127|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952128|NCT01164761|Ramipril|ramipril|mesh-list
56952129|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56952130|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
56952131|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952132|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952133|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56952134|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
56952135|NCT03385096|Melphalan|melphalan|mesh-list
56952136|NCT03385096|Busulfan|busulfan|mesh-list
56952137|NCT03385096|Etoposide|etoposide|mesh-list
56952138|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952139|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
56952140|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952141|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56952142|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56952143|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
56952144|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952145|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952146|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56952147|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56952148|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56952149|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56952150|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952151|NCT02526875|Amlodipine|amlodipine|mesh-list
56952152|NCT02526875|Telmisartan|telmisartan|mesh-list
56952153|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56952154|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56952155|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56952156|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952157|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56952158|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952159|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
56952160|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56952161|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56952162|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
56952163|NCT04222699|Mupirocin|mupirocin|mesh-list
56952164|NCT04222699|Calcium|calcium|mesh-list
56952165|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56952166|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952167|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56952168|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952169|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
56952170|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56952171|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56952172|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952173|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952174|NCT01269203|Curcumin|curcumin|mesh-list
56952175|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56952176|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56952177|NCT01269203|Analgesics|analgesics|mesh-ancestor
56952178|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
56952179|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952180|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952181|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56952182|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56952183|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952184|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952185|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952186|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
56952187|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56952188|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
56952189|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952190|NCT01160627|Expectorants|expectorants|mesh-ancestor
56952191|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
56952192|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56952193|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
56952194|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952195|NCT01160627|Protective Agents|protective agents|mesh-ancestor
56952196|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952197|NCT01160627|Antidotes|antidotes|mesh-ancestor
56952198|NCT04075513|Insulin|insulin|mesh-list
56952199|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56952200|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
56952201|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
56952202|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56952203|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952204|NCT03877679|Triamcinolone|triamcinolone|mesh-list
56952205|NCT03877679|Curcumin|curcumin|mesh-list
56952206|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56952207|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
56952208|NCT03877679|Hormones|hormones|mesh-ancestor
56952209|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952210|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952211|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952212|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952213|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56952214|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56952215|NCT03877679|Analgesics|analgesics|mesh-ancestor
56952216|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
56952217|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952218|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56952219|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952220|NCT03748303|Pregnanolone|pregnanolone|mesh-list
56952221|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
56952222|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952223|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952224|NCT03330249|Cisplatin|cisplatin|mesh-list
56952225|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952226|NCT04652206|Gemcitabine|gemcitabine|mesh-list
56952227|NCT04652206|Paclitaxel|paclitaxel|mesh-list
56952228|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56873076|NCT01269996|Metformin|metformin|mesh-list
56952229|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952230|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56952231|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56952232|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56952233|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952234|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56952235|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
56952236|NCT04652206|Antiviral Agents|antiviral agents|mesh-ancestor
56952237|NCT04652206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952238|NCT04652206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952239|NCT04652206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952240|NCT04652206|Immunologic Factors|immunologic factors|mesh-ancestor
56952241|NCT04652206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952242|NCT01269281|Sumatriptan|sumatriptan|mesh-list
56952243|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56952244|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56952245|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56952246|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
56952247|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952248|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952249|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952250|NCT02778204|Maraviroc|maraviroc|mesh-list
56952251|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56952252|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56952253|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952254|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56952255|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56952256|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
56952257|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952258|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56952259|NCT01160705|Docetaxel|docetaxel|mesh-list
56952260|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952261|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
56952262|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
56952263|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
56952264|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952265|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56952266|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
56952267|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56952268|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
56952269|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56952270|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952271|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56952272|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56952273|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952274|NCT04498780|Valsartan|valsartan|mesh-list
56952275|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56952276|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56952277|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56952278|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56952279|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952280|NCT03261336|Vitamin D|vitamin d|mesh-list
56952281|NCT03261336|Calcitriol|calcitriol|mesh-list
56952282|NCT03261336|Ketoconazole|ketoconazole|mesh-list
56952283|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
56952284|NCT03261336|Vitamins|vitamins|mesh-ancestor
56952285|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
56952286|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952287|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56952288|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56952289|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56952290|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
56952291|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952292|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56952293|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56952294|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952295|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952296|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56952297|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
56952298|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952299|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56952300|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56952301|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56952302|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56952303|NCT05540223|Sirolimus|sirolimus|mesh-list
56952304|NCT05540223|Everolimus|everolimus|mesh-list
56952305|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952306|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952307|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
56952308|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952309|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56952310|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634718|NCT04262765|Amlodipine|amlodipine|mesh-list
56952311|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56952312|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
56952313|NCT03384862|Folic Acid|folic acid|mesh-list
56952314|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
56952315|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
56952316|NCT03384862|Vitamins|vitamins|mesh-ancestor
56952317|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
56952318|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952319|NCT03384862|Hematinics|hematinics|mesh-ancestor
56952320|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
56952321|NCT01269437|Budesonide|budesonide|mesh-list
56952322|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56952323|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56952324|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
56952325|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952326|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952327|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56952328|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
56952329|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
56952330|NCT01269437|Hormones|hormones|mesh-ancestor
56952331|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952332|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56952333|NCT04163952|Panitumumab|panitumumab|mesh-list
56952334|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56952335|NCT04163952|Antibodies|antibodies|mesh-list
56952336|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
56952337|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56952338|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
56952339|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952340|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952341|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
56952342|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
56952343|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952344|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
56952345|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952346|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952347|NCT00462748|Atorvastatin|atorvastatin|mesh-list
56952348|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56952349|NCT00462748|Simvastatin|simvastatin|mesh-list
56952350|NCT00462748|Ezetimibe|ezetimibe|mesh-list
56952351|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56952352|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56952353|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
56952354|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952355|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56952356|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56952357|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952358|NCT01161017|Topiramate|topiramate|mesh-list
56952359|NCT01161017|Amitriptyline|amitriptyline|mesh-list
56952360|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
56952361|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56952362|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952363|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56952364|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
56952365|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56952366|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56952367|NCT01161017|Analgesics|analgesics|mesh-ancestor
56952368|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
56952369|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952370|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56952371|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56952372|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56952373|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952374|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
56952375|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952376|NCT03935685|Mirtazapine|mirtazapine|mesh-list
56952377|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
56952378|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56952379|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56952380|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
56952381|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
56952382|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952383|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952384|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952385|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56634762|NCT00609401|Sorafenib|sorafenib|mesh-list
56952386|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56952387|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952388|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56952389|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56952390|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56952391|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
56952392|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56952393|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56952394|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
56952395|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56952396|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56952397|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
56952398|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952399|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56952400|NCT03238911|Hematinics|hematinics|mesh-ancestor
56952402|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56952403|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56952404|NCT01269515|Analgesics|analgesics|mesh-ancestor
56952405|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
56952406|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952407|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952408|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56952409|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56952410|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56952411|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56952412|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952413|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952414|NCT00418834|Atorvastatin|atorvastatin|mesh-list
56952415|NCT00418834|Ezetimibe|ezetimibe|mesh-list
56952416|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56952417|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56952418|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
56952419|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952420|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56952421|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56952422|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952423|NCT01269671|Peppermint oil|peppermint oil|mesh-list
56952424|NCT01269671|Melatonin|melatonin|mesh-list
56952425|NCT01269671|Simethicone|simethicone|mesh-list
56952426|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
56952427|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952428|NCT01269671|Protective Agents|protective agents|mesh-ancestor
56952429|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952430|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952431|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
56952432|NCT01269671|Emollients|emollients|mesh-ancestor
56952433|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
56952434|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
56952435|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
56952436|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952437|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56952438|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
56952439|NCT04407286|Vitamin D|vitamin d|mesh-list
56952440|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
56952441|NCT04407286|Vitamins|vitamins|mesh-ancestor
56952442|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
56952443|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952444|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56952445|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56952446|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56952447|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
56952448|NCT03276975|Coagulants|coagulants|mesh-ancestor
56952449|NCT03125746|Exemestane|exemestane|mesh-list
56952450|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952451|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56952452|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56952453|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952454|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952455|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56952456|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
56952457|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952458|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952459|NCT03877601|Bevacizumab|bevacizumab|mesh-list
56952460|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634837|NCT00933985|Doxorubicin|doxorubicin|mesh-list
56952461|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952462|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56952463|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56952464|NCT03877601|Growth Substances|growth substances|mesh-ancestor
56952465|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952466|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
56952467|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56952468|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56952469|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56952470|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
56952471|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952472|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952473|NCT03297216|Progestins|progestins|mesh-ancestor
56952474|NCT03297216|Hormones|hormones|mesh-ancestor
56952475|NCT03260868|Insulin|insulin|mesh-list
56952476|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56952477|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
56952478|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
56952479|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
56952480|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56952481|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952482|NCT01165385|Cisplatin|cisplatin|mesh-list
56952483|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952484|NCT01267487|Heparin|heparin|mesh-list
56952485|NCT01267487|Calcium heparin|calcium heparin|mesh-list
56952486|NCT01267487|Protamines|protamines|mesh-list
56952487|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
56952488|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56952489|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56952490|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952491|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
56952492|NCT01267487|Coagulants|coagulants|mesh-ancestor
56952493|NCT01267643|Alefacept|alefacept|mesh-list
56952494|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
56952495|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
56952496|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952497|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
56952498|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56952499|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952500|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952501|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56952502|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56952503|NCT01269827|Protective Agents|protective agents|mesh-ancestor
56952504|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952505|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
56952506|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56952507|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
56952508|NCT03388372|Temozolomide|temozolomide|mesh-list
56952509|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
56952510|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56952511|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
56952512|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952513|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952514|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952515|NCT05173246|Paclitaxel|paclitaxel|mesh-list
56952516|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56952517|NCT05173246|Cisplatin|cisplatin|mesh-list
56952518|NCT05173246|Carboplatin|carboplatin|mesh-list
56952519|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56952520|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952521|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
56952522|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
56952523|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
56952524|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952525|NCT01167101|Pantoprazole|pantoprazole|mesh-list
56952526|NCT01167101|Rebamipide|rebamipide|mesh-list
56952527|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56952528|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56952529|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56952530|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952531|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952532|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
56952533|NCT01167101|Protective Agents|protective agents|mesh-ancestor
56952534|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952535|NCT05173090|Ropivacaine|ropivacaine|mesh-list
56952536|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
56952537|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
56952538|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952539|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952540|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
56952541|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952543|NCT02526953|Capecitabine|capecitabine|mesh-list
56952544|NCT02526953|Mitomycins|mitomycins|mesh-list
56952545|NCT02526953|Mitomycin|mitomycin|mesh-list
56952546|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56952547|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952548|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56952549|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56952550|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56952551|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952552|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56952553|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
56952554|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56952555|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
56952556|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56952557|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952558|NCT05172934|Tenecteplase|tenecteplase|mesh-list
56952559|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56952560|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56952561|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952562|NCT03258762|Leucovorin|leucovorin|mesh-list
56952563|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
56952564|NCT03258762|Calcium|calcium|mesh-list
56952565|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
56952566|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56952567|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952568|NCT03258762|Antidotes|antidotes|mesh-ancestor
56952569|NCT03258762|Protective Agents|protective agents|mesh-ancestor
56952570|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
56952571|NCT03258762|Vitamins|vitamins|mesh-ancestor
56952572|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
56952573|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
56952574|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56952575|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56952576|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952577|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56952578|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952579|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952580|NCT05427669|Leucovorin|leucovorin|mesh-list
56952581|NCT05427669|Fluorouracil|fluorouracil|mesh-list
56952582|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
56952583|NCT05427669|Irinotecan|irinotecan|mesh-list
56952584|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
56952585|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
56952586|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952587|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56952588|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952589|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952590|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
56952591|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952592|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56952593|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56952594|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952595|NCT05427669|Antidotes|antidotes|mesh-ancestor
56952596|NCT05427669|Protective Agents|protective agents|mesh-ancestor
56952597|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
56952598|NCT05427669|Vitamins|vitamins|mesh-ancestor
56952599|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
56952600|NCT01270373|Docetaxel|docetaxel|mesh-list
56952601|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952602|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
56952603|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
56952604|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
56952605|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952606|NCT03713086|Vaccines|vaccines|mesh-list
56952607|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
56873446|NCT01282398|Simvastatin|simvastatin|mesh-list
56952608|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952609|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
56952610|NCT05355051|Azacitidine|azacitidine|mesh-list
56952611|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952612|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634984|NCT00937261|Risperidone|risperidone|mesh-list
56952613|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56952614|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
56952615|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952616|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952617|NCT01271231|Azithromycin|azithromycin|mesh-list
56952618|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56952619|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952620|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
56952621|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56952622|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
56952623|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952624|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
56952625|NCT03697876|Protective Agents|protective agents|mesh-ancestor
56952626|NCT04526691|Carboplatin|carboplatin|mesh-list
56952627|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
56952628|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952629|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952630|NCT01280669|Sirolimus|sirolimus|mesh-list
56952631|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56952632|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952633|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56952634|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952635|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
56952636|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952637|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
56952638|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952639|NCT01169909|Ranibizumab|ranibizumab|mesh-list
56952640|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56952641|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56952642|NCT01169909|Growth Substances|growth substances|mesh-ancestor
56952643|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952644|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
56952645|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952646|NCT04502589|Disulfiram|disulfiram|mesh-list
56952647|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56952648|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56952649|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952650|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952651|NCT04485039|Sevelamer|sevelamer|mesh-list
56952652|NCT04485039|Calcium acetate|calcium acetate|mesh-list
56952653|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
56952654|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
56952655|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952656|NCT03387904|Irinotecan|irinotecan|mesh-list
56952657|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56952658|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56952659|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952660|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952661|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952662|NCT03291288|Tolbutamide|tolbutamide|mesh-list
56952663|NCT03291288|Midazolam|midazolam|mesh-list
56952664|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56952665|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56952666|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952667|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952668|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56952669|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56952670|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56952671|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56952672|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
56952673|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
56952674|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
56952675|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
56952676|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952677|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952678|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56952679|NCT05172310|FAPI-46|fapi-46|mesh-list
56952680|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56952681|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952682|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56952683|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952684|NCT04084626|Lenalidomide|lenalidomide|mesh-list
56952685|NCT04084626|Antibodies|antibodies|mesh-list
56952686|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
56952687|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952688|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56952689|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56952690|NCT04084626|Growth Substances|growth substances|mesh-ancestor
56952691|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
56952692|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952693|NCT03387826|Ticagrelor|ticagrelor|mesh-list
56952694|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56952695|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56952696|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56952697|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56952698|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56952699|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
56952700|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952701|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952702|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952703|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56952704|NCT03384238|Panitumumab|panitumumab|mesh-list
56952705|NCT03384238|Antibodies|antibodies|mesh-list
56952706|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
56952707|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56952708|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
56952709|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952710|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952711|NCT03871517|Aspirin|aspirin|mesh-list
56952712|NCT03871517|Indobufen|indobufen|mesh-list
56952713|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56952714|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56952715|NCT03871517|Analgesics|analgesics|mesh-ancestor
56952716|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
56952717|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952718|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952719|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56952720|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56952721|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56952722|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56952723|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952724|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56952725|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56952726|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952727|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
56952728|NCT03387592|Leucovorin|leucovorin|mesh-list
56952729|NCT03387592|Fluorouracil|fluorouracil|mesh-list
56952730|NCT03387592|Capecitabine|capecitabine|mesh-list
56952731|NCT03387592|Temozolomide|temozolomide|mesh-list
56952732|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
56952733|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
56952734|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952735|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56952736|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952737|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952738|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
56952739|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952740|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56952741|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
56952742|NCT03387592|Antidotes|antidotes|mesh-ancestor
56952743|NCT03387592|Protective Agents|protective agents|mesh-ancestor
56952744|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
56952745|NCT03387592|Vitamins|vitamins|mesh-ancestor
56952746|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
56952747|NCT04445506|Dexamethasone|dexamethasone|mesh-list
56952748|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56952749|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
56952750|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
56952751|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952752|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952753|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56952754|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
56952755|NCT04445506|Hormones|hormones|mesh-ancestor
56952756|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952757|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56952758|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952759|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
56952760|NCT04428333|Fluorouracil|fluorouracil|mesh-list
56952761|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952762|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952763|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
56952764|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952765|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56952766|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952767|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
56952768|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952770|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
56952771|NCT03379012|Testosterone|testosterone|mesh-list
56952772|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
56952773|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
56952774|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56952775|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952776|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56952777|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56952778|NCT03379012|Growth Substances|growth substances|mesh-ancestor
56952779|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952780|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
56952781|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56952782|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952783|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952784|NCT03379012|Androgens|androgens|mesh-ancestor
56952785|NCT03379012|Hormones|hormones|mesh-ancestor
56952786|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952787|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56952788|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
56952789|NCT03383302|Nivolumab|nivolumab|mesh-list
56952790|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952791|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952792|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56952793|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952794|NCT03493126|Estradiol|estradiol|mesh-list
56952795|NCT03493126|Estrogens|estrogens|mesh-ancestor
56952796|NCT03493126|Hormones|hormones|mesh-ancestor
56952797|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952798|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952799|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56952800|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56952801|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952802|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952803|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
56952804|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952805|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
56952806|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56952807|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56952808|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952809|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
56952810|NCT03386656|Coagulants|coagulants|mesh-ancestor
56952811|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56952812|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56952813|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56952814|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952815|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952816|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56952817|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56952818|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56952819|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
56952820|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56952821|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952822|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56952823|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56952824|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
56952825|NCT01281605|Insulin|insulin|mesh-list
56952826|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56952827|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
56952828|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56952829|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952830|NCT01170143|Trastuzumab|trastuzumab|mesh-list
56952831|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952832|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952833|NCT05171530|Lenvatinib|lenvatinib|mesh-list
56952834|NCT05171530|Taxane|taxane|mesh-list
56952835|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952836|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56952837|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952838|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952839|NCT02936037|Biotin|biotin|mesh-list
56952840|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
56952841|NCT02936037|Vitamins|vitamins|mesh-ancestor
56952842|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
56635208|NCT02732262|Oxycodone|oxycodone|mesh-list
56952843|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952844|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
56952845|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56952846|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952847|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952848|NCT01283789|Everolimus|everolimus|mesh-list
56952849|NCT01283789|Lapatinib|lapatinib|mesh-list
56952850|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952851|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952852|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
56952853|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952854|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56952855|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952856|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952857|NCT03383068|Metformin|metformin|mesh-list
56952858|NCT03383068|Exenatide|exenatide|mesh-list
56952859|NCT03383068|Acarbose|acarbose|mesh-list
56952860|NCT03383068|Orlistat|orlistat|mesh-list
56952861|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56952862|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952863|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56952864|NCT03383068|Incretins|incretins|mesh-ancestor
56952865|NCT03383068|Hormones|hormones|mesh-ancestor
56952866|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952867|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56952868|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952869|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952870|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56952871|NCT03378310|Linrodostat|linrodostat|mesh-list
56952872|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952873|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952874|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
56952875|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56952876|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952877|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56952878|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
56952879|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56952880|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952881|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952882|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952883|NCT04094298|FX006|fx006|mesh-list
56952884|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56952885|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
56952886|NCT04094298|Hormones|hormones|mesh-ancestor
56952887|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56952888|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952889|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56952890|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
56952891|NCT04194151|Propofol|propofol|mesh-list
56952892|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56952893|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952894|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952895|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56952896|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
56952897|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
56952898|NCT01281761|Irinotecan|irinotecan|mesh-list
56952899|NCT01281761|Cetuximab|cetuximab|mesh-list
56952900|NCT01281761|Simvastatin|simvastatin|mesh-list
56952901|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56952902|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56952903|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952904|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952905|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952906|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952907|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56952908|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56952909|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
56873751|NCT01173978|Prednisolone|prednisolone|mesh-list
56952910|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56952911|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56952912|NCT04280328|Daratumumab|daratumumab|mesh-list
56952913|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952914|NCT03748147|Misoprostol|misoprostol|mesh-list
56952915|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56952916|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
56952917|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56635280|NCT00610103|Apomorphine|apomorphine|mesh-list
56952918|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952920|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56952921|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
56952922|NCT01580813|Acipimox|acipimox|mesh-list
56952923|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56952924|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
56952925|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952926|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56952927|NCT04446364|Disinfectants|disinfectants|mesh-list
56952928|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952929|NCT01588535|Benzocaine|benzocaine|mesh-list
56952930|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
56952931|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
56952932|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952933|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952934|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
56952935|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952936|NCT01165931|Riociguat|riociguat|mesh-list
56952937|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
56952938|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952939|NCT03441282|Fentanyl|fentanyl|mesh-list
56952940|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56952941|NCT03441282|Narcotics|narcotics|mesh-ancestor
56952942|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56952943|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952944|NCT03441282|Analgesics|analgesics|mesh-ancestor
56952945|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
56952946|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952947|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56952948|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56952949|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
56952950|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
56952951|NCT01274273|Interferons|interferons|mesh-list
56952952|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
56952953|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
56952954|NCT01274273|Aldesleukin|aldesleukin|mesh-list
56952955|NCT01274273|Bevacizumab|bevacizumab|mesh-list
56952956|NCT01274273|Interleukin-2|interleukin-2|mesh-list
56952957|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952958|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952959|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56952960|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56952961|NCT01274273|Growth Substances|growth substances|mesh-ancestor
56952962|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56952963|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
56952964|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
56952965|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56952966|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
56952967|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56952968|NCT01274273|Analgesics|analgesics|mesh-ancestor
56952969|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
56952970|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56952971|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56952972|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56952973|NCT03452865|Esomeprazole|esomeprazole|mesh-list
56952974|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56952975|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56952976|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56952977|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56952978|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952979|NCT04058353|Ivacaftor|ivacaftor|mesh-list
56952980|NCT04058353|Elexacaftor|elexacaftor|mesh-list
56952981|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56952982|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56952983|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56952984|NCT01167725|Leucovorin|leucovorin|mesh-list
56952985|NCT01167725|Bevacizumab|bevacizumab|mesh-list
56873822|NCT03865680|Fluorides|fluorides|mesh-list
56952986|NCT01167725|Cetuximab|cetuximab|mesh-list
56952987|NCT01167725|Fluorouracil|fluorouracil|mesh-list
56952988|NCT01167725|Capecitabine|capecitabine|mesh-list
56952989|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
56952990|NCT01167725|Irinotecan|irinotecan|mesh-list
56952991|NCT01167725|Mitomycins|mitomycins|mesh-list
56952992|NCT01167725|Mitomycin|mitomycin|mesh-list
56952993|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
56952994|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56952995|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56952996|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56952997|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56952998|NCT01167725|Growth Substances|growth substances|mesh-ancestor
56952999|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953000|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
56953001|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
56953002|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953003|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56953004|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56953005|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
56953006|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56953007|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56953008|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953009|NCT01167725|Antidotes|antidotes|mesh-ancestor
56953010|NCT01167725|Protective Agents|protective agents|mesh-ancestor
56953011|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
56953012|NCT01167725|Vitamins|vitamins|mesh-ancestor
56953013|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
56953014|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56953015|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
56953016|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56953017|NCT04446130|Decitabine|decitabine|mesh-list
56953018|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56953019|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
56953020|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953021|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953022|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953023|NCT03226275|Amlodipine|amlodipine|mesh-list
56953024|NCT03226275|Bisoprolol|bisoprolol|mesh-list
56953025|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56953026|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56953027|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953028|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953029|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56953030|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953031|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
56953032|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
56953033|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
56953034|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953035|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56953036|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56953037|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56953038|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953039|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953040|NCT03382756|Choline|choline|mesh-list
56953041|NCT03382756|Atorvastatin|atorvastatin|mesh-list
56953042|NCT03382756|Fenofibrate|fenofibrate|mesh-list
56953043|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56953044|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56953045|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
56953046|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953047|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56953048|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56953049|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953050|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
56953051|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56953052|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
56953053|NCT01166087|Fluoxetine|fluoxetine|mesh-list
56953054|NCT01166087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56953055|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56953056|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953057|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953058|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953059|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
56953060|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953061|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56953062|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
56953063|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56953064|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56953065|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56953066|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953067|NCT01170767|Bevacizumab|bevacizumab|mesh-list
56953068|NCT01170767|Ranibizumab|ranibizumab|mesh-list
56953069|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56953070|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953071|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56953072|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56953074|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953075|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
56953076|NCT01170845|Sivelestat|sivelestat|mesh-list
56953077|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56953078|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
56953079|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953080|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953081|NCT01150890|Brodalumab|brodalumab|mesh-list
56953082|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
56953083|NCT01167803|Desflurane|desflurane|mesh-list
56953084|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56953085|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
56953086|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
56953087|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953088|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953089|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56953090|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56953091|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953092|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953093|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56953094|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953095|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953096|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
56953097|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953098|NCT01275911|Remifentanil|remifentanil|mesh-list
56953099|NCT01275911|Esmolol|esmolol|mesh-list
56953100|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56953101|NCT01275911|Narcotics|narcotics|mesh-ancestor
56953102|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953103|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953104|NCT01275911|Analgesics|analgesics|mesh-ancestor
56953105|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
56953106|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953107|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56953108|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56953109|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56953110|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953111|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953112|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953113|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
56953114|NCT01166165|Vitamin D|vitamin d|mesh-list
56953115|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56953116|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953117|NCT01166165|Vitamins|vitamins|mesh-ancestor
56953118|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
56953119|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56953120|NCT03286218|Alprazolam|alprazolam|mesh-list
56953121|NCT03286218|Lasmiditan|lasmiditan|mesh-list
56953122|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56953123|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953124|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953125|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56953126|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56953127|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56953128|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
56953129|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
56953130|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953131|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953132|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56953133|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
56953134|NCT03745261|Fluticasone|fluticasone|mesh-list
56953135|NCT03745261|Xhance|xhance|mesh-list
56953136|NCT03745261|Bromides|bromides|mesh-list
56953137|NCT03745261|Albuterol|albuterol|mesh-list
56953138|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
56953139|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56953140|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56953141|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56953142|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56953143|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
56953144|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953145|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635506|NCT02802722|Vitamin D|vitamin d|mesh-list
56953146|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56953147|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
56953148|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
56953149|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56953150|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
56953151|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56953152|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
56953153|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953154|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953155|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56953156|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56953157|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56953158|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953159|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
56953160|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
56953161|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56953162|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
56953163|NCT03745261|Hormones|hormones|mesh-ancestor
56953164|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56953165|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
56953166|NCT03744949|Remifentanil|remifentanil|mesh-list
56953167|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56953168|NCT03744949|Narcotics|narcotics|mesh-ancestor
56953169|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953170|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953171|NCT03744949|Analgesics|analgesics|mesh-ancestor
56953172|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
56953173|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953174|NCT03870581|Warfarin|warfarin|mesh-list
56953175|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
56953176|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56953177|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953178|NCT04016779|Viloxazine|viloxazine|mesh-list
56953179|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56953180|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
56953181|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56953182|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56953183|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56953184|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953185|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953186|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953187|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953188|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953189|NCT03870503|Misoprostol|misoprostol|mesh-list
56953190|NCT03870503|Oxytocin|oxytocin|mesh-list
56953191|NCT03870503|Carbetocin|carbetocin|mesh-list
56953192|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
56953193|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56953194|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953195|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56953196|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
56953197|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56953198|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56953199|NCT02857426|Nivolumab|nivolumab|mesh-list
56953200|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56953201|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953202|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56953203|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953204|NCT05181033|Letrozole|letrozole|mesh-list
56953205|NCT05181033|Lenvatinib|lenvatinib|mesh-list
56953206|NCT05181033|Fulvestrant|fulvestrant|mesh-list
56953207|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953208|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56953209|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56953210|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953211|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953212|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56953213|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
56953214|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56953215|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953216|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56953217|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56953218|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56953219|NCT05666765|Isotretinoin|isotretinoin|mesh-list
56953220|NCT05666765|Silymarin|silymarin|mesh-list
56953221|NCT05666765|Dermatologic Agents|dermatologic agents|mesh-ancestor
56953222|NCT05666765|Antioxidants|antioxidants|mesh-ancestor
56953223|NCT05666765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953224|NCT05666765|Protective Agents|protective agents|mesh-ancestor
56953225|NCT05666765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953226|NCT01127256|Carbamazepine|carbamazepine|mesh-list
56953227|NCT01127256|Zonisamide|zonisamide|mesh-list
56953228|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
56953229|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
56953230|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56953231|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953232|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953233|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56953234|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56953235|NCT01127256|Analgesics|analgesics|mesh-ancestor
56953236|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
56953237|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953238|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56953239|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953240|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953241|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56953242|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56953243|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56953244|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56953245|NCT03377842|Leucovorin|leucovorin|mesh-list
56953246|NCT03377842|Apatinib|apatinib|mesh-list
56953247|NCT03377842|Fluorouracil|fluorouracil|mesh-list
56953248|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
56953249|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953250|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56953251|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953252|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953253|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
56953254|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56953255|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56953256|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
56953257|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953258|NCT03377842|Antidotes|antidotes|mesh-ancestor
56953259|NCT03377842|Protective Agents|protective agents|mesh-ancestor
56953260|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
56953261|NCT03377842|Vitamins|vitamins|mesh-ancestor
56953262|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
56953263|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56953264|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
56953265|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953266|NCT01277705|Vaccines|vaccines|mesh-list
56953267|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
56953268|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953269|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
56953270|NCT04757337|Doxorubicin|doxorubicin|mesh-list
56953271|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56953272|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
56953273|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953274|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953275|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56953276|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
56953277|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953278|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953279|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56953280|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56953281|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56953282|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56953283|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953284|NCT03946527|Lanreotide|lanreotide|mesh-list
56953285|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953286|NCT03377608|Tenofovir|tenofovir|mesh-list
56953287|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56953288|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
56953289|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
56953290|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953291|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56953292|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56953293|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953294|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953295|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56953296|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56953297|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56953298|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
56953299|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56953300|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953301|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56953302|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56953303|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56953304|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953305|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56953306|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56953307|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56953309|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
56953310|NCT01282073|Cyclosporins|cyclosporins|mesh-list
56953311|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953312|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953313|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56953314|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
56953315|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953316|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
56953317|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953318|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
56953319|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953320|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56953321|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56953322|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953323|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56953324|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
56953325|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953326|NCT01166477|Ritonavir|ritonavir|mesh-list
56953327|NCT01166477|Lopinavir|lopinavir|mesh-list
56953328|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56953329|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56953330|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
56953331|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953332|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953333|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56953334|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56953335|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
56953336|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953337|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56953338|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56953339|NCT01282151|Cisplatin|cisplatin|mesh-list
56953340|NCT01282151|Pemetrexed|pemetrexed|mesh-list
56953341|NCT01282151|Docetaxel|docetaxel|mesh-list
56953342|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953343|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953344|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953345|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56953346|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56953347|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
56953348|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
56953349|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
56953350|NCT03377218|Iodine|iodine|mesh-list
56953351|NCT03377218|Selenium|selenium|mesh-list
56953352|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
56953353|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56953354|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953355|NCT03377218|Trace Elements|trace elements|mesh-ancestor
56953356|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
56953357|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953358|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
56953359|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953360|NCT03377218|Protective Agents|protective agents|mesh-ancestor
56953361|NCT01168505|Teferrol|teferrol|mesh-list
56953362|NCT01168505|Hematinics|hematinics|mesh-ancestor
56953363|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
56953364|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
56953365|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874199|NCT01179828|Oxycodone|oxycodone|mesh-list
56953366|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56953367|NCT03867929|Vitamin D|vitamin d|mesh-list
56953368|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56953369|NCT03867929|Calcifediol|calcifediol|mesh-list
56953370|NCT03867929|Vitamins|vitamins|mesh-ancestor
56953371|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
56953372|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953373|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56953374|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
56953375|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56953376|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56953377|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953378|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56953379|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953380|NCT01171469|Imiquimod|imiquimod|mesh-list
56953381|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56953382|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
56953383|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953384|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953385|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
56953386|NCT02695992|Metoprolol|metoprolol|mesh-list
56953387|NCT02695992|Diltiazem|diltiazem|mesh-list
56953388|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56953389|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56953390|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
56953391|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
56953392|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953393|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953394|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56953395|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56953396|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56953397|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953398|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953399|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953400|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56953401|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953402|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56953403|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
56953404|NCT04050865|Dexamethasone|dexamethasone|mesh-list
56953405|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56953406|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
56953407|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
56953408|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953409|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953410|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56953411|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
56953412|NCT04050865|Hormones|hormones|mesh-ancestor
56953413|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56953414|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56953415|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953416|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
56953417|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
56953418|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56953419|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56953420|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953421|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953422|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953423|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953424|NCT01171547|Daptomycin|daptomycin|mesh-list
56953425|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953426|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953427|NCT04048681|Cocaine|cocaine|mesh-list
56953428|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
56953429|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
56953430|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953431|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953432|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
56953433|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953434|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56953435|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56953436|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56953437|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953438|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953439|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
56953440|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953441|NCT01282385|Simvastatin|simvastatin|mesh-list
56953442|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56953443|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56953444|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
56953445|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953446|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56953447|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56953448|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953449|NCT01166711|Chromium|chromium|mesh-list
56953450|NCT01166711|Paclitaxel|paclitaxel|mesh-list
56953451|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56953452|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56953453|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953454|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
56953455|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
56953456|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
56953457|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953458|NCT01166711|Trace Elements|trace elements|mesh-ancestor
56953459|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
56953460|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953461|NCT01168739|Quercetin|quercetin|mesh-list
56953462|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
56953463|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953464|NCT01168739|Protective Agents|protective agents|mesh-ancestor
56953465|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953466|NCT01171781|Cisplatin|cisplatin|mesh-list
56953467|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953468|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
56953469|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
56953470|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953471|NCT01171859|Doxycycline|doxycycline|mesh-list
56953472|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56953473|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953474|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953475|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
56953476|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56953477|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56953478|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
56953479|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56953480|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56953481|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
56953482|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
56953483|NCT02652468|Rituximab|rituximab|mesh-list
56953484|NCT02652468|Fludarabine|fludarabine|mesh-list
56953485|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
56953486|NCT02652468|Tacrolimus|tacrolimus|mesh-list
56953487|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56953488|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
56953489|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953490|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953491|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56953492|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
56953493|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953494|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953495|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56953496|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56953497|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56953498|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
56953499|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56953500|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953501|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56953502|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56953503|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
56953504|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953505|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953506|NCT04673877|Vancomycin|vancomycin|mesh-list
56953507|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953508|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953509|NCT01166789|Lubiprostone|lubiprostone|mesh-list
56953510|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56953511|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953512|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953513|NCT01314339|Desloratadine|desloratadine|mesh-list
56953514|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56953515|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
56953516|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953517|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953518|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953519|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56953520|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56953521|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
56953522|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
56953523|NCT05179512|Fluticasone|fluticasone|mesh-list
56953524|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
56953525|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56953526|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56953527|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56953528|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56953529|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
56953530|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953531|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953532|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56953533|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
56953534|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
56953535|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56953536|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
56953537|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56953538|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
56953539|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953540|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953541|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56953542|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56953543|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56953544|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953545|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
56953546|NCT05179512|Hormones|hormones|mesh-ancestor
56953547|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56953548|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
56953549|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56953550|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
56953551|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56953552|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56953553|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953554|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953555|NCT01168817|Urological Agents|urological agents|mesh-ancestor
56953556|NCT01279811|Dopamine|dopamine|mesh-list
56953557|NCT01279811|Norepinephrine|norepinephrine|mesh-list
56953558|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56953559|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56953560|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56953561|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953562|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953563|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953564|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953565|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
56953566|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
56953567|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953568|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56953569|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
56953570|NCT01279811|Protective Agents|protective agents|mesh-ancestor
56953571|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
56953572|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953573|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953574|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56953575|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56953576|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953577|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953578|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953579|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56953580|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56953581|NCT03745105|Dexamethasone|dexamethasone|mesh-list
56953582|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
56953583|NCT03745105|Piroxicam|piroxicam|mesh-list
56953584|NCT03745105|Mepivacaine|mepivacaine|mesh-list
56953585|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56953586|NCT03745105|BB 1101|bb 1101|mesh-list
56953587|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56953588|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
56953589|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
56953590|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953591|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953592|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56953593|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
56953594|NCT03745105|Hormones|hormones|mesh-ancestor
56953595|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56953596|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56953597|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953598|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
56953600|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953601|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
56953602|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
56953603|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953604|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953605|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56953606|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56953607|NCT03745105|Analgesics|analgesics|mesh-ancestor
56953608|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953609|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56953610|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
56953611|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56953612|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56953613|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56953614|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953615|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953616|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
56953617|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953618|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953619|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56953620|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953621|NCT03744247|Lenvatinib|lenvatinib|mesh-list
56953622|NCT03744247|Antibodies|antibodies|mesh-list
56953623|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
56953624|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
56953625|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953626|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953627|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56953628|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953629|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953630|NCT01282619|Huperzine A|huperzine a|mesh-list
56953631|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56953632|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953633|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953634|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
56953635|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953636|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953637|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56953638|NCT01282619|Protective Agents|protective agents|mesh-ancestor
56953639|NCT01282697|Sirolimus|sirolimus|mesh-list
56953640|NCT01282697|Irinotecan|irinotecan|mesh-list
56953641|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56953642|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56953643|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953644|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953645|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953646|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953647|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953648|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56953649|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
56953650|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56953651|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
56953652|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953653|NCT01169597|Prednisone|prednisone|mesh-list
56953654|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56953655|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
56953656|NCT01169597|Hormones|hormones|mesh-ancestor
56953657|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56953658|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953659|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56953660|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953661|NCT02527798|Furosemide|furosemide|mesh-list
56953662|NCT02527798|Diuretics|diuretics|mesh-ancestor
56953663|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
56953664|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953665|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56953666|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56953667|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953668|NCT05331911|Propofol|propofol|mesh-list
56953669|NCT05331911|Sevoflurane|sevoflurane|mesh-list
56953670|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56636026|NCT00940303|Leucovorin|leucovorin|mesh-list
56953671|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953672|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953673|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56953674|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
56953675|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
56953676|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56953677|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56953678|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56953679|NCT03857542|Pilocarpine|pilocarpine|mesh-list
56953680|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56953681|NCT03857542|Miotics|miotics|mesh-ancestor
56953682|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
56953683|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953684|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953685|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56953686|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56953687|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
56953688|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953689|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953690|NCT01172717|Panitumumab|panitumumab|mesh-list
56953691|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56953692|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953693|NCT03751631|Phenylephrine|phenylephrine|mesh-list
56953694|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
56953695|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56953696|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56953697|NCT03751631|Tropicamide|tropicamide|mesh-list
56953698|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56953699|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
56953700|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
56953701|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953702|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953703|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
56953704|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56953705|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
56953706|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
56953707|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56953708|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56953709|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56953710|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953711|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953712|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953713|NCT03751631|Protective Agents|protective agents|mesh-ancestor
56953714|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56953715|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56953716|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
56953717|NCT03866681|Sirolimus|sirolimus|mesh-list
56953718|NCT03866681|Warfarin|warfarin|mesh-list
56953719|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953720|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953721|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56953722|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953723|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
56953724|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56953725|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
56953726|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953727|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
56953728|NCT03649659|Fluorides|fluorides|mesh-list
56953729|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
56953730|NCT03649659|Protective Agents|protective agents|mesh-ancestor
56953731|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953732|NCT03736369|Esomeprazole|esomeprazole|mesh-list
56953733|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56953734|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56953735|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56953736|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953737|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953738|NCT03867695|Ropivacaine|ropivacaine|mesh-list
56953739|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
56953740|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
56953741|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953742|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953743|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
56953744|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953745|NCT03579771|Gemcitabine|gemcitabine|mesh-list
56953746|NCT03579771|Paclitaxel|paclitaxel|mesh-list
56953747|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56953748|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56953749|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953750|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
56953751|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
56953752|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
56953753|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953754|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56953755|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
56953756|NCT03579771|Antiviral Agents|antiviral agents|mesh-ancestor
56953757|NCT03579771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953758|NCT03579771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953759|NCT03579771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56953760|NCT03579771|Immunologic Factors|immunologic factors|mesh-ancestor
56953761|NCT03579771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953763|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
56953764|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953765|NCT01172171|Protective Agents|protective agents|mesh-ancestor
56953766|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953767|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953768|NCT03655717|Ethanol|ethanol|mesh-list
56953769|NCT03655717|Dronabinol|dronabinol|mesh-list
56953770|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56953771|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953772|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953773|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953774|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
56953775|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56953776|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56953777|NCT03655717|Analgesics|analgesics|mesh-ancestor
56953778|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
56953779|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953780|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56953781|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56953782|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953783|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953784|NCT03655717|Hormones|hormones|mesh-ancestor
56953785|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56953786|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
56953787|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56953788|NCT03222531|Velpatasvir|velpatasvir|mesh-list
56953789|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
56953790|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953791|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
56953792|NCT03867071|Hematinics|hematinics|mesh-ancestor
56953793|NCT04911166|Atezolizumab|atezolizumab|mesh-list
56953794|NCT04911166|Interleukin-12|interleukin-12|mesh-list
56953795|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953796|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56953797|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
56953798|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953799|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56953800|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56953801|NCT04911166|Growth Substances|growth substances|mesh-ancestor
56953802|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
56953803|NCT01284413|Gemcitabine|gemcitabine|mesh-list
56953804|NCT01284413|Cisplatin|cisplatin|mesh-list
56953805|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953806|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56953807|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
56953808|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953809|NCT01284413|Antiviral Agents|antiviral agents|mesh-ancestor
56953810|NCT01284413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953811|NCT01284413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953812|NCT01284413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56953813|NCT01284413|Immunologic Factors|immunologic factors|mesh-ancestor
56953814|NCT01284413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953815|NCT05152017|Vaccines|vaccines|mesh-list
56953816|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
56953817|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953818|NCT03866993|Paclitaxel|paclitaxel|mesh-list
56953819|NCT03866993|Carboplatin|carboplatin|mesh-list
56636216|NCT00562861|Citalopram|citalopram|mesh-list
56953820|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56953821|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953822|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56953823|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
56953824|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56953825|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953826|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
56953827|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56953828|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
56953829|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953830|NCT05142735|Expectorants|expectorants|mesh-ancestor
56953831|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
56953832|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56953833|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
56953834|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953835|NCT05142735|Protective Agents|protective agents|mesh-ancestor
56953836|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953837|NCT05142735|Antidotes|antidotes|mesh-ancestor
56953838|NCT01172405|Ibuprofen|ibuprofen|mesh-list
56953839|NCT01172405|Caffeine|caffeine|mesh-list
56953840|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56953841|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56953842|NCT01172405|Analgesics|analgesics|mesh-ancestor
56953843|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
56953844|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953845|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953846|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56953847|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953848|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56953849|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953850|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953851|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56953852|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56953853|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56953854|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56953855|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
56953856|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953857|NCT03375424|Vedolizumab|vedolizumab|mesh-list
56953858|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56953859|NCT03187197|Dabigatran|dabigatran|mesh-list
56953860|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
56953861|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56953862|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
56953863|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953864|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953865|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
56953866|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
56953867|NCT01284647|Sucralfate|sucralfate|mesh-list
56953868|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56953869|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56953870|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953871|NCT04000009|Pimavanserin|pimavanserin|mesh-list
56953872|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56953873|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56953874|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56953875|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56953876|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56953877|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953878|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56953879|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56953880|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56953881|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
56953882|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953883|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953884|NCT03282240|Vaccines|vaccines|mesh-list
56953885|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
56953886|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953887|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
56953888|NCT01284725|Azathioprine|azathioprine|mesh-list
56953889|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56953890|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56953891|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874721|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56953892|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56953893|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
56953894|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953895|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636254|NCT02798510|Gemcitabine|gemcitabine|mesh-list
56953896|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953897|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953898|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
56953899|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56953900|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
56953901|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953902|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953903|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
56953904|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56953905|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56953907|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
56953908|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953909|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56953910|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56953911|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56953912|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953913|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953914|NCT03744091|Dronabinol|dronabinol|mesh-list
56953915|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
56953916|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953917|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56953918|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56953919|NCT03744091|Analgesics|analgesics|mesh-ancestor
56953920|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
56953921|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56953922|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56953923|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56953924|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953925|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953926|NCT03744091|Hormones|hormones|mesh-ancestor
56953927|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56953928|NCT03376594|Loratadine|loratadine|mesh-list
56953929|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
56953930|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
56953931|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56953932|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56953933|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56953934|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
56953935|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
56953936|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953937|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953938|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953939|NCT03381664|Quinidine|quinidine|mesh-list
56953940|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
56953941|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
56953942|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
56953943|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56953944|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56953945|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953946|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953947|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953948|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56953949|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56953950|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953951|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56953952|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
56953953|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56953954|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56953955|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953956|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953957|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56953958|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56953959|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
56953960|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56953961|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56953962|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55735468|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56953963|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56953964|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56953965|NCT04060758|Latanoprost|latanoprost|mesh-list
56953966|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56953967|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56953968|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56953969|NCT03863405|Metformin|metformin|mesh-list
56953970|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56636322|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953971|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953973|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56953974|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953975|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56953976|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56953977|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56953978|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953979|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56953980|NCT04024891|Phentolamine|phentolamine|mesh-list
56953981|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56953982|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56953983|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56953984|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56953985|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56953986|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56953987|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56953988|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56953989|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56953990|NCT01178021|Chloroquine|chloroquine|mesh-list
56953991|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56953992|NCT01178021|Primaquine|primaquine|mesh-list
56953993|NCT01178021|Amebicides|amebicides|mesh-ancestor
56953994|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56953995|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56953996|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56953997|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
56953998|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56953999|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56954000|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56954001|NCT01178021|Analgesics|analgesics|mesh-ancestor
56954002|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
56954003|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954004|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954005|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954006|NCT01178021|Filaricides|filaricides|mesh-ancestor
56954007|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
56954008|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
56954009|NCT03250182|Budesonide|budesonide|mesh-list
56954010|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
56954011|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
56954012|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954013|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56954014|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
56954015|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954016|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954017|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56954018|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
56954019|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
56954020|NCT03250182|Hormones|hormones|mesh-ancestor
56954021|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56954022|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56954023|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56954024|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56954025|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
56954026|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954027|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954028|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56954029|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56954030|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56954031|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
56954032|NCT04478734|Thiamine|thiamine|mesh-list
56954033|NCT04478734|Biotin|biotin|mesh-list
56954034|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
56954035|NCT04478734|Vitamins|vitamins|mesh-ancestor
56954036|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
56954037|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954038|NCT01173263|Propofol|propofol|mesh-list
56954039|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56954040|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954041|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954042|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56954043|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
56954044|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
56954045|NCT03381430|Gefitinib|gefitinib|mesh-list
56636424|NCT04258163|Letrozole|letrozole|mesh-list
56954046|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954047|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56954048|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954049|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954051|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56954052|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56954053|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954054|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954055|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
56954056|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954057|NCT03993379|Ipilimumab|ipilimumab|mesh-list
56954058|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954059|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954060|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56954061|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954062|NCT03866447|Vitamin D|vitamin d|mesh-list
56954063|NCT03866447|Adapalene|adapalene|mesh-list
56954064|NCT03866447|Vitamins|vitamins|mesh-ancestor
56954065|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
56954066|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954067|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56954068|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56954069|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56954070|NCT03866447|Analgesics|analgesics|mesh-ancestor
56954071|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
56954072|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954073|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954074|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56954075|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
56954076|NCT01175291|Leucovorin|leucovorin|mesh-list
56954077|NCT01175291|Bevacizumab|bevacizumab|mesh-list
56954078|NCT01175291|Fluorouracil|fluorouracil|mesh-list
56954079|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
56954080|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
56954081|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954082|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954083|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56954084|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56954085|NCT01175291|Growth Substances|growth substances|mesh-ancestor
56954086|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954087|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
56954088|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
56954089|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954090|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56954091|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954092|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
56954093|NCT01175291|Antidotes|antidotes|mesh-ancestor
56954094|NCT01175291|Protective Agents|protective agents|mesh-ancestor
56954095|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
56954096|NCT01175291|Vitamins|vitamins|mesh-ancestor
56954097|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
56954098|NCT03230266|Insulin|insulin|mesh-list
56954099|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56954100|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954101|NCT03732469|Acetaminophen|acetaminophen|mesh-list
56954102|NCT03732469|Fentanyl|fentanyl|mesh-list
56954103|NCT03732469|Propofol|propofol|mesh-list
56954104|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56954105|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954106|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954107|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56954108|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
56954109|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
56954110|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56954111|NCT03732469|Narcotics|narcotics|mesh-ancestor
56954112|NCT03732469|Analgesics|analgesics|mesh-ancestor
56954113|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
56954114|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954115|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56954116|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56954117|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
56954118|NCT03381352|Capecitabine|capecitabine|mesh-list
56954119|NCT03381352|Mitomycins|mitomycins|mesh-list
56954120|NCT03381352|Mitomycin|mitomycin|mesh-list
56954121|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56954122|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
56954123|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954124|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954125|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56954126|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
56954127|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56954128|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954129|NCT03735433|Aspirin|aspirin|mesh-list
56954130|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56954131|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56954132|NCT03735433|Analgesics|analgesics|mesh-ancestor
56954133|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
56954134|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954135|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954136|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954137|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56954138|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56954139|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56954140|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954141|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56954142|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56954143|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954144|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
56954145|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
56954146|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56954147|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
56954148|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954149|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954150|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56954151|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
56954152|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56954153|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954154|NCT03381118|Cytarabine|cytarabine|mesh-list
56954155|NCT03381118|Nivolumab|nivolumab|mesh-list
56954156|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954157|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954158|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56954159|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954160|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56954161|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
56954162|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
56954163|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954164|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954165|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
56954166|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954167|NCT03375112|Bupivacaine|bupivacaine|mesh-list
56954168|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
56954169|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
56954170|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954171|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954172|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
56954173|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954174|NCT02954575|Factor VIII|factor viii|mesh-list
56954175|NCT02954575|Coagulants|coagulants|mesh-ancestor
56954176|NCT02997358|Doxorubicin|doxorubicin|mesh-list
56954177|NCT02997358|Trabectedin|trabectedin|mesh-list
56954178|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56954179|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954180|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56954181|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56954182|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954183|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954184|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56954185|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
56954186|NCT03375034|Clonazepam|clonazepam|mesh-list
56954187|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
56954188|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
56954189|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
56954190|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954191|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954192|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954193|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
56954194|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56954195|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
56954196|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954197|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
56954198|NCT03381040|Protective Agents|protective agents|mesh-ancestor
56954199|NCT03376048|Ropivacaine|ropivacaine|mesh-list
56636553|NCT02797340|Metformin|metformin|mesh-list
56954200|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
56954201|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
56954202|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954203|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954204|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
56954205|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954206|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
56954207|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
56954208|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56954209|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954210|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56954211|NCT01285037|Gemcitabine|gemcitabine|mesh-list
56954212|NCT01285037|Cetuximab|cetuximab|mesh-list
56954213|NCT01285037|Ramucirumab|ramucirumab|mesh-list
56954214|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954215|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56954216|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
56954217|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954218|NCT01285037|Antiviral Agents|antiviral agents|mesh-ancestor
56954219|NCT01285037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954220|NCT01285037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954221|NCT01285037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954222|NCT01285037|Immunologic Factors|immunologic factors|mesh-ancestor
56954223|NCT01285037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954224|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954225|NCT03732391|Carboplatin|carboplatin|mesh-list
56954226|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
56954227|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954228|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954229|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
56954230|NCT03374722|Narcotics|narcotics|mesh-ancestor
56954231|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954232|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954233|NCT03374722|Analgesics|analgesics|mesh-ancestor
56954234|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
56954235|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954236|NCT03207243|Fluticasone|fluticasone|mesh-list
56954237|NCT03207243|Xhance|xhance|mesh-list
56954238|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56954239|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954240|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56954241|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
56954242|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954243|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954244|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56954245|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
56954246|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
56954247|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56954248|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56954249|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56954250|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56954251|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
56954252|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954253|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954254|NCT01285271|Sevoflurane|sevoflurane|mesh-list
56954255|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56954256|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56954257|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
56954258|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
56954259|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954260|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954261|NCT03982069|Vaccines|vaccines|mesh-list
56954262|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
56954263|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954264|NCT03219723|Amoxicillin|amoxicillin|mesh-list
56954265|NCT03219723|Metronidazole|metronidazole|mesh-list
56954266|NCT03219723|Clarithromycin|clarithromycin|mesh-list
56954267|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56954268|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954269|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56954270|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56954271|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56954272|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954273|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954274|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56954275|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56954276|NCT03628417|Bleomycin|bleomycin|mesh-list
56954277|NCT03628417|Calcium|calcium|mesh-list
56954278|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56954279|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954280|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56954281|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954282|NCT03369964|Atezolizumab|atezolizumab|mesh-list
56954283|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
56954284|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954285|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954286|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
56954287|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954288|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954289|NCT01173809|Amiodarone|amiodarone|mesh-list
56954290|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56954291|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
56954292|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56954293|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56954294|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954295|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56954296|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56954297|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56954298|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954299|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56954300|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56954301|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56954302|NCT03375580|Metformin|metformin|mesh-list
56954303|NCT03375580|Simvastatin|simvastatin|mesh-list
56954304|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56954305|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954306|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56954307|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56954308|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
56954309|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954310|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56954311|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56954312|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954313|NCT03340896|Docetaxel|docetaxel|mesh-list
56954314|NCT03340896|Fluorouracil|fluorouracil|mesh-list
56954315|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954316|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
56954317|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
56954318|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
56954319|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954320|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
56954321|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56954322|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954323|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
56954324|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954325|NCT03282981|Timolol|timolol|mesh-list
56954326|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56954327|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56954328|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
56954329|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954330|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954331|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954332|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56954333|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56954334|NCT01286909|Lycopene|lycopene|mesh-list
56954335|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954336|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
56954337|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954338|NCT01286909|Protective Agents|protective agents|mesh-ancestor
56954339|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954340|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56954341|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56954342|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954343|NCT02954887|Cannabidiol|cannabidiol|mesh-list
56954344|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
56954345|NCT03860129|Sevoflurane|sevoflurane|mesh-list
56954346|NCT03860129|Desflurane|desflurane|mesh-list
56954347|NCT03860129|Isoflurane|isoflurane|mesh-list
56954348|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56954349|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56636701|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56954351|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
56954352|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954353|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954354|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56954355|NCT03369808|Vaccines|vaccines|mesh-list
56954356|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
56954357|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954358|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56954359|NCT03369808|Antacids|antacids|mesh-ancestor
56954360|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954361|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56954362|NCT02525237|Apatinib|apatinib|mesh-list
56954363|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954364|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56954365|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954366|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954367|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
56954368|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954369|NCT03369574|Reslizumab|reslizumab|mesh-list
56954370|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56954371|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
56954372|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56954373|NCT02651740|Rifaximin|rifaximin|mesh-list
56954374|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56954375|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954376|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56954377|NCT03862391|Analgesics|analgesics|mesh-list
56954378|NCT03862391|Antiemetics|antiemetics|mesh-list
56954379|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
56954380|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954381|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954382|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
56954383|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56954384|NCT03859583|Capsaicin|capsaicin|mesh-list
56954385|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
56954386|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56954387|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
56954388|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954389|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954390|NCT03369262|Atosiban|atosiban|mesh-list
56954391|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
56954392|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56954393|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954394|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
56954395|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56954396|NCT03276078|Bromides|bromides|mesh-list
56954397|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
56954398|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56954399|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
56954400|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954401|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954402|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56954403|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
56954404|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56954405|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56954406|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56954407|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
56954408|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954409|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954410|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
56954411|NCT01288547|Theobromine|theobromine|mesh-list
56954412|NCT01288547|Caffeine|caffeine|mesh-list
56954413|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56954414|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954415|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56954416|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954417|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954418|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56954419|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56954420|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
56954421|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954422|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56954423|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
56636777|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56954424|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954425|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56954426|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
56954427|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
56954428|NCT03373864|Anesthetics|anesthetics|mesh-list
56954429|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954430|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954432|NCT04597320|Midazolam|midazolam|mesh-list
56954433|NCT04597320|Esketamine|esketamine|mesh-list
56954434|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56954435|NCT04597320|Narcotics|narcotics|mesh-ancestor
56954436|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954437|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954438|NCT04597320|Analgesics|analgesics|mesh-ancestor
56954439|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
56954440|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954441|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56954442|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56954443|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
56954444|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
56954445|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56954446|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56954447|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56954448|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56954449|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
56954450|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
56954451|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954452|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954453|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
56954454|NCT03373708|Tamoxifen|tamoxifen|mesh-list
56954455|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
56954456|NCT03373708|Docetaxel|docetaxel|mesh-list
56954457|NCT03373708|Letrozole|letrozole|mesh-list
56954458|NCT03373708|Epirubicin|epirubicin|mesh-list
56954459|NCT03373708|Goserelin|goserelin|mesh-list
56954460|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954461|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
56954462|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954463|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56954464|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56954465|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
56954466|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954467|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954468|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56954469|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56954470|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56954471|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56954472|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56954473|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56954474|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954475|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56954476|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
56954477|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56954478|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56954479|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56954480|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56954481|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56954482|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56954483|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56954484|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56954485|NCT02519608|Aspirin|aspirin|mesh-list
56954486|NCT02519608|Clopidogrel|clopidogrel|mesh-list
56954487|NCT02519608|Ticagrelor|ticagrelor|mesh-list
56954488|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56954489|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56954490|NCT02519608|Analgesics|analgesics|mesh-ancestor
56954491|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
56954492|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954493|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954494|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954495|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56954496|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56954497|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56954498|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954499|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56954500|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56954501|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954502|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
56954503|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56954504|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56954505|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56954506|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
56954507|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954508|NCT05181852|Pregabalin|pregabalin|mesh-list
56954509|NCT05181852|Analgesics|analgesics|mesh-ancestor
56954510|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
56954511|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954512|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954513|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
56954514|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56954515|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56954516|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954517|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56954518|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56954519|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56954520|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954521|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56954522|NCT04584684|Ethanol|ethanol|mesh-list
56954523|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56954524|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
56954525|NCT04584684|Povidone|povidone|mesh-list
56954526|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56954527|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954528|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954529|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954530|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
56954531|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
56954532|NCT03748823|Ravulizumab|ravulizumab|mesh-list
56954533|NCT03748823|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56954534|NCT03748823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954535|NCT03748823|Immunologic Factors|immunologic factors|mesh-ancestor
56954536|NCT03748823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954537|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
56954538|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56954539|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56954540|NCT03124420|Amoxicillin|amoxicillin|mesh-list
56954541|NCT03124420|Clarithromycin|clarithromycin|mesh-list
56954542|NCT03124420|Lansoprazole|lansoprazole|mesh-list
56954543|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
56954544|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56954545|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954546|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56954547|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954548|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954549|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56954550|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56954551|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56954552|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56954553|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56954554|NCT03231228|Cefazolin|cefazolin|mesh-list
56954555|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56954556|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954557|NCT03510468|Pyridoxine|pyridoxine|mesh-list
56954558|NCT03510468|Isoniazid|isoniazid|mesh-list
56954559|NCT03510468|Rifapentine|rifapentine|mesh-list
56954560|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
56954561|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56954562|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954563|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56954564|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56954565|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
56954566|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954567|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56954568|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
56954569|NCT03510468|Vitamins|vitamins|mesh-ancestor
56954570|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
56954571|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954572|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56954573|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
56954574|NCT01178645|Cytarabine|cytarabine|mesh-list
56954575|NCT01178645|Etoposide|etoposide|mesh-list
56954576|NCT01178645|Melphalan|melphalan|mesh-list
56954577|NCT01178645|Busulfan|busulfan|mesh-list
56954578|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56954580|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56954581|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56954582|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954583|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954584|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56954585|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
56954586|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
56954587|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954588|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954589|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
56954590|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954591|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56954592|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
56954593|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56954594|NCT01285505|Alprazolam|alprazolam|mesh-list
56954595|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56954596|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954597|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954598|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56954599|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56954600|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56954601|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
56954602|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
56954603|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954604|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954605|NCT03372850|Esomeprazole|esomeprazole|mesh-list
56954606|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56954607|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56954608|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56954609|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954610|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954611|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
56954612|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56954613|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
56954614|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954615|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
56954616|NCT04525066|Protective Agents|protective agents|mesh-ancestor
56954617|NCT03230838|Meropenem|meropenem|mesh-list
56954618|NCT03230838|Tazobactam|tazobactam|mesh-list
56954619|NCT03230838|Ceftolozane|ceftolozane|mesh-list
56954620|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56954621|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56954622|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954623|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56954624|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954625|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954626|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56954627|NCT03230838|Renal Agents|renal agents|mesh-ancestor
56954628|NCT03362788|Vitamin K|vitamin k|mesh-list
56954629|NCT03362788|Anticoagulants|anticoagulants|mesh-list
56954630|NCT03362788|Vitamins|vitamins|mesh-ancestor
56954631|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
56954632|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954633|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56954634|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56954635|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954636|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
56954637|NCT03362788|Coagulants|coagulants|mesh-ancestor
56954638|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
56954639|NCT03368794|Narcotics|narcotics|mesh-ancestor
56954640|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954641|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954642|NCT03368794|Analgesics|analgesics|mesh-ancestor
56954643|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
56954644|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954645|NCT03862079|Tazobactam|tazobactam|mesh-list
56954646|NCT03862079|Piperacillin|piperacillin|mesh-list
56954647|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56954648|NCT03862079|Nystatin|nystatin|mesh-list
56954649|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55735786|NCT05283161|Dronabinol|dronabinol|mesh-list
56954650|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637027|NCT03110822|Hormones|hormones|mesh-ancestor
56954651|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56954652|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954653|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954654|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
56954655|NCT03862079|Ionophores|ionophores|mesh-ancestor
56954656|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56954657|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56954658|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954659|NCT01179269|Paclitaxel|paclitaxel|mesh-list
56954660|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56954661|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954662|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
56954663|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
56954664|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
56954665|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954666|NCT00165724|Donepezil|donepezil|mesh-list
56954667|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56954668|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954669|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954670|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
56954671|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954672|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954673|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
56954674|NCT01287455|Vitamin D|vitamin d|mesh-list
56954675|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
56954676|NCT01287455|Vitamins|vitamins|mesh-ancestor
56954677|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
56954678|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954679|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56954680|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56954681|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56954682|NCT04965090|Lazertinib|lazertinib|mesh-list
56954683|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56954684|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954685|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954686|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954687|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954688|NCT03865511|Osimertinib|osimertinib|mesh-list
56954689|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954690|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56954691|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954692|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954693|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
56954694|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954695|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954696|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
56954697|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56954698|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954699|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56954700|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56954701|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
56954702|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56954703|NCT01287689|Antibodies|antibodies|mesh-list
56954704|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
56954705|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
56954706|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954707|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
56954708|NCT01179503|Vitamin D|vitamin d|mesh-list
56954709|NCT01179503|Calcium|calcium|mesh-list
56954710|NCT01179503|Vitamins|vitamins|mesh-ancestor
56954711|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
56954712|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954713|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56954714|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56954715|NCT03117049|Paclitaxel|paclitaxel|mesh-list
56954716|NCT03117049|Bevacizumab|bevacizumab|mesh-list
56954717|NCT03117049|Carboplatin|carboplatin|mesh-list
56954718|NCT03117049|Nivolumab|nivolumab|mesh-list
56954719|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56954720|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954721|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
56954722|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
56954723|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
56954724|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875565|NCT03726996|Desipramine|desipramine|mesh-list
56954725|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954726|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56954727|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56954728|NCT03117049|Growth Substances|growth substances|mesh-ancestor
56954729|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954730|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
56954731|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56954732|NCT03372304|Ropivacaine|ropivacaine|mesh-list
56954733|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
56954734|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
56954735|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954736|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954737|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
56954738|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954739|NCT02525081|Ramipril|ramipril|mesh-list
56954740|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56954741|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
56954742|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954743|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954744|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56954745|NCT05566548|Bilirubin|bilirubin|mesh-list
56954746|NCT05566548|Antioxidants|antioxidants|mesh-ancestor
56954747|NCT05566548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954748|NCT05566548|Protective Agents|protective agents|mesh-ancestor
56954749|NCT05566548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954750|NCT02525003|Vitamin D|vitamin d|mesh-list
56954751|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
56954752|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
56954753|NCT02525003|Vitamins|vitamins|mesh-list
56954754|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
56954755|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954756|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56954757|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56954758|NCT05181150|Glucagon|glucagon|mesh-list
56954759|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56954760|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56954761|NCT05181150|Hormones|hormones|mesh-ancestor
56954762|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56954763|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954764|NCT05181150|Incretins|incretins|mesh-ancestor
56954765|NCT03464448|Teriflunomide|teriflunomide|mesh-list
56954766|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56954767|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56954768|NCT03464448|Analgesics|analgesics|mesh-ancestor
56954769|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
56954770|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954771|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954772|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954773|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56954774|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954775|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
56954776|NCT03362008|Varenicline|varenicline|mesh-list
56954777|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56954778|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56954779|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
56954780|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954781|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954782|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954783|NCT03123406|Cinacalcet|cinacalcet|mesh-list
56954784|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56954785|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954786|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56954787|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
56954788|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56954789|NCT01179659|Pantoprazole|pantoprazole|mesh-list
56954790|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56954791|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56954792|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56954793|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954794|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954795|NCT04523818|Fluorouracil|fluorouracil|mesh-list
56954796|NCT04523818|Capecitabine|capecitabine|mesh-list
56954797|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
56954798|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954799|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56954800|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954801|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954802|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
56637146|NCT02783846|Analgesics|analgesics|mesh-ancestor
56954803|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954805|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
56954806|NCT03361774|Protective Agents|protective agents|mesh-ancestor
56954807|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954808|NCT04523740|Acetaminophen|acetaminophen|mesh-list
56954809|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56954810|NCT04523740|Analgesics|analgesics|mesh-ancestor
56954811|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
56954812|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954813|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954814|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
56954815|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
56954816|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56954817|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
56954818|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56954819|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
56954820|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954821|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954822|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
56954823|NCT04523662|Apatinib|apatinib|mesh-list
56954824|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954825|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56954826|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954827|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954828|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
56954829|NCT03371992|Nivolumab|nivolumab|mesh-list
56954830|NCT03371992|Atezolizumab|atezolizumab|mesh-list
56954831|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56954832|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954833|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56954834|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954835|NCT03682705|Upadacitinib|upadacitinib|mesh-list
56954836|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56954837|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56954838|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954839|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954840|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56954841|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
56954842|NCT03361618|Astringents|astringents|mesh-ancestor
56954843|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954844|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
56954845|NCT01314495|Abatacept|abatacept|mesh-list
56954846|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56954847|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954848|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954849|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954850|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
56954851|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954852|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56954853|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56954854|NCT03123484|Gefitinib|gefitinib|mesh-list
56954855|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954856|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56954857|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954858|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954859|NCT03179787|Aripiprazole|aripiprazole|mesh-list
56954860|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
56954861|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56954862|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56954863|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56954864|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954865|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954866|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
56954867|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
56954868|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954869|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954870|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56954871|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56954872|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
56954873|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56954874|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56954875|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56954876|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56954877|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
56954878|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
56954879|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
56954880|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954881|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
56954882|NCT02956057|Protective Agents|protective agents|mesh-ancestor
56954883|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954884|NCT02956057|Vitamins|vitamins|mesh-ancestor
56954885|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
56954886|NCT02956057|Cathartics|cathartics|mesh-ancestor
56954887|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56954888|NCT04526470|Paclitaxel|paclitaxel|mesh-list
56954889|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56954890|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954891|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56954892|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56954893|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56954894|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954895|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
56954896|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56954897|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954898|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
56954899|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56954900|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56954901|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56954902|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
56954903|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56954904|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954905|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954906|NCT04526236|Methadone|methadone|mesh-list
56954907|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56954908|NCT04526236|Narcotics|narcotics|mesh-ancestor
56954909|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56954910|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954911|NCT04526236|Analgesics|analgesics|mesh-ancestor
56954912|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
56954913|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954914|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
56954915|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
56954916|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
56954917|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56954918|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56954919|NCT01179971|Analgesics|analgesics|mesh-ancestor
56954920|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
56954921|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56954922|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954923|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56954924|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56954925|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56954926|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
56954927|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954928|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56954929|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
56954930|NCT04237584|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56954931|NCT04237584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954932|NCT03681691|Estradiol|estradiol|mesh-list
56954933|NCT03681691|Estrogens|estrogens|mesh-ancestor
56954934|NCT03681691|Hormones|hormones|mesh-ancestor
56954935|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56954936|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954937|NCT01289171|Glycolic acid|glycolic acid|mesh-list
56954938|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
56954939|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
56954940|NCT03360760|Doxorubicin|doxorubicin|mesh-list
56954941|NCT03360760|Methotrexate|methotrexate|mesh-list
56954942|NCT03360760|Ifosfamide|ifosfamide|mesh-list
56954943|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
56954944|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954945|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56954946|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56954947|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56954948|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735787|NCT05283161|Cannabidiol|cannabidiol|mesh-list
56954949|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954950|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56954951|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
56954952|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56954953|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954954|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56954955|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
56954956|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
56954957|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56954958|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56954959|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
56954960|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56954961|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56954962|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56954963|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
56954965|NCT01285661|Warfarin|warfarin|mesh-list
56954966|NCT01285661|Anticoagulants|anticoagulants|mesh-list
56954967|NCT01285661|Vitamins|vitamins|mesh-ancestor
56954968|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
56954969|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56954970|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56954971|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56954972|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954973|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
56954974|NCT01285661|Coagulants|coagulants|mesh-ancestor
56954975|NCT03360682|Tenofovir|tenofovir|mesh-list
56954976|NCT03360682|Lamivudine|lamivudine|mesh-list
56954977|NCT03360682|Emtricitabine|emtricitabine|mesh-list
56954978|NCT03360682|Dolutegravir|dolutegravir|mesh-list
56954979|NCT03360682|Abacavir|abacavir|mesh-list
56954980|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
56954981|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56954982|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56954983|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56954984|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56954985|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954986|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56954987|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56954988|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56954989|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56954990|NCT01180205|Amlodipine|amlodipine|mesh-list
56954991|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56954992|NCT01180205|Telmisartan|telmisartan|mesh-list
56954993|NCT01180205|Olmesartan|olmesartan|mesh-list
56954994|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56954995|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56954996|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56954997|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56954998|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56954999|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56955000|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955001|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
56955002|NCT01180205|Diuretics|diuretics|mesh-ancestor
56955003|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
56955004|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56955005|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56955006|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56955007|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
56955008|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56955009|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56955010|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955011|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
56955012|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955013|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955014|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
56955015|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56955016|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955017|NCT03860831|Midazolam|midazolam|mesh-list
56955018|NCT03860831|Ketamine|ketamine|mesh-list
56955019|NCT03860831|Analgesics|analgesics|mesh-ancestor
56955020|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
56955021|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955022|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955023|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56955024|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56875866|NCT05281926|Nivolumab|nivolumab|mesh-list
56955025|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
56955026|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
56955027|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955028|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56955029|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56955030|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955031|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955032|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56955033|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56955034|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56955035|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56955036|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56955037|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
56955038|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
56955040|NCT04006210|Carbidopa|carbidopa|mesh-list
56955041|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56955042|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56955043|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
56955044|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955045|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955046|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955047|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56955048|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955049|NCT01064479|Cisplatin|cisplatin|mesh-list
56955050|NCT01064479|Carboplatin|carboplatin|mesh-list
56955051|NCT01064479|Docetaxel|docetaxel|mesh-list
56955052|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56955053|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955054|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
56955055|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
56955056|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
56955057|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955058|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56955059|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955060|NCT04218708|Nicotine|nicotine|mesh-list
56955061|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56955062|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
56955063|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955064|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955065|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56955066|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56955067|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
56955068|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955069|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955070|NCT03667326|Aspirin|aspirin|mesh-list
56955071|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56955072|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56955073|NCT03667326|Analgesics|analgesics|mesh-ancestor
56955074|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
56955075|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955076|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955077|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955078|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56955079|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56955080|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56955081|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955082|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56955083|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56955084|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955085|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
56955086|NCT04525300|Liraglutide|liraglutide|mesh-list
56955087|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56955088|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955089|NCT04525300|Incretins|incretins|mesh-ancestor
56955090|NCT04525300|Hormones|hormones|mesh-ancestor
56955091|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955092|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
56955093|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56955094|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955095|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955096|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56955097|NCT05305248|Analgesics|analgesics|mesh-ancestor
56955098|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
55735788|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
56875940|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56955099|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955100|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56955101|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56955102|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56955103|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
56955104|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955105|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955106|NCT03865121|Nicotine|nicotine|mesh-list
56955107|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56955108|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
56955109|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955110|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955111|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56955112|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56955113|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
56955114|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955115|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955116|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
56955117|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56955118|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
56955119|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955120|NCT03680911|Expectorants|expectorants|mesh-ancestor
56955121|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
56955122|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56955123|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
56955124|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955125|NCT03680911|Protective Agents|protective agents|mesh-ancestor
56955126|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955127|NCT03680911|Antidotes|antidotes|mesh-ancestor
56955128|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
56955129|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56955130|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955131|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955132|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56955133|NCT03370588|Analgesics|analgesics|mesh-ancestor
56955134|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
56955135|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955136|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56955137|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56955138|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56955139|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
56955140|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955141|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955142|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
56955143|NCT05156814|Progestins|progestins|mesh-ancestor
56955144|NCT05156814|Hormones|hormones|mesh-ancestor
56955145|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955146|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955147|NCT01289483|Fospropofol|fospropofol|mesh-list
56955148|NCT01289483|Propofol|propofol|mesh-list
56955149|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56955150|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955151|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955152|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56955153|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
56955154|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
56955155|NCT03680521|Nivolumab|nivolumab|mesh-list
56955156|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56955157|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955158|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56955159|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955160|NCT01289327|Midazolam|midazolam|mesh-list
56955161|NCT01289327|Alfentanil|alfentanil|mesh-list
56955162|NCT01289327|Propofol|propofol|mesh-list
56955163|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56955164|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955165|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955166|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56955167|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
56955168|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
56955169|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56955170|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56955171|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56955172|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56955173|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
56955174|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
56955175|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955176|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955177|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56955178|NCT01289327|Narcotics|narcotics|mesh-ancestor
56955179|NCT01289327|Analgesics|analgesics|mesh-ancestor
56955180|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
56955181|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955183|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
56955184|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955185|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56955186|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
56955187|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955188|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955189|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56955190|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
56955191|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
56955192|NCT01181063|Hormones|hormones|mesh-ancestor
56955193|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955194|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56955195|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56955196|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56955197|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
56955198|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955199|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955200|NCT02596997|Brincidofovir|brincidofovir|mesh-list
56955201|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
56955202|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955203|NCT04521868|Sulforaphane|sulforaphane|mesh-list
56955204|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56955205|NCT04521868|Protective Agents|protective agents|mesh-ancestor
56955206|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955207|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955208|NCT03649477|Carbetocin|carbetocin|mesh-list
56955209|NCT03649477|Oxytocin|oxytocin|mesh-list
56955210|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
56955211|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56955212|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955213|NCT03359746|Grazoprevir|grazoprevir|mesh-list
56955214|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56955215|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
56955216|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955217|NCT01310101|Dexamethasone|dexamethasone|mesh-list
56955218|NCT01310101|Ofatumumab|ofatumumab|mesh-list
56955219|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955220|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
56955221|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
56955222|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955223|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955224|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56955225|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
56955226|NCT01310101|Hormones|hormones|mesh-ancestor
56955227|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955228|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56955229|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955230|NCT03639727|Mannitol|mannitol|mesh-list
56955231|NCT03639727|Citric Acid|citric acid|mesh-list
56955232|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
56955233|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56955234|NCT03639727|Diuretics|diuretics|mesh-ancestor
56955235|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
56955236|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955237|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
56955238|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56955239|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
56955240|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
56955241|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955242|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56955243|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56955244|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955245|NCT04523272|Sunitinib|sunitinib|mesh-list
56955246|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955247|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56955248|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56955249|NCT04523272|Growth Substances|growth substances|mesh-ancestor
56955250|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955251|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
56955252|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56955253|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955254|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955255|NCT01289561|Ethanol|ethanol|mesh-list
56955256|NCT01289561|Quinine|quinine|mesh-list
56955257|NCT01289561|Caffeine|caffeine|mesh-list
56955258|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56955259|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955260|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955261|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955262|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56955263|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56955264|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955265|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955266|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56955267|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56955268|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
56955269|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955270|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
56955271|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56955272|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56955273|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56955274|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56955275|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955276|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56955278|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
56955279|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
56955280|NCT03855527|Fluorides|fluorides|mesh-list
56955281|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
56955282|NCT03855527|Protective Agents|protective agents|mesh-ancestor
56955283|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955284|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56955285|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955286|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
56955287|NCT03366064|Pemetrexed|pemetrexed|mesh-list
56955288|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955289|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955290|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955291|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56955292|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56955293|NCT03677401|Serlopitant|serlopitant|mesh-list
56955294|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56955295|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955296|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955297|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955298|NCT03357874|Clopidogrel|clopidogrel|mesh-list
56955299|NCT03357874|Ticagrelor|ticagrelor|mesh-list
56955300|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56955301|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56955302|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56955303|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56955304|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
56955305|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955306|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955307|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955308|NCT01286051|Ganirelix|ganirelix|mesh-list
56955309|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
56955310|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955311|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955312|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56955313|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56955314|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56955315|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56955316|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955317|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955318|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955319|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
56955320|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56955321|NCT02359513|Fluoxetine|fluoxetine|mesh-list
56955322|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
56955323|NCT02359513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56955324|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56955325|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56955326|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955327|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955328|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
56955329|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955330|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56955331|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56955332|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56955333|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56955334|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955335|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
56955336|NCT01184495|Hematinics|hematinics|mesh-ancestor
56955337|NCT03864575|Celecoxib|celecoxib|mesh-list
56955338|NCT03864575|Nivolumab|nivolumab|mesh-list
56955339|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56955340|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955341|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56955342|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955343|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56955344|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56955345|NCT03864575|Analgesics|analgesics|mesh-ancestor
56955346|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
56955347|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955348|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955349|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955350|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56955351|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56955352|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56955353|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955354|NCT03357718|Midazolam|midazolam|mesh-list
56955355|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
56955356|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56955357|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955358|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955359|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56955360|NCT03357718|Analgesics|analgesics|mesh-ancestor
56955361|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
56955362|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955363|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56955364|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56955365|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56955366|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
56955367|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955368|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955369|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56955370|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56955371|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56955372|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56955373|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56955374|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
56955375|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
56955376|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
56955377|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
56955378|NCT04521400|Interferons|interferons|mesh-list
56955379|NCT04521400|Ritonavir|ritonavir|mesh-list
56955380|NCT04521400|Lopinavir|lopinavir|mesh-list
56955381|NCT04521400|Interferon-beta|interferon-beta|mesh-list
56955382|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
56955383|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955384|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
56955385|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955386|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56955387|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56955388|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
56955389|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955390|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955391|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56955392|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56955393|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56955394|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56955395|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
56955396|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955397|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56955398|NCT03864185|Rituximab|rituximab|mesh-list
56955399|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56955400|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955401|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
56955402|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955403|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56955404|NCT01185119|Glucagon|glucagon|mesh-list
56955405|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56955406|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56955408|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955409|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955410|NCT01185119|Incretins|incretins|mesh-ancestor
56955411|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
56955412|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
56955413|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56955414|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56955415|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955416|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56955417|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
56955418|NCT01185197|Prednisolone|prednisolone|mesh-list
56955419|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56955420|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955421|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56955422|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
56955423|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56955424|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955425|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955426|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955427|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955428|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
56955429|NCT01185197|Hormones|hormones|mesh-ancestor
56955430|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955431|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955432|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56955433|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56955434|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
56955435|NCT03733873|Coagulants|coagulants|mesh-ancestor
56955436|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56955437|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
56955438|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955439|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56955440|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
56955441|NCT03733639|Coagulants|coagulants|mesh-ancestor
56955442|NCT03733561|Rotigotine|rotigotine|mesh-list
56955443|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
56955444|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
56955445|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955446|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955447|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955448|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
56955449|NCT03358888|Narcotics|narcotics|mesh-ancestor
56955450|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955451|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955452|NCT03358888|Analgesics|analgesics|mesh-ancestor
56955453|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
56955454|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955455|NCT01291121|Ranibizumab|ranibizumab|mesh-list
56955456|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56955457|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56955458|NCT01291121|Growth Substances|growth substances|mesh-ancestor
56955459|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955460|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
56955461|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955462|NCT01187849|Metformin|metformin|mesh-list
56955463|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56955464|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955465|NCT04522882|Insulin|insulin|mesh-list
56955466|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56955467|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955468|NCT03123718|Methotrexate|methotrexate|mesh-list
56955469|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56955470|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
56955471|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56955472|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955473|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56955474|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
56955475|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955476|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955477|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
56637825|NCT02708628|Heparin|heparin|mesh-list
56955478|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955479|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56955480|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56955481|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
56955482|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56955483|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56955484|NCT01185743|Olanzapine|olanzapine|mesh-list
56955485|NCT01185743|Ziprasidone|ziprasidone|mesh-list
56955486|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
56955487|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
56955488|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955489|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955490|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56955491|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56955492|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56955493|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955494|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56955495|NCT01185743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56955496|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56955497|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56955498|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955499|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955500|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
56955501|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56955502|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56955503|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
56955504|NCT01188005|Vitamins|vitamins|mesh-list
56955505|NCT01188005|Vitamin E|vitamin e|mesh-list
56955506|NCT01188005|Vitamin A|vitamin a|mesh-list
56955507|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
56955508|NCT01188005|Allopurinol|allopurinol|mesh-list
56955509|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56955510|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
56955511|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955512|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
56955513|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955514|NCT01188005|Protective Agents|protective agents|mesh-ancestor
56955515|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
56955516|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955517|NCT01188005|Expectorants|expectorants|mesh-ancestor
56955518|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
56955519|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56955520|NCT01188005|Antidotes|antidotes|mesh-ancestor
56955521|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
56955522|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955523|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
56955524|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56955525|NCT04445194|Vaccines|vaccines|mesh-list
56955526|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
56955527|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955528|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56955529|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
56955530|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56955531|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56955532|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955533|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955534|NCT01291199|Urological Agents|urological agents|mesh-ancestor
56955535|NCT04444726|Betamethasone|betamethasone|mesh-list
56955536|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
56955537|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56955538|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
56955539|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56955540|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955541|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
56955542|NCT04444726|Hormones|hormones|mesh-ancestor
56955543|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955544|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955545|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56955546|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
56955547|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
56955548|NCT03733327|Busulfan|busulfan|mesh-list
56955549|NCT03733327|Etoposide|etoposide|mesh-list
56955550|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56955551|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
56955552|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955553|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56637893|NCT02712528|Sufentanil|sufentanil|mesh-list
56955554|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56955555|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
56955556|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955557|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955558|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56955559|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56955560|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56955561|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56955562|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955563|NCT03733171|Epinephrine|epinephrine|mesh-list
56955564|NCT03733171|Hemostatics|hemostatics|mesh-list
56955565|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56955566|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56955567|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
56955568|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955569|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955570|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955571|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56955572|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56955573|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
56955574|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955575|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56955576|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
56955577|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
56955578|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
56955579|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56955580|NCT03733171|Coagulants|coagulants|mesh-ancestor
56955581|NCT03207750|Vaccines|vaccines|mesh-list
56955582|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56955583|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
56955584|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955585|NCT01185977|Fluoxetine|fluoxetine|mesh-list
56955586|NCT01185977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56955587|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56955588|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56955589|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955590|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955591|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
56955592|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955593|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56955594|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
56955595|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56955596|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56955597|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56955598|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955599|NCT03857399|Caspofungin|caspofungin|mesh-list
56955600|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
56955601|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955602|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955603|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955604|NCT04520620|Enoxaparin|enoxaparin|mesh-list
56955605|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
56955606|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56955607|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56955608|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955609|NCT03857711|Amiodarone|amiodarone|mesh-list
56955610|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56955611|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
56955612|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56955613|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56955614|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955615|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56955616|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56955617|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56955618|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955619|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56955620|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56955621|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55735789|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
56876462|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56955622|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56955623|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56955624|NCT03847896|Budesonide|budesonide|mesh-list
56955625|NCT03847896|Albuterol|albuterol|mesh-list
56955626|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955627|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56637966|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
56955628|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
56955629|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955630|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955631|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56955632|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
56955633|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
56955634|NCT03847896|Hormones|hormones|mesh-ancestor
56955635|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955636|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
56955637|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56955638|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56955639|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56955640|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56955641|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
56955642|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955643|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955644|NCT01186289|Atorvastatin|atorvastatin|mesh-list
56955645|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56955646|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56955647|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
56955648|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955649|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56955650|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56955651|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955652|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56955653|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
56955654|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955655|NCT01291823|Gefitinib|gefitinib|mesh-list
56955656|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955657|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56955658|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955659|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955660|NCT01181765|Infliximab|infliximab|mesh-list
56955661|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
56955662|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56955663|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56955664|NCT01186445|Morphine|morphine|mesh-list
56955665|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56955666|NCT01186445|Narcotics|narcotics|mesh-ancestor
56955667|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955668|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955669|NCT01186445|Analgesics|analgesics|mesh-ancestor
56955670|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
56955671|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955672|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
56955673|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56955674|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955675|NCT04520230|Budesonide|budesonide|mesh-list
56955676|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
56955677|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
56955678|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56955679|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955680|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56955681|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
56955682|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955683|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955684|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56955685|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
56955686|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
56955687|NCT04520230|Hormones|hormones|mesh-ancestor
56955688|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955689|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56955690|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56955691|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56955692|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
56955693|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876537|NCT01205880|Calcitriol|calcitriol|mesh-list
56955694|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955695|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
56955696|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56955697|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
56955698|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
56955699|NCT03619837|Velpatasvir|velpatasvir|mesh-list
56955700|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56955701|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
56955703|NCT03852563|Petrolatum|petrolatum|mesh-list
56955704|NCT03852563|Emollients|emollients|mesh-ancestor
56955705|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
56955706|NCT01188317|Ibuprofen|ibuprofen|mesh-list
56955707|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56955708|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56955709|NCT01188317|Analgesics|analgesics|mesh-ancestor
56955710|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
56955711|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955712|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955713|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955714|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56955715|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56955716|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955717|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955718|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
56955719|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955720|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56955721|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955722|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955723|NCT03739021|Ropivacaine|ropivacaine|mesh-list
56955724|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
56955725|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
56955726|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955727|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955728|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
56955729|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955730|NCT03738943|Pyridoxine|pyridoxine|mesh-list
56955731|NCT03738943|Pyridoxal|pyridoxal|mesh-list
56955732|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
56955733|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
56955734|NCT03738943|Adenosine|adenosine|mesh-list
56955735|NCT03738943|Nitroprusside|nitroprusside|mesh-list
56955736|NCT03738943|Acetylcholine|acetylcholine|mesh-list
56955737|NCT03738943|Vitamins|vitamins|mesh-ancestor
56955738|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
56955739|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955740|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
56955741|NCT03738943|Analgesics|analgesics|mesh-ancestor
56955742|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
56955743|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955744|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56955745|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
56955746|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56955747|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
56955748|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
56955749|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955750|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955751|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56955752|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56955753|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56955754|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
56955755|NCT03178851|Atezolizumab|atezolizumab|mesh-list
56955756|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56955757|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955758|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
56955759|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955760|NCT01291979|Lidocaine|lidocaine|mesh-list
56955761|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
56955762|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
56955763|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955764|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955765|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
56955766|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955767|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56955768|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56955769|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56955770|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56876612|NCT01560390|Ketamine|ketamine|mesh-list
56955771|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955772|NCT04443634|Bupivacaine|bupivacaine|mesh-list
56955773|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
56955774|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
56955775|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955776|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955777|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
56955778|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955779|NCT03643159|Aripiprazole|aripiprazole|mesh-list
56955780|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
56955781|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
56955782|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56955783|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56955784|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955785|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955786|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
56955787|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
56955788|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955789|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955790|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56955791|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56955792|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
56955793|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56955794|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56955795|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56955796|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56955797|NCT03205566|Lamivudine|lamivudine|mesh-list
56955798|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
56955799|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56955800|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56955801|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955802|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955803|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
56955804|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955805|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56955806|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56955807|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56955808|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56955809|NCT01181999|Rituximab|rituximab|mesh-list
56955810|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56955811|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955812|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
56955813|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955814|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56955815|NCT04509232|Fluorides|fluorides|mesh-list
56955816|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
56955817|NCT04509232|Protective Agents|protective agents|mesh-ancestor
56955818|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955819|NCT03732235|Bevacizumab|bevacizumab|mesh-list
56955820|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
56955821|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56955822|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955823|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56955824|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56955825|NCT03732235|Growth Substances|growth substances|mesh-ancestor
56955826|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955827|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
56955828|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56955829|NCT03732235|Estrogens|estrogens|mesh-ancestor
56955830|NCT03732235|Hormones|hormones|mesh-ancestor
56955831|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56955832|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56955833|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
56955834|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56955835|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56955836|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
56955837|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955838|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56955839|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56955840|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955841|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955842|NCT01182077|Midazolam|midazolam|mesh-list
56955843|NCT01182077|Peficitinib|peficitinib|mesh-list
55735870|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
56876683|NCT01303536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56955844|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56955845|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56955846|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955847|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955848|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56955849|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56955850|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56955851|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56955852|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
56955853|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
56955854|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
56955855|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
56955856|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955857|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955858|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955859|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56955860|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
56955861|NCT03618823|Acetaminophen|acetaminophen|mesh-list
56955862|NCT03618823|Ibuprofen|ibuprofen|mesh-list
56955863|NCT03618823|Oxycodone|oxycodone|mesh-list
56955864|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56955865|NCT03618823|Analgesics|analgesics|mesh-ancestor
56955866|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
56955867|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955868|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955869|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
56955870|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56955871|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56955872|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56955873|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56955874|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955875|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955876|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56955877|NCT03618823|Narcotics|narcotics|mesh-ancestor
56955878|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955879|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56955880|NCT01188707|Belinostat|belinostat|mesh-list
56955881|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955882|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56955883|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955884|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955885|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56955886|NCT03356158|Cetuximab|cetuximab|mesh-list
56955887|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56955888|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955889|NCT03356080|Cytarabine|cytarabine|mesh-list
56955890|NCT03356080|Decitabine|decitabine|mesh-list
56955891|NCT03356080|Tretinoin|tretinoin|mesh-list
56955892|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56955893|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
56955894|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955895|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955896|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
56955897|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955898|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56955899|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
56955900|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955901|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955902|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
56955903|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
56955904|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
56955905|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56955906|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56955907|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
56955908|NCT02937636|Fluorides|fluorides|mesh-list
56955909|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
56955910|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
56955911|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
56955912|NCT02937636|Protective Agents|protective agents|mesh-ancestor
56955913|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955914|NCT03638635|Bupivacaine|bupivacaine|mesh-list
56955915|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
56955916|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
56955917|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955918|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736264|NCT03342417|Ipilimumab|ipilimumab|mesh-list
56955919|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
56955920|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955921|NCT02518516|Atorvastatin|atorvastatin|mesh-list
56955922|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56955923|NCT02518516|Simvastatin|simvastatin|mesh-list
56955924|NCT02518516|Pravastatin|pravastatin|mesh-list
56955925|NCT02518516|Lovastatin|lovastatin|mesh-list
56955926|NCT02518516|L 647318|l 647318|mesh-list
56955927|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
56955928|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56955929|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56955930|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
56955931|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955932|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56955933|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56955934|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955935|NCT04508686|Capecitabine|capecitabine|mesh-list
56955936|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56955937|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
56955938|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955939|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56955940|NCT02518438|Tramadol|tramadol|mesh-list
56955941|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56955942|NCT02518438|Narcotics|narcotics|mesh-ancestor
56955943|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955944|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955945|NCT02518438|Analgesics|analgesics|mesh-ancestor
56955946|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
56955947|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955948|NCT04521556|Morphine|morphine|mesh-list
56955949|NCT04521556|Tramadol|tramadol|mesh-list
56955950|NCT04521556|Anesthetics|anesthetics|mesh-list
56955951|NCT04521556|Ropivacaine|ropivacaine|mesh-list
56955952|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56955953|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955954|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56955955|NCT04521556|Narcotics|narcotics|mesh-ancestor
56955956|NCT04521556|Analgesics|analgesics|mesh-ancestor
56955957|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
56955958|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955959|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
56955960|NCT03204279|Palonosetron|palonosetron|mesh-list
56955961|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
56955962|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
56955963|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955964|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955965|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56955966|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56955967|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56955968|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
56955969|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56955970|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955971|NCT02524301|Diprenorphine|diprenorphine|mesh-list
56955972|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56955973|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955974|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
56955975|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56955976|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
56955977|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56955978|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56955979|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955980|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
56955981|NCT03122782|Coagulants|coagulants|mesh-ancestor
56955982|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
56955983|NCT01291433|Tocopherols|tocopherols|mesh-list
56955984|NCT01291433|Vitamin E|vitamin e|mesh-list
56955985|NCT01291433|Tocotrienols|tocotrienols|mesh-list
56955986|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
56955987|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
56955988|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56955989|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56955990|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56955991|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56955992|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56955993|NCT01291433|Protective Agents|protective agents|mesh-ancestor
56955994|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56955995|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
56955996|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56876849|NCT01381354|Riboflavin|riboflavin|mesh-list
56955997|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
56955998|NCT01291433|Vitamins|vitamins|mesh-ancestor
56955999|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
56956000|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56956001|NCT01314144|Bupivacaine|bupivacaine|mesh-list
56956002|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
56956003|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
56956004|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956005|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956006|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
56956007|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638341|NCT02597283|Sirolimus|sirolimus|mesh-list
56956008|NCT02954653|Cytarabine|cytarabine|mesh-list
56956009|NCT02954653|Azacitidine|azacitidine|mesh-list
56956011|NCT02954653|Daunorubicin|daunorubicin|mesh-list
56956012|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56956013|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
56956014|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956015|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956016|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
56956017|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956018|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956019|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
56956020|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956021|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956022|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56956023|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56956024|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56956025|NCT04895748|Everolimus|everolimus|mesh-list
56956026|NCT04895748|Spartalizumab|spartalizumab|mesh-list
56956027|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956028|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956029|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
56956030|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956031|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56956032|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956033|NCT04508452|Bevacizumab|bevacizumab|mesh-list
56956034|NCT04508452|Capecitabine|capecitabine|mesh-list
56956035|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
56956036|NCT04508452|Irinotecan|irinotecan|mesh-list
56956037|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56956038|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956039|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56956040|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56956041|NCT04508452|Growth Substances|growth substances|mesh-ancestor
56956042|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956043|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
56956044|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56956045|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
56956046|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956047|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56956048|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56956049|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956050|NCT03856853|Pirfenidone|pirfenidone|mesh-list
56956051|NCT03856853|Analgesics|analgesics|mesh-ancestor
56956052|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
56956053|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956054|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956055|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56956056|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56956057|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56956058|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56956059|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956060|NCT03732703|Thalidomide|thalidomide|mesh-list
56956061|NCT03732703|Dexamethasone|dexamethasone|mesh-list
56956062|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
56956063|NCT03732703|Venetoclax|venetoclax|mesh-list
56956064|NCT03732703|Daratumumab|daratumumab|mesh-list
56956065|NCT03732703|Pomalidomide|pomalidomide|mesh-list
56956066|NCT03732703|Ixazomib|ixazomib|mesh-list
56956067|NCT03732703|BB 1101|bb 1101|mesh-list
56956068|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56956069|NCT03732703|Glycine|glycine|mesh-list
56956070|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56956071|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
56956072|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
56956073|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956074|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956075|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56956076|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
56956077|NCT03732703|Hormones|hormones|mesh-ancestor
56956078|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56956079|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56956080|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956081|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
56956082|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956083|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956084|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
56956085|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56956086|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56956087|NCT03732703|Growth Substances|growth substances|mesh-ancestor
56956088|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
56956089|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956090|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
56956091|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56956092|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956093|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
56956094|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956096|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
56956097|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56956098|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956099|NCT03123016|Apremilast|apremilast|mesh-list
56956100|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56956101|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56956102|NCT03123016|Analgesics|analgesics|mesh-ancestor
56956103|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
56956104|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956105|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956106|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56956107|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56956108|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56956109|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56956110|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956111|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956112|NCT03636477|Nivolumab|nivolumab|mesh-list
56956113|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56956114|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956115|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56956116|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956117|NCT03732001|Docetaxel|docetaxel|mesh-list
56956118|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956119|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
56956120|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
56956121|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
56956122|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956123|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
56956124|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56956125|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56956126|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
56956127|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56956128|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56956129|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956130|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
56956131|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956132|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956133|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56956134|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
56956135|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
56956136|NCT01186835|Protective Agents|protective agents|mesh-ancestor
56956137|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56956138|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956139|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
56956140|NCT04812951|Cyclosporine|cyclosporine|mesh-list
56956141|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56956142|NCT04812951|Cyclosporins|cyclosporins|mesh-list
56956143|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956144|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956145|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956146|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
56956147|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956148|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
56956149|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956150|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
56956151|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56956152|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56956153|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56956154|NCT05666089|Acetylcysteine|acetylcysteine|mesh-list
56956155|NCT05666089|Calcium|calcium|mesh-list
56956156|NCT05666089|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56956157|NCT05666089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56956158|NCT05666089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956159|NCT05666089|Antiviral Agents|antiviral agents|mesh-ancestor
56956160|NCT05666089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956161|NCT05666089|Expectorants|expectorants|mesh-ancestor
56956162|NCT05666089|Respiratory System Agents|respiratory system agents|mesh-ancestor
56956163|NCT05666089|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56956164|NCT05666089|Antioxidants|antioxidants|mesh-ancestor
56956165|NCT05666089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956166|NCT05666089|Protective Agents|protective agents|mesh-ancestor
56956167|NCT05666089|Antidotes|antidotes|mesh-ancestor
56956168|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
56956169|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56956170|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56956171|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
56956172|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956173|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56956174|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56956175|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956176|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956177|NCT04597476|Fucoidan|fucoidan|mesh-list
56956178|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56956179|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56956180|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
56956181|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956182|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56956183|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56956184|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956185|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56956186|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956187|NCT02730208|Ivacaftor|ivacaftor|mesh-list
56956188|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56956189|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56956190|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956191|NCT01291511|Iloperidone|iloperidone|mesh-list
56956192|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56956193|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56956194|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956195|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956196|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56956197|NCT01292213|Dimercaprol|dimercaprol|mesh-list
56956198|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
56956199|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
56956200|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956201|NCT03122938|Lactoferrin|lactoferrin|mesh-list
56956202|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956203|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
56956204|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
56956205|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56956206|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956207|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
56956208|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956209|NCT03782532|Prednisone|prednisone|mesh-list
56956210|NCT03782532|Prednisolone|prednisolone|mesh-list
56956211|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56956212|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
56956213|NCT03782532|Hormones|hormones|mesh-ancestor
56956214|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56956215|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956216|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56956217|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956218|NCT03355768|Romidepsin|romidepsin|mesh-list
56956219|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56956220|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956221|NCT03349840|Insulin|insulin|mesh-list
56956222|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56956223|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
56877064|NCT01303926|Growth Substances|growth substances|mesh-ancestor
56956224|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56956225|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956226|NCT03170271|Benralizumab|benralizumab|mesh-list
56956227|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56956228|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
56956229|NCT03355612|Capecitabine|capecitabine|mesh-list
56956230|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
56956231|NCT03355612|Apatinib|apatinib|mesh-list
56956232|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56956233|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
56956234|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956235|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956236|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56956237|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956238|NCT03732547|Poly I-C|poly i-c|mesh-list
56956239|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
56956240|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956241|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
56956242|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
56956243|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956244|NCT04503850|Mirabegron|mirabegron|mesh-list
56956245|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56956246|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56956247|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56956248|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56956249|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
56956250|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956251|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956252|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956253|NCT04503850|Urological Agents|urological agents|mesh-ancestor
56956254|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56956255|NCT03349684|Metformin|metformin|mesh-list
56956256|NCT03349684|Acarbose|acarbose|mesh-list
56956257|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56956258|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956259|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56956260|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956261|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956262|NCT03856697|Gefitinib|gefitinib|mesh-list
56956263|NCT03856697|Maleic acid|maleic acid|mesh-list
56956264|NCT03856697|Abivertinib|abivertinib|mesh-list
56956265|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956266|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956267|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956268|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56956269|NCT03349606|Amphetamine|amphetamine|mesh-list
56956270|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
56956271|NCT03349606|FLB 457|flb 457|mesh-list
56956272|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56956273|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956274|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
56956275|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
56956276|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956277|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
56956278|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956279|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956280|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
56956281|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56956282|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56956283|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56956284|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56956285|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56956286|NCT02843451|Silymarin|silymarin|mesh-list
56956287|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
56956288|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956289|NCT02843451|Protective Agents|protective agents|mesh-ancestor
56956290|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956291|NCT03355300|Cannabidiol|cannabidiol|mesh-list
56956292|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
56956293|NCT01292525|Tacrolimus|tacrolimus|mesh-list
56956294|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956295|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
56956296|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956297|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56877141|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956298|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956299|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956300|NCT01189019|Ranibizumab|ranibizumab|mesh-list
56956301|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56956302|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56956303|NCT01189019|Growth Substances|growth substances|mesh-ancestor
56956304|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956305|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
56956306|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956307|NCT01183247|Sirolimus|sirolimus|mesh-list
56956308|NCT01183247|Prednisone|prednisone|mesh-list
56956309|NCT01183247|Everolimus|everolimus|mesh-list
56956310|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56956311|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
56956312|NCT01183247|Hormones|hormones|mesh-ancestor
56956313|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56956314|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956315|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56956316|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956317|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956318|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
56956319|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56956320|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956321|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56956322|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
56956324|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956325|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956326|NCT04507750|Apatinib|apatinib|mesh-list
56956327|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956328|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56956329|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956330|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956331|NCT03633331|Letrozole|letrozole|mesh-list
56956332|NCT03633331|Fulvestrant|fulvestrant|mesh-list
56956333|NCT03633331|Palbociclib|palbociclib|mesh-list
56956334|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956335|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56956336|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56956337|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956338|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956339|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56956340|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
56956341|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56956342|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956343|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56956344|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56956345|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56956346|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
56956347|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
56956348|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
56956349|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56956350|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56956351|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956352|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956353|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956354|NCT01187303|Ofatumumab|ofatumumab|mesh-list
56956355|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956356|NCT01187459|Vitamin D|vitamin d|mesh-list
56956357|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
56956358|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
56956359|NCT01187459|Vitamins|vitamins|mesh-list
56956360|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
56956361|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956362|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56956363|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56956364|NCT01187537|Bupivacaine|bupivacaine|mesh-list
56956365|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
56956366|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
56956367|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956368|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956369|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
56956370|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956371|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56956372|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56956373|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56956374|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56956375|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956376|NCT01290419|Vaccines|vaccines|mesh-list
56956377|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
56956378|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956379|NCT03737773|Methamphetamine|methamphetamine|mesh-list
56956380|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56956381|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956382|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
56956383|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
56956384|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956385|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
56956386|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956387|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956388|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
56956389|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56956390|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56956391|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56956392|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56956393|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56956394|NCT01060579|Latanoprost|latanoprost|mesh-list
56956395|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56956396|NCT04443946|Sufentanil|sufentanil|mesh-list
56956397|NCT04443946|Propofol|propofol|mesh-list
56956398|NCT04443946|Sevoflurane|sevoflurane|mesh-list
56956399|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56956400|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956401|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956402|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56956403|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
56956404|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
56956405|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56956406|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56956407|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56956408|NCT04443946|Narcotics|narcotics|mesh-ancestor
56956409|NCT04443946|Analgesics|analgesics|mesh-ancestor
56956410|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
56956411|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956412|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56956413|NCT03729973|Lidocaine|lidocaine|mesh-list
56956414|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
56956415|NCT03729973|Ketamine|ketamine|mesh-list
56956416|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56956417|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
56956418|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
56956419|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956420|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956421|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
56956422|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956423|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56956424|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56956425|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56956426|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56956427|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956428|NCT03729973|Analgesics|analgesics|mesh-ancestor
56956429|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56956430|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56956431|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
56956432|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56956433|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56956434|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956435|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
56956436|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56956437|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56956438|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
56956439|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56956440|NCT01189253|Doxorubicin|doxorubicin|mesh-list
56956441|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56956442|NCT01189253|Trabectedin|trabectedin|mesh-list
56956443|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56956444|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956445|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56956446|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56956447|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956448|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956449|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56956450|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
56956451|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
56956452|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56956453|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
56956454|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956455|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956456|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56956457|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
56956458|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56956459|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
56956460|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956461|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956462|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56956463|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
56956464|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
56956465|NCT04443868|Protective Agents|protective agents|mesh-ancestor
56956466|NCT03851393|Citric Acid|citric acid|mesh-list
56956467|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
56956468|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
56956469|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56956470|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
56956471|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
56956472|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956473|NCT04443556|Tramadol|tramadol|mesh-list
56956474|NCT04443556|Anesthetics|anesthetics|mesh-list
56956475|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
56956476|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956477|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956478|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56956479|NCT04443556|Narcotics|narcotics|mesh-ancestor
56956480|NCT04443556|Analgesics|analgesics|mesh-ancestor
56956481|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
56956482|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956483|NCT01187615|Cisplatin|cisplatin|mesh-list
56956484|NCT01187615|Pemetrexed|pemetrexed|mesh-list
56956485|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956486|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956487|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956488|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56956489|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56956490|NCT05375097|Erenumab|erenumab|mesh-list
56956491|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56956492|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956493|NCT05375097|Analgesics|analgesics|mesh-ancestor
56956494|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
56956495|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956496|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956497|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56956498|NCT02752191|Hematinics|hematinics|mesh-ancestor
56956499|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56956500|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56956501|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
56956502|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56956503|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
56956504|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956505|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
56956506|NCT01290497|Protective Agents|protective agents|mesh-ancestor
56956507|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
56956508|NCT04509466|Pegaspargase|pegaspargase|mesh-list
56956509|NCT04509466|Asparaginase|asparaginase|mesh-list
56956510|NCT04509466|Analgesics|analgesics|mesh-ancestor
56956511|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
56956512|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956513|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956514|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956515|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56956516|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56956517|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956518|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956519|NCT03738215|Cariprazine|cariprazine|mesh-list
56956520|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56956521|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56956522|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956523|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956524|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56956525|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
56956526|NCT03016377|Fludarabine|fludarabine|mesh-list
56956527|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956528|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
56956529|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956530|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56956531|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56956532|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
56956533|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956534|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956535|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56956536|NCT04503460|Fluticasone|fluticasone|mesh-list
56956537|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56956538|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56956539|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56956540|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56956541|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
56956542|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956543|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956544|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56956545|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
56956546|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
56956547|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56956548|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56956549|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56956550|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56956551|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
56956552|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956553|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956554|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
56956555|NCT04503460|Hormones|hormones|mesh-ancestor
56956556|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56956557|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
56956558|NCT05352321|Gemcitabine|gemcitabine|mesh-list
56956559|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956560|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56956561|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
56956562|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956563|NCT05352321|Antiviral Agents|antiviral agents|mesh-ancestor
56956564|NCT05352321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956565|NCT05352321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956566|NCT05352321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956567|NCT05352321|Immunologic Factors|immunologic factors|mesh-ancestor
56956568|NCT05352321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956569|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56956570|NCT03199911|Erythromycin|erythromycin|mesh-list
56956571|NCT03199911|Bacitracin|bacitracin|mesh-list
56956572|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956573|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56956574|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56956575|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956576|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956577|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56956578|NCT02517814|Vitamin D|vitamin d|mesh-list
56956579|NCT02517814|Vitamins|vitamins|mesh-ancestor
56956580|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
56956581|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956582|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56956583|NCT05303727|Cyclosporine|cyclosporine|mesh-list
56956584|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
56956585|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
56956586|NCT05303727|Melphalan|melphalan|mesh-list
56956587|NCT05303727|Busulfan|busulfan|mesh-list
56956588|NCT05303727|Thiotepa|thiotepa|mesh-list
56956589|NCT05303727|Methotrexate|methotrexate|mesh-list
56956590|NCT05303727|Fludarabine|fludarabine|mesh-list
56956591|NCT05303727|Topotecan|topotecan|mesh-list
56956592|NCT05303727|Tacrolimus|tacrolimus|mesh-list
56956593|NCT05303727|Cyclosporins|cyclosporins|mesh-list
56956594|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56956595|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956596|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
56956597|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956598|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56877443|NCT05693844|Paclitaxel|paclitaxel|mesh-list
56956599|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56956600|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
56956601|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956602|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956603|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56956604|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56956605|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
56956606|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56956607|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56956608|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
56956609|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
56956610|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956611|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56956612|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56956613|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56956614|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
56956615|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956616|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56956617|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56956618|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
56956619|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56956620|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56956621|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56956622|NCT05480800|Vaccines|vaccines|mesh-list
56956623|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
56956624|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956625|NCT04502368|Dimercaprol|dimercaprol|mesh-list
56956626|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
56956627|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
56956628|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956629|NCT04984083|Vitamin K|vitamin k|mesh-list
56956630|NCT04984083|Vitamins|vitamins|mesh-ancestor
56956631|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
56956632|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956633|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56956634|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56956635|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956636|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
56956637|NCT04984083|Coagulants|coagulants|mesh-ancestor
56956638|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56956639|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
56956640|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956641|NCT05654506|Daratumumab|daratumumab|mesh-list
56956642|NCT05654506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956643|NCT05224089|Dexamethasone|dexamethasone|mesh-list
56956644|NCT05224089|Epinephrine|epinephrine|mesh-list
56956645|NCT05224089|Bupivacaine|bupivacaine|mesh-list
56956646|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56956647|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
56956648|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
56956649|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956650|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956651|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56956652|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
56956653|NCT05224089|Hormones|hormones|mesh-ancestor
56956654|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56956655|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56956656|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956657|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956658|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
56956659|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
56956660|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956661|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
56956662|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56956663|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56956664|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
56956665|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956666|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56956667|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56956668|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56956669|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
56956670|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
56956671|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
56956672|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56956673|NCT01581203|Interferons|interferons|mesh-list
56956674|NCT01581203|Ribavirin|ribavirin|mesh-list
56956675|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
56956676|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
56956677|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56956678|NCT01581203|Asunaprevir|asunaprevir|mesh-list
56956679|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956680|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
56956681|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956682|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
56956683|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956684|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
56956685|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956686|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
56956687|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956688|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56956689|NCT03168555|Cathartics|cathartics|mesh-ancestor
56956690|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56956691|NCT03235050|Liraglutide|liraglutide|mesh-list
56956693|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956695|NCT03235050|Hormones|hormones|mesh-ancestor
56956696|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56956697|NCT04933149|Ketamine|ketamine|mesh-list
56956698|NCT04933149|Analgesics|analgesics|mesh-ancestor
56956699|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
56956700|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956701|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956702|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56956703|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56956704|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
56956705|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
56956706|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956707|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56956708|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56956709|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956710|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956711|NCT01189721|Propofol|propofol|mesh-list
56956712|NCT01189721|Sevoflurane|sevoflurane|mesh-list
56956713|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56956714|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956715|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956716|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56956717|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
56956718|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
56956719|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56956720|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56956721|NCT03167619|Durvalumab|durvalumab|mesh-list
56956722|NCT03167619|Olaparib|olaparib|mesh-list
56956723|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56956724|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956725|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56956726|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956727|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956728|NCT03198507|Amoxicillin|amoxicillin|mesh-list
56956729|NCT03198507|Rifabutin|rifabutin|mesh-list
56956730|NCT03198507|Omeprazole|omeprazole|mesh-list
56956731|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56956732|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956733|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56956734|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56956735|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56956736|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956737|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956738|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56956739|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
56956740|NCT03850769|Paclitaxel|paclitaxel|mesh-list
56956741|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56956742|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956743|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
56956744|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
56956745|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
56956746|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956747|NCT04663464|Abaloparatide|abaloparatide|mesh-list
56956748|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
56956749|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56956750|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956751|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56956752|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56956753|NCT04469595|Aflibercept|aflibercept|mesh-list
56956754|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56956755|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56956756|NCT04469595|Growth Substances|growth substances|mesh-ancestor
56956757|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956758|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
56956759|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956760|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56956761|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
56956762|NCT04469595|Hormones|hormones|mesh-ancestor
56956763|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56956764|NCT01292993|Metformin|metformin|mesh-list
56956765|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56956766|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56956767|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956768|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56956769|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956771|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
56956772|NCT03849833|Vitamins|vitamins|mesh-ancestor
56956773|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
56956774|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956775|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56956776|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56956777|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
56956778|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56956779|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956780|NCT04910711|Dolutegravir|dolutegravir|mesh-list
56956781|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56956782|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
56956783|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
56956784|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56956785|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
56956786|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56956787|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956788|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56956789|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56956790|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56956791|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56956792|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56956793|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956794|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956795|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56956796|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56956797|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
56956798|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956799|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56956800|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56956801|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56956802|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956803|NCT01191203|Copper|copper|mesh-list
56956804|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56956805|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
56956806|NCT01191203|Trace Elements|trace elements|mesh-ancestor
56956807|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
56956808|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956809|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56956810|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56956811|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56956812|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
56956813|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56956814|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56956815|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56956816|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56956817|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56956818|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956819|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
56956820|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56956821|NCT03197883|Protective Agents|protective agents|mesh-ancestor
56956822|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956823|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
56956824|NCT05665465|Nicotine|nicotine|mesh-list
56956825|NCT05665465|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56956826|NCT05665465|Autonomic Agents|autonomic agents|mesh-ancestor
56956827|NCT05665465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956828|NCT05665465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956829|NCT05665465|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56956830|NCT05665465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56956831|NCT05665465|Cholinergic Agents|cholinergic agents|mesh-ancestor
56956832|NCT05665465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956833|NCT05665465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956834|NCT03729505|Lidocaine|lidocaine|mesh-list
56956835|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
56956836|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
56956837|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
56956838|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956839|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956840|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
56956841|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956842|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56956843|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56956844|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56956845|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56956846|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956847|NCT03729505|Analgesics|analgesics|mesh-ancestor
56956848|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
56956849|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56956850|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56956851|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
56956852|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56956853|NCT03234036|Ritonavir|ritonavir|mesh-list
56956854|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
56956855|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56956856|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56956857|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
56956858|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956859|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956860|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56956861|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56956862|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
56956863|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956864|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56956865|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56956866|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
56956867|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56956868|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56956869|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956870|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
56956871|NCT03606109|Coagulants|coagulants|mesh-ancestor
56956872|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56956873|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56956874|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956875|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
56956876|NCT01193855|Dutasteride|dutasteride|mesh-list
56956877|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56956878|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56956879|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956880|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956881|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
56956882|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56956883|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956884|NCT01190345|Bevacizumab|bevacizumab|mesh-list
56956885|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56956886|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956887|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56956888|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56956889|NCT01190345|Growth Substances|growth substances|mesh-ancestor
56956890|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956891|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
56956892|NCT02729896|Rituximab|rituximab|mesh-list
56956893|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
56956894|NCT02729896|Atezolizumab|atezolizumab|mesh-list
56956895|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56956896|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956897|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
56956898|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877744|NCT03790020|Bupivacaine|bupivacaine|mesh-list
56956899|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56956900|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
56956901|NCT04540380|Rituximab|rituximab|mesh-list
56956902|NCT04540380|Fludarabine|fludarabine|mesh-list
56956903|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56956904|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
56956905|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956906|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56956907|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56956908|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
56956909|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956910|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956911|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56956912|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56956913|NCT04506034|Lidocaine|lidocaine|mesh-list
56956914|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
56956915|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
56956916|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956917|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956918|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
56956919|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956920|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56956921|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56956922|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56956923|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56956924|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956925|NCT01294631|Canagliflozin|canagliflozin|mesh-list
56956926|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56956927|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956928|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56956929|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956930|NCT03849209|Pancrelipase|pancrelipase|mesh-list
56956931|NCT03849209|Pancreatin|pancreatin|mesh-list
56956932|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56956933|NCT05342662|Methamphetamine|methamphetamine|mesh-list
56956934|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56956935|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956936|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
56956937|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
56956938|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956939|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
56956940|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956941|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956942|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
56956943|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56956944|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56956945|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56956946|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56956947|NCT03847571|Acetazolamide|acetazolamide|mesh-list
56956948|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
56956949|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56956950|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56956951|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956952|NCT03847571|Diuretics|diuretics|mesh-ancestor
56956953|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
56956954|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956955|NCT01293149|Clonidine|clonidine|mesh-list
56956956|NCT01293149|Ropivacaine|ropivacaine|mesh-list
56956957|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
56956958|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
56956959|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956960|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956961|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
56956962|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56956963|NCT01293149|Analgesics|analgesics|mesh-ancestor
56956964|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56956965|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
56956966|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
56956967|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56956968|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56956969|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56956970|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
56956971|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956972|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956973|NCT04454424|Midazolam|midazolam|mesh-list
56956974|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56956975|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56956976|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56956977|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956978|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56956979|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56956980|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56956981|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56956982|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
56956983|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
56956984|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
56639320|NCT04313088|Eluxadoline|eluxadoline|mesh-list
56956985|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
56956986|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56956987|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56956988|NCT03348046|Infliximab|infliximab|mesh-list
56956989|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
56956990|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56956991|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56956992|NCT05653492|Sulforaphane|sulforaphane|mesh-list
56956993|NCT05653492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56956994|NCT05653492|Protective Agents|protective agents|mesh-ancestor
56956995|NCT05653492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56956996|NCT05653492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56956997|NCT04505644|Lidocaine|lidocaine|mesh-list
56956998|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
56956999|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
56957000|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957001|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957002|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
56957003|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957004|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56957005|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56957006|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56957007|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56957008|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957009|NCT04505800|Tryptophan|tryptophan|mesh-list
56957010|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56957011|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
56957012|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56957013|NCT05200156|Choline|choline|mesh-list
56957014|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
56957015|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56957016|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
56957017|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957018|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56957019|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56957020|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
56957021|NCT03347968|Warfarin|warfarin|mesh-list
56957022|NCT03347968|Esmolol|esmolol|mesh-list
56957023|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
56957024|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56957025|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56957026|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56957027|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
56957028|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957029|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957030|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957031|NCT01191593|Ropivacaine|ropivacaine|mesh-list
56957032|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
56957033|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
56957034|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957035|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957036|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
56957037|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957038|NCT03347890|Liraglutide|liraglutide|mesh-list
56957039|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56957040|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957041|NCT03347890|Incretins|incretins|mesh-ancestor
56957042|NCT03347890|Hormones|hormones|mesh-ancestor
56957043|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957044|NCT01296503|Thalidomide|thalidomide|mesh-list
56957045|NCT01296503|Dexamethasone|dexamethasone|mesh-list
56957046|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
56957047|NCT01296503|BB 1101|bb 1101|mesh-list
56957048|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957049|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
56957050|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
56957051|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957052|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957053|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56957054|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
56957055|NCT01296503|Hormones|hormones|mesh-ancestor
56957056|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957057|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56957058|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957059|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
56957060|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957061|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957063|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
56957064|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
56957065|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56957066|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957067|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56957068|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56957069|NCT01296503|Growth Substances|growth substances|mesh-ancestor
56957070|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
56957071|NCT01295099|Triamcinolone|triamcinolone|mesh-list
56957072|NCT01295099|Fluorouracil|fluorouracil|mesh-list
56957073|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
56957074|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957075|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56957076|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957077|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56957078|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
56957079|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957080|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957081|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
56957082|NCT01295099|Hormones|hormones|mesh-ancestor
56957083|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957084|NCT01426529|Norepinephrine|norepinephrine|mesh-list
56957085|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
56957086|NCT01426529|Giapreza|giapreza|mesh-list
56957087|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
56957088|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56957089|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56957090|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
56957091|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957092|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957093|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957094|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
56957095|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
56957096|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957097|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56957098|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56957099|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
56957100|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957101|NCT03122158|Citalopram|citalopram|mesh-list
56957102|NCT03122158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56957103|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56957104|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56957105|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957106|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957107|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
56957108|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957109|NCT03122158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56957110|NCT03122158|Antidepressive Agents|antidepressive agents|mesh-ancestor
56957111|NCT03122158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56957112|NCT02668653|Cytarabine|cytarabine|mesh-list
56957113|NCT02668653|Daunorubicin|daunorubicin|mesh-list
56957114|NCT02668653|Idarubicin|idarubicin|mesh-list
56957115|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56957116|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
56957117|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957118|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957119|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
56957120|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957121|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56957122|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
56957123|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957124|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56957125|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56957126|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56957127|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957128|NCT03555565|Metformin|metformin|mesh-list
56957129|NCT03555565|Alogliptin|alogliptin|mesh-list
56957130|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56957131|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957132|NCT03555565|Incretins|incretins|mesh-ancestor
56957133|NCT03555565|Hormones|hormones|mesh-ancestor
56957134|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639482|NCT04177875|Paclitaxel|paclitaxel|mesh-list
56957135|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56957136|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
56957137|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957138|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957139|NCT01190735|Caffeine|caffeine|mesh-list
56957140|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56957141|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957142|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56957143|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957144|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957145|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56957146|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56957147|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
56957148|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957149|NCT02985957|Prednisone|prednisone|mesh-list
56957150|NCT02985957|Nivolumab|nivolumab|mesh-list
56957151|NCT02985957|Ipilimumab|ipilimumab|mesh-list
56957152|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957153|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
56957154|NCT02985957|Hormones|hormones|mesh-ancestor
56957155|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957156|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957157|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56957158|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957159|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56957160|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56957161|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957162|NCT05097118|Ketamine|ketamine|mesh-list
56957163|NCT05097118|Bupivacaine|bupivacaine|mesh-list
56957164|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
56957165|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
56957166|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957167|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957168|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
56957169|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957170|NCT05097118|Analgesics|analgesics|mesh-ancestor
56957171|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56957172|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56957173|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
56957174|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56957175|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56957176|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957177|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957178|NCT01194791|Dexamethasone|dexamethasone|mesh-list
56957179|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
56957180|NCT01194791|Lenalidomide|lenalidomide|mesh-list
56957181|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56957182|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
56957183|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957184|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56957185|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56957186|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
56957187|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957188|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957189|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56957190|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957191|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
56957192|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
56957193|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957194|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56957195|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
56957196|NCT01194791|Hormones|hormones|mesh-ancestor
56957197|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957198|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56957199|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56957200|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56957201|NCT01194791|Growth Substances|growth substances|mesh-ancestor
56957202|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
56957203|NCT03351322|Minoxidil|minoxidil|mesh-list
56957204|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56957205|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
56957206|NCT01296971|Ribavirin|ribavirin|mesh-list
56957207|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56639544|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
56957209|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957210|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
56957211|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957212|NCT01195181|Ribavirin|ribavirin|mesh-list
56957213|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
56957214|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957215|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
56957216|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957217|NCT03845699|Fentanyl|fentanyl|mesh-list
56957218|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56957219|NCT03845699|Narcotics|narcotics|mesh-ancestor
56957220|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957221|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957222|NCT03845699|Analgesics|analgesics|mesh-ancestor
56957223|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
56957224|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957225|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56957226|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56957227|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
56957228|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
56957229|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56957230|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957231|NCT00709618|Vinorelbine|vinorelbine|mesh-list
56957232|NCT00709618|Lapatinib|lapatinib|mesh-list
56957233|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56957234|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957235|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
56957236|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
56957237|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
56957238|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957239|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56957240|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957241|NCT01195259|Metformin|metformin|mesh-list
56957242|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
56957243|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56957244|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957245|NCT05584228|Azathioprine|azathioprine|mesh-list
56957246|NCT05584228|Infliximab|infliximab|mesh-list
56957247|NCT05584228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56957248|NCT05584228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56957249|NCT05584228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56957250|NCT05584228|Antimetabolites|antimetabolites|mesh-ancestor
56957251|NCT05584228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957252|NCT05584228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56957253|NCT05584228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957254|NCT05584228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56957255|NCT05584228|Immunologic Factors|immunologic factors|mesh-ancestor
56957256|NCT05584228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957257|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56957258|NCT03193047|Evolocumab|evolocumab|mesh-list
56957259|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56957260|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56957261|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
56957262|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957263|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56957264|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957265|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56957266|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957267|NCT04504552|Avelumab|avelumab|mesh-list
56957268|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56957269|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957270|NCT03845387|Pramipexole|pramipexole|mesh-list
56957271|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
56957272|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957273|NCT03845387|Protective Agents|protective agents|mesh-ancestor
56957274|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957275|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56957276|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56957277|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
56957278|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
56957279|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957280|NCT01295177|Insulin|insulin|mesh-list
56957281|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56957282|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56639618|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56957283|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957284|NCT02918019|Astegolimab|astegolimab|mesh-list
56957285|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56957286|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957287|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
56957288|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957289|NCT04848454|Vinorelbine|vinorelbine|mesh-list
56957290|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957291|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56957292|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
56957293|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
56957294|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
56957295|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957296|NCT04842292|Heparin|heparin|mesh-list
56957297|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
56957298|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56957299|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56957300|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957301|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
56957302|NCT01191983|Hematinics|hematinics|mesh-ancestor
56957303|NCT03055988|Fluticasone|fluticasone|mesh-list
56957304|NCT03055988|Xhance|xhance|mesh-list
56957305|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
56957306|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56957307|NCT03055988|Olodaterol|olodaterol|mesh-list
56957308|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957309|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56957310|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
56957311|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957312|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957313|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56957314|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
56957315|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
56957316|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56957317|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
56957318|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56957319|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
56957320|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957321|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957322|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56957323|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56957324|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56957325|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
56957326|NCT03346642|Decitabine|decitabine|mesh-list
56957327|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56957328|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56957329|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
56957330|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957331|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957332|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957333|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
56957334|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56957335|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
56957336|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957337|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56957338|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957339|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957340|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957341|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56957342|NCT04789304|Midazolam|midazolam|mesh-list
56957343|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56957344|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56957345|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957346|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957347|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56957348|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56957349|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56957350|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56957351|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
56957352|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
56957353|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
56957354|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
56957355|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957356|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957357|NCT04780724|Nitrox|nitrox|mesh-list
56957358|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56957359|NCT04780724|Protective Agents|protective agents|mesh-ancestor
56957360|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957362|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56957363|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56957364|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957365|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
56957366|NCT03128866|Coagulants|coagulants|mesh-ancestor
56957367|NCT05583214|Dexamethasone|dexamethasone|mesh-list
56957368|NCT05583214|Ondansetron|ondansetron|mesh-list
56957369|NCT05583214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957370|NCT05583214|Antiemetics|antiemetics|mesh-ancestor
56957371|NCT05583214|Autonomic Agents|autonomic agents|mesh-ancestor
56957372|NCT05583214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957373|NCT05583214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957374|NCT05583214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56957375|NCT05583214|Glucocorticoids|glucocorticoids|mesh-ancestor
56957376|NCT05583214|Hormones|hormones|mesh-ancestor
56957377|NCT05583214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957378|NCT05583214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56957379|NCT05583214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957380|NCT05583214|Antipruritics|antipruritics|mesh-ancestor
56957381|NCT05583214|Dermatologic Agents|dermatologic agents|mesh-ancestor
56957382|NCT05583214|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56957383|NCT05583214|Serotonin Agents|serotonin agents|mesh-ancestor
56957384|NCT05583214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957385|NCT05583214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957386|NCT05583214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56957387|NCT05583214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56957388|NCT05583214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957389|NCT05583214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56957390|NCT05583214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56957391|NCT02871297|Vortioxetine|vortioxetine|mesh-list
56957392|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
56957393|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56957394|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56957395|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56957396|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957397|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957398|NCT02871297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56957399|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56957400|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56957401|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957402|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957403|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
56957404|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56957405|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56957406|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56957407|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56957408|NCT03628430|Lidocaine|lidocaine|mesh-list
56957409|NCT03628430|Epinephrine|epinephrine|mesh-list
56957410|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
56957411|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
56957412|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957413|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957414|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
56957415|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957416|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56957417|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56957418|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56957419|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56957420|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957421|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56957422|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56957423|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
56957424|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957425|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56957426|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56957427|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
56957428|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56957429|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
56957430|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
56957431|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
56957432|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56957433|NCT03121846|Apatinib|apatinib|mesh-list
56957434|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957435|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56957436|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957437|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957438|NCT03122314|Acetaminophen|acetaminophen|mesh-list
56957439|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56957440|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56957441|NCT03122314|Analgesics|analgesics|mesh-ancestor
56957442|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
56957443|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957444|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957445|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
56957446|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56957447|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957448|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56957449|NCT03554005|Acetaminophen|acetaminophen|mesh-list
56957450|NCT03554005|Interferons|interferons|mesh-list
56957451|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
56957452|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
56957453|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56957454|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957455|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
56957456|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957457|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56957458|NCT03554005|Analgesics|analgesics|mesh-ancestor
56957459|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
56957460|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957461|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957462|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
56957463|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
56957464|NCT00709228|Ribavirin|ribavirin|mesh-list
56957465|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56957466|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
56957467|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957468|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
56957469|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957470|NCT01584557|Tolvaptan|tolvaptan|mesh-list
56957471|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56957472|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957473|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
56957474|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957475|NCT04783857|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56957476|NCT04783857|Medroxyprogesterone|medroxyprogesterone|mesh-list
56957477|NCT04783857|Progesterone|progesterone|mesh-list
56957478|NCT04783857|Progestins|progestins|mesh-ancestor
56957479|NCT04783857|Hormones|hormones|mesh-ancestor
56957480|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957481|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957482|NCT04783857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56957483|NCT04783857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56957484|NCT04783857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56957485|NCT04783857|Contraceptive Agents|contraceptive agents|mesh-ancestor
56957486|NCT04783857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56957487|NCT04783857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56957488|NCT04783857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56957489|NCT04783857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56957490|NCT04783857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56957491|NCT04783857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957492|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56957493|NCT05214872|Calcium|calcium|mesh-list
56957494|NCT05214872|Mitogens|mitogens|mesh-list
56957495|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56957496|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957497|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
56957498|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957499|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
56957500|NCT01195571|Vaccines|vaccines|mesh-list
56957501|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
56957502|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957503|NCT03219372|Pravastatin|pravastatin|mesh-list
56957504|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56957505|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56957506|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
56957507|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957508|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56957509|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56957511|NCT03304080|Trastuzumab|trastuzumab|mesh-list
56957512|NCT03304080|Pertuzumab|pertuzumab|mesh-list
56957513|NCT03304080|Palbociclib|palbociclib|mesh-list
56957514|NCT03304080|Anastrozole|anastrozole|mesh-list
56957515|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56957516|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957517|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56957518|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957519|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957520|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56957521|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56957522|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56957523|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56957524|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56957525|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957526|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957527|NCT02422641|Methotrexate|methotrexate|mesh-list
56957528|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56957529|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
56957530|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56957531|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957532|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56957533|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
56957534|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957535|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957536|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
56957537|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957538|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56957539|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56957540|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
56957541|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56957542|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56957543|NCT03628040|Ropivacaine|ropivacaine|mesh-list
56957544|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
56957545|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
56957546|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957547|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957548|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
56957549|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957550|NCT04715763|Telmisartan|telmisartan|mesh-list
56957551|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56957552|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56957553|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56957554|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957555|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
56957556|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56957557|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
56957558|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957559|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957560|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56957561|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
56957562|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56957563|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
56957564|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957565|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957566|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56957567|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
56957568|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
56957569|NCT04338828|Protective Agents|protective agents|mesh-ancestor
56957570|NCT01295567|Dipyridamole|dipyridamole|mesh-list
56957571|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56957572|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957573|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957574|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56957575|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
56957576|NCT04323046|Nivolumab|nivolumab|mesh-list
56957577|NCT04323046|Ipilimumab|ipilimumab|mesh-list
56957578|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56957579|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957580|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56957581|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957582|NCT01192529|Phentermine|phentermine|mesh-list
56957583|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56957584|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957585|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
56957586|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56957587|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
56957588|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
56957589|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957590|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
56957591|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957592|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957593|NCT01195649|Sorafenib|sorafenib|mesh-list
56957594|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957595|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56957596|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957597|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957598|NCT01195727|Apixaban|apixaban|mesh-list
56957599|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56957600|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
56957601|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56957602|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
56957603|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957604|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957605|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
56957606|NCT04958876|Naltrexone|naltrexone|mesh-list
56957607|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56957608|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56957609|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957610|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
56957611|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957612|NCT01195805|Amiloride|amiloride|mesh-list
56957613|NCT01195805|Spironolactone|spironolactone|mesh-list
56957614|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56957615|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
56957616|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957617|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957618|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56957619|NCT01195805|Diuretics|diuretics|mesh-ancestor
56957620|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
56957621|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56957622|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56957623|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56957624|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957625|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56957626|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
56957627|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56957628|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957629|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
56957630|NCT01791478|Letrozole|letrozole|mesh-list
56957631|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
56957632|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957633|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56957634|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56957635|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957636|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957637|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56957638|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
56957639|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957640|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957641|NCT03845153|Metformin|metformin|mesh-list
56957642|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56957643|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957644|NCT00198718|Vitamin A|vitamin a|mesh-list
56957645|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
56957646|NCT00198718|Vitamins|vitamins|mesh-ancestor
56957647|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
56957648|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957649|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
56957650|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957651|NCT00198718|Protective Agents|protective agents|mesh-ancestor
56957652|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56957653|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639997|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957655|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56957656|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56957657|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957658|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56957659|NCT01192763|R04929097|r04929097|mesh-list
56957660|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957661|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957662|NCT04539548|Prednisolone|prednisolone|mesh-list
56957663|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957664|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
56957665|NCT04539548|Hormones|hormones|mesh-ancestor
56957666|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957667|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957668|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56957669|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957670|NCT00708916|Apremilast|apremilast|mesh-list
56957671|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56957672|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56957673|NCT00708916|Analgesics|analgesics|mesh-ancestor
56957674|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
56957675|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957676|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957677|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957678|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56957679|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56957680|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56957681|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957682|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957683|NCT02352753|Denosumab|denosumab|mesh-list
56957684|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56957685|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957686|NCT04245514|Durvalumab|durvalumab|mesh-list
56957687|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56957688|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957689|NCT05510063|Adalimumab|adalimumab|mesh-list
56957690|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957691|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56957692|NCT02517736|Sorafenib|sorafenib|mesh-list
56957693|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957694|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56957695|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957696|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957697|NCT03727971|Omalizumab|omalizumab|mesh-list
56957698|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56957699|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56957700|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
56957701|NCT03939104|Artesunate|artesunate|mesh-list
56957702|NCT03939104|Lumefantrine|lumefantrine|mesh-list
56957703|NCT03939104|Artemether|artemether|mesh-list
56957704|NCT03939104|Piperaquine|piperaquine|mesh-list
56957705|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56957706|NCT03939104|Amodiaquine|amodiaquine|mesh-list
56957707|NCT03939104|Mefloquine|mefloquine|mesh-list
56957708|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
56957709|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56957710|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56957711|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957712|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957713|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
56957714|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
56957715|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56957716|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
56957717|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
56957718|NCT03844841|Propofol|propofol|mesh-list
56957719|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56957720|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957721|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957722|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56957723|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
56957724|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
56957725|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56957726|NCT03844841|Analgesics|analgesics|mesh-ancestor
56957727|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
56640067|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957728|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957729|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56957730|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56957731|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56957732|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
56957733|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957734|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957735|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
56957736|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
56957737|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957738|NCT04501900|Clopidogrel|clopidogrel|mesh-list
56957739|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56957740|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56957741|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56957742|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56957743|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
56957744|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957745|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957746|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957747|NCT03637556|Deferasirox|deferasirox|mesh-list
56957748|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56957749|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
56957750|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
56957751|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957752|NCT04641351|Triamcinolone|triamcinolone|mesh-list
56957753|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56957754|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56957755|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56957756|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957757|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
56957758|NCT04641351|Hormones|hormones|mesh-ancestor
56957759|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957760|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957761|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56957762|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
56957763|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957764|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957765|NCT01193387|Insulin|insulin|mesh-list
56957766|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56957767|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
56957768|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56957769|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957770|NCT01198223|Nystatin|nystatin|mesh-list
56957771|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56957772|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56957773|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
56957774|NCT01198223|Ionophores|ionophores|mesh-ancestor
56957775|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56957776|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957777|NCT05049278|Phenylephrine|phenylephrine|mesh-list
56957778|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
56957779|NCT05049278|Norepinephrine|norepinephrine|mesh-list
56957780|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56957781|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
56957782|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
56957783|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957784|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957785|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
56957786|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56957787|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
56957788|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
56957789|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56957790|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56957791|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56957792|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
56957793|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736796|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
56878652|NCT03770208|Lidocaine|lidocaine|mesh-list
56957794|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957795|NCT05049278|Protective Agents|protective agents|mesh-ancestor
56957796|NCT01193465|Anesthetics|anesthetics|mesh-list
56957797|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957798|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957799|NCT03347344|Riluzole|riluzole|mesh-list
56957800|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
56957801|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56957802|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56957803|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957804|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957805|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957806|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56957807|NCT03347344|Protective Agents|protective agents|mesh-ancestor
56957808|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
56957809|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56957810|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957811|NCT03173456|Acetaminophen|acetaminophen|mesh-list
56957812|NCT03173456|Ibuprofen|ibuprofen|mesh-list
56957813|NCT03173456|Oxycodone|oxycodone|mesh-list
56957814|NCT03173456|Hydrocodone|hydrocodone|mesh-list
56957815|NCT03173456|Codeine|codeine|mesh-list
56957816|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56957817|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56957818|NCT03173456|Analgesics|analgesics|mesh-ancestor
56957819|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
56957820|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957821|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957822|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957823|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56957824|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56957825|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957826|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957827|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56957828|NCT03173456|Narcotics|narcotics|mesh-ancestor
56957829|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957830|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
56957831|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
56957832|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
56957833|NCT01193621|Haloperidol|haloperidol|mesh-list
56957834|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
56957835|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
56957836|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
56957837|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957838|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957839|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56957840|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56957841|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56957842|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957843|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56957844|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56957845|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
56957846|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957847|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957848|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56957849|NCT02517424|Dronabinol|dronabinol|mesh-list
56957850|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
56957851|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957852|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56957853|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56957854|NCT02517424|Analgesics|analgesics|mesh-ancestor
56957855|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
56957856|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957857|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56957858|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56957859|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957860|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957861|NCT02517424|Hormones|hormones|mesh-ancestor
56957862|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957863|NCT01567904|Semuloparin|semuloparin|mesh-list
56957864|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56957865|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56957866|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957867|NCT01196507|Carvedilol|carvedilol|mesh-list
56957868|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56957869|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56957870|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
56957871|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957872|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957873|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957874|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56957875|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
56957876|NCT01196507|Protective Agents|protective agents|mesh-ancestor
56957877|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56957878|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56957879|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56957880|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
56957881|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56957882|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56957883|NCT05670509|Midazolam|midazolam|mesh-list
56957884|NCT05670509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56957885|NCT05670509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56957886|NCT05670509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957887|NCT05670509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957888|NCT05670509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56957889|NCT05670509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56957890|NCT05670509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56957891|NCT05670509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56957892|NCT05670509|Anesthetics, General|anesthetics, general|mesh-ancestor
56957893|NCT05670509|Anesthetics|anesthetics|mesh-ancestor
56957894|NCT05670509|GABA Modulators|gaba modulators|mesh-ancestor
56957895|NCT05670509|GABA Agents|gaba agents|mesh-ancestor
56957896|NCT05670509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957897|NCT05670509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957898|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
56957899|NCT05282771|Clobetasol|clobetasol|mesh-list
56957900|NCT05282771|Halobetasol|halobetasol|mesh-list
56957901|NCT05282771|Tazarotene|tazarotene|mesh-list
56957902|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
56957903|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
56957904|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
56957905|NCT05282771|Vitamins|vitamins|mesh-ancestor
56957906|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
56957907|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957908|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56957909|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957910|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
56957911|NCT05282771|Hormones|hormones|mesh-ancestor
56957912|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957913|NCT05487833|Insulin|insulin|mesh-list
56957914|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56957915|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957916|NCT03600805|Prednisone|prednisone|mesh-list
56957917|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957918|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
56957919|NCT03600805|Hormones|hormones|mesh-ancestor
56957920|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56957921|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957922|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56957923|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957924|NCT01198379|Aspirin|aspirin|mesh-list
56957925|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56957926|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56957927|NCT01198379|Analgesics|analgesics|mesh-ancestor
56957928|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
56957929|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957930|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957931|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56957932|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56957933|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56957934|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56957935|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957936|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56957937|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56957938|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957939|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
56957940|NCT03848039|Vaccines|vaccines|mesh-list
56957941|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
56957942|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957943|NCT01296269|Vasopressins|vasopressins|mesh-list
56957944|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
56957945|NCT01296269|Oxytocin|oxytocin|mesh-list
56957946|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
56957947|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56957948|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957949|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
56957950|NCT01296269|Coagulants|coagulants|mesh-ancestor
56957951|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56957952|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56957953|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
56957954|NCT05595772|Mitogens|mitogens|mesh-list
56957955|NCT05595772|Mitosis Modulators|mitosis modulators|mesh-ancestor
56957956|NCT05595772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957957|NCT03844451|Epinephrine|epinephrine|mesh-list
56957958|NCT03844451|Bupivacaine|bupivacaine|mesh-list
56957959|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
56957960|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
56957961|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56957962|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957963|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
56957964|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56957965|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56957966|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56957967|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
56957968|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56957969|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957970|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56957971|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56957972|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
56957973|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56957974|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
56957975|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
56957976|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
56957977|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56957978|NCT03346096|Thiotepa|thiotepa|mesh-list
56957979|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56957980|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
56957981|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957982|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56957983|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56957984|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56957985|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
56957986|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957987|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
56957988|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56957989|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56957990|NCT03386214|Pevonedistat|pevonedistat|mesh-list
56957991|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957992|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56957993|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56957994|NCT01198535|Cetuximab|cetuximab|mesh-list
56957995|NCT01198535|Antibodies|antibodies|mesh-list
56957996|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
56957997|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56957998|NCT01198535|R04929097|r04929097|mesh-list
56957999|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
56958000|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958001|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958002|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958003|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958004|NCT05081219|Insulin|insulin|mesh-list
56958005|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56958006|NCT05081219|Empagliflozin|empagliflozin|mesh-list
56958007|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56958008|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958009|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56958010|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958011|NCT03909334|Osimertinib|osimertinib|mesh-list
56958012|NCT03909334|Ramucirumab|ramucirumab|mesh-list
56958013|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958014|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56958015|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958016|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958017|NCT03860038|Dexamethasone|dexamethasone|mesh-list
56958018|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56958019|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
56958020|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
56958021|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958022|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958023|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958024|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
56958025|NCT03860038|Hormones|hormones|mesh-ancestor
56958026|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958027|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56958028|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958029|NCT03773302|Gemcitabine|gemcitabine|mesh-list
56958030|NCT03773302|Infigratinib|infigratinib|mesh-list
56958031|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958032|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56958033|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
56958034|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958035|NCT03773302|Antiviral Agents|antiviral agents|mesh-ancestor
56958036|NCT03773302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958037|NCT03773302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958038|NCT03773302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958039|NCT03773302|Immunologic Factors|immunologic factors|mesh-ancestor
56958040|NCT03773302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958041|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
56958043|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958044|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
56958045|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958046|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958047|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56958048|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
56958049|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958050|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958051|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56958052|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958053|NCT04897841|Bupivacaine|bupivacaine|mesh-list
56958054|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
56958055|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
56958056|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958057|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958058|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
56958059|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958060|NCT05016947|Dexamethasone|dexamethasone|mesh-list
56958061|NCT05016947|Venetoclax|venetoclax|mesh-list
56958062|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56958063|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56958064|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
56958065|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
56958066|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958067|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958068|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958069|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
56958070|NCT05016947|Hormones|hormones|mesh-ancestor
56958071|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958072|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56958073|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958074|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958075|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56958076|NCT01198925|Piperacillin|piperacillin|mesh-list
56958077|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56958078|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958079|NCT03844139|Glycerol|glycerol|mesh-list
56958080|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56958081|NCT03844139|Protective Agents|protective agents|mesh-ancestor
56958082|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958083|NCT04883255|Dronabinol|dronabinol|mesh-list
56958084|NCT04883255|Cannabidiol|cannabidiol|mesh-list
56958085|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
56958086|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
56958087|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958088|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56958089|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56958090|NCT04883255|Analgesics|analgesics|mesh-ancestor
56958091|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
56958092|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958093|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56958094|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56958095|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56958096|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958097|NCT04883255|Hormones|hormones|mesh-ancestor
56958098|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958099|NCT04500496|Isoniazid|isoniazid|mesh-list
56958100|NCT04500496|Dinoprostone|dinoprostone|mesh-list
56958101|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
56958102|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56958103|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958104|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
56958105|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56958106|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958107|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56958108|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56958109|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
56958110|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958111|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56958112|NCT01199081|Dronedarone|dronedarone|mesh-list
56958113|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56958114|NCT04989335|Fludarabine|fludarabine|mesh-list
56958115|NCT04989335|Clofarabine|clofarabine|mesh-list
56958116|NCT04989335|Bisantrene|bisantrene|mesh-list
56958117|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958118|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56958119|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
56958120|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958121|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56958122|NCT02297438|Letrozole|letrozole|mesh-list
56958123|NCT02297438|Palbociclib|palbociclib|mesh-list
56958124|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958125|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56958126|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56958127|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958128|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958129|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56958130|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
56958131|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958132|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958133|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56958134|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56958135|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56958136|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56958137|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958138|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958139|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
56958140|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958141|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
56958142|NCT05670353|Contraceptive Agents|contraceptive agents|mesh-list
56958143|NCT05670353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-list
56958144|NCT05670353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56958145|NCT05670353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958146|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
56958147|NCT01199159|Pyridoxal|pyridoxal|mesh-list
56958148|NCT01199159|Pyridoxine|pyridoxine|mesh-list
56958149|NCT01199159|Misoprostol|misoprostol|mesh-list
56958150|NCT01199159|Vitamins|vitamins|mesh-ancestor
56958151|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
56958152|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958153|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56958154|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
56958155|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56958156|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56958157|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958158|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
56958159|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
56958160|NCT05669963|Lactoferrin|lactoferrin|mesh-list
56958161|NCT05669963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958162|NCT02507440|Lidocaine|lidocaine|mesh-list
56958163|NCT02507440|Propofol|propofol|mesh-list
56958164|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
56958165|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
56958166|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958167|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958168|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
56958169|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958170|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55736946|NCT03424733|Interferon-beta|interferon-beta|mesh-list
56958171|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56958172|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56958173|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958174|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958175|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56958176|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56958177|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
56958178|NCT02507362|Riboflavin|riboflavin|mesh-list
56958179|NCT02507362|Dextrans|dextrans|mesh-list
56958180|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
56958181|NCT02507362|Vitamins|vitamins|mesh-ancestor
56958183|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958184|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56958185|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
56958186|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
56958187|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
56958188|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
56958189|NCT05640830|Paclitaxel|paclitaxel|mesh-list
56958190|NCT05640830|Bevacizumab|bevacizumab|mesh-list
56958191|NCT05640830|Trastuzumab|trastuzumab|mesh-list
56958192|NCT05640830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56958193|NCT05640830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958194|NCT05640830|Tubulin Modulators|tubulin modulators|mesh-ancestor
56958195|NCT05640830|Antimitotic Agents|antimitotic agents|mesh-ancestor
56958196|NCT05640830|Mitosis Modulators|mitosis modulators|mesh-ancestor
56958197|NCT05640830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958198|NCT05640830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958199|NCT05640830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56958200|NCT05640830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56958201|NCT05640830|Growth Substances|growth substances|mesh-ancestor
56958202|NCT05640830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958203|NCT05640830|Growth Inhibitors|growth inhibitors|mesh-ancestor
56958204|NCT02507284|SRX246|srx246|mesh-list
56958205|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56958206|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958207|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
56958208|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958209|NCT03730961|Furosemide|furosemide|mesh-list
56958210|NCT03730961|Diuretics|diuretics|mesh-ancestor
56958211|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
56958212|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958213|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56958214|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958215|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958216|NCT01078454|Dexamethasone|dexamethasone|mesh-list
56958217|NCT01078454|Bortezomib|bortezomib|mesh-list
56958218|NCT01078454|Melphalan|melphalan|mesh-list
56958219|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56958220|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
56958221|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
56958222|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958223|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958224|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958225|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
56958226|NCT01078454|Hormones|hormones|mesh-ancestor
56958227|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958228|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56958229|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958230|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56958231|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
56958232|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958233|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56958234|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958235|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
56958236|NCT02968602|Minocycline|minocycline|mesh-list
56958237|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56958238|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958239|NCT03345004|Vitamin D|vitamin d|mesh-list
56958240|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
56958241|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
56958242|NCT03345004|Vitamins|vitamins|mesh-list
56958243|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
56958244|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958245|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56958246|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56958247|NCT03034356|Levetiracetam|levetiracetam|mesh-list
56958248|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
56958249|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
56958250|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
56958251|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958252|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958253|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56958254|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958255|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958256|NCT03552523|Pancrelipase|pancrelipase|mesh-list
56958257|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958258|NCT03728101|Dabigatran|dabigatran|mesh-list
56958259|NCT03728101|Simvastatin|simvastatin|mesh-list
56958260|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56958261|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56958262|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
56958263|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958264|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56958265|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56958266|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958267|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
56958268|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56958269|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
56958270|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
56958271|NCT03844217|Tryptophan|tryptophan|mesh-list
56958272|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56958273|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
56958274|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56958275|NCT04170972|Insulin|insulin|mesh-list
56958276|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56958277|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958278|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
56958279|NCT02515864|Dotinurad|dotinurad|mesh-list
56958280|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56958281|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56958282|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958283|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56958284|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56958285|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958286|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958287|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958288|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56958289|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
56958290|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56958291|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958292|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56958293|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56958294|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56958295|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
56958296|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
56958297|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958298|NCT02515864|Renal Agents|renal agents|mesh-ancestor
56958299|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
56958300|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
56958301|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
56958302|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56958303|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958304|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958305|NCT02892409|Amoxicillin|amoxicillin|mesh-list
56958306|NCT02892409|Clarithromycin|clarithromycin|mesh-list
56958307|NCT02892409|Lansoprazole|lansoprazole|mesh-list
56958308|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
56958309|NCT02892409|Bismuth|bismuth|mesh-list
56958310|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56958311|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958312|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56958313|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958314|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958315|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56958316|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56958317|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56958318|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958319|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56958320|NCT02892409|Antacids|antacids|mesh-ancestor
56958321|NCT02507128|Liraglutide|liraglutide|mesh-list
56958322|NCT02507128|Glucagon|glucagon|mesh-list
56958323|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56879187|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958324|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56958325|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958326|NCT02507128|Incretins|incretins|mesh-ancestor
56958327|NCT02507128|Hormones|hormones|mesh-ancestor
56958328|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958329|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958330|NCT03844529|Lidocaine|lidocaine|mesh-list
56958331|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
56958332|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
56640659|NCT00649467|Topiramate|topiramate|mesh-list
56958333|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958334|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958335|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
56958336|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958337|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56958338|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56958339|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56958340|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958341|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958342|NCT02292758|Bevacizumab|bevacizumab|mesh-list
56958343|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56958344|NCT02292758|Cetuximab|cetuximab|mesh-list
56958345|NCT02292758|Irinotecan|irinotecan|mesh-list
56958346|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
56958347|NCT02292758|Antibodies|antibodies|mesh-list
56958348|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
56958349|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56958350|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
56958351|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958352|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56958353|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56958354|NCT02292758|Growth Substances|growth substances|mesh-ancestor
56958355|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958356|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
56958357|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
56958358|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56958359|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56958360|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958361|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958362|NCT03727867|Mitogens|mitogens|mesh-list
56958363|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
56958364|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958365|NCT02832648|Selenium|selenium|mesh-list
56958366|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
56958367|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958368|NCT02832648|Protective Agents|protective agents|mesh-ancestor
56958369|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958370|NCT02832648|Trace Elements|trace elements|mesh-ancestor
56958371|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
56958372|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
56958373|NCT04497766|Analgesics|analgesics|mesh-ancestor
56958374|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
56958375|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958376|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958377|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
56958378|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958379|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56958380|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
56958381|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56958382|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958383|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958384|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56958385|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
56958386|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56958387|NCT03841721|Linezolid|linezolid|mesh-list
56958388|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56958389|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958390|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56958391|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958392|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958393|NCT03164057|Cytarabine|cytarabine|mesh-list
56958394|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
56958395|NCT03164057|Methotrexate|methotrexate|mesh-list
56958396|NCT03164057|Azacitidine|azacitidine|mesh-list
56958397|NCT03164057|Decitabine|decitabine|mesh-list
56958398|NCT03164057|Fludarabine|fludarabine|mesh-list
56958399|NCT03164057|Etoposide|etoposide|mesh-list
56958400|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
56958401|NCT03164057|Sorafenib|sorafenib|mesh-list
56958402|NCT03164057|Daunorubicin|daunorubicin|mesh-list
56958403|NCT03164057|Asparaginase|asparaginase|mesh-list
56958404|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
56958405|NCT03164057|Idarubicin|idarubicin|mesh-list
56640734|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56958406|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
56958407|NCT03164057|Razoxane|razoxane|mesh-list
56958408|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
56958409|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56958410|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
56958411|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56958412|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958413|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56958414|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
56958415|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958416|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958417|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
56958418|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958419|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56958420|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958421|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
56958422|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958423|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56958424|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56958425|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56958426|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56958427|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
56958428|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958429|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56958430|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56958431|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56958432|NCT03164057|Analgesics|analgesics|mesh-ancestor
56958433|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
56958434|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958435|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56958436|NCT03164057|Protective Agents|protective agents|mesh-ancestor
56958437|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56958438|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56958439|NCT03620526|Iloprost|iloprost|mesh-list
56958440|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56958441|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
56958442|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
56958443|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
56958444|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56958445|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56958446|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958447|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958448|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958449|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958450|NCT03843749|Trastuzumab|trastuzumab|mesh-list
56958451|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958452|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958453|NCT01199783|Vancomycin|vancomycin|mesh-list
56958454|NCT01199783|Daptomycin|daptomycin|mesh-list
56958455|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56958456|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958457|NCT03192306|Ethanol|ethanol|mesh-list
56958458|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56958459|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958460|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958461|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958462|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
56958463|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56958464|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
56958465|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958466|NCT03216954|Expectorants|expectorants|mesh-ancestor
56958467|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
56958468|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56958469|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
56958470|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958471|NCT03216954|Protective Agents|protective agents|mesh-ancestor
56958472|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958473|NCT03216954|Antidotes|antidotes|mesh-ancestor
56958474|NCT05669807|Paclitaxel|paclitaxel|mesh-list
56958475|NCT05669807|Irinotecan|irinotecan|mesh-list
56958476|NCT05669807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56958477|NCT05669807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56958478|NCT05669807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958479|NCT05669807|Tubulin Modulators|tubulin modulators|mesh-ancestor
56958480|NCT05669807|Antimitotic Agents|antimitotic agents|mesh-ancestor
56958481|NCT05669807|Mitosis Modulators|mitosis modulators|mesh-ancestor
56958482|NCT05669807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958483|NCT05669807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56958484|NCT05669807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56958485|NCT05669807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958486|NCT03599089|Acetaminophen|acetaminophen|mesh-list
56958487|NCT03599089|Ketorolac|ketorolac|mesh-list
56958488|NCT03599089|Oxycodone|oxycodone|mesh-list
56958489|NCT03599089|Bupivacaine|bupivacaine|mesh-list
56958490|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
56958491|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
56958492|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958493|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958494|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
56958495|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958496|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56958497|NCT03599089|Analgesics|analgesics|mesh-ancestor
56958498|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
56958499|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56958500|NCT03599089|Narcotics|narcotics|mesh-ancestor
56958501|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56958502|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56958503|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958504|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56958505|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958506|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958507|NCT03597529|Melatonin|melatonin|mesh-list
56958508|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
56958509|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958510|NCT03597529|Protective Agents|protective agents|mesh-ancestor
56958511|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958512|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958513|NCT03991091|Oxytocin|oxytocin|mesh-list
56958514|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
56958515|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56958516|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958517|NCT05420454|Paclitaxel|paclitaxel|mesh-list
56958518|NCT05420454|Docetaxel|docetaxel|mesh-list
56958519|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56958520|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
56958521|NCT05420454|Carboplatin|carboplatin|mesh-list
56958522|NCT05420454|Trastuzumab|trastuzumab|mesh-list
56958523|NCT05420454|Epirubicin|epirubicin|mesh-list
56958524|NCT05420454|Pertuzumab|pertuzumab|mesh-list
56958525|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56958526|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958527|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
56958528|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
56958529|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
56958530|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958531|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958532|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
56958533|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958534|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958535|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56958536|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
56958537|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56958538|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958539|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56958540|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56958541|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56958542|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958543|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
56958544|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
56958545|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958546|NCT04667507|Dexamethasone|dexamethasone|mesh-list
56958547|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56958548|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
56958549|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
56958550|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958551|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958552|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958553|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
56958554|NCT04667507|Hormones|hormones|mesh-ancestor
56958555|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958556|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56958557|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958558|NCT01200251|Bimatoprost|bimatoprost|mesh-list
56958559|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56958560|NCT03597139|Cyclosporine|cyclosporine|mesh-list
56958561|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56958562|NCT03597139|Cyclosporins|cyclosporins|mesh-list
56958563|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958564|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958565|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958566|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
56958567|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958568|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
56958569|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958570|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
56958571|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958572|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56958573|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56958574|NCT01202435|Pregabalin|pregabalin|mesh-list
56958575|NCT01202435|Analgesics|analgesics|mesh-ancestor
56958576|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
56958577|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958578|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958579|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
56958580|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56958581|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958582|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958583|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56958584|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56958585|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56958586|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958587|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56958588|NCT05406102|Propofol|propofol|mesh-list
56958589|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56958590|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958591|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958592|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56958593|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
56958594|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
56958595|NCT01204307|Cisplatin|cisplatin|mesh-list
56958596|NCT01204307|Docetaxel|docetaxel|mesh-list
56958597|NCT01204307|Pemetrexed|pemetrexed|mesh-list
56958598|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958599|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
56958600|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
56958601|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
56958602|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958603|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958604|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56958605|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56958606|NCT00708214|Letrozole|letrozole|mesh-list
56958607|NCT00708214|Afatinib|afatinib|mesh-list
56958608|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958609|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56958610|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56958611|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958612|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958613|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56958614|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
56958615|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958616|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958617|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56958618|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
56958619|NCT02506894|Analgesics|analgesics|mesh-ancestor
56958620|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
56958621|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958622|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958623|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
56958624|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958625|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56958626|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
56958627|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56958628|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958629|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958630|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56958631|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
56958632|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56958633|NCT03909737|Azithromycin|azithromycin|mesh-list
56958634|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56958635|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958636|NCT04891250|Ivermectin|ivermectin|mesh-list
56640958|NCT02754362|Poly ICLC|poly iclc|mesh-list
56958637|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56958638|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958639|NCT03570697|Evolocumab|evolocumab|mesh-list
56958640|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56958641|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56958642|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
56958643|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958644|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56958645|NCT02511574|Progesterone|progesterone|mesh-list
56958646|NCT02511574|Progestins|progestins|mesh-ancestor
56958647|NCT02511574|Hormones|hormones|mesh-ancestor
56958648|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958649|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958650|NCT01200641|Gabapentin|gabapentin|mesh-list
56958651|NCT01200641|Melatonin|melatonin|mesh-list
56958652|NCT01200641|Analgesics|analgesics|mesh-ancestor
56958653|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
56958654|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958655|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958656|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
56958657|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56958658|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56958659|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958660|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56958661|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56958662|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56958663|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56958664|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958665|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
56958666|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
56958667|NCT01200641|Protective Agents|protective agents|mesh-ancestor
56958668|NCT01856270|Amitriptyline|amitriptyline|mesh-list
56958669|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56958670|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
56958671|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56958672|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56958673|NCT01856270|Analgesics|analgesics|mesh-ancestor
56958674|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
56958675|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958676|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958677|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56958678|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56958679|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958680|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958681|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
56958682|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56958683|NCT04573751|Verapamil|verapamil|mesh-list
56958684|NCT04573751|Epinephrine|epinephrine|mesh-list
56958685|NCT04573751|Racepinephrine|racepinephrine|mesh-list
56958686|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
56958687|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56958688|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56958689|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
56958690|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56958691|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958692|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958693|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56958694|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56958695|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
56958696|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958697|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56958698|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
56958699|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
56958700|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
56958701|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56958702|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56958703|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56958704|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958705|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56958706|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
56958707|NCT02511340|HH-GV-678|hh-gv-678|mesh-list
56958708|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641031|NCT02705508|Antiviral Agents|antiviral agents|mesh-ancestor
56958709|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958710|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958711|NCT02506348|Diclofenac|diclofenac|mesh-list
56958713|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56958714|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56958715|NCT02506348|Analgesics|analgesics|mesh-ancestor
56958716|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
56958717|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958718|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958719|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56958720|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958721|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56958722|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958723|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958724|NCT01318070|Pioglitazone|pioglitazone|mesh-list
56958725|NCT01318070|Alogliptin|alogliptin|mesh-list
56958726|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56958727|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958728|NCT01318070|Incretins|incretins|mesh-ancestor
56958729|NCT01318070|Hormones|hormones|mesh-ancestor
56958730|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56958731|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56958732|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
56958733|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958734|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958735|NCT01202513|Bimatoprost|bimatoprost|mesh-list
56958736|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56958737|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56958738|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56958739|NCT03835715|Vortioxetine|vortioxetine|mesh-list
56958740|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
56958741|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56958742|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56958743|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56958744|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958745|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958746|NCT03835715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56958747|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56958748|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958749|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958750|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56958751|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
56958752|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56958753|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56958754|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56958755|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56958756|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
56958757|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56958758|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56958759|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958760|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958761|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
56958762|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56958763|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958764|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56958765|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958766|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56958767|NCT03843281|Acetaminophen|acetaminophen|mesh-list
56958768|NCT03843281|Morphine|morphine|mesh-list
56958769|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56958770|NCT03843281|Narcotics|narcotics|mesh-ancestor
56958771|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958772|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958773|NCT03843281|Analgesics|analgesics|mesh-ancestor
56958774|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
56958775|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958776|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56958777|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
56958778|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56958779|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
56958780|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958781|NCT03843515|Nivolumab|nivolumab|mesh-list
56958782|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958783|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641103|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
56958784|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56958785|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958787|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56958788|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56958789|NCT00245960|Analgesics|analgesics|mesh-ancestor
56958790|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
56958791|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958792|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958793|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56958794|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958795|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958796|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958797|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
56958798|NCT04443322|Durvalumab|durvalumab|mesh-list
56958799|NCT04443322|Lenvatinib|lenvatinib|mesh-list
56958800|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56958801|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958802|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958803|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
56958804|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958805|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56958806|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958807|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958808|NCT01202825|Simeprevir|simeprevir|mesh-list
56958809|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
56958810|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958811|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
56958812|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958813|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958814|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56958815|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56958816|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958817|NCT05222204|Gemcitabine|gemcitabine|mesh-list
56958818|NCT05222204|Paclitaxel|paclitaxel|mesh-list
56958819|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56958820|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958821|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
56958822|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
56958823|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
56958824|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958825|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56958826|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
56958827|NCT05222204|Antiviral Agents|antiviral agents|mesh-ancestor
56958828|NCT05222204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958829|NCT05222204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958830|NCT05222204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958831|NCT05222204|Immunologic Factors|immunologic factors|mesh-ancestor
56958832|NCT05222204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958833|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
56958834|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56958835|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
56958836|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56958837|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
56958838|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958839|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958840|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
56958841|NCT05631236|Methamphetamine|methamphetamine|mesh-list
56958842|NCT05631236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56958843|NCT05631236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958844|NCT05631236|Sympathomimetics|sympathomimetics|mesh-ancestor
56958845|NCT05631236|Autonomic Agents|autonomic agents|mesh-ancestor
56958846|NCT05631236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958847|NCT05631236|Dopamine Agents|dopamine agents|mesh-ancestor
56958848|NCT05631236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736947|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
56879715|NCT05154994|Durvalumab|durvalumab|mesh-list
56958849|NCT05631236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958850|NCT05631236|Adrenergic Agents|adrenergic agents|mesh-ancestor
56958851|NCT05631236|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56958852|NCT05631236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56958853|NCT05631236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56958854|NCT05631236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56958855|NCT05218616|Sunitinib|sunitinib|mesh-list
56958856|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958857|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56958858|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56958859|NCT05218616|Growth Substances|growth substances|mesh-ancestor
56958860|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958861|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
56958862|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56958863|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958864|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958866|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
56958867|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958868|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958869|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
56958870|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958871|NCT03215706|Paclitaxel|paclitaxel|mesh-list
56958872|NCT03215706|Carboplatin|carboplatin|mesh-list
56958873|NCT03215706|Nivolumab|nivolumab|mesh-list
56958874|NCT03215706|Pemetrexed|pemetrexed|mesh-list
56958875|NCT03215706|Ipilimumab|ipilimumab|mesh-list
56958876|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56958877|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958878|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
56958879|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
56958880|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
56958881|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958882|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958883|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56958884|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958885|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56958886|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56958887|NCT02510950|Temozolomide|temozolomide|mesh-list
56958888|NCT02510950|Poly ICLC|poly iclc|mesh-list
56958889|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56958890|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
56958891|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958892|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958893|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
56958894|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
56958895|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958896|NCT05221892|Thiamine|thiamine|mesh-list
56958897|NCT05221892|Pyridoxine|pyridoxine|mesh-list
56958898|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
56958899|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
56958900|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
56958901|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958902|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
56958903|NCT05221892|Vitamins|vitamins|mesh-ancestor
56958904|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
56958905|NCT05221892|Hematinics|hematinics|mesh-ancestor
56958906|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
56958907|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56958908|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958909|NCT05221736|Ethanol|ethanol|mesh-list
56958910|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56958911|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958912|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958913|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958914|NCT05651594|Leucovorin|leucovorin|mesh-list
56958915|NCT05651594|Pembrolizumab|pembrolizumab|mesh-list
56958916|NCT05651594|Fluorouracil|fluorouracil|mesh-list
56958917|NCT05651594|Oxaliplatin|oxaliplatin|mesh-list
56958918|NCT05651594|Propranolol|propranolol|mesh-list
56958919|NCT05651594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56958920|NCT05651594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56958921|NCT05651594|Antimetabolites|antimetabolites|mesh-ancestor
56958922|NCT05651594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958923|NCT05651594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56958924|NCT05651594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56958925|NCT05651594|Immunologic Factors|immunologic factors|mesh-ancestor
56958926|NCT05651594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958927|NCT05651594|Antidotes|antidotes|mesh-ancestor
56958928|NCT05651594|Protective Agents|protective agents|mesh-ancestor
56958929|NCT05651594|Vitamin B Complex|vitamin b complex|mesh-ancestor
56958930|NCT05651594|Vitamins|vitamins|mesh-ancestor
56958931|NCT05651594|Micronutrients|micronutrients|mesh-ancestor
56958932|NCT05651594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56958933|NCT05651594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56958934|NCT05651594|Adrenergic Agents|adrenergic agents|mesh-ancestor
56958948|NCT04454411|Analgesics|analgesics|mesh-ancestor
56958949|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
56958950|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958951|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56958952|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56958953|NCT02505568|Infliximab|infliximab|mesh-list
56958954|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
56958955|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56958956|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958957|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56958958|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56958959|NCT05217836|Hepcidins|hepcidins|mesh-list
56958960|NCT05217836|Chrysarobin|chrysarobin|mesh-list
56958961|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56958962|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56958963|NCT05217836|Analgesics|analgesics|mesh-ancestor
56958964|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
56958965|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958966|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958967|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56958968|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56958969|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56958982|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
56958983|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56958984|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56958985|NCT02514538|Acetaminophen|acetaminophen|mesh-list
56958986|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56958987|NCT02514538|Analgesics|analgesics|mesh-ancestor
56958988|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
56958989|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958990|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958991|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
56958992|NCT05669417|Magnesium Sulfate|magnesium sulfate|mesh-list
56958993|NCT05669417|Analgesics|analgesics|mesh-ancestor
56958994|NCT05669417|Sensory System Agents|sensory system agents|mesh-ancestor
56958995|NCT05669417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56958996|NCT05669417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958997|NCT05669417|Anesthetics|anesthetics|mesh-ancestor
56958998|NCT05669417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958999|NCT05669417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56959000|NCT05669417|Anticonvulsants|anticonvulsants|mesh-ancestor
56959001|NCT05669417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56959002|NCT05669417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56959003|NCT05669417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959004|NCT05669417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56959005|NCT05669417|Tocolytic Agents|tocolytic agents|mesh-ancestor
56959006|NCT05669417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56959007|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
56959008|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56959009|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959010|NCT02504944|Propranolol|propranolol|mesh-list
56959011|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56959012|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56959013|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56959014|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56959015|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
56959016|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959017|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959018|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959019|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56959020|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56959021|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
56959022|NCT01201499|Morphine|morphine|mesh-list
56959023|NCT01201499|Remifentanil|remifentanil|mesh-list
56879864|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
56959024|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56959025|NCT01201499|Narcotics|narcotics|mesh-ancestor
56959026|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959027|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959028|NCT01201499|Analgesics|analgesics|mesh-ancestor
56959029|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
56959030|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959031|NCT03473639|Capecitabine|capecitabine|mesh-list
56959032|NCT03473639|Entinostat|entinostat|mesh-list
56959033|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56959034|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
56959035|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959036|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959037|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56959038|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959039|NCT03121690|Prednisone|prednisone|mesh-list
56959040|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959041|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
56959042|NCT03121690|Hormones|hormones|mesh-ancestor
56959043|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56959044|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959045|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56959046|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959047|NCT03831269|Azithromycin|azithromycin|mesh-list
56959048|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56959049|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959050|NCT02504476|Midazolam|midazolam|mesh-list
56959051|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56959052|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56959053|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959054|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959055|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56959056|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56959057|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56959058|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56959059|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
56959060|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
56959061|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
56959062|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
56959063|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959064|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959065|NCT02504398|Methamphetamine|methamphetamine|mesh-list
56959066|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56959067|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959068|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
56959069|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
56959070|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959071|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
56959072|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959073|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959074|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
56959075|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56959076|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56959077|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56959078|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56959079|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56959080|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56959081|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959082|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
56959083|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
56641405|NCT05323422|Ketamine|ketamine|mesh-list
56959084|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959085|NCT03830489|Protective Agents|protective agents|mesh-ancestor
56959086|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959087|NCT03830489|Vitamins|vitamins|mesh-ancestor
56959088|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
56959089|NCT02509468|Sirolimus|sirolimus|mesh-list
56959090|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56959091|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959092|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56959093|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959094|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
56959095|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959096|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
56879939|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
56959097|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959098|NCT03344614|Apatinib|apatinib|mesh-list
56959099|NCT03344614|Raltitrexed|raltitrexed|mesh-list
56959100|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959101|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56959102|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959103|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959104|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56959105|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
56959106|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56959107|NCT01205087|Omeprazole|omeprazole|mesh-list
56959108|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56959109|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56959110|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56959111|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959112|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959113|NCT01205243|Abacavir|abacavir|mesh-list
56959114|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56959115|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56959116|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959117|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959118|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
56959119|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959120|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56959121|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56959122|NCT02504164|Midazolam|midazolam|mesh-list
56959123|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56959124|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56959125|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959126|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959127|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56959128|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56959129|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56959130|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56959131|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
56959132|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
56959133|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
56959134|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
56959135|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959136|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959137|NCT02509234|Irinotecan|irinotecan|mesh-list
56959138|NCT02509234|Trabectedin|trabectedin|mesh-list
56959139|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56959140|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56959141|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959142|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959143|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959144|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56959145|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
56959146|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
56959147|NCT01205321|Bombesin|bombesin|mesh-list
56959148|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959149|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959150|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959151|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56959152|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
56959153|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56959154|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959155|NCT03566485|Atezolizumab|atezolizumab|mesh-list
56959156|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959157|NCT02513290|Loratadine|loratadine|mesh-list
56959158|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
56959159|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
56959160|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56959161|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56959162|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56959163|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
56959164|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
56959165|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959166|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959167|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959168|NCT02501200|Ezetimibe|ezetimibe|mesh-list
56959169|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56959170|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56880046|NCT04531098|Vaccines|vaccines|mesh-list
56959171|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
56959172|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959173|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56959174|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56959175|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959176|NCT02501278|Cisplatin|cisplatin|mesh-list
56959177|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959178|NCT03176238|Everolimus|everolimus|mesh-list
56959179|NCT03176238|Exemestane|exemestane|mesh-list
56959180|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959181|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959182|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
56959183|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959184|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56959185|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56959186|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959187|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959188|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56959189|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
56959190|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56959191|NCT01957332|Trastuzumab|trastuzumab|mesh-list
56959192|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56959193|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959194|NCT01205711|Leucovorin|leucovorin|mesh-list
56959195|NCT01205711|Fluorouracil|fluorouracil|mesh-list
56959196|NCT01205711|Irinotecan|irinotecan|mesh-list
56959197|NCT01205711|Calcium|calcium|mesh-list
56959198|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
56959199|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56959200|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959201|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
56959202|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959203|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56959204|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959205|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959206|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
56959207|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56959208|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56959209|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959210|NCT01205711|Antidotes|antidotes|mesh-ancestor
56959211|NCT01205711|Protective Agents|protective agents|mesh-ancestor
56959212|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
56959213|NCT01205711|Vitamins|vitamins|mesh-ancestor
56959214|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
56959215|NCT02508922|Vitamin D|vitamin d|mesh-list
56959216|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
56959217|NCT02508922|Vitamins|vitamins|mesh-ancestor
56959218|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
56959219|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959220|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56959221|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56959222|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
56959223|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959224|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56959225|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959226|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959227|NCT03730675|Sorafenib|sorafenib|mesh-list
56959228|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959229|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56959230|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959231|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959232|NCT01765140|Amifampridine|amifampridine|mesh-list
56959233|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56959234|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959235|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959236|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56959237|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56959238|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959239|NCT01345682|Methotrexate|methotrexate|mesh-list
56959240|NCT01345682|Afatinib|afatinib|mesh-list
56959241|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56959242|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
56959243|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56959244|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959245|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56959246|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
56959247|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959248|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959249|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
56959250|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959251|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56959252|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959253|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
56959254|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56959255|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56959256|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56959257|NCT02503462|Ritonavir|ritonavir|mesh-list
56959258|NCT02503462|Darunavir|darunavir|mesh-list
56959259|NCT02503462|Cobicistat|cobicistat|mesh-list
56959260|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56959261|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56959262|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
56959263|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959264|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959265|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56959266|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56959267|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
56959268|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959269|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56959270|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56959271|NCT03343678|Venetoclax|venetoclax|mesh-list
56959272|NCT03343678|BI 836826|bi 836826|mesh-list
56959273|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959274|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56959275|NCT05216822|Racecadotril|racecadotril|mesh-list
56959276|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
56959277|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56959278|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
56959279|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959280|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959281|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
56959282|NCT04498936|Ledipasvir|ledipasvir|mesh-list
56959283|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56959284|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
56959285|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
56959286|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959287|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56959288|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
56959289|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56959290|NCT03627260|Protective Agents|protective agents|mesh-ancestor
56959291|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959292|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
56959293|NCT05706038|Adalimumab|adalimumab|mesh-list
56959294|NCT05706038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959295|NCT05706038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56959296|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
56959297|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
56959298|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959299|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959300|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959301|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56959302|NCT05126264|Ibuprofen|ibuprofen|mesh-list
56959303|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56959304|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56959305|NCT05126264|Analgesics|analgesics|mesh-ancestor
56959306|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
56959307|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959308|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959309|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959310|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56641630|NCT04218500|Niacin|niacin|mesh-list
56959311|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56959312|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959313|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959314|NCT03001817|Fenofibrate|fenofibrate|mesh-list
56959315|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56959316|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
56959317|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959318|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56959319|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
55737022|NCT03441373|Glutarimide|glutarimide|mesh-list
56880163|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56959320|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56959321|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56959322|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959323|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
56959324|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
56959325|NCT03590743|Apixaban|apixaban|mesh-list
56959326|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56959327|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
56959328|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56959329|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
56959330|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959331|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959332|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
56959333|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
56959334|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959335|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56959336|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959337|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959338|NCT05643794|Rozanolixizumab|rozanolixizumab|mesh-list
56959339|NCT05643794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959340|NCT05643794|Immunologic Factors|immunologic factors|mesh-ancestor
56959341|NCT05643794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959342|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56959343|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
56959344|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959345|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
56959346|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56959347|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
56959348|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959349|NCT03121222|Expectorants|expectorants|mesh-ancestor
56959350|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
56959351|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56959352|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
56959353|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959354|NCT03121222|Protective Agents|protective agents|mesh-ancestor
56959355|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959356|NCT03121222|Antidotes|antidotes|mesh-ancestor
56959357|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56959358|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56959359|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56959360|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56959361|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
56959362|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959363|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56959364|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56959365|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959366|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56959367|NCT05705804|Atorvastatin|atorvastatin|mesh-list
56959368|NCT05705804|Pitavastatin|pitavastatin|mesh-list
56959369|NCT05705804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56959370|NCT05705804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56959371|NCT05705804|Antimetabolites|antimetabolites|mesh-ancestor
56959372|NCT05705804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959373|NCT05705804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56959374|NCT05705804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56959375|NCT05705804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959376|NCT03344302|Oxytocin|oxytocin|mesh-list
56959377|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
56959378|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56959379|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959380|NCT03545503|Ketamine|ketamine|mesh-list
56959381|NCT03545503|Etomidate|etomidate|mesh-list
56959382|NCT03545503|Analgesics|analgesics|mesh-ancestor
56959383|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
56959384|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959385|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641700|NCT04218734|Metformin|metformin|mesh-list
56959386|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56959387|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56959388|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
56959389|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
56959390|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959391|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55737023|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
56959392|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56959393|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959394|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959395|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56959396|NCT01297829|Ibuprofen|ibuprofen|mesh-list
56959397|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56959398|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56959399|NCT01297829|Analgesics|analgesics|mesh-ancestor
56959400|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
56959401|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959402|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959403|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959404|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56959405|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56959406|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959407|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959408|NCT03829943|Vitamin D|vitamin d|mesh-list
56959409|NCT03829943|Vitamins|vitamins|mesh-ancestor
56959410|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
56959411|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959412|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56959413|NCT02508142|Scopolamine|scopolamine|mesh-list
56959414|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56959415|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56959416|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
56959417|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
56959418|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959419|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959420|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56959421|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
56959422|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56959423|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
56959424|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959425|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959426|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56959427|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
56959428|NCT02508220|Oxytocin|oxytocin|mesh-list
56959429|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
56959430|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56959431|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959432|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
56959433|NCT01297907|Miotics|miotics|mesh-ancestor
56959434|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
56959435|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959436|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959437|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56959438|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56959439|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
56959440|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56959441|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56959442|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
56959443|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959444|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959445|NCT02508064|Fostemsavir|fostemsavir|mesh-list
56959446|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56959447|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56959448|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
56959449|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959450|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56959451|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56959452|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959453|NCT05705570|Cyclophosphamide|cyclophosphamide|mesh-list
56959454|NCT05705570|Fludarabine|fludarabine|mesh-list
56959455|NCT05705570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959456|NCT05705570|Immunologic Factors|immunologic factors|mesh-ancestor
56959457|NCT05705570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959458|NCT05705570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56959459|NCT05705570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56959460|NCT05705570|Alkylating Agents|alkylating agents|mesh-ancestor
56959461|NCT05705570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959462|NCT05705570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959463|NCT05705570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56959464|NCT05670236|Lidocaine|lidocaine|mesh-list
56959465|NCT05670236|Anesthetics, Local|anesthetics, local|mesh-ancestor
56959466|NCT05670236|Anesthetics|anesthetics|mesh-ancestor
56880316|NCT05203744|Tafenoquine|tafenoquine|mesh-list
56959467|NCT05670236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959468|NCT05670236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959469|NCT05670236|Sensory System Agents|sensory system agents|mesh-ancestor
56959470|NCT05670236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959471|NCT05670236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56959472|NCT05670236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56959473|NCT05670236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56959474|NCT05670236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56959475|NCT05670236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959476|NCT03214380|Insulin|insulin|mesh-list
56959477|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56959478|NCT03214380|Metformin|metformin|mesh-list
56959479|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
56959480|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
56959481|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56959482|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56959483|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959484|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959485|NCT04498234|Bupivacaine|bupivacaine|mesh-list
56959486|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
56959487|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
56959488|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959489|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959490|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
56959491|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959492|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
56959493|NCT03343444|Ledipasvir|ledipasvir|mesh-list
56959494|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
56959495|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959496|NCT03819101|Aspirin|aspirin|mesh-list
56959497|NCT03819101|Atorvastatin|atorvastatin|mesh-list
56959498|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56959499|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56959500|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
56959501|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959502|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56959503|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56959504|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959505|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56959506|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56959507|NCT03819101|Analgesics|analgesics|mesh-ancestor
56959508|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
56959509|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959510|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959511|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959512|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56959513|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56959514|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56959515|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56959516|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56959517|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
56959518|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56959519|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
56959520|NCT05199324|Cefazolin|cefazolin|mesh-list
56959521|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
56959522|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56959523|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
56959524|NCT05199324|Trimethoprim|trimethoprim|mesh-list
56959525|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
56959526|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959527|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56959528|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56959529|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959530|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959531|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959532|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56959533|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56959534|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56959535|NCT05199324|Renal Agents|renal agents|mesh-ancestor
56959536|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
56959537|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56959538|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56959539|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56959540|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56959541|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56959542|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56959543|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56959544|NCT03343366|Metronidazole|metronidazole|mesh-list
56959545|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959546|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56959547|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56959548|NCT05648006|Bevacizumab|bevacizumab|mesh-list
56959549|NCT05648006|Capecitabine|capecitabine|mesh-list
56959550|NCT05648006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56959551|NCT05648006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959552|NCT05648006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56959553|NCT05648006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56959554|NCT05648006|Growth Substances|growth substances|mesh-ancestor
56959555|NCT05648006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959556|NCT05648006|Growth Inhibitors|growth inhibitors|mesh-ancestor
56959557|NCT05648006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56959558|NCT05648006|Antimetabolites|antimetabolites|mesh-ancestor
56959559|NCT05648006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959560|NCT01298297|Morphine|morphine|mesh-list
56959561|NCT01298297|Buprenorphine|buprenorphine|mesh-list
56959562|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56959563|NCT01298297|Narcotics|narcotics|mesh-ancestor
56959564|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959565|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959566|NCT01298297|Analgesics|analgesics|mesh-ancestor
56959567|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
56959568|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959569|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56959570|NCT03818945|Listerine|listerine|mesh-list
56959571|NCT03818945|Fluorides|fluorides|mesh-list
56959572|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
56959573|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
56959574|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
56959575|NCT03818945|Protective Agents|protective agents|mesh-ancestor
56959576|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959577|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56959578|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959579|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
56959580|NCT04300751|Narcotics|narcotics|mesh-ancestor
56959581|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959582|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959583|NCT04300751|Analgesics|analgesics|mesh-ancestor
56959584|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
56959585|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959586|NCT03842423|Anesthetics|anesthetics|mesh-list
56959587|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959588|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959589|NCT03172026|Maraviroc|maraviroc|mesh-list
56959590|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56959591|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56959592|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959593|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56959594|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56959595|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
56959596|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959597|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56959598|NCT01201577|Azithromycin|azithromycin|mesh-list
56959599|NCT01201577|Sulfalene|sulfalene|mesh-list
56959600|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56959601|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959602|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56959603|NCT01201577|Renal Agents|renal agents|mesh-ancestor
56959604|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
56959605|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56959606|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56959607|NCT04496050|Alprostadil|alprostadil|mesh-list
56959608|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56959609|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
56959610|NCT04496050|Urological Agents|urological agents|mesh-ancestor
56959611|NCT01300793|Rituximab|rituximab|mesh-list
56959612|NCT01300793|Carboplatin|carboplatin|mesh-list
56959613|NCT01300793|Etoposide|etoposide|mesh-list
56959614|NCT01300793|Bortezomib|bortezomib|mesh-list
56959615|NCT01300793|Ifosfamide|ifosfamide|mesh-list
56959616|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
56959617|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880467|NCT04578106|Trastuzumab|trastuzumab|mesh-list
56959618|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959619|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
56959620|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959621|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56959622|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56959623|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56959624|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56959625|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959626|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959627|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56959628|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
56959629|NCT03342040|Bupivacaine|bupivacaine|mesh-list
56959630|NCT03342040|Ropivacaine|ropivacaine|mesh-list
56959631|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
56959632|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
56959633|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959634|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959635|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
56959636|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959637|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56959638|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56959639|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959640|NCT03336970|Calcium|calcium|mesh-list
56959641|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56959642|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959643|NCT03336814|Terlipressin|terlipressin|mesh-list
56959644|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56959645|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56959646|NCT02495584|Vitamin D|vitamin d|mesh-list
56959647|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
56959648|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
56959649|NCT02495584|Vitamins|vitamins|mesh-list
56959650|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
56959651|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959652|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56959653|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56959654|NCT02495818|Lidocaine|lidocaine|mesh-list
56959655|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
56959656|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
56959657|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959658|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959659|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
56959660|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959661|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56959662|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56959663|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56959664|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56959665|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959666|NCT02495662|Prednisolone|prednisolone|mesh-list
56959667|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56959668|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
56959669|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56959670|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
56959671|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56959672|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
56959673|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959674|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
56959675|NCT02495662|Hormones|hormones|mesh-ancestor
56959676|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56959677|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959678|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56959679|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959680|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
56959681|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
56959682|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959683|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56959684|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56959685|NCT02495662|Protective Agents|protective agents|mesh-ancestor
56959686|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56959687|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56959688|NCT02496052|Estradiol|estradiol|mesh-list
56959689|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56959690|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
56959691|NCT02496052|Estrogens|estrogens|mesh-ancestor
56959692|NCT02496052|Hormones|hormones|mesh-ancestor
56959693|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56959694|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959695|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56959696|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
56959697|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56959698|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56959699|NCT02496052|Progestins|progestins|mesh-ancestor
56959700|NCT01206569|Tacrolimus|tacrolimus|mesh-list
56959701|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959702|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
56959703|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959704|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56959705|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959706|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959707|NCT01206647|Metformin|metformin|mesh-list
56959708|NCT01206647|Saxagliptin|saxagliptin|mesh-list
56959709|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56959710|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959711|NCT01206647|Incretins|incretins|mesh-ancestor
56959712|NCT01206647|Hormones|hormones|mesh-ancestor
56959713|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56959714|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56959715|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
56959716|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959717|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959718|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
56959719|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56959720|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
56959721|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959722|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959723|NCT02495272|Oxytocin|oxytocin|mesh-list
56959724|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
56959725|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56959726|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959727|NCT03336346|Efavirenz|efavirenz|mesh-list
56959728|NCT03336346|Dolutegravir|dolutegravir|mesh-list
56959729|NCT03336346|Etonogestrel|etonogestrel|mesh-list
56959730|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56959731|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56959732|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959733|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959734|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
56959735|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959736|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56959737|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56959738|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56959739|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56959740|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56959741|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56959742|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56959743|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56959744|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56959745|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56959746|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56959747|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
56959748|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56959749|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959750|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56959751|NCT03841292|Varenicline|varenicline|mesh-list
56959752|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56959753|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56959754|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
56959755|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959756|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959757|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959758|NCT03814577|Antioxidants|antioxidants|mesh-list
56959759|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959760|NCT03814577|Protective Agents|protective agents|mesh-ancestor
56959761|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959762|NCT03730363|Pentamidine|pentamidine|mesh-list
56959763|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
56959764|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959765|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56959766|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56959767|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56959768|NCT01206803|Ganirelix|ganirelix|mesh-list
56959769|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
56959770|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56959771|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959772|NCT03335956|Pioglitazone|pioglitazone|mesh-list
56959773|NCT03335956|Prednisone|prednisone|mesh-list
56959774|NCT03335956|Cortisone|cortisone|mesh-list
56959775|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959776|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
56959777|NCT03335956|Hormones|hormones|mesh-ancestor
56959778|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56959779|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959780|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56959781|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959782|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56959783|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
56959784|NCT03817931|Mirabegron|mirabegron|mesh-list
56959785|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56959786|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
56959787|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
56959788|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
56959789|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56959790|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
56959791|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959792|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959793|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959794|NCT03817931|Urological Agents|urological agents|mesh-ancestor
56959795|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56959796|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
56959797|NCT01206881|Docetaxel|docetaxel|mesh-list
56959798|NCT01206881|Doxorubicin|doxorubicin|mesh-list
56959799|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56959800|NCT01206881|Trastuzumab|trastuzumab|mesh-list
56959801|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959802|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
56959803|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959804|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56959805|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56959806|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
56959807|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959808|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959809|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56959810|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
56959811|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
56959812|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
56959813|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56959814|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56959815|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56959816|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959817|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56959818|NCT02494804|Temozolomide|temozolomide|mesh-list
56959819|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56959820|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
56959821|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959822|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959823|NCT04724252|Gabapentin|gabapentin|mesh-list
56959824|NCT04724252|Analgesics|analgesics|mesh-ancestor
56959825|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
56959826|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959827|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959828|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
56959829|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56959830|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56959831|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959832|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56959833|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56959834|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56959835|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959836|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959837|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
56959838|NCT04666454|Adenosine|adenosine|mesh-list
56959839|NCT04666454|Dipyridamole|dipyridamole|mesh-list
56959840|NCT04666454|Apixaban|apixaban|mesh-list
56959841|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56959842|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
56959843|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56959844|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
56959845|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959846|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959847|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
56959848|NCT04666454|Analgesics|analgesics|mesh-ancestor
56959849|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
56959850|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959851|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959852|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56959853|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
56959854|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56959855|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
56959856|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
56959857|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959858|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56959859|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56959860|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56959861|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
56959862|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959863|NCT03814343|Amphotericin B|amphotericin b|mesh-list
56959864|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56959865|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56959866|NCT03814343|Amebicides|amebicides|mesh-ancestor
56959867|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56959868|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56959869|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959870|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56959871|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
56959872|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56959873|NCT03814343|Protective Agents|protective agents|mesh-ancestor
56959874|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959875|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56959876|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
56959877|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959878|NCT03817541|Propofol|propofol|mesh-list
56959879|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56959880|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959881|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959882|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56959883|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
56959884|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
56959885|NCT03341494|Thalidomide|thalidomide|mesh-list
56959886|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959887|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
56959888|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959889|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
56959890|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56959891|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959892|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56959893|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56959894|NCT03341494|Growth Substances|growth substances|mesh-ancestor
56959895|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
56959896|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959897|NCT03586609|Cytarabine|cytarabine|mesh-list
56959898|NCT03586609|Azacitidine|azacitidine|mesh-list
56959899|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56959900|NCT03586609|Venetoclax|venetoclax|mesh-list
56959901|NCT03586609|Cladribine|cladribine|mesh-list
56959902|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56959903|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
56959904|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959905|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959906|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
56959907|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959908|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959909|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
56959910|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959911|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959912|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56959913|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
56959914|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959915|NCT03725995|Lidocaine|lidocaine|mesh-list
56959916|NCT03725995|Midazolam|midazolam|mesh-list
56959917|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
56959919|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959920|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959921|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
56959922|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959923|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56959924|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56959925|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56959926|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56959927|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959928|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56959929|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56959930|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56959931|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56959932|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56959933|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56959934|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
56959935|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
56959936|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
56959937|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56959938|NCT03341260|Diclofenac|diclofenac|mesh-list
56959939|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56959940|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56959941|NCT03341260|Analgesics|analgesics|mesh-ancestor
56959942|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
56959943|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959944|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959945|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959946|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56959947|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56959948|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959949|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959950|NCT03052400|Mifepristone|mifepristone|mesh-list
56959951|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56959952|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
56959953|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56959954|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959955|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56959956|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56959957|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56959958|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
56959959|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56959960|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56959961|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
56959962|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56959963|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
56959964|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56959965|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56959966|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56959967|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
56959968|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959969|NCT03341104|Bupivacaine|bupivacaine|mesh-list
56959970|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
56959971|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
56959972|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56959973|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959974|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
56959975|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959976|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
56959977|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
56959978|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56959979|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56959980|NCT03335098|Thalidomide|thalidomide|mesh-list
56959981|NCT03335098|Dexamethasone|dexamethasone|mesh-list
56959982|NCT03335098|Bortezomib|bortezomib|mesh-list
56959983|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56959984|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
56959985|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
56959986|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56959987|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959988|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56959989|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
56959990|NCT03335098|Hormones|hormones|mesh-ancestor
56959991|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56959992|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56959993|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56959994|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56959995|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
56959996|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
56959997|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56959998|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56959999|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56960000|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56960001|NCT03335098|Growth Substances|growth substances|mesh-ancestor
56960002|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
56960004|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56960005|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56960006|NCT03639571|Analgesics|analgesics|mesh-ancestor
56960007|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
56960008|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960009|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960010|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960011|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960012|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56960013|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960014|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960015|NCT03052322|Adalimumab|adalimumab|mesh-list
56960016|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960017|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960018|NCT03722173|Itraconazole|itraconazole|mesh-list
56960019|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
56960020|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960021|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56960022|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56960023|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960024|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960025|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56960026|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
56960027|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960028|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960029|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56960030|NCT03521791|Bromfenac|bromfenac|mesh-list
56960031|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56960032|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56960033|NCT03521791|Analgesics|analgesics|mesh-ancestor
56960034|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
56960035|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960036|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960037|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960038|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960039|NCT03521635|Pramipexole|pramipexole|mesh-list
56960040|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
56960041|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960042|NCT03521635|Protective Agents|protective agents|mesh-ancestor
56960043|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960044|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56960045|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56960046|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
56960047|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
56960048|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960049|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
56960050|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56960051|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960052|NCT03813641|Capecitabine|capecitabine|mesh-list
56960053|NCT03813641|Raltitrexed|raltitrexed|mesh-list
56960054|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56960055|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
56960056|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960057|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960058|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56960059|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960060|NCT02492464|Red yeast rice|red yeast rice|mesh-list
56960061|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56960062|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56960063|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56960064|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
56960065|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960066|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960067|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56960068|NCT05255159|Furosemide|furosemide|mesh-list
56960069|NCT05255159|Diuretics|diuretics|mesh-ancestor
56960070|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
56960071|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960072|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56960073|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56960074|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960075|NCT03340558|Atezolizumab|atezolizumab|mesh-list
56960076|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960077|NCT04905108|Riboflavin|riboflavin|mesh-list
56960078|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
56960079|NCT04905108|Vitamins|vitamins|mesh-ancestor
56960080|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
56960081|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960082|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56960083|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
56960084|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
56960085|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56960086|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
56960087|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960088|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
56960089|NCT04443166|Protective Agents|protective agents|mesh-ancestor
56960090|NCT01560221|Buprenorphine|buprenorphine|mesh-list
56960091|NCT01560221|Methadone|methadone|mesh-list
56960092|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56960093|NCT01560221|Narcotics|narcotics|mesh-ancestor
56960094|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960095|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960096|NCT01560221|Analgesics|analgesics|mesh-ancestor
56960097|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
56960098|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960099|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56960100|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
56960101|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
56960102|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
56960103|NCT03813329|Calcium|calcium|mesh-list
56960104|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56960105|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960106|NCT03813329|Antacids|antacids|mesh-ancestor
56960107|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960108|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960109|NCT03639415|Oxycodone|oxycodone|mesh-list
56960110|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56960111|NCT03639415|Narcotics|narcotics|mesh-ancestor
56960112|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960113|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960114|NCT03639415|Analgesics|analgesics|mesh-ancestor
56960115|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
56960116|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960117|NCT02492386|Everolimus|everolimus|mesh-list
56960118|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960119|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56960120|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
56960121|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960122|NCT03340168|Bisphenol A|bisphenol a|mesh-list
56960123|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56960124|NCT03340168|Estrogens|estrogens|mesh-ancestor
56960125|NCT03340168|Hormones|hormones|mesh-ancestor
56960126|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960127|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960128|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56960129|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
56960130|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960131|NCT03340168|Protective Agents|protective agents|mesh-ancestor
56960132|NCT01299701|Vadimezan|vadimezan|mesh-list
56960133|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960134|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56960135|NCT01299779|Laxatives|laxatives|mesh-ancestor
56960136|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960137|NCT02343042|Clarithromycin|clarithromycin|mesh-list
56960138|NCT02343042|Dexamethasone|dexamethasone|mesh-list
56960139|NCT02343042|Lenalidomide|lenalidomide|mesh-list
56960140|NCT02343042|Bortezomib|bortezomib|mesh-list
56960141|NCT02343042|Daratumumab|daratumumab|mesh-list
56960143|NCT02343042|Ixazomib|ixazomib|mesh-list
56960144|NCT02343042|Elotuzumab|elotuzumab|mesh-list
56960145|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960146|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
56960147|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
56880997|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
56960148|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960149|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960150|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960151|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
56960152|NCT02343042|Hormones|hormones|mesh-ancestor
56960153|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960154|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56960155|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960156|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
56960157|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56960158|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56960159|NCT02343042|Growth Substances|growth substances|mesh-ancestor
56960160|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
56960161|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56960162|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960163|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56960164|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960165|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960166|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56960167|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56960168|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
56960169|NCT03812939|Octreotide|octreotide|mesh-list
56960170|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960171|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56960172|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960173|NCT03339700|Gemcitabine|gemcitabine|mesh-list
56960174|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
56960175|NCT03339700|Busulfan|busulfan|mesh-list
56960176|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56960177|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
56960178|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960179|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960180|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56960181|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
56960182|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960183|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960184|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56960185|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56960186|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
56960187|NCT03339700|Antiviral Agents|antiviral agents|mesh-ancestor
56960188|NCT03339700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960189|NCT03339700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960190|NCT05661149|Insulin|insulin|mesh-list
56960191|NCT05661149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56960192|NCT05661149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960193|NCT01299857|Rituximab|rituximab|mesh-list
56960194|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56960195|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960196|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
56960197|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960198|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960199|NCT03478969|Insulin|insulin|mesh-list
56960200|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56960201|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960202|NCT03812783|Sorafenib|sorafenib|mesh-list
56960203|NCT03812783|Folfirinox|folfirinox|mesh-list
56960204|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960205|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56960206|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960207|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960208|NCT02500498|Abatacept|abatacept|mesh-list
56960209|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56960210|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960211|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960212|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56960213|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
56547621|NCT00645073|Cefdinir|cefdinir|mesh-list
56960214|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960215|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960216|NCT05644223|Edaravone|edaravone|mesh-list
56960217|NCT05644223|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56960219|NCT05644223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960220|NCT05644223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56960221|NCT05644223|Protective Agents|protective agents|mesh-ancestor
56960222|NCT05644223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960223|NCT02500108|Domperidone|domperidone|mesh-list
56960224|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
56960225|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
56960226|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960227|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960228|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960229|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56960230|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
56960231|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960232|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960233|NCT02499874|Tenofovir|tenofovir|mesh-list
56960234|NCT02499874|Lamivudine|lamivudine|mesh-list
56960235|NCT02499874|Zidovudine|zidovudine|mesh-list
56960236|NCT02499874|Emtricitabine|emtricitabine|mesh-list
56960237|NCT02499874|Efavirenz|efavirenz|mesh-list
56960238|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56960239|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
56960240|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960241|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56960242|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56960243|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960244|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960245|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56960246|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56960247|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
56960248|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56960249|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56960250|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56960251|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56960252|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56960253|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56960254|NCT02492308|Basiliximab|basiliximab|mesh-list
56960255|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56960256|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
56960257|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960258|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
56960259|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
56960260|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56960261|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56960262|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56960263|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960264|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56960265|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56960266|NCT03339544|Celecoxib|celecoxib|mesh-list
56960267|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56960268|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56960269|NCT03339544|Analgesics|analgesics|mesh-ancestor
56960270|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
56960271|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960272|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960273|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960274|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960275|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56960276|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56960277|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960278|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960279|NCT03332602|Vitamins|vitamins|mesh-list
56960280|NCT03332602|Folic Acid|folic acid|mesh-list
56960281|NCT03332602|Vitamin A|vitamin a|mesh-list
56960282|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
56960283|NCT03332602|Fesoterodine|fesoterodine|mesh-list
56960284|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
56960285|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
56960286|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960287|NCT03332602|Hematinics|hematinics|mesh-ancestor
56960288|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
56960289|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56960290|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
56960291|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
56960293|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
56960294|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960295|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56960296|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881147|NCT04229290|Dolutegravir|dolutegravir|mesh-list
56960297|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56960298|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56960299|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
56960300|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960301|NCT03332602|Urological Agents|urological agents|mesh-ancestor
56960302|NCT01302353|Isoflurane|isoflurane|mesh-list
56960303|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56960304|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
56960305|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
56960306|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960307|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960308|NCT03812315|Propolis|propolis|mesh-list
56960309|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960310|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
56960311|NCT03332524|Ibuprofen|ibuprofen|mesh-list
56960312|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56960313|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56960314|NCT03332524|Analgesics|analgesics|mesh-ancestor
56960315|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
56960316|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960317|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960318|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960319|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960320|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56960321|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960322|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960323|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
56960324|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
56960325|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56960326|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
56960327|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
56960328|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960329|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56960330|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
56960331|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
56960332|NCT03812003|Remifentanil|remifentanil|mesh-list
56960333|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56960334|NCT03812003|Narcotics|narcotics|mesh-ancestor
56960335|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960336|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960337|NCT03812003|Analgesics|analgesics|mesh-ancestor
56960338|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
56960339|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960340|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
56960341|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56960342|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56960343|NCT04874610|Prednisolone|prednisolone|mesh-list
56960344|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
56960345|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56960346|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
56960347|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960348|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
56960349|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
56960350|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960351|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960352|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960353|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
56960354|NCT04874610|Hormones|hormones|mesh-ancestor
56960355|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960356|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56960357|NCT04874610|Protective Agents|protective agents|mesh-ancestor
56960358|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56960359|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960360|NCT03518125|Vaccines|vaccines|mesh-list
56960361|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
56960362|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960363|NCT02492230|Warfarin|warfarin|mesh-list
56960364|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
56960365|NCT05623319|Pembrolizumab|pembrolizumab|mesh-list
56960366|NCT05623319|Olaparib|olaparib|mesh-list
56960367|NCT05623319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56960368|NCT05623319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960369|NCT05623319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56960370|NCT05623319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960371|NCT05623319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960372|NCT03169530|Ethanol|ethanol|mesh-list
56960373|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56960374|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960375|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960376|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960377|NCT03723187|Heparin|heparin|mesh-list
56960378|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
56960379|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56960380|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56960381|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960382|NCT02440230|Anastrozole|anastrozole|mesh-list
56960383|NCT02440230|Exemestane|exemestane|mesh-list
56960384|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56960385|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960386|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56960387|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56960388|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960389|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960390|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56960391|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
56960392|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960393|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960394|NCT03478891|Ansuvimab|ansuvimab|mesh-list
56960395|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
56960396|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960397|NCT00706966|Dutasteride|dutasteride|mesh-list
56960398|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56960399|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56960400|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960401|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960402|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
56960403|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960404|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960405|NCT01330524|Triamcinolone|triamcinolone|mesh-list
56960406|NCT01330524|Bevacizumab|bevacizumab|mesh-list
56960407|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56960408|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960409|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56960410|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56960411|NCT01330524|Growth Substances|growth substances|mesh-ancestor
56960412|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960413|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
56960414|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960415|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
56960416|NCT01330524|Hormones|hormones|mesh-ancestor
56960417|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960418|NCT01560065|Folic Acid|folic acid|mesh-list
56960419|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
56960420|NCT01560065|Inositol|inositol|mesh-list
56960421|NCT01560065|Hematinics|hematinics|mesh-ancestor
56960422|NCT01560065|Vitamins|vitamins|mesh-ancestor
56960423|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
56960424|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960425|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56960426|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56960427|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960428|NCT01302587|Albuterol|albuterol|mesh-list
56960429|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56960430|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
56960431|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960432|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960433|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56960434|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
56960435|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
56960436|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56960437|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56960438|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56960439|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56960440|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
56960441|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960442|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960444|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960445|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960446|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
56960447|NCT03018288|Temozolomide|temozolomide|mesh-list
56960448|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56960449|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960450|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56960451|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
56960452|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960453|NCT03515941|Leucovorin|leucovorin|mesh-list
56960454|NCT03515941|Fluorouracil|fluorouracil|mesh-list
56960455|NCT03515941|Capecitabine|capecitabine|mesh-list
56960456|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
56960457|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
56960458|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960459|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56960460|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960461|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56960462|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
56960463|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960464|NCT03515941|Antidotes|antidotes|mesh-ancestor
56960465|NCT03515941|Protective Agents|protective agents|mesh-ancestor
56960466|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
56960467|NCT03515941|Vitamins|vitamins|mesh-ancestor
56960468|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
56960469|NCT04606914|Maytansine|maytansine|mesh-list
56960470|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56960471|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960472|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
56960473|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
56960474|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
56960475|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960476|NCT02492074|Dronabinol|dronabinol|mesh-list
56960477|NCT02492074|Cannabidiol|cannabidiol|mesh-list
56960478|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
56960479|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
56960480|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960481|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56960482|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56960483|NCT02492074|Analgesics|analgesics|mesh-ancestor
56960484|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
56960485|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960486|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56960487|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56960488|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960489|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960490|NCT02492074|Hormones|hormones|mesh-ancestor
56960491|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960492|NCT03819647|Stiripentol|stiripentol|mesh-list
56960493|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
56960494|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
56960495|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960496|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960497|NCT02498860|Pemetrexed|pemetrexed|mesh-list
56960498|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960499|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960500|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960501|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56960502|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56960503|NCT03011034|Daratumumab|daratumumab|mesh-list
56960504|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960505|NCT05464966|Insulin|insulin|mesh-list
56960506|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56960507|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960508|NCT03815435|Anesthetics|anesthetics|mesh-list
56960509|NCT03815435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960510|NCT03815435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960511|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
56960512|NCT03515629|Cemiplimab|cemiplimab|mesh-list
56960513|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56960514|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960515|NCT01302821|Tryptophan|tryptophan|mesh-list
56960516|NCT01302821|Vaccines|vaccines|mesh-list
56960517|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
56960518|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960519|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56960520|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
56960521|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56960522|NCT04971954|Nicotine|nicotine|mesh-list
56960523|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56960524|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
56960525|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960526|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960527|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56960528|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56960529|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
56960530|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960531|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960532|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56960533|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
56960534|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960535|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56960536|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960537|NCT03512353|Dexamethasone|dexamethasone|mesh-list
56960538|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960539|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
56960540|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
56960541|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960542|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960543|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960544|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
56960545|NCT03512353|Hormones|hormones|mesh-ancestor
56960546|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960547|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56960548|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960549|NCT04959006|Antioxidants|antioxidants|mesh-list
56960550|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960551|NCT04959006|Protective Agents|protective agents|mesh-ancestor
56960552|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960553|NCT01300637|Metformin|metformin|mesh-list
56960554|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56960555|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960556|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56960557|NCT04851522|Eusol|eusol|mesh-list
56960558|NCT04851522|Petrolatum|petrolatum|mesh-list
56960559|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
56960560|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960561|NCT04851522|Emollients|emollients|mesh-ancestor
56960562|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
56960563|NCT03512275|Antibodies|antibodies|mesh-list
56960564|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56960565|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
56960566|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960567|NCT03809897|Nicotine|nicotine|mesh-list
56960568|NCT03809897|Varenicline|varenicline|mesh-list
56960569|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56960570|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
56960571|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960572|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960573|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56960574|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56960575|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
56960576|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960577|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960578|NCT03473197|Diacetylrhein|diacetylrhein|mesh-list
56960579|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960580|NCT01560299|Methimazole|methimazole|mesh-list
56960581|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
56960582|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
56960583|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960584|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960585|NCT03337828|Ethanol|ethanol|mesh-list
56960586|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56960587|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960588|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960589|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960590|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
56960591|NCT03510715|Niacin|niacin|mesh-list
56960592|NCT03510715|Niacinamide|niacinamide|mesh-list
56960593|NCT03510715|Atorvastatin|atorvastatin|mesh-list
56960594|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56960595|NCT03510715|Simvastatin|simvastatin|mesh-list
56642910|NCT02720978|Oxytocin|oxytocin|mesh-list
56960596|NCT03510715|Ezetimibe|ezetimibe|mesh-list
56960597|NCT03510715|Pravastatin|pravastatin|mesh-list
56960598|NCT03510715|Lovastatin|lovastatin|mesh-list
56960599|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
56960600|NCT03510715|Fenofibrate|fenofibrate|mesh-list
56960601|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56960602|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56960603|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
56960604|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960605|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56960606|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56960607|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960608|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
56960609|NCT03510715|Vitamins|vitamins|mesh-ancestor
56960610|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
56960611|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960612|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
56960613|NCT03815279|Dexamethasone|dexamethasone|mesh-list
56960614|NCT03815279|Lenalidomide|lenalidomide|mesh-list
56960615|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960616|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
56960617|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
56960618|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960619|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960620|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960621|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
56960622|NCT03815279|Hormones|hormones|mesh-ancestor
56960623|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960624|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56960625|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960626|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
56960627|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56960628|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56960629|NCT03815279|Growth Substances|growth substances|mesh-ancestor
56960630|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
56960631|NCT03814733|Ketamine|ketamine|mesh-list
56960632|NCT03814733|Alprazolam|alprazolam|mesh-list
56960633|NCT03814733|Analgesics|analgesics|mesh-ancestor
56960634|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
56960635|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960636|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960637|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56960638|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56960639|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
56960640|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
56960641|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960642|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56960643|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56960644|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960645|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960646|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56960647|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56960648|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56960649|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56960650|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
56960651|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
56960652|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
56960653|NCT03721627|Ledipasvir|ledipasvir|mesh-list
56960654|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56960655|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
56960656|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960657|NCT03811223|Evolocumab|evolocumab|mesh-list
56960658|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56960659|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56960660|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
56960661|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960662|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56960663|NCT03723031|Misoprostol|misoprostol|mesh-list
56960664|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56960665|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
56960666|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56960667|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960668|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56960669|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960670|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
56642980|NCT04167176|Lidocaine|lidocaine|mesh-list
56960671|NCT03722875|Apatinib|apatinib|mesh-list
56960672|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960673|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56960674|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960675|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960676|NCT04860713|Aspirin|aspirin|mesh-list
56960677|NCT04860713|Ketamine|ketamine|mesh-list
56881522|NCT05052970|Analgesics|analgesics|mesh-ancestor
56960678|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56960679|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56960680|NCT04860713|Analgesics|analgesics|mesh-ancestor
56960681|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
56960682|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960683|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960684|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960685|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960686|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56960687|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56960688|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960689|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56960690|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56960691|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960692|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
56960693|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56960694|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56960695|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
56960696|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
56960697|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960698|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56960699|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56960700|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960701|NCT03528577|Albuterol|albuterol|mesh-list
56960702|NCT03528577|Procaterol|procaterol|mesh-list
56960703|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56960704|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
56960705|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960706|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960707|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56960708|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
56960709|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
56960710|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56960711|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56960712|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56960713|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56960714|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
56960715|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960716|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960717|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
56960718|NCT05432414|Dexamethasone|dexamethasone|mesh-list
56960719|NCT05432414|Bortezomib|bortezomib|mesh-list
56960720|NCT05432414|Pomalidomide|pomalidomide|mesh-list
56960721|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960722|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
56960723|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
56960724|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960725|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960726|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960727|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
56960728|NCT05432414|Hormones|hormones|mesh-ancestor
56960729|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960730|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56960731|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960732|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
56960733|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56960734|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56960735|NCT05432414|Growth Substances|growth substances|mesh-ancestor
56960736|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
56960737|NCT03796403|Diclofenac|diclofenac|mesh-list
56960738|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56960739|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56960740|NCT03796403|Analgesics|analgesics|mesh-ancestor
56960741|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
56960742|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960743|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960744|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56960745|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960746|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56960747|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960748|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960749|NCT00706654|Aripiprazole|aripiprazole|mesh-list
56960750|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
56960751|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56960752|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56960753|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56960754|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960755|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960756|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
56960757|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
56960758|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960759|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960760|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56960761|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56960762|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
56960763|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56960764|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56960765|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56960766|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56960767|NCT03471871|Lemborexant|lemborexant|mesh-list
56960768|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56960769|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960770|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960771|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56960772|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56960773|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960774|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960775|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
56960776|NCT04313153|Hematinics|hematinics|mesh-ancestor
56960777|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
56960778|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56960779|NCT03337672|Midazolam|midazolam|mesh-list
56960780|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
56960781|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56960782|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960783|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960784|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56960785|NCT03337672|Analgesics|analgesics|mesh-ancestor
56960786|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
56960787|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960788|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56960789|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56960790|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56960791|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
56960792|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960793|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960794|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56960795|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56960796|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56960797|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56960798|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56960799|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
56960800|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
56960801|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
56960802|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
56960803|NCT03330808|Anesthetics|anesthetics|mesh-list
56960804|NCT03330808|Ropivacaine|ropivacaine|mesh-list
56960805|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960806|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960807|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
56960808|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
56960809|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960810|NCT01303055|Metformin|metformin|mesh-list
56960811|NCT01303055|Alogliptin|alogliptin|mesh-list
56960812|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56960813|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960814|NCT01303055|Incretins|incretins|mesh-ancestor
56960815|NCT01303055|Hormones|hormones|mesh-ancestor
56960816|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960817|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56960818|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
56960819|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960820|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960821|NCT05474560|Allopurinol|allopurinol|mesh-list
56960822|NCT05474560|Febuxostat|febuxostat|mesh-list
56960823|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
56960824|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960825|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881675|NCT05707234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56960826|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
56960827|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56960828|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56960830|NCT05474560|Protective Agents|protective agents|mesh-ancestor
56960831|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960832|NCT03636048|Bupivacaine|bupivacaine|mesh-list
56960833|NCT03636048|Anesthetics|anesthetics|mesh-list
56960834|NCT03636048|Propofol|propofol|mesh-list
56960835|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
56960836|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960837|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960838|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
56960839|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960840|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56960841|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56960842|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
56960843|NCT05347238|Dopamine|dopamine|mesh-list
56960844|NCT05347238|Norepinephrine|norepinephrine|mesh-list
56960845|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56960846|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56960847|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
56960848|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960849|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960850|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960851|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
56960852|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
56960853|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960854|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56960855|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56960856|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
56960857|NCT05347238|Protective Agents|protective agents|mesh-ancestor
56960858|NCT03527173|Vaccines|vaccines|mesh-list
56960859|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
56960860|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960861|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
56960862|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56960863|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56960864|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960865|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
56960866|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
56960867|NCT01303601|Olanzapine|olanzapine|mesh-list
56960868|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
56960869|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
56960870|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960871|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960872|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56960873|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56960874|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56960875|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960876|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56960877|NCT01303601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56960878|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56960879|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56960880|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960881|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960882|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
56960883|NCT00707980|Vortioxetine|vortioxetine|mesh-list
56960884|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
56960885|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56960886|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56960887|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56960888|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960889|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960890|NCT00707980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56960891|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56960892|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56960893|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960894|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56960895|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
56960896|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56960897|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56960898|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56960899|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56960900|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56960901|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
56960902|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56960903|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56960904|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
56960905|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960906|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960907|NCT03051620|Alendronate|alendronate|mesh-list
56960908|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56960909|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960910|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
56960911|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56960912|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
56960913|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960914|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
56960915|NCT02861183|Protective Agents|protective agents|mesh-ancestor
56960916|NCT02498002|Lidocaine|lidocaine|mesh-list
56960917|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
56960918|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
56960919|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960920|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960921|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
56960922|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960923|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56960924|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56960925|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56960926|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56960927|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960928|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
56960929|NCT03810209|Analgesics|analgesics|mesh-ancestor
56960930|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
56960931|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56960932|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960933|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
56960934|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960935|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56960936|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
56960937|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56960938|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56960939|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960940|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56960941|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
56960942|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56960943|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
56960944|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960945|NCT01303679|Paclitaxel|paclitaxel|mesh-list
56960946|NCT01303679|Bevacizumab|bevacizumab|mesh-list
56960947|NCT01303679|Exemestane|exemestane|mesh-list
56960948|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56960949|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960950|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
56960951|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
56960952|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
56960953|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960954|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56960955|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56960956|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56960957|NCT01303679|Growth Substances|growth substances|mesh-ancestor
56960958|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960959|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
56960960|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56960961|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56960962|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56960963|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56960964|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
56960965|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56960966|NCT03337282|Anesthetics|anesthetics|mesh-list
56960967|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56960968|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960969|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
56960970|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56960971|NCT03801707|Velpatasvir|velpatasvir|mesh-list
56960972|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
56960973|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881826|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56960974|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56960975|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56960976|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56960977|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
56960978|NCT04239872|Calcium|calcium|mesh-list
56960979|NCT04239872|Fluorides|fluorides|mesh-list
56960980|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56960981|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960982|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56960983|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
56960984|NCT04239872|Protective Agents|protective agents|mesh-ancestor
56960985|NCT03164772|Durvalumab|durvalumab|mesh-list
56960986|NCT03164772|Tremelimumab|tremelimumab|mesh-list
56960987|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56960988|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56960989|NCT03801317|Micronutrients|micronutrients|mesh-list
56960990|NCT03801317|Trace Elements|trace elements|mesh-list
56960991|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56960992|NCT03337126|Metronidazole|metronidazole|mesh-list
56960993|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56960994|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56960995|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56960996|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56960997|NCT04710732|Enoxaparin|enoxaparin|mesh-list
56960998|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
56960999|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
56961000|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56961001|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56961002|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961003|NCT05014334|Amoxicillin|amoxicillin|mesh-list
56961004|NCT05014334|Clarithromycin|clarithromycin|mesh-list
56961005|NCT05014334|Rabeprazole|rabeprazole|mesh-list
56961006|NCT05014334|Bismuth|bismuth|mesh-list
56961007|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56961008|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961009|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56961010|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961011|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961012|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56961013|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56961014|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56961015|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56961016|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56961017|NCT05014334|Antacids|antacids|mesh-ancestor
56961018|NCT02497378|Dexamethasone|dexamethasone|mesh-list
56961019|NCT02497378|Bortezomib|bortezomib|mesh-list
56961020|NCT02497378|Daratumumab|daratumumab|mesh-list
56961021|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961022|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
56961023|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
56961024|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961025|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961026|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56961027|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
56961028|NCT02497378|Hormones|hormones|mesh-ancestor
56961029|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56961030|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56961031|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961032|NCT02497222|RNS60|rns60|mesh-list
56961033|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56961034|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56961035|NCT02497222|Analgesics|analgesics|mesh-ancestor
56961036|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
56961037|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961038|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961039|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961040|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961041|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56961042|NCT02491606|Tafenoquine|tafenoquine|mesh-list
56961043|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
56961044|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56961045|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56961046|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961047|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56961048|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56961049|NCT03050450|Lenalidomide|lenalidomide|mesh-list
56961050|NCT03050450|Vorinostat|vorinostat|mesh-list
56881910|NCT05598424|Hormones|hormones|mesh-ancestor
56961051|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
56961052|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961053|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56961054|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56961055|NCT03050450|Growth Substances|growth substances|mesh-ancestor
56961056|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
56961057|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961058|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56961059|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961060|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961061|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
56961062|NCT03505021|Simendan|simendan|mesh-list
56961063|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56961064|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
56961065|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56961066|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56961067|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961068|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961069|NCT03505021|Protective Agents|protective agents|mesh-ancestor
56961070|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961071|NCT04232306|Bupivacaine|bupivacaine|mesh-list
56961072|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
56961073|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
56961074|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961075|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961076|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
56961077|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961078|NCT03793283|Insulin|insulin|mesh-list
56961079|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56961080|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56961081|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961082|NCT02496988|Temozolomide|temozolomide|mesh-list
56961083|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56961084|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
56961085|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961086|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961087|NCT03793205|Lenograstim|lenograstim|mesh-list
56961088|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56961089|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
56961090|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961091|NCT03329248|Leucovorin|leucovorin|mesh-list
56961092|NCT03329248|Paclitaxel|paclitaxel|mesh-list
56961093|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
56961094|NCT03329248|Bevacizumab|bevacizumab|mesh-list
56961095|NCT03329248|Fluorouracil|fluorouracil|mesh-list
56961096|NCT03329248|Capecitabine|capecitabine|mesh-list
56961097|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
56961098|NCT03329248|Avelumab|avelumab|mesh-list
56961099|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56961100|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961101|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56961102|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56961103|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56961104|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961105|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56961106|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
56961107|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961108|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961109|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56961110|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
56961111|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56961112|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961113|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56961114|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56961115|NCT03329248|Growth Substances|growth substances|mesh-ancestor
56961116|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
56961117|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
56961118|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56961119|NCT03329248|Antidotes|antidotes|mesh-ancestor
56961120|NCT03329248|Protective Agents|protective agents|mesh-ancestor
56961121|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
56961122|NCT03329248|Vitamins|vitamins|mesh-ancestor
56961123|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
56961124|NCT03795311|Bevacizumab|bevacizumab|mesh-list
56961125|NCT03795311|Folfirinox|folfirinox|mesh-list
55737024|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
56961126|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961127|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961128|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56961129|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56961130|NCT03795311|Growth Substances|growth substances|mesh-ancestor
56961131|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961132|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
56961133|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
56961134|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
56961135|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
56961136|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
56961137|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56961138|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56961139|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961140|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961141|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961142|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
56961143|NCT03792971|Protective Agents|protective agents|mesh-ancestor
56961144|NCT03328936|Melphalan|melphalan|mesh-list
56961145|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56961146|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
56961147|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961148|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961149|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56961150|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56961151|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
56961152|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961153|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56961154|NCT02496754|Hormones|hormones|mesh-ancestor
56961155|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56961156|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961157|NCT04887194|Nivolumab|nivolumab|mesh-list
56961158|NCT04887194|Digoxin|digoxin|mesh-list
56961159|NCT04887194|Midazolam|midazolam|mesh-list
56961160|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
56961161|NCT04887194|Warfarin|warfarin|mesh-list
56961162|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56961163|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961164|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961165|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56961166|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961167|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56961168|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56961169|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961170|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961171|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56961172|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56961173|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56961174|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56961175|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
56961176|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
56961177|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
56961178|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
56961179|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961180|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56961181|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56961182|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
56961183|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56961184|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56961185|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961186|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
56961187|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56961188|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56961189|NCT04887194|Protective Agents|protective agents|mesh-ancestor
56961190|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
56961191|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
56961192|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56961193|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56961194|NCT02496910|Amlodipine|amlodipine|mesh-list
56961195|NCT02496910|Telmisartan|telmisartan|mesh-list
56961196|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
56961197|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56961198|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56961199|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56961200|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56961201|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961202|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56961203|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961204|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
56961205|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56961206|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56961207|NCT02496910|Diuretics|diuretics|mesh-ancestor
56961208|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
56961209|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56961210|NCT03342352|Carboplatin|carboplatin|mesh-list
56961211|NCT03342352|Fluorouracil|fluorouracil|mesh-list
56961212|NCT03342352|Nivolumab|nivolumab|mesh-list
56961213|NCT03342352|Cetuximab|cetuximab|mesh-list
56961214|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961215|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
56961216|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961217|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56961218|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56961219|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
56961220|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961221|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961222|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56961223|NCT03120442|Fentanyl|fentanyl|mesh-list
56961224|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
56961225|NCT03120442|Propofol|propofol|mesh-list
56961226|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56961227|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961228|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961229|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56961230|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
56961231|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
56961232|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56961233|NCT03120442|Analgesics|analgesics|mesh-ancestor
56961234|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
56961235|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961236|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56961237|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56961238|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56961239|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56961240|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961241|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961242|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56961243|NCT03120442|Narcotics|narcotics|mesh-ancestor
56961244|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56961245|NCT05625347|Aspirin|aspirin|mesh-list
56961246|NCT05625347|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56961247|NCT05625347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56961248|NCT05625347|Analgesics|analgesics|mesh-ancestor
56961249|NCT05625347|Sensory System Agents|sensory system agents|mesh-ancestor
56961250|NCT05625347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961251|NCT05625347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961252|NCT05625347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961253|NCT05625347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961254|NCT05625347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56961255|NCT05625347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56961256|NCT05625347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961257|NCT05625347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56961258|NCT05625347|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56961259|NCT05625347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961260|NCT05625347|Antipyretics|antipyretics|mesh-ancestor
56961261|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
56961262|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56961263|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56961264|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56961265|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
56961266|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961267|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961268|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961269|NCT00852696|Urological Agents|urological agents|mesh-ancestor
56961270|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56961271|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56961272|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961273|NCT03324490|Fentanyl|fentanyl|mesh-list
56961274|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
56961275|NCT03324490|Bupivacaine|bupivacaine|mesh-list
56961276|NCT03324490|Anesthetics|anesthetics|mesh-list
56961277|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
56961278|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961279|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961280|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
56961281|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961282|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56961283|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56961285|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56961286|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56961287|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56961288|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
56961289|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961290|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961291|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56961292|NCT03324490|Narcotics|narcotics|mesh-ancestor
56961293|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56961294|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56961295|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
56961296|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
56961297|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56961298|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
56961299|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
56961300|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961301|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961302|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
56961303|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961304|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961305|NCT04072952|Palbociclib|palbociclib|mesh-list
56961306|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961307|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56961308|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961309|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961310|NCT04509050|Ivacaftor|ivacaftor|mesh-list
56961311|NCT04509050|Elexacaftor|elexacaftor|mesh-list
56961312|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56961313|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56961314|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961315|NCT03798821|Sulfalene|sulfalene|mesh-list
56961316|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961317|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56961318|NCT03798821|Renal Agents|renal agents|mesh-ancestor
56961319|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
56961320|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56961321|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56961322|NCT03324334|Antibodies|antibodies|mesh-list
56961323|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
56961324|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961325|NCT03792815|Etoposide|etoposide|mesh-list
56961326|NCT03792815|Melphalan|melphalan|mesh-list
56961327|NCT03792815|Busulfan|busulfan|mesh-list
56961328|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56961329|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961330|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56961331|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56961332|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961333|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961334|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56961335|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
56961336|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56961337|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56961338|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
56961339|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961340|NCT04381364|Ciclesonide|ciclesonide|mesh-list
56961341|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
56961342|NCT04381364|Hormones|hormones|mesh-ancestor
56961343|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56961344|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961345|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56961346|NCT01331382|Resveratrol|resveratrol|mesh-list
56961347|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
56961348|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961349|NCT01331382|Protective Agents|protective agents|mesh-ancestor
56961350|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961351|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882199|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56961352|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56961353|NCT03794765|Metronidazole|metronidazole|mesh-list
56961354|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
56961355|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961356|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56961357|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56961358|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56961359|NCT05547542|Carfentanil|carfentanil|mesh-list
56961360|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56961361|NCT05547542|Narcotics|narcotics|mesh-ancestor
56961362|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961363|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961364|NCT05547542|Analgesics|analgesics|mesh-ancestor
56961365|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
56961366|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961367|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
56961368|NCT03043664|Lanreotide|lanreotide|mesh-list
56961369|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961370|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961371|NCT02496286|Bevacizumab|bevacizumab|mesh-list
56961372|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961373|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961374|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56961375|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56961376|NCT02496286|Growth Substances|growth substances|mesh-ancestor
56961377|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961378|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
56961379|NCT01489176|Regadenoson|regadenoson|mesh-list
56961380|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56961381|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56961382|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
56961383|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
56961384|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961385|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961386|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961387|NCT03792503|Pemetrexed|pemetrexed|mesh-list
56961388|NCT03792503|Apatinib|apatinib|mesh-list
56961389|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961390|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961391|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961392|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56961393|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56961394|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56961395|NCT03794843|Nimodipine|nimodipine|mesh-list
56961396|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56961397|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56961398|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56961399|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961400|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56961401|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961402|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
56961403|NCT01333800|Ciclesonide|ciclesonide|mesh-list
56961404|NCT01333800|Beclomethasone|beclomethasone|mesh-list
56961405|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961406|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
56961407|NCT01333800|Hormones|hormones|mesh-ancestor
56961408|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56961409|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961410|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56961411|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
56961412|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56961413|NCT04024436|Fulvestrant|fulvestrant|mesh-list
56961414|NCT04024436|Futibatinib|futibatinib|mesh-list
56961415|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56961416|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961417|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56961418|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56961419|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
56961420|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56961421|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961422|NCT04494100|Lidocaine|lidocaine|mesh-list
56961423|NCT04494100|Epinephrine|epinephrine|mesh-list
56961424|NCT04494100|Ropivacaine|ropivacaine|mesh-list
56961425|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
56643724|NCT04002362|Triamcinolone|triamcinolone|mesh-list
56961426|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
56961427|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961428|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961429|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
56961430|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961431|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56961432|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56961433|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56961434|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56961435|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961436|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56961437|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56961438|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
56961439|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961440|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56961441|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56961443|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56961444|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
56961445|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
56961446|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
56961447|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56961448|NCT01333878|Abatacept|abatacept|mesh-list
56961449|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56961450|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961451|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961452|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56961453|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
56961454|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961455|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961456|NCT01439802|Copper|copper|mesh-list
56961457|NCT01439802|Trace Elements|trace elements|mesh-ancestor
56961458|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
56961459|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961460|NCT03328312|Atropine|atropine|mesh-list
56961461|NCT03328312|Neostigmine|neostigmine|mesh-list
56961462|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56961463|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56961464|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56961465|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
56961466|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961467|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961468|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56961469|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
56961470|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
56961471|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
56961472|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56961473|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56961474|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
56961475|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961476|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961477|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56961478|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961479|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56961480|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
56961481|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56961482|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56961483|NCT03328234|Paclitaxel|paclitaxel|mesh-list
56961484|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56961485|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56961486|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961487|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
56961488|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
56961489|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
56961490|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961491|NCT04781192|Durvalumab|durvalumab|mesh-list
56961492|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961493|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961494|NCT03323710|Sunitinib|sunitinib|mesh-list
56961495|NCT03323710|Propranolol|propranolol|mesh-list
56961496|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961497|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56961498|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56961499|NCT03323710|Growth Substances|growth substances|mesh-ancestor
56961500|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961501|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
56961502|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56961503|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961504|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961505|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56961506|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56961507|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
56961508|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961509|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56961510|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56961511|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
56961512|NCT03792269|Capecitabine|capecitabine|mesh-list
56961513|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
56961514|NCT03792269|Irinotecan|irinotecan|mesh-list
56961515|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56961516|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
56961517|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961518|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961519|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56961520|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56961521|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961522|NCT03850574|Venetoclax|venetoclax|mesh-list
56961523|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961524|NCT02488564|Metformin|metformin|mesh-list
56961525|NCT02488564|Docetaxel|docetaxel|mesh-list
56961526|NCT02488564|Doxorubicin|doxorubicin|mesh-list
56961527|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56961528|NCT02488564|Trastuzumab|trastuzumab|mesh-list
56961529|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56961530|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961531|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961532|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
56961533|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
56961534|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
56961535|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961536|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56961537|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56961538|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56961539|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961540|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961541|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
56961542|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56961543|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
56961544|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961545|NCT02966873|Expectorants|expectorants|mesh-ancestor
56961546|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
56961547|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56961548|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
56961549|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961550|NCT02966873|Protective Agents|protective agents|mesh-ancestor
56961551|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961552|NCT02966873|Antidotes|antidotes|mesh-ancestor
56961553|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
56961554|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961555|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961556|NCT04697186|Amoxicillin|amoxicillin|mesh-list
56961557|NCT04697186|Clarithromycin|clarithromycin|mesh-list
56961558|NCT04697186|Rabeprazole|rabeprazole|mesh-list
56961559|NCT04697186|Bismuth|bismuth|mesh-list
56961560|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56961561|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961562|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56961563|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961564|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961565|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56961566|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56961567|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56961568|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56961569|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56961570|NCT04697186|Antacids|antacids|mesh-ancestor
56961571|NCT02488642|Isosorbide|isosorbide|mesh-list
56961572|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56961573|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56961574|NCT02488642|Misoprostol|misoprostol|mesh-list
56961575|NCT02488642|Oxytocin|oxytocin|mesh-list
56961576|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
56961577|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56961578|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643871|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56961579|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56961580|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
56961581|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56961582|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56961583|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56961584|NCT02488642|Diuretics|diuretics|mesh-ancestor
56961585|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
56961586|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
56961587|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56961588|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961589|NCT02488486|Remifentanil|remifentanil|mesh-list
56961590|NCT02488486|Propofol|propofol|mesh-list
56961591|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56961592|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961593|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961594|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56961595|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
56961596|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
56961597|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56961598|NCT02488486|Narcotics|narcotics|mesh-ancestor
56961599|NCT02488486|Analgesics|analgesics|mesh-ancestor
56961600|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
56961601|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961602|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
56961603|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961604|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961605|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
56961606|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961607|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
56961608|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961609|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961610|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56961611|NCT03327766|Calcifediol|calcifediol|mesh-list
56961612|NCT03327766|Vitamins|vitamins|mesh-ancestor
56961613|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
56961614|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961615|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56961616|NCT03798119|Tenofovir|tenofovir|mesh-list
56961617|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
56961618|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961619|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56961620|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56961621|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961622|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961623|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56961624|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56961625|NCT03794219|Naproxen|naproxen|mesh-list
56961626|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56961627|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56961628|NCT03794219|Analgesics|analgesics|mesh-ancestor
56961629|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
56961630|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961631|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961632|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961633|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961634|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
56961635|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56961636|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961637|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961638|NCT01297764|Dexamethasone|dexamethasone|mesh-list
56961639|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
56961640|NCT01297764|Lenalidomide|lenalidomide|mesh-list
56961641|NCT01297764|Vorinostat|vorinostat|mesh-list
56961642|NCT01297764|BB 1101|bb 1101|mesh-list
56961643|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961644|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
56961645|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
56961646|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961647|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961648|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56961649|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
56961650|NCT01297764|Hormones|hormones|mesh-ancestor
56961651|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56961652|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56961653|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961654|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
56882503|NCT03243838|Apatinib|apatinib|mesh-list
56961655|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961656|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961657|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
56961658|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56961659|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56961660|NCT01297764|Growth Substances|growth substances|mesh-ancestor
56961661|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
56961662|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56961663|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
56961664|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56961665|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961666|NCT03050060|Nelfinavir|nelfinavir|mesh-list
56961667|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
56961668|NCT03050060|Nivolumab|nivolumab|mesh-list
56961669|NCT03050060|Atezolizumab|atezolizumab|mesh-list
56961670|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56961671|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961672|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961673|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56961674|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961675|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
56961676|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961677|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56961678|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56961679|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
56961680|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961681|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56961682|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56961683|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
56961684|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961685|NCT01334112|Axitinib|axitinib|mesh-list
56961686|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961687|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56961688|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961689|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961690|NCT03791957|Chrysarobin|chrysarobin|mesh-list
56961691|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56961692|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56961693|NCT03791957|Analgesics|analgesics|mesh-ancestor
56961694|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
56961695|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961696|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961697|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961698|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961699|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
56961700|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
56961701|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961702|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56961703|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
56961704|NCT03792113|Coagulants|coagulants|mesh-ancestor
56961705|NCT02491528|Insulin|insulin|mesh-list
56961706|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56961707|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
56961708|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
56961709|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56961710|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56961711|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961712|NCT01304927|Vitamin D|vitamin d|mesh-list
56961713|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
56961714|NCT01304927|Calcium|calcium|mesh-list
56961715|NCT01304927|Vitamins|vitamins|mesh-ancestor
56961716|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
56961717|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961718|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56961719|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56961720|NCT05464940|Caffeine|caffeine|mesh-list
56961721|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56961722|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961723|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56961724|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961725|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961726|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56961727|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56961728|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
56961729|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961730|NCT01305551|Metformin|metformin|mesh-list
56961731|NCT01305551|Saxagliptin|saxagliptin|mesh-list
56961732|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56961733|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961734|NCT01305551|Incretins|incretins|mesh-ancestor
56961736|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56961737|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56961738|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
56961739|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961740|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961741|NCT03799757|Bupivacaine|bupivacaine|mesh-list
56961742|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
56961743|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
56961744|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961745|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961746|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
56961747|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961748|NCT03611738|Docetaxel|docetaxel|mesh-list
56961749|NCT03611738|Ceritinib|ceritinib|mesh-list
56961750|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961751|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
56961752|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
56961753|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
56961754|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961755|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56961756|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961757|NCT03327454|Etanercept|etanercept|mesh-list
56961758|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56961759|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56961760|NCT03327454|Analgesics|analgesics|mesh-ancestor
56961761|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
56961762|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961763|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961764|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961765|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961766|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56961767|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56961768|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
56961769|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
56961770|NCT03799913|Fludarabine|fludarabine|mesh-list
56961771|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56961772|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
56961773|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961774|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961775|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56961776|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
56961777|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961778|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961779|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56961780|NCT01304069|Etoricoxib|etoricoxib|mesh-list
56961781|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56961782|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56961783|NCT01304069|Analgesics|analgesics|mesh-ancestor
56961784|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
56961785|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961786|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961787|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961788|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961789|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56961790|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56961791|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961792|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961793|NCT05459402|Methadone|methadone|mesh-list
56961794|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56961795|NCT05459402|Narcotics|narcotics|mesh-ancestor
56961796|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961797|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961798|NCT05459402|Analgesics|analgesics|mesh-ancestor
56961799|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
56961800|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961801|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
56961802|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
56961803|NCT03799601|Carboplatin|carboplatin|mesh-list
56961804|NCT03799601|Docetaxel|docetaxel|mesh-list
56961805|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961806|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
56644110|NCT02693210|Rituximab|rituximab|mesh-list
56961807|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
56961808|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
56961809|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961810|NCT03535688|Cycloserine|cycloserine|mesh-list
56961811|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56961812|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961813|NCT03535688|Renal Agents|renal agents|mesh-ancestor
56961814|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56961815|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
56961816|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56961817|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
56961818|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961819|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
56961820|NCT03791801|Rocuronium|rocuronium|mesh-list
56961821|NCT03791801|Neostigmine|neostigmine|mesh-list
56961822|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56961823|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56961824|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56961825|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961826|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961827|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56961828|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961829|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961830|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
56961831|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961832|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56961833|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
56961834|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56961835|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56961836|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56961837|NCT01305083|Udenafil|udenafil|mesh-list
56961838|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56961839|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56961840|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961841|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961842|NCT03791723|Valsartan|valsartan|mesh-list
56961843|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56961844|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56961845|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56961846|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56961847|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961848|NCT05452070|Lidocaine|lidocaine|mesh-list
56961849|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
56961850|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
56961851|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961852|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961853|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
56961854|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961855|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56961856|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56961857|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56961858|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56961859|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961860|NCT03920657|Deferasirox|deferasirox|mesh-list
56961861|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56961862|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
56961863|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
56961864|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961865|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56961866|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56961867|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961868|NCT03501277|Pioglitazone|pioglitazone|mesh-list
56961869|NCT03501277|Alogliptin|alogliptin|mesh-list
56961870|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56961871|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961872|NCT03501277|Incretins|incretins|mesh-ancestor
56961873|NCT03501277|Hormones|hormones|mesh-ancestor
56961874|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56961875|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56961876|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
56961877|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882728|NCT02032810|Ipilimumab|ipilimumab|mesh-list
56961878|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961879|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
56961880|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56961881|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961882|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56961883|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961884|NCT03797729|Tirofiban|tirofiban|mesh-list
56961885|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56961886|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56961887|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961888|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56961889|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56961890|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56961891|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56961892|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56961893|NCT02487706|Dolutegravir|dolutegravir|mesh-list
56961894|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56961895|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56961896|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56961897|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961898|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56961899|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56961900|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
56961901|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56961902|NCT04551950|Paclitaxel|paclitaxel|mesh-list
56961903|NCT04551950|Bevacizumab|bevacizumab|mesh-list
56961904|NCT04551950|Carboplatin|carboplatin|mesh-list
56961905|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56961906|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961907|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
56961908|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
56961909|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
56961910|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961911|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961912|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56961913|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56961914|NCT04551950|Growth Substances|growth substances|mesh-ancestor
56961915|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961916|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
56961917|NCT03772925|Belinostat|belinostat|mesh-list
56961918|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56961919|NCT03772925|Pevonedistat|pevonedistat|mesh-list
56961920|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961921|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961922|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56961923|NCT03326752|Nivolumab|nivolumab|mesh-list
56961924|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56961925|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56961926|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961927|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961928|NCT03326674|Capecitabine|capecitabine|mesh-list
56961929|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56961930|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
56961931|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961932|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644246|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
56644247|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644248|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
56644249|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644250|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56644251|NCT02706470|Progestins|progestins|mesh-ancestor
56644252|NCT02706470|Hormones|hormones|mesh-ancestor
56644253|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644254|NCT03769766|Curcumin|curcumin|mesh-list
56644255|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56644256|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56644257|NCT03769766|Analgesics|analgesics|mesh-ancestor
56644258|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
56644259|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644260|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644261|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644262|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644263|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644266|NCT03767348|Nivolumab|nivolumab|mesh-list
56961933|NCT01316900|Bromides|bromides|mesh-list
56961934|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
56961935|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56961936|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
56961937|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961938|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961939|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56961940|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
56961941|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
56961942|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56961943|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
56961944|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961945|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961946|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
56961947|NCT03714815|Macitentan|macitentan|mesh-list
56961948|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56961949|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56961950|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961951|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56961952|NCT02490982|Teriflunomide|teriflunomide|mesh-list
56961953|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56961954|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56961955|NCT02490982|Analgesics|analgesics|mesh-ancestor
56961956|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
56961957|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961958|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961959|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56961960|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56961961|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56961962|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
56961963|NCT03322150|Atropine|atropine|mesh-list
56961964|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
56961965|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56961966|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56961967|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56961968|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
56961969|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56961970|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961971|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56961972|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
56961973|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
56961974|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
56961975|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56961976|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56961977|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
56961978|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56961979|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56961980|NCT00936390|Leuprolide|leuprolide|mesh-list
56961981|NCT00936390|Goserelin|goserelin|mesh-list
56961982|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56961983|NCT00936390|Flutamide|flutamide|mesh-list
56961984|NCT00936390|Bicalutamide|bicalutamide|mesh-list
56961985|NCT00936390|Buserelin|buserelin|mesh-list
56961986|NCT00936390|Androgens|androgens|mesh-list
56961987|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-list
56961988|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56961989|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
56961990|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56961991|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56961992|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56961993|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56961994|NCT00936390|Hormones|hormones|mesh-ancestor
56961995|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644329|NCT04789928|Gentamicins|gentamicins|mesh-list
56961996|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
56644330|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56644331|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644332|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56644333|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644334|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644335|NCT00612950|Glucagon|glucagon|mesh-list
56644336|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56644337|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56644338|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56882874|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
56961997|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
56961998|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56961999|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
56962000|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56962001|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
56962002|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56962003|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56962004|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962005|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
56962006|NCT03326596|Coagulants|coagulants|mesh-ancestor
56962008|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56962009|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56962010|NCT03499873|Analgesics|analgesics|mesh-ancestor
56962011|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
56962012|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962013|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962014|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56962015|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56962016|NCT01305707|Diazepam|diazepam|mesh-list
56962017|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56962018|NCT01305707|Lorazepam|lorazepam|mesh-list
56962019|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
56962020|NCT01305707|Dexetimide|dexetimide|mesh-list
56962021|NCT01305707|Olanzapine|olanzapine|mesh-list
56962022|NCT01305707|Risperidone|risperidone|mesh-list
56962023|NCT01305707|Aripiprazole|aripiprazole|mesh-list
56962024|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56962025|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
56962026|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
56962027|NCT01305707|Mirtazapine|mirtazapine|mesh-list
56962028|NCT01305707|Citalopram|citalopram|mesh-list
56962029|NCT01305707|Sertraline|sertraline|mesh-list
56962030|NCT01305707|Fluoxetine|fluoxetine|mesh-list
56962031|NCT01305707|Paroxetine|paroxetine|mesh-list
56962032|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56962033|NCT01305707|Nortriptyline|nortriptyline|mesh-list
56962034|NCT01305707|Imipramine|imipramine|mesh-list
56962035|NCT01305707|Clomipramine|clomipramine|mesh-list
56962036|NCT01305707|Mianserin|mianserin|mesh-list
56962037|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
56962038|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56962039|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
56962040|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962041|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962042|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962043|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56962044|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962045|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56962046|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56962047|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
56962048|NCT01305707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56962049|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56962050|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962051|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56962052|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56962053|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56962054|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
56962055|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
56962056|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962057|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56962058|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56962059|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
56962060|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
56962061|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56962062|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
56962063|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56962064|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56962065|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56962066|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56962067|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56962068|NCT01305707|Analgesics|analgesics|mesh-ancestor
56962069|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
56962070|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56962071|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56962072|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962073|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
56882949|NCT03735368|Pregabalin|pregabalin|mesh-list
56962074|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
56962075|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56962076|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56962078|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
56962079|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56962080|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
56962081|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
56962082|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56962083|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56962084|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56962085|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
56962086|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56962087|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56962088|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56962089|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56962090|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56962091|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
56962092|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
56962093|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56962094|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56962095|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56962096|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
56962097|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962098|NCT03722329|Eculizumab|eculizumab|mesh-list
56962099|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56962100|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56962101|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
56962102|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962103|NCT03467971|Metformin|metformin|mesh-list
56962104|NCT03467971|Gliclazide|gliclazide|mesh-list
56962105|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56962106|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962107|NCT03319498|Peppermint oil|peppermint oil|mesh-list
56962108|NCT03319498|Mineral Oil|mineral oil|mesh-list
56962109|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
56962110|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
56962111|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962112|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962113|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56962114|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
56962115|NCT03319498|Emollients|emollients|mesh-ancestor
56962116|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
56962117|NCT03791099|Metronidazole|metronidazole|mesh-list
56962118|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962119|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56962120|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56962121|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56962122|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
56962123|NCT03791255|Calcium|calcium|mesh-list
56962124|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56962125|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962126|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56962127|NCT03742349|Spartalizumab|spartalizumab|mesh-list
56962128|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56962129|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962130|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962131|NCT03326128|Bupropion|bupropion|mesh-list
56962132|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56962133|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
56962134|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56962135|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56962136|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56962137|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962138|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962139|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
56962140|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962141|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962142|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56962143|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56962144|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962145|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56962146|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56962147|NCT03794297|Trametinib|trametinib|mesh-list
56962148|NCT03794297|Dabrafenib|dabrafenib|mesh-list
56962149|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56962150|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962151|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56962152|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962153|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962154|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56962155|NCT03794297|Protective Agents|protective agents|mesh-ancestor
56962156|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962157|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56962158|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
56962159|NCT03048500|Metformin|metformin|mesh-list
56962160|NCT03048500|Nivolumab|nivolumab|mesh-list
56962161|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56962162|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962163|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56962164|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962165|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56962166|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962167|NCT03790787|Empagliflozin|empagliflozin|mesh-list
56962168|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56962169|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962170|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56962171|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962172|NCT01334268|Paclitaxel|paclitaxel|mesh-list
56962173|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56962174|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962175|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
56962176|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
56962177|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
56962178|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962179|NCT04493398|Erythritol|erythritol|mesh-list
56962180|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
56962181|NCT00908076|Lubiprostone|lubiprostone|mesh-list
56962182|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56962183|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962184|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962185|NCT01305317|Atorvastatin|atorvastatin|mesh-list
56962186|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56962187|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56962188|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
56962189|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962190|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56962191|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56962192|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962193|NCT02613416|Denosumab|denosumab|mesh-list
56962194|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56962195|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962196|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
56962197|NCT03326050|Rifampin|rifampin|mesh-list
56962198|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
56962199|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56962200|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962201|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56962202|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56962203|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962204|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962205|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962206|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56962207|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56962208|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56962209|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
56962210|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
56962211|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56962212|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56962213|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56962214|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56962215|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56962216|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56962217|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56962218|NCT01334424|Propofol|propofol|mesh-list
56962219|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56962220|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962221|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962222|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56962223|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
56644541|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
56962224|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
56962225|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56962226|NCT05664685|Bismuth|bismuth|mesh-list
56962227|NCT05664685|Antacids|antacids|mesh-ancestor
56962228|NCT05664685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962229|NCT05664685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56962230|NCT03793517|Decitabine|decitabine|mesh-list
56962231|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56962232|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
56962233|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962234|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962235|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962236|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
56962237|NCT02886702|Tazarotene|tazarotene|mesh-list
56962238|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
56962239|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
56962240|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
56962241|NCT02886702|Vitamins|vitamins|mesh-ancestor
56962242|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
56962243|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962244|NCT03498313|Estradiol|estradiol|mesh-list
56962245|NCT03498313|Progesterone|progesterone|mesh-list
56962246|NCT03498313|Estrogens|estrogens|mesh-ancestor
56962247|NCT03498313|Hormones|hormones|mesh-ancestor
56962248|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56962249|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962250|NCT03498313|Progestins|progestins|mesh-ancestor
56962251|NCT03721081|Lidocaine|lidocaine|mesh-list
56962252|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
56962253|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
56962254|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962255|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962256|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
56962257|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962258|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56962259|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56962260|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56962261|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962262|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962263|NCT04493554|Vasopressins|vasopressins|mesh-list
56962264|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
56962265|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
56962266|NCT04493554|Coagulants|coagulants|mesh-ancestor
56962267|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56962268|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56962269|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
56962270|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962271|NCT02601014|Nivolumab|nivolumab|mesh-list
56962272|NCT02601014|Ipilimumab|ipilimumab|mesh-list
56962273|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56962274|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962275|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56962276|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962277|NCT01307046|Losartan|losartan|mesh-list
56962278|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56962279|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56962280|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56962281|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56962282|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962283|NCT05419115|Furosemide|furosemide|mesh-list
56962284|NCT05419115|Diuretics|diuretics|mesh-ancestor
56962285|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
56962286|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962287|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56962288|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962289|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962290|NCT04463394|Vasopressins|vasopressins|mesh-list
56962291|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
56962292|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
56962293|NCT04463394|Coagulants|coagulants|mesh-ancestor
56962294|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56962295|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56962296|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
55737256|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883177|NCT00071487|Belimumab|belimumab|mesh-list
56962297|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962298|NCT02490592|Fluorides|fluorides|mesh-list
56962299|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
56962300|NCT02490592|Protective Agents|protective agents|mesh-ancestor
56962301|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962302|NCT03075462|Apatinib|apatinib|mesh-list
56962303|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962304|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56962305|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962306|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962307|NCT01305395|Sirolimus|sirolimus|mesh-list
56962308|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56962309|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962310|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56962311|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962312|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
56962313|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56962314|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
56962315|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962316|NCT02886624|Grazoprevir|grazoprevir|mesh-list
56962317|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56962318|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
56962319|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962320|NCT02516696|Clarithromycin|clarithromycin|mesh-list
56962321|NCT02516696|Dexamethasone|dexamethasone|mesh-list
56962322|NCT02516696|Lenalidomide|lenalidomide|mesh-list
56962323|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56962324|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
56962325|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
56962326|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962327|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962328|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56962329|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
56962330|NCT02516696|Hormones|hormones|mesh-ancestor
56962331|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56962332|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56962333|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962334|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
56962335|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56962336|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56962337|NCT02516696|Growth Substances|growth substances|mesh-ancestor
56962338|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
56962339|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56962340|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962341|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56962342|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962343|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962344|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56962345|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56962346|NCT02487316|Crizotinib|crizotinib|mesh-list
56962347|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962348|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56962349|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962350|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962351|NCT02490436|Cetuximab|cetuximab|mesh-list
56962352|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56962353|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962354|NCT03318718|Rocuronium|rocuronium|mesh-list
56962355|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962356|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56962357|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56962358|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56962359|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962360|NCT03325348|Labetalol|labetalol|mesh-list
56962361|NCT03325348|Nifedipine|nifedipine|mesh-list
56962362|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56962363|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962364|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962365|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56962366|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962367|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
56962368|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
56962369|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56962370|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56962371|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56962372|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
56962373|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962374|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56962376|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
56962377|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962378|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56962379|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56962380|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
56962381|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
56962382|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
56962383|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962384|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962385|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
56962386|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962387|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
56962388|NCT03325270|Trace Elements|trace elements|mesh-ancestor
56962389|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
56962390|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962391|NCT02963766|Dulaglutide|dulaglutide|mesh-list
56962392|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56962393|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962394|NCT01334502|Prednisone|prednisone|mesh-list
56962395|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
56962396|NCT01334502|Rituximab|rituximab|mesh-list
56962397|NCT01334502|Doxorubicin|doxorubicin|mesh-list
56962398|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56962399|NCT01334502|Vincristine|vincristine|mesh-list
56962400|NCT01334502|Everolimus|everolimus|mesh-list
56962401|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56962402|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
56962403|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962404|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56962405|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56962406|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
56962407|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962408|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962409|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56962410|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56962411|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56962412|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56962413|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56962414|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962415|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56962416|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
56962417|NCT01334502|Hormones|hormones|mesh-ancestor
56962418|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56962419|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56962420|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56962421|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
56962422|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
56962423|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
56962424|NCT02487082|Melatonin|melatonin|mesh-list
56962425|NCT02487082|Donepezil|donepezil|mesh-list
56962426|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
56962427|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962428|NCT02487082|Protective Agents|protective agents|mesh-ancestor
56962429|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962430|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962431|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56962432|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962433|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
56962434|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962435|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
56962436|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56962437|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56962438|NCT03788681|Estradiol|estradiol|mesh-list
56962439|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56962440|NCT03788681|Estrogens|estrogens|mesh-ancestor
56962441|NCT03788681|Hormones|hormones|mesh-ancestor
56962442|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56962443|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962444|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56962445|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
56962446|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56962447|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56962448|NCT01308203|Niacin|niacin|mesh-list
56962449|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56962450|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
56962451|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962452|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56962453|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
56962454|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
56962455|NCT01308203|Vitamins|vitamins|mesh-ancestor
56962456|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
56962457|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962458|NCT03790085|Olanzapine|olanzapine|mesh-list
56962459|NCT03790085|Risperidone|risperidone|mesh-list
56962460|NCT03790085|Aripiprazole|aripiprazole|mesh-list
56962461|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56962462|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
56962463|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962464|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962465|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962466|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56962467|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56962468|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962469|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56962470|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56962471|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
56962472|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
56962473|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
56962474|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962475|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56962476|NCT03790085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56962477|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56962478|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962479|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
56962480|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
56962481|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56962482|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56962483|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56962484|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56962485|NCT01306097|Zinc|zinc|mesh-list
56962486|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
56962487|NCT01306097|Trace Elements|trace elements|mesh-ancestor
56962488|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
56962489|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962490|NCT01306097|Astringents|astringents|mesh-ancestor
56962491|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
56962492|NCT03790007|Bupivacaine|bupivacaine|mesh-list
56962493|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
56962494|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
56962495|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962496|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962497|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
56962498|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962499|NCT03789695|Dabigatran|dabigatran|mesh-list
56962500|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
56962501|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56962502|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
56962503|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962504|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962505|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
56962506|NCT03785873|Leucovorin|leucovorin|mesh-list
56962507|NCT03785873|Fluorouracil|fluorouracil|mesh-list
56962508|NCT03785873|Nivolumab|nivolumab|mesh-list
56962509|NCT03785873|Irinotecan|irinotecan|mesh-list
56962510|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
56962511|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962512|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56962513|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962514|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56962515|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
56962516|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962517|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56962518|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56962519|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56962520|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56962521|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962522|NCT03785873|Antidotes|antidotes|mesh-ancestor
56962523|NCT03785873|Protective Agents|protective agents|mesh-ancestor
56883411|NCT02906332|Hormones|hormones|mesh-ancestor
56962524|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
56962525|NCT03785873|Vitamins|vitamins|mesh-ancestor
56962526|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
56962527|NCT00739674|Losartan|losartan|mesh-list
56962528|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56962529|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
56962531|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56962532|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962533|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56962534|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56962535|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56962536|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56962537|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962538|NCT00739674|Diuretics|diuretics|mesh-ancestor
56962539|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
56962540|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56962541|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962542|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
56962543|NCT01306409|Hematinics|hematinics|mesh-ancestor
56962544|NCT05060315|Treprostinil|treprostinil|mesh-list
56962545|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56962546|NCT01331928|Docetaxel|docetaxel|mesh-list
56962547|NCT01331928|Capecitabine|capecitabine|mesh-list
56962548|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
56962549|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962550|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
56962551|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
56962552|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
56962553|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962554|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56962555|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
56962556|NCT01334580|Methadone|methadone|mesh-list
56962557|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56962558|NCT01334580|Narcotics|narcotics|mesh-ancestor
56962559|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962560|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962561|NCT01334580|Analgesics|analgesics|mesh-ancestor
56962562|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
56962563|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962564|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
56962565|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
56962566|NCT02694588|Infliximab|infliximab|mesh-list
56962567|NCT02694588|Vedolizumab|vedolizumab|mesh-list
56962568|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
56962569|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56962570|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56962571|NCT03789539|Vaccines|vaccines|mesh-list
56962572|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
56962573|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962574|NCT00400218|Losartan|losartan|mesh-list
56962575|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56962576|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56962577|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56962578|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56962579|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56962580|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962581|NCT00400218|Diuretics|diuretics|mesh-ancestor
56962582|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
56962583|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962584|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56962585|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962586|NCT02486848|Minoxidil|minoxidil|mesh-list
56962587|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56962588|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56962589|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
56962590|NCT01306565|Atorvastatin|atorvastatin|mesh-list
56962591|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56962592|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56962593|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
56962594|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962595|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56962596|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56962597|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962598|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
56962599|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56962600|NCT03786029|Acetaminophen|acetaminophen|mesh-list
56962601|NCT03786029|Ibuprofen|ibuprofen|mesh-list
56962602|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56962603|NCT03786029|Analgesics|analgesics|mesh-ancestor
56962604|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
56962605|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962606|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962608|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56962609|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56962610|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56962611|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56962612|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962613|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962614|NCT01334892|Cyclosporine|cyclosporine|mesh-list
56962615|NCT01334892|Cyclosporins|cyclosporins|mesh-list
56962616|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962617|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962618|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56962619|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
56962620|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962621|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
56962622|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962623|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
56962624|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56962625|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56962626|NCT04730219|Paclitaxel|paclitaxel|mesh-list
56962627|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56962628|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962629|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
56962630|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
56962631|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
56962632|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962633|NCT04492774|Dexamethasone|dexamethasone|mesh-list
56962634|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56962635|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
56962636|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
56962637|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962638|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962639|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56962640|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
56962641|NCT04492774|Hormones|hormones|mesh-ancestor
56962642|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56962643|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56962644|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962645|NCT03321292|Aspirin|aspirin|mesh-list
56962646|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56962647|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56962648|NCT03321292|Analgesics|analgesics|mesh-ancestor
56962649|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
56962650|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962651|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962652|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56962653|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56962654|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56962655|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56962656|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962657|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56962658|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56962659|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962660|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
56962661|NCT01306721|Fexofenadine|fexofenadine|mesh-list
56962662|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
56962663|NCT01306721|Ephedrine|ephedrine|mesh-list
56962664|NCT01306721|Terfenadine|terfenadine|mesh-list
56962665|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56962666|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
56962667|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962668|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962669|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56962670|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
56962671|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
56962672|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56962673|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56962674|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
56962675|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
55737564|NCT03109795|Clonidine|clonidine|mesh-list
56962676|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962677|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962678|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56962679|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56962680|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56962681|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
56962682|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
56962684|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
56962685|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962686|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56962687|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962688|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962689|NCT02486926|Remifentanil|remifentanil|mesh-list
56962690|NCT02486926|Alfentanil|alfentanil|mesh-list
56962691|NCT02486926|Thiopental|thiopental|mesh-list
56962692|NCT02486926|Sevoflurane|sevoflurane|mesh-list
56962693|NCT02486926|Rocuronium|rocuronium|mesh-list
56962694|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56962695|NCT02486926|Narcotics|narcotics|mesh-ancestor
56962696|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962697|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962698|NCT02486926|Analgesics|analgesics|mesh-ancestor
56962699|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
56962700|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962701|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56962702|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56962703|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
56962704|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
56962705|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56962706|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56962707|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56962708|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56962709|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
56962710|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56962711|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
56962712|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
56962713|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962714|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962715|NCT01335048|Clopidogrel|clopidogrel|mesh-list
56962716|NCT01335048|Atorvastatin|atorvastatin|mesh-list
56962717|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56962718|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56962719|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
56962720|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962721|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56962722|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56962723|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962724|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56962725|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56962726|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56962727|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56962728|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
56962729|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962730|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962731|NCT05693675|Methadone|methadone|mesh-list
56962732|NCT05693675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56962733|NCT05693675|Narcotics|narcotics|mesh-ancestor
56962734|NCT05693675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962735|NCT05693675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962736|NCT05693675|Analgesics|analgesics|mesh-ancestor
56962737|NCT05693675|Sensory System Agents|sensory system agents|mesh-ancestor
56962738|NCT05693675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962739|NCT05693675|Antitussive Agents|antitussive agents|mesh-ancestor
56962740|NCT05693675|Respiratory System Agents|respiratory system agents|mesh-ancestor
56962741|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
56962742|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56962743|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56962744|NCT01567475|Rituximab|rituximab|mesh-list
56962745|NCT01567475|Everolimus|everolimus|mesh-list
56962746|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56962747|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962748|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
56962749|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962750|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56962751|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56962752|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
56883626|NCT05462548|Hematinics|hematinics|mesh-ancestor
56291116|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56962753|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56962755|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
56962756|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962757|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962758|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56962759|NCT03435055|Analgesics|analgesics|mesh-ancestor
56962760|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
56962761|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962762|NCT05693246|Glycopyrrolate|glycopyrrolate|mesh-list
56962763|NCT05693246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56962764|NCT05693246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56962765|NCT05693246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56962766|NCT05693246|Cholinergic Agents|cholinergic agents|mesh-ancestor
56962767|NCT05693246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962768|NCT05693246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962769|NCT05693246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962770|NCT03316066|Ropivacaine|ropivacaine|mesh-list
56962771|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
56962772|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
56962773|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962774|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962775|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
56962776|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962777|NCT01308437|Insulin|insulin|mesh-list
56962778|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56962779|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
56962780|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56962781|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962782|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
56962783|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56962784|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
56962785|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962786|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56962787|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56962788|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
56962789|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962790|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962791|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56962792|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56962793|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56962794|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56962795|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962796|NCT01335360|Nevirapine|nevirapine|mesh-list
56962797|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56962798|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56962799|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962800|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962801|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
56962802|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962803|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56962804|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56962805|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56962806|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56962807|NCT02489266|Aldesleukin|aldesleukin|mesh-list
56962808|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
56962809|NCT02489266|Fludarabine|fludarabine|mesh-list
56962810|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56962811|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
56962812|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962813|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56962814|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56962815|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
56962816|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962817|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962818|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56962819|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56962820|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56962821|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
56962822|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962823|NCT03434119|Insulin|insulin|mesh-list
56962824|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56962825|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
56962826|NCT03434119|Lixisenatide|lixisenatide|mesh-list
56962827|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56962828|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962830|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56962831|NCT02484352|Narcotics|narcotics|mesh-ancestor
56962832|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962833|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962834|NCT02484352|Analgesics|analgesics|mesh-ancestor
56962835|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
56962836|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962837|NCT01308671|Varenicline|varenicline|mesh-list
56962838|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56962839|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56962840|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
56962841|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962842|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962843|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962844|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
56962845|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56962846|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
56962847|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56962848|NCT03315676|Esomeprazole|esomeprazole|mesh-list
56962849|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56962850|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56962851|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56962852|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962853|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962854|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
56962855|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56962856|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
56962857|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962858|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962859|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56962860|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
56962861|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
56962862|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56962863|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
56962864|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962865|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962866|NCT02486458|Listerine|listerine|mesh-list
56962867|NCT02486458|Fluorides|fluorides|mesh-list
56962868|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
56962869|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
56962870|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
56962871|NCT02486458|Protective Agents|protective agents|mesh-ancestor
56962872|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962873|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56962874|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962875|NCT01335516|Terlipressin|terlipressin|mesh-list
56962876|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56962877|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56962878|NCT05694923|Empagliflozin|empagliflozin|mesh-list
56962879|NCT05694923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56962880|NCT05694923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962881|NCT05694923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56962882|NCT05694923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962883|NCT01332396|Lapatinib|lapatinib|mesh-list
56962884|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962885|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56962886|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962887|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962888|NCT03719053|Tenofovir|tenofovir|mesh-list
56962889|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
56962890|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962891|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56962892|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56962893|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962894|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962895|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56962896|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56962897|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56962898|NCT03526848|Antibodies|antibodies|mesh-list
56962899|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
56962900|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56645207|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883804|NCT00086385|Bupropion|bupropion|mesh-list
56962901|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
56962902|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962903|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56962904|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
56962905|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
56962906|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962907|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56962908|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56962909|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
56962910|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962911|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962912|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56962913|NCT01332552|Ritonavir|ritonavir|mesh-list
56962914|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56962915|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56962916|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
56962917|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962918|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962919|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56962920|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56962921|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
56962922|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962923|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56962924|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56962925|NCT03720223|Bupivacaine|bupivacaine|mesh-list
56962926|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
56962927|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
56962928|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962929|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962930|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
56962931|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962932|NCT03160716|Lidocaine|lidocaine|mesh-list
56962933|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
56962934|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
56962935|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962936|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962937|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
56962938|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962939|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56962940|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56962941|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56962942|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56962943|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962944|NCT00092664|Simvastatin|simvastatin|mesh-list
56962945|NCT00092664|Ezetimibe|ezetimibe|mesh-list
56962946|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56962947|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56962948|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
56962949|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962950|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56962951|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56962952|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962953|NCT02483884|Bombesin|bombesin|mesh-list
56962954|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56962955|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962956|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962957|NCT03317548|Progesterone|progesterone|mesh-list
56962958|NCT03317548|Progestins|progestins|mesh-ancestor
56962959|NCT03317548|Hormones|hormones|mesh-ancestor
56962960|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56962961|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962962|NCT00092586|Ezetimibe|ezetimibe|mesh-list
56962963|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56962964|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56962965|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
56962966|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962967|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56962968|NCT03786887|Nalbuphine|nalbuphine|mesh-list
56962969|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56962970|NCT03786887|Narcotics|narcotics|mesh-ancestor
56962971|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56962972|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883850|NCT03383770|Anesthetics|anesthetics|mesh-list
56962973|NCT03786887|Analgesics|analgesics|mesh-ancestor
56962974|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
56962975|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56962976|NCT03787043|Metformin|metformin|mesh-list
56962977|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56962978|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56962979|NCT00090168|Atorvastatin|atorvastatin|mesh-list
56962980|NCT00090168|Simvastatin|simvastatin|mesh-list
56962981|NCT00090168|Ezetimibe|ezetimibe|mesh-list
56962982|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56962983|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56962984|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
56962985|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962986|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56962987|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56962988|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962989|NCT01332786|Tigecycline|tigecycline|mesh-list
56962990|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56962991|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56962992|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56962993|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56962994|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56962995|NCT01338090|Bevacizumab|bevacizumab|mesh-list
56962996|NCT01338090|Everolimus|everolimus|mesh-list
56962997|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
56962998|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56962999|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963000|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56963001|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56963002|NCT01338090|Growth Substances|growth substances|mesh-ancestor
56963003|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963004|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
56963005|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56963006|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
56963007|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56963008|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963009|NCT01307969|Lidocaine|lidocaine|mesh-list
56963010|NCT01307969|Epinephrine|epinephrine|mesh-list
56963011|NCT01307969|Racepinephrine|racepinephrine|mesh-list
56963012|NCT01307969|Ropivacaine|ropivacaine|mesh-list
56963013|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
56963014|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
56963015|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
56963016|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963017|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963018|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
56963019|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963020|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56963021|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56963022|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56963023|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56963024|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963025|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56963026|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56963027|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
56963028|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963029|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56963030|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56963031|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
56963032|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56963033|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
56963034|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
56963035|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
56963036|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56963037|NCT03786419|Atezolizumab|atezolizumab|mesh-list
56963038|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963039|NCT01338324|Simvastatin|simvastatin|mesh-list
56963040|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56963041|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56963042|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
56963043|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963044|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56963045|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56963046|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963047|NCT01336062|Paclitaxel|paclitaxel|mesh-list
56963048|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56963049|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56963050|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963051|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
56963052|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
56963053|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
56963054|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963055|NCT05694221|Metformin|metformin|mesh-list
56963056|NCT05694221|Digoxin|digoxin|mesh-list
56963057|NCT05694221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56963058|NCT05694221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963059|NCT05694221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56963060|NCT05694221|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56963061|NCT05694221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963062|NCT05694221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963063|NCT05694221|Protective Agents|protective agents|mesh-ancestor
56963064|NCT01308047|Bupivacaine|bupivacaine|mesh-list
56963065|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
56963066|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
56963067|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963068|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963069|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
56963070|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963071|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
56963072|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
56963073|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
56963074|NCT03777761|Tucatinib|tucatinib|mesh-list
56963075|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56963076|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963077|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56963078|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56963079|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963080|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963081|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963082|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56963083|NCT01316861|Acarbose|acarbose|mesh-list
56963084|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56963085|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963086|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963087|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56963088|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963089|NCT01336218|Rifampin|rifampin|mesh-list
56963090|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56963091|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
56963092|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56963093|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963094|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
56963095|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56963096|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963097|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963098|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56963099|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56963100|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56963101|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56963102|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56963103|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56963104|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56963105|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963106|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56963107|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963108|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
56963109|NCT03776279|Analgesics|analgesics|mesh-ancestor
56963110|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
56963111|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963112|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963113|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963114|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56963115|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56963116|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963117|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963118|NCT01561391|Factor VIII|factor viii|mesh-list
56963119|NCT01561391|Coagulants|coagulants|mesh-ancestor
56963120|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
56963121|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56963122|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963123|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963124|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963125|NCT03775655|Analgesics|analgesics|mesh-ancestor
56963126|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
56963127|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963128|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56963129|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56963130|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56963131|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
56963132|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963133|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963134|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
56963135|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56963136|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963137|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
56963138|NCT03781895|Vitamin D|vitamin d|mesh-list
56963139|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56963140|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963141|NCT03781895|Vitamins|vitamins|mesh-ancestor
56963142|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
56963143|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56963144|NCT00706030|Vinorelbine|vinorelbine|mesh-list
56963145|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56963146|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963147|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
56963148|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
56963149|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
56963150|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963151|NCT03781505|Acetaminophen|acetaminophen|mesh-list
56963152|NCT03781505|Ropivacaine|ropivacaine|mesh-list
56963153|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
56963154|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
56963155|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963156|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963157|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
56963158|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963159|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963160|NCT03781505|Analgesics|analgesics|mesh-ancestor
56963161|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
56963162|NCT03781115|Olanzapine|olanzapine|mesh-list
56963163|NCT03781115|Ziprasidone|ziprasidone|mesh-list
56963164|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
56963165|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
56963166|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963167|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963168|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56963169|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56963170|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56963171|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963172|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56963173|NCT03781115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56963174|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56963175|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56963176|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963177|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963178|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
56963179|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56963180|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56963181|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
56963182|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56963183|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
56963184|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56963185|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56963186|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56963187|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963188|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963189|NCT01313429|Celecoxib|celecoxib|mesh-list
56963190|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
56963191|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56963192|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
56963193|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963194|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56963195|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56963196|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
56963197|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963198|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963199|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56963200|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56963201|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963202|NCT01313429|Analgesics|analgesics|mesh-ancestor
56963203|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
56963204|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963205|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963206|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56963207|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56963208|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963209|NCT03488251|Gemcitabine|gemcitabine|mesh-list
56963210|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
56963211|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56963212|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
56963213|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963214|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963215|NCT03488251|Antiviral Agents|antiviral agents|mesh-ancestor
56963216|NCT03488251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963217|NCT03488251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963218|NCT03488251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56963219|NCT03488251|Immunologic Factors|immunologic factors|mesh-ancestor
56963220|NCT03488251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963221|NCT03158688|Dexamethasone|dexamethasone|mesh-list
56963222|NCT03158688|Daratumumab|daratumumab|mesh-list
56963223|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963224|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
56963225|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
56963226|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963227|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963228|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56963229|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
56963230|NCT03158688|Hormones|hormones|mesh-ancestor
56963231|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56963232|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56963233|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963234|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
56963235|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56963236|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963237|NCT02727322|Renal Agents|renal agents|mesh-ancestor
56963238|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56963239|NCT03315520|Cytarabine|cytarabine|mesh-list
56963240|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
56963241|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56963242|NCT03315520|Etoposide|etoposide|mesh-list
56963243|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56963244|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
56963245|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963246|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56963247|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56963248|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
56963249|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963250|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963251|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56963252|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56963253|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56963254|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56963255|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963256|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56963257|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
56963258|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
56963259|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963260|NCT02483182|Acyclovir|acyclovir|mesh-list
56963261|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
56963262|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963263|NCT01338558|Bevacizumab|bevacizumab|mesh-list
56963264|NCT01338558|Cetuximab|cetuximab|mesh-list
56963265|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56963266|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963267|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56963268|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56963269|NCT01338558|Growth Substances|growth substances|mesh-ancestor
56963270|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963271|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
56963272|NCT03780569|Temozolomide|temozolomide|mesh-list
56963273|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56963274|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
56963275|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963276|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963277|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56963278|NCT03487549|Cantharidin|cantharidin|mesh-list
56963279|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963280|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963281|NCT01313585|Beclomethasone|beclomethasone|mesh-list
56963282|NCT01313585|Albuterol|albuterol|mesh-list
56963283|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56963284|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
56963285|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963286|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963287|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56963288|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
56963289|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
56963290|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56963291|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56963292|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56963293|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56963294|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
56963295|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963296|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963297|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963298|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
56963299|NCT01313585|Hormones|hormones|mesh-ancestor
56963300|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56963301|NCT01561235|Hormones|hormones|mesh-list
56963302|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56963303|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963304|NCT02485990|Olaparib|olaparib|mesh-list
56963305|NCT02485990|Tremelimumab|tremelimumab|mesh-list
56963306|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56963307|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963308|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963309|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963310|NCT01313819|Amantadine|amantadine|mesh-list
56963311|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56963312|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56963313|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
56963314|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963315|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
56963316|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963317|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963318|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963319|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963320|NCT01313819|Analgesics|analgesics|mesh-ancestor
56963321|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
56963322|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963323|NCT03315442|Caffeine|caffeine|mesh-list
56963324|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56963325|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963326|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56963327|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963328|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963329|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56963330|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56963331|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
56963332|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963333|NCT03464383|Citalopram|citalopram|mesh-list
56963334|NCT03464383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56963335|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56963336|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56963337|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963338|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963339|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
56963340|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963341|NCT03464383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56963342|NCT03464383|Antidepressive Agents|antidepressive agents|mesh-ancestor
56963343|NCT03464383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56963344|NCT03315364|Paclitaxel|paclitaxel|mesh-list
56963345|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56963346|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56963347|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963348|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
56963349|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
56963350|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
56963351|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963353|NCT03779633|Estrogens|estrogens|mesh-ancestor
56963354|NCT03779633|Hormones|hormones|mesh-ancestor
56963355|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56963356|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963357|NCT03720067|Propranolol|propranolol|mesh-list
56963358|NCT03720067|Carvedilol|carvedilol|mesh-list
56963359|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56963360|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56963361|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56963362|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
56963363|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963364|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56963365|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56963366|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963367|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56963368|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56963369|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
56963370|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963371|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963372|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56963373|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56963374|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
56963375|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
56963376|NCT03720067|Protective Agents|protective agents|mesh-ancestor
56963377|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56963378|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56963379|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56963380|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56963381|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56963382|NCT01444092|Budesonide|budesonide|mesh-list
56963383|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963384|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56963385|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
56963386|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963387|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963388|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56963389|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
56963390|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
56963391|NCT01444092|Hormones|hormones|mesh-ancestor
56963392|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56963393|NCT03719989|Azacitidine|azacitidine|mesh-list
56963394|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56963395|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
56963396|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963397|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963398|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963399|NCT05462470|Liver Extracts|liver extracts|mesh-list
56963400|NCT05462470|Hematinics|hematinics|mesh-ancestor
56963401|NCT03779087|Amoxicillin|amoxicillin|mesh-list
56963402|NCT03779087|Levofloxacin|levofloxacin|mesh-list
56963403|NCT03779087|Ofloxacin|ofloxacin|mesh-list
56963404|NCT03779087|Tetracycline|tetracycline|mesh-list
56963405|NCT03779087|Esomeprazole|esomeprazole|mesh-list
56963406|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56963407|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963408|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56963409|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56963410|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56963411|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963412|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963413|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56963414|NCT03779087|Renal Agents|renal agents|mesh-ancestor
56963415|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56963416|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56963417|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963418|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56963419|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55737943|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56963420|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56963421|NCT01265784|Ertapenem|ertapenem|mesh-list
56963422|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56963423|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963424|NCT05692271|Propranolol|propranolol|mesh-list
56963425|NCT05692271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56963426|NCT05692271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56963427|NCT05692271|Adrenergic Agents|adrenergic agents|mesh-ancestor
56963428|NCT05692271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963429|NCT05692271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963430|NCT05692271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963431|NCT05692271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56963432|NCT05692271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56963433|NCT05692271|Vasodilator Agents|vasodilator agents|mesh-ancestor
56963434|NCT03774953|Vitamins|vitamins|mesh-list
56963435|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
56963436|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963437|NCT02483026|Vitamin D|vitamin d|mesh-list
56963438|NCT02483026|Vitamins|vitamins|mesh-list
56963439|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
56963440|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963441|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56963442|NCT02483104|Paclitaxel|paclitaxel|mesh-list
56963443|NCT02483104|Carboplatin|carboplatin|mesh-list
56963444|NCT02483104|Veliparib|veliparib|mesh-list
56963445|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56963446|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963447|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
56963448|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
56963449|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
56963450|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963451|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56963452|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963453|NCT00116220|Goserelin|goserelin|mesh-list
56963454|NCT00116220|Flutamide|flutamide|mesh-list
56963455|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963456|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56963457|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963458|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
56963459|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
56963460|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56963461|NCT03785015|Aspirin|aspirin|mesh-list
56963462|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56963463|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963464|NCT03785015|Analgesics|analgesics|mesh-ancestor
56963465|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
56963466|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963467|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963468|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963469|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56963470|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56963471|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56963472|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963473|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56963474|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56963475|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963476|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
56963477|NCT04867343|Fentanyl|fentanyl|mesh-list
56963478|NCT04867343|Remifentanil|remifentanil|mesh-list
56963479|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56963480|NCT04867343|Narcotics|narcotics|mesh-ancestor
56963481|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963482|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963483|NCT04867343|Analgesics|analgesics|mesh-ancestor
56963484|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
56963485|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963486|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56963487|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56963488|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
56963489|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
56963490|NCT05185518|Insulin|insulin|mesh-list
56963491|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56963492|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963493|NCT03316690|Metformin|metformin|mesh-list
56963494|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56963495|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963496|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
56884375|NCT05231590|Paraproteins|paraproteins|mesh-list
56963497|NCT03315052|Prednisone|prednisone|mesh-list
56963498|NCT03315052|Budesonide|budesonide|mesh-list
56645808|NCT00700076|Analgesics|analgesics|mesh-ancestor
56963499|NCT03315052|Tacrolimus|tacrolimus|mesh-list
56963500|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963501|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
56963502|NCT03315052|Hormones|hormones|mesh-ancestor
56963503|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56963504|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963505|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56963506|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963507|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56963508|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
56963509|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56963510|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963511|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963512|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56963513|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56963514|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
56963515|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56963516|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963517|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56963518|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
56963519|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963520|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56963521|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
56963522|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
56963523|NCT03778619|Rituximab|rituximab|mesh-list
56963524|NCT03778619|Fludarabine|fludarabine|mesh-list
56963525|NCT03778619|Interleukin-2|interleukin-2|mesh-list
56963526|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56963527|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
56963528|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963529|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56963530|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56963531|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
56963532|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963533|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963534|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56963535|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56963536|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963537|NCT03778619|Analgesics|analgesics|mesh-ancestor
56963538|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
56963539|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963540|NCT05714176|Lactoferrin|lactoferrin|mesh-list
56963541|NCT05714176|Dextrans|dextrans|mesh-list
56963542|NCT05714176|Iron-Dextran Complex|iron-dextran complex|mesh-list
56963543|NCT05714176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963544|NCT05714176|Anticoagulants|anticoagulants|mesh-ancestor
56963545|NCT05714176|Plasma Substitutes|plasma substitutes|mesh-ancestor
56963546|NCT05714176|Blood Substitutes|blood substitutes|mesh-ancestor
56963547|NCT05714176|Hematinics|hematinics|mesh-ancestor
56963548|NCT03156504|Ketamine|ketamine|mesh-list
56963549|NCT03156504|Analgesics|analgesics|mesh-ancestor
56963550|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
56963551|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963552|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963553|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56963554|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56963555|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
56963556|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
56963557|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963558|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56963559|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56963560|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963561|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963562|NCT01333332|Capecitabine|capecitabine|mesh-list
56963563|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56963564|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
56963565|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963566|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963567|NCT03316534|Aspirin|aspirin|mesh-list
56963568|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56963569|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56884462|NCT03701698|Hormones|hormones|mesh-ancestor
56963570|NCT03316534|Analgesics|analgesics|mesh-ancestor
56963571|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
56963572|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963573|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963574|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645886|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963576|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56963577|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56963578|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963579|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56963580|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56963581|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963582|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
56963583|NCT04476420|Betamethasone|betamethasone|mesh-list
56963584|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
56963585|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56963586|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
56963587|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56963588|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963589|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
56963590|NCT04476420|Hormones|hormones|mesh-ancestor
56963591|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56963592|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963593|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56963594|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
56963595|NCT03778541|Temozolomide|temozolomide|mesh-list
56963596|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56963597|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
56963598|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963599|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963600|NCT02479828|Ropivacaine|ropivacaine|mesh-list
56963601|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
56963602|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
56963603|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963604|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963605|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
56963606|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963607|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
56963608|NCT01320449|Hematinics|hematinics|mesh-ancestor
56963609|NCT03430063|Ipilimumab|ipilimumab|mesh-list
56963610|NCT03430063|Cemiplimab|cemiplimab|mesh-list
56963611|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56963612|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963613|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56963614|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963615|NCT03158220|Vaccines|vaccines|mesh-list
56963616|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
56963617|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963618|NCT01308983|Amiloride|amiloride|mesh-list
56963619|NCT01308983|Diuretics|diuretics|mesh-ancestor
56963620|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
56963621|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963622|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56963623|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56963624|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56963625|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963626|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56963627|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56963628|NCT01336842|Pemetrexed|pemetrexed|mesh-list
56963629|NCT01336842|Panobinostat|panobinostat|mesh-list
56963630|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963631|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963632|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963633|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56963634|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56963635|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56963636|NCT05178407|Micronutrients|micronutrients|mesh-list
56963637|NCT05178407|Trace Elements|trace elements|mesh-list
56963638|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963639|NCT01339026|Clopidogrel|clopidogrel|mesh-list
56963640|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56963641|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56963642|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56884523|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56963643|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56963644|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56963645|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
56963646|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963647|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963649|NCT05683223|Sertraline|sertraline|mesh-list
56963650|NCT05683223|Antidepressive Agents|antidepressive agents|mesh-ancestor
56963651|NCT05683223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56963652|NCT05683223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56963653|NCT05683223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56963654|NCT05683223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56963655|NCT05683223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963656|NCT05683223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963657|NCT05683223|Serotonin Agents|serotonin agents|mesh-ancestor
56963658|NCT05683223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963659|NCT03314740|Paclitaxel|paclitaxel|mesh-list
56963660|NCT03314740|Olaparib|olaparib|mesh-list
56963661|NCT03314740|Cediranib|cediranib|mesh-list
56963662|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56963663|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963664|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
56963665|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
56963666|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
56963667|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963668|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56963669|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963670|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56963671|NCT04739813|Prednisone|prednisone|mesh-list
56963672|NCT04739813|Lenalidomide|lenalidomide|mesh-list
56963673|NCT04739813|Venetoclax|venetoclax|mesh-list
56963674|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
56963675|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963676|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
56963677|NCT04739813|Hormones|hormones|mesh-ancestor
56963678|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56963679|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963680|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56963681|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963682|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
56963683|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56963684|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56963685|NCT04739813|Growth Substances|growth substances|mesh-ancestor
56963686|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
56963687|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56963688|NCT02482636|Vaccines|vaccines|mesh-list
56963689|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56963690|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
56963691|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963692|NCT02482402|Iloprost|iloprost|mesh-list
56963693|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56963694|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
56963695|NCT03774095|Pycnogenols|pycnogenols|mesh-list
56963696|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56963697|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
56963698|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963699|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
56963700|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963701|NCT03774095|Protective Agents|protective agents|mesh-ancestor
56963702|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56963703|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
56963704|NCT01333410|Tacrolimus|tacrolimus|mesh-list
56963705|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56963706|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
56963707|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963708|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56963709|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963710|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963711|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963712|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
56963713|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56963714|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
56963715|NCT02482090|Fludarabine|fludarabine|mesh-list
56963716|NCT02482090|Interleukin-2|interleukin-2|mesh-list
55738024|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
56963717|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56963718|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
56963719|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963720|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56963721|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56963722|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
56963723|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963725|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56963726|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963727|NCT02482090|Analgesics|analgesics|mesh-ancestor
56963728|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
56963729|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963730|NCT02482324|Ibuprofen|ibuprofen|mesh-list
56963731|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56963732|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963733|NCT02482324|Analgesics|analgesics|mesh-ancestor
56963734|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
56963735|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963736|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963737|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963738|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56963739|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56963740|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963741|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963742|NCT05185284|Remdesivir|remdesivir|mesh-list
56963743|NCT05185284|Favipiravir|favipiravir|mesh-list
56963744|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
56963745|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963746|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
56963747|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963748|NCT03784703|Atorvastatin|atorvastatin|mesh-list
56963749|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56963750|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56963751|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56963752|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
56963753|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963754|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56963755|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56963756|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963757|NCT02724592|Fluorides|fluorides|mesh-list
56963758|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
56963759|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
56963760|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
56963761|NCT02724592|Protective Agents|protective agents|mesh-ancestor
56963762|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963763|NCT02476864|Macitentan|macitentan|mesh-list
56963764|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56963765|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56963766|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963767|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56963768|NCT02668770|Ipilimumab|ipilimumab|mesh-list
56963769|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56963770|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963771|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56963772|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963773|NCT05451550|Anesthetics|anesthetics|mesh-list
56963774|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963775|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963776|NCT02476708|Curcumin|curcumin|mesh-list
56963777|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56963778|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963779|NCT02476708|Analgesics|analgesics|mesh-ancestor
56963780|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
56963781|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963782|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963783|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963784|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56963785|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963786|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963787|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963788|NCT02479204|Atenolol|atenolol|mesh-list
56963789|NCT02479204|Diltiazem|diltiazem|mesh-list
56963790|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56884674|NCT03435692|Morphine|morphine|mesh-list
56963791|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56963792|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
56963793|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
56963794|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963795|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963796|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56963797|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56963798|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56963799|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
56963800|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963801|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963802|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56963803|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56963804|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56963805|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
56963806|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
56963807|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
56963808|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963809|NCT01339572|Plerixafor|plerixafor|mesh-list
56963810|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56963811|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56963812|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
56963813|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963814|NCT05481736|Psilocybin|psilocybin|mesh-list
56963815|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
56963816|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963817|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56963818|NCT04199117|Nicotine|nicotine|mesh-list
56963819|NCT04199117|Varenicline|varenicline|mesh-list
56963820|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56963821|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
56963822|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963823|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963824|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56963825|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56963826|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
56963827|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963828|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963829|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
56963830|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56963831|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
56963832|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963833|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963834|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56963835|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
56963836|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
56963837|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56963838|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
56963839|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963840|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963841|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
56963842|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
56963843|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56963844|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56963845|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963846|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963847|NCT03154476|Urological Agents|urological agents|mesh-ancestor
56963848|NCT03784391|Nifurtimox|nifurtimox|mesh-list
56963849|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56963850|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56963851|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56963852|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963853|NCT04148105|Cilostazol|cilostazol|mesh-list
56963854|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56963855|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
56963856|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963857|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963858|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56963859|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
56963860|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56963861|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56963862|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963863|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56963864|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
56963865|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56963866|NCT04148105|Protective Agents|protective agents|mesh-ancestor
56963867|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56963868|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56963869|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963870|NCT02476552|Niraparib|niraparib|mesh-list
56963871|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56963872|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963873|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963874|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963876|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56963877|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56963878|NCT01316718|Analgesics|analgesics|mesh-ancestor
56963879|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
56963880|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56963881|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963882|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56963883|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56963884|NCT01316952|Carvedilol|carvedilol|mesh-list
56963885|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56963886|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
56963887|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
56963888|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963889|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963890|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963891|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56963892|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
56963893|NCT01316952|Protective Agents|protective agents|mesh-ancestor
56963894|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56963895|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56963896|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56963897|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
56963898|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56963899|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56963900|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56963901|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56963902|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963903|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
56963904|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
56963905|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56963906|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
56963907|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56963908|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963909|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56963910|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56963911|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56963912|NCT03768713|Suvorexant|suvorexant|mesh-list
56963913|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56963914|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56963915|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56963916|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963917|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56963918|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56963919|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963920|NCT02481076|Monensin|monensin|mesh-list
56963921|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
56963922|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963923|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56963924|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56963925|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
56963926|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
56963927|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
56963928|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963929|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963930|NCT02481076|Ionophores|ionophores|mesh-ancestor
56963931|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56963932|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
56963933|NCT05386888|Paclitaxel|paclitaxel|mesh-list
56963934|NCT05386888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56963935|NCT05386888|Carboplatin|carboplatin|mesh-list
56963936|NCT05386888|Pemetrexed|pemetrexed|mesh-list
56963937|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56963938|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884840|NCT04498468|Dexamethasone|dexamethasone|mesh-list
56963939|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56963940|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56963941|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56963942|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963943|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646260|NCT02821832|Rifampin|rifampin|mesh-list
56963944|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56963945|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56963946|NCT05713396|Losartan|losartan|mesh-list
56963947|NCT05713396|Quinapril|quinapril|mesh-list
56963948|NCT05713396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56963949|NCT05713396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56963950|NCT05713396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56963951|NCT05713396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56963952|NCT05713396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963953|NCT05713396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56963954|NCT05713396|Protease Inhibitors|protease inhibitors|mesh-ancestor
56963955|NCT05713396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963956|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
56963957|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
56963958|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963959|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56963960|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56963961|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963962|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
56963963|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56963964|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
56963965|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
56963966|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963967|NCT02475382|Nivolumab|nivolumab|mesh-list
56963968|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56963969|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963970|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56963971|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963972|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56963973|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
56963974|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56963975|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
56963976|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963977|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
56963978|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
56963979|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56963980|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
56963981|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56963982|NCT05371288|Protective Agents|protective agents|mesh-ancestor
56963983|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963984|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
56963985|NCT05371288|Vitamins|vitamins|mesh-ancestor
56963986|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
56963987|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
56963988|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56963989|NCT05371288|Expectorants|expectorants|mesh-ancestor
56963990|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56963991|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56963992|NCT05371288|Antidotes|antidotes|mesh-ancestor
56963993|NCT02478424|Cyclosporine|cyclosporine|mesh-list
56963994|NCT02478424|Methotrexate|methotrexate|mesh-list
56963995|NCT02478424|Cannabidiol|cannabidiol|mesh-list
56963996|NCT02478424|Cyclosporins|cyclosporins|mesh-list
56963997|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56963998|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
56963999|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56964000|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964001|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56964002|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
56964003|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964004|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964005|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
56964006|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964007|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56964008|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964009|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
56964010|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964011|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56884928|NCT01613118|Irbesartan|irbesartan|mesh-list
56964012|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
56964013|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964014|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56964015|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
56964016|NCT03712787|Tilavonemab|tilavonemab|mesh-list
56964017|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
56964018|NCT02478268|Xenon|xenon|mesh-list
56964019|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56964020|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
56964021|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
56964022|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964023|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964024|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
56964025|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964026|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
56964027|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964028|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964029|NCT03768557|Minocycline|minocycline|mesh-list
56964030|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56964031|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964032|NCT03783845|Amoxicillin|amoxicillin|mesh-list
56964033|NCT03783845|Metronidazole|metronidazole|mesh-list
56964034|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56964035|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964036|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56964037|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56964038|NCT01560689|Budesonide|budesonide|mesh-list
56964039|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
56964040|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56964041|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56964042|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
56964043|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964044|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964045|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56964046|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
56964047|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
56964048|NCT01560689|Hormones|hormones|mesh-ancestor
56964049|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964050|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56964051|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56964052|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56964053|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
56964054|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964055|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964056|NCT02474914|Octreotide|octreotide|mesh-list
56964057|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56964058|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56964059|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964060|NCT03769103|Osimertinib|osimertinib|mesh-list
56964061|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964062|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56964063|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964064|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964065|NCT04998214|Thrombin|thrombin|mesh-list
56964066|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
56964067|NCT04998214|Coagulants|coagulants|mesh-ancestor
56964068|NCT01309607|Paclitaxel|paclitaxel|mesh-list
56964069|NCT01309607|Carboplatin|carboplatin|mesh-list
56964070|NCT01309607|Lapatinib|lapatinib|mesh-list
56964071|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56964072|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964073|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
56964074|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
56964075|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
56964076|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964077|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56964078|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964079|NCT04967248|Fulvestrant|fulvestrant|mesh-list
56964080|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56964081|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964082|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56964083|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56964084|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
56964085|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964086|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964087|NCT05708638|Anesthetics|anesthetics|mesh-list
56964088|NCT05708638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964089|NCT05708638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964090|NCT04960618|Gemcitabine|gemcitabine|mesh-list
56964091|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
56964092|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56964093|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
56964094|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964095|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964096|NCT04960618|Antiviral Agents|antiviral agents|mesh-ancestor
56964104|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56964105|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
56964106|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964107|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
56964108|NCT03783455|Protective Agents|protective agents|mesh-ancestor
56964109|NCT05305066|Adalimumab|adalimumab|mesh-list
56964110|NCT05305066|Etanercept|etanercept|mesh-list
56964111|NCT05305066|Golimumab|golimumab|mesh-list
56964112|NCT05305066|Upadacitinib|upadacitinib|mesh-list
56964113|NCT05305066|Tofacitinib|tofacitinib|mesh-list
56964114|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56964115|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964116|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56964117|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56964118|NCT05305066|Analgesics|analgesics|mesh-ancestor
56964119|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
56964120|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964121|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964122|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56964123|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964124|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
56964125|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56964126|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964127|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964128|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56964129|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56964130|NCT05251714|Fulvestrant|fulvestrant|mesh-list
56964131|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56964132|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964133|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56964134|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56964135|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
56964136|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964137|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964138|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
56964139|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56964140|NCT02477956|Vitamin D|vitamin d|mesh-list
56964141|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
56964142|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
56964143|NCT02477956|Vitamins|vitamins|mesh-list
56964144|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
56964145|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964146|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56964147|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56964148|NCT02472574|Plasminogen|plasminogen|mesh-list
56964149|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56964150|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56964151|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56964152|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964153|NCT05708248|Pentoxifylline|pentoxifylline|mesh-list
56964154|NCT05708248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56964155|NCT05708248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964156|NCT05708248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964157|NCT05708248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56964158|NCT05708248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56964159|NCT05708248|Protective Agents|protective agents|mesh-ancestor
56964160|NCT05708248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964161|NCT05708248|Vasodilator Agents|vasodilator agents|mesh-ancestor
56964162|NCT05708248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56964163|NCT05708248|Antioxidants|antioxidants|mesh-ancestor
56646480|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56964185|NCT03772223|Albuterol|albuterol|mesh-list
56964186|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56964187|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56964188|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
56964189|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738025|NCT02735707|Tazobactam|tazobactam|mesh-list
56964190|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964191|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56964192|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
56964193|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
56964194|NCT03772223|Hormones|hormones|mesh-ancestor
56964195|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964196|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
56964197|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56964198|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56964199|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56964200|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56964201|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
56964202|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964203|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964204|NCT03783299|Lumefantrine|lumefantrine|mesh-list
56964205|NCT03783299|Artemether|artemether|mesh-list
56964206|NCT03783299|Primaquine|primaquine|mesh-list
56964207|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56964208|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
56964209|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56964210|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56964211|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964212|NCT03771755|Acetaminophen|acetaminophen|mesh-list
56964213|NCT03771755|Ibuprofen|ibuprofen|mesh-list
56964214|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56964215|NCT03771755|Analgesics|analgesics|mesh-ancestor
56964216|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
56964217|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964218|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964219|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
56964220|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56964221|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56964222|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964223|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56964224|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964225|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964226|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56964227|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
56964228|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56964229|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
56964230|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56964231|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964232|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56964233|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56964234|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964235|NCT05432531|Cyclophosphamide|cyclophosphamide|mesh-list
56964236|NCT05432531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964237|NCT05432531|Immunologic Factors|immunologic factors|mesh-ancestor
56964238|NCT05432531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964239|NCT05432531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964240|NCT05432531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56964241|NCT05432531|Alkylating Agents|alkylating agents|mesh-ancestor
56964242|NCT05432531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964243|NCT05432531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964244|NCT05432531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56964245|NCT01309685|Varenicline|varenicline|mesh-list
56964246|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56964247|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56964248|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
56964249|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964250|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964251|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964252|NCT03782987|Itraconazole|itraconazole|mesh-list
56964253|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
56964254|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964255|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56964256|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56964257|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964258|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964259|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56964260|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
56964261|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964262|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885125|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56964263|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56964264|NCT03972527|Analgesics|analgesics|mesh-list
56964265|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
56964266|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964267|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964268|NCT03772067|Insulin|insulin|mesh-list
56964269|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56964270|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56964271|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56964272|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964273|NCT03772067|Incretins|incretins|mesh-ancestor
56964274|NCT03772067|Hormones|hormones|mesh-ancestor
56964275|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964276|NCT03771677|Interferons|interferons|mesh-list
56964277|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
56964278|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
56964279|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964280|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
56964281|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964282|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
56964283|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964284|NCT03783065|Propranolol|propranolol|mesh-list
56964285|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56964286|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56964287|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
56964288|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964289|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964290|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964291|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56964292|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56964293|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
56964294|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
56964295|NCT03766997|Betamethasone|betamethasone|mesh-list
56964296|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
56964297|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56964298|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
56964299|NCT03766997|Hormones|hormones|mesh-ancestor
56964300|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964301|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964302|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56964303|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
56964304|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
56964305|NCT03782831|Antibodies|antibodies|mesh-list
56964306|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
56964307|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964308|NCT05539391|Rocuronium|rocuronium|mesh-list
56964309|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56964310|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56964311|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56964312|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964313|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964314|NCT03766607|Paclitaxel|paclitaxel|mesh-list
56964315|NCT03766607|Trastuzumab|trastuzumab|mesh-list
56964316|NCT03766607|Ramucirumab|ramucirumab|mesh-list
56964317|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56964318|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964319|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
56964320|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
56964321|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
56964322|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964323|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56964324|NCT01567709|Vorinostat|vorinostat|mesh-list
56964325|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964326|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56964327|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964328|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964329|NCT03765827|Vitamins|vitamins|mesh-list
56964330|NCT03765827|Vitamin E|vitamin e|mesh-list
56964331|NCT03765827|Tocopherols|tocopherols|mesh-list
56964332|NCT03765827|Tocotrienols|tocotrienols|mesh-list
56964333|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
56964334|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
56964335|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964336|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
55891120|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56964337|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964338|NCT03765827|Protective Agents|protective agents|mesh-ancestor
56964339|NCT04384367|Naproxen|naproxen|mesh-list
56964340|NCT04384367|Rizatriptan|rizatriptan|mesh-list
56964341|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56964342|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56964343|NCT04384367|Analgesics|analgesics|mesh-ancestor
56964344|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
56964345|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964346|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964347|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56964348|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964349|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
56964350|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56964351|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964352|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964353|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56964354|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
56964355|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964356|NCT03771053|Simvastatin|simvastatin|mesh-list
56964357|NCT03771053|Ezetimibe|ezetimibe|mesh-list
56964358|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56964359|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56964360|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
56964361|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964362|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56964363|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56964364|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964365|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
56964366|NCT03770663|Azathioprine|azathioprine|mesh-list
56964367|NCT03770663|Tacrolimus|tacrolimus|mesh-list
56964368|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964369|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
56964370|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964371|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964372|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56964373|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
56964374|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964375|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964376|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56964377|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56964378|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964379|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
56964380|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56964381|NCT03048422|Tenofovir|tenofovir|mesh-list
56964382|NCT03048422|Emtricitabine|emtricitabine|mesh-list
56964383|NCT03048422|Efavirenz|efavirenz|mesh-list
56964384|NCT03048422|Dolutegravir|dolutegravir|mesh-list
56964385|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56964386|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56964387|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56964388|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
56964389|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964390|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56964391|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56964392|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964393|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964394|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56964395|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56964396|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56964397|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56964398|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56964399|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56964400|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56964401|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56964402|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56964403|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56964404|NCT01561781|Digoxin|digoxin|mesh-list
56964405|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56964406|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56964407|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964408|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964409|NCT01561781|Protective Agents|protective agents|mesh-ancestor
56964410|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964411|NCT04259255|Edaravone|edaravone|mesh-list
56964412|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56964413|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
56964414|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964415|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56964416|NCT04259255|Protective Agents|protective agents|mesh-ancestor
56964417|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964418|NCT03770039|PF-06700841|pf-06700841|mesh-list
56964419|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56964420|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964421|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964422|NCT01321775|Paclitaxel|paclitaxel|mesh-list
56964423|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
56964424|NCT01321775|Bevacizumab|bevacizumab|mesh-list
56964425|NCT01321775|Trastuzumab|trastuzumab|mesh-list
56964426|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56964427|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964428|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
56964429|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
56964430|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
56964431|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964432|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964433|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
56964434|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964435|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964436|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56964437|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
56964438|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56964439|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56964440|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56964441|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56964442|NCT01321775|Growth Substances|growth substances|mesh-ancestor
56964443|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
56964444|NCT05514509|Cabotegravir|cabotegravir|mesh-list
56964445|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56964446|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56964447|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964448|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964449|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56964450|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56964451|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
56964452|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964453|NCT03764267|Lidocaine|lidocaine|mesh-list
56964454|NCT03764267|Remifentanil|remifentanil|mesh-list
56964455|NCT03764267|Anesthetics|anesthetics|mesh-list
56964456|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
56964457|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
56964458|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964459|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964460|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
56964461|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964462|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56964463|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56964464|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56964465|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56964466|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964467|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56964468|NCT03764267|Narcotics|narcotics|mesh-ancestor
56964469|NCT03764267|Analgesics|analgesics|mesh-ancestor
56964470|NCT01321931|Nicotine|nicotine|mesh-list
56964471|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56964472|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
56964473|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964474|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964475|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56964476|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56964477|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
56964478|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964479|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964480|NCT03763409|Losartan|losartan|mesh-list
56964481|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56964482|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56964483|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56964484|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56964485|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964486|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56964487|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56964488|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964489|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
56964490|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56964491|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964492|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964493|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56964494|NCT03762785|Analgesics|analgesics|mesh-ancestor
56964495|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
56964496|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964497|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56964498|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56964499|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56964500|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
56964501|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964502|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964503|NCT03758729|Nivolumab|nivolumab|mesh-list
56964504|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56964505|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964506|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56964507|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964508|NCT03756623|Metformin|metformin|mesh-list
56964509|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56964510|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964511|NCT03599453|Interferons|interferons|mesh-list
56964512|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
56964513|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
56964514|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56964515|NCT03599453|Poly I-C|poly i-c|mesh-list
56964516|NCT03599453|Celecoxib|celecoxib|mesh-list
56964517|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
56964518|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
56964519|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
56964520|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
56964521|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56964522|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964523|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
56964524|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964525|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
56964526|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964527|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56964528|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56964529|NCT03599453|Analgesics|analgesics|mesh-ancestor
56964530|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
56964531|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964532|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56964533|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964534|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56964535|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56964536|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964537|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964538|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
56964539|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56964540|NCT03756233|Remifentanil|remifentanil|mesh-list
56964541|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56964542|NCT03756233|Narcotics|narcotics|mesh-ancestor
56964543|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646862|NCT05000658|Hormones|hormones|mesh-ancestor
56964544|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964545|NCT03756233|Analgesics|analgesics|mesh-ancestor
56964546|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
56964547|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964548|NCT03758339|Tucatinib|tucatinib|mesh-list
56964549|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964550|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56964551|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964552|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964553|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
56964554|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
56964555|NCT03565913|Calcium|calcium|mesh-list
56964556|NCT03565913|Calcium acetate|calcium acetate|mesh-list
56964557|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56964558|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964559|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56964560|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
56964561|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
56964562|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964563|NCT03565913|Cathartics|cathartics|mesh-ancestor
56964564|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56964565|NCT05085665|Ivermectin|ivermectin|mesh-list
56964566|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56964567|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964568|NCT05004077|Amiodarone|amiodarone|mesh-list
56964569|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56964570|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
56964571|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56964572|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56964573|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964574|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56964575|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56964576|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56964577|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964578|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56964579|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56964580|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56964581|NCT03755609|Fentanyl|fentanyl|mesh-list
56964582|NCT03755609|Oxycodone|oxycodone|mesh-list
56964583|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56964584|NCT03755609|Narcotics|narcotics|mesh-ancestor
56964585|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964586|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964587|NCT03755609|Analgesics|analgesics|mesh-ancestor
56964588|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
56964589|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964590|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56964591|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56964592|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
56964593|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
56964594|NCT02928224|Leucovorin|leucovorin|mesh-list
56964595|NCT02928224|Folic Acid|folic acid|mesh-list
56964596|NCT02928224|Fluorouracil|fluorouracil|mesh-list
56964597|NCT02928224|Irinotecan|irinotecan|mesh-list
56964598|NCT02928224|Cetuximab|cetuximab|mesh-list
56964599|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
56964600|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
56964601|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964602|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56964603|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964604|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964605|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
56964606|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964607|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56964608|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56964609|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964610|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56964611|NCT02928224|Antidotes|antidotes|mesh-ancestor
56964612|NCT02928224|Protective Agents|protective agents|mesh-ancestor
56964613|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
56964614|NCT02928224|Vitamins|vitamins|mesh-ancestor
56964615|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
56964616|NCT02928224|Hematinics|hematinics|mesh-ancestor
56964617|NCT03760445|Cytarabine|cytarabine|mesh-list
56964618|NCT03760445|Posaconazole|posaconazole|mesh-list
56964619|NCT03760445|Daunorubicin|daunorubicin|mesh-list
56964620|NCT03760445|Idarubicin|idarubicin|mesh-list
56964621|NCT03760445|Midostaurin|midostaurin|mesh-list
56964622|NCT03760445|Midazolam|midazolam|mesh-list
56964623|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56964624|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
56964625|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964626|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964627|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
56964628|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964629|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964630|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
56964631|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964632|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56964633|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56964634|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964635|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56964636|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56964637|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56964638|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56964639|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
56964640|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
56964641|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
56964642|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
56964643|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964644|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56964645|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56964646|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56964647|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964648|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
56964649|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56964650|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56964651|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56964652|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56964653|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56964654|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56964655|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
56964656|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964657|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56964658|NCT05460377|Vaccines|vaccines|mesh-list
56964659|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
56964660|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964661|NCT04956575|Vaccines|vaccines|mesh-list
56964662|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
56964663|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964664|NCT05692856|Clenbuterol|clenbuterol|mesh-list
56964665|NCT05692856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56964666|NCT05692856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56964667|NCT05692856|Adrenergic Agents|adrenergic agents|mesh-ancestor
56964668|NCT05692856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964669|NCT05692856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964670|NCT05692856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964671|NCT05692856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56964672|NCT05692856|Autonomic Agents|autonomic agents|mesh-ancestor
56964673|NCT05692856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964674|NCT05692856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56964675|NCT05692856|Respiratory System Agents|respiratory system agents|mesh-ancestor
56964676|NCT05692856|Sympathomimetics|sympathomimetics|mesh-ancestor
56964677|NCT05432804|Temozolomide|temozolomide|mesh-list
56964678|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56964679|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
56964680|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964681|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964682|NCT04300556|Farletuzumab|farletuzumab|mesh-list
56964683|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964684|NCT03755531|Oxytocin|oxytocin|mesh-list
56964685|NCT03755531|Carbetocin|carbetocin|mesh-list
56964686|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
56964687|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56964688|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964689|NCT04854707|Menotropins|menotropins|mesh-list
56964690|NCT04854707|Hormones|hormones|mesh-list
56964691|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56964692|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964693|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964694|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56964695|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
56964696|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56647001|NCT04315350|Analgesics|analgesics|mesh-ancestor
56964697|NCT03215069|Empagliflozin|empagliflozin|mesh-list
56964698|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56964699|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964700|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56964701|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964702|NCT03759353|Lactoferrin|lactoferrin|mesh-list
56964703|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964704|NCT03757559|Hydromorphone|hydromorphone|mesh-list
56964705|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56964706|NCT03757559|Narcotics|narcotics|mesh-ancestor
56964707|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964708|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964709|NCT03757559|Analgesics|analgesics|mesh-ancestor
56964710|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
56964711|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885576|NCT01092039|Lactoferrin|lactoferrin|mesh-list
56964712|NCT05668949|Pembrolizumab|pembrolizumab|mesh-list
56964713|NCT05668949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56964714|NCT05668949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964715|NCT05415917|Gemcitabine|gemcitabine|mesh-list
56964716|NCT05415917|Capecitabine|capecitabine|mesh-list
56964717|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56964718|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
56964719|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964720|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964721|NCT05415917|Antiviral Agents|antiviral agents|mesh-ancestor
56964722|NCT05415917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964723|NCT05415917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964724|NCT05415917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964725|NCT05415917|Immunologic Factors|immunologic factors|mesh-ancestor
56964726|NCT05415917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964727|NCT04792073|Avelumab|avelumab|mesh-list
56964728|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56964729|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964730|NCT02780804|Entinostat|entinostat|mesh-list
56964731|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964732|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56964733|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964734|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964735|NCT01322711|Atorvastatin|atorvastatin|mesh-list
56964736|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56964737|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56964738|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
56964739|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964740|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56964741|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56964742|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964743|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56964744|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56964745|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964746|NCT03041792|Liraglutide|liraglutide|mesh-list
56964747|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56964748|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964749|NCT03041792|Incretins|incretins|mesh-ancestor
56964750|NCT03041792|Hormones|hormones|mesh-ancestor
56964751|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964752|NCT03753581|Cytarabine|cytarabine|mesh-list
56964753|NCT03753581|Methotrexate|methotrexate|mesh-list
56964754|NCT03753581|Etoposide|etoposide|mesh-list
56964755|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56964756|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
56964757|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964758|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964759|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
56964760|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964761|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964762|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
56964763|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964764|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56964765|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56964766|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56964767|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964768|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56964769|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
56964770|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56964771|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
56964772|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56964773|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964774|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56964775|NCT04507763|Etanercept|etanercept|mesh-list
56964776|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56964777|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56964778|NCT04507763|Analgesics|analgesics|mesh-ancestor
56964779|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
56964780|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964781|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964782|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56964783|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964784|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56964785|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964786|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
56964787|NCT00705484|Infliximab|infliximab|mesh-list
56964788|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56964789|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56964790|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964791|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
56964792|NCT05358626|Antibodies|antibodies|mesh-list
56964793|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
56964794|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
56964795|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964796|NCT03753269|Fasudil|fasudil|mesh-list
56964797|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56964798|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56964799|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964800|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56964801|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964802|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
56964803|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56964804|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964805|NCT05459441|Pemetrexed|pemetrexed|mesh-list
56964806|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964807|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964808|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964809|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56964810|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56964811|NCT04523831|Doxycycline|doxycycline|mesh-list
56964812|NCT04523831|Ivermectin|ivermectin|mesh-list
56964813|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56964814|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964815|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
56964816|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56964817|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56964818|NCT05691764|Cyclosporine|cyclosporine|mesh-list
56964819|NCT05691764|Cyclosporins|cyclosporins|mesh-list
56964820|NCT05691764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964821|NCT05691764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964822|NCT05691764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964823|NCT05691764|Immunologic Factors|immunologic factors|mesh-ancestor
56964824|NCT05691764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964825|NCT05691764|Antifungal Agents|antifungal agents|mesh-ancestor
56964826|NCT05691764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964827|NCT05691764|Dermatologic Agents|dermatologic agents|mesh-ancestor
56964828|NCT05691764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964829|NCT05691764|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56964830|NCT05275907|Amlodipine|amlodipine|mesh-list
56964831|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
56964832|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56964833|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56964834|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56964835|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964836|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56964837|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964838|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
56964839|NCT05275907|Diuretics|diuretics|mesh-ancestor
56964840|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
56964841|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56964842|NCT04707664|Sargramostim|sargramostim|mesh-list
56964843|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
56964844|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964845|NCT01316276|Amikacin|amikacin|mesh-list
56964846|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56964847|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964848|NCT02474290|Sorafenib|sorafenib|mesh-list
56964849|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964850|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56964851|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964852|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964853|NCT02474212|Enoxaparin|enoxaparin|mesh-list
56964854|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
56964855|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56964856|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56964857|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964858|NCT05200286|Olorofim|olorofim|mesh-list
56964859|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
56964860|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964861|NCT02474446|Vitamin D|vitamin d|mesh-list
56964862|NCT02474446|Vitamins|vitamins|mesh-ancestor
56964863|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
56964864|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964865|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56964866|NCT05199818|Palonosetron|palonosetron|mesh-list
56964867|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
56964868|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
56964869|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964870|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964871|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56964872|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56964873|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56964874|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
56964875|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964876|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964877|NCT02474134|Interferons|interferons|mesh-list
56964878|NCT02474134|Interferon-beta|interferon-beta|mesh-list
56964879|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
56964880|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964881|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
56964882|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964883|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
56964884|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964885|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56964886|NCT02473900|Oseltamivir|oseltamivir|mesh-list
56964887|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
56964888|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964889|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964890|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964891|NCT02471950|Isoflurane|isoflurane|mesh-list
56964892|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56964893|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
56964894|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
56964895|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964896|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964897|NCT01322867|Alprazolam|alprazolam|mesh-list
56964898|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56964899|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964900|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964901|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56964902|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56964903|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56964904|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
56964905|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
56964906|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964907|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964908|NCT05597722|Amphetamine|amphetamine|mesh-list
56964909|NCT05597722|Adderall|adderall|mesh-list
56964910|NCT05597722|Dextroamphetamine|dextroamphetamine|mesh-list
56964911|NCT05597722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56964912|NCT05597722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964913|NCT05597722|Sympathomimetics|sympathomimetics|mesh-ancestor
56964914|NCT05597722|Autonomic Agents|autonomic agents|mesh-ancestor
56964915|NCT05597722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964916|NCT05597722|Dopamine Agents|dopamine agents|mesh-ancestor
56964917|NCT05597722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56964918|NCT05597722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964919|NCT05597722|Adrenergic Agents|adrenergic agents|mesh-ancestor
56964920|NCT05597722|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56964921|NCT05597722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56964922|NCT05597722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56964923|NCT05597722|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56964924|NCT04624828|Androgens|androgens|mesh-list
56964925|NCT04624828|Hormones|hormones|mesh-ancestor
56964926|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964927|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964928|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56964929|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
56964930|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964931|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
56964932|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964933|NCT02477488|Allopurinol|allopurinol|mesh-list
56964934|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
56964935|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964936|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964937|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
56964938|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56964939|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56964940|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
56964941|NCT02477488|Protective Agents|protective agents|mesh-ancestor
56964942|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964943|NCT05163106|Letrozole|letrozole|mesh-list
56964944|NCT05163106|Goserelin|goserelin|mesh-list
56964945|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964946|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56964947|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56964948|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964949|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964950|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56964951|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
56964952|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56964953|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964954|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56964955|NCT05589844|Vaccines|vaccines|mesh-list
56964956|NCT05589844|Immunologic Factors|immunologic factors|mesh-ancestor
56964957|NCT05589844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964958|NCT02477098|Ropivacaine|ropivacaine|mesh-list
56964959|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
56964960|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
56964961|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964962|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964963|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
56964964|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964965|NCT04518046|Nivolumab|nivolumab|mesh-list
56964966|NCT04518046|Ipilimumab|ipilimumab|mesh-list
56964967|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56964968|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964969|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56964970|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964971|NCT05571670|Sirolimus|sirolimus|mesh-list
56964972|NCT05571670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964973|NCT05571670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56964974|NCT05571670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964975|NCT05571670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56964976|NCT05571670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56964977|NCT05571670|Antifungal Agents|antifungal agents|mesh-ancestor
56964978|NCT05571670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964979|NCT05571670|Immunologic Factors|immunologic factors|mesh-ancestor
56964980|NCT02473354|Remifentanil|remifentanil|mesh-list
56964981|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56964982|NCT02473354|Narcotics|narcotics|mesh-ancestor
56964983|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56964984|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964985|NCT02473354|Analgesics|analgesics|mesh-ancestor
56964986|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
56964987|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56964988|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
56964989|NCT02470858|Asunaprevir|asunaprevir|mesh-list
56964990|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
56964991|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964992|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
56964993|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964994|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964995|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56964996|NCT02473198|Morphine|morphine|mesh-list
56964997|NCT02473198|Bupivacaine|bupivacaine|mesh-list
56964998|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
56964999|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
56965000|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965001|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965002|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
56965003|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965004|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56965005|NCT02473198|Narcotics|narcotics|mesh-ancestor
56965006|NCT02473198|Analgesics|analgesics|mesh-ancestor
56965007|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56965008|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56965009|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965010|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965011|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56965012|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965013|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965014|NCT03614728|Azacitidine|azacitidine|mesh-list
56965015|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
56965016|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56965017|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
56965018|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965019|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965020|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965021|NCT05069974|Linezolid|linezolid|mesh-list
56965022|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56965023|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965024|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56965025|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965026|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965027|NCT05190770|Triamcinolone|triamcinolone|mesh-list
56965028|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56965029|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56965030|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56965031|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965032|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
56965033|NCT05190770|Hormones|hormones|mesh-ancestor
56965034|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56965035|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965036|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56965037|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
56965038|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965039|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965040|NCT05336266|Ketorolac|ketorolac|mesh-list
56965041|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56965042|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56965043|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56965044|NCT05336266|Analgesics|analgesics|mesh-ancestor
56965045|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
56965046|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965047|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965048|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965049|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965050|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56965051|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965052|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965053|NCT02470780|Rifaximin|rifaximin|mesh-list
56965054|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56965055|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965056|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56965057|NCT04283500|Buprenorphine|buprenorphine|mesh-list
56965058|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56965059|NCT04283500|Naloxone|naloxone|mesh-list
56965060|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56965061|NCT04283500|Narcotics|narcotics|mesh-ancestor
56965062|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965063|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965064|NCT04283500|Analgesics|analgesics|mesh-ancestor
56965065|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
56965066|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965067|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56965068|NCT05180292|Carvedilol|carvedilol|mesh-list
56965069|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56965070|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56965071|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
56965072|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965073|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965074|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965075|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56965077|NCT05180292|Protective Agents|protective agents|mesh-ancestor
56965078|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56965079|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56965080|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56965081|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
56965082|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56965083|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56965084|NCT01315938|Abatacept|abatacept|mesh-list
56965085|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56965086|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965087|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965088|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56965089|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
56965090|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965091|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965092|NCT01339884|Resveratrol|resveratrol|mesh-list
56965093|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
56965094|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965095|NCT01339884|Protective Agents|protective agents|mesh-ancestor
56965096|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965097|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965098|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56965099|NCT04736394|Epirubicin|epirubicin|mesh-list
56965100|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56965101|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965102|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56965103|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56965104|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965105|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965106|NCT01341834|Everolimus|everolimus|mesh-list
56965107|NCT01341834|Panobinostat|panobinostat|mesh-list
56965108|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965109|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56965110|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
56965111|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965112|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56965113|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965114|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965115|NCT01340118|Budesonide|budesonide|mesh-list
56965116|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965117|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56965118|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
56965119|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965120|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965121|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56965122|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
56965123|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
56965124|NCT01340118|Hormones|hormones|mesh-ancestor
56965125|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56965126|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
56965127|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56965128|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56965129|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56965130|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965131|NCT02470702|Oritavancin|oritavancin|mesh-list
56965132|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56965133|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965134|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56965135|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
56965136|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56965137|NCT04409964|Lidocaine|lidocaine|mesh-list
56965138|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
56965139|NCT04409964|Remifentanil|remifentanil|mesh-list
56965140|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
56965141|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
56965142|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965143|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965144|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
56965145|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965146|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56965147|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56965148|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56965149|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56965150|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965151|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56965152|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56965153|NCT04409964|Analgesics|analgesics|mesh-ancestor
56965154|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56965155|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56965156|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56965157|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
56965158|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965159|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56965160|NCT04409964|Narcotics|narcotics|mesh-ancestor
56965161|NCT01342146|Hormones|hormones|mesh-list
56965162|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891121|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
56965163|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965164|NCT03212716|Oseltamivir|oseltamivir|mesh-list
56965165|NCT03212716|Diltiazem|diltiazem|mesh-list
56965166|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
56965167|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965168|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965169|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965170|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56965171|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56965172|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56965173|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56965174|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965175|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
56965176|NCT04762836|Cycloserine|cycloserine|mesh-list
56965177|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56965178|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965179|NCT04762836|Renal Agents|renal agents|mesh-ancestor
56965180|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56965181|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
56965182|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56965183|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
56965184|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965185|NCT00705406|Peramivir|peramivir|mesh-list
56965186|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
56965187|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965188|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965189|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965190|NCT01342224|Gemcitabine|gemcitabine|mesh-list
56965191|NCT01342224|Tadalafil|tadalafil|mesh-list
56965192|NCT01342224|Sargramostim|sargramostim|mesh-list
56965193|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
56965194|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965195|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56965196|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
56965197|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965198|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965199|NCT01342224|Antiviral Agents|antiviral agents|mesh-ancestor
56965200|NCT01342224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965201|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965202|NCT01342224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56965203|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
56965204|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56965205|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56965206|NCT01342224|Urological Agents|urological agents|mesh-ancestor
56965207|NCT03155178|Ethanol|ethanol|mesh-list
56965208|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
56965209|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56965210|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56965211|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965212|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965213|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965214|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
56965215|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56965216|NCT02470546|Metformin|metformin|mesh-list
56965217|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56965218|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965219|NCT03310762|Silicon|silicon|mesh-list
56965220|NCT03310762|Trace Elements|trace elements|mesh-ancestor
56965221|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
56965222|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965223|NCT03173950|Nivolumab|nivolumab|mesh-list
56965224|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56965225|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965226|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56965227|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965229|NCT03310606|Lactams|lactams|mesh-list
56965230|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965231|NCT01315704|Vitamin D|vitamin d|mesh-list
56965232|NCT01315704|Vitamins|vitamins|mesh-ancestor
56965233|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
56965234|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965235|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56965236|NCT03107884|Metformin|metformin|mesh-list
56965237|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56965238|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965239|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
56965240|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886099|NCT03679780|Nitroprusside|nitroprusside|mesh-list
56965241|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
56965242|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965243|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965244|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56965245|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
56965246|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965247|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965248|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56965249|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
56965250|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56965251|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
56965252|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965253|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
56965254|NCT04702776|Protective Agents|protective agents|mesh-ancestor
56965255|NCT03310372|Temozolomide|temozolomide|mesh-list
56965256|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56965257|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
56965258|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965259|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965260|NCT02980276|Metformin|metformin|mesh-list
56965261|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56965262|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965263|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56965264|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56965265|NCT01342614|Metformin|metformin|mesh-list
56965266|NCT01342614|Fosinopril|fosinopril|mesh-list
56965267|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56965268|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965269|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56965270|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
56965271|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965272|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965273|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56965274|NCT01342692|Lenalidomide|lenalidomide|mesh-list
56965275|NCT01342692|Azacitidine|azacitidine|mesh-list
56965276|NCT01342692|Idarubicin|idarubicin|mesh-list
56965277|NCT01342692|Valproic Acid|valproic acid|mesh-list
56965278|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
56965279|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965280|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56965281|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56965282|NCT01342692|Growth Substances|growth substances|mesh-ancestor
56965283|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
56965284|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965285|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56965286|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
56965287|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965288|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965289|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
56965290|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
56965291|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965292|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
56965293|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56965294|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965295|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56965296|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56965297|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56965298|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56965299|NCT05153772|Octreotide|octreotide|mesh-list
56965300|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56965301|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56965302|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965303|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
56965304|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56965305|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56965306|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56965307|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965308|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
56965309|NCT03310060|Coagulants|coagulants|mesh-ancestor
56965311|NCT03879694|Sargramostim|sargramostim|mesh-list
56965312|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56965313|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
56965314|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
56965315|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965316|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886179|NCT03680404|Tempol|tempol|mesh-list
56965317|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56965318|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56965319|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56965320|NCT02520778|Osimertinib|osimertinib|mesh-list
56965321|NCT02520778|Navitoclax|navitoclax|mesh-list
56965322|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965323|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56965324|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965325|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965326|NCT03740958|Argatroban|argatroban|mesh-list
56965327|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
56965328|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56965329|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
56965330|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965331|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965332|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
56965333|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56965334|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
56965335|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56965336|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
56965337|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965338|NCT03685188|Sufentanil|sufentanil|mesh-list
56965339|NCT03685188|Oxycodone|oxycodone|mesh-list
56965340|NCT03685188|Dsuvia|dsuvia|mesh-list
56965341|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56965342|NCT03685188|Narcotics|narcotics|mesh-ancestor
56965343|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965344|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965345|NCT03685188|Analgesics|analgesics|mesh-ancestor
56965346|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
56965347|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965348|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56965349|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56965350|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
56965351|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
56965352|NCT02305654|Paclitaxel|paclitaxel|mesh-list
56965353|NCT02305654|Ifosfamide|ifosfamide|mesh-list
56965354|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56965355|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965356|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
56965357|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
56965358|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
56965359|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965360|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56965361|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
56965362|NCT05251584|Gentamicins|gentamicins|mesh-list
56965363|NCT05251584|Mupirocin|mupirocin|mesh-list
56965364|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56965365|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965366|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56965367|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965368|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965369|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
56965370|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56965371|NCT02108860|Abatacept|abatacept|mesh-list
56965372|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56965373|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965374|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965375|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56965376|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
56965377|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965379|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56965380|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56965381|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
56965382|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965383|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965384|NCT03309592|Ambrisentan|ambrisentan|mesh-list
56965385|NCT03309592|Tadalafil|tadalafil|mesh-list
56965386|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
56965387|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56965388|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56965389|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965390|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965391|NCT03309592|Urological Agents|urological agents|mesh-ancestor
56965392|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56965393|NCT01434316|Veliparib|veliparib|mesh-list
56965394|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56965395|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965396|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965397|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965398|NCT04641312|Dulaglutide|dulaglutide|mesh-list
56965399|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56965400|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965401|NCT03078192|Xenon|xenon|mesh-list
56965402|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56965403|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
56965404|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
56965405|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965406|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965407|NCT00703846|Ketoconazole|ketoconazole|mesh-list
56965408|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
56965409|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965410|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56965411|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56965412|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965413|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965414|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56965415|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
56965416|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56965417|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965418|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56965419|NCT05130060|Trifluridine|trifluridine|mesh-list
56965420|NCT05130060|Vaccines|vaccines|mesh-list
56965421|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
56965422|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965423|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
56965424|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965425|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
56965426|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965427|NCT03309436|Clomiphene|clomiphene|mesh-list
56965428|NCT03309436|Enclomiphene|enclomiphene|mesh-list
56965429|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
56965430|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56965431|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
56965432|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56965433|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965434|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56965435|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
56965436|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56965437|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56965438|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56965439|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
56965440|NCT05183334|Tramadol|tramadol|mesh-list
56965441|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
56965442|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56965443|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56965444|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965445|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965446|NCT05183334|Urological Agents|urological agents|mesh-ancestor
56965447|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56965448|NCT05183334|Narcotics|narcotics|mesh-ancestor
56965449|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647745|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56965450|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965451|NCT05183334|Analgesics|analgesics|mesh-ancestor
56965452|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
56965453|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965454|NCT03304444|Bupivacaine|bupivacaine|mesh-list
56965455|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
56965456|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
56965457|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965458|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965459|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
56965460|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965462|NCT03304288|Tretinoin|tretinoin|mesh-list
56965463|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56965464|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965465|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
56965466|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886324|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
56965467|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965468|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
56965469|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
56965470|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56965471|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965472|NCT03313960|Insulin|insulin|mesh-list
56965473|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56965474|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965475|NCT03308890|Entecavir|entecavir|mesh-list
56965476|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
56965477|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965478|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56965479|NCT03313726|Hormones|hormones|mesh-ancestor
56965480|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56965481|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965482|NCT03303976|Vaccines|vaccines|mesh-list
56965483|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56965484|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
56965485|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965486|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
56965487|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56965488|NCT03313414|Velpatasvir|velpatasvir|mesh-list
56965489|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
56965490|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965491|NCT02468518|Vitamin E|vitamin e|mesh-list
56965492|NCT02468518|Vitamins|vitamins|mesh-ancestor
56965493|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
56965494|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965495|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
56965496|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965497|NCT02468518|Protective Agents|protective agents|mesh-ancestor
56965498|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56965499|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
56965500|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
56965501|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965502|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965503|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
56965504|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965505|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56965506|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
56965507|NCT05262322|Apixaban|apixaban|mesh-list
56965508|NCT05262322|Edoxaban|edoxaban|mesh-list
56965509|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56965510|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
56965511|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56965512|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
56965513|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965514|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965515|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
56965516|NCT04490980|Butorphanol|butorphanol|mesh-list
56965517|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56965518|NCT04490980|Narcotics|narcotics|mesh-ancestor
56965519|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965520|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965521|NCT04490980|Analgesics|analgesics|mesh-ancestor
56965522|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
56965523|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965524|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
56965525|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
56647834|NCT00616538|Xhance|xhance|mesh-list
56965549|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965550|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965551|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965552|NCT01314872|Urological Agents|urological agents|mesh-ancestor
56965553|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56965554|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56965555|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56965556|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56965557|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965558|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
56965559|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965560|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965561|NCT00703924|Paromomycin|paromomycin|mesh-list
56965562|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56965563|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965564|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56965565|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56965566|NCT03302650|Norepinephrine|norepinephrine|mesh-list
56965567|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
56965568|NCT03302650|Giapreza|giapreza|mesh-list
56965569|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
56965570|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56965571|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56965572|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
56965573|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965574|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965575|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965576|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
56965577|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
56965578|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965579|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56965580|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56965581|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
56965582|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647893|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56965602|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56965603|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965604|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965605|NCT03312478|Antibodies|antibodies|mesh-list
56965606|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965607|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
56965608|NCT03312244|Bromides|bromides|mesh-list
56965609|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56965610|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
56965611|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56965612|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965613|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965614|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
56965615|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965616|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965617|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
56965618|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56965619|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56965620|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56965621|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56965622|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965623|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
56965624|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965625|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965626|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56965627|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965628|NCT00739050|Simvastatin|simvastatin|mesh-list
56965629|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56965630|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56965631|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
56965632|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965633|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56965634|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56965635|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965636|NCT03302182|Ritonavir|ritonavir|mesh-list
56965637|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56965638|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56965639|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
56965640|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965641|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965642|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56965643|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56965644|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
56965645|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965646|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56965647|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56965648|NCT01343862|Cycloserine|cycloserine|mesh-list
56965649|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56965650|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965651|NCT01343862|Renal Agents|renal agents|mesh-ancestor
56965652|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56965653|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
56965654|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56965655|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
56965656|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965657|NCT00604812|Rizatriptan|rizatriptan|mesh-list
56965658|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56965659|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
56965660|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965661|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965662|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965663|NCT04347408|Antibodies|antibodies|mesh-list
56965664|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
56965665|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965666|NCT03306550|Aspirin|aspirin|mesh-list
56965667|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56965668|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56965669|NCT03306550|Analgesics|analgesics|mesh-ancestor
56965670|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
56965671|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965672|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965673|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965674|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965675|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56965676|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56965677|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965678|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56965679|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56965680|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965682|NCT03306472|Letrozole|letrozole|mesh-list
56965683|NCT03306472|Megestrol|megestrol|mesh-list
56965684|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
56965685|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965686|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56965687|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56965688|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965689|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965690|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56965691|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
56965692|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56965693|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965694|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56965695|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56965696|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56965697|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
56965698|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56965699|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56965700|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56965701|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56965702|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
56965703|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56965704|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
56965705|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56965706|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965707|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56965708|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56965709|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965710|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
56965711|NCT03311464|Adalimumab|adalimumab|mesh-list
56965712|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965713|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965714|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
56965715|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
56965716|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965717|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56965718|NCT05211024|Penicillins|penicillins|mesh-list
56965719|NCT05211024|Penicillin G|penicillin g|mesh-list
56965720|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56965721|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
56965722|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56965723|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965724|NCT02468206|Polidocanol|polidocanol|mesh-list
56965725|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56965726|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56965727|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
56965728|NCT03233854|Fludarabine|fludarabine|mesh-list
56965729|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
56965730|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56965731|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
56965732|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965733|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965734|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56965735|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
56965736|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965737|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965738|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56965739|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56965740|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
56965741|NCT01344174|Lamivudine|lamivudine|mesh-list
56965742|NCT01344174|Dexamethasone|dexamethasone|mesh-list
56965743|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965744|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
56965745|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
56965746|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648045|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
56965747|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965748|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56965750|NCT01344174|Hormones|hormones|mesh-ancestor
56965751|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56965752|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56965753|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965754|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56965755|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56965756|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965757|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965758|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
56965759|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965760|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56965761|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56965762|NCT05162274|Lazertinib|lazertinib|mesh-list
56965763|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56965764|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965765|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965766|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56965767|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
56965768|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
56965769|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965770|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56965771|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56965772|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56965773|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965774|NCT02468908|Molgramostim|molgramostim|mesh-list
56965775|NCT02468908|Sargramostim|sargramostim|mesh-list
56965776|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
56965777|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965778|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965779|NCT02468128|Nalbuphine|nalbuphine|mesh-list
56965780|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56965781|NCT02468128|Narcotics|narcotics|mesh-ancestor
56965782|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965783|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965784|NCT02468128|Analgesics|analgesics|mesh-ancestor
56965785|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
56965786|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965787|NCT03305536|Vitamin D|vitamin d|mesh-list
56965788|NCT03305536|Vitamins|vitamins|mesh-list
56965789|NCT03305536|Vitamin K|vitamin k|mesh-list
56965790|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
56965791|NCT03305536|Vitamin MK 7|vitamin mk 7|mesh-list
56965792|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
56965793|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965794|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56965795|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56965796|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56965797|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965798|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
56965799|NCT03305536|Coagulants|coagulants|mesh-ancestor
56965800|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
56965801|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56965802|NCT03210688|Prednisone|prednisone|mesh-list
56965803|NCT03210688|Prednisolone|prednisolone|mesh-list
56965804|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965805|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
56965806|NCT03210688|Hormones|hormones|mesh-ancestor
56965807|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56965808|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965809|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56965810|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965811|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56965812|NCT03210688|Vitamins|vitamins|mesh-ancestor
56965813|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
56965814|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
56965815|NCT02467426|Analgesics|analgesics|mesh-ancestor
56965816|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
56965817|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965818|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965819|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965820|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56965821|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56965822|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965823|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965824|NCT04296942|Trastuzumab|trastuzumab|mesh-list
56965825|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56965826|NCT04296942|Maytansine|maytansine|mesh-list
56965827|NCT04296942|Entinostat|entinostat|mesh-list
56965828|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56965829|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965830|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56965831|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
56965832|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
56965833|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
56965834|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965835|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56965836|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965837|NCT01344564|Leuprolide|leuprolide|mesh-list
56965838|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56965839|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
56965840|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56965841|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965842|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56965843|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965844|NCT01344720|Etoricoxib|etoricoxib|mesh-list
56965845|NCT01344720|Oxycodone|oxycodone|mesh-list
56965846|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56965847|NCT01344720|Narcotics|narcotics|mesh-ancestor
56965848|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965849|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965850|NCT01344720|Analgesics|analgesics|mesh-ancestor
56965851|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
56965852|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965853|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56965854|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56965855|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965856|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965857|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56965858|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56965859|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965860|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965861|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56965862|NCT03220854|Antibodies|antibodies|mesh-list
56965863|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
56965864|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56965865|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
56965866|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965867|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965868|NCT03305068|Celecoxib|celecoxib|mesh-list
56965869|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56965870|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56965871|NCT03305068|Analgesics|analgesics|mesh-ancestor
56965872|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
56965873|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965874|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965875|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56965876|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965877|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56965878|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56965879|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965880|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965881|NCT04490590|Etoposide|etoposide|mesh-list
56965882|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56965883|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965884|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56965885|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56965886|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965887|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965888|NCT03299998|Anesthetics|anesthetics|mesh-list
56965889|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965890|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965891|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
56965892|NCT05485012|Narcotics|narcotics|mesh-ancestor
56965893|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56965894|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965895|NCT05485012|Analgesics|analgesics|mesh-ancestor
56965896|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
56965897|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56965898|NCT01522976|Lenalidomide|lenalidomide|mesh-list
56965899|NCT01522976|Azacitidine|azacitidine|mesh-list
56965900|NCT01522976|Vorinostat|vorinostat|mesh-list
56965901|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
56965902|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965903|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56965904|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56965905|NCT01522976|Growth Substances|growth substances|mesh-ancestor
56965906|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
56965907|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965908|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56965909|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
56965910|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965911|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965912|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56965913|NCT03144804|Lamivudine|lamivudine|mesh-list
56965914|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56965915|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56965916|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965917|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965918|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
56965919|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56965920|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56965921|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56965922|NCT05417594|Temozolomide|temozolomide|mesh-list
56965923|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56965924|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
56965925|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965926|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965927|NCT03735420|Xanthohumol|xanthohumol|mesh-list
56965928|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965929|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56965930|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56965931|NCT03735420|Growth Substances|growth substances|mesh-ancestor
56965932|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965933|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
56965934|NCT03299842|Fenfluramine|fenfluramine|mesh-list
56965935|NCT03299842|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56965936|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56965937|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56965938|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965939|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965940|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
56965941|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965942|NCT02720536|Deferasirox|deferasirox|mesh-list
56965943|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56965944|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
56965945|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
56965946|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965947|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
56965948|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
56965949|NCT03168438|Fludarabine|fludarabine|mesh-list
56965950|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56965951|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
56965952|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965953|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965954|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56886786|NCT01979536|Cytarabine|cytarabine|mesh-list
56965955|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
56965956|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965957|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965958|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56965959|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56965960|NCT03299296|Enoxaparin|enoxaparin|mesh-list
56965961|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
56965962|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56965963|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
56965964|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56965965|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
56965966|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965967|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965968|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
56965969|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56965970|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56965971|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
56965972|NCT03137784|Bromides|bromides|mesh-list
56965973|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
56965974|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56965975|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56965976|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56965977|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
56965978|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56965979|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965980|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965981|NCT05384938|Benralizumab|benralizumab|mesh-list
56965982|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56965983|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
56965984|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
56965985|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56965986|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56965987|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
56965988|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56965989|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
56965990|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56965991|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965992|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
56965993|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
56965994|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965995|NCT01347996|Interleukin-2|interleukin-2|mesh-list
56965996|NCT01347996|Histamine|histamine|mesh-list
56965997|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
56965998|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965999|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56966000|NCT01347996|Analgesics|analgesics|mesh-ancestor
56966001|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
56966002|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966003|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966004|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
56966005|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
56966006|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966007|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966008|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56966009|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
56966010|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56966011|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
56966012|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966013|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
56966014|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966015|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
56966016|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56966017|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56966018|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966019|NCT02466802|Urological Agents|urological agents|mesh-ancestor
56966020|NCT01348308|Maraviroc|maraviroc|mesh-list
56966021|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56966022|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56966023|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966024|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56966025|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56966026|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
56966027|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966028|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56966029|NCT04074174|Acetaminophen|acetaminophen|mesh-list
56966030|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
56966031|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
56966032|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56966033|NCT04074174|Analgesics|analgesics|mesh-ancestor
56966034|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
56966035|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966036|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966037|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
56966038|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56966039|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56966040|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
56966041|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966042|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966043|NCT03620292|Bevacizumab|bevacizumab|mesh-list
56966044|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966045|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966046|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56966047|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56966048|NCT03620292|Growth Substances|growth substances|mesh-ancestor
56966049|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966050|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
56966051|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
56966052|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56966053|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966054|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966055|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56966056|NCT01353378|Analgesics|analgesics|mesh-ancestor
56966057|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
56966058|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966059|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56966060|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56966061|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56966062|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
56966063|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966064|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966065|NCT05245006|Antibodies|antibodies|mesh-list
56966066|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
56966067|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
56966068|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966069|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
56966070|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56966071|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56966072|NCT01465334|Prednisolone|prednisolone|mesh-list
56966073|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
56966074|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
56966075|NCT01465334|Ofatumumab|ofatumumab|mesh-list
56966076|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56966077|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
56966078|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56966079|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
56966080|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
56966081|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966082|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966083|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56966084|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
56966085|NCT01465334|Hormones|hormones|mesh-ancestor
56966086|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966087|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56966088|NCT01465334|Protective Agents|protective agents|mesh-ancestor
56966089|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56966090|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966091|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966092|NCT04019262|Temozolomide|temozolomide|mesh-list
56966093|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56966094|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
56966095|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966096|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966097|NCT03694002|Paclitaxel|paclitaxel|mesh-list
56966098|NCT03694002|Carboplatin|carboplatin|mesh-list
56966099|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56966100|NCT03694002|Ramucirumab|ramucirumab|mesh-list
56966101|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56966102|NCT03694002|Antibodies|antibodies|mesh-list
56966103|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
56966104|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56966105|NCT03694002|Lexatumumab|lexatumumab|mesh-list
56966106|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56966107|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966108|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
56966109|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
56966110|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
56966111|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966112|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
56966113|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966114|NCT05549726|Cabotegravir|cabotegravir|mesh-list
56966115|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56966116|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56966117|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966118|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966119|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56966120|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56966121|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
56966122|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648421|NCT04250051|Vidarabine|vidarabine|mesh-list
56966123|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
56966124|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56966125|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966126|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966127|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56966128|NCT01353456|Analgesics|analgesics|mesh-ancestor
56966129|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
56966130|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966131|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56966132|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56966133|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56966134|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
56966135|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966136|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966137|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
56966138|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56966139|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966140|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966141|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56966142|NCT04289142|Analgesics|analgesics|mesh-ancestor
56966143|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
56966144|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966145|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56966146|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56966147|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56966148|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
56966149|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966150|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966151|NCT04953962|Nivolumab|nivolumab|mesh-list
56966152|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966153|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966154|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56966155|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966156|NCT04948814|Vancomycin|vancomycin|mesh-list
56966157|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56966158|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966159|NCT02718898|Ixekizumab|ixekizumab|mesh-list
56966160|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
56966161|NCT05726734|Amoxicillin|amoxicillin|mesh-list
56966162|NCT05726734|Metronidazole|metronidazole|mesh-list
56966163|NCT05726734|Potassium Citrate|potassium citrate|mesh-list
56966164|NCT05726734|Esomeprazole|esomeprazole|mesh-list
56966165|NCT05726734|Bismuth|bismuth|mesh-list
56966166|NCT05726734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966167|NCT05726734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56966168|NCT05726734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966169|NCT05726734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56966170|NCT05726734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56966171|NCT05726734|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56966172|NCT05726734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56966173|NCT05726734|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56966174|NCT05726734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966175|NCT05726734|Antacids|antacids|mesh-ancestor
56966176|NCT05726734|Diuretics|diuretics|mesh-ancestor
56966177|NCT05726734|Natriuretic Agents|natriuretic agents|mesh-ancestor
56966178|NCT05726734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966179|NCT05726734|Expectorants|expectorants|mesh-ancestor
56966180|NCT05726734|Respiratory System Agents|respiratory system agents|mesh-ancestor
56966181|NCT01317966|Rituximab|rituximab|mesh-list
56966182|NCT01317966|Oprelvekin|oprelvekin|mesh-list
56966183|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966184|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966185|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
56966186|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966187|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56966188|NCT01345734|Liraglutide|liraglutide|mesh-list
56966189|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56966190|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966191|NCT01345734|Incretins|incretins|mesh-ancestor
56966192|NCT01345734|Hormones|hormones|mesh-ancestor
56966193|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966194|NCT04674670|Naltrexone|naltrexone|mesh-list
56966195|NCT04674670|Bromocriptine|bromocriptine|mesh-list
56966196|NCT04674670|Amisulpride|amisulpride|mesh-list
56966197|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56648492|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
56966198|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56966199|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966201|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966202|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56966203|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56966204|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966205|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56966206|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56966207|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
56966208|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966209|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966210|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56966211|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
56966212|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56966213|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56966214|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
56966215|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966216|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
56966217|NCT01318044|Thiopental|thiopental|mesh-list
56966218|NCT01318044|Propofol|propofol|mesh-list
56966219|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56966220|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966221|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966222|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56966223|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
56966224|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
56966225|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
56966226|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
56966227|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
56966228|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966229|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966230|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56966231|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56966232|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56966233|NCT01353846|Estradiol|estradiol|mesh-list
56966234|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56966235|NCT01353846|Progesterone|progesterone|mesh-list
56966236|NCT01353846|Estrogens|estrogens|mesh-ancestor
56966237|NCT01353846|Hormones|hormones|mesh-ancestor
56966238|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966239|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966240|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56966241|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
56966242|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56966243|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56966244|NCT01353846|Progestins|progestins|mesh-ancestor
56966245|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
56966246|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56966247|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966248|NCT01349010|Probucol|probucol|mesh-list
56966249|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56966250|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56966251|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
56966252|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966253|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56966254|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
56966255|NCT01349010|Protective Agents|protective agents|mesh-ancestor
56966256|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966257|NCT05232370|Losartan|losartan|mesh-list
56966258|NCT05232370|Enalapril|enalapril|mesh-list
56966259|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56966260|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56966261|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56966262|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56966263|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56966264|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56966265|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966266|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
56966267|NCT01349088|Niacinamide|niacinamide|mesh-list
56966268|NCT01349088|Capecitabine|capecitabine|mesh-list
56966269|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
56966270|NCT01349088|Imetelstat|imetelstat|mesh-list
56966271|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56966272|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
56648572|NCT02674308|Vedolizumab|vedolizumab|mesh-list
56966273|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966274|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966275|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56966276|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966277|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
56966278|NCT01349088|Vitamins|vitamins|mesh-ancestor
56966279|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
56966280|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966281|NCT04490434|Celecoxib|celecoxib|mesh-list
56966282|NCT04490434|Naproxen|naproxen|mesh-list
56966283|NCT04490434|Meloxicam|meloxicam|mesh-list
56966284|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56966285|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56966286|NCT04490434|Analgesics|analgesics|mesh-ancestor
56966287|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
56966288|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966289|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966290|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56966291|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56966292|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56966293|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56966294|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966295|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966296|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
56966297|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
56966298|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56966299|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
56966300|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966301|NCT03143166|Telmisartan|telmisartan|mesh-list
56966302|NCT03143166|Dabigatran|dabigatran|mesh-list
56966303|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56966304|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56966305|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56966306|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966307|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
56966308|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56966309|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
56966310|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966311|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
56966312|NCT02466568|Nivolumab|nivolumab|mesh-list
56966313|NCT02466568|Vaccines|vaccines|mesh-list
56966314|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
56966315|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966316|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966317|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966318|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56966319|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966320|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
56966321|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966322|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966323|NCT02466022|Fentanyl|fentanyl|mesh-list
56966324|NCT02466022|Midazolam|midazolam|mesh-list
56966325|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
56966326|NCT02466022|Bupivacaine|bupivacaine|mesh-list
56966327|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
56966328|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
56966329|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966330|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966331|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
55726700|NCT01601626|Ethambutol|ethambutol|mesh-list
56966332|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966333|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56966334|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56966335|NCT02466022|Analgesics|analgesics|mesh-ancestor
56966336|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56966337|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56966338|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56966339|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
56966340|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966341|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966342|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56966343|NCT02466022|Narcotics|narcotics|mesh-ancestor
56966344|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56966345|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56966346|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
56648645|NCT00644124|Aflibercept|aflibercept|mesh-list
56966347|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56966348|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56966349|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56966350|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
56966351|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
56966352|NCT03937596|Cycloserine|cycloserine|mesh-list
56966353|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56966354|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966355|NCT03937596|Renal Agents|renal agents|mesh-ancestor
56966356|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56966357|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
56966358|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56966359|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
56966360|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966361|NCT04606264|Dexamethasone|dexamethasone|mesh-list
56966362|NCT04606264|Morphine|morphine|mesh-list
56966363|NCT04606264|Hydromorphone|hydromorphone|mesh-list
56966364|NCT04606264|Ondansetron|ondansetron|mesh-list
56966365|NCT04606264|Aprepitant|aprepitant|mesh-list
56966366|NCT04606264|Dimenhydrinate|dimenhydrinate|mesh-list
56966367|NCT04606264|Perphenazine|perphenazine|mesh-list
56966368|NCT04606264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56966369|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
56966370|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
56966371|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966372|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966373|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56966374|NCT04606264|Glucocorticoids|glucocorticoids|mesh-ancestor
56966375|NCT04606264|Hormones|hormones|mesh-ancestor
56966376|NCT04606264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966377|NCT04606264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56966378|NCT04606264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966379|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56966380|NCT04606264|Narcotics|narcotics|mesh-ancestor
56966381|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966382|NCT04606264|Analgesics|analgesics|mesh-ancestor
56966383|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
56966384|NCT04606264|Antipruritics|antipruritics|mesh-ancestor
56966385|NCT04606264|Dermatologic Agents|dermatologic agents|mesh-ancestor
56966386|NCT04606264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56966387|NCT04606264|Serotonin Agents|serotonin agents|mesh-ancestor
56966388|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966389|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966390|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56966391|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56966392|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56966393|NCT04606264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56966394|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56966395|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56966396|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
56966397|NCT04606264|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56966398|NCT04606264|Histamine Antagonists|histamine antagonists|mesh-ancestor
56966399|NCT04606264|Histamine Agents|histamine agents|mesh-ancestor
56966400|NCT03578172|Menotropins|menotropins|mesh-list
56966401|NCT03578172|Hormones|hormones|mesh-list
56966402|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966403|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966404|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56966405|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
56966406|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56966407|NCT03928158|Valsartan|valsartan|mesh-list
56990938|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966408|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56966409|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56966410|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56966411|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56966412|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966413|NCT05174884|Etonogestrel|etonogestrel|mesh-list
56966414|NCT05174884|Desogestrel|desogestrel|mesh-list
56966415|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56966416|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
56966417|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56966418|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966419|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56966420|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56966421|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56966422|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56966423|NCT05174884|Progestins|progestins|mesh-ancestor
56966424|NCT05174884|Hormones|hormones|mesh-ancestor
56966425|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966427|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56966428|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56966429|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56966430|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56966431|NCT02466490|Diuretics|diuretics|mesh-ancestor
56966432|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
56966433|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966434|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56966435|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56966436|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966437|NCT04547842|Dexamethasone|dexamethasone|mesh-list
56966438|NCT04547842|Mirtazapine|mirtazapine|mesh-list
56966439|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56966440|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
56966441|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
56966442|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966443|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966444|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56966445|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
56966446|NCT04547842|Hormones|hormones|mesh-ancestor
56966447|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966448|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56966449|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966450|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
56966451|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56966452|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56966453|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
56966454|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
56966455|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966456|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966457|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56966458|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56966459|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966460|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56966461|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56966462|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56966463|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
56966464|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56966465|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56966466|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
56966467|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56966468|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
56966469|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
56966470|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966471|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
56966472|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966473|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966474|NCT00702052|Everolimus|everolimus|mesh-list
56966475|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966476|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56966477|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
56966478|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966479|NCT00658814|Azacitidine|azacitidine|mesh-list
56966480|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
56966481|NCT00658814|Calicheamicins|calicheamicins|mesh-list
56966482|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56966483|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
56966484|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966485|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966486|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966487|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966488|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56966489|NCT01354470|Modafinil|modafinil|mesh-list
56966490|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56966491|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966492|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56966493|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56966494|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56966495|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966496|NCT01349556|Tretinoin|tretinoin|mesh-list
56648791|NCT00644748|Analgesics|analgesics|mesh-ancestor
56966497|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966498|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
56966499|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56966500|NCT01354704|Enoxaparin|enoxaparin|mesh-list
56966501|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
56966502|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56966503|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56966504|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966505|NCT01346670|Lovastatin|lovastatin|mesh-list
56966506|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56966507|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56966508|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
56966509|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966510|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56966511|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56966512|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966513|NCT03136068|Digoxin|digoxin|mesh-list
56966514|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56966515|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56966516|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966517|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966518|NCT03136068|Protective Agents|protective agents|mesh-ancestor
56966519|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966520|NCT01350024|Lidocaine|lidocaine|mesh-list
56966521|NCT01350024|Epinephrine|epinephrine|mesh-list
56966522|NCT01350024|Racepinephrine|racepinephrine|mesh-list
56966523|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
56966524|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
56966525|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
56966526|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966527|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966528|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
56966529|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966530|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56966531|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56966532|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56966533|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56966534|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966535|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56966536|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56966537|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
56966538|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966539|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56966540|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56966541|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
56966542|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56966543|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
56966544|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
56966545|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
56966546|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56966547|NCT01318590|Triamcinolone|triamcinolone|mesh-list
56966548|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56966549|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56966550|NCT01318590|Bupivacaine|bupivacaine|mesh-list
56966551|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56966552|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
56966553|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
56966554|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966555|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966556|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
56966557|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966558|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56966559|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
56966560|NCT01318590|Hormones|hormones|mesh-ancestor
56966561|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966562|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56966563|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
56966564|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966565|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966566|NCT01346826|Infliximab|infliximab|mesh-list
56966567|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
56966568|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56966569|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56966570|NCT01354860|Lobeline|lobeline|mesh-list
56966571|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56966572|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
56966573|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966574|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966575|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56966576|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56966577|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
56966578|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966579|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966580|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
56966581|NCT02556606|Midazolam|midazolam|mesh-list
56966582|NCT02556606|Ketamine|ketamine|mesh-list
56966583|NCT02556606|Analgesics|analgesics|mesh-ancestor
56966584|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
56966585|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966586|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966587|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56966588|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56966589|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
56966590|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
56966591|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966592|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56966593|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56966594|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966595|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966596|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56966597|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56966598|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56966599|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56966600|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56966601|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
56966602|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
56966603|NCT01355562|Interleukin-2|interleukin-2|mesh-list
56966604|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966605|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56966606|NCT01355562|Analgesics|analgesics|mesh-ancestor
56966607|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
56966608|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966609|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966610|NCT01350570|Loperamide|loperamide|mesh-list
56966611|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
56966612|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56966613|NCT01355718|Repaglinide|repaglinide|mesh-list
56966614|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56966615|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966616|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56966617|NCT03377790|Cantharidin|cantharidin|mesh-list
56966618|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966619|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966620|NCT01347294|Bleomycin|bleomycin|mesh-list
56966621|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56966622|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966623|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
56966624|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56966625|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56966626|NCT02422368|Prednisolone|prednisolone|mesh-list
56966627|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
56966628|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56966629|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
56966630|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56966631|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
56966632|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
56966633|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966634|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966635|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56966636|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
56966637|NCT02422368|Hormones|hormones|mesh-ancestor
56966638|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966639|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56966640|NCT02422368|Protective Agents|protective agents|mesh-ancestor
56966641|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56966642|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966643|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
56966644|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
56966645|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966646|NCT01355952|Protective Agents|protective agents|mesh-ancestor
56966647|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966648|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
56966649|NCT01355952|Vitamins|vitamins|mesh-ancestor
56966650|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
56966651|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56966652|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56966653|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966654|NCT00644228|Dexamethasone|dexamethasone|mesh-list
56966655|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
56966656|NCT00644228|Lenalidomide|lenalidomide|mesh-list
56966657|NCT00644228|Bortezomib|bortezomib|mesh-list
56966658|NCT00644228|Ichthammol|ichthammol|mesh-list
56966659|NCT00644228|BB 1101|bb 1101|mesh-list
56966660|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56966661|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
56966662|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
56966663|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966664|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966665|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56966666|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
56966667|NCT00644228|Hormones|hormones|mesh-ancestor
56966668|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966669|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56966670|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966671|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
56966672|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966673|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966674|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
56966675|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56966676|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56966677|NCT00644228|Growth Substances|growth substances|mesh-ancestor
56966678|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
56966679|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56966680|NCT05720572|Antazoline|antazoline|mesh-list
56966681|NCT05720572|Propafenone|propafenone|mesh-list
56966682|NCT05720572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56966683|NCT05720572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56966684|NCT05720572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56966685|NCT05720572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56966686|NCT05720572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966687|NCT05720572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56966688|NCT05720572|Histamine Antagonists|histamine antagonists|mesh-ancestor
56966689|NCT05720572|Histamine Agents|histamine agents|mesh-ancestor
56966690|NCT05720572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966691|NCT05720572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966692|NCT05720572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56966693|NCT05111002|Doxycycline|doxycycline|mesh-list
56966694|NCT05111002|Lefamulin|lefamulin|mesh-list
56966695|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56966696|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966697|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
56966698|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56966699|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56966700|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
56966701|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
56966702|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56966703|NCT05716750|Vitamin D|vitamin d|mesh-list
56966704|NCT05716750|Vitamins|vitamins|mesh-ancestor
56966705|NCT05716750|Micronutrients|micronutrients|mesh-ancestor
56966706|NCT05716750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966707|NCT05716750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56966708|NCT01350882|Rituximab|rituximab|mesh-list
56966709|NCT01350882|Citric Acid|citric acid|mesh-list
56966710|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
56966711|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966712|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966713|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
56966714|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966715|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56966716|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
56966717|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56966718|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
56966719|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
56966720|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966721|NCT01844856|Ertapenem|ertapenem|mesh-list
56966722|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56966723|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966724|NCT00618098|Thrombin|thrombin|mesh-list
56966725|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
56966726|NCT00618098|Coagulants|coagulants|mesh-ancestor
56966727|NCT02464228|Tipifarnib|tipifarnib|mesh-list
56966728|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966729|NCT01351038|Capecitabine|capecitabine|mesh-list
56966730|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
56966731|NCT01351038|Panitumumab|panitumumab|mesh-list
56966732|NCT01351038|Epirubicin|epirubicin|mesh-list
56966733|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56966734|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
56966735|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966736|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966737|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966738|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56966739|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56966740|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56966741|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966742|NCT01817166|Vitamin D|vitamin d|mesh-list
56966743|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
56966744|NCT01817166|Vitamins|vitamins|mesh-ancestor
56966745|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
56966746|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966747|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56966748|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56966749|NCT02464462|Vitamin D|vitamin d|mesh-list
56966750|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
56966751|NCT02464462|Calcium|calcium|mesh-list
56966752|NCT02464462|Vitamins|vitamins|mesh-ancestor
56966753|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
56966754|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966755|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56966756|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56966757|NCT04270864|Nivolumab|nivolumab|mesh-list
56966758|NCT04270864|Ipilimumab|ipilimumab|mesh-list
56966759|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966760|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966761|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56966762|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966763|NCT01318668|Vaccines|vaccines|mesh-list
56966764|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
56966765|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966766|NCT01351272|Methylphenidate|methylphenidate|mesh-list
56966767|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56966768|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966769|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56966770|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56966771|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56966772|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966773|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
56966774|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966775|NCT01351428|Nifedipine|nifedipine|mesh-list
56966776|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56966777|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56966778|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966779|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56966780|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966781|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
56966782|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
56966783|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56966784|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56966785|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56966786|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887613|NCT03376672|Hormones|hormones|mesh-ancestor
56966787|NCT00588770|Bevacizumab|bevacizumab|mesh-list
56966788|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56966789|NCT00588770|Cisplatin|cisplatin|mesh-list
56966790|NCT00588770|Carboplatin|carboplatin|mesh-list
56966791|NCT00588770|Docetaxel|docetaxel|mesh-list
56966792|NCT00588770|Fluorouracil|fluorouracil|mesh-list
56966793|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
56966794|NCT00588770|Antibodies|antibodies|mesh-list
56966795|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
56966796|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56966797|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
56966798|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966799|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56966800|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56966801|NCT00588770|Growth Substances|growth substances|mesh-ancestor
56966802|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966803|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
56966804|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
56966805|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
56966806|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
56966807|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
56966808|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966809|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
56966810|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56966811|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56966812|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
56966813|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
56966814|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966816|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56966817|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966818|NCT05668936|Moxifloxacin|moxifloxacin|mesh-list
56966819|NCT05668936|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56966820|NCT05668936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56966821|NCT05668936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966822|NCT05668936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56966823|NCT05668936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56966824|NCT05668936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966825|NCT05668936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966826|NCT05668936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966827|NCT05668936|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56966828|NCT05668936|Contraceptive Agents|contraceptive agents|mesh-ancestor
56966829|NCT05668936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56966830|NCT05668936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966831|NCT05668936|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56966832|NCT05668936|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56966833|NCT05668936|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56966834|NCT01351818|Hormones|hormones|mesh-list
56966835|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966836|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966837|NCT02463994|Atezolizumab|atezolizumab|mesh-list
56966838|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966839|NCT04235686|Amphetamine|amphetamine|mesh-list
56966840|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
56966841|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56966842|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966843|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
56966844|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
56966845|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966846|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
56966847|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966848|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966849|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
56966850|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56966851|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56966852|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56966853|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56966854|NCT02079948|Folic Acid|folic acid|mesh-list
56966855|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
56966856|NCT02079948|Methotrexate|methotrexate|mesh-list
56966857|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56966858|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
56966859|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56966860|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990939|NCT03527537|Insulin|insulin|mesh-list
56887686|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56966861|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56966862|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
56966863|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966864|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966865|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
56966866|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966867|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56966868|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56966869|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
56966870|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56966871|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56966872|NCT02079948|Hematinics|hematinics|mesh-ancestor
56966873|NCT02079948|Vitamins|vitamins|mesh-ancestor
56966874|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
56966875|NCT01357902|Lamotrigine|lamotrigine|mesh-list
56966876|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
56966877|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56966878|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56966879|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966880|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56966881|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966883|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56966884|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966885|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56966886|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56966887|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
56966888|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56966889|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966890|NCT00359684|Cysteamine|cysteamine|mesh-list
56966891|NCT00359684|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56966892|NCT00359684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966893|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
56966894|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
56966895|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966896|NCT01352130|Ondansetron|ondansetron|mesh-list
56966897|NCT01352130|Granisetron|granisetron|mesh-list
56966898|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
56966899|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
56966900|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
56966901|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966902|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966903|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56966904|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
56966905|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
56966906|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56966907|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
56966908|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56966909|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966910|NCT01352130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56966911|NCT01352130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56966912|NCT01352130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966913|NCT01352130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56966914|NCT01352130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56966915|NCT05605834|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56966916|NCT05605834|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56966917|NCT05605834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966918|NCT00005780|Prednisone|prednisone|mesh-list
56966919|NCT00005780|Cyclophosphamide|cyclophosphamide|mesh-list
56966920|NCT00005780|Doxorubicin|doxorubicin|mesh-list
56966921|NCT00005780|Etoposide|etoposide|mesh-list
56966922|NCT00005780|Vincristine|vincristine|mesh-list
56966923|NCT00005780|Sargramostim|sargramostim|mesh-list
56966924|NCT00005780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56966925|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
56966926|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966927|NCT00005780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56966928|NCT00005780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56966929|NCT00005780|Alkylating Agents|alkylating agents|mesh-ancestor
56966930|NCT00005780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966931|NCT00005780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966932|NCT00005780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56966933|NCT00005780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56966934|NCT00005780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56990940|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56966935|NCT00005780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56966936|NCT00005780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966937|NCT00005780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56966938|NCT00005780|Glucocorticoids|glucocorticoids|mesh-ancestor
56966939|NCT00005780|Hormones|hormones|mesh-ancestor
56966940|NCT00005780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56966941|NCT00005780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56966942|NCT00005780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56966943|NCT00005780|Tubulin Modulators|tubulin modulators|mesh-ancestor
56966944|NCT00005780|Antimitotic Agents|antimitotic agents|mesh-ancestor
56966945|NCT00005780|Mitosis Modulators|mitosis modulators|mesh-ancestor
56966946|NCT01356732|Sufentanil|sufentanil|mesh-list
56966947|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56966948|NCT01356732|Narcotics|narcotics|mesh-ancestor
56966949|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966950|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966951|NCT01356732|Analgesics|analgesics|mesh-ancestor
56966952|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
56966953|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966954|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56966955|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56966956|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
56966957|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
56966958|NCT02463682|Insulin|insulin|mesh-list
56966959|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56966960|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966961|NCT05315648|Anesthetics|anesthetics|mesh-list
56966962|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966963|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966964|NCT05386472|Ritonavir|ritonavir|mesh-list
56966965|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56966966|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56966967|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
56966968|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966969|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966970|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56966971|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56966972|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
56966973|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966974|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56966975|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56966976|NCT01978938|Levofloxacin|levofloxacin|mesh-list
56966977|NCT01978938|Ofloxacin|ofloxacin|mesh-list
56966978|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56966979|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56966980|NCT01978938|Renal Agents|renal agents|mesh-ancestor
56966981|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56966982|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56966983|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56966984|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56966985|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56966986|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56966987|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56966988|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56966989|NCT02465320|Lidocaine|lidocaine|mesh-list
56966990|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
56966991|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
56966992|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56966993|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56966994|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
56966995|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56966996|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56966997|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56966998|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56966999|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56967000|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967001|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
56967002|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
56967003|NCT05382338|Lomustine|lomustine|mesh-list
56967004|NCT05382338|Cisplatin|cisplatin|mesh-list
56967005|NCT05382338|Vincristine|vincristine|mesh-list
56967006|NCT05382338|Mesna|mesna|mesh-list
56967007|NCT05382338|Antidotes|antidotes|mesh-list
56967008|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967009|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
56967010|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967011|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56967012|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56967013|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
56967014|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967015|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967016|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56967017|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56967018|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
56967019|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
56967020|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
56967021|NCT05382338|Protective Agents|protective agents|mesh-ancestor
56967022|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
56967023|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
56967024|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56967025|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967026|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
56967027|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
56649317|NCT02663700|Artesunate|artesunate|mesh-list
56967028|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
56967029|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
56967030|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
56967031|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967032|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967033|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
56967034|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967035|NCT04141696|Midazolam|midazolam|mesh-list
56967036|NCT04141696|Ketamine|ketamine|mesh-list
56967037|NCT04141696|Analgesics|analgesics|mesh-ancestor
56967038|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
56967039|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967040|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967041|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56967042|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56967043|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
56967044|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
56967045|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967046|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56967047|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56967048|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967049|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967050|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56967051|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56967052|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56967053|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56967054|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56967055|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
56967056|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
56967057|NCT03228186|Docetaxel|docetaxel|mesh-list
56967058|NCT03228186|Pevonedistat|pevonedistat|mesh-list
56967059|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967060|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
56967061|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
56967062|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
56967063|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967064|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967065|NCT04105114|Buspirone|buspirone|mesh-list
56967066|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56967067|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56967068|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967069|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967070|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56967071|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56967072|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
56967073|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967074|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967075|NCT05573230|Cyclosporine|cyclosporine|mesh-list
56967076|NCT05573230|Midazolam|midazolam|mesh-list
56967077|NCT05573230|Cyclosporins|cyclosporins|mesh-list
56967078|NCT05573230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56967079|NCT05573230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56967080|NCT05573230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967081|NCT05573230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967082|NCT05573230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56967083|NCT05573230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56967084|NCT05573230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56967085|NCT05573230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56967086|NCT05573230|Anesthetics, General|anesthetics, general|mesh-ancestor
56967087|NCT05573230|Anesthetics|anesthetics|mesh-ancestor
56967088|NCT05573230|GABA Modulators|gaba modulators|mesh-ancestor
56967089|NCT05573230|GABA Agents|gaba agents|mesh-ancestor
56967090|NCT05573230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967091|NCT05573230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967092|NCT05573230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967093|NCT05573230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967094|NCT05573230|Immunologic Factors|immunologic factors|mesh-ancestor
56967095|NCT05573230|Antifungal Agents|antifungal agents|mesh-ancestor
56967096|NCT05573230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967097|NCT05573230|Dermatologic Agents|dermatologic agents|mesh-ancestor
56967098|NCT05573230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56967099|NCT05573230|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56967100|NCT04088188|Gemcitabine|gemcitabine|mesh-list
56967101|NCT04088188|Cisplatin|cisplatin|mesh-list
56967102|NCT04088188|Ivosidenib|ivosidenib|mesh-list
56967103|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967104|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56967105|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
56967106|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967107|NCT04088188|Antiviral Agents|antiviral agents|mesh-ancestor
56967108|NCT04088188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967109|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967110|NCT04088188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967111|NCT04088188|Immunologic Factors|immunologic factors|mesh-ancestor
56967112|NCT04088188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967114|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
56967115|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967116|NCT04047862|Paclitaxel|paclitaxel|mesh-list
56967117|NCT04047862|Etoposide|etoposide|mesh-list
56967118|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56967119|NCT04047862|Carboplatin|carboplatin|mesh-list
56967120|NCT04047862|Fluorouracil|fluorouracil|mesh-list
56967121|NCT04047862|Capecitabine|capecitabine|mesh-list
56967122|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
56967123|NCT04047862|Pemetrexed|pemetrexed|mesh-list
56967124|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56967125|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967126|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
56967127|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
56967128|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
56967129|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967130|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
56967131|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56967132|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967133|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
56967134|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967135|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56967136|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56967137|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967138|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56967139|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56967140|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
56967141|NCT00116142|Docetaxel|docetaxel|mesh-list
56967142|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
56967143|NCT00116142|Androgens|androgens|mesh-list
56967144|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56967145|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967146|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
56967147|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
56967148|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
56967149|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967150|NCT00116142|Hormones|hormones|mesh-ancestor
56967151|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967152|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967153|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
56967154|NCT00116142|Protective Agents|protective agents|mesh-ancestor
56967155|NCT00116142|Vitamins|vitamins|mesh-ancestor
56967156|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
56967157|NCT00116142|Estrogens|estrogens|mesh-ancestor
56967158|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56967159|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
56967160|NCT05547256|Vaccines|vaccines|mesh-list
56967161|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
56967162|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967163|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
56967164|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
56967165|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56967166|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56967167|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967168|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967169|NCT01757782|Urological Agents|urological agents|mesh-ancestor
56967170|NCT02023905|Everolimus|everolimus|mesh-list
56967171|NCT02023905|Temozolomide|temozolomide|mesh-list
56967172|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967173|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967174|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
56967175|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967176|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56967177|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
56967178|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967179|NCT01330563|Ketoconazole|ketoconazole|mesh-list
56967180|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
56967181|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967182|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56967184|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967185|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967186|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56967187|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967188|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967189|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967190|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56967191|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
56967192|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967193|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56967194|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967195|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967196|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
56967197|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
56967198|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967199|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967200|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967201|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
56967202|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
56967203|NCT04897503|Riboflavin|riboflavin|mesh-list
56967204|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
56967205|NCT04897503|Vitamins|vitamins|mesh-ancestor
56967206|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
56967207|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967208|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56967209|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
56967210|NCT01333917|Curcumin|curcumin|mesh-list
56967211|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56967212|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56967213|NCT01333917|Analgesics|analgesics|mesh-ancestor
56967214|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
56967215|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967216|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967217|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56967218|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56967219|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967220|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967221|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967222|NCT03129360|Levetiracetam|levetiracetam|mesh-list
56967223|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
56967224|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
56967225|NCT01315275|Ranibizumab|ranibizumab|mesh-list
56967226|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56967227|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56967228|NCT01315275|Growth Substances|growth substances|mesh-ancestor
56967229|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967230|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
56967231|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967232|NCT01319448|Artesunate|artesunate|mesh-list
56967233|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
56967234|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
56967235|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56967236|NCT01319448|Amodiaquine|amodiaquine|mesh-list
56967237|NCT01319448|Mefloquine|mefloquine|mesh-list
56967238|NCT01319448|Proguanil|proguanil|mesh-list
56967239|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
56967240|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56967241|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56967242|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967243|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967244|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
56967245|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
56967246|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56967247|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
56967248|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56967249|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967250|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967251|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56967252|NCT01319448|Renal Agents|renal agents|mesh-ancestor
56967253|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
56967254|NCT04360551|Telmisartan|telmisartan|mesh-list
56967255|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56967256|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56967257|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56967258|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967259|NCT01334073|Everolimus|everolimus|mesh-list
56967260|NCT01334073|Axitinib|axitinib|mesh-list
56967261|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967262|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967263|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
56967264|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967265|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56967266|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967267|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967268|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56967269|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56967270|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967271|NCT01928199|Incretins|incretins|mesh-ancestor
56967272|NCT01928199|Hormones|hormones|mesh-ancestor
56967273|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967274|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56967275|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
56967276|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967277|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967278|NCT01845441|Fentanyl|fentanyl|mesh-list
56967279|NCT01845441|Midazolam|midazolam|mesh-list
56967280|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
56967281|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56967282|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967283|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967284|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56967285|NCT01845441|Analgesics|analgesics|mesh-ancestor
56967286|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
56967287|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967288|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56967289|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56967290|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56967291|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
56967292|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967293|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967294|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56967295|NCT01845441|Narcotics|narcotics|mesh-ancestor
56967296|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56967297|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56967298|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
56967299|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
56967300|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56967301|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56967302|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56967303|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
56967304|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
56967305|NCT03296488|Fentanyl|fentanyl|mesh-list
56967306|NCT03296488|Nalbuphine|nalbuphine|mesh-list
56967307|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56967308|NCT03296488|Narcotics|narcotics|mesh-ancestor
56967309|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967310|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967311|NCT03296488|Analgesics|analgesics|mesh-ancestor
56967312|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
56967313|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967314|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56967315|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56967316|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
56967317|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
56967318|NCT01365936|Menotropins|menotropins|mesh-list
56967319|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56967320|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
56967321|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56967322|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967323|NCT01334151|Insulin|insulin|mesh-list
56967324|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56967325|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
56967326|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56967327|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967328|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56967329|NCT04216017|Lidocaine|lidocaine|mesh-list
56967330|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
56967331|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
56967332|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967333|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967334|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
56967335|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967336|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56967337|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56967338|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56967339|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56967340|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967341|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56967343|NCT04216017|Hormones|hormones|mesh-ancestor
56967344|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967345|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967346|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
56967347|NCT03296410|Vaccines|vaccines|mesh-list
56967348|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
56967349|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967350|NCT05189184|Paclitaxel|paclitaxel|mesh-list
56967351|NCT05189184|Apatinib|apatinib|mesh-list
56967352|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56967353|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56967354|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967355|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
56967356|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
56967357|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
56967358|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967359|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56967360|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967361|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56967362|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56967363|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
56967364|NCT04623099|Citalopram|citalopram|mesh-list
56967365|NCT04623099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56967366|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56967367|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56967368|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967369|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967370|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
56967371|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967372|NCT04623099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56967373|NCT04623099|Antidepressive Agents|antidepressive agents|mesh-ancestor
56967374|NCT04623099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56967375|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56967376|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967377|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56967378|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56967379|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967380|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967381|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56967382|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967383|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967384|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967385|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
56967386|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56967387|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967388|NCT03619538|Nefopam|nefopam|mesh-list
56967389|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56967390|NCT03619538|Analgesics|analgesics|mesh-ancestor
56967391|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
56967392|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967393|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967394|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
56967395|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56967396|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
56967397|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56967398|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967399|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56967400|NCT01366326|Bromides|bromides|mesh-list
56967401|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
56967402|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
56967403|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56967404|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967405|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
56967406|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967407|NCT01822275|Temozolomide|temozolomide|mesh-list
56967408|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56967409|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
56967410|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967411|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967412|NCT01331421|Exemestane|exemestane|mesh-list
56967413|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967414|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56967415|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56967416|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967417|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967418|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56967419|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967420|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967421|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967422|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
56967423|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56967424|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56967425|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56967426|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56967427|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
56967428|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56967429|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967430|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56967431|NCT01656434|Estrogens|estrogens|mesh-ancestor
56967432|NCT01656434|Hormones|hormones|mesh-ancestor
56967433|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967434|NCT01656434|Trace Elements|trace elements|mesh-ancestor
56967435|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
56967436|NCT01319214|Propranolol|propranolol|mesh-list
56967437|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56967438|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56967439|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
56967440|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967441|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967442|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967443|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56967444|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56967445|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
56967446|NCT01359228|Rifaximin|rifaximin|mesh-list
56967447|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56967448|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967449|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56967450|NCT02461030|Listerine|listerine|mesh-list
56967451|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
56967452|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
56967453|NCT02461030|Protective Agents|protective agents|mesh-ancestor
56967454|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967455|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56967456|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967457|NCT05168618|Atezolizumab|atezolizumab|mesh-list
56967458|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56967459|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967460|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
56967461|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967462|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56967463|NCT01599494|Progesterone|progesterone|mesh-list
56967464|NCT01599494|Ganirelix|ganirelix|mesh-list
56967465|NCT01599494|Progestins|progestins|mesh-ancestor
56967466|NCT01599494|Hormones|hormones|mesh-ancestor
56967467|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967468|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967469|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56967470|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967471|NCT03295786|Dopamine|dopamine|mesh-list
56967472|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56967473|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
56967474|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
56967475|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967476|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967477|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
56967478|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967479|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967480|NCT03295786|Protective Agents|protective agents|mesh-ancestor
56967481|NCT03194932|Cytarabine|cytarabine|mesh-list
56967482|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
56967483|NCT03194932|Methotrexate|methotrexate|mesh-list
56967484|NCT03194932|Azacitidine|azacitidine|mesh-list
56967485|NCT03194932|Venetoclax|venetoclax|mesh-list
56967486|NCT03194932|Idarubicin|idarubicin|mesh-list
56967487|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56967488|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
56967489|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56967490|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967491|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56967492|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
56967493|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967494|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967495|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
56967496|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967497|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56967498|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967499|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
56967500|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56967501|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56967502|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
56967503|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967504|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56967505|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56967506|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56967507|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56967508|NCT03037580|Treprostinil|treprostinil|mesh-list
56967509|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56967510|NCT05154734|Belimumab|belimumab|mesh-list
56967511|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967512|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
56967513|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967514|NCT05262764|Empagliflozin|empagliflozin|mesh-list
56967515|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56967516|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967517|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56967518|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967519|NCT02978404|Nivolumab|nivolumab|mesh-list
56967520|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56967521|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967522|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56967523|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967524|NCT04441918|Antibodies|antibodies|mesh-list
56967525|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56967526|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
56967527|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967528|NCT05014412|Dexamethasone|dexamethasone|mesh-list
56967529|NCT05014412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56967530|NCT05014412|Antiemetics|antiemetics|mesh-ancestor
56967531|NCT05014412|Autonomic Agents|autonomic agents|mesh-ancestor
56967532|NCT05014412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967533|NCT05014412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967534|NCT05014412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56967535|NCT05014412|Glucocorticoids|glucocorticoids|mesh-ancestor
56967536|NCT05014412|Hormones|hormones|mesh-ancestor
56967537|NCT05014412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967538|NCT05014412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56967539|NCT05014412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967540|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
56967541|NCT01331655|Drospirenone|drospirenone|mesh-list
56967542|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56967543|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967544|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55726701|NCT01601626|Rifabutin|rifabutin|mesh-list
56888358|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
56967545|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967546|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56967547|NCT01331655|Diuretics|diuretics|mesh-ancestor
56967548|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
56967549|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
56967550|NCT01331655|Vitamins|vitamins|mesh-ancestor
56967551|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
56967552|NCT03289390|Acetaminophen|acetaminophen|mesh-list
56967553|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56967554|NCT03289390|Analgesics|analgesics|mesh-ancestor
56967555|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
56967556|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967557|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967558|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
56967559|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
56967560|NCT02308527|Temozolomide|temozolomide|mesh-list
56967561|NCT02308527|Bevacizumab|bevacizumab|mesh-list
56967562|NCT02308527|Irinotecan|irinotecan|mesh-list
56967563|NCT02308527|Topotecan|topotecan|mesh-list
56967564|NCT02308527|Dinutuximab|dinutuximab|mesh-list
56967565|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967566|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
56967567|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967568|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56967569|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56967570|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
56967571|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967572|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967573|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56967574|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56967575|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56967576|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56967577|NCT02308527|Growth Substances|growth substances|mesh-ancestor
56967578|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
56967579|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56967580|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56967581|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967582|NCT03382977|Carmustine|carmustine|mesh-list
56967583|NCT03382977|Lomustine|lomustine|mesh-list
56967584|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56967585|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
56967586|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967587|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967588|NCT00897104|Sumatriptan|sumatriptan|mesh-list
56967589|NCT00897104|Rizatriptan|rizatriptan|mesh-list
56967590|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56967591|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56967592|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56967593|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
56967594|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967595|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967596|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967597|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56967598|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56967599|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967600|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967601|NCT04332068|Ivermectin|ivermectin|mesh-list
56967602|NCT04332068|Permethrin|permethrin|mesh-list
56967603|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56967604|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967605|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967606|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967607|NCT03295162|Melatonin|melatonin|mesh-list
56967608|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
56967609|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967610|NCT03295162|Protective Agents|protective agents|mesh-ancestor
56967611|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967612|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967613|NCT05237492|Tramadol|tramadol|mesh-list
56967614|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56967615|NCT05237492|Narcotics|narcotics|mesh-ancestor
56967616|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967617|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967618|NCT05237492|Analgesics|analgesics|mesh-ancestor
56967619|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
56967620|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967621|NCT03295084|Capecitabine|capecitabine|mesh-list
56967622|NCT03295084|Irinotecan|irinotecan|mesh-list
56967623|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56967624|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
56967625|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967626|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967627|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56967628|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56967629|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967630|NCT04710134|Reslizumab|reslizumab|mesh-list
56967631|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56967632|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
56967633|NCT01339689|Ganaxolone|ganaxolone|mesh-list
56967634|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
56967635|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967636|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967637|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967638|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
56967639|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
56967640|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56967642|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967643|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967644|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967645|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56967646|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56967647|NCT01336803|Hematinics|hematinics|mesh-ancestor
56967648|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56967649|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56967650|NCT03635931|Mitogens|mitogens|mesh-list
56967651|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
56967652|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967653|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
56967654|NCT02550652|Prednisone|prednisone|mesh-list
56967655|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
56967656|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
56967657|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56967658|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
56967659|NCT02550652|Hormones|hormones|mesh-ancestor
56967660|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967661|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967662|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56967663|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967664|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56967665|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56967666|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
56967667|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56967668|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967669|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967670|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967671|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
56967672|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
56967673|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967674|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56967675|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56967676|NCT02550652|Protective Agents|protective agents|mesh-ancestor
56967677|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56967678|NCT01331967|Pioglitazone|pioglitazone|mesh-list
56967679|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56967680|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967681|NCT00696878|Progesterone|progesterone|mesh-list
56967682|NCT00696878|Progestins|progestins|mesh-ancestor
56967683|NCT00696878|Hormones|hormones|mesh-ancestor
56967684|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967685|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967686|NCT04493151|Imipenem|imipenem|mesh-list
56967687|NCT04493151|Relebactam|relebactam|mesh-list
56967688|NCT04493151|Cilastatin|cilastatin|mesh-list
56967689|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56967690|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967691|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
56967692|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967693|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967694|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56967695|NCT00731757|Adalimumab|adalimumab|mesh-list
56967696|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56888510|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
56967697|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56967698|NCT03108274|Fexofenadine|fexofenadine|mesh-list
56967699|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
56967700|NCT03108274|Midazolam|midazolam|mesh-list
56967701|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56967702|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56967703|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967704|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967705|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56649990|NCT02652234|Growth Substances|growth substances|mesh-ancestor
56649991|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649992|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
56649993|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649994|NCT04211012|Paclitaxel|paclitaxel|mesh-list
56649995|NCT04211012|Cisplatin|cisplatin|mesh-list
56967707|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56967708|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56967709|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
56967710|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
56967711|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
56967712|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
56967713|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967714|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967715|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56967716|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967717|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56967718|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
56967719|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56967720|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967721|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967722|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56967723|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56967724|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56967725|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
56967726|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
56967727|NCT02278588|Rasagiline|rasagiline|mesh-list
56967728|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56967729|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967730|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967731|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56967732|NCT02278588|Protective Agents|protective agents|mesh-ancestor
56967733|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967734|NCT03288610|Vasopressins|vasopressins|mesh-list
56967735|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
56967736|NCT03288610|Coagulants|coagulants|mesh-ancestor
56967737|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56967738|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56967739|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
56967740|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967741|NCT00696800|Progesterone|progesterone|mesh-list
56967742|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56967743|NCT00696800|Ganirelix|ganirelix|mesh-list
56967744|NCT00696800|Progestins|progestins|mesh-ancestor
56967745|NCT00696800|Hormones|hormones|mesh-ancestor
56967746|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967747|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967748|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967749|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
56967750|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56967751|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967752|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
56967753|NCT03288532|Durvalumab|durvalumab|mesh-list
56967754|NCT03288532|Tremelimumab|tremelimumab|mesh-list
56967755|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56967756|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967757|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56967758|NCT00598208|Hormones|hormones|mesh-ancestor
56967759|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967760|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967761|NCT00480662|Alendronate|alendronate|mesh-list
56967762|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56967763|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967764|NCT00398606|Alendronate|alendronate|mesh-list
56967765|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
56967766|NCT00398606|Calcium|calcium|mesh-list
56967767|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56967768|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967769|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967770|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56967771|NCT00398606|Antacids|antacids|mesh-ancestor
56967772|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56967773|NCT00395408|Beclomethasone|beclomethasone|mesh-list
56967774|NCT00395408|Montelukast|montelukast|mesh-list
56967775|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967776|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967777|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
56967778|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56967779|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56967780|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967781|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967782|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56967783|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56967785|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
56967786|NCT00395408|Hormones|hormones|mesh-ancestor
56967787|NCT02462044|Iodine|iodine|mesh-list
56967788|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
56967789|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56967790|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967791|NCT02462044|Trace Elements|trace elements|mesh-ancestor
56967792|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
56967793|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967794|NCT00289874|Montelukast|montelukast|mesh-list
56967795|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56967796|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
56967797|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56967798|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967799|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967800|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967801|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56967802|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56967803|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967804|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56967805|NCT00245570|Montelukast|montelukast|mesh-list
56967806|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56967807|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
56967808|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967809|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967810|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56967811|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
56967812|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56967813|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56967814|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56967815|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
56967816|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967817|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967818|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56967819|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967820|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967821|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56967822|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56967823|NCT02461888|Dexamethasone|dexamethasone|mesh-list
56967824|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
56967825|NCT02461888|Ixazomib|ixazomib|mesh-list
56967826|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967827|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
56967828|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967829|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56967830|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56967831|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
56967832|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967833|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967834|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56967835|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56967836|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
56967837|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
56967838|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967839|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56967840|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
56967841|NCT02461888|Hormones|hormones|mesh-ancestor
56888657|NCT00041067|Docetaxel|docetaxel|mesh-list
56967842|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56967843|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56967844|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
56967845|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967846|NCT00229970|Montelukast|montelukast|mesh-list
56967847|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56967848|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
56967849|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56967850|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
56967851|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650150|NCT02648490|Acetaminophen|acetaminophen|mesh-list
56967852|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967853|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56967854|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56967855|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967856|NCT00111722|Rizatriptan|rizatriptan|mesh-list
56967857|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967858|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967859|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967860|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56967861|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
56967862|NCT04626596|Etonogestrel|etonogestrel|mesh-list
56967863|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56967864|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
56967865|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56967866|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967867|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56967868|NCT05235100|Apatinib|apatinib|mesh-list
56967869|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967870|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56967871|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967872|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967873|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
56967874|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56967875|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56967876|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56967877|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56967878|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967879|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
56967880|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56967881|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967882|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56967883|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967884|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
56967885|NCT00092066|Vitamin D|vitamin d|mesh-list
56967886|NCT00092066|Alendronate|alendronate|mesh-list
56967887|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56967888|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967889|NCT00092066|Vitamins|vitamins|mesh-ancestor
56967890|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
56967891|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56967892|NCT01466686|Temozolomide|temozolomide|mesh-list
56967893|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56967894|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
56967895|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967896|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967897|NCT00840177|Cytarabine|cytarabine|mesh-list
56967898|NCT00840177|Idarubicin|idarubicin|mesh-list
56967899|NCT00840177|Pravastatin|pravastatin|mesh-list
56967900|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56967901|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
56967902|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967903|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967904|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
56967905|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56967906|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967907|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
56967908|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967909|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56967910|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56967911|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56967912|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967913|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56967914|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56967915|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56967916|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56967917|NCT04091750|Nivolumab|nivolumab|mesh-list
56967918|NCT04091750|Ipilimumab|ipilimumab|mesh-list
56967919|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56967920|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967921|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56967922|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967923|NCT01334619|Ropivacaine|ropivacaine|mesh-list
56967924|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
56650219|NCT04244981|Thrombin|thrombin|mesh-list
56967925|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
56967926|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967927|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967928|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
56967929|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56967930|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
56967931|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56967932|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967933|NCT00457275|Ezetimibe|ezetimibe|mesh-list
56967934|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56967935|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56967936|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
56967937|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967938|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56967939|NCT03294070|Amlodipine|amlodipine|mesh-list
56967940|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56967941|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56967942|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56967943|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967944|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56967945|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967946|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
56967947|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
56967948|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
56967949|NCT04479566|Calcium|calcium|mesh-list
56967950|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56967951|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967952|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
56967953|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56967954|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967955|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967956|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
56967957|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56967958|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56967959|NCT04479566|Antacids|antacids|mesh-ancestor
56967960|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56967961|NCT03293992|Latanoprost|latanoprost|mesh-list
56967962|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56967963|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56967964|NCT01332201|Tacrolimus|tacrolimus|mesh-list
56967965|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967966|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
56967967|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967968|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56967969|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967970|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967971|NCT01332279|Everolimus|everolimus|mesh-list
56967972|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56967973|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967974|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967975|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
56967976|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967977|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56967978|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56967979|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967980|NCT04994132|Dactinomycin|dactinomycin|mesh-list
56967981|NCT04994132|Cactinomycin|cactinomycin|mesh-list
56967982|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
56967983|NCT04994132|Vincristine|vincristine|mesh-list
56967984|NCT04994132|Vinorelbine|vinorelbine|mesh-list
56967985|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56967986|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
56967987|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56967988|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56967989|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56967990|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
56967991|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56967992|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56967993|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56967994|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56967995|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
56967996|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
56967997|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
56967998|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56967999|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968000|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56968001|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56968002|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968003|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56968004|NCT03298906|Ticlopidine|ticlopidine|mesh-list
56968005|NCT03298906|Esketamine|esketamine|mesh-list
56968006|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
56968007|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56968008|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56968009|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56968010|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968011|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56968012|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56968013|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56968014|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56968015|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
56968016|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968017|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968018|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56968019|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56968020|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968021|NCT03092817|Dexamethasone|dexamethasone|mesh-list
56968022|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968023|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
56968024|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
56968025|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968026|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968027|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56968028|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
56968029|NCT03092817|Hormones|hormones|mesh-ancestor
56968030|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968031|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56968032|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968033|NCT03697629|Daratumumab|daratumumab|mesh-list
56968034|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968035|NCT03501381|Aldesleukin|aldesleukin|mesh-list
56968036|NCT03501381|Interleukin-2|interleukin-2|mesh-list
56968037|NCT03501381|Entinostat|entinostat|mesh-list
56968038|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968039|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56968040|NCT03501381|Analgesics|analgesics|mesh-ancestor
56968041|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
56968042|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968043|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968044|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56968045|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56968046|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
56968047|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968048|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56968049|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968050|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968051|NCT00398541|Losartan|losartan|mesh-list
56968052|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56968053|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56968054|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56968055|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56968056|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56968057|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968058|NCT00398541|Diuretics|diuretics|mesh-ancestor
56968059|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
56968060|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888897|NCT01327521|Cisplatin|cisplatin|mesh-list
56968061|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56968062|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56968063|NCT03286582|Clobetasol|clobetasol|mesh-list
56968064|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968065|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
56968066|NCT03286582|Hormones|hormones|mesh-ancestor
56968067|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968068|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968069|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56968070|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56968071|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
56968072|NCT05202002|Hormones|hormones|mesh-ancestor
56968073|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968074|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968075|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968076|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968078|NCT02460640|Ropivacaine|ropivacaine|mesh-list
56968079|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56968080|NCT02460640|Narcotics|narcotics|mesh-ancestor
56968081|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968082|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968083|NCT02460640|Analgesics|analgesics|mesh-ancestor
56968084|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
56968085|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968086|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
56968087|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
56968088|NCT03298516|Azacitidine|azacitidine|mesh-list
56968089|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56968090|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
56968091|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968092|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968093|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968094|NCT04045028|Rituximab|rituximab|mesh-list
56968095|NCT04045028|Atezolizumab|atezolizumab|mesh-list
56968096|NCT04045028|Daratumumab|daratumumab|mesh-list
56968097|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968098|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968099|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
56968100|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968101|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56968102|NCT05120960|Osimertinib|osimertinib|mesh-list
56968103|NCT05120960|Tepotinib|tepotinib|mesh-list
56968104|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968105|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56968106|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968107|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968108|NCT05169866|Amiodarone|amiodarone|mesh-list
56968109|NCT05169866|Nifekalant|nifekalant|mesh-list
56968110|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56968111|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
56968112|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56968113|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56968114|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968115|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56968116|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56968117|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56968118|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968119|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56968120|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56968121|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56968122|NCT03843008|Melatonin|melatonin|mesh-list
56968123|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
56968124|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968125|NCT03843008|Protective Agents|protective agents|mesh-ancestor
56968126|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968127|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968128|NCT03285802|Everolimus|everolimus|mesh-list
56968129|NCT03285802|Letrozole|letrozole|mesh-list
56968130|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968131|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968132|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
56968133|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968134|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56968135|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56968136|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968137|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968138|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56968139|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
56968140|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968141|NCT03285568|Palbociclib|palbociclib|mesh-list
56968142|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968143|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56968144|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968145|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968146|NCT05130086|Islatravir|islatravir|mesh-list
56968147|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
56968148|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968149|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968150|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968151|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56968152|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56968153|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56968154|NCT02461186|Piperaquine|piperaquine|mesh-list
56968156|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
56968157|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56968158|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56968159|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968160|NCT04921670|Infliximab|infliximab|mesh-list
56968161|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56968162|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56968163|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56968164|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
56968165|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56968166|NCT03512210|Velpatasvir|velpatasvir|mesh-list
56968167|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
56968168|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968169|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
56968170|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
56968171|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56968172|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
56968173|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968174|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968175|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56968176|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
56968177|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56968178|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56968179|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56968180|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
56968181|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968182|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968183|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968184|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
56968185|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56968186|NCT03292822|Paclitaxel|paclitaxel|mesh-list
56968187|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56968188|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968189|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
56968190|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
56968191|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
56968192|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968193|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
56968194|NCT03297502|Tacrolimus|tacrolimus|mesh-list
56968195|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56968196|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56968197|NCT03297502|Analgesics|analgesics|mesh-ancestor
56968198|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
56968199|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968200|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968201|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968202|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56968203|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
56968204|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968205|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
56968206|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56968207|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968208|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968209|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
56968210|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
56889038|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56968211|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56968212|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56968213|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968214|NCT03292744|Vitamins|vitamins|mesh-ancestor
56968215|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
56968216|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56968217|NCT03035942|Dexamethasone|dexamethasone|mesh-list
56968218|NCT03035942|Ondansetron|ondansetron|mesh-list
56968219|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968220|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
56968221|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
56968222|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968223|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968224|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56968226|NCT03035942|Hormones|hormones|mesh-ancestor
56968227|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968228|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56968229|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968230|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
56968231|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
56968232|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56968233|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
56968234|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968235|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968236|NCT03035942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56968237|NCT03035942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56968238|NCT03035942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968239|NCT03035942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56968240|NCT03035942|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56968241|NCT02820519|Loxapine|loxapine|mesh-list
56968242|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56968243|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56968244|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968245|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968246|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56968247|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56968248|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
56968249|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968250|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968251|NCT03831932|Osimertinib|osimertinib|mesh-list
56968252|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968253|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56968254|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968255|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968256|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56968257|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56968258|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
56968259|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56968260|NCT02616146|Etonogestrel|etonogestrel|mesh-list
56968261|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56968262|NCT02616146|Estradiol|estradiol|mesh-list
56968263|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56968264|NCT02616146|Estrogens|estrogens|mesh-ancestor
56968265|NCT02616146|Hormones|hormones|mesh-ancestor
56968266|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968267|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968268|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56968269|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
56968270|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56968271|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56968272|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56968273|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56968274|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56968275|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56968276|NCT01332747|Atorvastatin|atorvastatin|mesh-list
56968277|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56968278|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56968279|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
56968280|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968281|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56968282|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56968283|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968284|NCT03442413|Nicotine|nicotine|mesh-list
56889111|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
56968285|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56968286|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
56968287|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968288|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968289|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56968290|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56968291|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
56968292|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968293|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968294|NCT01337427|Interferons|interferons|mesh-list
56968295|NCT01337427|Interferon-beta|interferon-beta|mesh-list
56968296|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
56650597|NCT02827643|Vitamin D|vitamin d|mesh-list
56968297|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968299|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968300|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
56968301|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968302|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56968303|NCT02459938|Glucagon|glucagon|mesh-list
56968304|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56968305|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56968306|NCT02459938|Hormones|hormones|mesh-ancestor
56968307|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968308|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968309|NCT02459938|Incretins|incretins|mesh-ancestor
56968310|NCT03284164|Tenofovir|tenofovir|mesh-list
56968311|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
56968312|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968313|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56968314|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56968315|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968316|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968317|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56968318|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56968319|NCT01337583|Dapivirine|dapivirine|mesh-list
56968320|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56968321|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56968322|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
56968323|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968324|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
56968325|NCT03107962|Antibodies|antibodies|mesh-list
56968326|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
56968327|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
56968328|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968329|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968330|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968331|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
56968332|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56968333|NCT04891172|Antibodies|antibodies|mesh-list
56968334|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
56968335|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56968336|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
56968337|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968338|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
56968339|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968340|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968341|NCT01335321|Triamcinolone|triamcinolone|mesh-list
56968342|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
56968343|NCT01335321|Hylan|hylan|mesh-list
56968344|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968345|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
56968346|NCT01335321|Hormones|hormones|mesh-ancestor
56968347|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968348|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968349|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
56968350|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
56968351|NCT01335321|Protective Agents|protective agents|mesh-ancestor
56968352|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56968353|NCT01333137|Gemcitabine|gemcitabine|mesh-list
56968354|NCT01333137|Carboplatin|carboplatin|mesh-list
56968355|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968356|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56968357|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
56968358|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968359|NCT01333137|Antiviral Agents|antiviral agents|mesh-ancestor
56968360|NCT01333137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968361|NCT01333137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968362|NCT01333137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968363|NCT01333137|Immunologic Factors|immunologic factors|mesh-ancestor
56968364|NCT01333137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968365|NCT03282838|Celecoxib|celecoxib|mesh-list
56968366|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56650667|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
56968367|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56968368|NCT03282838|Analgesics|analgesics|mesh-ancestor
56968369|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
56968370|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968371|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968372|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968373|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56968374|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56968375|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56968376|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968377|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968378|NCT04431466|Ivermectin|ivermectin|mesh-list
56968379|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56968380|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968381|NCT03291418|Naproxen|naproxen|mesh-list
56968382|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56968383|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56968384|NCT03291418|Analgesics|analgesics|mesh-ancestor
56968385|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
56968386|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968387|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968388|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968389|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56968390|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
56968391|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56968392|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968393|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968394|NCT02885181|Methotrexate|methotrexate|mesh-list
56968395|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56968396|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
56968397|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56968398|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968399|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56968400|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
56968401|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968402|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968403|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
56968404|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968405|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56968406|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968407|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
56968408|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56968409|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56968410|NCT02459782|Anesthetics|anesthetics|mesh-list
56968411|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968412|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968413|NCT04239040|Nivolumab|nivolumab|mesh-list
56968414|NCT04239040|Ipilimumab|ipilimumab|mesh-list
56968415|NCT04239040|Vaccines|vaccines|mesh-list
56968416|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
56968417|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968418|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968419|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968420|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56968421|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968422|NCT02884089|Metformin|metformin|mesh-list
56968423|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56968424|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968425|NCT01315431|Capecitabine|capecitabine|mesh-list
56968426|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56968427|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
56968428|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968429|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968430|NCT00092625|Ezetimibe|ezetimibe|mesh-list
56968431|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56968432|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56968433|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
55726702|NCT01601626|Vitamins|vitamins|mesh-ancestor
56968434|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968435|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56968436|NCT04135846|Doxazosin|doxazosin|mesh-list
56968437|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56968438|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56968439|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56968440|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56968441|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
56968442|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968443|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968444|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968445|NCT01333449|Decitabine|decitabine|mesh-list
56968446|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56968447|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
56968448|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968449|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968450|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968451|NCT04853199|Quercetin|quercetin|mesh-list
56968452|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
56968453|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968454|NCT04853199|Protective Agents|protective agents|mesh-ancestor
56968455|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968456|NCT01341717|Metformin|metformin|mesh-list
56968457|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56968458|NCT01341717|Glimepiride|glimepiride|mesh-list
56968459|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56968460|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968461|NCT01341717|Incretins|incretins|mesh-ancestor
56968462|NCT01341717|Hormones|hormones|mesh-ancestor
56968463|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968464|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56968465|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
56968466|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968467|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968468|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56968469|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968470|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
56968471|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
56968472|NCT03157089|Afatinib|afatinib|mesh-list
56968473|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968474|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968475|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56968476|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968477|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968478|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
56968479|NCT01338129|Vitamins|vitamins|mesh-ancestor
56968480|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
56968481|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968482|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
56968483|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968484|NCT01338129|Protective Agents|protective agents|mesh-ancestor
56968485|NCT05181969|Dextrans|dextrans|mesh-list
56968486|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
56968487|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
56968488|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
56968489|NCT00092157|Simvastatin|simvastatin|mesh-list
56968490|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56968491|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56968492|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
56968493|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968494|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56968495|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56968496|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968497|NCT00089895|Eptifibatide|eptifibatide|mesh-list
56968498|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56968499|NCT05166291|Anesthetics|anesthetics|mesh-list
56968500|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968501|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968502|NCT01338441|Erythromycin|erythromycin|mesh-list
56968503|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
56968504|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56968505|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
56968506|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56968507|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968508|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889333|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
56968509|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56968510|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968511|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968512|NCT01341951|Lenograstim|lenograstim|mesh-list
56968513|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56968514|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
56968515|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968516|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
56968517|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968518|NCT02714218|Nivolumab|nivolumab|mesh-list
56968519|NCT02714218|Ipilimumab|ipilimumab|mesh-list
56968520|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968521|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650817|NCT03703856|Memantine|memantine|mesh-list
56968522|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56968523|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968525|NCT05185869|Paclitaxel|paclitaxel|mesh-list
56968526|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56968527|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968528|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
56968529|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
56968530|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
56968531|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968532|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56968533|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
56968534|NCT05185869|Antiviral Agents|antiviral agents|mesh-ancestor
56968535|NCT05185869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968536|NCT05185869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968537|NCT05185869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968538|NCT05185869|Immunologic Factors|immunologic factors|mesh-ancestor
56968539|NCT05185869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968540|NCT01338675|Busulfan|busulfan|mesh-list
56968541|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
56968542|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968543|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968544|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
56968545|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968546|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56968547|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968548|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56968549|NCT01338753|Bevacizumab|bevacizumab|mesh-list
56968550|NCT01338753|Docetaxel|docetaxel|mesh-list
56968551|NCT01338753|Doxorubicin|doxorubicin|mesh-list
56968552|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968553|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968554|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56968555|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56968556|NCT01338753|Growth Substances|growth substances|mesh-ancestor
56968557|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968558|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
56968559|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
56968560|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
56968561|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
56968562|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968563|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56968564|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56968565|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56968566|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968567|NCT02457286|Metformin|metformin|mesh-list
56968568|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56968569|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968570|NCT01338909|Clopidogrel|clopidogrel|mesh-list
56968571|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56968572|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56968573|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56968574|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56968575|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56968576|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
56968577|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968578|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968579|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968580|NCT03282136|Incretins|incretins|mesh-list
56968581|NCT03282136|Hormones|hormones|mesh-ancestor
56968582|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968583|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968584|NCT03264586|Lidocaine|lidocaine|mesh-list
56968585|NCT03264586|Prilocaine|prilocaine|mesh-list
56968586|NCT03264586|Mepivacaine|mepivacaine|mesh-list
56968587|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56968588|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
56968589|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
56968590|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968591|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968592|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
56968593|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968594|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56650900|NCT02646072|Ketorolac|ketorolac|mesh-list
56968595|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56968596|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56968597|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56968598|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968599|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56968600|NCT01342731|Tigecycline|tigecycline|mesh-list
56968601|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56968602|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968603|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56968604|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968605|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968606|NCT01339065|Ketamine|ketamine|mesh-list
56968607|NCT01339065|Analgesics|analgesics|mesh-ancestor
56968608|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
56968609|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968610|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968611|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56968612|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56968613|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
56968614|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
56968615|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968616|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56968617|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56968618|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968619|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968620|NCT02460016|Ziresovir|ziresovir|mesh-list
56968621|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
56968622|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968623|NCT05151159|Antibodies|antibodies|mesh-list
56968624|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
56968625|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968626|NCT05187507|Theobromine|theobromine|mesh-list
56968627|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56968628|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
56968629|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968630|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968631|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56968632|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
56968633|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
56968634|NCT01339143|Pioglitazone|pioglitazone|mesh-list
56968635|NCT01339143|Vildagliptin|vildagliptin|mesh-list
56968636|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56968637|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968638|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56968639|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
56968640|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968641|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968642|NCT03264430|Ketamine|ketamine|mesh-list
56968643|NCT03264430|Bupivacaine|bupivacaine|mesh-list
56968644|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
56968645|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
56968646|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968647|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968648|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
56968649|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968650|NCT03264430|Analgesics|analgesics|mesh-ancestor
56968651|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56968652|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56968653|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
56968654|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56889489|NCT01210521|Vitamin D|vitamin d|mesh-list
56968655|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56968656|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968657|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968658|NCT05250843|Lenvatinib|lenvatinib|mesh-list
56968659|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968660|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56968661|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968662|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968663|NCT03264274|Aflibercept|aflibercept|mesh-list
56968664|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56968665|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56968666|NCT03264274|Growth Substances|growth substances|mesh-ancestor
56968667|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968668|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
56968669|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968671|NCT02457208|Isoniazid|isoniazid|mesh-list
56968672|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
56968673|NCT02457208|Ethambutol|ethambutol|mesh-list
56968674|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56968675|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
56968676|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56968677|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968678|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
56968679|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56968680|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968681|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968682|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56968683|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56968684|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56968685|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56968686|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56968687|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56968688|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56968689|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56968690|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
56968691|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56968692|NCT02457130|Clopidogrel|clopidogrel|mesh-list
56968693|NCT02457130|Ticagrelor|ticagrelor|mesh-list
56968694|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56968695|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56968696|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56968697|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56968698|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
56968699|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968700|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968701|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968702|NCT01340235|Erythromycin|erythromycin|mesh-list
56968703|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
56968704|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56968705|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
56968706|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56968707|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968708|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56968709|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56968710|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968711|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968712|NCT03263962|Canrenone|canrenone|mesh-list
56968713|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56968714|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
56968715|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968716|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968717|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56968718|NCT03263962|Diuretics|diuretics|mesh-ancestor
56968719|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
56968720|NCT05186649|Warfarin|warfarin|mesh-list
56968721|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
56968722|NCT05184465|Anesthetics|anesthetics|mesh-list
56968723|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968724|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968725|NCT03152019|Tacrolimus|tacrolimus|mesh-list
56968726|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968727|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
56968728|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968729|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56968730|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968731|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968732|NCT02714062|Topiramate|topiramate|mesh-list
56968733|NCT02714062|Phentermine|phentermine|mesh-list
56968734|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
56968735|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56968736|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968737|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56968738|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
56968739|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56968740|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
56968741|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
56968742|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968744|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968745|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968746|NCT03280342|Topiramate|topiramate|mesh-list
56968747|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
56968748|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56968749|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968750|NCT04965519|Trastuzumab|trastuzumab|mesh-list
56968751|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968752|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968753|NCT03279796|Betamethasone|betamethasone|mesh-list
56968754|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968755|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
56968756|NCT03279796|Hormones|hormones|mesh-ancestor
56968757|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56968758|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968759|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56968760|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
56968761|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
56968762|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
56968763|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
56968764|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968765|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968766|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
56968767|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968768|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
56968769|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56968770|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968771|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968772|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
56968773|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968774|NCT05183997|Verapamil|verapamil|mesh-list
56968775|NCT05183997|Thrombin|thrombin|mesh-list
56968776|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56968777|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56968778|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56968779|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968780|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56968781|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968782|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
56968783|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
56968784|NCT05183997|Coagulants|coagulants|mesh-ancestor
56968785|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
56968786|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968787|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968788|NCT05119101|Analgesics|analgesics|mesh-ancestor
56968789|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
56968790|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968791|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968792|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
56968793|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56968794|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
56968795|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56968796|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56968797|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56968798|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
56968799|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56968800|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
56968801|NCT01340547|Ifosfamide|ifosfamide|mesh-list
56968802|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56968803|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
56889639|NCT01115985|Atorvastatin|atorvastatin|mesh-list
56968804|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968805|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968806|NCT05183841|Fenoterol|fenoterol|mesh-list
56968807|NCT05183841|Ipratropium|ipratropium|mesh-list
56968808|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
56968809|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
56968810|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968811|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968812|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56968813|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
56968814|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56968815|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
56968816|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968817|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968818|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
56968819|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
56968820|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56968821|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56968822|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56968823|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56968824|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
56968825|NCT03277222|Insulin|insulin|mesh-list
56968826|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56968827|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968828|NCT04931667|Lorecivivint|lorecivivint|mesh-list
56968829|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968830|NCT03262948|Paclitaxel|paclitaxel|mesh-list
56968831|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56968832|NCT03262948|Carboplatin|carboplatin|mesh-list
56968833|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56968834|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968835|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
56968836|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
56968837|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
56968838|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968839|NCT03276598|Losartan|losartan|mesh-list
56968840|NCT03276598|Amlodipine|amlodipine|mesh-list
56968841|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56968842|NCT03276598|Bisoprolol|bisoprolol|mesh-list
56968843|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56968844|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56968845|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56968846|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968847|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56968848|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968849|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
56968850|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56968851|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56968852|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56968853|NCT03276598|Diuretics|diuretics|mesh-ancestor
56968854|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
56968855|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56968856|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
56968857|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
56968858|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968859|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56968860|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56968861|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56968862|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
56968863|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968864|NCT03262792|Andrographolide|andrographolide|mesh-list
56968865|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968866|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56968867|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56968868|NCT03262792|Analgesics|analgesics|mesh-ancestor
56968869|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
56968870|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968871|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968872|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56968873|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56968874|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56968875|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968876|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
56968877|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56968878|NCT01359462|Tolvaptan|tolvaptan|mesh-list
56968879|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56968880|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968881|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
56968882|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968883|NCT02875392|Fucoidan|fucoidan|mesh-list
56968884|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56968885|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56968886|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
56968887|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968888|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
56968889|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56968890|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56968891|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968892|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56968893|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56968894|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968895|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968896|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968897|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56968898|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
56968899|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56968900|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968901|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56968902|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56968903|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56968904|NCT03267628|Morphine|morphine|mesh-list
56968905|NCT03267628|Anesthetics|anesthetics|mesh-list
56968906|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
56968907|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56968908|NCT03267628|Narcotics|narcotics|mesh-ancestor
56968909|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968910|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968911|NCT03267628|Analgesics|analgesics|mesh-ancestor
56968912|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
56968913|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968914|NCT01359696|Gemcitabine|gemcitabine|mesh-list
56968915|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56968916|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
56968917|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968918|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968919|NCT01359696|Antiviral Agents|antiviral agents|mesh-ancestor
56968920|NCT01359696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56968921|NCT01359696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56968922|NCT01359696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968923|NCT01359696|Immunologic Factors|immunologic factors|mesh-ancestor
56968924|NCT01359696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968925|NCT03268018|Calcium|calcium|mesh-list
56968926|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56968927|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968928|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56968929|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56968930|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56968931|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968932|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968933|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56968934|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56968935|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56968936|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
56968937|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968938|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968939|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56968940|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56968941|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
56968942|NCT01367028|Bevacizumab|bevacizumab|mesh-list
56968943|NCT01367028|Trastuzumab|trastuzumab|mesh-list
56968944|NCT01367028|Docetaxel|docetaxel|mesh-list
56968945|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56968946|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56968947|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56968948|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56968949|NCT01367028|Growth Substances|growth substances|mesh-ancestor
56968950|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968951|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
56968952|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56968953|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56968954|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56968955|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968956|NCT03965962|Vaccines|vaccines|mesh-list
56968957|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
56968958|NCT03965962|Antibodies|antibodies|mesh-list
56968959|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
56968960|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56968961|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56968962|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
56968963|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968964|NCT03273088|Etanercept|etanercept|mesh-list
56968965|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56968966|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56968967|NCT03273088|Analgesics|analgesics|mesh-ancestor
56968968|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
56968969|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968970|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968971|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968972|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56968973|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56968974|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56968975|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
56968976|NCT04235634|Alprostadil|alprostadil|mesh-list
56968977|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56968978|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
56968979|NCT04235634|Urological Agents|urological agents|mesh-ancestor
56968980|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
56968981|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56968982|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56968983|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56968984|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56968985|NCT03262090|Analgesics|analgesics|mesh-ancestor
56968986|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
56968987|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56968988|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56968989|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56968990|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56968991|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
56968992|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56968993|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56968995|NCT03151551|Ixekizumab|ixekizumab|mesh-list
56968996|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968997|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56968998|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
56968999|NCT03267316|Gemcitabine|gemcitabine|mesh-list
56969000|NCT03267316|Paclitaxel|paclitaxel|mesh-list
56969001|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56969002|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969003|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
56969004|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
56969005|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
56969006|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969007|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56969008|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
56969009|NCT03267316|Antiviral Agents|antiviral agents|mesh-ancestor
56969010|NCT03267316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969011|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969012|NCT03267316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56969013|NCT03267316|Immunologic Factors|immunologic factors|mesh-ancestor
56969014|NCT03267316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969015|NCT01359930|Naltrexone|naltrexone|mesh-list
56969016|NCT01359930|Bupropion|bupropion|mesh-list
56969017|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56969018|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56969019|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969020|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
56969021|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969022|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56969023|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
56969024|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56969025|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56969026|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56969027|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56889860|NCT01216839|Everolimus|everolimus|mesh-list
56969028|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969029|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
56969030|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969031|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56969032|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56969033|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969034|NCT05075512|Fulvestrant|fulvestrant|mesh-list
56969035|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56969036|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969037|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56969038|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56969039|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
56969040|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969041|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969042|NCT01316757|Paclitaxel|paclitaxel|mesh-list
56969043|NCT01316757|Carboplatin|carboplatin|mesh-list
56969044|NCT01316757|Cetuximab|cetuximab|mesh-list
56969045|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56969046|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56969047|NCT01316757|Antibodies|antibodies|mesh-list
56969048|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
56969049|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56969050|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56969051|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969052|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
56969053|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
56969054|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
56969055|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969056|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
56969057|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969058|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56969059|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969060|NCT05074966|Cetuximab|cetuximab|mesh-list
56969061|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56969062|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969063|NCT03266926|Bupivacaine|bupivacaine|mesh-list
56969064|NCT03266926|Estrogens|estrogens|mesh-list
56969065|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56969066|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
56969067|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
56969068|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969069|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969070|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
56969071|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969072|NCT03266926|Hormones|hormones|mesh-ancestor
56969073|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969074|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
56969075|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56969076|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
56969077|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969078|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969079|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56969080|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
56969081|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56969082|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56969083|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56969084|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
56969085|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969086|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969087|NCT01367418|Sufentanil|sufentanil|mesh-list
56969088|NCT01367418|Morphine|morphine|mesh-list
56969089|NCT01367418|Bupivacaine|bupivacaine|mesh-list
56969090|NCT01367418|Ropivacaine|ropivacaine|mesh-list
56969091|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
56969092|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
56969093|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969094|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969095|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
56969096|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969097|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56969098|NCT01367418|Narcotics|narcotics|mesh-ancestor
56969099|NCT01367418|Analgesics|analgesics|mesh-ancestor
56969100|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56969101|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56969102|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
56969103|NCT01360086|Leucovorin|leucovorin|mesh-list
56969104|NCT01360086|Fluorouracil|fluorouracil|mesh-list
56969105|NCT01360086|Cetuximab|cetuximab|mesh-list
56969106|NCT01360086|Calcium|calcium|mesh-list
56969107|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
56969108|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969109|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56969110|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969111|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
56969112|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969113|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56969114|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56651398|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
56969115|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
56969116|NCT01360086|Antidotes|antidotes|mesh-ancestor
56969117|NCT01360086|Protective Agents|protective agents|mesh-ancestor
56969118|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
56969119|NCT01360086|Vitamins|vitamins|mesh-ancestor
56969120|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
56969121|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56969122|NCT02458924|Niacin|niacin|mesh-list
56969123|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56969124|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
56969125|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969126|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56969127|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
56969128|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
56969129|NCT02458924|Vitamins|vitamins|mesh-ancestor
56969130|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
56969131|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969132|NCT01367496|Naltrexone|naltrexone|mesh-list
56969133|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
56969134|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56969135|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969136|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
56969137|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969138|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56969139|NCT02459158|Arbekacin|arbekacin|mesh-list
56969140|NCT02459158|Dibekacin|dibekacin|mesh-list
56969141|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56969142|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969143|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56969144|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
56969145|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56969146|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969147|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
56969148|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969149|NCT04693689|Vaccines|vaccines|mesh-list
56969150|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
56969151|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969152|NCT03126786|Triamcinolone|triamcinolone|mesh-list
56969153|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56969154|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56969155|NCT03126786|Aflibercept|aflibercept|mesh-list
56969156|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56969157|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56969158|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
56969159|NCT03126786|Hormones|hormones|mesh-ancestor
56969160|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969161|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969162|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56969163|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
56969164|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969165|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969166|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56969167|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56969168|NCT03126786|Growth Substances|growth substances|mesh-ancestor
56969169|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
56969170|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969171|NCT01367652|Letrozole|letrozole|mesh-list
56969172|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969173|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56969174|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56969175|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969176|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969177|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56969178|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
56969179|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969180|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969181|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56969182|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
56969183|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56969184|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
56969185|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56969186|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969187|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56969188|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56969189|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56969190|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969191|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56969192|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56969193|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56969194|NCT03146403|Vaccines|vaccines|mesh-list
56969195|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
56969196|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969197|NCT01360476|Vitamin D|vitamin d|mesh-list
56969198|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
56969199|NCT01360476|Vitamins|vitamins|mesh-ancestor
56969200|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
56969201|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969202|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56969203|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56969204|NCT01317069|Fluorouracil|fluorouracil|mesh-list
56969205|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
56969206|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969207|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56969208|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969209|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56969210|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
56969211|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969212|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56969213|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56969214|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56969215|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
56969216|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969217|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969218|NCT01317225|Progestins|progestins|mesh-ancestor
56969219|NCT01317225|Hormones|hormones|mesh-ancestor
56969220|NCT01363206|Ipilimumab|ipilimumab|mesh-list
56969221|NCT01363206|Molgramostim|molgramostim|mesh-list
56969222|NCT01363206|Sargramostim|sargramostim|mesh-list
56969223|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56969224|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969225|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56969226|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969227|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
56969228|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969229|NCT04962022|Ritonavir|ritonavir|mesh-list
56969230|NCT04962022|Itraconazole|itraconazole|mesh-list
56969231|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56969232|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56969233|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
56969234|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969235|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969236|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56969237|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56969238|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
56969239|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969240|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56969241|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56969242|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
56969243|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56969244|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56969245|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
56969246|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969247|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969248|NCT01344213|Celecoxib|celecoxib|mesh-list
56969249|NCT01344213|Pregabalin|pregabalin|mesh-list
56969250|NCT01344213|Analgesics|analgesics|mesh-ancestor
56969251|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
55726703|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
56969252|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969253|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969254|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
56969255|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56969256|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56969257|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969258|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56969259|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56969260|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56969261|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969262|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56969263|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56969264|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56969265|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651555|NCT00653874|Bilirubin|bilirubin|mesh-list
56969267|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56969268|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56969269|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969270|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
56969271|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56969272|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
56969273|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56969274|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
56969275|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969276|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969277|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
56969278|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56969279|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56969280|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56969281|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56969282|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969283|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969284|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969285|NCT01363284|Analgesics|analgesics|mesh-ancestor
56969286|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
56969287|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969288|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
56969289|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56969290|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
56969291|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56969292|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56969293|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969294|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
56969295|NCT01344291|Curcumin|curcumin|mesh-list
56969296|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56969297|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56969298|NCT01344291|Analgesics|analgesics|mesh-ancestor
56969299|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
56969300|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969301|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969302|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56969303|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56969304|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969305|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969306|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969307|NCT01367964|Hormones|hormones|mesh-list
56969308|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56969309|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56969310|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
56969311|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969312|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969313|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969314|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969315|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
56969316|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969317|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56969318|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969319|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969320|NCT04733560|Bupivacaine|bupivacaine|mesh-list
56969321|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
56969322|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
56969323|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890164|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969324|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969325|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
56969326|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969327|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
56969328|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56969329|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
56969330|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969331|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969332|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56969333|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
56969334|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56969335|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
56969336|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969337|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969338|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56969339|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
56969340|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
56969341|NCT01347957|Protective Agents|protective agents|mesh-ancestor
56969342|NCT03632044|Ropivacaine|ropivacaine|mesh-list
56969343|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
56969344|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
56969345|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969346|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969347|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
56969348|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969349|NCT04735965|Meperidine|meperidine|mesh-list
56969350|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
56969351|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56969352|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969353|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969354|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56969355|NCT04735965|Analgesics|analgesics|mesh-ancestor
56969356|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
56969357|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969358|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56969359|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56969360|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56969361|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
56969362|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969363|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969364|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56969365|NCT04735965|Narcotics|narcotics|mesh-ancestor
56969366|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56969367|NCT04291599|Ketorolac|ketorolac|mesh-list
56969368|NCT04291599|Morphine|morphine|mesh-list
56969369|NCT04291599|Hydromorphone|hydromorphone|mesh-list
56969370|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56969371|NCT04291599|Narcotics|narcotics|mesh-ancestor
56969372|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969373|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969374|NCT04291599|Analgesics|analgesics|mesh-ancestor
56969375|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
56969376|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969377|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56969378|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56969379|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56969380|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56969381|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56969382|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969383|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969384|NCT02456428|Insulin|insulin|mesh-list
56969385|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56969386|NCT02456428|Metformin|metformin|mesh-list
56969387|NCT02456428|Pioglitazone|pioglitazone|mesh-list
56969388|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56969389|NCT02456428|Liraglutide|liraglutide|mesh-list
56969390|NCT02456428|Exenatide|exenatide|mesh-list
56969391|NCT02456428|Glimepiride|glimepiride|mesh-list
56969392|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
56969393|NCT02456428|Vildagliptin|vildagliptin|mesh-list
56969394|NCT02456428|Saxagliptin|saxagliptin|mesh-list
56969395|NCT02456428|Acarbose|acarbose|mesh-list
56969396|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56969397|NCT02456428|Repaglinide|repaglinide|mesh-list
56969398|NCT02456428|Gliclazide|gliclazide|mesh-list
56969399|NCT02456428|Glipizide|glipizide|mesh-list
56890283|NCT01221129|Zinc|zinc|mesh-list
56969400|NCT02456428|Biguanides|biguanides|mesh-list
56969401|NCT02456428|Voglibose|voglibose|mesh-list
56969402|NCT02456428|Tolbutamide|tolbutamide|mesh-list
56969403|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56969404|NCT02456428|Nateglinide|nateglinide|mesh-list
56969405|NCT02456428|Miglitol|miglitol|mesh-list
56969406|NCT02456428|Troglitazone|troglitazone|mesh-list
56969407|NCT02456428|Meglitinide|meglitinide|mesh-list
56969408|NCT02456428|Acetohexamide|acetohexamide|mesh-list
56969409|NCT02456428|Buformin|buformin|mesh-list
56969410|NCT02456428|Phenformin|phenformin|mesh-list
56969411|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
56969412|NCT02456428|Glibornuride|glibornuride|mesh-list
56969413|NCT02456428|Tolazamide|tolazamide|mesh-list
56969414|NCT02456428|Carbutamide|carbutamide|mesh-list
56969415|NCT02456428|Gliquidone|gliquidone|mesh-list
56969416|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56969417|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
56969418|NCT02456428|Incretins|incretins|mesh-list
56969419|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969420|NCT02456428|Hormones|hormones|mesh-ancestor
56969421|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969422|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
56969423|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969424|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969425|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56969426|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56969427|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56969428|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
56969429|NCT03259516|Cytarabine|cytarabine|mesh-list
56969430|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
56969431|NCT03259516|Melphalan|melphalan|mesh-list
56969432|NCT03259516|Nivolumab|nivolumab|mesh-list
56969433|NCT03259516|Fludarabine|fludarabine|mesh-list
56969434|NCT03259516|Azacitidine|azacitidine|mesh-list
56969435|NCT03259516|Tretinoin|tretinoin|mesh-list
56969436|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
56969437|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56969438|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
56969439|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969440|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56969441|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56969442|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
56969443|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969444|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969445|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56969446|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56969447|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56969448|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56969449|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
56969450|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
56969451|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969452|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969453|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
56969454|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56969455|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56969456|NCT03259516|Urological Agents|urological agents|mesh-ancestor
56969457|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
56969458|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
56969459|NCT01344681|Itraconazole|itraconazole|mesh-list
56969460|NCT01344681|Micafungin|micafungin|mesh-list
56969461|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
56969462|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969463|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56969464|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56969465|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969466|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969467|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56969468|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
56969469|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969470|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969471|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56969472|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
56969473|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56969474|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969475|NCT03259672|Sevoflurane|sevoflurane|mesh-list
56969476|NCT03259672|Desflurane|desflurane|mesh-list
56969477|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56969478|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56969479|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
56969480|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
56969481|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969482|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969483|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
56969484|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56969485|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56969486|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
56969487|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969488|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56969489|NCT02456194|Calcium|calcium|mesh-list
56969490|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56969491|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969492|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969493|NCT03265288|Fenretinide|fenretinide|mesh-list
56969494|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969495|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56969496|NCT03265288|Protective Agents|protective agents|mesh-ancestor
56969497|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969498|NCT03261310|Acetaminophen|acetaminophen|mesh-list
56969499|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56969500|NCT03261310|Analgesics|analgesics|mesh-ancestor
56969501|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
56969502|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969503|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969504|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
56969505|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
56969506|NCT02456350|Fludarabine|fludarabine|mesh-list
56969507|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56969508|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
56969509|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969510|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56969511|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56969512|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
56969513|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969514|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969515|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56969516|NCT03132636|Cemiplimab|cemiplimab|mesh-list
56969517|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56969518|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969519|NCT01319370|Minoxidil|minoxidil|mesh-list
56969520|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56969521|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
56969522|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
56969523|NCT01363752|Sirolimus|sirolimus|mesh-list
56969524|NCT01363752|Tacrolimus|tacrolimus|mesh-list
56969525|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56969526|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
56969527|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969528|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56969529|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969530|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969531|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56969532|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969533|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56969534|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
56969535|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56969536|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969537|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
56969538|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56969539|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
56969540|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56969541|NCT01360710|Irbesartan|irbesartan|mesh-list
56969542|NCT01360710|Moxonidine|moxonidine|mesh-list
56969543|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56969544|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56969545|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56969546|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969547|NCT01360788|Albuterol|albuterol|mesh-list
56969548|NCT01360788|Ipratropium|ipratropium|mesh-list
56969549|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56969550|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
56969551|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969552|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969553|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56969554|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
56969555|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
56969556|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56969557|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56969558|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56969559|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56969560|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
56969561|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969562|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969563|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56969564|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
56969565|NCT01361022|Brotizolam|brotizolam|mesh-list
56969566|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56969567|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969568|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969569|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56651845|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
56969570|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56969571|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56969572|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
56969573|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969574|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56969575|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56969576|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969577|NCT02713204|Aflibercept|aflibercept|mesh-list
56969578|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56969579|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56969580|NCT02713204|Growth Substances|growth substances|mesh-ancestor
56969581|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969582|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
56969583|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969584|NCT03695172|Ropivacaine|ropivacaine|mesh-list
56969585|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
56969586|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
56969587|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969588|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969589|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
56969590|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969591|NCT01364376|Leucovorin|leucovorin|mesh-list
56969592|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
56969593|NCT01364376|Calcium|calcium|mesh-list
56969594|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
56969595|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56969596|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969597|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969598|NCT01364376|Antidotes|antidotes|mesh-ancestor
56969599|NCT01364376|Protective Agents|protective agents|mesh-ancestor
56969600|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
56969601|NCT01364376|Vitamins|vitamins|mesh-ancestor
56969602|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
56969603|NCT01348503|Lenalidomide|lenalidomide|mesh-list
56969604|NCT01348503|Sorafenib|sorafenib|mesh-list
56969605|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
56969606|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969607|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56969608|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56969609|NCT01348503|Growth Substances|growth substances|mesh-ancestor
56969610|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
56969611|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969612|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56969613|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969614|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969615|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56969616|NCT01369290|Citalopram|citalopram|mesh-list
56969617|NCT01369290|Bupropion|bupropion|mesh-list
56969618|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56969619|NCT01369290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56969620|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56969621|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56969622|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969623|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969624|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
56969625|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969626|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56969627|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
56969628|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56969629|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969630|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56969631|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
56969632|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56969633|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56969634|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969635|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56969636|NCT01369290|Analgesics|analgesics|mesh-ancestor
56969637|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
56969638|NCT03533452|Ropivacaine|ropivacaine|mesh-list
56969639|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
56969640|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
56969641|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969642|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969643|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
56969644|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651939|NCT02641938|Analgesics|analgesics|mesh-ancestor
56969645|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
56969646|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56969647|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56969648|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56969649|NCT04359147|Yohimbine|yohimbine|mesh-list
56969650|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56969651|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
56969652|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
56969653|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969654|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969655|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56969656|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56969657|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56969658|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
56969659|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969660|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969661|NCT04359147|Urological Agents|urological agents|mesh-ancestor
56969662|NCT01369368|Azacitidine|azacitidine|mesh-list
56969663|NCT01369368|Valproic Acid|valproic acid|mesh-list
56969664|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56969665|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
56969666|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969667|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969668|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969669|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
56969670|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
56969671|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969672|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969673|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
56969674|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56969675|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969676|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56969677|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
56969678|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56969679|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969680|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
56969681|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
56969682|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969683|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969684|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
56969685|NCT01369602|Vitamins|vitamins|mesh-ancestor
56969686|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
56969687|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969688|NCT03252496|Ephedrine|ephedrine|mesh-list
56969689|NCT03252496|Fentanyl|fentanyl|mesh-list
56969690|NCT03252496|Bupivacaine|bupivacaine|mesh-list
56969691|NCT03252496|Oxytocin|oxytocin|mesh-list
56969692|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
56969693|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
56969694|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969695|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969696|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
56969697|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969698|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56969699|NCT03252496|Narcotics|narcotics|mesh-ancestor
56969700|NCT03252496|Analgesics|analgesics|mesh-ancestor
56969701|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56969702|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56969703|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
56969704|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
56969705|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56969706|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56969707|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
56969708|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
56969709|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56969710|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
56969711|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969712|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969713|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
56969714|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
56969715|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969716|NCT03252418|Protective Agents|protective agents|mesh-ancestor
56969717|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969718|NCT03252418|Vitamins|vitamins|mesh-ancestor
56969719|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
56969720|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
56969721|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56969722|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56969723|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969724|NCT01364688|Vitamins|vitamins|mesh-ancestor
56969725|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
56969726|NCT01370148|Conivaptan|conivaptan|mesh-list
56969727|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56969728|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969729|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
56969730|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969731|NCT04684953|Hormones|hormones|mesh-list
56969732|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969733|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969734|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
56969735|NCT01349127|Vitamin D|vitamin d|mesh-list
56969736|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
56969737|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
56969738|NCT01349127|Vitamins|vitamins|mesh-list
56969739|NCT01349127|Calcium|calcium|mesh-list
56969740|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
56969741|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969742|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56969743|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56969744|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56969745|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
56969746|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969747|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969748|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56969749|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969750|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
56969751|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
56969752|NCT01349205|Caffeine|caffeine|mesh-list
56969753|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56969754|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969755|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56969756|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969757|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969758|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56969759|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56969760|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
56969761|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969762|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
56969763|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969764|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56969765|NCT01349205|Protective Agents|protective agents|mesh-ancestor
56969766|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56969767|NCT01349205|Analgesics|analgesics|mesh-ancestor
56969768|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
56969769|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969770|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56969771|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56969772|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56969773|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56969774|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969775|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969776|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969777|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56969778|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
56969779|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56969780|NCT03982485|Paclitaxel|paclitaxel|mesh-list
56969781|NCT03982485|Apatinib|apatinib|mesh-list
56969782|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56969783|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969784|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
56969785|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
56969786|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
56969787|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969788|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56969789|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969790|NCT03966339|Hormones|hormones|mesh-list
56969791|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969792|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969793|NCT03251872|Olaparib|olaparib|mesh-list
56969794|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56969795|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969796|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969797|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969798|NCT03160521|Risperidone|risperidone|mesh-list
56969799|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56969800|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
56969801|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969802|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969803|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969804|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56969805|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56969806|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969807|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56969808|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56969809|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
56969810|NCT01365000|Naloxegol|naloxegol|mesh-list
56969811|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56969812|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969813|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
56969814|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969815|NCT03147040|Carboplatin|carboplatin|mesh-list
56969816|NCT03147040|Atezolizumab|atezolizumab|mesh-list
56969817|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969818|NCT03251170|Fentanyl|fentanyl|mesh-list
56969819|NCT03251170|Midazolam|midazolam|mesh-list
56969820|NCT03251170|Ketamine|ketamine|mesh-list
56969821|NCT03251170|Analgesics|analgesics|mesh-ancestor
56969822|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
56969823|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969824|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969825|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56969826|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56969827|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
56969828|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
56969829|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969830|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56969831|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56969832|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969833|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969834|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56969835|NCT03251170|Narcotics|narcotics|mesh-ancestor
56969836|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56969837|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56969838|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56969839|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56969840|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56969841|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
56969842|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
56969843|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
56969844|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
56969845|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
56969846|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56969847|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56969848|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56969849|NCT03539601|Analgesics|analgesics|mesh-ancestor
56969850|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
56969851|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969852|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969853|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56969854|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
56969855|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56969856|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
56969857|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56969858|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969859|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969860|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
56969861|NCT02455180|Vitamins|vitamins|mesh-ancestor
56969862|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
56969863|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969864|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
56969865|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652149|NCT02821169|Ropivacaine|ropivacaine|mesh-list
56969866|NCT02455180|Protective Agents|protective agents|mesh-ancestor
56969867|NCT03514719|Avelumab|avelumab|mesh-list
56969868|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56969869|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56969870|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969871|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
56969872|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969873|NCT01349439|Propranolol|propranolol|mesh-list
56969874|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56969875|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56969876|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
56969877|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969878|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969879|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969880|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56969881|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56969882|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
56969883|NCT03245554|Propranolol|propranolol|mesh-list
56969884|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56969885|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56969886|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
56969887|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969888|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969889|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969890|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56969891|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56969892|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
56969893|NCT01346007|Vaccines|vaccines|mesh-list
56969894|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56969895|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
56969896|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969897|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
56969898|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
56969899|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
56969900|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969901|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969902|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
56969903|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969904|NCT03004131|Fluticasone|fluticasone|mesh-list
56969905|NCT03004131|Xhance|xhance|mesh-list
56969906|NCT03004131|Loratadine|loratadine|mesh-list
56969907|NCT03004131|Azelastine|azelastine|mesh-list
56969908|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56969909|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56969910|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
56969911|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969912|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969913|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56969914|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
56969915|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
56969916|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56969917|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
56969918|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56969919|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56969920|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
56969921|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
56969922|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969923|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969924|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56969925|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969926|NCT01350063|Troclosene|troclosene|mesh-list
56969927|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
56969928|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969929|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
56969930|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
56969931|NCT03421041|Dexamethasone|dexamethasone|mesh-list
56969932|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56969933|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
56969934|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
56969935|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969936|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969937|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56969938|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
56969939|NCT03421041|Hormones|hormones|mesh-ancestor
56969940|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56969941|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56969942|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969943|NCT03244774|Paclitaxel|paclitaxel|mesh-list
56969944|NCT03244774|Fluorouracil|fluorouracil|mesh-list
56969945|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
56969946|NCT03244774|Apatinib|apatinib|mesh-list
56969947|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56969948|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969949|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
56969950|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
56969951|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
56969952|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969953|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
56969954|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56969955|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56969956|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
56969957|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969958|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56969959|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969960|NCT02903823|Baclofen|baclofen|mesh-list
56969961|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56969962|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969963|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56969964|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969965|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56969966|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
56969967|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
56969968|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56969969|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969970|NCT03244930|Plerixafor|plerixafor|mesh-list
56969971|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56969972|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56969973|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
56969974|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56969975|NCT02855697|Olaparib|olaparib|mesh-list
56969976|NCT02855697|Cediranib|cediranib|mesh-list
56969977|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56969978|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56969979|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56969980|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56969981|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56969982|NCT03894501|Methadone|methadone|mesh-list
56969983|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56969984|NCT03894501|Narcotics|narcotics|mesh-ancestor
56969985|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56969986|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969987|NCT03894501|Analgesics|analgesics|mesh-ancestor
56969988|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
56969989|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969990|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
56969991|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
56969992|NCT01346865|Cilostazol|cilostazol|mesh-list
56969993|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56969994|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
56969995|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56969996|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56969997|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56969998|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
56969999|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56970000|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56970001|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970002|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56970003|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
56970004|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56970005|NCT01346865|Protective Agents|protective agents|mesh-ancestor
56970006|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56970007|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56970008|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970009|NCT03244462|Methotrexate|methotrexate|mesh-list
56970010|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56970011|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
56970012|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56970013|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970014|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56970015|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
56970016|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970017|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970018|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
56970019|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970021|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56970022|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
56970023|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970024|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56970025|NCT01350609|Candesartan|candesartan|mesh-list
56970026|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
56970027|NCT01350609|Nifedipine|nifedipine|mesh-list
56970028|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56970029|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56970030|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56970031|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970032|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56970033|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56970034|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56970035|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970036|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
56970037|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
56970038|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56970039|NCT03244540|Acetaminophen|acetaminophen|mesh-list
56970040|NCT03244540|Dipyrone|dipyrone|mesh-list
56970041|NCT03244540|Ketoprofen|ketoprofen|mesh-list
56970042|NCT03244540|Bupivacaine|bupivacaine|mesh-list
56970043|NCT03244540|Ropivacaine|ropivacaine|mesh-list
56970044|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
56970045|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
56970046|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970047|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970048|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
56970049|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970050|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970051|NCT03244540|Analgesics|analgesics|mesh-ancestor
56970052|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
56970053|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56970054|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56970055|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970056|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56970057|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970058|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970059|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56970060|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
56970061|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
56970062|NCT03853317|Avelumab|avelumab|mesh-list
56970063|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56970064|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970065|NCT02454868|Remifentanil|remifentanil|mesh-list
56970066|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56970067|NCT02454868|Narcotics|narcotics|mesh-ancestor
56970068|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970069|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970070|NCT02454868|Analgesics|analgesics|mesh-ancestor
56970071|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
56970072|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970073|NCT03753087|Empagliflozin|empagliflozin|mesh-list
56970074|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56970075|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970076|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56970077|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970078|NCT02454712|Naltrexone|naltrexone|mesh-list
56970079|NCT02454712|Oxycodone|oxycodone|mesh-list
56970080|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56970081|NCT02454712|Narcotics|narcotics|mesh-ancestor
56970082|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970083|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970084|NCT02454712|Analgesics|analgesics|mesh-ancestor
56970085|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
56970086|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970087|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56970088|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56970089|NCT00832455|Montelukast|montelukast|mesh-list
56970090|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56970091|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
56970092|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56970093|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
56652368|NCT02815787|Glyburide|glyburide|mesh-list
56970094|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970095|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970096|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56970097|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56970098|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970100|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56970101|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
56970102|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56970103|NCT04487392|Estrogens|estrogens|mesh-list
56970104|NCT04487392|Hormones|hormones|mesh-ancestor
56970105|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970106|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970107|NCT01350921|Ticagrelor|ticagrelor|mesh-list
56970108|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56970109|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56970110|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56970111|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56970112|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
56970113|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970114|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970115|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970116|NCT00423579|Simvastatin|simvastatin|mesh-list
56970117|NCT00423579|Ezetimibe|ezetimibe|mesh-list
56970118|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56970119|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56970120|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56970121|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
56970122|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970123|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56970124|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56970125|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970126|NCT03243604|Hormones|hormones|mesh-list
56970127|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970128|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970129|NCT04520685|Cannabidiol|cannabidiol|mesh-list
56970130|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
56970131|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56970132|NCT02454556|Hormones|hormones|mesh-ancestor
56970133|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970134|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970135|NCT01352559|Milnacipran|milnacipran|mesh-list
56970136|NCT01352559|Mirtazapine|mirtazapine|mesh-list
56970137|NCT01352559|Sertraline|sertraline|mesh-list
56970138|NCT01352559|Fluoxetine|fluoxetine|mesh-list
56970139|NCT01352559|Paroxetine|paroxetine|mesh-list
56970140|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56970141|NCT01352559|Nortriptyline|nortriptyline|mesh-list
56970142|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
56970143|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56970144|NCT01352559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56970145|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56970146|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56970147|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970148|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970149|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
56970150|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891000|NCT03925701|Metformin|metformin|mesh-list
56970151|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56970152|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56970153|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56970154|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970155|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56970156|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56970157|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
56970158|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
56970159|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56970160|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56970161|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970162|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56970163|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56652439|NCT02815475|Analgesics|analgesics|mesh-ancestor
56970164|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56970166|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56970167|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56970168|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56970169|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970170|NCT01352559|Analgesics|analgesics|mesh-ancestor
56970171|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
56970172|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970173|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56970174|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56970175|NCT03247972|Evolocumab|evolocumab|mesh-list
56970176|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56970177|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56970178|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
56970179|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970180|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56970181|NCT03269409|Coal Tar|coal tar|mesh-list
56970182|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
56970183|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56970184|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
56970185|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56970186|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
56970187|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56970188|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
56970189|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970190|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970191|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
56970192|NCT03778372|Methadone|methadone|mesh-list
56970193|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56970194|NCT03778372|Narcotics|narcotics|mesh-ancestor
56970195|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970196|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970197|NCT03778372|Analgesics|analgesics|mesh-ancestor
56970198|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
56970199|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970200|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
56970201|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
56970202|NCT03246880|Tadalafil|tadalafil|mesh-list
56970203|NCT03246880|Tamsulosin|tamsulosin|mesh-list
56970204|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
56970205|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56970206|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56970207|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970208|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970209|NCT03246880|Urological Agents|urological agents|mesh-ancestor
56970210|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56970211|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56970212|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56970213|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
56970214|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970215|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970216|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
56970217|NCT03257722|Idelalisib|idelalisib|mesh-list
56970218|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56970219|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970220|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970221|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970222|NCT03268005|Insulin|insulin|mesh-list
56970223|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56970224|NCT03268005|Metformin|metformin|mesh-list
56970225|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
56970226|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
56970227|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56970228|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56970229|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970230|NCT03239314|Dexamethasone|dexamethasone|mesh-list
56970231|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56970232|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56970233|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
56970234|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
56970235|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970236|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970237|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56970238|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
56970239|NCT03239314|Hormones|hormones|mesh-ancestor
56970240|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970241|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56970242|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970244|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
56970245|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
56970246|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56970247|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
56970248|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56970249|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970250|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56970251|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56970252|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56970253|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56970254|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56970255|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970256|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
56970257|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56970258|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
56970259|NCT02454088|Triamcinolone|triamcinolone|mesh-list
56970260|NCT02454088|Calcium|calcium|mesh-list
56970261|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56970262|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970263|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56970264|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56970265|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
56970266|NCT02454088|Hormones|hormones|mesh-ancestor
56970267|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970268|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56970269|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970270|NCT02456116|Analgesics|analgesics|mesh-ancestor
56970271|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
56970272|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970273|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970274|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56970275|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970276|NCT03239236|Anesthetics|anesthetics|mesh-list
56970277|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970278|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970279|NCT03257800|Ketamine|ketamine|mesh-list
56970280|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
56970281|NCT03257800|Sevoflurane|sevoflurane|mesh-list
56970282|NCT03257800|Analgesics|analgesics|mesh-ancestor
56970283|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
56970284|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970285|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970286|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56970287|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56970288|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
56970289|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
56970290|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970291|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56970292|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56970293|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970294|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970295|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56970296|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56970297|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970298|NCT01353339|Levofloxacin|levofloxacin|mesh-list
56970299|NCT01353339|Ofloxacin|ofloxacin|mesh-list
56970300|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56970301|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970302|NCT01353339|Renal Agents|renal agents|mesh-ancestor
56970303|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56970304|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56970305|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56970306|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970307|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970308|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970309|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56970310|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56970311|NCT03239080|Denosumab|denosumab|mesh-list
56970312|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56970313|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970314|NCT03149055|Isavuconazole|isavuconazole|mesh-list
56970315|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
56970316|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970317|NCT01352091|Goserelin|goserelin|mesh-list
56970318|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56970319|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970320|NCT02954523|Dasatinib|dasatinib|mesh-list
56970321|NCT02954523|Osimertinib|osimertinib|mesh-list
56970322|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970323|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56970324|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970325|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970326|NCT04486612|Anesthetics|anesthetics|mesh-list
56970327|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970328|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970329|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
56970330|NCT01353729|Zanamivir|zanamivir|mesh-list
56970331|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56970332|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56970333|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970334|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56970335|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56970336|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970337|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970338|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970339|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56970340|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
56970341|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56970342|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970343|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56970344|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56970345|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56970346|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
56970347|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
56970348|NCT01357317|Calcium|calcium|mesh-list
56970349|NCT01357317|Calcium acetate|calcium acetate|mesh-list
56970350|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56970351|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970352|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56970353|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
56970354|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
56970355|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970356|NCT03238612|Clarithromycin|clarithromycin|mesh-list
56970357|NCT03238612|Oseltamivir|oseltamivir|mesh-list
56970358|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
56970359|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56970360|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970361|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56970362|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970363|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970364|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56970365|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56970366|NCT03137121|Olanzapine|olanzapine|mesh-list
56970367|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
56970368|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
56970369|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970370|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970371|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56970372|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56970373|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56970374|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970375|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56970376|NCT03137121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56970377|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56970378|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56970379|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970380|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970381|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
56970382|NCT02453776|Infliximab|infliximab|mesh-list
56970383|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
56970384|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56970385|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652664|NCT04237493|Glimepiride|glimepiride|mesh-list
56970386|NCT03256864|Everolimus|everolimus|mesh-list
56970388|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56970389|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
56970390|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970391|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56970392|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970393|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970394|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970395|NCT01317849|Vitamins|vitamins|mesh-list
56970396|NCT01317849|Folic Acid|folic acid|mesh-list
56970397|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
56970398|NCT01317849|Pyridoxine|pyridoxine|mesh-list
56970399|NCT01317849|Pyridoxal|pyridoxal|mesh-list
56970400|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
56970401|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
56970402|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
56970403|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970404|NCT01317849|Hematinics|hematinics|mesh-ancestor
56970405|NCT01317927|Belinostat|belinostat|mesh-list
56970406|NCT01317927|Warfarin|warfarin|mesh-list
56970407|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
56970408|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970409|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56970410|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970411|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970412|NCT04251585|Insulin|insulin|mesh-list
56970413|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56970414|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970415|NCT04418427|Aflibercept|aflibercept|mesh-list
56970416|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56970417|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56970418|NCT04418427|Growth Substances|growth substances|mesh-ancestor
56970419|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970420|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
56970421|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970422|NCT02901483|Cisplatin|cisplatin|mesh-list
56970423|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970424|NCT02874651|Apatinib|apatinib|mesh-list
56970425|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970426|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56970427|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970428|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970429|NCT02453932|Donepezil|donepezil|mesh-list
56970430|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56970431|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970432|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970433|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
56970434|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970435|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970436|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
56970437|NCT04385433|Pravastatin|pravastatin|mesh-list
56970438|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56970439|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56970440|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
56970441|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970442|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56970443|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56970444|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970445|NCT00700570|Bevacizumab|bevacizumab|mesh-list
56970446|NCT00700570|Capecitabine|capecitabine|mesh-list
56970447|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
56970448|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56970449|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970450|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56970451|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56970452|NCT00700570|Growth Substances|growth substances|mesh-ancestor
56970453|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970454|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
56970455|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56970456|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
56970457|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970458|NCT02453698|Methylphenidate|methylphenidate|mesh-list
56970459|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56970460|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970461|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56970462|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56970463|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56970464|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970465|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
56970466|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970467|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56970468|NCT01354275|Hormones|hormones|mesh-ancestor
56970469|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970470|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970471|NCT01318161|Morphine|morphine|mesh-list
56970472|NCT01318161|Ropivacaine|ropivacaine|mesh-list
56970473|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56970474|NCT01318161|Narcotics|narcotics|mesh-ancestor
56970475|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970476|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970477|NCT01318161|Analgesics|analgesics|mesh-ancestor
56970478|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
56970479|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970480|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
56970481|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
56970482|NCT03255226|Tolvaptan|tolvaptan|mesh-list
56970483|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56970484|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970485|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
56970486|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970487|NCT02455726|Pregabalin|pregabalin|mesh-list
56970488|NCT02455726|Oxycodone|oxycodone|mesh-list
56970489|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
56970490|NCT02455726|Analgesics|analgesics|mesh-ancestor
56970491|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
56970492|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970493|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970494|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
56970495|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56970496|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56970497|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970498|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56970499|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56970500|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56970501|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970502|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56970503|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56970504|NCT02455726|Narcotics|narcotics|mesh-ancestor
56970505|NCT02455726|Antacids|antacids|mesh-ancestor
56970506|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56970507|NCT04488172|Vitamins|vitamins|mesh-list
56970508|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
56970509|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970510|NCT03239860|Antibodies|antibodies|mesh-list
56970511|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56970512|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
56970513|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970514|NCT04486690|Ketamine|ketamine|mesh-list
56970515|NCT04486690|Propofol|propofol|mesh-list
56970516|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56970517|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970518|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970519|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56970520|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
56970521|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
56970522|NCT04486690|Analgesics|analgesics|mesh-ancestor
56970523|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
56970524|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970525|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56891380|NCT03919383|Lenvatinib|lenvatinib|mesh-list
56970526|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56970527|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56970528|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970529|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970530|NCT02101788|Tamoxifen|tamoxifen|mesh-list
56970531|NCT02101788|Paclitaxel|paclitaxel|mesh-list
56970532|NCT02101788|Doxorubicin|doxorubicin|mesh-list
56970533|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56970534|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56970535|NCT02101788|Letrozole|letrozole|mesh-list
56970536|NCT02101788|Topotecan|topotecan|mesh-list
56970537|NCT02101788|Trametinib|trametinib|mesh-list
56970538|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56970539|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56970540|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970541|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
56970542|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
56970543|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
56970544|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970545|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56970546|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56970547|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56970548|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970549|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56970550|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56970551|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56970552|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
56970553|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970554|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970555|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56970556|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56970557|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56970558|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56970559|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56970560|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56970561|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56970562|NCT02101788|Protective Agents|protective agents|mesh-ancestor
56970563|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56970564|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
56970565|NCT03255148|Oxytocin|oxytocin|mesh-list
56970566|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
56970567|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56970568|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970569|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
56970570|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
56970571|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970572|NCT03236818|Bosentan|bosentan|mesh-list
56970573|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
56970574|NCT03236818|Tadalafil|tadalafil|mesh-list
56970575|NCT03236818|Macitentan|macitentan|mesh-list
56970576|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
56970577|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56970578|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56970579|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970580|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970581|NCT03236818|Urological Agents|urological agents|mesh-ancestor
56970582|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56970583|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56970584|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56970585|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56970586|NCT03236974|Fulvestrant|fulvestrant|mesh-list
56970587|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56970588|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970589|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56970590|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56970591|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
56970592|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970593|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970594|NCT03748043|Lactoferrin|lactoferrin|mesh-list
56970595|NCT03748043|Teferrol|teferrol|mesh-list
56970596|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970597|NCT03748043|Hematinics|hematinics|mesh-ancestor
56970598|NCT03750773|Gabapentin|gabapentin|mesh-list
56970599|NCT03750773|Analgesics|analgesics|mesh-ancestor
56970600|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
56970601|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970602|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970603|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
56970604|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56970605|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56970606|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970607|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56970608|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56970609|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56970610|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970611|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970612|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
56970613|NCT02874924|Sirolimus|sirolimus|mesh-list
56970614|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56970615|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970616|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56970617|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970618|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
56970619|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56970620|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
56970621|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970622|NCT04425863|Aspirin|aspirin|mesh-list
56970623|NCT04425863|Ivermectin|ivermectin|mesh-list
56970624|NCT04425863|Dexamethasone|dexamethasone|mesh-list
56970625|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
56970626|NCT04425863|Enoxaparin|enoxaparin|mesh-list
56970627|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56970628|NCT04425863|BB 1101|bb 1101|mesh-list
56970629|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56970630|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
56970631|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
56970632|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970633|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970634|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56970635|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
56970636|NCT04425863|Hormones|hormones|mesh-ancestor
56970637|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970638|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56970639|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970640|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
56970641|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970642|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970643|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56970644|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970645|NCT04425863|Analgesics|analgesics|mesh-ancestor
56970646|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
56970647|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970648|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56970649|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56970650|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56970651|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56970652|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
56970653|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
56970654|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56970655|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970656|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
56970657|NCT01370772|Rituximab|rituximab|mesh-list
56970658|NCT01370772|Fludarabine|fludarabine|mesh-list
56970659|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56970660|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
56970661|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970662|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970663|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56970664|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
56970665|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970666|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970667|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56970668|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56970669|NCT01842282|Amlexanox|amlexanox|mesh-list
56970670|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56970671|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
56970672|NCT03234244|Vitamin D|vitamin d|mesh-list
56970673|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
56970674|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56970675|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970676|NCT03234244|Vitamins|vitamins|mesh-ancestor
56970677|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
56970678|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56970679|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56970680|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56970681|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
56970682|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970683|NCT03234400|Dapivirine|dapivirine|mesh-list
56970684|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56970685|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56970686|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
56970687|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970688|NCT03254368|ZGN-1061|zgn-1061|mesh-list
56970689|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970690|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970691|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56970692|NCT03236740|Metformin|metformin|mesh-list
56970693|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56970694|NCT03236740|Estradiol|estradiol|mesh-list
56970695|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56970696|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970697|NCT03236740|Estrogens|estrogens|mesh-ancestor
56970698|NCT03236740|Hormones|hormones|mesh-ancestor
56970699|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970700|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56970701|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
56970702|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56970703|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56970704|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56970705|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56970706|NCT02453464|Leucovorin|leucovorin|mesh-list
56970707|NCT02453464|Irinotecan|irinotecan|mesh-list
56970708|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56970709|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56970710|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970711|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970712|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970713|NCT02453464|Antidotes|antidotes|mesh-ancestor
56970714|NCT02453464|Protective Agents|protective agents|mesh-ancestor
56970715|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970716|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
56970717|NCT02453464|Vitamins|vitamins|mesh-ancestor
56970718|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
56970719|NCT03233932|Leuprolide|leuprolide|mesh-list
56970720|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56970721|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
56970722|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56970723|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970724|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56970725|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970726|NCT03236584|Tenofovir|tenofovir|mesh-list
56970727|NCT03236584|Lamivudine|lamivudine|mesh-list
56970728|NCT03236584|Adefovir|adefovir|mesh-list
56970729|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
56970730|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970731|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56970732|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56970733|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970734|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970735|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56970736|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56970737|NCT01164228|Gemcitabine|gemcitabine|mesh-list
56970738|NCT01164228|Sunitinib|sunitinib|mesh-list
56970739|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56970740|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
56970741|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970742|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970743|NCT01164228|Antiviral Agents|antiviral agents|mesh-ancestor
56970744|NCT01164228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970745|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970746|NCT01164228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56970747|NCT01164228|Immunologic Factors|immunologic factors|mesh-ancestor
56970748|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970749|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56970750|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56970751|NCT01164228|Growth Substances|growth substances|mesh-ancestor
56970752|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
56970753|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55726852|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
56970754|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56970755|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970756|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56970757|NCT04614168|Glycerol|glycerol|mesh-list
56970758|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970759|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56970760|NCT04614168|Protective Agents|protective agents|mesh-ancestor
56970761|NCT01365312|Ethanol|ethanol|mesh-list
56970762|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56970763|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970764|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970765|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970766|NCT04495283|Acetaminophen|acetaminophen|mesh-list
56970767|NCT04495283|Pregabalin|pregabalin|mesh-list
56970768|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970769|NCT04495283|Analgesics|analgesics|mesh-ancestor
56970771|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970772|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970773|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
56970774|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
56970775|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56970776|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56970777|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970778|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56970779|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56970780|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56970781|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970782|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56970783|NCT03634020|Sirolimus|sirolimus|mesh-list
56970784|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56970785|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970786|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56970787|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970788|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
56970789|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56970790|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
56970791|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970792|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56970793|NCT03253276|Cathartics|cathartics|mesh-ancestor
56970794|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56970795|NCT01372644|Pasireotide|pasireotide|mesh-list
56970796|NCT01372644|Hormones|hormones|mesh-ancestor
56970797|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970798|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970799|NCT03253198|Bupivacaine|bupivacaine|mesh-list
56970800|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
56970801|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
56970802|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970803|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970804|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
56970805|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970806|NCT04285086|Anagrelide|anagrelide|mesh-list
56970807|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56970808|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56970809|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970810|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56970811|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56970812|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56970813|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
56970814|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970815|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970816|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970817|NCT04234464|Budesonide|budesonide|mesh-list
56970818|NCT04234464|Albuterol|albuterol|mesh-list
56970819|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56970820|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56970821|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
56970822|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970823|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970824|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56970825|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
56970826|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
56970827|NCT04234464|Hormones|hormones|mesh-ancestor
56970828|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970829|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
56970830|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56970831|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56970832|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56970833|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56970834|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
56970835|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970836|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970837|NCT03233152|Nivolumab|nivolumab|mesh-list
56970838|NCT03233152|Ipilimumab|ipilimumab|mesh-list
56970839|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56970840|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56970841|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970842|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56970843|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970844|NCT03229096|Apatinib|apatinib|mesh-list
56970845|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970846|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56970847|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970848|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970849|NCT03123588|Anagrelide|anagrelide|mesh-list
56970850|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56970851|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56970852|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970853|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56970854|NCT02452918|Oritavancin|oritavancin|mesh-list
56970855|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56970856|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970857|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
56970858|NCT02821026|Sirolimus|sirolimus|mesh-list
56970859|NCT02821026|Etanercept|etanercept|mesh-list
56970860|NCT02821026|Tacrolimus|tacrolimus|mesh-list
56970861|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
56970862|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56970863|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56970864|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
56970865|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970866|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56970867|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970868|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970869|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56970870|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970871|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56970872|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
56970873|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56970874|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970875|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
56970876|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56970877|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970878|NCT02821026|Analgesics|analgesics|mesh-ancestor
56970879|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
56970880|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970881|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56970882|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970883|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56970884|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
56970885|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56970886|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
56970887|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
56970888|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56970889|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970890|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970891|NCT03228628|Analgesics|analgesics|mesh-ancestor
56970892|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
56970893|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970894|NCT03232450|Aspirin|aspirin|mesh-list
56970895|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56970896|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970897|NCT03232450|Analgesics|analgesics|mesh-ancestor
56970898|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
56970899|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970900|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970901|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56970902|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970903|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56970904|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56891738|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
56970905|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970906|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56970907|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56970908|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970909|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
56970910|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
56970911|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56970912|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56970913|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
56970914|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970915|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
56970916|NCT05359211|Fludarabine|fludarabine|mesh-list
56970917|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56970918|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
56970919|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970920|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970921|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56970922|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
56970923|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970924|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970925|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56970926|NCT03613181|Paclitaxel|paclitaxel|mesh-list
56970927|NCT03613181|Capecitabine|capecitabine|mesh-list
56970928|NCT03613181|Methotrexate|methotrexate|mesh-list
56970929|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56970930|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970931|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
56970932|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
56970933|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
56970934|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970935|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56970936|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
56970937|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56970938|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
56970939|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56970940|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970941|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
56970942|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970943|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56970944|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56970945|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
56970946|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970947|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56970948|NCT04948697|Bevacizumab|bevacizumab|mesh-list
56970949|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56970950|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970951|NCT04948697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56970952|NCT04948697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56970953|NCT04948697|Growth Substances|growth substances|mesh-ancestor
56970954|NCT04948697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970955|NCT04948697|Growth Inhibitors|growth inhibitors|mesh-ancestor
56970956|NCT04358549|Favipiravir|favipiravir|mesh-list
56970957|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
56970958|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56970959|NCT01562483|Dronabinol|dronabinol|mesh-list
56970960|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
56970961|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970962|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56970963|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56970964|NCT01562483|Analgesics|analgesics|mesh-ancestor
56970965|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
56970966|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56970967|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56970968|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56970969|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56970970|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970971|NCT01562483|Hormones|hormones|mesh-ancestor
56970972|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56970973|NCT00700180|Bevacizumab|bevacizumab|mesh-list
56970974|NCT00700180|Carboplatin|carboplatin|mesh-list
56970975|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56970976|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56970977|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56970978|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56970979|NCT00700180|Growth Substances|growth substances|mesh-ancestor
56970980|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970981|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
56970982|NCT03222544|Methylene Blue|methylene blue|mesh-list
56970983|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56970984|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56970985|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
56970986|NCT03228862|Vitamin D|vitamin d|mesh-list
56970987|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56970988|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56970989|NCT03228862|Vitamins|vitamins|mesh-ancestor
56970990|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
56970991|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56970992|NCT03228238|Vitamins|vitamins|mesh-list
56970993|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
56970994|NCT03228238|Vitamin E|vitamin e|mesh-list
56970995|NCT03228238|Tocopherols|tocopherols|mesh-list
56970996|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
56970997|NCT03228238|Atorvastatin|atorvastatin|mesh-list
56970998|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
56970999|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971000|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56971001|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56971002|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56971003|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
56971004|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971005|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56971006|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56971007|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971008|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
56971009|NCT03228238|Protective Agents|protective agents|mesh-ancestor
56971010|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971011|NCT03232216|Vitamin D|vitamin d|mesh-list
56971012|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
56971013|NCT03232216|Vitamins|vitamins|mesh-ancestor
56971014|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
56971015|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971016|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56971017|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56971018|NCT03231982|Amlodipine|amlodipine|mesh-list
56971019|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56971020|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56971021|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971022|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971023|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56971024|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971025|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
56971026|NCT03222310|Itraconazole|itraconazole|mesh-list
56971027|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
56971028|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971029|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56971030|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56971031|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971032|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971033|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56971034|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
56971035|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56971036|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971037|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56971038|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
56971039|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56971040|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971041|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
56971042|NCT03231436|Bupivacaine|bupivacaine|mesh-list
56971043|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
56971044|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
56971045|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971046|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971047|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
56971048|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971049|NCT02452450|Acetaminophen|acetaminophen|mesh-list
56971050|NCT02452450|Ibuprofen|ibuprofen|mesh-list
56971051|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56891893|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
56971052|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56971053|NCT02452450|Analgesics|analgesics|mesh-ancestor
56971054|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
56971055|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971056|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971057|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971058|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971059|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56971060|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971061|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971062|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
56971063|NCT01204684|Poly ICLC|poly iclc|mesh-list
56971064|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
56971065|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
56971066|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971067|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
56971068|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56971069|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971070|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971071|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56971072|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971073|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56971075|NCT00238420|Trastuzumab|trastuzumab|mesh-list
56971076|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56971077|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56971078|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56971079|NCT00238420|Antibodies|antibodies|mesh-list
56971080|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
56971081|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56971082|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56971083|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971084|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
56971085|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
56971086|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
56971087|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971088|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
56971089|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971090|NCT03221998|Acetaminophen|acetaminophen|mesh-list
56971091|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56971092|NCT03221998|Analgesics|analgesics|mesh-ancestor
56971093|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
56971094|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971095|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971096|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
56971097|NCT04492475|Interferons|interferons|mesh-list
56971098|NCT04492475|Interferon-beta|interferon-beta|mesh-list
56971099|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
56971100|NCT04492475|Remdesivir|remdesivir|mesh-list
56971101|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971102|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
56971103|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971104|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
56971105|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971106|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56971107|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
56971108|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971109|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
56971110|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56971111|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
56971112|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971113|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
56971114|NCT04936763|Protective Agents|protective agents|mesh-ancestor
56971115|NCT03230734|Docetaxel|docetaxel|mesh-list
56971116|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971117|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56971118|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56971119|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56971120|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971121|NCT03226522|Bupropion|bupropion|mesh-list
56971122|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56971123|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
56971124|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56971125|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56971126|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56971127|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971128|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971129|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
56971130|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971131|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971132|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56971133|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56971134|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971135|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
56971136|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56971137|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971138|NCT03750383|Cyclosporine|cyclosporine|mesh-list
56971139|NCT03750383|Prednisone|prednisone|mesh-list
56971140|NCT03750383|Cyclosporins|cyclosporins|mesh-list
56971141|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971142|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
56971143|NCT03750383|Hormones|hormones|mesh-ancestor
56971144|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56971145|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971146|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56971147|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971148|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971149|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971150|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56971151|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
56971152|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
56971153|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971154|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
56971155|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971156|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56971157|NCT03226210|Insulin|insulin|mesh-list
56971158|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
56971159|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56971160|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971161|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
56971162|NCT05351489|Bupivacaine|bupivacaine|mesh-list
56971163|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
56971164|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
56971165|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971166|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971167|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
56971168|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971169|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56971170|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56971171|NCT05351489|Analgesics|analgesics|mesh-ancestor
56971172|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56971173|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56971174|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56971175|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
56971176|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971177|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971178|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56971179|NCT03229954|Hematinics|hematinics|mesh-ancestor
56971180|NCT03220126|Mirikizumab|mirikizumab|mesh-list
56971181|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56971182|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56971183|NCT03220126|Analgesics|analgesics|mesh-ancestor
56971184|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
56971185|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971186|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971187|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971188|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971189|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56971190|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56971191|NCT02452684|Eszopiclone|eszopiclone|mesh-list
56971192|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56971193|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971194|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971195|NCT03119428|Nivolumab|nivolumab|mesh-list
56971196|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56971197|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971198|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56971199|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971200|NCT04345367|Abrocitinib|abrocitinib|mesh-list
55726853|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971201|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56971202|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971203|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971204|NCT02452606|Levodopa|levodopa|mesh-list
56971205|NCT02452606|Carbidopa|carbidopa|mesh-list
56971206|NCT02452606|Entacapone|entacapone|mesh-list
56971207|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56971208|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56971209|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
56971210|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971211|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971212|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971213|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56971214|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971215|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56971216|NCT03225352|Aspirin|aspirin|mesh-list
56971217|NCT03225352|Ibuprofen|ibuprofen|mesh-list
56971218|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56971219|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56971220|NCT03225352|Analgesics|analgesics|mesh-ancestor
56971221|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
56971222|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971223|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971224|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971225|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971226|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56971227|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56971228|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971229|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56971230|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56971231|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971232|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
56971233|NCT03208270|Antithrombins|antithrombins|mesh-list
56971234|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
56971235|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56971236|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
56971237|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971238|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971239|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
56971240|NCT03208426|Amoxicillin|amoxicillin|mesh-list
56971241|NCT03208426|Metronidazole|metronidazole|mesh-list
56971242|NCT03208426|Clarithromycin|clarithromycin|mesh-list
56971243|NCT03208426|Tetracycline|tetracycline|mesh-list
56971244|NCT03208426|Esomeprazole|esomeprazole|mesh-list
56971245|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56971246|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971247|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56971248|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56971249|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56971250|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56971251|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56971252|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971253|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971254|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56971255|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56971256|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56971257|NCT03216070|Dasatinib|dasatinib|mesh-list
56971258|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971259|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56971260|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971261|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971262|NCT03215602|Pyrantel|pyrantel|mesh-list
56971263|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
56971264|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
56971265|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
56971266|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56971267|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971268|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56971269|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56971270|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56971271|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971272|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971273|NCT02450968|Dexamethasone|dexamethasone|mesh-list
56971274|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971275|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
56971276|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
56971277|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971278|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971279|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56971280|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
56971281|NCT02450968|Hormones|hormones|mesh-ancestor
56971282|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56971283|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56971284|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971285|NCT03749915|Tetracaine|tetracaine|mesh-list
56971286|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
56971287|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
56971288|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971289|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971290|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
56971291|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971292|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
56971293|NCT03119116|Apixaban|apixaban|mesh-list
56971294|NCT03119116|Dabigatran|dabigatran|mesh-list
56971295|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56971296|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
56971297|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56971298|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
56971299|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971300|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971301|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
56971302|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
56971303|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
56971304|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56971305|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56971306|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971307|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971308|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971309|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971310|NCT04403399|Varenicline|varenicline|mesh-list
56971311|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56971312|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56971313|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
56971314|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971315|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971316|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971317|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
56971318|NCT03224572|Vitamins|vitamins|mesh-ancestor
56971319|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
56971320|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971321|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
56971322|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971323|NCT03224572|Protective Agents|protective agents|mesh-ancestor
56971324|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56971325|NCT02452216|Hematinics|hematinics|mesh-ancestor
56971326|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56971327|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56971328|NCT03207334|Cytarabine|cytarabine|mesh-list
56971329|NCT03207334|Midostaurin|midostaurin|mesh-list
56971330|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56971331|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
56971332|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971333|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971334|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
56971335|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971336|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56971337|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
56971338|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971339|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56971340|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971341|NCT03212950|Insulin|insulin|mesh-list
56971342|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56971343|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
56971344|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
56971345|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56971346|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56971347|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971348|NCT04459715|Cisplatin|cisplatin|mesh-list
56971349|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971350|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
56971351|NCT01561937|Warfarin|warfarin|mesh-list
56971352|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
56971353|NCT03210766|Nabilone|nabilone|mesh-list
56971354|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
56892195|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
56971355|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
56971356|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971357|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971358|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56971359|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56971360|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56971361|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971362|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56971363|NCT03747341|Fentanyl|fentanyl|mesh-list
56971364|NCT03747341|Oxycodone|oxycodone|mesh-list
56971365|NCT03747341|Buprenorphine|buprenorphine|mesh-list
56971366|NCT03747341|Ondansetron|ondansetron|mesh-list
56971367|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56653640|NCT02676986|Exemestane|exemestane|mesh-list
56971368|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56971369|NCT03747341|Narcotics|narcotics|mesh-ancestor
56971370|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971371|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971372|NCT03747341|Analgesics|analgesics|mesh-ancestor
56971373|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
56971374|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971375|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56971376|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56971377|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
56971378|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
56971379|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56971380|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
56971381|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
56971382|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56971383|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
56971384|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
56971385|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56971386|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
56971387|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971388|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971389|NCT03747341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56971390|NCT03747341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56971391|NCT03747341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56971392|NCT03747341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56971393|NCT04401293|Heparin|heparin|mesh-list
56971394|NCT04401293|Enoxaparin|enoxaparin|mesh-list
56971395|NCT04401293|Calcium heparin|calcium heparin|mesh-list
56971396|NCT04401293|Dalteparin|dalteparin|mesh-list
56971397|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
56971398|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
56971399|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56971400|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56971401|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971402|NCT03209908|Tenofovir|tenofovir|mesh-list
56971403|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
56971404|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971405|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56971406|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56971407|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971408|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971409|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56971410|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56971411|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56971412|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56971413|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
56971414|NCT03224338|Dolutegravir|dolutegravir|mesh-list
56971415|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56971416|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56971417|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971418|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971419|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56971420|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56971421|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
56971422|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971423|NCT04318535|Griseofulvin|griseofulvin|mesh-list
56971424|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
56971425|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971426|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
56971427|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56971428|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
56971429|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56971430|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892266|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971431|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56971432|NCT03224416|Ethanol|ethanol|mesh-list
56971433|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56971434|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971435|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971436|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971437|NCT01562561|Repaglinide|repaglinide|mesh-list
56971438|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
56971439|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
56971440|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
56971441|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56971442|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971443|NCT03206944|Aspirin|aspirin|mesh-list
56971444|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56971445|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56971446|NCT03206944|Analgesics|analgesics|mesh-ancestor
56971447|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
56971448|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971449|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971450|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971451|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971452|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56971453|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56971454|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971455|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56971456|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56971457|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971458|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
56971459|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56971460|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56971461|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971462|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971463|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
56971464|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971465|NCT03206554|Ropivacaine|ropivacaine|mesh-list
56971466|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
56971467|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
56971468|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971469|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971470|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
56971471|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971472|NCT03209206|Docetaxel|docetaxel|mesh-list
56971473|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971474|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56971475|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56971476|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56971477|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971478|NCT03223402|Lamivudine|lamivudine|mesh-list
56971479|NCT03223402|Nevirapine|nevirapine|mesh-list
56971480|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56971481|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56971482|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971483|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971484|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
56971485|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971486|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56971487|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56971488|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56971489|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56971490|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56971491|NCT03208972|Menotropins|menotropins|mesh-list
56971492|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56971493|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971494|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56971495|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
56971496|NCT03206866|Antibodies|antibodies|mesh-list
56971497|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
56971498|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971499|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
56971500|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
56971501|NCT02451748|Prednisone|prednisone|mesh-list
56971502|NCT02451748|Triamcinolone|triamcinolone|mesh-list
56971503|NCT02451748|Naproxen|naproxen|mesh-list
56971504|NCT02451748|Methotrexate|methotrexate|mesh-list
56971505|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
56971506|NCT02451748|Leflunomide|leflunomide|mesh-list
56971507|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971508|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
56971509|NCT02451748|Hormones|hormones|mesh-ancestor
56971510|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56971511|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971512|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56971513|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971514|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56971515|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
56971516|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56971517|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56971518|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
56971519|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971520|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
56971521|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971522|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56653791|NCT02676674|Vitamin D|vitamin d|mesh-list
56971523|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56971524|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
56971525|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971526|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56971527|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
56971528|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56971529|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56971530|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971531|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56971532|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56971534|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
56971535|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971536|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
56971537|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56971538|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56971539|NCT03208894|Furosemide|furosemide|mesh-list
56971540|NCT03208894|Diuretics|diuretics|mesh-ancestor
56971541|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
56971542|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971543|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56971544|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971545|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971546|NCT02450656|Docetaxel|docetaxel|mesh-list
56971547|NCT02450656|Afatinib|afatinib|mesh-list
56971548|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971549|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
56971550|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
56971551|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
56971552|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971553|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56971554|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971555|NCT03206320|Lidocaine|lidocaine|mesh-list
56971556|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
56971557|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
56971558|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971559|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971560|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
56971561|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971562|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56971563|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56971564|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56971565|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971566|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971567|NCT04448561|Morphine|morphine|mesh-list
56971568|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56971569|NCT04448561|Narcotics|narcotics|mesh-ancestor
56971570|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971571|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971572|NCT04448561|Analgesics|analgesics|mesh-ancestor
56971573|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
56971574|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971575|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
56971576|NCT03206008|Analgesics|analgesics|mesh-ancestor
56971577|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
56971578|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971579|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971580|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
56971581|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971582|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56971583|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
56971584|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56971585|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971586|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971587|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56971588|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
56971589|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56971590|NCT04978259|Remdesivir|remdesivir|mesh-list
56971591|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
56971592|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971593|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
56971594|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971595|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
56971596|NCT03208582|Diphosphonates|diphosphonates|mesh-list
56971597|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56971598|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971599|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971600|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56971601|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971602|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56971604|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
56971605|NCT03200938|Trace Elements|trace elements|mesh-ancestor
56971606|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
56971607|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971608|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
56971609|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
56971610|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56971611|NCT03200938|Protective Agents|protective agents|mesh-ancestor
56971612|NCT04297241|Isosorbide|isosorbide|mesh-list
56971613|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56971614|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56971615|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56971616|NCT04297241|Diuretics|diuretics|mesh-ancestor
56971617|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
56971618|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971619|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
56971620|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56971621|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971622|NCT04292171|Gabapentin|gabapentin|mesh-list
56971623|NCT04292171|Analgesics|analgesics|mesh-ancestor
56971624|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
56971625|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971626|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971627|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
56971628|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56971629|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56971630|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971631|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56971632|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56971633|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56971634|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971635|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971636|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
56971637|NCT03200782|Empagliflozin|empagliflozin|mesh-list
56971638|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56971639|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56971640|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971641|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56971642|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971643|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971644|NCT02449954|Ketorolac|ketorolac|mesh-list
56971645|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56971646|NCT02449954|Morphine|morphine|mesh-list
56971647|NCT02449954|Tramadol|tramadol|mesh-list
56971648|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56971649|NCT02449954|Narcotics|narcotics|mesh-ancestor
56971650|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971651|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971652|NCT02449954|Analgesics|analgesics|mesh-ancestor
56971653|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
55727472|NCT03525821|Analgesics|analgesics|mesh-ancestor
56971654|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971655|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56971656|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56971657|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971658|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971659|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56971660|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971661|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971662|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
56971663|NCT04393493|Furosemide|furosemide|mesh-list
56971664|NCT04393493|Spironolactone|spironolactone|mesh-list
56971665|NCT04393493|Diuretics|diuretics|mesh-ancestor
56971666|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
56971667|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653937|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56653938|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56653939|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653940|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56971668|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56971669|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971670|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971671|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56971672|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
56971673|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56971674|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56971675|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56971676|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56971677|NCT02448082|Ichthammol|ichthammol|mesh-list
56971678|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
56971679|NCT03205228|Flupenthixol|flupenthixol|mesh-list
56971680|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
56971681|NCT03205228|Omeprazole|omeprazole|mesh-list
56971682|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56971683|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56971684|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56971685|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971686|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971687|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56971688|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56971689|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971690|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971691|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56971692|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56971693|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
56971694|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971695|NCT03195946|Midazolam|midazolam|mesh-list
56971696|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56971697|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56971698|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971699|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971700|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56971701|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56971702|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56971703|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56971704|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
56971705|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
56971706|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
56971707|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
56971708|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971709|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971710|NCT04285229|Ixekizumab|ixekizumab|mesh-list
56971711|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
56971712|NCT03204760|Dexamethasone|dexamethasone|mesh-list
56971713|NCT03204760|Prednisolone|prednisolone|mesh-list
56971714|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971715|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
56971716|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
56971717|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971718|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971719|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56971720|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
56971721|NCT03204760|Hormones|hormones|mesh-ancestor
56971722|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56971723|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56892567|NCT03760263|Tacrolimus|tacrolimus|mesh-list
56971724|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971725|NCT03200392|Chromium|chromium|mesh-list
56971726|NCT03200392|Trace Elements|trace elements|mesh-ancestor
56971727|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
56971728|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971729|NCT03200080|Amphetamine|amphetamine|mesh-list
56971730|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
56971731|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56971732|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971733|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
56971734|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
56971735|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971736|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
56971737|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971738|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971739|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
56971740|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56971741|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56971742|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971743|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56971744|NCT03200236|Nicotine|nicotine|mesh-list
56971745|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56971746|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
56971747|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971748|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971749|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56971750|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56971751|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
56971752|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971753|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971754|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
56971755|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
56971756|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56971757|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
56971758|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971759|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971760|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56971761|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
56971762|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971763|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971764|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56971765|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56971766|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56971767|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
56971768|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56971769|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971770|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971771|NCT02447380|Docetaxel|docetaxel|mesh-list
56971772|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971773|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56971774|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56971775|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56971776|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971777|NCT02447224|Metronidazole|metronidazole|mesh-list
56971778|NCT02447224|Ertapenem|ertapenem|mesh-list
56971779|NCT02447224|Cefdinir|cefdinir|mesh-list
56971780|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971781|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56971782|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56971783|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56971784|NCT03199690|Rifampin|rifampin|mesh-list
56971785|NCT03199690|Dolutegravir|dolutegravir|mesh-list
56971786|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56971787|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
56971788|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56971789|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971790|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
56971791|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56971792|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971793|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971794|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56971795|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56971796|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55727784|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
56971797|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56971798|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56971799|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56971800|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56971801|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56971802|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56971803|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56971804|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
56971805|NCT03204058|Metformin|metformin|mesh-list
56971806|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56971807|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56971808|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971809|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56971810|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56971811|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
56971812|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971813|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56971814|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56971815|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971816|NCT03203746|Lycopene|lycopene|mesh-list
56971817|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971818|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
56971819|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971820|NCT03203746|Protective Agents|protective agents|mesh-ancestor
56971821|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971822|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56971823|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56971824|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971826|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
56971827|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56971828|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
56971829|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971830|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56971831|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56971832|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
56971833|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
56971834|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56971835|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56971836|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56971837|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56971838|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971839|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
56971840|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56971841|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971842|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56971843|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971844|NCT03203356|Hormones|hormones|mesh-list
56971845|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56971846|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971847|NCT04280705|Remdesivir|remdesivir|mesh-list
56971848|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
56971849|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971850|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
56971851|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971852|NCT03203590|Carboplatin|carboplatin|mesh-list
56971853|NCT03203590|Vinorelbine|vinorelbine|mesh-list
56971854|NCT03203590|Gefitinib|gefitinib|mesh-list
56971855|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971856|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56971857|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
56971858|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
56971859|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
56971860|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971861|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56971862|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971863|NCT02077166|Rituximab|rituximab|mesh-list
56971864|NCT02077166|Lenalidomide|lenalidomide|mesh-list
56971865|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56971866|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971867|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
56971868|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971869|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971870|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56971871|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56892722|NCT01146483|Pantoprazole|pantoprazole|mesh-list
56971872|NCT02077166|Growth Substances|growth substances|mesh-ancestor
56971873|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
56971874|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56971875|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
56971876|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56971877|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56971878|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971879|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971880|NCT02450188|Urological Agents|urological agents|mesh-ancestor
56971881|NCT03198676|Poly I-C|poly i-c|mesh-list
56971882|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
56971883|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971884|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
56971885|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
56971886|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971887|NCT04484506|Prednisone|prednisone|mesh-list
56971888|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
56971889|NCT04484506|Etoposide|etoposide|mesh-list
56971890|NCT04484506|Vincristine|vincristine|mesh-list
56971891|NCT04484506|Pegaspargase|pegaspargase|mesh-list
56971892|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654164|NCT02635074|Cytarabine|cytarabine|mesh-list
56971893|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
56971894|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971895|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56971896|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56971897|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
56971898|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971899|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971900|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56971901|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56971902|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
56971903|NCT04484506|Hormones|hormones|mesh-ancestor
56971904|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56971905|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56971906|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56971907|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56971908|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56971909|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971910|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
56971911|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
56971912|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
56971913|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
56971914|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56971915|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971916|NCT02449564|Sirolimus|sirolimus|mesh-list
56971917|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56971918|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971919|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56971920|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971921|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
56971922|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56971923|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
56971924|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971925|NCT02449720|Ropivacaine|ropivacaine|mesh-list
56971926|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
56971927|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
56971928|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971929|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971930|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
56971931|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971932|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
56971933|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
56971934|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56971935|NCT03194620|Procyanidin|procyanidin|mesh-list
56971936|NCT03194620|Theaflavin|theaflavin|mesh-list
56971937|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
56971938|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971939|NCT03194620|Protective Agents|protective agents|mesh-ancestor
56971940|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971941|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56971942|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56971943|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56971944|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56971945|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971946|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
56971947|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971948|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56971949|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56971950|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56971951|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
56971952|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
56971953|NCT02445976|Seviteronel|seviteronel|mesh-list
56971954|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56971955|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56971956|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56971957|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971958|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56971959|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56971960|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56971961|NCT03198208|Fentanyl|fentanyl|mesh-list
56971962|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56971963|NCT03198208|Narcotics|narcotics|mesh-ancestor
56971964|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56971965|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971966|NCT03198208|Analgesics|analgesics|mesh-ancestor
56971967|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
56971968|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56971969|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56971970|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56971971|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
56971972|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
56971973|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
56971974|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
56971975|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56971976|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56971977|NCT01044056|NuvaRing|nuvaring|mesh-list
56971978|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
56971979|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56971980|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971981|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56971982|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56971983|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56971984|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56971985|NCT01044056|Estrogens|estrogens|mesh-ancestor
56971986|NCT01044056|Hormones|hormones|mesh-ancestor
56971987|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56971988|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56971989|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56971990|NCT01005056|Desogestrel|desogestrel|mesh-list
56971991|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56971992|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56971993|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56971994|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
56971995|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56971996|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56971997|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56971998|NCT01005056|Estrogens|estrogens|mesh-ancestor
56971999|NCT01005056|Hormones|hormones|mesh-ancestor
56972000|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972001|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56972002|NCT01005056|Progestins|progestins|mesh-ancestor
56972003|NCT04796714|Aspirin|aspirin|mesh-list
56972004|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56972005|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56972006|NCT04796714|Analgesics|analgesics|mesh-ancestor
56972007|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
56972008|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972009|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972010|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972011|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56972012|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56972013|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56972014|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972015|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56972016|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56972017|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972018|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
56972019|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
56972020|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56972021|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56972022|NCT02445898|Prednisolone|prednisolone|mesh-list
56972023|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
56972024|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56972025|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
56972026|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972027|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
56972028|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
56972029|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972030|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972031|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56972032|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
56972033|NCT02445898|Hormones|hormones|mesh-ancestor
56972034|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972035|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56972036|NCT02445898|Protective Agents|protective agents|mesh-ancestor
56972037|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56972038|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972039|NCT03501368|Trametinib|trametinib|mesh-list
56972040|NCT03501368|Ceritinib|ceritinib|mesh-list
56972041|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972042|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56972043|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972044|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972045|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
56972046|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56972047|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56972048|NCT03198130|Cemiplimab|cemiplimab|mesh-list
56972049|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56972050|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972051|NCT04238780|Fentanyl|fentanyl|mesh-list
56972052|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56972053|NCT04238780|Narcotics|narcotics|mesh-ancestor
56972054|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972055|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972056|NCT04238780|Analgesics|analgesics|mesh-ancestor
56972057|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
56972058|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972059|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56972060|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56972061|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
56972062|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
56972063|NCT00944216|Emollients|emollients|mesh-list
56972064|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
56972065|NCT04238663|Bevacizumab|bevacizumab|mesh-list
56972066|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56972067|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972068|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56972069|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56972070|NCT04238663|Growth Substances|growth substances|mesh-ancestor
56972071|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972072|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
56972073|NCT00878462|Asenapine|asenapine|mesh-list
56972074|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56972075|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56972076|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972077|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972078|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56972079|NCT03197818|Budesonide|budesonide|mesh-list
56972080|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
56972081|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972082|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56972083|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
56972084|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972085|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972086|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56972087|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
56972088|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
56972089|NCT03197818|Hormones|hormones|mesh-ancestor
56972090|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972091|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56972092|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56972093|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56972094|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
56972095|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972096|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972097|NCT03442088|Apremilast|apremilast|mesh-list
56972098|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56972099|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56972100|NCT03442088|Analgesics|analgesics|mesh-ancestor
56972101|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
56972102|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972103|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972104|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972105|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56972106|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56972107|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56972108|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972109|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972110|NCT01562405|Dexamethasone|dexamethasone|mesh-list
56972111|NCT01562405|Lenalidomide|lenalidomide|mesh-list
56972112|NCT01562405|Pomalidomide|pomalidomide|mesh-list
56972113|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972114|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
56972115|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
56972116|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972117|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972118|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56972119|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
56972120|NCT01562405|Hormones|hormones|mesh-ancestor
56972121|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972122|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56972123|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972124|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
56972125|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56972126|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56972127|NCT01562405|Growth Substances|growth substances|mesh-ancestor
56972128|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
56972129|NCT03119194|Opicapone|opicapone|mesh-list
56972130|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56972131|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972132|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972133|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56972134|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56972135|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56972136|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56972137|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56972138|NCT03107338|Analgesics|analgesics|mesh-ancestor
56972139|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
56972140|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972141|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972142|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972143|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56972144|NCT05581940|Bupivacaine|bupivacaine|mesh-list
56972145|NCT05581940|Anesthetics|anesthetics|mesh-list
56972146|NCT05581940|Anesthetics, Local|anesthetics, local|mesh-ancestor
56972147|NCT05581940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972148|NCT05581940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972149|NCT05581940|Sensory System Agents|sensory system agents|mesh-ancestor
56972150|NCT05581940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972151|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
56972152|NCT02445508|Sevelamer|sevelamer|mesh-list
56972153|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
56972154|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
56972155|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972156|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56972157|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56972158|NCT03197584|Leucovorin|leucovorin|mesh-list
56972159|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
56972160|NCT03197584|Bevacizumab|bevacizumab|mesh-list
56972161|NCT03197584|Fluorouracil|fluorouracil|mesh-list
56972162|NCT03197584|Capecitabine|capecitabine|mesh-list
56972163|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
56972164|NCT03197584|Fulvestrant|fulvestrant|mesh-list
56972165|NCT03197584|Avelumab|avelumab|mesh-list
56972166|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972167|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972168|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56972169|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
56972170|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972171|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56972172|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56972173|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
56972174|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56972175|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56972176|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56972177|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56972178|NCT03197584|Growth Substances|growth substances|mesh-ancestor
56972179|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
56972180|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
56972181|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56972182|NCT03197584|Antidotes|antidotes|mesh-ancestor
56972183|NCT03197584|Protective Agents|protective agents|mesh-ancestor
56972184|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
56972185|NCT03197584|Vitamins|vitamins|mesh-ancestor
56972186|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
56972187|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56972188|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56972189|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56972190|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
56972191|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972192|NCT03722576|Calcium|calcium|mesh-list
56972193|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56654467|NCT05252546|Loperamide|loperamide|mesh-list
56972194|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972195|NCT03416348|Ethanol|ethanol|mesh-list
56972196|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56972197|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56972198|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972199|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972200|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
56972201|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56972202|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56972203|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56972204|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56972205|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972206|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
56972207|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972208|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972209|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56972210|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972211|NCT02449486|Ropivacaine|ropivacaine|mesh-list
56972212|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
56972213|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
56972214|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972215|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972216|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
56972217|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972218|NCT03202186|Progesterone|progesterone|mesh-list
56972219|NCT03202186|Progestins|progestins|mesh-ancestor
56972220|NCT03202186|Hormones|hormones|mesh-ancestor
56972221|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972222|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972223|NCT03625076|Lidocaine|lidocaine|mesh-list
56972224|NCT03625076|Propofol|propofol|mesh-list
56972225|NCT03625076|Etomidate|etomidate|mesh-list
56972226|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
56972227|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
56972228|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972229|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972230|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
56972231|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972232|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56972233|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56972234|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56972235|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56972236|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972237|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56972238|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56972239|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
56972240|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56972241|NCT02445352|Ezetimibe|ezetimibe|mesh-list
56972242|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56972243|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56972244|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
56972245|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728598|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56972246|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56972247|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56972248|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972249|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
56972250|NCT03693989|Difluprednate|difluprednate|mesh-list
56972251|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
56972252|NCT03693989|Hormones|hormones|mesh-ancestor
56972253|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972254|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972255|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972256|NCT04944212|Vitamin D|vitamin d|mesh-list
56972257|NCT04944212|Vitamins|vitamins|mesh-ancestor
56972258|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
56972259|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972260|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56972261|NCT03197740|Donepezil|donepezil|mesh-list
56972262|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56972263|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972264|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972265|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
56972266|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972267|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972268|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
56972269|NCT03201796|Levofloxacin|levofloxacin|mesh-list
56972270|NCT03201796|Ofloxacin|ofloxacin|mesh-list
56972271|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
56972272|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56972273|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56972274|NCT03201796|Renal Agents|renal agents|mesh-ancestor
56972275|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56972276|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56972277|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56972278|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972279|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972280|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972281|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56972282|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56972283|NCT02727998|Midazolam|midazolam|mesh-list
56972284|NCT02727998|Ketamine|ketamine|mesh-list
56972285|NCT02727998|Analgesics|analgesics|mesh-ancestor
56972286|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
56972287|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972288|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972289|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56972290|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56972291|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
56972292|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
56972293|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972294|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56972295|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56972296|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972297|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972298|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56972299|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56972300|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56972301|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56972302|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56972303|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
56972304|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
56972305|NCT02636270|Mecasermin|mecasermin|mesh-list
56972306|NCT02636270|Growth Substances|growth substances|mesh-ancestor
56972307|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972308|NCT02108990|Acetaminophen|acetaminophen|mesh-list
56972309|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56972310|NCT02108990|Analgesics|analgesics|mesh-ancestor
56972311|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
56972312|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972313|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972314|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
56972315|NCT03194074|Propofol|propofol|mesh-list
56972316|NCT03194074|Desflurane|desflurane|mesh-list
56972317|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56972318|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972319|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972320|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56972321|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
56972322|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
56972323|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56972324|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56972325|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56972326|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56972327|NCT04179461|Vitamin D|vitamin d|mesh-list
56972328|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
56972329|NCT04179461|Fluticasone|fluticasone|mesh-list
56972330|NCT04179461|Xhance|xhance|mesh-list
56972331|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
56972332|NCT04179461|Cetirizine|cetirizine|mesh-list
56972333|NCT04179461|Loratadine|loratadine|mesh-list
56972334|NCT04179461|Azithromycin|azithromycin|mesh-list
56972335|NCT04179461|Budesonide|budesonide|mesh-list
56972336|NCT04179461|Beclomethasone|beclomethasone|mesh-list
56972337|NCT04179461|Emollients|emollients|mesh-list
56972338|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
56972339|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
56972340|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56972341|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56972342|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
56972343|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56972344|NCT04179461|Vitamins|vitamins|mesh-ancestor
56972345|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
56972346|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972347|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56972348|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972349|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56972350|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
56972351|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972352|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56972353|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
56972354|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
56972355|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56972356|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56972357|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
56972358|NCT04179461|Hormones|hormones|mesh-ancestor
56972359|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972360|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56972361|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56972362|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56972363|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56972364|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56972365|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
56972366|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972367|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972368|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
56972369|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56972370|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
56972371|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56972372|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
56972373|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
56972374|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
56972375|NCT04844528|Niacinamide|niacinamide|mesh-list
56972376|NCT04844528|Niacin|niacin|mesh-list
56972377|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
56972378|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
56972379|NCT04844528|Vitamins|vitamins|mesh-ancestor
56972380|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
56972381|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972382|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56972383|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
56972384|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972385|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56972386|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
56972387|NCT03196882|Iron|iron|mesh-list
56972388|NCT03196882|Trace Elements|trace elements|mesh-ancestor
56972389|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
56972390|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972391|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
56972392|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56972393|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
56972394|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56972395|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56972396|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972397|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56972398|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972399|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56972400|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972401|NCT00521222|Fluticasone|fluticasone|mesh-list
56972402|NCT00521222|Xhance|xhance|mesh-list
56972403|NCT00521222|Albuterol|albuterol|mesh-list
56972404|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56972405|NCT00521222|Ipratropium|ipratropium|mesh-list
56972406|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56972407|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972408|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56972409|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
56972410|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972411|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972412|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56972413|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
56972414|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56972415|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56972416|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56972417|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56972418|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56972419|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
56972420|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972421|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972422|NCT00521222|Tocolytic Agents|tocolytic agents|mesh-ancestor
56972423|NCT00521222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56972424|NCT00521222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56972425|NCT00521222|Cholinergic Agents|cholinergic agents|mesh-ancestor
56972426|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
56972427|NCT00521222|Hormones|hormones|mesh-ancestor
56972428|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972429|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
56972430|NCT01562717|Ibuprofen|ibuprofen|mesh-list
56972431|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56972432|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56972433|NCT01562717|Analgesics|analgesics|mesh-ancestor
56972434|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
56972435|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972436|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972437|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972438|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56972439|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56972440|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972441|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972442|NCT03196648|Fluorides|fluorides|mesh-list
56972443|NCT03196648|Antioxidants|antioxidants|mesh-list
56972444|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
56972445|NCT03196648|Protective Agents|protective agents|mesh-ancestor
56972446|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972447|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972448|NCT03625310|Listerine|listerine|mesh-list
56972449|NCT03625310|Fluorides|fluorides|mesh-list
56972450|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
56972451|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
56972452|NCT03625310|Protective Agents|protective agents|mesh-ancestor
56972453|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972454|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56972455|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56972456|NCT05058404|Prednisone|prednisone|mesh-list
56972457|NCT05058404|Rituximab|rituximab|mesh-list
56972458|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56972459|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
56972460|NCT05058404|Vincristine|vincristine|mesh-list
56972461|NCT05058404|Doxorubicin|doxorubicin|mesh-list
56972462|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56972463|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972464|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
56972465|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972466|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56972467|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56972468|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
56972469|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972470|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56972471|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56972472|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972473|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
56972474|NCT05058404|Hormones|hormones|mesh-ancestor
56972475|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972476|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56972477|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56972478|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
56972479|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
56972480|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
56972481|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56972482|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56972483|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56972484|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972485|NCT03118336|Empagliflozin|empagliflozin|mesh-list
56972486|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56972487|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972488|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56972489|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972490|NCT02444572|Enoxaparin|enoxaparin|mesh-list
56972491|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
56972492|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56972493|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56972494|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972495|NCT04165031|Docetaxel|docetaxel|mesh-list
56972496|NCT04165031|Cetuximab|cetuximab|mesh-list
56972497|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56972498|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972499|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
56972500|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
56972501|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
56972502|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972503|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56972504|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56972505|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972507|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56972508|NCT05480150|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56972509|NCT05480150|Citalopram|citalopram|mesh-list
56972510|NCT05480150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56972511|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56972512|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56972513|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972514|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972515|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
56972516|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972517|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56972518|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
56972519|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56972520|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56972521|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56972522|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
56972523|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
56972524|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972525|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56972526|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56972527|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
56972528|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56972529|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56972530|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972531|NCT05480150|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56972532|NCT05480150|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56972533|NCT05480150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56972534|NCT05480150|Adrenergic Agents|adrenergic agents|mesh-ancestor
56972535|NCT05480150|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56972536|NCT05480150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56972537|NCT05480150|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56972538|NCT05480150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56972539|NCT05480150|Dopamine Agents|dopamine agents|mesh-ancestor
56972540|NCT05464628|Atorvastatin|atorvastatin|mesh-list
56972541|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56972542|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56972543|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
56972544|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972545|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56972546|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56972547|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972548|NCT02449252|Prednisone|prednisone|mesh-list
56972549|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
56972550|NCT02449252|Doxorubicin|doxorubicin|mesh-list
56972551|NCT02449252|Vincristine|vincristine|mesh-list
56972552|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56972553|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
56972554|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972555|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56972556|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56972557|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
56972558|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972559|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972560|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56972561|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56972562|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56972563|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56972564|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972565|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972566|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
56972567|NCT02449252|Hormones|hormones|mesh-ancestor
56972568|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972569|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56972570|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56972571|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
56972572|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
56972574|NCT03193918|Paclitaxel|paclitaxel|mesh-list
56972575|NCT03193918|Ramucirumab|ramucirumab|mesh-list
56972576|NCT03193918|Crenolanib|crenolanib|mesh-list
56972577|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56972578|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972579|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
56972580|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
56972581|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
56972582|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972583|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
56972584|NCT03117790|Morphine|morphine|mesh-list
56972585|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56972586|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972587|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972588|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56972589|NCT03117790|Analgesics|analgesics|mesh-ancestor
56972590|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
56972591|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972592|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56972593|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56972594|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56972595|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
56972596|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972597|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972598|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56972599|NCT03117790|Narcotics|narcotics|mesh-ancestor
56972600|NCT03193372|Azelaic acid|azelaic acid|mesh-list
56972601|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972602|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
56972603|NCT03034772|Timolol|timolol|mesh-list
56972604|NCT03034772|Dorzolamide|dorzolamide|mesh-list
56972605|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
56972606|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56972607|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56972608|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
56972609|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972610|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972611|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972612|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56972613|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56972614|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56972615|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56972616|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56972617|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972618|NCT05358548|Paclitaxel|paclitaxel|mesh-list
56972619|NCT05358548|Carboplatin|carboplatin|mesh-list
56972620|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
56972621|NCT05358548|Fluorouracil|fluorouracil|mesh-list
56972622|NCT05358548|Pemetrexed|pemetrexed|mesh-list
56972623|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56972624|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972625|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
56972626|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
56972627|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
56972628|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728599|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
56972629|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56972630|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
56972631|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56972632|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56972633|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
56972634|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972635|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972636|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56972637|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56972638|NCT03193606|Fluorides|fluorides|mesh-list
56972639|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
56972640|NCT03193606|Protective Agents|protective agents|mesh-ancestor
56972641|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972642|NCT02448784|Donepezil|donepezil|mesh-list
56972643|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56972644|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972645|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972646|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
56972647|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654912|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
56972648|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972649|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
56972650|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
56972651|NCT04050488|Astringents|astringents|mesh-ancestor
56972652|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972653|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
56972654|NCT02584478|Paclitaxel|paclitaxel|mesh-list
56972655|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56972656|NCT02584478|Carboplatin|carboplatin|mesh-list
56972657|NCT02584478|Doxorubicin|doxorubicin|mesh-list
56972658|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56972659|NCT02584478|Topotecan|topotecan|mesh-list
56972660|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56972661|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972662|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
56972663|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
56972664|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
56972665|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972666|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56972667|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56972668|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56972669|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972670|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56972671|NCT03365908|Ropivacaine|ropivacaine|mesh-list
56972672|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
56972673|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
56972674|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972675|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972676|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
56972677|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972678|NCT04779554|Mitomycins|mitomycins|mesh-list
56972679|NCT04779554|Mitomycin|mitomycin|mesh-list
56972680|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56972681|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972682|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
56972683|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972684|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56972685|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972686|NCT02444260|Lidocaine|lidocaine|mesh-list
56972687|NCT02444260|Midazolam|midazolam|mesh-list
56972688|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56972689|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56972690|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972691|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972692|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56972693|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56972694|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56972695|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56972696|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
56972697|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
56972698|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
56972699|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
56972700|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972701|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972702|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
56972703|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
56972704|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972705|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56972706|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56972707|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56972708|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56972709|NCT03195634|Carvedilol|carvedilol|mesh-list
56972710|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56972711|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56972712|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56972713|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972714|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972715|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972716|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56972717|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
56972718|NCT03195634|Protective Agents|protective agents|mesh-ancestor
56972719|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56972720|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56972721|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56972722|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
56972723|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56972724|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56972726|NCT02448550|Calcium heparin|calcium heparin|mesh-list
56972727|NCT02448550|Bivalirudin|bivalirudin|mesh-list
56972728|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
56972729|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56972730|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56972731|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972732|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
56972733|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56972734|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
56972735|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972736|NCT03701750|Heparin|heparin|mesh-list
56972737|NCT03701750|Enoxaparin|enoxaparin|mesh-list
56972738|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56972739|NCT03701750|Tinzaparin|tinzaparin|mesh-list
56972740|NCT03701750|Dalteparin|dalteparin|mesh-list
56972741|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
56972742|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
56972743|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56972744|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56972745|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972746|NCT03704246|Antibodies|antibodies|mesh-list
56972747|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56972748|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
56972749|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972750|NCT05239910|Tenalisib|tenalisib|mesh-list
56972751|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
56972752|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972753|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972754|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
56972755|NCT03701672|Analgesics|analgesics|mesh-list
56972756|NCT03701672|Narcotics|narcotics|mesh-ancestor
56972757|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972758|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972759|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
56972760|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972761|NCT04594694|Bezafibrate|bezafibrate|mesh-list
56972762|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56972763|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
56972764|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972765|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56972766|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
56972767|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56972768|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56972769|NCT03746249|Lenvatinib|lenvatinib|mesh-list
56972770|NCT03746249|Antibodies|antibodies|mesh-list
56972771|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
56972772|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
56972773|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972774|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972775|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56972776|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972777|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972778|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
56972779|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
56972780|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
56972781|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
55728756|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
56972782|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972783|NCT03698474|Analgesics|analgesics|mesh-ancestor
56972784|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
56972785|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972786|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972787|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
56972788|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972789|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56972790|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
56972791|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56972792|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56972793|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56972794|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
56972795|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56972796|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
56972797|NCT03698474|Protective Agents|protective agents|mesh-ancestor
56972798|NCT03698474|Vitamins|vitamins|mesh-ancestor
56655084|NCT00659412|Alefacept|alefacept|mesh-list
56972799|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
56972800|NCT03698474|Cathartics|cathartics|mesh-ancestor
56972801|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56972802|NCT04710368|Evolocumab|evolocumab|mesh-list
56972803|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56972804|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56972805|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
56972806|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972807|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56972808|NCT04709276|Carboplatin|carboplatin|mesh-list
56972809|NCT04709276|Nivolumab|nivolumab|mesh-list
56972810|NCT04709276|Ipilimumab|ipilimumab|mesh-list
56972811|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972812|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56972813|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56972814|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972815|NCT01194622|Fluticasone|fluticasone|mesh-list
56972816|NCT01194622|Xhance|xhance|mesh-list
56972817|NCT01194622|Azelastine|azelastine|mesh-list
56972818|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972819|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56972820|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
56972821|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972822|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972823|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56972824|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
56972825|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56972826|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56972827|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56972828|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972829|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972830|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56972831|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56972832|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
56972833|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
56972834|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972835|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56972836|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
56972837|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56972838|NCT02448316|Prednisolone|prednisolone|mesh-list
56972839|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
56972840|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56972841|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
56972842|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972843|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
56972844|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
56972845|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972846|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972847|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56972848|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
56972849|NCT02448316|Hormones|hormones|mesh-ancestor
56972850|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972851|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56972852|NCT02448316|Protective Agents|protective agents|mesh-ancestor
56972853|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56972854|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972855|NCT04564898|Trifluridine|trifluridine|mesh-list
56972856|NCT04564898|Bevacizumab|bevacizumab|mesh-list
56972857|NCT04564898|Capecitabine|capecitabine|mesh-list
56972858|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56972859|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972860|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56972861|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56972862|NCT04564898|Growth Substances|growth substances|mesh-ancestor
56972863|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972864|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
56972865|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56972866|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
56972867|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972868|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
56972869|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56972870|NCT02443714|Insulin|insulin|mesh-list
56972871|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56972872|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
56972873|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56972874|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972875|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
56972876|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56972877|NCT03703154|Tacrolimus|tacrolimus|mesh-list
56972878|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56972879|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
56972880|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972881|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56972882|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972883|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972884|NCT04545554|Vitamin D|vitamin d|mesh-list
56972885|NCT04545554|Calcium|calcium|mesh-list
56972886|NCT04545554|Vitamins|vitamins|mesh-ancestor
56972887|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
56972888|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972889|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56972890|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56972891|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
56972892|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
56972893|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972894|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
56972895|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
56972896|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56972897|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56972898|NCT03190642|Prednisolone|prednisolone|mesh-list
56972899|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
56972900|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56972901|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
56972902|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972903|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
56972904|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
56972905|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972906|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972907|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56972908|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
56972909|NCT03190642|Hormones|hormones|mesh-ancestor
56972910|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56972911|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56972912|NCT03190642|Protective Agents|protective agents|mesh-ancestor
56972913|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56972914|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972915|NCT03702530|Albendazole|albendazole|mesh-list
56972916|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
56972917|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56972918|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56972919|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
56972920|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56972921|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56972922|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
56972923|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
56972924|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
56972925|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972926|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56972927|NCT02443246|Vitamin D|vitamin d|mesh-list
56972928|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
56972929|NCT02443246|Vitamins|vitamins|mesh-ancestor
56972930|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
56972931|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972932|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56972933|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56972934|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56972935|NCT03031496|Amiloride|amiloride|mesh-list
56972936|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
56972937|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56972938|NCT03031496|Diuretics|diuretics|mesh-ancestor
56972939|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
56972940|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972941|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56972942|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56972943|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972944|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56972945|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56972946|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56972947|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56972948|NCT03187912|Riboflavin|riboflavin|mesh-list
56972949|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
56972950|NCT03187912|Vitamins|vitamins|mesh-ancestor
56972951|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
56972952|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972953|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56972955|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
56972956|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56972957|NCT02443012|Nepafenac|nepafenac|mesh-list
56972958|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56972959|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56972960|NCT02443012|Analgesics|analgesics|mesh-ancestor
56972961|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
56972962|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972963|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972964|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56972965|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56972966|NCT04670432|Troxerutin|troxerutin|mesh-list
56972967|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
56972968|NCT03701126|Bupivacaine|bupivacaine|mesh-list
56972969|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
56972970|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
56972971|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56972972|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972973|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
56972974|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972975|NCT04370054|Factor VIII|factor viii|mesh-list
56972976|NCT04370054|Coagulants|coagulants|mesh-ancestor
56972977|NCT03702140|Teriparatide|teriparatide|mesh-list
56972978|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56972979|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972980|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56972981|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56972982|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56972983|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56972984|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56972985|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972986|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972987|NCT02433808|Neostigmine|neostigmine|mesh-list
56972988|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56972989|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56972990|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56972991|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
56972992|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56972993|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56972994|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56972995|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
56972996|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56972997|NCT03701984|Lidocaine|lidocaine|mesh-list
56972998|NCT03701984|Tramadol|tramadol|mesh-list
56972999|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
56973000|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
56973001|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973002|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973003|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
56973004|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973005|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56973006|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56973007|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56973008|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56973009|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973010|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56973011|NCT03701984|Narcotics|narcotics|mesh-ancestor
56973012|NCT03701984|Analgesics|analgesics|mesh-ancestor
56973013|NCT04651400|Antithrombins|antithrombins|mesh-list
56973014|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
56973015|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56973016|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
56973017|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973018|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973019|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
56973020|NCT02439190|Aspirin|aspirin|mesh-list
56973021|NCT02439190|Clopidogrel|clopidogrel|mesh-list
56973022|NCT02439190|BMS-986120|bms-986120|mesh-list
56973023|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56973024|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973025|NCT02439190|Analgesics|analgesics|mesh-ancestor
56973026|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
56973027|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973028|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973030|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973031|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56973032|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56973033|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973034|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56973035|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56973036|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973037|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
56973038|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56973039|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56973040|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56973041|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
56973042|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973043|NCT02442466|BQ 788|bq 788|mesh-list
56973044|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56973045|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56973046|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56973047|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973048|NCT04336982|Azacitidine|azacitidine|mesh-list
56973049|NCT04336982|Venetoclax|venetoclax|mesh-list
56973050|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56973051|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
56973052|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973053|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973054|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973055|NCT02439034|Acetaminophen|acetaminophen|mesh-list
56973056|NCT02439034|Ketoprofen|ketoprofen|mesh-list
56973057|NCT02439034|Codeine|codeine|mesh-list
56973058|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973059|NCT02439034|Analgesics|analgesics|mesh-ancestor
56973060|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
56973061|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973062|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973063|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
56973064|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56973065|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973066|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973067|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56973068|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973069|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973070|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56973071|NCT02439034|Narcotics|narcotics|mesh-ancestor
56973072|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973073|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
56973074|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
56973075|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
56973076|NCT04239092|Temozolomide|temozolomide|mesh-list
56973077|NCT04239092|Irinotecan|irinotecan|mesh-list
56973078|NCT04239092|Topotecan|topotecan|mesh-list
56973079|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56973080|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
56973081|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973082|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973083|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56973084|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
56973085|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973086|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973087|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56973088|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56973089|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56973090|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973091|NCT04483492|Caffeine|caffeine|mesh-list
56973092|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
56973093|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973094|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56973095|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973096|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56973097|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973098|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56973099|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56973100|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
56973101|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973102|NCT03186742|Eplerenone|eplerenone|mesh-list
56973103|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56973104|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
56973105|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973106|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973107|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56973108|NCT03186742|Diuretics|diuretics|mesh-ancestor
56973109|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
56973110|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56973111|NCT03186664|Nabiximols|nabiximols|mesh-list
56973112|NCT03186664|Analgesics|analgesics|mesh-ancestor
56973113|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
56973114|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973115|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973116|NCT02441842|Atenolol|atenolol|mesh-list
56973117|NCT02441842|Lisinopril|lisinopril|mesh-list
56973118|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56973119|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
56973120|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973121|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973122|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56973123|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56973124|NCT02441842|Protective Agents|protective agents|mesh-ancestor
56973125|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973126|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56973127|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
56973128|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
56973129|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973130|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56973131|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56973132|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56973133|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
56973134|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973135|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
56973136|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56973137|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56973138|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973139|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
56973140|NCT02438566|Coagulants|coagulants|mesh-ancestor
56973141|NCT02433652|Vaccines|vaccines|mesh-list
56973142|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
56973143|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973144|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
56973145|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56973146|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
56973147|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56973148|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973149|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56973150|NCT02433418|Diclofenac|diclofenac|mesh-list
56973151|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56973152|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973153|NCT02433418|Analgesics|analgesics|mesh-ancestor
56973154|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
56973155|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973156|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973157|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973158|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973159|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56973160|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973161|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973162|NCT02433730|Testosterone|testosterone|mesh-list
56973163|NCT02433730|Androgens|androgens|mesh-ancestor
56973164|NCT02433730|Hormones|hormones|mesh-ancestor
56973165|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973166|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973167|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
56973168|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56973169|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
56973170|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56973171|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
56973172|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973173|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973174|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
56973175|NCT02441530|Vitamin D|vitamin d|mesh-list
56973176|NCT02441530|Vitamins|vitamins|mesh-list
56973177|NCT02441530|Vitamin E|vitamin e|mesh-list
56973178|NCT02441530|Ibuprofen|ibuprofen|mesh-list
56973179|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
56973180|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973181|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56973182|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56973183|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973184|NCT02441530|Analgesics|analgesics|mesh-ancestor
56973185|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
56973186|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973187|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973188|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973189|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56973190|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973191|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973192|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
56973193|NCT02441530|Protective Agents|protective agents|mesh-ancestor
56973194|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
56973195|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
56973196|NCT02433184|Etanercept|etanercept|mesh-list
56973197|NCT02433184|Methotrexate|methotrexate|mesh-list
56973198|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56973199|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
56973200|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56973201|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973202|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56973203|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
56973204|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973205|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973206|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
56973207|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973208|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56973209|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56973210|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
56973211|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973212|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56973213|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
56973214|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56973215|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56973216|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973217|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56973218|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973219|NCT02433184|Analgesics|analgesics|mesh-ancestor
56973220|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
56973221|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973222|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973223|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56973224|NCT02438020|Metformin|metformin|mesh-list
56973225|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56973226|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973227|NCT02440750|Dienogest|dienogest|mesh-list
56973228|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
56973229|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56973230|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
56973231|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56973232|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973233|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56973234|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56973235|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56973236|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56973237|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
56973238|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973239|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56973240|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973241|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
56973242|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56973243|NCT02432872|Cytarabine|cytarabine|mesh-list
56973244|NCT02432872|Daunorubicin|daunorubicin|mesh-list
56973245|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56973246|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
56973247|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973248|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973249|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
56973250|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973251|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56973252|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
56655506|NCT00967213|Ranibizumab|ranibizumab|mesh-list
56973253|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973254|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56973255|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56973256|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56973257|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973258|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56973259|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56973260|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
56973261|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973262|NCT02436928|Vaccines|vaccines|mesh-list
56973263|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
56973264|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973265|NCT02436538|Hormones|hormones|mesh-list
56973266|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973267|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973268|NCT02436694|Dexamethasone|dexamethasone|mesh-list
56973269|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
56973270|NCT02436694|Ropivacaine|ropivacaine|mesh-list
56973271|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
56973272|NCT02436694|Anesthetics|anesthetics|mesh-list
56973273|NCT02436694|BB 1101|bb 1101|mesh-list
56973274|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973275|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
56973276|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
56973277|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973278|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973279|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56973280|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
56973281|NCT02436694|Hormones|hormones|mesh-ancestor
56973282|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973283|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56973284|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973285|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
56973286|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973287|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973288|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973289|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
56973290|NCT03186040|Lacosamide|lacosamide|mesh-list
56973291|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
56973292|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56973293|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56973294|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56973295|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973296|NCT02659020|Gemcitabine|gemcitabine|mesh-list
56973297|NCT02659020|Docetaxel|docetaxel|mesh-list
56973298|NCT02659020|Olaratumab|olaratumab|mesh-list
56973299|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56973300|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
56973301|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973302|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973303|NCT02659020|Antiviral Agents|antiviral agents|mesh-ancestor
56973304|NCT02659020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973305|NCT02659020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973306|NCT02659020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56973307|NCT02659020|Immunologic Factors|immunologic factors|mesh-ancestor
56973308|NCT02659020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973309|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
56973310|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
56973311|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
56973312|NCT03482011|Mirikizumab|mirikizumab|mesh-list
56973313|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56973314|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973315|NCT03482011|Analgesics|analgesics|mesh-ancestor
56973316|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
56973317|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973318|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973319|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973320|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973321|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56973322|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56973323|NCT02436226|Citric Acid|citric acid|mesh-list
56973324|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
56973325|NCT02436226|Clomiphene|clomiphene|mesh-list
56973326|NCT02436226|Enclomiphene|enclomiphene|mesh-list
56973327|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
56973328|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56973329|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
56973330|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56973331|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
56973332|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
56973333|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973334|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56973335|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
56973336|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973337|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973338|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56973339|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
56973340|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56973341|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56973342|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56973343|NCT01374126|Azithromycin|azithromycin|mesh-list
56973344|NCT01374126|Artesunate|artesunate|mesh-list
56973345|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56973346|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973347|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
56973348|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56973349|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56973350|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973351|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
56973352|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
56973353|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56973354|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
56973355|NCT02584920|Rituximab|rituximab|mesh-list
56973356|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56973357|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973358|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
56973359|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973360|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973361|NCT02431936|Prazosin|prazosin|mesh-list
56973362|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56973363|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56973364|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56973365|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56973366|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
56973367|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973368|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973369|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973370|NCT02440828|Tobramycin|tobramycin|mesh-list
56973371|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56973372|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973373|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56973374|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56973375|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973376|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973377|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56973378|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
56973379|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973380|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973381|NCT03789318|Acetaminophen|acetaminophen|mesh-list
56973382|NCT03789318|Fentanyl|fentanyl|mesh-list
56973383|NCT03789318|Oxycodone|oxycodone|mesh-list
56973384|NCT03789318|Hydromorphone|hydromorphone|mesh-list
56973385|NCT03789318|Bupivacaine|bupivacaine|mesh-list
56973386|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
56973387|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
56894240|NCT03708848|Antacids|antacids|mesh-ancestor
56973388|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973389|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973390|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
56973391|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973392|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56973393|NCT03789318|Narcotics|narcotics|mesh-ancestor
56973394|NCT03789318|Analgesics|analgesics|mesh-ancestor
56973395|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56973396|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56973397|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
56973398|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973399|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
56973400|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
56973401|NCT04518410|Gabexate|gabexate|mesh-list
56973402|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
56973403|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56973404|NCT04518410|Antibodies|antibodies|mesh-list
56973405|NCT04518410|Camostat|camostat|mesh-list
56973406|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
56973407|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973408|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
56973409|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973410|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973411|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56973412|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56973413|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
56973414|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
56973415|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973416|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
56973417|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56973418|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973419|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56973420|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
56973421|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56973422|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973423|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973424|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973425|NCT05160090|Bupropion|bupropion|mesh-list
56973426|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56973427|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
56973428|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56973429|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56973430|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56973431|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56973432|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973433|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
56973434|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973435|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973436|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56973437|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56973438|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973439|NCT00695214|Propofol|propofol|mesh-list
56973440|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56973441|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973442|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973443|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56973444|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
56973445|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
56973446|NCT04516616|Paclitaxel|paclitaxel|mesh-list
56973447|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56973448|NCT04516616|Cisplatin|cisplatin|mesh-list
56973449|NCT04516616|Antibodies|antibodies|mesh-list
56973450|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56973451|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56973452|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973453|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
56973454|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
56973455|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
56973456|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973457|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
56973458|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973459|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
56973460|NCT04322318|Ifosfamide|ifosfamide|mesh-list
56973461|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
56973462|NCT04322318|Carboplatin|carboplatin|mesh-list
56973463|NCT04322318|Doxorubicin|doxorubicin|mesh-list
56973464|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56973465|NCT04322318|Irinotecan|irinotecan|mesh-list
56973466|NCT04322318|Etoposide|etoposide|mesh-list
56973467|NCT04322318|Vincristine|vincristine|mesh-list
56973468|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
56973469|NCT04322318|Daunorubicin|daunorubicin|mesh-list
56973470|NCT04322318|Topotecan|topotecan|mesh-list
56973471|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
56973472|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56973473|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
56973474|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973475|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973476|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56973477|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
56973478|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973479|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973480|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56973481|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56973482|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56973484|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973485|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56973486|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56973487|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
56973488|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
56973489|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
56973490|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
56973491|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
56973492|NCT00511134|Eszopiclone|eszopiclone|mesh-list
56973493|NCT00511134|Bupropion|bupropion|mesh-list
56973494|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56973495|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
56973496|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56973497|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56973498|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56973499|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56973500|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973501|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
56973502|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973503|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973504|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56973505|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56973506|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973507|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56973508|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973509|NCT05103228|Menotropins|menotropins|mesh-list
56973510|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56973511|NCT05103228|Hormones|hormones|mesh-ancestor
56973512|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973513|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973514|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56973515|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
56973516|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56973517|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56973518|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973519|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56973520|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973521|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973522|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
56973523|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56973524|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
56973525|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973526|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
56973527|NCT05082480|Protective Agents|protective agents|mesh-ancestor
56973528|NCT03190798|Canagliflozin|canagliflozin|mesh-list
56973529|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56973530|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973531|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56973532|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973533|NCT03696290|Aztreonam|aztreonam|mesh-list
56973534|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56973535|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973536|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
56973537|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56973538|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973539|NCT03692546|Bupivacaine|bupivacaine|mesh-list
56973540|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
56973541|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
56973542|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973543|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973544|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
56973545|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973546|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56973547|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
56973548|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973549|NCT02434822|Vaccines|vaccines|mesh-list
56973550|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
56973551|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973552|NCT01371474|Paroxetine|paroxetine|mesh-list
56973553|NCT01371474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56973554|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56655820|NCT05327699|Ketamine|ketamine|mesh-list
56973555|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56973556|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973557|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973558|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
56973559|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973560|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56973561|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
56973562|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56973563|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56973564|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56973565|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973566|NCT03185104|Fluorides|fluorides|mesh-list
56973567|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
56973568|NCT03185104|Protective Agents|protective agents|mesh-ancestor
56973569|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973570|NCT01319994|Metformin|metformin|mesh-list
56973571|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56973572|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973573|NCT02430298|Melatonin|melatonin|mesh-list
56973574|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
56973575|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973576|NCT02430298|Protective Agents|protective agents|mesh-ancestor
56973577|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973578|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973579|NCT03626376|Valacyclovir|valacyclovir|mesh-list
56973580|NCT03626376|Acyclovir|acyclovir|mesh-list
56973581|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56973582|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56973583|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
56973584|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973585|NCT05007522|Ketotifen|ketotifen|mesh-list
56973586|NCT05007522|Indomethacin|indomethacin|mesh-list
56973587|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56973588|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973589|NCT05007522|Analgesics|analgesics|mesh-ancestor
56973590|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
56973591|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973592|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973593|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973594|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973595|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
56973596|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
56973597|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56973598|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56973599|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973600|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973601|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
56973602|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
56973603|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56973604|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
56973605|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
56973606|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973607|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56973608|NCT03695822|Mirabegron|mirabegron|mesh-list
56973609|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56973610|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56973611|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56973612|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
56973613|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973614|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973615|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973616|NCT03695822|Urological Agents|urological agents|mesh-ancestor
56973617|NCT03718507|Atropine|atropine|mesh-list
56973618|NCT03718507|Fentanyl|fentanyl|mesh-list
56973619|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56973620|NCT03718507|Narcotics|narcotics|mesh-ancestor
56973621|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973622|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973623|NCT03718507|Analgesics|analgesics|mesh-ancestor
56973624|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
56973625|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973626|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56973627|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56973628|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
56973629|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
56973630|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56973631|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56973632|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
56973633|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56973634|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
56973635|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
56973636|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
56973637|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56973638|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56973639|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
56973640|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973641|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973642|NCT03695744|Dexamethasone|dexamethasone|mesh-list
56973643|NCT03695744|Bortezomib|bortezomib|mesh-list
56973644|NCT03695744|Daratumumab|daratumumab|mesh-list
56973645|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973646|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
56973647|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
56973648|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973649|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973650|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56973651|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
56973652|NCT03695744|Hormones|hormones|mesh-ancestor
56973653|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973654|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56973655|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973656|NCT01374282|Penicillamine|penicillamine|mesh-list
56973657|NCT01374282|Antidotes|antidotes|mesh-ancestor
56973658|NCT01374282|Protective Agents|protective agents|mesh-ancestor
56973659|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973660|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
56973661|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
56973662|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973663|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973664|NCT03691922|Epinephrine|epinephrine|mesh-list
56973665|NCT03691922|Racepinephrine|racepinephrine|mesh-list
56973666|NCT03691922|Bupivacaine|bupivacaine|mesh-list
56973667|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
56973668|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
56973669|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
56973670|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973671|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973672|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
56973673|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973674|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56973675|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56973676|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
56973677|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973678|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973679|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56973680|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56973681|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
56973682|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56973683|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
56973684|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
56973685|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
56973686|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56973687|NCT03453151|Anesthetics|anesthetics|mesh-list
56973688|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
56973689|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973690|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894530|NCT03708458|Antidotes|antidotes|mesh-ancestor
56973691|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
56973692|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973693|NCT03433248|Empagliflozin|empagliflozin|mesh-list
56973694|NCT03433248|Gliclazide|gliclazide|mesh-list
56973695|NCT03433248|Linagliptin|linagliptin|mesh-list
56973696|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56973697|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973698|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56973699|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973700|NCT03433248|Incretins|incretins|mesh-ancestor
56973701|NCT03433248|Hormones|hormones|mesh-ancestor
56973702|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973703|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56973704|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
56973705|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973706|NCT03691688|Aspirin|aspirin|mesh-list
56973707|NCT03691688|Clopidogrel|clopidogrel|mesh-list
56973708|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56973709|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973710|NCT03691688|Analgesics|analgesics|mesh-ancestor
56973711|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
56973712|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973713|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973714|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973715|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973716|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56973717|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56973718|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973719|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56973720|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56973721|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973722|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
56973723|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56973724|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56973725|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56973726|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
56973727|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973728|NCT02887248|Gemcitabine|gemcitabine|mesh-list
56973729|NCT02887248|Paclitaxel|paclitaxel|mesh-list
56973730|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56973731|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973732|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56973733|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56973734|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56973735|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973736|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56973737|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
56973738|NCT02887248|Antiviral Agents|antiviral agents|mesh-ancestor
56973739|NCT02887248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973740|NCT02887248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973741|NCT02887248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56973742|NCT02887248|Immunologic Factors|immunologic factors|mesh-ancestor
56973743|NCT02887248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973744|NCT02425462|Dienogest|dienogest|mesh-list
56973745|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56973746|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
56973747|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56973748|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973749|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56973750|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56973751|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56973752|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56973753|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
56973754|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973755|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56973756|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973757|NCT03452527|Aflibercept|aflibercept|mesh-list
56973758|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
56973759|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56973760|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56973761|NCT03452527|Growth Substances|growth substances|mesh-ancestor
56973762|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894606|NCT05631717|Sensory System Agents|sensory system agents|mesh-ancestor
56973763|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
56973764|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973765|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
56973766|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
56973767|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56973768|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973769|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973770|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973771|NCT04878510|Analgesics|analgesics|mesh-ancestor
56973772|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
56973773|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973774|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56973775|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56973776|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56973777|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
56973778|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973779|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656033|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
56973780|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
56973781|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56973782|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
56973783|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973784|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973785|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56973786|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
56973787|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
56973788|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56973789|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
56973790|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973791|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973792|NCT02800824|Budesonide|budesonide|mesh-list
56973793|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973794|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56973795|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
56973796|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973797|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973798|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56973799|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
56973800|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
56973801|NCT02800824|Hormones|hormones|mesh-ancestor
56973802|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973803|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56973804|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56973805|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973806|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973807|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56973808|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56973809|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973810|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
56973811|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973812|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56973813|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
56973814|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56973815|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56973816|NCT03715699|Prednisone|prednisone|mesh-list
56973817|NCT03715699|Leflunomide|leflunomide|mesh-list
56973818|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973819|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
56973820|NCT03715699|Hormones|hormones|mesh-ancestor
56973821|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56973822|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973823|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56973824|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973825|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973826|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973827|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56973828|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
56973829|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
56973830|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56973831|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
56973832|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973833|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973834|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56973835|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
56973836|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56973837|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
56973838|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973839|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973840|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56973841|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
56973842|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
56973843|NCT04776408|Protective Agents|protective agents|mesh-ancestor
56973844|NCT02429596|Lamotrigine|lamotrigine|mesh-list
56973845|NCT02429596|Carbamazepine|carbamazepine|mesh-list
56973846|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
56973847|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56973848|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56973849|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973850|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56973851|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973852|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56973853|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56973854|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973855|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56973856|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56973857|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
56973858|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56973859|NCT02429596|Analgesics|analgesics|mesh-ancestor
56973860|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
56973861|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973862|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56973863|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56973864|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
56973865|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
56973866|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973867|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973868|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973869|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
56973870|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
56973871|NCT02653092|Heparin|heparin|mesh-list
56973872|NCT02653092|Anticoagulants|anticoagulants|mesh-list
56973873|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56973874|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56973875|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56973876|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973877|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56973878|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56973879|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56973880|NCT03691454|Docetaxel|docetaxel|mesh-list
56973881|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
56973882|NCT03691454|Trastuzumab|trastuzumab|mesh-list
56973883|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973884|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
56973885|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
56973886|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
56973887|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973888|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56973889|NCT03718273|Digoxin|digoxin|mesh-list
56973890|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56973891|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56973892|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973893|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973894|NCT03718273|Protective Agents|protective agents|mesh-ancestor
56973895|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973896|NCT02421640|Cisplatin|cisplatin|mesh-list
56973897|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973898|NCT04166318|Fluorouracil|fluorouracil|mesh-list
56973899|NCT04166318|Capecitabine|capecitabine|mesh-list
56973900|NCT04166318|Mitomycins|mitomycins|mesh-list
56973901|NCT04166318|Mitomycin|mitomycin|mesh-list
56973902|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
56973903|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973904|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56973905|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973906|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56973907|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
56973908|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973909|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56973910|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
56973911|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56973912|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973913|NCT03715387|Bacitracin|bacitracin|mesh-list
56973914|NCT03715387|Polymyxin B|polymyxin b|mesh-list
56973915|NCT03715387|Tacrolimus|tacrolimus|mesh-list
56973916|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56973917|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
56973918|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973919|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56973920|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973921|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973922|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56973923|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973924|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56973925|NCT03715309|Lenalidomide|lenalidomide|mesh-list
56973926|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
56973927|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973928|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56973929|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56973930|NCT03715309|Growth Substances|growth substances|mesh-ancestor
56973931|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
56973932|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973933|NCT03179254|Metformin|metformin|mesh-list
56973934|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56973935|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973936|NCT04147715|Dolutegravir|dolutegravir|mesh-list
56973937|NCT04147715|Midazolam|midazolam|mesh-list
56973938|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56973939|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56973940|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973941|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973942|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56973943|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56973944|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56973945|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56973946|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
56973947|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
56973948|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
56973949|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
56973950|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56973951|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56973952|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56973953|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56973954|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56973955|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56973956|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56973957|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
56973958|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973959|NCT02420938|Rituximab|rituximab|mesh-list
56973960|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56973961|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973962|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
56973963|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973964|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56973965|NCT02429440|Molgramostim|molgramostim|mesh-list
56973966|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56973967|NCT02429440|Sargramostim|sargramostim|mesh-list
56973968|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56973969|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
56973970|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973971|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973972|NCT02429518|Miltefosine|miltefosine|mesh-list
56973973|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
56973974|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56973975|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56973976|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56973977|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56973978|NCT00708526|Anesthetics|anesthetics|mesh-list
56973979|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973980|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973981|NCT03712735|Fentanyl|fentanyl|mesh-list
56973982|NCT03712735|Bupivacaine|bupivacaine|mesh-list
56973983|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
56973984|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
56973985|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56973986|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56973987|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
56973988|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56973989|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56973990|NCT03712735|Narcotics|narcotics|mesh-ancestor
56973991|NCT03712735|Analgesics|analgesics|mesh-ancestor
56973992|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56973993|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56973994|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
56973995|NCT03182218|Heparin|heparin|mesh-list
56973996|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56973997|NCT03182218|Tinzaparin|tinzaparin|mesh-list
56973998|NCT03182218|Dalteparin|dalteparin|mesh-list
56973999|NCT03182218|Anticoagulants|anticoagulants|mesh-list
56974000|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56974001|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56974002|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974003|NCT02452554|Maytansine|maytansine|mesh-list
56974004|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
56974005|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56974006|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56974007|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974008|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
56974009|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
56974010|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
56974011|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974012|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56974013|NCT03182296|Exenatide|exenatide|mesh-list
56974014|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974015|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974016|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56974017|NCT03182296|Incretins|incretins|mesh-ancestor
56974018|NCT03182296|Hormones|hormones|mesh-ancestor
56974019|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974020|NCT03182374|Hylan|hylan|mesh-list
56974021|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
56974022|NCT03182374|Protective Agents|protective agents|mesh-ancestor
56974023|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974024|NCT03718039|Aprepitant|aprepitant|mesh-list
56974025|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
56974026|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
56974027|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974028|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974029|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56974030|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56974031|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974032|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974033|NCT01319682|Lidocaine|lidocaine|mesh-list
56974034|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
56974035|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
56974036|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974037|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974038|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
56974039|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974040|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56974041|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56974042|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56974043|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56974044|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974045|NCT04009577|Lemborexant|lemborexant|mesh-list
56974046|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56974047|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974048|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974049|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56974050|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56974051|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974052|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974053|NCT02176668|Esomeprazole|esomeprazole|mesh-list
56974054|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56974055|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56974056|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56974057|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974058|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974059|NCT03712423|Docetaxel|docetaxel|mesh-list
56974060|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894906|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974061|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
56974062|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
56974063|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
56974064|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974065|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
56974066|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
56974067|NCT04620252|Citric Acid|citric acid|mesh-list
56974068|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
56974069|NCT04620252|Calcium|calcium|mesh-list
56974070|NCT04620252|Fluorides|fluorides|mesh-list
56974071|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56974072|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974073|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56974074|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
56974075|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56974076|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
56974077|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
56974078|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974079|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
56974080|NCT04620252|Protective Agents|protective agents|mesh-ancestor
56974081|NCT04620252|Antacids|antacids|mesh-ancestor
56974082|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56974083|NCT03694886|Caffeine|caffeine|mesh-list
56974084|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56974085|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974086|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56974087|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974088|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974089|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56974090|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56974091|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
56974092|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974093|NCT05602675|Repaglinide|repaglinide|mesh-list
56974094|NCT05602675|Methotrexate|methotrexate|mesh-list
56974095|NCT05602675|Midazolam|midazolam|mesh-list
56974096|NCT05602675|Dextromethorphan|dextromethorphan|mesh-list
56974097|NCT05602675|Warfarin|warfarin|mesh-list
56974098|NCT05602675|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56974099|NCT05602675|Abortifacient Agents|abortifacient agents|mesh-ancestor
56974100|NCT05602675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56974101|NCT05602675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974102|NCT05602675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56974103|NCT05602675|Antimetabolites|antimetabolites|mesh-ancestor
56974104|NCT05602675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974105|NCT05602675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974106|NCT05602675|Dermatologic Agents|dermatologic agents|mesh-ancestor
56974107|NCT05602675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974108|NCT05602675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56974109|NCT05602675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56974110|NCT05602675|Immunologic Factors|immunologic factors|mesh-ancestor
56974111|NCT05602675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56974112|NCT05602675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56974113|NCT05602675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56974114|NCT05602675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56974115|NCT05602675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974116|NCT05602675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56974117|NCT05602675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56974118|NCT05602675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974119|NCT05602675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56974120|NCT05602675|Anesthetics, General|anesthetics, general|mesh-ancestor
56974121|NCT05602675|Anesthetics|anesthetics|mesh-ancestor
56974122|NCT05602675|GABA Modulators|gaba modulators|mesh-ancestor
56974123|NCT05602675|GABA Agents|gaba agents|mesh-ancestor
56974124|NCT05602675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974125|NCT05602675|Anticoagulants|anticoagulants|mesh-ancestor
56974126|NCT05602675|Antitussive Agents|antitussive agents|mesh-ancestor
56974127|NCT05602675|Respiratory System Agents|respiratory system agents|mesh-ancestor
56974128|NCT05602675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56974129|NCT05602675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56974130|NCT05602675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974131|NCT03714685|Firibastat|firibastat|mesh-list
56974132|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56974133|NCT02705716|Fluorides|fluorides|mesh-list
56974134|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
56974135|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
56894982|NCT03905967|Lenvatinib|lenvatinib|mesh-list
56974136|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
56974137|NCT02705716|Protective Agents|protective agents|mesh-ancestor
56974138|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974139|NCT02429050|Morphine|morphine|mesh-list
56974140|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56974141|NCT02429050|Narcotics|narcotics|mesh-ancestor
56974142|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974143|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974144|NCT02429050|Analgesics|analgesics|mesh-ancestor
56974145|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
56974146|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974147|NCT02417142|Exenatide|exenatide|mesh-list
56974148|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974149|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974150|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56974151|NCT02417142|Incretins|incretins|mesh-ancestor
56974152|NCT02417142|Hormones|hormones|mesh-ancestor
56974153|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974154|NCT04135937|Bupropion|bupropion|mesh-list
56974155|NCT04135937|Nicotine|nicotine|mesh-list
56974156|NCT04135937|Varenicline|varenicline|mesh-list
56974157|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56974158|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
56974159|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974160|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974161|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56974162|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56974163|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
56974164|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974165|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974166|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56974167|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
56974168|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974169|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56974170|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56974171|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56974172|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
56974173|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56974174|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56974175|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974176|NCT01374750|Cyclosporine|cyclosporine|mesh-list
56974177|NCT01374750|Sirolimus|sirolimus|mesh-list
56974178|NCT01374750|Tacrolimus|tacrolimus|mesh-list
56974179|NCT01374750|Cyclosporins|cyclosporins|mesh-list
56974180|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56974181|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
56974182|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974183|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56974184|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974185|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974186|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
56974187|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974188|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
56974189|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56974190|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56974191|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56974192|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974193|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
56974194|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56974195|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
56974196|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56974197|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974198|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56974199|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56974200|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56974201|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56974202|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56974203|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56974204|NCT01374828|Analgesics|analgesics|mesh-ancestor
56974205|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
56974206|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974207|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974208|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56974209|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56974210|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56974211|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974212|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974213|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
56974214|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56974215|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974216|NCT03744767|Spironolactone|spironolactone|mesh-list
56974217|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56974218|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
56974219|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974220|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974221|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56974222|NCT03744767|Diuretics|diuretics|mesh-ancestor
56974223|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
56974224|NCT02428972|Propofol|propofol|mesh-list
56974225|NCT02428972|Sevoflurane|sevoflurane|mesh-list
56974226|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56974227|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974228|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974229|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56974230|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
56974231|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
56974232|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56974233|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56656494|NCT02783183|Pregabalin|pregabalin|mesh-list
56974234|NCT03699332|Labetuzumab|labetuzumab|mesh-list
56974235|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56974236|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974237|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56974238|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
56974239|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974240|NCT03178708|Amantadine|amantadine|mesh-list
56974241|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56974242|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56974243|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
56974244|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974245|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
56974246|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974247|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974248|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974249|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56974250|NCT03178708|Analgesics|analgesics|mesh-ancestor
56974251|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
56974252|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974253|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56974254|NCT00787176|Oxytocin|oxytocin|mesh-list
56974255|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
56974256|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56974257|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974258|NCT03744689|Bupivacaine|bupivacaine|mesh-list
56974259|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
56974260|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
56974261|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974262|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974263|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
56974264|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974265|NCT02424214|Ionophores|ionophores|mesh-list
56974266|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56974267|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974268|NCT03712111|Norepinephrine|norepinephrine|mesh-list
56974269|NCT03712111|Bupivacaine|bupivacaine|mesh-list
56974270|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
56974271|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
56974272|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974273|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974274|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
56974275|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974276|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56974277|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56974278|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
56974279|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974280|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974281|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
56974282|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
56974283|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56974284|NCT02925494|Norethindrone|norethindrone|mesh-list
56974285|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
56974286|NCT02925494|Estradiol|estradiol|mesh-list
56974287|NCT02925494|Estrogens|estrogens|mesh-ancestor
56974288|NCT02925494|Hormones|hormones|mesh-ancestor
56974289|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974290|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974291|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56974292|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
56974293|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56974294|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56974295|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56974296|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56974297|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56974298|NCT03717415|Carboplatin|carboplatin|mesh-list
56974299|NCT03717415|Rebastinib|rebastinib|mesh-list
56974300|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974301|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56974302|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974303|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974304|NCT03689894|Rituximab|rituximab|mesh-list
56974305|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56974306|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974307|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
56656565|NCT00693927|Fludarabine|fludarabine|mesh-list
56974308|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974309|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56974310|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
56974311|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56974312|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974313|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56974314|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56974315|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974316|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974317|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974318|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
56974319|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
56974320|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
56974321|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974322|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974323|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
56974324|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974325|NCT03711253|Tenofovir|tenofovir|mesh-list
56974326|NCT03711253|Emtricitabine|emtricitabine|mesh-list
56974327|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
56974328|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974329|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56974330|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56974331|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974332|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974333|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56974334|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56974335|NCT03119610|Oxytocin|oxytocin|mesh-list
56974336|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
56974337|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56974338|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974339|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56974340|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974341|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974342|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974343|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56974344|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
56974345|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56974346|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56974347|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974348|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
56974349|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
56974350|NCT03689114|Topiramate|topiramate|mesh-list
56974351|NCT03689114|Lamotrigine|lamotrigine|mesh-list
56974352|NCT03689114|Zonisamide|zonisamide|mesh-list
56974353|NCT03689114|Carbamazepine|carbamazepine|mesh-list
56974354|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
56974355|NCT03689114|Gabapentin|gabapentin|mesh-list
56974356|NCT03689114|Levetiracetam|levetiracetam|mesh-list
56974357|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
56974358|NCT03689114|Valproic Acid|valproic acid|mesh-list
56974359|NCT03689114|Analgesics|analgesics|mesh-ancestor
56974360|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
56974361|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974362|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974363|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56974364|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56974365|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974366|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974367|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56974368|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56974369|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974370|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974371|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
56974372|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974373|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
56974374|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56974375|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56974376|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56974377|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56974378|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56974379|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974380|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
56974381|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56974382|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56974383|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56974384|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56974385|NCT04040946|Choline|choline|mesh-list
56974386|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
56974387|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56974388|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
56974389|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974390|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56974391|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56974392|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
56974393|NCT03689855|Atezolizumab|atezolizumab|mesh-list
56974394|NCT03689855|Ramucirumab|ramucirumab|mesh-list
56974395|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974396|NCT02952001|Triamcinolone|triamcinolone|mesh-list
56974397|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56974398|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56974399|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56974400|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56974401|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
56974402|NCT02952001|Hormones|hormones|mesh-ancestor
56974403|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974404|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974405|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56974406|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
56974407|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974408|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974409|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56974410|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974411|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974412|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
56974413|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
56974414|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
56974415|NCT01311739|Vitamins|vitamins|mesh-ancestor
56974416|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
56974417|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974418|NCT01311739|Hematinics|hematinics|mesh-ancestor
56974419|NCT05507359|Benzocaine|benzocaine|mesh-list
56974420|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
56974421|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
56974422|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974423|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974424|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
56974425|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974426|NCT04123067|Pioglitazone|pioglitazone|mesh-list
56974427|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974428|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974429|NCT03703050|Nivolumab|nivolumab|mesh-list
56974430|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56974431|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974432|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56974433|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974434|NCT03688958|Iodine|iodine|mesh-list
56974435|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
56974436|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56974437|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974438|NCT03688958|Trace Elements|trace elements|mesh-ancestor
56974439|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
56974440|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974441|NCT04117607|Rezafungin|rezafungin|mesh-list
56974442|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
56974443|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974444|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
56974445|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974446|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56974447|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974448|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974449|NCT05192304|Maleic acid|maleic acid|mesh-list
56974450|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974451|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974452|NCT03693872|Dopamine|dopamine|mesh-list
56974453|NCT03693872|Apomorphine|apomorphine|mesh-list
56974454|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
56974455|NCT03693872|Emetics|emetics|mesh-ancestor
56974456|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974457|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
56974458|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974459|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56974460|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
56974461|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974462|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974463|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56974464|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
56974465|NCT03693872|Protective Agents|protective agents|mesh-ancestor
56974466|NCT03693638|Fentanyl|fentanyl|mesh-list
56974467|NCT03693638|Bupivacaine|bupivacaine|mesh-list
56974468|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
56974469|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
56974470|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974471|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974472|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
56974473|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974474|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56974475|NCT03693638|Narcotics|narcotics|mesh-ancestor
56974476|NCT03693638|Analgesics|analgesics|mesh-ancestor
56974477|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56974478|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56974479|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
56974480|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
56974481|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56974482|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
56974483|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974484|NCT01319838|Isotretinoin|isotretinoin|mesh-list
56974485|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
56974486|NCT03693560|Metformin|metformin|mesh-list
56974487|NCT03693560|Glimepiride|glimepiride|mesh-list
56974488|NCT03693560|Vildagliptin|vildagliptin|mesh-list
56974489|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974490|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974491|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56974492|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56974493|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
56974494|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56974495|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
56974496|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974497|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974498|NCT05191914|Fulvestrant|fulvestrant|mesh-list
56974499|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56974500|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974501|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56974502|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56974503|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
56974504|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974505|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974506|NCT04060394|Prednisone|prednisone|mesh-list
56974507|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56974508|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
56974509|NCT04060394|Hormones|hormones|mesh-ancestor
56974510|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974511|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974512|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56974513|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974514|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
56974515|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56974516|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974517|NCT03743987|Pemetrexed|pemetrexed|mesh-list
56974518|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974519|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974520|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974521|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56974522|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56974523|NCT03693326|Spartalizumab|spartalizumab|mesh-list
56974524|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56974525|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974526|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974527|NCT03988907|Midazolam|midazolam|mesh-list
56974528|NCT03988907|Risdiplam|risdiplam|mesh-list
56974529|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56974530|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56974531|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974532|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974533|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56974534|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56974535|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974536|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56656782|NCT00648830|Clarithromycin|clarithromycin|mesh-list
56974537|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
56974538|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
56974540|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
56974541|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974542|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974543|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56974544|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974545|NCT03693248|Paclitaxel|paclitaxel|mesh-list
56974546|NCT03693248|Carboplatin|carboplatin|mesh-list
56974547|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56974548|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974549|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56974550|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56974551|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56974552|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974553|NCT03987191|Insulin|insulin|mesh-list
56974554|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
56974555|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56974556|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974557|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974558|NCT01373970|Pantoprazole|pantoprazole|mesh-list
56974559|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56974560|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56974561|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56974562|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974563|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974564|NCT04050098|Metformin|metformin|mesh-list
56974565|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974566|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974567|NCT03745625|Propofol|propofol|mesh-list
56974568|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56974569|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974570|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974571|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56974572|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
56974573|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
56974574|NCT03698630|Dexamethasone|dexamethasone|mesh-list
56974575|NCT03698630|Prednisolone|prednisolone|mesh-list
56974576|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56974577|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
56974578|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56974579|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
56974580|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56974581|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
56974582|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56974583|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
56974584|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
56974585|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974586|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974587|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56974588|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
56974589|NCT03698630|Hormones|hormones|mesh-ancestor
56895429|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
56974590|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974591|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56974592|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974593|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56974594|NCT03698630|Protective Agents|protective agents|mesh-ancestor
56974595|NCT01375452|Letrozole|letrozole|mesh-list
56974596|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974597|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56974598|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56974599|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974600|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974601|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56974602|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
56974603|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974604|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974605|NCT03046836|Oxytocin|oxytocin|mesh-list
56974606|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
56974607|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56974608|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974609|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
56974610|NCT03400033|Hematinics|hematinics|mesh-ancestor
56974611|NCT05123820|Midazolam|midazolam|mesh-list
56974612|NCT05123820|Omeprazole|omeprazole|mesh-list
56974613|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56974614|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56974616|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974617|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56974618|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56974619|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974620|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56974621|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
56974622|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
56974623|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
56974624|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
56974625|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974626|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974627|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56974628|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56974629|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56974630|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974631|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56974632|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
56974633|NCT02876835|Hematinics|hematinics|mesh-ancestor
56974634|NCT03503318|Risperidone|risperidone|mesh-list
56974635|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56974636|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
56974637|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974638|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974639|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974640|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56974641|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56974642|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974643|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974644|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56974645|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
56974646|NCT01375920|Metyrapone|metyrapone|mesh-list
56974647|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
56974648|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974649|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974650|NCT03683108|Resveratrol|resveratrol|mesh-list
56974651|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
56974652|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974653|NCT03683108|Protective Agents|protective agents|mesh-ancestor
56974654|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974655|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974656|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56974657|NCT05137860|Bortezomib|bortezomib|mesh-list
56974658|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974659|NCT03682952|Alprostadil|alprostadil|mesh-list
56974660|NCT03682952|Beraprost|beraprost|mesh-list
56974661|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56974662|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
56974663|NCT03682952|Urological Agents|urological agents|mesh-ancestor
56974664|NCT03682718|Misoprostol|misoprostol|mesh-list
56974665|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56895508|NCT01259193|Sorafenib|sorafenib|mesh-list
56974666|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
56974667|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56974668|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974669|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56974670|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56974671|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
56974672|NCT03682640|Insulin|insulin|mesh-list
56974673|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56974674|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
56974675|NCT03682640|Azithromycin|azithromycin|mesh-list
56974676|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974677|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974678|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56974679|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974680|NCT04084769|Vaccines|vaccines|mesh-list
56974681|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
56974682|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974683|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
56974684|NCT01376076|Risperidone|risperidone|mesh-list
56974685|NCT01376076|Cariprazine|cariprazine|mesh-list
56974686|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56974687|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56974688|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974689|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56974690|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56974691|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974692|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974693|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974694|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56974695|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
56974696|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56974697|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974698|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56974699|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56974700|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56974701|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56974702|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
56974703|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974704|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56974705|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56974706|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974707|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974708|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56974709|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
56974710|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56974711|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56974712|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56974713|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56974714|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974715|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974716|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974717|NCT03395353|Analgesics|analgesics|mesh-ancestor
56974718|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
56974719|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974720|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
56974721|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974722|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
56974723|NCT01376154|Lamivudine|lamivudine|mesh-list
56974724|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56974725|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56974726|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974727|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974728|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
56974729|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974730|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56974731|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56974732|NCT01562951|Adalimumab|adalimumab|mesh-list
56974733|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56974734|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56974735|NCT01375842|Atezolizumab|atezolizumab|mesh-list
56974736|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974737|NCT03682367|Gabapentin|gabapentin|mesh-list
56974738|NCT03682367|Analgesics|analgesics|mesh-ancestor
56974739|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
56974740|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56974741|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974742|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
56974743|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56974744|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56974745|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974746|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974747|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56974748|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56974749|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974750|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974751|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
56974752|NCT05170464|Caffeine|caffeine|mesh-list
56974753|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56974754|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974755|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56974756|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974757|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974758|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56974759|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56974760|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
56974761|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974762|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
56974763|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56974764|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974765|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974766|NCT03394885|Paclitaxel|paclitaxel|mesh-list
56974767|NCT03394885|Bevacizumab|bevacizumab|mesh-list
56974768|NCT03394885|Carboplatin|carboplatin|mesh-list
56974769|NCT03394885|Atezolizumab|atezolizumab|mesh-list
56974770|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56974771|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974772|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
56974773|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
56974774|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
56974775|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974776|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56974777|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56974778|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56974779|NCT03394885|Growth Substances|growth substances|mesh-ancestor
56974780|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974781|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
56974782|NCT01361373|Levodopa|levodopa|mesh-list
56974783|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56974784|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56974785|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
56974786|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974787|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974788|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974789|NCT03677336|Progesterone|progesterone|mesh-list
56974790|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
56974791|NCT03677336|Progestins|progestins|mesh-ancestor
56974792|NCT03677336|Hormones|hormones|mesh-ancestor
56974793|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974794|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974795|NCT03793478|Cytarabine|cytarabine|mesh-list
56974796|NCT03793478|Fludarabine|fludarabine|mesh-list
56974797|NCT03793478|Etoposide|etoposide|mesh-list
56974798|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974799|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56974800|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
56974801|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974802|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56974803|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
56974804|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974805|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56974806|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56974807|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56974808|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974809|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
56974810|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974811|NCT02877927|Linezolid|linezolid|mesh-list
56974812|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56974813|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974814|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56974815|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974816|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974817|NCT02706886|Lumasiran|lumasiran|mesh-list
56974818|NCT02706886|Renal Agents|renal agents|mesh-ancestor
56974819|NCT03112590|Interferons|interferons|mesh-list
56974820|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
56974821|NCT03112590|Paclitaxel|paclitaxel|mesh-list
56974822|NCT03112590|Trastuzumab|trastuzumab|mesh-list
56974823|NCT03112590|Pertuzumab|pertuzumab|mesh-list
56974824|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56974825|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974826|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
56974827|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
56974828|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
56974829|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974830|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56974831|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
56974832|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974833|NCT02809131|Levofloxacin|levofloxacin|mesh-list
56974834|NCT02809131|Ofloxacin|ofloxacin|mesh-list
56974835|NCT02809131|Clindamycin|clindamycin|mesh-list
56974836|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
56974837|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
56974838|NCT02809131|Cephalexin|cephalexin|mesh-list
56974839|NCT02809131|Polymyxins|polymyxins|mesh-list
56974840|NCT02809131|Bacitracin|bacitracin|mesh-list
56974841|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56974842|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974843|NCT02809131|Renal Agents|renal agents|mesh-ancestor
56974844|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56974845|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56974846|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56974847|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974848|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974849|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974850|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56974851|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56974852|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56974853|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56974854|NCT05032950|Ritonavir|ritonavir|mesh-list
56974855|NCT05032950|Midazolam|midazolam|mesh-list
56974856|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56974857|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56974858|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56974859|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974860|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56974861|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56974862|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56974863|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56974864|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
56974865|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
56974866|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
56974867|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
56974868|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974869|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974870|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56974871|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56974872|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
56974873|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974874|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56974875|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56974876|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
56974877|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974878|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56974879|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56974880|NCT04074161|Liraglutide|liraglutide|mesh-list
56974881|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56974882|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974883|NCT04074161|Incretins|incretins|mesh-ancestor
56974884|NCT04074161|Hormones|hormones|mesh-ancestor
56974885|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974886|NCT01442649|Leucovorin|leucovorin|mesh-list
56974887|NCT01442649|Folic Acid|folic acid|mesh-list
56974888|NCT01442649|Bevacizumab|bevacizumab|mesh-list
56974889|NCT01442649|Cetuximab|cetuximab|mesh-list
56974890|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
56974891|NCT01442649|Irinotecan|irinotecan|mesh-list
56974892|NCT01442649|Fluorouracil|fluorouracil|mesh-list
56974893|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
56974894|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56974895|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974896|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56974897|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56974898|NCT01442649|Growth Substances|growth substances|mesh-ancestor
56974899|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974900|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
56974901|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56974902|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56974903|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974904|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974905|NCT01442649|Antidotes|antidotes|mesh-ancestor
56974906|NCT01442649|Protective Agents|protective agents|mesh-ancestor
56974907|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
56974908|NCT01442649|Vitamins|vitamins|mesh-ancestor
56974909|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
56974910|NCT01442649|Hematinics|hematinics|mesh-ancestor
56974911|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
56974912|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56974913|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56974914|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
56974915|NCT04995120|Paclitaxel|paclitaxel|mesh-list
56974916|NCT04995120|Cisplatin|cisplatin|mesh-list
56974917|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56974918|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974919|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
56974920|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
56974921|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
56974922|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974923|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
56974924|NCT01376232|Glycine|glycine|mesh-list
56974925|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
56974926|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974927|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974928|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974929|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56974930|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
56974931|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56974932|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56974933|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56974934|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974935|NCT01354665|Interferons|interferons|mesh-list
56974936|NCT01354665|Interferon-beta|interferon-beta|mesh-list
56974937|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
56974938|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974939|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
56974940|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974941|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
56974942|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974943|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56974944|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56974945|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56974946|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56974947|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974948|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
56974949|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56974950|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974951|NCT05008575|Fludarabine|fludarabine|mesh-list
56974952|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
56974953|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974954|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974955|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56974956|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
56974957|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974958|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56974959|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56974960|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
56974961|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56974962|NCT05759754|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56974963|NCT05759754|Protease Inhibitors|protease inhibitors|mesh-ancestor
56974964|NCT05759754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56974965|NCT05759754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974966|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56974967|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56974968|NCT03111108|Grazoprevir|grazoprevir|mesh-list
56974969|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
56974970|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974971|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56974972|NCT00702520|Hormones|hormones|mesh-list
56974973|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56974974|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56974975|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974976|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
56974977|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56974978|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
56974979|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56974980|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56974981|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56974982|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974983|NCT05198856|Thalidomide|thalidomide|mesh-list
56974984|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56974985|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
56974986|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56974987|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
56974988|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56974989|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56974990|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56974991|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56974992|NCT05198856|Growth Substances|growth substances|mesh-ancestor
56974993|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
56974994|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56974995|NCT02876601|Defibrotide|defibrotide|mesh-list
56974996|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56974997|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56974998|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56974999|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56975000|NCT04059536|Aspirin|aspirin|mesh-list
56975001|NCT04059536|Heparin|heparin|mesh-list
56975002|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56975003|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56975004|NCT04059536|Analgesics|analgesics|mesh-ancestor
56975005|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
56975006|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975007|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975008|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975009|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56975010|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56975011|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56975012|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975013|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56975014|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56975015|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975016|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
56975017|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
56975018|NCT05711628|Gemcitabine|gemcitabine|mesh-list
56975019|NCT05711628|Carboplatin|carboplatin|mesh-list
56975020|NCT05711628|Doxorubicin|doxorubicin|mesh-list
56975021|NCT05711628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56975022|NCT05711628|Pembrolizumab|pembrolizumab|mesh-list
56975023|NCT05711628|Etoposide|etoposide|mesh-list
56975024|NCT05711628|Etoposide phosphate|etoposide phosphate|mesh-list
56975025|NCT05711628|Vinorelbine|vinorelbine|mesh-list
56975026|NCT05711628|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56975027|NCT05711628|Ifosfamide|ifosfamide|mesh-list
56975028|NCT05711628|Isophosphamide mustard|isophosphamide mustard|mesh-list
56975029|NCT05711628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56975030|NCT05711628|Podophyllotoxin|podophyllotoxin|mesh-list
56975031|NCT05711628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56975032|NCT05711628|Antibodies|antibodies|mesh-list
56975033|NCT05711628|Immunoglobulins|immunoglobulins|mesh-list
56975034|NCT05711628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56975035|NCT05711628|Immunoconjugates|immunoconjugates|mesh-list
56975036|NCT05711628|Immunologic Factors|immunologic factors|mesh-ancestor
56975037|NCT05711628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975038|NCT05711628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975039|NCT05711628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56975040|NCT05711628|Antimetabolites|antimetabolites|mesh-ancestor
56975041|NCT05711628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975042|NCT05711628|Antiviral Agents|antiviral agents|mesh-ancestor
56975043|NCT05711628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975044|NCT05711628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975045|NCT05711628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56975046|NCT05711628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56975047|NCT05711628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56975048|NCT05711628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56975049|NCT05711628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56975050|NCT05711628|Tubulin Modulators|tubulin modulators|mesh-ancestor
56975051|NCT05711628|Antimitotic Agents|antimitotic agents|mesh-ancestor
56975052|NCT05711628|Mitosis Modulators|mitosis modulators|mesh-ancestor
56975053|NCT05711628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56975054|NCT05711628|Alkylating Agents|alkylating agents|mesh-ancestor
56975055|NCT05711628|Keratolytic Agents|keratolytic agents|mesh-ancestor
56975056|NCT05711628|Dermatologic Agents|dermatologic agents|mesh-ancestor
56975057|NCT03178396|Melatonin|melatonin|mesh-list
56975058|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
56975059|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975060|NCT03178396|Protective Agents|protective agents|mesh-ancestor
56975061|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975062|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975063|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
56975064|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56975065|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
56975066|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975067|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
56975068|NCT03677258|Protective Agents|protective agents|mesh-ancestor
56975069|NCT01361763|Dabigatran|dabigatran|mesh-list
56975070|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
56975071|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56975072|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
56975073|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975074|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975075|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
56975076|NCT02420782|Itraconazole|itraconazole|mesh-list
56975077|NCT02420782|Midazolam|midazolam|mesh-list
56975078|NCT02420782|Pilocarpine|pilocarpine|mesh-list
56975079|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56975080|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56975081|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975082|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975083|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56975084|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56975085|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56975086|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56975087|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
56975088|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
56975089|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
56975090|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
56975091|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975092|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975093|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
56975094|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975095|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56975096|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56975097|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975098|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56975099|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
56975100|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975101|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56975102|NCT02420782|Miotics|miotics|mesh-ancestor
56975103|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
56975104|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975105|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56975106|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56975107|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
56975108|NCT04054193|Dexamethasone|dexamethasone|mesh-list
56975109|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
56975110|NCT04054193|Aprepitant|aprepitant|mesh-list
56975111|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
56975112|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975113|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
56975114|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
56975115|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975116|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975117|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975118|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
56975119|NCT04054193|Hormones|hormones|mesh-ancestor
56975120|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56895960|NCT01264497|Tesamorelin|tesamorelin|mesh-list
56975121|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56975122|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975123|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56975124|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975125|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975126|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56975127|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
56975128|NCT03394027|TIC10 compound|tic10 compound|mesh-list
56975129|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975130|NCT03682172|Glucagon|glucagon|mesh-list
56975131|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56975132|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975133|NCT03682172|Hormones|hormones|mesh-ancestor
56975134|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975135|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975136|NCT03682172|Incretins|incretins|mesh-ancestor
56975137|NCT03184480|Fluticasone|fluticasone|mesh-list
56975138|NCT03184480|Xhance|xhance|mesh-list
56975139|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975140|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56975141|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
56975142|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975143|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975144|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56975145|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
56657380|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
56975146|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
56975147|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56975148|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
56975149|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56975150|NCT03136107|Protective Agents|protective agents|mesh-ancestor
56975151|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975152|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
56975153|NCT03686774|Memantine|memantine|mesh-list
56975154|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56975155|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56975156|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
56975157|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975158|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975159|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975160|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56975161|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56975162|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
56975163|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56975164|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975165|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56975166|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975167|NCT01562795|Fluorometholone|fluorometholone|mesh-list
56975168|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56975169|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
56975170|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56975171|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56975172|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
56975173|NCT01562795|Hormones|hormones|mesh-ancestor
56975174|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975175|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975176|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56975177|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
56975178|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
56975179|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56975180|NCT02424136|Antibodies|antibodies|mesh-list
56975181|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
56975182|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975183|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56975184|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
56975185|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975186|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56975187|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
56975188|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56975189|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
56975190|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975191|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975192|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56975193|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
56975194|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
56975195|NCT02424136|Protective Agents|protective agents|mesh-ancestor
56975196|NCT03770676|Selenium|selenium|mesh-list
56975197|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
56975198|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975199|NCT03770676|Protective Agents|protective agents|mesh-ancestor
56975200|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975201|NCT03770676|Trace Elements|trace elements|mesh-ancestor
56975202|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
56975203|NCT04860804|Aspirin|aspirin|mesh-list
56975204|NCT04860804|Ketamine|ketamine|mesh-list
56975205|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56975206|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56975207|NCT04860804|Analgesics|analgesics|mesh-ancestor
56975208|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
56975209|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975210|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975211|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975212|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56975213|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56975214|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56975215|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975216|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56975217|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56975218|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975219|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
56975220|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56975221|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56975222|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
56975223|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
56975224|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975225|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56975226|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56975227|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975228|NCT01361841|Bimatoprost|bimatoprost|mesh-list
56975229|NCT01361841|Travoprost|travoprost|mesh-list
56975230|NCT01361841|Latanoprost|latanoprost|mesh-list
56975231|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56975232|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56975233|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56975234|NCT02583789|Treprostinil|treprostinil|mesh-list
56975235|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56975236|NCT01355367|Nifedipine|nifedipine|mesh-list
56975237|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56975238|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56975239|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975240|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56975241|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975242|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
56975243|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
56975244|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56975245|NCT05759520|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56975246|NCT05759520|Immunologic Factors|immunologic factors|mesh-ancestor
56975247|NCT05759520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975248|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56975249|NCT02427880|Furosemide|furosemide|mesh-list
56975250|NCT02427880|Acetazolamide|acetazolamide|mesh-list
56975251|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56975252|NCT02427880|Diuretics|diuretics|mesh-ancestor
56975253|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
56975254|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975255|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56975256|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56975257|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975258|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56975259|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
56975260|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56975261|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975262|NCT01355445|Irinotecan|irinotecan|mesh-list
56975263|NCT01355445|Vincristine|vincristine|mesh-list
56975264|NCT01355445|Temozolomide|temozolomide|mesh-list
56975265|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56975266|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56975267|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990941|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975268|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975269|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975270|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56975271|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
56975272|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
56975273|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
56975274|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56975275|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
56975276|NCT05759442|Metformin|metformin|mesh-list
56975277|NCT05759442|Acetic Acid|acetic acid|mesh-list
56975278|NCT05759442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56975279|NCT05759442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975280|NCT05759442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56975281|NCT05759442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975282|NCT02420080|Brincidofovir|brincidofovir|mesh-list
56975283|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
56975284|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975285|NCT04483258|Sevoflurane|sevoflurane|mesh-list
56975286|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56975287|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56975288|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
56975289|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
56975290|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975291|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975292|NCT02532231|Nivolumab|nivolumab|mesh-list
56975293|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56975294|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975295|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56975296|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657536|NCT02778425|Hormones|hormones|mesh-ancestor
56975297|NCT01355757|Anesthetics|anesthetics|mesh-list
56975299|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975300|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975301|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
56975302|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975303|NCT02507505|Anesthetics|anesthetics|mesh-list
56975304|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975305|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975306|NCT03181360|Tenecteplase|tenecteplase|mesh-list
56975307|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56975308|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56975309|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975310|NCT05759364|Papaverine|papaverine|mesh-list
56975311|NCT05759364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56975312|NCT05759364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975313|NCT05759364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975314|NCT05759364|Vasodilator Agents|vasodilator agents|mesh-ancestor
56975315|NCT05759364|Urological Agents|urological agents|mesh-ancestor
56975316|NCT04275531|Anesthetics|anesthetics|mesh-list
56975317|NCT04275531|Propofol|propofol|mesh-list
56975318|NCT04275531|Sevoflurane|sevoflurane|mesh-list
56975319|NCT04275531|Isoflurane|isoflurane|mesh-list
56975320|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975321|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975322|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56975323|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56975324|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
56975325|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56975326|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56975327|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
56975328|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
56975329|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975330|NCT03689712|Protective Agents|protective agents|mesh-ancestor
56975331|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975332|NCT01361997|Ethanol|ethanol|mesh-list
56975333|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
56975334|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56975335|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975336|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975337|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975338|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
56975339|NCT04750824|Afatinib|afatinib|mesh-list
56975340|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975341|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56975342|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990942|NCT01496118|Panobinostat|panobinostat|mesh-list
56975343|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975344|NCT03180970|Lugol's solution|lugol's solution|mesh-list
56975345|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56975346|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
56975347|NCT03180970|Coagulants|coagulants|mesh-ancestor
56975348|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
56975349|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
56975350|NCT03631446|Citric Acid|citric acid|mesh-list
56975351|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
56975352|NCT03631446|Cathartics|cathartics|mesh-ancestor
56975353|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975354|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
56975355|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56975356|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
56975357|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
56975358|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975359|NCT03631446|Antacids|antacids|mesh-ancestor
56975360|NCT01362153|Golimumab|golimumab|mesh-list
56975361|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56975362|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56975363|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975364|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56975365|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
56975366|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975367|NCT03184324|Esomeprazole|esomeprazole|mesh-list
56975368|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56975369|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975370|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56975371|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975372|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975373|NCT02427334|Dienogest|dienogest|mesh-list
56975374|NCT02427334|Fluoxetine|fluoxetine|mesh-list
56975375|NCT02427334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56975376|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56975377|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56975378|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975379|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975380|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
56975381|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975382|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56975383|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
56975384|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56975385|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56975386|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56975387|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975388|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56975389|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
56975390|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56975391|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56975392|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56975393|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56975394|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56975395|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
56975396|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975397|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56975398|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975399|NCT03620253|Modafinil|modafinil|mesh-list
56975400|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56975401|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975402|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56975403|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56975404|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56975405|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975406|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
56975407|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56975408|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56975409|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
56975410|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975411|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975412|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56975413|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
56975414|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
56975415|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56975416|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
56975417|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975418|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975419|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56975420|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56975421|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56975422|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
56975423|NCT01358253|Cytarabine|cytarabine|mesh-list
56975424|NCT01358253|Dexamethasone|dexamethasone|mesh-list
56975425|NCT01358253|Prednisone|prednisone|mesh-list
56975426|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
56975427|NCT01358253|Rituximab|rituximab|mesh-list
56975428|NCT01358253|Doxorubicin|doxorubicin|mesh-list
56975429|NCT01358253|Methotrexate|methotrexate|mesh-list
56975430|NCT01358253|Vincristine|vincristine|mesh-list
56975431|NCT01358253|Asparaginase|asparaginase|mesh-list
56975432|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
56975433|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56975434|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
56975435|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975436|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56975437|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56975438|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
56975439|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975440|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975441|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56975442|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56975443|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975444|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
56975445|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
56975446|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975447|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975448|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
56975449|NCT01358253|Hormones|hormones|mesh-ancestor
56975450|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975451|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56975452|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56975453|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56975454|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56975455|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975456|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56975457|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
56975458|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56975459|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56975460|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
56975461|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
56975462|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56975463|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56975464|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
56975465|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975466|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56975467|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
56975468|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
56975469|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
56975470|NCT03548064|Vaccines|vaccines|mesh-list
56975471|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
56975472|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975473|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56975474|NCT03180346|Laxatives|laxatives|mesh-ancestor
56975475|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975476|NCT01356225|Ketorolac|ketorolac|mesh-list
56975477|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56975478|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56975479|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56975480|NCT01356225|Analgesics|analgesics|mesh-ancestor
56975481|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
56975482|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975483|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975484|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975485|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56975486|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56975487|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975488|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975489|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
56975490|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56975491|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56975492|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896338|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56975493|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
56975494|NCT02427412|Coagulants|coagulants|mesh-ancestor
56975495|NCT01356303|Docetaxel|docetaxel|mesh-list
56975496|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975497|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
56975498|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
56975499|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
56975500|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975501|NCT02220309|Pramipexole|pramipexole|mesh-list
56975502|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
56975503|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975504|NCT02220309|Protective Agents|protective agents|mesh-ancestor
56975505|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975506|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56975507|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56975508|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
56975509|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
56975510|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975511|NCT02419534|Diltiazem|diltiazem|mesh-list
56975512|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56975513|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56975514|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56975515|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975516|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56975517|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975518|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
56975519|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56975520|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
56975521|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975522|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56975523|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
56975524|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975525|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975526|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56975527|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56975528|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56975529|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
56975530|NCT01358409|Nebivolol|nebivolol|mesh-list
56975531|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56975532|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
56975533|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56975534|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56975535|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56975536|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
56975537|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975538|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975539|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975540|NCT02423590|Gemcitabine|gemcitabine|mesh-list
56975541|NCT02423590|Carboplatin|carboplatin|mesh-list
56975542|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975543|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56975544|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
56975545|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975546|NCT02423590|Antiviral Agents|antiviral agents|mesh-ancestor
56975547|NCT02423590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975548|NCT02423590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975549|NCT02423590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56975550|NCT02423590|Immunologic Factors|immunologic factors|mesh-ancestor
56975551|NCT02423590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975552|NCT01362309|Cycloserine|cycloserine|mesh-list
56975553|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56975554|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975555|NCT01362309|Renal Agents|renal agents|mesh-ancestor
56975556|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56975557|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
56975558|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56975559|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
56975560|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975561|NCT03710863|Vorolanib|vorolanib|mesh-list
56975562|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56975563|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975564|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975565|NCT03178084|Lamivudine|lamivudine|mesh-list
56975566|NCT03178084|Zidovudine|zidovudine|mesh-list
56975567|NCT03178084|Efavirenz|efavirenz|mesh-list
56975568|NCT03178084|Maraviroc|maraviroc|mesh-list
56975569|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56975570|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56975571|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975572|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975573|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
56975574|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975575|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56975576|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56975577|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
56975578|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56975579|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56975580|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56975581|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56975582|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56975583|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56975584|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56975585|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56975586|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56975587|NCT01356381|Vildagliptin|vildagliptin|mesh-list
56975588|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56975589|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975590|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56975591|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
56975592|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975593|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975594|NCT03117166|Lidocaine|lidocaine|mesh-list
56657828|NCT02660762|BB 1101|bb 1101|mesh-list
56975596|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
56975597|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975598|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975599|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
56975600|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975601|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56975602|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56975603|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56975604|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56975605|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975606|NCT03302286|Mannitol|mannitol|mesh-list
56975607|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56975608|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56975609|NCT03302286|Diuretics|diuretics|mesh-ancestor
56975610|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
56975611|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975612|NCT05669664|Leuprolide|leuprolide|mesh-list
56975613|NCT05669664|Androgen Antagonists|androgen antagonists|mesh-list
56975614|NCT05669664|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56975615|NCT05669664|Fertility Agents|fertility agents|mesh-ancestor
56975616|NCT05669664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56975617|NCT05669664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975618|NCT05669664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56975619|NCT05669664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975620|NCT05669664|Hormone Antagonists|hormone antagonists|mesh-ancestor
56975621|NCT05669664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975622|NCT01356615|Heparin|heparin|mesh-list
56975623|NCT01356615|Calcium heparin|calcium heparin|mesh-list
56975624|NCT01356615|Enoxaparin|enoxaparin|mesh-list
56975625|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56975626|NCT01356615|Tinzaparin|tinzaparin|mesh-list
56975627|NCT01356615|Dalteparin|dalteparin|mesh-list
56975628|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
56975629|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
56975630|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56975631|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56975632|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975633|NCT04591002|Osimertinib|osimertinib|mesh-list
56975634|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975635|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56975636|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975637|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975638|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
56975639|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
56975640|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56975641|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56975642|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975643|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975644|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975645|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56975646|NCT04583592|Gabexate|gabexate|mesh-list
56975647|NCT04583592|Camostat|camostat|mesh-list
56975648|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
56975649|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975650|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975651|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56975652|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56975653|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
56975654|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
56975655|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56975656|NCT02418988|Estrogens|estrogens|mesh-ancestor
56975657|NCT02418988|Hormones|hormones|mesh-ancestor
56975658|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975659|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975660|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56975661|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975662|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
56975663|NCT05005182|Luspatercept|luspatercept|mesh-list
56975664|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56975665|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975666|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
56657906|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
56975667|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975668|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975669|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56975670|NCT05005182|Hematinics|hematinics|mesh-ancestor
56975671|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
56975672|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975673|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56975674|NCT01356927|Etonogestrel|etonogestrel|mesh-list
56975675|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56975676|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
56975677|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56975678|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975679|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56975680|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56975681|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56975682|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975683|NCT03439670|Prednisone|prednisone|mesh-list
56975684|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975685|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
56975686|NCT03439670|Hormones|hormones|mesh-ancestor
56975687|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975688|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975689|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56975690|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975691|NCT02930343|Folic Acid|folic acid|mesh-list
56975692|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
56975693|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
56975694|NCT02930343|Prednisolone|prednisolone|mesh-list
56975695|NCT02930343|Methotrexate|methotrexate|mesh-list
56975696|NCT02930343|Leflunomide|leflunomide|mesh-list
56975697|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
56975698|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56975699|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
56975700|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56975701|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975702|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56975703|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
56975704|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975705|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975706|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
56975707|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975708|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56975709|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56975710|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
56975711|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56975712|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56975713|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975714|NCT02930343|Hormones|hormones|mesh-ancestor
56896561|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
56975715|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975716|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56975717|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975718|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975719|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
56975720|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56975721|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56975722|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975723|NCT02930343|Hematinics|hematinics|mesh-ancestor
56975724|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
56975725|NCT02930343|Vitamins|vitamins|mesh-ancestor
56975726|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
56975727|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56975728|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56975729|NCT02930343|Analgesics|analgesics|mesh-ancestor
56975730|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
56975731|NCT03686618|Secretin|secretin|mesh-list
56975732|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975733|NCT03686618|Hormones|hormones|mesh-ancestor
56975734|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975735|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975736|NCT02426866|Efavirenz|efavirenz|mesh-list
56975737|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56975738|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56975739|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975740|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975741|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
56975742|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975743|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56975744|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56975745|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56975746|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56975747|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56975748|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56975750|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56975751|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975752|NCT02423824|Incretins|incretins|mesh-ancestor
56975753|NCT02423824|Hormones|hormones|mesh-ancestor
56975754|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975755|NCT01012167|Galantamine|galantamine|mesh-list
56975756|NCT01012167|Oxytocin|oxytocin|mesh-list
56975757|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
56975758|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56975759|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975760|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56975761|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975762|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975763|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
56975764|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975765|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56975766|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
56975767|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975768|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
56975769|NCT05649540|Amoxicillin|amoxicillin|mesh-list
56975770|NCT05649540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56975771|NCT05649540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975772|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
56975773|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975774|NCT05189067|Paclitaxel|paclitaxel|mesh-list
56975775|NCT05189067|Docetaxel|docetaxel|mesh-list
56975776|NCT05189067|Trastuzumab|trastuzumab|mesh-list
56975777|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56975778|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975779|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
56975780|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
56975781|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
56975782|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975783|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56975784|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56975785|NCT02422966|Acetaminophen|acetaminophen|mesh-list
56975786|NCT02422966|Ibuprofen|ibuprofen|mesh-list
56975787|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56975788|NCT02422966|Analgesics|analgesics|mesh-ancestor
56975789|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
56975790|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975791|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975792|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
56975793|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56975794|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975795|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56975796|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56975797|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975798|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975799|NCT05647122|Osimertinib|osimertinib|mesh-list
56975800|NCT05647122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975801|NCT05647122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56975802|NCT05647122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975803|NCT05647122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975804|NCT02422888|Ticagrelor|ticagrelor|mesh-list
56975805|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56975806|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56975807|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56975808|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56975809|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56975810|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
56975811|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975812|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975813|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975814|NCT03633552|Temozolomide|temozolomide|mesh-list
56975815|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56975816|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
56658053|NCT00983047|Docetaxel|docetaxel|mesh-list
56975817|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975818|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975819|NCT05760456|Metformin|metformin|mesh-list
56975820|NCT05760456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56975821|NCT05760456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975822|NCT02418130|Inositol|inositol|mesh-list
56975823|NCT02418130|Thiamine|thiamine|mesh-list
56975824|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56975825|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
56975826|NCT02418130|Vitamins|vitamins|mesh-ancestor
56975827|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
56975828|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975829|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56975830|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975831|NCT03391765|Tilavonemab|tilavonemab|mesh-list
56975832|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
56975833|NCT02802228|Ifetroban|ifetroban|mesh-list
56975834|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56975835|NCT02801448|Sulforaphane|sulforaphane|mesh-list
56975836|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56975837|NCT02801448|Protective Agents|protective agents|mesh-ancestor
56975838|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975839|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975840|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
56975841|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
56975842|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56975843|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975844|NCT03674177|Vaccines|vaccines|mesh-list
56975845|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
56975846|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975847|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
56975848|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975849|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
56975850|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975851|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975852|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56975853|NCT02417896|Spironolactone|spironolactone|mesh-list
56975854|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56975855|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
56975856|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975857|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975858|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56975859|NCT02417896|Diuretics|diuretics|mesh-ancestor
56975860|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
56975861|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56975862|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56975863|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975864|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56975865|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975866|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
56975867|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56975868|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
56975869|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56975870|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56975871|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
56975872|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975873|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
56975874|NCT03116776|Protective Agents|protective agents|mesh-ancestor
56975875|NCT02505204|Clonidine|clonidine|mesh-list
56975876|NCT02505204|Analgesics|analgesics|mesh-ancestor
56975877|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
56975878|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975879|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975880|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56975881|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
56975882|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
56975883|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56975884|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56975885|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56975886|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
56975887|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975888|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975889|NCT04351698|Montelukast|montelukast|mesh-list
56975890|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56975891|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
56975892|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56975893|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
56975894|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56975895|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975896|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56975897|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56975898|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975899|NCT01359423|Cilostazol|cilostazol|mesh-list
56975900|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56975901|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
56975902|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975903|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975904|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56975905|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
56975906|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56975907|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56975908|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975909|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56975910|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
56975911|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56975912|NCT01359423|Protective Agents|protective agents|mesh-ancestor
56975913|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56975914|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56975915|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975916|NCT01363089|Ketorolac|ketorolac|mesh-list
56975917|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56975918|NCT01363089|Phenylephrine|phenylephrine|mesh-list
56975919|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
56975920|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56975921|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56975922|NCT01363089|Analgesics|analgesics|mesh-ancestor
56975923|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
56975924|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975925|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975926|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975927|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56975928|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56975929|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975930|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975931|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56975932|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56975933|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
56975934|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975935|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
56975936|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
56975937|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
55728757|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975938|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56975939|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
56975940|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56975941|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
56975942|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56975943|NCT01363089|Protective Agents|protective agents|mesh-ancestor
56975944|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56975945|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56975946|NCT05627232|Diphenhydramine|diphenhydramine|mesh-list
56975947|NCT05627232|Promethazine|promethazine|mesh-list
56975948|NCT05627232|Cytarabine|cytarabine|mesh-list
56975949|NCT05627232|Daunorubicin|daunorubicin|mesh-list
56975950|NCT05627232|Palbociclib|palbociclib|mesh-list
56975951|NCT05627232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56975952|NCT05627232|Antimetabolites|antimetabolites|mesh-ancestor
56975953|NCT05627232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975954|NCT05627232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975955|NCT05627232|Antiviral Agents|antiviral agents|mesh-ancestor
56975956|NCT05627232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56975957|NCT05627232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56975958|NCT05627232|Immunologic Factors|immunologic factors|mesh-ancestor
56975959|NCT05627232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975960|NCT05627232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56975961|NCT05627232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56975962|NCT05627232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56975963|NCT05627232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975964|NCT05627232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56975965|NCT05627232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56975966|NCT05627232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56975967|NCT05627232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975968|NCT05627232|Anesthetics, Local|anesthetics, local|mesh-ancestor
56975969|NCT05627232|Anesthetics|anesthetics|mesh-ancestor
56975970|NCT05627232|Sensory System Agents|sensory system agents|mesh-ancestor
56975971|NCT05627232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975972|NCT05627232|Antiemetics|antiemetics|mesh-ancestor
56975973|NCT05627232|Autonomic Agents|autonomic agents|mesh-ancestor
56975974|NCT05627232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56975975|NCT05627232|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56975976|NCT05627232|Histamine Antagonists|histamine antagonists|mesh-ancestor
56975977|NCT05627232|Histamine Agents|histamine agents|mesh-ancestor
56975978|NCT05627232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56975979|NCT05627232|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56975980|NCT05627232|Antipruritics|antipruritics|mesh-ancestor
56975981|NCT05627232|Dermatologic Agents|dermatologic agents|mesh-ancestor
56975982|NCT03681548|Doxorubicin|doxorubicin|mesh-list
56975983|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56975984|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56975985|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56975986|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56975987|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56975988|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56975989|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56975990|NCT02417506|Ibuprofen|ibuprofen|mesh-list
56975991|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56975992|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56975993|NCT02417506|Analgesics|analgesics|mesh-ancestor
56975994|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
56975995|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56975996|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56975997|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56975998|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56975999|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56976000|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976001|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976002|NCT05188911|Prednisone|prednisone|mesh-list
56976003|NCT05188911|Androgens|androgens|mesh-list
56976004|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976005|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
56976006|NCT05188911|Hormones|hormones|mesh-ancestor
56976007|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976008|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976009|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56976010|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976011|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56976012|NCT03676946|Antibodies|antibodies|mesh-list
56976013|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
56976014|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56976015|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
56976016|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976017|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976018|NCT01363167|Vitamin D|vitamin d|mesh-list
56976019|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
56976020|NCT01363167|Vitamins|vitamins|mesh-ancestor
56976021|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
56976022|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976023|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56976024|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56976025|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
56976026|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56976027|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976028|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976029|NCT02422654|Eliglustat|eliglustat|mesh-list
56976030|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976031|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976032|NCT05188833|Paroxetine|paroxetine|mesh-list
56976033|NCT05188833|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56976034|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56976035|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56976036|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976037|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976038|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
56976039|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976040|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56976041|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
56658274|NCT02579434|Midazolam|midazolam|mesh-list
56976042|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56976043|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56976044|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56976045|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976046|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
56976047|NCT02426164|Epinephrine|epinephrine|mesh-list
56976048|NCT02426164|Morphine|morphine|mesh-list
56976049|NCT02426164|Bupivacaine|bupivacaine|mesh-list
56976050|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
56976051|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
56976052|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976053|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976054|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
56976055|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976056|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56976057|NCT02426164|Narcotics|narcotics|mesh-ancestor
56976058|NCT02426164|Analgesics|analgesics|mesh-ancestor
56976059|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976060|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
56976061|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
56976062|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56976063|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
56976064|NCT02426164|Hormones|hormones|mesh-ancestor
56976065|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976066|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56976067|NCT02426164|Protective Agents|protective agents|mesh-ancestor
56976068|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56976069|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56976070|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
56976071|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976072|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976073|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56976074|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56976075|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56976076|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
56976077|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
56976078|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
56976079|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56976080|NCT03745157|Insulin|insulin|mesh-list
56976081|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
56976082|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56976083|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976084|NCT02426008|Mitogens|mitogens|mesh-list
56976085|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56976086|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976087|NCT02425852|Prednisolone|prednisolone|mesh-list
56976088|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
56976089|NCT02425852|Azathioprine|azathioprine|mesh-list
56976090|NCT02425852|Infliximab|infliximab|mesh-list
56976091|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976092|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
56976093|NCT02425852|Hormones|hormones|mesh-ancestor
56976094|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976095|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976096|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56976097|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976098|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56976099|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56976100|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56976101|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
56976102|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976103|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56976104|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56976105|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
56976106|NCT04050371|Tenofovir|tenofovir|mesh-list
56976107|NCT04050371|Emtricitabine|emtricitabine|mesh-list
56976108|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
56976109|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976110|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56976111|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56976112|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976113|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976114|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56976115|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56976116|NCT04447287|Buprenorphine|buprenorphine|mesh-list
56976117|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56976118|NCT04447287|ASP8062|asp8062|mesh-list
56976119|NCT04447287|Naloxone|naloxone|mesh-list
56976120|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56976121|NCT04447287|Narcotics|narcotics|mesh-ancestor
56976122|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976123|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976124|NCT04447287|Analgesics|analgesics|mesh-ancestor
56976125|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
56976126|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976127|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56976128|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
56976129|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
56976130|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976131|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976132|NCT01879319|Evolocumab|evolocumab|mesh-list
56976133|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56976134|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56976135|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56976136|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
56976137|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976138|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56976139|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
56976140|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976141|NCT04165122|Valacyclovir|valacyclovir|mesh-list
56976142|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
56976143|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976144|NCT02422030|Atorvastatin|atorvastatin|mesh-list
56976145|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
56976146|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56976147|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56976148|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
56976149|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976150|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56976151|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56976152|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976153|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
56976154|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976155|NCT01365897|Modafinil|modafinil|mesh-list
56976156|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56976157|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976158|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56976159|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56976160|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56976161|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976162|NCT02422108|Denosumab|denosumab|mesh-list
56976163|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56976164|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976165|NCT01359657|Dexamethasone|dexamethasone|mesh-list
56976166|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
56976167|NCT01359657|Lenalidomide|lenalidomide|mesh-list
56976168|NCT01359657|Bortezomib|bortezomib|mesh-list
56976169|NCT01359657|BB 1101|bb 1101|mesh-list
56976170|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56976171|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976172|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
56976173|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
56976174|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976175|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976176|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56976177|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
56976178|NCT01359657|Hormones|hormones|mesh-ancestor
56976179|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976180|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56976181|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976182|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
56976183|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976184|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976185|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
56976186|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56976187|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56976188|NCT01359657|Growth Substances|growth substances|mesh-ancestor
56976189|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
56976190|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56976191|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
56976192|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56976193|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56976194|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
56304609|NCT00037219|Anidulafungin|anidulafungin|mesh-list
56976195|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976196|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
56976197|NCT02417116|Protective Agents|protective agents|mesh-ancestor
56976198|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
56976199|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
56976200|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
56976201|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976202|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976203|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56976204|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56976205|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56976206|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976207|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56976208|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56976209|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
56976210|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976211|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976212|NCT03177850|Acetazolamide|acetazolamide|mesh-list
56976213|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
56976214|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56976215|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976216|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976217|NCT03177850|Diuretics|diuretics|mesh-ancestor
56976218|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
56976219|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976220|NCT03102918|Cannabidiol|cannabidiol|mesh-list
56976221|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
56976222|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
56976223|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56976224|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56976225|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56976226|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56976227|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976228|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
56976229|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976230|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976231|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56976232|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976233|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56976234|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
56976235|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56976236|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
56976237|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56976238|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976239|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56897084|NCT03563170|Vitamins|vitamins|mesh-ancestor
56976240|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56976241|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976242|NCT03177538|Menotropins|menotropins|mesh-list
56976243|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56976244|NCT03177538|Hormones|hormones|mesh-ancestor
56976245|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976246|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976247|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56976248|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
56976249|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56976250|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
56976251|NCT01363323|Naltrexone|naltrexone|mesh-list
56976252|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
56976253|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56976254|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976255|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56976256|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56976257|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976258|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976259|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976260|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976261|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56976262|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
56976263|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976264|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56976265|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
56976266|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
56976267|NCT03106948|Penicillamine|penicillamine|mesh-list
56976268|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
56976269|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976270|NCT03106948|Protective Agents|protective agents|mesh-ancestor
56976271|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976272|NCT03106948|Vitamins|vitamins|mesh-ancestor
56976273|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
56976274|NCT03106948|Antidotes|antidotes|mesh-ancestor
56976275|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
56976276|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
56976277|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56976278|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
56976279|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56976280|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976281|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
56976282|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976283|NCT01881048|Celecoxib|celecoxib|mesh-list
56976284|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56976285|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56976286|NCT01881048|Analgesics|analgesics|mesh-ancestor
56976287|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
56976288|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976289|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976290|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976291|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56976292|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56976293|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56976294|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976295|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976296|NCT01363557|Gefitinib|gefitinib|mesh-list
56976297|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976298|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56976299|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976300|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976301|NCT01346475|Valacyclovir|valacyclovir|mesh-list
56976302|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
56976303|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976304|NCT05415228|Edetic Acid|edetic acid|mesh-list
56976305|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56976306|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
56976307|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
56976308|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976309|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
56976310|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56976311|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56976312|NCT01338636|Ambrisentan|ambrisentan|mesh-list
56976313|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56976314|NCT05753670|Tamsulosin|tamsulosin|mesh-list
56976315|NCT05753670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56976316|NCT05753670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56976317|NCT05753670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56976318|NCT05753670|Adrenergic Agents|adrenergic agents|mesh-ancestor
56976319|NCT05753670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976320|NCT05753670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976321|NCT05753670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976322|NCT05753670|Urological Agents|urological agents|mesh-ancestor
56976323|NCT02416258|Betamethasone|betamethasone|mesh-list
56976324|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
56976325|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56976326|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
56976327|NCT02416258|Calcipotriene|calcipotriene|mesh-list
56976328|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56976329|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976330|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
56976331|NCT02416258|Hormones|hormones|mesh-ancestor
56976332|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976333|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976334|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56976335|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
56976336|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
56976337|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
56976338|NCT02410720|Cathartics|cathartics|mesh-ancestor
56976339|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56976340|NCT02416570|Clarithromycin|clarithromycin|mesh-list
56976341|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56976342|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976343|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56976344|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976345|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976346|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56976347|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56976348|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
56976349|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56976350|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976351|NCT05328336|Paclitaxel|paclitaxel|mesh-list
56976352|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56976353|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976354|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
56976355|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
56976356|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
56976357|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976358|NCT02873754|Bupropion|bupropion|mesh-list
56976359|NCT02873754|Nicotine|nicotine|mesh-list
56976360|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56976361|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
56976362|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976363|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976364|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56976365|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56976366|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
56976367|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976368|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976369|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56976370|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
56976371|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56976372|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56976373|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56976374|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56976375|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
56976376|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56976377|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56976378|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976379|NCT03669614|Gallium citrate|gallium citrate|mesh-list
56976380|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976381|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56976382|NCT05200260|Niraparib|niraparib|mesh-list
56976383|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56976384|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976385|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976386|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976387|NCT02416804|Buprenorphine|buprenorphine|mesh-list
56976388|NCT02416804|Tramadol|tramadol|mesh-list
56976389|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56976390|NCT02416804|Narcotics|narcotics|mesh-ancestor
56976391|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976392|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976393|NCT02416804|Analgesics|analgesics|mesh-ancestor
56976394|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
56976395|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976396|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56976397|NCT04792320|Charcoal|charcoal|mesh-list
56976398|NCT04792320|Antidotes|antidotes|mesh-ancestor
56976399|NCT04792320|Protective Agents|protective agents|mesh-ancestor
56976400|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976401|NCT03176758|Anesthetics|anesthetics|mesh-list
56976402|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
56976403|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976404|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976405|NCT03177070|Methylene Blue|methylene blue|mesh-list
56976406|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976407|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976408|NCT03680612|Cefepime|cefepime|mesh-list
56976409|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
56976410|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56976411|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976412|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56976413|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976414|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976415|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
56976416|NCT02410096|Miotics|miotics|mesh-ancestor
56976417|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
56976418|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976419|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976420|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56976421|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56976422|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
56976423|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56976424|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56976425|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
56976426|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976427|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976428|NCT04046939|Pramipexole|pramipexole|mesh-list
56976429|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
56976430|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976431|NCT04046939|Protective Agents|protective agents|mesh-ancestor
56976432|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976433|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56976434|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56976435|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
56976436|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
56976437|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976438|NCT05188131|Diclofenac|diclofenac|mesh-list
56976439|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56976440|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56976441|NCT05188131|Analgesics|analgesics|mesh-ancestor
56976442|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
56976443|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976444|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976445|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976446|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56976447|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56976448|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976449|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976450|NCT03651206|Niraparib|niraparib|mesh-list
56976451|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56976452|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976453|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976454|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976455|NCT01360437|Ticagrelor|ticagrelor|mesh-list
56976456|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56976457|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56976458|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56976459|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56976460|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56976461|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
56976462|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897313|NCT01283919|Pantoprazole|pantoprazole|mesh-list
56976463|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976464|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976465|NCT02409862|Oxytocin|oxytocin|mesh-list
56976466|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
56976467|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56976468|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976469|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
56976470|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
56976471|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56976472|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56976473|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976474|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976475|NCT01360671|Urological Agents|urological agents|mesh-ancestor
56976476|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
56976477|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56976478|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
56976479|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976480|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56976481|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56976482|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
56976483|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976484|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976485|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56976486|NCT02955797|Vaccines|vaccines|mesh-list
56976487|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
56976488|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976489|NCT03680378|Cefepime|cefepime|mesh-list
56976490|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56976491|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976492|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56976493|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
56658726|NCT02651792|Meperidine|meperidine|mesh-list
56976494|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56976495|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56976496|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
56976497|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976498|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976499|NCT05418348|Nimodipine|nimodipine|mesh-list
56976500|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56976501|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56976502|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56976503|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976504|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56976505|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976506|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
56976507|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56976508|NCT03258554|Cetuximab|cetuximab|mesh-list
56976509|NCT03258554|Durvalumab|durvalumab|mesh-list
56976510|NCT03258554|Antibodies|antibodies|mesh-list
56976511|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
56976512|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56976513|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
56976514|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
56976515|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976516|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976517|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
56976518|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56976519|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976520|NCT04885530|Fluticasone|fluticasone|mesh-list
56976521|NCT04885530|Xhance|xhance|mesh-list
56976522|NCT04885530|Ivermectin|ivermectin|mesh-list
56976523|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
56976524|NCT04885530|Montelukast|montelukast|mesh-list
56976525|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976526|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56976527|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
56976528|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976529|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976530|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56976531|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
56976532|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
56976533|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56976534|NCT04885530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56976535|NCT04885530|Hormone Antagonists|hormone antagonists|mesh-ancestor
56990943|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976536|NCT04885530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976537|NCT04885530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56976538|NCT04885530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56976539|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976540|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976541|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56976542|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976543|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56976544|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56976545|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976546|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56976547|NCT04885530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56976548|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56976549|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56976550|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976551|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
56976552|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56976553|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
56976554|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56976555|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56976556|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56976557|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
56976558|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
56976559|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56976560|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56976561|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976562|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976563|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976564|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56976565|NCT03176524|Glucagon|glucagon|mesh-list
56976566|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56658800|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56976567|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56976568|NCT03176524|Hormones|hormones|mesh-ancestor
56976569|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976570|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976571|NCT03176524|Incretins|incretins|mesh-ancestor
56976572|NCT03676088|Mitogens|mitogens|mesh-list
56976573|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56976574|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976575|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
56976576|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56976577|NCT02414464|Calcium|calcium|mesh-list
56976578|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56976579|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976580|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56976581|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56976582|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976583|NCT03226418|Cytarabine|cytarabine|mesh-list
56976584|NCT03226418|Azacitidine|azacitidine|mesh-list
56976585|NCT03226418|Decitabine|decitabine|mesh-list
56976586|NCT03226418|Daunorubicin|daunorubicin|mesh-list
56976587|NCT03226418|Venetoclax|venetoclax|mesh-list
56976588|NCT03226418|Idarubicin|idarubicin|mesh-list
56976589|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56976590|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
56976591|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976592|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976593|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
56976594|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976595|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56976596|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
56976597|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976598|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976599|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56976600|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56976601|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56976602|NCT04039503|Tirzepatide|tirzepatide|mesh-list
56976603|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56976604|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976605|NCT04039503|Incretins|incretins|mesh-ancestor
56976606|NCT04039503|Hormones|hormones|mesh-ancestor
56976607|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976608|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
56976609|NCT05418114|Analgesics|analgesics|mesh-ancestor
56976610|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
56976611|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976612|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976613|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
56976614|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976615|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56976616|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
56976617|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56976618|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56976619|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976620|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56976621|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
56976622|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56976623|NCT05528952|Bevacizumab|bevacizumab|mesh-list
56976624|NCT05528952|Atezolizumab|atezolizumab|mesh-list
56976625|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56976626|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976627|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56976628|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56976629|NCT05528952|Growth Substances|growth substances|mesh-ancestor
56976630|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976631|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
56976632|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
56976633|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56976634|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
56976635|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56976636|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976637|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56976638|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56976639|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56976640|NCT03672812|Liraglutide|liraglutide|mesh-list
56658874|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658875|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976641|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56976642|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976643|NCT03672812|Incretins|incretins|mesh-ancestor
56976644|NCT03672812|Hormones|hormones|mesh-ancestor
56976645|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976646|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56976647|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976648|NCT05029726|Clonidine|clonidine|mesh-list
56976649|NCT05029726|Epinephrine|epinephrine|mesh-list
56976650|NCT05029726|Bupivacaine|bupivacaine|mesh-list
56976651|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
56976652|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
56976653|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976654|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976655|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
56976656|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976657|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56976658|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56976659|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
56976660|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976661|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976662|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56976663|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56976664|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
56976665|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56976666|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
56976667|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
56976668|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
56976669|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56976670|NCT05029726|Analgesics|analgesics|mesh-ancestor
56976671|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56976672|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
56976673|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56976674|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
56976675|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56976676|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976677|NCT05007652|Plerixafor|plerixafor|mesh-list
56976678|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56976679|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56976680|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
56976681|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976682|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
56976683|NCT03632772|Mirabegron|mirabegron|mesh-list
56976684|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56976685|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56976686|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
56976687|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976688|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976689|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976690|NCT03632772|Urological Agents|urological agents|mesh-ancestor
56976691|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56976692|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56976693|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56976694|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
56976695|NCT01360749|Lidocaine|lidocaine|mesh-list
56976696|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
56976697|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
56976698|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976699|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976700|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
56976701|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976702|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56976703|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56976704|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56658956|NCT04005469|Treprostinil|treprostinil|mesh-list
56658957|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56658958|NCT02651324|Ketamine|ketamine|mesh-list
56658959|NCT02651324|Analgesics|analgesics|mesh-ancestor
56658960|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
56976705|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56658961|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658962|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658963|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56976706|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976707|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
56976708|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56976709|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56976710|NCT01367301|Paclitaxel|paclitaxel|mesh-list
56976711|NCT01367301|Carboplatin|carboplatin|mesh-list
56976712|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56976713|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976714|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
56976715|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
56976716|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
56976717|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976718|NCT03675854|Cefazolin|cefazolin|mesh-list
56976719|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56976720|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976721|NCT01360827|Cisplatin|cisplatin|mesh-list
56976722|NCT01360827|Fluorouracil|fluorouracil|mesh-list
56976723|NCT01360827|Cetuximab|cetuximab|mesh-list
56976724|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976725|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
56976726|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976727|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56976728|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56976729|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
56976730|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976731|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56976732|NCT03171610|Fentanyl|fentanyl|mesh-list
56976733|NCT03171610|Sufentanil|sufentanil|mesh-list
56976734|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56976735|NCT03171610|Narcotics|narcotics|mesh-ancestor
56976736|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976737|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976738|NCT03171610|Analgesics|analgesics|mesh-ancestor
56976739|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
56976740|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976741|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56976742|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56976743|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
56976744|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
56976745|NCT01364181|Udenafil|udenafil|mesh-list
56976746|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56976747|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56976748|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729135|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
56897613|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56976749|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976750|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
56976751|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56976752|NCT03679442|Antidotes|antidotes|mesh-list
56976753|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976754|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
56976755|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976756|NCT03679442|Expectorants|expectorants|mesh-ancestor
56976757|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56976758|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56976759|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
56976760|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976761|NCT03679442|Protective Agents|protective agents|mesh-ancestor
56976762|NCT01367535|Naltrexone|naltrexone|mesh-list
56976763|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
56976764|NCT01367535|Paroxetine|paroxetine|mesh-list
56976765|NCT01367535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56976766|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56976767|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56976768|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976769|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976770|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
56976771|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976772|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56976773|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
56976774|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56976775|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56976776|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56976777|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976778|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56976779|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
56976780|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976781|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56976782|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
56976783|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56976784|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976785|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
56976786|NCT04482712|Sirolimus|sirolimus|mesh-list
56976787|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56976788|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976789|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56976790|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976791|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
56976792|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56976793|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
56976794|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976795|NCT02409004|Rifampin|rifampin|mesh-list
56976796|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56976797|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
56976798|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56976799|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976800|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
56976801|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56976802|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976803|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976804|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56976805|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56976806|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56976807|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56976808|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56976809|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56976810|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
56976811|NCT03131895|Lansoprazole|lansoprazole|mesh-list
56976812|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56976813|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56976814|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56976815|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976816|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976817|NCT03215030|Dexamethasone|dexamethasone|mesh-list
56976818|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976819|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
56976820|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
56976821|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976822|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976823|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56976824|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
56976825|NCT03215030|Hormones|hormones|mesh-ancestor
56976826|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976827|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56976828|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976829|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
56976830|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56976831|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976832|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
56976833|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976834|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
56976835|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56976836|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976837|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56976838|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976839|NCT01364415|Pasireotide|pasireotide|mesh-list
56976840|NCT01364415|Hormones|hormones|mesh-ancestor
56976841|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56976842|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976843|NCT03176446|Anesthetics|anesthetics|mesh-list
56976844|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
56976845|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976846|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976847|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
56976848|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976849|NCT03176212|Milk fat globule|milk fat globule|mesh-list
56976850|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56976851|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
56976852|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
56976853|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976854|NCT04035473|Paclitaxel|paclitaxel|mesh-list
56976855|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56976856|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976857|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
56976858|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
56976859|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
56976860|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976861|NCT02408926|Vaccines|vaccines|mesh-list
56976862|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
56976863|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976864|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
56976865|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56976866|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976867|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
56976868|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56976869|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56976870|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976871|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
56976872|NCT03738527|Coagulants|coagulants|mesh-ancestor
56976873|NCT02915978|Fentanyl|fentanyl|mesh-list
56976874|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56976875|NCT02915978|Narcotics|narcotics|mesh-ancestor
56976876|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976877|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976878|NCT02915978|Analgesics|analgesics|mesh-ancestor
56976879|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
56976880|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976881|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56976882|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56976883|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
56976884|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
56976885|NCT02412904|Menotropins|menotropins|mesh-list
56976886|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56976887|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
56976888|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56976889|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976890|NCT02408302|Midazolam|midazolam|mesh-list
56976891|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56976892|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56976893|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976894|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976895|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56897763|NCT02822794|Ribavirin|ribavirin|mesh-list
56976896|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56976897|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56976898|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56976899|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
56976900|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
56976901|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
56976902|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
56976903|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976904|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976905|NCT02408146|Celecoxib|celecoxib|mesh-list
56976906|NCT02408146|Parecoxib|parecoxib|mesh-list
56976907|NCT02408146|Fentanyl|fentanyl|mesh-list
56976908|NCT02408146|Ondansetron|ondansetron|mesh-list
56976909|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56976910|NCT02408146|Narcotics|narcotics|mesh-ancestor
56976911|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56976912|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976913|NCT02408146|Analgesics|analgesics|mesh-ancestor
56976914|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
56976915|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976916|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56976917|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56976918|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
56976919|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
56976920|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976921|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56976922|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56976923|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56976924|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56976925|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56976926|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56976927|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56976928|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
56976929|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
56976930|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56976931|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
56976932|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
56976933|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56659170|NCT02655146|Estradiol|estradiol|mesh-list
56976934|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
56976935|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56976936|NCT02408146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56976937|NCT02408146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56976938|NCT02408146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56976939|NCT02408146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56976940|NCT03175666|Leucovorin|leucovorin|mesh-list
56976941|NCT03175666|Paclitaxel|paclitaxel|mesh-list
56976942|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
56976943|NCT03175666|Bevacizumab|bevacizumab|mesh-list
56976944|NCT03175666|Fluorouracil|fluorouracil|mesh-list
56976945|NCT03175666|Capecitabine|capecitabine|mesh-list
56976946|NCT03175666|Avelumab|avelumab|mesh-list
56976947|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56976948|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976949|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
56976950|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
56976951|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
56976952|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976953|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56976954|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
56976955|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976956|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56976957|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56976958|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
56976959|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56976960|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56976961|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56976962|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56976963|NCT03175666|Growth Substances|growth substances|mesh-ancestor
56976964|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
56976965|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
56976966|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56976967|NCT03175666|Antidotes|antidotes|mesh-ancestor
56976968|NCT03175666|Protective Agents|protective agents|mesh-ancestor
56976969|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
56976970|NCT03175666|Vitamins|vitamins|mesh-ancestor
56976971|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
56976972|NCT03101358|Paclitaxel|paclitaxel|mesh-list
56976973|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56976974|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56976975|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976976|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56976977|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56976978|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56976979|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976980|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
56976981|NCT03171220|Fludarabine|fludarabine|mesh-list
56976982|NCT03171220|Interleukin-2|interleukin-2|mesh-list
56976983|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56976984|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
56976985|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976986|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56976987|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56976988|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
56976989|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56976990|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56976991|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56976992|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56976993|NCT03171220|Analgesics|analgesics|mesh-ancestor
56976994|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
56976995|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56976996|NCT04853004|Antibodies|antibodies|mesh-list
56976997|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
56976998|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56976999|NCT03116542|Alovudine|alovudine|mesh-list
56977000|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
56977001|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977002|NCT03170596|Tazarotene|tazarotene|mesh-list
56977003|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
56977004|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
56977005|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
56977006|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
56977007|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977008|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
56977009|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977010|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977011|NCT05183412|Methamphetamine|methamphetamine|mesh-list
56977012|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56977013|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977014|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
56977015|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
56977016|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977017|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
56977018|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977019|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977020|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
56977021|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56977022|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56977023|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977024|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56977025|NCT03173326|Anesthetics|anesthetics|mesh-list
56977026|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977027|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977028|NCT03172858|Oxytocin|oxytocin|mesh-list
56977029|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
56977030|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56977031|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977032|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
56977033|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56977034|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56977035|NCT02403856|Prednisolone|prednisolone|mesh-list
56977036|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
56977037|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56977038|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
56977039|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56977040|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
56977041|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
56977042|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977043|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977044|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56977045|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
56977046|NCT02403856|Hormones|hormones|mesh-ancestor
56977047|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56897910|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977048|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56977049|NCT02403856|Protective Agents|protective agents|mesh-ancestor
56977050|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56977051|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977052|NCT03170284|Bevacizumab|bevacizumab|mesh-list
56977053|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977054|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977055|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56977056|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56977057|NCT03170284|Growth Substances|growth substances|mesh-ancestor
56977058|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977059|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
56977060|NCT02407912|Cisplatin|cisplatin|mesh-list
56977061|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977062|NCT03170050|Lidocaine|lidocaine|mesh-list
56977063|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
56977064|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
56977065|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977066|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977067|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
56977068|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977069|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56977070|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56977071|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56977072|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977073|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977074|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56977075|NCT02407834|Eusol|eusol|mesh-list
56977076|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
56977077|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977078|NCT03169738|Leucovorin|leucovorin|mesh-list
56977079|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
56977080|NCT03169738|Bevacizumab|bevacizumab|mesh-list
56977081|NCT03169738|Fluorouracil|fluorouracil|mesh-list
56977082|NCT03169738|Capecitabine|capecitabine|mesh-list
56977083|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
56977084|NCT03169738|Nivolumab|nivolumab|mesh-list
56977085|NCT03169738|Fulvestrant|fulvestrant|mesh-list
56659343|NCT00656526|Lidocaine|lidocaine|mesh-list
56977086|NCT03169738|Avelumab|avelumab|mesh-list
56977087|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977088|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977089|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56977090|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
56977091|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977092|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56977093|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56977094|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
56977095|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56977096|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977097|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56977098|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56977099|NCT03169738|Growth Substances|growth substances|mesh-ancestor
56977100|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
56977101|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
56977102|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56977103|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56977104|NCT03169738|Antidotes|antidotes|mesh-ancestor
56977105|NCT03169738|Protective Agents|protective agents|mesh-ancestor
56977106|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
56977107|NCT03169738|Vitamins|vitamins|mesh-ancestor
56977108|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
56977109|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56977110|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56977111|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56977112|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
56977113|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56977114|NCT02407600|Aprepitant|aprepitant|mesh-list
56977115|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
56977116|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
56977117|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
56977118|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977119|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977120|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56977121|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56897986|NCT01287351|Xhance|xhance|mesh-list
56977122|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977123|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977124|NCT02403544|Capecitabine|capecitabine|mesh-list
56977125|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
56977126|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56977127|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
56977128|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977129|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977130|NCT02411344|Pertuzumab|pertuzumab|mesh-list
56977131|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977132|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977133|NCT03657095|Beraprost|beraprost|mesh-list
56977134|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56977135|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
56977136|NCT02407366|Carboplatin|carboplatin|mesh-list
56977137|NCT02407366|Pemetrexed|pemetrexed|mesh-list
56977138|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977139|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977140|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977141|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56977142|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56977143|NCT03738137|Lidocaine|lidocaine|mesh-list
56977144|NCT03738137|Midazolam|midazolam|mesh-list
56977145|NCT03738137|Sufentanil|sufentanil|mesh-list
56977146|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
56977147|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
56977148|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977149|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977150|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
56977151|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977152|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56977153|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56977154|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56977155|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977156|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977157|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56977158|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56977159|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56977160|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56977161|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56977162|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56659393|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977163|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
56977164|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
56977165|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
56977166|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977167|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56977168|NCT03738137|Narcotics|narcotics|mesh-ancestor
56977169|NCT03738137|Analgesics|analgesics|mesh-ancestor
56977170|NCT02407210|Olmesartan|olmesartan|mesh-list
56977171|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56977172|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56977173|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56977174|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56977175|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56977176|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977177|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
56977178|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56977179|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56977180|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977181|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
56977182|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
56977183|NCT03175042|Chrysarobin|chrysarobin|mesh-list
56977184|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56977185|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56977186|NCT03175042|Analgesics|analgesics|mesh-ancestor
56977187|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
56977188|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977189|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977190|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56977191|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56977192|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
56977193|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56977194|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729287|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898055|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
56977195|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977196|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56977197|NCT03738059|Analgesics|analgesics|mesh-ancestor
56977198|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
56977199|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977200|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56977201|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56977202|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56977203|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
56977204|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977205|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977206|NCT05233462|Bupivacaine|bupivacaine|mesh-list
56977207|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
56977208|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
56977209|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977210|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977211|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
56977212|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977213|NCT02700412|Cannabidiol|cannabidiol|mesh-list
56977214|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
56977215|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
56977216|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977217|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977218|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
56977219|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56977220|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56977221|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56977222|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977223|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977224|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
56977225|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977226|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977227|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56977228|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977229|NCT02288832|Azithromycin|azithromycin|mesh-list
56977230|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56977231|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977232|NCT03116308|Opicapone|opicapone|mesh-list
56977233|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56977234|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977235|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977236|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56977237|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56977238|NCT03665441|Leucovorin|leucovorin|mesh-list
56977239|NCT03665441|Gemcitabine|gemcitabine|mesh-list
56977240|NCT03665441|Paclitaxel|paclitaxel|mesh-list
56977241|NCT03665441|Irinotecan|irinotecan|mesh-list
56977242|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56977243|NCT03665441|Asparaginase|asparaginase|mesh-list
56977244|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56977245|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977246|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
56977247|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
56977248|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
56977249|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977250|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56977251|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
56977252|NCT03665441|Antiviral Agents|antiviral agents|mesh-ancestor
56977253|NCT03665441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977254|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977255|NCT03665441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56977256|NCT03665441|Immunologic Factors|immunologic factors|mesh-ancestor
56977257|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977258|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56977259|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56977260|NCT03665441|Antidotes|antidotes|mesh-ancestor
56977261|NCT03665441|Protective Agents|protective agents|mesh-ancestor
56977262|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
56977263|NCT03665441|Vitamins|vitamins|mesh-ancestor
56977264|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
56977265|NCT03169660|Aflibercept|aflibercept|mesh-list
56977266|NCT03169660|Mitogens|mitogens|mesh-list
56977267|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
56977268|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
56990944|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56898139|NCT03562468|Niacin|niacin|mesh-list
56977269|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977270|NCT03169660|Growth Substances|growth substances|mesh-ancestor
56977271|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977272|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56977273|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56977274|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
56977275|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977276|NCT02401828|Dolutegravir|dolutegravir|mesh-list
56977277|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56977278|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56977279|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977280|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977281|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56977282|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56977283|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
56977284|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977285|NCT02401594|Enoxaparin|enoxaparin|mesh-list
56977286|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
56977287|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56977288|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
56977289|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56977290|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
56977291|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977292|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977293|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
56977294|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56977295|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56977296|NCT02406508|Sorafenib|sorafenib|mesh-list
56977297|NCT02406508|Melphalan|melphalan|mesh-list
56977298|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977299|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56977300|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977301|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977302|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56977303|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
56977304|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56977305|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56977306|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
56977307|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977308|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56977309|NCT03662789|Hematinics|hematinics|mesh-ancestor
56977310|NCT04481932|Trastuzumab|trastuzumab|mesh-list
56977311|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977312|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977313|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
56977314|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
56977315|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56977316|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56977317|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977318|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977319|NCT03169582|Urological Agents|urological agents|mesh-ancestor
56977320|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
56977321|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56977322|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56977323|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56977324|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977325|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977326|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
56977327|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977328|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977329|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56977330|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977331|NCT03169504|Fluticasone|fluticasone|mesh-list
56977332|NCT03169504|Xhance|xhance|mesh-list
56977333|NCT03169504|Bromides|bromides|mesh-list
56977334|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
56977335|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56977336|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56977337|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
56977338|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977339|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977340|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56977341|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
56977342|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
56977343|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56977344|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
56977345|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56977346|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
56977347|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977348|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977349|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
56977350|NCT03169426|Carvedilol|carvedilol|mesh-list
56977351|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56977352|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56977353|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
56977354|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977355|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977356|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977357|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56977358|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
56977359|NCT03169426|Protective Agents|protective agents|mesh-ancestor
56977360|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56977361|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977362|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56977363|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
56977364|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56977365|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56977366|NCT03580928|Venetoclax|venetoclax|mesh-list
56977367|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
56977368|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
56977369|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977370|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977371|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
56977372|NCT03169348|Ledipasvir|ledipasvir|mesh-list
56977373|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56977374|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
56977375|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977376|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
56977377|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56977378|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56977379|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977380|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
56977381|NCT03631355|Coagulants|coagulants|mesh-ancestor
56977382|NCT03571568|Rituximab|rituximab|mesh-list
56977383|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977384|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977385|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
56977386|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977387|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56977388|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
56977389|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56977390|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977391|NCT03679052|Clonidine|clonidine|mesh-list
56977392|NCT03679052|Mirtazapine|mirtazapine|mesh-list
56977393|NCT03679052|Analgesics|analgesics|mesh-ancestor
56977394|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
56977395|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977396|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977397|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56977398|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
56977399|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
56977400|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56977401|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56977402|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56977403|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
56977404|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977405|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977406|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
56977407|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56977408|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56977409|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
56977410|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
56977411|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56977412|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56977413|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977414|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56977415|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56977416|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56977417|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56898289|NCT03855579|Simendan|simendan|mesh-list
56977418|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56977419|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
56977420|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56977421|NCT03540914|Acetazolamide|acetazolamide|mesh-list
56977422|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
56977423|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56977424|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977425|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977426|NCT03540914|Diuretics|diuretics|mesh-ancestor
56977427|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
56977428|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977429|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
56977430|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56977431|NCT03629249|Growth Substances|growth substances|mesh-ancestor
56977432|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977433|NCT03671174|Aspirin|aspirin|mesh-list
56977434|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
56977435|NCT03671174|Prednisone|prednisone|mesh-list
56977436|NCT03671174|Heparin|heparin|mesh-list
56977437|NCT03671174|Enoxaparin|enoxaparin|mesh-list
56977438|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56977439|NCT03671174|Tinzaparin|tinzaparin|mesh-list
56977440|NCT03671174|Dalteparin|dalteparin|mesh-list
56977441|NCT03671174|Nadroparin|nadroparin|mesh-list
56977442|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56977443|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
56977444|NCT03671174|Hormones|hormones|mesh-ancestor
56977445|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56977446|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977447|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56977448|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977449|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56977450|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56977451|NCT03671174|Analgesics|analgesics|mesh-ancestor
56977452|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
56977453|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977454|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56977455|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56977456|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56977457|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977458|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56977459|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56977460|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977461|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
56977462|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
56977463|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
56977464|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56977465|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56977466|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977467|NCT03172234|Amantadine|amantadine|mesh-list
56977468|NCT03172234|Gabapentin|gabapentin|mesh-list
56977469|NCT03172234|Analgesics|analgesics|mesh-ancestor
56977470|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
56977471|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977472|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977473|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
56977474|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56977475|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56977476|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977477|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56977478|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56977479|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56977480|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977481|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977482|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
56977483|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56977484|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56977485|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
56977486|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977487|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
56977488|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56977489|NCT03533582|Gemcitabine|gemcitabine|mesh-list
56977490|NCT03533582|Cisplatin|cisplatin|mesh-list
56977491|NCT03533582|Carboplatin|carboplatin|mesh-list
56977492|NCT03533582|Doxorubicin|doxorubicin|mesh-list
56977493|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56977494|NCT03533582|Fluorouracil|fluorouracil|mesh-list
56898363|NCT01290939|Bevacizumab|bevacizumab|mesh-list
56977495|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
56977496|NCT03533582|Irinotecan|irinotecan|mesh-list
56977497|NCT03533582|Etoposide|etoposide|mesh-list
56977498|NCT03533582|Vincristine|vincristine|mesh-list
56977499|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
56977500|NCT03533582|Sorafenib|sorafenib|mesh-list
56977501|NCT03533582|Daunorubicin|daunorubicin|mesh-list
56977502|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
56977503|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977504|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56977505|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
56977506|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977507|NCT03533582|Antiviral Agents|antiviral agents|mesh-ancestor
56977508|NCT03533582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977509|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977510|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56977511|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
56977512|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977513|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56977514|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56977515|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56977516|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56977517|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56977518|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56977519|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56977520|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56977521|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56977522|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
56977523|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
56977524|NCT03709849|Citric Acid|citric acid|mesh-list
56977525|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
56977526|NCT03709849|Clomiphene|clomiphene|mesh-list
56977527|NCT03709849|Enclomiphene|enclomiphene|mesh-list
56977528|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
56977529|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
56977530|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56977531|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
56977532|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
56977533|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977534|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56977535|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
56977536|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56977537|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977538|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56977539|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
56977540|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56977541|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56977542|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56977543|NCT05343325|Paclitaxel|paclitaxel|mesh-list
56977544|NCT05343325|Cisplatin|cisplatin|mesh-list
56977545|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56977546|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56977554|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
56977555|NCT03349333|Vitamins|vitamins|mesh-ancestor
56977556|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
56977557|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977558|NCT03349333|Hematinics|hematinics|mesh-ancestor
56977559|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
56977560|NCT03365791|Spartalizumab|spartalizumab|mesh-list
56977561|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56977562|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977563|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977564|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
56977565|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56977566|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
56977567|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
56977568|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977569|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977570|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56977571|NCT03365011|Analgesics|analgesics|mesh-ancestor
56977572|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
56977573|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977574|NCT03627767|Abrocitinib|abrocitinib|mesh-list
56977575|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56977576|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977577|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898433|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977578|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56977579|NCT03732365|Cefazolin|cefazolin|mesh-list
56977580|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977581|NCT03732287|Anesthetics|anesthetics|mesh-list
56977582|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977583|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977584|NCT02142738|Gemcitabine|gemcitabine|mesh-list
56977585|NCT02142738|Paclitaxel|paclitaxel|mesh-list
56977586|NCT02142738|Carboplatin|carboplatin|mesh-list
56977587|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
56977588|NCT02142738|Pemetrexed|pemetrexed|mesh-list
56977589|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56977590|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977591|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
56977592|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
56977593|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
56977594|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977595|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56977596|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
56977597|NCT02142738|Antiviral Agents|antiviral agents|mesh-ancestor
56977598|NCT02142738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977599|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977600|NCT02142738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56977601|NCT02142738|Immunologic Factors|immunologic factors|mesh-ancestor
56977602|NCT02142738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977603|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977604|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56977605|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56977606|NCT03617861|Secretin|secretin|mesh-list
56977607|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56977608|NCT03617861|Hormones|hormones|mesh-ancestor
56977609|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56977610|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977618|NCT03614975|Vaccines|vaccines|mesh-list
56977619|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
56977620|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659840|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56977621|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
56977622|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56977623|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977624|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56977625|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56977626|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977627|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977628|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977629|NCT03096288|Evolocumab|evolocumab|mesh-list
56977630|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56977631|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56977632|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
56977633|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977634|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56977635|NCT03731897|Lidocaine|lidocaine|mesh-list
56977636|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
56977637|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
56977638|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977639|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977640|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
56977641|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977642|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56977643|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56977644|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56977645|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977646|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977647|NCT02072148|Cisplatin|cisplatin|mesh-list
56977648|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977649|NCT04456608|Aspirin|aspirin|mesh-list
56977650|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56977651|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56977652|NCT04456608|Analgesics|analgesics|mesh-ancestor
56977653|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
56977654|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977655|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977656|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56977657|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56977658|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56977659|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56977660|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977661|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56977662|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56977663|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977664|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
56977665|NCT04450212|Vitamin K|vitamin k|mesh-list
56977666|NCT04450212|Vitamins|vitamins|mesh-ancestor
56977667|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
56977668|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977669|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56977670|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56977671|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977672|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
56977673|NCT04450212|Coagulants|coagulants|mesh-ancestor
56977674|NCT05074290|Taxane|taxane|mesh-list
56977675|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977676|NCT03095508|Menthol|menthol|mesh-list
56977677|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
56977678|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
56977679|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56977680|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
56977681|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56977682|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56977683|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
56977684|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977685|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977686|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
56977687|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56977688|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977689|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977690|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56977691|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56977692|NCT03731741|Protective Agents|protective agents|mesh-ancestor
56977693|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977694|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
56977695|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56977696|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
56977697|NCT03736187|Metronidazole|metronidazole|mesh-list
56659917|NCT02696915|Fentanyl|fentanyl|mesh-list
56977699|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977700|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56977701|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56977702|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56977703|NCT03731429|Lidocaine|lidocaine|mesh-list
56977704|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
56977705|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
56977706|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977707|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977708|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
56977709|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977710|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56977711|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56977712|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56977713|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977714|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977715|NCT03735563|Fentanyl|fentanyl|mesh-list
56977716|NCT03735563|Ketamine|ketamine|mesh-list
56977717|NCT03735563|Analgesics|analgesics|mesh-ancestor
56977718|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
56977719|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977720|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977721|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56977722|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56977723|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
56977724|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
56977725|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977726|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56977727|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56977728|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977729|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977730|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56977731|NCT03735563|Narcotics|narcotics|mesh-ancestor
56977732|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56898581|NCT01180413|Lercanidipine|lercanidipine|mesh-list
56977733|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56977734|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
56977735|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
56977736|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977737|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
56977738|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56977739|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56977740|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977741|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
56977742|NCT03653429|Coagulants|coagulants|mesh-ancestor
56977743|NCT03731117|Furosemide|furosemide|mesh-list
56977744|NCT03731117|Diuretics|diuretics|mesh-ancestor
56977745|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
56977746|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977747|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56977748|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977749|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977750|NCT03735251|Metoprolol|metoprolol|mesh-list
56977751|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56977752|NCT03735251|Diuretics|diuretics|mesh-list
56977753|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
56977754|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977755|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56977756|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56977757|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
56977758|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
56977759|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977760|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56977761|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56977762|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56977763|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
56977764|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977765|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977766|NCT03098550|Nivolumab|nivolumab|mesh-list
56977767|NCT03098550|Daratumumab|daratumumab|mesh-list
56977768|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977769|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977770|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56977771|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977772|NCT03095118|Daratumumab|daratumumab|mesh-list
56977773|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977774|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
56977775|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977776|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977777|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
56977778|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56977779|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56977780|NCT05013216|Poly ICLC|poly iclc|mesh-list
56977781|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
56977782|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
56977783|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977784|NCT04606446|Letrozole|letrozole|mesh-list
56977785|NCT04606446|Fulvestrant|fulvestrant|mesh-list
56977786|NCT04606446|Palbociclib|palbociclib|mesh-list
56977787|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977788|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56977789|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56977790|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977791|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977792|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56977793|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
56977794|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56977795|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977796|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56977797|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56977798|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56977799|NCT03169114|Amikacin|amikacin|mesh-list
56977800|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56977801|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977802|NCT03115762|Bevacizumab|bevacizumab|mesh-list
56977803|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977804|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977805|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56977806|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56977807|NCT03115762|Growth Substances|growth substances|mesh-ancestor
56977808|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977809|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
56977810|NCT03168958|Methadone|methadone|mesh-list
56977811|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56977812|NCT03168958|Narcotics|narcotics|mesh-ancestor
56977813|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977814|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977815|NCT03168958|Analgesics|analgesics|mesh-ancestor
56977816|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
56977817|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977818|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
56977819|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
56977820|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
56977821|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56977822|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977823|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977824|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56977825|NCT03632460|Analgesics|analgesics|mesh-ancestor
56977826|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
56977827|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977828|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56977829|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56977830|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56977831|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
56977832|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977833|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977834|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
56977835|NCT05418660|Nivolumab|nivolumab|mesh-list
56977836|NCT05418660|Atezolizumab|atezolizumab|mesh-list
56977837|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56977838|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977839|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56977840|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977841|NCT03364309|Ixekizumab|ixekizumab|mesh-list
56977842|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
56977843|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56977844|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56977845|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977847|NCT05166096|Aspirin|aspirin|mesh-list
56977848|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56977849|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56977850|NCT05166096|Analgesics|analgesics|mesh-ancestor
56977851|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
56977852|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977853|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977854|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56977855|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56977856|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56977857|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56977858|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977859|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56977860|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56977861|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977862|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
56977863|NCT04544202|Trametinib|trametinib|mesh-list
56977864|NCT04544202|Dabrafenib|dabrafenib|mesh-list
56977865|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977866|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56977867|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56977868|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977869|NCT03168412|Vaccines|vaccines|mesh-list
56977870|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
56977871|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977872|NCT05110638|Luliconazole|luliconazole|mesh-list
56977873|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
56977874|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977875|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
56977876|NCT03700788|Calcium|calcium|mesh-list
56977877|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56977878|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977879|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56977880|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977881|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
56977882|NCT03334903|Gabapentin|gabapentin|mesh-list
56977883|NCT03334903|Analgesics|analgesics|mesh-ancestor
56977884|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
56977885|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977886|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977887|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
56977888|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56977889|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56977890|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977891|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56977892|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56977893|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56977894|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977895|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977896|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
56977897|NCT03168100|Dexamethasone|dexamethasone|mesh-list
56977898|NCT03168100|Lenalidomide|lenalidomide|mesh-list
56977899|NCT03168100|Bortezomib|bortezomib|mesh-list
56977900|NCT03168100|Elotuzumab|elotuzumab|mesh-list
56977901|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56977902|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
56977903|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
56977904|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977905|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977906|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56977907|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
56977908|NCT03168100|Hormones|hormones|mesh-ancestor
56977909|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56977910|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56977911|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977912|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
56977913|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56977914|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56977915|NCT03168100|Growth Substances|growth substances|mesh-ancestor
56977916|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
56977917|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56977918|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56977919|NCT03709381|Cosyntropin|cosyntropin|mesh-list
56977920|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
56977921|NCT03709381|Hormones|hormones|mesh-ancestor
56977922|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56977923|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977924|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977925|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977926|NCT01353664|Romidepsin|romidepsin|mesh-list
56977927|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56977928|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977929|NCT02395744|Paclitaxel|paclitaxel|mesh-list
56977930|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56977931|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977932|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
56977933|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
56977934|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
56977935|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977936|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56977937|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56977938|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977939|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
56977940|NCT03168568|Valsartan|valsartan|mesh-list
56977941|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56977942|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56977943|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56977944|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56977945|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977946|NCT02400112|Vancomycin|vancomycin|mesh-list
56977947|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56977948|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56977949|NCT02694328|Olanzapine|olanzapine|mesh-list
56977950|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
56977951|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
56977952|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977953|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977954|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56977955|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56977956|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56977957|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977958|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56977959|NCT02694328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56977960|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56977961|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977962|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977963|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977964|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
56977965|NCT02395510|Vortioxetine|vortioxetine|mesh-list
56977966|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
56977967|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56977968|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56977969|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56977970|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977971|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977972|NCT02395510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56977973|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56977974|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56977975|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977976|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56977977|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
56977978|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56977979|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56977980|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56977981|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56977982|NCT02399800|Triamcinolone|triamcinolone|mesh-list
56977983|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56977984|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56977985|NCT02399800|Bupivacaine|bupivacaine|mesh-list
56977986|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56977987|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
56977988|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
56977989|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56977990|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56977991|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
56977992|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56977993|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56977995|NCT02399800|Hormones|hormones|mesh-ancestor
56977996|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56977997|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56977998|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
56977999|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978000|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978001|NCT02399566|Pemetrexed|pemetrexed|mesh-list
56978002|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56978003|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978004|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978005|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978006|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56978007|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56978008|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56978009|NCT03167164|Leucovorin|leucovorin|mesh-list
56978010|NCT03167164|Paclitaxel|paclitaxel|mesh-list
56978011|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
56978012|NCT03167164|Bevacizumab|bevacizumab|mesh-list
56978013|NCT03167164|Fluorouracil|fluorouracil|mesh-list
56978014|NCT03167164|Capecitabine|capecitabine|mesh-list
56978015|NCT03167164|Avelumab|avelumab|mesh-list
56978016|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56978017|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978018|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
56978019|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
56978020|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
56978021|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978022|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56978023|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
56978024|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978025|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56978026|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56978027|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
56978028|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56978029|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56978030|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56978031|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56978032|NCT03167164|Growth Substances|growth substances|mesh-ancestor
56978033|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
56978034|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
56978035|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56978036|NCT03167164|Antidotes|antidotes|mesh-ancestor
56978037|NCT03167164|Protective Agents|protective agents|mesh-ancestor
56978038|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
56978039|NCT03167164|Vitamins|vitamins|mesh-ancestor
56978040|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
56978041|NCT05745142|Sunitinib|sunitinib|mesh-list
56978042|NCT05745142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978043|NCT05745142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56978044|NCT05745142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56978045|NCT05745142|Growth Substances|growth substances|mesh-ancestor
56978046|NCT05745142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978047|NCT05745142|Growth Inhibitors|growth inhibitors|mesh-ancestor
56978048|NCT05745142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56978049|NCT05745142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978050|NCT05745142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978051|NCT03334747|Lumefantrine|lumefantrine|mesh-list
56978052|NCT03334747|Artemether|artemether|mesh-list
56978053|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56978054|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
56978055|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56978056|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56978057|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978058|NCT02394652|Metformin|metformin|mesh-list
56978059|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56978060|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56978061|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978062|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56978063|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978064|NCT02394496|Fulvestrant|fulvestrant|mesh-list
56978065|NCT02394496|Lapatinib|lapatinib|mesh-list
56978066|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56978067|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56978068|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978069|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56978070|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56978071|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
56978072|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978073|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978074|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56978075|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978076|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978077|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56978079|NCT02394418|Propofol|propofol|mesh-list
56978080|NCT02394418|Sevoflurane|sevoflurane|mesh-list
56978081|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56978082|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978083|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978084|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56978085|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
56978086|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
56978087|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56978088|NCT02394418|Analgesics|analgesics|mesh-ancestor
56978089|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
56978090|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978091|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56978092|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56978093|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56978094|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
56978095|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978096|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978097|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56978098|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56978099|NCT02693002|Norethindrone|norethindrone|mesh-list
56978100|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
56978101|NCT02693002|Estradiol|estradiol|mesh-list
56978102|NCT02693002|Estrogens|estrogens|mesh-ancestor
56978103|NCT02693002|Hormones|hormones|mesh-ancestor
56978104|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978105|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978106|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56978107|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
56978108|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56978109|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56978110|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56978111|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56978112|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56978113|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
56978114|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56978115|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56978116|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978117|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
56978118|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
56978119|NCT03707509|Gemcitabine|gemcitabine|mesh-list
56978120|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978121|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56978122|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
56978123|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978124|NCT03707509|Antiviral Agents|antiviral agents|mesh-ancestor
56978125|NCT03707509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978126|NCT03707509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978127|NCT03707509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56978128|NCT03707509|Immunologic Factors|immunologic factors|mesh-ancestor
56978129|NCT03707509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978130|NCT03710395|Nifedipine|nifedipine|mesh-list
56978131|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56978132|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56978133|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978134|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56978135|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978136|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
56978137|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
56978138|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56978139|NCT03093870|Capecitabine|capecitabine|mesh-list
56978140|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56978141|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
56978142|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978143|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978144|NCT05744908|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
56978145|NCT05744908|Anticoagulants|anticoagulants|mesh-ancestor
56978146|NCT02394106|Ofatumumab|ofatumumab|mesh-list
56978147|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978148|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
56978149|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56978150|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
56978151|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978152|NCT04793646|Expectorants|expectorants|mesh-ancestor
56978153|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
56978154|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56978155|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
56978156|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978157|NCT04793646|Protective Agents|protective agents|mesh-ancestor
56978158|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978159|NCT04793646|Antidotes|antidotes|mesh-ancestor
56978160|NCT03607890|Nivolumab|nivolumab|mesh-list
56978161|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56978162|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978163|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56978164|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978165|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
56978166|NCT02393482|Vitamin D|vitamin d|mesh-list
56978167|NCT02393482|Leuprolide|leuprolide|mesh-list
56978168|NCT02393482|Tibolone|tibolone|mesh-list
56978169|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
56978170|NCT02393482|Hormones|hormones|mesh-list
56978171|NCT02393482|Estradiol|estradiol|mesh-list
56978172|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56978173|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978174|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978175|NCT02393482|Estrogens|estrogens|mesh-ancestor
56978176|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56978177|NCT02393482|Antacids|antacids|mesh-ancestor
56978178|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978179|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56978180|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56978181|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
56978182|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56978183|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978184|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
56978185|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
56978186|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56978187|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56978188|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
56978189|NCT02393482|Vitamins|vitamins|mesh-ancestor
56978190|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
56978191|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56978192|NCT03528642|Temozolomide|temozolomide|mesh-list
56978193|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56978194|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
56978195|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978196|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978197|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
56978198|NCT03346057|Rocuronium|rocuronium|mesh-list
56978199|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
56978200|NCT03346057|Neostigmine|neostigmine|mesh-list
56978201|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56978202|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56978203|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56978204|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978205|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978206|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56978207|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978208|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978209|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
56978210|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978211|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56978212|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
56978213|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56978214|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56978215|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56978216|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56978217|NCT03166306|Bevacizumab|bevacizumab|mesh-list
56978218|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56660442|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
56978219|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978220|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56978221|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56978222|NCT03166306|Growth Substances|growth substances|mesh-ancestor
56978223|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978224|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
56978225|NCT02398630|Hormones|hormones|mesh-list
56978226|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978227|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978228|NCT02398552|Sunitinib|sunitinib|mesh-list
56978229|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978230|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56978231|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56978232|NCT02398552|Growth Substances|growth substances|mesh-ancestor
56978233|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978234|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
56978235|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56978236|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978237|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978238|NCT03345979|Aripiprazole|aripiprazole|mesh-list
56978239|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56978240|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
56978241|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
56978242|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56978243|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56978244|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56978245|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978246|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978247|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
56978248|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
56978249|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978250|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978251|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56978252|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56978253|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
56978254|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56978255|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56978256|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56978257|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56978258|NCT02696434|Naltrexone|naltrexone|mesh-list
56978259|NCT02696434|Buprenorphine|buprenorphine|mesh-list
56978260|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56978261|NCT02696434|Narcotics|narcotics|mesh-ancestor
56978262|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978263|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978264|NCT02696434|Analgesics|analgesics|mesh-ancestor
56978265|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
56978266|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978267|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56978268|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56978269|NCT03709147|Metformin|metformin|mesh-list
56978270|NCT03709147|Carboplatin|carboplatin|mesh-list
56978271|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
56978272|NCT03709147|Pemetrexed|pemetrexed|mesh-list
56978273|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978274|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56978275|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978276|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56978277|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978278|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978279|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56978280|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56978281|NCT02398474|Ropivacaine|ropivacaine|mesh-list
56978282|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
56978283|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
56978284|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978285|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978286|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
56978287|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978288|NCT03710317|Misoprostol|misoprostol|mesh-list
56978289|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
56978290|NCT03710317|Carbetocin|carbetocin|mesh-list
56978291|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56978292|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56978293|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978294|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
56978295|NCT03710317|Coagulants|coagulants|mesh-ancestor
56978296|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56978297|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
56978298|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56978299|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978300|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56978301|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56978302|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
56978303|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
56978304|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56978305|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56978306|NCT02392780|Prednisolone|prednisolone|mesh-list
56978307|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
56978308|NCT02392780|Cannabidiol|cannabidiol|mesh-list
56978309|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56978310|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
56978311|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56978312|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56978313|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
56978314|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
56978315|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978316|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978317|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56978318|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
56978319|NCT02392780|Hormones|hormones|mesh-ancestor
56978320|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978321|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56978322|NCT02392780|Protective Agents|protective agents|mesh-ancestor
56978323|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56978324|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978325|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
56978326|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978327|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978328|NCT04053478|Phenylephrine|phenylephrine|mesh-list
56978329|NCT04053478|Vasopressins|vasopressins|mesh-list
56978330|NCT04053478|Arginine Vasopressin|arginine vasopressin|mesh-list
56978331|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
56978332|NCT04053478|Norepinephrine|norepinephrine|mesh-list
56899185|NCT01192113|Vitamins|vitamins|mesh-ancestor
56978333|NCT04053478|Ephedrine|ephedrine|mesh-list
56978334|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56978335|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
56978336|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
56978337|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978338|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978339|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
56978340|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56978341|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
56978342|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
56978343|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56978344|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56978345|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56978346|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
56978347|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978348|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978349|NCT04053478|Protective Agents|protective agents|mesh-ancestor
56978350|NCT04053478|Hemostatics|hemostatics|mesh-ancestor
56978351|NCT04053478|Coagulants|coagulants|mesh-ancestor
56978352|NCT04053478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56978353|NCT04053478|Natriuretic Agents|natriuretic agents|mesh-ancestor
56978354|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56978355|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56978356|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56978357|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
56978358|NCT04468776|Zolpidem|zolpidem|mesh-list
56978359|NCT04468776|Trazodone|trazodone|mesh-list
56978360|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56978361|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56978362|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978363|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978364|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56978365|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
56978366|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
56978367|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978368|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978369|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56978370|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56978371|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56978372|NCT04468776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56978373|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56978374|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56978376|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56978377|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
56978378|NCT03593915|Azacitidine|azacitidine|mesh-list
56978379|NCT03593915|Decitabine|decitabine|mesh-list
56978380|NCT03593915|Alvocidib|alvocidib|mesh-list
56978381|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56978382|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
56978383|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978384|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978385|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978386|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
56978387|NCT03593915|Growth Substances|growth substances|mesh-ancestor
56978388|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978389|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56978390|NCT02392702|Ivacaftor|ivacaftor|mesh-list
56978391|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56978392|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56978393|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978394|NCT02392468|BI 409306|bi 409306|mesh-list
56978395|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56978396|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978397|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978398|NCT02397928|Carboplatin|carboplatin|mesh-list
56978399|NCT02397928|Pemetrexed|pemetrexed|mesh-list
56978400|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978401|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978402|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978403|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56978404|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56978405|NCT03734627|Acetaminophen|acetaminophen|mesh-list
56978406|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
56978407|NCT03734627|Octreotide|octreotide|mesh-list
56978408|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56978409|NCT03734627|Analgesics|analgesics|mesh-ancestor
56978410|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
56978411|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978412|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978413|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
56978414|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56978415|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56978416|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978417|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978418|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56978419|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56978420|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56978421|NCT02397772|Albendazole|albendazole|mesh-list
56978422|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
56978423|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56978424|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978425|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
56978426|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56978427|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56978428|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
56978429|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
56978430|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
56978431|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978432|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978433|NCT03592277|Vitamins|vitamins|mesh-list
56978434|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
56978435|NCT03592277|Thiamine|thiamine|mesh-list
56978436|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
56978437|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978438|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
56978439|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978440|NCT03592277|Protective Agents|protective agents|mesh-ancestor
56978441|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
56978442|NCT03106402|Bromfenac|bromfenac|mesh-list
56978443|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56660678|NCT02758925|Cytarabine|cytarabine|mesh-list
56978444|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56978445|NCT03106402|Analgesics|analgesics|mesh-ancestor
56978446|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
56978447|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978448|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978450|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56978451|NCT03734159|Ropivacaine|ropivacaine|mesh-list
56978452|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
56978453|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
56978454|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978455|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978456|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
56978457|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978458|NCT02397382|Midazolam|midazolam|mesh-list
56978459|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
56978460|NCT02397382|Caffeine|caffeine|mesh-list
56978461|NCT02397382|Omeprazole|omeprazole|mesh-list
56978462|NCT02397382|Warfarin|warfarin|mesh-list
56978463|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56978464|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56978465|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978466|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978467|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56978468|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56978469|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56978470|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56978471|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
56978472|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
56978473|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
56978474|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
56978475|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978476|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978477|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
56978478|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56978479|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56978480|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978481|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56978482|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56978483|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
56978484|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56978485|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56978486|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56978487|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
56978488|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
56978489|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56978490|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56978491|NCT02697916|Aspirin|aspirin|mesh-list
56978492|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56978493|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56978494|NCT02697916|Analgesics|analgesics|mesh-ancestor
56978495|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
56978496|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978497|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978498|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56978499|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56978500|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56978501|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56978502|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978503|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56978504|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56978505|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978506|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
56978507|NCT04762680|Vaccines|vaccines|mesh-list
56978508|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
56978509|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978510|NCT03650387|Lidocaine|lidocaine|mesh-list
56978511|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
56978512|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
56978513|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978514|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978515|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
56978516|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978517|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56978518|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56978519|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56978520|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56660740|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
56978521|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978522|NCT02392156|Factor VIII|factor viii|mesh-list
56978523|NCT02392156|Coagulants|coagulants|mesh-ancestor
56978524|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
56978525|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56978526|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56978527|NCT03359473|GSK2881078|gsk2881078|mesh-list
56978528|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
56978529|NCT03359473|Hormones|hormones|mesh-ancestor
56978530|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978531|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978532|NCT03632304|Anesthetics|anesthetics|mesh-list
56978533|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978534|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978535|NCT02397538|Amlodipine|amlodipine|mesh-list
56978536|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56978537|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56978538|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56978539|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56978540|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978541|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56978542|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978543|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
56978544|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56978545|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56978546|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
56978547|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56978548|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56978549|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978550|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
56978551|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56978552|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978553|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56978554|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56978555|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978556|NCT03359395|Alfentanil|alfentanil|mesh-list
56978557|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56978558|NCT03359395|Narcotics|narcotics|mesh-ancestor
56990945|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978559|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978560|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978561|NCT03359395|Analgesics|analgesics|mesh-ancestor
56978562|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
56978563|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978564|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56978565|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
56978566|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
56978567|NCT03733691|Lenalidomide|lenalidomide|mesh-list
56978568|NCT03733691|Ixazomib|ixazomib|mesh-list
56978569|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
56978570|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978571|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56978572|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56978573|NCT03733691|Growth Substances|growth substances|mesh-ancestor
56978574|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
56978575|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978576|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
56978577|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978578|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978579|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
56978580|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56978581|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
56978582|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978583|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978584|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56978585|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
56978586|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
56978587|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56978588|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
56978589|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978590|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978591|NCT05741632|Moxifloxacin|moxifloxacin|mesh-list
56978592|NCT05741632|Levofloxacin|levofloxacin|mesh-list
56978593|NCT05741632|Ofloxacin|ofloxacin|mesh-list
56978594|NCT05741632|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56978595|NCT05741632|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56978596|NCT05741632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56978597|NCT05741632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978598|NCT05741632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56978599|NCT05741632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56978600|NCT05741632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978601|NCT05741632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978602|NCT05741632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978603|NCT05741632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56978604|NCT05741632|Renal Agents|renal agents|mesh-ancestor
56978605|NCT05741632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56978606|NCT05741632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56978607|NCT03093402|Dronabinol|dronabinol|mesh-list
56978608|NCT03093402|Lenabasum|lenabasum|mesh-list
56978609|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56978610|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56978611|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978612|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978613|NCT03093402|Hormones|hormones|mesh-ancestor
56978614|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978615|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978616|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
56978617|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56978618|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56978619|NCT03093402|Analgesics|analgesics|mesh-ancestor
56978620|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
56978621|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978622|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
56978623|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978624|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
56978625|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
56978626|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
56978627|NCT03733379|Amoxicillin|amoxicillin|mesh-list
56978628|NCT03733379|Metronidazole|metronidazole|mesh-list
56978629|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56978630|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978631|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56978632|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56978633|NCT05733676|Calcium|calcium|mesh-list
56978634|NCT05733676|Fluorides|fluorides|mesh-list
56978635|NCT05733676|Caseins|caseins|mesh-list
56978636|NCT05733676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56978637|NCT05733676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978638|NCT05733676|Cariostatic Agents|cariostatic agents|mesh-ancestor
56978639|NCT05733676|Protective Agents|protective agents|mesh-ancestor
56978640|NCT05733676|Chelating Agents|chelating agents|mesh-ancestor
56978641|NCT05733676|Sequestering Agents|sequestering agents|mesh-ancestor
56978642|NCT05733676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978643|NCT03343639|Serlopitant|serlopitant|mesh-list
56978644|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56978645|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978646|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978647|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978648|NCT04479748|Dexamethasone|dexamethasone|mesh-list
56978649|NCT04479748|Prednisolone|prednisolone|mesh-list
56978650|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56978651|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
56978652|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56978653|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
56978654|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56978655|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
56978656|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56978657|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
56978658|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
56978659|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978660|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978661|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56978662|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
56978663|NCT04479748|Hormones|hormones|mesh-ancestor
56978664|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978665|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56978666|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978667|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56978668|NCT04479748|Protective Agents|protective agents|mesh-ancestor
56978669|NCT02690974|Valsartan|valsartan|mesh-list
56978670|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56978671|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56978672|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56978673|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56978674|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978675|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56978676|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
56978677|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56978678|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
56978679|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978680|NCT03584009|Venetoclax|venetoclax|mesh-list
56978681|NCT03584009|Fulvestrant|fulvestrant|mesh-list
56978682|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978683|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56978684|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56978685|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56978686|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
56978687|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978688|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978689|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
56978690|NCT03709927|Fosfomycin|fosfomycin|mesh-list
56978691|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56978692|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978693|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56978694|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56978695|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978696|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978697|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978698|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56978699|NCT03730181|Isoniazid|isoniazid|mesh-list
56978700|NCT03730181|Rifapentine|rifapentine|mesh-list
56978701|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
56978702|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56978703|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978704|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56978705|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56978706|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
56978707|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978708|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56978709|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56978710|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
56978711|NCT04167462|BMS-986165|bms-986165|mesh-list
56978712|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
56978713|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56978714|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978715|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978716|NCT04160520|Morphine|morphine|mesh-list
56978717|NCT04160520|Pramipexole|pramipexole|mesh-list
56978718|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56978719|NCT04160520|Narcotics|narcotics|mesh-ancestor
56978720|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978721|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978722|NCT04160520|Analgesics|analgesics|mesh-ancestor
56978723|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
56978724|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978725|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
56978726|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978727|NCT04160520|Protective Agents|protective agents|mesh-ancestor
56978728|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56978729|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56978730|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
56978731|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
56978732|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978733|NCT03583385|Metformin|metformin|mesh-list
56978734|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56978735|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978736|NCT05288335|Methamphetamine|methamphetamine|mesh-list
56978737|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56978738|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978739|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
56978740|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
56978741|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978742|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
56978743|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978744|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978745|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
56978746|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56978750|NCT04792801|Choline|choline|mesh-list
56978751|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
56978752|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56978753|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
56978754|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978755|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56978756|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56978757|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
56978758|NCT05420922|Lenvatinib|lenvatinib|mesh-list
56978759|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56978760|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978761|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56978762|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978763|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978764|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
56978765|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56978766|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978767|NCT03582215|Salicylates|salicylates|mesh-list
56978768|NCT03582215|Avobenzone|avobenzone|mesh-list
56978769|NCT03582215|Homosalate|homosalate|mesh-list
56978770|NCT03582215|Oxybenzone|oxybenzone|mesh-list
56978771|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
56978772|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
56978773|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
56978774|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56978775|NCT03582215|Protective Agents|protective agents|mesh-ancestor
56978776|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978777|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
56978778|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56978779|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56978780|NCT03582215|Analgesics|analgesics|mesh-ancestor
56978781|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
56978782|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978783|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56978784|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56978785|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56978786|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978787|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978788|NCT05175703|Paclitaxel|paclitaxel|mesh-list
56978789|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56978790|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978791|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
56978792|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
56978793|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
56978794|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978795|NCT04102800|Benralizumab|benralizumab|mesh-list
56978796|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56978797|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
56978798|NCT05175547|Clevidipine|clevidipine|mesh-list
56978799|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56978800|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56978801|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978802|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56978803|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978807|NCT03323346|Disulfiram|disulfiram|mesh-list
56978808|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56978809|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56978810|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978811|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978812|NCT05628571|Fluorides|fluorides|mesh-list
56978813|NCT05628571|Cariostatic Agents|cariostatic agents|mesh-ancestor
56978814|NCT05628571|Protective Agents|protective agents|mesh-ancestor
56978815|NCT05628571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978816|NCT05255016|Riboflavin|riboflavin|mesh-list
56978817|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
56978818|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
56978819|NCT05255016|Vitamins|vitamins|mesh-ancestor
56978820|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
56978821|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978822|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56978823|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
56978824|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56978825|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56978826|NCT05178888|Palbociclib|palbociclib|mesh-list
56978827|NCT05178888|Adagrasib|adagrasib|mesh-list
56978828|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978829|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56978830|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978831|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978832|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
56978833|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56978834|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978835|NCT03342001|Calcitonin|calcitonin|mesh-list
56978836|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
56978837|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56978838|NCT03342001|Katacalcin|katacalcin|mesh-list
56978839|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56978840|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978841|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56978842|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
56978843|NCT03579719|Itraconazole|itraconazole|mesh-list
56978844|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
56978845|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978846|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56978847|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56978848|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978849|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978850|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56978851|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
56978852|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978853|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978854|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56978855|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
56978856|NCT03631602|Clotrimazole|clotrimazole|mesh-list
56978857|NCT03631602|Miconazole|miconazole|mesh-list
56978858|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978859|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56978860|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56978861|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56978862|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978863|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978864|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56978865|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
56978866|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56978867|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978868|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56978869|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56978870|NCT02688088|Midazolam|midazolam|mesh-list
56978871|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
56978872|NCT02688088|Caffeine|caffeine|mesh-list
56978873|NCT02688088|Warfarin|warfarin|mesh-list
56978874|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56978875|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56978876|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978877|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978878|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56978879|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56978880|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56978881|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56978882|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
56978883|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
56978884|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
56978885|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
56978886|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978887|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978888|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
56978889|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56978890|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56978891|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978892|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56978893|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56978894|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
56978895|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
56978896|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
56978897|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56978898|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56978899|NCT03641651|Frovatriptan|frovatriptan|mesh-list
56978900|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56978901|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
56978902|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978903|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978904|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978905|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
56978906|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56978907|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978908|NCT05666219|Aminophylline|aminophylline|mesh-list
56978909|NCT05666219|Theophylline|theophylline|mesh-list
56978910|NCT05666219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56978911|NCT05666219|Autonomic Agents|autonomic agents|mesh-ancestor
56978912|NCT05666219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978913|NCT05666219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978914|NCT05666219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56978915|NCT05666219|Respiratory System Agents|respiratory system agents|mesh-ancestor
56978916|NCT05666219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56978917|NCT05666219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56978918|NCT05666219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978919|NCT05666219|Vasodilator Agents|vasodilator agents|mesh-ancestor
56978920|NCT05666219|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56978921|NCT05666219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56978922|NCT05666219|Purinergic Agents|purinergic agents|mesh-ancestor
56978923|NCT05666219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978924|NCT05666219|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56978925|NCT05666219|Protective Agents|protective agents|mesh-ancestor
56978926|NCT02949271|Fentanyl|fentanyl|mesh-list
56978927|NCT02949271|Ropivacaine|ropivacaine|mesh-list
56978928|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
56978929|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
56978930|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978931|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978932|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
56978933|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978934|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56978935|NCT02949271|Narcotics|narcotics|mesh-ancestor
56978936|NCT02949271|Analgesics|analgesics|mesh-ancestor
56978937|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56978938|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56978939|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
56978940|NCT03339583|Zopiclone|zopiclone|mesh-list
55729444|NCT02302547|Emtricitabine|emtricitabine|mesh-list
56978941|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56978942|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56978943|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978944|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
56978945|NCT03639779|Antidotes|antidotes|mesh-ancestor
56978946|NCT03639779|Protective Agents|protective agents|mesh-ancestor
56978947|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978948|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
56978949|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978950|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
56978951|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56978952|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978953|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
56978954|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
56978955|NCT05583721|Regadenoson|regadenoson|mesh-list
56978956|NCT05583721|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56978957|NCT05583721|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56978958|NCT05583721|Purinergic Agonists|purinergic agonists|mesh-ancestor
56978959|NCT05583721|Purinergic Agents|purinergic agents|mesh-ancestor
56978960|NCT05583721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56978961|NCT05583721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978962|NCT05583721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978963|NCT05682547|Lubricant Eye Drops|lubricant eye drops|mesh-list
56978964|NCT05682547|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56978965|NCT05682547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56978966|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
56978967|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56978968|NCT05173441|Antibodies|antibodies|mesh-list
56978969|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
56978970|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978971|NCT03708133|Nifurtimox|nifurtimox|mesh-list
56978973|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56978974|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56978975|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56978977|NCT05075161|Analgesics|analgesics|mesh-ancestor
56978978|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
56978979|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56978980|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56978981|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56978982|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56978983|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56978984|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56978985|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978986|NCT05518903|FAPI-46|fapi-46|mesh-list
56978987|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56978988|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978989|NCT05065957|Capecitabine|capecitabine|mesh-list
56978990|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56978991|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
56978992|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56978993|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56978994|NCT05095831|Pancrelipase|pancrelipase|mesh-list
56978995|NCT05095831|Pancreatin|pancreatin|mesh-list
56978996|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56978997|NCT03638869|Methadone|methadone|mesh-list
56978998|NCT03638869|D-methadone|d-methadone|mesh-list
56978999|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56979000|NCT03638869|Narcotics|narcotics|mesh-ancestor
56979001|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56979002|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979003|NCT03638869|Analgesics|analgesics|mesh-ancestor
56979004|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
56979005|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979006|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
56979007|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
56979008|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56979009|NCT03091920|Praliciguat|praliciguat|mesh-list
56979010|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56979011|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
56979012|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979013|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56979014|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
56979015|NCT03338569|Vitamins|vitamins|mesh-ancestor
56979016|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
56979017|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979018|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
56899861|NCT01566825|Amitriptyline|amitriptyline|mesh-list
56979019|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979020|NCT03338569|Protective Agents|protective agents|mesh-ancestor
56979021|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
56979022|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56979023|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979024|NCT05053633|Anesthetics|anesthetics|mesh-list
56979025|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56979026|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979029|NCT03337477|Insulin|insulin|mesh-list
56979030|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56979031|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56979032|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979033|NCT03707899|Amlodipine|amlodipine|mesh-list
56979034|NCT03707899|Telmisartan|telmisartan|mesh-list
56979035|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56979036|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56979037|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56979038|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56979039|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56979040|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979041|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56979042|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979043|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
56979044|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56979045|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56661270|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
56979046|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
56979047|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56979048|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56979050|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56979051|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56979052|NCT05490511|Cannabidiol|cannabidiol|mesh-list
56979053|NCT05490511|Tacrolimus|tacrolimus|mesh-list
56979054|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979055|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
56979056|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979057|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56979058|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979059|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979060|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
56979061|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
56979062|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56979063|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979064|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56979065|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56979066|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979067|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
56979068|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56979069|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56979070|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979071|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
56979072|NCT03706339|Coagulants|coagulants|mesh-ancestor
56979073|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56979074|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
56979075|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56979076|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56979077|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56979078|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56979079|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979080|NCT03639558|Promethazine|promethazine|mesh-list
56979081|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
56979082|NCT03639558|Haloperidol|haloperidol|mesh-list
56979083|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
56979084|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
56979085|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
56979086|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
56979087|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979088|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979089|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56979090|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56979091|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56979092|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56979093|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56979094|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56979095|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
56979096|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979097|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979098|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56979099|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
56979100|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
56979101|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56979102|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
56979103|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
56979104|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56979105|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56979106|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56979107|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
56979108|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
56979109|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
56979110|NCT05477485|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56979111|NCT05477485|Antiviral Agents|antiviral agents|mesh-ancestor
56979112|NCT05477485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979113|NCT01353508|Valsartan|valsartan|mesh-list
56979114|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56979115|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56979116|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56979117|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56979118|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979119|NCT01568268|Palonosetron|palonosetron|mesh-list
56979120|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
56661343|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56979121|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
56979127|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
56979128|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979129|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979130|NCT04911361|Dexamethasone|dexamethasone|mesh-list
56979131|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56979132|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
56979133|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
56979134|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979135|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979136|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56979137|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
56979138|NCT04911361|Hormones|hormones|mesh-ancestor
56979139|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979140|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56979141|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979142|NCT04475731|Ponatinib|ponatinib|mesh-list
56979143|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979144|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56979145|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979146|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979147|NCT03087786|Nicotine|nicotine|mesh-list
56979148|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56979149|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
56979150|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979151|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979152|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56979153|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56979154|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
56979155|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979156|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979157|NCT03635957|Folic Acid|folic acid|mesh-list
56979158|NCT03635957|Methotrexate|methotrexate|mesh-list
56979159|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56979160|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
56979161|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56979162|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979163|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56979164|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
56979165|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979166|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979167|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
56979168|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979169|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56979170|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979171|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
56979172|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729445|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
56979173|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56979174|NCT03635957|Hematinics|hematinics|mesh-ancestor
56979175|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
56979176|NCT03635957|Vitamins|vitamins|mesh-ancestor
56979177|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
56979185|NCT05005507|Tenofovir|tenofovir|mesh-list
56979186|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56979187|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
56979188|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979189|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56979190|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56979191|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979192|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979193|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56979194|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56979195|NCT04739358|Tepotinib|tepotinib|mesh-list
56979196|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979197|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56979198|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56979199|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979200|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
56979201|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
56979202|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
56979203|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979204|NCT05593666|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56979205|NCT05593666|Antifungal Agents|antifungal agents|mesh-ancestor
56979206|NCT05593666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979207|NCT05593666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56979208|NCT05593666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56979209|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
56979210|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56979211|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56979212|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
56979213|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979214|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979215|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979216|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
56979217|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
56979218|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979219|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
56979220|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56979221|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
56979222|NCT02684344|Tamsulosin|tamsulosin|mesh-list
56979223|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56979224|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56979225|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56979226|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
56979227|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979228|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979229|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979230|NCT02684344|Urological Agents|urological agents|mesh-ancestor
56979231|NCT05574400|Caffeine|caffeine|mesh-list
56979232|NCT05574400|Caffeine citrate|caffeine citrate|mesh-list
56979233|NCT05574400|Citric Acid|citric acid|mesh-list
56979234|NCT05574400|Sodium Citrate|sodium citrate|mesh-list
56979235|NCT05574400|Anticoagulants|anticoagulants|mesh-ancestor
56979236|NCT05574400|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56979237|NCT05574400|Chelating Agents|chelating agents|mesh-ancestor
56979238|NCT05574400|Sequestering Agents|sequestering agents|mesh-ancestor
56979239|NCT05574400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979240|NCT05574400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56979241|NCT05574400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979242|NCT05574400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56979243|NCT05574400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979244|NCT05574400|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56979245|NCT05574400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56979246|NCT05574400|Purinergic Agents|purinergic agents|mesh-ancestor
56979247|NCT05574400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979248|NCT05199571|Ofatumumab|ofatumumab|mesh-list
56979249|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979250|NCT03974100|Denosumab|denosumab|mesh-list
56979251|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56979252|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979253|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
56979254|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
56979255|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
56979256|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
56979257|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56979258|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979259|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56979260|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56979261|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56979262|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56979263|NCT05029999|Doxorubicin|doxorubicin|mesh-list
56979264|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56979265|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56979266|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979267|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56979268|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56979269|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979270|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979271|NCT04055818|Niacinamide|niacinamide|mesh-list
56979272|NCT04055818|Niacin|niacin|mesh-list
56979273|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
56979295|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56979296|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
56979297|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979298|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979299|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56979300|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56979301|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979302|NCT01374568|Incretins|incretins|mesh-ancestor
56979303|NCT01374568|Hormones|hormones|mesh-ancestor
56979304|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979305|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56979306|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
56979307|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979308|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979309|NCT02991456|Ondansetron|ondansetron|mesh-list
56979310|NCT02991456|Rolapitant|rolapitant|mesh-list
56979311|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
56979312|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
56979313|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979314|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979315|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56979316|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
56979317|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
56979318|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56979319|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
56979320|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979321|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979322|NCT02991456|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56979323|NCT02991456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56979324|NCT02991456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56979325|NCT02991456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56979326|NCT02991456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56979327|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56661566|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
56979364|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56979365|NCT01312363|Protective Agents|protective agents|mesh-ancestor
56979366|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
56979367|NCT01312441|Vitamin D|vitamin d|mesh-list
56979368|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56979369|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979370|NCT01312441|Vitamins|vitamins|mesh-ancestor
56979371|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
56979372|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56979373|NCT02682784|Oxytocin|oxytocin|mesh-list
56979374|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
56979375|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56979376|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979377|NCT02946463|Eculizumab|eculizumab|mesh-list
56979378|NCT02946463|Ravulizumab|ravulizumab|mesh-list
56979379|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56979380|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979381|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
56979382|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979383|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
56979384|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
56979385|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56979386|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
56979387|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979388|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
56979389|NCT03705949|Protective Agents|protective agents|mesh-ancestor
56979390|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56979391|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56979392|NCT03162562|Oregovomab|oregovomab|mesh-list
56979393|NCT03162562|Poly ICLC|poly iclc|mesh-list
56979394|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
56979395|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
56979396|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979397|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979398|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979399|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
56979400|NCT03164590|Ketamine|ketamine|mesh-list
56979401|NCT03164590|Bupivacaine|bupivacaine|mesh-list
56979402|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
56979403|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
56979404|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56979405|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979406|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
56979407|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979408|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56979409|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56979410|NCT03164590|Analgesics|analgesics|mesh-ancestor
56979411|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56979412|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56979413|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56979414|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
56979415|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979416|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979417|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56979418|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56979419|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
56979420|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56979421|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56979422|NCT05119075|Dopamine|dopamine|mesh-list
56979423|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
56979424|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56979425|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
56979426|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
56979430|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979431|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979432|NCT05119075|Protective Agents|protective agents|mesh-ancestor
56979433|NCT03387852|Fluticasone|fluticasone|mesh-list
56979434|NCT03387852|Xhance|xhance|mesh-list
56979435|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56979436|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56979437|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56979438|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56979439|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56979440|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
56979441|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979442|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979443|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56979444|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
56979445|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56979446|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56979447|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56979448|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56979449|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56979450|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
56979451|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979452|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979453|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
56979454|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
56979455|NCT03387852|Hormones|hormones|mesh-ancestor
56979456|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979457|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
56979458|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
56979459|NCT02679274|Testosterone|testosterone|mesh-list
56979460|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
56979461|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
56979462|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56979463|NCT02679274|Androgens|androgens|mesh-ancestor
56979464|NCT02679274|Hormones|hormones|mesh-ancestor
56979465|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979466|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979467|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56979468|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979469|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
56979470|NCT03141684|Bevacizumab|bevacizumab|mesh-list
56979471|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56979472|NCT03141684|Atezolizumab|atezolizumab|mesh-list
56979473|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
56979474|NCT03141684|Antibodies|antibodies|mesh-list
56979475|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
56979476|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56979477|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
56979478|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979479|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56979480|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56979481|NCT03141684|Growth Substances|growth substances|mesh-ancestor
56979482|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979483|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
56979484|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
56979488|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56979489|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56979490|NCT03620929|Estradiol|estradiol|mesh-list
56979491|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56979492|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
56979493|NCT03620929|Estrogens|estrogens|mesh-ancestor
56979494|NCT03620929|Hormones|hormones|mesh-ancestor
56979495|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979496|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979497|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56979498|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
56979499|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56979500|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56979501|NCT03620929|Progestins|progestins|mesh-ancestor
56979502|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
56979503|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979504|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979505|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56979506|NCT05308849|beta-Lactams|beta-lactams|mesh-list
56979507|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979508|NCT02678416|Acetaminophen|acetaminophen|mesh-list
56979509|NCT02678416|Morphine|morphine|mesh-list
56979510|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56979511|NCT02678416|Narcotics|narcotics|mesh-ancestor
56979512|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56979513|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979514|NCT02678416|Analgesics|analgesics|mesh-ancestor
56979515|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
56979516|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979517|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56979518|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
56979519|NCT03164668|Menthol|menthol|mesh-list
56979520|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
56979521|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
56979522|NCT03164512|Cannabidiol|cannabidiol|mesh-list
56979523|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
56979524|NCT02677922|Azacitidine|azacitidine|mesh-list
56979525|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56979526|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
56979527|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979528|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979529|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979530|NCT02680756|Ferric maltol|ferric maltol|mesh-list
56979531|NCT02680756|Hematinics|hematinics|mesh-ancestor
56979532|NCT03631836|Bevacizumab|bevacizumab|mesh-list
56979533|NCT03631836|Antibodies|antibodies|mesh-list
56979534|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56979535|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979536|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979537|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56979538|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56979539|NCT03631836|Growth Substances|growth substances|mesh-ancestor
56979540|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979541|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
56979542|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
56979543|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56979544|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56979545|NCT05431582|Bevacizumab|bevacizumab|mesh-list
56979546|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
56979547|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979548|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979549|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56979550|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56979551|NCT05431582|Growth Substances|growth substances|mesh-ancestor
56979552|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979553|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
56979554|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
56979555|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56979556|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
56979557|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979558|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979559|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56979560|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
56979561|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56979562|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56979563|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56979564|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
56979565|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979566|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979567|NCT05422066|Prednisone|prednisone|mesh-list
56979568|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
56979569|NCT05422066|Rituximab|rituximab|mesh-list
56979570|NCT05422066|Doxorubicin|doxorubicin|mesh-list
56979571|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56979572|NCT05422066|Vincristine|vincristine|mesh-list
56979573|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979574|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
56979575|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979576|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661795|NCT03454529|Simvastatin|simvastatin|mesh-list
56979577|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56979578|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
56979579|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979580|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979581|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56979582|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979583|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56979584|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56979585|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56979586|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979587|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56979588|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
56979590|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979591|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56979592|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56979593|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56979594|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56979595|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56979596|NCT03670706|Analgesics|analgesics|mesh-list
56979597|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
56979598|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979599|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979600|NCT03114280|Carboplatin|carboplatin|mesh-list
56979601|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979602|NCT03186638|Ibuprofen|ibuprofen|mesh-list
56979603|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56979604|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56979605|NCT03186638|Analgesics|analgesics|mesh-ancestor
56979606|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
56979607|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979608|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979609|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56979610|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56979611|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56979612|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979613|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979614|NCT03161678|Clopidogrel|clopidogrel|mesh-list
56979615|NCT03161678|Ticagrelor|ticagrelor|mesh-list
56979616|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56979617|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56979618|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56979619|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56979620|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
56979621|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979622|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979623|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979624|NCT05597280|Rifampin|rifampin|mesh-list
56979625|NCT05597280|Bedaquiline|bedaquiline|mesh-list
56979626|NCT05597280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56979627|NCT05597280|Antitubercular Agents|antitubercular agents|mesh-ancestor
56979628|NCT05597280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56979629|NCT05597280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979630|NCT05597280|Leprostatic Agents|leprostatic agents|mesh-ancestor
56979631|NCT05597280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56979632|NCT05597280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979633|NCT05597280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979634|NCT05597280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56979635|NCT05597280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56979636|NCT05597280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56979637|NCT05597280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56979638|NCT05597280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56979639|NCT05597280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56979640|NCT03674606|Aspirin|aspirin|mesh-list
56979641|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56979642|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56979643|NCT03674606|Analgesics|analgesics|mesh-ancestor
56979644|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
56979645|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979646|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979647|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56979648|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56979649|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56979650|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56979651|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979652|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56979653|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56979654|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979655|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
56979656|NCT02677324|Venetoclax|venetoclax|mesh-list
56979657|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979658|NCT03108846|Citalopram|citalopram|mesh-list
56979659|NCT03108846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56979660|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56979661|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56979662|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979663|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979664|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
56979665|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979666|NCT03108846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56979667|NCT03108846|Antidepressive Agents|antidepressive agents|mesh-ancestor
56979668|NCT03108846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56979669|NCT03163966|Methotrexate|methotrexate|mesh-list
56979670|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56979671|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
56979672|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56979673|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979674|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56979675|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
56979676|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979677|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979678|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
56979679|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979680|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56979681|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979682|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
56979683|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56979684|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56979685|NCT03678116|Caffeine|caffeine|mesh-list
56979686|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56979687|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979688|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56979689|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979690|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979691|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56979692|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56979693|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
56979694|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979695|NCT03678038|Triamcinolone|triamcinolone|mesh-list
56979696|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56979697|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56979698|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56979699|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56979700|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
56979701|NCT03678038|Hormones|hormones|mesh-ancestor
56979702|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979703|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979704|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979705|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
56979706|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979707|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979708|NCT03163420|Diclofenac|diclofenac|mesh-list
56979709|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56979710|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56979711|NCT03163420|Analgesics|analgesics|mesh-ancestor
56979712|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
56979713|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979714|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979715|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56979716|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56979717|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56979718|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979719|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979720|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
56979721|NCT04440436|Fludarabine|fludarabine|mesh-list
56979722|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979723|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
56979724|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979726|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56979727|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
56979728|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979729|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979730|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56979731|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56979732|NCT05405686|Hormones|hormones|mesh-ancestor
56979733|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979734|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979735|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56979736|NCT04711122|Cephalosporins|cephalosporins|mesh-list
56979737|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979738|NCT05272696|Paclitaxel|paclitaxel|mesh-list
56979739|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
56979740|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56979741|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979742|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
56979743|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
56979744|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
56979745|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979746|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979747|NCT05563116|Calcium|calcium|mesh-list
56979748|NCT05563116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56979749|NCT05563116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979750|NCT03520946|Ramucirumab|ramucirumab|mesh-list
56979751|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979752|NCT03709758|Cytarabine|cytarabine|mesh-list
56979753|NCT03709758|Daunorubicin|daunorubicin|mesh-list
56979754|NCT03709758|Venetoclax|venetoclax|mesh-list
56979755|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56979756|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
56979757|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979758|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979759|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
56979760|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979761|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979762|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
56979763|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979764|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56979765|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56979766|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56979767|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979768|NCT03674060|Sorafenib|sorafenib|mesh-list
56979769|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979770|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56979771|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979772|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979773|NCT02849496|Atezolizumab|atezolizumab|mesh-list
56979774|NCT02849496|Olaparib|olaparib|mesh-list
56979775|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56979776|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56979777|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979778|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979779|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979780|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
56979781|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979782|NCT03163576|Niacin|niacin|mesh-list
56979783|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56979784|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
56979785|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979786|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56979787|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
56979788|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
56979789|NCT03163576|Vitamins|vitamins|mesh-ancestor
56979790|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
56979791|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979792|NCT03032172|Risdiplam|risdiplam|mesh-list
56979793|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56979794|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979795|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979796|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
56979797|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56979798|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979799|NCT01104350|Gemcitabine|gemcitabine|mesh-list
56979800|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56979801|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
56979802|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979803|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979804|NCT01104350|Antiviral Agents|antiviral agents|mesh-ancestor
56979805|NCT01104350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979806|NCT01104350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979807|NCT01104350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979808|NCT01104350|Immunologic Factors|immunologic factors|mesh-ancestor
56979809|NCT01104350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979810|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
56979811|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979812|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979813|NCT03673280|Morphine|morphine|mesh-list
56979814|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56979815|NCT03673280|Narcotics|narcotics|mesh-ancestor
56979816|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56979817|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979818|NCT03673280|Analgesics|analgesics|mesh-ancestor
56979819|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
56979820|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979821|NCT05420220|Axitinib|axitinib|mesh-list
56979822|NCT05420220|Antibodies|antibodies|mesh-list
56979823|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
56979824|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979825|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979826|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56979827|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979828|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979829|NCT05383560|Vaccines|vaccines|mesh-list
56979830|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
56979831|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979832|NCT01382004|Azithromycin|azithromycin|mesh-list
56979833|NCT01382004|Penicillins|penicillins|mesh-list
56979834|NCT01382004|Penicillin G|penicillin g|mesh-list
56979835|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56979836|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
56979837|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56979838|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979839|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
56979840|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56979841|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56979842|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979843|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
56979844|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
56979845|NCT01381848|Doripenem|doripenem|mesh-list
56979846|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56979847|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979848|NCT04546620|Prednisolone|prednisolone|mesh-list
56900614|NCT02815540|Cannabidiol|cannabidiol|mesh-list
56979849|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56979850|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
56979851|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56979852|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
56979853|NCT04546620|Prednisone|prednisone|mesh-list
56979854|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
56979855|NCT04546620|Rituximab|rituximab|mesh-list
56979856|NCT04546620|Doxorubicin|doxorubicin|mesh-list
56979857|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56979858|NCT04546620|Vincristine|vincristine|mesh-list
56979859|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
56979860|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56979861|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
56979862|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979863|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
56979864|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979865|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56979866|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56979867|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
56979868|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979869|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979870|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56979871|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979872|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56662088|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56979873|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56979874|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56979875|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979876|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56979877|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
56979878|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
56979879|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
56979880|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56979881|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
56979882|NCT04546620|Hormones|hormones|mesh-ancestor
56979883|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979884|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56979885|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
56979886|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
56979887|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979888|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56979889|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56979890|NCT04546620|Protective Agents|protective agents|mesh-ancestor
56979891|NCT04058210|Ivacaftor|ivacaftor|mesh-list
56979892|NCT04058210|Elexacaftor|elexacaftor|mesh-list
56979893|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56979894|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56979895|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979896|NCT02250300|Ixazomib|ixazomib|mesh-list
56979897|NCT02250300|Glycine|glycine|mesh-list
56979898|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979899|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
56979900|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979901|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979902|NCT02250300|Glycine Agents|glycine agents|mesh-ancestor
56979903|NCT02250300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979904|NCT02250300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979905|NCT03020966|Acetaminophen|acetaminophen|mesh-list
56979906|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56979907|NCT03020966|Analgesics|analgesics|mesh-ancestor
56979908|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
56979909|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979910|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979911|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
56979912|NCT04051268|Vaccines|vaccines|mesh-list
56979913|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
56979914|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979915|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
56979916|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56979917|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56979918|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979919|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
56979920|NCT04595786|Coagulants|coagulants|mesh-ancestor
56979921|NCT02108652|Atezolizumab|atezolizumab|mesh-list
56979922|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979923|NCT01381614|Bevacizumab|bevacizumab|mesh-list
56900690|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
56979924|NCT01381614|Sunitinib|sunitinib|mesh-list
56979925|NCT01381614|Sorafenib|sorafenib|mesh-list
56979926|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56979927|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979928|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56979929|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56979930|NCT01381614|Growth Substances|growth substances|mesh-ancestor
56979931|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979932|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
56979933|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56979934|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979935|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979936|NCT01381536|Belimumab|belimumab|mesh-list
56979937|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56979938|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
56979939|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979940|NCT01950390|Bevacizumab|bevacizumab|mesh-list
56979941|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56979942|NCT01950390|Ipilimumab|ipilimumab|mesh-list
56979943|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
56979944|NCT01950390|Antibodies|antibodies|mesh-list
56979945|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
56979946|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56979947|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
56979948|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979949|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56979950|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56979951|NCT01950390|Growth Substances|growth substances|mesh-ancestor
56979952|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662177|NCT00990847|Procaterol|procaterol|mesh-list
56979953|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
56979954|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
56979955|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56979956|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979957|NCT03162406|Vitamin D|vitamin d|mesh-list
56979958|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
56979959|NCT03162406|Vitamins|vitamins|mesh-ancestor
56979960|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
56979961|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979962|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56979963|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56979964|NCT02946385|Vaccines|vaccines|mesh-list
56979965|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
56979966|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979967|NCT02694718|Capecitabine|capecitabine|mesh-list
56979968|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
56979969|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56979970|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
56979971|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979972|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979973|NCT05681299|Liraglutide|liraglutide|mesh-list
56979974|NCT05681299|Hormones|hormones|mesh-list
56979975|NCT05681299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56979976|NCT05681299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979977|NCT05681299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56979978|NCT05681299|Incretins|incretins|mesh-ancestor
56979979|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56979980|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56979981|NCT04908787|Paclitaxel|paclitaxel|mesh-list
56979982|NCT04908787|Doxorubicin|doxorubicin|mesh-list
56979983|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56979984|NCT04908787|Topotecan|topotecan|mesh-list
56979985|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56979986|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979987|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
56979988|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
56979989|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
56979990|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979991|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56979992|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56979993|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56979994|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979995|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56979996|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
56979997|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56979998|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
56979999|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56980000|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
56980001|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980002|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980003|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
56980004|NCT05681221|Calcium|calcium|mesh-list
56980005|NCT05681221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56980006|NCT05681221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980007|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
56980008|NCT04303507|Chloroquine|chloroquine|mesh-list
56980009|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
56980010|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56980011|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56980012|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980013|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980014|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980015|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980016|NCT04303507|Amebicides|amebicides|mesh-ancestor
56980017|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
56980018|NCT03202537|Lansoprazole|lansoprazole|mesh-list
56980019|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56980020|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56980021|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56980022|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980023|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980024|NCT03179761|Vaccines|vaccines|mesh-list
56980025|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
56980026|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980027|NCT01772472|Trastuzumab|trastuzumab|mesh-list
56980028|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56980029|NCT01772472|Maytansine|maytansine|mesh-list
56980030|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980031|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980032|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56980033|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56980034|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56980035|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56980036|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980037|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56980038|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980039|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980040|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980042|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
56980043|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56980044|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56980045|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980046|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
56980047|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980048|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980049|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56980050|NCT04788667|Analgesics|analgesics|mesh-ancestor
56980051|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
56980052|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980053|NCT04138615|Morphine|morphine|mesh-list
56980054|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56980055|NCT04138615|Narcotics|narcotics|mesh-ancestor
56980056|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980057|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980058|NCT04138615|Analgesics|analgesics|mesh-ancestor
56980059|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
56980060|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980061|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
56980062|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56980063|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980064|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
56980065|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56980066|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980067|NCT03018938|Insulin|insulin|mesh-list
56980068|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56980069|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980070|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980071|NCT04776499|Perphenazine|perphenazine|mesh-list
56980072|NCT04776499|Riociguat|riociguat|mesh-list
56980073|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
56980074|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
56900884|NCT02048020|Paclitaxel|paclitaxel|mesh-list
56980075|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980076|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56980077|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56980078|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980079|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980080|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56980081|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56980082|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
56980083|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980084|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
56980085|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
56980086|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
56980087|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56980088|NCT03668054|Bevacizumab|bevacizumab|mesh-list
56980089|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980090|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980091|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56980092|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56980093|NCT03668054|Growth Substances|growth substances|mesh-ancestor
56980094|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980095|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
56980096|NCT04698187|Nivolumab|nivolumab|mesh-list
56980097|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980098|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980099|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56980100|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980101|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
56980102|NCT03623048|Propolis|propolis|mesh-list
56980103|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56980104|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980105|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
56980106|NCT03016598|Oxytocin|oxytocin|mesh-list
56980107|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
56980108|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56980109|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980110|NCT04857931|Colchicine|colchicine|mesh-list
56980111|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
56980112|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980113|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
56980114|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
56980115|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
56980116|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980117|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980118|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56980119|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56980120|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56980121|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
56980122|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980123|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980124|NCT03017846|Cantharidin|cantharidin|mesh-list
56980125|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980126|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980127|NCT03638401|Morphine|morphine|mesh-list
56980128|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56980129|NCT03638401|Narcotics|narcotics|mesh-ancestor
56980130|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980131|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980132|NCT03638401|Analgesics|analgesics|mesh-ancestor
56980133|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
56980134|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980135|NCT03666650|Edoxaban|edoxaban|mesh-list
56980136|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56980137|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
56980138|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56980139|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
56980140|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980141|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980142|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
56980143|NCT04672291|Poly I-C|poly i-c|mesh-list
56980144|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56980145|NCT04672291|Poly ICLC|poly iclc|mesh-list
56980146|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
56980147|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
56980148|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980149|NCT04672291|Laxatives|laxatives|mesh-ancestor
56980150|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56980151|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
56980152|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980153|NCT02942485|Metronidazole|metronidazole|mesh-list
56980154|NCT02942485|Tinidazole|tinidazole|mesh-list
56980155|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980156|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56980157|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56980158|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56980159|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
56980160|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980161|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56980162|NCT03666494|Fentanyl|fentanyl|mesh-list
56980163|NCT03666494|Ketamine|ketamine|mesh-list
56980164|NCT03666494|Propofol|propofol|mesh-list
56980165|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56980166|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980167|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980168|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56980169|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
56980170|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
56980171|NCT03666494|Analgesics|analgesics|mesh-ancestor
56980172|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
56980173|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980174|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56980175|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56980176|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56980177|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980178|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980179|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56980180|NCT03666494|Narcotics|narcotics|mesh-ancestor
56980181|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56980182|NCT03666884|Cyclosporine|cyclosporine|mesh-list
56980183|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56980184|NCT03666884|Cyclosporins|cyclosporins|mesh-list
56980185|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56980186|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980187|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980188|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56980189|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
56980190|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980191|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
56980192|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980193|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
56980194|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980195|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56980196|NCT02942407|Warfarin|warfarin|mesh-list
56980197|NCT02942407|Apixaban|apixaban|mesh-list
56980198|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
56980199|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56980200|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
56980201|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56980202|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
56980203|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980204|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980205|NCT02921035|Interferons|interferons|mesh-list
56980206|NCT02921035|Interferon-beta|interferon-beta|mesh-list
56980207|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
56980208|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980209|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
56980210|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980211|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
56980212|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980213|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56980214|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56980215|NCT03006848|Avelumab|avelumab|mesh-list
56980216|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980217|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980218|NCT03667352|Fentanyl|fentanyl|mesh-list
56980219|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56980220|NCT03667352|Narcotics|narcotics|mesh-ancestor
56980221|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980222|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980223|NCT03667352|Analgesics|analgesics|mesh-ancestor
56980224|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
56980225|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980226|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56980227|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56900985|NCT02050672|Inositol|inositol|mesh-list
56980228|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
56980229|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
56980230|NCT03320941|Licogliflozin|licogliflozin|mesh-list
56980231|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56980232|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980233|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980234|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980235|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
56980236|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56980237|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980238|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980239|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980240|NCT03557281|GSK656|gsk656|mesh-list
56980241|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56980242|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980243|NCT02573233|Fluticasone|fluticasone|mesh-list
56980244|NCT02573233|Xhance|xhance|mesh-list
56980245|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
56980246|NCT02573233|Budesonide|budesonide|mesh-list
56980247|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
56980248|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56980249|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56980250|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56980251|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
56980252|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980253|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980254|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56980255|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
56980256|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
56980257|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56980258|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
56980259|NCT02573233|Hormones|hormones|mesh-ancestor
56980260|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56980261|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56980262|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56980263|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56980264|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
56980265|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980266|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980267|NCT03867487|Empagliflozin|empagliflozin|mesh-list
56980268|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56980269|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980270|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980271|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980272|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
56980273|NCT01569048|Remifentanil|remifentanil|mesh-list
56980274|NCT01569048|Propofol|propofol|mesh-list
56980275|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56980276|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980277|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980278|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56980279|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
56980280|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
56980281|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56980282|NCT01569048|Analgesics|analgesics|mesh-ancestor
56980283|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
56980284|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980285|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56980286|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56980287|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56980288|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56980289|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980290|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980291|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56980292|NCT01569048|Narcotics|narcotics|mesh-ancestor
56980293|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56980294|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
56980295|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56980296|NCT01380912|Prednisolone|prednisolone|mesh-list
56980297|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
56980298|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56980299|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
56980300|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56980301|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
56980302|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
56980303|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980304|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980305|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56980306|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
56980307|NCT01380912|Hormones|hormones|mesh-ancestor
56980308|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56980309|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56980310|NCT01380912|Protective Agents|protective agents|mesh-ancestor
56980311|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56980312|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980313|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56980314|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56980315|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56980316|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56980317|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980318|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980319|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980320|NCT03315793|Analgesics|analgesics|mesh-ancestor
56980321|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
56980322|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980323|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
56980324|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56980325|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
56980326|NCT01569204|Dexamethasone|dexamethasone|mesh-list
56980327|NCT01569204|Prednisone|prednisone|mesh-list
56980328|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
56980329|NCT01569204|Dacarbazine|dacarbazine|mesh-list
56980330|NCT01569204|Doxorubicin|doxorubicin|mesh-list
56980331|NCT01569204|Etoposide|etoposide|mesh-list
56980332|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56980333|NCT01569204|Procarbazine|procarbazine|mesh-list
56980334|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56980335|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
56980336|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980337|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980338|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56980339|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
56980340|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980341|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980342|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56980343|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56980344|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
56980345|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
56980346|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980347|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56980348|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
56980349|NCT01569204|Hormones|hormones|mesh-ancestor
56980350|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56980351|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56980352|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56980353|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56980354|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56980355|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980356|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56980357|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980358|NCT02676466|Losartan|losartan|mesh-list
56980359|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56980360|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56980361|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56980362|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56980363|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980364|NCT04439890|Carboplatin|carboplatin|mesh-list
56980365|NCT04439890|Pemetrexed|pemetrexed|mesh-list
56980366|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980367|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980368|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980369|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56980370|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56980371|NCT03635892|Nivolumab|nivolumab|mesh-list
56980372|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980373|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980374|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55729519|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
56980375|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980376|NCT02324725|Naltrexone|naltrexone|mesh-list
56980377|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56980378|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56980379|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980380|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
56980381|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980382|NCT01380678|Bevacizumab|bevacizumab|mesh-list
56980383|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56980384|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
56980385|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56980386|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980387|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980388|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56980389|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56980390|NCT01380678|Growth Substances|growth substances|mesh-ancestor
56980391|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980392|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
56980393|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
56980394|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980395|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980396|NCT01380600|Molgramostim|molgramostim|mesh-list
56980397|NCT01380600|Sargramostim|sargramostim|mesh-list
56980398|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
56980399|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980400|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980401|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
56980402|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
56980403|NCT03264118|Coagulants|coagulants|mesh-ancestor
56980404|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
56980405|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980406|NCT05675800|Psilocybin|psilocybin|mesh-list
56980407|NCT05675800|Hallucinogens|hallucinogens|mesh-ancestor
56980408|NCT05675800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980409|NCT05675800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56980411|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56980412|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56980413|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
56980414|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980415|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56980416|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56980417|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980418|NCT05675644|Drospirenone|drospirenone|mesh-list
56980419|NCT05675644|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56980420|NCT05675644|Hormone Antagonists|hormone antagonists|mesh-ancestor
56980421|NCT05675644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56980422|NCT05675644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980423|NCT05675644|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56980424|NCT05675644|Diuretics|diuretics|mesh-ancestor
56980425|NCT05675644|Natriuretic Agents|natriuretic agents|mesh-ancestor
56980426|NCT05010772|Decitabine|decitabine|mesh-list
56980427|NCT05010772|Venetoclax|venetoclax|mesh-list
56980428|NCT05010772|Ivosidenib|ivosidenib|mesh-list
56980429|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56980430|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
56980431|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980432|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980433|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980434|NCT02579044|Everolimus|everolimus|mesh-list
56980435|NCT02579044|Lonafarnib|lonafarnib|mesh-list
56980436|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980437|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56980438|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
56980439|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980440|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980441|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980442|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
56980443|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56980444|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56980445|NCT02464696|Prednisolone|prednisolone|mesh-list
56980446|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
56980447|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56980448|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
56980449|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56980450|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
56980451|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
56901210|NCT01303107|Bupivacaine|bupivacaine|mesh-list
56980452|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980453|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980454|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56980455|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
56980456|NCT02464696|Hormones|hormones|mesh-ancestor
56980457|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56980458|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56980459|NCT02464696|Protective Agents|protective agents|mesh-ancestor
56980460|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56980461|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980462|NCT04503694|Nivolumab|nivolumab|mesh-list
56980463|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980464|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980465|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56980466|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980467|NCT03525379|Resveratrol|resveratrol|mesh-list
56980468|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
56980469|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980470|NCT03525379|Protective Agents|protective agents|mesh-ancestor
56980471|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980472|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980473|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56980474|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56980475|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56980476|NCT03476551|Diuretics|diuretics|mesh-ancestor
56980477|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
56980478|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980479|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56980480|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56980481|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980482|NCT04702789|Timolol|timolol|mesh-list
56980483|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56980484|NCT04702789|Dorzolamide|dorzolamide|mesh-list
56980485|NCT04702789|Latanoprost|latanoprost|mesh-list
56980486|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56980487|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56980488|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
56980489|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980490|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980491|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980492|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56980493|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56980494|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56980495|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56980496|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56980497|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56980498|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56980499|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56980500|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980501|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56980502|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56980503|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980504|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980505|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980506|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
56980507|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980508|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980509|NCT01380522|Metronidazole|metronidazole|mesh-list
56980510|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980511|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56980512|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56980513|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56980514|NCT03469284|Methylene Blue|methylene blue|mesh-list
56980515|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980516|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980518|NCT02913326|Dabigatran|dabigatran|mesh-list
56980519|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
56980520|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
56980521|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56980522|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
56980523|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980524|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980525|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56980526|NCT03725891|Aspirin|aspirin|mesh-list
56980527|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56980528|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56980529|NCT03725891|Analgesics|analgesics|mesh-ancestor
56980530|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
56980531|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980532|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980533|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56980534|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980535|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56980536|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56980537|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980538|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56980539|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56980540|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980541|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
56980542|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
56980543|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
56980544|NCT03751163|Hydroquinone|hydroquinone|mesh-list
56980545|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56980546|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56980547|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980548|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
56980549|NCT03751163|Coagulants|coagulants|mesh-ancestor
56980550|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56980551|NCT03751163|Protective Agents|protective agents|mesh-ancestor
56980552|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980553|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
56980554|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
56980555|NCT03639545|Metformin|metformin|mesh-list
56980556|NCT03639545|Empagliflozin|empagliflozin|mesh-list
56980558|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980559|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56980560|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980561|NCT03181386|Warfarin|warfarin|mesh-list
56980562|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
56980563|NCT03181386|Dabigatran|dabigatran|mesh-list
56980564|NCT03181386|Apixaban|apixaban|mesh-list
56980565|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
56980566|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56980567|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
56980568|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56980569|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
56980570|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980571|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980572|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
56980573|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56980574|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
56980575|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56980576|NCT03639467|Gemcitabine|gemcitabine|mesh-list
56980577|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980578|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56980579|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
56980580|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980581|NCT03639467|Antiviral Agents|antiviral agents|mesh-ancestor
56980582|NCT03639467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980583|NCT03639467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980584|NCT03639467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56980585|NCT03639467|Immunologic Factors|immunologic factors|mesh-ancestor
56980586|NCT03639467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980587|NCT01382706|Docetaxel|docetaxel|mesh-list
56980588|NCT01382706|Lapatinib|lapatinib|mesh-list
56980589|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980590|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
56980591|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
56980592|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
56980593|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980594|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56980595|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980596|NCT03665402|Isoniazid|isoniazid|mesh-list
56980597|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
56980598|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56980599|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980600|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56980601|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56980602|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
56980603|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980604|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56980605|NCT01380288|Rivastigmine|rivastigmine|mesh-list
56980606|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56980607|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980608|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980609|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
56980610|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980611|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980612|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56980613|NCT01380288|Protective Agents|protective agents|mesh-ancestor
56980614|NCT03110484|Pemetrexed|pemetrexed|mesh-list
56980615|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56980616|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980617|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980618|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980619|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56980620|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56980621|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56980622|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
56980623|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980624|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980625|NCT00002874|Bicalutamide|bicalutamide|mesh-list
56980626|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
56980627|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
56980628|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56980629|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980630|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980631|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56980632|NCT03001076|Ezetimibe|ezetimibe|mesh-list
56980633|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56980634|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56980635|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
56980636|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980637|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56980638|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980639|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980640|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980641|NCT03555305|Insulin|insulin|mesh-list
56980642|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56980643|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
56980644|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980645|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980646|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56980647|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980648|NCT05422716|Baclofen|baclofen|mesh-list
56980649|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56980650|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980651|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56980652|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980653|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56980654|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
56980655|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
56980656|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980657|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980658|NCT03728777|Resveratrol|resveratrol|mesh-list
56980659|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
56980660|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980661|NCT03728777|Protective Agents|protective agents|mesh-ancestor
56980662|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980663|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980664|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56980665|NCT05421936|Osimertinib|osimertinib|mesh-list
56980666|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980667|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56980668|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980669|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980670|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56980671|NCT01382472|Simvastatin|simvastatin|mesh-list
56980672|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56980673|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56980674|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
56901438|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
56980675|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980676|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56980677|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56980678|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980679|NCT03725423|Apatinib|apatinib|mesh-list
56980680|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980681|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56980682|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980683|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980684|NCT03521141|Nicotine|nicotine|mesh-list
56980685|NCT03521141|Varenicline|varenicline|mesh-list
56980686|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56980687|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
56980688|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980689|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980690|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56980691|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56980692|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
56980693|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980694|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980695|NCT03725267|Melatonin|melatonin|mesh-list
56980696|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
56980697|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980698|NCT03725267|Protective Agents|protective agents|mesh-ancestor
56980699|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980700|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980701|NCT02997176|Talazoparib|talazoparib|mesh-list
56980702|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56980703|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980704|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980705|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980706|NCT03000452|Durvalumab|durvalumab|mesh-list
56980707|NCT03000452|Daratumumab|daratumumab|mesh-list
56980708|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980709|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980710|NCT03664388|Clopidogrel|clopidogrel|mesh-list
56980711|NCT03664388|Ticagrelor|ticagrelor|mesh-list
56980712|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56980713|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56980714|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56980715|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56980716|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
56980717|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980718|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980719|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980720|NCT01373164|Gemcitabine|gemcitabine|mesh-list
56980721|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56980722|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
56980723|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980724|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980725|NCT01373164|Antiviral Agents|antiviral agents|mesh-ancestor
56980726|NCT01373164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980727|NCT01373164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980728|NCT01373164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56980729|NCT01373164|Immunologic Factors|immunologic factors|mesh-ancestor
56980730|NCT01373164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980731|NCT02999984|Busulfan|busulfan|mesh-list
56980732|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
56980733|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980734|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56980735|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
56980736|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980737|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56980738|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980739|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56980740|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56980741|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
56980742|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980743|NCT03312907|Rituximab|rituximab|mesh-list
56980744|NCT03312907|Belimumab|belimumab|mesh-list
56980745|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56980746|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980747|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980748|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
56980749|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980750|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980751|NCT02999672|Trastuzumab|trastuzumab|mesh-list
56980752|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56980753|NCT02999672|Maytansine|maytansine|mesh-list
56980754|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980755|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980756|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56980757|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
56980758|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
56980759|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
56980760|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980761|NCT03664622|Ketamine|ketamine|mesh-list
56980762|NCT03664622|Morphine|morphine|mesh-list
56980763|NCT03664622|Analgesics|analgesics|mesh-ancestor
56980764|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
56980765|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980766|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980767|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56980768|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56980769|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
56980770|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
56980771|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980772|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56980773|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56980774|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980775|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980776|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56980777|NCT03664622|Narcotics|narcotics|mesh-ancestor
56980778|NCT04303858|Atezolizumab|atezolizumab|mesh-list
56980779|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980780|NCT04056182|Lofexidine|lofexidine|mesh-list
56980781|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56980782|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56980783|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980784|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
56980785|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980786|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56980787|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56980788|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56980789|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
56980790|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980791|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980792|NCT03573323|Ixekizumab|ixekizumab|mesh-list
56980793|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
56980794|NCT04058054|Histamine|histamine|mesh-list
56980795|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
56980796|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
56980797|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980798|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980799|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980800|NCT04498286|Antibodies|antibodies|mesh-list
56980801|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
56980802|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980803|NCT01069172|Dipivefrin|dipivefrin|mesh-list
56980804|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56980805|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
56980806|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980807|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980808|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980809|NCT04245280|Ropivacaine|ropivacaine|mesh-list
56980810|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56980811|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
56980812|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
56980813|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980814|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980815|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
56980816|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56980817|NCT03724955|Estradiol|estradiol|mesh-list
56980818|NCT03724955|Estrogens|estrogens|mesh-ancestor
56980819|NCT03724955|Hormones|hormones|mesh-ancestor
56980820|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56980821|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980822|NCT04220008|Gemcitabine|gemcitabine|mesh-list
56980823|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
56980824|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
56980825|NCT04220008|Busulfan|busulfan|mesh-list
56980826|NCT04220008|Rituximab|rituximab|mesh-list
56980827|NCT04220008|Vorinostat|vorinostat|mesh-list
56980828|NCT04220008|Clofarabine|clofarabine|mesh-list
56980829|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56980830|NCT04220008|Tacrolimus|tacrolimus|mesh-list
56980831|NCT04220008|Antibodies|antibodies|mesh-list
56980832|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
56980833|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56980834|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56980835|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
56980836|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980837|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980838|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56980839|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
56980840|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980841|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980842|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56980843|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56980844|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
56980845|NCT04220008|Antiviral Agents|antiviral agents|mesh-ancestor
56980846|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980847|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980848|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56980849|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56980850|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56980851|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
56980852|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56980853|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56980854|NCT03721991|Butyric Acid|butyric acid|mesh-list
56980855|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663069|NCT00686322|Cisplatin|cisplatin|mesh-list
56980856|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980857|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980858|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
56980859|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
56980860|NCT02911688|Vitamin E|vitamin e|mesh-list
56980861|NCT02911688|Tocopherols|tocopherols|mesh-list
56980862|NCT02911688|Tocotrienols|tocotrienols|mesh-list
56980863|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
56980864|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
56980865|NCT02911688|Vitamins|vitamins|mesh-ancestor
56980866|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
56980867|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980868|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
56980869|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980870|NCT02911688|Protective Agents|protective agents|mesh-ancestor
56980871|NCT03435458|Misoprostol|misoprostol|mesh-list
56980872|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56980873|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
56980874|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56980875|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980876|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56980877|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56980878|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
56980879|NCT05580250|Metformin|metformin|mesh-list
56980880|NCT05580250|Simvastatin|simvastatin|mesh-list
56980881|NCT05580250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980882|NCT05580250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980883|NCT05580250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56980884|NCT05580250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56980885|NCT05580250|Antimetabolites|antimetabolites|mesh-ancestor
56980886|NCT05580250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980887|NCT05580250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56980888|NCT05580250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56980889|NCT05580250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980890|NCT03431948|Nivolumab|nivolumab|mesh-list
56980891|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980892|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980893|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56980894|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980895|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
56980896|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56980897|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
56901666|NCT04753515|Midazolam|midazolam|mesh-list
56980898|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
56980899|NCT03662516|Estradiol|estradiol|mesh-list
56980900|NCT03662516|Abrocitinib|abrocitinib|mesh-list
56980901|NCT03662516|Estrogens|estrogens|mesh-ancestor
56980902|NCT03662516|Hormones|hormones|mesh-ancestor
56980903|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56980904|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980905|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56980906|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56980907|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56980908|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56980909|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56980910|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56980911|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980912|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980913|NCT03572933|Pregnanolone|pregnanolone|mesh-list
56980914|NCT03572933|Ganaxolone|ganaxolone|mesh-list
56980915|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
56980916|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980917|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980918|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980919|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
56980920|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
56980921|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
56980922|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56980923|NCT03728465|Nivolumab|nivolumab|mesh-list
56980924|NCT03728465|Ipilimumab|ipilimumab|mesh-list
56980925|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56980926|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56980927|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56980928|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980929|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
56980930|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56663156|NCT05116891|Antidotes|antidotes|mesh-ancestor
56980932|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980933|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56980934|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
56980935|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56980936|NCT02994056|Velpatasvir|velpatasvir|mesh-list
56980937|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
56980938|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980939|NCT03728153|Fluoxetine|fluoxetine|mesh-list
56980940|NCT03728153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56980941|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56980942|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56980943|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56980944|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56980945|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
56980946|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980947|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56980948|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
56980949|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56980950|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56980951|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56980952|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56980953|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
56980954|NCT04056806|Terlipressin|terlipressin|mesh-list
56980955|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56980956|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56980957|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56980958|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56980959|NCT05675410|Deoxyglucose|deoxyglucose|mesh-list
56980960|NCT05675410|Prednisone|prednisone|mesh-list
56980961|NCT05675410|Prednisolone|prednisolone|mesh-list
56980962|NCT05675410|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56980963|NCT05675410|Methylprednisolone|methylprednisolone|mesh-list
56980964|NCT05675410|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56980965|NCT05675410|Prednisolone acetate|prednisolone acetate|mesh-list
56980966|NCT05675410|Hydrocortisone|hydrocortisone|mesh-list
56980967|NCT05675410|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56980968|NCT05675410|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56980969|NCT05675410|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56980970|NCT05675410|Cortisone|cortisone|mesh-list
56980971|NCT05675410|Cyclophosphamide|cyclophosphamide|mesh-list
56901741|NCT03787953|Antibodies|antibodies|mesh-list
56980972|NCT05675410|Dacarbazine|dacarbazine|mesh-list
56980973|NCT05675410|Doxorubicin|doxorubicin|mesh-list
56980974|NCT05675410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56980975|NCT05675410|Nivolumab|nivolumab|mesh-list
56980976|NCT05675410|Etoposide|etoposide|mesh-list
56980977|NCT05675410|Etoposide phosphate|etoposide phosphate|mesh-list
56980978|NCT05675410|Vincristine|vincristine|mesh-list
56980979|NCT05675410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56980980|NCT05675410|Bleomycin|bleomycin|mesh-list
56980981|NCT05675410|Vinblastine|vinblastine|mesh-list
56980982|NCT05675410|Podophyllotoxin|podophyllotoxin|mesh-list
56980983|NCT05675410|Procarbazine|procarbazine|mesh-list
56980984|NCT05675410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56980985|NCT05675410|Antibodies|antibodies|mesh-list
56980986|NCT05675410|Immunoglobulins|immunoglobulins|mesh-list
56980987|NCT05675410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56980988|NCT05675410|Immunoconjugates|immunoconjugates|mesh-list
56980989|NCT05675410|Imidazole|imidazole|mesh-list
56980990|NCT05675410|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56980991|NCT05675410|Prednisolone phosphate|prednisolone phosphate|mesh-list
56980992|NCT05675410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56980993|NCT05675410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56980994|NCT05675410|Immunologic Factors|immunologic factors|mesh-ancestor
56980995|NCT05675410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56980996|NCT05675410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980997|NCT05675410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56980998|NCT05675410|Alkylating Agents|alkylating agents|mesh-ancestor
56980999|NCT05675410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981000|NCT05675410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981001|NCT05675410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56981002|NCT05675410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56981003|NCT05675410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56981004|NCT05675410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56981005|NCT05675410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981006|NCT05675410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981007|NCT05675410|Glucocorticoids|glucocorticoids|mesh-ancestor
56981008|NCT05675410|Hormones|hormones|mesh-ancestor
56981009|NCT05675410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981010|NCT05675410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56981011|NCT05675410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56981012|NCT05675410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56981013|NCT05675410|Tubulin Modulators|tubulin modulators|mesh-ancestor
56981014|NCT05675410|Antimitotic Agents|antimitotic agents|mesh-ancestor
56981015|NCT05675410|Mitosis Modulators|mitosis modulators|mesh-ancestor
56981016|NCT05675410|Antiemetics|antiemetics|mesh-ancestor
56981017|NCT05675410|Autonomic Agents|autonomic agents|mesh-ancestor
56981018|NCT05675410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981019|NCT05675410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56981020|NCT05675410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56981021|NCT05675410|Protective Agents|protective agents|mesh-ancestor
56981022|NCT05675410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56981023|NCT05675410|Keratolytic Agents|keratolytic agents|mesh-ancestor
56981024|NCT05675410|Dermatologic Agents|dermatologic agents|mesh-ancestor
56981025|NCT05675410|Antimetabolites|antimetabolites|mesh-ancestor
56981026|NCT05675410|Antiviral Agents|antiviral agents|mesh-ancestor
56981027|NCT05675410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981028|NCT03305575|Bupivacaine|bupivacaine|mesh-list
56981029|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
56981030|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
56981031|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
56981032|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981033|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981034|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
56981035|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981036|NCT02993822|Maleic acid|maleic acid|mesh-list
56981037|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981038|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981039|NCT02391844|Oxycodone|oxycodone|mesh-list
56981040|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56981041|NCT02391844|Narcotics|narcotics|mesh-ancestor
56981042|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981043|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981044|NCT02391844|Analgesics|analgesics|mesh-ancestor
56981045|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
56981046|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981047|NCT02391688|Fexofenadine|fexofenadine|mesh-list
56981048|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
56981049|NCT02391688|Midazolam|midazolam|mesh-list
56981050|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
56981051|NCT02391688|Caffeine|caffeine|mesh-list
56981052|NCT02391688|Bupropion|bupropion|mesh-list
56981053|NCT02391688|Omeprazole|omeprazole|mesh-list
56981054|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56981055|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56981056|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981057|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981058|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56981059|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56981060|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56981061|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56981062|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
56981063|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
56981064|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
56981065|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
56981066|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981067|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981068|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56981069|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56981070|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981071|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56981072|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56981073|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
56981074|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56981075|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56981076|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56981077|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56981078|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
56981079|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56981080|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56981081|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56981082|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
56981083|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56981084|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56981085|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
56981086|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
56981087|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56981088|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56981089|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56981090|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56981091|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56981092|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
56981093|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
56981094|NCT02391688|Analgesics|analgesics|mesh-ancestor
56981095|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
56981096|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981097|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56981098|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56981099|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981100|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56981101|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56981102|NCT01068860|Insulin|insulin|mesh-list
56981103|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56981104|NCT01068860|Metformin|metformin|mesh-list
56981105|NCT01068860|Glimepiride|glimepiride|mesh-list
56981106|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
56981107|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
56981108|NCT01068860|Glyburide|glyburide|mesh-list
56981109|NCT01068860|Glipizide|glipizide|mesh-list
56981110|NCT01068860|Troglitazone|troglitazone|mesh-list
56981111|NCT01068860|Tolbutamide|tolbutamide|mesh-list
56981112|NCT01068860|Acetohexamide|acetohexamide|mesh-list
56981113|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
56981114|NCT01068860|Tolazamide|tolazamide|mesh-list
56981115|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
56981116|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56981117|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56981118|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981119|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56981120|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56981121|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
56981122|NCT04056650|Caffeine|caffeine|mesh-list
56981123|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56981124|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981125|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56981126|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729805|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
56981127|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981128|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56981129|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56981130|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
56981131|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981132|NCT04055480|Insulin|insulin|mesh-list
56981133|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56981134|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
56981135|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
56981136|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56981137|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981138|NCT03158090|Lanreotide|lanreotide|mesh-list
56981139|NCT03158090|Octreotide|octreotide|mesh-list
56981140|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981141|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56981142|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56981143|NCT02670538|Cariprazine|cariprazine|mesh-list
56981144|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56981145|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56981146|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981147|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981148|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56981149|NCT04056910|Nivolumab|nivolumab|mesh-list
56981150|NCT04056910|Ivosidenib|ivosidenib|mesh-list
56981151|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56981152|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981153|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56981154|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981155|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981156|NCT03727763|Cetuximab|cetuximab|mesh-list
56981157|NCT03727763|Vemurafenib|vemurafenib|mesh-list
56981158|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56981159|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981160|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56981161|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981162|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981163|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56981164|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
56981165|NCT02991482|Gemcitabine|gemcitabine|mesh-list
56981166|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
56981167|NCT02991482|Vinorelbine|vinorelbine|mesh-list
56981168|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56981169|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
56981170|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981171|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981172|NCT02991482|Antiviral Agents|antiviral agents|mesh-ancestor
56981173|NCT02991482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981174|NCT02991482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981175|NCT02991482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56981176|NCT02991482|Immunologic Factors|immunologic factors|mesh-ancestor
56981177|NCT02991482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981178|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56981179|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56981180|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
56981181|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
56981182|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
56981183|NCT02391142|Lidocaine|lidocaine|mesh-list
56981184|NCT02391142|Ropivacaine|ropivacaine|mesh-list
56981185|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
56981186|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
56981187|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981188|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981189|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
56981190|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981191|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56981192|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56981193|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56981194|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56981195|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981196|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56981197|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
56981198|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981199|NCT04479202|Bentonite|bentonite|mesh-list
56981200|NCT04479202|Antidotes|antidotes|mesh-ancestor
56981201|NCT04479202|Protective Agents|protective agents|mesh-ancestor
56981202|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981203|NCT01372618|Pasireotide|pasireotide|mesh-list
56981204|NCT01372618|Hormones|hormones|mesh-ancestor
56981205|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981206|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981207|NCT03304873|Retapamulin|retapamulin|mesh-list
56981208|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56981209|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981210|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
56981211|NCT04526509|Fludarabine|fludarabine|mesh-list
56981212|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56981213|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
56981214|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981215|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56981216|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56981217|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
56981218|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981219|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981220|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56981221|NCT03660020|Anesthetics|anesthetics|mesh-list
56981222|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
56981223|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981224|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981225|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
56981226|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981227|NCT03661892|Dronabinol|dronabinol|mesh-list
56981228|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
56981229|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981230|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56981231|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56981232|NCT03661892|Analgesics|analgesics|mesh-ancestor
56981233|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
56981234|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981235|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56981236|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56981237|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981239|NCT03661892|Hormones|hormones|mesh-ancestor
56981240|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981241|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56981242|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56981243|NCT03658850|Diuretics|diuretics|mesh-ancestor
56981244|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
56981245|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981246|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56981247|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56981248|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981249|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
56981250|NCT03659162|Clotrimazole|clotrimazole|mesh-list
56981251|NCT03659162|Miconazole|miconazole|mesh-list
56981252|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981253|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56981254|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56981255|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56981256|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981257|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981258|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56981259|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
56981260|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981261|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981262|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56981263|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56981264|NCT03659084|Deferasirox|deferasirox|mesh-list
56981265|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56981266|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
56981267|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
56981268|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981269|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56981270|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56981271|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56981272|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
56981273|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981274|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56981275|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56981276|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981277|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56981278|NCT02921750|Laxatives|laxatives|mesh-ancestor
56981279|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56981280|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56981281|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981282|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
56981283|NCT03622502|Remifentanil|remifentanil|mesh-list
56981284|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56981285|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981286|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981287|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56981288|NCT03622502|Analgesics|analgesics|mesh-ancestor
56981289|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
56981290|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981291|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56981292|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56981293|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56981294|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
56981295|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981296|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981297|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56981298|NCT03622502|Narcotics|narcotics|mesh-ancestor
56981299|NCT04397354|Dexamethasone|dexamethasone|mesh-list
56981300|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
56981301|NCT04397354|BB 1101|bb 1101|mesh-list
56981302|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981303|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
56981304|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
56981305|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981306|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981307|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56981308|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
56981309|NCT04397354|Hormones|hormones|mesh-ancestor
56981310|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981311|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56981312|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981313|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
56981314|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981315|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981316|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56981317|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56981318|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56981319|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
56981320|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981321|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56981322|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56981323|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981324|NCT01068158|Ivermectin|ivermectin|mesh-list
56981325|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56981326|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981327|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56981328|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
56981329|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981330|NCT01067846|Cycloserine|cycloserine|mesh-list
56981331|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56981332|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981333|NCT01067846|Renal Agents|renal agents|mesh-ancestor
56981334|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56981335|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
56981336|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56981337|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
56981338|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981339|NCT03874234|GSK3186899|gsk3186899|mesh-list
56981340|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56981341|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981342|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981343|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
56981344|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56981345|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981346|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56981347|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56981348|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729806|NCT03135795|Remifentanil|remifentanil|mesh-list
56902113|NCT02059564|Liraglutide|liraglutide|mesh-list
56981349|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981350|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981351|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
56981352|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981353|NCT05275777|Paclitaxel|paclitaxel|mesh-list
56981354|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
56981355|NCT05275777|Doxorubicin|doxorubicin|mesh-list
56981356|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56981357|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981358|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
56981359|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
56981360|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
56981361|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981362|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56981363|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
56981364|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981365|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56981366|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56981367|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
56981368|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56981369|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56981370|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56981371|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56981372|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981373|NCT05275699|Glycine|glycine|mesh-list
56981374|NCT05275699|Glycine Agents|glycine agents|mesh-ancestor
56981375|NCT05275699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981376|NCT05275699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981377|NCT05275699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981378|NCT05672212|Sufentanil|sufentanil|mesh-list
56981379|NCT05672212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56981380|NCT05672212|Narcotics|narcotics|mesh-ancestor
56981381|NCT05672212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981382|NCT05672212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981383|NCT05672212|Analgesics|analgesics|mesh-ancestor
56981384|NCT05672212|Sensory System Agents|sensory system agents|mesh-ancestor
56981385|NCT05672212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981386|NCT05672212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56981387|NCT05672212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56981388|NCT05672212|Anesthetics, General|anesthetics, general|mesh-ancestor
56981389|NCT05672212|Anesthetics|anesthetics|mesh-ancestor
56981390|NCT02390674|Cyclosporine|cyclosporine|mesh-list
56981391|NCT02390674|Cyclosporins|cyclosporins|mesh-list
56981392|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981393|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981394|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56981395|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
56981396|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981397|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
56981398|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981399|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
56981400|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56981401|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56981402|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56981403|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56981404|NCT04438382|Prednisone|prednisone|mesh-list
56981405|NCT04438382|Cortisone|cortisone|mesh-list
56981406|NCT04438382|Infliximab|infliximab|mesh-list
56981407|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
56981408|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56981409|NCT04438382|Antibodies|antibodies|mesh-list
56981410|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
56981411|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56981412|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
56981413|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981414|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
56981415|NCT04438382|Hormones|hormones|mesh-ancestor
56981416|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981417|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981418|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56981419|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981420|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
56981421|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56981422|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56981423|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729807|NCT03135795|Dsuvia|dsuvia|mesh-list
56981424|NCT02663674|Fluconazole|fluconazole|mesh-list
56981425|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
56981426|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981427|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56981428|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56981429|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981430|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981431|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56981432|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
56981433|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981434|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981435|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56981436|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56981437|NCT01005745|Aldesleukin|aldesleukin|mesh-list
56981438|NCT01005745|Interleukin-2|interleukin-2|mesh-list
56981439|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981440|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56981441|NCT01005745|Analgesics|analgesics|mesh-ancestor
56981442|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
56981443|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981444|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981445|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56981446|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56981447|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
56981448|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981449|NCT03657212|Zolpidem|zolpidem|mesh-list
56981450|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56981451|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56981452|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981453|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981454|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56981455|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
56981456|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
56981457|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981458|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981459|NCT03310411|Sumatriptan|sumatriptan|mesh-list
56981461|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56981462|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56981463|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56981464|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
56981465|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981466|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981467|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981468|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
56981469|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
56981470|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56981471|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981472|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981473|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
56981474|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56981475|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981476|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981477|NCT02390440|Bupivacaine|bupivacaine|mesh-list
56981478|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
56981479|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
56981480|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981481|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981482|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
56981483|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981484|NCT03677830|Acetaminophen|acetaminophen|mesh-list
56981485|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56981486|NCT03677830|Analgesics|analgesics|mesh-ancestor
56981487|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
56981488|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981489|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981490|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
56981491|NCT02199691|Vaccines|vaccines|mesh-list
56981492|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
56981493|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981494|NCT05671510|Docetaxel|docetaxel|mesh-list
56981495|NCT05671510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981496|NCT05671510|Tubulin Modulators|tubulin modulators|mesh-ancestor
56981497|NCT05671510|Antimitotic Agents|antimitotic agents|mesh-ancestor
56981498|NCT05671510|Mitosis Modulators|mitosis modulators|mesh-ancestor
56981499|NCT05671510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981500|NCT05667454|Atropine|atropine|mesh-list
56981501|NCT05667454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56981502|NCT05667454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56981503|NCT05667454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56981504|NCT05667454|Autonomic Agents|autonomic agents|mesh-ancestor
56981505|NCT05667454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981506|NCT05667454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981507|NCT05667454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56981508|NCT05667454|Respiratory System Agents|respiratory system agents|mesh-ancestor
56981509|NCT05667454|Mydriatics|mydriatics|mesh-ancestor
56981510|NCT05667454|Parasympatholytics|parasympatholytics|mesh-ancestor
56981511|NCT05667454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56981512|NCT05667454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56981513|NCT05667454|Cholinergic Agents|cholinergic agents|mesh-ancestor
56981514|NCT05667454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981515|NCT05667454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981516|NCT02389972|Dasatinib|dasatinib|mesh-list
56981517|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981518|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56981519|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981520|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981521|NCT03502330|Nivolumab|nivolumab|mesh-list
56981522|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56981523|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981524|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56981525|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981526|NCT03495232|Cimetidine|cimetidine|mesh-list
56981527|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56981528|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56981529|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56981530|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
56981531|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
56981532|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981533|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981534|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981535|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56981536|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56981537|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981538|NCT02389582|Enoxaparin|enoxaparin|mesh-list
56981539|NCT02389582|Dabigatran|dabigatran|mesh-list
56981540|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
56981541|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56981542|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56981543|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981544|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
56981545|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56981546|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
56981547|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981548|NCT02389426|Bosentan|bosentan|mesh-list
56981549|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56981550|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56981551|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981552|NCT02389348|Artefenomel|artefenomel|mesh-list
56981553|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
56981554|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56981555|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56981556|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981557|NCT02387242|Rifampin|rifampin|mesh-list
56981558|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56981559|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
56981560|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56981561|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981562|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
56981563|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56981564|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981565|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981566|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56981567|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56981568|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56981569|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56981570|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56981571|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56981572|NCT03656588|Iodine|iodine|mesh-list
56902342|NCT02059876|Paclitaxel|paclitaxel|mesh-list
56981573|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
56981574|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56981575|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
56981576|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56981577|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56981578|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981579|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
56981580|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
56981581|NCT03656588|Trace Elements|trace elements|mesh-ancestor
56981582|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
56981583|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981584|NCT02387086|Aspirin|aspirin|mesh-list
56981585|NCT02387086|Thalidomide|thalidomide|mesh-list
56981586|NCT02387086|Gefitinib|gefitinib|mesh-list
56981587|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56981588|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56981589|NCT02387086|Analgesics|analgesics|mesh-ancestor
56981590|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
56981591|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981592|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981593|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981594|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56981595|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56981596|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56981597|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981598|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56981599|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56981600|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981601|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
56981602|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56981603|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
56981604|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
56981605|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56981606|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981607|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56981608|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56981609|NCT02387086|Growth Substances|growth substances|mesh-ancestor
56981610|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
56981611|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981612|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56981613|NCT02383030|Fulvestrant|fulvestrant|mesh-list
56981614|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56981615|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981616|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56981617|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56981618|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
56981619|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981620|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981621|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56981622|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
56981623|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981624|NCT05366764|Albuterol|albuterol|mesh-list
56981625|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56981626|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
56981627|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981628|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981629|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56981630|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
56981631|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
56981632|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56981633|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56981634|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56981635|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56981636|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
56981637|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981638|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981639|NCT02983604|Fulvestrant|fulvestrant|mesh-list
56981640|NCT02983604|Exemestane|exemestane|mesh-list
56981641|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56981642|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981643|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56981644|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56981645|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
56052579|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981646|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981647|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981648|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56981649|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56981650|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981651|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981652|NCT03656432|Fluorides|fluorides|mesh-list
56981653|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
56981654|NCT03656432|Protective Agents|protective agents|mesh-ancestor
56981655|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981656|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
56981657|NCT02386462|Propofol|propofol|mesh-list
56981658|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56981659|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981660|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981661|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56981662|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
56981663|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
56981664|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56981665|NCT02386462|Analgesics|analgesics|mesh-ancestor
56981666|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
56981667|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981668|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56981669|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56981670|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56981671|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
56981672|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981673|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981674|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
56981675|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
56981676|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981677|NCT02382328|Protective Agents|protective agents|mesh-ancestor
56981678|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981679|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
56981680|NCT02382328|Vitamins|vitamins|mesh-ancestor
56981681|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
56981682|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56981683|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56981684|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981685|NCT02382094|Bicalutamide|bicalutamide|mesh-list
56981686|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
56981687|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
56981688|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981689|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981690|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981691|NCT02386150|Vaccines|vaccines|mesh-list
56981692|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
56981693|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981694|NCT02377180|Anesthetics|anesthetics|mesh-list
56981695|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
56981696|NCT02377180|Capsaicin|capsaicin|mesh-list
56981697|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56981698|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981699|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
56981700|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981701|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
56981702|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
56981703|NCT04364048|Cisplatin|cisplatin|mesh-list
56981704|NCT04364048|Carboplatin|carboplatin|mesh-list
56981705|NCT04364048|Etoposide|etoposide|mesh-list
56981706|NCT04364048|Pemetrexed|pemetrexed|mesh-list
56981707|NCT04364048|Durvalumab|durvalumab|mesh-list
56981708|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56981709|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981710|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56981711|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56981712|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56981713|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981714|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981715|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56981716|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56981717|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56981718|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
56981719|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981720|NCT03656042|Lenograstim|lenograstim|mesh-list
56981721|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56981722|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
56981723|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981724|NCT03655964|Olmesartan|olmesartan|mesh-list
56981725|NCT03655964|Nebivolol|nebivolol|mesh-list
56981726|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
56981727|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56981728|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56981729|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981730|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
56981731|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56981732|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56981733|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56981734|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
56981735|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981736|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981737|NCT02982590|Warfarin|warfarin|mesh-list
56981738|NCT02982590|Apixaban|apixaban|mesh-list
56981739|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
56981740|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56981741|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
56981742|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56981743|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
56981744|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981745|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981746|NCT02381548|Belinostat|belinostat|mesh-list
56981747|NCT02381548|Adavosertib|adavosertib|mesh-list
56981748|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981749|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981750|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981751|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56981752|NCT02381314|Ipilimumab|ipilimumab|mesh-list
56981753|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56981754|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981755|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56981756|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981757|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
56981758|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981759|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56981760|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981761|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981762|NCT02386072|Mirabegron|mirabegron|mesh-list
56981763|NCT02386072|Oxybutynin|oxybutynin|mesh-list
56981764|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56981765|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56981766|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56981767|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56981768|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
56981769|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981770|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981771|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981772|NCT02386072|Urological Agents|urological agents|mesh-ancestor
56981773|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56981774|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
56981775|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
56981776|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
56981777|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981778|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
56981779|NCT02381470|Amoxicillin|amoxicillin|mesh-list
56981780|NCT02381470|Rifampin|rifampin|mesh-list
56981781|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56981782|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
56981783|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
56981784|NCT02381470|Cefadroxil|cefadroxil|mesh-list
56981785|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56981786|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981787|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56981788|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
56981789|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
56981790|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56981791|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981792|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981793|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56981794|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56981795|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56981796|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56981797|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56981798|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56981799|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56981800|NCT02381158|Beclomethasone|beclomethasone|mesh-list
56981801|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981802|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
56981803|NCT02381158|Hormones|hormones|mesh-ancestor
56981804|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981805|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981806|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56981807|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
56981808|NCT04190056|Tamoxifen|tamoxifen|mesh-list
56981809|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
56981810|NCT04190056|Vorinostat|vorinostat|mesh-list
56981811|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56981812|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981813|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56981814|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
56981815|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981816|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981817|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56981818|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56981819|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56981820|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56981821|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56981822|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981823|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981824|NCT02381080|Voriconazole|voriconazole|mesh-list
56981825|NCT02381080|Erythromycin|erythromycin|mesh-list
56981826|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
56981827|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56981828|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
56981829|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
56981830|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981831|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56981832|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56981833|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981834|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981835|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56981836|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56981837|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981838|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981839|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56981840|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56981841|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56981842|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56981843|NCT04694248|Aspirin|aspirin|mesh-list
56981844|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
56981845|NCT04694248|Anticoagulants|anticoagulants|mesh-list
56981846|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56981847|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56981848|NCT04694248|Analgesics|analgesics|mesh-ancestor
56981849|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
56981850|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981851|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981852|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981853|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56981854|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56981855|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56981856|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981857|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56981858|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56981859|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981860|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
56981861|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56981862|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
56981863|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56981864|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
56981865|NCT02376478|Folic Acid|folic acid|mesh-list
56981866|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
56981867|NCT02376478|Adalimumab|adalimumab|mesh-list
56981868|NCT02376478|Etanercept|etanercept|mesh-list
56981869|NCT02376478|Methotrexate|methotrexate|mesh-list
56902636|NCT02060656|Hormones|hormones|mesh-ancestor
56981870|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
56981871|NCT02376478|Infliximab|infliximab|mesh-list
56981872|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
56981873|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56981874|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
56981875|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56981876|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981877|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56981878|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
56981879|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981880|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981881|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56981882|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981883|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56981884|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
56981885|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56981886|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56981887|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56981888|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56981889|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56981890|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56981891|NCT02376478|Analgesics|analgesics|mesh-ancestor
56981892|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
56981893|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981894|NCT02376478|Hematinics|hematinics|mesh-ancestor
56981895|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
56981896|NCT02376478|Vitamins|vitamins|mesh-ancestor
56981897|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
56981898|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981899|NCT02385448|Dienogest|dienogest|mesh-list
56981900|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56981901|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56981902|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56981903|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
56981904|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56981905|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981906|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56981907|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56981908|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56981909|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56981910|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
56981911|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981912|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56981913|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981914|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56981915|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56981916|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56981917|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56981918|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56981919|NCT02385058|Mebendazole|mebendazole|mesh-list
56981920|NCT02385058|Piperazine|piperazine|mesh-list
56981921|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
56981922|NCT02385058|DMP 777|dmp 777|mesh-list
56981923|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
56981924|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
56981925|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56981926|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981927|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
56981928|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
56981929|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
56981930|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981931|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56981932|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981933|NCT02376088|Methimazole|methimazole|mesh-list
56981934|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
56981935|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
56981936|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981937|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981938|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
56981939|NCT03310021|Apixaban|apixaban|mesh-list
56981940|NCT03310021|Edoxaban|edoxaban|mesh-list
56981941|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56981942|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
56981943|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56981944|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
56981945|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981946|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981947|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
56981948|NCT03333109|Erenumab|erenumab|mesh-list
56981949|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56981950|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981951|NCT03333109|Analgesics|analgesics|mesh-ancestor
56981952|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
56981953|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56981954|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981955|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56981956|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56981957|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56981958|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
56981959|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
56981960|NCT01312831|Vitamins|vitamins|mesh-ancestor
56981961|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
56981962|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981963|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
56981964|NCT01312831|Hematinics|hematinics|mesh-ancestor
56981965|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56981966|NCT03296527|Hormones|hormones|mesh-ancestor
56981967|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56981968|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981969|NCT04431193|Oxytocin|oxytocin|mesh-list
56981970|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
56981971|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56981972|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981973|NCT03293485|Imipenem|imipenem|mesh-list
56981974|NCT03293485|Relebactam|relebactam|mesh-list
56981975|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
56981976|NCT03293485|Cilastatin|cilastatin|mesh-list
56981977|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56981978|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56981979|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
56981980|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56981981|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981982|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56981983|NCT03309943|Propranolol|propranolol|mesh-list
56981984|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56981985|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56981986|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
56981987|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56981988|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981989|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981990|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56981991|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56981992|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
56981993|NCT01732627|Vaccines|vaccines|mesh-list
56981994|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
56981995|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56981996|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56981997|NCT03331315|Celecoxib|celecoxib|mesh-list
56981998|NCT03331315|Ketorolac|ketorolac|mesh-list
56981999|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56982000|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56982001|NCT03331315|Analgesics|analgesics|mesh-ancestor
56982002|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
56982003|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982004|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982005|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982006|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982007|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56982008|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56982009|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982010|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982011|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
56982012|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
56982013|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982014|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982015|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982016|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
56982017|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
56902797|NCT04529720|Vaccines|vaccines|mesh-list
56982018|NCT02661490|Vaccines|vaccines|mesh-list
56982019|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
56982020|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982021|NCT03287791|Azelaic acid|azelaic acid|mesh-list
56982022|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
56982023|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56982024|NCT03287791|Protective Agents|protective agents|mesh-ancestor
56982025|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982026|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
56982027|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982028|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56982029|NCT03287635|Hormones|hormones|mesh-ancestor
56982030|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56982031|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982032|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
56982033|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56982034|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982035|NCT03287089|Renal Agents|renal agents|mesh-ancestor
56982036|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982037|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
56982038|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56982039|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982040|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
56982041|NCT02385136|Temozolomide|temozolomide|mesh-list
56982042|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56982043|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
56982044|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982045|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982046|NCT04927780|Leucovorin|leucovorin|mesh-list
56982047|NCT04927780|Fluorouracil|fluorouracil|mesh-list
56982048|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
56982049|NCT04927780|Irinotecan|irinotecan|mesh-list
56982050|NCT04927780|Calcium|calcium|mesh-list
56982051|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
56982052|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56982053|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982054|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
56982055|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982056|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56982057|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982058|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982059|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
56982060|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56982061|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56982062|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982063|NCT04927780|Antidotes|antidotes|mesh-ancestor
56982064|NCT04927780|Protective Agents|protective agents|mesh-ancestor
56982065|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
56982066|NCT04927780|Vitamins|vitamins|mesh-ancestor
56982067|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
56982068|NCT02940691|Grazoprevir|grazoprevir|mesh-list
56982069|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56982070|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
56982071|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982072|NCT04949269|BMS-986165|bms-986165|mesh-list
56982073|NCT04949269|Famotidine|famotidine|mesh-list
56982074|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56982075|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56982076|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56982077|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
56982078|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
56982079|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982080|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982081|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982082|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
56982083|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56982084|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982085|NCT02379754|Gentamicins|gentamicins|mesh-list
56982086|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982087|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982088|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56982089|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982090|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982091|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
56982092|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56982093|NCT01313377|Gemcitabine|gemcitabine|mesh-list
56982094|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
56982095|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56982096|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
56982097|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982098|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982099|NCT01313377|Antiviral Agents|antiviral agents|mesh-ancestor
56982100|NCT01313377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982101|NCT01313377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982102|NCT01313377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982103|NCT01313377|Immunologic Factors|immunologic factors|mesh-ancestor
56982104|NCT01313377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982105|NCT02384746|Fulvestrant|fulvestrant|mesh-list
56982106|NCT02384746|Ixazomib|ixazomib|mesh-list
56982107|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56982108|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982109|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56982110|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56982111|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
56982112|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56982113|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982114|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
56982115|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982116|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982117|NCT02375464|Octreotide|octreotide|mesh-list
56982118|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56982119|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56982120|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982121|NCT03113344|Amoxicillin|amoxicillin|mesh-list
56982122|NCT03113344|Azithromycin|azithromycin|mesh-list
56982123|NCT03113344|Meropenem|meropenem|mesh-list
56982124|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
56982125|NCT03113344|Penicillins|penicillins|mesh-list
56982126|NCT03113344|Imipenem|imipenem|mesh-list
56982127|NCT03113344|Erythromycin|erythromycin|mesh-list
56982128|NCT03113344|Ceftazidime|ceftazidime|mesh-list
56982129|NCT03113344|Ampicillin|ampicillin|mesh-list
56982130|NCT03113344|Cephalosporins|cephalosporins|mesh-list
56982131|NCT03113344|Acyclovir|acyclovir|mesh-list
56982132|NCT03113344|Ganciclovir|ganciclovir|mesh-list
56982133|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
56982134|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982135|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982136|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982137|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982138|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56982139|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56982141|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56982142|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
56982143|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982144|NCT02384512|Rasagiline|rasagiline|mesh-list
56982145|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56982146|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982147|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982148|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56982149|NCT02384512|Protective Agents|protective agents|mesh-ancestor
56982150|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982151|NCT02379676|Clopidogrel|clopidogrel|mesh-list
56982152|NCT02379676|Ticagrelor|ticagrelor|mesh-list
56982153|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56982154|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56982155|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56982156|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56982157|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
56982158|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982159|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982160|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982161|NCT04715230|Lorazepam|lorazepam|mesh-list
56982162|NCT04715230|Haloperidol|haloperidol|mesh-list
56982163|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
56982164|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
56982165|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
56982166|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982167|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982168|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56982169|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56982170|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56982171|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902937|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
56982172|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56982173|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56982174|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
56982175|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982176|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982177|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56982178|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
56982179|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56982180|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56982181|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
56982182|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
56982183|NCT02384122|Octreotide|octreotide|mesh-list
56982184|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56982185|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56982186|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982187|NCT02378740|Ketamine|ketamine|mesh-list
56982188|NCT02378740|Analgesics|analgesics|mesh-ancestor
56982189|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
56982190|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982191|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982192|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56982193|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56982194|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
56982195|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
56982196|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56982197|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56982198|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56982199|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982200|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982201|NCT01411267|Cytarabine|cytarabine|mesh-list
56982202|NCT01411267|Methotrexate|methotrexate|mesh-list
56982203|NCT01411267|Etoposide|etoposide|mesh-list
56982204|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
56982205|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56982206|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
56982207|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56982208|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982209|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56982210|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
56982211|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982212|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982213|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
56982214|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982215|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56982216|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982217|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
56982218|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982219|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56982220|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56982221|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56982222|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56982223|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
56982224|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982225|NCT03113110|Empagliflozin|empagliflozin|mesh-list
56982226|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56982227|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982228|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56982229|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982230|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
56982231|NCT04828486|Futibatinib|futibatinib|mesh-list
56982232|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56982233|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982234|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56982235|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982236|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982237|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982238|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56982239|NCT02383888|BI 425809|bi 425809|mesh-list
56982240|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
56982241|NCT04628338|Interferons|interferons|mesh-list
56982242|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
56982243|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982244|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
56982245|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982246|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
56982247|NCT03130959|Nivolumab|nivolumab|mesh-list
56982248|NCT03130959|Ipilimumab|ipilimumab|mesh-list
56982249|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56982250|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982251|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56982252|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982253|NCT04553692|Leucovorin|leucovorin|mesh-list
56982254|NCT04553692|Gemcitabine|gemcitabine|mesh-list
56982255|NCT04553692|Bevacizumab|bevacizumab|mesh-list
56982256|NCT04553692|Docetaxel|docetaxel|mesh-list
56982257|NCT04553692|Fluorouracil|fluorouracil|mesh-list
56982258|NCT04553692|Irinotecan|irinotecan|mesh-list
56982259|NCT04553692|Azacitidine|azacitidine|mesh-list
56982260|NCT04553692|Venetoclax|venetoclax|mesh-list
56982261|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56982262|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982263|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56982264|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56982265|NCT04553692|Growth Substances|growth substances|mesh-ancestor
56982266|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982267|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
56982268|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56982269|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
56982270|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982271|NCT04553692|Antiviral Agents|antiviral agents|mesh-ancestor
56982272|NCT04553692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982273|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982274|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982275|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
56982276|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
56982277|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
56982278|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
56982279|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56982280|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56982281|NCT04553692|Antidotes|antidotes|mesh-ancestor
56982282|NCT04553692|Protective Agents|protective agents|mesh-ancestor
56982283|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
56982284|NCT04553692|Vitamins|vitamins|mesh-ancestor
56982285|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
56664489|NCT02733341|Cangrelor|cangrelor|mesh-list
56982286|NCT01370031|Charcoal|charcoal|mesh-list
56982287|NCT01370031|Antidotes|antidotes|mesh-ancestor
56982288|NCT01370031|Protective Agents|protective agents|mesh-ancestor
56982289|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982290|NCT02373514|Acetaminophen|acetaminophen|mesh-list
56982291|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56982292|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56982293|NCT02373514|Analgesics|analgesics|mesh-ancestor
56982294|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
56982295|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982296|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982297|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
56982298|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56982299|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982300|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982301|NCT01364493|Capecitabine|capecitabine|mesh-list
56982302|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
56982303|NCT01364493|Trastuzumab|trastuzumab|mesh-list
56982304|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56982305|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
56982306|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982307|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982308|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56982309|NCT01370187|Montelukast|montelukast|mesh-list
56982310|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56982311|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
56982312|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56982313|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
56982314|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56982315|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982316|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56982317|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56982318|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982319|NCT04483960|Nafamostat|nafamostat|mesh-list
56982320|NCT04483960|Enoxaparin|enoxaparin|mesh-list
56982321|NCT04483960|Dalteparin|dalteparin|mesh-list
56982322|NCT04483960|Tinzaparin|tinzaparin|mesh-list
56982323|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56982324|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
56982325|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56982326|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56982327|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982328|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56982329|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56982330|NCT04483960|Analgesics|analgesics|mesh-ancestor
56982331|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
56982332|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982333|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982334|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982335|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982336|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
56982337|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982338|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56982339|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56982340|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56982341|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982342|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
56982343|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
56982344|NCT01370343|Cyclosporine|cyclosporine|mesh-list
56982345|NCT01370343|Cyclosporins|cyclosporins|mesh-list
56982346|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
56982347|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982348|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982349|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982350|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
56982351|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982352|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
56982353|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982354|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
56982355|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982356|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56982357|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
56982358|NCT01370343|Vitamins|vitamins|mesh-ancestor
56982359|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
56982360|NCT01368003|Dutasteride|dutasteride|mesh-list
56982361|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56982362|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56982363|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982364|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982365|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
56982366|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56982367|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982368|NCT01364571|Vaccines|vaccines|mesh-list
56982369|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
56982370|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982371|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56982372|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56982373|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982374|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
56982375|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56982376|NCT03933904|Sirolimus|sirolimus|mesh-list
56982377|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982378|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982379|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56982380|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982381|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
56982382|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982383|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
56982384|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982385|NCT02377648|Everolimus|everolimus|mesh-list
56982386|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982387|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982388|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
56982389|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982390|NCT02371408|Ribavirin|ribavirin|mesh-list
56982391|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
56982392|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
56982393|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982394|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
56982395|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982396|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
56982397|NCT01364805|Gemcitabine|gemcitabine|mesh-list
56982398|NCT01364805|Vitamins|vitamins|mesh-ancestor
56982399|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
56982400|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982401|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56982402|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
56982403|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982404|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982405|NCT01364805|Antiviral Agents|antiviral agents|mesh-ancestor
56982406|NCT01364805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982407|NCT01364805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982408|NCT01364805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982409|NCT01364805|Immunologic Factors|immunologic factors|mesh-ancestor
56982410|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
56982411|NCT01364805|Protective Agents|protective agents|mesh-ancestor
56982412|NCT01370889|Resveratrol|resveratrol|mesh-list
56982413|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
56982414|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982415|NCT01370889|Protective Agents|protective agents|mesh-ancestor
56982416|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982417|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982418|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56982419|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56982420|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56982421|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982422|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56982423|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982424|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
56982425|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56982426|NCT04382404|Velpatasvir|velpatasvir|mesh-list
56982427|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
56982428|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982429|NCT02371096|Rituximab|rituximab|mesh-list
56982430|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56982431|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982432|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
56982433|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982434|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982435|NCT04420455|Enoximone|enoximone|mesh-list
56982436|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56982437|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
56982438|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56982439|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56982440|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982441|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982442|NCT04420455|Protective Agents|protective agents|mesh-ancestor
56982443|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982444|NCT04381936|Aspirin|aspirin|mesh-list
56982445|NCT04381936|Empagliflozin|empagliflozin|mesh-list
56982446|NCT04381936|Ritonavir|ritonavir|mesh-list
56982447|NCT04381936|Lopinavir|lopinavir|mesh-list
56982448|NCT04381936|Azithromycin|azithromycin|mesh-list
56982449|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
56982450|NCT04381936|Colchicine|colchicine|mesh-list
56982451|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56982452|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56982453|NCT04381936|Antibodies|antibodies|mesh-list
56982454|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
56982455|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
56982456|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982457|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56982458|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56982459|NCT04381936|Analgesics|analgesics|mesh-ancestor
56982460|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
56982461|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982462|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982463|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982464|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56982465|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56982466|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982467|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56982468|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56982469|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982470|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
56982471|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56982472|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56903235|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
56982473|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
56982474|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56982475|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56982476|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
56982477|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982478|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56982479|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56982480|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982481|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
56982482|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56982483|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56982484|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56982485|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56982486|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
56982487|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
56982488|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
56982489|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
56982490|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982491|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
56982492|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982493|NCT03124407|Capsaicin|capsaicin|mesh-list
56982494|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
56982495|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
56982496|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
56982497|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982498|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982499|NCT01364961|Resveratrol|resveratrol|mesh-list
56982500|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
56982501|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982502|NCT01364961|Protective Agents|protective agents|mesh-ancestor
56982503|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982504|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982505|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56982506|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
56982507|NCT02370862|Neostigmine|neostigmine|mesh-list
56982508|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56982509|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982510|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982511|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
56982512|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982513|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982514|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56664713|NCT04001725|Dexamethasone|dexamethasone|mesh-list
56982515|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
56982516|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982517|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56982518|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56982519|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56982520|NCT03620578|Nivolumab|nivolumab|mesh-list
56982521|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56982522|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982523|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56982524|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982525|NCT02373280|Amoxicillin|amoxicillin|mesh-list
56982526|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
56982527|NCT02373280|Metronidazole|metronidazole|mesh-list
56982528|NCT02373280|Clarithromycin|clarithromycin|mesh-list
56982529|NCT02373280|Esomeprazole|esomeprazole|mesh-list
56982530|NCT02373280|Bismuth|bismuth|mesh-list
56982531|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56982532|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982533|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982534|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56982535|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56982536|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982537|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982538|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982539|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56982540|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
56982541|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56982542|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982543|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56982544|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56982545|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56982546|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56982547|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56982548|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56982549|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56982550|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56982551|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56982552|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56982553|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56982554|NCT02373280|Antacids|antacids|mesh-ancestor
56982555|NCT02370550|Cyclosporine|cyclosporine|mesh-list
56982556|NCT02370550|Prednisone|prednisone|mesh-list
56982557|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
56982558|NCT02370550|Calcium|calcium|mesh-list
56982559|NCT02370550|Cyclosporins|cyclosporins|mesh-list
56982560|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56982561|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982562|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982563|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
56982564|NCT02370550|Hormones|hormones|mesh-ancestor
56982565|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56982566|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56982567|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982568|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982569|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982570|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982571|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
56982572|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
56982573|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982574|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56982575|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982576|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56982577|NCT02370550|Antacids|antacids|mesh-ancestor
56982578|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56982579|NCT02365402|Entecavir|entecavir|mesh-list
56982580|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
56982581|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982582|NCT02364934|Propofol|propofol|mesh-list
56982583|NCT02364934|Sevoflurane|sevoflurane|mesh-list
56982584|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56982585|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56982586|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982587|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56982588|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
56982589|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
56982590|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56982591|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56982592|NCT02372656|Metformin|metformin|mesh-list
56982593|NCT02372656|Simvastatin|simvastatin|mesh-list
56982594|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56982595|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982596|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56982597|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56982598|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
56982599|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982600|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56982601|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56982602|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982603|NCT01368627|Sirolimus|sirolimus|mesh-list
56982604|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982605|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982606|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56982607|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982608|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
56982609|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982610|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
56982611|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982612|NCT02358681|Ketorolac|ketorolac|mesh-list
56982613|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56982614|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56982615|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56982616|NCT02358681|Analgesics|analgesics|mesh-ancestor
56982617|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
56982618|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982619|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982620|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982621|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982622|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56982623|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982624|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982625|NCT03123861|Gabapentin|gabapentin|mesh-list
56982626|NCT03123861|Analgesics|analgesics|mesh-ancestor
56982627|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
56982628|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982629|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982630|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
56982631|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56982632|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56982633|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56982634|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56982635|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56982636|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56982637|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982638|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982639|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
56982640|NCT01368783|Ritonavir|ritonavir|mesh-list
56982641|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56982642|NCT01368783|Tenofovir|tenofovir|mesh-list
56982643|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56982644|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56982645|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
56982646|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982647|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982648|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56982649|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56982650|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
56982651|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982652|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56982653|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56982654|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56982655|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56982656|NCT01509339|Vancomycin|vancomycin|mesh-list
56982657|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982658|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982659|NCT03123471|Apremilast|apremilast|mesh-list
56982660|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56982661|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56982662|NCT03123471|Analgesics|analgesics|mesh-ancestor
56982663|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
56982664|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982665|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982666|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982668|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56982669|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56982670|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982671|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982672|NCT02661178|Emodepside|emodepside|mesh-list
56982673|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56982674|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982675|NCT01365117|Insulin|insulin|mesh-list
56982676|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56982677|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56982678|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982679|NCT02372812|Dexamethasone|dexamethasone|mesh-list
56982680|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982681|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
56982682|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
56982683|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982684|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982685|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56982686|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
56982687|NCT02372812|Hormones|hormones|mesh-ancestor
56982688|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56982689|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56982690|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982691|NCT02365012|Midodrine|midodrine|mesh-list
56982692|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
56982693|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
56982694|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982695|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982696|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56982697|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56982698|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56903458|NCT03695367|Analgesics|analgesics|mesh-ancestor
56982699|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56982700|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
56982701|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982702|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982703|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56982704|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982705|NCT01365351|Hormones|hormones|mesh-list
56982706|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56982707|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982708|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
56982709|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56982710|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982711|NCT01372449|Memantine|memantine|mesh-list
56982712|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56982713|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56982714|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
56982715|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982716|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982717|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982718|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56982719|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56982720|NCT04666389|Atorvastatin|atorvastatin|mesh-list
56982721|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56982722|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56982723|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
56982724|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982725|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56982726|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56982727|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982728|NCT02372110|Caffeine|caffeine|mesh-list
56982729|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56982730|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982731|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56982732|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982733|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982734|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56982735|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56982736|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
56982737|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982738|NCT02372188|Caffeine|caffeine|mesh-list
56664942|NCT04002349|Hormones|hormones|mesh-ancestor
56982739|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56982740|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982741|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56982742|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982743|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982744|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56982745|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56982746|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
56982747|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982749|NCT01371435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56982750|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56982751|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56982752|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982753|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982754|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
56982755|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982756|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56982757|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
56982758|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56982759|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56982760|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56982761|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982762|NCT01369719|Deferasirox|deferasirox|mesh-list
56982763|NCT01369719|Deferoxamine|deferoxamine|mesh-list
56982764|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56982765|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
56982766|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
56982767|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982768|NCT01369719|Siderophores|siderophores|mesh-ancestor
56982769|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
56982770|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56982771|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
56982772|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982773|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
56982774|NCT02369380|Protective Agents|protective agents|mesh-ancestor
56982775|NCT02038816|Azacitidine|azacitidine|mesh-list
56982776|NCT02038816|Deferasirox|deferasirox|mesh-list
56982777|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56982778|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
56982779|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982780|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982781|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982782|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56982783|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
56982784|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
56982785|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
56982786|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56982787|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982788|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
56982789|NCT02358850|Acetaminophen|acetaminophen|mesh-list
56982790|NCT02358850|Oxycodone|oxycodone|mesh-list
56982791|NCT02358850|Hydromorphone|hydromorphone|mesh-list
56982792|NCT02358850|Hydrocodone|hydrocodone|mesh-list
56982793|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56982794|NCT02358850|Analgesics|analgesics|mesh-ancestor
56982795|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
56982796|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982797|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982798|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
56982799|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56982800|NCT02358850|Narcotics|narcotics|mesh-ancestor
56982801|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56982802|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
56982803|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
56982804|NCT02359162|Gemcitabine|gemcitabine|mesh-list
56982805|NCT02359162|Prednisone|prednisone|mesh-list
56982806|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
56982807|NCT02359162|Doxorubicin|doxorubicin|mesh-list
56982808|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
56982809|NCT02359162|Etoposide|etoposide|mesh-list
56982810|NCT02359162|Vincristine|vincristine|mesh-list
56982811|NCT02359162|Pegaspargase|pegaspargase|mesh-list
56982812|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982813|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
56982814|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982815|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982816|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56982817|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
56982818|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982819|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982820|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56982821|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56982822|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
56982823|NCT02359162|Antiviral Agents|antiviral agents|mesh-ancestor
56982824|NCT02359162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982825|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982826|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56982827|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56982828|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56982829|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982830|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
56982831|NCT02359162|Hormones|hormones|mesh-ancestor
56982832|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56982833|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56982834|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56982835|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
56982836|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
56982837|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
56982838|NCT03634605|Tetracycline|tetracycline|mesh-list
56982839|NCT03634605|Lidocaine|lidocaine|mesh-list
56982840|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
56982841|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
56982842|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56982843|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982844|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
56982845|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982846|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56052580|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
56982847|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56982848|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56982849|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56982850|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982851|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982852|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982853|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56982854|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982855|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
56982856|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982857|NCT02363764|Dimercaprol|dimercaprol|mesh-list
56982858|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
56982859|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
56982860|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982861|NCT03654794|Tacrolimus|tacrolimus|mesh-list
56982862|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982863|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
56982864|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982865|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56982866|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982867|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982868|NCT03654170|BI 425809|bi 425809|mesh-list
56982869|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
56982870|NCT02369146|UB-421|ub-421|mesh-list
56982871|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56982872|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
56982873|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982874|NCT02363452|Lamivudine|lamivudine|mesh-list
56982875|NCT02363452|Zidovudine|zidovudine|mesh-list
56982876|NCT02363452|Abacavir|abacavir|mesh-list
56982877|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56982878|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56982879|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982880|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982881|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
56982882|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982883|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56982884|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56982885|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
56982886|NCT03634137|Afamelanotide|afamelanotide|mesh-list
56982887|NCT03634137|alpha-MSH|alpha-msh|mesh-list
56982888|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
56982889|NCT03634137|Hormones|hormones|mesh-ancestor
56665120|NCT00656006|Ribavirin|ribavirin|mesh-list
56982890|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56982891|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982893|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56982894|NCT02358694|Antibodies|antibodies|mesh-list
56982895|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
56982896|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982897|NCT04473807|Sotalol|sotalol|mesh-list
56982898|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56982899|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56982900|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
56982901|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56982902|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982903|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982904|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56982905|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
56982906|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
56982907|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982908|NCT02323659|Interferons|interferons|mesh-list
56982909|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
56982910|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
56982911|NCT02323659|Methotrexate|methotrexate|mesh-list
56982912|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56982913|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
56982914|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56982915|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982916|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56982917|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
56982918|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982919|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982920|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
56982921|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982922|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56903698|NCT02068690|BI 425809|bi 425809|mesh-list
56982923|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982924|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
56982925|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982926|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56982927|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
56982928|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982929|NCT03634059|Apatinib|apatinib|mesh-list
56982930|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982931|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56982932|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982933|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982934|NCT02358304|Calcitonin|calcitonin|mesh-list
56982935|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
56982936|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56982937|NCT02358304|Katacalcin|katacalcin|mesh-list
56982938|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56982939|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982940|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56982941|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
56982942|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
56982943|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56982944|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56982945|NCT01316523|Rituximab|rituximab|mesh-list
56982946|NCT01316523|Lenalidomide|lenalidomide|mesh-list
56982947|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56982948|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982949|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
56982950|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982951|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982952|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56982953|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56982954|NCT01316523|Growth Substances|growth substances|mesh-ancestor
56982955|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
56982956|NCT02362906|Azithromycin|azithromycin|mesh-list
56982957|NCT02362906|Erythromycin|erythromycin|mesh-list
56982958|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
56982959|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56982960|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
56982961|NCT02362906|Cephalosporins|cephalosporins|mesh-list
56982962|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982963|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982964|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56982965|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56982966|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982967|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982968|NCT04469530|Sirolimus|sirolimus|mesh-list
56982969|NCT04469530|Celecoxib|celecoxib|mesh-list
56982970|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
56982971|NCT04469530|Etoposide|etoposide|mesh-list
56982972|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56982973|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
56982974|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56982975|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982976|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56982977|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
56982978|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56982979|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56982980|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56982981|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56982982|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56982983|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56982984|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56982985|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56982986|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56982987|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56982988|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
56982989|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56982990|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56982991|NCT04469530|Analgesics|analgesics|mesh-ancestor
56982992|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
56982993|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56982994|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56982995|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56982996|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56982997|NCT03085914|Leucovorin|leucovorin|mesh-list
56982998|NCT03085914|Gemcitabine|gemcitabine|mesh-list
56982999|NCT03085914|Paclitaxel|paclitaxel|mesh-list
56983000|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56983001|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
56983002|NCT03085914|Carboplatin|carboplatin|mesh-list
56983003|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
56983004|NCT03085914|Fluorouracil|fluorouracil|mesh-list
56983005|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
56983006|NCT03085914|Pemetrexed|pemetrexed|mesh-list
56983007|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56983008|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983009|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
56983010|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
56983011|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
56983012|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983013|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56983014|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
56983015|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983016|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983017|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56983018|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
56983019|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56983020|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56983021|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
56983022|NCT03085914|Antiviral Agents|antiviral agents|mesh-ancestor
56983023|NCT03085914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983024|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983025|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983026|NCT03085914|Antidotes|antidotes|mesh-ancestor
56983027|NCT03085914|Protective Agents|protective agents|mesh-ancestor
56983028|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
56983029|NCT03085914|Vitamins|vitamins|mesh-ancestor
56983030|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
56983031|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56983032|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56983033|NCT02467608|Isoniazid|isoniazid|mesh-list
56983034|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
56983035|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56983036|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983037|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56983038|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56983039|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
56983040|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983041|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56983042|NCT02368288|Entecavir|entecavir|mesh-list
56983043|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
56983044|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983045|NCT02357524|Oritavancin|oritavancin|mesh-list
56983046|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56983047|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983048|NCT02368054|Epinephrine|epinephrine|mesh-list
56983049|NCT02368054|Racepinephrine|racepinephrine|mesh-list
56983050|NCT02368054|Bupivacaine|bupivacaine|mesh-list
56983051|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
56983052|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
56983053|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
56983054|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983055|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983056|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
56983057|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983058|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56983059|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56983060|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
56983061|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983062|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983063|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56983064|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56983065|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
56983066|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56983067|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
56983068|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
56983069|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
56983070|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56983071|NCT02357602|Tenofovir|tenofovir|mesh-list
56983072|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
56983073|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983074|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56983075|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56903835|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
56983076|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983077|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983078|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56983079|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56983080|NCT01379196|Azithromycin|azithromycin|mesh-list
56983081|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56983082|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983083|NCT01382238|Dolutegravir|dolutegravir|mesh-list
56983084|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56983085|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56983086|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983087|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983088|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56983089|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56983090|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
56983091|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983092|NCT03112564|Fentanyl|fentanyl|mesh-list
56983093|NCT03112564|Sevoflurane|sevoflurane|mesh-list
56983094|NCT03112564|Rocuronium|rocuronium|mesh-list
56983095|NCT03112564|Cisatracurium|cisatracurium|mesh-list
56983096|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56983097|NCT03112564|Narcotics|narcotics|mesh-ancestor
56983098|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983099|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983100|NCT03112564|Analgesics|analgesics|mesh-ancestor
56983101|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
56983102|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983103|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56983104|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56983105|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
56983106|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
56983107|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56983108|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56983109|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56983110|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56983111|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56983112|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
56983113|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
56983114|NCT01379976|Vitamins|vitamins|mesh-ancestor
56983115|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
56983116|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983117|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
56983118|NCT01379898|Doxazosin|doxazosin|mesh-list
56983119|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
56983120|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56983121|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56983122|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56983123|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56983124|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
56983125|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983126|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983127|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983128|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
56983129|NCT02362516|BI 425809|bi 425809|mesh-list
56983130|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
56983131|NCT02367664|Vaccines|vaccines|mesh-list
56983132|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
56983133|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983134|NCT05421000|Anesthetics|anesthetics|mesh-list
56983135|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983136|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983137|NCT05419362|Avelumab|avelumab|mesh-list
56983138|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983139|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983140|NCT02357212|Adenosine|adenosine|mesh-list
56983141|NCT02357212|Analgesics|analgesics|mesh-ancestor
56983142|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
56983143|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983144|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983145|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56983146|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
56983147|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56983148|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
56983149|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
56983150|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052581|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
56983151|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983152|NCT01382160|Adalimumab|adalimumab|mesh-list
56983153|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56983154|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983155|NCT00735748|Tramadol|tramadol|mesh-list
56983156|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56983157|NCT00735748|Narcotics|narcotics|mesh-ancestor
56983158|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983159|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983160|NCT00735748|Analgesics|analgesics|mesh-ancestor
56983161|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
56983162|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983163|NCT02367196|Rituximab|rituximab|mesh-list
56983164|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983165|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983166|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
56983167|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983168|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983169|NCT05418504|Anesthetics|anesthetics|mesh-list
56983170|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983171|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983172|NCT03408886|Vancomycin|vancomycin|mesh-list
56983173|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56983174|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983175|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
56983176|NCT03323476|Prednisone|prednisone|mesh-list
56983177|NCT03323476|Rituximab|rituximab|mesh-list
56983178|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56983179|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983180|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983181|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
56983182|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983183|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983184|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56983185|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56983186|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
56983187|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56983188|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983189|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983190|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983191|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56983192|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
56983193|NCT03323476|Hormones|hormones|mesh-ancestor
56983194|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983195|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56983196|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
56983197|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56983198|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
56983199|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56983200|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983201|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56983203|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983204|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983205|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56983206|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983207|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56983208|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
56983209|NCT02366884|Clotrimazole|clotrimazole|mesh-list
56983210|NCT02366884|Miconazole|miconazole|mesh-list
56983211|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
56983212|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983213|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56983214|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56983215|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56983216|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983217|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983218|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56983219|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
56983220|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983221|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983222|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56983223|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56983224|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56983225|NCT02361502|Mirabegron|mirabegron|mesh-list
56983226|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56983227|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56983228|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56983229|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
56983230|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983231|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983232|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983233|NCT02361502|Urological Agents|urological agents|mesh-ancestor
56983234|NCT02367118|Prednisone|prednisone|mesh-list
56983235|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56983236|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
56983237|NCT02367118|Hormones|hormones|mesh-ancestor
56983238|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983239|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983240|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56983241|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983242|NCT00979212|Paclitaxel|paclitaxel|mesh-list
56983243|NCT00979212|Carboplatin|carboplatin|mesh-list
56983244|NCT00979212|Panitumumab|panitumumab|mesh-list
56983245|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56983246|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983247|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
56983248|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
56983249|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
56983250|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983251|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983252|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
56983253|NCT02361190|Testosterone|testosterone|mesh-list
56983254|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
56983255|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
56983256|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56983257|NCT02361190|Androgens|androgens|mesh-ancestor
56983258|NCT02361190|Hormones|hormones|mesh-ancestor
56983259|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983260|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983261|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56983262|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983263|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
56983264|NCT02361112|Capecitabine|capecitabine|mesh-list
56983265|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56983266|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
56983267|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983268|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983269|NCT02360956|Olmesartan|olmesartan|mesh-list
56983270|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56983271|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
56983272|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56983273|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56983274|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983275|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56983276|NCT02360800|Hemostatics|hemostatics|mesh-list
56983277|NCT02360800|Coagulants|coagulants|mesh-ancestor
56983278|NCT03501966|Acetazolamide|acetazolamide|mesh-list
56983279|NCT03501966|Diuretics|diuretics|mesh-list
56983280|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
56983281|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983282|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
56983283|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56983284|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983285|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983286|NCT02355184|Leronlimab|leronlimab|mesh-list
56983287|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56983288|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56983289|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983290|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56983291|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56983292|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
56983293|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983294|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
56983295|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56983296|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
56983297|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983298|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
56983299|NCT03477630|Protective Agents|protective agents|mesh-ancestor
56983300|NCT02981342|Gemcitabine|gemcitabine|mesh-list
56904063|NCT05050305|Hormones|hormones|mesh-ancestor
56983301|NCT02981342|Capecitabine|capecitabine|mesh-list
56983302|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56983303|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
56983304|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983305|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983306|NCT02981342|Antiviral Agents|antiviral agents|mesh-ancestor
56983307|NCT02981342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983308|NCT02981342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983309|NCT02981342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56983310|NCT02981342|Immunologic Factors|immunologic factors|mesh-ancestor
56983311|NCT02981342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983312|NCT02639026|Durvalumab|durvalumab|mesh-list
56983313|NCT02639026|Tremelimumab|tremelimumab|mesh-list
56983314|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983315|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983316|NCT02360644|Vitamin D|vitamin d|mesh-list
56983317|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
56983318|NCT02360644|Vitamins|vitamins|mesh-ancestor
56983319|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
56983320|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983321|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56983322|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56983323|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
56983324|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56983325|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
56983326|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983327|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983328|NCT02354950|Cabotegravir|cabotegravir|mesh-list
56983329|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56983330|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56983331|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983332|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983333|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56983334|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56983335|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
56983336|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983337|NCT02980874|Triamcinolone|triamcinolone|mesh-list
56983338|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56983339|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56983340|NCT02980874|Aflibercept|aflibercept|mesh-list
56983341|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56983342|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56983343|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
56547649|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
56983344|NCT02980874|Hormones|hormones|mesh-ancestor
56983345|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983346|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983347|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56983349|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983350|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983351|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56983352|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56983353|NCT02980874|Growth Substances|growth substances|mesh-ancestor
56983354|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
56983355|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983356|NCT02354872|Nicotine|nicotine|mesh-list
56983357|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56983358|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
56983359|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983360|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983361|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56983362|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56983363|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
56983364|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983365|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983366|NCT02354638|Nicotine|nicotine|mesh-list
56983367|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56983368|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
56983369|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983370|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983371|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56983372|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56983373|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
56983374|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052582|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983375|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983376|NCT02360254|Insulin|insulin|mesh-list
56983377|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56983378|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983379|NCT03121014|Methotrexate|methotrexate|mesh-list
56983380|NCT03121014|Fludarabine|fludarabine|mesh-list
56983381|NCT03121014|Busulfan|busulfan|mesh-list
56983382|NCT03121014|Tacrolimus|tacrolimus|mesh-list
56983383|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
56983384|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56983385|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
56983386|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56983387|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983388|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56983389|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
56983390|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983391|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983392|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
56983393|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983394|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56983395|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56983396|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
56983397|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983398|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56983399|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56983400|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
56983401|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56983402|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56983403|NCT03112642|Anesthetics|anesthetics|mesh-list
56983404|NCT03112642|Bupivacaine|bupivacaine|mesh-list
56983405|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
56983406|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983407|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983408|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
56983409|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983410|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56983411|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56983412|NCT01377324|Estradiol|estradiol|mesh-list
56983413|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56983414|NCT01377324|Estrogens|estrogens|mesh-ancestor
56983415|NCT01377324|Hormones|hormones|mesh-ancestor
56983416|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983417|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983418|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56983419|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
56983420|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56665622|NCT02723435|Midostaurin|midostaurin|mesh-list
56983421|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56983422|NCT02359942|Citric Acid|citric acid|mesh-list
56983423|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
56983424|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
56983425|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56983426|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
56983427|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
56983428|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983429|NCT02354560|Erythromycin|erythromycin|mesh-list
56983430|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
56983431|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56983432|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
56983433|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56983434|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983435|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56983436|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56983437|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983438|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983439|NCT01378884|Domperidone|domperidone|mesh-list
56983440|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
56983441|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
56983442|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983443|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983444|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56983445|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56983446|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
56983447|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983448|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983449|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
56983450|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56983451|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
56983452|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983453|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983454|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56983455|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56983456|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
56983457|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56983458|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
56983459|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983460|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983461|NCT05383482|Paclitaxel|paclitaxel|mesh-list
56983462|NCT05383482|Docetaxel|docetaxel|mesh-list
56983463|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56983464|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983465|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
56983466|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
56983467|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
56983468|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983469|NCT02354170|Mifepristone|mifepristone|mesh-list
56983470|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56983471|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
56983472|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56983473|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983474|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56983475|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56983476|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56983477|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
56983478|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56983479|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56983480|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
56983481|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983482|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
56983483|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56983484|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56983485|NCT01377246|Octreotide|octreotide|mesh-list
56983486|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56983487|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56983488|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983489|NCT02353936|Afatinib|afatinib|mesh-list
56983490|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983491|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56983492|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983493|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983494|NCT02353858|Fluorouracil|fluorouracil|mesh-list
56983495|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
56983496|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983497|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56983498|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983499|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56983500|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
56983501|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983502|NCT02353702|Ropivacaine|ropivacaine|mesh-list
56983503|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
56983504|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
56983505|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983506|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983507|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
56983508|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983509|NCT02532660|Dexetimide|dexetimide|mesh-list
56983510|NCT02532660|Citalopram|citalopram|mesh-list
56983511|NCT02532660|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56983512|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56983513|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56983514|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983515|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983516|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
56983517|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983518|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56983519|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
56983520|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56983521|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56983522|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56904294|NCT02084446|Everolimus|everolimus|mesh-list
56983523|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
56983524|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
56983525|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983526|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56983527|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56983528|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
56983529|NCT01377168|Naltrexone|naltrexone|mesh-list
56983530|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56983531|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56983532|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983533|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
56983534|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983535|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
56983536|NCT02892149|Hematinics|hematinics|mesh-ancestor
56983537|NCT05335356|Ustekinumab|ustekinumab|mesh-list
56983538|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
56983539|NCT02348398|Topotecan|topotecan|mesh-list
56983540|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56983541|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56983542|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983543|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983544|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983545|NCT05278338|Denosumab|denosumab|mesh-list
56983546|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56983547|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983548|NCT03721757|Nivolumab|nivolumab|mesh-list
56983549|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983550|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983551|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56983552|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983553|NCT03727607|Propofol|propofol|mesh-list
56983554|NCT03727607|Desflurane|desflurane|mesh-list
56983555|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56983556|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983557|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983558|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56983559|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
56983560|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
56983561|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56983562|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
56983563|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56983564|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56983565|NCT03157804|Plerixafor|plerixafor|mesh-list
56983566|NCT03157804|Lenograstim|lenograstim|mesh-list
56983567|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56983568|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
56983569|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983570|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56983571|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56983572|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
56983573|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983574|NCT03157414|Empagliflozin|empagliflozin|mesh-list
56983575|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56983576|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983577|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56983578|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983579|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56983580|NCT03147196|Bicalutamide|bicalutamide|mesh-list
56983581|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
56983582|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
56983583|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983584|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983585|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983586|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56983587|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56983588|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56983589|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56983590|NCT03153436|Inositol|inositol|mesh-list
56983591|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
56983592|NCT03153436|Vitamins|vitamins|mesh-ancestor
56983593|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
56983594|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983595|NCT03544229|Maleic acid|maleic acid|mesh-list
56983596|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983597|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983598|NCT02351908|Tenofovir|tenofovir|mesh-list
56983599|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
56983600|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56983601|NCT02351908|Dolutegravir|dolutegravir|mesh-list
56983602|NCT02351908|Cobicistat|cobicistat|mesh-list
56983603|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56983604|NCT02351908|Elvitegravir|elvitegravir|mesh-list
56983605|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
56983606|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983607|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56983608|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56983609|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983610|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983611|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56983612|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56983613|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56983614|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56983615|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56983616|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56983617|NCT01371240|Secretin|secretin|mesh-list
56983618|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56983619|NCT01371240|Hormones|hormones|mesh-ancestor
56983620|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983621|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983622|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56983623|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56983624|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983625|NCT03723941|Etoposide|etoposide|mesh-list
56983626|NCT03723941|Mitotane|mitotane|mesh-list
56983627|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983628|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56983629|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56983630|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56983631|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983632|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983633|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56983634|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
56983635|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56983636|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
56983637|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983638|NCT00775476|Expectorants|expectorants|mesh-ancestor
56983639|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
56983640|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56983641|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
56983642|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665851|NCT00730366|Renal Agents|renal agents|mesh-ancestor
56983643|NCT00775476|Protective Agents|protective agents|mesh-ancestor
56983644|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983645|NCT00775476|Antidotes|antidotes|mesh-ancestor
56983646|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
56983647|NCT03721679|Nivolumab|nivolumab|mesh-list
56983648|NCT03721679|Durvalumab|durvalumab|mesh-list
56983649|NCT03721679|Atezolizumab|atezolizumab|mesh-list
56983650|NCT03721679|Poly ICLC|poly iclc|mesh-list
56983651|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983652|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983653|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56983654|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983655|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
56983656|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
56983657|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983658|NCT03639948|Carboplatin|carboplatin|mesh-list
56983659|NCT03639948|Docetaxel|docetaxel|mesh-list
56983660|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
56983661|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983662|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
56983663|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
56983664|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
56983665|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983666|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983667|NCT03968406|Talazoparib|talazoparib|mesh-list
56983668|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56983669|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983670|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983671|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983672|NCT03510455|Infigratinib|infigratinib|mesh-list
56983673|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983674|NCT03509675|Ibuprofen|ibuprofen|mesh-list
56983675|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56983676|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56983677|NCT03509675|Analgesics|analgesics|mesh-ancestor
56983678|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
56983679|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983680|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983681|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56983682|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983683|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56983684|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983685|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983686|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
56983687|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
56983688|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56983689|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56983690|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983691|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983692|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983693|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983694|NCT04852224|Leuprolide|leuprolide|mesh-list
56983695|NCT04852224|Goserelin|goserelin|mesh-list
56983696|NCT04852224|Androgens|androgens|mesh-list
56983697|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56983698|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
56983699|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56983700|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983701|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56983702|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983703|NCT04852224|Hormones|hormones|mesh-ancestor
56983704|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983705|NCT02353078|Sucralfate|sucralfate|mesh-list
56983706|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56983707|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56983708|NCT03509207|Vorinostat|vorinostat|mesh-list
56983709|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983710|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56983711|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983712|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983713|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
56983714|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983715|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
56983716|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983717|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983718|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56983720|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
56983721|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983722|NCT03727295|Protective Agents|protective agents|mesh-ancestor
56983723|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983724|NCT01378650|Cilostazol|cilostazol|mesh-list
56983725|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56983726|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
56983727|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983728|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983729|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56983730|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
56983731|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56983732|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56983733|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983734|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56983735|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
56983736|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56983737|NCT01378650|Protective Agents|protective agents|mesh-ancestor
56983738|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56983739|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56983740|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983741|NCT04796922|Rituximab|rituximab|mesh-list
56983742|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
56983743|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983744|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983745|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
56983746|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983747|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983748|NCT03723785|Insulin|insulin|mesh-list
56983749|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56983750|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56983751|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983752|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
56983753|NCT04469868|Narcotics|narcotics|mesh-ancestor
56983754|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983755|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983756|NCT04469868|Analgesics|analgesics|mesh-ancestor
56983757|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
56983758|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983759|NCT03543137|Nicotine|nicotine|mesh-list
56983760|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56983761|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
56983762|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983763|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983764|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56983765|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56983766|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
56983767|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983768|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983769|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56983770|NCT04747314|Aripiprazole|aripiprazole|mesh-list
56983771|NCT04747314|Mirtazapine|mirtazapine|mesh-list
56983772|NCT04747314|Citalopram|citalopram|mesh-list
56983773|NCT04747314|Bupropion|bupropion|mesh-list
56983774|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56983775|NCT04747314|Sertraline|sertraline|mesh-list
56983776|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
56983777|NCT04747314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56983778|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56983779|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56983780|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983781|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983782|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
56983783|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983784|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56983785|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56983786|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983787|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56983788|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
56983789|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56983790|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56983791|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983792|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56983793|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56983794|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983795|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
56983796|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56983797|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56983798|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56983799|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56983800|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56983801|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56983802|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56983803|NCT04747314|Analgesics|analgesics|mesh-ancestor
56983804|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
56983805|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56983806|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
56983807|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
56983808|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56983809|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56983810|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56983811|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56983812|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
56983813|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56983814|NCT03146650|Nivolumab|nivolumab|mesh-list
56983815|NCT03146650|Ipilimumab|ipilimumab|mesh-list
56983816|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983817|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983818|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56983819|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983820|NCT02343484|Ethanol|ethanol|mesh-list
56983821|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56983822|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983823|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983824|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983825|NCT03630042|Rituximab|rituximab|mesh-list
56983826|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
56983827|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56983828|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983829|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
56983830|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983831|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983832|NCT03073980|Acetaminophen|acetaminophen|mesh-list
56983833|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56983834|NCT03073980|Analgesics|analgesics|mesh-ancestor
56983835|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
56983836|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983837|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983838|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
56983839|NCT04117932|Ustekinumab|ustekinumab|mesh-list
56983840|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
56983841|NCT03930186|Apremilast|apremilast|mesh-list
56983842|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56983843|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56983844|NCT03930186|Analgesics|analgesics|mesh-ancestor
56983845|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
56983846|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983847|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983848|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56983849|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56983850|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56983851|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56983852|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983853|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983854|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56983855|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56983856|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56983857|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56983858|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983859|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983860|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983861|NCT02351440|Analgesics|analgesics|mesh-ancestor
56983862|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
56983863|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983864|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
56983865|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56983866|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
56983867|NCT02351128|Lanreotide|lanreotide|mesh-list
56983868|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983869|NCT02343250|Valsartan|valsartan|mesh-list
56983870|NCT02343250|Cilnidipine|cilnidipine|mesh-list
56983871|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56983872|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56983873|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56983874|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983875|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56983876|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56983877|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56983878|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983879|NCT03781440|Lidocaine|lidocaine|mesh-list
56983880|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
56983881|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
56983882|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983883|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983884|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
56983885|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56983886|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56983887|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56983888|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56983889|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56983890|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983891|NCT03565211|Progesterone|progesterone|mesh-list
56983892|NCT03565211|Progestins|progestins|mesh-ancestor
56983893|NCT03565211|Hormones|hormones|mesh-ancestor
56983894|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983895|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983896|NCT03740100|Sirolimus|sirolimus|mesh-list
56983897|NCT03740100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56983898|NCT03740100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983899|NCT03740100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56983900|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983901|NCT03740100|Antifungal Agents|antifungal agents|mesh-ancestor
56983902|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56983903|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
56983904|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983905|NCT03723395|Repaglinide|repaglinide|mesh-list
56983906|NCT03723395|Tolbutamide|tolbutamide|mesh-list
56983907|NCT03723395|Itraconazole|itraconazole|mesh-list
56983908|NCT03723395|Rifampin|rifampin|mesh-list
56983909|NCT03723395|Tucatinib|tucatinib|mesh-list
56983910|NCT03723395|Digoxin|digoxin|mesh-list
56983911|NCT03723395|Midazolam|midazolam|mesh-list
56983912|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
56983913|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56983914|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56983915|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56983916|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983917|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56983918|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56983919|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56983920|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56983921|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
56983922|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
56983923|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
56983924|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
56983925|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983926|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983927|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
56983928|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56983929|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56983930|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56983931|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983932|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56983933|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
56983934|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56983935|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56983936|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56983937|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
56983938|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56983939|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
56983940|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56983941|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56983942|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56983943|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56983944|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56983945|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56983946|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56983947|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56983948|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56983949|NCT03723395|Protective Agents|protective agents|mesh-ancestor
56983950|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56983951|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56983952|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56983953|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56983954|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
56983955|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56983956|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56983957|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56983958|NCT03531905|Ezetimibe|ezetimibe|mesh-list
56983959|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56983960|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56983961|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
56983962|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983963|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56983964|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56983965|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56983966|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983967|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56983968|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56983969|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983970|NCT02346682|Clonazepam|clonazepam|mesh-list
56983971|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56983972|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56983973|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56983974|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56983975|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983976|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983977|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983978|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56983979|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
56983980|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56983981|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
56983982|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
56983983|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
56983984|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56983985|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
56983986|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983987|NCT05764590|Sevelamer|sevelamer|mesh-list
56983988|NCT05764590|Chelating Agents|chelating agents|mesh-ancestor
56983989|NCT05764590|Sequestering Agents|sequestering agents|mesh-ancestor
56983990|NCT05764590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983991|NCT05764512|Endorphins|endorphins|mesh-list
56983992|NCT05764512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56983993|NCT05764512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56983994|NCT05764512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56983995|NCT02342392|Ranibizumab|ranibizumab|mesh-list
56983996|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56983997|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56983998|NCT02342392|Growth Substances|growth substances|mesh-ancestor
56983999|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984000|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
56984001|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984002|NCT02342002|Misoprostol|misoprostol|mesh-list
56984003|NCT02342002|Mifepristone|mifepristone|mesh-list
56984004|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56984005|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
56984006|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56984007|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984008|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56984009|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984010|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
56984011|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56984012|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56984013|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56984014|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56984015|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
56984016|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56984017|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56984018|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
56984019|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56984020|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
56984021|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56984022|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56984023|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
56984024|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984025|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984026|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56984027|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56984028|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984029|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984030|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984031|NCT02345902|Haloperidol|haloperidol|mesh-list
56984032|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
56984033|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
56984034|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
56984035|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984036|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984037|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984038|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56984039|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56984040|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984041|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56984042|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56984043|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
56984044|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984045|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984046|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56984047|NCT03601806|Thalidomide|thalidomide|mesh-list
56984048|NCT03601806|Pomalidomide|pomalidomide|mesh-list
56984049|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984050|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
56984051|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984052|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
56984053|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984054|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984055|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56984056|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56984057|NCT03601806|Growth Substances|growth substances|mesh-ancestor
56984058|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
56984059|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984060|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
56984061|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
56984062|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56984063|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56984064|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984065|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984066|NCT02345980|Urological Agents|urological agents|mesh-ancestor
56984067|NCT02345746|Leucovorin|leucovorin|mesh-list
56984068|NCT02345746|Folic Acid|folic acid|mesh-list
56984069|NCT02345746|Fluorouracil|fluorouracil|mesh-list
56984070|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
56984071|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
56984072|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
56984073|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984074|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56984075|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984076|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984077|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
56984078|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984079|NCT02345746|Antidotes|antidotes|mesh-ancestor
56984080|NCT02345746|Protective Agents|protective agents|mesh-ancestor
56984081|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
56984082|NCT02345746|Vitamins|vitamins|mesh-ancestor
56984083|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
56984084|NCT02345746|Hematinics|hematinics|mesh-ancestor
56984085|NCT03794778|Paclitaxel|paclitaxel|mesh-list
56984086|NCT03794778|Carboplatin|carboplatin|mesh-list
56984087|NCT03794778|Doxorubicin|doxorubicin|mesh-list
56984088|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56984089|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56984090|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666317|NCT00857649|Memantine|memantine|mesh-list
56984091|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56984092|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56984093|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56984094|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984095|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56984096|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56984097|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56984098|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984099|NCT02341300|Iron|iron|mesh-list
56984100|NCT02341300|Trace Elements|trace elements|mesh-ancestor
56984101|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
56984102|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984103|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56984104|NCT05462496|Metronidazole|metronidazole|mesh-list
56984105|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
56984106|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56984107|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
56984108|NCT05462496|Folfirinox|folfirinox|mesh-list
56984109|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56984110|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984111|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984112|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
56984113|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56984114|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56984115|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56984116|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56984117|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052583|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904894|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
56984118|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984119|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56984120|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56984121|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56984122|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56984123|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56984124|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56984125|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56984126|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
56984127|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984128|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984129|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984130|NCT02345590|Eplerenone|eplerenone|mesh-list
56984131|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56984132|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
56984133|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56984134|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984135|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56984136|NCT02345590|Diuretics|diuretics|mesh-ancestor
56984137|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
56984138|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56984139|NCT03723083|Thalidomide|thalidomide|mesh-list
56984140|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984141|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
56984142|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984143|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
56984144|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984145|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984146|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56984147|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56984148|NCT03723083|Growth Substances|growth substances|mesh-ancestor
56984149|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
56984150|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984151|NCT03774810|Zolpidem|zolpidem|mesh-list
56984152|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56984153|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56984154|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984155|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984156|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56984157|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
56984158|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
56984159|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984160|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984161|NCT04029688|Cytarabine|cytarabine|mesh-list
56984162|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
56984163|NCT04029688|Fludarabine|fludarabine|mesh-list
56984164|NCT04029688|Topotecan|topotecan|mesh-list
56984165|NCT04029688|Venetoclax|venetoclax|mesh-list
56984166|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984167|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
56984168|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984169|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56984170|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56984171|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
56984172|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984173|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984174|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56984175|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56984176|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
56984177|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
56984178|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984179|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56984180|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56984181|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984182|NCT03562481|Lidocaine|lidocaine|mesh-list
56984183|NCT03562481|Epinephrine|epinephrine|mesh-list
56984184|NCT03562481|Racepinephrine|racepinephrine|mesh-list
56984185|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
56984186|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
56984187|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
56984188|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984189|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984190|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
56984191|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984192|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56984193|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56984194|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56984195|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56984196|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984197|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56984198|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56984199|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
56984200|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984201|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56984202|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56984203|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
56984204|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56984205|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
56984206|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
56984207|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
56984208|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56984209|NCT03726593|Artesunate|artesunate|mesh-list
56984210|NCT03726593|Mefloquine|mefloquine|mesh-list
56984211|NCT03726593|Atovaquone|atovaquone|mesh-list
56984212|NCT03726593|Pyronaridine|pyronaridine|mesh-list
56984213|NCT03726593|Proguanil|proguanil|mesh-list
56984214|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56984215|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
56984216|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56984217|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56984218|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984219|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984220|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
56984221|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
56984222|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56984223|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
56984224|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984225|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984226|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
56984227|NCT04007224|Oxytocin|oxytocin|mesh-list
56984228|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
56984229|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56984230|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984231|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
56984232|NCT03197064|Aprepitant|aprepitant|mesh-list
56984233|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
56984234|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
56984235|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984236|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984237|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984238|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56984239|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984240|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666463|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
56984241|NCT02345044|Eplerenone|eplerenone|mesh-list
56984242|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56984243|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
56984244|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56984245|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984246|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56984247|NCT02345044|Diuretics|diuretics|mesh-ancestor
56984248|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
56984249|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56984251|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56984252|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984253|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56984254|NCT02349802|Incretins|incretins|mesh-ancestor
56984255|NCT02349802|Hormones|hormones|mesh-ancestor
56984256|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56984257|NCT03120624|Iodine|iodine|mesh-list
56984258|NCT03120624|Interferons|interferons|mesh-list
56984259|NCT03120624|Interferon-beta|interferon-beta|mesh-list
56984260|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56984261|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
56984262|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984263|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
56984264|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984265|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
56984266|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984267|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56984268|NCT03120624|Trace Elements|trace elements|mesh-ancestor
56984269|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
56984270|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56984271|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984272|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984273|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56984274|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
56984275|NCT03145714|Anesthetics|anesthetics|mesh-list
56984276|NCT03145714|Propofol|propofol|mesh-list
56984277|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984278|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984279|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56984280|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56984281|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
56984282|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56984283|NCT03145714|Analgesics|analgesics|mesh-ancestor
56984284|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
56984285|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984286|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56984287|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56984288|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56984289|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
56984290|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984291|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984292|NCT02349958|Doxorubicin|doxorubicin|mesh-list
56984293|NCT02349958|Cisplatin|cisplatin|mesh-list
56984294|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56984295|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984296|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56984297|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56984298|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984299|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984300|NCT04872426|Insulin|insulin|mesh-list
56984301|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56984302|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984303|NCT02344888|Folic Acid|folic acid|mesh-list
56984304|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
56984305|NCT02344888|Prednisolone|prednisolone|mesh-list
56984306|NCT02344888|Citric Acid|citric acid|mesh-list
56984307|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
56984308|NCT02344888|Clomiphene|clomiphene|mesh-list
56984309|NCT02344888|Enclomiphene|enclomiphene|mesh-list
56984310|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
56984311|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
56984312|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56984313|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
56984314|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
56984315|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984316|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56984317|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
56984318|NCT02344888|Hormones|hormones|mesh-ancestor
56984319|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56984320|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984321|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56984322|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984323|NCT02344888|Hematinics|hematinics|mesh-ancestor
56984324|NCT02344888|Vitamins|vitamins|mesh-ancestor
56984325|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
56984326|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56984327|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
56984328|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56984329|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
56984330|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56984331|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56984332|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56984333|NCT02921022|Gemcitabine|gemcitabine|mesh-list
56984334|NCT02921022|Paclitaxel|paclitaxel|mesh-list
56984335|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56984336|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984337|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
56984338|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
56984339|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
56984340|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984341|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56984342|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
56984343|NCT02921022|Antiviral Agents|antiviral agents|mesh-ancestor
56984344|NCT02921022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984345|NCT02921022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984346|NCT02921022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984347|NCT02921022|Immunologic Factors|immunologic factors|mesh-ancestor
56984348|NCT02921022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984349|NCT03497429|Niraparib|niraparib|mesh-list
56984350|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56984351|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984352|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984353|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984354|NCT03146104|Propofol|propofol|mesh-list
56984355|NCT03146104|Isoflurane|isoflurane|mesh-list
56984356|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56984357|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984358|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984359|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56984360|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
56984361|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
56984362|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56984363|NCT03497039|Diclofenac|diclofenac|mesh-list
56984364|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56984365|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56984366|NCT03497039|Analgesics|analgesics|mesh-ancestor
56984367|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
56984368|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984369|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984370|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56984371|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56984372|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56984373|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984374|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984375|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
56984376|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56984377|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56984378|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
56984379|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984380|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984381|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984382|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
56984383|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
56984384|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984385|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
56984386|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56984387|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
56984388|NCT02349490|Hemostatics|hemostatics|mesh-list
56984389|NCT02349490|Coagulants|coagulants|mesh-ancestor
56984390|NCT03720899|Nicotine|nicotine|mesh-list
56984391|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56984392|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
56984393|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984394|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984395|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56984397|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
56984398|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984399|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984400|NCT02340988|Oritavancin|oritavancin|mesh-list
56984401|NCT02340988|Warfarin|warfarin|mesh-list
56984402|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
56984403|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984404|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984405|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
56984406|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56984407|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984408|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
56984409|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56984410|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984411|NCT05665283|Ensartinib|ensartinib|mesh-list
56984412|NCT05665283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984413|NCT05665283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56984414|NCT05665283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984415|NCT05665283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984416|NCT02344810|Leucovorin|leucovorin|mesh-list
56984417|NCT02344810|Fluorouracil|fluorouracil|mesh-list
56984418|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
56984419|NCT02344810|Calcium|calcium|mesh-list
56984420|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
56984421|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729808|NCT03135795|Bromides|bromides|mesh-list
56984422|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984423|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
56984424|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984425|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56984426|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984427|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984428|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
56984429|NCT02344810|Antidotes|antidotes|mesh-ancestor
56984430|NCT02344810|Protective Agents|protective agents|mesh-ancestor
56984431|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
56984432|NCT02344810|Vitamins|vitamins|mesh-ancestor
56984433|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
56984434|NCT03071094|Nivolumab|nivolumab|mesh-list
56984435|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56984436|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984437|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56984438|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984439|NCT03148990|Vaccines|vaccines|mesh-list
56984440|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
56984441|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984442|NCT04477642|Abatacept|abatacept|mesh-list
56984443|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56984444|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984445|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984446|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984447|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
56984448|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984449|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56984450|NCT02344732|Polymyxins|polymyxins|mesh-list
56984451|NCT02344732|Neomycin|neomycin|mesh-list
56984452|NCT02344732|Polymyxin B|polymyxin b|mesh-list
56984453|NCT02344732|Dexamethasone|dexamethasone|mesh-list
56984454|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56984455|NCT02344732|Homatropine|homatropine|mesh-list
56984456|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56984457|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
56984458|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
56984459|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984460|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984461|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984462|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
56984463|NCT02344732|Hormones|hormones|mesh-ancestor
56984464|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56984465|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56984466|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984467|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56984468|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984469|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984470|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56984471|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666680|NCT01000831|Vaccines|vaccines|mesh-list
56984472|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984473|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
56984474|NCT03720665|Caffeine|caffeine|mesh-list
56984475|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56984476|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984477|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56984478|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984479|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984480|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56984481|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56984482|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
56984483|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984484|NCT03726281|Nivolumab|nivolumab|mesh-list
56984485|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56984486|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984487|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56984488|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984489|NCT02344264|Ropivacaine|ropivacaine|mesh-list
56984490|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
56984491|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
56984492|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984493|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984494|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
56984495|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905274|NCT02102698|Ecopipam|ecopipam|mesh-list
56984496|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
56984497|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
56984498|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
56984499|NCT02339662|Gabapentin|gabapentin|mesh-list
56984500|NCT02339662|Amitriptyline|amitriptyline|mesh-list
56984501|NCT02339662|Analgesics|analgesics|mesh-ancestor
56984502|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
56984503|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984504|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984505|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
56984506|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56984507|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56984508|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984509|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56984510|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56984511|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56984512|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984513|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984514|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
56984515|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56984516|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
56984517|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56984518|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56984519|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56984520|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56984521|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
56984522|NCT02343718|Sirolimus|sirolimus|mesh-list
56984523|NCT02343718|Vinblastine|vinblastine|mesh-list
56984524|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984525|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984526|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56984527|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984528|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
56984529|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984530|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
56984531|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984532|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56984533|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
56984534|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
56984535|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
56984536|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984537|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56984538|NCT03148522|Mirtazapine|mirtazapine|mesh-list
56984539|NCT03148522|Citalopram|citalopram|mesh-list
56984540|NCT03148522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56984541|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56984542|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56984543|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666750|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56984544|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984545|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
56984546|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984547|NCT03148522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56984548|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
56984549|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56984550|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984551|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56984552|NCT03148522|Analgesics|analgesics|mesh-ancestor
56984553|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
56984554|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
56984555|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56984556|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
56984557|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
56984558|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56984559|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56984560|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984561|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56984562|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56984563|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56984564|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
56984565|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56984566|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56905348|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
56984567|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56984568|NCT03148444|Cephalexin|cephalexin|mesh-list
56984569|NCT03148444|Roxithromycin|roxithromycin|mesh-list
56984570|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984571|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984572|NCT03148132|Bevacizumab|bevacizumab|mesh-list
56984573|NCT03148132|Ranibizumab|ranibizumab|mesh-list
56984574|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56984575|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984576|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56984577|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56984578|NCT03148132|Growth Substances|growth substances|mesh-ancestor
56984579|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984580|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
56984581|NCT02339350|Methotrexate|methotrexate|mesh-list
56984582|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56984583|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
56984584|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56984585|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984586|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56984587|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
56984588|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984589|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984590|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
56984591|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984592|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56984593|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984594|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
56984595|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56984596|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56984597|NCT05166304|Rebamipide|rebamipide|mesh-list
56984598|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56984599|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984600|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
56984601|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984602|NCT05166304|Protective Agents|protective agents|mesh-ancestor
56984603|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984604|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984605|NCT02339428|Diclofenac|diclofenac|mesh-list
56984606|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56984607|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56984608|NCT02339428|Analgesics|analgesics|mesh-ancestor
56984609|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
56984610|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984611|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984612|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56984613|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56984614|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56984615|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984616|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666827|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
56984617|NCT02337322|Ritonavir|ritonavir|mesh-list
56984618|NCT02337322|Darunavir|darunavir|mesh-list
56984619|NCT02337322|Dolutegravir|dolutegravir|mesh-list
56984620|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56984621|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56984622|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
56984623|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984624|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984625|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56984626|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56984627|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
56984628|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984629|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56984630|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56984631|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56984632|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56984633|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
56984634|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56984635|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
56984636|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984637|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
56984638|NCT02337166|Protective Agents|protective agents|mesh-ancestor
56984639|NCT03148288|Vitamin D|vitamin d|mesh-list
56984640|NCT03148288|Vitamins|vitamins|mesh-ancestor
56984641|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
56984642|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984643|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56984644|NCT02039362|Tenofovir|tenofovir|mesh-list
56984645|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
56984646|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984647|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56984648|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56984649|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984650|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984651|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56984652|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56984653|NCT02339116|Bevacizumab|bevacizumab|mesh-list
56984654|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
56984655|NCT02339116|Irinotecan|irinotecan|mesh-list
56984656|NCT02339116|Fluorouracil|fluorouracil|mesh-list
56984657|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56984658|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984659|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56984660|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56984661|NCT02339116|Growth Substances|growth substances|mesh-ancestor
56984662|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984663|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
56984664|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56984665|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56984666|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984667|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984668|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
56984669|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56984670|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984671|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
56984672|NCT04824274|Fentanyl|fentanyl|mesh-list
56984673|NCT04824274|Morphine|morphine|mesh-list
56984674|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56984675|NCT04824274|Narcotics|narcotics|mesh-ancestor
56984676|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984677|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984678|NCT04824274|Analgesics|analgesics|mesh-ancestor
56984679|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
56984680|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984681|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56984682|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56984683|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
56984684|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
56984685|NCT02348788|Chloroquine|chloroquine|mesh-list
56984686|NCT02348788|Lumefantrine|lumefantrine|mesh-list
56984687|NCT02348788|Artemether|artemether|mesh-list
56984688|NCT02348788|Primaquine|primaquine|mesh-list
56984689|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56984690|NCT02348788|Amebicides|amebicides|mesh-ancestor
56984691|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56984692|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56984693|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984694|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
56984695|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56984696|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
56984697|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56984698|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56984699|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984700|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
56984701|NCT04754230|Coagulants|coagulants|mesh-ancestor
56984702|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56984703|NCT02338570|Everolimus|everolimus|mesh-list
56984704|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984705|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984706|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
56984707|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984708|NCT02336854|Tacrolimus|tacrolimus|mesh-list
56984709|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984710|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
56984711|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984712|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56984713|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984714|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984715|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56984716|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
56984717|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984718|NCT02332174|Rufinamide|rufinamide|mesh-list
56984719|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
56984720|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56984721|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56984722|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56984723|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984724|NCT03726125|Insulin|insulin|mesh-list
56984725|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56984726|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
56984727|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56984728|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984729|NCT02336308|Ketamine|ketamine|mesh-list
56984730|NCT02336308|Analgesics|analgesics|mesh-ancestor
56984731|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
56984732|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984733|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984734|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56984735|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56984736|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
56984737|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
56984738|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984739|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56984740|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56984741|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984742|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984743|NCT02336386|Dexamethasone|dexamethasone|mesh-list
56984744|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
56984745|NCT02336386|Doxorubicin|doxorubicin|mesh-list
56984746|NCT02336386|Bortezomib|bortezomib|mesh-list
56984747|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984748|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
56984749|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984750|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56984751|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56984752|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
56984753|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984754|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984755|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56984756|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56984757|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
56984758|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
56984759|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984760|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984761|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
56984762|NCT02336386|Hormones|hormones|mesh-ancestor
56984763|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56984764|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56984765|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984766|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56984767|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56984768|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56984769|NCT02337712|Etoposide|etoposide|mesh-list
56984770|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667031|NCT01004575|Cobalt|cobalt|mesh-list
56984771|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56984772|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56984773|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56984774|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984775|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984776|NCT03049540|Tadalafil|tadalafil|mesh-list
56984777|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
56984778|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56984779|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56984780|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984781|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984782|NCT03049540|Urological Agents|urological agents|mesh-ancestor
56984783|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56984784|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56984785|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56984786|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
56984787|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984788|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984789|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984790|NCT03492281|Urological Agents|urological agents|mesh-ancestor
56984791|NCT02336152|Anesthetics|anesthetics|mesh-list
56905588|NCT01562301|Docetaxel|docetaxel|mesh-list
56984792|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984793|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984794|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
56984795|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56984796|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56984797|NCT02331862|Prednisolone|prednisolone|mesh-list
56984798|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
56984799|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56984800|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
56984801|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56984802|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
56984803|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
56984804|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984805|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984806|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984807|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
56984808|NCT02331862|Hormones|hormones|mesh-ancestor
56984809|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56984810|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56984811|NCT02331862|Protective Agents|protective agents|mesh-ancestor
56984812|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56984813|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984814|NCT03525119|Vaccines|vaccines|mesh-list
56984815|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
56984816|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984817|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
56984818|NCT05230654|Aprepitant|aprepitant|mesh-list
56984819|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
56984820|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
56984821|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984822|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984823|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984824|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56984825|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984826|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984827|NCT02039518|Gemcitabine|gemcitabine|mesh-list
56984828|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56984829|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
56984830|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984831|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984832|NCT02039518|Antiviral Agents|antiviral agents|mesh-ancestor
56984833|NCT02039518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984834|NCT02039518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984835|NCT02039518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984836|NCT02039518|Immunologic Factors|immunologic factors|mesh-ancestor
56984837|NCT02039518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984838|NCT03722381|Amlodipine|amlodipine|mesh-list
56984839|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56984840|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56984841|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56984842|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984843|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56667058|NCT01004731|Cetuximab|cetuximab|mesh-list
56984844|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984845|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
56984846|NCT04352608|Vaccines|vaccines|mesh-list
56984847|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
56984848|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984849|NCT03722303|Cortisone|cortisone|mesh-list
56984850|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56984851|NCT03558503|Mitomycins|mitomycins|mesh-list
56984852|NCT03558503|Mitomycin|mitomycin|mesh-list
56984853|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56984854|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984855|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
56984856|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984857|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56984858|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984859|NCT02331706|Interferons|interferons|mesh-list
56984860|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
56984861|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
56984862|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984863|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
56984864|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984865|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
56984866|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984867|NCT04400838|Vaccines|vaccines|mesh-list
56984868|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
56984869|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984870|NCT03489863|Ticagrelor|ticagrelor|mesh-list
56984871|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56984872|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56984873|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56984874|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56984875|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56984876|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
56984877|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984878|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984879|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984880|NCT04344444|Azithromycin|azithromycin|mesh-list
56984881|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
56984882|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984883|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984884|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
56984885|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56984886|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56984887|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984888|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984889|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56984890|NCT03489551|Haloperidol|haloperidol|mesh-list
56984891|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
56984892|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
56984893|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984894|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984895|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984896|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56984897|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56984898|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56984899|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56984900|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56984901|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
56984902|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984903|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984904|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56984905|NCT05762952|Dapagliflozin|dapagliflozin|mesh-list
56984906|NCT05762952|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56984907|NCT05762952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984908|NCT05762952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56984909|NCT05762952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984910|NCT02335684|Methamphetamine|methamphetamine|mesh-list
56984911|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56984912|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984913|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
56984914|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
56984915|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984916|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
56984917|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984918|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984919|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
56984920|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56984921|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56984922|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56984923|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56984924|NCT05198388|Endorphins|endorphins|mesh-list
56984925|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984926|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984927|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984928|NCT04210180|Varenicline|varenicline|mesh-list
56984929|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56984930|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56984931|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
56984932|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984933|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984934|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984935|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56984936|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
56984937|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56984938|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56984939|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56984940|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56984941|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56984942|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984943|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56984944|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56984945|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984946|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
56984947|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56984948|NCT03105310|Interferons|interferons|mesh-list
56984949|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
56984950|NCT03105310|Ezetimibe|ezetimibe|mesh-list
56984951|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984952|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
56984953|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984954|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
56984955|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984956|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56984957|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56984958|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
56984959|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984960|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56984961|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
56984962|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56984963|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984964|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56984965|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56984966|NCT03105466|Tacrolimus|tacrolimus|mesh-list
56984967|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56984968|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
56984969|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984970|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56984971|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56984972|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56984973|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56984974|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56984975|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984976|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984977|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
56984978|NCT03105466|Hormones|hormones|mesh-ancestor
56984979|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56984980|NCT02335372|Acetic Acid|acetic acid|mesh-list
56984981|NCT02335372|Proflavine|proflavine|mesh-list
56984982|NCT02335372|Retinol acetate|retinol acetate|mesh-list
56984983|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56984984|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56984985|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56984986|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
56984987|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56984988|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56984989|NCT02335372|Protective Agents|protective agents|mesh-ancestor
56984990|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56984991|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56984992|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
56984993|NCT03488225|Leucovorin|leucovorin|mesh-list
56984995|NCT03488225|Cytarabine|cytarabine|mesh-list
56984996|NCT03488225|Dexamethasone|dexamethasone|mesh-list
56984997|NCT03488225|Prednisone|prednisone|mesh-list
56984998|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
56984999|NCT03488225|Cortisone|cortisone|mesh-list
56985000|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
56985001|NCT03488225|Rituximab|rituximab|mesh-list
56985002|NCT03488225|Doxorubicin|doxorubicin|mesh-list
56985003|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56985004|NCT03488225|Methotrexate|methotrexate|mesh-list
56985005|NCT03488225|Vincristine|vincristine|mesh-list
56985006|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
56985007|NCT03488225|Ofatumumab|ofatumumab|mesh-list
56985008|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56985009|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56985010|NCT03488225|Antibodies|antibodies|mesh-list
56985011|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
56985012|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56985013|NCT03488225|BB 1101|bb 1101|mesh-list
56985014|NCT03488225|Calcium|calcium|mesh-list
56985015|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
56985016|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985017|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
56985018|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985019|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56985020|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56985021|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
56985022|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985023|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985024|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56985025|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985026|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
56985027|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
56985028|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985029|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56985030|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
56985031|NCT03488225|Hormones|hormones|mesh-ancestor
56985032|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985033|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56985034|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56985035|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56985036|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56985037|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985038|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56985039|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56985040|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56985041|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
56985042|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56985043|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56985044|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
56985045|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
56985046|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56985047|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56985048|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
56985049|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985050|NCT03488225|Antidotes|antidotes|mesh-ancestor
56985051|NCT03488225|Protective Agents|protective agents|mesh-ancestor
56985052|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
56985053|NCT03488225|Vitamins|vitamins|mesh-ancestor
56985054|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
56985055|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56985056|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
56985057|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
56985058|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
56985059|NCT03488225|Hematinics|hematinics|mesh-ancestor
56985060|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
56985061|NCT02334904|Risperidone|risperidone|mesh-list
56985062|NCT02334904|Aripiprazole|aripiprazole|mesh-list
56985063|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56985064|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
56985065|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985066|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985067|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985068|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56985069|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56985070|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985071|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56985072|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56985073|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
56985074|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
56985075|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
56985076|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56985077|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56985078|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56985079|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56985080|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56985081|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56985082|NCT03437447|Praziquantel|praziquantel|mesh-list
56985083|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
56985084|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56985085|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985086|NCT03720041|Dexamethasone|dexamethasone|mesh-list
56985087|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
56985088|NCT03720041|Lenalidomide|lenalidomide|mesh-list
56985089|NCT03720041|Ixazomib|ixazomib|mesh-list
56985090|NCT03720041|BB 1101|bb 1101|mesh-list
56985091|NCT03720041|Glycine|glycine|mesh-list
56985092|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985093|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
56985094|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
56985095|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729809|NCT03135795|Propofol|propofol|mesh-list
56905868|NCT03745599|Diclofenac|diclofenac|mesh-list
56985096|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985097|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56985098|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
56985099|NCT03720041|Hormones|hormones|mesh-ancestor
56985100|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985101|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56985102|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985103|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
56985104|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985105|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985106|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
56985107|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56985108|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56985109|NCT03720041|Growth Substances|growth substances|mesh-ancestor
56985110|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
56985111|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
56985112|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985113|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
56985114|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56985115|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
56985116|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985117|NCT02334670|Fluconazole|fluconazole|mesh-list
56985118|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
56985119|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985120|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56985121|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56985122|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985123|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985124|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56985125|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
56985126|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985127|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985128|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56985129|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56985130|NCT02974868|PF-06700841|pf-06700841|mesh-list
56985131|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56985132|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985133|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985134|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56985135|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56985136|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
56985137|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56985138|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
56985139|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56985140|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985141|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56985142|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56985143|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985144|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
56985145|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56985146|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
56667347|NCT02638922|Estrogens|estrogens|mesh-ancestor
56985147|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985148|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
56985149|NCT05076526|Protective Agents|protective agents|mesh-ancestor
56985150|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
56985151|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56985152|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985153|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56985154|NCT03143998|Grazoprevir|grazoprevir|mesh-list
56985155|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
56985156|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985157|NCT02334046|Remifentanil|remifentanil|mesh-list
56985158|NCT02334046|Sevoflurane|sevoflurane|mesh-list
56985159|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56985160|NCT02334046|Narcotics|narcotics|mesh-ancestor
56985161|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985162|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985163|NCT02334046|Analgesics|analgesics|mesh-ancestor
56985164|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
56985165|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985166|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56905945|NCT02112214|Bismuth|bismuth|mesh-list
56985167|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56985168|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
56985169|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
56985170|NCT02330380|Adalimumab|adalimumab|mesh-list
56985171|NCT02330380|Etanercept|etanercept|mesh-list
56985172|NCT02330380|Methotrexate|methotrexate|mesh-list
56985173|NCT02330380|Ustekinumab|ustekinumab|mesh-list
56985174|NCT02330380|Acitretin|acitretin|mesh-list
56985175|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56985176|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
56985177|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56985178|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985179|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56985180|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
56985181|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985182|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985183|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
56985184|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985185|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56985186|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985187|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
56985188|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56985189|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56985190|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985191|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56985192|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56985193|NCT02330380|Analgesics|analgesics|mesh-ancestor
56985194|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
56985195|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985196|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56985197|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
56985198|NCT04278404|Metformin|metformin|mesh-list
56985199|NCT04278404|Interferons|interferons|mesh-list
56985200|NCT04278404|Ritonavir|ritonavir|mesh-list
56985201|NCT04278404|Ribavirin|ribavirin|mesh-list
56985202|NCT04278404|Lopinavir|lopinavir|mesh-list
56985203|NCT04278404|Oseltamivir|oseltamivir|mesh-list
56985204|NCT04278404|Remdesivir|remdesivir|mesh-list
56985205|NCT04278404|Azithromycin|azithromycin|mesh-list
56985206|NCT04278404|Clindamycin|clindamycin|mesh-list
56985207|NCT04278404|Meropenem|meropenem|mesh-list
56985208|NCT04278404|Voriconazole|voriconazole|mesh-list
56985209|NCT04278404|Ceftazidime|ceftazidime|mesh-list
56985210|NCT04278404|Fosfomycin|fosfomycin|mesh-list
56985211|NCT04278404|Cefepime|cefepime|mesh-list
56985212|NCT04278404|Cefdinir|cefdinir|mesh-list
56985213|NCT04278404|Dexamethasone|dexamethasone|mesh-list
56985214|NCT04278404|Budesonide|budesonide|mesh-list
56985215|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
56985216|NCT04278404|Colchicine|colchicine|mesh-list
56985217|NCT04278404|Amiodarone|amiodarone|mesh-list
56985218|NCT04278404|Bosentan|bosentan|mesh-list
56985219|NCT04278404|Guanfacine|guanfacine|mesh-list
56985220|NCT04278404|Labetalol|labetalol|mesh-list
56985221|NCT04278404|Nicardipine|nicardipine|mesh-list
56985222|NCT04278404|Nifedipine|nifedipine|mesh-list
56985223|NCT04278404|Milrinone|milrinone|mesh-list
56985224|NCT04278404|Furosemide|furosemide|mesh-list
56985225|NCT04278404|Spironolactone|spironolactone|mesh-list
56985226|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
56985227|NCT04278404|Oxycodone|oxycodone|mesh-list
56985228|NCT04278404|Gabapentin|gabapentin|mesh-list
56985229|NCT04278404|Nalbuphine|nalbuphine|mesh-list
56985230|NCT04278404|Clobazam|clobazam|mesh-list
56985231|NCT04278404|Zolpidem|zolpidem|mesh-list
56985232|NCT04278404|Risperidone|risperidone|mesh-list
56985233|NCT04278404|Amphetamine|amphetamine|mesh-list
56985234|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
56985235|NCT04278404|Sertraline|sertraline|mesh-list
56985236|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
56985237|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
56985238|NCT04278404|Terbutaline|terbutaline|mesh-list
56985239|NCT04278404|Sevelamer|sevelamer|mesh-list
56985240|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985241|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
56985242|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
56985243|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985244|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985245|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56985246|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
56985247|NCT04278404|Hormones|hormones|mesh-ancestor
56985248|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985249|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56985250|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985251|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
56985252|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985253|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985254|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56985255|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56985256|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985257|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56985258|NCT04278404|Analgesics|analgesics|mesh-ancestor
56985259|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
56985260|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56985261|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56985262|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56985263|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
56985264|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985265|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
56985266|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985267|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56985268|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56985269|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56985270|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56985271|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56985272|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56985273|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56985274|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56985275|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56985276|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
56985277|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56985278|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56985279|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
56985280|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56985281|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56985282|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
56985283|NCT04278404|Coagulants|coagulants|mesh-ancestor
56985284|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56985285|NCT04278404|Narcotics|narcotics|mesh-ancestor
56985286|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
56985287|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56985288|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56985289|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56985290|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56985291|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56985292|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
56985293|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56985294|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
56985295|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56985296|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56985297|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
56985298|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
56985299|NCT04278404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56985300|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56985301|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56985302|NCT04278404|Diuretics|diuretics|mesh-ancestor
56985303|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
56985304|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56985305|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
56985306|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
56985307|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
56985308|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
56985309|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56985310|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
56985311|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56985312|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56985313|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56985314|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56985315|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
56985316|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
56985317|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56985318|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
56985319|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56985320|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56985321|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56985322|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56985323|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
56985324|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
56985325|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56985326|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56985327|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56985328|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56985329|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56985330|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56985331|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56985332|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
56985333|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56985334|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56985335|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56985336|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56985337|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
56985338|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
56985339|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56985340|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56985341|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56985342|NCT04278404|Protective Agents|protective agents|mesh-ancestor
56985343|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56985344|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56985345|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56985346|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56985347|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56985348|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56985349|NCT02333890|Chloroquine|chloroquine|mesh-list
56985350|NCT02333890|Amebicides|amebicides|mesh-ancestor
56985351|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56985352|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56985353|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985354|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
56985355|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56985356|NCT02330302|Ropivacaine|ropivacaine|mesh-list
56985357|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
56985358|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
56985359|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985360|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985361|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
56985362|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985363|NCT03143530|Ropivacaine|ropivacaine|mesh-list
56985364|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
56985365|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
56985366|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985367|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985368|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
56985369|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985370|NCT01065818|Telbivudine|telbivudine|mesh-list
56985371|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
56985372|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985373|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56985374|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985375|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985376|NCT03697408|Everolimus|everolimus|mesh-list
56985377|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985378|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985379|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
56985380|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985381|NCT02318277|Durvalumab|durvalumab|mesh-list
56985382|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56985383|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667571|NCT00530023|Insulin|insulin|mesh-list
56985384|NCT03143452|Lidocaine|lidocaine|mesh-list
56985385|NCT03143452|Tetracaine|tetracaine|mesh-list
56985386|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56985387|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
56985388|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
56985389|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985390|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985391|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
56985392|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985393|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56985394|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56985395|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56985396|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56985397|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985398|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56985399|NCT01063868|Oxycodone|oxycodone|mesh-list
56985400|NCT01063868|Tapentadol|tapentadol|mesh-list
56906179|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
56985401|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56985402|NCT01063868|Narcotics|narcotics|mesh-ancestor
56985403|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985404|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985405|NCT01063868|Analgesics|analgesics|mesh-ancestor
56985406|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
56985407|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985408|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56985409|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56985410|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56985411|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985412|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
56985413|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985414|NCT04993924|Cetrorelix|cetrorelix|mesh-list
56985415|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56985416|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
56985417|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56985418|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985419|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
56985420|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985421|NCT02330068|Citalopram|citalopram|mesh-list
56985422|NCT02330068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56985423|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56985424|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56985425|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985426|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985427|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
56985428|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985429|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56985430|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
56985431|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56985432|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
56985433|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56985434|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985435|NCT01312857|Panitumumab|panitumumab|mesh-list
56985436|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56985437|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985438|NCT02974010|Cycloserine|cycloserine|mesh-list
56985439|NCT02974010|Ketamine|ketamine|mesh-list
56985440|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56985441|NCT02974010|Analgesics|analgesics|mesh-ancestor
56985442|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
56985443|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985444|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985445|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56985446|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56985447|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
56985448|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
56985449|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985450|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56985451|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56985452|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985453|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985454|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56985455|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985456|NCT02974010|Renal Agents|renal agents|mesh-ancestor
56985458|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
56985459|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56985460|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
56985461|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56985462|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56985463|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56985464|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56985465|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56985466|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56985467|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
56985468|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56985469|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56985470|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
56985471|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56985472|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56985473|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
56985474|NCT01061606|Sirolimus|sirolimus|mesh-list
56985475|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56985476|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985477|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56985478|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985479|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
56985480|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985481|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
56985482|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985483|NCT04696822|Epinephrine|epinephrine|mesh-list
56985484|NCT04696822|Racepinephrine|racepinephrine|mesh-list
56985485|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
56985486|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56985487|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56985488|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
56985489|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985490|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985491|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985492|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56985493|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56985494|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
56985495|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985496|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56985497|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
56985498|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
56985499|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
56985500|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56985501|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
56985502|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56985503|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56985504|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985505|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
56985506|NCT02329756|Coagulants|coagulants|mesh-ancestor
56985507|NCT02329288|Triamcinolone|triamcinolone|mesh-list
56985508|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56985509|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56985510|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56985511|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985512|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
56985513|NCT02329288|Hormones|hormones|mesh-ancestor
56985514|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985515|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985516|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985517|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
56985518|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985519|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985520|NCT02333188|Leucovorin|leucovorin|mesh-list
56985521|NCT02333188|Paclitaxel|paclitaxel|mesh-list
56985522|NCT02333188|Fluorouracil|fluorouracil|mesh-list
56985523|NCT02333188|Irinotecan|irinotecan|mesh-list
56985524|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56985525|NCT02333188|Calcium|calcium|mesh-list
56985526|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
56985527|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56985528|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985529|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56985530|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56985531|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56985532|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985533|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56985534|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985535|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
56985536|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56985537|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985538|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
56985539|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56985540|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56985541|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985542|NCT02333188|Antidotes|antidotes|mesh-ancestor
56985543|NCT02333188|Protective Agents|protective agents|mesh-ancestor
56985544|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
56985545|NCT02333188|Vitamins|vitamins|mesh-ancestor
56985546|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
56985547|NCT02329054|Favipiravir|favipiravir|mesh-list
56985548|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
56985549|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985550|NCT03122457|C 1027|c 1027|mesh-list
56985551|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56985552|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
56985553|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56985554|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985555|NCT04407988|Letrozole|letrozole|mesh-list
56985556|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985557|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56985558|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56985559|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985560|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985561|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56985562|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
56985563|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985564|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985565|NCT02329132|Ranibizumab|ranibizumab|mesh-list
56985566|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56985567|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56985568|NCT02329132|Growth Substances|growth substances|mesh-ancestor
56985569|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985570|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
56985571|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985572|NCT04342078|Vitamin D|vitamin d|mesh-list
56985573|NCT04342078|Vitamins|vitamins|mesh-ancestor
56985574|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
56985575|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985576|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56985577|NCT02332954|Vortioxetine|vortioxetine|mesh-list
56985578|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
56985579|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56985580|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56985581|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56985582|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985583|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985584|NCT02332954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56985585|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56985586|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56985587|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985588|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985589|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
56985590|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56985591|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56985592|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56985593|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56985594|NCT01372761|CKD732|ckd732|mesh-list
56985595|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56985596|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56985597|NCT01372761|Growth Substances|growth substances|mesh-ancestor
56985598|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985599|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
56985600|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985601|NCT03873675|Hormones|hormones|mesh-list
56985602|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
56985603|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985604|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985605|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56985606|NCT05173857|Paclitaxel|paclitaxel|mesh-list
56985607|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56985608|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985609|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
56985610|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
56985611|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
56985612|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985613|NCT05133297|Tofacitinib|tofacitinib|mesh-list
56985614|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56985615|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985616|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985617|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
56985618|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56985619|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985620|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985621|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56985622|NCT03417999|Analgesics|analgesics|mesh-ancestor
56985623|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
56985624|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985625|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56985626|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56985627|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56985628|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
56985629|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985630|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985631|NCT03142516|Leucovorin|leucovorin|mesh-list
56985632|NCT03142516|Folic Acid|folic acid|mesh-list
56985633|NCT03142516|Fluorouracil|fluorouracil|mesh-list
56985634|NCT03142516|Irinotecan|irinotecan|mesh-list
56985635|NCT03142516|Panitumumab|panitumumab|mesh-list
56985636|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
56985637|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
56985638|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985639|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56985640|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985641|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985642|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
56985643|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985644|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56985645|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56985646|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985647|NCT03142516|Antidotes|antidotes|mesh-ancestor
56985648|NCT03142516|Protective Agents|protective agents|mesh-ancestor
56985649|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
56985650|NCT03142516|Vitamins|vitamins|mesh-ancestor
56985651|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
56985652|NCT03142516|Hematinics|hematinics|mesh-ancestor
56985653|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56985654|NCT03719729|Rifaximin|rifaximin|mesh-list
56985655|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56985656|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985657|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56985658|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
56985659|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
56985660|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
56985661|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985662|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985663|NCT03714113|Antibodies|antibodies|mesh-list
56985664|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
56985665|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985666|NCT03472547|Diacetylrhein|diacetylrhein|mesh-list
56985667|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985668|NCT00799396|Aspirin|aspirin|mesh-list
56985669|NCT00799396|Clopidogrel|clopidogrel|mesh-list
56985670|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56985671|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56985672|NCT00799396|Analgesics|analgesics|mesh-ancestor
56985673|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
56985674|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985675|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985676|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985677|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56985678|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56985679|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56985680|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985681|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56985682|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56985683|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985684|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
56985685|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56985686|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56985687|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56985688|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
56985689|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985690|NCT02624128|Cetuximab|cetuximab|mesh-list
56985691|NCT02624128|Valproic Acid|valproic acid|mesh-list
56985692|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985693|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56985694|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
56985695|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985696|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985697|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
56985698|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985699|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985700|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
56985701|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56985702|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985703|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56985704|NCT03469349|Actovegin|actovegin|mesh-list
56985705|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56985706|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985707|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56985708|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56985709|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
56985710|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985711|NCT03469349|Protective Agents|protective agents|mesh-ancestor
56985712|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56985713|NCT03467945|Metformin|metformin|mesh-list
56985714|NCT03467945|Gliclazide|gliclazide|mesh-list
56985715|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56985716|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985717|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56985718|NCT03719261|Eusol|eusol|mesh-list
56985719|NCT03719261|Chitosan|chitosan|mesh-list
56985720|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56985721|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56985722|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
56985723|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985724|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56985725|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
56985726|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
56985727|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
56985728|NCT03719261|Coagulants|coagulants|mesh-ancestor
56985729|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
56985730|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985731|NCT00069238|Prednisone|prednisone|mesh-list
56985732|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
56985733|NCT00069238|Doxorubicin|doxorubicin|mesh-list
56985734|NCT00069238|Etoposide|etoposide|mesh-list
56985735|NCT00069238|Vincristine|vincristine|mesh-list
56985736|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
56985737|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985738|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
56985739|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985740|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56985741|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56985742|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
56985743|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985744|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985745|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56985746|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56985747|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56985748|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56985749|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985750|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985751|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
56985752|NCT00069238|Hormones|hormones|mesh-ancestor
56985753|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985754|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56985755|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56985756|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
56985757|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
56985758|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
56985759|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56985760|NCT03639155|Glycine|glycine|mesh-list
56985761|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
56985762|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985763|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985764|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985765|NCT05080348|Ropivacaine|ropivacaine|mesh-list
56985766|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
56985767|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
56985768|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985769|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985770|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
56985771|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985772|NCT03073200|Etanercept|etanercept|mesh-list
56985773|NCT03073200|Ixekizumab|ixekizumab|mesh-list
56985774|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56985775|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56985776|NCT03073200|Analgesics|analgesics|mesh-ancestor
56985777|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
56906553|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
56985778|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985779|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985780|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985781|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56985782|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56985783|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985784|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
56985785|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
56985786|NCT02030860|Gemcitabine|gemcitabine|mesh-list
56985787|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56985788|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56985789|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
56985790|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985791|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985792|NCT02030860|Antiviral Agents|antiviral agents|mesh-ancestor
56985793|NCT02030860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985794|NCT02030860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985795|NCT02030860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985796|NCT02030860|Immunologic Factors|immunologic factors|mesh-ancestor
56985797|NCT02030860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985798|NCT01569984|Bevacizumab|bevacizumab|mesh-list
56985799|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56985800|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985801|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56985802|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56985803|NCT01569984|Growth Substances|growth substances|mesh-ancestor
56985804|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985805|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
56985806|NCT02328118|Triamcinolone|triamcinolone|mesh-list
56985807|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56985808|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56985809|NCT02328118|Ranibizumab|ranibizumab|mesh-list
56985810|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56985811|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56985812|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56985813|NCT02328118|Growth Substances|growth substances|mesh-ancestor
56985814|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985815|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
56985816|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985817|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985818|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
56985819|NCT02328118|Hormones|hormones|mesh-ancestor
56985820|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985821|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56985822|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
56985823|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985824|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985825|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
56985826|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985827|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56985828|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985829|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985830|NCT05079880|Caffeine|caffeine|mesh-list
56985831|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
56985832|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985833|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56985834|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985835|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56985836|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985837|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56985838|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56985839|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
56985840|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985841|NCT03716765|Vitamin D|vitamin d|mesh-list
56985842|NCT03716765|Vitamins|vitamins|mesh-ancestor
56985843|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
56985844|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985845|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56985846|NCT03629418|Phenylephrine|phenylephrine|mesh-list
56985847|NCT03629418|Norepinephrine|norepinephrine|mesh-list
56985848|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56985849|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
56985850|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
56985851|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906623|NCT02117596|Sirolimus|sirolimus|mesh-list
56985852|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985853|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
56985854|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56985855|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
56985856|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
56985857|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56985858|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56985859|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56985860|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
56985861|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985862|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985863|NCT03629418|Protective Agents|protective agents|mesh-ancestor
56985864|NCT03070002|Denosumab|denosumab|mesh-list
56985865|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56985866|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985867|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
56985868|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56985869|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56985870|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56985871|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56985872|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985873|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
56985874|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985875|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985876|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56985877|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985878|NCT02918318|Esketamine|esketamine|mesh-list
56985879|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
56985880|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56985881|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
56985882|NCT04926454|Bupivacaine|bupivacaine|mesh-list
56985883|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
56985884|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
56985885|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985886|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985887|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
56985888|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985889|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56985890|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56985891|NCT04926454|Analgesics|analgesics|mesh-ancestor
56985892|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56985893|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56985894|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56985895|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56985896|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985897|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985898|NCT03652376|Benralizumab|benralizumab|mesh-list
56985899|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56985900|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
56985901|NCT05200143|Nivolumab|nivolumab|mesh-list
56985902|NCT05200143|Ipilimumab|ipilimumab|mesh-list
56985903|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56985904|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985905|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56985906|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985907|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
56985908|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56985909|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985910|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
56985911|NCT01372839|Atorvastatin|atorvastatin|mesh-list
56985912|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56985913|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56985914|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
56985915|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985916|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56985917|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56985918|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985919|NCT01065350|Ketamine|ketamine|mesh-list
56985920|NCT01065350|Propofol|propofol|mesh-list
56985921|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56985922|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56985923|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985924|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56985925|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
56985926|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
56985927|NCT01065350|Analgesics|analgesics|mesh-ancestor
56985928|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
56985929|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985930|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56985931|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56985932|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56985933|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985934|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985935|NCT02914977|Daunorubicin|daunorubicin|mesh-list
56985936|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56985937|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985938|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56985939|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56985940|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985941|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985942|NCT03718715|Metformin|metformin|mesh-list
56985943|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56985944|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985945|NCT05079022|Aflutinib|aflutinib|mesh-list
56985946|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56985947|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56985948|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985949|NCT05078788|Triamcinolone|triamcinolone|mesh-list
56985950|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56985951|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
56985952|NCT05078788|Hormones|hormones|mesh-ancestor
56985953|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985954|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985955|NCT02032654|Floxacillin|floxacillin|mesh-list
56985956|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56985957|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56985958|NCT04734886|Vitamin D|vitamin d|mesh-list
56985959|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
56985960|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
56985961|NCT04734886|Vitamins|vitamins|mesh-list
56985962|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
56985963|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985964|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56985965|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56985966|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56985967|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
56985968|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56985969|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56985970|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
56985971|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56985972|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
56985973|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56985974|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985975|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
56985976|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56985977|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
56985978|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56985979|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985980|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
56985981|NCT03114969|Hormones|hormones|mesh-ancestor
56985982|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56985983|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
56985984|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56668174|NCT02624388|Estrogens|estrogens|mesh-ancestor
56985985|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
56985986|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985988|NCT03144778|Ipilimumab|ipilimumab|mesh-list
56985989|NCT03144778|Tremelimumab|tremelimumab|mesh-list
56985990|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
56985991|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56985992|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
56985993|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56985994|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56985995|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
56985996|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56985997|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56985998|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56985999|NCT03142360|Beraprost|beraprost|mesh-list
56986000|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56986001|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
56986002|NCT05124678|Isoniazid|isoniazid|mesh-list
56986003|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
56986004|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56986005|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986006|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56986007|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56986008|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
56986009|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986010|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56986011|NCT05761860|Oxycodone|oxycodone|mesh-list
56986012|NCT05761860|Oxytocin|oxytocin|mesh-list
56986013|NCT05761860|Oxytocics|oxytocics|mesh-ancestor
56986014|NCT05761860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56986015|NCT05761860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986016|NCT05761860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56986017|NCT05761860|Narcotics|narcotics|mesh-ancestor
56986018|NCT05761860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986019|NCT05761860|Analgesics|analgesics|mesh-ancestor
56986020|NCT05761860|Sensory System Agents|sensory system agents|mesh-ancestor
56986021|NCT05761860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986022|NCT03122145|Capsaicin|capsaicin|mesh-list
56986023|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
56986024|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
56986025|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
56986026|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986027|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986028|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
56986029|NCT05081674|Nivolumab|nivolumab|mesh-list
56986030|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56986031|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56986032|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986033|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56986034|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986035|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986036|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986037|NCT05003076|Methamphetamine|methamphetamine|mesh-list
56986038|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56986039|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986040|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
56986041|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
56986042|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986043|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
56986044|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986045|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986046|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
56986047|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56986048|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56986049|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56986050|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56986051|NCT03144856|Apatinib|apatinib|mesh-list
56986052|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986053|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986054|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986055|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986056|NCT03141970|Prednisone|prednisone|mesh-list
56986057|NCT03141970|Prednisolone|prednisolone|mesh-list
56986058|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56986059|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
56986060|NCT03141970|Hormones|hormones|mesh-ancestor
56986061|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56986062|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986063|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56986064|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986065|NCT04949022|Insulin|insulin|mesh-list
56986066|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56986067|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986068|NCT02327338|Ibuprofen|ibuprofen|mesh-list
56986069|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56986070|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56986071|NCT02327338|Analgesics|analgesics|mesh-ancestor
56986072|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
56986073|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729810|NCT03135795|Sevoflurane|sevoflurane|mesh-list
56906853|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
56986074|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986075|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56986076|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986077|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56986078|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986079|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986080|NCT02327416|Entecavir|entecavir|mesh-list
56986081|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56986082|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
56986083|NCT02327416|Adefovir|adefovir|mesh-list
56986084|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56986085|NCT02327416|Molgramostim|molgramostim|mesh-list
56986086|NCT02327416|Sargramostim|sargramostim|mesh-list
56986087|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
56986088|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986089|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
56986090|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986091|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56986092|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56986093|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986094|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986095|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986096|NCT02926950|Metformin|metformin|mesh-list
56986097|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56986098|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56986099|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986100|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56986101|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986102|NCT01064414|Canagliflozin|canagliflozin|mesh-list
56986103|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56986104|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986105|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56986106|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986107|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
56986108|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
56986109|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56986110|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56986111|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986112|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56986113|NCT03433703|Lenvatinib|lenvatinib|mesh-list
56986114|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986115|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986116|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986117|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986118|NCT01374633|Sevoflurane|sevoflurane|mesh-list
56986119|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56986120|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56986121|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
56986122|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
56986123|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986124|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986125|NCT01178814|Lenalidomide|lenalidomide|mesh-list
56986126|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
56986127|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986128|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56986129|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56986130|NCT01178814|Growth Substances|growth substances|mesh-ancestor
56986131|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
56668323|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56986132|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986133|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
56986134|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
56986135|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986136|NCT05762484|Clindamycin|clindamycin|mesh-list
56986137|NCT05762484|Clindamycin palmitate|clindamycin palmitate|mesh-list
56986138|NCT05762484|Clindamycin phosphate|clindamycin phosphate|mesh-list
56986139|NCT05762484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56986140|NCT05762484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986141|NCT05762484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56986142|NCT05762484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729811|NCT03135795|Citric Acid|citric acid|mesh-list
56986143|NCT05762484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986144|NCT03462641|Flumazenil|flumazenil|mesh-list
56986145|NCT03462641|Antidotes|antidotes|mesh-ancestor
56986146|NCT03462641|Protective Agents|protective agents|mesh-ancestor
56986147|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986148|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
56986149|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
56986150|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986151|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986152|NCT05201352|Trifluridine|trifluridine|mesh-list
56986153|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
56986154|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986155|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
56986156|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986157|NCT04128956|Aspirin|aspirin|mesh-list
56986158|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56986159|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56986160|NCT04128956|Analgesics|analgesics|mesh-ancestor
56986161|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
56986162|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986163|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986164|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56986165|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986166|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56986167|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56986168|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986169|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56986170|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56986171|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986172|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
56986173|NCT05761704|Anticoagulants|anticoagulants|mesh-list
56986174|NCT03652142|Nivolumab|nivolumab|mesh-list
56986175|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56986176|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986177|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56986178|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986179|NCT05762328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56986180|NCT05762328|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56986181|NCT05762328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986182|NCT05762328|Antitubercular Agents|antitubercular agents|mesh-ancestor
56986183|NCT04629378|Amoxicillin|amoxicillin|mesh-list
56986184|NCT04629378|Meropenem|meropenem|mesh-list
56986185|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
56986186|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
56986187|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
56986188|NCT04629378|Bedaquiline|bedaquiline|mesh-list
56986189|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56986190|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56986191|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986192|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56986193|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986194|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986195|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
56986196|NCT03651674|Olanzapine|olanzapine|mesh-list
56986197|NCT03651674|Clozapine|clozapine|mesh-list
56986198|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
56986199|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
56986200|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986201|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986202|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56986203|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56986204|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56986205|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986206|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56986207|NCT03651674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56986208|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56986209|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56986210|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986211|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986212|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
56986213|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56986214|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
56986215|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
56986216|NCT01061840|Molgramostim|molgramostim|mesh-list
56986217|NCT01061840|Modafinil|modafinil|mesh-list
56986218|NCT01061840|Vaccines|vaccines|mesh-list
56986219|NCT01061840|Sargramostim|sargramostim|mesh-list
56986220|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
56986221|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986222|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986223|NCT01061840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56986224|NCT01061840|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56986225|NCT01061840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56986226|NCT01061840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56986227|NCT01061840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986228|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56986229|NCT02926638|Rilotumumab|rilotumumab|mesh-list
56986230|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56986231|NCT02926638|Antibodies|antibodies|mesh-list
56986232|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
56986233|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56986234|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
56986235|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986236|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986237|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986238|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986239|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986240|NCT03650582|Glucagon|glucagon|mesh-list
56986241|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56986242|NCT03650582|Hormones|hormones|mesh-ancestor
56986243|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56986244|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986245|NCT02903030|Silicon|silicon|mesh-list
56986246|NCT02903030|Trace Elements|trace elements|mesh-ancestor
56986247|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
56986248|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986249|NCT02969408|Albuterol|albuterol|mesh-list
56986250|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56986251|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
56986252|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986253|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986254|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56986255|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
56986256|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
56986257|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56986258|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56986259|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56986260|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56986261|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
56986262|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986263|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986264|NCT04528134|Listerine|listerine|mesh-list
56986265|NCT04528134|Fluorides|fluorides|mesh-list
56986266|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
56986267|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
56986268|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
56986269|NCT04528134|Protective Agents|protective agents|mesh-ancestor
56986270|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986271|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56986272|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986273|NCT05180214|Ketorolac|ketorolac|mesh-list
56986274|NCT05180214|Bupivacaine|bupivacaine|mesh-list
56986275|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
56986276|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
56986277|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986278|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986279|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
56986280|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986281|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56986282|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56668464|NCT00734890|Bevacizumab|bevacizumab|mesh-list
56986283|NCT05180214|Analgesics|analgesics|mesh-ancestor
56986284|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56986285|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986286|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56986287|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986288|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986289|NCT01060124|Fentanyl|fentanyl|mesh-list
56986290|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56986291|NCT01060124|Narcotics|narcotics|mesh-ancestor
56986292|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729812|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
56907109|NCT05243290|Niacin|niacin|mesh-list
56986293|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986294|NCT01060124|Analgesics|analgesics|mesh-ancestor
56986295|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
56986296|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986297|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56986298|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56986299|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
56986300|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
56986301|NCT03461003|Losartan|losartan|mesh-list
56986302|NCT03461003|Amlodipine|amlodipine|mesh-list
56986303|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56986304|NCT03461003|Lisinopril|lisinopril|mesh-list
56986305|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56986306|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56986307|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56986308|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986309|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56986310|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986311|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
56986312|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56986313|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56986314|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56986315|NCT03461003|Diuretics|diuretics|mesh-ancestor
56986316|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
56986317|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56986318|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56986319|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
56986320|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986321|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56986322|NCT03461003|Protective Agents|protective agents|mesh-ancestor
56986323|NCT03650348|Atezolizumab|atezolizumab|mesh-list
56986324|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986325|NCT05761470|Paclitaxel|paclitaxel|mesh-list
56986326|NCT05761470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56986327|NCT05761470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986328|NCT05761470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56986329|NCT05761470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56986330|NCT05761470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56986331|NCT05761470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986332|NCT02904902|Adalimumab|adalimumab|mesh-list
56986333|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56986334|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986335|NCT03650270|Phenytoin|phenytoin|mesh-list
56986336|NCT03650270|Midazolam|midazolam|mesh-list
56986337|NCT03650270|Phenobarbital|phenobarbital|mesh-list
56986338|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56986339|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56986340|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986341|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986342|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56986343|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56986344|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56986345|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56986346|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
56986347|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
56668536|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56986348|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
56668537|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56668538|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56668539|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56668540|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668541|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668542|NCT05153395|Insulin|insulin|mesh-list
56668543|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56668544|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56668545|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986349|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
56986350|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986351|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986352|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
56986353|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56986354|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56986355|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56986356|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56986357|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56986358|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56986359|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56986360|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56986361|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56986362|NCT05285228|Fluorides|fluorides|mesh-list
56986363|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
56986364|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
56986365|NCT05285228|Protective Agents|protective agents|mesh-ancestor
56986366|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986367|NCT04075526|Vancomycin|vancomycin|mesh-list
56986368|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
56986369|NCT04075526|Povidone|povidone|mesh-list
56986370|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56986371|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986372|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
56986373|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
56986374|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56986375|NCT05204628|Crizotinib|crizotinib|mesh-list
56986376|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986377|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986378|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986379|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986380|NCT03650738|Paclitaxel|paclitaxel|mesh-list
56986381|NCT03650738|Carboplatin|carboplatin|mesh-list
56986382|NCT03650738|Apatinib|apatinib|mesh-list
56986383|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56986384|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986385|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
56986386|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
56986387|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
56986388|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986389|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986390|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986391|NCT02904200|Silicon|silicon|mesh-list
56986392|NCT02904200|Trace Elements|trace elements|mesh-ancestor
56986393|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
56986394|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986395|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56986396|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
56986397|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986398|NCT03621800|Menthol|menthol|mesh-list
56986399|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
56986400|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
56986401|NCT03649334|Ketorolac|ketorolac|mesh-list
56986402|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56986403|NCT03649334|Fentanyl|fentanyl|mesh-list
56986404|NCT03649334|Ketamine|ketamine|mesh-list
56986405|NCT03649334|Analgesics|analgesics|mesh-ancestor
56986406|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
56986407|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986408|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986409|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56986410|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56986411|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
56986412|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
56986413|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986414|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56986415|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56986416|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986417|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986418|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56986419|NCT03649334|Narcotics|narcotics|mesh-ancestor
56986420|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56986421|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56668611|NCT04873063|Hormones|hormones|mesh-ancestor
56668625|NCT00735280|Heparin|heparin|mesh-list
56986422|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56986423|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56986424|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986425|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56986426|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986427|NCT02901548|Durvalumab|durvalumab|mesh-list
56986428|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56986429|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986430|NCT03457727|Omeprazole|omeprazole|mesh-list
56986431|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56986432|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56986433|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56986434|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986435|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986436|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
56986437|NCT05285384|Paraproteins|paraproteins|mesh-list
56986438|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
56986439|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986440|NCT03648554|Dulaglutide|dulaglutide|mesh-list
56986441|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56986442|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986443|NCT05284994|Osimertinib|osimertinib|mesh-list
56986444|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986445|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986446|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986447|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986448|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56986449|NCT03068754|Hormones|hormones|mesh-ancestor
56986450|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56986451|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986452|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
56986453|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56986454|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
56986455|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986456|NCT03430895|Durvalumab|durvalumab|mesh-list
56986457|NCT03430895|Tremelimumab|tremelimumab|mesh-list
56986458|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56986459|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986460|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
56986461|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56986462|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56986463|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986464|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
56986465|NCT04996368|Coagulants|coagulants|mesh-ancestor
56986466|NCT05745480|Analgesics, Opioid|analgesics, opioid|mesh-list
56986467|NCT05745480|Narcotics|narcotics|mesh-ancestor
56986468|NCT05745480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986469|NCT05745480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986470|NCT05745480|Analgesics|analgesics|mesh-ancestor
56986471|NCT05745480|Sensory System Agents|sensory system agents|mesh-ancestor
56986472|NCT05745480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986473|NCT03452189|Vancomycin|vancomycin|mesh-list
56986474|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56986475|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986476|NCT00603954|Fludarabine|fludarabine|mesh-list
56986477|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
56986478|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56986479|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986480|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56986481|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
56986482|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986483|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56986484|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
56986485|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986486|NCT03427619|Picibanil|picibanil|mesh-list
56986487|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986488|NCT03712475|Pregabalin|pregabalin|mesh-list
56986489|NCT03712475|Analgesics|analgesics|mesh-ancestor
56986490|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
56986491|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986492|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986493|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
56986494|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56986495|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56986496|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986497|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56986498|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56986499|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56986500|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986501|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56986502|NCT02435433|Ramucirumab|ramucirumab|mesh-list
56986503|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986504|NCT01372371|Vancomycin|vancomycin|mesh-list
56986505|NCT01372371|Gentamicins|gentamicins|mesh-list
56986506|NCT01372371|Cefuroxime|cefuroxime|mesh-list
56986507|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
56986508|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56986509|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986510|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56986511|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986512|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986513|NCT03120351|Lidocaine|lidocaine|mesh-list
56986514|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
56986515|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
56986516|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986517|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986518|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
56986519|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986520|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56986521|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56986522|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56986523|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56986524|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986525|NCT01374789|Panitumumab|panitumumab|mesh-list
56986526|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56986527|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986528|NCT02354703|Ondansetron|ondansetron|mesh-list
56986529|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
56986530|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
56986531|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986532|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986533|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56986534|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
56986535|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
56986536|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56986537|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
56986538|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986539|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986540|NCT02354703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56986541|NCT02354703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56986542|NCT02354703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986543|NCT02354703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56986544|NCT02354703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56986545|NCT05008887|Fluorouracil|fluorouracil|mesh-list
56986546|NCT05008887|Methotrexate|methotrexate|mesh-list
56986547|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
56986548|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986549|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56986550|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986551|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56986552|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
56986553|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986554|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56986555|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
56986556|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56986557|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
56986558|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986559|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56986560|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986561|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56986562|NCT01376193|Naratriptan|naratriptan|mesh-list
56986563|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56986564|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56986565|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56986566|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
56986567|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986568|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986569|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986570|NCT04944771|Rabeprazole|rabeprazole|mesh-list
56986571|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56986572|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56986573|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56668773|NCT04131582|Metformin|metformin|mesh-list
56986574|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986575|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986577|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56986578|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
56986579|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986580|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56986581|NCT05197101|Oxytocin|oxytocin|mesh-list
56986582|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
56986583|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56986584|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986585|NCT01375101|Quercetin|quercetin|mesh-list
56986586|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
56986587|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986588|NCT01375101|Protective Agents|protective agents|mesh-ancestor
56986589|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986590|NCT04865289|Paclitaxel|paclitaxel|mesh-list
56986591|NCT04865289|Carboplatin|carboplatin|mesh-list
56986592|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
56986593|NCT04865289|Lenvatinib|lenvatinib|mesh-list
56986594|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56986595|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986596|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
56986597|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
56986598|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
56986599|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986600|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56986601|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986602|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986603|NCT03633591|Tolcapone|tolcapone|mesh-list
56986604|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56986605|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56986606|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56986607|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986608|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986609|NCT01376271|Paroxetine|paroxetine|mesh-list
56986610|NCT01376271|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56986611|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56986612|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56986613|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986614|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986615|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
56986616|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986617|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56986618|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
56986619|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56986620|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56986621|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56986622|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986623|NCT04885881|Lidocaine|lidocaine|mesh-list
56986624|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
56986625|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
56986626|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986627|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986628|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
56986629|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986630|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56986631|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56986632|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56986633|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56986634|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986635|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
56986636|NCT04820205|Ketamine|ketamine|mesh-list
56986637|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
56986638|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56986639|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986640|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986641|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56986642|NCT04820205|Analgesics|analgesics|mesh-ancestor
56986643|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
56986644|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986645|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56986646|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56986647|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56986648|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
56986649|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986650|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986651|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56986652|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56986653|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
56986654|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
56986655|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56986656|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56986657|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56986658|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56986659|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986660|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
56986661|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
56986662|NCT05195619|Vaccines|vaccines|mesh-list
56986663|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
56986664|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986665|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56986666|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986667|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56986668|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
56986669|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986670|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986671|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56986672|NCT01375335|Dobutamine|dobutamine|mesh-list
56986673|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56986674|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
56986675|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
56986676|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986677|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986678|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56986679|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56986680|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56986681|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
56986682|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986683|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986684|NCT01375335|Protective Agents|protective agents|mesh-ancestor
56986685|NCT01373463|Carboplatin|carboplatin|mesh-list
56986686|NCT01373463|Pemetrexed|pemetrexed|mesh-list
56986687|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986688|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986689|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986690|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56986691|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56986692|NCT04585893|Rituximab|rituximab|mesh-list
56986693|NCT04585893|Etoposide|etoposide|mesh-list
56986694|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56986695|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986696|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
56986697|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986698|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986699|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56986700|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56986701|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56986702|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986703|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986704|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56986705|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56986706|NCT03113409|Naltrexone|naltrexone|mesh-list
56986707|NCT03113409|Buprenorphine|buprenorphine|mesh-list
56986708|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56986709|NCT03113409|Narcotics|narcotics|mesh-ancestor
56986710|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986711|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986712|NCT03113409|Analgesics|analgesics|mesh-ancestor
56986713|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
56986714|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986715|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56986716|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56986717|NCT05193747|Anesthetics|anesthetics|mesh-list
56986718|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986719|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986720|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
56986721|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986722|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986724|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56986725|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56986726|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
56986727|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986728|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986729|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986730|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56907534|NCT02138812|Paclitaxel|paclitaxel|mesh-list
56986731|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56986732|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
56986733|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56986734|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56986735|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56986736|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56986737|NCT01373697|Ibuprofen|ibuprofen|mesh-list
56986738|NCT01373697|Ketoprofen|ketoprofen|mesh-list
56986739|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56986740|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56986741|NCT01373697|Analgesics|analgesics|mesh-ancestor
56986742|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
56986743|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986744|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986745|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56986746|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986747|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56986748|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986749|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986750|NCT01375881|Ritonavir|ritonavir|mesh-list
56986751|NCT01375881|Darunavir|darunavir|mesh-list
56986752|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56986753|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56986754|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
56986755|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986756|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986757|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56986758|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56986759|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
56986760|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986761|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56986762|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56986763|NCT04690023|Ropivacaine|ropivacaine|mesh-list
56986764|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
56986765|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
56986766|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986767|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986768|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
56986769|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986770|NCT03066804|Valsartan|valsartan|mesh-list
56986771|NCT03066804|Enalapril|enalapril|mesh-list
56986772|NCT03066804|Enalaprilat|enalaprilat|mesh-list
56986773|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56986774|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56986775|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56986776|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56986777|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986778|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56986779|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
56986780|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986781|NCT03712397|Irinotecan|irinotecan|mesh-list
56986782|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56986783|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56986784|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986785|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986786|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986787|NCT05759949|Fulvestrant|fulvestrant|mesh-list
56986788|NCT05759949|Palbociclib|palbociclib|mesh-list
56986789|NCT05759949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56986790|NCT05759949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986791|NCT05759949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56986792|NCT05759949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56986793|NCT05759949|Hormone Antagonists|hormone antagonists|mesh-ancestor
56668990|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
56986794|NCT05759949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56986795|NCT05759949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986796|NCT05759949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986797|NCT05759949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986798|NCT05759949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986799|NCT04269213|Cytarabine|cytarabine|mesh-list
56986800|NCT04269213|Daunorubicin|daunorubicin|mesh-list
56986801|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56986802|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
56986803|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986804|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986805|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
56986806|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986807|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56986808|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
56986809|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986810|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56986811|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56986812|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56986813|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986814|NCT03629262|Sufentanil|sufentanil|mesh-list
56986815|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
56986817|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56986818|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986819|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986820|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56986821|NCT03629262|Analgesics|analgesics|mesh-ancestor
56986822|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
56986823|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986824|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56986825|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56986826|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56986827|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
56986828|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986829|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986830|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56986831|NCT03629262|Narcotics|narcotics|mesh-ancestor
56986832|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56986833|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56986834|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
56986835|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
56986836|NCT05208294|Sulpiride|sulpiride|mesh-list
56986837|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56986838|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56986839|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986840|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986841|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56986842|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56986843|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
56986844|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986845|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986846|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56986847|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
56986848|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
56986849|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56986850|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56986851|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
56986852|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986853|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56986854|NCT05207904|Paclitaxel|paclitaxel|mesh-list
56986855|NCT05207904|Carboplatin|carboplatin|mesh-list
56986856|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56986857|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986858|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
56986859|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
56986860|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
56986861|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986862|NCT05207514|Ethanol|ethanol|mesh-list
56986863|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
56986864|NCT05207514|Docetaxel|docetaxel|mesh-list
56986865|NCT05207514|Doxorubicin|doxorubicin|mesh-list
56986866|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56986867|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
56986868|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986869|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986870|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56986871|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
56986872|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986873|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986874|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56986875|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
56986876|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
56986877|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
56986878|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56986879|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56986880|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56986881|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986882|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56986883|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986884|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986885|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
56986886|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56986887|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
56986888|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986889|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986890|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56986891|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
56986892|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56986893|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
56986894|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986895|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986896|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56986897|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
56986898|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
56986899|NCT05213676|Protective Agents|protective agents|mesh-ancestor
56986900|NCT05207436|Oxytocin|oxytocin|mesh-list
56986901|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
56986902|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56986903|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986904|NCT05760807|Oxytocin|oxytocin|mesh-list
56986905|NCT05760807|Oxytocics|oxytocics|mesh-ancestor
56986906|NCT05760807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56986907|NCT05760807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986908|NCT03118947|Pimavanserin|pimavanserin|mesh-list
56986909|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56986910|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56986911|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56986912|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56986913|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986914|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986915|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56986916|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56986917|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56986918|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
56986919|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986920|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986921|NCT03998319|Tenecteplase|tenecteplase|mesh-list
56986922|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56986923|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56986924|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986925|NCT03953079|Sunitinib|sunitinib|mesh-list
56986926|NCT03953079|Aflibercept|aflibercept|mesh-list
56986927|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986928|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56986929|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56986930|NCT03953079|Growth Substances|growth substances|mesh-ancestor
56986931|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986932|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
56986933|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986934|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986935|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986936|NCT03794427|Anesthetics|anesthetics|mesh-list
56986937|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986938|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986939|NCT05759481|Propofol|propofol|mesh-list
56986940|NCT05759481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56986941|NCT05759481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986942|NCT05759481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986943|NCT05759481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56986944|NCT05759481|Anesthetics, General|anesthetics, general|mesh-ancestor
56986945|NCT05759481|Anesthetics|anesthetics|mesh-ancestor
56986946|NCT03410901|Antibodies|antibodies|mesh-list
56986947|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
56986948|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986949|NCT03357939|Adalimumab|adalimumab|mesh-list
56986950|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56986951|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56986952|NCT03567057|Amantadine|amantadine|mesh-list
56986953|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56986954|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56986955|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
56986956|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986957|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
56986958|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56986959|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986960|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986961|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56986962|NCT03567057|Analgesics|analgesics|mesh-ancestor
56986963|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
56986964|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56986965|NCT03057600|Paclitaxel|paclitaxel|mesh-list
56986966|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56986967|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986968|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
56986969|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
56986970|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
56986971|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986972|NCT04382937|Ribavirin|ribavirin|mesh-list
56986973|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56986974|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
56986975|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986976|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
56986977|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56986978|NCT05212662|Cysteamine|cysteamine|mesh-list
56986979|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56986980|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986981|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
56986982|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986983|NCT03107091|Terlipressin|terlipressin|mesh-list
56986984|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56986985|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56986986|NCT03849768|Gefitinib|gefitinib|mesh-list
56986987|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56986988|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56986989|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56986990|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56986991|NCT05760261|Midazolam|midazolam|mesh-list
56986992|NCT05760261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56986993|NCT05760261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56986994|NCT05760261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56986995|NCT05760261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56986996|NCT05760261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56986997|NCT05760261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56986998|NCT05760261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56986999|NCT05760261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56987000|NCT05760261|Anesthetics, General|anesthetics, general|mesh-ancestor
56987001|NCT05760261|Anesthetics|anesthetics|mesh-ancestor
56987002|NCT05760261|GABA Modulators|gaba modulators|mesh-ancestor
56987003|NCT05760261|GABA Agents|gaba agents|mesh-ancestor
56987004|NCT05760261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987005|NCT05760261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987006|NCT03189693|Anesthetics|anesthetics|mesh-list
56987007|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669213|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669214|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56669215|NCT04298099|Ropivacaine|ropivacaine|mesh-list
56669216|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
56669217|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
56669218|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987008|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987009|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
56987010|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987011|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987012|NCT03824808|Lidocaine|lidocaine|mesh-list
56987013|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
56987014|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
56987015|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987016|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987017|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
56987018|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987019|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56987020|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56987021|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56987022|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56907837|NCT02135224|Fentanyl|fentanyl|mesh-list
56987023|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987024|NCT05734716|Epoetin Alfa|epoetin alfa|mesh-list
56987025|NCT05734716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56987026|NCT05734716|Hematinics|hematinics|mesh-ancestor
56987027|NCT05733000|Thioctic Acid|thioctic acid|mesh-list
56987028|NCT05733000|Gemcitabine|gemcitabine|mesh-list
56987029|NCT05733000|Hydroxychloroquine|hydroxychloroquine|mesh-list
56987030|NCT05733000|Fluorouracil|fluorouracil|mesh-list
56987031|NCT05733000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56987032|NCT05733000|Antimetabolites|antimetabolites|mesh-ancestor
56987033|NCT05733000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987034|NCT05733000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987035|NCT05733000|Antiviral Agents|antiviral agents|mesh-ancestor
56987036|NCT05733000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987037|NCT05733000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987038|NCT05733000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987039|NCT05733000|Immunologic Factors|immunologic factors|mesh-ancestor
56987040|NCT05733000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987041|NCT05733000|Antimalarials|antimalarials|mesh-ancestor
56987042|NCT05733000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56987043|NCT05733000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56987044|NCT05733000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987045|NCT05733000|Antioxidants|antioxidants|mesh-ancestor
56987046|NCT05733000|Protective Agents|protective agents|mesh-ancestor
56987047|NCT05733000|Vitamin B Complex|vitamin b complex|mesh-ancestor
56987048|NCT05733000|Vitamins|vitamins|mesh-ancestor
56987049|NCT05733000|Micronutrients|micronutrients|mesh-ancestor
56987050|NCT04879368|Trifluridine|trifluridine|mesh-list
56987051|NCT04879368|Paclitaxel|paclitaxel|mesh-list
56987052|NCT04879368|Docetaxel|docetaxel|mesh-list
56987053|NCT04879368|Nivolumab|nivolumab|mesh-list
56987054|NCT04879368|Irinotecan|irinotecan|mesh-list
56987055|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56987056|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987057|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56987058|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56987059|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56987060|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987061|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987062|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56987063|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56987064|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56987065|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987066|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
56987067|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
56987068|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987069|NCT03417180|Remifentanil|remifentanil|mesh-list
56987070|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56987071|NCT03417180|Narcotics|narcotics|mesh-ancestor
56987072|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987073|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987074|NCT03417180|Analgesics|analgesics|mesh-ancestor
56987075|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
56987076|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987077|NCT03085095|Leuprolide|leuprolide|mesh-list
56987078|NCT03085095|Relugolix|relugolix|mesh-list
56987079|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56987080|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
56987081|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56987082|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987083|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987084|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987085|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
56987086|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
56987087|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987088|NCT02891811|Thalidomide|thalidomide|mesh-list
56987089|NCT02891811|Dexamethasone|dexamethasone|mesh-list
56987090|NCT02891811|Lenalidomide|lenalidomide|mesh-list
56987091|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987092|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
56987093|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
56987094|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987095|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987096|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987097|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
56987099|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987100|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987101|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987102|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
56987103|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56987104|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56987105|NCT02891811|Growth Substances|growth substances|mesh-ancestor
56987106|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
56987107|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987108|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
56987109|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56987110|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987111|NCT02811783|Naloxone|naloxone|mesh-list
56987112|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56987113|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987114|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
56987115|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987116|NCT02652195|Oxytocin|oxytocin|mesh-list
56987117|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
56987118|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56987119|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987120|NCT02649855|Docetaxel|docetaxel|mesh-list
56987121|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987122|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
56987123|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
56987124|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
56987125|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987126|NCT05720715|Cyclosporine|cyclosporine|mesh-list
56987127|NCT05720715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56987128|NCT05720715|Cyclosporins|cyclosporins|mesh-list
56987129|NCT05720715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987130|NCT05720715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987131|NCT05720715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987132|NCT05720715|Immunologic Factors|immunologic factors|mesh-ancestor
56987133|NCT05720715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987134|NCT05720715|Antifungal Agents|antifungal agents|mesh-ancestor
56987135|NCT05720715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987136|NCT05720715|Dermatologic Agents|dermatologic agents|mesh-ancestor
56987137|NCT05720715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987138|NCT05720715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56987139|NCT05720715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56987140|NCT02310867|Abatacept|abatacept|mesh-list
56987141|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56987142|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987143|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987144|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987145|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
56987146|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987147|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987148|NCT03106077|Maytansine|maytansine|mesh-list
56987149|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56987150|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987151|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
56987152|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
56987153|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
56987154|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987155|NCT03648008|Morphine|morphine|mesh-list
56987156|NCT03648008|Hydromorphone|hydromorphone|mesh-list
56987157|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56987158|NCT03648008|Narcotics|narcotics|mesh-ancestor
56987159|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987160|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987161|NCT03648008|Analgesics|analgesics|mesh-ancestor
56987162|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
56987163|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669354|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
56987164|NCT05702541|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56987165|NCT05702541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56987166|NCT05702541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987167|NCT05701527|Pembrolizumab|pembrolizumab|mesh-list
56987168|NCT05701527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987169|NCT05701527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987170|NCT05253495|Cytarabine|cytarabine|mesh-list
56987171|NCT05253495|Etoposide|etoposide|mesh-list
56987172|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56987173|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987174|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56987175|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56987176|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987177|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987178|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56987179|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
56987180|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
56987181|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987182|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987183|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
56987184|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987185|NCT05054751|Fulvestrant|fulvestrant|mesh-list
56987186|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987187|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987188|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56987189|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56987190|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
56987191|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987192|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987193|NCT00604617|Interferons|interferons|mesh-list
56987194|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
56987195|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987196|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
56987197|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987198|NCT03426995|Cantharidin|cantharidin|mesh-list
56987199|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987200|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987201|NCT05200299|Leucovorin|leucovorin|mesh-list
56987202|NCT05200299|Fluorouracil|fluorouracil|mesh-list
56987203|NCT05200299|Capecitabine|capecitabine|mesh-list
56987204|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
56987205|NCT05200299|Irinotecan|irinotecan|mesh-list
56987206|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
56987207|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
56987208|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987209|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56987210|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987211|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987212|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
56987213|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987214|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56987215|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56987216|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987217|NCT05200299|Antidotes|antidotes|mesh-ancestor
56987218|NCT05200299|Protective Agents|protective agents|mesh-ancestor
56987219|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
56987220|NCT05200299|Vitamins|vitamins|mesh-ancestor
56987221|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
56987222|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
56987223|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987224|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987225|NCT03822975|Heparin|heparin|mesh-list
56987226|NCT03822975|Calcium heparin|calcium heparin|mesh-list
56987227|NCT03822975|Bivalirudin|bivalirudin|mesh-list
56987228|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
56987229|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56987230|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56987231|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987232|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
56987233|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56987234|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
56987235|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987236|NCT05732532|Dexamethasone|dexamethasone|mesh-list
56987237|NCT05732532|Lidocaine|lidocaine|mesh-list
56987238|NCT05732532|Bupivacaine|bupivacaine|mesh-list
56987239|NCT05732532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987240|NCT05732532|Antiemetics|antiemetics|mesh-ancestor
56987241|NCT05732532|Autonomic Agents|autonomic agents|mesh-ancestor
56987242|NCT05732532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987243|NCT05732532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987244|NCT05732532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987246|NCT05732532|Hormones|hormones|mesh-ancestor
56987247|NCT05732532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987248|NCT05732532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987249|NCT05732532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987250|NCT05732532|Anesthetics, Local|anesthetics, local|mesh-ancestor
56987251|NCT05732532|Anesthetics|anesthetics|mesh-ancestor
56987252|NCT05732532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987253|NCT05732532|Sensory System Agents|sensory system agents|mesh-ancestor
56987254|NCT05732532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56987255|NCT05732532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56987256|NCT05732532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56987257|NCT05732532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56987258|NCT05732532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987259|NCT05178225|Ubiquinone|ubiquinone|mesh-list
56987260|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
56987261|NCT05178225|Anticoagulants|anticoagulants|mesh-list
56987262|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
56987263|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987264|NCT05178225|Vitamins|vitamins|mesh-ancestor
56987265|NCT02969018|PF-06700841|pf-06700841|mesh-list
56987266|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56987267|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987268|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987269|NCT03255096|Rituximab|rituximab|mesh-list
56987270|NCT03255096|Venetoclax|venetoclax|mesh-list
56987271|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987272|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987273|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
56987274|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987275|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987276|NCT01319721|Mitomycins|mitomycins|mesh-list
56987277|NCT01319721|Mitomycin|mitomycin|mesh-list
56987278|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56987279|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987280|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
56987281|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987282|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56987283|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987284|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
56987285|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
56987286|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987287|NCT05210166|Protective Agents|protective agents|mesh-ancestor
56987288|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987289|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56987290|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987291|NCT05542407|Atezolizumab|atezolizumab|mesh-list
56987292|NCT05542407|TIC10 compound|tic10 compound|mesh-list
56987293|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987294|NCT03792867|Doxorubicin|doxorubicin|mesh-list
56987295|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56987296|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987297|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56987298|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56987299|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987300|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987301|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
56987302|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
56987303|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56987304|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56987305|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987306|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987307|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987308|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987309|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
56987310|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
56987311|NCT05139849|Vasopressins|vasopressins|mesh-list
56987312|NCT05139849|Arginine Vasopressin|arginine vasopressin|mesh-list
56987313|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987314|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
56987315|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
56987316|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987317|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987318|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987319|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
56987320|NCT05139849|Hormones|hormones|mesh-ancestor
56987321|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987322|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56987323|NCT05139849|Protective Agents|protective agents|mesh-ancestor
56987325|NCT05139849|Coagulants|coagulants|mesh-ancestor
56987326|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56987327|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56987328|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
56987329|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
56987330|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
56987331|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987332|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
56987333|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56987334|NCT05327361|Protective Agents|protective agents|mesh-ancestor
56987335|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987336|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
56987337|NCT03315741|Pirfenidone|pirfenidone|mesh-list
56987338|NCT03315741|Analgesics|analgesics|mesh-ancestor
56987339|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
56987340|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987341|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987342|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56987343|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56987344|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987345|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987346|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987347|NCT05077449|Fulvestrant|fulvestrant|mesh-list
56987348|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987349|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987350|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56987351|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56987352|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
56987353|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987354|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987355|NCT03632733|Tetracycline|tetracycline|mesh-list
56987356|NCT03632733|Clotrimazole|clotrimazole|mesh-list
56987357|NCT03632733|Miconazole|miconazole|mesh-list
56987358|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56987359|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987360|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56987361|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987362|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987363|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56987364|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
56987365|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56987366|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56987367|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56987368|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
56987369|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987370|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987371|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56987372|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56987373|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56987374|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987375|NCT05305287|Pioglitazone|pioglitazone|mesh-list
56987376|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56987377|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987378|NCT03259425|Nivolumab|nivolumab|mesh-list
56987379|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987380|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987381|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56987382|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987383|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
56987384|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987385|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987386|NCT03061188|Nivolumab|nivolumab|mesh-list
56987387|NCT03061188|Veliparib|veliparib|mesh-list
56987388|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987389|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987390|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56987391|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987392|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56987393|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987394|NCT05588453|Temozolomide|temozolomide|mesh-list
56987395|NCT05588453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56987396|NCT05588453|Alkylating Agents|alkylating agents|mesh-ancestor
56987397|NCT05588453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987398|NCT05588453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987399|NCT03775200|Psilocybin|psilocybin|mesh-list
56987400|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
56987401|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987402|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56987403|NCT05188326|Azacitidine|azacitidine|mesh-list
56987404|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56987405|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
56987406|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987407|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987408|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987409|NCT05186454|Dexamethasone|dexamethasone|mesh-list
56987410|NCT05186454|Midazolam|midazolam|mesh-list
56987411|NCT05186454|Morphine|morphine|mesh-list
56987412|NCT05186454|Bupivacaine|bupivacaine|mesh-list
56987413|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987414|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
56987415|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
56987416|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987417|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987418|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987419|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
56987420|NCT05186454|Hormones|hormones|mesh-ancestor
56987421|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987422|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987423|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987424|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
56987425|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
56987426|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987427|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
56987428|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56987429|NCT05186454|Narcotics|narcotics|mesh-ancestor
56987430|NCT05186454|Analgesics|analgesics|mesh-ancestor
56987431|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56987432|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56987433|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56987434|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56987435|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56987436|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56987437|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
56987438|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
56987439|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
56987440|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987441|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987442|NCT02113878|Cisplatin|cisplatin|mesh-list
56987443|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987444|NCT05176080|Fulvestrant|fulvestrant|mesh-list
56987445|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987446|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987447|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56987448|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56987449|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56987450|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987451|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987452|NCT05162898|Lenvatinib|lenvatinib|mesh-list
56987453|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987454|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56987455|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987456|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987457|NCT05113290|Sorafenib|sorafenib|mesh-list
56987458|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987459|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56987460|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987461|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987462|NCT03477162|Metformin|metformin|mesh-list
56987463|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56987464|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987465|NCT03461952|Nivolumab|nivolumab|mesh-list
56987466|NCT03461952|Ipilimumab|ipilimumab|mesh-list
56987467|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987468|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987469|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56987470|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987471|NCT03619824|Gemcitabine|gemcitabine|mesh-list
56987472|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987473|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56987474|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
56987475|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987476|NCT03619824|Antiviral Agents|antiviral agents|mesh-ancestor
56987477|NCT03619824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987478|NCT03619824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987479|NCT03619824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987480|NCT03619824|Immunologic Factors|immunologic factors|mesh-ancestor
56987481|NCT03619824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987482|NCT01759836|Atorvastatin|atorvastatin|mesh-list
56987483|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56987484|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56987485|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
56987486|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987487|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56987488|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56987489|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987490|NCT03447821|Rifamycins|rifamycins|mesh-list
56987491|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
56987492|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56987493|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987494|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987495|NCT05630339|Vitamin D|vitamin d|mesh-list
56987496|NCT05630339|Cholecalciferol|cholecalciferol|mesh-list
56987497|NCT05630339|Vitamins|vitamins|mesh-ancestor
56987498|NCT05630339|Micronutrients|micronutrients|mesh-ancestor
56987499|NCT05630339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987500|NCT05630339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56987501|NCT05630339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56987502|NCT04968366|Temozolomide|temozolomide|mesh-list
56987503|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56987504|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
56987505|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987506|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987507|NCT03447353|Acetaminophen|acetaminophen|mesh-list
56987508|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56987509|NCT03447353|Hydrocodone|hydrocodone|mesh-list
56987510|NCT03447353|Alprazolam|alprazolam|mesh-list
56987511|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56987512|NCT03447353|Analgesics|analgesics|mesh-ancestor
56987513|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
56987514|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987515|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987516|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
56987517|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56987518|NCT03447353|Narcotics|narcotics|mesh-ancestor
56987519|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987520|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
56987521|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
56987522|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56987523|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56987524|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56987525|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56987526|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
56987527|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
56987528|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987529|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987530|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56987531|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987532|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987533|NCT05723874|Bosentan|bosentan|mesh-list
56987534|NCT05723874|BI 425809|bi 425809|mesh-list
56987535|NCT05723874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56987536|NCT05723874|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56987537|NCT05723874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987538|NCT05723874|Nootropic Agents|nootropic agents|mesh-ancestor
56987539|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56987540|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56987541|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987542|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56987543|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56987544|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56987545|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987546|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
56987547|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987548|NCT00710970|Tamoxifen|tamoxifen|mesh-list
56987549|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56987550|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56987551|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
56987552|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987553|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987554|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56908356|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
56987555|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987556|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56987557|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56987558|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56987559|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
56987560|NCT03422159|Thiamine|thiamine|mesh-list
56987561|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
56987562|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56987563|NCT03422159|Vitamins|vitamins|mesh-ancestor
56987564|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
56987565|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987566|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987567|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
56987568|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987569|NCT03422159|Protective Agents|protective agents|mesh-ancestor
56987570|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
56987571|NCT03421379|Glucagon|glucagon|mesh-list
56987572|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56987573|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987574|NCT03421379|Hormones|hormones|mesh-ancestor
56987575|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987576|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987577|NCT03421379|Incretins|incretins|mesh-ancestor
56987578|NCT03712241|Indomethacin|indomethacin|mesh-list
56987579|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56987580|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56987581|NCT03712241|Analgesics|analgesics|mesh-ancestor
56987582|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
56987583|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987584|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987585|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987586|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987587|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
56987588|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
56987589|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56987590|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56987591|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987592|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987593|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
56987594|NCT02675946|Cetuximab|cetuximab|mesh-list
56987595|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987596|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987597|NCT02900378|Valsartan|valsartan|mesh-list
56987598|NCT02900378|Enalapril|enalapril|mesh-list
56987599|NCT02900378|Enalaprilat|enalaprilat|mesh-list
56987600|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56987601|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56987602|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56987603|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56987604|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987605|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56987606|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
56987607|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987608|NCT03058692|Vaccines|vaccines|mesh-list
56987609|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
56987610|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987611|NCT03647150|Amoxicillin|amoxicillin|mesh-list
56987612|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56987613|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987614|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
56987615|NCT03056352|Promethazine|promethazine|mesh-list
56987616|NCT03056352|Metoclopramide|metoclopramide|mesh-list
56987617|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56987618|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56987619|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987620|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987621|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
56987622|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
56987623|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
56987624|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987625|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
56987626|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
56987627|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987628|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56987629|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
56987630|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
56987631|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987632|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987633|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56987634|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
56987635|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
56987636|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56987637|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56987638|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
56987640|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
56987641|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987642|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
56987643|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
56987644|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
56987645|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987646|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987647|NCT03647072|Famotidine|famotidine|mesh-list
56987648|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56987649|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987650|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56987651|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
56987652|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
56987653|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987654|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987655|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987656|NCT05284136|Prednisolone|prednisolone|mesh-list
56987657|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987658|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
56987659|NCT05284136|Hormones|hormones|mesh-ancestor
56987660|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987661|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987662|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987663|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987664|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
56987665|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56987666|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56987667|NCT03875690|Prednisolone|prednisolone|mesh-list
56987668|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
56987669|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56987670|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
56987671|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987672|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
56987673|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
56987674|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987675|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987676|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987677|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
56987678|NCT03875690|Hormones|hormones|mesh-ancestor
56987679|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987680|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56987681|NCT03875690|Protective Agents|protective agents|mesh-ancestor
56987682|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987683|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987684|NCT03646916|Dexamethasone|dexamethasone|mesh-list
56987685|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
56987686|NCT03646916|BB 1101|bb 1101|mesh-list
56987687|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987688|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
56987689|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
56987690|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987691|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987692|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987693|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
56987694|NCT03646916|Hormones|hormones|mesh-ancestor
56987695|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987696|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987697|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987698|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
56987699|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987700|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987701|NCT04305756|Enoxaparin|enoxaparin|mesh-list
56987702|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
56987703|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56987704|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55729813|NCT03135795|Rocuronium|rocuronium|mesh-list
56908508|NCT03544996|Insulin|insulin|mesh-list
56987705|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987706|NCT05283980|Bupivacaine|bupivacaine|mesh-list
56987707|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
56987708|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
56987709|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987710|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987711|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
56987712|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987713|NCT03645980|Sorafenib|sorafenib|mesh-list
56987714|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987715|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56987716|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987717|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987718|NCT04315038|Anesthetics|anesthetics|mesh-list
56987719|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987720|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987721|NCT03645200|Apatinib|apatinib|mesh-list
56987722|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987723|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56987724|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987725|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987726|NCT03055338|Risperidone|risperidone|mesh-list
56987727|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56987728|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
56987729|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987730|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987731|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987732|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56987733|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56987734|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987735|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56987736|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56987737|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
56987738|NCT03645668|Meropenem|meropenem|mesh-list
56987739|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56987740|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987741|NCT04186494|Liraglutide|liraglutide|mesh-list
56987742|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56987743|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987744|NCT04186494|Incretins|incretins|mesh-ancestor
56987745|NCT04186494|Hormones|hormones|mesh-ancestor
56987746|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987747|NCT03712163|Ketotifen|ketotifen|mesh-list
56987748|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
56987749|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
56987750|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56987751|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
56987752|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
56987753|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987754|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987755|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987756|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56987757|NCT01311167|Dexamethasone|dexamethasone|mesh-list
56987758|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987759|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
56987760|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
56987761|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987762|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987763|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987764|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
56987765|NCT01311167|Hormones|hormones|mesh-ancestor
56987766|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987767|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987768|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987769|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56987770|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987771|NCT04233840|Nivolumab|nivolumab|mesh-list
56987772|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987773|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987774|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56987775|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987776|NCT02896400|Nicotine|nicotine|mesh-list
56987777|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56908580|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56987778|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
56987779|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987780|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987781|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56987782|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56987783|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
56987784|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987785|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987786|NCT03404843|Fasudil|fasudil|mesh-list
56987787|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56987788|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56987789|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987790|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56987791|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987792|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
56987793|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56987794|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987795|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
56987796|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56987797|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987798|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987799|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56987800|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56987801|NCT05284448|Protective Agents|protective agents|mesh-ancestor
56987802|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987803|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
56987804|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56987805|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
56987806|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
56987807|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987808|NCT03444155|Folic Acid|folic acid|mesh-list
56987809|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
56987810|NCT03444155|Vitamins|vitamins|mesh-ancestor
56987811|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
56987812|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987813|NCT03444155|Hematinics|hematinics|mesh-ancestor
56987814|NCT02898116|Durvalumab|durvalumab|mesh-list
56987815|NCT02898116|Ensartinib|ensartinib|mesh-list
56987816|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987817|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987818|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56987819|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987820|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987821|NCT03717701|Metformin|metformin|mesh-list
56987822|NCT03717701|Esomeprazole|esomeprazole|mesh-list
56987823|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56987824|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987825|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56987826|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987827|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56987828|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987829|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987830|NCT03658304|Mitomycins|mitomycins|mesh-list
56987831|NCT03658304|Mitomycin|mitomycin|mesh-list
56987832|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56987833|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987834|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
56987835|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987836|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56987837|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987838|NCT04538040|Tenofovir|tenofovir|mesh-list
56987839|NCT04538040|Emtricitabine|emtricitabine|mesh-list
56987840|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56987841|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
56987842|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987843|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56987844|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56987845|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987846|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987847|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56987848|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56987849|NCT02297412|Minocycline|minocycline|mesh-list
56987850|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56987851|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987852|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
56987853|NCT03644576|Ephedrine|ephedrine|mesh-list
56987854|NCT03644576|Ozanimod|ozanimod|mesh-list
56987855|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56987856|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
56987857|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987858|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987859|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56987860|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
56987861|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
56987862|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56987863|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56987864|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
56987865|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
56987866|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987867|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987868|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56987869|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987870|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
56987871|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56987872|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56987873|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56987874|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56987875|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56987876|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56987877|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56987878|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56987879|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
56987880|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987881|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987882|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987883|NCT03418727|Laxatives|laxatives|mesh-ancestor
56987884|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987885|NCT01180374|Dronabinol|dronabinol|mesh-list
56987886|NCT01180374|Cannabidiol|cannabidiol|mesh-list
56987887|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
56987888|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
56987889|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987890|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56987891|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56987892|NCT01180374|Analgesics|analgesics|mesh-ancestor
56987893|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
56987894|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987895|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56987896|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56987897|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56987898|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987899|NCT01180374|Hormones|hormones|mesh-ancestor
56987900|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987901|NCT03418571|Gontivimab|gontivimab|mesh-list
56987902|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
56987903|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56987904|NCT03715517|Morphine|morphine|mesh-list
56987905|NCT03715517|Hydromorphone|hydromorphone|mesh-list
56987906|NCT03715517|Bupivacaine|bupivacaine|mesh-list
56987907|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56987908|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
56987909|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
56987910|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987911|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987912|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
56987913|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987914|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56987915|NCT03715517|Narcotics|narcotics|mesh-ancestor
56987916|NCT03715517|Analgesics|analgesics|mesh-ancestor
56987917|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
56987918|NCT03717467|Analgesics|analgesics|mesh-ancestor
56987919|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
56987920|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987921|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987922|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
56987923|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56987924|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56987925|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
56987926|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56908730|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
56987927|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56987928|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987929|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56987930|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
56987931|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56987932|NCT01318122|Pioglitazone|pioglitazone|mesh-list
56987933|NCT01318122|Alogliptin|alogliptin|mesh-list
56987934|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56987935|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987936|NCT01318122|Incretins|incretins|mesh-ancestor
56987937|NCT01318122|Hormones|hormones|mesh-ancestor
56987938|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987939|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56987940|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
56987941|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987942|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987943|NCT02954159|Vedolizumab|vedolizumab|mesh-list
56987944|NCT02954159|Tacrolimus|tacrolimus|mesh-list
56987945|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987946|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
56987947|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987948|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56987949|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56987950|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987951|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987952|NCT03737136|Bortezomib|bortezomib|mesh-list
56987953|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987954|NCT03763422|Temozolomide|temozolomide|mesh-list
56987955|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56987956|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
56987957|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987958|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987959|NCT03667716|Nivolumab|nivolumab|mesh-list
56987960|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56987961|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987962|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56987963|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987964|NCT03740334|Dexamethasone|dexamethasone|mesh-list
56987965|NCT03740334|Everolimus|everolimus|mesh-list
56987966|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987967|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
56987968|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
56987969|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987970|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987971|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987972|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
56987973|NCT03740334|Hormones|hormones|mesh-ancestor
56987974|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56987975|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56987976|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987977|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987978|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
56987979|NCT03440411|Dexamethasone|dexamethasone|mesh-list
56987980|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
56987981|NCT03440411|Pomalidomide|pomalidomide|mesh-list
56987982|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56987983|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
56987984|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56987985|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56987986|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56987987|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
56987988|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56987989|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56987990|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56987991|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56987992|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
56987993|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
56987994|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56987995|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56987996|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
56987997|NCT03440411|Hormones|hormones|mesh-ancestor
56987998|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730044|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56908801|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
56987999|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56988000|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56988001|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56988002|NCT03440411|Growth Substances|growth substances|mesh-ancestor
56988003|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
56988004|NCT03714737|Vaccines|vaccines|mesh-list
56988005|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
56988006|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988007|NCT03389555|Vitamins|vitamins|mesh-list
56988008|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
56988009|NCT03389555|Thiamine|thiamine|mesh-list
56988010|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
56988011|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
56988012|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988013|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988014|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
56988015|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988016|NCT03389555|Protective Agents|protective agents|mesh-ancestor
56988017|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
56988018|NCT03505710|Trastuzumab|trastuzumab|mesh-list
56988019|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56988020|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988021|NCT03395639|Heparin|heparin|mesh-list
56988022|NCT03395639|Enoxaparin|enoxaparin|mesh-list
56988023|NCT03395639|Warfarin|warfarin|mesh-list
56988024|NCT03395639|Edoxaban|edoxaban|mesh-list
56988025|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
56988026|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56988027|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56988028|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988029|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56988030|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
56988031|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56988032|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
56988033|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988034|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
56988035|NCT03353922|Tolperisone|tolperisone|mesh-list
56988036|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56988037|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
56988038|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56988039|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56988040|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988041|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56988042|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988043|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56988044|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988045|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
56988046|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56988047|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988048|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
56988049|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56988050|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988051|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56988052|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988053|NCT05467553|Tenofovir|tenofovir|mesh-list
56988054|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56988055|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
56988056|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988057|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56988058|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56988059|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988060|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988061|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56988062|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56988063|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56988064|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988065|NCT02942004|Pregnanolone|pregnanolone|mesh-list
56988066|NCT02942004|Brexanolone|brexanolone|mesh-list
56988067|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
56988068|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988069|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988070|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670263|NCT00525031|Interferons|interferons|mesh-list
56988071|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
56988072|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
56988073|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
56988074|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988075|NCT03414983|Leucovorin|leucovorin|mesh-list
56988076|NCT03414983|Bevacizumab|bevacizumab|mesh-list
56988077|NCT03414983|Nivolumab|nivolumab|mesh-list
56988078|NCT03414983|Fluorouracil|fluorouracil|mesh-list
56988079|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
56988080|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56988081|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988082|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56988083|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56988084|NCT03414983|Growth Substances|growth substances|mesh-ancestor
56988085|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988086|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
56988087|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
56988088|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988089|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56988090|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988091|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
56988092|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56988093|NCT03414983|Antidotes|antidotes|mesh-ancestor
56988094|NCT03414983|Protective Agents|protective agents|mesh-ancestor
56988095|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
56988096|NCT03414983|Vitamins|vitamins|mesh-ancestor
56988097|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
56988098|NCT03414359|Lidocaine|lidocaine|mesh-list
56988099|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
56988100|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
56988101|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
56988102|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988103|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988104|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
56988105|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988106|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56988107|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56988108|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56988109|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56988110|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988111|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
56988112|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
56988113|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988114|NCT02583048|Dolutegravir|dolutegravir|mesh-list
56988115|NCT02583048|Bedaquiline|bedaquiline|mesh-list
56988116|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56988117|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56988118|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988119|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988120|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56988121|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56988122|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
56988123|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988124|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
56988125|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56988126|NCT04661137|Dexamethasone|dexamethasone|mesh-list
56988127|NCT04661137|Daratumumab|daratumumab|mesh-list
56988128|NCT04661137|Pomalidomide|pomalidomide|mesh-list
56988129|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988130|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
56988131|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
56988132|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988133|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988134|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988135|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
56988136|NCT04661137|Hormones|hormones|mesh-ancestor
56988137|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56988138|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56988139|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988140|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
56988141|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56988142|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56988143|NCT04661137|Growth Substances|growth substances|mesh-ancestor
56988144|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
56988145|NCT03274687|Androgens|androgens|mesh-list
56988146|NCT03274687|Hormones|hormones|mesh-ancestor
56988147|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56988148|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670327|NCT04476277|Biotin|biotin|mesh-list
56988149|NCT02542956|Bupivacaine|bupivacaine|mesh-list
56988150|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
56988151|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
56988152|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988153|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988154|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
56988155|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988156|NCT03274453|Ketamine|ketamine|mesh-list
56988157|NCT03274453|Analgesics|analgesics|mesh-ancestor
56988158|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
56988159|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988160|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988161|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56988162|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56988163|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
56988164|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
56988165|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988166|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56988167|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56988168|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988169|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988170|NCT02313870|Clobetasol|clobetasol|mesh-list
56988171|NCT02313870|Methotrexate|methotrexate|mesh-list
56988172|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56988173|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
56988174|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56988175|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988176|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56988177|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
56988178|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988179|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988180|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
56988181|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988182|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56988183|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988184|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
56988185|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988186|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56988187|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988188|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
56988189|NCT02313870|Hormones|hormones|mesh-ancestor
56988190|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56988191|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
56988192|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56988193|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56988194|NCT01942122|Analgesics|analgesics|mesh-ancestor
56988195|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
56988196|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988197|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988198|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988199|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988200|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56988201|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988202|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988203|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
56988204|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56988205|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56988206|NCT02236806|Ramipril|ramipril|mesh-list
56988207|NCT02236806|Bisoprolol|bisoprolol|mesh-list
56988208|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56988209|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
56988210|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988211|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988212|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56988213|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
56988214|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
56988215|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988216|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670401|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670402|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670403|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56670404|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56670405|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
56988217|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56909024|NCT03818399|Analgesics|analgesics|mesh-ancestor
56988218|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56988219|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56988220|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
56988221|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988222|NCT01578954|Lenalidomide|lenalidomide|mesh-list
56988223|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
56988224|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988225|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56988226|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56988227|NCT01578954|Growth Substances|growth substances|mesh-ancestor
56988228|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
56988229|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988230|NCT00659646|Levofloxacin|levofloxacin|mesh-list
56988231|NCT00659646|Ofloxacin|ofloxacin|mesh-list
56988232|NCT00659646|Gentamicins|gentamicins|mesh-list
56988233|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56988234|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988235|NCT00659646|Renal Agents|renal agents|mesh-ancestor
56988236|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56988237|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56988238|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56988239|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988240|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988241|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988242|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56988243|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56988244|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56988245|NCT02236572|Everolimus|everolimus|mesh-list
56988246|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988247|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988248|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
56988249|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988250|NCT03054870|Xenon|xenon|mesh-list
56988251|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56988252|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
56988253|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
56988254|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988255|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988256|NCT05448677|Bevacizumab|bevacizumab|mesh-list
56988257|NCT05448677|Atezolizumab|atezolizumab|mesh-list
56988258|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56988259|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988260|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56988261|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56988262|NCT05448677|Growth Substances|growth substances|mesh-ancestor
56988263|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988264|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
56988265|NCT05222646|Metoclopramide|metoclopramide|mesh-list
56988266|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
56988267|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
56988268|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988269|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988270|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988271|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56988272|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56988273|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
56988274|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988275|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988276|NCT04538352|Insulin|insulin|mesh-list
56988277|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56988278|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
56988279|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56988280|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988281|NCT05222334|Bupivacaine|bupivacaine|mesh-list
56988282|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
56988283|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
56988284|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988285|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988286|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
56988287|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988288|NCT04465266|Tolperisone|tolperisone|mesh-list
56988289|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56988290|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988291|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56988292|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909100|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
56988293|NCT04434300|Daptomycin|daptomycin|mesh-list
56988294|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56988295|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988296|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
56988297|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
56988298|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56988299|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56988300|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988301|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988302|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988303|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988304|NCT04108962|Benralizumab|benralizumab|mesh-list
56988305|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56988306|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
56988307|NCT04865796|Lactoferrin|lactoferrin|mesh-list
56988308|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988309|NCT04811118|Docetaxel|docetaxel|mesh-list
56988310|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988311|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56988312|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56988313|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56988314|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988315|NCT05221164|Aspirin|aspirin|mesh-list
56988316|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56988317|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56988318|NCT05221164|Analgesics|analgesics|mesh-ancestor
56988319|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
56988320|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988321|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988322|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988323|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988324|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56988325|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56988326|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988327|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56988328|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56988329|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988330|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
56988331|NCT04647084|Lidocaine|lidocaine|mesh-list
56988332|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
56988333|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
56988334|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988335|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988336|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
56988337|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988338|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56988339|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56988340|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56988341|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56988342|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988343|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
56988344|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56988345|NCT03627546|Velpatasvir|velpatasvir|mesh-list
56988346|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
56988347|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988348|NCT04620798|Antibodies|antibodies|mesh-list
56988349|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
56988350|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988351|NCT05220228|Prucalopride|prucalopride|mesh-list
56988352|NCT05220228|Laxatives|laxatives|mesh-ancestor
56988353|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988354|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56988355|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56988356|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
56988357|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988358|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988359|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988360|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
56988361|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
56988362|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56670548|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988363|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56670549|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
56670550|NCT01455389|Hormones|hormones|mesh-ancestor
56670552|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56988364|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988365|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988366|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988367|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988368|NCT04765644|Celecoxib|celecoxib|mesh-list
56988369|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56988370|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56988371|NCT04765644|Analgesics|analgesics|mesh-ancestor
56988372|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
56988373|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988374|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988375|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988376|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988377|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56988378|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56988379|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988380|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988381|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
56988382|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56988383|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56988384|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56988385|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56988386|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988387|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
56988388|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988389|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988390|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56988391|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988392|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56988393|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56988394|NCT05197374|Estradiol|estradiol|mesh-list
56988395|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56988396|NCT05197374|Estrogens|estrogens|mesh-ancestor
56988397|NCT05197374|Hormones|hormones|mesh-ancestor
56988398|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56988399|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988400|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56988401|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
56988402|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56988403|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56988404|NCT02951819|Dexamethasone|dexamethasone|mesh-list
56988405|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
56988406|NCT02951819|Bortezomib|bortezomib|mesh-list
56988407|NCT02951819|Daratumumab|daratumumab|mesh-list
56988408|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988409|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
56988410|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988411|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988412|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56988413|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
56988414|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988415|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988416|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56988417|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988418|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
56988419|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
56988420|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988421|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988422|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
56988423|NCT02951819|Hormones|hormones|mesh-ancestor
56988424|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56988425|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56988426|NCT05191290|Heparin|heparin|mesh-list
56988427|NCT05191290|Calcium heparin|calcium heparin|mesh-list
56988428|NCT05191290|Citric Acid|citric acid|mesh-list
56988429|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
56988430|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
56988431|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56988432|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
56988433|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
56988434|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988435|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56988436|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56988437|NCT05627544|Anesthetics|anesthetics|mesh-list
56909246|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
56988438|NCT05627544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988439|NCT05627544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988440|NCT05189028|Gemcitabine|gemcitabine|mesh-list
56988441|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988442|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56988443|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
56988444|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988445|NCT05189028|Antiviral Agents|antiviral agents|mesh-ancestor
56988446|NCT05189028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988447|NCT05189028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988448|NCT05189028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988449|NCT05189028|Immunologic Factors|immunologic factors|mesh-ancestor
56988450|NCT05189028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988451|NCT05609370|Bevacizumab|bevacizumab|mesh-list
56988452|NCT05609370|Capecitabine|capecitabine|mesh-list
56988453|NCT05609370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56988454|NCT05609370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988455|NCT05609370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56988456|NCT05609370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56988457|NCT05609370|Growth Substances|growth substances|mesh-ancestor
56988458|NCT05609370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988459|NCT05609370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56988460|NCT05609370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56988461|NCT05609370|Antimetabolites|antimetabolites|mesh-ancestor
56988462|NCT05609370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988463|NCT05706870|Clobetasol|clobetasol|mesh-list
56988464|NCT05706870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988465|NCT05706870|Glucocorticoids|glucocorticoids|mesh-ancestor
56988466|NCT05706870|Hormones|hormones|mesh-ancestor
56988467|NCT05706870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56988468|NCT05706870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988469|NCT03383783|Listerine|listerine|mesh-list
56988470|NCT03383783|Fluorides|fluorides|mesh-list
56988471|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
56988472|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
56988473|NCT03383783|Protective Agents|protective agents|mesh-ancestor
56988474|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988475|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56988476|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988477|NCT03627390|Molybdenum|molybdenum|mesh-list
56988478|NCT03627390|Trace Elements|trace elements|mesh-ancestor
56988479|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
56988480|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988481|NCT03709745|Ranibizumab|ranibizumab|mesh-list
56988482|NCT03709745|Aflibercept|aflibercept|mesh-list
56988483|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56988484|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56988485|NCT03709745|Growth Substances|growth substances|mesh-ancestor
56988486|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988487|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
56988488|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988489|NCT05570526|Melatonin|melatonin|mesh-list
56988490|NCT05570526|Antioxidants|antioxidants|mesh-ancestor
56988491|NCT05570526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988492|NCT05570526|Protective Agents|protective agents|mesh-ancestor
56988493|NCT05570526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988494|NCT05570526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988495|NCT03707639|Apatinib|apatinib|mesh-list
56988496|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988497|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56988498|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988499|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988500|NCT03334721|Gabapentin|gabapentin|mesh-list
56988501|NCT03334721|Analgesics|analgesics|mesh-ancestor
56988502|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
56988503|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988504|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988505|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
56988506|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56988507|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56988508|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988509|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56988510|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56988511|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56988512|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988513|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988514|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
56988515|NCT05706402|Acetylcysteine|acetylcysteine|mesh-list
56988516|NCT05706402|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56988517|NCT05706402|Antiviral Agents|antiviral agents|mesh-ancestor
56988518|NCT05706402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988519|NCT05706402|Expectorants|expectorants|mesh-ancestor
56988520|NCT05706402|Respiratory System Agents|respiratory system agents|mesh-ancestor
56988521|NCT05706402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56988522|NCT05706402|Antioxidants|antioxidants|mesh-ancestor
56988523|NCT05706402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988524|NCT05706402|Protective Agents|protective agents|mesh-ancestor
56988525|NCT05706402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988526|NCT05706402|Antidotes|antidotes|mesh-ancestor
56988527|NCT05706090|Fentanyl|fentanyl|mesh-list
56988528|NCT05706090|Anesthetics|anesthetics|mesh-ancestor
56988529|NCT05706090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988530|NCT05706090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988531|NCT05706090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56988532|NCT05706090|Narcotics|narcotics|mesh-ancestor
56988533|NCT05706090|Analgesics|analgesics|mesh-ancestor
56988534|NCT05706090|Sensory System Agents|sensory system agents|mesh-ancestor
56988535|NCT05706090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988536|NCT05706090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56988537|NCT05706090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56988538|NCT05706090|Anesthetics, General|anesthetics, general|mesh-ancestor
56988539|NCT03380429|Albuterol|albuterol|mesh-list
56988540|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56988541|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
56988542|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988543|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988544|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56988545|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
56988546|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
56988547|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56988548|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56988549|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56988550|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56988551|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
56988552|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988553|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988554|NCT05096442|Paclitaxel|paclitaxel|mesh-list
56988555|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56988556|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56988557|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988558|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56988559|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56988560|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56988561|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988562|NCT01313143|Esmolol|esmolol|mesh-list
56988563|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56988564|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56988565|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56988566|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
56988567|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988568|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988569|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988570|NCT05705856|Ustekinumab|ustekinumab|mesh-list
56988571|NCT05705856|Dermatologic Agents|dermatologic agents|mesh-ancestor
56988572|NCT05071794|Propofol|propofol|mesh-list
56988573|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56988574|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988575|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988576|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56988577|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
56988578|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
56988579|NCT03280537|Omalizumab|omalizumab|mesh-list
56988580|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56988581|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56988582|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
56988583|NCT05618730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56988584|NCT05618730|Lubricant Eye Drops|lubricant eye drops|mesh-list
56988585|NCT05618730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56988586|NCT05029050|Clonidine|clonidine|mesh-list
56988587|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
56988588|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56988589|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988590|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988591|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56988593|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
56988594|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988595|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56988596|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56988597|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56988598|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
56988599|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988600|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988601|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56988602|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
56988603|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
56988604|NCT05553366|Acetaminophen|acetaminophen|mesh-list
56988605|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56988606|NCT05553366|Analgesics|analgesics|mesh-ancestor
56988607|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
56988608|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988609|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988610|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
56988612|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
56988613|NCT04690231|Apatinib|apatinib|mesh-list
56988614|NCT04690231|Ifosfamide|ifosfamide|mesh-list
56988615|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
56988616|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56988617|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988618|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56988619|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56988620|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988621|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988622|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56988623|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56988624|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
56988625|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56988626|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56988627|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56988628|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
56988629|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988630|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56988631|NCT04998006|Ethanol|ethanol|mesh-list
56988632|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56988633|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988634|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988635|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988636|NCT04234945|Doxycycline|doxycycline|mesh-list
56988637|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56988638|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988639|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
56988640|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56988641|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56988642|NCT05615220|Ecopipam|ecopipam|mesh-list
56988643|NCT05615220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56988644|NCT05615220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56988645|NCT05615220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988646|NCT05615220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988647|NCT05615220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56988648|NCT05615220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56988649|NCT05615220|Dopamine Agents|dopamine agents|mesh-ancestor
56988650|NCT05615220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988651|NCT05615220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988652|NCT03316807|Vaccines|vaccines|mesh-list
56988653|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
56988654|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988655|NCT03328897|Omalizumab|omalizumab|mesh-list
56988656|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56988657|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56988658|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
56988659|NCT04918758|Sucralfate|sucralfate|mesh-list
56988660|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56988661|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988662|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
56988663|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56988664|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988665|NCT03378635|Glucagon|glucagon|mesh-list
56909471|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988666|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988667|NCT03378635|Hormones|hormones|mesh-ancestor
56988668|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56988669|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988671|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56988672|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56988673|NCT01182727|Analgesics|analgesics|mesh-ancestor
56988674|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
56988675|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988676|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988677|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988678|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988679|NCT05550714|Anesthetics|anesthetics|mesh-list
56988680|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988681|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988682|NCT03334409|Vitamins|vitamins|mesh-list
56988683|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
56988684|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
56988685|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988686|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
56988687|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988688|NCT03334409|Protective Agents|protective agents|mesh-ancestor
56988689|NCT02891915|Amoxicillin|amoxicillin|mesh-list
56988690|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
56988691|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
56988692|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56988693|NCT02891915|Cefdinir|cefdinir|mesh-list
56988694|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56988695|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988696|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56988697|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988698|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988699|NCT05233566|Ketamine|ketamine|mesh-list
56988700|NCT05233566|Analgesics|analgesics|mesh-ancestor
56988701|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
56988702|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988703|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988704|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56988705|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56988706|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
56988707|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
56988708|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988709|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56988710|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56988711|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988712|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988713|NCT05230368|Decitabine|decitabine|mesh-list
56988714|NCT05230368|Romidepsin|romidepsin|mesh-list
56988715|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56988716|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
56988717|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988718|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988719|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988720|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56988721|NCT03046446|FX006|fx006|mesh-list
56988722|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988723|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
56988724|NCT03046446|Hormones|hormones|mesh-ancestor
56988725|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56988726|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988727|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988728|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
56988729|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
56988730|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988731|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
56988732|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988733|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988734|NCT05035303|Epinephrine|epinephrine|mesh-list
56988735|NCT05035303|Norepinephrine|norepinephrine|mesh-list
56988736|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56988737|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56988738|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
56988739|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988740|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670920|NCT00516139|Lamotrigine|lamotrigine|mesh-list
56988741|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988742|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56988743|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56988744|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
56988745|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988746|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56988747|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
56988748|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
56988749|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
56988750|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56988751|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56988752|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
56988753|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988754|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56988755|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988756|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
56988757|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56988758|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988759|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56988760|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
56988761|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56988762|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988763|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988764|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988765|NCT04580394|Oxybutynin|oxybutynin|mesh-list
56988766|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56988767|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56988768|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56988769|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56988770|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988771|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
56988772|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988773|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988774|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
56988775|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
56988776|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988777|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56988778|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56988779|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
56988780|NCT04580394|Urological Agents|urological agents|mesh-ancestor
56988781|NCT03713580|Venetoclax|venetoclax|mesh-list
56988782|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988783|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56988784|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56988785|NCT04385173|Temozolomide|temozolomide|mesh-list
56988786|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56988787|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
56988788|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988789|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988790|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
56988791|NCT03707249|Hematinics|hematinics|mesh-ancestor
56988792|NCT05682911|Simvastatin|simvastatin|mesh-list
56988793|NCT05682911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56988794|NCT05682911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56988795|NCT05682911|Antimetabolites|antimetabolites|mesh-ancestor
56988796|NCT05682911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988797|NCT05682911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56988798|NCT05682911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56988799|NCT05682911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988800|NCT04625088|Atropine|atropine|mesh-list
56988801|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56988802|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56988803|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56988804|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
56988805|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988806|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988807|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56988808|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
56988809|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
56988810|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
56988811|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56988812|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56988813|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
56988814|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988815|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988816|NCT03568422|Paclitaxel|paclitaxel|mesh-list
56988817|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56988818|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988819|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
56988820|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
56988821|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
56988822|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988823|NCT03535350|Temozolomide|temozolomide|mesh-list
56988824|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56988825|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
56988826|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988827|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988828|NCT02547493|Abatacept|abatacept|mesh-list
56988829|NCT02547493|Vaccines|vaccines|mesh-list
56988830|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56988831|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
56988832|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988833|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56988834|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988835|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988836|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988837|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988838|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
56988839|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56988840|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988841|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
56988842|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
56988843|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988844|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988845|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988846|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
56988847|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
56988848|NCT03257995|Maleic acid|maleic acid|mesh-list
56988849|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988850|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988851|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56988852|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56988853|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
56988854|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988855|NCT03049488|Antacids|antacids|mesh-ancestor
56988856|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988857|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988858|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
56988859|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56988860|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56988861|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988862|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56988863|NCT04484922|Analgesics|analgesics|mesh-ancestor
56988864|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
56988865|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988866|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56988867|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56988868|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56988869|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
56988870|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988871|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988872|NCT04446390|Listerine|listerine|mesh-list
56988873|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
56988874|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
56988875|NCT04446390|Protective Agents|protective agents|mesh-ancestor
56988876|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988877|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56988878|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988879|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56988880|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56988881|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56988882|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56988883|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988884|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988885|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909696|NCT03229538|Protective Agents|protective agents|mesh-ancestor
56988886|NCT04504812|Analgesics|analgesics|mesh-ancestor
56988887|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
56988888|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988889|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
56988890|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56988891|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
56988892|NCT02338921|Metformin|metformin|mesh-list
56988893|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56988894|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
56988895|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56988896|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988897|NCT02338921|Incretins|incretins|mesh-ancestor
56988898|NCT02338921|Hormones|hormones|mesh-ancestor
56988899|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56988900|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56988901|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
56988902|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988903|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988904|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56988905|NCT01313845|Amantadine|amantadine|mesh-list
56988906|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56988907|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56988908|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
56988909|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56988910|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
56988911|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988912|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988913|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988914|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56988915|NCT01313845|Analgesics|analgesics|mesh-ancestor
56988916|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
56988917|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988918|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
56988919|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56988920|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56988921|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
56988922|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988923|NCT04745845|Norepinephrine|norepinephrine|mesh-list
56988924|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56988925|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56988926|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
56988927|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56988928|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988929|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988930|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
56988931|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
56988932|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988933|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56988934|NCT04173247|Mineral Oil|mineral oil|mesh-list
56988935|NCT04173247|Emollients|emollients|mesh-ancestor
56988936|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
56988937|NCT03196986|Bevacizumab|bevacizumab|mesh-list
56988938|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56988939|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988940|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56988941|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56988942|NCT03196986|Growth Substances|growth substances|mesh-ancestor
56988943|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988944|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
56988945|NCT04051632|Insulin|insulin|mesh-list
56988946|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56988947|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988948|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
56988949|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56988950|NCT04423237|Deferasirox|deferasirox|mesh-list
56988951|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56988952|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
56988953|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
56988954|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988955|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
56988956|NCT03107988|Topotecan|topotecan|mesh-list
56988957|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988958|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
56988959|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909771|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988960|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988961|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56988962|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
56988963|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988964|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56988965|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56988966|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56988967|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56988968|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988969|NCT05511870|Etripamil|etripamil|mesh-list
56988970|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56988971|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56988972|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988973|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56988974|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988975|NCT03043560|Ezogabine|ezogabine|mesh-list
56988976|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
56988977|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56988978|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988979|NCT02145403|Tacrolimus|tacrolimus|mesh-list
56988980|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56988981|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
56988982|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988983|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56988984|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56988985|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56988986|NCT02899988|Mirikizumab|mirikizumab|mesh-list
56988987|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56988988|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56988989|NCT02899988|Analgesics|analgesics|mesh-ancestor
56988990|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
56988991|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56988992|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56988993|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56988994|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56988995|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56988996|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56988997|NCT03646526|Amitriptyline|amitriptyline|mesh-list
56988998|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56988999|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
56989000|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56989001|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56989002|NCT03646526|Analgesics|analgesics|mesh-ancestor
56989003|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
56989004|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989005|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989006|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56989007|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56989008|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989009|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989010|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56989011|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989012|NCT03646370|Tenofovir|tenofovir|mesh-list
56989013|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
56989014|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989015|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56989016|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56989017|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989018|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989019|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56989020|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56989021|NCT03646292|Pioglitazone|pioglitazone|mesh-list
56989022|NCT03646292|Empagliflozin|empagliflozin|mesh-list
56989023|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56989024|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989025|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56989026|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989027|NCT03345407|Albuterol|albuterol|mesh-list
56989028|NCT03345407|Nemiralisib|nemiralisib|mesh-list
56989029|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56989030|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
56909849|NCT03540472|Tacrolimus|tacrolimus|mesh-list
56989031|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989032|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989033|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56989034|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
56989035|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
56989036|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56989037|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56989038|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56989039|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56989040|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
56989041|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989042|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989043|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56989044|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989046|NCT02537418|Tremelimumab|tremelimumab|mesh-list
56989047|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56989048|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989049|NCT03626298|Niacinamide|niacinamide|mesh-list
56989050|NCT03626298|Niacin|niacin|mesh-list
56989051|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
56989052|NCT03626298|Adapalene|adapalene|mesh-list
56989053|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
56989054|NCT03626298|Vitamins|vitamins|mesh-ancestor
56989055|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
56989056|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989057|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56989058|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
56989059|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989060|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56989061|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
56989062|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56989063|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56989064|NCT03626298|Analgesics|analgesics|mesh-ancestor
56989065|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
56989066|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989067|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989068|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989069|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
56989070|NCT03644264|Sevelamer|sevelamer|mesh-list
56989071|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
56989072|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
56989073|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989074|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
56989075|NCT02298348|Sorafenib|sorafenib|mesh-list
56989076|NCT02298348|Topotecan|topotecan|mesh-list
56989077|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56989078|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
56989079|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989080|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989081|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56989082|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
56989083|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989084|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989085|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56989086|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56989087|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989088|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56989089|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56989090|NCT03641456|Dexamethasone|dexamethasone|mesh-list
56989091|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
56989092|NCT03641456|Lenalidomide|lenalidomide|mesh-list
56989093|NCT03641456|Bortezomib|bortezomib|mesh-list
56989094|NCT03641456|BB 1101|bb 1101|mesh-list
56989095|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989096|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
56989097|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
56989098|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989099|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989100|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56989101|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
56989102|NCT03641456|Hormones|hormones|mesh-ancestor
56989103|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989104|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56989105|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989106|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
56909934|NCT00113087|Enalapril|enalapril|mesh-list
56989107|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989108|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989109|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
56989110|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56989111|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56989112|NCT03641456|Growth Substances|growth substances|mesh-ancestor
56989113|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
56989114|NCT03240133|Berotralstat|berotralstat|mesh-list
56989115|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989116|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989117|NCT03814356|Methylphenidate|methylphenidate|mesh-list
56989118|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56989119|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989120|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56989121|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56989122|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989123|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989124|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
56989125|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989126|NCT03707171|Liraglutide|liraglutide|mesh-list
56989127|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56989128|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989129|NCT03707171|Incretins|incretins|mesh-ancestor
56989130|NCT03707171|Hormones|hormones|mesh-ancestor
56989131|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989132|NCT02101944|Dexamethasone|dexamethasone|mesh-list
56989133|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
56989134|NCT02101944|Ichthammol|ichthammol|mesh-list
56989135|NCT02101944|BB 1101|bb 1101|mesh-list
56989136|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989137|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
56989138|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
56989139|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989140|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989141|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56989142|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
56989143|NCT02101944|Hormones|hormones|mesh-ancestor
56989144|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989145|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56989146|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989147|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56989148|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989149|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989150|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
56989151|NCT02030964|Eflornithine|eflornithine|mesh-list
56989152|NCT02030964|Celecoxib|celecoxib|mesh-list
56989153|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
56989154|NCT02030964|Topotecan|topotecan|mesh-list
56989155|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56989156|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
56989157|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989158|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989159|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56989160|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
56989161|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989162|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989163|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56989164|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56989165|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56989166|NCT02030964|Analgesics|analgesics|mesh-ancestor
56989167|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
56989168|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989169|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989170|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56989171|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56989172|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989173|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56989174|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56989175|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56989176|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56989177|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56989178|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989179|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56989180|NCT03372083|Deferasirox|deferasirox|mesh-list
56989181|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56989182|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
56989183|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
56989184|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989185|NCT03044886|Vitamin D|vitamin d|mesh-list
56989186|NCT03044886|Vitamins|vitamins|mesh-ancestor
56989187|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
56989188|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989189|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56989190|NCT02961764|Dalbavancin|dalbavancin|mesh-list
56989191|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56989192|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989193|NCT03371459|Albuterol|albuterol|mesh-list
56989194|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56989195|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
56989196|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989197|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989198|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56989199|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
56989200|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
56989201|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56989202|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56989203|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56989204|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56989205|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
56989206|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989207|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989208|NCT03371381|Nivolumab|nivolumab|mesh-list
56989209|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56989210|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989211|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56989212|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989213|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
56989214|NCT03044730|Capecitabine|capecitabine|mesh-list
56989215|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56989216|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989217|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56989218|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
56989219|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989220|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
56989221|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56989222|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56989223|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989224|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
56989225|NCT05326997|Coagulants|coagulants|mesh-ancestor
56989226|NCT03738852|Insulin|insulin|mesh-list
56989227|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56989228|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989229|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56989230|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989231|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56989232|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989233|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989234|NCT04783233|Chitosan|chitosan|mesh-list
56989235|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56989236|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56989237|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56989238|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
56989239|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989240|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56989241|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
56989242|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
56989243|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
56989244|NCT04783233|Coagulants|coagulants|mesh-ancestor
56989245|NCT05251233|Pantoprazole|pantoprazole|mesh-list
56989246|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56989247|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56989248|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56989249|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989250|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989251|NCT04777539|Natalizumab|natalizumab|mesh-list
56989252|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
56989253|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989254|NCT04664829|Capecitabine|capecitabine|mesh-list
56989255|NCT04664829|Bexarotene|bexarotene|mesh-list
56910070|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56989256|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56989257|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
56989258|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989259|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989260|NCT02951429|Pirfenidone|pirfenidone|mesh-list
56989261|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
56989262|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
56989263|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56989264|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56671452|NCT04729205|Mitomycins|mitomycins|mesh-list
56989265|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989266|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989267|NCT02951429|Urological Agents|urological agents|mesh-ancestor
56989268|NCT02951429|Analgesics|analgesics|mesh-ancestor
56989269|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
56989270|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989271|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989272|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56989273|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56989274|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989275|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989276|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989277|NCT04622709|Furosemide|furosemide|mesh-list
56989278|NCT04622709|Diuretics|diuretics|mesh-list
56989279|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56989280|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
56989281|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989282|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989283|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989284|NCT05423379|Everolimus|everolimus|mesh-list
56989285|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989286|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56989287|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
56989288|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989289|NCT05214807|Chitosan|chitosan|mesh-list
56989290|NCT05214807|Hylan|hylan|mesh-list
56989291|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56989292|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56989293|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
56989294|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989295|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56989296|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
56989297|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
56989298|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
56989299|NCT05214807|Coagulants|coagulants|mesh-ancestor
56989300|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
56989301|NCT05214807|Protective Agents|protective agents|mesh-ancestor
56989302|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989303|NCT02454855|Melatonin|melatonin|mesh-list
56989304|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
56989305|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989306|NCT02454855|Protective Agents|protective agents|mesh-ancestor
56989307|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989308|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56989309|NCT03343067|Norethindrone|norethindrone|mesh-list
56989310|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
56989311|NCT03343067|Estradiol|estradiol|mesh-list
56989312|NCT03343067|Estrogens|estrogens|mesh-ancestor
56989313|NCT03343067|Hormones|hormones|mesh-ancestor
56989314|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989315|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989316|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56989317|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
56989318|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56989319|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56989320|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56989321|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56989322|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56989323|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56989324|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56989325|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989326|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
56989327|NCT04707183|Lidocaine|lidocaine|mesh-list
56989328|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
56910156|NCT03726177|Aspirin|aspirin|mesh-list
56989329|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
56989330|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56989331|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989332|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
56989333|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989334|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56989335|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56989336|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56989337|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989338|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989339|NCT04703205|Ivermectin|ivermectin|mesh-list
56989340|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56989341|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989342|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
56989343|NCT03706781|Benzydamine|benzydamine|mesh-list
56989344|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56989345|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989346|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989347|NCT03706703|Carboplatin|carboplatin|mesh-list
56989348|NCT03706703|Docetaxel|docetaxel|mesh-list
56989349|NCT03706703|Pemetrexed|pemetrexed|mesh-list
56989350|NCT03706703|Endostar protein|endostar protein|mesh-list
56989351|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989352|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
56989353|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
56989354|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
56989355|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989356|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989357|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56989358|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56989359|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56989360|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56989361|NCT03706703|Growth Substances|growth substances|mesh-ancestor
56989362|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989363|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
56989364|NCT05642403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56989365|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
56989366|NCT03706547|Fludarabine|fludarabine|mesh-list
56989367|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56989368|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
56989369|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989370|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989371|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56989372|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
56989373|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989374|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989375|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56989376|NCT05682209|Octreotide|octreotide|mesh-list
56989377|NCT05682209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56989378|NCT05682209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56989379|NCT05682209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989380|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
56989381|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56989382|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
56989383|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56989384|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
56989385|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989386|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989387|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
56989388|NCT03708497|Misoprostol|misoprostol|mesh-list
56989389|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
56989390|NCT03708497|Carbetocin|carbetocin|mesh-list
56989391|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56989392|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56989393|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989394|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
56989395|NCT03708497|Coagulants|coagulants|mesh-ancestor
56989396|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56989397|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
56989398|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56989399|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989400|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56989401|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56989402|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
56989403|NCT04608903|Sulforaphane|sulforaphane|mesh-list
56989404|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56989405|NCT04608903|Protective Agents|protective agents|mesh-ancestor
56989406|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989407|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989408|NCT05681975|Antibodies|antibodies|mesh-list
56989409|NCT05681975|Immunoglobulins|immunoglobulins|mesh-list
56989410|NCT05681975|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56989411|NCT05681975|Immunoglobulin G|immunoglobulin g|mesh-list
56989412|NCT05681975|Immunologic Factors|immunologic factors|mesh-ancestor
56989413|NCT05681975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989414|NCT05216744|Doxycycline|doxycycline|mesh-list
56989415|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
56989416|NCT05216744|Cefixime|cefixime|mesh-list
56989417|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56989418|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989419|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
56989420|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56989421|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56989422|NCT05681897|Minoxidil|minoxidil|mesh-list
56989423|NCT05681897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56989424|NCT05681897|Vasodilator Agents|vasodilator agents|mesh-ancestor
56989425|NCT03341273|Azithromycin|azithromycin|mesh-list
56989426|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56989427|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989428|NCT01345058|Lacosamide|lacosamide|mesh-list
56989429|NCT01345058|Levetiracetam|levetiracetam|mesh-list
56989430|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
56989431|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
56989432|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56989433|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56989434|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989435|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989436|NCT05149131|Leuprolide|leuprolide|mesh-list
56989437|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56989438|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
56989439|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56989440|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989441|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56989442|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989443|NCT01345292|Listerine|listerine|mesh-list
56989444|NCT01345292|Fluorides|fluorides|mesh-list
56989445|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
56989446|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
56989447|NCT01345292|Protective Agents|protective agents|mesh-ancestor
56989448|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989449|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56989450|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989451|NCT03340961|Doxycycline|doxycycline|mesh-list
56989452|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56989453|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989454|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
56989455|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56989456|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56989457|NCT05372367|Rifampin|rifampin|mesh-list
56989458|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56989459|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
56989460|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56989461|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989462|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
56989463|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56989464|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989465|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989466|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56989467|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56989468|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56989469|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56989470|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56989471|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56989472|NCT03708341|Melatonin|melatonin|mesh-list
56989473|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
56989474|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989475|NCT03708341|Protective Agents|protective agents|mesh-ancestor
56989476|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989477|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56989478|NCT03643874|Albuterol|albuterol|mesh-list
56989479|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56989480|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
56989481|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989482|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989483|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56989484|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
56989485|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
56989486|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56989487|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56989488|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56989489|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56989490|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
56671682|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56989491|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989492|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989493|NCT03254485|Praliciguat|praliciguat|mesh-list
56989494|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56989495|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
56989496|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989497|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56989498|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
56989499|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56989500|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
56989501|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989502|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56989503|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989504|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989505|NCT01068704|Letrozole|letrozole|mesh-list
56989506|NCT01068704|Lapatinib|lapatinib|mesh-list
56989507|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989508|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56989509|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56989510|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989511|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989512|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56989513|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
56989514|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989515|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989516|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56989517|NCT03339401|Brincidofovir|brincidofovir|mesh-list
56989518|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
56989519|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989520|NCT05179525|Risperidone|risperidone|mesh-list
56989521|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56989522|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
56989523|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989524|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989525|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989526|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56989527|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56989528|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56989529|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56989530|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56989531|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
56989532|NCT03370289|Vaccines|vaccines|mesh-list
56989533|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
56989534|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989535|NCT01344824|Bevacizumab|bevacizumab|mesh-list
56989536|NCT01344824|Carboplatin|carboplatin|mesh-list
56989537|NCT01344824|Pemetrexed|pemetrexed|mesh-list
56989538|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56989539|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56989540|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989541|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56989542|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56989543|NCT01344824|Growth Substances|growth substances|mesh-ancestor
56989544|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989545|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
56989546|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989547|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989548|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56989549|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56989550|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56989551|NCT05507580|Upadacitinib|upadacitinib|mesh-list
56989552|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56989553|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56989554|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989555|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989556|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989557|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56989558|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
56989559|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989560|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
56989561|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56989562|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56989563|NCT05137496|Prednisolone|prednisolone|mesh-list
56989564|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
56989565|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56989566|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
56989567|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989569|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
56989570|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989571|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989572|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56989573|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
56989574|NCT05137496|Hormones|hormones|mesh-ancestor
56989575|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989576|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56989577|NCT05137496|Protective Agents|protective agents|mesh-ancestor
56989578|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56989579|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989580|NCT04025359|Dronabinol|dronabinol|mesh-list
56989581|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
56989582|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989583|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56989584|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56989585|NCT04025359|Analgesics|analgesics|mesh-ancestor
56989586|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
56989587|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989588|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56989589|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56989590|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989591|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989592|NCT04025359|Hormones|hormones|mesh-ancestor
56989593|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989594|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56989595|NCT02959892|Amphetamine|amphetamine|mesh-list
56989596|NCT02959892|Naxagolide|naxagolide|mesh-list
56989597|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56989598|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989599|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
56989600|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
56989601|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989602|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
56989603|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989604|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989605|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
56989606|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56989607|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56989608|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989609|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56989610|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
56989611|NCT01661400|Thalidomide|thalidomide|mesh-list
56989612|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
56989613|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56989614|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
56989615|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989616|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989617|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56989618|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
56989619|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989620|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989621|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56989622|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
56989623|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56989624|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989625|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56989626|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56989627|NCT01661400|Growth Substances|growth substances|mesh-ancestor
56989628|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
56910449|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
56989629|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56989630|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56989631|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56989632|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989633|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989634|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56989635|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989636|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989637|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
56989638|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989639|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
56671820|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
56989641|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989642|NCT05179213|Azacitidine|azacitidine|mesh-list
56989643|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56989644|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
56989645|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989646|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989647|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989648|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
56989649|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56989650|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989651|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56989652|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989653|NCT03367793|Metronidazole|metronidazole|mesh-list
56989654|NCT03367793|Methamphetamine|methamphetamine|mesh-list
56989655|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56989656|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989657|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
56989658|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
56989659|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989660|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
56989661|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989662|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989663|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
56989664|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56989665|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56989666|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989667|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56989668|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989669|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56989670|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56989671|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56989672|NCT05178745|Fluorouracil|fluorouracil|mesh-list
56989673|NCT05178745|Irinotecan|irinotecan|mesh-list
56989674|NCT05178745|Aflibercept|aflibercept|mesh-list
56989675|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
56989676|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989677|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56989678|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989679|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56989680|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
56989681|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989682|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56989683|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56989684|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989685|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56989686|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56989687|NCT05178745|Growth Substances|growth substances|mesh-ancestor
56989688|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
56989689|NCT05178511|Ensartinib|ensartinib|mesh-list
56989690|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989691|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56989692|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989693|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989694|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56989695|NCT03995641|Bupivacaine|bupivacaine|mesh-list
56989696|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
56989697|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
56989698|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56989699|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989700|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
56989701|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989702|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989703|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
56989704|NCT03995641|Hormones|hormones|mesh-ancestor
56989705|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989706|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56989707|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
56989708|NCT04105231|Cannabidiol|cannabidiol|mesh-list
56989709|NCT04105231|Risperidone|risperidone|mesh-list
56989710|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56989711|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
56989712|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671895|NCT00670670|Caseins|caseins|mesh-list
56989716|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56989717|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56989718|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56989719|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56989720|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
56989721|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
56989722|NCT03557749|Dimercaprol|dimercaprol|mesh-list
56989723|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
56989724|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
56989725|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989727|NCT03532555|Trace Elements|trace elements|mesh-ancestor
56989728|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
56989729|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989730|NCT03993457|Citalopram|citalopram|mesh-list
56989731|NCT03993457|Bupropion|bupropion|mesh-list
56989732|NCT03993457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56989733|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56989734|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989735|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989736|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989737|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
56989738|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989739|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56989740|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
56989741|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56989742|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56989743|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
56989744|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56989745|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56989746|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989747|NCT04677439|HH-GV-678|hh-gv-678|mesh-list
56989748|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56989749|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989750|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989751|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56989752|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
56989753|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989754|NCT05689710|Inositol|inositol|mesh-list
56989755|NCT05689710|Vitamin B Complex|vitamin b complex|mesh-ancestor
56989756|NCT05689710|Vitamins|vitamins|mesh-ancestor
56989757|NCT05689710|Micronutrients|micronutrients|mesh-ancestor
56989758|NCT05689710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989759|NCT02777424|Thrombin|thrombin|mesh-list
56989760|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
56989761|NCT02777424|Coagulants|coagulants|mesh-ancestor
56989762|NCT01347073|Glycerol|glycerol|mesh-list
56989763|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56989764|NCT01347073|Protective Agents|protective agents|mesh-ancestor
56989765|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989769|NCT01315236|Amikacin|amikacin|mesh-list
56989770|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56989771|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989772|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56989773|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
56989774|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
56989775|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989776|NCT05627466|Magrolimab|magrolimab|mesh-list
56989777|NCT05627466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56989778|NCT05627466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989779|NCT05620914|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
56989780|NCT05620914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56989781|NCT05620914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989782|NCT05572255|Cenobamate|cenobamate|mesh-list
56910599|NCT02169154|Analgesics|analgesics|mesh-ancestor
56989783|NCT05572255|Anticonvulsants|anticonvulsants|mesh-ancestor
56989784|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
56989785|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56989786|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989787|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
56989788|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56989789|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989790|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56989791|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989792|NCT05199311|Dexamethasone|dexamethasone|mesh-list
56989793|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989794|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
56989795|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
56989796|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989797|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989798|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56989799|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
56989800|NCT05199311|Hormones|hormones|mesh-ancestor
56989801|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989802|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56989803|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989804|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
56989805|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
56989806|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56989807|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56989808|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989809|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989810|NCT03710369|Urological Agents|urological agents|mesh-ancestor
56989811|NCT03706157|Doxorubicin|doxorubicin|mesh-list
56989812|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56989813|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56989814|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989815|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56989816|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56989817|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989818|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989819|NCT03707795|Betamethasone|betamethasone|mesh-list
56989820|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
56989821|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56989822|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
56989823|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
56989824|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
56989825|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56989826|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989827|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
56989828|NCT03707795|Hormones|hormones|mesh-ancestor
56989829|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56989830|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989831|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56989832|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
56989833|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56989834|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
56989835|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989836|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
56989837|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56989838|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989839|NCT05171231|Hemostatics|hemostatics|mesh-list
56989840|NCT05171231|Coagulants|coagulants|mesh-ancestor
56989841|NCT05692986|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56989842|NCT05692986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989843|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
56989844|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989845|NCT05692908|Immunoconjugates|immunoconjugates|mesh-list
56989846|NCT05692908|Immunologic Factors|immunologic factors|mesh-ancestor
56989847|NCT05692908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989848|NCT05058924|Aspirin|aspirin|mesh-list
56989849|NCT05058924|Heparin|heparin|mesh-list
56989850|NCT05058924|Calcium heparin|calcium heparin|mesh-list
56989851|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56989852|NCT05058924|Tinzaparin|tinzaparin|mesh-list
56989853|NCT05058924|Dalteparin|dalteparin|mesh-list
56989854|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56989855|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56989856|NCT05058924|Analgesics|analgesics|mesh-ancestor
56989857|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
56989858|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989859|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989860|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989861|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672057|NCT01015339|Paclitaxel|paclitaxel|mesh-list
56989862|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56989863|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56989864|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989865|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56989866|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56989867|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989868|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
56989869|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
56989870|NCT05681429|Acetaminophen|acetaminophen|mesh-list
56989872|NCT05681429|Lidocaine|lidocaine|mesh-list
56989873|NCT05681429|Dexmedetomidine|dexmedetomidine|mesh-list
56989874|NCT05681429|Sevoflurane|sevoflurane|mesh-list
56989875|NCT05681429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56989876|NCT05681429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56989877|NCT05681429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989878|NCT05681429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56989879|NCT05681429|Analgesics|analgesics|mesh-ancestor
56989880|NCT05681429|Sensory System Agents|sensory system agents|mesh-ancestor
56989881|NCT05681429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989882|NCT05681429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56989883|NCT05681429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56989884|NCT05681429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56989885|NCT05681429|Adrenergic Agents|adrenergic agents|mesh-ancestor
56989886|NCT05681429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989887|NCT05681429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989888|NCT05681429|Antipyretics|antipyretics|mesh-ancestor
56989889|NCT05681429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56989890|NCT05681429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56989891|NCT05681429|Anesthetics, General|anesthetics, general|mesh-ancestor
56989892|NCT05681429|Anesthetics|anesthetics|mesh-ancestor
56989893|NCT05681429|Anesthetics, Local|anesthetics, local|mesh-ancestor
56989894|NCT05681429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56989895|NCT05681429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56989896|NCT05681429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56989897|NCT05681429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56989898|NCT05681429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56989899|NCT05681429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56989900|NCT05681429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989901|NCT05681429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56989902|NCT05681429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56989903|NCT05681429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989904|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
56989905|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56989906|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56989907|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989908|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
56989909|NCT05020860|Paclitaxel|paclitaxel|mesh-list
56989910|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
56989911|NCT05020860|Carboplatin|carboplatin|mesh-list
56989912|NCT05020860|Doxorubicin|doxorubicin|mesh-list
56989913|NCT05020860|Pembrolizumab|pembrolizumab|mesh-list
56989914|NCT05020860|Trastuzumab|trastuzumab|mesh-list
56989915|NCT05020860|Pertuzumab|pertuzumab|mesh-list
56989916|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56989917|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989918|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
56989919|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
56989920|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
56989921|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989922|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56989923|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
56989924|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989925|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989926|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56989927|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
56989928|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56989929|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56989930|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56989931|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56989932|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989933|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56989934|NCT05603832|Acetaminophen|acetaminophen|mesh-list
56989935|NCT05603832|Bupivacaine|bupivacaine|mesh-list
56672117|NCT04155554|Tenofovir|tenofovir|mesh-list
56989936|NCT05603832|Methocarbamol|methocarbamol|mesh-list
56989937|NCT05603832|Anesthetics, Local|anesthetics, local|mesh-ancestor
56989939|NCT05603832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56989940|NCT05603832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989941|NCT05603832|Sensory System Agents|sensory system agents|mesh-ancestor
56989942|NCT05603832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989943|NCT05603832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56989944|NCT05603832|Analgesics|analgesics|mesh-ancestor
56989945|NCT05603832|Antipyretics|antipyretics|mesh-ancestor
56989946|NCT05603832|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56989947|NCT05603832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56989948|NCT04999020|Ravulizumab|ravulizumab|mesh-list
56989949|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56989950|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56989951|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
56989952|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989953|NCT02949011|Oseltamivir|oseltamivir|mesh-list
56989954|NCT02949011|Baloxavir|baloxavir|mesh-list
56989955|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
56989956|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56989957|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989958|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989959|NCT05409066|Rituximab|rituximab|mesh-list
56989960|NCT05409066|Lenalidomide|lenalidomide|mesh-list
56989961|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56989962|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989963|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
56989964|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989965|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56989966|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56989967|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56989968|NCT05409066|Growth Substances|growth substances|mesh-ancestor
56989969|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
56989970|NCT03705533|Telmisartan|telmisartan|mesh-list
56989971|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56989972|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56989973|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56989974|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989975|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
56989976|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
56989977|NCT03357341|Albuterol|albuterol|mesh-list
56989978|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56989979|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
56989980|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56989981|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989982|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56989983|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
56989984|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
56989985|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56989986|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56989987|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56989988|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56989989|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
56989990|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56989991|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989992|NCT05148234|Decitabine|decitabine|mesh-list
56989993|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56989994|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
56989995|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989996|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56989997|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56989998|NCT05177237|Endostar protein|endostar protein|mesh-list
56989999|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56990000|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56990001|NCT05177237|Growth Substances|growth substances|mesh-ancestor
56990002|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990003|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
56990004|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990005|NCT05681273|Empagliflozin|empagliflozin|mesh-list
56990006|NCT05681273|Valsartan|valsartan|mesh-list
56990007|NCT05681273|Atorvastatin|atorvastatin|mesh-list
56990008|NCT05681273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56990009|NCT05681273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56990010|NCT05681273|Antimetabolites|antimetabolites|mesh-ancestor
56990011|NCT05681273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990012|NCT05681273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56990013|NCT05681273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56990015|NCT05681273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56990016|NCT05681273|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56990017|NCT05681273|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56990018|NCT05681273|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56990019|NCT05681273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56990020|NCT05681273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990021|NCT05648435|Lithium Carbonate|lithium carbonate|mesh-list
56990022|NCT05648435|Antidepressive Agents|antidepressive agents|mesh-ancestor
56990023|NCT05648435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56990024|NCT05648435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990025|NCT05648435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990026|NCT05648435|Antimanic Agents|antimanic agents|mesh-ancestor
56990027|NCT05648435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56990028|NCT05648435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990029|NCT05648435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990030|NCT05147376|Curcumin|curcumin|mesh-list
56990031|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56990032|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56990033|NCT05147376|Analgesics|analgesics|mesh-ancestor
56990034|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
56990035|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990036|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990037|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56990038|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56990039|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990040|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990041|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990042|NCT05175131|Mebeverine|mebeverine|mesh-list
56990043|NCT05175131|Simethicone|simethicone|mesh-list
56990044|NCT05175131|Alverine|alverine|mesh-list
56990045|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
56990046|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990047|NCT05175131|Emollients|emollients|mesh-ancestor
56990048|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
56990049|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
56990050|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
56990051|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
56990052|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990053|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990054|NCT04507373|Simvastatin|simvastatin|mesh-list
56990055|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56990056|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56990057|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
56990058|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990059|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56990060|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56990061|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990062|NCT01312337|Gefitinib|gefitinib|mesh-list
56990063|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990064|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56990065|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990066|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990067|NCT05229653|Ketamine|ketamine|mesh-list
56990068|NCT05229653|Analgesics|analgesics|mesh-ancestor
56990069|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
56990070|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990071|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990072|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56990073|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56990074|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
56990075|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
56990076|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990077|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56990078|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56990079|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990080|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990081|NCT05418582|Carbamazepine|carbamazepine|mesh-list
56990082|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
56990083|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
56990084|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56990085|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990086|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990087|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56990088|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56990089|NCT05418582|Analgesics|analgesics|mesh-ancestor
56990090|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
56990091|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990092|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56990093|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56990094|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990095|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56990096|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56990097|NCT05551949|Estradiol|estradiol|mesh-list
56990098|NCT05551949|Estrogens|estrogens|mesh-ancestor
56990099|NCT05551949|Hormones|hormones|mesh-ancestor
56990100|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990101|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990102|NCT05541497|Varenicline|varenicline|mesh-list
56990103|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56990104|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56990105|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
56990106|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990107|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990108|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990109|NCT05283954|Ivermectin|ivermectin|mesh-list
56990110|NCT05283954|Albendazole|albendazole|mesh-list
56990111|NCT05283954|Prednisolone|prednisolone|mesh-list
56990112|NCT05283954|Fluoxetine|fluoxetine|mesh-list
56990113|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990114|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56990115|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
56990116|NCT05283954|Hormones|hormones|mesh-ancestor
56990117|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990118|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56990119|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990120|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990121|NCT05283954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56990122|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56990123|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56990124|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990125|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
56990126|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56990127|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
56990128|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56990129|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56990130|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56990131|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990132|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56990133|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990134|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
56990135|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
56990136|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56990137|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56990138|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
56990139|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
56990140|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
56990141|NCT01312415|Morphine|morphine|mesh-list
56990142|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
56990143|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56990144|NCT01312415|Narcotics|narcotics|mesh-ancestor
56990145|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990146|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990147|NCT01312415|Analgesics|analgesics|mesh-ancestor
56990148|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
56990149|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990150|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
56990151|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
56990152|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
56990153|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56990154|NCT03036852|Velpatasvir|velpatasvir|mesh-list
56990155|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
56990156|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990157|NCT01312493|Panitumumab|panitumumab|mesh-list
56990158|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990159|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672344|NCT01010425|Hormones|hormones|mesh-list
56990160|NCT05346354|Ravulizumab|ravulizumab|mesh-list
56990161|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56990162|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56990163|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
56990164|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990165|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
56990166|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56990167|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
56990168|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990169|NCT05122559|Expectorants|expectorants|mesh-ancestor
56990170|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
56990171|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56990172|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
56990173|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990174|NCT05122559|Protective Agents|protective agents|mesh-ancestor
56990175|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990176|NCT05122559|Antidotes|antidotes|mesh-ancestor
56990177|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
56990178|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990179|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990180|NCT04313244|Vaccines|vaccines|mesh-list
56990181|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
56990182|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990183|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
56990184|NCT05279898|Ketamine|ketamine|mesh-list
56990185|NCT05279898|Remifentanil|remifentanil|mesh-list
56990186|NCT05279898|Propofol|propofol|mesh-list
56990187|NCT05279898|Ropivacaine|ropivacaine|mesh-list
56990188|NCT05279898|Rocuronium|rocuronium|mesh-list
56990189|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56990190|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990191|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990192|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56990193|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
56990194|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
56990195|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56990196|NCT05279898|Analgesics|analgesics|mesh-ancestor
56990197|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
56990198|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990199|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56990200|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56990201|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56990202|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
56990203|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990204|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990205|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56990206|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56990207|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56990208|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
56990209|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56990210|NCT05279898|Narcotics|narcotics|mesh-ancestor
56990211|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56990212|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56990213|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56990214|NCT05309694|Copper|copper|mesh-list
56990215|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
56990216|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56990217|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990218|NCT05309694|Trace Elements|trace elements|mesh-ancestor
56990219|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
56990220|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
56990221|NCT05268510|Olaparib|olaparib|mesh-list
56990222|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990223|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990224|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56990225|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990226|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990227|NCT05030441|Ivosidenib|ivosidenib|mesh-list
56990228|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990229|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990230|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990231|NCT05020769|Osimertinib|osimertinib|mesh-list
56990232|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990233|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56990234|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990235|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990236|NCT04952753|Leucovorin|leucovorin|mesh-list
56990237|NCT04952753|Bevacizumab|bevacizumab|mesh-list
56990239|NCT04952753|Irinotecan|irinotecan|mesh-list
56990240|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
56990241|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990242|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990243|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56990244|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56990245|NCT04952753|Growth Substances|growth substances|mesh-ancestor
56990246|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990247|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
56990248|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56990249|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56990250|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990251|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990252|NCT04952753|Antidotes|antidotes|mesh-ancestor
56990253|NCT04952753|Protective Agents|protective agents|mesh-ancestor
56990254|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
56990255|NCT04952753|Vitamins|vitamins|mesh-ancestor
56990256|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
56990257|NCT05438303|Celecoxib|celecoxib|mesh-list
56990258|NCT05438303|Midazolam|midazolam|mesh-list
56990259|NCT05438303|Omeprazole|omeprazole|mesh-list
56990260|NCT05438303|Dabigatran|dabigatran|mesh-list
56990261|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56990262|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56990263|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990264|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990265|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56990266|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56990267|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56990268|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56990269|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
56990270|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
56990271|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
56990272|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
56990273|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990274|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990275|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56990276|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56990277|NCT05438303|Analgesics|analgesics|mesh-ancestor
56990278|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
56990279|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990280|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56990281|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56990282|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56990283|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56990284|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990285|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56990286|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56990287|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56990288|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
56990289|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56990290|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
56990291|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
56990292|NCT05432141|Vaccines|vaccines|mesh-list
56990293|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
56990294|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990295|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
56990296|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56990297|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990298|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56990299|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990300|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
56990301|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990302|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56990303|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990304|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990305|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
56990306|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990307|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990308|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56990309|NCT04906889|Lidocaine|lidocaine|mesh-list
56990310|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
56990311|NCT04906889|Remifentanil|remifentanil|mesh-list
56990312|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
56990313|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
56990314|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990315|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990316|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
56990317|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990318|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56990319|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56990320|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56990321|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56990322|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990323|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56990324|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56990325|NCT04906889|Analgesics|analgesics|mesh-ancestor
56990326|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56990327|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56990328|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56990329|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
56990330|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990331|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56990332|NCT04906889|Narcotics|narcotics|mesh-ancestor
56990333|NCT02948777|Evolocumab|evolocumab|mesh-list
56990334|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56990335|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56990336|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
56990337|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990338|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56990339|NCT04868747|Lidocaine|lidocaine|mesh-list
56990340|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
56990341|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
56990342|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990343|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990344|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
56990345|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990346|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56990347|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56990348|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56990349|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56990350|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990351|NCT04817345|Plerixafor|plerixafor|mesh-list
56990352|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56990353|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56990354|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
56990355|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990356|NCT05330273|Efavirenz|efavirenz|mesh-list
56990357|NCT05330273|Lumefantrine|lumefantrine|mesh-list
56990358|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56990359|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56990360|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990361|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990362|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
56990363|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990364|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56990365|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56990366|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56990367|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56990368|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56990369|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56990370|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
56990371|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56990372|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56990373|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56990374|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
56990375|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990376|NCT04533737|Brodalumab|brodalumab|mesh-list
56990377|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
56990378|NCT05254847|Capecitabine|capecitabine|mesh-list
56990379|NCT05254847|Lenvatinib|lenvatinib|mesh-list
56990380|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56990381|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
56990382|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990383|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990384|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56990385|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990386|NCT05249699|Isoniazid|isoniazid|mesh-list
56672565|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
56990387|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
56990388|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56990389|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990390|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56990391|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56990392|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
56990393|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990394|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56990395|NCT04751669|Trace Elements|trace elements|mesh-list
56990396|NCT04751669|Micronutrients|micronutrients|mesh-list
56990397|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990398|NCT04731233|Triamcinolone|triamcinolone|mesh-list
56990399|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56990400|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56990401|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56990402|NCT04731233|Mitogens|mitogens|mesh-list
56990403|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56990404|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
56990405|NCT04731233|Hormones|hormones|mesh-ancestor
56990406|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990407|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990408|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56990409|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
56990410|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990411|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990412|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
56990413|NCT04417517|Azacitidine|azacitidine|mesh-list
56990414|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56990415|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
56990416|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990417|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990418|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990419|NCT04695977|Nivolumab|nivolumab|mesh-list
56990420|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990421|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990422|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56990423|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990424|NCT03093155|Bevacizumab|bevacizumab|mesh-list
56990425|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990426|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990427|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56990428|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56990429|NCT03093155|Growth Substances|growth substances|mesh-ancestor
56990430|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990431|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
56990432|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56990433|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56990434|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56990435|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56990436|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990437|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
56990438|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990439|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990440|NCT03629873|Cytarabine|cytarabine|mesh-list
56990441|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
56990442|NCT03629873|Carmustine|carmustine|mesh-list
56990443|NCT03629873|Etoposide|etoposide|mesh-list
56990444|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56990445|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
56990446|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990447|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56990448|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56990449|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
56990450|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990451|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990452|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56990453|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56990454|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56990455|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56990456|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990457|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56990458|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
56990459|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
56990460|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990461|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
56990462|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56990463|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990464|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990465|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
56990466|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990467|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990468|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
56990469|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
56990470|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56990471|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56990472|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990473|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990474|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990475|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56990476|NCT02864147|Imiquimod|imiquimod|mesh-list
56990477|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56990478|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
56990479|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990480|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990481|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
56990482|NCT04258631|Hydromorphone|hydromorphone|mesh-list
56990483|NCT04258631|Bupivacaine|bupivacaine|mesh-list
56990484|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
56990485|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
56990486|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990487|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990488|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
56990489|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990490|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56990491|NCT04258631|Narcotics|narcotics|mesh-ancestor
56990492|NCT04258631|Analgesics|analgesics|mesh-ancestor
56990493|NCT02931695|Hormones|hormones|mesh-list
56990494|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990495|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990496|NCT03638063|Adenosine|adenosine|mesh-list
56990497|NCT03638063|Capsaicin|capsaicin|mesh-list
56990498|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
56990499|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
56990500|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
56990501|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990502|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990503|NCT03638063|Analgesics|analgesics|mesh-ancestor
56990504|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56990505|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
56990506|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56990507|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
56990508|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
56990509|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990510|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990511|NCT04869371|Prednisone|prednisone|mesh-list
56990512|NCT04869371|Docetaxel|docetaxel|mesh-list
56990513|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56990514|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990515|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
56990516|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
56990517|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
56990518|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990519|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56990520|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
56990521|NCT04869371|Hormones|hormones|mesh-ancestor
56990522|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990523|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990524|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56990525|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
56990526|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56990527|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
56990528|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56990529|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56990530|NCT02710331|Ethanol|ethanol|mesh-list
56990531|NCT02710331|Dronabinol|dronabinol|mesh-list
56990532|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56990533|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730339|NCT04778176|Carbidopa|carbidopa|mesh-list
56990534|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990535|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990536|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
56990537|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56990538|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56990539|NCT02710331|Analgesics|analgesics|mesh-ancestor
56990540|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
56990541|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990542|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56990543|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56990544|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990545|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990546|NCT02710331|Hormones|hormones|mesh-ancestor
56990547|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990548|NCT02885753|Leucovorin|leucovorin|mesh-list
56990549|NCT02885753|Folic Acid|folic acid|mesh-list
56990550|NCT02885753|Bevacizumab|bevacizumab|mesh-list
56990551|NCT02885753|Panitumumab|panitumumab|mesh-list
56990552|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
56990553|NCT02885753|Irinotecan|irinotecan|mesh-list
56990554|NCT02885753|Fluorouracil|fluorouracil|mesh-list
56990555|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
56990556|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990557|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990558|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56990559|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56990560|NCT02885753|Growth Substances|growth substances|mesh-ancestor
56990561|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990562|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
56990563|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56990564|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56990565|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990566|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990567|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
56990568|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56990569|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56990570|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
56990571|NCT02885753|Antidotes|antidotes|mesh-ancestor
56990572|NCT02885753|Protective Agents|protective agents|mesh-ancestor
56990573|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
56990574|NCT02885753|Vitamins|vitamins|mesh-ancestor
56990575|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
56990576|NCT02885753|Hematinics|hematinics|mesh-ancestor
56990577|NCT03320057|Mifepristone|mifepristone|mesh-list
56990578|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56990579|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
56990580|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56990581|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990582|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56990583|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56990584|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56990585|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
56990586|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56990587|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56990588|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
56990589|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990590|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
56990591|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56990592|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56990593|NCT04741139|Acetaminophen|acetaminophen|mesh-list
56990594|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
56990595|NCT04741139|Promethazine|promethazine|mesh-list
56990596|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56990597|NCT04741139|Analgesics|analgesics|mesh-ancestor
56990598|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
56990599|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990600|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990601|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
56990602|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56990603|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56990604|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990605|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
56990606|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
56990607|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
56990608|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
56990609|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56990610|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56990611|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
56990612|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
56990613|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990614|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990615|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56990616|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
56990617|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
56990618|NCT02227199|Carboplatin|carboplatin|mesh-list
56990619|NCT02227199|Etoposide|etoposide|mesh-list
56990620|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
56990621|NCT02227199|Ifosfamide|ifosfamide|mesh-list
56990622|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
56990623|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56990624|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
56990625|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56990626|NCT02227199|Antibodies|antibodies|mesh-list
56990627|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
56990628|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56990629|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
56990630|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
56990631|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990632|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990633|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56990634|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56990635|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56990636|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990637|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990638|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56990639|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
56990640|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
56990641|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
56990642|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
56990643|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
56990644|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
56990645|NCT04853147|Dexamethasone|dexamethasone|mesh-list
56990646|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
56990647|NCT04853147|Palonosetron|palonosetron|mesh-list
56990648|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
56990649|NCT04853147|Aprepitant|aprepitant|mesh-list
56990650|NCT04853147|BB 1101|bb 1101|mesh-list
56990651|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56990652|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
56990653|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
56990654|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990655|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990656|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56990657|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
56990658|NCT04853147|Hormones|hormones|mesh-ancestor
56990659|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990660|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56990661|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990662|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
56990663|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990664|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990665|NCT04853147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56990666|NCT04853147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56990667|NCT04853147|Serotonin Agents|serotonin agents|mesh-ancestor
56990668|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990669|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56990670|NCT03473561|Racecadotril|racecadotril|mesh-list
56990671|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
56990672|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56990673|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
56990674|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990675|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990676|NCT04689347|Leucovorin|leucovorin|mesh-list
56990677|NCT04689347|Bevacizumab|bevacizumab|mesh-list
56990678|NCT04689347|Fluorouracil|fluorouracil|mesh-list
56990679|NCT04689347|Irinotecan|irinotecan|mesh-list
56990680|NCT04689347|Temozolomide|temozolomide|mesh-list
56990681|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990682|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990683|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56990684|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56990685|NCT04689347|Growth Substances|growth substances|mesh-ancestor
56990686|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990687|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
56990688|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
56990689|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990690|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56990691|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56990692|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
56990693|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56990694|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56990695|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990696|NCT04689347|Antidotes|antidotes|mesh-ancestor
56990697|NCT04689347|Protective Agents|protective agents|mesh-ancestor
56990698|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
56990699|NCT04689347|Vitamins|vitamins|mesh-ancestor
56990700|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
56990701|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56990702|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
56990703|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56990704|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
56990705|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990706|NCT01268579|Ribavirin|ribavirin|mesh-list
56990707|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
56990708|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990709|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
56990710|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990711|NCT02420795|TIC10 compound|tic10 compound|mesh-list
56990712|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990713|NCT02384759|Aflibercept|aflibercept|mesh-list
56990714|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56990715|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56990716|NCT02384759|Growth Substances|growth substances|mesh-ancestor
56990717|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990718|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
56990719|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990720|NCT05276687|Vancomycin|vancomycin|mesh-list
56990721|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
56990722|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56990723|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990724|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56990725|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
56990726|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56990727|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990728|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56990729|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990730|NCT03332771|Metformin|metformin|mesh-list
56990731|NCT03332771|Glimepiride|glimepiride|mesh-list
56990732|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56990733|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56990734|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990735|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56990736|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56990737|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
56990738|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56990739|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990740|NCT03625830|Paclitaxel|paclitaxel|mesh-list
56990741|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56990742|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990743|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
56990744|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
56990745|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
56990746|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990747|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
56990748|NCT04108104|Prazosin|prazosin|mesh-list
56990749|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56990750|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56990751|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56990752|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56990753|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
56990754|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990755|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990756|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990757|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
56990758|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
56990759|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56990760|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56911569|NCT02185924|Ropivacaine|ropivacaine|mesh-list
56990761|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
56990762|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
56990763|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56990764|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
56990765|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56990766|NCT05304468|Cisplatin|cisplatin|mesh-list
56990767|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990768|NCT05246670|Palmidrol|palmidrol|mesh-list
56990769|NCT05246670|Analgesics|analgesics|mesh-ancestor
56990770|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
56990771|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990772|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990773|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56990774|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56990775|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56990776|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56990777|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
56990778|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990779|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56990780|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56990781|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990782|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990783|NCT05246670|Hormones|hormones|mesh-ancestor
56990784|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990785|NCT04731480|Propofol|propofol|mesh-list
56990786|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56990787|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990788|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990789|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56990790|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
56990791|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
56990792|NCT03039192|Esketamine|esketamine|mesh-list
56990793|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
56990794|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56990795|NCT03698279|Vaccines|vaccines|mesh-list
56990796|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
56990797|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990798|NCT03038880|Ranibizumab|ranibizumab|mesh-list
56990799|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56990800|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56990801|NCT03038880|Growth Substances|growth substances|mesh-ancestor
56990802|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990803|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
56990804|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990805|NCT05211336|Prednisone|prednisone|mesh-list
56990806|NCT05211336|Lenalidomide|lenalidomide|mesh-list
56990807|NCT05211336|Venetoclax|venetoclax|mesh-list
56990808|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
56990809|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56990810|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
56990811|NCT05211336|Hormones|hormones|mesh-ancestor
56990812|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990813|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990814|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56990815|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990816|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
56990817|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56990818|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56990819|NCT05211336|Growth Substances|growth substances|mesh-ancestor
56990820|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
56990821|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990822|NCT03035916|Anesthetics|anesthetics|mesh-list
56990823|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56990824|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990825|NCT01702571|Trastuzumab|trastuzumab|mesh-list
56990826|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56990827|NCT01702571|Maytansine|maytansine|mesh-list
56990828|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990829|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990830|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56990831|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
56990832|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
56990833|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
56990834|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990835|NCT01578239|Octreotide|octreotide|mesh-list
56924231|NCT03931369|Tolvaptan|tolvaptan|mesh-list
56925366|NCT02296762|Sirolimus|sirolimus|mesh-list
56925575|NCT01356680|Vinblastine|vinblastine|mesh-list
56925955|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
56926105|NCT03507634|Lidocaine|lidocaine|mesh-list
56926710|NCT05177731|Decitabine|decitabine|mesh-list
56926799|NCT03502642|Morphine|morphine|mesh-list
56926861|NCT03508102|Narcotics|narcotics|mesh-ancestor
56927460|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
56927918|NCT04496908|Misoprostol|misoprostol|mesh-list
56928074|NCT01146145|Ketamine|ketamine|mesh-list
56928221|NCT03491410|Analgesics|analgesics|mesh-ancestor
56929422|NCT05195294|Lenvatinib|lenvatinib|mesh-list
56929494|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56930092|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
56930542|NCT03525834|Everolimus|everolimus|mesh-list
56930612|NCT03632876|Vitamin A|vitamin a|mesh-list
56930763|NCT03903367|Analgesics|analgesics|mesh-ancestor
56930986|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
56930987|NCT03909529|Digoxin|digoxin|mesh-list
56930988|NCT03909529|Spironolactone|spironolactone|mesh-list
56930989|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56930990|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
56930991|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56930992|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56930993|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56930994|NCT03909529|Diuretics|diuretics|mesh-ancestor
56930995|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
56930996|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56930997|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56930998|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56930999|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56931000|NCT03909529|Protective Agents|protective agents|mesh-ancestor
56931001|NCT04927052|Lidocaine|lidocaine|mesh-list
56931002|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
56931003|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
56931004|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56931005|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56931006|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
56931007|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56931008|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56931013|NCT01149499|Valacyclovir|valacyclovir|mesh-list
56931970|NCT03884881|Meropenem|meropenem|mesh-list
56932123|NCT03880981|Ibuprofen|ibuprofen|mesh-list
56932267|NCT01266187|Leucovorin|leucovorin|mesh-list
56932343|NCT00075725|Hormones|hormones|mesh-ancestor
56932643|NCT03882775|Bivalirudin|bivalirudin|mesh-list
56932797|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56933172|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56933325|NCT01164787|Trandolapril|trandolapril|mesh-list
56933632|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
56933779|NCT03863977|BB 1101|bb 1101|mesh-list
56933876|NCT03867097|Iloprost|iloprost|mesh-list
56934004|NCT01288339|Panitumumab|panitumumab|mesh-list
56934086|NCT01286857|Silicon|silicon|mesh-list
56934232|NCT01288573|Plerixafor|plerixafor|mesh-list
56934604|NCT01181401|Docetaxel|docetaxel|mesh-list
56934754|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56935282|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
56935360|NCT01291927|Pancrelipase|pancrelipase|mesh-list
56935438|NCT03948191|Prednisolone|prednisolone|mesh-list
56935583|NCT01588093|Mecasermin|mecasermin|mesh-list
56935809|NCT04312841|Acetic Acid|acetic acid|mesh-list
56935965|NCT05039801|Paclitaxel|paclitaxel|mesh-list
56936038|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
56936483|NCT01109693|Sertraline|sertraline|mesh-list
56936560|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
56936637|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
56937160|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56937533|NCT01198639|Analgesics|analgesics|mesh-ancestor
56937682|NCT05667727|Autonomic Agents|autonomic agents|mesh-ancestor
56937834|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56939107|NCT01218581|Letrozole|letrozole|mesh-list
56939331|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56939535|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56939984|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
56940209|NCT01302613|Leucovorin|leucovorin|mesh-list
56940822|NCT03810391|Butorphanol|butorphanol|mesh-list
56941204|NCT03801902|Durvalumab|durvalumab|mesh-list
56941272|NCT03792217|Eusol|eusol|mesh-list
56941501|NCT03791905|Paclitaxel|paclitaxel|mesh-list
56941663|NCT05364099|Lidocaine|lidocaine|mesh-list
56941954|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
56942109|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56942406|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56942632|NCT05681247|Ezetimibe|ezetimibe|mesh-list
56943385|NCT03777085|Rituximab|rituximab|mesh-list
56943459|NCT03780673|Rifaximin|rifaximin|mesh-list
56943987|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
56944211|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
56540057|NCT05215873|Misoprostol|misoprostol|mesh-list
56944283|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56944284|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56944285|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
56944286|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56944287|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56944288|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944289|NCT01235273|Hormones|hormones|mesh-list
56944291|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56944427|NCT03449524|CXA-10|cxa-10|mesh-list
56944641|NCT01380548|Iron|iron|mesh-list
56944664|NCT04701424|Insulin|insulin|mesh-list
56944823|NCT02927834|Prednisone|prednisone|mesh-list
56945039|NCT01243697|Progestins|progestins|mesh-ancestor
56945260|NCT03779035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56945344|NCT04327024|Verinurad|verinurad|mesh-list
56945492|NCT01146041|Rivastigmine|rivastigmine|mesh-list
56945786|NCT03770923|Montelukast|montelukast|mesh-list
56946322|NCT01567657|Midazolam|midazolam|mesh-list
56946478|NCT03426202|Modafinil|modafinil|mesh-list
56946771|NCT03414892|Globalagliatin|globalagliatin|mesh-list
56947140|NCT03273387|Trimetazidine|trimetazidine|mesh-list
56947592|NCT03392740|Lisinopril|lisinopril|mesh-list
56947593|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56947594|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
56947595|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56947601|NCT04919317|Dexamethasone|dexamethasone|mesh-list
56947749|NCT03399526|Vitamins|vitamins|mesh-ancestor
56947816|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56947817|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56947818|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
56947819|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56947820|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56947821|NCT03256695|Albuterol|albuterol|mesh-list
56947822|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56947823|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
56947826|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56947893|NCT01988571|Atorvastatin|atorvastatin|mesh-list
56947896|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
56948185|NCT03697993|Renal Agents|renal agents|mesh-ancestor
56948338|NCT01481272|Antidotes|antidotes|mesh-ancestor
56948639|NCT03680274|Vitamins|vitamins|mesh-ancestor
56948790|NCT03249909|Laxatives|laxatives|mesh-ancestor
56949089|NCT05762744|Exenatide|exenatide|mesh-list
56949896|NCT04691856|Ibuprofen|ibuprofen|mesh-list
56950001|NCT03908333|Paclitaxel|paclitaxel|mesh-list
56950077|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56950147|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56950306|NCT03629210|Hormones|hormones|mesh-ancestor
56950371|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56950445|NCT03747523|Vitamin D|vitamin d|mesh-list
56950591|NCT03903887|Antibodies|antibodies|mesh-list
56950672|NCT04314037|Praziquantel|praziquantel|mesh-list
56950742|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
56951190|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
56951489|NCT01156883|Cytarabine|cytarabine|mesh-list
56951788|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
56952401|NCT01269515|Etoricoxib|etoricoxib|mesh-list
56952542|NCT02526953|Paclitaxel|paclitaxel|mesh-list
56952769|NCT03379012|Sunitinib|sunitinib|mesh-list
56952919|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56953073|NCT01170767|Growth Substances|growth substances|mesh-ancestor
56953308|NCT01282073|Cyclosporine|cyclosporine|mesh-list
56953599|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
56953762|NCT01172171|Melatonin|melatonin|mesh-list
56953906|NCT01173107|Colchicine|colchicine|mesh-list
56953972|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
56954050|NCT01288157|Golimumab|golimumab|mesh-list
56954350|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
56954431|NCT04597320|Fentanyl|fentanyl|mesh-list
56954579|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56954804|NCT03361774|Fluorides|fluorides|mesh-list
56954964|NCT01285661|Vitamin K|vitamin k|mesh-list
56955039|NCT04006210|Levodopa|levodopa|mesh-list
56955182|NCT01181063|Budesonide|budesonide|mesh-list
56955277|NCT01289561|Analgesics|analgesics|mesh-ancestor
56955407|NCT01185119|Hormones|hormones|mesh-ancestor
56955702|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56956010|NCT02954653|Decitabine|decitabine|mesh-list
56956095|NCT03636555|Oxytocin|oxytocin|mesh-list
56956323|NCT03349216|Anesthetics|anesthetics|mesh-list
56956692|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56956694|NCT03235050|Incretins|incretins|mesh-ancestor
56956770|NCT03849833|Vitamin D|vitamin d|mesh-list
56957062|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56957208|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
56957361|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
56957510|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56957654|NCT04500808|Macitentan|macitentan|mesh-list
56958042|NCT03844763|Avelumab|avelumab|mesh-list
56958182|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
56958712|NCT02506348|Nepafenac|nepafenac|mesh-list
56958786|NCT00245960|Etanercept|etanercept|mesh-list
56958865|NCT02505880|Anesthetics|anesthetics|mesh-list
56958935|NCT05651594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56958936|NCT05651594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56958937|NCT05651594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56958938|NCT05651594|Vasodilator Agents|vasodilator agents|mesh-ancestor
56958939|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
56958940|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56958941|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56958942|NCT04454411|Naltrexone|naltrexone|mesh-list
56958943|NCT04454411|Buprenorphine|buprenorphine|mesh-list
56958944|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56958945|NCT04454411|Narcotics|narcotics|mesh-ancestor
56958946|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56958947|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56959918|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
56960003|NCT03639571|Ibuprofen|ibuprofen|mesh-list
56960142|NCT02343042|Pomalidomide|pomalidomide|mesh-list
56960218|NCT05644223|Antioxidants|antioxidants|mesh-ancestor
56960292|NCT03332602|Protective Agents|protective agents|mesh-ancestor
56960443|NCT03723109|Anesthetics|anesthetics|mesh-list
56960829|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
56961284|NCT03324490|Analgesics|analgesics|mesh-ancestor
56961442|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
56961735|NCT01305551|Hormones|hormones|mesh-ancestor
56962007|NCT03499873|Nepafenac|nepafenac|mesh-list
56962077|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
56962375|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
56962530|NCT00739674|Calcium|calcium|mesh-list
56962607|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
56962683|NCT01337466|Fialuridine|fialuridine|mesh-list
56962754|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
56962829|NCT02484352|Oxycodone|oxycodone|mesh-list
56963352|NCT03779633|Estradiol|estradiol|mesh-list
56963575|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56963648|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56963724|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56963875|NCT01316718|Mesalamine|mesalamine|mesh-list
56964097|NCT04960618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56964098|NCT04960618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56964099|NCT04960618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56964100|NCT04960618|Immunologic Factors|immunologic factors|mesh-ancestor
56964101|NCT04960618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964102|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56964103|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
56964179|NCT05685394|Dapagliflozin|dapagliflozin|mesh-list
56964180|NCT05685394|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56964181|NCT05685394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56964182|NCT05685394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56964183|NCT05685394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56964184|NCT03772223|Budesonide|budesonide|mesh-list
56965076|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
56965228|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56965310|NCT03879694|Octreotide|octreotide|mesh-list
56965378|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56965461|NCT03304288|Rituximab|rituximab|mesh-list
56965526|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56965527|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56965528|NCT03307720|Hormones|hormones|mesh-list
56965529|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56965530|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56965531|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56965540|NCT04608786|Capecitabine|capecitabine|mesh-list
56965541|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56965542|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
56965543|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56965544|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56965545|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56965546|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56965547|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56965548|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
56965601|NCT01343706|BI 409306|bi 409306|mesh-list
56965681|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
56965749|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
56966200|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
56966426|NCT01354158|Droxidopa|droxidopa|mesh-list
56966815|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
56966882|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56967113|NCT05550142|Vaccines|vaccines|mesh-list
56967183|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56967342|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
56967641|NCT00702806|Ganirelix|ganirelix|mesh-list
56967706|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56967784|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56968077|NCT02460640|Morphine|morphine|mesh-list
56968155|NCT02461186|Artenimol|artenimol|mesh-list
56968225|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
56968298|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
56968524|NCT05185869|Gemcitabine|gemcitabine|mesh-list
56968670|NCT02457208|Rifampin|rifampin|mesh-list
56968743|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
56968994|NCT03151551|Adalimumab|adalimumab|mesh-list
56969266|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56970020|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56970099|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
56970165|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
56970243|NCT03241888|Megestrol|megestrol|mesh-list
56970387|NCT03256864|Tacrolimus|tacrolimus|mesh-list
56970770|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
56653338|NCT03973177|Phenol|phenol|mesh-list
56971074|NCT00238420|Paclitaxel|paclitaxel|mesh-list
56971533|NCT02451748|Analgesics|analgesics|mesh-ancestor
56971603|NCT03200938|Zinc|zinc|mesh-list
56971825|NCT03203668|Choline|choline|mesh-list
56972506|NCT05480150|Dexetimide|dexetimide|mesh-list
56972573|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
56972725|NCT02448550|Heparin|heparin|mesh-list
56972954|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
56973029|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56973483|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56974539|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
56974615|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56975298|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
56975595|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
56975749|NCT02423824|Liraglutide|liraglutide|mesh-list
56977547|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56977548|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
56977549|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
56977550|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
56977551|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56977552|NCT03349333|Folic Acid|folic acid|mesh-list
56977553|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
56977698|NCT03736187|Cephalexin|cephalexin|mesh-list
56977846|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
56977994|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
56978078|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
56978375|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
56978449|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56978747|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56978748|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56978749|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56978972|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56978976|NCT05075161|Pirfenidone|pirfenidone|mesh-list
56979049|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979122|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979123|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979124|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56979125|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56979126|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56979274|NCT04055818|Decitabine|decitabine|mesh-list
56979275|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
56979276|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56979277|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
56979278|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979279|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56979280|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979281|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
56979282|NCT04055818|Vitamins|vitamins|mesh-ancestor
56979283|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
56979284|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979285|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56979286|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56979287|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
56979288|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
56979289|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
56979290|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56979291|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56979292|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56979293|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979294|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979357|NCT01312363|Rivastigmine|rivastigmine|mesh-list
56979358|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56979359|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56979360|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56979361|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
56979362|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56979363|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979427|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56979428|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56979429|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
56979589|NCT05422066|Hormones|hormones|mesh-ancestor
56979725|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56980041|NCT04788667|Erenumab|erenumab|mesh-list
56980410|NCT02674204|Atorvastatin|atorvastatin|mesh-list
56980517|NCT02913326|Warfarin|warfarin|mesh-list
56980557|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56980931|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
56981238|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56981460|NCT03310411|Lasmiditan|lasmiditan|mesh-list
56982140|NCT03113266|Antibodies|antibodies|mesh-list
56982667|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56982748|NCT01371435|Paroxetine|paroxetine|mesh-list
56982892|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
56983202|NCT04013334|Nivolumab|nivolumab|mesh-list
56983348|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
56983719|NCT03727295|Idebenone|idebenone|mesh-list
56984250|NCT02349802|Exenatide|exenatide|mesh-list
56984396|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56984994|NCT03488225|Folic Acid|folic acid|mesh-list
56985457|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56985987|NCT03144778|Durvalumab|durvalumab|mesh-list
56986576|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
56986723|NCT03633747|Propranolol|propranolol|mesh-list
56986816|NCT03629262|Dsuvia|dsuvia|mesh-list
56987098|NCT02891811|Hormones|hormones|mesh-ancestor
56987245|NCT05732532|Glucocorticoids|glucocorticoids|mesh-ancestor
56987324|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
56987639|NCT04360980|Colchicine|colchicine|mesh-list
56988592|NCT05029050|Analgesics|analgesics|mesh-ancestor
56988611|NCT04690231|Etoposide|etoposide|mesh-list
56988670|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56989045|NCT02537418|Durvalumab|durvalumab|mesh-list
56989568|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
56989640|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56989713|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56989714|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56989715|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56989726|NCT03532555|Zinc|zinc|mesh-list
56989871|NCT05681429|Parecoxib|parecoxib|mesh-list
56989938|NCT05603832|Anesthetics|anesthetics|mesh-ancestor
56990014|NCT05681273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990238|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
56991162|NCT03301649|Ivermectin|ivermectin|mesh-list
56991217|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
56991884|NCT02117700|Antidotes|antidotes|mesh-ancestor
56992260|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990836|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56993531|NCT03259074|Adalimumab|adalimumab|mesh-list
56993683|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
56993986|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
56994137|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
56994211|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994289|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
56994589|NCT03617432|Hormones|hormones|mesh-ancestor
56994828|NCT02993250|Simeprevir|simeprevir|mesh-list
56990837|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995431|NCT03635905|Gabapentin|gabapentin|mesh-list
56995663|NCT03953807|Hormones|hormones|mesh-ancestor
56990838|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56990839|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990840|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56990841|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990842|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56990843|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990844|NCT03231709|Alogliptin|alogliptin|mesh-list
56990845|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56990846|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990847|NCT03231709|Incretins|incretins|mesh-ancestor
56990848|NCT03231709|Hormones|hormones|mesh-ancestor
56990849|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990850|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56990851|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
56990852|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990853|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990854|NCT01220531|Cyclosporine|cyclosporine|mesh-list
56990855|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
56990856|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
56990857|NCT01220531|Prednisolone|prednisolone|mesh-list
56990858|NCT01220531|Tacrolimus|tacrolimus|mesh-list
56990859|NCT01220531|Cyclosporins|cyclosporins|mesh-list
56990860|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56995996|NCT03635827|Xenon|xenon|mesh-list
56990861|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
56996391|NCT01334905|Mirabegron|mirabegron|mesh-list
56996534|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
56996610|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56990862|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996759|NCT02591615|Paclitaxel|paclitaxel|mesh-list
56990863|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
56997060|NCT01064622|Antiviral Agents|antiviral agents|mesh-ancestor
56997135|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
56990864|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997288|NCT01380015|Analgesics|analgesics|mesh-ancestor
56997434|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
56997660|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
56997855|NCT04064931|Niacin|niacin|mesh-list
56997906|NCT03585062|Paclitaxel|paclitaxel|mesh-list
56998187|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
56998263|NCT04052880|Dexamethasone|dexamethasone|mesh-list
56998334|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
56998409|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998514|NCT04876677|Hormones|hormones|mesh-ancestor
56998707|NCT03646266|Rocuronium|rocuronium|mesh-list
56998939|NCT03619785|Acetaminophen|acetaminophen|mesh-list
56999019|NCT02962284|Prednisolone|prednisolone|mesh-list
56990865|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56990866|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999914|NCT03564704|Idarubicin|idarubicin|mesh-list
56999991|NCT02838134|Rocuronium|rocuronium|mesh-list
57000070|NCT02833844|Evolocumab|evolocumab|mesh-list
56682289|NCT00683644|Zinc|zinc|mesh-list
57000209|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001354|NCT05170139|Caffeine|caffeine|mesh-list
57001635|NCT02058212|Trace Elements|trace elements|mesh-ancestor
57002315|NCT05208879|Carotenoids|carotenoids|mesh-list
57002388|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002837|NCT01352065|Ambrisentan|ambrisentan|mesh-list
57003366|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003441|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
57003515|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57003608|NCT02074280|Rifaximin|rifaximin|mesh-list
57003694|NCT03353675|Nivolumab|nivolumab|mesh-list
57004118|NCT01354925|Insulin|insulin|mesh-list
57004204|NCT03634735|Thiamine|thiamine|mesh-list
57004415|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
57006036|NCT02104778|Hormones|hormones|mesh-ancestor
57006405|NCT01368536|Diuretics|diuretics|mesh-ancestor
57007017|NCT03634189|Cannabidiol|cannabidiol|mesh-list
57007383|NCT03050307|Lansoprazole|lansoprazole|mesh-list
57007762|NCT00799110|Imiquimod|imiquimod|mesh-list
57008067|NCT05037487|Hormones|hormones|mesh-ancestor
57008138|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
57008293|NCT01363115|Vitamin D|vitamin d|mesh-list
57008440|NCT05198804|Niraparib|niraparib|mesh-list
57009190|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57009797|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57010042|NCT02842866|Vaccines|vaccines|mesh-list
57010256|NCT04704219|Lenvatinib|lenvatinib|mesh-list
57010331|NCT05132699|Cannabidiol|cannabidiol|mesh-list
57010561|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57011080|NCT05139875|Triamcinolone|triamcinolone|mesh-list
57011827|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011900|NCT03378466|Heparin|heparin|mesh-list
57012277|NCT01966471|Epirubicin|epirubicin|mesh-list
57012508|NCT05707572|Prednisolone|prednisolone|mesh-list
57012801|NCT04500509|Analgesics|analgesics|mesh-ancestor
57013180|NCT05640479|Analgesics|analgesics|mesh-ancestor
57013259|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
57013329|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57013405|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
57013487|NCT05071703|Carboplatin|carboplatin|mesh-list
57014158|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57014305|NCT02147678|Narcotics|narcotics|mesh-ancestor
57014457|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014533|NCT02156570|Ribavirin|ribavirin|mesh-list
57014608|NCT05199285|Nivolumab|nivolumab|mesh-list
57015128|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
57015200|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57015804|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016330|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016554|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
57016774|NCT02171702|Afatinib|afatinib|mesh-list
57016935|NCT03959085|Leucovorin|leucovorin|mesh-list
57017004|NCT03959085|Vitamins|vitamins|mesh-ancestor
57017373|NCT02173886|Bupropion|bupropion|mesh-list
57017681|NCT02182622|Prednisone|prednisone|mesh-list
57018413|NCT02256956|Analgesics|analgesics|mesh-ancestor
57018480|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018627|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57018847|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
57018920|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57019219|NCT02196662|Mesalamine|mesalamine|mesh-list
57019370|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
57019445|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
57019674|NCT03492671|Gemcitabine|gemcitabine|mesh-list
57019754|NCT02068170|Renal Agents|renal agents|mesh-ancestor
57019831|NCT01377103|Hormones|hormones|mesh-ancestor
57020045|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
57020122|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
57020200|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
57020419|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
57020626|NCT02076828|Zinc|zinc|mesh-list
57021148|NCT03075163|Ondansetron|ondansetron|mesh-list
57021226|NCT02567175|Domperidone|domperidone|mesh-list
57021376|NCT02226926|Aspirin|aspirin|mesh-list
57021448|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57021526|NCT02275533|Nivolumab|nivolumab|mesh-list
57021674|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
57021972|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
57022124|NCT03818828|Iodine|iodine|mesh-list
57022672|NCT04477018|Iron|iron|mesh-list
57022805|NCT02263352|Carotenoids|carotenoids|mesh-list
57023019|NCT01569919|Pemetrexed|pemetrexed|mesh-list
57023092|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57023170|NCT01378676|Protective Agents|protective agents|mesh-ancestor
57023321|NCT04865614|Sevoflurane|sevoflurane|mesh-list
57023391|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
57023469|NCT04444492|Ranibizumab|ranibizumab|mesh-list
57023615|NCT03267589|Durvalumab|durvalumab|mesh-list
57023914|NCT02086032|Estrogens|estrogens|mesh-list
57023917|NCT02086032|Hormones|hormones|mesh-ancestor
57024137|NCT01281254|Trebananib|trebananib|mesh-list
57024517|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
57024605|NCT02764541|Tamoxifen|tamoxifen|mesh-list
57024891|NCT00882440|Enalapril|enalapril|mesh-list
57025264|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
57026298|NCT04910230|Niacin|niacin|mesh-list
57026387|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
57026535|NCT00625664|Gemcitabine|gemcitabine|mesh-list
57026611|NCT00694928|Butoconazole|butoconazole|mesh-list
57027598|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
57027973|NCT03658785|Aldesleukin|aldesleukin|mesh-list
57028045|NCT01068717|Hormones|hormones|mesh-ancestor
57028343|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028497|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028647|NCT00051038|Entecavir|entecavir|mesh-list
57029247|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
57029860|NCT03552666|Vitamin D|vitamin d|mesh-list
57029930|NCT04221555|Docetaxel|docetaxel|mesh-list
57030305|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
57030530|NCT02118090|Filaricides|filaricides|mesh-ancestor
57030602|NCT03665506|Trifluridine|trifluridine|mesh-list
57030677|NCT03094234|Propranolol|propranolol|mesh-list
57030754|NCT01794520|Venetoclax|venetoclax|mesh-list
57030900|NCT02121990|Olaparib|olaparib|mesh-list
57031052|NCT00141284|Zidovudine|zidovudine|mesh-list
57031200|NCT04712734|Iloperidone|iloperidone|mesh-list
57031509|NCT05706337|Propofol|propofol|mesh-list
57031582|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
57031725|NCT05193968|Terbutaline|terbutaline|mesh-list
57032176|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032253|NCT02130804|Analgesics|analgesics|mesh-ancestor
57032844|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
57032919|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57033004|NCT04030195|Fludarabine|fludarabine|mesh-list
57033138|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57033442|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
57033517|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57033595|NCT01344759|Propofol|propofol|mesh-list
57033671|NCT05691517|Exatecan|exatecan|mesh-list
57033740|NCT04900350|Azacitidine|azacitidine|mesh-list
57034038|NCT02297594|Ziresovir|ziresovir|mesh-list
57034114|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
57034207|NCT02301494|Imiquimod|imiquimod|mesh-list
57034493|NCT02143362|Narcotics|narcotics|mesh-ancestor
57034639|NCT02312180|Plasminogen|plasminogen|mesh-list
57035330|NCT03210558|Hormones|hormones|mesh-ancestor
57035766|NCT03097120|Estrogens|estrogens|mesh-list
57035844|NCT02324738|Artenimol|artenimol|mesh-list
57036373|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57036455|NCT03503409|Ivosidenib|ivosidenib|mesh-list
57036522|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57036898|NCT05043142|Antibodies|antibodies|mesh-list
57037125|NCT03096028|Vitamins|vitamins|mesh-ancestor
57037212|NCT02153424|Apixaban|apixaban|mesh-list
57037272|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
57037807|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
57037897|NCT02762370|FX006|fx006|mesh-list
57037950|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
57038101|NCT05019586|Renal Agents|renal agents|mesh-ancestor
57038847|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
57039144|NCT00711607|Estrogens|estrogens|mesh-ancestor
57039294|NCT02161614|Estrogens|estrogens|mesh-ancestor
57039535|NCT00101166|Vaccines|vaccines|mesh-list
57039664|NCT05431270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57040246|NCT03539328|Paclitaxel|paclitaxel|mesh-list
57040495|NCT02131597|Guadecitabine|guadecitabine|mesh-list
57040570|NCT02171832|Olodaterol|olodaterol|mesh-list
57040869|NCT03067792|Vitamins|vitamins|mesh-ancestor
57040934|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57041253|NCT04233190|Budesonide|budesonide|mesh-list
57041462|NCT02182050|Nintedanib|nintedanib|mesh-list
57041690|NCT03576963|Nivolumab|nivolumab|mesh-list
57041770|NCT05425420|Methadone|methadone|mesh-list
57042365|NCT02183220|Analgesics|analgesics|mesh-ancestor
57042509|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
57042965|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043115|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
57043264|NCT02257008|Ritonavir|ritonavir|mesh-list
57043417|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
57043562|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57043781|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
57043927|NCT03532854|Valsartan|valsartan|mesh-list
57044230|NCT04973722|Denosumab|denosumab|mesh-list
57044542|NCT04075747|Venetoclax|venetoclax|mesh-list
57044610|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044687|NCT03350035|Ganaxolone|ganaxolone|mesh-list
57044842|NCT03058744|Clobetasol|clobetasol|mesh-list
57045211|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
57045447|NCT03480308|Hormones|hormones|mesh-ancestor
57045702|NCT05258474|Niacin|niacin|mesh-list
57046293|NCT04921930|Artesunate|artesunate|mesh-list
57046359|NCT03060850|Abivertinib|abivertinib|mesh-list
57046433|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
57047175|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
57047328|NCT05085782|Propranolol|propranolol|mesh-list
57047552|NCT03161054|Prednisone|prednisone|mesh-list
57047930|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57048008|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
57048086|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
57048381|NCT02802735|Analgesics|analgesics|mesh-ancestor
57048543|NCT02061267|Niacin|niacin|mesh-list
57048907|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048985|NCT03412890|Norethindrone|norethindrone|mesh-list
57049358|NCT04856098|Antidotes|antidotes|mesh-ancestor
57049434|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
57049582|NCT05411094|Durvalumab|durvalumab|mesh-list
57049803|NCT03130556|Rabeprazole|rabeprazole|mesh-list
57049952|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57050937|NCT03465488|Albendazole|albendazole|mesh-list
57051391|NCT03460808|Antidotes|antidotes|mesh-ancestor
57051543|NCT05618236|Atropine|atropine|mesh-list
57051684|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
57051832|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052279|NCT04501614|Ponatinib|ponatinib|mesh-list
57052464|NCT03447470|Nivolumab|nivolumab|mesh-list
57052531|NCT00765804|Hormones|hormones|mesh-ancestor
57052813|NCT00744276|Danazol|danazol|mesh-list
57053329|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053633|NCT05616442|Vitamin E|vitamin e|mesh-list
57053850|NCT02072811|Daunorubicin|daunorubicin|mesh-list
57053931|NCT01369485|Caffeine|caffeine|mesh-list
57054110|NCT03422510|CXA-10|cxa-10|mesh-list
57054371|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57054969|NCT04426552|Analgesics|analgesics|mesh-ancestor
57055119|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
57055363|NCT00715988|Methadone|methadone|mesh-list
57055796|NCT05328388|Lycopene|lycopene|mesh-list
57056197|NCT02095665|Tamsulosin|tamsulosin|mesh-list
57056915|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
57057748|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57059024|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
57059179|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059400|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
57059559|NCT02252913|Docetaxel|docetaxel|mesh-list
57059627|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
57059849|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
57059930|NCT05572749|Metformin|metformin|mesh-list
57060004|NCT01567995|Hormones|hormones|mesh-ancestor
57060078|NCT05537584|Bupropion|bupropion|mesh-list
57060148|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
57060597|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
57060676|NCT03388970|Vitamin K|vitamin k|mesh-list
57060748|NCT04680988|Antiviral Agents|antiviral agents|mesh-ancestor
57060894|NCT03851614|Durvalumab|durvalumab|mesh-list
57061385|NCT03386630|Dsuvia|dsuvia|mesh-list
57061568|NCT03517020|Nebivolol|nebivolol|mesh-list
57061867|NCT02148393|Progestins|progestins|mesh-ancestor
57062017|NCT03542955|Etoricoxib|etoricoxib|mesh-list
57062164|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57062399|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
57062839|NCT03124082|Analgesics|analgesics|mesh-ancestor
57063004|NCT03366584|Zinc|zinc|mesh-list
57063285|NCT02307396|Amisulpride|amisulpride|mesh-list
57063363|NCT02312232|Levodopa|levodopa|mesh-list
57063438|NCT02308098|Budesonide|budesonide|mesh-list
57063586|NCT03360734|Necitumumab|necitumumab|mesh-list
57063663|NCT03506256|Norfloxacin|norfloxacin|mesh-list
57063740|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57063890|NCT05532280|Etoricoxib|etoricoxib|mesh-list
57064196|NCT03350126|Nivolumab|nivolumab|mesh-list
57064647|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
57065027|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065102|NCT05515120|Analgesics|analgesics|mesh-ancestor
57065403|NCT04834362|Insulin|insulin|mesh-list
57065559|NCT02516462|Hormones|hormones|mesh-list
57066774|NCT00707174|Imiquimod|imiquimod|mesh-list
57067144|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067221|NCT03332888|Rituximab|rituximab|mesh-list
57067447|NCT05501158|Tamoxifen|tamoxifen|mesh-list
56990867|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990868|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
56990869|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56990870|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
56990871|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56990872|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56990873|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990874|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56990875|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
56990876|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56990877|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56990878|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
56990879|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
56990880|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56990881|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56990882|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
56990883|NCT01220531|Hormones|hormones|mesh-ancestor
56990884|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56990885|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56990886|NCT01220531|Protective Agents|protective agents|mesh-ancestor
56990887|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56990888|NCT05255471|Olaparib|olaparib|mesh-list
56990889|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56990890|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990891|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990892|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990893|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
56990894|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990895|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990896|NCT02941523|Carboplatin|carboplatin|mesh-list
56990897|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067523|NCT02491970|Xhance|xhance|mesh-list
57067804|NCT05045170|Propofol|propofol|mesh-list
57068013|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
57068166|NCT02181309|Analgesics|analgesics|mesh-ancestor
57068922|NCT03314792|Oxycodone|oxycodone|mesh-list
57069304|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
56990898|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
56990899|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57069992|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
57070282|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
57070508|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
57070734|NCT03475524|Metformin|metformin|mesh-list
57070891|NCT04542200|Antibodies|antibodies|mesh-list
57071105|NCT05783479|Estrogens|estrogens|mesh-ancestor
57071260|NCT05751148|Prilocaine|prilocaine|mesh-list
56990900|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57071791|NCT05457972|Hormones|hormones|mesh-ancestor
57072315|NCT04899349|Metformin|metformin|mesh-list
57072388|NCT04730349|Nivolumab|nivolumab|mesh-list
57072463|NCT04565990|Selexipag|selexipag|mesh-list
57072918|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
57073071|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073297|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
56990901|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073754|NCT03474510|Bupivacaine|bupivacaine|mesh-list
57074127|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
57074272|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
57074656|NCT03302390|Lidocaine|lidocaine|mesh-list
57074721|NCT03301454|Paclitaxel|paclitaxel|mesh-list
57074868|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57074942|NCT03308708|Norepinephrine|norepinephrine|mesh-list
57075092|NCT05162430|Propofol|propofol|mesh-list
57075480|NCT01230957|Vaccines|vaccines|mesh-list
57075546|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
57075693|NCT01369095|Analgesics|analgesics|mesh-ancestor
57075920|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076070|NCT03135171|Pertuzumab|pertuzumab|mesh-list
57076149|NCT03600714|Interferons|interferons|mesh-list
57076369|NCT01007721|Fluticasone|fluticasone|mesh-list
56990902|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57076607|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
57076674|NCT03296306|Cisplatin|cisplatin|mesh-list
57077578|NCT00751803|Eletriptan|eletriptan|mesh-list
57077719|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
57078400|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56990903|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57078543|NCT02459288|Clopidogrel|clopidogrel|mesh-list
57078693|NCT05492968|Norepinephrine|norepinephrine|mesh-list
57079074|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
56990904|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079299|NCT02283645|Minoxidil|minoxidil|mesh-list
57079668|NCT04486508|Heparin|heparin|mesh-list
57080341|NCT02966093|Lenvatinib|lenvatinib|mesh-list
57080640|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
57080953|NCT00480831|Paclitaxel|paclitaxel|mesh-list
57081162|NCT00468039|Metformin|metformin|mesh-list
57081386|NCT05459194|Hormones|hormones|mesh-ancestor
57081607|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57081685|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57081911|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
57081986|NCT00055575|Scopolamine|scopolamine|mesh-list
57082062|NCT03133923|Vaccines|vaccines|mesh-list
57082309|NCT02303821|Hormones|hormones|mesh-ancestor
57082369|NCT05216237|Apatinib|apatinib|mesh-list
57082436|NCT03628079|Mebendazole|mebendazole|mesh-list
57082588|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082660|NCT03203408|Hylan|hylan|mesh-list
57083346|NCT04176393|Ivosidenib|ivosidenib|mesh-list
57083446|NCT03528915|Rifamycins|rifamycins|mesh-list
57083572|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
57084775|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57084847|NCT03053063|Selonsertib|selonsertib|mesh-list
57085154|NCT03620669|Durvalumab|durvalumab|mesh-list
57085228|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
57085306|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57085608|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
57085686|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086079|NCT03172988|BB 1101|bb 1101|mesh-list
57086210|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086288|NCT02411318|Ethanol|ethanol|mesh-list
57086361|NCT03522051|Calcium|calcium|mesh-list
57086661|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086734|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
57086961|NCT02299557|Phenylephrine|phenylephrine|mesh-list
57087418|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57087567|NCT05745818|Colchicine|colchicine|mesh-list
57088188|NCT03943888|Atropine|atropine|mesh-list
57088633|NCT00943397|Montelukast|montelukast|mesh-list
57088845|NCT03433313|Trastuzumab|trastuzumab|mesh-list
57089146|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089673|NCT02143414|Prednisone|prednisone|mesh-list
57089897|NCT05439460|Epinephrine|epinephrine|mesh-list
57089980|NCT01373151|Adalimumab|adalimumab|mesh-list
57090198|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
57090587|NCT00403793|Hormones|hormones|mesh-ancestor
57090950|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091033|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
57091174|NCT04277663|Interferons|interferons|mesh-list
57091706|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57091784|NCT04460001|Triamcinolone|triamcinolone|mesh-list
57091863|NCT03623711|Citalopram|citalopram|mesh-list
57091938|NCT05607316|Metformin|metformin|mesh-list
57092108|NCT05348824|Eusol|eusol|mesh-list
57092239|NCT05255770|Benzocaine|benzocaine|mesh-list
57092385|NCT03480867|Temozolomide|temozolomide|mesh-list
57092835|NCT05159830|Cannabidiol|cannabidiol|mesh-list
57093519|NCT03471585|Dronabinol|dronabinol|mesh-list
57094057|NCT03662113|Emollients|emollients|mesh-ancestor
57094132|NCT02915159|Abatacept|abatacept|mesh-list
57094435|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57094700|NCT04985890|UB-421|ub-421|mesh-list
57094739|NCT02380118|Midazolam|midazolam|mesh-list
57094909|NCT03008915|Aspirin|aspirin|mesh-list
57095040|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
57095135|NCT02373722|Petrolatum|petrolatum|mesh-list
57095418|NCT02367560|Prednisolone|prednisolone|mesh-list
57095711|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096014|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
57096388|NCT04205305|Labetalol|labetalol|mesh-list
57096843|NCT02967679|Vitamins|vitamins|mesh-ancestor
57096993|NCT03645187|Analgesics|analgesics|mesh-ancestor
57097442|NCT05161351|Vitamins|vitamins|mesh-ancestor
57097519|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
57097757|NCT03655535|PAZ320|paz320|mesh-list
57098050|NCT05321511|Hormones|hormones|mesh-ancestor
57098291|NCT04943224|Trametinib|trametinib|mesh-list
57098423|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
57098499|NCT03652493|Carboplatin|carboplatin|mesh-list
57098573|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
57099170|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
57099250|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
57099478|NCT03618355|Sirolimus|sirolimus|mesh-list
57099932|NCT02358200|Paclitaxel|paclitaxel|mesh-list
57100314|NCT03393819|Ethanol|ethanol|mesh-list
57100684|NCT03146858|Enoxaparin|enoxaparin|mesh-list
57100835|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
57101135|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
57101375|NCT03146000|Meloxicam|meloxicam|mesh-list
57101592|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
57101669|NCT02341274|Tacrolimus|tacrolimus|mesh-list
57101741|NCT03112226|Estradiol|estradiol|mesh-list
57101964|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
57102042|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
57102435|NCT03385161|Ethanol|ethanol|mesh-list
57102783|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57102930|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103311|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
57103385|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57103609|NCT05049902|Diuretics|diuretics|mesh-ancestor
57103687|NCT03141476|Cefuroxime|cefuroxime|mesh-list
57103913|NCT03374007|Antibodies|antibodies|mesh-list
57103989|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
57104287|NCT04427241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104608|NCT03600727|Propofol|propofol|mesh-list
57105278|NCT03352869|Hormones|hormones|mesh-ancestor
57105743|NCT00588991|Carboplatin|carboplatin|mesh-list
57105959|NCT03122067|Oxytocin|oxytocin|mesh-list
57106032|NCT00770809|Paclitaxel|paclitaxel|mesh-list
57106259|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57106405|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57106634|NCT03329378|Paclitaxel|paclitaxel|mesh-list
57106706|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57106853|NCT02844439|XL647|xl647|mesh-list
57106938|NCT05103098|Misoprostol|misoprostol|mesh-list
57107017|NCT02238197|Ipratropium|ipratropium|mesh-list
57107086|NCT02245867|Antibodies|antibodies|mesh-list
57107163|NCT04394117|Losartan|losartan|mesh-list
57107248|NCT04482686|Vitamin D|vitamin d|mesh-list
57107386|NCT03569995|Methotrexate|methotrexate|mesh-list
57107461|NCT05708755|Valganciclovir|valganciclovir|mesh-list
57107836|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57107911|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
57108365|NCT03324867|Insulin|insulin|mesh-list
57108448|NCT05112692|Cetrorelix|cetrorelix|mesh-list
57108522|NCT03564301|Metronidazole|metronidazole|mesh-list
57108666|NCT03335007|Aceclofenac|aceclofenac|mesh-list
57108840|NCT02492373|Clobetasol|clobetasol|mesh-list
57108967|NCT04493463|Prednisolone|prednisolone|mesh-list
56990905|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109270|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57109344|NCT02483793|Tamsulosin|tamsulosin|mesh-list
57109506|NCT00584246|Pregabalin|pregabalin|mesh-list
57109571|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
57109718|NCT02489097|Analgesics|analgesics|mesh-ancestor
57109793|NCT02482857|Aspirin|aspirin|mesh-list
57110546|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57111009|NCT02474433|Misoprostol|misoprostol|mesh-list
57111075|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
57111452|NCT02049073|Hormones|hormones|mesh-ancestor
57111517|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
57111741|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
57111976|NCT03945591|Bortezomib|bortezomib|mesh-list
57112129|NCT03313791|Caseins|caseins|mesh-list
57112267|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112718|NCT03263936|Cytarabine|cytarabine|mesh-list
57113015|NCT01673594|Naltrexone|naltrexone|mesh-list
57113092|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
57113164|NCT03308396|Durvalumab|durvalumab|mesh-list
57113315|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113462|NCT02060851|Iron|iron|mesh-list
57113919|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
57113988|NCT02064517|Calcium|calcium|mesh-list
57114140|NCT02461329|Polygeline|polygeline|mesh-list
57114515|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57114663|NCT02078167|Policosanol|policosanol|mesh-list
57114813|NCT02084719|Antibodies|antibodies|mesh-list
57114887|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
57115038|NCT02086747|Analgesics|analgesics|mesh-ancestor
57115261|NCT05046860|Dalbavancin|dalbavancin|mesh-list
57115412|NCT04155008|Dronabinol|dronabinol|mesh-list
57116088|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
57116459|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
57116532|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57116607|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
57116903|NCT02117401|Midazolam|midazolam|mesh-list
57117284|NCT02122003|Sorafenib|sorafenib|mesh-list
57118361|NCT03071822|Etoposide|etoposide|mesh-list
57118492|NCT02134093|Midazolam|midazolam|mesh-list
56990906|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990907|NCT00360425|Hematinics|hematinics|mesh-ancestor
57118876|NCT03245853|Riboflavin|riboflavin|mesh-list
56800970|NCT00286234|Niacin|niacin|mesh-list
56990908|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57119414|NCT02239835|Ritonavir|ritonavir|mesh-list
57119556|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
57119713|NCT02135887|Leucovorin|leucovorin|mesh-list
56990909|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57120395|NCT05004116|Irinotecan|irinotecan|mesh-list
56990910|NCT02938585|Factor VIII|factor viii|mesh-list
56990911|NCT02938585|Coagulants|coagulants|mesh-ancestor
57121297|NCT05085002|Letrozole|letrozole|mesh-list
56990912|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57121664|NCT03063710|Olaparib|olaparib|mesh-list
57121739|NCT05030623|Tadalafil|tadalafil|mesh-list
57122042|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
57122267|NCT02806973|Glucagon|glucagon|mesh-list
57122411|NCT02052323|Artesunate|artesunate|mesh-list
57122498|NCT02056847|Calcium|calcium|mesh-list
57122567|NCT02388724|Lansoprazole|lansoprazole|mesh-list
56990913|NCT00233597|Hematinics|hematinics|mesh-ancestor
57122864|NCT02796677|Bromides|bromides|mesh-list
57123154|NCT02072213|Tamsulosin|tamsulosin|mesh-list
57123906|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
56673088|NCT00822237|Vaccines|vaccines|mesh-list
57124065|NCT01975831|Durvalumab|durvalumab|mesh-list
57124130|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
57124276|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57124428|NCT03234387|Acetylcholine|acetylcholine|mesh-list
57124504|NCT03056846|Sulfalene|sulfalene|mesh-list
57124649|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
57124874|NCT04407650|Metformin|metformin|mesh-list
57125099|NCT02143765|Acarbose|acarbose|mesh-list
57125405|NCT02376166|Metformin|metformin|mesh-list
56990914|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57126168|NCT03196401|Durvalumab|durvalumab|mesh-list
57126318|NCT02444013|Folic Acid|folic acid|mesh-list
57126539|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
56990915|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56990916|NCT04282811|Venetoclax|venetoclax|mesh-list
57126962|NCT04906772|Ketamine|ketamine|mesh-list
57127067|NCT04896164|Analgesics|analgesics|mesh-ancestor
57127219|NCT02152423|Enoxaparin|enoxaparin|mesh-list
57127525|NCT02157181|Rituximab|rituximab|mesh-list
57127749|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
57127901|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57128012|NCT02339506|Hormones|hormones|mesh-ancestor
57128049|NCT02090933|Celecoxib|celecoxib|mesh-list
57128135|NCT03045770|Vitamins|vitamins|mesh-ancestor
57128349|NCT02093585|Tenofovir|tenofovir|mesh-list
56990917|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990918|NCT03229759|Octenidine|octenidine|mesh-list
57128947|NCT03041948|Morphine|morphine|mesh-list
57129174|NCT03189069|Dabigatran|dabigatran|mesh-list
57129329|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
57129480|NCT02425137|Gemcitabine|gemcitabine|mesh-list
57129628|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
57130319|NCT02336074|Vorinostat|vorinostat|mesh-list
57130388|NCT04826822|Diuretics|diuretics|mesh-ancestor
57130543|NCT02112929|Xenon|xenon|mesh-list
57130685|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131068|NCT02125409|Aspirin|aspirin|mesh-list
57131291|NCT05615636|Lenalidomide|lenalidomide|mesh-list
57131431|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57131884|NCT02134379|Miconazole|miconazole|mesh-list
57132022|NCT04090190|Oxybutynin|oxybutynin|mesh-list
57132271|NCT05474924|Budesonide|budesonide|mesh-list
57132878|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
57133102|NCT05610956|Empagliflozin|empagliflozin|mesh-list
57133247|NCT03107169|Vancomycin|vancomycin|mesh-list
56990919|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133701|NCT02167165|Digoxin|digoxin|mesh-list
57133928|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57134006|NCT02418273|Denosumab|denosumab|mesh-list
57134229|NCT02167321|Vitamins|vitamins|mesh-ancestor
57134533|NCT02412813|Cobalt|cobalt|mesh-list
57134609|NCT05539118|Interferons|interferons|mesh-list
57134758|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57135586|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135660|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57135829|NCT04597268|Midazolam|midazolam|mesh-list
57136560|NCT02183155|Indomethacin|indomethacin|mesh-list
57136634|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
57137011|NCT02183701|Losartan|losartan|mesh-list
57137680|NCT04270747|Aflibercept|aflibercept|mesh-list
56819845|NCT01064726|Xhance|xhance|mesh-list
57138133|NCT04058197|Deferoxamine|deferoxamine|mesh-list
57138362|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138512|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57138671|NCT02221063|Thiamine|thiamine|mesh-list
57138758|NCT02174861|Erenumab|erenumab|mesh-list
57138891|NCT02231281|Zidovudine|zidovudine|mesh-list
56990920|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56990921|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
56990922|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990923|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990924|NCT03620825|Indomethacin|indomethacin|mesh-list
56990925|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56990926|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57139107|NCT02141321|Alprostadil|alprostadil|mesh-list
56923724|NCT03593018|Gemcitabine|gemcitabine|mesh-list
56885808|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56885809|NCT03729804|Dexamethasone|dexamethasone|mesh-list
56885810|NCT03729804|Lenalidomide|lenalidomide|mesh-list
56885811|NCT03729804|Bortezomib|bortezomib|mesh-list
56885812|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885813|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
56885814|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
56885816|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885817|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56885818|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
56885819|NCT03729804|Hormones|hormones|mesh-ancestor
56885820|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885821|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56885822|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885823|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
56885824|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56885825|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56885826|NCT03729804|Growth Substances|growth substances|mesh-ancestor
56885827|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
56885828|NCT04118920|Insulin|insulin|mesh-list
56885829|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56885830|NCT04118920|Lubricant Eye Drops|lubricant eye drops|mesh-list
56885831|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56885832|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885833|NCT04118920|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56885834|NCT04118920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56885835|NCT03639480|Amlodipine|amlodipine|mesh-list
56885836|NCT03639480|Valsartan|valsartan|mesh-list
56885837|NCT03639480|Atorvastatin|atorvastatin|mesh-list
56885838|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56885839|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56885840|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
56885841|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885842|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56885843|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56885844|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885845|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56885846|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56885847|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56885848|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56885849|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885850|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
56885851|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56885852|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56885853|NCT03689998|Melatonin|melatonin|mesh-list
56885854|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
56885855|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885856|NCT03689998|Protective Agents|protective agents|mesh-ancestor
56885857|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885858|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885859|NCT03948178|Simendan|simendan|mesh-list
56885860|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56885861|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
56885862|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56885863|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56885864|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885865|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885866|NCT03948178|Protective Agents|protective agents|mesh-ancestor
56885867|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885868|NCT03687034|Temozolomide|temozolomide|mesh-list
56885869|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56885870|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
56885871|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885872|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885873|NCT03520920|Rituximab|rituximab|mesh-list
56885874|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
56885875|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56885876|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885877|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
56885878|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885879|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885880|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56885881|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895437|NCT02454426|Vortioxetine|vortioxetine|mesh-list
56923795|NCT03426254|Talazoparib|talazoparib|mesh-list
56885882|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885883|NCT03686878|Lifitegrast|lifitegrast|mesh-list
56885884|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56885885|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56885886|NCT03682198|Phenylephrine|phenylephrine|mesh-list
56885888|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56885889|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
56885890|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
56885891|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885892|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885893|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
56885894|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56885895|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
56885896|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
56885897|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56885898|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56885899|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56885900|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
56885901|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885902|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885903|NCT03682198|Protective Agents|protective agents|mesh-ancestor
56885904|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
56885905|NCT02953340|Docetaxel|docetaxel|mesh-list
56885906|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56885907|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
56885908|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885909|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885910|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56885911|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
56885912|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885913|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885914|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56885915|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
56885916|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
56885917|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
56885918|NCT03554772|Celecoxib|celecoxib|mesh-list
56885919|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56885920|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56885921|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56885922|NCT03554772|Analgesics|analgesics|mesh-ancestor
56885923|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
56885924|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885925|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885926|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885927|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885928|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56885929|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56885930|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885931|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885932|NCT03624010|Simendan|simendan|mesh-list
56885933|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56885934|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
56885935|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56885936|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56885937|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885938|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885939|NCT03624010|Protective Agents|protective agents|mesh-ancestor
56885940|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885941|NCT03686722|Metformin|metformin|mesh-list
56885942|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56885943|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885944|NCT04629976|Tenofovir|tenofovir|mesh-list
56885945|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
56885946|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885947|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56885948|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56885949|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885950|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885951|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56885952|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56885953|NCT03728946|Bupivacaine|bupivacaine|mesh-list
56885954|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
56885955|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
56885956|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885957|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885958|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
56885959|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885960|NCT03553758|Ketamine|ketamine|mesh-list
56885962|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
56885963|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885964|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885965|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56885966|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56885967|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
56885968|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
56885969|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885970|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56885971|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56885972|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885973|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885974|NCT02954354|Oseltamivir|oseltamivir|mesh-list
56885975|NCT02954354|Baloxavir|baloxavir|mesh-list
56885976|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
56885977|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885978|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885979|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885980|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
56885981|NCT03519516|Levofloxacin|levofloxacin|mesh-list
56885982|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56885983|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56885984|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56885985|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885986|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56885987|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56885988|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885989|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885990|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885991|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56885992|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56885993|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56885994|NCT03519516|Renal Agents|renal agents|mesh-ancestor
56885995|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
56885996|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
56885997|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885998|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885999|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886000|NCT03519204|Lidocaine|lidocaine|mesh-list
56886001|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
56886002|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
56886003|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886004|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886005|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
56886006|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886007|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56886008|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56886009|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56886010|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56886011|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886012|NCT03624166|Ketamine|ketamine|mesh-list
56886013|NCT03624166|Anesthetics|anesthetics|mesh-list
56886014|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
56886015|NCT03624166|Analgesics|analgesics|mesh-ancestor
56886016|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
56886017|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596764|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
56886018|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886019|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56886020|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56886021|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886022|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56886023|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56886024|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886025|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886026|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
56886027|NCT03518112|Leucovorin|leucovorin|mesh-list
56886028|NCT03518112|Folic Acid|folic acid|mesh-list
56886029|NCT03518112|Cytarabine|cytarabine|mesh-list
56886030|NCT03518112|Dexamethasone|dexamethasone|mesh-list
56886031|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
56886032|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
56886033|NCT03518112|Rituximab|rituximab|mesh-list
56886035|NCT03518112|Vincristine|vincristine|mesh-list
56886036|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
56886037|NCT03518112|Blinatumomab|blinatumomab|mesh-list
56886038|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56886039|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
56886040|NCT03518112|Antibodies|antibodies|mesh-list
56886041|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
56886042|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56886043|NCT03518112|Lenograstim|lenograstim|mesh-list
56886044|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56886045|NCT03518112|BB 1101|bb 1101|mesh-list
56886046|NCT03518112|Calcium|calcium|mesh-list
56886047|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
56886048|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886049|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
56886050|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886051|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886052|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56886053|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
56886054|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886055|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886056|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56886057|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886058|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
56886059|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
56886060|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886061|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886062|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
56886063|NCT03518112|Hormones|hormones|mesh-ancestor
56886064|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56886065|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56886066|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
56886067|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886068|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56886069|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56886070|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56886071|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
56886072|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56886073|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56886074|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
56886075|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
56886076|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56886077|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56886078|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
56886079|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886080|NCT03518112|Antidotes|antidotes|mesh-ancestor
56886081|NCT03518112|Protective Agents|protective agents|mesh-ancestor
56886082|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
56886083|NCT03518112|Vitamins|vitamins|mesh-ancestor
56886084|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
56886085|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56886086|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56886087|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
56886088|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
56886089|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
56886090|NCT03518112|Hematinics|hematinics|mesh-ancestor
56886091|NCT03686254|Bevacizumab|bevacizumab|mesh-list
56886092|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56886093|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886094|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56596836|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56886095|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56886096|NCT03686254|Growth Substances|growth substances|mesh-ancestor
56886097|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886098|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
56886100|NCT03679780|BQ 788|bq 788|mesh-list
56886101|NCT03679780|Nitroarginine|nitroarginine|mesh-list
56886102|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
56886103|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56886104|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
56886105|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56886106|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886107|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56886108|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56886109|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886110|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
56886111|NCT03659734|Narcotics|narcotics|mesh-ancestor
56886112|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886113|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886114|NCT03659734|Analgesics|analgesics|mesh-ancestor
56886115|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
56886116|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886117|NCT03680716|Ropivacaine|ropivacaine|mesh-list
56886118|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
56886119|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
56886120|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886121|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886122|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
56886123|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886124|NCT03680638|Allopurinol|allopurinol|mesh-list
56886126|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
56886127|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886128|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886129|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
56886130|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886131|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56886132|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
56886133|NCT03680638|Protective Agents|protective agents|mesh-ancestor
56886134|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886135|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56886136|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56886137|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56886138|NCT03680560|Trastuzumab|trastuzumab|mesh-list
56886139|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56886140|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886141|NCT03444298|Vitamin E|vitamin e|mesh-list
56886142|NCT03444298|Tocopherols|tocopherols|mesh-list
56886143|NCT03444298|Tocotrienols|tocotrienols|mesh-list
56886144|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
56886145|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
56886146|NCT03444298|Vitamins|vitamins|mesh-ancestor
56886147|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
56886148|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886149|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
56886150|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886151|NCT03444298|Protective Agents|protective agents|mesh-ancestor
56886152|NCT03640312|Candesartan|candesartan|mesh-list
56886153|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56886154|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56886155|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56886156|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886157|NCT03639610|Dexamethasone|dexamethasone|mesh-list
56886158|NCT03639610|Melphalan|melphalan|mesh-list
56886159|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886160|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
56886161|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
56886162|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886163|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886164|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886165|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
56886166|NCT03639610|Hormones|hormones|mesh-ancestor
56596912|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56886167|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56886168|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56886169|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886170|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56886171|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
56886172|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886173|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56886174|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886175|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
56886176|NCT03680404|Allopurinol|allopurinol|mesh-list
56886177|NCT03680404|Phenylephrine|phenylephrine|mesh-list
56886178|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
56886180|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56886181|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
56886182|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
56886183|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886184|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924100|NCT02273375|Durvalumab|durvalumab|mesh-list
56886185|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
56886186|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56886187|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
56886188|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
56886189|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56886190|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56886191|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56886192|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
56886193|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886194|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886195|NCT03680404|Protective Agents|protective agents|mesh-ancestor
56886196|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
56886197|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886198|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
56886199|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886200|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56886201|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
56886202|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56886203|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56886204|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56886205|NCT03685630|Brivaracetam|brivaracetam|mesh-list
56886206|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
56886207|NCT02954406|Gemcitabine|gemcitabine|mesh-list
56886208|NCT02954406|Rituximab|rituximab|mesh-list
56886209|NCT02954406|Lenalidomide|lenalidomide|mesh-list
56886210|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56886211|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56886212|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886213|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
56886214|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886215|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886216|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56886217|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
56886218|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886219|NCT02954406|Antiviral Agents|antiviral agents|mesh-ancestor
56886220|NCT02954406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886221|NCT02954406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886222|NCT02954406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886223|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56886224|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56886225|NCT02954406|Growth Substances|growth substances|mesh-ancestor
56886226|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
56886227|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56886228|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
56886229|NCT01310478|Endostatins|endostatins|mesh-list
56886230|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56886231|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56886232|NCT01310478|Growth Substances|growth substances|mesh-ancestor
56886233|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886234|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
56886235|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886236|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
56886237|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56886238|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
56886239|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886240|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
56886241|NCT03728244|Protective Agents|protective agents|mesh-ancestor
56886242|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56596986|NCT04215237|Atorvastatin|atorvastatin|mesh-list
56886243|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56886244|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56886245|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
56886246|NCT03721614|Sirolimus|sirolimus|mesh-list
56886247|NCT03721614|Everolimus|everolimus|mesh-list
56886248|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886249|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886250|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
56886251|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886252|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56886253|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886254|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56886255|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
56886256|NCT03727620|Amoxicillin|amoxicillin|mesh-list
56886257|NCT03727620|Metronidazole|metronidazole|mesh-list
56886258|NCT03727620|Doxycycline|doxycycline|mesh-list
56886259|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904585|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904586|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56904587|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
56904588|NCT02090920|Nifedipine|nifedipine|mesh-list
56904589|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56904590|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56904591|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904592|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56904593|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904594|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
56904595|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
56904596|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56904597|NCT02086474|Bupivacaine|bupivacaine|mesh-list
56904598|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
56904599|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
56904600|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
56886260|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886261|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56886262|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56886263|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
56886264|NCT03727464|Propofol|propofol|mesh-list
56886265|NCT03727464|Sevoflurane|sevoflurane|mesh-list
56886266|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56886267|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886268|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886269|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56886270|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
56886271|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
56886272|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56886273|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56886274|NCT03508830|Bupivacaine|bupivacaine|mesh-list
56886275|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
56886276|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
56886277|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886278|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886279|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
56886280|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886281|NCT03381274|Osimertinib|osimertinib|mesh-list
56886282|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886283|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56886284|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886285|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886286|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56886287|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56886288|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
56886289|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56886290|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
56886291|NCT03724578|Fluorides|fluorides|mesh-list
56886292|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
56886293|NCT03724578|Protective Agents|protective agents|mesh-ancestor
56886294|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886295|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56886296|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886297|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
56886298|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886299|NCT03721380|Methadone|methadone|mesh-list
56886300|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56886301|NCT03721380|Narcotics|narcotics|mesh-ancestor
56886302|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886303|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821087|NCT03962296|Calcium|calcium|mesh-list
56821160|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
56821161|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56821162|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56821163|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821164|NCT00068692|Antidotes|antidotes|mesh-ancestor
56821165|NCT00068692|Protective Agents|protective agents|mesh-ancestor
56821166|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
56821167|NCT00068692|Vitamins|vitamins|mesh-ancestor
56821168|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
56821375|NCT00290498|Dexamethasone|dexamethasone|mesh-list
56821449|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
56821450|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821476|NCT01022645|Copper|copper|mesh-list
56821595|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821671|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56821672|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56821821|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56821822|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56821855|NCT01327066|Droxidopa|droxidopa|mesh-list
56822043|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822136|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
56822192|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
56822264|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56822265|NCT00283712|Infliximab|infliximab|mesh-list
56822339|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
56822340|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822341|NCT00447005|Axitinib|axitinib|mesh-list
56822410|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56822411|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56822557|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56822629|NCT00262002|Vaccines|vaccines|mesh-list
56822703|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
56822778|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56822779|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56822851|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822855|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
56822933|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
56823000|NCT01096420|Topiramate|topiramate|mesh-list
56823074|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
56823075|NCT00222105|Hormones|hormones|mesh-ancestor
56823146|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
56823222|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56823297|NCT00145509|Asenapine|asenapine|mesh-list
56823303|NCT03965871|Esketamine|esketamine|mesh-list
56823372|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56823373|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56823444|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823449|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
56823518|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
56823596|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56823671|NCT01097512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823672|NCT01097512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823755|NCT01323335|Uric Acid|uric acid|mesh-list
56823823|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56823972|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
56824046|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824047|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56824048|NCT01097902|Ibuprofen|ibuprofen|mesh-list
56824049|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56824117|NCT01097980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56824191|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824270|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824344|NCT01030601|Dexamethasone|dexamethasone|mesh-list
56824420|NCT01098760|Sorafenib|sorafenib|mesh-list
56824495|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
56824651|NCT00127101|Vorinostat|vorinostat|mesh-list
56824723|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56824726|NCT01087840|Tenofovir|tenofovir|mesh-list
56824797|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824807|NCT01099462|Ibuprofen|ibuprofen|mesh-list
56824874|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824946|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
56825020|NCT03950050|Expectorants|expectorants|mesh-ancestor
56825093|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825241|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
56825243|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
56825314|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56825316|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
56825387|NCT01089088|Antiviral Agents|antiviral agents|mesh-ancestor
56825388|NCT01089088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825389|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825460|NCT01103518|Hormones|hormones|mesh-ancestor
56825464|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
56825533|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825608|NCT01103830|Lumefantrine|lumefantrine|mesh-list
56825609|NCT01103830|Artemether|artemether|mesh-list
56825683|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825684|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56825983|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
56825986|NCT01109134|Tirofiban|tirofiban|mesh-list
56826056|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56826138|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
56826210|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56826285|NCT01109758|Fenofibrate|fenofibrate|mesh-list
56826583|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56826733|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56826806|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56826880|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
56826954|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56827029|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827030|NCT01127464|Poly ICLC|poly iclc|mesh-list
56827106|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
56827330|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
56827401|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827472|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
56827547|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56827621|NCT03925090|Cisplatin|cisplatin|mesh-list
56827622|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827695|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56827776|NCT03919084|Nicotine|nicotine|mesh-list
56827845|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827926|NCT01133470|Fexofenadine|fexofenadine|mesh-list
56827997|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56828073|NCT05402722|Antibodies|antibodies|mesh-list
56828146|NCT01137994|Lapatinib|lapatinib|mesh-list
56828147|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56828219|NCT01138852|Cefuroxime|cefuroxime|mesh-list
56828295|NCT01236586|Dexamethasone|dexamethasone|mesh-list
56828371|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
56828372|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56828445|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
56828598|NCT05335018|Lenalidomide|lenalidomide|mesh-list
56828673|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
56828674|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828821|NCT00121641|Saxagliptin|saxagliptin|mesh-list
56828825|NCT00121641|Hormones|hormones|mesh-ancestor
56828972|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56828977|NCT01144702|Artesunate|artesunate|mesh-list
56829120|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56829197|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
56829198|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829345|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56829420|NCT01147276|Vildagliptin|vildagliptin|mesh-list
56829570|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829717|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
56829718|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829790|NCT01251640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829865|NCT03902782|Bupivacaine|bupivacaine|mesh-list
56829940|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
56830014|NCT03901690|Imiquimod|imiquimod|mesh-list
56830015|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56830016|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
56830086|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830162|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
56830245|NCT03894280|Hormones|hormones|mesh-ancestor
56830383|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56830459|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56830468|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
56830532|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
56830618|NCT03887650|Hormones|hormones|mesh-ancestor
56830682|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56830754|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830826|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
56830900|NCT01155232|Teriparatide|teriparatide|mesh-list
56830901|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
56830975|NCT01157026|Tocopherols|tocopherols|mesh-list
56830976|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56831047|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
56831124|NCT01160068|Metformin|metformin|mesh-list
56831195|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831268|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56831269|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
56831341|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
56831343|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831424|NCT01167010|Hormones|hormones|mesh-ancestor
56831495|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
56831641|NCT01273402|Antibodies|antibodies|mesh-list
56831719|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
56831792|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
56831866|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
56831946|NCT01284478|Dexamethasone|dexamethasone|mesh-list
56832012|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832088|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
56832091|NCT00166296|Antidepressive Agents|antidepressive agents|mesh-ancestor
56832165|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56832236|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56832314|NCT01172236|Lactoferrin|lactoferrin|mesh-list
56832391|NCT01172470|Gemcitabine|gemcitabine|mesh-list
56832462|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
56832463|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56832535|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56832611|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832687|NCT02525302|Halofuginone|halofuginone|mesh-list
56832763|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832837|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832838|NCT01286896|Sunitinib|sunitinib|mesh-list
56832990|NCT03739528|Ofloxacin|ofloxacin|mesh-list
56833057|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833137|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
56833237|NCT01080066|Cetuximab|cetuximab|mesh-list
56833287|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
56833357|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56833358|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56833430|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56833580|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833581|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833655|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833728|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56833803|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56833879|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
56833954|NCT03846388|Hormones|hormones|mesh-list
56834027|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56834028|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834029|NCT01193452|Leucovorin|leucovorin|mesh-list
56834101|NCT05670808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56834103|NCT05670808|Mydriatics|mydriatics|mesh-ancestor
56834175|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834185|NCT03844984|Midazolam|midazolam|mesh-list
56834250|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834332|NCT03249142|Durvalumab|durvalumab|mesh-list
56834471|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56834619|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834620|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56834621|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834622|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
56834623|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56834624|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
56834625|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834626|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
56834627|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834628|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834629|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
56834630|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834631|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
56834632|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56834633|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834634|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56834651|NCT02605486|Palbociclib|palbociclib|mesh-list
56834692|NCT02047474|Irinotecan|irinotecan|mesh-list
56834768|NCT01204996|Doxorubicin|doxorubicin|mesh-list
56834769|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56834838|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
56834912|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834988|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56834994|NCT01297894|Colistin|colistin|mesh-list
56835065|NCT03818308|Velpatasvir|velpatasvir|mesh-list
56835138|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
56835212|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835285|NCT01078038|Sirolimus|sirolimus|mesh-list
56835435|NCT00126594|Interferons|interferons|mesh-list
56835509|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835581|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835657|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56835658|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
56835805|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56835881|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
56836107|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56836179|NCT05623540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836180|NCT05622838|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56836251|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836324|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836336|NCT03790228|Pemetrexed|pemetrexed|mesh-list
56836403|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
56836474|NCT01038089|Protective Agents|protective agents|mesh-ancestor
56836475|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836476|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836549|NCT05694286|Protective Agents|protective agents|mesh-ancestor
56836626|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56836700|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56836703|NCT03781258|Warfarin|warfarin|mesh-list
56836852|NCT01561222|Vitamins|vitamins|mesh-ancestor
56836853|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
56836859|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
56836997|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
56837054|NCT03783520|Eusol|eusol|mesh-list
56837074|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
56837224|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837225|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56837226|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56837227|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56837228|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56837229|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
56837230|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56837231|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
56837232|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56837233|NCT03967496|Protective Agents|protective agents|mesh-ancestor
56837234|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
56837235|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
56837236|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837237|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56837238|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56837239|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56837240|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
56837241|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837242|NCT00412061|Everolimus|everolimus|mesh-list
56837243|NCT00412061|Octreotide|octreotide|mesh-list
56548061|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
56837244|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837245|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56837284|NCT03769714|Bupivacaine|bupivacaine|mesh-list
56837427|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837428|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
56837500|NCT03762928|Efavirenz|efavirenz|mesh-list
56837574|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56837648|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
56837723|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56837798|NCT03760354|Prednisolone|prednisolone|mesh-list
56837946|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
56838097|NCT01326468|Sirolimus|sirolimus|mesh-list
56838177|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
56838321|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838494|NCT03756220|Thiamine|thiamine|mesh-list
56838547|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56838548|NCT04607980|Ustekinumab|ustekinumab|mesh-list
56838550|NCT04953910|Decitabine|decitabine|mesh-list
56838626|NCT03758014|Lomustine|lomustine|mesh-list
56838695|NCT01076582|Estrogens|estrogens|mesh-ancestor
56838766|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56838921|NCT03963336|Diuretics|diuretics|mesh-ancestor
56839068|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839139|NCT00096018|Growth Substances|growth substances|mesh-ancestor
56839141|NCT01079754|Morphine|morphine|mesh-list
56839213|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56839445|NCT04171414|Adalimumab|adalimumab|mesh-list
56839592|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839593|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839665|NCT04060654|Analgesics|analgesics|mesh-ancestor
56839742|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
56839747|NCT00112736|Sirolimus|sirolimus|mesh-list
56839814|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839895|NCT05163496|Psilocybin|psilocybin|mesh-list
56839966|NCT03656692|Hormones|hormones|mesh-ancestor
56839969|NCT04439266|Crizotinib|crizotinib|mesh-list
56840037|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840117|NCT01040429|Clonidine|clonidine|mesh-list
56840189|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56840192|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840263|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840338|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56840340|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
56840412|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840486|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
56840487|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56840561|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840635|NCT00400517|Thalidomide|thalidomide|mesh-list
56840710|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
56840713|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
56840784|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
56840861|NCT00090584|Urological Agents|urological agents|mesh-ancestor
56840937|NCT00089648|Sunitinib|sunitinib|mesh-list
56841013|NCT00388583|Vaccines|vaccines|mesh-list
56841083|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56841084|NCT00387881|Analgesics|analgesics|mesh-ancestor
56841156|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56841157|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56841309|NCT03961698|Paclitaxel|paclitaxel|mesh-list
56841379|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56841397|NCT00084266|Vancomycin|vancomycin|mesh-list
56841454|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841528|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56841529|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
56841530|NCT04116398|Dexamethasone|dexamethasone|mesh-list
56841531|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841532|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
56841533|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
56841534|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841537|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
56841596|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56841670|NCT03739294|Fluticasone|fluticasone|mesh-list
56841820|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
56841897|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
56841898|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56841971|NCT03579940|Lasmiditan|lasmiditan|mesh-list
56842195|NCT00096135|Daunorubicin|daunorubicin|mesh-list
56842271|NCT01080729|Hormones|hormones|mesh-list
56842344|NCT00082407|Hormones|hormones|mesh-ancestor
56842346|NCT01080963|Daptomycin|daptomycin|mesh-list
56842418|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842492|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
56842568|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56842645|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56842719|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56842869|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56842942|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843091|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843163|NCT05782426|Mitosis Modulators|mitosis modulators|mesh-ancestor
56843164|NCT05782426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843169|NCT05782348|Listerine|listerine|mesh-list
56843170|NCT05782348|Sodium Fluoride|sodium fluoride|mesh-list
56843238|NCT05781698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56843314|NCT05781035|Dexmedetomidine|dexmedetomidine|mesh-list
56843462|NCT05590234|Bupivacaine|bupivacaine|mesh-list
56843540|NCT05541146|Paclitaxel|paclitaxel|mesh-list
56843611|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56843612|NCT05525416|Protective Agents|protective agents|mesh-ancestor
56843613|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56843614|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56843615|NCT05503030|Nintedanib|nintedanib|mesh-list
56843616|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843617|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56843618|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843619|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843620|NCT05496192|Nivolumab|nivolumab|mesh-list
56843621|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843622|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843623|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56843624|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843625|NCT05491512|Carboplatin|carboplatin|mesh-list
56843626|NCT05491512|Fluorouracil|fluorouracil|mesh-list
56843627|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843628|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
56843629|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843630|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56843631|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843632|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
56843633|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843634|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56843635|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56843636|NCT05477576|Everolimus|everolimus|mesh-list
56843637|NCT05477576|Sunitinib|sunitinib|mesh-list
56843638|NCT05477576|Octreotide|octreotide|mesh-list
56843639|NCT05477576|Lanreotide|lanreotide|mesh-list
56843640|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843641|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843642|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
56843643|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843644|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56843645|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56843651|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56843652|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56843653|NCT05469737|Azacitidine|azacitidine|mesh-list
56843654|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56843655|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
56843656|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843657|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843658|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843659|NCT05462756|Insulin|insulin|mesh-list
56843660|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56843661|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
56843662|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
56843663|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56843664|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843665|NCT05449405|Chlorpheniramine|chlorpheniramine|mesh-list
56843666|NCT05449405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557791|NCT02793466|Durvalumab|durvalumab|mesh-list
56886304|NCT03721380|Analgesics|analgesics|mesh-ancestor
56886305|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
56886306|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886307|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
56886308|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
56886309|NCT03568500|Olanzapine|olanzapine|mesh-list
56886310|NCT03568500|Risperidone|risperidone|mesh-list
56886311|NCT03568500|Aripiprazole|aripiprazole|mesh-list
56886312|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56886313|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56886314|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
56886315|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886316|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886317|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886318|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56597071|NCT02584465|Tamoxifen|tamoxifen|mesh-list
56886319|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56886320|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886321|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56886322|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56886323|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
56886325|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
56886326|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886327|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886328|NCT03568500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56886329|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56886330|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56886331|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
56886332|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
56886333|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56886334|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56886335|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56886336|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56886337|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
56886338|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56886339|NCT03910738|Testosterone|testosterone|mesh-list
56886340|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
56886341|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
56886342|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56886343|NCT03910738|Androgens|androgens|mesh-ancestor
56886344|NCT03910738|Hormones|hormones|mesh-ancestor
56886345|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843667|NCT05449405|Antipruritics|antipruritics|mesh-ancestor
56843668|NCT05449405|Dermatologic Agents|dermatologic agents|mesh-ancestor
56843669|NCT05449405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56843670|NCT05449405|Histamine Antagonists|histamine antagonists|mesh-ancestor
56843671|NCT05449405|Histamine Agents|histamine agents|mesh-ancestor
56843672|NCT05449405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843673|NCT05449405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843674|NCT05449405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56843675|NCT05432518|Everolimus|everolimus|mesh-list
56843676|NCT05432518|Dasatinib|dasatinib|mesh-list
56843677|NCT05432518|Olaparib|olaparib|mesh-list
56843678|NCT05432518|Palbociclib|palbociclib|mesh-list
56886346|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886347|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56886348|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886349|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
56886350|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56886351|NCT03685084|Piperacillin|piperacillin|mesh-list
56886352|NCT03685084|Cefepime|cefepime|mesh-list
56886353|NCT03685084|Lactams|lactams|mesh-list
56886354|NCT03685084|beta-Lactams|beta-lactams|mesh-list
56886355|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
56886356|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56886357|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886358|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
56886359|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56886360|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886361|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886362|NCT03724266|Chitosan|chitosan|mesh-list
56886363|NCT03724266|Calcium|calcium|mesh-list
56886364|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56886365|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886366|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56886367|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56886368|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
56886369|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886370|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56886371|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
56886372|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
56886373|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
56886374|NCT03724266|Coagulants|coagulants|mesh-ancestor
56886375|NCT03679390|Ketamine|ketamine|mesh-list
56886376|NCT03679390|Analgesics|analgesics|mesh-ancestor
56886377|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
56886378|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886379|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886380|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56886381|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56886382|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
56886383|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
56886384|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886385|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56886386|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56886387|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886388|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886389|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
56886390|NCT03676504|Fludarabine|fludarabine|mesh-list
56886391|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886392|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
56886393|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886394|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886395|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56886396|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
56886397|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886398|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886399|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56886400|NCT03684772|Digoxin|digoxin|mesh-list
56843679|NCT05432518|Afatinib|afatinib|mesh-list
56843680|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843681|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843682|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
56843683|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843684|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56843685|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843686|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843687|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56843691|NCT05412706|Niraparib|niraparib|mesh-list
56843692|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56843693|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843694|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843695|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843696|NCT05407675|Nivolumab|nivolumab|mesh-list
56886401|NCT03684772|Furosemide|furosemide|mesh-list
56886402|NCT03684772|Diuretics|diuretics|mesh-ancestor
56886403|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
56886404|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886405|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56886406|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56886407|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886408|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56886409|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56886410|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886411|NCT03684772|Protective Agents|protective agents|mesh-ancestor
56886412|NCT03601078|Lenalidomide|lenalidomide|mesh-list
56886413|NCT03601078|Immunologic Factors|immunologic factors|mesh-ancestor
56886414|NCT03601078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886415|NCT03601078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56886416|NCT03601078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56886417|NCT03601078|Growth Substances|growth substances|mesh-ancestor
56886418|NCT03601078|Growth Inhibitors|growth inhibitors|mesh-ancestor
56886419|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886420|NCT03676114|Ketamine|ketamine|mesh-list
56886421|NCT03676114|Analgesics|analgesics|mesh-ancestor
56886422|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
56886423|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886424|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886425|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56886426|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56886427|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
56886428|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
56886429|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886430|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56886431|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56886432|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886433|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886434|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
56886435|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886436|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
56886437|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56886438|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56886439|NCT03025828|Hormones|hormones|mesh-ancestor
56886440|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843697|NCT05407675|Ipilimumab|ipilimumab|mesh-list
56843698|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843699|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843700|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56843701|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843702|NCT05403385|Carboplatin|carboplatin|mesh-list
56843703|NCT05403385|Pemetrexed|pemetrexed|mesh-list
56843704|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843705|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843706|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843707|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56843708|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56843709|NCT05394740|Leucovorin|leucovorin|mesh-list
56843710|NCT05394740|Fluorouracil|fluorouracil|mesh-list
56886441|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886442|NCT03568630|Chrysarobin|chrysarobin|mesh-list
56886443|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56886444|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56886445|NCT03568630|Analgesics|analgesics|mesh-ancestor
56886446|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
56886447|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886448|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886449|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886450|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886451|NCT03546816|Serlopitant|serlopitant|mesh-list
56886452|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56886453|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886454|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886455|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886456|NCT03563716|Atezolizumab|atezolizumab|mesh-list
56886457|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886458|NCT03675802|Misoprostol|misoprostol|mesh-list
56886459|NCT03675802|Dinoprostone|dinoprostone|mesh-list
56886460|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56886461|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
56886462|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56886463|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886464|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56886465|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886466|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
56886467|NCT03678610|Ionomycin|ionomycin|mesh-list
56886468|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
56886469|NCT03678610|Ionophores|ionophores|mesh-ancestor
56886470|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56886471|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597209|NCT00915460|Interferons|interferons|mesh-list
56886472|NCT03675646|Morphine|morphine|mesh-list
56886473|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56886474|NCT03675646|Narcotics|narcotics|mesh-ancestor
56886475|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886476|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886477|NCT03675646|Analgesics|analgesics|mesh-ancestor
56886478|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
56886479|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886480|NCT03678532|Midazolam|midazolam|mesh-list
56886481|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56886482|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56886483|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886484|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886485|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56886486|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56886487|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56843711|NCT05394740|Capecitabine|capecitabine|mesh-list
56843712|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
56886488|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56886489|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
56886490|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
56886491|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
56886492|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
56886493|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886494|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886495|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
56886496|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56886497|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886498|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56886500|NCT03678142|Imipenem|imipenem|mesh-list
56886501|NCT03678142|Floxacillin|floxacillin|mesh-list
56886502|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886503|NCT03522298|GDC-0084|gdc-0084|mesh-list
56886504|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886505|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886506|NCT03674866|Insulin|insulin|mesh-list
56886507|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56886508|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886509|NCT03623776|Carboplatin|carboplatin|mesh-list
56886510|NCT03623776|Pemetrexed|pemetrexed|mesh-list
56886511|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886512|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886513|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886514|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56886515|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56886516|NCT03683914|Dinoprostone|dinoprostone|mesh-list
56886517|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
56886518|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56886519|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886520|NCT03448406|Empagliflozin|empagliflozin|mesh-list
56886521|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56886522|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886523|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56886524|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886525|NCT00064701|Cyclosporine|cyclosporine|mesh-list
56886526|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
56886527|NCT00064701|Tacrolimus|tacrolimus|mesh-list
56886528|NCT00064701|Cyclosporins|cyclosporins|mesh-list
56886529|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886530|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
56886531|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886532|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56886533|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886534|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886535|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
56886536|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886537|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56886538|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886539|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56886540|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886541|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56886542|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
56886543|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56886544|NCT02990338|Dexamethasone|dexamethasone|mesh-list
56886545|NCT02990338|Pomalidomide|pomalidomide|mesh-list
56886546|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886547|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
56886548|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
56886549|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886550|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886551|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886552|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
56886553|NCT02990338|Hormones|hormones|mesh-ancestor
56886554|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56886555|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56886556|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886557|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
56886558|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56886559|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56886560|NCT02990338|Growth Substances|growth substances|mesh-ancestor
56886561|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
56886562|NCT00064077|Gemcitabine|gemcitabine|mesh-list
56843713|NCT05394740|Nivolumab|nivolumab|mesh-list
56843714|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
56843715|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843716|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56886563|NCT00064077|Paclitaxel|paclitaxel|mesh-list
56886564|NCT00064077|Vinorelbine|vinorelbine|mesh-list
56886565|NCT00064077|Cisplatin|cisplatin|mesh-list
56886566|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56886567|NCT00064077|Topotecan|topotecan|mesh-list
56886568|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56886569|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886570|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
56886571|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
56886572|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
56886573|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886574|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56886575|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
56886576|NCT00064077|Antiviral Agents|antiviral agents|mesh-ancestor
56886577|NCT00064077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886578|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886579|NCT00064077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886580|NCT00064077|Immunologic Factors|immunologic factors|mesh-ancestor
56886581|NCT00064077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886582|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56886583|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56886584|NCT03674008|Propofol|propofol|mesh-list
56886585|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56886586|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886587|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886588|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56886589|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
56886590|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
56886591|NCT00063999|Paclitaxel|paclitaxel|mesh-list
56886592|NCT00063999|Cisplatin|cisplatin|mesh-list
56886593|NCT00063999|Carboplatin|carboplatin|mesh-list
56886594|NCT00063999|Doxorubicin|doxorubicin|mesh-list
56886595|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56886596|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56886597|NCT00063999|Lenograstim|lenograstim|mesh-list
56886598|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56886599|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886600|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
56886601|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
56886602|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
56886603|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886604|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56886605|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56886606|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56886607|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886608|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56886609|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
56886610|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886611|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
56886612|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56886613|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886614|NCT01092351|Renal Agents|renal agents|mesh-ancestor
56886615|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56886616|NCT02910700|Nivolumab|nivolumab|mesh-list
56886617|NCT02910700|Trametinib|trametinib|mesh-list
56886618|NCT02910700|Dabrafenib|dabrafenib|mesh-list
56886619|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56886620|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886621|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56886622|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886623|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56886624|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886625|NCT02878798|Topiramate|topiramate|mesh-list
56886626|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
56886627|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56886628|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886629|NCT03673384|Fluticasone|fluticasone|mesh-list
56886630|NCT03673384|Xhance|xhance|mesh-list
56886631|NCT03673384|Histamine|histamine|mesh-list
56886632|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56843717|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886633|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56886634|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
56886635|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886636|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886637|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56886638|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
56886639|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
56886640|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56886641|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
56886642|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
56886643|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886644|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886646|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
56886647|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886648|NCT03023878|Dexamethasone|dexamethasone|mesh-list
56886649|NCT03023878|Blinatumomab|blinatumomab|mesh-list
56886650|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886651|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
56886652|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
56886653|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886654|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886655|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886656|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
56886657|NCT03023878|Hormones|hormones|mesh-ancestor
56886658|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56886659|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56886660|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886661|NCT03670888|Rituximab|rituximab|mesh-list
56886662|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56886663|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886664|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
56886665|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886666|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886667|NCT03023722|Maytansine|maytansine|mesh-list
56886668|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56886669|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886670|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
56886671|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
56886672|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
56886673|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886674|NCT03623230|Bupivacaine|bupivacaine|mesh-list
56886675|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56886676|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
56886677|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
56886678|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886679|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886680|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
56886681|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886682|NCT02624596|Midazolam|midazolam|mesh-list
56886683|NCT02624596|Ketamine|ketamine|mesh-list
56886684|NCT02624596|Analgesics|analgesics|mesh-ancestor
56886685|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
56886686|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886687|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886688|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56886689|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56886690|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
56886691|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
56886692|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886693|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56886694|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56886695|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886696|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886697|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56886698|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56886699|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56886700|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56886701|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56886702|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
56886703|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
56886704|NCT02553460|Leucovorin|leucovorin|mesh-list
56886705|NCT02553460|Cytarabine|cytarabine|mesh-list
56886706|NCT02553460|Dexamethasone|dexamethasone|mesh-list
56886707|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
56843718|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843719|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
56843720|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843721|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843722|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56843723|NCT05394740|Antidotes|antidotes|mesh-ancestor
56843724|NCT05394740|Protective Agents|protective agents|mesh-ancestor
56554505|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843725|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
56843726|NCT05394740|Vitamins|vitamins|mesh-ancestor
56843727|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
56843728|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56843729|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56558248|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
56886708|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
56886709|NCT02553460|Methotrexate|methotrexate|mesh-list
56886710|NCT02553460|Etoposide|etoposide|mesh-list
56886711|NCT02553460|Vincristine|vincristine|mesh-list
56886712|NCT02553460|Bortezomib|bortezomib|mesh-list
56886713|NCT02553460|Asparaginase|asparaginase|mesh-list
56886714|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
56886715|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
56886716|NCT02553460|Vorinostat|vorinostat|mesh-list
56886717|NCT02553460|Pegaspargase|pegaspargase|mesh-list
56886718|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
56886719|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886720|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
56886721|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886722|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886723|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56886724|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
56886725|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886726|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886727|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56886728|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886729|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
56886730|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
56886731|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886732|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886733|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
56886734|NCT02553460|Hormones|hormones|mesh-ancestor
56886735|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56886736|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56886737|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56886738|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
56886739|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56886740|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56886741|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
56886742|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
56886743|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886744|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56886745|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56886746|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56886747|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56886748|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56886749|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
56886750|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886751|NCT02553460|Antidotes|antidotes|mesh-ancestor
56886752|NCT02553460|Protective Agents|protective agents|mesh-ancestor
56886753|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
56886754|NCT02553460|Vitamins|vitamins|mesh-ancestor
56886755|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
56886756|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
56886757|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
56886758|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
56886759|NCT02553460|Analgesics|analgesics|mesh-ancestor
56886760|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
56886761|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56886762|NCT03669562|Alprostadil|alprostadil|mesh-list
56886763|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56886764|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
56886765|NCT03669562|Urological Agents|urological agents|mesh-ancestor
56886766|NCT03669484|Fentanyl|fentanyl|mesh-list
56886767|NCT03669484|Bromides|bromides|mesh-list
56886768|NCT03669484|Propofol|propofol|mesh-list
56886769|NCT03669484|Rocuronium|rocuronium|mesh-list
56886770|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56886771|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56886772|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886773|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56886774|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
56886775|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
56886776|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56886777|NCT03669484|Narcotics|narcotics|mesh-ancestor
56886778|NCT03669484|Analgesics|analgesics|mesh-ancestor
56886779|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
56886780|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886781|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56886782|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
56886783|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56886784|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56886785|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56886787|NCT01979536|Dexamethasone|dexamethasone|mesh-list
56886788|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
56886789|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
56886790|NCT01979536|Ifosfamide|ifosfamide|mesh-list
56886791|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
56886792|NCT01979536|Doxorubicin|doxorubicin|mesh-list
56886793|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56886794|NCT01979536|Methotrexate|methotrexate|mesh-list
56886795|NCT01979536|Etoposide|etoposide|mesh-list
56886796|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
56886797|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56886798|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
56886799|NCT01979536|Crizotinib|crizotinib|mesh-list
56886800|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56886801|NCT01979536|Antibodies|antibodies|mesh-list
56886802|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
56886803|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56886804|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
56886805|NCT01979536|BB 1101|bb 1101|mesh-list
56886806|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886807|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
56886808|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886809|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886810|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56886811|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
56886812|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886813|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886814|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56886815|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886816|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
56886817|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
56886818|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886819|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886820|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
56886821|NCT01979536|Hormones|hormones|mesh-ancestor
56886822|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56886823|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56886824|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
56886825|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886826|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56886827|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56886828|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56886829|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56886830|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
56886831|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56886832|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56886833|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
56886834|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56886835|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56886836|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56886837|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56886838|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
56843730|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843731|NCT05375084|Nivolumab|nivolumab|mesh-list
56843732|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843733|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843734|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56843735|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843736|NCT05371093|Prednisone|prednisone|mesh-list
56843737|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
56843738|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56843739|NCT05371093|Rituximab|rituximab|mesh-list
56843740|NCT05371093|Doxorubicin|doxorubicin|mesh-list
56843741|NCT05371093|Fludarabine|fludarabine|mesh-list
56843742|NCT05371093|Vincristine|vincristine|mesh-list
56843743|NCT05371093|Lenalidomide|lenalidomide|mesh-list
56843744|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843745|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
56558386|NCT02883647|Tenofovir|tenofovir|mesh-list
56886839|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886840|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
56886841|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
56886842|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
56886843|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
56886844|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56886845|NCT01525966|Paclitaxel|paclitaxel|mesh-list
56886846|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56886847|NCT01525966|Carboplatin|carboplatin|mesh-list
56886848|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56886849|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886850|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
56886851|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
56886852|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
56886853|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886854|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
56886855|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56886856|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886857|NCT03668860|Dexamethasone|dexamethasone|mesh-list
56886858|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
56886859|NCT03668860|Betamethasone|betamethasone|mesh-list
56886860|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
56886861|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56886862|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
56886863|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
56886864|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56886865|NCT03668860|BB 1101|bb 1101|mesh-list
56886866|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886867|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
56886868|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
56886869|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886870|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886871|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886872|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
56886873|NCT03668860|Hormones|hormones|mesh-ancestor
56886874|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56886875|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56886876|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886877|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
56886878|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886879|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886880|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56886881|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
56886882|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56843746|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843747|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56843748|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56843749|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
56843750|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843751|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843752|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56843753|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843754|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56843755|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56843756|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56843757|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886883|NCT00062751|Sirolimus|sirolimus|mesh-list
56886884|NCT00062751|Letrozole|letrozole|mesh-list
56886885|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886886|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56886887|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56886888|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886889|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886890|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56886891|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
56886892|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56886893|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886894|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56886895|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886896|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56886897|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
56886898|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886899|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
56886900|NCT00945724|Cytarabine|cytarabine|mesh-list
56886901|NCT00945724|Prednisolone|prednisolone|mesh-list
56886902|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
56886903|NCT00945724|Rituximab|rituximab|mesh-list
56886904|NCT00945724|Doxorubicin|doxorubicin|mesh-list
56886905|NCT00945724|Methotrexate|methotrexate|mesh-list
56886906|NCT00945724|Vincristine|vincristine|mesh-list
56886907|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886908|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
56886909|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886910|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886911|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56886912|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
56886913|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886914|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886915|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56886916|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56886917|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56886918|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56886919|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56886920|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886921|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56886922|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
56886923|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56886924|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56886925|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
56886926|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
56886927|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56886928|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56886929|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
56886930|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886931|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56843758|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56843759|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
56843760|NCT05371093|Hormones|hormones|mesh-ancestor
56843761|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843762|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56843763|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56843764|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
56843765|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
56843766|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
56843767|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56558514|NCT02947516|Liver Extracts|liver extracts|mesh-list
56886932|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
56886933|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
56886934|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
56886935|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886936|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
56886937|NCT00945724|Hormones|hormones|mesh-ancestor
56597664|NCT00774046|Cytarabine|cytarabine|mesh-list
56886938|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56886939|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56886940|NCT00258310|Capecitabine|capecitabine|mesh-list
56886941|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56886942|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
56904627|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56886943|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886944|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886945|NCT00062439|Docetaxel|docetaxel|mesh-list
56886946|NCT00062439|Etoposide|etoposide|mesh-list
56886947|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886948|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
56886949|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
56886950|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
56886951|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886952|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56886953|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56886954|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56886955|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886956|NCT01099059|Amantadine|amantadine|mesh-list
56886957|NCT01099059|Methylphenidate|methylphenidate|mesh-list
56886958|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56886959|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886960|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56886961|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56886962|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56886963|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886964|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
56886965|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56886966|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56886967|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56886968|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
56886969|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886970|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56886971|NCT01099059|Analgesics|analgesics|mesh-ancestor
56886972|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
56886973|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886974|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
56886975|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56886976|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56886977|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886978|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886979|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56886980|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
56886981|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843768|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56886982|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
56886983|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56886984|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56886985|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
56886986|NCT00031551|Etanercept|etanercept|mesh-list
56886987|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56886988|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56886989|NCT00031551|Analgesics|analgesics|mesh-ancestor
56886990|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
56886991|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56886992|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56886993|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56886994|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56886995|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56886996|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56886997|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
56886998|NCT01099137|Vildagliptin|vildagliptin|mesh-list
56886999|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56887000|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887001|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56887002|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
56887003|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887004|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887005|NCT01092975|Phenylephrine|phenylephrine|mesh-list
56887006|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
56887007|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56887008|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
56887009|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
56887010|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887011|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887012|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
56887013|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56887014|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
56887015|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
56887016|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56887017|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56887018|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56887019|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
56887020|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887021|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887022|NCT01092975|Protective Agents|protective agents|mesh-ancestor
56887023|NCT01584297|Ketoconazole|ketoconazole|mesh-list
56887024|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
56887025|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887026|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56887027|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56887028|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887029|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887030|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56887031|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
56887032|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887033|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887034|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56887035|NCT00049257|Paclitaxel|paclitaxel|mesh-list
56887036|NCT00049257|Carboplatin|carboplatin|mesh-list
56887037|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56887038|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887039|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
56887040|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
56887041|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
56887042|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887043|NCT03951987|Charcoal|charcoal|mesh-list
56887044|NCT03951987|Antidotes|antidotes|mesh-ancestor
56887045|NCT03951987|Protective Agents|protective agents|mesh-ancestor
56887046|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887047|NCT00601900|Tamoxifen|tamoxifen|mesh-list
56887048|NCT00601900|Bevacizumab|bevacizumab|mesh-list
56887049|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56887050|NCT00601900|Letrozole|letrozole|mesh-list
56887051|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
56887052|NCT00601900|Antibodies|antibodies|mesh-list
56887053|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
56887054|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56843769|NCT05371093|Growth Substances|growth substances|mesh-ancestor
56843770|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
56887055|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
56887056|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887057|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56887058|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56887059|NCT00601900|Growth Substances|growth substances|mesh-ancestor
56887060|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887061|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
56887062|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
56887063|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887064|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56887065|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56887066|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887067|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56887068|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
56887069|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887070|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887071|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56887072|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56887073|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56887074|NCT03668470|Dulaglutide|dulaglutide|mesh-list
56887075|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56887076|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887077|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
56887078|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56887079|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
56887080|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887081|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887082|NCT03020914|Methamphetamine|methamphetamine|mesh-list
56887083|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56887084|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887085|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
56887086|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
56887087|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887088|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
56887089|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887090|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887092|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56887093|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56887094|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56887095|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56887096|NCT03018340|Pimavanserin|pimavanserin|mesh-list
56887097|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56887098|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56887099|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56887100|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56887101|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887102|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887103|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56887104|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56887105|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56887106|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
56887107|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887108|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887109|NCT00048165|Cyclosporine|cyclosporine|mesh-list
56887110|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
56887111|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
56887112|NCT00048165|Cyclosporins|cyclosporins|mesh-list
56887113|NCT00048165|Daclizumab|daclizumab|mesh-list
56887114|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887115|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887116|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56887117|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
56887118|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887119|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
56887120|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887121|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
56887122|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887123|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56887124|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56887125|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843771|NCT05334056|Cocaine|cocaine|mesh-list
56843772|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
56843773|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
56843774|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843775|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843776|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
56843777|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843778|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56843779|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56843780|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56843781|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56887126|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56887127|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
56887128|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56887129|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56887130|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
56887131|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
56887132|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887133|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56887135|NCT00048165|Hormones|hormones|mesh-ancestor
56887136|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887137|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56887138|NCT00048165|Protective Agents|protective agents|mesh-ancestor
56887139|NCT01099527|Capecitabine|capecitabine|mesh-list
56887140|NCT01099527|Everolimus|everolimus|mesh-list
56887141|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56887142|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
56887143|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887144|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887145|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56887146|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
56887147|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887148|NCT01093365|Varenicline|varenicline|mesh-list
56887149|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56887150|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56887151|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
56887152|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887153|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887154|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887155|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
56887156|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56887157|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
56887158|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887159|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
56887160|NCT03955497|Protective Agents|protective agents|mesh-ancestor
56887161|NCT01099605|Bupivacaine|bupivacaine|mesh-list
56887162|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
56887163|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
56887164|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887165|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887166|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
56887167|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887168|NCT00059787|Paclitaxel|paclitaxel|mesh-list
56887169|NCT00059787|Carboplatin|carboplatin|mesh-list
56887170|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56887171|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56887172|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887173|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
56887174|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
56887175|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
56887176|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887177|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56887178|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887179|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
56843782|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843783|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
56887180|NCT01099839|Miglitol|miglitol|mesh-list
56887181|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56887182|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887183|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56887184|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887185|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887186|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56887187|NCT00058539|Pertuzumab|pertuzumab|mesh-list
56887188|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887189|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887190|NCT03956823|Amlodipine|amlodipine|mesh-list
56887191|NCT03956823|Telmisartan|telmisartan|mesh-list
56887192|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56887193|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56887194|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56887195|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887196|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56887197|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887198|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
56887199|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56887200|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56887201|NCT03015532|Bupivacaine|bupivacaine|mesh-list
56887202|NCT03015532|Ropivacaine|ropivacaine|mesh-list
56887203|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
56887205|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887206|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887207|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
56887208|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887209|NCT03954873|Glucagon|glucagon|mesh-list
56887210|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56887211|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887212|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56887213|NCT03954873|Hormones|hormones|mesh-ancestor
56887214|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887215|NCT03954873|Incretins|incretins|mesh-ancestor
56887216|NCT03951831|Docetaxel|docetaxel|mesh-list
56887217|NCT03951831|Leuprolide|leuprolide|mesh-list
56887218|NCT03951831|Cemiplimab|cemiplimab|mesh-list
56887219|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887220|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
56887221|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
56887222|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
56887223|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887224|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56887225|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
56887226|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56887227|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887228|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887229|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887230|NCT03954639|Bupivacaine|bupivacaine|mesh-list
56887231|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
56887232|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
56887233|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887234|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887235|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
56887236|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887237|NCT01095939|Benazepril|benazepril|mesh-list
56887238|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56887239|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
56887240|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887241|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887242|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56887243|NCT03015220|Dulaglutide|dulaglutide|mesh-list
56887244|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56887245|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887246|NCT00022659|Bevacizumab|bevacizumab|mesh-list
56887247|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56887248|NCT00022659|Antibodies|antibodies|mesh-list
56887249|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
56887250|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56843784|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843785|NCT05299242|Adalimumab|adalimumab|mesh-list
56843786|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56843787|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56843788|NCT05273996|Bupropion|bupropion|mesh-list
56843789|NCT05273996|Sertraline|sertraline|mesh-list
56843790|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56843791|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56843792|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
56843793|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56843794|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56843795|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56887251|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887252|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56887253|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56887254|NCT00022659|Growth Substances|growth substances|mesh-ancestor
56887255|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887256|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
56887257|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
56887258|NCT03018106|Estrogens|estrogens|mesh-list
56887259|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56887260|NCT03018106|Hormones|hormones|mesh-ancestor
56887261|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887262|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887263|NCT03018028|Liraglutide|liraglutide|mesh-list
56887264|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56887265|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887266|NCT03018028|Incretins|incretins|mesh-ancestor
56887267|NCT03018028|Hormones|hormones|mesh-ancestor
56887268|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887269|NCT03667222|Minocycline|minocycline|mesh-list
56887270|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56887271|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887272|NCT03667300|Linagliptin|linagliptin|mesh-list
56887273|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56887274|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887275|NCT03667300|Incretins|incretins|mesh-ancestor
56887276|NCT03667300|Hormones|hormones|mesh-ancestor
56887277|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887278|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56887279|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
56887280|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887281|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887282|NCT03667066|Clopidogrel|clopidogrel|mesh-list
56887283|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56887284|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56887285|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56887286|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56887287|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
56887288|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887289|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887290|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887291|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
56887292|NCT00021255|Carboplatin|carboplatin|mesh-list
56887293|NCT00021255|Docetaxel|docetaxel|mesh-list
56887294|NCT00021255|Doxorubicin|doxorubicin|mesh-list
56887295|NCT00021255|Trastuzumab|trastuzumab|mesh-list
56887296|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56887297|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
56887298|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887299|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887300|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56887301|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
55895655|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
56843796|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56843797|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843798|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
56843799|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843800|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843801|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56558913|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56887302|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887303|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887304|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56887305|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
56887306|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
56887307|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
56887308|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56887309|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56598054|NCT02280525|Cytarabine|cytarabine|mesh-list
56887310|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56887311|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887312|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887313|NCT03012334|Alprazolam|alprazolam|mesh-list
56887314|NCT03012334|Lasmiditan|lasmiditan|mesh-list
56887315|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56887316|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887317|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887318|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56887319|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56887320|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56887321|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
56887322|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
56887323|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887324|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887325|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56887326|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
56887327|NCT03951285|Niacinamide|niacinamide|mesh-list
56887328|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
56887329|NCT03951285|Vitamins|vitamins|mesh-ancestor
56887330|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
56887331|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887332|NCT04571944|Suvorexant|suvorexant|mesh-list
56887333|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56887334|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56887335|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887336|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887337|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56887338|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887339|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887340|NCT04052932|Allopurinol|allopurinol|mesh-list
56887341|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
56887342|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887343|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887344|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
56887345|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887346|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56887347|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
56887348|NCT04052932|Protective Agents|protective agents|mesh-ancestor
56887349|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887350|NCT03006562|Heparin|heparin|mesh-list
56887351|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
56887352|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56887353|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56887354|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887356|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56887357|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887358|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56887359|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887360|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
56887361|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843802|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56843803|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843804|NCT05273996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56843805|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
56843806|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56843807|NCT05272384|Nivolumab|nivolumab|mesh-list
56843808|NCT05272384|Decitabine|decitabine|mesh-list
56843809|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843810|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843811|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56843812|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843813|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56843814|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
56558980|NCT02689726|Imiquimod|imiquimod|mesh-list
56887362|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
56887363|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887364|NCT03007966|Clonidine|clonidine|mesh-list
56887365|NCT03007966|Epinephrine|epinephrine|mesh-list
56887366|NCT03007966|Bupivacaine|bupivacaine|mesh-list
56887367|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
56887368|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
56887369|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887370|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887371|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
56887372|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887373|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56887374|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56887375|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
56887376|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887377|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887378|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56887379|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56887380|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
56887381|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56887382|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
56887383|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
56887384|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
56887385|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56887386|NCT03007966|Analgesics|analgesics|mesh-ancestor
56887387|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56887388|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
56887389|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56887390|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56887391|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56887392|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
56887393|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887394|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56887395|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56887396|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
56887397|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
56887398|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887399|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887400|NCT03541044|Nicotine|nicotine|mesh-list
56887401|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56887402|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
56887403|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887404|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887405|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56887406|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56887407|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
56887408|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843815|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843816|NCT05264025|Fexofenadine|fexofenadine|mesh-list
56843817|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56843818|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56843819|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56843820|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
56843821|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
56843822|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843823|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843824|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843825|NCT05262244|Bevacizumab|bevacizumab|mesh-list
56843826|NCT05262244|Vedolizumab|vedolizumab|mesh-list
56843827|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843828|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843829|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56843830|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56843831|NCT05262244|Growth Substances|growth substances|mesh-ancestor
56559041|NCT01078974|Dexamethasone|dexamethasone|mesh-list
56887409|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887410|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
56887411|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56887412|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887413|NCT03540030|Acetaminophen|acetaminophen|mesh-list
56887414|NCT03540030|Celecoxib|celecoxib|mesh-list
56887415|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56887416|NCT03540030|Lidocaine|lidocaine|mesh-list
56887417|NCT03540030|Gabapentin|gabapentin|mesh-list
56887418|NCT03540030|Propofol|propofol|mesh-list
56887419|NCT03540030|Sevoflurane|sevoflurane|mesh-list
56887420|NCT03540030|Desflurane|desflurane|mesh-list
56887421|NCT03540030|Rocuronium|rocuronium|mesh-list
56887422|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
56887423|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
56887424|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
56887425|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887426|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887427|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
56887428|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887429|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56887430|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56887431|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56887432|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56887433|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887434|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56887435|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56887436|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
56887437|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56887439|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
56887440|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56887441|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56887442|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56887443|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56887444|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887445|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56887446|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56887447|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887448|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
56887449|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56843832|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843833|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
56843834|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56843835|NCT05255991|Treprostinil|treprostinil|mesh-list
56843836|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56843837|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
56843838|NCT05255666|Irinotecan|irinotecan|mesh-list
56843839|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843840|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843841|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56843842|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56843843|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559098|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56887450|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56887451|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56887452|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56887453|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56887454|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887455|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
56887456|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56887457|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56887458|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56887459|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56887460|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56887461|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
56887462|NCT00008385|Selenium|selenium|mesh-list
56887463|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
56887464|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887465|NCT00008385|Protective Agents|protective agents|mesh-ancestor
56887466|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887467|NCT00008385|Trace Elements|trace elements|mesh-ancestor
56887468|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
56887469|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
56887470|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
56887471|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56887472|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
56887473|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887474|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887475|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56887476|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
56887477|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887478|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887479|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56887480|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887481|NCT03003520|Prednisone|prednisone|mesh-list
56887482|NCT03003520|Prednisolone|prednisolone|mesh-list
56887483|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
56887484|NCT03003520|Rituximab|rituximab|mesh-list
56887485|NCT03003520|Doxorubicin|doxorubicin|mesh-list
56887486|NCT03003520|Vincristine|vincristine|mesh-list
56887487|NCT03003520|Lenalidomide|lenalidomide|mesh-list
56887488|NCT03003520|Durvalumab|durvalumab|mesh-list
56887489|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56887490|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
56887491|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887492|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887493|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56887494|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
56887495|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887496|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887497|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56887498|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887499|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56887500|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56843844|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843845|NCT05254639|Donepezil|donepezil|mesh-list
56843846|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56843847|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843848|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843849|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
56843850|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843851|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843852|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
56843853|NCT05251948|Capecitabine|capecitabine|mesh-list
56843854|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
56843855|NCT05251948|Atezolizumab|atezolizumab|mesh-list
56843856|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56559171|NCT01092780|Modafinil|modafinil|mesh-list
56887501|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56887502|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887503|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56887504|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
56887505|NCT03003520|Hormones|hormones|mesh-ancestor
56887506|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887507|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887508|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56887509|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
56887510|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
56887511|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
56887512|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56887513|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56887514|NCT03003520|Growth Substances|growth substances|mesh-ancestor
56887515|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
56887516|NCT03665740|Resveratrol|resveratrol|mesh-list
56887517|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
56887518|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887519|NCT03665740|Protective Agents|protective agents|mesh-ancestor
56887520|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887521|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887522|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56887523|NCT03665350|Insulin|insulin|mesh-list
56887524|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56887525|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887526|NCT03665428|Bismuth|bismuth|mesh-list
56887527|NCT03665428|Antacids|antacids|mesh-ancestor
56887528|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887529|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56887530|NCT03669328|Anesthetics|anesthetics|mesh-list
56887531|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887532|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887533|NCT02912650|Acetaminophen|acetaminophen|mesh-list
56887534|NCT02912650|Ibuprofen|ibuprofen|mesh-list
56887535|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56887536|NCT02912650|Analgesics|analgesics|mesh-ancestor
56887537|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
56887538|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887539|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887540|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
56887541|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56887542|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56887543|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887544|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56887545|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887546|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887547|NCT03002038|Rituximab|rituximab|mesh-list
56887548|NCT03002038|Azathioprine|azathioprine|mesh-list
56843857|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
56559225|NCT04227886|Irinotecan|irinotecan|mesh-list
56887549|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887550|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887551|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
56887552|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887553|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887554|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
56887555|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887556|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56887557|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56887558|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
56887559|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56887560|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887561|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887562|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56887563|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56887564|NCT03664414|Protective Agents|protective agents|mesh-ancestor
56887565|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887566|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
56887567|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56887568|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
56887569|NCT02911948|Insulin|insulin|mesh-list
56887570|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56887571|NCT02911948|Liraglutide|liraglutide|mesh-list
56887572|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
56887573|NCT02911948|Xultophy|xultophy|mesh-list
56887574|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56887575|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887576|NCT02911948|Incretins|incretins|mesh-ancestor
56887577|NCT02911948|Hormones|hormones|mesh-ancestor
56887578|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887579|NCT03622918|Rifampin|rifampin|mesh-list
56887580|NCT03622918|Colistin|colistin|mesh-list
56887581|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56887582|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
56887583|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56887584|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887585|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
56887586|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56887587|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887588|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887589|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56887590|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56887591|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56887592|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56887593|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56887594|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56887595|NCT03487666|Capecitabine|capecitabine|mesh-list
56887596|NCT03487666|Nivolumab|nivolumab|mesh-list
56887597|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56887598|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
56887599|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887600|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887601|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887602|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56887603|NCT03376672|Dexamethasone|dexamethasone|mesh-list
56887604|NCT03376672|Lenalidomide|lenalidomide|mesh-list
56887605|NCT03376672|Ixazomib|ixazomib|mesh-list
56887606|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56887607|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
56887608|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
56887609|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887610|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887611|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56887612|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
56598347|NCT01005680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56887614|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887615|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887616|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887617|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
56887618|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56887619|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56843858|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843859|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843860|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
56843861|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56843862|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843863|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56843864|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843865|NCT05244213|Paclitaxel|paclitaxel|mesh-list
56843866|NCT05244213|Carboplatin|carboplatin|mesh-list
56843867|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56843868|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843869|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
56843870|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
56887620|NCT03376672|Growth Substances|growth substances|mesh-ancestor
56887621|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
56887622|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
56887623|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887624|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887625|NCT03367312|Xenon|xenon|mesh-list
56887626|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56887627|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
56887628|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
56887629|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887630|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887631|NCT00027027|Pertuzumab|pertuzumab|mesh-list
56887632|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887633|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887634|NCT00046839|Celecoxib|celecoxib|mesh-list
56887635|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
56887636|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56887637|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56887638|NCT00046839|Analgesics|analgesics|mesh-ancestor
56887639|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
56887640|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887641|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887642|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56887643|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56887644|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56887645|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887646|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887647|NCT00006903|Fulvestrant|fulvestrant|mesh-list
56887648|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887649|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887650|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56887651|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56887652|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
56904628|NCT04397445|Ranitidine|ranitidine|mesh-list
56887653|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887654|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887655|NCT03951597|Gemcitabine|gemcitabine|mesh-list
56887656|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
56887657|NCT03951597|Lenvatinib|lenvatinib|mesh-list
56887658|NCT03951597|Antibodies|antibodies|mesh-list
56887659|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
56887660|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887661|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56887662|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
56887663|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887664|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887665|NCT03951597|Antiviral Agents|antiviral agents|mesh-ancestor
56887666|NCT03951597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887667|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887668|NCT03951597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56887669|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56887670|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
56887671|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887672|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887673|NCT01101009|Amlodipine|amlodipine|mesh-list
56887674|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56887675|NCT01101009|Olmesartan|olmesartan|mesh-list
56887676|NCT01101009|Perindopril|perindopril|mesh-list
56887677|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56887678|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56887679|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56887680|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887681|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56887682|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887683|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
56887684|NCT01101009|Diuretics|diuretics|mesh-ancestor
56887685|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
56598423|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56887687|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56887688|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56887689|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56887690|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
56887691|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887692|NCT02996500|Tofacitinib|tofacitinib|mesh-list
56887693|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56887694|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887695|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887696|NCT00006489|Naltrexone|naltrexone|mesh-list
56887697|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56887698|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56887699|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887700|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
56887701|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887702|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56887703|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887705|NCT03720756|Trace Elements|trace elements|mesh-ancestor
56887706|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
56887707|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887708|NCT00025233|Bevacizumab|bevacizumab|mesh-list
56887709|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56887710|NCT00025233|Antibodies|antibodies|mesh-list
56887711|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
56887712|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56887713|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887714|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56887715|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56887716|NCT00025233|Growth Substances|growth substances|mesh-ancestor
56887717|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887718|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
56887719|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
56887720|NCT00025155|Epothilones|epothilones|mesh-list
56887721|NCT00025155|Epothilone B|epothilone b|mesh-list
56887722|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
56887723|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
56887724|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
56887725|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887726|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887727|NCT02998996|Endocine|endocine|mesh-list
56887729|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
56887730|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887731|NCT03663478|Ropivacaine|ropivacaine|mesh-list
56887732|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
56887733|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
56887734|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887735|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887736|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
56887737|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887738|NCT02994940|Acetaminophen|acetaminophen|mesh-list
56887739|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56887740|NCT02994940|Analgesics|analgesics|mesh-ancestor
56887741|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
56887742|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887743|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887744|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
56843871|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
56843872|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843873|NCT05233956|Chrysarobin|chrysarobin|mesh-list
56843874|NCT05233956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56843875|NCT05233956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56843876|NCT05233956|Analgesics|analgesics|mesh-ancestor
56843877|NCT05233956|Sensory System Agents|sensory system agents|mesh-ancestor
56843878|NCT05233956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843879|NCT05233956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843880|NCT05233956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56887745|NCT04053322|Durvalumab|durvalumab|mesh-list
56887746|NCT04053322|Olaparib|olaparib|mesh-list
56887747|NCT04053322|Fulvestrant|fulvestrant|mesh-list
56887748|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887749|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887750|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56887751|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887752|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887753|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887754|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56887755|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56887756|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
56887757|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887758|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887759|NCT02994394|Tolvaptan|tolvaptan|mesh-list
56598501|NCT04075201|Vaccines|vaccines|mesh-list
56887760|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56887761|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887762|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
56887763|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887764|NCT01063270|Rifampin|rifampin|mesh-list
56887765|NCT01063270|Clindamycin|clindamycin|mesh-list
56887766|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
56887767|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
56887768|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56887769|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
56887770|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56887771|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887772|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
56887773|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56887774|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887775|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887776|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56887777|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56887778|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56887779|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56887780|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56887781|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56887782|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56887783|NCT00023673|Paclitaxel|paclitaxel|mesh-list
56887784|NCT00023673|Carboplatin|carboplatin|mesh-list
56887785|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56887786|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887787|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
56887788|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
56887789|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
56887790|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887791|NCT01069900|Amoxicillin|amoxicillin|mesh-list
56887792|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
56887793|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
56887794|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
56887795|NCT01069900|Ertapenem|ertapenem|mesh-list
56887796|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56843881|NCT05233956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56843882|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56843883|NCT05231148|Calcium|calcium|mesh-list
56887797|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56887798|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56887799|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887801|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56887802|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887803|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887804|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887805|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56887806|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
56887807|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56887808|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887809|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56887810|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56887811|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56887812|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56887813|NCT03417544|Trastuzumab|trastuzumab|mesh-list
56887814|NCT03417544|Pertuzumab|pertuzumab|mesh-list
56887815|NCT03417544|Atezolizumab|atezolizumab|mesh-list
56887816|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887817|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887818|NCT00006237|Interferons|interferons|mesh-list
56887819|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
56887820|NCT00006237|Aldesleukin|aldesleukin|mesh-list
56887821|NCT00006237|Interleukin-2|interleukin-2|mesh-list
56887822|NCT00006237|Dacarbazine|dacarbazine|mesh-list
56887823|NCT00006237|Vinblastine|vinblastine|mesh-list
56887824|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887825|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
56887826|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887827|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
56887828|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887829|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56887830|NCT00006237|Analgesics|analgesics|mesh-ancestor
56887831|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
56887832|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887833|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56887834|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56887835|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56887836|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
56887837|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887838|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56887839|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56887840|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56887841|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56887842|NCT04056754|Prednisone|prednisone|mesh-list
56887843|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
56887844|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56887845|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
56887846|NCT04056754|Hormones|hormones|mesh-ancestor
56887847|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887848|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887849|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887850|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887851|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56887852|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887853|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887854|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
56887855|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56887856|NCT04056442|Cannabidiol|cannabidiol|mesh-list
56887857|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
56887858|NCT03662620|Amlodipine|amlodipine|mesh-list
56887859|NCT03662620|Telmisartan|telmisartan|mesh-list
56887860|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
56887861|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56887862|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56887863|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56887864|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887865|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56887866|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887867|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
56843884|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56843885|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843886|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56843887|NCT05219487|Risdiplam|risdiplam|mesh-list
56843888|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56843889|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843890|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843891|NCT05204927|Prednisone|prednisone|mesh-list
56887868|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56887869|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56887870|NCT03662620|Diuretics|diuretics|mesh-ancestor
56887871|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
56887872|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56887873|NCT03661684|Prednisone|prednisone|mesh-list
56887875|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
56887876|NCT03661684|Hormones|hormones|mesh-ancestor
56887877|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56887878|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887879|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887880|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887881|NCT02993926|Leuprolide|leuprolide|mesh-list
56887882|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56887883|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
56887884|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56887885|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887886|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887887|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887888|NCT04055506|Ritonavir|ritonavir|mesh-list
56887889|NCT04055506|BMS-986165|bms-986165|mesh-list
56887890|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56887891|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56887892|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
56887893|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887894|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887895|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56887896|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56887897|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
56887898|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56887899|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56887900|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56887901|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
56887902|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56887903|NCT02993224|Deferasirox|deferasirox|mesh-list
56887904|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56887905|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
56887906|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
56887907|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887908|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
56887909|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56887910|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887911|NCT03415178|Atorvastatin|atorvastatin|mesh-list
56887912|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56887913|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56887914|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56887915|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
56887916|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887917|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56887918|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56887919|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887920|NCT02992132|Pimavanserin|pimavanserin|mesh-list
56887921|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56887922|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56887923|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56887924|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56887925|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887926|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843892|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56843893|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
56843894|NCT05204927|Hormones|hormones|mesh-ancestor
56843895|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843896|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843897|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56887927|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56887928|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56887929|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56887930|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
56887931|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887932|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887933|NCT03444584|Metformin|metformin|mesh-list
56887934|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56887935|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887936|NCT03717740|Esomeprazole|esomeprazole|mesh-list
56887937|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56887938|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56887939|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56887940|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887941|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887942|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
56887943|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56887944|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56887945|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887946|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56887947|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887948|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56887950|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56887951|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
56887952|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56887953|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887954|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56887955|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56887956|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
56887957|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887958|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887959|NCT03494816|Axitinib|axitinib|mesh-list
56887960|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56887961|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56887962|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887963|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887964|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
56887965|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
56887966|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56887967|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887968|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887969|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
56887970|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56887971|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887972|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887973|NCT03713762|Lidocaine|lidocaine|mesh-list
56887974|NCT03713762|Fentanyl|fentanyl|mesh-list
56887975|NCT03713762|Bupivacaine|bupivacaine|mesh-list
56887976|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
56887977|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
56887978|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56887979|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56887980|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
56887981|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598726|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
56887982|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56887983|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56887984|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56887985|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56887986|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843898|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843899|NCT05198934|Trifluridine|trifluridine|mesh-list
56843900|NCT05198934|Panitumumab|panitumumab|mesh-list
56843901|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843902|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843903|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
56843904|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843905|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
56843906|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56843907|NCT05169112|Leuprolide|leuprolide|mesh-list
56843908|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56843909|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
56843910|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56843911|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843912|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56843913|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843914|NCT05139420|Topiramate|topiramate|mesh-list
56843915|NCT05139420|Phentermine|phentermine|mesh-list
56843916|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
56843917|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56843918|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843919|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56843920|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
56887987|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56887988|NCT03713762|Narcotics|narcotics|mesh-ancestor
56887989|NCT03713762|Analgesics|analgesics|mesh-ancestor
56887990|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56887991|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56887992|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
56887993|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56887994|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56887995|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
56887996|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56887997|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56887998|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56887999|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888000|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888001|NCT02991040|Lidocaine|lidocaine|mesh-list
56888002|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
56888003|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
56888004|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888005|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888006|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
56888007|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888008|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56888009|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56888010|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56888011|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56888012|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888013|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
56888014|NCT03660436|BMS-986165|bms-986165|mesh-list
56888015|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56888016|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843921|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56843922|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
56843923|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
56843924|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843925|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
56843926|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843927|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843928|NCT05137184|Fentanyl|fentanyl|mesh-list
56843929|NCT05137184|Morphine|morphine|mesh-list
56843930|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
56843931|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56843932|NCT05137184|Narcotics|narcotics|mesh-ancestor
56559764|NCT02617849|Carboplatin|carboplatin|mesh-list
56888017|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56888018|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
56888020|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888021|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888022|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888023|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
56888024|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56888025|NCT01068730|Metformin|metformin|mesh-list
56888026|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888027|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888028|NCT01068652|Insulin|insulin|mesh-list
56888029|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56888030|NCT01068652|Metformin|metformin|mesh-list
56888031|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
56888032|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
56888033|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56888034|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
56888035|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
56888036|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56888037|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888038|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888039|NCT03658720|Ibuprofen|ibuprofen|mesh-list
56888040|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56888041|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56888042|NCT03658720|Analgesics|analgesics|mesh-ancestor
56888043|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
56888044|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888045|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888046|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56888047|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56888048|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56888049|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888050|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888051|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
56888052|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56888053|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56598813|NCT02539537|Leucovorin|leucovorin|mesh-list
56888054|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888055|NCT03658330|Naltrexone|naltrexone|mesh-list
56888056|NCT03658330|Ketamine|ketamine|mesh-list
56888057|NCT03658330|Analgesics|analgesics|mesh-ancestor
56888058|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
56888059|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888060|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888061|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56888062|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56888063|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
56888064|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
56888065|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888066|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56888067|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56843933|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843934|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843935|NCT05137184|Analgesics|analgesics|mesh-ancestor
56843936|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
56843937|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843938|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56843939|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56843940|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
56843941|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
56843942|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56888068|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888069|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888070|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56888071|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56888072|NCT02920528|Ketamine|ketamine|mesh-list
56888073|NCT02920528|Analgesics|analgesics|mesh-ancestor
56888074|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
56888075|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888076|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888077|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56888078|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56888079|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
56888080|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
56888081|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888082|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56888083|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56888084|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888085|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888086|NCT01068418|Vitamin D|vitamin d|mesh-list
56888087|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
56888088|NCT01068418|Vitamins|vitamins|mesh-ancestor
56888089|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
56888090|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150371|NCT05710146|Tranexamic Acid|tranexamic acid|mesh-list
56888091|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56888092|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56888093|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
56888094|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888095|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888096|NCT03657550|Niacin|niacin|mesh-list
56888097|NCT03657550|Amlodipine|amlodipine|mesh-list
56888098|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56888099|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56888100|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56888101|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888102|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56888103|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888104|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
56888105|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56888106|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
56888107|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56888108|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
56888109|NCT03657550|Vitamins|vitamins|mesh-ancestor
56888110|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
56888111|NCT02920450|Paclitaxel|paclitaxel|mesh-list
56888112|NCT02920450|Carboplatin|carboplatin|mesh-list
56888113|NCT02920450|Gedatolisib|gedatolisib|mesh-list
56888114|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56888115|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888116|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
56888117|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
56888118|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
56888119|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888120|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56888121|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888122|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
56843943|NCT05128734|Temozolomide|temozolomide|mesh-list
56843944|NCT05128734|Olaparib|olaparib|mesh-list
56843945|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56843946|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
56843947|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843948|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843949|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56843950|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843951|NCT05097209|Gemcitabine|gemcitabine|mesh-list
56888123|NCT03622450|Levofloxacin|levofloxacin|mesh-list
56888124|NCT03622450|Gentamicins|gentamicins|mesh-list
56888125|NCT03622450|Meropenem|meropenem|mesh-list
56888126|NCT03622450|Amikacin|amikacin|mesh-list
56888127|NCT03622450|Colistin|colistin|mesh-list
56888128|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56888129|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888130|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56888131|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56888132|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888133|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888134|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888135|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56888136|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56888137|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56888138|NCT03622450|Renal Agents|renal agents|mesh-ancestor
56888139|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56888140|NCT03657862|Fluorides|fluorides|mesh-list
56888141|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
56888142|NCT03657862|Protective Agents|protective agents|mesh-ancestor
56888143|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888144|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
56888145|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56888146|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888147|NCT02919436|Tamsulosin|tamsulosin|mesh-list
56888148|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56888149|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56888150|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56888151|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
56888152|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888153|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888154|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888155|NCT02919436|Urological Agents|urological agents|mesh-ancestor
56888156|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56888157|NCT03657472|Atorvastatin|atorvastatin|mesh-list
56568806|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
56888158|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56888159|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56888160|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
56888161|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888162|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56888163|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56888164|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888165|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56888166|NCT04440358|Carboplatin|carboplatin|mesh-list
56888167|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888168|NCT04438330|Nickel|nickel|mesh-list
56888169|NCT04438330|Trace Elements|trace elements|mesh-ancestor
56888170|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
56888171|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888172|NCT03803475|Edetic Acid|edetic acid|mesh-list
56888173|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56888174|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
56888175|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
56888176|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888177|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
56888178|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56888179|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56843952|NCT05097209|Cisplatin|cisplatin|mesh-list
56843953|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843954|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56843955|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
56843956|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843957|NCT05097209|Antiviral Agents|antiviral agents|mesh-ancestor
56843958|NCT05097209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56843959|NCT05097209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843960|NCT05097209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843961|NCT05097209|Immunologic Factors|immunologic factors|mesh-ancestor
56843962|NCT05097209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843963|NCT05090384|Prednisone|prednisone|mesh-list
56843964|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56843965|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
56843966|NCT05090384|Hormones|hormones|mesh-ancestor
56843967|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843968|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843969|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56843970|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843971|NCT05069038|Palbociclib|palbociclib|mesh-list
56559966|NCT04121611|Analgesics|analgesics|mesh-ancestor
56888180|NCT02682004|Serotonin|serotonin|mesh-list
56888181|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56888182|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
56888183|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888184|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888185|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888186|NCT00005937|Cyclosporine|cyclosporine|mesh-list
56888187|NCT00005937|Cyclosporins|cyclosporins|mesh-list
56888188|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56888189|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888190|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888191|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56888192|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
56888193|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888194|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
56888195|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888196|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
56888197|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56888198|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56888199|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
56888200|NCT01096329|Testosterone|testosterone|mesh-list
56888201|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
56888202|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
56888203|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56888204|NCT01096329|Androgens|androgens|mesh-ancestor
56598953|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
56888205|NCT01096329|Hormones|hormones|mesh-ancestor
56888206|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56888207|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888208|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56888209|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888210|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
56888211|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
56888212|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56843972|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843973|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56843974|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843975|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843976|NCT05067998|Vitamins|vitamins|mesh-list
56843977|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
56843978|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843979|NCT05065411|Everolimus|everolimus|mesh-list
56843980|NCT05065411|Fulvestrant|fulvestrant|mesh-list
56843981|NCT05065411|Exemestane|exemestane|mesh-list
56843982|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843983|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843984|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
56843985|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843986|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56843987|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56843988|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56843989|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
56560018|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56888213|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56888214|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888215|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
56888216|NCT02908516|Coagulants|coagulants|mesh-ancestor
56888217|NCT03717350|Meropenem|meropenem|mesh-list
56888218|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56888219|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888220|NCT03713372|Antibodies|antibodies|mesh-list
56888221|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56888222|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
56888223|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888224|NCT03656614|Neostigmine|neostigmine|mesh-list
56888225|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56888226|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888227|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888228|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
56888229|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888230|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888231|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56888232|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
56888233|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888234|NCT02906644|Nicotine|nicotine|mesh-list
56888235|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56888236|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
56888237|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888238|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888239|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56888240|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56888241|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
56888242|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888243|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888244|NCT02982772|Nicotine|nicotine|mesh-list
56888245|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56888246|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
56888247|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888248|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888249|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56888250|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56888251|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
56843990|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843991|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56888252|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888253|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888254|NCT03713216|Morphine|morphine|mesh-list
56888255|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56888256|NCT03713216|Narcotics|narcotics|mesh-ancestor
56888257|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888258|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888259|NCT03713216|Analgesics|analgesics|mesh-ancestor
56888260|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
56888261|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888262|NCT02098954|Gemcitabine|gemcitabine|mesh-list
56888263|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56888264|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56888265|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
56888266|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888267|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888268|NCT02098954|Antiviral Agents|antiviral agents|mesh-ancestor
56888269|NCT02098954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888270|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888271|NCT02098954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56888272|NCT02098954|Immunologic Factors|immunologic factors|mesh-ancestor
56888273|NCT02098954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888274|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56888275|NCT03655834|Pemetrexed|pemetrexed|mesh-list
56888276|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888277|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888278|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888279|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56888280|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56888281|NCT03488108|Minoxidil|minoxidil|mesh-list
56888282|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56888283|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
56888284|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
56888285|NCT03712670|Aflibercept|aflibercept|mesh-list
56888286|NCT03712670|Carotenoids|carotenoids|mesh-list
56888287|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56888288|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56888289|NCT03712670|Growth Substances|growth substances|mesh-ancestor
56888290|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888291|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
56888292|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888293|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
56888294|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888295|NCT03712670|Protective Agents|protective agents|mesh-ancestor
56888296|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56888297|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56888298|NCT03712670|Analgesics|analgesics|mesh-ancestor
56888299|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
56888300|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888301|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56888302|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56888303|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
56888304|NCT05658380|Atropine|atropine|mesh-list
56888305|NCT05658380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56888306|NCT05658380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56888307|NCT05658380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56888308|NCT05658380|Autonomic Agents|autonomic agents|mesh-ancestor
56888309|NCT05658380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888310|NCT05658380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888311|NCT05658380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56888312|NCT05658380|Respiratory System Agents|respiratory system agents|mesh-ancestor
56888314|NCT05658380|Parasympatholytics|parasympatholytics|mesh-ancestor
56888315|NCT05658380|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56888316|NCT05658380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56888317|NCT05658380|Cholinergic Agents|cholinergic agents|mesh-ancestor
56888318|NCT05658380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888319|NCT05658380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888320|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
56888321|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56888322|NCT03486392|Liraglutide|liraglutide|mesh-list
56843992|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56843993|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843994|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843995|NCT05058651|Cisplatin|cisplatin|mesh-list
56843996|NCT05058651|Carboplatin|carboplatin|mesh-list
56843997|NCT05058651|Etoposide|etoposide|mesh-list
56843998|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
56843999|NCT05058651|Atezolizumab|atezolizumab|mesh-list
56844000|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
56844001|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56844002|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844003|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56844004|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56844005|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56844006|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844007|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844008|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
56844009|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844010|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
56844011|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
56844012|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
56888323|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888324|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888325|NCT03486392|Incretins|incretins|mesh-ancestor
56888326|NCT03486392|Hormones|hormones|mesh-ancestor
56888327|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56888328|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
56888329|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
56888330|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
56888331|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888332|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56888333|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56888334|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56888335|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
56888336|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888337|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888338|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56888339|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56888340|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
56888341|NCT04297150|Apixaban|apixaban|mesh-list
56888342|NCT04297150|Edoxaban|edoxaban|mesh-list
56888343|NCT04297150|Dabigatran|dabigatran|mesh-list
56888344|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56888345|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
56888346|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56888347|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
56888348|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888349|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888350|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
56888351|NCT03486314|Rifampin|rifampin|mesh-list
56888352|NCT03486314|Paclitaxel|paclitaxel|mesh-list
56888353|NCT03486314|Docetaxel|docetaxel|mesh-list
56888354|NCT03486314|Carboplatin|carboplatin|mesh-list
56888355|NCT03486314|Pevonedistat|pevonedistat|mesh-list
56599110|NCT00770224|Hormones|hormones|mesh-ancestor
56888356|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56888357|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844013|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
56844014|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
56844015|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56844016|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56844017|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
56844018|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56844019|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844020|NCT05021991|Pramoxine|pramoxine|mesh-list
56844021|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
56844022|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
56844023|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56844024|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844025|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
56844026|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844027|NCT05001880|Bevacizumab|bevacizumab|mesh-list
56844028|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56844029|NCT05001880|Carboplatin|carboplatin|mesh-list
56888359|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
56888360|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
56888361|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888362|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56888363|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
56888364|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56888365|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888366|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
56888367|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56888368|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888369|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56888370|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56888371|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56888372|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56888373|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56888374|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56888375|NCT02975206|Serlopitant|serlopitant|mesh-list
56888376|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56888377|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888378|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888379|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888380|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56568813|NCT04187014|Coagulants|coagulants|mesh-ancestor
56888381|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56888382|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
56888383|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56888384|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56888385|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56888386|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888387|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888388|NCT02980042|Rituximab|rituximab|mesh-list
56888389|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
56888390|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56888391|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888392|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
56888393|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888394|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56888395|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
56888396|NCT01066000|Hematinics|hematinics|mesh-ancestor
56888397|NCT01065844|Nelfinavir|nelfinavir|mesh-list
56888398|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56844031|NCT05001880|Atezolizumab|atezolizumab|mesh-list
56844032|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
56844033|NCT05001880|Antibodies|antibodies|mesh-list
56844034|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
56844035|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56844036|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
56844037|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844038|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56844039|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56844040|NCT05001880|Growth Substances|growth substances|mesh-ancestor
56844041|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844042|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
56844043|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
56844044|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844045|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888399|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56888400|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
56888401|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888402|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888403|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56888404|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56888405|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
56888406|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888407|NCT00004635|Thalidomide|thalidomide|mesh-list
56888408|NCT00004635|Leuprolide|leuprolide|mesh-list
56888409|NCT00004635|Goserelin|goserelin|mesh-list
56888410|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56888411|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
56888412|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888413|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
56888414|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56888415|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888416|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56888417|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56888418|NCT00004635|Growth Substances|growth substances|mesh-ancestor
56888419|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
56888420|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888421|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56888422|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
56888423|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56888424|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56888425|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
56888426|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56888427|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
56888428|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888429|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56888430|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56888431|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
56888432|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888433|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888434|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56888435|NCT03951051|Olmesartan|olmesartan|mesh-list
56888436|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56888437|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56888438|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56888439|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56888440|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888441|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
56888442|NCT01103115|Vitamin D|vitamin d|mesh-list
56888443|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
56888444|NCT01103115|Calcium|calcium|mesh-list
56054371|NCT01280643|Capecitabine|capecitabine|mesh-list
56844046|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56844047|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56844048|NCT05001776|PENTA|penta|mesh-list
56844049|NCT05001776|Fondaparinux|fondaparinux|mesh-list
56844050|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56844051|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
56844052|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56844053|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
56844054|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560318|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
56888445|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56888446|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888447|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56888448|NCT01103115|Vitamins|vitamins|mesh-ancestor
56888449|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
56888450|NCT01103115|Antacids|antacids|mesh-ancestor
56888451|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888452|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56888453|NCT01103193|Remifentanil|remifentanil|mesh-list
56888454|NCT01103193|Sevoflurane|sevoflurane|mesh-list
56888455|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56888456|NCT01103193|Narcotics|narcotics|mesh-ancestor
56888457|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888458|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888459|NCT01103193|Analgesics|analgesics|mesh-ancestor
56888460|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
56888461|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888462|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56888463|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56888464|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
56888465|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
56888466|NCT03949101|Atropine|atropine|mesh-list
56888467|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56888468|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56888469|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56888470|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56888471|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56888472|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
56888473|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888474|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888475|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56888476|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
56888477|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
56888478|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
56888479|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56888480|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56888481|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
56888482|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888483|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888484|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
56888485|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56888486|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
56888487|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56888488|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888489|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56888490|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56888491|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56888492|NCT00003645|Leuprolide|leuprolide|mesh-list
56888493|NCT00003645|Goserelin|goserelin|mesh-list
56888494|NCT00003645|Flutamide|flutamide|mesh-list
56888495|NCT00003645|Bicalutamide|bicalutamide|mesh-list
56888496|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56888497|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
56888498|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56888499|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888500|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56888501|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888502|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
56844055|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844056|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
56844057|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56844058|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56844059|NCT04991974|Buprenorphine|buprenorphine|mesh-list
56844060|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56844061|NCT04991974|Naloxone|naloxone|mesh-list
56844062|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56844063|NCT04991974|Narcotics|narcotics|mesh-ancestor
56844064|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56844065|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844066|NCT04991974|Analgesics|analgesics|mesh-ancestor
56844067|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
56844068|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844069|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56844070|NCT04977479|Vaccines|vaccines|mesh-list
56844071|NCT04977479|Immunologic Factors|immunologic factors|mesh-ancestor
56844072|NCT04977479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844073|NCT04971473|Hormones|hormones|mesh-list
56844074|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560389|NCT01706692|Analgesics|analgesics|mesh-ancestor
56888503|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
56888504|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56888505|NCT02918968|Flutamide|flutamide|mesh-list
56888506|NCT02918968|Androgens|androgens|mesh-list
56888507|NCT02918968|Hormones|hormones|mesh-ancestor
56599253|NCT00620295|Gemcitabine|gemcitabine|mesh-list
56888508|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56888509|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888511|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
56888512|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56888513|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888514|NCT01065766|Metformin|metformin|mesh-list
56888515|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56888516|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888517|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888518|NCT01065766|Incretins|incretins|mesh-ancestor
56888519|NCT01065766|Hormones|hormones|mesh-ancestor
56888520|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56888521|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56888522|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
56888523|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888524|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888525|NCT03653260|Lidocaine|lidocaine|mesh-list
56888526|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
56888527|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
56888528|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888529|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888530|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
56888531|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888532|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56888533|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56888534|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56888535|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56844075|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844076|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56844077|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844078|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844079|NCT04943588|Antibodies|antibodies|mesh-list
56844080|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
56888536|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888537|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56888538|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56888539|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56888540|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888541|NCT04054960|Levodopa|levodopa|mesh-list
56888542|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56888543|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56888544|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
56888545|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888546|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888547|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888548|NCT00042939|Docetaxel|docetaxel|mesh-list
56888549|NCT00042939|Irinotecan|irinotecan|mesh-list
56888550|NCT00042939|Cetuximab|cetuximab|mesh-list
56888551|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888552|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
56888553|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
56888554|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
56888555|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888556|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56888557|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56888558|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888559|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56888560|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
56888561|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56888562|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56888563|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888564|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
56888565|NCT04055194|Coagulants|coagulants|mesh-ancestor
56888566|NCT04252612|Pramlintide|pramlintide|mesh-list
56888567|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888568|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888569|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
56888570|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888571|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
56888572|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888573|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888574|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56888575|NCT02530047|Interferons|interferons|mesh-list
56888576|NCT02530047|Interferon-beta|interferon-beta|mesh-list
56888577|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888578|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
56888579|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888580|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
56888581|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888582|NCT02529969|Curcumin|curcumin|mesh-list
56888583|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56888584|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56888585|NCT02529969|Analgesics|analgesics|mesh-ancestor
56888586|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
56888587|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888588|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888589|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56888590|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56888591|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888592|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888593|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888594|NCT01584687|Omalizumab|omalizumab|mesh-list
56888595|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56888596|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56888597|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
56888598|NCT01101789|Triclosan|triclosan|mesh-list
56844081|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
56844082|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844083|NCT04917692|Empagliflozin|empagliflozin|mesh-list
56844084|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56844085|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844086|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56844087|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844088|NCT04915248|Dexamethasone|dexamethasone|mesh-list
56844089|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
56844090|NCT04915248|Bortezomib|bortezomib|mesh-list
56844091|NCT04915248|Daratumumab|daratumumab|mesh-list
56844092|NCT04915248|BB 1101|bb 1101|mesh-list
56888599|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56888600|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888601|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56888602|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56888603|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
56888604|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888605|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56888606|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
56888607|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888608|NCT01103739|Simvastatin|simvastatin|mesh-list
56888609|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56888610|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56888611|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
56888612|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888613|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56888614|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56888615|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888616|NCT04054024|Erenumab|erenumab|mesh-list
56888617|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56888618|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888619|NCT04054024|Analgesics|analgesics|mesh-ancestor
56888620|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
56888621|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888622|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888623|NCT00002931|Paclitaxel|paclitaxel|mesh-list
56888624|NCT00002931|Etoposide|etoposide|mesh-list
56888625|NCT00002931|Carboplatin|carboplatin|mesh-list
56888626|NCT00002931|Ifosfamide|ifosfamide|mesh-list
56888627|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56888628|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888629|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
56888630|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
56888631|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
56888632|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888633|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56888634|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56888635|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888636|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56888637|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
56888638|NCT02918266|Scopolamine|scopolamine|mesh-list
56888639|NCT02918266|Donepezil|donepezil|mesh-list
56888640|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56888641|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56888642|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888643|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888644|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
56888645|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888646|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888647|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
56888648|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56888649|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
56888650|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
56844093|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56844094|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56844095|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
56844096|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
56844097|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844098|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844099|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56844100|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
56844101|NCT04915248|Hormones|hormones|mesh-ancestor
56844102|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844103|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56844104|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844105|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
56844106|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844107|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844108|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
56844109|NCT04903197|Lenalidomide|lenalidomide|mesh-list
56844110|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
56844111|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560579|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
56888651|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888652|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56888653|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
56888654|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56888655|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56888656|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
56888658|NCT00041067|Trastuzumab|trastuzumab|mesh-list
56888659|NCT00041067|Vinorelbine|vinorelbine|mesh-list
56888660|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888661|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
56888662|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
56888663|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
56888664|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888665|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56888666|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56888667|NCT01063036|Tenofovir|tenofovir|mesh-list
56888668|NCT01063036|Entecavir|entecavir|mesh-list
56888669|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
56888670|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888671|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56888672|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56888673|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888674|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888675|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56888676|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56888677|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
56888678|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56888679|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56888680|NCT03652480|Prednisolone|prednisolone|mesh-list
56888681|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
56888682|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56888683|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
56888684|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56888685|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
56888686|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
56888687|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844112|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56844113|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56844114|NCT04903197|Growth Substances|growth substances|mesh-ancestor
56844115|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
56844116|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844117|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
56844118|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
56844119|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844120|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
56844121|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56844122|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56844123|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560653|NCT01130051|Colchicine|colchicine|mesh-list
56888688|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888689|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56888690|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
56888691|NCT03652480|Hormones|hormones|mesh-ancestor
56888692|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56888693|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56888694|NCT03652480|Protective Agents|protective agents|mesh-ancestor
56888695|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56888696|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888697|NCT03622060|Nicardipine|nicardipine|mesh-list
56888698|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
56888699|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
56888700|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56888701|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56888702|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56888703|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888704|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56888705|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888706|NCT00040365|Amifostine|amifostine|mesh-list
56888707|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56888708|NCT00040365|Protective Agents|protective agents|mesh-ancestor
56888709|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888710|NCT02974114|Acetaminophen|acetaminophen|mesh-list
56888711|NCT02974114|Caffeine|caffeine|mesh-list
56888712|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56888713|NCT02974114|Analgesics|analgesics|mesh-ancestor
56888714|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
56888715|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888716|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888717|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
56888718|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56888719|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56888720|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888721|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888722|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56888723|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56888724|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
56888725|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888726|NCT00001959|Pirfenidone|pirfenidone|mesh-list
56888727|NCT00001959|Analgesics|analgesics|mesh-ancestor
56888728|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
56888729|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888730|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888731|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56888732|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56888733|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56888734|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56888735|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844124|NCT04898114|Urological Agents|urological agents|mesh-ancestor
56844125|NCT04898114|Analgesics|analgesics|mesh-ancestor
56844126|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
56844127|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844128|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844129|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
56844130|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56844131|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56844132|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
56844133|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56844134|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56844135|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56844136|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
56844137|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56844138|NCT04893785|Temozolomide|temozolomide|mesh-list
56888736|NCT03950505|Pioglitazone|pioglitazone|mesh-list
56888737|NCT03950505|Alogliptin|alogliptin|mesh-list
56888738|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888739|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888740|NCT03950505|Incretins|incretins|mesh-ancestor
56888741|NCT03950505|Hormones|hormones|mesh-ancestor
56888742|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56888743|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56888744|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
56888745|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888746|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888747|NCT00001941|Daclizumab|daclizumab|mesh-list
56888748|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56888749|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
56888750|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888751|NCT01061866|Thalidomide|thalidomide|mesh-list
56888752|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56888753|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
56888754|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888755|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
56888756|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56888757|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888758|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56888759|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56888760|NCT01061866|Growth Substances|growth substances|mesh-ancestor
56888761|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
56888762|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888764|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
56888765|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888766|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888767|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
56888768|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888769|NCT03948477|Pantoprazole|pantoprazole|mesh-list
56888770|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56888771|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56888772|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56888773|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888774|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888775|NCT03953781|Levetiracetam|levetiracetam|mesh-list
56888776|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
56888777|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
56888778|NCT01103817|Vitamin D|vitamin d|mesh-list
56888779|NCT01103817|Vitamins|vitamins|mesh-ancestor
56888780|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
56888781|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888782|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56844139|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56844140|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
56844141|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844142|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844143|NCT04892446|Dexamethasone|dexamethasone|mesh-list
56888783|NCT01102101|Remifentanil|remifentanil|mesh-list
56888784|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56888785|NCT01102101|Narcotics|narcotics|mesh-ancestor
56888786|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888787|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888788|NCT01102101|Analgesics|analgesics|mesh-ancestor
56888789|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
56888790|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56888791|NCT03950271|Capecitabine|capecitabine|mesh-list
56888792|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
56888793|NCT03950271|Trastuzumab|trastuzumab|mesh-list
56888794|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56888795|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
56888796|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888797|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888798|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56888799|NCT01102335|Telbivudine|telbivudine|mesh-list
56888800|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
56888801|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888802|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56888803|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599556|NCT03551691|Omeprazole|omeprazole|mesh-list
56888804|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888805|NCT02973100|Dulaglutide|dulaglutide|mesh-list
56888806|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888807|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888808|NCT01105611|Ritonavir|ritonavir|mesh-list
56888809|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56888810|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
56888811|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56888812|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56888813|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
56888814|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888815|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888816|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56888817|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56888818|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
56888819|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888820|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56888821|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56888822|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56888823|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56888824|NCT05497557|Omeprazole|omeprazole|mesh-list
56888825|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56888826|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56888827|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56888828|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888829|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888830|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56888831|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56888832|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
56888833|NCT05415267|Vaccines|vaccines|mesh-list
56888834|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
56888835|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888836|NCT03948243|Tolbutamide|tolbutamide|mesh-list
56888837|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
56888838|NCT03948243|Alprazolam|alprazolam|mesh-list
56888839|NCT03948243|Caffeine|caffeine|mesh-list
56888840|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56888841|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888842|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56888843|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888844|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888845|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56888846|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56844144|NCT04892446|Bortezomib|bortezomib|mesh-list
56844145|NCT04892446|Daratumumab|daratumumab|mesh-list
56844146|NCT04892446|Pomalidomide|pomalidomide|mesh-list
56844147|NCT04892446|Magrolimab|magrolimab|mesh-list
56844148|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56844149|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
56844150|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
56844151|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844152|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844153|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56844154|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
56844155|NCT04892446|Hormones|hormones|mesh-ancestor
56844156|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844157|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56888847|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
56888848|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888849|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
56888850|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
56888851|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56888852|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56888853|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56888854|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888855|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56888856|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56888857|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56888858|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
56888859|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
56888860|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888861|NCT01482286|Metformin|metformin|mesh-list
56888862|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56888863|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888864|NCT03651934|Iron|iron|mesh-list
56888865|NCT03651934|Selenium|selenium|mesh-list
56888866|NCT03651934|Trace Elements|trace elements|mesh-ancestor
56888867|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
56888868|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888869|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
56888870|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888871|NCT03651934|Protective Agents|protective agents|mesh-ancestor
56888872|NCT02972632|Vortioxetine|vortioxetine|mesh-list
56888873|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
56888874|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56888875|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56888876|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56888877|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888878|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888879|NCT02972632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56888880|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56888881|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56888882|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888883|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888884|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
56888885|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56888886|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56888887|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56888888|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56888889|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
56888890|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
56888891|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
56888892|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888893|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888894|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
56888895|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844158|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844159|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
56844160|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56844161|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56844162|NCT04892446|Growth Substances|growth substances|mesh-ancestor
56844163|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
56844164|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844165|NCT04881747|Lasmiditan|lasmiditan|mesh-list
56844166|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56844167|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
56844168|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56844169|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844170|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888896|NCT01327521|Gemcitabine|gemcitabine|mesh-list
56888898|NCT01327521|Doxorubicin|doxorubicin|mesh-list
56888899|NCT01327521|Fluorouracil|fluorouracil|mesh-list
56888900|NCT01327521|Epirubicin|epirubicin|mesh-list
56888901|NCT01327521|Mitomycins|mitomycins|mesh-list
56888902|NCT01327521|Mitomycin|mitomycin|mesh-list
56888903|NCT01327521|Maleic acid|maleic acid|mesh-list
56888904|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888905|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56888906|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
56888907|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888908|NCT01327521|Antiviral Agents|antiviral agents|mesh-ancestor
56888909|NCT01327521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56888910|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888911|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56888912|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
56888913|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888914|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56888915|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56888916|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56888917|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
56888918|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56888919|NCT04899921|Nivolumab|nivolumab|mesh-list
56888920|NCT04899921|Ipilimumab|ipilimumab|mesh-list
56888921|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56888922|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888923|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56888924|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888925|NCT01104519|Niacin|niacin|mesh-list
56888926|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
56888927|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56888928|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
56888929|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888930|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56888931|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
56888932|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
56888933|NCT01104519|Vitamins|vitamins|mesh-ancestor
56888934|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
56888935|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888936|NCT03944733|Iron|iron|mesh-list
56888937|NCT03944733|Trace Elements|trace elements|mesh-ancestor
56888938|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
56888939|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888940|NCT01060384|Lenalidomide|lenalidomide|mesh-list
56888941|NCT01060384|Ofatumumab|ofatumumab|mesh-list
56888942|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
56888943|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888944|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56888945|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56888946|NCT01060384|Growth Substances|growth substances|mesh-ancestor
56888947|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
56844171|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
56844172|NCT04880434|Fludarabine|fludarabine|mesh-list
56844173|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844174|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
56844175|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844176|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56844177|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56844178|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
56844179|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844180|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844181|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56844182|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
56844183|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844184|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844185|NCT04869943|Exemestane|exemestane|mesh-list
56844186|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844187|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56844188|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56844189|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888948|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888949|NCT01328223|Sorafenib|sorafenib|mesh-list
56888950|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888951|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56888952|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56888953|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888954|NCT03961971|Spartalizumab|spartalizumab|mesh-list
56888955|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56888956|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888957|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888958|NCT01060150|Methylphenidate|methylphenidate|mesh-list
56888959|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56888960|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888961|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56888962|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56888963|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56888964|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888965|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
56888966|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888967|NCT03863223|Docetaxel|docetaxel|mesh-list
56888968|NCT03863223|Trastuzumab|trastuzumab|mesh-list
56888969|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56888970|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
56888971|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
56888972|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
56888973|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888974|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56888975|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
56888976|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
56888977|NCT02970292|Pimavanserin|pimavanserin|mesh-list
56888978|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56888979|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56888980|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56888981|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56888982|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151271|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
56888983|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844190|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844191|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56844192|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
56844193|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844194|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844195|NCT04862949|Bevacizumab|bevacizumab|mesh-list
56844196|NCT04862949|Atezolizumab|atezolizumab|mesh-list
56844197|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56888984|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56888985|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56888986|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56888987|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
56888988|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56888989|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888990|NCT03944655|Anesthetics|anesthetics|mesh-list
56888991|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56888992|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888993|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
56888994|NCT05276895|Quercetin|quercetin|mesh-list
56888995|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
56888996|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56888997|NCT05276895|Protective Agents|protective agents|mesh-ancestor
56888998|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56888999|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56889000|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
56889001|NCT02971228|Glucagon|glucagon|mesh-list
56889002|NCT02971228|Pancrelipase|pancrelipase|mesh-list
56889003|NCT02971228|Pancreatin|pancreatin|mesh-list
56889004|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56889005|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56889006|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889007|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889008|NCT02971228|Hormones|hormones|mesh-ancestor
56889009|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889010|NCT02971228|Incretins|incretins|mesh-ancestor
56889011|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56889012|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56889013|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
56889014|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56889015|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56889016|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889017|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
56889018|NCT03741075|Coagulants|coagulants|mesh-ancestor
56889019|NCT01104987|Alendronate|alendronate|mesh-list
56889020|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56889021|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889022|NCT01106235|Aldesleukin|aldesleukin|mesh-list
56889023|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
56889024|NCT01106235|Interleukin-2|interleukin-2|mesh-list
56889025|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56889026|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
56889027|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889028|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56889029|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56889030|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
56889031|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889032|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889033|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56889034|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56889035|NCT01106235|Analgesics|analgesics|mesh-ancestor
56889036|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
56889037|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889039|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56889040|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
56889041|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889042|NCT02969590|Leuprolide|leuprolide|mesh-list
56889043|NCT02969590|Norethindrone|norethindrone|mesh-list
56844198|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844199|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56844200|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56844201|NCT04862949|Growth Substances|growth substances|mesh-ancestor
56844202|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844203|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
56844204|NCT04862663|Fulvestrant|fulvestrant|mesh-list
56844205|NCT04862663|Palbociclib|palbociclib|mesh-list
56844206|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56844207|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844208|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56844209|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56889044|NCT02969590|Estradiol|estradiol|mesh-list
56889045|NCT02969590|Estrogens|estrogens|mesh-list
56889046|NCT02969590|Progesterone|progesterone|mesh-list
56889047|NCT02969590|Progestins|progestins|mesh-list
56889048|NCT02969590|Hormones|hormones|mesh-ancestor
56889049|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889050|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889051|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56889052|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
56889053|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56889054|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56889055|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56889056|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
56889057|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56889058|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889059|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56889060|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56889061|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56889062|NCT03650998|Ropivacaine|ropivacaine|mesh-list
56889063|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
56889064|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
56889065|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56889066|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889067|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
56889068|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889069|NCT04053400|Ketamine|ketamine|mesh-list
56889070|NCT04053400|Analgesics|analgesics|mesh-ancestor
56889071|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
56889072|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889073|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889074|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56889075|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56889076|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
56889077|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
56889078|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56889079|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56889080|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56889081|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889082|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889083|NCT03345849|Upadacitinib|upadacitinib|mesh-list
56889084|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56889085|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56889086|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889087|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889088|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56889089|NCT01109043|Bisoprolol|bisoprolol|mesh-list
56889090|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56889091|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
56889092|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
56889093|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889094|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844210|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
56844211|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844212|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844213|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56844214|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844215|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844216|NCT04848974|Cytarabine|cytarabine|mesh-list
56889095|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56889096|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56889097|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56889098|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
56889099|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889100|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889101|NCT01109121|Allopurinol|allopurinol|mesh-list
56889102|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
56889103|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889104|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889105|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
56889106|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56889107|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56889108|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
56889109|NCT01109121|Protective Agents|protective agents|mesh-ancestor
56599850|NCT01007552|Gemcitabine|gemcitabine|mesh-list
56889110|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889112|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56889113|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56889114|NCT01106547|Prednisolone|prednisolone|mesh-list
56889115|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
56889116|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56889117|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
56889118|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56889119|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
56889120|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
56889121|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889122|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889123|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889124|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
56889125|NCT01106547|Hormones|hormones|mesh-ancestor
56889126|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889127|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56889128|NCT01106547|Protective Agents|protective agents|mesh-ancestor
56889129|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56889130|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889131|NCT01105299|Anastrozole|anastrozole|mesh-list
56889132|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56889133|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889134|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56889135|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56889137|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889138|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56889139|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
56889140|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889141|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889142|NCT03947229|Clopidogrel|clopidogrel|mesh-list
56889143|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56889144|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56889145|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56889146|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56889147|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
56889148|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889149|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889150|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889151|NCT03011307|Oxytocin|oxytocin|mesh-list
56889152|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
56889153|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56844217|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56844218|NCT04848974|Cladribine|cladribine|mesh-list
56844219|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56844220|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
56844221|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844222|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844223|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
56844224|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844225|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844226|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
56844227|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844228|NCT04844866|Gemcitabine|gemcitabine|mesh-list
56844229|NCT04844866|Rituximab|rituximab|mesh-list
56844230|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
56844231|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56844232|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56844233|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
56844234|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844235|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889154|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889155|NCT01327755|Selenium|selenium|mesh-list
56889156|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
56889157|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889158|NCT01327755|Protective Agents|protective agents|mesh-ancestor
56889159|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889160|NCT01327755|Trace Elements|trace elements|mesh-ancestor
56889161|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
56889162|NCT01848639|Spironolactone|spironolactone|mesh-list
56889163|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56889164|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
56889165|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889166|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889167|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56889168|NCT01848639|Diuretics|diuretics|mesh-ancestor
56889169|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
56889170|NCT04537923|Insulin|insulin|mesh-list
56889171|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56889172|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
56889173|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
56889174|NCT04537923|Tirzepatide|tirzepatide|mesh-list
56889175|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56889176|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889177|NCT04537923|Incretins|incretins|mesh-ancestor
56889178|NCT04537923|Hormones|hormones|mesh-ancestor
56889179|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889180|NCT04523493|Lenvatinib|lenvatinib|mesh-list
56889181|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889182|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56889183|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889184|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889185|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
56889186|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56889187|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
56889188|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56889189|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889190|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56889191|NCT01118793|Clopidogrel|clopidogrel|mesh-list
56889192|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56844236|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
56844237|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844238|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56844239|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56844240|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
56844241|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844242|NCT04844866|Antiviral Agents|antiviral agents|mesh-ancestor
56844243|NCT04844866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844244|NCT04844866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889193|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56889194|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56889195|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56889196|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
56889197|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889198|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889199|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889200|NCT00127335|Atorvastatin|atorvastatin|mesh-list
56889201|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56889202|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56889203|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
56889204|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889205|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56889206|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56889207|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889209|NCT01109511|Naloxone|naloxone|mesh-list
56889210|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56889211|NCT01109511|Narcotics|narcotics|mesh-ancestor
56889212|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56889213|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889214|NCT01109511|Analgesics|analgesics|mesh-ancestor
56889215|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
56889216|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889217|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56889218|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56889219|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889220|NCT01112085|Ranibizumab|ranibizumab|mesh-list
56889221|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56889222|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56889223|NCT01112085|Growth Substances|growth substances|mesh-ancestor
56889224|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889225|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
56889226|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889227|NCT01328301|Methamphetamine|methamphetamine|mesh-list
56889228|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56889229|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889230|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
56889231|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
56889232|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889233|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
56889234|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889235|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889236|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
56889237|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56889238|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56889239|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56889240|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56889241|NCT01328457|Paromomycin|paromomycin|mesh-list
56889242|NCT01328457|Neomycin|neomycin|mesh-list
56889243|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889244|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889245|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56889246|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56889247|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56889248|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054372|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
56844245|NCT04844866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844246|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56844247|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
56844248|NCT04840823|Enoxacin|enoxacin|mesh-list
56844249|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56844250|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844251|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56844252|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56844253|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844254|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561326|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
56889249|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889250|NCT01109823|Levofloxacin|levofloxacin|mesh-list
56889251|NCT01109823|Ofloxacin|ofloxacin|mesh-list
56889252|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56889253|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889254|NCT01109823|Renal Agents|renal agents|mesh-ancestor
56889255|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889256|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56889257|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56889258|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889259|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889260|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889261|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56889262|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56889263|NCT03943407|Imiquimod|imiquimod|mesh-list
56889264|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
56889265|NCT03943407|Doxepin|doxepin|mesh-list
56889266|NCT03943407|Menthol|menthol|mesh-list
56889267|NCT03943407|Histamine|histamine|mesh-list
56889268|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
56889269|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
56889270|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
56889271|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
56889272|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889273|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889274|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889275|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56889276|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
56889277|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889278|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
56889279|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56889280|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56889281|NCT03943407|Protective Agents|protective agents|mesh-ancestor
56889282|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56889283|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56889285|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56889286|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
56889287|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56889288|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
56889289|NCT01209351|Teduglutide|teduglutide|mesh-list
56889290|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889291|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56889292|NCT01209351|Protective Agents|protective agents|mesh-ancestor
56889293|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889294|NCT02529579|Gemcitabine|gemcitabine|mesh-list
56889295|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56889296|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
56889297|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889298|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889299|NCT02529579|Antiviral Agents|antiviral agents|mesh-ancestor
56889300|NCT02529579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889301|NCT02529579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889302|NCT02529579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56889303|NCT02529579|Immunologic Factors|immunologic factors|mesh-ancestor
56844255|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844256|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56844257|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56844258|NCT04825704|Bupivacaine|bupivacaine|mesh-list
56844259|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
56844260|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
56844261|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56844262|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844263|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
56844264|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844265|NCT04781959|Lenograstim|lenograstim|mesh-list
56844266|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56844267|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
56844268|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844269|NCT04777851|Nivolumab|nivolumab|mesh-list
56844270|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844271|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844272|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844273|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844274|NCT04729608|Paclitaxel|paclitaxel|mesh-list
56889304|NCT02529579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889305|NCT01209429|Hormones|hormones|mesh-list
56889306|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889307|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889308|NCT01110291|Docetaxel|docetaxel|mesh-list
56889309|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889310|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
56889311|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
56889312|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
56889313|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889314|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56889315|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
56889316|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56889317|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56889318|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889319|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889320|NCT01207947|Urological Agents|urological agents|mesh-ancestor
56889321|NCT01107639|Docetaxel|docetaxel|mesh-list
56889322|NCT01107639|Cetuximab|cetuximab|mesh-list
56889323|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889324|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
56889325|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
56889326|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
56889327|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889328|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56889329|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
56889330|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56889331|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56889332|NCT03942861|Prednisolone|prednisolone|mesh-list
56889334|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56889335|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
56889336|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56889337|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
56889338|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
56844275|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56844276|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844277|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
56844278|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
56844279|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
56844280|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844281|NCT04712903|Carboplatin|carboplatin|mesh-list
56889339|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889340|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889341|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889342|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
56889343|NCT03942861|Hormones|hormones|mesh-ancestor
56889344|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889345|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56889346|NCT03942861|Protective Agents|protective agents|mesh-ancestor
56889347|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56889348|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889349|NCT01107951|Dexamethasone|dexamethasone|mesh-list
56889350|NCT01107951|Rituximab|rituximab|mesh-list
56889351|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56889352|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889353|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
56889354|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889355|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56889356|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56889357|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
56889358|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
56889359|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889360|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889361|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
56889362|NCT01107951|Hormones|hormones|mesh-ancestor
56889363|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889364|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56889365|NCT01108029|Memantine|memantine|mesh-list
56889366|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56889367|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56889368|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
56889369|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889370|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889371|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889372|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56889373|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56889374|NCT03941925|Levan|levan|mesh-list
56889375|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889376|NCT01110603|Paclitaxel|paclitaxel|mesh-list
56889377|NCT01110603|Carboplatin|carboplatin|mesh-list
56889378|NCT01110603|Doxorubicin|doxorubicin|mesh-list
56889379|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56889380|NCT01110603|Niraparib|niraparib|mesh-list
56889381|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56889382|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889383|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
56889384|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
56889385|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
56889386|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889387|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56889388|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56889389|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56889390|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889391|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56889392|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
56889393|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56889394|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889395|NCT01112787|Tazarotene|tazarotene|mesh-list
56889396|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
56889397|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
56889398|NCT01108107|Capecitabine|capecitabine|mesh-list
56889399|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
56889400|NCT01108107|Panitumumab|panitumumab|mesh-list
56844282|NCT04712903|Etoposide|etoposide|mesh-list
56844283|NCT04712903|Durvalumab|durvalumab|mesh-list
56844284|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844285|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56844286|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56844287|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56844288|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844289|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561507|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
56889401|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56889402|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
56889403|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889404|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889405|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56889406|NCT01111227|Propofol|propofol|mesh-list
56889407|NCT01111227|Isoflurane|isoflurane|mesh-list
56889408|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56889409|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56889410|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889411|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56889412|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
56889413|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
56889414|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56889415|NCT01111383|Tobramycin|tobramycin|mesh-list
56889416|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889417|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889418|NCT01208649|Exenatide|exenatide|mesh-list
56889419|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56889420|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889421|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56889422|NCT01208649|Incretins|incretins|mesh-ancestor
56889423|NCT01208649|Hormones|hormones|mesh-ancestor
56889424|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889425|NCT01211847|Diazoxide|diazoxide|mesh-list
56889426|NCT01211847|Choline|choline|mesh-list
56889427|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
56889428|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56889429|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
56889430|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889431|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889432|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56889433|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
56889434|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56889435|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
56889436|NCT01210287|Lamivudine|lamivudine|mesh-list
56889437|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56889438|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56889439|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889440|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889441|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
56889442|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889443|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56889444|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56889445|NCT01211925|Aspirin|aspirin|mesh-list
56889446|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56889447|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56889448|NCT01211925|Analgesics|analgesics|mesh-ancestor
56889449|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
56889450|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889451|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889452|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56889453|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56889454|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56889455|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56889456|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889457|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56844290|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844291|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
56844292|NCT04710277|Narcotics|narcotics|mesh-ancestor
56844293|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56844294|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844295|NCT04710277|Analgesics|analgesics|mesh-ancestor
56844296|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
56844297|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844298|NCT04708470|Entinostat|entinostat|mesh-list
56844299|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844300|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56844301|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844302|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844303|NCT04697628|Gemcitabine|gemcitabine|mesh-list
56844304|NCT04697628|Irinotecan|irinotecan|mesh-list
56844305|NCT04697628|Pemetrexed|pemetrexed|mesh-list
56844306|NCT04697628|Topotecan|topotecan|mesh-list
56844307|NCT04697628|Vinorelbine|vinorelbine|mesh-list
56889458|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56889459|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889460|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
56889461|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
56889462|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56889463|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56889464|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56889465|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
56889466|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889467|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56889468|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56889469|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889470|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889471|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56889472|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56889473|NCT01328145|Aspirin|aspirin|mesh-list
56889474|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56889475|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56889476|NCT01328145|Analgesics|analgesics|mesh-ancestor
56889477|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
56889478|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889479|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889480|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56889481|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56889482|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56889483|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56889484|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889485|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56889486|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56889487|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889488|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
56889490|NCT01210521|Vitamins|vitamins|mesh-ancestor
56889491|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
56889492|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889493|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56889494|NCT01210599|Pamidronate|pamidronate|mesh-list
56889495|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56889496|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889497|NCT03944889|Capsaicin|capsaicin|mesh-list
56889498|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
56889499|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
56844308|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
56844309|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56844310|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
56844311|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844312|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844313|NCT04697628|Antiviral Agents|antiviral agents|mesh-ancestor
56844314|NCT04697628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844315|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844316|NCT04697628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844317|NCT04697628|Immunologic Factors|immunologic factors|mesh-ancestor
56889500|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
56889501|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889502|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889503|NCT01210677|Prednisone|prednisone|mesh-list
56889504|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56889505|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
56889506|NCT01210677|Hormones|hormones|mesh-ancestor
56889507|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889508|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889509|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56889510|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889512|NCT01210755|Dabigatran|dabigatran|mesh-list
56889513|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56889514|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
56889515|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56889516|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
56889517|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889518|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889519|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
56889520|NCT01210911|Metformin|metformin|mesh-list
56889521|NCT01210911|Gemcitabine|gemcitabine|mesh-list
56889522|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56889523|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56889524|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
56889525|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889526|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889527|NCT01210911|Antiviral Agents|antiviral agents|mesh-ancestor
56889528|NCT01210911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889529|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889530|NCT01210911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56889531|NCT01210911|Immunologic Factors|immunologic factors|mesh-ancestor
56889532|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889533|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56889534|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56889535|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
56889536|NCT01115049|Hexetidine|hexetidine|mesh-list
56889537|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56889538|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889539|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
56889540|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
56889541|NCT03941535|Vitamin K|vitamin k|mesh-list
56889542|NCT03941535|Vitamins|vitamins|mesh-ancestor
56889543|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
56889544|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889545|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56889546|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56889547|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889548|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
56889549|NCT03941535|Coagulants|coagulants|mesh-ancestor
56889550|NCT01115127|Inositol|inositol|mesh-list
56889551|NCT01115127|Melatonin|melatonin|mesh-list
56889552|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
56889553|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889554|NCT01115127|Protective Agents|protective agents|mesh-ancestor
56889555|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889556|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56889557|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
56844318|NCT04697628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844319|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56844320|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56844321|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56844322|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56844323|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56844324|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
56889558|NCT01115127|Vitamins|vitamins|mesh-ancestor
56889559|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
56889560|NCT01211223|Amoxicillin|amoxicillin|mesh-list
56889561|NCT01211223|Metronidazole|metronidazole|mesh-list
56889562|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889563|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889564|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56889565|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56889566|NCT01113489|Beclomethasone|beclomethasone|mesh-list
56889567|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56889568|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
56889569|NCT01113489|Hormones|hormones|mesh-ancestor
56889570|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889571|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889572|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56889573|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
56889574|NCT01115439|Artesunate|artesunate|mesh-list
56889575|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
56889576|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
56889577|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56889578|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
56889579|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56889580|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56889581|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889582|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889583|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
56889584|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
56889585|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56151878|NCT04929834|Emollients|emollients|mesh-list
56889586|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
56889587|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56889588|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889589|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889590|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56889591|NCT01115439|Renal Agents|renal agents|mesh-ancestor
56889592|NCT01212315|Triclosan|triclosan|mesh-list
56889593|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56889594|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889595|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56889596|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56889597|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
56889598|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889599|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56889600|NCT03938259|Fentanyl|fentanyl|mesh-list
56889601|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56889602|NCT03938259|Narcotics|narcotics|mesh-ancestor
56889603|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56889604|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889605|NCT03938259|Analgesics|analgesics|mesh-ancestor
56889606|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
56889607|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889608|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56889609|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56889610|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
56889611|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
56889612|NCT03939663|Misoprostol|misoprostol|mesh-list
56889613|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56889614|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
56889615|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56889616|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889617|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56889618|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889619|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
56844325|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555114|NCT00673621|Miotics|miotics|mesh-ancestor
56844326|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
56844327|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844328|NCT04677049|Niacin|niacin|mesh-list
56844329|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
56844330|NCT04677049|Vitamins|vitamins|mesh-ancestor
56844331|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
56844332|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844333|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
56844334|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56844335|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
56844336|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844337|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56844338|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
56844339|NCT04652245|Fluticasone|fluticasone|mesh-list
56844340|NCT04652245|Xhance|xhance|mesh-list
56844341|NCT04652245|Azelastine|azelastine|mesh-list
56844342|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56844343|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56844344|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
56889620|NCT01213407|Temozolomide|temozolomide|mesh-list
56889621|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56889622|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
56889623|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889624|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889625|NCT01211457|Decitabine|decitabine|mesh-list
56889626|NCT01211457|Venetoclax|venetoclax|mesh-list
56889627|NCT01211457|Sapacitabine|sapacitabine|mesh-list
56889628|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56889629|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
56889630|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889631|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889632|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889633|NCT01213563|Insulin|insulin|mesh-list
56889634|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56889635|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
56889636|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
56889637|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56889638|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889640|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56889641|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56889642|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
56889643|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889644|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56889645|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56889646|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889647|NCT01116063|Iloprost|iloprost|mesh-list
56889648|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56889649|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
56889650|NCT01116219|Bevacizumab|bevacizumab|mesh-list
56889651|NCT01116219|Pemetrexed|pemetrexed|mesh-list
56889652|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56889653|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56889654|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889655|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56889656|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56889657|NCT01116219|Growth Substances|growth substances|mesh-ancestor
56054373|NCT01280643|Irinotecan|irinotecan|mesh-list
56844345|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844346|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844347|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56844348|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
56844349|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
56844350|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56561829|NCT00941655|Antidotes|antidotes|mesh-ancestor
56889658|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889659|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
56889660|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889661|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889662|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56889663|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56889664|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56889665|NCT01213719|Betaine|betaine|mesh-list
56889666|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889667|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
56889668|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56889669|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
56889670|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889671|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56889672|NCT01114191|Ketoconazole|ketoconazole|mesh-list
56889673|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
56889674|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889675|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56889676|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56889677|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889678|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889679|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56889680|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
56889681|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889682|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889683|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56889684|NCT01211691|Antibodies|antibodies|mesh-list
56889685|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56889686|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
56889687|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889688|NCT03937869|Secnidazole|secnidazole|mesh-list
56889689|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56889690|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56889691|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889692|NCT01116531|Pregabalin|pregabalin|mesh-list
56889693|NCT01116531|Tramadol|tramadol|mesh-list
56889694|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56889695|NCT01116531|Analgesics|analgesics|mesh-ancestor
56889696|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
56889697|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889698|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889699|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
56889700|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56889701|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56889702|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889703|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56889704|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56889705|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56889706|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56889707|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56889708|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56889709|NCT01116531|Narcotics|narcotics|mesh-ancestor
56889710|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56600448|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
56889711|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56889712|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889713|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
56889714|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
56889715|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
56889716|NCT03939975|Nivolumab|nivolumab|mesh-list
56844351|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56844352|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844353|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844354|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56844355|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56844356|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
56844357|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
56844358|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56844359|NCT04642287|Fluorouracil|fluorouracil|mesh-list
56844360|NCT04642287|Calcipotriene|calcipotriene|mesh-list
56844361|NCT04642287|Petrolatum|petrolatum|mesh-list
56844362|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
56904610|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889717|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56889718|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889719|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56889720|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889721|NCT01116609|Epinephrine|epinephrine|mesh-list
56889722|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56889723|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56889724|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
56889725|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889726|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889727|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889728|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56889729|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56889730|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
56889731|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889732|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56889734|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
56889735|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
56889736|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56889737|NCT01118403|Ampicillin|ampicillin|mesh-list
56889738|NCT01118403|Sulbactam|sulbactam|mesh-list
56889739|NCT01118403|Sultamicillin|sultamicillin|mesh-list
56889740|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889741|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889742|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56889743|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889744|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889745|NCT01121835|Insulin|insulin|mesh-list
56889746|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56889747|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
56889748|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
56889749|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56889750|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889751|NCT03788967|Ertapenem|ertapenem|mesh-list
56889752|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889753|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889754|NCT01118559|Darexaban|darexaban|mesh-list
56889755|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56889756|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
56889757|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56889758|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
56889759|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889760|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889761|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
56889762|NCT01216293|Esomeprazole|esomeprazole|mesh-list
56889763|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
56889764|NCT01216293|Lansoprazole|lansoprazole|mesh-list
56889765|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56889766|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56889767|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56889768|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054374|NCT01280643|Antibodies|antibodies|mesh-list
56844363|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844364|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56844365|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844366|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844367|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
56844368|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844369|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
56844370|NCT04642287|Emollients|emollients|mesh-ancestor
56844371|NCT04635735|Ipilimumab|ipilimumab|mesh-list
56844372|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56889769|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889770|NCT01216371|Sunitinib|sunitinib|mesh-list
56889771|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889772|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56889773|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56889774|NCT01216371|Growth Substances|growth substances|mesh-ancestor
56889775|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889776|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
56889777|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56889778|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889779|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889780|NCT01118871|Ritonavir|ritonavir|mesh-list
56889781|NCT01118871|Darunavir|darunavir|mesh-list
56889782|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56889783|NCT01118871|Etravirine|etravirine|mesh-list
56889784|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56889785|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56889786|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
56600543|NCT01014767|Vitamins|vitamins|mesh-ancestor
56889787|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889788|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889789|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56889790|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56889791|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
56889792|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889793|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56889794|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56889795|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56889796|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56889797|NCT01216449|Citalopram|citalopram|mesh-list
56889798|NCT01216449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56889799|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56889800|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56889801|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889802|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889803|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
56889804|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889805|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56889806|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
56889807|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56889808|NCT03937401|Oxytocin|oxytocin|mesh-list
56889809|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
56889810|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56889811|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889812|NCT03939273|Metronidazole|metronidazole|mesh-list
56889813|NCT03939273|Vancomycin|vancomycin|mesh-list
56889814|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
56889815|NCT03939273|Fluconazole|fluconazole|mesh-list
56889816|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889817|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889818|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56889819|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56889820|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56889821|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56844373|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844374|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844375|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844376|NCT04595513|Sirolimus|sirolimus|mesh-list
56844377|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56844378|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844379|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56844380|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844381|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
56562022|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
56889822|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889823|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889824|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889825|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56889826|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56889827|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
56889828|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56889829|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56889830|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
56889831|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889832|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889833|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56889834|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56889835|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
56889836|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56889837|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
56889838|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889839|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56889840|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56889841|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56889842|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56889843|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889844|NCT01216605|Oxytocin|oxytocin|mesh-list
56889845|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
56889846|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56889847|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889848|NCT01213095|Rituximab|rituximab|mesh-list
56889849|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56889850|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889851|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
56889852|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889853|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56889854|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
56889855|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56889856|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
56889857|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889858|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
56600605|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
56889859|NCT03938883|Protective Agents|protective agents|mesh-ancestor
56889861|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889862|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56889863|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
56889864|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889865|NCT01119651|Tazarotene|tazarotene|mesh-list
56889866|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
56889867|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
56889868|NCT03971877|Polymyxins|polymyxins|mesh-list
56889869|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889870|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889871|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
56889872|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56889873|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889874|NCT01119885|Fentanyl|fentanyl|mesh-list
56889875|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56889876|NCT01119885|Narcotics|narcotics|mesh-ancestor
56844382|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844383|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
56844384|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844385|NCT04592237|Carboplatin|carboplatin|mesh-list
56844386|NCT04592237|Niraparib|niraparib|mesh-list
56844387|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844388|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56844389|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844390|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844391|NCT04564339|Ravulizumab|ravulizumab|mesh-list
56844392|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56889877|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56889878|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889879|NCT01119885|Analgesics|analgesics|mesh-ancestor
56889880|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
56889881|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56889882|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56889884|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
56889885|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
56889886|NCT03935217|Secnidazole|secnidazole|mesh-list
56889887|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56889888|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56889889|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889890|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
56889891|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889892|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
56889893|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56889894|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56889895|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889896|NCT01219023|Urological Agents|urological agents|mesh-ancestor
56889897|NCT01124487|Insulin|insulin|mesh-list
56889898|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56889899|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889900|NCT01120119|Calcitriol|calcitriol|mesh-list
56889901|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56889902|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889903|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56889904|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56889905|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889906|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56889907|NCT01120119|Vitamins|vitamins|mesh-ancestor
56889908|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
56889909|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56889910|NCT01219101|Citric Acid|citric acid|mesh-list
56889911|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
56889912|NCT01219101|Clomiphene|clomiphene|mesh-list
56889913|NCT01219101|Enclomiphene|enclomiphene|mesh-list
56889914|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
56889915|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
56889916|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56889917|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
56889918|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
56889919|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889920|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56889921|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
56889922|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889923|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889924|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56889925|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
56889926|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56889927|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56889928|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56889929|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56889930|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844393|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844394|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
56844395|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844396|NCT04551430|Nivolumab|nivolumab|mesh-list
56844397|NCT04551430|Ipilimumab|ipilimumab|mesh-list
56844398|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844399|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844400|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844401|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844402|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
56562149|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562150|NCT05629234|Osimertinib|osimertinib|mesh-list
56562151|NCT05629234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562152|NCT05629234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56562153|NCT05629234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889931|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56889932|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889933|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889934|NCT01122615|Sirolimus|sirolimus|mesh-list
56889935|NCT01122615|Sunitinib|sunitinib|mesh-list
56889936|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889937|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56889938|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56889939|NCT01122615|Growth Substances|growth substances|mesh-ancestor
56889940|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889941|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
56889942|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56889943|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889944|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889945|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889946|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56889947|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56889948|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
56889949|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56889950|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
56889951|NCT01217697|Prednisone|prednisone|mesh-list
56889952|NCT01217697|Prednisolone|prednisolone|mesh-list
56889953|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
56889954|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56889955|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
56889956|NCT01217697|Hormones|hormones|mesh-ancestor
56889957|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889958|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889959|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56889960|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889961|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56889962|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889963|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889964|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
56889965|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56889967|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889968|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56889969|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889970|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889971|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56889972|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
56889973|NCT01124799|Simeprevir|simeprevir|mesh-list
56889974|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56889975|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844403|NCT04548752|Olaparib|olaparib|mesh-list
56844404|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56844405|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844406|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844407|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844408|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844409|NCT04543110|Durvalumab|durvalumab|mesh-list
56844410|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56889976|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56889977|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56889978|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889979|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889980|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56889981|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56889982|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56889983|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
56889984|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
56889985|NCT01124877|Ziprasidone|ziprasidone|mesh-list
56889986|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56889987|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
56889988|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56889989|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56889990|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56889991|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56889992|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56889993|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56889994|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56889995|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56889996|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
56889997|NCT01219413|Perindopril|perindopril|mesh-list
56889998|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56889999|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
56890000|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890001|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890002|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56890003|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
56890004|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
56890005|NCT03783039|Coagulants|coagulants|mesh-ancestor
56890006|NCT03933501|Amoxicillin|amoxicillin|mesh-list
56890007|NCT03933501|Metronidazole|metronidazole|mesh-list
56890008|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56890009|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890010|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56890011|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56890012|NCT01122771|Amphotericin B|amphotericin b|mesh-list
56890013|NCT01122771|Paromomycin|paromomycin|mesh-list
56890014|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56890015|NCT01122771|Miltefosine|miltefosine|mesh-list
56890016|NCT01122771|Amebicides|amebicides|mesh-ancestor
56890017|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56890018|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56890019|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890020|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56890021|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
56890022|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890023|NCT01125033|Vitamins|vitamins|mesh-list
56890024|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
56890025|NCT01125033|Vitamin E|vitamin e|mesh-list
56890026|NCT01125033|Tocopherols|tocopherols|mesh-list
56890027|NCT01125033|Tocotrienols|tocotrienols|mesh-list
56890028|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
56890029|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
56890030|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890031|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
56890032|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890033|NCT01125033|Protective Agents|protective agents|mesh-ancestor
56152317|NCT01942668|Progestins|progestins|mesh-ancestor
56890034|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56890035|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56844411|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844412|NCT04539938|Trastuzumab|trastuzumab|mesh-list
56844413|NCT04539938|Tucatinib|tucatinib|mesh-list
56844414|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844415|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844416|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56844417|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844418|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890037|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56890038|NCT01120665|Hormones|hormones|mesh-ancestor
56890039|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56890040|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890041|NCT01120665|Estrogens|estrogens|mesh-ancestor
56890042|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56890043|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
56890044|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56890045|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56890046|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
56890047|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890048|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56890049|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890050|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890051|NCT01125423|Milnacipran|milnacipran|mesh-list
56890052|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
56890053|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56890054|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56890055|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56890056|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890057|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890058|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890059|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56890060|NCT01125423|Analgesics|analgesics|mesh-ancestor
56890061|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
56890062|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890063|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
56890064|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56890065|NCT01219569|Propofol|propofol|mesh-list
56890066|NCT01219569|Sevoflurane|sevoflurane|mesh-list
56890067|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56890068|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890069|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890070|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56890071|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
56890072|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
56890073|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56890074|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56890075|NCT03933345|Naloxone|naloxone|mesh-list
56890076|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56890077|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890078|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
56890079|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890080|NCT01121055|Lorazepam|lorazepam|mesh-list
56890081|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
56890082|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
56890083|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
56890084|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890085|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890086|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56890087|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56890088|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890089|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56890090|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56890091|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56890092|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
56890093|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
56890094|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56844419|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
56844420|NCT04487652|Vitamins|vitamins|mesh-ancestor
56844421|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
56844422|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844423|NCT04461639|Factor VIII|factor viii|mesh-list
56844424|NCT04461639|Coagulants|coagulants|mesh-ancestor
56844425|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
56844426|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844427|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844428|NCT04447183|Iodine|iodine|mesh-list
56844429|NCT04447183|Hormones|hormones|mesh-list
56844430|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844431|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562349|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
56890095|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890096|NCT01121133|Rifampin|rifampin|mesh-list
56890097|NCT01121133|Navitoclax|navitoclax|mesh-list
56890098|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56890099|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
56890100|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56890101|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890102|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
56890103|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56890104|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890105|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890106|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56890107|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56890108|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56890109|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56890110|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56890111|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56890112|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890113|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
56890114|NCT01214889|Vaccines|vaccines|mesh-list
56890115|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
56890116|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890117|NCT01123317|Oxytocin|oxytocin|mesh-list
56890118|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
56890119|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56890120|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890121|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
56890122|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56890123|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890124|NCT01123473|Fluorouracil|fluorouracil|mesh-list
56890125|NCT01123473|Capecitabine|capecitabine|mesh-list
56890126|NCT01123473|Epirubicin|epirubicin|mesh-list
56890127|NCT01123473|Lapatinib|lapatinib|mesh-list
56890128|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890129|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
56890130|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890131|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56890132|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56890133|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
56890134|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890135|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56890136|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56890137|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56890138|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890139|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56890140|NCT01123551|Morphine|morphine|mesh-list
56890141|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56890142|NCT01123551|Narcotics|narcotics|mesh-ancestor
56890143|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56844432|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56844433|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890144|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890145|NCT01123551|Analgesics|analgesics|mesh-ancestor
56890146|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
56890147|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890148|NCT01125657|Darexaban|darexaban|mesh-list
56890149|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56890150|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
56890151|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56890152|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
56890153|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890154|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890155|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
56890156|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
56890157|NCT03934203|BI 409306|bi 409306|mesh-list
56890158|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56890159|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890160|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56890161|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56890162|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890163|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890165|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56890166|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
56890167|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56890168|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56890169|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890170|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
56890171|NCT03934047|Coagulants|coagulants|mesh-ancestor
56890172|NCT01218711|Losartan|losartan|mesh-list
56890173|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56890174|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56890175|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56890176|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56568825|NCT02689024|Diclofenac|diclofenac|mesh-list
56890177|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56890178|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890179|NCT01218711|Diuretics|diuretics|mesh-ancestor
56890180|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
56890181|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890182|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56890183|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56890184|NCT01125891|Gemcitabine|gemcitabine|mesh-list
56890185|NCT01125891|ON 01910|on 01910|mesh-list
56890186|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56890187|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
56890188|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890189|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890190|NCT01125891|Antiviral Agents|antiviral agents|mesh-ancestor
56890191|NCT01125891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890192|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890193|NCT01125891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56890194|NCT01125891|Immunologic Factors|immunologic factors|mesh-ancestor
56890195|NCT01125891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890196|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56890197|NCT01124253|Endostatins|endostatins|mesh-list
56890198|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56890199|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56890200|NCT01124253|Growth Substances|growth substances|mesh-ancestor
56890201|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890202|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
56890203|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890204|NCT01215669|Vaccines|vaccines|mesh-list
56890205|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
56890206|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890207|NCT01222221|Temozolomide|temozolomide|mesh-list
56890208|NCT01222221|Sargramostim|sargramostim|mesh-list
56890209|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56890210|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
56890211|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890212|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890213|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
56890214|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844434|NCT04447183|Trace Elements|trace elements|mesh-ancestor
56890215|NCT01220661|Cefotetan|cefotetan|mesh-list
56890216|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56890217|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890218|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
56890219|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56890220|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890221|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
56890222|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56890223|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56890224|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
56890225|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890226|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890227|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56890228|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56890229|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
56890230|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890231|NCT03928353|Ticagrelor|ticagrelor|mesh-list
56890232|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56890233|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56890234|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56890235|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56890236|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
56890237|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890238|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890239|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890240|NCT03931863|Ondansetron|ondansetron|mesh-list
56890241|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
56890242|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
56890243|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890244|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890245|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56890246|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
56890247|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
56890248|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56890249|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
56890250|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904629|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56890251|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890252|NCT03931863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56890253|NCT03931863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56890254|NCT03931863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890255|NCT03931863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56890256|NCT03931863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56890257|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56890258|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56890259|NCT01226355|Sirolimus|sirolimus|mesh-list
56890260|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56890261|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890262|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56890263|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890264|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
56890265|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56890266|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
56890267|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890268|NCT01129089|Micronutrients|micronutrients|mesh-list
56890269|NCT01129089|Trace Elements|trace elements|mesh-list
56890270|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890271|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
56890272|NCT01129323|Fludarabine|fludarabine|mesh-list
56890273|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
56890274|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56890275|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
56890276|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890277|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56890278|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56890279|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
56890280|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890281|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890282|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56890284|NCT01221129|Trace Elements|trace elements|mesh-ancestor
56890285|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
56890286|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890287|NCT01222923|Risperidone|risperidone|mesh-list
56890288|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56844435|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
56844436|NCT04444921|Paclitaxel|paclitaxel|mesh-list
56844437|NCT04444921|Carboplatin|carboplatin|mesh-list
56844438|NCT04444921|Nivolumab|nivolumab|mesh-list
56844439|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56844440|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56844441|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844442|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
56844443|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
56844444|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
56844445|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844446|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844447|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844448|NCT04429334|Nangibotide|nangibotide|mesh-list
56844449|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56844450|NCT04421820|Leucovorin|leucovorin|mesh-list
56844451|NCT04421820|Fluorouracil|fluorouracil|mesh-list
56844452|NCT04421820|Oxaliplatin|oxaliplatin|mesh-list
56844453|NCT04421820|Antimetabolites|antimetabolites|mesh-ancestor
56844454|NCT04421820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844455|NCT04421820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56844456|NCT04421820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844457|NCT04421820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562572|NCT03633058|Ketamine|ketamine|mesh-list
56890289|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
56890290|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890291|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890292|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890293|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56890294|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56890295|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890296|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56890297|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56890298|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
56890299|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56890300|NCT01223079|Hormones|hormones|mesh-ancestor
56890301|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56890302|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890303|NCT03648970|Pravastatin|pravastatin|mesh-list
56890304|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56890305|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56890306|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
56890307|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890308|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56890309|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56890310|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601053|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
56890311|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
56890312|NCT03927963|Propofol|propofol|mesh-list
56890313|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56890314|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890315|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844458|NCT04421820|Immunologic Factors|immunologic factors|mesh-ancestor
56844459|NCT04421820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844460|NCT04421820|Antidotes|antidotes|mesh-ancestor
56844461|NCT04421820|Protective Agents|protective agents|mesh-ancestor
56844462|NCT04421820|Vitamin B Complex|vitamin b complex|mesh-ancestor
56844463|NCT04421820|Vitamins|vitamins|mesh-ancestor
56844464|NCT04421820|Micronutrients|micronutrients|mesh-ancestor
56844465|NCT04408443|Vitamin D|vitamin d|mesh-list
56844466|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
56844467|NCT04408443|Vitamins|vitamins|mesh-ancestor
56890316|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56890317|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
56890318|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
56890319|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56890320|NCT03927963|Analgesics|analgesics|mesh-ancestor
56890321|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
56890322|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890323|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56890324|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56890325|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56890327|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890328|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890329|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56890330|NCT01127529|Protein C|protein c|mesh-list
56890331|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
56890332|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56890333|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56890334|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890335|NCT01226667|Pregabalin|pregabalin|mesh-list
56890336|NCT01226667|Analgesics|analgesics|mesh-ancestor
56890337|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
56890338|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890339|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890340|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
56890341|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56890342|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56890343|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890344|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56890345|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56890346|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56890347|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890348|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56890349|NCT03927807|Misoprostol|misoprostol|mesh-list
56890350|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56890351|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
56890352|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56890353|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890354|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56890355|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56890356|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
56890357|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
56890358|NCT05284942|Prednisone|prednisone|mesh-list
56890359|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56890360|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
56890361|NCT05284942|Hormones|hormones|mesh-ancestor
56890362|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56890363|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890364|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56890365|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890366|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56890367|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56890368|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
56890369|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56890370|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890371|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890372|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890373|NCT03648034|Ropivacaine|ropivacaine|mesh-list
56844468|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
56844469|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844470|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56844471|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56844472|NCT04404283|Rituximab|rituximab|mesh-list
56844473|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56844474|NCT04404283|Lenalidomide|lenalidomide|mesh-list
56844475|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844476|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844477|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
56844478|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844479|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56844480|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56844481|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56844482|NCT04404283|Growth Substances|growth substances|mesh-ancestor
56844483|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
56890374|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
56890375|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
56890376|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890377|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890378|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
56890379|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890380|NCT01129479|Galantamine|galantamine|mesh-list
56890381|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56890382|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890383|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890384|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
56601139|NCT02573935|Clarithromycin|clarithromycin|mesh-list
56890385|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890386|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890387|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56890388|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
56890389|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890390|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
56890391|NCT03647956|Bevacizumab|bevacizumab|mesh-list
56890392|NCT03647956|Carboplatin|carboplatin|mesh-list
56890393|NCT03647956|Pemetrexed|pemetrexed|mesh-list
56890394|NCT03647956|Atezolizumab|atezolizumab|mesh-list
56890395|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56890396|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890397|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56890398|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56890399|NCT03647956|Growth Substances|growth substances|mesh-ancestor
56890400|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890401|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
56890402|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890403|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890404|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56890405|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56890406|NCT01221675|Antibodies|antibodies|mesh-list
56890407|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
56890408|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890409|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
56890410|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56890411|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
56844493|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
56844494|NCT04396457|Pemetrexed|pemetrexed|mesh-list
56844495|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844496|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562726|NCT01125917|Narcotics|narcotics|mesh-ancestor
56890412|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
56890413|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890414|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890415|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56890416|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56890417|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56890418|NCT02968576|Tenofovir|tenofovir|mesh-list
56890419|NCT02968576|Emtricitabine|emtricitabine|mesh-list
56890420|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56890421|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
56890422|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890423|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56890424|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56890425|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890426|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890427|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56890428|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56890429|NCT01127217|Losartan|losartan|mesh-list
56890430|NCT01127217|Amlodipine|amlodipine|mesh-list
56890431|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56890432|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56890433|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56890434|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890435|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56890436|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890437|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
56890438|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56890439|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56890440|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56890441|NCT01226901|Niraparib|niraparib|mesh-list
56890442|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56890443|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890444|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890445|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890446|NCT03648658|Acetaminophen|acetaminophen|mesh-list
56890447|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56890448|NCT03648658|Analgesics|analgesics|mesh-ancestor
56890449|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
56890450|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890451|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890452|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
56890453|NCT03931239|Vaccines|vaccines|mesh-list
56890454|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
56890455|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890456|NCT03927495|Paclitaxel|paclitaxel|mesh-list
56890457|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56890458|NCT03927495|Cisplatin|cisplatin|mesh-list
56890459|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56890460|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890461|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
56890462|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
56890463|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
56890464|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890465|NCT02966002|Aspirin|aspirin|mesh-list
56890466|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56890467|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56890468|NCT02966002|Analgesics|analgesics|mesh-ancestor
56890469|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
56890470|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890471|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844497|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844498|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844499|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56562792|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
56890472|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56890473|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56890474|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56890475|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56890476|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890477|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56890478|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56890479|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890480|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
56890481|NCT01127295|Tamoxifen|tamoxifen|mesh-list
56890482|NCT01127295|Letrozole|letrozole|mesh-list
56890483|NCT01127295|Anastrozole|anastrozole|mesh-list
56890484|NCT01127295|Exemestane|exemestane|mesh-list
56890485|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890486|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56890487|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56890488|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890489|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890490|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56890491|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
56890492|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56890493|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890494|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56890495|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56890496|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56890497|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56890498|NCT01129713|Esomeprazole|esomeprazole|mesh-list
56890499|NCT01129713|Omeprazole|omeprazole|mesh-list
56890500|NCT01129713|Lansoprazole|lansoprazole|mesh-list
56890501|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56890502|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56890503|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56890504|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890505|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890506|NCT01221831|Dienogest|dienogest|mesh-list
56890507|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56890508|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56890509|NCT01221831|Estradiol|estradiol|mesh-list
56890510|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56890511|NCT01221831|Estrogens|estrogens|mesh-ancestor
56890512|NCT01221831|Hormones|hormones|mesh-ancestor
56890513|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56890514|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890515|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56890516|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
56890517|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56890518|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56890519|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56890520|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56890521|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56890522|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
56890523|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56890524|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890525|NCT03931317|Timolol|timolol|mesh-list
56890526|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890527|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56890528|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56890529|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
56890530|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890531|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890532|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56890533|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56890534|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
56890535|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56890536|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56890537|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844500|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56890538|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
56890539|NCT01221909|Coagulants|coagulants|mesh-ancestor
56890540|NCT04013542|Nivolumab|nivolumab|mesh-list
56890541|NCT04013542|Ipilimumab|ipilimumab|mesh-list
56890542|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56890543|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890544|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56890545|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890546|NCT02900092|Ganaxolone|ganaxolone|mesh-list
56890547|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
56890548|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890549|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890550|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890551|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
56890552|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
56890553|NCT01130025|Tinzaparin|tinzaparin|mesh-list
56890554|NCT01130025|Warfarin|warfarin|mesh-list
56890555|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
56890556|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56890557|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56890558|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890559|NCT03925155|Iodine|iodine|mesh-list
56890560|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
56890561|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56890562|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890563|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
56890564|NCT03925155|Trace Elements|trace elements|mesh-ancestor
56890565|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
56890566|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890567|NCT01131195|Paclitaxel|paclitaxel|mesh-list
56890568|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
56890569|NCT01131195|Bevacizumab|bevacizumab|mesh-list
56890570|NCT01131195|Capecitabine|capecitabine|mesh-list
56890571|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56890572|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890573|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
56890574|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
56890575|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
56890576|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890577|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56890578|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
56890579|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890580|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56890581|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56890582|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
56890583|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56890584|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56890585|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56890586|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56890587|NCT01131195|Growth Substances|growth substances|mesh-ancestor
56890588|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
56890589|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56890590|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
56890591|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
56890592|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
56890593|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890594|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56890595|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890596|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890597|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
56890598|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56890599|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56890600|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890601|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56890602|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56890603|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56890604|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56890605|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
56890606|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890607|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56890608|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56890609|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890610|NCT01228227|Atorvastatin|atorvastatin|mesh-list
56890611|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56054375|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
56844501|NCT04380740|Abatacept|abatacept|mesh-list
56844502|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844503|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844504|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844505|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844506|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
56844507|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844508|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56844509|NCT04377204|Lidocaine|lidocaine|mesh-list
56844510|NCT04377204|Bupivacaine|bupivacaine|mesh-list
56844511|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
56844512|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
56844513|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56844514|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844515|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
56844516|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844517|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56844518|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56844519|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56844520|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56890612|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56890613|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56890614|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
56890615|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890616|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56890617|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56890618|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890619|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
56890620|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890621|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56890622|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890623|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890625|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
56890626|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
56890627|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56890628|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56890629|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
56890630|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890631|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890632|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56890633|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
56890634|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
56890635|NCT03740373|Hormones|hormones|mesh-ancestor
56890636|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56890637|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56890638|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56890639|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56890640|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
56890641|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890642|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890643|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56890644|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56890645|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56844521|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844522|NCT04367233|Anesthetics|anesthetics|mesh-list
56844523|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56844524|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844525|NCT04349267|Nivolumab|nivolumab|mesh-list
56844526|NCT04349267|Cetuximab|cetuximab|mesh-list
56844527|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844528|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844529|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844530|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844531|NCT04346589|Antibodies|antibodies|mesh-list
56844532|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
56844533|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56844534|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
56844535|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844536|NCT04331067|Paclitaxel|paclitaxel|mesh-list
56844537|NCT04331067|Carboplatin|carboplatin|mesh-list
56890646|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
56890647|NCT01228305|Acetaminophen|acetaminophen|mesh-list
56890648|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56890649|NCT01228305|Analgesics|analgesics|mesh-ancestor
56890650|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
56890651|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890652|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890653|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
56890654|NCT02902120|Grazoprevir|grazoprevir|mesh-list
56890655|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
56890656|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890657|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
56890658|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
56890659|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890660|NCT01131273|Buprenorphine|buprenorphine|mesh-list
56890661|NCT01131273|Methadone|methadone|mesh-list
56890662|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56890663|NCT01131273|Naloxone|naloxone|mesh-list
56890664|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56890665|NCT01131273|Narcotics|narcotics|mesh-ancestor
56890666|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890667|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890668|NCT01131273|Analgesics|analgesics|mesh-ancestor
56890669|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
56890670|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890671|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56890672|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
56890673|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
56890674|NCT03646318|Ketanserin|ketanserin|mesh-list
56890675|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56890676|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56890677|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56890678|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
56890679|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890680|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890681|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890682|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
56890683|NCT01130181|Vitamin D|vitamin d|mesh-list
56890684|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56890685|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601434|NCT00639873|Analgesics|analgesics|mesh-ancestor
56890686|NCT01130181|Vitamins|vitamins|mesh-ancestor
56890687|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
55895856|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56844538|NCT04331067|Nivolumab|nivolumab|mesh-list
56844539|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56844540|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844541|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
56844542|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
56844543|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
56844544|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844545|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844546|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844547|NCT04329221|Calcitriol|calcitriol|mesh-list
56890688|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56890689|NCT03621514|Lidocaine|lidocaine|mesh-list
56890690|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
56890691|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
56890692|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890693|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890694|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
56890695|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890696|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56904630|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56890697|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56890698|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56890699|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56890700|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890701|NCT01127841|Rituximab|rituximab|mesh-list
56890702|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56890703|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56890704|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890705|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
56890706|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890707|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56890708|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56890709|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
56890710|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890711|NCT01227603|Candesartan|candesartan|mesh-list
56890712|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
56890713|NCT01227603|Nifedipine|nifedipine|mesh-list
56890714|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56890715|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56890716|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56890717|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890718|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56890719|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56890720|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56890721|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890722|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
56890723|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
56890724|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56890725|NCT01130259|Iniparib|iniparib|mesh-list
56890726|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56890727|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890728|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890729|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890730|NCT01585623|Metoprolol|metoprolol|mesh-list
56890731|NCT01585623|Midazolam|midazolam|mesh-list
56890732|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56890733|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56890734|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890735|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890736|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56890737|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56890738|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56890739|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56844548|NCT04329221|Fluorouracil|fluorouracil|mesh-list
56844549|NCT04329221|Calcipotriene|calcipotriene|mesh-list
56844550|NCT04329221|Petrolatum|petrolatum|mesh-list
56844551|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
56844552|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844553|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56844554|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844555|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844556|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
56844557|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890740|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
56890741|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
56890742|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
56890743|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
56890744|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890745|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890746|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56890747|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56890748|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
56890749|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
56890750|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890751|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56890752|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56890753|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56890754|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
56890755|NCT03926559|Morphine|morphine|mesh-list
56890756|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56890757|NCT03926559|Narcotics|narcotics|mesh-ancestor
56890758|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890759|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890760|NCT03926559|Analgesics|analgesics|mesh-ancestor
56890761|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
56890762|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890763|NCT01228617|Nicotine|nicotine|mesh-list
56890764|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56890765|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
56890766|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890767|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890768|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56890769|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56890770|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
56890772|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890773|NCT01227759|Tyrothricin|tyrothricin|mesh-list
56890774|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56890775|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890776|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56890777|NCT03923829|Zinc|zinc|mesh-list
56890778|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
56890779|NCT03923829|Trace Elements|trace elements|mesh-ancestor
56890780|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
56890781|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890782|NCT03923829|Astringents|astringents|mesh-ancestor
56890783|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
56890784|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
56890785|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56890786|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
56890787|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890788|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890789|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
56890790|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890791|NCT03923751|Anesthetics|anesthetics|mesh-list
56890792|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890793|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890794|NCT03923361|Propofol|propofol|mesh-list
56890795|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56890796|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890797|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844558|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
56844559|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56844560|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56844561|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56844562|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56844563|NCT04329221|Vitamins|vitamins|mesh-ancestor
56844564|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
56844565|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56844566|NCT04329221|Emollients|emollients|mesh-ancestor
56844567|NCT04324840|Temozolomide|temozolomide|mesh-list
56563185|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890798|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56890799|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
56890800|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
56890801|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56890802|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
56890803|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890804|NCT03740295|Protective Agents|protective agents|mesh-ancestor
56890805|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890806|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56890807|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56890808|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890809|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56890810|NCT02965378|Docetaxel|docetaxel|mesh-list
56890811|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890812|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
56890813|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
56890814|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
56890815|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890816|NCT01224093|Rituximab|rituximab|mesh-list
56890817|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56890818|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890819|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
56890820|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890821|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56890822|NCT03772041|Tolvaptan|tolvaptan|mesh-list
56890823|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56890824|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890825|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
56890826|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890827|NCT03922815|Fentanyl|fentanyl|mesh-list
56890828|NCT03922815|Propofol|propofol|mesh-list
56890829|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56890830|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890831|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890832|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56890833|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
56890834|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
56890835|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56890836|NCT03922815|Narcotics|narcotics|mesh-ancestor
56890837|NCT03922815|Analgesics|analgesics|mesh-ancestor
56890838|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
56890839|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890840|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56890841|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56890842|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56890843|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56890844|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890845|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
56890846|NCT01227915|Hormones|hormones|mesh-ancestor
56890847|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56890848|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890849|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56890850|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56890851|NCT01224405|Docetaxel|docetaxel|mesh-list
56844568|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56844569|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
56844570|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844571|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844572|NCT04316013|Lidocaine|lidocaine|mesh-list
56844573|NCT04316013|Propofol|propofol|mesh-list
56844574|NCT04316013|Sevoflurane|sevoflurane|mesh-list
56844575|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
56844576|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
56844577|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890852|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890853|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
56890854|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
56890855|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
56890856|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890857|NCT02899156|Flumazenil|flumazenil|mesh-list
56890858|NCT02899156|Antidotes|antidotes|mesh-ancestor
56890859|NCT02899156|Protective Agents|protective agents|mesh-ancestor
56890860|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890861|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
56890862|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
56890863|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890864|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890865|NCT01131429|Cisplatin|cisplatin|mesh-list
56890866|NCT01131429|Docetaxel|docetaxel|mesh-list
56890867|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56890868|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890869|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
56890870|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
56890871|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
56890872|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890873|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56890874|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890875|NCT03645304|Ropivacaine|ropivacaine|mesh-list
56890876|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
56890877|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
56890878|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890879|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890880|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
56890881|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890882|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56890883|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
56890884|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
56890885|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890886|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
56890887|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56890888|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56890889|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56890890|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56890891|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890892|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
56890893|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890894|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890895|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56890896|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890897|NCT03927274|Topotecan|topotecan|mesh-list
56890898|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56890899|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56890900|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890901|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890902|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890903|NCT03646006|Bupivacaine|bupivacaine|mesh-list
56890904|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
56890905|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
56890906|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56844578|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844579|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
56844580|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844581|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56844582|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56844583|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56844584|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56844585|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844586|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56844587|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56844588|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
56844589|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56890907|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890908|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
56890909|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890910|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
56890911|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
56890912|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
56890913|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890914|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890915|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890916|NCT03854344|Lidocaine|lidocaine|mesh-list
56890917|NCT03854344|Bupivacaine|bupivacaine|mesh-list
56890918|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
56890919|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
56890920|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890921|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890922|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
56890923|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890924|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56890925|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56890926|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56890927|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56890928|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890929|NCT03912220|Niacinamide|niacinamide|mesh-list
56890930|NCT03912220|Niacin|niacin|mesh-list
56890931|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
56890932|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
56890933|NCT03912220|Vitamins|vitamins|mesh-ancestor
56890934|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
56890935|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890936|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56890937|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
56890938|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890939|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56890940|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
56890941|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56890942|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56890943|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
56890944|NCT03609424|Spartalizumab|spartalizumab|mesh-list
56890945|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56890946|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56890947|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56890948|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890949|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56890950|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56890951|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56890952|NCT03644446|Bisoprolol|bisoprolol|mesh-list
56890953|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56890954|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
56890955|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
56844590|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56844591|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
56844592|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56844593|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
56844594|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844595|NCT04312594|Expectorants|expectorants|mesh-ancestor
56844596|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
56844597|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56844598|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
56844599|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890956|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890957|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890958|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56890959|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56890960|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56890961|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
56890962|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890963|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890964|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
56890965|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56890966|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
56890967|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56890968|NCT03673462|Vaccines|vaccines|mesh-list
56890969|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
56890970|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890971|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
56890972|NCT05283850|Calcium|calcium|mesh-list
56890973|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56890974|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890975|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56890976|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
56890977|NCT03925779|Remifentanil|remifentanil|mesh-list
56890978|NCT03925779|Propofol|propofol|mesh-list
56890979|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56890980|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56890981|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890982|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56890983|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
56890984|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
56890985|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56890986|NCT03925779|Analgesics|analgesics|mesh-ancestor
56890987|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
56890988|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56890989|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56890990|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56890991|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56890992|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56890993|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56890994|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56890995|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56890997|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56890998|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
56890999|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891001|NCT03925701|Vildagliptin|vildagliptin|mesh-list
56891002|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56891003|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891004|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56891005|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
56891006|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891007|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891008|NCT01224717|Teriparatide|teriparatide|mesh-list
56891009|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56891010|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891011|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56891012|NCT03925233|Tamoxifen|tamoxifen|mesh-list
56844600|NCT04312594|Protective Agents|protective agents|mesh-ancestor
56844601|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844602|NCT04312594|Antidotes|antidotes|mesh-ancestor
56844603|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56844604|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
56844605|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56844606|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844607|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891013|NCT03925233|Toremifene|toremifene|mesh-list
56891014|NCT03925233|Gemcitabine|gemcitabine|mesh-list
56891015|NCT03925233|Vinorelbine|vinorelbine|mesh-list
56891016|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
56891017|NCT03925233|Bevacizumab|bevacizumab|mesh-list
56891018|NCT03925233|Carboplatin|carboplatin|mesh-list
56891019|NCT03925233|Doxorubicin|doxorubicin|mesh-list
56891020|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56891021|NCT03925233|Fluorouracil|fluorouracil|mesh-list
56891022|NCT03925233|Capecitabine|capecitabine|mesh-list
56891023|NCT03925233|Methotrexate|methotrexate|mesh-list
56891024|NCT03925233|Trastuzumab|trastuzumab|mesh-list
56891025|NCT03925233|Letrozole|letrozole|mesh-list
56891026|NCT03925233|Apatinib|apatinib|mesh-list
56891027|NCT03925233|Epirubicin|epirubicin|mesh-list
56891028|NCT03925233|Olaparib|olaparib|mesh-list
56891029|NCT03925233|Fulvestrant|fulvestrant|mesh-list
56891030|NCT03925233|Anastrozole|anastrozole|mesh-list
56891031|NCT03925233|Exemestane|exemestane|mesh-list
56891032|NCT03925233|Endostatins|endostatins|mesh-list
56891033|NCT03925233|Pirarubicin|pirarubicin|mesh-list
56891034|NCT03925233|Citric Acid|citric acid|mesh-list
56891035|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
56891036|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56891037|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891038|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
56891039|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
56891040|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
56891041|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891042|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891043|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
56891044|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891045|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891046|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56891047|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
56891048|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56891049|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56891050|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56891051|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56891052|NCT03925233|Growth Substances|growth substances|mesh-ancestor
56891053|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
56891054|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56891055|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
56891056|NCT03925233|Antiviral Agents|antiviral agents|mesh-ancestor
56891057|NCT03925233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891058|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891059|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56891060|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56891061|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56891062|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56601832|NCT00640263|Ritonavir|ritonavir|mesh-list
56891063|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
56891064|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56891065|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
56891066|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56891067|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56891068|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
56891069|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56891070|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
56891071|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
56891072|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56891073|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56891074|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56844608|NCT04269902|Venetoclax|venetoclax|mesh-list
56844609|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
56844610|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844611|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844612|NCT04264897|Metformin|metformin|mesh-list
56844613|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56844614|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891075|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
56891076|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56891077|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56891078|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56891079|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56891080|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56891081|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56891082|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56891083|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56891084|NCT01130805|Capecitabine|capecitabine|mesh-list
56891085|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
56891086|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56891087|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
56891088|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891089|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891090|NCT01345162|Ketorolac|ketorolac|mesh-list
56891091|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56891092|NCT01345162|Tramadol|tramadol|mesh-list
56891093|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56891094|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56891095|NCT01345162|Analgesics|analgesics|mesh-ancestor
56891096|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
56891097|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891098|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891099|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891100|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891101|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56891102|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891103|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891104|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56891105|NCT01345162|Narcotics|narcotics|mesh-ancestor
56891106|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56891107|NCT01131039|Gemcitabine|gemcitabine|mesh-list
56891108|NCT01131039|Bevacizumab|bevacizumab|mesh-list
56891109|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56891110|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891111|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56891112|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56891113|NCT01131039|Growth Substances|growth substances|mesh-ancestor
56891114|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891115|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
56891116|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56891117|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
56891118|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891119|NCT01131039|Antiviral Agents|antiviral agents|mesh-ancestor
56891120|NCT01131039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891121|NCT01131039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891122|NCT01131039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891123|NCT01131039|Immunologic Factors|immunologic factors|mesh-ancestor
56891124|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
56891125|NCT01229085|Salicylates|salicylates|mesh-list
56891126|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891127|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
56891128|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
56891129|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
56891130|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56891131|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56891132|NCT01229085|Analgesics|analgesics|mesh-ancestor
56891133|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
56891134|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891135|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844615|NCT04254107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56844616|NCT04254107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844617|NCT04254107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844618|NCT04225026|Manganese|manganese|mesh-list
56844619|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
56844620|NCT04225026|Trace Elements|trace elements|mesh-ancestor
56844621|NCT04225026|Micronutrients|micronutrients|mesh-ancestor
56844622|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844623|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
56844624|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891136|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891137|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891138|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56891139|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891140|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891141|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56891142|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891143|NCT03643666|Dexamethasone|dexamethasone|mesh-list
56891144|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
56891145|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891146|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
56891147|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
56891148|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891149|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891150|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56891151|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
56891152|NCT03643666|Hormones|hormones|mesh-ancestor
56891153|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56891154|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56891155|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891156|NCT03643666|Analgesics|analgesics|mesh-ancestor
56891157|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
56891158|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
56891159|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56891160|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56891161|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
56891162|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56891163|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56891164|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891165|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56891166|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
56891167|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56891168|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
56891169|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56891170|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
56891171|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891172|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
56891173|NCT03643588|Protective Agents|protective agents|mesh-ancestor
56891174|NCT01224951|Beclomethasone|beclomethasone|mesh-list
56891175|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891176|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
56891177|NCT01224951|Hormones|hormones|mesh-ancestor
56891178|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56891179|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891180|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56891181|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
56891182|NCT03641404|Ergothioneine|ergothioneine|mesh-list
56891183|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
56891184|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891185|NCT03641404|Protective Agents|protective agents|mesh-ancestor
56891186|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891187|NCT01131741|Epinephrine|epinephrine|mesh-list
56891188|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56891189|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56891190|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
56844625|NCT04225026|Protective Agents|protective agents|mesh-ancestor
56904611|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891191|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891192|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891193|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891194|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56891195|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56891196|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
56891197|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891198|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56891199|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
56891200|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
56891201|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
56891202|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56891203|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56891204|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891205|NCT03921567|Lidocaine|lidocaine|mesh-list
56891206|NCT03921567|Ketamine|ketamine|mesh-list
56891207|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
56891208|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
56891209|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56891210|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891211|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
56891212|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891213|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56891214|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56891215|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56891216|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56891217|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891218|NCT03921567|Analgesics|analgesics|mesh-ancestor
56891219|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56891220|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56891221|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
56891222|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56891223|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56891224|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891225|NCT01229241|Anesthetics|anesthetics|mesh-list
56891226|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
56891227|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56891228|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891229|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
56891230|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891231|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
56891232|NCT05252884|Calcitriol|calcitriol|mesh-list
56891233|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
56891234|NCT05252884|Calcium|calcium|mesh-list
56891235|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56891236|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891237|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56891238|NCT05252884|Antacids|antacids|mesh-ancestor
56891239|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891240|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56891241|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56891242|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56891243|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56891244|NCT05252884|Vitamins|vitamins|mesh-ancestor
56891245|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
56891246|NCT03921177|Micronutrients|micronutrients|mesh-list
56891247|NCT03921177|Trace Elements|trace elements|mesh-list
56891248|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891249|NCT01229319|Imiquimod|imiquimod|mesh-list
56891250|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56891251|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
56891252|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891253|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891254|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
56891255|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
56891256|NCT03921099|Vitamins|vitamins|mesh-ancestor
56891257|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
56891258|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891259|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
56891260|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891261|NCT03921099|Protective Agents|protective agents|mesh-ancestor
56891262|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56891263|NCT02962648|Hematinics|hematinics|mesh-ancestor
56891264|NCT03920631|Nivolumab|nivolumab|mesh-list
56891265|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56891266|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891267|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56891268|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891269|NCT03930069|Vasopressins|vasopressins|mesh-list
56891270|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
56891271|NCT03930069|Misoprostol|misoprostol|mesh-list
56891272|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56891273|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
56891274|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56891275|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891276|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56891277|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56891278|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
56891279|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
56891280|NCT03930069|Coagulants|coagulants|mesh-ancestor
56891281|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56891282|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56891283|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
56891284|NCT01132443|Clindamycin|clindamycin|mesh-list
56891285|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
56891286|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
56891287|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56891288|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56891289|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891290|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56891291|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891292|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891293|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
56891294|NCT01132521|Urinastatin|urinastatin|mesh-list
56891295|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
56891296|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56891297|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
56891298|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891299|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891300|NCT01132599|Choline|choline|mesh-list
56891301|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
56891302|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56891303|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
56891304|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891305|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56891306|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56891307|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
56891308|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
56891309|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56563763|NCT05380713|Durvalumab|durvalumab|mesh-list
56891310|NCT03929835|Protective Agents|protective agents|mesh-ancestor
56891311|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891312|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
56891313|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56891314|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56891315|NCT01132677|Prednisolone|prednisolone|mesh-list
56891316|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
56891317|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56891318|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
56891319|NCT01132677|Hylan|hylan|mesh-list
56891320|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891321|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
56891322|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
56891323|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891324|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891325|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56891326|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
56891327|NCT01132677|Hormones|hormones|mesh-ancestor
56891328|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56891329|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56891330|NCT01132677|Protective Agents|protective agents|mesh-ancestor
56891331|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56891332|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891333|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
56891334|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
56891335|NCT02961790|Oxybutynin|oxybutynin|mesh-list
56891336|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
56891337|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
56891338|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891339|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891340|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56891341|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56891342|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
56891343|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891344|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891345|NCT02961790|Urological Agents|urological agents|mesh-ancestor
56891346|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56891347|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891348|NCT02961790|Renal Agents|renal agents|mesh-ancestor
56891349|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56891350|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56891351|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56891352|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891353|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891354|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56891355|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56891356|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891357|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
56891358|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891359|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
56891360|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56891361|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
56891362|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891363|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
56891364|NCT03920553|Protective Agents|protective agents|mesh-ancestor
56891365|NCT03643900|Indomethacin|indomethacin|mesh-list
56602109|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56891366|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56891367|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56891368|NCT03643900|Analgesics|analgesics|mesh-ancestor
56891369|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
56891370|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891371|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891372|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891373|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891374|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
56891375|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
56563829|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
56891376|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56891377|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56891378|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891379|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891381|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891382|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56891383|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891384|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891385|NCT01131897|Levetiracetam|levetiracetam|mesh-list
56891386|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
56891387|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
56891388|NCT01225419|Plerixafor|plerixafor|mesh-list
56891389|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56891390|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56891391|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
56891392|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891393|NCT03919461|Etodolac|etodolac|mesh-list
56891394|NCT03919461|Propranolol|propranolol|mesh-list
56891395|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56891396|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56891397|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
56891398|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891399|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891400|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891401|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56891402|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56891403|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
56891404|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56891405|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56891406|NCT03919461|Analgesics|analgesics|mesh-ancestor
56891407|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
56891408|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891409|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891410|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891411|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56891412|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56891413|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891414|NCT02528877|Sirolimus|sirolimus|mesh-list
56891415|NCT02528877|Fludarabine|fludarabine|mesh-list
56891416|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
56891417|NCT02528877|Melphalan|melphalan|mesh-list
56891418|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
56891419|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56891420|NCT02528877|Tacrolimus|tacrolimus|mesh-list
56891421|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891422|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56891423|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
56891424|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891425|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891426|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
56891427|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891428|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56891429|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891430|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56891431|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891432|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56891433|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
56891434|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56891435|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
56891436|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56891437|NCT03918993|Tadalafil|tadalafil|mesh-list
56891438|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
56891439|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56891440|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56891441|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891442|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891443|NCT03918993|Urological Agents|urological agents|mesh-ancestor
56891444|NCT03920475|Sertraline|sertraline|mesh-list
56891445|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56891446|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
56891447|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56891448|NCT03920475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56891449|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56891450|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56844667|NCT04177108|Paclitaxel|paclitaxel|mesh-list
56844668|NCT04177108|Atezolizumab|atezolizumab|mesh-list
56844669|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56844670|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56844671|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844672|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
56844673|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
56844674|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
56844675|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891451|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891452|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891453|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
56891454|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891455|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56891456|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56891457|NCT03920319|Bupropion|bupropion|mesh-list
56891458|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56891459|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
56891460|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56891461|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56891462|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56891463|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56891464|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891465|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
56891466|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891467|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891468|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56891469|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56891470|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891471|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
56891472|NCT03920397|Vitamin D|vitamin d|mesh-list
56891473|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56891474|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891475|NCT03920397|Vitamins|vitamins|mesh-ancestor
56891476|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
56891477|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56891478|NCT01131975|Lamotrigine|lamotrigine|mesh-list
56891479|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
56891480|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56891481|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56891482|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891483|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56891484|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891485|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56891486|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56891487|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56891488|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56891489|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56891490|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
56891491|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56891492|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891493|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56891494|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56891495|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891496|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891497|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891498|NCT01128699|Bevacizumab|bevacizumab|mesh-list
56891499|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56891500|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891501|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56891502|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56844676|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
56844677|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844678|NCT04145115|Nivolumab|nivolumab|mesh-list
56844679|NCT04145115|Ipilimumab|ipilimumab|mesh-list
56844680|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844681|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844682|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844683|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844684|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
56844685|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56844686|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56844687|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844688|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
56844689|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
56844690|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844691|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56844692|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56844693|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56844694|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56844695|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844696|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56844697|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844698|NCT04111627|Analgesics|analgesics|mesh-ancestor
56891503|NCT01128699|Growth Substances|growth substances|mesh-ancestor
56891504|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891505|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
56891506|NCT01329627|Paclitaxel|paclitaxel|mesh-list
56891507|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56891508|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
56891509|NCT01329627|Doxorubicin|doxorubicin|mesh-list
56891510|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56891511|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56891512|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891513|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
56891514|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
56891515|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
56891516|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891517|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891518|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
56891519|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891520|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891521|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56891522|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
56891523|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56891524|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56891525|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56891526|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56891527|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891528|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
56891529|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
56844699|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
56844700|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844701|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
56844702|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56844703|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
56844704|NCT04111458|Trametinib|trametinib|mesh-list
56844705|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844706|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56844707|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844708|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844709|NCT04109066|Paclitaxel|paclitaxel|mesh-list
56844710|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
56844711|NCT04109066|Nivolumab|nivolumab|mesh-list
56844712|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56844713|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891530|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56891531|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56891532|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891533|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891534|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891535|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891536|NCT01132911|Bortezomib|bortezomib|mesh-list
56891537|NCT01132911|Vorinostat|vorinostat|mesh-list
56891538|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891539|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56891540|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891541|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891542|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56891543|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56891544|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891545|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
56891546|NCT01132989|Lenalidomide|lenalidomide|mesh-list
56891547|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
56891548|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891549|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56891550|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56891551|NCT01132989|Growth Substances|growth substances|mesh-ancestor
56891552|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
56891553|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891554|NCT01225653|Latanoprost|latanoprost|mesh-list
56891555|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56891556|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56891557|NCT01134861|Cisplatin|cisplatin|mesh-list
56891558|NCT01134861|Etoposide|etoposide|mesh-list
56891559|NCT01134861|Vinblastine|vinblastine|mesh-list
56891560|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891561|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56891562|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56891563|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56891564|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891565|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891566|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
56891567|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
56891568|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
56891569|NCT01133223|Plasminogen|plasminogen|mesh-list
56891570|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56891571|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56891572|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56891573|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891574|NCT01233219|Morphine|morphine|mesh-list
56891575|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56891576|NCT01233219|Narcotics|narcotics|mesh-ancestor
56844714|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56844715|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56844716|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56844717|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844718|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844719|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
56844720|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844721|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56844722|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56844723|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
56891577|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56891578|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891579|NCT01233219|Analgesics|analgesics|mesh-ancestor
56891580|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
56891581|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891582|NCT02960854|Nivolumab|nivolumab|mesh-list
56891583|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56891584|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891585|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56891586|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891587|NCT01133301|Naltrexone|naltrexone|mesh-list
56891588|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56891589|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56891590|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891591|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
56891592|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891593|NCT03918135|Acetaminophen|acetaminophen|mesh-list
56891594|NCT03918135|Ibuprofen|ibuprofen|mesh-list
56891595|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56891596|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56891597|NCT03918135|Analgesics|analgesics|mesh-ancestor
56891598|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
56891599|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891600|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891601|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891602|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891603|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56891604|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891605|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891606|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
56891607|NCT05480475|Dabigatran|dabigatran|mesh-list
56891608|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56891609|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56891610|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56891611|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
56891612|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891613|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56891614|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56891615|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891616|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
56891617|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56891618|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
56891619|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
56891620|NCT03642184|Empagliflozin|empagliflozin|mesh-list
56891621|NCT03642184|Linagliptin|linagliptin|mesh-list
56891622|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56891623|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891624|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56891625|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891626|NCT03642184|Incretins|incretins|mesh-ancestor
56891627|NCT03642184|Hormones|hormones|mesh-ancestor
56891628|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56891629|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56844724|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56844725|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844726|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844755|NCT04090710|Nivolumab|nivolumab|mesh-list
56844756|NCT04090710|Ipilimumab|ipilimumab|mesh-list
56844757|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844758|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844759|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56891630|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
56891631|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891632|NCT01137591|Acetaminophen|acetaminophen|mesh-list
56891633|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
56891634|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56891635|NCT01137591|Analgesics|analgesics|mesh-ancestor
56891636|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
56891637|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891638|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891639|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
56891640|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
56891641|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891642|NCT01137591|Expectorants|expectorants|mesh-ancestor
56891643|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
56891644|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56891645|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
56891646|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891647|NCT01137591|Protective Agents|protective agents|mesh-ancestor
56891648|NCT01133457|Finasteride|finasteride|mesh-list
56891649|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56891650|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56891651|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891652|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891653|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
56891654|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56891655|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891656|NCT01133457|Urological Agents|urological agents|mesh-ancestor
56891657|NCT01135563|Sirolimus|sirolimus|mesh-list
56891658|NCT01135563|Vinblastine|vinblastine|mesh-list
56891659|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56891660|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891661|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56891662|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844760|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844761|NCT04085445|Paclitaxel|paclitaxel|mesh-list
56844762|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56844763|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844764|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
56844765|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
56844766|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
56844767|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844768|NCT04069312|Azithromycin|azithromycin|mesh-list
56844769|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56844770|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891663|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
56891664|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891665|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
56891666|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891667|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56891668|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
56891669|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
56891670|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
56891671|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891672|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
56891673|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56891674|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56891675|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56891676|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56891677|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891678|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
56891679|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891680|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891681|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56891682|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891683|NCT03764631|Empagliflozin|empagliflozin|mesh-list
56891684|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56891685|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56891686|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891687|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56891688|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891689|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
56891690|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891691|NCT01135641|Cyclosporine|cyclosporine|mesh-list
56891692|NCT01135641|Rituximab|rituximab|mesh-list
56891693|NCT01135641|Cyclosporins|cyclosporins|mesh-list
56891694|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56891695|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891696|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
56891697|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891698|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891699|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891700|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891701|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891702|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
56891703|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891704|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
56891705|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56891706|NCT03640156|Oxytocin|oxytocin|mesh-list
56891707|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
56891708|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56891709|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891710|NCT01230723|Everolimus|everolimus|mesh-list
56891711|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891712|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891713|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
56564244|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891714|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891715|NCT05401071|Rifapentine|rifapentine|mesh-list
56891716|NCT05401071|Rifampin|rifampin|mesh-list
56891717|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56891718|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
56891719|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56891720|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891721|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
56891722|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56891723|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891724|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891725|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56891726|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56891727|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56891728|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56891729|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56891730|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56891731|NCT01135953|Cycloserine|cycloserine|mesh-list
56568848|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56891732|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56891733|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891734|NCT01135953|Renal Agents|renal agents|mesh-ancestor
56891735|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56891736|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
56891737|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56602492|NCT00754390|Calcium|calcium|mesh-list
56891739|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891740|NCT01136031|Paclitaxel|paclitaxel|mesh-list
56891741|NCT01136031|Irinotecan|irinotecan|mesh-list
56891742|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56891743|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891744|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
56891745|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
56891746|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
56891747|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891748|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56891749|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56891750|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891751|NCT05400915|Paclitaxel|paclitaxel|mesh-list
56891752|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56891753|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891754|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
56891755|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
56891756|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
56891757|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891758|NCT01137903|Amoxicillin|amoxicillin|mesh-list
56891759|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
56891760|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
56891761|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
56891762|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56891763|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56891764|NCT01137903|Trimethoprim|trimethoprim|mesh-list
56891765|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
56891766|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56891767|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891768|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56891769|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56891770|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891771|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891772|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891773|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56891774|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56891775|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56891776|NCT01137903|Renal Agents|renal agents|mesh-ancestor
56891777|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
56891778|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56891779|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56891780|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56891781|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56891782|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56891783|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56891784|NCT03739671|Vitamin D|vitamin d|mesh-list
56891785|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
56891786|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
56891787|NCT03739671|Vitamins|vitamins|mesh-list
56891788|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
56891789|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891790|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56891791|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56891792|NCT01233453|Umirolimus|umirolimus|mesh-list
56891793|NCT01233453|Everolimus|everolimus|mesh-list
56891794|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891795|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891796|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
56891797|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891798|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891799|NCT01133925|Sirolimus|sirolimus|mesh-list
56891800|NCT01133925|Paclitaxel|paclitaxel|mesh-list
56891801|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56891802|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891803|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
56891804|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
56891805|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
56891806|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891807|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56891808|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891809|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56891810|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
56891811|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891812|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
56891813|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891814|NCT01232439|Aticaprant|aticaprant|mesh-list
56891815|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891816|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
56891817|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891818|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56891819|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
56891820|NCT01138137|Paclitaxel|paclitaxel|mesh-list
56891821|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56891822|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56891823|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891824|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
56891825|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
56891826|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
56891827|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891828|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
56844810|NCT03983954|Durvalumab|durvalumab|mesh-list
56844811|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
56844812|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56844813|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
56844814|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844815|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844816|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
56844817|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891829|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891830|NCT01138137|Expectorants|expectorants|mesh-ancestor
56891831|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
56891832|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56891833|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
56891834|NCT01138137|Protective Agents|protective agents|mesh-ancestor
56891835|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891836|NCT01138137|Antidotes|antidotes|mesh-ancestor
56891837|NCT05410821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56891838|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56891839|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
56891840|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
56891841|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891842|NCT01231113|Artesunate|artesunate|mesh-list
56891843|NCT01231113|Piperaquine|piperaquine|mesh-list
56891844|NCT01231113|Amodiaquine|amodiaquine|mesh-list
56891845|NCT01231113|Artenimol|artenimol|mesh-list
56891846|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
56891847|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56891848|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56891849|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891850|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891851|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
56891852|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
56891853|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56891854|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
56891855|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
56891856|NCT01136421|Bromides|bromides|mesh-list
56891857|NCT01136421|Ipratropium|ipratropium|mesh-list
56891858|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
56891859|NCT01136421|Analgesics|analgesics|mesh-ancestor
56891860|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
56891861|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891862|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891863|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
56891864|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56891865|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56891866|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56891867|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56891868|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891869|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56891870|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
56891871|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56891872|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56891873|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
56891874|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56891875|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
56891876|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56891877|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
56891878|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891879|NCT03769311|Cetuximab|cetuximab|mesh-list
56891880|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56891881|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891882|NCT01136499|Panobinostat|panobinostat|mesh-list
56891883|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891884|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56891885|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891886|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844818|NCT03982277|Rifampin|rifampin|mesh-list
56844819|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56844820|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
56844821|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56844822|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844823|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
56844824|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56844825|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844826|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844827|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56844828|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56844829|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56844830|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56844831|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56844832|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56844833|NCT03940352|Venetoclax|venetoclax|mesh-list
56844834|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844835|NCT03939897|Fulvestrant|fulvestrant|mesh-list
56844836|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56844837|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844838|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56564439|NCT01118351|Sunitinib|sunitinib|mesh-list
56891887|NCT01231191|Acetaminophen|acetaminophen|mesh-list
56891888|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56891889|NCT01231191|Analgesics|analgesics|mesh-ancestor
56891890|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
56891891|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891892|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891894|NCT01138449|Vitamin A|vitamin a|mesh-list
56891895|NCT01138449|Vitamins|vitamins|mesh-ancestor
56891896|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
56891897|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891898|NCT05402865|Denosumab|denosumab|mesh-list
56891899|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56891900|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891901|NCT01138605|Ritonavir|ritonavir|mesh-list
56891902|NCT01138605|Darunavir|darunavir|mesh-list
56891903|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56891904|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56891905|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
56891906|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891907|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891908|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56891909|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56891910|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
56891911|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891912|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56891913|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56891914|NCT01138683|Diuretics|diuretics|mesh-list
56891915|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
56891916|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891917|NCT04767243|Methamphetamine|methamphetamine|mesh-list
56891918|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56844839|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56844840|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
56844841|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844842|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844843|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
56844844|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
56844845|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844846|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
56844847|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891919|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891920|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
56891921|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
56891922|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891923|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
56891924|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56891925|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891926|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
56891927|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56891928|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56891929|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56891930|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56891931|NCT01138839|Dexamethasone|dexamethasone|mesh-list
56891932|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56891933|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
56891934|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
56891935|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56891936|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891937|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56891938|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
56891939|NCT01138839|Hormones|hormones|mesh-ancestor
56891940|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56891941|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56891942|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891943|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56891944|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56891945|NCT01234701|Liver Extracts|liver extracts|mesh-list
56891946|NCT01234701|Hematinics|hematinics|mesh-ancestor
56891947|NCT04721613|Melatonin|melatonin|mesh-list
56891948|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
56891949|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891950|NCT04721613|Protective Agents|protective agents|mesh-ancestor
56891951|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891952|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56891953|NCT05275179|Posaconazole|posaconazole|mesh-list
56891954|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
56891955|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891956|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56891957|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56891958|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56891959|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56891960|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56891961|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891962|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891963|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56602707|NCT02620579|Propranolol|propranolol|mesh-list
56891964|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
56891965|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56891966|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891967|NCT01139151|Cytarabine|cytarabine|mesh-list
56891968|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56891969|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
56891970|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891971|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891972|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
56844848|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56844849|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56844850|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
56844851|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844852|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844853|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56844854|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844855|NCT03914443|Cisplatin|cisplatin|mesh-list
56844856|NCT03914443|Docetaxel|docetaxel|mesh-list
56844857|NCT03914443|Fluorouracil|fluorouracil|mesh-list
56555639|NCT04239586|Glyburide|glyburide|mesh-list
56844859|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844860|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
56844861|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
56844862|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
56891973|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891974|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891975|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
56891976|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891977|NCT01234857|Sirolimus|sirolimus|mesh-list
56891978|NCT01234857|Exemestane|exemestane|mesh-list
56891979|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56891980|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891981|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56891982|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56891983|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56891984|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56891985|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56891986|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
56891987|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56891988|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56891989|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56891990|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56891991|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56891992|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
56891993|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56891994|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
56891995|NCT01233843|Carboplatin|carboplatin|mesh-list
56891996|NCT01233843|Fluorouracil|fluorouracil|mesh-list
56891997|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56891998|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
56891999|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892000|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56892001|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892002|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
56892003|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892004|NCT01234935|Gemcitabine|gemcitabine|mesh-list
56892005|NCT01234935|Dasatinib|dasatinib|mesh-list
56892006|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56892007|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
56892008|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892009|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892010|NCT01234935|Antiviral Agents|antiviral agents|mesh-ancestor
56892011|NCT01234935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892012|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892013|NCT01234935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892014|NCT01234935|Immunologic Factors|immunologic factors|mesh-ancestor
56892015|NCT01234935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892016|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56892017|NCT03674541|Bromides|bromides|mesh-list
56892018|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56892019|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
56844863|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844864|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
56844865|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56844866|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844867|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
56844868|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844869|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56564612|NCT02881619|Etodolac|etodolac|mesh-list
56892020|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56892021|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892022|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892023|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
56892024|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892025|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892026|NCT01235013|Maraviroc|maraviroc|mesh-list
56892027|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56892028|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56892029|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892030|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56892031|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56892032|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
56892033|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892034|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56892035|NCT01236495|Morphine|morphine|mesh-list
56892036|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56892037|NCT01236495|Narcotics|narcotics|mesh-ancestor
56892038|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892039|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892040|NCT01236495|Analgesics|analgesics|mesh-ancestor
56892041|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
56892042|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892043|NCT01143129|Dexamethasone|dexamethasone|mesh-list
56892044|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56892045|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
56892046|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
56892047|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892048|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892049|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56892050|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
56892051|NCT01143129|Hormones|hormones|mesh-ancestor
56892052|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892053|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56892054|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892055|NCT03559647|Atezolizumab|atezolizumab|mesh-list
56892056|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892057|NCT01139463|Haloperidol|haloperidol|mesh-list
56892058|NCT01139463|Olanzapine|olanzapine|mesh-list
56892059|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
56892060|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
56892061|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
56892062|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892063|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892064|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56892065|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56892066|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56892067|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892068|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56892069|NCT01139463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56892070|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56892071|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892072|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892073|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892074|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
56892075|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56892076|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
56892077|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56892078|NCT03640468|Lidocaine|lidocaine|mesh-list
56844870|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844871|NCT03881696|Omalizumab|omalizumab|mesh-list
56844872|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
56844873|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56844874|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844875|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56844876|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56844877|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
56844878|NCT03815890|Nivolumab|nivolumab|mesh-list
56844879|NCT03815890|Ipilimumab|ipilimumab|mesh-list
56844880|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844881|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844882|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56892079|NCT03640468|Midazolam|midazolam|mesh-list
56892080|NCT03640468|Ketamine|ketamine|mesh-list
56892081|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
56892082|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
56892083|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892084|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892085|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
56892086|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892087|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56892088|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56892089|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56892090|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892091|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892092|NCT03640468|Analgesics|analgesics|mesh-ancestor
56892093|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56892094|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56892095|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
56892096|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56892097|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56892098|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892099|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56892100|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56892101|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56892102|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56892103|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56892104|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
56892105|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
56892106|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
56892107|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
56892108|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56892109|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892110|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892111|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56892112|NCT03640390|Analgesics|analgesics|mesh-ancestor
56892113|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
56602856|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
56892114|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892115|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56892116|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56892117|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56892118|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
56892119|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892120|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892121|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
56892122|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56892123|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
56892124|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56892125|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892126|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56892127|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
56844883|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844884|NCT03794583|Treprostinil|treprostinil|mesh-list
56844885|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56564721|NCT00613600|Cathartics|cathartics|mesh-ancestor
56892128|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56892129|NCT03618472|Metformin|metformin|mesh-list
56892130|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56892131|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892132|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
56892133|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892134|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892135|NCT03618316|Cimetidine|cimetidine|mesh-list
56892136|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56892137|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56892138|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56892139|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
56892140|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
56892141|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892142|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892143|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892144|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56892145|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56892146|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892147|NCT03445533|Ipilimumab|ipilimumab|mesh-list
56892148|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892149|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892150|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56892151|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892152|NCT01336972|Tolvaptan|tolvaptan|mesh-list
56892153|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56892154|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892155|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
56892156|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892157|NCT03537508|Vaccines|vaccines|mesh-list
56892158|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
56892159|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892160|NCT03513952|Atezolizumab|atezolizumab|mesh-list
56892161|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56892162|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892163|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
56892164|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892165|NCT03618082|Desflurane|desflurane|mesh-list
56892166|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56892167|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
56892168|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
56892169|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892170|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892171|NCT01236651|Drotaverin|drotaverin|mesh-list
56892172|NCT01236651|Meperidine|meperidine|mesh-list
56892173|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56892174|NCT01236651|Narcotics|narcotics|mesh-ancestor
56892175|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892176|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892177|NCT01236651|Analgesics|analgesics|mesh-ancestor
56892178|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
56892179|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892180|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56892181|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
56892182|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
56892183|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
56892184|NCT04484025|Ebselen|ebselen|mesh-list
56892185|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56892186|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56892187|NCT04484025|Analgesics|analgesics|mesh-ancestor
56844895|NCT03777657|Capecitabine|capecitabine|mesh-list
56564785|NCT00613288|Hormones|hormones|mesh-ancestor
56892188|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
56892189|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892190|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892191|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56892192|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56892193|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56892194|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56892196|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892197|NCT04484025|Protective Agents|protective agents|mesh-ancestor
56892198|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56892199|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892200|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56892201|NCT03370276|Nivolumab|nivolumab|mesh-list
56892202|NCT03370276|Cetuximab|cetuximab|mesh-list
56892203|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892204|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892205|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56892206|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892207|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
56892208|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56892209|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56892210|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56892211|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892212|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892213|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
56892214|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892215|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892216|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56892217|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892218|NCT03318094|Nitroprusside|nitroprusside|mesh-list
56892219|NCT03318094|Phentolamine|phentolamine|mesh-list
56892220|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56892221|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
56892222|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56892223|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
56892224|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56892225|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892226|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
56892227|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892228|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892229|NCT03616288|Thiamine|thiamine|mesh-list
56892230|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
56892231|NCT03616288|Vitamins|vitamins|mesh-ancestor
56892232|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
56892233|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892234|NCT02873338|Cytarabine|cytarabine|mesh-list
56892235|NCT02873338|Idarubicin|idarubicin|mesh-list
56892236|NCT02873338|Heparin|heparin|mesh-list
56892237|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56892238|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
56892239|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892240|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892241|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
56892242|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892243|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892244|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
56892245|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892246|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
56892247|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56892248|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56892249|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56892250|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56892251|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56892252|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892254|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56892255|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892256|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56892257|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892258|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
56892259|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892260|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
56844896|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
56844897|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844898|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56844899|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
56844900|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844901|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
56844902|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844903|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844904|NCT03711474|Dexamethasone|dexamethasone|mesh-list
56844905|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56844906|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
56844907|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
56844908|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56844909|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844910|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56844911|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
56892261|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892262|NCT02872012|Lidocaine|lidocaine|mesh-list
56892263|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
56892264|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
56892265|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892267|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
56892268|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892269|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56892270|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56892271|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56892272|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892273|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892274|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
56892275|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892276|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892277|NCT03615430|Anesthetics|anesthetics|mesh-list
56892278|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
56892279|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892280|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892281|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
56892282|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892283|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56892284|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56892285|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56892286|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56892287|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56892288|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56892289|NCT03613792|Fentanyl|fentanyl|mesh-list
56892290|NCT03613792|Midazolam|midazolam|mesh-list
56892291|NCT03613792|Ketamine|ketamine|mesh-list
56892292|NCT03613792|Remifentanil|remifentanil|mesh-list
56892293|NCT03613792|Analgesics|analgesics|mesh-ancestor
56892294|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
56892295|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892296|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892297|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56892298|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56892299|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
56892300|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
56892301|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892302|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56892303|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56892304|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895857|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
56844912|NCT03711474|Hormones|hormones|mesh-ancestor
56844913|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844914|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56844915|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844916|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
56844917|NCT03682536|Luspatercept|luspatercept|mesh-list
56844918|NCT03682536|Hematinics|hematinics|mesh-ancestor
56844919|NCT03675893|Metformin|metformin|mesh-list
56844920|NCT03675893|Letrozole|letrozole|mesh-list
56844921|NCT03675893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56844922|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844923|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892305|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892306|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56892307|NCT03613792|Narcotics|narcotics|mesh-ancestor
56892308|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56892309|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56892310|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56892311|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56892312|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56892313|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
56892314|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
56892315|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
56892316|NCT03276832|Imiquimod|imiquimod|mesh-list
56892317|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892318|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892319|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56892320|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
56892321|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892322|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
56892323|NCT04837768|Progesterone|progesterone|mesh-list
56892324|NCT04837768|Progestins|progestins|mesh-ancestor
56892325|NCT04837768|Hormones|hormones|mesh-ancestor
56892326|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892327|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892328|NCT02869438|Benralizumab|benralizumab|mesh-list
56892329|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56892330|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
56892331|NCT02868892|Pemetrexed|pemetrexed|mesh-list
56892332|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892333|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892334|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892335|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56892336|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56892337|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
56892338|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56603086|NCT02678949|Xhance|xhance|mesh-list
56892339|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892340|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892341|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56892342|NCT03613558|Analgesics|analgesics|mesh-ancestor
56892343|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
56892344|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892345|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56892346|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56892347|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56892348|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
56892349|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892350|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892351|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
56892352|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56892353|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892354|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56892355|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56892356|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844924|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56844925|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56844926|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844927|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844928|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56844929|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
56844930|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844931|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
56844932|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56844933|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844934|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
56844935|NCT03622788|Fludarabine|fludarabine|mesh-list
56844936|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56844937|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56844938|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
56844939|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844940|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56844941|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56844942|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
56892357|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892358|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892359|NCT03310125|Colchicine|colchicine|mesh-list
56892360|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
56892361|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56892362|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
56892363|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
56892364|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
56892365|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892366|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892367|NCT03613168|Trastuzumab|trastuzumab|mesh-list
56892368|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892369|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892370|NCT01141881|Bevacizumab|bevacizumab|mesh-list
56892371|NCT01141881|Plasminogen|plasminogen|mesh-list
56892372|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56892373|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892374|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892375|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56892376|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56892377|NCT01141881|Growth Substances|growth substances|mesh-ancestor
56892378|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892379|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
56892380|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56892381|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56892382|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892383|NCT04707430|Progesterone|progesterone|mesh-list
56892384|NCT04707430|Progestins|progestins|mesh-ancestor
56892385|NCT04707430|Hormones|hormones|mesh-ancestor
56892386|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892387|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892388|NCT03611920|Tetracycline|tetracycline|mesh-list
56892389|NCT03611920|Dexamethasone|dexamethasone|mesh-list
56892390|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56892391|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
56892392|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
56844943|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844944|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844945|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56844946|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56844947|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
56844948|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844949|NCT03482024|Tirzepatide|tirzepatide|mesh-list
56844950|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56844951|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844952|NCT03482024|Incretins|incretins|mesh-ancestor
56844953|NCT03482024|Hormones|hormones|mesh-ancestor
56844954|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844955|NCT03423199|Tamoxifen|tamoxifen|mesh-list
56844956|NCT03423199|Goserelin|goserelin|mesh-list
56844957|NCT03423199|Palbociclib|palbociclib|mesh-list
56844958|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56844959|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
56844960|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56844961|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844962|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56844963|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892393|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892394|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892395|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56892396|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
56892397|NCT03611920|Hormones|hormones|mesh-ancestor
56892398|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892399|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56892400|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892401|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56892402|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892403|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56892404|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892405|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892406|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56892407|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56892408|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
56892409|NCT02936752|Entinostat|entinostat|mesh-list
56892410|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56892411|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892412|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892413|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892414|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892415|NCT05383534|Propofol|propofol|mesh-list
56892416|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56892417|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892418|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892419|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56892420|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
56892421|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
56892422|NCT01235325|Vitamin K|vitamin k|mesh-list
56892423|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
56892424|NCT01235325|Vitamins|vitamins|mesh-ancestor
56844964|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56844965|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56844966|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56844967|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56844968|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844969|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844970|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
56844971|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56844972|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56844973|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56844974|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
56892425|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
56892426|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892427|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56892428|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56892429|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892430|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
56892431|NCT01235325|Coagulants|coagulants|mesh-ancestor
56892432|NCT01140009|Vaccines|vaccines|mesh-list
56892433|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
56892434|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892435|NCT01235637|Sufentanil|sufentanil|mesh-list
56892436|NCT01235637|Alfentanil|alfentanil|mesh-list
56892437|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56892438|NCT01235637|Narcotics|narcotics|mesh-ancestor
56892439|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892440|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892441|NCT01235637|Analgesics|analgesics|mesh-ancestor
56892442|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
56892443|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892444|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56892445|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56892446|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
56892447|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
56892448|NCT01143831|Vitamins|vitamins|mesh-list
56892449|NCT01143831|Vitamin K|vitamin k|mesh-list
56892450|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
56892451|NCT01143831|Menatetrenone|menatetrenone|mesh-list
56892452|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
56892453|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892454|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56892455|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56892456|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892457|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
56892458|NCT01143831|Coagulants|coagulants|mesh-ancestor
56892459|NCT04966299|Erythritol|erythritol|mesh-list
56892460|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
56892461|NCT01143987|Cinacalcet|cinacalcet|mesh-list
56892462|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56892463|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892464|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56892465|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
56892466|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892467|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
56892468|NCT01144065|Testosterone|testosterone|mesh-list
56892469|NCT01144065|Androgens|androgens|mesh-ancestor
56892470|NCT01144065|Hormones|hormones|mesh-ancestor
56892471|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892472|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892473|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56892474|NCT01142505|Mannitol|mannitol|mesh-list
56892475|NCT01142505|Montelukast|montelukast|mesh-list
56892476|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56480242|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
56892477|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
56892478|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56844975|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
56844976|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56844977|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56844978|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844979|NCT03418532|Osimertinib|osimertinib|mesh-list
56844980|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844981|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56844982|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56844983|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844984|NCT03417401|Plasminogen|plasminogen|mesh-list
56844985|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56844986|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56565153|NCT01052844|Analgesics|analgesics|mesh-ancestor
56892479|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
56892480|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892481|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892482|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56892483|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56892484|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892485|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56892487|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
56892488|NCT01236963|Listerine|listerine|mesh-list
56892489|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56892490|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892491|NCT02908672|Atezolizumab|atezolizumab|mesh-list
56892492|NCT02908672|Vemurafenib|vemurafenib|mesh-list
56892493|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56892494|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892495|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
56892496|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892497|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56892498|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892499|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892500|NCT02572167|Nivolumab|nivolumab|mesh-list
56892501|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56892502|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892503|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892504|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56892505|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892506|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
56892507|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56892508|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
56892509|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56892510|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892511|NCT01336738|Incretins|incretins|mesh-ancestor
56892512|NCT01336738|Hormones|hormones|mesh-ancestor
56892513|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892514|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56892515|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
56892516|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892517|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892518|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
56892519|NCT01336738|Vitamins|vitamins|mesh-ancestor
56892520|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
56892521|NCT01140399|Dopamine|dopamine|mesh-list
56892522|NCT01140399|Furosemide|furosemide|mesh-list
56892523|NCT01140399|Diuretics|diuretics|mesh-ancestor
56892524|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
56892525|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892526|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56844987|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56844988|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56844989|NCT03400332|Nivolumab|nivolumab|mesh-list
56844990|NCT03400332|Ipilimumab|ipilimumab|mesh-list
56844991|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844992|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844993|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56844994|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892527|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892528|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892529|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56892530|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
56892531|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
56892532|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892533|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
56892534|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892535|NCT01140399|Protective Agents|protective agents|mesh-ancestor
56892536|NCT02410317|Morphine|morphine|mesh-list
56892537|NCT02410317|Ropivacaine|ropivacaine|mesh-list
56892538|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56892539|NCT02410317|Narcotics|narcotics|mesh-ancestor
56892540|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892541|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892542|NCT02410317|Analgesics|analgesics|mesh-ancestor
56892543|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
56892544|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892545|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
56892546|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
56892547|NCT02258451|Everolimus|everolimus|mesh-list
56892548|NCT02258451|Exemestane|exemestane|mesh-list
56892549|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56892550|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892551|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892552|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
56892553|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892554|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56892555|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56892556|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892557|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892558|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56892559|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
56892560|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892561|NCT01237119|Liraglutide|liraglutide|mesh-list
56892562|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56892563|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892564|NCT01237119|Incretins|incretins|mesh-ancestor
56892565|NCT01237119|Hormones|hormones|mesh-ancestor
56892566|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892568|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892569|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
56892570|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892571|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56892572|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892573|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892574|NCT01237275|Sertraline|sertraline|mesh-list
56892575|NCT01237275|Fluoxetine|fluoxetine|mesh-list
56892576|NCT01237275|Paroxetine|paroxetine|mesh-list
56892577|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
56892578|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56892579|NCT01237275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56892580|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56892581|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892582|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892583|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892584|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
56892585|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56844995|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
56844996|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56844997|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56844998|NCT03322631|Tirzepatide|tirzepatide|mesh-list
56844999|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56845000|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845001|NCT03322631|Incretins|incretins|mesh-ancestor
56845002|NCT03322631|Hormones|hormones|mesh-ancestor
56845003|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845004|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
56845005|NCT03290612|Vitamins|vitamins|mesh-ancestor
56845006|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
56845007|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845008|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
56845009|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845010|NCT03290612|Protective Agents|protective agents|mesh-ancestor
56845011|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
56845012|NCT03262142|Tazobactam|tazobactam|mesh-list
56845013|NCT03262142|Piperacillin|piperacillin|mesh-list
56845014|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56845015|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56845016|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845017|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56845018|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56845019|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845020|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845021|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845022|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56845023|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56892586|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56892587|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56892588|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56892589|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892590|NCT04880499|Folic Acid|folic acid|mesh-list
56892591|NCT04880499|Riboflavin|riboflavin|mesh-list
56892592|NCT04880499|Vitamins|vitamins|mesh-ancestor
56892593|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
56892594|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892595|NCT04880499|Hematinics|hematinics|mesh-ancestor
56892596|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
56892597|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56892598|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
56892599|NCT04867785|Dulaglutide|dulaglutide|mesh-list
56892600|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56892601|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892602|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
56892603|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56845024|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56845025|NCT03173248|Azacitidine|azacitidine|mesh-list
56845026|NCT03173248|Ivosidenib|ivosidenib|mesh-list
56845027|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845028|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
56845029|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845030|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845031|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845032|NCT03161522|Fluorouracil|fluorouracil|mesh-list
56845033|NCT03161522|Capecitabine|capecitabine|mesh-list
56845034|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
56845035|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845036|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845037|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845038|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845039|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
56845040|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845041|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56845042|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845043|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845044|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56845045|NCT03057795|Nivolumab|nivolumab|mesh-list
56845046|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56845047|NCT03057795|Antibodies|antibodies|mesh-list
56845048|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
56845049|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56845050|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
56845051|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
56845052|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845053|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845054|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56845055|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845056|NCT03018704|Topiramate|topiramate|mesh-list
56565340|NCT00823576|Ropivacaine|ropivacaine|mesh-list
56892604|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56892605|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56892606|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892607|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892608|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
56892609|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892610|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892611|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56845057|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
56845058|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56892612|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892613|NCT02033434|Ketamine|ketamine|mesh-list
56892614|NCT02033434|Analgesics|analgesics|mesh-ancestor
56892615|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
56892616|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892617|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892618|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56892619|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56892620|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
56892621|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
56892622|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892623|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56892624|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56892625|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892626|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892627|NCT02033512|Hormones|hormones|mesh-list
56892628|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892629|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892630|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
56892631|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892632|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56892633|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892634|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892635|NCT02860546|Nivolumab|nivolumab|mesh-list
56892636|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892637|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892638|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56892639|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892640|NCT01982955|Carboplatin|carboplatin|mesh-list
56892641|NCT01982955|Pemetrexed|pemetrexed|mesh-list
56892642|NCT01982955|Gefitinib|gefitinib|mesh-list
56892643|NCT01982955|Tepotinib|tepotinib|mesh-list
56892644|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892645|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892646|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892647|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56892648|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56892649|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56892650|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
56892651|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56892652|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
56892653|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892654|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
56892655|NCT01144533|Protective Agents|protective agents|mesh-ancestor
56892656|NCT01238055|Docetaxel|docetaxel|mesh-list
56892657|NCT01238055|Sunitinib|sunitinib|mesh-list
56892658|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892659|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
56892660|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
56892661|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
56892662|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892663|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56892664|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56892665|NCT01238055|Growth Substances|growth substances|mesh-ancestor
56892666|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892667|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
56892668|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56892669|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892670|NCT01144923|Gabapentin|gabapentin|mesh-list
56892671|NCT01144923|Nortriptyline|nortriptyline|mesh-list
56892672|NCT01144923|Analgesics|analgesics|mesh-ancestor
56892673|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
56892674|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892675|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892676|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
56892677|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56892678|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56892679|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892680|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56892681|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56892682|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56845059|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845060|NCT03012529|Riboflavin|riboflavin|mesh-list
56845061|NCT03012529|Rifampin|rifampin|mesh-list
56845062|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56845063|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
56845064|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56845065|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845066|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
56845067|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56845068|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845069|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565458|NCT04259073|Pregabalin|pregabalin|mesh-list
56892683|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892684|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892685|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
56892686|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56892687|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
56892688|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56892689|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56892690|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892691|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
56892692|NCT01329783|Maraviroc|maraviroc|mesh-list
56892693|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56892694|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56892695|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892696|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56892697|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56892698|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
56892699|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892700|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56892701|NCT01238133|Paclitaxel|paclitaxel|mesh-list
56892702|NCT01238133|Carboplatin|carboplatin|mesh-list
56892703|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56892704|NCT01238133|R04929097|r04929097|mesh-list
56892705|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56892706|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892707|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
56892708|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
56892709|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
56892710|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892711|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892712|NCT01145079|Sirolimus|sirolimus|mesh-list
56892713|NCT01145079|Everolimus|everolimus|mesh-list
56892714|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892715|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892716|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
56892717|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892718|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56892719|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892720|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56892721|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
56892723|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56892724|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56892725|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56892726|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
56892727|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892728|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56892729|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56892730|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892731|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56892732|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56892733|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56892734|NCT00396279|Vitamin D|vitamin d|mesh-list
56892735|NCT00396279|Denosumab|denosumab|mesh-list
56845070|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56845071|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56845072|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56845073|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56845074|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56845075|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56845076|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
56845077|NCT03012529|Vitamins|vitamins|mesh-ancestor
56845078|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
56845079|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845080|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56845081|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
56892736|NCT00396279|Calcium|calcium|mesh-list
56892737|NCT00396279|Vitamins|vitamins|mesh-ancestor
56892738|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
56892739|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892740|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56892741|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56892742|NCT01238367|Factor VIII|factor viii|mesh-list
56892743|NCT01238367|Coagulants|coagulants|mesh-ancestor
56892744|NCT01347866|Irinotecan|irinotecan|mesh-list
56892745|NCT01347866|Gedatolisib|gedatolisib|mesh-list
56892746|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56892747|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56892748|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892749|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892750|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892751|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56892752|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56892753|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
56892754|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56892755|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892756|NCT05470868|Naphazoline|naphazoline|mesh-list
56892757|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56892758|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56892759|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
56892760|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892761|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892762|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892763|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
56892764|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56892765|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
56892766|NCT03485222|Empagliflozin|empagliflozin|mesh-list
56892767|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56892768|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892769|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56892770|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892771|NCT01347554|Everolimus|everolimus|mesh-list
56892772|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892773|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892774|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
56892775|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892776|NCT05567354|Oxycodone|oxycodone|mesh-list
56892777|NCT05567354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56892778|NCT05567354|Narcotics|narcotics|mesh-ancestor
56892779|NCT05567354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892780|NCT05567354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892781|NCT05567354|Analgesics|analgesics|mesh-ancestor
56892782|NCT05567354|Sensory System Agents|sensory system agents|mesh-ancestor
56892783|NCT05567354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892784|NCT03482882|Pimavanserin|pimavanserin|mesh-list
56892785|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56845082|NCT02978612|Capecitabine|capecitabine|mesh-list
56845083|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56892786|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56892787|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56892788|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56892789|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892790|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892791|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56892792|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56892793|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56892794|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
56892795|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892796|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892797|NCT03480932|Interferons|interferons|mesh-list
56892798|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
56892799|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
56892800|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56892801|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
56892802|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892803|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
56892804|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892805|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
56892806|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892807|NCT03387020|Everolimus|everolimus|mesh-list
56892808|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892809|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892810|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
56892811|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892812|NCT03386474|Aflibercept|aflibercept|mesh-list
56892813|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56892814|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56892815|NCT03386474|Growth Substances|growth substances|mesh-ancestor
56892816|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892817|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
56892818|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892819|NCT02446600|Gemcitabine|gemcitabine|mesh-list
56892820|NCT02446600|Paclitaxel|paclitaxel|mesh-list
56892821|NCT02446600|Carboplatin|carboplatin|mesh-list
56892822|NCT02446600|Doxorubicin|doxorubicin|mesh-list
56892823|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56892824|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56892825|NCT02446600|Olaparib|olaparib|mesh-list
56892826|NCT02446600|Cediranib|cediranib|mesh-list
56892827|NCT02446600|Maleic acid|maleic acid|mesh-list
56892828|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56892829|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892830|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
56892831|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
56892832|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
56892833|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892834|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56892835|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
56892836|NCT02446600|Antiviral Agents|antiviral agents|mesh-ancestor
56892837|NCT02446600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892838|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892839|NCT02446600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892840|NCT02446600|Immunologic Factors|immunologic factors|mesh-ancestor
56892841|NCT02446600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892842|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56892843|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56892844|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56892845|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56892846|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56892847|NCT03405818|Tavaborole|tavaborole|mesh-list
56892848|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
56892849|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892850|NCT03403634|Interferons|interferons|mesh-list
56892851|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
56892852|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
56892853|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56892854|NCT03403634|Celecoxib|celecoxib|mesh-list
56892855|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
56892856|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892857|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
56892858|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892859|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
55895934|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845084|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
56845085|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845086|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845087|NCT02970500|Methylphenidate|methylphenidate|mesh-list
56845088|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56845089|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845090|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56565639|NCT02702206|Triamcinolone|triamcinolone|mesh-list
56892860|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892861|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56892862|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56892863|NCT03403634|Analgesics|analgesics|mesh-ancestor
56892864|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
56892865|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892866|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56892867|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56892868|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56892869|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56892870|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892871|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892872|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56892873|NCT02863354|Aflibercept|aflibercept|mesh-list
56892874|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56892875|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56892876|NCT02863354|Growth Substances|growth substances|mesh-ancestor
56892877|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892878|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
56892879|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892880|NCT02859454|Avelumab|avelumab|mesh-list
56892881|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892882|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892883|NCT02862730|Pancrelipase|pancrelipase|mesh-list
56892884|NCT02862730|Pancreatin|pancreatin|mesh-list
56892885|NCT02862730|Hormones|hormones|mesh-list
56892886|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892887|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56892888|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56892889|NCT03401450|Bupivacaine|bupivacaine|mesh-list
56892890|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
56892891|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
56892892|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892893|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892894|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
56892895|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892896|NCT03609970|Vitamin D|vitamin d|mesh-list
56892897|NCT03609970|Vitamins|vitamins|mesh-ancestor
56892898|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
56892899|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892900|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56892901|NCT03610282|Propofol|propofol|mesh-list
56892902|NCT03610282|Methylphenidate|methylphenidate|mesh-list
56892903|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56892904|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56892905|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892906|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56892907|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
56892908|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
56892909|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56892910|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56892911|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56892912|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56892913|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892914|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
56892915|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892916|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56892917|NCT02862574|Methotrexate|methotrexate|mesh-list
56845091|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56845092|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56845093|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845094|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
56892918|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56892919|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
56892920|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56892921|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892922|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56892923|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
56892924|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892925|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892927|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892928|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56892929|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56892930|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
56892931|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56892932|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56892933|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56892934|NCT05383300|Oxytocin|oxytocin|mesh-list
56892935|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
56892936|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56892937|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892938|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56892939|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56892940|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892941|NCT02862106|Vaccines|vaccines|mesh-list
56892942|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
56892943|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892944|NCT03609892|Amoxicillin|amoxicillin|mesh-list
56892945|NCT03609892|Tetracycline|tetracycline|mesh-list
56892946|NCT03609892|Furazolidone|furazolidone|mesh-list
56892947|NCT03609892|Esomeprazole|esomeprazole|mesh-list
56892948|NCT03609892|Bismuth|bismuth|mesh-list
56892949|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56892950|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56892951|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56892952|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56892953|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56892954|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892955|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892956|NCT03609892|Antacids|antacids|mesh-ancestor
56892957|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56892958|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56892959|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56892960|NCT03609892|Renal Agents|renal agents|mesh-ancestor
56892961|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56892962|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56892963|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56892964|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56892965|NCT03609814|Fludarabine|fludarabine|mesh-list
56892966|NCT03609814|Clofarabine|clofarabine|mesh-list
56892967|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892968|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56892969|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
56892970|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892971|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
56892972|NCT02457598|Idelalisib|idelalisib|mesh-list
56892973|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56892974|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56892975|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892976|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892977|NCT02859142|Nicotine|nicotine|mesh-list
56892978|NCT02859142|Varenicline|varenicline|mesh-list
56892979|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56892980|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
56892981|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892982|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892983|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56892984|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56892985|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
56845095|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56845096|NCT02951130|Milrinone|milrinone|mesh-list
56845097|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56845098|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56845099|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
56845100|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56845101|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56845102|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845103|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845104|NCT02951130|Protective Agents|protective agents|mesh-ancestor
56845105|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845106|NCT02810743|Olaparib|olaparib|mesh-list
56845107|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56845108|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56892986|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56892987|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56892988|NCT01863550|Dexamethasone|dexamethasone|mesh-list
56892989|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
56892990|NCT01863550|Lenalidomide|lenalidomide|mesh-list
56892991|NCT01863550|Bortezomib|bortezomib|mesh-list
56892992|NCT01863550|Ichthammol|ichthammol|mesh-list
56892993|NCT01863550|BB 1101|bb 1101|mesh-list
56892994|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56892995|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
56892996|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
56892997|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56892998|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56892999|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893000|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
56893001|NCT01863550|Hormones|hormones|mesh-ancestor
56893002|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893003|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56893004|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893005|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
56893006|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56893007|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56893008|NCT01863550|Growth Substances|growth substances|mesh-ancestor
56893009|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
56893010|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
56893011|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893012|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893013|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56603760|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893014|NCT03351608|Atropine|atropine|mesh-list
56893015|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
56893016|NCT03351608|Neostigmine|neostigmine|mesh-list
56893017|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56893018|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56893019|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56893020|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
56893021|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893022|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893023|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56893024|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
56893025|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
56893026|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
56893027|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56893028|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56893029|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
56893030|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893031|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893032|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56845109|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845110|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845111|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
56845112|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845113|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845114|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845115|NCT02617407|Listerine|listerine|mesh-list
56845116|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
56845117|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
56845118|NCT02617407|Protective Agents|protective agents|mesh-ancestor
56845119|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845120|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56845121|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845122|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
56845123|NCT02537509|Vitamin D|vitamin d|mesh-list
56845124|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56845125|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845126|NCT02537509|Vitamins|vitamins|mesh-ancestor
56845127|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
56845128|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56845129|NCT02490878|Bevacizumab|bevacizumab|mesh-list
56845130|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845131|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893033|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893034|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56893035|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56893036|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56893037|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
56893038|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893039|NCT03382418|Antacids|antacids|mesh-ancestor
56893040|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893041|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893042|NCT03382262|Triamcinolone|triamcinolone|mesh-list
56893043|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56893044|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56893045|NCT03382262|FX006|fx006|mesh-list
56893046|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56893047|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893048|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
56893049|NCT03382262|Hormones|hormones|mesh-ancestor
56893050|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893051|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893052|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893053|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
56893054|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893055|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893056|NCT02236936|Cetuximab|cetuximab|mesh-list
56893057|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893058|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56893059|NCT03638960|Bupivacaine|bupivacaine|mesh-list
56893060|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
56893061|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
56893062|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845132|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56845133|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56845134|NCT02490878|Growth Substances|growth substances|mesh-ancestor
56845135|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845136|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
56845137|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
56845138|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845139|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845140|NCT02386800|Panobinostat|panobinostat|mesh-list
56845141|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845142|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56565899|NCT02705482|Durvalumab|durvalumab|mesh-list
56893063|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893064|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
56893065|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893066|NCT02259790|Amlodipine|amlodipine|mesh-list
56893067|NCT02259790|Telmisartan|telmisartan|mesh-list
56893068|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56893069|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56893070|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56893071|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56893072|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893073|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56893074|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893075|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
56893076|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56893077|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56893078|NCT02857270|Gemcitabine|gemcitabine|mesh-list
56893079|NCT02857270|Paclitaxel|paclitaxel|mesh-list
56893080|NCT02857270|Cetuximab|cetuximab|mesh-list
56893081|NCT02857270|Midazolam|midazolam|mesh-list
56893082|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56893083|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893084|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
56893085|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
56893086|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
56893087|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893088|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56893089|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
56893090|NCT02857270|Antiviral Agents|antiviral agents|mesh-ancestor
56893091|NCT02857270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893092|NCT02857270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893093|NCT02857270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893094|NCT02857270|Immunologic Factors|immunologic factors|mesh-ancestor
56893095|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893096|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56893097|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56893098|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893099|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56893100|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56893101|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56893102|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56893103|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
56893104|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
56893105|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
56893106|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
56893107|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893108|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56893109|NCT03609190|Ketamine|ketamine|mesh-list
56893110|NCT03609190|Analgesics|analgesics|mesh-ancestor
56893111|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
56893112|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893113|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893114|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56845143|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845144|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845145|NCT02359175|Acetaminophen|acetaminophen|mesh-list
56845146|NCT02359175|Fentanyl|fentanyl|mesh-list
56845147|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
56845148|NCT02359175|Bupivacaine|bupivacaine|mesh-list
56845149|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
56845150|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
56893115|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56893116|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
56893117|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
56893118|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893119|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56893120|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56893121|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893122|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893123|NCT02856880|Zinc|zinc|mesh-list
56893124|NCT02856880|Trace Elements|trace elements|mesh-ancestor
56893125|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
56893126|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893127|NCT02856802|Sumatriptan|sumatriptan|mesh-list
56893128|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56893129|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56893130|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56893131|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
56893132|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893133|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893134|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893135|NCT02157610|Nicotine|nicotine|mesh-list
56893136|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56893137|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
56893138|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893139|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893140|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56893141|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56893142|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
56893143|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893144|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893145|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
56893146|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56893147|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
56893148|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893149|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
56893150|NCT03381248|Protective Agents|protective agents|mesh-ancestor
56893151|NCT02024230|Warfarin|warfarin|mesh-list
56893152|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
56893153|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
56893154|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56893155|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
56893156|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56893157|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
56893158|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893159|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893160|NCT03380390|Phenylephrine|phenylephrine|mesh-list
56893161|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
56893162|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56893163|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56893164|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893165|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893166|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893167|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893168|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
56893169|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
56893170|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893171|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
56893172|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56893173|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
56893174|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56893175|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
56845151|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845152|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845153|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
56845154|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845155|NCT02359175|Narcotics|narcotics|mesh-ancestor
56845156|NCT02359175|Analgesics|analgesics|mesh-ancestor
56845157|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56845158|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56845159|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
56845160|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56845161|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
56845162|NCT02332850|Dexamethasone|dexamethasone|mesh-list
56845163|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56845164|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
56845165|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
56845166|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845167|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845168|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893176|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56893177|NCT03380390|Protective Agents|protective agents|mesh-ancestor
56893178|NCT01935778|Docetaxel|docetaxel|mesh-list
56893179|NCT01935778|Capecitabine|capecitabine|mesh-list
56893180|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
56893181|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893182|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56893183|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56893184|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56893185|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893186|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56893187|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
56893188|NCT02034292|Aspirin|aspirin|mesh-list
56893189|NCT02034292|Clopidogrel|clopidogrel|mesh-list
56893190|NCT02034292|APD791|apd791|mesh-list
56893191|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56893192|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56893193|NCT02034292|Analgesics|analgesics|mesh-ancestor
56893194|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
56893195|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893196|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893197|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893198|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56893199|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56893200|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56893201|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893202|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56893203|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56893204|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893205|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
56893206|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56893207|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56893208|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56893209|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
56893210|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893211|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56893212|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56893213|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
56893214|NCT01758328|Fludarabine|fludarabine|mesh-list
56893215|NCT01758328|Melphalan|melphalan|mesh-list
56893216|NCT01758328|Busulfan|busulfan|mesh-list
56845169|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
56845170|NCT02332850|Hormones|hormones|mesh-ancestor
56845171|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845172|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56845173|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845174|NCT02310321|Cytarabine|cytarabine|mesh-list
56845175|NCT02310321|Idarubicin|idarubicin|mesh-list
56845176|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845177|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
56845178|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845179|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845180|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
56845181|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845182|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845183|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
56893217|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56893218|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893219|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893220|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893221|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
56893222|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893223|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56893224|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
56893225|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56893226|NCT04125550|Propofol|propofol|mesh-list
56893227|NCT04125550|Sevoflurane|sevoflurane|mesh-list
56893228|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56893229|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893230|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893231|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56893232|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
56893233|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
56893234|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56893235|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56893236|NCT02237326|Acetic Acid|acetic acid|mesh-list
56893237|NCT02237326|Retinol acetate|retinol acetate|mesh-list
56893238|NCT02237326|Lugol's solution|lugol's solution|mesh-list
56893239|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56893240|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893241|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56893242|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
56893243|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893244|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56893245|NCT02237326|Protective Agents|protective agents|mesh-ancestor
56893246|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893247|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
56893248|NCT02237326|Coagulants|coagulants|mesh-ancestor
56893250|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56893251|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56893252|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56893253|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893254|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893255|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893256|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893257|NCT02034604|Urological Agents|urological agents|mesh-ancestor
56893258|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
56893259|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56893260|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56893261|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893262|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895987|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
56845184|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845185|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56845186|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56845187|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56845188|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845189|NCT02262325|Etoposide|etoposide|mesh-list
56845190|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
56845191|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845192|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56845193|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56845194|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56845195|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566146|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
56893263|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893264|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893265|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
56893266|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
56893267|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893268|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
56893269|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56893270|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
56893271|NCT02035072|Gemcitabine|gemcitabine|mesh-list
56893272|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
56893273|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56893274|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
56893275|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893276|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893277|NCT02035072|Antiviral Agents|antiviral agents|mesh-ancestor
56893278|NCT02035072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893279|NCT02035072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893280|NCT02035072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893281|NCT02035072|Immunologic Factors|immunologic factors|mesh-ancestor
56893282|NCT02035072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893283|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
56893284|NCT00358215|Hematinics|hematinics|mesh-ancestor
56893285|NCT03605758|Ivermectin|ivermectin|mesh-list
56893286|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56893287|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893288|NCT03605056|Dexamethasone|dexamethasone|mesh-list
56893289|NCT03605056|Lenalidomide|lenalidomide|mesh-list
56893290|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893291|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
56893292|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
56893293|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893294|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893295|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893296|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
56893297|NCT03605056|Hormones|hormones|mesh-ancestor
56893298|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893299|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56893300|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893301|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
56893302|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56893303|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56893304|NCT03605056|Growth Substances|growth substances|mesh-ancestor
56893305|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
56893306|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
56893307|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56893308|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893309|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56893310|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
56893311|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56893312|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845196|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845197|NCT02205762|Cytarabine|cytarabine|mesh-list
56845198|NCT02205762|Prednisone|prednisone|mesh-list
56845199|NCT02205762|Indomethacin|indomethacin|mesh-list
56893313|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893314|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893316|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
56893317|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893318|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56893319|NCT03604354|Pregabalin|pregabalin|mesh-list
56893320|NCT03604354|Tapentadol|tapentadol|mesh-list
56893321|NCT03604354|Analgesics|analgesics|mesh-ancestor
56893322|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
56893323|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893324|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893325|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
56893326|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56893327|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56893328|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893329|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56893330|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56893331|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56893332|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893333|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56893334|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56893335|NCT03604354|Narcotics|narcotics|mesh-ancestor
56893336|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56893337|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56893338|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893339|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893340|NCT03603418|Dexamethasone|dexamethasone|mesh-list
56893341|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
56893342|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56893343|NCT03603418|BB 1101|bb 1101|mesh-list
56893344|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893345|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
56893346|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
56893347|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893348|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893349|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893350|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
56893351|NCT03603418|Hormones|hormones|mesh-ancestor
56893352|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893353|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56893354|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893355|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
56893356|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893357|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893358|NCT03184870|Leucovorin|leucovorin|mesh-list
56893359|NCT03184870|Gemcitabine|gemcitabine|mesh-list
56893360|NCT03184870|Paclitaxel|paclitaxel|mesh-list
56893361|NCT03184870|Fluorouracil|fluorouracil|mesh-list
56893362|NCT03184870|Nivolumab|nivolumab|mesh-list
56893363|NCT03184870|Irinotecan|irinotecan|mesh-list
56893364|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56893365|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893366|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
56893367|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
56893368|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
56893369|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893370|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56893371|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
56893372|NCT03184870|Antiviral Agents|antiviral agents|mesh-ancestor
56893373|NCT03184870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893374|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893375|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893376|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
56893377|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893378|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56893379|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56893380|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56893381|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56893382|NCT03184870|Antidotes|antidotes|mesh-ancestor
56845200|NCT02205762|Methotrexate|methotrexate|mesh-list
56845201|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
56845202|NCT02205762|Vinblastine|vinblastine|mesh-list
56845203|NCT02205762|Cladribine|cladribine|mesh-list
56845204|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
56845205|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56845206|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
56845207|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56845208|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893383|NCT03184870|Protective Agents|protective agents|mesh-ancestor
56893384|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
56893385|NCT03184870|Vitamins|vitamins|mesh-ancestor
56893386|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
56893387|NCT02034838|Ritonavir|ritonavir|mesh-list
56893388|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56893389|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56893390|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56893391|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
56893392|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893393|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893394|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56893395|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56893396|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
56893397|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893398|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56893399|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56893400|NCT03287908|Dexamethasone|dexamethasone|mesh-list
56893401|NCT03287908|Pomalidomide|pomalidomide|mesh-list
56893402|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893403|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
56893404|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
56893405|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893406|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893407|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893408|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
56893409|NCT03287908|Hormones|hormones|mesh-ancestor
56893410|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893411|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56893412|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893413|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
56893414|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56893415|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56893416|NCT03287908|Growth Substances|growth substances|mesh-ancestor
56893417|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
56893418|NCT02852434|Lidocaine|lidocaine|mesh-list
56893419|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
56893420|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
56893421|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893422|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893423|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
56893424|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893425|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56893426|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56893427|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56893428|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56893429|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893430|NCT03606928|Leucovorin|leucovorin|mesh-list
56893431|NCT03606928|Docetaxel|docetaxel|mesh-list
56893432|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
56893433|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893434|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
56893435|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
56893436|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
56893437|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893438|NCT03606928|Antidotes|antidotes|mesh-ancestor
56893439|NCT03606928|Protective Agents|protective agents|mesh-ancestor
56893440|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893441|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
56893442|NCT03606928|Vitamins|vitamins|mesh-ancestor
56893443|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
56845209|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
56845210|NCT02205762|Hormones|hormones|mesh-ancestor
56845211|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845212|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845213|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56845214|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845215|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56845216|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
56845217|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56845218|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845219|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
56845220|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893444|NCT02903368|Prednisone|prednisone|mesh-list
56893445|NCT02903368|Leuprolide|leuprolide|mesh-list
56893446|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
56893447|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893448|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
56893449|NCT02903368|Hormones|hormones|mesh-ancestor
56893450|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893451|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893452|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56893453|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893454|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56893455|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
56893456|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56893457|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56893458|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893459|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893460|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
56893461|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56893462|NCT03602248|Methamphetamine|methamphetamine|mesh-list
56893463|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56893464|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893465|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
56893466|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
56893467|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893468|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
56893469|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893470|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893471|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893472|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56893473|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56893474|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56893475|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56893476|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56893477|NCT03602638|Acarbose|acarbose|mesh-list
56893478|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56893479|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893480|NCT03602638|Incretins|incretins|mesh-ancestor
56893481|NCT03602638|Hormones|hormones|mesh-ancestor
56893482|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893483|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56893484|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
56893485|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893486|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893487|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56893488|NCT02237560|Camphor|camphor|mesh-list
56893489|NCT02237560|Salicylates|salicylates|mesh-list
56893490|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
56893491|NCT02237560|Menthol|menthol|mesh-list
56845221|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
56845222|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845223|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56845224|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845225|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
56845226|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845227|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56845228|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
56845229|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845230|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56845231|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
56845232|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
56845233|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
56845234|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56845235|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56845236|NCT02205762|Analgesics|analgesics|mesh-ancestor
56845237|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
56845238|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845239|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
56845240|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
56845241|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56845242|NCT01996267|Paclitaxel|paclitaxel|mesh-list
56845243|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
56845244|NCT01996267|Carboplatin|carboplatin|mesh-list
56845245|NCT01996267|Fluorouracil|fluorouracil|mesh-list
56845246|NCT01996267|Trastuzumab|trastuzumab|mesh-list
56845247|NCT01996267|Pertuzumab|pertuzumab|mesh-list
56893492|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56893493|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893494|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
56893495|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
56893496|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56893497|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56893498|NCT02237560|Analgesics|analgesics|mesh-ancestor
56893499|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
56893500|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893501|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893502|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893503|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56893504|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56893505|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893506|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893507|NCT03602014|Droxidopa|droxidopa|mesh-list
56893508|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56893509|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56893510|NCT03601624|Dexamethasone|dexamethasone|mesh-list
56893511|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
56893512|NCT03601624|Pomalidomide|pomalidomide|mesh-list
56893513|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893514|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
56893515|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893516|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845248|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56845249|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845250|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
56845251|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
56845252|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
56845253|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845254|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845255|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
56845256|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845257|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845258|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56845259|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
56845260|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56845261|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
56845262|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845263|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845264|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
56845265|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56566479|NCT01021878|Icodextrin|icodextrin|mesh-list
56893517|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56893518|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
56893519|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893520|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893521|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56893522|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893523|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
56893524|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
56893525|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893526|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893527|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
56893528|NCT03601624|Hormones|hormones|mesh-ancestor
56893529|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893530|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56893531|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56893532|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56893533|NCT03601624|Growth Substances|growth substances|mesh-ancestor
56893534|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
56893535|NCT03899428|Sorafenib|sorafenib|mesh-list
56893536|NCT03899428|Durvalumab|durvalumab|mesh-list
56893537|NCT03899428|Lenvatinib|lenvatinib|mesh-list
56893538|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893539|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56893540|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893541|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893542|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56893543|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
56893544|NCT02238418|Vitamin D|vitamin d|mesh-list
56893545|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56893546|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893547|NCT02238418|Vitamins|vitamins|mesh-ancestor
56604286|NCT02653833|Tadalafil|tadalafil|mesh-list
56893548|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
56893549|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56893550|NCT00697684|Clofarabine|clofarabine|mesh-list
56893551|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56893552|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845266|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
56845267|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845268|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
56845269|NCT01934218|Protective Agents|protective agents|mesh-ancestor
56845270|NCT01898117|Paclitaxel|paclitaxel|mesh-list
56845271|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56845272|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
56845273|NCT01898117|Carboplatin|carboplatin|mesh-list
56845274|NCT01898117|Atezolizumab|atezolizumab|mesh-list
56845275|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56845276|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56845277|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845278|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
56845279|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
56845280|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
56845281|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845282|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845283|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
56845284|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845285|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845286|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56845287|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
56845288|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56845289|NCT01810913|Cisplatin|cisplatin|mesh-list
56845290|NCT01810913|Docetaxel|docetaxel|mesh-list
56845291|NCT01810913|Cetuximab|cetuximab|mesh-list
56845292|NCT01810913|Atezolizumab|atezolizumab|mesh-list
56845293|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56845294|NCT01810913|Antibodies|antibodies|mesh-list
56845295|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
56845296|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56845297|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
56845298|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893553|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
56893554|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893555|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893556|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
56893557|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893558|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893559|NCT02850016|Romidepsin|romidepsin|mesh-list
56893560|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56893561|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56893562|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893563|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893564|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845299|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845300|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
56845301|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
56845302|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
56845303|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845304|NCT01623167|Cyclosporine|cyclosporine|mesh-list
56845305|NCT01623167|Cyclosporins|cyclosporins|mesh-list
56845306|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56556082|NCT00633802|Risperidone|risperidone|mesh-list
56845307|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845308|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845309|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845310|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
56845311|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845312|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
56845313|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845314|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
56845315|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845316|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56845317|NCT01597388|Fulvestrant|fulvestrant|mesh-list
56845318|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56845319|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845320|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56845321|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56566566|NCT01104701|Incretins|incretins|mesh-ancestor
56893565|NCT02849704|Pancrelipase|pancrelipase|mesh-list
56893566|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893567|NCT03600766|Mirabegron|mirabegron|mesh-list
56893568|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56893569|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56893570|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56893571|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893572|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893573|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893574|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893575|NCT03600766|Urological Agents|urological agents|mesh-ancestor
56893576|NCT03600454|Anesthetics|anesthetics|mesh-list
56893577|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893578|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893579|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
56893580|NCT03594604|Norethindrone|norethindrone|mesh-list
56893581|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
56893582|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
56893583|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56893584|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56893585|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893586|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56893587|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56893588|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56893589|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56893590|NCT02689258|Bupivacaine|bupivacaine|mesh-list
56845322|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
56893591|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
56893592|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
56893593|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893594|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893595|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
56893596|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893597|NCT02238184|Ipratropium|ipratropium|mesh-list
56893598|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56893599|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
56893600|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893601|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893602|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56893603|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
56893604|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56893605|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
56893606|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893607|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893608|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
56893609|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56893610|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56893611|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893612|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56893613|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56893614|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
56893615|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56893616|NCT03600064|Misoprostol|misoprostol|mesh-list
56893617|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56893618|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
56893619|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56893620|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893621|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56893622|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56604361|NCT00733525|Fluoxetine|fluoxetine|mesh-list
56893623|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
56893624|NCT02721082|Nicotine|nicotine|mesh-list
56893625|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56893626|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
56893627|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893628|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893629|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56893630|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56893631|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
56893632|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893633|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893634|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56893635|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56893636|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
56893637|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893638|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893639|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56893640|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
56893641|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56893642|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56893643|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56893644|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893645|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893646|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893647|NCT03577912|Anesthetics|anesthetics|mesh-list
56893648|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893649|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893650|NCT02238262|Telmisartan|telmisartan|mesh-list
56893651|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56893652|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56893653|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56893654|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893655|NCT03577834|Acetic Acid|acetic acid|mesh-list
56893656|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56893657|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893658|NCT03373760|Durvalumab|durvalumab|mesh-list
56893659|NCT03373760|Ipilimumab|ipilimumab|mesh-list
56893660|NCT03373760|Tremelimumab|tremelimumab|mesh-list
56893661|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
56893662|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56893663|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
56845323|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845324|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845325|NCT01233635|Losartan|losartan|mesh-list
56845326|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56845327|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56845328|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56845329|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56845330|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845331|NCT01125228|Interferons|interferons|mesh-list
56845332|NCT01125228|Interferon-alpha|interferon-alpha|mesh-list
56845333|NCT01125228|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56845334|NCT01125228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845335|NCT01125228|Antiviral Agents|antiviral agents|mesh-ancestor
56845336|NCT01125228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845337|NCT01125228|Immunologic Factors|immunologic factors|mesh-ancestor
56845338|NCT01125228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845339|NCT00385606|Gemcitabine|gemcitabine|mesh-list
56845340|NCT00385606|Rofecoxib|rofecoxib|mesh-list
56845341|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566677|NCT00918645|Calcium|calcium|mesh-list
56893664|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56893665|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893666|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
56893667|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893668|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56893669|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893670|NCT03707678|Albuterol|albuterol|mesh-list
56893671|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56893672|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
56893673|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893674|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893675|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56893676|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
56893677|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
56893678|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56893679|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56893680|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56893681|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56893682|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893683|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893684|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893685|NCT02949128|Ravulizumab|ravulizumab|mesh-list
56893686|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56893687|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893688|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
56893689|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893690|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
56893691|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56893692|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893693|NCT04773002|Anesthetics|anesthetics|mesh-list
56893694|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893695|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604446|NCT05742295|Vitamin K|vitamin k|mesh-list
56893696|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56893697|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56845342|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845343|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
56566734|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
56893698|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893699|NCT02849080|Incretins|incretins|mesh-ancestor
56893700|NCT02849080|Hormones|hormones|mesh-ancestor
56893701|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893702|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56893703|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
56893704|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893705|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893706|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
56893707|NCT03346070|Rocuronium|rocuronium|mesh-list
56893708|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
56893709|NCT03346070|Neostigmine|neostigmine|mesh-list
56893710|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56893711|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56893712|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56893713|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893714|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893715|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56893716|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893717|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893718|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
56893719|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893720|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56893721|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
56893722|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56893723|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56893724|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56893725|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56893726|NCT03590626|Dulaglutide|dulaglutide|mesh-list
56893727|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56893728|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893729|NCT03579784|Paclitaxel|paclitaxel|mesh-list
56893730|NCT03579784|Durvalumab|durvalumab|mesh-list
56893731|NCT03579784|Olaparib|olaparib|mesh-list
56893732|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56893733|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893734|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
56893735|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
56893736|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
56893737|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893738|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56893739|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56893740|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893741|NCT02238340|Ketoprofen|ketoprofen|mesh-list
56893742|NCT02238340|Morphine|morphine|mesh-list
56893743|NCT02238340|Oxycodone|oxycodone|mesh-list
56893744|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56893745|NCT02238340|Narcotics|narcotics|mesh-ancestor
56893746|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893747|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893748|NCT02238340|Analgesics|analgesics|mesh-ancestor
56893749|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
56893750|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893751|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56893752|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56893753|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893754|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56893755|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56893756|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893757|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893758|NCT03577132|Atezolizumab|atezolizumab|mesh-list
56893759|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893760|NCT05194124|alpha-MSH|alpha-msh|mesh-list
56893761|NCT05194124|Hormones|hormones|mesh-ancestor
56893762|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893763|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893764|NCT02250664|Nicotine|nicotine|mesh-list
56893765|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56893766|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
56893767|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845344|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845345|NCT00385606|Antiviral Agents|antiviral agents|mesh-ancestor
56845346|NCT00385606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845347|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845348|NCT00385606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845349|NCT00385606|Immunologic Factors|immunologic factors|mesh-ancestor
56845350|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845351|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56845352|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56845353|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56845354|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56845355|NCT00385606|Analgesics|analgesics|mesh-ancestor
56845356|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
56566806|NCT00832819|Lenvatinib|lenvatinib|mesh-list
56893768|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893769|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56893770|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56604507|NCT05538247|Indomethacin|indomethacin|mesh-list
56893771|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
56893772|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893773|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893774|NCT02239276|Stiripentol|stiripentol|mesh-list
56893775|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
56893776|NCT03576820|Lidocaine|lidocaine|mesh-list
56893777|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56893778|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
56893779|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
56893780|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893781|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893782|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
56893783|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893784|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56893785|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56893786|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56893787|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56893788|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893789|NCT03579082|Decitabine|decitabine|mesh-list
56893790|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56893791|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
56893792|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893793|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893794|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893795|NCT03579004|Paclitaxel|paclitaxel|mesh-list
56893796|NCT03579004|Fluorouracil|fluorouracil|mesh-list
56893797|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56893798|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893799|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56893800|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56893801|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56893802|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893803|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
56893804|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56893805|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893806|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
56893807|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893808|NCT03576508|Lidocaine|lidocaine|mesh-list
56893809|NCT03576508|Epinephrine|epinephrine|mesh-list
56893810|NCT03576508|Capsaicin|capsaicin|mesh-list
56893811|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
56893812|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
56893813|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845357|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845358|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893814|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893815|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
56893816|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893817|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56893818|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56893819|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56893820|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56893821|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893822|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56893823|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56893824|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
56893825|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893826|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56893827|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56893828|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
56893829|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56893830|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
56893831|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
56893832|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
56893833|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56893834|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
56893835|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
56893836|NCT02646982|Candesartan|candesartan|mesh-list
56893837|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56893838|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56893839|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56893840|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893841|NCT03576040|Edotreotide|edotreotide|mesh-list
56893842|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56893843|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893844|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
56893845|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56893846|NCT03574246|Benzydamine|benzydamine|mesh-list
56893847|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56893848|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893849|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
56893850|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
56893851|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893852|NCT02239900|Ipilimumab|ipilimumab|mesh-list
56893853|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56893854|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893855|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56893856|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893857|NCT03574090|Amoxicillin|amoxicillin|mesh-list
56893858|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
56893859|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
56893860|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56893861|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56893862|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893863|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56893864|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893865|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893866|NCT03573934|Glucagon|glucagon|mesh-list
56893867|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56893868|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893869|NCT03573934|Hormones|hormones|mesh-ancestor
56893870|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893871|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893872|NCT03573934|Incretins|incretins|mesh-ancestor
56893873|NCT02229136|Prednisolone|prednisolone|mesh-list
56893874|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
56893875|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893876|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
56893877|NCT02229136|Hormones|hormones|mesh-ancestor
56893878|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893879|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893880|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56893881|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893882|NCT02523898|Metformin|metformin|mesh-list
56893883|NCT02523898|Clomiphene|clomiphene|mesh-list
56845359|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845360|NCT00353158|Doxycycline|doxycycline|mesh-list
56845361|NCT00353158|Voriconazole|voriconazole|mesh-list
56845362|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56845363|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845364|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
56845365|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56845366|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56845367|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
56845368|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56845369|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56845370|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566942|NCT00705445|Zinc|zinc|mesh-list
56893884|NCT02523898|Enclomiphene|enclomiphene|mesh-list
56893885|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
56893886|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56893887|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893888|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56893889|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
56893890|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56893891|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56893892|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
56893893|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56893894|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56893895|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56893904|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893905|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56893906|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56893907|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56893908|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893909|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893910|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56893911|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56893912|NCT02244502|Paclitaxel|paclitaxel|mesh-list
56893913|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56893914|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893915|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
56893916|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
56893917|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
56893918|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893919|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
56893920|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56893921|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56893922|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893923|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56893924|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56893925|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
56893926|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56893927|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893936|NCT02951156|Gemcitabine|gemcitabine|mesh-list
56893937|NCT02951156|Rituximab|rituximab|mesh-list
56893938|NCT02951156|Avelumab|avelumab|mesh-list
56893939|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
56893940|NCT02951156|Azacitidine|azacitidine|mesh-list
56893941|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56893942|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56893943|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893944|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
56893945|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893946|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56893947|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56893948|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
56893949|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893950|NCT02951156|Antiviral Agents|antiviral agents|mesh-ancestor
56845371|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845372|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56845373|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
56845374|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845375|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845376|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56556170|NCT04425538|Infliximab|infliximab|mesh-list
56845386|NCT03721744|Gemcitabine|gemcitabine|mesh-list
56845387|NCT03721744|Paclitaxel|paclitaxel|mesh-list
56845388|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56845389|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845390|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
56893951|NCT02951156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893952|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893953|NCT02951156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893954|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56893955|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
56893956|NCT03571594|Octreotide|octreotide|mesh-list
56893957|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56893958|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56893959|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893960|NCT03571438|Sirolimus|sirolimus|mesh-list
56893961|NCT03571438|Sunitinib|sunitinib|mesh-list
56893962|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56893963|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56893964|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56893965|NCT03571438|Growth Substances|growth substances|mesh-ancestor
56893966|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56893967|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
56893968|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56893969|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56893970|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56893971|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56893972|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893973|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56893974|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
56893975|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56893976|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
56893977|NCT01874860|Doxycycline|doxycycline|mesh-list
56893978|NCT01874860|Clindamycin|clindamycin|mesh-list
56893979|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
56893980|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
56893981|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
56893982|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
56893983|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56893984|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56893985|NCT01874860|Prednisolone|prednisolone|mesh-list
56893986|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
56893987|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
56893988|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56893989|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
56893990|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56893991|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56893992|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56893993|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
56893994|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56845391|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
56845392|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
56845393|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845394|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845395|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
56845396|NCT03721744|Antiviral Agents|antiviral agents|mesh-ancestor
56845397|NCT03721744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845398|NCT03721744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845399|NCT03721744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845400|NCT03721744|Immunologic Factors|immunologic factors|mesh-ancestor
56845401|NCT03721744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845402|NCT01589354|Ropivacaine|ropivacaine|mesh-list
56845403|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
56845404|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
56845405|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56893995|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56893996|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
56893997|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
56893998|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893999|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894000|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894001|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
56894002|NCT01874860|Hormones|hormones|mesh-ancestor
56894003|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56894004|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56894005|NCT01874860|Protective Agents|protective agents|mesh-ancestor
56894006|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56894007|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894008|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56894009|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894010|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894011|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56894012|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
56894013|NCT03570346|Hemay005|hemay005|mesh-list
56894014|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
56894015|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56894016|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56894017|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894018|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894019|NCT03571126|Olanzapine|olanzapine|mesh-list
56894020|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
56894021|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
56894022|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894023|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894024|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894025|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56894026|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56894027|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894028|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56894029|NCT03571126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56894030|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56894031|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894032|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894033|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894034|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
56894035|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
56894036|NCT03570112|Velpatasvir|velpatasvir|mesh-list
56894037|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
56894038|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894039|NCT03572686|Dexamethasone|dexamethasone|mesh-list
56845406|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845407|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
56845408|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845409|NCT01583660|Acetaminophen|acetaminophen|mesh-list
56845410|NCT01583660|Celecoxib|celecoxib|mesh-list
56845411|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56845412|NCT01583660|Oxycodone|oxycodone|mesh-list
56845413|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56845414|NCT01583660|Analgesics|analgesics|mesh-ancestor
56845415|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
56845416|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845417|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845418|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
56845419|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56845420|NCT01583660|Narcotics|narcotics|mesh-ancestor
56845421|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894040|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
56894041|NCT03572686|Ropivacaine|ropivacaine|mesh-list
56894042|NCT03572686|BB 1101|bb 1101|mesh-list
56894043|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894044|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
56894045|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
56894046|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156343|NCT02431650|Primaquine|primaquine|mesh-list
56894047|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894048|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894049|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
56894050|NCT03572686|Hormones|hormones|mesh-ancestor
56894051|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56894052|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56894053|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894054|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
56894055|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894056|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894057|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
56894058|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
56894059|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894060|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
56894061|NCT02523820|Fluticasone|fluticasone|mesh-list
56894062|NCT02523820|Xhance|xhance|mesh-list
56894063|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894064|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56894065|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
56894066|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894067|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894068|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56894069|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
56894070|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
56894071|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56894072|NCT03369704|Omalizumab|omalizumab|mesh-list
56894073|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56894074|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56894075|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
56894076|NCT03709160|Bumetanide|bumetanide|mesh-list
56894077|NCT03709160|Diuretics|diuretics|mesh-ancestor
56894078|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
56894079|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894080|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56894081|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894082|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894083|NCT05332496|Bevacizumab|bevacizumab|mesh-list
56567181|NCT00917553|Doxycycline|doxycycline|mesh-list
56894084|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56894085|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56894086|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894087|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56894088|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56894089|NCT05332496|Growth Substances|growth substances|mesh-ancestor
56894090|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894091|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
56894092|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894093|NCT03567304|Rilpivirine|rilpivirine|mesh-list
56894094|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56894095|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56894096|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894097|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894098|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
56894099|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894100|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56894101|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56894102|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
56894103|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894104|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56894105|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894106|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894107|NCT03566914|Tadalafil|tadalafil|mesh-list
56894108|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
56894109|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56894110|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56894111|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894112|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894113|NCT03566914|Urological Agents|urological agents|mesh-ancestor
56894114|NCT03709082|Trastuzumab|trastuzumab|mesh-list
56894115|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56894116|NCT03709082|Letrozole|letrozole|mesh-list
56894117|NCT03709082|Palbociclib|palbociclib|mesh-list
56894118|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56894119|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894120|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56894122|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894123|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894124|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56894125|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
56894126|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56894127|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894128|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56894129|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
56894130|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
56894131|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
56894132|NCT02839876|Acetaminophen|acetaminophen|mesh-list
56894133|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56894134|NCT02839876|Analgesics|analgesics|mesh-ancestor
56894135|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
56894136|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894137|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894138|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
56894139|NCT01312064|Rituximab|rituximab|mesh-list
56894140|NCT01312064|Everolimus|everolimus|mesh-list
56894141|NCT01312064|Tacrolimus|tacrolimus|mesh-list
56894142|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
56894143|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56894144|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894145|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
56894146|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894147|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894148|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56894149|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56894150|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894151|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894152|NCT05682716|Nitroglycerin|nitroglycerin|mesh-list
56894153|NCT05682716|Vasodilator Agents|vasodilator agents|mesh-ancestor
56894154|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
56894155|NCT03566134|DA-8010|da-8010|mesh-list
56894156|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56894157|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56845422|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56845423|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56845424|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845425|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56845426|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56845427|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845428|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845429|NCT03960866|Phentolamine|phentolamine|mesh-list
56845430|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56845431|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56845432|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56845433|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56845434|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
56845435|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56845436|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845437|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845438|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56845439|NCT01089218|Amoxicillin|amoxicillin|mesh-list
56845440|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
56894158|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
56894159|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894160|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894161|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894162|NCT03566134|Urological Agents|urological agents|mesh-ancestor
56894163|NCT03101722|Huperzine A|huperzine a|mesh-list
56894164|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
56894165|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894166|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894167|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
56894168|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894169|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894170|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56894171|NCT03101722|Protective Agents|protective agents|mesh-ancestor
56894172|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
56894173|NCT03088852|Cathartics|cathartics|mesh-ancestor
56894174|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894175|NCT03568474|Fluorides|fluorides|mesh-list
56894176|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
56894177|NCT03568474|Protective Agents|protective agents|mesh-ancestor
56894178|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894179|NCT03345836|Upadacitinib|upadacitinib|mesh-list
56894180|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56894181|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56894182|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894183|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894184|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894185|NCT03708926|Abaloparatide|abaloparatide|mesh-list
56894186|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56894187|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894188|NCT03567928|Propofol|propofol|mesh-list
56894189|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56894190|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894191|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894192|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56894193|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
56845441|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
56845442|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56845443|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56845444|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845445|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56845446|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845447|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845448|NCT03957668|Lactulose|lactulose|mesh-list
56845449|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56894194|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
56894195|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56894196|NCT03565354|Hematinics|hematinics|mesh-ancestor
56894197|NCT03363776|Nivolumab|nivolumab|mesh-list
56894198|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56894199|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894200|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56894201|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894202|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
56894203|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56894204|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56894205|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894206|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
56894207|NCT03565276|Coagulants|coagulants|mesh-ancestor
56894208|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
56894209|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56894210|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
56894211|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894212|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894213|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894214|NCT03708848|Metronidazole|metronidazole|mesh-list
56894215|NCT03708848|Clarithromycin|clarithromycin|mesh-list
56894216|NCT03708848|Levofloxacin|levofloxacin|mesh-list
56894217|NCT03708848|Ofloxacin|ofloxacin|mesh-list
56894218|NCT03708848|Tetracycline|tetracycline|mesh-list
56894219|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
56894220|NCT03708848|Esomeprazole|esomeprazole|mesh-list
56894221|NCT03708848|Bismuth|bismuth|mesh-list
56894222|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894223|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894224|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56894225|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56894226|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56894227|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56894228|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894229|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56894230|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894231|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56894232|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56894233|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56894234|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56894235|NCT03708848|Renal Agents|renal agents|mesh-ancestor
56894236|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56894237|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56894238|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894239|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56894241|NCT03708848|Diuretics|diuretics|mesh-ancestor
56894242|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
56894243|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894244|NCT03708848|Expectorants|expectorants|mesh-ancestor
56894245|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
56894246|NCT05399498|Psilocybin|psilocybin|mesh-list
56894247|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
56894248|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894249|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56894250|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
56894251|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
56845450|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56845451|NCT03957668|Laxatives|laxatives|mesh-ancestor
56845452|NCT01089452|Amlodipine|amlodipine|mesh-list
56845453|NCT01089452|Olmesartan|olmesartan|mesh-list
56845454|NCT01089452|Perindopril|perindopril|mesh-list
56845455|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56845456|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56845457|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56845458|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845459|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56845460|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894252|NCT05395052|Nivolumab|nivolumab|mesh-list
56894253|NCT05395052|Trastuzumab|trastuzumab|mesh-list
56894254|NCT05395052|Fludarabine|fludarabine|mesh-list
56894255|NCT05395052|Cetuximab|cetuximab|mesh-list
56894256|NCT05395052|Atezolizumab|atezolizumab|mesh-list
56894257|NCT05395052|Interleukin-2|interleukin-2|mesh-list
56894258|NCT05395052|Avelumab|avelumab|mesh-list
56894259|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56894260|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56894261|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
56894262|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894263|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894264|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56894265|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
56894266|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894267|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894268|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56894269|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56894270|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56894271|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56894272|NCT05395052|Analgesics|analgesics|mesh-ancestor
56894273|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
56894274|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894275|NCT03564652|Azithromycin|azithromycin|mesh-list
56894276|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56894277|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894278|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56894279|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56894280|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56894281|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56894282|NCT05681780|Cyclophosphamide|cyclophosphamide|mesh-list
56894283|NCT05681780|Nivolumab|nivolumab|mesh-list
56894284|NCT05681780|Fludarabine|fludarabine|mesh-list
56894285|NCT05681780|Interleukin-2|interleukin-2|mesh-list
56894286|NCT05681780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56894287|NCT05681780|Immunologic Factors|immunologic factors|mesh-ancestor
56894288|NCT05681780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894289|NCT05681780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894290|NCT05681780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56894291|NCT05681780|Alkylating Agents|alkylating agents|mesh-ancestor
56894292|NCT05681780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894293|NCT05681780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894294|NCT05681780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56894295|NCT05681780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56894296|NCT05681780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56894297|NCT05681780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56894298|NCT05681780|Analgesics|analgesics|mesh-ancestor
56894299|NCT05681780|Sensory System Agents|sensory system agents|mesh-ancestor
56894300|NCT05681780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894301|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
56894302|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56894303|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56894304|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894305|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
56845461|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
56845462|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56845463|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56845464|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56845465|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
56845466|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845467|NCT04880980|Itraconazole|itraconazole|mesh-list
56845468|NCT04880980|Terbinafine|terbinafine|mesh-list
56845469|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
56845470|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567441|NCT02871648|Eplerenone|eplerenone|mesh-list
56894306|NCT03710330|Coagulants|coagulants|mesh-ancestor
56894307|NCT03710252|Ritonavir|ritonavir|mesh-list
56894308|NCT03710252|Ribavirin|ribavirin|mesh-list
56894309|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56894310|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56894311|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
56894312|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894313|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894314|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56894315|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56894316|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
56894317|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894318|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56894319|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56894320|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
56894321|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
56894322|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894323|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894324|NCT05170334|Belinostat|belinostat|mesh-list
56894325|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894326|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56894327|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894328|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894329|NCT03705884|Prednisolone|prednisolone|mesh-list
56894330|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894331|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
56894332|NCT03705884|Hormones|hormones|mesh-ancestor
56894333|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56894334|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894335|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56894336|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894337|NCT03359174|Tretinoin|tretinoin|mesh-list
56894338|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894339|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
56894340|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
56894341|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
56894342|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56894343|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56894344|NCT03564106|Prednisolone|prednisolone|mesh-list
56894345|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
56894346|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56894347|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
56894348|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894349|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
56894350|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
56894351|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894352|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894353|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894354|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
56894355|NCT03564106|Hormones|hormones|mesh-ancestor
56894356|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56894357|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56894358|NCT03564106|Protective Agents|protective agents|mesh-ancestor
56894359|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56845471|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56845472|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56845473|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845474|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845475|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56845476|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
56845477|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56567503|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56894360|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894361|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
56894362|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894363|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
56894364|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
56894365|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
56894366|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
56894367|NCT00093015|Hematinics|hematinics|mesh-ancestor
56894368|NCT01145703|Vitamin D|vitamin d|mesh-list
56894369|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
56894370|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
56894371|NCT01145703|Vitamins|vitamins|mesh-list
56894372|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
56894373|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894374|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56894375|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56894376|NCT05137587|Ketamine|ketamine|mesh-list
56894377|NCT05137587|Propofol|propofol|mesh-list
56894378|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56894379|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894380|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894381|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56894382|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
56894383|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
56894384|NCT05137587|Analgesics|analgesics|mesh-ancestor
56894385|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
56894386|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894387|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56894388|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56894389|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56894390|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894391|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894392|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
56894393|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56894394|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
56894395|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56894396|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
56894397|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894398|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894399|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
56894400|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56894401|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
56894402|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56894403|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56894404|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56894405|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894406|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894407|NCT03913455|Carboplatin|carboplatin|mesh-list
56894408|NCT03913455|Guadecitabine|guadecitabine|mesh-list
56894409|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894410|NCT03358472|Carboplatin|carboplatin|mesh-list
56894411|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
56894412|NCT03358472|Fluorouracil|fluorouracil|mesh-list
56894413|NCT03358472|Cetuximab|cetuximab|mesh-list
56894414|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894415|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56894416|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
56894417|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845478|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845479|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56845480|NCT01583504|Anesthetics|anesthetics|mesh-list
56845481|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
56894418|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56894419|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56894420|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
56894421|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894422|NCT01238523|Calpastatin|calpastatin|mesh-list
56894423|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56156719|NCT02538354|Riboflavin|riboflavin|mesh-list
56894425|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894426|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894427|NCT03708536|Bevacizumab|bevacizumab|mesh-list
56894428|NCT03708536|Capecitabine|capecitabine|mesh-list
56894429|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56894430|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894431|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56894432|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56894433|NCT03708536|Growth Substances|growth substances|mesh-ancestor
56894434|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894435|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
56894436|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56894437|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
56894438|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894439|NCT03705728|Remifentanil|remifentanil|mesh-list
56894440|NCT03705728|Propofol|propofol|mesh-list
56894441|NCT03705728|Sevoflurane|sevoflurane|mesh-list
56894442|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56894443|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894444|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894445|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56894446|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
56894447|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
56894448|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56894449|NCT03705728|Narcotics|narcotics|mesh-ancestor
56894450|NCT03705728|Analgesics|analgesics|mesh-ancestor
56894451|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
56894452|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894453|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56894454|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56894455|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
56894456|NCT05177666|Trastuzumab|trastuzumab|mesh-list
56894457|NCT05177666|Pertuzumab|pertuzumab|mesh-list
56894458|NCT05177666|Vemurafenib|vemurafenib|mesh-list
56894459|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56894460|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894461|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56894462|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894463|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894464|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
56894465|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56894466|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
56894467|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
56894468|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56894469|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
56894470|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894471|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894472|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56894473|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
56894474|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894475|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894476|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56894477|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894478|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
56894479|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
56894480|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894481|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894482|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
56894483|NCT03342638|Hormones|hormones|mesh-ancestor
56894484|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56894485|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56845482|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845483|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845484|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
56567646|NCT04648540|Analgesics|analgesics|mesh-ancestor
56894486|NCT03342638|Protective Agents|protective agents|mesh-ancestor
56894487|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56894488|NCT01246323|Fentanyl|fentanyl|mesh-list
56894489|NCT01246323|Morphine|morphine|mesh-list
56894490|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
56894491|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894492|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894493|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56894494|NCT01246323|Narcotics|narcotics|mesh-ancestor
56894495|NCT01246323|Analgesics|analgesics|mesh-ancestor
56894496|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
56894497|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894498|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56894499|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56894500|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
56894501|NCT05160363|Piperaquine|piperaquine|mesh-list
56894502|NCT05160363|Pyronaridine|pyronaridine|mesh-list
56894503|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
56894504|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56894505|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56894506|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894507|NCT05177276|Irinotecan|irinotecan|mesh-list
56894508|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56894509|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56894510|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894511|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894512|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894513|NCT02528175|Capecitabine|capecitabine|mesh-list
56894514|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56894515|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
56894516|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894517|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894518|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
56894519|NCT03708458|Indomethacin|indomethacin|mesh-list
56894520|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56894521|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
56894522|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894523|NCT03708458|Expectorants|expectorants|mesh-ancestor
56894524|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
56894525|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56894526|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
56894527|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894528|NCT03708458|Protective Agents|protective agents|mesh-ancestor
56894529|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894531|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56894532|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56894533|NCT03708458|Analgesics|analgesics|mesh-ancestor
56894534|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
56894535|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894536|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894537|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894538|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
56894539|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
56894540|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56894541|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56894542|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894543|NCT05625555|Midazolam|midazolam|mesh-list
56894544|NCT05625555|Ketamine|ketamine|mesh-list
56894545|NCT05625555|Analgesics|analgesics|mesh-ancestor
56894546|NCT05625555|Sensory System Agents|sensory system agents|mesh-ancestor
56894547|NCT05625555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894548|NCT05625555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894549|NCT05625555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56894550|NCT05625555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56894551|NCT05625555|Anesthetics, General|anesthetics, general|mesh-ancestor
56894552|NCT05625555|Anesthetics|anesthetics|mesh-ancestor
56894553|NCT05625555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894554|NCT05625555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56894555|NCT05625555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56845485|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845487|NCT01583036|Ezogabine|ezogabine|mesh-list
56894556|NCT05625555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894557|NCT05625555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894558|NCT05625555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56894559|NCT05625555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56894560|NCT05625555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56894561|NCT05625555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56894562|NCT05625555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56894563|NCT05625555|GABA Modulators|gaba modulators|mesh-ancestor
56894564|NCT05625555|GABA Agents|gaba agents|mesh-ancestor
56894565|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56894566|NCT05039073|Nivolumab|nivolumab|mesh-list
56894567|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56894568|NCT05039073|Antibodies|antibodies|mesh-list
56894569|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
56894570|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56894571|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
56894572|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
56894573|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894574|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894575|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56894576|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894578|NCT01251471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56894579|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56894580|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894581|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894582|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894583|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
56894584|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894585|NCT01251471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56894586|NCT01251471|Antidepressive Agents|antidepressive agents|mesh-ancestor
56894587|NCT01251471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56894588|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
56894589|NCT01247805|Citric Acid|citric acid|mesh-list
56894590|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
56894591|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
56894592|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56894593|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
56894594|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
56894595|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894596|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
56894597|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56894598|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56894599|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894600|NCT01247805|Urological Agents|urological agents|mesh-ancestor
56894601|NCT05631717|Aldesleukin|aldesleukin|mesh-list
56894602|NCT05631717|Interleukin-2|interleukin-2|mesh-list
56894603|NCT05631717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894604|NCT05631717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56894605|NCT05631717|Analgesics|analgesics|mesh-ancestor
56894607|NCT05631717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894608|NCT05631717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894609|NCT05631717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56894610|NCT05631717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56894611|NCT05631717|Antiviral Agents|antiviral agents|mesh-ancestor
56894612|NCT05631717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894613|NCT01239459|Teriflunomide|teriflunomide|mesh-list
56894614|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
56894615|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56894616|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56894617|NCT01239459|Analgesics|analgesics|mesh-ancestor
56894618|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
56894619|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894620|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894621|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894622|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894623|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56894624|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
56894625|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56894626|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56894627|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
56894628|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894629|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56845488|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56845489|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56845490|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845491|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845492|NCT01583036|Protective Agents|protective agents|mesh-ancestor
56845493|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845494|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
56845495|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56845496|NCT01091792|Bevacizumab|bevacizumab|mesh-list
56845497|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845498|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894630|NCT01147731|Warfarin|warfarin|mesh-list
56894631|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
56894632|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
56894633|NCT01147731|Incretins|incretins|mesh-ancestor
56894634|NCT01147731|Hormones|hormones|mesh-ancestor
56894635|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56894636|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894637|NCT03912285|Losartan|losartan|mesh-list
56894638|NCT03912285|Amlodipine|amlodipine|mesh-list
56894639|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56894640|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56894641|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894642|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894643|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56894644|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894645|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
56894646|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56894647|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56894648|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56894649|NCT05132829|Azithromycin|azithromycin|mesh-list
56894650|NCT05132829|Cefazolin|cefazolin|mesh-list
56894651|NCT05132829|Indomethacin|indomethacin|mesh-list
56894652|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56894653|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894654|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56894655|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56894656|NCT05132829|Analgesics|analgesics|mesh-ancestor
56894657|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
56894658|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894659|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894660|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894661|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894662|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
56894663|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
56894664|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56894665|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56894666|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894667|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894668|NCT01251627|Decitabine|decitabine|mesh-list
56894669|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56894670|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
56894671|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894672|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894673|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894674|NCT01146093|Pravastatin|pravastatin|mesh-list
56894675|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56894676|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56894677|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
56894678|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894679|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56894680|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56894681|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845499|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56845500|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56845501|NCT01091792|Growth Substances|growth substances|mesh-ancestor
56845502|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845503|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
56845504|NCT03510910|Acetaminophen|acetaminophen|mesh-list
56845505|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56845506|NCT03510910|Analgesics|analgesics|mesh-ancestor
56845507|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
56845508|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845509|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845510|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
56845511|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
56845512|NCT01091870|Citric Acid|citric acid|mesh-list
56845513|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
56845514|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
56845515|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56845516|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
56845517|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
56845518|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845519|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
56845520|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56845521|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56894682|NCT02452983|Sertraline|sertraline|mesh-list
56894683|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
56894684|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56894685|NCT02452983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56894686|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56894687|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894688|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894689|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894690|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
56894691|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894692|NCT03911817|Midodrine|midodrine|mesh-list
56894693|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
56894694|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
56894695|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894696|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894697|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56894698|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56894699|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56894700|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56894701|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
56894702|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894703|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894704|NCT01239849|Atorvastatin|atorvastatin|mesh-list
56894705|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56894706|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56894707|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
56894708|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894709|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56894710|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56845522|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845523|NCT01091870|Urological Agents|urological agents|mesh-ancestor
56845524|NCT03509350|Vitamins|vitamins|mesh-list
56845525|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
56845526|NCT03509350|Thiamine|thiamine|mesh-list
56845527|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
56845528|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56845529|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56845530|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56845531|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
56845532|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316300|NCT00012506|Etanercept|etanercept|mesh-list
56894711|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894712|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
56894713|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894714|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
56894715|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
56894716|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56894717|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56894718|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894719|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894720|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894721|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894722|NCT04880655|Bacitracin|bacitracin|mesh-list
56894723|NCT04880655|Petrolatum|petrolatum|mesh-list
56894724|NCT04880655|Emollients|emollients|mesh-ancestor
56894725|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
56894726|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56894727|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894728|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56894729|NCT04865835|Metformin|metformin|mesh-list
56894730|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56894731|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894732|NCT03911271|Atropine|atropine|mesh-list
56894733|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56894734|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56894735|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56894736|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
56894737|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894738|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894739|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56894740|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
56894741|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
56894742|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
56894743|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56894744|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56894745|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
56894746|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894747|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894748|NCT01248195|Olanzapine|olanzapine|mesh-list
56894749|NCT01248195|Clozapine|clozapine|mesh-list
56894750|NCT01248195|Amisulpride|amisulpride|mesh-list
56894751|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
56894752|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
56894753|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894754|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894755|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894756|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56894757|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56894758|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894759|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56894760|NCT01248195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56894761|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56894762|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894763|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894764|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894765|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
56845533|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56845534|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
56845535|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845536|NCT03509350|Protective Agents|protective agents|mesh-ancestor
56845537|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
56845538|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56845539|NCT00072410|Antibodies|antibodies|mesh-list
56845540|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
56845541|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56894766|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56894767|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
56894768|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
56894769|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56894770|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
56894771|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56894772|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
56894773|NCT03910803|Brodalumab|brodalumab|mesh-list
56894774|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
56894775|NCT04776447|Carboplatin|carboplatin|mesh-list
56894776|NCT04776447|Atezolizumab|atezolizumab|mesh-list
56894777|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894778|NCT03910647|Pantoprazole|pantoprazole|mesh-list
56894779|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56894780|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894781|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56894782|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894783|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894784|NCT03709940|Methylphenidate|methylphenidate|mesh-list
56894785|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56894786|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894787|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56894788|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56894789|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894790|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894791|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
56894792|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894793|NCT05681312|Amoxicillin|amoxicillin|mesh-list
56894794|NCT05681312|Metronidazole|metronidazole|mesh-list
56894795|NCT05681312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56894796|NCT05681312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894797|NCT05681312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56894798|NCT05681312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56894799|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
56894800|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56894801|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894802|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56894803|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56894804|NCT01147029|Growth Substances|growth substances|mesh-ancestor
56894805|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894806|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
56894807|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894808|NCT03915561|Parecoxib|parecoxib|mesh-list
56894809|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56894810|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56894811|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894812|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894813|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56894814|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56894815|NCT03915561|Analgesics|analgesics|mesh-ancestor
56894816|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
56894817|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894818|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894819|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56894820|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56894821|NCT01148277|Fentanyl|fentanyl|mesh-list
56894822|NCT01148277|Midazolam|midazolam|mesh-list
56894823|NCT01148277|Propofol|propofol|mesh-list
56894824|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56845542|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
56845617|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
56845695|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56845768|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845774|NCT00098787|Antidotes|antidotes|mesh-ancestor
56845843|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56845915|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
56846003|NCT03720340|Oprelvekin|oprelvekin|mesh-list
56846065|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846067|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846138|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846139|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846211|NCT01099436|Docetaxel|docetaxel|mesh-list
56846285|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
56846286|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
56846359|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
56846433|NCT05625854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846434|NCT05625854|Sensory System Agents|sensory system agents|mesh-ancestor
56846507|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
56846654|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846656|NCT01085721|Expectorants|expectorants|mesh-ancestor
56846807|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846883|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56846885|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
56846959|NCT01103336|Nicorandil|nicorandil|mesh-list
56847029|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
56847030|NCT00004088|Melphalan|melphalan|mesh-list
56847175|NCT05617118|GABA Agonists|gaba agonists|mesh-ancestor
56847176|NCT05617118|GABA Agents|gaba agents|mesh-ancestor
56847251|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56847325|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56847399|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
56847400|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
56847469|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847543|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847544|NCT03957174|Rivastigmine|rivastigmine|mesh-list
56847617|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56847690|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847761|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847762|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847836|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847912|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847987|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848213|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56848286|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848361|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
56848436|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848437|NCT03942926|Sirolimus|sirolimus|mesh-list
56848512|NCT04542824|Vincristine|vincristine|mesh-list
56848587|NCT04464122|Somatostatin|somatostatin|mesh-list
56848658|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
56848733|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56848806|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
56848956|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56849030|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56849031|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56920176|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
56849121|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56849195|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849270|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56849302|NCT01058291|Emetics|emetics|mesh-ancestor
56849345|NCT01113164|Ondansetron|ondansetron|mesh-list
56849418|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849491|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849564|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
56849640|NCT01114100|Sertraline|sertraline|mesh-list
56849641|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
56849642|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56849657|NCT01117298|Tadalafil|tadalafil|mesh-list
56849710|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
56849711|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849782|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849784|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
56849856|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56849937|NCT01122368|Micafungin|micafungin|mesh-list
56850004|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56850009|NCT01125254|Amlodipine|amlodipine|mesh-list
56850151|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850223|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850299|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56850371|NCT05681728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56850377|NCT05535166|Carboplatin|carboplatin|mesh-list
56850445|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56850518|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
56850591|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
56850739|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850812|NCT00323063|Gemcitabine|gemcitabine|mesh-list
56850963|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
56851037|NCT00321737|Lansoprazole|lansoprazole|mesh-list
56851043|NCT03928262|Benralizumab|benralizumab|mesh-list
56851112|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851261|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851339|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
56851412|NCT01227590|Lopinavir|lopinavir|mesh-list
56851639|NCT01134848|Narcotics|narcotics|mesh-ancestor
56851641|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851712|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851713|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851714|NCT01133210|Maraviroc|maraviroc|mesh-list
56851715|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56851784|NCT05400902|Apatinib|apatinib|mesh-list
56851858|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56851859|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56851860|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56851861|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56851862|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
56851863|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
56851934|NCT01133912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852012|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56852085|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56852086|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56852160|NCT04895098|Ezetimibe|ezetimibe|mesh-list
56852236|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852310|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852387|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56852388|NCT04700176|Growth Substances|growth substances|mesh-ancestor
56852389|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
56852390|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
56852391|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
56852392|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
56852393|NCT01144910|Miotics|miotics|mesh-ancestor
56852394|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
56852538|NCT01238276|Cefazolin|cefazolin|mesh-list
56852612|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56852613|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
56852615|NCT05173688|Propofol|propofol|mesh-list
56852687|NCT04705480|Pregabalin|pregabalin|mesh-list
56852756|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56852763|NCT01048229|Rasagiline|rasagiline|mesh-list
56852831|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56852832|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852905|NCT04971746|Nintedanib|nintedanib|mesh-list
56852918|NCT00369161|Everolimus|everolimus|mesh-list
56852978|NCT01240850|Hormones|hormones|mesh-ancestor
56853053|NCT01237262|Analgesics|analgesics|mesh-ancestor
56853126|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
56853127|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56853150|NCT03912974|Citalopram|citalopram|mesh-list
56853198|NCT01147718|Incretins|incretins|mesh-ancestor
56853199|NCT01147718|Hormones|hormones|mesh-ancestor
56853204|NCT03915938|Ketamine|ketamine|mesh-list
56853271|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56853282|NCT01251926|Bevacizumab|bevacizumab|mesh-list
56853345|NCT00075504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853420|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56853494|NCT05617664|Mirabegron|mirabegron|mesh-list
56853495|NCT05617664|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56853568|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853648|NCT03275350|Naltrexone|naltrexone|mesh-list
56853716|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56853794|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853868|NCT01148576|Vitamins|vitamins|mesh-ancestor
56853869|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
56853870|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853940|NCT05570786|Hormones|hormones|mesh-ancestor
56854015|NCT03894800|Fentanyl|fentanyl|mesh-list
56854016|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
56854089|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
56854095|NCT03644186|Paclitaxel|paclitaxel|mesh-list
56854240|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
56854468|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
56854536|NCT01154426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56854610|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854686|NCT01260974|Caspofungin|caspofungin|mesh-list
56854758|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854832|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
56854833|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
56854905|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56854978|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56854979|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
56855056|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
56855204|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
56855205|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
56855279|NCT01161134|Meloxicam|meloxicam|mesh-list
56855351|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56855352|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56855423|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56855496|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56855500|NCT01281566|Cisapride|cisapride|mesh-list
56855646|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855718|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56855719|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56855864|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56856236|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
56856311|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856320|NCT01286090|Cisapride|cisapride|mesh-list
56856382|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56856533|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856608|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56856762|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
56856836|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856911|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856984|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56856998|NCT03858062|Insulin|insulin|mesh-list
56857058|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857134|NCT00056160|Dexamethasone|dexamethasone|mesh-list
56857210|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56857284|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
56857358|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857362|NCT01182974|Acetaminophen|acetaminophen|mesh-list
56857431|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56857507|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
56857582|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
56857658|NCT00057876|Antiviral Agents|antiviral agents|mesh-ancestor
56857736|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56857748|NCT01293734|Budesonide|budesonide|mesh-list
56857809|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857882|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
56857957|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858032|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56858042|NCT04728646|Hormones|hormones|mesh-ancestor
56858105|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56858181|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858255|NCT05671172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858256|NCT05671172|Sensory System Agents|sensory system agents|mesh-ancestor
56858257|NCT05671172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858258|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56858259|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56858260|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858261|NCT05177926|Tenofovir|tenofovir|mesh-list
56858262|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
56858263|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858264|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56858265|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56858266|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858267|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858268|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56858269|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56858270|NCT01193192|Vitamins|vitamins|mesh-list
56858271|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
56858313|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
56858388|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56858462|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56858463|NCT01196234|Carboplatin|carboplatin|mesh-list
56858464|NCT01196234|Gefitinib|gefitinib|mesh-list
56858465|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56858466|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858467|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
56858468|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
56858469|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
56858470|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858471|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56858472|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858473|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56858537|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
56858541|NCT01190462|Simvastatin|simvastatin|mesh-list
56858612|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56858695|NCT04057456|Nabilone|nabilone|mesh-list
56858764|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56858839|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56858910|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56858911|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56858980|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
56859056|NCT02654132|Growth Substances|growth substances|mesh-ancestor
56859057|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
56859129|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
56859205|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56859211|NCT05669768|Tamoxifen|tamoxifen|mesh-list
56859279|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859280|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56859350|NCT05667818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859426|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
56859502|NCT01205984|Hormones|hormones|mesh-ancestor
56859503|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859574|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56859575|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56859649|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859650|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56859651|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56859719|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
56859727|NCT01201928|Insulin|insulin|mesh-list
56859792|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859869|NCT02935894|Analgesics|analgesics|mesh-ancestor
56859940|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860023|NCT01300676|Estradiol|estradiol|mesh-list
56860089|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
56860090|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860091|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860092|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
56860093|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860094|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
56860159|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56860172|NCT01097382|Zolpidem|zolpidem|mesh-list
56860232|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860305|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860381|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860458|NCT03216226|Glucagon|glucagon|mesh-list
56860602|NCT00271505|Bevacizumab|bevacizumab|mesh-list
56860751|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860829|NCT03365362|Varenicline|varenicline|mesh-list
56860899|NCT01314508|Mecasermin|mecasermin|mesh-list
56860973|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860974|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860976|NCT03175120|Insulin|insulin|mesh-list
56861048|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861121|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
56861122|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
56861193|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
56861194|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861195|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
56861196|NCT03445858|Decitabine|decitabine|mesh-list
56861197|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56861198|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861199|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56861260|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56861335|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
56861407|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861482|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56861555|NCT05150782|Vitamins|vitamins|mesh-ancestor
56861556|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
56861629|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861630|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56861702|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861705|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56861776|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56861852|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56861927|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56862001|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
56862075|NCT03816020|Niacin|niacin|mesh-list
56862156|NCT01303952|Eculizumab|eculizumab|mesh-list
56862224|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56862225|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
56862297|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56862451|NCT05624528|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56862600|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862601|NCT03787940|Isoniazid|isoniazid|mesh-list
56862746|NCT05690048|Growth Substances|growth substances|mesh-ancestor
56862854|NCT01560962|Tobramycin|tobramycin|mesh-list
56862975|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862978|NCT00243503|Trastuzumab|trastuzumab|mesh-list
56863047|NCT05668988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56863136|NCT01309490|Ribavirin|ribavirin|mesh-list
56863203|NCT03779516|Lidocaine|lidocaine|mesh-list
56863349|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
56863423|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56863502|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56863572|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863578|NCT01345708|Hormones|hormones|mesh-ancestor
56863648|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863721|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863724|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56863790|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863791|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56863793|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56863794|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863795|NCT01347424|Paclitaxel|paclitaxel|mesh-list
56863796|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56863797|NCT01347424|Carboplatin|carboplatin|mesh-list
56863798|NCT01347424|Endostatins|endostatins|mesh-list
56863799|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56863800|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863801|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
56863802|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
56863803|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
56863804|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863805|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56863806|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56863807|NCT01347424|Growth Substances|growth substances|mesh-ancestor
56863810|NCT01322438|Rifampin|rifampin|mesh-list
56863845|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
56863848|NCT01337362|Insulin|insulin|mesh-list
56863920|NCT01348204|Quercetin|quercetin|mesh-list
56863927|NCT00166504|Ezetimibe|ezetimibe|mesh-list
56863994|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863995|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56863996|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56863997|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56863998|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
56863999|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56864000|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56864001|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56864065|NCT05096312|Zinc|zinc|mesh-list
56864209|NCT03757364|Methotrexate|methotrexate|mesh-list
56864210|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56864284|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
56864356|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56864438|NCT01349764|Vitamin D|vitamin d|mesh-list
56864506|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864510|NCT01318096|Tenofovir|tenofovir|mesh-list
56864580|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
56864581|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
56864582|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56864654|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56864655|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56864800|NCT00003222|Interleukin-2|interleukin-2|mesh-list
56864877|NCT00002850|Renal Agents|renal agents|mesh-ancestor
56864953|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
56865027|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56865028|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56865101|NCT00027378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56865175|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56865251|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
56865325|NCT03951402|Analgesics|analgesics|mesh-ancestor
56865401|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56865496|NCT00233987|Melphalan|melphalan|mesh-list
56865546|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56865622|NCT01356472|Imipenem|imipenem|mesh-list
56865623|NCT01356472|Cilastatin|cilastatin|mesh-list
56865695|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
56865696|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865697|NCT05460416|Aspirin|aspirin|mesh-list
56865700|NCT05460416|Analgesics|analgesics|mesh-ancestor
56865766|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865840|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
56865841|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56865843|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
56865912|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
56865987|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
56866062|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
56866137|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866210|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
56866211|NCT03747614|Hormones|hormones|mesh-ancestor
56866214|NCT04089514|Adalimumab|adalimumab|mesh-list
56866284|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866286|NCT01358500|Analgesics|analgesics|mesh-ancestor
56866361|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
56866450|NCT02567578|YH12852|yh12852|mesh-list
56866505|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56866506|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56866509|NCT00745134|Curcumin|curcumin|mesh-list
56866581|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56866653|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
56866663|NCT05010590|Denosumab|denosumab|mesh-list
56866728|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56866729|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866801|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
56866804|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
56866871|NCT01114542|Insulin|insulin|mesh-list
56866872|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56866873|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
56866874|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56866875|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866876|NCT02529540|Methamphetamine|methamphetamine|mesh-list
56866877|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56866878|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866879|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
56866880|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
56866881|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866882|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
56866885|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
56866933|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866934|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56867008|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
56867009|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56867099|NCT01115322|Tazarotene|tazarotene|mesh-list
56867158|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
56867163|NCT01212432|Daptomycin|daptomycin|mesh-list
56867232|NCT01328652|Lansoprazole|lansoprazole|mesh-list
56867304|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867378|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867461|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
56867529|NCT04816162|Analgesics|analgesics|mesh-ancestor
56867604|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
56867679|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867752|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56867825|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867826|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
56867899|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868047|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868120|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868121|NCT01215708|Tamsulosin|tamsulosin|mesh-list
56868191|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
56868192|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868264|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868313|NCT01221402|Niacin|niacin|mesh-list
56868337|NCT01127490|Analgesics|analgesics|mesh-ancestor
56868410|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56868411|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
56868412|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868413|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868414|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868415|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56868416|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56868417|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
56868418|NCT03932292|Calcium|calcium|mesh-list
56868420|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868473|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
56868474|NCT01127724|Vitamins|vitamins|mesh-list
56868475|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
56868476|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
56868477|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
56868478|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
56868479|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868480|NCT01127724|Hematinics|hematinics|mesh-ancestor
56868481|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
56868482|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56868483|NCT03103906|Protective Agents|protective agents|mesh-ancestor
56868484|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868485|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56868486|NCT05675098|Methylphenidate|methylphenidate|mesh-list
56868487|NCT05675098|Modafinil|modafinil|mesh-list
56868488|NCT05675098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56868489|NCT05675098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868490|NCT05675098|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56868491|NCT05675098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56868492|NCT05675098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56868493|NCT05675098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868494|NCT05675098|Dopamine Agents|dopamine agents|mesh-ancestor
56868528|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
56868678|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
56868754|NCT03923010|Itraconazole|itraconazole|mesh-list
56868829|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
56868904|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868905|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868906|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868907|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56868908|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56868909|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868910|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868911|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56868970|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56868971|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56869120|NCT01232010|Mirodenafil|mirodenafil|mesh-list
56869266|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869339|NCT01232400|Esmolol|esmolol|mesh-list
56869417|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
56869489|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56869564|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
56869638|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869710|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56869863|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
56869937|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
56384620|NCT00131300|Hylan|hylan|mesh-list
56870087|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870094|NCT03970577|Hormones|hormones|mesh-ancestor
56870158|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56870159|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
56870231|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56870305|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
56870306|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870377|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56870378|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870379|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
56870380|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870381|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
56870382|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581173|NCT01098110|Asenapine|asenapine|mesh-list
56870383|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
56870385|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870386|NCT04604548|Protective Agents|protective agents|mesh-ancestor
56870387|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870449|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870520|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870746|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
56870748|NCT03632590|Analgesics|analgesics|mesh-ancestor
56870820|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56870821|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56870822|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
56870823|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870824|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56870826|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870891|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56870900|NCT03912402|Paclitaxel|paclitaxel|mesh-list
56870963|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56870964|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
56870965|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870966|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870967|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870968|NCT01253694|Ranibizumab|ranibizumab|mesh-list
56870969|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870975|NCT03915444|Gemcitabine|gemcitabine|mesh-list
56871032|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56871107|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
56871108|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871109|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871110|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871111|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56871112|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
56871113|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
56871114|NCT01253928|Pioglitazone|pioglitazone|mesh-list
56871115|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56871116|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871117|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
56871118|NCT01252524|Psyllium|psyllium|mesh-list
56871119|NCT01252524|Calcium|calcium|mesh-list
56871120|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56871122|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
56871169|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871170|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871171|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56871172|NCT03913650|Bupivacaine|bupivacaine|mesh-list
56871173|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
56871174|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
56871175|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871176|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871177|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
56871178|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871179|NCT02874742|Dexamethasone|dexamethasone|mesh-list
56871180|NCT02874742|Lenalidomide|lenalidomide|mesh-list
56871181|NCT02874742|Bortezomib|bortezomib|mesh-list
56871182|NCT02874742|Daratumumab|daratumumab|mesh-list
56871183|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56871230|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
56871231|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871232|NCT03909594|Analgesics|analgesics|mesh-ancestor
56871299|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871371|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871372|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56871373|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56871374|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871375|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871376|NCT03984214|Hormones|hormones|mesh-ancestor
56871378|NCT01150344|Artemether|artemether|mesh-list
56871441|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
56871442|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
56871443|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871444|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871445|NCT04113538|Aflibercept|aflibercept|mesh-list
56871446|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56871510|NCT03904056|Growth Substances|growth substances|mesh-ancestor
56871511|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871512|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
56871513|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871514|NCT03897660|Vitamins|vitamins|mesh-list
56871515|NCT03897660|Vitamin K|vitamin k|mesh-list
56871516|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
56871517|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
56871518|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871519|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56871520|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56871524|NCT03901170|Letrozole|letrozole|mesh-list
56871574|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
56871575|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871576|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871577|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56871578|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56871579|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56871580|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56871582|NCT01586286|Nifedipine|nifedipine|mesh-list
56871583|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56871584|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871585|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871586|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56871587|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871588|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
56871589|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
56871590|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56871591|NCT01257048|Budesonide|budesonide|mesh-list
56871592|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
56871593|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56871629|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56871630|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56871631|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56871634|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
56871698|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56871773|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871775|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56871846|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871921|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56871995|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56871996|NCT01260012|Praziquantel|praziquantel|mesh-list
56871997|NCT01260012|Antioxidants|antioxidants|mesh-list
56871998|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871999|NCT01260012|Protective Agents|protective agents|mesh-ancestor
56872000|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872001|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
56872002|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56872003|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872004|NCT03888924|Vaccines|vaccines|mesh-list
56872005|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
56872006|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
56872007|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872008|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56872009|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56872010|NCT01151592|Hematinics|hematinics|mesh-ancestor
56872011|NCT01151670|Pioglitazone|pioglitazone|mesh-list
56872012|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56872013|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872014|NCT03888846|Colchicine|colchicine|mesh-list
56872015|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
56872016|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
56872017|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56872051|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872052|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872053|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56872054|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56872055|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872056|NCT01260246|Incretins|incretins|mesh-ancestor
56872057|NCT01260246|Hormones|hormones|mesh-ancestor
56872058|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872063|NCT03888534|Ixazomib|ixazomib|mesh-list
56872193|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56872270|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56872340|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872343|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56872413|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56872414|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
56872415|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
56872416|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872417|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872418|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872419|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56872420|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56872421|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56872422|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872423|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
56872424|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
56872425|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
56872427|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
56872475|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872476|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872477|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
56872478|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872488|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
56872543|NCT01158144|Endostar protein|endostar protein|mesh-list
56872618|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872691|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
56872763|NCT01159080|Tacrolimus|tacrolimus|mesh-list
56872764|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872765|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
56872766|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872767|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56872768|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872769|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872771|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872772|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56872773|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
56872774|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56872775|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872776|NCT01160952|Itraconazole|itraconazole|mesh-list
56872777|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
56872778|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872791|NCT01161108|Melatonin|melatonin|mesh-list
56872845|NCT01267344|Gemcitabine|gemcitabine|mesh-list
56872898|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56872899|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56872900|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56872971|NCT01269606|Insulin|insulin|mesh-list
56873044|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873045|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873046|NCT01269216|Antidotes|antidotes|mesh-ancestor
56873047|NCT01269216|Protective Agents|protective agents|mesh-ancestor
56873048|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873049|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
56873050|NCT01269216|Vitamins|vitamins|mesh-ancestor
56873051|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
56873052|NCT03874806|Ropivacaine|ropivacaine|mesh-list
56873112|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873115|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
56873183|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
56873258|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
56873334|NCT01273584|Metformin|metformin|mesh-list
56873483|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56873496|NCT01172028|Docetaxel|docetaxel|mesh-list
56873557|NCT02526030|Ziprasidone|ziprasidone|mesh-list
56873565|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
56873630|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873701|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
56873781|NCT01174212|Vancomycin|vancomycin|mesh-list
56873851|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873852|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
56873926|NCT00047008|Cisplatin|cisplatin|mesh-list
56874000|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
56874074|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
56874076|NCT03751098|Tropicamide|tropicamide|mesh-list
56874149|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
56874150|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874151|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56874152|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56874153|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56874154|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56874155|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56874156|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56874157|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56874158|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56874159|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
56874160|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56874161|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
56874162|NCT05548426|Linezolid|linezolid|mesh-list
56874163|NCT05548426|Penicillins|penicillins|mesh-list
56874283|NCT01181232|Zolpidem|zolpidem|mesh-list
56874284|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56874360|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56874470|NCT03857334|Cortivazol|cortivazol|mesh-list
56874505|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56389228|NCT04697641|Z 338|z 338|mesh-list
56874652|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
56874803|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56874880|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
56875033|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875035|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
56875182|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875333|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875334|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56875493|NCT02627092|Copper|copper|mesh-list
56875560|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
56875561|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875633|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56875783|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56875857|NCT03674112|Pertuzumab|pertuzumab|mesh-list
56586651|NCT05658861|Caseins|caseins|mesh-list
56875933|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
56876006|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56876007|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56876008|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876009|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876010|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
56876011|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876073|NCT01206270|Castor Oil|castor oil|mesh-list
56876074|NCT01206270|Testosterone|testosterone|mesh-list
56876219|NCT05668572|Vaccines|vaccines|mesh-list
56876297|NCT02918292|Fludarabine|fludarabine|mesh-list
56876369|NCT05602818|GABA Agents|gaba agents|mesh-ancestor
56876450|NCT03816072|Phenylephrine|phenylephrine|mesh-list
56876519|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
56876596|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56876747|NCT03799536|Sotalol|sotalol|mesh-list
56876899|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876973|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876974|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877045|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56877046|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
56877047|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56877048|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877122|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56877198|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
56877273|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877345|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877422|NCT05404048|Atezolizumab|atezolizumab|mesh-list
56877572|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
56877573|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
56877574|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56877575|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56877576|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877577|NCT04839328|Hemay005|hemay005|mesh-list
56877578|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
56877579|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56877580|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56877581|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877582|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877583|NCT03785496|Spartalizumab|spartalizumab|mesh-list
56877584|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56877585|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877586|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877587|NCT01307202|Gabapentin|gabapentin|mesh-list
56877588|NCT01307202|Analgesics|analgesics|mesh-ancestor
56877589|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
56588362|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
56877590|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877591|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877592|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
56877593|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56877653|NCT03790566|Bupivacaine|bupivacaine|mesh-list
56877725|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
56877796|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56877954|NCT03776838|Fentanyl|fentanyl|mesh-list
56878020|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
56878096|NCT05762536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878168|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
56878321|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878324|NCT03777930|Growth Substances|growth substances|mesh-ancestor
56878394|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56878470|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56878544|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
56878620|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56878627|NCT03767322|Allopurinol|allopurinol|mesh-list
56878695|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878770|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56878771|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
56878772|NCT03769818|Hormones|hormones|mesh-ancestor
56878843|NCT03766074|Vitamins|vitamins|mesh-ancestor
56878919|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878993|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
56879068|NCT05115630|Melphalan|melphalan|mesh-list
56879069|NCT05115630|Fludarabine|fludarabine|mesh-list
56879142|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56879143|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
56879144|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56879145|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879146|NCT05536102|Doxorubicin|doxorubicin|mesh-list
56879147|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56879148|NCT05536102|Capecitabine|capecitabine|mesh-list
56879149|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
56879150|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56879151|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879152|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56879153|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56879154|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879156|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56879209|NCT05692570|Ritonavir|ritonavir|mesh-list
56879279|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
56879280|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879352|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
56879435|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
56990946|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990947|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56990948|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56990949|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879850|NCT03529942|FX006|fx006|mesh-list
56879882|NCT04189952|Ifosfamide|ifosfamide|mesh-list
56879957|NCT03746444|Anesthetics|anesthetics|mesh-list
56990950|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880030|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
56990951|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56990952|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56880254|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
56990953|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990954|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
56880404|NCT05324358|Morphine|morphine|mesh-list
56990955|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990956|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
56990957|NCT05014776|Ipilimumab|ipilimumab|mesh-list
56990958|NCT05014776|Tadalafil|tadalafil|mesh-list
56880553|NCT04764630|Naloxone|naloxone|mesh-list
56990959|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56990960|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990961|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56990962|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990963|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
56990964|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56990965|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56990966|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990967|NCT05014776|Urological Agents|urological agents|mesh-ancestor
56990968|NCT03329573|Paroxetine|paroxetine|mesh-list
56990969|NCT03329573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56990970|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56990971|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56990972|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990973|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990974|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
56990975|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990976|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56990977|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
56990978|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56990979|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56990980|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56990981|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56990982|NCT00492349|Varenicline|varenicline|mesh-list
56990983|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56990984|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56990985|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
56990986|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990987|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990988|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990989|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56990990|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56880825|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56990991|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56990992|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56990993|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56990994|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56990995|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56990996|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
56990997|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56990998|NCT03308825|Vaccines|vaccines|mesh-list
56880958|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56880959|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
56880960|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
56880961|NCT04105998|Oxytocin|oxytocin|mesh-list
56880962|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
56880963|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56990999|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
56991000|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991001|NCT04235855|Liver Extracts|liver extracts|mesh-list
56991002|NCT04235855|Hematinics|hematinics|mesh-ancestor
56991003|NCT03328325|Vaccines|vaccines|mesh-list
56991004|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
56991005|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991006|NCT03476603|Irbesartan|irbesartan|mesh-list
56991007|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56991008|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56991009|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56991010|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991011|NCT03476525|Fluoxetine|fluoxetine|mesh-list
56991012|NCT03476525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56881041|NCT04235608|Propofol|propofol|mesh-list
56991013|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56991014|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56991015|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991016|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991017|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
56991018|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991019|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56991020|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
56991021|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56991022|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56991023|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56991024|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991025|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
56991026|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56991027|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991028|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991029|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56991030|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
56991031|NCT03226249|Doxorubicin|doxorubicin|mesh-list
56991032|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56991033|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
56991034|NCT03226249|Dacarbazine|dacarbazine|mesh-list
56991035|NCT03226249|Vinblastine|vinblastine|mesh-list
56991036|NCT03226249|Imidazole|imidazole|mesh-list
56991037|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56991038|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56991039|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991040|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56991041|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56991042|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991043|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881224|NCT02728648|Narcotics|narcotics|mesh-ancestor
56991044|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56991045|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56991046|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56991047|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
56991048|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56991049|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
56991050|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
56991051|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
56991052|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
56991053|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
56991054|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991055|NCT04229095|Suvorexant|suvorexant|mesh-list
56991056|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56991057|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56991058|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991059|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991060|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56991061|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673236|NCT02625506|Analgesics|analgesics|mesh-ancestor
56991062|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991063|NCT03665545|Poly I-C|poly i-c|mesh-list
56991064|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
56991065|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56991066|NCT03665545|Poly ICLC|poly iclc|mesh-list
56991067|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56991068|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991069|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
56991070|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
56881430|NCT01765400|Clopidogrel|clopidogrel|mesh-list
56991071|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881505|NCT05052970|Bortezomib|bortezomib|mesh-list
56991072|NCT03665545|Laxatives|laxatives|mesh-ancestor
56991073|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56991074|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
56991075|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991076|NCT03305081|Copper|copper|mesh-list
56991077|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
56881561|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56991078|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56991079|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
56991080|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56991081|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991082|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56991083|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56991084|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56991085|NCT03305081|Trace Elements|trace elements|mesh-ancestor
56991086|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
56991087|NCT04079881|Insulin|insulin|mesh-list
56991088|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56991089|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56882071|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56991090|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991091|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
56991092|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56991093|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
56991094|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991095|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
56991096|NCT03223909|Protective Agents|protective agents|mesh-ancestor
56991097|NCT03733925|Golimumab|golimumab|mesh-list
56991098|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56991099|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991100|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56991101|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
56991102|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991103|NCT03649711|Aspirin|aspirin|mesh-list
56991104|NCT03649711|Clopidogrel|clopidogrel|mesh-list
56991105|NCT03649711|Ticagrelor|ticagrelor|mesh-list
56991106|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56991107|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56991108|NCT03649711|Analgesics|analgesics|mesh-ancestor
56991109|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
56991110|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991111|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991112|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991113|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56882356|NCT00972478|Hormones|hormones|mesh-ancestor
56991114|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56991115|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56991116|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991117|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56991118|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56991119|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991120|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
56991121|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56991122|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56991123|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56991124|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
56991125|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991126|NCT03897673|Iron|iron|mesh-list
56991127|NCT03897673|Trace Elements|trace elements|mesh-ancestor
56991128|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
56991129|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991130|NCT03273257|Riociguat|riociguat|mesh-list
56991131|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
56882502|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882504|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882505|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56882506|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882507|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882508|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
56882509|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56882511|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56991132|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991133|NCT02553473|Doxycycline|doxycycline|mesh-list
56991134|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56991135|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991136|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
56991137|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56991138|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56991139|NCT04270877|Naltrexone|naltrexone|mesh-list
56991140|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56991141|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56991142|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882564|NCT05692960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56882565|NCT05692960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56882566|NCT05692960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882567|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
56991143|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
56991144|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991145|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56991146|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56991147|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56991148|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56991149|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991150|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991151|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991152|NCT03271151|Analgesics|analgesics|mesh-ancestor
56991153|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
56991154|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991155|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
56991156|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56991157|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
56991158|NCT04237649|Spartalizumab|spartalizumab|mesh-list
56991159|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56991160|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991161|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991163|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56991164|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991165|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56991166|NCT01144416|Hormones|hormones|mesh-ancestor
56991167|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991168|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882830|NCT00092092|Montelukast|montelukast|mesh-list
56991169|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
56991170|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56882839|NCT00092092|Hormones|hormones|mesh-ancestor
56991171|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
56991172|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
56991173|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991174|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991175|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991176|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56991177|NCT00335777|Analgesics|analgesics|mesh-ancestor
56991178|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
56991179|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991180|NCT03764137|Panitumumab|panitumumab|mesh-list
56991181|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56991182|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991183|NCT02889809|Fluticasone|fluticasone|mesh-list
56991184|NCT02889809|Xhance|xhance|mesh-list
56991185|NCT02889809|Montelukast|montelukast|mesh-list
56991186|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883478|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56991187|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56883631|NCT03408340|Propofol|propofol|mesh-list
56991188|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
56991189|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991190|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991191|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56991192|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
56991193|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
56991194|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56883709|NCT03725228|Lidocaine|lidocaine|mesh-list
56991195|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56991196|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
56991197|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991198|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56991199|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56991200|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991201|NCT03625518|Oxytocin|oxytocin|mesh-list
56991202|NCT03625518|Dinoprostone|dinoprostone|mesh-list
56991203|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
56991204|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56991205|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991206|NCT00972738|Loratadine|loratadine|mesh-list
56991207|NCT00972738|Montelukast|montelukast|mesh-list
56991208|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56991209|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
56991210|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56883805|NCT00086385|Nicotine|nicotine|mesh-list
56991211|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
56883911|NCT02668822|Analgesics|analgesics|mesh-ancestor
56883985|NCT05665088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991212|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884056|NCT03033784|Oxytocin|oxytocin|mesh-list
56991213|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884138|NCT03726788|Triamcinolone|triamcinolone|mesh-list
56991214|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56991215|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56884277|NCT05506930|Narcotics|narcotics|mesh-ancestor
56884349|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56884575|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56991216|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991218|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
56991219|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56991220|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56991221|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56991222|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
56991223|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
56991224|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991225|NCT03452839|Meropenem|meropenem|mesh-list
56991226|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56991227|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991228|NCT04701281|Capecitabine|capecitabine|mesh-list
56991229|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56991230|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
56884866|NCT03697564|Gemcitabine|gemcitabine|mesh-list
56884940|NCT03702400|Phenylephrine|phenylephrine|mesh-list
56885014|NCT03430856|Insulin|insulin|mesh-list
56885164|NCT00033657|Camptothecin|camptothecin|mesh-list
56991231|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991232|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991233|NCT03882918|Gaboxadol|gaboxadol|mesh-list
56991234|NCT03882918|Analgesics|analgesics|mesh-ancestor
56991235|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
56991236|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991237|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991238|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
56991239|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
56991240|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
56991241|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885375|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991242|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991243|NCT04180397|Furosemide|furosemide|mesh-list
56991244|NCT04180397|Diuretics|diuretics|mesh-ancestor
56991245|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
56991246|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991247|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56885745|NCT03715478|Hormones|hormones|mesh-ancestor
56991248|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56885815|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885887|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
56885961|NCT03553758|Analgesics|analgesics|mesh-ancestor
56886034|NCT03518112|Methotrexate|methotrexate|mesh-list
56991249|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56886125|NCT03680638|Tempol|tempol|mesh-list
56991250|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
56991251|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56991252|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
56991253|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56991254|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
56886499|NCT03678142|Vancomycin|vancomycin|mesh-list
56991255|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56886645|NCT02915302|Vaccines|vaccines|mesh-list
56991256|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991257|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
56991258|NCT03295721|Bupivacaine|bupivacaine|mesh-list
56991259|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
56991260|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
56991261|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991262|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991263|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
56991264|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991265|NCT00803790|Vitamin D|vitamin d|mesh-list
56991266|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
56991267|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
56991268|NCT00803790|Alendronate|alendronate|mesh-list
56991269|NCT00803790|Vitamins|vitamins|mesh-list
56991270|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
56991271|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991272|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56991273|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56991274|NCT00442338|Aminophylline|aminophylline|mesh-list
56991275|NCT00442338|Theophylline|theophylline|mesh-list
56991276|NCT00442338|Montelukast|montelukast|mesh-list
56991277|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56991278|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
56991279|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56991280|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
56991281|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991282|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991283|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56991284|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56673461|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
56991285|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991286|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56991287|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
56991288|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991289|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56991290|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56991291|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991292|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56887091|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
56991293|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56991294|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
56887134|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
56887204|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
56991295|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56887355|NCT03666208|Sirolimus|sirolimus|mesh-list
56887438|NCT03540030|Analgesics|analgesics|mesh-ancestor
56991296|NCT00442338|Protective Agents|protective agents|mesh-ancestor
56991297|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
56887704|NCT03720756|Nickel|nickel|mesh-list
56887728|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56887800|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56887874|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56887949|NCT03717662|Nicotine|nicotine|mesh-list
56888019|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56991298|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56991299|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56991300|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991301|NCT02316834|Talazoparib|talazoparib|mesh-list
56991302|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56991303|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991304|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991305|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991306|NCT02975934|Docetaxel|docetaxel|mesh-list
56991307|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
56888313|NCT05658380|Mydriatics|mydriatics|mesh-ancestor
56991308|NCT02975934|Rucaparib|rucaparib|mesh-list
56991309|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991310|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
56888763|NCT03652714|Anesthetics|anesthetics|mesh-list
56991311|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
56991312|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
56889136|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889208|NCT01109511|Oxycodone|oxycodone|mesh-list
56889284|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991313|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991314|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56991315|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56889511|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
56991316|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
56991317|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56889733|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
56889883|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56889966|NCT01214343|Sorafenib|sorafenib|mesh-list
56890036|NCT01120665|Estradiol|estradiol|mesh-list
56991318|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991319|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56991320|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56991321|NCT02879136|Methylphenidate|methylphenidate|mesh-list
56991322|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56991323|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56991324|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56890326|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
56991325|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56890624|NCT03740373|Budesonide|budesonide|mesh-list
56890771|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991326|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56890996|NCT03925779|Narcotics|narcotics|mesh-ancestor
56991327|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56991328|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991329|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
56991330|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991331|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56991332|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
56991333|NCT00250458|Rizatriptan|rizatriptan|mesh-list
56991334|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56991335|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
56991336|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991337|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991338|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991339|NCT01965132|Adalimumab|adalimumab|mesh-list
56991340|NCT01965132|Etanercept|etanercept|mesh-list
56991341|NCT01965132|Golimumab|golimumab|mesh-list
56991342|NCT01965132|Abatacept|abatacept|mesh-list
56991343|NCT01965132|Infliximab|infliximab|mesh-list
56991344|NCT01965132|Upadacitinib|upadacitinib|mesh-list
56991345|NCT01965132|Ustekinumab|ustekinumab|mesh-list
56991346|NCT01965132|Ixekizumab|ixekizumab|mesh-list
56991347|NCT01965132|Tofacitinib|tofacitinib|mesh-list
56991348|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991349|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
56991350|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991351|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991352|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991353|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
56991354|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56892253|NCT03616132|Sirolimus|sirolimus|mesh-list
56991355|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56991356|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56991357|NCT01965132|Analgesics|analgesics|mesh-ancestor
56892486|NCT01142505|Diuretics|diuretics|mesh-ancestor
56991358|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
56991359|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991360|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56991361|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56892926|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
56991362|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991363|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56893249|NCT02034604|Tamsulosin|tamsulosin|mesh-list
56893315|NCT03604744|Psilocybin|psilocybin|mesh-list
56991364|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991365|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56991366|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56991367|NCT01667133|Ponatinib|ponatinib|mesh-list
56991368|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991369|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56893896|NCT02845336|Celecoxib|celecoxib|mesh-list
56893897|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
56893898|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56893899|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56893900|NCT02845336|Analgesics|analgesics|mesh-ancestor
56893901|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
56893902|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56893903|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991370|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894121|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56991371|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991372|NCT01891344|Rucaparib|rucaparib|mesh-list
56894424|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
56991373|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56894577|NCT01251471|Citalopram|citalopram|mesh-list
56991374|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991375|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991376|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991377|NCT01498770|Olanzapine|olanzapine|mesh-list
56991378|NCT01498770|Risperidone|risperidone|mesh-list
56991379|NCT01498770|Aripiprazole|aripiprazole|mesh-list
56895025|NCT01254123|Incretins|incretins|mesh-ancestor
56991380|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56991381|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56991382|NCT01498770|Ziprasidone|ziprasidone|mesh-list
56991383|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56991384|NCT01498770|Clozapine|clozapine|mesh-list
56991385|NCT01498770|Asenapine|asenapine|mesh-list
56991386|NCT01498770|Amisulpride|amisulpride|mesh-list
56991387|NCT01498770|Iloperidone|iloperidone|mesh-list
56991388|NCT01498770|Sertindole|sertindole|mesh-list
56991389|NCT01498770|Zotepine|zotepine|mesh-list
56991390|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56991391|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
56895570|NCT01260753|Xhance|xhance|mesh-list
56991392|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991393|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991394|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991395|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56991396|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56991397|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991398|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56991399|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56991400|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
56991401|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
56991402|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
56991403|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991404|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56991405|NCT01498770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56991406|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56991407|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56991408|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
56991409|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
56991410|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56991411|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56991412|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56991413|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56991414|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56991415|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56991416|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56991417|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
56991418|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
56991419|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
56991420|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56991421|NCT00140946|Montelukast|montelukast|mesh-list
56991422|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991423|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991424|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
56991425|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56991426|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56991427|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
56991428|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991429|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56991430|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56991431|NCT01267812|Rituximab|rituximab|mesh-list
56991432|NCT01267812|Bortezomib|bortezomib|mesh-list
56991433|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56991434|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991435|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
56991436|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991437|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991438|NCT00095004|Rizatriptan|rizatriptan|mesh-list
56991439|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991440|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991441|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991442|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56991443|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
56991444|NCT00967746|Etonogestrel|etonogestrel|mesh-list
56991445|NCT00967746|Desogestrel|desogestrel|mesh-list
56991446|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56991447|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
56991448|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56991449|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991450|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56991451|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56991452|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56991453|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56991454|NCT00967746|Progestins|progestins|mesh-ancestor
56991455|NCT00967746|Hormones|hormones|mesh-ancestor
56991456|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991457|NCT00092118|Montelukast|montelukast|mesh-list
56991458|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56991459|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
56991460|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56991461|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
56894825|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991462|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991463|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991464|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56991465|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56991466|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991467|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56991468|NCT00920634|Hormones|hormones|mesh-ancestor
56991469|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991470|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991471|NCT00092040|Alendronate|alendronate|mesh-list
56991472|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
56991473|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991474|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991475|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56991476|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56991477|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56991478|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56991479|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
56991480|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991481|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56991482|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991483|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991484|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
56991485|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991486|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56991487|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991488|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991489|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
56991490|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991491|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991492|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56991493|NCT04856904|Trifarotene|trifarotene|mesh-list
56991494|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
56991495|NCT05416827|Dexamethasone|dexamethasone|mesh-list
56991496|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991497|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
56991498|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
56991499|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991500|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991501|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56991502|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
56991503|NCT05416827|Hormones|hormones|mesh-ancestor
56991504|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991505|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56991506|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991507|NCT05472792|Tamoxifen|tamoxifen|mesh-list
56991508|NCT05472792|Toremifene|toremifene|mesh-list
56991509|NCT05472792|Letrozole|letrozole|mesh-list
56991510|NCT05472792|Fulvestrant|fulvestrant|mesh-list
56991511|NCT05472792|Anastrozole|anastrozole|mesh-list
56991512|NCT05472792|Exemestane|exemestane|mesh-list
56991513|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991514|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56991515|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56991516|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991517|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991518|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56991519|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
56991520|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991521|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991522|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56991523|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56991524|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56991525|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56991526|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56991527|NCT05626803|Vaccines|vaccines|mesh-list
56991528|NCT05626803|Immunologic Factors|immunologic factors|mesh-ancestor
56991529|NCT05626803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991530|NCT04961619|Trametinib|trametinib|mesh-list
56991531|NCT04961619|Dabrafenib|dabrafenib|mesh-list
56991532|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991533|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56991534|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991535|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991536|NCT05076513|Niraparib|niraparib|mesh-list
56991537|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56991538|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991539|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991540|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991541|NCT04979910|Ixekizumab|ixekizumab|mesh-list
56991542|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56991543|NCT05422794|Paclitaxel|paclitaxel|mesh-list
56991544|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56991545|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
56991546|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56991547|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991548|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
56991549|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
56991550|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
56991551|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991552|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56991553|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
56991554|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56991555|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991556|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56991557|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991558|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
56991559|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56991560|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56991561|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56991562|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56991563|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991564|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
56991565|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991566|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991567|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56991568|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991569|NCT05391126|Irinotecan|irinotecan|mesh-list
56991570|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56991571|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56991572|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991573|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991574|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991575|NCT05418309|Paclitaxel|paclitaxel|mesh-list
56991576|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56991577|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991578|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
56991579|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
56991580|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
56991581|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991582|NCT05137548|Tenofovir|tenofovir|mesh-list
56991583|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
56991584|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991585|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56991586|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56991587|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991588|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991589|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56991590|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56991591|NCT05044611|Amiloride|amiloride|mesh-list
56991592|NCT05044611|Diuretics|diuretics|mesh-ancestor
56991593|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
56991594|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991595|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56991596|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56991597|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56991598|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991599|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56991600|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56991601|NCT05091294|Anesthetics|anesthetics|mesh-list
56991602|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
56991603|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991604|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991605|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
56991606|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991607|NCT04520178|Carbidopa|carbidopa|mesh-list
56991608|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
56991609|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56991610|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56991611|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
56991612|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991613|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991614|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991615|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56991616|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991617|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56991618|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
56991619|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56991620|NCT05320926|Aspirin|aspirin|mesh-list
56991621|NCT05320926|Clopidogrel|clopidogrel|mesh-list
56991622|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56991623|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56991624|NCT05320926|Analgesics|analgesics|mesh-ancestor
56991625|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
56991626|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991627|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991628|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991629|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991630|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56991631|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56991632|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991633|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56991634|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56991635|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991636|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
56991637|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56991638|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56991639|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56991640|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
56991641|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991642|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
56991643|NCT05296512|Lenvatinib|lenvatinib|mesh-list
56991644|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56991645|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991646|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56991647|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991648|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991649|NCT05417997|Clarithromycin|clarithromycin|mesh-list
56991650|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
56991651|NCT05417997|Favipiravir|favipiravir|mesh-list
56991652|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
56991653|NCT05417997|Enoxaparin|enoxaparin|mesh-list
56991654|NCT05417997|Lansoprazole|lansoprazole|mesh-list
56991655|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991656|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
56991657|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
56991658|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991659|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991660|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56991661|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
56991662|NCT05417997|Hormones|hormones|mesh-ancestor
56991663|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991664|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56991665|NCT05417997|Protective Agents|protective agents|mesh-ancestor
56991666|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56991667|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991668|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56991669|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991670|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991671|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56991672|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56991673|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
56991674|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56991675|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56991676|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56991677|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56991678|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
56991679|NCT03856788|Bupivacaine|bupivacaine|mesh-list
56991680|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
56991681|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
56991682|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991683|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991684|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
56991685|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991686|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
56991687|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
56991688|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991689|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
56991690|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991691|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991692|NCT04981509|Listerine|listerine|mesh-list
56991693|NCT04981509|Bevacizumab|bevacizumab|mesh-list
56991694|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56991695|NCT04981509|Atezolizumab|atezolizumab|mesh-list
56991696|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
56991697|NCT04981509|Antibodies|antibodies|mesh-list
56991698|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
56991699|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56991700|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
56991701|NCT04981509|Fluorides|fluorides|mesh-list
56991702|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
56991703|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991704|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56991705|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56991706|NCT04981509|Growth Substances|growth substances|mesh-ancestor
56991707|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991708|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
56991709|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
56991710|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
56991711|NCT04981509|Protective Agents|protective agents|mesh-ancestor
56991712|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56991713|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991714|NCT03242759|Pirfenidone|pirfenidone|mesh-list
56991715|NCT03242759|Nintedanib|nintedanib|mesh-list
56991716|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991717|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56991718|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991719|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991720|NCT03242759|Analgesics|analgesics|mesh-ancestor
56991721|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
56991722|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991723|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991724|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56991725|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56991726|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991727|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991728|NCT03243552|Levodopa|levodopa|mesh-list
56991729|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56991730|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56991731|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
56991732|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991733|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991734|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991735|NCT03625050|Celecoxib|celecoxib|mesh-list
56991736|NCT03625050|Esomeprazole|esomeprazole|mesh-list
56991737|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56991738|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56991739|NCT03625050|Analgesics|analgesics|mesh-ancestor
56991740|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
56991741|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991742|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991743|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991744|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991745|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56991746|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56991747|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991748|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991749|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56991750|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56991751|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56991752|NCT03257813|Timolol|timolol|mesh-list
56991753|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56991754|NCT03257813|Dorzolamide|dorzolamide|mesh-list
56991755|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56991756|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56991757|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
56991758|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991759|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991760|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991761|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56991762|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56991763|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56991764|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56991765|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56991766|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56991767|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991768|NCT03210259|Adalimumab|adalimumab|mesh-list
56991769|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991770|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991771|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
56991772|NCT04319757|Fludarabine|fludarabine|mesh-list
56991773|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56991774|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
56991775|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991776|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991777|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56991778|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
56991779|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991780|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991781|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56991782|NCT05180461|Ivermectin|ivermectin|mesh-list
56991783|NCT05180461|Emodepside|emodepside|mesh-list
56991784|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56991785|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991786|NCT02496611|Exenatide|exenatide|mesh-list
56991787|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56991788|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991789|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56991790|NCT02496611|Incretins|incretins|mesh-ancestor
56991791|NCT02496611|Hormones|hormones|mesh-ancestor
56991792|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56991793|NCT03636295|Warfarin|warfarin|mesh-list
56991794|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
56991795|NCT03237481|Bupivacaine|bupivacaine|mesh-list
56991796|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
56991797|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
56991798|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991799|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991800|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
56991801|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991802|NCT03704220|Warfarin|warfarin|mesh-list
56991803|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
56991804|NCT03222349|Diazepam|diazepam|mesh-list
56991805|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56991806|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
56991807|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
56991808|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
56991809|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991810|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991811|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56991812|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56991813|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991814|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56991815|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56991816|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56991817|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56991818|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56991819|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56991820|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
56991821|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
56991822|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
56991823|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
56991824|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991825|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991826|NCT02927925|Daratumumab|daratumumab|mesh-list
56991827|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991828|NCT04795245|Afatinib|afatinib|mesh-list
56991829|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991830|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56991831|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991832|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991833|NCT03208933|Pirfenidone|pirfenidone|mesh-list
56991834|NCT03208933|Analgesics|analgesics|mesh-ancestor
56991835|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
56991836|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991837|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991838|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56991839|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56991840|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991841|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991842|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991843|NCT02499120|Cetuximab|cetuximab|mesh-list
56991844|NCT02499120|Palbociclib|palbociclib|mesh-list
56991845|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56991846|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991847|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56991848|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991849|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991850|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
56991851|NCT01568307|Serotonin|serotonin|mesh-list
56991852|NCT01568307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56991853|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56991854|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56991855|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
56991856|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991857|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991858|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991859|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56991860|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56991861|NCT02415036|Melphalan|melphalan|mesh-list
56991862|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56991863|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
56991864|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991865|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991866|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56991867|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56991868|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
56991869|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991870|NCT04752267|Clevudine|clevudine|mesh-list
56991871|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
56991872|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991873|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
56991874|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56991875|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
56991876|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56991877|NCT02117700|Expectorants|expectorants|mesh-ancestor
56991878|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
56991879|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56991880|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
56991881|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991882|NCT02117700|Protective Agents|protective agents|mesh-ancestor
56991883|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991885|NCT03257267|Cemiplimab|cemiplimab|mesh-list
56991886|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56991887|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991888|NCT02932579|Acetaminophen|acetaminophen|mesh-list
56991889|NCT02932579|Ibuprofen|ibuprofen|mesh-list
56991890|NCT02932579|Oxycodone|oxycodone|mesh-list
56991891|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56991892|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56991893|NCT02932579|Analgesics|analgesics|mesh-ancestor
56991894|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
56991895|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991896|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991897|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991898|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991899|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56991900|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895619|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
56991901|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991902|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56991903|NCT02932579|Narcotics|narcotics|mesh-ancestor
56991904|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56991905|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
56991906|NCT04748757|Annexin A5|annexin a5|mesh-list
56991907|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991908|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991909|NCT03207451|Aspirin|aspirin|mesh-list
56991910|NCT03207451|Clopidogrel|clopidogrel|mesh-list
56991911|NCT03207451|Vorapaxar|vorapaxar|mesh-list
56991912|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56991913|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56991914|NCT03207451|Analgesics|analgesics|mesh-ancestor
56991915|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
56991916|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991917|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991918|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991919|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56991920|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56991921|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56991922|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991923|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56991924|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56991925|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991926|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
56991927|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56991928|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56991929|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56991930|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
56991931|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991932|NCT02476097|Esomeprazole|esomeprazole|mesh-list
56991933|NCT02476097|Omeprazole|omeprazole|mesh-list
56991934|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56991935|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56991936|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56991937|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56991938|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991939|NCT05089123|Vaccines|vaccines|mesh-list
56991940|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
56991941|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991942|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56991943|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56991944|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991945|NCT03948035|Dexamethasone|dexamethasone|mesh-list
56991946|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
56991947|NCT03948035|Lenalidomide|lenalidomide|mesh-list
56991948|NCT03948035|Elotuzumab|elotuzumab|mesh-list
56991949|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991950|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
56991951|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
56991952|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991953|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991954|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56991955|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
56991956|NCT03948035|Hormones|hormones|mesh-ancestor
56991957|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674142|NCT04138238|Sirolimus|sirolimus|mesh-list
56991958|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56991959|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56991960|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
56991961|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56991962|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56991963|NCT03948035|Growth Substances|growth substances|mesh-ancestor
56991964|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
56991965|NCT02361125|Methylphenidate|methylphenidate|mesh-list
56991966|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56991967|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991968|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56991969|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56991970|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56991971|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991972|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
56991973|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991974|NCT03701256|Atracurium|atracurium|mesh-list
56991975|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56991976|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56991977|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56991978|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991979|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991980|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56991981|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56991982|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
56991983|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56991984|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56991985|NCT04780581|Dexamethasone|dexamethasone|mesh-list
56991986|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
56991987|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56991988|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56991989|NCT04780581|Prednisolone|prednisolone|mesh-list
56991990|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
56991991|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56991992|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
56991993|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56991994|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
56991995|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
56991996|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56991997|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56991998|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56991999|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
56992000|NCT04780581|Hormones|hormones|mesh-ancestor
56992001|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992002|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56992003|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992004|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56992005|NCT04780581|Protective Agents|protective agents|mesh-ancestor
56992006|NCT01526135|Gemcitabine|gemcitabine|mesh-list
56992007|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56992008|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
56992009|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992010|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992011|NCT01526135|Antiviral Agents|antiviral agents|mesh-ancestor
56992012|NCT01526135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992013|NCT01526135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992014|NCT01526135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56992015|NCT01526135|Immunologic Factors|immunologic factors|mesh-ancestor
56992016|NCT01526135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992017|NCT03641313|Irinotecan|irinotecan|mesh-list
56992018|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56992019|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56992020|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992021|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992022|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992023|NCT03701022|Apatinib|apatinib|mesh-list
56992024|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992025|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56992026|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992027|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992028|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
56992029|NCT04221165|Narcotics|narcotics|mesh-ancestor
56992030|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992031|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992032|NCT04221165|Analgesics|analgesics|mesh-ancestor
56992033|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
56992034|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992035|NCT03255629|Glucagon|glucagon|mesh-list
56992036|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56992037|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56992038|NCT03255629|Hormones|hormones|mesh-ancestor
56992039|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992040|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992041|NCT03255629|Incretins|incretins|mesh-ancestor
56992042|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
56992043|NCT04622007|Pemetrexed|pemetrexed|mesh-list
56992044|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992045|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992046|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895620|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56992047|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992048|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56992049|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56992050|NCT01143779|Telbivudine|telbivudine|mesh-list
56992051|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
56992052|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992053|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56992054|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992055|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992056|NCT03703596|Docetaxel|docetaxel|mesh-list
56992057|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992058|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
56992059|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
56992060|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
56992061|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992062|NCT01137773|Insulin|insulin|mesh-list
56992063|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56992064|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56992065|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992066|NCT03698292|Metoclopramide|metoclopramide|mesh-list
56992067|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
56992068|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
56992069|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992070|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992071|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56992072|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56992073|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56992074|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
56992075|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992076|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992077|NCT04614909|Temozolomide|temozolomide|mesh-list
56992078|NCT04614909|Olaparib|olaparib|mesh-list
56992079|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56992080|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
56992081|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992082|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992083|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56992084|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992085|NCT04613271|Azithromycin|azithromycin|mesh-list
56992086|NCT04613271|Favipiravir|favipiravir|mesh-list
56992087|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56992088|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992089|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
56992090|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56992091|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992092|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992093|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56992094|NCT03631953|Trametinib|trametinib|mesh-list
56992095|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992096|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56992097|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992098|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992099|NCT01030575|Inositol|inositol|mesh-list
56992100|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
56992101|NCT01030575|Vitamins|vitamins|mesh-ancestor
56992102|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
56992103|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992104|NCT04352205|Thalidomide|thalidomide|mesh-list
56992105|NCT04352205|Dexamethasone|dexamethasone|mesh-list
56992106|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
56992107|NCT04352205|Lenalidomide|lenalidomide|mesh-list
56674297|NCT00819039|Aprepitant|aprepitant|mesh-list
56992108|NCT04352205|Bortezomib|bortezomib|mesh-list
56992109|NCT04352205|Daratumumab|daratumumab|mesh-list
56992110|NCT04352205|Ichthammol|ichthammol|mesh-list
56992111|NCT04352205|BB 1101|bb 1101|mesh-list
56992112|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992113|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
56992114|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
56992115|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992116|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992117|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56992118|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
56992119|NCT04352205|Hormones|hormones|mesh-ancestor
56992120|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992121|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56992122|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992123|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
56992124|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992125|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992126|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
56992127|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56992128|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56992129|NCT04352205|Growth Substances|growth substances|mesh-ancestor
56992130|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
56992131|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56992132|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
56992133|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56992134|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992135|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
56992136|NCT04215471|Antibodies|antibodies|mesh-list
56992137|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
56992138|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
56992139|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992140|NCT04058067|Aflibercept|aflibercept|mesh-list
56992141|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56992142|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56992143|NCT04058067|Growth Substances|growth substances|mesh-ancestor
56992144|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992145|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
56992146|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992147|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
56992148|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56992149|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56992150|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
56992151|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992152|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992153|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992154|NCT03106987|Olaparib|olaparib|mesh-list
56992155|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56992156|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992157|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992158|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992159|NCT05040217|Mitogens|mitogens|mesh-list
56992160|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
56992161|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992162|NCT02932267|Adapalene|adapalene|mesh-list
56992163|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56992164|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56992165|NCT02932267|Analgesics|analgesics|mesh-ancestor
56992166|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
56992167|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992168|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992169|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992170|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992171|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
56992172|NCT03217591|Praliciguat|praliciguat|mesh-list
56992173|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56992174|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
56992175|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992176|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56992177|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56992178|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56992179|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992180|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
56992181|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
56992182|NCT03697824|Fludarabine|fludarabine|mesh-list
56992183|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56992184|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
56992185|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992186|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992187|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56992188|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
56992189|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992190|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992191|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56992192|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992193|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56992194|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56992195|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992196|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56992197|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992198|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992199|NCT03697746|Acetaminophen|acetaminophen|mesh-list
56992200|NCT03697746|Ibuprofen|ibuprofen|mesh-list
56992201|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56992202|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56992203|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56992204|NCT03697746|Analgesics|analgesics|mesh-ancestor
56992205|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
56992206|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992207|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992208|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992209|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992210|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56992211|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992212|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992213|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
56992214|NCT03697668|Piperaquine|piperaquine|mesh-list
56992215|NCT03697668|Artenimol|artenimol|mesh-list
56992216|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
56992217|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992218|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56992219|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992220|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992221|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
56992222|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56992223|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56992224|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992225|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
56992226|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56992227|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
56992228|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992229|NCT03702738|Expectorants|expectorants|mesh-ancestor
56992230|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
56992231|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56992232|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
56992233|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992234|NCT03702738|Protective Agents|protective agents|mesh-ancestor
56992235|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992236|NCT03702738|Antidotes|antidotes|mesh-ancestor
56992237|NCT03702582|Warfarin|warfarin|mesh-list
56992238|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
56992239|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
56992240|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56992241|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
56992242|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56992243|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
56992244|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992245|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992246|NCT03697044|Irinotecan|irinotecan|mesh-list
56992247|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56992248|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56992249|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992250|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992251|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992252|NCT03699774|Firuglipel|firuglipel|mesh-list
56992253|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56992254|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56992255|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56992256|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
56992257|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992258|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56992259|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56992261|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56992262|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992263|NCT03699696|Propofol|propofol|mesh-list
56992264|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56992265|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992266|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992267|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56992268|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
56992269|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
56992270|NCT03702426|Norfloxacin|norfloxacin|mesh-list
56992271|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56992272|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992273|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56992274|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56992275|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992276|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992277|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992278|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56992279|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56992280|NCT04684368|Carboplatin|carboplatin|mesh-list
56992281|NCT04684368|Etoposide|etoposide|mesh-list
56992282|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
56992283|NCT04684368|Ifosfamide|ifosfamide|mesh-list
56992284|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
56992285|NCT04684368|Thiotepa|thiotepa|mesh-list
56992286|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
56992287|NCT04684368|Lenograstim|lenograstim|mesh-list
56992288|NCT04684368|Mesna|mesna|mesh-list
56992289|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992290|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56992291|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56992292|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56992293|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992294|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992295|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56992296|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
56992297|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992298|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56992299|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
56992300|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56992301|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56992302|NCT04684368|Protective Agents|protective agents|mesh-ancestor
56992303|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
56992304|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56992305|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56992306|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56992307|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56992308|NCT00265941|Cetuximab|cetuximab|mesh-list
56992309|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992310|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992311|NCT03377361|Nivolumab|nivolumab|mesh-list
56992312|NCT03377361|Ipilimumab|ipilimumab|mesh-list
56992313|NCT03377361|Trametinib|trametinib|mesh-list
56992314|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992315|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992316|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56992317|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992318|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56992319|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992320|NCT03699384|Azacitidine|azacitidine|mesh-list
56992321|NCT03699384|Avelumab|avelumab|mesh-list
56992322|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56992323|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
56992324|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992325|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992326|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992327|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992328|NCT04477512|Prednisone|prednisone|mesh-list
56992329|NCT04477512|Nivolumab|nivolumab|mesh-list
56992330|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
56992331|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992332|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
56992333|NCT04477512|Hormones|hormones|mesh-ancestor
56992334|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992335|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992336|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56992337|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992338|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992339|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56992340|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992341|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56992342|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992343|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
56992344|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56992345|NCT04546425|Vaccines|vaccines|mesh-list
56992346|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56992347|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
56992348|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992349|NCT05378763|Docetaxel|docetaxel|mesh-list
56992350|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992351|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
56992352|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
56992353|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
56992354|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992355|NCT03203473|Nivolumab|nivolumab|mesh-list
56992356|NCT03203473|Ipilimumab|ipilimumab|mesh-list
56992357|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992358|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992359|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56992360|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992361|NCT02937571|Dexamethasone|dexamethasone|mesh-list
56992362|NCT02937571|Lenalidomide|lenalidomide|mesh-list
56992363|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992364|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
56992365|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
56992366|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992367|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992368|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56992369|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
56992370|NCT02937571|Hormones|hormones|mesh-ancestor
56992371|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992372|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56992373|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992374|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
56992375|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56992376|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56992377|NCT02937571|Growth Substances|growth substances|mesh-ancestor
56992378|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
56992379|NCT03201211|Vaccines|vaccines|mesh-list
56992380|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
56992381|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992382|NCT04624945|Thromboplastin|thromboplastin|mesh-list
56992383|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
56992384|NCT04624945|Coagulants|coagulants|mesh-ancestor
56992385|NCT03566511|Diazoxide|diazoxide|mesh-list
56992386|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56992387|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
56992388|NCT04472949|Carboplatin|carboplatin|mesh-list
56992389|NCT04472949|Etoposide|etoposide|mesh-list
56992390|NCT04472949|Durvalumab|durvalumab|mesh-list
56992391|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992392|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56992393|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56992394|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56992395|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992396|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992397|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992398|NCT03696186|Phenobarbital|phenobarbital|mesh-list
56992399|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
56992400|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56992401|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992402|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992403|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56992404|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56992405|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992406|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992407|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
56992408|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
56992409|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56992410|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56992411|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56992412|NCT03698916|Celecoxib|celecoxib|mesh-list
56992413|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56992414|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56992415|NCT03698916|Analgesics|analgesics|mesh-ancestor
56992416|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
56992417|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569855|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
56992418|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992419|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992420|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992421|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56992422|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56992423|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992424|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992425|NCT03336333|Rituximab|rituximab|mesh-list
56992426|NCT03336333|Venetoclax|venetoclax|mesh-list
56992427|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56992428|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
56992429|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992430|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992431|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
56992432|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992433|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992434|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56992435|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
56992436|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992437|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56992438|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992439|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
56992440|NCT03695952|Nivolumab|nivolumab|mesh-list
56992441|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56992442|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992443|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992444|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992445|NCT04431453|Remdesivir|remdesivir|mesh-list
56992446|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
56992447|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992448|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
56992449|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992450|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
56992451|NCT03695640|Analgesics|analgesics|mesh-ancestor
56992452|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
56992453|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992454|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992455|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
56992456|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992457|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56992458|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
56992459|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56992460|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56992461|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992462|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56992463|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
56992464|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56992465|NCT03698682|Levofloxacin|levofloxacin|mesh-list
56992466|NCT03698682|Ofloxacin|ofloxacin|mesh-list
56992467|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56992468|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992469|NCT03698682|Renal Agents|renal agents|mesh-ancestor
56992470|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56992471|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56992472|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56992473|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992474|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992475|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992476|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56992477|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56992478|NCT03029832|Atezolizumab|atezolizumab|mesh-list
56992479|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992480|NCT05598567|Anesthetics|anesthetics|mesh-list
56992481|NCT05598567|Sevoflurane|sevoflurane|mesh-list
56992482|NCT05598567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674659|NCT01946711|Budesonide|budesonide|mesh-list
56992483|NCT05598567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992484|NCT05598567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56992485|NCT05598567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56992486|NCT05598567|Anesthetics, General|anesthetics, general|mesh-ancestor
56992487|NCT03701880|Bisoprolol|bisoprolol|mesh-list
56992488|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56992489|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
56992490|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
56992491|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992492|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992493|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56992494|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56992495|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56992496|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
56992497|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992498|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992499|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
56992500|NCT03692754|Dexamethasone|dexamethasone|mesh-list
56992501|NCT03692754|Atorvastatin|atorvastatin|mesh-list
56992502|NCT03692754|Calcium|calcium|mesh-list
56992503|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992504|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
56992505|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
56992506|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992507|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992508|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56992509|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
56992510|NCT03692754|Hormones|hormones|mesh-ancestor
56992511|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992512|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56992513|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992514|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56992515|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56992516|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56992517|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56992518|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
56992519|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992520|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56992521|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56992522|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992523|NCT04224558|Acetaminophen|acetaminophen|mesh-list
56992524|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
56992525|NCT04224558|Promethazine|promethazine|mesh-list
56992526|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
56992527|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56992528|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
56992529|NCT04224558|Fludarabine|fludarabine|mesh-list
56992530|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
56992531|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56992532|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
56992533|NCT04224558|Antibodies|antibodies|mesh-list
56992534|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
56992535|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56992536|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56992537|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56992538|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
56992539|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992540|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992541|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56992542|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
56992543|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992544|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992545|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56992546|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56992547|NCT04224558|Analgesics|analgesics|mesh-ancestor
56992548|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
56992549|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992550|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
56992551|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992552|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
56992553|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
56992554|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56992555|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
56992556|NCT04224558|Hormones|hormones|mesh-ancestor
56992557|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992558|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56992559|NCT04224558|Protective Agents|protective agents|mesh-ancestor
56992560|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56992561|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56992562|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56992563|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992564|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
56992565|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
56992566|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56992567|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
56992568|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
56992569|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992570|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56992571|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
56992572|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
56992573|NCT05598411|Methylprednisolone|methylprednisolone|mesh-list
56992574|NCT05598411|Glucocorticoids|glucocorticoids|mesh-list
56992575|NCT05598411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992576|NCT05598411|Antiemetics|antiemetics|mesh-ancestor
56992577|NCT05598411|Autonomic Agents|autonomic agents|mesh-ancestor
56992578|NCT05598411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992579|NCT05598411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992580|NCT05598411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56992581|NCT05598411|Hormones|hormones|mesh-ancestor
56992582|NCT05598411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992583|NCT05598411|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56992584|NCT05598411|Protective Agents|protective agents|mesh-ancestor
56992585|NCT03688230|Cetuximab|cetuximab|mesh-list
56992586|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992587|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992588|NCT03694236|Durvalumab|durvalumab|mesh-list
56992589|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992590|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992591|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
56992592|NCT03692286|Calcium|calcium|mesh-list
56992593|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56992594|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992595|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56992596|NCT03694080|Calcium|calcium|mesh-list
56992597|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56992598|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992599|NCT04302870|Memantine|memantine|mesh-list
56992600|NCT04302870|Trazodone|trazodone|mesh-list
56992601|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56992602|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56992603|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56992604|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
56992605|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992606|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992607|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992608|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56992609|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56992610|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56992611|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56992612|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992613|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56992614|NCT04302870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56992615|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56992616|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56992617|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
56992618|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56992619|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
56992620|NCT04207944|Sulindac|sulindac|mesh-list
56992621|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56992622|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56992623|NCT04207944|Analgesics|analgesics|mesh-ancestor
56992624|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
56992625|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992626|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992627|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992628|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992629|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992630|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56992631|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992632|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992633|NCT04203498|Nabiximols|nabiximols|mesh-list
56992634|NCT04203498|Analgesics|analgesics|mesh-ancestor
56992635|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
56992636|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992637|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992638|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
56992639|NCT03691896|Vitamin D|vitamin d|mesh-list
56992640|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56992641|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992642|NCT03691896|Vitamins|vitamins|mesh-ancestor
56992643|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
56992644|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56992645|NCT03691818|Ibuprofen|ibuprofen|mesh-list
56992646|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56992647|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56992648|NCT03691818|Analgesics|analgesics|mesh-ancestor
56992649|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
56992650|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992651|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992652|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992653|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992654|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56992655|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992656|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992657|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56992658|NCT03687606|Menotropins|menotropins|mesh-list
56992659|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56992660|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992661|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56992662|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
56992663|NCT03691662|Timolol|timolol|mesh-list
56992664|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56992665|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56992666|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992667|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56992668|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56992669|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
56992670|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992671|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992672|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56992673|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56992674|NCT04059978|Remifentanil|remifentanil|mesh-list
56992675|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56992676|NCT04059978|Narcotics|narcotics|mesh-ancestor
56992677|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992678|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992679|NCT04059978|Analgesics|analgesics|mesh-ancestor
56992680|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
56992681|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992682|NCT03199963|Tamoxifen|tamoxifen|mesh-list
56992683|NCT03199963|Afimoxifene|afimoxifene|mesh-list
56992684|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56992685|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
56992686|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992687|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992688|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56992689|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992690|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56992691|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56992692|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56992693|NCT03636685|Paclitaxel|paclitaxel|mesh-list
56992694|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56992695|NCT03636685|Carboplatin|carboplatin|mesh-list
56992696|NCT03636685|Pemetrexed|pemetrexed|mesh-list
56992697|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56992698|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992699|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
56992700|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
56992701|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
56992702|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992703|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992704|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56992705|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56992706|NCT03257631|Thalidomide|thalidomide|mesh-list
56992707|NCT03257631|Pomalidomide|pomalidomide|mesh-list
56992708|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
56992709|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992710|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56992711|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56992712|NCT03257631|Growth Substances|growth substances|mesh-ancestor
56992713|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
56992714|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992715|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56992716|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
56992717|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56992718|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992719|NCT03883581|Quinidine|quinidine|mesh-list
56992720|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
56992721|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
56992722|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
56992723|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
56992724|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56992725|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56992726|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992727|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992728|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992729|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56992730|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56992731|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
56992732|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56992733|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
56992734|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56992735|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56992736|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992737|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992738|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56992739|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56992740|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
56992741|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56992742|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56992743|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56992744|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56992745|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56992746|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
56992747|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56992748|NCT03824535|Fluorides|fluorides|mesh-list
56992749|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56992750|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992751|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
56992752|NCT03824535|Protective Agents|protective agents|mesh-ancestor
56895655|NCT03887169|Hematinics|hematinics|mesh-ancestor
56992753|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992754|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
56992755|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
56992756|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992757|NCT03113643|Azacitidine|azacitidine|mesh-list
56992758|NCT03113643|Venetoclax|venetoclax|mesh-list
56992759|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56992760|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
56992761|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992762|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992763|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992764|NCT03091491|Nivolumab|nivolumab|mesh-list
56992765|NCT03091491|Ipilimumab|ipilimumab|mesh-list
56992766|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992767|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992768|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56992769|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992770|NCT05598255|Dexamethasone|dexamethasone|mesh-list
56992771|NCT05598255|Levobupivacaine|levobupivacaine|mesh-list
56992772|NCT05598255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56992773|NCT05598255|Antiemetics|antiemetics|mesh-ancestor
56992774|NCT05598255|Autonomic Agents|autonomic agents|mesh-ancestor
56992775|NCT05598255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992776|NCT05598255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992777|NCT05598255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56992778|NCT05598255|Glucocorticoids|glucocorticoids|mesh-ancestor
56992779|NCT05598255|Hormones|hormones|mesh-ancestor
56992780|NCT05598255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992781|NCT05598255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56992782|NCT05598255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992783|NCT05598255|Anesthetics, Local|anesthetics, local|mesh-ancestor
56992784|NCT05598255|Anesthetics|anesthetics|mesh-ancestor
56992785|NCT05598255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992786|NCT05598255|Sensory System Agents|sensory system agents|mesh-ancestor
56992787|NCT04733235|Progesterone|progesterone|mesh-list
56992788|NCT04733235|Hormones|hormones|mesh-ancestor
56992789|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992790|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992791|NCT04733235|Progestins|progestins|mesh-ancestor
56992792|NCT05598177|Dexmedetomidine|dexmedetomidine|mesh-list
56992793|NCT05598177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56992794|NCT05598177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992795|NCT05598177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992796|NCT05598177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56992797|NCT05598177|Analgesics|analgesics|mesh-ancestor
56992798|NCT05598177|Sensory System Agents|sensory system agents|mesh-ancestor
56992799|NCT05598177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992800|NCT05598177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56895666|NCT03887013|Trimetazidine|trimetazidine|mesh-list
56992801|NCT05598177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56992802|NCT05598177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56992803|NCT05598177|Adrenergic Agents|adrenergic agents|mesh-ancestor
56992804|NCT05598177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992805|NCT05598177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992806|NCT03740529|Rituximab|rituximab|mesh-list
56992807|NCT03740529|Venetoclax|venetoclax|mesh-list
56992808|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992809|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992810|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
56992811|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992812|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992813|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
56992814|NCT03029208|Hematinics|hematinics|mesh-ancestor
56992815|NCT04284774|Tipifarnib|tipifarnib|mesh-list
56992816|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992817|NCT05212623|Vaccines|vaccines|mesh-list
56992818|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
56992819|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992820|NCT03093909|Gemcitabine|gemcitabine|mesh-list
56992821|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56992822|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
56992823|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992824|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992825|NCT03093909|Antiviral Agents|antiviral agents|mesh-ancestor
56992826|NCT03093909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992827|NCT03093909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992828|NCT03093909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56992829|NCT03093909|Immunologic Factors|immunologic factors|mesh-ancestor
56992830|NCT03093909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992831|NCT03228537|Cisplatin|cisplatin|mesh-list
56992832|NCT03228537|Pemetrexed|pemetrexed|mesh-list
56992833|NCT03228537|Atezolizumab|atezolizumab|mesh-list
56992834|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56992835|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992836|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992837|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992838|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56992839|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56992840|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
56992841|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992842|NCT03693222|Morphine|morphine|mesh-list
56992843|NCT03693222|Tramadol|tramadol|mesh-list
56992844|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56992845|NCT03693222|Narcotics|narcotics|mesh-ancestor
56992846|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992847|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992848|NCT03693222|Analgesics|analgesics|mesh-ancestor
56992849|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
56992850|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992851|NCT03215511|Selitrectinib|selitrectinib|mesh-list
56992852|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992853|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992854|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
56992855|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56992856|NCT03693066|Disinfectants|disinfectants|mesh-list
56992857|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56675036|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56992858|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56992859|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
56992860|NCT03631641|Nivolumab|nivolumab|mesh-list
56992861|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992862|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992863|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56992864|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992865|NCT03631875|Ketamine|ketamine|mesh-list
56992866|NCT03631875|Propofol|propofol|mesh-list
56992867|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56992868|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992869|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992870|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56992871|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
56992872|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
56992873|NCT03631875|Analgesics|analgesics|mesh-ancestor
56992874|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
56992875|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992876|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56992877|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56992878|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56992879|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992880|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992881|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56992882|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
56992883|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992884|NCT03158805|Liraglutide|liraglutide|mesh-list
56992885|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56992886|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992887|NCT03158805|Incretins|incretins|mesh-ancestor
56992888|NCT03158805|Hormones|hormones|mesh-ancestor
56992889|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56992890|NCT03197935|Paclitaxel|paclitaxel|mesh-list
56992891|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
56992892|NCT03197935|Doxorubicin|doxorubicin|mesh-list
56992893|NCT03197935|Atezolizumab|atezolizumab|mesh-list
56992894|NCT03197935|Antibodies|antibodies|mesh-list
56992895|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56992896|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992897|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
56992898|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
56992899|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
56992900|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992901|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56992902|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
56992903|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992904|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992905|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56992906|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
56992907|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56992908|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56992909|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56992910|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56992911|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992912|NCT04941261|Vaccines|vaccines|mesh-list
56992913|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
56992914|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992915|NCT05597709|Insulin|insulin|mesh-list
56992916|NCT05597709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56992917|NCT05597709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992918|NCT04863885|Nivolumab|nivolumab|mesh-list
56992919|NCT04863885|Ipilimumab|ipilimumab|mesh-list
56992920|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992921|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992922|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56992923|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992924|NCT02917629|Pioglitazone|pioglitazone|mesh-list
56992925|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56992926|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992927|NCT05417841|Insulin|insulin|mesh-list
56992928|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56992929|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
56992930|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
56992931|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56992932|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56992933|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992934|NCT03691038|Pregabalin|pregabalin|mesh-list
56992935|NCT03691038|Analgesics|analgesics|mesh-ancestor
56992936|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
56992937|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992938|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992939|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
56992940|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56992941|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56992942|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992943|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56992944|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56992945|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56992946|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56992947|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56992948|NCT02927847|Nicotine|nicotine|mesh-list
56992949|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56992950|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
56992951|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992952|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992953|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56992954|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56992955|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
56992956|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992957|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992958|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56992959|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
56992960|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56992961|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992962|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
56992963|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56992964|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56992965|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
56992966|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56992967|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
56992968|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992969|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992970|NCT01568853|Norepinephrine|norepinephrine|mesh-list
56992971|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56992972|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56992973|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
56992974|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992975|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992976|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992977|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
56992978|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
56992979|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56992980|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56992981|NCT02960438|Quetmolimab|quetmolimab|mesh-list
56992982|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56992983|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56992984|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56992985|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992986|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56992987|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56992988|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56992989|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56992990|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
56992991|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56992992|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
56992993|NCT05411991|Acetazolamide|acetazolamide|mesh-list
56992994|NCT05411991|Bumetanide|bumetanide|mesh-list
56992995|NCT05411991|Diuretics|diuretics|mesh-list
56992996|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56992997|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
56992998|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56992999|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
56993000|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56993001|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993002|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993003|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56993004|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56993005|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56993006|NCT02839707|Bevacizumab|bevacizumab|mesh-list
56993007|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56993008|NCT02839707|Doxorubicin|doxorubicin|mesh-list
56993009|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56993010|NCT02839707|Atezolizumab|atezolizumab|mesh-list
56993011|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
56993012|NCT02839707|Antibodies|antibodies|mesh-list
56993013|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
56993014|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56993015|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
56993016|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993017|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56993018|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56993019|NCT02839707|Growth Substances|growth substances|mesh-ancestor
56993020|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993021|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
56993022|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
56993023|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56993024|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56993025|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56993026|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993027|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993028|NCT03690414|Atropine|atropine|mesh-list
56993029|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56993030|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56993031|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56993032|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56993033|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56993034|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
56993035|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993036|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993037|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56993038|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
56993039|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
56993040|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
56993041|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56993042|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56993043|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
56993044|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993045|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993046|NCT02959970|Dapsone|dapsone|mesh-list
56993047|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993048|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
56993049|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56993050|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56993051|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56993052|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993053|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993054|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
56993055|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56993056|NCT03779334|Risdiplam|risdiplam|mesh-list
56993057|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56993058|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993059|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993060|NCT02740335|Protein C|protein c|mesh-list
56993061|NCT02740335|Protein S|protein s|mesh-list
56993062|NCT02740335|Thrombin|thrombin|mesh-list
56993063|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
56993064|NCT02740335|Coagulants|coagulants|mesh-ancestor
56993065|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
56993066|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56993067|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56993068|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993069|NCT03580369|Omalizumab|omalizumab|mesh-list
56993070|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56993071|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56993072|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
56993073|NCT05351151|Lidocaine|lidocaine|mesh-list
56993074|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
56993075|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
56993076|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993077|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993078|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
56993079|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993080|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56993081|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56993082|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56993083|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56993084|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993085|NCT04801849|Vitamin E|vitamin e|mesh-list
56993086|NCT04801849|Tocopherols|tocopherols|mesh-list
56993087|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
56993088|NCT04801849|Vitamins|vitamins|mesh-ancestor
56993089|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
56993090|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993091|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
56993092|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993093|NCT04801849|Protective Agents|protective agents|mesh-ancestor
56993094|NCT01568931|Coal Tar|coal tar|mesh-list
56993095|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
56993096|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
56993097|NCT04800367|Denosumab|denosumab|mesh-list
56993098|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56993099|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993100|NCT05523609|Vitamin D|vitamin d|mesh-list
56993101|NCT05523609|Letrozole|letrozole|mesh-list
56993102|NCT05523609|Vitamins|vitamins|mesh-ancestor
56993103|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
56993104|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993105|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56993106|NCT05523609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993107|NCT05523609|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56993108|NCT05523609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56993109|NCT05523609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993110|NCT05523609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993111|NCT05523609|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56993112|NCT05523609|Hormone Antagonists|hormone antagonists|mesh-ancestor
56993113|NCT05523609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56993114|NCT03713658|Risperidone|risperidone|mesh-list
56993115|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56993116|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56993117|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
56993118|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993119|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993120|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993121|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56993122|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56993123|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993124|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56993125|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56993126|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
56993127|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56993128|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56993129|NCT04603365|Temozolomide|temozolomide|mesh-list
56993130|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56993131|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993132|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
56993133|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993134|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993135|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993136|NCT05475717|Alprostadil|alprostadil|mesh-list
56993137|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56993138|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
56993139|NCT05475717|Urological Agents|urological agents|mesh-ancestor
56993140|NCT05133687|Bupivacaine|bupivacaine|mesh-list
56993141|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
56993142|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
56993143|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993144|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993145|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
56993146|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993147|NCT03685032|Dexamethasone|dexamethasone|mesh-list
56993148|NCT03685032|Ondansetron|ondansetron|mesh-list
56993149|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56993150|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
56993151|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
56993152|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993153|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993154|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56993155|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
56993156|NCT03685032|Hormones|hormones|mesh-ancestor
56993157|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56993158|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56993159|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993160|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
56993161|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
56993162|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56993163|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
56993164|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993165|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993166|NCT03685032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56993167|NCT03685032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56570597|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
56993168|NCT03685032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993169|NCT03685032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56993170|NCT03685032|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56993171|NCT02451111|Rituximab|rituximab|mesh-list
56993172|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56993173|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993174|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
56993175|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993176|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993177|NCT03689010|Azelaic acid|azelaic acid|mesh-list
56993178|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993179|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
56993180|NCT05101551|Gemcitabine|gemcitabine|mesh-list
56993181|NCT05101551|Topotecan|topotecan|mesh-list
56993182|NCT05101551|Talazoparib|talazoparib|mesh-list
56993183|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56993184|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
56993185|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993186|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993187|NCT05101551|Antiviral Agents|antiviral agents|mesh-ancestor
56993188|NCT05101551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993189|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993190|NCT05101551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56993191|NCT05101551|Immunologic Factors|immunologic factors|mesh-ancestor
56993192|NCT05101551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993193|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56993194|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56993195|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56993196|NCT03710772|Cytarabine|cytarabine|mesh-list
56993197|NCT03710772|Dexamethasone|dexamethasone|mesh-list
56993198|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
56993199|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
56993200|NCT03710772|Rituximab|rituximab|mesh-list
56993201|NCT03710772|Doxorubicin|doxorubicin|mesh-list
56993202|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56993203|NCT03710772|Methotrexate|methotrexate|mesh-list
56993204|NCT03710772|Vincristine|vincristine|mesh-list
56993205|NCT03710772|Venetoclax|venetoclax|mesh-list
56993206|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56993207|NCT03710772|Antibodies|antibodies|mesh-list
56993208|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
56993209|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56993210|NCT03710772|BB 1101|bb 1101|mesh-list
56993211|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56993212|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
56993213|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993214|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993215|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993216|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
56993217|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993218|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993219|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56993220|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56993221|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
56993222|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
56993223|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993224|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56993225|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
56993226|NCT03710772|Hormones|hormones|mesh-ancestor
56993227|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56993228|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56993229|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
56993230|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993231|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56993232|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56993233|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56993234|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56993235|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
56993236|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56993237|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56993238|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
56993239|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
56993240|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56993241|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56993242|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
56993243|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895699|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
56993244|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56993245|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
56993246|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
56993247|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
56993248|NCT05451771|Dexamethasone|dexamethasone|mesh-list
56993249|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
56993250|NCT05451771|Venetoclax|venetoclax|mesh-list
56993251|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56993252|NCT05451771|Daratumumab|daratumumab|mesh-list
56993253|NCT05451771|Pomalidomide|pomalidomide|mesh-list
56993254|NCT05451771|Ixazomib|ixazomib|mesh-list
56993255|NCT05451771|BB 1101|bb 1101|mesh-list
56993256|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56993257|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
56993258|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
56993259|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993260|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993261|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56993262|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
56993263|NCT05451771|Hormones|hormones|mesh-ancestor
56993264|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56993265|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56993266|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993267|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
56993268|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993269|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993270|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993271|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
56993272|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
56993273|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56993274|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56993275|NCT05451771|Growth Substances|growth substances|mesh-ancestor
56993276|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
56993277|NCT03680976|CXA-10|cxa-10|mesh-list
56993278|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56993279|NCT03684876|Diuretics|diuretics|mesh-list
56993280|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
56993281|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993282|NCT05387343|Vaccines|vaccines|mesh-list
56993283|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
56993284|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993285|NCT04220775|Atezolizumab|atezolizumab|mesh-list
56993286|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993287|NCT01381887|Canagliflozin|canagliflozin|mesh-list
56993288|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56993289|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993290|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56993291|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993292|NCT04877379|Ceftibuten|ceftibuten|mesh-list
56993293|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56993294|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993295|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
56993296|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56993297|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993298|NCT03684330|Vitamin D|vitamin d|mesh-list
56993299|NCT03684330|Vitamins|vitamins|mesh-ancestor
56993300|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
56675483|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56675484|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56675485|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56675486|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56675487|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
56675488|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56675489|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56675490|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56675491|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56675492|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56675493|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675494|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56675495|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
56675496|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
56675499|NCT03672695|Venetoclax|venetoclax|mesh-list
56993301|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993302|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56993303|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
56993304|NCT03688464|Promethazine|promethazine|mesh-list
56993305|NCT03688464|Melatonin|melatonin|mesh-list
56993306|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
56993307|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993308|NCT03688464|Protective Agents|protective agents|mesh-ancestor
56993309|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993310|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993311|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56993312|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56993313|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
56993314|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
56993315|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
56993316|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993317|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
56993318|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
56993319|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56993320|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56993321|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
56993322|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
56993323|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993324|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56993325|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
56993326|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
56993327|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
56993328|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56993329|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993330|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
56993331|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
56993332|NCT01381809|Hematinics|hematinics|mesh-ancestor
56993333|NCT03677466|Tenecteplase|tenecteplase|mesh-list
56993334|NCT03677466|Streptokinase|streptokinase|mesh-list
56993335|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56993336|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56993337|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993338|NCT03447132|Fulvestrant|fulvestrant|mesh-list
56993339|NCT03447132|Goserelin|goserelin|mesh-list
56993340|NCT03447132|Palbociclib|palbociclib|mesh-list
56993341|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56993342|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993343|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56993344|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56993345|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
56993346|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56993347|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993348|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56993349|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993350|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993351|NCT04133623|Ibuprofen|ibuprofen|mesh-list
56993352|NCT04133623|Ketorolac|ketorolac|mesh-list
56993353|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56993354|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56993355|NCT04133623|Analgesics|analgesics|mesh-ancestor
56993356|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
56993357|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993358|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993359|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56993360|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993361|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56993362|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993363|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993364|NCT03850782|Bimatoprost|bimatoprost|mesh-list
56993365|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56993366|NCT03425838|Letrozole|letrozole|mesh-list
56993367|NCT03425838|Fulvestrant|fulvestrant|mesh-list
56993368|NCT03425838|Palbociclib|palbociclib|mesh-list
56993369|NCT03425838|Anastrozole|anastrozole|mesh-list
56993370|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56993371|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993372|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56993373|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993374|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895706|NCT01259817|Analgesics|analgesics|mesh-ancestor
56993375|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56993376|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
56993377|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56993378|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993379|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56993380|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56993381|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56993382|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56993383|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
56993384|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993385|NCT03188185|Naltrexone|naltrexone|mesh-list
56993386|NCT03188185|Buprenorphine|buprenorphine|mesh-list
56993387|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56993388|NCT03188185|Narcotics|narcotics|mesh-ancestor
56993389|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993390|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993391|NCT03188185|Analgesics|analgesics|mesh-ancestor
56993392|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
56993393|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993394|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56993395|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56993396|NCT03679182|Olanzapine|olanzapine|mesh-list
56993397|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
56993398|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
56993399|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993400|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993401|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56993402|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56993403|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56993404|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993405|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56993406|NCT03679182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56993407|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56993408|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56993409|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993410|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993411|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
56993412|NCT03184987|Albuterol|albuterol|mesh-list
56993413|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56993414|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
56993415|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993416|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993417|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56993418|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
56993419|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
56993420|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56993421|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56993422|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56993423|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56993424|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
56993425|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993426|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993427|NCT03193333|Timolol|timolol|mesh-list
56993428|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56993429|NCT03193333|Dorzolamide|dorzolamide|mesh-list
56993430|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56993431|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56993432|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56993433|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56993434|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
56993435|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993436|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895707|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
56993437|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993438|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56993439|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56993440|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56993441|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56993442|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56993443|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56993444|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993445|NCT03026166|Nivolumab|nivolumab|mesh-list
56993446|NCT03026166|Ipilimumab|ipilimumab|mesh-list
56993447|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56993448|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993449|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56675640|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
56993450|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993451|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
56993452|NCT03345576|Testosterone|testosterone|mesh-list
56993453|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
56993454|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
56993455|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56993456|NCT03345576|Androgens|androgens|mesh-ancestor
56993457|NCT03345576|Hormones|hormones|mesh-ancestor
56993458|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56993459|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993460|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56993461|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993462|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
56993463|NCT03573648|Palbociclib|palbociclib|mesh-list
56993464|NCT03573648|Avelumab|avelumab|mesh-list
56993465|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993466|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56993467|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993468|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993469|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56993470|NCT03026088|Bisoprolol|bisoprolol|mesh-list
56993471|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56993472|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
56993473|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
56993474|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993475|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993476|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56993477|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56993478|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56993479|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
56993480|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993481|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993482|NCT03328884|Irinotecan|irinotecan|mesh-list
56993483|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56993484|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56993485|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993486|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993487|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993488|NCT03678792|Morphine|morphine|mesh-list
56993489|NCT03678792|Buprenorphine|buprenorphine|mesh-list
56993490|NCT03678792|Tramadol|tramadol|mesh-list
56993491|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56993492|NCT03678792|Naloxone|naloxone|mesh-list
56993493|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56993494|NCT03678792|Narcotics|narcotics|mesh-ancestor
56993495|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993496|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993497|NCT03678792|Analgesics|analgesics|mesh-ancestor
56993498|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
56993499|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993500|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56993501|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56993502|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56993503|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56993504|NCT03301506|Seladelpar|seladelpar|mesh-list
56993505|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56993506|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
56993507|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993508|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56993509|NCT03181789|Interleukin-12|interleukin-12|mesh-list
56993510|NCT03181789|Vaccines|vaccines|mesh-list
56993511|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
56993512|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993513|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56993514|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56993515|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56993516|NCT03181789|Growth Substances|growth substances|mesh-ancestor
56993517|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
56993518|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993519|NCT03678090|Plasminogen|plasminogen|mesh-list
56993520|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56993521|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56993522|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56993523|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993524|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56993525|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56993526|NCT03678012|Hematinics|hematinics|mesh-ancestor
56993527|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56993528|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56993529|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56993530|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993532|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56993533|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993534|NCT03676374|Prucalopride|prucalopride|mesh-list
56993535|NCT03676374|Laxatives|laxatives|mesh-ancestor
56993536|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56993537|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56993538|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56993539|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
56993540|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993541|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993542|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993543|NCT03676296|Puerarin|puerarin|mesh-list
56993544|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
56993545|NCT03676140|Azithromycin|azithromycin|mesh-list
56993546|NCT03676140|Ivermectin|ivermectin|mesh-list
56993547|NCT03676140|Albendazole|albendazole|mesh-list
56993548|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
56993549|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56993550|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993551|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56993552|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
56993553|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
56993554|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56993555|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56993556|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
56993557|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
56993558|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
56993559|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993560|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993561|NCT03676140|Filaricides|filaricides|mesh-ancestor
56993562|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
56993563|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56993564|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993565|NCT04059198|Tenofovir|tenofovir|mesh-list
56993566|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
56993567|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993568|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56993569|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56993570|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993571|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993572|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56993573|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56993574|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
56993575|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56993576|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993577|NCT03246906|Cyclosporine|cyclosporine|mesh-list
56993578|NCT03246906|Sirolimus|sirolimus|mesh-list
56993579|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
56993580|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
56993581|NCT03246906|Cyclosporins|cyclosporins|mesh-list
56993582|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56993583|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
56993584|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993585|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993586|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993587|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
56993588|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993589|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993590|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56993591|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993592|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
56993593|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993594|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56993595|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56993596|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56993597|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56993598|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
56993599|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56993600|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
56993601|NCT02875314|Thiotepa|thiotepa|mesh-list
56993602|NCT02875314|Cisplatin|cisplatin|mesh-list
56993603|NCT02875314|Carboplatin|carboplatin|mesh-list
56993604|NCT02875314|Methotrexate|methotrexate|mesh-list
56993605|NCT02875314|Etoposide|etoposide|mesh-list
56993606|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
56993607|NCT02875314|Vincristine|vincristine|mesh-list
56993608|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56993609|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
56993610|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993611|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993612|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993613|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
56993614|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993615|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993616|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56993617|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56993618|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
56993619|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56993620|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56993621|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
56993622|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
56993623|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993624|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56993625|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56993626|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56993627|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56993628|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56993629|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
56993630|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
56993631|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
56993632|NCT03675594|Cobalt|cobalt|mesh-list
56993633|NCT03675594|Chromium|chromium|mesh-list
56993634|NCT03675594|Trace Elements|trace elements|mesh-ancestor
56993635|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
56993636|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993637|NCT03671538|Pemetrexed|pemetrexed|mesh-list
56993638|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993639|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993640|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993641|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56993642|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56993643|NCT05420467|Paclitaxel|paclitaxel|mesh-list
56993644|NCT05420467|Docetaxel|docetaxel|mesh-list
56993645|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56993646|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
56993647|NCT05420467|Carboplatin|carboplatin|mesh-list
56993648|NCT05420467|Trastuzumab|trastuzumab|mesh-list
56993649|NCT05420467|Epirubicin|epirubicin|mesh-list
56993650|NCT05420467|Pertuzumab|pertuzumab|mesh-list
56993651|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56993652|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993653|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
56993654|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
56993655|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
56993656|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993657|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56993658|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
56993659|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993660|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993661|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993662|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
56993663|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56895721|NCT01261689|Dsuvia|dsuvia|mesh-list
56993664|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56993665|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56993666|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56993667|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56993668|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993669|NCT03022578|Lomustine|lomustine|mesh-list
56993670|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993671|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
56993672|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993673|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993674|NCT03671070|Epinephrine|epinephrine|mesh-list
56993675|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56993676|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56993677|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
56993678|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993679|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993680|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993681|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56993682|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56993684|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993685|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56993686|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
56993687|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
56993688|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
56993689|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56993690|NCT03670758|Protein S|protein s|mesh-list
56993691|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
56993692|NCT03674658|Propafenone|propafenone|mesh-list
56993693|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56993694|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56993695|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56993696|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56993697|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993698|NCT03623256|Fentanyl|fentanyl|mesh-list
56993699|NCT03623256|Bupivacaine|bupivacaine|mesh-list
56993700|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
56993701|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
56993702|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993703|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993704|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
56993705|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993706|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56993707|NCT03623256|Narcotics|narcotics|mesh-ancestor
56993708|NCT03623256|Analgesics|analgesics|mesh-ancestor
56993709|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56993710|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56993711|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
56993712|NCT03082014|Losartan|losartan|mesh-list
56993713|NCT03082014|Atenolol|atenolol|mesh-list
56993714|NCT03082014|Amlodipine|amlodipine|mesh-list
56993715|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56993716|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56993717|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56993718|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993719|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56993720|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993721|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
56993722|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56993723|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56993724|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56993725|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
56993726|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
56993727|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993728|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56993729|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56993730|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56993731|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
56993732|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993733|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
56993734|NCT03670212|Yohimbine|yohimbine|mesh-list
56993735|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56993736|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
56993737|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
56993738|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993739|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993740|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56993741|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56993742|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56993743|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56993744|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993745|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993746|NCT03670212|Urological Agents|urological agents|mesh-ancestor
56993747|NCT03165955|Paclitaxel|paclitaxel|mesh-list
56993748|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56993749|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993750|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
56993751|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
56993752|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
56993753|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993754|NCT05263921|Ritonavir|ritonavir|mesh-list
56993755|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56993756|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56993757|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
56993758|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993759|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993760|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56993761|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56993762|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
56993763|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993764|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56993765|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56993766|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56993767|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993768|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993769|NCT02400216|Cholic Acids|cholic acids|mesh-list
56993770|NCT02400216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56993771|NCT03048084|Levetiracetam|levetiracetam|mesh-list
56993772|NCT03048084|Valproic Acid|valproic acid|mesh-list
56993773|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
56993774|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
56993775|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993776|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993777|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
56993778|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993779|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993780|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
56993781|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56993782|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993783|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56993784|NCT02329860|Apatinib|apatinib|mesh-list
56993785|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993786|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56993787|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993788|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993789|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
56993790|NCT02251548|Rituximab|rituximab|mesh-list
56993791|NCT02251548|Fludarabine|fludarabine|mesh-list
56993792|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56993793|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
56993794|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993795|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993796|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993797|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
56993798|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993799|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993800|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56993801|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56993802|NCT03165721|Guadecitabine|guadecitabine|mesh-list
56993803|NCT03165721|Azacitidine|azacitidine|mesh-list
56993804|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993805|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56993806|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
56993807|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993808|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993809|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
56993810|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
56993811|NCT02224872|Fludarabine|fludarabine|mesh-list
56993812|NCT02224872|Tacrolimus|tacrolimus|mesh-list
56993813|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
56993814|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56993815|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
56993816|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993817|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993818|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993819|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
56993820|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993821|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993822|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56993823|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56993824|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993825|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56993826|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56993827|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
56993828|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56993829|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993830|NCT02187198|Buprenorphine|buprenorphine|mesh-list
56993831|NCT02187198|Naloxone|naloxone|mesh-list
56993832|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56993833|NCT02187198|Narcotics|narcotics|mesh-ancestor
56993834|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993835|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993836|NCT02187198|Analgesics|analgesics|mesh-ancestor
56993837|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
56993838|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993839|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56993840|NCT05132101|Palbociclib|palbociclib|mesh-list
56993841|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993842|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56993843|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993844|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993845|NCT03735121|Atezolizumab|atezolizumab|mesh-list
56993846|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993847|NCT02682511|Ifetroban|ifetroban|mesh-list
56993848|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56993849|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
56993850|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56993851|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993852|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993853|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56993854|NCT04969705|Analgesics|analgesics|mesh-ancestor
56993855|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
56993856|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993857|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56993858|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56993859|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56993860|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
56993861|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993862|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993863|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
56993864|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56993865|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993866|NCT02085408|Cytarabine|cytarabine|mesh-list
56993867|NCT02085408|Decitabine|decitabine|mesh-list
56993868|NCT02085408|Clofarabine|clofarabine|mesh-list
56993869|NCT02085408|Azacitidine|azacitidine|mesh-list
56993870|NCT02085408|Daunorubicin|daunorubicin|mesh-list
56993871|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56993872|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
56993873|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993874|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993875|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
56993876|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993877|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56993878|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
56993879|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993880|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56993881|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56993882|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56993883|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993884|NCT01829958|Prednisone|prednisone|mesh-list
56993885|NCT01829958|Rituximab|rituximab|mesh-list
56993886|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56993887|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993888|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
56993889|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993890|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993891|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56993892|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
56993893|NCT01829958|Hormones|hormones|mesh-ancestor
56993894|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56993895|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56993896|NCT03021642|Tepotinib|tepotinib|mesh-list
56993897|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993898|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
56993899|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
56993900|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56993901|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56993902|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
56993903|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993904|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56993905|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
56993906|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56993907|NCT03021486|Haloperidol|haloperidol|mesh-list
56993908|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
56993909|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
56993910|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
56993911|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
56993912|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993913|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993914|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56993915|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56993916|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56993917|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56993918|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56993919|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56993920|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
56993921|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993922|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993923|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56993924|NCT03023046|Prednisone|prednisone|mesh-list
56993925|NCT03023046|Cortisone|cortisone|mesh-list
56993926|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
56993927|NCT03023046|Rituximab|rituximab|mesh-list
56993928|NCT03023046|Doxorubicin|doxorubicin|mesh-list
56993929|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56993930|NCT03023046|Etoposide|etoposide|mesh-list
56993931|NCT03023046|Vincristine|vincristine|mesh-list
56993932|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
56993933|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
56993934|NCT03023046|Daunorubicin|daunorubicin|mesh-list
56993935|NCT03023046|Dasatinib|dasatinib|mesh-list
56993936|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
56993937|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56993938|NCT03023046|Antibodies|antibodies|mesh-list
56993939|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
56993940|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56993941|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56993942|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
56993943|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993944|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56993945|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56993946|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
56993947|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993948|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56993949|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56993950|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56993951|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56993952|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56993953|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56993954|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56993955|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
56993956|NCT03023046|Hormones|hormones|mesh-ancestor
56993957|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56993958|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56993959|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56993960|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
56993961|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
56993962|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
56993963|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56993964|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
56993965|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
56993966|NCT03668262|Atracurium|atracurium|mesh-list
56993967|NCT03668262|Cisatracurium|cisatracurium|mesh-list
56993968|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56993969|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56993970|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56993971|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56993972|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993973|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56993974|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56993975|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
56993976|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56993977|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993978|NCT03668964|Vitamin D|vitamin d|mesh-list
56993979|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
56676163|NCT00858780|Etanercept|etanercept|mesh-list
56993980|NCT03668964|Vitamins|vitamins|mesh-list
56993981|NCT03668964|Vitamin E|vitamin e|mesh-list
56993982|NCT03668964|Tocopherols|tocopherols|mesh-list
56993983|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
56993984|NCT03668964|Vitamin A|vitamin a|mesh-list
56993985|NCT03668964|Riboflavin|riboflavin|mesh-list
56993987|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
56993988|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56993989|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56993990|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56993991|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
56993992|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56993993|NCT03668964|Protective Agents|protective agents|mesh-ancestor
56993994|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56993995|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
56993996|NCT03668730|Paclitaxel|paclitaxel|mesh-list
56993997|NCT03668730|Fluorouracil|fluorouracil|mesh-list
56993998|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56993999|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994000|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994001|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994002|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994003|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994004|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
56994005|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56994006|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994007|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
56994008|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994009|NCT03021018|Lorazepam|lorazepam|mesh-list
56994010|NCT03021018|Brivaracetam|brivaracetam|mesh-list
56994011|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
56994012|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
56994013|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
56994014|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994015|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994016|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994017|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56994018|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994019|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56994020|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56994021|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56994022|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
56994023|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
56994024|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994025|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994026|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
56994027|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56994028|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56994029|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994030|NCT03175549|Apremilast|apremilast|mesh-list
56994031|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56994032|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994033|NCT03175549|Analgesics|analgesics|mesh-ancestor
56571468|NCT02655874|Vaccines|vaccines|mesh-list
56994034|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
56994035|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994036|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994037|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994038|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994039|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56994040|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56994041|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994042|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994043|NCT01314937|Mebendazole|mebendazole|mesh-list
56994044|NCT01314937|Piperazine|piperazine|mesh-list
56994045|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
56994046|NCT01314937|DMP 777|dmp 777|mesh-list
56994047|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
56994048|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
56994049|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56994050|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994051|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994052|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994053|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994054|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994055|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994056|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994057|NCT04718155|Atorvastatin|atorvastatin|mesh-list
56994058|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56994059|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56994060|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
56676234|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994061|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994062|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56994063|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56994064|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994065|NCT04668859|Midodrine|midodrine|mesh-list
56994066|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
56994067|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
56994068|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994069|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994070|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56994071|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56994072|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56994073|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56994074|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
56994075|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994076|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994077|NCT04648969|Hormones|hormones|mesh-list
56994078|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56994079|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994080|NCT02924688|Fluticasone|fluticasone|mesh-list
56994081|NCT02924688|Albuterol|albuterol|mesh-list
56994082|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56994083|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56994084|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994085|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56994086|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
56994087|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994088|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994089|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56994090|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
56994091|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
56994092|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56994093|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56994094|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56994095|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56994096|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
56994097|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994098|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994099|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
56994100|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56994101|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
56994102|NCT02924688|Hormones|hormones|mesh-ancestor
56994103|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56994104|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
56994105|NCT03668418|Gemcitabine|gemcitabine|mesh-list
56994106|NCT03668418|Camptothecin|camptothecin|mesh-list
56994107|NCT03668418|Docetaxel|docetaxel|mesh-list
56994108|NCT03668418|Fluorouracil|fluorouracil|mesh-list
56994109|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
56994110|NCT03668418|Irinotecan|irinotecan|mesh-list
56994111|NCT03668418|Epirubicin|epirubicin|mesh-list
56994112|NCT03668418|Taxane|taxane|mesh-list
56994113|NCT03668418|Antimetabolites|antimetabolites|mesh-list
56994114|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56994115|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994116|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994117|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994118|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994119|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994120|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56994121|NCT03668418|Antiviral Agents|antiviral agents|mesh-ancestor
56994122|NCT03668418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994123|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994124|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994125|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
56994126|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994127|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56994128|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56994129|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56994130|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56994131|NCT02177695|Gemcitabine|gemcitabine|mesh-list
56994132|NCT02177695|Doxorubicin|doxorubicin|mesh-list
56994133|NCT02177695|Methotrexate|methotrexate|mesh-list
56994134|NCT02177695|Vinblastine|vinblastine|mesh-list
56994135|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994136|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56994138|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994139|NCT02177695|Antiviral Agents|antiviral agents|mesh-ancestor
56994140|NCT02177695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994141|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994142|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994143|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
56994144|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994145|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56994146|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56994147|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56994148|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56994149|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
56994150|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56994151|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
56994152|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56994153|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994154|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56994155|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56994156|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994157|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994158|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994159|NCT03011892|Triamcinolone|triamcinolone|mesh-list
56994160|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994161|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
56994162|NCT03011892|Hormones|hormones|mesh-ancestor
56994163|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56994164|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994165|NCT02125513|Paclitaxel|paclitaxel|mesh-list
56994166|NCT02125513|Carboplatin|carboplatin|mesh-list
56994167|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56994168|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994169|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994170|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994171|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994172|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994173|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
56994174|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56994175|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994176|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
56994177|NCT03666546|Methamphetamine|methamphetamine|mesh-list
56994178|NCT03666546|Lactulose|lactulose|mesh-list
56994179|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994180|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56994181|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994182|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
56994183|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
56994184|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994185|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
56994186|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994187|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994188|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56994189|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56994190|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56994191|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56994192|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56994193|NCT03012828|Moxidectin|moxidectin|mesh-list
56994194|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
56994195|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56994196|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994197|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
56994198|NCT03666390|Midazolam|midazolam|mesh-list
56994199|NCT03666390|Ketamine|ketamine|mesh-list
56994200|NCT03666390|Analgesics|analgesics|mesh-ancestor
56994201|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
56994202|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994203|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994204|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56994205|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56994206|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
56994207|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
56994208|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994209|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56676384|NCT00639743|Tenecteplase|tenecteplase|mesh-list
56994210|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56994212|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994213|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56994214|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56994215|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56994216|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56994217|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56994218|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
56994219|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
56994220|NCT03003390|Enoxaparin|enoxaparin|mesh-list
56994221|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
56994222|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56994223|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56994224|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994225|NCT03003000|Ibuprofen|ibuprofen|mesh-list
56994226|NCT03003000|Caffeine|caffeine|mesh-list
56994227|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56994228|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994229|NCT03003000|Analgesics|analgesics|mesh-ancestor
56994230|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
56994231|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994232|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994233|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994234|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994235|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56994236|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994237|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994238|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56994239|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56994240|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56994241|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56994242|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
56994243|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994244|NCT03665766|Cycloserine|cycloserine|mesh-list
56994245|NCT03665766|Tacrolimus|tacrolimus|mesh-list
56994246|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994247|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
56994248|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994249|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56994250|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994251|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994252|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56994253|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994254|NCT03665766|Renal Agents|renal agents|mesh-ancestor
56994255|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56994256|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
56994257|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56994258|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
56994259|NCT03546894|Ceritinib|ceritinib|mesh-list
56994260|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994261|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56994262|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994263|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994264|NCT03637361|Methadone|methadone|mesh-list
56994265|NCT03637361|D-methadone|d-methadone|mesh-list
56994266|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56994267|NCT03637361|Narcotics|narcotics|mesh-ancestor
56994268|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994269|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994270|NCT03637361|Analgesics|analgesics|mesh-ancestor
56994271|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
56994272|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994273|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
56994274|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
56994275|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994276|NCT04083599|Gemcitabine|gemcitabine|mesh-list
56994277|NCT04083599|Paclitaxel|paclitaxel|mesh-list
56994278|NCT04083599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56994279|NCT04083599|Carboplatin|carboplatin|mesh-list
56994280|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
56994281|NCT04083599|Pemetrexed|pemetrexed|mesh-list
56994282|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56994283|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994284|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994285|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994286|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994287|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994288|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56994290|NCT04083599|Antiviral Agents|antiviral agents|mesh-ancestor
56994291|NCT04083599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994292|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994293|NCT04083599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994294|NCT04083599|Immunologic Factors|immunologic factors|mesh-ancestor
56994295|NCT04083599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994296|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56994297|NCT04083599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56994298|NCT04083599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56994299|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
56994300|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994301|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56994302|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994303|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994304|NCT03254459|Morphine|morphine|mesh-list
56994305|NCT03254459|Oxycodone|oxycodone|mesh-list
56994306|NCT03254459|Buprenorphine|buprenorphine|mesh-list
56994307|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56994308|NCT03254459|Narcotics|narcotics|mesh-ancestor
56994309|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994310|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994311|NCT03254459|Analgesics|analgesics|mesh-ancestor
56994312|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
56994313|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994314|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56994315|NCT03620591|Lidocaine|lidocaine|mesh-list
56994316|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
56994317|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
56994318|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994319|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994320|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
56994321|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994322|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56994323|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56994324|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56994325|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56994326|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994327|NCT02903381|Dexamethasone|dexamethasone|mesh-list
56994328|NCT02903381|Nivolumab|nivolumab|mesh-list
56994329|NCT02903381|Lenalidomide|lenalidomide|mesh-list
56994330|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994331|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
56994332|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
56994333|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994334|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994335|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994336|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
56994337|NCT02903381|Hormones|hormones|mesh-ancestor
56994338|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56994339|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56994340|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994341|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56994342|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56994343|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994344|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
56994345|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56994346|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56994347|NCT02903381|Growth Substances|growth substances|mesh-ancestor
56994348|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
56994349|NCT05178953|Zinc|zinc|mesh-list
56994350|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
56994351|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
56994352|NCT05178953|Trace Elements|trace elements|mesh-ancestor
56994353|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
56994354|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994355|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56994356|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994357|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994358|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56994359|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56994360|NCT05178953|Protective Agents|protective agents|mesh-ancestor
56994361|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
56994362|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56994363|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
56994364|NCT05178953|Astringents|astringents|mesh-ancestor
56994365|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
56994366|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
56994367|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56994368|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994369|NCT03251963|Enoxaparin|enoxaparin|mesh-list
56994370|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
56994371|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
56994372|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56994373|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56994374|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994375|NCT03287219|Methylene Blue|methylene blue|mesh-list
56994376|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994377|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994378|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
56994379|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56994380|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994381|NCT05572229|Lenalidomide|lenalidomide|mesh-list
56994382|NCT05572229|Daratumumab|daratumumab|mesh-list
56994383|NCT05572229|Immunologic Factors|immunologic factors|mesh-ancestor
56994384|NCT05572229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994385|NCT05572229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56994386|NCT05572229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56994387|NCT05572229|Growth Substances|growth substances|mesh-ancestor
56994388|NCT05572229|Growth Inhibitors|growth inhibitors|mesh-ancestor
56994389|NCT05572229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994390|NCT03249935|Azithromycin|azithromycin|mesh-list
56994391|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56994392|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994393|NCT03622073|Misoprostol|misoprostol|mesh-list
56994394|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56994395|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
56994396|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56994397|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994398|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56994399|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994400|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
56994401|NCT03000348|Cysteamine|cysteamine|mesh-list
56994402|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56994403|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994404|NCT03664986|Bupivacaine|bupivacaine|mesh-list
56994405|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
56994406|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
56994407|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994408|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994409|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
56994410|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994411|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
56994412|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56994413|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994414|NCT03247673|Bevacizumab|bevacizumab|mesh-list
56994415|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56994416|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994417|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56994418|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56994419|NCT03247673|Growth Substances|growth substances|mesh-ancestor
56994420|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994421|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56994422|NCT03665610|Ozanimod|ozanimod|mesh-list
56994423|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56994424|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994425|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994426|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
56994427|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994428|NCT03664908|Antibodies|antibodies|mesh-list
56994429|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
56994430|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994431|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56994432|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56994433|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
56994434|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994435|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56994436|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56994437|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
56994438|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
56994439|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994440|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994441|NCT03664440|Nevirapine|nevirapine|mesh-list
56994442|NCT03664440|Rilpivirine|rilpivirine|mesh-list
56994443|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56994444|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56994445|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994446|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994447|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
56994448|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994449|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56994450|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56994451|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56994452|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56994453|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56994454|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56994455|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994456|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
56994457|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
56994458|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56994459|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56994460|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
56994461|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994462|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994463|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994464|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994465|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56994466|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994467|NCT03240575|Fluticasone|fluticasone|mesh-list
56994468|NCT03240575|Xhance|xhance|mesh-list
56994469|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
56994470|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56994471|NCT03240575|Olodaterol|olodaterol|mesh-list
56994472|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994473|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56994474|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
56994475|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994476|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994477|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56994478|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
56994479|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
56994480|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56994481|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
56994482|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56994483|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
56994484|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994485|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994486|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56994487|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56994488|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56994489|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
56994490|NCT04651439|Lenograstim|lenograstim|mesh-list
56994491|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56994492|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
56994493|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994494|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
56994495|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56994496|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994497|NCT03690947|Ranibizumab|ranibizumab|mesh-list
56994498|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56994499|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56994500|NCT03690947|Growth Substances|growth substances|mesh-ancestor
56994501|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994502|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
56994503|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994504|NCT03268499|Cisplatin|cisplatin|mesh-list
56994505|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994506|NCT02999178|Nintedanib|nintedanib|mesh-list
56994507|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994508|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56994509|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994510|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994511|NCT02999100|Oxytocin|oxytocin|mesh-list
56994512|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
56994513|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56994514|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994515|NCT02749370|Etanercept|etanercept|mesh-list
56994516|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56994517|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994518|NCT02749370|Analgesics|analgesics|mesh-ancestor
56994519|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
56994520|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994521|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994522|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994523|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994524|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994525|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994526|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
56994527|NCT03618758|Paclitaxel|paclitaxel|mesh-list
56994528|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56994529|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994530|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994531|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994532|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994533|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994534|NCT03617900|Acetaminophen|acetaminophen|mesh-list
56994535|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994536|NCT03617900|Analgesics|analgesics|mesh-ancestor
56994537|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
56994538|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994539|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994540|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
56994541|NCT04987892|Tamsulosin|tamsulosin|mesh-list
56994542|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56994543|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56994544|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56994545|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
56994546|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994547|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994548|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994549|NCT04987892|Urological Agents|urological agents|mesh-ancestor
56994550|NCT05384366|Paclitaxel|paclitaxel|mesh-list
56994551|NCT05384366|Carboplatin|carboplatin|mesh-list
56994552|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56994553|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994554|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994555|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994556|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994557|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994558|NCT03616808|Hemostatics|hemostatics|mesh-list
56994559|NCT03616808|Coagulants|coagulants|mesh-ancestor
56994560|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
56994561|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56994562|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994563|NCT03617510|Analgesics|analgesics|mesh-ancestor
56994564|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
56994565|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994566|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994567|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994568|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994569|NCT03617432|Prednisone|prednisone|mesh-list
56994570|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
56994571|NCT03617432|Doxorubicin|doxorubicin|mesh-list
56994572|NCT03617432|Etoposide|etoposide|mesh-list
56994573|NCT03617432|Vincristine|vincristine|mesh-list
56994574|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994575|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
56994576|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994577|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994578|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56994579|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
56994580|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994581|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994582|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56994583|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56994584|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56994585|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56994586|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994587|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994588|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
56994590|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56994591|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56994592|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56994593|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994594|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994595|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994596|NCT02996682|Ribavirin|ribavirin|mesh-list
56994597|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56994598|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
56994599|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994600|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
56994601|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994602|NCT02873702|Lansoprazole|lansoprazole|mesh-list
56994603|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
56994604|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56994605|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994606|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56994607|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994608|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994609|NCT03616262|Lidocaine|lidocaine|mesh-list
56994610|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
56994611|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
56994612|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994613|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994614|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
56994615|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994616|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56994617|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56994618|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56994619|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56994620|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994621|NCT03615950|Vitamin D|vitamin d|mesh-list
56994622|NCT03615950|Vitamins|vitamins|mesh-ancestor
56994623|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
56994624|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994625|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56994626|NCT02911116|Ustekinumab|ustekinumab|mesh-list
56994627|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
56994628|NCT03664050|Letrozole|letrozole|mesh-list
56572059|NCT00849901|Fluoxetine|fluoxetine|mesh-list
56994629|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994630|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56994631|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56994632|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994633|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994634|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56994635|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
56994636|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56994637|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994638|NCT04055844|Decitabine|decitabine|mesh-list
56994639|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56994640|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
56994641|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994642|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994643|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994644|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56994645|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56994646|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
56994647|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56994648|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994649|NCT04494438|Rituximab|rituximab|mesh-list
56994650|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56994651|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994652|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
56994653|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994654|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994655|NCT04057482|Dequalinium|dequalinium|mesh-list
56994656|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56994657|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994658|NCT03662412|Sirolimus|sirolimus|mesh-list
56994659|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56994660|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994661|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56994662|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994663|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
56994664|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994665|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
56994666|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994667|NCT02870972|Berotralstat|berotralstat|mesh-list
56994668|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994669|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994670|NCT03214367|Insulin|insulin|mesh-list
56994671|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56994672|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
56994673|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
56994674|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56994675|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994676|NCT03662958|Leuprolide|leuprolide|mesh-list
56994677|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56994678|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
56994679|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56994680|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994681|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56994682|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994683|NCT03231371|Adenosine|adenosine|mesh-list
56994684|NCT03231371|Analgesics|analgesics|mesh-ancestor
56994685|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
56994686|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994687|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994688|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56994689|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
56994690|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56994691|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
56994692|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
56994693|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994694|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994695|NCT03663114|Lenvatinib|lenvatinib|mesh-list
56994696|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994697|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56994698|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994699|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994700|NCT03526679|Lenvatinib|lenvatinib|mesh-list
56994701|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895744|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
56994702|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56994703|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994704|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994705|NCT04057326|Pancreatin|pancreatin|mesh-list
56994706|NCT04057326|Pancrelipase|pancrelipase|mesh-list
56994707|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994708|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56994709|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56994710|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56994711|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
56994712|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994713|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994714|NCT05384210|Gabapentin|gabapentin|mesh-list
56994715|NCT05384210|Milnacipran|milnacipran|mesh-list
56994716|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
56994717|NCT05384210|Analgesics|analgesics|mesh-ancestor
56994718|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
56994719|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994720|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994721|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
56994722|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56994723|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56994724|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994725|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56994726|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56994727|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56994728|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994729|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994730|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
56994731|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56994732|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56994733|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56994734|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994735|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
56994736|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
56994737|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56994738|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
56994739|NCT02032394|Povidone|povidone|mesh-list
56994740|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56994741|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994742|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
56994743|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
56994744|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
56994745|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
56994746|NCT03239483|Dapivirine|dapivirine|mesh-list
56994747|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56994748|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56994749|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
56994750|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994751|NCT01068912|Favipiravir|favipiravir|mesh-list
56994752|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
56994753|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994754|NCT04056702|Ivacaftor|ivacaftor|mesh-list
56994755|NCT04056702|Elexacaftor|elexacaftor|mesh-list
56994756|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56994757|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56994758|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994759|NCT03662100|Mirikizumab|mirikizumab|mesh-list
56994760|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56994761|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994762|NCT03662100|Analgesics|analgesics|mesh-ancestor
56994763|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
56994764|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994765|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994766|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994767|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994768|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56994769|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994770|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
56994771|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56994772|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994773|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994774|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994775|NCT03612440|Analgesics|analgesics|mesh-ancestor
56895746|NCT01157247|Narcotics|narcotics|mesh-ancestor
56994776|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
56994777|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994778|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56994779|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56994780|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56994781|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
56994782|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994783|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994784|NCT03662724|Venetoclax|venetoclax|mesh-list
56994785|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994786|NCT03662568|Ritonavir|ritonavir|mesh-list
56994787|NCT03662568|Tenofovir|tenofovir|mesh-list
56994788|NCT03662568|Entecavir|entecavir|mesh-list
56994789|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56994790|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56994791|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
56994792|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994793|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994794|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56994795|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56994796|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
56994797|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994798|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56994799|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56994800|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56994801|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56994802|NCT03031730|Dexamethasone|dexamethasone|mesh-list
56994803|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
56994804|NCT03031730|Lenalidomide|lenalidomide|mesh-list
56994805|NCT03031730|Ichthammol|ichthammol|mesh-list
56994806|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56994807|NCT03031730|BB 1101|bb 1101|mesh-list
56994808|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994809|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
56994810|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
56994811|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994812|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994813|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994814|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
56994815|NCT03031730|Hormones|hormones|mesh-ancestor
56994816|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56994817|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56994818|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994819|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
56994820|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994821|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994822|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
56994823|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56994824|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56994825|NCT03031730|Growth Substances|growth substances|mesh-ancestor
56994826|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
56994827|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
56994829|NCT02993250|Odalasvir|odalasvir|mesh-list
56994830|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
56994831|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994832|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
56994833|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994834|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994835|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56994836|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56994837|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56994838|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56994839|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994840|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
56994841|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994842|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994843|NCT05383820|Ketorolac|ketorolac|mesh-list
56994844|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56994845|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56994846|NCT05383820|Analgesics|analgesics|mesh-ancestor
56994847|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
56994848|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572284|NCT02646904|Beclomethasone|beclomethasone|mesh-list
56994849|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994850|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994851|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994852|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56994853|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994854|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994855|NCT03611504|Hemostatics|hemostatics|mesh-list
56994856|NCT03611504|Coagulants|coagulants|mesh-ancestor
56994857|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56994858|NCT02954510|Hematinics|hematinics|mesh-ancestor
56994859|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56994860|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56994861|NCT02032784|Octreotide|octreotide|mesh-list
56994862|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994863|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56994864|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994865|NCT03611426|Thrombin|thrombin|mesh-list
56994866|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
56994867|NCT03611426|Coagulants|coagulants|mesh-ancestor
56994868|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56994869|NCT03658746|Amoxicillin|amoxicillin|mesh-list
56994870|NCT03658746|Metronidazole|metronidazole|mesh-list
56994871|NCT03658746|Clarithromycin|clarithromycin|mesh-list
56994872|NCT03658746|Levofloxacin|levofloxacin|mesh-list
56994873|NCT03658746|Ofloxacin|ofloxacin|mesh-list
56994874|NCT03658746|Tetracycline|tetracycline|mesh-list
56994875|NCT03658746|Tinidazole|tinidazole|mesh-list
56994876|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56994877|NCT03658746|Furazolidone|furazolidone|mesh-list
56994878|NCT03658746|Bismuth|bismuth|mesh-list
56994879|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56994880|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994881|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
56994882|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56994883|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56994884|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56994885|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994886|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994887|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56994888|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56994889|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56994890|NCT03658746|Renal Agents|renal agents|mesh-ancestor
56994891|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56994892|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56994893|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994894|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56994895|NCT03658746|Antacids|antacids|mesh-ancestor
56994896|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994897|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56994898|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56994899|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56994900|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
56994901|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
56994902|NCT02990910|Narcotics|narcotics|mesh-ancestor
56994903|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56994904|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994905|NCT02990910|Analgesics|analgesics|mesh-ancestor
56994906|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
56994907|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994908|NCT04056000|Caffeine|caffeine|mesh-list
56994909|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56994910|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994911|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56994912|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994913|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994914|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56994915|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56994916|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
56994917|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56994918|NCT03611348|Latanoprost|latanoprost|mesh-list
56994919|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56994920|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56994921|NCT02033018|Aflibercept|aflibercept|mesh-list
56994922|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56994923|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56994924|NCT02033018|Growth Substances|growth substances|mesh-ancestor
56994925|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994926|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
56994927|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994928|NCT03155100|Dexamethasone|dexamethasone|mesh-list
56994929|NCT03155100|Elotuzumab|elotuzumab|mesh-list
56994930|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56994931|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994932|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
56994933|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
56994934|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994935|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994936|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994937|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
56994938|NCT03155100|Hormones|hormones|mesh-ancestor
56994939|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56994940|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56994941|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994942|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
56994943|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994944|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994945|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56994946|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994947|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994948|NCT03658590|Dexamethasone|dexamethasone|mesh-list
56994949|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56994950|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
56994951|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
56994952|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56994953|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994954|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56994955|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
56994956|NCT03658590|Hormones|hormones|mesh-ancestor
56994957|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56994958|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56994959|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994960|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
56994961|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
56994962|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56994963|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56994964|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994965|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994966|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994967|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56994968|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
56994969|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994970|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56994971|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56994972|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
56994973|NCT03941093|Leucovorin|leucovorin|mesh-list
56994974|NCT03941093|Gemcitabine|gemcitabine|mesh-list
56994975|NCT03941093|Paclitaxel|paclitaxel|mesh-list
56994976|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56994977|NCT03941093|Irinotecan|irinotecan|mesh-list
56994978|NCT03941093|Fluorouracil|fluorouracil|mesh-list
56994979|NCT03941093|Folfirinox|folfirinox|mesh-list
56994980|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
56994981|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56994982|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56994983|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
56994984|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
56994985|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
56994986|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56994987|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56994988|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
56994989|NCT03941093|Antiviral Agents|antiviral agents|mesh-ancestor
56994990|NCT03941093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56994991|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56994992|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56994993|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
56994994|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56994995|NCT03941093|Antidotes|antidotes|mesh-ancestor
56994996|NCT03941093|Protective Agents|protective agents|mesh-ancestor
56994997|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
56994998|NCT03941093|Vitamins|vitamins|mesh-ancestor
56994999|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
56995000|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56995001|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56995002|NCT03917381|Docetaxel|docetaxel|mesh-list
56995003|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
56995004|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995005|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
56995006|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
56995007|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
56995008|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995009|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995010|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56995011|NCT02033408|Amoxicillin|amoxicillin|mesh-list
56995012|NCT02033408|Metronidazole|metronidazole|mesh-list
56995013|NCT02033408|Vancomycin|vancomycin|mesh-list
56995014|NCT02033408|Doxycycline|doxycycline|mesh-list
56995015|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
56995016|NCT02033408|Gentamicins|gentamicins|mesh-list
56995017|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995018|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56995019|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56995020|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
56995021|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56995022|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56995023|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995024|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995025|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995026|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56995027|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56995028|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56995029|NCT03610880|Yimitasvir|yimitasvir|mesh-list
56995030|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
56995031|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995032|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
56995033|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56995034|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56995035|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56995036|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56995037|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995038|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
56995039|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995040|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995041|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56995042|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677202|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
56995043|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56995044|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56995045|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
56995046|NCT02560298|Paclitaxel|paclitaxel|mesh-list
56995047|NCT02560298|Cisplatin|cisplatin|mesh-list
56995048|NCT02560298|Carboplatin|carboplatin|mesh-list
56995049|NCT02560298|Fluorouracil|fluorouracil|mesh-list
56995050|NCT02560298|Capecitabine|capecitabine|mesh-list
56995051|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56995052|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56995053|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995054|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
56995055|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
56995056|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
56995057|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995058|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
56995059|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56995060|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56995061|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
56995062|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995063|NCT03063619|Tamoxifen|tamoxifen|mesh-list
56995064|NCT03063619|Afimoxifene|afimoxifene|mesh-list
56995065|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56995066|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
56995067|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56995068|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995069|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56995070|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995071|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56995072|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56995073|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56995074|NCT01330615|Lidocaine|lidocaine|mesh-list
56995075|NCT01330615|Prilocaine|prilocaine|mesh-list
56995076|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56995077|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
56995078|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
56995079|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995080|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995081|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
56995082|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995083|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56995084|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56995085|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56995086|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56995087|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995088|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56995089|NCT05034029|Metformin|metformin|mesh-list
56995090|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56995091|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995092|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56995093|NCT03237065|Hematinics|hematinics|mesh-ancestor
56995094|NCT03620461|Gemcitabine|gemcitabine|mesh-list
56995095|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56995096|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56995097|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
56995098|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995099|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995100|NCT03620461|Antiviral Agents|antiviral agents|mesh-ancestor
56995101|NCT03620461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995102|NCT03620461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995103|NCT03620461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56995104|NCT03620461|Immunologic Factors|immunologic factors|mesh-ancestor
56995105|NCT03620461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995106|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
56995107|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56995108|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56995109|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
56995110|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995111|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995112|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995113|NCT01314781|Urological Agents|urological agents|mesh-ancestor
56995114|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56995115|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56995116|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56995117|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56995118|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995119|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
56995120|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995121|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995122|NCT04377451|Metformin|metformin|mesh-list
56995123|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56995124|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995125|NCT02863328|Empagliflozin|empagliflozin|mesh-list
56995126|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56995127|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995128|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56995129|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995130|NCT03040141|Oseltamivir|oseltamivir|mesh-list
56995131|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
56995132|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995133|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995134|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995135|NCT02937701|Infliximab|infliximab|mesh-list
56995136|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56995137|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995138|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56995139|NCT05186623|Ustekinumab|ustekinumab|mesh-list
56995140|NCT05186623|Vedolizumab|vedolizumab|mesh-list
56995141|NCT05186623|Tofacitinib|tofacitinib|mesh-list
56995142|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
56995143|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56995144|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995145|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995146|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995147|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
56995148|NCT04602845|Fentanyl|fentanyl|mesh-list
56995149|NCT04602845|Midazolam|midazolam|mesh-list
56995150|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56995151|NCT04602845|Narcotics|narcotics|mesh-ancestor
56995152|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995153|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995154|NCT04602845|Analgesics|analgesics|mesh-ancestor
56995155|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
56995156|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995157|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56995158|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56995159|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
56995160|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
56995161|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56995162|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56995163|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56995164|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56995165|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
56995166|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
56995167|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995168|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995169|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56995170|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56995171|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56995172|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56995173|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56995174|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995175|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
56995176|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56995177|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995178|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56995179|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56995180|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995181|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995182|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995183|NCT03168919|Temozolomide|temozolomide|mesh-list
56995184|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56995185|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
56995186|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995187|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995188|NCT03205163|Factor VIII|factor viii|mesh-list
56995189|NCT03205163|Coagulants|coagulants|mesh-ancestor
56995190|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
56995191|NCT03638947|Povidone|povidone|mesh-list
56995192|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
56995193|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
56995194|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56995195|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995196|NCT03502681|Avelumab|avelumab|mesh-list
56995197|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995198|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995199|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
56995200|NCT04938817|Lenvatinib|lenvatinib|mesh-list
56995201|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995202|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995203|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56995204|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995205|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995206|NCT02502266|Paclitaxel|paclitaxel|mesh-list
56995207|NCT02502266|Doxorubicin|doxorubicin|mesh-list
56995208|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56995209|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56995210|NCT02502266|Topotecan|topotecan|mesh-list
56995211|NCT02502266|Olaparib|olaparib|mesh-list
56995212|NCT02502266|Cediranib|cediranib|mesh-list
56995213|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56995214|NCT02502266|Maleic acid|maleic acid|mesh-list
56995215|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56995216|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995217|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
56995218|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
56995219|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
56995220|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995221|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56995222|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56995223|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56995224|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995225|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56995226|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56995227|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
56995228|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56995229|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
56995230|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56995231|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995232|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56995233|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56995234|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56995235|NCT03636373|Triamcinolone|triamcinolone|mesh-list
56995236|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56995237|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56995238|NCT03636373|Etanercept|etanercept|mesh-list
56995239|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56995240|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56995241|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
56995242|NCT03636373|Hormones|hormones|mesh-ancestor
56995243|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56995244|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995245|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56995246|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
56995247|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995248|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995249|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56995250|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56995251|NCT03636373|Analgesics|analgesics|mesh-ancestor
56995252|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
56995253|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995254|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56995255|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995256|NCT04485325|Etanercept|etanercept|mesh-list
56995257|NCT04485325|Tofacitinib|tofacitinib|mesh-list
56995258|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56995259|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56995260|NCT04485325|Analgesics|analgesics|mesh-ancestor
56995261|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
56995262|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995263|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995264|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56995265|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56995266|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995267|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56995268|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
56995269|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56995270|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995271|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995272|NCT03610178|Insulin|insulin|mesh-list
56995273|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56995274|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56995275|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995276|NCT02033798|Tamsulosin|tamsulosin|mesh-list
56995277|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56995278|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56995279|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56995280|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
56995281|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995282|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995283|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995284|NCT02033798|Urological Agents|urological agents|mesh-ancestor
56995285|NCT02887183|Valsartan|valsartan|mesh-list
56995286|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56995287|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56995288|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56995289|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56995290|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995291|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
56995292|NCT03660306|Anesthetics|anesthetics|mesh-list
56995293|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995294|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995295|NCT03660306|Narcotics|narcotics|mesh-ancestor
56995296|NCT03660306|Analgesics|analgesics|mesh-ancestor
56995297|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
56995298|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995299|NCT01067352|Hormones|hormones|mesh-list
56995300|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56995301|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995302|NCT02920242|Rifaximin|rifaximin|mesh-list
56995303|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56995304|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995305|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995306|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56995307|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56995308|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56995309|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56995310|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995311|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995312|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
56995313|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995314|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56995315|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56995316|NCT03203447|Triamcinolone|triamcinolone|mesh-list
56995317|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56995318|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56995319|NCT03203447|Bevacizumab|bevacizumab|mesh-list
56995320|NCT03203447|Ranibizumab|ranibizumab|mesh-list
56995321|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56995322|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995323|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995324|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56995325|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56995326|NCT03203447|Growth Substances|growth substances|mesh-ancestor
56995327|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995328|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
56995329|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56995330|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
56995331|NCT03203447|Hormones|hormones|mesh-ancestor
56995332|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56995333|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56995334|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
56995335|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995336|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995337|NCT01068678|Insulin|insulin|mesh-list
56995338|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56995339|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
56995340|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56995341|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995342|NCT03202511|Tenofovir|tenofovir|mesh-list
56995343|NCT03202511|Emtricitabine|emtricitabine|mesh-list
56995344|NCT03202511|Probenecid|probenecid|mesh-list
56995345|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
56995346|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995347|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56995348|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56995349|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995350|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995351|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56995352|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56995353|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
56995354|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
56995355|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56995356|NCT03202511|Renal Agents|renal agents|mesh-ancestor
56995357|NCT03637049|Midazolam|midazolam|mesh-list
56995358|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56995359|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56995360|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995361|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995362|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56995363|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56995364|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56995365|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56995366|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
56995367|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
56995368|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
56995369|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
56995370|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995371|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995372|NCT03636971|Mannitol|mannitol|mesh-list
56995373|NCT03636971|Sorbitol|sorbitol|mesh-list
56995374|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
56995375|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56995376|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
56995377|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995378|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
56995379|NCT03636971|Protective Agents|protective agents|mesh-ancestor
56995380|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56995381|NCT03636971|Diuretics|diuretics|mesh-ancestor
56995382|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
56995383|NCT03636971|Cathartics|cathartics|mesh-ancestor
56995384|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995385|NCT03610100|Gemcitabine|gemcitabine|mesh-list
56995386|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56995387|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
56995388|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995389|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995390|NCT03610100|Antiviral Agents|antiviral agents|mesh-ancestor
56995391|NCT03610100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995392|NCT03610100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995393|NCT03610100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56995394|NCT03610100|Immunologic Factors|immunologic factors|mesh-ancestor
56995395|NCT03610100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995396|NCT03657966|Gemcitabine|gemcitabine|mesh-list
56995397|NCT03657966|Paclitaxel|paclitaxel|mesh-list
56995398|NCT03657966|Carboplatin|carboplatin|mesh-list
56995399|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56995400|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995401|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
56995402|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
56995403|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
56995404|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995405|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56995406|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
56995407|NCT03657966|Antiviral Agents|antiviral agents|mesh-ancestor
56995408|NCT03657966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995409|NCT03657966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995410|NCT03657966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56995411|NCT03657966|Immunologic Factors|immunologic factors|mesh-ancestor
56995412|NCT03657966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995413|NCT03659292|Anesthetics|anesthetics|mesh-list
56995414|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995415|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995416|NCT03659058|Colchicine|colchicine|mesh-list
56995417|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56995418|NCT03659058|Antioxidants|antioxidants|mesh-list
56995419|NCT03659058|Silymarin|silymarin|mesh-list
56995420|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
56995421|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56995422|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
56995423|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
56995424|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
56995425|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995426|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995427|NCT03659058|Protective Agents|protective agents|mesh-ancestor
56995428|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995429|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56995430|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995432|NCT03635905|Analgesics|analgesics|mesh-ancestor
56995433|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
56995434|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995435|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995436|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
56995437|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56995438|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56995439|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995440|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56995441|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56995442|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56995443|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995444|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995445|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
56995446|NCT02960113|Scopolamine|scopolamine|mesh-list
56995447|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56995448|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56995449|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
56995450|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
56995451|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995452|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995453|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995454|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
56995455|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56995456|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
56995457|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995458|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995459|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56995460|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
56995461|NCT04458324|Buspirone|buspirone|mesh-list
56995462|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56995463|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56995464|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995465|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995466|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56995467|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56995468|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
56995469|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995470|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995471|NCT03657420|Dexamethasone|dexamethasone|mesh-list
56995472|NCT03657420|Pomalidomide|pomalidomide|mesh-list
56995473|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56995474|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
56995475|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
56995476|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995477|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995478|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995479|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
56995480|NCT03657420|Hormones|hormones|mesh-ancestor
56995481|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56995482|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56995483|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995484|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
56995485|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56995486|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56995487|NCT03657420|Growth Substances|growth substances|mesh-ancestor
56995488|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
56995489|NCT02984982|Anticoagulants|anticoagulants|mesh-list
56995490|NCT02984982|Atorvastatin|atorvastatin|mesh-list
56995491|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56995492|NCT02984982|Ezetimibe|ezetimibe|mesh-list
56995493|NCT02984982|Fenofibrate|fenofibrate|mesh-list
56995494|NCT02984982|Bezafibrate|bezafibrate|mesh-list
56995495|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56995496|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56995497|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
56995498|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995499|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56995500|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56995501|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995502|NCT03656484|Metronidazole|metronidazole|mesh-list
56995503|NCT03656484|Tetracycline|tetracycline|mesh-list
56995504|NCT03656484|Melatonin|melatonin|mesh-list
56995505|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
56995506|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995507|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56995508|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56995509|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56995510|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
56995511|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995512|NCT03656484|Protective Agents|protective agents|mesh-ancestor
56995513|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995514|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995515|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56995516|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
56995517|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
56995518|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56995519|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995520|NCT04309578|Capecitabine|capecitabine|mesh-list
56995521|NCT04309578|Trastuzumab|trastuzumab|mesh-list
56995522|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995523|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56995524|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
56995525|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995526|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995527|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
56995528|NCT03656952|PF-06700841|pf-06700841|mesh-list
56995529|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56995530|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995531|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56995532|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56995533|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995534|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995535|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995536|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56995537|NCT02981472|Vitamin K|vitamin k|mesh-list
56995538|NCT02981472|Heparin|heparin|mesh-list
56995539|NCT02981472|Enoxaparin|enoxaparin|mesh-list
56995540|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56995541|NCT02981472|Tinzaparin|tinzaparin|mesh-list
56995542|NCT02981472|Dalteparin|dalteparin|mesh-list
56995543|NCT02981472|Warfarin|warfarin|mesh-list
56995544|NCT02981472|Apixaban|apixaban|mesh-list
56995545|NCT02981472|Vitamins|vitamins|mesh-ancestor
56995546|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
56995547|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995548|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
56995549|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56995550|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56995551|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995552|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56995553|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
56995554|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56995555|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
56995556|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995557|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56995558|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
56995559|NCT02981472|Coagulants|coagulants|mesh-ancestor
56995560|NCT03656172|Chrysarobin|chrysarobin|mesh-list
56995561|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56995562|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56995563|NCT03656172|Analgesics|analgesics|mesh-ancestor
56995564|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
56995565|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995566|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995567|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56995568|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56995569|NCT03656094|Docetaxel|docetaxel|mesh-list
56995570|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
56995571|NCT03656094|Pemetrexed|pemetrexed|mesh-list
56995572|NCT03656094|Vinorelbine|vinorelbine|mesh-list
56995573|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995574|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
56995575|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
56995576|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
56995577|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995578|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995579|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995580|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56995581|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56995582|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56995583|NCT04298034|Labetalol|labetalol|mesh-list
56995584|NCT04298034|Nifedipine|nifedipine|mesh-list
56995585|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56995586|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56995587|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995588|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56995589|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995590|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
56995591|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
56995592|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56995593|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56995594|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56995595|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
56995596|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995597|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56995598|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
56995599|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
56995600|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995601|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56995602|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56995603|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56995604|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
56995605|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995606|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995607|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
56995608|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995609|NCT00849667|Carboplatin|carboplatin|mesh-list
56995610|NCT00849667|Taxane|taxane|mesh-list
56995611|NCT00849667|Farletuzumab|farletuzumab|mesh-list
56995612|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995613|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56995614|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
56995615|NCT03201419|Coagulants|coagulants|mesh-ancestor
56995616|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56995617|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
56995618|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995619|NCT01764633|Evolocumab|evolocumab|mesh-list
56995620|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56995621|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56995622|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
56995623|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995624|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56995625|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56995626|NCT02924389|Dolutegravir|dolutegravir|mesh-list
56995627|NCT02924389|Triumeq|triumeq|mesh-list
56995628|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56995629|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56995630|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995631|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995632|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
56995633|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995634|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56995635|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56995636|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56995637|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56995638|NCT01315093|Heparin|heparin|mesh-list
56995639|NCT01315093|Calcium heparin|calcium heparin|mesh-list
56995640|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56995641|NCT01315093|Tinzaparin|tinzaparin|mesh-list
56995642|NCT01315093|Dalteparin|dalteparin|mesh-list
56995643|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
56995644|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56995645|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56995646|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995647|NCT01331707|Everolimus|everolimus|mesh-list
56995648|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995649|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56995650|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
56995651|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995652|NCT02956447|Hormones|hormones|mesh-list
56995653|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56995654|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995655|NCT03953807|Dexamethasone|dexamethasone|mesh-list
56995656|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56995657|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
56995658|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
56995659|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995660|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995661|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995662|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
56995664|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56995665|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56995666|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995667|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
56995668|NCT03662711|Olodaterol|olodaterol|mesh-list
56995669|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
56995670|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995671|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995672|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56995673|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
56995674|NCT02923531|Nivolumab|nivolumab|mesh-list
56995675|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995676|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995677|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56995678|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995679|NCT02934503|Carboplatin|carboplatin|mesh-list
56995680|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
56995681|NCT02934503|Etoposide|etoposide|mesh-list
56995682|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995683|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995684|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56995685|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56995686|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56995687|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995688|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995689|NCT04563247|Antibodies|antibodies|mesh-list
56995690|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
56995691|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995692|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
56995693|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56995694|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995695|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995696|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56995697|NCT01314209|Analgesics|analgesics|mesh-ancestor
56995698|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
56995699|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995700|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56995701|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56995702|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56995703|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
56995704|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995705|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995706|NCT05431075|Amoxicillin|amoxicillin|mesh-list
56995707|NCT05431075|Tetracycline|tetracycline|mesh-list
56995708|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
56995709|NCT05431075|Esomeprazole|esomeprazole|mesh-list
56995710|NCT05431075|Bismuth|bismuth|mesh-list
56995711|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995712|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56995713|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995714|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56995715|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995716|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56995717|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995718|NCT05431075|Antacids|antacids|mesh-ancestor
56995719|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56995720|NCT05431075|Diuretics|diuretics|mesh-ancestor
56995721|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
56995722|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995723|NCT05431075|Expectorants|expectorants|mesh-ancestor
56995724|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
56995725|NCT03636659|Amphotericin B|amphotericin b|mesh-list
56995726|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56995727|NCT03636659|Amebicides|amebicides|mesh-ancestor
56995728|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56995729|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56995730|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995731|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56995732|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
56995733|NCT04892173|Cetuximab|cetuximab|mesh-list
56995734|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995735|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995736|NCT03198767|Licogliflozin|licogliflozin|mesh-list
56995737|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
56995738|NCT03198767|Psyllium|psyllium|mesh-list
56995739|NCT03198767|Calcium|calcium|mesh-list
56995740|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56995741|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995742|NCT03198767|Antacids|antacids|mesh-ancestor
56995743|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995744|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995745|NCT03198767|Cathartics|cathartics|mesh-ancestor
56995746|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56995747|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56995748|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
56995749|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
56995750|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56995751|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
56995752|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995753|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995754|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56995755|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
56995756|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56995757|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56995758|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56995759|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
56995760|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995761|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995762|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56995763|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56995764|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56995765|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
56995766|NCT01331785|Midodrine|midodrine|mesh-list
56995767|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
56995768|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
56995769|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995770|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995771|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56995772|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56995773|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56995774|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56995775|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
56995776|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995777|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995778|NCT01382589|Afamelanotide|afamelanotide|mesh-list
56995779|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
56677951|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
56995780|NCT04495621|Cetuximab|cetuximab|mesh-list
56995781|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995782|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995783|NCT03671759|Caffeine|caffeine|mesh-list
56995784|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56995785|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995786|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56995787|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995788|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995789|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56995790|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56995791|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
56995792|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995793|NCT01384227|Proflavine|proflavine|mesh-list
56995794|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56995795|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995796|NCT01382511|Simvastatin|simvastatin|mesh-list
56995797|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56995798|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56995799|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
56995800|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995801|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56995802|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56995803|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995804|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
56995805|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56995806|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995807|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995808|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56995809|NCT04916197|Analgesics|analgesics|mesh-ancestor
56995810|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
56995811|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995812|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56995813|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56995814|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56995815|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
56995816|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995817|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995818|NCT03684447|Propofol|propofol|mesh-list
56995819|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56995820|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995821|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995822|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56995823|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
56995824|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
56995825|NCT04505059|Anesthetics|anesthetics|mesh-list
56995826|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995827|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995828|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56995829|NCT04217135|Hydralazine|hydralazine|mesh-list
56995830|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56995831|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
56995832|NCT01337401|Cediranib|cediranib|mesh-list
56995833|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995834|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56995835|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995836|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995837|NCT04178603|Insulin|insulin|mesh-list
56995838|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56995839|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995840|NCT01333891|Nitroprusside|nitroprusside|mesh-list
56995841|NCT01333891|Phenylephrine|phenylephrine|mesh-list
56995842|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
56995843|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56995844|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
56995845|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
56995846|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995847|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995848|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
56995849|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56995850|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
56995851|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
56995852|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56995853|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56678026|NCT02671175|Piperaquine|piperaquine|mesh-list
56995854|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56995855|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56995856|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995857|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995858|NCT01333891|Protective Agents|protective agents|mesh-ancestor
56995859|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56995860|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
56995861|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56995862|NCT04853875|Amoxicillin|amoxicillin|mesh-list
56995863|NCT04853875|Metronidazole|metronidazole|mesh-list
56995864|NCT04853875|Clarithromycin|clarithromycin|mesh-list
56995865|NCT04853875|Tetracycline|tetracycline|mesh-list
56995866|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56995867|NCT04853875|Bismuth|bismuth|mesh-list
56995868|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56995869|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995870|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56995871|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56995872|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56995873|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995874|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995875|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56995876|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56995877|NCT04853875|Antacids|antacids|mesh-ancestor
56995878|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56995879|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56995880|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56995881|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56995882|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995883|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
56995884|NCT03196505|Bupivacaine|bupivacaine|mesh-list
56995885|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
56995886|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
56995887|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56995888|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995889|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
56995890|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995891|NCT01334047|Vaccines|vaccines|mesh-list
56995892|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
56995893|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995894|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
56995895|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56995896|NCT03196349|Warfarin|warfarin|mesh-list
56995897|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
56995898|NCT03196349|Apixaban|apixaban|mesh-list
56995899|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
56995900|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56995901|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
56995902|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56995903|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
56995904|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995905|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995906|NCT01331941|Paclitaxel|paclitaxel|mesh-list
56995907|NCT01331941|Trebananib|trebananib|mesh-list
56995908|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56995909|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995910|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
56995911|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
56995912|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
56995913|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995914|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56995915|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56995916|NCT01331941|Growth Substances|growth substances|mesh-ancestor
56995917|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995918|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
56995919|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
56995920|NCT02886715|Tazarotene|tazarotene|mesh-list
56995921|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
56995922|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
56995923|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
56995924|NCT02886715|Vitamins|vitamins|mesh-ancestor
56995925|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
56995926|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995927|NCT01337791|Telbivudine|telbivudine|mesh-list
56995928|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
56995929|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995930|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56995931|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995932|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995933|NCT01334203|Ranolazine|ranolazine|mesh-list
56995934|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56995935|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56995936|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995937|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
56995938|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56995939|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
56995940|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56995941|NCT01569165|Fluorides|fluorides|mesh-list
56995942|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
56995943|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
56995944|NCT01569165|Protective Agents|protective agents|mesh-ancestor
56995945|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995946|NCT04259749|Menthol|menthol|mesh-list
56995947|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
56995948|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
56995949|NCT03575793|Nivolumab|nivolumab|mesh-list
56995950|NCT03575793|Ipilimumab|ipilimumab|mesh-list
56995951|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56995952|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56995953|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56995954|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995955|NCT02535091|Cenobamate|cenobamate|mesh-list
56995956|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
56995957|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56995958|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56995959|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56995960|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
56995961|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995962|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56995963|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56995964|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995965|NCT01382199|Lactoferrin|lactoferrin|mesh-list
56995966|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56995967|NCT01381497|Naproxen|naproxen|mesh-list
56995968|NCT01381497|Sumatriptan|sumatriptan|mesh-list
56995969|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56995970|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56995971|NCT01381497|Analgesics|analgesics|mesh-ancestor
56995972|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
56995973|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56995974|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995975|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56995976|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56995977|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
56995978|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56995979|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56995980|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995981|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56995982|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56995983|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56995984|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
56995985|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995986|NCT04221997|Sertraline|sertraline|mesh-list
56995987|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
56995988|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56995989|NCT04221997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56995990|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56995991|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56995992|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56995993|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56995994|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
56995995|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56995997|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56995998|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
56995999|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
56996000|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996001|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996002|NCT01338103|Rituximab|rituximab|mesh-list
56996003|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996004|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996005|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
56996006|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996007|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996008|NCT03369665|Cladribine|cladribine|mesh-list
56996009|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996010|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996011|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
56996012|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996013|NCT03621761|Modafinil|modafinil|mesh-list
56996014|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56996015|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996016|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56996017|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56996018|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56996019|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996020|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
56996021|NCT03318861|Fludarabine|fludarabine|mesh-list
56996022|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996023|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
56996024|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996025|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996026|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56996027|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
56996028|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996029|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996030|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56996031|NCT03084315|Nicotine|nicotine|mesh-list
56996032|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56996033|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
56996034|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996035|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996036|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56895772|NCT03894189|Doxapram|doxapram|mesh-list
56996037|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56996038|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
56996039|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996040|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996041|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
56996042|NCT03187301|Apomorphine|apomorphine|mesh-list
56996043|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56996044|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996045|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56996046|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56996047|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996048|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996049|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996050|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996051|NCT03187301|Emetics|emetics|mesh-ancestor
56996052|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
56996053|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996054|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56996055|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
56996056|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
56996057|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996058|NCT01381185|Aspirin|aspirin|mesh-list
56996059|NCT01381185|Clopidogrel|clopidogrel|mesh-list
56996060|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56996061|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56996062|NCT01381185|Analgesics|analgesics|mesh-ancestor
56996063|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
56996064|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996065|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996066|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996067|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996068|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56996069|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56996070|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996071|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56996072|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56996073|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996074|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
56996075|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56996076|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56996077|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56996078|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
56996079|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996080|NCT02946047|Ixazomib|ixazomib|mesh-list
56996081|NCT02946047|Glycine|glycine|mesh-list
56996082|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996083|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
56996084|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996085|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996086|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
56996087|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996088|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996089|NCT05422131|Clozapine|clozapine|mesh-list
56996090|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56996091|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
56996092|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996093|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996094|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996095|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56996096|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56996097|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996098|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56996099|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
56996100|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
56996101|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
56996102|NCT05421897|Temozolomide|temozolomide|mesh-list
56996103|NCT05421897|Irinotecan|irinotecan|mesh-list
56996104|NCT05421897|Topotecan|topotecan|mesh-list
56996105|NCT05421897|Dinutuximab|dinutuximab|mesh-list
56996106|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996107|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
56996108|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996109|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996110|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56996111|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
56996112|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996113|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996114|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56996115|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56996116|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56996117|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996118|NCT03077919|Ropivacaine|ropivacaine|mesh-list
56996119|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
56996120|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
56996121|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996122|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996123|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
56996124|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996125|NCT01380951|Telbivudine|telbivudine|mesh-list
56996126|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
56996127|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996128|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56996129|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996130|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996131|NCT01377597|Ranibizumab|ranibizumab|mesh-list
56996132|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56996133|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56996134|NCT01377597|Growth Substances|growth substances|mesh-ancestor
56996135|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996136|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
56996137|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996138|NCT03382301|Cyclosporine|cyclosporine|mesh-list
56996139|NCT03382301|Cyclosporins|cyclosporins|mesh-list
56996140|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996141|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996142|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996143|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
56996144|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996145|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
56996146|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996147|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
56996148|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996149|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56996150|NCT03287375|Cisplatin|cisplatin|mesh-list
56996151|NCT03287375|Doxorubicin|doxorubicin|mesh-list
56996152|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
56678320|NCT00648401|Verapamil|verapamil|mesh-list
56678328|NCT02663999|Diazepam|diazepam|mesh-list
56996153|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996154|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56996155|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56996156|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56996157|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996158|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996159|NCT03881059|Ustekinumab|ustekinumab|mesh-list
56996160|NCT03881059|BMS-986165|bms-986165|mesh-list
56996161|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
56996162|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56996163|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996164|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996165|NCT01338337|Azacitidine|azacitidine|mesh-list
56996166|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56996167|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
56996168|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996169|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996170|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996171|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
56996172|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56996173|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56996174|NCT02836925|Ledipasvir|ledipasvir|mesh-list
56996175|NCT02836925|Velpatasvir|velpatasvir|mesh-list
56996176|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
56996177|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996178|NCT03083847|Chloroquine|chloroquine|mesh-list
56996179|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56996180|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
56996181|NCT03083847|Amebicides|amebicides|mesh-ancestor
56996182|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56996183|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56996184|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996185|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
56996186|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996187|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56996188|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56996189|NCT03083847|Analgesics|analgesics|mesh-ancestor
56996190|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
56996191|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996192|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996193|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996194|NCT03083847|Filaricides|filaricides|mesh-ancestor
56996195|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
56996196|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
56996197|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56996198|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996199|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996200|NCT03082677|Ixazomib|ixazomib|mesh-list
56996201|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996202|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
56996203|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996204|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996205|NCT03136055|Paclitaxel|paclitaxel|mesh-list
56996206|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
56996207|NCT03136055|Irinotecan|irinotecan|mesh-list
56996208|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56996209|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996210|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
56996211|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
56996212|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
56996213|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996214|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996215|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56996216|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56996217|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996218|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
56996219|NCT03221309|Narcotics|narcotics|mesh-ancestor
56996220|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996221|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996222|NCT03221309|Analgesics|analgesics|mesh-ancestor
56996223|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
56996224|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996225|NCT05353829|Methotrexate|methotrexate|mesh-list
56996226|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56996227|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
56996228|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56678394|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
56996229|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996230|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56996231|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
56996232|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996233|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996234|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
56996235|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996236|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56996237|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996238|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
56996239|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996240|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56996241|NCT03426657|Durvalumab|durvalumab|mesh-list
56996242|NCT03426657|Tremelimumab|tremelimumab|mesh-list
56996243|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996244|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996245|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
56996246|NCT02858180|Ledipasvir|ledipasvir|mesh-list
56996247|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
56996248|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996249|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56996250|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56996251|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996252|NCT03609086|Melatonin|melatonin|mesh-list
56996253|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
56996254|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996255|NCT03609086|Protective Agents|protective agents|mesh-ancestor
56996256|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895777|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56996257|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996258|NCT00730717|Adalimumab|adalimumab|mesh-list
56996259|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996260|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996261|NCT01332409|Fluticasone|fluticasone|mesh-list
56996262|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56996263|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56996264|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996265|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56996266|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
56996267|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996268|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996269|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56996270|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
56996271|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56996272|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56996273|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56996274|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56996275|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56996276|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
56996277|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996278|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996279|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
56996280|NCT01332409|Hormones|hormones|mesh-ancestor
56996281|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56996282|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
56996283|NCT03181451|Ferric maltol|ferric maltol|mesh-list
56996284|NCT03181451|Hematinics|hematinics|mesh-ancestor
56996285|NCT03495973|Ustekinumab|ustekinumab|mesh-list
56996286|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
56996287|NCT00480805|Losartan|losartan|mesh-list
56996288|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56996289|NCT00480805|Ramipril|ramipril|mesh-list
56996290|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56996291|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56996292|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56996293|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56996294|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996295|NCT00480805|Diuretics|diuretics|mesh-ancestor
56996296|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
56996297|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996298|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56996299|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56996300|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56996301|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
56996302|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996303|NCT00406783|Desloratadine|desloratadine|mesh-list
56996304|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56996305|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
56996306|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996307|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996308|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996309|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56996310|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56996311|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
56996312|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
56996313|NCT03179891|Diazepam|diazepam|mesh-list
56996314|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56996315|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
56996316|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
56996317|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
56996318|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996319|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996320|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56996321|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56996322|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996323|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56996324|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56996325|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56996326|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56996327|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56996328|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56996329|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
56996330|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
56996331|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
56996332|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
56996333|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996334|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996335|NCT01334671|Atorvastatin|atorvastatin|mesh-list
56996336|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56996337|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56996338|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
56996339|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996340|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56996341|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56996342|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996343|NCT01332565|Dolutegravir|dolutegravir|mesh-list
56996344|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56996345|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56996346|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996347|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996348|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56996349|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56996350|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
56996351|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996352|NCT02861417|Vidarabine|vidarabine|mesh-list
56996353|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
56996354|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
56996355|NCT02861417|Busulfan|busulfan|mesh-list
56996356|NCT02861417|Thiotepa|thiotepa|mesh-list
56996357|NCT02861417|Fludarabine|fludarabine|mesh-list
56996358|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
56996359|NCT02861417|Tacrolimus|tacrolimus|mesh-list
56996360|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996361|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
56996362|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996363|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996364|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56996365|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
56996366|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996367|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996368|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56996369|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56996370|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
56996371|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
56996372|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996373|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56996374|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996375|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56996376|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56996377|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
56996378|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56996379|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56996380|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56996381|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996382|NCT02736227|Everolimus|everolimus|mesh-list
56996383|NCT02736227|Tacrolimus|tacrolimus|mesh-list
56996384|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996385|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
56996386|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996387|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56996388|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996389|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996390|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996392|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56996393|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56996394|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56996395|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
56996396|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996397|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996398|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996399|NCT01334905|Urological Agents|urological agents|mesh-ancestor
56996400|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
56996401|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996402|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
56996403|NCT05030129|Pyridoxal|pyridoxal|mesh-list
56996404|NCT05030129|Pyridoxine|pyridoxine|mesh-list
56996405|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
56996406|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
56996407|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
56996408|NCT05030129|Vitamins|vitamins|mesh-ancestor
56996409|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
56996410|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996411|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
56996412|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56996413|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
56996414|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56996415|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56996416|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56996417|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
56996418|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996419|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996420|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
56996421|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
56996422|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
56996423|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
56996424|NCT05017025|Osimertinib|osimertinib|mesh-list
56996425|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996426|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56996427|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996428|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996429|NCT03260023|Avelumab|avelumab|mesh-list
56996430|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996431|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996432|NCT01339039|Plerixafor|plerixafor|mesh-list
56996433|NCT01339039|Bevacizumab|bevacizumab|mesh-list
56996434|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996435|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996436|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56996437|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56996438|NCT01339039|Growth Substances|growth substances|mesh-ancestor
56996439|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996440|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
56996441|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56996442|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56996443|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
56996444|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996445|NCT03176459|Bupivacaine|bupivacaine|mesh-list
56996446|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
56996447|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
56996448|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996449|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996450|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
56996451|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996452|NCT01332955|Ribavirin|ribavirin|mesh-list
56996453|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56996454|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
56996455|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996456|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
56678611|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996457|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996458|NCT05224895|Anesthetics|anesthetics|mesh-list
56996459|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996460|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996461|NCT01335373|Metronidazole|metronidazole|mesh-list
56996462|NCT01335373|Miconazole|miconazole|mesh-list
56996463|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996464|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56996465|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56996466|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56996467|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
56996468|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56996469|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56996470|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996471|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996472|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56996473|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
56996474|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56996475|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996476|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56996477|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56996478|NCT01333267|Hormones|hormones|mesh-list
56996479|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
56996480|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
56996481|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
56996482|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
56996483|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56996484|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996485|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56996486|NCT01335529|Interferons|interferons|mesh-list
56996487|NCT01335529|Ribavirin|ribavirin|mesh-list
56996488|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
56996489|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
56996490|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56996491|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996492|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
56996493|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996494|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
56996495|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996496|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
56996497|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996498|NCT00308347|Losartan|losartan|mesh-list
56996499|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56996500|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56996501|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56996502|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56996503|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996504|NCT02186834|Dexamethasone|dexamethasone|mesh-list
56996505|NCT02186834|Doxorubicin|doxorubicin|mesh-list
56996506|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56996507|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996508|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
56996509|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
56996510|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996511|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996512|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56996513|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
56996514|NCT02186834|Hormones|hormones|mesh-ancestor
56996515|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56996516|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56996517|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996518|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56996519|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56996520|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56996521|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996522|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996523|NCT04335890|Vaccines|vaccines|mesh-list
56996524|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
56996525|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996526|NCT01379157|Imipenem|imipenem|mesh-list
56996527|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56996528|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996529|NCT01538966|Octreotide|octreotide|mesh-list
56996530|NCT01538966|Lanreotide|lanreotide|mesh-list
56996531|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56996532|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56996533|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996535|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56996536|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56996537|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996538|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996539|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56996540|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56996541|NCT01377285|Protective Agents|protective agents|mesh-ancestor
56996542|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996543|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
56996544|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56996545|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
56996546|NCT02905266|Nivolumab|nivolumab|mesh-list
56996547|NCT02905266|Ipilimumab|ipilimumab|mesh-list
56996548|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996549|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996550|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56996551|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996552|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
56996553|NCT01380717|Calcium|calcium|mesh-list
56996554|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56996555|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56996556|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56996557|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996558|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56996559|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
56996560|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996561|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996562|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
56996563|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996564|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56996565|NCT03080493|Acetaminophen|acetaminophen|mesh-list
56996566|NCT03080493|Ibuprofen|ibuprofen|mesh-list
56996567|NCT03080493|Gabapentin|gabapentin|mesh-list
56996568|NCT03080493|Codeine|codeine|mesh-list
56996569|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56996570|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56996571|NCT03080493|Analgesics|analgesics|mesh-ancestor
56996572|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
56996573|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996574|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996575|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
56996576|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56996577|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996578|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996579|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56996580|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996581|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996582|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
56996583|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56996584|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56996585|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996586|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56996587|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56996588|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56996589|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996590|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
56996591|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56996592|NCT03080493|Narcotics|narcotics|mesh-ancestor
56996593|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
56996594|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
56996595|NCT03080493|Laxatives|laxatives|mesh-ancestor
56996596|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56996597|NCT02906007|Bedaquiline|bedaquiline|mesh-list
56996598|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
56996599|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56996600|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996601|NCT01339910|Vidarabine|vidarabine|mesh-list
56996602|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
56996603|NCT01339910|Melphalan|melphalan|mesh-list
56996604|NCT01339910|Busulfan|busulfan|mesh-list
56996605|NCT01339910|Fludarabine|fludarabine|mesh-list
56996606|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
56996607|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996608|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
56996609|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996611|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56996612|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
56996613|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996614|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996615|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56996616|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56996617|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
56996618|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
56996619|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996620|NCT02647827|Metformin|metformin|mesh-list
56996621|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56996622|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996623|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
56996624|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56996625|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
56996626|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996627|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996628|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56996629|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
56996630|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56996631|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
56996632|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996633|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996634|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56996635|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
56996636|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
56996637|NCT03655392|Protective Agents|protective agents|mesh-ancestor
56996638|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
56996639|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996640|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
56996641|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996642|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996643|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56996644|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
56996645|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996646|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996647|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56996648|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
56996649|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996650|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
56996651|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996652|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996653|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56996654|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
56996655|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996656|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996657|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56996658|NCT01356290|Cytarabine|cytarabine|mesh-list
56996659|NCT01356290|Thalidomide|thalidomide|mesh-list
56996660|NCT01356290|Celecoxib|celecoxib|mesh-list
56996661|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
56996662|NCT01356290|Bevacizumab|bevacizumab|mesh-list
56996663|NCT01356290|Etoposide|etoposide|mesh-list
56996664|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
56996665|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
56996666|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996667|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
56996668|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996669|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996670|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56996671|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
56996672|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996673|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996674|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56996675|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996676|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56996677|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56996678|NCT01356290|Growth Substances|growth substances|mesh-ancestor
56996679|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
56996680|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56996681|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56678844|NCT00698126|Insulin|insulin|mesh-list
56996682|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56996683|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996684|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56996685|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
56996686|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
56996687|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996688|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56996689|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56996690|NCT01356290|Analgesics|analgesics|mesh-ancestor
56996691|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
56996692|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996693|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996694|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56996695|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56996696|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
56996697|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56996698|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56996699|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56996700|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56996701|NCT04203290|Bupivacaine|bupivacaine|mesh-list
56996702|NCT04203290|Sevoflurane|sevoflurane|mesh-list
56996703|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
56996704|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
56996705|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996706|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996707|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
56996708|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996709|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56996710|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56996711|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
56996712|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56996713|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
56996714|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996715|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
56996716|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996717|NCT03654612|Apatinib|apatinib|mesh-list
56996718|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996719|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56996720|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996721|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996722|NCT01066104|Omalizumab|omalizumab|mesh-list
56996723|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56996724|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56996725|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56996726|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
56996727|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
56996728|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996729|NCT02736968|Auranofin|auranofin|mesh-list
56996730|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996731|NCT03608306|Methamphetamine|methamphetamine|mesh-list
56996732|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56996733|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996734|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
56996735|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
56996736|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996737|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
56996738|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996739|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996740|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
56996741|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56996742|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56996743|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56996744|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56996745|NCT03654144|Dienogest|dienogest|mesh-list
56996746|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
56996747|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
56996748|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56996749|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56996750|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996751|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56996752|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56996753|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56996754|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56996755|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
56996756|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56996757|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56996758|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996760|NCT02591615|Carboplatin|carboplatin|mesh-list
56996761|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
56996762|NCT02591615|Pemetrexed|pemetrexed|mesh-list
56996763|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56996764|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996765|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
56996766|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
56996767|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
56996768|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996769|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996770|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996771|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56996772|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56996773|NCT03077607|Itraconazole|itraconazole|mesh-list
56996774|NCT03077607|Rifampin|rifampin|mesh-list
56996775|NCT03077607|Talazoparib|talazoparib|mesh-list
56996776|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
56996777|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996778|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56996779|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56996780|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996781|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996782|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56996783|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
56996784|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56996785|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996786|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56996787|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56996788|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
56996789|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56996790|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
56996791|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56996792|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56996793|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56996794|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56996795|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56996796|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56996797|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56996798|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56996799|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996800|NCT04215588|Hemostatics|hemostatics|mesh-list
56996801|NCT04215588|Coagulants|coagulants|mesh-ancestor
56996802|NCT01377051|Maleic acid|maleic acid|mesh-list
56996803|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996804|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996805|NCT03217175|Glucagon|glucagon|mesh-list
56996806|NCT03217175|Pancrelipase|pancrelipase|mesh-list
56996807|NCT03217175|Pancreatin|pancreatin|mesh-list
56996808|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996809|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56996810|NCT03217175|Hormones|hormones|mesh-ancestor
56996811|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56996812|NCT01379079|Aspirin|aspirin|mesh-list
56996813|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
56996814|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
56996815|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
56996816|NCT01379079|Calcium|calcium|mesh-list
56996817|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56996818|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996819|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56996820|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56996821|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56996822|NCT01379079|Analgesics|analgesics|mesh-ancestor
56996823|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
56996824|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996825|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996826|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996827|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56678989|NCT00691210|Vitamins|vitamins|mesh-ancestor
56996828|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56996829|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996830|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56996831|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56996832|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996833|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
56996834|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
56996835|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996836|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996837|NCT01379001|Scopolamine|scopolamine|mesh-list
56996838|NCT01379001|Donepezil|donepezil|mesh-list
56996839|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56996840|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56996841|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996842|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996843|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
56996844|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996845|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996846|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
56996847|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56996848|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
56996849|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
56996850|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996851|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56996852|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
56996853|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56996854|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56996855|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
56996856|NCT03172325|Folic Acid|folic acid|mesh-list
56996857|NCT03172325|Prednisolone|prednisolone|mesh-list
56996858|NCT03172325|Adalimumab|adalimumab|mesh-list
56996859|NCT03172325|Methotrexate|methotrexate|mesh-list
56996860|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56996861|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
56996862|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56996863|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996864|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56996865|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
56996866|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996867|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996868|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
56996869|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996870|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56996871|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996872|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
56996873|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56996874|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56996875|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56996876|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
56996877|NCT03172325|Hormones|hormones|mesh-ancestor
56996878|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56996879|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56996880|NCT03172325|Hematinics|hematinics|mesh-ancestor
56996881|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
56996882|NCT03172325|Vitamins|vitamins|mesh-ancestor
56996883|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
56996884|NCT03653520|Diazepam|diazepam|mesh-list
56996885|NCT03653520|Tramadol|tramadol|mesh-list
56996886|NCT03653520|Ondansetron|ondansetron|mesh-list
56996887|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
56996888|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
56996889|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996890|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996891|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56996892|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
56996893|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
56996894|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56996895|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
56996896|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996897|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996898|NCT03653520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56996899|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56996900|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996901|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56996902|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56325388|NCT03431350|Hormones|hormones|mesh-ancestor
56996903|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56996904|NCT03653520|Narcotics|narcotics|mesh-ancestor
56996905|NCT03653520|Analgesics|analgesics|mesh-ancestor
56996906|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
56996907|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56996908|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
56996909|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56996910|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56996911|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56996912|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56996913|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
56996914|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
56996915|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
56996916|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
56996917|NCT01208090|Ponesimod|ponesimod|mesh-list
56996918|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56996919|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996920|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996921|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
56996922|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996923|NCT01380483|Doxycycline|doxycycline|mesh-list
56996924|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56996925|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996926|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
56996927|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56996928|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56996929|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
56996930|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56996931|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56996932|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
56996933|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56996934|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996935|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996936|NCT01378845|Bosentan|bosentan|mesh-list
56996937|NCT01378845|Alprostadil|alprostadil|mesh-list
56996938|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56996939|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56996940|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996941|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56996942|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
56996943|NCT01378845|Urological Agents|urological agents|mesh-ancestor
56996944|NCT04884399|Ranibizumab|ranibizumab|mesh-list
56996945|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56996946|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56996947|NCT04884399|Growth Substances|growth substances|mesh-ancestor
56996948|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996949|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
56996950|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996951|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
56996952|NCT03264404|Azacitidine|azacitidine|mesh-list
56996953|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56996954|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996955|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56996956|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
56996957|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996958|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996959|NCT04904549|Vaccines|vaccines|mesh-list
56996960|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
56996961|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996962|NCT03607916|Morphine|morphine|mesh-list
56996963|NCT03607916|Prilocaine|prilocaine|mesh-list
56996964|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56996965|NCT03607916|Narcotics|narcotics|mesh-ancestor
56996966|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56996967|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996968|NCT03607916|Analgesics|analgesics|mesh-ancestor
56996969|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
56996970|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56996971|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
56996972|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
56996973|NCT01141712|Cytarabine|cytarabine|mesh-list
56996974|NCT01141712|Etoposide|etoposide|mesh-list
56996975|NCT01141712|Melphalan|melphalan|mesh-list
56996976|NCT01141712|Carmustine|carmustine|mesh-list
56996977|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56996978|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56996979|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56996980|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56996981|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56996982|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56996983|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56996984|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
56996985|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
56996986|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56996987|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56996988|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
56996989|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996990|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56996991|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
56996992|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56996993|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
56996994|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56996995|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
56996996|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56996997|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
56996998|NCT02034890|Protective Agents|protective agents|mesh-ancestor
56996999|NCT02015351|Bevacizumab|bevacizumab|mesh-list
56997000|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56997001|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997002|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56997003|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56997004|NCT02015351|Growth Substances|growth substances|mesh-ancestor
56997005|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997006|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
56997007|NCT03604796|Acetaminophen|acetaminophen|mesh-list
56997008|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56997009|NCT03604796|Analgesics|analgesics|mesh-ancestor
56997010|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
56997011|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997012|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997013|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
56997014|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
56997015|NCT02237534|Calcium|calcium|mesh-list
56997016|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56997017|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997018|NCT02237534|Antacids|antacids|mesh-ancestor
56997019|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997020|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56997021|NCT03606902|Fentanyl|fentanyl|mesh-list
56997022|NCT03606902|Bupivacaine|bupivacaine|mesh-list
56997023|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
56997024|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
56997025|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997026|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997027|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
56997028|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997029|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56997030|NCT03606902|Narcotics|narcotics|mesh-ancestor
56997031|NCT03606902|Analgesics|analgesics|mesh-ancestor
56997032|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56997033|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56997034|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
56997035|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
56997036|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56997037|NCT03606824|Pitavastatin|pitavastatin|mesh-list
56997038|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56997039|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56997040|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56997041|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
56997042|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997043|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997044|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56997045|NCT03604016|Tenofovir|tenofovir|mesh-list
56997046|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
56997047|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997048|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56997049|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56997050|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997051|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997052|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56997053|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56997054|NCT01064622|Gemcitabine|gemcitabine|mesh-list
56997055|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
56997056|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56997057|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
56997058|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997059|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997061|NCT01064622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997062|NCT01064622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997063|NCT01064622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997064|NCT01064622|Immunologic Factors|immunologic factors|mesh-ancestor
56997065|NCT01064622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997066|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56997067|NCT01063764|Levetiracetam|levetiracetam|mesh-list
56574488|NCT05779241|Risperidone|risperidone|mesh-list
56997068|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
56997069|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
56997070|NCT04053972|Lenvatinib|lenvatinib|mesh-list
56997071|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997072|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56997073|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997074|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997075|NCT01380249|Bromides|bromides|mesh-list
56997076|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
56997077|NCT04054518|Durvalumab|durvalumab|mesh-list
56997078|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56997079|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997080|NCT03652896|Liver Extracts|liver extracts|mesh-list
56997081|NCT03652896|Hematinics|hematinics|mesh-ancestor
56997082|NCT04591275|Denosumab|denosumab|mesh-list
56997083|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56997084|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997085|NCT04565847|Albuterol|albuterol|mesh-list
56997086|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56997087|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
56997088|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997089|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997090|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56997091|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
56997092|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
56997093|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56997094|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56997095|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56997096|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56997097|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
56997098|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997099|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997100|NCT03075891|Doxycycline|doxycycline|mesh-list
56997101|NCT03075891|Ivermectin|ivermectin|mesh-list
56997102|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56997103|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997104|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
56997105|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56997106|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56997107|NCT02013167|Blinatumomab|blinatumomab|mesh-list
56997108|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997109|NCT01378533|Paclitaxel|paclitaxel|mesh-list
56997110|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
56997111|NCT01378533|Carboplatin|carboplatin|mesh-list
56997112|NCT01378533|Epirubicin|epirubicin|mesh-list
56997113|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56997114|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997115|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
56997116|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
56997117|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
56997118|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997119|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997120|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
56997121|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997122|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56997123|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56997124|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
56997125|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56997126|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56997127|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56997128|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56997129|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997130|NCT02630199|Paclitaxel|paclitaxel|mesh-list
56997131|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56997132|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997133|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
56997134|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
56997136|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997137|NCT02588781|Pemetrexed|pemetrexed|mesh-list
56997138|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997139|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997140|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997141|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56997142|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56997143|NCT01063062|Methotrexate|methotrexate|mesh-list
56997144|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56997145|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
56997146|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56997147|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997148|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56997149|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
56997150|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997151|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997152|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
56997153|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997154|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56997155|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997156|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
56997157|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56997158|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56997159|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
56997160|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
56997161|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
56997162|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56997163|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56997164|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
56997165|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
56997166|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997167|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997168|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997169|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56997170|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
56997171|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56997172|NCT04483115|Tadalafil|tadalafil|mesh-list
56997173|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
56997174|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56997175|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56997176|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997177|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997178|NCT04483115|Urological Agents|urological agents|mesh-ancestor
56997179|NCT04054362|Gemcitabine|gemcitabine|mesh-list
56997180|NCT04054362|Paclitaxel|paclitaxel|mesh-list
56997181|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56997182|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56997183|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997184|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
56997185|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
56997186|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
56997187|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997188|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56997189|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
56997190|NCT04054362|Antiviral Agents|antiviral agents|mesh-ancestor
56997191|NCT04054362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997192|NCT04054362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997193|NCT04054362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997194|NCT04054362|Immunologic Factors|immunologic factors|mesh-ancestor
56997195|NCT04054362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997196|NCT04467281|Daratumumab|daratumumab|mesh-list
56997197|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997198|NCT01378143|Pentamidine|pentamidine|mesh-list
56997199|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
56997200|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997201|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56997202|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56997203|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56997204|NCT02973048|Bupivacaine|bupivacaine|mesh-list
56997205|NCT02973048|Prilocaine|prilocaine|mesh-list
56997206|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
56997207|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
56997208|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997209|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997210|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
56997211|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997212|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
56997213|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56997214|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997215|NCT03342027|Bupropion|bupropion|mesh-list
56895796|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
56997216|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56997217|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
56997218|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56997219|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56997220|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56997221|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56997222|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997223|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
56997224|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997225|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997226|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56997227|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56997228|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997229|NCT04054206|Ibudilast|ibudilast|mesh-list
56997230|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56997231|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
56997232|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997233|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997234|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56997235|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
56997236|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56997237|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997238|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997239|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56997240|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
56997241|NCT03603938|Losartan|losartan|mesh-list
56997242|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56997243|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56997244|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56997245|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56997246|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997247|NCT03652116|Meperidine|meperidine|mesh-list
56997248|NCT03652116|Bupivacaine|bupivacaine|mesh-list
56997249|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
56997250|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
56997251|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997252|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997253|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
56997254|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997255|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56997256|NCT03652116|Narcotics|narcotics|mesh-ancestor
56997257|NCT03652116|Analgesics|analgesics|mesh-ancestor
56997258|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56997259|NCT04428671|Cemiplimab|cemiplimab|mesh-list
56997260|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56997261|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997262|NCT02232087|Fluticasone|fluticasone|mesh-list
56997263|NCT02232087|Xhance|xhance|mesh-list
56997264|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56997265|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56997266|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56997267|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56997268|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
56997269|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997270|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997271|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56997272|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
56997273|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
56997274|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56997275|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56997276|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56997277|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56997278|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
56997279|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997280|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997281|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
56997282|NCT02232087|Hormones|hormones|mesh-ancestor
56997283|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56997284|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
56997285|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
56997286|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56997287|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56997289|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
56997290|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997291|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997292|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56997293|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56997294|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
56997295|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997296|NCT01380015|Protective Agents|protective agents|mesh-ancestor
56997297|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56997298|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56997299|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
56997300|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997301|NCT03603626|Pregabalin|pregabalin|mesh-list
56997302|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997303|NCT03603626|Analgesics|analgesics|mesh-ancestor
56997304|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
56997305|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997306|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
56997307|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56997308|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56997309|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997310|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56997311|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56997312|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56997313|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997314|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56997315|NCT01765218|Topiramate|topiramate|mesh-list
56997316|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
56997317|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56997318|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997319|NCT03651882|Oxytocin|oxytocin|mesh-list
56997320|NCT03651882|Carbetocin|carbetocin|mesh-list
56997321|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
56997322|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56997323|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997324|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
56997325|NCT02972502|Promethazine|promethazine|mesh-list
56997326|NCT02972502|Haloperidol|haloperidol|mesh-list
56997327|NCT02972502|Metoclopramide|metoclopramide|mesh-list
56997328|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
56997329|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56997330|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56997331|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997332|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997333|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
56997334|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
56997335|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
56997336|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997337|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
56997338|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
56997339|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56997340|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56997341|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
56997342|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
56997343|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997344|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997345|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56997346|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
56997347|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
56997348|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56997349|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56997350|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56997351|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56997352|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
56997353|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56997354|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56997355|NCT03606590|Sorafenib|sorafenib|mesh-list
56997356|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997357|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56997358|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997359|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997360|NCT03163667|Everolimus|everolimus|mesh-list
56997361|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997362|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997363|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
56997364|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997365|NCT03603548|Tacrolimus|tacrolimus|mesh-list
56997366|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997367|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
56997368|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997369|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56997370|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997371|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997372|NCT03954782|Nintedanib|nintedanib|mesh-list
56997373|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997374|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56997375|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997376|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997377|NCT03651726|Palmidrol|palmidrol|mesh-list
56997378|NCT03651726|Dronabinol|dronabinol|mesh-list
56997379|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
56997380|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997381|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56997382|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56997383|NCT03651726|Analgesics|analgesics|mesh-ancestor
56997384|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
56997385|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997386|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56997387|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56997388|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997389|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997390|NCT03651726|Hormones|hormones|mesh-ancestor
56997391|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56997392|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56997393|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56997394|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56997395|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
56997396|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997397|NCT00107250|Paclitaxel|paclitaxel|mesh-list
56997398|NCT00107250|Carboplatin|carboplatin|mesh-list
56997399|NCT00107250|Capecitabine|capecitabine|mesh-list
56997400|NCT00107250|Cediranib|cediranib|mesh-list
56997401|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56997402|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997403|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
56997404|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
56997405|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
56997406|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997407|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56997408|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
56997409|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997410|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56997411|NCT03167411|Exenatide|exenatide|mesh-list
56997412|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
56997413|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56997414|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997415|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56997416|NCT03167411|Incretins|incretins|mesh-ancestor
56997417|NCT03167411|Hormones|hormones|mesh-ancestor
56997418|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56997419|NCT02237768|Dirithromycin|dirithromycin|mesh-list
56997420|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56997421|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997422|NCT05461833|Octylonium|octylonium|mesh-list
56997423|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56997424|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56997425|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997426|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56997427|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997428|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56997429|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
56997430|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
56997431|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997432|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56997433|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56997435|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997436|NCT01560585|Isotretinoin|isotretinoin|mesh-list
56997437|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
56997438|NCT01376427|Dexamethasone|dexamethasone|mesh-list
56997439|NCT01376427|Methotrexate|methotrexate|mesh-list
56997440|NCT01376427|Vincristine|vincristine|mesh-list
56997441|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56997442|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
56997443|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
56997444|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997445|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997446|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56997447|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
56997448|NCT01376427|Hormones|hormones|mesh-ancestor
56997449|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56997450|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56997451|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997452|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56997453|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
56997454|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56997455|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56997456|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
56997457|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997458|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
56997459|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997460|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56997461|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997462|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
56997463|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56997464|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56997465|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56997466|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
56997467|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
56997468|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
56997469|NCT05764395|Pembrolizumab|pembrolizumab|mesh-list
56997470|NCT05764395|ON 01910|on 01910|mesh-list
56997471|NCT05764395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56997472|NCT05764395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997473|NCT05764395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56997474|NCT05764395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997475|NCT05764395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997476|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56997477|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997478|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997479|NCT05462535|Losartan|losartan|mesh-list
56997480|NCT05462535|Amlodipine|amlodipine|mesh-list
56997481|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
56997482|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56997483|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56997484|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56997485|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997486|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56997487|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997488|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
56997489|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56997490|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56997491|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56997492|NCT05462535|Diuretics|diuretics|mesh-ancestor
56997493|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
56997494|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56997495|NCT05764317|Amlodipine|amlodipine|mesh-list
56997496|NCT05764317|Perindopril|perindopril|mesh-list
56997497|NCT05764317|Atorvastatin|atorvastatin|mesh-list
56997498|NCT05764317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56997499|NCT05764317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56997500|NCT05764317|Antimetabolites|antimetabolites|mesh-ancestor
56997501|NCT05764317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997502|NCT05764317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56997503|NCT05764317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56997504|NCT05764317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997505|NCT05764317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56997506|NCT05764317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56679667|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
56997507|NCT05764317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56997508|NCT05764317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56997509|NCT05764317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997510|NCT05764317|Vasodilator Agents|vasodilator agents|mesh-ancestor
56997511|NCT05764317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56997512|NCT05764317|Protease Inhibitors|protease inhibitors|mesh-ancestor
56997513|NCT05461365|Insulin|insulin|mesh-list
56997514|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56997515|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56997516|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997517|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56997518|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997519|NCT02317991|Paclitaxel|paclitaxel|mesh-list
56997520|NCT02317991|Ramucirumab|ramucirumab|mesh-list
56997521|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56997522|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997523|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
56997524|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
56997525|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
56997526|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997527|NCT03602690|Ritonavir|ritonavir|mesh-list
56997528|NCT03602690|Darunavir|darunavir|mesh-list
56997529|NCT03602690|Dolutegravir|dolutegravir|mesh-list
56997530|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56997531|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56997532|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
56997533|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997534|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997535|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56997536|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56997537|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
56997538|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997539|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56997540|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56997541|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56997542|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56997543|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56997544|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997545|NCT02978495|Paclitaxel|paclitaxel|mesh-list
56997546|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
56997547|NCT02978495|Carboplatin|carboplatin|mesh-list
56997548|NCT02978495|Doxorubicin|doxorubicin|mesh-list
56997549|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56997550|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997551|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
56997552|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
56997553|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
56997554|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997555|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997556|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
56997557|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997558|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56997559|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56997560|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
56997561|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56997562|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56997563|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56997564|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56997565|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997566|NCT02237690|Doxorubicin|doxorubicin|mesh-list
56997567|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56997568|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56997569|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997570|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56997571|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56997572|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997573|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997574|NCT04788017|Ziresovir|ziresovir|mesh-list
56997575|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
56997576|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997577|NCT03600974|Domperidone|domperidone|mesh-list
56997578|NCT03600974|Citalopram|citalopram|mesh-list
56997579|NCT03600974|Esomeprazole|esomeprazole|mesh-list
56997580|NCT03600974|Omeprazole|omeprazole|mesh-list
56997581|NCT03600974|Rabeprazole|rabeprazole|mesh-list
56997582|NCT03600974|Pantoprazole|pantoprazole|mesh-list
56997583|NCT03600974|Lansoprazole|lansoprazole|mesh-list
56997584|NCT03600974|Mosapride|mosapride|mesh-list
56997585|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
56997586|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56997587|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56997588|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56997589|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997590|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997591|NCT03600974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56997592|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56997593|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56997594|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
56997595|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997596|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56997597|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
56997598|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56997599|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
56997600|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997601|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
56997602|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56997603|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
56997604|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56997605|NCT03075267|Budesonide|budesonide|mesh-list
56997606|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
56997607|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
56997608|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56997609|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56997610|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
56997611|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997612|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997613|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56997614|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
56997615|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
56997616|NCT03075267|Hormones|hormones|mesh-ancestor
56997617|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56997618|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56997619|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56997620|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56997621|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
56997622|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894826|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997623|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997624|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56997625|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56997626|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56997627|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
56997628|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
56997629|NCT03600506|Sympatholytics|sympatholytics|mesh-list
56997630|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56997631|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997632|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997633|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56997634|NCT03600506|Analgesics|analgesics|mesh-ancestor
56997635|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
56997636|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997637|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56997638|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56997639|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56997640|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
56997641|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997642|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997643|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
56997644|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
56997645|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56997646|NCT03074331|Velpatasvir|velpatasvir|mesh-list
56997647|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
56997648|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997649|NCT02237924|Endostar protein|endostar protein|mesh-list
56997650|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56997651|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56997652|NCT02237924|Growth Substances|growth substances|mesh-ancestor
56997653|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997654|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
56997655|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997656|NCT03825302|Mannitol|mannitol|mesh-list
56997657|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
56997658|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56997659|NCT03825302|Diuretics|diuretics|mesh-ancestor
56997661|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997662|NCT03825302|Miotics|miotics|mesh-ancestor
56997663|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
56997664|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997665|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56997666|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56997667|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
56997668|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56997669|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56997670|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
56997671|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997672|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997673|NCT02238392|Adenosine|adenosine|mesh-list
56997674|NCT02238392|Analgesics|analgesics|mesh-ancestor
56997675|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
56997676|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997677|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997678|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56997679|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
56997680|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56997681|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
56997682|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
56997683|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894827|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56997684|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997685|NCT02260193|Glycine|glycine|mesh-list
56997686|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
56997687|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997688|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997689|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997690|NCT02849678|Lidocaine|lidocaine|mesh-list
56997691|NCT02849678|Ropivacaine|ropivacaine|mesh-list
56997692|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
56997693|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
56997694|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997695|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997696|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
56997697|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997698|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56997699|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56997700|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56997701|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56997702|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997703|NCT04295577|Niraparib|niraparib|mesh-list
56895873|NCT03885141|Zolpidem|zolpidem|mesh-list
56997704|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56997705|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997706|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997707|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997708|NCT02238158|Ipratropium|ipratropium|mesh-list
56997709|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56997710|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
56997711|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997712|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997713|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56997714|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
56997715|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56997716|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
56997717|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997718|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997719|NCT02238314|Ritonavir|ritonavir|mesh-list
56997720|NCT02238314|Tipranavir|tipranavir|mesh-list
56997721|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56997722|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56997723|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56997724|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
56997725|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997726|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997727|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56997728|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56997729|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
56997730|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997731|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56679888|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56997732|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56997733|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56997734|NCT02238470|Warfarin|warfarin|mesh-list
56997735|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
56997736|NCT02238470|Dabigatran|dabigatran|mesh-list
56997737|NCT02238470|Apixaban|apixaban|mesh-list
56997738|NCT02238470|Anticoagulants|anticoagulants|mesh-list
56997739|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56997740|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
56997741|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56997742|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
56997743|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997744|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997745|NCT03586934|Acetaminophen|acetaminophen|mesh-list
56997746|NCT03586934|Celecoxib|celecoxib|mesh-list
56997747|NCT03586934|Ketorolac|ketorolac|mesh-list
56997748|NCT03586934|Meloxicam|meloxicam|mesh-list
56997749|NCT03586934|Morphine|morphine|mesh-list
56997750|NCT03586934|Oxycodone|oxycodone|mesh-list
56997751|NCT03586934|Tramadol|tramadol|mesh-list
56997752|NCT03586934|Hydrocodone|hydrocodone|mesh-list
56997753|NCT03586934|Ropivacaine|ropivacaine|mesh-list
56997754|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56997755|NCT03586934|Narcotics|narcotics|mesh-ancestor
56997756|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997757|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997758|NCT03586934|Analgesics|analgesics|mesh-ancestor
56997759|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
56997760|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997761|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
56997762|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
56997763|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56997764|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
56997765|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56997766|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56997767|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56997768|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56997769|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56997770|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997771|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997772|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
56997773|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
56997774|NCT03586154|Ketamine|ketamine|mesh-list
56997775|NCT03586154|Bupivacaine|bupivacaine|mesh-list
56997776|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
56997777|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
56997778|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997779|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997780|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
56997781|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997782|NCT03586154|Analgesics|analgesics|mesh-ancestor
56997783|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56997784|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56997785|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
56997786|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56997787|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56997788|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997789|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997790|NCT03629847|Everolimus|everolimus|mesh-list
56997791|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997792|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997793|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
56997794|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997795|NCT01314833|Paclitaxel|paclitaxel|mesh-list
56997796|NCT01314833|Docetaxel|docetaxel|mesh-list
56997797|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
56997798|NCT01314833|Fluorouracil|fluorouracil|mesh-list
56997799|NCT01314833|Epirubicin|epirubicin|mesh-list
56997800|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56997801|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997802|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
56997803|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
56997804|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
56997805|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997806|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997807|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
56679964|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
56997808|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997809|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56997810|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56997811|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
56997812|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56997813|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
56997814|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56997815|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56997816|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56997817|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56997818|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997819|NCT03579836|Gemcitabine|gemcitabine|mesh-list
56997820|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56997821|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
56997822|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997823|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997824|NCT03579836|Antiviral Agents|antiviral agents|mesh-ancestor
56997825|NCT03579836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997826|NCT03579836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997827|NCT03579836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997828|NCT03579836|Immunologic Factors|immunologic factors|mesh-ancestor
56997829|NCT03579836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997830|NCT02737826|Buprenorphine|buprenorphine|mesh-list
56997831|NCT02737826|Gabapentin|gabapentin|mesh-list
56997832|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56997833|NCT02737826|Narcotics|narcotics|mesh-ancestor
56997834|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997835|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997836|NCT02737826|Analgesics|analgesics|mesh-ancestor
56997837|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
56997838|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997839|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56997840|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
56997841|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56997842|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56997843|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56997844|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56997845|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56997846|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997847|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997848|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
56997849|NCT03367715|Nivolumab|nivolumab|mesh-list
56997850|NCT03367715|Ipilimumab|ipilimumab|mesh-list
56997851|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56997852|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997853|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56997854|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997856|NCT04064931|Vitamins|vitamins|mesh-ancestor
56997857|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
56997858|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997859|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56997860|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
56997861|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997862|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56997863|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
56997864|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
56997865|NCT03577652|Ticagrelor|ticagrelor|mesh-list
56997866|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56997867|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56997868|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56997869|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56997870|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
56997871|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997872|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997873|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997874|NCT03620513|Lidocaine|lidocaine|mesh-list
56997875|NCT03620513|Phenylephrine|phenylephrine|mesh-list
56997876|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
56997877|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
56997878|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
56997879|NCT03620513|Ephedrine|ephedrine|mesh-list
56997880|NCT03620513|Anesthetics|anesthetics|mesh-list
56997881|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
56997882|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997883|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997884|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
56680036|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
56997885|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997886|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56997887|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56997888|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56997889|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56997890|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997891|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56997892|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56997893|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
56997894|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997895|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
56997896|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
56997897|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56997898|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
56997899|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56997900|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
56997901|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56997902|NCT03620513|Protective Agents|protective agents|mesh-ancestor
56997903|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56997904|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56997905|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56997907|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56997908|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997909|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
56997910|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
56997911|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
56997912|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997913|NCT03584360|Calcitriol|calcitriol|mesh-list
56997914|NCT03584360|Betamethasone|betamethasone|mesh-list
56997915|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
56997916|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56997917|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
56997918|NCT03584360|Calcipotriene|calcipotriene|mesh-list
56997919|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56997920|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56997921|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
56997922|NCT03584360|Hormones|hormones|mesh-ancestor
56997923|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56997924|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997925|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56997926|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
56997927|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
56997928|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56997929|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56997930|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56997931|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997932|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56997933|NCT03584360|Vitamins|vitamins|mesh-ancestor
56997934|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
56997935|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56997936|NCT05763771|Nicotine|nicotine|mesh-list
56997937|NCT05763771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56997938|NCT05763771|Autonomic Agents|autonomic agents|mesh-ancestor
56997939|NCT05763771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997940|NCT05763771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997941|NCT05763771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56997942|NCT05763771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56997943|NCT05763771|Cholinergic Agents|cholinergic agents|mesh-ancestor
56997944|NCT05763771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997945|NCT05763771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997946|NCT03579758|Gemcitabine|gemcitabine|mesh-list
56997947|NCT03579758|Capecitabine|capecitabine|mesh-list
56997948|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997949|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56997950|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
56997951|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997952|NCT03579758|Antiviral Agents|antiviral agents|mesh-ancestor
56997953|NCT03579758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997954|NCT03579758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997955|NCT03579758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56997956|NCT03579758|Immunologic Factors|immunologic factors|mesh-ancestor
56997957|NCT03579758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997958|NCT03577574|Anesthetics|anesthetics|mesh-list
56997959|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56997960|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997961|NCT01130519|Bevacizumab|bevacizumab|mesh-list
56997962|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56997963|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56997964|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56997965|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56997966|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56997967|NCT01130519|Growth Substances|growth substances|mesh-ancestor
56997968|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997969|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
56997970|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56997971|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56997972|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997973|NCT01330901|Ustekinumab|ustekinumab|mesh-list
56997974|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56997975|NCT02428647|Zinc|zinc|mesh-list
56997976|NCT02428647|Trace Elements|trace elements|mesh-ancestor
56997977|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
56997978|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997979|NCT01071395|Amantadine|amantadine|mesh-list
56997980|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56997981|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56997982|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
56997983|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56997984|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
56997985|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56997986|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56997987|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997988|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56997989|NCT01071395|Analgesics|analgesics|mesh-ancestor
56997990|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
56997991|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56997992|NCT00335816|Leucovorin|leucovorin|mesh-list
56997993|NCT00335816|Fluorouracil|fluorouracil|mesh-list
56997994|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
56997995|NCT00335816|Calcium|calcium|mesh-list
56997996|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
56997997|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56997998|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56997999|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
56998000|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998001|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56998002|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998003|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998004|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
56998005|NCT00335816|Antidotes|antidotes|mesh-ancestor
56998006|NCT00335816|Protective Agents|protective agents|mesh-ancestor
56998007|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
56998008|NCT00335816|Vitamins|vitamins|mesh-ancestor
56998009|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
56998010|NCT03577496|Peppermint oil|peppermint oil|mesh-list
56998011|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
56998012|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
56998013|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998014|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998015|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998016|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
56998017|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
56998018|NCT03582878|Sirolimus|sirolimus|mesh-list
56998019|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56998020|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998021|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56998022|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
56998023|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56998024|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998025|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998026|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998027|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
56998028|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998029|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
56998030|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998031|NCT05763693|Azithromycin|azithromycin|mesh-list
56998032|NCT05763693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56998033|NCT05763693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680187|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
56998034|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
56998035|NCT02238704|Iron|iron|mesh-list
56998036|NCT02238704|Folic Acid|folic acid|mesh-list
56998037|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
56998038|NCT02238704|Calcium|calcium|mesh-list
56998039|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56998040|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998041|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56998042|NCT02238704|Trace Elements|trace elements|mesh-ancestor
56998043|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
56998044|NCT02238704|Hematinics|hematinics|mesh-ancestor
56998045|NCT02238704|Vitamins|vitamins|mesh-ancestor
56998046|NCT01331135|Sirolimus|sirolimus|mesh-list
56998047|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56998048|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998049|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56998050|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998051|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
56998052|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998053|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
56998054|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998055|NCT03577184|Metformin|metformin|mesh-list
56998056|NCT03577184|Vildagliptin|vildagliptin|mesh-list
56998057|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56998058|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998059|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56998060|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
56998061|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998062|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998063|NCT02849171|Choline|choline|mesh-list
56998064|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
56998065|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56998066|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
56998067|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998068|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998069|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56998070|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
56998071|NCT02238860|Tenofovir|tenofovir|mesh-list
56998072|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
56998073|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998074|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56998075|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56998076|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998077|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998078|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56998079|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56998080|NCT01333709|Folfirinox|folfirinox|mesh-list
56998081|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998082|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
56998083|NCT04869137|Lenvatinib|lenvatinib|mesh-list
56998084|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56998085|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998086|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56998087|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998088|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998089|NCT00364637|Anesthetics|anesthetics|mesh-list
56998090|NCT00364637|Sevoflurane|sevoflurane|mesh-list
56998091|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998092|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998093|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56998094|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56998095|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
56998096|NCT00493961|Hormones|hormones|mesh-list
56998097|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998098|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998099|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56998100|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56998101|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56998102|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56998103|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998104|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998105|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998106|NCT02903238|Analgesics|analgesics|mesh-ancestor
56998107|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
56998108|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998109|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
56998110|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56998111|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
56998112|NCT01329809|Molgramostim|molgramostim|mesh-list
56998113|NCT01329809|Sargramostim|sargramostim|mesh-list
56998114|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
56998115|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998116|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998117|NCT02847260|Treprostinil|treprostinil|mesh-list
56998118|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56998119|NCT01331447|Exemestane|exemestane|mesh-list
56998120|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998121|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56998122|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56998123|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998124|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998125|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56998126|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
56998127|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998128|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998129|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
56998130|NCT02968563|Idelalisib|idelalisib|mesh-list
56998131|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56998132|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998133|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998134|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998135|NCT01329887|Ketanserin|ketanserin|mesh-list
56998136|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56998137|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56998138|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56998139|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
56998140|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998141|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998142|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998143|NCT01334099|Tremelimumab|tremelimumab|mesh-list
56998144|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998145|NCT01331525|Ipilimumab|ipilimumab|mesh-list
56998146|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56998147|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998148|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56998149|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998150|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56998151|NCT01334177|Cetuximab|cetuximab|mesh-list
56998152|NCT01334177|Antibodies|antibodies|mesh-list
56998153|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
56998154|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56998155|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
56998156|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998157|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998158|NCT04098393|Fludarabine|fludarabine|mesh-list
56998159|NCT04098393|Melphalan|melphalan|mesh-list
56998160|NCT04098393|Busulfan|busulfan|mesh-list
56998161|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56998162|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998163|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998164|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998165|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
56998166|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998167|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56998168|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
56998169|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56998170|NCT03649230|Palonosetron|palonosetron|mesh-list
56998171|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
56998172|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
56998173|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998174|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998175|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998176|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56998177|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56998178|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
56998179|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998180|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998181|NCT05762523|Vaccines|vaccines|mesh-list
56998182|NCT05762523|Immunologic Factors|immunologic factors|mesh-ancestor
56998183|NCT05762523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998184|NCT02796261|Eflornithine|eflornithine|mesh-list
56998185|NCT02796261|Lomustine|lomustine|mesh-list
56998186|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56998188|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998189|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998190|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56998191|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56998192|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56998193|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998194|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56998195|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998196|NCT02904096|Lidocaine|lidocaine|mesh-list
56998197|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
56998198|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
56998199|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998200|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998201|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
56998202|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998203|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56998204|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56998205|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56998206|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56998207|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998208|NCT04079712|Nivolumab|nivolumab|mesh-list
56998209|NCT04079712|Ipilimumab|ipilimumab|mesh-list
56998210|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56998211|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998212|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56998213|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998214|NCT02586675|Tamoxifen|tamoxifen|mesh-list
56998215|NCT02586675|Goserelin|goserelin|mesh-list
56998216|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56998217|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
56998218|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56894828|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
56998219|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998220|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56998221|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998222|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56998223|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56998224|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56998225|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
56998226|NCT03648528|Vitamin D|vitamin d|mesh-list
56998227|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56998228|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998229|NCT03648528|Vitamins|vitamins|mesh-ancestor
56998230|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
56998231|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56998232|NCT03161405|Itraconazole|itraconazole|mesh-list
56998233|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998234|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998235|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
56998236|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998237|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56998238|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56998239|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56998240|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
56998241|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998242|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998243|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56998244|NCT01813929|Metformin|metformin|mesh-list
56998245|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56998246|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998247|NCT01502085|Dexamethasone|dexamethasone|mesh-list
56998248|NCT01502085|Vorinostat|vorinostat|mesh-list
56998249|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998250|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
56998251|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
56998252|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998253|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998254|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998255|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
56998256|NCT01502085|Hormones|hormones|mesh-ancestor
56998257|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56680405|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56998258|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56998259|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998260|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56998261|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998262|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998264|NCT04052880|Lenalidomide|lenalidomide|mesh-list
56998265|NCT04052880|Bortezomib|bortezomib|mesh-list
56998266|NCT04052880|Daratumumab|daratumumab|mesh-list
56998267|NCT04052880|Ixazomib|ixazomib|mesh-list
56998268|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998269|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
56998270|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
56998271|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998272|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998273|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998274|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
56998275|NCT04052880|Hormones|hormones|mesh-ancestor
56998276|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998277|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56998278|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998279|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
56998280|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56998281|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56998282|NCT04052880|Growth Substances|growth substances|mesh-ancestor
56998283|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
56998284|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
56998285|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998286|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998287|NCT03648684|Caffeine|caffeine|mesh-list
56998288|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56998289|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998290|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56998291|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894829|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
56998292|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998293|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56998294|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56998295|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
56998296|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998297|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56998298|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56998299|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998300|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998301|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56998302|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56998303|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998304|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
56998305|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998306|NCT02901054|Ondansetron|ondansetron|mesh-list
56998307|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
56998308|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
56998309|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998310|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998311|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998312|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
56998313|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
56998314|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56998315|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
56998316|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998317|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998318|NCT02901054|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56998319|NCT02901054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56998320|NCT02901054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998321|NCT02901054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56998322|NCT02901054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56998323|NCT03647670|Midazolam|midazolam|mesh-list
56998324|NCT03647670|Abrocitinib|abrocitinib|mesh-list
56998325|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56998326|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56998327|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998328|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998329|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56998330|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56998331|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56998332|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56998333|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
56998335|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
56998336|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
56998337|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998338|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998339|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56998340|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998341|NCT02966340|Prazosin|prazosin|mesh-list
56998342|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56998343|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56998344|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56998345|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56998346|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
56998347|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998348|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998349|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998350|NCT05284734|Anesthetics|anesthetics|mesh-list
56998351|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998352|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998353|NCT05170893|Ubiquinone|ubiquinone|mesh-list
56998354|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
56998355|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
56998356|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998357|NCT05170893|Vitamins|vitamins|mesh-ancestor
56998358|NCT05761041|Listerine|listerine|mesh-list
56998359|NCT05761041|Fluorides|fluorides|mesh-list
56998360|NCT05761041|Sodium Fluoride|sodium fluoride|mesh-list
56998361|NCT05761041|Fluorides, Topical|fluorides, topical|mesh-list
56998362|NCT05761041|Cariostatic Agents|cariostatic agents|mesh-ancestor
56998363|NCT05761041|Protective Agents|protective agents|mesh-ancestor
56998364|NCT05761041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998365|NCT05761041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56998366|NCT05761041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998367|NCT03629379|Ustekinumab|ustekinumab|mesh-list
56998368|NCT03629379|Vedolizumab|vedolizumab|mesh-list
56998369|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
56998370|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998371|NCT05055999|Atezolizumab|atezolizumab|mesh-list
56998372|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998373|NCT05205837|Letrozole|letrozole|mesh-list
56998374|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998375|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56998376|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56998377|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998378|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998379|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56998380|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
56998381|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998382|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998383|NCT05205603|Mesalamine|mesalamine|mesh-list
56998384|NCT05205603|Infliximab|infliximab|mesh-list
56998385|NCT05205603|Vedolizumab|vedolizumab|mesh-list
56998386|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
56998387|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998388|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56998389|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56998390|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56998391|NCT05205603|Analgesics|analgesics|mesh-ancestor
56998392|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
56998393|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998394|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998395|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998396|NCT03578900|Citric Acid|citric acid|mesh-list
56998397|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
56998398|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
56998399|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56998400|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
56998401|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
56998402|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998403|NCT02550002|Aflibercept|aflibercept|mesh-list
56998404|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56998405|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56998406|NCT02550002|Growth Substances|growth substances|mesh-ancestor
56998407|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998408|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
56998410|NCT03574376|Bupivacaine|bupivacaine|mesh-list
56998411|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
56998412|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
56998413|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998414|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998415|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
56998416|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998417|NCT03576794|Prednisolone|prednisolone|mesh-list
56998418|NCT03576794|Leflunomide|leflunomide|mesh-list
56998419|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998420|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
56998421|NCT03576794|Hormones|hormones|mesh-ancestor
56998422|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998423|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998424|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56998425|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998426|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998427|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998428|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998429|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
56998430|NCT03578822|Aspirin|aspirin|mesh-list
56998431|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56998432|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56998433|NCT03578822|Analgesics|analgesics|mesh-ancestor
56998434|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
56998435|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998436|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998437|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998438|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56998439|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56998440|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56998441|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894830|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56998442|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56998443|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56998444|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998445|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
56998446|NCT03576638|Levodopa|levodopa|mesh-list
56998447|NCT03576638|Carbidopa|carbidopa|mesh-list
56998448|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56998449|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56998450|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56998451|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
56998452|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998453|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998454|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998455|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56998456|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998457|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56998458|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
56998459|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
56998460|NCT04284657|Citric Acid|citric acid|mesh-list
56998461|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
56998462|NCT04284657|Pravastatin|pravastatin|mesh-list
56998463|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
56998464|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56998465|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
56998466|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
56998467|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998468|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56998469|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56998470|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
56998471|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56998472|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56998473|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998474|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56998475|NCT01569945|Clomiphene|clomiphene|mesh-list
56998476|NCT01569945|Menotropins|menotropins|mesh-list
56998477|NCT01569945|Estradiol|estradiol|mesh-list
56998478|NCT01569945|Estrogens|estrogens|mesh-ancestor
56998479|NCT01569945|Hormones|hormones|mesh-ancestor
56998480|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998481|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998482|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56998483|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
56998484|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56998485|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56998486|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56998487|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56998488|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56998489|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
56998490|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56998491|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
56998492|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56998493|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56998494|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
56998495|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56998496|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998497|NCT04876677|Beclomethasone|beclomethasone|mesh-list
56998498|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
56998499|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
56998500|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56998501|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
56998502|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998503|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998504|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56998505|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
56998506|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56998507|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56998508|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56998509|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
56998510|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998511|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998512|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998513|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
56998515|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998516|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56998517|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56998518|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56998519|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
56998520|NCT03578432|Everolimus|everolimus|mesh-list
56998521|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998522|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998523|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
56998524|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998525|NCT03578354|Atenolol|atenolol|mesh-list
56998526|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
56998527|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56998528|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56998529|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
56998530|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
56998531|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998532|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998533|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56998534|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56998535|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56998536|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
56998537|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998538|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998539|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56998540|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56998541|NCT05204979|Misoprostol|misoprostol|mesh-list
56998542|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56998543|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
56998544|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56998545|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998546|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56998547|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998548|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
56998549|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56998550|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998551|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56998552|NCT02239952|Sunitinib|sunitinib|mesh-list
56998553|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998554|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56998555|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998556|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998557|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56998558|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56998559|NCT02239952|Growth Substances|growth substances|mesh-ancestor
56998560|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998561|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
56998562|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56998563|NCT03647280|Epirubicin|epirubicin|mesh-list
56998564|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998565|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998566|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56998567|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56998568|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56998569|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998570|NCT04716699|Lidocaine|lidocaine|mesh-list
56998571|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
56998572|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
56998573|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998574|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998575|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
56998576|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998577|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56998578|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56998579|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56998580|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56998581|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998582|NCT03578042|Losartan|losartan|mesh-list
56998583|NCT03578042|Amlodipine|amlodipine|mesh-list
56998584|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56998585|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56998586|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56998587|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56998588|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894831|NCT01148277|Narcotics|narcotics|mesh-ancestor
56998589|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56998590|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998591|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
56998592|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56998593|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56998594|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56998595|NCT03578042|Diuretics|diuretics|mesh-ancestor
56998596|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
56998597|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56998598|NCT03646500|Remifentanil|remifentanil|mesh-list
56998599|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56998600|NCT03646500|Narcotics|narcotics|mesh-ancestor
56998601|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998602|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998603|NCT03646500|Analgesics|analgesics|mesh-ancestor
56998604|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
56998605|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998606|NCT03574064|Glucagon|glucagon|mesh-list
56998607|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56998608|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56998609|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56998610|NCT03574064|Hormones|hormones|mesh-ancestor
56998611|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998612|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998613|NCT03574064|Incretins|incretins|mesh-ancestor
56998614|NCT03573986|Bevacizumab|bevacizumab|mesh-list
56998615|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56998616|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998617|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56998618|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56998619|NCT03573986|Growth Substances|growth substances|mesh-ancestor
56998620|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998621|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
56998622|NCT03959592|Carotenoids|carotenoids|mesh-list
56998623|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
56998624|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998625|NCT03959592|Protective Agents|protective agents|mesh-ancestor
56998626|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998627|NCT04087395|Lidocaine|lidocaine|mesh-list
56998628|NCT04087395|Anesthetics|anesthetics|mesh-list
56998629|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
56998630|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680757|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
56998631|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998632|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
56998633|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998634|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56998635|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56998636|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56998637|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56998638|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998639|NCT03573596|Dasatinib|dasatinib|mesh-list
56998640|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998641|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56998642|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998643|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998644|NCT03621618|Dobutamine|dobutamine|mesh-list
56998645|NCT03621618|Norepinephrine|norepinephrine|mesh-list
56998646|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56998647|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56998648|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
56998649|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998650|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998651|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998652|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
56998653|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
56998654|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998655|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56998656|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56998657|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56998658|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56998659|NCT03621618|Protective Agents|protective agents|mesh-ancestor
56998660|NCT03944304|Paclitaxel|paclitaxel|mesh-list
56998661|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56998662|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998663|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
56998664|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
56998665|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
56998666|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998667|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
56998668|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56998669|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56998670|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
56998671|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998672|NCT04671615|Palbociclib|palbociclib|mesh-list
56998673|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998674|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56998675|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998676|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998677|NCT03645876|Capecitabine|capecitabine|mesh-list
56998678|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
56998679|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56998680|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
56998681|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998682|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998683|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56998684|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998685|NCT02899728|Cisplatin|cisplatin|mesh-list
56998686|NCT02899728|Carboplatin|carboplatin|mesh-list
56998687|NCT02899728|Etoposide|etoposide|mesh-list
56998688|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
56998689|NCT02899728|Olaparib|olaparib|mesh-list
56998690|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
56998691|NCT02899728|Cediranib|cediranib|mesh-list
56998692|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56998693|NCT02899728|Maleic acid|maleic acid|mesh-list
56998694|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998695|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56998696|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56998697|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56998698|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998699|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998700|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
56998701|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
56998702|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
56998703|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
56998704|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
56998705|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56998706|NCT03646266|Bromides|bromides|mesh-list
56998708|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
56998709|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56998710|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56998711|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56998712|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998713|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998714|NCT04052178|Capsaicin|capsaicin|mesh-list
56998715|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
56998716|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56998717|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
56998718|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998719|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998720|NCT03645642|Midodrine|midodrine|mesh-list
56998721|NCT03645642|Diuretics|diuretics|mesh-list
56998722|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
56998723|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998724|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
56998725|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
56998726|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998727|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56998728|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56998729|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56998730|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56998731|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
56998732|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998733|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998734|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56998735|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
56998736|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998737|NCT03768492|Caffeine|caffeine|mesh-list
56998738|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56998739|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998740|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56998741|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998742|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998743|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56998744|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56998745|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
56998746|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998747|NCT01345188|Ranolazine|ranolazine|mesh-list
56998748|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56998749|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56998750|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998751|NCT03852459|Ibuprofen|ibuprofen|mesh-list
56998752|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56998753|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56998754|NCT03852459|Analgesics|analgesics|mesh-ancestor
56998755|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
56998756|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998757|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998758|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998759|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56998760|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56998761|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998762|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998763|NCT03580902|Buprenorphine|buprenorphine|mesh-list
56998764|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56998765|NCT03580902|Naloxone|naloxone|mesh-list
56998766|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56998767|NCT03580902|Narcotics|narcotics|mesh-ancestor
56998768|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998769|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998770|NCT03580902|Analgesics|analgesics|mesh-ancestor
56998771|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
56998772|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998773|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56998774|NCT02896296|Buprenorphine|buprenorphine|mesh-list
56998775|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56998776|NCT02896296|Narcotics|narcotics|mesh-ancestor
56998777|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998778|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998779|NCT02896296|Analgesics|analgesics|mesh-ancestor
56998780|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
56998781|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998782|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56998783|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
56998784|NCT03644706|Diuretics|diuretics|mesh-ancestor
56998785|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
56998786|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998787|NCT03644706|Expectorants|expectorants|mesh-ancestor
56998788|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
56998789|NCT03740919|Insulin|insulin|mesh-list
56998790|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56998791|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
56998792|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
56998793|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56998794|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998795|NCT01335685|Prednisone|prednisone|mesh-list
56998796|NCT01335685|Melphalan|melphalan|mesh-list
56998797|NCT01335685|Ixazomib|ixazomib|mesh-list
56998798|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998799|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
56998800|NCT01335685|Hormones|hormones|mesh-ancestor
56998801|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998802|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998803|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56998804|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998805|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56998806|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
56998807|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998808|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56998809|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998810|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
56998811|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
56998812|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998813|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
56998814|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56998815|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998816|NCT04462965|Temozolomide|temozolomide|mesh-list
56998817|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56998818|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
56998819|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998820|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998821|NCT02962297|Vitamin E|vitamin e|mesh-list
56998822|NCT02962297|Vitamins|vitamins|mesh-ancestor
56998823|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
56998824|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998825|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
56998826|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998827|NCT02962297|Protective Agents|protective agents|mesh-ancestor
56998828|NCT01339663|Aldesleukin|aldesleukin|mesh-list
56998829|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
56998830|NCT01339663|Interleukin-2|interleukin-2|mesh-list
56998831|NCT01339663|Vaccines|vaccines|mesh-list
56998832|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
56998833|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998834|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998835|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56998836|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56998837|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
56998838|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998839|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998840|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56998841|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56998842|NCT01339663|Analgesics|analgesics|mesh-ancestor
56998843|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
56998844|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998845|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56998846|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56998847|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
56998848|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998849|NCT00092599|Ezetimibe|ezetimibe|mesh-list
56998850|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56998851|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56998852|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
56998853|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998854|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56998855|NCT03737565|Tryptophan|tryptophan|mesh-list
56998856|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56998857|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
56998858|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56998859|NCT02889133|Iron|iron|mesh-list
56998860|NCT02889133|Dextrans|dextrans|mesh-list
56998861|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
56998862|NCT02889133|Trace Elements|trace elements|mesh-ancestor
56998863|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
56998864|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998865|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
56998866|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
56998867|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
56998868|NCT02889133|Hematinics|hematinics|mesh-ancestor
56998869|NCT01333423|Roscovitine|roscovitine|mesh-list
56998870|NCT01333423|Doxorubicin|doxorubicin|mesh-list
56998871|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56998872|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56998873|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998874|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56998875|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56998876|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998877|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998878|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
56998879|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998880|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56998881|NCT00092209|Losartan|losartan|mesh-list
56998882|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56998883|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56998884|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56998885|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56998886|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56998887|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998888|NCT00092209|Diuretics|diuretics|mesh-ancestor
56998889|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
56998890|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998891|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56998892|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56998893|NCT01339741|Vitamin D|vitamin d|mesh-list
56998894|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
56998895|NCT01339741|Vitamins|vitamins|mesh-ancestor
56998896|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
56998897|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998898|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56998899|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56998900|NCT00003777|Fluorouracil|fluorouracil|mesh-list
56998901|NCT00003777|Amifostine|amifostine|mesh-list
56998902|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56998903|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
56998904|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998905|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56998906|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998907|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
56998908|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998909|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56998910|NCT00003777|Protective Agents|protective agents|mesh-ancestor
56998911|NCT01339819|Dabigatran|dabigatran|mesh-list
56998912|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
56998913|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
56998914|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56998915|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
56998916|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998917|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998918|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
56998919|NCT02963922|Liraglutide|liraglutide|mesh-list
56998920|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56998921|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998922|NCT02963922|Incretins|incretins|mesh-ancestor
56998923|NCT02963922|Hormones|hormones|mesh-ancestor
56998924|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56998925|NCT00090181|Diclofenac|diclofenac|mesh-list
56998926|NCT00090181|Etoricoxib|etoricoxib|mesh-list
56998927|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56998928|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56998929|NCT00090181|Analgesics|analgesics|mesh-ancestor
56998930|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
56998931|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998932|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998933|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998934|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56998935|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56998936|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998937|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998938|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56998940|NCT03619785|Ibuprofen|ibuprofen|mesh-list
56998941|NCT03619785|Ketorolac|ketorolac|mesh-list
56998942|NCT03619785|Fentanyl|fentanyl|mesh-list
56998943|NCT03619785|Ketamine|ketamine|mesh-list
56998944|NCT03619785|Morphine|morphine|mesh-list
56998945|NCT03619785|Gabapentin|gabapentin|mesh-list
56998946|NCT03619785|Hydromorphone|hydromorphone|mesh-list
56998947|NCT03619785|Hydrocodone|hydrocodone|mesh-list
56998948|NCT03619785|Bupivacaine|bupivacaine|mesh-list
56998949|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
56998950|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
56998951|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56998952|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998953|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
56998954|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56998955|NCT03619785|Analgesics|analgesics|mesh-ancestor
56998956|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56998957|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56998958|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
56998959|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56998960|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56998961|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56998962|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998963|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56998964|NCT03619785|Narcotics|narcotics|mesh-ancestor
56998965|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56998966|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56998967|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
56998968|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56998969|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56998970|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56998971|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56998972|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998973|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
56998974|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56998975|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56998976|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56998977|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
56998978|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
56998979|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
56998980|NCT02881567|Daclizumab|daclizumab|mesh-list
56998981|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998982|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
56998983|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998984|NCT05184517|Cyclosporine|cyclosporine|mesh-list
56998985|NCT05184517|Cyclosporins|cyclosporins|mesh-list
56998986|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56998987|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56998988|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56998989|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
56998990|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56998991|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
56998992|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56998993|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
56998994|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56998995|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56998996|NCT03642990|Niacinamide|niacinamide|mesh-list
56998997|NCT03642990|Niacin|niacin|mesh-list
56998998|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
56998999|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
56999000|NCT03642990|Vitamins|vitamins|mesh-ancestor
56999001|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
56999002|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999003|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56999004|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
56999005|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999006|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56999007|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
56999008|NCT03184155|Nicardipine|nicardipine|mesh-list
56999009|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56999010|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56999011|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56999012|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999013|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56999014|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999015|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
56999016|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
56999017|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56999018|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56999020|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
56999021|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
56999022|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56999023|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
56999024|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999025|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
56999026|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
56999027|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999028|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999029|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56999030|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
56999031|NCT02962284|Hormones|hormones|mesh-ancestor
56999032|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56999033|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56999034|NCT02962284|Protective Agents|protective agents|mesh-ancestor
56999035|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56999036|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999037|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56999038|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999039|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999040|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
56999041|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56999042|NCT03642600|Folic Acid|folic acid|mesh-list
56999043|NCT03642600|Inositol|inositol|mesh-list
56999044|NCT03642600|Liraglutide|liraglutide|mesh-list
56999045|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56999046|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999047|NCT03642600|Incretins|incretins|mesh-ancestor
56999048|NCT03642600|Hormones|hormones|mesh-ancestor
56999049|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56999050|NCT03642600|Hematinics|hematinics|mesh-ancestor
56999051|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
56999052|NCT03642600|Vitamins|vitamins|mesh-ancestor
56999053|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
56999054|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
56999055|NCT01069692|Hematinics|hematinics|mesh-ancestor
56999056|NCT05183178|Ticagrelor|ticagrelor|mesh-list
56999057|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56999058|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56999059|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56999060|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56999061|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56999062|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
56999063|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999064|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999065|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999066|NCT00026312|Vitamin A|vitamin a|mesh-list
56999067|NCT00026312|Aldesleukin|aldesleukin|mesh-list
56999068|NCT00026312|Interleukin-2|interleukin-2|mesh-list
56999069|NCT00026312|Tretinoin|tretinoin|mesh-list
56999070|NCT00026312|Dinutuximab|dinutuximab|mesh-list
56999071|NCT00026312|Isotretinoin|isotretinoin|mesh-list
56999072|NCT00026312|Sargramostim|sargramostim|mesh-list
56999073|NCT00026312|Vitamins|vitamins|mesh-ancestor
56999074|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
56999075|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999076|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999077|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56999078|NCT00026312|Analgesics|analgesics|mesh-ancestor
56999079|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
56999080|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999081|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
56999082|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56999083|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56999084|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
56999085|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999086|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
56999087|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56999088|NCT03161093|Naproxen|naproxen|mesh-list
56999089|NCT03161093|Fasinumab|fasinumab|mesh-list
56999090|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56999091|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56999092|NCT03161093|Analgesics|analgesics|mesh-ancestor
56999093|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
56999094|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999095|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999096|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999097|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56999098|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
56999099|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56999100|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999101|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999102|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
56999103|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56999104|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
56999105|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999106|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999107|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56999108|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
56999109|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56999110|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
56999111|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999112|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999113|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56999114|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
56999115|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
56999116|NCT03573284|Protective Agents|protective agents|mesh-ancestor
56999117|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
56999118|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999119|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999120|NCT01334333|Tacrolimus|tacrolimus|mesh-list
56999121|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999122|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
56999123|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999124|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56999125|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999126|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999127|NCT03573050|Rivastigmine|rivastigmine|mesh-list
56999128|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56999129|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999130|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999131|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
56999132|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999133|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999134|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56999135|NCT03573050|Protective Agents|protective agents|mesh-ancestor
56999136|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
56999137|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56999138|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999139|NCT02847494|Dexamethasone|dexamethasone|mesh-list
56999140|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
56999141|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56999142|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56999143|NCT02847494|Prednisolone|prednisolone|mesh-list
56999144|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
56999145|NCT02847494|Metoclopramide|metoclopramide|mesh-list
56999146|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56999147|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
56999148|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999149|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
56999150|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
56999151|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999152|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999153|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56999154|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
56999155|NCT02847494|Hormones|hormones|mesh-ancestor
56999156|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56999157|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56999158|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999159|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56999160|NCT02847494|Protective Agents|protective agents|mesh-ancestor
56999161|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56999162|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56681262|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
56999163|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
56999164|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999165|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999166|NCT02554253|Ketamine|ketamine|mesh-list
56999167|NCT02554253|Propofol|propofol|mesh-list
56999168|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56999169|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56999170|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999171|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56999172|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
56999173|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
56999174|NCT02554253|Analgesics|analgesics|mesh-ancestor
56999175|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
56999176|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999177|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56999178|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56999179|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56999180|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999181|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999182|NCT02239484|Tadalafil|tadalafil|mesh-list
56999183|NCT02239484|Tamsulosin|tamsulosin|mesh-list
56999184|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
56999185|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56999186|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56999187|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999188|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999189|NCT02239484|Urological Agents|urological agents|mesh-ancestor
56999190|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56999191|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56999192|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56999193|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
56999194|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999195|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999196|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
56999197|NCT03575234|Nivolumab|nivolumab|mesh-list
56999198|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999199|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
56999200|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999201|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56999202|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56999203|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
56999204|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999205|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999206|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56999207|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56999208|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56999209|NCT04508855|Heparin|heparin|mesh-list
56999210|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56999211|NCT04508855|Tinzaparin|tinzaparin|mesh-list
56999212|NCT04508855|Dalteparin|dalteparin|mesh-list
56999213|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
56999214|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56999215|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56999216|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999217|NCT03575078|Olaparib|olaparib|mesh-list
56999218|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56999219|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999220|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999221|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999222|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
56999223|NCT03157583|Glycerol|glycerol|mesh-list
56999224|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56999225|NCT03157583|Protective Agents|protective agents|mesh-ancestor
56999226|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999227|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56999228|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56999229|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
56999230|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56999231|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56999232|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999233|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
56999234|NCT03570710|Coagulants|coagulants|mesh-ancestor
56999235|NCT01337765|Dactolisib|dactolisib|mesh-list
56999236|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999237|NCT01307033|Losartan|losartan|mesh-list
56999238|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56999239|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56999240|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56999241|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56999242|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999243|NCT04475705|Propofol|propofol|mesh-list
56999244|NCT04475705|Sevoflurane|sevoflurane|mesh-list
56999245|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56999246|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56999247|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999248|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56999249|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
56999250|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
56999251|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56999252|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56999253|NCT03158311|Fluticasone|fluticasone|mesh-list
56999254|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
56999255|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56999256|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999257|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56999258|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
56999259|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999260|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999261|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56999262|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
56999263|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
56999264|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56999265|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
56999266|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56999267|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
56999268|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999269|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999270|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56999271|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56999272|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56999273|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
56999274|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56999275|NCT02244866|Hormones|hormones|mesh-ancestor
56999276|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56999277|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999278|NCT01334567|Tenofovir|tenofovir|mesh-list
56999279|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
56999280|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999281|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56999282|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56999283|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999284|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999285|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56999286|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56999287|NCT04398329|Bupivacaine|bupivacaine|mesh-list
56999288|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
56999289|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
56999290|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56999291|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999292|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
56999293|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999294|NCT00449111|Losartan|losartan|mesh-list
56999295|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56999296|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56999297|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56999298|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56999299|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999300|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
56999301|NCT03568916|Apixaban|apixaban|mesh-list
56999302|NCT03568916|Dabigatran|dabigatran|mesh-list
56999303|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56999304|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
56999305|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56999306|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
56999307|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999308|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999309|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
56999310|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
56999311|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
56999312|NCT01334645|Coagulants|coagulants|mesh-ancestor
56999313|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56681395|NCT00670553|Panobinostat|panobinostat|mesh-list
56999314|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56999315|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
56999316|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999317|NCT03571490|Ropivacaine|ropivacaine|mesh-list
56999318|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
56999319|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
56999320|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56999321|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999322|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
56999323|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999324|NCT01331993|Naproxen|naproxen|mesh-list
56999325|NCT01331993|Esomeprazole|esomeprazole|mesh-list
56999326|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56999327|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56999328|NCT01331993|Analgesics|analgesics|mesh-ancestor
56999329|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
56999330|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999331|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999332|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999333|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56999334|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
56999335|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56999336|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999337|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999338|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56999339|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56999340|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56999341|NCT01338077|Omeprazole|omeprazole|mesh-list
56999342|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56999343|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56999344|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56999345|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999346|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999347|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
56999348|NCT03570320|Narcotics|narcotics|mesh-ancestor
56999349|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56999350|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999351|NCT03570320|Analgesics|analgesics|mesh-ancestor
56999352|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
56999353|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999354|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
56999355|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56999356|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56999357|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999358|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56999359|NCT04266665|Analgesics|analgesics|mesh-ancestor
56999360|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
56999361|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999362|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56999363|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56999364|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56999365|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
56999366|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999367|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999368|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
56999369|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56999370|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56999371|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999372|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
56999373|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
56999374|NCT01338311|Albuterol|albuterol|mesh-list
56999375|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56999376|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
56999377|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999378|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999379|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56999380|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
56999381|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
56999382|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56999383|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56999384|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56999385|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56999386|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
56999387|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999388|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999389|NCT01334879|Ranibizumab|ranibizumab|mesh-list
56999390|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56999391|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56999392|NCT01334879|Growth Substances|growth substances|mesh-ancestor
56999393|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999394|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
56999395|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999396|NCT01315795|Lanreotide|lanreotide|mesh-list
56999397|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999398|NCT03570164|Sevoflurane|sevoflurane|mesh-list
56999399|NCT03570164|Desflurane|desflurane|mesh-list
56999400|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56999401|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56999402|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
56999403|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
56999404|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56999405|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999406|NCT01315951|Petrolatum|petrolatum|mesh-list
56999407|NCT01315951|Emollients|emollients|mesh-ancestor
56999408|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
56999409|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
56999410|NCT05184049|Epalrestat|epalrestat|mesh-list
56999411|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
56999412|NCT05184049|Vitamins|vitamins|mesh-ancestor
56999413|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
56999414|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999415|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999416|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999417|NCT01336543|Gemcitabine|gemcitabine|mesh-list
56999418|NCT01336543|Cisplatin|cisplatin|mesh-list
56999419|NCT01336543|Etoposide|etoposide|mesh-list
56999420|NCT01336543|Pemetrexed|pemetrexed|mesh-list
56999421|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999422|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56999423|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
56999424|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999425|NCT01336543|Antiviral Agents|antiviral agents|mesh-ancestor
56999426|NCT01336543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999427|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999428|NCT01336543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999429|NCT01336543|Immunologic Factors|immunologic factors|mesh-ancestor
56999430|NCT01336543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999431|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56999432|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56999433|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56999434|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56999435|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56999436|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56999437|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
56999438|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999439|NCT01336621|Ezogabine|ezogabine|mesh-list
56999440|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
56999441|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56999442|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999443|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
56999444|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
56999445|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56999446|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
56999447|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999448|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999449|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56999450|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
56999451|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56999452|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56999453|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56999454|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
56999455|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999456|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999457|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999458|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
56999459|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56999460|NCT01340521|Clomiphene|clomiphene|mesh-list
56999461|NCT01340521|Enclomiphene|enclomiphene|mesh-list
56999462|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
56999463|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56999464|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
56999465|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56999466|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999467|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56999468|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
56999469|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56999470|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56999471|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56999472|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56999473|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
56999474|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999475|NCT01340599|Protective Agents|protective agents|mesh-ancestor
56999476|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999477|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56999478|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56999479|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999480|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56999481|NCT01335035|Deferasirox|deferasirox|mesh-list
56999482|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56999483|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
56999484|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
56999485|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999486|NCT01340677|Canagliflozin|canagliflozin|mesh-list
56999487|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56999488|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999489|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56999490|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999491|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
56999492|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56999493|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56999494|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
56999495|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999496|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56999497|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
56999498|NCT01340833|Dabrafenib|dabrafenib|mesh-list
56999499|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999500|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56999501|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999502|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999503|NCT01332383|Naratriptan|naratriptan|mesh-list
56999504|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56999505|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56999506|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56999507|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
56999508|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999509|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999510|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999511|NCT01342237|Carboplatin|carboplatin|mesh-list
56999512|NCT01342237|Etoposide|etoposide|mesh-list
56999513|NCT01342237|Melphalan|melphalan|mesh-list
56999514|NCT01342237|Topotecan|topotecan|mesh-list
56999515|NCT01342237|Thiotepa|thiotepa|mesh-list
56999516|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999517|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56999518|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56999519|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56999520|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999521|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999522|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56999523|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
56999524|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56999525|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999526|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
56999527|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999528|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56999529|NCT01337323|Fluticasone|fluticasone|mesh-list
56999530|NCT01337323|Xhance|xhance|mesh-list
56999531|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999532|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56999533|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
56999534|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999535|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999536|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56999537|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
56999538|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
56999539|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56999540|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
56999541|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
56999542|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
56999543|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999544|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
56999545|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56999546|NCT04830943|Protective Agents|protective agents|mesh-ancestor
56999547|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999548|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
56999549|NCT04429321|Nivolumab|nivolumab|mesh-list
56999550|NCT04429321|Ipilimumab|ipilimumab|mesh-list
56999551|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56999552|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999553|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56999554|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999555|NCT03067610|Paclitaxel|paclitaxel|mesh-list
56999556|NCT03067610|Cisplatin|cisplatin|mesh-list
56999557|NCT03067610|Carboplatin|carboplatin|mesh-list
56999558|NCT03067610|Cetuximab|cetuximab|mesh-list
56999559|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56999560|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999561|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56999562|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56999563|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56999564|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999565|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56999566|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
56999567|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
56999568|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56999569|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
56999570|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999571|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999572|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56999573|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
56999574|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56999575|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56999576|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56999577|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
56999578|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999579|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999580|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999581|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
56999582|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56999583|NCT05182957|Lenalidomide|lenalidomide|mesh-list
56999584|NCT05182957|Azacitidine|azacitidine|mesh-list
56999585|NCT05182957|Antibodies|antibodies|mesh-list
56999586|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
56999587|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56999588|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
56999589|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999590|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56999591|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56999592|NCT05182957|Growth Substances|growth substances|mesh-ancestor
56999593|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
56999594|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999595|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56999596|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
56999597|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999598|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999599|NCT00092651|Simvastatin|simvastatin|mesh-list
56999600|NCT00092651|Ezetimibe|ezetimibe|mesh-list
56999601|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56999602|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56999603|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56999604|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
56999605|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999606|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56999607|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56999608|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999609|NCT04889599|Docetaxel|docetaxel|mesh-list
56999610|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999611|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
56999612|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
56999613|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
56999614|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999615|NCT01342627|Sorafenib|sorafenib|mesh-list
56999616|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999617|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56999618|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999619|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999620|NCT03160703|Fluorides|fluorides|mesh-list
56999621|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
56999622|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
56999623|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
56999624|NCT03160703|Protective Agents|protective agents|mesh-ancestor
56999625|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999626|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
56999627|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
56999628|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56999629|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56999630|NCT01332617|Prednisolone|prednisolone|mesh-list
56999631|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
56999632|NCT01332617|Diclofenac|diclofenac|mesh-list
56999633|NCT01332617|Bortezomib|bortezomib|mesh-list
56999634|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56999635|NCT01332617|Simvastatin|simvastatin|mesh-list
56999636|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56999637|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
56999638|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999639|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999640|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
56999641|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
56999642|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999643|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999644|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56999645|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
56999646|NCT01332617|Hormones|hormones|mesh-ancestor
56999647|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56999648|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56999649|NCT01332617|Protective Agents|protective agents|mesh-ancestor
56999650|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56999651|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56999652|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56999653|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
56999654|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999655|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56999656|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56999657|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999658|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56999659|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56999660|NCT01332617|Analgesics|analgesics|mesh-ancestor
56999661|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
56999662|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56999663|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56999664|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56999665|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
56999666|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56999667|NCT03569696|Nivolumab|nivolumab|mesh-list
56999668|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56999669|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999670|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56999671|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999672|NCT00092573|Ezetimibe|ezetimibe|mesh-list
56999673|NCT00092573|Fenofibrate|fenofibrate|mesh-list
56999674|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56999675|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56999676|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
56999677|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999678|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56999679|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56999680|NCT01342939|Incretins|incretins|mesh-list
56999681|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56999682|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999683|NCT01342939|Hormones|hormones|mesh-ancestor
56999684|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56999685|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56999686|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
56999687|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681755|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
56999688|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999689|NCT03569540|Glyburide|glyburide|mesh-list
56999690|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56999691|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999692|NCT05708690|Tranexamic Acid|tranexamic acid|mesh-list
56999693|NCT05708690|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56999694|NCT05708690|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56999695|NCT05708690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999696|NCT05708690|Hemostatics|hemostatics|mesh-ancestor
56999697|NCT05708690|Coagulants|coagulants|mesh-ancestor
56999698|NCT04851821|Quercetin|quercetin|mesh-list
56999699|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
56999700|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999701|NCT04851821|Protective Agents|protective agents|mesh-ancestor
56999702|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999703|NCT03379727|Midostaurin|midostaurin|mesh-list
56999704|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999705|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56999706|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999707|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999708|NCT02247128|Aspirin|aspirin|mesh-list
56999709|NCT02247128|Clopidogrel|clopidogrel|mesh-list
56999710|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56999711|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56999712|NCT02247128|Analgesics|analgesics|mesh-ancestor
56999713|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
56999714|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999715|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999716|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999717|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56999718|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56999719|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56999720|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999721|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56999722|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56999723|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999724|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
56999725|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56999726|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56999727|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56999728|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
56999729|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999730|NCT01339481|Abatacept|abatacept|mesh-list
56999731|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56999732|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999733|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999734|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999735|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
56999736|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999737|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56999738|NCT01344031|Fulvestrant|fulvestrant|mesh-list
56999739|NCT01344031|Anastrozole|anastrozole|mesh-list
56999740|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56999741|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999742|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56999743|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56999744|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
56999745|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56999746|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999747|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56999748|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56999749|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999750|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999751|NCT01332929|Bevacizumab|bevacizumab|mesh-list
56999752|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56999753|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999754|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56999755|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56999756|NCT01332929|Growth Substances|growth substances|mesh-ancestor
56999757|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999758|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
56999759|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
56999760|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999761|NCT02247986|Methylphenidate|methylphenidate|mesh-list
56999762|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56999763|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999764|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56999765|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56999766|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56999767|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999768|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
56999769|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999770|NCT03567434|Ethanol|ethanol|mesh-list
56999771|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56999772|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999773|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56999774|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999775|NCT05708534|Abatacept|abatacept|mesh-list
56999776|NCT05708534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56999777|NCT05708534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999778|NCT05708534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999779|NCT05708534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999780|NCT05708534|Immunologic Factors|immunologic factors|mesh-ancestor
56999781|NCT05708534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999782|NCT05708534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56999783|NCT03000374|Leucovorin|leucovorin|mesh-list
56999784|NCT03000374|Fluorouracil|fluorouracil|mesh-list
56999785|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
56999786|NCT03000374|Panitumumab|panitumumab|mesh-list
56999787|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
56999788|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999789|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56999790|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999791|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999792|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
56999793|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999794|NCT03000374|Antidotes|antidotes|mesh-ancestor
56999795|NCT03000374|Protective Agents|protective agents|mesh-ancestor
56999796|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
56999797|NCT03000374|Vitamins|vitamins|mesh-ancestor
56999798|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
56999799|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56999800|NCT03566576|Docetaxel|docetaxel|mesh-list
56999801|NCT03566576|Pemetrexed|pemetrexed|mesh-list
56999802|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999803|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
56999804|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
56999805|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56999806|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999807|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999808|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56999809|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56999810|NCT04377997|Heparin|heparin|mesh-list
56999811|NCT04377997|Calcium heparin|calcium heparin|mesh-list
56999812|NCT04377997|Enoxaparin|enoxaparin|mesh-list
56999813|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56999814|NCT04377997|Tinzaparin|tinzaparin|mesh-list
56999815|NCT04377997|Dalteparin|dalteparin|mesh-list
56999816|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
56999817|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56999818|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56999819|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999820|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
56999821|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56999822|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999823|NCT04758949|Nivolumab|nivolumab|mesh-list
56999824|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56999825|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999826|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56999827|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999828|NCT05099107|Albuterol|albuterol|mesh-list
56999829|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56999830|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
56999831|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999832|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999833|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56999834|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
56681901|NCT02627807|Docetaxel|docetaxel|mesh-list
56999835|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
56999836|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56999837|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56999838|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56999839|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56999840|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
56999841|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999842|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999843|NCT03566030|Tenofovir|tenofovir|mesh-list
56999844|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
56999845|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999846|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56999847|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56999848|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999849|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999850|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56999851|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56999852|NCT01333085|Paclitaxel|paclitaxel|mesh-list
56999853|NCT01333085|Carboplatin|carboplatin|mesh-list
56999854|NCT01333085|Everolimus|everolimus|mesh-list
56999855|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56999856|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999857|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
56999858|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
56999859|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
56999860|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999861|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999862|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
56999863|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999864|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56999865|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56999866|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
56999867|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999868|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999869|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56999870|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
56999871|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56999872|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56999873|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56999874|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
56999875|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999876|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999877|NCT04734535|Thrombin|thrombin|mesh-list
56999878|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56999879|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
56999880|NCT04734535|Coagulants|coagulants|mesh-ancestor
56999881|NCT03565406|Nivolumab|nivolumab|mesh-list
56999882|NCT03565406|Ipilimumab|ipilimumab|mesh-list
56999883|NCT03565406|Mocetinostat|mocetinostat|mesh-list
56999884|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56999885|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999886|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56999887|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999888|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56999889|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999890|NCT04734379|Fasudil|fasudil|mesh-list
56999891|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56999892|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56999893|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999894|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56999895|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999896|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
56999897|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56999898|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999899|NCT01339871|Vorinostat|vorinostat|mesh-list
56999900|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999901|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56999902|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999903|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999904|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
56999905|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56999906|NCT03564704|Cytarabine|cytarabine|mesh-list
56999907|NCT03564704|Dexamethasone|dexamethasone|mesh-list
56999908|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
56999909|NCT03564704|Methotrexate|methotrexate|mesh-list
56999910|NCT03564704|Etoposide|etoposide|mesh-list
56999911|NCT03564704|Vincristine|vincristine|mesh-list
56999912|NCT03564704|Doxorubicin|doxorubicin|mesh-list
56999913|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
56999915|NCT03564704|Pegaspargase|pegaspargase|mesh-list
56999916|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999917|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
56999918|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999919|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56999920|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56999921|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
56999922|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999923|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56999924|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56999925|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56999926|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
56999927|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
56999928|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999929|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56999930|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
56999931|NCT03564704|Hormones|hormones|mesh-ancestor
56999932|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56999933|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56999934|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56999935|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
56999936|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56999937|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56999938|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
56999939|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
56999940|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999941|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56999942|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56999943|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56999944|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56999945|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56999946|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
56999947|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56999948|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
56999949|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
56999950|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
56999951|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56999952|NCT03564548|Morphine|morphine|mesh-list
56999953|NCT03564548|Oxycodone|oxycodone|mesh-list
56999954|NCT03564548|Hydromorphone|hydromorphone|mesh-list
56999955|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56999956|NCT03564548|Narcotics|narcotics|mesh-ancestor
56999957|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56999958|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999959|NCT03564548|Analgesics|analgesics|mesh-ancestor
56999960|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
56999961|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999962|NCT05353010|Tacrolimus|tacrolimus|mesh-list
56999963|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56999964|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
56999965|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999966|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56999967|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999968|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999969|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56999970|NCT05352854|Pilocarpine|pilocarpine|mesh-list
56999971|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56999972|NCT05352854|Miotics|miotics|mesh-ancestor
56999973|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
56999974|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999975|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999976|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56999977|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56999978|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
56999979|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56999980|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999981|NCT01841177|Milrinone|milrinone|mesh-list
56999982|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56999983|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56999984|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
56999985|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56999986|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56999987|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56999988|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56999989|NCT01841177|Protective Agents|protective agents|mesh-ancestor
56999990|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999992|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56999993|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56999994|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56999995|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56999996|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56999997|NCT03150589|Ranibizumab|ranibizumab|mesh-list
56999998|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56895935|NCT01155765|Clopidogrel|clopidogrel|mesh-list
56999999|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57000000|NCT03150589|Growth Substances|growth substances|mesh-ancestor
57000001|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000002|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
57000003|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000004|NCT05708300|Vaccines|vaccines|mesh-list
57000005|NCT05708300|Immunologic Factors|immunologic factors|mesh-ancestor
57000006|NCT05708300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000007|NCT05340452|Clarithromycin|clarithromycin|mesh-list
57000008|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000009|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000010|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57000011|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000012|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000013|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57000014|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57000015|NCT03145207|Lidocaine|lidocaine|mesh-list
57000016|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
57000017|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
57000018|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000019|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000020|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
57000021|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000022|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57000023|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57000024|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57000025|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000026|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000027|NCT02836652|Aspirin|aspirin|mesh-list
57000028|NCT02836652|Warfarin|warfarin|mesh-list
57000029|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57000030|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57000031|NCT02836652|Analgesics|analgesics|mesh-ancestor
57000032|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
57000033|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000034|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000035|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000036|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000037|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57000038|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57000039|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000040|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57000041|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57000042|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000043|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
57000044|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
57000045|NCT02836496|Prednisone|prednisone|mesh-list
57000046|NCT02836496|Prednisolone|prednisolone|mesh-list
57000047|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000048|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
57000049|NCT02836496|Hormones|hormones|mesh-ancestor
57000050|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57000051|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000052|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57000053|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000054|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
57000055|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57000056|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000057|NCT05250661|Propolis|propolis|mesh-list
57000058|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000059|NCT01345279|Paclitaxel|paclitaxel|mesh-list
57000060|NCT01345279|Topotecan|topotecan|mesh-list
57000061|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57000062|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000063|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
57000064|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
57000065|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
57000066|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000067|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57000068|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57000069|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000071|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57000072|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57000073|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
57000074|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000075|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57000076|NCT01345357|Gemcitabine|gemcitabine|mesh-list
57000077|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000078|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57000079|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
57000080|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000081|NCT01345357|Antiviral Agents|antiviral agents|mesh-ancestor
57000082|NCT01345357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000083|NCT01345357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000084|NCT01345357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57000085|NCT01345357|Immunologic Factors|immunologic factors|mesh-ancestor
57000086|NCT01345357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000087|NCT01333631|Valproic Acid|valproic acid|mesh-list
57000088|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
57000089|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000090|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000091|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
57000092|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000093|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000094|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
57000095|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57000096|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000097|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57000098|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
57000099|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
57000100|NCT04611763|Analgesics|analgesics|mesh-ancestor
57000101|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
57000102|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000103|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000104|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57000105|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57000106|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000107|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000108|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57000109|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000110|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000111|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
57000112|NCT01341782|Calcitriol|calcitriol|mesh-list
57000113|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
57000114|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57000115|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000116|NCT01341782|Vitamins|vitamins|mesh-ancestor
57000117|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
57000118|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57000119|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000120|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
57000121|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57000122|NCT01341782|Protective Agents|protective agents|mesh-ancestor
57000123|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57000124|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000125|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000126|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57000127|NCT02607319|Bemiparin|bemiparin|mesh-list
57000128|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
57000129|NCT02250157|Irinotecan|irinotecan|mesh-list
57000130|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57000131|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57000132|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000133|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000134|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000135|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
57000136|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56682190|NCT04276857|Antidotes|antidotes|mesh-ancestor
57000137|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
57000138|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000139|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
57000140|NCT03564158|Meropenem|meropenem|mesh-list
57000141|NCT03564158|Vaborbactam|vaborbactam|mesh-list
57000142|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000143|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000144|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57000145|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57000146|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000147|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000148|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000149|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57000150|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
57000151|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57000152|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57000153|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57000154|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000155|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000156|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
57000157|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000158|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000159|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57000160|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000161|NCT01345981|Lidocaine|lidocaine|mesh-list
57000162|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
57000163|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
57000164|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000165|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000166|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
57000167|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000168|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57000169|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57000170|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57000171|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000172|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000173|NCT04541797|Empagliflozin|empagliflozin|mesh-list
57000174|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57000175|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000176|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57000177|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000178|NCT00871351|Atorvastatin|atorvastatin|mesh-list
57000179|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57000180|NCT00871351|Ezetimibe|ezetimibe|mesh-list
57000181|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57000182|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57000183|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
57000184|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000185|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57000186|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57000187|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000188|NCT04920331|Erenumab|erenumab|mesh-list
57000189|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57000190|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000191|NCT04920331|Analgesics|analgesics|mesh-ancestor
57000192|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
57000193|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000194|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000195|NCT02745080|Adalimumab|adalimumab|mesh-list
57000196|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000197|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000198|NCT01346137|Meloxicam|meloxicam|mesh-list
57000199|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57000200|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57000201|NCT01346137|Analgesics|analgesics|mesh-ancestor
57000202|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
57000203|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000204|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000205|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000206|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000207|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57000208|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57000210|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000211|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
57000212|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000213|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
57000214|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57000215|NCT00442897|Atorvastatin|atorvastatin|mesh-list
57000216|NCT00442897|Simvastatin|simvastatin|mesh-list
57000217|NCT00442897|Ezetimibe|ezetimibe|mesh-list
57000218|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57000219|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57000220|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
57000221|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000222|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57000223|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57000224|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000225|NCT01346215|Heparin|heparin|mesh-list
57000226|NCT01346215|Calcium heparin|calcium heparin|mesh-list
57000227|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
57000228|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57000229|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57000230|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000231|NCT02834390|Cytarabine|cytarabine|mesh-list
57000232|NCT02834390|Daunorubicin|daunorubicin|mesh-list
57000233|NCT02834390|Idarubicin|idarubicin|mesh-list
57000234|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57000235|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
57000236|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000237|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000238|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
57000239|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000240|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57000241|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
57000242|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000243|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57000244|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57000245|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57000246|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000247|NCT01317433|Doxycycline|doxycycline|mesh-list
57000248|NCT01317433|Cetuximab|cetuximab|mesh-list
57000249|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57000250|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000251|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000252|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000253|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
57000254|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57000255|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57000256|NCT01317511|Caseins|caseins|mesh-list
57000257|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
57000258|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
57000259|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000260|NCT01356602|Triamcinolone|triamcinolone|mesh-list
57000261|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57000262|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57000263|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57000264|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57000265|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000266|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
57000267|NCT01356602|Hormones|hormones|mesh-ancestor
56894832|NCT01148277|Analgesics|analgesics|mesh-ancestor
57000268|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57000269|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000270|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57000271|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
57000272|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000273|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000274|NCT01347853|Ketorolac|ketorolac|mesh-list
57000275|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57000276|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57000277|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57000278|NCT01347853|Analgesics|analgesics|mesh-ancestor
57000279|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
57000280|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682336|NCT00823212|Aspirin|aspirin|mesh-list
57000281|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000282|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000283|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000284|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57000285|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000286|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000287|NCT01346917|Lidocaine|lidocaine|mesh-list
57000288|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
57000289|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
57000290|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000291|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000292|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
57000293|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000294|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57000295|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57000296|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57000297|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000298|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000299|NCT01348009|Cisplatin|cisplatin|mesh-list
57000300|NCT01348009|Capecitabine|capecitabine|mesh-list
57000301|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000302|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57000303|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
57000304|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000305|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
57000306|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000307|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57000308|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000309|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000310|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
57000311|NCT01348243|Lidocaine|lidocaine|mesh-list
57000312|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
57000313|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
57000314|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000315|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000316|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
57000317|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000318|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57000319|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57000320|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57000321|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000322|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000323|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57000324|NCT01348321|Levamisole|levamisole|mesh-list
57000325|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57000326|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
57000327|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000328|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
57000329|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
57000330|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57000331|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000332|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000333|NCT03772951|Clozapine|clozapine|mesh-list
57000334|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57000335|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
57000336|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000337|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000338|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000339|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57000340|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57000341|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000342|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57000343|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
57000344|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
57000345|NCT01343329|Propranolol|propranolol|mesh-list
57000346|NCT01343329|Esmolol|esmolol|mesh-list
57000347|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57000348|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57000349|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
57000350|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000351|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000352|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000353|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57000354|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57000355|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
57000356|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56682409|NCT00840996|Lidocaine|lidocaine|mesh-list
57000357|NCT01317589|Fentanyl|fentanyl|mesh-list
57000358|NCT01317589|Methadone|methadone|mesh-list
57000359|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57000360|NCT01317589|Narcotics|narcotics|mesh-ancestor
57000361|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000362|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000363|NCT01317589|Analgesics|analgesics|mesh-ancestor
57000364|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
57000365|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000366|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57000367|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57000368|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
57000369|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
57000370|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
57000371|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
57000372|NCT02825420|Trabectedin|trabectedin|mesh-list
57000373|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57000374|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
57000375|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000376|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000377|NCT03715153|Bumetanide|bumetanide|mesh-list
57000378|NCT03715153|Diuretics|diuretics|mesh-ancestor
57000379|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
57000380|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000381|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57000382|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000383|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000384|NCT02829944|Ketorolac|ketorolac|mesh-list
57000385|NCT02829944|Ropivacaine|ropivacaine|mesh-list
57000386|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
57000387|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
57000388|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000389|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000390|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
57000391|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000392|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57000393|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57000394|NCT02829944|Analgesics|analgesics|mesh-ancestor
57000395|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000396|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895972|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000397|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57000398|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000399|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000400|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
57000401|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57000402|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000403|NCT05212610|Vaccines|vaccines|mesh-list
57000404|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
57000405|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000406|NCT03563534|Fluorides|fluorides|mesh-list
57000407|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
57000408|NCT03563534|Protective Agents|protective agents|mesh-ancestor
57000409|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000410|NCT03563144|Leucovorin|leucovorin|mesh-list
57000411|NCT03563144|Gemcitabine|gemcitabine|mesh-list
57000412|NCT03563144|Paclitaxel|paclitaxel|mesh-list
57000413|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
57000414|NCT03563144|Bevacizumab|bevacizumab|mesh-list
57000415|NCT03563144|Fluorouracil|fluorouracil|mesh-list
57000416|NCT03563144|Capecitabine|capecitabine|mesh-list
57000417|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
57000418|NCT03563144|Avelumab|avelumab|mesh-list
57000419|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57000420|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000421|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
57000422|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
57000423|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
57000424|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000425|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57000426|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
57000427|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000428|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000429|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57000430|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
56682478|NCT05428306|Analgesics|analgesics|mesh-ancestor
57000431|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57000432|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57000433|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57000434|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57000435|NCT03563144|Growth Substances|growth substances|mesh-ancestor
57000436|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
57000437|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57000438|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
57000439|NCT03563144|Antiviral Agents|antiviral agents|mesh-ancestor
57000440|NCT03563144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000441|NCT03563144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000442|NCT03563144|Antidotes|antidotes|mesh-ancestor
57000443|NCT03563144|Protective Agents|protective agents|mesh-ancestor
57000444|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
57000445|NCT03563144|Vitamins|vitamins|mesh-ancestor
57000446|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
57000447|NCT01338818|Methylphenidate|methylphenidate|mesh-list
57000448|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57000449|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000450|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57000451|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57000452|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000453|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000454|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
57000455|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000456|NCT05310110|Lidocaine|lidocaine|mesh-list
57000457|NCT05310110|Propofol|propofol|mesh-list
57000458|NCT05310110|Cisatracurium|cisatracurium|mesh-list
57000459|NCT05310110|Atracurium|atracurium|mesh-list
57000460|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
57000461|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
57000462|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000463|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000464|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
57000465|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000466|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57000467|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57000468|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57000469|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000470|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000471|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57000472|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57000473|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
57000474|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57000475|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57000476|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57000477|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57000478|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57000479|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
57000480|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000481|NCT02823470|Ivacaftor|ivacaftor|mesh-list
57000482|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57000483|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000484|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000485|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
57000486|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
57000487|NCT05294588|Cefixime|cefixime|mesh-list
57000488|NCT05294588|Vaccines|vaccines|mesh-list
57000489|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
57000490|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000491|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000492|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000493|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57000494|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57000495|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000496|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000497|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000498|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57000499|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57000500|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
57000501|NCT04697576|Nivolumab|nivolumab|mesh-list
57000502|NCT04697576|Ipilimumab|ipilimumab|mesh-list
57000503|NCT04697576|Vaccines|vaccines|mesh-list
57000504|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
57000505|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000506|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57000507|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000508|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57000509|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000510|NCT03562754|Heparin|heparin|mesh-list
57000511|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
57000512|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000513|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57000514|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57000515|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
57000516|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
57000517|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
57000518|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000519|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000520|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
57000521|NCT01371656|Levofloxacin|levofloxacin|mesh-list
57000522|NCT01371656|Ofloxacin|ofloxacin|mesh-list
57000523|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57000524|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000525|NCT01371656|Renal Agents|renal agents|mesh-ancestor
57000526|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000527|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57000528|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57000529|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000530|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000531|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000532|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57000533|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57000534|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57000535|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57000536|NCT01354964|Vitamin D|vitamin d|mesh-list
57000537|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
57000538|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
57000539|NCT01354964|Vitamins|vitamins|mesh-list
57000540|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
57000541|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000542|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57000543|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57000544|NCT02259998|Dipyridamole|dipyridamole|mesh-list
57000545|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57000546|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000547|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000548|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57000549|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
57000550|NCT02035904|Morphine|morphine|mesh-list
57000551|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
57000552|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57000553|NCT02035904|Narcotics|narcotics|mesh-ancestor
57000554|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000555|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000556|NCT02035904|Analgesics|analgesics|mesh-ancestor
57000557|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
57000558|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000559|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
57000560|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
57000561|NCT04110080|Anesthetics|anesthetics|mesh-list
57000562|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000563|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000564|NCT02035982|Rivastigmine|rivastigmine|mesh-list
57000565|NCT02035982|Donepezil|donepezil|mesh-list
57000566|NCT02035982|Galantamine|galantamine|mesh-list
57000567|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
57000568|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000569|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000570|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
57000571|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000572|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000573|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
57000574|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57000575|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
57000576|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000577|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57000578|NCT02035982|Protective Agents|protective agents|mesh-ancestor
57000579|NCT05707832|Amphotericin B|amphotericin b|mesh-list
57000580|NCT05707832|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
57000581|NCT05707832|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
57000582|NCT05707832|Amebicides|amebicides|mesh-ancestor
57000583|NCT05707832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57000584|NCT05707832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57000585|NCT05707832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000586|NCT05707832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000587|NCT05707832|Antifungal Agents|antifungal agents|mesh-ancestor
57000588|NCT05707832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57000589|NCT05707832|Protease Inhibitors|protease inhibitors|mesh-ancestor
57000590|NCT05707832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000591|NCT05707832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000592|NCT05707832|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57000593|NCT05707832|Protective Agents|protective agents|mesh-ancestor
57000594|NCT05707832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000595|NCT05707832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000596|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
57000597|NCT02822222|Cathartics|cathartics|mesh-ancestor
57000598|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57000599|NCT05707754|Bupivacaine|bupivacaine|mesh-list
57000600|NCT05707754|Anesthetics, Local|anesthetics, local|mesh-ancestor
57000601|NCT05707754|Anesthetics|anesthetics|mesh-ancestor
57000602|NCT05707754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000603|NCT05707754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000604|NCT05707754|Sensory System Agents|sensory system agents|mesh-ancestor
57000605|NCT05707754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000606|NCT02821910|Metformin|metformin|mesh-list
57000607|NCT02821910|Empagliflozin|empagliflozin|mesh-list
57000608|NCT02821910|Linagliptin|linagliptin|mesh-list
57000609|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57000610|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000611|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57000612|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000613|NCT02821910|Incretins|incretins|mesh-ancestor
57000614|NCT02821910|Hormones|hormones|mesh-ancestor
57000615|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57000616|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57000617|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
57000618|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000619|NCT03819452|Vitamin D|vitamin d|mesh-list
57000620|NCT03819452|Vitamins|vitamins|mesh-ancestor
57000621|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
57000622|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000623|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57000624|NCT03138655|Vedolizumab|vedolizumab|mesh-list
57000625|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57000626|NCT05707520|Mycophenolic Acid|mycophenolic acid|mesh-list
57000627|NCT05707520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57000628|NCT05707520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000629|NCT05707520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57000630|NCT05707520|Antitubercular Agents|antitubercular agents|mesh-ancestor
57000631|NCT05707520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000632|NCT05707520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000633|NCT05707520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000634|NCT05707520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000635|NCT04412785|Cyclosporine|cyclosporine|mesh-list
57000636|NCT04412785|Cyclosporins|cyclosporins|mesh-list
57000637|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000638|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000639|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57000640|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
57000641|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000642|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
57000643|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000644|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
57000645|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000646|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57000647|NCT01352611|Baclofen|baclofen|mesh-list
57000648|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57000649|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000650|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57000651|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000652|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57000653|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
57000654|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
57000655|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000656|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000657|NCT02819804|Nivolumab|nivolumab|mesh-list
57000658|NCT02819804|Dasatinib|dasatinib|mesh-list
57000659|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57000660|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682709|NCT00679042|Hormones|hormones|mesh-ancestor
57000661|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57000662|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000663|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57000664|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000665|NCT02819726|Rituximab|rituximab|mesh-list
57000666|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57000667|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000668|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
57000669|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000670|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000671|NCT02816138|Nicotine|nicotine|mesh-list
57000672|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57000673|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
57000674|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000675|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000676|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57000677|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57000678|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
57000679|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000680|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000681|NCT02036060|Prednisone|prednisone|mesh-list
57000682|NCT02036060|Docetaxel|docetaxel|mesh-list
57000683|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000684|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
57000685|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
57000686|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
57000687|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000688|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000689|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
57000690|NCT02036060|Hormones|hormones|mesh-ancestor
57000691|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57000692|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000693|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57000694|NCT02036372|Insulin|insulin|mesh-list
57000695|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57000696|NCT02036372|Liraglutide|liraglutide|mesh-list
57000697|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57000698|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000699|NCT02036372|Incretins|incretins|mesh-ancestor
57000700|NCT02036372|Hormones|hormones|mesh-ancestor
57000701|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57000702|NCT02036528|Doxycycline|doxycycline|mesh-list
57000703|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
57000704|NCT02036528|Gentamicins|gentamicins|mesh-list
57000705|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000706|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000707|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
57000708|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57000709|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57000710|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57000711|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57000712|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000713|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000714|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000715|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57000716|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57000717|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57000718|NCT02880865|Vaccines|vaccines|mesh-list
57000719|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
57000720|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000721|NCT03635125|Metoprolol|metoprolol|mesh-list
57000722|NCT03635125|Nebivolol|nebivolol|mesh-list
57000723|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57000724|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57000725|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
57000726|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
57000727|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000728|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000729|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57000730|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57000731|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57000732|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
57000733|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000734|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682774|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57000735|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
57000736|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57000737|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57000738|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57000739|NCT01854385|Sumatriptan|sumatriptan|mesh-list
57000740|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57000741|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57000742|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57000743|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
57000744|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000745|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000746|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000747|NCT02047838|Hormones|hormones|mesh-list
57000748|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57000749|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57000750|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000751|NCT01318681|Fluticasone|fluticasone|mesh-list
57000752|NCT01318681|Xhance|xhance|mesh-list
57000753|NCT01318681|Cetirizine|cetirizine|mesh-list
57000754|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000755|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57000756|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
57000757|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000758|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000759|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57000760|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
57000761|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
57000762|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57000763|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57000764|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57000765|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
57000766|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
57000767|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000768|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000769|NCT03604159|Buprenorphine|buprenorphine|mesh-list
57000770|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
57000771|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57000772|NCT03604159|Narcotics|narcotics|mesh-ancestor
57000773|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000774|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000775|NCT03604159|Analgesics|analgesics|mesh-ancestor
57000776|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
57000777|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000778|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57000779|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57000780|NCT01353235|Prednisolone|prednisolone|mesh-list
57000781|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000782|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
57000783|NCT01353235|Hormones|hormones|mesh-ancestor
57000784|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57000785|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000786|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57000787|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000788|NCT02048228|Clopidogrel|clopidogrel|mesh-list
57000789|NCT02048228|Ticagrelor|ticagrelor|mesh-list
57000790|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57000791|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57000792|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57000793|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57000794|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
57000795|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000796|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000797|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000798|NCT03046927|Vitamin D|vitamin d|mesh-list
57000799|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
57000800|NCT03046927|Vitamins|vitamins|mesh-ancestor
57000801|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
57000802|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000803|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57000804|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57000805|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
57000806|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57000807|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
57000808|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000809|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000810|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57000811|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
57000812|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57000813|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57000814|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57000815|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
57000816|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000817|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000818|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
57000819|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
57000820|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000821|NCT02048384|Metformin|metformin|mesh-list
57000822|NCT02048384|Sirolimus|sirolimus|mesh-list
57000823|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57000824|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000825|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000826|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000827|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57000828|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000829|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
57000830|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57000831|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
57000832|NCT01353391|Metformin|metformin|mesh-list
57000833|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57000834|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000835|NCT01349335|Tolvaptan|tolvaptan|mesh-list
57000836|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57000837|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000838|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
57000839|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000840|NCT03009487|Amlodipine|amlodipine|mesh-list
57000841|NCT03009487|Olmesartan|olmesartan|mesh-list
57000842|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
57000843|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
57000844|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57000845|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57000846|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57000847|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57000848|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000849|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57000850|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000851|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
57000852|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57000853|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57000854|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
57000855|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57000856|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57000857|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000858|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57000859|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57000860|NCT02048540|Bevacizumab|bevacizumab|mesh-list
57000861|NCT02048540|Docetaxel|docetaxel|mesh-list
57000862|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
57000863|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57000864|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000865|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57000866|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57000867|NCT02048540|Growth Substances|growth substances|mesh-ancestor
57000868|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000869|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
57000870|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
57000871|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
57000872|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
57000873|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000874|NCT01353469|Insulin|insulin|mesh-list
57000875|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57000876|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57000877|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000878|NCT03562130|Teduglutide|teduglutide|mesh-list
57000879|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57000880|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57000881|NCT03562130|Protective Agents|protective agents|mesh-ancestor
57000882|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000883|NCT02050178|Gemcitabine|gemcitabine|mesh-list
57000884|NCT02050178|Paclitaxel|paclitaxel|mesh-list
57000885|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57000886|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000887|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
57000888|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
57000889|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
57000890|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000891|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57000892|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
57000893|NCT02050178|Antiviral Agents|antiviral agents|mesh-ancestor
57000894|NCT02050178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000895|NCT02050178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000896|NCT02050178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57000897|NCT02050178|Immunologic Factors|immunologic factors|mesh-ancestor
57000898|NCT02050178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000899|NCT02048852|Menthol|menthol|mesh-list
57000900|NCT02048852|Nicotine|nicotine|mesh-list
57000901|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57000902|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
57000903|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000904|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000905|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57000906|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57000907|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
57000908|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000909|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000910|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
57000911|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
57000912|NCT02048930|Budesonide|budesonide|mesh-list
57000913|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000914|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57000915|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
57000916|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000917|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000918|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57000919|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
57000920|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
57000921|NCT02048930|Hormones|hormones|mesh-ancestor
57000922|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57000923|NCT02049320|Remifentanil|remifentanil|mesh-list
57000924|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57000925|NCT02049320|Narcotics|narcotics|mesh-ancestor
57000926|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57000927|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000928|NCT02049320|Analgesics|analgesics|mesh-ancestor
57000929|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
57000930|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000931|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
57000932|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57000933|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000934|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
57000935|NCT02050802|Macitentan|macitentan|mesh-list
57000936|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57000937|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000938|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57000939|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57000940|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000941|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000942|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000943|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57000944|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57000945|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57000946|NCT02051738|Mebendazole|mebendazole|mesh-list
57000947|NCT02051738|Piperazine|piperazine|mesh-list
57000948|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
57000949|NCT02051738|DMP 777|dmp 777|mesh-list
57000950|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
57000951|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
57000952|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57000953|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57000954|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
57000955|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
57000956|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
57000957|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000958|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57000959|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000960|NCT02050958|Ibuprofen|ibuprofen|mesh-list
57000961|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57000962|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57000963|NCT02050958|Analgesics|analgesics|mesh-ancestor
57000964|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
57000965|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000966|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000967|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57000968|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57000969|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57000970|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57000971|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000972|NCT02037464|Capsaicin|capsaicin|mesh-list
57000973|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
57000974|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
57000975|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
57000976|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000977|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000978|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
57000979|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57000980|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000981|NCT02051894|Dobutamine|dobutamine|mesh-list
57000982|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57000983|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
57000984|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
57000985|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57000986|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000987|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57000988|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57000989|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57000990|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
57000991|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57000992|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000993|NCT02051894|Protective Agents|protective agents|mesh-ancestor
57000994|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
57000995|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
57000996|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57000997|NCT01357681|Protective Agents|protective agents|mesh-ancestor
57000998|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57000999|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
57001000|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57001001|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001002|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57001003|NCT01543633|Propofol|propofol|mesh-list
57001004|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57001005|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001006|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001007|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57001008|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
57001009|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
57001010|NCT03561740|Capecitabine|capecitabine|mesh-list
57001011|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57001012|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
57001013|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001014|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001015|NCT01357759|Gimsilumab|gimsilumab|mesh-list
57001016|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001017|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
57001018|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001019|NCT02052128|Onapristone|onapristone|mesh-list
57001020|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001021|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57001022|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
57001023|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57001024|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001025|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
57001026|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001027|NCT01349413|Esomeprazole|esomeprazole|mesh-list
57001028|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57001029|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57001030|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57001031|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001032|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001033|NCT01349647|Vaccines|vaccines|mesh-list
57001034|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
57001035|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001036|NCT02806232|Praziquantel|praziquantel|mesh-list
57001037|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
57001038|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57001039|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001040|NCT02908087|Liraglutide|liraglutide|mesh-list
57001041|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57001042|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001043|NCT02908087|Incretins|incretins|mesh-ancestor
57001044|NCT02908087|Hormones|hormones|mesh-ancestor
57001045|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001046|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
57001047|NCT02053766|Propofol|propofol|mesh-list
57001048|NCT02053766|Sevoflurane|sevoflurane|mesh-list
57001049|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57001050|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001051|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001052|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57001053|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
57001054|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
57001055|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57001056|NCT02053766|Analgesics|analgesics|mesh-ancestor
57001057|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
57001058|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001059|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57001060|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57001061|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57001062|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
57001063|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001064|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001065|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57001066|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57001067|NCT02053922|Misoprostol|misoprostol|mesh-list
57001068|NCT02053922|Oxytocin|oxytocin|mesh-list
57001069|NCT02053922|Carbetocin|carbetocin|mesh-list
57001070|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57001071|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
57001072|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57001073|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001074|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57001075|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57001076|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
57001077|NCT02054000|Tirofiban|tirofiban|mesh-list
57001078|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57001079|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57001080|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001081|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57001082|NCT02054078|Bevacizumab|bevacizumab|mesh-list
57001083|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57001084|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001085|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57001086|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57001087|NCT02054078|Growth Substances|growth substances|mesh-ancestor
57001088|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001089|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
57001090|NCT00392327|Vitamin A|vitamin a|mesh-list
57001091|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
57001092|NCT00392327|Cisplatin|cisplatin|mesh-list
57001093|NCT00392327|Carboplatin|carboplatin|mesh-list
57001094|NCT00392327|Vincristine|vincristine|mesh-list
57001095|NCT00392327|Tretinoin|tretinoin|mesh-list
57001096|NCT00392327|Isotretinoin|isotretinoin|mesh-list
57001097|NCT00392327|Lenograstim|lenograstim|mesh-list
57001098|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57001099|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
57001100|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001101|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001102|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57001103|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
57001104|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001105|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001106|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57001107|NCT00392327|Vitamins|vitamins|mesh-ancestor
57001108|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
57001109|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57001110|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57001111|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
57001112|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
57001113|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
57001114|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
57001115|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
57001116|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
57001117|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57001118|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57001119|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57001120|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57001121|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001122|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
57001123|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001124|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001125|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57001126|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001127|NCT01336595|Cobalt|cobalt|mesh-list
57001128|NCT01336595|Triamcinolone|triamcinolone|mesh-list
57001129|NCT01336595|Trace Elements|trace elements|mesh-ancestor
57001130|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
57001131|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001132|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001133|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
57001134|NCT01336595|Hormones|hormones|mesh-ancestor
57001135|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001136|NCT01336751|Insulin|insulin|mesh-list
57001137|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57001138|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
57001139|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
57001140|NCT01336751|Protamines|protamines|mesh-list
57001141|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57001142|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001143|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
57001144|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001145|NCT01336751|Coagulants|coagulants|mesh-ancestor
57001146|NCT01336829|Rilpivirine|rilpivirine|mesh-list
57001147|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57001148|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57001149|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001150|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001151|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
57001152|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001153|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57001154|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57001155|NCT02960490|Quetmolimab|quetmolimab|mesh-list
57001156|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001157|NCT05184179|Olmesartan|olmesartan|mesh-list
57001158|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
57001159|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57001160|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57001161|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57001162|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
57001163|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001164|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57001165|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57001166|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001167|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57001168|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57001169|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57001170|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57001171|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
57001172|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001173|NCT01065012|Udenafil|udenafil|mesh-list
57001174|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57001175|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57001176|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001177|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001178|NCT01315691|Amikacin|amikacin|mesh-list
57001179|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57001180|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001181|NCT05654090|Sulbactam|sulbactam|mesh-list
57001182|NCT05654090|Cefoperazone|cefoperazone|mesh-list
57001183|NCT05654090|Sulperazone|sulperazone|mesh-list
57001184|NCT05654090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57001185|NCT05654090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001186|NCT05654090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57001187|NCT05654090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001188|NCT05654090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001189|NCT05654090|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57001190|NCT05654090|Renal Agents|renal agents|mesh-ancestor
57001191|NCT02054468|Remifentanil|remifentanil|mesh-list
57001192|NCT02054468|Propofol|propofol|mesh-list
57001193|NCT02054468|Rocuronium|rocuronium|mesh-list
57001194|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57001195|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001196|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001197|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57001198|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
57001199|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
57001200|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57001201|NCT02054468|Narcotics|narcotics|mesh-ancestor
57001202|NCT02054468|Analgesics|analgesics|mesh-ancestor
57001203|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
57001204|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001205|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57001206|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57001207|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57001208|NCT03640650|Triamcinolone|triamcinolone|mesh-list
57001209|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57001210|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57001211|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57001212|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57001213|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57001214|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
57001215|NCT03640650|Hormones|hormones|mesh-ancestor
57001216|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001217|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001218|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57001219|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
57001220|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001221|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001222|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57001223|NCT05183555|Edotreotide|edotreotide|mesh-list
57001224|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57001225|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001226|NCT02052908|Naproxen|naproxen|mesh-list
57001227|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57001228|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57001229|NCT02052908|Analgesics|analgesics|mesh-ancestor
57001230|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
57001231|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001232|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001233|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001234|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001235|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
57001236|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57001237|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001238|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001239|NCT01336985|Irinotecan|irinotecan|mesh-list
57001240|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57001241|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57001242|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001243|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001244|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001245|NCT01337219|Tobramycin|tobramycin|mesh-list
57001246|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57001247|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001248|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57001249|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
57001250|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
57001251|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001252|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
57001253|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001254|NCT03635411|Niacinamide|niacinamide|mesh-list
57001255|NCT03635411|Niacin|niacin|mesh-list
57001256|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
57001257|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
57001258|NCT03635411|Vitamins|vitamins|mesh-ancestor
57001259|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
57001260|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001261|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57001262|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
57001263|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001264|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57001265|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
57001266|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
57001267|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001268|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
57001269|NCT02748512|Hormones|hormones|mesh-ancestor
57001270|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001271|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001272|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
57001273|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
57001274|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
57001275|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001276|NCT02053142|Acyclovir|acyclovir|mesh-list
57001277|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
57001278|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001279|NCT01316549|Fludarabine|fludarabine|mesh-list
57001280|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001281|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57001282|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
57001283|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001284|NCT01341743|Entecavir|entecavir|mesh-list
57001285|NCT01341743|Adefovir|adefovir|mesh-list
57001286|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
57001287|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
57001288|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001289|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57001290|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57001291|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001292|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001293|NCT01341275|Vaccines|vaccines|mesh-list
57001294|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
57001295|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001296|NCT01353937|Plerixafor|plerixafor|mesh-list
57001297|NCT01353937|Becaplermin|becaplermin|mesh-list
57001298|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57001299|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57001300|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
57001301|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001302|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
57001303|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
57001304|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57001305|NCT01353937|Growth Substances|growth substances|mesh-ancestor
57001306|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001307|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57001308|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57001309|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
57001310|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001311|NCT02053298|Timolol|timolol|mesh-list
57001312|NCT02053298|Dorzolamide|dorzolamide|mesh-list
57001313|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57001314|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57001315|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
57001316|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001317|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001318|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001319|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57001320|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57001321|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57001322|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001323|NCT02054936|Warfarin|warfarin|mesh-list
57001324|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
57001325|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
57001326|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57001327|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
57001328|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57001329|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
57001330|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001331|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001332|NCT04782791|Nivolumab|nivolumab|mesh-list
57001333|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57001334|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001335|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57001336|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001337|NCT01341353|Amiodarone|amiodarone|mesh-list
57001338|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
57001339|NCT01341353|Calcium|calcium|mesh-list
57001340|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57001341|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001342|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57001343|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
57001344|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57001345|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57001346|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001347|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57001348|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57001349|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57001350|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001351|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57001352|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57001353|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57001355|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57001356|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001357|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57001358|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001359|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001360|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57001361|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57001362|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
57001363|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001364|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
57001365|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57001366|NCT02056184|Adalimumab|adalimumab|mesh-list
57001367|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001368|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001369|NCT02800928|Aticaprant|aticaprant|mesh-list
57001370|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57001371|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001372|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
57001373|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001374|NCT02056418|Prednisone|prednisone|mesh-list
57001375|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
57001376|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001377|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
57001378|NCT02056418|Hormones|hormones|mesh-ancestor
57001379|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001380|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001381|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57001382|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001383|NCT02055014|Liraglutide|liraglutide|mesh-list
57001384|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57001385|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001386|NCT02055014|Incretins|incretins|mesh-ancestor
57001387|NCT02055014|Hormones|hormones|mesh-ancestor
57001388|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001389|NCT02055170|Finasteride|finasteride|mesh-list
57001390|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57001391|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57001392|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001393|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001394|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
55896073|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57001395|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001396|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001397|NCT02055170|Urological Agents|urological agents|mesh-ancestor
57001398|NCT04490993|Epirubicin|epirubicin|mesh-list
57001399|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57001400|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001401|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57001402|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57001403|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001404|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001405|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
57001406|NCT02055482|Hematinics|hematinics|mesh-ancestor
57001407|NCT02059460|Terlipressin|terlipressin|mesh-list
57001408|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57001409|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57001410|NCT02055716|Sulforaphane|sulforaphane|mesh-list
57001411|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57001412|NCT02055716|Protective Agents|protective agents|mesh-ancestor
56683459|NCT00820950|Hormones|hormones|mesh-ancestor
57001413|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001414|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001415|NCT04739735|Anesthetics|anesthetics|mesh-list
57001416|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001417|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001418|NCT02059616|Amlodipine|amlodipine|mesh-list
57001419|NCT02059616|Candesartan|candesartan|mesh-list
57001420|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
57001421|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57001422|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57001423|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57001424|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001425|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57001426|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001427|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
57001428|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57001429|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57001430|NCT04356209|Pravastatin|pravastatin|mesh-list
57001431|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57001432|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57001433|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
57001434|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001435|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57001436|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57001437|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001438|NCT02059694|Lidocaine|lidocaine|mesh-list
57001439|NCT02059694|Epinephrine|epinephrine|mesh-list
57001440|NCT02059694|Racepinephrine|racepinephrine|mesh-list
57001441|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
57001442|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
57001443|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
57001444|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001445|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001446|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
57001447|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001448|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57001449|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57001450|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57001451|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57001452|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001453|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57001454|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57001455|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
57001456|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001457|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57001458|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57001459|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
57001460|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57001461|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
57001462|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
57001463|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
57001464|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57001465|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
57001466|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
57001467|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001468|NCT02056730|Calcium|calcium|mesh-list
57001469|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57001470|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001471|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
57001472|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57001473|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001474|NCT03560804|Olmesartan|olmesartan|mesh-list
57001475|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
57001476|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57001477|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57001478|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57001479|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001480|NCT03560804|Diuretics|diuretics|mesh-ancestor
57001481|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
57001482|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001483|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57001484|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56683530|NCT00771394|Tamsulosin|tamsulosin|mesh-list
57001485|NCT03150719|Ivacaftor|ivacaftor|mesh-list
57001486|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57001487|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57001488|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001489|NCT02059772|Ranibizumab|ranibizumab|mesh-list
57001490|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57001491|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57001492|NCT02059772|Growth Substances|growth substances|mesh-ancestor
57001493|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001494|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
57001495|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001496|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
57001497|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57001498|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57001499|NCT01344083|Analgesics|analgesics|mesh-ancestor
57001500|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
57001501|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001502|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001503|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001504|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001505|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57001506|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57001507|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57001508|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
57001509|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
57001510|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001511|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001512|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
57001513|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57001514|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
57001515|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001516|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001517|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57001518|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
57001519|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001520|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001521|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57001522|NCT00982111|Pemetrexed|pemetrexed|mesh-list
57001523|NCT00982111|Necitumumab|necitumumab|mesh-list
57001524|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001525|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001526|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001527|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57001528|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57001529|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57001530|NCT03057951|Empagliflozin|empagliflozin|mesh-list
57001531|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57001532|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001533|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57001534|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001535|NCT02060318|Infliximab|infliximab|mesh-list
57001536|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
57001537|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57001538|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001539|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
57001540|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57001541|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57001542|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
57001543|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001544|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001545|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001546|NCT01318837|Urological Agents|urological agents|mesh-ancestor
57001547|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
57001548|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57001549|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57001550|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001551|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
57001552|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
57001553|NCT01350037|Remifentanil|remifentanil|mesh-list
57001554|NCT01350037|Alfentanil|alfentanil|mesh-list
57001555|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57001556|NCT01350037|Narcotics|narcotics|mesh-ancestor
57001557|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683600|NCT00766480|Fluorouracil|fluorouracil|mesh-list
57001558|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001559|NCT01350037|Analgesics|analgesics|mesh-ancestor
57001560|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
57001561|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001562|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57001563|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
57001564|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
57001565|NCT02060006|Meloxicam|meloxicam|mesh-list
57001566|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
57001567|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57001568|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57001569|NCT02060006|Analgesics|analgesics|mesh-ancestor
57001570|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
57001571|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001572|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001573|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001574|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001575|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57001576|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001577|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001578|NCT03620435|Atezolizumab|atezolizumab|mesh-list
57001579|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001580|NCT03497156|Lercanidipine|lercanidipine|mesh-list
57001581|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57001582|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57001583|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57001584|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001585|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57001586|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001587|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
57001588|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
57001589|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001590|NCT04686773|Vaccines|vaccines|mesh-list
57001591|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
57001592|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001593|NCT02956278|Allopurinol|allopurinol|mesh-list
57001594|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
57001595|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001596|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001597|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
57001598|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001599|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57001600|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
57001601|NCT02956278|Protective Agents|protective agents|mesh-ancestor
57001602|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001603|NCT02060396|Aspirin|aspirin|mesh-list
57001604|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57001605|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57001606|NCT02060396|Analgesics|analgesics|mesh-ancestor
57001607|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
57001608|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001609|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001610|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001611|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001612|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57001613|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57001614|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001615|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57001616|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57001617|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001618|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
57001619|NCT01358071|Doxorubicin|doxorubicin|mesh-list
57001620|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57001621|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57001622|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001623|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57001624|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57001625|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001626|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001627|NCT02058212|Vitamin E|vitamin e|mesh-list
57001628|NCT02058212|Selenium|selenium|mesh-list
57001629|NCT02058212|Vitamins|vitamins|mesh-ancestor
57001630|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
56683675|NCT00668746|Minocycline|minocycline|mesh-list
57001631|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001632|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
57001633|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001634|NCT02058212|Protective Agents|protective agents|mesh-ancestor
57001636|NCT02058446|Amlodipine|amlodipine|mesh-list
57001637|NCT02058446|Valsartan|valsartan|mesh-list
57001638|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
57001639|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57001640|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57001641|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57001642|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001643|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57001644|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001645|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
57001646|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57001647|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57001648|NCT02842827|Tretinoin|tretinoin|mesh-list
57001649|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001650|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
57001651|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
57001652|NCT01354405|Lanreotide|lanreotide|mesh-list
57001653|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001654|NCT03363035|Enoxaparin|enoxaparin|mesh-list
57001655|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
57001656|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57001657|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
57001658|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57001659|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
57001660|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001661|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001662|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
57001663|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57001664|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57001665|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
57001666|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
57001667|NCT02582775|Busulfan|busulfan|mesh-list
57001668|NCT02582775|Fludarabine|fludarabine|mesh-list
57001669|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
57001670|NCT02582775|Tacrolimus|tacrolimus|mesh-list
57001671|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
57001672|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57001673|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57001674|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
57001675|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001676|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001677|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57001678|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
57001679|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001680|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001681|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57001682|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57001683|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
57001684|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001685|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57001686|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001687|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57001688|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57001689|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
57001690|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57001691|NCT02060552|Diacetylrhein|diacetylrhein|mesh-list
57001692|NCT02060552|Colchicine|colchicine|mesh-list
57001693|NCT02060552|Febuxostat|febuxostat|mesh-list
57001694|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
57001695|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001696|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
57001697|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
57001698|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
57001699|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001700|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001701|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001702|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
57001703|NCT05384574|Vitamin D|vitamin d|mesh-list
57001704|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57001705|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001706|NCT05384574|Vitamins|vitamins|mesh-ancestor
57001707|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
57001708|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57001709|NCT04355585|Colchicine|colchicine|mesh-list
57001710|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
57001711|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001712|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
57001713|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
57001714|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
57001715|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001716|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001717|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57001718|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001719|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57001720|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001721|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001722|NCT01344395|Ketorolac|ketorolac|mesh-list
57001723|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57001724|NCT01344395|Ropivacaine|ropivacaine|mesh-list
57001725|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
57001726|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
57001727|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001728|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001729|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
57001730|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001731|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57001732|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57001733|NCT01344395|Analgesics|analgesics|mesh-ancestor
57001734|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001735|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001736|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57001737|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001738|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001739|NCT02291445|Peppermint oil|peppermint oil|mesh-list
57001740|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
57001741|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
57001742|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001743|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001744|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57001745|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
57001746|NCT02062112|Laxatives|laxatives|mesh-list
57001747|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57001748|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
57001749|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
57001750|NCT01342289|Fludarabine|fludarabine|mesh-list
57001751|NCT01342289|Tacrolimus|tacrolimus|mesh-list
57001752|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57001753|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
57001754|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001755|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001756|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57001757|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
57001758|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001759|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001760|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57001761|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57001762|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001763|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57001764|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57001765|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
57001766|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57001767|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001768|NCT02062190|Resveratrol|resveratrol|mesh-list
57001769|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
57001770|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001771|NCT02062190|Protective Agents|protective agents|mesh-ancestor
57001772|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001773|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001774|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57001775|NCT05601752|Nivolumab|nivolumab|mesh-list
57001776|NCT05601752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57001777|NCT05601752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001778|NCT05601752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57001779|NCT05601752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001780|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
57001781|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57001782|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57001783|NCT01354483|Prednisolone|prednisolone|mesh-list
57001784|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
57001785|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
57001786|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57001787|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
57001788|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001789|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
57001790|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
57001791|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001792|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001793|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57001794|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
57001795|NCT01354483|Hormones|hormones|mesh-ancestor
57001796|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001797|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57001798|NCT01354483|Protective Agents|protective agents|mesh-ancestor
57001799|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57001800|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001801|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
57001802|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57001803|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001804|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001805|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
57001806|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57001807|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001808|NCT03618264|Dexamethasone|dexamethasone|mesh-list
57001809|NCT03618264|Ropivacaine|ropivacaine|mesh-list
57001810|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001811|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
57001812|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
57001813|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001814|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001815|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57001816|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
57001817|NCT03618264|Hormones|hormones|mesh-ancestor
57001818|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001819|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57001820|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001821|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
57001822|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
57001823|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001824|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
57001825|NCT03617016|Domperidone|domperidone|mesh-list
57001826|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
57001827|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
57001828|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001829|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001830|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57001831|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57001832|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
57001833|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001834|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001835|NCT02060786|Clopidogrel|clopidogrel|mesh-list
57001836|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57001837|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57001838|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57001839|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57001840|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
57001841|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001842|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001843|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001844|NCT03153137|Macitentan|macitentan|mesh-list
57001845|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57001846|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57001847|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001848|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57001849|NCT03617484|Bortezomib|bortezomib|mesh-list
57001850|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001851|NCT01344473|Caseins|caseins|mesh-list
57001852|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
57001853|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
57001854|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001855|NCT03618108|Azithromycin|azithromycin|mesh-list
57001856|NCT03618108|Doxycycline|doxycycline|mesh-list
57001857|NCT03618108|Rifabutin|rifabutin|mesh-list
57001858|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683894|NCT00838578|Irinotecan|irinotecan|mesh-list
57001859|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001860|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
57001861|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57001862|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57001863|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57001864|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
57001865|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57001866|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57001867|NCT02236728|Pramipexole|pramipexole|mesh-list
57001868|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
57001869|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001870|NCT02236728|Protective Agents|protective agents|mesh-ancestor
57001871|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001872|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57001873|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57001874|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
57001875|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
57001876|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001877|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57001878|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
57001879|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001880|NCT01342679|Dasatinib|dasatinib|mesh-list
57001881|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001882|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57001883|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001884|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001885|NCT01342835|Propofol|propofol|mesh-list
57001886|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57001887|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001888|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001889|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57001890|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
57001891|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
57001892|NCT01344863|Trastuzumab|trastuzumab|mesh-list
57001893|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57001894|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001895|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
57001896|NCT03139279|Propofol|propofol|mesh-list
57001897|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57001898|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57001899|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001900|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57001901|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
57001902|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
57001903|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57001904|NCT03139279|Analgesics|analgesics|mesh-ancestor
57001905|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
57001906|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001907|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57001908|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57001909|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57001910|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
57001911|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001912|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001913|NCT02562599|Raltitrexed|raltitrexed|mesh-list
57001914|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001915|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57001916|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
57001917|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001918|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57001919|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001920|NCT03311958|Nivolumab|nivolumab|mesh-list
57001921|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57001922|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001923|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57001924|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001925|NCT02225405|Cisplatin|cisplatin|mesh-list
57001926|NCT02225405|Docetaxel|docetaxel|mesh-list
57001927|NCT02225405|Nintedanib|nintedanib|mesh-list
57001928|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57001929|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
57001930|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
57001931|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
57001932|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001933|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57001934|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001935|NCT01370642|Ribavirin|ribavirin|mesh-list
57001936|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
57001937|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001938|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
57001939|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001940|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
57001941|NCT03138967|Bromides|bromides|mesh-list
57001942|NCT03138967|Rocuronium|rocuronium|mesh-list
57001943|NCT03138967|Neostigmine|neostigmine|mesh-list
57001944|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
57001945|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57001946|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57001947|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57001948|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001949|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001950|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57001951|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001952|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001953|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
57001954|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001955|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57001956|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
57001957|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57001958|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57001959|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57001960|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
57001961|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
57001962|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001963|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
57001964|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57001965|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001966|NCT01358383|Naproxen|naproxen|mesh-list
57001967|NCT01358383|Esomeprazole|esomeprazole|mesh-list
57001968|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57001969|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57001970|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57001971|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001972|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57001973|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57001974|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57001975|NCT01358383|Analgesics|analgesics|mesh-ancestor
57001976|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
57001977|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57001978|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001979|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57001980|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57001981|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
57001982|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57001983|NCT03560336|Liraglutide|liraglutide|mesh-list
57001984|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57001985|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57001986|NCT03560336|Incretins|incretins|mesh-ancestor
57001987|NCT03560336|Hormones|hormones|mesh-ancestor
57001988|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57001989|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
57001990|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57001991|NCT03615768|Clindamycin|clindamycin|mesh-list
57001992|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
57001993|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
57001994|NCT03615768|Adapalene|adapalene|mesh-list
57001995|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57001996|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57001997|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57001998|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57001999|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002000|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57002001|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57002002|NCT03615768|Analgesics|analgesics|mesh-ancestor
57002003|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
57002004|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002005|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002006|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002007|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57002008|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
57002009|NCT02061644|Anesthetics|anesthetics|mesh-list
57002010|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002011|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002012|NCT03793400|Bevacizumab|bevacizumab|mesh-list
57002013|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002014|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002015|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57002016|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57002017|NCT03793400|Growth Substances|growth substances|mesh-ancestor
57002018|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002019|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
57002020|NCT01318369|Diazepam|diazepam|mesh-list
57002021|NCT01318369|Dronabinol|dronabinol|mesh-list
57002022|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
57002023|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002024|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57002025|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57002026|NCT01318369|Analgesics|analgesics|mesh-ancestor
57002027|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
57002028|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002029|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57002030|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57002031|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002032|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002033|NCT01318369|Hormones|hormones|mesh-ancestor
57002034|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002035|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57002036|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
57002037|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
57002038|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
57002039|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57002040|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57002041|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896057|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
57002042|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57002043|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57002044|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57002045|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57002046|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57002047|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
57002048|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
57002049|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
57002050|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
57002051|NCT03479684|Warfarin|warfarin|mesh-list
57002052|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
57002053|NCT03614052|Tamsulosin|tamsulosin|mesh-list
57002054|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57002055|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57002056|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57002057|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
57002058|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002059|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002060|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002061|NCT03614052|Urological Agents|urological agents|mesh-ancestor
57002062|NCT02062892|Sirolimus|sirolimus|mesh-list
57002063|NCT02062892|Everolimus|everolimus|mesh-list
57002064|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002065|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57002066|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
57002067|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002068|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57002069|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002070|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57002071|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
57002072|NCT02063360|Ritonavir|ritonavir|mesh-list
57002073|NCT02063360|Darunavir|darunavir|mesh-list
57002074|NCT02063360|Fostemsavir|fostemsavir|mesh-list
57002075|NCT02063360|Etravirine|etravirine|mesh-list
57002076|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57002077|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57002078|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
57002079|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002080|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002081|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57002082|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57002083|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
57002084|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002085|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57002086|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57002087|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57002088|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57002089|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57002090|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57002091|NCT03614832|Clopidogrel|clopidogrel|mesh-list
57002092|NCT03614832|Ticagrelor|ticagrelor|mesh-list
57002093|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57002094|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57002095|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57002096|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57002097|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
57002098|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002099|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002100|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002101|NCT05210595|Clopidogrel|clopidogrel|mesh-list
57002102|NCT05210595|Ticagrelor|ticagrelor|mesh-list
57002103|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57002104|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57002105|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57002106|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57002107|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
57002108|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002109|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002110|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002111|NCT05210517|Empagliflozin|empagliflozin|mesh-list
57002112|NCT05210517|Benzbromarone|benzbromarone|mesh-list
57002113|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57002114|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002115|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57002116|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002117|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
57002118|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
57002119|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57002120|NCT05210517|Renal Agents|renal agents|mesh-ancestor
57002121|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
57002122|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57002123|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
57002124|NCT02061800|Melphalan|melphalan|mesh-list
57002125|NCT02061800|Busulfan|busulfan|mesh-list
57002126|NCT02061800|Thiotepa|thiotepa|mesh-list
57002127|NCT02061800|Fludarabine|fludarabine|mesh-list
57002128|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
57002129|NCT02061800|Tacrolimus|tacrolimus|mesh-list
57002130|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57002131|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
57002132|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002133|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57002134|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57002135|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
57002136|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002137|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002138|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57002139|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57002140|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002141|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002142|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
57002143|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
57002144|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002145|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57002146|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
57002147|NCT02061800|Hormones|hormones|mesh-ancestor
57002148|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002149|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57002150|NCT02061800|Protective Agents|protective agents|mesh-ancestor
57002151|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57002152|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002153|NCT01350817|Docetaxel|docetaxel|mesh-list
57002154|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57002155|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002156|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
57002157|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
57002158|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
57002159|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002160|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57002161|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684196|NCT00818454|Albuterol|albuterol|mesh-list
57002162|NCT01986075|Amphetamine|amphetamine|mesh-list
57002163|NCT01986075|Adderall|adderall|mesh-list
57002164|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57002165|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002166|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
57002167|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
57002168|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002169|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
57002170|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002171|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002172|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
57002173|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57002174|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57002175|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57002176|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57002177|NCT02061878|Bexarotene|bexarotene|mesh-list
57002178|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002179|NCT00394355|Fluticasone|fluticasone|mesh-list
57002180|NCT00394355|Xhance|xhance|mesh-list
57002181|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
57002182|NCT00394355|Montelukast|montelukast|mesh-list
57002183|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002184|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57002185|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
57002186|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002187|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002188|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57002189|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
57002190|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
57002191|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57002192|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57002193|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
57002194|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002195|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57002196|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57002197|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002198|NCT02797808|Sertraline|sertraline|mesh-list
57002199|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
57002200|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57002201|NCT02797808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57002202|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57002203|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57002204|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002205|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002206|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
57002207|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002208|NCT02796560|Travoprost|travoprost|mesh-list
57002209|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57002210|NCT01316081|Vitamins|vitamins|mesh-list
57002211|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
57002212|NCT01316081|Vitamin E|vitamin e|mesh-list
57002213|NCT01316081|Tocopherols|tocopherols|mesh-list
57002214|NCT01316081|Tocotrienols|tocotrienols|mesh-list
57002215|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
57002216|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
57002217|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002218|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
57002219|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002220|NCT01316081|Protective Agents|protective agents|mesh-ancestor
57002221|NCT00958737|Leucovorin|leucovorin|mesh-list
57002222|NCT00958737|Fluorouracil|fluorouracil|mesh-list
57002223|NCT00958737|Capecitabine|capecitabine|mesh-list
57002224|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
57002225|NCT00958737|Calcium|calcium|mesh-list
57002226|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
57002227|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57002228|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002229|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
57002230|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002231|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57002232|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002233|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57002234|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
57002235|NCT00958737|Antidotes|antidotes|mesh-ancestor
57002236|NCT00958737|Protective Agents|protective agents|mesh-ancestor
57002237|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
57002238|NCT00958737|Vitamins|vitamins|mesh-ancestor
57002239|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
57002240|NCT02062034|Vitamins|vitamins|mesh-list
57002241|NCT02062034|Vitamin E|vitamin e|mesh-list
57002242|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
57002243|NCT02062034|Ubiquinone|ubiquinone|mesh-list
57002244|NCT02062034|Antioxidants|antioxidants|mesh-list
57002245|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
57002246|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002247|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002248|NCT02062034|Protective Agents|protective agents|mesh-ancestor
57002249|NCT00344487|Ritonavir|ritonavir|mesh-list
57002250|NCT00344487|Lopinavir|lopinavir|mesh-list
57002251|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57002252|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57002253|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
57002254|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002255|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002256|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57002257|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57002258|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
57002259|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002260|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57002261|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57002262|NCT03789968|Tenofovir|tenofovir|mesh-list
57002263|NCT03789968|Emtricitabine|emtricitabine|mesh-list
57002264|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57002265|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
57002266|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002267|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57002268|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57002269|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002270|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002271|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57002272|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57002273|NCT05089643|Capecitabine|capecitabine|mesh-list
57002274|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57002275|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
57002276|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002277|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002278|NCT02871492|Acyclovir|acyclovir|mesh-list
57002279|NCT02871492|Pritelivir|pritelivir|mesh-list
57002280|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
57002281|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002282|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002283|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002284|NCT03613974|Lidocaine|lidocaine|mesh-list
57002285|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
57002286|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
57002287|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002288|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002289|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
57002290|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002291|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57002292|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57002293|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57002294|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57002295|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002296|NCT01343225|Ritonavir|ritonavir|mesh-list
57002297|NCT01343225|Darunavir|darunavir|mesh-list
57002298|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
57002299|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57002300|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57002301|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57002302|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
57002303|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002304|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002305|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57002306|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57002307|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
57002308|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002309|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57002310|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56684356|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002311|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57002312|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57002313|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57002314|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57002316|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
57002317|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002318|NCT05208879|Protective Agents|protective agents|mesh-ancestor
57002319|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002320|NCT04739865|Psilocybin|psilocybin|mesh-list
57002321|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
57002322|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002323|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57002324|NCT01370408|Dexamethasone|dexamethasone|mesh-list
57002325|NCT01370408|Ondansetron|ondansetron|mesh-list
57002326|NCT01370408|Palonosetron|palonosetron|mesh-list
57002327|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002328|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
57002329|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
57002330|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002331|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002332|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57002333|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
57002334|NCT01370408|Hormones|hormones|mesh-ancestor
57002335|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002336|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57002337|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002338|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
57002339|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
57002340|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57002341|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
57002342|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002343|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002344|NCT01370408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57002345|NCT01370408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57002346|NCT01370408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002347|NCT01370408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57002348|NCT01370408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57002349|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57002350|NCT04769388|Carboplatin|carboplatin|mesh-list
57002351|NCT04769388|Pemetrexed|pemetrexed|mesh-list
57002352|NCT04769388|Osimertinib|osimertinib|mesh-list
57002353|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002354|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002355|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002356|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57002357|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57002358|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57002359|NCT03294109|Bupivacaine|bupivacaine|mesh-list
57002360|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
57002361|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
57002362|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002363|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002364|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
57002365|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002366|NCT01345643|Chrysarobin|chrysarobin|mesh-list
57002367|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57002368|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57002369|NCT01345643|Analgesics|analgesics|mesh-ancestor
57002370|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
57002371|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002372|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002373|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002374|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57002375|NCT02065466|Paclitaxel|paclitaxel|mesh-list
57002376|NCT02065466|Bevacizumab|bevacizumab|mesh-list
57002377|NCT02065466|Temozolomide|temozolomide|mesh-list
57002378|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57002379|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002380|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
57002381|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
57002382|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
57002383|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002384|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002385|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57002386|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57002387|NCT02065466|Growth Substances|growth substances|mesh-ancestor
57002389|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
57002390|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57002391|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
57002392|NCT03446040|Nivolumab|nivolumab|mesh-list
57002393|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002394|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002395|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57002396|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002397|NCT05208801|Morphine|morphine|mesh-list
57002398|NCT05208801|Bupivacaine|bupivacaine|mesh-list
57002399|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
57002400|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
57002401|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002402|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002403|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
57002404|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002405|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57002406|NCT05208801|Narcotics|narcotics|mesh-ancestor
57002407|NCT05208801|Analgesics|analgesics|mesh-ancestor
57002408|NCT02064140|Rocuronium|rocuronium|mesh-list
57002409|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57002410|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57002411|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57002412|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002413|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002414|NCT05190627|Loratadine|loratadine|mesh-list
57002415|NCT05190627|Sirolimus|sirolimus|mesh-list
57002416|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57002417|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002418|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57002419|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002420|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
57002421|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57002422|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
57002423|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002424|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
57002425|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
57002426|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57002427|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57002428|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57002429|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
57002430|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
57002431|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002432|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002433|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
57002434|NCT01343303|Naproxen|naproxen|mesh-list
57002435|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57002436|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57002437|NCT01343303|Analgesics|analgesics|mesh-ancestor
57002438|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
57002439|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002440|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002441|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002442|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57002443|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
57002444|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57002445|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002446|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002447|NCT01343381|Heparin|heparin|mesh-list
57002448|NCT01343381|Calcium heparin|calcium heparin|mesh-list
57002449|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
57002450|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57002451|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57002452|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002453|NCT03620149|Denosumab|denosumab|mesh-list
57002454|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57002455|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002456|NCT02064374|Metformin|metformin|mesh-list
57002457|NCT02064374|Dolutegravir|dolutegravir|mesh-list
57002458|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57002459|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002460|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57002461|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57002462|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002463|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002464|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57002465|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57002466|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
57002467|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002468|NCT01355263|Vitamin A|vitamin a|mesh-list
57002469|NCT01355263|Vitamins|vitamins|mesh-ancestor
57002470|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
57002471|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002472|NCT03613428|Prednisone|prednisone|mesh-list
57002473|NCT03613428|Vincristine|vincristine|mesh-list
57002474|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002475|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
57002476|NCT03613428|Hormones|hormones|mesh-ancestor
57002477|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002478|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002479|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57002480|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002481|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57002482|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
57002483|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
57002484|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
57002485|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002486|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
57002487|NCT02064530|Bupivacaine|bupivacaine|mesh-list
57002488|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
57002489|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
57002490|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002491|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002492|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
57002493|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002494|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57002495|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57002496|NCT02064530|Analgesics|analgesics|mesh-ancestor
57002497|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57002498|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57002499|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57002500|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
57002501|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002502|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002503|NCT05134857|Zonisamide|zonisamide|mesh-list
57002504|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
57002505|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57002506|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57002507|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002508|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57002509|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002510|NCT01359085|Pregabalin|pregabalin|mesh-list
57002511|NCT01359085|Analgesics|analgesics|mesh-ancestor
57002512|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
57002513|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002514|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002515|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
57002516|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57002517|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57002518|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002519|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57002520|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57002521|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57002522|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002523|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57002524|NCT04322357|Prednisone|prednisone|mesh-list
57002525|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
57002526|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002527|NCT04322357|Hormones|hormones|mesh-ancestor
57002528|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002529|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002530|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57002531|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002532|NCT01351285|Remifentanil|remifentanil|mesh-list
57002533|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57002534|NCT01351285|Narcotics|narcotics|mesh-ancestor
57002535|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002536|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002537|NCT01351285|Analgesics|analgesics|mesh-ancestor
57002538|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
57002539|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002540|NCT02032290|Clopidogrel|clopidogrel|mesh-list
57002541|NCT02032290|Ticagrelor|ticagrelor|mesh-list
57002542|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57002543|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57002544|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57002545|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57002546|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
57002547|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002548|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002549|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002550|NCT03379428|Trastuzumab|trastuzumab|mesh-list
57002551|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002552|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002553|NCT03628131|Carboplatin|carboplatin|mesh-list
57002554|NCT03628131|Etoposide|etoposide|mesh-list
57002555|NCT03628131|Ifosfamide|ifosfamide|mesh-list
57002556|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002557|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57002558|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57002559|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57002560|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002561|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002562|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57002563|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
57002564|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
57002565|NCT03560024|Growth Substances|growth substances|mesh-ancestor
57002566|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002567|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
57002568|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002569|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002570|NCT05095857|Ketamine|ketamine|mesh-list
57002571|NCT05095857|Esketamine|esketamine|mesh-list
57002572|NCT05095857|Analgesics|analgesics|mesh-ancestor
57002573|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
57002574|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002575|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002576|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57002577|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57002578|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
57002579|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
57002580|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002581|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57002582|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57002583|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002584|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002585|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
57002586|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57002587|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57002588|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57002589|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
57002590|NCT03612492|Lidocaine|lidocaine|mesh-list
57002591|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
57002592|NCT03612492|Anesthetics|anesthetics|mesh-list
57002593|NCT03612492|Esmolol|esmolol|mesh-list
57002594|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002595|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002596|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
57002597|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002598|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57002599|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57002600|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57002601|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57002602|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002603|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57002604|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57002605|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
57002606|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002607|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57002608|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
57002609|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57002610|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57002611|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57002612|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
57002613|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57002614|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002615|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57002616|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57002617|NCT03730337|Nivolumab|nivolumab|mesh-list
57002618|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002619|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002620|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57002621|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002622|NCT01351597|Docetaxel|docetaxel|mesh-list
57002623|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
57002624|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002625|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
57002626|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
57002627|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
57002628|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002629|NCT02793128|Mitomycins|mitomycins|mesh-list
57002630|NCT02793128|Mitomycin|mitomycin|mesh-list
57002631|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57002632|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002633|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
57002634|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002635|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57002636|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002637|NCT03612180|Metoprolol|metoprolol|mesh-list
57002638|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57002639|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57002640|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
57002641|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
57002642|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002643|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002644|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57002645|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57002646|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57002647|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
57002648|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002649|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002650|NCT04400799|Enoxaparin|enoxaparin|mesh-list
57002651|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
57002652|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57002653|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57002654|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002655|NCT01359241|Insulin|insulin|mesh-list
57002656|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57002657|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002658|NCT02068196|Ipilimumab|ipilimumab|mesh-list
57002659|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002660|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002661|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57002662|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002663|NCT03142451|Minocycline|minocycline|mesh-list
57002664|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57002665|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002666|NCT04065789|Dexamethasone|dexamethasone|mesh-list
57002667|NCT04065789|Lenalidomide|lenalidomide|mesh-list
57002668|NCT04065789|Daratumumab|daratumumab|mesh-list
57002669|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002670|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
57002671|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
57002672|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002673|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002674|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57002675|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
57002676|NCT04065789|Hormones|hormones|mesh-ancestor
57002677|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002678|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57002679|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002680|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
57002681|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57002682|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57002683|NCT04065789|Growth Substances|growth substances|mesh-ancestor
57002684|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
57002685|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
57002686|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
57002687|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002688|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
57002689|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002690|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002691|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
57002692|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002693|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002694|NCT02064842|Ritonavir|ritonavir|mesh-list
57002695|NCT02064842|Simeprevir|simeprevir|mesh-list
57002696|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57002697|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57002698|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
57002699|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002700|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002701|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57002702|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57002703|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
57002704|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002705|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57002706|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57002707|NCT04192266|Estradiol|estradiol|mesh-list
57002708|NCT04192266|Estrogens|estrogens|mesh-ancestor
57002709|NCT04192266|Hormones|hormones|mesh-ancestor
57002710|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002711|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002712|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
57002713|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57002714|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002715|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002716|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57002717|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57002718|NCT01359397|Bevacizumab|bevacizumab|mesh-list
57002719|NCT01359397|Trastuzumab|trastuzumab|mesh-list
57002720|NCT01359397|Docetaxel|docetaxel|mesh-list
57002721|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
57002722|NCT01359397|Capecitabine|capecitabine|mesh-list
57002723|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002724|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002725|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57002726|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57002727|NCT01359397|Growth Substances|growth substances|mesh-ancestor
57002728|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002729|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
57002730|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
57002731|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
57002732|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
57002733|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002734|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57002735|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
57002736|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
57002737|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57002738|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57002739|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
57002740|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002741|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002742|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002743|NCT05250245|Urological Agents|urological agents|mesh-ancestor
57002744|NCT01347983|Methotrexate|methotrexate|mesh-list
57002745|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57002746|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
57002747|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57002748|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002749|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57002750|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
57002751|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002752|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002753|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
57002754|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002755|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57002756|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57002757|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
57002758|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57002759|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57002760|NCT05249933|Benzocaine|benzocaine|mesh-list
57002761|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
57002762|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
57002763|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002764|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002765|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
57002766|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002767|NCT02032836|Iloprost|iloprost|mesh-list
57002768|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57002769|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
57002770|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
57002771|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
57002772|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
57002773|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002774|NCT02465593|Fluorouracil|fluorouracil|mesh-list
57002775|NCT02465593|Capecitabine|capecitabine|mesh-list
57002776|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
57002777|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002778|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57002779|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002780|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57002781|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
57002782|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002783|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
57002784|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002785|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
57002786|NCT02424019|Hormones|hormones|mesh-ancestor
57002787|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002788|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002789|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
57002790|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002791|NCT03611244|Benzocaine|benzocaine|mesh-list
57002792|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
57002793|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
57002794|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002795|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002796|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
57002797|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002798|NCT01359709|Nicotine|nicotine|mesh-list
57002799|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57002800|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
57002801|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002802|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002803|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57002804|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57002805|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
57002806|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002807|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002808|NCT02826486|Leucovorin|leucovorin|mesh-list
57002809|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
57002810|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002811|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002812|NCT02826486|Antidotes|antidotes|mesh-ancestor
57002813|NCT02826486|Protective Agents|protective agents|mesh-ancestor
57002814|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002815|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
57002816|NCT02826486|Vitamins|vitamins|mesh-ancestor
57002817|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
57002818|NCT02825940|Gemcitabine|gemcitabine|mesh-list
57002819|NCT02825940|Atezolizumab|atezolizumab|mesh-list
57002820|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002821|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57002822|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
57002823|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002824|NCT02825940|Antiviral Agents|antiviral agents|mesh-ancestor
57002825|NCT02825940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002826|NCT02825940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002827|NCT02825940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57002828|NCT02825940|Immunologic Factors|immunologic factors|mesh-ancestor
57002829|NCT02825940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002830|NCT02304991|Glycerol|glycerol|mesh-list
57002831|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57002832|NCT02304991|Protective Agents|protective agents|mesh-ancestor
57002833|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002834|NCT02069132|Warfarin|warfarin|mesh-list
57002835|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
57002836|NCT01352065|Bosentan|bosentan|mesh-list
57002838|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57002839|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57002840|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002841|NCT01356043|Niacin|niacin|mesh-list
57002842|NCT01356043|Amlodipine|amlodipine|mesh-list
57002843|NCT01356043|Telmisartan|telmisartan|mesh-list
57002844|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57002845|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57002846|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896074|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
57002847|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002848|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57002849|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002850|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
57002851|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57002852|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57002853|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57002854|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
57002855|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57002856|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
57002857|NCT01356043|Vitamins|vitamins|mesh-ancestor
57002858|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
57002859|NCT02065388|Warfarin|warfarin|mesh-list
57002860|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
57002861|NCT01317563|Vitamin A|vitamin a|mesh-list
57002862|NCT01317563|Selenium|selenium|mesh-list
57002863|NCT01317563|Vitamins|vitamins|mesh-ancestor
57002864|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
57002865|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002866|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
57002867|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002868|NCT01317563|Protective Agents|protective agents|mesh-ancestor
57002869|NCT01317563|Trace Elements|trace elements|mesh-ancestor
57002870|NCT02067338|Morphine|morphine|mesh-list
57002871|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
57002872|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57002873|NCT02067338|Narcotics|narcotics|mesh-ancestor
57002874|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002875|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002876|NCT02067338|Analgesics|analgesics|mesh-ancestor
57002877|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
57002878|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002879|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
57002880|NCT02067338|Coagulants|coagulants|mesh-ancestor
57002881|NCT01352143|Thrombin|thrombin|mesh-list
57002882|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
57002883|NCT01352143|Coagulants|coagulants|mesh-ancestor
57002884|NCT03911661|Warfarin|warfarin|mesh-list
57002885|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
57002886|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
57002887|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
57002888|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
57002889|NCT05188495|Trastuzumab|trastuzumab|mesh-list
57002890|NCT05188495|Pertuzumab|pertuzumab|mesh-list
57002891|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57002892|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002893|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
57002894|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002895|NCT01356121|Midazolam|midazolam|mesh-list
57002896|NCT01356121|Propofol|propofol|mesh-list
57002897|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57002898|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57002899|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002900|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57002901|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
57002902|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
57002903|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57002904|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57002905|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57002906|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57002907|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
57002908|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
57002909|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002910|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002911|NCT01336608|Fluticasone|fluticasone|mesh-list
57002912|NCT01336608|Xhance|xhance|mesh-list
57002913|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002914|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57002915|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
57002916|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002917|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002918|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57002919|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
57002920|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
57002921|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57002922|NCT03628521|Gemcitabine|gemcitabine|mesh-list
57002923|NCT03628521|Carboplatin|carboplatin|mesh-list
57002924|NCT03628521|Pemetrexed|pemetrexed|mesh-list
57002925|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57002926|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57002927|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57002928|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
57002929|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002930|NCT03628521|Antiviral Agents|antiviral agents|mesh-ancestor
57002931|NCT03628521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57002932|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57002933|NCT03628521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57002934|NCT03628521|Immunologic Factors|immunologic factors|mesh-ancestor
57002935|NCT03628521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002936|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57002937|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57002938|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57002939|NCT05697003|Fluticasone|fluticasone|mesh-list
57002940|NCT05697003|Xhance|xhance|mesh-list
57002941|NCT05697003|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57002942|NCT05697003|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57002943|NCT05697003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57002944|NCT05697003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57002945|NCT05697003|Autonomic Agents|autonomic agents|mesh-ancestor
57002946|NCT05697003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002947|NCT05697003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002948|NCT05697003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57002949|NCT05697003|Respiratory System Agents|respiratory system agents|mesh-ancestor
57002950|NCT05697003|Dermatologic Agents|dermatologic agents|mesh-ancestor
57002951|NCT05697003|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57002952|NCT05697003|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57002953|NCT05697003|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57002954|NCT05697003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57002955|NCT05697003|Adrenergic Agents|adrenergic agents|mesh-ancestor
57002956|NCT05697003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002957|NCT05697003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002958|NCT05697003|Glucocorticoids|glucocorticoids|mesh-ancestor
57002959|NCT05697003|Hormones|hormones|mesh-ancestor
57002960|NCT05697003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57002961|NCT05697003|Sympathomimetics|sympathomimetics|mesh-ancestor
57002962|NCT02069522|Carotenoids|carotenoids|mesh-list
57002963|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
57002964|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002965|NCT02069522|Protective Agents|protective agents|mesh-ancestor
57002966|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002967|NCT01361425|Methyldopa|methyldopa|mesh-list
57002968|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57002969|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
57002970|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
57002971|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57002972|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002973|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57002974|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57002975|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57002976|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
57002977|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002978|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002979|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
57002980|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57002981|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57002982|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
57002983|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57002984|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002985|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002986|NCT01356355|Urological Agents|urological agents|mesh-ancestor
57002987|NCT01356433|Vitamins|vitamins|mesh-list
57002988|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
57002989|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
57002990|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57002991|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
57002992|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002993|NCT01356433|Protective Agents|protective agents|mesh-ancestor
57002994|NCT03691727|Tirofiban|tirofiban|mesh-list
57002995|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57002996|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57002997|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57002998|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57002999|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57003000|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
57003001|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57003002|NCT01356511|Dexamethasone|dexamethasone|mesh-list
57003003|NCT01356511|Prednisone|prednisone|mesh-list
57003004|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003005|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
57003006|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
57003007|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003008|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003009|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003010|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
57003011|NCT01356511|Hormones|hormones|mesh-ancestor
57003012|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003013|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57003014|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003015|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
57003016|NCT02069990|Vitamin D|vitamin d|mesh-list
57003017|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57003018|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003019|NCT02069990|Vitamins|vitamins|mesh-ancestor
57003020|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
57003021|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57003022|NCT05076409|Fluconazole|fluconazole|mesh-list
57003023|NCT05076409|BI 425809|bi 425809|mesh-list
57003024|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
57003025|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003026|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57003027|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57003028|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003029|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003030|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57003031|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
57003032|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003033|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003034|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57003035|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57003036|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
57003037|NCT02076386|Dolutegravir|dolutegravir|mesh-list
57003038|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57003039|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57003040|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003041|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003042|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57003043|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57003044|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
57003045|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003046|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
57003047|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57003048|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003049|NCT02072330|Amlodipine|amlodipine|mesh-list
57003050|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57003051|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
57003052|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57003053|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57003054|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57003055|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003056|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57003057|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003058|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
57003059|NCT02072330|Diuretics|diuretics|mesh-ancestor
57003060|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
57003061|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57003062|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57003063|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56685096|NCT00782548|Analgesics|analgesics|mesh-ancestor
57003064|NCT02072408|Aflibercept|aflibercept|mesh-list
57003065|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57003066|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57003067|NCT02072408|Growth Substances|growth substances|mesh-ancestor
57003068|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003069|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
57003070|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003071|NCT02070458|Cytarabine|cytarabine|mesh-list
57003072|NCT02070458|Etoposide|etoposide|mesh-list
57003073|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
57003074|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
57003075|NCT02070458|Ixazomib|ixazomib|mesh-list
57003076|NCT02070458|Glycine|glycine|mesh-list
57003077|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
57003078|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57003079|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003080|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57003081|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57003082|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003083|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003084|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57003085|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
57003086|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
57003087|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003088|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57003089|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
57003090|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003091|NCT02070458|Analgesics|analgesics|mesh-ancestor
57003092|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
57003093|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003094|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
57003095|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
57003096|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003097|NCT03131479|Licogliflozin|licogliflozin|mesh-list
57003098|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57003099|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003100|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003101|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003102|NCT03629327|Aspirin|aspirin|mesh-list
57003103|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57003104|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003105|NCT03629327|Analgesics|analgesics|mesh-ancestor
57003106|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
57003107|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003108|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003109|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003110|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57003111|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57003112|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57003113|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003114|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57003115|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57003116|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003117|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
57003118|NCT04984369|Cetuximab|cetuximab|mesh-list
57003119|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003120|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003121|NCT02077010|Milrinone|milrinone|mesh-list
57003122|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57003123|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57003124|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
57003125|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57003126|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57003127|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003128|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003129|NCT02077010|Protective Agents|protective agents|mesh-ancestor
57003130|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003131|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
57003132|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57003133|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
57003134|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003135|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
57003136|NCT01319461|Protective Agents|protective agents|mesh-ancestor
57003137|NCT02072720|Bevacizumab|bevacizumab|mesh-list
56685182|NCT00695201|Irinotecan|irinotecan|mesh-list
57003138|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003139|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003140|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57003141|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57003142|NCT02072720|Growth Substances|growth substances|mesh-ancestor
57003143|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003144|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
57003145|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
57003146|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57003147|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
57003148|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
57003149|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003150|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003151|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003152|NCT01356745|Analgesics|analgesics|mesh-ancestor
57003153|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
57003154|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003155|NCT02072798|Cefuroxime|cefuroxime|mesh-list
57003156|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
57003157|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57003158|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003159|NCT04943549|Bupivacaine|bupivacaine|mesh-list
57003160|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
57003161|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
57003162|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003163|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003164|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
57003165|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003166|NCT03578081|Dexamethasone|dexamethasone|mesh-list
57003167|NCT03578081|Ondansetron|ondansetron|mesh-list
57003168|NCT03578081|Olanzapine|olanzapine|mesh-list
57003169|NCT03578081|Palonosetron|palonosetron|mesh-list
57003170|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
57003171|NCT03578081|Aprepitant|aprepitant|mesh-list
57003172|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003173|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
57003174|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
57003175|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003176|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003177|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003178|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
57003179|NCT03578081|Hormones|hormones|mesh-ancestor
57003180|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003181|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57003182|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003183|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
57003184|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
57003185|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57003186|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
57003187|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003188|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003189|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57003190|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57003191|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003192|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57003193|NCT03578081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57003194|NCT03578081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57003195|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57003196|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57003197|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57003198|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57003199|NCT04252105|Antioxidants|antioxidants|mesh-list
57003200|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003201|NCT04252105|Protective Agents|protective agents|mesh-ancestor
57003202|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003203|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
57003204|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
57003205|NCT02077322|Coagulants|coagulants|mesh-ancestor
57003206|NCT02077400|Cefazolin|cefazolin|mesh-list
57003207|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57003208|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003209|NCT02077478|Remifentanil|remifentanil|mesh-list
57003210|NCT02077478|Propofol|propofol|mesh-list
57003211|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57003212|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003213|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003214|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57003215|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
57003216|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
57003217|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57003218|NCT02077478|Narcotics|narcotics|mesh-ancestor
57003219|NCT02077478|Analgesics|analgesics|mesh-ancestor
57003220|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
57003221|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003222|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
57003223|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
57003224|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57003225|NCT02077556|Prednisolone|prednisolone|mesh-list
57003226|NCT02077556|Everolimus|everolimus|mesh-list
57003227|NCT02077556|Tacrolimus|tacrolimus|mesh-list
57003228|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57003229|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
57003230|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003231|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57003232|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003233|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003234|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003235|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57003236|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57003237|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
57003238|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57003239|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003240|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003241|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
57003242|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
57003243|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003244|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003245|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
57003246|NCT02077556|Hormones|hormones|mesh-ancestor
57003247|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003248|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57003249|NCT02077556|Protective Agents|protective agents|mesh-ancestor
57003250|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57003251|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
57003252|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57003253|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57003254|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003255|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
57003256|NCT02930941|Coagulants|coagulants|mesh-ancestor
57003257|NCT02077634|Prednisone|prednisone|mesh-list
57003258|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
57003259|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003260|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
57003261|NCT02077634|Hormones|hormones|mesh-ancestor
57003262|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003263|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003264|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57003265|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003266|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57003267|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003268|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003269|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
57003270|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57003271|NCT01365403|Carbamazepine|carbamazepine|mesh-list
57003272|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
57003273|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
57003274|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57003275|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003276|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003277|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57003278|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003279|NCT01365403|Analgesics|analgesics|mesh-ancestor
57003280|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
57003281|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003282|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57003283|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57003284|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003285|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57003286|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57003287|NCT01352663|Insulin|insulin|mesh-list
57003288|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
57003289|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003290|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003291|NCT01362361|Nintedanib|nintedanib|mesh-list
56685325|NCT02624531|Cisplatin|cisplatin|mesh-list
57003292|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003293|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57003294|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003295|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003296|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
57003297|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57003298|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003299|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003300|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003301|NCT02077712|Analgesics|analgesics|mesh-ancestor
57003302|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
57003303|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003304|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57003305|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57003306|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57003307|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
57003308|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003309|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003310|NCT02073734|Dexamethasone|dexamethasone|mesh-list
57003311|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003312|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
57003313|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
57003314|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003315|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003316|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003317|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
57003318|NCT02073734|Hormones|hormones|mesh-ancestor
57003319|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003320|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57003321|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003322|NCT02071004|Aspirin|aspirin|mesh-list
57003323|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57003324|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003325|NCT02071004|Analgesics|analgesics|mesh-ancestor
57003326|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
57003327|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003328|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003329|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003330|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57003331|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57003332|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57003333|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003334|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57003335|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57003336|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003337|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
57003338|NCT02071160|Melatonin|melatonin|mesh-list
57003339|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
57003340|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003341|NCT02071160|Protective Agents|protective agents|mesh-ancestor
57003342|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003343|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003344|NCT03131713|Acetaminophen|acetaminophen|mesh-list
57003345|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003346|NCT03131713|Analgesics|analgesics|mesh-ancestor
57003347|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
57003348|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003349|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003350|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
57003351|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
57003352|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003353|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003354|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
57003355|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
57003356|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
57003357|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57003358|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003359|NCT02930005|Analgesics|analgesics|mesh-ancestor
57003360|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
57003361|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003362|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003363|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003364|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57003365|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57003367|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003368|NCT01349387|Metformin|metformin|mesh-list
57003369|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003370|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003371|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
57003372|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
57003373|NCT01361269|Clindamycin|clindamycin|mesh-list
57003374|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
57003375|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
57003376|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
57003377|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57003378|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003379|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57003380|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003381|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003382|NCT01353209|Letrozole|letrozole|mesh-list
57003383|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003384|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57003385|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57003386|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003387|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003388|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57003389|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
57003390|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003391|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003392|NCT03637491|Avelumab|avelumab|mesh-list
57003393|NCT03637491|Talazoparib|talazoparib|mesh-list
57003394|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003395|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003396|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57003397|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003398|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003399|NCT01363063|Ketorolac|ketorolac|mesh-list
57003400|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57003401|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57003402|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003403|NCT01363063|Analgesics|analgesics|mesh-ancestor
57003404|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
57003405|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003406|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003407|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003408|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57003409|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57003410|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003411|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003412|NCT04550455|Cladribine|cladribine|mesh-list
57003413|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003414|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57003415|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
57003416|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003417|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57003418|NCT01349699|Deferasirox|deferasirox|mesh-list
57003419|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57003420|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
57003421|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
57003422|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003423|NCT01349699|Hematinics|hematinics|mesh-ancestor
57003424|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
57003425|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57003426|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
57003427|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003428|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003429|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003430|NCT03628443|Mitogens|mitogens|mesh-list
57003431|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
57003432|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003433|NCT01365871|Anesthetics|anesthetics|mesh-list
57003434|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003435|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003436|NCT01349777|Clopidogrel|clopidogrel|mesh-list
57003437|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57003438|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57003439|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57003440|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57003442|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003443|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003444|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003445|NCT03446157|Cetuximab|cetuximab|mesh-list
57003446|NCT03446157|Palbociclib|palbociclib|mesh-list
57003447|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003448|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003449|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57003450|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003451|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003452|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
57003453|NCT04700007|Promethazine|promethazine|mesh-list
57003454|NCT04700007|Morphine|morphine|mesh-list
57003455|NCT04700007|Capsaicin|capsaicin|mesh-list
57003456|NCT04700007|Histamine|histamine|mesh-list
57003457|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-list
57003458|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57003459|NCT04700007|Narcotics|narcotics|mesh-ancestor
57003460|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003461|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003462|NCT04700007|Analgesics|analgesics|mesh-ancestor
57003463|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
57003464|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003465|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
57003466|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
57003467|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57003468|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57003469|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
57003470|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
57003471|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
57003472|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
57003473|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003474|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57003475|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
57003476|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003477|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003478|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57003479|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
57003480|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
57003481|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003482|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003483|NCT01318655|Naloxegol|naloxegol|mesh-list
57003484|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57003485|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003486|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
57003487|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003488|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
57003489|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003490|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
57003491|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57003492|NCT02961881|Blinatumomab|blinatumomab|mesh-list
57003493|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003494|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57003495|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57003496|NCT01350089|Ethanol|ethanol|mesh-list
57003497|NCT01350089|Caffeine|caffeine|mesh-list
57003498|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57003499|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003500|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003501|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003502|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57003503|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57003504|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003505|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003506|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57003507|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57003508|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
57003509|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003510|NCT03137303|Albuterol|albuterol|mesh-list
57003511|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57003512|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
57003513|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003514|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003516|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
57003517|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
57003518|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57003519|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57003520|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57003521|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57003522|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
57003523|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003524|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003525|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
57003526|NCT03296553|Valganciclovir|valganciclovir|mesh-list
57003527|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
57003528|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003529|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
57003530|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57003531|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003532|NCT01370707|Metformin|metformin|mesh-list
57003533|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003534|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003535|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57003536|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003537|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
57003538|NCT01363609|Liraglutide|liraglutide|mesh-list
57003539|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003540|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003541|NCT01363609|Incretins|incretins|mesh-ancestor
57003542|NCT01363609|Hormones|hormones|mesh-ancestor
57003543|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003544|NCT03060447|Vesatolimod|vesatolimod|mesh-list
57003545|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
57003546|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003547|NCT04623567|Metformin|metformin|mesh-list
57003548|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003549|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003550|NCT01712789|Dexamethasone|dexamethasone|mesh-list
57003551|NCT01712789|Pomalidomide|pomalidomide|mesh-list
57003552|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003553|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
57003554|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
57003555|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003556|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003557|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003558|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
57003559|NCT01712789|Hormones|hormones|mesh-ancestor
57003560|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003561|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57003562|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003563|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
57003564|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57003565|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57003566|NCT01712789|Growth Substances|growth substances|mesh-ancestor
57003567|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
57003568|NCT01350323|Bevacizumab|bevacizumab|mesh-list
57003569|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003570|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003571|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57003572|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57003573|NCT01350323|Growth Substances|growth substances|mesh-ancestor
57003574|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003575|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
57003576|NCT01357811|Digoxin|digoxin|mesh-list
57003577|NCT01357811|Eliglustat|eliglustat|mesh-list
57003578|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57003579|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57003580|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003581|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003582|NCT01357811|Protective Agents|protective agents|mesh-ancestor
57003583|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003584|NCT03074318|Avelumab|avelumab|mesh-list
57003585|NCT03074318|Trabectedin|trabectedin|mesh-list
57003586|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57003587|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003588|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003589|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57003590|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
57003591|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003592|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
57003593|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003594|NCT02071316|Esomeprazole|esomeprazole|mesh-list
57003595|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
57003596|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57003597|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57003598|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003599|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
57003600|NCT02071316|Coagulants|coagulants|mesh-ancestor
57003601|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57003602|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003603|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57003604|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003605|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57003606|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57003607|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003609|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57003610|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003611|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003612|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57003613|NCT02077946|Liraglutide|liraglutide|mesh-list
57003614|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003615|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003616|NCT02077946|Incretins|incretins|mesh-ancestor
57003617|NCT02077946|Hormones|hormones|mesh-ancestor
57003618|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003619|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57003620|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
57003621|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003622|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003623|NCT03559790|Tenofovir|tenofovir|mesh-list
57003624|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
57003625|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003626|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57003627|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57003628|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003629|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003630|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57003631|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57003632|NCT02079974|Pravastatin|pravastatin|mesh-list
57003633|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57003634|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57003635|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
57003636|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003637|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57003638|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57003639|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003640|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
57003641|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
57003642|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003643|NCT01317953|Protective Agents|protective agents|mesh-ancestor
57003644|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003645|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
57003646|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57003647|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003648|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57003649|NCT02078336|Atropine|atropine|mesh-list
57003650|NCT02078336|Midazolam|midazolam|mesh-list
57003651|NCT02078336|Droperidol|droperidol|mesh-list
57003652|NCT02078336|Lorazepam|lorazepam|mesh-list
57003653|NCT02078336|Biperiden|biperiden|mesh-list
57003654|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57003655|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57003656|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003657|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003658|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57003659|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57003660|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57003661|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57003662|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
57003663|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
57003664|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
57003665|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
56685700|NCT00851630|Lamivudine|lamivudine|mesh-list
57003666|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003667|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003668|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57003669|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57003670|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
57003671|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003672|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57003673|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
57003674|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
57003675|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
57003676|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57003677|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57003678|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
57003679|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
57003680|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
57003681|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003682|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57003683|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57003684|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57003685|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57003686|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57003687|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
57003688|NCT01353833|Aldesleukin|aldesleukin|mesh-list
57003689|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003690|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57003691|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57003692|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
57003693|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003695|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003696|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003697|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57003698|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003699|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
57003700|NCT01350713|Povidone|povidone|mesh-list
57003701|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
57003702|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
57003703|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57003704|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003705|NCT02075294|Entecavir|entecavir|mesh-list
57003706|NCT02075294|Adefovir|adefovir|mesh-list
57003707|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
57003708|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
57003709|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003710|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57003711|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57003712|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003713|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003714|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57003715|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
57003716|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57003717|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57003718|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57003719|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003720|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003721|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
57003722|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57003723|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57003724|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003725|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003726|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57003727|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57003728|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57003729|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
57003730|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003731|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003732|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57003733|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57003734|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
57003735|NCT02078648|Poly I-C|poly i-c|mesh-list
57003736|NCT02078648|Bevacizumab|bevacizumab|mesh-list
57003737|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57003738|NCT02078648|Poly ICLC|poly iclc|mesh-list
57003739|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003740|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003741|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57003742|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57003743|NCT02078648|Growth Substances|growth substances|mesh-ancestor
57003744|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003745|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
57003746|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
57003747|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
57003748|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
57003749|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003750|NCT02078648|Laxatives|laxatives|mesh-ancestor
57003751|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003752|NCT01358045|Calcitriol|calcitriol|mesh-list
57003753|NCT01358045|Diclofenac|diclofenac|mesh-list
57003754|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57003755|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003756|NCT01358045|Analgesics|analgesics|mesh-ancestor
57003757|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
57003758|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003759|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003760|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003761|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57003762|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57003763|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003764|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003765|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57003766|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57003767|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57003768|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57003769|NCT01358045|Vitamins|vitamins|mesh-ancestor
57003770|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
57003771|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57003772|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
57003773|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57003774|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
57003775|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003776|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003777|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
57003778|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
57003779|NCT04300985|Anesthetics|anesthetics|mesh-list
57003780|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003781|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003782|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57003783|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003784|NCT04300985|Analgesics|analgesics|mesh-ancestor
57003785|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
57003786|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003787|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57003788|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57003789|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57003790|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
57003791|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003792|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003793|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57003794|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
57003795|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57003796|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57003797|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57003798|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
57003799|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57003800|NCT02079194|Aspirin|aspirin|mesh-list
57003801|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57003802|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003803|NCT02079194|Analgesics|analgesics|mesh-ancestor
57003804|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
57003805|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003806|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003807|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57003808|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57003809|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57003810|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57003811|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003812|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57003813|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57003814|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003815|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
57003816|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
57003817|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57003818|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
57003819|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003820|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003821|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57003822|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
57003823|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57003824|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
57003825|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003826|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003827|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57003828|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
57003829|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
57003830|NCT01351493|Protective Agents|protective agents|mesh-ancestor
57003831|NCT01318187|Acetaminophen|acetaminophen|mesh-list
57003832|NCT01318187|Morphine|morphine|mesh-list
57003833|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57003834|NCT01318187|Narcotics|narcotics|mesh-ancestor
57003835|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003836|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003837|NCT01318187|Analgesics|analgesics|mesh-ancestor
57003838|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
57003839|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003840|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57003841|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
57003842|NCT01358435|Insulin|insulin|mesh-list
57003843|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57003844|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
57003845|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
57003846|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
57003847|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003848|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003849|NCT01318265|Ketoconazole|ketoconazole|mesh-list
57003850|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
57003851|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57003852|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57003853|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57003854|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003855|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003856|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57003857|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
57003858|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003859|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003860|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57003861|NCT01354457|Epratuzumab|epratuzumab|mesh-list
57003862|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003863|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003864|NCT02079350|Polygeline|polygeline|mesh-list
57003865|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
57003866|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
57003867|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
57003868|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57003869|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
57003870|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57003871|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57003872|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003873|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57003874|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003875|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57003876|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57003877|NCT03060980|Empagliflozin|empagliflozin|mesh-list
57003878|NCT03060980|Glimepiride|glimepiride|mesh-list
57003879|NCT03060980|Exenatide|exenatide|mesh-list
57003880|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57003881|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003882|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57003883|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003884|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57003885|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57003886|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
57003887|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57003888|NCT03060980|Incretins|incretins|mesh-ancestor
57003889|NCT03060980|Hormones|hormones|mesh-ancestor
57003890|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57003891|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
57003892|NCT01358591|Calcium|calcium|mesh-list
57003893|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57003894|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003895|NCT01358591|Antacids|antacids|mesh-ancestor
57003896|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003897|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003898|NCT02081144|Nicotine|nicotine|mesh-list
57003899|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57003900|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
57003901|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003902|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003903|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57003904|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57003905|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
57003906|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003907|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003908|NCT02083328|Mannitol|mannitol|mesh-list
57003909|NCT02083328|Caffeine|caffeine|mesh-list
57003910|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57003911|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003912|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57003913|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003914|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003915|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57003916|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57003917|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
57003918|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003919|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57003920|NCT02083328|Diuretics|diuretics|mesh-ancestor
57003921|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
57003922|NCT02079506|Candesartan|candesartan|mesh-list
57003923|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57003924|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57003925|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57003926|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
57003927|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003928|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57003929|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57003930|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003931|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57003932|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57003933|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57003934|NCT02940548|Amlodipine|amlodipine|mesh-list
57003935|NCT02940548|Nifedipine|nifedipine|mesh-list
57003936|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57003937|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57003938|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57003939|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003940|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57003941|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003942|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
57003943|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
57003944|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57003945|NCT01366183|Paclitaxel|paclitaxel|mesh-list
57003946|NCT01366183|Carboplatin|carboplatin|mesh-list
57003947|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57003948|NCT01366183|Lenograstim|lenograstim|mesh-list
57003949|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57003950|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003951|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
57003952|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
57003953|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
57003954|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003955|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57003956|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
57003957|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003958|NCT03134183|Misoprostol|misoprostol|mesh-list
57003959|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57003960|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
57003961|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57003962|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003963|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56685998|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
57003964|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57003965|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
57003966|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
57003967|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57003968|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003969|NCT01354613|Amlodipine|amlodipine|mesh-list
57003970|NCT01354613|Dobutamine|dobutamine|mesh-list
57003971|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57003972|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57003973|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57003974|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003975|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57003976|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57003977|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
57003978|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57003979|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
57003980|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
57003981|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57003982|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57003983|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57003984|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57003985|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
57003986|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57003987|NCT01354613|Protective Agents|protective agents|mesh-ancestor
57003988|NCT02083640|Palbociclib|palbociclib|mesh-list
57003989|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57003990|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57003991|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57003992|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003993|NCT01352039|Heparin|heparin|mesh-list
57003994|NCT01352039|Calcium heparin|calcium heparin|mesh-list
57003995|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
57003996|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57003997|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57003998|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57003999|NCT04419337|Metformin|metformin|mesh-list
57004000|NCT04419337|Pioglitazone|pioglitazone|mesh-list
57004001|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57004002|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57004003|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004004|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004005|NCT01359059|Pregabalin|pregabalin|mesh-list
57004006|NCT01359059|Analgesics|analgesics|mesh-ancestor
57004007|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
57004008|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004009|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004010|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
57004011|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57004012|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57004013|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004014|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57004015|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57004016|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57004017|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004018|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57004019|NCT02576574|Gemcitabine|gemcitabine|mesh-list
57004020|NCT02576574|Paclitaxel|paclitaxel|mesh-list
57004021|NCT02576574|Carboplatin|carboplatin|mesh-list
57004022|NCT02576574|Pemetrexed|pemetrexed|mesh-list
57004023|NCT02576574|Avelumab|avelumab|mesh-list
57004024|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57004025|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57004026|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004027|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
57004028|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
57004029|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
57004030|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004031|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57004032|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
57004033|NCT02576574|Antiviral Agents|antiviral agents|mesh-ancestor
57004034|NCT02576574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004035|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004036|NCT02576574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57004037|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
57004038|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004039|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57004040|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57004041|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57004042|NCT05189093|Antibodies|antibodies|mesh-list
57004043|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57004044|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
57004045|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004046|NCT01371331|Tacrolimus|tacrolimus|mesh-list
57004047|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57004048|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
57004049|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004050|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57004051|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004052|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004053|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
57004054|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57004055|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004056|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
57004057|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004058|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
57004059|NCT03133793|Vitamins|vitamins|mesh-ancestor
57004060|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
57004061|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004062|NCT03133481|Ropivacaine|ropivacaine|mesh-list
57004063|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
57004064|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
57004065|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004066|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004067|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
57004068|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004069|NCT01366651|Doripenem|doripenem|mesh-list
57004070|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57004071|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004072|NCT05124509|Vaccines|vaccines|mesh-list
57004073|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
57004074|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004075|NCT02864316|Nivolumab|nivolumab|mesh-list
57004076|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57004077|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004078|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57004079|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004080|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
57004081|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57004082|NCT01361399|Aspirin|aspirin|mesh-list
57004083|NCT01361399|Lidocaine|lidocaine|mesh-list
57004084|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
57004085|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
57004086|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004087|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004088|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
57004089|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004090|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57004091|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57004092|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57004093|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57004094|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004095|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57004096|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57004097|NCT01361399|Analgesics|analgesics|mesh-ancestor
57004098|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57004099|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57004100|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57004101|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57004102|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57004103|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57004104|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004105|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
57004106|NCT02862600|Perhexiline|perhexiline|mesh-list
57004107|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57004108|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57004109|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004110|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57004111|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004112|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
57004113|NCT03913195|Ibalizumab|ibalizumab|mesh-list
57004114|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57004115|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57004116|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
57004117|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004119|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57004120|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004121|NCT03556345|Trastuzumab|trastuzumab|mesh-list
57004122|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57004123|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004124|NCT03610230|Iron|iron|mesh-list
57004125|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57004126|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
57004127|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
57004128|NCT03610230|Trace Elements|trace elements|mesh-ancestor
57004129|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
57004130|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004131|NCT03610230|Hematinics|hematinics|mesh-ancestor
57004132|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
57004133|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
57004134|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004135|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004136|NCT05188859|Pemetrexed|pemetrexed|mesh-list
57004137|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004138|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004139|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004140|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57004141|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57004142|NCT02033538|Paclitaxel|paclitaxel|mesh-list
57004143|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57004144|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57004145|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004146|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
57004147|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
57004148|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
57004149|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004150|NCT02792192|Atezolizumab|atezolizumab|mesh-list
57004151|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004152|NCT03609996|Ranibizumab|ranibizumab|mesh-list
57004153|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57004154|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57004155|NCT03609996|Growth Substances|growth substances|mesh-ancestor
57004156|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004157|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
57004158|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004159|NCT02088008|Valsartan|valsartan|mesh-list
57004160|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57004161|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57004162|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57004163|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004164|NCT01361789|Dexamethasone|dexamethasone|mesh-list
57004165|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
57004166|NCT01361789|Etoricoxib|etoricoxib|mesh-list
57004167|NCT01361789|Parecoxib|parecoxib|mesh-list
57004168|NCT01361789|Valdecoxib|valdecoxib|mesh-list
57004169|NCT01361789|BB 1101|bb 1101|mesh-list
57004170|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57004171|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
57004172|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
57004173|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004174|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004175|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004176|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
57004177|NCT01361789|Hormones|hormones|mesh-ancestor
57004178|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004179|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57004180|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004181|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
57004182|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004183|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004184|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57004185|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57004186|NCT01361789|Analgesics|analgesics|mesh-ancestor
57004187|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
57004188|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57004189|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57004190|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57004191|NCT02964507|Fulvestrant|fulvestrant|mesh-list
57004192|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57004193|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004194|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57004195|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57004196|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
57004197|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004198|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004199|NCT02083874|Cannabidiol|cannabidiol|mesh-list
57004200|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
57004201|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
57004202|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57004203|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004205|NCT03634735|Vitamins|vitamins|mesh-ancestor
57004206|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
57004207|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004208|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
57004209|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57004210|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
57004211|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57004212|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57004213|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004214|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
57004215|NCT02084342|Coagulants|coagulants|mesh-ancestor
57004216|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57004217|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
57004218|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004219|NCT01371487|Trametinib|trametinib|mesh-list
57004220|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004221|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57004222|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004223|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004224|NCT02084420|Pantoprazole|pantoprazole|mesh-list
57004225|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57004226|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004227|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57004228|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004229|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004230|NCT01367431|Xanthohumol|xanthohumol|mesh-list
57004231|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004232|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57004233|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57004234|NCT01367431|Growth Substances|growth substances|mesh-ancestor
57004235|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004236|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
57004237|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
57004238|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57004239|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004240|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
57004241|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004242|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
57004243|NCT01364701|Tadalafil|tadalafil|mesh-list
57004244|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
57004245|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57004246|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57004247|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004248|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004249|NCT01364701|Urological Agents|urological agents|mesh-ancestor
57004250|NCT02440464|Fludarabine|fludarabine|mesh-list
57004251|NCT02440464|Bortezomib|bortezomib|mesh-list
57004252|NCT02440464|Melphalan|melphalan|mesh-list
57004253|NCT02440464|Ixazomib|ixazomib|mesh-list
57004254|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004255|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004256|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57004257|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
57004258|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004259|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57004260|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
57004261|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56686294|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
57004262|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
57004263|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004264|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
57004265|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57004266|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004267|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
57004268|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004269|NCT02088398|Ricolinostat|ricolinostat|mesh-list
57004270|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004271|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57004272|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004273|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004274|NCT02084576|Ketorolac|ketorolac|mesh-list
57004275|NCT02084576|Nepafenac|nepafenac|mesh-list
57004276|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57004277|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57004278|NCT02084576|Analgesics|analgesics|mesh-ancestor
57004279|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
57004280|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004281|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004282|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57004283|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57004284|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57004285|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004286|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004287|NCT03131453|CNP520|cnp520|mesh-list
57004288|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004289|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004290|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
57004291|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
57004292|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
57004293|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004294|NCT02084654|Exenatide|exenatide|mesh-list
57004295|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57004296|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004297|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57004298|NCT02084654|Incretins|incretins|mesh-ancestor
57004299|NCT02084654|Hormones|hormones|mesh-ancestor
57004300|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004301|NCT01367743|Epinephrine|epinephrine|mesh-list
57004302|NCT01367743|Norepinephrine|norepinephrine|mesh-list
57004303|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
57004304|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57004305|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57004306|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
57004307|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004308|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004309|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004310|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57004311|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57004312|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
57004313|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004314|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57004315|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
57004316|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
57004317|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
57004318|NCT02084732|Sorafenib|sorafenib|mesh-list
57004319|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004320|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57004321|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004322|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004323|NCT02780401|Vaccines|vaccines|mesh-list
57004324|NCT02780401|Sargramostim|sargramostim|mesh-list
57004325|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
57004326|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004327|NCT02533232|Minocycline|minocycline|mesh-list
57004328|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57004329|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004330|NCT02673151|Edetic Acid|edetic acid|mesh-list
57004331|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57004332|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
57004333|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
57004334|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004335|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
57004336|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57004337|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57004338|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57004339|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
56686367|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57004340|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57004341|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57004342|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004343|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57004344|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
57004345|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
57004346|NCT05042947|Hormones|hormones|mesh-ancestor
57004347|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004348|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004349|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004350|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004351|NCT02082236|Sufentanil|sufentanil|mesh-list
57004352|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57004353|NCT02082236|Narcotics|narcotics|mesh-ancestor
57004354|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004355|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004356|NCT02082236|Analgesics|analgesics|mesh-ancestor
57004357|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
57004358|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004359|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57004360|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57004361|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
57004362|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
57004363|NCT03557996|Listerine|listerine|mesh-list
57004364|NCT03557996|Fluorides|fluorides|mesh-list
57004365|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
57004366|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
57004367|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
57004368|NCT03557996|Protective Agents|protective agents|mesh-ancestor
57004369|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004370|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57004371|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004372|NCT03131219|Ravulizumab|ravulizumab|mesh-list
57004373|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57004374|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57004375|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
57004376|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004377|NCT02296801|Letrozole|letrozole|mesh-list
57004378|NCT02296801|Palbociclib|palbociclib|mesh-list
57004379|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004380|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57004381|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57004382|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004383|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004384|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57004385|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
57004386|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004387|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004388|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57004389|NCT02859324|Nivolumab|nivolumab|mesh-list
57004390|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57004391|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004392|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57004393|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004394|NCT02085590|Vaccines|vaccines|mesh-list
57004395|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
57004396|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
57004397|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004398|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57004399|NCT02143063|Cocaine|cocaine|mesh-list
57004400|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
57004401|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
57004402|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004403|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004404|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
57004405|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004406|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57004407|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57004408|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57004409|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57004410|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004411|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
57004412|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004413|NCT02088866|Lidocaine|lidocaine|mesh-list
57004414|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
57004416|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004417|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004418|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
57004419|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004420|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57004421|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57004422|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57004423|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57004424|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004425|NCT02859246|Guaifenesin|guaifenesin|mesh-list
57004426|NCT02859246|Expectorants|expectorants|mesh-ancestor
57004427|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
57004428|NCT02088944|Infliximab|infliximab|mesh-list
57004429|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
57004430|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004431|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57004432|NCT02073097|Acyclovir|acyclovir|mesh-list
57004433|NCT02073097|Prednisone|prednisone|mesh-list
57004434|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
57004435|NCT02073097|Rituximab|rituximab|mesh-list
57004436|NCT02073097|Doxorubicin|doxorubicin|mesh-list
57004437|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57004438|NCT02073097|Vincristine|vincristine|mesh-list
57004439|NCT02073097|Lenograstim|lenograstim|mesh-list
57004440|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57004441|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
57004442|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004443|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57004444|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57004445|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
57004446|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004447|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004448|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57004449|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57004450|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57004451|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57004452|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57004453|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004454|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57004455|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
57004456|NCT02073097|Hormones|hormones|mesh-ancestor
57004457|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004458|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57004459|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57004460|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
57004461|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
57004462|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
57004463|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57004464|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
57004465|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004466|NCT02921997|Vaccines|vaccines|mesh-list
57004467|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
57004468|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004469|NCT04989829|Omeprazole|omeprazole|mesh-list
57004470|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57004471|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004472|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57004473|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004474|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004475|NCT02791490|Metformin|metformin|mesh-list
57004476|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57004477|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57004478|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004479|NCT02791490|Incretins|incretins|mesh-ancestor
57004480|NCT02791490|Hormones|hormones|mesh-ancestor
57004481|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004482|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57004483|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
57004484|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004485|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004486|NCT04635631|Talazoparib|talazoparib|mesh-list
57004487|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57004488|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686539|NCT00814320|Antibodies|antibodies|mesh-list
57004489|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004490|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004491|NCT02085824|Enoxaparin|enoxaparin|mesh-list
57004492|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
57004493|NCT02085824|Dabigatran|dabigatran|mesh-list
57004494|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57004495|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
57004496|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57004497|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
57004498|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004499|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004500|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
57004501|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57004502|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57004503|NCT01368445|Azelastine|azelastine|mesh-list
57004504|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57004505|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
57004506|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004507|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004508|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57004509|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
57004510|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
57004511|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004512|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004513|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57004514|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57004515|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57004516|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
57004517|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
57004518|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004519|NCT02085902|Ropivacaine|ropivacaine|mesh-list
57004520|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
57004521|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
57004522|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004523|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004524|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
57004525|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004526|NCT01368757|Lenalidomide|lenalidomide|mesh-list
57004527|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
57004528|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004529|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57004530|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57004531|NCT01368757|Growth Substances|growth substances|mesh-ancestor
57004532|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
57004533|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004534|NCT02086292|Lidocaine|lidocaine|mesh-list
57004535|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
57004536|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
57004537|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004538|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004539|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
57004540|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004541|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57004542|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57004543|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57004544|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57004545|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004546|NCT04431375|Tenofovir|tenofovir|mesh-list
57004547|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
57004548|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004549|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57004550|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57004551|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004552|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004553|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57004554|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57004555|NCT02425644|Teriflunomide|teriflunomide|mesh-list
57004556|NCT02425644|Ponesimod|ponesimod|mesh-list
57004557|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57004558|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57004559|NCT02425644|Analgesics|analgesics|mesh-ancestor
57004560|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
57004561|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004562|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004563|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57004564|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57004565|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57004566|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
57004567|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57004568|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004569|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
57004570|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57004571|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
57004572|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57004573|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
57004574|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004575|NCT02086526|Metformin|metformin|mesh-list
57004576|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57004577|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004578|NCT04180995|Axitinib|axitinib|mesh-list
57004579|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004580|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57004581|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004582|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004583|NCT02089178|Remifentanil|remifentanil|mesh-list
57004584|NCT02089178|Anesthetics|anesthetics|mesh-list
57004585|NCT02089178|Propofol|propofol|mesh-list
57004586|NCT02089178|Sevoflurane|sevoflurane|mesh-list
57004587|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004588|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004589|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57004590|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57004591|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
57004592|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57004593|NCT02089178|Narcotics|narcotics|mesh-ancestor
57004594|NCT02089178|Analgesics|analgesics|mesh-ancestor
57004595|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
57004596|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004597|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57004598|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57004599|NCT02089256|Liraglutide|liraglutide|mesh-list
57004600|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57004601|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004602|NCT02089256|Incretins|incretins|mesh-ancestor
57004603|NCT02089256|Hormones|hormones|mesh-ancestor
57004604|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004605|NCT02861664|Fluorides|fluorides|mesh-list
57004606|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
57004607|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
57004608|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
57004609|NCT02861664|Protective Agents|protective agents|mesh-ancestor
57004610|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004611|NCT02086838|Dextrans|dextrans|mesh-list
57004612|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
57004613|NCT02086838|Hematinics|hematinics|mesh-list
57004614|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
57004615|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
57004616|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
57004617|NCT02236962|Pioglitazone|pioglitazone|mesh-list
57004618|NCT02236962|Ephedrine|ephedrine|mesh-list
57004619|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57004620|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896115|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
57004621|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57004622|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
57004623|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
57004624|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004625|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57004626|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
57004627|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004628|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004629|NCT02086994|Misoprostol|misoprostol|mesh-list
57004630|NCT02086994|Carbetocin|carbetocin|mesh-list
57004631|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57004632|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
57004633|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57004634|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004635|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57004636|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004637|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
57004638|NCT05664711|Bupivacaine|bupivacaine|mesh-list
57004639|NCT05664711|Anesthetics, Local|anesthetics, local|mesh-ancestor
57004640|NCT05664711|Anesthetics|anesthetics|mesh-ancestor
57004641|NCT05664711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004642|NCT05664711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004643|NCT05664711|Sensory System Agents|sensory system agents|mesh-ancestor
57004644|NCT05664711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004645|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57004646|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57004647|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004648|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57004649|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004650|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004651|NCT03284853|Latanoprost|latanoprost|mesh-list
57004652|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57004653|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57004654|NCT02087384|Vaccines|vaccines|mesh-list
57004655|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
57004656|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004657|NCT02087462|Vitamins|vitamins|mesh-list
57004658|NCT02087462|Thiamine|thiamine|mesh-list
57004659|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
57004660|NCT02087462|Diclofenac|diclofenac|mesh-list
57004661|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
57004662|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004663|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57004664|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57004665|NCT02087462|Analgesics|analgesics|mesh-ancestor
57004666|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
57004667|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004668|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57004669|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57004670|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57004671|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004672|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004673|NCT02087540|Telmisartan|telmisartan|mesh-list
57004674|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57004675|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57004676|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57004677|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
57004678|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004679|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57004680|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57004681|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004682|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57004683|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57004684|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57004685|NCT03055221|Treprostinil|treprostinil|mesh-list
57004686|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57004687|NCT03206463|Dronabinol|dronabinol|mesh-list
57004688|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
57004689|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004690|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57004691|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57004692|NCT03206463|Analgesics|analgesics|mesh-ancestor
57004693|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
57004694|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004695|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57004696|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57004697|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004698|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004699|NCT03206463|Hormones|hormones|mesh-ancestor
57004700|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004701|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
57004702|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57004703|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
57004704|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004705|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
57004706|NCT02091674|Protective Agents|protective agents|mesh-ancestor
57004707|NCT01218555|Lenalidomide|lenalidomide|mesh-list
57004708|NCT01218555|Everolimus|everolimus|mesh-list
57004709|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
57004710|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004711|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57004712|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57004713|NCT01218555|Growth Substances|growth substances|mesh-ancestor
57004714|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
57004715|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004716|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57004717|NCT02091830|Acetaminophen|acetaminophen|mesh-list
57004718|NCT02091830|Cortisone|cortisone|mesh-list
57004719|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57004720|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
57004721|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57004722|NCT02091830|Analgesics|analgesics|mesh-ancestor
57004723|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
57004724|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004725|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004726|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
57004727|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57004728|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
57004729|NCT01111305|Reslizumab|reslizumab|mesh-list
57004730|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57004731|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
57004732|NCT01111305|Filaricides|filaricides|mesh-ancestor
57004733|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
57004734|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
57004735|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57004736|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004737|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
57004738|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004739|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004740|NCT03752307|Prednisone|prednisone|mesh-list
57004741|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
57004742|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
57004743|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57004744|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
57004745|NCT03752307|Hormones|hormones|mesh-ancestor
57004746|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004747|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004748|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57004749|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004750|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
57004751|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
57004752|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004753|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004754|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57004755|NCT03752307|Protective Agents|protective agents|mesh-ancestor
57004756|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57004757|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57004758|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
57004759|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004760|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004761|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
57004762|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
57004763|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
57004764|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57004765|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
57004766|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57004767|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004768|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004769|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
57004770|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
57004771|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004772|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004773|NCT02091908|Lactitol|lactitol|mesh-list
57004774|NCT02091908|Vaccines|vaccines|mesh-list
57004775|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
57004776|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004777|NCT02091908|Cathartics|cathartics|mesh-ancestor
57004778|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004779|NCT03627897|Bupivacaine|bupivacaine|mesh-list
57004780|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
57004781|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
57004782|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004783|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004784|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
57004785|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004786|NCT01372111|Cisplatin|cisplatin|mesh-list
57004787|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004788|NCT03125941|Dexamethasone|dexamethasone|mesh-list
57004789|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686817|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004790|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
57004791|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
57004792|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004793|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004794|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004795|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
57004796|NCT03125941|Hormones|hormones|mesh-ancestor
57004797|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004798|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57004799|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004800|NCT02092142|Vaccines|vaccines|mesh-list
57004801|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
57004802|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004803|NCT02095886|BMS-955176|bms-955176|mesh-list
57004804|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57004805|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57004806|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
57004807|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004808|NCT01372579|Carboplatin|carboplatin|mesh-list
57004809|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004810|NCT02090036|Lumefantrine|lumefantrine|mesh-list
57004811|NCT02090036|Artemether|artemether|mesh-list
57004812|NCT02090036|Primaquine|primaquine|mesh-list
57004813|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57004814|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
57004815|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57004816|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57004817|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004818|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57004819|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57004820|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004821|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
57004822|NCT02092376|Vitamin D|vitamin d|mesh-list
57004823|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57004824|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004825|NCT02092376|Vitamins|vitamins|mesh-ancestor
57004826|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
57004827|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57004828|NCT05452928|Valacyclovir|valacyclovir|mesh-list
57004829|NCT05452928|Acyclovir|acyclovir|mesh-list
57004830|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
57004831|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004832|NCT03125395|Ivacaftor|ivacaftor|mesh-list
57004833|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57004834|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57004835|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004836|NCT01369303|Tenofovir|tenofovir|mesh-list
57004837|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
57004838|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004839|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57004840|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57004841|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004842|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004843|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57004844|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57004845|NCT02092532|Aflibercept|aflibercept|mesh-list
57004846|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57004847|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57004848|NCT02092532|Growth Substances|growth substances|mesh-ancestor
57004849|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004850|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
57004851|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004852|NCT02092766|Artesunate|artesunate|mesh-list
57004853|NCT02092766|Quinine|quinine|mesh-list
57004854|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
57004855|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57004856|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57004857|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004858|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004859|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
57004860|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
57004861|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57004862|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
57004863|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57004864|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004865|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57004866|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004867|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57004868|NCT02092766|Analgesics|analgesics|mesh-ancestor
57004869|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
57004870|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57004871|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
57004872|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57004873|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
57004874|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004875|NCT02721069|Diazepam|diazepam|mesh-list
57004876|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57004877|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
57004878|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
57004879|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
57004880|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004881|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004882|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004883|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57004884|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004885|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57004886|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57004887|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57004888|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57004889|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57004890|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57004891|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
57004892|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
57004893|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
57004894|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
57004895|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004896|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004897|NCT02093000|Bevacizumab|bevacizumab|mesh-list
57004898|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57004899|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004900|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57004901|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57004902|NCT02093000|Growth Substances|growth substances|mesh-ancestor
57004903|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004904|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
57004905|NCT00261807|Daptomycin|daptomycin|mesh-list
57004906|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57004907|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004908|NCT05672901|Estradiol|estradiol|mesh-list
57004909|NCT05672901|Estrogens|estrogens|mesh-ancestor
57004910|NCT05672901|Hormones|hormones|mesh-ancestor
57004911|NCT05672901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57004912|NCT05672901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004913|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
57004914|NCT02090504|Oxazepam|oxazepam|mesh-list
57004915|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57004916|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57004917|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
57004918|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
57004919|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004920|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004921|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57004922|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57004923|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57004924|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57004925|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
57004926|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
57004927|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004928|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004929|NCT01567059|Cytarabine|cytarabine|mesh-list
57004930|NCT01567059|Decitabine|decitabine|mesh-list
57004931|NCT01567059|Azacitidine|azacitidine|mesh-list
57004932|NCT01567059|Tosedostat|tosedostat|mesh-list
57004933|NCT01567059|Glycine|glycine|mesh-list
57004934|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57004935|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
57004936|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004937|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004938|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
57004939|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004940|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57004941|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
57004942|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004943|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004944|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
56686967|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57004945|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004946|NCT02090738|Amoxicillin|amoxicillin|mesh-list
57004947|NCT02090738|Clarithromycin|clarithromycin|mesh-list
57004948|NCT02090738|Acetazolamide|acetazolamide|mesh-list
57004949|NCT02090738|Esomeprazole|esomeprazole|mesh-list
57004950|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57004951|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57004952|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57004953|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57004954|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57004955|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004956|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004957|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57004958|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57004959|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57004960|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
57004961|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57004962|NCT02090738|Diuretics|diuretics|mesh-ancestor
57004963|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
57004964|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004965|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
57004966|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57004967|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57004968|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57004969|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57004970|NCT03441555|Venetoclax|venetoclax|mesh-list
57004971|NCT03441555|Alvocidib|alvocidib|mesh-list
57004972|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57004973|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
57004974|NCT03441555|Growth Substances|growth substances|mesh-ancestor
57004975|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004976|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57004977|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57004978|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004979|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57004980|NCT03346239|Citalopram|citalopram|mesh-list
57004981|NCT03346239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57004982|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57004983|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57004984|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57004985|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57004986|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
57004987|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004988|NCT03346239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57004989|NCT03346239|Antidepressive Agents|antidepressive agents|mesh-ancestor
57004990|NCT03346239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57004991|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
57004992|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57004993|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57004994|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57004995|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57004996|NCT05218161|Analgesics|analgesics|mesh-ancestor
57004997|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
57004998|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57004999|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57005000|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57005001|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57005002|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
57005003|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005004|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005005|NCT02861586|Vaccines|vaccines|mesh-list
57005006|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
57005007|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005008|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57005009|NCT02099240|Amoxicillin|amoxicillin|mesh-list
57005010|NCT02099240|Azithromycin|azithromycin|mesh-list
57005011|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
57005012|NCT02099240|Vancomycin|vancomycin|mesh-list
57005013|NCT02099240|Clarithromycin|clarithromycin|mesh-list
57005014|NCT02099240|Doxycycline|doxycycline|mesh-list
57005015|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
57005016|NCT02099240|Levofloxacin|levofloxacin|mesh-list
57005017|NCT02099240|Ofloxacin|ofloxacin|mesh-list
57005018|NCT02099240|Minocycline|minocycline|mesh-list
57005019|NCT02099240|Rifampin|rifampin|mesh-list
57005020|NCT02099240|Clindamycin|clindamycin|mesh-list
57005021|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
57005022|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
57005023|NCT02099240|Gentamicins|gentamicins|mesh-list
57005024|NCT02099240|Isoniazid|isoniazid|mesh-list
57005025|NCT02099240|Meropenem|meropenem|mesh-list
56687041|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
57005026|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
57005027|NCT02099240|Tazobactam|tazobactam|mesh-list
57005028|NCT02099240|Linezolid|linezolid|mesh-list
57005029|NCT02099240|Cycloserine|cycloserine|mesh-list
57005030|NCT02099240|Piperacillin|piperacillin|mesh-list
57005031|NCT02099240|Metronidazole|metronidazole|mesh-list
57005032|NCT02099240|Penicillins|penicillins|mesh-list
57005033|NCT02099240|Imipenem|imipenem|mesh-list
57005034|NCT02099240|Amikacin|amikacin|mesh-list
57005035|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
57005036|NCT02099240|Erythromycin|erythromycin|mesh-list
57005037|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
57005038|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
57005039|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
57005040|NCT02099240|Ceftazidime|ceftazidime|mesh-list
57005041|NCT02099240|Colistin|colistin|mesh-list
57005042|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57005043|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
57005044|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
57005045|NCT02099240|Ampicillin|ampicillin|mesh-list
57005046|NCT02099240|Rifabutin|rifabutin|mesh-list
57005047|NCT02099240|Rifapentine|rifapentine|mesh-list
57005048|NCT02099240|Cefuroxime|cefuroxime|mesh-list
57005049|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
57005050|NCT02099240|Fosfomycin|fosfomycin|mesh-list
57005051|NCT02099240|Mupirocin|mupirocin|mesh-list
57005052|NCT02099240|Cefepime|cefepime|mesh-list
57005053|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57005054|NCT02099240|Paromomycin|paromomycin|mesh-list
57005055|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
57005056|NCT02099240|Polymyxins|polymyxins|mesh-list
57005057|NCT02099240|Aztreonam|aztreonam|mesh-list
57005058|NCT02099240|Neomycin|neomycin|mesh-list
57005059|NCT02099240|Bacitracin|bacitracin|mesh-list
57005060|NCT02099240|Cefotaxime|cefotaxime|mesh-list
57005061|NCT02099240|Cefoxitin|cefoxitin|mesh-list
57005062|NCT02099240|Sulbactam|sulbactam|mesh-list
57005063|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
57005064|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
57005065|NCT02099240|Polymyxin B|polymyxin b|mesh-list
57005066|NCT02099240|Cefixime|cefixime|mesh-list
57005067|NCT02099240|Cefdinir|cefdinir|mesh-list
57005068|NCT02099240|Penicillin G|penicillin g|mesh-list
57005069|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
57005070|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
57005071|NCT02099240|Norfloxacin|norfloxacin|mesh-list
57005072|NCT02099240|Cloxacillin|cloxacillin|mesh-list
57005073|NCT02099240|Cefprozil|cefprozil|mesh-list
57005074|NCT02099240|Cephalosporins|cephalosporins|mesh-list
57005075|NCT02099240|Oxacillin|oxacillin|mesh-list
57005076|NCT02099240|Streptomycin|streptomycin|mesh-list
57005077|NCT02099240|Nafcillin|nafcillin|mesh-list
57005078|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
57005079|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
57005080|NCT02099240|Ticarcillin|ticarcillin|mesh-list
57005081|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
57005082|NCT02099240|Penicillin V|penicillin v|mesh-list
57005083|NCT02099240|Sultamicillin|sultamicillin|mesh-list
57005084|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
57005085|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
57005086|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
57005087|NCT02099240|Cefoperazone|cefoperazone|mesh-list
57005088|NCT02099240|Ethionamide|ethionamide|mesh-list
57005089|NCT02099240|Kanamycin|kanamycin|mesh-list
57005090|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
57005091|NCT02099240|Ceftibuten|ceftibuten|mesh-list
57005092|NCT02099240|Lincomycin|lincomycin|mesh-list
57005093|NCT02099240|Demeclocycline|demeclocycline|mesh-list
57005094|NCT02099240|Dirithromycin|dirithromycin|mesh-list
57005095|NCT02099240|Cefotetan|cefotetan|mesh-list
57005096|NCT02099240|Capreomycin|capreomycin|mesh-list
57005097|NCT02099240|Cefaclor|cefaclor|mesh-list
57005098|NCT02099240|Mafenide|mafenide|mesh-list
57005099|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
57005100|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
57005101|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
57005102|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
57005103|NCT02099240|Tobramycin|tobramycin|mesh-list
57005104|NCT02099240|Netilmicin|netilmicin|mesh-list
57005105|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
57005106|NCT02099240|Novobiocin|novobiocin|mesh-list
57005107|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
57005108|NCT02099240|Virginiamycin|virginiamycin|mesh-list
57005109|NCT02099240|Enoxacin|enoxacin|mesh-list
57005110|NCT02099240|Methicillin|methicillin|mesh-list
57005111|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57005112|NCT02099240|Bacampicillin|bacampicillin|mesh-list
57005113|NCT02099240|Carbenicillin|carbenicillin|mesh-list
57005114|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
57005115|NCT02099240|Mezlocillin|mezlocillin|mesh-list
57005116|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
57005117|NCT02099240|Cefamandole|cefamandole|mesh-list
57005118|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
57005119|NCT02099240|Cefonicid|cefonicid|mesh-list
57005120|NCT02099240|Cefmetazole|cefmetazole|mesh-list
57005121|NCT02099240|Loracarbef|loracarbef|mesh-list
57005122|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
57005123|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
57005124|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
57005125|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
57005126|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
57005127|NCT02099240|Methacycline|methacycline|mesh-list
57005128|NCT02099240|Tetracycline|tetracycline|mesh-list
57005129|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
57005130|NCT02099240|Dalfopristin|dalfopristin|mesh-list
57005131|NCT02099240|Spectinomycin|spectinomycin|mesh-list
57005132|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57005133|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
57005134|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
57005135|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
57005136|NCT02099240|Methenamine|methenamine|mesh-list
57005137|NCT02099240|Sulperazone|sulperazone|mesh-list
57005138|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
57005139|NCT02099240|Cinoxacin|cinoxacin|mesh-list
57005140|NCT02099240|Trimethoprim|trimethoprim|mesh-list
57005141|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
57005142|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
57005143|NCT02099240|Procaine|procaine|mesh-list
57005144|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57005145|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57005146|NCT02099240|Cilastatin|cilastatin|mesh-list
57005147|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005148|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
57005149|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57005150|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57005151|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005152|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005153|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005154|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57005155|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
57005156|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57005157|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005158|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57005159|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57005160|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57005161|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57005162|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57005163|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57005164|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
57005165|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57005166|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57005167|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57005168|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57005169|NCT02099240|Renal Agents|renal agents|mesh-ancestor
57005170|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
57005171|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57005172|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57005173|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57005174|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57005175|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57005176|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57005177|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57005178|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57005179|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57005180|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
57005181|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57005182|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57005183|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57005184|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57005185|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57005186|NCT02099240|Analgesics|analgesics|mesh-ancestor
57005187|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
57005188|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005189|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57005190|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57005191|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
57005192|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57005193|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57005194|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57005195|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
57005196|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
57005197|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
57005198|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005199|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57005200|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57005201|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57005202|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57005203|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
57005204|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
57005205|NCT02245230|Trimethaphan|trimethaphan|mesh-list
57005206|NCT02245230|Phenylephrine|phenylephrine|mesh-list
57005207|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
57005208|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
57005209|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57005210|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
57005211|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
57005212|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005213|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005214|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
57005215|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57005216|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
57005217|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
57005218|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57005219|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57005220|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57005221|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
57005222|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005223|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005224|NCT02245230|Protective Agents|protective agents|mesh-ancestor
57005225|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57005226|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
57005227|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57005228|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
57005229|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57005230|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57005231|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
57005232|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
57005233|NCT05215743|Antioxidants|antioxidants|mesh-list
57005234|NCT05215743|Deferoxamine|deferoxamine|mesh-list
57005235|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
57005236|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005237|NCT05215743|Expectorants|expectorants|mesh-ancestor
57005238|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
57005239|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57005240|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005241|NCT05215743|Protective Agents|protective agents|mesh-ancestor
57005242|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005243|NCT05215743|Siderophores|siderophores|mesh-ancestor
57005244|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57005245|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
57005246|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
57005247|NCT02099396|Gemcitabine|gemcitabine|mesh-list
57005248|NCT02099396|Docetaxel|docetaxel|mesh-list
57005249|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57005250|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
57005251|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005252|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005253|NCT02099396|Antiviral Agents|antiviral agents|mesh-ancestor
57005254|NCT02099396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005255|NCT02099396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005256|NCT02099396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57005257|NCT02099396|Immunologic Factors|immunologic factors|mesh-ancestor
57005258|NCT02099396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005259|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
57005260|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
57005261|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
57005262|NCT05215665|Lenvatinib|lenvatinib|mesh-list
57005263|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005264|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57005265|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005266|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005267|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
57005268|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57005269|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57005270|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
56687264|NCT00837434|Adalimumab|adalimumab|mesh-list
57005271|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005272|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57005273|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57005274|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005275|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005276|NCT05217069|Leucovorin|leucovorin|mesh-list
57005277|NCT05217069|Folic Acid|folic acid|mesh-list
57005278|NCT05217069|Irinotecan|irinotecan|mesh-list
57005279|NCT05217069|Cetuximab|cetuximab|mesh-list
57005280|NCT05217069|Avelumab|avelumab|mesh-list
57005281|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
57005282|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57005283|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57005284|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005285|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005286|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005287|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57005288|NCT05217069|Antidotes|antidotes|mesh-ancestor
57005289|NCT05217069|Protective Agents|protective agents|mesh-ancestor
57005290|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005291|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
57005292|NCT05217069|Vitamins|vitamins|mesh-ancestor
57005293|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
57005294|NCT05217069|Hematinics|hematinics|mesh-ancestor
57005295|NCT02065635|Propofol|propofol|mesh-list
57005296|NCT02065635|Sevoflurane|sevoflurane|mesh-list
57005297|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57005298|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005299|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005300|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57005301|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
57005302|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
57005303|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57005304|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57005305|NCT03628053|Blinatumomab|blinatumomab|mesh-list
57005306|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
57005307|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005308|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57005309|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57005310|NCT02100176|Dopamine|dopamine|mesh-list
57005311|NCT02100176|Rotigotine|rotigotine|mesh-list
57005312|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
57005313|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
57005314|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005315|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005316|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005317|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57005318|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
57005319|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
57005320|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005321|NCT02100176|Protective Agents|protective agents|mesh-ancestor
57005322|NCT02250482|Factor VIII|factor viii|mesh-list
57005323|NCT02250482|Coagulants|coagulants|mesh-ancestor
57005324|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57005325|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57005326|NCT05189145|Hormones|hormones|mesh-list
57005327|NCT05189145|Estradiol|estradiol|mesh-list
57005328|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57005329|NCT05189145|Progesterone|progesterone|mesh-list
57005330|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
57005331|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005332|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005333|NCT05189145|Estrogens|estrogens|mesh-ancestor
57005334|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57005335|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
57005336|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57005337|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57005338|NCT05189145|Progestins|progestins|mesh-ancestor
57005339|NCT04967079|Trametinib|trametinib|mesh-list
57005340|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005341|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57005342|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005343|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005344|NCT03556592|Metoprolol|metoprolol|mesh-list
57005345|NCT03556592|Midazolam|midazolam|mesh-list
57005346|NCT03556592|Caffeine|caffeine|mesh-list
57005347|NCT03556592|Omeprazole|omeprazole|mesh-list
57005348|NCT03556592|Warfarin|warfarin|mesh-list
57005349|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57005350|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57005351|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005352|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005353|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57005354|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57005355|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57005356|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57005357|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
57005358|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
57005359|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
57005360|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
57005361|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005362|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005363|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
57005364|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57005365|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57005366|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005367|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57005368|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57005369|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
57005370|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57005371|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57005372|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57005373|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57005374|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57005375|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
57005376|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
57005377|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005378|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57005379|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57005380|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57005381|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
57005382|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
57005383|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57005384|NCT04964193|Cyproterone|cyproterone|mesh-list
57005385|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
57005386|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57005387|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57005388|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57005389|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
57005390|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57005391|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005392|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57005393|NCT04964193|Estrogens|estrogens|mesh-ancestor
57005394|NCT04964193|Hormones|hormones|mesh-ancestor
57005395|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005396|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
57005397|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
57005398|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005399|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57005400|NCT02100488|Insulin|insulin|mesh-list
57005401|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57005402|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57005403|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005404|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
57005405|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57005406|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005407|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57005408|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
57005409|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57005410|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005411|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005412|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005413|NCT04865497|Vaccines|vaccines|mesh-list
57005414|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
57005415|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005416|NCT05665725|Siltuximab|siltuximab|mesh-list
57005417|NCT05665725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57005418|NCT05665725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005419|NCT05665725|Immunologic Factors|immunologic factors|mesh-ancestor
57005420|NCT05665725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005421|NCT02098148|Xenon|xenon|mesh-list
57005422|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57005423|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
57005424|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
57005425|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005426|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005427|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57005428|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57005429|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005430|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005431|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57005432|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57005433|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005434|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
57005435|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005436|NCT05168527|Gemcitabine|gemcitabine|mesh-list
57005437|NCT05168527|Paclitaxel|paclitaxel|mesh-list
57005438|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57005439|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005440|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
57005441|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
57005442|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
57005443|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005444|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57005445|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
57005446|NCT05168527|Antiviral Agents|antiviral agents|mesh-ancestor
57005447|NCT05168527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005448|NCT05168527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005449|NCT05168527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57005450|NCT05168527|Immunologic Factors|immunologic factors|mesh-ancestor
57005451|NCT05168527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005452|NCT02098460|Cilostazol|cilostazol|mesh-list
57005453|NCT02098460|Atorvastatin|atorvastatin|mesh-list
57005454|NCT02098460|Probucol|probucol|mesh-list
57005455|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57005456|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57005457|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
57005458|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005459|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57005460|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57005461|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005462|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57005463|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
57005464|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005465|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005466|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57005467|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
57005468|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57005469|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57005470|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57005471|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
57005472|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57005473|NCT02098460|Protective Agents|protective agents|mesh-ancestor
57005474|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57005475|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57005476|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
57005477|NCT02095574|Venetoclax|venetoclax|mesh-list
57005478|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005479|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
57005480|NCT04230265|Fludarabine|fludarabine|mesh-list
57005481|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57005482|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
57005483|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005484|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57005485|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57005486|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
57005487|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005488|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005489|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57005490|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57005491|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005492|NCT02095730|Vitamins|vitamins|mesh-list
57005493|NCT02095730|Riboflavin|riboflavin|mesh-list
57005494|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
57005495|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
57005496|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005497|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57005498|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
57005499|NCT02102438|Paclitaxel|paclitaxel|mesh-list
57005500|NCT02102438|Carboplatin|carboplatin|mesh-list
57005501|NCT02102438|Trastuzumab|trastuzumab|mesh-list
57005502|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57005503|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005504|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
57005505|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
57005506|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
57005507|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005508|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57005509|NCT02098616|Asunaprevir|asunaprevir|mesh-list
57005510|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
57005511|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005512|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005513|NCT02102516|Ketorolac|ketorolac|mesh-list
57005514|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57005515|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57005516|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57005517|NCT02102516|Analgesics|analgesics|mesh-ancestor
57005518|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
57005519|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005520|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005521|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57005522|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57005523|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57005524|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005525|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005526|NCT02106182|Silodosin|silodosin|mesh-list
57005527|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57005528|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57005529|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57005530|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
57005531|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005532|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005533|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005534|NCT02106182|Urological Agents|urological agents|mesh-ancestor
57005535|NCT01369693|Lobeline|lobeline|mesh-list
57005536|NCT01369693|Nicotine|nicotine|mesh-list
57005537|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57005538|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
57005539|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005540|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005541|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57005542|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57005543|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
57005544|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005545|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005546|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
57005547|NCT02102594|Bortezomib|bortezomib|mesh-list
57005548|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005549|NCT02102672|Trimetazidine|trimetazidine|mesh-list
57005550|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
57005551|NCT03121261|Clonidine|clonidine|mesh-list
57005552|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
57005553|NCT03121261|Analgesics|analgesics|mesh-ancestor
57005554|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
57005555|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005556|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005557|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57005558|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
57005559|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
57005560|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57005561|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57005562|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57005563|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
57005564|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005565|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005566|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
57005567|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
57005568|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005569|NCT04249323|Prednisone|prednisone|mesh-list
57005570|NCT04249323|Cortisone|cortisone|mesh-list
57005571|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57005572|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
57005573|NCT04249323|Hormones|hormones|mesh-ancestor
57005574|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005575|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005576|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57005577|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005578|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57005579|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57005580|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005581|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005582|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57005583|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
57005584|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005585|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005586|NCT02102828|Aspirin|aspirin|mesh-list
57005587|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57005588|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57005589|NCT02102828|Analgesics|analgesics|mesh-ancestor
57005590|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
57005591|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005592|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005593|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57005594|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57005595|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57005596|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57005597|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005598|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57005599|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57005600|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005601|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
57005602|NCT01372423|Lubiprostone|lubiprostone|mesh-list
57005603|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57005604|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894833|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
57005605|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005606|NCT04218357|Probenecid|probenecid|mesh-list
57005607|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
57005608|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
57005609|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57005610|NCT04218357|Renal Agents|renal agents|mesh-ancestor
57005611|NCT02106650|Leucovorin|leucovorin|mesh-list
57005612|NCT02106650|Folic Acid|folic acid|mesh-list
57005613|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
57005614|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
57005615|NCT02106650|Vitamins|vitamins|mesh-ancestor
57005616|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
57005617|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005618|NCT02106650|Antidotes|antidotes|mesh-ancestor
57005619|NCT02106650|Protective Agents|protective agents|mesh-ancestor
57005620|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
57005621|NCT02106650|Hematinics|hematinics|mesh-ancestor
57005622|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57005623|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005624|NCT01376011|Quercetin|quercetin|mesh-list
57005625|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
57005626|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005627|NCT01376011|Protective Agents|protective agents|mesh-ancestor
57005628|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005629|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
57005630|NCT04033107|Metformin|metformin|mesh-list
57005631|NCT04033107|Vitamins|vitamins|mesh-ancestor
57005632|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
57005633|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005634|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57005635|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
57005636|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005637|NCT04033107|Protective Agents|protective agents|mesh-ancestor
57005638|NCT02106806|Zinc|zinc|mesh-list
57005639|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
57005640|NCT02106806|Trace Elements|trace elements|mesh-ancestor
57005641|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
57005642|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005643|NCT02106806|Astringents|astringents|mesh-ancestor
57005644|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
57005645|NCT02966119|Aspirin|aspirin|mesh-list
57005646|NCT02966119|Clopidogrel|clopidogrel|mesh-list
57005647|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57005648|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57005649|NCT02966119|Analgesics|analgesics|mesh-ancestor
57005650|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
57005651|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005652|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005653|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57005654|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57005655|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57005656|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57005657|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005658|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57005659|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57005660|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005661|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
57005662|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57005663|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57005664|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57005665|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
57005666|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005667|NCT02101892|Amitriptyline|amitriptyline|mesh-list
57005668|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57005669|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
57005670|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57005671|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57005672|NCT02101892|Analgesics|analgesics|mesh-ancestor
57005673|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
57005674|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005675|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005676|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57005677|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57005678|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57005679|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005680|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
57005681|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005682|NCT03634111|Morphine|morphine|mesh-list
57005683|NCT03634111|Ropivacaine|ropivacaine|mesh-list
57005684|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57005685|NCT03634111|Narcotics|narcotics|mesh-ancestor
57005686|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005687|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005688|NCT03634111|Analgesics|analgesics|mesh-ancestor
57005689|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
57005690|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005691|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
57005692|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
57005693|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57005694|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57005695|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57005696|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
57005697|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005698|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005699|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57005700|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57005701|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
57005702|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005703|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
57005704|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57005705|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
57005706|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57005707|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005708|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57005709|NCT02250794|Insulin|insulin|mesh-list
57005710|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57005711|NCT02250794|Metformin|metformin|mesh-list
57005712|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
57005713|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57005714|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
57005715|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57005716|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005717|NCT02250794|Incretins|incretins|mesh-ancestor
57005718|NCT02250794|Hormones|hormones|mesh-ancestor
57005719|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005720|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57005721|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
57005722|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005723|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005724|NCT02103374|Terbutaline|terbutaline|mesh-list
57005725|NCT02103374|Ipratropium|ipratropium|mesh-list
57005726|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57005727|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
57005728|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005729|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005730|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57005731|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
57005732|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57005733|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
57005734|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005735|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005736|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
57005737|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
57005738|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57005739|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57005740|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57005741|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57005742|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
57005743|NCT03555188|Ondansetron|ondansetron|mesh-list
57005744|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
57005745|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
57005746|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005747|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005748|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57005749|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
57005750|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
57005751|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57005752|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
57005753|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005754|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005755|NCT03555188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57005756|NCT03555188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57005757|NCT03555188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005758|NCT03555188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57005759|NCT03555188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57005760|NCT05707221|Chlorhexidine|chlorhexidine|mesh-list
57005761|NCT05707221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57005762|NCT05707221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005763|NCT05707221|Disinfectants|disinfectants|mesh-ancestor
57005764|NCT03117361|Dexamethasone|dexamethasone|mesh-list
57005765|NCT03117361|Bortezomib|bortezomib|mesh-list
57005766|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57005767|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
57005768|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
57005769|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005770|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005771|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57005772|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
57005773|NCT03117361|Hormones|hormones|mesh-ancestor
57005774|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005775|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57005776|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005777|NCT03840291|Edoxaban|edoxaban|mesh-list
57005778|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57005779|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
57005780|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57005781|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
57005782|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005783|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005784|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
57005785|NCT03053427|Gabapentin|gabapentin|mesh-list
57005786|NCT03053427|Analgesics|analgesics|mesh-ancestor
57005787|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
57005788|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005789|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005790|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
57005791|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57005792|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57005793|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005794|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57005795|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57005796|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57005797|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57005798|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005799|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
57005800|NCT02107118|Complement Factor H|complement factor h|mesh-list
57005801|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57005802|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57005803|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
57005804|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005805|NCT05081089|Lumefantrine|lumefantrine|mesh-list
57005806|NCT05081089|Artemether|artemether|mesh-list
57005807|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
56687783|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
57005808|NCT05081089|Primaquine|primaquine|mesh-list
57005809|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
57005810|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57005811|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
57005812|NCT05081089|Amodiaquine|amodiaquine|mesh-list
57005813|NCT05081089|Tafenoquine|tafenoquine|mesh-list
57005814|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
57005815|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57005816|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57005817|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005818|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57005819|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005820|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005821|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57005822|NCT05081089|Renal Agents|renal agents|mesh-ancestor
57005823|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57005824|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57005825|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005826|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57005827|NCT03554408|Antibodies|antibodies|mesh-list
57005828|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
57005829|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57005830|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
57005831|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005832|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005833|NCT02103686|Pregabalin|pregabalin|mesh-list
57005834|NCT02103686|Analgesics|analgesics|mesh-ancestor
57005835|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
57005836|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005837|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005838|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
57005839|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57005840|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57005841|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005842|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57005843|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57005844|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57005845|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005846|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57005847|NCT02110082|Cetuximab|cetuximab|mesh-list
57005848|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57005849|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005850|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57005851|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
57005852|NCT02103764|Desogestrel|desogestrel|mesh-list
57005853|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57005854|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57005855|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57005856|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
57005857|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57005858|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005859|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57005860|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57005861|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57005862|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57005863|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005864|NCT02103764|Progestins|progestins|mesh-ancestor
57005865|NCT02103764|Hormones|hormones|mesh-ancestor
57005866|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005867|NCT02110316|Voriconazole|voriconazole|mesh-list
57005868|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
57005869|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005870|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57005871|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57005872|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005873|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005874|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57005875|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
57005876|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005877|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005878|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57005879|NCT05625087|Fulvestrant|fulvestrant|mesh-list
57005880|NCT05625087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57005881|NCT05625087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687860|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57005882|NCT05625087|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57005883|NCT05625087|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57005884|NCT05625087|Hormone Antagonists|hormone antagonists|mesh-ancestor
57005885|NCT05625087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005886|NCT05625087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005887|NCT02110394|Rituximab|rituximab|mesh-list
57005888|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57005889|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57005890|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005891|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
57005892|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005893|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57005894|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57005895|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
57005896|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005897|NCT02373241|Losartan|losartan|mesh-list
57005898|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57005899|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57005900|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57005901|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57005902|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005903|NCT02103998|Iodine|iodine|mesh-list
57005904|NCT02103998|Hormones|hormones|mesh-list
57005905|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005906|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005907|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57005908|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005909|NCT02103998|Trace Elements|trace elements|mesh-ancestor
57005910|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
57005911|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
57005912|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57005913|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57005914|NCT01941589|Prednisolone|prednisolone|mesh-list
57005915|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
57005916|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
57005917|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57005918|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57005919|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57005920|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57005921|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
57005922|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57005923|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
57005924|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
57005925|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005926|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005927|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57005928|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
57005929|NCT01941589|Hormones|hormones|mesh-ancestor
57005930|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005931|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57005932|NCT01941589|Protective Agents|protective agents|mesh-ancestor
57005933|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57005934|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005935|NCT01845649|Estradiol|estradiol|mesh-list
57005936|NCT01845649|Estrogens|estrogens|mesh-ancestor
57005937|NCT01845649|Hormones|hormones|mesh-ancestor
57005938|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005939|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005940|NCT01345929|Levofloxacin|levofloxacin|mesh-list
57005941|NCT01345929|Ofloxacin|ofloxacin|mesh-list
57005942|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57005943|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005944|NCT01345929|Renal Agents|renal agents|mesh-ancestor
57005945|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57005946|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57005947|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57005948|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57005949|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005950|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005951|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57005952|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57005953|NCT02107742|Lidocaine|lidocaine|mesh-list
57005954|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
57005955|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
57005956|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57005957|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005958|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
57005959|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005960|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57005961|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57005962|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57005963|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57005964|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57005965|NCT02250872|Cisplatin|cisplatin|mesh-list
57005966|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005967|NCT02110784|Piperaquine|piperaquine|mesh-list
57005968|NCT02110784|Artenimol|artenimol|mesh-list
57005969|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
57005970|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57005971|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57005972|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57005973|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
57005974|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57005975|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57005976|NCT04988425|Prednisolone|prednisolone|mesh-list
57005977|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
57005978|NCT04988425|Antibodies|antibodies|mesh-list
57005979|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57005980|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57005981|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
57005982|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
57005983|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57005984|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57005985|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
57005986|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
57005987|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57005988|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57005989|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
57005990|NCT04988425|Hormones|hormones|mesh-ancestor
57005991|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57005992|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57005993|NCT04988425|Protective Agents|protective agents|mesh-ancestor
57005994|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57005995|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005996|NCT01343901|Bevacizumab|bevacizumab|mesh-list
57005997|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57005998|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57005999|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57006000|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57006001|NCT01343901|Growth Substances|growth substances|mesh-ancestor
57006002|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006003|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
57006004|NCT05617521|Caffeine|caffeine|mesh-list
57006005|NCT05617521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57006006|NCT05617521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006007|NCT05617521|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57006008|NCT05617521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006009|NCT05617521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006010|NCT05617521|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57006011|NCT05617521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57006012|NCT05617521|Purinergic Agents|purinergic agents|mesh-ancestor
57006013|NCT05617521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006014|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57006015|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006016|NCT02104700|Tenofovir|tenofovir|mesh-list
57006017|NCT02104700|Emtricitabine|emtricitabine|mesh-list
57006018|NCT02104700|Rilpivirine|rilpivirine|mesh-list
57006019|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
57006020|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006021|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57006022|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57006023|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006024|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006025|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57006026|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57006027|NCT02104778|Dexamethasone|dexamethasone|mesh-list
57006028|NCT02104778|Epinephrine|epinephrine|mesh-list
57006029|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688016|NCT00856583|Sertindole|sertindole|mesh-list
57006030|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
57006031|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
57006032|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006033|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006034|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006035|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
56896161|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57006037|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006038|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57006039|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006040|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57006041|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57006042|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
57006043|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006044|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006045|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57006046|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57006047|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57006048|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
57006049|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
57006050|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
57006051|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57006052|NCT02108366|Oseltamivir|oseltamivir|mesh-list
57006053|NCT02108366|Celecoxib|celecoxib|mesh-list
57006054|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57006055|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57006056|NCT02108366|Analgesics|analgesics|mesh-ancestor
57006057|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
57006058|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006059|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006060|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006061|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006062|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57006063|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57006064|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006065|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006066|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
57006067|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006068|NCT05706207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57006069|NCT05706207|Antibodies|antibodies|mesh-list
57006070|NCT05706207|Immunoglobulins|immunoglobulins|mesh-list
57006071|NCT05706207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57006072|NCT05706207|Immunologic Factors|immunologic factors|mesh-ancestor
57006073|NCT05706207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006074|NCT05706207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006075|NCT02105090|Anesthetics|anesthetics|mesh-list
57006076|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
57006077|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006078|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006079|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006080|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
57006081|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
57006082|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57006083|NCT03553628|Propolis|propolis|mesh-list
57006084|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57006085|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006086|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
57006087|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
57006088|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57006089|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
57006090|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57006091|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006092|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
57006093|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006094|NCT01343823|Ecallantide|ecallantide|mesh-list
57006095|NCT01343823|Analgesics|analgesics|mesh-ancestor
57006096|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
57006097|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006098|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006099|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57006100|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57006101|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006102|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006103|NCT02251184|Aspirin|aspirin|mesh-list
57006104|NCT02251184|Dipyridamole|dipyridamole|mesh-list
57006105|NCT02251184|Lansoprazole|lansoprazole|mesh-list
57006106|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
57006107|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
57006108|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57006109|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57006110|NCT02251184|Analgesics|analgesics|mesh-ancestor
57006111|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
57006112|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006113|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006114|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006115|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006116|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57006117|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57006118|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006119|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57006120|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57006121|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006122|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
57006123|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57006124|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006125|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57006126|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57006127|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
57006128|NCT02108756|Pantoprazole|pantoprazole|mesh-list
57006129|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57006130|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006131|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57006132|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006133|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006134|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
57006135|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006136|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57006137|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006138|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006139|NCT01318083|Glimepiride|glimepiride|mesh-list
57006140|NCT01318083|Alogliptin|alogliptin|mesh-list
57006141|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57006142|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57006143|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006144|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57006145|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
57006146|NCT01318083|Incretins|incretins|mesh-ancestor
57006147|NCT01318083|Hormones|hormones|mesh-ancestor
57006148|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006149|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57006150|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
57006151|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006152|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006153|NCT05545137|Fosfomycin|fosfomycin|mesh-list
57006154|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
57006155|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57006156|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006157|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57006158|NCT05545137|Renal Agents|renal agents|mesh-ancestor
57006159|NCT02105714|Formaldehyde|formaldehyde|mesh-list
57006160|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
57006161|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006162|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57006163|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57006164|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006165|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57006166|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006167|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
57006168|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006169|NCT03817515|Sirolimus|sirolimus|mesh-list
57006170|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57006171|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006172|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57006173|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006174|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
57006175|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57006176|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
57006177|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006178|NCT02105870|Abciximab|abciximab|mesh-list
57006179|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
57006180|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57006181|NCT02112422|Dexamethasone|dexamethasone|mesh-list
57006182|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
57006183|NCT02112422|BB 1101|bb 1101|mesh-list
57006184|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006185|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
57006186|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
57006187|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006188|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006189|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006190|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
57006191|NCT02112422|Hormones|hormones|mesh-ancestor
57006192|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006193|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57006194|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006195|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
57006196|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006197|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006198|NCT02109614|Niacin|niacin|mesh-list
57006199|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57006200|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
57006201|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006202|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57006203|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
57006204|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
57006205|NCT02109614|Vitamins|vitamins|mesh-ancestor
57006206|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
57006207|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006208|NCT02106104|Glimepiride|glimepiride|mesh-list
57006209|NCT02106104|Linagliptin|linagliptin|mesh-list
57006210|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57006211|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57006212|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006213|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57006214|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
57006215|NCT02106104|Incretins|incretins|mesh-ancestor
57006216|NCT02106104|Hormones|hormones|mesh-ancestor
57006217|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006218|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57006219|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
57006220|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006221|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006222|NCT05590377|Daratumumab|daratumumab|mesh-list
57006223|NCT05590377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006224|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57006225|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57006226|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006227|NCT01376323|Incretins|incretins|mesh-ancestor
57006228|NCT01376323|Hormones|hormones|mesh-ancestor
57006229|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006230|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57006231|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
57006232|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006233|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006234|NCT02113904|Adalimumab|adalimumab|mesh-list
57006235|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006236|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006237|NCT05613777|BI 425809|bi 425809|mesh-list
57006238|NCT05613777|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
57006239|NCT05613777|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
57006240|NCT05613777|Nootropic Agents|nootropic agents|mesh-ancestor
57006241|NCT05613777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57006242|NCT05613777|Contraceptive Agents|contraceptive agents|mesh-ancestor
57006243|NCT05613777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57006244|NCT05613777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006245|NCT05613777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57006246|NCT05613777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57006247|NCT05613777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57006248|NCT05613777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57006249|NCT05613777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57006250|NCT05613777|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
57006251|NCT05613777|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57006252|NCT05613777|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57006253|NCT05438979|Calcium|calcium|mesh-list
57006254|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57006255|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006256|NCT05432115|Amoxicillin|amoxicillin|mesh-list
57006257|NCT05432115|Tetracycline|tetracycline|mesh-list
57006258|NCT05432115|Esomeprazole|esomeprazole|mesh-list
57006259|NCT05432115|Bismuth|bismuth|mesh-list
57006260|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57006261|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006262|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57006263|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006264|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57006265|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006266|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006267|NCT05432115|Antacids|antacids|mesh-ancestor
57006268|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57006269|NCT02114528|Amiodarone|amiodarone|mesh-list
57006270|NCT02114528|Sotalol|sotalol|mesh-list
57006271|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
57006272|NCT02114528|Mexiletine|mexiletine|mesh-list
57006273|NCT02114528|Procainamide|procainamide|mesh-list
57006274|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
57006275|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57006276|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57006277|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006278|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57006279|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57006280|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57006281|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006282|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57006283|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57006284|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57006285|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57006286|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57006287|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
57006288|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006289|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006290|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
57006291|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
57006292|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006293|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57006294|NCT02113202|Bevacizumab|bevacizumab|mesh-list
57006295|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57006296|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006297|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57006298|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57006299|NCT02113202|Growth Substances|growth substances|mesh-ancestor
57006300|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006301|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
57006302|NCT01376401|Prednisone|prednisone|mesh-list
57006303|NCT01376401|Bortezomib|bortezomib|mesh-list
57006304|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57006305|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006306|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
57006307|NCT01376401|Hormones|hormones|mesh-ancestor
57006308|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006309|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006310|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57006311|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006312|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57006313|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
57006314|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006315|NCT02119520|Atorvastatin|atorvastatin|mesh-list
57006316|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57006317|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57006318|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
57006319|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006320|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57006321|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57006322|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006323|NCT05699811|Paclitaxel|paclitaxel|mesh-list
57006324|NCT05699811|Cyclophosphamide|cyclophosphamide|mesh-list
57006325|NCT05699811|Antibodies|antibodies|mesh-list
57006326|NCT05699811|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57006327|NCT05699811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57006328|NCT05699811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006329|NCT05699811|Tubulin Modulators|tubulin modulators|mesh-ancestor
57006330|NCT05699811|Antimitotic Agents|antimitotic agents|mesh-ancestor
57006331|NCT05699811|Mitosis Modulators|mitosis modulators|mesh-ancestor
57006332|NCT05699811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006333|NCT05699811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57006334|NCT05699811|Immunologic Factors|immunologic factors|mesh-ancestor
57006335|NCT05699811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006336|NCT05699811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006337|NCT05699811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57006338|NCT05699811|Alkylating Agents|alkylating agents|mesh-ancestor
57006339|NCT05699811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57006340|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
57006341|NCT03961789|Narcotics|narcotics|mesh-ancestor
57006342|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006343|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006344|NCT03961789|Analgesics|analgesics|mesh-ancestor
57006345|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
57006346|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006347|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
57006348|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
57006349|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
57006350|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006351|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006352|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57006353|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57006354|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57006355|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
57006356|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006357|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57006358|NCT01376713|Dacarbazine|dacarbazine|mesh-list
57006359|NCT01376713|Ofatumumab|ofatumumab|mesh-list
57006360|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57006361|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57006362|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
57006363|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006364|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006365|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
57006366|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006367|NCT03728179|Aspirin|aspirin|mesh-list
57006368|NCT03728179|Celecoxib|celecoxib|mesh-list
57006369|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
57006370|NCT03728179|Nivolumab|nivolumab|mesh-list
57006371|NCT03728179|Ipilimumab|ipilimumab|mesh-list
57006372|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57006373|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
57006374|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006375|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006376|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57006377|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
57006378|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006379|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006380|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57006381|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57006382|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57006383|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57006384|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57006385|NCT03728179|Analgesics|analgesics|mesh-ancestor
57006386|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
57006387|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006388|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006389|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57006390|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57006391|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57006392|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57006393|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006394|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
57006395|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57006396|NCT01368536|Amlodipine|amlodipine|mesh-list
57006397|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
57006398|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57006399|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57006400|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57006401|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006402|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57006403|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006404|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
57006406|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
57006407|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57006408|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
57006409|NCT05103735|Remifentanil|remifentanil|mesh-list
57006410|NCT05103735|Propofol|propofol|mesh-list
57006411|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57006412|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006413|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006414|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57006415|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
57006416|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
57006417|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57006418|NCT05103735|Analgesics|analgesics|mesh-ancestor
57006419|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
57006420|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006421|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57006422|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57006423|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57006424|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
57006425|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006426|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006427|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57006428|NCT05103735|Narcotics|narcotics|mesh-ancestor
57006429|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
57006430|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57006431|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57006432|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006433|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006434|NCT01319929|Hormones|hormones|mesh-ancestor
57006435|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006436|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006437|NCT03633565|Prednisolone|prednisolone|mesh-list
57006438|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57006439|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
57006440|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57006441|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
57006442|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
57006443|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57006444|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
57006445|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
57006446|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006447|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
57006448|NCT03633565|Hormones|hormones|mesh-ancestor
57006449|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006450|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006451|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57006452|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006453|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
57006454|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
57006455|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006456|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006457|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57006458|NCT03633565|Protective Agents|protective agents|mesh-ancestor
57006459|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
57006460|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57006461|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006462|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006463|NCT03633565|Urological Agents|urological agents|mesh-ancestor
57006464|NCT02120066|Plasminogen|plasminogen|mesh-list
57006465|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57006466|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57006467|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57006468|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006469|NCT01373359|Misoprostol|misoprostol|mesh-list
57006470|NCT01373359|Oxytocin|oxytocin|mesh-list
57006471|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
57006472|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57006473|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006474|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57006475|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
57006476|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57006477|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006478|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
57006479|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57006480|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006481|NCT02251964|Rituximab|rituximab|mesh-list
57006482|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57006483|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006484|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
57006485|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006486|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006487|NCT04739995|Naltrexone|naltrexone|mesh-list
57006488|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57006489|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57006490|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006491|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
57006492|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006493|NCT02120612|Naloxone|naloxone|mesh-list
57006494|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57006495|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006496|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
57006497|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006498|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
57006499|NCT02115152|Fluorouracil|fluorouracil|mesh-list
57006500|NCT02115152|Capecitabine|capecitabine|mesh-list
57006501|NCT02115152|Epirubicin|epirubicin|mesh-list
57006502|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57006503|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
57006504|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006505|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006506|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57006507|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
57006508|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006509|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006510|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57006511|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
57006512|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57006513|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57006514|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57006515|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57006516|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006517|NCT02115464|Metformin|metformin|mesh-list
57006518|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57006519|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006520|NCT02858076|Aflibercept|aflibercept|mesh-list
57006521|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
57006522|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57006523|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57006524|NCT02858076|Growth Substances|growth substances|mesh-ancestor
57006525|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006526|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
57006527|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006528|NCT01319695|Hormones|hormones|mesh-list
57006529|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57006530|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006531|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006532|NCT04594759|Isotretinoin|isotretinoin|mesh-list
57006533|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
57006534|NCT02123498|Omeprazole|omeprazole|mesh-list
57006535|NCT02123498|Pantoprazole|pantoprazole|mesh-list
57006536|NCT02123498|Ranitidine|ranitidine|mesh-list
57006537|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
57006538|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57006539|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006540|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57006541|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006542|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006543|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57006544|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
57006545|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
57006546|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006547|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006548|NCT02115776|Amoxicillin|amoxicillin|mesh-list
57006549|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
57006550|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
57006551|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
57006552|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57006553|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006554|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57006555|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
57006556|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57006557|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006558|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006559|NCT02123654|Asunaprevir|asunaprevir|mesh-list
57006560|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
57006561|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006562|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006563|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
57006564|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
57006565|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57006566|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006567|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57006568|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57006569|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
57006570|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57006571|NCT03609294|Linagliptin|linagliptin|mesh-list
57006572|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57006573|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006574|NCT03609294|Incretins|incretins|mesh-ancestor
57006575|NCT03609294|Hormones|hormones|mesh-ancestor
57006576|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006577|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57006578|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
57006579|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006580|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006581|NCT01917552|Capecitabine|capecitabine|mesh-list
57006582|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57006583|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
57006584|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006585|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006586|NCT01873326|Paclitaxel|paclitaxel|mesh-list
57006587|NCT01873326|Etoposide|etoposide|mesh-list
57006588|NCT01873326|Ifosfamide|ifosfamide|mesh-list
57006589|NCT01873326|Bleomycin|bleomycin|mesh-list
57006590|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57006591|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006592|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
57006593|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
57006594|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
57006595|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006596|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57006597|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57006598|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006599|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57006600|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
57006601|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57006602|NCT01261728|Gemcitabine|gemcitabine|mesh-list
57006603|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006604|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57006605|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
57006606|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006607|NCT01261728|Antiviral Agents|antiviral agents|mesh-ancestor
57006608|NCT01261728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006609|NCT01261728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006610|NCT01261728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57006611|NCT01261728|Immunologic Factors|immunologic factors|mesh-ancestor
57006612|NCT01261728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006613|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
57006614|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
57006615|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57006616|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006617|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006618|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
57006619|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57006620|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006621|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006622|NCT05020899|Nicotine|nicotine|mesh-list
57006623|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57006624|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
57006625|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006626|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006627|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57006628|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57006629|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
57006630|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006631|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006632|NCT03119701|Interferons|interferons|mesh-list
57006633|NCT03119701|Interferon-beta|interferon-beta|mesh-list
57006634|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
57006635|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006636|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
57006637|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006638|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
57006639|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006640|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57006641|NCT03717129|Tenofovir|tenofovir|mesh-list
57006642|NCT03717129|Emtricitabine|emtricitabine|mesh-list
57006643|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57006644|NCT03717129|Cobicistat|cobicistat|mesh-list
57006645|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57006646|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57006647|NCT03717129|Elvitegravir|elvitegravir|mesh-list
57006648|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
57006649|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006650|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57006651|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57006652|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006653|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006654|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57006655|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57006656|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57006657|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57006658|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57006659|NCT03627039|Metformin|metformin|mesh-list
57006660|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
57006661|NCT03627039|Empagliflozin|empagliflozin|mesh-list
57006662|NCT03627039|Canagliflozin|canagliflozin|mesh-list
57006663|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57006664|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006665|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57006666|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006667|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
57006668|NCT01374373|Hematinics|hematinics|mesh-ancestor
57006669|NCT02116556|Rifaximin|rifaximin|mesh-list
57006670|NCT02116556|Prednisone|prednisone|mesh-list
57006671|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006672|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
57006673|NCT02116556|Hormones|hormones|mesh-ancestor
57006674|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006675|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006676|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57006677|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006678|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57006679|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006680|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006681|NCT03634345|Fluconazole|fluconazole|mesh-list
57006682|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
57006683|NCT03634345|Abrocitinib|abrocitinib|mesh-list
57006684|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
57006685|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006686|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57006687|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57006688|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006689|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006690|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57006691|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
57006692|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006693|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006694|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57006695|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57006696|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57006697|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57006698|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006699|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57006700|NCT03634345|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57006701|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57006702|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57006703|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006704|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
57006705|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57006706|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
57006707|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57006708|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57006709|NCT03553238|Cytarabine|cytarabine|mesh-list
57006710|NCT03553238|Dexamethasone|dexamethasone|mesh-list
57006711|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
57006712|NCT03553238|Methotrexate|methotrexate|mesh-list
57006713|NCT03553238|Etoposide|etoposide|mesh-list
57006714|NCT03553238|Vincristine|vincristine|mesh-list
57006715|NCT03553238|Doxorubicin|doxorubicin|mesh-list
57006716|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
57006717|NCT03553238|Idarubicin|idarubicin|mesh-list
57006718|NCT03553238|Pegaspargase|pegaspargase|mesh-list
57006719|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57006720|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
57006721|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006722|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006723|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57006724|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
57006725|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006726|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006727|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57006728|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006729|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
57006730|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
57006731|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006732|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006733|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
57006734|NCT03553238|Hormones|hormones|mesh-ancestor
57006735|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006736|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57006737|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57006738|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
57006739|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57006740|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57006741|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
57006742|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
57006743|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006744|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57006745|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57006746|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57006747|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57006748|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57006749|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
57006750|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006751|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
57006752|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
57006753|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
57006754|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57006755|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
57006756|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57006757|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006758|NCT01373593|Lidocaine|lidocaine|mesh-list
57006759|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
57006760|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
57006761|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006762|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006763|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
57006764|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006765|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57006766|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57006767|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57006768|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57006769|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006770|NCT02116712|Saracatinib|saracatinib|mesh-list
57006771|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006772|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006773|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006774|NCT02116790|Naproxen|naproxen|mesh-list
57006775|NCT02116790|Levodopa|levodopa|mesh-list
57006776|NCT02116790|Carbidopa|carbidopa|mesh-list
57006777|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57006778|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57006779|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57006780|NCT02116790|Analgesics|analgesics|mesh-ancestor
57006781|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
57006782|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006783|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006784|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57006785|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006786|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
57006787|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57006788|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006789|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006790|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57006791|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57006792|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
57006793|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006794|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57006795|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57006796|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
57006797|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
57006798|NCT02859961|Leronlimab|leronlimab|mesh-list
57006799|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
57006800|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57006801|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57006802|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006803|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57006804|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57006805|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
57006806|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006807|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
57006808|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006809|NCT02124200|Nicotine|nicotine|mesh-list
57006810|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57006811|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
57006812|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006813|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006814|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57006815|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57006816|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
57006817|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006818|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006819|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
57006820|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
57006821|NCT04503993|Antibodies|antibodies|mesh-list
57006822|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
57006823|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
57006824|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006825|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
57006826|NCT02116868|Nicardipine|nicardipine|mesh-list
57006827|NCT02116868|Urapidil|urapidil|mesh-list
57006828|NCT02116868|Remifentanil|remifentanil|mesh-list
57006829|NCT02116868|Esmolol|esmolol|mesh-list
57006830|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57006831|NCT02116868|Narcotics|narcotics|mesh-ancestor
57006832|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006833|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006834|NCT02116868|Analgesics|analgesics|mesh-ancestor
57006835|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
57006836|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006837|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57006838|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57006839|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57006840|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
57006841|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006842|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006843|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57006844|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57006845|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57006846|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
57006847|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57006848|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
57006849|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57006850|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57006851|NCT02679781|Midazolam|midazolam|mesh-list
57006852|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57006853|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57006854|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006855|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006856|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57006857|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57006858|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57006859|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57006860|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
57006861|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
57006862|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
57006863|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
57006864|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006865|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006866|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
57006867|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57006868|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006869|NCT02624869|Evolocumab|evolocumab|mesh-list
57006870|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57006871|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57006872|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
57006873|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006874|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57006875|NCT02121782|Vaccines|vaccines|mesh-list
57006876|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
57006877|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006878|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
57006879|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
57006880|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006881|NCT03553082|Propofol|propofol|mesh-list
57006882|NCT03553082|Sevoflurane|sevoflurane|mesh-list
57006883|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57006884|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006885|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006886|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57006887|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
57006888|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
57006889|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57006890|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57006891|NCT03318393|Heparin|heparin|mesh-list
57006892|NCT03318393|Calcium heparin|calcium heparin|mesh-list
57006893|NCT03318393|Bivalirudin|bivalirudin|mesh-list
57006894|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
57006895|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57006896|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57006897|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006898|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
57006899|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57006900|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
57006901|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006902|NCT03110029|Efinaconazole|efinaconazole|mesh-list
57006903|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
57006904|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57006905|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
57006906|NCT03552146|Propofol|propofol|mesh-list
57006907|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57006908|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006909|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006910|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57006911|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
57006912|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
57006913|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57006914|NCT03552146|Analgesics|analgesics|mesh-ancestor
57006915|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
57006916|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006917|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57006918|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57006919|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57006920|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
57006921|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006922|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006923|NCT01374763|Oxycodone|oxycodone|mesh-list
57006924|NCT01374763|Naloxone|naloxone|mesh-list
57006925|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57006926|NCT01374763|Narcotics|narcotics|mesh-ancestor
57006927|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006928|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006929|NCT01374763|Analgesics|analgesics|mesh-ancestor
57006930|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
57006931|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006932|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57006933|NCT02747004|Tamoxifen|tamoxifen|mesh-list
57006934|NCT02747004|Loperamide|loperamide|mesh-list
57006935|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
57006936|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57006937|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
57006938|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57006939|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006940|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57006941|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006942|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57006943|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57006944|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57006945|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57006946|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
57006947|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57006948|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006949|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006950|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57006951|NCT04454515|Analgesics|analgesics|mesh-ancestor
57006952|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
57006953|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006954|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57006955|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57006956|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57006957|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
57006958|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006959|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006960|NCT02122172|Afatinib|afatinib|mesh-list
57006961|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006962|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57006963|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57006964|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006965|NCT03608514|Terlipressin|terlipressin|mesh-list
57006966|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57006967|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57006968|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
57006969|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57006970|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
57006971|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006972|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57006973|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57006974|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
57006975|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006976|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57006977|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57006978|NCT02117726|Midazolam|midazolam|mesh-list
57006979|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
57006980|NCT02117726|Propofol|propofol|mesh-list
57006981|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57006982|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57006983|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57006984|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57006985|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
57006986|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
57006987|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57006988|NCT02117726|Analgesics|analgesics|mesh-ancestor
57006989|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
57006990|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57006991|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57006992|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57006993|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57006994|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
57006995|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57006996|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57006997|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57006998|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57006999|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57007000|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57007001|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
57007002|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
57007003|NCT02733432|Fluconazole|fluconazole|mesh-list
57007004|NCT02733432|Rezafungin|rezafungin|mesh-list
57007005|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
57007006|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007007|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57007008|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57007009|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007010|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007011|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57007012|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
57007013|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007014|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007015|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57007016|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57007018|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
57007019|NCT03608046|Irinotecan|irinotecan|mesh-list
57007020|NCT03608046|Cetuximab|cetuximab|mesh-list
57007021|NCT03608046|Avelumab|avelumab|mesh-list
57007022|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57007023|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57007024|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007025|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007026|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007027|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57007028|NCT02122484|Colchicine|colchicine|mesh-list
57007029|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
57007030|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007031|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
57007032|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
57007033|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
57007034|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007035|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007036|NCT04106856|Losartan|losartan|mesh-list
57007037|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57007038|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57007039|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57007040|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57007041|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007042|NCT03606018|Insulin|insulin|mesh-list
57007043|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57007044|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
57007045|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57007046|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007047|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
57007048|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
57007049|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57007050|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57007051|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007052|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007053|NCT01373749|Urological Agents|urological agents|mesh-ancestor
57007054|NCT04045795|Dexamethasone|dexamethasone|mesh-list
57007055|NCT04045795|Pomalidomide|pomalidomide|mesh-list
57007056|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57007057|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007058|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
57007059|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
57007060|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007061|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007062|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57007063|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
57007064|NCT04045795|Hormones|hormones|mesh-ancestor
57007065|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007066|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57007067|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007068|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
57007069|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57007070|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57007071|NCT04045795|Growth Substances|growth substances|mesh-ancestor
57007072|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
57007073|NCT03605940|Methoxsalen|methoxsalen|mesh-list
57007074|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57007075|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
57007076|NCT03607734|Amoxicillin|amoxicillin|mesh-list
57007077|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57007078|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007079|NCT02035488|Tobramycin|tobramycin|mesh-list
57007080|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57007081|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007082|NCT03602430|Vitamin D|vitamin d|mesh-list
57007083|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
57007084|NCT03602430|Vitamins|vitamins|mesh-ancestor
57007085|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
57007086|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007087|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57007088|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57007089|NCT02260544|Doxorubicin|doxorubicin|mesh-list
57007090|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57007091|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57007092|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007093|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57007094|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57007095|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007096|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007097|NCT05470647|Interleukin-4|interleukin-4|mesh-list
57007098|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57007099|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
57007100|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007101|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007102|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007103|NCT04409665|Ketamine|ketamine|mesh-list
57007104|NCT04409665|Analgesics|analgesics|mesh-ancestor
57007105|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
57007106|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007107|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007108|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57007109|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57007110|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
57007111|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
57007112|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007113|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57007114|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57007115|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007116|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007117|NCT05468619|Valacyclovir|valacyclovir|mesh-list
57007118|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
57007119|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007120|NCT02854800|Varenicline|varenicline|mesh-list
57007121|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57007122|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57007123|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
57007124|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007125|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007126|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007127|NCT03552770|Bevacizumab|bevacizumab|mesh-list
57007128|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57007129|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007130|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57007131|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57007132|NCT03552770|Growth Substances|growth substances|mesh-ancestor
57007133|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007134|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
57007135|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
57007136|NCT02127164|Eusol|eusol|mesh-list
57007137|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
57007138|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007139|NCT02931539|Valganciclovir|valganciclovir|mesh-list
57007140|NCT02931539|Ganciclovir|ganciclovir|mesh-list
57007141|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
57007142|NCT02931539|Cidofovir|cidofovir|mesh-list
57007143|NCT02931539|Foscarnet|foscarnet|mesh-list
57007144|NCT02931539|Maribavir|maribavir|mesh-list
57007145|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
57007146|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007147|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57007148|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007149|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007150|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57007151|NCT03602118|Phenobarbital|phenobarbital|mesh-list
57007152|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
57007153|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57007154|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007155|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007156|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57007157|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57007158|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007159|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007160|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
57007161|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
57007162|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57007163|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57007164|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57007165|NCT02125682|Atorvastatin|atorvastatin|mesh-list
57007166|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57007167|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57007168|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
57007169|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007170|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57007171|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57007172|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007173|NCT03610711|Nivolumab|nivolumab|mesh-list
57007174|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57007175|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007176|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57007177|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007178|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
57007179|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57007180|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57007181|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57007182|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007183|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
57007184|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007185|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007186|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57007187|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007188|NCT02131220|Tirofiban|tirofiban|mesh-list
57007189|NCT02131220|Saruplase|saruplase|mesh-list
57007190|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57007191|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57007192|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007193|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57007194|NCT04042077|Vancomycin|vancomycin|mesh-list
57007195|NCT04042077|Tazobactam|tazobactam|mesh-list
57007196|NCT04042077|Linezolid|linezolid|mesh-list
57007197|NCT04042077|Piperacillin|piperacillin|mesh-list
57007198|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57007199|NCT04042077|Tigecycline|tigecycline|mesh-list
57007200|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57007201|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007202|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57007203|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007204|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007205|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57007206|NCT03557359|Nivolumab|nivolumab|mesh-list
57007207|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57007208|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007209|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57007210|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007211|NCT05760313|Linaclotide|linaclotide|mesh-list
57007212|NCT05760313|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57007213|NCT05760313|Enzyme Activators|enzyme activators|mesh-ancestor
57007214|NCT05760313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007215|NCT05760313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57007216|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57007217|NCT02127320|Ezetimibe|ezetimibe|mesh-list
57007218|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57007219|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57007220|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
57007221|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007222|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57007223|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57007224|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007225|NCT03522415|Methotrexate|methotrexate|mesh-list
57007226|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57007227|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
57007228|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57007229|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007230|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57007231|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
57007232|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007233|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007234|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
57007235|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007236|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57007237|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007238|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
57007239|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007240|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57007241|NCT04226833|Entrectinib|entrectinib|mesh-list
57007242|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57007243|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007244|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007245|NCT02131298|Itraconazole|itraconazole|mesh-list
57007246|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
57007247|NCT02131298|Palbociclib|palbociclib|mesh-list
57007248|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
57007249|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007250|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57007251|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57007252|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007253|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007254|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57007255|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
57007256|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007257|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007258|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57007259|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007260|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57007261|NCT01375387|Lacosamide|lacosamide|mesh-list
57007262|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
57007263|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57007264|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57007265|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894834|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007266|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007267|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
57007268|NCT02853318|Bevacizumab|bevacizumab|mesh-list
57007269|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
57007270|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57007271|NCT02853318|Antibodies|antibodies|mesh-list
57007272|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
57007273|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57007274|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
57007275|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
57007276|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007277|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
57007278|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007279|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007280|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57007281|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
57007282|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007283|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007284|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57007285|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57007286|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57007287|NCT02853318|Growth Substances|growth substances|mesh-ancestor
57007288|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
57007289|NCT05541471|Digoxin|digoxin|mesh-list
57007290|NCT05541471|Midazolam|midazolam|mesh-list
57007291|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57007292|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57007293|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007294|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007295|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57007296|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57007297|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57007298|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57007299|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
57007300|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
57007301|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
57007302|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
57007303|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007304|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007305|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57007306|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57007307|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007308|NCT05541471|Protective Agents|protective agents|mesh-ancestor
57007309|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
57007310|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57007311|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57007312|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
57007313|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
57007314|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007315|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007316|NCT03604224|Canagliflozin|canagliflozin|mesh-list
57007317|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57007318|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007319|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57007320|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007321|NCT02237820|Dexamethasone|dexamethasone|mesh-list
57007322|NCT02237820|Prednisone|prednisone|mesh-list
57007323|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007324|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
57007325|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
57007326|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007327|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007328|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57007329|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
57007330|NCT02237820|Hormones|hormones|mesh-ancestor
57007331|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007332|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57007333|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007334|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57007335|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
57007336|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007337|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57007338|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57007339|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007340|NCT02404155|Clozapine|clozapine|mesh-list
57007341|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57007342|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
57007343|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007344|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007345|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007346|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57007347|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57007348|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007349|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57007350|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
57007351|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
57007352|NCT02127788|Micafungin|micafungin|mesh-list
57007353|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
57007354|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007355|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
57007356|NCT02131688|Analgesics|analgesics|mesh-ancestor
57007357|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
57007358|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007359|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007360|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007361|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57007362|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57007363|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007364|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007365|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
57007366|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57007367|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
57007368|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007369|NCT02126462|Antacids|antacids|mesh-ancestor
57007370|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007371|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57007372|NCT03113071|Decitabine|decitabine|mesh-list
57007373|NCT03113071|Digoxin|digoxin|mesh-list
57007374|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57007375|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
57007376|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007377|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007378|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007379|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57007380|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57007381|NCT03113071|Protective Agents|protective agents|mesh-ancestor
57007382|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007384|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
57007385|NCT03050307|Bismuth|bismuth|mesh-list
57007386|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57007387|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57007388|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57007389|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007390|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007391|NCT03050307|Antacids|antacids|mesh-ancestor
57007392|NCT02127866|Beclomethasone|beclomethasone|mesh-list
57007393|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
57007394|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
57007395|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57007396|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
57007397|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007398|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007399|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57007400|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
57007401|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57007402|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57007403|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57007404|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
57007405|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007406|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007407|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57007408|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57007409|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57007410|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
57007411|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007412|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
57007413|NCT02127866|Hormones|hormones|mesh-ancestor
57007414|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007415|NCT03550508|Antibodies|antibodies|mesh-list
57007416|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57007417|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
57007418|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007419|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
57007420|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57007421|NCT03607578|Protective Agents|protective agents|mesh-ancestor
57007422|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007423|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
57007424|NCT05461131|Azithromycin|azithromycin|mesh-list
57007425|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57007426|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007427|NCT05760079|Lactoferrin|lactoferrin|mesh-list
57007428|NCT05760079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007429|NCT03603834|Leucovorin|leucovorin|mesh-list
57007430|NCT03603834|Fluorouracil|fluorouracil|mesh-list
57007431|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
57007432|NCT03603834|Irinotecan|irinotecan|mesh-list
57007433|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
57007434|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007435|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57007436|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007437|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007438|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
57007439|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007440|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57007441|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57007442|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007443|NCT03603834|Antidotes|antidotes|mesh-ancestor
57007444|NCT03603834|Protective Agents|protective agents|mesh-ancestor
57007445|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
57007446|NCT03603834|Vitamins|vitamins|mesh-ancestor
57007447|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
57007448|NCT03601338|Bemiparin|bemiparin|mesh-list
57007449|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
57007450|NCT02128022|Glyburide|glyburide|mesh-list
57007451|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57007452|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007453|NCT03256045|Dexamethasone|dexamethasone|mesh-list
57007454|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
57007455|NCT03256045|Panobinostat|panobinostat|mesh-list
57007456|NCT03256045|Ichthammol|ichthammol|mesh-list
57007457|NCT03256045|BB 1101|bb 1101|mesh-list
57007458|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007459|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
57007460|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
57007461|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007462|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007463|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57007464|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
57007465|NCT03256045|Hormones|hormones|mesh-ancestor
57007466|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007467|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56896208|NCT05156684|Protective Agents|protective agents|mesh-ancestor
57007468|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007469|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
57007470|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007471|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007472|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57007473|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
57007474|NCT03603756|Paclitaxel|paclitaxel|mesh-list
57007475|NCT03603756|Irinotecan|irinotecan|mesh-list
57007476|NCT03603756|Apatinib|apatinib|mesh-list
57007477|NCT03603756|Nedaplatin|nedaplatin|mesh-list
57007478|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57007479|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007480|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
57007481|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
57007482|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
57007483|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007484|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57007485|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57007486|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007487|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57007488|NCT02372409|Doxorubicin|doxorubicin|mesh-list
57007489|NCT02372409|Etoposide|etoposide|mesh-list
57007490|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
57007491|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57007492|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007493|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57007494|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57007495|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007496|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007497|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57007498|NCT03626259|Losartan|losartan|mesh-list
57007499|NCT03626259|Amlodipine|amlodipine|mesh-list
57007500|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57007501|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57007502|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57007503|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007504|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57007505|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007506|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
57007507|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57007508|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57007509|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57007510|NCT03601260|Allopurinol|allopurinol|mesh-list
57007511|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
57007512|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007513|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007514|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
57007515|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007516|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57007517|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
57007518|NCT03601260|Protective Agents|protective agents|mesh-ancestor
57007519|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007520|NCT05193253|Liver Extracts|liver extracts|mesh-list
57007521|NCT05193253|Hematinics|hematinics|mesh-ancestor
57007522|NCT04629651|Captopril|captopril|mesh-list
57007523|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57007524|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
56896231|NCT01159275|Lopinavir|lopinavir|mesh-list
57007525|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007526|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007527|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57007528|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
57007529|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57007530|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007531|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
57007532|NCT03600948|Sirolimus|sirolimus|mesh-list
57007533|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57007534|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007535|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57007536|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007537|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
57007538|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007539|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
57007540|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007541|NCT02132000|Tamoxifen|tamoxifen|mesh-list
57007542|NCT02132000|Toremifene|toremifene|mesh-list
57007543|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57007544|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
57007545|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007546|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007547|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57007548|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007549|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57007550|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57007551|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57007552|NCT03607110|Fentanyl|fentanyl|mesh-list
57007553|NCT03607110|Ketamine|ketamine|mesh-list
57007554|NCT03607110|Analgesics|analgesics|mesh-ancestor
57007555|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
57007556|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007557|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007558|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57007559|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57007560|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
57007561|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
57007562|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007563|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57007564|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57007565|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007566|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007567|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57007568|NCT03607110|Narcotics|narcotics|mesh-ancestor
57007569|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57007570|NCT03118765|Bromides|bromides|mesh-list
57007571|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57007572|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
57007573|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57007574|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
57007575|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007576|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896245|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
57007577|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57007578|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
57007579|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
57007580|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57007581|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
57007582|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007583|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007584|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
57007585|NCT02128100|Leucovorin|leucovorin|mesh-list
57007586|NCT02128100|Fluorouracil|fluorouracil|mesh-list
57007587|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
57007588|NCT02128100|Irinotecan|irinotecan|mesh-list
57007589|NCT02128100|Folfirinox|folfirinox|mesh-list
57007590|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
57007591|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007592|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57007593|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007594|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007595|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
57007596|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007597|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57007598|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57007599|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007600|NCT02128100|Antidotes|antidotes|mesh-ancestor
57007601|NCT02128100|Protective Agents|protective agents|mesh-ancestor
57007602|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
57007603|NCT02128100|Vitamins|vitamins|mesh-ancestor
57007604|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
57007605|NCT03603366|Aspirin|aspirin|mesh-list
57007606|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57007607|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57007608|NCT03603366|Analgesics|analgesics|mesh-ancestor
57007609|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
57007610|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007611|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007612|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007613|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007614|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57007615|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57007616|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007617|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57007618|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57007619|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007620|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
57007621|NCT02128178|Enoxaparin|enoxaparin|mesh-list
57007622|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
57007623|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
57007624|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57007625|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57007626|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007627|NCT03600870|Midodrine|midodrine|mesh-list
57007628|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
57007629|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
57007630|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007631|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007632|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57007633|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57007634|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57007635|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57007636|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
57007637|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007638|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007639|NCT02128334|Leuprolide|leuprolide|mesh-list
57007640|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57007641|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
57007642|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57007643|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007644|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57007645|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007646|NCT01375699|Doxorubicin|doxorubicin|mesh-list
57007647|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57007648|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
57007649|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57007650|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007651|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57007652|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57007653|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007654|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007655|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
57007656|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57007657|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57007658|NCT01375699|Urological Agents|urological agents|mesh-ancestor
57007659|NCT01373983|Ziconotide|ziconotide|mesh-list
57007660|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57007661|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57007662|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007663|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57007664|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007665|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57007666|NCT01373983|Protective Agents|protective agents|mesh-ancestor
57007667|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57007668|NCT01373983|Analgesics|analgesics|mesh-ancestor
57007669|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
57007670|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007671|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57007672|NCT05173597|Hormones|hormones|mesh-ancestor
57007673|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007674|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007675|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
57007676|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57007677|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
57007678|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007679|NCT03149107|Expectorants|expectorants|mesh-ancestor
57007680|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
57007681|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57007682|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
57007683|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007684|NCT03149107|Protective Agents|protective agents|mesh-ancestor
57007685|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007686|NCT03149107|Antidotes|antidotes|mesh-ancestor
57007687|NCT03135301|Metformin|metformin|mesh-list
57007688|NCT03135301|Letrozole|letrozole|mesh-list
57007689|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57007690|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007691|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007692|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57007693|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57007694|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007695|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007696|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57007697|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
57007698|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007699|NCT03602898|Cyclosporine|cyclosporine|mesh-list
57007700|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
57007701|NCT03602898|Busulfan|busulfan|mesh-list
57007702|NCT03602898|Methotrexate|methotrexate|mesh-list
57007703|NCT03602898|Fludarabine|fludarabine|mesh-list
57007704|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
57007705|NCT03602898|Tacrolimus|tacrolimus|mesh-list
57007706|NCT03602898|Cyclosporins|cyclosporins|mesh-list
57007707|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57007708|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007709|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
57007710|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007711|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007712|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57007713|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
57007714|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007715|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007716|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57007717|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57007718|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
57007719|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57007720|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57007721|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
57007722|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
57007723|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007724|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57007725|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57007726|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57007727|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
57007728|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007729|NCT02983747|Loxoprofen|loxoprofen|mesh-list
57007730|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57007731|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57007732|NCT02983747|Analgesics|analgesics|mesh-ancestor
57007733|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
57007734|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007735|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007736|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007737|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007738|NCT05759845|Topiramate|topiramate|mesh-list
57007739|NCT05759845|Amitriptyline|amitriptyline|mesh-list
57007740|NCT05759845|Anticonvulsants|anticonvulsants|mesh-ancestor
57007741|NCT05759845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57007742|NCT05759845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007743|NCT05759845|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57007744|NCT05759845|Antidepressive Agents|antidepressive agents|mesh-ancestor
57007745|NCT05759845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57007746|NCT05759845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57007747|NCT05759845|Analgesics|analgesics|mesh-ancestor
57007748|NCT05759845|Sensory System Agents|sensory system agents|mesh-ancestor
57007749|NCT05759845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007750|NCT05759845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57007751|NCT05759845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57007752|NCT05759845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57007753|NCT05759845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007754|NCT05759845|Adrenergic Agents|adrenergic agents|mesh-ancestor
57007755|NCT05759845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007756|NCT03931291|Azacitidine|azacitidine|mesh-list
57007757|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57007758|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
57007759|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007760|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007761|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007763|NCT00799110|Vaccines|vaccines|mesh-list
57007764|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
57007765|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007766|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57007767|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007768|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
57007769|NCT05199727|Tadalafil|tadalafil|mesh-list
57007770|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
57007771|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57007772|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57007773|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007774|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007775|NCT05199727|Urological Agents|urological agents|mesh-ancestor
57007776|NCT02132234|Adalimumab|adalimumab|mesh-list
57007777|NCT02132234|Etanercept|etanercept|mesh-list
57007778|NCT02132234|Infliximab|infliximab|mesh-list
57007779|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
57007780|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007781|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007782|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
57007783|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57007784|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57007785|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57007786|NCT02132234|Analgesics|analgesics|mesh-ancestor
57007787|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
57007788|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007789|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007790|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007791|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
57007792|NCT02132390|Toremifene|toremifene|mesh-list
57007793|NCT02132390|Goserelin|goserelin|mesh-list
57007794|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57007795|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007796|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57007797|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57007798|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
57007799|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007800|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896269|NCT01263171|Leucovorin|leucovorin|mesh-list
57007801|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57007802|NCT02128646|Ketorolac|ketorolac|mesh-list
57007803|NCT02128646|Bupivacaine|bupivacaine|mesh-list
57007804|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
57007805|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
57007806|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007807|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007808|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
57007809|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007810|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57007811|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57007812|NCT02128646|Analgesics|analgesics|mesh-ancestor
57007813|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007814|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007815|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57007816|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007817|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007818|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57007819|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
57007820|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
57007821|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007822|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007823|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
57007824|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57007825|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007826|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
57007827|NCT05198947|Ivermectin|ivermectin|mesh-list
57007828|NCT05198947|Permethrin|permethrin|mesh-list
57007829|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57007830|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007831|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007832|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007833|NCT01367834|Hormones|hormones|mesh-list
57007834|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007835|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007836|NCT03106753|Bupivacaine|bupivacaine|mesh-list
57007837|NCT03106753|Terbutaline|terbutaline|mesh-list
57007838|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
57007839|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
57007840|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007841|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007842|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
57007843|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007844|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57007845|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
57007846|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57007847|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
57007848|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
57007849|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
57007850|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57007851|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57007852|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57007853|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57007854|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
57007855|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007856|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007857|NCT05730205|Etonogestrel|etonogestrel|mesh-list
57007858|NCT05730205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57007859|NCT05730205|Contraceptive Agents|contraceptive agents|mesh-ancestor
57007860|NCT05730205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57007861|NCT05730205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007862|NCT05730205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57007863|NCT02125461|Durvalumab|durvalumab|mesh-list
57007864|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57007865|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007866|NCT02133014|Fluorouracil|fluorouracil|mesh-list
57007867|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
57007868|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007869|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57007870|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007871|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007872|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
57007873|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007874|NCT05759455|Vitamin D|vitamin d|mesh-list
57007875|NCT05759455|Vitamins|vitamins|mesh-ancestor
57007876|NCT05759455|Micronutrients|micronutrients|mesh-ancestor
57007877|NCT05759455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007878|NCT05759455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57007879|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57007880|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57007881|NCT02129114|Estradiol|estradiol|mesh-list
57007882|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57007883|NCT02129114|Estrogens|estrogens|mesh-ancestor
57007884|NCT02129114|Hormones|hormones|mesh-ancestor
57007885|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57007886|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007887|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57007888|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
57007889|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57007890|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57007891|NCT02136992|Pirfenidone|pirfenidone|mesh-list
57007892|NCT02136992|Analgesics|analgesics|mesh-ancestor
57007893|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
57007894|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007895|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007896|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57007897|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57007898|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007899|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007900|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007901|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
57007902|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57007903|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007904|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57007905|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57007906|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007907|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007908|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007909|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57007910|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57007911|NCT02129270|Lidocaine|lidocaine|mesh-list
57007912|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
57007913|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
57007914|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007915|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007916|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
57007917|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007918|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57007919|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57007920|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57007921|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57007922|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007923|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
57007924|NCT05370547|Fludarabine|fludarabine|mesh-list
57007925|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007926|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
57007927|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007928|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007929|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57007930|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
57007931|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007932|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007933|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57007934|NCT02133326|Acetaminophen|acetaminophen|mesh-list
57007935|NCT02133326|Ibuprofen|ibuprofen|mesh-list
57007936|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57007937|NCT02133326|Analgesics|analgesics|mesh-ancestor
57007938|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
57007939|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007940|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007941|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
57007942|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57007943|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57007944|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57007945|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56896272|NCT01263171|Calcium|calcium|mesh-list
57007946|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57007947|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007948|NCT02137616|Olanzapine|olanzapine|mesh-list
57007949|NCT02137616|Risperidone|risperidone|mesh-list
57007950|NCT02137616|Aripiprazole|aripiprazole|mesh-list
57007951|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57007952|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57007953|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
57007954|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57007955|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007956|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007957|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57007958|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57007959|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007960|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57007961|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57007962|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
57007963|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
57007964|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
57007965|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57007966|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57007967|NCT02137616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57007968|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57007969|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57007970|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
57007971|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
57007972|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57007973|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57007974|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57007975|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57007976|NCT02133638|Propofol|propofol|mesh-list
57007977|NCT02133638|Sevoflurane|sevoflurane|mesh-list
57007978|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57007979|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57007980|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007981|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57007982|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
57007983|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
57007984|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56689959|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
57007985|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57007986|NCT02545283|Cytarabine|cytarabine|mesh-list
57007987|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57007988|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
57007989|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57007990|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57007991|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
57007992|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57007993|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57007994|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
57007995|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57007996|NCT02137928|Carboplatin|carboplatin|mesh-list
57007997|NCT02137928|Etoposide|etoposide|mesh-list
57007998|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
57007999|NCT02137928|Vincristine|vincristine|mesh-list
57008000|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008001|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57008002|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57008003|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57008004|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008005|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008006|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
57008007|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
57008008|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
57008009|NCT02138084|Ritonavir|ritonavir|mesh-list
57008010|NCT02138084|Fostemsavir|fostemsavir|mesh-list
57008011|NCT02138084|Rifabutin|rifabutin|mesh-list
57008012|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57008013|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57008014|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
57008015|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008016|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008017|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57008018|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57008019|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
57008020|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008021|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57008022|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57008023|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57008024|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57008025|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
57008026|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57008027|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57008028|NCT02129582|Methotrexate|methotrexate|mesh-list
57008029|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
57008030|NCT02129582|Fludarabine|fludarabine|mesh-list
57008031|NCT02129582|Busulfan|busulfan|mesh-list
57008032|NCT02129582|Tacrolimus|tacrolimus|mesh-list
57008033|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
57008034|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57008035|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
57008036|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57008037|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
57008038|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57008039|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008040|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57008041|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
57008042|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008043|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008044|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
57008045|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008046|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57008047|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57008048|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
57008049|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57008050|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57008051|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57008052|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
57008053|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57008054|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57008055|NCT05037487|Dronabinol|dronabinol|mesh-list
57008056|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
57008057|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008058|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57008059|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008060|NCT05037487|Analgesics|analgesics|mesh-ancestor
57008061|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
57008062|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008063|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57008064|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57008065|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008066|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008068|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008069|NCT05162443|Adagrasib|adagrasib|mesh-list
57008070|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008071|NCT05566795|Antineoplastic Agents|antineoplastic agents|mesh-list
57008072|NCT02138396|Fentanyl|fentanyl|mesh-list
57008073|NCT02138396|Naltrexone|naltrexone|mesh-list
57008074|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57008075|NCT02138396|Narcotics|narcotics|mesh-ancestor
57008076|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008077|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008078|NCT02138396|Analgesics|analgesics|mesh-ancestor
57008079|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
57008080|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008081|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57008082|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57008083|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
57008084|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
57008085|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57008086|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57008087|NCT04560881|Vaccines|vaccines|mesh-list
57008088|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
57008089|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008090|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
57008091|NCT02828761|Calcium|calcium|mesh-list
57008092|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57008093|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008094|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57008095|NCT02875613|Avelumab|avelumab|mesh-list
57008096|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57008097|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008098|NCT02815267|Minocycline|minocycline|mesh-list
57008099|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57008100|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008101|NCT02130440|Resveratrol|resveratrol|mesh-list
57008102|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
57008103|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008104|NCT02130440|Protective Agents|protective agents|mesh-ancestor
57008105|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008106|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008107|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57008108|NCT02138552|Octenidine|octenidine|mesh-list
57008109|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008110|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57008111|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57008112|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57008113|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57008114|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008115|NCT02138708|Adenosine|adenosine|mesh-list
57008116|NCT02138708|Acetylcholine|acetylcholine|mesh-list
57008117|NCT02138708|Analgesics|analgesics|mesh-ancestor
57008118|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
57008119|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008120|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008121|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57008122|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
57008123|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57008124|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
57008125|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
57008126|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008127|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008128|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57008129|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
57008130|NCT03633175|Progesterone|progesterone|mesh-list
57008131|NCT03633175|Progestins|progestins|mesh-ancestor
57008132|NCT03633175|Hormones|hormones|mesh-ancestor
57008133|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008134|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008135|NCT02539693|Lidocaine|lidocaine|mesh-list
57008136|NCT02539693|Clonidine|clonidine|mesh-list
57008137|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
57008139|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008140|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008141|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
57008142|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008143|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57008144|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57008145|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57008146|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57008147|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008148|NCT02539693|Analgesics|analgesics|mesh-ancestor
57008149|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57008150|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
57008151|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
57008152|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57008153|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57008154|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57008155|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
57008156|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008157|NCT05062135|Progesterone|progesterone|mesh-list
57008158|NCT05062135|Progestins|progestins|mesh-ancestor
57008159|NCT05062135|Hormones|hormones|mesh-ancestor
57008160|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008161|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008162|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57008163|NCT02134106|Polymyxins|polymyxins|mesh-list
57008164|NCT02134106|Doripenem|doripenem|mesh-list
57008165|NCT02134106|Polymyxin B|polymyxin b|mesh-list
57008166|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57008167|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008168|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
57008169|NCT01354301|Everolimus|everolimus|mesh-list
57008170|NCT01354301|Tacrolimus|tacrolimus|mesh-list
57008171|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
57008172|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57008173|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
57008174|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008175|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57008176|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008177|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008178|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008179|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57008180|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57008181|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
57008182|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57008183|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008184|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
57008185|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57008186|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57008187|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
57008188|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008189|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57008190|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57008191|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
57008192|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008193|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008194|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57008195|NCT01343277|Dacarbazine|dacarbazine|mesh-list
57008196|NCT01343277|Trabectedin|trabectedin|mesh-list
57008197|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57008198|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
57008199|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008200|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008201|NCT04856293|Crizotinib|crizotinib|mesh-list
57008202|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008203|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57008204|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008205|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008206|NCT02253212|Carboplatin|carboplatin|mesh-list
57008207|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008208|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
57008209|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
57008210|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
57008211|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57008212|NCT01355939|Protective Agents|protective agents|mesh-ancestor
57008213|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008214|NCT01356017|Amlodipine|amlodipine|mesh-list
57008215|NCT01356017|Telmisartan|telmisartan|mesh-list
57008216|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57008217|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57008218|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57008219|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008220|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57008221|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008222|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
57008223|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57008224|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57008225|NCT02139098|Amitriptyline|amitriptyline|mesh-list
57008226|NCT02139098|Zolpidem|zolpidem|mesh-list
57008227|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57008228|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57008229|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008230|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008231|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57008232|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
57008233|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
57008234|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008235|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008236|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57008237|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
57008238|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57008239|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008240|NCT02139098|Analgesics|analgesics|mesh-ancestor
57008241|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
57008242|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008243|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57008244|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57008245|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57008246|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
57008247|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
57008248|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57008249|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008250|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
57008251|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
57008252|NCT02487979|Immunotoxins|immunotoxins|mesh-list
57008253|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57008254|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
57008255|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008256|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57008257|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008258|NCT02130830|Lidocaine|lidocaine|mesh-list
57008259|NCT02130830|Prilocaine|prilocaine|mesh-list
57008260|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
57008261|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
57008262|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008263|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008264|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
57008265|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008266|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57008267|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57008268|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57008269|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57008270|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008271|NCT04471727|Atezolizumab|atezolizumab|mesh-list
57008272|NCT04471727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008273|NCT01360151|Ranibizumab|ranibizumab|mesh-list
57008274|NCT01360151|Verteporfin|verteporfin|mesh-list
57008275|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57008276|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57008277|NCT01360151|Growth Substances|growth substances|mesh-ancestor
57008278|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008279|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
57008280|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008281|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57008282|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
57008283|NCT01363037|Maraviroc|maraviroc|mesh-list
57008284|NCT01363037|Dapivirine|dapivirine|mesh-list
57008285|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57008286|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56690273|NCT02605356|Bortezomib|bortezomib|mesh-list
57008287|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008288|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57008289|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57008290|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
57008291|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008292|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57008294|NCT01363115|Calcium|calcium|mesh-list
57008295|NCT01363115|Vitamins|vitamins|mesh-ancestor
57008296|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
57008297|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008298|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57008299|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57008300|NCT01356329|Heparin|heparin|mesh-list
57008301|NCT01356329|Enoxaparin|enoxaparin|mesh-list
57008302|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
57008303|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57008304|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57008305|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008306|NCT05579522|Hyaluronic Acid|hyaluronic acid|mesh-list
57008307|NCT05579522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57008308|NCT05579522|Immunologic Factors|immunologic factors|mesh-ancestor
57008309|NCT05579522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008310|NCT05579522|Viscosupplements|viscosupplements|mesh-ancestor
57008311|NCT05579522|Protective Agents|protective agents|mesh-ancestor
57008312|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57008313|NCT04560127|Apatinib|apatinib|mesh-list
57008314|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008315|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57008316|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008317|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008318|NCT01363193|Heparin|heparin|mesh-list
57008319|NCT01363193|Calcium heparin|calcium heparin|mesh-list
57008320|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
57008321|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57008322|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57008323|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008324|NCT01319279|Hydrocodone|hydrocodone|mesh-list
57008325|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57008326|NCT01319279|Narcotics|narcotics|mesh-ancestor
57008327|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008328|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008329|NCT01319279|Analgesics|analgesics|mesh-ancestor
57008330|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
57008331|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008332|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
57008333|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
57008334|NCT01363271|Vancomycin|vancomycin|mesh-list
57008335|NCT01363271|Linezolid|linezolid|mesh-list
57008336|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57008337|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008338|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57008339|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008340|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008341|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57008342|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008343|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57008344|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008345|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008346|NCT01360463|Methadone|methadone|mesh-list
57008347|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57008348|NCT01360463|Narcotics|narcotics|mesh-ancestor
57008349|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008350|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008351|NCT01360463|Analgesics|analgesics|mesh-ancestor
57008352|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
57008353|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008354|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
57008355|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
57008356|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57008357|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690336|NCT00812422|Analgesics|analgesics|mesh-ancestor
57008358|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57008359|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57008360|NCT03103087|Norethindrone|norethindrone|mesh-list
57008361|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
57008362|NCT03103087|Estradiol|estradiol|mesh-list
57008363|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57008364|NCT03103087|Relugolix|relugolix|mesh-list
57008365|NCT03103087|Estrogens|estrogens|mesh-ancestor
57008366|NCT03103087|Hormones|hormones|mesh-ancestor
57008367|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008368|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008369|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57008370|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
57008371|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57008372|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57008373|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57008374|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57008375|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57008376|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
57008377|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
57008378|NCT05579288|Nitrous Oxide|nitrous oxide|mesh-list
57008379|NCT05579288|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57008380|NCT05579288|Anesthetics, General|anesthetics, general|mesh-ancestor
57008381|NCT05579288|Anesthetics|anesthetics|mesh-ancestor
57008382|NCT05579288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008383|NCT05579288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008384|NCT05579288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008385|NCT05579288|Analgesics|analgesics|mesh-ancestor
57008386|NCT05579288|Sensory System Agents|sensory system agents|mesh-ancestor
57008387|NCT05579288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008388|NCT03132467|Durvalumab|durvalumab|mesh-list
57008389|NCT03132467|Ipilimumab|ipilimumab|mesh-list
57008390|NCT03132467|Tremelimumab|tremelimumab|mesh-list
57008391|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
57008392|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57008393|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
57008394|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57008395|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008396|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
57008397|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008398|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57008399|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008400|NCT02134964|Dapansutrile|dapansutrile|mesh-list
57008401|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57008402|NCT01363583|Epoprostenol|epoprostenol|mesh-list
57008403|NCT01363583|Tezosentan|tezosentan|mesh-list
57008404|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57008405|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57008406|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
57008407|NCT02135120|Morphine|morphine|mesh-list
57008408|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008409|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008410|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57008411|NCT02135120|Narcotics|narcotics|mesh-ancestor
57008412|NCT02135120|Analgesics|analgesics|mesh-ancestor
57008413|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
57008414|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008415|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
57008416|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008417|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57008418|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008419|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008420|NCT01319357|Saxagliptin|saxagliptin|mesh-list
57008421|NCT01319357|Incretins|incretins|mesh-ancestor
57008422|NCT01319357|Hormones|hormones|mesh-ancestor
57008423|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008424|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008425|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57008426|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
57008427|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008428|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008429|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57008430|NCT02135354|Azithromycin|azithromycin|mesh-list
57008431|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57008432|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008433|NCT02055053|Bupivacaine|bupivacaine|mesh-list
57008434|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
57008435|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
57008436|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008437|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008438|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
57008439|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008441|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57008442|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008443|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008444|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008445|NCT02303431|Edoxaban|edoxaban|mesh-list
57008446|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57008447|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
57008448|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57008449|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
57008450|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008451|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008452|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
57008453|NCT02135510|Metoclopramide|metoclopramide|mesh-list
57008454|NCT02135510|Palonosetron|palonosetron|mesh-list
57008455|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
57008456|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
57008457|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008458|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008459|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56585832|NCT00777829|Zolpidem|zolpidem|mesh-list
57008460|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57008461|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57008462|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
57008463|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008464|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008465|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57008466|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57008467|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
57008468|NCT02004275|Dexamethasone|dexamethasone|mesh-list
57008469|NCT02004275|Pomalidomide|pomalidomide|mesh-list
57008470|NCT02004275|Ixazomib|ixazomib|mesh-list
57008471|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57008472|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
57008473|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
57008474|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008475|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008476|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57008477|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
57008478|NCT02004275|Hormones|hormones|mesh-ancestor
57008479|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008480|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57008481|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008482|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
57008483|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57008484|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57008485|NCT02004275|Growth Substances|growth substances|mesh-ancestor
57008486|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
57008487|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
57008488|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008489|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008490|NCT03548714|Ethanol|ethanol|mesh-list
57008491|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57008492|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008493|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008494|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008495|NCT02135588|Plasminogen|plasminogen|mesh-list
57008496|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57008497|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57008498|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57008499|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008500|NCT05578664|Pembrolizumab|pembrolizumab|mesh-list
57008501|NCT05578664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57008502|NCT05578664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008503|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
57008504|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008505|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57008506|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008507|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008508|NCT01363817|Dexamethasone|dexamethasone|mesh-list
57008509|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57008510|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
57008511|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
57008512|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690488|NCT05645406|Estradiol|estradiol|mesh-list
57008513|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008514|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57008515|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
57008516|NCT01363817|Hormones|hormones|mesh-ancestor
57008517|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008518|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57008519|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008520|NCT02140268|Midazolam|midazolam|mesh-list
57008521|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57008522|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57008523|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008524|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008525|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57008526|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57008527|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57008528|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57008529|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
57008530|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
57008531|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
56585888|NCT05326087|Cetrorelix|cetrorelix|mesh-list
57008532|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
57008533|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008534|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008535|NCT05578352|Insulin|insulin|mesh-list
57008536|NCT05578352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57008537|NCT05578352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008538|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
57008539|NCT03602508|Mirabegron|mirabegron|mesh-list
57008540|NCT03602508|Fesoterodine|fesoterodine|mesh-list
57008541|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
57008542|NCT03602508|Oxybutynin|oxybutynin|mesh-list
57008543|NCT03602508|Darifenacin|darifenacin|mesh-list
57008544|NCT03602508|Propiverine|propiverine|mesh-list
57008545|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57008546|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57008547|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
57008548|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008549|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008550|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008551|NCT03602508|Urological Agents|urological agents|mesh-ancestor
57008552|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57008553|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57008554|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57008555|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
57008556|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
57008557|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
57008558|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008559|NCT03549728|Lenograstim|lenograstim|mesh-list
57008560|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57008561|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
57008562|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008563|NCT01356797|Fentanyl|fentanyl|mesh-list
57008564|NCT01356797|Bupivacaine|bupivacaine|mesh-list
57008565|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
57008566|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
57008567|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
57008568|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008569|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008570|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
57008571|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008572|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57008573|NCT01356797|Narcotics|narcotics|mesh-ancestor
57008574|NCT01356797|Analgesics|analgesics|mesh-ancestor
57008575|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57008576|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57008577|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
57008578|NCT02238132|Ipratropium|ipratropium|mesh-list
57008579|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57008580|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
57008581|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008582|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008583|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57008584|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
57008585|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57008586|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
57008587|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008588|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690557|NCT00646906|Aspirin|aspirin|mesh-list
57008589|NCT05200429|Ivacaftor|ivacaftor|mesh-list
57008590|NCT05200429|Elexacaftor|elexacaftor|mesh-list
57008591|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57008592|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57008593|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008594|NCT05578196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57008595|NCT02135822|Gemcitabine|gemcitabine|mesh-list
57008596|NCT02135822|Paclitaxel|paclitaxel|mesh-list
57008597|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57008598|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57008599|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008600|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
57008601|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
57008602|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
57008603|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008604|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57008605|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
57008606|NCT02135822|Antiviral Agents|antiviral agents|mesh-ancestor
57008607|NCT02135822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008608|NCT02135822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008609|NCT02135822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57008610|NCT02135822|Immunologic Factors|immunologic factors|mesh-ancestor
57008611|NCT02135822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008612|NCT02238210|Ipratropium|ipratropium|mesh-list
57008613|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57008614|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
57008615|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008616|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008617|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57008618|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
57008619|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57008620|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
57008621|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008622|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008623|NCT05739955|Disinfectants|disinfectants|mesh-list
57008624|NCT05739955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008625|NCT02978456|Sirolimus|sirolimus|mesh-list
57008626|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57008627|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008628|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57008629|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008630|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
57008631|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57008632|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
57008633|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008634|NCT05736913|Vaccines|vaccines|mesh-list
57008635|NCT05736913|Immunologic Factors|immunologic factors|mesh-ancestor
57008636|NCT05736913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008637|NCT03598452|Ganciclovir|ganciclovir|mesh-list
57008638|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
57008639|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
57008640|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008641|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57008642|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008643|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008644|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57008645|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57008646|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57008647|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57008648|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008649|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008650|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008651|NCT03549026|Analgesics|analgesics|mesh-ancestor
57008652|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
57008653|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008654|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
57008655|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57008656|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
57008657|NCT03101371|Iodine|iodine|mesh-list
57008658|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
57008659|NCT03101371|Povidone|povidone|mesh-list
57008660|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57008661|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008662|NCT03101371|Trace Elements|trace elements|mesh-ancestor
57008663|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
57008664|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008665|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
57008666|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
57008667|NCT03588078|Azacitidine|azacitidine|mesh-list
57008668|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57008669|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
57008670|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008671|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008672|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008673|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57008674|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
57008675|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57008676|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
57008677|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57008678|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008679|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57008680|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57008681|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008682|NCT05494190|Docetaxel|docetaxel|mesh-list
57008683|NCT05494190|Capecitabine|capecitabine|mesh-list
57008684|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008685|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
57008686|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
57008687|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
57008688|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008689|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57008690|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
57008691|NCT05364073|Aflutinib|aflutinib|mesh-list
57008692|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57008693|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008694|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008695|NCT02850276|Bromides|bromides|mesh-list
57008696|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
57008697|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
57008698|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57008699|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008700|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008701|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
57008702|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008703|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008704|NCT04961593|Caspofungin|caspofungin|mesh-list
57008705|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
57008706|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008707|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008708|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008709|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
57008710|NCT03862170|Cefazolin|cefazolin|mesh-list
57008711|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57008712|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008713|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57008714|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57008715|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008716|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008717|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008718|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57008719|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57008720|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
57008721|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
57008722|NCT05577806|Dydrogesterone|dydrogesterone|mesh-list
57008723|NCT05577806|Progestins|progestins|mesh-ancestor
57008724|NCT05577806|Hormones|hormones|mesh-ancestor
57008725|NCT05577806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008726|NCT05577806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008727|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
57008728|NCT03548948|Iron|iron|mesh-list
57008729|NCT03548948|Trace Elements|trace elements|mesh-ancestor
57008730|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
57008731|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008732|NCT02238444|Aspirin|aspirin|mesh-list
57008733|NCT02238444|Heparin|heparin|mesh-list
57008734|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57008735|NCT02238444|Tinzaparin|tinzaparin|mesh-list
57008736|NCT02238444|Dalteparin|dalteparin|mesh-list
57008737|NCT02238444|Dipyridamole|dipyridamole|mesh-list
57008738|NCT02238444|Warfarin|warfarin|mesh-list
56690707|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
57008739|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57008740|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008741|NCT02238444|Analgesics|analgesics|mesh-ancestor
57008742|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
57008743|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008744|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008745|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57008746|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57008747|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57008748|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57008749|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008750|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57008751|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57008752|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008753|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
57008754|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
57008755|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57008756|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
57008757|NCT03131687|Dulaglutide|dulaglutide|mesh-list
57008758|NCT03131687|Tirzepatide|tirzepatide|mesh-list
57008759|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57008760|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008761|NCT03131687|Incretins|incretins|mesh-ancestor
57008762|NCT03131687|Hormones|hormones|mesh-ancestor
57008763|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008764|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
57008765|NCT03579888|Fludarabine|fludarabine|mesh-list
57008766|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57008767|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
57008768|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008769|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57008770|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57008771|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
57008772|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008773|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008774|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57008775|NCT05344027|Mitotane|mitotane|mesh-list
57008776|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57008777|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008778|NCT05430698|Antibodies|antibodies|mesh-list
57008779|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
57008780|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008781|NCT03585894|Ketorolac|ketorolac|mesh-list
57008782|NCT03585894|Sumatriptan|sumatriptan|mesh-list
57008783|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57008784|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008785|NCT03585894|Analgesics|analgesics|mesh-ancestor
57008786|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
57008787|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008788|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008789|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57008790|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57008791|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57008792|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008793|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008794|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57008795|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57008796|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57008797|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
57008798|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008799|NCT04912921|Palmidrol|palmidrol|mesh-list
57008800|NCT04912921|Curcumin|curcumin|mesh-list
57008801|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57008802|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008803|NCT04912921|Analgesics|analgesics|mesh-ancestor
57008804|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
57008805|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008806|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008807|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57008808|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57008809|NCT04912921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008810|NCT04912921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008811|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008812|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
57008813|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690782|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57008814|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57008815|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57008816|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008817|NCT04912921|Hormones|hormones|mesh-ancestor
57008818|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008819|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57008820|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
57008821|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
57008822|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008823|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008824|NCT05420324|Paclitaxel|paclitaxel|mesh-list
57008825|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
57008826|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57008827|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008828|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
57008829|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
57008830|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
57008831|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008832|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57008833|NCT02238288|Acetaminophen|acetaminophen|mesh-list
57008834|NCT02238288|Lidocaine|lidocaine|mesh-list
57008835|NCT02238288|Epinephrine|epinephrine|mesh-list
57008836|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
57008837|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
57008838|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
57008839|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008840|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008841|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
57008842|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008843|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57008844|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57008845|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57008846|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57008847|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008848|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008849|NCT02238288|Analgesics|analgesics|mesh-ancestor
57008850|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
57008851|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57008852|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57008853|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
57008854|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008855|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57008856|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57008857|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
57008858|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57008859|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
57008860|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
57008861|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
57008862|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57008863|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57008864|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57008865|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
57008866|NCT02238288|Coagulants|coagulants|mesh-ancestor
57008867|NCT01561040|Vitamin D|vitamin d|mesh-list
57008868|NCT01561040|Vitamin A|vitamin a|mesh-list
57008869|NCT01561040|Vitamins|vitamins|mesh-ancestor
57008870|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
57008871|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008872|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57008873|NCT03590496|Calcium|calcium|mesh-list
57008874|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57008875|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008876|NCT05577260|Dexmedetomidine|dexmedetomidine|mesh-list
57008877|NCT05577260|Bupivacaine|bupivacaine|mesh-list
57008878|NCT05577260|Anesthetics, Local|anesthetics, local|mesh-ancestor
57008879|NCT05577260|Anesthetics|anesthetics|mesh-ancestor
57008880|NCT05577260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008881|NCT05577260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008882|NCT05577260|Sensory System Agents|sensory system agents|mesh-ancestor
57008883|NCT05577260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008884|NCT05577260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57008885|NCT05577260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008886|NCT05577260|Analgesics|analgesics|mesh-ancestor
56690859|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
57008887|NCT05577260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57008888|NCT05577260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57008889|NCT05577260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57008890|NCT05577260|Adrenergic Agents|adrenergic agents|mesh-ancestor
57008891|NCT05577260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008892|NCT05577260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008893|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
57008894|NCT03760562|Hormones|hormones|mesh-ancestor
57008895|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57008896|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008897|NCT01357031|Amitriptyline|amitriptyline|mesh-list
57008898|NCT01357031|Melatonin|melatonin|mesh-list
57008899|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
57008900|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008901|NCT01357031|Protective Agents|protective agents|mesh-ancestor
57008902|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008903|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008904|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57008905|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
57008906|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57008907|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008908|NCT01357031|Analgesics|analgesics|mesh-ancestor
57008909|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
57008910|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008911|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57008912|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57008913|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57008914|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
57008915|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008916|NCT01357109|Bosentan|bosentan|mesh-list
57008917|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57008918|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57008919|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008920|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57008921|NCT04792580|Lifitegrast|lifitegrast|mesh-list
57008922|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57008923|NCT02253446|Diclofenac|diclofenac|mesh-list
57008924|NCT02253446|Piroxicam|piroxicam|mesh-list
57008925|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57008926|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57008927|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57008928|NCT02253446|Analgesics|analgesics|mesh-ancestor
57008929|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
57008930|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008931|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008932|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57008933|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57008934|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57008935|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57008936|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008937|NCT05417893|Sirolimus|sirolimus|mesh-list
57008938|NCT05417893|Everolimus|everolimus|mesh-list
57008939|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008940|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57008941|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
57008942|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008943|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57008944|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008945|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57008946|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
57008947|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
57008948|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57008949|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008950|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008951|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
57008952|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57008953|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57008954|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008955|NCT03347617|Hematinics|hematinics|mesh-ancestor
57008956|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57008957|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57008958|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
57008959|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
57008960|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008961|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57008962|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57008963|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
56690930|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57008964|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896299|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57008965|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008966|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57008967|NCT01563224|Baclofen|baclofen|mesh-list
57008968|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57008969|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008970|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57008971|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008972|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57008973|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
57008974|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
57008975|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008976|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008977|NCT01369979|Imidacloprid|imidacloprid|mesh-list
57008978|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
57008979|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57008980|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57008981|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008982|NCT03577860|Bupivacaine|bupivacaine|mesh-list
57008983|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
57008984|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
57008985|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008986|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008987|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
57008988|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57008989|NCT03577782|Vedolizumab|vedolizumab|mesh-list
57008990|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57008991|NCT03432065|Buspirone|buspirone|mesh-list
57008992|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57008993|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57008994|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57008995|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57008996|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57008997|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57008998|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
57008999|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009000|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009001|NCT03577626|Hemay005|hemay005|mesh-list
57009002|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
57009003|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57009004|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57009005|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009006|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009007|NCT03412799|Gemcitabine|gemcitabine|mesh-list
57009008|NCT03412799|Paclitaxel|paclitaxel|mesh-list
57009009|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57009010|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57009011|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009012|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
57009013|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
57009014|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
57009015|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009016|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57009017|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
57009018|NCT03412799|Antiviral Agents|antiviral agents|mesh-ancestor
57009019|NCT03412799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009020|NCT03412799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009021|NCT03412799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57009022|NCT03412799|Immunologic Factors|immunologic factors|mesh-ancestor
57009023|NCT03412799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009024|NCT03579732|Aspirin|aspirin|mesh-list
57009025|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57009026|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57009027|NCT03579732|Analgesics|analgesics|mesh-ancestor
57009028|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
57009029|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009030|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009031|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009032|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57009033|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57009034|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57009035|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009036|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57009037|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57009038|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009039|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
57009040|NCT02259816|Amlodipine|amlodipine|mesh-list
57009041|NCT02259816|Telmisartan|telmisartan|mesh-list
57009042|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57009043|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57009044|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57009045|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009046|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57009047|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009048|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
57009049|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57009050|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57009051|NCT01567735|Simeprevir|simeprevir|mesh-list
57009052|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
57009053|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009054|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
57009055|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009056|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009057|NCT04631471|Ibudilast|ibudilast|mesh-list
57009058|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57009059|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
57009060|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009061|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009062|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57009063|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
57009064|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57009065|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009066|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009067|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57009068|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
57009069|NCT03577392|Capecitabine|capecitabine|mesh-list
57009070|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
57009071|NCT03577392|Endostatins|endostatins|mesh-list
57009072|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57009073|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
57009074|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009075|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009076|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57009077|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57009078|NCT03577392|Growth Substances|growth substances|mesh-ancestor
57009079|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009080|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
57009081|NCT03579576|Ribavirin|ribavirin|mesh-list
57009082|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
57009083|NCT03579576|Velpatasvir|velpatasvir|mesh-list
57009084|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
57009085|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009086|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
57009087|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009088|NCT01364519|Fluticasone|fluticasone|mesh-list
57009089|NCT01364519|Xhance|xhance|mesh-list
57009090|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009091|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57009092|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
57009093|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009094|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009095|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57009096|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
57009097|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
57009098|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57009099|NCT04721132|Bevacizumab|bevacizumab|mesh-list
57009100|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57009101|NCT04721132|Atezolizumab|atezolizumab|mesh-list
57009102|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
57009103|NCT04721132|Antibodies|antibodies|mesh-list
57009104|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
57009105|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57009106|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
57009107|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009108|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57009109|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57009110|NCT04721132|Growth Substances|growth substances|mesh-ancestor
57009111|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009112|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
57009113|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
57009114|NCT03577158|Insulin|insulin|mesh-list
57009115|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57009116|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009117|NCT02253914|Ritonavir|ritonavir|mesh-list
57009118|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57009119|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57009120|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
57009121|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009122|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009123|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57009124|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57009125|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
57009126|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009127|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57009128|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57009129|NCT01364675|Metformin|metformin|mesh-list
57009130|NCT01364675|Enalapril|enalapril|mesh-list
57009131|NCT01364675|Simvastatin|simvastatin|mesh-list
57009132|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57009133|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009134|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57009135|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57009136|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
57009137|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009138|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57009139|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57009140|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009141|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57009142|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
57009143|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57009144|NCT02253758|Propofol|propofol|mesh-list
57009145|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57009146|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009147|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009148|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57009149|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
57009150|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
57009151|NCT04505735|Corticosterone|corticosterone|mesh-list
57009152|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009153|NCT03547232|Indomethacin|indomethacin|mesh-list
57009154|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57009155|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57009156|NCT03547232|Analgesics|analgesics|mesh-ancestor
57009157|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
57009158|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009159|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009160|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009161|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57009162|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
57009163|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
57009164|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57009165|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57009166|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009167|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009168|NCT02250534|Nicotine|nicotine|mesh-list
57009169|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57009170|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
57009171|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009172|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009173|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57009174|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57009175|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
57009176|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009177|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009178|NCT01370135|Ranibizumab|ranibizumab|mesh-list
57009179|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57009180|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57009181|NCT01370135|Growth Substances|growth substances|mesh-ancestor
57009182|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009183|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
57009184|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009185|NCT05266586|Ezetimibe|ezetimibe|mesh-list
57009186|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57009187|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57009188|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
57009189|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009191|NCT01370291|Risperidone|risperidone|mesh-list
57009192|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57009193|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
57009194|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009195|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009196|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009197|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57009198|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57009199|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009200|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57009201|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57009202|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
57009203|NCT05575544|Morphine|morphine|mesh-list
57009204|NCT05575544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57009205|NCT05575544|Narcotics|narcotics|mesh-ancestor
57009206|NCT05575544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009207|NCT05575544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009208|NCT05575544|Analgesics|analgesics|mesh-ancestor
57009209|NCT05575544|Sensory System Agents|sensory system agents|mesh-ancestor
57009210|NCT05575544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009211|NCT05179772|Olanzapine|olanzapine|mesh-list
57009212|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
57009213|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
57009214|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009215|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009216|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57009217|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57009218|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57009219|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009220|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57009221|NCT05179772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57009222|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57009223|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57009224|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009225|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009226|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
57009227|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57009228|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57009229|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009230|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
57009231|NCT04703426|Sargramostim|sargramostim|mesh-list
57009232|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009233|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009234|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
57009235|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009236|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
57009237|NCT01364987|Peficitinib|peficitinib|mesh-list
57009238|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57009239|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009240|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57009241|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
57009242|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57009243|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009244|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009245|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009246|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57009247|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
57009248|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009249|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
57009250|NCT01365923|Remifentanil|remifentanil|mesh-list
57009251|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57009252|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009253|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009254|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57009255|NCT01365923|Analgesics|analgesics|mesh-ancestor
57009256|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
57009257|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009258|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57009259|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57009260|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57009261|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
57009262|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009263|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009264|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57009265|NCT01365923|Narcotics|narcotics|mesh-ancestor
57009266|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
57009267|NCT05264168|Apixaban|apixaban|mesh-list
57009268|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57009269|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
57009270|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57009271|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
57009272|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009273|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009274|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
57009275|NCT01370915|Vitamins|vitamins|mesh-list
57009276|NCT01370915|Pregabalin|pregabalin|mesh-list
57009277|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
57009278|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009279|NCT01370915|Analgesics|analgesics|mesh-ancestor
57009280|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
57009281|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009282|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
57009283|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57009284|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57009285|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009286|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57009287|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57009288|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57009289|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009290|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57009291|NCT05574998|Paclitaxel|paclitaxel|mesh-list
57009292|NCT05574998|Cisplatin|cisplatin|mesh-list
57009293|NCT05574998|Carboplatin|carboplatin|mesh-list
57009294|NCT05574998|Pemetrexed|pemetrexed|mesh-list
57009295|NCT05574998|Endostar protein|endostar protein|mesh-list
57009296|NCT05574998|Endostatins|endostatins|mesh-list
57009297|NCT05574998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57009298|NCT05574998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009299|NCT05574998|Tubulin Modulators|tubulin modulators|mesh-ancestor
57009300|NCT05574998|Antimitotic Agents|antimitotic agents|mesh-ancestor
57009301|NCT05574998|Mitosis Modulators|mitosis modulators|mesh-ancestor
57009302|NCT05574998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009303|NCT05574998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009304|NCT05574998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57009305|NCT05574998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57009306|NCT05574998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57009307|NCT05574998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57009308|NCT05574998|Growth Substances|growth substances|mesh-ancestor
57009309|NCT05574998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009310|NCT05574998|Growth Inhibitors|growth inhibitors|mesh-ancestor
57009311|NCT03547778|Misoprostol|misoprostol|mesh-list
57009312|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57009313|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
57009314|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57009315|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009316|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57009317|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57009318|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
57009319|NCT03547700|Ixazomib|ixazomib|mesh-list
57009320|NCT03547700|Romidepsin|romidepsin|mesh-list
57009321|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009322|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
57009323|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009324|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009325|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57009326|NCT02239458|Saxagliptin|saxagliptin|mesh-list
57009327|NCT02239458|Incretins|incretins|mesh-ancestor
57009328|NCT02239458|Hormones|hormones|mesh-ancestor
57009329|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57009330|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009331|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57009332|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
57009333|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009334|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009335|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57009336|NCT03578874|Capecitabine|capecitabine|mesh-list
57009337|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
57009338|NCT03578874|Sorafenib|sorafenib|mesh-list
57009339|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57009340|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
57009341|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009342|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009343|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57009344|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009345|NCT04586504|Midazolam|midazolam|mesh-list
57009346|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57009347|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57009348|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009349|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009350|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57009351|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57009352|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57009353|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57009354|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
57009355|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
57009356|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
57009357|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
57009358|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009359|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009360|NCT01366001|Buprenorphine|buprenorphine|mesh-list
57009361|NCT01366001|ALKS-33|alks-33|mesh-list
57009362|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57009363|NCT01366001|Narcotics|narcotics|mesh-ancestor
57009364|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009365|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009366|NCT01366001|Analgesics|analgesics|mesh-ancestor
57009367|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
57009368|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009369|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57009370|NCT01365065|Vorinostat|vorinostat|mesh-list
57009371|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009372|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57009373|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009374|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009375|NCT03576456|Alprazolam|alprazolam|mesh-list
57009376|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57009377|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009378|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009379|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57009380|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57009381|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57009382|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
57009383|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
57009384|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009385|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009386|NCT03576378|Prednisone|prednisone|mesh-list
57009387|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
57009388|NCT03576378|Etoposide|etoposide|mesh-list
57009389|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
57009390|NCT03576378|Procarbazine|procarbazine|mesh-list
57009391|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57009392|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
57009393|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009394|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57009395|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57009396|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
57009397|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009398|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009399|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57009400|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009401|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
57009402|NCT03576378|Hormones|hormones|mesh-ancestor
57009403|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57009404|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57009405|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57009406|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57009407|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57009408|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009409|NCT03576378|Analgesics|analgesics|mesh-ancestor
57009410|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
57009411|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009412|NCT05572190|Hydrocodone|hydrocodone|mesh-list
57009413|NCT05572190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57009414|NCT05572190|Narcotics|narcotics|mesh-ancestor
57009415|NCT05572190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009416|NCT05572190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009417|NCT05572190|Analgesics|analgesics|mesh-ancestor
57009418|NCT05572190|Sensory System Agents|sensory system agents|mesh-ancestor
57009419|NCT05572190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009420|NCT05572190|Antitussive Agents|antitussive agents|mesh-ancestor
57009421|NCT05572190|Respiratory System Agents|respiratory system agents|mesh-ancestor
57009422|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57009423|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57009424|NCT05567588|Pembrolizumab|pembrolizumab|mesh-list
57009425|NCT05567588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009426|NCT05567588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009427|NCT03124199|Rifaximin|rifaximin|mesh-list
57009428|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57009429|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009430|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57009431|NCT03578640|Grazoprevir|grazoprevir|mesh-list
57009432|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
57009433|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009434|NCT04465916|Tenofovir|tenofovir|mesh-list
57009435|NCT04465916|Entecavir|entecavir|mesh-list
57009436|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
57009437|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009438|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57009439|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57009440|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009441|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009442|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57009443|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57009444|NCT01366235|Chloroquine|chloroquine|mesh-list
57009445|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
57009446|NCT01366235|Amebicides|amebicides|mesh-ancestor
57009447|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57009448|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57009449|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009450|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
57009451|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57009452|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57009453|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57009454|NCT01366235|Analgesics|analgesics|mesh-ancestor
57009455|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
57009456|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009457|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009458|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009459|NCT01366235|Filaricides|filaricides|mesh-ancestor
57009460|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
57009461|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
57009462|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
57009463|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57009464|NCT04871165|Antibodies|antibodies|mesh-list
57009465|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
57009466|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009467|NCT04465760|Antibodies|antibodies|mesh-list
57009468|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
57009469|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
57009470|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009471|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
57009472|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009473|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009474|NCT01366313|Acetaminophen|acetaminophen|mesh-list
57009475|NCT01366313|Morphine|morphine|mesh-list
57009476|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57009477|NCT01366313|Narcotics|narcotics|mesh-ancestor
57009478|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009479|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009480|NCT01366313|Analgesics|analgesics|mesh-ancestor
57009481|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
57009482|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009483|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57009484|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
57009485|NCT05561738|Niacinamide|niacinamide|mesh-list
57009486|NCT05561738|Niacin|niacin|mesh-list
57009487|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
57009488|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
57009489|NCT05561738|Vitamins|vitamins|mesh-ancestor
57009490|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
57009491|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009492|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57009493|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
57009494|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009495|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57009496|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
57009497|NCT02253524|Metoclopramide|metoclopramide|mesh-list
57009498|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
57009499|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
57009500|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
57009501|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009502|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009503|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57009504|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57009505|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57009506|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
57009507|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009508|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009509|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57009510|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
57009511|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
57009512|NCT03575598|Nivolumab|nivolumab|mesh-list
57009513|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009514|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009515|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57009516|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009517|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57009518|NCT02253602|Hematinics|hematinics|mesh-ancestor
57009519|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57009520|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57009521|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
57009522|NCT03575520|Doxorubicin|doxorubicin|mesh-list
57009523|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57009524|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
57009525|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009526|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57009527|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57009528|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
57009529|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009530|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009531|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57009532|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57009533|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57009534|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57009535|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009536|NCT01366391|Metformin|metformin|mesh-list
57009537|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57009538|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009539|NCT04408586|Topiramate|topiramate|mesh-list
57009540|NCT04408586|Phentermine|phentermine|mesh-list
57009541|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
57009542|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57009543|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009544|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57009545|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
57009546|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57009547|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
57009548|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
57009549|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009550|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
57009551|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009552|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009553|NCT04398524|Cemiplimab|cemiplimab|mesh-list
57009554|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009555|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009556|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
57009557|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
57009558|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
57009559|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009560|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57009561|NCT02239614|Antacids|antacids|mesh-ancestor
57009562|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009563|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57009564|NCT03572400|Gemcitabine|gemcitabine|mesh-list
57009565|NCT03572400|Durvalumab|durvalumab|mesh-list
57009566|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57009567|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
57009568|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009569|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009570|NCT03572400|Antiviral Agents|antiviral agents|mesh-ancestor
57009571|NCT03572400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009572|NCT03572400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009573|NCT03572400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57009574|NCT03572400|Immunologic Factors|immunologic factors|mesh-ancestor
57009575|NCT03572400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009576|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009577|NCT02253836|Ritonavir|ritonavir|mesh-list
57009578|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57009579|NCT02253836|Tipranavir|tipranavir|mesh-list
57009580|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57009581|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57009582|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
57009583|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009584|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009585|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57009586|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57009587|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
57009588|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009589|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57009590|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57009591|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57009592|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57009593|NCT02241018|Antibodies|antibodies|mesh-list
57009594|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57009595|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
57009596|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
57009597|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009598|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009599|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009600|NCT04039022|Dextromethorphan|dextromethorphan|mesh-list
57009601|NCT04039022|Bupropion|bupropion|mesh-list
57009602|NCT04039022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57009603|NCT04039022|Antidepressive Agents|antidepressive agents|mesh-ancestor
57009604|NCT04039022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57009605|NCT04039022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57009606|NCT04039022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57009607|NCT04039022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57009608|NCT04039022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009609|NCT04039022|Dopamine Agents|dopamine agents|mesh-ancestor
57009610|NCT04039022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009611|NCT04039022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009612|NCT04039022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57009613|NCT04039022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57009614|NCT04039022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009615|NCT04039022|Antitussive Agents|antitussive agents|mesh-ancestor
57009616|NCT04039022|Respiratory System Agents|respiratory system agents|mesh-ancestor
57009617|NCT04039022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57009618|NCT04039022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57009619|NCT03572088|Terlipressin|terlipressin|mesh-list
57009620|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57009621|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57009622|NCT00109772|Lenalidomide|lenalidomide|mesh-list
57009623|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
57009624|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009625|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57009626|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57009627|NCT00109772|Growth Substances|growth substances|mesh-ancestor
57009628|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
57009629|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009630|NCT03572010|Fesoterodine|fesoterodine|mesh-list
57009631|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57009632|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57009633|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
57009634|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009635|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009636|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009637|NCT03572010|Urological Agents|urological agents|mesh-ancestor
57009638|NCT01560104|Paclitaxel|paclitaxel|mesh-list
57009639|NCT01560104|Carboplatin|carboplatin|mesh-list
57009640|NCT01560104|Veliparib|veliparib|mesh-list
57009641|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57009642|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009643|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
57009644|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
57009645|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
57009646|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009647|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57009648|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009649|NCT00101972|Antibodies|antibodies|mesh-list
57009650|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57009651|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
57009652|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009653|NCT02245932|Resveratrol|resveratrol|mesh-list
57009654|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
57009655|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009656|NCT02245932|Protective Agents|protective agents|mesh-ancestor
57009657|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009658|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009659|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57009660|NCT05095922|Valsartan|valsartan|mesh-list
57009661|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
57009662|NCT05095922|Calcium|calcium|mesh-list
57009663|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57009664|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009665|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57009666|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57009667|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57009668|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009669|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
57009670|NCT05095922|Coagulants|coagulants|mesh-ancestor
57009671|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57009672|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57009673|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009674|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009675|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009676|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57009677|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
57009678|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57009679|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57009680|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009681|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
57009682|NCT03756896|Dexamethasone|dexamethasone|mesh-list
57009683|NCT03756896|Pomalidomide|pomalidomide|mesh-list
57009684|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009685|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
57009686|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
57009687|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009688|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009689|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57009690|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
57009691|NCT03756896|Hormones|hormones|mesh-ancestor
57009692|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57009693|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57009694|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009695|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
57009696|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57009697|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57009698|NCT03756896|Growth Substances|growth substances|mesh-ancestor
57009699|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
57009700|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
57009701|NCT04944368|Paraproteins|paraproteins|mesh-list
57009702|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
57009703|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009704|NCT04268498|Acetaminophen|acetaminophen|mesh-list
57009705|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
57009706|NCT04268498|Promethazine|promethazine|mesh-list
57009707|NCT04268498|Dexamethasone|dexamethasone|mesh-list
57009708|NCT04268498|Lenalidomide|lenalidomide|mesh-list
57009709|NCT04268498|Bortezomib|bortezomib|mesh-list
57009710|NCT04268498|Daratumumab|daratumumab|mesh-list
57009711|NCT04268498|Montelukast|montelukast|mesh-list
57009712|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009713|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
57009714|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
57009715|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009716|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009717|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57009718|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
57009719|NCT04268498|Hormones|hormones|mesh-ancestor
57009720|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691676|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
57009721|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57009722|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009723|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
57009724|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57009725|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57009726|NCT04268498|Growth Substances|growth substances|mesh-ancestor
57009727|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
57009728|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57009729|NCT04268498|Analgesics|analgesics|mesh-ancestor
57009730|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
57009731|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
57009732|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57009733|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
57009734|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57009735|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
57009736|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57009737|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57009738|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009739|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57009740|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57009741|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009742|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
57009743|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
57009744|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57009745|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
57009746|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
57009747|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009748|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57009749|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
57009750|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
57009751|NCT04260464|PF-06700841|pf-06700841|mesh-list
57009752|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57009753|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009754|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009755|NCT03651518|Rituximab|rituximab|mesh-list
57009756|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57009757|NCT03651518|Ustekinumab|ustekinumab|mesh-list
57009758|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009759|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009760|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
57009761|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009762|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57009763|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
57009764|NCT03546530|Interferons|interferons|mesh-list
57009765|NCT03546530|Resveratrol|resveratrol|mesh-list
57009766|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009767|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
57009768|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009769|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
57009770|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009771|NCT03546530|Protective Agents|protective agents|mesh-ancestor
57009772|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009773|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009774|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57009775|NCT03568994|Cytarabine|cytarabine|mesh-list
57009776|NCT03568994|Atovaquone|atovaquone|mesh-list
57009777|NCT03568994|Etoposide|etoposide|mesh-list
57009778|NCT03568994|Daunorubicin|daunorubicin|mesh-list
57009779|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
57009780|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57009781|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009782|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57009783|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57009784|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009785|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009786|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57009787|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
57009788|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
57009789|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009790|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57009791|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
57009792|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009793|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57009794|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009795|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
57009796|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57009798|NCT04203056|Aripiprazole|aripiprazole|mesh-list
57009799|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
57009800|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
57009801|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57009802|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57009803|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57009804|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009805|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009806|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
57009807|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
57009808|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009809|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009810|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57009811|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57009812|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
57009813|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57009814|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57009815|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57009816|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57009817|NCT04894994|Ipilimumab|ipilimumab|mesh-list
57009818|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009819|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009820|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57009821|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009822|NCT01366547|Lamivudine|lamivudine|mesh-list
57009823|NCT01366547|Abacavir|abacavir|mesh-list
57009824|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
57009825|NCT01366547|Dolutegravir|dolutegravir|mesh-list
57009826|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57009827|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57009828|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009829|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009830|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
57009831|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009832|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57009833|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57009834|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57009835|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57009836|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
57009837|NCT05190341|Ibuprofen|ibuprofen|mesh-list
57009838|NCT05190341|Ketorolac|ketorolac|mesh-list
57009839|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57009840|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57009841|NCT05190341|Analgesics|analgesics|mesh-ancestor
57009842|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
57009843|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009844|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009845|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009846|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57009847|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57009848|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009849|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009850|NCT04347239|Leronlimab|leronlimab|mesh-list
57009851|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57009852|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57009853|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009854|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57009855|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57009856|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
57009857|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009858|NCT00109928|Gemcitabine|gemcitabine|mesh-list
57009859|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
57009860|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57009861|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57009862|NCT00109928|Prednisolone|prednisolone|mesh-list
57009863|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
57009864|NCT00109928|Etoposide|etoposide|mesh-list
57009865|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57009866|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
57009867|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009868|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57009869|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
57009870|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009871|NCT00109928|Antiviral Agents|antiviral agents|mesh-ancestor
57009872|NCT00109928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009873|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009874|NCT00109928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57009875|NCT00109928|Immunologic Factors|immunologic factors|mesh-ancestor
57009876|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896362|NCT01161147|Meloxicam|meloxicam|mesh-list
57009877|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57009878|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57009879|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57009880|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009881|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
57009882|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
57009883|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009884|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57009885|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
57009886|NCT00109928|Hormones|hormones|mesh-ancestor
57009887|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57009888|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57009889|NCT00109928|Protective Agents|protective agents|mesh-ancestor
57009890|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57009891|NCT01358877|Paclitaxel|paclitaxel|mesh-list
57009892|NCT01358877|Docetaxel|docetaxel|mesh-list
57009893|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
57009894|NCT01358877|Carboplatin|carboplatin|mesh-list
57009895|NCT01358877|Doxorubicin|doxorubicin|mesh-list
57009896|NCT01358877|Fluorouracil|fluorouracil|mesh-list
57009897|NCT01358877|Trastuzumab|trastuzumab|mesh-list
57009898|NCT01358877|Epirubicin|epirubicin|mesh-list
57009899|NCT01358877|Pertuzumab|pertuzumab|mesh-list
57009900|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57009901|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009902|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
57009903|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
57009904|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
57009905|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009906|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57009907|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
57009908|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009909|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57009910|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57009911|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
57009912|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57009913|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57009914|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57009915|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57009916|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009917|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
57009918|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57009919|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009920|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
57009921|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009922|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
57009923|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57009924|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009925|NCT00109850|Irinotecan|irinotecan|mesh-list
57009926|NCT00109850|Cetuximab|cetuximab|mesh-list
57009927|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009928|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57009929|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57009930|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009931|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009932|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009933|NCT03318770|Dasatinib|dasatinib|mesh-list
57009934|NCT03318770|Blinatumomab|blinatumomab|mesh-list
57009935|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009936|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57009937|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57009938|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009939|NCT03437421|Vitamin D|vitamin d|mesh-list
57009940|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
57009941|NCT03437421|Vitamins|vitamins|mesh-ancestor
57009942|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
57009943|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009944|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57009945|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57009946|NCT01065519|Umirolimus|umirolimus|mesh-list
57009947|NCT01065519|Everolimus|everolimus|mesh-list
57009948|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009949|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57009950|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
57009951|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009952|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57009953|NCT05539989|Vaccines|vaccines|mesh-list
57009954|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
57009955|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
57009956|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009957|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57009958|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57009959|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57009960|NCT01810016|Poly I-C|poly i-c|mesh-list
57009961|NCT01810016|Ipilimumab|ipilimumab|mesh-list
57009962|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57009963|NCT01810016|Vaccines|vaccines|mesh-list
57009964|NCT01810016|Poly ICLC|poly iclc|mesh-list
57009965|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
57009966|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
57009967|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009968|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57009969|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57009970|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57009971|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57009972|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
57009973|NCT01810016|Laxatives|laxatives|mesh-ancestor
57009974|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57009975|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
57009976|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57009977|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57009978|NCT01722266|Liraglutide|liraglutide|mesh-list
57009979|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57009980|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009981|NCT01722266|Incretins|incretins|mesh-ancestor
57009982|NCT01722266|Hormones|hormones|mesh-ancestor
57009983|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57009984|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
57009985|NCT03545516|Bupivacaine|bupivacaine|mesh-list
57009986|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
57009987|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
57009988|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57009989|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57009990|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
57009991|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57009992|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57009993|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57009994|NCT03545516|Analgesics|analgesics|mesh-ancestor
57009995|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57009996|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57009997|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57009998|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
57009999|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010000|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010001|NCT02254148|Metoprolol|metoprolol|mesh-list
57010002|NCT02254148|Digoxin|digoxin|mesh-list
57010003|NCT02254148|Midazolam|midazolam|mesh-list
57010004|NCT02254148|Caffeine|caffeine|mesh-list
57010005|NCT02254148|Omeprazole|omeprazole|mesh-list
57010006|NCT02254148|Warfarin|warfarin|mesh-list
57010007|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57010008|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57010009|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010010|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010011|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57010012|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57010013|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57010014|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57010015|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
57010016|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
57010017|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
57010018|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
57010019|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010020|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010021|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
57010022|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57010023|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57010024|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010025|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57010026|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57010027|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
57010028|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57010029|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57010030|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57010031|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57010032|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57010033|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
57010034|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
57010035|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010036|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57010037|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57010038|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57010039|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
57010040|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57010041|NCT02254148|Protective Agents|protective agents|mesh-ancestor
57010043|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
57010044|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010045|NCT01316913|Bromides|bromides|mesh-list
57010046|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
57010047|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57010048|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
57010049|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010050|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010051|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57010052|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
57010053|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
57010054|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57010055|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
57010056|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010057|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010058|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
57010059|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
57010060|NCT02875067|Lenalidomide|lenalidomide|mesh-list
57010061|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010062|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010063|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
57010064|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010065|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57010066|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57010067|NCT02875067|Growth Substances|growth substances|mesh-ancestor
57010068|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
57010069|NCT03570294|Atosiban|atosiban|mesh-list
57010070|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
57010071|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010072|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010073|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
57010074|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57010075|NCT02143622|Cetuximab|cetuximab|mesh-list
57010076|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010077|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010078|NCT02781506|Nivolumab|nivolumab|mesh-list
57010079|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010080|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010081|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57010082|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010083|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57010084|NCT03571230|Amoxicillin|amoxicillin|mesh-list
57010085|NCT03571230|Metronidazole|metronidazole|mesh-list
57010086|NCT03571230|Clarithromycin|clarithromycin|mesh-list
57010087|NCT03571230|Levofloxacin|levofloxacin|mesh-list
57010088|NCT03571230|Tetracycline|tetracycline|mesh-list
57010089|NCT03571230|Tinidazole|tinidazole|mesh-list
57010090|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57010091|NCT03571230|Furazolidone|furazolidone|mesh-list
57010092|NCT03571230|Bismuth|bismuth|mesh-list
57010093|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57010094|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010095|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
57010096|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57010097|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57010098|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57010099|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010100|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010101|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57010102|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57010103|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57010104|NCT03571230|Renal Agents|renal agents|mesh-ancestor
57010105|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57010106|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57010107|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010108|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57010109|NCT03571230|Antacids|antacids|mesh-ancestor
57010110|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57010111|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57010112|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57010113|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57010114|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
57010115|NCT03368963|Trifluridine|trifluridine|mesh-list
57010116|NCT03368963|Irinotecan|irinotecan|mesh-list
57010117|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57010118|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57010119|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010120|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010121|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010122|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
57010123|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
57010124|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010125|NCT05489211|Leucovorin|leucovorin|mesh-list
57010126|NCT05489211|Bevacizumab|bevacizumab|mesh-list
57010127|NCT05489211|Nivolumab|nivolumab|mesh-list
57010128|NCT05489211|Durvalumab|durvalumab|mesh-list
57010129|NCT05489211|Carboplatin|carboplatin|mesh-list
57010130|NCT05489211|Fluorouracil|fluorouracil|mesh-list
57010131|NCT05489211|Capecitabine|capecitabine|mesh-list
57010132|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010133|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010134|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57010135|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57010136|NCT05489211|Growth Substances|growth substances|mesh-ancestor
57010137|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010138|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
57010139|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
57010140|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010141|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57010142|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57010143|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
57010144|NCT05489211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57010145|NCT05489211|Antidotes|antidotes|mesh-ancestor
57010146|NCT05489211|Protective Agents|protective agents|mesh-ancestor
57010147|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
57010148|NCT05489211|Vitamins|vitamins|mesh-ancestor
57010149|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
57010150|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57010151|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57010152|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
57010153|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010154|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010155|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57010156|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
57010157|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57010158|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57010159|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57010160|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
57010161|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010162|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010163|NCT02143934|Chloroquine|chloroquine|mesh-list
57010164|NCT02143934|Lumefantrine|lumefantrine|mesh-list
57010165|NCT02143934|Artemether|artemether|mesh-list
57010166|NCT02143934|Primaquine|primaquine|mesh-list
57010167|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57010168|NCT02143934|Amebicides|amebicides|mesh-ancestor
57010169|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57010170|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57010171|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010172|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
57010173|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57010174|NCT03096847|Letrozole|letrozole|mesh-list
57010175|NCT03096847|Goserelin|goserelin|mesh-list
57010176|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010177|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57010178|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57010179|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010180|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010181|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57010182|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
57010183|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010184|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010185|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57010186|NCT04753879|Gemcitabine|gemcitabine|mesh-list
57010187|NCT04753879|Paclitaxel|paclitaxel|mesh-list
57010188|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
57010189|NCT04753879|Capecitabine|capecitabine|mesh-list
57010190|NCT04753879|Irinotecan|irinotecan|mesh-list
57010191|NCT04753879|Olaparib|olaparib|mesh-list
57010192|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57010193|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010194|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
57010195|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
57010196|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
57010197|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010198|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57010199|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
57010200|NCT04753879|Antiviral Agents|antiviral agents|mesh-ancestor
57010201|NCT04753879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010202|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010203|NCT04753879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57010204|NCT04753879|Immunologic Factors|immunologic factors|mesh-ancestor
57010205|NCT04753879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010206|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010207|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57010208|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57010209|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57010210|NCT02846532|Aspirin|aspirin|mesh-list
57010211|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
57010212|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57010213|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
57010214|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57010215|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
57010216|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010217|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010218|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
57010219|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57010220|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57010221|NCT02846532|Analgesics|analgesics|mesh-ancestor
57010222|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
57010223|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010224|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010225|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57010226|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57010227|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57010228|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57010229|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57010230|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57010231|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
57010232|NCT01371461|Paroxetine|paroxetine|mesh-list
57010233|NCT01371461|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57010234|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57010235|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57010236|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010237|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010238|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
57010239|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010240|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57010241|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
57010242|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57010243|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57010244|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57010245|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010246|NCT05324423|Colchicine|colchicine|mesh-list
57010247|NCT05324423|Febuxostat|febuxostat|mesh-list
57010248|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
57010249|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57010250|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
57010251|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
57010252|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
57010253|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010254|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010255|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
57010257|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010258|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010259|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57010260|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010261|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010262|NCT00842348|Lanreotide|lanreotide|mesh-list
57010263|NCT00842348|Somatostatin|somatostatin|mesh-list
57010264|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010265|NCT00842348|Hormones|hormones|mesh-ancestor
57010266|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010267|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010268|NCT05443971|Durvalumab|durvalumab|mesh-list
57010269|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
57010270|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57010271|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
57010272|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010273|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010274|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
57010275|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010276|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
57010277|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57010278|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57010279|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57010280|NCT02144246|Norgestimate|norgestimate|mesh-list
57010281|NCT02144246|Norgestrel|norgestrel|mesh-list
57010282|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57010283|NCT02144246|Estradiol|estradiol|mesh-list
57010284|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57010285|NCT02144246|Estrogens|estrogens|mesh-ancestor
57010286|NCT02144246|Hormones|hormones|mesh-ancestor
57010287|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010288|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010289|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57010290|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
57010291|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57010292|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57010293|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57010294|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57010295|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57010296|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57010297|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010298|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57010299|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57010300|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010301|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010302|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010303|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57010304|NCT03095521|Menthol|menthol|mesh-list
57010305|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
57010306|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
57010307|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
57010308|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57010309|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
57010310|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57010311|NCT00715442|Sunitinib|sunitinib|mesh-list
57010312|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010313|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57010314|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57010315|NCT00715442|Growth Substances|growth substances|mesh-ancestor
57010316|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010317|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
57010318|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57010319|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010320|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010321|NCT05251909|Benralizumab|benralizumab|mesh-list
57010322|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57010323|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
57010324|NCT05242315|Tacrolimus|tacrolimus|mesh-list
57010325|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57010326|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
57010327|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010328|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57010329|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010330|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010332|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57010333|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
57010334|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
57010335|NCT03569046|Bupivacaine|bupivacaine|mesh-list
57010336|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
57010337|NCT03569046|Anesthetics|anesthetics|mesh-list
57010338|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
57010339|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010340|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010341|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
57010342|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010343|NCT02935595|Ketamine|ketamine|mesh-list
57010344|NCT02935595|Analgesics|analgesics|mesh-ancestor
57010345|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
57010346|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010347|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010348|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57010349|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57010350|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
57010351|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
57010352|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010353|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57010354|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57010355|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010356|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010357|NCT02649673|Topotecan|topotecan|mesh-list
57010358|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57010359|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57010360|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010361|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010362|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010363|NCT03568968|Niacinamide|niacinamide|mesh-list
57010364|NCT03568968|Niacin|niacin|mesh-list
57010365|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
57010366|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
57010367|NCT03568968|Vitamins|vitamins|mesh-ancestor
57010368|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
57010369|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010370|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57010371|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
57010372|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010373|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57010374|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
57010375|NCT02817347|Tazobactam|tazobactam|mesh-list
57010376|NCT02817347|Piperacillin|piperacillin|mesh-list
57010377|NCT02817347|Dexamethasone|dexamethasone|mesh-list
57010378|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
57010379|NCT02817347|BB 1101|bb 1101|mesh-list
57010380|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57010381|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
57010382|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
57010383|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010384|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010385|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57010386|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
57010387|NCT02817347|Hormones|hormones|mesh-ancestor
57010388|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010389|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57010390|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010391|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
57010392|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010393|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010394|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57010395|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010396|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57010397|NCT01373021|Fentanyl|fentanyl|mesh-list
57010398|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
57010399|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57010400|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010401|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010402|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57010403|NCT01373021|Analgesics|analgesics|mesh-ancestor
57010404|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
57010405|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010406|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57010407|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57010408|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57010409|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
57010410|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010411|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010412|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57010413|NCT01373021|Narcotics|narcotics|mesh-ancestor
57010414|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57010415|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57010416|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
57010417|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
57010418|NCT02690558|Gemcitabine|gemcitabine|mesh-list
57010419|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
57010420|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010421|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57010422|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
57010423|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010424|NCT02690558|Antiviral Agents|antiviral agents|mesh-ancestor
57010425|NCT02690558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010426|NCT02690558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010427|NCT02690558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57010428|NCT02690558|Immunologic Factors|immunologic factors|mesh-ancestor
57010429|NCT02690558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010430|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010431|NCT03568578|Entecavir|entecavir|mesh-list
57010432|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
57010433|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010434|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
57010435|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57010436|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010437|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
57010438|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010439|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
57010440|NCT02140736|Hematinics|hematinics|mesh-ancestor
57010441|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
57010442|NCT05417035|Androgens|androgens|mesh-ancestor
57010443|NCT05417035|Hormones|hormones|mesh-ancestor
57010444|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010445|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010446|NCT05708742|Bupivacaine|bupivacaine|mesh-list
57010447|NCT05708742|Anesthetics, Local|anesthetics, local|mesh-list
57010448|NCT05708742|Anesthetics|anesthetics|mesh-list
57010449|NCT05708742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010450|NCT05708742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010451|NCT05708742|Sensory System Agents|sensory system agents|mesh-ancestor
57010452|NCT05708742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010453|NCT03095287|Factor VIII|factor viii|mesh-list
57010454|NCT03095287|Coagulants|coagulants|mesh-ancestor
57010455|NCT01335581|Tretinoin|tretinoin|mesh-list
57010456|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010457|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
56896392|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
57010458|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
57010459|NCT05204563|Imipenem|imipenem|mesh-list
57010460|NCT05204563|Relebactam|relebactam|mesh-list
57010461|NCT05204563|Cilastatin|cilastatin|mesh-list
57010462|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57010463|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010464|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
57010465|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010466|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010467|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57010468|NCT01367561|Naloxone|naloxone|mesh-list
57010469|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
57010470|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57010471|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010472|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
57010473|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010474|NCT02140814|Niacinamide|niacinamide|mesh-list
57010475|NCT02140814|Niacin|niacin|mesh-list
57010476|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
57010477|NCT02140814|Vitamins|vitamins|mesh-ancestor
57010478|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
57010479|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010480|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
57010481|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57010482|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
57010483|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010484|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57010485|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
57010486|NCT03015090|Theophylline|theophylline|mesh-list
57010487|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57010488|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
57010489|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010490|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010491|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57010492|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
57010493|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57010494|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010495|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010496|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
57010497|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57010498|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57010499|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
57010500|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010501|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
57010502|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010503|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010504|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
57010505|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57010506|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57010507|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010508|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
57010509|NCT02620748|Coagulants|coagulants|mesh-ancestor
57010510|NCT02144792|Verapamil|verapamil|mesh-list
57010511|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57010512|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57010513|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57010514|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010515|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57010516|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010517|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
57010518|NCT03566394|Gabapentin|gabapentin|mesh-list
57010519|NCT03566394|Analgesics|analgesics|mesh-ancestor
57010520|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
57010521|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010522|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010523|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
57010524|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57010525|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57010526|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010527|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57010528|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57010529|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57010530|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010531|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010532|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
57010533|NCT00033293|Prednisone|prednisone|mesh-list
57010534|NCT00033293|Cortisone|cortisone|mesh-list
57010535|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
57010536|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
57010537|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57010538|NCT00033293|Antibodies|antibodies|mesh-list
57010539|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
57010540|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57010541|NCT00033293|Immunoglobulin G|immunoglobulin g|mesh-list
57010542|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57010543|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
57010544|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010545|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57010546|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57010547|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
57010548|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010549|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010550|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57010551|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57010552|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
57010553|NCT00033293|Hormones|hormones|mesh-ancestor
57010554|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010555|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57010556|NCT03566316|Amlodipine|amlodipine|mesh-list
57010557|NCT03566316|Telmisartan|telmisartan|mesh-list
57010558|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
57010559|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57010560|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57010562|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57010563|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010564|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57010565|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010566|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
57010567|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57010568|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57010569|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
57010570|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57010571|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57010572|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010573|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57010574|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57010575|NCT02145104|Valsartan|valsartan|mesh-list
57010576|NCT02145104|Cilnidipine|cilnidipine|mesh-list
57010577|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57010578|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57010579|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57010580|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010581|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57010582|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57010583|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57010584|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010585|NCT02145338|Trimethoprim|trimethoprim|mesh-list
57010586|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
57010587|NCT02145338|Cephalexin|cephalexin|mesh-list
57010588|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57010589|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010590|NCT02145338|Renal Agents|renal agents|mesh-ancestor
57010591|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
57010592|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57010593|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57010594|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57010595|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010596|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010597|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57010598|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57010599|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57010600|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57010601|NCT01373333|Amifampridine|amifampridine|mesh-list
57010602|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57010603|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896404|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
57010604|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010605|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57010606|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57010607|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010608|NCT03565536|Sorafenib|sorafenib|mesh-list
57010609|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010610|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57010611|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010612|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010613|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
57010614|NCT03565458|Empagliflozin|empagliflozin|mesh-list
57010615|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57010616|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010617|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57010618|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010619|NCT03565302|Terbutaline|terbutaline|mesh-list
57010620|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
57010621|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57010622|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
57010623|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010624|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010625|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57010626|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
57010627|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57010628|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57010629|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57010630|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
57010631|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010632|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010633|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
57010634|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
57010635|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57010636|NCT05193227|Lidocaine|lidocaine|mesh-list
57010637|NCT05193227|Bupivacaine|bupivacaine|mesh-list
57010638|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
57010639|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
57010640|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010641|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010642|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
57010643|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010644|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57010645|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57010646|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57010647|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57010648|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010649|NCT01372007|Lanreotide|lanreotide|mesh-list
57010650|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010651|NCT01373411|Ticagrelor|ticagrelor|mesh-list
57010652|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57010653|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57010654|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57010655|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57010656|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
57010657|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010658|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010659|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010660|NCT03567408|Bivalirudin|bivalirudin|mesh-list
57010661|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
57010662|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57010663|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
57010664|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010665|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010666|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
57010667|NCT05354076|Doxorubicin|doxorubicin|mesh-list
57010668|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57010669|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57010670|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010671|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57010672|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57010673|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010674|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010675|NCT05106335|Docetaxel|docetaxel|mesh-list
57010676|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010677|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
57010678|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
57010679|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
57010680|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010681|NCT05192681|Docetaxel|docetaxel|mesh-list
57010682|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010683|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
57010684|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
57010685|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
57010686|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010687|NCT05192213|Thiamine|thiamine|mesh-list
57010688|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
57010689|NCT05192213|Vitamins|vitamins|mesh-ancestor
57010690|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
57010691|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010692|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57010693|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
57010694|NCT02039674|Paclitaxel|paclitaxel|mesh-list
57010695|NCT02039674|Bevacizumab|bevacizumab|mesh-list
57010696|NCT02039674|Carboplatin|carboplatin|mesh-list
57010697|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
57010698|NCT02039674|Pemetrexed|pemetrexed|mesh-list
57010699|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57010700|NCT02039674|Ipilimumab|ipilimumab|mesh-list
57010701|NCT02039674|Gefitinib|gefitinib|mesh-list
57010702|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57010703|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010704|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
57010705|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
57010706|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
57010707|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010708|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010709|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57010710|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57010711|NCT02039674|Growth Substances|growth substances|mesh-ancestor
57010712|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010713|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
57010714|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010715|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57010716|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57010717|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57010718|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57010719|NCT03099187|Pirfenidone|pirfenidone|mesh-list
57010720|NCT03099187|Analgesics|analgesics|mesh-ancestor
57010721|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
57010722|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010723|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010724|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57010725|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57010726|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57010727|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57010728|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010729|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
57010730|NCT04162756|Fludarabine|fludarabine|mesh-list
57010731|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57010732|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
57010733|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010734|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57010735|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57010736|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
57010737|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010738|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010739|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57010740|NCT04544267|Vaccines|vaccines|mesh-list
57010741|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
57010742|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010743|NCT04895488|Vortioxetine|vortioxetine|mesh-list
57010744|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
57010745|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
57010746|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57010747|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57010748|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57010749|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010750|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010751|NCT04895488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57010752|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57010753|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57010754|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010755|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010756|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
57010757|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57010758|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57010759|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57010760|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57010761|NCT04342715|Paromomycin|paromomycin|mesh-list
57010762|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
57010763|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57010764|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010765|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57010766|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57010767|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
57010768|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57010769|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
57010770|NCT01368341|Amoxicillin|amoxicillin|mesh-list
57010771|NCT01368341|Doxycycline|doxycycline|mesh-list
57010772|NCT01368341|Penicillin V|penicillin v|mesh-list
57010773|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57010774|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010775|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
57010776|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57010777|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57010778|NCT01368419|Endostar protein|endostar protein|mesh-list
57010779|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56692723|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010780|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57010781|NCT01368419|Growth Substances|growth substances|mesh-ancestor
57010782|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010783|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
57010784|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010785|NCT04639219|Trastuzumab|trastuzumab|mesh-list
57010786|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010787|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010788|NCT04455100|Itraconazole|itraconazole|mesh-list
57010789|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
57010790|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010791|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57010792|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57010793|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010794|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010795|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57010796|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
57010797|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010798|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010799|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57010800|NCT04439578|Rifampin|rifampin|mesh-list
57010801|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57010802|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
57010803|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57010804|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010805|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
57010806|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57010807|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010808|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010809|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57010810|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57010811|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57010812|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57010813|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57010814|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57010815|NCT04623775|Paclitaxel|paclitaxel|mesh-list
57010816|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57010817|NCT04623775|Carboplatin|carboplatin|mesh-list
57010818|NCT04623775|Nivolumab|nivolumab|mesh-list
57010819|NCT04623775|Pemetrexed|pemetrexed|mesh-list
57010820|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57010821|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010822|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
57010823|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
57010824|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
57010825|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010826|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010827|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57010828|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010829|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57010830|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57010831|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
57010832|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57010833|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57010834|NCT03110848|Prednisolone|prednisolone|mesh-list
57010835|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
57010836|NCT03110848|Atorvastatin|atorvastatin|mesh-list
57010837|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57010838|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
57010839|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
57010840|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57010841|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57010842|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
57010843|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010844|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57010845|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57010846|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010847|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57010848|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
57010849|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
57010850|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010851|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010852|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57010853|NCT03110848|Hormones|hormones|mesh-ancestor
57010854|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010855|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57010856|NCT03110848|Protective Agents|protective agents|mesh-ancestor
57010857|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57010858|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010859|NCT03139474|Hormones|hormones|mesh-list
57010860|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
57010861|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010862|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010863|NCT04300231|Hydromorphone|hydromorphone|mesh-list
57010864|NCT04300231|Bupivacaine|bupivacaine|mesh-list
57010865|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
57010866|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
57010867|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010868|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010869|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
57010870|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010871|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57010872|NCT04300231|Narcotics|narcotics|mesh-ancestor
57010873|NCT04300231|Analgesics|analgesics|mesh-ancestor
57010874|NCT05407441|Nivolumab|nivolumab|mesh-list
57010875|NCT05407441|Ipilimumab|ipilimumab|mesh-list
57010876|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010877|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010878|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57010879|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010880|NCT01368887|Niacinamide|niacinamide|mesh-list
57010881|NCT01368887|Niacin|niacin|mesh-list
57010882|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
57010883|NCT01368887|Calcipotriene|calcipotriene|mesh-list
57010884|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
57010885|NCT01368887|Vitamins|vitamins|mesh-ancestor
57010886|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
57010887|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010888|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57010889|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
57010890|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010891|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57010892|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
57010893|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
57010894|NCT01369043|Vitamins|vitamins|mesh-list
57010895|NCT01369043|Vitamin E|vitamin e|mesh-list
57010896|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
57010897|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010898|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
57010899|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010900|NCT01369043|Protective Agents|protective agents|mesh-ancestor
57010901|NCT04477096|Emtricitabine|emtricitabine|mesh-list
57010902|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
57010903|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57010904|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57010905|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57010906|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010907|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010908|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57010909|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57010910|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
57010911|NCT01369121|Hormones|hormones|mesh-ancestor
57010912|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57010913|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010914|NCT03868150|Amiodarone|amiodarone|mesh-list
57010915|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57010916|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
57010917|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57010918|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57010919|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010920|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57010921|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57010922|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57010923|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010924|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57010925|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57010926|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57010927|NCT03521687|Apremilast|apremilast|mesh-list
57010928|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57010929|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57010930|NCT03521687|Analgesics|analgesics|mesh-ancestor
57010931|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
57010932|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010933|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010934|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57010935|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57010936|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57010937|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57010938|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010939|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010940|NCT03141658|Ketamine|ketamine|mesh-list
57010941|NCT03141658|Analgesics|analgesics|mesh-ancestor
57010942|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
57010943|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010944|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010945|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57010946|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57010947|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
57010948|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
57010949|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010950|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57010951|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57010952|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010953|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010954|NCT03498131|Melatonin|melatonin|mesh-list
57010955|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
57010956|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010957|NCT03498131|Protective Agents|protective agents|mesh-ancestor
57010958|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010959|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010960|NCT01319825|Milnacipran|milnacipran|mesh-list
57010961|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
57010962|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57010963|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57010964|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57010965|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010966|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57010967|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010968|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57010969|NCT01319825|Analgesics|analgesics|mesh-ancestor
57010970|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
57010971|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010972|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
57010973|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57010974|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
57010975|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
57010976|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57010977|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010978|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
57010979|NCT01369277|Vitamins|vitamins|mesh-ancestor
57010980|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
57010981|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010982|NCT02983006|Nivolumab|nivolumab|mesh-list
57010983|NCT02983006|DS-8273a|ds-8273a|mesh-list
57010984|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57010985|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57010986|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57010987|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57010988|NCT05046184|Midazolam|midazolam|mesh-list
57010989|NCT05046184|Ketamine|ketamine|mesh-list
57010990|NCT05046184|Analgesics|analgesics|mesh-ancestor
57010991|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
57010992|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57010993|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57010994|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57010995|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57010996|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
57010997|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
57010998|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57010999|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57011000|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56692946|NCT00764517|Antibodies|antibodies|mesh-list
57011001|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011002|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011003|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57011004|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57011005|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57011006|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57011007|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57011008|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
57011009|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
57011010|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
57011011|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
57011012|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011013|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
57011014|NCT03811756|Vitamins|vitamins|mesh-ancestor
57011015|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
57011016|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011017|NCT03141268|Lactulose|lactulose|mesh-list
56896433|NCT01161459|Prednisone|prednisone|mesh-list
57011018|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57011019|NCT03316781|Adalimumab|adalimumab|mesh-list
57011020|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57011021|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57011022|NCT01319903|Antibodies|antibodies|mesh-list
57011023|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57011024|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
57011025|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011026|NCT02839200|Zolpidem|zolpidem|mesh-list
57011027|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57011028|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57011029|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011030|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011031|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57011032|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
57011033|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
57011034|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011035|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011036|NCT01369667|Vitamin D|vitamin d|mesh-list
57011037|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
57011038|NCT01369667|Vitamins|vitamins|mesh-ancestor
57011039|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
57011040|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011041|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57011042|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57011043|NCT03564912|Capecitabine|capecitabine|mesh-list
57011044|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
57011045|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57011046|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
57011047|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011048|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011049|NCT03551626|Trametinib|trametinib|mesh-list
57011050|NCT03551626|Dabrafenib|dabrafenib|mesh-list
57011051|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011052|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57011053|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011054|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011055|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
57011056|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
57011057|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011058|NCT05760053|Cisplatin|cisplatin|mesh-list
57011059|NCT05760053|Carboplatin|carboplatin|mesh-list
57011060|NCT05760053|Etoposide|etoposide|mesh-list
57011061|NCT05760053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011062|NCT05760053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57011063|NCT05760053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57011064|NCT05760053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57011065|NCT05760053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011066|NCT05760053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011067|NCT03245008|Fasinumab|fasinumab|mesh-list
57011068|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57011069|NCT03245008|Analgesics|analgesics|mesh-ancestor
57011070|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
57011071|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011072|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011073|NCT03118739|Febuxostat|febuxostat|mesh-list
57011074|NCT03118739|Verinurad|verinurad|mesh-list
57011075|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
57011076|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57011077|NCT03181126|Venetoclax|venetoclax|mesh-list
57011078|NCT03181126|Navitoclax|navitoclax|mesh-list
57011079|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011081|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57011082|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57011083|NCT05139875|Betamethasone|betamethasone|mesh-list
57011084|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
57011085|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57011086|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
57011087|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
57011088|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57011089|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57011090|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57011091|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
57011092|NCT05139875|Hormones|hormones|mesh-ancestor
57011093|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011094|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011095|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011096|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
57011097|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011098|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011099|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57011100|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
57011101|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57011102|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011103|NCT01375985|Radavirsen|radavirsen|mesh-list
57011104|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
57011105|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011106|NCT05384821|Irinotecan|irinotecan|mesh-list
57011107|NCT05384821|Etoposide|etoposide|mesh-list
57011108|NCT05384821|Vincristine|vincristine|mesh-list
57011109|NCT05384821|Temozolomide|temozolomide|mesh-list
57011110|NCT05384821|Tretinoin|tretinoin|mesh-list
57011111|NCT05384821|Isotretinoin|isotretinoin|mesh-list
57011112|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57011113|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57011114|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011115|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011116|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011117|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57011118|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57011119|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
57011120|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
57011121|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
57011122|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57011123|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
57011124|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
57011125|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
57011126|NCT02654080|Vaccines|vaccines|mesh-list
57011127|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
57011128|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011129|NCT05375305|Morphine|morphine|mesh-list
57011130|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57011131|NCT05375305|Narcotics|narcotics|mesh-ancestor
57011132|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011133|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011134|NCT05375305|Analgesics|analgesics|mesh-ancestor
57011135|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
57011136|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011137|NCT03140332|Sorafenib|sorafenib|mesh-list
57011138|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011139|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57011140|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011141|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011142|NCT05027425|Durvalumab|durvalumab|mesh-list
57011143|NCT05027425|Tremelimumab|tremelimumab|mesh-list
57011144|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57011145|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011146|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
57011147|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57011148|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011149|NCT00921115|Fulvestrant|fulvestrant|mesh-list
57011150|NCT00921115|Anastrozole|anastrozole|mesh-list
57011151|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57011152|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011153|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57011154|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57011155|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
57011156|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011157|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011158|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57011159|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57011160|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011161|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011162|NCT05024773|Paclitaxel|paclitaxel|mesh-list
57011163|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
57011164|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57011165|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011166|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
57011167|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
57011168|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
57011169|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011170|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57011171|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
57011172|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011173|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
57011174|NCT05024773|Protective Agents|protective agents|mesh-ancestor
57011175|NCT02832167|Nivolumab|nivolumab|mesh-list
57011176|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57011177|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011178|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57011179|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011180|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
57011181|NCT04941040|Anesthetics|anesthetics|mesh-list
57011182|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011183|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011184|NCT04941040|Narcotics|narcotics|mesh-ancestor
57011185|NCT04941040|Analgesics|analgesics|mesh-ancestor
57011186|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
57011187|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011188|NCT00913705|Carboplatin|carboplatin|mesh-list
57011189|NCT00913705|Paclitaxel|paclitaxel|mesh-list
57011190|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57011191|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011192|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57011193|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
57011194|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
57011195|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
57011196|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011197|NCT04934410|Midazolam|midazolam|mesh-list
57011198|NCT04934410|Etomidate|etomidate|mesh-list
57011199|NCT04934410|Sevoflurane|sevoflurane|mesh-list
57011200|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57011201|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57011202|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011203|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011204|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57011205|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57011206|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57011207|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57011208|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
57011209|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
57011210|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
57011211|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
57011212|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011213|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011214|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57011215|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57011216|NCT02787239|Rituximab|rituximab|mesh-list
57011217|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57011218|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011219|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
57011220|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011221|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57011222|NCT03140956|Levodopa|levodopa|mesh-list
57011223|NCT03140956|Carbidopa|carbidopa|mesh-list
57011224|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57011225|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57011226|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
57011227|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011228|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011229|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011230|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57011231|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011232|NCT02681237|Olaparib|olaparib|mesh-list
57011233|NCT02681237|Cediranib|cediranib|mesh-list
57011234|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57011235|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011236|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011237|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011238|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57011239|NCT00089245|Iodine|iodine|mesh-list
57011240|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
57011241|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57011242|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011243|NCT00089245|Trace Elements|trace elements|mesh-ancestor
57011244|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
57011245|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011246|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
57011247|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57011248|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57011249|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011250|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
57011251|NCT05082142|Coagulants|coagulants|mesh-ancestor
57011252|NCT02674529|Citalopram|citalopram|mesh-list
57011253|NCT02674529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57011254|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57011255|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57011256|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011257|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011258|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
57011259|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011260|NCT02674529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57011261|NCT02674529|Antidepressive Agents|antidepressive agents|mesh-ancestor
57011262|NCT02674529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57011263|NCT05081986|Cycloserine|cycloserine|mesh-list
57011264|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57011265|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011266|NCT05081986|Renal Agents|renal agents|mesh-ancestor
57011267|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57011268|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
57011269|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57011270|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
57011271|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011272|NCT05418907|Exenatide|exenatide|mesh-list
57011273|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57011274|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011275|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57011276|NCT05418907|Incretins|incretins|mesh-ancestor
57011277|NCT05418907|Hormones|hormones|mesh-ancestor
57011278|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011279|NCT02838420|Crizotinib|crizotinib|mesh-list
57011280|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011281|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57011282|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011283|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011284|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57011285|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57011286|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011287|NCT03632317|Everolimus|everolimus|mesh-list
57011288|NCT03632317|Panobinostat|panobinostat|mesh-list
57011289|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011290|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011291|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
57011292|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011293|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57011294|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011295|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011296|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
57011297|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57011298|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011299|NCT02653963|Triamcinolone|triamcinolone|mesh-list
57011300|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57011301|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
57011302|NCT02653963|Hormones|hormones|mesh-ancestor
57011303|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011304|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693239|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57011305|NCT03097861|Lubiprostone|lubiprostone|mesh-list
57011306|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57011307|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57011308|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011309|NCT03910673|Fosfomycin|fosfomycin|mesh-list
57011310|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57011311|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011312|NCT01376141|Sumatriptan|sumatriptan|mesh-list
57011313|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57011314|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57011315|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57011316|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
57011317|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011318|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011319|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011320|NCT03642067|Nivolumab|nivolumab|mesh-list
57011321|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57011322|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011323|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57011324|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011325|NCT01816139|Estradiol|estradiol|mesh-list
57011326|NCT01816139|Estrogens|estrogens|mesh-ancestor
57011327|NCT01816139|Hormones|hormones|mesh-ancestor
57011328|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011329|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011330|NCT04052776|Levodopa|levodopa|mesh-list
57011331|NCT04052776|Carbidopa|carbidopa|mesh-list
57011332|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57011333|NCT04052776|Buspirone|buspirone|mesh-list
57011334|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57011335|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57011336|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
57011337|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011338|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011339|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011340|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57011341|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011342|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57011343|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57011344|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011345|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57011346|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57011347|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
57011348|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57011349|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
57011350|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
57011351|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
57011352|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57011353|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57011354|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57011355|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57011356|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011357|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
57011358|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011359|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011360|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57011361|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011362|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
57011363|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57011364|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011365|NCT05041673|Metformin|metformin|mesh-list
57011366|NCT05041673|Liraglutide|liraglutide|mesh-list
57011367|NCT05041673|Empagliflozin|empagliflozin|mesh-list
57011368|NCT05041673|Vildagliptin|vildagliptin|mesh-list
57011369|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57011370|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011371|NCT05041673|Incretins|incretins|mesh-ancestor
57011372|NCT05041673|Hormones|hormones|mesh-ancestor
57011373|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011374|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57011375|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011376|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57011377|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
56693315|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
57011378|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011379|NCT03907540|Belumosudil|belumosudil|mesh-list
57011380|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57011381|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011382|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011383|NCT05759429|Melatonin|melatonin|mesh-list
57011384|NCT05759429|Antioxidants|antioxidants|mesh-ancestor
57011385|NCT05759429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011386|NCT05759429|Protective Agents|protective agents|mesh-ancestor
57011387|NCT05759429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011388|NCT05759429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011389|NCT04005209|Ketamine|ketamine|mesh-list
57011390|NCT04005209|Analgesics|analgesics|mesh-ancestor
57011391|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
57011392|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011393|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011394|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57011395|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57011396|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
57011397|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
57011398|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011399|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57011400|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57011401|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011402|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011403|NCT03904108|Ramucirumab|ramucirumab|mesh-list
57011404|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011405|NCT02833350|Folic Acid|folic acid|mesh-list
57011406|NCT02833350|Adalimumab|adalimumab|mesh-list
57011407|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57011408|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57011409|NCT02833350|Hematinics|hematinics|mesh-ancestor
57011410|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
57011411|NCT02833350|Vitamins|vitamins|mesh-ancestor
57011412|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
57011413|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011414|NCT03137134|Crizotinib|crizotinib|mesh-list
57011415|NCT03137134|Esomeprazole|esomeprazole|mesh-list
57011416|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57011417|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57011418|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57011419|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011420|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011421|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011422|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57011423|NCT03137368|Tamoxifen|tamoxifen|mesh-list
57011424|NCT03137368|Exemestane|exemestane|mesh-list
57011425|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57011426|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
57011427|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011428|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011429|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57011430|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011431|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57011432|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57011433|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57011434|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57011435|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57011436|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011437|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011438|NCT03138616|Vitamin D|vitamin d|mesh-list
57011439|NCT03138616|Vitamins|vitamins|mesh-ancestor
57011440|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
57011441|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011442|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57011443|NCT03137290|Neostigmine|neostigmine|mesh-list
57011444|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57011445|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011446|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011447|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
57011448|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011449|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011450|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57011451|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
57011452|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011453|NCT03782818|Olaparib|olaparib|mesh-list
57011454|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57011455|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011456|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011457|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011458|NCT05391724|Brincidofovir|brincidofovir|mesh-list
57011459|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
57011460|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011461|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
57011462|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57011463|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011464|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011465|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57011466|NCT03355534|Analgesics|analgesics|mesh-ancestor
57011467|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
57011468|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011469|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57011470|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57011471|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57011472|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
57011473|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011474|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011475|NCT05385562|Triamcinolone|triamcinolone|mesh-list
57011476|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57011477|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57011478|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
57011479|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57011480|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57011481|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
57011482|NCT05385562|Hormones|hormones|mesh-ancestor
57011483|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011484|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011485|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011486|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
57011487|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011488|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011489|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57011490|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
57011491|NCT05385562|Protective Agents|protective agents|mesh-ancestor
57011492|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
57011493|NCT01343043|Fludarabine|fludarabine|mesh-list
57011494|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011495|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
57011496|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011497|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57011498|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57011499|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
57011500|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011501|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011502|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57011503|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57011504|NCT03139708|Phenylephrine|phenylephrine|mesh-list
57011505|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
57011506|NCT03139708|Tropicamide|tropicamide|mesh-list
57011507|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57011508|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
57011509|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
57011510|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011511|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011512|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
57011513|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57011514|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
57011515|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
57011516|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57011517|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57011518|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57011519|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
57011520|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011521|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011522|NCT03139708|Protective Agents|protective agents|mesh-ancestor
57011523|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57011524|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57011525|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57011526|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56693465|NCT00766506|Analgesics|analgesics|mesh-ancestor
57011527|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
57011528|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57011529|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56588887|NCT00913666|Interferons|interferons|mesh-list
57011530|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
57011531|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011532|NCT05330364|Cladribine|cladribine|mesh-list
57011533|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011534|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011535|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
57011536|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011537|NCT05087368|Vaccines|vaccines|mesh-list
57011538|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
57011539|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011540|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57011541|NCT05087134|Choline|choline|mesh-list
57011542|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
57011543|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57011544|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
57011545|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011546|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57011547|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57011548|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
57011549|NCT03048747|Tolvaptan|tolvaptan|mesh-list
57011550|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57011551|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011552|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
57011553|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011554|NCT05086822|Irinotecan|irinotecan|mesh-list
57011555|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57011556|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57011557|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011558|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011559|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011560|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
57011561|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57011562|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011563|NCT04051827|Midazolam|midazolam|mesh-list
57011564|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57011565|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57011566|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011567|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011568|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57011569|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57011570|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57011571|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57011572|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
57011573|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
57011574|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
57011575|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
57011576|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011577|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011578|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
57011579|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011580|NCT05325502|Mannitol|mannitol|mesh-list
57011581|NCT05325502|Caffeine|caffeine|mesh-list
57011582|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57011583|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011584|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57011585|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011586|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011587|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57011588|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57011589|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
57011590|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011591|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57011592|NCT05325502|Diuretics|diuretics|mesh-ancestor
57011593|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
57011594|NCT02123823|Everolimus|everolimus|mesh-list
57011595|NCT02123823|Exemestane|exemestane|mesh-list
57011596|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011597|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011598|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
57011599|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011600|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57011601|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57011602|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011603|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011604|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57011605|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
57011606|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011607|NCT05085652|Anesthetics|anesthetics|mesh-list
57011608|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011609|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011610|NCT03136510|Apixaban|apixaban|mesh-list
57011611|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57011612|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
57011613|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57011614|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
57011615|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011616|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011617|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
57011618|NCT05692245|Dexamethasone|dexamethasone|mesh-list
57011619|NCT05692245|Ondansetron|ondansetron|mesh-list
57011620|NCT05692245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57011621|NCT05692245|Antiemetics|antiemetics|mesh-ancestor
57011622|NCT05692245|Autonomic Agents|autonomic agents|mesh-ancestor
57011623|NCT05692245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011624|NCT05692245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011625|NCT05692245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57011626|NCT05692245|Glucocorticoids|glucocorticoids|mesh-ancestor
57011627|NCT05692245|Hormones|hormones|mesh-ancestor
57011628|NCT05692245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011629|NCT05692245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57011630|NCT05692245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011631|NCT05692245|Antipruritics|antipruritics|mesh-ancestor
57011632|NCT05692245|Dermatologic Agents|dermatologic agents|mesh-ancestor
57011633|NCT05692245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57011634|NCT05692245|Serotonin Agents|serotonin agents|mesh-ancestor
57011635|NCT05692245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011636|NCT05692245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011637|NCT05692245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57011638|NCT05692245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57011639|NCT05692245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011640|NCT05692245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57011641|NCT05692245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57011642|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
57011643|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57011644|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57011645|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57011646|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57011647|NCT05085106|Analgesics|analgesics|mesh-ancestor
57011648|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
57011649|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011650|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011651|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57011652|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57011653|NCT05692167|Dexmedetomidine|dexmedetomidine|mesh-list
57011654|NCT05692167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57011655|NCT05692167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011656|NCT05692167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011657|NCT05692167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57011658|NCT05692167|Analgesics|analgesics|mesh-ancestor
57011659|NCT05692167|Sensory System Agents|sensory system agents|mesh-ancestor
57011660|NCT05692167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011661|NCT05692167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57011662|NCT05692167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57011663|NCT05692167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57011664|NCT05692167|Adrenergic Agents|adrenergic agents|mesh-ancestor
57011665|NCT05692167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011666|NCT05692167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011667|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
57011668|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
57011669|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57011670|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57011671|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011672|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011673|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011674|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57011675|NCT00159796|Olanzapine|olanzapine|mesh-list
57011676|NCT00159796|Asenapine|asenapine|mesh-list
57011677|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
57011678|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
57011679|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57011680|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011681|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57011682|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57011683|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57011684|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011685|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57011686|NCT00159796|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57011687|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57011688|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57011689|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011690|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011691|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
57011692|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57011693|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57011694|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011695|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
57011696|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57011697|NCT03327844|Metronidazole|metronidazole|mesh-list
57011698|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
57011699|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57011700|NCT03327844|Calcium|calcium|mesh-list
57011701|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57011702|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011703|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57011704|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011705|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
57011706|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57011707|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57011708|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57011709|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57011710|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011711|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011712|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011713|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57011714|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57011715|NCT05691699|Itraconazole|itraconazole|mesh-list
57011716|NCT05691699|Antifungal Agents|antifungal agents|mesh-ancestor
57011717|NCT05691699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011718|NCT05691699|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57011719|NCT05691699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57011720|NCT05691699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011721|NCT05691699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011722|NCT05691699|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57011723|NCT05691699|Hormone Antagonists|hormone antagonists|mesh-ancestor
57011724|NCT05691699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011725|NCT05691699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011726|NCT05691699|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57011727|NCT02133196|Aldesleukin|aldesleukin|mesh-list
57011728|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
57011729|NCT02133196|Fludarabine|fludarabine|mesh-list
57011730|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011731|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
57011732|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011733|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57011734|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57011735|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
57011736|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011737|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011738|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57011739|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57011740|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57011741|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
57011742|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011743|NCT05691465|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
57011744|NCT05691465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011745|NCT05691465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57011746|NCT05008510|Camptothecin|camptothecin|mesh-list
57011747|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
57011748|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57011749|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011750|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57011751|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57011752|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011753|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011754|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
57011755|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011756|NCT05194995|Cetuximab|cetuximab|mesh-list
57011757|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57011758|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011759|NCT05187039|Anesthetics|anesthetics|mesh-list
57011760|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57011761|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011762|NCT03136666|Candesartan|candesartan|mesh-list
57011763|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
57011764|NCT03136666|Nifedipine|nifedipine|mesh-list
57011765|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57011766|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57011767|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57011768|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011769|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57011770|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57011771|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57011772|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011773|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
57011774|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
57011775|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57011776|NCT03255083|Osimertinib|osimertinib|mesh-list
57011777|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011778|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57011779|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011780|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011781|NCT04861558|Fluorouracil|fluorouracil|mesh-list
57011782|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
57011783|NCT04861558|Irinotecan|irinotecan|mesh-list
57011784|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
57011785|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011786|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57011787|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011788|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011789|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
57011790|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011791|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57011792|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57011793|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011794|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
57011795|NCT03735537|Teriparatide|teriparatide|mesh-list
57011796|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57011797|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57011798|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011799|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57011800|NCT04531059|Metronidazole|metronidazole|mesh-list
57011801|NCT04531059|Minocycline|minocycline|mesh-list
57011802|NCT04531059|Tetracycline|tetracycline|mesh-list
57011803|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
57011804|NCT04531059|Esomeprazole|esomeprazole|mesh-list
57011805|NCT04531059|Bismuth|bismuth|mesh-list
57011806|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011807|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011808|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57011809|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57011810|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57011811|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57011812|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57011813|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57011814|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011815|NCT04531059|Antacids|antacids|mesh-ancestor
57011816|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57011817|NCT04531059|Diuretics|diuretics|mesh-ancestor
57011818|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
57011819|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011820|NCT04531059|Expectorants|expectorants|mesh-ancestor
57011821|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
57011822|NCT05168163|Atezolizumab|atezolizumab|mesh-list
57011823|NCT05168163|Lenvatinib|lenvatinib|mesh-list
57011824|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57011825|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011826|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57011828|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011829|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
57011830|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011831|NCT05090176|Povidone|povidone|mesh-list
57011832|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
57011833|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
57011834|NCT04530981|Repaglinide|repaglinide|mesh-list
57011835|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57011836|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011837|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
57011838|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57011839|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57011840|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011841|NCT05669625|Vaccines|vaccines|mesh-list
57011842|NCT05669625|Immunologic Factors|immunologic factors|mesh-ancestor
57011843|NCT05669625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011844|NCT05659563|Tamoxifen|tamoxifen|mesh-list
57011845|NCT05659563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57011846|NCT05659563|Hormone Antagonists|hormone antagonists|mesh-ancestor
57011847|NCT05659563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011848|NCT05659563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011849|NCT05659563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57011850|NCT05659563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011851|NCT05659563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57011852|NCT05659563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57011853|NCT05659563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57011854|NCT04558294|Ketanserin|ketanserin|mesh-list
57011855|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
57011856|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
57011857|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011858|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57011859|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57011860|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
57011861|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011862|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011863|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57011864|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57011865|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57011866|NCT05057247|Docetaxel|docetaxel|mesh-list
57011867|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011868|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
57011869|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
57011870|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
57011871|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011872|NCT05628363|Androgens|androgens|mesh-list
57011873|NCT05628363|Hormones|hormones|mesh-ancestor
57011874|NCT05628363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011875|NCT05628363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011876|NCT05626257|Omalizumab|omalizumab|mesh-list
57011877|NCT05626257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57011878|NCT05626257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57011879|NCT05626257|Respiratory System Agents|respiratory system agents|mesh-ancestor
57011880|NCT04396821|Gemcitabine|gemcitabine|mesh-list
57011881|NCT04396821|Paclitaxel|paclitaxel|mesh-list
57011882|NCT04396821|Nivolumab|nivolumab|mesh-list
57011883|NCT04396821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57011884|NCT04396821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57011885|NCT04396821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011886|NCT04396821|Tubulin Modulators|tubulin modulators|mesh-ancestor
57011887|NCT04396821|Antimitotic Agents|antimitotic agents|mesh-ancestor
57011888|NCT04396821|Mitosis Modulators|mitosis modulators|mesh-ancestor
57011889|NCT04396821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011890|NCT04396821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57011891|NCT04396821|Antimetabolites|antimetabolites|mesh-ancestor
57011892|NCT04396821|Antiviral Agents|antiviral agents|mesh-ancestor
57011893|NCT04396821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011894|NCT04396821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011895|NCT04396821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011896|NCT04396821|Immunologic Factors|immunologic factors|mesh-ancestor
57011897|NCT04396821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011898|NCT04396821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693840|NCT00759681|Thrombin|thrombin|mesh-list
57011899|NCT04396821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57011901|NCT03378466|Calcium heparin|calcium heparin|mesh-list
57011902|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
57011903|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57011904|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57011905|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011906|NCT04507438|Donepezil|donepezil|mesh-list
57011907|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57011908|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011909|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011910|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
57011911|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57011912|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011913|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
57011914|NCT05077540|Misoprostol|misoprostol|mesh-list
57011915|NCT05077540|Oxytocin|oxytocin|mesh-list
57011916|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
57011917|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57011918|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011919|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57011920|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
57011921|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57011922|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57011923|NCT05413551|Isoniazid|isoniazid|mesh-list
57011924|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
57011925|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57011926|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57011927|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57011928|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57011929|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
57011930|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011931|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57011932|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
57011933|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57011934|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011935|NCT02470585|Paclitaxel|paclitaxel|mesh-list
57011936|NCT02470585|Carboplatin|carboplatin|mesh-list
57011937|NCT02470585|Veliparib|veliparib|mesh-list
57011938|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57011939|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011940|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
57011941|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
57011942|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
57011943|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011944|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57011945|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011946|NCT02744898|Paclitaxel|paclitaxel|mesh-list
57011947|NCT02744898|Carboplatin|carboplatin|mesh-list
57011948|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57011949|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57011950|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011951|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
57011952|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
57011953|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
57011954|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011955|NCT03587311|Paclitaxel|paclitaxel|mesh-list
57011956|NCT03587311|Maytansine|maytansine|mesh-list
57011957|NCT03587311|Bevacizumab|bevacizumab|mesh-list
57011958|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57011959|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57011960|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
57011961|NCT03587311|Antibodies|antibodies|mesh-list
57011962|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
57011963|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57011964|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
57011965|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57011966|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57011967|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
57011968|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
57011969|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
57011970|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011971|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57011972|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57011973|NCT03587311|Growth Substances|growth substances|mesh-ancestor
57011974|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011975|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
57011976|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
57011977|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
57011978|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
57011979|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
57011980|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011981|NCT03097315|Triamcinolone|triamcinolone|mesh-list
57011982|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57011983|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57011984|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57011985|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57011986|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
57011987|NCT03097315|Hormones|hormones|mesh-ancestor
57011988|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57011989|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57011990|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57011991|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
57011992|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57011993|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57011994|NCT05530707|Niacinamide|niacinamide|mesh-list
57011995|NCT05530707|Niacin|niacin|mesh-list
57011996|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
57011997|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
57011998|NCT05530707|Vitamins|vitamins|mesh-ancestor
57011999|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
57012000|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012001|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57012002|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
57012003|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012004|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57012005|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
57012006|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57012007|NCT05515575|Niraparib|niraparib|mesh-list
57012008|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57012009|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012010|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012011|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012012|NCT04827147|Methamphetamine|methamphetamine|mesh-list
57012013|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57012014|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012015|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
57012016|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
57012017|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012018|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
57012019|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57012020|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012021|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
57012022|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57012023|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57012024|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57012025|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57012026|NCT03093415|Grazoprevir|grazoprevir|mesh-list
57012027|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
57012028|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
57012029|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012030|NCT01358526|Oxycodone|oxycodone|mesh-list
57012031|NCT01358526|Naloxone|naloxone|mesh-list
57012032|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57012033|NCT01358526|Narcotics|narcotics|mesh-ancestor
57012034|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012035|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012036|NCT01358526|Analgesics|analgesics|mesh-ancestor
57012037|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
57012038|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012039|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57012040|NCT05434689|Dexamethasone|dexamethasone|mesh-list
57012041|NCT05434689|Daratumumab|daratumumab|mesh-list
57012042|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57012043|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
57012044|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
57012045|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012046|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012047|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57012048|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
57012049|NCT05434689|Hormones|hormones|mesh-ancestor
56693989|NCT00831701|Tamsulosin|tamsulosin|mesh-list
57012050|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012051|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57012052|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012053|NCT01310010|Dasatinib|dasatinib|mesh-list
57012054|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012055|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012056|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012057|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012058|NCT02830776|Bimatoprost|bimatoprost|mesh-list
57012059|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57012060|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57012061|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57012062|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
57012063|NCT05400603|Irinotecan|irinotecan|mesh-list
57012064|NCT05400603|Temozolomide|temozolomide|mesh-list
57012065|NCT05400603|Dinutuximab|dinutuximab|mesh-list
57012066|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57012067|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57012068|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012069|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012070|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012071|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57012072|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
57012073|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57012074|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012075|NCT03563664|Danazol|danazol|mesh-list
57012076|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57012077|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
57012078|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012079|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012080|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
57012081|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
57012082|NCT01904136|Melphalan|melphalan|mesh-list
57012083|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
57012084|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
57012085|NCT01904136|Fludarabine|fludarabine|mesh-list
57012086|NCT01904136|Tacrolimus|tacrolimus|mesh-list
57012087|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012088|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
57012089|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012090|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57012091|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57012092|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
57012093|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012094|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012095|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57012096|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57012097|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012098|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57012099|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57012100|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
57012101|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57012102|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012103|NCT03041181|Gemcitabine|gemcitabine|mesh-list
57012104|NCT03041181|Docetaxel|docetaxel|mesh-list
57012105|NCT03041181|Nivolumab|nivolumab|mesh-list
57012106|NCT03041181|Pemetrexed|pemetrexed|mesh-list
57012107|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57012108|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
57012109|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012110|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012111|NCT03041181|Antiviral Agents|antiviral agents|mesh-ancestor
57012112|NCT03041181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012113|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012114|NCT03041181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012115|NCT03041181|Immunologic Factors|immunologic factors|mesh-ancestor
57012116|NCT03041181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012117|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
57012118|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
57012119|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
57012120|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57012121|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57012122|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57012123|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57012124|NCT05351229|Morphine|morphine|mesh-list
57012125|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57012126|NCT05351229|Narcotics|narcotics|mesh-ancestor
57012127|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012128|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012129|NCT05351229|Analgesics|analgesics|mesh-ancestor
57012130|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
57012131|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012132|NCT05121909|Listerine|listerine|mesh-list
57012133|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
57012134|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
57012135|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
57012136|NCT05121909|Protective Agents|protective agents|mesh-ancestor
57012137|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012138|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012139|NCT02828124|Nivolumab|nivolumab|mesh-list
57012140|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57012141|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012142|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57012143|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012144|NCT04761393|Xenon|xenon|mesh-list
57012145|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57012146|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
57012147|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
57012148|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012149|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012150|NCT05120895|Pravastatin|pravastatin|mesh-list
57012151|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57012152|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57012153|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
57012154|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012155|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57012156|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57012157|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012158|NCT02829996|Latanoprost|latanoprost|mesh-list
57012159|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57012160|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57012161|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
57012162|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012163|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012164|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012165|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012166|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57012167|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012168|NCT05113251|Paclitaxel|paclitaxel|mesh-list
57012169|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
57012170|NCT05113251|Doxorubicin|doxorubicin|mesh-list
57012171|NCT05113251|Trastuzumab|trastuzumab|mesh-list
57012172|NCT05113251|Pertuzumab|pertuzumab|mesh-list
57012173|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57012174|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012175|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
57012176|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
57012177|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
57012178|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012179|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012180|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
57012181|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012182|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57012183|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57012184|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
57012185|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57012186|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57012187|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57012188|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57012189|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012190|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57012191|NCT05197062|Aticaprant|aticaprant|mesh-list
57012192|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57012193|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012194|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
57012195|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012196|NCT05000736|Fulvestrant|fulvestrant|mesh-list
57012197|NCT05000736|Palbociclib|palbociclib|mesh-list
57012198|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57012199|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57012200|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012201|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57012202|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57012203|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
57012204|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012205|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012206|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012207|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012208|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012209|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57012210|NCT03828162|Anticoagulants|anticoagulants|mesh-list
57012211|NCT03563040|Methoxsalen|methoxsalen|mesh-list
57012212|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57012213|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
57012214|NCT03094416|Esomeprazole|esomeprazole|mesh-list
57012215|NCT03094416|Omeprazole|omeprazole|mesh-list
57012216|NCT03094416|Rabeprazole|rabeprazole|mesh-list
57012217|NCT03094416|Pantoprazole|pantoprazole|mesh-list
57012218|NCT03094416|Lansoprazole|lansoprazole|mesh-list
57012219|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
57012220|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57012221|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57012222|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57012223|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012224|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012225|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
57012226|NCT05109429|Narcotics|narcotics|mesh-ancestor
57012227|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012228|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012229|NCT05109429|Analgesics|analgesics|mesh-ancestor
57012230|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
57012231|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012232|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
57012233|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57012234|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
57012235|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57012236|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012237|NCT01338870|Incretins|incretins|mesh-ancestor
57012238|NCT01338870|Hormones|hormones|mesh-ancestor
57012239|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012240|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57012241|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
57012242|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012243|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012244|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
57012245|NCT01338870|Vitamins|vitamins|mesh-ancestor
57012246|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
57012247|NCT02824224|Tamoxifen|tamoxifen|mesh-list
57012248|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57012249|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
57012250|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012251|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012252|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57012253|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012254|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57012255|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57012256|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57012257|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
57012258|NCT01338792|Pemetrexed|pemetrexed|mesh-list
57012259|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012260|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012261|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012262|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57012263|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57012264|NCT01314105|Carboplatin|carboplatin|mesh-list
57012265|NCT01314105|Nintedanib|nintedanib|mesh-list
57012266|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012267|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012268|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012269|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012270|NCT01966471|Maytansine|maytansine|mesh-list
57012271|NCT01966471|Docetaxel|docetaxel|mesh-list
57012272|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
57012273|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
57012274|NCT01966471|Doxorubicin|doxorubicin|mesh-list
57012275|NCT01966471|Fluorouracil|fluorouracil|mesh-list
57012276|NCT01966471|Trastuzumab|trastuzumab|mesh-list
57012278|NCT01966471|Pertuzumab|pertuzumab|mesh-list
57012279|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57012280|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012281|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
57012282|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
57012283|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
57012284|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012285|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012286|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
57012287|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012288|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57012289|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57012290|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
57012291|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57012292|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57012293|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57012294|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57012295|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012296|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
57012297|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57012298|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57012299|NCT03845517|PF-06700841|pf-06700841|mesh-list
57012300|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012301|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012302|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012303|NCT05330377|Cytarabine|cytarabine|mesh-list
57012304|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
57012305|NCT05330377|Cladribine|cladribine|mesh-list
57012306|NCT05330377|Lenograstim|lenograstim|mesh-list
57012307|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57012308|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
57012309|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012310|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012311|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
57012312|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012313|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012314|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
57012315|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012316|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57012317|NCT05330377|Analgesics|analgesics|mesh-ancestor
57012318|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
57012319|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012320|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57012321|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57012322|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012323|NCT04188847|Apatinib|apatinib|mesh-list
57012324|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012325|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012326|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012327|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012328|NCT05255107|Riboflavin|riboflavin|mesh-list
57012329|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
57012330|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
57012331|NCT05255107|Vitamins|vitamins|mesh-ancestor
57012332|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
57012333|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012334|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57012335|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
57012336|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57012337|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57012338|NCT03227471|Ivacaftor|ivacaftor|mesh-list
57012339|NCT03227471|Elexacaftor|elexacaftor|mesh-list
57012340|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55896135|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
57012341|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57012342|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012343|NCT01354314|Fluconazole|fluconazole|mesh-list
57012344|NCT01354314|Paroxetine|paroxetine|mesh-list
57012345|NCT01354314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57012346|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57012347|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57012348|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012349|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57012350|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
57012351|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012352|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57012353|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
57012354|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57012355|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57012356|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57012357|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012358|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
57012359|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012360|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57012361|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57012362|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
57012363|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012364|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57012365|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57012366|NCT04509336|Orphenadrine|orphenadrine|mesh-list
57012367|NCT04509336|Baclofen|baclofen|mesh-list
57012368|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57012369|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012370|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57012371|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012372|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57012373|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
57012374|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
57012375|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57012376|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012377|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57012378|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57012379|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
57012380|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
57012381|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57012382|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57012383|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
57012384|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
57012385|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57012386|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012387|NCT03194321|Tacrolimus|tacrolimus|mesh-list
57012388|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012389|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
57012390|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012391|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57012392|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012393|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012394|NCT05231460|Narcotics|narcotics|mesh-list
57012395|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012396|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012397|NCT05231460|Analgesics|analgesics|mesh-ancestor
57012398|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
57012399|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012400|NCT01374581|Artesunate|artesunate|mesh-list
57012401|NCT01374581|Lumefantrine|lumefantrine|mesh-list
57012402|NCT01374581|Artemether|artemether|mesh-list
57012403|NCT01374581|Amodiaquine|amodiaquine|mesh-list
57012404|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57012405|NCT01374581|Quinine|quinine|mesh-list
57012406|NCT01374581|Clindamycin|clindamycin|mesh-list
57012407|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
57012408|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
57012409|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
57012410|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57012411|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57012412|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012413|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012414|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
57012415|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
57012416|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57012417|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
57012418|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57012419|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57012420|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012421|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012422|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57012423|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012424|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57012425|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694360|NCT04093050|Vasopressins|vasopressins|mesh-list
57012426|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57012427|NCT01374581|Analgesics|analgesics|mesh-ancestor
57012428|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
57012429|NCT01354938|Clarithromycin|clarithromycin|mesh-list
57012430|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57012431|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012432|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57012433|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012434|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012435|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57012436|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57012437|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57012438|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
57012439|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57012440|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012441|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012442|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57012443|NCT01374737|Analgesics|analgesics|mesh-ancestor
57012444|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
57012445|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012446|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57012447|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57012448|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57012449|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
57012450|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57012451|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012452|NCT03631615|Antibodies|antibodies|mesh-list
57012453|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
57012454|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012455|NCT01376453|Fluorouracil|fluorouracil|mesh-list
57012456|NCT01376453|Sorafenib|sorafenib|mesh-list
57012457|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
57012458|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012459|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57012460|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012461|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012462|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
57012463|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012464|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012465|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012466|NCT05107219|Linaclotide|linaclotide|mesh-list
57012467|NCT05107219|Plecanatide|plecanatide|mesh-list
57012468|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57012469|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
57012470|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012471|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57012472|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57012473|NCT01568125|Incretins|incretins|mesh-list
57012474|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012475|NCT01568125|Hormones|hormones|mesh-ancestor
57012476|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012477|NCT03360721|Prednisone|prednisone|mesh-list
57012478|NCT03360721|Cortisone|cortisone|mesh-list
57012479|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
57012480|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57012481|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
57012482|NCT03360721|Hormones|hormones|mesh-ancestor
57012483|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012484|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012485|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57012486|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896459|NCT01268163|Docetaxel|docetaxel|mesh-list
57012487|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57012488|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012489|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012490|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
57012491|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57012492|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
57012493|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57012494|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012495|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57012496|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012497|NCT02288897|Temozolomide|temozolomide|mesh-list
57012498|NCT02288897|Dacarbazine|dacarbazine|mesh-list
57012499|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57012500|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57012501|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
57012502|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012503|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012504|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57012505|NCT05707572|Methylprednisolone|methylprednisolone|mesh-list
57012506|NCT05707572|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57012507|NCT05707572|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57012509|NCT05707572|Prednisolone acetate|prednisolone acetate|mesh-list
57012510|NCT05707572|Lidocaine|lidocaine|mesh-list
57012511|NCT05707572|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57012512|NCT05707572|Prednisolone phosphate|prednisolone phosphate|mesh-list
57012513|NCT05707572|Anesthetics, Local|anesthetics, local|mesh-ancestor
57012514|NCT05707572|Anesthetics|anesthetics|mesh-ancestor
57012515|NCT05707572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012516|NCT05707572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012517|NCT05707572|Sensory System Agents|sensory system agents|mesh-ancestor
57012518|NCT05707572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012519|NCT05707572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57012520|NCT05707572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57012521|NCT05707572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57012522|NCT05707572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57012523|NCT05707572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012524|NCT05707572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57012525|NCT05707572|Antiemetics|antiemetics|mesh-ancestor
57012526|NCT05707572|Autonomic Agents|autonomic agents|mesh-ancestor
57012527|NCT05707572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57012528|NCT05707572|Glucocorticoids|glucocorticoids|mesh-ancestor
57012529|NCT05707572|Hormones|hormones|mesh-ancestor
57012530|NCT05707572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012531|NCT05707572|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57012532|NCT05707572|Protective Agents|protective agents|mesh-ancestor
57012533|NCT05707572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57012534|NCT05707572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012535|NCT04280562|Acetaminophen|acetaminophen|mesh-list
57012536|NCT04280562|Analgesics|analgesics|mesh-list
57012537|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57012538|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
57012539|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012540|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012541|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
57012542|NCT02035800|Adalimumab|adalimumab|mesh-list
57012543|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57012544|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57012545|NCT03993912|Dexamethasone|dexamethasone|mesh-list
57012546|NCT03993912|Lenalidomide|lenalidomide|mesh-list
57012547|NCT03993912|Daratumumab|daratumumab|mesh-list
57012548|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57012549|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
57012550|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
57012551|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012552|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012553|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57012554|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
57012555|NCT03993912|Hormones|hormones|mesh-ancestor
57012556|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012557|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57012558|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012559|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
57012560|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57012561|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57012562|NCT03993912|Growth Substances|growth substances|mesh-ancestor
57012563|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
57012564|NCT01568749|Acetaminophen|acetaminophen|mesh-list
57012565|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57012566|NCT01568749|Analgesics|analgesics|mesh-ancestor
57012567|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
57012568|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012569|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012570|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
57012571|NCT02819310|Laxatives|laxatives|mesh-list
57012572|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56694509|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57012573|NCT01375361|Albuterol|albuterol|mesh-list
57012574|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57012575|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
57012576|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012577|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012578|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57012579|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
57012580|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
57012581|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57012582|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57012583|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57012584|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57012585|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
57012586|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57012587|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012588|NCT04206787|Afatinib|afatinib|mesh-list
57012589|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012590|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012591|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012592|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012593|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
57012594|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57012595|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
57012596|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012597|NCT01376765|Antacids|antacids|mesh-ancestor
57012598|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012599|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57012600|NCT03278509|Metoprolol|metoprolol|mesh-list
57012601|NCT03278509|Bisoprolol|bisoprolol|mesh-list
57012602|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57012603|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57012604|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
57012605|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
57012606|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012607|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012608|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57012609|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57012610|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57012611|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
57012612|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57012613|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012614|NCT05754593|Hormones|hormones|mesh-list
57012615|NCT05754593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012616|NCT05754593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012617|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
57012618|NCT01358201|Cytarabine|cytarabine|mesh-list
57012619|NCT01358201|Dexamethasone|dexamethasone|mesh-list
57012620|NCT01358201|Methotrexate|methotrexate|mesh-list
57012621|NCT01358201|Vincristine|vincristine|mesh-list
57012622|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57012623|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
57012624|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
57012625|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012626|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012627|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57012628|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
57012629|NCT01358201|Hormones|hormones|mesh-ancestor
57012630|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012631|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57012632|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012633|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57012634|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
57012635|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57012636|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57012637|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
57012638|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012639|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
57012640|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012641|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57012642|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012643|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
57012644|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57012645|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57012646|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57012647|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
57012648|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
57012649|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
57012650|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
57012651|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012652|NCT02971501|Bevacizumab|bevacizumab|mesh-list
57012653|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57012654|NCT02971501|Osimertinib|osimertinib|mesh-list
57012655|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
57012656|NCT02971501|Antibodies|antibodies|mesh-list
57012657|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
57012658|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57012659|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
57012660|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012661|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57012662|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57012663|NCT02971501|Growth Substances|growth substances|mesh-ancestor
57012664|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012665|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
57012666|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
57012667|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012668|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012669|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012670|NCT02969083|Gemcitabine|gemcitabine|mesh-list
57012671|NCT02969083|Cisplatin|cisplatin|mesh-list
57012672|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012673|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57012674|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
57012675|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012676|NCT02969083|Antiviral Agents|antiviral agents|mesh-ancestor
57012677|NCT02969083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012678|NCT02969083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012679|NCT02969083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012680|NCT02969083|Immunologic Factors|immunologic factors|mesh-ancestor
57012681|NCT02969083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012682|NCT04166773|Tirzepatide|tirzepatide|mesh-list
57012683|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57012684|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012685|NCT04166773|Incretins|incretins|mesh-ancestor
57012686|NCT04166773|Hormones|hormones|mesh-ancestor
57012687|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012688|NCT05748587|Iron|iron|mesh-list
57012689|NCT05748587|Deferoxamine|deferoxamine|mesh-list
57012690|NCT05748587|Trace Elements|trace elements|mesh-ancestor
57012691|NCT05748587|Micronutrients|micronutrients|mesh-ancestor
57012692|NCT05748587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012693|NCT05748587|Siderophores|siderophores|mesh-ancestor
57012694|NCT05748587|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57012695|NCT05748587|Chelating Agents|chelating agents|mesh-ancestor
57012696|NCT05748587|Sequestering Agents|sequestering agents|mesh-ancestor
57012697|NCT05748587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012698|NCT04726475|Cannabidiol|cannabidiol|mesh-list
57012699|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
57012700|NCT02951767|Atezolizumab|atezolizumab|mesh-list
57012701|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012702|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57012703|NCT03091777|Metronidazole|metronidazole|mesh-list
57012704|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896465|NCT04745780|Inositol|inositol|mesh-list
57012705|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57012706|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57012707|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57012708|NCT05603741|Lidocaine|lidocaine|mesh-list
57012709|NCT05603741|Anesthetics, Local|anesthetics, local|mesh-ancestor
57012710|NCT05603741|Anesthetics|anesthetics|mesh-ancestor
57012711|NCT05603741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012712|NCT05603741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012713|NCT05603741|Sensory System Agents|sensory system agents|mesh-ancestor
57012714|NCT05603741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012715|NCT05603741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57012716|NCT05603741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57012717|NCT05603741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57012718|NCT05603741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57012719|NCT05603741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012720|NCT05392361|Gabapentin|gabapentin|mesh-list
57012721|NCT05392361|Baclofen|baclofen|mesh-list
57012722|NCT05392361|Analgesics|analgesics|mesh-ancestor
57012723|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
57012724|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012725|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012726|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
57012727|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57012728|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57012729|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012730|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57012731|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57012732|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57012733|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57012734|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012735|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
57012736|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57012737|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57012738|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57012739|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
57012740|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
57012741|NCT05338541|Etoposide|etoposide|mesh-list
57012742|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57012743|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012744|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57012745|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57012746|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012747|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012748|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
57012749|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57012750|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012751|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012752|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57012753|NCT05335655|Analgesics|analgesics|mesh-ancestor
57012754|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
57012755|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012756|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57012757|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57012758|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57012759|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
57012760|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57012761|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012762|NCT04589351|Ezetimibe|ezetimibe|mesh-list
57012763|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57012764|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57012765|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
57012766|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012767|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57012768|NCT02818998|Aflibercept|aflibercept|mesh-list
57012769|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57012770|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57012771|NCT02818998|Growth Substances|growth substances|mesh-ancestor
57012772|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012773|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
57012774|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012775|NCT05760677|Metformin|metformin|mesh-list
57012776|NCT05760677|Pioglitazone|pioglitazone|mesh-list
57012777|NCT05760677|Orlistat|orlistat|mesh-list
57012778|NCT05760677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57012779|NCT05760677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012780|NCT05760677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012781|NCT05760677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012782|NCT05760677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57012783|NCT05760677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57012784|NCT02821416|Benralizumab|benralizumab|mesh-list
57012785|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57012786|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
57012787|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57012788|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57012789|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012790|NCT03108521|Incretins|incretins|mesh-ancestor
57012791|NCT03108521|Hormones|hormones|mesh-ancestor
57012792|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012793|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57012794|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
57012795|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012796|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012797|NCT04500509|Diclofenac|diclofenac|mesh-list
57012798|NCT04500509|Dinoprostone|dinoprostone|mesh-list
57012799|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57012800|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57012802|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
57012803|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012804|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012805|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57012806|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57012807|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57012808|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012809|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012810|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
57012811|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57012812|NCT05760599|Bevacizumab|bevacizumab|mesh-list
57012813|NCT05760599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57012814|NCT05760599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012815|NCT05760599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57012816|NCT05760599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57012817|NCT05760599|Growth Substances|growth substances|mesh-ancestor
57012818|NCT05760599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012819|NCT05760599|Growth Inhibitors|growth inhibitors|mesh-ancestor
57012820|NCT04441073|Lidocaine|lidocaine|mesh-list
57012821|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
57012822|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
57012823|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012824|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012825|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
57012826|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012827|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57012828|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57012829|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57012830|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57012831|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012832|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
57012833|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57012834|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012835|NCT02817828|Drospirenone|drospirenone|mesh-list
57012836|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57012837|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
57012838|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012839|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012840|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57012841|NCT02817828|Diuretics|diuretics|mesh-ancestor
57012842|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
57012843|NCT03632681|Insulin|insulin|mesh-list
57012844|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57012845|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57012846|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012847|NCT05597995|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
57012848|NCT05597995|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57012849|NCT05597995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57012850|NCT05597917|Trabectedin|trabectedin|mesh-list
57012851|NCT05597917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57012852|NCT05597917|Alkylating Agents|alkylating agents|mesh-ancestor
57012853|NCT05597917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012854|NCT05597917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012855|NCT03796650|Vancomycin|vancomycin|mesh-list
57012856|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57012857|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012858|NCT05597527|Apatinib|apatinib|mesh-list
57012859|NCT05597527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012860|NCT05597527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012861|NCT05597527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012862|NCT05597527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012863|NCT02888743|Durvalumab|durvalumab|mesh-list
57012864|NCT02888743|Ipilimumab|ipilimumab|mesh-list
57012865|NCT02888743|Tremelimumab|tremelimumab|mesh-list
57012866|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
57012867|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57012868|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
57012869|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57012870|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012871|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
57012872|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012873|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56694836|NCT02611505|Esketamine|esketamine|mesh-list
57012874|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012875|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
57012876|NCT02883049|Leucovorin|leucovorin|mesh-list
57012877|NCT02883049|Folic Acid|folic acid|mesh-list
57012878|NCT02883049|Cytarabine|cytarabine|mesh-list
57012879|NCT02883049|Dexamethasone|dexamethasone|mesh-list
57012880|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
57012881|NCT02883049|Prednisone|prednisone|mesh-list
57012882|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
57012883|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57012884|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57012885|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57012886|NCT02883049|Cortisone|cortisone|mesh-list
57012887|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
57012888|NCT02883049|Doxorubicin|doxorubicin|mesh-list
57012889|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57012890|NCT02883049|Methotrexate|methotrexate|mesh-list
57012891|NCT02883049|Etoposide|etoposide|mesh-list
57012892|NCT02883049|Vincristine|vincristine|mesh-list
57012893|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
57012894|NCT02883049|Daunorubicin|daunorubicin|mesh-list
57012895|NCT02883049|Asparaginase|asparaginase|mesh-list
57012896|NCT02883049|Dasatinib|dasatinib|mesh-list
57012897|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
57012898|NCT02883049|Clofarabine|clofarabine|mesh-list
57012899|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
57012900|NCT02883049|Pegaspargase|pegaspargase|mesh-list
57012901|NCT02883049|Thioguanine|thioguanine|mesh-list
57012902|NCT02883049|BB 1101|bb 1101|mesh-list
57012903|NCT02883049|Calcium|calcium|mesh-list
57012904|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
57012905|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
57012906|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57012907|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
57012908|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012909|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57012910|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57012911|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
57012912|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012913|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012914|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57012915|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57012916|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
57012917|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
57012918|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012919|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57012920|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
57012921|NCT02883049|Hormones|hormones|mesh-ancestor
57012922|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012923|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57012924|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
57012925|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012926|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57012927|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57012928|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57012929|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57012930|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57012931|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57012932|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
57012933|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57012934|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57012935|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
57012936|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
57012937|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57012938|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57012939|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57012940|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
57012941|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012942|NCT02883049|Antidotes|antidotes|mesh-ancestor
57012943|NCT02883049|Protective Agents|protective agents|mesh-ancestor
57012944|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
57012945|NCT02883049|Vitamins|vitamins|mesh-ancestor
57012946|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
57012947|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
57012948|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
57012949|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
57012950|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012951|NCT02883049|Hematinics|hematinics|mesh-ancestor
57012952|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
57012953|NCT04721873|Topiramate|topiramate|mesh-list
57012954|NCT04721873|Phentermine|phentermine|mesh-list
57012955|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
57012956|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57012957|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012958|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57012959|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
57012960|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57012961|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
57012962|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
57012963|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012964|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
57012965|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57012966|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012967|NCT05198609|Apatinib|apatinib|mesh-list
57012968|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012969|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57012970|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012971|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012972|NCT05198141|Letrozole|letrozole|mesh-list
57012973|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012974|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57012975|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57012976|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012977|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012978|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57012979|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
57012980|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57012981|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012982|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
57012983|NCT02813694|Lefamulin|lefamulin|mesh-list
57012984|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57012985|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57012986|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57012987|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57012988|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57012989|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57012990|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57012991|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
57012992|NCT03632161|Bupivacaine|bupivacaine|mesh-list
57012993|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
57012994|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
57012995|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57012996|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57012997|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
57012998|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57012999|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57013000|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57013001|NCT03632161|Analgesics|analgesics|mesh-ancestor
57013002|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57013003|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57013004|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57013005|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
57013006|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013007|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013008|NCT03103919|Rotigotine|rotigotine|mesh-list
57013009|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
57013010|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
57013011|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013012|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013013|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013014|NCT04173325|Nivolumab|nivolumab|mesh-list
57013015|NCT04173325|Irinotecan|irinotecan|mesh-list
57013016|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013017|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013018|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57013019|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013020|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57013021|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57013022|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013023|NCT02810964|Sulforaphane|sulforaphane|mesh-list
57013024|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57013025|NCT02810964|Protective Agents|protective agents|mesh-ancestor
57013026|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013027|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013028|NCT05571319|Metformin|metformin|mesh-list
57013029|NCT05571319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57013030|NCT05571319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013031|NCT04073147|Venetoclax|venetoclax|mesh-list
57013032|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
57013033|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013034|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013035|NCT05676203|Docetaxel|docetaxel|mesh-list
57013036|NCT05676203|Androgens|androgens|mesh-list
57013037|NCT05676203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013038|NCT05676203|Tubulin Modulators|tubulin modulators|mesh-ancestor
57013039|NCT05676203|Antimitotic Agents|antimitotic agents|mesh-ancestor
57013040|NCT05676203|Mitosis Modulators|mitosis modulators|mesh-ancestor
57013041|NCT05676203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013042|NCT05676203|Hormones|hormones|mesh-ancestor
57013043|NCT05676203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013044|NCT05676203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013045|NCT02707159|Gemcitabine|gemcitabine|mesh-list
57013046|NCT02707159|Paclitaxel|paclitaxel|mesh-list
57013047|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57013048|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57013049|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013050|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
57013051|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
57013052|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
57013053|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013054|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57013055|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
57013056|NCT02707159|Antiviral Agents|antiviral agents|mesh-ancestor
57013057|NCT02707159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013058|NCT02707159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013059|NCT02707159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013060|NCT02707159|Immunologic Factors|immunologic factors|mesh-ancestor
57013061|NCT02707159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013062|NCT04113187|Propranolol|propranolol|mesh-list
57013063|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57013064|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57013065|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
57013066|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013067|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013068|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013069|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57013070|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57013071|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
57013072|NCT03103763|Warfarin|warfarin|mesh-list
57013073|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
57013074|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57013075|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57013076|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57013077|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
57013078|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013079|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57013080|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57013081|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013082|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
57013083|NCT05353439|Topotecan|topotecan|mesh-list
57013084|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013085|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013086|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57013087|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57013088|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013089|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013090|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
57013091|NCT04011475|Olodaterol|olodaterol|mesh-list
57013092|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57013093|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
57013094|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013095|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013096|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57013097|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
57013098|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
57013099|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57013100|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
57013101|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013102|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013103|NCT05110781|Atezolizumab|atezolizumab|mesh-list
57013104|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57013105|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013106|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
57013107|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013108|NCT05658575|Dapansutrile|dapansutrile|mesh-list
57013109|NCT05658575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57013110|NCT04138277|Miglustat|miglustat|mesh-list
57013111|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013112|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013113|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57013114|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57013115|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
57013116|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013117|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57013118|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57013119|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013120|NCT03663335|Tacrolimus|tacrolimus|mesh-list
57013121|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013122|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
57013123|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013124|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57013125|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013126|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013127|NCT03632915|Lacosamide|lacosamide|mesh-list
57013128|NCT03632915|Phenytoin|phenytoin|mesh-list
57013129|NCT03632915|Ketamine|ketamine|mesh-list
57013130|NCT03632915|Levetiracetam|levetiracetam|mesh-list
57013131|NCT03632915|Valproic Acid|valproic acid|mesh-list
57013132|NCT03632915|Phenobarbital|phenobarbital|mesh-list
57013133|NCT03632915|Analgesics|analgesics|mesh-ancestor
57013134|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
57013135|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013136|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013137|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57013138|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57013139|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
57013140|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
57013141|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013142|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57013143|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57013144|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013145|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013146|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
57013147|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
57013148|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013149|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
57013150|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
57013151|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57013152|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57013153|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57013154|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57013155|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57013156|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57013157|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57013158|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57013159|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
57013160|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57013161|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57013162|NCT05649605|Methyltestosterone|methyltestosterone|mesh-list
57013163|NCT05649605|Testosterone|testosterone|mesh-list
57013164|NCT05649605|Testosterone undecanoate|testosterone undecanoate|mesh-list
57013165|NCT05649605|Testosterone enanthate|testosterone enanthate|mesh-list
57013166|NCT05649605|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57013167|NCT05649605|Androgens|androgens|mesh-ancestor
57013168|NCT05649605|Hormones|hormones|mesh-ancestor
57013169|NCT05649605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013170|NCT05649605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013171|NCT05649605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57013172|NCT05649605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013173|NCT05649605|Anabolic Agents|anabolic agents|mesh-ancestor
57013174|NCT05640479|Pregabalin|pregabalin|mesh-list
57013175|NCT05640479|Dexmedetomidine|dexmedetomidine|mesh-list
57013176|NCT05640479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57013177|NCT05640479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013178|NCT05640479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013179|NCT05640479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57013181|NCT05640479|Sensory System Agents|sensory system agents|mesh-ancestor
57013182|NCT05640479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013183|NCT05640479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57013184|NCT05640479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57013185|NCT05640479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57013186|NCT05640479|Adrenergic Agents|adrenergic agents|mesh-ancestor
57013187|NCT05640479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013188|NCT05640479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013189|NCT05640479|Anticonvulsants|anticonvulsants|mesh-ancestor
57013190|NCT05640479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57013191|NCT05640479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57013192|NCT05640479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57013193|NCT05640479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57013194|NCT05640479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57013195|NCT05640479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57013196|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
57013197|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57013198|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57013199|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013200|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
57013201|NCT05309525|Coagulants|coagulants|mesh-ancestor
57013202|NCT04905563|Acetaminophen|acetaminophen|mesh-list
57013203|NCT04905563|Ibuprofen|ibuprofen|mesh-list
57013204|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
57013205|NCT04905563|Hydrocodone|hydrocodone|mesh-list
57013206|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57013207|NCT04905563|Analgesics|analgesics|mesh-ancestor
57013208|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
57013209|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013210|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013211|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
57013212|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57013213|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57013214|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57013215|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57013216|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013217|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013218|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57013219|NCT04905563|Narcotics|narcotics|mesh-ancestor
57013220|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013221|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
57013222|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
57013223|NCT05253131|Durvalumab|durvalumab|mesh-list
57013224|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013225|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013226|NCT02810418|Paclitaxel|paclitaxel|mesh-list
57013227|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57013228|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013229|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
57013230|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
57013231|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
57013232|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013233|NCT02959541|Leucovorin|leucovorin|mesh-list
57013234|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
57013235|NCT02959541|Antidotes|antidotes|mesh-ancestor
57013236|NCT02959541|Protective Agents|protective agents|mesh-ancestor
57013237|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013238|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
57013239|NCT02959541|Vitamins|vitamins|mesh-ancestor
57013240|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
57013241|NCT02675465|Miglustat|miglustat|mesh-list
57013242|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013243|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013244|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57013245|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57013246|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
57013247|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013248|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57013249|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57013250|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013251|NCT05705700|Dutasteride|dutasteride|mesh-list
57013252|NCT05705700|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57013253|NCT05705700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57013254|NCT05705700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013255|NCT05705700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013256|NCT05705700|Hormone Antagonists|hormone antagonists|mesh-ancestor
57013257|NCT05705700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013258|NCT05705700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013260|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013261|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013262|NCT03562416|Nintedanib|nintedanib|mesh-list
57013263|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013264|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57013265|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013266|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013267|NCT05614739|Pembrolizumab|pembrolizumab|mesh-list
57013268|NCT05614739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013269|NCT05614739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013270|NCT02260050|Epinastine|epinastine|mesh-list
57013271|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57013272|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
57013273|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
57013274|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013275|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013276|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013277|NCT05211323|Gemcitabine|gemcitabine|mesh-list
57013278|NCT05211323|Bevacizumab|bevacizumab|mesh-list
57013279|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57013280|NCT05211323|Cisplatin|cisplatin|mesh-list
57013281|NCT05211323|Atezolizumab|atezolizumab|mesh-list
57013282|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
57013283|NCT05211323|Antibodies|antibodies|mesh-list
57013284|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
57013285|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57013286|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
57013287|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013288|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57013289|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57013290|NCT05211323|Growth Substances|growth substances|mesh-ancestor
57013291|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013292|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
57013293|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
57013294|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57013295|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
57013296|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013297|NCT05211323|Antiviral Agents|antiviral agents|mesh-ancestor
57013298|NCT05211323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013299|NCT05211323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013300|NCT05211323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013301|NCT02036736|Propofol|propofol|mesh-list
57013302|NCT02036736|Anesthetics|anesthetics|mesh-list
57013303|NCT02036736|Desflurane|desflurane|mesh-list
57013304|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57013305|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013306|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013307|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57013308|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
57013309|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57013310|NCT05693688|Atosiban|atosiban|mesh-list
57013311|NCT05693688|Hormone Antagonists|hormone antagonists|mesh-ancestor
57013312|NCT05693688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013313|NCT05693688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013314|NCT05693688|Tocolytic Agents|tocolytic agents|mesh-ancestor
57013315|NCT05693688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57013316|NCT02047422|Metolazone|metolazone|mesh-list
57013317|NCT02047422|Furosemide|furosemide|mesh-list
57013318|NCT02047422|Spironolactone|spironolactone|mesh-list
57013319|NCT02047422|Diuretics|diuretics|mesh-ancestor
57013320|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
57013321|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013322|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57013323|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57013324|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013325|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57013326|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
57013327|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695232|NCT00731679|Rifaximin|rifaximin|mesh-list
57013328|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57013330|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57013331|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
57013332|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57013333|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57013334|NCT02048358|Prednisolone|prednisolone|mesh-list
57013335|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
57013336|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57013337|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
57013338|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57013339|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
57013340|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
57013341|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013342|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013343|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57013344|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
57013345|NCT02048358|Hormones|hormones|mesh-ancestor
57013346|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013347|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57013348|NCT02048358|Protective Agents|protective agents|mesh-ancestor
57013349|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57013350|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013351|NCT02928029|Dexamethasone|dexamethasone|mesh-list
57013352|NCT02928029|Bortezomib|bortezomib|mesh-list
57013353|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57013354|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57013355|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
57013356|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
57013357|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013358|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013359|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57013360|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
57013361|NCT02928029|Hormones|hormones|mesh-ancestor
57013362|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013363|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57013364|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013365|NCT02050074|Metformin|metformin|mesh-list
57013366|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
57013367|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57013368|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013369|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57013370|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57013371|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
57013372|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013373|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57013374|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
57013375|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57013376|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
57013377|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
57013378|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013379|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013380|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57013381|NCT02050152|Analgesics|analgesics|mesh-ancestor
57013382|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
57013383|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013384|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
57013385|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
57013386|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57013387|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57013388|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
57013389|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013390|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
57013391|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57013392|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013393|NCT04740905|Aflibercept|aflibercept|mesh-list
57013394|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57013395|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57013396|NCT04740905|Growth Substances|growth substances|mesh-ancestor
57013397|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013398|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
57013399|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013400|NCT05176223|Edetic Acid|edetic acid|mesh-list
57013401|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57013402|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
57013403|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
57013404|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013406|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57013407|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57013408|NCT04717193|Epinephrine|epinephrine|mesh-list
57013409|NCT04717193|Racepinephrine|racepinephrine|mesh-list
57013410|NCT04717193|Bupivacaine|bupivacaine|mesh-list
57013411|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
57013412|NCT04717193|Anesthetics|anesthetics|mesh-list
57013413|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
57013414|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013415|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013416|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
57013417|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013418|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57013419|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57013420|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
57013421|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013422|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013423|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57013424|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57013425|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
57013426|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57013427|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
57013428|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
57013429|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
57013430|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57013431|NCT05172245|Cisplatin|cisplatin|mesh-list
57013432|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013433|NCT05212025|Gemcitabine|gemcitabine|mesh-list
57013434|NCT05212025|Adavosertib|adavosertib|mesh-list
57013435|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57013436|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
57013437|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013438|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013439|NCT05212025|Antiviral Agents|antiviral agents|mesh-ancestor
57013440|NCT05212025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013441|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013442|NCT05212025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013443|NCT05212025|Immunologic Factors|immunologic factors|mesh-ancestor
57013444|NCT05212025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013445|NCT02051868|Paclitaxel|paclitaxel|mesh-list
57013446|NCT02051868|Carboplatin|carboplatin|mesh-list
57013447|NCT02051868|Fluorouracil|fluorouracil|mesh-list
57013448|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57013449|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013450|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
57013451|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
57013452|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
57013453|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013454|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
57013455|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57013456|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013457|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
57013458|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013459|NCT04696757|Capecitabine|capecitabine|mesh-list
57013460|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57013461|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
57013462|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013463|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013464|NCT02049294|Omalizumab|omalizumab|mesh-list
57013465|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57013466|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57013467|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
57013468|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
57013469|NCT02051946|Diuretics|diuretics|mesh-ancestor
57013470|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
57013471|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013472|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013473|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013474|NCT02049606|Nabumetone|nabumetone|mesh-list
57013475|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57013476|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57013477|NCT02049606|Analgesics|analgesics|mesh-ancestor
57013478|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
57013479|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013480|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013481|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57013482|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57013483|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57013484|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57013485|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013486|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013488|NCT05071703|Etoposide|etoposide|mesh-list
57013489|NCT05071703|Topotecan|topotecan|mesh-list
57013490|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013491|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57013492|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57013493|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57013494|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013495|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013496|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57013497|NCT02037516|Neostigmine|neostigmine|mesh-list
57013498|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57013499|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013500|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013501|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
57013502|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013503|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013504|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57013505|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
57013506|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013507|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
57013508|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
57013509|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57013510|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57013511|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57013512|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57013513|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013514|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
57013515|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013516|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013517|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57013518|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013519|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57013520|NCT02037672|Metformin|metformin|mesh-list
57013521|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57013522|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013523|NCT02049762|Aspirin|aspirin|mesh-list
57013524|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57013525|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57013526|NCT02049762|Analgesics|analgesics|mesh-ancestor
57013527|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
57013528|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013529|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013530|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57013531|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57013532|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57013533|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57013534|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013535|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57013536|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57013537|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013538|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
57013539|NCT03561558|Ibuprofen|ibuprofen|mesh-list
57013540|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57013541|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57013542|NCT03561558|Analgesics|analgesics|mesh-ancestor
57013543|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
57013544|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013545|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013546|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57013547|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57013548|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57013549|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013550|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013551|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
57013552|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013553|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013554|NCT04639115|Ozanimod|ozanimod|mesh-list
57013555|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57013556|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013557|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013558|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
57013559|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013560|NCT04260659|Lidocaine|lidocaine|mesh-list
57013561|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
57013562|NCT04260659|Fentanyl|fentanyl|mesh-list
57013563|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
57013564|NCT04260659|Ketamine|ketamine|mesh-list
57013565|NCT04260659|Remifentanil|remifentanil|mesh-list
57013566|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
57013567|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
57013568|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013569|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013570|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
57013571|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013572|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57013573|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57013574|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57013575|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57013576|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013577|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57013578|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57013579|NCT04260659|Analgesics|analgesics|mesh-ancestor
57013580|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57013581|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57013582|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57013583|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
57013584|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013585|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57013586|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57013587|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
57013588|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57013589|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57013590|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57013591|NCT04260659|Narcotics|narcotics|mesh-ancestor
57013592|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57013593|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
57013594|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57013595|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57013596|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
57013597|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57013598|NCT04564547|Islatravir|islatravir|mesh-list
57013599|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
57013600|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013601|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013602|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013603|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57013604|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57013605|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57013606|NCT05102669|Antibodies|antibodies|mesh-list
57013607|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
57013608|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013609|NCT05068661|Fentanyl|fentanyl|mesh-list
57013610|NCT05068661|Bupivacaine|bupivacaine|mesh-list
57013611|NCT05068661|Ropivacaine|ropivacaine|mesh-list
57013612|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57013613|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
57013614|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
57013615|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013616|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013617|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
57013618|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013619|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57013620|NCT05068661|Narcotics|narcotics|mesh-ancestor
57013621|NCT05068661|Analgesics|analgesics|mesh-ancestor
57013622|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57013623|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57013624|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
57013625|NCT04455815|Gabexate|gabexate|mesh-list
57013626|NCT04455815|Camostat|camostat|mesh-list
57013627|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
56695524|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57013628|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013629|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013630|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57013631|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57013632|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
57013633|NCT04197713|Olaparib|olaparib|mesh-list
57013634|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57013635|NCT04197713|Adavosertib|adavosertib|mesh-list
57013636|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013637|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013638|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013639|NCT04303403|Trametinib|trametinib|mesh-list
57013640|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013641|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57013642|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013643|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013644|NCT04148495|Acetaminophen|acetaminophen|mesh-list
57013645|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57013646|NCT04148495|Analgesics|analgesics|mesh-ancestor
57013647|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
57013648|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013649|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013650|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
57013651|NCT05060003|Atezolizumab|atezolizumab|mesh-list
57013652|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013653|NCT04203641|Doxorubicin|doxorubicin|mesh-list
57013654|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57013655|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013656|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57013657|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57013658|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013659|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013660|NCT05051189|Fentanyl|fentanyl|mesh-list
57013661|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57013662|NCT05051189|Narcotics|narcotics|mesh-ancestor
57013663|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013664|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013665|NCT05051189|Analgesics|analgesics|mesh-ancestor
57013666|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
57013667|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013668|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57013669|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57013670|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
57013671|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
57013672|NCT04521647|Nicotine|nicotine|mesh-list
57013673|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57013674|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
57013675|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013676|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013677|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57013678|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57013679|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
57013680|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013681|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013682|NCT04172597|Loperamide|loperamide|mesh-list
57013683|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
57013684|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57013685|NCT04047641|Cytarabine|cytarabine|mesh-list
57013686|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
57013687|NCT04047641|Idarubicin|idarubicin|mesh-list
57013688|NCT04047641|Cladribine|cladribine|mesh-list
57013689|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57013690|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
57013691|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013692|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013693|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
57013694|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013695|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013696|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
57013697|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013698|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57013699|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57013700|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57013701|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013702|NCT00446225|Gemcitabine|gemcitabine|mesh-list
57013703|NCT00446225|Carboplatin|carboplatin|mesh-list
57013704|NCT00446225|Docetaxel|docetaxel|mesh-list
57013705|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57013706|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013707|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
57013708|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
57013709|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
57013710|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013711|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57013712|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013713|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57013714|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
57013715|NCT00446225|Antiviral Agents|antiviral agents|mesh-ancestor
57013716|NCT00446225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013717|NCT00446225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013718|NCT00446225|Immunologic Factors|immunologic factors|mesh-ancestor
57013719|NCT00446225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013720|NCT03080935|Evolocumab|evolocumab|mesh-list
57013721|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57013722|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57013723|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
57013724|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013725|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57013726|NCT04479449|Otaplimastat|otaplimastat|mesh-list
57013727|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57013728|NCT04479449|Protective Agents|protective agents|mesh-ancestor
57013729|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013730|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
57013731|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013732|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013733|NCT03148795|Talazoparib|talazoparib|mesh-list
57013734|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57013735|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013736|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013737|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013738|NCT04986605|Methoxsalen|methoxsalen|mesh-list
57013739|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57013740|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
57013741|NCT04390399|Leucovorin|leucovorin|mesh-list
57013742|NCT04390399|Gemcitabine|gemcitabine|mesh-list
57013743|NCT04390399|Paclitaxel|paclitaxel|mesh-list
57013744|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
57013745|NCT04390399|Fluorouracil|fluorouracil|mesh-list
57013746|NCT04390399|Irinotecan|irinotecan|mesh-list
57013747|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57013748|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013749|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
57013750|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
57013751|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
57013752|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013753|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013754|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
57013755|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013756|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57013757|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57013758|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
57013759|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57013760|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57013761|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
57013762|NCT04390399|Antiviral Agents|antiviral agents|mesh-ancestor
57013763|NCT04390399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013764|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013765|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57013766|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57013767|NCT04390399|Antidotes|antidotes|mesh-ancestor
57013768|NCT04390399|Protective Agents|protective agents|mesh-ancestor
57013769|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
57013770|NCT04390399|Vitamins|vitamins|mesh-ancestor
57013771|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
57013772|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
57013773|NCT01383655|Analgesics|analgesics|mesh-ancestor
57013774|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
57013775|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57013776|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013777|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
57013778|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57013779|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57013780|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
57013781|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57013782|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57013783|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013784|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57013785|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
57013786|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57013787|NCT01568281|Anastrozole|anastrozole|mesh-list
57013788|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57013789|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013790|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57013791|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57013792|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013793|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013794|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57013795|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
57013796|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013797|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013798|NCT03949855|Rituximab|rituximab|mesh-list
57013799|NCT03949855|Belimumab|belimumab|mesh-list
57013800|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013801|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013802|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
57013803|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013804|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57013805|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013806|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
57013807|NCT02921789|Prednisone|prednisone|mesh-list
57013808|NCT02921789|Tacrolimus|tacrolimus|mesh-list
57013809|NCT02921789|Basiliximab|basiliximab|mesh-list
57013810|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591169|NCT02754687|Hormones|hormones|mesh-ancestor
57013811|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
57013812|NCT02921789|Hormones|hormones|mesh-ancestor
57013813|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013814|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013815|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57013816|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013817|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013818|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
57013819|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57013820|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013821|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013822|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57013823|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57013824|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
57013825|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57013826|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013827|NCT02564900|Camptothecin|camptothecin|mesh-list
57013828|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
57013829|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57013830|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013831|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57013832|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57013833|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013834|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013835|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
57013836|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013837|NCT01568333|Decitabine|decitabine|mesh-list
57013838|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57013839|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
57013840|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013841|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013842|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013843|NCT03437005|Ketoconazole|ketoconazole|mesh-list
57013844|NCT03437005|Desonide|desonide|mesh-list
57013845|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
57013846|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013847|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57013848|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57013849|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013850|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013851|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57013852|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
57013853|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013854|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695751|NCT05757167|Lumefantrine|lumefantrine|mesh-list
57013855|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57013856|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57013857|NCT03943823|Estrogens|estrogens|mesh-list
57013858|NCT03943823|Hormones|hormones|mesh-ancestor
57013859|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57013860|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013861|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57013862|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013863|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57013864|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013865|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013866|NCT02484248|Ketotifen|ketotifen|mesh-list
57013867|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
57013868|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
57013869|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57013870|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
57013871|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
57013872|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013873|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013874|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013875|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57013876|NCT02419742|Paclitaxel|paclitaxel|mesh-list
57013877|NCT02419742|Docetaxel|docetaxel|mesh-list
57013878|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
57013879|NCT02419742|Carboplatin|carboplatin|mesh-list
57013880|NCT02419742|Doxorubicin|doxorubicin|mesh-list
57013881|NCT02419742|Trastuzumab|trastuzumab|mesh-list
57013882|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57013883|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013884|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
57013885|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
57013886|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
57013887|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013888|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57013889|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
57013890|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013891|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57013892|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57013893|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
57013894|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57013895|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57013896|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57013897|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57013898|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013899|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013900|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
57013901|NCT02409290|Levofloxacin|levofloxacin|mesh-list
57013902|NCT02409290|Isoniazid|isoniazid|mesh-list
57013903|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
57013904|NCT02409290|Ethambutol|ethambutol|mesh-list
57013905|NCT02409290|Bedaquiline|bedaquiline|mesh-list
57013906|NCT02409290|Clofazimine|clofazimine|mesh-list
57013907|NCT02409290|Kanamycin|kanamycin|mesh-list
57013908|NCT02409290|Prothionamide|prothionamide|mesh-list
57013909|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57013910|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57013911|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57013912|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57013913|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013914|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013915|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013916|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57013917|NCT02409290|Renal Agents|renal agents|mesh-ancestor
57013918|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57013919|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57013920|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
57013921|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57013922|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57013923|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
57013924|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57013925|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57013926|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
57013927|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57013928|NCT02898077|Paclitaxel|paclitaxel|mesh-list
56695835|NCT00591149|Docetaxel|docetaxel|mesh-list
57013929|NCT02898077|Ramucirumab|ramucirumab|mesh-list
57013930|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57013931|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013932|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
57013933|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
57013934|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
57013935|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013936|NCT02145884|Timolol|timolol|mesh-list
57013937|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013938|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57013939|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57013940|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
57013941|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013942|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013943|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57013944|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57013945|NCT03544814|Cisplatin|cisplatin|mesh-list
57013946|NCT03544814|Pemetrexed|pemetrexed|mesh-list
57013947|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013948|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013949|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013950|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57013951|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57013952|NCT03097133|Esketamine|esketamine|mesh-list
57013953|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
57013954|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57013955|NCT02148380|Carboplatin|carboplatin|mesh-list
57013956|NCT02148380|Pemetrexed|pemetrexed|mesh-list
57013957|NCT02148380|Gefitinib|gefitinib|mesh-list
57013958|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013959|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013960|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013961|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57013962|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57013963|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57013964|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57013965|NCT02146118|Silybin|silybin|mesh-list
57013966|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013967|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57013968|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57013969|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013970|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57013971|NCT02146118|Protective Agents|protective agents|mesh-ancestor
57013972|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013973|NCT02142140|Methylphenidate|methylphenidate|mesh-list
57013974|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
57013975|NCT02142140|Adderall|adderall|mesh-list
57013976|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
57013977|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
57013978|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57013979|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013980|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57013981|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57013982|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57013983|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013984|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
57013985|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57013986|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57013987|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
57013988|NCT02142218|Nivolumab|nivolumab|mesh-list
57013989|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57013990|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57013991|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57013992|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57013993|NCT02142296|Aflibercept|aflibercept|mesh-list
57013994|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57013995|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57013996|NCT02142296|Growth Substances|growth substances|mesh-ancestor
57013997|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57013998|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
57013999|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014000|NCT02142530|Belinostat|belinostat|mesh-list
57014001|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014002|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57014003|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695910|NCT04111328|Sufentanil|sufentanil|mesh-list
57014004|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014005|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
57014006|NCT01383343|Leucovorin|leucovorin|mesh-list
57014007|NCT01383343|Folic Acid|folic acid|mesh-list
57014008|NCT01383343|Bevacizumab|bevacizumab|mesh-list
57014009|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57014010|NCT01383343|Fluorouracil|fluorouracil|mesh-list
57014011|NCT01383343|Irinotecan|irinotecan|mesh-list
57014012|NCT01383343|Sorafenib|sorafenib|mesh-list
57014013|NCT01383343|Camptothecin|camptothecin|mesh-list
57014014|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
57014015|NCT01383343|Antibodies|antibodies|mesh-list
57014016|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
57014017|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57014018|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
57014019|NCT01383343|Calcium|calcium|mesh-list
57014020|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
57014021|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014022|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57014023|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57014024|NCT01383343|Growth Substances|growth substances|mesh-ancestor
57014025|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014026|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
57014027|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
57014028|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57014029|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57014030|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
57014031|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014032|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57014033|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014034|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57014035|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57014036|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014037|NCT01383343|Antidotes|antidotes|mesh-ancestor
57014038|NCT01383343|Protective Agents|protective agents|mesh-ancestor
57014039|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
57014040|NCT01383343|Vitamins|vitamins|mesh-ancestor
57014041|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
57014042|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57014043|NCT01383343|Hematinics|hematinics|mesh-ancestor
57014044|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57014045|NCT03631147|Rifaximin|rifaximin|mesh-list
57014046|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57014047|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014048|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57014049|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
57014050|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57014051|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57014052|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014053|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57014054|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014055|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57014056|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
57014057|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
57014058|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014059|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014060|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014061|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57014062|NCT05344495|Midazolam|midazolam|mesh-list
57014063|NCT05344495|Bupivacaine|bupivacaine|mesh-list
57014064|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
57014065|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
57014066|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014067|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014068|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
57014069|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014070|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57014071|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57014072|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57014073|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57014074|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57014075|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57014076|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
57014077|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
57014078|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
57014079|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014080|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014081|NCT01593241|Carboplatin|carboplatin|mesh-list
57014082|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014083|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57014084|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57014085|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014086|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
57014087|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57014088|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
57014089|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014090|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
57014091|NCT02782676|Protective Agents|protective agents|mesh-ancestor
57014092|NCT03033095|Etanercept|etanercept|mesh-list
57014093|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57014094|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57014095|NCT03033095|Analgesics|analgesics|mesh-ancestor
57014096|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
57014097|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014098|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014099|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014100|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57014101|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57014102|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014103|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
57014104|NCT02142920|Gedatolisib|gedatolisib|mesh-list
57014105|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57014106|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014107|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014108|NCT05359835|Edetic Acid|edetic acid|mesh-list
57014109|NCT05359835|Calcium|calcium|mesh-list
57014110|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
57014111|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57014112|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014113|NCT05359835|Antidotes|antidotes|mesh-ancestor
57014114|NCT05359835|Protective Agents|protective agents|mesh-ancestor
57014115|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
57014116|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
57014117|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014118|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57014119|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
57014120|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57014121|NCT01383785|Abciximab|abciximab|mesh-list
57014122|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
57014123|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57014124|NCT02923739|Paclitaxel|paclitaxel|mesh-list
57014125|NCT02923739|Bevacizumab|bevacizumab|mesh-list
57014126|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57014127|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57014128|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
57014129|NCT02923739|Antibodies|antibodies|mesh-list
57014130|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
57014131|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57014132|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
57014133|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57014134|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014135|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
57014136|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
57014137|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
57014138|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014139|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57014140|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57014141|NCT02923739|Growth Substances|growth substances|mesh-ancestor
57014142|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014143|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
57014144|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
57014145|NCT02146976|Propofol|propofol|mesh-list
57014146|NCT02146976|Sevoflurane|sevoflurane|mesh-list
57014147|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57014148|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014149|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014150|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57014151|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
57014152|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
57014153|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57014154|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57014155|NCT02147054|Rocuronium|rocuronium|mesh-list
57014156|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57014157|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57014159|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014160|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014161|NCT00107978|Vancomycin|vancomycin|mesh-list
57014162|NCT00107978|Telavancin|telavancin|mesh-list
57014163|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57014164|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014165|NCT02781818|Triamcinolone|triamcinolone|mesh-list
57014166|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57014167|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57014168|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57014169|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014170|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
57014171|NCT02781818|Hormones|hormones|mesh-ancestor
57014172|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014173|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014174|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014175|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
57014176|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014177|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014178|NCT02149628|Propofol|propofol|mesh-list
57014179|NCT02149628|Desflurane|desflurane|mesh-list
57014180|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57014181|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014182|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014183|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57014184|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
57014185|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
57014186|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57014187|NCT02927873|Vaccines|vaccines|mesh-list
57014188|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
57014189|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014190|NCT02460419|Capecitabine|capecitabine|mesh-list
57014191|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57014192|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
57014193|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014194|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014195|NCT03600701|Atezolizumab|atezolizumab|mesh-list
57014196|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57014197|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014198|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
57014199|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014200|NCT01568411|Itraconazole|itraconazole|mesh-list
57014201|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
57014202|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014203|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57014204|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57014205|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014206|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014207|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57014208|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
57014209|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014210|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014211|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57014212|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
57014213|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
57014214|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
57014215|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014216|NCT03464045|Empagliflozin|empagliflozin|mesh-list
57014217|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57014218|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57014219|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014220|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57014221|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014222|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
57014223|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014224|NCT03631901|Diazepam|diazepam|mesh-list
57014225|NCT03631901|Melatonin|melatonin|mesh-list
57014226|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
57014227|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014228|NCT03631901|Protective Agents|protective agents|mesh-ancestor
57014229|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696130|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
57014230|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014231|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57014232|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
57014233|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
57014234|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
57014235|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014236|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57014237|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57014238|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57014239|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57014240|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57014241|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57014242|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57014243|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57014244|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
57014245|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
57014246|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
57014247|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
57014248|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014249|NCT01383395|Cilostazol|cilostazol|mesh-list
57014250|NCT01383395|Simvastatin|simvastatin|mesh-list
57014251|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57014252|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57014253|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
57014254|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014255|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57014256|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57014257|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014258|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57014259|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
57014260|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014261|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014262|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57014263|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
57014264|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57014265|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57014266|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57014267|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
57014268|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57014269|NCT01383395|Protective Agents|protective agents|mesh-ancestor
57014270|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57014271|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57014272|NCT05084651|Itraconazole|itraconazole|mesh-list
57014273|NCT05084651|Lumefantrine|lumefantrine|mesh-list
57014274|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
57014275|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014276|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57014277|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57014278|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014279|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014280|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57014281|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
57014282|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014283|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014284|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57014285|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
57014286|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57014287|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57014288|NCT02781584|Firsocostat|firsocostat|mesh-list
57014289|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014290|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014291|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
57014292|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57014293|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
57014294|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014295|NCT02147678|Remifentanil|remifentanil|mesh-list
57014296|NCT02147678|Propofol|propofol|mesh-list
57014297|NCT02147678|Etomidate|etomidate|mesh-list
57014298|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
57014299|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014300|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014301|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57014302|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57014303|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
57014304|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56696201|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
57014306|NCT02147678|Analgesics|analgesics|mesh-ancestor
57014307|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
57014308|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014309|NCT02151344|Vaccines|vaccines|mesh-list
57014310|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
57014311|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014312|NCT02155634|Lenalidomide|lenalidomide|mesh-list
57014313|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
56896517|NCT02404688|Ethanol|ethanol|mesh-list
57014314|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014315|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57014316|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57014317|NCT02155634|Growth Substances|growth substances|mesh-ancestor
57014318|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
57014319|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014320|NCT02151812|Paclitaxel|paclitaxel|mesh-list
57014321|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57014322|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57014323|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014324|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
57014325|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
57014326|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
57014327|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014328|NCT02151968|Anesthetics|anesthetics|mesh-list
57014329|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
57014330|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014331|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014332|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
57014333|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014334|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57014335|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
57014336|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57014337|NCT02255084|Menthol|menthol|mesh-list
57014338|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
57014339|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
57014340|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57014341|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57014342|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
57014343|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014344|NCT02255162|Cytarabine|cytarabine|mesh-list
57014345|NCT02255162|Lenalidomide|lenalidomide|mesh-list
57014346|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57014347|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
57014348|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014349|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014350|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
57014351|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014352|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014353|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
57014354|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014355|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57014356|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57014357|NCT02255162|Growth Substances|growth substances|mesh-ancestor
57014358|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
57014359|NCT02152358|Acyclovir|acyclovir|mesh-list
57014360|NCT02152358|Ganciclovir|ganciclovir|mesh-list
57014361|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
57014362|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
57014363|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014364|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57014365|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014366|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014367|NCT02152514|Sufentanil|sufentanil|mesh-list
57014368|NCT02152514|Morphine|morphine|mesh-list
57014369|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57014370|NCT02152514|Narcotics|narcotics|mesh-ancestor
57014371|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014372|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014373|NCT02152514|Analgesics|analgesics|mesh-ancestor
57014374|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
57014375|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014376|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57014377|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57014378|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
57014379|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
57014380|NCT02261090|Pramipexole|pramipexole|mesh-list
57014381|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
57014382|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014383|NCT02261090|Protective Agents|protective agents|mesh-ancestor
57014384|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014385|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57014386|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57014387|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
57014388|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
57014389|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014390|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
57014391|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57014392|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014393|NCT01307423|Thalidomide|thalidomide|mesh-list
57014394|NCT01307423|Apremilast|apremilast|mesh-list
57014395|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57014396|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57014397|NCT01307423|Analgesics|analgesics|mesh-ancestor
57014398|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
57014399|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014400|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014401|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014402|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57014403|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57014404|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57014405|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014406|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014407|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014408|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
57014409|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
57014410|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57014411|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014412|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57014413|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57014414|NCT01307423|Growth Substances|growth substances|mesh-ancestor
57014415|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
57014416|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014417|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
57014418|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57014419|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57014420|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57014421|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57014422|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014423|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
57014424|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014425|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014426|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57014427|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014428|NCT02156336|Ranolazine|ranolazine|mesh-list
57014429|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57014430|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57014431|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014432|NCT03542240|Curcumin|curcumin|mesh-list
57014433|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57014434|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57014435|NCT03542240|Analgesics|analgesics|mesh-ancestor
57014436|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
57014437|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014438|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014439|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014440|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57014441|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014442|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014443|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014444|NCT00911183|Prednisone|prednisone|mesh-list
57014445|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
57014446|NCT00911183|Rituximab|rituximab|mesh-list
57014447|NCT00911183|Doxorubicin|doxorubicin|mesh-list
57014448|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57014449|NCT00911183|Vincristine|vincristine|mesh-list
57014450|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014451|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
57014452|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014453|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57014454|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56696360|NCT00734994|Mitomycins|mitomycins|mesh-list
57014455|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
57014456|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014458|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57014459|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57014460|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57014461|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57014462|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57014463|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014464|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014465|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
57014466|NCT00911183|Hormones|hormones|mesh-ancestor
57014467|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014468|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57014469|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57014470|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
57014471|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
57014472|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
57014473|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
57014474|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57014475|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014476|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
57014477|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57014478|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014479|NCT05420441|Chitosan|chitosan|mesh-list
57014480|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57014481|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57014482|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
57014483|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014484|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57014485|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
57014486|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
57014487|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
57014488|NCT05420441|Coagulants|coagulants|mesh-ancestor
57014489|NCT05598593|Cytarabine|cytarabine|mesh-list
57014490|NCT05598593|Fludarabine|fludarabine|mesh-list
57014491|NCT05598593|Busulfan|busulfan|mesh-list
57014492|NCT05598593|Thiotepa|thiotepa|mesh-list
57014493|NCT05598593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014494|NCT05598593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57014495|NCT05598593|Antimetabolites|antimetabolites|mesh-ancestor
57014496|NCT05598593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014497|NCT05598593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014498|NCT05598593|Immunologic Factors|immunologic factors|mesh-ancestor
57014499|NCT05598593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014500|NCT05598593|Antiviral Agents|antiviral agents|mesh-ancestor
57014501|NCT05598593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014502|NCT05598593|Alkylating Agents|alkylating agents|mesh-ancestor
57014503|NCT05598593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57014504|NCT05598593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57014505|NCT05337449|Fluorides|fluorides|mesh-list
57014506|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
57014507|NCT05337449|Protective Agents|protective agents|mesh-ancestor
57014508|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014509|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
57014510|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
57014511|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57014512|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57014513|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014514|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
57014515|NCT02150720|Coagulants|coagulants|mesh-ancestor
57014516|NCT02153060|Dexamethasone|dexamethasone|mesh-list
57014517|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
57014518|NCT02153060|BB 1101|bb 1101|mesh-list
57014519|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014520|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
57014521|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
57014522|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014523|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014524|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57014525|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
57014526|NCT02153060|Hormones|hormones|mesh-ancestor
57014527|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014528|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57014529|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014530|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
57014531|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014532|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014534|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
57014535|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
57014536|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014537|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
57014538|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014539|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
57014540|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57014541|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014542|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
57014543|NCT02156726|Fludarabine|fludarabine|mesh-list
57014544|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014545|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
57014546|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014547|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57014548|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57014549|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
57014550|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014551|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014552|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57014553|NCT02153450|Metformin|metformin|mesh-list
57014554|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57014555|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014556|NCT05598281|Digoxin|digoxin|mesh-list
57014557|NCT05598281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57014558|NCT05598281|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57014559|NCT05598281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014560|NCT05598281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014561|NCT05598281|Protective Agents|protective agents|mesh-ancestor
57014562|NCT05598281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014563|NCT03092375|Ribavirin|ribavirin|mesh-list
57014564|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
57014565|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014566|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
57014567|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014568|NCT01995513|Prednisone|prednisone|mesh-list
57014569|NCT01995513|Prednisolone|prednisolone|mesh-list
57014570|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
57014571|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014572|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
57014573|NCT01995513|Hormones|hormones|mesh-ancestor
57014574|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014575|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014576|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57014577|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014578|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57014579|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014580|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014581|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
57014582|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57014583|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
57014584|NCT04678401|Thiotepa|thiotepa|mesh-list
57014585|NCT04678401|Fludarabine|fludarabine|mesh-list
57014586|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014587|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
57014588|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014589|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57014590|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57014591|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
57014592|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014593|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014594|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57014595|NCT04633239|Olaparib|olaparib|mesh-list
57014596|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57014597|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014598|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014599|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014600|NCT03180359|Vaccines|vaccines|mesh-list
57014601|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
57014602|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014603|NCT03687957|Temozolomide|temozolomide|mesh-list
57014604|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57014605|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
57014606|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014607|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014609|NCT05199285|Ipilimumab|ipilimumab|mesh-list
57014610|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57014611|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014612|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57014613|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014614|NCT01304511|Ganirelix|ganirelix|mesh-list
57014615|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
57014616|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014617|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014618|NCT04808973|Lamivudine|lamivudine|mesh-list
57014619|NCT04808973|Dolutegravir|dolutegravir|mesh-list
57014620|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57014621|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57014622|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014623|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014624|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
57014625|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014626|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57014627|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57014628|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57014629|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57014630|NCT00103610|Plerixafor|plerixafor|mesh-list
57014631|NCT00103610|Lenograstim|lenograstim|mesh-list
57014632|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57014633|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
57014634|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014635|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57014636|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57014637|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
57014638|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014639|NCT04871321|Gemcitabine|gemcitabine|mesh-list
57014640|NCT04871321|Paclitaxel|paclitaxel|mesh-list
57014641|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57014642|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014643|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
57014644|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
57014645|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
57014646|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014647|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57014648|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
57014649|NCT04871321|Antiviral Agents|antiviral agents|mesh-ancestor
57014650|NCT04871321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014651|NCT04871321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014652|NCT04871321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014653|NCT04871321|Immunologic Factors|immunologic factors|mesh-ancestor
57014654|NCT04871321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014655|NCT02156960|Denosumab|denosumab|mesh-list
57014656|NCT02156960|Teriparatide|teriparatide|mesh-list
57014657|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57014658|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014659|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57014660|NCT02153606|Glycerol|glycerol|mesh-list
57014661|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57014662|NCT02153606|Protective Agents|protective agents|mesh-ancestor
57014663|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014664|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
57014665|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57014666|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57014667|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57014668|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014669|NCT04687631|Bevacizumab|bevacizumab|mesh-list
57014670|NCT04687631|Cetuximab|cetuximab|mesh-list
57014671|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57014672|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014673|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57014674|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57014675|NCT04687631|Growth Substances|growth substances|mesh-ancestor
57014676|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014677|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
57014678|NCT04833023|Olanzapine|olanzapine|mesh-list
57014679|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
57014680|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
56696572|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
57014681|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014682|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014683|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57014684|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57014685|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57014686|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014687|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57014688|NCT04833023|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57014689|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57014690|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57014691|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014692|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014693|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
57014694|NCT03091439|Dalbavancin|dalbavancin|mesh-list
57014695|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57014696|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014697|NCT03631823|Temozolomide|temozolomide|mesh-list
57014698|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57014699|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
57014700|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014701|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014702|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
57014703|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57014704|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
57014705|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57014706|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
57014707|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014708|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014709|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
57014710|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
57014711|NCT02154074|Isoflurane|isoflurane|mesh-list
57014712|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
57014713|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014714|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014715|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57014716|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57014717|NCT02154074|Analgesics|analgesics|mesh-ancestor
57014718|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
57014719|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014720|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57014721|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57014722|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57014723|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
57014724|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014725|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014726|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57014727|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
57014728|NCT05593055|Eplerenone|eplerenone|mesh-list
57014729|NCT05593055|Chlorthalidone|chlorthalidone|mesh-list
57014730|NCT05593055|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57014731|NCT05593055|Hormone Antagonists|hormone antagonists|mesh-ancestor
57014732|NCT05593055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014733|NCT05593055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014734|NCT05593055|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57014735|NCT05593055|Diuretics|diuretics|mesh-ancestor
57014736|NCT05593055|Natriuretic Agents|natriuretic agents|mesh-ancestor
57014737|NCT05593055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57014738|NCT05593055|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57014739|NCT05593055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57014740|NCT05593055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014741|NCT05460455|Antibodies|antibodies|mesh-list
57014742|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57014743|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
57014744|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014745|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57014746|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
57014747|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014748|NCT01382147|Daunorubicin|daunorubicin|mesh-list
57014749|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
57014750|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57014751|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014752|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57014753|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57014754|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014755|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014756|NCT01382147|Analgesics|analgesics|mesh-ancestor
57014757|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
57014758|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014759|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014760|NCT01381835|Simeprevir|simeprevir|mesh-list
57014761|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
57014762|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014763|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
57014764|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014765|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014766|NCT04429685|Ketamine|ketamine|mesh-list
57014767|NCT04429685|Analgesics|analgesics|mesh-ancestor
57014768|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
57014769|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014770|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014771|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57014772|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57014773|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
57014774|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
57014775|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014776|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57014777|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57014778|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014779|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014780|NCT01384279|Metformin|metformin|mesh-list
57014781|NCT01384279|Topiramate|topiramate|mesh-list
57014782|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57014783|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014784|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
57014785|NCT01381601|Bevacizumab|bevacizumab|mesh-list
57014786|NCT01381601|Sunitinib|sunitinib|mesh-list
57014787|NCT01381601|Sorafenib|sorafenib|mesh-list
57014788|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57014789|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014790|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57014791|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57014792|NCT01381601|Growth Substances|growth substances|mesh-ancestor
57014793|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014794|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
57014795|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57014796|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014797|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014798|NCT02823353|Fenofibrate|fenofibrate|mesh-list
57014799|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57014800|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
57014801|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014802|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57014803|NCT04509193|Warfarin|warfarin|mesh-list
57014804|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
57014805|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
57014806|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57014807|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
57014808|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57014809|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
57014810|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014811|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014812|NCT02697383|Dexamethasone|dexamethasone|mesh-list
57014813|NCT02697383|Ixazomib|ixazomib|mesh-list
57014814|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014815|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
57014816|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
57014817|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014818|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014819|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57014820|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
57014821|NCT02697383|Hormones|hormones|mesh-ancestor
57014822|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014823|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57014824|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014825|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
57014826|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014827|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014828|NCT04173949|Ramipril|ramipril|mesh-list
57014829|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57014830|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
57014831|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014832|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014833|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57014834|NCT05422001|Ketamine|ketamine|mesh-list
57014835|NCT05422001|Analgesics|analgesics|mesh-ancestor
57014836|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
57014837|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014838|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014839|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57014840|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57014841|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
57014842|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
57014843|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014844|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57014845|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57014846|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014847|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014848|NCT01382017|Lacosamide|lacosamide|mesh-list
57014849|NCT01382017|Carbamazepine|carbamazepine|mesh-list
57014850|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
57014851|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57014852|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57014853|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57014854|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014855|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
57014856|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57014857|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014858|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014859|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57014860|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57014861|NCT01382017|Analgesics|analgesics|mesh-ancestor
57014862|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
57014863|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014864|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57014865|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57014866|NCT01381523|Naproxen|naproxen|mesh-list
57014867|NCT01381523|Sumatriptan|sumatriptan|mesh-list
57014868|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57014869|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57014870|NCT01381523|Analgesics|analgesics|mesh-ancestor
57014871|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
57014872|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014873|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014874|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014875|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57014876|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
57014877|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57014878|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014879|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014880|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57014881|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57014882|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57014883|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
57014884|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014885|NCT04233047|Fostemsavir|fostemsavir|mesh-list
57014886|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57014887|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57014888|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
57014889|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014890|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57014891|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57014892|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014893|NCT01381445|Clobetasol|clobetasol|mesh-list
57014894|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57014895|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
57014896|NCT01381445|Hormones|hormones|mesh-ancestor
56894835|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57014897|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014898|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014899|NCT03083639|Esomeprazole|esomeprazole|mesh-list
57014900|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57014901|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57014902|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57014903|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696798|NCT04030091|Insulin|insulin|mesh-list
57014904|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014905|NCT02927431|Oseltamivir|oseltamivir|mesh-list
57014906|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
57014907|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014908|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014909|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014910|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
57014911|NCT05027893|Cefixime|cefixime|mesh-list
57014912|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57014913|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014914|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57014915|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57014916|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014917|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014918|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014919|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
57014920|NCT04113083|Provitamins|provitamins|mesh-ancestor
57014921|NCT04113083|Vitamins|vitamins|mesh-ancestor
57014922|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
57014923|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014924|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57014925|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
57014926|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014927|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
57014928|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57014929|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
57014930|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014931|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
57014932|NCT04989361|Protective Agents|protective agents|mesh-ancestor
57014933|NCT01381289|Ivacaftor|ivacaftor|mesh-list
57014934|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57014935|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57014936|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014937|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57014938|NCT04899193|Hormones|hormones|mesh-ancestor
57014939|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014940|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014941|NCT01381705|Rituximab|rituximab|mesh-list
57014942|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57014943|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014944|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
57014945|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014946|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57014947|NCT04401709|Gemcitabine|gemcitabine|mesh-list
57014948|NCT04401709|Capecitabine|capecitabine|mesh-list
57014949|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57014950|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
57014951|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014952|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57014953|NCT04401709|Antiviral Agents|antiviral agents|mesh-ancestor
57014954|NCT04401709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014955|NCT04401709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57014956|NCT04401709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57014957|NCT04401709|Immunologic Factors|immunologic factors|mesh-ancestor
57014958|NCT04401709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014959|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
57014960|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
57014961|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57014962|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
57014963|NCT01381627|Remifentanil|remifentanil|mesh-list
57014964|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57014965|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57014966|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014967|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57014968|NCT01381627|Analgesics|analgesics|mesh-ancestor
57014969|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
57014970|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57014971|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57014972|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57014973|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57014974|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
57014975|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014976|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014977|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57014978|NCT01381627|Narcotics|narcotics|mesh-ancestor
57014979|NCT00974571|Cetirizine|cetirizine|mesh-list
57014980|NCT00974571|Montelukast|montelukast|mesh-list
57014981|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57014982|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
57014983|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57014984|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
57014985|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57014986|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57014987|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57014988|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57014989|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57014990|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57014991|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57014992|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57014993|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
57014994|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
57014995|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57014996|NCT02766608|Budesonide|budesonide|mesh-list
57014997|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
57014998|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
57014999|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015000|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57015001|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
57015002|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015003|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015004|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57015005|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
57015006|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
57015007|NCT02766608|Hormones|hormones|mesh-ancestor
57015008|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015009|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57015010|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57015011|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57015012|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
57015013|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015014|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015015|NCT01382407|Cetuximab|cetuximab|mesh-list
57015016|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015017|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015018|NCT02235857|Dextrans|dextrans|mesh-list
57015019|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
57015020|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
57015021|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
57015022|NCT05082285|Vaccines|vaccines|mesh-list
57015023|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
57015024|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015025|NCT03317119|Trifluridine|trifluridine|mesh-list
57015026|NCT03317119|Trametinib|trametinib|mesh-list
57015027|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015028|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57015029|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015030|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015031|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
57015032|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
57015033|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015034|NCT04356495|Ciclesonide|ciclesonide|mesh-list
57015035|NCT04356495|Interferons|interferons|mesh-list
57015036|NCT04356495|Interferon-beta|interferon-beta|mesh-list
57015037|NCT04356495|Telmisartan|telmisartan|mesh-list
57015038|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
57015039|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015040|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015041|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
57015042|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015043|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56894836|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57015044|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57015045|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57015046|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015047|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
57015048|NCT04356495|Hormones|hormones|mesh-ancestor
57015049|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015050|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57015051|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
57015052|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57015053|NCT05345249|Ropivacaine|ropivacaine|mesh-list
57015054|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
57015055|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
57015056|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015057|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015058|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
57015059|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015060|NCT02154230|Calcium|calcium|mesh-list
57015061|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57015062|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015063|NCT04200963|Nivolumab|nivolumab|mesh-list
57015064|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015065|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015066|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57015067|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015068|NCT02157428|Flumazenil|flumazenil|mesh-list
57015069|NCT02157428|Antidotes|antidotes|mesh-ancestor
57015070|NCT02157428|Protective Agents|protective agents|mesh-ancestor
57015071|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015072|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
57015073|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
57015074|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015075|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015076|NCT00960141|Loratadine|loratadine|mesh-list
57015077|NCT00960141|Montelukast|montelukast|mesh-list
57015078|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57015079|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
57015080|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57015081|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015082|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015083|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015084|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57015085|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57015086|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015087|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
57015088|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
57015089|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57015090|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57015091|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57015092|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
57015093|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
57015094|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015095|NCT00759655|Factor VIII|factor viii|mesh-list
57015096|NCT00759655|Coagulants|coagulants|mesh-ancestor
57015097|NCT03918915|Atropine|atropine|mesh-list
57015098|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57015099|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57015100|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57015101|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
57015102|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015103|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015104|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57015105|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
57015106|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
57015107|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
57015108|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57015109|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57015110|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
57015111|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015112|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015113|NCT02255006|Glyburide|glyburide|mesh-list
57015114|NCT02255006|Celecoxib|celecoxib|mesh-list
57015115|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57015116|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015117|NCT02255006|Analgesics|analgesics|mesh-ancestor
57015118|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
57015119|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015120|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015121|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015122|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015123|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57015124|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57015125|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015126|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015127|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57015129|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015130|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015131|NCT00103142|Sargramostim|sargramostim|mesh-list
57015132|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
57015133|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015134|NCT00943683|Montelukast|montelukast|mesh-list
57015135|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57015136|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
57015137|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57015138|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015139|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015140|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015141|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57015142|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57015143|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015144|NCT03542006|Brinzolamide|brinzolamide|mesh-list
57015145|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57015146|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015147|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015148|NCT02154464|Acetaminophen|acetaminophen|mesh-list
57015149|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015150|NCT02154464|Analgesics|analgesics|mesh-ancestor
57015151|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
57015152|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015153|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015154|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
57015155|NCT00911547|Beclomethasone|beclomethasone|mesh-list
57015156|NCT00911547|Montelukast|montelukast|mesh-list
57015157|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57015158|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
57015159|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57015160|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015161|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015162|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015163|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57015164|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57015165|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015166|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015167|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
57015168|NCT00911547|Hormones|hormones|mesh-ancestor
57015169|NCT02159690|Prednisone|prednisone|mesh-list
57015170|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
57015171|NCT02159690|Dutasteride|dutasteride|mesh-list
57015172|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015173|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
57015174|NCT02159690|Hormones|hormones|mesh-ancestor
57015175|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015176|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015177|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57015178|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015179|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57015180|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015181|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015182|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015183|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57015184|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57015185|NCT02157818|Midazolam|midazolam|mesh-list
57015186|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
57015187|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57015188|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015189|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015190|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015191|NCT02157818|Analgesics|analgesics|mesh-ancestor
57015192|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
57015193|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015194|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57015195|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57015196|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57015197|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
57015198|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697098|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57015199|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015201|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57015202|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57015203|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57015204|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57015205|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
57015206|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
57015207|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
57015208|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
57015209|NCT00899379|Rizatriptan|rizatriptan|mesh-list
57015210|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57015211|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
57015212|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015213|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015214|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015215|NCT04326439|Cytarabine|cytarabine|mesh-list
57015216|NCT04326439|Etoposide|etoposide|mesh-list
57015217|NCT04326439|Daunorubicin|daunorubicin|mesh-list
57015218|NCT04326439|Sorafenib|sorafenib|mesh-list
57015219|NCT04326439|Asparaginase|asparaginase|mesh-list
57015220|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
57015221|NCT04326439|Calicheamicins|calicheamicins|mesh-list
57015222|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57015223|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015224|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57015225|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57015226|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015227|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015228|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57015229|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
57015230|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
57015231|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015232|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015233|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
57015234|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015235|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57015236|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57015237|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015238|NCT03541928|Valacyclovir|valacyclovir|mesh-list
57015239|NCT03541928|Leuprolide|leuprolide|mesh-list
57015240|NCT03541928|Bicalutamide|bicalutamide|mesh-list
57015241|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57015242|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
57015243|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57015244|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015245|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57015246|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896617|NCT05433272|Vaccines|vaccines|mesh-list
57015247|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
57015248|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015249|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015250|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
57015251|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015252|NCT00145795|Ritonavir|ritonavir|mesh-list
57015253|NCT00145795|Lopinavir|lopinavir|mesh-list
57015254|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57015255|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57015256|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
57015257|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015258|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015259|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57015260|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57015261|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
57015262|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015263|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57015264|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57015265|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57015266|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
57015267|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015268|NCT00898677|Sumatriptan|sumatriptan|mesh-list
57015269|NCT00898677|Rizatriptan|rizatriptan|mesh-list
57015270|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57015271|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57015272|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57015273|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
57015274|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015275|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015276|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015277|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
57015278|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57015279|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015280|NCT02154776|Letrozole|letrozole|mesh-list
57015281|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015282|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57015283|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57015284|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015285|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015286|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57015287|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015288|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015289|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015290|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
57015291|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
57015292|NCT03388749|Annamycin|annamycin|mesh-list
57015293|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57015294|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015295|NCT02770820|Aldesleukin|aldesleukin|mesh-list
57015296|NCT02770820|Interleukin-2|interleukin-2|mesh-list
57015297|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015298|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015299|NCT02770820|Analgesics|analgesics|mesh-ancestor
57015300|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
57015301|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015302|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015303|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57015304|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57015305|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
57015306|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015307|NCT02154854|Tacrolimus|tacrolimus|mesh-list
57015308|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015309|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
57015310|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015311|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57015312|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015313|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015314|NCT03330405|Avelumab|avelumab|mesh-list
57015315|NCT03330405|Talazoparib|talazoparib|mesh-list
57015316|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57015317|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015318|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015319|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
57015320|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015321|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57015322|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015323|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015324|NCT02160080|Interferons|interferons|mesh-list
57015325|NCT02160080|Ribavirin|ribavirin|mesh-list
57015326|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
57015327|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015328|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
57015329|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015330|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
57015331|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015332|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
57015333|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015334|NCT05422183|Lenvatinib|lenvatinib|mesh-list
57015335|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015336|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57015337|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015338|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015339|NCT02160158|Fesoterodine|fesoterodine|mesh-list
57015340|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57015341|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57015342|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
57015343|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015344|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015345|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015346|NCT02160158|Urological Agents|urological agents|mesh-ancestor
57015347|NCT03283761|Leucovorin|leucovorin|mesh-list
57015348|NCT03283761|Paclitaxel|paclitaxel|mesh-list
57015349|NCT03283761|Fluorouracil|fluorouracil|mesh-list
57015350|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
57015351|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57015352|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015353|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
57015354|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
57015355|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
57015356|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015357|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
57015358|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57015359|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015360|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
57015361|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015362|NCT03283761|Antidotes|antidotes|mesh-ancestor
57015363|NCT03283761|Protective Agents|protective agents|mesh-ancestor
57015364|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
57015365|NCT03283761|Vitamins|vitamins|mesh-ancestor
57015366|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
57015367|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
57015368|NCT02160236|Tenoxicam|tenoxicam|mesh-list
57015369|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57015370|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015371|NCT02160236|Analgesics|analgesics|mesh-ancestor
57015372|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
57015373|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015374|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015375|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015376|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015377|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57015378|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015379|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015380|NCT02154932|Misoprostol|misoprostol|mesh-list
57015381|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57015382|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
57015383|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57015384|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015385|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57015386|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57015387|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
57015388|NCT02158286|Acetaminophen|acetaminophen|mesh-list
57015389|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015390|NCT02158286|Analgesics|analgesics|mesh-ancestor
57015391|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
57015392|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015393|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015394|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
57015395|NCT01377415|Bupivacaine|bupivacaine|mesh-list
57015396|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
57015397|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
57015398|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015399|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015400|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
57015401|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015402|NCT02155088|Gemcitabine|gemcitabine|mesh-list
57015403|NCT02155088|Paclitaxel|paclitaxel|mesh-list
57015404|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57015405|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015406|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
57015407|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
57015408|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
57015409|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015410|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57015411|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
57015412|NCT02155088|Antiviral Agents|antiviral agents|mesh-ancestor
57015413|NCT02155088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015414|NCT02155088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015415|NCT02155088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015416|NCT02155088|Immunologic Factors|immunologic factors|mesh-ancestor
57015417|NCT02155088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015418|NCT03207867|Spartalizumab|spartalizumab|mesh-list
57015419|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57015420|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015421|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015422|NCT02160548|Atropine|atropine|mesh-list
57015423|NCT02160548|Albuterol|albuterol|mesh-list
57015424|NCT02160548|Pralidoxime|pralidoxime|mesh-list
57015425|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57015426|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
57015427|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015428|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015429|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57015430|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
57015431|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
57015432|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57015433|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57015434|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57015435|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57015436|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
57015437|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015438|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015439|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57015440|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57015441|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
57015442|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
57015443|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57015444|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57015445|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
57015446|NCT02160548|Antidotes|antidotes|mesh-ancestor
57015447|NCT02160548|Protective Agents|protective agents|mesh-ancestor
57015448|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
57015449|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
57015450|NCT02158598|Vitamin D|vitamin d|mesh-list
57015451|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
57015452|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
57015453|NCT02158598|Vitamins|vitamins|mesh-list
57015454|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
57015455|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015456|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57015457|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57015458|NCT03082729|Apremilast|apremilast|mesh-list
57015459|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57015460|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015461|NCT03082729|Analgesics|analgesics|mesh-ancestor
57015462|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
57015463|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015464|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015465|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015466|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015467|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57015468|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57015469|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015470|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015471|NCT02160704|Enclomiphene|enclomiphene|mesh-list
57015472|NCT02160704|Clomiphene|clomiphene|mesh-list
57015473|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
57015474|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57015475|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015476|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015477|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015478|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57015479|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
57015480|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57015481|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57015482|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57015483|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
57015484|NCT03542552|Nifedipine|nifedipine|mesh-list
57015485|NCT03542552|Analgesics|analgesics|mesh-ancestor
57015486|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
57015487|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015488|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015489|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
57015490|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015491|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57015492|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
57015493|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57015494|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57015495|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015496|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57015497|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
57015498|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57015499|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
57015500|NCT05002569|Nivolumab|nivolumab|mesh-list
57015501|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015502|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015503|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57015504|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015505|NCT02155166|Ibuprofen|ibuprofen|mesh-list
57015506|NCT02155166|Lidocaine|lidocaine|mesh-list
57015507|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
57015508|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
57015509|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015510|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015511|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
57015512|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015513|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57015514|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57015515|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57015516|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57015517|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015518|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57015519|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015520|NCT02155166|Analgesics|analgesics|mesh-ancestor
57015521|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015522|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015523|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57015524|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015525|NCT00398931|Alendronate|alendronate|mesh-list
57015526|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015527|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57015528|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57015529|NCT00920361|Hormones|hormones|mesh-ancestor
57015530|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015531|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015532|NCT00651807|Etonogestrel|etonogestrel|mesh-list
57015533|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57015534|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
57015535|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57015536|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015537|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57015538|NCT03246529|Lenograstim|lenograstim|mesh-list
57015539|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57015540|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
57015541|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015542|NCT02158910|Donepezil|donepezil|mesh-list
57015543|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57015544|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015545|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015546|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
57015547|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015548|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015549|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
57015550|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
57015551|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015552|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015553|NCT03077659|Paclitaxel|paclitaxel|mesh-list
57015554|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57015555|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015556|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
57015557|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
57015558|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
57015559|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015560|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
56592907|NCT05755048|Maytansine|maytansine|mesh-list
57015561|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015562|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015563|NCT02807883|Blinatumomab|blinatumomab|mesh-list
57015564|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015565|NCT05563155|Dexamethasone|dexamethasone|mesh-list
57015566|NCT05563155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015567|NCT05563155|Antiemetics|antiemetics|mesh-ancestor
57015568|NCT05563155|Autonomic Agents|autonomic agents|mesh-ancestor
57015569|NCT05563155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015570|NCT05563155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015571|NCT05563155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57015572|NCT05563155|Glucocorticoids|glucocorticoids|mesh-ancestor
57015573|NCT05563155|Hormones|hormones|mesh-ancestor
57015574|NCT05563155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015575|NCT05563155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57015576|NCT05563155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015577|NCT04051047|Gemcitabine|gemcitabine|mesh-list
57015578|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57015579|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
57015580|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015581|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015582|NCT04051047|Antiviral Agents|antiviral agents|mesh-ancestor
57015583|NCT04051047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015584|NCT04051047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015585|NCT04051047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015586|NCT04051047|Immunologic Factors|immunologic factors|mesh-ancestor
57015587|NCT04051047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015588|NCT00102440|Allopurinol|allopurinol|mesh-list
57015589|NCT00102440|Febuxostat|febuxostat|mesh-list
57015590|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
57015591|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015592|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015593|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
57015594|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015595|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57015596|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
57015597|NCT00102440|Protective Agents|protective agents|mesh-ancestor
57015598|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015599|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
57015600|NCT03113617|Bombesin|bombesin|mesh-list
57015601|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015602|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015603|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015604|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57015605|NCT05224167|Melatonin|melatonin|mesh-list
57015606|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
57015607|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
57015608|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015609|NCT05224167|Protective Agents|protective agents|mesh-ancestor
57015610|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015611|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015612|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
57015613|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
57015614|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57015615|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
57015616|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
57015617|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015618|NCT01377259|Anesthetics|anesthetics|mesh-list
57015619|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015620|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015621|NCT02884219|Ibuprofen|ibuprofen|mesh-list
57015622|NCT02884219|Indomethacin|indomethacin|mesh-list
57015623|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
57015624|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57015625|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015626|NCT02884219|Analgesics|analgesics|mesh-ancestor
57015627|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
57015628|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015629|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015630|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015631|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015632|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015633|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015634|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
57015635|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
57015636|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57015637|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57015638|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57015639|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57015640|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015641|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015642|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57015643|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57015644|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015645|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
57015646|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015647|NCT03909607|Ketamine|ketamine|mesh-list
57015648|NCT03909607|Analgesics|analgesics|mesh-ancestor
57015649|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
56697549|NCT05690087|Lidocaine|lidocaine|mesh-list
57015650|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015651|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015652|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57015653|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57015654|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
57015655|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
57015656|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015657|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57015658|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57015659|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015660|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015661|NCT03902509|Pirfenidone|pirfenidone|mesh-list
57015662|NCT03902509|Analgesics|analgesics|mesh-ancestor
57015663|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
57015664|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015665|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015666|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57015667|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015668|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015669|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015670|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015671|NCT04935177|Antibodies|antibodies|mesh-list
57015672|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
57015673|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57015674|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
57015675|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57015676|NCT04935177|Eculizumab|eculizumab|mesh-list
57015677|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
57015678|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015679|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57015680|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015681|NCT02166632|Bupivacaine|bupivacaine|mesh-list
57015682|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
57015683|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
57015684|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015685|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015686|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
57015687|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015688|NCT02161952|Pirfenidone|pirfenidone|mesh-list
57015689|NCT02161952|Analgesics|analgesics|mesh-ancestor
57015690|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
57015691|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015692|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015693|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57015694|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015695|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015696|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015697|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015698|NCT04993677|Carboplatin|carboplatin|mesh-list
57015699|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
57015700|NCT04993677|Pemetrexed|pemetrexed|mesh-list
57015701|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015702|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015703|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015704|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015705|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57015706|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57015707|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
57015708|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57015709|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
57015710|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57015711|NCT04795869|Antibodies|antibodies|mesh-list
57015712|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
57015713|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57015714|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
57015715|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
57015716|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015717|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015718|NCT04050735|Ethanol|ethanol|mesh-list
57015719|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57015720|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015721|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015722|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015723|NCT04784559|Remdesivir|remdesivir|mesh-list
57015724|NCT04784559|Favipiravir|favipiravir|mesh-list
57015725|NCT04784559|Dexamethasone|dexamethasone|mesh-list
57015726|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015727|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
57015728|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
57015729|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015730|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015731|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57015732|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
57015733|NCT04784559|Hormones|hormones|mesh-ancestor
57015734|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015735|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57015736|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015737|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
57015738|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015739|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
57015740|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015741|NCT03704181|Colchicine|colchicine|mesh-list
57015742|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
57015743|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015744|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
57015745|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
57015746|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
57015747|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015748|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015749|NCT03625011|Gabapentin|gabapentin|mesh-list
57015750|NCT03625011|Analgesics|analgesics|mesh-ancestor
57015751|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
57015752|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015753|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015754|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
57015755|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57015756|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57015757|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015758|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57015759|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57015760|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57015761|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57015762|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015763|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
57015764|NCT03625167|Petrolatum|petrolatum|mesh-list
57015765|NCT03625167|Emollients|emollients|mesh-ancestor
57015766|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
57015767|NCT04576455|Fulvestrant|fulvestrant|mesh-list
57015768|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57015769|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57015770|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015771|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57015772|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57015773|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015774|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015775|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015776|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57015777|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015778|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015779|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
57015780|NCT04892277|Fludarabine|fludarabine|mesh-list
57015781|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015782|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
57015783|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015784|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015785|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57015786|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
57015787|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015788|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015789|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57015790|NCT04718727|Olanzapine|olanzapine|mesh-list
57015791|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
57015792|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
57015793|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015794|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015795|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57015796|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57015797|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57015798|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015799|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56697698|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
57015800|NCT04718727|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57015801|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57015802|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57015803|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015805|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
57015806|NCT03701529|Anesthetics|anesthetics|mesh-list
57015807|NCT03701529|Propofol|propofol|mesh-list
57015808|NCT03701529|Sevoflurane|sevoflurane|mesh-list
57015809|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015810|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015811|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57015812|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57015813|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
57015814|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57015815|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57015816|NCT04559139|Gemcitabine|gemcitabine|mesh-list
57015817|NCT04559139|Cisplatin|cisplatin|mesh-list
57015818|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015819|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57015820|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
57015821|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015822|NCT04559139|Antiviral Agents|antiviral agents|mesh-ancestor
57015823|NCT04559139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015824|NCT04559139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015825|NCT04559139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015826|NCT04559139|Immunologic Factors|immunologic factors|mesh-ancestor
57015827|NCT04559139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015828|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57015829|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
57015830|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015831|NCT04535271|Gemcitabine|gemcitabine|mesh-list
57015832|NCT04535271|Dacarbazine|dacarbazine|mesh-list
57015833|NCT04535271|Trabectedin|trabectedin|mesh-list
57015834|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57015835|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
57015836|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015837|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015838|NCT04535271|Antiviral Agents|antiviral agents|mesh-ancestor
57015839|NCT04535271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015840|NCT04535271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015841|NCT04535271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015842|NCT04535271|Immunologic Factors|immunologic factors|mesh-ancestor
57015843|NCT04535271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015844|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57015845|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
57015846|NCT04553133|Letrozole|letrozole|mesh-list
57015847|NCT04553133|Fulvestrant|fulvestrant|mesh-list
57015848|NCT04553133|Palbociclib|palbociclib|mesh-list
57015849|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015850|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57015851|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57015852|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015853|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015854|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57015855|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015856|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015857|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015858|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57015859|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57015860|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57015861|NCT03701451|Decitabine|decitabine|mesh-list
57015862|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57015863|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
57015864|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015865|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015866|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015867|NCT03703089|Gemcitabine|gemcitabine|mesh-list
57015868|NCT03703089|Paclitaxel|paclitaxel|mesh-list
57015869|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57015870|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015871|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
57015872|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
57015873|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
57015874|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015875|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57015876|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
57015877|NCT03703089|Antiviral Agents|antiviral agents|mesh-ancestor
57015878|NCT03703089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015879|NCT03703089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015880|NCT03703089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015881|NCT03703089|Immunologic Factors|immunologic factors|mesh-ancestor
57015882|NCT03703089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015883|NCT04543617|Atezolizumab|atezolizumab|mesh-list
57015884|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57015885|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015886|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
57015887|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015888|NCT02807844|Spartalizumab|spartalizumab|mesh-list
57015889|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57015890|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015891|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015892|NCT02763566|Letrozole|letrozole|mesh-list
57015893|NCT02763566|Fulvestrant|fulvestrant|mesh-list
57015894|NCT02763566|Anastrozole|anastrozole|mesh-list
57015895|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015896|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57015897|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57015898|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015899|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015900|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57015901|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
57015902|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57015903|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015904|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57015905|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57015906|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
57015907|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57015908|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57015909|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57015910|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015911|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
57015912|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896705|NCT04722848|Ponatinib|ponatinib|mesh-list
57015913|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015914|NCT02052180|Bupivacaine|bupivacaine|mesh-list
57015915|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
57015916|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
57015917|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015918|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015919|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
57015920|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015921|NCT03561402|Teriflunomide|teriflunomide|mesh-list
57015922|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57015923|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015924|NCT03561402|Analgesics|analgesics|mesh-ancestor
57015925|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
57015926|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015927|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015928|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015929|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015930|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57015931|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
57015932|NCT04542135|Sulindac|sulindac|mesh-list
57015933|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57015934|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57015935|NCT04542135|Analgesics|analgesics|mesh-ancestor
57015936|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
57015937|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015938|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015939|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57015940|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57015941|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015942|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57015943|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57015944|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015945|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
57015946|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015947|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697873|NCT00774800|Insulin|insulin|mesh-list
57015948|NCT02805972|Naloxone|naloxone|mesh-list
57015949|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57015950|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015951|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
57015952|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015953|NCT03702621|Bupivacaine|bupivacaine|mesh-list
57015954|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
57015955|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
57015956|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015957|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015958|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
57015959|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015960|NCT02052258|Oxytocin|oxytocin|mesh-list
57015961|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
57015962|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57015963|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015964|NCT02053818|Sufentanil|sufentanil|mesh-list
57015965|NCT02053818|Remifentanil|remifentanil|mesh-list
57015966|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57015967|NCT02053818|Narcotics|narcotics|mesh-ancestor
57015968|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015969|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015970|NCT02053818|Analgesics|analgesics|mesh-ancestor
57015971|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
57015972|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57015973|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57015974|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57015975|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
57015976|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
57015977|NCT03702387|Anesthetics|anesthetics|mesh-list
57015978|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57015979|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57015980|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
57015981|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57015982|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57015983|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015984|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
57015985|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
57015986|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57015987|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
57015988|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
57015989|NCT03031899|Coagulants|coagulants|mesh-ancestor
57015990|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
57015991|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015992|NCT03700905|Nivolumab|nivolumab|mesh-list
57015993|NCT03700905|Ipilimumab|ipilimumab|mesh-list
57015994|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57015995|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57015996|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57015997|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57015998|NCT03700749|Iodine|iodine|mesh-list
57015999|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
57016000|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57016001|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
57016002|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
57016003|NCT03700749|Povidone|povidone|mesh-list
57016004|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57016005|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016006|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
57016007|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
57016008|NCT03700749|Trace Elements|trace elements|mesh-ancestor
57016009|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
57016010|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016011|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
57016012|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
57016013|NCT04522323|Lenvatinib|lenvatinib|mesh-list
57016014|NCT04522323|Axitinib|axitinib|mesh-list
57016015|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016016|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57016017|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016018|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016019|NCT03086369|Gemcitabine|gemcitabine|mesh-list
57016020|NCT03086369|Paclitaxel|paclitaxel|mesh-list
57016021|NCT03086369|Olaratumab|olaratumab|mesh-list
57016022|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57016023|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016024|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
57016025|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
57016026|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
57016027|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016028|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57016029|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
57016030|NCT03086369|Antiviral Agents|antiviral agents|mesh-ancestor
57016031|NCT03086369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016032|NCT03086369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016033|NCT03086369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016034|NCT03086369|Immunologic Factors|immunologic factors|mesh-ancestor
57016035|NCT03086369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016036|NCT00101582|Cisplatin|cisplatin|mesh-list
57016037|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016038|NCT05326373|Fluorides|fluorides|mesh-list
57016039|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
57016040|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
57016041|NCT05326373|Protective Agents|protective agents|mesh-ancestor
57016042|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016043|NCT02166944|Tamoxifen|tamoxifen|mesh-list
57016044|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57016045|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
57016046|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016047|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016048|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57016049|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016050|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57016051|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57016052|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57016053|NCT04665843|Atezolizumab|atezolizumab|mesh-list
57016054|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016055|NCT03540836|Cortisone|cortisone|mesh-list
57016056|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57016057|NCT03198351|Teriflunomide|teriflunomide|mesh-list
57016058|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57016059|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57016060|NCT03198351|Analgesics|analgesics|mesh-ancestor
57016061|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
57016062|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016063|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016064|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57016065|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016066|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016067|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
57016068|NCT04211675|Irinotecan|irinotecan|mesh-list
57016069|NCT04211675|Temozolomide|temozolomide|mesh-list
57016070|NCT04211675|Dinutuximab|dinutuximab|mesh-list
57016071|NCT04211675|Sargramostim|sargramostim|mesh-list
57016072|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57016073|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57016074|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016075|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016076|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016077|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57016078|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
57016079|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
57016080|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016081|NCT02162264|Donepezil|donepezil|mesh-list
57016082|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57016083|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016084|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016085|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
57016086|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016087|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016088|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
57016089|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
57016090|NCT03700515|Hematinics|hematinics|mesh-ancestor
57016091|NCT04740008|Nicotine|nicotine|mesh-list
57016092|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57016093|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
57016094|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016095|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016096|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57016097|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57016098|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
57016099|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016100|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016101|NCT03700359|Etoposide|etoposide|mesh-list
57016102|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57016103|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016104|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57016105|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57016106|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016107|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016108|NCT02167178|Polygeline|polygeline|mesh-list
57016109|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
57016110|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
57016111|NCT03625089|Atorvastatin|atorvastatin|mesh-list
57016112|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57016113|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57016114|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
57016115|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016116|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57016117|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57016118|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016119|NCT01378949|Morphine|morphine|mesh-list
57016120|NCT01378949|Bupivacaine|bupivacaine|mesh-list
57016121|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
57016122|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
57016123|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57016124|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016125|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
57016126|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016127|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57016128|NCT01378949|Narcotics|narcotics|mesh-ancestor
57016129|NCT01378949|Analgesics|analgesics|mesh-ancestor
57016130|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
57016131|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57016132|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016133|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016134|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57016135|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57016136|NCT01381055|Protective Agents|protective agents|mesh-ancestor
56894837|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57016137|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016138|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
57016139|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57016140|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
57016141|NCT04649229|Aprepitant|aprepitant|mesh-list
57016142|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57016143|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
57016144|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
57016145|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016146|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016147|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57016148|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57016149|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016150|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016151|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57016152|NCT01912625|Paclitaxel|paclitaxel|mesh-list
57016153|NCT01912625|Carboplatin|carboplatin|mesh-list
57016154|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57016155|NCT01912625|Trametinib|trametinib|mesh-list
57016156|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57016157|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016158|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
57016159|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
57016160|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
57016161|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016162|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57016163|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016164|NCT03122613|Curcumin|curcumin|mesh-list
57016165|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57016166|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57016167|NCT03122613|Analgesics|analgesics|mesh-ancestor
57016168|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
57016169|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016170|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016171|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57016172|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016173|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016174|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016175|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698076|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
57016176|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
57016177|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57016178|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57016179|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016180|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
57016181|NCT03540368|Coagulants|coagulants|mesh-ancestor
57016182|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57016183|NCT04631601|Androgens|androgens|mesh-list
57016184|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
57016185|NCT04631601|Hormones|hormones|mesh-ancestor
57016186|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016187|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016188|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016189|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016190|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
57016191|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
57016192|NCT02255396|Estradiol|estradiol|mesh-list
57016193|NCT02255396|Estrogens|estrogens|mesh-ancestor
57016194|NCT02255396|Hormones|hormones|mesh-ancestor
57016195|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016196|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016197|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
57016198|NCT02163980|Ropivacaine|ropivacaine|mesh-list
57016199|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57016200|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57016201|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016202|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57016203|NCT02163980|Analgesics|analgesics|mesh-ancestor
57016204|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
57016205|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016206|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57016207|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57016208|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57016209|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
57016210|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016211|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016212|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
57016213|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
57016214|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57016215|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57016216|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
57016217|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016218|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016219|NCT01569035|Warfarin|warfarin|mesh-list
57016220|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
57016221|NCT03841565|Dexamethasone|dexamethasone|mesh-list
57016222|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
57016223|NCT03841565|Daratumumab|daratumumab|mesh-list
57016224|NCT03841565|Pomalidomide|pomalidomide|mesh-list
57016225|NCT03841565|Ichthammol|ichthammol|mesh-list
57016226|NCT03841565|BB 1101|bb 1101|mesh-list
57016227|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57016228|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
57016229|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
57016230|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016231|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016232|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57016233|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
57016234|NCT03841565|Hormones|hormones|mesh-ancestor
57016235|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016236|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57016237|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016238|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016239|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016240|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016241|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
57016242|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57016243|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57016244|NCT03841565|Growth Substances|growth substances|mesh-ancestor
57016245|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
57016246|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
57016247|NCT02162966|Colistin|colistin|mesh-list
57016248|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57016249|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016250|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
57016251|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57016252|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57016253|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57016254|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016255|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
57016256|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016257|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016258|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57016259|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016260|NCT01595321|Leucovorin|leucovorin|mesh-list
57016261|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
57016262|NCT01595321|Fluorouracil|fluorouracil|mesh-list
57016263|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
57016264|NCT01595321|Irinotecan|irinotecan|mesh-list
57016265|NCT01595321|Folfirinox|folfirinox|mesh-list
57016266|NCT01595321|Vaccines|vaccines|mesh-list
57016267|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
57016268|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016269|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016270|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016271|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57016272|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
57016273|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016274|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016275|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57016276|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
57016277|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57016278|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57016279|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57016280|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016281|NCT01595321|Antidotes|antidotes|mesh-ancestor
57016282|NCT01595321|Protective Agents|protective agents|mesh-ancestor
57016283|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
57016284|NCT01595321|Vitamins|vitamins|mesh-ancestor
57016285|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
57016286|NCT02164214|Etanercept|etanercept|mesh-list
57016287|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57016288|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57016289|NCT02164214|Analgesics|analgesics|mesh-ancestor
57016290|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
57016291|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016292|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016293|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57016294|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016295|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57016296|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016297|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
57016298|NCT03722849|Adenosine|adenosine|mesh-list
57016299|NCT03722849|Capsaicin|capsaicin|mesh-list
57016300|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
57016301|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
57016302|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
57016303|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016304|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016305|NCT03722849|Analgesics|analgesics|mesh-ancestor
57016306|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57016307|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
57016308|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57016309|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
57016310|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
57016311|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016312|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016313|NCT02170844|Dabigatran|dabigatran|mesh-list
57016314|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
57016315|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57016316|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016317|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016318|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016319|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
57016320|NCT02170922|Dabigatran|dabigatran|mesh-list
57016321|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
57016322|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57016323|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016324|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016325|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016326|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
57016327|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
57016328|NCT02167958|Fludarabine|fludarabine|mesh-list
57016329|NCT02167958|Tacrolimus|tacrolimus|mesh-list
57016331|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
57016332|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016333|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016334|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57016335|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
57016336|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016337|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016338|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57016339|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57016340|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016341|NCT01384331|NuvaRing|nuvaring|mesh-list
57016342|NCT01384331|Desogestrel|desogestrel|mesh-list
57016343|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57016344|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
57016345|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57016346|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016347|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57016348|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57016349|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57016350|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57016351|NCT01384331|Progestins|progestins|mesh-ancestor
57016352|NCT01384331|Hormones|hormones|mesh-ancestor
57016353|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016354|NCT03699423|Atropine|atropine|mesh-list
57016355|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57016356|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57016357|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57016358|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57016359|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57016360|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
57016361|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016362|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016363|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57016364|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
57016365|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
57016366|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
57016367|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57016368|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57016369|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
57016370|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016371|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016372|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
57016373|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57016374|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57016375|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016376|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57016377|NCT02164448|Analgesics|analgesics|mesh-ancestor
57016378|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
57016379|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016380|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57016381|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57016382|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57016383|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
57016384|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016385|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016386|NCT03612713|Oxycodone|oxycodone|mesh-list
57016387|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57016388|NCT03612713|Narcotics|narcotics|mesh-ancestor
57016389|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57016390|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016391|NCT03612713|Analgesics|analgesics|mesh-ancestor
57016392|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
57016393|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016394|NCT01380509|Metronidazole|metronidazole|mesh-list
57016395|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016396|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57016397|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57016398|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57016399|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57016400|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57016401|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57016402|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
56698315|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
57016403|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016404|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57016405|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57016406|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016407|NCT04853043|Cetuximab|cetuximab|mesh-list
57016408|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57016409|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016410|NCT00976131|Ubiquinone|ubiquinone|mesh-list
57016411|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
57016412|NCT00976131|Cyclophosphamide|cyclophosphamide|mesh-list
57016413|NCT00976131|Doxorubicin|doxorubicin|mesh-list
57016414|NCT00976131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016415|NCT00976131|Immunologic Factors|immunologic factors|mesh-ancestor
57016416|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016417|NCT00976131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016418|NCT00976131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57016419|NCT00976131|Alkylating Agents|alkylating agents|mesh-ancestor
57016420|NCT00976131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016421|NCT00976131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016422|NCT00976131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57016423|NCT00976131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57016424|NCT00976131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57016425|NCT00976131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57016426|NCT00976131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016427|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
57016428|NCT00976131|Vitamins|vitamins|mesh-ancestor
57016429|NCT01384253|Trastuzumab|trastuzumab|mesh-list
57016430|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57016431|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016432|NCT03631277|Calcium|calcium|mesh-list
57016433|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57016434|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016435|NCT02171000|Dabigatran|dabigatran|mesh-list
57016436|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
57016437|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57016438|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016439|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016440|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016441|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
57016442|NCT04841265|Vitamin D|vitamin d|mesh-list
57016443|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
57016444|NCT04841265|Vitamins|vitamins|mesh-ancestor
57016445|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
57016446|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016447|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57016448|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57016449|NCT02164604|Ranibizumab|ranibizumab|mesh-list
57016450|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57016451|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57016452|NCT02164604|Growth Substances|growth substances|mesh-ancestor
57016453|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016454|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
57016455|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016456|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
57016457|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016458|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
57016459|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016460|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016461|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57016462|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
57016463|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016464|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016465|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57016466|NCT04571645|Heparin|heparin|mesh-list
57016467|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
57016468|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57016469|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57016470|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016471|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
57016472|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57016473|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
57016474|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
57016475|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57016476|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016477|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57016478|NCT04050267|Analgesics|analgesics|mesh-ancestor
57016479|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
57016480|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016481|NCT02759120|Doxycycline|doxycycline|mesh-list
57016482|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57016483|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57016484|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
57016485|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
57016486|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57016487|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57016488|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57016489|NCT02759120|Renal Agents|renal agents|mesh-ancestor
57016490|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
57016491|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57016492|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
57016493|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
57016494|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
57016495|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57016496|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
57016497|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57016498|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016499|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57016500|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57016501|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57016502|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57016503|NCT01569113|Estrogens|estrogens|mesh-ancestor
57016504|NCT01569113|Hormones|hormones|mesh-ancestor
57016505|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016506|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57016507|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
57016508|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57016509|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57016510|NCT03699033|Paclitaxel|paclitaxel|mesh-list
57016511|NCT03699033|Carboplatin|carboplatin|mesh-list
57016512|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57016513|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016514|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
57016515|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
57016516|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
57016517|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016518|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
57016519|NCT03697239|Gemcitabine|gemcitabine|mesh-list
57016520|NCT03697239|Paclitaxel|paclitaxel|mesh-list
57016521|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57016522|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57016523|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016524|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
57016525|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
57016526|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
57016527|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016528|NCT03697239|Vitamins|vitamins|mesh-ancestor
57016529|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
57016530|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016531|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57016532|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
57016533|NCT03697239|Antiviral Agents|antiviral agents|mesh-ancestor
57016534|NCT03697239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016535|NCT03697239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016536|NCT03697239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016537|NCT03697239|Immunologic Factors|immunologic factors|mesh-ancestor
57016538|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
57016539|NCT03697239|Protective Agents|protective agents|mesh-ancestor
57016540|NCT01380431|Lisinopril|lisinopril|mesh-list
57016541|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57016542|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016543|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016544|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016545|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57016546|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57016547|NCT01380431|Protective Agents|protective agents|mesh-ancestor
57016548|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016549|NCT03697161|Gaboxadol|gaboxadol|mesh-list
57016550|NCT03697161|Analgesics|analgesics|mesh-ancestor
57016551|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
57016552|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016553|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016555|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
57016556|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
57016557|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016558|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016559|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
57016560|NCT03164993|Doxorubicin|doxorubicin|mesh-list
57016561|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57016562|NCT03164993|Atezolizumab|atezolizumab|mesh-list
57016563|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016564|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
57016565|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016566|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016567|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57016568|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
57016569|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016570|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016571|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57016572|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57016573|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57016574|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57016575|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016576|NCT02171156|Nintedanib|nintedanib|mesh-list
57016577|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016578|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57016579|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016580|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016581|NCT01380353|Diclofenac|diclofenac|mesh-list
56894838|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57016582|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
57016583|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57016584|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57016585|NCT01380353|Analgesics|analgesics|mesh-ancestor
57016586|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
57016587|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016588|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016589|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57016590|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016591|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57016592|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016593|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016594|NCT04670081|Niacinamide|niacinamide|mesh-list
57016595|NCT04670081|Niacin|niacin|mesh-list
57016596|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
57016597|NCT04670081|Psilocybin|psilocybin|mesh-list
57016598|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
57016599|NCT04670081|Vitamins|vitamins|mesh-ancestor
57016600|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
57016601|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016602|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57016603|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
57016604|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016605|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57016606|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
57016607|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
57016608|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57016609|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
57016610|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57016611|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
57016612|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016613|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
57016614|NCT02168426|Protective Agents|protective agents|mesh-ancestor
57016615|NCT01380275|Docetaxel|docetaxel|mesh-list
57016616|NCT01380275|Irinotecan|irinotecan|mesh-list
57016617|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698534|NCT05678205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698535|NCT05678205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56698536|NCT05678205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56698537|NCT05678205|Alkylating Agents|alkylating agents|mesh-ancestor
56698538|NCT05678205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698539|NCT05678205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698540|NCT05678205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56698541|NCT04112147|Ubiquinone|ubiquinone|mesh-list
56698542|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
57016618|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
57016619|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
57016620|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
57016621|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016622|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57016623|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57016624|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016625|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
57016626|NCT02171390|Testosterone|testosterone|mesh-list
57016627|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
57016628|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
57016629|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57016630|NCT02171390|Androgens|androgens|mesh-ancestor
57016631|NCT02171390|Hormones|hormones|mesh-ancestor
57016632|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016633|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016634|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57016635|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016636|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
57016637|NCT01378481|Vorinostat|vorinostat|mesh-list
57016638|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016639|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57016640|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016641|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016642|NCT02171468|Dabigatran|dabigatran|mesh-list
57016643|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
57016644|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57016645|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016646|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016647|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016648|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
57016649|NCT03502031|Losartan|losartan|mesh-list
57016650|NCT03502031|Valsartan|valsartan|mesh-list
57016651|NCT03502031|Enalapril|enalapril|mesh-list
57016652|NCT03502031|Enalaprilat|enalaprilat|mesh-list
57016653|NCT03502031|Lisinopril|lisinopril|mesh-list
57016654|NCT03502031|Perindopril|perindopril|mesh-list
57016655|NCT03502031|Spironolactone|spironolactone|mesh-list
57016656|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57016657|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57016658|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57016659|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016660|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57016661|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57016662|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
57016663|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016664|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016665|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57016666|NCT03502031|Diuretics|diuretics|mesh-ancestor
57016667|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
57016668|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57016669|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016670|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016671|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57016672|NCT03502031|Protective Agents|protective agents|mesh-ancestor
57016673|NCT02171546|Fexofenadine|fexofenadine|mesh-list
57016674|NCT02171546|Quinidine|quinidine|mesh-list
57016675|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
57016676|NCT02171546|Dabigatran|dabigatran|mesh-list
57016677|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
57016678|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57016679|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016680|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016681|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016682|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
57016683|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57016684|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57016685|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57016686|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
57016687|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
57016688|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016689|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016690|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57016691|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57016692|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
57016693|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57016694|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
57016695|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57016696|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57016697|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016698|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57016699|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57016700|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
57016701|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57016702|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57016703|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57016704|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57016705|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57016706|NCT02171624|Quinidine|quinidine|mesh-list
57016707|NCT02171624|Dabigatran|dabigatran|mesh-list
57016708|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
57016709|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57016710|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016711|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016712|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016713|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
57016714|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57016715|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57016716|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
57016717|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016718|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016719|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57016720|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
57016721|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57016722|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57016723|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016724|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57016725|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57016726|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
57016727|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57016728|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57016729|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57016730|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57016731|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57016732|NCT03705351|Temozolomide|temozolomide|mesh-list
57016733|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57016734|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
57016735|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016736|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016737|NCT03705195|Gliclazide|gliclazide|mesh-list
57016738|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57016739|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016740|NCT00101192|Cetuximab|cetuximab|mesh-list
57016741|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016742|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57016743|NCT03688269|Dexamethasone|dexamethasone|mesh-list
57016744|NCT03688269|Ropivacaine|ropivacaine|mesh-list
57016745|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57016746|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
57016747|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
57016748|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016749|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016750|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57016751|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
57016752|NCT03688269|Hormones|hormones|mesh-ancestor
57016753|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016754|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57016755|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016756|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
57016757|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
57016758|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57016759|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
57016760|NCT03688191|Sirolimus|sirolimus|mesh-list
57016761|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57016762|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016763|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57016764|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016765|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
57016766|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016767|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
57016768|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016769|NCT02164838|Axitinib|axitinib|mesh-list
57016770|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016771|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57016772|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016773|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016775|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016776|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57016777|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016778|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016779|NCT02171780|Olodaterol|olodaterol|mesh-list
57016780|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57016781|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
57016782|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016783|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016784|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57016785|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
57016786|NCT02172014|Fentanyl|fentanyl|mesh-list
57016787|NCT02172014|Midazolam|midazolam|mesh-list
57016788|NCT02172014|Citric Acid|citric acid|mesh-list
57016789|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
57016790|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57016791|NCT02172014|Narcotics|narcotics|mesh-ancestor
57016792|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57016793|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016794|NCT02172014|Analgesics|analgesics|mesh-ancestor
57016795|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
57016796|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016797|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57016798|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57016799|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
57016800|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
57016801|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57016802|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57016803|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57016804|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57016805|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
57016806|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
57016807|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016808|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016809|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
57016810|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57016811|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
57016812|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
57016813|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
57016814|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57016815|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
57016816|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016817|NCT04627922|Expectorants|expectorants|mesh-ancestor
57016818|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
57016819|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57016820|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
57016821|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016822|NCT04627922|Protective Agents|protective agents|mesh-ancestor
57016823|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016824|NCT04627922|Antidotes|antidotes|mesh-ancestor
57016825|NCT02172170|Empagliflozin|empagliflozin|mesh-list
57016826|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57016827|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016828|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57016829|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016830|NCT02255942|Zinc|zinc|mesh-list
57016831|NCT02255942|Iron|iron|mesh-list
57016832|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
57016833|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
57016834|NCT02255942|Trace Elements|trace elements|mesh-ancestor
57016835|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
57016836|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016837|NCT02255942|Astringents|astringents|mesh-ancestor
57016838|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
57016839|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
57016840|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57016841|NCT02255942|Protective Agents|protective agents|mesh-ancestor
57016842|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
57016843|NCT03029247|Hematinics|hematinics|mesh-ancestor
57016844|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
57016845|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57016846|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57016847|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016848|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57016849|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57016850|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016851|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016852|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016853|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57016854|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
57016855|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57016856|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016857|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57016858|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57016859|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57016860|NCT03624309|Docetaxel|docetaxel|mesh-list
57016861|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016862|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
57016863|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
57016864|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
57016865|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016866|NCT04327791|Baloxavir|baloxavir|mesh-list
57016867|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
57016868|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016869|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016870|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016871|NCT03624231|Durvalumab|durvalumab|mesh-list
57016872|NCT03624231|Tremelimumab|tremelimumab|mesh-list
57016873|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57016874|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016875|NCT03692013|Losartan|losartan|mesh-list
57016876|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57016877|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57016878|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57016879|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57016880|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016881|NCT03695835|Sargramostim|sargramostim|mesh-list
57016882|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
57016883|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016884|NCT03687255|Tazobactam|tazobactam|mesh-list
57016885|NCT03687255|Piperacillin|piperacillin|mesh-list
57016886|NCT03687255|Cefepime|cefepime|mesh-list
57016887|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57016888|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
57016889|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57016890|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57016891|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57016892|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016893|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016894|NCT04190433|Carvedilol|carvedilol|mesh-list
57016895|NCT04190433|Lisinopril|lisinopril|mesh-list
57016896|NCT04190433|Spironolactone|spironolactone|mesh-list
57016897|NCT04190433|Pravastatin|pravastatin|mesh-list
57016898|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57016899|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
57016900|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016901|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016902|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57016903|NCT04190433|Diuretics|diuretics|mesh-ancestor
57016904|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
57016905|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57016906|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57016907|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
57016908|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57016909|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016910|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57016911|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
57016912|NCT04190433|Protective Agents|protective agents|mesh-ancestor
57016913|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57016914|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57016915|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57016916|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
57016917|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57016918|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57016919|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57016920|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57016921|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
57016922|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57016923|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57016924|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016925|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57016926|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016927|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57016928|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
57016929|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57016930|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
57016931|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016932|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
57016933|NCT03691467|Protective Agents|protective agents|mesh-ancestor
57016934|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
57016936|NCT03959085|Folic Acid|folic acid|mesh-list
57016937|NCT03959085|Cytarabine|cytarabine|mesh-list
57016938|NCT03959085|Dexamethasone|dexamethasone|mesh-list
57016939|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
57016940|NCT03959085|Prednisolone|prednisolone|mesh-list
57016941|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56896727|NCT05363384|Metformin|metformin|mesh-list
57016942|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
57016943|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57016944|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
57016945|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
57016946|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57016947|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57016948|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57016949|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
57016950|NCT03959085|Doxorubicin|doxorubicin|mesh-list
57016951|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57016952|NCT03959085|Methotrexate|methotrexate|mesh-list
57016953|NCT03959085|Vincristine|vincristine|mesh-list
57016954|NCT03959085|Daunorubicin|daunorubicin|mesh-list
57016955|NCT03959085|Asparaginase|asparaginase|mesh-list
57016956|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
57016957|NCT03959085|Pegaspargase|pegaspargase|mesh-list
57016958|NCT03959085|Thioguanine|thioguanine|mesh-list
57016959|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
57016960|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57016961|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
57016962|NCT03959085|BB 1101|bb 1101|mesh-list
57016963|NCT03959085|Calcium|calcium|mesh-list
57016964|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
57016965|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
57016966|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57016967|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
57016968|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57016969|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57016970|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57016971|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
57016972|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57016973|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57016974|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57016975|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57016976|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
57016977|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
57016978|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57016979|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57016980|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
57016981|NCT03959085|Hormones|hormones|mesh-ancestor
57016982|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57016983|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57016984|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
57016985|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57016986|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57016987|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57016988|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57016989|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57016990|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57016991|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57016992|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
57016993|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57016994|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57016995|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
57016996|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
57016997|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56698916|NCT04607421|Antidotes|antidotes|mesh-ancestor
57016998|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57016999|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
57017000|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017001|NCT03959085|Antidotes|antidotes|mesh-ancestor
57017002|NCT03959085|Protective Agents|protective agents|mesh-ancestor
57017003|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
57017005|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
57017006|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57017007|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
57017008|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
57017009|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
57017010|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57017011|NCT03959085|Hematinics|hematinics|mesh-ancestor
57017012|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57017013|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
57017014|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017015|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017016|NCT02165930|Naltrexone|naltrexone|mesh-list
57017017|NCT02165930|Oxycodone|oxycodone|mesh-list
57017018|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57017019|NCT02165930|Narcotics|narcotics|mesh-ancestor
57017020|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57017021|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017022|NCT02165930|Analgesics|analgesics|mesh-ancestor
57017023|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
57017024|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017025|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57017026|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57017027|NCT03694977|Spartalizumab|spartalizumab|mesh-list
57017028|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57017029|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017030|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017031|NCT02172248|Metformin|metformin|mesh-list
57017032|NCT02172248|Empagliflozin|empagliflozin|mesh-list
57017033|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57017034|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017035|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57017036|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017037|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
57017038|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57017039|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
57017040|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017041|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017042|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57017043|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
57017044|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
57017045|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57017046|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
57017047|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017048|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017049|NCT02169596|Ticagrelor|ticagrelor|mesh-list
57017050|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57017051|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57017052|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57017053|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57017054|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
57017055|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017056|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017057|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017058|NCT03937635|Dexamethasone|dexamethasone|mesh-list
57017059|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
57017060|NCT03937635|Lenalidomide|lenalidomide|mesh-list
57017061|NCT03937635|Daratumumab|daratumumab|mesh-list
57017062|NCT03937635|Ichthammol|ichthammol|mesh-list
57017063|NCT03937635|BB 1101|bb 1101|mesh-list
57017064|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017065|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
57017066|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
57017067|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017068|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017069|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57017070|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
57017071|NCT03937635|Hormones|hormones|mesh-ancestor
57017072|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017073|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57017074|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017075|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
57017076|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57017077|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57017078|NCT03937635|Growth Substances|growth substances|mesh-ancestor
57017079|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
57017080|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017081|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017082|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017083|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
57017084|NCT02169752|Ambrisentan|ambrisentan|mesh-list
57017085|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57017086|NCT02172404|Ipratropium|ipratropium|mesh-list
57017087|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57017088|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
57017089|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017090|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017091|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57017092|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
57017093|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57017094|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
57017095|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017096|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017097|NCT00109538|Lonafarnib|lonafarnib|mesh-list
57017098|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017099|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017100|NCT02172482|Bromides|bromides|mesh-list
57017101|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
57017102|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57017103|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
57017104|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017105|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017106|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57017107|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
57017108|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
57017109|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57017110|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
57017111|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017112|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017113|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
57017114|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
57017115|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57017116|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
57017117|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017118|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017119|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57017120|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
57017121|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
57017122|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57017123|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
57017124|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017125|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017126|NCT00106808|Pioglitazone|pioglitazone|mesh-list
57017127|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57017128|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017129|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
57017130|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57017131|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
57017132|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017133|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
57017134|NCT02166554|Protective Agents|protective agents|mesh-ancestor
57017135|NCT02174666|Vitamin D|vitamin d|mesh-list
57017136|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
57017137|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
57017138|NCT02174666|Vitamins|vitamins|mesh-list
57017139|NCT02174666|Genistein|genistein|mesh-list
57017140|NCT02174666|Biochanin A|biochanin a|mesh-list
57017141|NCT02174666|Daidzein|daidzein|mesh-list
57017142|NCT02174666|Formononetin|formononetin|mesh-list
57017143|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
57017144|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017145|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57017146|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57017147|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57017148|NCT02174666|Protective Agents|protective agents|mesh-ancestor
56699063|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56699064|NCT04548999|Protective Agents|protective agents|mesh-ancestor
56699065|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
56699066|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
56699069|NCT04544007|Poly ICLC|poly iclc|mesh-list
57017149|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017150|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57017151|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017152|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017153|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
57017154|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57017155|NCT02174666|Estrogens|estrogens|mesh-ancestor
57017156|NCT02174666|Hormones|hormones|mesh-ancestor
57017157|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017158|NCT03687021|Progesterone|progesterone|mesh-list
57017159|NCT03687021|Progestins|progestins|mesh-ancestor
57017160|NCT03687021|Hormones|hormones|mesh-ancestor
57017161|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017162|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017163|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
57017164|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
57017165|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017166|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
57017167|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57017168|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57017169|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
57017170|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017171|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017172|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57017173|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
57017174|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
57017175|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57017176|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
57017177|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017178|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017179|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57017180|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57017181|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57017182|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
57017183|NCT04305327|Ustekinumab|ustekinumab|mesh-list
57017184|NCT04305327|Brodalumab|brodalumab|mesh-list
57017185|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
57017186|NCT02174900|Lumefantrine|lumefantrine|mesh-list
57017187|NCT02174900|Artemether|artemether|mesh-list
57017188|NCT02174900|Primaquine|primaquine|mesh-list
57017189|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57017190|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
57017191|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57017192|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57017193|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017194|NCT02170610|Pantoprazole|pantoprazole|mesh-list
57017195|NCT02170610|Dabigatran|dabigatran|mesh-list
57017196|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57017197|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57017198|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57017199|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017200|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017201|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
57017202|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57017203|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017204|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
57017205|NCT02173106|Cyclosporine|cyclosporine|mesh-list
57017206|NCT02173106|Cyclosporins|cyclosporins|mesh-list
57017207|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017208|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017209|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57017210|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
57017211|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017212|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
57017213|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017214|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
57017215|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017216|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57017217|NCT03932721|Evolocumab|evolocumab|mesh-list
57017218|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56699141|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017219|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57017220|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
57017221|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017222|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57017223|NCT00106340|Metformin|metformin|mesh-list
57017224|NCT00106340|Glimepiride|glimepiride|mesh-list
57017225|NCT00106340|Vildagliptin|vildagliptin|mesh-list
57017226|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57017227|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017228|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57017229|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57017230|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
57017231|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57017232|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017233|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017234|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017235|NCT03538496|Bupivacaine|bupivacaine|mesh-list
57017236|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
57017237|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
56896732|NCT05363384|Hormones|hormones|mesh-ancestor
57017238|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57017239|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017240|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
57017241|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017242|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
57017243|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57017244|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57017245|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017246|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
57017247|NCT03686787|Coagulants|coagulants|mesh-ancestor
57017248|NCT03694587|Ibuprofen|ibuprofen|mesh-list
57017249|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57017250|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57017251|NCT03694587|Analgesics|analgesics|mesh-ancestor
57017252|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
57017253|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017254|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017255|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017256|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017257|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57017258|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017259|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017260|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57017261|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017262|NCT02170766|Pantoprazole|pantoprazole|mesh-list
57017263|NCT02170766|Dabigatran|dabigatran|mesh-list
57017264|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57017265|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57017266|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57017267|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017268|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017269|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
57017270|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57017271|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017272|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
57017273|NCT03694119|Phenelzine|phenelzine|mesh-list
57017274|NCT03694119|Ozanimod|ozanimod|mesh-list
57017275|NCT03694119|Tyramine|tyramine|mesh-list
57017276|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57017277|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017278|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57017279|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
57017280|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017281|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
57017282|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57017283|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57017284|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017285|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
57017286|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
57017287|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017288|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57017289|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57017290|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57017291|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
57017292|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017293|NCT02178254|Fosfomycin|fosfomycin|mesh-list
57017294|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57017295|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017296|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
57017297|NCT02173262|Lenograstim|lenograstim|mesh-list
57017298|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56699214|NCT02583633|Nifedipine|nifedipine|mesh-list
57017299|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017300|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57017301|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57017302|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017303|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017304|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017305|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57017306|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57017307|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57017308|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
57017309|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017310|NCT02173418|Ropivacaine|ropivacaine|mesh-list
57017311|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
57017312|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
57017313|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57017314|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017315|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
57017316|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017317|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
57017318|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017319|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
57017320|NCT02178488|Vitamin D|vitamin d|mesh-list
57017321|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57017322|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017323|NCT02178488|Vitamins|vitamins|mesh-ancestor
57017324|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
57017325|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57017326|NCT02173652|Linagliptin|linagliptin|mesh-list
57017327|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57017328|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017329|NCT02173652|Incretins|incretins|mesh-ancestor
57017330|NCT02173652|Hormones|hormones|mesh-ancestor
57017331|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017332|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57017333|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017334|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017335|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017336|NCT02173730|Pantoprazole|pantoprazole|mesh-list
57017337|NCT02173730|Dabigatran|dabigatran|mesh-list
57017338|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57017339|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57017340|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57017341|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017342|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017343|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
57017344|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57017345|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017346|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
57017347|NCT02175446|Bevacizumab|bevacizumab|mesh-list
57017348|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57017349|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017350|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57017351|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57017352|NCT02175446|Growth Substances|growth substances|mesh-ancestor
57017353|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017354|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
57017355|NCT02178644|Capecitabine|capecitabine|mesh-list
57017356|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57017357|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
57017358|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017359|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017360|NCT03686163|Mitogens|mitogens|mesh-list
57017361|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
57017362|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017363|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
57017364|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
57017365|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57017366|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
57017367|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57017368|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017369|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57017370|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57017371|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57017372|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56699286|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017374|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57017375|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
57017376|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57017377|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57017378|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57017379|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57017380|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017381|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
57017382|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017383|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017384|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57017385|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57017386|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017387|NCT02173964|Pinaverium|pinaverium|mesh-list
57017388|NCT02173964|Bromides|bromides|mesh-list
57017389|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
57017390|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57017391|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57017392|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017393|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57017394|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017395|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
57017396|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
57017397|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017398|NCT02175602|Citalopram|citalopram|mesh-list
57017399|NCT02175602|Sertraline|sertraline|mesh-list
57017400|NCT02175602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57017401|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57017402|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57017403|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017404|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017405|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
57017406|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017407|NCT02175602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57017408|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
57017409|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57017410|NCT03686085|Dinoprostone|dinoprostone|mesh-list
57017411|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
57017412|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57017413|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017414|NCT02175680|Leronlimab|leronlimab|mesh-list
57017415|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57017416|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57017417|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017418|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57017419|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57017420|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
57017421|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017422|NCT03693885|Oxytocin|oxytocin|mesh-list
57017423|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
57017424|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57017425|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017426|NCT02174120|Propofol|propofol|mesh-list
57017427|NCT02174120|Etomidate|etomidate|mesh-list
57017428|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57017429|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57017430|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017431|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57017432|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
57017433|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
57017434|NCT02175914|Erythromycin|erythromycin|mesh-list
57017435|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
57017436|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
57017437|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
57017438|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57017439|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017440|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57017441|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57017442|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017443|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017444|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
57017445|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57017446|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57017447|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017448|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
57017449|NCT02753816|Coagulants|coagulants|mesh-ancestor
57017450|NCT02179034|Menthol|menthol|mesh-list
57017451|NCT02179034|Nicotine|nicotine|mesh-list
57017452|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57017453|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
57017454|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017455|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017456|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57017457|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57017458|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
57017459|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017460|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017461|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
57017462|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
57017463|NCT02174588|Midazolam|midazolam|mesh-list
57017464|NCT02174588|Propofol|propofol|mesh-list
57017465|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57017466|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57017467|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017468|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57017469|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
57017470|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
57017471|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57017472|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57017473|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57017474|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57017475|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
57017476|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
57017477|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017478|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017479|NCT03693573|Bevacizumab|bevacizumab|mesh-list
57017480|NCT03693573|Atezolizumab|atezolizumab|mesh-list
57017481|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57017482|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017483|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57017484|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57017485|NCT03693573|Growth Substances|growth substances|mesh-ancestor
57017486|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017487|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
57017488|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57017489|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
57017490|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57017491|NCT02176304|Prednisolone|prednisolone|mesh-list
57017492|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
57017493|NCT02176304|Lidocaine|lidocaine|mesh-list
57017494|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57017495|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
57017496|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
57017497|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
57017498|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57017499|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017500|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
57017501|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017502|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57017503|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57017504|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57017505|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57017506|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017507|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017508|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
57017509|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
57017510|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57017511|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
57017512|NCT02176304|Hormones|hormones|mesh-ancestor
57017513|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017514|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57017515|NCT02176304|Protective Agents|protective agents|mesh-ancestor
57017516|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57017517|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017518|NCT02176460|Colchicine|colchicine|mesh-list
57017519|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
57017520|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017521|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
57017522|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
57017523|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
57017524|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017525|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017526|NCT02256254|Simvastatin|simvastatin|mesh-list
57017527|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57017528|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57017529|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
57017530|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017531|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57017532|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57017533|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017534|NCT02182076|Nintedanib|nintedanib|mesh-list
57017535|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017536|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57017537|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017538|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017539|NCT02179268|Sertraline|sertraline|mesh-list
57017540|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57017541|NCT02179268|Citalopram|citalopram|mesh-list
57017542|NCT02179268|Reboxetine|reboxetine|mesh-list
57017543|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
57017544|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57017545|NCT02179268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57017546|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57017547|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57017548|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017549|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017550|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
57017551|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017552|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57017553|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57017554|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57017555|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
57017556|NCT02182154|Nintedanib|nintedanib|mesh-list
57017557|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017558|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57017559|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017560|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017561|NCT04115631|Cytarabine|cytarabine|mesh-list
57017562|NCT04115631|Rituximab|rituximab|mesh-list
57017563|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57017564|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57017565|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
57017566|NCT04115631|Antibodies|antibodies|mesh-list
57017567|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
57017568|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57017569|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
57017570|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017571|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017572|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017573|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57017574|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
57017575|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017576|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
57017577|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017578|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57017579|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57017580|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
57017581|NCT02182232|Paclitaxel|paclitaxel|mesh-list
57017582|NCT02182232|Carboplatin|carboplatin|mesh-list
57017583|NCT02182232|Nintedanib|nintedanib|mesh-list
57017584|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57017585|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017586|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
57017587|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
57017588|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
57017589|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017590|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57017591|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017592|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
57017593|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904652|NCT02086942|Bortezomib|bortezomib|mesh-list
57017594|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017595|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57017596|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57017597|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699513|NCT02581761|Misoprostol|misoprostol|mesh-list
57017598|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017599|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017600|NCT02176850|Telmisartan|telmisartan|mesh-list
57017601|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57017602|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57017603|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57017604|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017605|NCT03537326|Budesonide|budesonide|mesh-list
57017606|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017607|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57017608|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
57017609|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017610|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017611|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57017612|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
57017613|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
57017614|NCT03537326|Hormones|hormones|mesh-ancestor
57017615|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017616|NCT02182544|Ketotifen|ketotifen|mesh-list
57017617|NCT02182544|Epinastine|epinastine|mesh-list
57017618|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
57017619|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
57017620|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57017621|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
57017622|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
57017623|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017624|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017625|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017626|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57017627|NCT05141474|Aldesleukin|aldesleukin|mesh-list
57017628|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
57017629|NCT05141474|Fludarabine|fludarabine|mesh-list
57017630|NCT05141474|Interleukin-2|interleukin-2|mesh-list
57017631|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57017632|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
57017633|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017634|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017635|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57017636|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
57017637|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017638|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017639|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57017640|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57017641|NCT05141474|Analgesics|analgesics|mesh-ancestor
57017642|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
57017643|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017644|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57017645|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57017646|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
57017647|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017648|NCT02179658|Vancomycin|vancomycin|mesh-list
57017649|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
57017650|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57017651|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017652|NCT02177318|Bromides|bromides|mesh-list
57017653|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
57017654|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57017655|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
57017656|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896750|NCT01163799|Alefacept|alefacept|mesh-list
57017657|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017658|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57017659|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
57017660|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
57017661|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57017662|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
57017663|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017664|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017665|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
57017666|NCT02177396|Valsartan|valsartan|mesh-list
57017667|NCT02177396|Telmisartan|telmisartan|mesh-list
57017668|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57017669|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57017670|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57017671|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017672|NCT02030054|Atorvastatin|atorvastatin|mesh-list
57017673|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57017674|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57017675|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57017676|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
57017677|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017678|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57017679|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57017680|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017682|NCT02182622|Docetaxel|docetaxel|mesh-list
57017683|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017684|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
57017685|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
57017686|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
57017687|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017688|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017689|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
57017690|NCT02182622|Hormones|hormones|mesh-ancestor
57017691|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017692|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017693|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57017694|NCT03693183|Ketorolac|ketorolac|mesh-list
57017695|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57017696|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57017697|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57017698|NCT03693183|Analgesics|analgesics|mesh-ancestor
57017699|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
57017700|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017701|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017702|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017703|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017704|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57017705|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017706|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017707|NCT02182700|Bromides|bromides|mesh-list
57017708|NCT02182700|Albuterol|albuterol|mesh-list
57017709|NCT02182700|Ipratropium|ipratropium|mesh-list
57017710|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
57017711|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57017712|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
57017713|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017714|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017715|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57017716|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
57017717|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
57017718|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57017719|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57017720|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57017721|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57017722|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
57017723|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017724|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017725|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57017726|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
57017727|NCT02182778|Gemcitabine|gemcitabine|mesh-list
57017728|NCT02182778|Cisplatin|cisplatin|mesh-list
57017729|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017730|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57017731|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
57017732|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017733|NCT02182778|Antiviral Agents|antiviral agents|mesh-ancestor
57017734|NCT02182778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017735|NCT02182778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017736|NCT02182778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57017737|NCT02182778|Immunologic Factors|immunologic factors|mesh-ancestor
57017738|NCT02182778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017739|NCT03688971|Ketoconazole|ketoconazole|mesh-list
57017740|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
57017741|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017742|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57017743|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56699661|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
56699662|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
56699663|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
56699664|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017744|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017745|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017746|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57017747|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
57017748|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017749|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017750|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57017751|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
57017752|NCT02179814|Promethazine|promethazine|mesh-list
57017753|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57017754|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57017755|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57017756|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017757|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
57017758|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
57017759|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
57017760|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017761|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
57017762|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
57017763|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57017764|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57017765|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
57017766|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
57017767|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017768|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017769|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57017770|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
57017771|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
57017772|NCT02179970|Plerixafor|plerixafor|mesh-list
57017773|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57017774|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57017775|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
57017776|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017777|NCT04093323|Interferons|interferons|mesh-list
57017778|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
57017779|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
57017780|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
57017781|NCT04093323|Celecoxib|celecoxib|mesh-list
57017782|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57017783|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
57017784|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017785|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
57017786|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017787|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
57017788|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017789|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57017790|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57017791|NCT04093323|Analgesics|analgesics|mesh-ancestor
57017792|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
57017793|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017794|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017795|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017796|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57017797|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57017798|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017799|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017800|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57017801|NCT03537950|Cannabidiol|cannabidiol|mesh-list
57017802|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
57017803|NCT02182856|Bromides|bromides|mesh-list
57017804|NCT02182856|Albuterol|albuterol|mesh-list
57017805|NCT02182856|Ipratropium|ipratropium|mesh-list
57017806|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
57017807|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56699747|NCT05670743|Fluorides|fluorides|mesh-list
56699748|NCT05670743|Cariostatic Agents|cariostatic agents|mesh-ancestor
56699749|NCT05670743|Protective Agents|protective agents|mesh-ancestor
56699750|NCT05670743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699751|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
56699752|NCT04027517|Hematinics|hematinics|mesh-ancestor
56699753|NCT00588731|Cannabidiol|cannabidiol|mesh-list
56699754|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
56699755|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
56699756|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
56699757|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699758|NCT05629949|Docetaxel|docetaxel|mesh-list
56699759|NCT05629949|Trastuzumab|trastuzumab|mesh-list
56699766|NCT05628233|Azasetron|azasetron|mesh-list
57017808|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
57017809|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017810|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017811|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57017812|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
57017813|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
57017814|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57017815|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57017816|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57017817|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57017818|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
57017819|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017820|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017821|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57017822|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
57017823|NCT02183012|Ibuprofen|ibuprofen|mesh-list
57017824|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57017825|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57017826|NCT02183012|Analgesics|analgesics|mesh-ancestor
57017827|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
57017828|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017829|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017830|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017831|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017832|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57017833|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017834|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017835|NCT02180048|Caffeine|caffeine|mesh-list
57017836|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57017837|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017838|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57017839|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017840|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017841|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57017842|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57017843|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
57017844|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57017845|NCT03688659|Vancomycin|vancomycin|mesh-list
57017846|NCT03688659|Gentamicins|gentamicins|mesh-list
57017847|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57017848|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017849|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57017850|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017851|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017852|NCT03683043|Leuprolide|leuprolide|mesh-list
57017853|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57017854|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
57017855|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57017856|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017857|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57017858|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017859|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57017860|NCT02180204|Tenecteplase|tenecteplase|mesh-list
57017861|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57017862|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57017863|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017864|NCT02183090|Meloxicam|meloxicam|mesh-list
57017865|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57017866|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57017867|NCT02183090|Analgesics|analgesics|mesh-ancestor
57017868|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
57017869|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017870|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017871|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017872|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017873|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57017874|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57017875|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017876|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017877|NCT02177552|Carboplatin|carboplatin|mesh-list
57017878|NCT02177552|Docetaxel|docetaxel|mesh-list
57017879|NCT02177552|Capecitabine|capecitabine|mesh-list
57017880|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
57017881|NCT02177552|Epirubicin|epirubicin|mesh-list
57017882|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017883|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
57017884|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
57017885|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
57017886|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017887|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57017888|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
57017889|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57017890|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57017891|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57017892|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017893|NCT03682653|Azithromycin|azithromycin|mesh-list
57017894|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57017895|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017896|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
57017897|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57017898|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57017899|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57017900|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
57017901|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
57017902|NCT04062279|Autoantibodies|autoantibodies|mesh-list
57017903|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
57017904|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017905|NCT02183168|Indomethacin|indomethacin|mesh-list
57017906|NCT02183168|Meloxicam|meloxicam|mesh-list
57017907|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57017908|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57017909|NCT02183168|Analgesics|analgesics|mesh-ancestor
57017910|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
57017911|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017912|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017913|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57017914|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017915|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
57017916|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
57017917|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57017918|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57017919|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017920|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017921|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57017922|NCT02183246|Porfiromycin|porfiromycin|mesh-list
57017923|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57017924|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57017925|NCT02183324|Linagliptin|linagliptin|mesh-list
57017926|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57017927|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017928|NCT02183324|Incretins|incretins|mesh-ancestor
57017929|NCT02183324|Hormones|hormones|mesh-ancestor
57017930|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017931|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57017932|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017933|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017934|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017935|NCT02183402|Linagliptin|linagliptin|mesh-list
57017936|NCT02183402|Digoxin|digoxin|mesh-list
57017937|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57017938|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57017939|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017940|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017941|NCT02183402|Protective Agents|protective agents|mesh-ancestor
57017942|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017943|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57017944|NCT02183402|Incretins|incretins|mesh-ancestor
57017945|NCT02183402|Hormones|hormones|mesh-ancestor
57017946|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017947|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57017948|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017949|NCT02183480|Linagliptin|linagliptin|mesh-list
57017950|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57017951|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017952|NCT02183480|Incretins|incretins|mesh-ancestor
57017953|NCT02183480|Hormones|hormones|mesh-ancestor
57017954|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017955|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57017956|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017957|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017958|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017959|NCT05141864|Lidocaine|lidocaine|mesh-list
57017960|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
57017961|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
57017962|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57017963|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017964|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
57017965|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017966|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57017967|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57017968|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57017969|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57017970|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017971|NCT02180516|Meloxicam|meloxicam|mesh-list
57017972|NCT02180516|Etodolac|etodolac|mesh-list
57017973|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
57017974|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57017975|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57017976|NCT02180516|Analgesics|analgesics|mesh-ancestor
57017977|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
57017978|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57017979|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017980|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57017981|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57017982|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57017983|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017984|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017985|NCT02183636|Pioglitazone|pioglitazone|mesh-list
57017986|NCT02183636|Linagliptin|linagliptin|mesh-list
57017987|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57017988|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57017989|NCT02183636|Incretins|incretins|mesh-ancestor
57017990|NCT02183636|Hormones|hormones|mesh-ancestor
57017991|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57017992|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57017993|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
57017994|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57017995|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57017996|NCT02183948|Oxytocin|oxytocin|mesh-list
57017997|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
57017998|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57017999|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018000|NCT02184104|Caffeine|caffeine|mesh-list
57018001|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57018002|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018003|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57018004|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018005|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018006|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57018007|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57018008|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
57018009|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018010|NCT02184260|Dipyrone|dipyrone|mesh-list
57018011|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57018012|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018013|NCT02184260|Analgesics|analgesics|mesh-ancestor
57018014|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
57018015|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018016|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018017|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018018|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57018019|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
57018020|NCT03813147|Cytarabine|cytarabine|mesh-list
57018021|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
57018022|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57018023|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57018024|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57018025|NCT03813147|Methotrexate|methotrexate|mesh-list
57018026|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
57018027|NCT03813147|Azacitidine|azacitidine|mesh-list
57018028|NCT03813147|Fludarabine|fludarabine|mesh-list
57018029|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
57018030|NCT03813147|Pevonedistat|pevonedistat|mesh-list
56699975|NCT00756938|Losartan|losartan|mesh-list
57018031|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57018032|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
57018033|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57018034|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018035|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57018036|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
57018037|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018038|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018039|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
57018040|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57018041|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57018042|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
57018043|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57018044|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57018045|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
57018046|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018047|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018048|NCT03684837|Vitamin D|vitamin d|mesh-list
57018049|NCT03684837|Vitamins|vitamins|mesh-ancestor
57018050|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
57018051|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018052|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57018053|NCT03810417|Digoxin|digoxin|mesh-list
57018054|NCT03810417|Antibodies|antibodies|mesh-list
57018055|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
57018056|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
57018057|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018058|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57018059|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57018060|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018061|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018062|NCT03810417|Protective Agents|protective agents|mesh-ancestor
57018063|NCT03808155|Tamsulosin|tamsulosin|mesh-list
57018064|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57018065|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57018066|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57018067|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018068|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018069|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018070|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018071|NCT03808155|Urological Agents|urological agents|mesh-ancestor
57018072|NCT02752958|Fluorides|fluorides|mesh-list
57018073|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
57018074|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
57018075|NCT02752958|Protective Agents|protective agents|mesh-ancestor
57018076|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018077|NCT02181218|Gemcitabine|gemcitabine|mesh-list
57018078|NCT02181218|Dexamethasone|dexamethasone|mesh-list
57018079|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
57018080|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
57018081|NCT02181218|Romidepsin|romidepsin|mesh-list
57018082|NCT02181218|BB 1101|bb 1101|mesh-list
57018083|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018084|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
57018085|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
57018086|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018087|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018088|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57018089|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
57018090|NCT02181218|Hormones|hormones|mesh-ancestor
57018091|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018092|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57018093|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018094|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
57018095|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018096|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018097|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57018098|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
57018099|NCT02181218|Antiviral Agents|antiviral agents|mesh-ancestor
57018100|NCT02181218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018101|NCT02181218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57018102|NCT02181218|Immunologic Factors|immunologic factors|mesh-ancestor
57018103|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57018104|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57018105|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
57018106|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57018107|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
57018108|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57018109|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018110|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57018111|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57018112|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018113|NCT03682497|Spironolactone|spironolactone|mesh-list
57018114|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57018115|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
57018116|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018117|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018118|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57018119|NCT03682497|Diuretics|diuretics|mesh-ancestor
57018120|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
57018121|NCT02185898|Menthol|menthol|mesh-list
57018122|NCT02185898|Nicotine|nicotine|mesh-list
57018123|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57018124|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
57018125|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018126|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018127|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57018128|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57018129|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
57018130|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018131|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018132|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
57018133|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
57018134|NCT03794349|Eflornithine|eflornithine|mesh-list
57018135|NCT03794349|Irinotecan|irinotecan|mesh-list
57018136|NCT03794349|Camptothecin|camptothecin|mesh-list
57018137|NCT03794349|Temozolomide|temozolomide|mesh-list
57018138|NCT03794349|Dinutuximab|dinutuximab|mesh-list
57018139|NCT03794349|Sargramostim|sargramostim|mesh-list
57018140|NCT03794349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57018141|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57018142|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57018143|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018144|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018145|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018146|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57018147|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
57018148|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
57018149|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018150|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57018151|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57018152|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57018153|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57018154|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018155|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
57018156|NCT02805660|Durvalumab|durvalumab|mesh-list
57018157|NCT02805660|Mocetinostat|mocetinostat|mesh-list
57018158|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57018159|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018160|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57018161|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018162|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018163|NCT02186132|Atropine|atropine|mesh-list
57018164|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57018165|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57018166|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57018167|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
57018168|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018169|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018170|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57018171|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
57018172|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
57018173|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
57018174|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57018175|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57018176|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
57018177|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018178|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018179|NCT03536780|Gemcitabine|gemcitabine|mesh-list
57018180|NCT03536780|Avelumab|avelumab|mesh-list
57018181|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57018182|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
57018183|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018184|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018185|NCT03536780|Antiviral Agents|antiviral agents|mesh-ancestor
57018186|NCT03536780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018187|NCT03536780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018188|NCT03536780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57018189|NCT03536780|Immunologic Factors|immunologic factors|mesh-ancestor
57018190|NCT03536780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018191|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57018192|NCT02052336|Clarithromycin|clarithromycin|mesh-list
57018193|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57018194|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018195|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57018196|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018197|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018198|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57018199|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57018200|NCT02181920|Dipyrone|dipyrone|mesh-list
57018201|NCT02181920|Diclofenac|diclofenac|mesh-list
57018202|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57018203|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018204|NCT02181920|Analgesics|analgesics|mesh-ancestor
57018205|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
57018206|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018207|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018208|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018209|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57018210|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57018211|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018212|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018213|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
57018214|NCT02185118|Sevoflurane|sevoflurane|mesh-list
57018215|NCT02185118|Isoflurane|isoflurane|mesh-list
57018216|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57018217|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57018218|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
57018219|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
57018220|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018221|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018222|NCT02186366|Buspirone|buspirone|mesh-list
57018223|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57018224|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57018225|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018226|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018227|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57018228|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57018229|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
57018230|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018231|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018232|NCT02053974|Spironolactone|spironolactone|mesh-list
57018233|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57018234|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
57018235|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018236|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018237|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57018238|NCT02053974|Diuretics|diuretics|mesh-ancestor
57018239|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
57018240|NCT02185196|Vitamin D|vitamin d|mesh-list
57018241|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
57018242|NCT02185196|Vitamins|vitamins|mesh-ancestor
57018243|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
57018244|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018245|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57018246|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57018247|NCT02052492|Vitamin D|vitamin d|mesh-list
57018248|NCT02052492|Vitamins|vitamins|mesh-ancestor
57018249|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
57018250|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018251|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57018252|NCT02181998|Heparin|heparin|mesh-list
57018253|NCT02181998|Enoxaparin|enoxaparin|mesh-list
56700193|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
57018254|NCT02181998|Tenecteplase|tenecteplase|mesh-list
57018255|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
57018256|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57018257|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57018258|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018259|NCT02054052|Bevacizumab|bevacizumab|mesh-list
57018260|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57018261|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018262|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57018263|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57018264|NCT02054052|Growth Substances|growth substances|mesh-ancestor
57018265|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018266|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
57018267|NCT02185352|Cisplatin|cisplatin|mesh-list
57018268|NCT02185352|Etoposide|etoposide|mesh-list
57018269|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018270|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57018271|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57018272|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57018273|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018274|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018275|NCT02186600|Vitamin D|vitamin d|mesh-list
57018276|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
57018277|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
57018278|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
57018279|NCT02186600|Calcium|calcium|mesh-list
57018280|NCT02186600|Vitamins|vitamins|mesh-ancestor
57018281|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
57018282|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018283|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57018284|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57018285|NCT02186600|Antacids|antacids|mesh-ancestor
57018286|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018287|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57018288|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57018289|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57018290|NCT02052726|Vaccines|vaccines|mesh-list
57018291|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
57018292|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018293|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
57018294|NCT03617328|Poly ICLC|poly iclc|mesh-list
57018295|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
57018296|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018297|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57018298|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
57018299|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
57018300|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57018301|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018302|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018303|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018304|NCT02185430|Analgesics|analgesics|mesh-ancestor
57018305|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
57018306|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018307|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57018308|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57018309|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57018310|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018311|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018312|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018313|NCT03536390|Methylphenidate|methylphenidate|mesh-list
57018314|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57018315|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018316|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57018317|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57018318|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57018319|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018320|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
57018321|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018322|NCT03561870|Olaparib|olaparib|mesh-list
57018323|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57018324|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018325|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018326|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018327|NCT02186990|Propofol|propofol|mesh-list
57018328|NCT02186990|Etomidate|etomidate|mesh-list
57018329|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57018330|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018331|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018332|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57018333|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
57018334|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
57018335|NCT05657028|Lidocaine|lidocaine|mesh-list
57018336|NCT05657028|Dexmedetomidine|dexmedetomidine|mesh-list
57018337|NCT05657028|Anesthetics, Local|anesthetics, local|mesh-ancestor
57018338|NCT05657028|Anesthetics|anesthetics|mesh-ancestor
57018339|NCT05657028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018340|NCT05657028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018341|NCT05657028|Sensory System Agents|sensory system agents|mesh-ancestor
57018342|NCT05657028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018343|NCT05657028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57018344|NCT05657028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57018345|NCT05657028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57018346|NCT05657028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57018347|NCT05657028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018348|NCT05657028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57018349|NCT05657028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018350|NCT05657028|Analgesics|analgesics|mesh-ancestor
57018351|NCT05657028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57018352|NCT05657028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57018353|NCT05657028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57018354|NCT05657028|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018355|NCT05657028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018356|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
57018357|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57018358|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018359|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018360|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018361|NCT02187068|Analgesics|analgesics|mesh-ancestor
57018362|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
57018363|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018364|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57018365|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57018366|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57018367|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018368|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018369|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018370|NCT02054442|Methotrexate|methotrexate|mesh-list
57018371|NCT02054442|Cetuximab|cetuximab|mesh-list
57018372|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57018373|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
57018374|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57018375|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018376|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57018377|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
57018378|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018379|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018380|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
57018381|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018382|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57018383|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57018384|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
57018385|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57018386|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57018387|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57018388|NCT02054676|Ibuprofen|ibuprofen|mesh-list
57018389|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57018390|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018391|NCT02054676|Analgesics|analgesics|mesh-ancestor
57018392|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
57018393|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018394|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018395|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018396|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57018397|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57018398|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018399|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018400|NCT02256956|Amitriptyline|amitriptyline|mesh-list
57018401|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
57018402|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57018403|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57018404|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
57018405|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018406|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018407|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018408|NCT02256956|Urological Agents|urological agents|mesh-ancestor
57018409|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57018410|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
57018411|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57018412|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018414|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
57018415|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018416|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57018417|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57018418|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57018419|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018420|NCT02187536|Telmisartan|telmisartan|mesh-list
57018421|NCT02187536|Simvastatin|simvastatin|mesh-list
57018422|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57018423|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57018424|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
57018425|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018426|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57018427|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57018428|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018429|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57018430|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57018431|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57018432|NCT02256722|Propranolol|propranolol|mesh-list
57018433|NCT02256722|Bisoprolol|bisoprolol|mesh-list
57018434|NCT02256722|Acipimox|acipimox|mesh-list
57018435|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57018436|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57018437|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
57018438|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018439|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018440|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57018441|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
57018442|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57018443|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57018444|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57018445|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018446|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018447|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018448|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57018449|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57018450|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57018451|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57018452|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
57018453|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
57018454|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57018455|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57018456|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
57018457|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57018458|NCT02193620|Nalbuphine|nalbuphine|mesh-list
57018459|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57018460|NCT02193620|Narcotics|narcotics|mesh-ancestor
57018461|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018462|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018463|NCT02193620|Analgesics|analgesics|mesh-ancestor
57018464|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
57018465|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018466|NCT05624268|Psilocybin|psilocybin|mesh-list
57018467|NCT05624268|Hallucinogens|hallucinogens|mesh-ancestor
57018468|NCT05624268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018469|NCT05624268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57018470|NCT02187614|Acetaminophen|acetaminophen|mesh-list
57018471|NCT02187614|Diclofenac|diclofenac|mesh-list
57018472|NCT02187614|Morphine|morphine|mesh-list
57018473|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57018474|NCT02187614|Narcotics|narcotics|mesh-ancestor
57018475|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018476|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018477|NCT02187614|Analgesics|analgesics|mesh-ancestor
57018478|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
57018479|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700414|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
57018481|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
57018482|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57018483|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018484|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57018485|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57018486|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018487|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018488|NCT02030678|Irinotecan|irinotecan|mesh-list
57018489|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57018490|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57018491|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018492|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018493|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018494|NCT02054988|Caffeine|caffeine|mesh-list
57018495|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57018496|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018497|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57018498|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018499|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018500|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57018501|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57018502|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
57018503|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018504|NCT02191124|Mirtazapine|mirtazapine|mesh-list
57018505|NCT02191124|Paroxetine|paroxetine|mesh-list
57018506|NCT02191124|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57018507|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57018508|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57018509|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018510|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018511|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
57018512|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018513|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57018514|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
57018515|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57018516|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57018517|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57018518|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018519|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57018520|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
57018521|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
57018522|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57018523|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57018524|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018525|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57018526|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57018527|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57018528|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018529|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57018530|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57018531|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57018532|NCT02193698|Dexamethasone|dexamethasone|mesh-list
57018533|NCT02193698|Lenalidomide|lenalidomide|mesh-list
57018534|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018535|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
57018536|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
57018537|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018538|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018539|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57018540|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
57018541|NCT02193698|Hormones|hormones|mesh-ancestor
57018542|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018543|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57018544|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018545|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
57018546|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57018547|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57018548|NCT02193698|Growth Substances|growth substances|mesh-ancestor
57018549|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
57018550|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56700490|NCT04108013|Paclitaxel|paclitaxel|mesh-list
57018551|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57018552|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018553|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018554|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
57018555|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018556|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
57018557|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57018558|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57018559|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57018560|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018561|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018562|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018563|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
57018564|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57018565|NCT02191280|Quercetin|quercetin|mesh-list
57018566|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
57018567|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018568|NCT02191280|Protective Agents|protective agents|mesh-ancestor
57018569|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018570|NCT02055378|Atropine|atropine|mesh-list
57018571|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57018572|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57018573|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57018574|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
57018575|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018576|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018577|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57018578|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
57018579|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
57018580|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
57018581|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57018582|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57018583|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
57018584|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018585|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018586|NCT04558190|Ubiquinone|ubiquinone|mesh-list
57018587|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
57018588|NCT04558190|Albuterol|albuterol|mesh-list
57018589|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57018590|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
57018591|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018592|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018593|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57018594|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
57018595|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
57018596|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57018597|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57018598|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57018599|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57018600|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018601|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018602|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018603|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57018604|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57018605|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57018606|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
57018607|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
57018608|NCT02055456|Nandrolone|nandrolone|mesh-list
57018609|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
57018610|NCT02055456|Androgens|androgens|mesh-ancestor
57018611|NCT02055456|Hormones|hormones|mesh-ancestor
57018612|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018613|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018614|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
57018615|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57018616|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57018617|NCT03676959|Antibodies|antibodies|mesh-list
57018618|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
57018619|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57018620|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
57018621|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018622|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018623|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57018624|NCT03755973|Hormones|hormones|mesh-ancestor
57018625|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018626|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018628|NCT02056938|Basiliximab|basiliximab|mesh-list
57018629|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
57018630|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018631|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57018632|NCT02191670|Tenecteplase|tenecteplase|mesh-list
57018633|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57018634|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57018635|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018636|NCT02057094|Caseins|caseins|mesh-list
57018637|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
57018638|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
57018639|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018640|NCT02917941|Dexamethasone|dexamethasone|mesh-list
57018641|NCT02917941|Lenalidomide|lenalidomide|mesh-list
57018642|NCT02917941|Ixazomib|ixazomib|mesh-list
57018643|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018644|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
57018645|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
57018646|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018647|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018648|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57018649|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
57018650|NCT02917941|Hormones|hormones|mesh-ancestor
57018651|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018652|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57018653|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018654|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
57018655|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57018656|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57018657|NCT02917941|Growth Substances|growth substances|mesh-ancestor
57018658|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
57018659|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
57018660|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018661|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018662|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
57018663|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57018664|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018665|NCT02191748|Triamcinolone|triamcinolone|mesh-list
57018666|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018667|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
57018668|NCT02191748|Hormones|hormones|mesh-ancestor
56894839|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
57018669|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018670|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018671|NCT02191826|Tolcapone|tolcapone|mesh-list
57018672|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57018673|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57018674|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
57018675|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018676|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018677|NCT01333956|Pregabalin|pregabalin|mesh-list
57018678|NCT01333956|Analgesics|analgesics|mesh-ancestor
57018679|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
57018680|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018681|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018682|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
57018683|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57018684|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57018685|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018686|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57018687|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57018688|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57018689|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018690|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57018691|NCT03334617|Trastuzumab|trastuzumab|mesh-list
57018692|NCT03334617|Durvalumab|durvalumab|mesh-list
57018693|NCT03334617|Olaparib|olaparib|mesh-list
57018694|NCT03334617|Cediranib|cediranib|mesh-list
57018695|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57018696|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018697|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57018698|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018699|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018700|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57018701|NCT02057328|Telmisartan|telmisartan|mesh-list
57018702|NCT02057328|Nebivolol|nebivolol|mesh-list
57018703|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57018704|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57018705|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57018706|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018707|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
57018708|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57018709|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57018710|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57018711|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018712|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018713|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018714|NCT02057484|Tacrolimus|tacrolimus|mesh-list
57018715|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57018716|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
57018717|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018718|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57018719|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018720|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018721|NCT02192060|Triclosan|triclosan|mesh-list
57018722|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57018723|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018724|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57018725|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57018726|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
57018727|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018728|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57018729|NCT03876873|Anesthetics|anesthetics|mesh-list
57018730|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018731|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018732|NCT02188394|Bupivacaine|bupivacaine|mesh-list
57018733|NCT02188394|Anesthetics|anesthetics|mesh-list
57018734|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
57018735|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018736|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018737|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
57018738|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018739|NCT01333722|Acetaminophen|acetaminophen|mesh-list
56894840|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
57018740|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
57018741|NCT01333722|Hydrocodone|hydrocodone|mesh-list
57018742|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018743|NCT01333722|Analgesics|analgesics|mesh-ancestor
57018744|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
57018745|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018746|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018747|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
57018748|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57018749|NCT01333722|Narcotics|narcotics|mesh-ancestor
57018750|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018751|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
57018752|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
57018753|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57018754|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018755|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57018756|NCT02188472|Trimethoprim|trimethoprim|mesh-list
57018757|NCT02188472|Penicillins|penicillins|mesh-list
57018758|NCT02188472|Penicillin V|penicillin v|mesh-list
57018759|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57018760|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018761|NCT02188472|Renal Agents|renal agents|mesh-ancestor
57018762|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
57018763|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57018764|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57018765|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57018766|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018767|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018768|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57018769|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57018770|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57018771|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57018772|NCT02188550|Everolimus|everolimus|mesh-list
56700729|NCT01028287|Hormones|hormones|mesh-ancestor
57018773|NCT02188550|Letrozole|letrozole|mesh-list
57018774|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018775|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57018776|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
57018777|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018778|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57018779|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57018780|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018781|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018782|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57018783|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
57018784|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018785|NCT02059590|Isavuconazole|isavuconazole|mesh-list
57018786|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
57018787|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018788|NCT02057796|Efavirenz|efavirenz|mesh-list
57018789|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57018790|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57018791|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
57018792|NCT02057796|Rifampin|rifampin|mesh-list
57018793|NCT02057796|Isoniazid|isoniazid|mesh-list
57018794|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
57018795|NCT02057796|Ethambutol|ethambutol|mesh-list
57018796|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57018797|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57018798|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018799|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018800|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
57018801|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018802|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57018803|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57018804|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57018805|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57018806|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57018807|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57018808|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57018809|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57018810|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57018811|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
55896136|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
57018812|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57018813|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
57018814|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57018815|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57018816|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57018817|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57018818|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57018819|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
57018820|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57018821|NCT02192450|Insulin|insulin|mesh-list
57018822|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57018823|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
57018824|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
57018825|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
57018826|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57018827|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018828|NCT03284385|Adavosertib|adavosertib|mesh-list
57018829|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018830|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018831|NCT05648448|Oseltamivir|oseltamivir|mesh-list
57018832|NCT05648448|Favipiravir|favipiravir|mesh-list
57018833|NCT05648448|Zanamivir|zanamivir|mesh-list
57018834|NCT05648448|Peramivir|peramivir|mesh-list
57018835|NCT05648448|Baloxavir|baloxavir|mesh-list
57018836|NCT05648448|Laninamivir|laninamivir|mesh-list
57018837|NCT05648448|Antiviral Agents|antiviral agents|mesh-ancestor
57018838|NCT05648448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018839|NCT05648448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018840|NCT05648448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018841|NCT03560856|Fulvestrant|fulvestrant|mesh-list
57018842|NCT03560856|Palbociclib|palbociclib|mesh-list
57018843|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57018844|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018845|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57018846|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57018848|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018849|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018850|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57018851|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018852|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018853|NCT03676413|Fluticasone|fluticasone|mesh-list
57018854|NCT03676413|Xhance|xhance|mesh-list
57018855|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57018856|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57018857|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018858|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57018859|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
57018860|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018861|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018862|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57018863|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
57018864|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
57018865|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57018866|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57018867|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57018868|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57018869|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018870|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018871|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018872|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
57018873|NCT03676413|Hormones|hormones|mesh-ancestor
57018874|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018875|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
57018876|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57018877|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57018878|NCT01370694|Prednisolone|prednisolone|mesh-list
57018879|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
57018880|NCT01370694|Vincristine|vincristine|mesh-list
57018881|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57018882|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
57018883|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018884|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57018885|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57018886|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
57018887|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018888|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018889|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57018890|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57018891|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
57018892|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
57018893|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
57018894|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018895|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
57018896|NCT01370694|Hormones|hormones|mesh-ancestor
57018897|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018898|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57018899|NCT02256878|Amitriptyline|amitriptyline|mesh-list
57018900|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57018901|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
57018902|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57018903|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57018904|NCT02256878|Analgesics|analgesics|mesh-ancestor
57018905|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
57018906|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018907|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018908|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57018909|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57018910|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57018911|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018912|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018913|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018914|NCT02058186|Vitamin D|vitamin d|mesh-list
57018915|NCT02058186|Vitamins|vitamins|mesh-ancestor
57018916|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
57018917|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018918|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57018919|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
57018921|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57018922|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018923|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
57018924|NCT03676023|Coagulants|coagulants|mesh-ancestor
57018925|NCT02260206|Colchicine|colchicine|mesh-list
57018926|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
57018927|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57018928|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
57018929|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
57018930|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
57018931|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018932|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018933|NCT02661282|Temozolomide|temozolomide|mesh-list
57018934|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57018935|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
57018936|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018937|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018938|NCT02058576|Tamsulosin|tamsulosin|mesh-list
57018939|NCT02058576|Dutasteride|dutasteride|mesh-list
57018940|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57018941|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57018942|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57018943|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018944|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018945|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018946|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018947|NCT02058576|Urological Agents|urological agents|mesh-ancestor
57018948|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57018949|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57018950|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018951|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
57018952|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018953|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
57018954|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
57018955|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
57018956|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57018957|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018958|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57018959|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56596360|NCT05018221|Cathartics|cathartics|mesh-ancestor
57018960|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57018961|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
57018962|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57018963|NCT02189720|Amifampridine|amifampridine|mesh-list
57018964|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57018965|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018966|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018967|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57018968|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57018969|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018970|NCT03675555|Dexamethasone|dexamethasone|mesh-list
57018971|NCT03675555|Mirtazapine|mirtazapine|mesh-list
57018972|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57018973|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57018974|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
57018975|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
57018976|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57018977|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57018978|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57018979|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
57018980|NCT03675555|Hormones|hormones|mesh-ancestor
57018981|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57018982|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57018983|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57018984|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
57018985|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57018986|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57018987|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
57018988|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
57018989|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57018990|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57018991|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57018992|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57018993|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57018994|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57018995|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57018996|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57018997|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
57018998|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57018999|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57019000|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
57019001|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57019002|NCT02194166|Paclitaxel|paclitaxel|mesh-list
57019003|NCT02194166|Docetaxel|docetaxel|mesh-list
57019004|NCT02194166|Trastuzumab|trastuzumab|mesh-list
57019005|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57019006|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019007|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
57019008|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
57019009|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
57019010|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019011|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019012|NCT05654454|Paclitaxel|paclitaxel|mesh-list
57019013|NCT05654454|Bevacizumab|bevacizumab|mesh-list
57019014|NCT05654454|Carboplatin|carboplatin|mesh-list
57019015|NCT05654454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57019016|NCT05654454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019017|NCT05654454|Tubulin Modulators|tubulin modulators|mesh-ancestor
57019018|NCT05654454|Antimitotic Agents|antimitotic agents|mesh-ancestor
57019019|NCT05654454|Mitosis Modulators|mitosis modulators|mesh-ancestor
57019020|NCT05654454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019021|NCT05654454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019022|NCT05654454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57019023|NCT05654454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57019024|NCT05654454|Growth Substances|growth substances|mesh-ancestor
57019025|NCT05654454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019026|NCT05654454|Growth Inhibitors|growth inhibitors|mesh-ancestor
57019027|NCT03683277|Dexamethasone|dexamethasone|mesh-list
57019028|NCT03683277|Pomalidomide|pomalidomide|mesh-list
57019029|NCT03683277|Ixazomib|ixazomib|mesh-list
57019030|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57019031|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
57019032|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
57019033|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019034|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019035|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57019036|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
57019037|NCT03683277|Hormones|hormones|mesh-ancestor
57019038|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57019039|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57019040|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019041|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
57019042|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57019043|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57019044|NCT03683277|Growth Substances|growth substances|mesh-ancestor
57019045|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
57019046|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
57019047|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019048|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019049|NCT02193308|Amlodipine|amlodipine|mesh-list
57019050|NCT02193308|Telmisartan|telmisartan|mesh-list
57019051|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
57019052|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57019053|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57019054|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57019055|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019056|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57019057|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019058|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
57019059|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57019060|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57019061|NCT02060604|Ketorolac|ketorolac|mesh-list
57019062|NCT02060604|Ranibizumab|ranibizumab|mesh-list
57019063|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57019064|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57019065|NCT02060604|Growth Substances|growth substances|mesh-ancestor
56701016|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019066|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019067|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
57019068|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019069|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57019070|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57019071|NCT02060604|Analgesics|analgesics|mesh-ancestor
57019072|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
57019073|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019074|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57019075|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57019076|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57019077|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019078|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019079|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
57019080|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019081|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019082|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
57019083|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57019084|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019085|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57019086|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019087|NCT02194556|Gemcitabine|gemcitabine|mesh-list
57019088|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57019089|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
57019090|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019091|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019092|NCT02194556|Antiviral Agents|antiviral agents|mesh-ancestor
57019093|NCT02194556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019094|NCT02194556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019095|NCT02194556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019096|NCT02194556|Immunologic Factors|immunologic factors|mesh-ancestor
57019097|NCT02194556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019098|NCT02030912|Amoxicillin|amoxicillin|mesh-list
57019099|NCT02030912|Minocycline|minocycline|mesh-list
57019100|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019101|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019102|NCT02060916|PAZ320|paz320|mesh-list
57019103|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57019104|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019105|NCT04649060|Dexamethasone|dexamethasone|mesh-list
57019106|NCT04649060|Melphalan|melphalan|mesh-list
57019107|NCT04649060|Daratumumab|daratumumab|mesh-list
57019108|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57019109|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
57019110|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
57019111|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019112|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019113|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57019114|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
57019115|NCT04649060|Hormones|hormones|mesh-ancestor
57019116|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57019117|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57019118|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019119|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57019120|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
57019121|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019122|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57019123|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019124|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
57019125|NCT02797080|Interferons|interferons|mesh-list
57019126|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
57019127|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019128|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
57019129|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019130|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
57019131|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57019132|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
57019133|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019134|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019135|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57019136|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
57019137|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
57019138|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57019139|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
57019140|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019141|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019142|NCT02915835|Riociguat|riociguat|mesh-list
57019143|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
57019144|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019145|NCT01370616|Amoxicillin|amoxicillin|mesh-list
57019146|NCT01370616|Tazobactam|tazobactam|mesh-list
57019147|NCT01370616|Piperacillin|piperacillin|mesh-list
57019148|NCT01370616|Ertapenem|ertapenem|mesh-list
57019149|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57019150|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019151|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019152|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57019153|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019154|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019155|NCT02688881|Sirolimus|sirolimus|mesh-list
57019156|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019157|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019158|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57019159|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019160|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
57019161|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019162|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
57019163|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019164|NCT03560310|Ticagrelor|ticagrelor|mesh-list
57019165|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57019166|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57019167|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57019168|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57019169|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
57019170|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019171|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019172|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019173|NCT02197286|Vitamin D|vitamin d|mesh-list
57019174|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
57019175|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
57019176|NCT02197286|Vitamins|vitamins|mesh-list
57019177|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
57019178|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019179|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57019180|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57019181|NCT02197442|Valsartan|valsartan|mesh-list
57019182|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57019183|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57019184|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57019185|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019186|NCT03534674|Vitamin D|vitamin d|mesh-list
57019187|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
57019188|NCT03534674|Vitamins|vitamins|mesh-ancestor
57019189|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
57019190|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019191|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57019192|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57019193|NCT02063334|Vitamin D|vitamin d|mesh-list
57019194|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
57019195|NCT02063334|Vitamins|vitamins|mesh-ancestor
57019196|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
57019197|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019198|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57019199|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57019200|NCT02916927|Ketamine|ketamine|mesh-list
57019201|NCT02916927|Analgesics|analgesics|mesh-ancestor
57019202|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
57019203|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019204|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019205|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57019206|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57019207|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
57019208|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
57019209|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019210|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57019211|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57019212|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019213|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019214|NCT02197598|Nalmefene|nalmefene|mesh-list
57019215|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57019216|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019217|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
57019218|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019220|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57019221|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57019222|NCT02196662|Analgesics|analgesics|mesh-ancestor
57019223|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
57019224|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019225|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019226|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57019227|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57019228|NCT02195180|Leucovorin|leucovorin|mesh-list
57019229|NCT02195180|Gemcitabine|gemcitabine|mesh-list
57019230|NCT02195180|Fluorouracil|fluorouracil|mesh-list
57019231|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
57019232|NCT02195180|Asparaginase|asparaginase|mesh-list
57019233|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57019234|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
57019235|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019236|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019237|NCT02195180|Antiviral Agents|antiviral agents|mesh-ancestor
57019238|NCT02195180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019239|NCT02195180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019240|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019241|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
57019242|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019243|NCT02195180|Antidotes|antidotes|mesh-ancestor
57019244|NCT02195180|Protective Agents|protective agents|mesh-ancestor
57019245|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
57019246|NCT02195180|Vitamins|vitamins|mesh-ancestor
57019247|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
57019248|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
57019249|NCT03623529|Giapreza|giapreza|mesh-list
57019250|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
56896783|NCT01280175|Charcoal|charcoal|mesh-list
57019251|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57019252|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57019253|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
57019254|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019255|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019256|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
57019257|NCT03161379|Nivolumab|nivolumab|mesh-list
57019258|NCT03161379|Pancrelipase|pancrelipase|mesh-list
57019259|NCT03161379|Vaccines|vaccines|mesh-list
57019260|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
57019261|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019262|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019263|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57019264|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57019265|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
57019266|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019267|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019268|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57019269|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019270|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57019271|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57019272|NCT02197676|Guadecitabine|guadecitabine|mesh-list
57019273|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019274|NCT02916693|Mirabegron|mirabegron|mesh-list
57019275|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57019276|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57019277|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57019278|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
57019279|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019280|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019281|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019282|NCT02916693|Urological Agents|urological agents|mesh-ancestor
57019283|NCT02195336|Paclitaxel|paclitaxel|mesh-list
57019284|NCT02195336|Bevacizumab|bevacizumab|mesh-list
57019285|NCT02195336|Carboplatin|carboplatin|mesh-list
57019286|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57019287|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019288|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
57019289|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
57019290|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
57019291|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019292|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019293|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57019294|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57019295|NCT02195336|Growth Substances|growth substances|mesh-ancestor
57019296|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019297|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
57019298|NCT03679065|Acetaminophen|acetaminophen|mesh-list
57019299|NCT03679065|Dexamethasone|dexamethasone|mesh-list
57019300|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
57019301|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57019302|NCT03679065|BB 1101|bb 1101|mesh-list
57019303|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57019304|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
57019305|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
57019306|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019307|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019308|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57019309|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
57019310|NCT03679065|Hormones|hormones|mesh-ancestor
57019311|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57019312|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57019313|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019314|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
57019315|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019316|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019317|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57019318|NCT03679065|Analgesics|analgesics|mesh-ancestor
57019319|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
57019320|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
57019321|NCT02196740|Metronidazole|metronidazole|mesh-list
57019322|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
57019323|NCT02196740|Clindamycin|clindamycin|mesh-list
57019324|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
57019325|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
57019326|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
57019327|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019328|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019329|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57019330|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57019331|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57019332|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57019333|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019334|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019335|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019336|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57019337|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57019338|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57019339|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57019340|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57019341|NCT02195492|Hylan|hylan|mesh-list
57019342|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
57019343|NCT02195492|Protective Agents|protective agents|mesh-ancestor
57019344|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019345|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
57019346|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57019347|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019348|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57019349|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
57019350|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019351|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019352|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019353|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019354|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
57019355|NCT02919345|Glyburide|glyburide|mesh-list
57019356|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57019357|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019358|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57019359|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019360|NCT02195804|Ranitidine|ranitidine|mesh-list
57019361|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
57019362|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57019363|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57019364|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57019365|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
57019366|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
57019367|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019368|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019369|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019371|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
57019372|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
57019373|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019374|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019375|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
57019376|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019377|NCT03674385|Vitamin E|vitamin e|mesh-list
57019378|NCT03674385|Metformin|metformin|mesh-list
57019379|NCT03674385|Clomiphene|clomiphene|mesh-list
57019380|NCT03674385|Enclomiphene|enclomiphene|mesh-list
57019381|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
57019382|NCT03674385|Vitamins|vitamins|mesh-ancestor
57019383|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
57019384|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019385|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57019386|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019387|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
57019388|NCT03674385|Protective Agents|protective agents|mesh-ancestor
57019389|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57019390|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
57019391|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57019392|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57019393|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
57019394|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57019395|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57019396|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57019397|NCT02574455|Gemcitabine|gemcitabine|mesh-list
57019398|NCT02574455|Capecitabine|capecitabine|mesh-list
57019399|NCT02574455|Vinorelbine|vinorelbine|mesh-list
57019400|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57019401|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
57019402|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019403|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019404|NCT02574455|Antiviral Agents|antiviral agents|mesh-ancestor
57019405|NCT02574455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019406|NCT02574455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019407|NCT02574455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019408|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
57019409|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019410|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57019411|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
57019412|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
57019413|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
57019414|NCT03530397|Paclitaxel|paclitaxel|mesh-list
57019415|NCT03530397|Carboplatin|carboplatin|mesh-list
57019416|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
57019417|NCT03530397|Pemetrexed|pemetrexed|mesh-list
57019418|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57019419|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019420|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
57019421|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
57019422|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
57019423|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019424|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019425|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019426|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57019427|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57019428|NCT02197988|Fentanyl|fentanyl|mesh-list
57019429|NCT02197988|Bupivacaine|bupivacaine|mesh-list
57019430|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
57019431|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
57019432|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019433|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019434|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
57019435|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019436|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57019437|NCT02197988|Narcotics|narcotics|mesh-ancestor
57019438|NCT02197988|Analgesics|analgesics|mesh-ancestor
57019439|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57019440|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57019441|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
57019442|NCT03672357|Liver Extracts|liver extracts|mesh-list
57019443|NCT03672357|Hematinics|hematinics|mesh-ancestor
56701392|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
57019444|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57019446|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019447|NCT03674073|Vaccines|vaccines|mesh-list
57019448|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
57019449|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019450|NCT03440190|Methylphenidate|methylphenidate|mesh-list
57019451|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57019452|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019453|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57019454|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57019455|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57019456|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019457|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
57019458|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019459|NCT03673995|Inositol|inositol|mesh-list
57019460|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
57019461|NCT03673995|Vitamins|vitamins|mesh-ancestor
57019462|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
57019463|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019464|NCT01378091|Prednisone|prednisone|mesh-list
57019465|NCT01378091|Docetaxel|docetaxel|mesh-list
57019466|NCT01378091|Lenalidomide|lenalidomide|mesh-list
57019467|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019468|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
57019469|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
57019470|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
57019471|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019472|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57019473|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
57019474|NCT01378091|Hormones|hormones|mesh-ancestor
57019475|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57019476|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019477|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57019478|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
57019479|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57019480|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57019481|NCT01378091|Growth Substances|growth substances|mesh-ancestor
57019482|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
57019483|NCT02794974|Anesthetics|anesthetics|mesh-list
57019484|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019485|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019486|NCT02063568|Oxytocin|oxytocin|mesh-list
57019487|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
57019488|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57019489|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019490|NCT02257502|Aflibercept|aflibercept|mesh-list
57019491|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57019492|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57019493|NCT02257502|Growth Substances|growth substances|mesh-ancestor
57019494|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019495|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
57019496|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019497|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
57019498|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019499|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019500|NCT02450123|Sunitinib|sunitinib|mesh-list
57019501|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019502|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57019503|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57019504|NCT02450123|Growth Substances|growth substances|mesh-ancestor
57019505|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019506|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
57019507|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57019508|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019509|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019510|NCT02063802|Metformin|metformin|mesh-list
57019511|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57019512|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019513|NCT03672045|Carbetocin|carbetocin|mesh-list
57019514|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
57019515|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57019516|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019517|NCT02198300|Clopidogrel|clopidogrel|mesh-list
57019518|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57019519|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57019520|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57019521|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57019522|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
57019523|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019524|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019525|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019526|NCT03560232|Clindamycin|clindamycin|mesh-list
57019527|NCT03560232|Gentamicins|gentamicins|mesh-list
57019528|NCT03560232|Cefazolin|cefazolin|mesh-list
57019529|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
57019530|NCT03560232|Tazobactam|tazobactam|mesh-list
57019531|NCT03560232|Piperacillin|piperacillin|mesh-list
57019532|NCT03560232|Ampicillin|ampicillin|mesh-list
57019533|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57019534|NCT03560232|Sulbactam|sulbactam|mesh-list
57019535|NCT03560232|Sultamicillin|sultamicillin|mesh-list
57019536|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019537|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019538|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57019539|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019540|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019541|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57019542|NCT02201342|Udenafil|udenafil|mesh-list
57019543|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57019544|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57019545|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019546|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019547|NCT02201576|Bortezomib|bortezomib|mesh-list
57019548|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
57019549|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57019550|NCT02201576|Antibodies|antibodies|mesh-list
57019551|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
57019552|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57019553|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019554|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
57019555|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019556|NCT02198378|Acetaminophen|acetaminophen|mesh-list
57019557|NCT02198378|Morphine|morphine|mesh-list
57019558|NCT02198378|Entonox|entonox|mesh-list
57019559|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57019560|NCT02198378|Narcotics|narcotics|mesh-ancestor
57019561|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019562|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019563|NCT02198378|Analgesics|analgesics|mesh-ancestor
57019564|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
57019565|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019566|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57019567|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
57019568|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
57019569|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
57019570|NCT02063100|Losartan|losartan|mesh-list
57019571|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57019572|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57019573|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57019574|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57019575|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019576|NCT02198846|Insulin|insulin|mesh-list
57019577|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57019578|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019579|NCT02198924|Celecoxib|celecoxib|mesh-list
57019580|NCT02198924|Parecoxib|parecoxib|mesh-list
57019581|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57019582|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57019583|NCT02198924|Analgesics|analgesics|mesh-ancestor
57019584|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
57019585|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019586|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019587|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57019588|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57019589|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57019590|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57019591|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019592|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019593|NCT05462093|Liver Extracts|liver extracts|mesh-list
57019594|NCT05462093|Hematinics|hematinics|mesh-ancestor
57019595|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
57019596|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019597|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019598|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57019599|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57019600|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019601|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019602|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019603|NCT02202200|Palbociclib|palbociclib|mesh-list
57019604|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019605|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57019606|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019607|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019608|NCT02064504|Fluticasone|fluticasone|mesh-list
57019609|NCT02064504|Xhance|xhance|mesh-list
57019610|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57019611|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57019612|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
57019613|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019614|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019615|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57019616|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
57019617|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
57019618|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57019619|NCT02067936|Remifentanil|remifentanil|mesh-list
57019620|NCT02067936|Propofol|propofol|mesh-list
57019621|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57019622|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019623|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019624|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57019625|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
57019626|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
57019627|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57019628|NCT02067936|Narcotics|narcotics|mesh-ancestor
57019629|NCT02067936|Analgesics|analgesics|mesh-ancestor
57019630|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
57019631|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019632|NCT01377545|Anesthetics|anesthetics|mesh-list
57019633|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
57019634|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019635|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019636|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
57019637|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019638|NCT01379807|Docetaxel|docetaxel|mesh-list
57019639|NCT01379807|Panitumumab|panitumumab|mesh-list
57019640|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019641|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
57019642|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
57019643|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
57019644|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019645|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019646|NCT02202512|Naproxen|naproxen|mesh-list
57019647|NCT02202512|Cimetidine|cimetidine|mesh-list
57019648|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57019649|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57019650|NCT02202512|Analgesics|analgesics|mesh-ancestor
57019651|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
57019652|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019653|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019654|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57019655|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57019656|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
57019657|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57019658|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019659|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019660|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57019661|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57019662|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57019663|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
57019664|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
57019665|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019666|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57019667|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57019668|NCT02065752|Metformin|metformin|mesh-list
57019669|NCT02065752|Canagliflozin|canagliflozin|mesh-list
57019670|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56701623|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
57019671|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896811|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57019672|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57019673|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019675|NCT03492671|Paclitaxel|paclitaxel|mesh-list
57019676|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57019677|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019678|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
57019679|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
57019680|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
57019681|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019682|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57019683|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
57019684|NCT03492671|Antiviral Agents|antiviral agents|mesh-ancestor
57019685|NCT03492671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019686|NCT03492671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019687|NCT03492671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019688|NCT03492671|Immunologic Factors|immunologic factors|mesh-ancestor
57019689|NCT03492671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019690|NCT02206490|Naltrexone|naltrexone|mesh-list
57019691|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
57019692|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57019693|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57019694|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019695|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
57019696|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019697|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
57019698|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
57019699|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57019700|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57019701|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019702|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019703|NCT02068170|Azithromycin|azithromycin|mesh-list
57019704|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
57019705|NCT02068170|Clarithromycin|clarithromycin|mesh-list
57019706|NCT02068170|Levofloxacin|levofloxacin|mesh-list
57019707|NCT02068170|Erythromycin|erythromycin|mesh-list
57019708|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
57019709|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
57019710|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
57019711|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57019712|NCT02068170|Itraconazole|itraconazole|mesh-list
57019713|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
57019714|NCT02068170|Fluconazole|fluconazole|mesh-list
57019715|NCT02068170|Ketoconazole|ketoconazole|mesh-list
57019716|NCT02068170|Voriconazole|voriconazole|mesh-list
57019717|NCT02068170|Sunitinib|sunitinib|mesh-list
57019718|NCT02068170|Methadone|methadone|mesh-list
57019719|NCT02068170|Haloperidol|haloperidol|mesh-list
57019720|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
57019721|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57019722|NCT02068170|Tacrolimus|tacrolimus|mesh-list
57019723|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019724|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
57019725|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019726|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57019727|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019728|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019729|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019730|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019731|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57019732|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57019733|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019734|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57019735|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
57019736|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57019737|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57019738|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57019739|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57019740|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57019741|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57019742|NCT02068170|Growth Substances|growth substances|mesh-ancestor
57019743|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
57019744|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57019745|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56896821|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
57019746|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57019747|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57019748|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
57019749|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57019750|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57019751|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
57019752|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57019753|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57019755|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57019756|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57019757|NCT02068170|Narcotics|narcotics|mesh-ancestor
57019758|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019759|NCT02068170|Analgesics|analgesics|mesh-ancestor
57019760|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
57019761|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019762|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
57019763|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
57019764|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57019765|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57019766|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
57019767|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
57019768|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57019769|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57019770|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57019771|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57019772|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57019773|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
57019774|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019775|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57019776|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
57019777|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57019778|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57019779|NCT05545020|Chromium|chromium|mesh-list
57019780|NCT05545020|Trace Elements|trace elements|mesh-ancestor
57019781|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
57019782|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019783|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
57019784|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
57019785|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57019786|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019787|NCT02206646|Tenecteplase|tenecteplase|mesh-list
57019788|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57019789|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57019790|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019791|NCT02419417|Nivolumab|nivolumab|mesh-list
57019792|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019793|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019794|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57019795|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019796|NCT02068404|Nifedipine|nifedipine|mesh-list
57019797|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57019798|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57019799|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019800|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57019801|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019802|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
57019803|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
57019804|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57019805|NCT02068482|Rifaximin|rifaximin|mesh-list
57019806|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019807|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019808|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57019809|NCT02206802|Minoxidil|minoxidil|mesh-list
57019810|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57019811|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
57019812|NCT02065986|Tenofovir|tenofovir|mesh-list
57019813|NCT02065986|Emtricitabine|emtricitabine|mesh-list
57019814|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57019815|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
57019816|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019817|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57019818|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57019819|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597225|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57019820|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019821|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57019822|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57019823|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57019824|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
57019825|NCT02068560|Coagulants|coagulants|mesh-ancestor
57019826|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57019827|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
57019828|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019829|NCT01377103|Testosterone|testosterone|mesh-list
57019830|NCT01377103|Androgens|androgens|mesh-ancestor
57019832|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57019833|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019834|NCT01377025|Sorafenib|sorafenib|mesh-list
57019835|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019836|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57019837|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019838|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019839|NCT02203604|Aldesleukin|aldesleukin|mesh-list
57019840|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57019841|NCT02203604|Ipilimumab|ipilimumab|mesh-list
57019842|NCT02203604|Interleukin-2|interleukin-2|mesh-list
57019843|NCT02203604|Antibodies|antibodies|mesh-list
57019844|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
57019845|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57019846|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
57019847|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019848|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019849|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57019850|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019851|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57019852|NCT02203604|Analgesics|analgesics|mesh-ancestor
57019853|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
57019854|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019855|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57019856|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57019857|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
57019858|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019859|NCT02342275|Propranolol|propranolol|mesh-list
57019860|NCT02342275|Atenolol|atenolol|mesh-list
57019861|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57019862|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57019863|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
57019864|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019865|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019866|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019867|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57019868|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57019869|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
57019870|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
57019871|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
57019872|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019873|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57019874|NCT01827553|Gemcitabine|gemcitabine|mesh-list
57019875|NCT01827553|Folfirinox|folfirinox|mesh-list
57019876|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57019877|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
57019878|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019879|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019880|NCT01827553|Antiviral Agents|antiviral agents|mesh-ancestor
57019881|NCT01827553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019882|NCT01827553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019883|NCT01827553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019884|NCT01827553|Immunologic Factors|immunologic factors|mesh-ancestor
57019885|NCT01827553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019886|NCT02207348|Liraglutide|liraglutide|mesh-list
57019887|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57019888|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019889|NCT02207348|Incretins|incretins|mesh-ancestor
57019890|NCT02207348|Hormones|hormones|mesh-ancestor
57019891|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57019892|NCT02066454|Apixaban|apixaban|mesh-list
57019893|NCT02066454|Anticoagulants|anticoagulants|mesh-list
57019894|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57019895|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
57019896|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57019897|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
57019898|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019899|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019900|NCT00979693|Psilocybin|psilocybin|mesh-list
57019901|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
57019902|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019903|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57019904|NCT02207426|Tobramycin|tobramycin|mesh-list
57019905|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57019906|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019907|NCT00777491|Gemcitabine|gemcitabine|mesh-list
57019908|NCT00777491|Cisplatin|cisplatin|mesh-list
57019909|NCT00777491|Fluorouracil|fluorouracil|mesh-list
57019910|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019911|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57019912|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
57019913|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019914|NCT00777491|Antiviral Agents|antiviral agents|mesh-ancestor
57019915|NCT00777491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019916|NCT00777491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019917|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019918|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
57019919|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019920|NCT02199392|Lenvatinib|lenvatinib|mesh-list
57019921|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019922|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57019923|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019924|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019925|NCT05320627|Edoxaban|edoxaban|mesh-list
57019926|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57019927|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
57019928|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57019929|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
57019930|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019931|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019932|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
57019933|NCT03559920|Propofol|propofol|mesh-list
57019934|NCT03559920|Anesthetics|anesthetics|mesh-list
57019935|NCT03559920|Sevoflurane|sevoflurane|mesh-list
57019936|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57019937|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019938|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019939|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57019940|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
57019941|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57019942|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57019943|NCT02203760|Gemcitabine|gemcitabine|mesh-list
57019944|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57019945|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
57019946|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019947|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019948|NCT02203760|Antiviral Agents|antiviral agents|mesh-ancestor
57019949|NCT02203760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57019950|NCT02203760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019951|NCT02203760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019952|NCT02203760|Immunologic Factors|immunologic factors|mesh-ancestor
57019953|NCT02203760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019954|NCT03703271|Methotrexate|methotrexate|mesh-list
57019955|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57019956|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
57019957|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57019958|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019959|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57019960|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
57019961|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019962|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019963|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
57019964|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57019965|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57019966|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57019967|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
57019968|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57019969|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57019970|NCT03532802|Metoprolol|metoprolol|mesh-list
57019971|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57019972|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57019973|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
57019974|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
57019975|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019976|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019977|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57019978|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57019979|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57019980|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
57019981|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57019982|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019983|NCT03430531|Lidocaine|lidocaine|mesh-list
57019984|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
57019985|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
57019986|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57019987|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57019988|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
57019989|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57019990|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57019991|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57019992|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57019993|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57019994|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57019995|NCT02066532|Trastuzumab|trastuzumab|mesh-list
57019996|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57019997|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57019998|NCT05763329|Lemborexant|lemborexant|mesh-list
57019999|NCT05763329|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57020000|NCT05763329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020001|NCT05763329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020002|NCT05763329|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57020003|NCT05763329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57020004|NCT05763329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020005|NCT05763329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020006|NCT04088513|Aspirin|aspirin|mesh-list
57020007|NCT04088513|Clopidogrel|clopidogrel|mesh-list
57020008|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57020009|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020010|NCT04088513|Analgesics|analgesics|mesh-ancestor
57020011|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
57020012|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020013|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020014|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57020015|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57020016|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57020017|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57020018|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020019|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57020020|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57020021|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020022|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
57020023|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57020024|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57020025|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57020026|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
57020027|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020028|NCT02207660|Fluorouracil|fluorouracil|mesh-list
57020029|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020030|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
57020031|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020032|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57020033|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57020034|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
57020035|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020036|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
57020037|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57020038|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020039|NCT02069418|Alovudine|alovudine|mesh-list
57020040|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57020041|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57020042|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020043|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
57020044|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702014|NCT02574975|Budesonide|budesonide|mesh-list
57020046|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020047|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020048|NCT02208128|Bevacizumab|bevacizumab|mesh-list
57020049|NCT02208128|Sunitinib|sunitinib|mesh-list
57020050|NCT02208128|Everolimus|everolimus|mesh-list
57020051|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020052|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020053|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57020054|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57020055|NCT02208128|Growth Substances|growth substances|mesh-ancestor
57020056|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020057|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
57020058|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57020059|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
57020060|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57020061|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020062|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020063|NCT02066610|Selenium|selenium|mesh-list
57020064|NCT02066610|Selenious Acid|selenious acid|mesh-list
57020065|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
57020066|NCT02066610|Selenic Acid|selenic acid|mesh-list
57020067|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
57020068|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020069|NCT02066610|Protective Agents|protective agents|mesh-ancestor
57020070|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020071|NCT02066610|Trace Elements|trace elements|mesh-ancestor
57020072|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
57020073|NCT03077711|Trimethoprim|trimethoprim|mesh-list
57020074|NCT03077711|Methenamine|methenamine|mesh-list
57020075|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
57020076|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
57020077|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57020078|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020079|NCT03077711|Renal Agents|renal agents|mesh-ancestor
57020080|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
57020081|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57020082|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57020083|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57020084|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020085|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020086|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57020087|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57020088|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57020089|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57020090|NCT04374019|Artesunate|artesunate|mesh-list
57020091|NCT04374019|Ivermectin|ivermectin|mesh-list
57020092|NCT04374019|Camostat|camostat|mesh-list
57020093|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
57020094|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57020095|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57020096|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020097|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020098|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
57020099|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
57020100|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57020101|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
57020102|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
57020103|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020104|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020105|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57020106|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57020107|NCT02069808|Leuprolide|leuprolide|mesh-list
57020108|NCT02069808|Menotropins|menotropins|mesh-list
57020109|NCT02069808|Ganirelix|ganirelix|mesh-list
56896824|NCT02076620|Doxorubicin|doxorubicin|mesh-list
57020110|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57020111|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
57020112|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57020113|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020114|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57020115|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020116|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
57020117|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020118|NCT03673605|Warfarin|warfarin|mesh-list
56702076|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020119|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
57020120|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
57020121|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57020123|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57020124|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
57020125|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020126|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020127|NCT02069886|Deferasirox|deferasirox|mesh-list
57020128|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57020129|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
57020130|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
57020131|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020132|NCT04311463|Paroxetine|paroxetine|mesh-list
57020133|NCT04311463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57020134|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57020135|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57020136|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020137|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020138|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
57020139|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020140|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57020141|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
57020142|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57020143|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57020144|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57020145|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020146|NCT05553834|Cemiplimab|cemiplimab|mesh-list
57020147|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020148|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020149|NCT02065128|Capsaicin|capsaicin|mesh-list
57020150|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
57020151|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
57020152|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
57020153|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020154|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020155|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
57020156|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57020157|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
57020158|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020159|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
57020160|NCT03677895|Protective Agents|protective agents|mesh-ancestor
57020161|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57020162|NCT04295005|Empagliflozin|empagliflozin|mesh-list
57020163|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57020164|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020165|NCT04295005|Incretins|incretins|mesh-ancestor
57020166|NCT04295005|Hormones|hormones|mesh-ancestor
57020167|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020168|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57020169|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
57020170|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020171|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020172|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57020173|NCT03174353|Lanreotide|lanreotide|mesh-list
57020174|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020175|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57020176|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020177|NCT03054363|Letrozole|letrozole|mesh-list
57020178|NCT03054363|Palbociclib|palbociclib|mesh-list
57020179|NCT03054363|Tucatinib|tucatinib|mesh-list
57020180|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020181|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57020182|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57020183|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896137|NCT03228108|Fosfomycin|fosfomycin|mesh-list
57020184|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020185|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57020186|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
57020187|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020188|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020189|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57020190|NCT04080947|Montelukast|montelukast|mesh-list
57020191|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57020192|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
57020193|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57020194|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
57020195|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020196|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020197|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57020198|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57020199|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020201|NCT02066688|Vitamin D|vitamin d|mesh-list
57020202|NCT02066688|Folic Acid|folic acid|mesh-list
57020203|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
57020204|NCT02066688|Calcium|calcium|mesh-list
57020205|NCT02066688|Vitamins|vitamins|mesh-ancestor
57020206|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
57020207|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020208|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57020209|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57020210|NCT02066688|Hematinics|hematinics|mesh-ancestor
57020211|NCT03671733|Liraglutide|liraglutide|mesh-list
57020212|NCT03671733|Exenatide|exenatide|mesh-list
57020213|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57020214|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020215|NCT03671733|Incretins|incretins|mesh-ancestor
57020216|NCT03671733|Hormones|hormones|mesh-ancestor
57020217|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020218|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57020219|NCT03119363|Methamphetamine|methamphetamine|mesh-list
57020220|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57020221|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020222|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
57020223|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
57020224|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020225|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
57020226|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020227|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020228|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
57020229|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57020230|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57020231|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57020232|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57020233|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
57020234|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020235|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020236|NCT03671655|Paclitaxel|paclitaxel|mesh-list
57020237|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57020238|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020239|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
57020240|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
57020241|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
57020242|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020243|NCT02200094|Telmisartan|telmisartan|mesh-list
57020244|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57020245|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57020246|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57020247|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020248|NCT01370538|Esomeprazole|esomeprazole|mesh-list
57020249|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57020250|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57020251|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57020252|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020253|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020254|NCT03248297|Amoxicillin|amoxicillin|mesh-list
57020255|NCT03248297|Azithromycin|azithromycin|mesh-list
57020256|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57020257|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020258|NCT02208596|Pentazocine|pentazocine|mesh-list
57020259|NCT02208596|Propofol|propofol|mesh-list
57020260|NCT02208596|Etomidate|etomidate|mesh-list
57020261|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57020262|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020263|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020264|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57020265|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
57020266|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
57020267|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57020268|NCT02208596|Narcotics|narcotics|mesh-ancestor
57020269|NCT02208596|Analgesics|analgesics|mesh-ancestor
57020270|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
57020271|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020272|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57020273|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57020274|NCT02070120|Mitomycins|mitomycins|mesh-list
57020275|NCT02070120|Mitomycin|mitomycin|mesh-list
57020276|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57020277|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020278|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
57020279|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020280|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57020281|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020282|NCT02200172|Melatonin|melatonin|mesh-list
57020283|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
57020284|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020285|NCT02200172|Protective Agents|protective agents|mesh-ancestor
57020286|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020287|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020288|NCT03673137|Gemcitabine|gemcitabine|mesh-list
57020289|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57020290|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
57020291|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020292|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020293|NCT03673137|Antiviral Agents|antiviral agents|mesh-ancestor
57020294|NCT03673137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020295|NCT03673137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020296|NCT03673137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57020297|NCT03673137|Immunologic Factors|immunologic factors|mesh-ancestor
57020298|NCT03673137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020299|NCT02066844|Betamethasone|betamethasone|mesh-list
57020300|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
57020301|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57020302|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
57020303|NCT02066844|Lidocaine|lidocaine|mesh-list
57020304|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57020305|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
57020306|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
57020307|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020308|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020309|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
57020310|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020311|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57020312|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57020313|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57020314|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57020315|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020316|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57020317|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
57020318|NCT02066844|Hormones|hormones|mesh-ancestor
57020319|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020320|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57020321|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
57020322|NCT03669783|Dactinomycin|dactinomycin|mesh-list
57020323|NCT03669783|Carboplatin|carboplatin|mesh-list
57020324|NCT03669783|Doxorubicin|doxorubicin|mesh-list
57020325|NCT03669783|Etoposide|etoposide|mesh-list
57020326|NCT03669783|Vincristine|vincristine|mesh-list
57020327|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020328|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57020329|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57020330|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57020331|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020332|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020333|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57020334|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57020335|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020336|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57020337|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57020338|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
57020339|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
57020340|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
57020341|NCT02067078|Dexamethasone|dexamethasone|mesh-list
57020342|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
57020343|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57020344|NCT02067078|Clonidine|clonidine|mesh-list
57020345|NCT02067078|Epinephrine|epinephrine|mesh-list
57020346|NCT02067078|Racepinephrine|racepinephrine|mesh-list
57020347|NCT02067078|Ropivacaine|ropivacaine|mesh-list
57020348|NCT02067078|Bupivacaine|bupivacaine|mesh-list
57020349|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
57020350|NCT02067078|BB 1101|bb 1101|mesh-list
57020351|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57020352|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
57020353|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
57020354|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020355|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020356|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57020357|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
57020358|NCT02067078|Hormones|hormones|mesh-ancestor
57020359|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020360|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57020361|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020362|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
57020363|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020364|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020365|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
57020366|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
57020367|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020368|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
57020369|NCT02067078|Analgesics|analgesics|mesh-ancestor
57020370|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57020371|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
57020372|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57020373|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57020374|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57020375|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
57020376|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020377|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57020378|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57020379|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57020380|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
57020381|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
57020382|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
57020383|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57020384|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57020385|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020386|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57020387|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57020388|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
57020389|NCT05461235|Nivolumab|nivolumab|mesh-list
57020390|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020391|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020392|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57020393|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020394|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57020395|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
57020396|NCT02070198|Hormones|hormones|mesh-ancestor
57020397|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020398|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020399|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
57020400|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57020401|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
57020402|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57020403|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57020404|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57020405|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597836|NCT05189509|Plasminogen|plasminogen|mesh-list
57020406|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
57020407|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57020408|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57020409|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020410|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
57020411|NCT02918201|Coagulants|coagulants|mesh-ancestor
57020412|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
57020413|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57020414|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57020415|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57020416|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020417|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020418|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020420|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57020421|NCT02204852|Iloprost|iloprost|mesh-list
57020422|NCT02204852|Eptifibatide|eptifibatide|mesh-list
57020423|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57020424|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
57020425|NCT02070510|Lisinopril|lisinopril|mesh-list
57020426|NCT02070510|Warfarin|warfarin|mesh-list
57020427|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
57020428|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57020429|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
57020430|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020431|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020432|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57020433|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57020434|NCT02070510|Protective Agents|protective agents|mesh-ancestor
57020435|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020436|NCT02200562|Ipilimumab|ipilimumab|mesh-list
57020437|NCT02200562|Dabrafenib|dabrafenib|mesh-list
57020438|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020439|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020440|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57020441|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020442|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57020443|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020444|NCT02200640|Losartan|losartan|mesh-list
57020445|NCT02200640|Telmisartan|telmisartan|mesh-list
57020446|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57020447|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57020448|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57020449|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57020450|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020451|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
57020452|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57020453|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
57020454|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020455|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57020456|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
57020457|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57020458|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
57020459|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57020460|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020461|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57020462|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57020463|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020464|NCT02067780|Levofloxacin|levofloxacin|mesh-list
57020465|NCT02067780|Ofloxacin|ofloxacin|mesh-list
57020466|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57020467|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020468|NCT02067780|Renal Agents|renal agents|mesh-ancestor
57020469|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57020470|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57020471|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57020472|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020473|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020474|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020475|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57020476|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57020477|NCT02205164|Aprepitant|aprepitant|mesh-list
57020478|NCT02205164|Palonosetron|palonosetron|mesh-list
57020479|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
57020480|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
57020481|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020482|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020483|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57020484|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57020485|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020486|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020487|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57020488|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57020489|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
57020490|NCT02071212|Ticagrelor|ticagrelor|mesh-list
57020491|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56702449|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57020492|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57020493|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57020494|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57020495|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
57020496|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020497|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020498|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020499|NCT02072382|Metformin|metformin|mesh-list
57020500|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57020501|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020502|NCT02205242|Azithromycin|azithromycin|mesh-list
57020503|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57020504|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020505|NCT02071368|Metformin|metformin|mesh-list
57020506|NCT02071368|Canagliflozin|canagliflozin|mesh-list
57020507|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57020508|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020509|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57020510|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020511|NCT03402841|Olaparib|olaparib|mesh-list
57020512|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57020513|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020514|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020515|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020516|NCT02205398|Cetuximab|cetuximab|mesh-list
57020517|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020518|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020519|NCT04130659|Omeprazole|omeprazole|mesh-list
57020520|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57020521|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57020522|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57020523|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020524|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020525|NCT02220608|Bortezomib|bortezomib|mesh-list
57020526|NCT02220608|Lenograstim|lenograstim|mesh-list
57020527|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57020528|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
57020529|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020530|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020531|NCT03630367|Dexamethasone|dexamethasone|mesh-list
57020532|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57020533|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
57020534|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
57020535|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020536|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020537|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57020538|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
56702526|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702527|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56702528|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
56702529|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702530|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56702531|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
56702532|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56702533|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
56702534|NCT00710619|Coagulants|coagulants|mesh-ancestor
56702535|NCT05192460|Vaccines|vaccines|mesh-list
56702536|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
56702537|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702538|NCT00719433|Armin|armin|mesh-list
56702539|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56702540|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702541|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702542|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
56702543|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702544|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702545|NCT05128344|Vigabatrin|vigabatrin|mesh-list
56702546|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
56702547|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702548|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702549|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
56702550|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702551|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702580|NCT04978272|Piperaquine|piperaquine|mesh-list
57020539|NCT03630367|Hormones|hormones|mesh-ancestor
57020540|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020541|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57020542|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020543|NCT02258282|Etanercept|etanercept|mesh-list
57020544|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57020545|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020546|NCT02258282|Analgesics|analgesics|mesh-ancestor
57020547|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
57020548|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020549|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020550|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57020551|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57020552|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57020553|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57020554|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
57020555|NCT02076594|Docetaxel|docetaxel|mesh-list
57020556|NCT02076594|Capecitabine|capecitabine|mesh-list
57020557|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
57020558|NCT02076594|Epirubicin|epirubicin|mesh-list
57020559|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020560|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
57020561|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
57020562|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
57020563|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020564|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57020565|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
57020566|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57020567|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57020568|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57020569|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020570|NCT04175509|Acetaminophen|acetaminophen|mesh-list
57020571|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020572|NCT04175509|Analgesics|analgesics|mesh-ancestor
57020573|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
57020574|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020575|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020576|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
57020577|NCT02220842|Atezolizumab|atezolizumab|mesh-list
57020578|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
57020579|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020580|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020581|NCT02205554|Tramadol|tramadol|mesh-list
57020582|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57020583|NCT02205554|Narcotics|narcotics|mesh-ancestor
57020584|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020585|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020586|NCT02205554|Analgesics|analgesics|mesh-ancestor
57020587|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
57020588|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020589|NCT02076750|Vitamin D|vitamin d|mesh-list
57020590|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
57020591|NCT02076750|Vitamins|vitamins|mesh-ancestor
57020592|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
57020593|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020594|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57020595|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57020596|NCT05262608|Olaparib|olaparib|mesh-list
57020597|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57020598|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894841|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020599|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020600|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020601|NCT01380457|Dronabinol|dronabinol|mesh-list
57020602|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
57020603|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020604|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57020605|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020606|NCT01380457|Analgesics|analgesics|mesh-ancestor
57020607|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
57020608|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020609|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57020610|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57020611|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020612|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020613|NCT01380457|Hormones|hormones|mesh-ancestor
57020614|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020615|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
57020616|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020617|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020618|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020619|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57020620|NCT01380301|Miltefosine|miltefosine|mesh-list
57020621|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
57020622|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020623|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020624|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57020625|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57020627|NCT02076828|Glycine|glycine|mesh-list
57020628|NCT02076828|Trace Elements|trace elements|mesh-ancestor
57020629|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
57020630|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020631|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
57020632|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020633|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020634|NCT02221154|Folic Acid|folic acid|mesh-list
57020635|NCT02221154|Hematinics|hematinics|mesh-ancestor
57020636|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
57020637|NCT02221154|Vitamins|vitamins|mesh-ancestor
57020638|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
57020639|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020640|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
57020641|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57020642|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020643|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57020644|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57020645|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020646|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020647|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020648|NCT03787849|Anesthetics|anesthetics|mesh-list
57020649|NCT03787849|Propofol|propofol|mesh-list
57020650|NCT03787849|Sevoflurane|sevoflurane|mesh-list
57020651|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020652|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020653|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57020654|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57020655|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
57020656|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57020657|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57020658|NCT03777319|Prednisolone|prednisolone|mesh-list
57020659|NCT03777319|Spironolactone|spironolactone|mesh-list
57020660|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57020661|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
57020662|NCT03777319|Hormones|hormones|mesh-ancestor
57020663|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020664|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020665|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57020666|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020667|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57020668|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
57020669|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57020670|NCT03777319|Diuretics|diuretics|mesh-ancestor
57020671|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
57020672|NCT03671265|Apatinib|apatinib|mesh-list
57020673|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020674|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57020675|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020676|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020677|NCT02881957|Vitamin D|vitamin d|mesh-list
57020678|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
57020679|NCT02881957|Vitamins|vitamins|mesh-ancestor
57020680|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
57020681|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020682|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57020683|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57020684|NCT02206022|Remifentanil|remifentanil|mesh-list
57020685|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57020686|NCT02206022|Narcotics|narcotics|mesh-ancestor
57020687|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020688|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020689|NCT02206022|Analgesics|analgesics|mesh-ancestor
57020690|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
57020691|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020692|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
57020693|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
57020694|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
57020695|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020696|NCT02073552|Protective Agents|protective agents|mesh-ancestor
57020697|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020698|NCT02073552|Vitamins|vitamins|mesh-ancestor
57020699|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
57020700|NCT02073552|Laxatives|laxatives|mesh-ancestor
57020701|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57020702|NCT02210156|Micronutrients|micronutrients|mesh-list
57020703|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020704|NCT02080026|Chloroquine|chloroquine|mesh-list
57020705|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
57020706|NCT02080026|Atovaquone|atovaquone|mesh-list
57020707|NCT02080026|Proguanil|proguanil|mesh-list
57020708|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
57020709|NCT02080026|Amebicides|amebicides|mesh-ancestor
57020710|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57020711|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57020712|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020713|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
57020714|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57020715|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57020716|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020717|NCT02080026|Analgesics|analgesics|mesh-ancestor
57020718|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
57020719|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020720|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020721|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57020722|NCT02080026|Filaricides|filaricides|mesh-ancestor
57020723|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
57020724|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
57020725|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020726|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020727|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
57020728|NCT02206178|Acetaminophen|acetaminophen|mesh-list
57020729|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
57020730|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57020731|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020732|NCT02206178|Analgesics|analgesics|mesh-ancestor
57020733|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
57020734|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020735|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020736|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
57020737|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
57020738|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020739|NCT02206178|Expectorants|expectorants|mesh-ancestor
57020740|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
57020741|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57020742|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
57020743|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020744|NCT02206178|Protective Agents|protective agents|mesh-ancestor
57020745|NCT02206178|Antidotes|antidotes|mesh-ancestor
57020746|NCT02080104|Oxytocin|oxytocin|mesh-list
57020747|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
57020748|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57020749|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020750|NCT03463057|Atezolizumab|atezolizumab|mesh-list
57020751|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020752|NCT02211326|Warfarin|warfarin|mesh-list
57020753|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
57020754|NCT02691793|Sunitinib|sunitinib|mesh-list
57020755|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020756|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57020757|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57020758|NCT02691793|Growth Substances|growth substances|mesh-ancestor
57020759|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020760|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
57020761|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57020762|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020763|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020764|NCT02221622|Pregnanolone|pregnanolone|mesh-list
57020765|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57020766|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
57020767|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020768|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020769|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
57020770|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57020771|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
57020772|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020773|NCT02080182|Expectorants|expectorants|mesh-ancestor
57020774|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
57020775|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57020776|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
57020777|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020778|NCT02080182|Protective Agents|protective agents|mesh-ancestor
57020779|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020780|NCT02080182|Antidotes|antidotes|mesh-ancestor
57020781|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
57020782|NCT02750930|Incretins|incretins|mesh-ancestor
57020783|NCT02750930|Hormones|hormones|mesh-ancestor
57020784|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57020785|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020786|NCT02080416|Nelfinavir|nelfinavir|mesh-list
57020787|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57020788|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57020789|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
57020790|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020791|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020792|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57020793|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57020794|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
57020795|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020796|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
57020797|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57020798|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57020799|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020800|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
57020801|NCT02080494|Coagulants|coagulants|mesh-ancestor
57020802|NCT02213744|Gemcitabine|gemcitabine|mesh-list
57020803|NCT02213744|Capecitabine|capecitabine|mesh-list
57020804|NCT02213744|Trastuzumab|trastuzumab|mesh-list
57020805|NCT02213744|Vinorelbine|vinorelbine|mesh-list
57020806|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57020807|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
57020808|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020809|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020810|NCT02213744|Antiviral Agents|antiviral agents|mesh-ancestor
57020811|NCT02213744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020812|NCT02213744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020813|NCT02213744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57020814|NCT02213744|Immunologic Factors|immunologic factors|mesh-ancestor
57020815|NCT02213744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020816|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020817|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57020818|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
57020819|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
57020820|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
57020821|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
57020822|NCT01378741|Propofol|propofol|mesh-list
57020823|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57020824|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020825|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896831|NCT01270737|Daidzein|daidzein|mesh-list
57020826|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57020827|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
57020828|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
57020829|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020830|NCT01378741|Analgesics|analgesics|mesh-ancestor
57020831|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
57020832|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020833|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57020834|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57020835|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57020836|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
57020837|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020838|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020839|NCT04850599|Pomalidomide|pomalidomide|mesh-list
57020840|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57020841|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
57020842|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020843|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57020844|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57020845|NCT04850599|Growth Substances|growth substances|mesh-ancestor
57020846|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
57020847|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020848|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
57020849|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020850|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57020851|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020852|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020853|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
57020854|NCT02225054|Ropivacaine|ropivacaine|mesh-list
57020855|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57020856|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020857|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020858|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020859|NCT02225054|Analgesics|analgesics|mesh-ancestor
57020860|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
57020861|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020862|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57020863|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57020864|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57020865|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
57020866|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020867|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020868|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
57020869|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
57020870|NCT02080728|Ropivacaine|ropivacaine|mesh-list
57020871|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
57020872|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
57020873|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020874|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020875|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
57020876|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020877|NCT03078907|Selexipag|selexipag|mesh-list
57020878|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57020879|NCT02225210|Fentanyl|fentanyl|mesh-list
57020880|NCT02225210|Midazolam|midazolam|mesh-list
57020881|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
57020882|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57020883|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57020884|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020885|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57020886|NCT02225210|Analgesics|analgesics|mesh-ancestor
57020887|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
57020888|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57020889|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57020890|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57020891|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57020892|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
57020893|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57020894|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020895|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57020896|NCT02225210|Narcotics|narcotics|mesh-ancestor
57020897|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57020898|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57020899|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
57020900|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
57020901|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57020902|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57020903|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57020904|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
57020905|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
57020906|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
57020907|NCT02217020|Irinotecan|irinotecan|mesh-list
57020908|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020909|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57020910|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57020911|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020912|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020913|NCT03249714|Ofatumumab|ofatumumab|mesh-list
57020914|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57020915|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020916|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
57020917|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020918|NCT02222168|BI 409306|bi 409306|mesh-list
57020919|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57020920|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020921|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702968|NCT00740792|Xhance|xhance|mesh-list
57020922|NCT02925117|Upadacitinib|upadacitinib|mesh-list
57020923|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57020924|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57020925|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020926|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020927|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57020928|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
57020929|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57020930|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020931|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
57020932|NCT02225756|Cyclosporine|cyclosporine|mesh-list
57020933|NCT02225756|Cyclosporins|cyclosporins|mesh-list
57020934|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020935|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020936|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57020937|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
57020938|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020939|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
57020940|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020941|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
57020942|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57020943|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57020944|NCT02225834|Atorvastatin|atorvastatin|mesh-list
57020945|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57020946|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57020947|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
57020948|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020949|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57020950|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57020951|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020952|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
57020953|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020954|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
57020955|NCT02693535|Nivolumab|nivolumab|mesh-list
57020956|NCT02693535|Trastuzumab|trastuzumab|mesh-list
57020957|NCT02693535|Ipilimumab|ipilimumab|mesh-list
57020958|NCT02693535|Pertuzumab|pertuzumab|mesh-list
57020959|NCT02693535|Atezolizumab|atezolizumab|mesh-list
57020960|NCT02693535|Sunitinib|sunitinib|mesh-list
57020961|NCT02693535|Olaparib|olaparib|mesh-list
57020962|NCT02693535|Palbociclib|palbociclib|mesh-list
57020963|NCT02693535|Afatinib|afatinib|mesh-list
57020964|NCT02693535|Vemurafenib|vemurafenib|mesh-list
57020965|NCT02693535|Crizotinib|crizotinib|mesh-list
57020966|NCT02693535|Talazoparib|talazoparib|mesh-list
57020967|NCT02693535|Tucatinib|tucatinib|mesh-list
57020968|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57020969|NCT02693535|Entrectinib|entrectinib|mesh-list
57020970|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57020971|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020972|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57020973|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020974|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
57020975|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020976|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57020977|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57020978|NCT02693535|Growth Substances|growth substances|mesh-ancestor
57020979|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
57020980|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57020981|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020982|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57020983|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
57020984|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57020985|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57020986|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57020987|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57020988|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57020989|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57020990|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020991|NCT02074800|Siltuximab|siltuximab|mesh-list
57020992|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57020993|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57020994|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
57020995|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57020996|NCT04504045|Metformin|metformin|mesh-list
57020997|NCT04504045|Efavirenz|efavirenz|mesh-list
57020998|NCT04504045|Losartan|losartan|mesh-list
56702987|NCT04895436|Venetoclax|venetoclax|mesh-list
57020999|NCT04504045|Metoprolol|metoprolol|mesh-list
57021000|NCT04504045|Midazolam|midazolam|mesh-list
57021001|NCT04504045|Caffeine|caffeine|mesh-list
57021002|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57021003|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021004|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57021005|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57021006|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021007|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57021008|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57021009|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57021010|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57021011|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
57021012|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
57021013|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
57021014|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
57021015|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021016|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021017|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57021018|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57021019|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57021020|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57021021|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57021022|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57021023|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021024|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57021025|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57021026|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
57021027|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57021028|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57021029|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
57021030|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57021031|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57021032|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57021033|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57021034|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57021035|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57021036|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57021037|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
57021038|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
57021039|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021040|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57021041|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57021042|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57021043|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
57021044|NCT03283488|Megestrol|megestrol|mesh-list
57021045|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
57021046|NCT03283488|Mirtazapine|mirtazapine|mesh-list
57021047|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
57021048|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57021049|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57021050|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
57021051|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
57021052|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021053|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021054|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021055|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57021056|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57021057|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021058|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57021059|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57021060|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57021061|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
57021062|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57021063|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57021064|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
57021065|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57021066|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57021067|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57021068|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57021069|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
57021070|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57021071|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57021072|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56703059|NCT05683782|Chitosan|chitosan|mesh-list
57021073|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57021074|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021075|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
57021076|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57021077|NCT02258204|Ketamine|ketamine|mesh-list
57021078|NCT02258204|Analgesics|analgesics|mesh-ancestor
57021079|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
57021080|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021081|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021082|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57021083|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57021084|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
57021085|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
57021086|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021087|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57021088|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57021089|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021090|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021091|NCT02226068|Cyclosporine|cyclosporine|mesh-list
57021092|NCT02226068|Cyclosporins|cyclosporins|mesh-list
57021093|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021094|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021095|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57021096|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
57021097|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021098|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
57021099|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57021100|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
57021101|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57021102|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57021103|NCT02220218|Metformin|metformin|mesh-list
57021104|NCT02220218|Canagliflozin|canagliflozin|mesh-list
57021105|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57021106|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021107|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57021108|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021109|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57021110|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57021111|NCT02222480|Diuretics|diuretics|mesh-ancestor
57021112|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
57021113|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021114|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57021115|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57021116|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021117|NCT03670875|Curcumin|curcumin|mesh-list
57021118|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57021119|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57021120|NCT03670875|Analgesics|analgesics|mesh-ancestor
57021121|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
57021122|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021123|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021124|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57021125|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57021126|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021127|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021128|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021129|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
57021130|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57021131|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021132|NCT02220296|Insulin|insulin|mesh-list
57021133|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57021134|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
57021135|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57021136|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021137|NCT02074878|Sunitinib|sunitinib|mesh-list
57021138|NCT02074878|Crizotinib|crizotinib|mesh-list
57021139|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021140|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57021141|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57021142|NCT02074878|Growth Substances|growth substances|mesh-ancestor
57021143|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021144|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
57021145|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57021146|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021147|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021149|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
57021150|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
57021151|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021152|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021153|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57021154|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
57021155|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
57021156|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57021157|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
57021158|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021159|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021160|NCT03075163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57021161|NCT03075163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57021162|NCT03075163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021163|NCT03075163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57021164|NCT03075163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57021165|NCT02628405|Rituximab|rituximab|mesh-list
57021166|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57021167|NCT02628405|Carboplatin|carboplatin|mesh-list
57021168|NCT02628405|Etoposide|etoposide|mesh-list
57021169|NCT02628405|Lenalidomide|lenalidomide|mesh-list
57021170|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
57021171|NCT02628405|Ifosfamide|ifosfamide|mesh-list
57021172|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
57021173|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
57021174|NCT02628405|Antibodies|antibodies|mesh-list
57021175|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
57021176|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57021177|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
57021178|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021179|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021180|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57021181|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57021182|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57021183|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57021184|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021185|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021186|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57021187|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57021188|NCT02628405|Growth Substances|growth substances|mesh-ancestor
57021189|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
57021190|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57021191|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
57021192|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
57021193|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
57021194|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
57021195|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
57021196|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
57021197|NCT02220530|Fentanyl|fentanyl|mesh-list
57021198|NCT02220530|Midazolam|midazolam|mesh-list
57021199|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57021200|NCT02220530|Narcotics|narcotics|mesh-ancestor
57021201|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021202|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021203|NCT02220530|Analgesics|analgesics|mesh-ancestor
57021204|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
57021205|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021206|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57021207|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57021208|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
57021209|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
57021210|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57021211|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57021212|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57021213|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57021214|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
57021215|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
57021216|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021217|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021218|NCT02078232|Pancrelipase|pancrelipase|mesh-list
57021219|NCT02078232|Pancreatin|pancreatin|mesh-list
57021220|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57021221|NCT02075034|ON 01910|on 01910|mesh-list
57021222|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021223|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57021224|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021225|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021227|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
57021228|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
57021229|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021230|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021231|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57021232|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57021233|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
57021234|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021235|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021236|NCT02078388|Doxorubicin|doxorubicin|mesh-list
57021237|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57021238|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021239|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57021240|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57021241|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021242|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021243|NCT02222636|Fentanyl|fentanyl|mesh-list
57021244|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
57021245|NCT02222636|Anesthetics|anesthetics|mesh-list
57021246|NCT02222636|Sevoflurane|sevoflurane|mesh-list
57021247|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021248|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021249|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57021250|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57021251|NCT02222636|Analgesics|analgesics|mesh-ancestor
57021252|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
57021253|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021254|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57021255|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57021256|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57021257|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
57021258|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021259|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021260|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57021261|NCT02222636|Narcotics|narcotics|mesh-ancestor
57021262|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57021263|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57021264|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
57021265|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57021266|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57021267|NCT04058145|Plerixafor|plerixafor|mesh-list
57021268|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
57021269|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021270|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021271|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57021272|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57021273|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
57021274|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57021275|NCT02230982|Nintedanib|nintedanib|mesh-list
57021276|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021277|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57021278|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021279|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021280|NCT02075112|Genistein|genistein|mesh-list
57021281|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021282|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57021283|NCT02075112|Protective Agents|protective agents|mesh-ancestor
57021284|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021285|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57021286|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021287|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021288|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
57021289|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57021290|NCT02075112|Estrogens|estrogens|mesh-ancestor
57021291|NCT02075112|Hormones|hormones|mesh-ancestor
57021292|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57021293|NCT02223026|Metformin|metformin|mesh-list
57021294|NCT02223026|Linagliptin|linagliptin|mesh-list
57021295|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57021296|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021297|NCT02223026|Incretins|incretins|mesh-ancestor
57021298|NCT02223026|Hormones|hormones|mesh-ancestor
57021299|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57021300|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57021301|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
57021302|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021303|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021304|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57021305|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57021306|NCT02477384|Propranolol|propranolol|mesh-list
57021307|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57021308|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57021309|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
57021310|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021311|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021312|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021313|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57021314|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57021315|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
57021316|NCT02231294|Pramipexole|pramipexole|mesh-list
57021317|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
57021318|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021319|NCT02231294|Protective Agents|protective agents|mesh-ancestor
57021320|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021321|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57021322|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57021323|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
57021324|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
57021325|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021326|NCT02223416|Teriparatide|teriparatide|mesh-list
57021327|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57021328|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021329|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57021330|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
57021331|NCT02082054|Atropine|atropine|mesh-list
57021332|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
57021333|NCT02082054|Ephedrine|ephedrine|mesh-list
57021334|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57021335|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57021336|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57021337|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
57021338|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021339|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021340|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57021341|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
57021342|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
57021343|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
57021344|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57021345|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57021346|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
56598801|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
57021347|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021348|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021349|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
57021350|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57021351|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57021352|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
57021353|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
57021354|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
57021355|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
57021356|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57021357|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
57021358|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
57021359|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57021360|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57021361|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57021362|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
57021363|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021364|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021365|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57021366|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
57021367|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
57021368|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57021369|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021370|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57021371|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57021372|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57021373|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021374|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
57021375|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021377|NCT02226926|Dipyridamole|dipyridamole|mesh-list
57021378|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
57021379|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57021380|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57021381|NCT02226926|Analgesics|analgesics|mesh-ancestor
57021382|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
57021383|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021384|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021385|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57021386|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57021387|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57021388|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57021389|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021390|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57021391|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57021392|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021393|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
57021394|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57021395|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
57021396|NCT02924883|Trastuzumab|trastuzumab|mesh-list
57021397|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
57021398|NCT02924883|Atezolizumab|atezolizumab|mesh-list
57021399|NCT02924883|Maytansine|maytansine|mesh-list
57021400|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021401|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021402|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57021403|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
57021404|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
57021405|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
57021406|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021407|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
57021408|NCT02075970|Hematinics|hematinics|mesh-ancestor
57021409|NCT05764057|Dapagliflozin|dapagliflozin|mesh-list
57021410|NCT05764057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57021411|NCT05764057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021412|NCT05764057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57021413|NCT05764057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021414|NCT02227082|Olaparib|olaparib|mesh-list
57021415|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57021416|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021417|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021418|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021419|NCT01369680|Ketamine|ketamine|mesh-list
57021420|NCT01369680|Analgesics|analgesics|mesh-ancestor
57021421|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
57021422|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021423|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021424|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57021425|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57021426|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
57021427|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
57021428|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021429|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57021430|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57021431|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021432|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021433|NCT04780321|Antibodies|antibodies|mesh-list
57021434|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57021435|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
57021436|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021437|NCT03670095|Memantine|memantine|mesh-list
57021438|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57021439|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57021440|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
57021441|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021442|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021443|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021444|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57021445|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57021446|NCT01378039|Budesonide|budesonide|mesh-list
57021447|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57021449|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
57021450|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021451|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021452|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57021453|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
57021454|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
57021455|NCT01378039|Hormones|hormones|mesh-ancestor
57021456|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57021457|NCT01377961|Lycopene|lycopene|mesh-list
57021458|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57021459|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
57021460|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021461|NCT01377961|Protective Agents|protective agents|mesh-ancestor
57021462|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021463|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57021464|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57021465|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021466|NCT03558750|Rituximab|rituximab|mesh-list
57021467|NCT03558750|Nivolumab|nivolumab|mesh-list
57021468|NCT03558750|Lenalidomide|lenalidomide|mesh-list
57021469|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021470|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021471|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
57021472|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021473|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57021474|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57021475|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021476|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57021477|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57021478|NCT03558750|Growth Substances|growth substances|mesh-ancestor
57021479|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
57021480|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57021481|NCT02751320|Citric Acid|citric acid|mesh-list
57021482|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
57021483|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
57021484|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57021485|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
57021486|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
57021487|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021488|NCT04093219|Acetaminophen|acetaminophen|mesh-list
57021489|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57021490|NCT04093219|Analgesics|analgesics|mesh-ancestor
57021491|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
57021492|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021493|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021494|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
57021495|NCT02319837|Leuprolide|leuprolide|mesh-list
57021496|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57021497|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
57021498|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57021499|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021500|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57021501|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021502|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
57021503|NCT04931641|Trace Elements|trace elements|mesh-ancestor
57021504|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
57021505|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021506|NCT02083536|Docetaxel|docetaxel|mesh-list
57021507|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021508|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
57021509|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
57021510|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
57021511|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021512|NCT02231606|Methamphetamine|methamphetamine|mesh-list
57021513|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57021514|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021515|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
57021516|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
57021517|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021518|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
57021519|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021520|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021521|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
56703509|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
57021522|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57021523|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57021524|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57021525|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57021527|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021528|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021529|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57021530|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021531|NCT02083692|Metformin|metformin|mesh-list
57021532|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57021533|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021534|NCT02227550|Vitamin K|vitamin k|mesh-list
57021535|NCT02227550|Warfarin|warfarin|mesh-list
57021536|NCT02227550|Apixaban|apixaban|mesh-list
57021537|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
57021538|NCT02227550|Fluindione|fluindione|mesh-list
57021539|NCT02227550|Vitamins|vitamins|mesh-ancestor
57021540|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
57021541|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021542|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
57021543|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57021544|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
57021545|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57021546|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
57021547|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021548|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021549|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57021550|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57021551|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
57021552|NCT02227550|Coagulants|coagulants|mesh-ancestor
57021553|NCT02206035|Methotrexate|methotrexate|mesh-list
57021554|NCT02206035|Tacrolimus|tacrolimus|mesh-list
57021555|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57021556|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
57021557|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57021558|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021559|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57021560|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
57021561|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021562|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021563|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
57021564|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021565|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57021566|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57021567|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
57021568|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57021569|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57021570|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57021571|NCT02258828|Memantine|memantine|mesh-list
57021572|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57021573|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57021574|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
57021575|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021576|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021577|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021578|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57021579|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57021580|NCT02083068|Vaccines|vaccines|mesh-list
57021581|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
57021582|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
57021583|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021584|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57021585|NCT02228252|Caseins|caseins|mesh-list
57021586|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
57021587|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
57021588|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021589|NCT02070549|Trametinib|trametinib|mesh-list
57021590|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021591|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57021592|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021593|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021594|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
57021595|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57021596|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57021597|NCT02591953|Prednisolone|prednisolone|mesh-list
57021598|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
57021599|NCT02591953|Lidocaine|lidocaine|mesh-list
57021600|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57021601|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
57021602|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
57021603|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
57021604|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021605|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021606|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
57021607|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021608|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57021609|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57021610|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57021611|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57021612|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021613|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57021614|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
57021615|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
57021616|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57021617|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
57021618|NCT02591953|Hormones|hormones|mesh-ancestor
57021619|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57021620|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57021621|NCT02591953|Protective Agents|protective agents|mesh-ancestor
57021622|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57021623|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021624|NCT02223884|Carboplatin|carboplatin|mesh-list
57021625|NCT02223884|Docetaxel|docetaxel|mesh-list
57021626|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021627|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
57021628|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
57021629|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
57021630|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021631|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
57021632|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57021633|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
57021634|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021635|NCT02569489|Paclitaxel|paclitaxel|mesh-list
57021636|NCT02569489|Trastuzumab|trastuzumab|mesh-list
57021637|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57021638|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021639|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
57021640|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
57021641|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56896844|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57021642|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021643|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021644|NCT02079558|Oxytocin|oxytocin|mesh-list
57021645|NCT02079558|Carbetocin|carbetocin|mesh-list
57021646|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
57021647|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57021648|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021649|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
57021650|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57021651|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57021652|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57021653|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57021654|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021655|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
57021656|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021657|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021658|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57021659|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021660|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
57021661|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
57021662|NCT03669003|Coagulants|coagulants|mesh-ancestor
57021663|NCT05763823|Letermovir|letermovir|mesh-list
57021664|NCT05763823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57021665|NCT05763823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021666|NCT05763823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021667|NCT05763823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021668|NCT05763823|Antiviral Agents|antiviral agents|mesh-ancestor
57021669|NCT05763823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57021670|NCT04313959|Dexamethasone|dexamethasone|mesh-list
57021671|NCT04313959|Ropivacaine|ropivacaine|mesh-list
57021672|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57021673|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
57021675|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021676|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021677|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57021678|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
57021679|NCT04313959|Hormones|hormones|mesh-ancestor
57021680|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57021681|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57021682|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021683|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
57021684|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
57021685|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021686|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
57021687|NCT03073213|Ixekizumab|ixekizumab|mesh-list
57021688|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
57021689|NCT03070483|Vitamin D|vitamin d|mesh-list
57021690|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
57021691|NCT03070483|Vitamins|vitamins|mesh-ancestor
57021692|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
57021693|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021694|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57021695|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57021696|NCT05763667|Bupivacaine|bupivacaine|mesh-list
57021697|NCT05763667|Anesthetics, Local|anesthetics, local|mesh-ancestor
57021698|NCT05763667|Anesthetics|anesthetics|mesh-ancestor
57021699|NCT05763667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021700|NCT05763667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021701|NCT05763667|Sensory System Agents|sensory system agents|mesh-ancestor
57021702|NCT05763667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021703|NCT01704859|Vitamin D|vitamin d|mesh-list
57021704|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
57021705|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
57021706|NCT01704859|Vitamins|vitamins|mesh-list
57021707|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
57021708|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021709|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57021710|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57021711|NCT04107727|Cytarabine|cytarabine|mesh-list
57021712|NCT04107727|Idarubicin|idarubicin|mesh-list
57021713|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57021714|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
57021715|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021716|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021717|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
57021718|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57021719|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57021720|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
57021721|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021722|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57021723|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57021724|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57021725|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021726|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57021727|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57021728|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57021729|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57021730|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021731|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021732|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021733|NCT01074151|Analgesics|analgesics|mesh-ancestor
57021734|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
57021735|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021736|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
57021737|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57021738|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
57021739|NCT05761405|Ceftriaxone|ceftriaxone|mesh-list
57021740|NCT05761405|Amikacin|amikacin|mesh-list
57021741|NCT05761405|Mannitol|mannitol|mesh-list
57021742|NCT05761405|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57021743|NCT05761405|Diuretics|diuretics|mesh-ancestor
57021744|NCT05761405|Natriuretic Agents|natriuretic agents|mesh-ancestor
57021745|NCT05761405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021746|NCT05761405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57021747|NCT05761405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57021748|NCT03979885|Nicotine|nicotine|mesh-list
56703755|NCT04066803|Folic Acid|folic acid|mesh-list
57021749|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57021750|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
57021751|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021752|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021753|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57021754|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57021755|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
57021756|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021757|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021758|NCT02786329|Lidocaine|lidocaine|mesh-list
57021759|NCT02786329|Sevoflurane|sevoflurane|mesh-list
57021760|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
57021761|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
57021762|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021763|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021764|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
57021765|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021766|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57021767|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57021768|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57021769|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57021770|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021771|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57021772|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57021773|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
57021774|NCT05761951|Pembrolizumab|pembrolizumab|mesh-list
57021775|NCT05761951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021776|NCT05761951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021777|NCT05761327|Curcumin|curcumin|mesh-list
57021778|NCT05761327|Resveratrol|resveratrol|mesh-list
57021779|NCT05761327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57021780|NCT05761327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57021781|NCT05761327|Analgesics|analgesics|mesh-ancestor
57021782|NCT05761327|Sensory System Agents|sensory system agents|mesh-ancestor
57021783|NCT05761327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021784|NCT05761327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021785|NCT05761327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57021786|NCT05761327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57021787|NCT05761327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021788|NCT05761327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054469|NCT03781479|Amifampridine|amifampridine|mesh-list
57021789|NCT05761327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021790|NCT05761327|Antioxidants|antioxidants|mesh-ancestor
57021791|NCT05761327|Protective Agents|protective agents|mesh-ancestor
57021792|NCT05761327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57021793|NCT01757535|Azacitidine|azacitidine|mesh-list
57021794|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57021795|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
57021796|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021797|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021798|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021799|NCT02231762|Temozolomide|temozolomide|mesh-list
57021800|NCT02231762|Lanreotide|lanreotide|mesh-list
57021801|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57021802|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
57021803|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021804|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021805|NCT04507178|Nadroparin|nadroparin|mesh-list
57021806|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
57021807|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57021808|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57021809|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021810|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
57021811|NCT01191957|Busulfan|busulfan|mesh-list
57021812|NCT01191957|Fludarabine|fludarabine|mesh-list
57021813|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57021814|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
57021815|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021816|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57021817|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57021818|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
57021819|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021820|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703810|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021821|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57021822|NCT01050855|Busulfan|busulfan|mesh-list
57021823|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
57021824|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
57021825|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021826|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57021827|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
57021828|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021829|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57021830|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021831|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57021832|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021833|NCT04459286|Ritonavir|ritonavir|mesh-list
57021834|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57021835|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
57021836|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57021837|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57021838|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
57021839|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021840|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021841|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57021842|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57021843|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
57021844|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57021845|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57021846|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57021847|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57021848|NCT00744081|Topotecan|topotecan|mesh-list
57021849|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
57021850|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57021851|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57021852|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021853|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021854|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021855|NCT00744081|Analgesics|analgesics|mesh-ancestor
57021856|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
57021857|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021858|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021859|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57021860|NCT02229266|Cytarabine|cytarabine|mesh-list
57021861|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57021862|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
57021863|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021864|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021865|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
57021866|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57021867|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57021868|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
57021869|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021870|NCT02224040|Azithromycin|azithromycin|mesh-list
57021871|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
57021872|NCT02224040|Cefixime|cefixime|mesh-list
57021873|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57021874|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57021875|NCT04448834|Vincristine|vincristine|mesh-list
57021876|NCT04448834|Blinatumomab|blinatumomab|mesh-list
57021877|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57021878|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021879|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
57021880|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
57021881|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
57021882|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021883|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
57021884|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021885|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021886|NCT02232308|Lisinopril|lisinopril|mesh-list
57021887|NCT02232308|Nizatidine|nizatidine|mesh-list
57021888|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57021889|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
57021890|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021891|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021892|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57021893|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57021894|NCT02232308|Protective Agents|protective agents|mesh-ancestor
57021895|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021896|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57021897|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57021898|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57021899|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
57021900|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
57021901|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021902|NCT02232386|Rituximab|rituximab|mesh-list
57021903|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021904|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021905|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
57021906|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021907|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57021908|NCT02229734|Androgens|androgens|mesh-list
57021909|NCT02229734|Hormones|hormones|mesh-ancestor
57021910|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57021911|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021912|NCT04333160|Hylan|hylan|mesh-list
57021913|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
57021914|NCT04333160|Protective Agents|protective agents|mesh-ancestor
57021915|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021916|NCT02258906|Urinastatin|urinastatin|mesh-list
57021917|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57021918|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57021919|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
57021920|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021921|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021922|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57021923|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57021924|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57021925|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021926|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57021927|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57021928|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57021929|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57021930|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57021931|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021932|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
57021933|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021934|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57021935|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021936|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021937|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
57021938|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57021939|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021940|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57021941|NCT03068455|Nivolumab|nivolumab|mesh-list
57021942|NCT03068455|Ipilimumab|ipilimumab|mesh-list
57021943|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021944|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021945|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57021946|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021947|NCT03646994|Crizotinib|crizotinib|mesh-list
57021948|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021949|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57021950|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57021951|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021952|NCT03635996|Etripamil|etripamil|mesh-list
57021953|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57021954|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57021955|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021956|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57021957|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021958|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
57021959|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
57021960|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57021961|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57021962|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
57021963|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021964|NCT04209296|Ketamine|ketamine|mesh-list
57021965|NCT04209296|Analgesics|analgesics|mesh-ancestor
57021966|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
57021967|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57021968|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021969|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57021970|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57021971|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
57021973|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021974|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57021975|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57021976|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57021977|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021978|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57021979|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57021980|NCT02232932|Capecitabine|capecitabine|mesh-list
57021981|NCT02232932|Liver Extracts|liver extracts|mesh-list
57021982|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57021983|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
57021984|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57021985|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021986|NCT02232932|Hematinics|hematinics|mesh-ancestor
57021987|NCT02230358|Anesthetics|anesthetics|mesh-list
57021988|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57021989|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021990|NCT04114136|Metformin|metformin|mesh-list
57021991|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
57021992|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
57021993|NCT04114136|Nivolumab|nivolumab|mesh-list
57021994|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57021995|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57021996|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57021997|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57021998|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57021999|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022000|NCT04214288|Fulvestrant|fulvestrant|mesh-list
57022001|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57022002|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022003|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57022004|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57022005|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
57022006|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022007|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022008|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57022009|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57022010|NCT04049864|Lenalidomide|lenalidomide|mesh-list
57022011|NCT04049864|Vaccines|vaccines|mesh-list
57022012|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
57022013|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022014|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57022015|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57022016|NCT04049864|Growth Substances|growth substances|mesh-ancestor
57022017|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
57022018|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022019|NCT03475706|Solabegron|solabegron|mesh-list
57022020|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57022021|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57022022|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57022023|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
57022024|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022025|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022026|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022027|NCT05081102|Ibuprofen|ibuprofen|mesh-list
57022028|NCT05081102|Oxycodone|oxycodone|mesh-list
57022029|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57022030|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57022031|NCT05081102|Analgesics|analgesics|mesh-ancestor
57022032|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
57022033|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022034|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022035|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022036|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57022037|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57022038|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022039|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022040|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57022041|NCT05081102|Narcotics|narcotics|mesh-ancestor
57022042|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022043|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57022044|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57022045|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57022046|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
57022047|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022048|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57022049|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57022050|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022051|NCT03928184|Lorecivivint|lorecivivint|mesh-list
57022052|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022053|NCT02259374|Ropivacaine|ropivacaine|mesh-list
57022054|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
57022055|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
57022056|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022057|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022058|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
57022059|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022060|NCT03198728|Testosterone|testosterone|mesh-list
57022061|NCT03198728|Androgens|androgens|mesh-ancestor
57022062|NCT03198728|Hormones|hormones|mesh-ancestor
57022063|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022064|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022065|NCT04921982|Propranolol|propranolol|mesh-list
57022066|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57022067|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57022068|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
57022069|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022070|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022071|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022072|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57022073|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57022074|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
57022075|NCT04866056|Azacitidine|azacitidine|mesh-list
57022076|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57022077|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
57022078|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022079|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022080|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022081|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57022082|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57022083|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57022084|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022085|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022086|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57022087|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57022088|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022089|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
57022090|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022091|NCT04789148|Oxytocin|oxytocin|mesh-list
57022092|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
57022093|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57022094|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022095|NCT03191864|Fluticasone|fluticasone|mesh-list
57022096|NCT03191864|Xhance|xhance|mesh-list
57022097|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022098|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57022099|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
57022100|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022101|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022102|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57022103|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
57022104|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
57022105|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57022106|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
57022107|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57022108|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
57022109|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57022110|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
57022111|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022112|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022113|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
57022114|NCT03881852|Reboxetine|reboxetine|mesh-list
57022115|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
57022116|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57022117|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57022118|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57022119|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57022120|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022121|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
57022122|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022123|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022125|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
57022126|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57022127|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022128|NCT03818828|Trace Elements|trace elements|mesh-ancestor
57022129|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
57022130|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022131|NCT02804282|Furosemide|furosemide|mesh-list
57022132|NCT02804282|Diuretics|diuretics|mesh-ancestor
57022133|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
57022134|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022135|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57022136|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57022137|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022138|NCT02233244|Midazolam|midazolam|mesh-list
57022139|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57022140|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57022141|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022142|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022143|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57022144|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57022145|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57022146|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57022147|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
57022148|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
57022149|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
57022150|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
57022151|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022152|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022153|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
57022154|NCT02234882|Fostemsavir|fostemsavir|mesh-list
57022155|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57022156|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57022157|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57022158|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
57022159|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022160|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57022161|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57022162|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022163|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57022164|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57022165|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
57022166|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022167|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57022168|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57022169|NCT03729362|Miglustat|miglustat|mesh-list
57022170|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022171|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022172|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57022173|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57022174|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
57022175|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022176|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57022177|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57022178|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022179|NCT03727022|Lorecivivint|lorecivivint|mesh-list
57022180|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022181|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
57022182|NCT02233322|Hematinics|hematinics|mesh-ancestor
57022183|NCT02233400|Acetaminophen|acetaminophen|mesh-list
57022184|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57022185|NCT02233400|Analgesics|analgesics|mesh-ancestor
57022186|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
57022187|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022188|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022189|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
57022190|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
57022191|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56704187|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
57022192|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
57022193|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022194|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57022195|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022196|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57022197|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022198|NCT02235194|Chromium|chromium|mesh-list
57022199|NCT02235194|Picolinic acid|picolinic acid|mesh-list
57022200|NCT02235194|Trace Elements|trace elements|mesh-ancestor
57022201|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
57022202|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022203|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57022204|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
57022205|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
57022206|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022207|NCT03684278|Infliximab|infliximab|mesh-list
57022208|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
57022209|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57022210|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57022211|NCT02726659|Celecoxib|celecoxib|mesh-list
57022212|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57022213|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57022214|NCT02726659|Analgesics|analgesics|mesh-ancestor
57022215|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
57022216|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022217|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022218|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022219|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57022220|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57022221|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57022222|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022223|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022224|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57022225|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57022226|NCT04446962|Lenalidomide|lenalidomide|mesh-list
57022227|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
57022228|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022229|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57022230|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57022231|NCT04446962|Growth Substances|growth substances|mesh-ancestor
57022232|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
57022233|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022234|NCT03951961|Midostaurin|midostaurin|mesh-list
57022235|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022236|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57022237|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022238|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022239|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57022240|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57022241|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57022242|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57022243|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022244|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022245|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022246|NCT02232542|Analgesics|analgesics|mesh-ancestor
57022247|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
57022248|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022249|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
57022250|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57022251|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
57022252|NCT02600923|Letrozole|letrozole|mesh-list
57022253|NCT02600923|Palbociclib|palbociclib|mesh-list
57022254|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022255|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57022256|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57022257|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022258|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022259|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57022260|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
57022261|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022262|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022263|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57022264|NCT05761171|Cytarabine|cytarabine|mesh-list
57022265|NCT05761171|Prednisone|prednisone|mesh-list
57022266|NCT05761171|Prednisolone|prednisolone|mesh-list
57022267|NCT05761171|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57022268|NCT05761171|Methylprednisolone|methylprednisolone|mesh-list
57022269|NCT05761171|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57022270|NCT05761171|Prednisolone acetate|prednisolone acetate|mesh-list
57022271|NCT05761171|Hydrocortisone|hydrocortisone|mesh-list
57022272|NCT05761171|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57022273|NCT05761171|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57022274|NCT05761171|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57022275|NCT05761171|Cortisone|cortisone|mesh-list
57022276|NCT05761171|Methotrexate|methotrexate|mesh-list
57022277|NCT05761171|Fludarabine|fludarabine|mesh-list
57022278|NCT05761171|Fludarabine phosphate|fludarabine phosphate|mesh-list
57022279|NCT05761171|Vincristine|vincristine|mesh-list
57022280|NCT05761171|Asparaginase|asparaginase|mesh-list
57022281|NCT05761171|Pegaspargase|pegaspargase|mesh-list
57022282|NCT05761171|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57022283|NCT05761171|Prednisolone phosphate|prednisolone phosphate|mesh-list
57022284|NCT05761171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022285|NCT05761171|Glucocorticoids|glucocorticoids|mesh-ancestor
57022286|NCT05761171|Hormones|hormones|mesh-ancestor
57022287|NCT05761171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022288|NCT05761171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022289|NCT05761171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57022290|NCT05761171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022291|NCT05761171|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57022292|NCT05761171|Abortifacient Agents|abortifacient agents|mesh-ancestor
57022293|NCT05761171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57022294|NCT05761171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57022295|NCT05761171|Antimetabolites|antimetabolites|mesh-ancestor
57022296|NCT05761171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022297|NCT05761171|Dermatologic Agents|dermatologic agents|mesh-ancestor
57022298|NCT05761171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022299|NCT05761171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57022300|NCT05761171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57022301|NCT05761171|Immunologic Factors|immunologic factors|mesh-ancestor
57022302|NCT05761171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57022303|NCT05761171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57022304|NCT05761171|Antiviral Agents|antiviral agents|mesh-ancestor
57022305|NCT05761171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022306|NCT05761171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57022307|NCT05761171|Tubulin Modulators|tubulin modulators|mesh-ancestor
57022308|NCT05761171|Antimitotic Agents|antimitotic agents|mesh-ancestor
57022309|NCT05761171|Mitosis Modulators|mitosis modulators|mesh-ancestor
57022310|NCT05761171|Antiemetics|antiemetics|mesh-ancestor
57022311|NCT05761171|Autonomic Agents|autonomic agents|mesh-ancestor
57022312|NCT05761171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022313|NCT05761171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57022314|NCT05761171|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57022315|NCT05761171|Protective Agents|protective agents|mesh-ancestor
57022316|NCT02232776|Losartan|losartan|mesh-list
57022317|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57022318|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57022319|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57022320|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57022321|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022322|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
57022323|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57022324|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022325|NCT02235428|Bromides|bromides|mesh-list
57022326|NCT02235428|Albuterol|albuterol|mesh-list
57022327|NCT02235428|Ipratropium|ipratropium|mesh-list
57022328|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
57022329|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57022330|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
57022331|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022332|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022333|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57022334|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
57022335|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
57022336|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57022337|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57022338|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57022339|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57022340|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
57022341|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022342|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704336|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
57022343|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57022344|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
57022345|NCT03781219|Vemurafenib|vemurafenib|mesh-list
57022346|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022347|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57022348|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022349|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022350|NCT03070171|Dabigatran|dabigatran|mesh-list
57022351|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
57022352|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57022353|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
57022354|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022355|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022356|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
57022357|NCT02262572|Telmisartan|telmisartan|mesh-list
57022358|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57022359|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57022360|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57022361|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57022362|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022363|NCT02262572|Diuretics|diuretics|mesh-ancestor
57022364|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
57022365|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022366|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57022367|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57022368|NCT02235584|Dexamethasone|dexamethasone|mesh-list
57022369|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022370|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
57022371|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
57022372|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022373|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022374|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57022375|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
57022376|NCT02235584|Hormones|hormones|mesh-ancestor
57022377|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022378|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57022379|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022380|NCT02235662|Tenofovir|tenofovir|mesh-list
57022381|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
57022382|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
57022383|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022384|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57022385|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57022386|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022387|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022388|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57022389|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57022390|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57022391|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
57022392|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57022393|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022394|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57022395|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57022396|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57022397|NCT02262650|Telmisartan|telmisartan|mesh-list
57022398|NCT02262650|Clopidogrel|clopidogrel|mesh-list
57022399|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57022400|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57022401|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57022402|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57022403|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
57022404|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022405|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022406|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022407|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57022408|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57022409|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57022410|NCT01084252|Dexamethasone|dexamethasone|mesh-list
57022411|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
57022412|NCT01084252|BB 1101|bb 1101|mesh-list
57022413|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022414|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
57022415|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
57022416|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704407|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57022417|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022418|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57022419|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
57022420|NCT01084252|Hormones|hormones|mesh-ancestor
57022421|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022422|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57022423|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022424|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
57022425|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022426|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022427|NCT04106414|Nivolumab|nivolumab|mesh-list
57022428|NCT04106414|Linrodostat|linrodostat|mesh-list
57022429|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57022430|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022431|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57022432|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022433|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022434|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
57022435|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57022436|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022437|NCT02233556|Memantine|memantine|mesh-list
57022438|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57022439|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57022440|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
57022441|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022442|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022443|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022444|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57022445|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57022446|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57022447|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57022448|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022449|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
57022450|NCT02236052|Vaccines|vaccines|mesh-list
57022451|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
57022452|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022453|NCT04122196|Pregabalin|pregabalin|mesh-list
57022454|NCT04122196|Analgesics|analgesics|mesh-ancestor
57022455|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
57022456|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022457|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022458|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
57022459|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57022460|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57022461|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022462|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57022463|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57022464|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57022465|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022466|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57022467|NCT04908592|Dexamethasone|dexamethasone|mesh-list
57022468|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022469|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
57022470|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
57022471|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022472|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022473|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57022474|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
57022475|NCT04908592|Hormones|hormones|mesh-ancestor
57022476|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022477|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57022478|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022479|NCT04788550|Listerine|listerine|mesh-list
57022480|NCT04788550|Fluorides|fluorides|mesh-list
57022481|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
57022482|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
57022483|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
57022484|NCT04788550|Protective Agents|protective agents|mesh-ancestor
57022485|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022486|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57022487|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022488|NCT04016714|Vaccines|vaccines|mesh-list
57022489|NCT04016714|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57022490|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
57022491|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022492|NCT04759768|Naltrexone|naltrexone|mesh-list
57022493|NCT04759768|Nalmefene|nalmefene|mesh-list
57022494|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57022495|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022496|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
57022497|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022498|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57022499|NCT02564744|Rituximab|rituximab|mesh-list
57022500|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57022501|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022502|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
57022503|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022504|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57022505|NCT05759767|Tamsulosin|tamsulosin|mesh-list
57022506|NCT05759767|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57022507|NCT05759767|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57022508|NCT05759767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57022509|NCT05759767|Adrenergic Agents|adrenergic agents|mesh-ancestor
57022510|NCT05759767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022511|NCT05759767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022512|NCT05759767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022513|NCT05759767|Urological Agents|urological agents|mesh-ancestor
57022514|NCT02750306|Suvorexant|suvorexant|mesh-list
57022515|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57022516|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57022517|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022518|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022519|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57022520|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022521|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022522|NCT03845140|Praziquantel|praziquantel|mesh-list
57022523|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
57022524|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57022525|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022526|NCT01816165|Acipimox|acipimox|mesh-list
57022527|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57022528|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
57022529|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022530|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57022531|NCT04476680|Vitamin D|vitamin d|mesh-list
57022532|NCT04476680|Vitamins|vitamins|mesh-ancestor
57022533|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
57022534|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022535|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57022536|NCT04952350|Atorvastatin|atorvastatin|mesh-list
57022537|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57022538|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57022539|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
57022540|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022541|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57022542|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57022543|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022544|NCT05376202|Cetuximab|cetuximab|mesh-list
57022545|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57022546|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022547|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
57022548|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57022549|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57022550|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
57022551|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022552|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022553|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57022554|NCT01677988|Folfirinox|folfirinox|mesh-list
57022555|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022556|NCT02233790|Clopidogrel|clopidogrel|mesh-list
57022557|NCT02233790|Ticagrelor|ticagrelor|mesh-list
57022558|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57022559|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57022560|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57022561|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57022562|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
57022563|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022564|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022565|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022566|NCT04540120|Dapansutrile|dapansutrile|mesh-list
57022567|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022568|NCT02547818|Ibuprofen|ibuprofen|mesh-list
57022569|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57022570|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57022571|NCT02547818|Analgesics|analgesics|mesh-ancestor
57022572|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
57022573|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022574|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022575|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022576|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57022577|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57022578|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022579|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022580|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
57022581|NCT04539808|Leucovorin|leucovorin|mesh-list
57022582|NCT04539808|Folic Acid|folic acid|mesh-list
57022583|NCT04539808|Fluorouracil|fluorouracil|mesh-list
57022584|NCT04539808|Capecitabine|capecitabine|mesh-list
57022585|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
57022586|NCT04539808|Irinotecan|irinotecan|mesh-list
57022587|NCT04539808|Camptothecin|camptothecin|mesh-list
57022588|NCT04539808|Losartan|losartan|mesh-list
57022589|NCT04539808|Calcium|calcium|mesh-list
57022590|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
57022591|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57022592|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022593|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57022594|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
55891123|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57022595|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022596|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57022597|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022598|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57022599|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
57022600|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57022601|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57022602|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022603|NCT04539808|Antidotes|antidotes|mesh-ancestor
57022604|NCT04539808|Protective Agents|protective agents|mesh-ancestor
57022605|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
57022606|NCT04539808|Vitamins|vitamins|mesh-ancestor
57022607|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
57022608|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57022609|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57022610|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57022611|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57022612|NCT04539808|Hematinics|hematinics|mesh-ancestor
57022613|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57022614|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57022615|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
57022616|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57022617|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57022618|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
57022619|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022620|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022621|NCT03752918|Niacin|niacin|mesh-list
57022622|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
57022623|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
57022624|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57022625|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
57022626|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022627|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57022628|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
57022629|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
57022630|NCT03752918|Vitamins|vitamins|mesh-ancestor
57022631|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
57022632|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022633|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
57022634|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57022635|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
57022636|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022637|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57022638|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57022639|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57022640|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
57022641|NCT04058158|Eculizumab|eculizumab|mesh-list
57022642|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57022643|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57022644|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
57022645|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022646|NCT02263196|Ethanol|ethanol|mesh-list
57022647|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
57022648|NCT02263196|Povidone|povidone|mesh-list
57022649|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57022650|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022651|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022652|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022653|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
57022654|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
57022655|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
57022656|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022657|NCT02926573|Gabapentin|gabapentin|mesh-list
57022658|NCT02926573|Analgesics|analgesics|mesh-ancestor
57022659|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
57022660|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022661|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022662|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
57022663|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57022664|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57022665|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022666|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896857|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022667|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57022668|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57022669|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022670|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022671|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
57022673|NCT04477018|Chelating Agents|chelating agents|mesh-list
57022674|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
57022675|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022676|NCT04477018|Trace Elements|trace elements|mesh-ancestor
57022677|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022678|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
57022679|NCT05737576|Insulin Aspart|insulin aspart|mesh-list
57022680|NCT05737576|Insulin, Long-Acting|insulin, long-acting|mesh-list
57022681|NCT05737576|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
57022682|NCT05737576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57022683|NCT05737576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022684|NCT05113940|Midazolam|midazolam|mesh-list
57022685|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57022686|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57022687|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022688|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022689|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57022690|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57022691|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57022692|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57022693|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
57022694|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
57022695|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
57022696|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
57022697|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022698|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022699|NCT00158860|Valacyclovir|valacyclovir|mesh-list
57022700|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
57022701|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022702|NCT02490488|Gemcitabine|gemcitabine|mesh-list
57022703|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57022704|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
57022705|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022706|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022707|NCT02490488|Antiviral Agents|antiviral agents|mesh-ancestor
57022708|NCT02490488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022709|NCT02490488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022710|NCT02490488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57022711|NCT02490488|Immunologic Factors|immunologic factors|mesh-ancestor
57022712|NCT02490488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022713|NCT05737186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57022714|NCT05737186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022715|NCT05737186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57022716|NCT05737186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022717|NCT02654990|Dexamethasone|dexamethasone|mesh-list
57022718|NCT02654990|Bortezomib|bortezomib|mesh-list
57022719|NCT02654990|Panobinostat|panobinostat|mesh-list
57022720|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022721|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
57022722|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
57022723|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022724|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022725|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57022726|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
57022727|NCT02654990|Hormones|hormones|mesh-ancestor
57022728|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022729|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57022730|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022731|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57022732|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022733|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022734|NCT02471222|Amantadine|amantadine|mesh-list
57022735|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57022736|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57022737|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
57022738|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022739|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
57022740|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022741|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022742|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022743|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57022744|NCT02471222|Analgesics|analgesics|mesh-ancestor
57022745|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
57022746|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022747|NCT02636582|Molgramostim|molgramostim|mesh-list
57022748|NCT02636582|Vaccines|vaccines|mesh-list
57022749|NCT02636582|Sargramostim|sargramostim|mesh-list
57022750|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
57022751|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022752|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022753|NCT03136120|Bromides|bromides|mesh-list
57022754|NCT03136120|Ipratropium|ipratropium|mesh-list
57022755|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
57022756|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57022757|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
57022758|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022759|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022760|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57022761|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
57022762|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57022763|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
57022764|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022765|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022766|NCT01625234|Ensartinib|ensartinib|mesh-list
57022767|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022768|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57022769|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022770|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022771|NCT02264834|Sufentanil|sufentanil|mesh-list
57022772|NCT02264834|Dsuvia|dsuvia|mesh-list
57022773|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
57022774|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57022775|NCT02264834|Narcotics|narcotics|mesh-ancestor
57022776|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022777|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022778|NCT02264834|Analgesics|analgesics|mesh-ancestor
57022779|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
57022780|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022781|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57022782|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57022783|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
57022784|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
57022785|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
57022786|NCT05762419|Etoposide|etoposide|mesh-list
57022787|NCT05762419|Etoposide phosphate|etoposide phosphate|mesh-list
57022788|NCT05762419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57022789|NCT05762419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022790|NCT05762419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57022791|NCT05762419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57022792|NCT05762419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022793|NCT05762419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022794|NCT02264912|Clopidogrel|clopidogrel|mesh-list
57022795|NCT02264912|Ticagrelor|ticagrelor|mesh-list
57022796|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57022797|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
57022798|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57022799|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57022800|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57022801|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
57022802|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022803|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022804|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022806|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
57022807|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022808|NCT02263352|Protective Agents|protective agents|mesh-ancestor
57022809|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022810|NCT01435226|Ribavirin|ribavirin|mesh-list
57022811|NCT01435226|Ledipasvir|ledipasvir|mesh-list
57022812|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
57022813|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022814|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
57022815|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022816|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
57022817|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
57022818|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
57022819|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57022820|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57022821|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57022822|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022823|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57022824|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57022825|NCT04409509|Antibodies|antibodies|mesh-list
57022826|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57022827|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
57022828|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022829|NCT04401865|Riboflavin|riboflavin|mesh-list
57022830|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
57022831|NCT04401865|Vitamins|vitamins|mesh-ancestor
57022832|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
57022833|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022834|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57022835|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
57022836|NCT02609048|Seladelpar|seladelpar|mesh-list
57022837|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57022838|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
57022839|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022840|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57022841|NCT02265068|Ticagrelor|ticagrelor|mesh-list
57022842|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57022843|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57022844|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57022845|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57022846|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
57022847|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022848|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022849|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022850|NCT02262416|Leuprolide|leuprolide|mesh-list
57022851|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57022852|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
57022853|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57022854|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022855|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57022856|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022857|NCT01577654|Folic Acid|folic acid|mesh-list
57022858|NCT01577654|Docetaxel|docetaxel|mesh-list
57022859|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
57022860|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022861|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
57022862|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
57022863|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
57022864|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022865|NCT01577654|Hematinics|hematinics|mesh-ancestor
57022866|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
57022867|NCT01577654|Vitamins|vitamins|mesh-ancestor
57022868|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
57022869|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022870|NCT05736952|Topotecan|topotecan|mesh-list
56704859|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57022871|NCT05736952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57022872|NCT05736952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57022873|NCT05736952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022874|NCT05736952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022875|NCT05736952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022876|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
57022877|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57022878|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022879|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022880|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
57022881|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
57022882|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
57022883|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022884|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022885|NCT01418222|Leucovorin|leucovorin|mesh-list
57022886|NCT01418222|Bevacizumab|bevacizumab|mesh-list
57022887|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56896863|NCT02831764|Tenofovir|tenofovir|mesh-list
57022888|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022889|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57022890|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57022891|NCT01418222|Growth Substances|growth substances|mesh-ancestor
57022892|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022893|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
57022894|NCT01418222|Antidotes|antidotes|mesh-ancestor
57022895|NCT01418222|Protective Agents|protective agents|mesh-ancestor
57022896|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
57022897|NCT01418222|Vitamins|vitamins|mesh-ancestor
57022898|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
57022899|NCT05377606|Temazepam|temazepam|mesh-list
57022900|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57022901|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022902|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022903|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57022904|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57022905|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57022906|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
57022907|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
57022908|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57022909|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022910|NCT01256762|Paclitaxel|paclitaxel|mesh-list
57022911|NCT01256762|Bevacizumab|bevacizumab|mesh-list
57022912|NCT01256762|Imetelstat|imetelstat|mesh-list
57022913|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
57022914|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57022915|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022916|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
57022917|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
57022918|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
57022919|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022920|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57022921|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57022922|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57022923|NCT01256762|Growth Substances|growth substances|mesh-ancestor
57022924|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022925|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
57022926|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022927|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57022928|NCT01252628|Cetuximab|cetuximab|mesh-list
57022929|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57022930|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022931|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
57022932|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57022933|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022934|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022935|NCT04349371|Chloroquine|chloroquine|mesh-list
57022936|NCT04349371|Amebicides|amebicides|mesh-ancestor
57022937|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57022938|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57022939|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022940|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
57022941|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57022942|NCT01410188|Latanoprost|latanoprost|mesh-list
57022943|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57022944|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57022945|NCT01408082|Azithromycin|azithromycin|mesh-list
57022946|NCT01408082|Dexamethasone|dexamethasone|mesh-list
57022947|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
57022948|NCT01408082|BB 1101|bb 1101|mesh-list
57022949|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57022950|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
57022951|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
57022952|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022953|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022954|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57022955|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
57022956|NCT01408082|Hormones|hormones|mesh-ancestor
57022957|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022958|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57022959|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022960|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
57022961|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57022962|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896864|NCT02831764|Lamivudine|lamivudine|mesh-list
57022963|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57022964|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57022965|NCT03071263|Spironolactone|spironolactone|mesh-list
57022966|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57022967|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
57022968|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022969|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022970|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57022971|NCT03071263|Diuretics|diuretics|mesh-ancestor
57022972|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
57022973|NCT05200663|Tamoxifen|tamoxifen|mesh-list
57022974|NCT05200663|Vitamin E|vitamin e|mesh-list
57022975|NCT05200663|Vitamins|vitamins|mesh-ancestor
57022976|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
57022977|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022978|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57022979|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
57022980|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57022981|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57022982|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57022983|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57022984|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57022985|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57022986|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
57022987|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57022988|NCT05200663|Protective Agents|protective agents|mesh-ancestor
57022989|NCT02268422|Buprenorphine|buprenorphine|mesh-list
57022990|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57022991|NCT02268422|Narcotics|narcotics|mesh-ancestor
57022992|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57022993|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57022994|NCT02268422|Analgesics|analgesics|mesh-ancestor
57022995|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
57022996|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57022997|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57022998|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
57022999|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
57023000|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896865|NCT02831764|Emtricitabine|emtricitabine|mesh-list
57023001|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023002|NCT05049343|Ketamine|ketamine|mesh-list
57023003|NCT05049343|Analgesics|analgesics|mesh-ancestor
57023004|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
57023005|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023006|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023007|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57023008|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57023009|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
57023010|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
57023011|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023012|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57023013|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57023014|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023015|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023016|NCT01569919|Folic Acid|folic acid|mesh-list
57023017|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
57023018|NCT01569919|Dexamethasone|dexamethasone|mesh-list
56705013|NCT05700045|Analgesics|analgesics|mesh-ancestor
57023020|NCT01569919|Vitamins|vitamins|mesh-ancestor
57023021|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
57023022|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023023|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57023024|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
57023025|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
57023026|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023027|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023028|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
57023029|NCT01569919|Hormones|hormones|mesh-ancestor
57023030|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023031|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57023032|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023033|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023034|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023035|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57023036|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57023037|NCT01569919|Hematinics|hematinics|mesh-ancestor
57023038|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
57023039|NCT01399580|Atrasentan|atrasentan|mesh-list
57023040|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023041|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57023042|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57023043|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023044|NCT04069585|Lidocaine|lidocaine|mesh-list
57023045|NCT04069585|Anesthetics|anesthetics|mesh-list
57023046|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
57023047|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023048|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023049|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
57023050|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023051|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57023052|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57023053|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57023054|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57023055|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023056|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
57023057|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57023058|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
57023059|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023060|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57023061|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57023062|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
57023063|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023064|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023065|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57023066|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
57023067|NCT02265770|Cisplatin|cisplatin|mesh-list
57023068|NCT02265770|Carboplatin|carboplatin|mesh-list
57023069|NCT02265770|Methotrexate|methotrexate|mesh-list
57023070|NCT02265770|Etoposide|etoposide|mesh-list
57023071|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
57023072|NCT02265770|Vincristine|vincristine|mesh-list
57023073|NCT02265770|Valproic Acid|valproic acid|mesh-list
57023074|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57023075|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
57023076|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023077|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57023078|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57023079|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
57023080|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023081|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023082|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57023083|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57023084|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
57023085|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57023086|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57023087|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
57023088|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
57023089|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023090|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57023091|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56705090|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
57023093|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57023094|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57023095|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
57023096|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
57023097|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
57023098|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
57023099|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
57023100|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023101|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
57023102|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57023103|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023104|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57023105|NCT03066193|Palmidrol|palmidrol|mesh-list
57023106|NCT03066193|Dronabinol|dronabinol|mesh-list
57023107|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
57023108|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023109|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57023110|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57023111|NCT03066193|Analgesics|analgesics|mesh-ancestor
57023112|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
57023113|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023114|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57023115|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57023116|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023117|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023118|NCT03066193|Hormones|hormones|mesh-ancestor
57023119|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023120|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57023121|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57023122|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57023123|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
57023124|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023125|NCT02263976|Bromides|bromides|mesh-list
57023126|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
57023127|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
57023128|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57023129|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
57023130|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023131|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023132|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57023133|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
57023134|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
57023135|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57023136|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
57023137|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023138|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023139|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
57023140|NCT02263976|Miotics|miotics|mesh-ancestor
57023141|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57023142|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
57023143|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57023144|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57023145|NCT01382654|Azelastine|azelastine|mesh-list
57023146|NCT01382654|Epinastine|epinastine|mesh-list
57023147|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57023148|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
57023149|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023150|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023151|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57023152|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
57023153|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
57023154|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023155|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023156|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57023157|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57023158|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57023159|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
57023160|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
57023161|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023162|NCT01378676|Riluzole|riluzole|mesh-list
57023163|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
57023164|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57023165|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57023166|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023167|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023168|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023169|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57023171|NCT01377662|Methylphenidate|methylphenidate|mesh-list
57023172|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57023173|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023174|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57023175|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57023176|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57023177|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023178|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
57023179|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023180|NCT01371578|Ribavirin|ribavirin|mesh-list
57023181|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57023182|NCT01371578|Ledipasvir|ledipasvir|mesh-list
57023183|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
57023184|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023185|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
57023186|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023187|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
57023188|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023189|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57023190|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023191|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023192|NCT01205048|Lidocaine|lidocaine|mesh-list
57023193|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
57023194|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
57023195|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023196|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023197|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
57023198|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023199|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57023200|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57023201|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57023202|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57023203|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023204|NCT01498328|Bevacizumab|bevacizumab|mesh-list
57023205|NCT01498328|Rindopepimut|rindopepimut|mesh-list
57023206|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57023207|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023208|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57023209|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57023210|NCT01498328|Growth Substances|growth substances|mesh-ancestor
57023211|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023212|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
57023213|NCT01497704|Apatinib|apatinib|mesh-list
57023214|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023215|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57023216|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023217|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023218|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
57023219|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
57023220|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
57023221|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023222|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023223|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
57023224|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023225|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
57023226|NCT03911713|Ivacaftor|ivacaftor|mesh-list
57023227|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57023228|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57023229|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023230|NCT02264132|Pramipexole|pramipexole|mesh-list
57023231|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
57023232|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023233|NCT02264132|Protective Agents|protective agents|mesh-ancestor
57023234|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023235|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57023236|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57023237|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
57023238|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
57023239|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023240|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
57023241|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57023242|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023243|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023244|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57023245|NCT04540744|Tadalafil|tadalafil|mesh-list
57023246|NCT04540744|Macitentan|macitentan|mesh-list
57023247|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
57023248|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57023249|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57023250|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023251|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023252|NCT04540744|Urological Agents|urological agents|mesh-ancestor
57023253|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57023254|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57023255|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57023256|NCT01489046|Tenofovir|tenofovir|mesh-list
57023257|NCT01489046|Lamivudine|lamivudine|mesh-list
57023258|NCT01489046|Efavirenz|efavirenz|mesh-list
57023259|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
57023260|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023261|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57023262|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57023263|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023264|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023265|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57023266|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57023267|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57023268|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57023269|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57023270|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57023271|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57023272|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57023273|NCT01180634|Levofloxacin|levofloxacin|mesh-list
57023274|NCT01180634|Ofloxacin|ofloxacin|mesh-list
57023275|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57023276|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023277|NCT01180634|Renal Agents|renal agents|mesh-ancestor
57023278|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57023279|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57023280|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57023281|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023282|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023283|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023284|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57023285|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57023286|NCT02268890|Bortezomib|bortezomib|mesh-list
57023287|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023288|NCT02268968|Lidocaine|lidocaine|mesh-list
57023289|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
57023290|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
57023291|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023292|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023293|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
57023294|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023295|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57023296|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57023297|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57023298|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57023299|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023300|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
57023301|NCT01359566|Baclofen|baclofen|mesh-list
57023302|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57023303|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023304|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57023305|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023306|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57023307|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
57023308|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
57023309|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023310|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023311|NCT04885816|Sirolimus|sirolimus|mesh-list
57023312|NCT04885816|Everolimus|everolimus|mesh-list
57023313|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023314|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57023315|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
57023316|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023317|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57023318|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023319|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57023320|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
57023322|NCT04865614|Etomidate|etomidate|mesh-list
57023323|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57023324|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57023325|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
57023326|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
57023327|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023328|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023329|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57023330|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57023331|NCT02269046|Simvastatin|simvastatin|mesh-list
57023332|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57023333|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57023334|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
57023335|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023336|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57023337|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57023338|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023339|NCT04770454|Buspirone|buspirone|mesh-list
57023340|NCT04770454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57023341|NCT04770454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57023342|NCT04770454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023343|NCT04770454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023344|NCT04770454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57023345|NCT04770454|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57023346|NCT04770454|Serotonin Agents|serotonin agents|mesh-ancestor
57023347|NCT04770454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023348|NCT04770454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023349|NCT01483742|Ritonavir|ritonavir|mesh-list
57023350|NCT01483742|Ribavirin|ribavirin|mesh-list
57023351|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57023352|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57023353|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57023354|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
57023355|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023356|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023357|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57023358|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57023359|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
57023360|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023361|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57023362|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57023363|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
57023364|NCT04691128|Anesthetics|anesthetics|mesh-list
57023365|NCT04691128|Propofol|propofol|mesh-list
57023366|NCT04691128|Desflurane|desflurane|mesh-list
57023367|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023368|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023369|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57023370|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57023371|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
57023372|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57023373|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
57023374|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57023375|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023376|NCT02269202|Midazolam|midazolam|mesh-list
57023377|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57023378|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57023379|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023380|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023381|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57023382|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57023383|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57023384|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57023385|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
57023386|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
57023387|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
57023388|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
57023389|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023390|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023392|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57023393|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
57023394|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57023395|NCT01353248|Ribavirin|ribavirin|mesh-list
57023396|NCT01353248|Ledipasvir|ledipasvir|mesh-list
57023397|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
57023398|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023399|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
57023400|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023401|NCT05095636|Apatinib|apatinib|mesh-list
57023402|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023403|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57023404|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023405|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023406|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57023407|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
57023408|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023409|NCT05095480|Red yeast rice|red yeast rice|mesh-list
57023410|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57023411|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57023412|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57023413|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
57023414|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023415|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023416|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57023417|NCT02915016|Vaccines|vaccines|mesh-list
57023418|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
57023419|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
57023420|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023421|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57023422|NCT02269280|Azacitidine|azacitidine|mesh-list
57023423|NCT02269280|Decitabine|decitabine|mesh-list
57023424|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57023425|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
57023426|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023427|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023428|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023429|NCT01170650|Doxorubicin|doxorubicin|mesh-list
57023430|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57023431|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57023432|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023433|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57023434|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57023435|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023436|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023437|NCT04533646|Insulin|insulin|mesh-list
57023438|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57023439|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023440|NCT01168310|Fluticasone|fluticasone|mesh-list
57023441|NCT01168310|Xhance|xhance|mesh-list
57023442|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
57023443|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57023444|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57023445|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
57023446|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023447|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023448|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57023449|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
57023450|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
57023451|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57023452|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57023453|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57023454|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57023455|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
57023456|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023457|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023458|NCT01472198|Gemcitabine|gemcitabine|mesh-list
57023459|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57023460|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
57023461|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023462|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023463|NCT01472198|Antiviral Agents|antiviral agents|mesh-ancestor
57023464|NCT01472198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023465|NCT01472198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023466|NCT01472198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57023467|NCT01472198|Immunologic Factors|immunologic factors|mesh-ancestor
57023468|NCT01472198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023470|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57023471|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57023472|NCT04444492|Growth Substances|growth substances|mesh-ancestor
57023473|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023474|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
57023475|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023476|NCT02269358|Methotrexate|methotrexate|mesh-list
57023477|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57023478|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
57023479|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57023480|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023481|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57023482|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
57023483|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023484|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023485|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
57023486|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023487|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57023488|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57023489|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
57023490|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57023491|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57023492|NCT04504240|Famotidine|famotidine|mesh-list
57023493|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57023494|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023495|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57023496|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
57023497|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
57023498|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023499|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023500|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023501|NCT02088060|Cannabidiol|cannabidiol|mesh-list
57023502|NCT02088060|Olanzapine|olanzapine|mesh-list
57023503|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
57023504|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
57023505|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023506|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023507|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023508|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57023509|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57023510|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023511|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57023512|NCT02088060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57023513|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57023514|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57023515|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023516|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023517|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
57023518|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
57023519|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
57023520|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57023521|NCT02269514|Nicotine|nicotine|mesh-list
57023522|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57023523|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
57023524|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023525|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023526|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57023527|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57023528|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
57023529|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023530|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023531|NCT01332812|Dexamethasone|dexamethasone|mesh-list
57023532|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
57023533|NCT01332812|BB 1101|bb 1101|mesh-list
57023534|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57023535|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
57023536|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
57023537|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023538|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023539|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023540|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
57023541|NCT01332812|Hormones|hormones|mesh-ancestor
57023542|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023543|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57023544|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023545|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
57023546|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023547|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023548|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
57023549|NCT03408652|Denosumab|denosumab|mesh-list
57023550|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57023551|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023552|NCT01332656|Paclitaxel|paclitaxel|mesh-list
57023553|NCT01332656|Carboplatin|carboplatin|mesh-list
57023554|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57023555|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023556|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
57023557|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
57023558|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
57023559|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023560|NCT02084472|Petrolatum|petrolatum|mesh-list
57023561|NCT02084472|Glycerol|glycerol|mesh-list
57023562|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57023563|NCT02084472|Protective Agents|protective agents|mesh-ancestor
57023564|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023565|NCT02084472|Emollients|emollients|mesh-ancestor
57023566|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
57023567|NCT02266784|Nicotine|nicotine|mesh-list
57023568|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57023569|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
57023570|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023571|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023572|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57023573|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57023574|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
57023575|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023576|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023577|NCT02090790|Dexamethasone|dexamethasone|mesh-list
57023578|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
57023579|NCT02090790|BB 1101|bb 1101|mesh-list
57023580|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57023581|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
57023582|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
57023583|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023584|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023585|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023586|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
57023587|NCT02090790|Hormones|hormones|mesh-ancestor
57023588|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023589|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57023590|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023591|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
57023592|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023593|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023594|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
57023595|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57023596|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57023597|NCT01443728|Vitamin D|vitamin d|mesh-list
57023598|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
57023599|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
57023600|NCT01443728|Vitamins|vitamins|mesh-list
57023601|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
57023602|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023603|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57023604|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57023605|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
57023606|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
57023607|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023608|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023609|NCT01312454|Travoprost|travoprost|mesh-list
57023610|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57023611|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57023612|NCT02084784|Methylene Blue|methylene blue|mesh-list
57023613|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023614|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023616|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57023617|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023618|NCT02091180|Mannitol|mannitol|mesh-list
57023619|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57023620|NCT02091180|Diuretics|diuretics|mesh-ancestor
57023621|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
57023622|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023623|NCT02269748|Analgesics|analgesics|mesh-list
57023624|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
57023625|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023626|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023627|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
57023628|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57023629|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57023630|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
57023631|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023632|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023633|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023634|NCT03149809|Urological Agents|urological agents|mesh-ancestor
57023635|NCT04533880|Calcium|calcium|mesh-list
57023636|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57023637|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023638|NCT02269904|Fluorouracil|fluorouracil|mesh-list
57023639|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
57023640|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023641|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57023642|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023643|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57023644|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
57023645|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023646|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
57023647|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023648|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57023649|NCT01300208|CC-11050|cc-11050|mesh-list
57023650|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57023651|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57023652|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023653|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023654|NCT02085018|Omeprazole|omeprazole|mesh-list
57023655|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57023656|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023657|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57023658|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023659|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023660|NCT02091336|Metformin|metformin|mesh-list
57023661|NCT02091336|Glyburide|glyburide|mesh-list
57023662|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57023663|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023664|NCT01442090|Everolimus|everolimus|mesh-list
57023665|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023666|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57023667|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
57023668|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023669|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
57023670|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57023671|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023672|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57023673|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023674|NCT02088450|Nitrendipine|nitrendipine|mesh-list
57023675|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57023676|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57023677|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57023678|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023679|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57023680|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023681|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
57023682|NCT03688828|Amoxicillin|amoxicillin|mesh-list
57023683|NCT03688828|Clarithromycin|clarithromycin|mesh-list
57023684|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
57023685|NCT03688828|Esomeprazole|esomeprazole|mesh-list
57023686|NCT03688828|Bismuth|bismuth|mesh-list
57023687|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023688|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57023689|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023690|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57023691|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023692|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57023693|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023694|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57023695|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57023696|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57023697|NCT03688828|Antacids|antacids|mesh-ancestor
57023698|NCT03688828|Diuretics|diuretics|mesh-ancestor
57023699|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
57023700|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023701|NCT03688828|Expectorants|expectorants|mesh-ancestor
57023702|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
57023703|NCT02091492|Teriparatide|teriparatide|mesh-list
57023704|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57023705|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023706|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57023707|NCT02266940|DS-1971a|ds-1971a|mesh-list
57023708|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57023709|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57023710|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57023711|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023712|NCT03981952|Vaccines|vaccines|mesh-list
57023713|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
57023714|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023715|NCT04475120|Lactoferrin|lactoferrin|mesh-list
57023716|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023717|NCT02088528|Mitomycins|mitomycins|mesh-list
57023718|NCT02088528|Mitomycin|mitomycin|mesh-list
57023719|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57023720|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023721|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
56896928|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
57023722|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023723|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57023724|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023725|NCT03643822|Dexamethasone|dexamethasone|mesh-list
57023726|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
57023727|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
57023728|NCT03643822|BB 1101|bb 1101|mesh-list
57023729|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57023730|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
57023731|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
57023732|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023733|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023734|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023735|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
57023736|NCT03643822|Hormones|hormones|mesh-ancestor
57023737|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023738|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57023739|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023740|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
57023741|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023742|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023743|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57023744|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023745|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57023746|NCT03643822|Analgesics|analgesics|mesh-ancestor
57023747|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
57023748|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57023749|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57023750|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57023751|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
57023752|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023753|NCT03634150|Doxorubicin|doxorubicin|mesh-list
57023754|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57023755|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023756|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57023757|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57023758|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023759|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023760|NCT02092038|Temozolomide|temozolomide|mesh-list
57023761|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57023762|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
57023763|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023764|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023765|NCT02272166|Propofol|propofol|mesh-list
57023766|NCT02272166|Sevoflurane|sevoflurane|mesh-list
57023767|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57023768|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57023769|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023770|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57023771|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
57023772|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
57023773|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57023774|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57023775|NCT02088684|Fulvestrant|fulvestrant|mesh-list
57023776|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57023777|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023778|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57023779|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57023780|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
57023781|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023782|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023783|NCT01137968|Bevacizumab|bevacizumab|mesh-list
57023784|NCT01137968|Imetelstat|imetelstat|mesh-list
57023785|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
57023786|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57023787|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023788|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57023789|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57023790|NCT01137968|Growth Substances|growth substances|mesh-ancestor
57023791|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023792|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
57023793|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023794|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023795|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57023796|NCT01133990|Leucovorin|leucovorin|mesh-list
57023797|NCT01133990|Bevacizumab|bevacizumab|mesh-list
57023798|NCT01133990|Fluorouracil|fluorouracil|mesh-list
57023799|NCT01133990|Irinotecan|irinotecan|mesh-list
57023800|NCT01133990|Calcium|calcium|mesh-list
57023801|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
57023802|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57023803|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023804|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57023805|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57023806|NCT01133990|Growth Substances|growth substances|mesh-ancestor
57023807|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023808|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
57023809|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57023810|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
57023811|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023812|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57023813|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57023814|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
57023815|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57023816|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57023817|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023818|NCT01133990|Antidotes|antidotes|mesh-ancestor
57023819|NCT01133990|Protective Agents|protective agents|mesh-ancestor
57023820|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
57023821|NCT01133990|Vitamins|vitamins|mesh-ancestor
57023822|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
57023823|NCT02249910|Metformin|metformin|mesh-list
57023824|NCT02249910|Digoxin|digoxin|mesh-list
57023825|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57023826|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023827|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57023828|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57023829|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023830|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023831|NCT02249910|Protective Agents|protective agents|mesh-ancestor
57023832|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
57023833|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
57023834|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57023835|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023836|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
57023837|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023838|NCT02398396|Lactitol|lactitol|mesh-list
57023839|NCT02398396|Cathartics|cathartics|mesh-ancestor
57023840|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023841|NCT05628584|Metformin|metformin|mesh-list
57023842|NCT05628584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57023843|NCT05628584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023844|NCT02088918|Metformin|metformin|mesh-list
57023845|NCT02088918|Nateglinide|nateglinide|mesh-list
57023846|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57023847|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023848|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
57023849|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57023850|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023851|NCT02092428|Adenosine|adenosine|mesh-list
57023852|NCT02092428|Regadenoson|regadenoson|mesh-list
57023853|NCT02092428|Analgesics|analgesics|mesh-ancestor
57023854|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
57023855|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023856|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023857|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57023858|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
57023859|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57023860|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
57023861|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
57023862|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023863|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023864|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
57023865|NCT02783404|Amoxicillin|amoxicillin|mesh-list
57023866|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
57023867|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
57023868|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57023869|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023870|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57023871|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023872|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023873|NCT01097018|Capecitabine|capecitabine|mesh-list
57023874|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57023875|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
57023876|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023877|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023878|NCT01096862|Peficitinib|peficitinib|mesh-list
57023879|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023880|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023881|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57023882|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
57023883|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023884|NCT02092506|Amoxicillin|amoxicillin|mesh-list
57023885|NCT02092506|Metronidazole|metronidazole|mesh-list
57023886|NCT02092506|Clarithromycin|clarithromycin|mesh-list
57023887|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57023888|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57023889|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023890|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57023891|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57023892|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57023893|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57023894|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023895|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57023896|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57023897|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
57023898|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57023899|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023900|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57023901|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57023902|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
57023903|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023904|NCT01128530|Linezolid|linezolid|mesh-list
57023905|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57023906|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57023907|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57023908|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896963|NCT01167231|Acarbose|acarbose|mesh-list
57023909|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023910|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57023911|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57023912|NCT02086032|Estradiol|estradiol|mesh-list
56705913|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
57023913|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57023915|NCT02086032|Progesterone|progesterone|mesh-list
57023916|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
57023918|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023919|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023920|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57023921|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
57023922|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57023923|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57023924|NCT02086032|Progestins|progestins|mesh-ancestor
57023925|NCT02092818|Riociguat|riociguat|mesh-list
57023926|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
57023927|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023928|NCT02086188|Mirabegron|mirabegron|mesh-list
57023929|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57023930|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57023931|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57023932|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
57023933|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023934|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023935|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023936|NCT02086188|Urological Agents|urological agents|mesh-ancestor
57023937|NCT02267408|Warfarin|warfarin|mesh-list
57023938|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
57023939|NCT02092896|Liraglutide|liraglutide|mesh-list
57023940|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57023941|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023942|NCT02092896|Incretins|incretins|mesh-ancestor
57023943|NCT02092896|Hormones|hormones|mesh-ancestor
57023944|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023945|NCT02092974|Citalopram|citalopram|mesh-list
57023946|NCT02092974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57023947|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57023948|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57023949|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023950|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023951|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
57023952|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023953|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57023954|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
57023955|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57023956|NCT05097508|Bromides|bromides|mesh-list
57023957|NCT05097508|Rocuronium|rocuronium|mesh-list
57023958|NCT05097508|Atracurium|atracurium|mesh-list
57023959|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
57023960|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57023961|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57023962|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57023963|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023964|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023965|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57023966|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57023967|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
57023968|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023969|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023970|NCT02089308|Nicotine|nicotine|mesh-list
57023971|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57023972|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
57023973|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57023974|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023975|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57023976|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57023977|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
57023978|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57023979|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57023980|NCT00153920|Bortezomib|bortezomib|mesh-list
57023981|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023982|NCT05095714|Liver Extracts|liver extracts|mesh-list
57023983|NCT05095714|Hematinics|hematinics|mesh-ancestor
57023984|NCT02660242|Glucagon|glucagon|mesh-list
57023985|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57023986|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023987|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57023988|NCT02660242|Hormones|hormones|mesh-ancestor
57023989|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023990|NCT02660242|Incretins|incretins|mesh-ancestor
57023991|NCT02089386|Tamoxifen|tamoxifen|mesh-list
57023992|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57023993|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
57023994|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57023995|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57023996|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57023997|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57023998|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57023999|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57024000|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57024001|NCT05628038|Capecitabine|capecitabine|mesh-list
57024002|NCT05628038|Oxaliplatin|oxaliplatin|mesh-list
57024003|NCT05628038|Antibodies|antibodies|mesh-list
57024004|NCT05628038|Immunologic Factors|immunologic factors|mesh-ancestor
57024005|NCT05628038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024006|NCT05628038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57024007|NCT05628038|Antimetabolites|antimetabolites|mesh-ancestor
57024008|NCT05628038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024009|NCT05628038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024010|NCT03557580|Isosorbide|isosorbide|mesh-list
57024011|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57024012|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57024013|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57024014|NCT03557580|Diuretics|diuretics|mesh-ancestor
57024015|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
57024016|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024017|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
57024018|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57024019|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024020|NCT02089542|Methylene Blue|methylene blue|mesh-list
57024021|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024022|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024023|NCT01295060|Octreotide|octreotide|mesh-list
57024024|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57024025|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57024026|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024027|NCT02086656|Bevacizumab|bevacizumab|mesh-list
57024028|NCT02086656|Capecitabine|capecitabine|mesh-list
57024029|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
57024030|NCT02086656|Irinotecan|irinotecan|mesh-list
57024031|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57024032|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024033|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57024034|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57024035|NCT02086656|Growth Substances|growth substances|mesh-ancestor
57024036|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024037|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
57024038|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57024039|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
57024040|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024041|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57024042|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57024043|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024044|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
57024045|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024046|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57024047|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024048|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024049|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
57024050|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57024051|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57024052|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024053|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57024054|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57024055|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024056|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024057|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024058|NCT01126970|Orlistat|orlistat|mesh-list
57024059|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024060|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024061|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57024062|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57024063|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
57024064|NCT03557424|Cathartics|cathartics|mesh-ancestor
57024065|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57024066|NCT05057572|Carvedilol|carvedilol|mesh-list
57024067|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57024068|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57024069|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
57024070|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024071|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024072|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024073|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57024074|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
57024075|NCT05057572|Protective Agents|protective agents|mesh-ancestor
57024076|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57024077|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57024078|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57024079|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
57024080|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57024081|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57024082|NCT02093598|Sirolimus|sirolimus|mesh-list
57024083|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57024084|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024085|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57024086|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024087|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
57024088|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57024089|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
57024090|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024091|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
57024092|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57024093|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57024094|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57024095|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57024096|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024097|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
57024098|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024099|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024100|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57024101|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024102|NCT02621944|Melatonin|melatonin|mesh-list
57024103|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
57024104|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024105|NCT02621944|Protective Agents|protective agents|mesh-ancestor
57024106|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024107|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024108|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
57024109|NCT02087202|Ketamine|ketamine|mesh-list
57024110|NCT02087202|Analgesics|analgesics|mesh-ancestor
57024111|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
57024112|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024113|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024114|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57024115|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57024116|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
57024117|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
57024118|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024119|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57024120|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57024121|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024122|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024123|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57024124|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
57024125|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57024126|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57024127|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57024128|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
57024129|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57024130|NCT01283594|Levodopa|levodopa|mesh-list
57024131|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57024132|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57024133|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
57024134|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024135|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706128|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
57024136|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024138|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57024139|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57024140|NCT01281254|Growth Substances|growth substances|mesh-ancestor
57024141|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024142|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
57024143|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024144|NCT05104138|Eplerenone|eplerenone|mesh-list
57024145|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57024146|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
57024147|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024148|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024149|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57024150|NCT05104138|Diuretics|diuretics|mesh-ancestor
57024151|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
57024152|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57024153|NCT03072043|Azacitidine|azacitidine|mesh-list
57024154|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57024155|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
57024156|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024157|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024158|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024159|NCT05626010|Acetaminophen|acetaminophen|mesh-list
57024160|NCT05626010|Ibuprofen|ibuprofen|mesh-list
57024161|NCT05626010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57024162|NCT05626010|Analgesics|analgesics|mesh-ancestor
57024163|NCT05626010|Sensory System Agents|sensory system agents|mesh-ancestor
57024164|NCT05626010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024165|NCT05626010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024166|NCT05626010|Antipyretics|antipyretics|mesh-ancestor
57024167|NCT05626010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57024168|NCT05626010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57024169|NCT05626010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57024170|NCT05626010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57024171|NCT05626010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024172|NCT05626010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024173|NCT02089854|Toremifene|toremifene|mesh-list
57024174|NCT02089854|Anastrozole|anastrozole|mesh-list
57024175|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57024176|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024177|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57024178|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57024179|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024180|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024181|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57024182|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
57024183|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024184|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024185|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57024186|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57024187|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57024188|NCT05624840|Ritonavir|ritonavir|mesh-list
57024189|NCT05624840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57024190|NCT05624840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57024191|NCT05624840|Protease Inhibitors|protease inhibitors|mesh-ancestor
57024192|NCT05624840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024193|NCT05624840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024194|NCT05624840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57024195|NCT05624840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57024196|NCT05624840|Antiviral Agents|antiviral agents|mesh-ancestor
57024197|NCT05624840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024198|NCT05624840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57024199|NCT05624840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57024200|NCT02093910|Dexamethasone|dexamethasone|mesh-list
57024201|NCT02093910|Bortezomib|bortezomib|mesh-list
57024202|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57024203|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
57024204|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
57024205|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024206|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024207|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57024208|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
57024209|NCT02093910|Hormones|hormones|mesh-ancestor
57024210|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024211|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57024212|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024213|NCT05624138|Leucovorin|leucovorin|mesh-list
57024214|NCT05624138|Ketotifen|ketotifen|mesh-list
57024215|NCT05624138|Fluorouracil|fluorouracil|mesh-list
57024216|NCT05624138|Oxaliplatin|oxaliplatin|mesh-list
57024217|NCT05624138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024218|NCT05624138|Antimetabolites|antimetabolites|mesh-ancestor
57024219|NCT05624138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024220|NCT05624138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57024221|NCT05624138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024222|NCT05624138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57024223|NCT05624138|Immunologic Factors|immunologic factors|mesh-ancestor
57024224|NCT05624138|Antidotes|antidotes|mesh-ancestor
57024225|NCT05624138|Protective Agents|protective agents|mesh-ancestor
57024226|NCT05624138|Vitamin B Complex|vitamin b complex|mesh-ancestor
57024227|NCT05624138|Vitamins|vitamins|mesh-ancestor
57024228|NCT05624138|Micronutrients|micronutrients|mesh-ancestor
57024229|NCT05624138|Antipruritics|antipruritics|mesh-ancestor
57024230|NCT05624138|Dermatologic Agents|dermatologic agents|mesh-ancestor
57024231|NCT05624138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57024232|NCT05624138|Histamine Antagonists|histamine antagonists|mesh-ancestor
57024233|NCT05624138|Histamine Agents|histamine agents|mesh-ancestor
57024234|NCT05624138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024235|NCT05624138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57024236|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
57024237|NCT04437160|Epirubicin|epirubicin|mesh-list
57024238|NCT04437160|Pirarubicin|pirarubicin|mesh-list
57024239|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57024240|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
57024241|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024242|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57024243|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57024244|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
57024245|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024246|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024247|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57024248|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57024249|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57024250|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57024251|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024252|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
57024253|NCT02089932|Bupivacaine|bupivacaine|mesh-list
57024254|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
57024255|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
57024256|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024257|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024258|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
57024259|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024260|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57024261|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57024262|NCT02089932|Analgesics|analgesics|mesh-ancestor
57024263|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57024264|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57024265|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57024266|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
57024267|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024268|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024269|NCT01037036|Latanoprost|latanoprost|mesh-list
57024270|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57024271|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57024272|NCT05204641|Rifaximin|rifaximin|mesh-list
57024273|NCT05204641|Levodopa|levodopa|mesh-list
57024274|NCT05204641|Benserazide|benserazide|mesh-list
57024275|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57024276|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57024277|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
57024278|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024279|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024280|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024281|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57024282|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024283|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57024284|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024285|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
57024286|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
57024287|NCT03069313|Vitamins|vitamins|mesh-ancestor
57024288|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
57024289|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024290|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
57024291|NCT03069313|Hematinics|hematinics|mesh-ancestor
57024292|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
57024293|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57024294|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57024295|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024296|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
57024297|NCT02094066|Coagulants|coagulants|mesh-ancestor
57024298|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57024299|NCT01033292|Iniparib|iniparib|mesh-list
57024300|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024301|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024302|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024303|NCT03068767|Vitamin D|vitamin d|mesh-list
57024304|NCT03068767|Vitamins|vitamins|mesh-ancestor
57024305|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
57024306|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024307|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57024308|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
57024309|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024310|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
57024311|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
57024312|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
57024313|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57024314|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57024315|NCT01110902|S 20098|s 20098|mesh-list
57024316|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57024317|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024318|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024319|NCT05204173|Paclitaxel|paclitaxel|mesh-list
57024320|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57024321|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024322|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
57024323|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
57024324|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
57024325|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024326|NCT01025648|Epinephrine|epinephrine|mesh-list
57024327|NCT01025648|Racepinephrine|racepinephrine|mesh-list
57024328|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
57024329|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57024330|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57024331|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
57024332|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024333|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024334|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024335|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57024336|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57024337|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
57024338|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024339|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57024340|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
57024341|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
57024342|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
57024343|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57024344|NCT01110746|Insulin|insulin|mesh-list
57024345|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57024346|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57024347|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024348|NCT05622968|Dinoprostone|dinoprostone|mesh-list
57024349|NCT05622968|Oxytocics|oxytocics|mesh-ancestor
57024350|NCT05622968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57024351|NCT05622968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024352|NCT02268032|Androgens|androgens|mesh-list
57024353|NCT02268032|Hormones|hormones|mesh-ancestor
57024354|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024355|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024356|NCT03019965|Meropenem|meropenem|mesh-list
57024357|NCT03019965|Tazobactam|tazobactam|mesh-list
57024358|NCT03019965|Piperacillin|piperacillin|mesh-list
57024359|NCT03019965|Imipenem|imipenem|mesh-list
57024360|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57024361|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57024362|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024363|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57024364|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024365|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024366|NCT01468831|Minocycline|minocycline|mesh-list
57024367|NCT01468831|Bevacizumab|bevacizumab|mesh-list
57024368|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57024369|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024370|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57024371|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57024372|NCT01468831|Growth Substances|growth substances|mesh-ancestor
57024373|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024374|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
57024375|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57024376|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024377|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
57024378|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
57024379|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024380|NCT04475276|Protective Agents|protective agents|mesh-ancestor
57024381|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024382|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
57024383|NCT04475276|Vitamins|vitamins|mesh-ancestor
57024384|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
57024385|NCT05627414|Paclitaxel|paclitaxel|mesh-list
57024386|NCT05627414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57024387|NCT05627414|Tegafur|tegafur|mesh-list
57024388|NCT05627414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57024389|NCT05627414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024390|NCT05627414|Tubulin Modulators|tubulin modulators|mesh-ancestor
57024391|NCT05627414|Antimitotic Agents|antimitotic agents|mesh-ancestor
57024392|NCT05627414|Mitosis Modulators|mitosis modulators|mesh-ancestor
57024393|NCT05627414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024394|NCT05627414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57024395|NCT05627414|Antimetabolites|antimetabolites|mesh-ancestor
57024396|NCT05617508|Niacinamide|niacinamide|mesh-list
57024397|NCT05617508|Niacin|niacin|mesh-list
57024398|NCT05617508|Nicotinic Acids|nicotinic acids|mesh-list
57024399|NCT05617508|Vitamin B Complex|vitamin b complex|mesh-ancestor
57024400|NCT05617508|Vitamins|vitamins|mesh-ancestor
57024401|NCT05617508|Micronutrients|micronutrients|mesh-ancestor
57024402|NCT05617508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024403|NCT05617508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57024404|NCT05617508|Antimetabolites|antimetabolites|mesh-ancestor
57024405|NCT05617508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024406|NCT05617508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57024407|NCT05617508|Vasodilator Agents|vasodilator agents|mesh-ancestor
57024408|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57024409|NCT03018249|Entinostat|entinostat|mesh-list
57024410|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
57024411|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
57024412|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57024413|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57024414|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57024415|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
57024416|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57024417|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024418|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56054470|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57024419|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57024420|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57024421|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57024422|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024423|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024424|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024425|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
57024426|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57024427|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57024428|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57024429|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57024430|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024431|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
57024432|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024433|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024434|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57024435|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024436|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57024437|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706431|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024438|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024439|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
57024440|NCT04602975|Vaccines|vaccines|mesh-list
57024441|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
57024442|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024443|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57024444|NCT04602975|Antacids|antacids|mesh-ancestor
57024445|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024446|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57024447|NCT00905606|Topiramate|topiramate|mesh-list
57024448|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
57024449|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57024450|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024451|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
57024452|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
57024453|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
57024454|NCT03017235|Citric Acid|citric acid|mesh-list
57024455|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
57024456|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57024457|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
57024458|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
57024459|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024460|NCT03017235|Cathartics|cathartics|mesh-ancestor
57024461|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57024462|NCT03017235|Antacids|antacids|mesh-ancestor
57024463|NCT05191784|Bevacizumab|bevacizumab|mesh-list
57024464|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57024465|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024466|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57024467|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57024468|NCT05191784|Growth Substances|growth substances|mesh-ancestor
57024469|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024470|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
57024471|NCT05048134|Trametinib|trametinib|mesh-list
57024472|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024473|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57024474|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024475|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024476|NCT04438928|Micronutrients|micronutrients|mesh-list
57024477|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024478|NCT03667677|Amlodipine|amlodipine|mesh-list
57024479|NCT03667677|Tandospirone|tandospirone|mesh-list
57024480|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57024481|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57024482|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57024483|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024484|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57024485|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024486|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
57024487|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57024488|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57024489|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024490|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57024491|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57024492|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
57024493|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024494|NCT04588545|Trastuzumab|trastuzumab|mesh-list
57024495|NCT04588545|Pertuzumab|pertuzumab|mesh-list
57024496|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57024497|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024498|NCT04176718|Dexamethasone|dexamethasone|mesh-list
57024499|NCT04176718|Daratumumab|daratumumab|mesh-list
57024500|NCT04176718|Pomalidomide|pomalidomide|mesh-list
57024501|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57024502|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
57024503|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
57024504|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024505|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024506|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57024507|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
57024508|NCT04176718|Hormones|hormones|mesh-ancestor
57024509|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024510|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57024511|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024512|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
57024513|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57024514|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57024515|NCT04176718|Growth Substances|growth substances|mesh-ancestor
57024516|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
57024518|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57024519|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024520|NCT00813956|Gemcitabine|gemcitabine|mesh-list
57024521|NCT00813956|Carboplatin|carboplatin|mesh-list
57024522|NCT00813956|Iniparib|iniparib|mesh-list
57024523|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024524|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57024525|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
57024526|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024527|NCT00813956|Antiviral Agents|antiviral agents|mesh-ancestor
57024528|NCT00813956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024529|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024530|NCT00813956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57024531|NCT00813956|Immunologic Factors|immunologic factors|mesh-ancestor
57024532|NCT00813956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024533|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57024534|NCT01002248|Dexamethasone|dexamethasone|mesh-list
57024535|NCT01002248|Bortezomib|bortezomib|mesh-list
57024536|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57024537|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
57024538|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
57024539|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024540|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024541|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57024542|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
57024543|NCT01002248|Hormones|hormones|mesh-ancestor
57024544|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024545|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57024546|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024547|NCT02837029|Nivolumab|nivolumab|mesh-list
57024548|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57024549|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024550|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57024551|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024552|NCT03667131|Enalapril|enalapril|mesh-list
57024553|NCT03667131|Enalaprilat|enalaprilat|mesh-list
57024554|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
57024555|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57024556|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024557|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
57024558|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57024559|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57024560|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57024561|NCT02642965|Cytarabine|cytarabine|mesh-list
57024562|NCT02642965|Fludarabine|fludarabine|mesh-list
57024563|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
57024564|NCT02642965|Daunorubicin|daunorubicin|mesh-list
57024565|NCT02642965|Lenograstim|lenograstim|mesh-list
57024566|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024567|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57024568|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
57024569|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024570|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57024571|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
57024572|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024573|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
57024574|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024575|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57024576|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57024577|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57024578|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57024579|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024580|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
57024581|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57024582|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024583|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
57024584|NCT04976374|Gabapentin|gabapentin|mesh-list
57024585|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57024586|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024587|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024588|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57024589|NCT04976374|Analgesics|analgesics|mesh-ancestor
57024590|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
57024591|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024592|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57024593|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57024594|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57024595|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
57024596|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024597|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024598|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
57024599|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57024600|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57024601|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57024602|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57024603|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57024604|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
57024606|NCT02764541|Letrozole|letrozole|mesh-list
57024607|NCT02764541|Palbociclib|palbociclib|mesh-list
57024608|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024609|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57024610|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57024611|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024612|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024613|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57024614|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
57024615|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024616|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024617|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57024618|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57024619|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57024620|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57024621|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57024622|NCT00894530|Azithromycin|azithromycin|mesh-list
57024623|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57024624|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57024625|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57024626|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024627|NCT01376999|Hormones|hormones|mesh-list
57024628|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024629|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024630|NCT00892970|Azithromycin|azithromycin|mesh-list
57024631|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57024632|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57024633|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57024634|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024635|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57024636|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57024637|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024638|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57024639|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024640|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024641|NCT02201381|Metformin|metformin|mesh-list
57024642|NCT02201381|Doxycycline|doxycycline|mesh-list
57024643|NCT02201381|Mebendazole|mebendazole|mesh-list
57024644|NCT02201381|Atorvastatin|atorvastatin|mesh-list
57024645|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57024646|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024647|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57024648|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57024649|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
57024650|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024651|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57024652|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57024653|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024654|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57024655|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024656|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
57024657|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57024658|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57024659|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
57024660|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
57024661|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
57024662|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
57024663|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
56706653|NCT04086290|Androgens|androgens|mesh-list
57024664|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024665|NCT00803114|Morphine|morphine|mesh-list
57024666|NCT00803114|Narcotics|narcotics|mesh-list
57024667|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57024668|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024669|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024670|NCT00803114|Analgesics|analgesics|mesh-ancestor
57024671|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
57024672|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024673|NCT02059499|Fluorouracil|fluorouracil|mesh-list
57024674|NCT02059499|Imiquimod|imiquimod|mesh-list
57024675|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
57024676|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024677|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57024678|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024679|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57024680|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
57024681|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024682|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57024683|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
57024684|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
57024685|NCT05519384|Fludarabine|fludarabine|mesh-list
57024686|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57024687|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
57024688|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024689|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57024690|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57024691|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
57024692|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024693|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024694|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57024695|NCT05302271|Prednisone|prednisone|mesh-list
57024696|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57024697|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
57024698|NCT05302271|Hormones|hormones|mesh-ancestor
57024699|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024700|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024701|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57024702|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024703|NCT00799292|Vasopressins|vasopressins|mesh-list
57024704|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
57024705|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
57024706|NCT00799292|Coagulants|coagulants|mesh-ancestor
57024707|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57024708|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57024709|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
57024710|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024711|NCT02162849|Nicotine|nicotine|mesh-list
57024712|NCT02162849|Varenicline|varenicline|mesh-list
57024713|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57024714|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
57024715|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024716|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024717|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57024718|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57024719|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
57024720|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024721|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024722|NCT05371600|Midazolam|midazolam|mesh-list
57024723|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57024724|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57024725|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024726|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024727|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57024728|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57024729|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57024730|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57024731|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
57024732|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
57024733|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
57024734|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
57024735|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024736|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024737|NCT02914275|Vaccines|vaccines|mesh-list
57024738|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
57024739|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024740|NCT01941875|Progesterone|progesterone|mesh-list
57024741|NCT01941875|Progestins|progestins|mesh-ancestor
57024742|NCT01941875|Hormones|hormones|mesh-ancestor
57024743|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024744|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024745|NCT04287062|Suvorexant|suvorexant|mesh-list
57024746|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57024747|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57024748|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024749|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024750|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57024751|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024752|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024753|NCT05508074|Riluzole|riluzole|mesh-list
57024754|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
57024755|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57024756|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57024757|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024758|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024759|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024760|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57024761|NCT05508074|Protective Agents|protective agents|mesh-ancestor
57024762|NCT01814657|Lidocaine|lidocaine|mesh-list
57024763|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
57024764|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
57024765|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024766|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024767|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
57024768|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024769|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57024770|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57024771|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57024772|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57024773|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024774|NCT01773395|Methotrexate|methotrexate|mesh-list
57024775|NCT01773395|Fludarabine|fludarabine|mesh-list
57024776|NCT01773395|Busulfan|busulfan|mesh-list
57024777|NCT01773395|Tacrolimus|tacrolimus|mesh-list
57024778|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57024779|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
57024780|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57024781|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024782|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57024783|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
57024784|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024785|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024786|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
57024787|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024788|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57024789|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57024790|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
57024791|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57024792|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57024793|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57024794|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
57024795|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57024796|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57024797|NCT01000922|Insulin|insulin|mesh-list
57024798|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57024799|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
57024800|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57024801|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024802|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
57024803|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024804|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
57024805|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
57024806|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57024807|NCT03666195|Protective Agents|protective agents|mesh-ancestor
57024808|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024809|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
57024810|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57024811|NCT00889382|Paclitaxel|paclitaxel|mesh-list
57024812|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57024813|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024814|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
57024815|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
57024816|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
57024817|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024818|NCT04059003|Taxane|taxane|mesh-list
57024819|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024820|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
57024821|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57024822|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024823|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024824|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57024825|NCT05375188|Analgesics|analgesics|mesh-ancestor
57024826|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
57024827|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024828|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57024829|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57024830|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57024831|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
57024832|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024833|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024834|NCT00994292|Darexaban|darexaban|mesh-list
57024835|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57024836|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
57024837|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57024838|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
57024839|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024840|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024841|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
57024842|NCT02604433|Luspatercept|luspatercept|mesh-list
57024843|NCT02604433|Hematinics|hematinics|mesh-ancestor
57024844|NCT04437004|Fenfluramine|fenfluramine|mesh-list
57024845|NCT04437004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57024846|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57024847|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57024848|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024849|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024850|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
57024851|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024852|NCT04704050|Dronedarone|dronedarone|mesh-list
57024853|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57024854|NCT00992732|Valganciclovir|valganciclovir|mesh-list
57024855|NCT00992732|Ganciclovir|ganciclovir|mesh-list
57024856|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
57024857|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
57024858|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
57024859|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024860|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57024861|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024862|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024863|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024864|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
57024865|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57024866|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57024867|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57024868|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57024869|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024870|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
57024871|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024872|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024873|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57024874|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024875|NCT03006393|Infliximab|infliximab|mesh-list
57024876|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
57024877|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57024878|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57024879|NCT00991172|Fasinumab|fasinumab|mesh-list
57024880|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57024881|NCT00991172|Analgesics|analgesics|mesh-ancestor
57024882|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
57024883|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024884|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024885|NCT01383109|Pyronaridine|pyronaridine|mesh-list
57024886|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
57024887|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57024888|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57024889|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024890|NCT00882440|Losartan|losartan|mesh-list
57024892|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57024893|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57024894|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57024895|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57024896|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024897|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57024898|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
57024899|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024900|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
57024901|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024902|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57024903|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024904|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024905|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
57024906|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57024907|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
57024908|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024909|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024910|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57024911|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
57024912|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57024913|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57024914|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57024915|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
57024916|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024917|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024918|NCT05214157|Bupivacaine|bupivacaine|mesh-list
57024919|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
57024920|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
57024921|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024922|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024923|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
57024924|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57024925|NCT04549467|Tenofovir|tenofovir|mesh-list
57024926|NCT04549467|Lamivudine|lamivudine|mesh-list
57024927|NCT04549467|Emtricitabine|emtricitabine|mesh-list
57024928|NCT04549467|Dolutegravir|dolutegravir|mesh-list
57024929|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
57024930|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896990|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
57024931|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57024932|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57024933|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024934|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024935|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57024936|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57024937|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57024938|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57024939|NCT05476796|Trifluridine|trifluridine|mesh-list
57024940|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
57024941|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024942|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
57024943|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024944|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
57024945|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57024946|NCT03630341|Clomiphene|clomiphene|mesh-list
57024947|NCT03630341|Enclomiphene|enclomiphene|mesh-list
57024948|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
57024949|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57024950|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
57024951|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57024952|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024953|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57024954|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
57024955|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57024956|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57024957|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57024958|NCT02632396|Rituximab|rituximab|mesh-list
57024959|NCT02632396|Ixazomib|ixazomib|mesh-list
57024960|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57024961|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57024962|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
57024963|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024964|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57024965|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024966|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
57024967|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57024968|NCT05474846|Melatonin|melatonin|mesh-list
57024969|NCT05474846|Methylphenidate|methylphenidate|mesh-list
57024970|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
57024971|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024972|NCT05474846|Protective Agents|protective agents|mesh-ancestor
57024973|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024974|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024975|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57024976|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57024977|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57024978|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57024979|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
57024980|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57024981|NCT05102422|Propofol|propofol|mesh-list
57024982|NCT05102422|Sevoflurane|sevoflurane|mesh-list
57024983|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57024984|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57024985|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024986|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57024987|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
57024988|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
57024989|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57024990|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57024991|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
57024992|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57024993|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
57024994|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57024995|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57024996|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57024997|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
57024998|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57024999|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025000|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57025001|NCT04530838|Vaccines|vaccines|mesh-list
57025002|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57025003|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
57025004|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025005|NCT03665181|Bismuth|bismuth|mesh-list
57025006|NCT03665181|Antacids|antacids|mesh-ancestor
57025007|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025008|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57025009|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57025010|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025011|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025012|NCT05101954|Mitogens|mitogens|mesh-list
57025013|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
57025014|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025015|NCT00875108|Insulin|insulin|mesh-list
57025016|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57025017|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025018|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025019|NCT04044209|Nivolumab|nivolumab|mesh-list
57025020|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57025021|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025022|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57025023|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025024|NCT00001481|Estradiol|estradiol|mesh-list
57025025|NCT00001481|Progesterone|progesterone|mesh-list
57025026|NCT00001481|Estrogens|estrogens|mesh-ancestor
57025027|NCT00001481|Hormones|hormones|mesh-ancestor
57025028|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025029|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025030|NCT00001481|Progestins|progestins|mesh-ancestor
57025031|NCT05208931|Mitogens|mitogens|mesh-list
57025032|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
57025033|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
57025034|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025035|NCT05208931|Growth Substances|growth substances|mesh-ancestor
57025036|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025037|NCT04724759|Lidocaine|lidocaine|mesh-list
57025038|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
57025039|NCT04724759|Ketamine|ketamine|mesh-list
57025040|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
57025041|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
57025042|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025043|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025044|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
57025045|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025046|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025047|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57025048|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57025049|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025050|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025051|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57025052|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57025053|NCT04724759|Analgesics|analgesics|mesh-ancestor
57025054|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57025055|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57025056|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57025057|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
57025058|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025059|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57025060|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57025061|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
57025062|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57025063|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57025064|NCT03817463|Empagliflozin|empagliflozin|mesh-list
57025065|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57025066|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57025067|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025068|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025069|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025070|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
57025071|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025072|NCT05207683|Antibodies|antibodies|mesh-list
57025073|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
57025074|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
57025075|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025076|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57025077|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
57025078|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025079|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
57025080|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57025081|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57025082|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025083|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025084|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57025085|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57025086|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57025087|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57025088|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
57025089|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025090|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025091|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57025092|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57025093|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
57025094|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57025095|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57025096|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
57025097|NCT05213065|Bupivacaine|bupivacaine|mesh-list
57025098|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
57025099|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
57025100|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025101|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025102|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
57025103|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025104|NCT04578938|Ketamine|ketamine|mesh-list
57025105|NCT04578938|Analgesics|analgesics|mesh-ancestor
57025106|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
57025107|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025108|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025109|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57025110|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57025111|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
57025112|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
57025113|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025114|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57025115|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57025116|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025117|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025118|NCT00969722|Tretinoin|tretinoin|mesh-list
57025119|NCT00969722|Molgramostim|molgramostim|mesh-list
57025120|NCT00969722|Isotretinoin|isotretinoin|mesh-list
57025121|NCT00969722|Sargramostim|sargramostim|mesh-list
57025122|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025123|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
57025124|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
57025125|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
57025126|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025127|NCT05099614|Naloxone|naloxone|mesh-list
57025128|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57025129|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025130|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
57025131|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025132|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
57025133|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57025134|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57025135|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57025136|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025137|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025138|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
57025139|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025140|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025141|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57025142|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025143|NCT05283382|Cannabidiol|cannabidiol|mesh-list
57025144|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
57025145|NCT00869336|Luliconazole|luliconazole|mesh-list
57025146|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
57025147|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57025148|NCT02371889|Topiramate|topiramate|mesh-list
57025149|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
57025150|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025151|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025152|NCT00860288|Metformin|metformin|mesh-list
57025153|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57025154|NCT00860288|Vildagliptin|vildagliptin|mesh-list
57025155|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025156|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025157|NCT00860288|Incretins|incretins|mesh-ancestor
57025158|NCT00860288|Hormones|hormones|mesh-ancestor
57025159|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025160|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57025161|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
57025162|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025163|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025164|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57025165|NCT03630029|Hematinics|hematinics|mesh-ancestor
57025166|NCT05763953|Etripamil|etripamil|mesh-list
57025167|NCT05763953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57025168|NCT05763953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025169|NCT05763953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025170|NCT05763953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57025171|NCT05763953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025172|NCT05212597|Losartan|losartan|mesh-list
57025173|NCT05212597|Amlodipine|amlodipine|mesh-list
57025174|NCT05212597|Valsartan|valsartan|mesh-list
57025175|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57025176|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57025177|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57025178|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025179|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025180|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57025181|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025182|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
57025183|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57025184|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57025185|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025186|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57025187|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025188|NCT03629717|Vitamin D|vitamin d|mesh-list
57025189|NCT03629717|Denosumab|denosumab|mesh-list
57025190|NCT03629717|Calcium|calcium|mesh-list
57025191|NCT03629717|Vitamins|vitamins|mesh-ancestor
57025192|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
57025193|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025194|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57025195|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57025196|NCT05108350|Metformin|metformin|mesh-list
57025197|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025198|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025199|NCT00859430|Levetiracetam|levetiracetam|mesh-list
57025200|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
57025201|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
57025202|NCT00855764|Paclitaxel|paclitaxel|mesh-list
57025203|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57025204|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025205|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
57025206|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
57025207|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
57025208|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025209|NCT00959036|Methotrexate|methotrexate|mesh-list
57025210|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57025211|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
57025212|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57025213|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025214|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57025215|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
57025216|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025217|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025218|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
57025219|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025220|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57025221|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57025222|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
57025223|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57025224|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57025225|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
57025226|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
57025227|NCT04129723|Protective Agents|protective agents|mesh-ancestor
57025228|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025229|NCT04474262|Midodrine|midodrine|mesh-list
57025230|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
57025231|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
57025232|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025233|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025234|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57025235|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57025236|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57025237|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57025238|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
57025239|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025240|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025241|NCT05211583|Progesterone|progesterone|mesh-list
57025242|NCT05211583|Progestins|progestins|mesh-ancestor
57025243|NCT05211583|Hormones|hormones|mesh-ancestor
57025244|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025245|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025246|NCT04031599|Hormones|hormones|mesh-list
57025247|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025248|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025249|NCT04019821|Insulin|insulin|mesh-list
57025250|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57025251|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
57025252|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
57025253|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
57025254|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025255|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025256|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
57025257|NCT05186467|Analgesics|analgesics|mesh-ancestor
57025258|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
57025259|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025260|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025261|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
57025262|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707256|NCT00687297|Docetaxel|docetaxel|mesh-list
57025263|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025265|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57025266|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025267|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025268|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57025269|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
57025270|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57025271|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57025272|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
57025273|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57025274|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57025275|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57025276|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025277|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025278|NCT00768482|Buprenorphine|buprenorphine|mesh-list
57025279|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57025280|NCT00768482|Narcotics|narcotics|mesh-ancestor
57025281|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025282|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025283|NCT00768482|Analgesics|analgesics|mesh-ancestor
57025284|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
57025285|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025286|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57025287|NCT00840866|Cefprozil|cefprozil|mesh-list
57025288|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57025289|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57025290|NCT05043116|Vitamin D|vitamin d|mesh-list
57025291|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
57025292|NCT05043116|Vitamins|vitamins|mesh-ancestor
57025293|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
57025294|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025295|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57025296|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57025297|NCT00840632|Trandolapril|trandolapril|mesh-list
57025298|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56896995|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
57025299|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
57025300|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025301|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025302|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57025303|NCT00840476|Meloxicam|meloxicam|mesh-list
57025304|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57025305|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57025306|NCT00840476|Analgesics|analgesics|mesh-ancestor
57025307|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
57025308|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025309|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025310|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57025311|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57025312|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57025313|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57025314|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025315|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025316|NCT00765830|Vildagliptin|vildagliptin|mesh-list
57025317|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025318|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025319|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57025320|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
57025321|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025322|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025323|NCT03664869|Mitomycins|mitomycins|mesh-list
57025324|NCT03664869|Mitomycin|mitomycin|mesh-list
57025325|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57025326|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025327|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
57025328|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025329|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57025330|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025331|NCT00953420|Dexamethasone|dexamethasone|mesh-list
57025332|NCT00953420|Carboplatin|carboplatin|mesh-list
57025333|NCT00953420|Docetaxel|docetaxel|mesh-list
57025334|NCT00953420|Lenograstim|lenograstim|mesh-list
57025335|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57025336|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
57025337|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
57025338|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025339|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025340|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57025341|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
57025342|NCT00953420|Hormones|hormones|mesh-ancestor
57025343|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025344|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57025345|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025346|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
57025347|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
57025348|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
57025349|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025350|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57025351|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
57025352|NCT01602562|Valacyclovir|valacyclovir|mesh-list
57025353|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
57025354|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57025355|NCT01945775|Talazoparib|talazoparib|mesh-list
57025356|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57025357|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025358|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025359|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025360|NCT00839930|Cilostazol|cilostazol|mesh-list
57025361|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57025362|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
57025363|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025364|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025365|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57025366|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
57025367|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57025368|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57025369|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025370|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57025371|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
57025372|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57025373|NCT00839930|Protective Agents|protective agents|mesh-ancestor
57025374|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57025375|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57025376|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025377|NCT00838136|Lamotrigine|lamotrigine|mesh-list
57025378|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
57025379|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57025380|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025381|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025382|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57025383|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025384|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57025385|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57025386|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025387|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57025388|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57025389|NCT00944294|Adenosine|adenosine|mesh-list
57025390|NCT00944294|Binodenoson|binodenoson|mesh-list
57025391|NCT00944294|Analgesics|analgesics|mesh-ancestor
57025392|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
57025393|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025394|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025395|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025396|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
57025397|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57025398|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
57025399|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
57025400|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025401|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025402|NCT00758966|Naltrexone|naltrexone|mesh-list
57025403|NCT00758966|Fluoxetine|fluoxetine|mesh-list
57025404|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57025405|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57025406|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025407|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
57025408|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025409|NCT00758966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57025410|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56707407|NCT00750399|Ranibizumab|ranibizumab|mesh-list
57025411|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025412|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025413|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025414|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
57025415|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57025416|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
57025417|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57025418|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57025419|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57025420|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025421|NCT05083312|Fluticasone|fluticasone|mesh-list
57025422|NCT05083312|Xhance|xhance|mesh-list
57025423|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57025424|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57025425|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
57025426|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025427|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025428|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57025429|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
57025430|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
57025431|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57025432|NCT03072719|Fluorides|fluorides|mesh-list
57025433|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
57025434|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
57025435|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
57025436|NCT03072719|Protective Agents|protective agents|mesh-ancestor
57025437|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025438|NCT03617731|Dexamethasone|dexamethasone|mesh-list
57025439|NCT03617731|Lenalidomide|lenalidomide|mesh-list
57025440|NCT03617731|Bortezomib|bortezomib|mesh-list
57025441|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57025442|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
56897002|NCT01269021|Hormones|hormones|mesh-ancestor
57025443|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
57025444|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025445|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025446|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57025447|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
57025448|NCT03617731|Hormones|hormones|mesh-ancestor
57025449|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025450|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57025451|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025452|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
57025453|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57025454|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57025455|NCT03617731|Growth Substances|growth substances|mesh-ancestor
57025456|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
57025457|NCT05106400|Lidocaine|lidocaine|mesh-list
57025458|NCT05106400|Menthol|menthol|mesh-list
57025459|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
57025460|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
57025461|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025462|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025463|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
57025464|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025465|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025466|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57025467|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57025468|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025469|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025470|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
57025471|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
57025472|NCT00754988|Metformin|metformin|mesh-list
57025473|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57025474|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57025475|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025476|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025477|NCT00754988|Incretins|incretins|mesh-ancestor
57025478|NCT00754988|Hormones|hormones|mesh-ancestor
57025479|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025480|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57025481|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
57025482|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025483|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025484|NCT01416935|Amiodarone|amiodarone|mesh-list
57025485|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025486|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
57025487|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57025488|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025489|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025490|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57025491|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57025492|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57025493|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025494|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57025495|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57025496|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57025497|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
57025498|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57025499|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
57025500|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57025501|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025502|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025503|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
57025504|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025505|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025506|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57025507|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
57025508|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
57025509|NCT05012566|Protective Agents|protective agents|mesh-ancestor
57025510|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57025511|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025512|NCT05202665|Fluorides|fluorides|mesh-list
57025513|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
57025514|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
57025515|NCT05202665|Protective Agents|protective agents|mesh-ancestor
57025516|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025517|NCT04438772|Anesthetics|anesthetics|mesh-list
57025518|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025519|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025520|NCT04560634|Norepinephrine|norepinephrine|mesh-list
57025521|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57025522|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57025523|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
57025524|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025525|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025526|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025527|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
57025528|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
57025529|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025530|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57025531|NCT00927914|Ranirestat|ranirestat|mesh-list
57025532|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025533|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025534|NCT05261464|Metoprolol|metoprolol|mesh-list
57025535|NCT05261464|Diltiazem|diltiazem|mesh-list
57025536|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025537|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57025538|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
57025539|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
57025540|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025541|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025542|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57025543|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57025544|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57025545|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
57025546|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025547|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025548|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57025549|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025550|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57025551|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
57025552|NCT05681377|Flumazenil|flumazenil|mesh-list
57025553|NCT05681377|Antidotes|antidotes|mesh-ancestor
57025554|NCT05681377|Protective Agents|protective agents|mesh-ancestor
57025555|NCT05681377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025556|NCT05681377|GABA Modulators|gaba modulators|mesh-ancestor
57025557|NCT05681377|GABA Agents|gaba agents|mesh-ancestor
57025558|NCT05681377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025559|NCT05681377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025560|NCT05047939|Propofol|propofol|mesh-list
57025561|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57025562|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025563|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025564|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57025565|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
57025566|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
57025567|NCT00835796|Finasteride|finasteride|mesh-list
57025568|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57025569|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57025570|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025571|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025572|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
57025573|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025574|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025575|NCT00835796|Urological Agents|urological agents|mesh-ancestor
57025576|NCT05106712|Vitamin D|vitamin d|mesh-list
57025577|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
57025578|NCT05106712|Letrozole|letrozole|mesh-list
57025579|NCT05106712|Clomiphene|clomiphene|mesh-list
57025580|NCT05106712|Enclomiphene|enclomiphene|mesh-list
57025581|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
57025582|NCT05106712|Vitamins|vitamins|mesh-ancestor
57025583|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
57025584|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025585|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57025586|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025587|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57025588|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025589|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57025590|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57025591|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025592|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57025593|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
57025594|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025595|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57025596|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
57025597|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57025598|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57025599|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57025600|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
57025601|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57025602|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57025603|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025604|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025605|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025606|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
57025607|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025608|NCT00835640|Fexofenadine|fexofenadine|mesh-list
57025609|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57025610|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57025611|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57025612|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
57025613|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
57025614|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025615|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025616|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025617|NCT00752570|Trebananib|trebananib|mesh-list
57025618|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57025619|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57025620|NCT00752570|Growth Substances|growth substances|mesh-ancestor
57025621|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025622|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
57025623|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025624|NCT05083000|Topotecan|topotecan|mesh-list
57025625|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57025626|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57025627|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025628|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025629|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025630|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
57025631|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57025632|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56707635|NCT05533775|Rituximab|rituximab|mesh-list
57025633|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57025634|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025635|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025636|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
57025637|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025638|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025639|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57025640|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025641|NCT02942017|Brexanolone|brexanolone|mesh-list
57025642|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
57025643|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025644|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025645|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025646|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
57025647|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
57025648|NCT04447781|Citric Acid|citric acid|mesh-list
57025649|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
57025650|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
57025651|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57025652|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
57025653|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
57025654|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025655|NCT04364776|Durvalumab|durvalumab|mesh-list
57025656|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57025657|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025658|NCT00835484|Cefdinir|cefdinir|mesh-list
57025659|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56603166|NCT05442034|Mitogens|mitogens|mesh-list
57025660|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57025661|NCT00835406|Alendronate|alendronate|mesh-list
57025662|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57025663|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025664|NCT05202275|Olanzapine|olanzapine|mesh-list
57025665|NCT05202275|Aprepitant|aprepitant|mesh-list
57025666|NCT05202275|Palonosetron|palonosetron|mesh-list
57025667|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
57025668|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
57025669|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025670|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025671|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57025672|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57025673|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57025674|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025675|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57025676|NCT05202275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57025677|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57025678|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025679|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025680|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025681|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
57025682|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57025683|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57025684|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57025685|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
57025686|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025687|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57025688|NCT00745316|Adenosine|adenosine|mesh-list
57025689|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
57025690|NCT00745316|Analgesics|analgesics|mesh-ancestor
57025691|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
57025692|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025693|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025694|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025695|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
57025696|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57025697|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
57025698|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
57025699|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025700|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025701|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57025702|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57025703|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57025704|NCT00744926|Incretins|incretins|mesh-ancestor
57025705|NCT00744926|Hormones|hormones|mesh-ancestor
57025706|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025707|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025708|NCT03838744|Olaparib|olaparib|mesh-list
57025709|NCT03838744|Trabectedin|trabectedin|mesh-list
57025710|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57025711|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025712|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025713|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025714|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57025715|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
57025716|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
57025717|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
57025718|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025719|NCT05327348|Protective Agents|protective agents|mesh-ancestor
57025720|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025721|NCT05327348|Vitamins|vitamins|mesh-ancestor
57025722|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
57025723|NCT04695106|Aspirin|aspirin|mesh-list
57025724|NCT04695106|Dabigatran|dabigatran|mesh-list
57025725|NCT04695106|Clopidogrel|clopidogrel|mesh-list
57025726|NCT04695106|Ticagrelor|ticagrelor|mesh-list
57025727|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57025728|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57025729|NCT04695106|Analgesics|analgesics|mesh-ancestor
57025730|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
57025731|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025732|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025733|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57025734|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57025735|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57025736|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57025737|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025738|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57025739|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57025740|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025741|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
57025742|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57025743|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57025744|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57025745|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
57025746|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025747|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
57025748|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57025749|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
57025750|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
57025751|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
57025752|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57025753|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
57025754|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57025755|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
57025756|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025757|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025758|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
57025759|NCT03629639|Metformin|metformin|mesh-list
57025760|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025761|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025762|NCT00835172|Glimepiride|glimepiride|mesh-list
57025763|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025764|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025765|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025766|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57025767|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
57025768|NCT04941755|Famotidine|famotidine|mesh-list
57025769|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57025770|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57025771|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57025772|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
57025773|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
57025774|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025775|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025776|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025777|NCT04921735|Cisatracurium|cisatracurium|mesh-list
57025778|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57025779|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57025780|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025781|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025782|NCT01676116|Liraglutide|liraglutide|mesh-list
57025783|NCT01676116|Exenatide|exenatide|mesh-list
57025784|NCT01676116|Xultophy|xultophy|mesh-list
57025785|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025786|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025787|NCT01676116|Incretins|incretins|mesh-ancestor
57025788|NCT01676116|Hormones|hormones|mesh-ancestor
57025789|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025790|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57025791|NCT05200793|Metformin|metformin|mesh-list
57025792|NCT05200793|Empagliflozin|empagliflozin|mesh-list
57025793|NCT05200793|Linagliptin|linagliptin|mesh-list
57025794|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57025795|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025796|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57025797|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025798|NCT05200793|Incretins|incretins|mesh-ancestor
57025799|NCT05200793|Hormones|hormones|mesh-ancestor
57025800|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025801|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57025802|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
57025803|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025804|NCT03383224|Nicotine|nicotine|mesh-list
57025805|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57025806|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
57025807|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025808|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025809|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57025810|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57025811|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
57025812|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025813|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025814|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
57025815|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57025816|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025817|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025818|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57025819|NCT04720963|Analgesics|analgesics|mesh-ancestor
57025820|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
57025821|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025822|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57025823|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57025824|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57025825|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
57025826|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025827|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025828|NCT04699357|Atropine|atropine|mesh-list
57025829|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57025830|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57025831|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57025832|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
57025833|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025834|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025835|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57025836|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
57025837|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
57025838|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
57025839|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57025840|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57025841|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
57025842|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025843|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025844|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
57025845|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
57025846|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57025847|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57025848|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57025849|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025850|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025851|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57025852|NCT05198531|Gemcitabine|gemcitabine|mesh-list
57025853|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025854|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57025855|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
57025856|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025857|NCT05198531|Antiviral Agents|antiviral agents|mesh-ancestor
57025858|NCT05198531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57025859|NCT05198531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025860|NCT05198531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57025861|NCT05198531|Immunologic Factors|immunologic factors|mesh-ancestor
57025862|NCT05198531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025863|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
57025864|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025865|NCT04177706|Ketamine|ketamine|mesh-list
57025866|NCT04177706|Analgesics|analgesics|mesh-ancestor
57025867|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
57025868|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025869|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025870|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57025871|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57025872|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
57025873|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
57025874|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025875|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57025876|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57025877|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025878|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025879|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
57025880|NCT01869829|Clotrimazole|clotrimazole|mesh-list
57025881|NCT01869829|Miconazole|miconazole|mesh-list
57025882|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57025883|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57025884|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57025885|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57025886|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025887|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025888|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57025889|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
57025890|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025891|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025892|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57025893|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57025894|NCT02683018|Dronabinol|dronabinol|mesh-list
57025895|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
57025896|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025897|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57025898|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57025899|NCT02683018|Analgesics|analgesics|mesh-ancestor
57025900|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
57025901|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025902|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57025903|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57025904|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025905|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025906|NCT02683018|Hormones|hormones|mesh-ancestor
57025907|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025908|NCT03982576|Nicotine|nicotine|mesh-list
57025909|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57025910|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
57025911|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025912|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025913|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57025914|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57025915|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
57025916|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025917|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025918|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
57025919|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57025920|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57025921|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57025922|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025923|NCT02675842|Dronabinol|dronabinol|mesh-list
57025924|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
57025925|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025926|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57025927|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57025928|NCT02675842|Analgesics|analgesics|mesh-ancestor
57025929|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
57025930|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025931|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57025932|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57025933|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025934|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025935|NCT02675842|Hormones|hormones|mesh-ancestor
57025936|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57025937|NCT04528108|Hemostatics|hemostatics|mesh-list
57025938|NCT04528108|Coagulants|coagulants|mesh-ancestor
57025939|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
57025940|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57025941|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
57025942|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57025943|NCT05074121|Expectorants|expectorants|mesh-ancestor
57025944|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
57025945|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57025946|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
57025947|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025948|NCT05074121|Protective Agents|protective agents|mesh-ancestor
57025949|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025950|NCT05074121|Antidotes|antidotes|mesh-ancestor
57025951|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
57025952|NCT05216419|Vitamin D|vitamin d|mesh-list
57025953|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57025954|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025955|NCT05216419|Vitamins|vitamins|mesh-ancestor
57025956|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
57025957|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57025958|NCT04251689|Mannitol|mannitol|mesh-list
57025959|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57025960|NCT04251689|Diuretics|diuretics|mesh-ancestor
57025961|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
57025962|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025963|NCT04232423|Olanzapine|olanzapine|mesh-list
57025964|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
57025965|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
57025966|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57025967|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025968|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57025969|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57025970|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57025971|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57025972|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57025973|NCT04232423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57025974|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57025975|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025976|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025977|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025978|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
57025979|NCT05669833|Golimumab|golimumab|mesh-list
57025980|NCT05669833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57025981|NCT05669833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57025982|NCT05669833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57025983|NCT05669833|Immunologic Factors|immunologic factors|mesh-ancestor
57025984|NCT05669833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025985|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57025986|NCT04178993|Methylphenidate|methylphenidate|mesh-list
57025987|NCT04178993|Methamphetamine|methamphetamine|mesh-list
57025988|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57025989|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57025990|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57025991|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57025992|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57025993|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57025994|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
57025995|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57025996|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57025997|NCT04178993|Analgesics|analgesics|mesh-ancestor
57025998|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
57025999|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026000|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
57026001|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57026002|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
57026003|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
57026004|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026005|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57026006|NCT04107077|Mitomycins|mitomycins|mesh-list
57026007|NCT04107077|Mitomycin|mitomycin|mesh-list
57026008|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026009|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57026010|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
57026011|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026012|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57026013|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026014|NCT04436536|Methamphetamine|methamphetamine|mesh-list
57026015|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57026016|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026017|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
57026018|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
57026019|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026020|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
57026021|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026022|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026023|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026024|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57026025|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57026026|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57026027|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57026028|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
57026029|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
57026030|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57026031|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57026032|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026033|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026034|NCT03997097|Urological Agents|urological agents|mesh-ancestor
57026035|NCT05762003|Interferons|interferons|mesh-list
57026036|NCT05762003|Teriflunomide|teriflunomide|mesh-list
57026037|NCT05762003|Rituximab|rituximab|mesh-list
57026038|NCT05762003|Alemtuzumab|alemtuzumab|mesh-list
57026039|NCT05762003|Ofatumumab|ofatumumab|mesh-list
57026040|NCT05762003|Cladribine|cladribine|mesh-list
57026041|NCT05762003|Glatiramer Acetate|glatiramer acetate|mesh-list
57026042|NCT05762003|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57026043|NCT05762003|Ocrelizumab|ocrelizumab|mesh-list
57026044|NCT05762003|Natalizumab|natalizumab|mesh-list
57026045|NCT05762003|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57026046|NCT05762003|(T,G)-A-L|(t,g)-a-l|mesh-list
57026047|NCT05762003|Ponesimod|ponesimod|mesh-list
57026048|NCT05762003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026049|NCT05762003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026050|NCT05762003|Immunologic Factors|immunologic factors|mesh-ancestor
57026051|NCT05762003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026052|NCT05762003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026053|NCT05762003|Antiviral Agents|antiviral agents|mesh-ancestor
57026054|NCT05762003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026055|NCT05762003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026056|NCT05762003|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57026057|NCT05762003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026058|NCT05762003|Dermatologic Agents|dermatologic agents|mesh-ancestor
57026059|NCT05762003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57026060|NCT05762003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57026061|NCT05762003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57026062|NCT05762003|Analgesics|analgesics|mesh-ancestor
57026063|NCT05762003|Sensory System Agents|sensory system agents|mesh-ancestor
57026064|NCT05762003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026065|NCT05762003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57026066|NCT04094012|Isoniazid|isoniazid|mesh-list
57026067|NCT04094012|Rifapentine|rifapentine|mesh-list
57026068|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
57026069|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026070|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026071|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57026072|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57026073|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
57026074|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026075|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57026076|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57026077|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
57026078|NCT04644016|Cyclosporine|cyclosporine|mesh-list
57026079|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
56708079|NCT00679341|Docetaxel|docetaxel|mesh-list
57026080|NCT04644016|Fludarabine|fludarabine|mesh-list
57026081|NCT04644016|Busulfan|busulfan|mesh-list
57026082|NCT04644016|Clofarabine|clofarabine|mesh-list
57026083|NCT04644016|Cyclosporins|cyclosporins|mesh-list
57026084|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026085|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57026086|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
57026087|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026088|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026089|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
57026090|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026091|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026092|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
57026093|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026094|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
57026095|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026096|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57026097|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57026098|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57026099|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
57026100|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026101|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
57026102|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57026103|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57026104|NCT03679676|Omalizumab|omalizumab|mesh-list
57026105|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57026106|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57026107|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
57026108|NCT03001557|Lemborexant|lemborexant|mesh-list
57026109|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57026110|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026111|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026112|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57026113|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57026114|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026115|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026116|NCT03134612|Lidocaine|lidocaine|mesh-list
57026117|NCT03134612|Ondansetron|ondansetron|mesh-list
57026118|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
57026119|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
57026120|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026121|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026122|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
57026123|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026124|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57026125|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57026126|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57026127|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57026128|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026129|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
57026130|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
57026131|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57026132|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
57026133|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
57026134|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57026135|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
57026136|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026137|NCT03134612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57026138|NCT03134612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57026139|NCT03134612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57026140|NCT03134612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57026141|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57026142|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57026143|NCT04365985|Naltrexone|naltrexone|mesh-list
57026144|NCT04365985|Ketamine|ketamine|mesh-list
57026145|NCT04365985|Analgesics|analgesics|mesh-ancestor
57026146|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
57026147|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026148|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026149|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57026150|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57026151|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
57026152|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
57026153|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026154|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57026155|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57026156|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708159|NCT00919880|Paclitaxel|paclitaxel|mesh-list
57026157|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026158|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57026159|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57026160|NCT05111860|Bevacizumab|bevacizumab|mesh-list
57026161|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026162|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026163|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57026164|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57026165|NCT05111860|Growth Substances|growth substances|mesh-ancestor
57026166|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026167|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
57026168|NCT00830336|Azithromycin|azithromycin|mesh-list
57026169|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026170|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026171|NCT00830258|Pravastatin|pravastatin|mesh-list
57026172|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57026173|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57026174|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
57026175|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026176|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57026177|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57026178|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026179|NCT00830102|Fluticasone|fluticasone|mesh-list
57026180|NCT00830102|Xhance|xhance|mesh-list
57026181|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
57026182|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57026183|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57026184|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
57026185|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026186|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026187|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57026188|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
57026189|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
57026190|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57026191|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57026192|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57026193|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57026194|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026195|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026196|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026197|NCT03349775|Metformin|metformin|mesh-list
57026198|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57026199|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026200|NCT00830024|Alprazolam|alprazolam|mesh-list
57026201|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57026202|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026203|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026204|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57026205|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57026206|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57026207|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
57026208|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
57026209|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026210|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026211|NCT00829868|Zaleplon|zaleplon|mesh-list
57026212|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
57026213|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57026214|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026215|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026216|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
57026217|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
57026218|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026219|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026220|NCT00721760|Enoxaparin|enoxaparin|mesh-list
57026221|NCT00721760|Semuloparin|semuloparin|mesh-list
57026222|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
57026223|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
57026224|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57026225|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57026226|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026227|NCT00829790|Doxycycline|doxycycline|mesh-list
57026228|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026229|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026230|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
57026231|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57026232|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57026233|NCT03207815|Prednisone|prednisone|mesh-list
57026234|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57026235|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
57026236|NCT03207815|Hormones|hormones|mesh-ancestor
57026237|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57026238|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026239|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57026240|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026241|NCT02911935|Azithromycin|azithromycin|mesh-list
57026242|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026243|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026244|NCT05193487|Anesthetics|anesthetics|mesh-list
57026245|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026246|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026247|NCT03479762|Liraglutide|liraglutide|mesh-list
57026248|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57026249|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026250|NCT03479762|Incretins|incretins|mesh-ancestor
57026251|NCT03479762|Hormones|hormones|mesh-ancestor
57026252|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57026253|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
57026254|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57026255|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026256|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57026257|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57026258|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57026259|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026260|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
57026261|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026262|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57026263|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57026264|NCT05079802|Chitosan|chitosan|mesh-list
57026265|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026266|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
57026267|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57026268|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57026269|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
57026270|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026271|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57026272|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
57026273|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
57026274|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
57026275|NCT05079802|Coagulants|coagulants|mesh-ancestor
57026276|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57026277|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
57026278|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
57026279|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026280|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
57026281|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026282|NCT03899636|Folfirinox|folfirinox|mesh-list
57026283|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026284|NCT05761223|Pembrolizumab|pembrolizumab|mesh-list
57026285|NCT05761223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026286|NCT05761223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026287|NCT03386942|Farletuzumab|farletuzumab|mesh-list
57026288|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026289|NCT05093920|Doxorubicin|doxorubicin|mesh-list
57026290|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57026291|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57026292|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026293|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57026294|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57026295|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026296|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026297|NCT04910230|Niacinamide|niacinamide|mesh-list
57026299|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
57026300|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
57026301|NCT04910230|Vitamins|vitamins|mesh-ancestor
57026302|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
57026303|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026304|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57026305|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
57026306|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026307|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57026308|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
57026309|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
57026310|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026311|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026312|NCT05202821|Fluorides|fluorides|mesh-list
57026313|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
57026314|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
57026315|NCT05202821|Protective Agents|protective agents|mesh-ancestor
57026316|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026317|NCT02560805|Losartan|losartan|mesh-list
57026318|NCT02560805|Atenolol|atenolol|mesh-list
57026319|NCT02560805|Nitroprusside|nitroprusside|mesh-list
57026320|NCT02560805|Phenylephrine|phenylephrine|mesh-list
57026321|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
57026322|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57026323|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57026324|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57026325|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57026326|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026327|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57026328|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
57026329|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
57026330|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026331|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026332|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
57026333|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57026334|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
57026335|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
57026336|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57026337|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57026338|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57026339|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026340|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026341|NCT02560805|Protective Agents|protective agents|mesh-ancestor
57026342|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
57026343|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57026344|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57026345|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57026346|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
57026347|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57026348|NCT04615936|Methylene Blue|methylene blue|mesh-list
57026349|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026350|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026351|NCT03797222|Vitamin E|vitamin e|mesh-list
57026352|NCT03797222|Tocopherols|tocopherols|mesh-list
57026353|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
57026354|NCT03797222|Vitamins|vitamins|mesh-ancestor
57026355|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
57026356|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026357|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
57026358|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026359|NCT03797222|Protective Agents|protective agents|mesh-ancestor
57026360|NCT03755102|Osimertinib|osimertinib|mesh-list
57026361|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026362|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57026363|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026364|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026365|NCT04471675|Docetaxel|docetaxel|mesh-list
57026366|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026367|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
57026368|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
57026369|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
57026370|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026371|NCT04461028|Dexamethasone|dexamethasone|mesh-list
57026372|NCT04461028|Bupivacaine|bupivacaine|mesh-list
57026373|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57026374|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
57026375|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
57026376|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026377|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026378|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57026379|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
57026380|NCT04461028|Hormones|hormones|mesh-ancestor
57026381|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57026382|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57026383|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026384|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
57026385|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
57026386|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026388|NCT00716534|Paclitaxel|paclitaxel|mesh-list
57026389|NCT00716534|Carboplatin|carboplatin|mesh-list
57026390|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57026391|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026392|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
57026393|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
57026394|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
57026395|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026396|NCT04335058|Iron|iron|mesh-list
57026397|NCT04335058|Lactoferrin|lactoferrin|mesh-list
57026398|NCT04335058|Trace Elements|trace elements|mesh-ancestor
57026399|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
57026400|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026401|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026402|NCT02283476|Gemcitabine|gemcitabine|mesh-list
57026403|NCT02283476|Endostar protein|endostar protein|mesh-list
57026404|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026405|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57026406|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
57026407|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026408|NCT02283476|Antiviral Agents|antiviral agents|mesh-ancestor
57026409|NCT02283476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026410|NCT02283476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026411|NCT02283476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026412|NCT02283476|Immunologic Factors|immunologic factors|mesh-ancestor
57026413|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026414|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57026415|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57026416|NCT02283476|Growth Substances|growth substances|mesh-ancestor
57026417|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
57026418|NCT05156879|Aspirin|aspirin|mesh-list
57026419|NCT05156879|Drospirenone|drospirenone|mesh-list
57026420|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57026421|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
57026422|NCT05156879|Estradiol|estradiol|mesh-list
57026423|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57026424|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57026425|NCT05156879|Analgesics|analgesics|mesh-ancestor
57026426|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
57026427|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026428|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026429|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57026430|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026431|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57026432|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57026433|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026434|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57026435|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57026436|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026437|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
57026438|NCT05156879|Estrogens|estrogens|mesh-ancestor
57026439|NCT05156879|Hormones|hormones|mesh-ancestor
57026440|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57026441|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57026442|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
57026443|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57026444|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57026445|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57026446|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57026447|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57026448|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
57026449|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57026450|NCT05156879|Diuretics|diuretics|mesh-ancestor
57026451|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
57026452|NCT02283554|Metformin|metformin|mesh-list
57026453|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57026454|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026455|NCT00641732|Enoxaparin|enoxaparin|mesh-list
57026456|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
57026457|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
57026458|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57026459|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57026460|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026461|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57026462|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
57026463|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57026464|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
57026465|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026466|NCT00790829|Nicotine|nicotine|mesh-list
57026467|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57026468|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
57026469|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026470|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026471|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57026472|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57026473|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
57026474|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026475|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026476|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57026477|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57026478|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
57026479|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026480|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026481|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57026482|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
57026483|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57026484|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57026485|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57026486|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026487|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026488|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026489|NCT03065933|Clonidine|clonidine|mesh-list
57026490|NCT03065933|Analgesics|analgesics|mesh-ancestor
57026491|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
57026492|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026493|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026494|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57026495|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
57026496|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
57026497|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57026498|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57026499|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57026500|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026501|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026502|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026503|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
57026504|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026505|NCT04256629|Allopurinol|allopurinol|mesh-list
57026506|NCT04256629|Verinurad|verinurad|mesh-list
57026507|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
57026508|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026509|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026510|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
57026511|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026512|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57026513|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
57026514|NCT04256629|Protective Agents|protective agents|mesh-ancestor
57026515|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026516|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
57026517|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57026518|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026519|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
57026520|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
57026521|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
57026522|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57026523|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026524|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026525|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026526|NCT05125523|Sirolimus|sirolimus|mesh-list
57026527|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026528|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026529|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57026530|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026531|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
57026532|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026533|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
57026534|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026536|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026537|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57026538|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
57026539|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026540|NCT00625664|Antiviral Agents|antiviral agents|mesh-ancestor
57026541|NCT00625664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026542|NCT00625664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026543|NCT00625664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026544|NCT00625664|Immunologic Factors|immunologic factors|mesh-ancestor
57026545|NCT00625664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026546|NCT03790111|Gemcitabine|gemcitabine|mesh-list
57026547|NCT03790111|Cisplatin|cisplatin|mesh-list
57026548|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026549|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57026550|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
57026551|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026552|NCT03790111|Antiviral Agents|antiviral agents|mesh-ancestor
57026553|NCT03790111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026554|NCT03790111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026555|NCT03790111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026556|NCT03790111|Immunologic Factors|immunologic factors|mesh-ancestor
57026557|NCT03790111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026558|NCT02947165|Spartalizumab|spartalizumab|mesh-list
57026559|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57026560|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026561|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026562|NCT03629093|Anesthetics|anesthetics|mesh-list
57026563|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
57026564|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026565|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026566|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
57026567|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57026568|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026569|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026570|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57026571|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57026572|NCT02283710|Protective Agents|protective agents|mesh-ancestor
57026573|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026574|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
57026575|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57026576|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
57026577|NCT05055947|Atezolizumab|atezolizumab|mesh-list
57026578|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026579|NCT03943342|Venetoclax|venetoclax|mesh-list
57026580|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026581|NCT00357565|Cyclosporine|cyclosporine|mesh-list
57026582|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
57026583|NCT00357565|Fludarabine|fludarabine|mesh-list
57026584|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
57026585|NCT00357565|Melphalan|melphalan|mesh-list
57026586|NCT00357565|Busulfan|busulfan|mesh-list
57026587|NCT00357565|Cyclosporins|cyclosporins|mesh-list
57026588|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026589|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57026590|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
57026591|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026592|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026593|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
57026594|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026595|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026596|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
57026597|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026598|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
57026599|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026600|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57026601|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57026602|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57026603|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
57026604|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026605|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57026606|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
57026607|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57026608|NCT00694928|Clindamycin|clindamycin|mesh-list
57026609|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
57026610|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
57026612|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026613|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026614|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57026615|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026616|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026617|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
57026618|NCT03272464|Trametinib|trametinib|mesh-list
57026619|NCT03272464|Dabrafenib|dabrafenib|mesh-list
57026620|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026621|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57026622|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026623|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026624|NCT00694382|Semuloparin|semuloparin|mesh-list
57026625|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57026626|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57026627|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57026628|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026629|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
57026630|NCT05116228|Rituximab|rituximab|mesh-list
57026631|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026632|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026633|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
57026634|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026635|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026636|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
57026637|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57026638|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026639|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
57026640|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026641|NCT05116150|Protective Agents|protective agents|mesh-ancestor
57026642|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026643|NCT00136903|Cyclosporine|cyclosporine|mesh-list
57026644|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
57026645|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
57026646|NCT00136903|Prednisone|prednisone|mesh-list
57026647|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
57026648|NCT00136903|Tacrolimus|tacrolimus|mesh-list
57026649|NCT00136903|Cyclosporins|cyclosporins|mesh-list
57026650|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57026651|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
57026652|NCT00136903|Hormones|hormones|mesh-ancestor
57026653|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57026654|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026655|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57026656|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026657|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026658|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
57026659|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57026660|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026661|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026662|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
57026663|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026664|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
57026665|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026666|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57026667|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57026668|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
57026669|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026670|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
57026671|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
57026672|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026673|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57026674|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57026675|NCT00136903|Protective Agents|protective agents|mesh-ancestor
57026676|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
57026677|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
57026678|NCT04917029|Bupivacaine|bupivacaine|mesh-list
57026679|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
57026680|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
57026681|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026682|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026683|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
57026684|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026685|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57026686|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57026687|NCT04917029|Analgesics|analgesics|mesh-ancestor
57026688|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57026689|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57026690|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57026691|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026692|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026693|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026694|NCT04189510|Pancrelipase|pancrelipase|mesh-list
57026695|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57026696|NCT05722015|Paclitaxel|paclitaxel|mesh-list
57026697|NCT05722015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57026698|NCT05722015|Carboplatin|carboplatin|mesh-list
57026699|NCT05722015|Pembrolizumab|pembrolizumab|mesh-list
57026700|NCT05722015|Pemetrexed|pemetrexed|mesh-list
57026701|NCT05722015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57026702|NCT05722015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026703|NCT05722015|Tubulin Modulators|tubulin modulators|mesh-ancestor
57026704|NCT05722015|Antimitotic Agents|antimitotic agents|mesh-ancestor
57026705|NCT05722015|Mitosis Modulators|mitosis modulators|mesh-ancestor
57026706|NCT05722015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026707|NCT05722015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026708|NCT05722015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026709|NCT05722015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57026710|NCT05722015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57026711|NCT03632759|Liraglutide|liraglutide|mesh-list
57026712|NCT03632759|Golimumab|golimumab|mesh-list
57026713|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57026714|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026715|NCT03632759|Incretins|incretins|mesh-ancestor
57026716|NCT03632759|Hormones|hormones|mesh-ancestor
57026717|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57026718|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57026719|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57026720|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026721|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
57026722|NCT02953093|Acarbose|acarbose|mesh-list
57026723|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57026724|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026725|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026726|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57026727|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026728|NCT04518280|Capecitabine|capecitabine|mesh-list
57026729|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
57026730|NCT04518280|Antibodies|antibodies|mesh-list
57026731|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
57026732|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026733|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57026734|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
57026735|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026736|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026737|NCT00498836|Sorafenib|sorafenib|mesh-list
57026738|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026739|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57026740|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026741|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026742|NCT02283866|Desflurane|desflurane|mesh-list
57026743|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57026744|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
57026745|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
57026746|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026747|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026748|NCT04517110|Pregabalin|pregabalin|mesh-list
57026749|NCT04517110|Analgesics|analgesics|mesh-ancestor
57026750|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
57026751|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026752|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026753|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
57026754|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57026755|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57026756|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026757|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57026758|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57026759|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57026760|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026761|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57026762|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
57026763|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57026764|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
57026765|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026766|NCT02281058|Abatacept|abatacept|mesh-list
57026767|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57026768|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026769|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026770|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026771|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
57026772|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026773|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026774|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
57026775|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57026776|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57026777|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57026778|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57026779|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026780|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
57026781|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026782|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026783|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57026784|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026785|NCT05205317|Metformin|metformin|mesh-list
57026786|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57026787|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026788|NCT00691964|Etanercept|etanercept|mesh-list
57026789|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57026790|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57026791|NCT00691964|Analgesics|analgesics|mesh-ancestor
57026792|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
57026793|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026794|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026795|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57026796|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026797|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57026798|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026799|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
57026800|NCT04470908|Rifabutin|rifabutin|mesh-list
57026801|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
57026802|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026803|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57026804|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026805|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026806|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57026807|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026808|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57026809|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
57026810|NCT05756153|Cetuximab|cetuximab|mesh-list
57026811|NCT05756153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026812|NCT05756153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026813|NCT02281292|Ranibizumab|ranibizumab|mesh-list
57026814|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57026815|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57026816|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57026817|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57026818|NCT02281292|Growth Substances|growth substances|mesh-ancestor
57026819|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026820|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
57026821|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026822|NCT03723772|Insulin|insulin|mesh-list
57026823|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57026824|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57026825|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026826|NCT03292133|Gefitinib|gefitinib|mesh-list
57026827|NCT03292133|Nazartinib|nazartinib|mesh-list
57026828|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026829|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57026830|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026831|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026832|NCT02660827|Insulin|insulin|mesh-list
57026833|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57026834|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026835|NCT00491738|Bevacizumab|bevacizumab|mesh-list
57026836|NCT00491738|Sunitinib|sunitinib|mesh-list
57026837|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026838|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026839|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57026840|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57026841|NCT00491738|Growth Substances|growth substances|mesh-ancestor
57026842|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026843|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
57026844|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57026845|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026846|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026847|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
57026848|NCT04318678|Rituximab|rituximab|mesh-list
57026849|NCT04318678|Fludarabine|fludarabine|mesh-list
57026850|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026851|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
57026852|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026853|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026854|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57026855|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
57026856|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026857|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026858|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57026859|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026860|NCT02281370|Cyclosporine|cyclosporine|mesh-list
57026861|NCT02281370|Cyclosporins|cyclosporins|mesh-list
57026862|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026863|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026864|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57026865|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
57026866|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026867|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
57026868|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026869|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
57026870|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026871|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57026872|NCT00680342|Silymarin|silymarin|mesh-list
57026873|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
57026874|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026875|NCT00680342|Protective Agents|protective agents|mesh-ancestor
57026876|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026877|NCT04507503|Futibatinib|futibatinib|mesh-list
57026878|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026879|NCT04057365|Nivolumab|nivolumab|mesh-list
57026880|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026881|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026882|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57026883|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026884|NCT00616148|Cenobamate|cenobamate|mesh-list
57026885|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
57026886|NCT03622827|Endostar protein|endostar protein|mesh-list
57026887|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57026888|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57026889|NCT03622827|Growth Substances|growth substances|mesh-ancestor
57026890|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026891|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
57026892|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026893|NCT00486512|Aspirin|aspirin|mesh-list
57026894|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
57026895|NCT00486512|Calcitriol|calcitriol|mesh-list
57026896|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
57026897|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
57026898|NCT00486512|Calcium|calcium|mesh-list
57026899|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57026900|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026901|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57026902|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57026903|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57026904|NCT00486512|Analgesics|analgesics|mesh-ancestor
57026905|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
57026906|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026907|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57026908|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57026909|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57026910|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57026911|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026912|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57026913|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57026914|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57026915|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
57026916|NCT00486512|Antacids|antacids|mesh-ancestor
57026917|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57026918|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57026919|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57026920|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57026921|NCT00486512|Vitamins|vitamins|mesh-ancestor
57026922|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
57026923|NCT04057989|Ketamine|ketamine|mesh-list
57026924|NCT04057989|Analgesics|analgesics|mesh-ancestor
57026925|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
57026926|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57026927|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026928|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57026929|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57026930|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
57026931|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
57026932|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026933|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57026934|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57026935|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026936|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026937|NCT00486200|Valacyclovir|valacyclovir|mesh-list
57026938|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
57026939|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57026940|NCT03463408|Nivolumab|nivolumab|mesh-list
57026941|NCT03463408|Ipilimumab|ipilimumab|mesh-list
57026942|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57026943|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026944|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57026945|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026946|NCT00479258|Insulin|insulin|mesh-list
57026947|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57026948|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57026949|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026950|NCT00612170|Reboxetine|reboxetine|mesh-list
57026951|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
57026952|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57026953|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57026954|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57026955|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57026956|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026957|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026958|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026959|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026960|NCT05068336|Anesthetics|anesthetics|mesh-list
57026961|NCT05068336|Sevoflurane|sevoflurane|mesh-list
57026962|NCT05068336|Desflurane|desflurane|mesh-list
57026963|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57026964|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026965|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57026966|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57026967|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
57026968|NCT00607256|Reboxetine|reboxetine|mesh-list
57026969|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
57026970|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57026971|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57026972|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57026973|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57026974|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026975|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026976|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026977|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026978|NCT02774590|Timolol|timolol|mesh-list
57026979|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57026980|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57026981|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
57026982|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57026983|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57026984|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026985|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57026986|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57026987|NCT01069341|Ranibizumab|ranibizumab|mesh-list
57026988|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57026989|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57026990|NCT01069341|Growth Substances|growth substances|mesh-ancestor
57026991|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57026992|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
57026993|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57026994|NCT00676832|Prednisolone|prednisolone|mesh-list
57026995|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57026996|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
57026997|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57026998|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
57026999|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57027000|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
57027001|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027002|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
57027003|NCT00676832|Hormones|hormones|mesh-ancestor
57027004|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027005|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027006|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57027007|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027008|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
57027009|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
57027010|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027011|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57027012|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57027013|NCT00676832|Protective Agents|protective agents|mesh-ancestor
57027014|NCT01909414|Vaccines|vaccines|mesh-list
57027015|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
57027016|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027017|NCT00467402|S 20098|s 20098|mesh-list
57027018|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57027019|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027020|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027021|NCT02996097|Triamcinolone|triamcinolone|mesh-list
57027022|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57027023|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57027024|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57027025|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027026|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
57027027|NCT02996097|Hormones|hormones|mesh-ancestor
57027028|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027029|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027030|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027031|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
57027032|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027033|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027034|NCT04054713|Acetic Acid|acetic acid|mesh-list
57027035|NCT04054713|Retinol acetate|retinol acetate|mesh-list
57027036|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57027037|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027038|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57027039|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
57027040|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027041|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57027042|NCT04054713|Protective Agents|protective agents|mesh-ancestor
57027043|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027044|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
57027045|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57027046|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57027047|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027048|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
57027049|NCT02568124|Coagulants|coagulants|mesh-ancestor
57027050|NCT03314181|Dexamethasone|dexamethasone|mesh-list
57027051|NCT03314181|Bortezomib|bortezomib|mesh-list
57027052|NCT03314181|Venetoclax|venetoclax|mesh-list
57027053|NCT03314181|Daratumumab|daratumumab|mesh-list
57027054|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027055|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
57027056|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
57027057|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027058|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027059|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57027060|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
57027061|NCT03314181|Hormones|hormones|mesh-ancestor
57027062|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027063|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57027064|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027065|NCT03133832|Praziquantel|praziquantel|mesh-list
57027066|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
57027067|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57027068|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027069|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
57027070|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57027071|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027072|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027073|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57027074|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57027075|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57027076|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027077|NCT04161430|Incretins|incretins|mesh-ancestor
57027078|NCT04161430|Hormones|hormones|mesh-ancestor
57027079|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027080|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57027081|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
57027082|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027083|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027084|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
57027085|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57027086|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57027087|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
57027088|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027089|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027090|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57027091|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
57027092|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
57027093|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57027094|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
57027095|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027096|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027097|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57027098|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57027099|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57027100|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
57027101|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
57027102|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57027103|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
57027104|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027105|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027106|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57027107|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
57027108|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
57027109|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57027110|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
57027111|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027112|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027113|NCT04053699|Factor VIII|factor viii|mesh-list
57027114|NCT04053699|Coagulants|coagulants|mesh-ancestor
57027115|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
57027116|NCT04303000|Naloxone|naloxone|mesh-list
57027117|NCT04303000|Narcotics|narcotics|mesh-ancestor
57027118|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027119|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027120|NCT04303000|Analgesics|analgesics|mesh-ancestor
57027121|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
57027122|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027123|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57027124|NCT00672386|Metformin|metformin|mesh-list
57027125|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57027126|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027127|NCT04056897|Teriflunomide|teriflunomide|mesh-list
57027128|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57027129|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57027130|NCT04056897|Analgesics|analgesics|mesh-ancestor
57027131|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
57027132|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027133|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027134|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027135|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57027136|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027137|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
57027138|NCT02281682|Fluorouracil|fluorouracil|mesh-list
57027139|NCT02281682|Imiquimod|imiquimod|mesh-list
57027140|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
57027141|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
57027142|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027143|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57027144|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027145|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027146|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
57027147|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027148|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57027149|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
57027150|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57027151|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
57027152|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57027153|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57027154|NCT04056975|Antibodies|antibodies|mesh-list
57027155|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
57027156|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027157|NCT03662763|Guanfacine|guanfacine|mesh-list
57027158|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57027159|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57027160|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57027161|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57027162|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
57027163|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027164|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027165|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027166|NCT00458978|Cediranib|cediranib|mesh-list
57027167|NCT00458978|Maleic acid|maleic acid|mesh-list
57027168|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027169|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027170|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027171|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57027172|NCT00458276|Tezosentan|tezosentan|mesh-list
57027173|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
57027174|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
57027175|NCT04520074|Carboplatin|carboplatin|mesh-list
57027176|NCT04520074|Etoposide|etoposide|mesh-list
57027177|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027178|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
57027179|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027180|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57027181|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57027182|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
57027183|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027184|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027185|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57027186|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57027187|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57027188|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57027189|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027190|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57027191|NCT00455156|ST 1435|st 1435|mesh-list
57027192|NCT00455156|Estradiol|estradiol|mesh-list
57027193|NCT00455156|Estrogens|estrogens|mesh-ancestor
57027194|NCT00455156|Hormones|hormones|mesh-ancestor
57027195|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027196|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027197|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57027198|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
57027199|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57027200|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57027201|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57027202|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57027203|NCT03661515|Cytarabine|cytarabine|mesh-list
57027204|NCT03661515|Fludarabine|fludarabine|mesh-list
57027205|NCT03661515|Idarubicin|idarubicin|mesh-list
57027206|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027207|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57027208|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
57027209|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027210|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027211|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
57027212|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027213|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
57027214|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027215|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57027216|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57027217|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57027218|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027219|NCT01624480|Modafinil|modafinil|mesh-list
57027220|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57027221|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027222|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
57027223|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57027224|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57027225|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027226|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57027227|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57027228|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57027229|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57027230|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027231|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027232|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027233|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57027234|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
57027235|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57027236|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
57027237|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
57027238|NCT05073172|Petrolatum|petrolatum|mesh-list
57027239|NCT05073172|Mineral Oil|mineral oil|mesh-list
57027240|NCT05073172|Emollients|emollients|mesh-ancestor
57027241|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
57027242|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57027243|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027244|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57027245|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57027246|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
57027247|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57027248|NCT02284412|Neostigmine|neostigmine|mesh-list
57027249|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57027250|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027251|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027252|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
57027253|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027254|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027255|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57027256|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
57027257|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027258|NCT02789020|Rasagiline|rasagiline|mesh-list
57027259|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57027260|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027261|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027262|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57027263|NCT02789020|Protective Agents|protective agents|mesh-ancestor
57027264|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027265|NCT02284490|Pemetrexed|pemetrexed|mesh-list
57027266|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027267|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027268|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027269|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57027270|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57027271|NCT02273570|Vitamin D|vitamin d|mesh-list
57027272|NCT02273570|Calcium|calcium|mesh-list
57027273|NCT02273570|Vitamins|vitamins|mesh-ancestor
57027274|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
57027275|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027276|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57027277|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57027278|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
57027279|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57027280|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57027281|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57027282|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027283|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
57027284|NCT00579020|Dexamethasone|dexamethasone|mesh-list
57027285|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
57027286|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57027287|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57027288|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57027289|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57027290|NCT00579020|BB 1101|bb 1101|mesh-list
57027291|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027292|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
57027293|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
57027294|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027295|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027296|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57027297|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
57027298|NCT00579020|Hormones|hormones|mesh-ancestor
57027299|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027300|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57027301|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027302|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
57027303|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027304|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027305|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57027306|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027307|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57027308|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57027309|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57027310|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
57027311|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57027312|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57027313|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57027314|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57027315|NCT04530604|Defibrotide|defibrotide|mesh-list
57027316|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57027317|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57027318|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027319|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57027320|NCT04169698|Denosumab|denosumab|mesh-list
57027321|NCT04169698|Alendronate|alendronate|mesh-list
57027322|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57027323|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027324|NCT04470752|Capsaicin|capsaicin|mesh-list
57027325|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57027326|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
57027327|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
57027328|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
57027329|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027330|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027331|NCT02273804|Topiramate|topiramate|mesh-list
57027332|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
57027333|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57027334|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027335|NCT00578474|Ofloxacin|ofloxacin|mesh-list
57027336|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57027337|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57027338|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027339|NCT00578474|Renal Agents|renal agents|mesh-ancestor
57027340|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57027341|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57027342|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57027343|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027344|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027345|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027346|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57027347|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57027348|NCT00577148|Rimonabant|rimonabant|mesh-list
57027349|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57027350|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
57027351|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57027352|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027353|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027354|NCT00577148|Hormones|hormones|mesh-ancestor
57027355|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027356|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027357|NCT03673228|Nicotine|nicotine|mesh-list
57027358|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57027359|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
57027360|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027361|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027362|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57027363|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57027364|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
57027365|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027366|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027367|NCT00441896|Ganaxolone|ganaxolone|mesh-list
57027368|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
57027369|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027370|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027371|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027372|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
57027373|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
57027374|NCT05116462|Gemcitabine|gemcitabine|mesh-list
57027375|NCT05116462|Paclitaxel|paclitaxel|mesh-list
57027376|NCT05116462|Docetaxel|docetaxel|mesh-list
57027377|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57027378|NCT05116462|Carboplatin|carboplatin|mesh-list
57027379|NCT05116462|Pemetrexed|pemetrexed|mesh-list
57027380|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57027381|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027382|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
57027383|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
57027384|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
57027385|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027386|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57027387|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
57027388|NCT05116462|Antiviral Agents|antiviral agents|mesh-ancestor
57027389|NCT05116462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027390|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027391|NCT05116462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027392|NCT05116462|Immunologic Factors|immunologic factors|mesh-ancestor
57027393|NCT05116462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027394|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57027395|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57027396|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
57027397|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57027398|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
57027399|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027400|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
57027401|NCT05116306|Protective Agents|protective agents|mesh-ancestor
57027402|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57027403|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
57027404|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027405|NCT00570752|Atorvastatin|atorvastatin|mesh-list
57027406|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57027407|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57027408|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
57027409|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027410|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57027411|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57027412|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027413|NCT02282384|Oseltamivir|oseltamivir|mesh-list
57027414|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
57027415|NCT02282384|Antacids|antacids|mesh-ancestor
57027416|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027417|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57027418|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
57027419|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027420|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027421|NCT02989389|Itraconazole|itraconazole|mesh-list
57027422|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
57027423|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027424|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57027425|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57027426|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027427|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027428|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57027429|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
57027430|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027431|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027432|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57027433|NCT02653300|Insulin|insulin|mesh-list
57027434|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57027435|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027436|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57027437|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
57027438|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027439|NCT03187509|Torsemide|torsemide|mesh-list
57027440|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57027441|NCT03187509|Diuretics|diuretics|mesh-ancestor
57027442|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
57027443|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027444|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57027445|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57027446|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027447|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57027448|NCT00430508|Olmesartan|olmesartan|mesh-list
57027449|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
57027450|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57027451|NCT00430508|Diuretics|diuretics|mesh-ancestor
57027452|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
57027453|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027454|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57027455|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57027456|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027457|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57027458|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57027459|NCT04221880|Lidocaine|lidocaine|mesh-list
57027460|NCT04221880|Bupivacaine|bupivacaine|mesh-list
57027461|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57027462|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
57027463|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
57027464|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027465|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027466|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
57027467|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027468|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57027469|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57027470|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57027471|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57027472|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027473|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
57027474|NCT04055415|Expectorants|expectorants|mesh-list
57027475|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
57027476|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027477|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027478|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57027479|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
57027480|NCT00427856|Rituximab|rituximab|mesh-list
57027481|NCT00427856|Obatoclax|obatoclax|mesh-list
57027482|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57027483|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027484|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
57027485|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027486|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57027487|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027488|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027489|NCT00427154|Insulin|insulin|mesh-list
57027490|NCT00427154|Metformin|metformin|mesh-list
57027491|NCT00427154|Glimepiride|glimepiride|mesh-list
57027492|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
57027493|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57027494|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57027495|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027496|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57027497|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027498|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
57027499|NCT02988219|Epinephrine|epinephrine|mesh-list
57027500|NCT02988219|Fentanyl|fentanyl|mesh-list
57027501|NCT02988219|Bupivacaine|bupivacaine|mesh-list
57027502|NCT02988219|Anesthetics|anesthetics|mesh-list
57027503|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
57027504|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027505|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027506|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
57027507|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027508|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57027509|NCT02988219|Narcotics|narcotics|mesh-ancestor
57027510|NCT02988219|Analgesics|analgesics|mesh-ancestor
57027511|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57027512|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57027513|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
57027514|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57027515|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57027516|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
57027517|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027518|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027519|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57027520|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57027521|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
57027522|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57027523|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
57027524|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
57027525|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
57027526|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57027527|NCT01346059|Vancomycin|vancomycin|mesh-list
57027528|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57027529|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027530|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
57027531|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
57027532|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
57027533|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027534|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027535|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
57027536|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57027537|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57027538|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
57027539|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027540|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027541|NCT04548973|Esketamine|esketamine|mesh-list
57027542|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
57027543|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57027544|NCT02277938|Amantadine|amantadine|mesh-list
57027545|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57027546|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57027547|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
57027548|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027549|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
57027550|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897067|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027551|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027552|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027553|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57027554|NCT02277938|Analgesics|analgesics|mesh-ancestor
57027555|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
57027556|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027557|NCT00415142|Citalopram|citalopram|mesh-list
57027558|NCT00415142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57027559|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57027560|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57027561|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027562|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027563|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
57027564|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027565|NCT00415142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57027566|NCT00415142|Antidepressive Agents|antidepressive agents|mesh-ancestor
57027567|NCT00415142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57027568|NCT04708145|Aflibercept|aflibercept|mesh-list
57027569|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57027570|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57027571|NCT04708145|Growth Substances|growth substances|mesh-ancestor
57027572|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027573|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
57027574|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027575|NCT03661125|Saracatinib|saracatinib|mesh-list
57027576|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027577|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027578|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027579|NCT00413114|Obatoclax|obatoclax|mesh-list
57027580|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027581|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027582|NCT03016013|Methotrexate|methotrexate|mesh-list
57027583|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57027584|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
57027585|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57027586|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027587|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57027588|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
57027589|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027590|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027591|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
57027592|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027593|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57027594|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027595|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
57027596|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57027597|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57027599|NCT01318915|Sirolimus|sirolimus|mesh-list
57027600|NCT01318915|Rituximab|rituximab|mesh-list
57027601|NCT01318915|Tacrolimus|tacrolimus|mesh-list
57027602|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
57027603|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57027604|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57027605|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027606|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
57027607|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027608|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57027609|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027610|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57027611|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027612|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027613|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57027614|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57027615|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
57027616|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57027617|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027618|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
57027619|NCT04688177|Nicotine|nicotine|mesh-list
57027620|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
57027621|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57027622|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
57027623|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027624|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027625|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57027626|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57027627|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
57027628|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027629|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027630|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
57027631|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
57027632|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
57027633|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57027634|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027635|NCT00411242|S 20098|s 20098|mesh-list
57027636|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57027637|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027638|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027639|NCT04668365|Prednisone|prednisone|mesh-list
57027640|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
57027641|NCT04668365|Rituximab|rituximab|mesh-list
57027642|NCT04668365|Vincristine|vincristine|mesh-list
57027643|NCT04668365|Epirubicin|epirubicin|mesh-list
57027644|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
57027645|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027646|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
57027647|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027648|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57027649|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57027650|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
57027651|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027652|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027653|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57027654|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57027655|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027656|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
57027657|NCT04668365|Hormones|hormones|mesh-ancestor
57027658|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027659|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57027660|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57027661|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
57027662|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
57027663|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
57027664|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57027665|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57027666|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57027667|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027668|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57027669|NCT05203913|Paclitaxel|paclitaxel|mesh-list
57027670|NCT05203913|Nivolumab|nivolumab|mesh-list
57027671|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57027672|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027673|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
57027674|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
57027675|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
57027676|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027677|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57027678|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57027679|NCT00402428|Interferons|interferons|mesh-list
57027680|NCT00402428|Ribavirin|ribavirin|mesh-list
57027681|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
57027682|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
57027683|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57027684|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027685|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
57027686|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027687|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
57027688|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027689|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
57027690|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027691|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
57027692|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57027693|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57027694|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027695|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
57027696|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
57027697|NCT03660267|Caffeine|caffeine|mesh-list
57027698|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57027699|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027700|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57027701|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027702|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027703|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57027704|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57027705|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
57027706|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027707|NCT03950245|Glucagon|glucagon|mesh-list
57027708|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57027709|NCT03950245|Incretins|incretins|mesh-ancestor
57027710|NCT03950245|Hormones|hormones|mesh-ancestor
57027711|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027712|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027713|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57027714|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57027715|NCT03889249|Tenecteplase|tenecteplase|mesh-list
57027716|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57027717|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57027718|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027719|NCT00401570|Gemcitabine|gemcitabine|mesh-list
57027720|NCT00401570|Volociximab|volociximab|mesh-list
57027721|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57027722|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
57027723|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027724|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027725|NCT00401570|Antiviral Agents|antiviral agents|mesh-ancestor
57027726|NCT00401570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027727|NCT00401570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027728|NCT00401570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027729|NCT00401570|Immunologic Factors|immunologic factors|mesh-ancestor
57027730|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027731|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57027732|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57027733|NCT00401570|Growth Substances|growth substances|mesh-ancestor
57027734|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
57027735|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
57027736|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
57027737|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
57027738|NCT05193565|Sirolimus|sirolimus|mesh-list
57027739|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57027740|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027741|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57027742|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
57027743|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57027744|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027745|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027746|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027747|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
57027748|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027749|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
57027750|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027751|NCT04471922|Rabeprazole|rabeprazole|mesh-list
57027752|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57027753|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57027754|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57027755|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027756|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027757|NCT04368364|Morphine|morphine|mesh-list
57027758|NCT04368364|Bupivacaine|bupivacaine|mesh-list
57027759|NCT04368364|Ropivacaine|ropivacaine|mesh-list
57027760|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
57027761|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
57027762|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027763|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027764|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
57027765|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027766|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57027767|NCT04368364|Narcotics|narcotics|mesh-ancestor
57027768|NCT04368364|Analgesics|analgesics|mesh-ancestor
57027769|NCT05186779|Progestins|progestins|mesh-list
57027770|NCT05186779|Hormones|hormones|mesh-ancestor
57027771|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027772|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027773|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57027774|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
57027775|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027776|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
57027777|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027778|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
57027779|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027780|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
57027781|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57027782|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027783|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57027784|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027785|NCT05229796|Empagliflozin|empagliflozin|mesh-list
57027786|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57027787|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027788|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57027789|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027790|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
57027791|NCT04189588|Promethazine|promethazine|mesh-list
57027792|NCT04189588|Cetirizine|cetirizine|mesh-list
57027793|NCT04189588|Paclitaxel|paclitaxel|mesh-list
57027794|NCT04189588|Rituximab|rituximab|mesh-list
57027795|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57027796|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027797|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
57027798|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
57027799|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
57027800|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027801|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57027802|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
57027803|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027804|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57027805|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57027806|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57027807|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027808|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
57027809|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
57027810|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
57027811|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027812|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
57027813|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
57027814|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57027815|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57027816|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
57027817|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
57027818|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027819|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57027820|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
57027821|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
57027822|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57027823|NCT00151892|Mesalamine|mesalamine|mesh-list
57027824|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57027825|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57027826|NCT00151892|Analgesics|analgesics|mesh-ancestor
57027827|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
57027828|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027829|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027830|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027831|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57027832|NCT04175470|Tocotrienols|tocotrienols|mesh-list
57027833|NCT04175470|Vitamin E|vitamin e|mesh-list
57027834|NCT04175470|Tocopherols|tocopherols|mesh-list
57027835|NCT04175470|Bevacizumab|bevacizumab|mesh-list
57027836|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57027837|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027838|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57027839|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57027840|NCT04175470|Growth Substances|growth substances|mesh-ancestor
57027841|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027842|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
57027843|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
57027844|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027845|NCT04175470|Protective Agents|protective agents|mesh-ancestor
57027846|NCT04175470|Vitamins|vitamins|mesh-ancestor
57027847|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
57027848|NCT02740127|Dexamethasone|dexamethasone|mesh-list
57027849|NCT02740127|Clonidine|clonidine|mesh-list
57027850|NCT02740127|Epinephrine|epinephrine|mesh-list
57027851|NCT02740127|Propofol|propofol|mesh-list
57027852|NCT02740127|Ropivacaine|ropivacaine|mesh-list
57027853|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57027854|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
57027855|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
57027856|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027857|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027858|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57027859|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
57027860|NCT02740127|Hormones|hormones|mesh-ancestor
57027861|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027862|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57027863|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027864|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027865|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57027866|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027867|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57027868|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
57027869|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
57027870|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
57027871|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
57027872|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57027873|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57027874|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
57027875|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57027876|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57027877|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57027878|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57027879|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
57027880|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
57027881|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
57027882|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57027883|NCT02740127|Analgesics|analgesics|mesh-ancestor
57027884|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57027885|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
57027886|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57027887|NCT05008783|Capecitabine|capecitabine|mesh-list
57027888|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
57027889|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57027890|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
57027891|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027892|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027893|NCT04450498|Vaccines|vaccines|mesh-list
57027894|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
57027895|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027896|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
57027897|NCT00654992|Hematinics|hematinics|mesh-ancestor
57027898|NCT02921919|Talazoparib|talazoparib|mesh-list
57027899|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57027900|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027901|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027902|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027903|NCT00393068|Paclitaxel|paclitaxel|mesh-list
57027904|NCT00393068|Bevacizumab|bevacizumab|mesh-list
57027905|NCT00393068|Carboplatin|carboplatin|mesh-list
57027906|NCT00393068|Fluorouracil|fluorouracil|mesh-list
57027907|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57027908|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57027909|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027910|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
57027911|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
57027912|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
57027913|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027914|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57027915|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56605433|NCT04089592|Narcotics|narcotics|mesh-ancestor
57027916|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57027917|NCT00393068|Growth Substances|growth substances|mesh-ancestor
57027918|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027919|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
57027920|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
57027921|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57027922|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027923|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
57027924|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57027925|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027926|NCT04930315|Apatinib|apatinib|mesh-list
57027927|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027928|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57027929|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027930|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027931|NCT04769401|Progesterone|progesterone|mesh-list
57027932|NCT04769401|Progestins|progestins|mesh-ancestor
57027933|NCT04769401|Hormones|hormones|mesh-ancestor
57027934|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57027935|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027936|NCT02094222|Glycerol|glycerol|mesh-list
57027937|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57027938|NCT02094222|Protective Agents|protective agents|mesh-ancestor
57027939|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027940|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57027941|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57027942|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57027943|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
57027944|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027945|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57027946|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57027947|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57027948|NCT02090244|Teriparatide|teriparatide|mesh-list
57027949|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57027950|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027951|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57027952|NCT02282774|Lidocaine|lidocaine|mesh-list
57027953|NCT02282774|Bupivacaine|bupivacaine|mesh-list
57027954|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
57027955|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
57027956|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57027957|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027958|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
57027959|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57027960|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57027961|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57027962|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57027963|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57027964|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027965|NCT02090322|Bevacizumab|bevacizumab|mesh-list
57027966|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57027967|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027968|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57027969|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57027970|NCT02090322|Growth Substances|growth substances|mesh-ancestor
57027971|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027972|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
57027974|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
57027975|NCT03658785|Fludarabine|fludarabine|mesh-list
57027976|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57027977|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
57027978|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57027979|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57027980|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57027981|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
57027982|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027983|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027984|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57027985|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57027986|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57027987|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
57027988|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57027989|NCT02095782|Paclitaxel|paclitaxel|mesh-list
57027990|NCT02095782|Carboplatin|carboplatin|mesh-list
57027991|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57027992|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57027993|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57027994|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
57027995|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
57027996|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
57027997|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57027998|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57027999|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028000|NCT02094378|Esketamine|esketamine|mesh-list
57028001|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
57028002|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57028003|NCT02285738|Aspirin|aspirin|mesh-list
57028004|NCT02285738|Simvastatin|simvastatin|mesh-list
57028005|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028006|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028007|NCT02285738|Analgesics|analgesics|mesh-ancestor
57028008|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
57028009|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028010|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028011|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028012|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028013|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57028014|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57028015|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028016|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57028017|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57028018|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028019|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
57028020|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57028021|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57028022|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
57028023|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57028024|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57028025|NCT00650702|Latanoprost|latanoprost|mesh-list
57028026|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57028027|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57028028|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
57028029|NCT02090400|Calcium|calcium|mesh-list
57028030|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57028031|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028032|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57028033|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57028034|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
57028035|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028036|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57028037|NCT03134846|Cetuximab|cetuximab|mesh-list
57028038|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57028039|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028040|NCT01068717|Metformin|metformin|mesh-list
57028041|NCT01068717|Saxagliptin|saxagliptin|mesh-list
56710036|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57028042|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57028043|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028044|NCT01068717|Incretins|incretins|mesh-ancestor
57028046|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028047|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57028048|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
57028049|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028050|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028051|NCT02095938|Amisulpride|amisulpride|mesh-list
57028052|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57028053|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57028054|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028055|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028056|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57028057|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57028058|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
57028059|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028060|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028061|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57028062|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
57028063|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
57028064|NCT02285972|Tenoxicam|tenoxicam|mesh-list
57028065|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028066|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028067|NCT02285972|Analgesics|analgesics|mesh-ancestor
57028068|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
57028069|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028070|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028071|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028072|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028073|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57028074|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028075|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028076|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
57028077|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57028078|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028079|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
57028080|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
57028081|NCT02921763|Progestins|progestins|mesh-ancestor
57028082|NCT02921763|Hormones|hormones|mesh-ancestor
57028083|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028084|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028085|NCT03658473|Naproxen|naproxen|mesh-list
57028086|NCT03658473|Rabeprazole|rabeprazole|mesh-list
57028087|NCT03658473|Rebamipide|rebamipide|mesh-list
57028088|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028089|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028090|NCT03658473|Analgesics|analgesics|mesh-ancestor
57028091|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
57028092|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028093|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028094|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028095|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028096|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
57028097|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57028098|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028099|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028100|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57028101|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57028102|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57028103|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
57028104|NCT03658473|Protective Agents|protective agents|mesh-ancestor
57028105|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
57028106|NCT02096250|Edetic Acid|edetic acid|mesh-list
57028107|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
57028108|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
57028109|NCT02096250|Trace Elements|trace elements|mesh-ancestor
57028110|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
57028111|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028112|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57028113|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
57028114|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
57028115|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028116|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
57028117|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57028118|NCT02096250|Hematinics|hematinics|mesh-ancestor
57028119|NCT02096328|Murepavadin|murepavadin|mesh-list
57028120|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57028121|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028122|NCT01318135|Metformin|metformin|mesh-list
57028123|NCT01318135|Glimepiride|glimepiride|mesh-list
57028124|NCT01318135|Alogliptin|alogliptin|mesh-list
57028125|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57028126|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028127|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57028128|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57028129|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
57028130|NCT01318135|Incretins|incretins|mesh-ancestor
57028131|NCT01318135|Hormones|hormones|mesh-ancestor
57028132|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028133|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57028134|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
57028135|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028136|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028137|NCT02094924|Candesartan|candesartan|mesh-list
57028138|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
57028139|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57028140|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57028141|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57028142|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028143|NCT02286206|Clozapine|clozapine|mesh-list
57028144|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57028145|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
57028146|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028147|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028148|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028149|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57028150|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57028151|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028152|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57028153|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
57028154|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
57028155|NCT03104283|Apatinib|apatinib|mesh-list
57028156|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028157|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57028158|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028159|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028160|NCT00529178|Pravastatin|pravastatin|mesh-list
57028161|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57028162|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57028163|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
57028164|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028165|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57028166|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57028167|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028168|NCT00382460|Pravastatin|pravastatin|mesh-list
57028169|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57028170|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57028171|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
57028172|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028173|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57028174|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57028175|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028176|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57028177|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57028178|NCT02286596|Heparin|heparin|mesh-list
57028179|NCT02286596|Dextrans|dextrans|mesh-list
57028180|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
57028181|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57028182|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57028183|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028184|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
57028185|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
57028186|NCT02098824|Methylphenidate|methylphenidate|mesh-list
57028187|NCT02098824|Galantamine|galantamine|mesh-list
57028188|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57028189|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028190|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57028191|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57028192|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57028193|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028194|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
57028195|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028196|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57028197|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028198|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
57028199|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57028200|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
57028201|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028202|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
57028203|NCT03658317|Uric Acid|uric acid|mesh-list
57028204|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
57028205|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028206|NCT03658317|Protective Agents|protective agents|mesh-ancestor
57028207|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028208|NCT02286752|Neostigmine|neostigmine|mesh-list
57028209|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57028210|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028211|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028212|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
57028213|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028214|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028215|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57028216|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
57028217|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028218|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
57028219|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57028220|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028221|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028222|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028223|NCT04470050|Analgesics|analgesics|mesh-ancestor
57028224|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
57028225|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028226|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57028227|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57028228|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57028229|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
57028230|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028231|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028232|NCT02095314|Vaccines|vaccines|mesh-list
57028233|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
57028234|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028235|NCT02098980|Vitamin D|vitamin d|mesh-list
57028236|NCT02098980|Vitamins|vitamins|mesh-ancestor
57028237|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
57028238|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028239|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57028240|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57028241|NCT00372944|Capecitabine|capecitabine|mesh-list
57028242|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57028243|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
57028244|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028245|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028246|NCT02099136|Celecoxib|celecoxib|mesh-list
57028247|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028248|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028249|NCT02099136|Analgesics|analgesics|mesh-ancestor
57028250|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
57028251|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028252|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028253|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028254|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028255|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57028256|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57028257|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028258|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028259|NCT00117650|Etoposide|etoposide|mesh-list
57028260|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
57028261|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57028262|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028263|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57028264|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57028265|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028266|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028267|NCT02095548|Lorecivivint|lorecivivint|mesh-list
57028268|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028269|NCT00113438|Paclitaxel|paclitaxel|mesh-list
57028270|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
57028271|NCT00113438|Combretastatin|combretastatin|mesh-list
57028272|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57028273|NCT00113438|Carboplatin|carboplatin|mesh-list
57028274|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57028275|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028276|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
57028277|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
57028278|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
57028279|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028280|NCT04087408|Hormones|hormones|mesh-list
57028281|NCT04087408|Progesterone|progesterone|mesh-list
57028282|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028283|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028284|NCT04087408|Progestins|progestins|mesh-ancestor
57028285|NCT02099292|Rituximab|rituximab|mesh-list
57028286|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57028287|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028288|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
57028289|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028290|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028291|NCT02283242|Galantamine|galantamine|mesh-list
57028292|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57028293|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028294|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028295|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
57028296|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028297|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028298|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57028299|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
57028300|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028301|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
57028302|NCT02283320|Docetaxel|docetaxel|mesh-list
57028303|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028304|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
57028305|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
57028306|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
57028307|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028308|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
57028309|NCT03556098|Hormones|hormones|mesh-list
57028310|NCT03556098|Incretins|incretins|mesh-list
57028311|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028312|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028313|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57028314|NCT02286986|Cannabidiol|cannabidiol|mesh-list
57028315|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
57028316|NCT04995874|Micronutrients|micronutrients|mesh-list
57028317|NCT04995874|Trace Elements|trace elements|mesh-list
57028318|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028319|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
57028320|NCT02287064|Antibodies|antibodies|mesh-list
57028321|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
57028322|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57028323|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57028324|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
57028325|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028326|NCT02095704|Acetaminophen|acetaminophen|mesh-list
57028327|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028328|NCT02095704|Analgesics|analgesics|mesh-ancestor
57028329|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
57028330|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028331|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028332|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
57028333|NCT03098836|Prednisone|prednisone|mesh-list
57028334|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
57028335|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028336|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
57028337|NCT03098836|Hormones|hormones|mesh-ancestor
57028338|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028339|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028340|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57028341|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028342|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57028344|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028345|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
57028346|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57028347|NCT02099604|Vitamin D|vitamin d|mesh-list
57028348|NCT02099604|Interferons|interferons|mesh-list
57028349|NCT02099604|Ribavirin|ribavirin|mesh-list
57028350|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
57028351|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
57028352|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57028353|NCT02099604|Vitamins|vitamins|mesh-ancestor
57028354|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
57028355|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028356|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57028357|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028358|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
57028359|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028360|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
57028361|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028362|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
57028363|NCT02099916|Menotropins|menotropins|mesh-list
57028364|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028365|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57028366|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
57028367|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57028368|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57028369|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
57028370|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57028371|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
57028372|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57028373|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028374|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57028375|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57028376|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028377|NCT00366704|Risperidone|risperidone|mesh-list
57028378|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57028379|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
57028380|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028381|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028382|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028383|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57028384|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57028385|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028386|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57028387|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57028388|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
57028389|NCT02097264|Adalimumab|adalimumab|mesh-list
57028390|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028391|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028392|NCT04572100|Paclitaxel|paclitaxel|mesh-list
57028393|NCT04572100|Carboplatin|carboplatin|mesh-list
57028394|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57028395|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028396|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
57028397|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
57028398|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
57028399|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028400|NCT02097342|Linagliptin|linagliptin|mesh-list
57028401|NCT02097342|Voglibose|voglibose|mesh-list
57028402|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57028403|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028404|NCT02097342|Incretins|incretins|mesh-ancestor
57028405|NCT02097342|Hormones|hormones|mesh-ancestor
57028406|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028407|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57028408|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
57028409|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028410|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028411|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57028412|NCT04294498|Entecavir|entecavir|mesh-list
57028413|NCT04294498|Durvalumab|durvalumab|mesh-list
57028414|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57028415|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028416|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
57028417|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028418|NCT04059172|Ibuprofen|ibuprofen|mesh-list
57028419|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028420|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028421|NCT04059172|Analgesics|analgesics|mesh-ancestor
57028422|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
57028423|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028424|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028425|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028426|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028427|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57028428|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028429|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028430|NCT00359450|Taxane|taxane|mesh-list
57028431|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028432|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
57028433|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
57028434|NCT03530462|Rituximab|rituximab|mesh-list
57028435|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
57028436|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57028437|NCT03530462|Antibodies|antibodies|mesh-list
57028438|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
57028439|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57028440|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57028441|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
57028442|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028443|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028444|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57028445|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
57028446|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028447|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028448|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57028449|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57028450|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028451|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
57028452|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
57028453|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028454|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57028455|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
57028456|NCT03530462|Hormones|hormones|mesh-ancestor
57028457|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028458|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57028459|NCT03530462|Protective Agents|protective agents|mesh-ancestor
57028460|NCT02103192|Antioxidants|antioxidants|mesh-list
57028461|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028462|NCT02103192|Protective Agents|protective agents|mesh-ancestor
57028463|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028464|NCT04188418|Fentanyl|fentanyl|mesh-list
57028465|NCT04188418|Morphine|morphine|mesh-list
57028466|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57028467|NCT04188418|Narcotics|narcotics|mesh-ancestor
57028468|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028469|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028470|NCT04188418|Analgesics|analgesics|mesh-ancestor
57028471|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
57028472|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028473|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57028474|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57028475|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
57028476|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
57028477|NCT02097810|Entrectinib|entrectinib|mesh-list
57028478|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57028479|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028480|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028481|NCT02100462|Aspirin|aspirin|mesh-list
57028482|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57028483|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
57028484|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028485|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028486|NCT02100462|Analgesics|analgesics|mesh-ancestor
57028487|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
57028488|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028489|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028490|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56710493|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
57028491|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028492|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57028493|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57028494|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028495|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57028496|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57028498|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
57028499|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57028500|NCT02100462|Diuretics|diuretics|mesh-ancestor
57028501|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
57028502|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57028503|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57028504|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
57028505|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57028506|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
57028507|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028508|NCT00150176|Asenapine|asenapine|mesh-list
57028509|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57028510|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57028511|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028512|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028513|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57028514|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
57028515|NCT00961792|Promethazine|promethazine|mesh-list
57028516|NCT00961792|Ethanol|ethanol|mesh-list
57028517|NCT00961792|Caffeine|caffeine|mesh-list
57028518|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57028519|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028520|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57028521|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028522|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028523|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57028524|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57028525|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
57028526|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028527|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57028528|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028529|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028530|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57028531|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57028532|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
57028533|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
57028534|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
57028535|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028536|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
57028537|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
57028538|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57028539|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57028540|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
57028541|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
57028542|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57028543|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
57028544|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
57028545|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
57028546|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028547|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
57028548|NCT02100852|Chlorambucil|chlorambucil|mesh-list
57028549|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57028550|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028551|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57028552|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
57028553|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028554|NCT00057980|Celecoxib|celecoxib|mesh-list
57028555|NCT00057980|Epirubicin|epirubicin|mesh-list
57028556|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028557|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028558|NCT00057980|Analgesics|analgesics|mesh-ancestor
57028559|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
57028560|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028561|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028562|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028563|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028564|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57028565|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57028566|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028567|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710568|NCT00666237|Mitomycins|mitomycins|mesh-list
57028568|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57028569|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028570|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57028571|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57028572|NCT02985879|Tilavonemab|tilavonemab|mesh-list
57028573|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
57028574|NCT02097966|Ribavirin|ribavirin|mesh-list
57028575|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
57028576|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
57028577|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028578|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
57028579|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028580|NCT00052598|Aldesleukin|aldesleukin|mesh-list
57028581|NCT00052598|Interleukin-2|interleukin-2|mesh-list
57028582|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028583|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028584|NCT00052598|Analgesics|analgesics|mesh-ancestor
57028585|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
57028586|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028587|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028588|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57028589|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57028590|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
57028591|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028592|NCT05037994|Prednisolone|prednisolone|mesh-list
57028593|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57028594|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
57028595|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57028596|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
57028597|NCT05037994|Gabapentin|gabapentin|mesh-list
57028598|NCT05037994|Bupivacaine|bupivacaine|mesh-list
57028599|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57028600|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
57028601|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028602|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
57028603|NCT05037994|Hormones|hormones|mesh-ancestor
57028604|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028605|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028606|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57028607|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028608|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
57028609|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
57028610|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028611|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57028612|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57028613|NCT05037994|Protective Agents|protective agents|mesh-ancestor
57028614|NCT05037994|Analgesics|analgesics|mesh-ancestor
57028615|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
57028616|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
57028617|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57028618|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57028619|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028620|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57028621|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57028622|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57028623|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028624|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028625|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
57028626|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
57028627|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
57028628|NCT00052520|Aldesleukin|aldesleukin|mesh-list
57028629|NCT00052520|Interleukin-2|interleukin-2|mesh-list
57028630|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028631|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028632|NCT00052520|Analgesics|analgesics|mesh-ancestor
57028633|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
57028634|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028635|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028636|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57028637|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57028638|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
57028639|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028640|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
57028641|NCT05036434|Lenvatinib|lenvatinib|mesh-list
57028642|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57028643|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710649|NCT00782301|Maraviroc|maraviroc|mesh-list
57028644|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57028645|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028646|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028648|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
57028649|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028650|NCT05035186|Amoxicillin|amoxicillin|mesh-list
57028651|NCT05035186|Clarithromycin|clarithromycin|mesh-list
57028652|NCT05035186|Levofloxacin|levofloxacin|mesh-list
57028653|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57028654|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028655|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57028656|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028657|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028658|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57028659|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57028660|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57028661|NCT05035186|Renal Agents|renal agents|mesh-ancestor
57028662|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57028663|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57028664|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028665|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57028666|NCT01067469|Bevacizumab|bevacizumab|mesh-list
57028667|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57028668|NCT01067469|Lomustine|lomustine|mesh-list
57028669|NCT01067469|Antibodies|antibodies|mesh-list
57028670|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
57028671|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57028672|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028673|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57028674|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57028675|NCT01067469|Growth Substances|growth substances|mesh-ancestor
57028676|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028677|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
57028678|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
57028679|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57028680|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
57028681|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028682|NCT00050102|Ipilimumab|ipilimumab|mesh-list
57028683|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57028684|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028685|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57028686|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028687|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57028688|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
57028689|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
57028690|NCT02103660|Progestins|progestins|mesh-list
57028691|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57028692|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028693|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57028694|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57028695|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57028696|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57028697|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57028698|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57028699|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57028700|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028701|NCT02103660|Hormones|hormones|mesh-ancestor
57028702|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028703|NCT02788773|Durvalumab|durvalumab|mesh-list
57028704|NCT02788773|Tremelimumab|tremelimumab|mesh-list
57028705|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57028706|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028707|NCT00358982|Mocetinostat|mocetinostat|mesh-list
57028708|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57028709|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028710|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028711|NCT02101164|Denosumab|denosumab|mesh-list
57028712|NCT02101164|Pamidronate|pamidronate|mesh-list
57028713|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57028714|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028715|NCT00036608|Entecavir|entecavir|mesh-list
57028716|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
57028717|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028718|NCT02103738|Ranibizumab|ranibizumab|mesh-list
57028719|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57028720|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57028721|NCT02103738|Growth Substances|growth substances|mesh-ancestor
57028722|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028723|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
57028724|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028725|NCT02985021|Carboplatin|carboplatin|mesh-list
57028726|NCT02985021|Docetaxel|docetaxel|mesh-list
57028727|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028728|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
57028729|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
57028730|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
57028731|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028732|NCT05714540|Magnesium Sulfate|magnesium sulfate|mesh-list
57028733|NCT05714540|Ketamine|ketamine|mesh-list
57028734|NCT05714540|Analgesics|analgesics|mesh-ancestor
57028735|NCT05714540|Sensory System Agents|sensory system agents|mesh-ancestor
57028736|NCT05714540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028737|NCT05714540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028738|NCT05714540|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57028739|NCT05714540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57028740|NCT05714540|Anesthetics, General|anesthetics, general|mesh-ancestor
57028741|NCT05714540|Anesthetics|anesthetics|mesh-ancestor
57028742|NCT05714540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028743|NCT05714540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57028744|NCT05714540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57028745|NCT05714540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028746|NCT05714540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028747|NCT05714540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57028748|NCT05714540|Anticonvulsants|anticonvulsants|mesh-ancestor
57028749|NCT05714540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57028750|NCT05714540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57028751|NCT05714540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57028752|NCT05714540|Tocolytic Agents|tocolytic agents|mesh-ancestor
57028753|NCT05714540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57028754|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
57028755|NCT03107182|Promethazine|promethazine|mesh-list
57028756|NCT03107182|Dexamethasone|dexamethasone|mesh-list
57028757|NCT03107182|Paclitaxel|paclitaxel|mesh-list
57028758|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57028759|NCT03107182|Carboplatin|carboplatin|mesh-list
57028760|NCT03107182|Nivolumab|nivolumab|mesh-list
57028761|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
57028762|NCT03107182|Famotidine|famotidine|mesh-list
57028763|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57028764|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028765|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
57028766|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
57028767|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
57028768|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028769|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028770|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
57028771|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
57028772|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028773|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028774|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57028775|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
57028776|NCT03107182|Hormones|hormones|mesh-ancestor
57028777|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028778|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57028779|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57028780|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57028781|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
57028782|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028783|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57028784|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57028785|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57028786|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028787|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
57028788|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
57028789|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
57028790|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57028791|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
57028792|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
57028793|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028794|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56710786|NCT02799602|Hormones|hormones|mesh-ancestor
57028795|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
57028796|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
57028797|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57028798|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57028799|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
57028800|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57028801|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
57028802|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57028803|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028804|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57028805|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57028806|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57028807|NCT04441424|Azithromycin|azithromycin|mesh-list
57028808|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
57028809|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57028810|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028811|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
57028812|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57028813|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57028814|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028815|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028816|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028817|NCT03530228|Esomeprazole|esomeprazole|mesh-list
57028818|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57028819|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57028820|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57028821|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028822|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028823|NCT01066923|Aspirin|aspirin|mesh-list
57028824|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028825|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028826|NCT01066923|Analgesics|analgesics|mesh-ancestor
57028827|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
57028828|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028829|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028830|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028831|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028832|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57028833|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57028834|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028835|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57028836|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57028837|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028838|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
57028839|NCT03530150|Pirfenidone|pirfenidone|mesh-list
57028840|NCT03530150|Analgesics|analgesics|mesh-ancestor
57028841|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
57028842|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028843|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028844|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028845|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028846|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028847|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028848|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028849|NCT02098590|Chloroquine|chloroquine|mesh-list
57028850|NCT02098590|Atovaquone|atovaquone|mesh-list
57028851|NCT02098590|Proguanil|proguanil|mesh-list
57028852|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
57028853|NCT02098590|Amebicides|amebicides|mesh-ancestor
57028854|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57028855|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57028856|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028857|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
57028858|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028859|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028860|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028861|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
57028862|NCT03657381|Antibodies|antibodies|mesh-list
57028863|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57028864|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
57028865|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028866|NCT00005918|Lamivudine|lamivudine|mesh-list
57028867|NCT00005918|Efavirenz|efavirenz|mesh-list
57028868|NCT00005918|Stavudine|stavudine|mesh-list
57028869|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57028870|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57028871|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028872|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028873|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
57028874|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028875|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57028876|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56897099|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57028877|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57028878|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57028879|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57028880|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57028881|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57028882|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57028883|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
57028884|NCT02656797|Amphotericin B|amphotericin b|mesh-list
57028885|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
57028886|NCT02656797|Amebicides|amebicides|mesh-ancestor
57028887|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57028888|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57028889|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57028890|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57028891|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
57028892|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
57028893|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57028894|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57028895|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57028896|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57028897|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028898|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
57028899|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028900|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028901|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57028902|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028903|NCT02101476|Acetaminophen|acetaminophen|mesh-list
57028904|NCT02101476|Oxycodone|oxycodone|mesh-list
57028905|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028906|NCT02101476|Analgesics|analgesics|mesh-ancestor
57028907|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
57028908|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028909|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028910|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
57028911|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57028912|NCT02101476|Narcotics|narcotics|mesh-ancestor
57028913|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57028914|NCT02104128|Bupropion|bupropion|mesh-list
57028915|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57028916|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
57028917|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57028918|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57028919|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57028920|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57028921|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028922|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
57028923|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57028924|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028925|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57028926|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57028927|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028928|NCT00004916|Paclitaxel|paclitaxel|mesh-list
57028929|NCT00004916|Ifosfamide|ifosfamide|mesh-list
57028930|NCT00004916|Teniposide|teniposide|mesh-list
57028931|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57028932|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028933|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
57028934|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
57028935|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
57028936|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028937|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57028938|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
57028939|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57028940|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57028941|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028942|NCT02101632|Petrolatum|petrolatum|mesh-list
57028943|NCT02101632|Emollients|emollients|mesh-ancestor
57028944|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
57028945|NCT02101710|Isosorbide|isosorbide|mesh-list
57028946|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57028947|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57028948|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57028949|NCT02101710|Diuretics|diuretics|mesh-ancestor
57028950|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
57028951|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028952|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
57028953|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57028954|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028955|NCT03878368|Sulforaphane|sulforaphane|mesh-list
57028956|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57028957|NCT03878368|Protective Agents|protective agents|mesh-ancestor
57028958|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028959|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028960|NCT02910063|Blinatumomab|blinatumomab|mesh-list
57028961|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028962|NCT04441762|Ketorolac|ketorolac|mesh-list
57028963|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57028964|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57028965|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57028966|NCT04441762|Analgesics|analgesics|mesh-ancestor
57028967|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
57028968|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028969|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028970|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028971|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57028972|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57028973|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57028974|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57028975|NCT05695508|Dexamethasone|dexamethasone|mesh-list
57028976|NCT05695508|Lenalidomide|lenalidomide|mesh-list
57028977|NCT05695508|Bortezomib|bortezomib|mesh-list
57028978|NCT05695508|Daratumumab|daratumumab|mesh-list
57028979|NCT05695508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57028980|NCT05695508|Antiemetics|antiemetics|mesh-ancestor
57028981|NCT05695508|Autonomic Agents|autonomic agents|mesh-ancestor
57028982|NCT05695508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57028983|NCT05695508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57028984|NCT05695508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57028985|NCT05695508|Glucocorticoids|glucocorticoids|mesh-ancestor
57028986|NCT05695508|Hormones|hormones|mesh-ancestor
57028987|NCT05695508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57028988|NCT05695508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57028989|NCT05695508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57028990|NCT05695508|Immunologic Factors|immunologic factors|mesh-ancestor
57028991|NCT05695508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57028992|NCT05695508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57028993|NCT05695508|Growth Substances|growth substances|mesh-ancestor
57028994|NCT05695508|Growth Inhibitors|growth inhibitors|mesh-ancestor
57028995|NCT02104284|Mannitol|mannitol|mesh-list
57028996|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
57028997|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57028998|NCT02104284|Diuretics|diuretics|mesh-ancestor
57028999|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
57029000|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029001|NCT02104284|Miotics|miotics|mesh-ancestor
57029002|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
57029003|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029004|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57029005|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
57029006|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
57029007|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57029008|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57029009|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
57029010|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029011|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029012|NCT00337532|Paclitaxel|paclitaxel|mesh-list
57029013|NCT00337532|Cisplatin|cisplatin|mesh-list
57029014|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57029015|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029016|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
57029017|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
57029018|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029019|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029020|NCT02625441|Trastuzumab|trastuzumab|mesh-list
57029021|NCT02625441|Pertuzumab|pertuzumab|mesh-list
57029022|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57029023|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029024|NCT04209868|Bupivacaine|bupivacaine|mesh-list
57029025|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
57029026|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
57029027|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
57029028|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029029|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029030|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
57029031|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029032|NCT02361801|Dobutamine|dobutamine|mesh-list
57029033|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57029034|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
57029035|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
57029036|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029037|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029038|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57029039|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57029040|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57029041|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
57029042|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029043|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029044|NCT02361801|Protective Agents|protective agents|mesh-ancestor
57029045|NCT03965728|Methotrexate|methotrexate|mesh-list
57029046|NCT03965728|Midazolam|midazolam|mesh-list
57029047|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57029048|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
57029049|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57029050|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029051|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57029052|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
57029053|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029054|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029055|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
57029056|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029057|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57029058|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029059|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
57029060|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029061|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57029062|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57029063|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57029064|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029065|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57029066|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57029067|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57029068|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57029069|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
57029070|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
57029071|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
57029072|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
57029073|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029074|NCT00337454|Dasatinib|dasatinib|mesh-list
57029075|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029076|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57029077|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029078|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029079|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
57029080|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57029081|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57029082|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029083|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
57029084|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029085|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029086|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
57029087|NCT00004898|Etoposide|etoposide|mesh-list
57029088|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029089|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
57029090|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029091|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029092|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57029093|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
57029094|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029095|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711084|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029096|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57029097|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57029098|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57029099|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57029100|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029101|NCT02106468|Prednisone|prednisone|mesh-list
57029102|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57029103|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
57029104|NCT02106468|Hormones|hormones|mesh-ancestor
57029105|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57029106|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029107|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57029108|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029109|NCT03956446|Doxycycline|doxycycline|mesh-list
57029110|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57029111|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029112|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
57029113|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57029114|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57029115|NCT00325364|Insulin|insulin|mesh-list
57029116|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57029117|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57029118|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029119|NCT02104674|Montelukast|montelukast|mesh-list
57029120|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57029121|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
57029122|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57029123|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
57029124|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57029125|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029126|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57029127|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57029128|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029129|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
57029130|NCT01903330|Bevacizumab|bevacizumab|mesh-list
57029131|NCT01903330|Sargramostim|sargramostim|mesh-list
57029132|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029133|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
57029134|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029135|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029136|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57029137|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
57029138|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029139|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029140|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57029141|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57029142|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57029143|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57029144|NCT01903330|Growth Substances|growth substances|mesh-ancestor
57029145|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
57029146|NCT02907177|Ponesimod|ponesimod|mesh-list
57029147|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57029148|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029149|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029150|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
57029151|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029152|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
57029153|NCT00004172|Ifosfamide|ifosfamide|mesh-list
57029154|NCT00004172|Thiotepa|thiotepa|mesh-list
57029155|NCT00004172|Carboplatin|carboplatin|mesh-list
57029156|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029157|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
57029158|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029159|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029160|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57029161|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
57029162|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029163|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029164|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57029165|NCT04353310|Curcumin|curcumin|mesh-list
57029166|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57029167|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57029168|NCT04353310|Analgesics|analgesics|mesh-ancestor
57029169|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
57029170|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029171|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029172|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57029173|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029174|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029175|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029176|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029177|NCT00004166|Amifostine|amifostine|mesh-list
57029178|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57029179|NCT00004166|Protective Agents|protective agents|mesh-ancestor
57029180|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029181|NCT00004106|Temozolomide|temozolomide|mesh-list
57029182|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57029183|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
57029184|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029185|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029186|NCT00002246|Stavudine|stavudine|mesh-list
57029187|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
57029188|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029189|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57029190|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57029191|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029192|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
57029193|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029194|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57029195|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57029196|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57029197|NCT00002240|Nelfinavir|nelfinavir|mesh-list
57029198|NCT00002240|Didanosine|didanosine|mesh-list
57029199|NCT00002240|Stavudine|stavudine|mesh-list
57029200|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57029201|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57029202|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
57029203|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029204|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029205|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57029206|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57029207|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
57029208|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029209|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
57029210|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57029211|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57029212|NCT02250924|Caffeine|caffeine|mesh-list
57029213|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57029214|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029215|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57029216|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029217|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029218|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57029219|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57029220|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
57029221|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029222|NCT03645148|Molgramostim|molgramostim|mesh-list
57029223|NCT03645148|Sargramostim|sargramostim|mesh-list
57029224|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
57029225|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029226|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029227|NCT04082728|Dipyrone|dipyrone|mesh-list
57029228|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57029229|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57029230|NCT04082728|Analgesics|analgesics|mesh-ancestor
57029231|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
57029232|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029233|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029234|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57029235|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029236|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
57029237|NCT02906709|Insulin|insulin|mesh-list
57029238|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57029239|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029240|NCT00321308|Pemetrexed|pemetrexed|mesh-list
57029241|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029242|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029243|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029244|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57029245|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56711227|NCT00791271|Interferons|interferons|mesh-list
57029246|NCT02110134|Hydroquinone|hydroquinone|mesh-list
57029248|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029249|NCT02110134|Protective Agents|protective agents|mesh-ancestor
57029250|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029251|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57029252|NCT00318656|Metformin|metformin|mesh-list
57029253|NCT00318656|Glimepiride|glimepiride|mesh-list
57029254|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
57029255|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57029256|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029257|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57029258|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029259|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
57029260|NCT02110524|Paclitaxel|paclitaxel|mesh-list
57029261|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57029262|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029263|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
57029264|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
57029265|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029266|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029267|NCT00317486|Bosentan|bosentan|mesh-list
57029268|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57029269|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57029270|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029271|NCT02107170|Remifentanil|remifentanil|mesh-list
57029272|NCT02107170|Propofol|propofol|mesh-list
57029273|NCT02107170|Sevoflurane|sevoflurane|mesh-list
57029274|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57029275|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029276|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029277|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57029278|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
57029279|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
57029280|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57029281|NCT02107170|Narcotics|narcotics|mesh-ancestor
57029282|NCT02107170|Analgesics|analgesics|mesh-ancestor
57029283|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
57029284|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029285|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57029286|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57029287|NCT05725382|Remifentanil|remifentanil|mesh-list
57029288|NCT05725382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57029289|NCT05725382|Narcotics|narcotics|mesh-ancestor
57029290|NCT05725382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029291|NCT05725382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029292|NCT05725382|Analgesics|analgesics|mesh-ancestor
57029293|NCT05725382|Sensory System Agents|sensory system agents|mesh-ancestor
57029294|NCT05725382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029295|NCT00313196|Bosentan|bosentan|mesh-list
57029296|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57029297|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57029298|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029299|NCT03656679|Iodine|iodine|mesh-list
57029300|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57029301|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029302|NCT03656679|Trace Elements|trace elements|mesh-ancestor
57029303|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
57029304|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029305|NCT03663166|Nivolumab|nivolumab|mesh-list
57029306|NCT03663166|Ipilimumab|ipilimumab|mesh-list
57029307|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57029308|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029309|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57029310|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029311|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
57029312|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57029313|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57029314|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029315|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57029316|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57029317|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029318|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029319|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029320|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57029321|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
57029322|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57029323|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029324|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57029325|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57029326|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57029327|NCT02107716|Lidocaine|lidocaine|mesh-list
57029328|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
57029329|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
57029330|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029331|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029332|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
57029333|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029334|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57029335|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57029336|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57029337|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57029338|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029339|NCT02110992|Docetaxel|docetaxel|mesh-list
57029340|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029341|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
57029342|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
57029343|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029344|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029345|NCT03306394|Trifluridine|trifluridine|mesh-list
57029346|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
57029347|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029348|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
57029349|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029350|NCT03532178|Rocuronium|rocuronium|mesh-list
57029351|NCT03532178|Succinylcholine|succinylcholine|mesh-list
57029352|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57029353|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57029354|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57029355|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029356|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029357|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
57029358|NCT00311090|Idraparinux|idraparinux|mesh-list
57029359|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
57029360|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57029361|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
57029362|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57029363|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
57029364|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029365|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029366|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
57029367|NCT02105610|Anesthetics|anesthetics|mesh-list
57029368|NCT02105610|Sevoflurane|sevoflurane|mesh-list
57029369|NCT02105610|Desflurane|desflurane|mesh-list
57029370|NCT02105610|Isoflurane|isoflurane|mesh-list
57029371|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
57029372|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029373|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029374|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57029375|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57029376|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
57029377|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
57029378|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029379|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
57029380|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57029381|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57029382|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029383|NCT00301262|Urological Agents|urological agents|mesh-ancestor
57029384|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57029385|NCT02254941|Antibodies|antibodies|mesh-list
57029386|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
57029387|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57029388|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
57029389|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029390|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029391|NCT03598270|Gemcitabine|gemcitabine|mesh-list
57029392|NCT03598270|Paclitaxel|paclitaxel|mesh-list
57029393|NCT03598270|Carboplatin|carboplatin|mesh-list
57029394|NCT03598270|Doxorubicin|doxorubicin|mesh-list
57029395|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57029396|NCT03598270|Atezolizumab|atezolizumab|mesh-list
57029397|NCT03598270|Niraparib|niraparib|mesh-list
57029398|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57029399|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57029400|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029401|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
57029402|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
57029403|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029404|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029405|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57029406|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
57029407|NCT03598270|Antiviral Agents|antiviral agents|mesh-ancestor
57029408|NCT03598270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029409|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029410|NCT03598270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029411|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
57029412|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029413|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57029414|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57029415|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57029416|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57029417|NCT03077620|Suvorexant|suvorexant|mesh-list
57029418|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57029419|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57029420|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029421|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029422|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57029423|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029424|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029425|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
57029426|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57029427|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57029428|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029429|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
57029430|NCT03656445|Coagulants|coagulants|mesh-ancestor
57029431|NCT01903486|Prednisone|prednisone|mesh-list
57029432|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57029433|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
57029434|NCT01903486|Hormones|hormones|mesh-ancestor
57029435|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57029436|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029437|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57029438|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029439|NCT03656289|Etonogestrel|etonogestrel|mesh-list
57029440|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57029441|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
57029442|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57029443|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029444|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57029445|NCT00599170|Rituximab|rituximab|mesh-list
57029446|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57029447|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029448|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
57029449|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029450|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029451|NCT04256434|Nalbuphine|nalbuphine|mesh-list
57029452|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57029453|NCT04256434|Narcotics|narcotics|mesh-ancestor
57029454|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029455|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029456|NCT04256434|Analgesics|analgesics|mesh-ancestor
57029457|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
57029458|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029459|NCT03655665|Ofloxacin|ofloxacin|mesh-list
57029460|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57029461|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029462|NCT03655665|Renal Agents|renal agents|mesh-ancestor
57029463|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57029464|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57029465|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57029466|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029467|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029468|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029469|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57029470|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57029471|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
57029472|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57029473|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
57029474|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57029475|NCT02107950|Gemcitabine|gemcitabine|mesh-list
57029476|NCT02107950|Carboplatin|carboplatin|mesh-list
57029477|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029478|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57029479|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
57029480|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029481|NCT02107950|Antiviral Agents|antiviral agents|mesh-ancestor
57029482|NCT02107950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029483|NCT02107950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029484|NCT02107950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029485|NCT02107950|Immunologic Factors|immunologic factors|mesh-ancestor
57029486|NCT02107950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029487|NCT02113800|Everolimus|everolimus|mesh-list
57029488|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029489|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029490|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
57029491|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029492|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57029493|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
57029494|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57029495|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57029496|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57029497|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029498|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029499|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57029500|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57029501|NCT02112006|Bupivacaine|bupivacaine|mesh-list
57029502|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
57029503|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
57029504|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029505|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029506|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
57029507|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029508|NCT05128162|Psilocybin|psilocybin|mesh-list
57029509|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
57029510|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029511|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57029512|NCT02251158|Ritonavir|ritonavir|mesh-list
57029513|NCT02251158|Tipranavir|tipranavir|mesh-list
57029514|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57029515|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57029516|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57029517|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
57029518|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029519|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029520|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57029521|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57029522|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
57029523|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029524|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57029525|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57029526|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
57029527|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57029528|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
57029529|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029530|NCT05404516|Cytarabine|cytarabine|mesh-list
57029531|NCT05404516|Sorafenib|sorafenib|mesh-list
57029532|NCT05404516|Idarubicin|idarubicin|mesh-list
57029533|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57029534|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
57029535|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029536|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029537|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
57029538|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029539|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029540|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
57029541|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029542|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57029543|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029544|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57029545|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57029546|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57029547|NCT02114346|Atorvastatin|atorvastatin|mesh-list
57029548|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57029549|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57029550|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
57029551|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029552|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57029553|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57029554|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029555|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
57029556|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57029557|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57029558|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029559|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
57029560|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
57029561|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029562|NCT02108808|Clopidogrel|clopidogrel|mesh-list
57029563|NCT02108808|Ticagrelor|ticagrelor|mesh-list
57029564|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57029565|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57029566|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57029567|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57029568|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57029569|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
57029570|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029571|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029572|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029573|NCT05399290|Doxycycline|doxycycline|mesh-list
57029574|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57029575|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029576|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
57029577|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57029578|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57029579|NCT02108886|Montelukast|montelukast|mesh-list
57029580|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57029581|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
57029582|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57029583|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
57029584|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57029585|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029586|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57029587|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57029588|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029589|NCT02114502|Pyridoxine|pyridoxine|mesh-list
57029590|NCT02114502|Gemcitabine|gemcitabine|mesh-list
57029591|NCT02114502|Dexamethasone|dexamethasone|mesh-list
57029592|NCT02114502|Melphalan|melphalan|mesh-list
57029593|NCT02114502|Busulfan|busulfan|mesh-list
57029594|NCT02114502|Vorinostat|vorinostat|mesh-list
57029595|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57029596|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
57029597|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
57029598|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029599|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029600|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57029601|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
57029602|NCT02114502|Hormones|hormones|mesh-ancestor
57029603|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57029604|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57029605|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029606|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57029607|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
57029608|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029609|NCT02114502|Antiviral Agents|antiviral agents|mesh-ancestor
57029610|NCT02114502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029611|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029612|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029613|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
57029614|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57029615|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
57029616|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57029617|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57029618|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
57029619|NCT02114502|Vitamins|vitamins|mesh-ancestor
57029620|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
57029621|NCT03416179|Cytarabine|cytarabine|mesh-list
57029622|NCT03416179|Azacitidine|azacitidine|mesh-list
57029623|NCT03416179|Daunorubicin|daunorubicin|mesh-list
57029624|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57029625|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
57029626|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029627|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029628|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
57029629|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029630|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029631|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
57029632|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029633|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029634|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57029635|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57029636|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57029637|NCT03654027|Docetaxel|docetaxel|mesh-list
57029638|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029639|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
57029640|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
57029641|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029642|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029643|NCT02114658|Sorafenib|sorafenib|mesh-list
57029644|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029645|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57029646|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029647|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029648|NCT05126602|Vitamin D|vitamin d|mesh-list
57029649|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
57029650|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
57029651|NCT05126602|Vitamins|vitamins|mesh-list
57029652|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
57029653|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029654|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57029655|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57029656|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
57029657|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57029658|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57029659|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57029660|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029661|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
57029662|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029663|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029664|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57029665|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029666|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
57029667|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57029668|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029669|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57029670|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029671|NCT02112552|Paclitaxel|paclitaxel|mesh-list
57029672|NCT02112552|Carboplatin|carboplatin|mesh-list
57029673|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57029674|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029675|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
57029676|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
57029677|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029678|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029679|NCT02109354|Vaccines|vaccines|mesh-list
57029680|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
57029681|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029682|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
57029683|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
57029684|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57029685|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57029686|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029687|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029688|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029689|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029690|NCT02109510|Lidocaine|lidocaine|mesh-list
57029691|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
57029692|NCT02109510|Ketamine|ketamine|mesh-list
57029693|NCT02109510|Anesthetics|anesthetics|mesh-list
57029694|NCT02109510|Propofol|propofol|mesh-list
57029695|NCT02109510|Sevoflurane|sevoflurane|mesh-list
57029696|NCT02109510|Rocuronium|rocuronium|mesh-list
57029697|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
57029698|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029699|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711682|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
57029700|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
57029701|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029702|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57029703|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57029704|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57029705|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57029706|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029707|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57029708|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57029709|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
57029710|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57029711|NCT02109510|Analgesics|analgesics|mesh-ancestor
57029712|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57029713|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57029714|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57029715|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
57029716|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029717|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57029718|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57029719|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57029720|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57029721|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57029722|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57029723|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57029724|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57029725|NCT02109666|Abatacept|abatacept|mesh-list
57029726|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57029727|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029728|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029729|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029730|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
57029731|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029732|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029733|NCT02865928|Bupivacaine|bupivacaine|mesh-list
57029734|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
57029735|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
57029736|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029737|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029738|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
57029739|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029740|NCT02109900|Progesterone|progesterone|mesh-list
57029741|NCT02109900|Progestins|progestins|mesh-ancestor
57029742|NCT02109900|Hormones|hormones|mesh-ancestor
57029743|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57029744|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029745|NCT02112630|Interferons|interferons|mesh-list
57029746|NCT02112630|Ribavirin|ribavirin|mesh-list
57029747|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
57029748|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
57029749|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57029750|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
57029751|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57029752|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029753|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
57029754|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029755|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
57029756|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029757|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
57029758|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029759|NCT04873375|Cemiplimab|cemiplimab|mesh-list
57029760|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57029761|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029762|NCT05125588|Meloxicam|meloxicam|mesh-list
57029763|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57029764|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57029765|NCT05125588|Analgesics|analgesics|mesh-ancestor
57029766|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
57029767|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029768|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029769|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57029770|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029771|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57029772|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56711757|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029773|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029774|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029775|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
57029776|NCT02115204|Docetaxel|docetaxel|mesh-list
57029777|NCT02115204|Fluorouracil|fluorouracil|mesh-list
57029778|NCT02115204|Methotrexate|methotrexate|mesh-list
57029779|NCT02115204|Epirubicin|epirubicin|mesh-list
57029780|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029781|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
57029782|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029783|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029784|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57029785|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
57029786|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029787|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029788|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57029789|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
57029790|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
57029791|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029792|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
57029793|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57029794|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57029795|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
57029796|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57029797|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
57029798|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029799|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57029800|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57029801|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57029802|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57029803|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57029804|NCT02115360|Calcitonin|calcitonin|mesh-list
57029805|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
57029806|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
57029807|NCT02115360|Fentanyl|fentanyl|mesh-list
57029808|NCT02115360|Katacalcin|katacalcin|mesh-list
57029809|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57029810|NCT02115360|Narcotics|narcotics|mesh-ancestor
57029811|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029812|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029813|NCT02115360|Analgesics|analgesics|mesh-ancestor
57029814|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
57029815|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029816|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57029817|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57029818|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
57029819|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
57029820|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57029821|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57029822|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
57029823|NCT02432404|NuvaRing|nuvaring|mesh-list
57029824|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57029825|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
57029826|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57029827|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029828|NCT02113176|Minocycline|minocycline|mesh-list
57029829|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57029830|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029831|NCT02118870|Aspirin|aspirin|mesh-list
57029832|NCT02118870|Clopidogrel|clopidogrel|mesh-list
57029833|NCT02118870|Ticagrelor|ticagrelor|mesh-list
57029834|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57029835|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57029836|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57029837|NCT02118870|Analgesics|analgesics|mesh-ancestor
57029838|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
57029839|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029840|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029841|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57029842|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57029843|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57029844|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57029845|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029846|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57029847|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57029848|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029849|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
57029850|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57029851|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57029852|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57029853|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
57029854|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029855|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57029856|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
57029857|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57029858|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
57029859|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029861|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
57029862|NCT03552666|Vitamins|vitamins|mesh-ancestor
57029863|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
57029864|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029865|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57029866|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57029867|NCT02115594|Fulvestrant|fulvestrant|mesh-list
57029868|NCT02115594|Entinostat|entinostat|mesh-list
57029869|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57029870|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029871|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57029872|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57029873|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
57029874|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57029875|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029876|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57029877|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029878|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029879|NCT05125042|Amiodarone|amiodarone|mesh-list
57029880|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57029881|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
57029882|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57029883|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57029884|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029885|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57029886|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57029887|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57029888|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029889|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57029890|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57029891|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57029892|NCT02113332|Liraglutide|liraglutide|mesh-list
57029893|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57029894|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029895|NCT02113332|Incretins|incretins|mesh-ancestor
57029896|NCT02113332|Hormones|hormones|mesh-ancestor
57029897|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57029898|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57029899|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57029900|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
57029901|NCT02918877|Propofol|propofol|mesh-list
57029902|NCT02918877|Sevoflurane|sevoflurane|mesh-list
57029903|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57029904|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57029905|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029906|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57029907|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
57029908|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
57029909|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57029910|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57029911|NCT03652857|Apatinib|apatinib|mesh-list
57029912|NCT03652857|Vinorelbine|vinorelbine|mesh-list
57029913|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029914|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57029915|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029916|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029917|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57029918|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
57029919|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
57029920|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029921|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
56711934|NCT04072068|Edoxaban|edoxaban|mesh-list
57029922|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57029923|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029924|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57029925|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
57029926|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57029927|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57029928|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029929|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029931|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
57029932|NCT04221555|Durvalumab|durvalumab|mesh-list
57029933|NCT04221555|Tremelimumab|tremelimumab|mesh-list
57029934|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57029935|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57029936|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
57029937|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
57029938|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
57029939|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029940|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57029941|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
57029942|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029943|NCT02113566|Acetaminophen|acetaminophen|mesh-list
57029944|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57029945|NCT02113566|Analgesics|analgesics|mesh-ancestor
57029946|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
57029947|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57029948|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029949|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
57029950|NCT05124730|Metformin|metformin|mesh-list
57029951|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57029952|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029953|NCT02251626|Ubiquinone|ubiquinone|mesh-list
57029954|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
57029955|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
57029956|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029957|NCT02251626|Vitamins|vitamins|mesh-ancestor
57029958|NCT02123004|Clopidogrel|clopidogrel|mesh-list
57029959|NCT02123004|Ticagrelor|ticagrelor|mesh-list
57029960|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57029961|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57029962|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57029963|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57029964|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
57029965|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029966|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029967|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029968|NCT01674712|Simvastatin|simvastatin|mesh-list
57029969|NCT01674712|Fenofibrate|fenofibrate|mesh-list
57029970|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57029971|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57029972|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
57029973|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029974|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57029975|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57029976|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57029977|NCT01368432|Citalopram|citalopram|mesh-list
57029978|NCT01368432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57029979|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57029980|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57029981|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57029982|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029983|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
57029984|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029985|NCT01368432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57029986|NCT01368432|Antidepressive Agents|antidepressive agents|mesh-ancestor
57029987|NCT01368432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57029988|NCT05122780|Acetylcholine|acetylcholine|mesh-list
57029989|NCT05122780|Anticoagulants|anticoagulants|mesh-list
57029990|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
57029991|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
57029992|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57029993|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
57029994|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57029995|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711997|NCT00712556|Fluorides|fluorides|mesh-list
57029996|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57029997|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
57029998|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57029999|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
57030000|NCT02119806|Fentanyl|fentanyl|mesh-list
57030001|NCT02119806|Midazolam|midazolam|mesh-list
57030002|NCT02119806|Propofol|propofol|mesh-list
57030003|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57030004|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030005|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030006|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57030007|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
57030008|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
57030009|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57030010|NCT02119806|Narcotics|narcotics|mesh-ancestor
57030011|NCT02119806|Analgesics|analgesics|mesh-ancestor
57030012|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
57030013|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030014|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57030015|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57030016|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57030017|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57030018|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
57030019|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
57030020|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030021|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030022|NCT02119884|Octreotide|octreotide|mesh-list
57030023|NCT02119884|Terlipressin|terlipressin|mesh-list
57030024|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57030025|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57030026|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030027|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57030028|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57030029|NCT05104918|Vortioxetine|vortioxetine|mesh-list
57030030|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57030031|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57030032|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57030033|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57030034|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030035|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030036|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030037|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57030038|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
57030039|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57030040|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57030041|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57030042|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030043|NCT05104918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57030044|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
57030045|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57030046|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57030047|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57030048|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57030049|NCT05089942|Insulin|insulin|mesh-list
57030050|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57030051|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57030052|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030053|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
57030054|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57030055|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030056|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030057|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57030058|NCT04941508|Analgesics|analgesics|mesh-ancestor
57030059|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
57030060|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030061|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57030062|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57030063|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57030064|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
57030065|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030066|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030067|NCT01062555|Cyclosporine|cyclosporine|mesh-list
57030068|NCT01062555|Sirolimus|sirolimus|mesh-list
57030069|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
57030070|NCT01062555|Tacrolimus|tacrolimus|mesh-list
57030071|NCT01062555|Cyclosporins|cyclosporins|mesh-list
57030072|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030073|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
57030074|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030075|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57030076|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030077|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030078|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
57030079|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030080|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
57030081|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030082|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57030083|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030084|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57030085|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
57030086|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57030087|NCT03622047|Sufentanil|sufentanil|mesh-list
57030088|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
57030089|NCT03622047|Ropivacaine|ropivacaine|mesh-list
57030090|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57030091|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030092|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030093|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57030094|NCT03622047|Analgesics|analgesics|mesh-ancestor
57030095|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
57030096|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030097|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57030098|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57030099|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57030100|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
57030101|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030102|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030103|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
57030104|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
57030105|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57030106|NCT03622047|Narcotics|narcotics|mesh-ancestor
57030107|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57030108|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57030109|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
57030110|NCT05128630|Durvalumab|durvalumab|mesh-list
57030111|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030112|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030113|NCT05073562|Folic Acid|folic acid|mesh-list
57030114|NCT05073562|Mebendazole|mebendazole|mesh-list
57030115|NCT05073562|Piperazine|piperazine|mesh-list
57030116|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
57030117|NCT05073562|DMP 777|dmp 777|mesh-list
57030118|NCT05073562|Hematinics|hematinics|mesh-ancestor
57030119|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
57030120|NCT05073562|Vitamins|vitamins|mesh-ancestor
57030121|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
57030122|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030123|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
57030124|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
57030125|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57030126|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030127|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
57030128|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
57030129|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
57030130|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030131|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030132|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030133|NCT01368276|Molgramostim|molgramostim|mesh-list
57030134|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57030135|NCT01368276|Sargramostim|sargramostim|mesh-list
57030136|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
57030137|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030138|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030139|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030140|NCT04955938|Ivosidenib|ivosidenib|mesh-list
57030141|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030142|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030143|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030144|NCT02116842|Fentanyl|fentanyl|mesh-list
57030145|NCT02116842|Bupivacaine|bupivacaine|mesh-list
57030146|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
57030147|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
57030148|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030149|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030150|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
57030151|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030152|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57030153|NCT02116842|Narcotics|narcotics|mesh-ancestor
57030154|NCT02116842|Analgesics|analgesics|mesh-ancestor
57030155|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57030156|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57030157|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
57030158|NCT02120118|Docetaxel|docetaxel|mesh-list
57030159|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030160|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
57030161|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
57030162|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
57030163|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030164|NCT04054089|Tenofovir|tenofovir|mesh-list
57030165|NCT04054089|Lamivudine|lamivudine|mesh-list
57030166|NCT04054089|Emtricitabine|emtricitabine|mesh-list
57030167|NCT04054089|Dolutegravir|dolutegravir|mesh-list
57030168|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
57030169|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030170|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57030171|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57030172|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030173|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030174|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57030175|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57030176|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57030177|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57030178|NCT02120196|Rifaximin|rifaximin|mesh-list
57030179|NCT02120196|Norfloxacin|norfloxacin|mesh-list
57030180|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57030181|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030182|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57030183|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57030184|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57030185|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030186|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030187|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030188|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57030189|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57030190|NCT05001802|Ropivacaine|ropivacaine|mesh-list
57030191|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
57030192|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
57030193|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030194|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030195|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
57030196|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030197|NCT02120274|Vitamin D|vitamin d|mesh-list
57030198|NCT02120274|Vitamins|vitamins|mesh-list
57030199|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
57030200|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
57030201|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
57030202|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030203|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57030204|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
57030205|NCT02120274|Hematinics|hematinics|mesh-ancestor
57030206|NCT02402842|Docetaxel|docetaxel|mesh-list
57030207|NCT02402842|Fluorouracil|fluorouracil|mesh-list
57030208|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030209|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
57030210|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
57030211|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
57030212|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030213|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
57030214|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57030215|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030216|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
57030217|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030218|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
57030219|NCT03652467|Deferoxamine|deferoxamine|mesh-list
57030220|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57030221|NCT03652467|Estrogens|estrogens|mesh-ancestor
57030222|NCT03652467|Hormones|hormones|mesh-ancestor
57030223|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030224|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030225|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57030226|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030227|NCT03652467|Siderophores|siderophores|mesh-ancestor
57030228|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57030229|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
57030230|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
57030231|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030232|NCT02741570|Cisplatin|cisplatin|mesh-list
57030233|NCT02741570|Carboplatin|carboplatin|mesh-list
57030234|NCT02741570|Fluorouracil|fluorouracil|mesh-list
57030235|NCT02741570|Nivolumab|nivolumab|mesh-list
57030236|NCT02741570|Cetuximab|cetuximab|mesh-list
57030237|NCT02741570|Ipilimumab|ipilimumab|mesh-list
57030238|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030239|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
57030240|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030241|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57030242|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030243|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
57030244|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030245|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030246|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57030247|NCT01061775|Exenatide|exenatide|mesh-list
57030248|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57030249|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030250|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57030251|NCT01061775|Incretins|incretins|mesh-ancestor
57030252|NCT01061775|Hormones|hormones|mesh-ancestor
57030253|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030254|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57030255|NCT02123628|Doxycycline|doxycycline|mesh-list
57030256|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
57030257|NCT02123628|Levofloxacin|levofloxacin|mesh-list
57030258|NCT02123628|Rifampin|rifampin|mesh-list
57030259|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
57030260|NCT02123628|Linezolid|linezolid|mesh-list
57030261|NCT02123628|Cefepime|cefepime|mesh-list
57030262|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57030263|NCT02123628|Cefotaxime|cefotaxime|mesh-list
57030264|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
57030265|NCT02123628|Trimethoprim|trimethoprim|mesh-list
57030266|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
57030267|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030268|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57030269|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
57030270|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
57030271|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57030272|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57030273|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57030274|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57030275|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030276|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030277|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030278|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57030279|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57030280|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57030281|NCT02123628|Renal Agents|renal agents|mesh-ancestor
57030282|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
57030283|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57030284|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57030285|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57030286|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57030287|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57030288|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57030289|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57030290|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57030291|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57030292|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57030293|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57030294|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
57030295|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
57030296|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
57030297|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57030298|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57030299|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030300|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030301|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030302|NCT05045950|Memantine|memantine|mesh-list
57030303|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57030304|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57030306|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030307|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030308|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030309|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57030310|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57030311|NCT03528824|Diclofenac|diclofenac|mesh-list
57030312|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57030313|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57030314|NCT03528824|Analgesics|analgesics|mesh-ancestor
57030315|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
57030316|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030317|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030318|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030319|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030320|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57030321|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030322|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030323|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57030324|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57030325|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57030326|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
57030327|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030328|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57030329|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57030330|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030331|NCT00289640|Ipilimumab|ipilimumab|mesh-list
57030332|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030333|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030334|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57030335|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030336|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
57030337|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
57030338|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57030339|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030340|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030341|NCT03765632|Busulfan|busulfan|mesh-list
57030342|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
57030343|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030344|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030345|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
57030346|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030347|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57030348|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030349|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57030350|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
57030351|NCT02973477|Glimepiride|glimepiride|mesh-list
57030352|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57030353|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030354|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57030355|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030356|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57030357|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030358|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
57030359|NCT03552354|Argatroban|argatroban|mesh-list
57030360|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
57030361|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57030362|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
57030363|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030364|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030365|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
57030366|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57030367|NCT02288000|Memantine|memantine|mesh-list
57030368|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57030369|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57030370|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
57030371|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030372|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030373|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030374|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57030375|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57030376|NCT02788656|Valsartan|valsartan|mesh-list
57030377|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
57030378|NCT02788656|Giapreza|giapreza|mesh-list
57030379|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
57030380|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57030381|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
57030382|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
57030383|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
57030384|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57030385|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57030386|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030387|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
57030388|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57030389|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57030390|NCT05258110|Midazolam|midazolam|mesh-list
57030391|NCT05258110|BI 425809|bi 425809|mesh-list
57030392|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57030393|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57030394|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030395|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030396|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57030397|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57030398|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57030399|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57030400|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
57030401|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
57030402|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
57030403|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
57030404|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030405|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030406|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
57030407|NCT03652233|Nivolumab|nivolumab|mesh-list
57030408|NCT03652233|Afatinib|afatinib|mesh-list
57030409|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030410|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030411|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57030412|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030413|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57030414|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030415|NCT05581004|Atezolizumab|atezolizumab|mesh-list
57030416|NCT05581004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030417|NCT02117466|Cetuximab|cetuximab|mesh-list
57030418|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030419|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030420|NCT02117622|Insulin|insulin|mesh-list
57030421|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57030422|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030423|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
57030424|NCT04529902|Abatacept|abatacept|mesh-list
57030425|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57030426|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030427|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030428|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030429|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
57030430|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897122|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
57030431|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030432|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030433|NCT04693468|Palbociclib|palbociclib|mesh-list
57030434|NCT04693468|Axitinib|axitinib|mesh-list
57030435|NCT04693468|Crizotinib|crizotinib|mesh-list
57030436|NCT04693468|Talazoparib|talazoparib|mesh-list
57030437|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030438|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57030439|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030440|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030441|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57030442|NCT02288078|Dexamethasone|dexamethasone|mesh-list
57030443|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57030444|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030445|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
57030446|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
57030447|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030448|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030449|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56712430|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030450|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
57030451|NCT02288078|Hormones|hormones|mesh-ancestor
57030452|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030453|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57030454|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030455|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030456|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030457|NCT05220514|PK 11195|pk 11195|mesh-list
57030458|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030459|NCT02288234|Telavancin|telavancin|mesh-list
57030460|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57030461|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030462|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57030463|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57030464|NCT04654312|Diuretics|diuretics|mesh-ancestor
57030465|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
57030466|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030467|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57030468|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57030469|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030470|NCT02973087|Factor VIII|factor viii|mesh-list
57030471|NCT02973087|Coagulants|coagulants|mesh-ancestor
57030472|NCT05284656|Folic Acid|folic acid|mesh-list
57030473|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
57030474|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
57030475|NCT05284656|Hematinics|hematinics|mesh-ancestor
57030476|NCT05284656|Vitamins|vitamins|mesh-ancestor
57030477|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
57030478|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030479|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57030480|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030481|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030482|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57030483|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57030484|NCT05284656|Protective Agents|protective agents|mesh-ancestor
57030485|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
57030486|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57030487|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
57030488|NCT02124174|Azacitidine|azacitidine|mesh-list
57030489|NCT02124174|Valproic Acid|valproic acid|mesh-list
57030490|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57030491|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
57030492|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030493|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030494|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030495|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
57030496|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
57030497|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030498|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030499|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
57030500|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57030501|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030502|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57030503|NCT03956368|Atorvastatin|atorvastatin|mesh-list
57030504|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57030505|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57030506|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
57030507|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030508|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57030509|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57030510|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030511|NCT02124330|Bentonite|bentonite|mesh-list
57030512|NCT02124330|Antidotes|antidotes|mesh-ancestor
57030513|NCT02124330|Protective Agents|protective agents|mesh-ancestor
57030514|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030515|NCT02118090|Chloroquine|chloroquine|mesh-list
57030516|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
57030517|NCT02118090|Amebicides|amebicides|mesh-ancestor
57030518|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57030519|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57030520|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030521|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
57030522|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030523|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57030524|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57030525|NCT02118090|Analgesics|analgesics|mesh-ancestor
57030526|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
57030527|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030528|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030529|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030531|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
57030532|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
57030533|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
57030534|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030535|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030536|NCT03551808|Ketorolac|ketorolac|mesh-list
57030537|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57030538|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57030539|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57030540|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57030541|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57030542|NCT03551808|Analgesics|analgesics|mesh-ancestor
57030543|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
57030544|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030545|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030546|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030547|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030548|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57030549|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030550|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030551|NCT04053543|CXA-10|cxa-10|mesh-list
57030552|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030553|NCT04202458|Tenecteplase|tenecteplase|mesh-list
57030554|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57030555|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57030556|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030557|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
57030558|NCT00273650|Vitamins|vitamins|mesh-ancestor
57030559|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
57030560|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030561|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
57030562|NCT02121288|Clopidogrel|clopidogrel|mesh-list
57030563|NCT02121288|Ticagrelor|ticagrelor|mesh-list
57030564|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57030565|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57030566|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57030567|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57030568|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
57030569|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030570|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030571|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030572|NCT01525329|Fluorouracil|fluorouracil|mesh-list
57030573|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
57030574|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030575|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57030576|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030577|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030578|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
57030579|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030580|NCT02121366|Ethanol|ethanol|mesh-list
57030581|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57030582|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030583|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030584|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030585|NCT02121444|Interferons|interferons|mesh-list
57030586|NCT02121444|Interferon-beta|interferon-beta|mesh-list
57030587|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
57030588|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030589|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
57030590|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030591|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
57030592|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030593|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57030594|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
57030595|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57030596|NCT04413526|Estrogens|estrogens|mesh-ancestor
57030597|NCT04413526|Hormones|hormones|mesh-ancestor
57030598|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030599|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030600|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56712584|NCT00714740|Acetazolamide|acetazolamide|mesh-list
57030601|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030603|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
57030604|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030605|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
57030606|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030607|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
57030608|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57030609|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
57030610|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030611|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
57030612|NCT03318874|Protective Agents|protective agents|mesh-ancestor
57030613|NCT03551652|Rocuronium|rocuronium|mesh-list
57030614|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57030615|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57030616|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57030617|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030618|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030619|NCT00263042|Rimonabant|rimonabant|mesh-list
57030620|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57030621|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
57030622|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57030623|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030624|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030625|NCT00263042|Hormones|hormones|mesh-ancestor
57030626|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030627|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030628|NCT05002192|Eucalyptol|eucalyptol|mesh-list
57030629|NCT05002192|Ambroxol|ambroxol|mesh-list
57030630|NCT05002192|Expectorants|expectorants|mesh-list
57030631|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
57030632|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030633|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
57030634|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
57030635|NCT05002192|Protective Agents|protective agents|mesh-ancestor
57030636|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030637|NCT04973020|Efavirenz|efavirenz|mesh-list
57030638|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57030639|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57030640|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030641|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030642|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
57030643|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030644|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57030645|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57030646|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57030647|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57030648|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57030649|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57030650|NCT05724446|Prednisolone|prednisolone|mesh-list
57030651|NCT05724446|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57030652|NCT05724446|Methylprednisolone|methylprednisolone|mesh-list
57030653|NCT05724446|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57030654|NCT05724446|Prednisolone acetate|prednisolone acetate|mesh-list
57030655|NCT05724446|Clobetasol|clobetasol|mesh-list
57030656|NCT05724446|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57030657|NCT05724446|Prednisolone phosphate|prednisolone phosphate|mesh-list
57030658|NCT05724446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030659|NCT05724446|Glucocorticoids|glucocorticoids|mesh-ancestor
57030660|NCT05724446|Hormones|hormones|mesh-ancestor
57030661|NCT05724446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030662|NCT05724446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030663|NCT05724446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57030664|NCT05724446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030665|NCT05724446|Antiemetics|antiemetics|mesh-ancestor
57030666|NCT05724446|Autonomic Agents|autonomic agents|mesh-ancestor
57030667|NCT05724446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030668|NCT05724446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57030669|NCT05724446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57030670|NCT05724446|Protective Agents|protective agents|mesh-ancestor
57030671|NCT02124642|Folic Acid|folic acid|mesh-list
57030672|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
57030673|NCT02124642|Hematinics|hematinics|mesh-ancestor
57030674|NCT02124642|Vitamins|vitamins|mesh-ancestor
57030675|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
57030676|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030678|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57030679|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57030680|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
57030681|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030682|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030683|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030684|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57030685|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57030686|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
57030687|NCT00260156|Vildagliptin|vildagliptin|mesh-list
57030688|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57030689|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030690|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57030691|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
57030692|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030693|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030694|NCT04367103|Phenylephrine|phenylephrine|mesh-list
57030695|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
57030696|NCT04367103|Norepinephrine|norepinephrine|mesh-list
57030697|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57030698|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
57030699|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
57030700|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030701|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030702|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
57030703|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57030704|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
57030705|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
57030706|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57030707|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57030708|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57030709|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
57030710|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030711|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030712|NCT04367103|Protective Agents|protective agents|mesh-ancestor
57030713|NCT00260078|Ritonavir|ritonavir|mesh-list
57030714|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57030715|NCT00260078|Darunavir|darunavir|mesh-list
57030716|NCT00260078|Tenofovir|tenofovir|mesh-list
57030717|NCT00260078|Nevirapine|nevirapine|mesh-list
57030718|NCT00260078|Efavirenz|efavirenz|mesh-list
57030719|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57030720|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57030721|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
57030722|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030723|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030724|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57030725|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57030726|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
57030727|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030728|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57030729|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57030730|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57030731|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57030732|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57030733|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57030734|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57030735|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57030736|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57030737|NCT03034564|Droxidopa|droxidopa|mesh-list
57030738|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57030739|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57030740|NCT05342532|Amoxicillin|amoxicillin|mesh-list
57030741|NCT05342532|Clarithromycin|clarithromycin|mesh-list
57030742|NCT05342532|Omeprazole|omeprazole|mesh-list
57030743|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57030744|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030745|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57030746|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57030747|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57030748|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030749|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030750|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57030751|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57030752|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57030753|NCT01794520|Dexamethasone|dexamethasone|mesh-list
57030755|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030756|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
57030757|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
57030758|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030759|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030760|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57030761|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
57030762|NCT01794520|Hormones|hormones|mesh-ancestor
57030763|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030764|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57030765|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030766|NCT04469114|Tofacitinib|tofacitinib|mesh-list
57030767|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57030768|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030769|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030770|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
57030771|NCT02400567|Letrozole|letrozole|mesh-list
57030772|NCT02400567|Epirubicin|epirubicin|mesh-list
57030773|NCT02400567|Palbociclib|palbociclib|mesh-list
57030774|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030775|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
57030776|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030777|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030778|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57030779|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
57030780|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030781|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030782|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57030783|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57030784|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57030785|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030786|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57030787|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
57030788|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030789|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57030790|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57030791|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57030792|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57030793|NCT02971683|Abatacept|abatacept|mesh-list
57030794|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57030795|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030796|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030797|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030798|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
57030799|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030800|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030801|NCT05340582|Acetaminophen|acetaminophen|mesh-list
57030802|NCT05340582|Ibuprofen|ibuprofen|mesh-list
57030803|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57030804|NCT05340582|Analgesics|analgesics|mesh-ancestor
57030805|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
57030806|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030807|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030808|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
57030809|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57030810|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030811|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030812|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57030813|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030814|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030815|NCT05501054|Nivolumab|nivolumab|mesh-list
57030816|NCT05501054|Ipilimumab|ipilimumab|mesh-list
57030817|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030818|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030819|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57030820|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030821|NCT00228176|Rimonabant|rimonabant|mesh-list
57030822|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57030823|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
57030824|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57030825|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030826|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030827|NCT00228176|Hormones|hormones|mesh-ancestor
57030828|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030829|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030830|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
57030831|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
57030832|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030833|NCT01308190|Capecitabine|capecitabine|mesh-list
57030834|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57030835|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
57030836|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030837|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030838|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
57030839|NCT01210768|Doxorubicin|doxorubicin|mesh-list
57030840|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57030841|NCT01210768|Epirubicin|epirubicin|mesh-list
57030842|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030843|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
57030844|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030845|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030846|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57030847|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
57030848|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030849|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030850|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57030851|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57030852|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57030853|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57030854|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030855|NCT02971605|Psilocybin|psilocybin|mesh-list
57030856|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
57030857|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030858|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57030859|NCT04410874|Vaccines|vaccines|mesh-list
57030860|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
57030861|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030862|NCT02124954|Digoxin|digoxin|mesh-list
57030863|NCT02124954|Midazolam|midazolam|mesh-list
57030864|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57030865|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57030866|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030867|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030868|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57030869|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57030870|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57030871|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57030872|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
57030873|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
57030874|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
57030875|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
56897130|NCT01169805|Ramosetron|ramosetron|mesh-list
57030876|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030877|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030878|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57030879|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57030880|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030881|NCT02124954|Protective Agents|protective agents|mesh-ancestor
57030882|NCT04441112|Triamcinolone|triamcinolone|mesh-list
57030883|NCT04441112|Ketorolac|ketorolac|mesh-list
57030884|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57030885|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
57030886|NCT04441112|Hormones|hormones|mesh-ancestor
57030887|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030888|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030889|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030890|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030891|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57030892|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57030893|NCT04441112|Analgesics|analgesics|mesh-ancestor
57030894|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
57030895|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030896|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030897|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57030898|NCT02121990|Paclitaxel|paclitaxel|mesh-list
57030899|NCT02121990|Bevacizumab|bevacizumab|mesh-list
56712878|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030901|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57030902|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030903|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
57030904|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
57030905|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
57030906|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030907|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030908|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57030909|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57030910|NCT02121990|Growth Substances|growth substances|mesh-ancestor
57030911|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030912|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
57030913|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57030914|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030915|NCT05724056|Hyaluronic Acid|hyaluronic acid|mesh-list
57030916|NCT05724056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57030917|NCT05724056|Immunologic Factors|immunologic factors|mesh-ancestor
57030918|NCT05724056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030919|NCT05724056|Viscosupplements|viscosupplements|mesh-ancestor
57030920|NCT05724056|Protective Agents|protective agents|mesh-ancestor
57030921|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
57030922|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
57030923|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
57030924|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030925|NCT01060059|Exenatide|exenatide|mesh-list
57030926|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57030927|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030928|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57030929|NCT01060059|Incretins|incretins|mesh-ancestor
57030930|NCT01060059|Hormones|hormones|mesh-ancestor
57030931|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030932|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
57030933|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
57030934|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57030935|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57030936|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57030937|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030938|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030939|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030940|NCT04307797|Exenatide|exenatide|mesh-list
57030941|NCT04307797|Glucagon|glucagon|mesh-list
57030942|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57030943|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57030944|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030945|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57030946|NCT04307797|Incretins|incretins|mesh-ancestor
57030947|NCT04307797|Hormones|hormones|mesh-ancestor
57030948|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57030949|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57030950|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57030951|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
57030952|NCT02125188|Coagulants|coagulants|mesh-ancestor
57030953|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57030954|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
57030955|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030956|NCT02125344|Paclitaxel|paclitaxel|mesh-list
57030957|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
57030958|NCT02125344|Carboplatin|carboplatin|mesh-list
57030959|NCT02125344|Doxorubicin|doxorubicin|mesh-list
57030960|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57030961|NCT02125344|Trastuzumab|trastuzumab|mesh-list
57030962|NCT02125344|Epirubicin|epirubicin|mesh-list
57030963|NCT02125344|Pertuzumab|pertuzumab|mesh-list
57030964|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57030965|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57030966|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
57030967|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
57030968|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
57030969|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030970|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57030971|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
57030972|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030973|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57030974|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56712955|NCT00718952|Urological Agents|urological agents|mesh-ancestor
57030975|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
57030976|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57030977|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57030978|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57030979|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57030980|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57030981|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57030982|NCT05468840|Ketamine|ketamine|mesh-list
57030983|NCT05468840|Analgesics|analgesics|mesh-ancestor
57030984|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
57030985|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57030986|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57030987|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57030988|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57030989|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
57030990|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
57030991|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57030992|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57030993|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57030994|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57030995|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57030996|NCT05723900|Castor Oil|castor oil|mesh-list
57030997|NCT05723900|Cathartics|cathartics|mesh-ancestor
57030998|NCT05723900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57030999|NCT02127138|Sirolimus|sirolimus|mesh-list
57031000|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031001|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031002|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57031003|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031004|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
57031005|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57031006|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
57031007|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031008|NCT05726318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57031009|NCT05726318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031010|NCT03651531|Metformin|metformin|mesh-list
57031011|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57031012|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031013|NCT02903511|Metformin|metformin|mesh-list
57031014|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57031015|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031016|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
57031017|NCT05325528|Tegafur|tegafur|mesh-list
57031018|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031019|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57031020|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
57031021|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031022|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
57031023|NCT02125500|Ledipasvir|ledipasvir|mesh-list
57031024|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
57031025|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031026|NCT02125578|Interferons|interferons|mesh-list
57031027|NCT02125578|Interferon-beta|interferon-beta|mesh-list
57031028|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
57031029|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031030|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
57031031|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031032|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
57031033|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031034|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57031035|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57031036|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57031037|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57031038|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57031039|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031040|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031041|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57031042|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57031043|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031044|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
57031045|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031046|NCT05606965|Vaccines|vaccines|mesh-list
57031047|NCT05606965|Immunologic Factors|immunologic factors|mesh-ancestor
57031048|NCT05606965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031049|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57031050|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57031051|NCT00141284|Lamivudine|lamivudine|mesh-list
57031053|NCT00141284|Nelfinavir|nelfinavir|mesh-list
57031054|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57031055|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57031056|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031057|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031058|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
57031059|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031060|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57031061|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57031062|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
57031063|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57031064|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57031065|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
57031066|NCT05670379|Exenatide|exenatide|mesh-list
57031067|NCT05670379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57031068|NCT05670379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031069|NCT05670379|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57031070|NCT05670379|Incretins|incretins|mesh-ancestor
57031071|NCT05670379|Hormones|hormones|mesh-ancestor
57031072|NCT05670379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57031073|NCT04328506|Vorolanib|vorolanib|mesh-list
57031074|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031075|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031076|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031077|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
57031078|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031079|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031080|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57031081|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57031082|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031083|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031084|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031085|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
57031086|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57031087|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57031088|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031089|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
57031090|NCT02125890|Coagulants|coagulants|mesh-ancestor
57031091|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
57031092|NCT05433116|Lenvatinib|lenvatinib|mesh-list
57031093|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57031094|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031095|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031096|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031097|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031098|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
57031099|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57031100|NCT05287984|Rituximab|rituximab|mesh-list
57031101|NCT05287984|Fludarabine|fludarabine|mesh-list
57031102|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
57031103|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57031104|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
57031105|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031106|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57031107|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57031108|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
57031109|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031110|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031111|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57031112|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57031113|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031114|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031115|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
57031116|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57031117|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57031118|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
57031119|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031120|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031121|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031122|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
57031123|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
57031124|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031125|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
57031126|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57031127|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
57031128|NCT00134264|Atorvastatin|atorvastatin|mesh-list
57031129|NCT00134264|Torcetrapib|torcetrapib|mesh-list
57031130|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57031131|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57031132|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
57031133|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031134|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57031135|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57031136|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031137|NCT05285800|Bupivacaine|bupivacaine|mesh-list
57031138|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
57031139|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
57031140|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031141|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031142|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
57031143|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031144|NCT02122692|Itraconazole|itraconazole|mesh-list
57031145|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
57031146|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
57031147|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031148|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57031149|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57031150|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031151|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031152|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57031153|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
57031154|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57031155|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031156|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57031157|NCT05419466|Melatonin|melatonin|mesh-list
57031158|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
57031159|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031160|NCT05419466|Protective Agents|protective agents|mesh-ancestor
57031161|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031162|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031163|NCT00131924|Estrogens|estrogens|mesh-list
57031164|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
57031165|NCT00131924|Hormones|hormones|mesh-ancestor
57031166|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57031167|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031168|NCT05284474|Mitogens|mitogens|mesh-list
57031169|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
57031170|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031171|NCT05609695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57031172|NCT05609695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031173|NCT05609695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031174|NCT04246060|Cysteamine|cysteamine|mesh-list
57031175|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
57031176|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031177|NCT05129176|Metronidazole|metronidazole|mesh-list
57031178|NCT05129176|Levofloxacin|levofloxacin|mesh-list
57031179|NCT05129176|Ofloxacin|ofloxacin|mesh-list
57031180|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031181|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031182|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57031183|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57031184|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57031185|NCT05129176|Renal Agents|renal agents|mesh-ancestor
57031186|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57031187|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57031188|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031189|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031190|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031191|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57031192|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57031193|NCT02127684|Ranibizumab|ranibizumab|mesh-list
57031194|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57031195|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57031196|NCT02127684|Growth Substances|growth substances|mesh-ancestor
57031197|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031198|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
57031199|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031201|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57031202|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57031203|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031204|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031205|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031206|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57031207|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57031208|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57031209|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
57031210|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031211|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57031212|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57031213|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031214|NCT02127840|Epinephrine|epinephrine|mesh-list
57031215|NCT02127840|Racepinephrine|racepinephrine|mesh-list
57031216|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
57031217|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57031218|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57031219|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
57031220|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031221|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031222|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031223|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57031224|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57031225|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
57031226|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031227|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57031228|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
57031229|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
57031230|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
57031231|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57031232|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
57031233|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
57031234|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
57031235|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57031236|NCT05031442|Protective Agents|protective agents|mesh-ancestor
57031237|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031238|NCT02127918|Clobazam|clobazam|mesh-list
57031239|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
57031240|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57031241|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57031242|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031243|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031244|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031245|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57031246|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
57031247|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
57031248|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031249|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031250|NCT00127634|Insulin|insulin|mesh-list
57031251|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57031252|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
57031253|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57031254|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031255|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57031256|NCT02127996|Incretins|incretins|mesh-ancestor
57031257|NCT02127996|Hormones|hormones|mesh-ancestor
57031258|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57031259|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031260|NCT02131350|Ranibizumab|ranibizumab|mesh-list
57031261|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57031262|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57031263|NCT02131350|Growth Substances|growth substances|mesh-ancestor
57031264|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031265|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
57031266|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031267|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
57031268|NCT02128308|Levofloxacin|levofloxacin|mesh-list
57031269|NCT02128308|Ofloxacin|ofloxacin|mesh-list
57031270|NCT02128308|Cycloserine|cycloserine|mesh-list
57031271|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
57031272|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
57031273|NCT02128308|Streptomycin|streptomycin|mesh-list
57031274|NCT02128308|Kanamycin|kanamycin|mesh-list
57031275|NCT02128308|Prothionamide|prothionamide|mesh-list
57031276|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57031277|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031278|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031279|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57031280|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57031281|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031282|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031283|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031284|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57031285|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
57031286|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57031287|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031288|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57031289|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57031290|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57031291|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57031292|NCT02128308|Renal Agents|renal agents|mesh-ancestor
57031293|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57031294|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57031295|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57031296|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
57031297|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
57031298|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57031299|NCT02131506|Lapatinib|lapatinib|mesh-list
57031300|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57031301|NCT02131506|Doxorubicin|doxorubicin|mesh-list
57031302|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031303|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031304|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031305|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031306|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57031307|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57031308|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57031309|NCT01674010|Inositol|inositol|mesh-list
57031310|NCT01674010|Lamotrigine|lamotrigine|mesh-list
57031311|NCT01674010|Valproic Acid|valproic acid|mesh-list
57031312|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
57031313|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57031314|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57031315|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031316|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57031317|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031318|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57031319|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57031320|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031321|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031322|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57031323|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031324|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
57031325|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031326|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
57031327|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
57031328|NCT01674010|Vitamins|vitamins|mesh-ancestor
57031329|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
57031330|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
57031331|NCT04617938|Narcotics|narcotics|mesh-ancestor
57031332|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031333|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031334|NCT04617938|Analgesics|analgesics|mesh-ancestor
57031335|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
57031336|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031337|NCT02252328|Simvastatin|simvastatin|mesh-list
57031338|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57031339|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57031340|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
57031341|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031342|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57031343|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57031344|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031345|NCT05012254|Paclitaxel|paclitaxel|mesh-list
57031346|NCT05012254|Cisplatin|cisplatin|mesh-list
57031347|NCT05012254|Carboplatin|carboplatin|mesh-list
57031348|NCT05012254|Nivolumab|nivolumab|mesh-list
57031349|NCT05012254|Pemetrexed|pemetrexed|mesh-list
57031350|NCT05012254|Ipilimumab|ipilimumab|mesh-list
57031351|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57031352|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031353|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
57031354|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
57031355|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
57031356|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031357|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57031358|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57031359|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031360|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57031361|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57031362|NCT04656964|Midazolam|midazolam|mesh-list
57031363|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57031364|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57031365|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031366|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031367|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57031368|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57031369|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031370|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57031371|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
57031372|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
57031373|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
57031374|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
57031375|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031376|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031377|NCT02136030|Amphotericin B|amphotericin b|mesh-list
57031378|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
57031379|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
57031380|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
57031381|NCT02136030|Amebicides|amebicides|mesh-ancestor
57031382|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57031383|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57031384|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031385|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031386|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
57031387|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57031388|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57031389|NCT02131818|Amoxicillin|amoxicillin|mesh-list
57031390|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031391|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031392|NCT04605796|Bevacizumab|bevacizumab|mesh-list
57031393|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608915|NCT00723190|Clonidine|clonidine|mesh-list
57031394|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031395|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57031396|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57031397|NCT04605796|Growth Substances|growth substances|mesh-ancestor
57031398|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031399|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
57031400|NCT01345669|Afatinib|afatinib|mesh-list
57031401|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031402|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031403|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031404|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031405|NCT04313608|Gemcitabine|gemcitabine|mesh-list
57031406|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
57031407|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
57031408|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57031409|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
57031410|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031411|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031412|NCT04313608|Antiviral Agents|antiviral agents|mesh-ancestor
57031413|NCT04313608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031414|NCT04313608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031415|NCT04313608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57031416|NCT04313608|Immunologic Factors|immunologic factors|mesh-ancestor
57031417|NCT04313608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031418|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57031419|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
57031420|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57031421|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57031422|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57031423|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57031424|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031425|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
57031426|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031427|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031428|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57031429|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031430|NCT03202316|Atezolizumab|atezolizumab|mesh-list
57031431|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57031432|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031433|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
57031434|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031435|NCT03527732|Ivermectin|ivermectin|mesh-list
57031436|NCT03527732|Albendazole|albendazole|mesh-list
57031437|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57031438|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031439|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
57031440|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
57031441|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57031442|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57031443|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
57031444|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
57031445|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
57031446|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031447|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031448|NCT01673854|Ipilimumab|ipilimumab|mesh-list
57031449|NCT01673854|Vemurafenib|vemurafenib|mesh-list
57031450|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57031451|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031452|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57031453|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031454|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031455|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031456|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
57031457|NCT03549702|Povidone|povidone|mesh-list
57031458|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
57031459|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
57031460|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57031461|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031462|NCT02529904|Vaccines|vaccines|mesh-list
57031463|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
57031464|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031465|NCT03099356|Sirolimus|sirolimus|mesh-list
57031466|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
57031467|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57031468|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
56608968|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
57031469|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031470|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57031471|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57031472|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
57031473|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031474|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031475|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57031476|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031477|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031478|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57031479|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
57031480|NCT01367886|Fesoterodine|fesoterodine|mesh-list
57031481|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57031482|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57031483|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
57031484|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031485|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031486|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031487|NCT01367886|Urological Agents|urological agents|mesh-ancestor
57031488|NCT05097274|Choline|choline|mesh-list
57031489|NCT05097274|Lipotropic Agents|lipotropic agents|mesh-ancestor
57031490|NCT05097274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57031491|NCT05097274|Antimetabolites|antimetabolites|mesh-ancestor
57031492|NCT05097274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031493|NCT05097274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57031494|NCT05097274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57031495|NCT05097274|Nootropic Agents|nootropic agents|mesh-ancestor
57031496|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
57031497|NCT05222191|Spironolactone|spironolactone|mesh-list
57031498|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57031499|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
57031500|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57031501|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031502|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57031503|NCT05222191|Diuretics|diuretics|mesh-ancestor
57031504|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
57031505|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57031506|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57031507|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57031508|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031510|NCT05706337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57031511|NCT05706337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031512|NCT05706337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031513|NCT05706337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57031514|NCT05706337|Anesthetics, General|anesthetics, general|mesh-ancestor
57031515|NCT05706337|Anesthetics|anesthetics|mesh-ancestor
57031516|NCT05222113|Remdesivir|remdesivir|mesh-list
57031517|NCT05222113|Favipiravir|favipiravir|mesh-list
57031518|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
57031519|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031520|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
57031521|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031522|NCT03854578|Citalopram|citalopram|mesh-list
57031523|NCT03854578|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57031524|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57031525|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57031526|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031527|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031528|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
57031529|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031530|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57031531|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
57031532|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031533|NCT03038594|Hormones|hormones|mesh-list
57031534|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57031535|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031536|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
57031537|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57031538|NCT02136888|Ponesimod|ponesimod|mesh-list
57031539|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031540|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031541|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57031542|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57031543|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031544|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031545|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031546|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57031547|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
57031548|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57031549|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031550|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57031551|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57031552|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57031553|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57031554|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57031555|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
57031556|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57031557|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
57031558|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031559|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57031560|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57031561|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031562|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031563|NCT05252754|Indomethacin|indomethacin|mesh-list
57031564|NCT05252754|Tacrolimus|tacrolimus|mesh-list
57031565|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57031566|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
57031567|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031568|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57031569|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031570|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031571|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57031572|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57031573|NCT05252754|Analgesics|analgesics|mesh-ancestor
57031574|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
57031575|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031576|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57031577|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57031578|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
57031579|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
57031580|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57031581|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57031583|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
57031584|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
57031585|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57031586|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031587|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57031588|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031589|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031590|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
57031591|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57031592|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031593|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57031594|NCT02132442|Vitamin D|vitamin d|mesh-list
57031595|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
57031596|NCT02132442|Vitamins|vitamins|mesh-ancestor
57031597|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
57031598|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031599|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57031600|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57031601|NCT05010148|Lidocaine|lidocaine|mesh-list
57031602|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
57031603|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
57031604|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031605|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031606|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
57031607|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031608|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57031609|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57031610|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57031611|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57031612|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031613|NCT05138146|Doxorubicin|doxorubicin|mesh-list
57031614|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57031615|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57031616|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031617|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57031618|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57031619|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031620|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031621|NCT05221879|Enoxaparin|enoxaparin|mesh-list
57031622|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
57031623|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57031624|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57031625|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031626|NCT03450772|Pancrelipase|pancrelipase|mesh-list
57031627|NCT03450772|Pancreatin|pancreatin|mesh-list
57031628|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57031629|NCT02129088|Esketamine|esketamine|mesh-list
57031630|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
57031631|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031632|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
57031633|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57031634|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57031635|NCT05137522|Prednisolone|prednisolone|mesh-list
57031636|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
57031637|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57031638|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
57031639|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57031640|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
57031641|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
57031642|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031643|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031644|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57031645|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
57031646|NCT05137522|Hormones|hormones|mesh-ancestor
57031647|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713641|NCT04101383|Insulin|insulin|mesh-list
57031648|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57031649|NCT05137522|Protective Agents|protective agents|mesh-ancestor
57031650|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57031651|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031652|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
57031653|NCT02129166|Dasatinib|dasatinib|mesh-list
57031654|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031655|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031656|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031657|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031658|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
57031659|NCT02137278|Levodopa|levodopa|mesh-list
57031660|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
57031661|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
57031662|NCT02137278|Diuretics|diuretics|mesh-list
57031663|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031664|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
57031665|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031666|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
57031667|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031668|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031669|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57031670|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57031671|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57031672|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031673|NCT05705635|Docetaxel|docetaxel|mesh-list
57031674|NCT05705635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031675|NCT05705635|Tubulin Modulators|tubulin modulators|mesh-ancestor
57031676|NCT05705635|Antimitotic Agents|antimitotic agents|mesh-ancestor
57031677|NCT05705635|Mitosis Modulators|mitosis modulators|mesh-ancestor
57031678|NCT05705635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031679|NCT05204550|Heparin|heparin|mesh-list
57031680|NCT05204550|Calcium heparin|calcium heparin|mesh-list
57031681|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
57031682|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57031683|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56897148|NCT01283061|Zafirlukast|zafirlukast|mesh-list
57031684|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031685|NCT00085774|Albuterol|albuterol|mesh-list
57031686|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57031687|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
57031688|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031689|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031690|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57031691|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
57031692|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
57031693|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57031694|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57031695|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57031696|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57031697|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
57031698|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031699|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031700|NCT04491682|Megestrol|megestrol|mesh-list
57031701|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
57031702|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57031703|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57031704|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57031705|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
57031706|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031707|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57031708|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57031709|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031710|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57031711|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57031712|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57031713|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
57031714|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57031715|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031716|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57031717|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57031718|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57031719|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031720|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
57031721|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57031722|NCT05193968|Nitroprusside|nitroprusside|mesh-list
57031723|NCT05193968|Norepinephrine|norepinephrine|mesh-list
57031724|NCT05193968|Acetylcholine|acetylcholine|mesh-list
57031726|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57031727|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57031728|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
57031729|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031730|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031731|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031732|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
57031733|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
57031734|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031735|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57031736|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57031737|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
57031738|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57031739|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57031740|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
57031741|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57031742|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57031743|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
57031744|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
57031745|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57031746|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57031747|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57031748|NCT02137356|Capecitabine|capecitabine|mesh-list
57031749|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57031750|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
57031751|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031752|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031753|NCT05137288|Atropine|atropine|mesh-list
57031754|NCT05137288|Ondansetron|ondansetron|mesh-list
57031755|NCT05137288|Bupivacaine|bupivacaine|mesh-list
57031756|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
57031757|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
57031758|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031759|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031760|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
57031761|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031762|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
57031763|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
57031764|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57031765|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
57031766|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
57031767|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57031768|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
57031769|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031770|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031771|NCT05137288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57031772|NCT05137288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57031773|NCT05137288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031774|NCT05137288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57031775|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57031776|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57031777|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57031778|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57031779|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
57031780|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
57031781|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
57031782|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57031783|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57031784|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
57031785|NCT05135182|Metronidazole|metronidazole|mesh-list
57031786|NCT05135182|Furazolidone|furazolidone|mesh-list
57031787|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031788|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031789|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57031790|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57031791|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57031792|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57031793|NCT05135182|Renal Agents|renal agents|mesh-ancestor
57031794|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57031795|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57031796|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031797|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031798|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
57031799|NCT02137434|Calcium|calcium|mesh-list
57031800|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57031801|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031802|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57031803|NCT04965454|Choline|choline|mesh-list
57031804|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
57031805|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57031806|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
57031807|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031808|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57031809|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57031810|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
57031811|NCT02137668|Vancomycin|vancomycin|mesh-list
57031812|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031813|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031814|NCT04216472|Paclitaxel|paclitaxel|mesh-list
57031815|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57031816|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
57031817|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57031818|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031819|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
57031820|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
57031821|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
57031822|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031823|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031824|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
57031825|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
57031826|NCT03522428|Vitamins|vitamins|mesh-ancestor
57031827|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
57031828|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031829|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
57031830|NCT03522428|Hematinics|hematinics|mesh-ancestor
57031831|NCT05575999|Ketorolac|ketorolac|mesh-list
57031832|NCT05575999|Ketamine|ketamine|mesh-list
57031833|NCT05575999|Bupivacaine|bupivacaine|mesh-list
57031834|NCT05575999|Anesthetics, Local|anesthetics, local|mesh-ancestor
57031835|NCT05575999|Anesthetics|anesthetics|mesh-ancestor
57031836|NCT05575999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031837|NCT05575999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031838|NCT05575999|Sensory System Agents|sensory system agents|mesh-ancestor
57031839|NCT05575999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031840|NCT05575999|Analgesics|analgesics|mesh-ancestor
57031841|NCT05575999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57031842|NCT05575999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57031843|NCT05575999|Anesthetics, General|anesthetics, general|mesh-ancestor
57031844|NCT05575999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57031845|NCT05575999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57031846|NCT05575999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031847|NCT05575999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031848|NCT05575999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57031849|NCT05575999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57031850|NCT05575999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57031851|NCT05575999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57031852|NCT05575999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57031853|NCT05575999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031854|NCT01062399|Everolimus|everolimus|mesh-list
57031855|NCT01062399|Temozolomide|temozolomide|mesh-list
57031856|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031857|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57031858|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
57031859|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031860|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57031861|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
57031862|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031863|NCT05136508|Propofol|propofol|mesh-list
57031864|NCT05136508|Sevoflurane|sevoflurane|mesh-list
57031865|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57031866|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031867|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031868|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57031869|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
57031870|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
57031871|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57031872|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57031873|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
57031874|NCT02129322|Sorafenib|sorafenib|mesh-list
57031875|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031876|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031877|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031878|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031879|NCT05125978|Dipyrone|dipyrone|mesh-list
57031880|NCT05125978|Tramadol|tramadol|mesh-list
57031881|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57031882|NCT05125978|Narcotics|narcotics|mesh-ancestor
57031883|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031884|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031885|NCT05125978|Analgesics|analgesics|mesh-ancestor
57031886|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
57031887|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031888|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57031889|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57031890|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57031891|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57031892|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
57031893|NCT03767712|Antibodies|antibodies|mesh-list
57031894|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
57031895|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
57031896|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031897|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
57031898|NCT05221411|Tacrolimus|tacrolimus|mesh-list
57031899|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57031900|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
57031901|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031902|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57031903|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031904|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031905|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57031906|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031907|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57031908|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
57031909|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57031910|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57031911|NCT05306002|Antioxidants|antioxidants|mesh-list
57031912|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031913|NCT05306002|Protective Agents|protective agents|mesh-ancestor
57031914|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031915|NCT04346914|Carboplatin|carboplatin|mesh-list
57031916|NCT04346914|Etoposide|etoposide|mesh-list
57031917|NCT04346914|Antibodies|antibodies|mesh-list
57031918|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57031919|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
57031920|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031921|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031922|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57031923|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57031924|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57031925|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031926|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031927|NCT02129400|Anesthetics|anesthetics|mesh-list
57031928|NCT02129400|Xenon|xenon|mesh-list
57031929|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031930|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031931|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57031932|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
57031933|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57031934|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57031935|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031936|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031937|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57031938|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57031939|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031940|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
57031941|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031942|NCT02133378|Hemostatics|hemostatics|mesh-list
57031943|NCT02133378|Coagulants|coagulants|mesh-ancestor
57031944|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
57031945|NCT04171622|Lenvatinib|lenvatinib|mesh-list
57031946|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57031947|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031948|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031949|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031950|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031951|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57031952|NCT04880278|Nabilone|nabilone|mesh-list
57031953|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
57031954|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
57031955|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57031956|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031957|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57031958|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57031959|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57031960|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57031961|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57031962|NCT02138058|Topiramate|topiramate|mesh-list
57031963|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
57031964|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57031965|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031966|NCT02129634|Paclitaxel|paclitaxel|mesh-list
57031967|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57031968|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031969|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
57031970|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
57031971|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
57031972|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031973|NCT05174455|Niraparib|niraparib|mesh-list
57031974|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57031975|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031976|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031977|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031978|NCT05162053|Clopidogrel|clopidogrel|mesh-list
57031979|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57031980|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57031981|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57031982|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57031983|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
57031984|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57031985|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031986|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031987|NCT02138292|Trametinib|trametinib|mesh-list
57031988|NCT02138292|Digoxin|digoxin|mesh-list
57031989|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57031990|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57031991|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57031992|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57031993|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57031994|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57031995|NCT02138292|Protective Agents|protective agents|mesh-ancestor
57031996|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57031997|NCT02133612|Paclitaxel|paclitaxel|mesh-list
57031998|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57031999|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57032000|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032001|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
57032002|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
57032003|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
57032004|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032005|NCT03522194|Propofol|propofol|mesh-list
57032006|NCT03522194|Sevoflurane|sevoflurane|mesh-list
57032007|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57032008|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032009|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032010|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57032011|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
57032012|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
57032013|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57032014|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57032015|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
57032016|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57032017|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
57032018|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
57032019|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57032020|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032021|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
57032022|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
57032023|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032024|NCT04820686|Tenofovir|tenofovir|mesh-list
57032025|NCT04820686|Entecavir|entecavir|mesh-list
57032026|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
57032027|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714007|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
57032028|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57032029|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57032030|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032031|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032032|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57032033|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57032034|NCT02260908|Enoxaparin|enoxaparin|mesh-list
57032035|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
57032036|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57032037|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57032038|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032039|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
57032040|NCT02969655|Glycine|glycine|mesh-list
57032041|NCT02969655|Hematinics|hematinics|mesh-ancestor
57032042|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
57032043|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032044|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032045|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032046|NCT04488874|Mannitol|mannitol|mesh-list
57032047|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57032048|NCT04488874|Diuretics|diuretics|mesh-ancestor
57032049|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
57032050|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032051|NCT03651219|Irinotecan|irinotecan|mesh-list
57032052|NCT03651219|Apatinib|apatinib|mesh-list
57032053|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57032054|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57032055|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032056|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032057|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032058|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57032059|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57032060|NCT02648698|Levofloxacin|levofloxacin|mesh-list
57032061|NCT02648698|Tinidazole|tinidazole|mesh-list
57032062|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032063|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57032064|NCT02648698|Renal Agents|renal agents|mesh-ancestor
57032065|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57032066|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57032067|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032068|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032069|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032070|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57032071|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57032072|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
57032073|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57032074|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57032075|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57032076|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
57032077|NCT04059458|Calcium|calcium|mesh-list
57032078|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57032079|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032080|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57032081|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
57032082|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57032083|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032084|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032085|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57032086|NCT05304598|Analgesics|analgesics|mesh-ancestor
57032087|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
57032088|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032089|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57032090|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57032091|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57032092|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
57032093|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032094|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032095|NCT03524846|Vitamins|vitamins|mesh-list
57032096|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
57032097|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
57032098|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032099|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
57032100|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032101|NCT03524846|Protective Agents|protective agents|mesh-ancestor
56714086|NCT00711906|Renal Agents|renal agents|mesh-ancestor
57032102|NCT05134558|Xenon|xenon|mesh-list
57032103|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57032104|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
57032105|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
57032106|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032107|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032108|NCT02970669|Valsartan|valsartan|mesh-list
57032109|NCT02970669|Enalapril|enalapril|mesh-list
57032110|NCT02970669|Enalaprilat|enalaprilat|mesh-list
57032111|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57032112|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57032113|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57032114|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57032115|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032116|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57032117|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
57032118|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032119|NCT05304520|Natalizumab|natalizumab|mesh-list
57032120|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
57032121|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032122|NCT02134002|Disulfiram|disulfiram|mesh-list
57032123|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57032124|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
57032125|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609634|NCT04049539|Cytarabine|cytarabine|mesh-list
57032126|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032127|NCT03650361|Adapalene|adapalene|mesh-list
57032128|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57032129|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57032130|NCT03650361|Analgesics|analgesics|mesh-ancestor
57032131|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
57032132|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032133|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032134|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57032135|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57032136|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
57032137|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57032138|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
57032139|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032140|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57032141|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
57032142|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57032143|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
57032144|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57032145|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
57032146|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032147|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032148|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
57032149|NCT02902965|Dexamethasone|dexamethasone|mesh-list
57032150|NCT02902965|Bortezomib|bortezomib|mesh-list
57032151|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57032152|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
57032153|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
57032154|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032155|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032156|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032157|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
57032158|NCT02902965|Hormones|hormones|mesh-ancestor
57032159|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032160|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57032161|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032162|NCT02130414|Cyclosporine|cyclosporine|mesh-list
57032163|NCT02130414|Cyclosporins|cyclosporins|mesh-list
57032164|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032165|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032166|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57032167|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
57032168|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032169|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
57032170|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032171|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
57032172|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57032173|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57032174|NCT02642042|Docetaxel|docetaxel|mesh-list
57032175|NCT02642042|Trametinib|trametinib|mesh-list
56714158|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57032177|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
57032178|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
57032179|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
57032180|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032181|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57032182|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032183|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57032184|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
57032185|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032186|NCT02134470|Testosterone|testosterone|mesh-list
57032187|NCT02134470|Androgens|androgens|mesh-ancestor
57032188|NCT02134470|Hormones|hormones|mesh-ancestor
57032189|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032190|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032191|NCT02134626|Simvastatin|simvastatin|mesh-list
57032192|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57032193|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57032194|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
57032195|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032196|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57032197|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57032198|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032199|NCT02969187|Bupivacaine|bupivacaine|mesh-list
57032200|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
57032201|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
57032202|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032203|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032204|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
57032205|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032206|NCT04893655|Dobutamine|dobutamine|mesh-list
57032207|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57032208|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
57032209|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
57032210|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032211|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032212|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57032213|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57032214|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57032215|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
57032216|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032217|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032218|NCT04893655|Protective Agents|protective agents|mesh-ancestor
57032219|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57032220|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
57032221|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57032222|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
57032223|NCT05285085|Atorvastatin|atorvastatin|mesh-list
57032224|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57032225|NCT05285085|Simvastatin|simvastatin|mesh-list
57032226|NCT05285085|Pravastatin|pravastatin|mesh-list
57032227|NCT05285085|Pitavastatin|pitavastatin|mesh-list
57032228|NCT05285085|Lovastatin|lovastatin|mesh-list
57032229|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57032230|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57032231|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
57032232|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032233|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57032234|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57032235|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032236|NCT02139930|Nicotine|nicotine|mesh-list
57032237|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57032238|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
57032239|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032240|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032241|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57032242|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57032243|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
57032244|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032245|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032246|NCT04843111|Vaccines|vaccines|mesh-list
57032247|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
57032248|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032249|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
57032250|NCT02130804|Salicylates|salicylates|mesh-list
57032251|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57032252|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57032254|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
57032255|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032256|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032257|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57032258|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57032259|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57032260|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032261|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032262|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
57032263|NCT05303272|Abatacept|abatacept|mesh-list
57032264|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57032265|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032266|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57032267|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
57032268|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57032269|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032270|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032271|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032272|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57032273|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57032274|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
57032275|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032276|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57032277|NCT03549312|Tenofovir|tenofovir|mesh-list
57032278|NCT03549312|Emtricitabine|emtricitabine|mesh-list
57032279|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
57032280|NCT03549312|Cobicistat|cobicistat|mesh-list
57032281|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57032282|NCT03549312|Velpatasvir|velpatasvir|mesh-list
57032283|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57032284|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57032285|NCT03549312|Elvitegravir|elvitegravir|mesh-list
57032286|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
57032287|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032288|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57032289|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57032290|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032291|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032292|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57032293|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57032294|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57032295|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57032296|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57032297|NCT03649269|Bezafibrate|bezafibrate|mesh-list
57032298|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57032299|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
57032300|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032301|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57032302|NCT05698381|Acetic Acid|acetic acid|mesh-list
57032303|NCT05698381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57032304|NCT05698381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032305|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
57032306|NCT02134938|Cathartics|cathartics|mesh-ancestor
57032307|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032308|NCT05373446|Ritonavir|ritonavir|mesh-list
57032309|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57032310|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57032311|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
57032312|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032313|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032314|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57032315|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57032316|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
57032317|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032318|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57032319|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57032320|NCT05019716|Cisplatin|cisplatin|mesh-list
57032321|NCT05019716|Etoposide|etoposide|mesh-list
57032322|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
57032323|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
57032324|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032325|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57032326|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57032327|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57032328|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032329|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032330|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
57032331|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
57032332|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
57032333|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
57032334|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
57032335|NCT04734028|Clopidogrel|clopidogrel|mesh-list
57032336|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032337|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032338|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57032339|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57032340|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57032341|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57032342|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
57032343|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032344|NCT05285397|Liraglutide|liraglutide|mesh-list
57032345|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57032346|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032347|NCT05285397|Incretins|incretins|mesh-ancestor
57032348|NCT05285397|Hormones|hormones|mesh-ancestor
57032349|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032350|NCT03050359|Lansoprazole|lansoprazole|mesh-list
57032351|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
57032352|NCT03050359|Bismuth|bismuth|mesh-list
57032353|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57032354|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032355|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57032356|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032357|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032358|NCT03050359|Antacids|antacids|mesh-ancestor
57032359|NCT02140242|Daunorubicin|daunorubicin|mesh-list
57032360|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57032361|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032362|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57032363|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57032364|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032365|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032366|NCT05302726|Estrogens|estrogens|mesh-list
57032367|NCT05302726|Hormones|hormones|mesh-ancestor
57032368|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032369|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032370|NCT02253264|Rituximab|rituximab|mesh-list
57032371|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57032372|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032373|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
57032374|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032375|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57032376|NCT03648333|Niacin|niacin|mesh-list
57032377|NCT03648333|Amlodipine|amlodipine|mesh-list
57032378|NCT03648333|Valsartan|valsartan|mesh-list
57032379|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
57032380|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57032381|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57032382|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57032383|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032384|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57032385|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032386|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
57032387|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57032388|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57032389|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57032390|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
57032391|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57032392|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
57032393|NCT03648333|Vitamins|vitamins|mesh-ancestor
57032394|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
57032395|NCT02252796|Paclitaxel|paclitaxel|mesh-list
57032396|NCT02252796|Carboplatin|carboplatin|mesh-list
57032397|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57032398|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032399|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
57032400|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
57032401|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
57032402|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032403|NCT04529278|Liraglutide|liraglutide|mesh-list
57032404|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57032405|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032406|NCT04529278|Incretins|incretins|mesh-ancestor
57032407|NCT04529278|Hormones|hormones|mesh-ancestor
57032408|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032409|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
57032410|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57032411|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032412|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57032413|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57032414|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032415|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032416|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032417|NCT04256707|Docetaxel|docetaxel|mesh-list
57032418|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
57032419|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032420|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
57032421|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
57032422|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
57032423|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032424|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57032425|NCT04166474|Dolutegravir|dolutegravir|mesh-list
57032426|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57032427|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57032428|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032429|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032430|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57032431|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57032432|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
57032433|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032434|NCT04660123|Bismuth|bismuth|mesh-list
57032435|NCT04660123|Antacids|antacids|mesh-ancestor
57032436|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032437|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032438|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
57032439|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57032440|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57032441|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
57032442|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032443|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57032444|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
57032445|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57032446|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57032447|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032448|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
57032449|NCT05579418|Evolocumab|evolocumab|mesh-list
57032450|NCT05579418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57032451|NCT05579418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57032452|NCT05579418|Antimetabolites|antimetabolites|mesh-ancestor
57032453|NCT05579418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032454|NCT05579418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57032455|NCT02968173|Palivizumab|palivizumab|mesh-list
57032456|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
57032457|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032458|NCT05523895|Pimavanserin|pimavanserin|mesh-list
57032459|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57032460|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57032461|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57032462|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57032463|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032464|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032465|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57032466|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57032467|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57032468|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
57032469|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032470|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032471|NCT04848584|Vaccines|vaccines|mesh-list
57032472|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
57032473|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032474|NCT02135640|Denosumab|denosumab|mesh-list
56714467|NCT00857428|Oxymorphone|oxymorphone|mesh-list
57032475|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57032476|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032477|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57032478|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
57032479|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57032480|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
57032481|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032482|NCT04038099|Lidocaine|lidocaine|mesh-list
57032483|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
57032484|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
57032485|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032486|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032487|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
57032488|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032489|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57032490|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57032491|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57032492|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57032493|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032494|NCT00495508|Lumefantrine|lumefantrine|mesh-list
57032495|NCT00495508|Artemether|artemether|mesh-list
57032496|NCT00495508|Quinine|quinine|mesh-list
57032497|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57032498|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
57032499|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57032500|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57032501|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032502|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57032503|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032504|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57032505|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032506|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57032507|NCT00495508|Analgesics|analgesics|mesh-ancestor
57032508|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
57032509|NCT01554046|Methylphenidate|methylphenidate|mesh-list
57032510|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57032511|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032512|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57032513|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57032514|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57032515|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032516|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
57032517|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032518|NCT05284851|Vaccines|vaccines|mesh-list
57032519|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
57032520|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032521|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57032522|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57032523|NCT03049735|Norethindrone|norethindrone|mesh-list
57032524|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
57032525|NCT03049735|Estradiol|estradiol|mesh-list
57032526|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57032527|NCT03049735|Relugolix|relugolix|mesh-list
57032528|NCT03049735|Estrogens|estrogens|mesh-ancestor
57032529|NCT03049735|Hormones|hormones|mesh-ancestor
57032530|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032531|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032532|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57032533|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
57032534|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57032535|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57032536|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57032537|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57032538|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57032539|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
57032540|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
57032541|NCT04785638|Bupivacaine|bupivacaine|mesh-list
57032542|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
57032543|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
57032544|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032545|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032546|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
57032547|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032548|NCT04762472|Montelukast|montelukast|mesh-list
57032549|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57032550|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
57032551|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57032552|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
57032553|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032554|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032555|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57032556|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57032557|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032558|NCT01295944|Bevacizumab|bevacizumab|mesh-list
57032559|NCT01295944|Carboplatin|carboplatin|mesh-list
57032560|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57032561|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032562|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57032563|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57032564|NCT01295944|Growth Substances|growth substances|mesh-ancestor
57032565|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032566|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
57032567|NCT04742348|Levodopa|levodopa|mesh-list
57032568|NCT04742348|Carbidopa|carbidopa|mesh-list
57032569|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57032570|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57032571|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57032572|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
57032573|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032574|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032575|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032576|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57032577|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032578|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57032579|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
57032580|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
57032581|NCT03384784|Galantamine|galantamine|mesh-list
57032582|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57032583|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032584|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032585|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
57032586|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032587|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032588|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57032589|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
57032590|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032591|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
57032592|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
57032593|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57032594|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57032595|NCT02140632|Prednisolone|prednisolone|mesh-list
57032596|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
57032597|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57032598|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
57032599|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57032600|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
57032601|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
57032602|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032603|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032604|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032605|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
57032606|NCT02140632|Hormones|hormones|mesh-ancestor
57032607|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032608|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57032609|NCT02140632|Protective Agents|protective agents|mesh-ancestor
57032610|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57032611|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032612|NCT04712942|Azacitidine|azacitidine|mesh-list
57032613|NCT04712942|Pevonedistat|pevonedistat|mesh-list
57032614|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57032615|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
57032616|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032617|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032618|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032619|NCT05578404|Cholecalciferol|cholecalciferol|mesh-list
57032620|NCT05578404|Vitamin D|vitamin d|mesh-list
57032621|NCT05578404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57032622|NCT05578404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714615|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
57032623|NCT05578404|Vitamins|vitamins|mesh-ancestor
57032624|NCT05578404|Micronutrients|micronutrients|mesh-ancestor
57032625|NCT05578404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57032626|NCT03521960|Buspirone|buspirone|mesh-list
57032627|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57032628|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57032629|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032630|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032631|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57032632|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57032633|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
57032634|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032635|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032636|NCT05479578|Dexamethasone|dexamethasone|mesh-list
57032637|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
57032638|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
57032639|NCT05479578|Ichthammol|ichthammol|mesh-list
57032640|NCT05479578|BB 1101|bb 1101|mesh-list
57032641|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57032642|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
57032643|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032644|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57032645|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57032646|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
57032647|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032648|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032649|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57032650|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57032651|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
57032652|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
57032653|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032654|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032655|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
57032656|NCT05479578|Hormones|hormones|mesh-ancestor
57032657|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032658|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57032659|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
57032660|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032661|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
57032662|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
57032663|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032664|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
57032665|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
57032666|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57032667|NCT05363462|Vancomycin|vancomycin|mesh-list
57032668|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032669|NCT03915964|Adalimumab|adalimumab|mesh-list
57032670|NCT03915964|Etanercept|etanercept|mesh-list
57032671|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
57032672|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57032673|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57032674|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57032675|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57032676|NCT03915964|Analgesics|analgesics|mesh-ancestor
57032677|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
57032678|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032679|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032680|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032681|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57032682|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
57032683|NCT04853628|Ethanol|ethanol|mesh-list
57032684|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57032685|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032686|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032687|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032688|NCT03521726|Amoxicillin|amoxicillin|mesh-list
57032689|NCT03521726|Rabeprazole|rabeprazole|mesh-list
57032690|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57032691|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032692|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57032693|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032694|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57032695|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032696|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714685|NCT00718406|Metoprolol|metoprolol|mesh-list
57032697|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
57032698|NCT03546426|Interleukin-2|interleukin-2|mesh-list
57032699|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57032700|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032701|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57032702|NCT03546426|Analgesics|analgesics|mesh-ancestor
57032703|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
57032704|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032705|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032706|NCT02897349|Linagliptin|linagliptin|mesh-list
57032707|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57032708|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032709|NCT02897349|Incretins|incretins|mesh-ancestor
57032710|NCT02897349|Hormones|hormones|mesh-ancestor
57032711|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032712|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57032713|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
57032714|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032715|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032716|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
57032717|NCT04767984|Atorvastatin|atorvastatin|mesh-list
57032718|NCT04767984|Calcium|calcium|mesh-list
57032719|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57032720|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032721|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57032722|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57032723|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57032724|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
57032725|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032726|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57032727|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57032728|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032729|NCT03134378|Amoxicillin|amoxicillin|mesh-list
57032730|NCT03134378|Clarithromycin|clarithromycin|mesh-list
57032731|NCT03134378|Rabeprazole|rabeprazole|mesh-list
57032732|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57032733|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032734|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57032735|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032736|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032737|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57032738|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57032739|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57032740|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032741|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57032742|NCT05434104|Metronidazole|metronidazole|mesh-list
57032743|NCT05434104|Fluconazole|fluconazole|mesh-list
57032744|NCT05434104|Lactoferrin|lactoferrin|mesh-list
57032745|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032746|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57032747|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57032748|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57032749|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
57032750|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57032751|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57032752|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032753|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032754|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57032755|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
57032756|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032757|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032758|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57032759|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57032760|NCT00488072|Mirtazapine|mirtazapine|mesh-list
57032761|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
57032762|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57032763|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57032764|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
57032765|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
57032766|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032767|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032768|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032769|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57032770|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57032771|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032772|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57032773|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57032774|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57032775|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
57032776|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57032777|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57032778|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
57032779|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57032780|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
57032781|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57032782|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032783|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
57032784|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032785|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57032786|NCT03523832|Celecoxib|celecoxib|mesh-list
57032787|NCT03523832|Pregabalin|pregabalin|mesh-list
57032788|NCT03523832|Analgesics|analgesics|mesh-ancestor
57032789|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
57032790|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032791|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032792|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
57032793|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57032794|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57032795|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032796|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57032797|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57032798|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57032799|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032800|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57032801|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57032802|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57032803|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57032804|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57032805|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57032806|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57032807|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032808|NCT05577624|Rifampin|rifampin|mesh-list
57032809|NCT05577624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57032810|NCT05577624|Antitubercular Agents|antitubercular agents|mesh-ancestor
57032811|NCT05577624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57032812|NCT05577624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032813|NCT05577624|Leprostatic Agents|leprostatic agents|mesh-ancestor
57032814|NCT05577624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57032815|NCT05577624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032816|NCT05577624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032817|NCT05577624|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57032818|NCT05577624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57032819|NCT05577624|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57032820|NCT05577624|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57032821|NCT05577624|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57032822|NCT05577624|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57032823|NCT03294694|Fulvestrant|fulvestrant|mesh-list
57032824|NCT03294694|Spartalizumab|spartalizumab|mesh-list
57032825|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57032826|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032827|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57032828|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57032829|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
57032830|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032831|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032832|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57032833|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032834|NCT03523754|Isosorbide|isosorbide|mesh-list
57032835|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57032836|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57032837|NCT03523754|Misoprostol|misoprostol|mesh-list
57032838|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57032839|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
57032840|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57032841|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714837|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
57032842|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57032843|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57032845|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57032846|NCT03523754|Diuretics|diuretics|mesh-ancestor
57032847|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
57032848|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
57032849|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57032850|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032851|NCT04727034|Propofol|propofol|mesh-list
57032852|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57032853|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032854|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032855|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57032856|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
57032857|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
57032858|NCT03644511|Sorafenib|sorafenib|mesh-list
57032859|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032860|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57032861|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032862|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032863|NCT03290560|Kallikreins|kallikreins|mesh-list
57032864|NCT03290560|Coagulants|coagulants|mesh-ancestor
57032865|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
57032866|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
57032867|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57032868|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032869|NCT04723134|Leucovorin|leucovorin|mesh-list
57032870|NCT04723134|Folic Acid|folic acid|mesh-list
57032871|NCT04723134|Calcium|calcium|mesh-list
57032872|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
57032873|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57032874|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032875|NCT04723134|Antidotes|antidotes|mesh-ancestor
57032876|NCT04723134|Protective Agents|protective agents|mesh-ancestor
57032877|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
57032878|NCT04723134|Vitamins|vitamins|mesh-ancestor
57032879|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
57032880|NCT04723134|Hematinics|hematinics|mesh-ancestor
57032881|NCT01316419|Amlodipine|amlodipine|mesh-list
57032882|NCT01316419|Telmisartan|telmisartan|mesh-list
57032883|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57032884|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57032885|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57032886|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032887|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57032888|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032889|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
57032890|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57032891|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57032892|NCT03547362|Caseins|caseins|mesh-list
57032893|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
57032894|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
57032895|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032896|NCT04258150|Nivolumab|nivolumab|mesh-list
57032897|NCT04258150|Ipilimumab|ipilimumab|mesh-list
57032898|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57032899|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032900|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57032901|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032902|NCT02854696|Insulin|insulin|mesh-list
57032903|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57032904|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032905|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
57032906|NCT04664946|Protective Agents|protective agents|mesh-ancestor
57032907|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032908|NCT02289248|Ketamine|ketamine|mesh-list
57032909|NCT02289248|Analgesics|analgesics|mesh-ancestor
57032910|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
57032911|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032912|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032913|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57032914|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57032915|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
57032916|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
56714921|NCT05659290|Bevacizumab|bevacizumab|mesh-list
57032917|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57032918|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57032920|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032921|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032922|NCT02782468|Azacitidine|azacitidine|mesh-list
57032923|NCT02782468|Pevonedistat|pevonedistat|mesh-list
57032924|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57032925|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
57032926|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032927|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032928|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032929|NCT02253420|Itraconazole|itraconazole|mesh-list
57032930|NCT02253420|Rifampin|rifampin|mesh-list
57032931|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
57032932|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032933|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57032934|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57032935|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032936|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032937|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57032938|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
57032939|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032940|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032941|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57032942|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57032943|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
57032944|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57032945|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
57032946|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57032947|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57032948|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57032949|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57032950|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57032951|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57032952|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57032953|NCT02028364|Everolimus|everolimus|mesh-list
57032954|NCT02028364|Exemestane|exemestane|mesh-list
57032955|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57032956|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57032957|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
57032958|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032959|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57032960|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57032961|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032962|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032963|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57032964|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
57032965|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57032966|NCT02897115|Adalimumab|adalimumab|mesh-list
57032967|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57032968|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
57032969|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57032970|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57032971|NCT02897115|Analgesics|analgesics|mesh-ancestor
57032972|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
57032973|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57032974|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032975|NCT03806985|Psilocybin|psilocybin|mesh-list
57032976|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
57032977|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032978|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57032979|NCT02289482|Ritonavir|ritonavir|mesh-list
57032980|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
57032981|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57032982|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57032983|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
57032984|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57032985|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032986|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57032987|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57032988|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
57032989|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57032990|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57032991|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57032992|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
57032993|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
57032994|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57032995|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57032996|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
57032997|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57032998|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57032999|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57033000|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57033001|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57033002|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
57033003|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
57033005|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57033006|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
57033007|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033008|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033009|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57033010|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
57033011|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033012|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033013|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57033014|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57033015|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
57033016|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57033017|NCT02253966|Prednisolone|prednisolone|mesh-list
57033018|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
57033019|NCT02253966|Lidocaine|lidocaine|mesh-list
57033020|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57033021|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
57033022|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
57033023|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
57033024|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033025|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033026|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
57033027|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033028|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57033029|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57033030|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57033031|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57033032|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033033|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033034|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
57033035|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
57033036|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033037|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
57033038|NCT02253966|Hormones|hormones|mesh-ancestor
57033039|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033040|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57033041|NCT02253966|Protective Agents|protective agents|mesh-ancestor
57033042|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57033043|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033044|NCT01673620|Loratadine|loratadine|mesh-list
57033045|NCT01673620|Montelukast|montelukast|mesh-list
57033046|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57033047|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
57033048|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57033049|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
57033050|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033051|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033052|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57033053|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57033054|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033055|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
57033056|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
57033057|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57033058|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57033059|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57033060|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
56715054|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
57033061|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
57033062|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033063|NCT04671355|Fluticasone|fluticasone|mesh-list
57033064|NCT04671355|Xhance|xhance|mesh-list
57033065|NCT04671355|Beclomethasone|beclomethasone|mesh-list
57033066|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
57033067|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
57033068|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033069|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57033070|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
57033071|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033072|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033073|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57033074|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
57033075|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
57033076|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57033077|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57033078|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57033079|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57033080|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
57033081|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033082|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033083|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57033084|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57033085|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57033086|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
57033087|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
57033088|NCT04671355|Hormones|hormones|mesh-ancestor
57033089|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033090|NCT03773107|Dexamethasone|dexamethasone|mesh-list
57033091|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033092|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
57033093|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
57033094|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033095|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033096|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033097|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
57033098|NCT03773107|Hormones|hormones|mesh-ancestor
57033099|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033100|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57033101|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033102|NCT03521492|Vitamin D|vitamin d|mesh-list
57033103|NCT03521492|Calcium|calcium|mesh-list
57033104|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
57033105|NCT03521492|Hormones|hormones|mesh-list
57033106|NCT03521492|Vitamins|vitamins|mesh-ancestor
57033107|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
57033108|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033109|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57033110|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57033111|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033112|NCT03521414|Sevoflurane|sevoflurane|mesh-list
57033113|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57033114|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57033115|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
57033116|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
57033117|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033118|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033119|NCT00432094|Paclitaxel|paclitaxel|mesh-list
57033120|NCT00432094|Etoposide|etoposide|mesh-list
57033121|NCT00432094|Carboplatin|carboplatin|mesh-list
57033122|NCT00432094|Ifosfamide|ifosfamide|mesh-list
57033123|NCT00432094|Thiotepa|thiotepa|mesh-list
57033124|NCT00432094|Mesna|mesna|mesh-list
57033125|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57033126|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033127|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
57033128|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
57033129|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
57033130|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033131|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57033132|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57033133|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033134|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
57033135|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033136|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57033137|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
57033139|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57033140|NCT00432094|Protective Agents|protective agents|mesh-ancestor
57033141|NCT05575518|Rifamycins|rifamycins|mesh-list
57033142|NCT05575518|Fluoroquinolones|fluoroquinolones|mesh-list
57033143|NCT05575518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57033144|NCT05575518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033145|NCT05575518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57033146|NCT05575518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033147|NCT05575518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033148|NCT04562779|Naltrexone|naltrexone|mesh-list
57033149|NCT04562779|Ketamine|ketamine|mesh-list
57033150|NCT04562779|Analgesics|analgesics|mesh-ancestor
57033151|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
57033152|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033153|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033154|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57033155|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57033156|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
57033157|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
57033158|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033159|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57033160|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57033161|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033162|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033163|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57033164|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57033165|NCT03751761|Paclitaxel|paclitaxel|mesh-list
57033166|NCT03751761|Durvalumab|durvalumab|mesh-list
57033167|NCT03751761|Tremelimumab|tremelimumab|mesh-list
57033168|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57033169|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033170|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
57033171|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
57033172|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
57033173|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033174|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57033175|NCT03644823|Atezolizumab|atezolizumab|mesh-list
57033176|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033177|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
57033178|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57033179|NCT00072358|Irinotecan|irinotecan|mesh-list
57033180|NCT00072358|Temozolomide|temozolomide|mesh-list
57033181|NCT00072358|Molgramostim|molgramostim|mesh-list
57033182|NCT00072358|Isotretinoin|isotretinoin|mesh-list
57033183|NCT00072358|Antibodies|antibodies|mesh-list
57033184|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
57033185|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57033186|NCT00072358|Sargramostim|sargramostim|mesh-list
57033187|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
57033188|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
57033189|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033190|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033191|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57033192|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57033193|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033194|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033195|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57033196|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
57033197|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
57033198|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57033199|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033200|NCT03104998|Ubiquinone|ubiquinone|mesh-list
57033201|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
57033202|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
57033203|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033204|NCT03104998|Vitamins|vitamins|mesh-ancestor
57033205|NCT03990766|Theophylline|theophylline|mesh-list
57033206|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57033207|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
57033208|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033209|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033210|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57033211|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
57033212|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57033213|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715207|NCT00724178|Antacids|antacids|mesh-ancestor
57033214|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033215|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
57033216|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57033217|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57033218|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
57033219|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033220|NCT02294162|Ketamine|ketamine|mesh-list
57033221|NCT02294162|Analgesics|analgesics|mesh-ancestor
57033222|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
57033223|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033224|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033225|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57033226|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57033227|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
57033228|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
57033229|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033230|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57033231|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57033232|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033233|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033234|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
57033235|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57033236|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57033237|NCT05176158|Analgesics|analgesics|mesh-ancestor
57033238|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
57033239|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033240|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033241|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033242|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033243|NCT02294240|Folic Acid|folic acid|mesh-list
57033244|NCT02294240|Hematinics|hematinics|mesh-ancestor
57033245|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
57033246|NCT02294240|Vitamins|vitamins|mesh-ancestor
57033247|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
57033248|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033249|NCT04305691|Ixazomib|ixazomib|mesh-list
57033250|NCT04305691|Glycine|glycine|mesh-list
57033251|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033252|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033253|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
57033254|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033255|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
57033256|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033257|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033258|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
57033259|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57033260|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57033261|NCT04481724|Analgesics|analgesics|mesh-ancestor
57033262|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
57033263|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033264|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033265|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033266|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033267|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57033268|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
57033269|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033270|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57033271|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
57033272|NCT02298218|Meloxicam|meloxicam|mesh-list
57033273|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57033274|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57033275|NCT02298218|Analgesics|analgesics|mesh-ancestor
57033276|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
57033277|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033278|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033279|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033280|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033281|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57033282|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57033283|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033284|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033285|NCT03547830|Plerixafor|plerixafor|mesh-list
57033286|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57033287|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57033288|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
57033289|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033290|NCT04390945|Capecitabine|capecitabine|mesh-list
57033291|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57033292|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
57033293|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033294|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033295|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
57033296|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57033297|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033298|NCT02291666|Tolbutamide|tolbutamide|mesh-list
57033299|NCT02291666|Midazolam|midazolam|mesh-list
57033300|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
57033301|NCT02291666|Caffeine|caffeine|mesh-list
57033302|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
57033303|NCT02291666|Bupropion|bupropion|mesh-list
57033304|NCT02291666|Omeprazole|omeprazole|mesh-list
57033305|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57033306|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57033307|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033308|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033309|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57033310|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57033311|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57033312|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57033313|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
57033314|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
57033315|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
57033316|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
57033317|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033318|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033319|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57033320|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57033321|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033322|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57033323|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57033324|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
57033325|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57033326|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033327|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57033328|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57033329|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
57033330|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57033331|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57033332|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57033333|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
57033334|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57033335|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57033336|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
57033337|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
57033338|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57033339|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57033340|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57033341|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57033342|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57033343|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033344|NCT03102658|Micafungin|micafungin|mesh-list
57033345|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
56897194|NCT02526615|Metformin|metformin|mesh-list
57033346|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033347|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
57033348|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57033349|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033350|NCT03624985|Lidocaine|lidocaine|mesh-list
57033351|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
57033352|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
57033353|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033354|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033355|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
57033356|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033357|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57033358|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57033359|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57033360|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57033361|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033362|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
56715368|NCT04019106|Budesonide|budesonide|mesh-list
57033363|NCT03521024|Ether|ether|mesh-list
57033364|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
57033365|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57033366|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033367|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033368|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
57033369|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57033370|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033371|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033372|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57033373|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
57033374|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
57033375|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
57033376|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57033377|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033378|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
57033379|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
57033380|NCT02294552|Busulfan|busulfan|mesh-list
57033381|NCT02294552|Fludarabine|fludarabine|mesh-list
57033382|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
57033383|NCT02294552|Tacrolimus|tacrolimus|mesh-list
57033384|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57033385|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
57033386|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033387|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033388|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57033389|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
57033390|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033391|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033392|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57033393|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57033394|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
57033395|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57033396|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033397|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57033398|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57033399|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
57033400|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57033401|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033402|NCT05574036|Vitamin E|vitamin e|mesh-list
57033403|NCT05574036|Febuxostat|febuxostat|mesh-list
57033404|NCT05574036|Vitamins|vitamins|mesh-ancestor
57033405|NCT05574036|Micronutrients|micronutrients|mesh-ancestor
57033406|NCT05574036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033407|NCT05574036|Antioxidants|antioxidants|mesh-ancestor
57033408|NCT05574036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033409|NCT05574036|Protective Agents|protective agents|mesh-ancestor
57033410|NCT05574036|Gout Suppressants|gout suppressants|mesh-ancestor
57033411|NCT05574036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033412|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
57033413|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57033414|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033415|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57033416|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
57033417|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57033418|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033419|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033420|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033421|NCT03869944|Lamivudine|lamivudine|mesh-list
57033422|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57033423|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57033424|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033425|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033426|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
57033427|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033428|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57033429|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57033430|NCT03864094|Phenylephrine|phenylephrine|mesh-list
57033431|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
57033432|NCT03864094|Norepinephrine|norepinephrine|mesh-list
57033433|NCT03864094|Ephedrine|ephedrine|mesh-list
57033434|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
57033435|NCT03864094|Remifentanil|remifentanil|mesh-list
57033436|NCT03864094|Propofol|propofol|mesh-list
57033437|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57033438|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033439|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033440|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57033441|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
57033443|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57033444|NCT03864094|Narcotics|narcotics|mesh-ancestor
57033445|NCT03864094|Analgesics|analgesics|mesh-ancestor
57033446|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
57033447|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033448|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57033449|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
57033450|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
57033451|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
57033452|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57033453|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
57033454|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
57033455|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57033456|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57033457|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57033458|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
57033459|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033460|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033461|NCT03864094|Protective Agents|protective agents|mesh-ancestor
57033462|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57033463|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57033464|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57033465|NCT05573802|Dexamethasone|dexamethasone|mesh-list
57033466|NCT05573802|Lenalidomide|lenalidomide|mesh-list
57033467|NCT05573802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033468|NCT05573802|Antiemetics|antiemetics|mesh-ancestor
57033469|NCT05573802|Autonomic Agents|autonomic agents|mesh-ancestor
57033470|NCT05573802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033471|NCT05573802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033472|NCT05573802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033473|NCT05573802|Glucocorticoids|glucocorticoids|mesh-ancestor
57033474|NCT05573802|Hormones|hormones|mesh-ancestor
57033475|NCT05573802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033476|NCT05573802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57033477|NCT05573802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033478|NCT05573802|Immunologic Factors|immunologic factors|mesh-ancestor
57033479|NCT05573802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57033480|NCT05573802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57033481|NCT05573802|Growth Substances|growth substances|mesh-ancestor
57033482|NCT05573802|Growth Inhibitors|growth inhibitors|mesh-ancestor
57033483|NCT04435522|Maraviroc|maraviroc|mesh-list
57033484|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57033485|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57033486|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033487|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57033488|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56611019|NCT02582476|Bumetanide|bumetanide|mesh-list
57033489|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
57033490|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033491|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57033492|NCT03575325|Cytarabine|cytarabine|mesh-list
57033493|NCT03575325|Daunorubicin|daunorubicin|mesh-list
57033494|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57033495|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
57033496|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033497|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033498|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
57033499|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033500|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57033501|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
57033502|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033503|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57033504|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57033505|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57033506|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033507|NCT03843970|Bupivacaine|bupivacaine|mesh-list
57033508|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
57033509|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57033510|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
57033511|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
57033512|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033513|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033514|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
57033515|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033516|NCT03043651|Treprostinil|treprostinil|mesh-list
57033518|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
57033519|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
57033520|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033521|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57033522|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57033523|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
57033524|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033525|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033526|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57033527|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57033528|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
57033529|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033530|NCT02298530|Caffeine|caffeine|mesh-list
57033531|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57033532|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033533|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57033534|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033535|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033536|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57033537|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57033538|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
57033539|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033540|NCT05051436|Tadalafil|tadalafil|mesh-list
57033541|NCT05051436|Mirabegron|mirabegron|mesh-list
57033542|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
57033543|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57033544|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57033545|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033546|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033547|NCT05051436|Urological Agents|urological agents|mesh-ancestor
57033548|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57033549|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57033550|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57033551|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
57033552|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033553|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033554|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
57033555|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
57033556|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
57033557|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033558|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57033559|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
57033560|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033561|NCT05567094|Dexamethasone|dexamethasone|mesh-list
57033562|NCT05567094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033563|NCT05567094|Antiemetics|antiemetics|mesh-ancestor
57033564|NCT05567094|Autonomic Agents|autonomic agents|mesh-ancestor
57033565|NCT05567094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033566|NCT05567094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033567|NCT05567094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033568|NCT05567094|Glucocorticoids|glucocorticoids|mesh-ancestor
57033569|NCT05567094|Hormones|hormones|mesh-ancestor
57033570|NCT05567094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033571|NCT05567094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57033572|NCT05567094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033573|NCT03514550|Propofol|propofol|mesh-list
57033574|NCT03514550|Sevoflurane|sevoflurane|mesh-list
57033575|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57033576|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033577|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033578|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57033579|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
57033580|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
57033581|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57033582|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57033583|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
57033584|NCT04173988|Fludarabine|fludarabine|mesh-list
57033585|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57033586|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
57033587|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033588|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033589|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57033590|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
57033591|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033592|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033593|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57033594|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
57033596|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57033597|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033598|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033599|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57033600|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
57033601|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
57033602|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57033603|NCT01344759|Analgesics|analgesics|mesh-ancestor
57033604|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
57033605|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033606|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57033607|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57033608|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57033609|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
57033610|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033611|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033612|NCT04299438|Propranolol|propranolol|mesh-list
57033613|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57033614|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57033615|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
57033616|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033617|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033618|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033619|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57033620|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57033621|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
57033622|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
57033623|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57033624|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57033625|NCT03517670|Milrinone|milrinone|mesh-list
57033626|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57033627|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57033628|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
57033629|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57033630|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57033631|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033632|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033633|NCT03517670|Protective Agents|protective agents|mesh-ancestor
57033634|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033635|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
57033636|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57033637|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033638|NCT00109668|Beclomethasone|beclomethasone|mesh-list
57033639|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033640|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
57033641|NCT00109668|Hormones|hormones|mesh-ancestor
57033642|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033643|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033644|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57033645|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
57033646|NCT03104140|Ketamine|ketamine|mesh-list
57033647|NCT03104140|Thiopental|thiopental|mesh-list
57033648|NCT03104140|Analgesics|analgesics|mesh-ancestor
57033649|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
57033650|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033651|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033652|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57033653|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57033654|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
57033655|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
57033656|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033657|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57033658|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57033659|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033660|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033661|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
57033662|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57033663|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
57033664|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
57033665|NCT03520478|Bicalutamide|bicalutamide|mesh-list
57033666|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
57033667|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
57033668|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033669|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033670|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033672|NCT05691517|Camptothecin|camptothecin|mesh-list
57033673|NCT05691517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57033674|NCT05691517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57033675|NCT05691517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033676|NCT05691517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033677|NCT05691517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033678|NCT05691517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57033679|NCT00102648|Temozolomide|temozolomide|mesh-list
57033680|NCT00102648|Lonafarnib|lonafarnib|mesh-list
57033681|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57033682|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
57033683|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033684|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033685|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033686|NCT03290287|Bromides|bromides|mesh-list
57033687|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
57033688|NCT02253888|Ritonavir|ritonavir|mesh-list
57033689|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57033690|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57033691|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
57033692|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033693|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033694|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57033695|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57033696|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
57033697|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033698|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57033699|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57033700|NCT05430802|Pemetrexed|pemetrexed|mesh-list
57033701|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033702|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033703|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033704|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57033705|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57033706|NCT05524038|Dexamethasone|dexamethasone|mesh-list
57033707|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
57033708|NCT05524038|Bupivacaine|bupivacaine|mesh-list
57033709|NCT05524038|BB 1101|bb 1101|mesh-list
57033710|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033711|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
57033712|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
57033713|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033714|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033715|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033716|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
57033717|NCT05524038|Hormones|hormones|mesh-ancestor
57033718|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033719|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57033720|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033721|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
57033722|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033723|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033724|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
57033725|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
57033726|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033727|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
57033728|NCT03240835|Docetaxel|docetaxel|mesh-list
57033729|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033730|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
57033731|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
57033732|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
57033733|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033734|NCT04044534|Insulin|insulin|mesh-list
57033735|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57033736|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033737|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
57033738|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57033739|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033741|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57033742|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
57033743|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033744|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033745|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033746|NCT02292290|Pioglitazone|pioglitazone|mesh-list
57033747|NCT02292290|Liraglutide|liraglutide|mesh-list
57033748|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57033749|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033750|NCT02292290|Incretins|incretins|mesh-ancestor
57033751|NCT02292290|Hormones|hormones|mesh-ancestor
57033752|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033753|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
57033754|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57033755|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033756|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033757|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57033758|NCT02299232|Analgesics|analgesics|mesh-ancestor
57033759|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
57033760|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033761|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57033762|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57033763|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57033764|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
57033765|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033766|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033767|NCT02963493|Dexamethasone|dexamethasone|mesh-list
57033768|NCT02963493|Melphalan|melphalan|mesh-list
57033769|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033770|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
57033771|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
57033772|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033773|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033774|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033775|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
57033776|NCT02963493|Hormones|hormones|mesh-ancestor
57033777|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033778|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57033779|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033780|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57033781|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
57033782|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033783|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57033784|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57033785|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
57033786|NCT02299310|Valsartan|valsartan|mesh-list
57033787|NCT02299310|Perindopril|perindopril|mesh-list
57033788|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57033789|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57033790|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57033791|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033792|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57033793|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
57033794|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033795|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57033796|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57033797|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033798|NCT03519776|Progesterone|progesterone|mesh-list
57033799|NCT03519776|Progestins|progestins|mesh-ancestor
57033800|NCT03519776|Hormones|hormones|mesh-ancestor
57033801|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033802|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033803|NCT03643497|Meropenem|meropenem|mesh-list
57033804|NCT03643497|Linezolid|linezolid|mesh-list
57033805|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
57033806|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57033807|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57033808|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033809|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033810|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
57033811|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57033812|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
56715824|NCT03479268|Pevonedistat|pevonedistat|mesh-list
57033813|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033814|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033815|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57033816|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
57033817|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57033818|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
57033819|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033820|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033821|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57033822|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
57033823|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
57033824|NCT02295566|Protective Agents|protective agents|mesh-ancestor
57033825|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57033826|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
57033827|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033828|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57033829|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033830|NCT03516656|Heparin|heparin|mesh-list
57033831|NCT03516656|Calcium heparin|calcium heparin|mesh-list
57033832|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
57033833|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57033834|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57033835|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033836|NCT03738397|Upadacitinib|upadacitinib|mesh-list
57033837|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57033838|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
57033839|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033840|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57033841|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57033842|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033843|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033844|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033845|NCT03519542|Sunitinib|sunitinib|mesh-list
57033846|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033847|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57033848|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57033849|NCT03519542|Growth Substances|growth substances|mesh-ancestor
57033850|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033851|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
57033852|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57033853|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033854|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033855|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57033856|NCT03516500|Hematinics|hematinics|mesh-ancestor
57033857|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
57033858|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57033859|NCT02293148|Glycine|glycine|mesh-list
57033860|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57033861|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033862|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57033863|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57033864|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033865|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033866|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033867|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57033868|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
57033869|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57033870|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033871|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57033872|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57033873|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57033874|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
57033875|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57033876|NCT03519386|Travoprost|travoprost|mesh-list
57033877|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57033878|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57033879|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57033880|NCT03519152|Diclofenac|diclofenac|mesh-list
57033881|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57033882|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57033883|NCT03519152|Analgesics|analgesics|mesh-ancestor
57033884|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
57033885|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033886|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033887|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57033888|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033889|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57033890|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033891|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033892|NCT02959983|Eluxadoline|eluxadoline|mesh-list
57033893|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033894|NCT03516188|Antacids|antacids|mesh-list
57033895|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033896|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033897|NCT03512990|Bupivacaine|bupivacaine|mesh-list
57033898|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
57033899|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
57033900|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57033901|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033902|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
57033903|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57033904|NCT03512834|Paclitaxel|paclitaxel|mesh-list
57033905|NCT03512834|Avelumab|avelumab|mesh-list
57033906|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57033907|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033908|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
57033909|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
57033910|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
57033911|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033912|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57033913|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
57033914|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57033915|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57033916|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
57033917|NCT03640221|Diuretics|diuretics|mesh-ancestor
57033918|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
57033919|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033920|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57033921|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57033922|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033923|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57033924|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57033925|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57033926|NCT03518528|Estradiol|estradiol|mesh-list
57033927|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57033928|NCT03518528|Estrogens|estrogens|mesh-ancestor
57033929|NCT03518528|Hormones|hormones|mesh-ancestor
56897213|NCT03872661|Bevacizumab|bevacizumab|mesh-list
57033930|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57033931|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033932|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57033933|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
57033934|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57033935|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57033936|NCT03515798|Paclitaxel|paclitaxel|mesh-list
57033937|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57033938|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
57033939|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
57033940|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57033941|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033942|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
57033943|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
57033944|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
57033945|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033946|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57033947|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
57033948|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033949|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57033950|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57033951|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
57033952|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57033953|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57033954|NCT03041701|Dasatinib|dasatinib|mesh-list
57033955|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033956|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033957|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57033958|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57033959|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57033960|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
57033961|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57033962|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57033963|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57033964|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
57033965|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57033966|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033967|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57033968|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57033969|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57033970|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57033971|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033972|NCT02956629|Ribavirin|ribavirin|mesh-list
57033973|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
57033974|NCT02956629|Ruzasvir|ruzasvir|mesh-list
57033975|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
57033976|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57033977|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
57033978|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57033979|NCT02297204|Aflibercept|aflibercept|mesh-list
57033980|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57033981|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57033982|NCT02297204|Growth Substances|growth substances|mesh-ancestor
57033983|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033984|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
57033985|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033986|NCT02294006|Metformin|metformin|mesh-list
57033987|NCT02294006|Everolimus|everolimus|mesh-list
57033988|NCT02294006|Octreotide|octreotide|mesh-list
57033989|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57033990|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033991|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57033992|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57033993|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
57033994|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57033995|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57033996|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57033997|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57033998|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57033999|NCT02294084|Incretins|incretins|mesh-ancestor
57034000|NCT02294084|Hormones|hormones|mesh-ancestor
56897216|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034001|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57034002|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57034003|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
57034004|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034005|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034006|NCT01597258|Crizotinib|crizotinib|mesh-list
57034007|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034008|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57034009|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034010|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034011|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
57034012|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57034013|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
57034014|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034015|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
57034016|NCT02958267|Protective Agents|protective agents|mesh-ancestor
57034017|NCT02302430|Oxytocin|oxytocin|mesh-list
57034018|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
57034019|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57034020|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034021|NCT02300948|Folic Acid|folic acid|mesh-list
57034022|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
57034023|NCT02300948|Hematinics|hematinics|mesh-ancestor
57034024|NCT02300948|Vitamins|vitamins|mesh-ancestor
57034025|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
57034026|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034027|NCT02302508|Clopidogrel|clopidogrel|mesh-list
57034028|NCT02302508|Ticagrelor|ticagrelor|mesh-list
57034029|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57034030|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57034031|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57034032|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57034033|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57034034|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
57034035|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034036|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034037|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034039|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
57034040|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034041|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
57034042|NCT02301026|Hematinics|hematinics|mesh-ancestor
57034043|NCT01952574|Erenumab|erenumab|mesh-list
57034044|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57034045|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57034046|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034047|NCT01952574|Analgesics|analgesics|mesh-ancestor
57034048|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
57034049|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034050|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034051|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
57034052|NCT02302586|Morphine|morphine|mesh-list
57034053|NCT02302586|Bupivacaine|bupivacaine|mesh-list
57034054|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
57034055|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
57034056|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57034057|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034058|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
57034059|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034060|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57034061|NCT02302586|Narcotics|narcotics|mesh-ancestor
57034062|NCT02302586|Analgesics|analgesics|mesh-ancestor
57034063|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
57034064|NCT04484272|Narcotics|narcotics|mesh-ancestor
57034065|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57034066|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034067|NCT04484272|Analgesics|analgesics|mesh-ancestor
57034068|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
57034069|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034070|NCT01551472|Vitamin E|vitamin e|mesh-list
57034071|NCT01551472|Vitamins|vitamins|mesh-ancestor
57034072|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
57034073|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034074|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
57034075|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034076|NCT01551472|Protective Agents|protective agents|mesh-ancestor
57034077|NCT02254044|Maytansine|maytansine|mesh-list
57034078|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
57034079|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57034080|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034081|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
57034082|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
57034083|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
57034084|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034085|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034086|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
57034087|NCT02959437|Azacitidine|azacitidine|mesh-list
57034088|NCT02959437|INCB057643|incb057643|mesh-list
57034089|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034090|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034091|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57034092|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
57034093|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034094|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034095|NCT02297906|Ketorolac|ketorolac|mesh-list
57034096|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57034097|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57034098|NCT02297906|Analgesics|analgesics|mesh-ancestor
57034099|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
57034100|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034101|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034102|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57034103|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57034104|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57034105|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034106|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034107|NCT03511820|Amphotericin B|amphotericin b|mesh-list
57034108|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
57034109|NCT03511820|Amebicides|amebicides|mesh-ancestor
57034110|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57034111|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57034112|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034113|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57034115|NCT02957331|Propranolol|propranolol|mesh-list
57034116|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57034117|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57034118|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
57034119|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034120|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034121|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034122|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57034123|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57034124|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
57034125|NCT02298062|Infliximab|infliximab|mesh-list
57034126|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
57034127|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57034128|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57034129|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
57034130|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
57034131|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034132|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57034133|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034134|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034135|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
57034136|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57034137|NCT03748966|Calcitriol|calcitriol|mesh-list
57034138|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
57034139|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57034140|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034141|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57034142|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57034143|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034144|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57034145|NCT03748966|Vitamins|vitamins|mesh-ancestor
57034146|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
57034147|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57034148|NCT05015608|Carboplatin|carboplatin|mesh-list
57034149|NCT05015608|Pemetrexed|pemetrexed|mesh-list
57034150|NCT05015608|Osimertinib|osimertinib|mesh-list
57034151|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034152|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034153|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034154|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57034155|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57034156|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57034157|NCT03510416|Apatinib|apatinib|mesh-list
57034158|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034159|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57034160|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034161|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034162|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
57034163|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57034164|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034165|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
57034166|NCT02646124|Naproxen|naproxen|mesh-list
57034167|NCT02646124|Diazepam|diazepam|mesh-list
57034168|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57034169|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57034170|NCT02646124|Analgesics|analgesics|mesh-ancestor
57034171|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
57034172|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034173|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034174|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57034175|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57034176|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
57034177|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57034178|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034179|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034180|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57034181|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
57034182|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
57034183|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
57034184|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57034185|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57034186|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56716188|NCT00725946|Iodine|iodine|mesh-list
57034187|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57034188|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57034189|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57034190|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57034191|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57034192|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57034193|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
57034194|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
57034195|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
57034196|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
57034197|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034198|NCT02306564|Cabergoline|cabergoline|mesh-list
57034199|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57034200|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57034201|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
57034202|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
57034203|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034204|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034205|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034206|NCT02301494|Fluocinonide|fluocinonide|mesh-list
57034208|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57034209|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
57034210|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034211|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034212|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
57034213|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57034214|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
57034215|NCT02301494|Hormones|hormones|mesh-ancestor
57034216|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57034217|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57034218|NCT03101800|Azathioprine|azathioprine|mesh-list
57034219|NCT03101800|Allopurinol|allopurinol|mesh-list
57034220|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
57034221|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034222|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034223|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
57034224|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57034225|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57034226|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
57034227|NCT03101800|Protective Agents|protective agents|mesh-ancestor
57034228|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034229|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57034230|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034231|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57034232|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
57034233|NCT03507842|Cytarabine|cytarabine|mesh-list
57034234|NCT03507842|Daunorubicin|daunorubicin|mesh-list
57034235|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57034236|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
57034237|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034238|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034239|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
57034240|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034241|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57034242|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
57034243|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034244|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57034245|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57034246|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57034247|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034248|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
57034249|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
57034250|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57034251|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
57034252|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034253|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57034254|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57034255|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
57034256|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034257|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034258|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57034259|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034260|NCT03656926|Cyclosporine|cyclosporine|mesh-list
57034261|NCT03656926|Cyclosporins|cyclosporins|mesh-list
57034262|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716264|NCT02569814|Amlodipine|amlodipine|mesh-list
57034263|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034264|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57034265|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
57034266|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034267|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
57034268|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034269|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
57034270|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57034271|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57034272|NCT02301650|Tenofovir|tenofovir|mesh-list
57034273|NCT02301650|Lamivudine|lamivudine|mesh-list
57034274|NCT02301650|Telbivudine|telbivudine|mesh-list
57034275|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
57034276|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034277|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57034278|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57034279|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034280|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034281|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57034282|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57034283|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
57034284|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
57034285|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57034286|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57034287|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034288|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034289|NCT03510338|Urological Agents|urological agents|mesh-ancestor
57034290|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
57034291|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57034292|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57034293|NCT05150704|Prednisolone|prednisolone|mesh-list
57034294|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
57034295|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57034296|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
57034297|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57034298|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
57034299|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
57034300|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034301|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034302|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57034303|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
57034304|NCT05150704|Hormones|hormones|mesh-ancestor
57034305|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57034306|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57034307|NCT05150704|Protective Agents|protective agents|mesh-ancestor
57034308|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57034309|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034310|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
57034311|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034312|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034313|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57034314|NCT02301806|Glimepiride|glimepiride|mesh-list
57034315|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57034316|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034317|NCT02301806|Incretins|incretins|mesh-ancestor
57034318|NCT02301806|Hormones|hormones|mesh-ancestor
57034319|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57034320|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57034321|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
57034322|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034323|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034324|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57034325|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57034326|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
57034327|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
57034328|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57034329|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034330|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
57034331|NCT02301962|Panitumumab|panitumumab|mesh-list
57034332|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034333|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034334|NCT02639650|Dactinomycin|dactinomycin|mesh-list
57034335|NCT02639650|Paclitaxel|paclitaxel|mesh-list
57034336|NCT02639650|Etoposide|etoposide|mesh-list
57034337|NCT02639650|Vincristine|vincristine|mesh-list
57034338|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
57034339|NCT02639650|Carboplatin|carboplatin|mesh-list
57034340|NCT02639650|Methotrexate|methotrexate|mesh-list
57034341|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57034342|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034343|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
57034344|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
57034345|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
57034346|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034347|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57034348|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
57034349|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034350|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57034351|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57034352|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
57034353|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57034354|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57034355|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
57034356|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57034357|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57034358|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
57034359|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
57034360|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034361|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57034362|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57034363|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57034364|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57034365|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57034366|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034367|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57034368|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57034369|NCT02303444|Sorafenib|sorafenib|mesh-list
57034370|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034371|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57034372|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034373|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034374|NCT03581734|Vaccines|vaccines|mesh-list
57034375|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
57034376|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034377|NCT02306798|Mesalamine|mesalamine|mesh-list
57034378|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57034379|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57034380|NCT02306798|Analgesics|analgesics|mesh-ancestor
57034381|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
57034382|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034383|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034384|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57034385|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57034386|NCT02306954|Aldesleukin|aldesleukin|mesh-list
57034387|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034388|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57034389|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57034390|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
57034391|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034392|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
57034393|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
57034394|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034395|NCT03509714|Protective Agents|protective agents|mesh-ancestor
57034396|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034397|NCT03509714|Vitamins|vitamins|mesh-ancestor
57034398|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
57034399|NCT02302274|Flecainide|flecainide|mesh-list
57034400|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57034401|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57034402|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57034403|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57034404|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034405|NCT02303600|Montelukast|montelukast|mesh-list
57034406|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57034407|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
57034408|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57034409|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
57034410|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57034411|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034412|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57034413|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57034414|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034415|NCT04463342|Methamphetamine|methamphetamine|mesh-list
57034416|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57034417|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034418|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
57034419|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
57034420|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034421|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
57034422|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034423|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034424|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
57034425|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57034426|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57034427|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57034428|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57034429|NCT02303912|Carboplatin|carboplatin|mesh-list
57034430|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034431|NCT01597492|Belimumab|belimumab|mesh-list
57034432|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57034433|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
57034434|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034435|NCT04569994|Insulin|insulin|mesh-list
57034436|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57034437|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034438|NCT00109590|Ritonavir|ritonavir|mesh-list
57034439|NCT00109590|Lopinavir|lopinavir|mesh-list
57034440|NCT00109590|Zidovudine|zidovudine|mesh-list
57034441|NCT00109590|Nevirapine|nevirapine|mesh-list
57034442|NCT00109590|Didanosine|didanosine|mesh-list
57034443|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57034444|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57034445|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
57034446|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034447|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034448|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57034449|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57034450|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
57034451|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034452|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57034453|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57034454|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
57034455|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57034456|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57034457|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57034458|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57034459|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
57034460|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57034461|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57034462|NCT05243446|Losartan|losartan|mesh-list
57034463|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57034464|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57034465|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57034466|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57034467|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034468|NCT05213650|Methamphetamine|methamphetamine|mesh-list
57034469|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57034470|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034471|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
57034472|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
57034473|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034474|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
57034475|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034476|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034477|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
57034478|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57034479|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57034480|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57034481|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57034482|NCT02143362|Remifentanil|remifentanil|mesh-list
57034483|NCT02143362|Anesthetics|anesthetics|mesh-list
57034484|NCT02143362|Propofol|propofol|mesh-list
57034485|NCT02143362|Cisatracurium|cisatracurium|mesh-list
57034486|NCT02143362|Atracurium|atracurium|mesh-list
56716488|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034487|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57034488|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034489|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57034490|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57034491|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
57034492|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57034494|NCT02143362|Analgesics|analgesics|mesh-ancestor
57034495|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
57034496|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034497|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57034498|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57034499|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57034500|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57034501|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57034502|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
57034503|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034504|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034505|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
57034506|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57034507|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034508|NCT02143440|Insulin|insulin|mesh-list
57034509|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57034510|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034511|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
57034512|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
57034513|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57034514|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
57034515|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034516|NCT02143518|Antacids|antacids|mesh-ancestor
57034517|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034518|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57034519|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57034520|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
57034521|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034522|NCT03506828|Phenol|phenol|mesh-list
57034523|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57034524|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034525|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
57034526|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57034527|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57034528|NCT00054964|Albuterol|albuterol|mesh-list
57034529|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57034530|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
57034531|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034532|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034533|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57034534|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
57034535|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
57034536|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57034537|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57034538|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57034539|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57034540|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
57034541|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034542|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034543|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
57034544|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57034545|NCT02781558|Velpatasvir|velpatasvir|mesh-list
57034546|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
57034547|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034548|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
57034549|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57034550|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034551|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034552|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57034553|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57034554|NCT05073640|Protective Agents|protective agents|mesh-ancestor
57034555|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034556|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
57034557|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57034558|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
57034559|NCT05073094|Esmolol|esmolol|mesh-list
57034560|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57034561|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57034562|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57034563|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
57034564|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034565|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034566|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034567|NCT03509246|Doxorubicin|doxorubicin|mesh-list
57034568|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57034569|NCT03509246|Bortezomib|bortezomib|mesh-list
57034570|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57034571|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034572|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57034573|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57034574|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034575|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034576|NCT03509168|Misoprostol|misoprostol|mesh-list
57034577|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57034578|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
57034579|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57034580|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034581|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57034582|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57034583|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
57034584|NCT05072938|Nizatidine|nizatidine|mesh-list
57034585|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57034586|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57034587|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57034588|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
57034589|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
57034590|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034591|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034592|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034593|NCT03041311|Carboplatin|carboplatin|mesh-list
57034594|NCT03041311|Etoposide|etoposide|mesh-list
57034595|NCT03041311|Atezolizumab|atezolizumab|mesh-list
57034596|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034597|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57034598|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57034599|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57034600|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034601|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034602|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
57034603|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57034604|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57034605|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034606|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
57034607|NCT05072860|Coagulants|coagulants|mesh-ancestor
57034608|NCT02311946|Palbociclib|palbociclib|mesh-list
57034609|NCT02311946|Rabeprazole|rabeprazole|mesh-list
57034610|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57034611|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034612|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57034613|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034614|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034615|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57034616|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57034617|NCT04302766|Remdesivir|remdesivir|mesh-list
57034618|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
57034619|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034620|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
57034621|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034622|NCT02312102|Lenalidomide|lenalidomide|mesh-list
57034623|NCT02312102|Bortezomib|bortezomib|mesh-list
57034624|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
57034625|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034626|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57034627|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57034628|NCT02312102|Growth Substances|growth substances|mesh-ancestor
57034629|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
57034630|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034631|NCT05408221|Lenvatinib|lenvatinib|mesh-list
57034632|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034633|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57034634|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034635|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034636|NCT02307968|Insulin|insulin|mesh-list
57034637|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57034638|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034640|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57034641|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57034642|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034643|NCT03504566|Empagliflozin|empagliflozin|mesh-list
57034644|NCT03504566|Linagliptin|linagliptin|mesh-list
57034645|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
57034646|NCT03504566|Telmisartan|telmisartan|mesh-list
57034647|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57034648|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034649|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57034650|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034651|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57034652|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57034653|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57034654|NCT03504566|Incretins|incretins|mesh-ancestor
57034655|NCT03504566|Hormones|hormones|mesh-ancestor
57034656|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57034657|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57034658|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
57034659|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034660|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
57034661|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57034662|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
57034663|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57034664|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57034665|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57034666|NCT05070520|Lumefantrine|lumefantrine|mesh-list
57034667|NCT05070520|Artemether|artemether|mesh-list
57034668|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57034669|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
57034670|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57034671|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57034672|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034673|NCT05070598|Paclitaxel|paclitaxel|mesh-list
57034674|NCT05070598|Tegafur|tegafur|mesh-list
57034675|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57034676|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034677|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
57034678|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
57034679|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
57034680|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034681|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57034682|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
57034683|NCT03884452|Atorvastatin|atorvastatin|mesh-list
57034684|NCT03884452|Simvastatin|simvastatin|mesh-list
57034685|NCT03884452|Ezetimibe|ezetimibe|mesh-list
57034686|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57034687|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57034688|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
57034689|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034690|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57034691|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57034692|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034693|NCT03882892|Ezetimibe|ezetimibe|mesh-list
57034694|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57034695|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57034696|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
57034697|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034698|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57034699|NCT02305160|Poractant alfa|poractant alfa|mesh-list
57034700|NCT02305160|Beractant|beractant|mesh-list
57034701|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
57034702|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
57034703|NCT02305394|Ketamine|ketamine|mesh-list
57034704|NCT02305394|Propofol|propofol|mesh-list
57034705|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57034706|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57034707|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034708|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57034709|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
57034710|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
57034711|NCT02305394|Analgesics|analgesics|mesh-ancestor
57034712|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
57034713|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034714|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57034715|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57034716|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57034717|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034718|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034719|NCT05068960|Bupivacaine|bupivacaine|mesh-list
57034720|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
57034721|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
57034722|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57034723|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034724|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
57034725|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034726|NCT03569293|Upadacitinib|upadacitinib|mesh-list
57034727|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57034728|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57034729|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034730|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034731|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57034732|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
57034733|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57034734|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
57034735|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034736|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034737|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57034738|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
57034739|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57034740|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
57034741|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034742|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034743|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57034744|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
57034745|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
57034746|NCT02305550|Protective Agents|protective agents|mesh-ancestor
57034747|NCT01369212|Tenofovir|tenofovir|mesh-list
57034748|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57034749|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
57034750|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034751|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57034752|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57034753|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034754|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034755|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57034756|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57034757|NCT03506516|Ethanol|ethanol|mesh-list
57034758|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57034759|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034760|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57034761|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034762|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
57034763|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034764|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034765|NCT02643394|Acetaminophen|acetaminophen|mesh-list
57034766|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57034767|NCT02643394|Analgesics|analgesics|mesh-ancestor
57034768|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
57034769|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034770|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034771|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
57034772|NCT03101644|Darunavir|darunavir|mesh-list
57034773|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57034774|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57034775|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
57034776|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034777|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034778|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57034779|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57034780|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
57034781|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034782|NCT03132272|Autoantibodies|autoantibodies|mesh-list
57034783|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
57034784|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034785|NCT03503786|Paclitaxel|paclitaxel|mesh-list
57034786|NCT03503786|Carboplatin|carboplatin|mesh-list
57034787|NCT03503786|Avelumab|avelumab|mesh-list
57034788|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57034789|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034790|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
57034791|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
57034792|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
57034793|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034794|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034795|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
57034796|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57034797|NCT02308982|Antibodies|antibodies|mesh-list
57034798|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
57034799|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57034800|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
57034801|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034802|NCT05515627|Atezolizumab|atezolizumab|mesh-list
57034803|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034804|NCT02178436|Gemcitabine|gemcitabine|mesh-list
57034805|NCT02178436|Paclitaxel|paclitaxel|mesh-list
57034806|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57034807|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57034808|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034809|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
57034810|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
57034811|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
57034812|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034813|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57034814|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
57034815|NCT02178436|Antiviral Agents|antiviral agents|mesh-ancestor
57034816|NCT02178436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034817|NCT02178436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034818|NCT02178436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57034819|NCT02178436|Immunologic Factors|immunologic factors|mesh-ancestor
57034820|NCT02178436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034821|NCT02144064|Heparin|heparin|mesh-list
57034822|NCT02144064|Calcium heparin|calcium heparin|mesh-list
57034823|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
57034824|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57034825|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57034826|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034827|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
57034828|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57034829|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57034830|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57034831|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57034832|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
57034833|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034834|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57034835|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57034836|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034837|NCT02305940|Doxycycline|doxycycline|mesh-list
57034838|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57034839|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034840|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
57034841|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57034842|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57034843|NCT02312804|Paclitaxel|paclitaxel|mesh-list
57034844|NCT02312804|Carboplatin|carboplatin|mesh-list
57034845|NCT02312804|Infigratinib|infigratinib|mesh-list
57034846|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57034847|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034848|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
57034849|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
57034850|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
57034851|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034852|NCT03099616|Propofol|propofol|mesh-list
57034853|NCT03099616|Desflurane|desflurane|mesh-list
57034854|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57034855|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57034856|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034857|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57034858|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
57034859|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
57034860|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57034861|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
57034862|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57034863|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57034864|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034865|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
57034866|NCT04463966|Coagulants|coagulants|mesh-ancestor
57034867|NCT00794248|Fexofenadine|fexofenadine|mesh-list
57034868|NCT00794248|Desloratadine|desloratadine|mesh-list
57034869|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57034870|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
57034871|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034872|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034873|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034874|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57034875|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57034876|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
57034877|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
57034878|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57034879|NCT02309450|Asunaprevir|asunaprevir|mesh-list
57034880|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
57034881|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034882|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034883|NCT04475224|Mitogens|mitogens|mesh-list
57034884|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
57034885|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034886|NCT05483491|Aldesleukin|aldesleukin|mesh-list
57034887|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034888|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57034889|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56612473|NCT00662805|Xhance|xhance|mesh-list
57034890|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
57034891|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034892|NCT05370235|Afamelanotide|afamelanotide|mesh-list
57034893|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
57034894|NCT00353496|Lanreotide|lanreotide|mesh-list
57034895|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034896|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
57034897|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57034898|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57034899|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
57034900|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034901|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034902|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034903|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
57034904|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
57034905|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034906|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
57034907|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57034908|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
57034909|NCT03388190|Leucovorin|leucovorin|mesh-list
57034910|NCT03388190|Fluorouracil|fluorouracil|mesh-list
57034911|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
57034912|NCT03388190|Nivolumab|nivolumab|mesh-list
57034913|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
57034914|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
57034915|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034916|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57034917|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034918|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57034919|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
57034920|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034921|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034922|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57034923|NCT03388190|Antidotes|antidotes|mesh-ancestor
57034924|NCT03388190|Protective Agents|protective agents|mesh-ancestor
57034925|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
57034926|NCT03388190|Vitamins|vitamins|mesh-ancestor
57034927|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
57034928|NCT02313272|Bevacizumab|bevacizumab|mesh-list
57034929|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
57034930|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034931|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034932|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57034933|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57034934|NCT02313272|Growth Substances|growth substances|mesh-ancestor
57034935|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034936|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
57034937|NCT03473977|Benralizumab|benralizumab|mesh-list
57034938|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57034939|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
57034940|NCT01361464|Tipifarnib|tipifarnib|mesh-list
57034941|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034942|NCT03396211|Nivolumab|nivolumab|mesh-list
57034943|NCT03396211|Apatinib|apatinib|mesh-list
57034944|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034945|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034946|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57034947|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034948|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57034949|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034950|NCT04051255|Metronidazole|metronidazole|mesh-list
57034951|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57034952|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57034953|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57034954|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57034955|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
57034956|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034957|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034958|NCT03505736|Adenosine|adenosine|mesh-list
57034959|NCT03505736|Regadenoson|regadenoson|mesh-list
57034960|NCT03505736|Analgesics|analgesics|mesh-ancestor
57034961|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
57034962|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57034963|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034964|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57034965|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
56897239|NCT02526303|Calcium|calcium|mesh-list
57034966|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57034967|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
57034968|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
57034969|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57034970|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034971|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
57034972|NCT05374603|Durvalumab|durvalumab|mesh-list
57034973|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57034974|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034975|NCT02316626|Progesterone|progesterone|mesh-list
57034976|NCT02316626|Progestins|progestins|mesh-ancestor
57034977|NCT02316626|Hormones|hormones|mesh-ancestor
57034978|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57034979|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57034980|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
57034981|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57034982|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57034983|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034984|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
57034985|NCT03505502|Coagulants|coagulants|mesh-ancestor
57034986|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
57034987|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57034988|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034989|NCT04478266|Letrozole|letrozole|mesh-list
57034990|NCT04478266|Palbociclib|palbociclib|mesh-list
57034991|NCT04478266|Goserelin|goserelin|mesh-list
57034992|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57034993|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57034994|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57034995|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57034996|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57034997|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57034998|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
57034999|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035000|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035001|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57035002|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57035003|NCT02316704|Tacrine|tacrine|mesh-list
57035004|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57035005|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035006|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035007|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
57035008|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035009|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035010|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57035011|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
57035012|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035013|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
57035014|NCT03501680|Insulin|insulin|mesh-list
57035015|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57035016|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035017|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57035018|NCT02310074|Hormones|hormones|mesh-list
57035019|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57035020|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035021|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035022|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57035023|NCT02313584|Dabigatran|dabigatran|mesh-list
57035024|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
57035025|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57035026|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
57035027|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035028|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035029|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
57035030|NCT05063578|Lidocaine|lidocaine|mesh-list
57035031|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
57035032|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
57035033|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035034|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035035|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
57035036|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035037|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57035038|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57035039|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57035040|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035041|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035042|NCT05063422|Trimethoprim|trimethoprim|mesh-list
57035043|NCT05063422|Polymyxins|polymyxins|mesh-list
57035044|NCT05063422|Polymyxin B|polymyxin b|mesh-list
57035045|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57035046|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57035047|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035048|NCT05063422|Renal Agents|renal agents|mesh-ancestor
57035049|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
57035050|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57035051|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57035052|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57035053|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035054|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035055|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57035056|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57035057|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57035058|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57035059|NCT05063422|Laxatives|laxatives|mesh-ancestor
57035060|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57035061|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
57035062|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57035063|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57035064|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035065|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
57035066|NCT03782350|Coagulants|coagulants|mesh-ancestor
57035067|NCT03636256|Docetaxel|docetaxel|mesh-list
57035068|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035069|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
57035070|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
57035071|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
57035072|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035073|NCT03098680|Verapamil|verapamil|mesh-list
57035074|NCT03098680|Nicardipine|nicardipine|mesh-list
57035075|NCT03098680|Phentolamine|phentolamine|mesh-list
57035076|NCT03098680|Phenylephrine|phenylephrine|mesh-list
57035077|NCT03098680|Dobutamine|dobutamine|mesh-list
57035078|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
57035079|NCT03098680|Albuterol|albuterol|mesh-list
57035080|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57035081|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
57035082|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035083|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035084|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57035085|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
57035086|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
57035087|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57035088|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57035089|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57035090|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57035091|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
57035092|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035093|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035094|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57035095|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
57035096|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
57035097|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57035098|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
57035099|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57035100|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57035101|NCT03098680|Protective Agents|protective agents|mesh-ancestor
57035102|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57035103|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57035104|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035105|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57035106|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
57035107|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57035108|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57035109|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57035110|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57035111|NCT03098368|Rotigotine|rotigotine|mesh-list
57035112|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
57035113|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
57035114|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035115|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035116|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035117|NCT05062486|Curcumin|curcumin|mesh-list
57035118|NCT05062486|Resveratrol|resveratrol|mesh-list
57035119|NCT05062486|Quercetin|quercetin|mesh-list
57035120|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57035121|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57035122|NCT05062486|Analgesics|analgesics|mesh-ancestor
57035123|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
57035124|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035125|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035126|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57035127|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57035128|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035129|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035130|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035131|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
57035132|NCT05062486|Protective Agents|protective agents|mesh-ancestor
57035133|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57035134|NCT04474600|Propofol|propofol|mesh-list
57035135|NCT04474600|Desflurane|desflurane|mesh-list
57035136|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57035137|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035138|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035139|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57035140|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
57035141|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
57035142|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57035143|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
57035144|NCT02314208|Resveratrol|resveratrol|mesh-list
57035145|NCT02314208|Atorvastatin|atorvastatin|mesh-list
57035146|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57035147|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57035148|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
57035149|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035150|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57035151|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57035152|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035153|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
57035154|NCT02314208|Protective Agents|protective agents|mesh-ancestor
57035155|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035156|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57035157|NCT02314208|Cathartics|cathartics|mesh-ancestor
57035158|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57035159|NCT03100318|Dotinurad|dotinurad|mesh-list
57035160|NCT03100318|Benzbromarone|benzbromarone|mesh-list
57035161|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
57035162|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
57035163|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57035164|NCT03100318|Renal Agents|renal agents|mesh-ancestor
57035165|NCT02311010|Tacrolimus|tacrolimus|mesh-list
57035166|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57035167|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
56897246|NCT03869073|Evolocumab|evolocumab|mesh-list
57035168|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035169|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57035170|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035171|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035172|NCT05020600|Pregabalin|pregabalin|mesh-list
57035173|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57035174|NCT05020600|Amitriptyline|amitriptyline|mesh-list
57035175|NCT05020600|Analgesics|analgesics|mesh-ancestor
57035176|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
57035177|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035178|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035179|NCT05020600|Anticonvulsants|anticonvulsants|mesh-ancestor
57035180|NCT05020600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57035181|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035182|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035183|NCT05020600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57035184|NCT05020600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57035185|NCT05020600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57035186|NCT05020600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035187|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57035188|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57035189|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57035190|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035191|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
57035192|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
57035193|NCT05020600|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57035194|NCT05020600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57035195|NCT05020600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57035196|NCT05020600|Adrenergic Agents|adrenergic agents|mesh-ancestor
57035197|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57035198|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57035199|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57035200|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
57035201|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035202|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57035203|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57035204|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035205|NCT03132194|Dapsone|dapsone|mesh-list
57035206|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035207|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
57035208|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57035209|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57035210|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57035211|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035212|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035213|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
57035214|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57035215|NCT02311088|Caffeine|caffeine|mesh-list
57035216|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57035217|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035218|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57035219|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035220|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035221|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57035222|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57035223|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
57035224|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035225|NCT03501212|Anesthetics|anesthetics|mesh-list
57035226|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
57035227|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035228|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035229|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
57035230|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035231|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57035232|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
57035233|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035234|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57035235|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035236|NCT04435210|Hydralazine|hydralazine|mesh-list
57035237|NCT04435210|Nifedipine|nifedipine|mesh-list
57035238|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57035239|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035240|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035241|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57035242|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717241|NCT00740168|Bevacizumab|bevacizumab|mesh-list
57035243|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
57035244|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
57035245|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57035246|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57035247|NCT03501056|Antibodies|antibodies|mesh-list
57035248|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57035249|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
57035250|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035251|NCT03292146|Denosumab|denosumab|mesh-list
57035252|NCT03292146|Alendronate|alendronate|mesh-list
57035253|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57035254|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035255|NCT02144376|Psyllium|psyllium|mesh-list
57035256|NCT02144376|Cathartics|cathartics|mesh-ancestor
57035257|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57035258|NCT02314754|Misoprostol|misoprostol|mesh-list
57035259|NCT02314754|Mifepristone|mifepristone|mesh-list
57035260|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57035261|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
57035262|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57035263|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035264|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57035265|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57035266|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
57035267|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57035268|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57035269|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57035270|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57035271|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
57035272|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57035273|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57035274|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
57035275|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035276|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
57035277|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57035278|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57035279|NCT02317640|Testosterone|testosterone|mesh-list
57035280|NCT02317640|Androgens|androgens|mesh-ancestor
57035281|NCT02317640|Hormones|hormones|mesh-ancestor
57035282|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035283|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035284|NCT02716948|Nivolumab|nivolumab|mesh-list
57035285|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57035286|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035287|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57035288|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035289|NCT03500900|Vildagliptin|vildagliptin|mesh-list
57035290|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57035291|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035292|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57035293|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
57035294|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035295|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035296|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
57035297|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
57035298|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035299|NCT02141100|Thioguanine|thioguanine|mesh-list
57035300|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57035301|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
57035302|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035303|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035304|NCT02141178|Bupivacaine|bupivacaine|mesh-list
57035305|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
57035306|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
57035307|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035308|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035309|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
56897265|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57035310|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035311|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
57035312|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57035313|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035314|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035315|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57035316|NCT02141412|Analgesics|analgesics|mesh-ancestor
56717317|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035317|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
57035318|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035319|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57035320|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57035321|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57035322|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
57035323|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035324|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035325|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
57035326|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57035327|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035328|NCT03210558|Testosterone|testosterone|mesh-list
57035329|NCT03210558|Androgens|androgens|mesh-ancestor
57035331|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035332|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035333|NCT05046262|Calcium|calcium|mesh-list
57035334|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57035335|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035336|NCT05036824|Tinzaparin|tinzaparin|mesh-list
57035337|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57035338|NCT05036824|Dalteparin|dalteparin|mesh-list
57035339|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
57035340|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57035341|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57035342|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035343|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
57035344|NCT03184194|Nivolumab|nivolumab|mesh-list
57035345|NCT03184194|Daratumumab|daratumumab|mesh-list
57035346|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57035347|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57035348|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
57035349|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035350|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57035351|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57035352|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
57035353|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035354|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035355|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57035356|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57035357|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57035358|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
57035359|NCT04462250|Narcotics|narcotics|mesh-ancestor
57035360|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035361|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035362|NCT04462250|Analgesics|analgesics|mesh-ancestor
57035363|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
57035364|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035365|NCT02144766|Ropivacaine|ropivacaine|mesh-list
57035366|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
57035367|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
57035368|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035369|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035370|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
57035371|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035372|NCT05045248|Apraclonidine|apraclonidine|mesh-list
57035373|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57035374|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57035375|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57035376|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
57035377|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035378|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035379|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035380|NCT02144922|Pitavastatin|pitavastatin|mesh-list
57035381|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57035382|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57035383|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57035384|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
57035385|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035386|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035387|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57035388|NCT02261064|Amlodipine|amlodipine|mesh-list
57035389|NCT02261064|Telmisartan|telmisartan|mesh-list
57035390|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
57035391|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57035392|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57035393|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035394|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035395|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57035396|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035397|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
57035398|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57035399|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57035400|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57035401|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57035402|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035403|NCT05035498|Phenylephrine|phenylephrine|mesh-list
57035404|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
57035405|NCT05035498|Norepinephrine|norepinephrine|mesh-list
57035406|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
57035407|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57035408|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
57035409|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
57035410|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035411|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035412|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
57035413|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
57035414|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
57035415|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57035416|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57035417|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57035418|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
57035419|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035420|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035421|NCT05035498|Protective Agents|protective agents|mesh-ancestor
57035422|NCT03498326|Gemcitabine|gemcitabine|mesh-list
57035423|NCT03498326|Celecoxib|celecoxib|mesh-list
57035424|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57035425|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
57035426|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035427|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035428|NCT03498326|Antiviral Agents|antiviral agents|mesh-ancestor
57035429|NCT03498326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035430|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035431|NCT03498326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57035432|NCT03498326|Immunologic Factors|immunologic factors|mesh-ancestor
57035433|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035434|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57035435|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57035436|NCT03498326|Analgesics|analgesics|mesh-ancestor
57035437|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
57035438|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035439|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57035440|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57035441|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57035442|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57035443|NCT03498248|Lenograstim|lenograstim|mesh-list
57035444|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57035445|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
57035446|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035447|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
57035448|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
57035449|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57035450|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035451|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57035452|NCT03498170|Itraconazole|itraconazole|mesh-list
57035453|NCT03498170|Acumapimod|acumapimod|mesh-list
57035454|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
57035455|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035456|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57035457|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57035458|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035459|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035460|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57035461|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
57035462|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035463|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035464|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57035465|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57035466|NCT05055544|Fosfomycin|fosfomycin|mesh-list
57035467|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57035468|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035469|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
57035470|NCT03498092|Bupivacaine|bupivacaine|mesh-list
57035471|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
57035472|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
57035473|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035474|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035475|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
57035476|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035477|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57035478|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57035479|NCT03498092|Analgesics|analgesics|mesh-ancestor
57035480|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57035481|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57035482|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57035483|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
57035484|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035485|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035486|NCT03500432|Lidocaine|lidocaine|mesh-list
57035487|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
57035488|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
57035489|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035490|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035491|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
57035492|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035493|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57035494|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57035495|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57035496|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035497|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035498|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
57035499|NCT01951885|Methotrexate|methotrexate|mesh-list
57035500|NCT01951885|Tacrolimus|tacrolimus|mesh-list
57035501|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57035502|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
57035503|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57035504|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035505|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57035506|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
57035507|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035508|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035509|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
57035510|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035511|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57035512|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57035513|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
57035514|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57035515|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57035516|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57035517|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57035518|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57035519|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
57035520|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57035521|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035522|NCT02315690|Piperaquine|piperaquine|mesh-list
57035523|NCT02315690|Artenimol|artenimol|mesh-list
57035524|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
57035525|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57035526|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57035527|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035528|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
57035529|NCT02639338|Velpatasvir|velpatasvir|mesh-list
57035530|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
57035531|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035532|NCT01754857|Rituximab|rituximab|mesh-list
57035533|NCT01754857|Lenalidomide|lenalidomide|mesh-list
57035534|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57035535|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57035536|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035537|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
57035538|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035539|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57035540|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57035541|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57035542|NCT01754857|Growth Substances|growth substances|mesh-ancestor
57035543|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
57035544|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57035545|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
57035546|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035547|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
57035548|NCT03497702|Docetaxel|docetaxel|mesh-list
57035549|NCT03497702|Doxorubicin|doxorubicin|mesh-list
57035550|NCT03497702|Letrozole|letrozole|mesh-list
57035551|NCT03497702|Leuprolide|leuprolide|mesh-list
57035552|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57035553|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
57035554|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035555|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57035556|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57035557|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
57035558|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035559|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035560|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57035561|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
57035562|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
57035563|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
57035564|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57035565|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57035566|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57035567|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035568|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57035569|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57035570|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57035571|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
57035572|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035573|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57035574|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
57035575|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57035576|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57035577|NCT02900352|Zonisamide|zonisamide|mesh-list
57035578|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
57035579|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57035580|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035581|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035582|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57035583|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035584|NCT05283109|Vaccines|vaccines|mesh-list
57035585|NCT05283109|Poly ICLC|poly iclc|mesh-list
57035586|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
57035587|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035588|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
57035589|NCT05034406|Lidocaine|lidocaine|mesh-list
57035590|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
57035591|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
57035592|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
57035593|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035594|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035595|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
57035596|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035597|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57035598|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57035599|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57035600|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035601|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035602|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
57035603|NCT02254668|Everolimus|everolimus|mesh-list
57035604|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035605|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57035606|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
57035607|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035608|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57035609|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56717614|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
57035610|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
57035611|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57035612|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035613|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035614|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035615|NCT03095404|Lidocaine|lidocaine|mesh-list
57035616|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57035617|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
57035618|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
57035619|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035620|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035621|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
57035622|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035623|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57035624|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57035625|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57035626|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035627|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035628|NCT02145546|Amiodarone|amiodarone|mesh-list
57035629|NCT02145546|Sotalol|sotalol|mesh-list
57035630|NCT02145546|Propafenone|propafenone|mesh-list
57035631|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57035632|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
57035633|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57035634|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035635|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035636|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57035637|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57035638|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57035639|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035640|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57035641|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57035642|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57035643|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57035644|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57035645|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
57035646|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035647|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035648|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
57035649|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
57035650|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035651|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57035652|NCT03039673|Interleukin-2|interleukin-2|mesh-list
57035653|NCT03039673|Riluzole|riluzole|mesh-list
57035654|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035655|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57035656|NCT03039673|Analgesics|analgesics|mesh-ancestor
57035657|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
57035658|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035659|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035660|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
57035661|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57035662|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57035663|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035664|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035665|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57035666|NCT03039673|Protective Agents|protective agents|mesh-ancestor
57035667|NCT02145624|Vaccines|vaccines|mesh-list
57035668|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
57035669|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035670|NCT02321384|Ritonavir|ritonavir|mesh-list
57035671|NCT02321384|Midazolam|midazolam|mesh-list
57035672|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57035673|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57035674|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035675|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035676|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57035677|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57035678|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57035679|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57035680|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
57035681|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
57035682|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
57035683|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
57035684|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035685|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035686|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56717686|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
57035687|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57035688|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
57035689|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035690|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57035691|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57035692|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
57035693|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035694|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57035695|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57035696|NCT03095326|Zinc|zinc|mesh-list
57035697|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
57035698|NCT03095326|Vaccines|vaccines|mesh-list
57035699|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
57035700|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035701|NCT03095326|Trace Elements|trace elements|mesh-ancestor
57035702|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
57035703|NCT03095326|Astringents|astringents|mesh-ancestor
57035704|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
57035705|NCT02318810|Rocuronium|rocuronium|mesh-list
57035706|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57035707|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57035708|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57035709|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035710|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035711|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
57035712|NCT03500120|Captopril|captopril|mesh-list
57035713|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57035714|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
57035715|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035716|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035717|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57035718|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57035719|NCT02141958|Fenretinide|fenretinide|mesh-list
57035720|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035721|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57035722|NCT02141958|Protective Agents|protective agents|mesh-ancestor
57035723|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035724|NCT02142036|Trastuzumab|trastuzumab|mesh-list
57035725|NCT02142036|Cetuximab|cetuximab|mesh-list
57035726|NCT02142036|Panitumumab|panitumumab|mesh-list
57035727|NCT02142036|Everolimus|everolimus|mesh-list
57035728|NCT02142036|Sunitinib|sunitinib|mesh-list
57035729|NCT02142036|Dasatinib|dasatinib|mesh-list
57035730|NCT02142036|Lapatinib|lapatinib|mesh-list
57035731|NCT02142036|Gefitinib|gefitinib|mesh-list
57035732|NCT02142036|Afatinib|afatinib|mesh-list
57035733|NCT02142036|Vemurafenib|vemurafenib|mesh-list
57035734|NCT02142036|Dabrafenib|dabrafenib|mesh-list
57035735|NCT02142036|Crizotinib|crizotinib|mesh-list
56897287|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57035736|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57035737|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035738|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57035739|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
57035740|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035741|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57035742|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035743|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035744|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57035745|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57035746|NCT02142036|Growth Substances|growth substances|mesh-ancestor
57035747|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
57035748|NCT05053594|Neostigmine|neostigmine|mesh-list
57035749|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57035750|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035751|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035752|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
57035753|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035754|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035755|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57035756|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
57035757|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035758|NCT02318888|Icodextrin|icodextrin|mesh-list
57035759|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
57035760|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57035761|NCT02142192|Natalizumab|natalizumab|mesh-list
57035762|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
57035763|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035764|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57035765|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
57035767|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
57035768|NCT03097120|Hormones|hormones|mesh-ancestor
57035769|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035770|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035771|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57035772|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57035773|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57035774|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
57035775|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57035776|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57035777|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57035778|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57035779|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57035780|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035781|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
57035782|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57035783|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035784|NCT01255891|Androgens|androgens|mesh-list
57035785|NCT01255891|Hormones|hormones|mesh-ancestor
57035786|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035787|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035788|NCT02777190|Misoprostol|misoprostol|mesh-list
57035789|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57035790|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
57035791|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57035792|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035793|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57035794|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57035795|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
57035796|NCT03494426|Pregabalin|pregabalin|mesh-list
57035797|NCT03494426|Tramadol|tramadol|mesh-list
57035798|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
57035799|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
57035800|NCT03494426|Analgesics|analgesics|mesh-ancestor
57035801|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
57035802|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035803|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035804|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
57035805|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57035806|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57035807|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035808|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57035809|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57035810|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57035811|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035812|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57035813|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57035814|NCT03494426|Narcotics|narcotics|mesh-ancestor
57035815|NCT02432209|Orlistat|orlistat|mesh-list
57035816|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035817|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035818|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57035819|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57035820|NCT00108732|Metronidazole|metronidazole|mesh-list
57035821|NCT00108732|Goserelin|goserelin|mesh-list
57035822|NCT00108732|Bicalutamide|bicalutamide|mesh-list
57035823|NCT00108732|Vaccines|vaccines|mesh-list
57035824|NCT00108732|Sargramostim|sargramostim|mesh-list
57035825|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
57035826|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035827|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035828|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57035829|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
57035830|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
57035831|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57035832|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035833|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57035834|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57035835|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57035836|NCT02319200|Metformin|metformin|mesh-list
57035837|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57035838|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035839|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57035840|NCT02319278|Hematinics|hematinics|mesh-ancestor
57035841|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57035842|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57035843|NCT02324738|Piperaquine|piperaquine|mesh-list
57035845|NCT02324738|Mefloquine|mefloquine|mesh-list
57035846|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
57035847|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57035848|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57035849|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035850|NCT02321852|Mannitol|mannitol|mesh-list
57035851|NCT02321852|Triflusal|triflusal|mesh-list
57035852|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57035853|NCT02321852|Diuretics|diuretics|mesh-ancestor
57035854|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
57035855|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035856|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57035857|NCT03499886|Ketamine|ketamine|mesh-list
57035858|NCT03499886|Analgesics|analgesics|mesh-ancestor
57035859|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
57035860|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035861|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035862|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57035863|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57035864|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
57035865|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
57035866|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035867|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57035868|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57035869|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035870|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035871|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
57035872|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57035873|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035874|NCT02716038|Paclitaxel|paclitaxel|mesh-list
57035875|NCT02716038|Carboplatin|carboplatin|mesh-list
57035876|NCT02716038|Atezolizumab|atezolizumab|mesh-list
57035877|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57035878|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035879|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
57035880|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
57035881|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
57035882|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035883|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
57035884|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035885|NCT02322008|Adalimumab|adalimumab|mesh-list
57035886|NCT02322008|Infliximab|infliximab|mesh-list
57035887|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57035888|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57035889|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
57035890|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57035891|NCT02647554|Urinastatin|urinastatin|mesh-list
57035892|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
57035893|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57035894|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
57035895|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035896|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035897|NCT02558010|Morphine|morphine|mesh-list
57035898|NCT02558010|Methadone|methadone|mesh-list
57035899|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57035900|NCT02558010|Narcotics|narcotics|mesh-ancestor
57035901|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035902|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035903|NCT02558010|Analgesics|analgesics|mesh-ancestor
57035904|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
57035905|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035906|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
57035907|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
57035908|NCT03499730|Midazolam|midazolam|mesh-list
57035909|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57035910|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57035911|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035912|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035913|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57035914|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57035915|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57035916|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57035917|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
57035918|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
57035919|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
57035920|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
57035921|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035922|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035923|NCT02143050|Metformin|metformin|mesh-list
57035924|NCT02143050|Trametinib|trametinib|mesh-list
57035925|NCT02143050|Dabrafenib|dabrafenib|mesh-list
57035926|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57035927|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035928|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035929|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57035930|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035931|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035932|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
57035933|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57035934|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035935|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57035936|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035937|NCT02325362|Miglustat|miglustat|mesh-list
57035938|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
57035939|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035940|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035941|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57035942|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57035943|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
57035944|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035945|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57035946|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57035947|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035948|NCT03003962|Gemcitabine|gemcitabine|mesh-list
57035949|NCT03003962|Paclitaxel|paclitaxel|mesh-list
57035950|NCT03003962|Cisplatin|cisplatin|mesh-list
57035951|NCT03003962|Carboplatin|carboplatin|mesh-list
57035952|NCT03003962|Pemetrexed|pemetrexed|mesh-list
57035953|NCT03003962|Durvalumab|durvalumab|mesh-list
57035954|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57035955|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57035956|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
57035957|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
57035958|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
57035959|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035960|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57035961|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
57035962|NCT03003962|Antiviral Agents|antiviral agents|mesh-ancestor
57035963|NCT03003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035964|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57035965|NCT03003962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57035966|NCT03003962|Immunologic Factors|immunologic factors|mesh-ancestor
57035967|NCT03003962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035968|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57035969|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57035970|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57035971|NCT04462094|Ketamine|ketamine|mesh-list
57035972|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
57035973|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57035974|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035975|NCT04462094|Analgesics|analgesics|mesh-ancestor
57035976|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
57035977|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57035978|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57035979|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57035980|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
57035981|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57035982|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57035983|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57035984|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035985|NCT02325440|Natalizumab|natalizumab|mesh-list
57035986|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57035987|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
57035988|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57035989|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57035990|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57035991|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57035992|NCT03499184|Metronidazole|metronidazole|mesh-list
57035993|NCT03499184|Amoxicillin|amoxicillin|mesh-list
57035994|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57035995|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57035996|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57035997|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57035998|NCT00107952|Vancomycin|vancomycin|mesh-list
57035999|NCT00107952|Telavancin|telavancin|mesh-list
57036000|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57036001|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036002|NCT03499106|Itraconazole|itraconazole|mesh-list
57036003|NCT03499106|Praliciguat|praliciguat|mesh-list
57036004|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
57036005|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036006|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57036007|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57036008|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036009|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036010|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57036011|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
57036012|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57036013|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036014|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57036015|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57036016|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
57036017|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57036018|NCT02146638|Fentanyl|fentanyl|mesh-list
57036019|NCT02146638|Morphine|morphine|mesh-list
57036020|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57036021|NCT02146638|Narcotics|narcotics|mesh-ancestor
57036022|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036023|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036024|NCT02146638|Analgesics|analgesics|mesh-ancestor
57036025|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
57036026|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036027|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57036028|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57036029|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
57036030|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
57036031|NCT02320448|Cisplatin|cisplatin|mesh-list
57036032|NCT02320448|Doxorubicin|doxorubicin|mesh-list
57036033|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
57036034|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036035|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57036036|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57036037|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57036038|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036039|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036040|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
57036041|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
57036042|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036043|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57036044|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57036045|NCT03493568|Dolutegravir|dolutegravir|mesh-list
57036046|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57036047|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57036048|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57036049|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036050|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036051|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57036052|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57036053|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
57036054|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036055|NCT01366638|Ribavirin|ribavirin|mesh-list
57036056|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57036057|NCT01366638|Simeprevir|simeprevir|mesh-list
57036058|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
57036059|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036060|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
57036061|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036062|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
57036063|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036064|NCT02147808|Midazolam|midazolam|mesh-list
57036065|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57036066|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57036067|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036068|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718060|NCT00095784|Decitabine|decitabine|mesh-list
57036069|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57036070|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57036071|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57036072|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57036073|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
57036074|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
57036075|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
57036076|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
57036077|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036078|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036079|NCT03543072|Diphosphonates|diphosphonates|mesh-list
57036080|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57036081|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036082|NCT03493412|Verapamil|verapamil|mesh-list
57036083|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57036084|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57036085|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036086|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036087|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57036088|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036089|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
57036090|NCT02147964|Ketoconazole|ketoconazole|mesh-list
57036091|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
57036092|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57036093|NCT02147964|Testosterone|testosterone|mesh-list
57036094|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
57036095|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
57036096|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57036097|NCT02147964|Dutasteride|dutasteride|mesh-list
57036098|NCT02147964|Acyline|acyline|mesh-list
57036099|NCT02147964|Androgens|androgens|mesh-ancestor
57036100|NCT02147964|Hormones|hormones|mesh-ancestor
57036101|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57036102|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036103|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57036104|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036105|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
57036106|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
57036107|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036108|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57036109|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57036110|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036111|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036112|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57036113|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
57036114|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57036115|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57036116|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57036117|NCT02780700|Capecitabine|capecitabine|mesh-list
57036118|NCT02780700|Nintedanib|nintedanib|mesh-list
57036119|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57036120|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
57036121|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036122|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036123|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57036124|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036125|NCT02147262|Doxycycline|doxycycline|mesh-list
57036126|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57036127|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036128|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
57036129|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57036130|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57036131|NCT02447276|Fasinumab|fasinumab|mesh-list
57036132|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57036133|NCT02447276|Analgesics|analgesics|mesh-ancestor
57036134|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
57036135|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036136|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036137|NCT05100134|Ceritinib|ceritinib|mesh-list
57036138|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036139|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57036140|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036141|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036142|NCT05079620|Amoxicillin|amoxicillin|mesh-list
57036143|NCT05079620|Vancomycin|vancomycin|mesh-list
57036144|NCT05079620|Levofloxacin|levofloxacin|mesh-list
57036145|NCT05079620|Ofloxacin|ofloxacin|mesh-list
57036146|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
57036147|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57036148|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
57036149|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
57036150|NCT05079620|Cefepime|cefepime|mesh-list
57036151|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57036152|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036153|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57036154|NCT05079620|Renal Agents|renal agents|mesh-ancestor
57036155|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57036156|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57036157|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036158|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036159|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036160|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57036161|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57036162|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57036163|NCT02323412|Amoxicillin|amoxicillin|mesh-list
57036164|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57036165|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036166|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
57036167|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
57036168|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036169|NCT03109730|Tenofovir|tenofovir|mesh-list
57036170|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57036171|NCT03109730|Entecavir|entecavir|mesh-list
57036172|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
57036173|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036174|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57036175|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57036176|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036177|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036178|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57036179|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57036180|NCT03495206|Edaravone|edaravone|mesh-list
57036181|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57036182|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
57036183|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036184|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57036185|NCT03495206|Protective Agents|protective agents|mesh-ancestor
57036186|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036187|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
57036188|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57036189|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036190|NCT03491696|Metyrapone|metyrapone|mesh-list
57036191|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
57036192|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036193|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036194|NCT03492866|Gentamicins|gentamicins|mesh-list
57036195|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57036196|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036197|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57036198|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036199|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036200|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
57036201|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57036202|NCT03492710|Antibodies|antibodies|mesh-list
57036203|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
57036204|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036205|NCT03954938|Cocaine|cocaine|mesh-list
57036206|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
57036207|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
57036208|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036209|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036210|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
57036211|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036212|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57036213|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57036214|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57036215|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036216|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036217|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
57036218|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036219|NCT02148120|Beclomethasone|beclomethasone|mesh-list
57036220|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
57036221|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57036222|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
57036223|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036224|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036225|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57036226|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
57036227|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57036228|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57036229|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57036230|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
57036231|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036232|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036233|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57036234|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
57036235|NCT02148120|Hormones|hormones|mesh-ancestor
57036236|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57036237|NCT03492632|Hormones|hormones|mesh-list
57036238|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57036239|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036240|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
57036241|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57036242|NCT02147730|Anesthetics|anesthetics|mesh-list
57036243|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036244|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036245|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
57036246|NCT02151630|Salicylates|salicylates|mesh-list
57036247|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036248|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
57036249|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
57036250|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
57036251|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57036252|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57036253|NCT02151630|Analgesics|analgesics|mesh-ancestor
57036254|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
57036255|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036256|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036257|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57036258|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57036259|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57036260|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036261|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036262|NCT03494972|Tetracycline|tetracycline|mesh-list
57036263|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57036264|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036265|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57036266|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036267|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036268|NCT02224573|Cannabidiol|cannabidiol|mesh-list
57036269|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
57036270|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57036271|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57036272|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57036273|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036274|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036275|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
57036276|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036277|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57036278|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57036279|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
57036280|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57036281|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036282|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036283|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57036284|NCT02148432|Analgesics|analgesics|mesh-ancestor
57036285|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
57036286|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036287|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57036288|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57036289|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57036290|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
57036291|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036292|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036293|NCT03756961|Lidocaine|lidocaine|mesh-list
57036294|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
57036295|NCT03756961|Remifentanil|remifentanil|mesh-list
57036296|NCT03756961|Oxycodone|oxycodone|mesh-list
57036297|NCT03756961|Propofol|propofol|mesh-list
57036298|NCT03756961|Desflurane|desflurane|mesh-list
57036299|NCT03756961|Esketamine|esketamine|mesh-list
57036300|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
57036301|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
57036302|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036303|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036304|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
57036305|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036306|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57036307|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57036308|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57036309|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036310|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036311|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57036312|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57036313|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
57036314|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57036315|NCT03756961|Analgesics|analgesics|mesh-ancestor
57036316|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57036317|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57036318|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57036319|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
57036320|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036321|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57036322|NCT03756961|Narcotics|narcotics|mesh-ancestor
57036323|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57036324|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
57036325|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57036326|NCT03350984|Insulin|insulin|mesh-list
57036327|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57036328|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
57036329|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
57036330|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
57036331|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
57036332|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
57036333|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57036334|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036335|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
57036336|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57036337|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
57036338|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57036339|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
57036340|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036341|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036342|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
57036343|NCT03504423|Leucovorin|leucovorin|mesh-list
57036344|NCT03504423|Folic Acid|folic acid|mesh-list
57036345|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
57036346|NCT03504423|Irinotecan|irinotecan|mesh-list
57036347|NCT03504423|Folfirinox|folfirinox|mesh-list
57036348|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
57036349|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036350|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57036351|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57036352|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036353|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036354|NCT03504423|Antidotes|antidotes|mesh-ancestor
57036355|NCT03504423|Protective Agents|protective agents|mesh-ancestor
57036356|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036357|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
57036358|NCT03504423|Vitamins|vitamins|mesh-ancestor
57036359|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
57036360|NCT03504423|Hematinics|hematinics|mesh-ancestor
57036361|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57036362|NCT03097198|Tropicamide|tropicamide|mesh-list
57036363|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57036364|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
57036365|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
57036366|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036367|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036368|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57036369|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57036370|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
57036371|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036372|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036374|NCT02770248|Brinzolamide|brinzolamide|mesh-list
57036375|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57036376|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57036377|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57036378|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57036379|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
57036380|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036381|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036382|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036383|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57036384|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036385|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57036386|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57036387|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
57036388|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036389|NCT02686346|Etoposide|etoposide|mesh-list
57036390|NCT02686346|Ifosfamide|ifosfamide|mesh-list
57036391|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57036392|NCT02686346|Carboplatin|carboplatin|mesh-list
57036393|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57036394|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036395|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57036396|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57036397|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036398|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036399|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57036400|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
57036401|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57036402|NCT03489044|Levetiracetam|levetiracetam|mesh-list
57036403|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
56897301|NCT03868137|Ibuprofen|ibuprofen|mesh-list
57036404|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
57036405|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57036406|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57036407|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57036408|NCT01344369|Norethindrone|norethindrone|mesh-list
57036409|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
57036410|NCT01344369|Estradiol|estradiol|mesh-list
57036411|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57036412|NCT01344369|Estrogens|estrogens|mesh-ancestor
57036413|NCT01344369|Hormones|hormones|mesh-ancestor
57036414|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57036415|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036416|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57036417|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
57036418|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57036419|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57036420|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57036421|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57036422|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57036423|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57036424|NCT05108935|Buprenorphine|buprenorphine|mesh-list
57036425|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
57036426|NCT05108935|Naloxone|naloxone|mesh-list
57036427|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57036428|NCT05108935|Narcotics|narcotics|mesh-ancestor
57036429|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036430|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036431|NCT05108935|Analgesics|analgesics|mesh-ancestor
57036432|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
57036433|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036434|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57036435|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57036436|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57036437|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036438|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036439|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
57036440|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036441|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57036442|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57036443|NCT03491072|Fentanyl|fentanyl|mesh-list
57036444|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57036445|NCT03491072|Narcotics|narcotics|mesh-ancestor
57036446|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036447|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036448|NCT03491072|Analgesics|analgesics|mesh-ancestor
57036449|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
57036450|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036451|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57036452|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57036453|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
57036454|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
57036456|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036457|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036458|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036459|NCT03490994|Warfarin|warfarin|mesh-list
57036460|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
57036461|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
57036462|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57036463|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
57036464|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57036465|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
57036466|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036467|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036468|NCT01360762|Pentamidine|pentamidine|mesh-list
57036469|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
57036470|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036471|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57036472|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57036473|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57036474|NCT04382924|Ifenprodil|ifenprodil|mesh-list
57036475|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57036476|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57036477|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
57036478|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036479|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036480|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036481|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
57036482|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57036483|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57036484|NCT00002601|Doxorubicin|doxorubicin|mesh-list
57036485|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57036486|NCT00002601|Melphalan|melphalan|mesh-list
57036487|NCT00002601|Ifosfamide|ifosfamide|mesh-list
57036488|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036489|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57036490|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57036491|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57036492|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036493|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036494|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
57036495|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036496|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57036497|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
57036498|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57036499|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57036500|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
57036501|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
57036502|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
57036503|NCT03553563|Esomeprazole|esomeprazole|mesh-list
57036504|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57036505|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57036506|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57036507|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036508|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036509|NCT05693077|Vancomycin|vancomycin|mesh-list
57036510|NCT05693077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57036511|NCT05693077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036512|NCT02031861|Nifedipine|nifedipine|mesh-list
57036513|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57036514|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036515|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036516|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57036517|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036518|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
57036519|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
57036520|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57036521|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
56718515|NCT00874744|Hormones|hormones|mesh-ancestor
57036523|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
57036524|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57036525|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
57036526|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036527|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036528|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
57036529|NCT02645474|Ropivacaine|ropivacaine|mesh-list
57036530|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
57036531|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
57036532|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036533|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036534|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
57036535|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036536|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
57036537|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57036538|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
57036539|NCT05052814|Calcium|calcium|mesh-list
57036540|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57036541|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036542|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57036543|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036544|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
57036545|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
57036546|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
57036547|NCT03615417|Anesthetics|anesthetics|mesh-list
57036548|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036549|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036550|NCT02155530|Atorvastatin|atorvastatin|mesh-list
57036551|NCT02155530|Pravastatin|pravastatin|mesh-list
57036552|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57036553|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57036554|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
57036555|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036556|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57036557|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57036558|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036559|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
57036560|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
57036561|NCT03516279|Dasatinib|dasatinib|mesh-list
57036562|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57036563|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036564|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57036565|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036566|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036567|NCT05051956|Palbociclib|palbociclib|mesh-list
57036568|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036569|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57036570|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036571|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036572|NCT02769624|Treprostinil|treprostinil|mesh-list
57036573|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57036574|NCT03543774|Simvastatin|simvastatin|mesh-list
57036575|NCT03543774|Ezetimibe|ezetimibe|mesh-list
57036576|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
57036577|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57036578|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57036579|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
57036580|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036581|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57036582|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57036583|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036584|NCT03261830|Clindamycin|clindamycin|mesh-list
57036585|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
57036586|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
57036587|NCT03261830|Cefazolin|cefazolin|mesh-list
57036588|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57036589|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036590|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57036591|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036592|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036593|NCT02152176|Morphine|morphine|mesh-list
57036594|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57036595|NCT02152176|Narcotics|narcotics|mesh-ancestor
57036596|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036597|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036598|NCT02152176|Analgesics|analgesics|mesh-ancestor
57036599|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
57036600|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036601|NCT03617055|Cystatins|cystatins|mesh-list
57036602|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
57036603|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
57036604|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036605|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036606|NCT03488888|Bupivacaine|bupivacaine|mesh-list
57036607|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
57036608|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
57036609|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036610|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036611|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
57036612|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036613|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
57036614|NCT05031676|Anesthetics|anesthetics|mesh-list
57036615|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036616|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036617|NCT05031676|Narcotics|narcotics|mesh-ancestor
57036618|NCT05031676|Analgesics|analgesics|mesh-ancestor
57036619|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
57036620|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036621|NCT03488810|Hormones|hormones|mesh-list
57036622|NCT03488810|Androgens|androgens|mesh-list
57036623|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
57036624|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
57036625|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57036626|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036627|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
57036628|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57036629|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036630|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036631|NCT03572283|Bethanechol|bethanechol|mesh-list
57036632|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57036633|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
57036634|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036635|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036636|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57036637|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57036638|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
57036639|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036640|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036641|NCT02254824|Atorvastatin|atorvastatin|mesh-list
57036642|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57036643|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57036644|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
57036645|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036646|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57036647|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57036648|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036649|NCT01525316|Lactoferrin|lactoferrin|mesh-list
57036650|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036651|NCT01673386|Sunitinib|sunitinib|mesh-list
57036652|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036653|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57036654|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57036655|NCT01673386|Growth Substances|growth substances|mesh-ancestor
57036656|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036657|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
57036658|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57036659|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036660|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036661|NCT00103740|Vitamin D|vitamin d|mesh-list
57036662|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
57036663|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
57036664|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
57036665|NCT00103740|Calcium|calcium|mesh-list
57036666|NCT00103740|Vitamins|vitamins|mesh-ancestor
57036667|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
57036668|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036669|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57036670|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57036671|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57036672|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036673|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036674|NCT03616509|Hormones|hormones|mesh-list
57036675|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57036676|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036677|NCT02031939|Capecitabine|capecitabine|mesh-list
57036678|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
57036679|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57036680|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
57036681|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036682|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036683|NCT02869893|Secretin|secretin|mesh-list
57036684|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57036685|NCT02869893|Hormones|hormones|mesh-ancestor
57036686|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57036687|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036688|NCT04907214|Empagliflozin|empagliflozin|mesh-list
57036689|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57036690|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036691|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57036692|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036693|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
57036694|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57036695|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57036696|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036697|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57036698|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57036699|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036700|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036701|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036702|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57036703|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
57036704|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57036705|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036706|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57036707|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57036708|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57036709|NCT05118308|Liver Extracts|liver extracts|mesh-list
57036710|NCT05118308|Hematinics|hematinics|mesh-ancestor
57036711|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
57036712|NCT03617289|Analgesics|analgesics|mesh-ancestor
57036713|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
57036714|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036715|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036716|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
57036717|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036718|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57036719|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
57036720|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57036721|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036722|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036723|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57036724|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
57036725|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57036726|NCT02152410|Morphine|morphine|mesh-list
57036727|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57036728|NCT02152410|Narcotics|narcotics|mesh-ancestor
57036729|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036730|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036731|NCT02152410|Analgesics|analgesics|mesh-ancestor
57036732|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
57036733|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036734|NCT05043688|Paclitaxel|paclitaxel|mesh-list
57036735|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57036736|NCT05043688|Carboplatin|carboplatin|mesh-list
57036737|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57036738|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036739|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
57036740|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
57036741|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
57036742|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036743|NCT03614715|Interferons|interferons|mesh-list
57036744|NCT03614715|Interferon-beta|interferon-beta|mesh-list
57036745|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
57036746|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036747|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
57036748|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036749|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
57036750|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036751|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57036752|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
57036753|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57036754|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57036755|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57036756|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
57036757|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036758|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036759|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036760|NCT00363038|Vitamins|vitamins|mesh-list
57036761|NCT00363038|Vitamin K|vitamin k|mesh-list
57036762|NCT00363038|Vitamin A|vitamin a|mesh-list
57036763|NCT00363038|Petrolatum|petrolatum|mesh-list
57036764|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
57036765|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036766|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57036767|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57036768|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036769|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
57036770|NCT00363038|Coagulants|coagulants|mesh-ancestor
57036771|NCT00363038|Emollients|emollients|mesh-ancestor
57036772|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
57036773|NCT03489668|Metformin|metformin|mesh-list
57036774|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56614245|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57036775|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036776|NCT02872311|Vaccines|vaccines|mesh-list
57036777|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
57036778|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036779|NCT03614403|Vitamin D|vitamin d|mesh-list
57036780|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
57036781|NCT03614403|Vitamins|vitamins|mesh-ancestor
57036782|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
57036783|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036784|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57036785|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57036786|NCT03488186|Lansoprazole|lansoprazole|mesh-list
57036787|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
57036788|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57036789|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57036790|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57036791|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036792|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036793|NCT05103644|Atorvastatin|atorvastatin|mesh-list
57036794|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57036795|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57036796|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
57036797|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036798|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57036799|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57036800|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036801|NCT03887624|Ethosuximide|ethosuximide|mesh-list
57036802|NCT03887624|Citalopram|citalopram|mesh-list
57036803|NCT03887624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57036804|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57036805|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036806|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036807|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036808|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
57036809|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036810|NCT03887624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57036811|NCT03887624|Antidepressive Agents|antidepressive agents|mesh-ancestor
57036812|NCT03887624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57036813|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
57036814|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
57036815|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57036816|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036817|NCT03485846|Ritonavir|ritonavir|mesh-list
57036818|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57036819|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57036820|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
57036821|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036822|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036823|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57036824|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57036825|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
57036826|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036827|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57036828|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57036829|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
57036830|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57036831|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
57036832|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57036833|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
57036834|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036835|NCT03613857|Clopidogrel|clopidogrel|mesh-list
57036836|NCT03613857|Ticagrelor|ticagrelor|mesh-list
57036837|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57036838|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57036839|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57036840|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57036841|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
57036842|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036843|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036844|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036845|NCT03613389|Vitamin E|vitamin e|mesh-list
57036846|NCT03613389|Vitamins|vitamins|mesh-ancestor
57036847|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
57036848|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036849|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
57036850|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036851|NCT03613389|Protective Agents|protective agents|mesh-ancestor
57036852|NCT02259777|Amlodipine|amlodipine|mesh-list
57036853|NCT02259777|Telmisartan|telmisartan|mesh-list
57036854|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
57036855|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57036856|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57036857|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036858|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036859|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57036860|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036861|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
57036862|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57036863|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57036864|NCT03261375|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57036865|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
57036866|NCT03261375|Nifedipine|nifedipine|mesh-list
57036867|NCT03261375|Diuretics|diuretics|mesh-ancestor
57036868|NCT03261375|Natriuretic Agents|natriuretic agents|mesh-ancestor
57036869|NCT03261375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036870|NCT03261375|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57036871|NCT03261375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036872|NCT03261375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036873|NCT03261375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57036874|NCT03261375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57036875|NCT03261375|Vasodilator Agents|vasodilator agents|mesh-ancestor
57036876|NCT03261375|Tocolytic Agents|tocolytic agents|mesh-ancestor
57036877|NCT03261375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57036878|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57036879|NCT03613545|Rifaximin|rifaximin|mesh-list
57036880|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
57036881|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036882|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57036883|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57036884|NCT01361308|Paroxetine|paroxetine|mesh-list
57036885|NCT01361308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57036886|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57036887|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036888|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036889|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036890|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
57036891|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036892|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57036893|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
56718887|NCT00881686|Adenosine|adenosine|mesh-list
57036894|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57036895|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57036896|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57036897|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036899|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
57036900|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036901|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57036902|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036903|NCT00103662|Plerixafor|plerixafor|mesh-list
57036904|NCT00103662|Lenograstim|lenograstim|mesh-list
57036905|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57036906|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
57036907|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036908|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57036909|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57036910|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
57036911|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57036912|NCT03612219|Apatinib|apatinib|mesh-list
57036913|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036914|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57036915|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036916|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036917|NCT05030116|Domperidone|domperidone|mesh-list
57036918|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
57036919|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
57036920|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036921|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036922|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57036923|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57036924|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
57036925|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036926|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036927|NCT03015129|Durvalumab|durvalumab|mesh-list
57036928|NCT03015129|Tremelimumab|tremelimumab|mesh-list
57036929|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57036930|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036931|NCT02148978|Saxagliptin|saxagliptin|mesh-list
57036932|NCT02148978|Incretins|incretins|mesh-ancestor
57036933|NCT02148978|Hormones|hormones|mesh-ancestor
57036934|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57036935|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036936|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57036937|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
57036938|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036939|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036940|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57036941|NCT05048914|Acetaminophen|acetaminophen|mesh-list
57036942|NCT05048914|Dipyrone|dipyrone|mesh-list
57036943|NCT05048914|Ibuprofen|ibuprofen|mesh-list
57036944|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57036945|NCT05048914|Analgesics|analgesics|mesh-ancestor
57036946|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
57036947|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036948|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036949|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
57036950|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57036951|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57036952|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57036953|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57036954|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57036955|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036956|NCT03046017|Lidocaine|lidocaine|mesh-list
57036957|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
57036958|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
57036959|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57036960|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036961|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
57036962|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57036963|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57036964|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57036965|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57036966|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57036967|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036968|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
57036969|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57036970|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57036971|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57036972|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57036973|NCT02978625|Nivolumab|nivolumab|mesh-list
57036974|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57036975|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57036976|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036977|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57036978|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036979|NCT02149212|Aminaftone|aminaftone|mesh-list
57036980|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
57036981|NCT02149212|Coagulants|coagulants|mesh-ancestor
57036982|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
57036983|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
57036984|NCT03611985|Taxane|taxane|mesh-list
57036985|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57036986|NCT03097900|Caffeine|caffeine|mesh-list
57036987|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
57036988|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57036989|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57036990|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57036991|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57036992|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897310|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57036993|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57036994|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57036995|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
57036996|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57036997|NCT00104676|Paclitaxel|paclitaxel|mesh-list
57036998|NCT00104676|Etoposide|etoposide|mesh-list
57036999|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
57037000|NCT00104676|Ifosfamide|ifosfamide|mesh-list
57037001|NCT00104676|Bleomycin|bleomycin|mesh-list
57037002|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037003|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037004|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
57037005|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
57037006|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
57037007|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037008|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57037009|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57037010|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037011|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57037012|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
57037013|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57037014|NCT00354835|Dactinomycin|dactinomycin|mesh-list
57037015|NCT00354835|Cactinomycin|cactinomycin|mesh-list
57037016|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
57037017|NCT00354835|Irinotecan|irinotecan|mesh-list
57037018|NCT00354835|Vincristine|vincristine|mesh-list
57037019|NCT00354835|Camptothecin|camptothecin|mesh-list
57037020|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57037021|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
57037022|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037023|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57037024|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57037025|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
57037026|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037027|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037028|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57037029|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57037030|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57037031|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037032|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037033|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
57037034|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
57037035|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
57037036|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57037037|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037038|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57037039|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57037040|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57037041|NCT02768298|Enalapril|enalapril|mesh-list
57037042|NCT02768298|Enalaprilat|enalaprilat|mesh-list
57037043|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57037044|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57037045|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
57037046|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037047|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037048|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57037049|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57037050|NCT05028322|Imiquimod|imiquimod|mesh-list
57037051|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57037052|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
57037053|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037054|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037055|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
57037056|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
57037057|NCT03096340|Irinotecan|irinotecan|mesh-list
57037058|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037059|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037060|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57037061|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57037062|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037063|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037064|NCT02152800|Valacyclovir|valacyclovir|mesh-list
57037065|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
57037066|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037067|NCT02149758|Etoricoxib|etoricoxib|mesh-list
57037068|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57037069|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037070|NCT02149758|Analgesics|analgesics|mesh-ancestor
57037071|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
57037072|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037073|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037074|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037075|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57037076|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57037077|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57037078|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037079|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037080|NCT03542214|Calcium|calcium|mesh-list
57037081|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57037082|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037083|NCT03094468|Terbinafine|terbinafine|mesh-list
57037084|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
57037085|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037086|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037087|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037088|NCT05692843|Cyclosporine|cyclosporine|mesh-list
57037089|NCT05692843|Cyclosporins|cyclosporins|mesh-list
57037090|NCT05692843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037091|NCT05692843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037092|NCT05692843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57037093|NCT05692843|Immunologic Factors|immunologic factors|mesh-ancestor
57037094|NCT05692843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037095|NCT05692843|Antifungal Agents|antifungal agents|mesh-ancestor
57037096|NCT05692843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037097|NCT05692843|Dermatologic Agents|dermatologic agents|mesh-ancestor
57037098|NCT05692843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57037099|NCT05692843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57037100|NCT03744546|Tilavonemab|tilavonemab|mesh-list
57037101|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
57037102|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
57037103|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
57037104|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57037105|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57037106|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57037107|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037108|NCT03095872|Petrolatum|petrolatum|mesh-list
57037109|NCT03095872|Emollients|emollients|mesh-ancestor
57037110|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
57037111|NCT03096184|Apatinib|apatinib|mesh-list
57037112|NCT03096184|Tegafur|tegafur|mesh-list
57037113|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037114|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57037115|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037116|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037117|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57037118|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
57037119|NCT02157012|Tofacitinib|tofacitinib|mesh-list
57037120|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57037121|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037122|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037123|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
57037124|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
57037126|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
57037127|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037128|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
57037129|NCT03096028|Hematinics|hematinics|mesh-ancestor
57037130|NCT02149914|Rabeprazole|rabeprazole|mesh-list
57037131|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57037132|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57037133|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57037134|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037135|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037136|NCT02149992|Inositol|inositol|mesh-list
57037137|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
57037138|NCT02149992|Vitamins|vitamins|mesh-ancestor
57037139|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
57037140|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037141|NCT04833582|Gemcitabine|gemcitabine|mesh-list
57037142|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57037143|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
57037144|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037145|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037146|NCT04833582|Antiviral Agents|antiviral agents|mesh-ancestor
57037147|NCT04833582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037148|NCT04833582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037149|NCT04833582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57037150|NCT04833582|Immunologic Factors|immunologic factors|mesh-ancestor
57037151|NCT04833582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037152|NCT05041582|Citalopram|citalopram|mesh-list
57037153|NCT05041582|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57037154|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57037155|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57037156|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037157|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037158|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
57037159|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037160|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57037161|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
57037162|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57037163|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
57037164|NCT05041270|Nalbuphine|nalbuphine|mesh-list
57037165|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57037166|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57037167|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037168|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037169|NCT05041270|Analgesics|analgesics|mesh-ancestor
57037170|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
57037171|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037172|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57037173|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57037174|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57037175|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
57037176|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037177|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037178|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57037179|NCT05041270|Narcotics|narcotics|mesh-ancestor
57037180|NCT00324805|Gemcitabine|gemcitabine|mesh-list
57037181|NCT00324805|Bevacizumab|bevacizumab|mesh-list
57037182|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57037183|NCT00324805|Cisplatin|cisplatin|mesh-list
57037184|NCT00324805|Docetaxel|docetaxel|mesh-list
57037185|NCT00324805|Pemetrexed|pemetrexed|mesh-list
57037186|NCT00324805|Vinorelbine|vinorelbine|mesh-list
57037187|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
57037188|NCT00324805|Antibodies|antibodies|mesh-list
57037189|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
57037190|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57037191|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
57037192|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037193|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57037194|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57037195|NCT00324805|Growth Substances|growth substances|mesh-ancestor
57037196|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037197|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
57037198|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
57037199|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57037200|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
57037201|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037202|NCT00324805|Antiviral Agents|antiviral agents|mesh-ancestor
57037203|NCT00324805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037204|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037205|NCT00324805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57037206|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
57037207|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
57037208|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
57037209|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57037210|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57037211|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037213|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57037214|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
57037215|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57037216|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
57037217|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037218|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037219|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
57037220|NCT05027386|Irinotecan|irinotecan|mesh-list
57037221|NCT05027386|Temozolomide|temozolomide|mesh-list
57037222|NCT05027386|Apatinib|apatinib|mesh-list
57037223|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57037224|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57037225|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037226|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037227|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037228|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57037229|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
57037230|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57037231|NCT04434430|Gabapentin|gabapentin|mesh-list
57037232|NCT04434430|Analgesics|analgesics|mesh-ancestor
57037233|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
57037234|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037235|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037236|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
57037237|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57037238|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57037239|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57037240|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57037241|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57037242|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57037243|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037244|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037245|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
57037246|NCT03094156|Resveratrol|resveratrol|mesh-list
57037247|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
57037248|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
57037249|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037250|NCT03094156|Protective Agents|protective agents|mesh-ancestor
57037251|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037252|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037253|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57037254|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
57037255|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037256|NCT02964273|Tolvaptan|tolvaptan|mesh-list
57037257|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57037258|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037259|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
57037260|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037261|NCT05040724|Ivermectin|ivermectin|mesh-list
57037262|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57037263|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037264|NCT03542058|Carvedilol|carvedilol|mesh-list
57037265|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57037266|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57037267|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
57037268|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037269|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037270|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037271|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57037273|NCT03542058|Protective Agents|protective agents|mesh-ancestor
57037274|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57037275|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57037276|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57037277|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
57037278|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57037279|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57037280|NCT03321513|Bevacizumab|bevacizumab|mesh-list
57037281|NCT03321513|Aflibercept|aflibercept|mesh-list
57037282|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57037283|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037284|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57037285|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57037286|NCT03321513|Growth Substances|growth substances|mesh-ancestor
57037287|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037288|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
57037289|NCT02032797|Progesterone|progesterone|mesh-list
57037290|NCT02032797|Progestins|progestins|mesh-ancestor
57037291|NCT02032797|Hormones|hormones|mesh-ancestor
57037292|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037293|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037294|NCT05024266|Paclitaxel|paclitaxel|mesh-list
57037295|NCT05024266|Carboplatin|carboplatin|mesh-list
57037296|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037297|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037298|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
57037299|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
57037300|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
57037301|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037302|NCT05383521|Tinidazole|tinidazole|mesh-list
57037303|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
57037304|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037305|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57037306|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037307|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57037308|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57037309|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57037310|NCT02773368|Insulin|insulin|mesh-list
57037311|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57037312|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
57037313|NCT02773368|Liraglutide|liraglutide|mesh-list
57037314|NCT02773368|Xultophy|xultophy|mesh-list
57037315|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57037316|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037317|NCT02773368|Incretins|incretins|mesh-ancestor
57037318|NCT02773368|Hormones|hormones|mesh-ancestor
57037319|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037320|NCT02893917|Olaparib|olaparib|mesh-list
57037321|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57037322|NCT02893917|Cediranib|cediranib|mesh-list
57037323|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037324|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037325|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037326|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57037327|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
57037328|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57037329|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037330|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
57037331|NCT02157558|Fexofenadine|fexofenadine|mesh-list
57037332|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57037333|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57037334|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57037335|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
57037336|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
57037337|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037338|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037339|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037340|NCT05018182|Leucovorin|leucovorin|mesh-list
57037341|NCT05018182|Folic Acid|folic acid|mesh-list
57037342|NCT05018182|Fluorouracil|fluorouracil|mesh-list
57037343|NCT05018182|Capecitabine|capecitabine|mesh-list
57037344|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
57037345|NCT05018182|Irinotecan|irinotecan|mesh-list
57037346|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
57037347|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
56719344|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
57037348|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037349|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57037350|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037351|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57037352|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
57037353|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037354|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57037355|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57037356|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037357|NCT05018182|Antidotes|antidotes|mesh-ancestor
57037358|NCT05018182|Protective Agents|protective agents|mesh-ancestor
57037359|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
57037360|NCT05018182|Vitamins|vitamins|mesh-ancestor
57037361|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
57037362|NCT05018182|Hematinics|hematinics|mesh-ancestor
57037363|NCT04717765|Vitamin E|vitamin e|mesh-list
57037364|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
57037365|NCT04717765|Tocopherols|tocopherols|mesh-list
57037366|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
57037367|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037368|NCT04717765|Protective Agents|protective agents|mesh-ancestor
57037369|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037370|NCT04717765|Vitamins|vitamins|mesh-ancestor
57037371|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
57037372|NCT01336569|Timolol|timolol|mesh-list
57037373|NCT01336569|Travoprost|travoprost|mesh-list
57037374|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037375|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57037376|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57037377|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
57037378|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037379|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037380|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57037381|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57037382|NCT03092986|Paclitaxel|paclitaxel|mesh-list
57037383|NCT03092986|Vinblastine|vinblastine|mesh-list
57037384|NCT03092986|Carboplatin|carboplatin|mesh-list
57037385|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037386|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037387|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
57037388|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
57037389|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
57037390|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037391|NCT03092908|Acetic Acid|acetic acid|mesh-list
57037392|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57037393|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037394|NCT03543306|Trametinib|trametinib|mesh-list
57037395|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037396|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57037397|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037398|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037399|NCT02157792|Gemcitabine|gemcitabine|mesh-list
57037400|NCT02157792|Carboplatin|carboplatin|mesh-list
57037401|NCT02157792|Irinotecan|irinotecan|mesh-list
57037402|NCT02157792|Etoposide|etoposide|mesh-list
57037403|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037404|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57037405|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
57037406|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037407|NCT02157792|Antiviral Agents|antiviral agents|mesh-ancestor
57037408|NCT02157792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037409|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037410|NCT02157792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57037411|NCT02157792|Immunologic Factors|immunologic factors|mesh-ancestor
57037412|NCT02157792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037413|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57037414|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57037415|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037416|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57037417|NCT04829383|Bevacizumab|bevacizumab|mesh-list
57037418|NCT04829383|Atezolizumab|atezolizumab|mesh-list
57037419|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57037420|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037421|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57037422|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57037423|NCT04829383|Growth Substances|growth substances|mesh-ancestor
57037424|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037425|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
57037426|NCT05023408|Bleomycin|bleomycin|mesh-list
57037427|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57037428|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037429|NCT02772978|Tolcapone|tolcapone|mesh-list
57037430|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57037431|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57037432|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
57037433|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037434|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037435|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
57037436|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57037437|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57037438|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037439|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57037440|NCT02150616|Sevoflurane|sevoflurane|mesh-list
57037441|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57037442|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57037443|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
57037444|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
57037445|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57037446|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037447|NCT05164549|Buprenorphine|buprenorphine|mesh-list
57037448|NCT05164549|Methadone|methadone|mesh-list
57037449|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57037450|NCT05164549|Narcotics|narcotics|mesh-ancestor
57037451|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57037452|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037453|NCT05164549|Analgesics|analgesics|mesh-ancestor
57037454|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
57037455|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037456|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57037457|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
57037458|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
57037459|NCT00104052|Ribavirin|ribavirin|mesh-list
57037460|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57037461|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
57037462|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
57037463|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037464|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
57037465|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037466|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
57037467|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037468|NCT05038072|Triamcinolone|triamcinolone|mesh-list
57037469|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57037470|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57037471|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57037472|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037473|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
57037474|NCT05038072|Hormones|hormones|mesh-ancestor
57037475|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037476|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037477|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57037478|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
57037479|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037480|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037481|NCT02777970|Acetaminophen|acetaminophen|mesh-list
57037482|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
57037483|NCT02777970|Tramadol|tramadol|mesh-list
57037484|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037485|NCT02777970|Analgesics|analgesics|mesh-ancestor
57037486|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
57037487|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037488|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037489|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
57037490|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57037491|NCT02777970|Narcotics|narcotics|mesh-ancestor
57037492|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57037493|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57037494|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037495|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57037496|NCT01336023|Insulin|insulin|mesh-list
57037497|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57037498|NCT01336023|Liraglutide|liraglutide|mesh-list
57037499|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
57037500|NCT01336023|Xultophy|xultophy|mesh-list
57037501|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57037502|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037503|NCT01336023|Incretins|incretins|mesh-ancestor
57037504|NCT01336023|Hormones|hormones|mesh-ancestor
57037505|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037506|NCT02255292|Cannabidiol|cannabidiol|mesh-list
57037507|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
57037508|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57037509|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57037510|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
57037511|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037512|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56897322|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
57037513|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57037514|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037515|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037516|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57037517|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57037518|NCT02254980|Vitamin E|vitamin e|mesh-list
57037519|NCT02254980|Vitamins|vitamins|mesh-ancestor
57037520|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
57037521|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037522|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
57037523|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037524|NCT02254980|Protective Agents|protective agents|mesh-ancestor
57037525|NCT05281003|Paclitaxel|paclitaxel|mesh-list
57037526|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
57037527|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037528|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037529|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
57037530|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
57037531|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
57037532|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037533|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57037534|NCT02158182|Rifaximin|rifaximin|mesh-list
57037535|NCT02158182|Lactulose|lactulose|mesh-list
57037536|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
57037537|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57037538|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037539|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57037540|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
57037541|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57037542|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037543|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037544|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037545|NCT04786873|Clonidine|clonidine|mesh-list
57037546|NCT04786873|Analgesics|analgesics|mesh-ancestor
57037547|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
57037548|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037549|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037550|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57037551|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
57037552|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
57037553|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57037554|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57037555|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57037556|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
57037557|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037558|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037559|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
57037560|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57037561|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037562|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
57037563|NCT02154360|Aprepitant|aprepitant|mesh-list
57037564|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
57037565|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
57037566|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037567|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037568|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57037569|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57037570|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037571|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037572|NCT02033031|Bevacizumab|bevacizumab|mesh-list
57037573|NCT02033031|Ranibizumab|ranibizumab|mesh-list
57037574|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56719587|NCT01154335|Everolimus|everolimus|mesh-list
57037575|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037576|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57037577|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57037578|NCT02033031|Growth Substances|growth substances|mesh-ancestor
57037579|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037580|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
57037581|NCT05034367|Mannitol|mannitol|mesh-list
57037582|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57037583|NCT05034367|Diuretics|diuretics|mesh-ancestor
57037584|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
57037585|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037586|NCT02150928|Asparaginase|asparaginase|mesh-list
57037587|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037588|NCT05249101|Capecitabine|capecitabine|mesh-list
57037589|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57037590|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
57037591|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037592|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037593|NCT03611049|Vitamin D|vitamin d|mesh-list
57037594|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
57037595|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
57037596|NCT03611049|Vitamins|vitamins|mesh-list
57037597|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
57037598|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037599|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57037600|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57037601|NCT04822350|Avelumab|avelumab|mesh-list
57037602|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57037603|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037604|NCT03610893|Dexamethasone|dexamethasone|mesh-list
57037605|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
57037606|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037607|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
57037608|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
57037609|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037610|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037611|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57037612|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
57037613|NCT03610893|Hormones|hormones|mesh-ancestor
57037614|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037615|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57037616|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037617|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57037618|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57037619|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037620|NCT03610893|Analgesics|analgesics|mesh-ancestor
57037621|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
57037622|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57037623|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57037624|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57037625|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
57037626|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037627|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037628|NCT04737109|Androgens|androgens|mesh-list
57037629|NCT04737109|Hormones|hormones|mesh-ancestor
57037630|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037631|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037632|NCT02154438|Ketamine|ketamine|mesh-list
57037633|NCT02154438|Analgesics|analgesics|mesh-ancestor
57037634|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
57037635|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037636|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037637|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57037638|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57037639|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
57037640|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
57037641|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57037642|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57037643|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57037644|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037645|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037646|NCT02520921|Aspirin|aspirin|mesh-list
57037647|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57037648|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037649|NCT02520921|Analgesics|analgesics|mesh-ancestor
57037650|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
57037651|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037652|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037653|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037654|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57037655|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57037656|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57037657|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037658|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57037659|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57037660|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037661|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
57037662|NCT05655013|Zoledronic Acid|zoledronic acid|mesh-list
57037663|NCT05655013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57037664|NCT05655013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037665|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
57037666|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57037667|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57037668|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037669|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
57037670|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
57037671|NCT03610347|Paclitaxel|paclitaxel|mesh-list
57037672|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037673|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037674|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
57037675|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
57037676|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
57037677|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037678|NCT01518517|Asparaginase|asparaginase|mesh-list
57037679|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037680|NCT02863575|Ibuprofen|ibuprofen|mesh-list
57037681|NCT02863575|Caffeine|caffeine|mesh-list
57037682|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57037683|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037684|NCT02863575|Analgesics|analgesics|mesh-ancestor
57037685|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
57037686|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037687|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037688|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037689|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57037690|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57037691|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037692|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037693|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57037694|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57037695|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57037696|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57037697|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
57037698|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037699|NCT05021770|Thiotepa|thiotepa|mesh-list
57037700|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57037701|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
57037702|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037703|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037704|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57037705|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57037706|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
57037707|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037708|NCT04722523|Carboplatin|carboplatin|mesh-list
57037709|NCT04722523|Docetaxel|docetaxel|mesh-list
57037710|NCT04722523|Cetuximab|cetuximab|mesh-list
57037711|NCT04722523|Cemiplimab|cemiplimab|mesh-list
57037712|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037713|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
57037714|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
57037715|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
57037716|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037717|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57037718|NCT05230303|Caffeine|caffeine|mesh-list
57037719|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57037720|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037721|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57037722|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037723|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037724|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57037725|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57037726|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
57037727|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037728|NCT04287790|Naltrexone|naltrexone|mesh-list
57037729|NCT04287790|Disulfiram|disulfiram|mesh-list
57037730|NCT04287790|Acamprosate|acamprosate|mesh-list
57037731|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57037732|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57037733|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037734|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
57037735|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037736|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
57037737|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037738|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037739|NCT03723967|Paclitaxel|paclitaxel|mesh-list
57037740|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57037741|NCT03723967|Carboplatin|carboplatin|mesh-list
57037742|NCT03723967|Durvalumab|durvalumab|mesh-list
57037743|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57037744|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57037745|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037746|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
57037747|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
57037748|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
57037749|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037750|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57037751|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
57037752|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037753|NCT05008666|Azacitidine|azacitidine|mesh-list
57037754|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57037755|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
57037756|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037757|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037758|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037759|NCT05025787|Celecoxib|celecoxib|mesh-list
57037760|NCT05025787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57037761|NCT05025787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037762|NCT05025787|Analgesics|analgesics|mesh-ancestor
57037763|NCT05025787|Sensory System Agents|sensory system agents|mesh-ancestor
57037764|NCT05025787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037765|NCT05025787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037766|NCT05025787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037767|NCT05025787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57037768|NCT05025787|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57037769|NCT05025787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57037770|NCT05025787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037771|NCT05025787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037772|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57037773|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57037774|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037775|NCT03659461|Incretins|incretins|mesh-ancestor
57037776|NCT03659461|Hormones|hormones|mesh-ancestor
57037777|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037778|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57037779|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
57037780|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037781|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037782|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
57037783|NCT01227187|Protein C|protein c|mesh-list
57037784|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037785|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
57037786|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57037787|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57037788|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037789|NCT03088072|Aspirin|aspirin|mesh-list
57037790|NCT03088072|Warfarin|warfarin|mesh-list
57037791|NCT03088072|Edoxaban|edoxaban|mesh-list
57037792|NCT03088072|Clopidogrel|clopidogrel|mesh-list
57037793|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57037794|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037795|NCT03088072|Analgesics|analgesics|mesh-ancestor
57037796|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
57037797|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037798|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037799|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037800|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57037801|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57037802|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57037803|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037804|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57037805|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57037806|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037808|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57037809|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57037810|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57037811|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
57037812|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037813|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
57037814|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57037815|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
57037816|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57037817|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
57037818|NCT01077817|Alendronate|alendronate|mesh-list
57037819|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
57037820|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
57037821|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
57037822|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
57037823|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57037824|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037825|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57037826|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57037827|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037828|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57037829|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57037830|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
57037831|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037832|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57037833|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57037834|NCT02638012|Hemostatics|hemostatics|mesh-list
57037835|NCT02638012|Coagulants|coagulants|mesh-ancestor
57037836|NCT05014906|Minocycline|minocycline|mesh-list
57037837|NCT05014906|Azelaic acid|azelaic acid|mesh-list
57037838|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57037839|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037840|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037841|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
57037842|NCT00103506|Doxorubicin|doxorubicin|mesh-list
57037843|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57037844|NCT00103506|Bortezomib|bortezomib|mesh-list
57037845|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57037846|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037847|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57037848|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57037849|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037850|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037851|NCT02151240|Acyclovir|acyclovir|mesh-list
57037852|NCT02151240|Foscarnet|foscarnet|mesh-list
57037853|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
57037854|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
57037855|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037856|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57037857|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57037858|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037859|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037860|NCT03542760|Methylene Blue|methylene blue|mesh-list
57037861|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037862|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037863|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
57037864|NCT02159196|Albuterol|albuterol|mesh-list
57037865|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57037866|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
57037867|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037868|NCT02159196|Expectorants|expectorants|mesh-ancestor
57037869|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
57037870|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57037871|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
57037872|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037873|NCT02159196|Protective Agents|protective agents|mesh-ancestor
57037874|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037875|NCT02159196|Antidotes|antidotes|mesh-ancestor
57037876|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57037877|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
57037878|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037879|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57037880|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
56897327|NCT01168011|ON 01910|on 01910|mesh-list
57037881|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57037882|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57037883|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57037884|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57037885|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
57037886|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037887|NCT02765490|Simeprevir|simeprevir|mesh-list
57037888|NCT02765490|Odalasvir|odalasvir|mesh-list
57037889|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
57037890|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037891|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
57037892|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037893|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037894|NCT02762370|Triamcinolone|triamcinolone|mesh-list
57037895|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57037896|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57037898|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57037899|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037900|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
57037901|NCT02762370|Hormones|hormones|mesh-ancestor
57037902|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037903|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037904|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57037905|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
57037906|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037907|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037908|NCT02639182|Axitinib|axitinib|mesh-list
57037909|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037910|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57037911|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037912|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037913|NCT02863419|Liraglutide|liraglutide|mesh-list
57037914|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57037915|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037916|NCT02863419|Incretins|incretins|mesh-ancestor
57037917|NCT02863419|Hormones|hormones|mesh-ancestor
57037918|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037919|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57037920|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57037921|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57037922|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037923|NCT04961632|Tamoxifen|tamoxifen|mesh-list
57037924|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57037925|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
57037926|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57037927|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037928|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57037929|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57037930|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57037931|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57037932|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57037933|NCT02155374|Insulin|insulin|mesh-list
57037934|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57037935|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
57037936|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
57037937|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57037938|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037939|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
57037940|NCT02765100|Minocycline|minocycline|mesh-list
57037941|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57037942|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57037943|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
57037944|NCT03091894|Propofol|propofol|mesh-list
57037945|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57037946|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719932|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
57037947|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037948|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57037949|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
57037951|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037952|NCT03091894|Analgesics|analgesics|mesh-ancestor
57037953|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
57037954|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037955|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57037956|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57037957|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57037958|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
57037959|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57037960|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037961|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
57037962|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57037963|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037964|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57037965|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037966|NCT02761980|Acetaminophen|acetaminophen|mesh-list
57037967|NCT02761980|Ibuprofen|ibuprofen|mesh-list
57037968|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57037969|NCT02761980|Analgesics|analgesics|mesh-ancestor
57037970|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
57037971|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57037972|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037973|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
57037974|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57037975|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57037976|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57037977|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57037978|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037979|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037980|NCT05007340|Dimercaprol|dimercaprol|mesh-list
57037981|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
57037982|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
57037983|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037984|NCT05014048|Vitamin D|vitamin d|mesh-list
57037985|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
57037986|NCT05014048|Vitamins|vitamins|mesh-ancestor
57037987|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
57037988|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037989|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57037990|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57037991|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
57037992|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57037993|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57037994|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57037995|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57037996|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57037997|NCT02163174|Protective Agents|protective agents|mesh-ancestor
57037998|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57037999|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
57038000|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57038001|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
57038002|NCT01744912|Lenalidomide|lenalidomide|mesh-list
57038003|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
57038004|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038005|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57038006|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57038007|NCT01744912|Growth Substances|growth substances|mesh-ancestor
57038008|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
57038009|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038010|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
57038011|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
57038012|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57038013|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57038014|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038015|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038016|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038017|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57038018|NCT02159820|Paclitaxel|paclitaxel|mesh-list
57038019|NCT02159820|Carboplatin|carboplatin|mesh-list
57038020|NCT02159820|Decitabine|decitabine|mesh-list
57038021|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57038022|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038023|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
57038024|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
57038025|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
57038026|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038027|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57038028|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
57038029|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038030|NCT02862171|Dapivirine|dapivirine|mesh-list
57038031|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57038032|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57038033|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
57038034|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038035|NCT05013112|Metformin|metformin|mesh-list
57038036|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57038037|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57038038|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038039|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038040|NCT05013034|Basiliximab|basiliximab|mesh-list
57038041|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57038042|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
57038043|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038044|NCT02638948|Methotrexate|methotrexate|mesh-list
57038045|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57038046|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
57038047|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57038048|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038049|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57038050|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
57038051|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038052|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038053|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
57038054|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038055|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57038056|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57038057|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
57038058|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57038059|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57038060|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
57038061|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038062|NCT04465864|Dexamethasone|dexamethasone|mesh-list
57038063|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57038064|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
57038065|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
57038066|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038067|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038068|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57038069|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
57038070|NCT04465864|Hormones|hormones|mesh-ancestor
57038071|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038072|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57038073|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038074|NCT03091504|Albuterol|albuterol|mesh-list
57038075|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57038076|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
57038077|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038078|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038079|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57038080|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
57038081|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
57038082|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57038083|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57038084|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57038085|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57038086|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
57038087|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038088|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038089|NCT05019586|Amoxicillin|amoxicillin|mesh-list
57038090|NCT05019586|Clarithromycin|clarithromycin|mesh-list
57038091|NCT05019586|Levofloxacin|levofloxacin|mesh-list
57038092|NCT05019586|Ofloxacin|ofloxacin|mesh-list
57038093|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038094|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038095|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57038096|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038097|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038098|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57038099|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57038100|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57038102|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57038103|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57038104|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038105|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57038106|NCT03081676|Glimepiride|glimepiride|mesh-list
57038107|NCT03081676|Glucagon|glucagon|mesh-list
57038108|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
57038109|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57038110|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57038111|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57038112|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038113|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57038114|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
57038115|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57038116|NCT03081676|Hormones|hormones|mesh-ancestor
57038117|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038118|NCT03081676|Incretins|incretins|mesh-ancestor
57038119|NCT05013268|Paclitaxel|paclitaxel|mesh-list
57038120|NCT05013268|Docetaxel|docetaxel|mesh-list
57038121|NCT05013268|Carboplatin|carboplatin|mesh-list
57038122|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57038123|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038124|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
57038125|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
57038126|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
57038127|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038128|NCT00102960|Ritonavir|ritonavir|mesh-list
57038129|NCT00102960|Lopinavir|lopinavir|mesh-list
57038130|NCT00102960|Lamivudine|lamivudine|mesh-list
57038131|NCT00102960|Zidovudine|zidovudine|mesh-list
57038132|NCT00102960|Nevirapine|nevirapine|mesh-list
57038133|NCT00102960|Abacavir|abacavir|mesh-list
57038134|NCT00102960|Didanosine|didanosine|mesh-list
57038135|NCT00102960|Efavirenz|efavirenz|mesh-list
57038136|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57038137|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57038138|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
57038139|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038140|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038141|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57038142|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57038143|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
57038144|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038145|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57038146|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57038147|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57038148|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57038149|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
57038150|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57038151|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57038152|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57038153|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57038154|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57038155|NCT02858895|Interleukin-4|interleukin-4|mesh-list
57038156|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57038157|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
57038158|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038159|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038160|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57038161|NCT05018962|Paclitaxel|paclitaxel|mesh-list
57038162|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57038163|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038164|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
57038165|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
57038166|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
57038167|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038168|NCT02160054|Tacrolimus|tacrolimus|mesh-list
57038169|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57038170|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
57038171|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038172|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57038173|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038174|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038175|NCT03609489|Capecitabine|capecitabine|mesh-list
57038176|NCT03609489|Apatinib|apatinib|mesh-list
57038177|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57038178|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
57038179|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038180|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038181|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57038182|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038183|NCT02033967|Milrinone|milrinone|mesh-list
57038184|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
57038185|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57038186|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57038187|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57038188|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57038189|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038190|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038191|NCT02033967|Protective Agents|protective agents|mesh-ancestor
57038192|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038193|NCT02163330|Acetazolamide|acetazolamide|mesh-list
57038194|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
57038195|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57038196|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038197|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038198|NCT02163330|Diuretics|diuretics|mesh-ancestor
57038199|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
57038200|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038201|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
57038202|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
57038203|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
57038204|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038205|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
57038206|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57038207|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57038208|NCT02160132|Prednisolone|prednisolone|mesh-list
57038209|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
57038210|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57038211|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
57038212|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57038213|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
57038214|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
57038215|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038216|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038217|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57038218|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
57038219|NCT02160132|Hormones|hormones|mesh-ancestor
57038220|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038221|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57038222|NCT02160132|Protective Agents|protective agents|mesh-ancestor
57038223|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57038224|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038225|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
57038226|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57038227|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038228|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57038229|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57038230|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57038231|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038232|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
57038233|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038234|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
57038235|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
56897349|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
57038236|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038237|NCT02858037|Dapivirine|dapivirine|mesh-list
57038238|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57038239|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57038240|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
57038241|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038242|NCT01755975|Lenalidomide|lenalidomide|mesh-list
57038243|NCT01755975|Romidepsin|romidepsin|mesh-list
57038244|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
57038245|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038246|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57038247|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57038248|NCT01755975|Growth Substances|growth substances|mesh-ancestor
57038249|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
57038250|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038251|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57038252|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
57038253|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038254|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57038255|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038256|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038257|NCT01989585|Trametinib|trametinib|mesh-list
57038258|NCT01989585|Dabrafenib|dabrafenib|mesh-list
57038259|NCT01989585|Navitoclax|navitoclax|mesh-list
57038260|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038261|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57038262|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038263|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038264|NCT04266340|Midazolam|midazolam|mesh-list
57038265|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
57038266|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57038267|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038268|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038269|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57038270|NCT04266340|Analgesics|analgesics|mesh-ancestor
57038271|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
57038272|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038273|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57038274|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57038275|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57038276|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
57038277|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038278|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038279|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57038280|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57038281|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57038282|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57038283|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57038284|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
57038285|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
57038286|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
57038287|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
57038288|NCT02856555|Firsocostat|firsocostat|mesh-list
57038289|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038290|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038291|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
57038292|NCT02237079|Estrogens|estrogens|mesh-list
57038293|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
57038294|NCT02237079|Hormones|hormones|mesh-ancestor
57038295|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038296|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038297|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57038298|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57038299|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
57038300|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57038301|NCT04463680|Rifampin|rifampin|mesh-list
57038302|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57038303|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
57038304|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038305|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038306|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
57038307|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57038308|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897351|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038309|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038310|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57038311|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57038312|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57038313|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57038314|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57038315|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57038316|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
57038317|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038318|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038319|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57038320|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57038321|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038322|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038323|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038324|NCT05000086|Diphosphonates|diphosphonates|mesh-list
57038325|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
57038326|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57038327|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038328|NCT05010538|Sarecycline|sarecycline|mesh-list
57038329|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038330|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038331|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
57038332|NCT01242267|Thalidomide|thalidomide|mesh-list
57038333|NCT01242267|Bortezomib|bortezomib|mesh-list
57038334|NCT01242267|Melphalan|melphalan|mesh-list
57038335|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038336|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57038337|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
57038338|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038339|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57038340|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57038341|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
57038342|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038343|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
57038344|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038345|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038346|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57038347|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57038348|NCT01242267|Growth Substances|growth substances|mesh-ancestor
57038349|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
57038350|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57038351|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57038352|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57038353|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57038354|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57038355|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
57038356|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038357|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038358|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038359|NCT02635984|Olanzapine|olanzapine|mesh-list
57038360|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
57038361|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
57038362|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038363|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038364|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57038365|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57038366|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57038367|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038368|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57038369|NCT02635984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57038370|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57038371|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57038372|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038373|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038374|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
57038375|NCT03073408|Propofol|propofol|mesh-list
57038376|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57038377|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038378|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038379|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57038380|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
57038381|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
57038382|NCT04993222|Amphotericin B|amphotericin b|mesh-list
57038383|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
57038384|NCT04993222|Amebicides|amebicides|mesh-ancestor
57038385|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57038386|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57038387|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038388|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038389|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
57038390|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57038391|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57038392|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57038393|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038394|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038395|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57038396|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57038397|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038398|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
57038399|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038400|NCT02747043|Rituximab|rituximab|mesh-list
57038401|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57038402|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038403|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
57038404|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038405|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57038406|NCT05004142|Letrozole|letrozole|mesh-list
57038407|NCT05004142|Fulvestrant|fulvestrant|mesh-list
57038408|NCT05004142|Goserelin|goserelin|mesh-list
57038409|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038410|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57038411|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57038412|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038413|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038414|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57038415|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
57038416|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038417|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038418|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57038419|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57038420|NCT03076684|Allopurinol|allopurinol|mesh-list
57038421|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
57038422|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038423|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038424|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
57038425|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57038426|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57038427|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
57038428|NCT03076684|Protective Agents|protective agents|mesh-ancestor
57038429|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038430|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
57038431|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57038432|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
57038433|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038434|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038435|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57038436|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
57038437|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
57038438|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57038439|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
57038440|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038441|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038442|NCT03607851|Lacosamide|lacosamide|mesh-list
57038443|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
57038444|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57038445|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57038446|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57038447|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038448|NCT04999540|Fulvestrant|fulvestrant|mesh-list
57038449|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57038450|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038451|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57038452|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57038453|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
56054679|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
57038454|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038455|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038456|NCT03608007|Ensartinib|ensartinib|mesh-list
57038457|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038458|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57038459|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038460|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038461|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
57038462|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57038463|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57038464|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
57038465|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
57038466|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038467|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038468|NCT03075358|Lidocaine|lidocaine|mesh-list
57038469|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
57038470|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
57038471|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038472|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038473|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
57038474|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038475|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57038476|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57038477|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57038478|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57038479|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038480|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
57038481|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57038482|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57038483|NCT05003596|Prednisolone|prednisolone|mesh-list
57038484|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
57038485|NCT05003596|Narcotics|narcotics|mesh-list
57038486|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57038487|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
57038488|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57038489|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
57038490|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
57038491|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038492|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038493|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57038494|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
57038495|NCT05003596|Hormones|hormones|mesh-ancestor
57038496|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038497|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57038498|NCT05003596|Protective Agents|protective agents|mesh-ancestor
57038499|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57038500|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038501|NCT05003596|Analgesics|analgesics|mesh-ancestor
57038502|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
57038503|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038504|NCT02854527|Metformin|metformin|mesh-list
57038505|NCT02854527|Digoxin|digoxin|mesh-list
57038506|NCT02854527|Furosemide|furosemide|mesh-list
57038507|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57038508|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57038509|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038510|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57038511|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57038512|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
57038513|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038514|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57038515|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57038516|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038517|NCT02854527|Diuretics|diuretics|mesh-ancestor
57038518|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
57038519|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57038520|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57038521|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57038522|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57038523|NCT02854527|Protective Agents|protective agents|mesh-ancestor
57038524|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
57038525|NCT04460872|Testosterone|testosterone|mesh-list
57038526|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
57038527|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
57038528|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57038529|NCT04460872|Androgens|androgens|mesh-ancestor
57038530|NCT04460872|Hormones|hormones|mesh-ancestor
57038531|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038532|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038533|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57038534|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038535|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
57038536|NCT04433572|Sirolimus|sirolimus|mesh-list
57038537|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038538|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038539|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57038540|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038541|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
57038542|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57038543|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
57038544|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038545|NCT03073018|Fosinopril|fosinopril|mesh-list
57038546|NCT03073018|Pravastatin|pravastatin|mesh-list
57038547|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57038548|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57038549|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
57038550|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038551|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57038552|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57038553|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038554|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57038555|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
57038556|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57038557|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57038558|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
57038559|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
57038560|NCT03608241|Estradiol|estradiol|mesh-list
57038561|NCT03608241|Estrogens|estrogens|mesh-ancestor
57038562|NCT03608241|Hormones|hormones|mesh-ancestor
57038563|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038564|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038565|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57038566|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57038567|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57038568|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57038569|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
57038570|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57038571|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038572|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038573|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57038574|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57038575|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038576|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038577|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038578|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57038579|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
57038580|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57038581|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038582|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57038583|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57038584|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57038585|NCT03607383|Red yeast rice|red yeast rice|mesh-list
57038586|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57038587|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57038588|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57038589|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
57038590|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038591|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038592|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57038593|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
57038594|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
57038595|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
57038596|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038597|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038598|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
57038599|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038600|NCT03607149|Pemetrexed|pemetrexed|mesh-list
57038601|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038602|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038603|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038604|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57038605|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57038606|NCT04998838|Tenofovir|tenofovir|mesh-list
57038607|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
57038608|NCT04998838|Antibodies|antibodies|mesh-list
57038609|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
57038610|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57038611|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57038612|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
57038613|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038614|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57038615|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57038616|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038617|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038618|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57038619|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56720608|NCT01039363|Idarubicin|idarubicin|mesh-list
57038620|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
57038621|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038622|NCT03607071|Prednisolone|prednisolone|mesh-list
57038623|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57038624|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
57038625|NCT03607071|Hormones|hormones|mesh-ancestor
57038626|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038627|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038628|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57038629|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038630|NCT02035215|Atorvastatin|atorvastatin|mesh-list
57038631|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57038632|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57038633|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
57038634|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038635|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57038636|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57038637|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038638|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
57038639|NCT03605589|Blinatumomab|blinatumomab|mesh-list
57038640|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57038641|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038642|NCT05002270|Cetuximab|cetuximab|mesh-list
57038643|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57038644|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038645|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57038646|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57038647|NCT03074968|Benzydamine|benzydamine|mesh-list
57038648|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57038649|NCT04991584|Amoxicillin|amoxicillin|mesh-list
57038650|NCT04991584|Levofloxacin|levofloxacin|mesh-list
57038651|NCT04991584|Ofloxacin|ofloxacin|mesh-list
57038652|NCT04991584|Tetracycline|tetracycline|mesh-list
57038653|NCT04991584|Furazolidone|furazolidone|mesh-list
57038654|NCT04991584|Esomeprazole|esomeprazole|mesh-list
57038655|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038656|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038657|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57038658|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57038659|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57038660|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038661|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038662|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57038663|NCT04991584|Renal Agents|renal agents|mesh-ancestor
57038664|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57038665|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57038666|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038667|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57038668|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57038669|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57038670|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57038671|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57038672|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57038673|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57038674|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57038675|NCT05001412|Carboplatin|carboplatin|mesh-list
57038676|NCT05001412|Etoposide|etoposide|mesh-list
57038677|NCT05001412|Apatinib|apatinib|mesh-list
57038678|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038679|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57038680|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57038681|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57038682|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038683|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038684|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57038685|NCT04991896|Metoprolol|metoprolol|mesh-list
57038686|NCT04991896|Sotalol|sotalol|mesh-list
57038687|NCT04991896|Flecainide|flecainide|mesh-list
57038688|NCT04991896|Bisoprolol|bisoprolol|mesh-list
57038689|NCT04991896|Betaxolol|betaxolol|mesh-list
57038690|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57038691|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57038692|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
57038693|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
57038694|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038695|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038696|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57038697|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57038698|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57038699|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
57038700|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038701|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038702|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57038703|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57038704|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57038705|NCT03072394|Lidocaine|lidocaine|mesh-list
57038706|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
57038707|NCT03072394|Anesthetics|anesthetics|mesh-list
57038708|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038709|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038710|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
57038711|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038712|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57038713|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57038714|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57038715|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57038716|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038717|NCT03072082|Aspirin|aspirin|mesh-list
57038718|NCT03072082|Metoprolol|metoprolol|mesh-list
57038719|NCT03072082|Isosorbide|isosorbide|mesh-list
57038720|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57038721|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57038722|NCT03072082|Trimetazidine|trimetazidine|mesh-list
57038723|NCT03072082|Clopidogrel|clopidogrel|mesh-list
57038724|NCT03072082|Atorvastatin|atorvastatin|mesh-list
57038725|NCT03072082|Calcium|calcium|mesh-list
57038726|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57038727|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038728|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57038729|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57038730|NCT03072082|Analgesics|analgesics|mesh-ancestor
57038731|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
57038732|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038733|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57038734|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57038735|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57038736|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57038737|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038738|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57038739|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57038740|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038741|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
57038742|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57038743|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57038744|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
57038745|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57038746|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56897356|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57038747|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57038748|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57038749|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57038750|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
57038751|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038752|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57038753|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57038754|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
57038755|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
57038756|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57038757|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57038758|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57038759|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
57038760|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57038761|NCT03072082|Diuretics|diuretics|mesh-ancestor
57038762|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
57038763|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
57038764|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57038765|NCT04934020|Metronidazole|metronidazole|mesh-list
57038766|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038767|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57038768|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57038769|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57038770|NCT04904614|Letermovir|letermovir|mesh-list
57038771|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57038772|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038773|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038774|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038775|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
57038776|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57038777|NCT04987450|Prednisone|prednisone|mesh-list
57038778|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
57038779|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57038780|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57038781|NCT04987450|Prednisolone|prednisolone|mesh-list
57038782|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
57038783|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57038784|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
57038785|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57038786|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
57038787|NCT04987450|Hormones|hormones|mesh-ancestor
57038788|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038789|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038790|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57038791|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038792|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
57038793|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
57038794|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038795|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57038796|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57038797|NCT04987450|Protective Agents|protective agents|mesh-ancestor
57038798|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57038799|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
57038800|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
57038801|NCT03074578|Hormones|hormones|mesh-ancestor
57038802|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038803|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038804|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038805|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038806|NCT04991194|Zamicastat|zamicastat|mesh-list
57038807|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038808|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038809|NCT04918186|Durvalumab|durvalumab|mesh-list
57038810|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57038811|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038812|NCT03071770|Ivosidenib|ivosidenib|mesh-list
57038813|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038814|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038815|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038816|NCT04986982|Opicapone|opicapone|mesh-list
57038817|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
57038818|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038819|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038820|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57038821|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57038822|NCT03070054|Epinephrine|epinephrine|mesh-list
57038823|NCT03070054|Bupivacaine|bupivacaine|mesh-list
57038824|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
57038825|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
57038826|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038827|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038828|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
57038829|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038830|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57038831|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57038832|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
57038833|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038834|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038835|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57038836|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57038837|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
57038838|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57038839|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
57038840|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
57038841|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
57038842|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57038843|NCT04996498|Oxytocin|oxytocin|mesh-list
57038844|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
57038845|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57038846|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038848|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57038849|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
57038850|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038851|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
57038852|NCT03074344|Protective Agents|protective agents|mesh-ancestor
57038853|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
57038854|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
57038855|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038856|NCT02035371|Insulin|insulin|mesh-list
57038857|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57038858|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
57038859|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
57038860|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
57038861|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57038862|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038863|NCT03069820|Docetaxel|docetaxel|mesh-list
57038864|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038865|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
57038866|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
57038867|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
57038868|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038869|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
57038870|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57038871|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
57038872|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57038873|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
57038874|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038875|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038876|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
57038877|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
57038878|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
57038879|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
57038880|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038881|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038882|NCT03270501|Golimumab|golimumab|mesh-list
57038883|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57038884|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57038885|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57038886|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
57038887|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038888|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
57038889|NCT03606681|Calcium|calcium|mesh-list
57038890|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57038891|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038892|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57038893|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
57038894|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57038895|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
57038896|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57038897|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
57038898|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038899|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038900|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
57038901|NCT03605199|Denosumab|denosumab|mesh-list
57038902|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57038903|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038904|NCT03606369|Ondansetron|ondansetron|mesh-list
57038905|NCT03606369|Palonosetron|palonosetron|mesh-list
57038906|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
57038907|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
57038908|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038909|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038910|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57038911|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
57038912|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
57038913|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57038914|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
57038915|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038916|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038917|NCT03606369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57038918|NCT03606369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57038919|NCT03606369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038920|NCT03606369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57038921|NCT03606369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57038922|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57038923|NCT02635204|Clobetasol|clobetasol|mesh-list
57038924|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57038925|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
57038926|NCT02635204|Hormones|hormones|mesh-ancestor
57038927|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57038928|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038929|NCT00102804|Pemetrexed|pemetrexed|mesh-list
57038930|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038931|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038932|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038933|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57038934|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57038935|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57038936|NCT02163720|Doxorubicin|doxorubicin|mesh-list
57038937|NCT02163720|Trabectedin|trabectedin|mesh-list
57038938|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57038939|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038940|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57038941|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57038942|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57038943|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038944|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57038945|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
57038946|NCT03487874|Ropivacaine|ropivacaine|mesh-list
57038947|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
57038948|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
57038949|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57038950|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038951|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
57038952|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57038953|NCT01494662|Capecitabine|capecitabine|mesh-list
57038954|NCT01494662|Trastuzumab|trastuzumab|mesh-list
57038955|NCT01494662|Maytansine|maytansine|mesh-list
57038956|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
57038957|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57038958|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
57038959|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038960|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038961|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57038962|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57038963|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
57038964|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
57038965|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
57038966|NCT04989400|Misoprostol|misoprostol|mesh-list
57038967|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
57038968|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57038969|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
57038970|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57038971|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038972|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57038973|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57038974|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
57038975|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57038976|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
57038977|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57038978|NCT02163954|Clopidogrel|clopidogrel|mesh-list
57038979|NCT02163954|Ticagrelor|ticagrelor|mesh-list
57038980|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57038981|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57038982|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57038983|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57038984|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
57038985|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57038986|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038987|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038988|NCT04985656|Decitabine|decitabine|mesh-list
57038989|NCT04985656|Pevonedistat|pevonedistat|mesh-list
57038990|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57038991|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
57038992|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57038993|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57038994|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720982|NCT00712712|Analgesics|analgesics|mesh-ancestor
57038995|NCT02164032|Insulin|insulin|mesh-list
57038996|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57038997|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57038998|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57038999|NCT04682288|Levofloxacin|levofloxacin|mesh-list
57039000|NCT04682288|Ofloxacin|ofloxacin|mesh-list
57039001|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57039002|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039003|NCT04682288|Renal Agents|renal agents|mesh-ancestor
57039004|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57039005|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57039006|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57039007|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039008|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039009|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039010|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57039011|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57039012|NCT00968149|Montelukast|montelukast|mesh-list
57039013|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57039014|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
57039015|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57039016|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
57039017|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039018|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039019|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57039020|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57039021|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039022|NCT04985344|Propranolol|propranolol|mesh-list
57039023|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57039024|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57039025|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
57039026|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039027|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039028|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039029|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57039030|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57039031|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
57039032|NCT02164110|Vaccines|vaccines|mesh-list
57039033|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
57039034|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039035|NCT02167464|Coal Tar|coal tar|mesh-list
57039036|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
57039037|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
57039038|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
57039039|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
57039040|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039041|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039042|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57039043|NCT02167464|Diuretics|diuretics|mesh-ancestor
57039044|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
57039045|NCT03485456|Tobramycin|tobramycin|mesh-list
57039046|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57039047|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039048|NCT03487562|Amoxicillin|amoxicillin|mesh-list
57039049|NCT03487562|Clarithromycin|clarithromycin|mesh-list
57039050|NCT03487562|Lansoprazole|lansoprazole|mesh-list
57039051|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
57039052|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57039053|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039054|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57039055|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039056|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039057|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57039058|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57039059|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57039060|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57039061|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57039062|NCT03719924|Paclitaxel|paclitaxel|mesh-list
57039063|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57039064|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039065|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
57039066|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
57039067|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
57039068|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039069|NCT02167620|Metformin|metformin|mesh-list
57039070|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57039071|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039072|NCT03485300|Warfarin|warfarin|mesh-list
57039073|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
57039074|NCT00963469|Loratadine|loratadine|mesh-list
57039075|NCT00963469|Montelukast|montelukast|mesh-list
57039076|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57039077|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
57039078|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57039079|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
57039080|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039081|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039082|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57039083|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57039084|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039085|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
57039086|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
57039087|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57039088|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57039089|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57039090|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
57039091|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
57039092|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039093|NCT00897949|Rizatriptan|rizatriptan|mesh-list
57039094|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57039095|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
57039096|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039097|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039098|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039099|NCT05119855|Vaccines|vaccines|mesh-list
57039100|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
57039101|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039102|NCT04741945|Metformin|metformin|mesh-list
57039103|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57039104|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039105|NCT03487406|Aspirin|aspirin|mesh-list
57039106|NCT03487406|Ticagrelor|ticagrelor|mesh-list
57039107|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57039108|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57039109|NCT03487406|Analgesics|analgesics|mesh-ancestor
57039110|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
57039111|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039112|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039113|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039114|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039115|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57039116|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57039117|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039118|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57039119|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57039120|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039121|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
57039122|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57039123|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57039124|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57039125|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
57039126|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039127|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57039128|NCT00725491|Ganirelix|ganirelix|mesh-list
57039129|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
57039130|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57039131|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
57039132|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039133|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039134|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57039135|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57039136|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039137|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
57039138|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039139|NCT00724789|Ganirelix|ganirelix|mesh-list
57039140|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
57039141|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039142|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039143|NCT00711607|Estradiol|estradiol|mesh-list
57039145|NCT00711607|Hormones|hormones|mesh-ancestor
57039146|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039147|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039148|NCT02164578|Aspirin|aspirin|mesh-list
57039149|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
57039150|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57039151|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57039152|NCT02164578|Analgesics|analgesics|mesh-ancestor
57039153|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
57039154|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039155|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039156|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039157|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039158|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57039159|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57039160|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039161|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57039162|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57039163|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039164|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
57039165|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57039166|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
57039167|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57039168|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
57039169|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
57039170|NCT03893318|Lidocaine|lidocaine|mesh-list
57039171|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
57039172|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
57039173|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039174|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039175|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
57039176|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039177|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57039178|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57039179|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57039180|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57039181|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039182|NCT03625531|Letrozole|letrozole|mesh-list
57039183|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039184|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57039185|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57039186|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039187|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039188|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57039189|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
57039190|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039191|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039192|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
57039193|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57039194|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57039195|NCT02167698|Prednisolone|prednisolone|mesh-list
57039196|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
57039197|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57039198|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
57039199|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039200|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
57039201|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
57039202|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039203|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039204|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57039205|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
57039206|NCT02167698|Hormones|hormones|mesh-ancestor
57039207|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039208|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57039209|NCT02167698|Protective Agents|protective agents|mesh-ancestor
57039210|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57039211|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039212|NCT02634580|Ezetimibe|ezetimibe|mesh-list
57039213|NCT02634580|Evolocumab|evolocumab|mesh-list
57039214|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57039215|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57039216|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57039217|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
57039218|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039219|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57039220|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
57039221|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039222|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57039223|NCT00697255|Hormones|hormones|mesh-list
57039224|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57039225|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039226|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039227|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039228|NCT02164734|Remifentanil|remifentanil|mesh-list
57039229|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57039230|NCT02164734|Narcotics|narcotics|mesh-ancestor
57039231|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039232|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039233|NCT02164734|Analgesics|analgesics|mesh-ancestor
57039234|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
57039235|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039236|NCT00548912|Spironolactone|spironolactone|mesh-list
57039237|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57039238|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
57039239|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039240|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039241|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57039242|NCT00548912|Diuretics|diuretics|mesh-ancestor
57039243|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
57039244|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
57039245|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57039246|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039247|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57039248|NCT03071068|Antibodies|antibodies|mesh-list
57039249|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
57039250|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57039251|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
57039252|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039253|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039254|NCT03487172|Mannitol|mannitol|mesh-list
57039255|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57039256|NCT03487172|Diuretics|diuretics|mesh-ancestor
57039257|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
57039258|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039259|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
57039260|NCT04995016|Axitinib|axitinib|mesh-list
56616747|NCT00810589|Insulin|insulin|mesh-list
57039261|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57039262|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039263|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57039264|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039265|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039266|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
57039267|NCT04994860|Zamicastat|zamicastat|mesh-list
57039268|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
57039269|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57039270|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57039271|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039272|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039273|NCT04994860|Urological Agents|urological agents|mesh-ancestor
57039274|NCT03481400|Calcitonin|calcitonin|mesh-list
57039275|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
57039276|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
57039277|NCT03481400|Katacalcin|katacalcin|mesh-list
57039278|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57039279|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039280|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57039281|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
57039282|NCT02851407|Defibrotide|defibrotide|mesh-list
57039283|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57039284|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57039285|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039286|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57039287|NCT02167854|Trastuzumab|trastuzumab|mesh-list
57039288|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57039289|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039290|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57039291|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57039292|NCT02161614|Estradiol|estradiol|mesh-list
57039293|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57039295|NCT02161614|Hormones|hormones|mesh-ancestor
57039296|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039297|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039298|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57039299|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
57039300|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039301|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57039302|NCT04994626|Rituximab|rituximab|mesh-list
57039303|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57039304|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039305|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
57039306|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039307|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039308|NCT02168010|Neurotropin|neurotropin|mesh-list
57039309|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57039310|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
57039311|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039312|NCT02168010|Analgesics|analgesics|mesh-ancestor
57039313|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
57039314|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039315|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
57039316|NCT04994314|Fluorides|fluorides|mesh-list
57039317|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039318|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
57039319|NCT04994314|Protective Agents|protective agents|mesh-ancestor
57039320|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
57039321|NCT02161692|Carboplatin|carboplatin|mesh-list
57039322|NCT02161692|Etoposide|etoposide|mesh-list
57039323|NCT02161692|Bleomycin|bleomycin|mesh-list
57039324|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57039325|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
57039326|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039327|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039328|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57039329|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
57039330|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039331|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039332|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57039333|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57039334|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57039335|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57039336|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039337|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57039338|NCT02746575|Metoprolol|metoprolol|mesh-list
57039339|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57039340|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57039341|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
57039342|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
57039343|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039344|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039345|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57039346|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57039347|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57039348|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
57039349|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039350|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039351|NCT02161770|Osimertinib|osimertinib|mesh-list
57039352|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039353|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57039354|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039355|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039356|NCT03604575|Insulin|insulin|mesh-list
57039357|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57039358|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
57039359|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57039360|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039361|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
57039362|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57039363|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
57039364|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039365|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039366|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57039367|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
57039368|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57039369|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
57039370|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039371|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039372|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57039373|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
57039374|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
57039375|NCT04988932|Protective Agents|protective agents|mesh-ancestor
57039376|NCT03625466|Ivacaftor|ivacaftor|mesh-list
57039377|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57039378|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57039379|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039380|NCT03604419|Metformin|metformin|mesh-list
57039381|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57039382|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039383|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
57039384|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
57039385|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
57039386|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
57039387|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039388|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039389|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
57039390|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039391|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
57039392|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57039393|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57039394|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039395|NCT04985110|Renal Agents|renal agents|mesh-ancestor
57039396|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57039397|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
57039398|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57039399|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57039400|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
57039401|NCT02164812|Efavirenz|efavirenz|mesh-list
57039402|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57039403|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039404|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57039405|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57039406|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039407|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897365|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
57039408|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039409|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57039410|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57039411|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
57039412|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57039413|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57039414|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57039415|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57039416|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57039417|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57039418|NCT04988776|Bupivacaine|bupivacaine|mesh-list
57039419|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
57039420|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
57039421|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039422|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039423|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
57039424|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039425|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
57039426|NCT02853123|Olodaterol|olodaterol|mesh-list
57039427|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57039428|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
57039429|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039430|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039431|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57039432|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
57039433|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
57039434|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57039435|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
57039436|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039437|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039438|NCT02255370|Curcumin|curcumin|mesh-list
57039439|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57039440|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57039441|NCT02255370|Analgesics|analgesics|mesh-ancestor
57039442|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
57039443|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039444|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039445|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039446|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039447|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039448|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039449|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039450|NCT04984408|Vaccines|vaccines|mesh-list
57039451|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
57039452|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039453|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
57039454|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57039455|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57039456|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039457|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
57039458|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039459|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039460|NCT04459676|Mitogens|mitogens|mesh-list
57039461|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
57039462|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039463|NCT05376111|Azacitidine|azacitidine|mesh-list
57039464|NCT05376111|Venetoclax|venetoclax|mesh-list
57039465|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57039466|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
57039467|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039468|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039469|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039470|NCT02164890|Micafungin|micafungin|mesh-list
57039471|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
57039472|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039473|NCT02634346|Olanzapine|olanzapine|mesh-list
57039474|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
57039475|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
57039476|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039477|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039478|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57039479|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57039480|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57039481|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039482|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57039483|NCT02634346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57039484|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57039485|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57039486|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039487|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039488|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
57039489|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
57039490|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57039491|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57039492|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039493|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
57039494|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039495|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039496|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
57039497|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039498|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57039499|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039500|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039501|NCT02165046|Budesonide|budesonide|mesh-list
57039502|NCT02165046|Procaterol|procaterol|mesh-list
57039503|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039504|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57039505|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
57039506|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039507|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039508|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57039509|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
57039510|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
57039511|NCT02165046|Hormones|hormones|mesh-ancestor
57039512|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039513|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
57039514|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57039515|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57039516|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57039517|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
57039518|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039519|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039520|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
57039521|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
57039522|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57039523|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039524|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57039525|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039526|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57039527|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57039528|NCT03070678|Analgesics|analgesics|mesh-ancestor
57039529|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
57039530|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039531|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039532|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039533|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57039534|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039536|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
57039537|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039538|NCT04994236|Leucovorin|leucovorin|mesh-list
57039539|NCT04994236|Fluorouracil|fluorouracil|mesh-list
57039540|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
57039541|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
57039542|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039543|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57039544|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039545|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57039546|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
57039547|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039548|NCT04994236|Antidotes|antidotes|mesh-ancestor
57039549|NCT04994236|Protective Agents|protective agents|mesh-ancestor
57039550|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
57039551|NCT04994236|Vitamins|vitamins|mesh-ancestor
57039552|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
57039553|NCT03601611|Prednisolone|prednisolone|mesh-list
57039554|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039555|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
57039556|NCT03601611|Hormones|hormones|mesh-ancestor
57039557|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039558|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039559|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57039560|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039561|NCT03597945|Lidocaine|lidocaine|mesh-list
57039562|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
57039563|NCT03597945|Epinephrine|epinephrine|mesh-list
57039564|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
57039565|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
57039566|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039567|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039568|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
57039569|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039570|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57039571|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57039572|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57039573|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57039574|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039575|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57039576|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57039577|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
57039578|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039579|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57039580|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57039581|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
57039582|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57039583|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
57039584|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
57039585|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
57039586|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57039587|NCT03597945|Analgesics|analgesics|mesh-ancestor
56721608|NCT00625131|Bupropion|bupropion|mesh-list
57039588|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
57039589|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57039590|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57039591|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
57039592|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039593|NCT03601533|Phenol|phenol|mesh-list
57039594|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57039595|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039596|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
57039597|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57039598|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57039599|NCT03486626|Metformin|metformin|mesh-list
57039600|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57039601|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039602|NCT04983550|Doxorubicin|doxorubicin|mesh-list
57039603|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57039604|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57039605|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039606|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57039607|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57039608|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039609|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039610|NCT02255682|Simvastatin|simvastatin|mesh-list
57039611|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57039612|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57039613|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
57039614|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039615|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57039616|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57039617|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039618|NCT05153486|Ethanol|ethanol|mesh-list
57039619|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57039620|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039621|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039622|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039623|NCT03136263|Oxytocin|oxytocin|mesh-list
57039624|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
57039625|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039626|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039627|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
57039628|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57039629|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039630|NCT03486548|Dexamethasone|dexamethasone|mesh-list
57039631|NCT03486548|Lidocaine|lidocaine|mesh-list
57039632|NCT03486548|Bupivacaine|bupivacaine|mesh-list
57039633|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039634|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
57039635|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
57039636|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039637|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039638|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57039639|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
57039640|NCT03486548|Hormones|hormones|mesh-ancestor
57039641|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039642|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57039643|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039644|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
57039645|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
57039646|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039647|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
57039648|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57039649|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57039650|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57039651|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57039652|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039653|NCT04983160|Allopurinol|allopurinol|mesh-list
57039654|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
57039655|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039656|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039657|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
57039658|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039659|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57039660|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
57039661|NCT04983160|Protective Agents|protective agents|mesh-ancestor
57039662|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039663|NCT05431270|Antibodies|antibodies|mesh-list
57039665|NCT05431270|Immunologic Factors|immunologic factors|mesh-ancestor
57039666|NCT05431270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039667|NCT02759016|BI 836826|bi 836826|mesh-list
57039668|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57039669|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039670|NCT05379166|Azacitidine|azacitidine|mesh-list
57039671|NCT05379166|Venetoclax|venetoclax|mesh-list
57039672|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57039673|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
57039674|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039675|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039676|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039677|NCT02852967|Belumosudil|belumosudil|mesh-list
57039678|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57039679|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039680|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039681|NCT03593044|Atropine|atropine|mesh-list
57039682|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57039683|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57039684|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57039685|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
57039686|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039687|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039688|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57039689|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
57039690|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
57039691|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
57039692|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57039693|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57039694|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
57039695|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039696|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039697|NCT03597087|Anesthetics|anesthetics|mesh-list
57039698|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039699|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039700|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
57039701|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039702|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
57039703|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57039704|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039705|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039706|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57039707|NCT03596775|Analgesics|analgesics|mesh-ancestor
57039708|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
57039709|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039710|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57039711|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57039712|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57039713|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
57039714|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039715|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039716|NCT03066466|Methotrexate|methotrexate|mesh-list
57039717|NCT03066466|Atorvastatin|atorvastatin|mesh-list
57039718|NCT03066466|Tacrolimus|tacrolimus|mesh-list
57039719|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57039720|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
57039721|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039722|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039723|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57039724|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
57039725|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039726|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039727|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
57039728|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039729|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57039730|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57039731|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
57039732|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039733|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57039734|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57039735|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57039736|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57039737|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57039738|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57039739|NCT03603249|Trimetazidine|trimetazidine|mesh-list
57039740|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
57039741|NCT03068260|Acetaminophen|acetaminophen|mesh-list
57039742|NCT03068260|Ibuprofen|ibuprofen|mesh-list
57039743|NCT03068260|Morphine|morphine|mesh-list
57039744|NCT03068260|Ropivacaine|ropivacaine|mesh-list
57039745|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57039746|NCT03068260|Narcotics|narcotics|mesh-ancestor
57039747|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039748|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039749|NCT03068260|Analgesics|analgesics|mesh-ancestor
57039750|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
57039751|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039752|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
57039753|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
57039754|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57039755|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
57039756|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57039757|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039758|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039759|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57039760|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039761|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039762|NCT02237859|Vancomycin|vancomycin|mesh-list
57039763|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57039764|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039765|NCT03594825|Valsartan|valsartan|mesh-list
57039766|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57039767|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57039768|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57039769|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039770|NCT02162550|Exenatide|exenatide|mesh-list
57039771|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57039772|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039773|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57039774|NCT02162550|Incretins|incretins|mesh-ancestor
57039775|NCT02162550|Hormones|hormones|mesh-ancestor
57039776|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039777|NCT03600831|Docetaxel|docetaxel|mesh-list
57039778|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039779|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
57039780|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
57039781|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
57039782|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039783|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
57039784|NCT02852265|Etonogestrel|etonogestrel|mesh-list
57039785|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039786|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039787|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57039788|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57039789|NCT02162784|Budesonide|budesonide|mesh-list
57039790|NCT02162784|Albuterol|albuterol|mesh-list
57039791|NCT02162784|Procaterol|procaterol|mesh-list
57039792|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039793|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57039794|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
57039795|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039796|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039797|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57039798|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
57039799|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
57039800|NCT02162784|Hormones|hormones|mesh-ancestor
57039801|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039802|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
57039803|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039804|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57039805|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57039806|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57039807|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
57039808|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039809|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039810|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
57039811|NCT03539718|Taurolidine|taurolidine|mesh-list
56721823|NCT00628251|Olaparib|olaparib|mesh-list
57039812|NCT03539718|Heparin|heparin|mesh-list
57039813|NCT03539718|Calcium heparin|calcium heparin|mesh-list
57039814|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
57039815|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57039816|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57039817|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039818|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039819|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57039820|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039821|NCT02166450|Nystatin|nystatin|mesh-list
57039822|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57039823|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039824|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
57039825|NCT02166450|Ionophores|ionophores|mesh-ancestor
57039826|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57039827|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039828|NCT03600363|Metformin|metformin|mesh-list
57039829|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57039830|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039831|NCT03600129|Ropivacaine|ropivacaine|mesh-list
57039832|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
57039833|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
57039834|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039835|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039836|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
57039837|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039838|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
57039839|NCT02169570|Vitamin D|vitamin d|mesh-list
57039840|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
57039841|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
57039842|NCT02169570|Vitamins|vitamins|mesh-list
57039843|NCT02169570|Calcium|calcium|mesh-list
57039844|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
57039845|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039846|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57039847|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57039848|NCT02169648|Ranibizumab|ranibizumab|mesh-list
57039849|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57039850|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57039851|NCT02169648|Growth Substances|growth substances|mesh-ancestor
57039852|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039853|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
57039854|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039855|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57039856|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039857|NCT02170896|Pantoprazole|pantoprazole|mesh-list
57039858|NCT02170896|Dabigatran|dabigatran|mesh-list
57039859|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57039860|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57039861|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57039862|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039863|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039864|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
57039865|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57039866|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
57039867|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
57039868|NCT03594513|Dipyrone|dipyrone|mesh-list
57039869|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
57039870|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57039871|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039872|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
57039873|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57039874|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57039875|NCT03594513|Analgesics|analgesics|mesh-ancestor
57039876|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
57039877|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039878|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039879|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039880|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039881|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
57039882|NCT02633800|Carboplatin|carboplatin|mesh-list
57039883|NCT02633800|Cetuximab|cetuximab|mesh-list
57039884|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039885|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57039886|NCT02169804|Enclomiphene|enclomiphene|mesh-list
57039887|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57039888|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
57039889|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039890|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039891|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57039892|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
57039893|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039894|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57039895|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57039896|NCT02170974|Dabigatran|dabigatran|mesh-list
57039897|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
57039898|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57039899|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
57039900|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039901|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039902|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
57039903|NCT02174718|Vitamin D|vitamin d|mesh-list
57039904|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
57039905|NCT02174718|Vitamins|vitamins|mesh-ancestor
57039906|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
57039907|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039908|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57039909|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57039910|NCT05635162|Rituximab|rituximab|mesh-list
57039911|NCT05635162|Zanubrutinib|zanubrutinib|mesh-list
56897384|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
57039912|NCT05635162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57039913|NCT05635162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039914|NCT05635162|Immunologic Factors|immunologic factors|mesh-ancestor
57039915|NCT05635162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039916|NCT05635162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57039917|NCT05635162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57039918|NCT05635162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039919|NCT05635162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039920|NCT02238171|Ipratropium|ipratropium|mesh-list
57039921|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57039922|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
57039923|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039924|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039925|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57039926|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
57039927|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57039928|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
57039929|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57039930|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039931|NCT02169882|Rifampin|rifampin|mesh-list
57039932|NCT02169882|Dexamethasone|dexamethasone|mesh-list
57039933|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57039934|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
57039935|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
57039936|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039937|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57039938|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57039939|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
57039940|NCT02169882|Hormones|hormones|mesh-ancestor
57039941|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57039942|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57039943|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039944|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57039945|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
57039946|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57039947|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57039948|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
57039949|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57039950|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039951|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039952|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57039953|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57039954|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57039955|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57039956|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57039957|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57039958|NCT02595424|Carboplatin|carboplatin|mesh-list
57039959|NCT02595424|Capecitabine|capecitabine|mesh-list
57039960|NCT02595424|Etoposide|etoposide|mesh-list
57039961|NCT02595424|Temozolomide|temozolomide|mesh-list
57039962|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57039963|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57039964|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
56721959|NCT02549391|Cinacalcet|cinacalcet|mesh-list
57039965|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039966|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57039967|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57039968|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57039969|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039970|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57039971|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
57039972|NCT03602547|Vorolanib|vorolanib|mesh-list
57039973|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57039974|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57039975|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57039976|NCT03602469|Bupivacaine|bupivacaine|mesh-list
57039977|NCT03602469|Propofol|propofol|mesh-list
57039978|NCT03602469|Sevoflurane|sevoflurane|mesh-list
57039979|NCT03602469|Rocuronium|rocuronium|mesh-list
57039980|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
57039981|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
57039982|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57039983|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608112|NCT05381168|Calcium|calcium|mesh-list
57039984|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
57039985|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57039986|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57039987|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57039988|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
57039989|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57039990|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57039991|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57039992|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57039993|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57039994|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
57039995|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
57039996|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57039997|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
57039998|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57039999|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040000|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57040001|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57040002|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57040003|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57040004|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57040005|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
57040006|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57040007|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57040008|NCT05001373|Vaccines|vaccines|mesh-list
57040009|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
57040010|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040011|NCT02171052|Digoxin|digoxin|mesh-list
57040012|NCT02171052|Dabigatran|dabigatran|mesh-list
57040013|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
57040014|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57040015|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040016|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040017|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040018|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
57040019|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57040020|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57040021|NCT02171052|Protective Agents|protective agents|mesh-ancestor
57040022|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040023|NCT03591549|Fulvestrant|fulvestrant|mesh-list
57040024|NCT03591549|Goserelin|goserelin|mesh-list
57040025|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57040026|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040027|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57040028|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57040029|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
57040030|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040031|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040032|NCT02261220|Durvalumab|durvalumab|mesh-list
57040033|NCT02261220|Tremelimumab|tremelimumab|mesh-list
57040034|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040035|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040036|NCT02237937|Amitriptyline|amitriptyline|mesh-list
57040037|NCT02237937|Citalopram|citalopram|mesh-list
57040038|NCT02237937|Paroxetine|paroxetine|mesh-list
57040039|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57040040|NCT02237937|Sertraline|sertraline|mesh-list
57040041|NCT02237937|Nortriptyline|nortriptyline|mesh-list
57040042|NCT02237937|Trimipramine|trimipramine|mesh-list
57040043|NCT02237937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57040044|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57040045|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57040046|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040047|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040048|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
57040049|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040050|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57040051|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
57040052|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57040053|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040054|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56617570|NCT00643201|Enoxaparin|enoxaparin|mesh-list
57040055|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57040056|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040057|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57040058|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57040059|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57040060|NCT02237937|Analgesics|analgesics|mesh-ancestor
57040061|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
57040062|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57040063|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
57040064|NCT03659539|Propofol|propofol|mesh-list
57040065|NCT03659539|Desflurane|desflurane|mesh-list
57040066|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57040067|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040068|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040069|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57040070|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
57040071|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
57040072|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57040073|NCT02170116|Dabigatran|dabigatran|mesh-list
57040074|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
57040075|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57040076|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040077|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040078|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040079|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
57040080|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
57040081|NCT03539562|Promethazine|promethazine|mesh-list
57040082|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
57040083|NCT03539562|Morphine|morphine|mesh-list
57040084|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57040085|NCT03539562|Narcotics|narcotics|mesh-ancestor
57040086|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040087|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040088|NCT03539562|Analgesics|analgesics|mesh-ancestor
57040089|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
57040090|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040091|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
57040092|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
57040093|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57040094|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
57040095|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
57040096|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040097|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040098|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57040099|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57040100|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57040101|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
57040102|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
57040103|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
57040104|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
57040105|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57040106|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
57040107|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57040108|NCT03604315|Fluorides|fluorides|mesh-list
57040109|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57040110|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040111|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
56722104|NCT01042873|Dobutamine|dobutamine|mesh-list
57040112|NCT03604315|Protective Agents|protective agents|mesh-ancestor
57040113|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040114|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
57040115|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
57040116|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040117|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57040118|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57040119|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040120|NCT00394069|Montelukast|montelukast|mesh-list
57040121|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040122|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040123|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57040124|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
57040125|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040126|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040127|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57040128|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57040129|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040130|NCT03598959|Tofacitinib|tofacitinib|mesh-list
57040131|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57040132|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040133|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040134|NCT03649633|Vitamins|vitamins|mesh-list
57040135|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
57040136|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
57040137|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040138|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57040139|NCT02238717|Pregabalin|pregabalin|mesh-list
57040140|NCT02238717|PF-06372865|pf-06372865|mesh-list
57040141|NCT02238717|Analgesics|analgesics|mesh-ancestor
57040142|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
57040143|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040144|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040145|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
57040146|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57040147|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57040148|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040149|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57040150|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57040151|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57040152|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040153|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57040154|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
57040155|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
57040156|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040157|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57040158|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57040159|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040160|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
57040161|NCT03470311|Benralizumab|benralizumab|mesh-list
57040162|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040163|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040164|NCT03580005|Methylphenidate|methylphenidate|mesh-list
57040165|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57040166|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040167|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57040168|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57040169|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57040170|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040171|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
57040172|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040173|NCT03579927|Cytarabine|cytarabine|mesh-list
57040174|NCT03579927|Rituximab|rituximab|mesh-list
57040175|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57040176|NCT03579927|Etoposide|etoposide|mesh-list
57040177|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
57040178|NCT03579927|Melphalan|melphalan|mesh-list
57040179|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
57040180|NCT03579927|Carmustine|carmustine|mesh-list
57040181|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
57040182|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
57040183|NCT03579927|Antibodies|antibodies|mesh-list
57040184|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
57040185|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57040186|NCT03579927|Lenograstim|lenograstim|mesh-list
57040187|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
56722183|NCT00903838|Pramipexole|pramipexole|mesh-list
57040188|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040189|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040190|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57040191|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57040192|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57040193|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57040194|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040195|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040196|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57040197|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
57040198|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
57040199|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040200|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57040201|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57040202|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57040203|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
57040204|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57040205|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
57040206|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
57040207|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
57040208|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
57040209|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
57040210|NCT03587025|Amitriptyline|amitriptyline|mesh-list
57040211|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57040212|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
57040213|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57040214|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57040215|NCT03587025|Analgesics|analgesics|mesh-ancestor
57040216|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
57040217|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040218|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040219|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57040220|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57040221|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57040222|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040223|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
57040224|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040225|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57040226|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
57040227|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57040228|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
57040229|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040230|NCT00140881|Montelukast|montelukast|mesh-list
57040231|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040232|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040233|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57040234|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
57040235|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040236|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040237|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57040238|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57040239|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040240|NCT02848833|Empagliflozin|empagliflozin|mesh-list
57040241|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57040242|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040243|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57040244|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040245|NCT03539328|Gemcitabine|gemcitabine|mesh-list
57040247|NCT03539328|Doxorubicin|doxorubicin|mesh-list
57040248|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57040249|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
57040250|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57040251|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040252|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
57040253|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
57040254|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
57040255|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040256|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57040257|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
57040258|NCT03539328|Antiviral Agents|antiviral agents|mesh-ancestor
57040259|NCT03539328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040260|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040261|NCT03539328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56722252|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
57040262|NCT03539328|Immunologic Factors|immunologic factors|mesh-ancestor
57040263|NCT03539328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040264|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57040265|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57040266|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57040267|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040268|NCT00111709|Rizatriptan|rizatriptan|mesh-list
57040269|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040270|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040271|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040272|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57040273|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
57040274|NCT02171442|Dabigatran|dabigatran|mesh-list
57040275|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
57040276|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57040277|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040278|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040279|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040280|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
57040281|NCT05729932|Analgesics, Opioid|analgesics, opioid|mesh-list
57040282|NCT05729932|Narcotics|narcotics|mesh-ancestor
57040283|NCT05729932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040284|NCT05729932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040285|NCT05729932|Analgesics|analgesics|mesh-ancestor
57040286|NCT05729932|Sensory System Agents|sensory system agents|mesh-ancestor
57040287|NCT05729932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040288|NCT02035527|Docetaxel|docetaxel|mesh-list
57040289|NCT02035527|Sorafenib|sorafenib|mesh-list
57040290|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040291|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
57040292|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
57040293|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
57040294|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040295|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57040296|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040297|NCT00092131|Montelukast|montelukast|mesh-list
57040298|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040299|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040300|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57040301|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
57040302|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040303|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040304|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57040305|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57040306|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040307|NCT02170584|Dabigatran|dabigatran|mesh-list
57040308|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
57040309|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57040310|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040311|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040312|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040313|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
57040314|NCT03577977|Interferons|interferons|mesh-list
57040315|NCT03577977|Interferon-beta|interferon-beta|mesh-list
57040316|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
57040317|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040318|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
57040319|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040320|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
57040321|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040322|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57040323|NCT02668783|Ibuprofen|ibuprofen|mesh-list
57040324|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57040325|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57040326|NCT02668783|Etonogestrel|etonogestrel|mesh-list
57040327|NCT02668783|Estradiol|estradiol|mesh-list
57040328|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57040329|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57040330|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57040331|NCT02668783|Analgesics|analgesics|mesh-ancestor
57040332|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
57040333|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040334|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040335|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57040336|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57040337|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57040338|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040339|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040340|NCT02668783|Estrogens|estrogens|mesh-ancestor
57040341|NCT02668783|Hormones|hormones|mesh-ancestor
57040342|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040343|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57040344|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
57040345|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57040346|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57040347|NCT05010304|Amoxicillin|amoxicillin|mesh-list
57040348|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57040349|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040350|NCT03577899|Aflibercept|aflibercept|mesh-list
57040351|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57040352|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57040353|NCT03577899|Growth Substances|growth substances|mesh-ancestor
57040354|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040355|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
57040356|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040357|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
57040358|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57040359|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
57040360|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040361|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040362|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040363|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040364|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
57040365|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57040366|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
57040367|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040368|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040369|NCT02171520|Dabigatran|dabigatran|mesh-list
57040370|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
57040371|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57040372|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040373|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040374|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040375|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
57040376|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
57040377|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57040378|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040379|NCT00101010|Prednisone|prednisone|mesh-list
57040380|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
57040381|NCT00101010|Rituximab|rituximab|mesh-list
57040382|NCT00101010|Doxorubicin|doxorubicin|mesh-list
57040383|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57040384|NCT00101010|Vincristine|vincristine|mesh-list
57040385|NCT00101010|Lenograstim|lenograstim|mesh-list
57040386|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57040387|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
57040388|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040389|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57040390|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57040391|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
57040392|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040393|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040394|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57040395|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040396|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57040397|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57040398|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57040399|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040400|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57040401|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
57040402|NCT00101010|Hormones|hormones|mesh-ancestor
57040403|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040404|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57040405|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57040406|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57040407|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
57040408|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
57040409|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
57040410|NCT03539172|Apatinib|apatinib|mesh-list
57040411|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040412|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57040413|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040414|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040415|NCT03209401|Carboplatin|carboplatin|mesh-list
57040416|NCT03209401|Niraparib|niraparib|mesh-list
57040417|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617922|NCT04018417|Amebicides|amebicides|mesh-ancestor
57040418|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57040419|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040420|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040421|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
57040422|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
57040423|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040424|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57040425|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
57040426|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57040427|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040428|NCT04576104|Metformin|metformin|mesh-list
57040429|NCT04576104|Megestrol|megestrol|mesh-list
57040430|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
57040431|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57040432|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040433|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57040434|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57040435|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57040436|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
57040437|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57040438|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57040439|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57040440|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57040441|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040442|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
57040443|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57040444|NCT04859764|Betamethasone|betamethasone|mesh-list
57040445|NCT04859764|Bupivacaine|bupivacaine|mesh-list
57040446|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
57040447|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
57040448|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040449|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040450|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
57040451|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040452|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57040453|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
57040454|NCT04859764|Hormones|hormones|mesh-ancestor
57040455|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040456|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040457|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040458|NCT02170740|Pantoprazole|pantoprazole|mesh-list
57040459|NCT02170740|Dabigatran|dabigatran|mesh-list
57040460|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57040461|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57040462|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57040463|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040464|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040465|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
57040466|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57040467|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040468|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
57040469|NCT02848599|Morphine|morphine|mesh-list
57040470|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
57040471|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57040472|NCT02848599|Narcotics|narcotics|mesh-ancestor
57040473|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040474|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040475|NCT02848599|Analgesics|analgesics|mesh-ancestor
57040476|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
57040477|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040478|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
57040479|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
57040480|NCT02171598|Dabigatran|dabigatran|mesh-list
57040481|NCT02171598|Clopidogrel|clopidogrel|mesh-list
57040482|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57040483|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57040484|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57040485|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57040486|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
57040487|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040488|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040489|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040490|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
57040491|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56617995|NCT04044547|Rotigotine|rotigotine|mesh-list
57040492|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040493|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040494|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
57040496|NCT02131597|Azacitidine|azacitidine|mesh-list
57040497|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040498|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57040499|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
57040500|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040501|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040502|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
57040503|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040504|NCT02171676|Docetaxel|docetaxel|mesh-list
57040505|NCT02171676|Afatinib|afatinib|mesh-list
57040506|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040507|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
57040508|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
57040509|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
57040510|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040511|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57040512|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040513|NCT02027935|Aldesleukin|aldesleukin|mesh-list
57040514|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
57040515|NCT02027935|Ipilimumab|ipilimumab|mesh-list
57040516|NCT02027935|Interleukin-2|interleukin-2|mesh-list
57040517|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57040518|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
57040519|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040520|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57040521|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57040522|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
57040523|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040524|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040525|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57040526|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040527|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57040528|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57040529|NCT02027935|Analgesics|analgesics|mesh-ancestor
57040530|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
57040531|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040532|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57040533|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57040534|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
57040535|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040536|NCT03577743|Bevacizumab|bevacizumab|mesh-list
57040537|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040538|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040539|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57040540|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57040541|NCT03577743|Growth Substances|growth substances|mesh-ancestor
57040542|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040543|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
57040544|NCT04794790|Buprenorphine|buprenorphine|mesh-list
57040545|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
57040546|NCT04794790|Naloxone|naloxone|mesh-list
57040547|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57040548|NCT04794790|Narcotics|narcotics|mesh-ancestor
57040549|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040550|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040551|NCT04794790|Analgesics|analgesics|mesh-ancestor
57040552|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
57040553|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040554|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57040555|NCT02171754|Ritonavir|ritonavir|mesh-list
57040556|NCT02171754|Afatinib|afatinib|mesh-list
57040557|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57040558|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57040559|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040560|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040561|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722555|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
57040562|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57040563|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57040564|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
57040565|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040566|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57040567|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57040568|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040569|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57040571|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57040572|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
57040573|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040574|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040575|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040576|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040577|NCT02171910|Doxapram|doxapram|mesh-list
57040578|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57040579|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040580|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040581|NCT04721548|Minoxidil|minoxidil|mesh-list
57040582|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57040583|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
57040584|NCT02178306|Telmisartan|telmisartan|mesh-list
57040585|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57040586|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57040587|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57040588|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040589|NCT05729386|Metformin|metformin|mesh-list
57040590|NCT05729386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57040591|NCT05729386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040592|NCT05729308|Anesthetics|anesthetics|mesh-list
57040593|NCT05729308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040594|NCT05729308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040595|NCT00778999|Desogestrel|desogestrel|mesh-list
57040596|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57040597|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57040598|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57040599|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
57040600|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57040601|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040602|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57040603|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57040604|NCT00778999|Progestins|progestins|mesh-ancestor
57040605|NCT00778999|Hormones|hormones|mesh-ancestor
57040606|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040607|NCT02171988|Propranolol|propranolol|mesh-list
57040608|NCT02171988|Bisoprolol|bisoprolol|mesh-list
57040609|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
57040610|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57040611|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57040612|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
57040613|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040614|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040615|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040616|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57040617|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57040618|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
57040619|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
57040620|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
57040621|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040622|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57040623|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57040624|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040625|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
57040626|NCT00725413|Etonogestrel|etonogestrel|mesh-list
57040627|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57040628|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
57040629|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57040630|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040631|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57040632|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57040633|NCT00103038|Hematinics|hematinics|mesh-ancestor
57040634|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57040635|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57040636|NCT00620035|Etonogestrel|etonogestrel|mesh-list
57040637|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57040638|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
57040639|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57040640|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040641|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57040642|NCT00431431|Tibolone|tibolone|mesh-list
57040643|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
57040644|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
57040645|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040646|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040647|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57040648|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57040649|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040650|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57040651|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
57040652|NCT00431431|Hormones|hormones|mesh-ancestor
57040653|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
57040654|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57040655|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57040656|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57040657|NCT02175888|Iron|iron|mesh-list
57040658|NCT02175888|Trace Elements|trace elements|mesh-ancestor
57040659|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
57040660|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040661|NCT05577637|Tacrolimus|tacrolimus|mesh-list
57040662|NCT05577637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57040663|NCT05577637|Immunologic Factors|immunologic factors|mesh-ancestor
57040664|NCT05577637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040665|NCT05577637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57040666|NCT05577637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040667|NCT05577637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040668|NCT02763579|Carboplatin|carboplatin|mesh-list
57040669|NCT02763579|Etoposide|etoposide|mesh-list
57040670|NCT02763579|Atezolizumab|atezolizumab|mesh-list
57040671|NCT02763579|Antibodies|antibodies|mesh-list
57040672|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57040673|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
57040674|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040675|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040676|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57040677|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57040678|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57040679|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040680|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040681|NCT02176044|Nitroprusside|nitroprusside|mesh-list
57040682|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57040683|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
57040684|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57040685|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040686|NCT02176122|Meropenem|meropenem|mesh-list
57040687|NCT02176122|Tazobactam|tazobactam|mesh-list
57040688|NCT02176122|Piperacillin|piperacillin|mesh-list
57040689|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57040690|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57040691|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040692|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57040693|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040694|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040695|NCT02967757|Liraglutide|liraglutide|mesh-list
57040696|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57040697|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040698|NCT02967757|Incretins|incretins|mesh-ancestor
57040699|NCT02967757|Hormones|hormones|mesh-ancestor
57040700|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040701|NCT02261298|Nivolumab|nivolumab|mesh-list
57040702|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040703|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040704|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57040705|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040706|NCT04680052|Rituximab|rituximab|mesh-list
57040707|NCT04680052|Lenalidomide|lenalidomide|mesh-list
57040708|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040709|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040710|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
57040711|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040712|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57040713|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57040714|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57040715|NCT04680052|Growth Substances|growth substances|mesh-ancestor
57040716|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
57040717|NCT02176200|Fenoterol|fenoterol|mesh-list
57040718|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57040719|NCT02176200|Ipratropium|ipratropium|mesh-list
57040720|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57040721|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
57040722|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040723|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040724|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040725|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040726|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
57040727|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
57040728|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57040729|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57040730|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57040731|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57040732|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
57040733|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040734|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040735|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57040736|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
57040737|NCT03537612|Clonidine|clonidine|mesh-list
57040738|NCT03537612|Morphine|morphine|mesh-list
57040739|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57040740|NCT03537612|Narcotics|narcotics|mesh-ancestor
57040741|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040742|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040743|NCT03537612|Analgesics|analgesics|mesh-ancestor
57040744|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
57040745|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040746|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57040747|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
57040748|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
57040749|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57040750|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57040751|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57040752|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
57040753|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040754|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040755|NCT00336063|Azacitidine|azacitidine|mesh-list
57040756|NCT00336063|Vorinostat|vorinostat|mesh-list
57040757|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57040758|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
57040759|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040760|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040761|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040762|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57040763|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
57040764|NCT02172144|Olodaterol|olodaterol|mesh-list
57040765|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57040766|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040767|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57040768|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57040769|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040770|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040771|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040772|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040773|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57040774|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
57040775|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040776|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040777|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040778|NCT05729074|Pimecrolimus|pimecrolimus|mesh-list
57040779|NCT05729074|Varespladib methyl|varespladib methyl|mesh-list
57040780|NCT05729074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57040781|NCT05729074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57040782|NCT05729074|Analgesics|analgesics|mesh-ancestor
57040783|NCT05729074|Sensory System Agents|sensory system agents|mesh-ancestor
57040784|NCT05729074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040785|NCT05729074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040786|NCT05729074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57040787|NCT05729074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57040788|NCT05729074|Dermatologic Agents|dermatologic agents|mesh-ancestor
57040789|NCT05729074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57040790|NCT05729074|Immunologic Factors|immunologic factors|mesh-ancestor
57040791|NCT05729074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57040792|NCT05729074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040793|NCT05729074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040794|NCT05729074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
57040795|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57040796|NCT02176512|Telmisartan|telmisartan|mesh-list
57040797|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57040798|NCT02176512|Diuretics|diuretics|mesh-ancestor
57040799|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
57040800|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040801|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57040802|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57040803|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040804|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57040805|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57040806|NCT03537534|Lidocaine|lidocaine|mesh-list
57040807|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
57040808|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
57040809|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040810|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040811|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
57040812|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040813|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57040814|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57040815|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57040816|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57040817|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040818|NCT03068650|Rindopepimut|rindopepimut|mesh-list
57040819|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040820|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040821|NCT04646005|Cemiplimab|cemiplimab|mesh-list
57040822|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040823|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040824|NCT02757768|Tamsulosin|tamsulosin|mesh-list
57040825|NCT02757768|Mirabegron|mirabegron|mesh-list
57040826|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57040827|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57040828|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57040829|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
57040830|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040831|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040832|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040833|NCT02757768|Urological Agents|urological agents|mesh-ancestor
57040834|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57040835|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57040836|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57040837|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
57040838|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
57040839|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
57040840|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040841|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
57040842|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040843|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040844|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
57040845|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57040846|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040847|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57040848|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040849|NCT03067792|Leucovorin|leucovorin|mesh-list
57040850|NCT03067792|Docetaxel|docetaxel|mesh-list
57040851|NCT03067792|Fluorouracil|fluorouracil|mesh-list
57040852|NCT03067792|Irinotecan|irinotecan|mesh-list
57040853|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040854|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
57040855|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
57040856|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
57040857|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040858|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
56722845|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
57040859|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57040860|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57040861|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
57040862|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040863|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57040864|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57040865|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040866|NCT03067792|Antidotes|antidotes|mesh-ancestor
57040867|NCT03067792|Protective Agents|protective agents|mesh-ancestor
57040868|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
57040870|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
57040871|NCT05224999|Nivolumab|nivolumab|mesh-list
57040872|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57040873|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040874|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57040875|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040876|NCT03066154|Ritonavir|ritonavir|mesh-list
57040877|NCT03066154|Docetaxel|docetaxel|mesh-list
57040878|NCT03066154|Androgens|androgens|mesh-list
57040879|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040880|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
57040881|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
57040882|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
57040883|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040884|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57040885|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57040886|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040887|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040888|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57040889|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57040890|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
57040891|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040892|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57040893|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57040894|NCT03066154|Hormones|hormones|mesh-ancestor
57040895|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040896|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040897|NCT05224687|Daptomycin|daptomycin|mesh-list
57040898|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57040899|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040900|NCT02753946|Tazobactam|tazobactam|mesh-list
57040901|NCT02753946|Piperacillin|piperacillin|mesh-list
57040902|NCT02753946|Fosfomycin|fosfomycin|mesh-list
57040903|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57040904|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57040905|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57040906|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57040907|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040908|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040909|NCT02172222|Linagliptin|linagliptin|mesh-list
57040910|NCT02172222|Empagliflozin|empagliflozin|mesh-list
57040911|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57040912|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040913|NCT02172222|Incretins|incretins|mesh-ancestor
57040914|NCT02172222|Hormones|hormones|mesh-ancestor
57040915|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040916|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57040917|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
57040918|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57040919|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040920|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57040921|NCT03625219|Prednisone|prednisone|mesh-list
57040922|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57040923|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
57040924|NCT03625219|Hormones|hormones|mesh-ancestor
57040925|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57040926|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040927|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57040928|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57040929|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
57040930|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57040931|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040932|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57040933|NCT02179008|Latanoprost|latanoprost|mesh-list
57040935|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
57040936|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57040937|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
57040938|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040939|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040940|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040941|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040942|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
57040943|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57040944|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
57040945|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040946|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040947|NCT05223907|Propofol|propofol|mesh-list
57040948|NCT05223907|Etomidate|etomidate|mesh-list
57040949|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57040950|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040951|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040952|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57040953|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
57040954|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
57040955|NCT03065998|Baclofen|baclofen|mesh-list
57040956|NCT03065998|Opipramol|opipramol|mesh-list
57040957|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57040958|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040959|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57040960|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040961|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57040962|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
57040963|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
57040964|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040965|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040966|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57040967|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
57040968|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57040969|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57040970|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57040971|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57040972|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
57040973|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
57040974|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57040975|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
57040976|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040977|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040978|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57040979|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
57040980|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
57040981|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57040982|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
57040983|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57040984|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57040985|NCT05728528|Factor VIII|factor viii|mesh-list
57040986|NCT05728528|Coagulants|coagulants|mesh-ancestor
57040987|NCT02256228|Ropivacaine|ropivacaine|mesh-list
57040988|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
57040989|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
57040990|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040991|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040992|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
57040993|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57040994|NCT03067168|Bupivacaine|bupivacaine|mesh-list
57040995|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
57040996|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
57040997|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57040998|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57040999|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
57041000|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041001|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57041002|NCT04774237|Carbachol|carbachol|mesh-list
57041003|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56618518|NCT02586038|Hormones|hormones|mesh-ancestor
57041004|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57041005|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57041006|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57041007|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
57041008|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041009|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041010|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041011|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57041012|NCT04774237|Miotics|miotics|mesh-ancestor
57041013|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
57041014|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041015|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57041016|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
57041017|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041018|NCT04774237|Analgesics|analgesics|mesh-ancestor
57041019|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
57041020|NCT04774237|Protective Agents|protective agents|mesh-ancestor
57041021|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
57041022|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57041023|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
57041024|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041025|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041026|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57041027|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
57041028|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
57041029|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57041030|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
57041031|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041032|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041033|NCT02172534|Bromides|bromides|mesh-list
57041034|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
57041035|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57041036|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
57041037|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041038|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041039|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57041040|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
57041041|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
57041042|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57041043|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
57041044|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041045|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041046|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
57041047|NCT04713631|Artesunate|artesunate|mesh-list
57041048|NCT04713631|Curcumin|curcumin|mesh-list
57041049|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57041050|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041051|NCT04713631|Analgesics|analgesics|mesh-ancestor
57041052|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
57041053|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041054|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041055|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041056|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041057|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041058|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041059|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041060|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
57041061|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57041062|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57041063|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041064|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
57041065|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
57041066|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57041067|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
57041068|NCT04459078|Apatinib|apatinib|mesh-list
57041069|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57041070|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041071|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57041072|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041073|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041074|NCT05728372|Copper|copper|mesh-list
57041075|NCT05728372|Pembrolizumab|pembrolizumab|mesh-list
57041076|NCT05728372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041077|NCT05728372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041078|NCT05728372|Trace Elements|trace elements|mesh-ancestor
57041079|NCT05728372|Micronutrients|micronutrients|mesh-ancestor
57041080|NCT05728372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041081|NCT02756832|Alogliptin|alogliptin|mesh-list
57041082|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57041083|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041084|NCT02756832|Incretins|incretins|mesh-ancestor
56723064|NCT00391027|Insulin|insulin|mesh-list
57041085|NCT02756832|Hormones|hormones|mesh-ancestor
57041086|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041087|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57041088|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
57041089|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041090|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041091|NCT05728294|Ropivacaine|ropivacaine|mesh-list
57041092|NCT05728294|Anesthetics, Local|anesthetics, local|mesh-ancestor
57041093|NCT05728294|Anesthetics|anesthetics|mesh-ancestor
57041094|NCT05728294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041095|NCT05728294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041096|NCT05728294|Sensory System Agents|sensory system agents|mesh-ancestor
57041097|NCT05728294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041098|NCT00108810|Ketoprofen|ketoprofen|mesh-list
57041099|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57041100|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041101|NCT00108810|Analgesics|analgesics|mesh-ancestor
57041102|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
57041103|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041104|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041105|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041106|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041107|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57041108|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041109|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041110|NCT04448392|Valacyclovir|valacyclovir|mesh-list
57041111|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
57041112|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041113|NCT05588284|Rivaroxaban|rivaroxaban|mesh-list
57041114|NCT05588284|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57041115|NCT05588284|Antithrombins|antithrombins|mesh-ancestor
57041116|NCT05588284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57041117|NCT05588284|Protease Inhibitors|protease inhibitors|mesh-ancestor
57041118|NCT05588284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041119|NCT05588284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041120|NCT05588284|Anticoagulants|anticoagulants|mesh-ancestor
57041121|NCT02256150|Mizoribine|mizoribine|mesh-list
57041122|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
57041123|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57041124|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
57041125|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041126|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041127|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57041128|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
57041129|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041130|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041131|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57041132|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57041133|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041134|NCT02256150|Analgesics|analgesics|mesh-ancestor
57041135|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
57041136|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041137|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041138|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57041139|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041140|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57041141|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
57041142|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57041143|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57041144|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041145|NCT02177370|Fenoterol|fenoterol|mesh-list
57041146|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57041147|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
57041148|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041149|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041150|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57041151|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
57041152|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
57041153|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
57041154|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57041155|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57041156|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57041157|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57041158|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
57041159|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041160|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041161|NCT03538704|Metformin|metformin|mesh-list
57041162|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57041163|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041164|NCT02172768|Micafungin|micafungin|mesh-list
57041165|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
57041166|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041167|NCT02172846|Paclitaxel|paclitaxel|mesh-list
57041168|NCT02172846|Carboplatin|carboplatin|mesh-list
57041169|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57041170|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041171|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
57041172|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
57041173|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
57041174|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041175|NCT05727904|Pembrolizumab|pembrolizumab|mesh-list
57041176|NCT05727904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041177|NCT05727904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041178|NCT00106626|Pemetrexed|pemetrexed|mesh-list
57041179|NCT00106626|Vorinostat|vorinostat|mesh-list
57041180|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041181|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041182|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041183|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57041184|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57041185|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57041186|NCT02177448|Enalapril|enalapril|mesh-list
57041187|NCT02177448|Enalaprilat|enalaprilat|mesh-list
57041188|NCT02177448|Telmisartan|telmisartan|mesh-list
57041189|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57041190|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
57041191|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041192|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041193|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57041194|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57041195|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57041196|NCT03537144|Acetaminophen|acetaminophen|mesh-list
57041197|NCT03537144|Indomethacin|indomethacin|mesh-list
57041198|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041199|NCT03537144|Analgesics|analgesics|mesh-ancestor
57041200|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
57041201|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041202|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041203|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
57041204|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57041205|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041206|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041207|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
57041208|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
57041209|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57041210|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57041211|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041212|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041213|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
57041214|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041215|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041216|NCT02755818|Heparin|heparin|mesh-list
57041217|NCT02755818|Calcium heparin|calcium heparin|mesh-list
57041218|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
57041219|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57041220|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57041221|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041222|NCT02177760|Sirolimus|sirolimus|mesh-list
57041223|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57041224|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041225|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57041226|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041227|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
57041228|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57041229|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
57041230|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041231|NCT02173782|Fenoterol|fenoterol|mesh-list
57041232|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57041233|NCT02173782|Ipratropium|ipratropium|mesh-list
57041234|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57041235|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
57041236|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041237|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041238|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57041239|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
57041240|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
57041241|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
57041242|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57041243|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57041244|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57041245|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57041246|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
57041247|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041248|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041249|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57041250|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
57041251|NCT05571592|Cannabidiol|cannabidiol|mesh-list
57041252|NCT05571592|Anticonvulsants|anticonvulsants|mesh-ancestor
57041254|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
57041255|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57041256|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
57041257|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041258|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041259|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57041260|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
57041261|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57041262|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57041263|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57041264|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
57041265|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041266|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041267|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041268|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
57041269|NCT04233190|Hormones|hormones|mesh-ancestor
57041270|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041271|NCT05717374|Dexamethasone|dexamethasone|mesh-list
57041272|NCT05717374|Dexamethasone acetate|dexamethasone acetate|mesh-list
57041273|NCT05717374|Methylprednisolone|methylprednisolone|mesh-list
57041274|NCT05717374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57041275|NCT05717374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57041276|NCT05717374|Prednisolone|prednisolone|mesh-list
57041277|NCT05717374|Prednisolone acetate|prednisolone acetate|mesh-list
57041278|NCT05717374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57041279|NCT05717374|Prednisolone phosphate|prednisolone phosphate|mesh-list
57041280|NCT05717374|BB 1101|bb 1101|mesh-list
57041281|NCT05717374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041282|NCT05717374|Antiemetics|antiemetics|mesh-ancestor
57041283|NCT05717374|Autonomic Agents|autonomic agents|mesh-ancestor
57041284|NCT05717374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041285|NCT05717374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041286|NCT05717374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57041287|NCT05717374|Glucocorticoids|glucocorticoids|mesh-ancestor
57041288|NCT05717374|Hormones|hormones|mesh-ancestor
57041289|NCT05717374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041290|NCT05717374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57041291|NCT05717374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041292|NCT05717374|Protease Inhibitors|protease inhibitors|mesh-ancestor
57041293|NCT05717374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041294|NCT05717374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041295|NCT05717374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57041296|NCT05717374|Protective Agents|protective agents|mesh-ancestor
57041297|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
57041298|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
56897412|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
57041299|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57041300|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
57041301|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57041302|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041303|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57041304|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57041305|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57041306|NCT02174094|Clobazam|clobazam|mesh-list
57041307|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
57041308|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57041309|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57041310|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041311|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041312|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57041313|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57041314|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
57041315|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
57041316|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041317|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041318|NCT02174172|Interferons|interferons|mesh-list
57041319|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
57041320|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
57041321|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57041322|NCT02174172|Bevacizumab|bevacizumab|mesh-list
57041323|NCT02174172|Ipilimumab|ipilimumab|mesh-list
57041324|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
57041325|NCT02174172|Atezolizumab|atezolizumab|mesh-list
57041326|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041327|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041328|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57041329|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57041330|NCT02174172|Growth Substances|growth substances|mesh-ancestor
57041331|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041332|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
57041333|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
57041334|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041335|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57041336|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041337|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
57041338|NCT02180334|Acetaminophen|acetaminophen|mesh-list
57041339|NCT02180334|Linagliptin|linagliptin|mesh-list
57041340|NCT02180334|Mosapride|mosapride|mesh-list
57041341|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041342|NCT02180334|Analgesics|analgesics|mesh-ancestor
57041343|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
57041344|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041345|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041346|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
57041347|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041348|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57041349|NCT02180334|Incretins|incretins|mesh-ancestor
57041350|NCT02180334|Hormones|hormones|mesh-ancestor
57041351|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041352|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57041353|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
57041354|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041355|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57041356|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57041357|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
57041358|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041359|NCT02174250|Rifampin|rifampin|mesh-list
57041360|NCT02174250|Istradefylline|istradefylline|mesh-list
57041361|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57041362|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
57041363|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57041364|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041365|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
57041366|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57041367|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041368|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041369|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57041370|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57041371|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57041372|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56618879|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041373|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57041374|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57041375|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
57041376|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57041377|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57041378|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
57041379|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041380|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041381|NCT02174328|Aspirin|aspirin|mesh-list
57041382|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57041383|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041384|NCT02174328|Analgesics|analgesics|mesh-ancestor
57041385|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
57041386|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041387|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041388|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041389|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041390|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57041391|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57041392|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041393|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57041394|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57041395|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041396|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
57041397|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
57041398|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57041399|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041400|NCT02755116|Olanzapine|olanzapine|mesh-list
57041401|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
57041402|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
57041403|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041404|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041405|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57041406|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57041407|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57041408|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041409|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57041410|NCT02755116|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57041411|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57041412|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57041413|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041414|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041415|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
57041416|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
57041417|NCT02178150|Antacids|antacids|mesh-ancestor
57041418|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041419|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57041420|NCT04411030|Itraconazole|itraconazole|mesh-list
57041421|NCT04411030|Midazolam|midazolam|mesh-list
57041422|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57041423|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57041424|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041425|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041426|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57041427|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57041428|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57041429|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57041430|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
57041431|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
57041432|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
57041433|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
57041434|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041435|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041436|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
57041437|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041438|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57041439|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57041440|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041441|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57041442|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
57041443|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041444|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57041445|NCT04437654|Apixaban|apixaban|mesh-list
57041446|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57041447|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
57041448|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57041449|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
57041450|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041451|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041452|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
57041453|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
57041454|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57041455|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
57041456|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
57041457|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
57041458|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041459|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041460|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
57041461|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041463|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041464|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57041465|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041466|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041467|NCT02182128|Nintedanib|nintedanib|mesh-list
57041468|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041469|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57041470|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041471|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041472|NCT02182206|Nintedanib|nintedanib|mesh-list
57041473|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041474|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57041475|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041476|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041477|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
57041478|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041479|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
57041480|NCT02657889|Niraparib|niraparib|mesh-list
57041481|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041482|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041483|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57041484|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041485|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041486|NCT03536208|Warfarin|warfarin|mesh-list
57041487|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
57041488|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57041489|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57041490|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
57041491|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041492|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041493|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57041494|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
57041495|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57041496|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57041497|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57041498|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
57041499|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041500|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041501|NCT02631538|Rituximab|rituximab|mesh-list
57041502|NCT02631538|Belimumab|belimumab|mesh-list
57041503|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041504|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041505|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
57041506|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041507|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041508|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57041509|NCT03578679|Ivermectin|ivermectin|mesh-list
57041510|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57041511|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041512|NCT04930783|Nivolumab|nivolumab|mesh-list
57041513|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041514|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041515|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57041516|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041517|NCT05666206|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
57041518|NCT05666206|Hemostatics|hemostatics|mesh-ancestor
57041519|NCT05666206|Coagulants|coagulants|mesh-ancestor
57041520|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
57041521|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57041522|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041523|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57041524|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041525|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57041526|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041527|NCT05458375|Estradiol|estradiol|mesh-list
57041528|NCT05458375|Estrogens|estrogens|mesh-ancestor
57041529|NCT05458375|Hormones|hormones|mesh-ancestor
57041530|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041531|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041532|NCT02256462|Adalimumab|adalimumab|mesh-list
57041533|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041534|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041535|NCT02631148|Melatonin|melatonin|mesh-list
57041536|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
57041537|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041538|NCT02631148|Protective Agents|protective agents|mesh-ancestor
57041539|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041540|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041541|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
57041542|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57041543|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
57041544|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041545|NCT02239107|Expectorants|expectorants|mesh-ancestor
57041546|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
57041547|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57041548|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
57041549|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041550|NCT02239107|Protective Agents|protective agents|mesh-ancestor
57041551|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041552|NCT02239107|Antidotes|antidotes|mesh-ancestor
57041553|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
57041554|NCT02182518|Ephedrine|ephedrine|mesh-list
57041555|NCT02182518|Epinastine|epinastine|mesh-list
57041556|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57041557|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
57041558|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041559|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041560|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57041561|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
57041562|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
57041563|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57041564|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57041565|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
57041566|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
57041567|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041568|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041569|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57041570|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
57041571|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
57041572|NCT03881488|Pembrolizumab|pembrolizumab|mesh-list
57041573|NCT03881488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041574|NCT03881488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041575|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
57041576|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041577|NCT05289349|Propofol|propofol|mesh-list
57041578|NCT05289349|Sevoflurane|sevoflurane|mesh-list
57041579|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57041580|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041581|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041582|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57041583|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
57041584|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
57041585|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57041586|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57041587|NCT03810742|Irinotecan|irinotecan|mesh-list
57041588|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57041589|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57041590|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041591|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041592|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041593|NCT03574857|Metolazone|metolazone|mesh-list
57041594|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
57041595|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57041596|NCT03574857|Diuretics|diuretics|mesh-ancestor
57041597|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
57041598|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041599|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57041600|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57041601|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041602|NCT04200313|Pancrelipase|pancrelipase|mesh-list
57041603|NCT04200313|Pancreatin|pancreatin|mesh-list
57041604|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57041605|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
57041606|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57041607|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57041608|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041609|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
57041610|NCT02238639|Coagulants|coagulants|mesh-ancestor
57041611|NCT02186028|Vitamin D|vitamin d|mesh-list
57041612|NCT02186028|Vitamins|vitamins|mesh-ancestor
57041613|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
57041614|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041615|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57041616|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
57041617|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041618|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041619|NCT03574701|Vitamin A|vitamin a|mesh-list
57041620|NCT03574701|Vitamins|vitamins|mesh-ancestor
57041621|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
57041622|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041623|NCT02180880|Pregabalin|pregabalin|mesh-list
57041624|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
57041625|NCT02180880|Analgesics|analgesics|mesh-ancestor
57041626|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
57041627|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041628|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041629|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
57041630|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57041631|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57041632|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041633|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57041634|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57041635|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57041636|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041637|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57041638|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57041639|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57041640|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57041641|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57041642|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
57041643|NCT02186106|Vitamin D|vitamin d|mesh-list
57041644|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57041645|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041646|NCT02186106|Vitamins|vitamins|mesh-ancestor
57041647|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
57041648|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57041649|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
57041650|NCT03943147|BMS-986165|bms-986165|mesh-list
57041651|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57041652|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041653|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57041654|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
57041655|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57041656|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041657|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041658|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041659|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
57041660|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57041661|NCT02182752|Tramadol|tramadol|mesh-list
57041662|NCT02182752|Ropivacaine|ropivacaine|mesh-list
57041663|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
57041664|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
57041665|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041666|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041667|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
57041668|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041669|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57041670|NCT02182752|Narcotics|narcotics|mesh-ancestor
57041671|NCT02182752|Analgesics|analgesics|mesh-ancestor
57041672|NCT03536598|Amlodipine|amlodipine|mesh-list
57041673|NCT03536598|Valsartan|valsartan|mesh-list
57041674|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57041675|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57041676|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57041677|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57041678|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041679|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57041680|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041681|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
57041682|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57041683|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57041684|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
57041685|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57041686|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57041687|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041688|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57041689|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57041691|NCT03576963|Guadecitabine|guadecitabine|mesh-list
57041692|NCT03576963|Azacitidine|azacitidine|mesh-list
57041693|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041694|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041695|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57041696|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041697|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57041698|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
57041699|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041700|NCT02186496|Amlodipine|amlodipine|mesh-list
57041701|NCT02186496|Candesartan|candesartan|mesh-list
57041702|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57041703|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57041704|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57041705|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041706|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57041707|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041708|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
57041709|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57041710|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57041711|NCT05615194|Dexmedetomidine|dexmedetomidine|mesh-list
57041712|NCT05615194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57041713|NCT05615194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041714|NCT05615194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041715|NCT05615194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041716|NCT05615194|Analgesics|analgesics|mesh-ancestor
57041717|NCT05615194|Sensory System Agents|sensory system agents|mesh-ancestor
57041718|NCT05615194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041719|NCT05615194|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57041720|NCT05615194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57041721|NCT05615194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57041722|NCT05615194|Adrenergic Agents|adrenergic agents|mesh-ancestor
57041723|NCT05615194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041724|NCT05615194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041725|NCT02186574|Tenofovir|tenofovir|mesh-list
57041726|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
57041727|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041728|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57041729|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57041730|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041731|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041732|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57041733|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57041734|NCT03066700|Hemostatics|hemostatics|mesh-list
57041735|NCT03066700|Coagulants|coagulants|mesh-ancestor
57041736|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
57041737|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041738|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041739|NCT03066544|Dexamethasone|dexamethasone|mesh-list
57041740|NCT03066544|Ketorolac|ketorolac|mesh-list
57041741|NCT03066544|Naratriptan|naratriptan|mesh-list
57041742|NCT03066544|Bupivacaine|bupivacaine|mesh-list
57041743|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041744|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
57041745|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
57041746|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041747|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041748|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57041749|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
57041750|NCT03066544|Hormones|hormones|mesh-ancestor
57041751|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041752|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57041753|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041754|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
57041755|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
57041756|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041757|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
57041758|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57041759|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041760|NCT03066544|Analgesics|analgesics|mesh-ancestor
57041761|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041762|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57041763|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041764|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041765|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57041766|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57041767|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57041768|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
57041769|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041771|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57041772|NCT05425420|Narcotics|narcotics|mesh-ancestor
57041773|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041774|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041775|NCT05425420|Analgesics|analgesics|mesh-ancestor
57041776|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
57041777|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041778|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
57041779|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
57041780|NCT03182179|Ondansetron|ondansetron|mesh-list
57041781|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
57041782|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
57041783|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041784|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041785|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57041786|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
57041787|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
57041788|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57041789|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
57041790|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041791|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041792|NCT03182179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57041793|NCT03182179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57041794|NCT03182179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041795|NCT03182179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57041796|NCT03182179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57041797|NCT03576651|Bevacizumab|bevacizumab|mesh-list
57041798|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041799|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041800|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57041801|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57041802|NCT03576651|Growth Substances|growth substances|mesh-ancestor
57041803|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041804|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
57041805|NCT04116112|Hydralazine|hydralazine|mesh-list
57041806|NCT04116112|Labetalol|labetalol|mesh-list
57041807|NCT04116112|Nicardipine|nicardipine|mesh-list
57041808|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57041809|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
57041810|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57041811|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57041812|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
57041813|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041814|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041815|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041816|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
57041817|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
57041818|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041819|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57041820|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57041821|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57041822|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57041823|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57041824|NCT03064906|Pancrelipase|pancrelipase|mesh-list
57041825|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57041826|NCT03034135|Copper|copper|mesh-list
57041827|NCT03034135|Temozolomide|temozolomide|mesh-list
57041828|NCT03034135|Disulfiram|disulfiram|mesh-list
57041829|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57041830|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
57041831|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041832|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041833|NCT03034135|Trace Elements|trace elements|mesh-ancestor
57041834|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
57041835|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041836|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57041837|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
57041838|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041839|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57041840|NCT02239731|Doxycycline|doxycycline|mesh-list
57041841|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041842|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
57041843|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57041844|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57041845|NCT03571815|Listerine|listerine|mesh-list
57041846|NCT03571815|Fluorides|fluorides|mesh-list
57041847|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
57041848|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
57041849|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
57041850|NCT03571815|Protective Agents|protective agents|mesh-ancestor
57041851|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041852|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57041853|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041854|NCT03571737|Ibuprofen|ibuprofen|mesh-list
57041855|NCT03571737|Lidocaine|lidocaine|mesh-list
57041856|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
57041857|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
57041858|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041859|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041860|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
57041861|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041862|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57041863|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57041864|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57041865|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57041866|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041867|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57041868|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57041869|NCT03571737|Analgesics|analgesics|mesh-ancestor
57041870|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041871|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041872|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57041873|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041874|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
57041875|NCT05379634|Hormones|hormones|mesh-ancestor
57041876|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041877|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041878|NCT03573999|Mannitol|mannitol|mesh-list
57041879|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57041880|NCT03573999|Diuretics|diuretics|mesh-ancestor
57041881|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
57041882|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041883|NCT04606069|Regadenoson|regadenoson|mesh-list
57041884|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
57041885|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57041886|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
57041887|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
57041888|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041889|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041890|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041891|NCT03063190|Vitamin D|vitamin d|mesh-list
57041892|NCT03063190|Vitamins|vitamins|mesh-ancestor
57041893|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
57041894|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041895|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57041896|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
57041897|NCT03576105|Methylene Blue|methylene blue|mesh-list
57041898|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041899|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041900|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
57041901|NCT03573687|Caseins|caseins|mesh-list
57041902|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
57041903|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
57041904|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041905|NCT01671280|Azithromycin|azithromycin|mesh-list
57041906|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57041907|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041908|NCT04904302|Nivolumab|nivolumab|mesh-list
57041909|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57041910|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041911|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57041912|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041913|NCT04862260|Atorvastatin|atorvastatin|mesh-list
57041914|NCT04862260|Ezetimibe|ezetimibe|mesh-list
57041915|NCT04862260|Evolocumab|evolocumab|mesh-list
57041916|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57041917|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57041918|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
57041919|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041920|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57041921|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57041922|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041923|NCT03575637|Olanzapine|olanzapine|mesh-list
57041924|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
57041925|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
57041926|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041927|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041928|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57041929|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57041930|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57041931|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57041932|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57041933|NCT03575637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57041934|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57041935|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57041936|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041937|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57041938|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
57041939|NCT04851613|Fulvestrant|fulvestrant|mesh-list
57041940|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57041941|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041942|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57041943|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57041944|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
57041945|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041946|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041947|NCT03062800|Thalidomide|thalidomide|mesh-list
57041948|NCT03062800|Carboplatin|carboplatin|mesh-list
57041949|NCT03062800|Pemetrexed|pemetrexed|mesh-list
57041950|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041951|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57041952|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041953|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57041954|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57041955|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57041956|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
57041957|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041958|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
57041959|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57041960|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041961|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57041962|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57041963|NCT03062800|Growth Substances|growth substances|mesh-ancestor
57041964|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
57041965|NCT05709015|Chlorhexidine|chlorhexidine|mesh-list
57041966|NCT05709015|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57041967|NCT05709015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57041968|NCT05709015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57041969|NCT05709015|Disinfectants|disinfectants|mesh-ancestor
57041970|NCT05709015|Dermatologic Agents|dermatologic agents|mesh-ancestor
57041971|NCT03418779|Prednisolone|prednisolone|mesh-list
57041972|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
57041973|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
57041974|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
57041975|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041976|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57041977|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57041978|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
57041979|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57041980|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57041981|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57041982|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041983|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
57041984|NCT03418779|Hormones|hormones|mesh-ancestor
57041985|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041986|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57041987|NCT03573063|Androgens|androgens|mesh-list
57041988|NCT03573063|Hormones|hormones|mesh-ancestor
57041989|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57041990|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041991|NCT03572829|Dexamethasone|dexamethasone|mesh-list
57041992|NCT03572829|Ondansetron|ondansetron|mesh-list
57041993|NCT03572829|Aprepitant|aprepitant|mesh-list
57041994|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57041995|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
57041996|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
57041997|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57041998|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57041999|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57042000|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
57042001|NCT03572829|Hormones|hormones|mesh-ancestor
57042002|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042003|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57042004|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042005|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042006|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
57042007|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
57042008|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57042009|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
57042010|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042011|NCT03572829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57042012|NCT03572829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57042013|NCT03572829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042014|NCT03572829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57042015|NCT03572829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57042016|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57042017|NCT04585789|Tenofovir|tenofovir|mesh-list
57042018|NCT04585789|Entecavir|entecavir|mesh-list
57042019|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
57042020|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57042021|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
57042022|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042023|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57042024|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57042025|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042026|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042027|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57042028|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57042029|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
57042030|NCT03575247|Hormones|hormones|mesh-ancestor
57042031|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042032|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042033|NCT03704623|Acetaminophen|acetaminophen|mesh-list
57042034|NCT03704623|Parecoxib|parecoxib|mesh-list
57042035|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042036|NCT03704623|Analgesics|analgesics|mesh-ancestor
57042037|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
57042038|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042039|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042040|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
57042041|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57042042|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57042043|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042044|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042045|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57042046|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042047|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042048|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57042049|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57042050|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042051|NCT03572517|Morphine|morphine|mesh-list
57042052|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57042053|NCT03572517|Narcotics|narcotics|mesh-ancestor
57042054|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042055|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042056|NCT03572517|Analgesics|analgesics|mesh-ancestor
57042057|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
57042058|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042059|NCT04774393|Decitabine|decitabine|mesh-list
57042060|NCT04774393|Venetoclax|venetoclax|mesh-list
57042061|NCT04774393|Ivosidenib|ivosidenib|mesh-list
57042062|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57042063|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
57042064|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042065|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042066|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042067|NCT03570645|Dexamethasone|dexamethasone|mesh-list
57042068|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
57042069|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042070|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
57042071|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
57042072|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042073|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042074|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57042075|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
57042076|NCT03570645|Hormones|hormones|mesh-ancestor
57042077|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042078|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57042079|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042080|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57042081|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042082|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042083|NCT03570645|Analgesics|analgesics|mesh-ancestor
57042084|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
57042085|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57042086|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57042087|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57042088|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
57042089|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042090|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042091|NCT03940690|Bevacizumab|bevacizumab|mesh-list
57042092|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042093|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042094|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57042095|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57042096|NCT03940690|Growth Substances|growth substances|mesh-ancestor
57042097|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042098|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
57042099|NCT03567135|Temozolomide|temozolomide|mesh-list
57042100|NCT03567135|Apatinib|apatinib|mesh-list
57042101|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57042102|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
57042103|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042104|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042105|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57042106|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042107|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
57042108|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57042109|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57042110|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042111|NCT03698383|Trastuzumab|trastuzumab|mesh-list
57042112|NCT03698383|Gedatolisib|gedatolisib|mesh-list
57042113|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042114|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042115|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57042116|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042117|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042118|NCT04760782|Abaloparatide|abaloparatide|mesh-list
57042119|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57042120|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042121|NCT04441138|Durvalumab|durvalumab|mesh-list
57042122|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042123|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042124|NCT05708859|Tirzepatide|tirzepatide|mesh-list
57042125|NCT05708859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57042126|NCT05708859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042127|NCT05708859|Incretins|incretins|mesh-ancestor
57042128|NCT05708859|Hormones|hormones|mesh-ancestor
57042129|NCT05708859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042130|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
57042131|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57042132|NCT04740580|Glycine|glycine|mesh-list
57042133|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
57042134|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042135|NCT04740580|Expectorants|expectorants|mesh-ancestor
57042136|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
57042137|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57042138|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
57042139|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042140|NCT04740580|Protective Agents|protective agents|mesh-ancestor
57042141|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042142|NCT04740580|Antidotes|antidotes|mesh-ancestor
57042143|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
57042144|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042145|NCT03064282|Papaverine|papaverine|mesh-list
57042146|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57042147|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042148|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042149|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
57042150|NCT03064282|Urological Agents|urological agents|mesh-ancestor
57042151|NCT04679818|Fentanyl|fentanyl|mesh-list
57042152|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
57042153|NCT04679818|Narcotics|narcotics|mesh-ancestor
57042154|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042155|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042156|NCT04679818|Analgesics|analgesics|mesh-ancestor
57042157|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
57042158|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042159|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57042160|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57042161|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
57042162|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
57042163|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57042164|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042165|NCT03063112|Ethanol|ethanol|mesh-list
57042166|NCT03063112|Lidocaine|lidocaine|mesh-list
57042167|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
57042168|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
57042169|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042170|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042171|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
57042172|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042173|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57042174|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57042175|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57042176|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57042177|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042178|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57042179|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042180|NCT04767217|Lumefantrine|lumefantrine|mesh-list
57042181|NCT04767217|Artemether|artemether|mesh-list
57042182|NCT04767217|Piperaquine|piperaquine|mesh-list
57042183|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57042184|NCT04767217|Artenimol|artenimol|mesh-list
57042185|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
57042186|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57042187|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57042188|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042189|NCT03701503|Hormones|hormones|mesh-list
57042190|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042191|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042192|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
57042193|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57042194|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57042195|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57042196|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57042197|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042198|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
57042199|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042200|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042201|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57042202|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042203|NCT03698227|Doxorubicin|doxorubicin|mesh-list
57042204|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
57042205|NCT03698227|Razoxane|razoxane|mesh-list
57042206|NCT03698227|Olaratumab|olaratumab|mesh-list
57042207|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57042208|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042209|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57042210|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57042211|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042212|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724185|NCT05667428|Leuprolide|leuprolide|mesh-list
57042213|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57042214|NCT03698227|Protective Agents|protective agents|mesh-ancestor
57042215|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042216|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
57042217|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
57042218|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57042219|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042220|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57042221|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042222|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042223|NCT04434664|Metoprolol|metoprolol|mesh-list
57042224|NCT04434664|Amlodipine|amlodipine|mesh-list
57042225|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57042226|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57042227|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57042228|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042229|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57042230|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042231|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
57042232|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57042233|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
57042234|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
57042235|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042236|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57042237|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57042238|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57042239|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
57042240|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042241|NCT02181348|Vitamin E|vitamin e|mesh-list
57042242|NCT02181348|Vitamins|vitamins|mesh-ancestor
57042243|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
57042244|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042245|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
57042246|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042247|NCT02181348|Protective Agents|protective agents|mesh-ancestor
57042248|NCT02186886|Golimumab|golimumab|mesh-list
57042249|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57042250|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042251|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57042252|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
57042253|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042254|NCT03722680|Riluzole|riluzole|mesh-list
57042255|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
57042256|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57042257|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57042258|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042259|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042260|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042261|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57042262|NCT03722680|Protective Agents|protective agents|mesh-ancestor
57042263|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
57042264|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
57042265|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042266|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
57042267|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
57042268|NCT03536910|Coagulants|coagulants|mesh-ancestor
57042269|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57042270|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57042271|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
57042272|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042273|NCT04308174|Durvalumab|durvalumab|mesh-list
57042274|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042275|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042276|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
57042277|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57042278|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57042279|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042280|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
57042281|NCT03697681|Coagulants|coagulants|mesh-ancestor
57042282|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
57042283|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042284|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042285|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
57042286|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042287|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724261|NCT00836199|Vaccines|vaccines|mesh-list
57042288|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
57042289|NCT03645928|Nivolumab|nivolumab|mesh-list
57042290|NCT03645928|Ipilimumab|ipilimumab|mesh-list
57042291|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042292|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042293|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57042294|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042295|NCT02683239|Fasinumab|fasinumab|mesh-list
57042296|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042297|NCT02683239|Analgesics|analgesics|mesh-ancestor
57042298|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
57042299|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042300|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042301|NCT02183064|Meloxicam|meloxicam|mesh-list
57042302|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57042303|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042304|NCT02183064|Analgesics|analgesics|mesh-ancestor
57042305|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
57042306|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042307|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042308|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042309|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042310|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57042311|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57042312|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042313|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042314|NCT03704077|Paclitaxel|paclitaxel|mesh-list
57042315|NCT03704077|Nivolumab|nivolumab|mesh-list
57042316|NCT03704077|Ramucirumab|ramucirumab|mesh-list
57042317|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57042318|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042319|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
57042320|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
57042321|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
57042322|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042323|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042324|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57042325|NCT03618550|Gemcitabine|gemcitabine|mesh-list
57042326|NCT03618550|Doxorubicin|doxorubicin|mesh-list
57042327|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57042328|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
57042329|NCT03618550|Vinorelbine|vinorelbine|mesh-list
57042330|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57042331|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
57042332|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042333|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042334|NCT03618550|Antiviral Agents|antiviral agents|mesh-ancestor
57042335|NCT03618550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042336|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042337|NCT03618550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57042338|NCT03618550|Immunologic Factors|immunologic factors|mesh-ancestor
57042339|NCT03618550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042340|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57042341|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57042342|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57042343|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042344|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57042345|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
57042346|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
57042347|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
57042348|NCT02183142|Meloxicam|meloxicam|mesh-list
57042349|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57042350|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042351|NCT02183142|Analgesics|analgesics|mesh-ancestor
57042352|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
57042353|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042354|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042355|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042356|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042357|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57042358|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57042359|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042360|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042361|NCT02183220|Aspirin|aspirin|mesh-list
56724338|NCT04013464|Citalopram|citalopram|mesh-list
57042362|NCT02183220|Dipyrone|dipyrone|mesh-list
57042363|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57042364|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042366|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
57042367|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042368|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042369|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042370|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042371|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57042372|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57042373|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042374|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57042375|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57042376|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042377|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
57042378|NCT02187588|Ibuprofen|ibuprofen|mesh-list
57042379|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57042380|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042381|NCT02187588|Analgesics|analgesics|mesh-ancestor
57042382|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
57042383|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042384|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042385|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042386|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042387|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57042388|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042389|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042390|NCT03528694|Durvalumab|durvalumab|mesh-list
57042391|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
57042392|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042393|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042394|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57042395|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
57042396|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042397|NCT05364489|Bevacizumab|bevacizumab|mesh-list
57042398|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
57042399|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042400|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042401|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57042402|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57042403|NCT05364489|Growth Substances|growth substances|mesh-ancestor
57042404|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042405|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
57042406|NCT02183298|Linagliptin|linagliptin|mesh-list
57042407|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57042408|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042409|NCT02183298|Incretins|incretins|mesh-ancestor
57042410|NCT02183298|Hormones|hormones|mesh-ancestor
57042411|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042412|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57042413|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
57042414|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042415|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042416|NCT03697057|Anesthetics|anesthetics|mesh-list
57042417|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042418|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042419|NCT02183376|Linagliptin|linagliptin|mesh-list
57042420|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57042421|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042422|NCT02183376|Incretins|incretins|mesh-ancestor
57042423|NCT02183376|Hormones|hormones|mesh-ancestor
57042424|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042425|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57042426|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
57042427|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042428|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042429|NCT02187822|Taxane|taxane|mesh-list
57042430|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042431|NCT03696901|Dalbavancin|dalbavancin|mesh-list
57042432|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57042433|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042434|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
57042435|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
56724423|NCT00851175|Caffeine|caffeine|mesh-list
57042436|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57042437|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042438|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57042439|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
57042440|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57042441|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042442|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042443|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042444|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57042445|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57042446|NCT02187900|Protective Agents|protective agents|mesh-ancestor
57042447|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042448|NCT03062644|Celecoxib|celecoxib|mesh-list
57042449|NCT03062644|Tramadol|tramadol|mesh-list
57042450|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57042451|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042452|NCT03062644|Analgesics|analgesics|mesh-ancestor
57042453|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
57042454|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042455|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042456|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042457|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042458|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57042459|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57042460|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042461|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042462|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57042463|NCT03062644|Narcotics|narcotics|mesh-ancestor
57042464|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042465|NCT02190318|Losartan|losartan|mesh-list
57042466|NCT02190318|Spironolactone|spironolactone|mesh-list
57042467|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57042468|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57042469|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57042470|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57042471|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042472|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57042473|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
57042474|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042475|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042476|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57042477|NCT02190318|Diuretics|diuretics|mesh-ancestor
57042478|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
57042479|NCT04743661|Antipyretics|antipyretics|mesh-list
57042480|NCT04743661|Dexamethasone|dexamethasone|mesh-list
57042481|NCT04743661|Bevacizumab|bevacizumab|mesh-list
57042482|NCT04743661|Irinotecan|irinotecan|mesh-list
57042483|NCT04743661|Temozolomide|temozolomide|mesh-list
57042484|NCT04743661|Antiemetics|antiemetics|mesh-list
57042485|NCT04743661|Emetics|emetics|mesh-list
57042486|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
57042487|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
57042488|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042489|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042490|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57042491|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57042492|NCT04743661|Growth Substances|growth substances|mesh-ancestor
57042493|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042494|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
57042495|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042496|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
57042497|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042498|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57042499|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
57042500|NCT04743661|Hormones|hormones|mesh-ancestor
57042501|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042502|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57042503|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57042504|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57042505|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042506|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042507|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57042508|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
56724485|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
57042510|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042511|NCT02183532|Linagliptin|linagliptin|mesh-list
57042512|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57042513|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042514|NCT02183532|Incretins|incretins|mesh-ancestor
57042515|NCT02183532|Hormones|hormones|mesh-ancestor
57042516|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042517|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57042518|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
57042519|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042520|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042521|NCT02629822|Tenofovir|tenofovir|mesh-list
57042522|NCT02629822|Lamivudine|lamivudine|mesh-list
57042523|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
57042524|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042525|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57042526|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57042527|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042528|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042529|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57042530|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57042531|NCT03700801|Insulin|insulin|mesh-list
57042532|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57042533|NCT03700801|Metformin|metformin|mesh-list
57042534|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
57042535|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
57042536|NCT03700801|Saxagliptin|saxagliptin|mesh-list
57042537|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57042538|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042539|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57042540|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042541|NCT03700801|Incretins|incretins|mesh-ancestor
57042542|NCT03700801|Hormones|hormones|mesh-ancestor
57042543|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042544|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57042545|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
57042546|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042547|NCT03700645|Allopurinol|allopurinol|mesh-list
57042548|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
57042549|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042550|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042551|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
57042552|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042553|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57042554|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
57042555|NCT03700645|Protective Agents|protective agents|mesh-ancestor
57042556|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042557|NCT03493048|Leucovorin|leucovorin|mesh-list
57042558|NCT03493048|Fluorouracil|fluorouracil|mesh-list
57042559|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
57042560|NCT03493048|Irinotecan|irinotecan|mesh-list
57042561|NCT03493048|Cetuximab|cetuximab|mesh-list
57042562|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
57042563|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042564|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57042565|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042566|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57042567|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
57042568|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042569|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57042570|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57042571|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042572|NCT03493048|Antidotes|antidotes|mesh-ancestor
57042573|NCT03493048|Protective Agents|protective agents|mesh-ancestor
57042574|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
57042575|NCT03493048|Vitamins|vitamins|mesh-ancestor
57042576|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
57042577|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042578|NCT04499053|Durvalumab|durvalumab|mesh-list
57042579|NCT04499053|Tremelimumab|tremelimumab|mesh-list
57042580|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042581|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042582|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
57042583|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
57042584|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57042585|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57042586|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57042587|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042588|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57042589|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57042590|NCT03567447|Droxidopa|droxidopa|mesh-list
57042591|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57042592|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57042593|NCT03567369|Dexamethasone|dexamethasone|mesh-list
57042594|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
57042595|NCT03567369|BB 1101|bb 1101|mesh-list
57042596|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042597|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
57042598|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
57042599|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042600|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042601|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57042602|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
57042603|NCT03567369|Hormones|hormones|mesh-ancestor
57042604|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042605|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57042606|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042607|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
57042608|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042609|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042610|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
57042611|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042612|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042613|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
57042614|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57042615|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57042616|NCT03266146|Prednisolone|prednisolone|mesh-list
57042617|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
57042618|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57042619|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
57042620|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042621|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
56897436|NCT01172769|Sirolimus|sirolimus|mesh-list
57042622|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
57042623|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042624|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042625|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57042626|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
57042627|NCT03266146|Hormones|hormones|mesh-ancestor
57042628|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042629|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57042630|NCT03266146|Protective Agents|protective agents|mesh-ancestor
57042631|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57042632|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042633|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
57042634|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
57042635|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57042636|NCT03700489|Protective Agents|protective agents|mesh-ancestor
57042637|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042638|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
57042639|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57042640|NCT04553536|Sufentanil|sufentanil|mesh-list
57042641|NCT04553536|Remifentanil|remifentanil|mesh-list
57042642|NCT04553536|Dsuvia|dsuvia|mesh-list
57042643|NCT04553536|Bromides|bromides|mesh-list
57042644|NCT04553536|Propofol|propofol|mesh-list
57042645|NCT04553536|Esketamine|esketamine|mesh-list
57042646|NCT04553536|Rocuronium|rocuronium|mesh-list
57042647|NCT04553536|Cisatracurium|cisatracurium|mesh-list
57042648|NCT04553536|Atracurium|atracurium|mesh-list
57042649|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57042650|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042651|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042652|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57042653|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
57042654|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
57042655|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57042656|NCT04553536|Narcotics|narcotics|mesh-ancestor
57042657|NCT04553536|Analgesics|analgesics|mesh-ancestor
57042658|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
57042659|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042660|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
57042661|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57042662|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57042663|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57042664|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
57042665|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57042666|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57042667|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57042668|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
57042669|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042670|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042671|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57042672|NCT02800941|Warfarin|warfarin|mesh-list
57042673|NCT02800941|Anticoagulants|anticoagulants|mesh-list
57042674|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
57042675|NCT02800941|Fluindione|fluindione|mesh-list
57042676|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
57042677|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57042678|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
57042679|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
57042680|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042681|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042682|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042683|NCT03695887|Analgesics|analgesics|mesh-ancestor
57042684|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
57042685|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042686|NCT04432714|Prednisone|prednisone|mesh-list
57042687|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
57042688|NCT04432714|Rituximab|rituximab|mesh-list
57042689|NCT04432714|Doxorubicin|doxorubicin|mesh-list
57042690|NCT04432714|Etoposide|etoposide|mesh-list
57042691|NCT04432714|Vincristine|vincristine|mesh-list
57042692|NCT04432714|Lenalidomide|lenalidomide|mesh-list
57042693|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57042694|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
57042695|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042696|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042697|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57042698|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
57042699|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042700|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042701|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57042702|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042703|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57042704|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57042705|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57042706|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042707|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042708|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
57042709|NCT04432714|Hormones|hormones|mesh-ancestor
57042710|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042711|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57042712|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57042713|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
57042714|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
57042715|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
57042716|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57042717|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57042718|NCT04432714|Growth Substances|growth substances|mesh-ancestor
57042719|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
57042720|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
57042721|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042722|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042723|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
57042724|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
57042725|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57042726|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042727|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57042728|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57042729|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
57042730|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57042731|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
57042732|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57042733|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042734|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042735|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042736|NCT03624595|Analgesics|analgesics|mesh-ancestor
57042737|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
57042738|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042739|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57042740|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57042741|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57042742|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
57042743|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042744|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042745|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
57042746|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57042747|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57042748|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042749|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
57042750|NCT03063892|Coagulants|coagulants|mesh-ancestor
57042751|NCT03700333|Pemetrexed|pemetrexed|mesh-list
57042752|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042753|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042754|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042755|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57042756|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57042757|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
57042758|NCT03063580|Rifampin|rifampin|mesh-list
57042759|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57042760|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
57042761|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57042762|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042763|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
57042764|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57042765|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042766|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042767|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57042768|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57042769|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57042770|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57042771|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57042772|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57042773|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57042774|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57042775|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042776|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
57042777|NCT05353101|Cyclosporine|cyclosporine|mesh-list
57042778|NCT05353101|Tobramycin|tobramycin|mesh-list
57042779|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57042780|NCT05353101|Cyclosporins|cyclosporins|mesh-list
57042781|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042782|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042783|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57042784|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
57042785|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042786|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
57042787|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042788|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
57042789|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042790|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57042791|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57042792|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57042793|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57042794|NCT05139316|Prednisolone|prednisolone|mesh-list
57042795|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042796|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
57042797|NCT05139316|Hormones|hormones|mesh-ancestor
57042798|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042799|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042800|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57042801|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042802|NCT03700177|Dexamethasone|dexamethasone|mesh-list
57042803|NCT03700177|Ropivacaine|ropivacaine|mesh-list
57042804|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042805|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
57042806|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
57042807|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042808|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042809|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57042810|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
57042811|NCT03700177|Hormones|hormones|mesh-ancestor
57042812|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724787|NCT04012450|Anesthetics|anesthetics|mesh-list
57042813|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57042814|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042815|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
57042816|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
57042817|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042818|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
57042819|NCT02183610|Linagliptin|linagliptin|mesh-list
57042820|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57042821|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57042822|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042823|NCT02183610|Incretins|incretins|mesh-ancestor
57042824|NCT02183610|Hormones|hormones|mesh-ancestor
57042825|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57042826|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57042827|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
57042828|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042829|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042830|NCT02183688|Acetaminophen|acetaminophen|mesh-list
57042831|NCT02183688|Caffeine|caffeine|mesh-list
57042832|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042833|NCT02183688|Analgesics|analgesics|mesh-ancestor
57042834|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
57042835|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042836|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042837|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
57042838|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57042839|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57042840|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042841|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042842|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57042843|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56620365|NCT02830230|Cefixime|cefixime|mesh-list
57042844|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
57042845|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042846|NCT02190708|Midazolam|midazolam|mesh-list
57042847|NCT02190708|Omeprazole|omeprazole|mesh-list
57042848|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57042849|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57042850|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57042851|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042852|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042853|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57042854|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57042855|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57042856|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57042857|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
57042858|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
57042859|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
57042860|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
57042861|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57042862|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042863|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57042864|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57042865|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042866|NCT05338983|Anesthetics|anesthetics|mesh-list
57042867|NCT05338983|Mepivacaine|mepivacaine|mesh-list
57042868|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
57042869|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042870|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042871|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
57042872|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042873|NCT03063658|Acetaminophen|acetaminophen|mesh-list
57042874|NCT03063658|Ibuprofen|ibuprofen|mesh-list
57042875|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57042876|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57042877|NCT03063658|Analgesics|analgesics|mesh-ancestor
57042878|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
57042879|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042880|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042881|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57042882|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57042883|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57042884|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042885|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042886|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
57042887|NCT03695107|Nifedipine|nifedipine|mesh-list
57042888|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57042889|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57042890|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042891|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57042892|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042893|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
57042894|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
57042895|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57042896|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
57042897|NCT02835339|Analgesics|analgesics|mesh-ancestor
57042898|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
57042899|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042900|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042901|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
57042902|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042903|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57042904|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
57042905|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57042906|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57042907|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042908|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57042909|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
57042910|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57042911|NCT03695029|Tenofovir|tenofovir|mesh-list
57042912|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
57042913|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042914|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57042915|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57042916|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042917|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042918|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57042919|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57042920|NCT02259855|Interferons|interferons|mesh-list
57042921|NCT02259855|Ritonavir|ritonavir|mesh-list
57042922|NCT02259855|Ribavirin|ribavirin|mesh-list
57042923|NCT02259855|Tipranavir|tipranavir|mesh-list
57042924|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042925|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
57042926|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042927|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57042928|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57042929|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
57042930|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042931|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042932|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57042933|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57042934|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57042935|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57042936|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
57042937|NCT03703063|Leucovorin|leucovorin|mesh-list
57042938|NCT03703063|Gemcitabine|gemcitabine|mesh-list
57042939|NCT03703063|Paclitaxel|paclitaxel|mesh-list
57042940|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57042941|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042942|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
57042943|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
57042944|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
57042945|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042946|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57042947|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
57042948|NCT03703063|Antiviral Agents|antiviral agents|mesh-ancestor
57042949|NCT03703063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042950|NCT03703063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042951|NCT03703063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57042952|NCT03703063|Immunologic Factors|immunologic factors|mesh-ancestor
57042953|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042954|NCT03703063|Antidotes|antidotes|mesh-ancestor
57042955|NCT03703063|Protective Agents|protective agents|mesh-ancestor
57042956|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
57042957|NCT03703063|Vitamins|vitamins|mesh-ancestor
57042958|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
57042959|NCT03702985|Capecitabine|capecitabine|mesh-list
57042960|NCT03702985|Irinotecan|irinotecan|mesh-list
57042961|NCT03702985|Amifostine|amifostine|mesh-list
57042962|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57042963|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
57042964|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042966|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57042967|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57042968|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042969|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57042970|NCT03702985|Protective Agents|protective agents|mesh-ancestor
57042971|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042972|NCT05072314|Lidocaine|lidocaine|mesh-list
57042973|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
57042974|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
57042975|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57042976|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57042977|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
57042978|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57042979|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57042980|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57042981|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57042982|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57042983|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042984|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
57042985|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57042986|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57042987|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57042988|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57042989|NCT02184078|Nevirapine|nevirapine|mesh-list
57042990|NCT02184078|Rifabutin|rifabutin|mesh-list
57042991|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57042992|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57042993|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57042994|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57042995|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
57042996|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57042997|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57042998|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57042999|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57043000|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57043001|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57043002|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57043003|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
57043004|NCT02188368|Clarithromycin|clarithromycin|mesh-list
57043005|NCT02188368|Dexamethasone|dexamethasone|mesh-list
57043006|NCT02188368|Prednisone|prednisone|mesh-list
57043007|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
57043008|NCT02188368|Bortezomib|bortezomib|mesh-list
57043009|NCT02188368|Pomalidomide|pomalidomide|mesh-list
57043010|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043011|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
57043012|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043013|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043014|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57043015|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
57043016|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043017|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043018|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57043019|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043020|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
57043021|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
57043022|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043023|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043024|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
57043025|NCT02188368|Hormones|hormones|mesh-ancestor
57043026|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043027|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57043028|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043029|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57043030|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043031|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57043032|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57043033|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57043034|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57043035|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57043036|NCT02188368|Growth Substances|growth substances|mesh-ancestor
57043037|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
57043038|NCT04323436|Spartalizumab|spartalizumab|mesh-list
57043039|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57043040|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043041|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043042|NCT03694873|Celecoxib|celecoxib|mesh-list
57043043|NCT03694873|Tramadol|tramadol|mesh-list
57043044|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57043045|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57043046|NCT03694873|Analgesics|analgesics|mesh-ancestor
57043047|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
57043048|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043049|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043050|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043051|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043052|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57043053|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57043054|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043055|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043056|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57043057|NCT03694873|Narcotics|narcotics|mesh-ancestor
57043058|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57043059|NCT04306315|Brodalumab|brodalumab|mesh-list
57043060|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
57043061|NCT02191020|Acitretin|acitretin|mesh-list
57043062|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
57043063|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
57043064|NCT04476199|Decitabine|decitabine|mesh-list
57043065|NCT04476199|Venetoclax|venetoclax|mesh-list
57043066|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57043067|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
57043068|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043069|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043070|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043071|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
57043072|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
57043073|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
57043074|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57043075|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57043076|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043077|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043078|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043079|NCT04458259|Axitinib|axitinib|mesh-list
57043080|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043081|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57043082|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043083|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043084|NCT02184312|Nevirapine|nevirapine|mesh-list
57043085|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57043086|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57043087|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043088|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043089|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
57043090|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043091|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57043092|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57043093|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57043094|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57043095|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
57043096|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57043097|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043098|NCT02191332|Nevirapine|nevirapine|mesh-list
57043099|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57043100|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57043101|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043102|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043103|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
57043104|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043105|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57043106|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57043107|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57043108|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57043109|NCT04447027|Dexamethasone|dexamethasone|mesh-list
57043110|NCT04447027|Lenalidomide|lenalidomide|mesh-list
57043111|NCT04447027|Azacitidine|azacitidine|mesh-list
57043112|NCT04447027|Romidepsin|romidepsin|mesh-list
57043113|NCT04447027|Cc-486|cc-486|mesh-list
57043114|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043116|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
57043117|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043118|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043119|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043120|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
57043121|NCT04447027|Hormones|hormones|mesh-ancestor
57043122|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043123|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57043124|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043125|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
57043126|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57043127|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57043128|NCT04447027|Growth Substances|growth substances|mesh-ancestor
57043129|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
57043130|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57043131|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
57043132|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043133|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043134|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57043135|NCT02256774|Ritonavir|ritonavir|mesh-list
57043136|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
57043137|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57043138|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57043139|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
57043140|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043141|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043142|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57043143|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57043144|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
57043145|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043146|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57043147|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57043148|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57043149|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57043150|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
57043151|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57043152|NCT04285567|Rituximab|rituximab|mesh-list
57043153|NCT04285567|Fludarabine|fludarabine|mesh-list
57043154|NCT04285567|Venetoclax|venetoclax|mesh-list
57043155|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
57043156|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043157|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
57043158|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043159|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043160|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57043161|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
57043162|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043163|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043164|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57043165|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57043166|NCT02189304|Budesonide|budesonide|mesh-list
57043167|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
57043168|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
57043169|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
57043170|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043171|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57043172|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
57043173|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043174|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043175|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57043176|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
57043177|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
57043178|NCT02189304|Hormones|hormones|mesh-ancestor
57043179|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043180|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57043181|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57043182|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57043183|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
57043184|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043185|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043186|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57043187|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57043188|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57043189|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
57043190|NCT02184858|Lisinopril|lisinopril|mesh-list
57043191|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57043192|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
57043193|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043194|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043195|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57043196|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57043197|NCT02184858|Protective Agents|protective agents|mesh-ancestor
57043198|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043199|NCT03535662|Itraconazole|itraconazole|mesh-list
57043200|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
57043201|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043202|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57043203|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57043204|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043205|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043206|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57043207|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
57043208|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043209|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043210|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57043211|NCT03702205|Betaine|betaine|mesh-list
57043212|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043213|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
57043214|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57043215|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
57043216|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043217|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57043218|NCT03698851|Methamphetamine|methamphetamine|mesh-list
57043219|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57043220|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043221|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
57043222|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
57043223|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043224|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
57043225|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043226|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043227|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
57043228|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57043229|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57043230|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57043231|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57043232|NCT03125902|Paclitaxel|paclitaxel|mesh-list
57043233|NCT03125902|Atezolizumab|atezolizumab|mesh-list
57043234|NCT03125902|Antibodies|antibodies|mesh-list
57043235|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57043236|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57043237|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043238|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
57043239|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
57043240|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
57043241|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043242|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
57043243|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043244|NCT02189694|Hormones|hormones|mesh-list
57043245|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043246|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043247|NCT02189772|Metadoxine|metadoxine|mesh-list
57043248|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57043249|NCT05057806|Empagliflozin|empagliflozin|mesh-list
57043250|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57043251|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043252|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57043253|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043254|NCT02192424|Insulin|insulin|mesh-list
57043255|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57043256|NCT02192424|Metformin|metformin|mesh-list
57043257|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
57043258|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
57043259|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57043260|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043261|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
57043262|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57043263|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043265|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57043266|NCT02257008|Nelfinavir|nelfinavir|mesh-list
57043267|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57043268|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57043269|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
57043270|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043271|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043272|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57043273|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57043274|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
57043275|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043276|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57043277|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57043278|NCT03693391|Fluorides|fluorides|mesh-list
57043279|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
57043280|NCT03693391|Protective Agents|protective agents|mesh-ancestor
57043281|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043282|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
57043283|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043284|NCT02185326|Hormones|hormones|mesh-list
57043285|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043286|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043287|NCT04412707|Dexamethasone|dexamethasone|mesh-list
57043288|NCT04412707|Melphalan|melphalan|mesh-list
57043289|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043290|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
57043291|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
57043292|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043293|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043294|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043295|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
57043296|NCT04412707|Hormones|hormones|mesh-ancestor
57043297|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043298|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57043299|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043300|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57043301|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
57043302|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043303|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57043304|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043305|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
57043306|NCT03698695|Mefloquine|mefloquine|mesh-list
57043307|NCT03698695|Donepezil|donepezil|mesh-list
57043308|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57043309|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043310|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043311|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
57043312|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043313|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043314|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
57043315|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
57043316|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57043317|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57043318|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043319|NCT04729296|Golimumab|golimumab|mesh-list
57043320|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57043321|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043322|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043323|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
57043324|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043325|NCT03698617|Propofol|propofol|mesh-list
57043326|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57043327|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57043328|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043329|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57043330|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
57043331|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
57043332|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
57043333|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57043334|NCT02194374|Rituximab|rituximab|mesh-list
57043335|NCT02194374|Fludarabine|fludarabine|mesh-list
57043336|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
57043337|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043338|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
57043339|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043340|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043341|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57043342|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
57043343|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043344|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043345|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57043346|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57043347|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57043348|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
57043349|NCT02194452|Octreotide|octreotide|mesh-list
57043350|NCT02194452|Edotreotide|edotreotide|mesh-list
57043351|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043352|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57043353|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043354|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57043355|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043356|NCT01358721|Nivolumab|nivolumab|mesh-list
57043357|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57043358|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043359|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57043360|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043361|NCT02194686|Cilostazol|cilostazol|mesh-list
57043362|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57043363|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
57043364|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043365|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043366|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57043367|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
57043368|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57043369|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57043370|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043371|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57043372|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
57043373|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57043374|NCT02194686|Protective Agents|protective agents|mesh-ancestor
57043375|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57043376|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57043377|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043378|NCT04622995|Diazepam|diazepam|mesh-list
57043379|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57043380|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
57043381|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
57043382|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
57043383|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043384|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043385|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043386|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57043387|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57043388|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57043389|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57043390|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57043391|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57043392|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57043393|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57043394|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
57043395|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
57043396|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
57043397|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
57043398|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043399|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043400|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57043401|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
57043402|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043403|NCT02194764|Naltrexone|naltrexone|mesh-list
57043404|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57043405|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57043406|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043407|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
57043408|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043409|NCT02967640|Ketamine|ketamine|mesh-list
57043410|NCT02967640|Analgesics|analgesics|mesh-ancestor
56725405|NCT00755898|Amantadine|amantadine|mesh-list
57043411|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
57043412|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043413|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043414|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57043415|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57043416|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
57043418|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57043419|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57043420|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57043421|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043422|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043423|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
57043424|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57043425|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043426|NCT04233112|Melatonin|melatonin|mesh-list
57043427|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
57043428|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043429|NCT04233112|Protective Agents|protective agents|mesh-ancestor
57043430|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043431|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57043432|NCT00005584|Prednisone|prednisone|mesh-list
57043433|NCT00005584|Epirubicin|epirubicin|mesh-list
57043434|NCT00005584|Bleomycin|bleomycin|mesh-list
57043435|NCT00005584|Vinblastine|vinblastine|mesh-list
57043436|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043437|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
57043438|NCT00005584|Hormones|hormones|mesh-ancestor
57043439|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043440|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043441|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57043442|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043443|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57043444|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57043445|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57043446|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043447|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043448|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57043449|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
57043450|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
57043451|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
57043452|NCT02194218|Nevirapine|nevirapine|mesh-list
57043453|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57043454|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57043455|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043456|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043457|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
57043458|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043459|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57043460|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57043461|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57043462|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57043463|NCT02194296|Ambroxol|ambroxol|mesh-list
57043464|NCT02194296|Expectorants|expectorants|mesh-ancestor
57043465|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
57043466|NCT04230148|Triclabendazole|triclabendazole|mesh-list
57043467|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57043468|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
57043469|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57043470|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043471|NCT02197026|Hylan|hylan|mesh-list
57043472|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
57043473|NCT02197026|Protective Agents|protective agents|mesh-ancestor
57043474|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043475|NCT02197104|Choline|choline|mesh-list
57043476|NCT02197104|Lipotropic Agents|lipotropic agents|mesh-ancestor
57043477|NCT02197104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57043478|NCT02197104|Antimetabolites|antimetabolites|mesh-ancestor
57043479|NCT02197104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043480|NCT02197104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043481|NCT02197104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57043482|NCT02197104|Nootropic Agents|nootropic agents|mesh-ancestor
57043483|NCT02197182|Copper|copper|mesh-list
57043484|NCT02197182|Metronidazole|metronidazole|mesh-list
57043485|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043486|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57043487|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57043488|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57043489|NCT02197182|Trace Elements|trace elements|mesh-ancestor
57043490|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
57043491|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043492|NCT02197260|Amoxicillin|amoxicillin|mesh-list
57043493|NCT02197260|Metronidazole|metronidazole|mesh-list
57043494|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57043495|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043496|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57043497|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57043498|NCT03687931|Dexamethasone|dexamethasone|mesh-list
57043499|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043500|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
57043501|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
57043502|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043503|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043504|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043505|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
57043506|NCT03687931|Hormones|hormones|mesh-ancestor
57043507|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043508|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57043509|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043510|NCT04224493|Rituximab|rituximab|mesh-list
57043511|NCT04224493|Lenalidomide|lenalidomide|mesh-list
57043512|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57043513|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043514|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
57043515|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043516|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043517|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57043518|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57043519|NCT04224493|Growth Substances|growth substances|mesh-ancestor
57043520|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
57043521|NCT03534024|Curcumin|curcumin|mesh-list
57043522|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57043523|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57043524|NCT03534024|Analgesics|analgesics|mesh-ancestor
57043525|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
57043526|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043527|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043528|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043529|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043530|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043531|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043532|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043533|NCT02753686|Tamoxifen|tamoxifen|mesh-list
57043534|NCT02753686|Everolimus|everolimus|mesh-list
57043535|NCT02753686|Letrozole|letrozole|mesh-list
57043536|NCT02753686|Fulvestrant|fulvestrant|mesh-list
57043537|NCT02753686|Anastrozole|anastrozole|mesh-list
57043538|NCT02753686|Exemestane|exemestane|mesh-list
57043539|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043540|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043541|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
57043542|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043543|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57043544|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57043545|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043546|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043547|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57043548|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
57043549|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043550|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57043551|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57043552|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57043553|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57043554|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57043555|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
57043556|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57043557|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
57043558|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043559|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043560|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57043561|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
57043563|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
57043564|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043565|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043566|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57043567|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
57043568|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
57043569|NCT04216927|Protective Agents|protective agents|mesh-ancestor
57043570|NCT02329834|Furosemide|furosemide|mesh-list
57043571|NCT02329834|Diuretics|diuretics|mesh-ancestor
57043572|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
57043573|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043574|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57043575|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57043576|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043577|NCT02195466|Ritonavir|ritonavir|mesh-list
57043578|NCT02195466|Tipranavir|tipranavir|mesh-list
57043579|NCT02195466|Fluconazole|fluconazole|mesh-list
57043580|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57043581|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57043582|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
57043583|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043584|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043585|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57043586|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57043587|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
57043588|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043589|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57043590|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57043591|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
57043592|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57043593|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57043594|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
57043595|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043596|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043597|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57043598|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57043599|NCT02195544|Hylan|hylan|mesh-list
57043600|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
57043601|NCT02195544|Protective Agents|protective agents|mesh-ancestor
57043602|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043603|NCT02197494|Valsartan|valsartan|mesh-list
57043604|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57043605|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57043606|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57043607|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043608|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
57043609|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043610|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
57043611|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043612|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043613|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57043614|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
57043615|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043616|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043617|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57043618|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57043619|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
57043620|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043621|NCT03692299|Metronidazole|metronidazole|mesh-list
57043622|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043623|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57043624|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57043625|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57043626|NCT02197650|Asparaginase|asparaginase|mesh-list
57043627|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043628|NCT03682939|Vaccines|vaccines|mesh-list
57043629|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
57043630|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043631|NCT02201992|Crizotinib|crizotinib|mesh-list
57043632|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043633|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57043634|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043635|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043636|NCT03534492|Durvalumab|durvalumab|mesh-list
57043637|NCT03534492|Olaparib|olaparib|mesh-list
57043638|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57043639|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043640|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57043641|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043642|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043643|NCT03624283|Betahistine|betahistine|mesh-list
57043644|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
57043645|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
57043646|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
57043647|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043648|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043649|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043650|NCT03687463|Decitabine|decitabine|mesh-list
57043651|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57043652|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
57043653|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043654|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043655|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043656|NCT03692143|Alendronate|alendronate|mesh-list
57043657|NCT03692143|Teriparatide|teriparatide|mesh-list
57043658|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57043659|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043660|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57043661|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
57043662|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57043663|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043664|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57043665|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043666|NCT02197884|Clarithromycin|clarithromycin|mesh-list
57043667|NCT02197884|Itraconazole|itraconazole|mesh-list
57043668|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57043669|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043670|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57043671|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043672|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043673|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57043674|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57043675|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
57043676|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57043677|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57043678|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
57043679|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043680|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043681|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
57043682|NCT04196491|Fludarabine|fludarabine|mesh-list
57043683|NCT04196491|Lenalidomide|lenalidomide|mesh-list
57043684|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043685|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
57043686|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043687|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043688|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57043689|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
57043690|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043691|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043692|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57043693|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57043694|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57043695|NCT04196491|Growth Substances|growth substances|mesh-ancestor
57043696|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
57043697|NCT02201082|Amikacin|amikacin|mesh-list
57043698|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57043699|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043700|NCT03687229|Insulin|insulin|mesh-list
57043701|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57043702|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043703|NCT05085054|Osimertinib|osimertinib|mesh-list
57043704|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043705|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57043706|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043707|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043708|NCT03969121|Palbociclib|palbociclib|mesh-list
57043709|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043710|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57043711|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043712|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043713|NCT02201238|Diclofenac|diclofenac|mesh-list
57043714|NCT02201238|Menthol|menthol|mesh-list
57043715|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57043716|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57043717|NCT02201238|Analgesics|analgesics|mesh-ancestor
57043718|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
57043719|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043720|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043721|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043722|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043723|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57043724|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043725|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043726|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
57043727|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
57043728|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
57043729|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57043730|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57043731|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043732|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57043733|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57043734|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043735|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043736|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043737|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57043738|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
57043739|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57043740|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043741|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57043742|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57043743|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57043744|NCT02201316|Mosapride|mosapride|mesh-list
57043745|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043746|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043747|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57043748|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
57043749|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043750|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043751|NCT04195555|Ivosidenib|ivosidenib|mesh-list
57043752|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043753|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043754|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043755|NCT02198820|Anesthetics|anesthetics|mesh-list
57043756|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57043757|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043758|NCT02257476|Dexamethasone|dexamethasone|mesh-list
57043759|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043760|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
57043761|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
57043762|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043763|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043764|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043765|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
57043766|NCT02257476|Hormones|hormones|mesh-ancestor
57043767|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043768|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57043769|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043770|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
57043771|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57043772|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043773|NCT03946111|Naltrexone|naltrexone|mesh-list
57043774|NCT03946111|Bupropion|bupropion|mesh-list
57043775|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57043776|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57043777|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043778|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
56725768|NCT00862095|Analgesics|analgesics|mesh-ancestor
57043779|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043780|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57043782|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57043783|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57043784|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57043785|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57043786|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043787|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
57043788|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043789|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57043790|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57043791|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043792|NCT03943927|Metoprolol|metoprolol|mesh-list
57043793|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57043794|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57043795|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
57043796|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
57043797|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043798|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043799|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57043800|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57043801|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57043802|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
57043803|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043804|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043805|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
57043806|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57043807|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043808|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
57043809|NCT03687073|Silybin|silybin|mesh-list
57043810|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
57043811|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57043812|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043813|NCT03687073|Protective Agents|protective agents|mesh-ancestor
57043814|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043815|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57043816|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
57043817|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57043818|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043819|NCT02202564|Ganciclovir|ganciclovir|mesh-list
57043820|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
57043821|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
57043822|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043823|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57043824|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043825|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043826|NCT03029143|Vedolizumab|vedolizumab|mesh-list
57043827|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57043828|NCT02198508|Deferasirox|deferasirox|mesh-list
57043829|NCT02198508|Deferiprone|deferiprone|mesh-list
57043830|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57043831|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
57043832|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
57043833|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043834|NCT02202720|Sevoflurane|sevoflurane|mesh-list
57043835|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57043836|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57043837|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
57043838|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
57043839|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57043840|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043841|NCT02206308|Antibodies|antibodies|mesh-list
57043842|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57043843|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
57043844|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043845|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57043846|NCT03028129|Isoniazid|isoniazid|mesh-list
57043847|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043848|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
57043849|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57043850|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57043851|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
56725842|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043852|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043853|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57043854|NCT04059679|Aspirin|aspirin|mesh-list
57043855|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
57043856|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57043857|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57043858|NCT04059679|Analgesics|analgesics|mesh-ancestor
56897461|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
57043859|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
57043860|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043861|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043862|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043863|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043864|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57043865|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57043866|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043867|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57043868|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57043869|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043870|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
57043871|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57043872|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
57043873|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57043874|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
57043875|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
57043876|NCT03533556|Caffeine|caffeine|mesh-list
57043877|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57043878|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043879|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57043880|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043881|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043882|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57043883|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57043884|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
57043885|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57043886|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
57043887|NCT02206854|Analgesics|analgesics|mesh-ancestor
57043888|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
57043889|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043890|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043891|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57043892|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57043893|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043894|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043895|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57043896|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043897|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043898|NCT03624205|Paclitaxel|paclitaxel|mesh-list
57043899|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57043900|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043901|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
57043902|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
57043903|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
57043904|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043905|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
57043906|NCT02206932|Simeprevir|simeprevir|mesh-list
57043907|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
57043908|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043909|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
57043910|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043911|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043912|NCT02207010|Adavosertib|adavosertib|mesh-list
57043913|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043914|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043915|NCT02203422|Cyclosporine|cyclosporine|mesh-list
57043916|NCT02203422|Cyclosporins|cyclosporins|mesh-list
57043917|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043918|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043919|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57043920|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
57043921|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043922|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
57043923|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57043924|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
57043925|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043926|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57043928|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57043929|NCT03532854|Ezetimibe|ezetimibe|mesh-list
57043930|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57043931|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57043932|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
56897464|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57043933|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043934|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57043935|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57043936|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043937|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57043938|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57043939|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57043940|NCT02203500|Telmisartan|telmisartan|mesh-list
57043941|NCT02203500|Lacidipine|lacidipine|mesh-list
57043942|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57043943|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57043944|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57043945|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043946|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57043947|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57043948|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57043949|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043950|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
57043951|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043952|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
57043953|NCT02203656|Testosterone|testosterone|mesh-list
57043954|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
57043955|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
57043956|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57043957|NCT02203656|Androgens|androgens|mesh-ancestor
57043958|NCT02203656|Hormones|hormones|mesh-ancestor
57043959|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57043960|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043961|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57043962|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57043963|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
57043964|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
57043965|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
57043966|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
57043967|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57043968|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043969|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
57043970|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043971|NCT02199444|Sevelamer|sevelamer|mesh-list
57043972|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
57043973|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
57043974|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043975|NCT02199522|Propofol|propofol|mesh-list
57043976|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57043977|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57043978|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043979|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57043980|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
57043981|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
57043982|NCT03532698|Aspirin|aspirin|mesh-list
57043983|NCT03532698|Osimertinib|osimertinib|mesh-list
57043984|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57043985|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57043986|NCT03532698|Analgesics|analgesics|mesh-ancestor
57043987|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
57043988|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57043989|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57043990|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57043991|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57043992|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57043993|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57043994|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57043995|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57043996|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57043997|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57043998|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
57043999|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044000|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57044001|NCT04169737|Venetoclax|venetoclax|mesh-list
57044002|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
57044003|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
57044004|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044005|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57044006|NCT03690739|Gemcitabine|gemcitabine|mesh-list
57044007|NCT03690739|Paclitaxel|paclitaxel|mesh-list
57044008|NCT03690739|Bevacizumab|bevacizumab|mesh-list
57044009|NCT03690739|Carboplatin|carboplatin|mesh-list
57044010|NCT03690739|Trabectedin|trabectedin|mesh-list
57044011|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57044012|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044013|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
57044014|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
57044015|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
57044016|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044017|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57044018|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57044019|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57044020|NCT03690739|Growth Substances|growth substances|mesh-ancestor
57044021|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044022|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
57044023|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57044024|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
57044025|NCT03690739|Antiviral Agents|antiviral agents|mesh-ancestor
57044026|NCT03690739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044027|NCT03690739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044028|NCT03690739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044029|NCT03690739|Immunologic Factors|immunologic factors|mesh-ancestor
57044030|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57044031|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
57044032|NCT02199678|Ketamine|ketamine|mesh-list
57044033|NCT02199678|Analgesics|analgesics|mesh-ancestor
57044034|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
57044035|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044036|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044037|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57044038|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57044039|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
57044040|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
57044041|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044042|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57044043|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57044044|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044045|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044046|NCT03681613|Pyrantel|pyrantel|mesh-list
57044047|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
57044048|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
57044049|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
57044050|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57044051|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044052|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
57044053|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57044054|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57044055|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044056|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044057|NCT03690583|Zinc|zinc|mesh-list
57044058|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
57044059|NCT03690583|Trace Elements|trace elements|mesh-ancestor
57044060|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
57044061|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044062|NCT03690583|Astringents|astringents|mesh-ancestor
57044063|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
57044064|NCT02920008|Guadecitabine|guadecitabine|mesh-list
57044065|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044066|NCT01309672|Prednisone|prednisone|mesh-list
57044067|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
57044068|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044069|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
57044070|NCT01309672|Hormones|hormones|mesh-ancestor
57044071|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57044072|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044073|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57044074|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044075|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57044076|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044077|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044078|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
57044079|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57044080|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57044081|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
57044082|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57044083|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57044084|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044085|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
57044086|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
57044087|NCT02200146|Prednisone|prednisone|mesh-list
57044088|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044089|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
57044090|NCT02200146|Hormones|hormones|mesh-ancestor
57044091|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57044092|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044093|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57044094|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044095|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
57044096|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57044097|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57044098|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044099|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044100|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044101|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044102|NCT02208492|Levetiracetam|levetiracetam|mesh-list
57044103|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
57044104|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
57044105|NCT01933048|Vaccines|vaccines|mesh-list
57044106|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
57044107|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044108|NCT02208882|Midazolam|midazolam|mesh-list
57044109|NCT02208882|BMS-986120|bms-986120|mesh-list
57044110|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57044111|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57044112|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044113|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044114|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57044115|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57044116|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57044117|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57044118|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
57044119|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
57044120|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
57044121|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
57044122|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044123|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044124|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57044125|NCT03690115|Ponatinib|ponatinib|mesh-list
57044126|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044127|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57044128|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044129|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044130|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57044131|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57044132|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044133|NCT03703297|Durvalumab|durvalumab|mesh-list
57044134|NCT03703297|Tremelimumab|tremelimumab|mesh-list
57044135|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57044136|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044137|NCT01886794|Estrogens|estrogens|mesh-list
57044138|NCT01886794|Hormones|hormones|mesh-ancestor
57044139|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57044140|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044141|NCT02209350|Aspirin|aspirin|mesh-list
57044142|NCT02209350|Clopidogrel|clopidogrel|mesh-list
57044143|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57044144|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57044145|NCT02209350|Analgesics|analgesics|mesh-ancestor
57044146|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
57044147|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044148|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044149|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044150|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044151|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57044152|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57044153|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044154|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57044155|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57044156|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044157|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
57044158|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57044159|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57044160|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57044161|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
57044162|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044163|NCT02209428|Temozolomide|temozolomide|mesh-list
57044164|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57044165|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
57044166|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044167|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044168|NCT02200848|Rituximab|rituximab|mesh-list
57044169|NCT02200848|Lenalidomide|lenalidomide|mesh-list
57044170|NCT02200848|Glutarimide|glutarimide|mesh-list
57044171|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57044172|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044173|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
57044174|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044175|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044176|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57044177|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57044178|NCT02200848|Growth Substances|growth substances|mesh-ancestor
57044179|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
57044180|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57044181|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044182|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044183|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
57044184|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57044185|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044186|NCT02751450|Fluorides|fluorides|mesh-list
57044187|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
57044188|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
57044189|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
57044190|NCT02751450|Protective Agents|protective agents|mesh-ancestor
57044191|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044192|NCT02209740|Tenofovir|tenofovir|mesh-list
57044193|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
57044194|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044195|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57044196|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57044197|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044198|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044199|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57044200|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57044201|NCT02257788|Leronlimab|leronlimab|mesh-list
57044202|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57044203|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57044204|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044205|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57044206|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57044207|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
57044208|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044209|NCT02220660|Olodaterol|olodaterol|mesh-list
57044210|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57044211|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
57044212|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044213|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044214|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57044215|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
57044216|NCT01515748|Docetaxel|docetaxel|mesh-list
57044217|NCT01515748|Fluorouracil|fluorouracil|mesh-list
57044218|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
57044219|NCT01515748|Tegafur|tegafur|mesh-list
57044220|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044221|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
57044222|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
57044223|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
57044224|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044225|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
57044226|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57044227|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044228|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
57044229|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044231|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57044232|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044233|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
57044234|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57044235|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57044236|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57044237|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
57044238|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044239|NCT02209974|Fluticasone|fluticasone|mesh-list
57044240|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044241|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57044242|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
57044243|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044244|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044245|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57044246|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
57044247|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
57044248|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57044249|NCT02212392|Meropenem|meropenem|mesh-list
57044250|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57044251|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044252|NCT03679897|Ropivacaine|ropivacaine|mesh-list
57044253|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
57044254|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57044255|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
57044256|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
57044257|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044258|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044259|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
57044260|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044261|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
57044262|NCT03060070|Ketamine|ketamine|mesh-list
57044263|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57044264|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044265|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044266|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57044267|NCT03060070|Analgesics|analgesics|mesh-ancestor
57044268|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
57044269|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044270|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57044271|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57044272|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57044273|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
57044274|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044275|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044276|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57044277|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57044278|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
57044279|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
57044280|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57044281|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57044282|NCT03683563|Citric Acid|citric acid|mesh-list
57044283|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
57044284|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
57044285|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57044286|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
57044287|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
57044288|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044289|NCT03563625|Bupivacaine|bupivacaine|mesh-list
57044290|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
57044291|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
57044292|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044293|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044294|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
57044295|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044296|NCT02832375|Fluorides|fluorides|mesh-list
57044297|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
57044298|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
57044299|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
57044300|NCT02832375|Protective Agents|protective agents|mesh-ancestor
57044301|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044302|NCT04834024|Antibodies|antibodies|mesh-list
57044303|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57044304|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
57044305|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044306|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57044307|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044308|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
57044309|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044310|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
57044311|NCT02218476|Vitamins|vitamins|mesh-ancestor
57044312|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
57044313|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044314|NCT02205996|Insulin|insulin|mesh-list
57044315|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57044316|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57044317|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044318|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
57044319|NCT02220036|Antacids|antacids|mesh-ancestor
57044320|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044321|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57044322|NCT02220114|Vigabatrin|vigabatrin|mesh-list
57044323|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
57044324|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044325|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044326|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
57044327|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044328|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044329|NCT02221596|Vitamin D|vitamin d|mesh-list
57044330|NCT02221596|Vitamins|vitamins|mesh-ancestor
57044331|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
57044332|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044333|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57044334|NCT02221752|Folic Acid|folic acid|mesh-list
57044335|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
57044336|NCT02221752|Hematinics|hematinics|mesh-ancestor
57044337|NCT02221752|Vitamins|vitamins|mesh-ancestor
57044338|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
57044339|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044340|NCT04971382|Curcumin|curcumin|mesh-list
57044341|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57044342|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57044343|NCT04971382|Analgesics|analgesics|mesh-ancestor
57044344|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
57044345|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044346|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044347|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044348|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044349|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044350|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044351|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044352|NCT04971304|Lenograstim|lenograstim|mesh-list
57044353|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57044354|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
57044355|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044356|NCT02220348|Linaclotide|linaclotide|mesh-list
57044357|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57044358|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
57044359|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044360|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57044361|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
57044362|NCT04151680|Apixaban|apixaban|mesh-list
57044363|NCT04151680|Edoxaban|edoxaban|mesh-list
57044364|NCT04151680|Dabigatran|dabigatran|mesh-list
57044365|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57044366|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
57044367|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57044368|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
57044369|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044370|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044371|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
57044372|NCT02221830|Oxytocin|oxytocin|mesh-list
57044373|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
57044374|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57044375|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044376|NCT02224950|Emollients|emollients|mesh-list
57044377|NCT02224950|Chitosan|chitosan|mesh-list
57044378|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57044379|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57044380|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
57044381|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044382|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57044383|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
57044384|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
57044385|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
57044386|NCT02224950|Coagulants|coagulants|mesh-ancestor
57044387|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
57044388|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57044389|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
57044390|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57044391|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
57044392|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044393|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044394|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57044395|NCT04970602|Methylene Blue|methylene blue|mesh-list
57044396|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044397|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044398|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57044399|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044400|NCT02831673|Tenofovir|tenofovir|mesh-list
57044401|NCT02831673|Lamivudine|lamivudine|mesh-list
57044402|NCT02831673|Emtricitabine|emtricitabine|mesh-list
57044403|NCT02831673|Dolutegravir|dolutegravir|mesh-list
57044404|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
57044405|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044406|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57044407|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57044408|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044409|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044410|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57044411|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57044412|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57044413|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57044414|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
57044415|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57044416|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044417|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044418|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57044419|NCT04962958|Leucovorin|leucovorin|mesh-list
57044420|NCT04962958|Fluorouracil|fluorouracil|mesh-list
57044421|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
57044422|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
57044423|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044424|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57044425|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044426|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044427|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
57044428|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044429|NCT04962958|Antidotes|antidotes|mesh-ancestor
57044430|NCT04962958|Protective Agents|protective agents|mesh-ancestor
57044431|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
57044432|NCT04962958|Vitamins|vitamins|mesh-ancestor
57044433|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
57044434|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
57044435|NCT02031510|Bupivacaine|bupivacaine|mesh-list
57044436|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
57044437|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
57044438|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044439|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044440|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
57044441|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044442|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57044443|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57044444|NCT02031510|Analgesics|analgesics|mesh-ancestor
57044445|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57044446|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57044447|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57044448|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
57044449|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044450|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044451|NCT04961788|Antibodies|antibodies|mesh-list
57044452|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
57044453|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044454|NCT02222142|Anesthetics|anesthetics|mesh-list
57044455|NCT02222142|Isoflurane|isoflurane|mesh-list
57044456|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726451|NCT00695318|Hormones|hormones|mesh-ancestor
57044457|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044458|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57044459|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
57044460|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
57044461|NCT04425382|Ritonavir|ritonavir|mesh-list
57044462|NCT04425382|Lopinavir|lopinavir|mesh-list
57044463|NCT04425382|Darunavir|darunavir|mesh-list
57044464|NCT04425382|Cobicistat|cobicistat|mesh-list
57044465|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
57044466|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57044467|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57044468|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
57044469|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044470|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044471|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57044472|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57044473|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
57044474|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044475|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57044476|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57044477|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
57044478|NCT03563937|Apixaban|apixaban|mesh-list
57044479|NCT03563937|Edoxaban|edoxaban|mesh-list
57044480|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
57044481|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57044482|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
57044483|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57044484|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
57044485|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044486|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044487|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
57044488|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57044489|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57044490|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
57044491|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044492|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044493|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57044494|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
57044495|NCT02225418|Ropivacaine|ropivacaine|mesh-list
57044496|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
57044497|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
57044498|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044499|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044500|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
57044501|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044502|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57044503|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57044504|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
57044505|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044506|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044507|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57044508|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
57044509|NCT05057130|Cisplatin|cisplatin|mesh-list
57044510|NCT05057130|Doxorubicin|doxorubicin|mesh-list
57044511|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57044512|NCT05057130|Methotrexate|methotrexate|mesh-list
57044513|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044514|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57044515|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57044516|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57044517|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044518|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044519|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57044520|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
57044521|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57044522|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044523|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57044524|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
57044525|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
57044526|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57044527|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044528|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
57044529|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044530|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57044531|NCT02222220|Metoclopramide|metoclopramide|mesh-list
57044532|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
57044533|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
56726526|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
57044534|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044535|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044536|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57044537|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57044538|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57044539|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
57044540|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044541|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044543|NCT04075747|Midostaurin|midostaurin|mesh-list
57044544|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044545|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57044546|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044547|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044548|NCT05041062|Nivolumab|nivolumab|mesh-list
57044549|NCT05041062|Ipilimumab|ipilimumab|mesh-list
57044550|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57044551|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044552|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57044553|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044554|NCT03677323|Sufentanil|sufentanil|mesh-list
57044555|NCT03677323|Droperidol|droperidol|mesh-list
57044556|NCT03677323|Propofol|propofol|mesh-list
57044557|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57044558|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044559|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044560|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57044561|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
57044562|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
57044563|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57044564|NCT03677323|Narcotics|narcotics|mesh-ancestor
57044565|NCT03677323|Analgesics|analgesics|mesh-ancestor
57044566|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
57044567|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044568|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57044569|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
57044570|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
57044571|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57044572|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57044573|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57044574|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57044575|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57044576|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57044577|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
57044578|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044579|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044580|NCT02225652|Paclitaxel|paclitaxel|mesh-list
57044581|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
57044582|NCT02225652|Fluorouracil|fluorouracil|mesh-list
57044583|NCT02225652|Epirubicin|epirubicin|mesh-list
57044584|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57044585|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044586|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
57044587|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
57044588|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
57044589|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044590|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044591|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
57044592|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044593|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044594|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57044595|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
57044596|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57044597|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
57044598|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57044599|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57044600|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57044601|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57044602|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044603|NCT02222376|Pirfenidone|pirfenidone|mesh-list
57044604|NCT02222376|Analgesics|analgesics|mesh-ancestor
57044605|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
57044606|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044607|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622117|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
57044608|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57044609|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56726601|NCT05343156|Dexamethasone|dexamethasone|mesh-list
57044611|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044612|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044613|NCT02231658|Liraglutide|liraglutide|mesh-list
57044614|NCT02231658|Lixisenatide|lixisenatide|mesh-list
57044615|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57044616|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044617|NCT02231658|Incretins|incretins|mesh-ancestor
57044618|NCT02231658|Hormones|hormones|mesh-ancestor
57044619|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57044620|NCT04542408|Heparin|heparin|mesh-list
57044621|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57044622|NCT04542408|Tinzaparin|tinzaparin|mesh-list
57044623|NCT04542408|Dalteparin|dalteparin|mesh-list
57044624|NCT04542408|Edoxaban|edoxaban|mesh-list
57044625|NCT04542408|Anticoagulants|anticoagulants|mesh-list
57044626|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57044627|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57044628|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044629|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57044630|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
57044631|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57044632|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
57044633|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044634|NCT03059134|Mirabegron|mirabegron|mesh-list
57044635|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57044636|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57044637|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57044638|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
57044639|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044640|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044641|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044642|NCT03059134|Urological Agents|urological agents|mesh-ancestor
57044643|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
57044644|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
57044645|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044646|NCT02225886|Protective Agents|protective agents|mesh-ancestor
57044647|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044648|NCT02225886|Vitamins|vitamins|mesh-ancestor
57044649|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
57044650|NCT02928991|Vidarabine|vidarabine|mesh-list
57044651|NCT02928991|Fludarabine|fludarabine|mesh-list
57044652|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
57044653|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044654|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57044655|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
57044656|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044657|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044658|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
57044659|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044660|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
57044661|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044662|NCT03554317|Nivolumab|nivolumab|mesh-list
57044663|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
57044664|NCT03554317|Testosterone|testosterone|mesh-list
57044665|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
57044666|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
57044667|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57044668|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57044669|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044670|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57044671|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044672|NCT03554317|Androgens|androgens|mesh-ancestor
57044673|NCT03554317|Hormones|hormones|mesh-ancestor
57044674|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57044675|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044676|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57044677|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
57044678|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57044679|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57044680|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044681|NCT04957420|Rotigotine|rotigotine|mesh-list
57044682|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
57044683|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
57044684|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044685|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044686|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044688|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
57044689|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044690|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044691|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044692|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
57044693|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
57044694|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
57044695|NCT02905188|Fludarabine|fludarabine|mesh-list
57044696|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044697|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
57044698|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044699|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044700|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57044701|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
57044702|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044703|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044704|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57044705|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
57044706|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
57044707|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044708|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
57044709|NCT03671941|Ticagrelor|ticagrelor|mesh-list
57044710|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57044711|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57044712|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57044713|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57044714|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
57044715|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044716|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044717|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044718|NCT03058900|Methotrexate|methotrexate|mesh-list
57044719|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57044720|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
57044721|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57044722|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044723|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57044724|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
57044725|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044726|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044727|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
57044728|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044729|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57044730|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044731|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
57044732|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044733|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57044734|NCT02226510|Metformin|metformin|mesh-list
57044735|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57044736|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044737|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57044738|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57044739|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57044740|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57044741|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044742|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
57044743|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044744|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044745|NCT04956094|Uric Acid|uric acid|mesh-list
57044746|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
57044747|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044748|NCT04956094|Protective Agents|protective agents|mesh-ancestor
57044749|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044750|NCT03321643|Gemcitabine|gemcitabine|mesh-list
57044751|NCT03321643|Rituximab|rituximab|mesh-list
57044752|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57044753|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
57044754|NCT03321643|Atezolizumab|atezolizumab|mesh-list
57044755|NCT03321643|Antibodies|antibodies|mesh-list
57044756|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
57044757|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57044758|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
56726745|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57044759|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044760|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044761|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044762|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57044763|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
57044764|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044765|NCT03321643|Antiviral Agents|antiviral agents|mesh-ancestor
57044766|NCT03321643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044767|NCT03321643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044768|NCT03321643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044769|NCT03671707|Nicotine|nicotine|mesh-list
57044770|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57044771|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
57044772|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044773|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044774|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57044775|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57044776|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
57044777|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044778|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044779|NCT02226588|Misoprostol|misoprostol|mesh-list
57044780|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57044781|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
57044782|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57044783|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044784|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57044785|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57044786|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
57044787|NCT03676621|Misoprostol|misoprostol|mesh-list
57044788|NCT03676621|Oxytocin|oxytocin|mesh-list
57044789|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
57044790|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57044791|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044792|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57044793|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
57044794|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57044795|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57044796|NCT03678649|Capecitabine|capecitabine|mesh-list
57044797|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57044798|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
57044799|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044800|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044801|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
57044802|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57044803|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044804|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57044805|NCT02232360|Fenofibrate|fenofibrate|mesh-list
57044806|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57044807|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57044808|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
57044809|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044810|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57044811|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57044812|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044813|NCT02226978|Ritonavir|ritonavir|mesh-list
57044814|NCT02226978|Tipranavir|tipranavir|mesh-list
57044815|NCT02226978|Valacyclovir|valacyclovir|mesh-list
57044816|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57044817|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57044818|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
57044819|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044820|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044821|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57044822|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57044823|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
57044824|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044825|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57044826|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57044827|NCT02227056|Methylphenidate|methylphenidate|mesh-list
57044828|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57044829|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044830|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57044831|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56726823|NCT00860223|Digoxin|digoxin|mesh-list
57044832|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57044833|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044834|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
57044835|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044836|NCT05708157|Histamine Antagonists|histamine antagonists|mesh-list
57044837|NCT05708157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
57044838|NCT05708157|Histamine Agents|histamine agents|mesh-ancestor
57044839|NCT05708157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044840|NCT05708157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044841|NCT05708157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044843|NCT03058744|Halobetasol|halobetasol|mesh-list
57044844|NCT03058744|Tazarotene|tazarotene|mesh-list
57044845|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
57044846|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
57044847|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57044848|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044849|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
57044850|NCT03058744|Hormones|hormones|mesh-ancestor
57044851|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57044852|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044853|NCT02734537|Cisplatin|cisplatin|mesh-list
57044854|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044855|NCT03059056|Empagliflozin|empagliflozin|mesh-list
57044856|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57044857|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044858|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57044859|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044860|NCT03058666|Calfactant|calfactant|mesh-list
57044861|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
57044862|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
57044863|NCT02227212|Insulin|insulin|mesh-list
57044864|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
57044865|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57044866|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044867|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
57044868|NCT00303849|Carboplatin|carboplatin|mesh-list
57044869|NCT00303849|Etoposide|etoposide|mesh-list
57044870|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
57044871|NCT00303849|Melphalan|melphalan|mesh-list
57044872|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
57044873|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
57044874|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
57044875|NCT00303849|Mannitol|mannitol|mesh-list
57044876|NCT00303849|Antidotes|antidotes|mesh-list
57044877|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044878|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57044879|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57044880|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57044881|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044882|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044883|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57044884|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
57044885|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57044886|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57044887|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
57044888|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044889|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57044890|NCT00303849|Diuretics|diuretics|mesh-ancestor
57044891|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
57044892|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
57044893|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
57044894|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
57044895|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
57044896|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
57044897|NCT00303849|Protective Agents|protective agents|mesh-ancestor
57044898|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
57044899|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
57044900|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57044901|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57044902|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
57044903|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
57044904|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
56726895|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
57044905|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57044906|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
57044907|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044908|NCT01355523|Melatonin|melatonin|mesh-list
57044909|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
57044910|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044911|NCT01355523|Protective Agents|protective agents|mesh-ancestor
57044912|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044913|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044914|NCT04951726|Neostigmine|neostigmine|mesh-list
57044915|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57044916|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044917|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044918|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
57044919|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57044920|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044921|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57044922|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
57044923|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044924|NCT02227914|Sorafenib|sorafenib|mesh-list
57044925|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044926|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57044927|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044928|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044929|NCT04161456|Apremilast|apremilast|mesh-list
57044930|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57044931|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57044932|NCT04161456|Analgesics|analgesics|mesh-ancestor
57044933|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
57044934|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044935|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044936|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044937|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57044938|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57044939|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57044940|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044941|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044942|NCT02224014|Brotizolam|brotizolam|mesh-list
57044943|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57044944|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044945|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044946|NCT03671161|Insulin|insulin|mesh-list
57044947|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57044948|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044949|NCT04950400|Apatinib|apatinib|mesh-list
57044950|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044951|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57044952|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57044953|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044954|NCT04949932|Turmeric extract|turmeric extract|mesh-list
57044955|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
57044956|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044957|NCT04949932|Protective Agents|protective agents|mesh-ancestor
57044958|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044959|NCT02826603|Ustekinumab|ustekinumab|mesh-list
57044960|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
57044961|NCT02224170|Dexamethasone|dexamethasone|mesh-list
57044962|NCT02224170|Lidocaine|lidocaine|mesh-list
57044963|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57044964|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
57044965|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
57044966|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57044967|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044968|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57044969|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
57044970|NCT02224170|Hormones|hormones|mesh-ancestor
57044971|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57044972|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57044973|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044974|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
57044975|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
57044976|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57044977|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
57044978|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57044979|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57044980|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57044981|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57044982|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044983|NCT03563235|Calcitriol|calcitriol|mesh-list
57044984|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57044985|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57044986|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57044987|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57044988|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57044989|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57044990|NCT03563235|Vitamins|vitamins|mesh-ancestor
57044991|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
57044992|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57044993|NCT01329900|Etoposide|etoposide|mesh-list
57044994|NCT01329900|Ifosfamide|ifosfamide|mesh-list
57044995|NCT01329900|Ofatumumab|ofatumumab|mesh-list
57044996|NCT01329900|Lenograstim|lenograstim|mesh-list
57044997|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57044998|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57044999|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57045000|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57045001|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045002|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045003|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57045004|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
57045005|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57045006|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
57045007|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045008|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
57045009|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
57045010|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
57045011|NCT04948372|Terlipressin|terlipressin|mesh-list
57045012|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57045013|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57045014|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57045015|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045016|NCT04947826|Antibodies|antibodies|mesh-list
57045017|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
57045018|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
57045019|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045020|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
57045021|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
57045022|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57045023|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57045024|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
57045025|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045026|NCT02228616|Lactulose|lactulose|mesh-list
57045027|NCT02228616|Prucalopride|prucalopride|mesh-list
57045028|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57045029|NCT02228616|Laxatives|laxatives|mesh-ancestor
57045030|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
57045031|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57045032|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
57045033|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045034|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045035|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045036|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57045037|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
57045038|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045039|NCT03935958|Curcumin|curcumin|mesh-list
57045040|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57045041|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57045042|NCT03935958|Analgesics|analgesics|mesh-ancestor
57045043|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
57045044|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045045|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045046|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045047|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045048|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045049|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045050|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045051|NCT02744391|Levodopa|levodopa|mesh-list
57045052|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57045053|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57045054|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
57045055|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045056|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045057|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045058|NCT02228772|Cytarabine|cytarabine|mesh-list
57045059|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
57045060|NCT02228772|Doxorubicin|doxorubicin|mesh-list
57045061|NCT02228772|Methotrexate|methotrexate|mesh-list
57045062|NCT02228772|Vincristine|vincristine|mesh-list
57045063|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
57045064|NCT02228772|Ixazomib|ixazomib|mesh-list
57045065|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045066|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
57045067|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045068|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045069|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57045070|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
57045071|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045072|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045073|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57045074|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57045075|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57045076|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57045077|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045078|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57045079|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
57045080|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57045081|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57045082|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
57045083|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
57045084|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57045085|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57045086|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
57045087|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045088|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57045089|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
57045090|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
57045091|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
57045092|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
57045093|NCT03646968|Docetaxel|docetaxel|mesh-list
57045094|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045095|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
57045096|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
57045097|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
57045098|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045099|NCT02228850|Alprostadil|alprostadil|mesh-list
57045100|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57045101|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
57045102|NCT02228850|Urological Agents|urological agents|mesh-ancestor
57045103|NCT02822508|Laxatives|laxatives|mesh-list
57045104|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57045105|NCT03563001|Budesonide|budesonide|mesh-list
57045106|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
57045107|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045108|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57045109|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
57045110|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045111|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045112|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57045113|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
57045114|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
57045115|NCT03563001|Hormones|hormones|mesh-ancestor
57045116|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045117|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57045118|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57045119|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57045120|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
57045121|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045122|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045123|NCT04768101|Corticosterone|corticosterone|mesh-list
57045124|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045125|NCT02228928|Capsaicin|capsaicin|mesh-list
57045126|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
57045127|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
57045128|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
57045129|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045130|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045131|NCT03888378|Minocycline|minocycline|mesh-list
57045132|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56727120|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
57045133|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045134|NCT03603288|Idebenone|idebenone|mesh-list
57045135|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
57045136|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045137|NCT03603288|Protective Agents|protective agents|mesh-ancestor
57045138|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045139|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
57045140|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57045141|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57045142|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57045143|NCT03844074|Bevacizumab|bevacizumab|mesh-list
57045144|NCT03844074|Ranibizumab|ranibizumab|mesh-list
57045145|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57045146|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045147|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57045148|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57045149|NCT03844074|Growth Substances|growth substances|mesh-ancestor
57045150|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045151|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
57045152|NCT02624986|Rituximab|rituximab|mesh-list
57045153|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
57045154|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57045155|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045156|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
57045157|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045158|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045159|NCT04946734|Aspirin|aspirin|mesh-list
57045160|NCT04946734|Clopidogrel|clopidogrel|mesh-list
57045161|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57045162|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57045163|NCT04946734|Analgesics|analgesics|mesh-ancestor
57045164|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
57045165|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045166|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045167|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045168|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045169|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57045170|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57045171|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045172|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57045173|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57045174|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045175|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
57045176|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57045177|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57045178|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57045179|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
57045180|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045181|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
57045182|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045183|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
57045184|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045185|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045186|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57045187|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
57045188|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045189|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045190|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57045191|NCT04945096|Cytarabine|cytarabine|mesh-list
57045192|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
57045193|NCT04945096|Cyclosporine|cyclosporine|mesh-list
57045194|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
57045195|NCT04945096|Busulfan|busulfan|mesh-list
57045196|NCT04945096|Semustine|semustine|mesh-list
57045197|NCT04945096|Decitabine|decitabine|mesh-list
57045198|NCT04945096|Cyclosporins|cyclosporins|mesh-list
57045199|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
57045200|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57045201|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045202|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
57045203|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045204|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045205|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57045206|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
57045207|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045208|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045209|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57045210|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57045212|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
57045213|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045214|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045215|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
57045216|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
57045217|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57045218|NCT04945096|Expectorants|expectorants|mesh-ancestor
57045219|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
57045220|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57045221|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
57045222|NCT04945096|Protective Agents|protective agents|mesh-ancestor
57045223|NCT04430452|Durvalumab|durvalumab|mesh-list
57045224|NCT04430452|Ipilimumab|ipilimumab|mesh-list
57045225|NCT04430452|Tremelimumab|tremelimumab|mesh-list
57045226|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
57045227|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57045228|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
57045229|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57045230|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045231|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
57045232|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045233|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57045234|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045235|NCT04411654|Sirolimus|sirolimus|mesh-list
57045236|NCT04411654|Prednisone|prednisone|mesh-list
57045237|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
57045238|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57045239|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57045240|NCT04411654|Prednisolone|prednisolone|mesh-list
57045241|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
57045242|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57045243|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
57045244|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045245|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
57045246|NCT04411654|Hormones|hormones|mesh-ancestor
57045247|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045248|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045249|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57045250|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045251|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57045252|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045253|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57045254|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
57045255|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045256|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
57045257|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
57045258|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
57045259|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045260|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57045261|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57045262|NCT04411654|Protective Agents|protective agents|mesh-ancestor
57045263|NCT04944082|Ivermectin|ivermectin|mesh-list
57045264|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57045265|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045266|NCT04943692|Metformin|metformin|mesh-list
57045267|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57045268|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045269|NCT02587598|Cytarabine|cytarabine|mesh-list
57045270|NCT02587598|Azacitidine|azacitidine|mesh-list
57045271|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57045272|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
57045273|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045274|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045275|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
57045276|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045277|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045278|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
57045279|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045280|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045281|NCT04943536|Bicalutamide|bicalutamide|mesh-list
57045282|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
57045283|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
57045284|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045285|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045286|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045287|NCT04943146|Aspirin|aspirin|mesh-list
57045288|NCT04943146|Prednisone|prednisone|mesh-list
57045289|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045290|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
57045291|NCT04943146|Hormones|hormones|mesh-ancestor
57045292|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045293|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045294|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57045295|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045296|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57045297|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57045298|NCT04943146|Analgesics|analgesics|mesh-ancestor
57045299|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
57045300|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045301|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045302|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57045303|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57045304|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045305|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57045306|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57045307|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045308|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
57045309|NCT02485574|Calcium|calcium|mesh-list
57045310|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57045311|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045312|NCT04942834|Amiodarone|amiodarone|mesh-list
57045313|NCT04942834|Sotalol|sotalol|mesh-list
57045314|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
57045315|NCT04942834|Dronedarone|dronedarone|mesh-list
57045316|NCT04942834|Propafenone|propafenone|mesh-list
57045317|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
57045318|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57045319|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57045320|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045321|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57045322|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57045323|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57045324|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045325|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57045326|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57045327|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57045328|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57045329|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57045330|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
57045331|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045332|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045333|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
57045334|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
57045335|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897495|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
57045336|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57045337|NCT04941976|Benzydamine|benzydamine|mesh-list
57045338|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045339|NCT01291004|Drospirenone|drospirenone|mesh-list
57045340|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57045341|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57045342|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
57045343|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57045344|NCT01291004|Desogestrel|desogestrel|mesh-list
57045345|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
57045346|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
57045347|NCT01291004|Estradiol|estradiol|mesh-list
57045348|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57045349|NCT01291004|Estrogens|estrogens|mesh-ancestor
57045350|NCT01291004|Hormones|hormones|mesh-ancestor
57045351|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045352|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045353|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57045354|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57045355|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57045356|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57045357|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57045358|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57045359|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
57045360|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57045361|NCT01291004|Diuretics|diuretics|mesh-ancestor
57045362|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
57045363|NCT01291004|Progestins|progestins|mesh-ancestor
57045364|NCT04941118|Anesthetics|anesthetics|mesh-list
57045365|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
57045366|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045367|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045368|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
57045369|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045370|NCT04421092|Lidocaine|lidocaine|mesh-list
57045371|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
57045372|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
57045373|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045374|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045375|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
57045376|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045377|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57045378|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57045379|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57045380|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57045381|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045382|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
57045383|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045384|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
57045385|NCT00374660|Irofulven|irofulven|mesh-list
57045386|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045387|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57045388|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
57045389|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045390|NCT02624050|Propofol|propofol|mesh-list
57045391|NCT02624050|Methohexital|methohexital|mesh-list
57045392|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57045393|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045394|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045395|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57045396|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
57045397|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
57045398|NCT03131882|Triamcinolone|triamcinolone|mesh-list
57045399|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57045400|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57045401|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
57045402|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57045403|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045404|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
57045405|NCT03131882|Hormones|hormones|mesh-ancestor
57045406|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045407|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045408|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045409|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
57045410|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896776|NCT03204318|Estrogens|estrogens|mesh-ancestor
57045411|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045412|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57045413|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
57045414|NCT03131882|Protective Agents|protective agents|mesh-ancestor
57045415|NCT03483350|Midazolam|midazolam|mesh-list
57045416|NCT03483350|Granisetron|granisetron|mesh-list
57045417|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57045418|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57045419|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045420|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045421|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57045422|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57045423|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57045424|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57045425|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
57045426|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
57045427|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
57045428|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
57045429|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045430|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045431|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
57045432|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
57045433|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045434|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57045435|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57045436|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
57045437|NCT03480308|Dexamethasone|dexamethasone|mesh-list
56727416|NCT04039815|Thiamine|thiamine|mesh-list
57045438|NCT03480308|Fentanyl|fentanyl|mesh-list
57045439|NCT03480308|Bupivacaine|bupivacaine|mesh-list
57045440|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045441|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
57045442|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
57045443|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045444|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045445|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57045446|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
57045448|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045449|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57045450|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045451|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
57045452|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
57045453|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045454|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
57045455|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57045456|NCT03480308|Narcotics|narcotics|mesh-ancestor
57045457|NCT03480308|Analgesics|analgesics|mesh-ancestor
57045458|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57045459|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57045460|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
57045461|NCT05151614|Colchicine|colchicine|mesh-list
57045462|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
57045463|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045464|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
57045465|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
57045466|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
57045467|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045468|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045469|NCT04937140|Antibodies|antibodies|mesh-list
57045470|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
57045471|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045472|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
57045473|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57045474|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045475|NCT03482960|Xenon|xenon|mesh-list
57045476|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57045477|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
57045478|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
57045479|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045480|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045481|NCT04409002|Niraparib|niraparib|mesh-list
57045482|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57045483|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045484|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045485|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045486|NCT00099086|Docetaxel|docetaxel|mesh-list
57045487|NCT00099086|Leuprolide|leuprolide|mesh-list
57045488|NCT00099086|Goserelin|goserelin|mesh-list
57045489|NCT00099086|Bicalutamide|bicalutamide|mesh-list
57045490|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045491|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
57045492|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
57045493|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
57045494|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045495|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57045496|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
57045497|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57045498|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045499|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57045500|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
57045501|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
57045502|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045503|NCT03479996|Bupivacaine|bupivacaine|mesh-list
57045504|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
57045505|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
57045506|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045507|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045508|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
57045509|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045510|NCT04936282|Tacrolimus|tacrolimus|mesh-list
57045511|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045512|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
57045513|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045514|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57045515|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045516|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045517|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
57045518|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
57045519|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57045520|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57045521|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045522|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045523|NCT02524184|Urological Agents|urological agents|mesh-ancestor
57045524|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
57045525|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57045526|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
57045527|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045528|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
57045529|NCT04936204|Protective Agents|protective agents|mesh-ancestor
57045530|NCT03486236|Ivacaftor|ivacaftor|mesh-list
57045531|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57045532|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57045533|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045534|NCT04936126|Amantadine|amantadine|mesh-list
57045535|NCT04936126|Pramipexole|pramipexole|mesh-list
57045536|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57045537|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
57045538|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57045539|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57045540|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57045541|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045542|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045543|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
57045544|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045545|NCT04936126|Protective Agents|protective agents|mesh-ancestor
57045546|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57045547|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57045548|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
57045549|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
57045550|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045551|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
57045552|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045553|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57045554|NCT04936126|Analgesics|analgesics|mesh-ancestor
57045555|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
57045556|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045557|NCT03479918|Prednisone|prednisone|mesh-list
57045558|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
57045559|NCT03479918|Doxorubicin|doxorubicin|mesh-list
57045560|NCT03479918|Etoposide|etoposide|mesh-list
57045561|NCT03479918|Vincristine|vincristine|mesh-list
57045562|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045563|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
57045564|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045565|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045566|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57045567|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
57045568|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045569|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045570|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57045571|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57045572|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57045573|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57045574|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045575|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57045576|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045577|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
57045578|NCT03479918|Hormones|hormones|mesh-ancestor
57045579|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045580|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57045581|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
57045582|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
57045583|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
57045584|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
57045585|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045586|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045587|NCT03486080|Lenograstim|lenograstim|mesh-list
57045588|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56727586|NCT00872781|Quinapril|quinapril|mesh-list
57045589|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
57045590|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045591|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
57045592|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
57045593|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
57045594|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57045595|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045596|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045597|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57045598|NCT03477344|Analgesics|analgesics|mesh-ancestor
57045599|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
57045600|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045601|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57045602|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57045603|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57045604|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
57045605|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045606|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045607|NCT04933864|Methylene Blue|methylene blue|mesh-list
57045608|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045609|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045610|NCT03477266|Mosapride|mosapride|mesh-list
57045611|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57045612|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57045613|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
57045614|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045615|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045616|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045617|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57045618|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57045619|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
57045620|NCT04933084|Narcotics|narcotics|mesh-ancestor
57045621|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045622|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045623|NCT04933084|Analgesics|analgesics|mesh-ancestor
57045624|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
57045625|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045626|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
57045627|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
57045628|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
57045629|NCT03131336|Coagulants|coagulants|mesh-ancestor
57045630|NCT03482492|Acetaminophen|acetaminophen|mesh-list
57045631|NCT03482492|Tramadol|tramadol|mesh-list
57045632|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57045633|NCT03482492|Analgesics|analgesics|mesh-ancestor
57045634|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
57045635|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045636|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045637|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
57045638|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57045639|NCT03482492|Narcotics|narcotics|mesh-ancestor
57045640|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045641|NCT03477110|Temozolomide|temozolomide|mesh-list
57045642|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57045643|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
57045644|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045645|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045646|NCT03874286|Liver Extracts|liver extracts|mesh-list
57045647|NCT03874286|Hematinics|hematinics|mesh-ancestor
57045648|NCT04217954|Bevacizumab|bevacizumab|mesh-list
57045649|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57045650|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045651|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57045652|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57045653|NCT04217954|Growth Substances|growth substances|mesh-ancestor
57045654|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045655|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
57045656|NCT05259098|Sufentanil|sufentanil|mesh-list
57045657|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57045658|NCT05259098|Narcotics|narcotics|mesh-ancestor
57045659|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045660|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045661|NCT05259098|Analgesics|analgesics|mesh-ancestor
57045662|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
57045663|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045664|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57045665|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57045666|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
57045667|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
57045668|NCT03482180|Atorvastatin|atorvastatin|mesh-list
57045669|NCT03482180|Calcium|calcium|mesh-list
57045670|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57045671|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045672|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57045673|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57045674|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
57045675|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045676|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57045677|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57045678|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045679|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
57045680|NCT04390646|Hormones|hormones|mesh-ancestor
57045681|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045682|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045683|NCT03961568|Cenobamate|cenobamate|mesh-list
57045684|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
57045685|NCT04294550|Naloxegol|naloxegol|mesh-list
57045686|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57045687|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045688|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
57045689|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045690|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
57045691|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57045692|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045693|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045694|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57045695|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57045696|NCT03476564|Protective Agents|protective agents|mesh-ancestor
57045697|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045698|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
57045699|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57045700|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
57045701|NCT05258474|Niacinamide|niacinamide|mesh-list
57045703|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
57045704|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
57045705|NCT05258474|Vitamins|vitamins|mesh-ancestor
57045706|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
57045707|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045708|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57045709|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
57045710|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045711|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57045712|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
57045713|NCT03478436|Doxycycline|doxycycline|mesh-list
57045714|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57045715|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045716|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
57045717|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57045718|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57045719|NCT01338987|Alovudine|alovudine|mesh-list
57045720|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
57045721|NCT01338987|Busulfan|busulfan|mesh-list
57045722|NCT01338987|Methotrexate|methotrexate|mesh-list
57045723|NCT01338987|Fludarabine|fludarabine|mesh-list
57045724|NCT01338987|Leuprolide|leuprolide|mesh-list
57045725|NCT01338987|Tacrolimus|tacrolimus|mesh-list
57045726|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045727|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
57045728|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045729|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045730|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57045731|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
57045732|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045733|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045734|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57045735|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57045736|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
57045737|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57045738|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57045739|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
57045740|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
57045741|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045742|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57045743|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57045744|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57045745|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57045746|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
57045747|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57045748|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
57045749|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045750|NCT03717896|Thiamine|thiamine|mesh-list
57045751|NCT03717896|Vitamins|vitamins|mesh-ancestor
57045752|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
57045753|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045754|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
57045755|NCT03478280|Brodalumab|brodalumab|mesh-list
57045756|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
57045757|NCT04856007|Metformin|metformin|mesh-list
57045758|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
57045759|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57045760|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045761|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57045762|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045763|NCT04736979|Amoxicillin|amoxicillin|mesh-list
57045764|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
57045765|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
57045766|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57045767|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57045768|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045769|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57045770|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045771|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045772|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57045773|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57045774|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
57045775|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045776|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045777|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57045778|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
57045779|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
57045780|NCT03562923|Hormones|hormones|mesh-ancestor
57045781|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045782|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
57045783|NCT03593252|Metronidazole|metronidazole|mesh-list
57045784|NCT03593252|Cefazolin|cefazolin|mesh-list
57045785|NCT03593252|Neomycin|neomycin|mesh-list
57045786|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
57045787|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
57045788|NCT03593252|Citric Acid|citric acid|mesh-list
57045789|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
57045790|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045791|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57045792|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57045793|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57045794|NCT03593252|Cathartics|cathartics|mesh-ancestor
57045795|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57045796|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
57045797|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57045798|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
57045799|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
57045800|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045801|NCT03593252|Antacids|antacids|mesh-ancestor
57045802|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57045803|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045804|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
57045805|NCT03476174|Interleukin-2|interleukin-2|mesh-list
57045806|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57045807|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045808|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57045809|NCT03476174|Analgesics|analgesics|mesh-ancestor
57045810|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
57045811|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045812|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045813|NCT02523638|Interferons|interferons|mesh-list
57045814|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
57045815|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
57045816|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045817|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
57045818|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045819|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
57045820|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045821|NCT05257148|Nebivolol|nebivolol|mesh-list
57045822|NCT05257148|Zofenopril|zofenopril|mesh-list
57045823|NCT05257148|Captopril|captopril|mesh-list
57045824|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57045825|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
57045826|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57045827|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57045828|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57045829|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
57045830|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045831|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045832|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045833|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57045834|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
57045835|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045836|NCT03481790|Folic Acid|folic acid|mesh-list
57045837|NCT03481790|Lactoferrin|lactoferrin|mesh-list
57045838|NCT03481790|Vitamins|vitamins|mesh-ancestor
57045839|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
57045840|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045841|NCT03481790|Hematinics|hematinics|mesh-ancestor
57045842|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
57045843|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045844|NCT03475862|Oxycodone|oxycodone|mesh-list
57045845|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57045846|NCT03475862|Narcotics|narcotics|mesh-ancestor
57045847|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045848|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045849|NCT03475862|Analgesics|analgesics|mesh-ancestor
57045850|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
57045851|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045852|NCT03368066|Cosyntropin|cosyntropin|mesh-list
57045853|NCT03368066|Hormones|hormones|mesh-ancestor
57045854|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045855|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045856|NCT03475628|Daratumumab|daratumumab|mesh-list
57045857|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045858|NCT05195450|Tenofovir|tenofovir|mesh-list
57045859|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
57045860|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045861|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57045862|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57045863|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045864|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045865|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57045866|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57045867|NCT03477422|Meropenem|meropenem|mesh-list
57045868|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
57045869|NCT03477422|Sulbactam|sulbactam|mesh-list
57045870|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57045871|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045872|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57045873|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045874|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045875|NCT01355289|Interferons|interferons|mesh-list
57045876|NCT01355289|Ribavirin|ribavirin|mesh-list
57045877|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045878|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
57045879|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045880|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
57045881|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045882|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57045883|NCT03473210|Erythromycin|erythromycin|mesh-list
57045884|NCT03473210|Ampicillin|ampicillin|mesh-list
57045885|NCT03473210|Dexamethasone|dexamethasone|mesh-list
57045886|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045887|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
57045888|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
57045889|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57045890|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045891|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57045892|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
57045893|NCT03473210|Hormones|hormones|mesh-ancestor
57045894|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045895|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57045896|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045897|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045898|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045899|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045900|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57045901|NCT03473132|Thrombin|thrombin|mesh-list
57045902|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
57045903|NCT03473132|Coagulants|coagulants|mesh-ancestor
57045904|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
57045905|NCT03475160|Citric Acid|citric acid|mesh-list
57045906|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
57045907|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
57045908|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57045909|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
57045910|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
57045911|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045912|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
57045913|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57045914|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57045915|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57045916|NCT03475160|Urological Agents|urological agents|mesh-ancestor
57045917|NCT00308516|Leucovorin|leucovorin|mesh-list
57045918|NCT00308516|Bevacizumab|bevacizumab|mesh-list
57045919|NCT00308516|Fluorouracil|fluorouracil|mesh-list
57045920|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
57045921|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57045922|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57045923|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57045924|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57045925|NCT00308516|Growth Substances|growth substances|mesh-ancestor
57045926|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045927|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
57045928|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
57045929|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045930|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57045931|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045932|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
57045933|NCT00308516|Antidotes|antidotes|mesh-ancestor
57045934|NCT00308516|Protective Agents|protective agents|mesh-ancestor
57045935|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
57045936|NCT00308516|Vitamins|vitamins|mesh-ancestor
57045937|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
57045938|NCT05155592|Adalimumab|adalimumab|mesh-list
57045939|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57045940|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045941|NCT03474614|Propranolol|propranolol|mesh-list
57045942|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57045943|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57045944|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
57045945|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045946|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045947|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045948|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57045949|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57045950|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
57045951|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
57045952|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
57045953|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57045954|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
57045955|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045956|NCT02737358|Expectorants|expectorants|mesh-ancestor
57045957|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
57045958|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57045959|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
57045960|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045961|NCT02737358|Protective Agents|protective agents|mesh-ancestor
57045962|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045963|NCT02737358|Antidotes|antidotes|mesh-ancestor
57045964|NCT05052710|Midazolam|midazolam|mesh-list
57045965|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57045966|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57045967|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57045968|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045969|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57045970|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57045971|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57045972|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57045973|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
57045974|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
57045975|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
57045976|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
57045977|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57045978|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045979|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
57045980|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57045981|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57045982|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57045983|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
57045984|NCT02866838|Coagulants|coagulants|mesh-ancestor
57045985|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
57045986|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57045987|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57045988|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57045989|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
57045990|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
57045991|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
57045992|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57045993|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
57045994|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57045995|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57045996|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57045997|NCT02523092|Hormones|hormones|mesh-ancestor
57045998|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57045999|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046000|NCT01354431|Nivolumab|nivolumab|mesh-list
57046001|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57046002|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046003|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57046004|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046005|NCT02736578|Cetuximab|cetuximab|mesh-list
57046006|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57046007|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046008|NCT02478788|Amphetamine|amphetamine|mesh-list
57046009|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57046010|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046011|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
57046012|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
57046013|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046014|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
57046015|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046016|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046017|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
57046018|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57046019|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57046020|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046021|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57046022|NCT05157542|Paclitaxel|paclitaxel|mesh-list
57046023|NCT05157542|Durvalumab|durvalumab|mesh-list
57046024|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57046025|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57046026|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046027|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
57046028|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
57046029|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
57046030|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046031|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57046032|NCT03472976|Imiquimod|imiquimod|mesh-list
57046033|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57046034|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
57046035|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046036|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046037|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
57046038|NCT03473600|Triamcinolone|triamcinolone|mesh-list
57046039|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57046040|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57046041|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57046042|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57046043|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
57046044|NCT03473600|Hormones|hormones|mesh-ancestor
57046045|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046046|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046047|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57046048|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
57046049|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046050|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046051|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57046052|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57046053|NCT02622724|Interferons|interferons|mesh-list
57046054|NCT02622724|Interferon-beta|interferon-beta|mesh-list
57046055|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
57046056|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046057|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
57046058|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046059|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
57046060|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046061|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57046062|NCT01354353|Aripiprazole|aripiprazole|mesh-list
57046063|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
57046064|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57046065|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57046066|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57046067|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046068|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046069|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
57046070|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
57046071|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046072|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046073|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57046074|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57046075|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
57046076|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57046077|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57046078|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57046079|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57046080|NCT03070899|OBE2109|obe2109|mesh-list
57046081|NCT03070899|Hormone Antagonists|hormone antagonists|mesh-ancestor
57046082|NCT03070899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046083|NCT03070899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046084|NCT04931524|Mitogens|mitogens|mesh-list
57046085|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
57046086|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046087|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
57046088|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
57046089|NCT03562611|Nalbuphine|nalbuphine|mesh-list
57046090|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57046091|NCT03562611|Narcotics|narcotics|mesh-ancestor
57046092|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046093|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046094|NCT03562611|Analgesics|analgesics|mesh-ancestor
57046095|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
57046096|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046097|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57046098|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57046099|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57046100|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57046101|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57046102|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046103|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046104|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57046105|NCT03057574|Hormones|hormones|mesh-ancestor
57046106|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046107|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046108|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
57046109|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
57046110|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
57046111|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046112|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046113|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
57046114|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046115|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57046116|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57046117|NCT04929652|Irinotecan|irinotecan|mesh-list
57046118|NCT04929652|Molgramostim|molgramostim|mesh-list
57046119|NCT04929652|Sargramostim|sargramostim|mesh-list
57046120|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57046121|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57046122|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046123|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046124|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728095|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57046125|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
57046126|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046127|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
57046128|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57046129|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57046130|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046131|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046132|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046133|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046134|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
57046135|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57046136|NCT04927936|Vaccines|vaccines|mesh-list
57046137|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
57046138|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046139|NCT04167813|Ondansetron|ondansetron|mesh-list
57046140|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
57046141|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
57046142|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046143|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046144|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57046145|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
57046146|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
57046147|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57046148|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
57046149|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046150|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046151|NCT04167813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57046152|NCT04167813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57046153|NCT04167813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046154|NCT04167813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57046155|NCT04167813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57046156|NCT03562533|Paclitaxel|paclitaxel|mesh-list
57046157|NCT03562533|Carboplatin|carboplatin|mesh-list
57046158|NCT03562533|Doxorubicin|doxorubicin|mesh-list
57046159|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57046160|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57046161|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046162|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
57046163|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
57046164|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
57046165|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046166|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57046167|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57046168|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57046169|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046170|NCT04927858|Empagliflozin|empagliflozin|mesh-list
57046171|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57046172|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046173|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57046174|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046175|NCT04014387|Zolpidem|zolpidem|mesh-list
57046176|NCT04014387|Suvorexant|suvorexant|mesh-list
57046177|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57046178|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57046179|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046180|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046181|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57046182|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
57046183|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
57046184|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046185|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046186|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57046187|NCT05707455|Chrysarobin|chrysarobin|mesh-list
57046188|NCT05707455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57046189|NCT05707455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57046190|NCT05707455|Analgesics|analgesics|mesh-ancestor
57046191|NCT05707455|Sensory System Agents|sensory system agents|mesh-ancestor
57046192|NCT05707455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046193|NCT05707455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046194|NCT05707455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57046195|NCT05707455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57046196|NCT04927000|Tofacitinib|tofacitinib|mesh-list
57046197|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56728169|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57046198|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046199|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046200|NCT04926532|Sorafenib|sorafenib|mesh-list
57046201|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046202|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57046203|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046204|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046205|NCT03842709|Pramipexole|pramipexole|mesh-list
57046206|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
57046207|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046208|NCT03842709|Protective Agents|protective agents|mesh-ancestor
57046209|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046210|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57046211|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57046212|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
57046213|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
57046214|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046215|NCT05707533|Cefoxitin|cefoxitin|mesh-list
57046216|NCT05707533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57046217|NCT05707533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046218|NCT03056482|Haloperidol|haloperidol|mesh-list
57046219|NCT03056482|Ondansetron|ondansetron|mesh-list
57046220|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
57046221|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
57046222|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
57046223|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046224|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046225|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57046226|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
57046227|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
57046228|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57046229|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
57046230|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046231|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046232|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57046233|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57046234|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046235|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57046236|NCT03056482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57046237|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57046238|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
57046239|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57046240|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
57046241|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
57046242|NCT02817555|Hematinics|hematinics|mesh-ancestor
57046243|NCT04924192|Irinotecan|irinotecan|mesh-list
57046244|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57046245|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57046246|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046247|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046248|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046249|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
57046250|NCT02036073|Hematinics|hematinics|mesh-ancestor
57046251|NCT02036229|Ivermectin|ivermectin|mesh-list
57046252|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57046253|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046254|NCT04404088|Rituximab|rituximab|mesh-list
57046255|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57046256|NCT04404088|Lenalidomide|lenalidomide|mesh-list
57046257|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
57046258|NCT04404088|Antibodies|antibodies|mesh-list
57046259|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
57046260|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57046261|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
57046262|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046263|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046264|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57046265|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57046266|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57046267|NCT04404088|Growth Substances|growth substances|mesh-ancestor
57046268|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
57046269|NCT05705427|Tenofovir|tenofovir|mesh-list
57046270|NCT05705427|Vaccines|vaccines|mesh-list
57046271|NCT05705427|Immunologic Factors|immunologic factors|mesh-ancestor
57046272|NCT05705427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046273|NCT05705427|Antiviral Agents|antiviral agents|mesh-ancestor
57046274|NCT05705427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046275|NCT05705427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57046276|NCT05705427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57046277|NCT05705427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046278|NCT05705427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046279|NCT05705427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57046280|NCT05705427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57046281|NCT04922008|Capecitabine|capecitabine|mesh-list
57046282|NCT04922008|Trastuzumab|trastuzumab|mesh-list
57046283|NCT04922008|Vinorelbine|vinorelbine|mesh-list
57046284|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57046285|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
57046286|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046287|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046288|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57046289|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57046290|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
57046291|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
57046292|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
57046294|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
57046295|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57046296|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57046297|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046298|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046299|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
57046300|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
57046301|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57046302|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
57046303|NCT03056092|Ranibizumab|ranibizumab|mesh-list
57046304|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57046305|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57046306|NCT03056092|Growth Substances|growth substances|mesh-ancestor
56623801|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
57046307|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046308|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
57046309|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046310|NCT04921306|Clenbuterol|clenbuterol|mesh-list
57046311|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57046312|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57046313|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
57046314|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046315|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046316|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046317|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57046318|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
57046319|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046320|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57046321|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
57046322|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
57046323|NCT04920760|Vitamin A|vitamin a|mesh-list
57046324|NCT04920760|Vitamins|vitamins|mesh-ancestor
57046325|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
57046326|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046327|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
57046328|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
57046329|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57046330|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046331|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046332|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
57046333|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57046334|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046335|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046336|NCT04920604|Anesthetics|anesthetics|mesh-list
57046337|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046338|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046339|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
57046340|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57046341|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
57046342|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046343|NCT04920448|Expectorants|expectorants|mesh-ancestor
57046344|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
57046345|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57046346|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
57046347|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046348|NCT04920448|Protective Agents|protective agents|mesh-ancestor
57046349|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046350|NCT04920448|Antidotes|antidotes|mesh-ancestor
57046351|NCT03061006|Warfarin|warfarin|mesh-list
57046352|NCT03061006|Dabigatran|dabigatran|mesh-list
57046353|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
57046354|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
57046355|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57046356|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
57046357|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046358|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046360|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57046361|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046362|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046363|NCT04432558|Acetaminophen|acetaminophen|mesh-list
57046364|NCT04432558|Diclofenac|diclofenac|mesh-list
57046365|NCT04432558|Tramadol|tramadol|mesh-list
57046366|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57046367|NCT04432558|Analgesics|analgesics|mesh-ancestor
57046368|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
57046369|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046370|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046371|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
57046372|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57046373|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57046374|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57046375|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57046376|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046377|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046378|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57046379|NCT04432558|Narcotics|narcotics|mesh-ancestor
57046380|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046381|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
57046382|NCT04761614|Leucovorin|leucovorin|mesh-list
57046383|NCT04761614|Folic Acid|folic acid|mesh-list
57046384|NCT04761614|Bevacizumab|bevacizumab|mesh-list
57046385|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57046386|NCT04761614|Fluorouracil|fluorouracil|mesh-list
57046387|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
57046388|NCT04761614|Riluzole|riluzole|mesh-list
57046389|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
57046390|NCT04761614|Antibodies|antibodies|mesh-list
57046391|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
57046392|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57046393|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
57046394|NCT04761614|Calcium|calcium|mesh-list
57046395|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
57046396|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046397|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57046398|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57046399|NCT04761614|Growth Substances|growth substances|mesh-ancestor
57046400|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046401|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
57046402|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
57046403|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57046404|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57046405|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
57046406|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046407|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57046408|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57046409|NCT04761614|Antidotes|antidotes|mesh-ancestor
57046410|NCT04761614|Protective Agents|protective agents|mesh-ancestor
57046411|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
57046412|NCT04761614|Vitamins|vitamins|mesh-ancestor
57046413|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
57046414|NCT04761614|Hematinics|hematinics|mesh-ancestor
57046415|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
57046416|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57046417|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57046418|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046419|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57046420|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
57046421|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57046422|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57046423|NCT04979650|Prednisolone|prednisolone|mesh-list
57046424|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
57046425|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57046426|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
56728392|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
57046427|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57046428|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
57046429|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
57046430|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046431|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046432|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57046434|NCT04979650|Hormones|hormones|mesh-ancestor
57046435|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046436|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57046437|NCT04979650|Protective Agents|protective agents|mesh-ancestor
57046438|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57046439|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046440|NCT04979884|Cyclosporine|cyclosporine|mesh-list
57046441|NCT04979884|Interleukin-2|interleukin-2|mesh-list
57046442|NCT04979884|Cyclosporins|cyclosporins|mesh-list
57046443|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046444|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046445|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57046446|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
57046447|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046448|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
57046449|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046450|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
57046451|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57046452|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57046453|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046454|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57046455|NCT04979884|Analgesics|analgesics|mesh-ancestor
57046456|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
57046457|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046458|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
57046459|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
57046460|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046461|NCT04650152|Fenofibrate|fenofibrate|mesh-list
57046462|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57046463|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
57046464|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046465|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57046466|NCT04967950|Methotrexate|methotrexate|mesh-list
57046467|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57046468|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57046469|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
57046470|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57046471|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046472|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57046473|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
57046474|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046475|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046476|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
57046477|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046478|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57046479|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57046480|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
57046481|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57046482|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57046483|NCT04967326|Carbamazepine|carbamazepine|mesh-list
57046484|NCT04967326|Phenytoin|phenytoin|mesh-list
57046485|NCT04967326|Valproic Acid|valproic acid|mesh-list
57046486|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
57046487|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046488|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046489|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
57046490|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046491|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046492|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
57046493|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57046494|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046495|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57046496|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57046497|NCT04967326|Analgesics|analgesics|mesh-ancestor
57046498|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
57046499|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046500|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57046501|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046502|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57046503|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57046504|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56728468|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
57046505|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57046506|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57046507|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57046508|NCT02620384|Metolazone|metolazone|mesh-list
57046509|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57046510|NCT02620384|Diuretics|diuretics|mesh-ancestor
57046511|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
57046512|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046513|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57046514|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046515|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046516|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57046517|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57046518|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046519|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046520|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57046521|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046522|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046523|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
57046524|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046525|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
57046526|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57046527|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57046528|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046529|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
57046530|NCT04918576|Coagulants|coagulants|mesh-ancestor
57046531|NCT03472508|Folic Acid|folic acid|mesh-list
57046532|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
57046533|NCT03472508|Enalapril|enalapril|mesh-list
57046534|NCT03472508|Enalaprilat|enalaprilat|mesh-list
57046535|NCT03472508|Hematinics|hematinics|mesh-ancestor
57046536|NCT03472508|Vitamins|vitamins|mesh-ancestor
57046537|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
57046538|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046539|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046540|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046541|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57046542|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
57046543|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57046544|NCT04966234|Posaconazole|posaconazole|mesh-list
57046545|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
57046546|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046547|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57046548|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57046549|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57046550|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57046551|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57046552|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046553|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046554|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57046555|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
57046556|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046557|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046558|NCT03915860|Trifarotene|trifarotene|mesh-list
57046559|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
57046560|NCT04170998|Metformin|metformin|mesh-list
57046561|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
57046562|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57046563|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046564|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57046565|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046566|NCT04965532|Anesthetics|anesthetics|mesh-list
57046567|NCT04965532|Propofol|propofol|mesh-list
57046568|NCT04965532|Sevoflurane|sevoflurane|mesh-list
57046569|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046570|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046571|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57046572|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57046573|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
57046574|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57046575|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57046576|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
57046577|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57046578|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046579|NCT03055546|Oxytocin|oxytocin|mesh-list
57046580|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
57046581|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57046582|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046583|NCT04918264|Capecitabine|capecitabine|mesh-list
57046584|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57046585|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
57046586|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046587|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046588|NCT04917718|Tacrolimus|tacrolimus|mesh-list
57046589|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57046590|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
57046591|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046592|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57046593|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046594|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046595|NCT04977778|Fluorides|fluorides|mesh-list
57046596|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
57046597|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
57046598|NCT04977778|Protective Agents|protective agents|mesh-ancestor
57046599|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046600|NCT03055234|Treprostinil|treprostinil|mesh-list
57046601|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57046602|NCT03055312|Bicalutamide|bicalutamide|mesh-list
57046603|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
57046604|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
57046605|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046606|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046607|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046608|NCT04977544|Sertraline|sertraline|mesh-list
57046609|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
57046610|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57046611|NCT04977544|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57046612|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57046613|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046614|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046615|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046616|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
57046617|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046618|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
57046619|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57046620|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57046621|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046622|NCT03769376|Salvin|salvin|mesh-list
57046623|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57046624|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046625|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
57046626|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046627|NCT03769376|Protective Agents|protective agents|mesh-ancestor
57046628|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046629|NCT05156450|Prednisone|prednisone|mesh-list
57046630|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
57046631|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57046632|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
57046633|NCT05156450|Hormones|hormones|mesh-ancestor
57046634|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046635|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046636|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57046637|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046638|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57046639|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046640|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046641|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
57046642|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57046643|NCT03060304|Tamoxifen|tamoxifen|mesh-list
57046644|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57046645|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57046646|NCT03060304|Estradiol|estradiol|mesh-list
57046647|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57046648|NCT03060304|Estrogens|estrogens|mesh-ancestor
57046649|NCT03060304|Hormones|hormones|mesh-ancestor
57046650|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046651|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046652|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57046653|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
57046654|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57046655|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57046656|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57046657|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
57046658|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57046659|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046660|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57046661|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57046662|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57046663|NCT04432402|Gemcitabine|gemcitabine|mesh-list
57046664|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
57046665|NCT04432402|Lenalidomide|lenalidomide|mesh-list
57046666|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046667|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
57046668|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046669|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57046670|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
57046671|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046672|NCT04432402|Antiviral Agents|antiviral agents|mesh-ancestor
57046673|NCT04432402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046674|NCT04432402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046675|NCT04432402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57046676|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57046677|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57046678|NCT04432402|Growth Substances|growth substances|mesh-ancestor
57046679|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
57046680|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
57046681|NCT04432324|Antibodies|antibodies|mesh-list
57046682|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
57046683|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57046684|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57046685|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
57046686|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046687|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
57046688|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57046689|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57046690|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57046691|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046692|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046693|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
57046694|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046695|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046696|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57046697|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046698|NCT04977388|Droxidopa|droxidopa|mesh-list
57046699|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57046700|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57046701|NCT04917484|Octreotide|octreotide|mesh-list
57046702|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
57046703|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57046704|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57046705|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046706|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57046707|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046708|NCT03470480|Methamphetamine|methamphetamine|mesh-list
57046709|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57046710|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046711|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
57046712|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
57046713|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046714|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
57046715|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046716|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046717|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
57046718|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57046719|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57046720|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046721|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57046722|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57046723|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57046724|NCT04917250|Gemcitabine|gemcitabine|mesh-list
57046725|NCT04917250|Dexamethasone|dexamethasone|mesh-list
56728691|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57046726|NCT04917250|Etoposide|etoposide|mesh-list
57046727|NCT04917250|Pegaspargase|pegaspargase|mesh-list
57046728|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57046729|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
57046730|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
57046731|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046732|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046733|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57046734|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
57046735|NCT04917250|Hormones|hormones|mesh-ancestor
57046736|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046737|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57046738|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046739|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57046740|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
57046741|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046742|NCT04917250|Antiviral Agents|antiviral agents|mesh-ancestor
57046743|NCT04917250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046744|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046745|NCT04917250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57046746|NCT04917250|Immunologic Factors|immunologic factors|mesh-ancestor
57046747|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56624239|NCT00873379|Protective Agents|protective agents|mesh-ancestor
57046748|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57046749|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57046750|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
57046751|NCT04859582|Fluorouracil|fluorouracil|mesh-list
57046752|NCT04859582|Capecitabine|capecitabine|mesh-list
57046753|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
57046754|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046755|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57046756|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
57046757|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046758|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57046759|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57046760|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
57046761|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046762|NCT03469700|Anesthetics|anesthetics|mesh-list
57046763|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046764|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046765|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
57046766|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
57046767|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57046768|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57046769|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046770|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046771|NCT04912726|Urological Agents|urological agents|mesh-ancestor
57046772|NCT02603900|Bupivacaine|bupivacaine|mesh-list
57046773|NCT02603900|Ropivacaine|ropivacaine|mesh-list
57046774|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
57046775|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
57046776|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046777|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046778|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
57046779|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046780|NCT01669798|Nintedanib|nintedanib|mesh-list
57046781|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046782|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57046783|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046784|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046785|NCT02334722|Levetiracetam|levetiracetam|mesh-list
57046786|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
57046787|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
57046788|NCT04458116|Curcumin|curcumin|mesh-list
57046789|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57046790|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57046791|NCT04458116|Analgesics|analgesics|mesh-ancestor
57046792|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
57046793|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046794|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046795|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57046796|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57046797|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046798|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046799|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046800|NCT04952324|Folic Acid|folic acid|mesh-list
57046801|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
57046802|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
57046803|NCT04952324|Vitamins|vitamins|mesh-ancestor
57046804|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
57046805|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046806|NCT04952324|Hematinics|hematinics|mesh-ancestor
57046807|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
57046808|NCT03469544|Hormones|hormones|mesh-list
57046809|NCT03469544|Antibodies|antibodies|mesh-list
57046810|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046811|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046812|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
57046813|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57046814|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046815|NCT04912258|Irinotecan|irinotecan|mesh-list
57046816|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57046817|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57046818|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046819|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046820|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046821|NCT01952288|Simvastatin|simvastatin|mesh-list
57046822|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57046823|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57046824|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
57046825|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046826|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57046827|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57046828|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046829|NCT03054532|Durvalumab|durvalumab|mesh-list
57046830|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57046831|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046832|NCT04975360|Caffeine|caffeine|mesh-list
57046833|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57046834|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046835|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57046836|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046837|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046838|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57046839|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57046840|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
57046841|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046842|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57046843|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
57046844|NCT00563576|Estradiol|estradiol|mesh-list
57046845|NCT00563576|Estrogens|estrogens|mesh-ancestor
57046846|NCT00563576|Hormones|hormones|mesh-ancestor
57046847|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046848|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046849|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57046850|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
57046851|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57046852|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57046853|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57046854|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57046855|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57046856|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57046857|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57046858|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046859|NCT04915846|Tamoxifen|tamoxifen|mesh-list
57046860|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57046861|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
57046862|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046863|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046864|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57046865|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046866|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57046867|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57046868|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57046869|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
57046870|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57046871|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
57046872|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046873|NCT04916080|Expectorants|expectorants|mesh-ancestor
57046874|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
57046875|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57046876|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
57046877|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046878|NCT04916080|Protective Agents|protective agents|mesh-ancestor
57046879|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046880|NCT04916080|Antidotes|antidotes|mesh-ancestor
57046881|NCT04774250|Zonisamide|zonisamide|mesh-list
57046882|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
57046883|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57046884|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046885|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046886|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57046887|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046888|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57046889|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
57046890|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046891|NCT03782636|Aldesleukin|aldesleukin|mesh-list
57046892|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046893|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57046894|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57046895|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
57046896|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046897|NCT04911244|Dimercaprol|dimercaprol|mesh-list
57046898|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
57046899|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
57046900|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046901|NCT03761810|Tretinoin|tretinoin|mesh-list
57046902|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57046903|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
57046904|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046905|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
57046906|NCT04915456|Prednisolone|prednisolone|mesh-list
57046907|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57046908|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
57046909|NCT04915456|Hormones|hormones|mesh-ancestor
57046910|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57046911|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046912|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57046913|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046914|NCT04841668|Metformin|metformin|mesh-list
57046915|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57046916|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046917|NCT04914910|Insulin|insulin|mesh-list
57046918|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57046919|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046920|NCT03469310|Acetaminophen|acetaminophen|mesh-list
57046921|NCT03469310|Tramadol|tramadol|mesh-list
57046922|NCT03469310|Codeine|codeine|mesh-list
57046923|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57046924|NCT03469310|Analgesics|analgesics|mesh-ancestor
57046925|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
57046926|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046927|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046928|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
57046929|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57046930|NCT03469310|Narcotics|narcotics|mesh-ancestor
57046931|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046932|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
57046933|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
57046934|NCT03527186|Risperidone|risperidone|mesh-list
57046935|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57046936|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
57046937|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046938|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046939|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046940|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57046941|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57046942|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046943|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57046944|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57046945|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
57046946|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
57046947|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57046948|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897542|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
57046949|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57046950|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046951|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57046952|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57046953|NCT04455464|Midodrine|midodrine|mesh-list
57046954|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
57046955|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
57046956|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046957|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046958|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57046959|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57046960|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57046961|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57046962|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
57046963|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046964|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046965|NCT04914598|Cisplatin|cisplatin|mesh-list
57046966|NCT04914598|Endostar protein|endostar protein|mesh-list
57046967|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57046968|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57046969|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57046970|NCT04914598|Growth Substances|growth substances|mesh-ancestor
57046971|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046972|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
57046973|NCT03054220|Tramadol|tramadol|mesh-list
57046974|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57046975|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
57046976|NCT03054220|Paroxetine|paroxetine|mesh-list
57046977|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57046978|NCT03054220|Narcotics|narcotics|mesh-ancestor
57046979|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57046980|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57046981|NCT03054220|Analgesics|analgesics|mesh-ancestor
57046982|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
57046983|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57046984|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57046985|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57046986|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57046987|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57046988|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57046989|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
57046990|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57046991|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
57046992|NCT03054220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57046993|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
57046994|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57046995|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57046996|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57046997|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57046998|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
57046999|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047000|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57047001|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57047002|NCT05388188|Sufentanil|sufentanil|mesh-list
57047003|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57047004|NCT05388188|Narcotics|narcotics|mesh-ancestor
57047005|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047006|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047007|NCT05388188|Analgesics|analgesics|mesh-ancestor
57047008|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
57047009|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047010|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57047011|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57047012|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
57047013|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
57047014|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
57047015|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047016|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047017|NCT04909918|Dexamethasone|dexamethasone|mesh-list
57047018|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
57047019|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57047020|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57047021|NCT04909918|Prednisolone|prednisolone|mesh-list
57047022|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
57047023|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57047024|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
57047025|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56728990|NCT00961324|Insulin|insulin|mesh-list
57047026|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
57047027|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
57047028|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047029|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047030|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57047031|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
57047032|NCT04909918|Hormones|hormones|mesh-ancestor
57047033|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047034|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57047035|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047036|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57047037|NCT04909918|Protective Agents|protective agents|mesh-ancestor
57047038|NCT04903678|Melphalan|melphalan|mesh-list
57047039|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57047040|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
57047041|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047042|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047043|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57047044|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047045|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
57047046|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047047|NCT04903366|Timolol|timolol|mesh-list
57047048|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047049|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57047050|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57047051|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
57047052|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047053|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047054|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57047055|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57047056|NCT03054610|Betamethasone|betamethasone|mesh-list
57047057|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
57047058|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57047059|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
57047060|NCT03054610|Ropivacaine|ropivacaine|mesh-list
57047061|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
57047062|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57047063|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
57047064|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57047065|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57047066|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
57047067|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
57047068|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047069|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047070|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
57047071|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047072|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57047073|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57047074|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047075|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
57047076|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047077|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047078|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
57047079|NCT03054610|Hormones|hormones|mesh-ancestor
57047080|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047081|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047082|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047083|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57047084|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57047085|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
57047086|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
57047087|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047088|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047089|NCT03053830|Ketamine|ketamine|mesh-list
57047090|NCT03053830|Analgesics|analgesics|mesh-ancestor
57047091|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
57047092|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047093|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047094|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57047095|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57047096|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
57047097|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
57047098|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047099|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57047100|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56729061|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
57047101|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047102|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047103|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
57047104|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57047105|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047106|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047107|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57047108|NCT03053284|Pasireotide|pasireotide|mesh-list
57047109|NCT03053284|Hormones|hormones|mesh-ancestor
57047110|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047111|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047112|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57047113|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57047114|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047115|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
57047116|NCT02811861|Everolimus|everolimus|mesh-list
57047117|NCT02811861|Sunitinib|sunitinib|mesh-list
57047118|NCT02811861|Lenvatinib|lenvatinib|mesh-list
57047119|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047120|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047121|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047122|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
57047123|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047124|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57047125|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57047126|NCT02811861|Growth Substances|growth substances|mesh-ancestor
57047127|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
57047128|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57047129|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047130|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047131|NCT04908982|Aspirin|aspirin|mesh-list
57047132|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57047133|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57047134|NCT04908982|Analgesics|analgesics|mesh-ancestor
57047135|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
57047136|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047137|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047138|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047139|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57047140|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57047141|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57047142|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047143|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57047144|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57047145|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047146|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
57047147|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
57047148|NCT04430998|Polaprezinc|polaprezinc|mesh-list
57047149|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57047150|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047151|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
57047152|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57047153|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57047154|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
57047155|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
57047156|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57047157|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
57047158|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047159|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047160|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047161|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047162|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57047163|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57047164|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57047165|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
57047166|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047167|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047168|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047169|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
57047170|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57047171|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
57047172|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57047173|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56729143|NCT00766818|Lopinavir|lopinavir|mesh-list
57047174|NCT04900948|Prednisolone|prednisolone|mesh-list
57047176|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
57047177|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
57047178|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57047179|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
57047180|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047181|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
57047182|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
57047183|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047184|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047185|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57047186|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
57047187|NCT04900948|Hormones|hormones|mesh-ancestor
57047188|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047189|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57047190|NCT04900948|Protective Agents|protective agents|mesh-ancestor
57047191|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57047192|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047193|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57047194|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57047195|NCT04900948|Analgesics|analgesics|mesh-ancestor
57047196|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
57047197|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57047198|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
57047199|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047200|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
57047201|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57047202|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047203|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047204|NCT04901104|Thymalfasin|thymalfasin|mesh-list
57047205|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57047206|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
57047207|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047208|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
57047209|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57047210|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57047211|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047212|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
57047213|NCT04907812|Coagulants|coagulants|mesh-ancestor
57047214|NCT01889186|Venetoclax|venetoclax|mesh-list
57047215|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047216|NCT04892212|Sirolimus|sirolimus|mesh-list
57047217|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047218|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047219|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57047220|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047221|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
57047222|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047223|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
57047224|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047225|NCT01510184|Rituximab|rituximab|mesh-list
57047226|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57047227|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047228|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047229|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
57047230|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047231|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57047232|NCT04907344|Paclitaxel|paclitaxel|mesh-list
57047233|NCT04907344|Carboplatin|carboplatin|mesh-list
57047234|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57047235|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047236|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
57047237|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
57047238|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
57047239|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047240|NCT04906876|Gemcitabine|gemcitabine|mesh-list
57047241|NCT04906876|Docetaxel|docetaxel|mesh-list
57047242|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57047243|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
57047244|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047245|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047246|NCT04906876|Antiviral Agents|antiviral agents|mesh-ancestor
57047247|NCT04906876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047248|NCT04906876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047249|NCT04906876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047250|NCT04906876|Immunologic Factors|immunologic factors|mesh-ancestor
57047251|NCT04906876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047252|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
57047253|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
57047254|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
57047255|NCT04891744|Thalidomide|thalidomide|mesh-list
57047256|NCT04891744|Dexamethasone|dexamethasone|mesh-list
57047257|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047258|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
57047259|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
57047260|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047261|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047262|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57047263|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
57047264|NCT04891744|Hormones|hormones|mesh-ancestor
57047265|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047266|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57047267|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047268|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047269|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
57047270|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
57047271|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047272|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047273|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57047274|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57047275|NCT04891744|Growth Substances|growth substances|mesh-ancestor
57047276|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
57047277|NCT04891900|Capecitabine|capecitabine|mesh-list
57047278|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
57047279|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57047280|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57047281|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
57047282|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047283|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047284|NCT04891588|Timolol|timolol|mesh-list
57047285|NCT04891588|Latanoprost|latanoprost|mesh-list
57047286|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57047287|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57047288|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047289|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57047290|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57047291|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
57047292|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047293|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047294|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57047295|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57047296|NCT03050866|Antiemetics|antiemetics|mesh-list
57047297|NCT03050866|Histamine|histamine|mesh-list
57047298|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
57047299|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
57047300|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
57047301|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
57047302|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047303|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047304|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047305|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
57047306|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047307|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57047308|NCT03052660|Midazolam|midazolam|mesh-list
57047309|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57047310|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57047311|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047312|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047313|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57047314|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57047315|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57047316|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57047317|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
57047318|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
57047319|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
57047320|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
57047321|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047322|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047323|NCT05162456|Antibodies|antibodies|mesh-list
57047324|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
57047325|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
56729281|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
57047326|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
57047327|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047329|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57047330|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57047331|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
57047332|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047333|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047334|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047335|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57047336|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57047337|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
57047338|NCT05137886|Decitabine|decitabine|mesh-list
57047339|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57047340|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57047341|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
57047342|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047343|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047344|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047345|NCT04976192|Omalizumab|omalizumab|mesh-list
57047346|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57047347|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047348|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047349|NCT04890418|Ketamine|ketamine|mesh-list
57047350|NCT04890418|Analgesics|analgesics|mesh-ancestor
57047351|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
57047352|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047353|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047354|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57047355|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57047356|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
57047357|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
57047358|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047359|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57047360|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57047361|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047362|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047363|NCT04455932|Liver Extracts|liver extracts|mesh-list
57047364|NCT04455932|Hematinics|hematinics|mesh-ancestor
57047365|NCT03051022|Dexamethasone|dexamethasone|mesh-list
57047366|NCT03051022|Morphine|morphine|mesh-list
57047367|NCT03051022|Bupivacaine|bupivacaine|mesh-list
57047368|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047369|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
57047370|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
57047371|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047372|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047373|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57047374|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
57047375|NCT03051022|Hormones|hormones|mesh-ancestor
57047376|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047377|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57047378|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047379|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
57047380|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
57047381|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047382|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
57047383|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57047384|NCT03051022|Narcotics|narcotics|mesh-ancestor
57047385|NCT03051022|Analgesics|analgesics|mesh-ancestor
57047386|NCT04648826|Azacitidine|azacitidine|mesh-list
57047387|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57047388|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
57047389|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047390|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047391|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047392|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
57047393|NCT03052348|Betamethasone|betamethasone|mesh-list
57047394|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
57047395|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57047396|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
57047397|NCT03052348|Ether|ether|mesh-list
57047398|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57047399|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047400|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
57047401|NCT03052348|Hormones|hormones|mesh-ancestor
57047402|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047403|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047404|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047405|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047406|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57047407|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
57047408|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
57047409|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047410|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047411|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047412|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57047413|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047414|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047415|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57047416|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047417|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047418|NCT04606394|Albuterol|albuterol|mesh-list
57047419|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57047420|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
57047421|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047422|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047423|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047424|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047425|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
57047426|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57047427|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57047428|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57047429|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57047430|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
57047431|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047432|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047433|NCT04577690|Epinephrine|epinephrine|mesh-list
57047434|NCT04577690|Racepinephrine|racepinephrine|mesh-list
57047435|NCT04577690|Bupivacaine|bupivacaine|mesh-list
57047436|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
57047437|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
57047438|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
57047439|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047440|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047441|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
57047442|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047443|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57047444|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57047445|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
57047446|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047447|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047448|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57047449|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57047450|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
57047451|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047452|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047453|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
57047454|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
57047455|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57047456|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
57047457|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
57047458|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
57047459|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57047460|NCT04101890|Protective Agents|protective agents|mesh-ancestor
57047461|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047462|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
57047463|NCT04456712|Levofloxacin|levofloxacin|mesh-list
57047464|NCT04456712|Ofloxacin|ofloxacin|mesh-list
57047465|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047466|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047467|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57047468|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57047469|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047470|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047471|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047472|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57047473|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57047474|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57047475|NCT04456712|Renal Agents|renal agents|mesh-ancestor
57047476|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57047477|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57047478|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047479|NCT04884490|Renal Agents|renal agents|mesh-ancestor
57047480|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047481|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
57047482|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57047483|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57047484|NCT04854434|Trifluridine|trifluridine|mesh-list
57047485|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
57047486|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047487|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047488|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
57047489|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047490|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
57047491|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047492|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
57047493|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57047494|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
57047495|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57047496|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
57047497|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047498|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047499|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047500|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047501|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57047502|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
57047503|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047504|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047505|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57047506|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
57047507|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
57047508|NCT04456088|Protective Agents|protective agents|mesh-ancestor
57047509|NCT04454840|Riluzole|riluzole|mesh-list
57047510|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
57047511|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57047512|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57047513|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047514|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047515|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047516|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57047517|NCT04454840|Protective Agents|protective agents|mesh-ancestor
57047518|NCT03050710|Lidocaine|lidocaine|mesh-list
57047519|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
57047520|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
57047521|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047522|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047523|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
57047524|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047525|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57047526|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57047527|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57047528|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57047529|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047530|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57047531|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57047532|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047533|NCT04897516|Benzonidazole|benzonidazole|mesh-list
57047534|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047535|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
57047536|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047537|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57047538|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57047539|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57047540|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047541|NCT03993314|Bupivacaine|bupivacaine|mesh-list
57047542|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
57047543|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
57047544|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
57047545|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047546|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047547|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
57047548|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047549|NCT04883164|Antibodies|antibodies|mesh-list
57047550|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
57047551|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047553|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
57047554|NCT03161054|Rituximab|rituximab|mesh-list
57047555|NCT03161054|Etoposide|etoposide|mesh-list
57047556|NCT03161054|Vinorelbine|vinorelbine|mesh-list
57047557|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047558|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
57047559|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047560|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57047561|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57047562|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
57047563|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047564|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047565|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57047566|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047567|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047568|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
57047569|NCT03161054|Hormones|hormones|mesh-ancestor
57047570|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047571|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57047572|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57047573|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57047574|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57047575|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047576|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
57047577|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
57047578|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
57047579|NCT03050554|Avelumab|avelumab|mesh-list
57047580|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047581|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047582|NCT03050164|Gefitinib|gefitinib|mesh-list
57047583|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047584|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57047585|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047586|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047587|NCT03049930|Ketamine|ketamine|mesh-list
57047588|NCT03049930|Analgesics|analgesics|mesh-ancestor
57047589|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
57047590|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047591|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047592|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57047593|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57047594|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
57047595|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
57047596|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625103|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047597|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57047598|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57047599|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047600|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047601|NCT02036463|Prednisone|prednisone|mesh-list
57047602|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047603|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
57047604|NCT02036463|Hormones|hormones|mesh-ancestor
57047605|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047606|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047607|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57047608|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047609|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
57047610|NCT04887844|Lidocaine|lidocaine|mesh-list
57047611|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
57047612|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
57047613|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047614|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047615|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
57047616|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047617|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57047618|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57047619|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57047620|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57047621|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047622|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047623|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
57047624|NCT04887844|Hormones|hormones|mesh-ancestor
57047625|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047626|NCT02595320|Capecitabine|capecitabine|mesh-list
57047627|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57047628|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
57047629|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047630|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047631|NCT02809053|Rituximab|rituximab|mesh-list
57047632|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047633|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047634|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
57047635|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047636|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57047637|NCT04666688|Gemcitabine|gemcitabine|mesh-list
57047638|NCT04666688|Paclitaxel|paclitaxel|mesh-list
57047639|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57047640|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047641|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
57047642|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
57047643|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
57047644|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047645|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57047646|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
57047647|NCT04666688|Antiviral Agents|antiviral agents|mesh-ancestor
57047648|NCT04666688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047649|NCT04666688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047650|NCT04666688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047651|NCT04666688|Immunologic Factors|immunologic factors|mesh-ancestor
57047652|NCT04666688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047653|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
57047654|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57047655|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57047656|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57047657|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57047658|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047659|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
57047660|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047661|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047662|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57047663|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047664|NCT02047539|Aspirin|aspirin|mesh-list
57047665|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57047666|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57047667|NCT02047539|Analgesics|analgesics|mesh-ancestor
57047668|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
57047669|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047670|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047671|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047672|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57047673|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57047674|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57047675|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047676|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57047677|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57047678|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047679|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
57047680|NCT02522858|Atropine|atropine|mesh-list
57047681|NCT02522858|Ephedrine|ephedrine|mesh-list
57047682|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
57047683|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57047684|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047685|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047686|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57047687|NCT02522858|Analgesics|analgesics|mesh-ancestor
57047688|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
57047689|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047690|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57047691|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57047692|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57047693|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
57047694|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047695|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047696|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57047697|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57047698|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57047699|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
57047700|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047701|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047702|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
57047703|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
57047704|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57047705|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57047706|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
57047707|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57047708|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
57047709|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57047710|NCT03728361|Nivolumab|nivolumab|mesh-list
57047711|NCT03728361|Temozolomide|temozolomide|mesh-list
57047712|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047713|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047714|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57047715|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047716|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57047717|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
57047718|NCT02036697|Fentanyl|fentanyl|mesh-list
57047719|NCT02036697|Morphine|morphine|mesh-list
57047720|NCT02036697|Bupivacaine|bupivacaine|mesh-list
57047721|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
57047722|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
57047723|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047724|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047725|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
57047726|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047727|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57047728|NCT02036697|Narcotics|narcotics|mesh-ancestor
57047729|NCT02036697|Analgesics|analgesics|mesh-ancestor
57047730|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57047731|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57047732|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
57047733|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
57047734|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047735|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047736|NCT03106688|Carfentanil|carfentanil|mesh-list
57047737|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57047738|NCT03106688|Narcotics|narcotics|mesh-ancestor
57047739|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047740|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047741|NCT03106688|Analgesics|analgesics|mesh-ancestor
57047742|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
57047743|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047744|NCT02037009|Anesthetics|anesthetics|mesh-list
57047745|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047746|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047747|NCT02260011|Bromides|bromides|mesh-list
57047748|NCT02260011|Norflurane|norflurane|mesh-list
57047749|NCT02260011|Ipratropium|ipratropium|mesh-list
57047750|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
57047751|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57047752|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
57047753|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047754|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047755|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047756|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047757|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57047758|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
57047759|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047760|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047761|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
57047762|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047763|NCT04886752|Vitamins|vitamins|mesh-list
57047764|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
57047765|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
57047766|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
57047767|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047768|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
57047769|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047770|NCT04886752|Protective Agents|protective agents|mesh-ancestor
57047771|NCT02047773|Meropenem|meropenem|mesh-list
57047772|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047773|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047774|NCT04895800|Caffeine|caffeine|mesh-list
56729735|NCT00545584|Hormones|hormones|mesh-ancestor
57047775|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57047776|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047777|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57047778|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047779|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047780|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57047781|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57047782|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
57047783|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047784|NCT04886362|Ivermectin|ivermectin|mesh-list
57047785|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57047786|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047787|NCT02048007|Azithromycin|azithromycin|mesh-list
57047788|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047789|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047790|NCT02048085|Clopidogrel|clopidogrel|mesh-list
57047791|NCT02048085|Ticagrelor|ticagrelor|mesh-list
57047792|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57047793|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57047794|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57047795|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57047796|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
57047797|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047798|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047799|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047800|NCT02808975|Adalimumab|adalimumab|mesh-list
57047801|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57047802|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57047803|NCT04885660|Lisinopril|lisinopril|mesh-list
57047804|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57047805|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
57047806|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047807|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047808|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57047809|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57047810|NCT04885660|Protective Agents|protective agents|mesh-ancestor
57047811|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047812|NCT02037633|Fentanyl|fentanyl|mesh-list
57047813|NCT02037633|Ropivacaine|ropivacaine|mesh-list
57047814|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
57047815|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
57047816|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047817|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047818|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
57047819|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047820|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57047821|NCT02037633|Narcotics|narcotics|mesh-ancestor
57047822|NCT02037633|Analgesics|analgesics|mesh-ancestor
57047823|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57047824|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57047825|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
57047826|NCT05684211|Cetuximab|cetuximab|mesh-list
57047827|NCT05684211|Antibodies|antibodies|mesh-list
57047828|NCT05684211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57047829|NCT05684211|Immunologic Factors|immunologic factors|mesh-ancestor
57047830|NCT05684211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047831|NCT05684211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57047832|NCT05684211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047833|NCT03130634|Silymarin|silymarin|mesh-list
57047834|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
57047835|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047836|NCT03130634|Protective Agents|protective agents|mesh-ancestor
57047837|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047838|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
57047839|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57047840|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57047841|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047842|NCT04880746|Cladribine|cladribine|mesh-list
57047843|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047844|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047845|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
57047846|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047847|NCT03050086|Minocycline|minocycline|mesh-list
57047848|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047849|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047850|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
57047851|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57047852|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57047853|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57047854|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
57047855|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047856|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047857|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047858|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
57047859|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57047860|NCT04885270|Cisplatin|cisplatin|mesh-list
57047861|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047862|NCT04885426|Metformin|metformin|mesh-list
57047863|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57047864|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047865|NCT04879420|Teriparatide|teriparatide|mesh-list
57047866|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
57047867|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57047868|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047869|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57047870|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57047871|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57047872|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047873|NCT02808819|Benralizumab|benralizumab|mesh-list
57047874|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57047875|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
57047876|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
57047877|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57047878|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
57047879|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57047880|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047881|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57047882|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57047883|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57047884|NCT04872322|Ropivacaine|ropivacaine|mesh-list
57047885|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57047886|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
57047887|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
57047888|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047889|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047890|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
57047891|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047892|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
57047893|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
57047894|NCT04879030|Levofloxacin|levofloxacin|mesh-list
57047895|NCT04879030|Meropenem|meropenem|mesh-list
57047896|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
57047897|NCT04879030|Tazobactam|tazobactam|mesh-list
57047898|NCT04879030|Piperacillin|piperacillin|mesh-list
57047899|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
57047900|NCT04879030|Imipenem|imipenem|mesh-list
57047901|NCT04879030|Ceftazidime|ceftazidime|mesh-list
57047902|NCT04879030|Ertapenem|ertapenem|mesh-list
57047903|NCT04879030|Lactams|lactams|mesh-list
57047904|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57047905|NCT04879030|Cefotaxime|cefotaxime|mesh-list
57047906|NCT04879030|Cefixime|cefixime|mesh-list
57047907|NCT04879030|beta-Lactams|beta-lactams|mesh-list
57047908|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
57047909|NCT04879030|Ticarcillin|ticarcillin|mesh-list
57047910|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047911|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047912|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57047913|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57047914|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047915|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047916|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047917|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57047918|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57047919|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57047920|NCT04879030|Renal Agents|renal agents|mesh-ancestor
57047921|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57047922|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57047923|NCT04878718|Vancomycin|vancomycin|mesh-list
57047924|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047925|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047926|NCT04878016|Carboplatin|carboplatin|mesh-list
57047927|NCT04878016|Etoposide|etoposide|mesh-list
57047928|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047929|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57047931|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57047932|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047933|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047934|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57047935|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57047936|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57047937|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57047938|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047939|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57047940|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57047941|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047942|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
57047943|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57047944|NCT04870372|Selegiline|selegiline|mesh-list
57047945|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
57047946|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57047947|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57047948|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57047949|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57047950|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047951|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047952|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57047953|NCT04870372|Protective Agents|protective agents|mesh-ancestor
57047954|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047955|NCT02048319|Ethanol|ethanol|mesh-list
57047956|NCT02048319|Pasireotide|pasireotide|mesh-list
57047957|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57047958|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047959|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047960|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047961|NCT02048319|Hormones|hormones|mesh-ancestor
57047962|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57047963|NCT01594762|Pexiganan|pexiganan|mesh-list
57047964|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57047965|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047966|NCT02048475|Desflurane|desflurane|mesh-list
57047967|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57047968|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
57047969|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
57047970|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57047971|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047972|NCT03562143|Iron|iron|mesh-list
57047973|NCT03562143|Trace Elements|trace elements|mesh-ancestor
57047974|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
57047975|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57047976|NCT02048865|Apixaban|apixaban|mesh-list
57047977|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57047978|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
57047979|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57047980|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
57047981|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047982|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047983|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
57047984|NCT02048943|Gemcitabine|gemcitabine|mesh-list
57047985|NCT02048943|Paclitaxel|paclitaxel|mesh-list
57047986|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57047987|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57047988|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57047989|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
57047990|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
57047991|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
57047992|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57047993|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57047994|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
57047995|NCT02048943|Antiviral Agents|antiviral agents|mesh-ancestor
57047996|NCT02048943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57047997|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57047998|NCT02048943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57047999|NCT02048943|Immunologic Factors|immunologic factors|mesh-ancestor
57048000|NCT02048943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048001|NCT02050893|Midazolam|midazolam|mesh-list
57048002|NCT02050893|Propofol|propofol|mesh-list
57048003|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
57048004|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048005|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048006|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57048007|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
57048009|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57048010|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57048011|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57048012|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57048013|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
57048014|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
57048015|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048016|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048017|NCT02806947|Sirolimus|sirolimus|mesh-list
57048018|NCT02806947|Prednisone|prednisone|mesh-list
57048019|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048020|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
57048021|NCT02806947|Hormones|hormones|mesh-ancestor
57048022|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048023|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048024|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57048025|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048026|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57048027|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048028|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57048029|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
57048030|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57048031|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
57048032|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
57048033|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048034|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
56625536|NCT02543671|Vitamin D|vitamin d|mesh-list
57048035|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048036|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048037|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57048038|NCT02037399|Dexamethasone|dexamethasone|mesh-list
57048039|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048040|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
57048041|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
57048042|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048043|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048044|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57048045|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
57048046|NCT02037399|Hormones|hormones|mesh-ancestor
57048047|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048048|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57048049|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048050|NCT02260089|Telmisartan|telmisartan|mesh-list
57048051|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57048052|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57048053|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57048054|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048055|NCT02049255|Bupivacaine|bupivacaine|mesh-list
57048056|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
57048057|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
57048058|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
57048059|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048060|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048061|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
57048062|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048063|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
57048064|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
57048065|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
57048066|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048067|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048068|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
57048069|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048070|NCT03561675|Acetazolamide|acetazolamide|mesh-list
57048071|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
57048072|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57048073|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048074|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048075|NCT03561675|Diuretics|diuretics|mesh-ancestor
57048076|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
57048077|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048078|NCT02049411|Ketamine|ketamine|mesh-list
57048079|NCT02049411|Analgesics|analgesics|mesh-ancestor
57048080|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
57048081|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048082|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048083|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57048084|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57048085|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
57048087|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048088|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57048089|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57048090|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048091|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048092|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
57048093|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048094|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
57048095|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
57048096|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
57048097|NCT02051751|Paclitaxel|paclitaxel|mesh-list
57048098|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57048099|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048100|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
57048101|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
57048102|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
57048103|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048104|NCT02049801|Cytarabine|cytarabine|mesh-list
57048105|NCT02049801|Idarubicin|idarubicin|mesh-list
57048106|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56897584|NCT01168791|Doxorubicin|doxorubicin|mesh-list
57048107|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
57048108|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048109|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048110|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
57048111|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048112|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57048113|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
57048114|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048115|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57048116|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57048117|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57048118|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048119|NCT02802345|Nintedanib|nintedanib|mesh-list
57048120|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
57048121|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
57048122|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57048123|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57048124|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048125|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048126|NCT02802345|Urological Agents|urological agents|mesh-ancestor
57048127|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048128|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57048129|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57048130|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
57048131|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57048132|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
57048133|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57048134|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048135|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57048136|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57048137|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048138|NCT02056041|Liver Extracts|liver extracts|mesh-list
57048139|NCT02056041|Hematinics|hematinics|mesh-ancestor
57048140|NCT02053857|Amoxicillin|amoxicillin|mesh-list
57048141|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57048142|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048143|NCT02053935|Dopamine|dopamine|mesh-list
57048144|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57048145|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
57048146|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
57048147|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048148|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048149|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
57048150|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048151|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048152|NCT02053935|Protective Agents|protective agents|mesh-ancestor
57048153|NCT02056353|Insulin|insulin|mesh-list
57048154|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57048155|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048156|NCT02056587|Everolimus|everolimus|mesh-list
57048157|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048158|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57048159|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
57048160|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048161|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57048162|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57048163|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
57048164|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
57048165|NCT02038335|Etonogestrel|etonogestrel|mesh-list
57048166|NCT02038335|Norethindrone|norethindrone|mesh-list
57048167|NCT02038335|Estradiol|estradiol|mesh-list
57048168|NCT02038335|Estrogens|estrogens|mesh-ancestor
57048169|NCT02038335|Hormones|hormones|mesh-ancestor
57048170|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048171|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048172|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57048173|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
57048174|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57048175|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57048176|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57048177|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57048178|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57048179|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57048180|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57048181|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048182|NCT02056665|Minocycline|minocycline|mesh-list
57048183|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57048184|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048185|NCT02056743|Fexofenadine|fexofenadine|mesh-list
57048186|NCT02056743|Losartan|losartan|mesh-list
57048187|NCT02056743|Midazolam|midazolam|mesh-list
57048188|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
57048189|NCT02056743|Caffeine|caffeine|mesh-list
57048190|NCT02056743|Omeprazole|omeprazole|mesh-list
57048191|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57048192|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57048193|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048194|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048195|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57048196|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57048197|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57048198|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57048199|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
57048200|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
57048201|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
57048202|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
57048203|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048204|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048205|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57048206|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57048207|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57048208|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57048209|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57048210|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57048211|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048212|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57048213|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57048214|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
57048215|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57048216|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57048217|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57048218|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
57048219|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
57048220|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57048221|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57048222|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57048223|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57048224|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57048225|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
57048226|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
57048227|NCT02054637|Lanreotide|lanreotide|mesh-list
57048228|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048229|NCT02052609|Brodalumab|brodalumab|mesh-list
57048230|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
57048231|NCT02054793|Itraconazole|itraconazole|mesh-list
57048232|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
57048233|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048234|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57048235|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57048236|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048237|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048238|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57048239|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
57048240|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048241|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048242|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57048243|NCT02052687|Imiquimod|imiquimod|mesh-list
57048244|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57048245|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
57048246|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048247|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048248|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
57048249|NCT02057289|Micafungin|micafungin|mesh-list
57048250|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
57048251|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048252|NCT02057367|Bupivacaine|bupivacaine|mesh-list
57048253|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
57048254|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
57048255|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048256|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048257|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
57048258|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048259|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
57048260|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57048261|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
57048262|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048263|NCT02054949|Expectorants|expectorants|mesh-ancestor
57048264|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
57048265|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57048266|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
57048267|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048268|NCT02054949|Protective Agents|protective agents|mesh-ancestor
57048269|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048270|NCT02054949|Antidotes|antidotes|mesh-ancestor
57048271|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57048272|NCT02748057|Ezetimibe|ezetimibe|mesh-list
57048273|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57048274|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57048275|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
57048276|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048277|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57048278|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57048279|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048280|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
57048281|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
57048282|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
57048283|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048284|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048285|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
57048286|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048287|NCT02057679|Amoxicillin|amoxicillin|mesh-list
57048288|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57048289|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048290|NCT02038491|Anesthetics|anesthetics|mesh-list
57048291|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048292|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048293|NCT02055183|Antitoxins|antitoxins|mesh-list
57048294|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
57048295|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
57048296|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048297|NCT02748213|Docetaxel|docetaxel|mesh-list
57048298|NCT02748213|Capecitabine|capecitabine|mesh-list
57048299|NCT02748213|Trastuzumab|trastuzumab|mesh-list
57048300|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048301|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
57048302|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
57048303|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
57048304|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048305|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56730259|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
57048306|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
57048307|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048308|NCT03804099|Aflibercept|aflibercept|mesh-list
57048309|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57048310|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57048311|NCT03804099|Growth Substances|growth substances|mesh-ancestor
57048312|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048313|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
57048314|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048315|NCT02058303|Bupivacaine|bupivacaine|mesh-list
57048316|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
57048317|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
57048318|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048319|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048320|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
57048321|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048322|NCT02058693|Amphetamine|amphetamine|mesh-list
57048323|NCT02058693|Adderall|adderall|mesh-list
57048324|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57048325|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048326|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
57048327|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
57048328|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048329|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
57048330|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048331|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048332|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
57048333|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57048334|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57048335|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57048336|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57048337|NCT05256472|Axitinib|axitinib|mesh-list
57048338|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048339|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57048340|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048341|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048342|NCT04870060|Curcumin|curcumin|mesh-list
57048343|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57048344|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57048345|NCT04870060|Analgesics|analgesics|mesh-ancestor
57048346|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
57048347|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048348|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048349|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048350|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57048351|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048352|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048353|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048354|NCT02613910|Acetaminophen|acetaminophen|mesh-list
57048355|NCT02613910|Cetirizine|cetirizine|mesh-list
57048356|NCT02613910|Prednisone|prednisone|mesh-list
57048357|NCT02613910|Prednisolone|prednisolone|mesh-list
57048358|NCT02613910|Ofatumumab|ofatumumab|mesh-list
57048359|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
57048360|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
57048361|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048362|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
57048363|NCT02613910|Hormones|hormones|mesh-ancestor
57048364|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048365|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048366|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57048367|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048368|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57048369|NCT02613910|Analgesics|analgesics|mesh-ancestor
57048370|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
57048371|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048372|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
57048373|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57048374|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57048375|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
57048376|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048377|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048378|NCT02802735|Apremilast|apremilast|mesh-list
57048379|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57048380|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57048382|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
57048383|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048384|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048385|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048386|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57048387|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57048388|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57048389|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048390|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048391|NCT03048214|Anesthetics|anesthetics|mesh-list
57048392|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048393|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048394|NCT02060955|Bevacizumab|bevacizumab|mesh-list
57048395|NCT02060955|Irinotecan|irinotecan|mesh-list
57048396|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048397|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048398|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57048399|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57048400|NCT02060955|Growth Substances|growth substances|mesh-ancestor
57048401|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048402|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
57048403|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57048404|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57048405|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048406|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048407|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57048408|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048409|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57048410|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048411|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048412|NCT05654649|Dexamethasone|dexamethasone|mesh-list
57048413|NCT05654649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048414|NCT05654649|Antiemetics|antiemetics|mesh-ancestor
57048415|NCT05654649|Autonomic Agents|autonomic agents|mesh-ancestor
57048416|NCT05654649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048417|NCT05654649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048418|NCT05654649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57048419|NCT05654649|Glucocorticoids|glucocorticoids|mesh-ancestor
57048420|NCT05654649|Hormones|hormones|mesh-ancestor
57048421|NCT05654649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048422|NCT05654649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57048423|NCT05654649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048424|NCT04877626|Artesunate|artesunate|mesh-list
57048425|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
57048426|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57048427|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57048428|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048429|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048430|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
57048431|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
57048432|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57048433|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
57048434|NCT05255848|Heparin|heparin|mesh-list
57048435|NCT05255848|Calcium heparin|calcium heparin|mesh-list
57048436|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
57048437|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57048438|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57048439|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048440|NCT04430062|Anesthetics|anesthetics|mesh-list
57048441|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048442|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048443|NCT02799381|Levodopa|levodopa|mesh-list
57048444|NCT02799381|Carbidopa|carbidopa|mesh-list
57048445|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57048446|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
57048447|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57048448|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
57048449|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048450|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048451|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048452|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57048453|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730408|NCT00978718|Trace Elements|trace elements|mesh-ancestor
57048454|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57048455|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
57048456|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
57048457|NCT04387942|Aldesleukin|aldesleukin|mesh-list
57048458|NCT04387942|Interleukin-2|interleukin-2|mesh-list
57048459|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048460|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57048461|NCT04387942|Analgesics|analgesics|mesh-ancestor
57048462|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
57048463|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048464|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048465|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57048466|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57048467|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
57048468|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048469|NCT01333059|Fentanyl|fentanyl|mesh-list
57048470|NCT01333059|Midazolam|midazolam|mesh-list
57048471|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57048472|NCT01333059|Narcotics|narcotics|mesh-ancestor
57048473|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048474|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048475|NCT01333059|Analgesics|analgesics|mesh-ancestor
57048476|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
57048477|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048478|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57048479|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57048480|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
57048481|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
57048482|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57048483|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57048484|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57048485|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57048486|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
57048487|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
57048488|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048489|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048490|NCT04865848|Anesthetics|anesthetics|mesh-list
57048491|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048492|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048493|NCT02060253|Paclitaxel|paclitaxel|mesh-list
57048494|NCT02060253|Trastuzumab|trastuzumab|mesh-list
57048495|NCT02060253|Pertuzumab|pertuzumab|mesh-list
57048496|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57048497|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048498|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
57048499|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
57048500|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
57048501|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048502|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048503|NCT04364620|Docetaxel|docetaxel|mesh-list
57048504|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048505|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
57048506|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
57048507|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
57048508|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048509|NCT03560973|Gemcitabine|gemcitabine|mesh-list
57048510|NCT03560973|Ramucirumab|ramucirumab|mesh-list
57048511|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57048512|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
57048513|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048514|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048515|NCT03560973|Antiviral Agents|antiviral agents|mesh-ancestor
57048516|NCT03560973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048517|NCT03560973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048518|NCT03560973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57048519|NCT03560973|Immunologic Factors|immunologic factors|mesh-ancestor
57048520|NCT03560973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048521|NCT04383574|Vaccines|vaccines|mesh-list
57048522|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
57048523|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048524|NCT03046108|Triamcinolone|triamcinolone|mesh-list
57048525|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57048526|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57048527|NCT03046108|Mepivacaine|mepivacaine|mesh-list
57048528|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56730502|NCT00896571|Estrogens|estrogens|mesh-ancestor
57048529|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048530|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
57048531|NCT03046108|Hormones|hormones|mesh-ancestor
57048532|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048533|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048534|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57048535|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
57048536|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048537|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048538|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
57048539|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
57048540|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048541|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
57048542|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048544|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
57048545|NCT02061267|Vitamins|vitamins|mesh-ancestor
57048546|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
57048547|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048548|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
57048549|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57048550|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
57048551|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048552|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57048553|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
57048554|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57048555|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57048556|NCT01370655|Diuretics|diuretics|mesh-ancestor
57048557|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
57048558|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048559|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57048560|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57048561|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048562|NCT02612194|Crizotinib|crizotinib|mesh-list
57048563|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048564|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57048565|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048566|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048567|NCT03044626|Nivolumab|nivolumab|mesh-list
57048568|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048569|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048570|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57048571|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048572|NCT04865224|Chrysarobin|chrysarobin|mesh-list
57048573|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57048574|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57048575|NCT04865224|Analgesics|analgesics|mesh-ancestor
57048576|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
57048577|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048578|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048579|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048580|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57048581|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
57048582|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57048583|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57048584|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048585|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
57048586|NCT04865380|Coagulants|coagulants|mesh-ancestor
57048587|NCT04869046|Acetaminophen|acetaminophen|mesh-list
57048588|NCT04869046|Ibuprofen|ibuprofen|mesh-list
57048589|NCT04869046|Analgesics|analgesics|mesh-list
57048590|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
57048591|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57048592|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
57048593|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048594|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048595|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
57048596|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57048597|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048598|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57048599|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57048600|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048601|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048602|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
57048603|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
57048604|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048605|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
57048606|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57048607|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57048608|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048609|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
57048610|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
57048611|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57048612|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
57048613|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048614|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
57048615|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57048616|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57048617|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57048618|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
57048619|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048620|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57048621|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57048622|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048623|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57048624|NCT05654415|Melatonin|melatonin|mesh-list
57048625|NCT05654415|Antioxidants|antioxidants|mesh-ancestor
57048626|NCT05654415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048627|NCT05654415|Protective Agents|protective agents|mesh-ancestor
57048628|NCT05654415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048629|NCT05654415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048630|NCT03044938|Albuterol|albuterol|mesh-list
57048631|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57048632|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
57048633|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048634|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048635|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57048636|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
57048637|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
57048638|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57048639|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57048640|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57048641|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57048642|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
57048643|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048644|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048645|NCT03045484|Oxycodone|oxycodone|mesh-list
57048646|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57048647|NCT03045484|Narcotics|narcotics|mesh-ancestor
57048648|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048649|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048650|NCT03045484|Analgesics|analgesics|mesh-ancestor
57048651|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
57048652|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048653|NCT04874506|TEMPO|tempo|mesh-list
57048654|NCT04874506|TEMPOL-H|tempol-h|mesh-list
57048655|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
57048656|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048657|NCT04874506|Protective Agents|protective agents|mesh-ancestor
57048658|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048659|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57048660|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
57048661|NCT04874428|Apixaban|apixaban|mesh-list
57048662|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57048663|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
57048664|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57048665|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
57048666|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048667|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048668|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
57048669|NCT04867720|Everolimus|everolimus|mesh-list
57048670|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048671|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57048672|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
57048673|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048674|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57048675|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57048676|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
57048677|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
57048678|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57048679|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048680|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57048681|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57048682|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57048683|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048684|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
57048685|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048686|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
57048687|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57048688|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048689|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
57048690|NCT03045406|Dalteparin|dalteparin|mesh-list
57048691|NCT03045406|Tinzaparin|tinzaparin|mesh-list
57048692|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57048693|NCT03045406|Apixaban|apixaban|mesh-list
57048694|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57048695|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
57048696|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57048697|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
57048698|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048699|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048700|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
57048701|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57048702|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57048703|NCT02798835|Dexamethasone|dexamethasone|mesh-list
57048704|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
57048705|NCT02798835|Fentanyl|fentanyl|mesh-list
57048706|NCT02798835|Bupivacaine|bupivacaine|mesh-list
57048707|NCT02798835|Ropivacaine|ropivacaine|mesh-list
57048708|NCT02798835|BB 1101|bb 1101|mesh-list
57048709|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048710|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
57048711|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
57048712|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048713|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048714|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57048715|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
57048716|NCT02798835|Hormones|hormones|mesh-ancestor
57048717|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048718|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57048719|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048720|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
57048721|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048722|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048723|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
57048724|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
57048725|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57048726|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
57048727|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57048728|NCT02798835|Narcotics|narcotics|mesh-ancestor
57048729|NCT02798835|Analgesics|analgesics|mesh-ancestor
57048730|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57048731|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57048732|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
57048733|NCT02061657|Misoprostol|misoprostol|mesh-list
57048734|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57048735|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
57048736|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57048737|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048738|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57048739|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57048740|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
57048741|NCT03048136|Nivolumab|nivolumab|mesh-list
57048742|NCT03048136|Ipilimumab|ipilimumab|mesh-list
57048743|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048744|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048745|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57048746|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048747|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
57048748|NCT02062203|Glycine|glycine|mesh-list
57048749|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57048750|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048751|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57048752|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57048753|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048754|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048755|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048756|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730706|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
57048757|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
57048758|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048759|NCT04863742|Prednisolone|prednisolone|mesh-list
57048760|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57048761|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
57048762|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57048763|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
57048764|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57048765|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
57048766|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048767|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
57048768|NCT04863742|Hormones|hormones|mesh-ancestor
57048769|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048770|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048771|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57048772|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048773|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
57048774|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
57048775|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048776|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57048777|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57048778|NCT04863742|Protective Agents|protective agents|mesh-ancestor
57048779|NCT02611882|Edetic Acid|edetic acid|mesh-list
57048780|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
57048781|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57048782|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
57048783|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
57048784|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048785|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
57048786|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57048787|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57048788|NCT02062281|Vaccines|vaccines|mesh-list
57048789|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57048790|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
57048791|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048792|NCT05590455|Adalimumab|adalimumab|mesh-list
57048793|NCT05590455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048794|NCT05590455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57048795|NCT03560583|Metoclopramide|metoclopramide|mesh-list
57048796|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
57048797|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
57048798|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048799|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048800|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57048801|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57048802|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57048803|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
57048804|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048805|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048806|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57048807|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57048808|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57048809|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57048810|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048811|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048812|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048813|NCT03560427|Analgesics|analgesics|mesh-ancestor
57048814|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
57048815|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048816|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
57048817|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57048818|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
57048819|NCT03797547|Aflibercept|aflibercept|mesh-list
57048820|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57048821|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57048822|NCT03797547|Growth Substances|growth substances|mesh-ancestor
57048823|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048824|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
57048825|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048826|NCT04867252|Inositol|inositol|mesh-list
57048827|NCT04867252|Metformin|metformin|mesh-list
57048828|NCT04867252|Pioglitazone|pioglitazone|mesh-list
57048829|NCT04867252|Resveratrol|resveratrol|mesh-list
56442036|NCT00298194|Z 338|z 338|mesh-list
57048830|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57048831|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048832|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
57048833|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048834|NCT04867252|Protective Agents|protective agents|mesh-ancestor
57048835|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048836|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57048837|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
57048838|NCT04867252|Vitamins|vitamins|mesh-ancestor
57048839|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
57048840|NCT04863274|Atorvastatin|atorvastatin|mesh-list
57048841|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57048842|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57048843|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
57048844|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048845|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57048846|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57048847|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048848|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
57048849|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57048850|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
57048851|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048852|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
57048853|NCT02063373|Protective Agents|protective agents|mesh-ancestor
57048854|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
57048855|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048856|NCT04873102|Danazol|danazol|mesh-list
57048857|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57048858|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
57048859|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048860|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048861|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57048862|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
57048863|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57048864|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
57048865|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048866|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048867|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57048868|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
57048869|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57048870|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57048871|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57048872|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
57048873|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048874|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048875|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57048876|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57048877|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57048878|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57048879|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048880|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048881|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57048882|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57048883|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048884|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
57048885|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048886|NCT04429282|Ibuprofen|ibuprofen|mesh-list
57048887|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57048888|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57048889|NCT04429282|Analgesics|analgesics|mesh-ancestor
57048890|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
57048891|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57048892|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048893|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57048894|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57048895|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57048896|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048897|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048898|NCT02063529|Leucovorin|leucovorin|mesh-list
57048899|NCT02063529|Fluorouracil|fluorouracil|mesh-list
57048900|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
57048901|NCT02063529|Irinotecan|irinotecan|mesh-list
57048902|NCT02063529|Cetuximab|cetuximab|mesh-list
57048903|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
57048904|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
57048905|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048906|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57048908|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57048909|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
56897601|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57048910|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048911|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57048912|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57048913|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048914|NCT02063529|Antidotes|antidotes|mesh-ancestor
57048915|NCT02063529|Protective Agents|protective agents|mesh-ancestor
57048916|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
57048917|NCT02063529|Vitamins|vitamins|mesh-ancestor
57048918|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
57048919|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048920|NCT02062983|Trastuzumab|trastuzumab|mesh-list
57048921|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048922|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048923|NCT02613208|Paclitaxel|paclitaxel|mesh-list
57048924|NCT02613208|Bevacizumab|bevacizumab|mesh-list
57048925|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57048926|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048927|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
57048928|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
57048929|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
57048930|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048931|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048932|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57048933|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57048934|NCT02613208|Growth Substances|growth substances|mesh-ancestor
57048935|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048936|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
57048937|NCT02063841|Bismuth|bismuth|mesh-list
57048938|NCT02063841|Antacids|antacids|mesh-ancestor
57048939|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048940|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57048941|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
57048942|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57048943|NCT04872634|Cetuximab|cetuximab|mesh-list
57048944|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048945|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048946|NCT01668784|Nivolumab|nivolumab|mesh-list
57048947|NCT01668784|Everolimus|everolimus|mesh-list
57048948|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048949|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048950|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57048951|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048952|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57048953|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
57048954|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048955|NCT02750514|Nivolumab|nivolumab|mesh-list
57048956|NCT02750514|Ipilimumab|ipilimumab|mesh-list
57048957|NCT02750514|Dasatinib|dasatinib|mesh-list
57048958|NCT02750514|Linrodostat|linrodostat|mesh-list
57048959|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57048960|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57048961|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57048962|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57048963|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57048964|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57048965|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
57048966|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57048967|NCT02229240|Incretins|incretins|mesh-ancestor
57048968|NCT02229240|Hormones|hormones|mesh-ancestor
57048969|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048970|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048971|NCT02820714|Laxatives|laxatives|mesh-list
57048972|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57048973|NCT02259426|Piperaquine|piperaquine|mesh-list
57048974|NCT02259426|Primaquine|primaquine|mesh-list
57048975|NCT02259426|Artenimol|artenimol|mesh-list
57048976|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
57048977|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57048978|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57048979|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57048980|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57048981|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57048982|NCT03738618|Hormones|hormones|mesh-ancestor
56730931|NCT00349921|Adenosine|adenosine|mesh-list
57048983|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048984|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048986|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
57048987|NCT03412890|Estradiol|estradiol|mesh-list
57048988|NCT03412890|Relugolix|relugolix|mesh-list
57048989|NCT03412890|Estrogens|estrogens|mesh-ancestor
57048990|NCT03412890|Hormones|hormones|mesh-ancestor
57048991|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57048992|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57048993|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57048994|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
57048995|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57048996|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57048997|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57048998|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57048999|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57049000|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
57049001|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
57049002|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
57049003|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57049004|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049005|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
57049006|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
57049007|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049008|NCT03340974|Protective Agents|protective agents|mesh-ancestor
57049009|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049010|NCT02229786|Acetaminophen|acetaminophen|mesh-list
57049011|NCT02229786|Scopolamine|scopolamine|mesh-list
57049012|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57049013|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57049014|NCT02229786|Analgesics|analgesics|mesh-ancestor
57049015|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
57049016|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049017|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049018|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
57049019|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
57049020|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
57049021|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57049022|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57049023|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
57049024|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049025|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049026|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57049027|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
57049028|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049029|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
57049030|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57049031|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57049032|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
57049033|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049034|NCT02229942|Rituximab|rituximab|mesh-list
57049035|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57049036|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049037|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
57049038|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049039|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57049040|NCT03047278|Cetirizine|cetirizine|mesh-list
57049041|NCT03047278|Gabapentin|gabapentin|mesh-list
57049042|NCT03047278|Analgesics|analgesics|mesh-ancestor
57049043|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
57049044|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049045|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049046|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
57049047|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57049048|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57049049|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049050|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57049051|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57049052|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57049053|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049054|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049055|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
57049056|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57049057|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57049058|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57049059|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
57049060|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
57049061|NCT03045016|Prazosin|prazosin|mesh-list
57049062|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57049063|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57049064|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57049065|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57049066|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
57049067|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049068|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049069|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049070|NCT04849858|Bupivacaine|bupivacaine|mesh-list
57049071|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
57049072|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
57049073|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049074|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049075|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
57049076|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049077|NCT03043612|Doxazosin|doxazosin|mesh-list
57049078|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57049079|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57049080|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57049081|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57049082|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
57049083|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049084|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049085|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049086|NCT02230176|Sunitinib|sunitinib|mesh-list
57049087|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
57049088|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049089|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57049090|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57049091|NCT02230176|Growth Substances|growth substances|mesh-ancestor
57049092|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049093|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
57049094|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57049095|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049096|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049097|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57049098|NCT02232516|Lenalidomide|lenalidomide|mesh-list
57049099|NCT02232516|Romidepsin|romidepsin|mesh-list
57049100|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
57049101|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049102|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57049103|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57049104|NCT02232516|Growth Substances|growth substances|mesh-ancestor
57049105|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
57049106|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049107|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57049108|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
57049109|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57049110|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
57049111|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57049112|NCT03647592|Bevacizumab|bevacizumab|mesh-list
57049113|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57049114|NCT03647592|Gefitinib|gefitinib|mesh-list
57049115|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57049116|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049117|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57049118|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57049119|NCT03647592|Growth Substances|growth substances|mesh-ancestor
57049120|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049121|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
57049122|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57049123|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049124|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049125|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57049126|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57049127|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
57049128|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049129|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049130|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57049131|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
57049132|NCT03180684|Imiquimod|imiquimod|mesh-list
57049133|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57049134|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
57049135|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049136|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049137|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
57049138|NCT04858516|Trastuzumab|trastuzumab|mesh-list
57049139|NCT04858516|Palbociclib|palbociclib|mesh-list
57049140|NCT04858516|Exemestane|exemestane|mesh-list
57049141|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57049142|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049143|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57049144|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049145|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049146|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57049147|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57049148|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57049149|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
57049150|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57049151|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049152|NCT03148860|Methotrexate|methotrexate|mesh-list
57049153|NCT03148860|Ustekinumab|ustekinumab|mesh-list
57049154|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57049155|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
57049156|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57049157|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049158|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57049159|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
57049160|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049161|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049162|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
57049163|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049164|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57049165|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57049166|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
57049167|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57049168|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57049169|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57049170|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57049171|NCT02232672|Choline|choline|mesh-list
57049172|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
57049173|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57049174|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
57049175|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049176|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049177|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57049178|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
57049179|NCT05072262|Dexamethasone|dexamethasone|mesh-list
57049180|NCT05072262|Nepafenac|nepafenac|mesh-list
57049181|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57049182|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
57049183|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
57049184|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049185|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049186|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049187|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
57049188|NCT05072262|Hormones|hormones|mesh-ancestor
57049189|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57049190|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57049191|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049192|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57049193|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57049194|NCT05072262|Analgesics|analgesics|mesh-ancestor
57049195|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
57049196|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57049197|NCT04858048|Anesthetics|anesthetics|mesh-list
57049198|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897605|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
57049199|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049200|NCT02234466|Dexamethasone|dexamethasone|mesh-list
57049201|NCT02234466|Ondansetron|ondansetron|mesh-list
57049202|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57049203|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
57049204|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
57049205|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049206|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049207|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049208|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
57049209|NCT02234466|Hormones|hormones|mesh-ancestor
57049210|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57049211|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57049212|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049213|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
57049214|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
57049215|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57049216|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
57049217|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049218|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049219|NCT02234466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57049220|NCT02234466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57049221|NCT02234466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049222|NCT02234466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57049223|NCT02234466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57049224|NCT02230800|Tocovid|tocovid|mesh-list
57049225|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
57049226|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57049227|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049228|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049229|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57049230|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57049231|NCT02230800|Protective Agents|protective agents|mesh-ancestor
57049232|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049233|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
57049234|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57049235|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
57049236|NCT02230800|Vitamins|vitamins|mesh-ancestor
57049237|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
57049238|NCT02234544|Vitamin D|vitamin d|mesh-list
57049239|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
57049240|NCT02234544|Ezetimibe|ezetimibe|mesh-list
57049241|NCT02234544|Vitamins|vitamins|mesh-ancestor
57049242|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
57049243|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049244|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57049245|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57049246|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57049247|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57049248|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
57049249|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049250|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57049251|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57049252|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57049253|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049254|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
57049255|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
57049256|NCT04860076|Nivolumab|nivolumab|mesh-list
57049257|NCT04860076|Ipilimumab|ipilimumab|mesh-list
57049258|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57049259|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049260|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57049261|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049262|NCT04856878|Vancomycin|vancomycin|mesh-list
57049263|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57049264|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049265|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
57049266|NCT04856644|Rifapentine|rifapentine|mesh-list
57049267|NCT04856644|Rifampin|rifampin|mesh-list
57049268|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57049269|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049270|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57049271|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57049272|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049273|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049274|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049275|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57049276|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
57049277|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
57049278|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57049279|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57049280|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57049281|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57049282|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56731226|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
57049283|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57049284|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57049285|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
57049286|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
57049287|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049288|NCT04984278|Nabiximols|nabiximols|mesh-list
57049289|NCT04984278|Analgesics|analgesics|mesh-ancestor
57049290|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
57049291|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049292|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049293|NCT02233218|Amlodipine|amlodipine|mesh-list
57049294|NCT02233218|Telmisartan|telmisartan|mesh-list
57049295|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57049296|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57049297|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57049298|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57049299|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049300|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57049301|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049302|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
57049303|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57049304|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57049305|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
57049306|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57049307|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57049308|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049309|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57049310|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57049311|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
57049312|NCT02262546|Pramipexole|pramipexole|mesh-list
57049313|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57049314|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57049315|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049316|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57049317|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57049318|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049319|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049320|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049321|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57049322|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
57049323|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57049324|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049325|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57049326|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57049327|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57049328|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
57049329|NCT02262546|Protective Agents|protective agents|mesh-ancestor
57049330|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57049331|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57049332|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
57049333|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
57049334|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049335|NCT04859530|Lugol's solution|lugol's solution|mesh-list
57049336|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
57049337|NCT04859530|Coagulants|coagulants|mesh-ancestor
57049338|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
57049339|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57049340|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57049341|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049342|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
56626842|NCT04222842|Vorolanib|vorolanib|mesh-list
57049343|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049344|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049345|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
57049346|NCT04856098|Bromides|bromides|mesh-list
57049347|NCT04856098|Maleic acid|maleic acid|mesh-list
57049348|NCT04856098|Charcoal|charcoal|mesh-list
57049349|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
57049350|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049351|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049352|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57049353|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57049354|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57049355|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
57049356|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049357|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049359|NCT04856098|Protective Agents|protective agents|mesh-ancestor
57049360|NCT04859452|Metformin|metformin|mesh-list
57049361|NCT04859452|Glyburide|glyburide|mesh-list
57049362|NCT04859452|Valsartan|valsartan|mesh-list
57049363|NCT04859452|Simvastatin|simvastatin|mesh-list
57049364|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57049365|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049366|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57049367|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57049368|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
57049369|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049370|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57049371|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57049372|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049373|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57049374|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57049375|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57049376|NCT02262624|Telmisartan|telmisartan|mesh-list
57049377|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57049378|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57049379|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57049380|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57049381|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049382|NCT02262624|Diuretics|diuretics|mesh-ancestor
57049383|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
57049384|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049385|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57049386|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57049387|NCT02233452|Ketamine|ketamine|mesh-list
57049388|NCT02233452|Methadone|methadone|mesh-list
57049389|NCT02233452|Analgesics|analgesics|mesh-ancestor
57049390|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
57049391|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049392|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049393|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57049394|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57049395|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
57049396|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
57049397|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049398|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57049399|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57049400|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049401|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049402|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57049403|NCT02233452|Narcotics|narcotics|mesh-ancestor
57049404|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
57049405|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
57049406|NCT02262702|Acetaminophen|acetaminophen|mesh-list
57049407|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57049408|NCT02262702|Analgesics|analgesics|mesh-ancestor
57049409|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
57049410|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049411|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049412|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
57049413|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57049414|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57049415|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049416|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
57049417|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
57049418|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
57049419|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049420|NCT04648020|Clonidine|clonidine|mesh-list
57049421|NCT04648020|Analgesics|analgesics|mesh-ancestor
57049422|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
57049423|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049424|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049425|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57049426|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
57049427|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
57049428|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57049429|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57049430|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57049431|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
57049432|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049433|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049435|NCT04845880|Paraproteins|paraproteins|mesh-list
57049436|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
57049437|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049438|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57049439|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57049440|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049441|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57049442|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049443|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049444|NCT03041506|Lidocaine|lidocaine|mesh-list
57049445|NCT03041506|Midazolam|midazolam|mesh-list
57049446|NCT03041506|Ketamine|ketamine|mesh-list
57049447|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
57049448|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
57049449|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049450|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049451|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
57049452|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049453|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57049454|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57049455|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57049456|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57049457|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049458|NCT03041506|Analgesics|analgesics|mesh-ancestor
57049459|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57049460|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57049461|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
57049462|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57049463|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57049464|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049465|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57049466|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57049467|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57049468|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57049469|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57049470|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
57049471|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
57049472|NCT02580708|Trametinib|trametinib|mesh-list
57049473|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049474|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57049475|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049476|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049477|NCT02262780|Telmisartan|telmisartan|mesh-list
57049478|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57049479|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57049480|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57049481|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049482|NCT04845646|Itraconazole|itraconazole|mesh-list
57049483|NCT04845646|Phenytoin|phenytoin|mesh-list
57049484|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
57049485|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049486|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57049487|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57049488|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049489|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049490|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57049491|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
57049492|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57049493|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049494|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57049495|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
57049496|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57049497|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57049498|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57049499|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57049500|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57049501|NCT02570490|Linezolid|linezolid|mesh-list
57049502|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
57049503|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57049504|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049505|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57049506|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049507|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049508|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
57049509|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57049510|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57049511|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57049512|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57049513|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049514|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
57049515|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049516|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049517|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57049518|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049519|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
57049520|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57049521|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049522|NCT02262858|Telmisartan|telmisartan|mesh-list
57049523|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57049524|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57049525|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57049526|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57049527|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049528|NCT02262858|Diuretics|diuretics|mesh-ancestor
57049529|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
57049530|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049531|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57049532|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57049533|NCT02235012|Ketamine|ketamine|mesh-list
57049534|NCT02235012|Analgesics|analgesics|mesh-ancestor
57049535|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
57049536|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049537|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049538|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57049539|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57049540|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
57049541|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
57049542|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049543|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57049544|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57049545|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049546|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049547|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57049548|NCT02262936|Fesoterodine|fesoterodine|mesh-list
57049549|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57049550|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57049551|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
57049552|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049553|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049554|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049555|NCT02262936|Urological Agents|urological agents|mesh-ancestor
57049556|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
57049557|NCT02262936|Coagulants|coagulants|mesh-ancestor
57049558|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57049559|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
57049560|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
57049561|NCT04838704|Methotrexate|methotrexate|mesh-list
57049562|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57049563|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
57049564|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57049565|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049566|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57049567|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
57049568|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049569|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049570|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
57049571|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049572|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57049573|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57049574|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
57049575|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57049576|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57049577|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57049578|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57049579|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
57049580|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57049581|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049583|NCT05411094|Olaparib|olaparib|mesh-list
57049584|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57049585|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
57049586|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57049587|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
57049588|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57049589|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049590|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
57049591|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049592|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049593|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049594|NCT02259738|Kallikreins|kallikreins|mesh-list
57049595|NCT02259738|Coagulants|coagulants|mesh-ancestor
57049596|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
57049597|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
57049598|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57049599|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049600|NCT04854460|Ivermectin|ivermectin|mesh-list
57049601|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57049602|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049603|NCT04854538|Budesonide|budesonide|mesh-list
57049604|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57049605|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57049606|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
57049607|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049608|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049609|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57049610|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
57049611|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
57049612|NCT04854538|Hormones|hormones|mesh-ancestor
57049613|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57049614|NCT05331690|Dexamethasone|dexamethasone|mesh-list
57049615|NCT05331690|Nepafenac|nepafenac|mesh-list
57049616|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57049617|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
57049618|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
57049619|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049620|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049621|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049622|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
57049623|NCT05331690|Hormones|hormones|mesh-ancestor
57049624|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57049625|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57049626|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049627|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57049628|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57049629|NCT05331690|Analgesics|analgesics|mesh-ancestor
57049630|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
57049631|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57049632|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
57049633|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049634|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049635|NCT02263170|Phenobarbital|phenobarbital|mesh-list
57049636|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
57049637|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57049638|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049639|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049640|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57049641|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57049642|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049643|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049644|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
57049645|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
57049646|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57049647|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57049648|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57049649|NCT05252988|Loperamide|loperamide|mesh-list
57049650|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
57049651|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
57049652|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049653|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57049654|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57049655|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
57049656|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049657|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57049658|NCT03038230|Antibodies|antibodies|mesh-list
57049659|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57049660|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
57049661|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049662|NCT04853758|Valsartan|valsartan|mesh-list
57049663|NCT04853758|Enalapril|enalapril|mesh-list
57049664|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57049665|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57049666|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
57049667|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57049668|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57049669|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57049670|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049671|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
57049672|NCT02784288|Paclitaxel|paclitaxel|mesh-list
57049673|NCT02784288|Carboplatin|carboplatin|mesh-list
57049674|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57049675|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049676|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
57049677|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
57049678|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
57049679|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049680|NCT03040180|Bleomycin|bleomycin|mesh-list
57049681|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57049682|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049683|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
57049684|NCT02235246|Analgesics|analgesics|mesh-ancestor
57049685|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
57049686|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049687|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049688|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
57049689|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049690|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57049691|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
57049692|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57049693|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57049694|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049695|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57049696|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
57049697|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57049698|NCT02235324|Leucovorin|leucovorin|mesh-list
57049699|NCT02235324|Fluorouracil|fluorouracil|mesh-list
57049700|NCT02235324|Aflibercept|aflibercept|mesh-list
57049701|NCT02235324|Calcium|calcium|mesh-list
57049702|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
57049703|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
57049704|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57049705|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049706|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
57049707|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049708|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57049709|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049710|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57049711|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
57049712|NCT02235324|Antidotes|antidotes|mesh-ancestor
57049713|NCT02235324|Protective Agents|protective agents|mesh-ancestor
57049714|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
57049715|NCT02235324|Vitamins|vitamins|mesh-ancestor
57049716|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
57049717|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57049718|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57049719|NCT02235324|Growth Substances|growth substances|mesh-ancestor
57049720|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
57049721|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
57049722|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57049723|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
57049724|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57049725|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049726|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57049727|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57049728|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57049729|NCT02263248|Buprenorphine|buprenorphine|mesh-list
57049730|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57049731|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57049732|NCT02263248|Narcotics|narcotics|mesh-ancestor
57049733|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049734|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049735|NCT02263248|Analgesics|analgesics|mesh-ancestor
57049736|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
57049737|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049738|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57049739|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57049740|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57049741|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57049742|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049743|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049744|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57049745|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
57049746|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57049747|NCT04838860|Siltuximab|siltuximab|mesh-list
57049748|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049749|NCT05389514|Gemcitabine|gemcitabine|mesh-list
57049750|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
57049751|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
57049752|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57049753|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
57049754|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049755|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57049756|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57049757|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
57049758|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049759|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049760|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57049761|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57049762|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
57049763|NCT05389514|Antiviral Agents|antiviral agents|mesh-ancestor
57049764|NCT05389514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049765|NCT05389514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049766|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57049767|NCT04853524|Tenofovir|tenofovir|mesh-list
57049768|NCT04853524|Emtricitabine|emtricitabine|mesh-list
57049769|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
57049770|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
57049771|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049772|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57049773|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57049774|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049775|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049776|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57049777|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57049778|NCT05382806|Flumazenil|flumazenil|mesh-list
57049779|NCT05382806|Antidotes|antidotes|mesh-ancestor
57049780|NCT05382806|Protective Agents|protective agents|mesh-ancestor
57049781|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049782|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
57049783|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
57049784|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049785|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049786|NCT04852510|Metformin|metformin|mesh-list
57049787|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57049788|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049789|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
57049790|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56897694|NCT02823574|Nivolumab|nivolumab|mesh-list
57049791|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049792|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049793|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57049794|NCT05163704|Analgesics|analgesics|mesh-ancestor
57049795|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
57049796|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049797|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57049798|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57049799|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57049800|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
57049801|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731762|NCT00605319|Fesoterodine|fesoterodine|mesh-list
57049802|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049804|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57049805|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049806|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57049807|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049808|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049809|NCT04838080|Vaccines|vaccines|mesh-list
57049810|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
57049811|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049812|NCT04842838|Paclitaxel|paclitaxel|mesh-list
57049813|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57049814|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049815|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
57049816|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
57049817|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
57049818|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049819|NCT03037606|Rabeprazole|rabeprazole|mesh-list
57049820|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57049821|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049822|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57049823|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049824|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049825|NCT03037372|Atorvastatin|atorvastatin|mesh-list
57049826|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57049827|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
57049828|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57049829|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57049830|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
57049831|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049832|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57049833|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049834|NCT04842526|Irinotecan|irinotecan|mesh-list
57049835|NCT04842526|Temozolomide|temozolomide|mesh-list
57049836|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57049837|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57049838|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049839|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049840|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049841|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57049842|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
57049843|NCT04850950|Tenofovir|tenofovir|mesh-list
57049844|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
57049845|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049846|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57049847|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57049848|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049849|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049850|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57049851|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57049852|NCT04841980|Rifaximin|rifaximin|mesh-list
57049853|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57049854|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049855|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049856|NCT05307770|Melatonin|melatonin|mesh-list
57049857|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
57049858|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049859|NCT05307770|Protective Agents|protective agents|mesh-ancestor
57049860|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049861|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049862|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
57049863|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57049864|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049865|NCT04850560|Decitabine|decitabine|mesh-list
57049866|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57049867|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
57049868|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049869|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049870|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049871|NCT04850404|Ropivacaine|ropivacaine|mesh-list
57049872|NCT04850404|Rocuronium|rocuronium|mesh-list
57049873|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
57049874|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
57049875|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049876|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049877|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
57049878|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049879|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57049880|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57049881|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57049882|NCT04428814|Ustekinumab|ustekinumab|mesh-list
57049883|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
57049884|NCT03036514|Sufentanil|sufentanil|mesh-list
57049885|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57049886|NCT03036514|Narcotics|narcotics|mesh-ancestor
57049887|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049888|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049889|NCT03036514|Analgesics|analgesics|mesh-ancestor
57049890|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
57049891|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049892|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57049893|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57049894|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
57049895|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
57049896|NCT04835896|Paclitaxel|paclitaxel|mesh-list
57049897|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57049898|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049899|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
57049900|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
57049901|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
57049902|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049903|NCT01668004|Golimumab|golimumab|mesh-list
57049904|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57049905|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57049906|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57049907|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
57049908|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049909|NCT04364230|Poly ICLC|poly iclc|mesh-list
57049910|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
57049911|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049912|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
57049913|NCT04835350|Pancrelipase|pancrelipase|mesh-list
57049914|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049915|NCT01667926|Ketamine|ketamine|mesh-list
57049916|NCT01667926|Analgesics|analgesics|mesh-ancestor
57049917|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
57049918|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049919|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049920|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57049921|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57049922|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
57049923|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
57049924|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57049925|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57049926|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57049927|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049928|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049929|NCT03039478|Erythritol|erythritol|mesh-list
57049930|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
57049931|NCT04832776|Bevacizumab|bevacizumab|mesh-list
57049932|NCT04832776|Cetuximab|cetuximab|mesh-list
57049933|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57049934|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57049935|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57049936|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57049937|NCT04832776|Growth Substances|growth substances|mesh-ancestor
57049938|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049939|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
57049940|NCT04835116|Acetaminophen|acetaminophen|mesh-list
57049941|NCT04835116|Tramadol|tramadol|mesh-list
57049942|NCT04835116|Analgesics|analgesics|mesh-list
57049943|NCT04835116|Orphenadrine|orphenadrine|mesh-list
57049944|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
57049945|NCT04835116|Bupivacaine|bupivacaine|mesh-list
57049946|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
57049947|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
57049948|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731906|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57049949|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049950|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
57049951|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57049953|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
57049954|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57049955|NCT04835116|Narcotics|narcotics|mesh-ancestor
57049956|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57049957|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57049958|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57049959|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57049960|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
57049961|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
57049962|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57049963|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57049964|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
57049965|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57049966|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049967|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
57049968|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57049969|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049970|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
57049971|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57049972|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57049973|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
57049974|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
57049975|NCT03036826|Meropenem|meropenem|mesh-list
57049976|NCT03036826|Tazobactam|tazobactam|mesh-list
57049977|NCT03036826|Piperacillin|piperacillin|mesh-list
57049978|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57049979|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57049980|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049981|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57049982|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049983|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049984|NCT03036046|Fluconazole|fluconazole|mesh-list
57049985|NCT03036046|Posaconazole|posaconazole|mesh-list
57049986|NCT03036046|Olorofim|olorofim|mesh-list
57049987|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
57049988|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57049989|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57049990|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57049991|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57049992|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57049993|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57049994|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
57049995|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57049996|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57049997|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56897710|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57049998|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57049999|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57050000|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57050001|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57050002|NCT04831528|Bevacizumab|bevacizumab|mesh-list
57050003|NCT04831528|Trastuzumab|trastuzumab|mesh-list
57050004|NCT04831528|Cetuximab|cetuximab|mesh-list
57050005|NCT04831528|Pertuzumab|pertuzumab|mesh-list
57050006|NCT04831528|Lapatinib|lapatinib|mesh-list
57050007|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57050008|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050009|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57050010|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57050011|NCT04831528|Growth Substances|growth substances|mesh-ancestor
57050012|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050013|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
57050014|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57050015|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050016|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050017|NCT04824586|Insulin|insulin|mesh-list
57050018|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57050019|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57050020|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050021|NCT04824898|Simvastatin|simvastatin|mesh-list
57050022|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57050023|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57050024|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
57050025|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050026|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57050027|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57050028|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050029|NCT04824352|Apatinib|apatinib|mesh-list
57050030|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050031|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57050032|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050033|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050034|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
57050035|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57050036|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57050037|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050038|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
57050039|NCT04319614|Coagulants|coagulants|mesh-ancestor
57050040|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
57050041|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57050042|NCT04823260|Niacinamide|niacinamide|mesh-list
57050043|NCT04823260|Niacin|niacin|mesh-list
57050044|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
57050045|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
57050046|NCT04823260|Vitamins|vitamins|mesh-ancestor
57050047|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
57050048|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050049|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57050050|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
57050051|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050052|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57050053|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
57050054|NCT04816240|Midodrine|midodrine|mesh-list
57050055|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
57050056|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
57050057|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050058|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050059|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57050060|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57050061|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57050062|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57050063|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
57050064|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050065|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050066|NCT04303780|Docetaxel|docetaxel|mesh-list
57050067|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050068|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050069|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050070|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050071|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050072|NCT04822012|Antibodies|antibodies|mesh-list
57050073|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
57050074|NCT04822012|Progesterone|progesterone|mesh-list
57050075|NCT04822012|Estrogens|estrogens|mesh-list
57050076|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
57050077|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050078|NCT04822012|Progestins|progestins|mesh-ancestor
57050079|NCT04822012|Hormones|hormones|mesh-ancestor
57050080|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57050081|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
57050082|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050083|NCT05399732|Cyclosporine|cyclosporine|mesh-list
57050084|NCT05399732|Luspatercept|luspatercept|mesh-list
57050085|NCT05399732|Cyclosporins|cyclosporins|mesh-list
57050086|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050087|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050088|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57050089|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
57050090|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050091|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
57050092|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050093|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
57050094|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57050095|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57050096|NCT05399732|Hematinics|hematinics|mesh-ancestor
57050097|NCT05399576|Nicorandil|nicorandil|mesh-list
57050098|NCT05399576|Verapamil|verapamil|mesh-list
57050099|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57050100|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57050101|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050102|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050103|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57050104|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050105|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
57050106|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57050107|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
57050108|NCT05399576|Vitamins|vitamins|mesh-ancestor
57050109|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
57050110|NCT05255900|Metyrapone|metyrapone|mesh-list
57050111|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
57050112|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050113|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050114|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57050115|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57050116|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050117|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
57050118|NCT05397938|Alendronate|alendronate|mesh-list
57050119|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57050120|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050121|NCT05133674|Tamoxifen|tamoxifen|mesh-list
57050122|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57050123|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
57050124|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57050125|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050126|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57050127|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050128|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57050129|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57050130|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57050131|NCT02522936|Muramidase|muramidase|mesh-list
57050132|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050133|NCT04525898|Methadone|methadone|mesh-list
57050134|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57050135|NCT04525898|Narcotics|narcotics|mesh-ancestor
57050136|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050137|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050138|NCT04525898|Analgesics|analgesics|mesh-ancestor
57050139|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
57050140|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050141|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
57050142|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
57050143|NCT04282070|Gemcitabine|gemcitabine|mesh-list
57050144|NCT04282070|Paclitaxel|paclitaxel|mesh-list
57050145|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57050146|NCT04282070|Cisplatin|cisplatin|mesh-list
57050147|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57050148|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050149|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050150|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050151|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050152|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050153|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57050154|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
57050155|NCT04282070|Antiviral Agents|antiviral agents|mesh-ancestor
57050156|NCT04282070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050157|NCT04282070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050158|NCT04282070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57050159|NCT04282070|Immunologic Factors|immunologic factors|mesh-ancestor
57050160|NCT04282070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050161|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
57050162|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57050163|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57050164|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050165|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
57050166|NCT04347122|Coagulants|coagulants|mesh-ancestor
57050167|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
57050168|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57050169|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
57050170|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050171|NCT03467438|Polaprezinc|polaprezinc|mesh-list
57050172|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57050173|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57050174|NCT05397236|Dexamethasone|dexamethasone|mesh-list
57050175|NCT05397236|Bupivacaine|bupivacaine|mesh-list
57050176|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57050177|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
57050178|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
57050179|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050180|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050181|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57050182|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
57050183|NCT05397236|Hormones|hormones|mesh-ancestor
57050184|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57050185|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57050186|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050187|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
57050188|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
57050189|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050190|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
57050191|NCT05439278|Temozolomide|temozolomide|mesh-list
57050192|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57050193|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
57050194|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050195|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050196|NCT03130010|Nefopam|nefopam|mesh-list
57050197|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57050198|NCT03130010|Analgesics|analgesics|mesh-ancestor
57050199|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
57050200|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050201|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050202|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
57050203|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57050204|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
57050205|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
57050206|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050207|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050208|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57050209|NCT05396144|Analgesics|analgesics|mesh-ancestor
57050210|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
57050211|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050212|NCT04201964|Tenecteplase|tenecteplase|mesh-list
57050213|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57050214|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57050215|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050216|NCT00157248|Dabigatran|dabigatran|mesh-list
57050217|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
57050218|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57050219|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
57050220|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050221|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050222|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
57050223|NCT02504580|Bupivacaine|bupivacaine|mesh-list
57050224|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
57050225|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
57050226|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050227|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050228|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
57050229|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050230|NCT02235402|Lacidipine|lacidipine|mesh-list
57050231|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
57050232|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57050233|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57050234|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050235|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050236|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57050237|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050238|NCT02235402|Diuretics|diuretics|mesh-ancestor
57050239|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
57050240|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57050241|NCT02235480|Tazarotene|tazarotene|mesh-list
57050242|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
57050243|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
57050244|NCT02235558|Verapamil|verapamil|mesh-list
57050245|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57050246|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57050247|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050248|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050249|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57050250|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050251|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
57050252|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
57050253|NCT04214418|Atezolizumab|atezolizumab|mesh-list
57050254|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050255|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
57050256|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57050257|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57050258|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050259|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050260|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050261|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57050262|NCT02233920|Oxitropium|oxitropium|mesh-list
57050263|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
57050264|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
57050265|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050266|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050267|NCT02235948|Folic Acid|folic acid|mesh-list
57050268|NCT02235948|Hematinics|hematinics|mesh-ancestor
57050269|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
57050270|NCT02235948|Vitamins|vitamins|mesh-ancestor
57050271|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
57050272|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050273|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
57050274|NCT02236026|ST 1435|st 1435|mesh-list
57050275|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57050276|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050277|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57050278|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57050279|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050280|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050281|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050282|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57050283|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
57050284|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57050285|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050286|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57050287|NCT02236182|Bromides|bromides|mesh-list
57050288|NCT02236182|Ipratropium|ipratropium|mesh-list
57050289|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
57050290|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57050291|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
57050292|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050293|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050294|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57050295|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
57050296|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57050297|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
57050298|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050299|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050300|NCT03466736|Flutemetamol|flutemetamol|mesh-list
57050301|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57050302|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050303|NCT04453280|Antibodies|antibodies|mesh-list
57050304|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
57050305|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050306|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
57050307|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57050308|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050309|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57050310|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57050311|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050312|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050313|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
57050314|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050315|NCT03466502|Vancomycin|vancomycin|mesh-list
57050316|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57050317|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050318|NCT05392634|Amoxicillin|amoxicillin|mesh-list
57050319|NCT05392634|Meropenem|meropenem|mesh-list
57050320|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
57050321|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
57050322|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57050323|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57050324|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050325|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050326|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050327|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57050328|NCT01593228|Gemcitabine|gemcitabine|mesh-list
57050329|NCT01593228|Paclitaxel|paclitaxel|mesh-list
57050330|NCT01593228|Carboplatin|carboplatin|mesh-list
57050331|NCT01593228|Doxorubicin|doxorubicin|mesh-list
57050332|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57050333|NCT01593228|Irinotecan|irinotecan|mesh-list
57050334|NCT01593228|Topotecan|topotecan|mesh-list
57050335|NCT01593228|Iniparib|iniparib|mesh-list
57050336|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57050337|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050338|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050339|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050340|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050341|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050342|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57050343|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
57050344|NCT01593228|Antiviral Agents|antiviral agents|mesh-ancestor
57050345|NCT01593228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050346|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050347|NCT01593228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57050348|NCT01593228|Immunologic Factors|immunologic factors|mesh-ancestor
57050349|NCT01593228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050350|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57050351|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57050352|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57050353|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57050354|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57050355|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57050356|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57050357|NCT03844620|Trifluridine|trifluridine|mesh-list
57050358|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
57050359|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050360|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
57050361|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050362|NCT02236260|Lidocaine|lidocaine|mesh-list
57050363|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
57050364|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
57050365|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627863|NCT00608881|Ubiquinone|ubiquinone|mesh-list
57050366|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050367|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
57050368|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050369|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57050370|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57050371|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57050372|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050373|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050374|NCT04502706|Rituximab|rituximab|mesh-list
57050375|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57050376|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050377|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
57050378|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050379|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57050380|NCT01555554|Propranolol|propranolol|mesh-list
57050381|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57050382|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57050383|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
57050384|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050385|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050386|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050387|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57050388|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57050389|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
57050390|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
57050391|NCT01435044|Ribavirin|ribavirin|mesh-list
57050392|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
57050393|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050394|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
57050395|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050396|NCT01434498|Ribavirin|ribavirin|mesh-list
57050397|NCT01434498|Ledipasvir|ledipasvir|mesh-list
57050398|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
57050399|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050400|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
57050401|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050402|NCT03735966|Carboplatin|carboplatin|mesh-list
57050403|NCT03735966|Docetaxel|docetaxel|mesh-list
57050404|NCT03735966|Trastuzumab|trastuzumab|mesh-list
57050405|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050406|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050407|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050408|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050409|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050410|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57050411|NCT03679650|Decitabine|decitabine|mesh-list
57050412|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57050413|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
57050414|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050415|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050416|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050417|NCT01554696|Methotrexate|methotrexate|mesh-list
57050418|NCT01554696|Peficitinib|peficitinib|mesh-list
57050419|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57050420|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
57050421|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57050422|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050423|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57050424|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
57050425|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050426|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050427|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
57050428|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050429|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57050430|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57050431|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
57050432|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57050433|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57050434|NCT02265276|Pioglitazone|pioglitazone|mesh-list
57050435|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57050436|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050437|NCT02263872|Minocycline|minocycline|mesh-list
57050438|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57050439|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050440|NCT02261376|DS-1971a|ds-1971a|mesh-list
57050441|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57050442|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57050443|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050444|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050445|NCT01535508|Vitamin D|vitamin d|mesh-list
57050446|NCT01535508|Vitamins|vitamins|mesh-ancestor
57050447|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
57050448|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050449|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57050450|NCT02626338|Cytarabine|cytarabine|mesh-list
57050451|NCT02626338|Fludarabine|fludarabine|mesh-list
57050452|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
57050453|NCT02626338|Etoposide|etoposide|mesh-list
57050454|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
57050455|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
57050456|NCT02626338|Idarubicin|idarubicin|mesh-list
57050457|NCT02626338|Crenolanib|crenolanib|mesh-list
57050458|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050459|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57050460|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
57050461|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050462|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57050463|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
57050464|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050465|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
57050466|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050467|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57050468|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57050469|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57050470|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050471|NCT02626338|Analgesics|analgesics|mesh-ancestor
57050472|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
57050473|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050474|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57050475|NCT01416402|Colchicine|colchicine|mesh-list
57050476|NCT01416402|Febuxostat|febuxostat|mesh-list
57050477|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
57050478|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57050479|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050480|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050481|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050482|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050483|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050484|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57050485|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57050486|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050487|NCT01414920|Incretins|incretins|mesh-ancestor
57050488|NCT01414920|Hormones|hormones|mesh-ancestor
57050489|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57050490|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57050491|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
57050492|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050493|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050494|NCT02263950|Artemether|artemether|mesh-list
57050495|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
57050496|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57050497|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57050498|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050499|NCT02261844|Resveratrol|resveratrol|mesh-list
57050500|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
57050501|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050502|NCT02261844|Protective Agents|protective agents|mesh-ancestor
57050503|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050504|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050505|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57050506|NCT02261922|Ticagrelor|ticagrelor|mesh-list
57050507|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57050508|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57050509|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57050510|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57050511|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57050512|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
57050513|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050514|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050515|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050516|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57050517|NCT02264106|Pantoprazole|pantoprazole|mesh-list
57050518|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57050519|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57050520|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57050521|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050522|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050523|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
57050524|NCT02262156|Serotonin|serotonin|mesh-list
57050525|NCT02262156|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
57050526|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57050527|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57050528|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
57050529|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050530|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050531|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050532|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57050533|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050534|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
57050535|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57050536|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050537|NCT02056782|Heparin|heparin|mesh-list
57050538|NCT02056782|Anticoagulants|anticoagulants|mesh-ancestor
57050539|NCT02056782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57050540|NCT02056782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57050541|NCT02056782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050542|NCT01516476|Liraglutide|liraglutide|mesh-list
57050543|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57050544|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050545|NCT01516476|Incretins|incretins|mesh-ancestor
57050546|NCT01516476|Hormones|hormones|mesh-ancestor
57050547|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57050548|NCT01516086|Fluticasone|fluticasone|mesh-list
57050549|NCT01516086|Xhance|xhance|mesh-list
57050550|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57050551|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57050552|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
57050553|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050554|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050555|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57050556|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
57050557|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
57050558|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57050559|NCT01497834|Asunaprevir|asunaprevir|mesh-list
57050560|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
57050561|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050562|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050563|NCT02265822|Midazolam|midazolam|mesh-list
57050564|NCT02265822|Melatonin|melatonin|mesh-list
57050565|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57050566|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57050567|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050568|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050569|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57050570|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57050571|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57050572|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57050573|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
57050574|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
57050575|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
57050576|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
57050577|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050578|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050579|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
57050580|NCT02265822|Protective Agents|protective agents|mesh-ancestor
57050581|NCT02607930|Lamivudine|lamivudine|mesh-list
57050582|NCT02607930|Triumeq|triumeq|mesh-list
57050583|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57050584|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57050585|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050586|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050587|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
57050588|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050589|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57050590|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57050591|NCT02264184|Paroxetine|paroxetine|mesh-list
57050592|NCT02264184|Tamsulosin|tamsulosin|mesh-list
57050593|NCT02264184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57050594|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57050595|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050596|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050597|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050598|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
57050599|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050600|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57050601|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
57050602|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57050603|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57050604|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57050605|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050606|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57050607|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57050608|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57050609|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
57050610|NCT02264184|Urological Agents|urological agents|mesh-ancestor
57050611|NCT01260870|Paclitaxel|paclitaxel|mesh-list
57050612|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57050613|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050614|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050615|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050616|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050617|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050618|NCT02266056|Rocuronium|rocuronium|mesh-list
57050619|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57050620|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57050621|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57050622|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050623|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050624|NCT01482390|Ribavirin|ribavirin|mesh-list
57050625|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57050626|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
57050627|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050628|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
57050629|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050630|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
57050631|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57050632|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
56732592|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
57050633|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050634|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050635|NCT01366014|Oxycodone|oxycodone|mesh-list
57050636|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57050637|NCT01366014|Narcotics|narcotics|mesh-ancestor
57050638|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050639|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050640|NCT01366014|Analgesics|analgesics|mesh-ancestor
57050641|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
57050642|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050643|NCT01361802|Ambroxol|ambroxol|mesh-list
57050644|NCT01361802|Expectorants|expectorants|mesh-ancestor
57050645|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
57050646|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
57050647|NCT01235754|Testosterone|testosterone|mesh-list
57050648|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
57050649|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
57050650|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57050651|NCT01235754|Androgens|androgens|mesh-ancestor
57050652|NCT01235754|Hormones|hormones|mesh-ancestor
57050653|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57050654|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050655|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57050656|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050657|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
57050658|NCT01234038|Paclitaxel|paclitaxel|mesh-list
57050659|NCT01234038|Carboplatin|carboplatin|mesh-list
57050660|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57050661|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050662|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050663|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050664|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050665|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050666|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
57050667|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57050668|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
57050669|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050670|NCT01229982|Latanoprost|latanoprost|mesh-list
57050671|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57050672|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57050673|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57050674|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
57050675|NCT01225380|Ribavirin|ribavirin|mesh-list
57050676|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
57050677|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050678|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
57050679|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050680|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
57050681|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050682|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
57050683|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57050684|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
57050685|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050686|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050687|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57050688|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
57050689|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57050690|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57050691|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57050692|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
57050693|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050694|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050695|NCT02266524|Tamsulosin|tamsulosin|mesh-list
57050696|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57050697|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57050698|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57050699|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
57050700|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050701|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050702|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050703|NCT02266524|Urological Agents|urological agents|mesh-ancestor
57050704|NCT01336686|Colchicine|colchicine|mesh-list
57050705|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
57050706|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57050707|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050708|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050709|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050710|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050711|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050712|NCT01455090|Ribavirin|ribavirin|mesh-list
57050713|NCT01455090|Asunaprevir|asunaprevir|mesh-list
57050714|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
57050715|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050716|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
57050717|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050718|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
57050719|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050720|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
57050721|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57050722|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050723|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57050724|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57050725|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050726|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050727|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050728|NCT01194960|Docetaxel|docetaxel|mesh-list
57050729|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050730|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050731|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050732|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050733|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050734|NCT01331850|Ritonavir|ritonavir|mesh-list
57050735|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57050736|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
57050737|NCT01331850|Ribavirin|ribavirin|mesh-list
57050738|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57050739|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57050740|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
57050741|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050742|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050743|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57050744|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57050745|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
57050746|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050747|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57050748|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57050749|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
57050750|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050751|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
57050752|NCT02101034|Cetuximab|cetuximab|mesh-list
57050753|NCT02101034|Palbociclib|palbociclib|mesh-list
57050754|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57050755|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050756|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57050757|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050758|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050759|NCT01328808|Acetaminophen|acetaminophen|mesh-list
57050760|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57050761|NCT01328808|Analgesics|analgesics|mesh-ancestor
57050762|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
57050763|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050764|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050765|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
57050766|NCT01968590|Vitamin D|vitamin d|mesh-list
57050767|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
57050768|NCT01968590|Vitamins|vitamins|mesh-ancestor
57050769|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
57050770|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050771|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57050772|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57050773|NCT05626998|Dexmedetomidine|dexmedetomidine|mesh-list
57050774|NCT05626998|Gabapentin|gabapentin|mesh-list
57050775|NCT05626998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57050776|NCT05626998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050777|NCT05626998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050778|NCT05626998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57050779|NCT05626998|Analgesics|analgesics|mesh-ancestor
57050780|NCT05626998|Sensory System Agents|sensory system agents|mesh-ancestor
56732745|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050781|NCT05626998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050782|NCT05626998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57050783|NCT05626998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57050784|NCT05626998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57050785|NCT05626998|Adrenergic Agents|adrenergic agents|mesh-ancestor
57050786|NCT05626998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57050787|NCT05626998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050788|NCT05626998|Anticonvulsants|anticonvulsants|mesh-ancestor
57050789|NCT05626998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57050790|NCT05626998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57050791|NCT05626998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57050792|NCT05626998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57050793|NCT05626998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57050794|NCT05626998|Antimanic Agents|antimanic agents|mesh-ancestor
57050795|NCT01314222|Pregabalin|pregabalin|mesh-list
57050796|NCT01314222|Analgesics|analgesics|mesh-ancestor
57050797|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
57050798|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050799|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050800|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
57050801|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57050802|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050803|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050804|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57050805|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57050806|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57050807|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050808|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57050809|NCT05222828|Mepivacaine|mepivacaine|mesh-list
57050810|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
57050811|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
57050812|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050813|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050814|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
57050815|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050816|NCT01309932|Interferons|interferons|mesh-list
57050817|NCT01309932|Ribavirin|ribavirin|mesh-list
57050818|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
57050819|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
57050820|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57050821|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
57050822|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
57050823|NCT01309932|Asunaprevir|asunaprevir|mesh-list
57050824|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050825|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
57050826|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050827|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
57050828|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050829|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
57050830|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050831|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050832|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57050833|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57050834|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57050835|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57050836|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57050837|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050838|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57050839|NCT01101594|Doxorubicin|doxorubicin|mesh-list
57050840|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57050841|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050842|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57050843|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57050844|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050845|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050846|NCT02269176|Losartan|losartan|mesh-list
57050847|NCT02269176|Telmisartan|telmisartan|mesh-list
57050848|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57050849|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57050850|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57050851|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57050852|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050853|NCT01094262|Oxycodone|oxycodone|mesh-list
57050854|NCT01094262|Analgesics|analgesics|mesh-list
57050855|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57050856|NCT01094262|Narcotics|narcotics|mesh-ancestor
57050857|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050858|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050859|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
57050860|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050861|NCT05626920|Disulfiram|disulfiram|mesh-list
57050862|NCT05626920|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57050863|NCT05626920|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
57050864|NCT05626920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050865|NCT05626920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050866|NCT04476186|Acyclovir|acyclovir|mesh-list
57050867|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
57050868|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050869|NCT03440216|Meropenem|meropenem|mesh-list
57050870|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
57050871|NCT03440216|Temocillin|temocillin|mesh-list
57050872|NCT03440216|Penicillins|penicillins|mesh-list
57050873|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57050874|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050875|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
57050876|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57050877|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
57050878|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57050879|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050880|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57050881|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57050882|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57050883|NCT03428126|Durvalumab|durvalumab|mesh-list
57050884|NCT03428126|Trametinib|trametinib|mesh-list
57050885|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57050886|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050887|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57050888|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050889|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050890|NCT05370716|Pregabalin|pregabalin|mesh-list
57050891|NCT05370716|Analgesics|analgesics|mesh-ancestor
57050892|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
57050893|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050894|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050895|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
57050896|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57050897|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57050898|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050899|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57050900|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57050901|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57050902|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050903|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57050904|NCT01038804|Docetaxel|docetaxel|mesh-list
57050905|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050906|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050907|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050908|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050909|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050910|NCT05118776|Bevacizumab|bevacizumab|mesh-list
57050911|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57050912|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050913|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57050914|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57050915|NCT05118776|Growth Substances|growth substances|mesh-ancestor
57050916|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050917|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
57050918|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
57050919|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57050920|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050921|NCT02269644|Azithromycin|azithromycin|mesh-list
57050922|NCT02269644|Linezolid|linezolid|mesh-list
57050923|NCT02269644|Dalbavancin|dalbavancin|mesh-list
57050924|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57050925|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050926|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57050927|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050928|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050929|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
57050930|NCT03367988|Anesthetics|anesthetics|mesh-list
57050931|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57050932|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050933|NCT03367988|Narcotics|narcotics|mesh-ancestor
57050934|NCT03367988|Analgesics|analgesics|mesh-ancestor
57050935|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
57050936|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050938|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
57050939|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57050940|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050941|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
57050942|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57050943|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57050944|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
57050945|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
57050946|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
57050947|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050948|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050949|NCT02267304|Morphine|morphine|mesh-list
57050950|NCT02267304|Naloxone|naloxone|mesh-list
57050951|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57050952|NCT02267304|Narcotics|narcotics|mesh-ancestor
57050953|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897732|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57050954|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050955|NCT02267304|Analgesics|analgesics|mesh-ancestor
57050956|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
57050957|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57050958|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57050959|NCT03465410|Tacrolimus|tacrolimus|mesh-list
57050960|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57050961|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
57050962|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050963|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57050964|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050965|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050966|NCT02522234|Lenograstim|lenograstim|mesh-list
57050967|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57050968|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
57050969|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050970|NCT00154284|Cyclosporine|cyclosporine|mesh-list
57050971|NCT00154284|Prednisone|prednisone|mesh-list
57050972|NCT00154284|Everolimus|everolimus|mesh-list
57050973|NCT00154284|Cyclosporins|cyclosporins|mesh-list
57050974|NCT00154284|Basiliximab|basiliximab|mesh-list
57050975|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57050976|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
57050977|NCT00154284|Hormones|hormones|mesh-ancestor
57050978|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57050979|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57050980|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57050981|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050982|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57050983|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050984|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57050985|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
57050986|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
57050987|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050988|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
57050989|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57050990|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57050991|NCT01037166|Entecavir|entecavir|mesh-list
57050992|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
57050993|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57050994|NCT03247712|Nivolumab|nivolumab|mesh-list
57050995|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57050996|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57050997|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57050998|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57050999|NCT04497584|Prednisone|prednisone|mesh-list
57051000|NCT04497584|Afatinib|afatinib|mesh-list
57051001|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57051002|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
57051003|NCT04497584|Hormones|hormones|mesh-ancestor
57051004|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57051005|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051006|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57051007|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051008|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57051009|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051010|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051011|NCT04491032|Anesthetics|anesthetics|mesh-list
57051012|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051013|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051014|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
57051015|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57051016|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051017|NCT04487756|Carboplatin|carboplatin|mesh-list
57051018|NCT04487756|Atezolizumab|atezolizumab|mesh-list
57051019|NCT04487756|Vaccines|vaccines|mesh-list
57051020|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
57051021|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051022|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051023|NCT04481204|Leucovorin|leucovorin|mesh-list
57051024|NCT04481204|Gemcitabine|gemcitabine|mesh-list
57051025|NCT04481204|Paclitaxel|paclitaxel|mesh-list
57051026|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57051027|NCT04481204|Cisplatin|cisplatin|mesh-list
57051028|NCT04481204|Fluorouracil|fluorouracil|mesh-list
57051029|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
57051030|NCT04481204|Irinotecan|irinotecan|mesh-list
57051031|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57051032|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051033|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
57051034|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
57051035|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
57051036|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051037|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051038|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
57051039|NCT04481204|Antiviral Agents|antiviral agents|mesh-ancestor
57051040|NCT04481204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051041|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051042|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051043|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
57051044|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051045|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57051046|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57051047|NCT04481204|Antidotes|antidotes|mesh-ancestor
57051048|NCT04481204|Protective Agents|protective agents|mesh-ancestor
57051049|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
57051050|NCT04481204|Vitamins|vitamins|mesh-ancestor
57051051|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
57051052|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
57051053|NCT01281462|Cephalosporins|cephalosporins|mesh-list
57051054|NCT01281462|Avibactam|avibactam|mesh-list
57051055|NCT01281462|Doripenem|doripenem|mesh-list
57051056|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57051057|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051058|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57051059|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051060|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051061|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
57051062|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051063|NCT01024062|Paclitaxel|paclitaxel|mesh-list
57051064|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57051065|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051066|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
57051067|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
57051068|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
57051069|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051070|NCT04453436|Tenofovir|tenofovir|mesh-list
57051071|NCT04453436|Lamivudine|lamivudine|mesh-list
57051072|NCT04453436|Dolutegravir|dolutegravir|mesh-list
57051073|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
57051074|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051075|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57051076|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57051077|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051078|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051079|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57051080|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57051081|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57051082|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57051083|NCT02267616|Etonogestrel|etonogestrel|mesh-list
57051084|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57051085|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
57051086|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57051087|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051088|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57051089|NCT05232734|Caffeine|caffeine|mesh-list
57051090|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
57051091|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051092|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57051093|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051094|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57051095|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897738|NCT03756129|Analgesics|analgesics|mesh-ancestor
57051096|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57051097|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57051098|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
57051099|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051100|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57051101|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57051102|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051103|NCT01023204|Paclitaxel|paclitaxel|mesh-list
57051104|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57051105|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051106|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
57051107|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
57051108|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
57051109|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051110|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
57051111|NCT04460456|Cemiplimab|cemiplimab|mesh-list
57051112|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57051113|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051114|NCT02268006|Capecitabine|capecitabine|mesh-list
57051115|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051116|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
57051117|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051118|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051119|NCT03462212|Paclitaxel|paclitaxel|mesh-list
57051120|NCT03462212|Bevacizumab|bevacizumab|mesh-list
57051121|NCT03462212|Carboplatin|carboplatin|mesh-list
57051122|NCT03462212|Rucaparib|rucaparib|mesh-list
57051123|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57051124|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051125|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
57051126|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
57051127|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
57051128|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051129|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57051130|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57051131|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57051132|NCT03462212|Growth Substances|growth substances|mesh-ancestor
57051133|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051134|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
57051135|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57051136|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051137|NCT01016808|Morphine|morphine|mesh-list
57051138|NCT01016808|Oxycodone|oxycodone|mesh-list
57051139|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57051140|NCT01016808|Narcotics|narcotics|mesh-ancestor
57051141|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051142|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051143|NCT01016808|Analgesics|analgesics|mesh-ancestor
57051144|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
57051145|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051146|NCT01014078|Azithromycin|azithromycin|mesh-list
57051147|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57051148|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57051149|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57051150|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051151|NCT02522078|Misoprostol|misoprostol|mesh-list
57051152|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57051153|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
57051154|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57051155|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051156|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57051157|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57051158|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
57051159|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
57051160|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57051161|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051162|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57051163|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
57051164|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57051165|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051166|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051167|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051168|NCT03468296|Aflibercept|aflibercept|mesh-list
57051169|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57051170|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57051171|NCT03468296|Growth Substances|growth substances|mesh-ancestor
57051172|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051173|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
57051174|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051175|NCT01130142|Gemcitabine|gemcitabine|mesh-list
57051176|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051177|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
57051178|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051179|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051180|NCT01130142|Antiviral Agents|antiviral agents|mesh-ancestor
57051181|NCT01130142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051182|NCT01130142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051183|NCT01130142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051184|NCT01130142|Immunologic Factors|immunologic factors|mesh-ancestor
57051185|NCT01130142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051186|NCT03464864|Treprostinil|treprostinil|mesh-list
57051187|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57051188|NCT03468140|Eculizumab|eculizumab|mesh-list
57051189|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57051190|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051191|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
57051192|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051193|NCT01009242|Methotrexate|methotrexate|mesh-list
57051194|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57051195|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
57051196|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57051197|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051198|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051199|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
57051200|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051201|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051202|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
57051203|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051204|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57051205|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051206|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
57051207|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57051208|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57051209|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
57051210|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57051211|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051212|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051213|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57051214|NCT03468062|Analgesics|analgesics|mesh-ancestor
57051215|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
57051216|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051217|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57051218|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57051219|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57051220|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
57051221|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051222|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051223|NCT03464552|Celecoxib|celecoxib|mesh-list
57051224|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57051225|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57051226|NCT03464552|Analgesics|analgesics|mesh-ancestor
57051227|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
57051228|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051229|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051230|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57051231|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57051232|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57051233|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57051234|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051235|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051236|NCT05628558|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57051237|NCT05628558|Hemostatics|hemostatics|mesh-ancestor
57051238|NCT05628558|Coagulants|coagulants|mesh-ancestor
56733194|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
57051239|NCT05628558|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57051240|NCT05628558|Natriuretic Agents|natriuretic agents|mesh-ancestor
57051241|NCT05628558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051242|NCT01007292|Rituximab|rituximab|mesh-list
57051243|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57051244|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051245|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
57051246|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051247|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57051248|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57051249|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
57051250|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051251|NCT01005108|Gabapentin|gabapentin|mesh-list
57051252|NCT01005108|Analgesics|analgesics|mesh-ancestor
57051253|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
57051254|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051255|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051256|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
57051257|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57051258|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57051259|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051260|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57051261|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57051262|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57051263|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051264|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051265|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
57051266|NCT00905346|Topiramate|topiramate|mesh-list
57051267|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
57051268|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57051269|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051270|NCT00902928|Enoxaparin|enoxaparin|mesh-list
57051271|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
57051272|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57051273|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57051274|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051275|NCT04777994|Mitogens|mitogens|mesh-list
57051276|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
57051277|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
57051278|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051279|NCT04777994|Growth Substances|growth substances|mesh-ancestor
57051280|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051281|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57051282|NCT04316702|Analgesics|analgesics|mesh-ancestor
57051283|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
57051284|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051285|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051286|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051287|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051288|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57051289|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57051290|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57051291|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051292|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
57051293|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
57051294|NCT01129674|Olanzapine|olanzapine|mesh-list
57051295|NCT01129674|Risperidone|risperidone|mesh-list
57051296|NCT01129674|Aripiprazole|aripiprazole|mesh-list
57051297|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57051298|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57051299|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
57051300|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051301|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051302|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051303|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57051304|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57051305|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051306|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57051307|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57051308|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
57051309|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
57051310|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
57051311|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051312|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57051313|NCT01129674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57051314|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57051315|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051316|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
57051317|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
57051318|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57051319|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57051320|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57051321|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57051322|NCT04750616|Niacinamide|niacinamide|mesh-list
57051323|NCT04750616|Niacin|niacin|mesh-list
57051324|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
57051325|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
57051326|NCT04750616|Vitamins|vitamins|mesh-ancestor
57051327|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
57051328|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051329|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57051330|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
57051331|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051332|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57051333|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
57051334|NCT05045378|Midazolam|midazolam|mesh-list
57051335|NCT05045378|Ketamine|ketamine|mesh-list
57051336|NCT05045378|Analgesics|analgesics|mesh-ancestor
57051337|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
57051338|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051339|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051340|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57051341|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57051342|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
57051343|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
57051344|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051345|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57051346|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57051347|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051348|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051349|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57051350|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57051351|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57051352|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57051353|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57051354|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
57051355|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
57051356|NCT05209152|Azacitidine|azacitidine|mesh-list
57051357|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051358|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
57051359|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051360|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051361|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051362|NCT03460964|Pilocarpine|pilocarpine|mesh-list
57051363|NCT03460964|Miotics|miotics|mesh-ancestor
57051364|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
57051365|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051366|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051367|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57051368|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57051369|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
57051370|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051371|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051372|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
57051373|NCT03460808|Atorvastatin|atorvastatin|mesh-list
57051374|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57051375|NCT03460808|Danazol|danazol|mesh-list
57051376|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57051377|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57051378|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
57051379|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051380|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57051381|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57051382|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051383|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
57051384|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051385|NCT03460808|Expectorants|expectorants|mesh-ancestor
57051386|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
57051387|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57051388|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
56733349|NCT00925977|Insulin|insulin|mesh-list
57051389|NCT03460808|Protective Agents|protective agents|mesh-ancestor
57051390|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051392|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57051393|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
57051394|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57051395|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
57051396|NCT05518110|Trametinib|trametinib|mesh-list
57051397|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
57051398|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57051399|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57051400|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051401|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051402|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051403|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57051404|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051405|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57051406|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57051407|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57051408|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
57051409|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051410|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051411|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57051412|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
57051413|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
57051414|NCT04946630|Hormones|hormones|mesh-ancestor
57051415|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57051416|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
57051417|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57051418|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57051419|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
57051420|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051421|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57051422|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
57051423|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051424|NCT04328844|Pemetrexed|pemetrexed|mesh-list
57051425|NCT04328844|Avelumab|avelumab|mesh-list
57051426|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051427|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051428|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051429|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57051430|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57051431|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57051432|NCT05627778|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57051433|NCT05627778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57051434|NCT05627778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051435|NCT01120470|Prednisone|prednisone|mesh-list
57051436|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57051437|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
57051438|NCT01120470|Hormones|hormones|mesh-ancestor
57051439|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57051440|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051441|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57051442|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051443|NCT01117584|Metformin|metformin|mesh-list
57051444|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
57051445|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57051446|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051447|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57051448|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051449|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
57051450|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57051451|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051452|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57051453|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051454|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051455|NCT00991068|Lidocaine|lidocaine|mesh-list
57051456|NCT00991068|Tetracaine|tetracaine|mesh-list
57051457|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
57051458|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
57051459|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051460|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051461|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
56733421|NCT00784446|Bevacizumab|bevacizumab|mesh-list
57051462|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051463|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57051464|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57051465|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57051466|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051467|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051468|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57051469|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57051470|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57051471|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051472|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051473|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051474|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051475|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57051476|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
57051477|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57051478|NCT01114308|Buprenorphine|buprenorphine|mesh-list
57051479|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57051480|NCT01114308|Narcotics|narcotics|mesh-ancestor
57051481|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051482|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051483|NCT01114308|Analgesics|analgesics|mesh-ancestor
57051484|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
57051485|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051486|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57051487|NCT05469126|Clarithromycin|clarithromycin|mesh-list
57051488|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57051489|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051490|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57051491|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051492|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051493|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57051494|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57051495|NCT00887250|Losartan|losartan|mesh-list
57051496|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57051497|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57051498|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57051499|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57051500|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051501|NCT00990912|Carboplatin|carboplatin|mesh-list
57051502|NCT00990912|Irinotecan|irinotecan|mesh-list
57051503|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051504|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57051505|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57051506|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051507|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051508|NCT00973284|Mannitol|mannitol|mesh-list
57051509|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57051510|NCT00973284|Diuretics|diuretics|mesh-ancestor
57051511|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
57051512|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051513|NCT02599402|Nivolumab|nivolumab|mesh-list
57051514|NCT02599402|Ipilimumab|ipilimumab|mesh-list
57051515|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57051516|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051517|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57051518|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051519|NCT04768166|Miglustat|miglustat|mesh-list
57051520|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051521|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051522|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57051523|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57051524|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
57051525|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051526|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57051527|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57051528|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051529|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
57051530|NCT04822090|Antibodies|antibodies|mesh-list
57051531|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
57051532|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57051533|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57051534|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
57051535|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051536|NCT03463382|Bupivacaine|bupivacaine|mesh-list
57051537|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
57051538|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
57051539|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051540|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051541|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
57051542|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051544|NCT05618236|Neostigmine|neostigmine|mesh-list
57051545|NCT05618236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57051546|NCT05618236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57051547|NCT05618236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57051548|NCT05618236|Autonomic Agents|autonomic agents|mesh-ancestor
57051549|NCT05618236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051550|NCT05618236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051551|NCT05618236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57051552|NCT05618236|Respiratory System Agents|respiratory system agents|mesh-ancestor
57051553|NCT05618236|Mydriatics|mydriatics|mesh-ancestor
57051554|NCT05618236|Parasympatholytics|parasympatholytics|mesh-ancestor
57051555|NCT05618236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57051556|NCT05618236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57051557|NCT05618236|Cholinergic Agents|cholinergic agents|mesh-ancestor
57051558|NCT05618236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051559|NCT05618236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051560|NCT05618236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57051561|NCT05618236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051562|NCT05618236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57051563|NCT00872430|Laxatives|laxatives|mesh-list
57051564|NCT00872430|Cathartics|cathartics|mesh-list
57051565|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57051566|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
57051567|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57051568|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
57051569|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051570|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051571|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57051572|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
57051573|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
57051574|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57051575|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
57051576|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051577|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051578|NCT04814056|Afatinib|afatinib|mesh-list
57051579|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051580|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57051581|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051582|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051583|NCT05627154|Citalopram|citalopram|mesh-list
57051584|NCT05627154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57051585|NCT05627154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57051586|NCT05627154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051587|NCT05627154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051588|NCT05627154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051589|NCT05627154|Serotonin Agents|serotonin agents|mesh-ancestor
57051590|NCT05627154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051591|NCT05627154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57051592|NCT05627154|Antidepressive Agents|antidepressive agents|mesh-ancestor
57051593|NCT05627154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57051594|NCT03974854|Gemcitabine|gemcitabine|mesh-list
57051595|NCT03974854|Capecitabine|capecitabine|mesh-list
57051596|NCT03974854|Irinotecan|irinotecan|mesh-list
57051597|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051598|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
57051599|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051600|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051601|NCT03974854|Antiviral Agents|antiviral agents|mesh-ancestor
57051602|NCT03974854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051603|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051604|NCT03974854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051605|NCT03974854|Immunologic Factors|immunologic factors|mesh-ancestor
57051606|NCT03974854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051607|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57051608|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57051609|NCT00957918|Nicotine|nicotine|mesh-list
57051610|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57051611|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
57051612|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051613|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051614|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57051615|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57051616|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
57051617|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051618|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051619|NCT02734862|Fluconazole|fluconazole|mesh-list
57051620|NCT02734862|Caspofungin|caspofungin|mesh-list
57051621|NCT02734862|Rezafungin|rezafungin|mesh-list
57051622|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
57051623|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051624|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57051625|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57051626|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051627|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051628|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57051629|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
57051630|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57051631|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051632|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57051633|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57051634|NCT00818844|Nepafenac|nepafenac|mesh-list
57051635|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57051636|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57051637|NCT00818844|Analgesics|analgesics|mesh-ancestor
57051638|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
57051639|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051640|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051641|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57051642|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57051643|NCT00862524|Gemcitabine|gemcitabine|mesh-list
57051644|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051645|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
57051646|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051647|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051648|NCT00862524|Antiviral Agents|antiviral agents|mesh-ancestor
57051649|NCT00862524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051650|NCT00862524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051651|NCT00862524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051652|NCT00862524|Immunologic Factors|immunologic factors|mesh-ancestor
57051653|NCT00862524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051654|NCT00858702|Olmesartan|olmesartan|mesh-list
57051655|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
57051656|NCT00858702|Diuretics|diuretics|mesh-list
57051657|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57051658|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57051659|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57051660|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051661|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
57051662|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051663|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
57051664|NCT00817986|Baclofen|baclofen|mesh-list
57051665|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57051666|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051667|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57051668|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051669|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57051670|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
57051671|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
57051672|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051673|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051674|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
57051675|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57051676|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051677|NCT00817362|Trastuzumab|trastuzumab|mesh-list
57051678|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57051679|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051680|NCT04176848|Durvalumab|durvalumab|mesh-list
57051681|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57051682|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051683|NCT04163978|Budesonide|budesonide|mesh-list
57051685|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57051686|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57051687|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
57051688|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051689|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051690|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57051691|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
57051692|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
57051693|NCT04163978|Hormones|hormones|mesh-ancestor
57051694|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57051695|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57051696|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
57051697|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051698|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051699|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57051700|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
57051701|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
57051702|NCT04163978|Protective Agents|protective agents|mesh-ancestor
57051703|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
57051704|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
57051705|NCT02598622|Vitamins|vitamins|mesh-ancestor
57051706|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
57051707|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051708|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
57051709|NCT00810732|Nifedipine|nifedipine|mesh-list
57051710|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
57051711|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57051712|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051713|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051714|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57051715|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051716|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
57051717|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
57051718|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57051719|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57051720|NCT03463070|Misoprostol|misoprostol|mesh-list
57051721|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57051722|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
57051723|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57051724|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051725|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57051726|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57051727|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
57051728|NCT00807612|Paclitaxel|paclitaxel|mesh-list
57051729|NCT00807612|Carboplatin|carboplatin|mesh-list
57051730|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57051731|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57051732|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051733|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
57051734|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
57051735|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
57051736|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051737|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
57051738|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051739|NCT00805350|SR 46349B|sr 46349b|mesh-list
57051740|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57051741|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57051742|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051743|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57051744|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57051745|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
57051746|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051747|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051748|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
57051749|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57051750|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57051751|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051752|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57051753|NCT03462836|Lidocaine|lidocaine|mesh-list
57051754|NCT03462836|Ketamine|ketamine|mesh-list
57051755|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
57051756|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
57051757|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56733721|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
57051758|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051759|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
57051760|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051761|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57051762|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57051763|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57051764|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051765|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051766|NCT03462836|Analgesics|analgesics|mesh-ancestor
57051767|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57051768|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57051769|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
57051770|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57051771|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57051772|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051773|NCT00849576|Insulin|insulin|mesh-list
57051774|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57051775|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
57051776|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57051777|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051778|NCT00841698|Paroxetine|paroxetine|mesh-list
57051779|NCT00841698|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57051780|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57051781|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051782|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051783|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051784|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
57051785|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051786|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57051787|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
57051788|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57051789|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57051790|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57051791|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051792|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
57051793|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57051794|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
57051795|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051796|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051797|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57051798|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
57051799|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57051800|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
57051801|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051802|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051803|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57051804|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
57051805|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
57051806|NCT04383002|Protective Agents|protective agents|mesh-ancestor
57051807|NCT00841542|Amlodipine|amlodipine|mesh-list
57051808|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57051809|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56897774|NCT01173549|Canagliflozin|canagliflozin|mesh-list
57051810|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051811|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051812|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57051813|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051814|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
57051815|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
57051816|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051817|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
57051818|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051819|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57051820|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57051821|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
57051822|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051823|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051824|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57051825|NCT00840840|Amoxicillin|amoxicillin|mesh-list
57051826|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
57051827|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
57051828|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57051829|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57051830|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051831|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57051833|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051834|NCT03595982|Nifedipine|nifedipine|mesh-list
57051835|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57051836|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051837|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051838|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57051839|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051840|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
57051841|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
57051842|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57051843|NCT00944970|Adenosine|adenosine|mesh-list
57051844|NCT00944970|Binodenoson|binodenoson|mesh-list
57051845|NCT00944970|Analgesics|analgesics|mesh-ancestor
57051846|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
57051847|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051848|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051849|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57051850|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
57051851|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57051852|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
57051853|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
57051854|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051855|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051856|NCT00840216|Clarithromycin|clarithromycin|mesh-list
57051857|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57051858|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051859|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57051860|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051861|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051862|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57051863|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57051864|NCT03462446|Vitamin K|vitamin k|mesh-list
57051865|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
57051866|NCT03462446|Vitamins|vitamins|mesh-ancestor
57051867|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
57051868|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051869|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57051870|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
57051871|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57051872|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
57051873|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051874|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051875|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
57051876|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57051877|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57051878|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
57051879|NCT03462446|Coagulants|coagulants|mesh-ancestor
57051880|NCT00944892|Fasinumab|fasinumab|mesh-list
57051881|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57051882|NCT00944892|Analgesics|analgesics|mesh-ancestor
57051883|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
57051884|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051885|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051886|NCT00939276|Nepafenac|nepafenac|mesh-list
57051887|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57051888|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57051889|NCT00939276|Analgesics|analgesics|mesh-ancestor
57051890|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
57051891|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57051892|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051893|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57051894|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57051895|NCT03455426|Letrozole|letrozole|mesh-list
57051896|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051897|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57051898|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57051899|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051900|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051901|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57051902|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
57051903|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57051904|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051905|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57051906|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57051907|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051908|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051909|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
57051910|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051911|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051912|NCT00791154|Carboplatin|carboplatin|mesh-list
57051913|NCT00791154|Etoposide|etoposide|mesh-list
57051914|NCT00791154|Rilotumumab|rilotumumab|mesh-list
57051915|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051916|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57051917|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57051918|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57051919|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051920|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051921|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57051922|NCT00938652|Gemcitabine|gemcitabine|mesh-list
57051923|NCT00938652|Carboplatin|carboplatin|mesh-list
57051924|NCT00938652|Iniparib|iniparib|mesh-list
57051925|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051926|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051927|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
57051928|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051929|NCT00938652|Antiviral Agents|antiviral agents|mesh-ancestor
57051930|NCT00938652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051931|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051932|NCT00938652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051933|NCT00938652|Immunologic Factors|immunologic factors|mesh-ancestor
57051934|NCT00938652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051935|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57051936|NCT00928590|Timolol|timolol|mesh-list
57051937|NCT00928590|Travoprost|travoprost|mesh-list
57051938|NCT00928590|Cloprostenol|cloprostenol|mesh-list
57051939|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897777|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57051940|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57051941|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57051942|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
57051943|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57051944|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051945|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57051946|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57051947|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
57051948|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57051949|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
57051950|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57051951|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57051952|NCT03512756|Gemcitabine|gemcitabine|mesh-list
57051953|NCT03512756|Sirolimus|sirolimus|mesh-list
57051954|NCT03512756|Capecitabine|capecitabine|mesh-list
57051955|NCT03512756|Phenytoin|phenytoin|mesh-list
57051956|NCT03512756|Methoxsalen|methoxsalen|mesh-list
57051957|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051958|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
57051959|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051960|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051961|NCT03512756|Antiviral Agents|antiviral agents|mesh-ancestor
57051962|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051963|NCT03512756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051964|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051965|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
57051966|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051967|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57051968|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57051969|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
57051970|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
57051971|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57051972|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57051973|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57051974|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57051975|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57051976|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57051977|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
57051978|NCT04697940|Cyclophosphamide|cyclophosphamide|mesh-list
57051979|NCT04697940|Fludarabine|fludarabine|mesh-list
57051980|NCT04697940|Fludarabine phosphate|fludarabine phosphate|mesh-list
57051981|NCT04697940|Decitabine|decitabine|mesh-list
57051982|NCT04697940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57051983|NCT04697940|Immunologic Factors|immunologic factors|mesh-ancestor
57051984|NCT04697940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57051985|NCT04697940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57051986|NCT04697940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57051987|NCT04697940|Alkylating Agents|alkylating agents|mesh-ancestor
57051988|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57051989|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57051990|NCT04697940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57051991|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57051992|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
57051993|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051994|NCT00836706|Clarithromycin|clarithromycin|mesh-list
57051995|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57051996|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57051997|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57051998|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57051999|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052000|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57052001|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57052002|NCT00836472|Metformin|metformin|mesh-list
57052003|NCT00836472|Glyburide|glyburide|mesh-list
57052004|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57052005|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052006|NCT04473846|Anesthetics|anesthetics|mesh-list
57052007|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57052008|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052009|NCT04179032|Belimumab|belimumab|mesh-list
57052010|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57052011|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
57052012|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052013|NCT03129698|Apatinib|apatinib|mesh-list
57052014|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052015|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57052016|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052017|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052018|NCT03355118|Anesthetics|anesthetics|mesh-list
57052019|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57052020|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052021|NCT03263078|Propofol|propofol|mesh-list
57052022|NCT03263078|Sevoflurane|sevoflurane|mesh-list
57052023|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57052024|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57052025|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052026|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57052027|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
57052028|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
57052029|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57052030|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57052031|NCT05349006|Azathioprine|azathioprine|mesh-list
57052032|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
57052033|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052034|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052035|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052036|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57052037|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
57052038|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052039|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57052040|NCT00785226|Sorafenib|sorafenib|mesh-list
57052041|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052042|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57052043|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052044|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052045|NCT03448640|Tropicamide|tropicamide|mesh-list
57052046|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
57052047|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
57052048|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052049|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052050|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57052051|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57052052|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
57052053|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052054|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052055|NCT00836004|Clindamycin|clindamycin|mesh-list
57052056|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
57052057|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
57052058|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052059|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052060|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57052061|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052062|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052063|NCT00917826|Valganciclovir|valganciclovir|mesh-list
57052064|NCT00917826|Ganciclovir|ganciclovir|mesh-list
57052065|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
57052066|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
57052067|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
57052068|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052069|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57052070|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052071|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052072|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052073|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
57052074|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052075|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052076|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57052077|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57052078|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052079|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052080|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052081|NCT03102320|Gemcitabine|gemcitabine|mesh-list
57052082|NCT03102320|Maytansine|maytansine|mesh-list
57052083|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052084|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052085|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
56897794|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57052086|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052087|NCT03102320|Antiviral Agents|antiviral agents|mesh-ancestor
57052088|NCT03102320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052089|NCT03102320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052090|NCT03102320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57052091|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
57052092|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052093|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57052094|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
57052095|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
57052096|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
57052097|NCT00835692|Clarithromycin|clarithromycin|mesh-list
57052098|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052099|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052100|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57052101|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052102|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052103|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57052104|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57052105|NCT00835614|Cefprozil|cefprozil|mesh-list
57052106|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052107|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052108|NCT00835536|Ribavirin|ribavirin|mesh-list
57052109|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
57052110|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052111|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
57052112|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052113|NCT01744652|Dasatinib|dasatinib|mesh-list
57052114|NCT01744652|Crizotinib|crizotinib|mesh-list
57052115|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052116|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57052117|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052118|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052119|NCT04561362|Pembrolizumab|pembrolizumab|mesh-list
57052120|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052121|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052122|NCT04060628|Docetaxel|docetaxel|mesh-list
57052123|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052124|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
57052125|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
57052126|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
57052127|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052128|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57052129|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
57052130|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57052131|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
57052132|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57052133|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052134|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57052135|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57052136|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052137|NCT04037072|Mitomycins|mitomycins|mesh-list
57052138|NCT04037072|Mitomycin|mitomycin|mesh-list
57052139|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57052140|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052141|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
57052142|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052143|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57052144|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052145|NCT04819438|Riluzole|riluzole|mesh-list
57052146|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
57052147|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57052148|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57052149|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052150|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052151|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052152|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57052153|NCT04819438|Protective Agents|protective agents|mesh-ancestor
57052154|NCT05616910|Nitric Oxide|nitric oxide|mesh-list
57052155|NCT05616910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57052156|NCT05616910|Autonomic Agents|autonomic agents|mesh-ancestor
56897796|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57052157|NCT05616910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052158|NCT05616910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052159|NCT05616910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57052160|NCT05616910|Respiratory System Agents|respiratory system agents|mesh-ancestor
57052161|NCT05616910|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57052162|NCT05616910|Antioxidants|antioxidants|mesh-ancestor
57052163|NCT05616910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052164|NCT05616910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052165|NCT05616910|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57052166|NCT05616910|Vasodilator Agents|vasodilator agents|mesh-ancestor
57052167|NCT05616910|Gasotransmitters|gasotransmitters|mesh-ancestor
57052168|NCT05616910|Protective Agents|protective agents|mesh-ancestor
57052169|NCT04537026|Dexamethasone|dexamethasone|mesh-list
57052170|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
57052171|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57052172|NCT04537026|BB 1101|bb 1101|mesh-list
57052173|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052174|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
57052175|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
57052176|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052177|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052178|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57052179|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
57052180|NCT04537026|Hormones|hormones|mesh-ancestor
57052181|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052182|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57052183|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052184|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
57052185|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052186|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052187|NCT04819828|Diclofenac|diclofenac|mesh-list
57052188|NCT04819828|Tamsulosin|tamsulosin|mesh-list
57052189|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57052190|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57052191|NCT04819828|Analgesics|analgesics|mesh-ancestor
57052192|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
57052193|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052194|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052195|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052196|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57052197|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57052198|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052199|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052200|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57052201|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56734230|NCT00570492|Xhance|xhance|mesh-list
57052202|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57052203|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
57052204|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052205|NCT04819828|Urological Agents|urological agents|mesh-ancestor
57052206|NCT02602288|Nicotine|nicotine|mesh-list
57052207|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57052208|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
57052209|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052210|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052211|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57052212|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57052213|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
57052214|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052215|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052216|NCT03745352|Azacitidine|azacitidine|mesh-list
57052217|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
57052218|NCT03745352|Pevonedistat|pevonedistat|mesh-list
57052219|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052220|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
57052221|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052222|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052223|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57052224|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57052225|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052226|NCT05617690|Propofol|propofol|mesh-list
57052227|NCT05617690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57052228|NCT05617690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897798|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
57052229|NCT05617690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052230|NCT05617690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57052231|NCT05617690|Anesthetics, General|anesthetics, general|mesh-ancestor
57052232|NCT05617690|Anesthetics|anesthetics|mesh-ancestor
57052233|NCT03448094|Resveratrol|resveratrol|mesh-list
57052234|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
57052235|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052236|NCT03448094|Protective Agents|protective agents|mesh-ancestor
57052237|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052238|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052239|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57052240|NCT04819204|Cetrorelix|cetrorelix|mesh-list
57052241|NCT04819204|Testosterone|testosterone|mesh-list
57052242|NCT04819204|Androgens|androgens|mesh-ancestor
57052243|NCT04819204|Hormones|hormones|mesh-ancestor
57052244|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052245|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052246|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57052247|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
57052248|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57052249|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
57052250|NCT02807454|Dexamethasone|dexamethasone|mesh-list
57052251|NCT02807454|Durvalumab|durvalumab|mesh-list
57052252|NCT02807454|Daratumumab|daratumumab|mesh-list
57052253|NCT02807454|Pomalidomide|pomalidomide|mesh-list
57052254|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052255|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
57052256|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
57052257|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052258|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052259|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57052260|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
57052261|NCT02807454|Hormones|hormones|mesh-ancestor
57052262|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052263|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57052264|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052265|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052266|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
57052267|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57052268|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57052269|NCT02807454|Growth Substances|growth substances|mesh-ancestor
57052270|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
57052271|NCT05320874|Antibodies|antibodies|mesh-list
57052272|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57052273|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
57052274|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052275|NCT03728556|Antibodies|antibodies|mesh-list
57052276|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57052277|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
57052278|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052280|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052281|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57052282|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052283|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052284|NCT05320640|Decitabine|decitabine|mesh-list
57052285|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57052286|NCT05320640|Antibodies|antibodies|mesh-list
57052287|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
57052288|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052289|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052290|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
57052291|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052292|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052293|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052294|NCT00835146|Ribavirin|ribavirin|mesh-list
57052295|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
57052296|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052297|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
57052298|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052299|NCT04472910|Folfirinox|folfirinox|mesh-list
57052300|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052301|NCT01479842|Rituximab|rituximab|mesh-list
57052302|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57052303|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052304|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052305|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
57052306|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052307|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57052308|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57052309|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
57052310|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052311|NCT04940052|Trametinib|trametinib|mesh-list
57052312|NCT04940052|Dabrafenib|dabrafenib|mesh-list
57052313|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052314|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57052315|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052316|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052317|NCT04818736|Vaccines|vaccines|mesh-list
57052318|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
57052319|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052320|NCT03719430|Doxorubicin|doxorubicin|mesh-list
57052321|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57052322|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052323|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57052324|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57052325|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052326|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052327|NCT04811326|Latanoprost|latanoprost|mesh-list
57052328|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57052329|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57052330|NCT00834990|Valproic Acid|valproic acid|mesh-list
57052331|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
57052332|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052333|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052334|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
57052335|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052336|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052337|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
57052338|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57052339|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57052340|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57052341|NCT04479072|Aspirin|aspirin|mesh-list
57052342|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57052343|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57052344|NCT04479072|Analgesics|analgesics|mesh-ancestor
57052345|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
57052346|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052347|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052348|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052349|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57052350|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57052351|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57052352|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734330|NCT04059224|Trametinib|trametinib|mesh-list
57052353|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57052354|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57052355|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052356|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
57052357|NCT04425018|Paclitaxel|paclitaxel|mesh-list
57052358|NCT04425018|Trastuzumab|trastuzumab|mesh-list
57052359|NCT04425018|Pertuzumab|pertuzumab|mesh-list
57052360|NCT04425018|Margetuximab|margetuximab|mesh-list
57052361|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57052362|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052363|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
57052364|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
57052365|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
57052366|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052367|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052368|NCT03036202|Epinephrine|epinephrine|mesh-list
57052369|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57052370|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57052371|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
57052372|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052373|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052374|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052375|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57052376|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57052377|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
57052378|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052379|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57052380|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
57052381|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
57052382|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
57052383|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57052384|NCT03245918|Aprepitant|aprepitant|mesh-list
57052385|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
57052386|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
57052387|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
57052388|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052389|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052390|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57052391|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57052392|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052393|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052394|NCT02597062|Dexamethasone|dexamethasone|mesh-list
57052395|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
57052396|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57052397|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
57052398|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052399|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57052400|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57052401|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
57052402|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052403|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052404|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57052405|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052406|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
57052407|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
57052408|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052409|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57052410|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
57052411|NCT02597062|Hormones|hormones|mesh-ancestor
57052412|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052413|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57052414|NCT00834756|Azithromycin|azithromycin|mesh-list
57052415|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052416|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052417|NCT00828854|Entinostat|entinostat|mesh-list
57052418|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57052419|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57052420|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052421|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052422|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57052423|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
57052424|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052425|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052426|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052427|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57052428|NCT00834522|Granisetron|granisetron|mesh-list
57052429|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
57052430|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
57052431|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052432|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052433|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57052434|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57052435|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
57052436|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052437|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052438|NCT00834444|Famciclovir|famciclovir|mesh-list
57052439|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
57052440|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052441|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57052442|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052443|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052444|NCT05174858|Hemostatics|hemostatics|mesh-list
57052445|NCT05174858|Coagulants|coagulants|mesh-ancestor
57052446|NCT04831294|Cannabidiol|cannabidiol|mesh-list
57052447|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
57052448|NCT00834132|Azithromycin|azithromycin|mesh-list
57052449|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052450|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052451|NCT00833664|Terbinafine|terbinafine|mesh-list
57052452|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
57052453|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052454|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052455|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052456|NCT00833586|Terbinafine|terbinafine|mesh-list
57052457|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
57052458|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052459|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052460|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052461|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
57052462|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
57052463|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052465|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052466|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052467|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57052468|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052469|NCT04397484|Lidocaine|lidocaine|mesh-list
57052470|NCT04397484|Epinephrine|epinephrine|mesh-list
57052471|NCT04397484|Racepinephrine|racepinephrine|mesh-list
57052472|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
57052473|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
57052474|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
57052475|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
57052476|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57052477|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052478|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
57052479|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052480|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57052481|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57052482|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57052483|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57052484|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052485|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57052486|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57052487|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
57052488|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052489|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57052490|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57052491|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
57052492|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57052493|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
57052494|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
57052495|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
57052496|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57052497|NCT04817800|Azelastine|azelastine|mesh-list
57052498|NCT04817800|Beclomethasone|beclomethasone|mesh-list
57052499|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052500|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
57052501|NCT04817800|Hormones|hormones|mesh-ancestor
57052502|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052503|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052504|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57052505|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
57052506|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57052507|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
57052508|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052509|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
57052510|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052511|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052512|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57052513|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57052514|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57052515|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
57052516|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
57052517|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052518|NCT00765804|Dexamethasone|dexamethasone|mesh-list
57052519|NCT00765804|Citric Acid|citric acid|mesh-list
57052520|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
57052521|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57052522|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57052523|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57052524|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052525|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
57052526|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
57052527|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052528|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052529|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57052530|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
57052532|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052533|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57052534|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052535|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052536|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
57052537|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57052538|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
57052539|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
57052540|NCT00764634|Vaccines|vaccines|mesh-list
57052541|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
57052542|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052543|NCT04345146|Bevacizumab|bevacizumab|mesh-list
57052544|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052545|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052546|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57052547|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57052548|NCT04345146|Growth Substances|growth substances|mesh-ancestor
57052549|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052550|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
57052551|NCT03443726|Epinephrine|epinephrine|mesh-list
57052552|NCT03443726|Carticaine|carticaine|mesh-list
57052553|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57052554|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57052555|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
57052556|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052557|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052558|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052559|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57052560|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57052561|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
57052562|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052563|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57052564|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
57052565|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
57052566|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
57052567|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57052568|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
57052569|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
57052570|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57052571|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
57052572|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57052573|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57052574|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052575|NCT00760344|Incretins|incretins|mesh-ancestor
57052576|NCT00760344|Hormones|hormones|mesh-ancestor
57052577|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052578|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57052579|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
57052580|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052581|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052582|NCT03443570|Rituximab|rituximab|mesh-list
57052583|NCT03443570|Bortezomib|bortezomib|mesh-list
57052584|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052585|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052586|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
57052587|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052588|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57052589|NCT02718404|Analgesics|analgesics|mesh-list
57052590|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
57052591|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052592|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052593|NCT03443492|Leucovorin|leucovorin|mesh-list
57052594|NCT03443492|Gemcitabine|gemcitabine|mesh-list
57052595|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
57052596|NCT03443492|Irinotecan|irinotecan|mesh-list
57052597|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
57052598|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052599|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
56904745|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052600|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052601|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052602|NCT03443492|Antiviral Agents|antiviral agents|mesh-ancestor
57052603|NCT03443492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052604|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052605|NCT03443492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57052606|NCT03443492|Immunologic Factors|immunologic factors|mesh-ancestor
57052607|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052608|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57052609|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57052610|NCT03443492|Antidotes|antidotes|mesh-ancestor
57052611|NCT03443492|Protective Agents|protective agents|mesh-ancestor
57052612|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
57052613|NCT03443492|Vitamins|vitamins|mesh-ancestor
57052614|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
57052615|NCT01333046|Azacitidine|azacitidine|mesh-list
57052616|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052617|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
57052618|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052619|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052620|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052621|NCT00724698|Desloratadine|desloratadine|mesh-list
57052622|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57052623|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
57052624|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052625|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052626|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052627|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57052628|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57052629|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
57052630|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
57052631|NCT00722592|Doxorubicin|doxorubicin|mesh-list
57052632|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57052633|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57052634|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052635|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57052636|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57052637|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052638|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052639|NCT00829998|Zaleplon|zaleplon|mesh-list
57052640|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
57052641|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57052642|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57052643|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052644|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
57052645|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
57052646|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052647|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052648|NCT00722358|Asunaprevir|asunaprevir|mesh-list
57052649|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
57052650|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052651|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052652|NCT00719550|Capecitabine|capecitabine|mesh-list
57052653|NCT00719550|Epirubicin|epirubicin|mesh-list
57052654|NCT00719550|Rilotumumab|rilotumumab|mesh-list
57052655|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052656|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052657|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
57052658|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052659|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57052660|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57052661|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57052662|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052663|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052664|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
57052665|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57052666|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
57052667|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052668|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052669|NCT05016518|Propofol|propofol|mesh-list
57052670|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57052671|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630179|NCT00908167|Cytarabine|cytarabine|mesh-list
57052672|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052673|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57052674|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
57052675|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
57052676|NCT04249362|Durvalumab|durvalumab|mesh-list
57052677|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052678|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052679|NCT03446534|Amoxicillin|amoxicillin|mesh-list
57052680|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052681|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052682|NCT00829764|Doxycycline|doxycycline|mesh-list
57052683|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052684|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052685|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
57052686|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57052687|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57052688|NCT00718224|Enoxaparin|enoxaparin|mesh-list
57052689|NCT00718224|Semuloparin|semuloparin|mesh-list
57052690|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
57052691|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57052692|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57052693|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052694|NCT03129542|Midodrine|midodrine|mesh-list
57052695|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
57052696|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
57052697|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052698|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052699|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57052700|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57052701|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57052702|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57052703|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
57052704|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052705|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052706|NCT03129074|Capecitabine|capecitabine|mesh-list
57052707|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052708|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
57052709|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052710|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052711|NCT03449654|Liraglutide|liraglutide|mesh-list
57052712|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57052713|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052714|NCT03449654|Incretins|incretins|mesh-ancestor
57052715|NCT03449654|Hormones|hormones|mesh-ancestor
57052716|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052717|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
57052718|NCT03388008|Prednisone|prednisone|mesh-list
57052719|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
57052720|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57052721|NCT03388008|Abatacept|abatacept|mesh-list
57052722|NCT03388008|Tacrolimus|tacrolimus|mesh-list
57052723|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
57052724|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052725|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
57052726|NCT03388008|Hormones|hormones|mesh-ancestor
57052727|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052728|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052729|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56734718|NCT00688064|Adapalene|adapalene|mesh-list
57052730|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052731|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57052732|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
57052733|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57052734|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052735|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052736|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57052737|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57052738|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
57052739|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052740|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052741|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
57052742|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
57052743|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052744|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57052745|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57052746|NCT03388008|Protective Agents|protective agents|mesh-ancestor
57052747|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57052748|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57052749|NCT00710580|Etanercept|etanercept|mesh-list
57052750|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57052751|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57052752|NCT00710580|Analgesics|analgesics|mesh-ancestor
57052753|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
57052754|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052755|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052756|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052757|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57052758|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57052759|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57052760|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
57052761|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57052762|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57052763|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052764|NCT00829686|Renal Agents|renal agents|mesh-ancestor
57052765|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57052766|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
57052767|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57052768|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57052769|NCT00829530|Ramipril|ramipril|mesh-list
57052770|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57052771|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
57052772|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052773|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052774|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57052775|NCT01377194|Milnacipran|milnacipran|mesh-list
57052776|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
57052777|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57052778|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57052779|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57052780|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052781|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052782|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052783|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
57052784|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57052785|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57052786|NCT01377194|Analgesics|analgesics|mesh-ancestor
57052787|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
57052788|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052789|NCT00829452|Ramipril|ramipril|mesh-list
57052790|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57052791|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
57052792|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052793|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052794|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57052795|NCT00747318|Fluticasone|fluticasone|mesh-list
57052796|NCT00747318|Xhance|xhance|mesh-list
57052797|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
57052798|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052799|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57052800|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
57052801|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052802|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052803|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57052804|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
57052805|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
57052806|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57052807|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57052808|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57052809|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57052810|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
57052811|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052812|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052814|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57052815|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
57052816|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052817|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052818|NCT03438344|Vaccines|vaccines|mesh-list
57052819|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
57052820|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052821|NCT04640402|Vaccines|vaccines|mesh-list
57052822|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
57052823|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052824|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57052825|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57052826|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052827|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
57052828|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57052829|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
57052830|NCT00692484|Povidone|povidone|mesh-list
57052831|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57052832|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052833|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
57052834|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
57052835|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
57052836|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
57052837|NCT00646542|Vildagliptin|vildagliptin|mesh-list
57052838|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57052839|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052840|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57052841|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
57052842|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052843|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052844|NCT05089370|Nivolumab|nivolumab|mesh-list
57052845|NCT05089370|Decitabine|decitabine|mesh-list
57052846|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052847|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052848|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57052849|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052850|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052851|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
57052852|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052853|NCT03256344|Atezolizumab|atezolizumab|mesh-list
57052854|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57052855|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052856|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052857|NCT02063139|Fluticasone|fluticasone|mesh-list
57052858|NCT02063139|Beclomethasone|beclomethasone|mesh-list
57052859|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052860|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57052861|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
57052862|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052863|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052864|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57052865|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
57052866|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
57052867|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57052868|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
57052869|NCT02063139|Hormones|hormones|mesh-ancestor
57052870|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052871|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
57052872|NCT03105336|Fludarabine|fludarabine|mesh-list
57052873|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57052874|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
57052875|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052876|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57052877|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57052878|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
57052879|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052880|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052881|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57052882|NCT00690456|Metformin|metformin|mesh-list
57052883|NCT00690456|Rimonabant|rimonabant|mesh-list
57052884|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57052885|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052886|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57052887|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
57052888|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57052889|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052890|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052891|NCT00690456|Hormones|hormones|mesh-ancestor
57052892|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052893|NCT01370499|Serotonin|serotonin|mesh-list
57052894|NCT01370499|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
57052895|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57052896|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
57052897|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052898|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052899|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052900|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57052901|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57052902|NCT03445286|Fluorides|fluorides|mesh-list
57052903|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
57052904|NCT03445286|Protective Agents|protective agents|mesh-ancestor
57052905|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052906|NCT00626106|Fulvestrant|fulvestrant|mesh-list
57052907|NCT00626106|Exemestane|exemestane|mesh-list
57052908|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57052909|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57052910|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052911|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57052912|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57052913|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
57052914|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57052915|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052916|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57052917|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57052918|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052919|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052920|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
57052921|NCT02064465|Lamotrigine|lamotrigine|mesh-list
57052922|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
57052923|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57052924|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57052925|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052926|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57052927|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052928|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57052929|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57052930|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57052931|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57052932|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57052933|NCT04530656|Vaccines|vaccines|mesh-list
57052934|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
57052935|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052936|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
57052937|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052938|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
57052939|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052940|NCT04509596|Capecitabine|capecitabine|mesh-list
57052941|NCT04509596|Trastuzumab|trastuzumab|mesh-list
57052942|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57052943|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
57052944|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052945|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57052946|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57052947|NCT01370265|Adenosine|adenosine|mesh-list
57052948|NCT01370265|Regadenoson|regadenoson|mesh-list
57052949|NCT01370265|Analgesics|analgesics|mesh-ancestor
57052950|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
57052951|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052952|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734923|NCT00792012|Temozolomide|temozolomide|mesh-list
57052953|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57052954|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
57052955|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57052956|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
57052957|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
57052958|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052959|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052960|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
57052961|NCT00734292|Fluticasone|fluticasone|mesh-list
57052962|NCT00734292|Xhance|xhance|mesh-list
57052963|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
57052964|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57052965|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57052966|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
57052967|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57052968|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052969|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57052970|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
57052971|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
57052972|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57052973|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57052974|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57052975|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57052976|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
57052977|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57052978|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052979|NCT00687882|Anticoagulants|anticoagulants|mesh-list
57052980|NCT02064621|Amlodipine|amlodipine|mesh-list
57052981|NCT02064621|Candesartan|candesartan|mesh-list
57052982|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
57052983|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57052984|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57052985|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57052986|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052987|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57052988|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57052989|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
57052990|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57052991|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57052992|NCT00684918|Obatoclax|obatoclax|mesh-list
57052993|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57052994|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57052995|NCT00726336|Tenofovir|tenofovir|mesh-list
57052996|NCT00726336|Dolutegravir|dolutegravir|mesh-list
57052997|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
57052998|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57052999|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57053000|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57053001|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053002|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053003|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57053004|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57053005|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57053006|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57053007|NCT02280720|Tryptophan|tryptophan|mesh-list
57053008|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57053009|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
57053010|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57053011|NCT02068131|Capecitabine|capecitabine|mesh-list
57053012|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57053013|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
57053014|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053015|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053016|NCT02989584|Gemcitabine|gemcitabine|mesh-list
57053017|NCT02989584|Atezolizumab|atezolizumab|mesh-list
57053018|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053019|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57053020|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
57053021|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053022|NCT02989584|Antiviral Agents|antiviral agents|mesh-ancestor
57053023|NCT02989584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053024|NCT02989584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053025|NCT02989584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57053026|NCT02989584|Immunologic Factors|immunologic factors|mesh-ancestor
56735003|NCT00754910|Trioxsalen|trioxsalen|mesh-list
57053027|NCT02989584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053028|NCT02068209|Tramadol|tramadol|mesh-list
57053029|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57053030|NCT02068209|Narcotics|narcotics|mesh-ancestor
57053031|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053032|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053033|NCT02068209|Analgesics|analgesics|mesh-ancestor
57053034|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
57053035|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053036|NCT00680784|Ketoprofen|ketoprofen|mesh-list
57053037|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57053038|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053039|NCT00680784|Analgesics|analgesics|mesh-ancestor
57053040|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
57053041|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053042|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053043|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57053044|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57053045|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57053046|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053047|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053048|NCT02068287|Esmolol|esmolol|mesh-list
57053049|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57053050|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57053051|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57053052|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
57053053|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053054|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053055|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053056|NCT02280876|Andrographolide|andrographolide|mesh-list
57053057|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57053058|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57053059|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053060|NCT02280876|Analgesics|analgesics|mesh-ancestor
57053061|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
57053062|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053063|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053064|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57053065|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57053066|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57053067|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053068|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
57053069|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57053070|NCT00680472|Ketoprofen|ketoprofen|mesh-list
57053071|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57053072|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053073|NCT00680472|Analgesics|analgesics|mesh-ancestor
57053074|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
57053075|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053076|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053077|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57053078|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57053079|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57053080|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053081|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053082|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
57053083|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
57053084|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
57053085|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57053086|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053087|NCT03444506|Analgesics|analgesics|mesh-ancestor
57053088|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
57053089|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053090|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053091|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57053092|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57053093|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57053094|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57053095|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57053096|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
57053097|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
57053098|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053099|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053100|NCT02065947|Lidocaine|lidocaine|mesh-list
57053101|NCT02065947|Epinephrine|epinephrine|mesh-list
57053102|NCT02065947|Racepinephrine|racepinephrine|mesh-list
57053103|NCT02065947|Fentanyl|fentanyl|mesh-list
57053104|NCT02065947|Midazolam|midazolam|mesh-list
57053105|NCT02065947|Ketamine|ketamine|mesh-list
57053106|NCT02065947|Bupivacaine|bupivacaine|mesh-list
57053107|NCT02065947|Propofol|propofol|mesh-list
57053108|NCT02065947|Sevoflurane|sevoflurane|mesh-list
57053109|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
57053110|NCT02065947|Atracurium|atracurium|mesh-list
57053111|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
57053112|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
57053113|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053114|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896777|NCT03204318|Hormones|hormones|mesh-ancestor
57053115|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
57053116|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053117|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57053118|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57053119|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57053120|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57053121|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053122|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57053123|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57053124|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
57053125|NCT02065947|Analgesics|analgesics|mesh-ancestor
57053126|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57053127|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57053128|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57053129|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053130|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57053131|NCT02065947|Narcotics|narcotics|mesh-ancestor
57053132|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57053133|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57053134|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57053135|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57053136|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
57053137|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
57053138|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57053139|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57053140|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57053141|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57053142|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
57053143|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57053144|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57053145|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
57053146|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57053147|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
57053148|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
57053149|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
57053150|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57053151|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57053152|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57053153|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57053154|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57053155|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57053156|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
57053157|NCT01359592|Prednisone|prednisone|mesh-list
57053158|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
57053159|NCT01359592|Rituximab|rituximab|mesh-list
57053160|NCT01359592|Doxorubicin|doxorubicin|mesh-list
57053161|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57053162|NCT01359592|Vincristine|vincristine|mesh-list
57053163|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57053164|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57053165|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
57053166|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053167|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57053168|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57053169|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
57053170|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053171|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053172|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57053173|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57053174|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57053175|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57053176|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56735146|NCT00681824|Thrombin|thrombin|mesh-list
57053177|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053178|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57053179|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
57053180|NCT01359592|Hormones|hormones|mesh-ancestor
57053181|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57053182|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57053183|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57053184|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
57053185|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
57053186|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
57053187|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57053188|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
57053189|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57053190|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053191|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053192|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053193|NCT03436472|Analgesics|analgesics|mesh-ancestor
57053194|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
57053195|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053196|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57053197|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57053198|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57053199|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
57053200|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053201|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053202|NCT02066103|Paclitaxel|paclitaxel|mesh-list
57053203|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57053204|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053205|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
57053206|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
57053207|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
57053208|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053209|NCT04809532|Tramadol|tramadol|mesh-list
57053210|NCT04809532|Bupivacaine|bupivacaine|mesh-list
57053211|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
57053212|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
57053213|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053214|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053215|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
57053216|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053217|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57053218|NCT04809532|Narcotics|narcotics|mesh-ancestor
57053219|NCT04809532|Analgesics|analgesics|mesh-ancestor
57053220|NCT04809142|Gemcitabine|gemcitabine|mesh-list
57053221|NCT04809142|Capecitabine|capecitabine|mesh-list
57053222|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
57053223|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57053224|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
57053225|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053226|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053227|NCT04809142|Antiviral Agents|antiviral agents|mesh-ancestor
57053228|NCT04809142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053229|NCT04809142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053230|NCT04809142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57053231|NCT04809142|Immunologic Factors|immunologic factors|mesh-ancestor
57053232|NCT04809142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053233|NCT02064777|Tacrolimus|tacrolimus|mesh-list
57053234|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57053235|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
57053236|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053237|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57053238|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053239|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053240|NCT02069145|Sorafenib|sorafenib|mesh-list
57053241|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
57053242|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053243|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57053244|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053245|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053246|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
57053247|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053248|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57053249|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
57053250|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053251|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
56735230|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
57053252|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
57053253|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053254|NCT03347331|Befiradol|befiradol|mesh-list
57053255|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57053256|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57053257|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
57053258|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053259|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053260|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053261|NCT05573373|Antineoplastic Agents|antineoplastic agents|mesh-list
57053262|NCT05573373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57053263|NCT05573373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053264|NCT05573373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053265|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
57053266|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57053267|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57053268|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053269|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
57053270|NCT03109652|Coagulants|coagulants|mesh-ancestor
57053271|NCT02069301|Fluoxetine|fluoxetine|mesh-list
57053272|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
57053273|NCT02069301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57053274|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57053275|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57053276|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053277|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053278|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
57053279|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053280|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57053281|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57053282|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57053283|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57053284|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053285|NCT03035656|Ropivacaine|ropivacaine|mesh-list
57053286|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
57053287|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
57053288|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053289|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053290|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
57053291|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053292|NCT03443960|Amitriptyline|amitriptyline|mesh-list
57053293|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
57053294|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57053295|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
57053296|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57053297|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57053298|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053299|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57053300|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053301|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57053302|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053303|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053304|NCT03443960|Analgesics|analgesics|mesh-ancestor
57053305|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
57053306|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57053307|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57053308|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57053309|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053310|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
57053311|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053312|NCT05616754|Vaccines|vaccines|mesh-list
57053313|NCT05616754|Immunologic Factors|immunologic factors|mesh-ancestor
57053314|NCT05616754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053315|NCT03440996|Listerine|listerine|mesh-list
57053316|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
57053317|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
57053318|NCT03440996|Protective Agents|protective agents|mesh-ancestor
57053319|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053320|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57053321|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053322|NCT04451174|Prednisone|prednisone|mesh-list
57053323|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57053324|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
57053325|NCT04451174|Hormones|hormones|mesh-ancestor
57053326|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57053327|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053328|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57053330|NCT04828642|Vitamins|vitamins|mesh-list
57053331|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
57053332|NCT04828642|Vitamin E|vitamin e|mesh-list
57053333|NCT04828642|Tocopherols|tocopherols|mesh-list
57053334|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
57053335|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053336|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
57053337|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053338|NCT04828642|Protective Agents|protective agents|mesh-ancestor
57053339|NCT03433352|Methimazole|methimazole|mesh-list
57053340|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
57053341|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
57053342|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
57053343|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57053344|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053345|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
57053346|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053347|NCT04828564|Ribavirin|ribavirin|mesh-list
57053348|NCT04828564|Favipiravir|favipiravir|mesh-list
57053349|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
57053350|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053351|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
57053352|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053353|NCT03435302|Temozolomide|temozolomide|mesh-list
57053354|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053355|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57053356|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
57053357|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053358|NCT04973150|Anesthetics|anesthetics|mesh-list
57053359|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053360|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053361|NCT04950608|Psilocybin|psilocybin|mesh-list
57053362|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
57053363|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053364|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57053365|NCT03433196|Atorvastatin|atorvastatin|mesh-list
57053366|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57053367|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57053368|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
57053369|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053370|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57053371|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57053372|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053373|NCT02792829|Lenvatinib|lenvatinib|mesh-list
57053374|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053375|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57053376|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053377|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053378|NCT02066571|Droxidopa|droxidopa|mesh-list
57053379|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57053380|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57053381|NCT02066649|Carvedilol|carvedilol|mesh-list
57053382|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57053383|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57053384|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
57053385|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053386|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053387|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053388|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57053389|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
57053390|NCT02066649|Protective Agents|protective agents|mesh-ancestor
57053391|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57053392|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57053393|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57053394|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
57053395|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57053396|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57053397|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
57053398|NCT02070003|Narcotics|narcotics|mesh-ancestor
56735377|NCT00798252|Paclitaxel|paclitaxel|mesh-list
57053399|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053400|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053401|NCT02070003|Analgesics|analgesics|mesh-ancestor
57053402|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
57053403|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053404|NCT02070159|Clopidogrel|clopidogrel|mesh-list
57053405|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57053406|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57053407|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57053408|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57053409|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57053410|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
57053411|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053412|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053413|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053414|NCT05619328|Vitamins|vitamins|mesh-list
57053415|NCT05619328|Vitamin B Complex|vitamin b complex|mesh-list
57053416|NCT05619328|Micronutrients|micronutrients|mesh-ancestor
57053417|NCT05619328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053418|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
57053419|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
57053420|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57053421|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053422|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57053423|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57053424|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053425|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053426|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053427|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57053428|NCT04827784|Anesthetics|anesthetics|mesh-list
57053429|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
57053430|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053431|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053432|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
57053433|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053434|NCT03986996|Amoxicillin|amoxicillin|mesh-list
57053435|NCT03986996|Metronidazole|metronidazole|mesh-list
57053436|NCT03986996|Doxycycline|doxycycline|mesh-list
57053437|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57053438|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053439|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57053440|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57053441|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
57053442|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
57053443|NCT04796428|Empagliflozin|empagliflozin|mesh-list
57053444|NCT04796428|Canagliflozin|canagliflozin|mesh-list
57053445|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57053446|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053447|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57053448|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053449|NCT03432728|Anesthetics|anesthetics|mesh-list
57053450|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053451|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053452|NCT04450160|Temozolomide|temozolomide|mesh-list
57053453|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57053454|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
57053455|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053456|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053457|NCT03432572|Riboflavin|riboflavin|mesh-list
57053458|NCT03432572|Thiamine|thiamine|mesh-list
57053459|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
57053460|NCT03432572|Vitamins|vitamins|mesh-ancestor
57053461|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
57053462|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053463|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57053464|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
57053465|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
57053466|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
57053467|NCT03854370|Povidone|povidone|mesh-list
57053468|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57053469|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053470|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
57053471|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
57053472|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
57053473|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
57053474|NCT02805504|Bupivacaine|bupivacaine|mesh-list
57053475|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
57053476|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
57053477|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053478|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053479|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
57053480|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053481|NCT02783508|Meperidine|meperidine|mesh-list
57053482|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
57053483|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57053484|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
57053485|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
57053486|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053487|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053488|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053489|NCT02783508|Analgesics|analgesics|mesh-ancestor
57053490|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
57053491|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053492|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57053493|NCT02783508|Narcotics|narcotics|mesh-ancestor
57053494|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57053495|NCT02071407|Midazolam|midazolam|mesh-list
57053496|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57053497|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57053498|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053499|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053500|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57053501|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57053502|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57053503|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57053504|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
57053505|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
57053506|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
57053507|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
57053508|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053509|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053510|NCT02281266|Entecavir|entecavir|mesh-list
57053511|NCT02281266|Thymalfasin|thymalfasin|mesh-list
57053512|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
57053513|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053514|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57053515|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
57053516|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053517|NCT00625326|Calcipotriene|calcipotriene|mesh-list
57053518|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
57053519|NCT03434054|Losartan|losartan|mesh-list
57053520|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57053521|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57053522|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57053523|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57053524|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053525|NCT03433976|Anesthetics|anesthetics|mesh-list
57053526|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053527|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053528|NCT04473144|Urinastatin|urinastatin|mesh-list
57053529|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57053530|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57053531|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
57053532|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053533|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053534|NCT02605642|Infliximab|infliximab|mesh-list
57053535|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
57053536|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57053537|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57053538|NCT00624858|Naltrexone|naltrexone|mesh-list
57053539|NCT00624858|Bupropion|bupropion|mesh-list
57053540|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57053541|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57053542|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053543|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
57053544|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053545|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57053546|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
57053547|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57053548|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57053549|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57053550|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57053551|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631067|NCT02741154|Letrozole|letrozole|mesh-list
57053552|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
57053553|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053554|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57053555|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57053556|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053557|NCT03128528|Empagliflozin|empagliflozin|mesh-list
57053558|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57053559|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053560|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57053561|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053562|NCT02071641|Sunitinib|sunitinib|mesh-list
57053563|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053564|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57053565|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57053566|NCT02071641|Growth Substances|growth substances|mesh-ancestor
57053567|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053568|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
57053569|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57053570|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053571|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053572|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
57053573|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57053574|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57053575|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053576|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
57053577|NCT02253810|Coagulants|coagulants|mesh-ancestor
57053578|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
57053579|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
57053580|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053581|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
57053582|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053583|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053584|NCT03298893|Nivolumab|nivolumab|mesh-list
57053585|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053586|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57053587|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57053588|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053589|NCT04673786|Ustekinumab|ustekinumab|mesh-list
57053590|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
57053591|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
57053592|NCT00673062|Ephedrine|ephedrine|mesh-list
57053593|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57053594|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
57053595|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053596|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053597|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57053598|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
57053599|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
57053600|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57053601|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57053602|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
57053603|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
57053604|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053605|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053606|NCT03559803|Cisplatin|cisplatin|mesh-list
57053607|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053608|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
57053609|NCT03439358|Analgesics|analgesics|mesh-ancestor
57053610|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
57053611|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053612|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053613|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
57053614|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053615|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57053616|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
57053617|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57053618|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57053619|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053620|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57053621|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
57053622|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57053623|NCT02072031|Sunitinib|sunitinib|mesh-list
57053624|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053625|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57053626|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57053627|NCT02072031|Growth Substances|growth substances|mesh-ancestor
57053628|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053629|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
57053630|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57053631|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053632|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053634|NCT05616442|Ketotifen|ketotifen|mesh-list
57053635|NCT05616442|Vitamins|vitamins|mesh-ancestor
57053636|NCT05616442|Micronutrients|micronutrients|mesh-ancestor
57053637|NCT05616442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053638|NCT05616442|Antioxidants|antioxidants|mesh-ancestor
57053639|NCT05616442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053640|NCT05616442|Protective Agents|protective agents|mesh-ancestor
57053641|NCT05616442|Antipruritics|antipruritics|mesh-ancestor
57053642|NCT05616442|Dermatologic Agents|dermatologic agents|mesh-ancestor
57053643|NCT05616442|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57053644|NCT05616442|Histamine Antagonists|histamine antagonists|mesh-ancestor
57053645|NCT05616442|Histamine Agents|histamine agents|mesh-ancestor
57053646|NCT05616442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053647|NCT05616442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57053648|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
57053649|NCT02065401|Antacids|antacids|mesh-ancestor
57053650|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053651|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57053652|NCT00620256|Timolol|timolol|mesh-list
57053653|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57053654|NCT00620256|Latanoprost|latanoprost|mesh-list
57053655|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57053656|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57053657|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57053658|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
57053659|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053660|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053661|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053662|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57053663|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57053664|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
57053665|NCT04805710|Clopidogrel|clopidogrel|mesh-list
57053666|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57053667|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57053668|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57053669|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57053670|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
57053671|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053672|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053673|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053674|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57053675|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
57053676|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57053677|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
57053678|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053679|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
57053680|NCT02076477|Docetaxel|docetaxel|mesh-list
57053681|NCT02076477|Pemetrexed|pemetrexed|mesh-list
57053682|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053683|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
57053684|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
57053685|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
57053686|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053687|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053688|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57053689|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57053690|NCT04879550|Antithrombins|antithrombins|mesh-list
57053691|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
57053692|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57053693|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
57053694|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053695|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053696|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
57053697|NCT00613002|Testosterone|testosterone|mesh-list
57053698|NCT00613002|Androgens|androgens|mesh-ancestor
57053699|NCT00613002|Hormones|hormones|mesh-ancestor
56735690|NCT00933309|Metformin|metformin|mesh-list
57053700|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57053701|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053702|NCT02076945|Lidocaine|lidocaine|mesh-list
57053703|NCT02076945|Bupivacaine|bupivacaine|mesh-list
57053704|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
57053705|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
57053706|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053707|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053708|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
57053709|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053710|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57053711|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57053712|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57053713|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57053714|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053715|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
57053716|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57053717|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053718|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
57053719|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
57053720|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57053721|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57053722|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
57053723|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053724|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053725|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57053726|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
57053727|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
57053728|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57053729|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
57053730|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053731|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053732|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57053733|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57053734|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57053735|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
57053736|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57053737|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57053738|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
57053739|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053740|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57053741|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57053742|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57053743|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
57053744|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053745|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57053746|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57053747|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053748|NCT02732912|Zopiclone|zopiclone|mesh-list
57053749|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57053750|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053751|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053752|NCT02792517|Erenumab|erenumab|mesh-list
57053753|NCT02792517|Norgestimate|norgestimate|mesh-list
57053754|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
57053755|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
57053756|NCT02792517|Estradiol|estradiol|mesh-list
57053757|NCT02792517|Estrogens|estrogens|mesh-ancestor
57053758|NCT02792517|Hormones|hormones|mesh-ancestor
57053759|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57053760|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053761|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57053762|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57053763|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57053764|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57053765|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053766|NCT02792517|Analgesics|analgesics|mesh-ancestor
57053767|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
57053768|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053769|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57053770|NCT03431714|Artesunate|artesunate|mesh-list
57053771|NCT03431714|Piperaquine|piperaquine|mesh-list
57053772|NCT03431714|Amodiaquine|amodiaquine|mesh-list
57053773|NCT03431714|Artenimol|artenimol|mesh-list
57053774|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
56735757|NCT00757874|Hormones|hormones|mesh-ancestor
57053775|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57053776|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57053777|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053778|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053779|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
57053780|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
57053781|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57053782|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
57053783|NCT03433586|Aspirin|aspirin|mesh-list
57053784|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57053785|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053786|NCT03433586|Analgesics|analgesics|mesh-ancestor
57053787|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
57053788|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053789|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053790|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57053791|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57053792|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57053793|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57053794|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053795|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57053796|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57053797|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053798|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
57053799|NCT03431558|Lactoferrin|lactoferrin|mesh-list
57053800|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053801|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
57053802|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053803|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
57053804|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053805|NCT02273622|Protective Agents|protective agents|mesh-ancestor
57053806|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053807|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57053808|NCT02077803|Metformin|metformin|mesh-list
57053809|NCT02077803|Canagliflozin|canagliflozin|mesh-list
57053810|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57053811|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053812|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57053813|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053814|NCT03897998|Naloxone|naloxone|mesh-list
57053815|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57053816|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053817|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
57053818|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053819|NCT03126435|Gemcitabine|gemcitabine|mesh-list
57053820|NCT03126435|Paclitaxel|paclitaxel|mesh-list
57053821|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57053822|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
57053823|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053824|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053825|NCT03126435|Antiviral Agents|antiviral agents|mesh-ancestor
57053826|NCT03126435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053827|NCT03126435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053828|NCT03126435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57053829|NCT03126435|Immunologic Factors|immunologic factors|mesh-ancestor
57053830|NCT03126435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053831|NCT03126435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57053832|NCT03126435|Tubulin Modulators|tubulin modulators|mesh-ancestor
57053833|NCT03126435|Antimitotic Agents|antimitotic agents|mesh-ancestor
57053834|NCT03126435|Mitosis Modulators|mitosis modulators|mesh-ancestor
57053835|NCT03336398|Ketamine|ketamine|mesh-list
57053836|NCT03336398|Analgesics|analgesics|mesh-ancestor
57053837|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
57053838|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053839|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053840|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57053841|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57053842|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
57053843|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
57053844|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053845|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57053846|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57053847|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053848|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053849|NCT02072811|Cytarabine|cytarabine|mesh-list
57053851|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
57053852|NCT02072811|Cladribine|cladribine|mesh-list
57053853|NCT02072811|Lenograstim|lenograstim|mesh-list
57053854|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57053855|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
57053856|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053857|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053858|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
57053859|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053860|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57053861|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
57053862|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053863|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57053864|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57053865|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57053866|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053867|NCT02072811|Analgesics|analgesics|mesh-ancestor
57053868|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
57053869|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053870|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57053871|NCT02080377|Glyburide|glyburide|mesh-list
57053872|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57053873|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053874|NCT02072967|Rituximab|rituximab|mesh-list
57053875|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57053876|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57053877|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053878|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
57053879|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053880|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57053881|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57053882|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
57053883|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053884|NCT02073357|Anesthetics|anesthetics|mesh-list
57053885|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053886|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053887|NCT02073669|Interferons|interferons|mesh-list
57053888|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
57053889|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053890|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
57053891|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57053892|NCT03428282|Anesthetics|anesthetics|mesh-list
57053893|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053894|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053895|NCT00463242|S 20098|s 20098|mesh-list
57053896|NCT00463242|Paroxetine|paroxetine|mesh-list
57053897|NCT00463242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57053898|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57053899|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57053900|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053901|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053902|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
57053903|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053904|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57053905|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
57053906|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57053907|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57053908|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57053909|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053910|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57053911|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053912|NCT02074137|Prednisone|prednisone|mesh-list
57053913|NCT02074137|Prednisolone|prednisolone|mesh-list
57053914|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57053915|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
57053916|NCT02074137|Hormones|hormones|mesh-ancestor
57053917|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57053918|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053919|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57053920|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053921|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57053922|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57053923|NCT00594984|Irinotecan|irinotecan|mesh-list
57053924|NCT00594984|Cetuximab|cetuximab|mesh-list
57053925|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57053926|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57053927|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053928|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053929|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57053930|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57053932|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57053933|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053934|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57053935|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053936|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053937|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57053938|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57053939|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
57053940|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053941|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
57053942|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57053943|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57053944|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053945|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053946|NCT03422978|Analgesics|analgesics|mesh-ancestor
57053947|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
57053948|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053949|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57053950|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57053951|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57053952|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
57053953|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053954|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053955|NCT02278692|Vitamin K|vitamin k|mesh-list
57053956|NCT02278692|Vitamins|vitamins|mesh-ancestor
57053957|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
57053958|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053959|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57053960|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57053961|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053962|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
57053963|NCT02278692|Coagulants|coagulants|mesh-ancestor
57053964|NCT02281968|Naproxen|naproxen|mesh-list
57053965|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57053966|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57053967|NCT02281968|Analgesics|analgesics|mesh-ancestor
57053968|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
57053969|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053970|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053971|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57053972|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57053973|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
57053974|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57053975|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053976|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053977|NCT02080845|Theobromine|theobromine|mesh-list
57053978|NCT02080845|Caffeine|caffeine|mesh-list
57053979|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57053980|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57053981|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57053982|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57053983|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57053984|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57053985|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57053986|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
57053987|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57053988|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57053989|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
57053990|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57053991|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57053992|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
57053993|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
57053994|NCT02284230|Liraglutide|liraglutide|mesh-list
57053995|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57053996|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735977|NCT00677534|Vitamins|vitamins|mesh-ancestor
57053997|NCT02284230|Incretins|incretins|mesh-ancestor
57053998|NCT02284230|Hormones|hormones|mesh-ancestor
57053999|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57054000|NCT02792088|Tenofovir|tenofovir|mesh-list
57054001|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
57054002|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054003|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57054004|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57054005|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054006|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054007|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57054008|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57054009|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57054010|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57054011|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57054012|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054013|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054014|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57054015|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054016|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054017|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
57054018|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054019|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
57054020|NCT00451152|Anecortave|anecortave|mesh-list
57054021|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57054022|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57054023|NCT00451152|Growth Substances|growth substances|mesh-ancestor
57054024|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054025|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
57054026|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054027|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054028|NCT02078583|Fentanyl|fentanyl|mesh-list
57054029|NCT02078583|Remifentanil|remifentanil|mesh-list
57054030|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57054031|NCT02078583|Narcotics|narcotics|mesh-ancestor
57054032|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054033|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054034|NCT02078583|Analgesics|analgesics|mesh-ancestor
57054035|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
57054036|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054037|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57054038|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57054039|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
57054040|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
57054041|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
57054042|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
57054043|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054044|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054045|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054046|NCT03069638|Analgesics|analgesics|mesh-ancestor
57054047|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
57054048|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054049|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57054050|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57054051|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57054052|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
57054053|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054054|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054055|NCT02948660|Zolpidem|zolpidem|mesh-list
57054056|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57054057|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57054058|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054059|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054060|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57054061|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
57054062|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
57054063|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054064|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054065|NCT02074605|Interferons|interferons|mesh-list
57054066|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
57054067|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054068|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
57054069|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054070|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
57054071|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054072|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
57054073|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57054074|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054075|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57054076|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57054077|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054078|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054079|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054080|NCT00583830|Paclitaxel|paclitaxel|mesh-list
57054081|NCT00583830|Carboplatin|carboplatin|mesh-list
57054082|NCT00583830|Mapatumumab|mapatumumab|mesh-list
57054083|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57054084|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57054085|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054086|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
57054087|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
57054088|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
57054089|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054090|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
57054091|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054092|NCT03430544|Cariprazine|cariprazine|mesh-list
57054093|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57054094|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57054095|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054096|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054097|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57054098|NCT00583674|Cisplatin|cisplatin|mesh-list
57054099|NCT00583674|Capecitabine|capecitabine|mesh-list
57054100|NCT00583674|Trebananib|trebananib|mesh-list
57054101|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054102|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57054103|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
57054104|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054105|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57054106|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57054107|NCT00583674|Growth Substances|growth substances|mesh-ancestor
57054108|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054109|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
57054111|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054112|NCT03430466|Fulvestrant|fulvestrant|mesh-list
57054113|NCT03430466|Tremelimumab|tremelimumab|mesh-list
57054114|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57054115|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054116|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57054117|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57054118|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
57054119|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57054120|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054121|NCT02280174|Linagliptin|linagliptin|mesh-list
57054122|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57054123|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054124|NCT02280174|Incretins|incretins|mesh-ancestor
57054125|NCT02280174|Hormones|hormones|mesh-ancestor
57054126|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57054127|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57054128|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
57054129|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054130|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054131|NCT00447564|Buprenorphine|buprenorphine|mesh-list
57054132|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57054133|NCT00447564|Narcotics|narcotics|mesh-ancestor
57054134|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054135|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054136|NCT00447564|Analgesics|analgesics|mesh-ancestor
57054137|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
57054138|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054139|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57054140|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
57054141|NCT00576810|Cathartics|cathartics|mesh-ancestor
57054142|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57054143|NCT00576342|Timolol|timolol|mesh-list
57054144|NCT00576342|Dorzolamide|dorzolamide|mesh-list
57054145|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57054146|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57054147|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57054148|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57054149|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
57054150|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054151|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054152|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054153|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57054154|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57054155|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57054156|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054157|NCT02282280|Prilocaine|prilocaine|mesh-list
57054158|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
57054159|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
57054160|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054161|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054162|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
57054163|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054164|NCT00442104|Ganaxolone|ganaxolone|mesh-list
57054165|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
57054166|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054167|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054168|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054169|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
57054170|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
57054171|NCT03429998|Evolocumab|evolocumab|mesh-list
57054172|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57054173|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57054174|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57054175|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
57054176|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054177|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57054178|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
57054179|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054180|NCT00658008|Paroxetine|paroxetine|mesh-list
57054181|NCT00658008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57054182|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57054183|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054184|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054185|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054186|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
57054187|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054188|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57054189|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
57054190|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57054191|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57054192|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57054193|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054194|NCT03427502|Epinephrine|epinephrine|mesh-list
57054195|NCT03427502|Bupivacaine|bupivacaine|mesh-list
57054196|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
57054197|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
57054198|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054199|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054200|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
57054201|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054202|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57054203|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57054204|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
57054205|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054206|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054207|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57054208|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57054209|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
57054210|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57054211|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
57054212|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
57054213|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
57054214|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57054215|NCT00440388|Rituximab|rituximab|mesh-list
57054216|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57054217|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054218|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
57054219|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054220|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054221|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57054222|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57054223|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054224|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
57054225|NCT04449224|Etanercept|etanercept|mesh-list
57054226|NCT04449224|Abatacept|abatacept|mesh-list
57054227|NCT04449224|Tofacitinib|tofacitinib|mesh-list
57054228|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57054229|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054230|NCT04449224|Analgesics|analgesics|mesh-ancestor
57054231|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
57054232|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054233|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054234|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054235|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054236|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57054237|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57054238|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
57054239|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56897859|NCT03863613|Hormones|hormones|mesh-ancestor
57054240|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054241|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054242|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57054243|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054244|NCT00437112|Insulin|insulin|mesh-list
57054245|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57054246|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
57054247|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57054248|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054249|NCT00434850|Gusperimus|gusperimus|mesh-list
57054250|NCT00434850|Sirolimus|sirolimus|mesh-list
57054251|NCT00434850|Etanercept|etanercept|mesh-list
57054252|NCT00434850|Tacrolimus|tacrolimus|mesh-list
57054253|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57054254|NCT00434850|Basiliximab|basiliximab|mesh-list
57054255|NCT00434850|Daclizumab|daclizumab|mesh-list
57054256|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57054257|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
57054258|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054259|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57054260|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054261|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054262|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57054263|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054264|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57054265|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054266|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
57054267|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57054268|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054269|NCT00434850|Analgesics|analgesics|mesh-ancestor
57054270|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
57054271|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054272|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054273|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054274|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57054275|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57054276|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57054277|NCT00434850|Protective Agents|protective agents|mesh-ancestor
57054278|NCT04449380|Interferons|interferons|mesh-list
57054279|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054280|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
57054281|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054282|NCT03128216|Bupivacaine|bupivacaine|mesh-list
57054283|NCT03128216|Ropivacaine|ropivacaine|mesh-list
57054284|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
57054285|NCT03128216|Anesthetics|anesthetics|mesh-list
57054286|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054287|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054288|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
57054289|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054290|NCT00566202|Citalopram|citalopram|mesh-list
57054291|NCT00566202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57054292|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57054293|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054294|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054295|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054296|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
57054297|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054298|NCT00566202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57054299|NCT00566202|Antidepressive Agents|antidepressive agents|mesh-ancestor
57054300|NCT00566202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57054301|NCT02280486|Glimepiride|glimepiride|mesh-list
57054302|NCT02280486|Saxagliptin|saxagliptin|mesh-list
57054303|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57054304|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57054305|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054306|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57054307|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
57054308|NCT02280486|Incretins|incretins|mesh-ancestor
57054309|NCT02280486|Hormones|hormones|mesh-ancestor
57054310|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57054311|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57054312|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
57054313|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054314|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054315|NCT00434226|Paclitaxel|paclitaxel|mesh-list
57054316|NCT00434226|Bevacizumab|bevacizumab|mesh-list
57054317|NCT00434226|Carboplatin|carboplatin|mesh-list
57054318|NCT00434226|Sunitinib|sunitinib|mesh-list
57054319|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57054320|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054321|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
57054322|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
57054323|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
57054324|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054325|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57054326|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57054327|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57054328|NCT00434226|Growth Substances|growth substances|mesh-ancestor
57054329|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054330|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
57054331|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57054332|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054333|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57054334|NCT00430950|Olmesartan|olmesartan|mesh-list
57054335|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
57054336|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57054337|NCT00430950|Diuretics|diuretics|mesh-ancestor
57054338|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
57054339|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054340|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57054341|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054342|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054343|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57054344|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57054345|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
57054346|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57054347|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57054348|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054349|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054350|NCT02081391|Tapentadol|tapentadol|mesh-list
57054351|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57054352|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57054353|NCT02081391|Narcotics|narcotics|mesh-ancestor
57054354|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054355|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054356|NCT02081391|Analgesics|analgesics|mesh-ancestor
57054357|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
57054358|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054359|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57054360|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57054361|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054362|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054363|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
57054364|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054365|NCT00549510|Lisinopril|lisinopril|mesh-list
57054366|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57054367|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
57054368|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054369|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054370|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57054372|NCT00549510|Protective Agents|protective agents|mesh-ancestor
57054373|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054374|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
57054375|NCT00430092|Difluprednate|difluprednate|mesh-list
57054376|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
57054377|NCT00430092|Hormones|hormones|mesh-ancestor
57054378|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57054379|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054380|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054381|NCT00427440|Rilotumumab|rilotumumab|mesh-list
57054382|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57054383|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57054384|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054385|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
57054386|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054387|NCT00650832|Darunavir|darunavir|mesh-list
57054388|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57054389|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57054390|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
57054391|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054392|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054393|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57054394|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57054395|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
57054396|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054397|NCT00425100|Fesoterodine|fesoterodine|mesh-list
57054398|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57054399|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57054400|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
57054401|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054402|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054403|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054404|NCT00425100|Urological Agents|urological agents|mesh-ancestor
57054405|NCT00546780|Bortezomib|bortezomib|mesh-list
57054406|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054407|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57054408|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
57054409|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
57054410|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054411|NCT00543582|Azacitidine|azacitidine|mesh-list
57054412|NCT00543582|Mocetinostat|mocetinostat|mesh-list
57054413|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57054414|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
57054415|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054416|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054417|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054418|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57054419|NCT00542724|Insulin|insulin|mesh-list
57054420|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57054421|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57054422|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054423|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57054424|NCT00412932|Olmesartan|olmesartan|mesh-list
57054425|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
57054426|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57054427|NCT00412932|Diuretics|diuretics|mesh-ancestor
57054428|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
57054429|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054430|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57054431|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054432|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054433|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57054434|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57054435|NCT00411528|Prednisone|prednisone|mesh-list
57054436|NCT00411528|Docetaxel|docetaxel|mesh-list
57054437|NCT00411528|Epothilone B|epothilone b|mesh-list
57054438|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054439|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
57054440|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
57054441|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
57054442|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054443|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054444|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
57054445|NCT00411528|Hormones|hormones|mesh-ancestor
56736454|NCT01055431|Iron|iron|mesh-list
57054446|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57054447|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054448|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57054449|NCT00384150|Galiximab|galiximab|mesh-list
57054450|NCT00384150|Rituximab|rituximab|mesh-list
57054451|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57054452|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054453|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
57054454|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054455|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054456|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054457|NCT00532038|Ketoprofen|ketoprofen|mesh-list
57054458|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57054459|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054460|NCT00532038|Analgesics|analgesics|mesh-ancestor
57054461|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
57054462|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632092|NCT05571514|Antacids|antacids|mesh-ancestor
57054463|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054464|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054465|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054466|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57054467|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054468|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054469|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
57054470|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57054471|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054472|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57054473|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
57054474|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57054475|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054476|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054477|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054478|NCT00401388|Allopurinol|allopurinol|mesh-list
57054479|NCT00401388|Antiemetics|antiemetics|mesh-list
57054480|NCT00401388|Loperamide|loperamide|mesh-list
57054481|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
57054482|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
57054483|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054484|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054485|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
57054486|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054487|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57054488|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
57054489|NCT00401388|Protective Agents|protective agents|mesh-ancestor
57054490|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054491|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57054492|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
57054493|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054494|NCT02282826|Acyclovir|acyclovir|mesh-list
57054495|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
57054496|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054497|NCT00374166|Paroxetine|paroxetine|mesh-list
57054498|NCT00374166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57054499|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57054500|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054501|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054502|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054503|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
57054504|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054505|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57054506|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
57054507|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57054508|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57054509|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57054510|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054511|NCT03559413|Imiquimod|imiquimod|mesh-list
57054512|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57054513|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
57054514|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054515|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054516|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
57054517|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
57054518|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57054519|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57054520|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57054521|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054522|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054523|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
57054524|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054525|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054526|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57054527|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054528|NCT02078973|Tolvaptan|tolvaptan|mesh-list
57054529|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57054530|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054531|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
57054532|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054533|NCT00397254|Rizatriptan|rizatriptan|mesh-list
57054534|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57054535|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
57054536|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054537|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054538|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054539|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
57054540|NCT01369641|Cisplatin|cisplatin|mesh-list
57054541|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054542|NCT01369641|Antidotes|antidotes|mesh-ancestor
57054543|NCT01369641|Protective Agents|protective agents|mesh-ancestor
57054544|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054545|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
57054546|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054547|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
57054548|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57054549|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054550|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
57054551|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
57054552|NCT02283060|Tenofovir|tenofovir|mesh-list
57054553|NCT02283060|Emtricitabine|emtricitabine|mesh-list
57054554|NCT02283060|Efavirenz|efavirenz|mesh-list
57054555|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57054556|NCT02283060|Cobicistat|cobicistat|mesh-list
57054557|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57054558|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57054559|NCT02283060|Elvitegravir|elvitegravir|mesh-list
57054560|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
57054561|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054562|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57054563|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57054564|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054565|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054566|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57054567|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57054568|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57054569|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57054570|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57054571|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57054572|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57054573|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57054574|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57054575|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57054576|NCT03559725|Menthol|menthol|mesh-list
57054577|NCT03559725|Nicotine|nicotine|mesh-list
57054578|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57054579|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
57054580|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054581|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054582|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57054583|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57054584|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
57054585|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054586|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054587|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
57054588|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
57054589|NCT00529152|Deferiprone|deferiprone|mesh-list
57054590|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57054591|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
57054592|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
57054593|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054594|NCT00525330|Metformin|metformin|mesh-list
57054595|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57054596|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054597|NCT02287272|Cimetidine|cimetidine|mesh-list
57054598|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57054599|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57054600|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57054601|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
57054602|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
57054603|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054604|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054605|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054606|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57054607|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57054608|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054609|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
57054610|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57054611|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054612|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57054613|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57054614|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054615|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054616|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054617|NCT04470414|Antibodies|antibodies|mesh-list
57054618|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
57054619|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
57054620|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054621|NCT00363636|Galiximab|galiximab|mesh-list
57054622|NCT00363636|Rituximab|rituximab|mesh-list
57054623|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57054624|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054625|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
57054626|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054627|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054628|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054629|NCT02605174|Lasmiditan|lasmiditan|mesh-list
57054630|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57054631|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
57054632|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054633|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054634|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054635|NCT00522834|Paclitaxel|paclitaxel|mesh-list
57054636|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57054637|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054638|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
57054639|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
57054640|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
57054641|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054642|NCT02075619|Amlodipine|amlodipine|mesh-list
57054643|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57054644|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57054645|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57054646|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054647|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054648|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57054649|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054650|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
57054651|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57054652|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57054653|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
57054654|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57054655|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57054656|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054657|NCT00358878|Satavaptan|satavaptan|mesh-list
57054658|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57054659|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054660|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
57054661|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054662|NCT02283372|Gemcitabine|gemcitabine|mesh-list
57054663|NCT02283372|Paclitaxel|paclitaxel|mesh-list
57054664|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57054665|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57054666|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054667|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
57054668|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
57054669|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
57054670|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054671|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57054672|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
57054673|NCT02283372|Antiviral Agents|antiviral agents|mesh-ancestor
57054674|NCT02283372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054675|NCT02283372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054676|NCT02283372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57054677|NCT02283372|Immunologic Factors|immunologic factors|mesh-ancestor
57054678|NCT02283372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054679|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56897971|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054680|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57054681|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57054682|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57054683|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054684|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054685|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054686|NCT00507936|Analgesics|analgesics|mesh-ancestor
57054687|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
57054688|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054689|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
57054690|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57054691|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
57054692|NCT04427020|Caseins|caseins|mesh-list
57054693|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
57054694|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
57054695|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054696|NCT02083575|Vitamins|vitamins|mesh-list
57054697|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
57054698|NCT02083575|Deferiprone|deferiprone|mesh-list
57054699|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
57054700|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054701|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
57054702|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054703|NCT02083575|Protective Agents|protective agents|mesh-ancestor
57054704|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57054705|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
57054706|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
57054707|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
57054708|NCT02286258|Edetic Acid|edetic acid|mesh-list
57054709|NCT02286258|Calcium|calcium|mesh-list
57054710|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57054711|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054712|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57054713|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
57054714|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
57054715|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054716|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
57054717|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57054718|NCT02088411|Diclofenac|diclofenac|mesh-list
57054719|NCT02088411|Wobenzym|wobenzym|mesh-list
57054720|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57054721|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054722|NCT02088411|Analgesics|analgesics|mesh-ancestor
57054723|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
57054724|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054725|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054726|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054727|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054728|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57054729|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054730|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054731|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57054732|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
57054733|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
57054734|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
57054735|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054736|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054737|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054738|NCT02604550|Naproxen|naproxen|mesh-list
57054739|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
57054740|NCT02604550|Ropivacaine|ropivacaine|mesh-list
57054741|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
57054742|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
57054743|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054744|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054745|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
57054746|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054747|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57054748|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054749|NCT02604550|Analgesics|analgesics|mesh-ancestor
57054750|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054751|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054752|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
57054753|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57054754|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054755|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054756|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57054757|NCT02604550|Narcotics|narcotics|mesh-ancestor
57054758|NCT02084043|Amikacin|amikacin|mesh-list
57054759|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57054760|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054761|NCT03530670|Midazolam|midazolam|mesh-list
57054762|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57054763|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57054764|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054765|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054766|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57054767|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57054768|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57054769|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57054770|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
57054771|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
57054772|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
57054773|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
57054774|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054775|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054776|NCT00120042|Misoprostol|misoprostol|mesh-list
57054777|NCT00120042|Oxytocin|oxytocin|mesh-list
57054778|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
57054779|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57054780|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054781|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57054782|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
57054783|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57054784|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57054785|NCT02084355|Fentanyl|fentanyl|mesh-list
57054786|NCT02084355|Oxycodone|oxycodone|mesh-list
57054787|NCT02084355|Hydromorphone|hydromorphone|mesh-list
57054788|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57054789|NCT02084355|Narcotics|narcotics|mesh-ancestor
57054790|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054791|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054792|NCT02084355|Analgesics|analgesics|mesh-ancestor
57054793|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
57054794|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054795|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57054796|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57054797|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
57054798|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
57054799|NCT00353574|Darusentan|darusentan|mesh-list
57054800|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57054801|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054802|NCT02082405|Dexamethasone|dexamethasone|mesh-list
57054803|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
57054804|NCT02082405|Bortezomib|bortezomib|mesh-list
57054805|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57054806|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
57054807|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054808|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054809|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57054810|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
57054811|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054812|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054813|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57054814|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736799|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57054815|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
57054816|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
57054817|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054818|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57054819|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
57054820|NCT02082405|Hormones|hormones|mesh-ancestor
57054821|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57054822|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57054823|NCT04428268|Chloroquine|chloroquine|mesh-list
57054824|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
57054825|NCT04428268|Losartan|losartan|mesh-list
57054826|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57054827|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57054828|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57054829|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57054830|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054831|NCT04428268|Amebicides|amebicides|mesh-ancestor
57054832|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57054833|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57054834|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054835|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
57054836|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57054837|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57054838|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054839|NCT04428268|Analgesics|analgesics|mesh-ancestor
57054840|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
57054841|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054842|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054843|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054844|NCT04428268|Filaricides|filaricides|mesh-ancestor
57054845|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
57054846|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
57054847|NCT02084433|Anesthetics|anesthetics|mesh-list
57054848|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054849|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054850|NCT00116298|Lamivudine|lamivudine|mesh-list
57054851|NCT00116298|Efavirenz|efavirenz|mesh-list
57054852|NCT00116298|Stavudine|stavudine|mesh-list
57054853|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57054854|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57054855|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054856|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054857|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
57054858|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054859|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57054860|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57054861|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57054862|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57054863|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57054864|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57054865|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57054866|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57054867|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
57054868|NCT04427098|Enoxaparin|enoxaparin|mesh-list
57054869|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
57054870|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
57054871|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57054872|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57054873|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054874|NCT00352560|Irbesartan|irbesartan|mesh-list
57054875|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57054876|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57054877|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57054878|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054879|NCT00115050|Darunavir|darunavir|mesh-list
57054880|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57054881|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57054882|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
57054883|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054884|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054885|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57054886|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57054887|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
57054888|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57054889|NCT05616364|Dexmedetomidine|dexmedetomidine|mesh-list
57054890|NCT05616364|Tramadol|tramadol|mesh-list
57054891|NCT05616364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56736873|NCT00675506|Hormones|hormones|mesh-list
57054892|NCT05616364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054893|NCT05616364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054894|NCT05616364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054895|NCT05616364|Analgesics|analgesics|mesh-ancestor
57054896|NCT05616364|Sensory System Agents|sensory system agents|mesh-ancestor
57054897|NCT05616364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054898|NCT05616364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57054899|NCT05616364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57054900|NCT05616364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57054901|NCT05616364|Adrenergic Agents|adrenergic agents|mesh-ancestor
57054902|NCT05616364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054903|NCT05616364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054904|NCT05616364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57054905|NCT05616364|Narcotics|narcotics|mesh-ancestor
57054906|NCT00345618|Biotin|biotin|mesh-list
57054907|NCT00345618|Enoxaparin|enoxaparin|mesh-list
57054908|NCT00345618|Warfarin|warfarin|mesh-list
57054909|NCT00345618|Idraparinux|idraparinux|mesh-list
57054910|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
57054911|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
57054912|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57054913|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57054914|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054915|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57054916|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
57054917|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57054918|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
57054919|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57054920|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
57054921|NCT00345618|Vitamins|vitamins|mesh-ancestor
57054922|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
57054923|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054924|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
57054925|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57054926|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054927|NCT01866111|Cenobamate|cenobamate|mesh-list
57054928|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
57054929|NCT02084589|Fentanyl|fentanyl|mesh-list
57054930|NCT02084589|Ropivacaine|ropivacaine|mesh-list
57054931|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
57054932|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
57054933|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054934|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054935|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
57054936|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054937|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57054938|NCT02084589|Narcotics|narcotics|mesh-ancestor
57054939|NCT02084589|Analgesics|analgesics|mesh-ancestor
57054940|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57054941|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57054942|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
57054943|NCT03557853|Golimumab|golimumab|mesh-list
57054944|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57054945|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57054946|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57054947|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
57054948|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054949|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
57054950|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57054951|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054952|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054953|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054954|NCT04346290|Analgesics|analgesics|mesh-ancestor
57054955|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
57054956|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054957|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57054958|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57054959|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57054960|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
57054961|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054962|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054963|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
57054964|NCT04426552|Sevoflurane|sevoflurane|mesh-list
57054965|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57054966|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57054967|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054968|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57054970|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
57054971|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57054972|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57054973|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57054974|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57054975|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
57054976|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57054977|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054978|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57054979|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57054980|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
57054981|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
57054982|NCT04803370|Antibodies|antibodies|mesh-list
57054983|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
57054984|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57054985|NCT01369329|Ustekinumab|ustekinumab|mesh-list
57054986|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
57054987|NCT04802980|Gemcitabine|gemcitabine|mesh-list
57054988|NCT04802980|Paclitaxel|paclitaxel|mesh-list
57054989|NCT04802980|Carboplatin|carboplatin|mesh-list
57054990|NCT04802980|Capecitabine|capecitabine|mesh-list
57054991|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
57054992|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57054993|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57054994|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
57054995|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
57054996|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
57054997|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57054998|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57054999|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
57055000|NCT04802980|Antiviral Agents|antiviral agents|mesh-ancestor
57055001|NCT04802980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055002|NCT04802980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055003|NCT04802980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57055004|NCT04802980|Immunologic Factors|immunologic factors|mesh-ancestor
57055005|NCT04802980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055006|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
57055007|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57055008|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57055009|NCT03558477|Esomeprazole|esomeprazole|mesh-list
57055010|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57055011|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57055012|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57055013|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055014|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055015|NCT04792840|Letrozole|letrozole|mesh-list
57055016|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055017|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57055018|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57055019|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055020|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055021|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57055022|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
57055023|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055024|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055025|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
57055026|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
57055027|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
57055028|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
57055029|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
57055030|NCT02085291|Norepinephrine|norepinephrine|mesh-list
57055031|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57055032|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57055033|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
57055034|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055035|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055036|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055037|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
57055038|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
56904748|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57055039|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055040|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57055041|NCT04792138|Phenobarbital|phenobarbital|mesh-list
57055042|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
56737029|NCT02559674|Gemcitabine|gemcitabine|mesh-list
57055043|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57055044|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055045|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055046|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57055047|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57055048|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055049|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055050|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
57055051|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
57055052|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57055053|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57055054|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57055055|NCT04802122|Propofol|propofol|mesh-list
57055056|NCT04802122|Sevoflurane|sevoflurane|mesh-list
57055057|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57055058|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055059|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055060|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57055061|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
57055062|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
57055063|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57055064|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57055065|NCT04784728|Lidocaine|lidocaine|mesh-list
57055066|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
57055067|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
57055068|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055069|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055070|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
57055071|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055072|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57055073|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57055074|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57055075|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57055076|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055077|NCT02085603|Saracatinib|saracatinib|mesh-list
57055078|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055079|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055080|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055081|NCT02090829|Oxytocin|oxytocin|mesh-list
57055082|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
57055083|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57055084|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055085|NCT04801888|Vaccines|vaccines|mesh-list
57055086|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
57055087|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055088|NCT02089503|Ranibizumab|ranibizumab|mesh-list
57055089|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57055090|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57055091|NCT02089503|Growth Substances|growth substances|mesh-ancestor
57055092|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055093|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
57055094|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055095|NCT02091063|Ricolinostat|ricolinostat|mesh-list
57055096|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055097|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57055098|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897984|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055099|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055100|NCT02091219|Vitamin D|vitamin d|mesh-list
57055101|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
57055102|NCT02091219|Calcifediol|calcifediol|mesh-list
57055103|NCT02091219|Vitamins|vitamins|mesh-ancestor
57055104|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
57055105|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055106|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57055107|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57055108|NCT02091297|Acetaminophen|acetaminophen|mesh-list
57055109|NCT02091297|Morphine|morphine|mesh-list
57055110|NCT02091297|Ropivacaine|ropivacaine|mesh-list
57055111|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57055112|NCT02091297|Narcotics|narcotics|mesh-ancestor
57055113|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055114|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055115|NCT02091297|Analgesics|analgesics|mesh-ancestor
57055116|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
57055117|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055118|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
57055120|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57055121|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
57055122|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
57055123|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57055124|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57055125|NCT04791202|Prednisolone|prednisolone|mesh-list
57055126|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
57055127|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57055128|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
57055129|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57055130|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
57055131|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
57055132|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055133|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055134|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57055135|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
57055136|NCT04791202|Hormones|hormones|mesh-ancestor
57055137|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055138|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57055139|NCT04791202|Protective Agents|protective agents|mesh-ancestor
57055140|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57055141|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055142|NCT04801342|Memantine|memantine|mesh-list
57055143|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57055144|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57055145|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
57055146|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055147|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055148|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055149|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57055150|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57055151|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57055152|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
57055153|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57055154|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055155|NCT02590588|Idelalisib|idelalisib|mesh-list
57055156|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055157|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055158|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055159|NCT02086227|Glucagon|glucagon|mesh-list
57055160|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57055161|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57055162|NCT02086227|Hormones|hormones|mesh-ancestor
57055163|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055164|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055165|NCT02086227|Incretins|incretins|mesh-ancestor
57055166|NCT02086929|Trazodone|trazodone|mesh-list
56897998|NCT01287351|Hormones|hormones|mesh-ancestor
57055167|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57055168|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57055169|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57055170|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57055171|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055172|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055173|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055174|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57055175|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
57055176|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57055177|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57055178|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57055179|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055180|NCT02086929|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57055181|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
57055182|NCT02249013|Paclitaxel|paclitaxel|mesh-list
57055183|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57055184|NCT02249013|Carboplatin|carboplatin|mesh-list
57055185|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57055186|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055187|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
57055188|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
57055189|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
57055190|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055191|NCT02249871|Omeprazole|omeprazole|mesh-list
57055192|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57055193|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57055194|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57055195|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055196|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055197|NCT02087007|Cilostazol|cilostazol|mesh-list
57055198|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57055199|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
57055200|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055201|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055202|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57055203|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
57055204|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57055205|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57055206|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055207|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57055208|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
57055209|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57055210|NCT02087007|Protective Agents|protective agents|mesh-ancestor
57055211|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57055212|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57055213|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055214|NCT01434602|Everolimus|everolimus|mesh-list
57055215|NCT01434602|Sorafenib|sorafenib|mesh-list
57055216|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055217|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57055218|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
57055219|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055220|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57055221|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055222|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055223|NCT02087475|Fluorouracil|fluorouracil|mesh-list
57055224|NCT02087475|Irinotecan|irinotecan|mesh-list
57055225|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
57055226|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055227|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57055228|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055229|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57055230|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
57055231|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055232|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57055233|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57055234|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055235|NCT03421496|Cannabidiol|cannabidiol|mesh-list
57055236|NCT03421496|Vigabatrin|vigabatrin|mesh-list
57055237|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
57055238|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055239|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055240|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
57055241|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055242|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055243|NCT05486949|Itraconazole|itraconazole|mesh-list
57055244|NCT05486949|Carbamazepine|carbamazepine|mesh-list
57055245|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
57055246|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055247|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57055248|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57055249|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055250|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055251|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57055252|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
57055253|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055254|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055255|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57055256|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
57055257|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
57055258|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57055259|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055260|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57055261|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57055262|NCT05486949|Analgesics|analgesics|mesh-ancestor
57055263|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
57055264|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055265|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56737246|NCT00941343|Urological Agents|urological agents|mesh-ancestor
57055266|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57055267|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57055268|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57055269|NCT03558243|Hemostatics|hemostatics|mesh-list
57055270|NCT03558243|Coagulants|coagulants|mesh-ancestor
57055271|NCT03426956|Canagliflozin|canagliflozin|mesh-list
57055272|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57055273|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055274|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57055275|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055276|NCT03557229|Vitamins|vitamins|mesh-list
57055277|NCT03557229|Vitamin E|vitamin e|mesh-list
57055278|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
57055279|NCT03557229|Melatonin|melatonin|mesh-list
57055280|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57055281|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
57055282|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055283|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
57055284|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055285|NCT03557229|Protective Agents|protective agents|mesh-ancestor
57055286|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055287|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
57055288|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055289|NCT03557229|Expectorants|expectorants|mesh-ancestor
57055290|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
57055291|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57055292|NCT03557229|Antidotes|antidotes|mesh-ancestor
57055293|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57055294|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
57055295|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57055296|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57055297|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57055298|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055299|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055300|NCT00940940|Vaccines|vaccines|mesh-list
57055301|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
57055302|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055303|NCT03557840|Temocillin|temocillin|mesh-list
57055304|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57055305|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055306|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
57055307|NCT02092701|Vitamin D|vitamin d|mesh-list
57055308|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57055309|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055310|NCT02092701|Vitamins|vitamins|mesh-ancestor
57055311|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
57055312|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57055313|NCT01767129|Quinidine|quinidine|mesh-list
57055314|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
57055315|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
57055316|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
57055317|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57055318|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57055319|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055320|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055321|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055322|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57055323|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57055324|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
57055325|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57055326|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
57055327|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57055328|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57055329|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055330|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055331|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57055332|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57055333|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
57055334|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57055335|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57055336|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57055337|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57055338|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57055339|NCT01309191|Minoxidil|minoxidil|mesh-list
57055340|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57055341|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
57055342|NCT03420638|Epinephrine|epinephrine|mesh-list
57055343|NCT03420638|Bupivacaine|bupivacaine|mesh-list
57055344|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
57055345|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
57055346|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055347|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055348|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
57055349|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055350|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57055351|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57055352|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
57055353|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055354|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055355|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57055356|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57055357|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
57055358|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57055359|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
57055360|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
57055361|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
57055362|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57055364|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57055365|NCT00715988|Narcotics|narcotics|mesh-ancestor
57055366|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055367|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055368|NCT00715988|Analgesics|analgesics|mesh-ancestor
57055369|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
57055370|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055371|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
57055372|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
57055373|NCT02093091|Vitremer|vitremer|mesh-list
57055374|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
57055375|NCT02093091|Protective Agents|protective agents|mesh-ancestor
57055376|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055377|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57055378|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
57055379|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055380|NCT03556917|Caffeine|caffeine|mesh-list
57055381|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57055382|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055383|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57055384|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055385|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055386|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57055387|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57055388|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
57055389|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055390|NCT02090439|Silodosin|silodosin|mesh-list
57055391|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57055392|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57055393|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57055394|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
57055395|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055396|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055397|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055398|NCT02090439|Urological Agents|urological agents|mesh-ancestor
57055399|NCT02696564|Losartan|losartan|mesh-list
57055400|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57055401|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57055402|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57055403|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57055404|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055405|NCT02093403|Decitabine|decitabine|mesh-list
57055406|NCT02093403|Azacitidine|azacitidine|mesh-list
57055407|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57055408|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
57055409|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055410|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055411|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055412|NCT03426176|Oxytocin|oxytocin|mesh-list
57055413|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
57055414|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57055415|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055416|NCT02095899|Rufinamide|rufinamide|mesh-list
57055417|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
57055418|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57055419|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57055420|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57055421|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055422|NCT03525002|Bromocriptine|bromocriptine|mesh-list
57055423|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57055424|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57055425|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
57055426|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055427|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055428|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
57055429|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
57055430|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055431|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055432|NCT03426020|Midazolam|midazolam|mesh-list
57055433|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57055434|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57055435|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055436|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055437|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57055438|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57055439|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57055440|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57055441|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
57055442|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
57055443|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
57055444|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
57055445|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055446|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055447|NCT03428906|Oxytocin|oxytocin|mesh-list
57055448|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
57055449|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57055450|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055451|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57055452|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
57055453|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57055454|NCT02521298|Prednisolone|prednisolone|mesh-list
57055455|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
57055456|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57055457|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
57055458|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57055459|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
57055460|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
57055461|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055462|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055463|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57055464|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
57055465|NCT02521298|Hormones|hormones|mesh-ancestor
57055466|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055467|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57055468|NCT02521298|Protective Agents|protective agents|mesh-ancestor
57055469|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57055470|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055471|NCT00389870|Cyclosporine|cyclosporine|mesh-list
57055472|NCT00389870|Irinotecan|irinotecan|mesh-list
57055473|NCT00389870|Panitumumab|panitumumab|mesh-list
57055474|NCT00389870|Cyclosporins|cyclosporins|mesh-list
57055475|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57055476|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57055477|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055478|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055479|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055480|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57055481|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
57055482|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055483|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
57055484|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055485|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
57055486|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57055487|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57055488|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57055489|NCT00295646|Tamoxifen|tamoxifen|mesh-list
57055490|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
57055491|NCT00295646|Anastrozole|anastrozole|mesh-list
57055492|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57055493|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
57055494|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055495|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055496|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57055497|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055498|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57055499|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57055500|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57055501|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57055502|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57055503|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055504|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055505|NCT03419858|Naloxone|naloxone|mesh-list
57055506|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57055507|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055508|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
57055509|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055510|NCT03417206|Remifentanil|remifentanil|mesh-list
57055511|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57055512|NCT03417206|Narcotics|narcotics|mesh-ancestor
57055513|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055514|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055515|NCT03417206|Analgesics|analgesics|mesh-ancestor
57055516|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
57055517|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055518|NCT00003716|Rituximab|rituximab|mesh-list
57055519|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57055520|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055521|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
57055522|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055523|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57055524|NCT02593786|Nivolumab|nivolumab|mesh-list
57055525|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57055526|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055527|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57055528|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055529|NCT03425708|Febuxostat|febuxostat|mesh-list
57055530|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
57055531|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57055532|NCT04650074|Lidocaine|lidocaine|mesh-list
57055533|NCT04650074|Ketamine|ketamine|mesh-list
57055534|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
57055535|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
57055536|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055537|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055538|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
57055539|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055540|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57055541|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57055542|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57055543|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57055544|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055545|NCT04650074|Analgesics|analgesics|mesh-ancestor
57055546|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57055547|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57055548|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
57055549|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57055550|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57055551|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055552|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
57055553|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57055554|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57055555|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055556|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055557|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57055558|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57055559|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57055560|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
57055561|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055562|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055563|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57055564|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57055565|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
57055566|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
57055567|NCT03425474|Propofol|propofol|mesh-list
57055568|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57055569|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055570|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055571|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57055572|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
57055573|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
57055574|NCT03419624|Metformin|metformin|mesh-list
57055575|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
57055576|NCT03419624|Exenatide|exenatide|mesh-list
57055577|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57055578|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055579|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57055580|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055581|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57055582|NCT03419624|Incretins|incretins|mesh-ancestor
57055583|NCT03419624|Hormones|hormones|mesh-ancestor
57055584|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055585|NCT02096055|Idarubicin|idarubicin|mesh-list
57055586|NCT02096055|Cladribine|cladribine|mesh-list
57055587|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
57055588|NCT02096055|Guadecitabine|guadecitabine|mesh-list
57055589|NCT02096055|Azacitidine|azacitidine|mesh-list
57055590|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57055591|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055592|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57055593|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57055594|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055595|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055596|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57055597|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
57055598|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055599|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57055600|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
57055601|NCT03425162|Morphine|morphine|mesh-list
57055602|NCT03425162|Bupivacaine|bupivacaine|mesh-list
57055603|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
57055604|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
57055605|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055606|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055607|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
57055608|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055609|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57055610|NCT03425162|Narcotics|narcotics|mesh-ancestor
57055611|NCT03425162|Analgesics|analgesics|mesh-ancestor
57055612|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
57055613|NCT02096133|Vitamin D|vitamin d|mesh-list
57055614|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57055615|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055616|NCT02096133|Vitamins|vitamins|mesh-ancestor
57055617|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
57055618|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57055619|NCT02096289|Thioridazine|thioridazine|mesh-list
57055620|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57055621|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57055622|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055623|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055624|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57055625|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57055626|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
57055627|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055628|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055629|NCT02090673|Exenatide|exenatide|mesh-list
57055630|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57055631|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055632|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57055633|NCT02090673|Incretins|incretins|mesh-ancestor
57055634|NCT02090673|Hormones|hormones|mesh-ancestor
57055635|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055636|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
57055637|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57055638|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
57055639|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055640|NCT03556371|Expectorants|expectorants|mesh-ancestor
57055641|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
57055642|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57055643|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
57055644|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055645|NCT03556371|Protective Agents|protective agents|mesh-ancestor
57055646|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055647|NCT03556371|Antidotes|antidotes|mesh-ancestor
57055648|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
57055649|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57055650|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055651|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57055652|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055653|NCT02975492|Vitamin D|vitamin d|mesh-list
57055654|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
57055655|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
57055656|NCT02975492|Vitamins|vitamins|mesh-list
57055657|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
57055658|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055659|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57055660|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57055661|NCT02827526|Ketamine|ketamine|mesh-list
57055662|NCT02827526|Analgesics|analgesics|mesh-ancestor
57055663|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
57055664|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055665|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055666|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57055667|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57055668|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
57055669|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
57055670|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055671|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57055672|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57055673|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055674|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055675|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57055676|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055677|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055678|NCT03425084|Morphine|morphine|mesh-list
57055679|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57055680|NCT03425084|Narcotics|narcotics|mesh-ancestor
57055681|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055682|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055683|NCT03425084|Analgesics|analgesics|mesh-ancestor
57055684|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
57055685|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055686|NCT03424928|Thalidomide|thalidomide|mesh-list
57055687|NCT03424928|Pomalidomide|pomalidomide|mesh-list
57055688|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
57055689|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055690|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57055691|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57055692|NCT03424928|Growth Substances|growth substances|mesh-ancestor
57055693|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
57055694|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055695|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57055696|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
57055697|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57055698|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055699|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
57055700|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57055701|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055702|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57055703|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055704|NCT04799002|Melphalan|melphalan|mesh-list
57055705|NCT04799002|Topotecan|topotecan|mesh-list
57055706|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57055707|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
57055708|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055709|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055710|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57055711|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57055712|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
57055713|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055714|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57055715|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57055716|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737706|NCT00657150|Enoxaparin|enoxaparin|mesh-list
57055717|NCT02096601|Levodopa|levodopa|mesh-list
57055718|NCT02096601|Carbidopa|carbidopa|mesh-list
57055719|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57055720|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57055721|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
57055722|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055723|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055724|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055725|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57055726|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055727|NCT02098785|Caffeine|caffeine|mesh-list
57055728|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
57055729|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055730|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57055731|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055732|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57055733|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055734|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57055735|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57055736|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
57055737|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055738|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57055739|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
57055740|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055741|NCT02521064|Prednisone|prednisone|mesh-list
57055742|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57055743|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
57055744|NCT02521064|Hormones|hormones|mesh-ancestor
57055745|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055746|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055747|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57055748|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055749|NCT02096913|Ibuprofen|ibuprofen|mesh-list
57055750|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57055751|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57055752|NCT02096913|Analgesics|analgesics|mesh-ancestor
57055753|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
57055754|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055755|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055756|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57055757|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57055758|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57055759|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055760|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055761|NCT03418610|Azelaic acid|azelaic acid|mesh-list
57055762|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055763|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
57055764|NCT04604366|Alprostadil|alprostadil|mesh-list
57055765|NCT04604366|Misoprostol|misoprostol|mesh-list
57055766|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57055767|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
57055768|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57055769|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055770|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57055771|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57055772|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
57055773|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57055774|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
57055775|NCT04604366|Urological Agents|urological agents|mesh-ancestor
57055776|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
57055777|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57055778|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055779|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055780|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57055781|NCT02099253|Analgesics|analgesics|mesh-ancestor
57055782|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
57055783|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055784|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57055785|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57055786|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57055787|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
57055788|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055789|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055790|NCT02099331|Melatonin|melatonin|mesh-list
57055791|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
57055792|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055793|NCT02099331|Protective Agents|protective agents|mesh-ancestor
57055794|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055795|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055797|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57055798|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
57055799|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055800|NCT05328388|Protective Agents|protective agents|mesh-ancestor
57055801|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055802|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57055803|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57055804|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055805|NCT02097069|Folic Acid|folic acid|mesh-list
57055806|NCT02097069|Inositol|inositol|mesh-list
57055807|NCT02097069|Hematinics|hematinics|mesh-ancestor
57055808|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
57055809|NCT02097069|Vitamins|vitamins|mesh-ancestor
57055810|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
57055811|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055812|NCT03424226|Acetazolamide|acetazolamide|mesh-list
57055813|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
57055814|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57055815|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055816|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055817|NCT03424226|Diuretics|diuretics|mesh-ancestor
57055818|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
57055819|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055820|NCT02250729|Pholcodine|pholcodine|mesh-list
57055821|NCT02250729|Analgesics|analgesics|mesh-ancestor
57055822|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
57055823|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055824|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055825|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
57055826|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
57055827|NCT02097147|Paroxetine|paroxetine|mesh-list
57055828|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
57055829|NCT02097147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57055830|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57055831|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57055832|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055833|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055834|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
57055835|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055836|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57055837|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
57055838|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57055839|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57055840|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57055841|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055842|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57055843|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57055844|NCT03556839|Paclitaxel|paclitaxel|mesh-list
57055845|NCT03556839|Bevacizumab|bevacizumab|mesh-list
57055846|NCT03556839|Carboplatin|carboplatin|mesh-list
57055847|NCT03556839|Atezolizumab|atezolizumab|mesh-list
57055848|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57055849|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055850|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
57055851|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
57055852|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
57055853|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055854|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57055855|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57055856|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57055857|NCT03556839|Growth Substances|growth substances|mesh-ancestor
57055858|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055859|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
57055860|NCT03415802|Paclitaxel|paclitaxel|mesh-list
57055861|NCT03415802|Tegafur|tegafur|mesh-list
57055862|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57055863|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055864|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
57055865|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
56737850|NCT00770744|Olanzapine|olanzapine|mesh-list
57055866|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
57055867|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055868|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57055869|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
57055870|NCT02099877|Fentanyl|fentanyl|mesh-list
57055871|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57055872|NCT02099877|Narcotics|narcotics|mesh-ancestor
57055873|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055874|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055875|NCT02099877|Analgesics|analgesics|mesh-ancestor
57055876|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
57055877|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055878|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57055879|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57055880|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
57055881|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
57055882|NCT02097381|Ritonavir|ritonavir|mesh-list
57055883|NCT02097381|Lopinavir|lopinavir|mesh-list
57055884|NCT02097381|Darunavir|darunavir|mesh-list
57055885|NCT02097381|Tenofovir|tenofovir|mesh-list
57055886|NCT02097381|Emtricitabine|emtricitabine|mesh-list
57055887|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57055888|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57055889|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
57055890|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055891|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055892|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57055893|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57055894|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
57055895|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055896|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57055897|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57055898|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57055899|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57055900|NCT02099955|Vitamin D|vitamin d|mesh-list
57055901|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
57055902|NCT02099955|Vitamins|vitamins|mesh-ancestor
57055903|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
57055904|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055905|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57055906|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57055907|NCT02097459|Tamoxifen|tamoxifen|mesh-list
57055908|NCT02097459|Toremifene|toremifene|mesh-list
57055909|NCT02097459|Anastrozole|anastrozole|mesh-list
57055910|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57055911|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
57055912|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57055913|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055914|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57055915|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57055916|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57055917|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57055918|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57055919|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57055920|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57055921|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055922|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055923|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
57055924|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57055925|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57055926|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055927|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
57055928|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
57055929|NCT02590432|Linaclotide|linaclotide|mesh-list
57055930|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57055931|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
57055932|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055933|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57055934|NCT02094339|Analgesics|analgesics|mesh-list
57055935|NCT02094339|Ropivacaine|ropivacaine|mesh-list
57055936|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
57055937|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
57055938|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055939|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055940|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
57055941|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055942|NCT03415646|Morphine|morphine|mesh-list
57055943|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57055944|NCT03415646|Narcotics|narcotics|mesh-ancestor
57055945|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055946|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055947|NCT03415646|Analgesics|analgesics|mesh-ancestor
57055948|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
57055949|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57055950|NCT03417518|Propofol|propofol|mesh-list
57055951|NCT03417518|Desflurane|desflurane|mesh-list
57055952|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57055953|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055954|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055955|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57055956|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
57055957|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
57055958|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57055959|NCT05169554|Amoxicillin|amoxicillin|mesh-list
57055960|NCT05169554|Clarithromycin|clarithromycin|mesh-list
57055961|NCT05169554|Rifampin|rifampin|mesh-list
57055962|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
57055963|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
57055964|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57055965|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57055966|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57055967|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57055968|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055969|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055970|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57055971|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57055972|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57055973|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
57055974|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
57055975|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57055976|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57055977|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57055978|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57055979|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57055980|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57055981|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57055982|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57055983|NCT04085458|Factor VIII|factor viii|mesh-list
57055984|NCT04085458|Coagulants|coagulants|mesh-ancestor
57055985|NCT02094651|Valproic Acid|valproic acid|mesh-list
57055986|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
57055987|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57055988|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57055989|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
57055990|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57055991|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57055992|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
57055993|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57055994|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57055995|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57055996|NCT02094807|Acetaminophen|acetaminophen|mesh-list
57055997|NCT02094807|Diclofenac|diclofenac|mesh-list
57055998|NCT02094807|Oxycodone|oxycodone|mesh-list
57055999|NCT02094807|Tramadol|tramadol|mesh-list
57056000|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056001|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056002|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056003|NCT02094807|Analgesics|analgesics|mesh-ancestor
57056004|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
57056005|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056006|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
57056007|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57056008|NCT02094807|Narcotics|narcotics|mesh-ancestor
57056009|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57056010|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056011|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57056012|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57056013|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056014|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056015|NCT05139472|Empagliflozin|empagliflozin|mesh-list
56738001|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
57056016|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57056017|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056018|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57056019|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056020|NCT04757090|Trastuzumab|trastuzumab|mesh-list
57056021|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57056022|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056023|NCT03397862|Donepezil|donepezil|mesh-list
57056024|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57056025|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056026|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056027|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
57056028|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056029|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056030|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
57056031|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
57056032|NCT02100267|Miotics|miotics|mesh-ancestor
57056033|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
57056034|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056035|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056036|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57056037|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
57056038|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
57056039|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57056040|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57056041|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
57056042|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056043|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056044|NCT02094963|Clopidogrel|clopidogrel|mesh-list
57056045|NCT02094963|Ticagrelor|ticagrelor|mesh-list
57056046|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57056047|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57056048|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57056049|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57056050|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
57056051|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056052|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056053|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056054|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57056055|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57056056|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056057|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
57056058|NCT03397706|Valganciclovir|valganciclovir|mesh-list
57056059|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
57056060|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056061|NCT02098317|Vitamin D|vitamin d|mesh-list
57056062|NCT02098317|Vitamins|vitamins|mesh-ancestor
57056063|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
57056064|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056065|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57056066|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
57056067|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57056068|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
57056069|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056070|NCT03900988|Expectorants|expectorants|mesh-ancestor
57056071|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
57056072|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57056073|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
57056074|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056075|NCT03900988|Protective Agents|protective agents|mesh-ancestor
57056076|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056077|NCT03900988|Antidotes|antidotes|mesh-ancestor
57056078|NCT02100423|Vitamin D|vitamin d|mesh-list
57056079|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
57056080|NCT02100423|Curcumin|curcumin|mesh-list
57056081|NCT02100423|Vitamins|vitamins|mesh-ancestor
57056082|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
57056083|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056084|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57056085|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57056086|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57056087|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056088|NCT02100423|Analgesics|analgesics|mesh-ancestor
57056089|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
57056090|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056091|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056092|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57056093|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056094|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056095|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056096|NCT05614648|Clonidine|clonidine|mesh-list
57056097|NCT05614648|Analgesics|analgesics|mesh-ancestor
57056098|NCT05614648|Sensory System Agents|sensory system agents|mesh-ancestor
57056099|NCT05614648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056100|NCT05614648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056101|NCT05614648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57056102|NCT05614648|Sympatholytics|sympatholytics|mesh-ancestor
57056103|NCT05614648|Autonomic Agents|autonomic agents|mesh-ancestor
57056104|NCT05614648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57056105|NCT05614648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57056106|NCT05614648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57056107|NCT05614648|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056108|NCT05614648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056109|NCT05614648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056110|NCT02520752|Midazolam|midazolam|mesh-list
57056111|NCT02520752|Caffeine|caffeine|mesh-list
57056112|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57056113|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57056114|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056115|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056116|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57056117|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57056118|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57056119|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57056120|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
57056121|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
57056122|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
57056123|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
57056124|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898113|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
57056125|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056126|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57056127|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57056128|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056129|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57056130|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57056131|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
57056132|NCT02095119|Gemcitabine|gemcitabine|mesh-list
57056133|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
57056134|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056135|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57056136|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
57056137|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056138|NCT02095119|Antiviral Agents|antiviral agents|mesh-ancestor
57056139|NCT02095119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056140|NCT02095119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056141|NCT02095119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57056142|NCT02095119|Immunologic Factors|immunologic factors|mesh-ancestor
57056143|NCT02095119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056144|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57056145|NCT02098629|Milrinone|milrinone|mesh-list
57056146|NCT02098629|Esmolol|esmolol|mesh-list
57056147|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57056148|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57056149|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57056150|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056151|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056152|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056153|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056154|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57056155|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57056156|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
57056157|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57056158|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57056159|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056160|NCT02098629|Protective Agents|protective agents|mesh-ancestor
57056161|NCT02095509|Enoxaparin|enoxaparin|mesh-list
57056162|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
57056163|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57056164|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57056165|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056166|NCT03397082|Lidocaine|lidocaine|mesh-list
57056167|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
57056168|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
57056169|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056170|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056171|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
57056172|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056173|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57056174|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57056175|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57056176|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57056177|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056178|NCT02101047|Phenylephrine|phenylephrine|mesh-list
57056179|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
57056180|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57056181|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
57056182|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
57056183|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056184|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056185|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
57056186|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57056187|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
57056188|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
57056189|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57056190|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57056191|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57056192|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056193|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056194|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056195|NCT02101047|Protective Agents|protective agents|mesh-ancestor
57056196|NCT02095665|Acetaminophen|acetaminophen|mesh-list
57056198|NCT02095665|Mirabegron|mirabegron|mesh-list
57056199|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57056200|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57056201|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57056202|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056203|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056204|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056205|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056206|NCT02095665|Urological Agents|urological agents|mesh-ancestor
57056207|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056208|NCT02095665|Analgesics|analgesics|mesh-ancestor
57056209|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
57056210|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056211|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
57056212|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57056213|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57056214|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57056215|NCT03548428|Atezolizumab|atezolizumab|mesh-list
57056216|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056217|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57056218|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57056219|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57056220|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
57056221|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056222|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57056223|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57056224|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056225|NCT02101203|Buspirone|buspirone|mesh-list
57056226|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57056227|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57056228|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056229|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056230|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57056231|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57056232|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
57056233|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056234|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056235|NCT04523246|Vaccines|vaccines|mesh-list
57056236|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
57056237|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056238|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
57056239|NCT03396380|Vitamin D|vitamin d|mesh-list
57056240|NCT03396380|Citric Acid|citric acid|mesh-list
57056241|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
57056242|NCT03396380|Clomiphene|clomiphene|mesh-list
57056243|NCT03396380|Enclomiphene|enclomiphene|mesh-list
57056244|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
57056245|NCT03396380|Calcium|calcium|mesh-list
57056246|NCT03396380|Vitamins|vitamins|mesh-ancestor
57056247|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
57056248|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056249|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57056250|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57056251|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
57056252|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57056253|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
57056254|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
57056255|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056256|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57056257|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
57056258|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056259|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57056260|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
57056261|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57056262|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57056263|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57056264|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
57056265|NCT05040568|Fludarabine|fludarabine|mesh-list
57056266|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
57056267|NCT05040568|Cetuximab|cetuximab|mesh-list
57056268|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57056269|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
57056270|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056271|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57056272|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57056273|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
57056274|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056275|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056276|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57056277|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57056278|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
57056279|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57056280|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
57056281|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57056282|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056283|NCT03414164|Procyanidin|procyanidin|mesh-list
57056284|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
57056285|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056286|NCT03414164|Protective Agents|protective agents|mesh-ancestor
57056287|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056288|NCT05613478|Apatinib|apatinib|mesh-list
57056289|NCT05613478|Chlorotrianisene|chlorotrianisene|mesh-list
57056290|NCT05613478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056291|NCT05613478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57056292|NCT05613478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056293|NCT05613478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056294|NCT05613478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57056295|NCT05613478|Estrogens|estrogens|mesh-ancestor
57056296|NCT05613478|Hormones|hormones|mesh-ancestor
57056297|NCT05613478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056298|NCT05613478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056299|NCT05613478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57056300|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
57056301|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57056302|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57056303|NCT03406988|Nifedipine|nifedipine|mesh-list
57056304|NCT03406988|Iloprost|iloprost|mesh-list
57056305|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57056306|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57056307|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056308|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57056309|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056310|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
57056311|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
57056312|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57056313|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57056314|NCT03406832|Nitroprusside|nitroprusside|mesh-list
57056315|NCT03406832|Tirofiban|tirofiban|mesh-list
57056316|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57056317|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
57056318|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57056319|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056320|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57056321|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57056322|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57056323|NCT03405974|Aspirin|aspirin|mesh-list
57056324|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57056325|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056326|NCT03405974|Analgesics|analgesics|mesh-ancestor
57056327|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
57056328|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056329|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056330|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056331|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57056332|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57056333|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57056334|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056335|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57056336|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57056337|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056338|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
57056339|NCT04337060|Lidocaine|lidocaine|mesh-list
57056340|NCT04337060|Morphine|morphine|mesh-list
57056341|NCT04337060|Bupivacaine|bupivacaine|mesh-list
57056342|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
57056343|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
57056344|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056345|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056346|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
57056347|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056348|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57056349|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57056350|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57056351|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57056352|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056353|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57056354|NCT04337060|Narcotics|narcotics|mesh-ancestor
57056355|NCT04337060|Analgesics|analgesics|mesh-ancestor
57056356|NCT04339036|Capecitabine|capecitabine|mesh-list
57056357|NCT04339036|Temozolomide|temozolomide|mesh-list
57056358|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57056359|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
57056360|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056361|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056362|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57056363|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
57056364|NCT04447274|Apatinib|apatinib|mesh-list
57056365|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056366|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57056367|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056368|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056369|NCT02977156|Ipilimumab|ipilimumab|mesh-list
57056370|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57056371|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056372|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57056373|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056374|NCT02885974|Gemcitabine|gemcitabine|mesh-list
57056375|NCT02885974|Celecoxib|celecoxib|mesh-list
57056376|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056377|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57056378|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
57056379|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056380|NCT02885974|Antiviral Agents|antiviral agents|mesh-ancestor
57056381|NCT02885974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056382|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056383|NCT02885974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57056384|NCT02885974|Immunologic Factors|immunologic factors|mesh-ancestor
57056385|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056386|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57056387|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056388|NCT02885974|Analgesics|analgesics|mesh-ancestor
57056389|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
57056390|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056391|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056392|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57056393|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57056394|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57056395|NCT04790032|Cangrelor|cangrelor|mesh-list
57056396|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57056397|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57056398|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57056399|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57056400|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
57056401|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056402|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056403|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056404|NCT02413138|Hormones|hormones|mesh-list
57056405|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056406|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056407|NCT01014598|Cisplatin|cisplatin|mesh-list
57056408|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056409|NCT03404804|Amoxicillin|amoxicillin|mesh-list
57056410|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57056411|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056412|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
57056413|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
57056414|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
57056415|NCT05611372|Rasagiline|rasagiline|mesh-list
57056416|NCT05611372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57056417|NCT05611372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056418|NCT05611372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056419|NCT05611372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57056420|NCT05611372|Protective Agents|protective agents|mesh-ancestor
57056421|NCT05611372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056422|NCT04776148|Trifluridine|trifluridine|mesh-list
57056423|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
57056424|NCT04776148|Lenvatinib|lenvatinib|mesh-list
57056425|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57056426|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056427|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57056428|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056429|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056430|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
57056431|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
57056432|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056433|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57056434|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
57056435|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57056436|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57056437|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57056438|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
57056439|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57056440|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056441|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57056442|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57056443|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57056444|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57056445|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056446|NCT05474950|Minocycline|minocycline|mesh-list
57056447|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57056448|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056449|NCT05613166|Everolimus|everolimus|mesh-list
57056450|NCT05613166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056451|NCT05613166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57056452|NCT05613166|Immunologic Factors|immunologic factors|mesh-ancestor
57056453|NCT05613166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056454|NCT05166668|Letrozole|letrozole|mesh-list
57056455|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056456|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57056457|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57056458|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056459|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056460|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57056461|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
57056462|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056463|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056464|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
57056465|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056466|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
57056467|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57056468|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57056469|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056470|NCT05558176|Urological Agents|urological agents|mesh-ancestor
57056471|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
57056472|NCT04748224|Bupivacaine|bupivacaine|mesh-list
57056473|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
57056474|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
57056475|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056476|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056477|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
57056478|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056479|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57056480|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056481|NCT04748224|Analgesics|analgesics|mesh-ancestor
57056482|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57056483|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57056484|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57056485|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056486|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056487|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056488|NCT03413150|Amiodarone|amiodarone|mesh-list
57056489|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57056490|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
57056491|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57056492|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57056493|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056494|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57056495|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57056496|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57056497|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056498|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57056499|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57056500|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57056501|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57056502|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57056503|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57056504|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57056505|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57056506|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57056507|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57056508|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056509|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056510|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056511|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056512|NCT03126578|Midazolam|midazolam|mesh-list
57056513|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57056514|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57056515|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056516|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056517|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57056518|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57056519|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57056520|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57056521|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
57056522|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
57056523|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
57056524|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
57056525|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056526|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056527|NCT03412994|Apatinib|apatinib|mesh-list
57056528|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056529|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57056530|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056531|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056532|NCT02588248|Peppermint oil|peppermint oil|mesh-list
57056533|NCT02588248|Menthol|menthol|mesh-list
57056534|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
57056535|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
57056536|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
57056537|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
57056538|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056539|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056540|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57056541|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
57056542|NCT03412682|Budesonide|budesonide|mesh-list
57056543|NCT03412682|Mesalamine|mesalamine|mesh-list
57056544|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056545|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57056546|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
57056547|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056548|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056549|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57056550|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
57056551|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
57056552|NCT03412682|Hormones|hormones|mesh-ancestor
57056553|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056554|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57056555|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056556|NCT03412682|Analgesics|analgesics|mesh-ancestor
57056557|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
57056558|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57056559|NCT03412526|Fludarabine|fludarabine|mesh-list
57056560|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056561|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
57056562|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57056563|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056564|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056565|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056566|NCT03126422|Analgesics|analgesics|mesh-ancestor
57056567|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
57056568|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056569|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57056570|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57056571|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57056572|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056573|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056574|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056575|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
57056576|NCT03395132|Betamethasone|betamethasone|mesh-list
57056577|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056578|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
57056579|NCT03395132|Hormones|hormones|mesh-ancestor
57056580|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056581|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056582|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57056583|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
57056584|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57056585|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056586|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57056587|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056588|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056589|NCT03127124|Leucovorin|leucovorin|mesh-list
57056590|NCT03127124|Fluorouracil|fluorouracil|mesh-list
57056591|NCT03127124|Bevacizumab|bevacizumab|mesh-list
57056592|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
57056593|NCT03127124|Calcium|calcium|mesh-list
57056594|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
57056595|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57056596|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056597|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
57056598|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056599|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57056600|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056601|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57056602|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
57056603|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57056604|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57056605|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57056606|NCT03127124|Growth Substances|growth substances|mesh-ancestor
57056607|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
57056608|NCT03127124|Antidotes|antidotes|mesh-ancestor
57056609|NCT03127124|Protective Agents|protective agents|mesh-ancestor
57056610|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
57056611|NCT03127124|Vitamins|vitamins|mesh-ancestor
57056612|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
57056613|NCT03399110|Capecitabine|capecitabine|mesh-list
57056614|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
57056615|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57056616|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
57056617|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056618|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056619|NCT05111912|Liraglutide|liraglutide|mesh-list
57056620|NCT05111912|Glucagon|glucagon|mesh-list
57056621|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57056622|NCT05111912|Incretins|incretins|mesh-ancestor
57056623|NCT05111912|Hormones|hormones|mesh-ancestor
57056624|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056625|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056626|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57056627|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57056628|NCT03127046|Aceclofenac|aceclofenac|mesh-list
57056629|NCT03127046|Diclofenac|diclofenac|mesh-list
57056630|NCT03127046|Esomeprazole|esomeprazole|mesh-list
57056631|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57056632|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57056633|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57056634|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898125|NCT05707468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056635|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056636|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57056637|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056638|NCT03127046|Analgesics|analgesics|mesh-ancestor
57056639|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
57056640|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056641|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056642|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056643|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57056644|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57056645|NCT05105672|Cisplatin|cisplatin|mesh-list
57056646|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056647|NCT03399032|Caspofungin|caspofungin|mesh-list
57056648|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
57056649|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056650|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056651|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056652|NCT03394820|Dexamethasone|dexamethasone|mesh-list
57056653|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056654|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
57056655|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
57056656|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056657|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056658|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57056659|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
57056660|NCT03394820|Hormones|hormones|mesh-ancestor
57056661|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056662|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57056663|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056664|NCT01328054|Lapatinib|lapatinib|mesh-list
57056665|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056666|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57056667|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056668|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056669|NCT05067920|Antibodies|antibodies|mesh-list
57056670|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
57056671|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056672|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57056673|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
57056674|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57056675|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57056676|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
57056677|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056678|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57056679|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57056680|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056681|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57056682|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57056683|NCT03398876|Nicotine|nicotine|mesh-list
57056684|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57056685|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
57056686|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056687|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056688|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57056689|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57056690|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
57056691|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056692|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056693|NCT03394586|Golimumab|golimumab|mesh-list
57056694|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57056695|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056696|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57056697|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
57056698|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056699|NCT03394430|Midazolam|midazolam|mesh-list
57056700|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
57056701|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57056702|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056703|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056704|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57056705|NCT03394430|Analgesics|analgesics|mesh-ancestor
57056706|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
57056707|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056708|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57056709|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57056710|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57056711|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056712|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056713|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056714|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57056715|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57056716|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57056717|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57056718|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57056719|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
57056720|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
57056721|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
57056722|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
57056723|NCT03394196|Ritonavir|ritonavir|mesh-list
57056724|NCT03394196|Lopinavir|lopinavir|mesh-list
57056725|NCT03394196|Darunavir|darunavir|mesh-list
57056726|NCT03394196|Tenofovir|tenofovir|mesh-list
57056727|NCT03394196|Lamivudine|lamivudine|mesh-list
57056728|NCT03394196|Zidovudine|zidovudine|mesh-list
57056729|NCT03394196|Emtricitabine|emtricitabine|mesh-list
57056730|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
57056731|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57056732|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57056733|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
57056734|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056735|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056736|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57056737|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57056738|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
57056739|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056740|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57056741|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57056742|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57056743|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57056744|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
57056745|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57056746|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57056747|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57056748|NCT03398018|Hormones|hormones|mesh-ancestor
57056749|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056750|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056751|NCT03411434|Methylphenidate|methylphenidate|mesh-list
57056752|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57056753|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056754|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57056755|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57056756|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57056757|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056758|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
57056759|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056760|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
57056761|NCT03126656|Testosterone|testosterone|mesh-list
57056762|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
57056763|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
57056764|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56738748|NCT04098653|Busulfan|busulfan|mesh-list
57056765|NCT03126656|Androgens|androgens|mesh-ancestor
57056766|NCT03126656|Hormones|hormones|mesh-ancestor
57056767|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056768|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056769|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57056770|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056771|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
57056772|NCT03385382|Dexamethasone|dexamethasone|mesh-list
57056773|NCT03385382|Ranibizumab|ranibizumab|mesh-list
57056774|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57056775|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
57056776|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
57056777|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056778|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056779|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57056780|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
57056781|NCT03385382|Hormones|hormones|mesh-ancestor
57056782|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57056783|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57056784|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056785|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57056786|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57056787|NCT03385382|Growth Substances|growth substances|mesh-ancestor
57056788|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
57056789|NCT03394118|Osimertinib|osimertinib|mesh-list
57056790|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056791|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57056792|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056793|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056794|NCT03389672|Anesthetics|anesthetics|mesh-list
57056795|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056796|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056797|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
57056798|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57056799|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056800|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57056801|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57056802|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056803|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056804|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056805|NCT01907360|Methylphenidate|methylphenidate|mesh-list
57056806|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57056807|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056808|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57056809|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57056810|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57056811|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056812|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
57056813|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056814|NCT03126188|Sertraline|sertraline|mesh-list
57056815|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57056816|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
57056817|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57056818|NCT03126188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57056819|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57056820|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57056821|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056822|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056823|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
57056824|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056825|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57056826|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57056827|NCT04446338|Antibodies|antibodies|mesh-list
57056828|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
57056829|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056830|NCT03393728|Propranolol|propranolol|mesh-list
57056831|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57056832|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57056833|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056834|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056835|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056836|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056837|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57056838|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57056839|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
57056840|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
57056841|NCT03393572|Nalbuphine|nalbuphine|mesh-list
57056842|NCT03393572|Bupivacaine|bupivacaine|mesh-list
57056843|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
57056844|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
57056845|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056846|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056847|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
57056848|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57056849|NCT03393572|Analgesics|analgesics|mesh-ancestor
57056850|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57056851|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
57056852|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57056853|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57056854|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056855|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57056856|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
57056857|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57056858|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57056859|NCT03393572|Narcotics|narcotics|mesh-ancestor
57056860|NCT03393416|Antibodies|antibodies|mesh-list
57056861|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
57056862|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056863|NCT04445948|Amoxicillin|amoxicillin|mesh-list
57056864|NCT04445948|Metronidazole|metronidazole|mesh-list
57056865|NCT04445948|Clarithromycin|clarithromycin|mesh-list
57056866|NCT04445948|Lactoferrin|lactoferrin|mesh-list
57056867|NCT04445948|Esomeprazole|esomeprazole|mesh-list
57056868|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57056869|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056870|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57056871|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57056872|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57056873|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57056874|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57056875|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056876|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056877|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57056878|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57056879|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57056880|NCT02479646|Lenograstim|lenograstim|mesh-list
57056881|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57056882|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
57056883|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056884|NCT02467868|Lenograstim|lenograstim|mesh-list
57056885|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57056886|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
57056887|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056888|NCT02106507|Everolimus|everolimus|mesh-list
57056889|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056890|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57056891|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
57056892|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056893|NCT02103465|Rotigotine|rotigotine|mesh-list
57056894|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
57056895|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
57056896|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056897|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056898|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056899|NCT02102139|Propofol|propofol|mesh-list
57056900|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57056901|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056902|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056903|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57056904|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
57056905|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
57056906|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
57056907|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
57056908|NCT02102295|Fluorides|fluorides|mesh-list
57056909|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
57056910|NCT02102295|Protective Agents|protective agents|mesh-ancestor
57056911|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056912|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
57056913|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056914|NCT02102295|Vitamins|vitamins|mesh-ancestor
57056916|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056917|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
57056918|NCT02102373|Laxatives|laxatives|mesh-ancestor
57056919|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57056920|NCT02103777|Caffeine|caffeine|mesh-list
57056921|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
57056922|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056923|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57056924|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056925|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57056926|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056927|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57056928|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57056929|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
57056930|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056931|NCT02104011|Propranolol|propranolol|mesh-list
57056932|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57056933|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57056934|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
57056935|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57056936|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056937|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056938|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57056939|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57056940|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
57056941|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
57056942|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57056943|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056944|NCT02251041|Tocopherols|tocopherols|mesh-list
57056945|NCT02251041|Vitamin E|vitamin e|mesh-list
57056946|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
57056947|NCT02251041|Infliximab|infliximab|mesh-list
57056948|NCT02251041|Epoprostenol|epoprostenol|mesh-list
57056949|NCT02251041|Tezosentan|tezosentan|mesh-list
57056950|NCT02251041|Melatonin|melatonin|mesh-list
57056951|NCT02251041|Antithrombins|antithrombins|mesh-list
57056952|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
57056953|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
57056954|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
57056955|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
57056956|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056957|NCT02251041|Protective Agents|protective agents|mesh-ancestor
57056958|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056959|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57056960|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
57056961|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57056962|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57056963|NCT02251041|Hematinics|hematinics|mesh-ancestor
57056964|NCT02251041|Vitamins|vitamins|mesh-ancestor
57056965|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
57056966|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57056967|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
57056968|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056969|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
57056970|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57056971|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57056972|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
57056973|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57056974|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57056975|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
57056976|NCT02104323|Endostatins|endostatins|mesh-list
57056977|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056978|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57056979|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57056980|NCT02104323|Growth Substances|growth substances|mesh-ancestor
57056981|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056982|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
57056983|NCT02107365|Interferons|interferons|mesh-list
57056984|NCT02107365|Ribavirin|ribavirin|mesh-list
57056985|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
57056986|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
57056987|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57056988|NCT02107365|Asunaprevir|asunaprevir|mesh-list
57056989|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57056990|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
57056991|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57056992|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
57056993|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57056994|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
57056995|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57056996|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
57056997|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57056998|NCT02110719|Acetaminophen|acetaminophen|mesh-list
57056999|NCT02110719|Dexamethasone|dexamethasone|mesh-list
57057000|NCT02110719|Ibuprofen|ibuprofen|mesh-list
57057001|NCT02110719|Celecoxib|celecoxib|mesh-list
57057002|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
57057003|NCT02110719|Oxycodone|oxycodone|mesh-list
57057004|NCT02110719|Gabapentin|gabapentin|mesh-list
57057005|NCT02110719|Hydromorphone|hydromorphone|mesh-list
57057006|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057007|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
57057008|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
57057009|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057010|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057011|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57057012|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
57057013|NCT02110719|Hormones|hormones|mesh-ancestor
57057014|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057015|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57057016|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057017|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057018|NCT02110719|Analgesics|analgesics|mesh-ancestor
57057019|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
57057020|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
57057021|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57057022|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057023|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57057024|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057025|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057026|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57057027|NCT02110719|Narcotics|narcotics|mesh-ancestor
57057028|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057029|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
57057030|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57057031|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57057032|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57057033|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57057034|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57057035|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057036|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
57057037|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57057038|NCT02105103|Insulin|insulin|mesh-list
57057039|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57057040|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057041|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57057042|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57057043|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57057044|NCT02107755|Ipilimumab|ipilimumab|mesh-list
57057045|NCT02107755|Antibodies|antibodies|mesh-list
57057046|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
57057047|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57057048|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
57057049|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057050|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057051|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57057052|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057053|NCT02110953|Irinotecan|irinotecan|mesh-list
57057054|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57057055|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57057056|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057057|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057058|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057059|NCT03554109|Leucovorin|leucovorin|mesh-list
57057060|NCT03554109|Paclitaxel|paclitaxel|mesh-list
57057061|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57057062|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
57057063|NCT03554109|Doxorubicin|doxorubicin|mesh-list
57057064|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57057065|NCT03554109|Fluorouracil|fluorouracil|mesh-list
57057066|NCT03554109|Avelumab|avelumab|mesh-list
56739044|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
57057067|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57057068|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057069|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
57057070|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
57057071|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
57057072|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057073|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057074|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
57057075|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057076|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057077|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57057078|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
57057079|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57057080|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57057081|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57057082|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57057083|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057084|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
57057085|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57057086|NCT03554109|Antidotes|antidotes|mesh-ancestor
57057087|NCT03554109|Protective Agents|protective agents|mesh-ancestor
57057088|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
57057089|NCT03554109|Vitamins|vitamins|mesh-ancestor
57057090|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
57057091|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57057092|NCT03554031|Hormones|hormones|mesh-list
57057093|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057094|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057095|NCT02111265|Sufentanil|sufentanil|mesh-list
57057096|NCT02111265|Remifentanil|remifentanil|mesh-list
57057097|NCT02111265|Cisatracurium|cisatracurium|mesh-list
57057098|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57057099|NCT02111265|Narcotics|narcotics|mesh-ancestor
57057100|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057101|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057102|NCT02111265|Analgesics|analgesics|mesh-ancestor
57057103|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
57057104|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057105|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57057106|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57057107|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
57057108|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
57057109|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57057110|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57057111|NCT02251119|Ritonavir|ritonavir|mesh-list
57057112|NCT02251119|Tipranavir|tipranavir|mesh-list
57057113|NCT02251119|Loperamide|loperamide|mesh-list
57057114|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
57057115|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57057116|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57057117|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
57057118|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057119|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057120|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57057121|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57057122|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
57057123|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057124|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57057125|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57057126|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57057127|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
57057128|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
57057129|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
57057130|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57057131|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057132|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057133|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057134|NCT02111421|Analgesics|analgesics|mesh-ancestor
57057135|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
57057136|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057137|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57057138|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57057139|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57057140|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
57057141|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057142|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057143|NCT02108301|Cyclosporine|cyclosporine|mesh-list
57057144|NCT02108301|Tacrolimus|tacrolimus|mesh-list
57057145|NCT02108301|Cyclosporins|cyclosporins|mesh-list
57057146|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057147|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
57057148|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898142|NCT03562468|Vitamins|vitamins|mesh-ancestor
57057149|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57057150|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057151|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057152|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
57057153|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057154|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
57057155|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057156|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
57057157|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
57057158|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57057159|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057160|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57057161|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57057162|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
57057163|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57057164|NCT02114073|Cyclosporine|cyclosporine|mesh-list
57057165|NCT02114073|Betamethasone|betamethasone|mesh-list
57057166|NCT02114073|Cyclosporins|cyclosporins|mesh-list
57057167|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057168|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057169|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057170|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
57057171|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057172|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
57057173|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057174|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
57057175|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057176|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57057177|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057178|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
57057179|NCT02114073|Hormones|hormones|mesh-ancestor
57057180|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057181|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57057182|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
57057183|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
57057184|NCT02114463|Analgesics|analgesics|mesh-list
57057185|NCT02114463|Ropivacaine|ropivacaine|mesh-list
57057186|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
57057187|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
57057188|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057189|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057190|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
57057191|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057192|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57057193|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057194|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057195|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057196|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57057197|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057198|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057199|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57057200|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57057201|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57057202|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
57057203|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057204|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57057205|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57057206|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057207|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
57057208|NCT02114775|Hormones|hormones|mesh-list
57057209|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057210|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057211|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
57057212|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57057213|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57057214|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057215|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057216|NCT02114775|Urological Agents|urological agents|mesh-ancestor
57057217|NCT02108847|Ropivacaine|ropivacaine|mesh-list
57057218|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
57057219|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
57057220|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56739192|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57057221|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057222|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
57057223|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057224|NCT02251431|Exenatide|exenatide|mesh-list
57057225|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57057226|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057227|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57057228|NCT02251431|Incretins|incretins|mesh-ancestor
57057229|NCT02251431|Hormones|hormones|mesh-ancestor
57057230|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057231|NCT03553329|Trametinib|trametinib|mesh-list
57057232|NCT03553329|Dabrafenib|dabrafenib|mesh-list
57057233|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057234|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57057235|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057236|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057237|NCT02115087|Morphine|morphine|mesh-list
57057238|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57057239|NCT02115087|Narcotics|narcotics|mesh-ancestor
57057240|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057241|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057242|NCT02115087|Analgesics|analgesics|mesh-ancestor
57057243|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
57057244|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057245|NCT02115243|Ipilimumab|ipilimumab|mesh-list
57057246|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57057247|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057248|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57057249|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057250|NCT02109315|Liraglutide|liraglutide|mesh-list
57057251|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057252|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57057253|NCT02109315|Incretins|incretins|mesh-ancestor
57057254|NCT02109315|Hormones|hormones|mesh-ancestor
57057255|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057256|NCT02112903|Vortioxetine|vortioxetine|mesh-list
57057257|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
57057258|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57057259|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57057260|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57057261|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057262|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057263|NCT02112903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57057264|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57057265|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57057266|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057267|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057268|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
57057269|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57057270|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57057271|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57057272|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57057273|NCT02112981|Sirolimus|sirolimus|mesh-list
57057274|NCT02112981|Everolimus|everolimus|mesh-list
57057275|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057276|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057277|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
57057278|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057279|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57057280|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057281|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57057282|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
57057283|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
57057284|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
57057285|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
57057286|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057287|NCT02116257|Propacetamol|propacetamol|mesh-list
57057288|NCT02116257|Analgesics|analgesics|mesh-ancestor
57057289|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
57057290|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057291|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057292|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57057293|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057294|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057295|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057296|NCT02109627|Cytarabine|cytarabine|mesh-list
57057297|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57057298|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
57057299|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057300|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057301|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
57057302|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057303|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057304|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
57057305|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057306|NCT02116569|Daratumumab|daratumumab|mesh-list
57057307|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057308|NCT02109783|Caffeine|caffeine|mesh-list
57057309|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57057310|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057311|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57057312|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057313|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057314|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57057315|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57057316|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
57057317|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057318|NCT02109861|Dexamethasone|dexamethasone|mesh-list
57057319|NCT02109861|Bortezomib|bortezomib|mesh-list
57057320|NCT02109861|Melphalan|melphalan|mesh-list
57057321|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057322|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
57057323|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
57057324|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057325|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057326|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57057327|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
57057328|NCT02109861|Hormones|hormones|mesh-ancestor
57057329|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057330|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57057331|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057332|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57057333|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
57057334|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057335|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57057336|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057337|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
57057338|NCT02118753|Eplerenone|eplerenone|mesh-list
57057339|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57057340|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
57057341|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057342|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057343|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57057344|NCT02118753|Diuretics|diuretics|mesh-ancestor
57057345|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
57057346|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57057347|NCT02118909|Itraconazole|itraconazole|mesh-list
57057348|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
57057349|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
57057350|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057351|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57057352|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57057353|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057354|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057355|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57057356|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
57057357|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057358|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057359|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57057360|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57057361|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57057362|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57057363|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057364|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57057365|NCT02118987|Omalizumab|omalizumab|mesh-list
57057366|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57057367|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57057368|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
57057369|NCT02119143|Vitamins|vitamins|mesh-list
57057370|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
57057371|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057372|NCT02116959|Carboplatin|carboplatin|mesh-list
57057373|NCT02116959|Etoposide|etoposide|mesh-list
57057374|NCT02116959|Vincristine|vincristine|mesh-list
57057375|NCT02116959|Melphalan|melphalan|mesh-list
57057376|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057377|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57057378|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57057379|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57057380|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057381|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057382|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
57057383|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
57057384|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
57057385|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57057386|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
57057387|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57057388|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057389|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
57057390|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057391|NCT03553173|Bupropion|bupropion|mesh-list
57057392|NCT03553173|Varenicline|varenicline|mesh-list
57057393|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57057394|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
57057395|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57057396|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57057397|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57057398|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57057399|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057400|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
57057401|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057402|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057403|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57057404|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57057405|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057406|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57057407|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57057408|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
57057409|NCT01330017|Loratadine|loratadine|mesh-list
57057410|NCT01330017|Phenylephrine|phenylephrine|mesh-list
57057411|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
57057412|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57057413|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
57057414|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
57057415|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057416|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057417|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
57057418|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57057419|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
57057420|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
57057421|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57057422|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57057423|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57057424|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
57057425|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057426|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057427|NCT01330017|Protective Agents|protective agents|mesh-ancestor
57057428|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
57057429|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
57057430|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57057431|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57057432|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57057433|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
57057434|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
57057435|NCT02123121|Resveratrol|resveratrol|mesh-list
57057436|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
57057437|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057438|NCT02123121|Protective Agents|protective agents|mesh-ancestor
57057439|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057440|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057441|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57057442|NCT02117583|Oxycodone|oxycodone|mesh-list
57057443|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57057444|NCT02117583|Narcotics|narcotics|mesh-ancestor
57057445|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057446|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057447|NCT02117583|Analgesics|analgesics|mesh-ancestor
57057448|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
57057449|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057450|NCT02117739|Dapsone|dapsone|mesh-list
57057451|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057452|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
57057453|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57057454|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57057455|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57057456|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057457|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057458|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
57057459|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57057460|NCT02251509|Metoprolol|metoprolol|mesh-list
57057461|NCT02251509|Carvedilol|carvedilol|mesh-list
57057462|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57057463|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57057464|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
57057465|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
57057466|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057467|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057468|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57057469|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57057470|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57057471|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
57057472|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057473|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057474|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
57057475|NCT02251509|Protective Agents|protective agents|mesh-ancestor
57057476|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57057477|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57057478|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57057479|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
57057480|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57057481|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57057482|NCT02986659|Metformin|metformin|mesh-list
57057483|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57057484|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057485|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57057486|NCT02118051|Progesterone|progesterone|mesh-list
57057487|NCT02118051|Ganirelix|ganirelix|mesh-list
57057488|NCT02118051|Progestins|progestins|mesh-ancestor
57057489|NCT02118051|Hormones|hormones|mesh-ancestor
57057490|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057491|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057492|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
57057493|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57057494|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
57057495|NCT02123355|Remifentanil|remifentanil|mesh-list
57057496|NCT02123355|Sevoflurane|sevoflurane|mesh-list
57057497|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
57057498|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
57057499|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057500|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057501|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57057502|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057503|NCT02123355|Analgesics|analgesics|mesh-ancestor
57057504|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
57057505|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057506|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57057507|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57057508|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57057509|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
57057510|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057511|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057512|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57057513|NCT02123355|Narcotics|narcotics|mesh-ancestor
57057514|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57057515|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57057516|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
57057517|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57057518|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57057519|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57057520|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57057521|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57057522|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
57057523|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57057524|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
57057525|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057526|NCT02123589|Fentanyl|fentanyl|mesh-list
57057527|NCT02123589|Midazolam|midazolam|mesh-list
57057528|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57057529|NCT02123589|Narcotics|narcotics|mesh-ancestor
57057530|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057531|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057532|NCT02123589|Analgesics|analgesics|mesh-ancestor
57057533|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
57057534|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057535|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57057536|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57057537|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
57057538|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
57057539|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57057540|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57057541|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57057542|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57057543|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
57057544|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
57057545|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057546|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057547|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
57057548|NCT02120547|Liver Extracts|liver extracts|mesh-list
57057549|NCT02120547|Hematinics|hematinics|mesh-ancestor
57057550|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57057551|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057552|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57057553|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57057554|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
57057555|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057556|NCT02120703|Pregabalin|pregabalin|mesh-list
57057557|NCT02120703|Gabapentin|gabapentin|mesh-list
57057558|NCT02120703|Analgesics|analgesics|mesh-ancestor
57057559|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
57057560|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057561|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057562|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
57057563|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56898176|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
57057564|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57057565|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057566|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57057567|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57057568|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57057569|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057570|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57057571|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57057572|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57057573|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057574|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
57057575|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
57057576|NCT02118285|Fludarabine|fludarabine|mesh-list
57057577|NCT02118285|Interleukin-2|interleukin-2|mesh-list
57057578|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057579|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
57057580|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057581|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057582|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57057583|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
57057584|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057585|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057586|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57057587|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057588|NCT02118285|Analgesics|analgesics|mesh-ancestor
57057589|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
57057590|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057591|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
57057592|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57057593|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56739574|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
57057594|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057595|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
57057596|NCT03552705|Coagulants|coagulants|mesh-ancestor
57057597|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
57057598|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057599|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57057600|NCT02118675|Protective Agents|protective agents|mesh-ancestor
57057601|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057602|NCT02123979|Rotigotine|rotigotine|mesh-list
57057603|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
57057604|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
57057605|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057606|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057607|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057608|NCT03552315|Chromium|chromium|mesh-list
57057609|NCT03552315|Trace Elements|trace elements|mesh-ancestor
57057610|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
57057611|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057612|NCT02120859|Paclitaxel|paclitaxel|mesh-list
57057613|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57057614|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057615|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
57057616|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
57057617|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
57057618|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057619|NCT02126943|Macitentan|macitentan|mesh-list
57057620|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57057621|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57057622|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057623|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57057624|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57057625|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57057626|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057627|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
57057628|NCT00150462|Dexamethasone|dexamethasone|mesh-list
57057629|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057630|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
57057631|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
57057632|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057633|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057634|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57057635|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
57057636|NCT00150462|Hormones|hormones|mesh-ancestor
57057637|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057638|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57057639|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057640|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57057641|NCT00095550|Irbesartan|irbesartan|mesh-list
57057642|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57057643|NCT00095550|Diuretics|diuretics|mesh-ancestor
57057644|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
57057645|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057646|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57057647|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57057648|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057649|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57057650|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57057651|NCT00095394|Irbesartan|irbesartan|mesh-list
57057652|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57057653|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57057654|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57057655|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057656|NCT00093132|Satraplatin|satraplatin|mesh-list
57057657|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057658|NCT05717400|Ribavirin|ribavirin|mesh-list
57057659|NCT05717400|Sofosbuvir|sofosbuvir|mesh-list
57057660|NCT05717400|Velpatasvir|velpatasvir|mesh-list
57057661|NCT05717400|Bevacizumab|bevacizumab|mesh-list
57057662|NCT05717400|Atezolizumab|atezolizumab|mesh-list
57057663|NCT05717400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57057664|NCT05717400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057665|NCT05717400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57057666|NCT05717400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57057667|NCT05717400|Growth Substances|growth substances|mesh-ancestor
57057668|NCT05717400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739654|NCT00653328|Doxorubicin|doxorubicin|mesh-list
57057669|NCT05717400|Growth Inhibitors|growth inhibitors|mesh-ancestor
57057670|NCT05717400|Antimetabolites|antimetabolites|mesh-ancestor
57057671|NCT05717400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057672|NCT05717400|Antiviral Agents|antiviral agents|mesh-ancestor
57057673|NCT05717400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057674|NCT00080106|Vaccines|vaccines|mesh-list
57057675|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
57057676|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057677|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
57057678|NCT00333216|Anecortave|anecortave|mesh-list
57057679|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57057680|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57057681|NCT00333216|Growth Substances|growth substances|mesh-ancestor
57057682|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057683|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
57057684|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057685|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057686|NCT00332748|Taxane|taxane|mesh-list
57057687|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057688|NCT03530436|Curcumin|curcumin|mesh-list
57057689|NCT03530436|Turmeric extract|turmeric extract|mesh-list
57057690|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57057691|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057692|NCT03530436|Analgesics|analgesics|mesh-ancestor
57057693|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
57057694|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057695|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057696|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057697|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057698|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057699|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057700|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057701|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
57057702|NCT03530436|Protective Agents|protective agents|mesh-ancestor
57057703|NCT03530280|Pregabalin|pregabalin|mesh-list
57057704|NCT03530280|Bupivacaine|bupivacaine|mesh-list
57057705|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
57057706|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
57057707|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057708|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057709|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
57057710|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057711|NCT03530280|Analgesics|analgesics|mesh-ancestor
57057712|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
57057713|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57057714|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57057715|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057716|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57057717|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57057718|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57057719|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57057720|NCT00079482|Cytarabine|cytarabine|mesh-list
57057721|NCT00079482|Etoposide|etoposide|mesh-list
57057722|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
57057723|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57057724|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057725|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57057726|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57057727|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057728|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057729|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57057730|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
57057731|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
57057732|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057733|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057734|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
57057735|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057736|NCT00079482|Analgesics|analgesics|mesh-ancestor
57057737|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
57057738|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057739|NCT00073866|Celecoxib|celecoxib|mesh-list
57057740|NCT00073866|Docetaxel|docetaxel|mesh-list
56739728|NCT00784940|Tamoxifen|tamoxifen|mesh-list
57057741|NCT00073866|Irinotecan|irinotecan|mesh-list
57057742|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057743|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
57057744|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
57057745|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
57057746|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057747|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57057749|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057750|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57057751|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057752|NCT00073866|Analgesics|analgesics|mesh-ancestor
57057753|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
57057754|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057755|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057756|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057757|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057758|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57057759|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57057760|NCT00325650|Rimonabant|rimonabant|mesh-list
57057761|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57057762|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
57057763|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57057764|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057765|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057766|NCT00325650|Hormones|hormones|mesh-ancestor
57057767|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057768|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057769|NCT00070590|Bosentan|bosentan|mesh-list
57057770|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57057771|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57057772|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057773|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57057774|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57057775|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57057776|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
57057777|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057778|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057779|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57057780|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57057781|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
57057782|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057783|NCT00058266|Genistein|genistein|mesh-list
57057784|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57057785|NCT00058266|Protective Agents|protective agents|mesh-ancestor
57057786|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057787|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057788|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57057789|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057790|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057791|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
57057792|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57057793|NCT00058266|Estrogens|estrogens|mesh-ancestor
57057794|NCT00058266|Hormones|hormones|mesh-ancestor
57057795|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57057796|NCT00313794|Tremelimumab|tremelimumab|mesh-list
57057797|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057798|NCT00313248|Sagopilone|sagopilone|mesh-list
57057799|NCT00313248|Epothilones|epothilones|mesh-list
57057800|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057801|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
57057802|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
57057803|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
57057804|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057805|NCT00310830|Bosentan|bosentan|mesh-list
57057806|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57057807|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57057808|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057809|NCT00035568|Metformin|metformin|mesh-list
57057810|NCT00035568|Glyburide|glyburide|mesh-list
57057811|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57057812|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057813|NCT00031512|Pleconaril|pleconaril|mesh-list
57057814|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
57057815|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057816|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
57057817|NCT00307398|Anecortave|anecortave|mesh-list
57057818|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56739792|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057819|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57057820|NCT00307398|Growth Substances|growth substances|mesh-ancestor
57057821|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057822|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
57057823|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057824|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057825|NCT01368081|Metformin|metformin|mesh-list
57057826|NCT01368081|Empagliflozin|empagliflozin|mesh-list
57057827|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57057828|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057829|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57057830|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057831|NCT02127489|Bupivacaine|bupivacaine|mesh-list
57057832|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
57057833|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
57057834|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057835|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057836|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
57057837|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057838|NCT02124369|Gemcitabine|gemcitabine|mesh-list
57057839|NCT02124369|Paclitaxel|paclitaxel|mesh-list
57057840|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57057841|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57057842|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057843|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
57057844|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
57057845|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
57057846|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057847|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57057848|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
57057849|NCT02124369|Antiviral Agents|antiviral agents|mesh-ancestor
57057850|NCT02124369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057851|NCT02124369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057852|NCT02124369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057853|NCT02124369|Immunologic Factors|immunologic factors|mesh-ancestor
57057854|NCT02124369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057855|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
57057856|NCT00004914|Hematinics|hematinics|mesh-ancestor
57057857|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
57057858|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57057859|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057860|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57057861|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
57057862|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57057863|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057864|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
57057865|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
57057866|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57057867|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
57057868|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057869|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
57057870|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057871|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057872|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57057873|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
57057874|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057875|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057876|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57057877|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
57057878|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057879|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
57057880|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057881|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
57057882|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57057883|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057884|NCT03551067|Midazolam|midazolam|mesh-list
57057885|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
57057886|NCT03551067|Ketamine|ketamine|mesh-list
57057887|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57057888|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057889|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057890|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057891|NCT03551067|Analgesics|analgesics|mesh-ancestor
57057892|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
56739868|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057893|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057894|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57057895|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57057896|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57057897|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
57057898|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057899|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057900|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57057901|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57057902|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
57057903|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
57057904|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57057905|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57057906|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57057907|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57057908|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57057909|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57057910|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
57057911|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
57057912|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
57057913|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
57057914|NCT03529266|Coagulants|coagulants|mesh-ancestor
57057915|NCT02128191|Ibuprofen|ibuprofen|mesh-list
57057916|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57057917|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57057918|NCT02128191|Analgesics|analgesics|mesh-ancestor
57057919|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
57057920|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057921|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057922|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57057923|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057924|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57057925|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057926|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057927|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
57057928|NCT00004896|Busulfan|busulfan|mesh-list
57057929|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057930|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
57057931|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057932|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057933|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57057934|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
57057935|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057936|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057937|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57057938|NCT02121951|Lidocaine|lidocaine|mesh-list
57057939|NCT02121951|Fentanyl|fentanyl|mesh-list
57057940|NCT02121951|Midazolam|midazolam|mesh-list
57057941|NCT02121951|Anesthetics|anesthetics|mesh-list
57057942|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
57057943|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
57057944|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57057945|NCT02121951|Narcotics|narcotics|mesh-ancestor
57057946|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57057947|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057948|NCT02121951|Analgesics|analgesics|mesh-ancestor
57057949|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
57057950|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57057951|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57057952|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57057953|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
57057954|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57057955|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57057956|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57057957|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57057958|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
57057959|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
57057960|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057961|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057962|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57057963|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57057964|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57057965|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57057966|NCT05473858|Phentolamine|phentolamine|mesh-list
57057967|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57057968|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57057969|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
57057970|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57057971|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057972|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057973|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57057974|NCT00004584|Ritonavir|ritonavir|mesh-list
57057975|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57057976|NCT00004584|Saquinavir|saquinavir|mesh-list
57057977|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57057978|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57057979|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
57057980|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57057981|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057982|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57057983|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57057984|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
57057985|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57057986|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57057987|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57057988|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
57057989|NCT00004230|Captopril|captopril|mesh-list
57057990|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57057991|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
57057992|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57057993|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57057994|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57057995|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
57057996|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57057997|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57057998|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57057999|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57058000|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
57058001|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898186|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
57058002|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57058003|NCT02252367|Tadalafil|tadalafil|mesh-list
57058004|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
57058005|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57058006|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57058007|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058008|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058009|NCT02252367|Urological Agents|urological agents|mesh-ancestor
57058010|NCT00004182|Irinotecan|irinotecan|mesh-list
57058011|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57058012|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57058013|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058014|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058015|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058016|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
57058017|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57058018|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
57058019|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058020|NCT02124525|Expectorants|expectorants|mesh-ancestor
57058021|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
57058022|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57058023|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
57058024|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058025|NCT02124525|Protective Agents|protective agents|mesh-ancestor
57058026|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058027|NCT02124525|Antidotes|antidotes|mesh-ancestor
57058028|NCT04331002|Triamcinolone|triamcinolone|mesh-list
57058029|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57058030|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57058031|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57058032|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058033|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
57058034|NCT04331002|Hormones|hormones|mesh-ancestor
57058035|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058036|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058037|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058038|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
57058039|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058040|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058041|NCT05725512|Prednisolone|prednisolone|mesh-list
57058042|NCT05725512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058043|NCT05725512|Glucocorticoids|glucocorticoids|mesh-ancestor
57058044|NCT05725512|Hormones|hormones|mesh-ancestor
57058045|NCT05725512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058046|NCT05725512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058047|NCT05725512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57058048|NCT05725512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058049|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
57058050|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
57058051|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57058052|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57058053|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058054|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058055|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058056|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57058057|NCT02128425|Leucovorin|leucovorin|mesh-list
57058058|NCT02128425|Fluorouracil|fluorouracil|mesh-list
57058059|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
57058060|NCT02128425|Irinotecan|irinotecan|mesh-list
57058061|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
57058062|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
57058063|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058064|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058065|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058066|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058067|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
57058068|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058069|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57058070|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57058071|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058072|NCT02128425|Antidotes|antidotes|mesh-ancestor
57058073|NCT02128425|Protective Agents|protective agents|mesh-ancestor
57058074|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
57058075|NCT02128425|Vitamins|vitamins|mesh-ancestor
57058076|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
57058077|NCT05641194|Caffeine|caffeine|mesh-list
57058078|NCT05641194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57058079|NCT05641194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058080|NCT05641194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57058081|NCT05641194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058082|NCT05641194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058083|NCT05641194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57058084|NCT05641194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57058085|NCT05641194|Purinergic Agents|purinergic agents|mesh-ancestor
57058086|NCT05641194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058087|NCT05616624|Gemcitabine|gemcitabine|mesh-list
57058088|NCT05616624|Docetaxel|docetaxel|mesh-list
57058089|NCT05616624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058090|NCT05616624|Antimetabolites|antimetabolites|mesh-ancestor
57058091|NCT05616624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058092|NCT05616624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058093|NCT05616624|Antiviral Agents|antiviral agents|mesh-ancestor
57058094|NCT05616624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058095|NCT05616624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058096|NCT05616624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058097|NCT05616624|Immunologic Factors|immunologic factors|mesh-ancestor
57058098|NCT05616624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058099|NCT05616624|Tubulin Modulators|tubulin modulators|mesh-ancestor
57058100|NCT05616624|Antimitotic Agents|antimitotic agents|mesh-ancestor
57058101|NCT05616624|Mitosis Modulators|mitosis modulators|mesh-ancestor
57058102|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
57058103|NCT03532620|Atorvastatin|atorvastatin|mesh-list
57058104|NCT03532620|Pitavastatin|pitavastatin|mesh-list
57058105|NCT03532620|Calcium|calcium|mesh-list
57058106|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57058107|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058108|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57058109|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57058110|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57058111|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
57058112|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058113|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57058114|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57058115|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058116|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
57058117|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57058118|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
57058119|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57058120|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058121|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57058122|NCT03529032|Methadone|methadone|mesh-list
57058123|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57058124|NCT03529032|Narcotics|narcotics|mesh-ancestor
57058125|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57058126|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058127|NCT03529032|Analgesics|analgesics|mesh-ancestor
57058128|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
57058129|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058130|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
57058131|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
57058132|NCT02122731|Amiloride|amiloride|mesh-list
57058133|NCT02122731|Diuretics|diuretics|mesh-ancestor
57058134|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
57058135|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058136|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
57058137|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57058138|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57058139|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058140|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
57058141|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57058142|NCT05458726|Paclitaxel|paclitaxel|mesh-list
57058143|NCT05458726|Carboplatin|carboplatin|mesh-list
57058144|NCT05458726|Pemetrexed|pemetrexed|mesh-list
57058145|NCT05458726|Osimertinib|osimertinib|mesh-list
57058146|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57058147|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058148|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
57058149|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
57058150|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
57058151|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058152|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058153|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57058154|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57058155|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57058156|NCT02122809|Chiauranib|chiauranib|mesh-list
57058157|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058158|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57058159|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058160|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058161|NCT00150618|Guanfacine|guanfacine|mesh-list
57058162|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57058163|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57058164|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57058165|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57058166|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
57058167|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058168|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058169|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058170|NCT05455294|Decitabine|decitabine|mesh-list
57058171|NCT05455294|Venetoclax|venetoclax|mesh-list
57058172|NCT05455294|Navitoclax|navitoclax|mesh-list
57058173|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058174|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
57058175|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058176|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058177|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058178|NCT03532464|Azithromycin|azithromycin|mesh-list
57058179|NCT03532464|Doxycycline|doxycycline|mesh-list
57058180|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57058181|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058182|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
57058183|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57058184|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57058185|NCT02128893|Isavuconazole|isavuconazole|mesh-list
57058186|NCT02128893|Esomeprazole|esomeprazole|mesh-list
57058187|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57058188|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57058189|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57058190|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058191|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058192|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
57058193|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740167|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57058194|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
57058195|NCT02128971|Trace Elements|trace elements|mesh-ancestor
57058196|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
57058197|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058198|NCT02288208|Tenofovir|tenofovir|mesh-list
57058199|NCT02288208|Entecavir|entecavir|mesh-list
57058200|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
57058201|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058202|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57058203|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57058204|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058205|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058206|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57058207|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57058208|NCT05610826|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
57058209|NCT05610826|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57058210|NCT05610826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058211|NCT02288286|Vaccines|vaccines|mesh-list
57058212|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
57058213|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058214|NCT02251977|Leucovorin|leucovorin|mesh-list
57058215|NCT02251977|Fluorouracil|fluorouracil|mesh-list
57058216|NCT02251977|Capecitabine|capecitabine|mesh-list
57058217|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058218|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
57058219|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058220|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058221|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058222|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058223|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
57058224|NCT02251977|Antidotes|antidotes|mesh-ancestor
57058225|NCT02251977|Protective Agents|protective agents|mesh-ancestor
57058226|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
57058227|NCT02251977|Vitamins|vitamins|mesh-ancestor
57058228|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
57058229|NCT03528954|Propofol|propofol|mesh-list
57058230|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57058231|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57058232|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058233|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57058234|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
57058235|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
57058236|NCT02125227|Metformin|metformin|mesh-list
57058237|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57058238|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57058239|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058240|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57058241|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57058242|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
57058243|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058244|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57058245|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57058246|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058247|NCT02129127|Paclitaxel|paclitaxel|mesh-list
57058248|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57058249|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058250|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
57058251|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
57058252|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
57058253|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058254|NCT05554822|Aspirin|aspirin|mesh-list
57058255|NCT05554822|Clopidogrel|clopidogrel|mesh-list
57058256|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57058257|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57058258|NCT05554822|Analgesics|analgesics|mesh-ancestor
57058259|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
57058260|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058261|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058262|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058263|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57058264|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57058265|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57058266|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058267|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57058268|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57058269|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058270|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
57058271|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57058272|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57058273|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57058274|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
57058275|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058276|NCT02125305|Metformin|metformin|mesh-list
57058277|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57058278|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058279|NCT00254904|Gemcitabine|gemcitabine|mesh-list
57058280|NCT00254904|Cisplatin|cisplatin|mesh-list
57058281|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058282|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058283|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
57058284|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058285|NCT00254904|Antiviral Agents|antiviral agents|mesh-ancestor
57058286|NCT00254904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058287|NCT00254904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058288|NCT00254904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058289|NCT00254904|Immunologic Factors|immunologic factors|mesh-ancestor
57058290|NCT00254904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058291|NCT05725122|Tamsulosin|tamsulosin|mesh-list
57058292|NCT05725122|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57058293|NCT05725122|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57058294|NCT05725122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57058295|NCT05725122|Adrenergic Agents|adrenergic agents|mesh-ancestor
57058296|NCT05725122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058297|NCT05725122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058298|NCT05725122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058299|NCT05725122|Urological Agents|urological agents|mesh-ancestor
57058300|NCT03880396|Cisplatin|cisplatin|mesh-list
57058301|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058302|NCT05554276|Antibodies|antibodies|mesh-list
57058303|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
57058304|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058305|NCT00253968|SR 46349B|sr 46349b|mesh-list
57058306|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57058307|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57058308|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058309|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57058310|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57058311|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
57058312|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058313|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058314|NCT05555862|Artesunate|artesunate|mesh-list
57058315|NCT05555862|Artenimol|artenimol|mesh-list
57058316|NCT05555862|Artemisinins|artemisinins|mesh-list
57058317|NCT05555862|Artemisinin|artemisinin|mesh-list
57058318|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
57058319|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57058320|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57058321|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058322|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058323|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
57058324|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
57058325|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57058326|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
57058327|NCT03544606|Pyridoxine|pyridoxine|mesh-list
57058328|NCT03544606|Isosorbide|isosorbide|mesh-list
57058329|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57058330|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57058331|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57058332|NCT03544606|Diuretics|diuretics|mesh-ancestor
57058333|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
57058334|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058335|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
57058336|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57058337|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058338|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
57058339|NCT03544606|Vitamins|vitamins|mesh-ancestor
57058340|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
57058341|NCT02741310|Sumatriptan|sumatriptan|mesh-list
57058342|NCT02741310|Erenumab|erenumab|mesh-list
57058343|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57058344|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57058345|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57058346|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
57058347|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058348|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058349|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058350|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57058351|NCT02741310|Analgesics|analgesics|mesh-ancestor
57058352|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
57058353|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058354|NCT05700448|Gemcitabine|gemcitabine|mesh-list
57058355|NCT05700448|Oxaliplatin|oxaliplatin|mesh-list
57058356|NCT05700448|Pegaspargase|pegaspargase|mesh-list
57058357|NCT05700448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058358|NCT05700448|Antimetabolites|antimetabolites|mesh-ancestor
57058359|NCT05700448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058360|NCT05700448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058361|NCT05700448|Antiviral Agents|antiviral agents|mesh-ancestor
57058362|NCT05700448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058363|NCT05700448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058364|NCT05700448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058365|NCT05700448|Immunologic Factors|immunologic factors|mesh-ancestor
57058366|NCT05700448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058367|NCT00243906|Plasminogen|plasminogen|mesh-list
57058368|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57058369|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57058370|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57058371|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058372|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
57058373|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57058374|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
57058375|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058376|NCT05537220|Expectorants|expectorants|mesh-ancestor
57058377|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
57058378|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57058379|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
57058380|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058381|NCT05537220|Protective Agents|protective agents|mesh-ancestor
57058382|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058383|NCT05537220|Antidotes|antidotes|mesh-ancestor
57058384|NCT01367457|Sirolimus|sirolimus|mesh-list
57058385|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57058386|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058387|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57058388|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058389|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
57058390|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058391|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
57058392|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058393|NCT05553496|Cyclosporine|cyclosporine|mesh-list
57058394|NCT05553496|Dexamethasone|dexamethasone|mesh-list
57058395|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
57058396|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
57058397|NCT05553496|Rituximab|rituximab|mesh-list
57058398|NCT05553496|Tacrolimus|tacrolimus|mesh-list
57058399|NCT05553496|Cyclosporins|cyclosporins|mesh-list
57058400|NCT05553496|BB 1101|bb 1101|mesh-list
57058401|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058402|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
57058403|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058404|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57058405|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57058406|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
57058407|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058408|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058409|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57058410|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57058411|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058412|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
57058413|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
57058414|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058415|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57058416|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
57058417|NCT05553496|Hormones|hormones|mesh-ancestor
57058418|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058419|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57058420|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
57058421|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058422|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57058423|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
57058424|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058425|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
57058426|NCT00239694|Vaccines|vaccines|mesh-list
57058427|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57058428|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
57058429|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058430|NCT05700214|Lidocaine|lidocaine|mesh-list
57058431|NCT05700214|Ropivacaine|ropivacaine|mesh-list
57058432|NCT05700214|Anesthetics, Local|anesthetics, local|mesh-ancestor
57058433|NCT05700214|Anesthetics|anesthetics|mesh-ancestor
57058434|NCT05700214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57058435|NCT05700214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058436|NCT05700214|Sensory System Agents|sensory system agents|mesh-ancestor
57058437|NCT05700214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058438|NCT05700214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57058439|NCT05700214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57058440|NCT05700214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57058441|NCT05700214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57058442|NCT05700214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058443|NCT05549284|Rituximab|rituximab|mesh-list
57058444|NCT05549284|Methotrexate|methotrexate|mesh-list
57058445|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57058446|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058447|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
57058448|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058449|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57058450|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57058451|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
57058452|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57058453|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058454|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
57058455|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058456|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
57058457|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058458|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57058459|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058460|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57058461|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
57058462|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57058463|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058464|NCT00232752|Sirolimus|sirolimus|mesh-list
57058465|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57058466|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058467|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57058468|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058469|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
57058470|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058471|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
57058472|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058473|NCT02125617|Prednisolone|prednisolone|mesh-list
57058474|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058475|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
57058476|NCT02125617|Hormones|hormones|mesh-ancestor
57058477|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058478|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058479|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57058480|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058481|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57058482|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
57058483|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57058484|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57058485|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57058486|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57058487|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058488|NCT00229008|Linezolid|linezolid|mesh-list
57058489|NCT00229008|Ceftazidime|ceftazidime|mesh-list
57058490|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
57058491|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
57058492|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57058493|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058494|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57058495|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058496|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058497|NCT05553184|Niacin|niacin|mesh-list
56740467|NCT01005628|Bortezomib|bortezomib|mesh-list
57058498|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
57058499|NCT05553184|Niacinamide|niacinamide|mesh-list
57058500|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
57058501|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57058502|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
57058503|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058504|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058505|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57058506|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
57058507|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57058508|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57058509|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57058510|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
57058511|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058512|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058513|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57058514|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
57058515|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57058516|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
57058517|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
57058518|NCT05553184|Vitamins|vitamins|mesh-ancestor
57058519|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
57058520|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
57058521|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
57058522|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058523|NCT05242029|Psilocybin|psilocybin|mesh-list
57058524|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
57058525|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058526|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57058527|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
57058528|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57058529|NCT03528564|Hematinics|hematinics|mesh-ancestor
57058530|NCT03531372|Antacids|antacids|mesh-list
57058531|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058532|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57058533|NCT02129595|Resveratrol|resveratrol|mesh-list
57058534|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
57058535|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058536|NCT02129595|Protective Agents|protective agents|mesh-ancestor
57058537|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058538|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058539|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57058540|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57058541|NCT02129673|Latanoprost|latanoprost|mesh-list
57058542|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57058543|NCT02260557|Selexipag|selexipag|mesh-list
57058544|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57058545|NCT02129829|Tenofovir|tenofovir|mesh-list
57058546|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
57058547|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058548|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57058549|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57058550|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058551|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058552|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57058553|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57058554|NCT02494882|Dexamethasone|dexamethasone|mesh-list
57058555|NCT02494882|Dasatinib|dasatinib|mesh-list
57058556|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058557|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
57058558|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
57058559|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058560|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058561|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57058562|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
57058563|NCT02494882|Hormones|hormones|mesh-ancestor
57058564|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058565|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57058566|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058567|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57058568|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058569|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058570|NCT02129985|Metformin|metformin|mesh-list
57058571|NCT02129985|Exenatide|exenatide|mesh-list
57058572|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57058573|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058574|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57058575|NCT02129985|Incretins|incretins|mesh-ancestor
56740542|NCT01006798|Vaccines|vaccines|mesh-list
57058576|NCT02129985|Hormones|hormones|mesh-ancestor
57058577|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058578|NCT01730638|Histamine|histamine|mesh-list
57058579|NCT01730638|Glycine|glycine|mesh-list
57058580|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
57058581|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
57058582|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058583|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058584|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058585|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
57058586|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
57058587|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57058588|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57058589|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058590|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57058591|NCT02252523|Analgesics|analgesics|mesh-ancestor
57058592|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
57058593|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058594|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57058595|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57058596|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57058597|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
57058598|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058599|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058600|NCT02132091|Vitamins|vitamins|mesh-list
57058601|NCT02132091|Vitamin E|vitamin e|mesh-list
57058602|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
57058603|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058604|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
57058605|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058606|NCT02132091|Protective Agents|protective agents|mesh-ancestor
57058607|NCT05548348|Aflutinib|aflutinib|mesh-list
57058608|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57058609|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058610|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058611|NCT05726370|Carboplatin|carboplatin|mesh-list
57058612|NCT05726370|Docetaxel|docetaxel|mesh-list
57058613|NCT05726370|Pembrolizumab|pembrolizumab|mesh-list
57058614|NCT05726370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058615|NCT05726370|Tubulin Modulators|tubulin modulators|mesh-ancestor
57058616|NCT05726370|Antimitotic Agents|antimitotic agents|mesh-ancestor
57058617|NCT05726370|Mitosis Modulators|mitosis modulators|mesh-ancestor
57058618|NCT05726370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058619|NCT05726370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57058620|NCT05726292|Androgens|androgens|mesh-list
57058621|NCT05726292|Hormones|hormones|mesh-ancestor
57058622|NCT05726292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058623|NCT05726292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058624|NCT04469010|Iron|iron|mesh-list
57058625|NCT04469010|Chelating Agents|chelating agents|mesh-list
57058626|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
57058627|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058628|NCT04469010|Trace Elements|trace elements|mesh-ancestor
57058629|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058630|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
57058631|NCT01121224|Clopidogrel|clopidogrel|mesh-list
57058632|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57058633|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57058634|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57058635|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57058636|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
57058637|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058638|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058639|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058640|NCT00138762|Atorvastatin|atorvastatin|mesh-list
57058641|NCT00138762|Torcetrapib|torcetrapib|mesh-list
57058642|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57058643|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57058644|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
57058645|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058646|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57058647|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57058648|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058649|NCT03531294|Aflibercept|aflibercept|mesh-list
57058650|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57058651|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57058652|NCT03531294|Growth Substances|growth substances|mesh-ancestor
57058653|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058654|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
57058655|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058656|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
57058657|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57058658|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57058659|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57058660|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57058661|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058662|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
57058663|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058664|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058665|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57058666|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058667|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
57058668|NCT05551624|Atorvastatin|atorvastatin|mesh-list
57058669|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57058670|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57058671|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57058672|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
57058673|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058674|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57058675|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57058676|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058677|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
57058678|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058679|NCT05551624|Expectorants|expectorants|mesh-ancestor
57058680|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
57058681|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57058682|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
57058683|NCT05551624|Protective Agents|protective agents|mesh-ancestor
57058684|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058685|NCT05551624|Antidotes|antidotes|mesh-ancestor
57058686|NCT00134238|Atorvastatin|atorvastatin|mesh-list
57058687|NCT00134238|Torcetrapib|torcetrapib|mesh-list
57058688|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57058689|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57058690|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
57058691|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058692|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57058693|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57058694|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058695|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
57058696|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57058697|NCT05464836|Venetoclax|venetoclax|mesh-list
57058698|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058699|NCT03550677|Anesthetics|anesthetics|mesh-list
57058700|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57058701|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058702|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
57058703|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058704|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
57058705|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058706|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058707|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57058708|NCT02132403|Gemcitabine|gemcitabine|mesh-list
57058709|NCT02132403|Milk fat globule|milk fat globule|mesh-list
57058710|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058711|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
57058712|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058713|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058714|NCT02132403|Antiviral Agents|antiviral agents|mesh-ancestor
57058715|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058716|NCT02132403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058717|NCT02132403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058718|NCT02132403|Immunologic Factors|immunologic factors|mesh-ancestor
57058719|NCT02132403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058720|NCT04264806|Azacitidine|azacitidine|mesh-list
57058721|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058722|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
57058723|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058724|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740702|NCT01008046|Metformin|metformin|mesh-list
57058725|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058726|NCT05699824|Carvedilol|carvedilol|mesh-list
57058727|NCT05699824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57058728|NCT05699824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57058729|NCT05699824|Adrenergic Agents|adrenergic agents|mesh-ancestor
57058730|NCT05699824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058731|NCT05699824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058732|NCT05699824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058733|NCT05699824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57058734|NCT05699824|Antioxidants|antioxidants|mesh-ancestor
57058735|NCT05699824|Protective Agents|protective agents|mesh-ancestor
57058736|NCT05699824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57058737|NCT05699824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57058738|NCT05699824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57058739|NCT05699824|Vasodilator Agents|vasodilator agents|mesh-ancestor
57058740|NCT05699824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57058741|NCT05699824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57058742|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57058743|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57058744|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
57058745|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058746|NCT00126984|Vaccines|vaccines|mesh-list
57058747|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
57058748|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058749|NCT02136147|Guanfacine|guanfacine|mesh-list
57058750|NCT02136147|Methylphenidate|methylphenidate|mesh-list
57058751|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
57058752|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57058753|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57058754|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058755|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57058756|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57058757|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57058758|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058759|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
57058760|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058761|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57058762|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
57058763|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57058764|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57058765|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57058766|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57058767|NCT05699746|Capecitabine|capecitabine|mesh-list
57058768|NCT05699746|Oxaliplatin|oxaliplatin|mesh-list
57058769|NCT05699746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058770|NCT05699746|Antimetabolites|antimetabolites|mesh-ancestor
57058771|NCT05699746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058772|NCT05699746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058773|NCT03549897|Albuterol|albuterol|mesh-list
57058774|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57058775|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
57058776|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058777|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058778|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57058779|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
57058780|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
57058781|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57058782|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57058783|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57058784|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57058785|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
57058786|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058787|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058788|NCT02133105|Simendan|simendan|mesh-list
57058789|NCT02133105|Dobutamine|dobutamine|mesh-list
57058790|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57058791|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
57058792|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57058793|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57058794|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058795|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058796|NCT02133105|Protective Agents|protective agents|mesh-ancestor
57058797|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058798|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
57058799|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
57058800|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058801|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57058802|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57058803|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57058804|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
57058805|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058806|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
57058807|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058808|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
57058809|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
57058810|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
57058811|NCT02136693|Psyllium|psyllium|mesh-list
57058812|NCT02136693|Cathartics|cathartics|mesh-ancestor
57058813|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57058814|NCT02136771|Vitamin D|vitamin d|mesh-list
57058815|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
57058816|NCT02136771|Vitamins|vitamins|mesh-ancestor
57058817|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
57058818|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058819|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57058820|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57058821|NCT00125970|Vaccines|vaccines|mesh-list
57058822|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
57058823|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058824|NCT03549663|Prednisone|prednisone|mesh-list
57058825|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
57058826|NCT03549663|Tacrolimus|tacrolimus|mesh-list
57058827|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058828|NCT03549663|Hormones|hormones|mesh-ancestor
57058829|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058830|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058831|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57058832|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058833|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058834|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
57058835|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57058836|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058837|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058838|NCT02137083|Docetaxel|docetaxel|mesh-list
57058839|NCT02137083|Fulvestrant|fulvestrant|mesh-list
57058840|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058841|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
57058842|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
57058843|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
57058844|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058845|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57058846|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57058847|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57058848|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
57058849|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058850|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058851|NCT02137161|Tobramycin|tobramycin|mesh-list
57058852|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
57058853|NCT02137161|Dexamethasone|dexamethasone|mesh-list
57058854|NCT02137161|Bromfenac|bromfenac|mesh-list
57058855|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57058856|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058857|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
57058858|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
57058859|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058860|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058861|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57058862|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
57058863|NCT02137161|Hormones|hormones|mesh-ancestor
57058864|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058865|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57058866|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058867|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57058868|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57058869|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058870|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57058871|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57058872|NCT02137161|Analgesics|analgesics|mesh-ancestor
57058873|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
57058874|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57058875|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
57058876|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57058877|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
57058878|NCT03527628|Dacarbazine|dacarbazine|mesh-list
57058879|NCT03527628|Doxorubicin|doxorubicin|mesh-list
57058880|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57058881|NCT03527628|Bleomycin|bleomycin|mesh-list
57058882|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57058883|NCT03527628|Vinblastine|vinblastine|mesh-list
57058884|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058885|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
57058886|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058887|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57058888|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57058889|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
57058890|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058891|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058892|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57058893|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57058894|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57058895|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57058896|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058897|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57058898|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57058899|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
57058900|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
57058901|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
57058902|NCT04466670|Aspirin|aspirin|mesh-list
57058903|NCT04466670|Heparin|heparin|mesh-list
57058904|NCT04466670|Calcium heparin|calcium heparin|mesh-list
57058905|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57058906|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57058907|NCT04466670|Analgesics|analgesics|mesh-ancestor
57058908|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
57058909|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058910|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058911|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058912|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57058913|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57058914|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57058915|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058916|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57058917|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57058918|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058919|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
57058920|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
57058921|NCT04468542|Triamcinolone|triamcinolone|mesh-list
57058922|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57058923|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57058924|NCT04468542|Bupivacaine|bupivacaine|mesh-list
57058925|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57058926|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
57058927|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
57058928|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57058929|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058930|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
57058931|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058932|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058933|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
57058934|NCT04468542|Hormones|hormones|mesh-ancestor
57058935|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058936|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57058937|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
57058938|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058939|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058940|NCT04550442|Azacitidine|azacitidine|mesh-list
57058941|NCT04550442|Venetoclax|venetoclax|mesh-list
57058942|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57058943|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
57058944|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058945|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058946|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058947|NCT03525522|Betamethasone|betamethasone|mesh-list
57058948|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57058949|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740912|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
57058950|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
57058951|NCT03525522|Hormones|hormones|mesh-ancestor
57058952|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57058953|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058954|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57058955|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
57058956|NCT03228732|Fluoxetine|fluoxetine|mesh-list
57058957|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57058958|NCT03228732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57058959|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57058960|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57058961|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058962|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058963|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
57058964|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058965|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57058966|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
57058967|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57058968|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57058969|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57058970|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57058971|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57058972|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
57058973|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57058974|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57058975|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57058976|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57058977|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
57058978|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058979|NCT04466436|Tryptophan|tryptophan|mesh-list
57058980|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57058981|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
57058982|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57058983|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57058984|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
57058985|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57058986|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57058987|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57058988|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57058989|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57058990|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
57058991|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57058992|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57058993|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57058994|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57058995|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57058996|NCT03576612|Valacyclovir|valacyclovir|mesh-list
57058997|NCT03576612|Acyclovir|acyclovir|mesh-list
57058998|NCT03576612|Nivolumab|nivolumab|mesh-list
57058999|NCT03576612|Temozolomide|temozolomide|mesh-list
57059000|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059001|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059002|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57059003|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059004|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57059005|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
57059006|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
57059007|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059008|NCT05230758|Metformin|metformin|mesh-list
57059009|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57059010|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059011|NCT03008382|Metoprolol|metoprolol|mesh-list
57059012|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57059013|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57059014|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
57059015|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
57059016|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059017|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059018|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57059019|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57059020|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57059021|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
57059022|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741000|NCT05774028|Analgesics|analgesics|mesh-ancestor
57059023|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059025|NCT02137239|Prednisone|prednisone|mesh-list
57059026|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
57059027|NCT02137239|Everolimus|everolimus|mesh-list
57059028|NCT02137239|Abatacept|abatacept|mesh-list
57059029|NCT02137239|Tacrolimus|tacrolimus|mesh-list
57059030|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
57059031|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57059032|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
57059033|NCT02137239|Hormones|hormones|mesh-ancestor
57059034|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059035|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059036|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57059037|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059038|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059039|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
57059040|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57059041|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059042|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059043|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57059044|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57059045|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
57059046|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57059047|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059048|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
57059049|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
57059050|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059051|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57059052|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57059053|NCT02137239|Protective Agents|protective agents|mesh-ancestor
57059054|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57059055|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57059056|NCT02137395|Dexamethasone|dexamethasone|mesh-list
57059057|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57059058|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
57059059|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
57059060|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059061|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059062|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57059063|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
57059064|NCT02137395|Hormones|hormones|mesh-ancestor
57059065|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059066|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57059067|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059068|NCT02137629|Azacitidine|azacitidine|mesh-list
57059069|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57059070|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
57059071|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059072|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898240|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
57059073|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059074|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57059075|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57059076|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059077|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059078|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
57059079|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059080|NCT04301934|Estradiol|estradiol|mesh-list
57059081|NCT04301934|Estrogens|estrogens|mesh-list
57059082|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
57059083|NCT04301934|Hormones|hormones|mesh-ancestor
57059084|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059085|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059086|NCT02261025|Aspirin|aspirin|mesh-list
57059087|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57059088|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57059089|NCT02261025|Analgesics|analgesics|mesh-ancestor
57059090|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
57059091|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059092|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059093|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57059094|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57059095|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57059096|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57059097|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059098|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57059099|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57059100|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059101|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
57059102|NCT02925234|Bevacizumab|bevacizumab|mesh-list
57059103|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
57059104|NCT02925234|Nivolumab|nivolumab|mesh-list
57059105|NCT02925234|Trastuzumab|trastuzumab|mesh-list
57059106|NCT02925234|Ipilimumab|ipilimumab|mesh-list
57059107|NCT02925234|Durvalumab|durvalumab|mesh-list
57059108|NCT02925234|Pertuzumab|pertuzumab|mesh-list
57059109|NCT02925234|Panitumumab|panitumumab|mesh-list
57059110|NCT02925234|Sunitinib|sunitinib|mesh-list
57059111|NCT02925234|Atezolizumab|atezolizumab|mesh-list
57059112|NCT02925234|Olaparib|olaparib|mesh-list
57059113|NCT02925234|Lenvatinib|lenvatinib|mesh-list
57059114|NCT02925234|Palbociclib|palbociclib|mesh-list
57059115|NCT02925234|Trametinib|trametinib|mesh-list
57059116|NCT02925234|Axitinib|axitinib|mesh-list
57059117|NCT02925234|Afatinib|afatinib|mesh-list
57059118|NCT02925234|Vemurafenib|vemurafenib|mesh-list
57059119|NCT02925234|Dabrafenib|dabrafenib|mesh-list
57059120|NCT02925234|Crizotinib|crizotinib|mesh-list
57059121|NCT02925234|Talazoparib|talazoparib|mesh-list
57059122|NCT02925234|Rucaparib|rucaparib|mesh-list
57059123|NCT02925234|Entrectinib|entrectinib|mesh-list
57059124|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059125|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059126|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57059127|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57059128|NCT02925234|Growth Substances|growth substances|mesh-ancestor
57059129|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059130|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
57059131|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57059132|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059133|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57059134|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059135|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57059136|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
57059137|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57059138|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059139|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059140|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57059141|NCT02137863|Analgesics|analgesics|mesh-ancestor
57059142|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
57059143|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059144|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57059145|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57059146|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57059147|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
57059148|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898241|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
57059149|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059150|NCT05177796|Paclitaxel|paclitaxel|mesh-list
57059151|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
57059152|NCT05177796|Carboplatin|carboplatin|mesh-list
57059153|NCT05177796|Doxorubicin|doxorubicin|mesh-list
57059154|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57059155|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
57059156|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57059157|NCT05177796|Daunorubicin|daunorubicin|mesh-list
57059158|NCT05177796|Panitumumab|panitumumab|mesh-list
57059159|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57059160|NCT05177796|Antibodies|antibodies|mesh-list
57059161|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
57059162|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57059163|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57059164|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059165|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
57059166|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
57059167|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
57059168|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059169|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059170|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
57059171|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059172|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57059173|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57059174|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
57059175|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57059176|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57059177|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57059178|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57059180|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
57059181|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
57059182|NCT02138019|Coagulants|coagulants|mesh-ancestor
57059183|NCT02133885|Minocycline|minocycline|mesh-list
57059184|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57059185|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059186|NCT02138409|Fentanyl|fentanyl|mesh-list
57059187|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57059188|NCT02138409|Narcotics|narcotics|mesh-ancestor
57059189|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059190|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059191|NCT02138409|Analgesics|analgesics|mesh-ancestor
57059192|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
57059193|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059194|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57059195|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57059196|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
57059197|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
57059198|NCT02138799|Rifampin|rifampin|mesh-list
57059199|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57059200|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
57059201|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57059202|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059203|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
57059204|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57059205|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059206|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059207|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57059208|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57059209|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57059210|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57059211|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57059212|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57059213|NCT05578287|Celecoxib|celecoxib|mesh-list
57059214|NCT05578287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57059215|NCT05578287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57059216|NCT05578287|Analgesics|analgesics|mesh-ancestor
57059217|NCT05578287|Sensory System Agents|sensory system agents|mesh-ancestor
57059218|NCT05578287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059219|NCT05578287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059220|NCT05578287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57059221|NCT05578287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57059222|NCT05578287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57059223|NCT05578287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57059224|NCT05578287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059225|NCT05578287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059226|NCT02975271|Serlopitant|serlopitant|mesh-list
57059227|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57059228|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059229|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059230|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059231|NCT02741076|Oxymorphone|oxymorphone|mesh-list
57059232|NCT02741076|Morphine|morphine|mesh-list
57059233|NCT02741076|Oxycodone|oxycodone|mesh-list
57059234|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
57059235|NCT02741076|Narcotics|narcotics|mesh-ancestor
57059236|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059237|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059238|NCT02741076|Analgesics|analgesics|mesh-ancestor
57059239|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
57059240|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059241|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57059242|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
57059243|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
57059244|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
57059245|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059246|NCT01666444|Doxorubicin|doxorubicin|mesh-list
57059247|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57059248|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57059249|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741227|NCT05667883|Hormones|hormones|mesh-ancestor
57059250|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57059251|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57059252|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059253|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059254|NCT05543122|Fluconazole|fluconazole|mesh-list
57059255|NCT05543122|Methotrexate|methotrexate|mesh-list
57059256|NCT05543122|Atenolol|atenolol|mesh-list
57059257|NCT05543122|Lamotrigine|lamotrigine|mesh-list
57059258|NCT05543122|Lacosamide|lacosamide|mesh-list
57059259|NCT05543122|Levetiracetam|levetiracetam|mesh-list
57059260|NCT05543122|Brivaracetam|brivaracetam|mesh-list
57059261|NCT05543122|Citalopram|citalopram|mesh-list
57059262|NCT05543122|Bupropion|bupropion|mesh-list
57059263|NCT05543122|Ezetimibe|ezetimibe|mesh-list
57059264|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57059265|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
57059266|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57059267|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059268|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57059269|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
57059270|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059271|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059272|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
57059273|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059274|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57059275|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059276|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
57059277|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57059278|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57059279|NCT05543122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57059280|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57059281|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57059282|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059283|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
57059284|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57059285|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
57059286|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57059287|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
57059288|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059289|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57059290|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57059291|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57059292|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57059293|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
57059294|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57059295|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57059296|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
57059297|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
57059298|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
57059299|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059300|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57059301|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57059302|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
57059303|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059304|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57059305|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57059306|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57059307|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57059308|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57059309|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57059310|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059311|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57059312|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57059313|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57059314|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57059315|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
57059316|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57059317|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57059318|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57059319|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
57059320|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57059321|NCT05120934|Amitriptyline|amitriptyline|mesh-list
57059322|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57059323|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57059324|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57059325|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059326|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059327|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059328|NCT05120934|Analgesics|analgesics|mesh-ancestor
57059329|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
57059330|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059331|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
57059332|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57059333|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
57059334|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57059335|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57059336|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57059337|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
57059338|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
57059339|NCT03548493|Fentanyl|fentanyl|mesh-list
57059340|NCT03548493|Propofol|propofol|mesh-list
57059341|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57059342|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059343|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059344|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57059345|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
57059346|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
57059347|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57059348|NCT03548493|Narcotics|narcotics|mesh-ancestor
57059349|NCT03548493|Analgesics|analgesics|mesh-ancestor
57059350|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
57059351|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059352|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57059353|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57059354|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
57059355|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57059356|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57059357|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059358|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57059359|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
57059360|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57059361|NCT02139267|Vaccines|vaccines|mesh-list
57059362|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
57059363|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059364|NCT05094336|Docetaxel|docetaxel|mesh-list
57059365|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059366|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
57059367|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
57059368|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
57059369|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059370|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57059371|NCT03549819|Cannabidiol|cannabidiol|mesh-list
57059372|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
57059373|NCT03549741|Cabergoline|cabergoline|mesh-list
57059374|NCT03549741|Clomiphene|clomiphene|mesh-list
57059375|NCT03549741|Enclomiphene|enclomiphene|mesh-list
57059376|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
57059377|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059378|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57059379|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
57059380|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059381|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059382|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57059383|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
57059384|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57059385|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57059386|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57059387|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57059388|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57059389|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
57059390|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
57059391|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059392|NCT03522402|Sevoflurane|sevoflurane|mesh-list
57059393|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57059394|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57059395|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
57059396|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
57059397|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059398|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059399|NCT02134899|Everolimus|everolimus|mesh-list
57059401|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059402|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059403|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
57059404|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059405|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059406|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059407|NCT05577819|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
57059408|NCT05577819|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57059409|NCT05577819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059410|NCT04102098|Bevacizumab|bevacizumab|mesh-list
57059411|NCT04102098|Atezolizumab|atezolizumab|mesh-list
57059412|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059413|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059414|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57059415|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57059416|NCT04102098|Growth Substances|growth substances|mesh-ancestor
57059417|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059418|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
57059419|NCT02135055|Midazolam|midazolam|mesh-list
57059420|NCT02135055|Morphine|morphine|mesh-list
57059421|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57059422|NCT02135055|Narcotics|narcotics|mesh-ancestor
57059423|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059424|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059425|NCT02135055|Analgesics|analgesics|mesh-ancestor
57059426|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
57059427|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059428|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57059429|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57059430|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57059431|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57059432|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57059433|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57059434|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
57059435|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
57059436|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
57059437|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
57059438|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059439|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059440|NCT05546710|Anesthetics|anesthetics|mesh-list
57059441|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059442|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059443|NCT02139579|Bevacizumab|bevacizumab|mesh-list
57059444|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059445|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059446|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57059447|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57059448|NCT02139579|Growth Substances|growth substances|mesh-ancestor
57059449|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059450|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
57059451|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
57059452|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
57059453|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059454|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
57059455|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57059456|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059457|NCT04076826|Midazolam|midazolam|mesh-list
57059458|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
57059459|NCT04076826|Propofol|propofol|mesh-list
57059460|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57059461|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059462|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059463|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57059464|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
57059465|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
57059466|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57059467|NCT04076826|Analgesics|analgesics|mesh-ancestor
57059468|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
57059469|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059470|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57059471|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57059472|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57059473|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
57059474|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059475|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059476|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57059477|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57059478|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57059479|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57059480|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
57059481|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
57059482|NCT05577585|Midazolam|midazolam|mesh-list
57059483|NCT05577585|Ketamine|ketamine|mesh-list
57059484|NCT05577585|Analgesics|analgesics|mesh-ancestor
57059485|NCT05577585|Sensory System Agents|sensory system agents|mesh-ancestor
57059486|NCT05577585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059487|NCT05577585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059488|NCT05577585|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57059489|NCT05577585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57059490|NCT05577585|Anesthetics, General|anesthetics, general|mesh-ancestor
57059491|NCT05577585|Anesthetics|anesthetics|mesh-ancestor
57059492|NCT05577585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059493|NCT05577585|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57059494|NCT05577585|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57059495|NCT05577585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059496|NCT05577585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059497|NCT05577585|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57059498|NCT05577585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57059499|NCT05577585|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57059500|NCT05577585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57059501|NCT05577585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57059502|NCT05577585|GABA Modulators|gaba modulators|mesh-ancestor
57059503|NCT05577585|GABA Agents|gaba agents|mesh-ancestor
57059504|NCT04465968|Durvalumab|durvalumab|mesh-list
57059505|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57059506|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059507|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059508|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
57059509|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059510|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
57059511|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57059512|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059513|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
57059514|NCT02689440|Venetoclax|venetoclax|mesh-list
57059515|NCT02689440|Dasatinib|dasatinib|mesh-list
57059516|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059517|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57059518|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059519|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059520|NCT05577507|Calcium Carbonate|calcium carbonate|mesh-list
57059521|NCT05577507|Cholestyramine Resin|cholestyramine resin|mesh-list
57059522|NCT05577507|Calcium|calcium|mesh-list
57059523|NCT05577507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57059524|NCT05577507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059525|NCT05577507|Antacids|antacids|mesh-ancestor
57059526|NCT05577507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059527|NCT05577507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57059528|NCT05577507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57059529|NCT05577507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57059530|NCT05577507|Antimetabolites|antimetabolites|mesh-ancestor
57059531|NCT05577507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57059532|NCT01565655|Peficitinib|peficitinib|mesh-list
57059533|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059534|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059535|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059536|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
57059537|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059538|NCT05535322|Insulin|insulin|mesh-list
57059539|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57059540|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059541|NCT05577273|Trimethoprim|trimethoprim|mesh-list
57059542|NCT05577273|Sulfamethoxazole|sulfamethoxazole|mesh-list
57059543|NCT05577273|Penicillins|penicillins|mesh-list
57059544|NCT05577273|Cefuroxime|cefuroxime|mesh-list
57059545|NCT05577273|Cefuroxime axetil|cefuroxime axetil|mesh-list
57059546|NCT05577273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57059547|NCT05577273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059548|NCT05577273|Renal Agents|renal agents|mesh-ancestor
57059549|NCT05577273|Antimalarials|antimalarials|mesh-ancestor
57059550|NCT05577273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57059551|NCT05577273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57059552|NCT05577273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57059553|NCT05577273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059554|NCT05577273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059555|NCT05577273|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57059556|NCT05577273|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57059557|NCT05577273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57059558|NCT05577273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57059560|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059561|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
57059562|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
57059563|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
57059564|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059565|NCT02253459|Capecitabine|capecitabine|mesh-list
57059566|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57059567|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
57059568|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059569|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059570|NCT02140047|Vaccines|vaccines|mesh-list
57059571|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
57059572|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059573|NCT02135913|Vitamin D|vitamin d|mesh-list
57059574|NCT02135913|Vitamins|vitamins|mesh-ancestor
57059575|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
57059576|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059577|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57059578|NCT05505279|Nicotine|nicotine|mesh-list
57059579|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57059580|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
57059581|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059582|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059583|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57059584|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57059585|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
57059586|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059587|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059588|NCT05541640|Lidocaine|lidocaine|mesh-list
57059589|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
57059590|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
57059591|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059592|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059593|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
57059594|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059595|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57059596|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57059597|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57059598|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57059599|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059600|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
57059601|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
57059602|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57059603|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059604|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57059605|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57059606|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059607|NCT02140281|Cefadroxil|cefadroxil|mesh-list
57059608|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57059609|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059610|NCT05545462|Doxycycline|doxycycline|mesh-list
57059611|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57059612|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059613|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
57059614|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57059615|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57059616|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
57059617|NCT05541172|Testosterone|testosterone|mesh-list
57059618|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
57059619|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
57059620|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57059621|NCT05541172|Androgens|androgens|mesh-ancestor
57059622|NCT05541172|Hormones|hormones|mesh-ancestor
57059623|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741589|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57059624|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059625|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57059626|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059628|NCT05545384|Rituximab|rituximab|mesh-list
57059629|NCT05545384|Azathioprine|azathioprine|mesh-list
57059630|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059631|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059632|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
57059633|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059634|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57059635|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
57059636|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059637|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57059638|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059639|NCT05478993|Dexamethasone|dexamethasone|mesh-list
57059640|NCT05478993|Pomalidomide|pomalidomide|mesh-list
57059641|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57059642|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
57059643|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
57059644|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059645|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059646|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57059647|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
57059648|NCT05478993|Hormones|hormones|mesh-ancestor
57059649|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059650|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57059651|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059652|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
57059653|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57059654|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57059655|NCT05478993|Growth Substances|growth substances|mesh-ancestor
57059656|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
57059657|NCT05699356|Estrogens|estrogens|mesh-list
57059658|NCT05699356|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57059659|NCT05699356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059660|NCT05699356|Hormones|hormones|mesh-ancestor
57059661|NCT05699356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059662|NCT05699356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57059663|NCT05699356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059664|NCT05699356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059665|NCT05699356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57059666|NCT05699356|Hormone Antagonists|hormone antagonists|mesh-ancestor
57059667|NCT02140437|Fulvestrant|fulvestrant|mesh-list
57059668|NCT02140437|Anastrozole|anastrozole|mesh-list
57059669|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57059670|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059671|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57059672|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57059673|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
57059674|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059675|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059676|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57059677|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57059678|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059679|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059680|NCT03937830|Bevacizumab|bevacizumab|mesh-list
57059681|NCT03937830|Durvalumab|durvalumab|mesh-list
57059682|NCT03937830|Doxorubicin|doxorubicin|mesh-list
57059683|NCT03937830|Tremelimumab|tremelimumab|mesh-list
57059684|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059685|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059686|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57059687|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57059688|NCT03937830|Growth Substances|growth substances|mesh-ancestor
57059689|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059690|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
57059691|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57059692|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57059693|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57059694|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059695|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059696|NCT05591560|Itraconazole|itraconazole|mesh-list
57059697|NCT05591560|Antifungal Agents|antifungal agents|mesh-ancestor
57059698|NCT05591560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059699|NCT05591560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57059700|NCT05591560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57059701|NCT05591560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059702|NCT05591560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059703|NCT05591560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57059704|NCT05591560|Hormone Antagonists|hormone antagonists|mesh-ancestor
57059705|NCT05591560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059706|NCT05591560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059707|NCT05591560|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57059708|NCT05540470|Chloroquine|chloroquine|mesh-list
57059709|NCT05540470|Primaquine|primaquine|mesh-list
57059710|NCT05540470|Tafenoquine|tafenoquine|mesh-list
57059711|NCT05540470|Amebicides|amebicides|mesh-ancestor
57059712|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57059713|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57059714|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059715|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
57059716|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57059717|NCT05009082|Paclitaxel|paclitaxel|mesh-list
57059718|NCT05009082|Bevacizumab|bevacizumab|mesh-list
57059719|NCT05009082|Carboplatin|carboplatin|mesh-list
57059720|NCT05009082|Niraparib|niraparib|mesh-list
57059721|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57059722|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059723|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
57059724|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
57059725|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
57059726|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059727|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059728|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57059729|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57059730|NCT05009082|Growth Substances|growth substances|mesh-ancestor
57059731|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059732|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
57059733|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57059734|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059735|NCT05575167|Vitamin D|vitamin d|mesh-list
57059736|NCT05575167|Alendronate|alendronate|mesh-list
57059737|NCT05575167|Zoledronic Acid|zoledronic acid|mesh-list
57059738|NCT05575167|Vitamins|vitamins|mesh-ancestor
57059739|NCT05575167|Micronutrients|micronutrients|mesh-ancestor
57059740|NCT05575167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059741|NCT05575167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57059742|NCT02140515|Hormones|hormones|mesh-list
57059743|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57059744|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059745|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059746|NCT02260947|Ibuprofen|ibuprofen|mesh-list
57059747|NCT02260947|Pregabalin|pregabalin|mesh-list
57059748|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57059749|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57059750|NCT02260947|Analgesics|analgesics|mesh-ancestor
57059751|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
57059752|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059753|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059754|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57059755|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57059756|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57059757|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059758|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059759|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
57059760|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57059761|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57059762|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57059763|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57059764|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57059765|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059766|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57059767|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57059768|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059769|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57059770|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059771|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059772|NCT03547791|Betamethasone|betamethasone|mesh-list
57059773|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
56741735|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57059774|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57059775|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
57059776|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57059777|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
57059778|NCT03547791|Hormones|hormones|mesh-ancestor
57059779|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059780|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059781|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57059782|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57059783|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
57059784|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
57059785|NCT04818177|Antibodies|antibodies|mesh-list
57059786|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
57059787|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57059788|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57059789|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
57059790|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059791|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57059792|NCT04425460|Favipiravir|favipiravir|mesh-list
57059793|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
57059794|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059795|NCT05576272|Gemcitabine|gemcitabine|mesh-list
57059796|NCT05576272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059797|NCT05576272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57059798|NCT05576272|Antimetabolites|antimetabolites|mesh-ancestor
57059799|NCT05576272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059800|NCT05576272|Antiviral Agents|antiviral agents|mesh-ancestor
57059801|NCT05576272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059802|NCT05576272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059803|NCT05576272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059804|NCT05576272|Immunologic Factors|immunologic factors|mesh-ancestor
57059805|NCT05576272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059806|NCT05179005|Imidacloprid|imidacloprid|mesh-list
57059807|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
57059808|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059809|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059810|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059811|NCT05576116|Pancrelipase|pancrelipase|mesh-list
57059812|NCT05576116|Pancreatin|pancreatin|mesh-list
57059813|NCT05576116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57059814|NCT04765137|Atorvastatin|atorvastatin|mesh-list
57059815|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57059816|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57059817|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
57059818|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059819|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57059820|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57059821|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059822|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
57059823|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
57059824|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
57059825|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57059826|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059827|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
57059828|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059829|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
57059830|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
57059831|NCT04703673|Ephedrine|ephedrine|mesh-list
57059832|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
57059833|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57059834|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
57059835|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57059836|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059837|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
57059838|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57059839|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
57059840|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059841|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059842|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57059843|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57059844|NCT05543746|Brexanolone|brexanolone|mesh-list
57059845|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
57059846|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57059847|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059848|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059850|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
57059851|NCT03526536|Insulin|insulin|mesh-list
57059852|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57059853|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57059854|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059855|NCT05413330|Triamcinolone|triamcinolone|mesh-list
57059856|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57059857|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57059858|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57059859|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57059860|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
57059861|NCT05413330|Hormones|hormones|mesh-ancestor
57059862|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059863|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059864|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059865|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
57059866|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059867|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059868|NCT05306301|Ponatinib|ponatinib|mesh-list
57059869|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059870|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57059871|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059872|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059873|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
57059874|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57059875|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
57059876|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059877|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
57059878|NCT05543434|Protective Agents|protective agents|mesh-ancestor
57059879|NCT01858896|Glucagon|glucagon|mesh-list
57059880|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57059881|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57059882|NCT01858896|Hormones|hormones|mesh-ancestor
57059883|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57059884|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059885|NCT01858896|Incretins|incretins|mesh-ancestor
57059886|NCT04940286|Gemcitabine|gemcitabine|mesh-list
57059887|NCT04940286|Paclitaxel|paclitaxel|mesh-list
57059888|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57059889|NCT04940286|Durvalumab|durvalumab|mesh-list
57059890|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
57059891|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57059892|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
57059893|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57059894|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059895|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
57059896|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
57059897|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
57059898|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059899|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57059900|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
57059901|NCT04940286|Antiviral Agents|antiviral agents|mesh-ancestor
57059902|NCT04940286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059903|NCT04940286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059904|NCT04940286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059905|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
57059906|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059907|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059908|NCT05538988|Cemiplimab|cemiplimab|mesh-list
57059909|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059910|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059911|NCT04667637|Edaravone|edaravone|mesh-list
57059912|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57059913|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
57059914|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059915|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57059916|NCT04667637|Protective Agents|protective agents|mesh-ancestor
57059917|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059918|NCT02253927|Ritonavir|ritonavir|mesh-list
57059919|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57059920|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57059921|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
57059922|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059923|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059924|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57059925|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57059926|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
57059927|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059928|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57059929|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57059931|NCT05572749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57059932|NCT05572749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059933|NCT03745144|Cladribine|cladribine|mesh-list
57059934|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56283712|NCT00006451|Hormones|hormones|mesh-ancestor
57059935|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
57059936|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059937|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059938|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
57059939|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059940|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57059941|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
57059942|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57059943|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57059944|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57059945|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57059946|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57059947|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57059948|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
57059949|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57059950|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57059951|NCT05697016|Sivelestat|sivelestat|mesh-list
57059952|NCT05697016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57059953|NCT05697016|Protease Inhibitors|protease inhibitors|mesh-ancestor
57059954|NCT05697016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57059955|NCT05697016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059956|NCT05696938|Niacinamide|niacinamide|mesh-list
57059957|NCT05696938|Niacin|niacin|mesh-list
57059958|NCT05696938|Nicotinic Acids|nicotinic acids|mesh-list
57059959|NCT05696938|Vitamin B Complex|vitamin b complex|mesh-ancestor
57059960|NCT05696938|Vitamins|vitamins|mesh-ancestor
57059961|NCT05696938|Micronutrients|micronutrients|mesh-ancestor
57059962|NCT05696938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059963|NCT05696938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57059964|NCT05696938|Antimetabolites|antimetabolites|mesh-ancestor
57059965|NCT05696938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059966|NCT05696938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57059967|NCT05696938|Vasodilator Agents|vasodilator agents|mesh-ancestor
57059968|NCT04644237|Trastuzumab|trastuzumab|mesh-list
57059969|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059970|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059971|NCT04634877|Paclitaxel|paclitaxel|mesh-list
57059972|NCT04634877|Docetaxel|docetaxel|mesh-list
57059973|NCT04634877|Cisplatin|cisplatin|mesh-list
57059974|NCT04634877|Carboplatin|carboplatin|mesh-list
57059975|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
57059976|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57059977|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059978|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
57059979|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
57059980|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
57059981|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57059982|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57059983|NCT04629495|Sirolimus|sirolimus|mesh-list
57059984|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57059985|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059986|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57059987|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059988|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
57059989|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57059990|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
57059991|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57059992|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
57059993|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57059994|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57059995|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57059996|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
57059997|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57059998|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57059999|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060000|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060001|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
57060002|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57060003|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
57060005|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57060006|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060007|NCT05567523|Midazolam|midazolam|mesh-list
57060008|NCT05567523|Dexmedetomidine|dexmedetomidine|mesh-list
57060009|NCT05567523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57060010|NCT05567523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060011|NCT05567523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060012|NCT05567523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57060013|NCT05567523|Analgesics|analgesics|mesh-ancestor
57060014|NCT05567523|Sensory System Agents|sensory system agents|mesh-ancestor
57060015|NCT05567523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060016|NCT05567523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57060017|NCT05567523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57060018|NCT05567523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57060019|NCT05567523|Adrenergic Agents|adrenergic agents|mesh-ancestor
57060020|NCT05567523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060021|NCT05567523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060022|NCT05567523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57060023|NCT05567523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57060024|NCT05567523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57060025|NCT05567523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57060026|NCT05567523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57060027|NCT05567523|Anesthetics, General|anesthetics, general|mesh-ancestor
57060028|NCT05567523|Anesthetics|anesthetics|mesh-ancestor
57060029|NCT05567523|GABA Modulators|gaba modulators|mesh-ancestor
57060030|NCT05567523|GABA Agents|gaba agents|mesh-ancestor
57060031|NCT02584504|Atorvastatin|atorvastatin|mesh-list
57060032|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57060033|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57060034|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
57060035|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060036|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57060037|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57060038|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060039|NCT04599777|Sorafenib|sorafenib|mesh-list
57060040|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060041|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060042|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060043|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060044|NCT05180799|Nivolumab|nivolumab|mesh-list
57060045|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060046|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060047|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57060048|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060049|NCT05044468|Lidocaine|lidocaine|mesh-list
57060050|NCT05044468|Bupivacaine|bupivacaine|mesh-list
57060051|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
57060052|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
57060053|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060054|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060055|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
57060056|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060057|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57060058|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57060059|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57060060|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57060061|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060062|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
57060063|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060064|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060065|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
57060066|NCT05007262|Calcium|calcium|mesh-list
57060067|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57060068|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060069|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
57060070|NCT05007262|Coagulants|coagulants|mesh-ancestor
57060071|NCT03546075|Resveratrol|resveratrol|mesh-list
57060072|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
56742033|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
57060073|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060074|NCT03546075|Protective Agents|protective agents|mesh-ancestor
57060075|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060076|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060077|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57060079|NCT05537584|Sertraline|sertraline|mesh-list
57060080|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57060081|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
57060082|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57060083|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57060084|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57060085|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57060086|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060087|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
57060088|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060089|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060090|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57060091|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57060092|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060093|NCT05537584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57060094|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
57060095|NCT02520154|Paclitaxel|paclitaxel|mesh-list
57060096|NCT02520154|Carboplatin|carboplatin|mesh-list
57060097|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
57060098|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57060099|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57060100|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060101|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
57060102|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
57060103|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
57060104|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060105|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060106|NCT01801072|Levetiracetam|levetiracetam|mesh-list
57060107|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
57060108|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
57060109|NCT04459377|Ketamine|ketamine|mesh-list
57060110|NCT04459377|Esketamine|esketamine|mesh-list
57060111|NCT04459377|Analgesics|analgesics|mesh-ancestor
57060112|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
57060113|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060114|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060115|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57060116|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57060117|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
57060118|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
57060119|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060120|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57060121|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57060122|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060123|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060124|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
57060125|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57060126|NCT00748618|Vitamin D|vitamin d|mesh-list
57060127|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
57060128|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
57060129|NCT00748618|Vitamins|vitamins|mesh-list
57060130|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
57060131|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060132|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57060133|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57060134|NCT04447755|Lenvatinib|lenvatinib|mesh-list
57060135|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060136|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060137|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060138|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060139|NCT02254005|Maytansine|maytansine|mesh-list
57060140|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
57060141|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57060142|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060143|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
57060144|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
57060145|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
57060146|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060147|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060149|NCT04404387|Vitamins|vitamins|mesh-ancestor
57060150|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
57060151|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060152|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
57060153|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060154|NCT04404387|Protective Agents|protective agents|mesh-ancestor
57060155|NCT03546855|Apatinib|apatinib|mesh-list
57060156|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060157|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060158|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060159|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060160|NCT05679310|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
57060161|NCT05679310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060162|NCT05679310|Antioxidants|antioxidants|mesh-ancestor
57060163|NCT05679310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060164|NCT05679310|Protective Agents|protective agents|mesh-ancestor
57060165|NCT05679310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060166|NCT05679310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57060167|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
57060168|NCT05537272|Tadalafil|tadalafil|mesh-list
57060169|NCT05537272|Tamsulosin|tamsulosin|mesh-list
57060170|NCT05537272|Vitamins|vitamins|mesh-ancestor
57060171|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
57060172|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060173|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
57060174|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060175|NCT05537272|Protective Agents|protective agents|mesh-ancestor
57060176|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
57060177|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57060178|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57060179|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060180|NCT05537272|Urological Agents|urological agents|mesh-ancestor
57060181|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57060182|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57060183|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57060184|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
57060185|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060186|NCT03979131|Avelumab|avelumab|mesh-list
57060187|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060188|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060189|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
57060190|NCT05537194|Calcium|calcium|mesh-list
57060191|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57060192|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060193|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57060194|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57060195|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060196|NCT05536882|Adapalene|adapalene|mesh-list
57060197|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57060198|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
57060199|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57060200|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57060201|NCT05536882|Analgesics|analgesics|mesh-ancestor
57060202|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
57060203|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060204|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060205|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57060206|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060207|NCT04605094|Benralizumab|benralizumab|mesh-list
57060208|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060209|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060210|NCT03931161|Evolocumab|evolocumab|mesh-list
57060211|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57060212|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57060213|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
57060214|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060215|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57060216|NCT05037123|Ketamine|ketamine|mesh-list
57060217|NCT05037123|Analgesics|analgesics|mesh-ancestor
57060218|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
57060219|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060220|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060221|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57060222|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57060223|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
57060224|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
57060225|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060226|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57060227|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57060228|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060229|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060230|NCT04354155|Enoxaparin|enoxaparin|mesh-list
57060231|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
57060232|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57060233|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57060234|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060235|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57060236|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
57060237|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060238|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
57060239|NCT04350021|Capecitabine|capecitabine|mesh-list
57060240|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57060241|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
57060242|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060243|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060244|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57060245|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
57060246|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060247|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060248|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57060249|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57060250|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
57060251|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57060252|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57060253|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060254|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060255|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57060256|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57060257|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060258|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
57060259|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060260|NCT03877965|Digoxin|digoxin|mesh-list
57060261|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57060262|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57060263|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060264|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060265|NCT03877965|Protective Agents|protective agents|mesh-ancestor
57060266|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060267|NCT03871491|Azithromycin|azithromycin|mesh-list
57060268|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57060269|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060270|NCT02253849|Ritonavir|ritonavir|mesh-list
57060271|NCT02253849|Tipranavir|tipranavir|mesh-list
57060272|NCT02253849|Carbamazepine|carbamazepine|mesh-list
57060273|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57060274|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57060275|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
57060276|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060277|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060278|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57060279|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57060280|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
57060281|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060282|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57060283|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57060284|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
57060285|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
57060286|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57060287|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060288|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060289|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57060290|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57060291|NCT02253849|Analgesics|analgesics|mesh-ancestor
57060292|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
57060293|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060294|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57060295|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57060296|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57060297|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57060298|NCT03545997|Montelukast|montelukast|mesh-list
57060299|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060300|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060301|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57060302|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
57060303|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57060304|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060305|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57060306|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57060307|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060308|NCT05696548|Nivolumab|nivolumab|mesh-list
57060309|NCT05696548|Lenvatinib|lenvatinib|mesh-list
57060310|NCT05696548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060311|NCT05696548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060312|NCT05696548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57060313|NCT05696548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060314|NCT05696548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060315|NCT05696548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060316|NCT03810495|Naltrexone|naltrexone|mesh-list
57060317|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57060318|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57060319|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060320|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
57060321|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060322|NCT04980885|Azacitidine|azacitidine|mesh-list
57060323|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57060324|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
57060325|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060326|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060327|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060328|NCT04184505|Azacitidine|azacitidine|mesh-list
57060329|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57060330|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
57060331|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060332|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060333|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060334|NCT03691935|Ropivacaine|ropivacaine|mesh-list
57060335|NCT03691935|Anesthetics|anesthetics|mesh-list
57060336|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
57060337|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060338|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060339|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
57060340|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060341|NCT03760458|Lamivudine|lamivudine|mesh-list
57060342|NCT03760458|Abacavir|abacavir|mesh-list
57060343|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
57060344|NCT03760458|Dolutegravir|dolutegravir|mesh-list
57060345|NCT03760458|Triumeq|triumeq|mesh-list
57060346|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57060347|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57060348|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060349|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060350|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
57060351|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060352|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57060353|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57060354|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57060355|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57060356|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
57060357|NCT02066415|Erenumab|erenumab|mesh-list
57060358|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57060359|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060360|NCT02066415|Analgesics|analgesics|mesh-ancestor
57060361|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
57060362|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060363|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060364|NCT04467918|Cannabidiol|cannabidiol|mesh-list
57060365|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
57060366|NCT02582866|Lacosamide|lacosamide|mesh-list
57060367|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
57060368|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57060369|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57060370|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57060371|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060372|NCT03737994|Cisplatin|cisplatin|mesh-list
57060373|NCT03737994|Carboplatin|carboplatin|mesh-list
57060374|NCT03737994|Pemetrexed|pemetrexed|mesh-list
57060375|NCT03737994|Crizotinib|crizotinib|mesh-list
57060376|NCT03737994|Ceritinib|ceritinib|mesh-list
57060377|NCT03737994|Ensartinib|ensartinib|mesh-list
57060378|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060379|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060380|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060381|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57060382|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57060383|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060384|NCT04720612|Omalizumab|omalizumab|mesh-list
57060385|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57060386|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060387|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060388|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
57060389|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57060390|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
57060391|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57060392|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
57060393|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060394|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060395|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
57060396|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57060397|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
57060398|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060399|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57060400|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57060401|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060402|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57060403|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060404|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060405|NCT04315558|Bromides|bromides|mesh-list
57060406|NCT04315558|Ipratropium|ipratropium|mesh-list
57060407|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
57060408|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57060409|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
57060410|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060411|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060412|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060413|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060414|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57060415|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
57060416|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060417|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060418|NCT04466904|Dulaglutide|dulaglutide|mesh-list
57060419|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57060420|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060421|NCT03524274|Antibodies|antibodies|mesh-list
57060422|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57060423|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
57060424|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060425|NCT02143479|Tacrolimus|tacrolimus|mesh-list
57060426|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57060427|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
57060428|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060429|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57060430|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060431|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060432|NCT01590069|Aldesleukin|aldesleukin|mesh-list
57060433|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060434|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57060435|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57060436|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
57060437|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060438|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57060439|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57060440|NCT02254239|Everolimus|everolimus|mesh-list
57060441|NCT02254239|Antibodies|antibodies|mesh-list
57060442|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
57060443|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57060444|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
57060445|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
57060446|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060447|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060448|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57060449|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
57060450|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57060451|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57060452|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
57060453|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060454|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060455|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060456|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060457|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57060458|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
57060459|NCT05088369|Protective Agents|protective agents|mesh-ancestor
57060460|NCT05681182|Amiodarone|amiodarone|mesh-list
57060461|NCT05681182|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57060462|NCT05681182|Vasodilator Agents|vasodilator agents|mesh-ancestor
57060463|NCT05681182|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57060464|NCT05681182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57060465|NCT05681182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060466|NCT05681182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57060467|NCT05681182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57060468|NCT05681182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57060469|NCT05681182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060470|NCT05681182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57060471|NCT05681182|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57060472|NCT05681182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57060473|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57060474|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57060475|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57060476|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
57060477|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060478|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57060479|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57060480|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060481|NCT02144025|Cyclosporine|cyclosporine|mesh-list
57060482|NCT02144025|Cyclosporins|cyclosporins|mesh-list
57060483|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060484|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060485|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57060486|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
57060487|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060488|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
57060489|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898387|NCT01290003|Tazobactam|tazobactam|mesh-list
57060490|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
57060491|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060492|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57060493|NCT01187199|Sirolimus|sirolimus|mesh-list
57060494|NCT01187199|Paclitaxel|paclitaxel|mesh-list
57060495|NCT01187199|Bevacizumab|bevacizumab|mesh-list
57060496|NCT01187199|Carboplatin|carboplatin|mesh-list
57060497|NCT01187199|Sorafenib|sorafenib|mesh-list
57060498|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57060499|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060500|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
57060501|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
57060502|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
57060503|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060504|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060505|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57060506|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57060507|NCT01187199|Growth Substances|growth substances|mesh-ancestor
57060508|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060509|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
57060510|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060511|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060512|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57060513|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060514|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57060515|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
57060516|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57060517|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
57060518|NCT03523650|Propranolol|propranolol|mesh-list
57060519|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57060520|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57060521|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
57060522|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060523|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060524|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060525|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57060526|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57060527|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
57060528|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
57060529|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060530|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060531|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060532|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060533|NCT02582632|Ritonavir|ritonavir|mesh-list
57060534|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57060535|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57060536|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
57060537|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060538|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060539|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57060540|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57060541|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
57060542|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060543|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57060544|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57060545|NCT05414032|Cetuximab|cetuximab|mesh-list
57060546|NCT05414032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060547|NCT05414032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060548|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57060549|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
57060550|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060551|NCT05381974|Psilocybin|psilocybin|mesh-list
57060552|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
57060553|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060554|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57060555|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
57060556|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060557|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060558|NCT05362318|Nicotine|nicotine|mesh-list
57060559|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57060560|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
57060561|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060562|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060563|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57060564|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57060565|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
57060566|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060567|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060568|NCT03523572|Nivolumab|nivolumab|mesh-list
57060569|NCT03523572|Trastuzumab|trastuzumab|mesh-list
57060570|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060571|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060572|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57060573|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060574|NCT00972309|Vaccines|vaccines|mesh-list
57060575|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
57060576|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060577|NCT03526224|Teriflunomide|teriflunomide|mesh-list
57060578|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57060579|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
57060580|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57060581|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
57060582|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060583|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57060584|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57060585|NCT03526224|Analgesics|analgesics|mesh-ancestor
57060586|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
57060587|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060588|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57060589|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060590|NCT03639246|Paclitaxel|paclitaxel|mesh-list
57060591|NCT03639246|Doxorubicin|doxorubicin|mesh-list
57060592|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57060593|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57060594|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060595|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
57060596|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
56453753|NCT00328718|Xhance|xhance|mesh-list
57060598|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060599|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57060600|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57060601|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57060602|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060603|NCT00545324|Fluticasone|fluticasone|mesh-list
57060604|NCT00545324|Montelukast|montelukast|mesh-list
57060605|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57060606|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57060607|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
57060608|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060609|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060610|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060611|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060612|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
57060613|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56898405|NCT01185405|Voriconazole|voriconazole|mesh-list
57060614|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060615|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57060616|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
57060617|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57060618|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57060619|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57060620|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
57060621|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
57060622|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
57060623|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57060624|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060625|NCT05093582|Cromakalim|cromakalim|mesh-list
57060626|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57060627|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57060628|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
57060629|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060630|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060631|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060632|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060633|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
57060634|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
57060635|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
57060636|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57060637|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
57060638|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060639|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
57060640|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060641|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
57060642|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060643|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060644|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57060645|NCT03609840|Thiotepa|thiotepa|mesh-list
57060646|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
57060647|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
57060648|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
57060649|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060650|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57060651|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57060652|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
57060653|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060654|NCT03389126|Avelumab|avelumab|mesh-list
57060655|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060656|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060657|NCT04212364|Naloxone|naloxone|mesh-list
57060658|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57060659|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060660|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
57060661|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060662|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
57060663|NCT04446104|Ivermectin|ivermectin|mesh-list
57060664|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
57060665|NCT04446104|Povidone|povidone|mesh-list
57060666|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
57060667|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57060668|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57060669|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060670|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060671|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060672|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060673|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
57060674|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
57060675|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57060677|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
57060678|NCT03388970|Vitamins|vitamins|mesh-ancestor
57060679|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
57060680|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060681|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57060682|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57060683|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060684|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
57060685|NCT03388970|Coagulants|coagulants|mesh-ancestor
57060686|NCT00616941|Poly ICLC|poly iclc|mesh-list
57060687|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
57060688|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
57060689|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
57060690|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060691|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57060692|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57060693|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57060694|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060695|NCT05677282|Azithromycin|azithromycin|mesh-list
57060696|NCT05677282|Rifaximin|rifaximin|mesh-list
57060697|NCT05677282|Loperamide|loperamide|mesh-list
57060698|NCT05677282|Antidiarrheals|antidiarrheals|mesh-list
57060699|NCT05677282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57060700|NCT05677282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060701|NCT05677282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57060702|NCT03388892|Paclitaxel|paclitaxel|mesh-list
57060703|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57060704|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060705|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
57060706|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
57060707|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
57060708|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060709|NCT02577718|Ethanol|ethanol|mesh-list
57060710|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
57060711|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57060712|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060713|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060714|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060715|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
57060716|NCT00520533|Sunitinib|sunitinib|mesh-list
57060717|NCT00520533|Antibodies|antibodies|mesh-list
57060718|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57060719|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
57060720|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060721|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060722|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57060723|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57060724|NCT00520533|Growth Substances|growth substances|mesh-ancestor
57060725|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
57060726|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060727|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060728|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060729|NCT03388814|Bupivacaine|bupivacaine|mesh-list
57060730|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
57060731|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
57060732|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060733|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060734|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
57060735|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060736|NCT04680988|Gemcitabine|gemcitabine|mesh-list
57060737|NCT04680988|Paclitaxel|paclitaxel|mesh-list
57060738|NCT04680988|Pemetrexed|pemetrexed|mesh-list
57060739|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57060740|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57060741|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060742|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
57060743|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
57060744|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
57060745|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060746|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57060747|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
57060749|NCT04680988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060750|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060751|NCT04680988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57060752|NCT04680988|Immunologic Factors|immunologic factors|mesh-ancestor
57060753|NCT04680988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060754|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57060755|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57060756|NCT02289144|Ceritinib|ceritinib|mesh-list
57060757|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060758|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060759|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060760|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060761|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
57060762|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57060763|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57060764|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060765|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060766|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57060767|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57060768|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57060769|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57060770|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
57060771|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060772|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060773|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57060774|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57060775|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
57060776|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57060777|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57060778|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
57060779|NCT02144415|Amphetamine|amphetamine|mesh-list
57060780|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
57060781|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
57060782|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57060783|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060784|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
57060785|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
57060786|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060787|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
57060788|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060789|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060790|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
57060791|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57060792|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57060793|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57060794|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57060795|NCT02739984|Evolocumab|evolocumab|mesh-list
57060796|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57060797|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57060798|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57060799|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
57060800|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060801|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57060802|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
57060803|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060804|NCT00496730|Atorvastatin|atorvastatin|mesh-list
57060805|NCT00496730|Simvastatin|simvastatin|mesh-list
57060806|NCT00496730|Ezetimibe|ezetimibe|mesh-list
57060807|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57060808|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57060809|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
57060810|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060811|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57060812|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57060813|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060814|NCT00446186|Montelukast|montelukast|mesh-list
57060815|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060816|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060817|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060818|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060819|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56742788|NCT03864042|Losartan|losartan|mesh-list
57060820|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
57060821|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57060822|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57060823|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57060824|NCT02140983|Liraglutide|liraglutide|mesh-list
57060825|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57060826|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060827|NCT02140983|Incretins|incretins|mesh-ancestor
57060828|NCT02140983|Hormones|hormones|mesh-ancestor
57060829|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57060830|NCT00394160|Montelukast|montelukast|mesh-list
57060831|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060832|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060833|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57060834|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
57060835|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57060836|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060837|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57060838|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57060839|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060840|NCT03392792|Plasminogen|plasminogen|mesh-list
57060841|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57060842|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57060843|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57060844|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060845|NCT02739828|Adalimumab|adalimumab|mesh-list
57060846|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57060847|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060848|NCT02141139|Ibuprofen|ibuprofen|mesh-list
57060849|NCT02141139|Ketorolac|ketorolac|mesh-list
57060850|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57060851|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57060852|NCT02141139|Analgesics|analgesics|mesh-ancestor
57060853|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
57060854|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060855|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060856|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57060857|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060858|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57060859|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060860|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060861|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
57060862|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060863|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060864|NCT05297032|Quercetin|quercetin|mesh-list
57060865|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
57060866|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060867|NCT05297032|Protective Agents|protective agents|mesh-ancestor
57060868|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060869|NCT03388580|Dimercaprol|dimercaprol|mesh-list
57060870|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
57060871|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
57060872|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060873|NCT03525912|Ketamine|ketamine|mesh-list
57060874|NCT03525912|Analgesics|analgesics|mesh-list
57060875|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
57060876|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060877|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060878|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57060879|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57060880|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
57060881|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
57060882|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060883|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57060884|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57060885|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060886|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060887|NCT02289378|Docetaxel|docetaxel|mesh-list
57060888|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
57060889|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060890|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
57060891|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
57060892|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742862|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
57060893|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060895|NCT03851614|Olaparib|olaparib|mesh-list
57060896|NCT03851614|Cediranib|cediranib|mesh-list
57060897|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060898|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060899|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57060900|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060901|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060902|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57060903|NCT04565600|Etoricoxib|etoricoxib|mesh-list
57060904|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57060905|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57060906|NCT04565600|Analgesics|analgesics|mesh-ancestor
57060907|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
57060908|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060909|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060910|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57060911|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060912|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57060913|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57060914|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060915|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060916|NCT05252416|Carboplatin|carboplatin|mesh-list
57060917|NCT05252416|Fulvestrant|fulvestrant|mesh-list
57060918|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060919|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57060920|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57060921|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57060922|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
57060923|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57060924|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060925|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
57060926|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
57060927|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57060928|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57060929|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060930|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060931|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060932|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060933|NCT03388346|Edetic Acid|edetic acid|mesh-list
57060934|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57060935|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
57060936|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
57060937|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060938|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
57060939|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57060940|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57060941|NCT05631730|Metoprolol|metoprolol|mesh-list
57060942|NCT05631730|Flecainide|flecainide|mesh-list
57060943|NCT05631730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57060944|NCT05631730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57060945|NCT05631730|Sympatholytics|sympatholytics|mesh-ancestor
57060946|NCT05631730|Autonomic Agents|autonomic agents|mesh-ancestor
57060947|NCT05631730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060948|NCT05631730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060949|NCT05631730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57060950|NCT05631730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57060951|NCT05631730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57060952|NCT05631730|Adrenergic Agents|adrenergic agents|mesh-ancestor
57060953|NCT05631730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57060954|NCT05631730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060955|NCT05631730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57060956|NCT05631730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57060957|NCT05631730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57060958|NCT00092144|Montelukast|montelukast|mesh-list
57060959|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060960|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060961|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
57060962|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57060963|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57060964|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
56742938|NCT03609216|Gemcitabine|gemcitabine|mesh-list
57060965|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57060966|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57060967|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57060968|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
57060969|NCT02289768|Salicylates|salicylates|mesh-list
57060970|NCT02289768|Fluorouracil|fluorouracil|mesh-list
57060971|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
57060972|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57060973|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57060974|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57060975|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57060976|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
57060977|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060978|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060979|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
57060980|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
57060981|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
57060982|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57060983|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57060984|NCT02289768|Analgesics|analgesics|mesh-ancestor
57060985|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
57060986|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57060987|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57060988|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57060989|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57060990|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57060991|NCT05526586|Ethanol|ethanol|mesh-list
57060992|NCT05526586|Listerine|listerine|mesh-list
57060993|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
57060994|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57060995|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57060996|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57060997|NCT04330430|Nivolumab|nivolumab|mesh-list
57060998|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57060999|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898482|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
57061000|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57061001|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061002|NCT03387956|Dexamethasone|dexamethasone|mesh-list
57061003|NCT03387956|Atropine|atropine|mesh-list
57061004|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57061005|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
57061006|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
57061007|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061008|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061009|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57061010|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
57061011|NCT03387956|Hormones|hormones|mesh-ancestor
57061012|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061013|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57061014|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061015|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57061016|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57061017|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57061018|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57061019|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
57061020|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
57061021|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
57061022|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57061023|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57061024|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
57061025|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061026|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061027|NCT03384524|Metoprolol|metoprolol|mesh-list
57061028|NCT03384524|Bromocriptine|bromocriptine|mesh-list
57061029|NCT03384524|Tamsulosin|tamsulosin|mesh-list
57061030|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57061031|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57061032|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
57061033|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
57061034|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061035|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061036|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56743018|NCT03521830|Nivolumab|nivolumab|mesh-list
57061037|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57061038|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57061039|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
57061040|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061041|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061042|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57061043|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57061044|NCT03384524|Urological Agents|urological agents|mesh-ancestor
57061045|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57061046|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57061047|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
57061048|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061049|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
57061050|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
57061051|NCT02289924|Aflibercept|aflibercept|mesh-list
57061052|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57061053|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57061054|NCT02289924|Growth Substances|growth substances|mesh-ancestor
57061055|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061056|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
57061057|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061058|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
57061059|NCT05189704|Narcotics|narcotics|mesh-ancestor
57061060|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061061|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061062|NCT05189704|Analgesics|analgesics|mesh-ancestor
57061063|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
57061064|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061065|NCT03391934|Leucovorin|leucovorin|mesh-list
57061066|NCT03391934|Fluorouracil|fluorouracil|mesh-list
57061067|NCT03391934|Irinotecan|irinotecan|mesh-list
57061068|NCT03391934|Cetuximab|cetuximab|mesh-list
57061069|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061070|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
57061071|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061072|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57061073|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061074|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061075|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
57061076|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57061077|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57061078|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061079|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061080|NCT03391934|Antidotes|antidotes|mesh-ancestor
57061081|NCT03391934|Protective Agents|protective agents|mesh-ancestor
57061082|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
57061083|NCT03391934|Vitamins|vitamins|mesh-ancestor
57061084|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
57061085|NCT03387644|Pregabalin|pregabalin|mesh-list
57061086|NCT03387644|Analgesics|analgesics|mesh-ancestor
57061087|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
57061088|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061089|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061090|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
57061091|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57061092|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061093|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061094|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57061095|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57061096|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57061097|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061098|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57061099|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
57061100|NCT02290002|Calcium|calcium|mesh-list
57061101|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57061102|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061103|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
57061104|NCT02290002|Coagulants|coagulants|mesh-ancestor
57061105|NCT05671900|Gemcitabine|gemcitabine|mesh-list
57061106|NCT05671900|Docetaxel|docetaxel|mesh-list
57061107|NCT05671900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57061108|NCT05671900|Antimetabolites|antimetabolites|mesh-ancestor
57061109|NCT05671900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061110|NCT05671900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061111|NCT05671900|Antiviral Agents|antiviral agents|mesh-ancestor
57061112|NCT05671900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061113|NCT05671900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061114|NCT05671900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061115|NCT05671900|Immunologic Factors|immunologic factors|mesh-ancestor
57061116|NCT05671900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061117|NCT05671900|Tubulin Modulators|tubulin modulators|mesh-ancestor
57061118|NCT05671900|Antimitotic Agents|antimitotic agents|mesh-ancestor
57061119|NCT05671900|Mitosis Modulators|mitosis modulators|mesh-ancestor
57061120|NCT02294292|Carvedilol|carvedilol|mesh-list
57061121|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57061122|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57061123|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
57061124|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061125|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061126|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061127|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57061128|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
57061129|NCT02294292|Protective Agents|protective agents|mesh-ancestor
57061130|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57061131|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061132|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57061133|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
57061134|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57061135|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57061136|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
57061137|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
57061138|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
57061139|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061140|NCT03387566|Growth Substances|growth substances|mesh-ancestor
57061141|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
57061142|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57061143|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
57061144|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061145|NCT03391856|Expectorants|expectorants|mesh-ancestor
56284951|NCT00000676|Fluconazole|fluconazole|mesh-list
57061146|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
57061147|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57061148|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
57061149|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061150|NCT03391856|Protective Agents|protective agents|mesh-ancestor
57061151|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061152|NCT03391856|Antidotes|antidotes|mesh-ancestor
57061153|NCT01664494|Capecitabine|capecitabine|mesh-list
57061154|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57061155|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
57061156|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061157|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061158|NCT02290470|Dexamethasone|dexamethasone|mesh-list
57061159|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
57061160|NCT02290470|Paclitaxel|paclitaxel|mesh-list
57061161|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57061162|NCT02290470|Carboplatin|carboplatin|mesh-list
57061163|NCT02290470|Olanzapine|olanzapine|mesh-list
57061164|NCT02290470|Palonosetron|palonosetron|mesh-list
57061165|NCT02290470|BB 1101|bb 1101|mesh-list
57061166|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57061167|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061168|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
57061169|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
57061170|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
57061171|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061172|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57061173|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
57061174|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
57061175|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061176|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061177|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57061178|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
57061179|NCT02290470|Hormones|hormones|mesh-ancestor
57061180|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061181|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57061182|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
57061183|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061184|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57061185|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57061186|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061187|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57061188|NCT02290470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57061189|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56743163|NCT03331198|Venetoclax|venetoclax|mesh-list
57061190|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061191|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061192|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
57061193|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57061194|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57061195|NCT05172518|Capecitabine|capecitabine|mesh-list
57061196|NCT05172518|Taxane|taxane|mesh-list
57061197|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57061198|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
57061199|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061200|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061201|NCT03724084|Cytarabine|cytarabine|mesh-list
57061202|NCT03724084|Daunorubicin|daunorubicin|mesh-list
57061203|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57061204|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
57061205|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061206|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061207|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
57061208|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061209|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061210|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
57061211|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061212|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57061213|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57061214|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57061215|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061216|NCT05172440|Axitinib|axitinib|mesh-list
57061217|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061218|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57061219|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061220|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061221|NCT02298582|Fentanyl|fentanyl|mesh-list
57061222|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57061223|NCT02298582|Narcotics|narcotics|mesh-ancestor
57061224|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061225|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061226|NCT02298582|Analgesics|analgesics|mesh-ancestor
57061227|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
57061228|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061229|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57061230|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57061231|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
57061232|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
57061233|NCT04446416|Bevacizumab|bevacizumab|mesh-list
57061234|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061235|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061236|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57061237|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57061238|NCT04446416|Growth Substances|growth substances|mesh-ancestor
57061239|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061240|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
57061241|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
57061242|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57061243|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57061244|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57061245|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061246|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061247|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
57061248|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061249|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061250|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57061251|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061252|NCT01396408|Sirolimus|sirolimus|mesh-list
57061253|NCT01396408|Sunitinib|sunitinib|mesh-list
57061254|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061255|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57061256|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57061257|NCT01396408|Growth Substances|growth substances|mesh-ancestor
57061258|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061259|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
57061260|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57061261|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061262|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061263|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56743237|NCT03150693|Hormones|hormones|mesh-ancestor
57061264|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061265|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57061266|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
57061267|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061268|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
57061269|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57061270|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57061271|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061272|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061273|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57061274|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061275|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061276|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
57061277|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061278|NCT05440942|Trametinib|trametinib|mesh-list
57061279|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061280|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57061281|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061282|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061283|NCT02291094|Lidocaine|lidocaine|mesh-list
57061284|NCT02291094|Remifentanil|remifentanil|mesh-list
57061285|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
57061286|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
57061287|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061288|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061289|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
57061290|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061291|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56285088|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
57061292|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57061293|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57061294|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061295|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061296|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57061297|NCT02291094|Narcotics|narcotics|mesh-ancestor
57061298|NCT02291094|Analgesics|analgesics|mesh-ancestor
57061299|NCT03387098|Leucovorin|leucovorin|mesh-list
57061300|NCT03387098|Paclitaxel|paclitaxel|mesh-list
57061301|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
57061302|NCT03387098|Bevacizumab|bevacizumab|mesh-list
57061303|NCT03387098|Fluorouracil|fluorouracil|mesh-list
57061304|NCT03387098|Capecitabine|capecitabine|mesh-list
57061305|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
57061306|NCT03387098|Avelumab|avelumab|mesh-list
57061307|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57061308|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061309|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
57061310|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
57061311|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
57061312|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061313|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061314|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
57061315|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061316|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57061317|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57061318|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
57061319|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57061320|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061321|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57061322|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57061323|NCT03387098|Growth Substances|growth substances|mesh-ancestor
57061324|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
57061325|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
57061326|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57061327|NCT03387098|Antidotes|antidotes|mesh-ancestor
57061328|NCT03387098|Protective Agents|protective agents|mesh-ancestor
57061329|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
57061330|NCT03387098|Vitamins|vitamins|mesh-ancestor
57061331|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
57061332|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57061333|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
57061334|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57061335|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061336|NCT02577016|Incretins|incretins|mesh-ancestor
57061337|NCT02577016|Hormones|hormones|mesh-ancestor
57061338|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061339|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57061340|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
57061341|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061342|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061343|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57061344|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
57061345|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57061346|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061347|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
57061348|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061349|NCT04465110|Protective Agents|protective agents|mesh-ancestor
57061350|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061351|NCT03391700|Rocuronium|rocuronium|mesh-list
57061352|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57061353|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57061354|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57061355|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061356|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061357|NCT02294838|Citric Acid|citric acid|mesh-list
57061358|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
57061359|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
57061360|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57061361|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
57061362|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
57061363|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061364|NCT03383822|Insulin|insulin|mesh-list
57061365|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57061366|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56285168|NCT00000799|Renal Agents|renal agents|mesh-ancestor
57061367|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061368|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57061369|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061370|NCT03383744|Vitamin A|vitamin a|mesh-list
57061371|NCT03383744|Vitamins|vitamins|mesh-ancestor
57061372|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
57061373|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061374|NCT05662358|Denosumab|denosumab|mesh-list
57061375|NCT05662358|Alendronate|alendronate|mesh-list
57061376|NCT05662358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57061377|NCT05662358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061378|NCT02294994|Tirofiban|tirofiban|mesh-list
57061379|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57061380|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57061381|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061382|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57061383|NCT03386630|Sufentanil|sufentanil|mesh-list
57061384|NCT03386630|Morphine|morphine|mesh-list
57061386|NCT03386630|Bupivacaine|bupivacaine|mesh-list
57061387|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
57061388|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
57061389|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061390|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061391|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
57061392|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061393|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57061394|NCT03386630|Narcotics|narcotics|mesh-ancestor
57061395|NCT03386630|Analgesics|analgesics|mesh-ancestor
57061396|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57061397|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57061398|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
57061399|NCT03132714|Amoxicillin|amoxicillin|mesh-list
57061400|NCT03132714|Metronidazole|metronidazole|mesh-list
57061401|NCT03132714|Clarithromycin|clarithromycin|mesh-list
57061402|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57061403|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061404|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57061405|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57061406|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57061407|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061408|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061409|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57061410|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57061411|NCT03386318|Oxycodone|oxycodone|mesh-list
57061412|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57061413|NCT03386318|Narcotics|narcotics|mesh-ancestor
57061414|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061415|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061416|NCT03386318|Analgesics|analgesics|mesh-ancestor
57061417|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
57061418|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061419|NCT03339284|Dexamethasone|dexamethasone|mesh-list
57061420|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
57061421|NCT03339284|Ropivacaine|ropivacaine|mesh-list
57061422|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57061423|NCT03339284|BB 1101|bb 1101|mesh-list
57061424|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57061425|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
57061426|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
57061427|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061428|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061429|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57061430|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
57061431|NCT03339284|Hormones|hormones|mesh-ancestor
57061432|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061433|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57061434|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061435|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
57061436|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
57061437|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061438|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
57061439|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
57061440|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061441|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061442|NCT02291562|Dronabinol|dronabinol|mesh-list
57061443|NCT02291562|Cannabidiol|cannabidiol|mesh-list
57061444|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
57061445|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
57061446|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061447|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57061448|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57061449|NCT02291562|Analgesics|analgesics|mesh-ancestor
57061450|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
57061451|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061452|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57061453|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57061454|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061455|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061456|NCT02291562|Hormones|hormones|mesh-ancestor
57061457|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061458|NCT03316586|Nivolumab|nivolumab|mesh-list
57061459|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061460|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061461|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57061462|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061463|NCT02994927|Prednisone|prednisone|mesh-list
57061464|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
57061465|NCT02994927|Rituximab|rituximab|mesh-list
57061466|NCT02994927|Azathioprine|azathioprine|mesh-list
57061467|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061468|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
57061469|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061470|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57061471|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57061472|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
57061473|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061474|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061475|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57061476|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061477|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57061478|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
57061479|NCT02994927|Hormones|hormones|mesh-ancestor
57061480|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061481|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57061482|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
57061483|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57061484|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57061485|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57061486|NCT02295150|Nadroparin|nadroparin|mesh-list
57061487|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
57061488|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57061489|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57061490|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743486|NCT02889523|Hormones|hormones|mesh-ancestor
57061491|NCT03390608|Trastuzumab|trastuzumab|mesh-list
57061492|NCT03390608|Estrogens|estrogens|mesh-list
57061493|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061494|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061495|NCT03390608|Hormones|hormones|mesh-ancestor
57061496|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061497|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061498|NCT03513822|Midazolam|midazolam|mesh-list
57061499|NCT03513822|Ketamine|ketamine|mesh-list
57061500|NCT03513822|Analgesics|analgesics|mesh-ancestor
57061501|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
57061502|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061503|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061504|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57061505|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57061506|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
57061507|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
57061508|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061509|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57061510|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57061511|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061512|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061513|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57061514|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57061515|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57061516|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57061517|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57061518|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
57061519|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
57061520|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57061521|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061522|NCT03513432|Ethanol|ethanol|mesh-list
57061523|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57061524|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061525|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061526|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061527|NCT02299440|Ketamine|ketamine|mesh-list
57061528|NCT02299440|Analgesics|analgesics|mesh-ancestor
57061529|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
57061530|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061531|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061532|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57061533|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57061534|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
57061535|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
57061536|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061537|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57061538|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57061539|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061540|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061541|NCT02299518|Cytarabine|cytarabine|mesh-list
57061542|NCT02299518|Etoposide|etoposide|mesh-list
57061543|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
57061544|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
57061545|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57061546|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061547|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57061548|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57061549|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061550|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061551|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57061552|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
57061553|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
57061554|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061555|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061556|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
57061557|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061558|NCT02299518|Analgesics|analgesics|mesh-ancestor
57061559|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
57061560|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061561|NCT02145195|Vitamin D|vitamin d|mesh-list
57061562|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
57061563|NCT02145195|Vitamins|vitamins|mesh-ancestor
57061564|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
57061565|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061566|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57061567|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57061569|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57061570|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
57061571|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57061572|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57061573|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57061574|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
57061575|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061576|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061577|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061578|NCT02254629|Laxatives|laxatives|mesh-list
57061579|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57061580|NCT02145585|Anesthetics|anesthetics|mesh-list
57061581|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061582|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061583|NCT02291796|Bezafibrate|bezafibrate|mesh-list
57061584|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57061585|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
57061586|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061587|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57061588|NCT03544827|Atropine|atropine|mesh-list
57061589|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57061590|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57061591|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57061592|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
57061593|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061594|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061595|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57061596|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
57061597|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
57061598|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
57061599|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57061600|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57061601|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
57061602|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061603|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061604|NCT00107991|Etanercept|etanercept|mesh-list
57061605|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57061606|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57061607|NCT00107991|Analgesics|analgesics|mesh-ancestor
57061608|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
57061609|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061610|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061611|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57061612|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57061613|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57061614|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061615|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
57061616|NCT03513276|Epinephrine|epinephrine|mesh-list
57061617|NCT03513276|Racepinephrine|racepinephrine|mesh-list
57061618|NCT03513276|Ropivacaine|ropivacaine|mesh-list
57061619|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
57061620|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
57061621|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
57061622|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061623|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061624|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
57061625|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061626|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57061627|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57061628|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
57061629|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061630|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061631|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57061632|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57061633|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
57061634|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57061635|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
57061636|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
57061637|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
57061638|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57061639|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
57061640|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56743624|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
57061641|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061642|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57061643|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061644|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
57061645|NCT03516630|Trazodone|trazodone|mesh-list
57061646|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57061647|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061648|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57061649|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57061650|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061651|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061652|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061653|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061654|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57061655|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57061656|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061657|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57061658|NCT03516630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57061659|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57061660|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061661|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061662|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
57061663|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57061664|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
57061665|NCT02142075|Daptomycin|daptomycin|mesh-list
57061666|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57061667|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061668|NCT02145975|Fentanyl|fentanyl|mesh-list
57061669|NCT02145975|Morphine|morphine|mesh-list
57061670|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
57061671|NCT02145975|Narcotics|narcotics|mesh-ancestor
57061672|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061673|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061674|NCT02145975|Analgesics|analgesics|mesh-ancestor
57061675|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
57061676|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061677|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57061678|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57061679|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
57061680|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
57061681|NCT02295852|Calcium|calcium|mesh-list
57061682|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57061683|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061684|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
57061685|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061686|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061687|NCT02295930|Bevacizumab|bevacizumab|mesh-list
57061688|NCT02295930|Cetuximab|cetuximab|mesh-list
57061689|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061690|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061691|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57061692|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57061693|NCT02295930|Growth Substances|growth substances|mesh-ancestor
57061694|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061695|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
57061696|NCT02142309|Pioglitazone|pioglitazone|mesh-list
57061697|NCT02142309|Glimepiride|glimepiride|mesh-list
57061698|NCT02142309|Canagliflozin|canagliflozin|mesh-list
57061699|NCT02142309|Vildagliptin|vildagliptin|mesh-list
57061700|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57061701|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061702|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57061703|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061704|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
57061705|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57061706|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061707|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57061708|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
57061709|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061710|NCT02146209|Metronidazole|metronidazole|mesh-list
57061711|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061712|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57061713|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57061714|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57061715|NCT02299908|Bupivacaine|bupivacaine|mesh-list
57061716|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
57061717|NCT02299908|Anesthetics|anesthetics|mesh-list
57061718|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57061719|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061720|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061721|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
57061722|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061723|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
57061724|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
57061725|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
57061726|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57061727|NCT02142543|Protective Agents|protective agents|mesh-ancestor
57061728|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061729|NCT03390374|Nystatin|nystatin|mesh-list
57061730|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57061731|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061732|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
57061733|NCT03390374|Ionophores|ionophores|mesh-ancestor
57061734|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061735|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061736|NCT03545373|Amoxicillin|amoxicillin|mesh-list
57061737|NCT03545373|Azithromycin|azithromycin|mesh-list
57061738|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57061739|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061740|NCT00492856|Methotrexate|methotrexate|mesh-list
57061741|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
57061742|NCT00492856|Tretinoin|tretinoin|mesh-list
57061743|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57061744|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
57061745|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57061746|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061747|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57061748|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
57061749|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061750|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061751|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
57061752|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061753|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57061754|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061755|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
57061756|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57061757|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57061758|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
57061759|NCT02142777|Equol|equol|mesh-list
57061760|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
57061761|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57061762|NCT02142777|Estrogens|estrogens|mesh-ancestor
57061763|NCT02142777|Hormones|hormones|mesh-ancestor
57061764|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061765|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061766|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
57061767|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061768|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061769|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
57061770|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57061771|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061772|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061773|NCT03544671|Vitamin D|vitamin d|mesh-list
57061774|NCT03544671|Vitamins|vitamins|mesh-ancestor
57061775|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
57061776|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061777|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57061778|NCT03390062|Apatinib|apatinib|mesh-list
57061779|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061780|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57061781|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061782|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061783|NCT03382886|Bevacizumab|bevacizumab|mesh-list
57061784|NCT03382886|Nivolumab|nivolumab|mesh-list
57061785|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061786|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061787|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57061788|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57061789|NCT03382886|Growth Substances|growth substances|mesh-ancestor
57061790|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061791|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
57061792|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57061793|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061794|NCT03125486|Belimumab|belimumab|mesh-list
57061795|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57061796|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
57061797|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061798|NCT02147925|Metformin|metformin|mesh-list
57061799|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
57061800|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57061801|NCT02147925|Liraglutide|liraglutide|mesh-list
57061802|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57061803|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061804|NCT02147925|Incretins|incretins|mesh-ancestor
57061805|NCT02147925|Hormones|hormones|mesh-ancestor
57061806|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061807|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57061808|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
57061809|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061810|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061811|NCT03544047|Paclitaxel|paclitaxel|mesh-list
57061812|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57061813|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061814|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
57061815|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
57061816|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
57061817|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061818|NCT03544125|Durvalumab|durvalumab|mesh-list
57061819|NCT03544125|Olaparib|olaparib|mesh-list
57061820|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57061821|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
57061822|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57061823|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
57061824|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061825|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061826|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
57061827|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061828|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061829|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061830|NCT02146911|Bupropion|bupropion|mesh-list
57061831|NCT02146911|Varenicline|varenicline|mesh-list
57061832|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57061833|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
57061834|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57061835|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57061836|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57061837|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061838|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061839|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
57061840|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061841|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061842|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57061843|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57061844|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061845|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57061846|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57061847|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
57061848|NCT02776683|Bevacizumab|bevacizumab|mesh-list
57061849|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57061850|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061851|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57061852|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57061853|NCT02776683|Growth Substances|growth substances|mesh-ancestor
57061854|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061855|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
57061856|NCT02963714|Vaccines|vaccines|mesh-list
57061857|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
57061858|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061859|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57061860|NCT02148393|Estradiol|estradiol|mesh-list
57061861|NCT02148393|Progesterone|progesterone|mesh-list
57061862|NCT02148393|Estrogens|estrogens|mesh-ancestor
57061863|NCT02148393|Hormones|hormones|mesh-ancestor
57061864|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061865|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061866|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56743852|NCT02601989|Tadalafil|tadalafil|mesh-list
57061868|NCT00104871|Bortezomib|bortezomib|mesh-list
57061869|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061870|NCT03385538|Clopidogrel|clopidogrel|mesh-list
57061871|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57061872|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57061873|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57061874|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57061875|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
57061876|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061877|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061878|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061879|NCT03380468|Pemetrexed|pemetrexed|mesh-list
57061880|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061881|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061882|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061883|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57061884|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57061885|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
57061886|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57061887|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57061888|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57061889|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061890|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57061891|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57061892|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57061893|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57061894|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
57061895|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061896|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061897|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57061898|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57061899|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
57061900|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57061901|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57061902|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
57061903|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
57061904|NCT02148549|Irinotecan|irinotecan|mesh-list
57061905|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061906|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57061907|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57061908|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061909|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061910|NCT03375398|PAZ320|paz320|mesh-list
57061911|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57061912|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061913|NCT02147535|Methylphenidate|methylphenidate|mesh-list
57061914|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57061915|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061916|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57061917|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57061918|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061919|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061920|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
57061921|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061922|NCT03446612|Nitroprusside|nitroprusside|mesh-list
57061923|NCT03446612|Acetylcholine|acetylcholine|mesh-list
57061924|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
57061925|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
57061926|NCT03446612|Hematinics|hematinics|mesh-ancestor
57061927|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57061928|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
57061929|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57061930|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061931|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57061932|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
57061933|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061934|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061935|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061936|NCT02148783|Methylphenidate|methylphenidate|mesh-list
57061937|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57061938|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061939|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57061940|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57061941|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57061942|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061943|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
57061944|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061945|NCT02155803|Hormones|hormones|mesh-list
57061946|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57061947|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
57061948|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
57061949|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57061950|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061951|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57061952|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061953|NCT02148861|Insulin|insulin|mesh-list
57061954|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57061955|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57061956|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061957|NCT02152059|Nintedanib|nintedanib|mesh-list
57061958|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57061959|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57061960|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061961|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061962|NCT02149095|Treprostinil|treprostinil|mesh-list
57061963|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57061964|NCT02149329|Meropenem|meropenem|mesh-list
57061965|NCT02149329|Imipenem|imipenem|mesh-list
57061966|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
57061967|NCT02149329|Cilastatin|cilastatin|mesh-list
57061968|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57061969|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57061970|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
57061971|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57061972|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061973|NCT03255512|Isosorbide|isosorbide|mesh-list
57061974|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57061975|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57061976|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57061977|NCT03255512|Diuretics|diuretics|mesh-ancestor
57061978|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
57061979|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061980|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
57061981|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57061982|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57061983|NCT02149407|Glycerol|glycerol|mesh-list
57061984|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57061985|NCT02149407|Protective Agents|protective agents|mesh-ancestor
57061986|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061987|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
57061988|NCT03543657|Hematinics|hematinics|mesh-ancestor
57061989|NCT04925193|Dexamethasone|dexamethasone|mesh-list
57061990|NCT04925193|Daratumumab|daratumumab|mesh-list
57061991|NCT04925193|Pomalidomide|pomalidomide|mesh-list
57061992|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57061993|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
57061994|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
57061995|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57061996|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57061997|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57061998|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
57061999|NCT04925193|Hormones|hormones|mesh-ancestor
57062000|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062001|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57062002|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062003|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
57062004|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57062005|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57062006|NCT04925193|Growth Substances|growth substances|mesh-ancestor
57062007|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
57062008|NCT02580058|Doxorubicin|doxorubicin|mesh-list
57062009|NCT02580058|Avelumab|avelumab|mesh-list
57062010|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57062011|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062012|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57062013|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57062014|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062015|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062016|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062018|NCT03542955|Analgesics|analgesics|mesh-list
57062019|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
57062020|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062021|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062022|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57062023|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57062024|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57062025|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062026|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57062027|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57062028|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062029|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062030|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
57062031|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062032|NCT03554044|Tamoxifen|tamoxifen|mesh-list
57062033|NCT03554044|Gemcitabine|gemcitabine|mesh-list
57062034|NCT03554044|Paclitaxel|paclitaxel|mesh-list
57062035|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57062036|NCT03554044|Carboplatin|carboplatin|mesh-list
57062037|NCT03554044|Letrozole|letrozole|mesh-list
57062038|NCT03554044|Fulvestrant|fulvestrant|mesh-list
57062039|NCT03554044|Anastrozole|anastrozole|mesh-list
57062040|NCT03554044|Exemestane|exemestane|mesh-list
57062041|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57062042|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57062043|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062044|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
57062045|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
57062046|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
57062047|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062048|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57062049|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
57062050|NCT03554044|Antiviral Agents|antiviral agents|mesh-ancestor
57062051|NCT03554044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062052|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062053|NCT03554044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062054|NCT03554044|Immunologic Factors|immunologic factors|mesh-ancestor
57062055|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062056|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57062057|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57062058|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57062059|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
57062060|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062061|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57062062|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57062063|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57062064|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57062065|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57062066|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062067|NCT05653882|Pembrolizumab|pembrolizumab|mesh-list
57062068|NCT05653882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062069|NCT05653882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062070|NCT03458260|Rituximab|rituximab|mesh-list
57062071|NCT03458260|Etoposide|etoposide|mesh-list
57062072|NCT03458260|Ifosfamide|ifosfamide|mesh-list
57062073|NCT03458260|Pixantrone|pixantrone|mesh-list
57062074|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062075|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062076|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
57062077|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062078|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062079|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57062080|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57062081|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57062082|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062083|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062084|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57062085|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
57062086|NCT04988074|Cemiplimab|cemiplimab|mesh-list
57062087|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062088|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062089|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
56744073|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
57062090|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062091|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
57062092|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57062093|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57062094|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062095|NCT00104637|Urological Agents|urological agents|mesh-ancestor
57062096|NCT04810208|Docetaxel|docetaxel|mesh-list
57062097|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062098|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
57062099|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
57062100|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
57062101|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062102|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
57062103|NCT04445636|Morphine|morphine|mesh-list
57062104|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57062105|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062106|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062107|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57062108|NCT04445636|Analgesics|analgesics|mesh-ancestor
57062109|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
57062110|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062111|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57062112|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57062113|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57062114|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
57062115|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062116|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062117|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57062118|NCT04445636|Narcotics|narcotics|mesh-ancestor
57062119|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
57062120|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062121|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062122|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
57062123|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57062124|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57062125|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062126|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
57062127|NCT02152917|Coagulants|coagulants|mesh-ancestor
57062128|NCT03111212|Iloprost|iloprost|mesh-list
57062129|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57062130|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
57062131|NCT03170206|Palbociclib|palbociclib|mesh-list
57062132|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062133|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57062134|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062135|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062136|NCT05424016|Propranolol|propranolol|mesh-list
57062137|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57062138|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57062139|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
57062140|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062141|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062142|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062143|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57062144|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57062145|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
57062146|NCT02149953|Glycine|glycine|mesh-list
57062147|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
57062148|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062149|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062150|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062151|NCT03380936|Tacrolimus|tacrolimus|mesh-list
57062152|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
57062153|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57062154|NCT03380936|Antibodies|antibodies|mesh-list
57062155|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
57062156|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57062157|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062158|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
57062159|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062160|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57062161|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062162|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062163|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
56744163|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
57062165|NCT02150031|Lidocaine|lidocaine|mesh-list
57062166|NCT02150031|Epinephrine|epinephrine|mesh-list
57062167|NCT02150031|Racepinephrine|racepinephrine|mesh-list
57062168|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
57062169|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
57062170|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
57062171|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062172|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062173|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
57062174|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062175|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57062176|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57062177|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57062178|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57062179|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062180|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57062181|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062182|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
57062183|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
57062184|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57062185|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57062186|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
57062187|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062188|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57062189|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57062190|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
57062191|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57062192|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
57062193|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
57062194|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
57062195|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57062196|NCT04655170|Albuterol|albuterol|mesh-list
57062197|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
57062198|NCT04655170|Ipratropium|ipratropium|mesh-list
57062199|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
57062200|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57062201|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
57062202|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062203|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062204|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57062205|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
57062206|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57062207|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57062208|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57062209|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
57062210|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062211|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062212|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
57062213|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57062214|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
57062215|NCT04651348|Antibodies|antibodies|mesh-list
57062216|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57062217|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
57062218|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062219|NCT02156661|Oxytocin|oxytocin|mesh-list
57062220|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
57062221|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57062222|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062223|NCT03065062|Palbociclib|palbociclib|mesh-list
57062224|NCT03065062|Gedatolisib|gedatolisib|mesh-list
57062225|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062226|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57062227|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062228|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062229|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
57062230|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57062231|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062232|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
57062233|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062234|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744228|NCT01067989|Analgesics|analgesics|mesh-ancestor
57062235|NCT03374540|Vitamin K|vitamin k|mesh-list
57062236|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
57062237|NCT03374540|Vitamins|vitamins|mesh-ancestor
57062238|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
57062239|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062240|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57062241|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
57062242|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57062243|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
57062244|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062245|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062246|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
57062247|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57062248|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57062249|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
57062250|NCT03374540|Coagulants|coagulants|mesh-ancestor
57062251|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57062252|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57062253|NCT03378674|Remifentanil|remifentanil|mesh-list
57062254|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57062255|NCT03378674|Narcotics|narcotics|mesh-ancestor
57062256|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062257|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062258|NCT03378674|Analgesics|analgesics|mesh-ancestor
57062259|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
57062260|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062261|NCT02157207|Vitamins|vitamins|mesh-list
57062262|NCT02157207|Vitamin E|vitamin e|mesh-list
57062263|NCT02157207|Antioxidants|antioxidants|mesh-list
57062264|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
57062265|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062266|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062267|NCT02157207|Protective Agents|protective agents|mesh-ancestor
57062268|NCT02261103|Pramipexole|pramipexole|mesh-list
57062269|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
57062270|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062271|NCT02261103|Protective Agents|protective agents|mesh-ancestor
57062272|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062273|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57062274|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57062275|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
57062276|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
57062277|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062278|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
57062279|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062280|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062281|NCT02766777|Lubiprostone|lubiprostone|mesh-list
57062282|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57062283|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57062284|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062285|NCT03374306|Atropine|atropine|mesh-list
57062286|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
57062287|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57062288|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57062289|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57062290|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
57062291|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062292|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062293|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57062294|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
57062295|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
57062296|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
57062297|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57062298|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57062299|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
57062300|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062301|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062302|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57062303|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57062304|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
57062305|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57062306|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57062307|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062308|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062309|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57062310|NCT05534230|Analgesics|analgesics|mesh-ancestor
57062311|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
57062312|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062313|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56744301|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57062314|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57062315|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57062316|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
57062317|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062318|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062319|NCT03369782|Rocuronium|rocuronium|mesh-list
57062320|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57062321|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57062322|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57062323|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062324|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062325|NCT00157014|Cyclosporine|cyclosporine|mesh-list
57062326|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
57062327|NCT00157014|Prednisone|prednisone|mesh-list
57062328|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
57062329|NCT00157014|Tacrolimus|tacrolimus|mesh-list
57062330|NCT00157014|Cyclosporins|cyclosporins|mesh-list
57062331|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57062332|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
57062333|NCT00157014|Hormones|hormones|mesh-ancestor
57062334|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062335|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062336|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57062337|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062338|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062339|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
57062340|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57062341|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062342|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062343|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
57062344|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062345|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
57062346|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062347|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57062348|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57062349|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
57062350|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57062351|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
57062352|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
57062353|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062354|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57062355|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57062356|NCT00157014|Protective Agents|protective agents|mesh-ancestor
57062357|NCT03374228|Linrodostat|linrodostat|mesh-list
57062358|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062359|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062360|NCT02778867|Fluticasone|fluticasone|mesh-list
57062361|NCT02778867|Xhance|xhance|mesh-list
57062362|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57062363|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57062364|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
57062365|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062366|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062367|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57062368|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
57062369|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
57062370|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57062371|NCT04232072|Ibuprofen|ibuprofen|mesh-list
57062372|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57062373|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57062374|NCT04232072|Analgesics|analgesics|mesh-ancestor
57062375|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
57062376|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062377|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062378|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57062379|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062380|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57062381|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062382|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062383|NCT02300064|Antioxidants|antioxidants|mesh-list
57062384|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062385|NCT02300064|Protective Agents|protective agents|mesh-ancestor
57062386|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062387|NCT02688712|Fluorouracil|fluorouracil|mesh-list
57062388|NCT02688712|Capecitabine|capecitabine|mesh-list
57062389|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
57062390|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062391|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57062392|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062393|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062394|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
57062395|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062396|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57062397|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57062398|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062400|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
57062401|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
57062402|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57062403|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57062404|NCT02519582|Niclosamide|niclosamide|mesh-list
57062405|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
57062406|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57062407|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
57062408|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57062409|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062410|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
57062411|NCT02467582|Aspirin|aspirin|mesh-list
57062412|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57062413|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57062414|NCT02467582|Analgesics|analgesics|mesh-ancestor
57062415|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
57062416|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062417|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062418|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57062419|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062420|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57062421|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57062422|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062423|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57062424|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57062425|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062426|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
57062427|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
57062428|NCT05467462|Oxytocin|oxytocin|mesh-list
57062429|NCT05467462|Carbetocin|carbetocin|mesh-list
57062430|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
57062431|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57062432|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062433|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57062434|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57062435|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062436|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
57062437|NCT05467462|Coagulants|coagulants|mesh-ancestor
57062438|NCT03369002|Seladelpar|seladelpar|mesh-list
57062439|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57062440|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
57062441|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062442|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57062443|NCT02778399|OBE2109|obe2109|mesh-list
57062444|NCT02778399|Hormone Antagonists|hormone antagonists|mesh-ancestor
57062445|NCT02778399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062446|NCT02778399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062447|NCT05533606|Lactams|lactams|mesh-list
57062448|NCT05533606|beta-Lactams|beta-lactams|mesh-list
57062449|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57062450|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062451|NCT02300376|Edetic Acid|edetic acid|mesh-list
57062452|NCT02300376|Calcium|calcium|mesh-list
57062453|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
57062454|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57062455|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062456|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
57062457|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57062458|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
57062459|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
56898517|NCT03854409|Aripiprazole|aripiprazole|mesh-list
57062460|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062461|NCT02300376|Antidotes|antidotes|mesh-ancestor
57062462|NCT02300376|Protective Agents|protective agents|mesh-ancestor
57062463|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57062464|NCT02296398|Romidepsin|romidepsin|mesh-list
57062465|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57062466|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062467|NCT03520062|Liraglutide|liraglutide|mesh-list
57062468|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57062469|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062470|NCT03520062|Incretins|incretins|mesh-ancestor
57062471|NCT03520062|Hormones|hormones|mesh-ancestor
57062472|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062473|NCT02206984|Tamoxifen|tamoxifen|mesh-list
57062474|NCT02206984|Fulvestrant|fulvestrant|mesh-list
57062475|NCT02206984|Anastrozole|anastrozole|mesh-list
57062476|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57062477|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
57062478|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062479|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062480|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57062481|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062482|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57062483|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57062484|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57062485|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57062486|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57062487|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57062488|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062489|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062490|NCT02141542|Tremelimumab|tremelimumab|mesh-list
57062491|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062492|NCT03512574|Pregabalin|pregabalin|mesh-list
57062493|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
57062494|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57062495|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062496|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062497|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57062498|NCT03512574|Analgesics|analgesics|mesh-ancestor
57062499|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
57062500|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062501|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57062502|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57062503|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57062504|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
57062505|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062506|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062507|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
57062508|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57062509|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57062510|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57062511|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57062512|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57062513|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57062514|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57062515|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57062516|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062517|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
57062518|NCT03377348|Triamcinolone|triamcinolone|mesh-list
57062519|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57062520|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57062521|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57062522|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57062523|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
57062524|NCT03377348|Hormones|hormones|mesh-ancestor
57062525|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062526|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062527|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062528|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
57062529|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062530|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062531|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57062532|NCT02255253|Telmisartan|telmisartan|mesh-list
57062533|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57062534|NCT02255253|Diuretics|diuretics|mesh-ancestor
57062535|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
57062536|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062537|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57062538|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744525|NCT00826566|Caffeine|caffeine|mesh-list
57062539|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062540|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57062541|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57062542|NCT02300688|Maleic acid|maleic acid|mesh-list
57062543|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062544|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062545|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57062546|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062547|NCT02151279|Chitosan|chitosan|mesh-list
57062548|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57062549|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57062550|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
57062551|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062552|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57062553|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
57062554|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
57062555|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
57062556|NCT02151279|Coagulants|coagulants|mesh-ancestor
57062557|NCT02159313|Riociguat|riociguat|mesh-list
57062558|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
57062559|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062560|NCT03515772|Darunavir|darunavir|mesh-list
57062561|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57062562|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57062563|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
57062564|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062565|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062566|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57062567|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57062568|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
57062569|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062570|NCT03519750|Melatonin|melatonin|mesh-list
57062571|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
57062572|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062573|NCT03519750|Protective Agents|protective agents|mesh-ancestor
57062574|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062575|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062576|NCT02158143|Vitamin D|vitamin d|mesh-list
57062577|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
57062578|NCT02158143|Vitamins|vitamins|mesh-ancestor
57062579|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
57062580|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062581|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57062582|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57062583|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
57062584|NCT02158221|Growth Substances|growth substances|mesh-ancestor
57062585|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062586|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
57062587|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062588|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062589|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
57062590|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57062591|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57062592|NCT02301000|Metronidazole|metronidazole|mesh-list
57062593|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062594|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57062595|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57062596|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57062597|NCT02292732|Trametinib|trametinib|mesh-list
57062598|NCT02292732|Norinyl|norinyl|mesh-list
57062599|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062600|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57062601|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062602|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062603|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57062604|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57062605|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57062606|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
57062607|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57062608|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062609|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57062610|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57062611|NCT03376958|Apatinib|apatinib|mesh-list
57062612|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062613|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57062614|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062615|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062616|NCT03367676|Docetaxel|docetaxel|mesh-list
57062617|NCT03367676|Trastuzumab|trastuzumab|mesh-list
57062618|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062619|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
57062620|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
57062621|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
57062622|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062623|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062624|NCT03515538|Cisplatin|cisplatin|mesh-list
57062625|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062626|NCT02158689|Letrozole|letrozole|mesh-list
57062627|NCT02158689|Menotropins|menotropins|mesh-list
57062628|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062629|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57062630|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57062631|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062632|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062633|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57062634|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
57062635|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062636|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062637|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57062638|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
57062639|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57062640|NCT03372200|Febuxostat|febuxostat|mesh-list
57062641|NCT03372200|Dotinurad|dotinurad|mesh-list
57062642|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
57062643|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062644|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
57062645|NCT03372200|Renal Agents|renal agents|mesh-ancestor
57062646|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
57062647|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57062648|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57062649|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062650|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
57062651|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
57062652|NCT02158845|Leuprolide|leuprolide|mesh-list
57062653|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
57062654|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57062655|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
57062656|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57062657|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062658|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57062659|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062660|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57062661|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
57062662|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57062663|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57062664|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57062665|NCT02292966|Asunaprevir|asunaprevir|mesh-list
57062666|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
57062667|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062668|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062669|NCT02519660|Lidocaine|lidocaine|mesh-list
57062670|NCT02519660|Tetracaine|tetracaine|mesh-list
57062671|NCT02519660|Prilocaine|prilocaine|mesh-list
57062672|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
57062673|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
57062674|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
57062675|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062676|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062677|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
57062678|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062679|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57062680|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57062681|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57062682|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57062683|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062684|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
57062685|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
57062686|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062687|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062688|NCT02297568|Vitamin D|vitamin d|mesh-list
57062689|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
57062690|NCT02297568|Vitamins|vitamins|mesh-ancestor
57062691|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
57062692|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062693|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57062694|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57062695|NCT03515382|Itraconazole|itraconazole|mesh-list
57062696|NCT03515382|Voriconazole|voriconazole|mesh-list
57062697|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
57062698|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062699|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57062700|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57062701|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062702|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062703|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57062704|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
57062705|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062706|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062707|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57062708|NCT03511560|Tacrolimus|tacrolimus|mesh-list
57062709|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062710|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
57062711|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062712|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57062713|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062714|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062715|NCT03688802|Varenicline|varenicline|mesh-list
57062716|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57062717|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57062718|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
57062719|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062720|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062721|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062722|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
57062723|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062724|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062725|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
57062726|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
57062727|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
57062728|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57062729|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57062730|NCT03371498|Prednisolone|prednisolone|mesh-list
57062731|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
57062732|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57062733|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
57062734|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57062735|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
57062736|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
57062737|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062738|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062739|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57062740|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
57062741|NCT03371498|Hormones|hormones|mesh-ancestor
57062742|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062743|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57062744|NCT03371498|Protective Agents|protective agents|mesh-ancestor
57062745|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57062746|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062747|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
57062748|NCT04525274|Ketamine|ketamine|mesh-list
57062749|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56286558|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
57062750|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062751|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062752|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57062753|NCT04525274|Analgesics|analgesics|mesh-ancestor
57062754|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
57062755|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062756|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57062757|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57062758|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57062759|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
57062760|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062761|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062762|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57062763|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57062764|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
57062765|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
57062766|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57062767|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57062768|NCT03376178|Lidocaine|lidocaine|mesh-list
57062769|NCT03376178|Ropivacaine|ropivacaine|mesh-list
57062770|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
57062771|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
57062772|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062773|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062774|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
57062775|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062776|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57062777|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57062778|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57062779|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57062780|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062781|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
57062782|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062783|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
57062784|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062785|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062786|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57062787|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
57062788|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062789|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062790|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57062791|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57062792|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57062793|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062794|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062795|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57062796|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57062797|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062798|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
57062799|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062800|NCT02302326|Folic Acid|folic acid|mesh-list
57062801|NCT02302326|Inositol|inositol|mesh-list
57062802|NCT02302326|Metformin|metformin|mesh-list
57062803|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57062804|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062805|NCT02302326|Hematinics|hematinics|mesh-ancestor
57062806|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
57062807|NCT02302326|Vitamins|vitamins|mesh-ancestor
57062808|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
57062809|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
57062810|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
57062811|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062812|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
57062813|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062814|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062815|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062816|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57062817|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57062818|NCT02293590|Analgesics|analgesics|mesh-ancestor
57062819|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
57062820|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062821|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57062822|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57062823|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57062824|NCT03124082|Lidocaine|lidocaine|mesh-list
57062825|NCT03124082|Clonidine|clonidine|mesh-list
57062826|NCT03124082|Ketamine|ketamine|mesh-list
57062827|NCT03124082|Remifentanil|remifentanil|mesh-list
57062828|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
57062829|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
57062830|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57062831|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062832|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
57062833|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062834|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57062835|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56744818|NCT02598869|Triamcinolone|triamcinolone|mesh-list
57062836|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57062837|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57062838|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062840|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57062841|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57062842|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
57062843|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57062844|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57062845|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062846|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57062847|NCT03124082|Narcotics|narcotics|mesh-ancestor
57062848|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57062849|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
57062850|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
57062851|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57062852|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57062853|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57062854|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
57062855|NCT03518502|Sorafenib|sorafenib|mesh-list
57062856|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062857|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57062858|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062859|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062860|NCT02301780|Aspirin|aspirin|mesh-list
57062861|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57062862|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57062863|NCT02301780|Analgesics|analgesics|mesh-ancestor
57062864|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
57062865|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57062866|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062867|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57062868|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062869|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57062870|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57062871|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062872|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57062873|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57062874|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062875|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
57062876|NCT04527068|Bevacizumab|bevacizumab|mesh-list
57062877|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57062878|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062879|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57062880|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57062881|NCT04527068|Growth Substances|growth substances|mesh-ancestor
57062882|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062883|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
57062884|NCT02739360|Idelalisib|idelalisib|mesh-list
57062885|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062886|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062887|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062888|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
57062889|NCT03123770|Docetaxel|docetaxel|mesh-list
57062890|NCT03123770|Doxorubicin|doxorubicin|mesh-list
57062891|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57062892|NCT03123770|Epirubicin|epirubicin|mesh-list
57062893|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062894|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
57062895|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062896|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062897|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57062898|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
57062899|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062900|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062901|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57062902|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
57062903|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
57062904|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
57062905|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57062906|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57062907|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57062908|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062909|NCT04464642|Methotrexate|methotrexate|mesh-list
57062910|NCT04464642|Tofacitinib|tofacitinib|mesh-list
57062911|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57062912|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
57062913|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57062914|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062915|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57062916|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
57062917|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062918|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062919|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
57062920|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062921|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57062922|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57062923|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
57062924|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062925|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57062926|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57062927|NCT02293668|Letrozole|letrozole|mesh-list
57062928|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062929|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57062930|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57062931|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062932|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062933|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57062934|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
57062935|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57062936|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062937|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
57062938|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
57062939|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
57062940|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062941|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
57062942|NCT04526210|Choline|choline|mesh-list
57062943|NCT04526210|Bupropion|bupropion|mesh-list
57062944|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57062945|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
57062946|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57062947|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57062948|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57062949|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57062950|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062951|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
57062952|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57062953|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062954|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57062955|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57062956|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062957|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
57062958|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57062959|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
57062960|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57062961|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57062962|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
57062963|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
57062964|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
57062965|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57062966|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57062967|NCT04526210|Growth Substances|growth substances|mesh-ancestor
57062968|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
57062969|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57062970|NCT03375632|Dotinurad|dotinurad|mesh-list
57062971|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
57062972|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
57062973|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57062974|NCT03375632|Renal Agents|renal agents|mesh-ancestor
57062975|NCT02302170|Vaccines|vaccines|mesh-list
57062976|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
57062977|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062978|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
57062979|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57062980|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062981|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
57062982|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57062983|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57062984|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
57062985|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57062986|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56744969|NCT00997750|Lornoxicam|lornoxicam|mesh-list
57062987|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57062988|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062989|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062990|NCT02293824|Caffeine|caffeine|mesh-list
57062991|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
57062992|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57062993|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57062994|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57062995|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57062996|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57062997|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57062998|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57062999|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
57063000|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063001|NCT03366584|Vitamin D|vitamin d|mesh-list
57063002|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
57063003|NCT03366584|Beta Carotene|beta carotene|mesh-list
57063005|NCT03366584|Dexamethasone|dexamethasone|mesh-list
57063006|NCT03366584|Carotenoids|carotenoids|mesh-list
57063007|NCT03366584|Picolinic acid|picolinic acid|mesh-list
57063008|NCT03366584|Vitamins|vitamins|mesh-ancestor
57063009|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
57063010|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063011|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063012|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
57063013|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
57063014|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063015|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57063016|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
57063017|NCT03366584|Hormones|hormones|mesh-ancestor
57063018|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063019|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57063020|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063021|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57063022|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57063023|NCT03366584|Trace Elements|trace elements|mesh-ancestor
57063024|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
57063025|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063026|NCT03366584|Protective Agents|protective agents|mesh-ancestor
57063027|NCT03366584|Provitamins|provitamins|mesh-ancestor
57063028|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57063029|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
57063030|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
57063031|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
57063032|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57063033|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063034|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063035|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57063036|NCT03370562|Analgesics|analgesics|mesh-ancestor
57063037|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
57063038|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063039|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57063040|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57063041|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57063042|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
57063043|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063044|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063045|NCT03370328|Peppermint oil|peppermint oil|mesh-list
57063046|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
57063047|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
57063048|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063049|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063050|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57063051|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
57063052|NCT02303106|Lamotrigine|lamotrigine|mesh-list
57063053|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
57063054|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57063055|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57063056|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063057|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57063058|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063059|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57063060|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57063061|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063062|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57063063|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57063064|NCT04525664|Amoxicillin|amoxicillin|mesh-list
57063065|NCT04525664|Clarithromycin|clarithromycin|mesh-list
57063066|NCT04525664|Omeprazole|omeprazole|mesh-list
57063067|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063068|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063069|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57063070|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57063071|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57063072|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063073|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063074|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57063075|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57063076|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57063077|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
57063078|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57063079|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063080|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063081|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
57063082|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063083|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063084|NCT03505008|Adalimumab|adalimumab|mesh-list
57063085|NCT03505008|Methotrexate|methotrexate|mesh-list
57063086|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57063087|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
57063088|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57063089|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063090|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57063091|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
57063092|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063093|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063094|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
57063095|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063096|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57063097|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57063098|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
57063099|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57063100|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57063101|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063102|NCT03507426|Ketamine|ketamine|mesh-list
57063103|NCT03507426|Analgesics|analgesics|mesh-ancestor
57063104|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
57063105|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063106|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063107|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57063108|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57063109|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
57063110|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
57063111|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063112|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57063113|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57063114|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063115|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063116|NCT02311530|Felodipine|felodipine|mesh-list
57063117|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57063118|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57063119|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57063120|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57063121|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063122|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57063123|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063124|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
57063125|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
57063126|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
57063127|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57063128|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57063129|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063130|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063131|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063132|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57063133|NCT02306772|Mesalamine|mesalamine|mesh-list
57063134|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56745115|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
57063135|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57063136|NCT02306772|Analgesics|analgesics|mesh-ancestor
57063137|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
57063138|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063139|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063140|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063141|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57063142|NCT03507348|Rituximab|rituximab|mesh-list
57063143|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063144|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063145|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
57063146|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063147|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57063148|NCT02518802|Pemetrexed|pemetrexed|mesh-list
57063149|NCT02518802|Gefitinib|gefitinib|mesh-list
57063150|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063151|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063152|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063153|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57063154|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57063155|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57063156|NCT04524026|Letrozole|letrozole|mesh-list
57063157|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57063158|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063159|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57063160|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063161|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063162|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57063163|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
57063164|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063165|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063166|NCT02311608|Octreotide|octreotide|mesh-list
57063167|NCT02311608|Terlipressin|terlipressin|mesh-list
57063168|NCT02311608|Somatostatin|somatostatin|mesh-list
57063169|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57063170|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57063171|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063172|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57063173|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57063174|NCT02311608|Hormones|hormones|mesh-ancestor
57063175|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063176|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063177|NCT02307006|Vancomycin|vancomycin|mesh-list
57063178|NCT02307006|Cefazolin|cefazolin|mesh-list
57063179|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
57063180|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063181|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063182|NCT03362684|Cetuximab|cetuximab|mesh-list
57063183|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063184|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063185|NCT02311686|Ethanol|ethanol|mesh-list
57063186|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57063187|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063188|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063189|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063190|NCT02311764|Carboplatin|carboplatin|mesh-list
57063191|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063192|NCT03365726|Dobutamine|dobutamine|mesh-list
57063193|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57063194|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
57063195|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
57063196|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063197|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063198|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57063199|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57063200|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57063201|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
57063202|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063203|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063204|NCT03365726|Protective Agents|protective agents|mesh-ancestor
57063205|NCT02303418|Oxytocin|oxytocin|mesh-list
57063206|NCT02303418|Carbetocin|carbetocin|mesh-list
57063207|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
57063208|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57063209|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745197|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
57063210|NCT03510000|Empagliflozin|empagliflozin|mesh-list
57063211|NCT03510000|Pancrelipase|pancrelipase|mesh-list
57063212|NCT03510000|Hormones|hormones|mesh-list
57063213|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063214|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063215|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57063216|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063217|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57063218|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57063219|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
57063220|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57063221|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57063222|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57063223|NCT03358082|Tacrolimus|tacrolimus|mesh-list
57063224|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57063225|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
57063226|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063227|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57063228|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063229|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063230|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063231|NCT03358004|Capecitabine|capecitabine|mesh-list
57063232|NCT03358004|Vinorelbine|vinorelbine|mesh-list
57063233|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57063234|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
57063235|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063236|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063237|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57063238|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
57063239|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
57063240|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
57063241|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
57063242|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57063243|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57063244|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063245|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57063246|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57063247|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
57063248|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063249|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063250|NCT03365336|Oseltamivir|oseltamivir|mesh-list
57063251|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
57063252|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063253|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063254|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063255|NCT03362216|Diclofenac|diclofenac|mesh-list
57063256|NCT03362216|Salicylates|salicylates|mesh-list
57063257|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
57063258|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57063259|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57063260|NCT03362216|Analgesics|analgesics|mesh-ancestor
57063261|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
57063262|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063263|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063264|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063265|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57063266|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57063267|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063268|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063269|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57063270|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
57063271|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57063272|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
57063273|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57063274|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063275|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57063276|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57063277|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063278|NCT02307396|Haloperidol|haloperidol|mesh-list
57063279|NCT02307396|Pimozide|pimozide|mesh-list
57063280|NCT02307396|Olanzapine|olanzapine|mesh-list
57063281|NCT02307396|Risperidone|risperidone|mesh-list
57063282|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57063283|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
57063284|NCT02307396|Ziprasidone|ziprasidone|mesh-list
57063286|NCT02307396|Perphenazine|perphenazine|mesh-list
57063287|NCT02307396|Sertindole|sertindole|mesh-list
57063288|NCT02307396|Fluphenazine|fluphenazine|mesh-list
57063289|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
57063290|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
57063291|NCT02307396|Sulpiride|sulpiride|mesh-list
57063292|NCT02307396|Thioridazine|thioridazine|mesh-list
57063293|NCT02307396|Clopenthixol|clopenthixol|mesh-list
57063294|NCT02307396|Fluspirilene|fluspirilene|mesh-list
57063295|NCT02307396|Perazine|perazine|mesh-list
57063296|NCT02307396|Bromperidol|bromperidol|mesh-list
57063297|NCT02307396|Benperidol|benperidol|mesh-list
57063298|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57063299|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
57063300|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063301|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063302|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063303|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57063304|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57063305|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063306|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57063307|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57063308|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
57063309|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
57063310|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
57063311|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063312|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57063313|NCT02307396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57063314|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57063315|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57063316|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
57063317|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57063318|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57063319|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57063320|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57063321|NCT03509688|Entecavir|entecavir|mesh-list
57063322|NCT03509688|Resveratrol|resveratrol|mesh-list
57063323|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
57063324|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063325|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
57063326|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063327|NCT03509688|Protective Agents|protective agents|mesh-ancestor
57063328|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063329|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063330|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57063331|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
57063332|NCT02303730|Exenatide|exenatide|mesh-list
57063333|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57063334|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063335|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57063336|NCT02303730|Incretins|incretins|mesh-ancestor
57063337|NCT02303730|Hormones|hormones|mesh-ancestor
57063338|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063339|NCT04524728|Letrozole|letrozole|mesh-list
57063340|NCT04524728|Fulvestrant|fulvestrant|mesh-list
57063341|NCT04524728|Palbociclib|palbociclib|mesh-list
57063342|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063343|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57063344|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57063345|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063346|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063347|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57063348|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
57063349|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063350|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063351|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57063352|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57063353|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57063354|NCT04523792|Buprenorphine|buprenorphine|mesh-list
57063355|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57063356|NCT04523792|Narcotics|narcotics|mesh-ancestor
57063357|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063358|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063359|NCT04523792|Analgesics|analgesics|mesh-ancestor
57063360|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
57063361|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063362|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57063364|NCT02312232|Carbidopa|carbidopa|mesh-list
57063365|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57063366|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57063367|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
57063368|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063369|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063370|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063371|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57063372|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063373|NCT02303886|Methylene Blue|methylene blue|mesh-list
57063374|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063375|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063376|NCT02518958|Nivolumab|nivolumab|mesh-list
57063377|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063378|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063379|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57063380|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063381|NCT03506802|Aldesleukin|aldesleukin|mesh-list
57063382|NCT03506802|Plerixafor|plerixafor|mesh-list
57063383|NCT03506802|Lenalidomide|lenalidomide|mesh-list
57063384|NCT03506802|Melphalan|melphalan|mesh-list
57063385|NCT03506802|Interleukin-2|interleukin-2|mesh-list
57063386|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
57063387|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
57063388|NCT03506802|Lenograstim|lenograstim|mesh-list
57063389|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57063390|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
57063391|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063392|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57063393|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57063394|NCT03506802|Growth Substances|growth substances|mesh-ancestor
57063395|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
57063396|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063397|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57063398|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
57063399|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063400|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57063401|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57063402|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57063403|NCT03506802|Analgesics|analgesics|mesh-ancestor
57063404|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
57063405|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063406|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57063407|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57063408|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
57063409|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063410|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
57063411|NCT02307864|Tramadol|tramadol|mesh-list
57063412|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57063413|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063414|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063415|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57063416|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57063417|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063418|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063419|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063420|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57063421|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
57063422|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57063423|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063424|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57063425|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57063426|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57063427|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57063428|NCT02307864|Narcotics|narcotics|mesh-ancestor
57063429|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063430|NCT02307864|Analgesics|analgesics|mesh-ancestor
57063431|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
57063432|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063433|NCT02304042|Oxytocin|oxytocin|mesh-list
57063434|NCT02304042|Carbetocin|carbetocin|mesh-list
56745418|NCT00311155|Amlodipine|amlodipine|mesh-list
57063435|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
57063436|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57063437|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063439|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
57063440|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
57063441|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063442|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57063443|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
57063444|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063445|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063446|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57063447|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
57063448|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
57063449|NCT02308098|Hormones|hormones|mesh-ancestor
57063450|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063451|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57063452|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57063453|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57063454|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
57063455|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063456|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063457|NCT03504072|Etanercept|etanercept|mesh-list
57063458|NCT03504072|Tofacitinib|tofacitinib|mesh-list
57063459|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57063460|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57063461|NCT03504072|Analgesics|analgesics|mesh-ancestor
57063462|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
57063463|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063464|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063465|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063466|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57063467|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57063468|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57063469|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
57063470|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57063471|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063472|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063473|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
57063474|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57063475|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
57063476|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063477|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063478|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063479|NCT02308254|Lixisenatide|lixisenatide|mesh-list
57063480|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57063481|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063482|NCT03361124|Oxytocin|oxytocin|mesh-list
57063483|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
57063484|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57063485|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063486|NCT03364088|Oxycodone|oxycodone|mesh-list
57063487|NCT03364088|Anesthetics|anesthetics|mesh-list
57063488|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063489|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063490|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57063491|NCT03364088|Narcotics|narcotics|mesh-ancestor
57063492|NCT03364088|Analgesics|analgesics|mesh-ancestor
57063493|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
57063494|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063495|NCT02304198|Udenafil|udenafil|mesh-list
57063496|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57063497|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57063498|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063499|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063500|NCT02304276|Calcium|calcium|mesh-list
57063501|NCT02304276|Fluorides|fluorides|mesh-list
57063502|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57063503|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063504|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
57063505|NCT02304276|Protective Agents|protective agents|mesh-ancestor
57063506|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57063507|NCT02308332|Tenofovir|tenofovir|mesh-list
57063508|NCT02308332|Emtricitabine|emtricitabine|mesh-list
57063509|NCT02308332|Rilpivirine|rilpivirine|mesh-list
57063510|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
56745489|NCT01068847|Renal Agents|renal agents|mesh-ancestor
57063511|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063512|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57063513|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57063514|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063515|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063516|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57063517|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57063518|NCT03509298|Antibodies|antibodies|mesh-list
57063519|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57063520|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
57063521|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063522|NCT03503994|Beclomethasone|beclomethasone|mesh-list
57063523|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063524|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
57063525|NCT03503994|Hormones|hormones|mesh-ancestor
57063526|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063527|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063528|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57063529|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
57063530|NCT01796002|Romidepsin|romidepsin|mesh-list
57063531|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57063532|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063533|NCT03509142|Sirolimus|sirolimus|mesh-list
57063534|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063535|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063536|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57063537|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063538|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
57063539|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57063540|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
57063541|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063542|NCT03356912|Prednisone|prednisone|mesh-list
57063543|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063544|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
57063545|NCT03356912|Hormones|hormones|mesh-ancestor
57063546|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063547|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063548|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57063549|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063550|NCT00102687|Azacitidine|azacitidine|mesh-list
57063551|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57063552|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
57063553|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063554|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063555|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063556|NCT04509440|Triamcinolone|triamcinolone|mesh-list
57063557|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57063558|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57063559|NCT04509440|Anesthetics|anesthetics|mesh-list
57063560|NCT04509440|Mepivacaine|mepivacaine|mesh-list
57063561|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
57063562|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57063563|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063564|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063565|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063566|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
57063567|NCT04509440|Hormones|hormones|mesh-ancestor
57063568|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063569|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57063570|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
57063571|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063572|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063573|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
57063574|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063575|NCT02312544|Timolol|timolol|mesh-list
57063576|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57063577|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57063578|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
57063579|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063580|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063581|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063582|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57063583|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57063584|NCT03360734|Cetuximab|cetuximab|mesh-list
57063585|NCT03360734|Panitumumab|panitumumab|mesh-list
57063587|NCT03360734|Antibodies|antibodies|mesh-list
57063588|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
57063589|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063590|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063591|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063592|NCT02308644|Bevacizumab|bevacizumab|mesh-list
57063593|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063594|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063595|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57063596|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57063597|NCT02308644|Growth Substances|growth substances|mesh-ancestor
57063598|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063599|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
57063600|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
57063601|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57063602|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063603|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063604|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57063605|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
57063606|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063607|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57063608|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063609|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063610|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
57063611|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063612|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
57063613|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063614|NCT04520126|Protective Agents|protective agents|mesh-ancestor
57063615|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063616|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57063617|NCT02304354|Rituximab|rituximab|mesh-list
57063618|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063619|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063620|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
57063621|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063622|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57063623|NCT03356600|Apatinib|apatinib|mesh-list
57063624|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063625|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57063626|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063627|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063628|NCT04454476|Trametinib|trametinib|mesh-list
57063629|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063630|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57063631|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063632|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063633|NCT00102531|Cisplatin|cisplatin|mesh-list
57063634|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063635|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
57063636|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
57063637|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063638|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063639|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57063640|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57063641|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
57063642|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57063643|NCT03360266|Listerine|listerine|mesh-list
57063644|NCT03360266|Fluorides|fluorides|mesh-list
57063645|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
57063646|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
57063647|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
57063648|NCT03360266|Protective Agents|protective agents|mesh-ancestor
57063649|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063650|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57063651|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063652|NCT02154789|Polidocanol|polidocanol|mesh-list
57063653|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57063654|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57063655|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57063656|NCT04729959|Atezolizumab|atezolizumab|mesh-list
57063657|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
57063658|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57063659|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
57063660|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063661|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
57063662|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063664|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063665|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063666|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57063667|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57063668|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063669|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063670|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063671|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57063672|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57063673|NCT03356444|Docetaxel|docetaxel|mesh-list
57063674|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
57063675|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063676|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
57063677|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
57063678|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
57063679|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063680|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57063681|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063682|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
57063683|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063684|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063685|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57063686|NCT03503604|Leucovorin|leucovorin|mesh-list
57063687|NCT03503604|Gemcitabine|gemcitabine|mesh-list
57063688|NCT03503604|Paclitaxel|paclitaxel|mesh-list
57063689|NCT03503604|Carboplatin|carboplatin|mesh-list
57063690|NCT03503604|Fluorouracil|fluorouracil|mesh-list
57063691|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
57063692|NCT03503604|Irinotecan|irinotecan|mesh-list
57063693|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56898559|NCT01186731|Docetaxel|docetaxel|mesh-list
57063694|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063695|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
57063696|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
57063697|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
57063698|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063699|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57063700|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
57063701|NCT03503604|Antiviral Agents|antiviral agents|mesh-ancestor
57063702|NCT03503604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063703|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063704|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57063705|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
57063706|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063707|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57063708|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57063709|NCT03503604|Antidotes|antidotes|mesh-ancestor
57063710|NCT03503604|Protective Agents|protective agents|mesh-ancestor
57063711|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
57063712|NCT03503604|Vitamins|vitamins|mesh-ancestor
57063713|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
57063714|NCT04508816|Cetuximab|cetuximab|mesh-list
57063715|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
57063716|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063717|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063718|NCT03359876|Warfarin|warfarin|mesh-list
57063719|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
57063720|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
57063721|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57063722|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
57063723|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57063724|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
57063725|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063726|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063727|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
57063728|NCT04508894|Ketamine|ketamine|mesh-list
57063729|NCT04508894|Bupivacaine|bupivacaine|mesh-list
57063730|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
57063731|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
57063732|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063733|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063734|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
57063735|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063736|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57063737|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57063738|NCT04508894|Analgesics|analgesics|mesh-ancestor
57063739|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57063741|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57063742|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
57063743|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063744|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063745|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57063746|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57063747|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
57063748|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57063749|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57063750|NCT05226832|Triamcinolone|triamcinolone|mesh-list
57063751|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063752|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
57063753|NCT05226832|Hormones|hormones|mesh-ancestor
57063754|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063755|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063756|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
57063757|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57063758|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
57063759|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063760|NCT03354572|Expectorants|expectorants|mesh-ancestor
57063761|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
57063762|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57063763|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
57063764|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063765|NCT03354572|Protective Agents|protective agents|mesh-ancestor
57063766|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063767|NCT03354572|Antidotes|antidotes|mesh-ancestor
57063768|NCT03359798|Narcotics|narcotics|mesh-list
57063769|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063770|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063771|NCT03359798|Analgesics|analgesics|mesh-ancestor
57063772|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
57063773|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063774|NCT02309346|Clindamycin|clindamycin|mesh-list
57063775|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
57063776|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
57063777|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063778|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063779|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57063780|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063781|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063782|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57063783|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57063784|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063785|NCT03354494|Desogestrel|desogestrel|mesh-list
57063786|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57063787|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57063788|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57063789|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
57063790|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57063791|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063792|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57063793|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57063794|NCT03354494|Progestins|progestins|mesh-ancestor
57063795|NCT03354494|Hormones|hormones|mesh-ancestor
57063796|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063797|NCT05530954|Calcium|calcium|mesh-list
57063798|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57063799|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063800|NCT03354338|Amoxicillin|amoxicillin|mesh-list
57063801|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063802|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063803|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
57063804|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063805|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063806|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57063807|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57063808|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063809|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063810|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063811|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57063812|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57063813|NCT02309424|Acetic Acid|acetic acid|mesh-list
57063814|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57063815|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063816|NCT03506178|Phenylephrine|phenylephrine|mesh-list
57063817|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
57063818|NCT03506178|Menthol|menthol|mesh-list
57063819|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
57063820|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
57063821|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57063822|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57063823|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
57063824|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063825|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063826|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063827|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
57063828|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
57063829|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063830|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
57063831|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57063832|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
57063833|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57063834|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
57063835|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57063836|NCT03506178|Protective Agents|protective agents|mesh-ancestor
57063837|NCT05210374|Copper|copper|mesh-list
57063838|NCT05210374|Doxorubicin|doxorubicin|mesh-list
57063839|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57063840|NCT05210374|Disulfiram|disulfiram|mesh-list
57063841|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57063842|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063843|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57063844|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57063845|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063846|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063847|NCT05210374|Trace Elements|trace elements|mesh-ancestor
57063848|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
57063849|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063850|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57063851|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
57063852|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
57063853|NCT02578186|Promethazine|promethazine|mesh-list
57063854|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57063855|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57063856|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57063857|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063858|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
57063859|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
57063860|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
57063861|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063862|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
57063863|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
57063864|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57063865|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57063866|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
57063867|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
57063868|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063869|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063870|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57063871|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
57063872|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
57063873|NCT04128436|Progesterone|progesterone|mesh-list
57063874|NCT04128436|Progestins|progestins|mesh-ancestor
57063875|NCT04128436|Hormones|hormones|mesh-ancestor
57063876|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063877|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063878|NCT02309658|Gemcitabine|gemcitabine|mesh-list
57063879|NCT02309658|Cisplatin|cisplatin|mesh-list
57063880|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063881|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57063882|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
57063883|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063884|NCT02309658|Antiviral Agents|antiviral agents|mesh-ancestor
57063885|NCT02309658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57063886|NCT02309658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063887|NCT02309658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57063888|NCT02309658|Immunologic Factors|immunologic factors|mesh-ancestor
57063889|NCT02309658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063891|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57063892|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57063893|NCT05532280|Analgesics|analgesics|mesh-ancestor
57063894|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
57063895|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063896|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063897|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063898|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57063899|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57063900|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57063901|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063902|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063903|NCT04517162|Povidone|povidone|mesh-list
57063904|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
57063905|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
57063906|NCT02155023|Insulin|insulin|mesh-list
57063907|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57063908|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57063909|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063910|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
57063911|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57063912|NCT02163213|Antibodies|antibodies|mesh-list
57063913|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
57063914|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063915|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
57063916|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57063917|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57063918|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063919|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
57063920|NCT04443920|Coagulants|coagulants|mesh-ancestor
57063921|NCT03359018|Apatinib|apatinib|mesh-list
57063922|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063923|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57063924|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063925|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063926|NCT05530252|Minocycline|minocycline|mesh-list
57063927|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57063928|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
57063929|NCT02163291|Paclitaxel|paclitaxel|mesh-list
57063930|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57063931|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063932|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
57063933|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
57063934|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
57063935|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063936|NCT04704921|Ranibizumab|ranibizumab|mesh-list
57063937|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57063938|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57063939|NCT04704921|Growth Substances|growth substances|mesh-ancestor
57063940|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063941|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
57063942|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063943|NCT03508440|Prednisone|prednisone|mesh-list
57063944|NCT03508440|Prednisolone|prednisolone|mesh-list
57063945|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063946|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
57063947|NCT03508440|Hormones|hormones|mesh-ancestor
57063948|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57063949|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063950|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57063951|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57063952|NCT03505788|Acetazolamide|acetazolamide|mesh-list
57063953|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
57063954|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57063955|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063956|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063957|NCT03505788|Diuretics|diuretics|mesh-ancestor
57063958|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
57063959|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063960|NCT02309970|Aspirin|aspirin|mesh-list
57063961|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57063962|NCT02309970|Warfarin|warfarin|mesh-list
57063963|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
57063964|NCT02309970|Dabigatran|dabigatran|mesh-list
57063965|NCT02309970|Apixaban|apixaban|mesh-list
57063966|NCT02309970|Clopidogrel|clopidogrel|mesh-list
57063967|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57063968|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57063969|NCT02309970|Analgesics|analgesics|mesh-ancestor
57063970|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
57063971|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57063972|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063973|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57063974|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57063975|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57063976|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57063977|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57063978|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57063979|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57063980|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57063981|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
57063982|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57063983|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57063984|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57063985|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
57063986|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57063987|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
57063988|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57063989|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
57063990|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57063991|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
57063992|NCT03353948|Metformin|metformin|mesh-list
57063993|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57063994|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57063995|NCT02161653|Pyridoxine|pyridoxine|mesh-list
57063996|NCT02161653|Prednisone|prednisone|mesh-list
57063997|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
57063998|NCT02161653|Metadoxine|metadoxine|mesh-list
57063999|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57064000|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
57064001|NCT02161653|Hormones|hormones|mesh-ancestor
57064002|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064003|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064004|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57064005|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064006|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57064007|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064008|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064009|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57064010|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57064011|NCT02161653|Protective Agents|protective agents|mesh-ancestor
57064012|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
57064013|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57064014|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
57064015|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57064016|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
57064017|NCT02161653|Vitamins|vitamins|mesh-ancestor
57064018|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
57064019|NCT02576938|Triamcinolone|triamcinolone|mesh-list
57064020|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57064021|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
57064022|NCT02576938|Hormones|hormones|mesh-ancestor
57064023|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064024|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064025|NCT04699461|Idelalisib|idelalisib|mesh-list
57064026|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
57064027|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064028|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064029|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064030|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064031|NCT02305836|Donepezil|donepezil|mesh-list
57064032|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57064033|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064034|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064035|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
57064036|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064037|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064038|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
57064039|NCT03503136|Cisplatin|cisplatin|mesh-list
57064040|NCT03503136|Docetaxel|docetaxel|mesh-list
57064041|NCT03503136|Fluorouracil|fluorouracil|mesh-list
57064042|NCT03503136|Capecitabine|capecitabine|mesh-list
57064043|NCT03503136|Nedaplatin|nedaplatin|mesh-list
57064044|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064045|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
57064046|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
57064047|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
57064048|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064049|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
57064050|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064051|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064052|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
57064053|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064054|NCT02305992|Bupivacaine|bupivacaine|mesh-list
57064055|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
57064056|NCT02305992|Anesthetics|anesthetics|mesh-list
57064057|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064058|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064059|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
57064060|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064061|NCT03355352|Sufentanil|sufentanil|mesh-list
57064062|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57064063|NCT03355352|Narcotics|narcotics|mesh-ancestor
57064064|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064065|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064066|NCT03355352|Analgesics|analgesics|mesh-ancestor
57064067|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
57064068|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064069|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57064070|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57064071|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
57064072|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
57064073|NCT05529940|Folfirinox|folfirinox|mesh-list
57064074|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064075|NCT04463784|Efavirenz|efavirenz|mesh-list
57064076|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57064077|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57064078|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064079|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064080|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
57064081|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064082|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57064083|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57064084|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57064085|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57064086|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57064087|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57064088|NCT02310360|Fallypride|fallypride|mesh-list
57064089|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57064090|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57064091|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
57064092|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064093|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064094|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064095|NCT03353480|Azithromycin|azithromycin|mesh-list
57064096|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57064097|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064098|NCT02306070|Metformin|metformin|mesh-list
57064099|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57064100|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064101|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
57064102|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57064103|NCT03353324|Bevacizumab|bevacizumab|mesh-list
57064104|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064105|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064106|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57064107|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57064108|NCT03353324|Growth Substances|growth substances|mesh-ancestor
57064109|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064110|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
57064111|NCT03354962|Nivolumab|nivolumab|mesh-list
57064112|NCT03354962|Ipilimumab|ipilimumab|mesh-list
57064113|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064114|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064115|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57064116|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746095|NCT02547480|Irinotecan|irinotecan|mesh-list
57064117|NCT05108428|Capecitabine|capecitabine|mesh-list
57064118|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064119|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
57064120|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064121|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064122|NCT04511468|Copper|copper|mesh-list
57064123|NCT04511468|Chromium|chromium|mesh-list
57064124|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
57064125|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064126|NCT04511468|Trace Elements|trace elements|mesh-ancestor
57064127|NCT05531422|Fentanyl|fentanyl|mesh-list
57064128|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57064129|NCT05531422|Narcotics|narcotics|mesh-ancestor
57064130|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064131|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064132|NCT05531422|Analgesics|analgesics|mesh-ancestor
57064133|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
57064134|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064135|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57064136|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57064137|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
57064138|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
57064139|NCT04646356|Tacrolimus|tacrolimus|mesh-list
57064140|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064141|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
57064142|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064143|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57064144|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064145|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064146|NCT03354806|Analgesics|analgesics|mesh-list
57064147|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
57064148|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064149|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064150|NCT05523934|Capsaicin|capsaicin|mesh-list
57064151|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
57064152|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
57064153|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
57064154|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064155|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064156|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
57064157|NCT05529082|Narcotics|narcotics|mesh-ancestor
57064158|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064159|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064160|NCT05529082|Analgesics|analgesics|mesh-ancestor
57064161|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
57064162|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064163|NCT05286814|Leucovorin|leucovorin|mesh-list
57064164|NCT05286814|Gemcitabine|gemcitabine|mesh-list
57064165|NCT05286814|Dexamethasone|dexamethasone|mesh-list
57064166|NCT05286814|Fluorouracil|fluorouracil|mesh-list
57064167|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
57064168|NCT05286814|Irinotecan|irinotecan|mesh-list
57064169|NCT05286814|Floxuridine|floxuridine|mesh-list
57064170|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57064171|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
57064172|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
57064173|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064174|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064175|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57064176|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
57064177|NCT05286814|Hormones|hormones|mesh-ancestor
57064178|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064179|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57064180|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064181|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064182|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
57064183|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064184|NCT05286814|Antiviral Agents|antiviral agents|mesh-ancestor
57064185|NCT05286814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064186|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064187|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064188|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
57064189|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57064190|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57064191|NCT05286814|Antidotes|antidotes|mesh-ancestor
57064192|NCT05286814|Protective Agents|protective agents|mesh-ancestor
57064193|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
57064194|NCT05286814|Vitamins|vitamins|mesh-ancestor
57064195|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
57064197|NCT03350126|Ipilimumab|ipilimumab|mesh-list
57064198|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064199|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064200|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57064201|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064202|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57064203|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57064204|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064205|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064206|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
57064207|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064208|NCT02314182|Bevacizumab|bevacizumab|mesh-list
57064209|NCT02314182|Capecitabine|capecitabine|mesh-list
57064210|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
57064211|NCT02314182|Irinotecan|irinotecan|mesh-list
57064212|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064213|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064214|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57064215|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57064216|NCT02314182|Growth Substances|growth substances|mesh-ancestor
57064217|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064218|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
57064219|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064220|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
56288044|NCT00001011|Zidovudine|zidovudine|mesh-list
57064221|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064222|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57064223|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57064224|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064225|NCT05531344|Tamsulosin|tamsulosin|mesh-list
57064226|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57064227|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57064228|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57064229|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
57064230|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064231|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064232|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064233|NCT05531344|Urological Agents|urological agents|mesh-ancestor
57064234|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
57064235|NCT05531266|Hormones|hormones|mesh-ancestor
57064236|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064237|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064238|NCT03349658|Anesthetics|anesthetics|mesh-list
57064239|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064240|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064241|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
57064242|NCT03353012|Etonogestrel|etonogestrel|mesh-list
57064243|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57064244|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
57064245|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57064246|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064247|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57064248|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57064249|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57064250|NCT05528458|Osimertinib|osimertinib|mesh-list
57064251|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064252|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57064253|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064254|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064255|NCT04462614|Heparin|heparin|mesh-list
57064256|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
57064257|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57064258|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57064259|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064260|NCT03349424|Somatostatin|somatostatin|mesh-list
57064261|NCT03349424|Hormones|hormones|mesh-ancestor
57064262|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064263|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064264|NCT03349346|Rituximab|rituximab|mesh-list
57064265|NCT03349346|Carboplatin|carboplatin|mesh-list
57064266|NCT03349346|Etoposide|etoposide|mesh-list
57064267|NCT03349346|Ifosfamide|ifosfamide|mesh-list
57064268|NCT03349346|Idelalisib|idelalisib|mesh-list
56746239|NCT00548847|Interferons|interferons|mesh-list
57064269|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064270|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064271|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
57064272|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064273|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57064274|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57064275|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57064276|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57064277|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064278|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064279|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57064280|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
57064281|NCT03502434|Petrolatum|petrolatum|mesh-list
57064282|NCT03502434|Emollients|emollients|mesh-ancestor
57064283|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
57064284|NCT03352700|Dyclonine|dyclonine|mesh-list
57064285|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
57064286|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
57064287|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064288|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064289|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
57064290|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064291|NCT05522998|Propofol|propofol|mesh-list
57064292|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57064293|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064294|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064295|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57064296|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
57064297|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
57064298|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
57064299|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57064300|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
57064301|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57064302|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064303|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57064304|NCT03498534|Isoniazid|isoniazid|mesh-list
57064305|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
57064306|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57064307|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064308|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57064309|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57064310|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
57064311|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064312|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57064313|NCT03502356|Azithromycin|azithromycin|mesh-list
57064314|NCT03502356|Cefazolin|cefazolin|mesh-list
57064315|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57064316|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064317|NCT03498456|Amoxicillin|amoxicillin|mesh-list
57064318|NCT03498456|Clarithromycin|clarithromycin|mesh-list
57064319|NCT03498456|Lansoprazole|lansoprazole|mesh-list
57064320|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
57064321|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57064322|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064323|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57064324|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064325|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064326|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57064327|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57064328|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57064329|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57064330|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57064331|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
57064332|NCT02317146|Analgesics|analgesics|mesh-ancestor
57064333|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
57064334|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064335|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064336|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
57064337|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064338|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57064339|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
57064340|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57064341|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57064342|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064343|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57064344|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
57064345|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57064346|NCT05528146|Psyllium|psyllium|mesh-list
57064347|NCT05528146|Cathartics|cathartics|mesh-ancestor
57064348|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57064349|NCT05553704|Metformin|metformin|mesh-list
57064350|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57064351|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064352|NCT03349112|Lidocaine|lidocaine|mesh-list
57064353|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
57064354|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
57064355|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064356|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064357|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
57064358|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064359|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57064360|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57064361|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57064362|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57064363|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064364|NCT03498222|Carboplatin|carboplatin|mesh-list
57064365|NCT03498222|Pemetrexed|pemetrexed|mesh-list
57064366|NCT03498222|Atezolizumab|atezolizumab|mesh-list
57064367|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064368|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064369|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064370|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57064371|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57064372|NCT02518022|Insulin|insulin|mesh-list
57064373|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
57064374|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
57064375|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57064376|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064377|NCT05527912|Rituximab|rituximab|mesh-list
57064378|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
57064379|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064380|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064381|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
57064382|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064383|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57064384|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57064385|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064386|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064387|NCT05504252|Fluorouracil|fluorouracil|mesh-list
57064388|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
57064389|NCT05504252|Nivolumab|nivolumab|mesh-list
57064390|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
57064391|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064392|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064393|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064394|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064395|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
57064396|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064397|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064398|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57064399|NCT03497988|Oxytocin|oxytocin|mesh-list
57064400|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
57064401|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57064402|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064403|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
57064404|NCT04610476|Prednisolone|prednisolone|mesh-list
57064405|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57064406|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
57064407|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57064408|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
57064409|NCT04610476|Adalimumab|adalimumab|mesh-list
57064410|NCT04610476|Etanercept|etanercept|mesh-list
57064411|NCT04610476|Apremilast|apremilast|mesh-list
57064412|NCT04610476|Golimumab|golimumab|mesh-list
57064413|NCT04610476|Methotrexate|methotrexate|mesh-list
57064414|NCT04610476|Abatacept|abatacept|mesh-list
57064415|NCT04610476|Infliximab|infliximab|mesh-list
57064416|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
57064417|NCT04610476|Ustekinumab|ustekinumab|mesh-list
57064418|NCT04610476|Ixekizumab|ixekizumab|mesh-list
57064419|NCT04610476|Tofacitinib|tofacitinib|mesh-list
57064420|NCT04610476|Leflunomide|leflunomide|mesh-list
56746465|NCT04913805|Niacin|niacin|mesh-list
57064421|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57064422|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
57064423|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57064424|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
57064425|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57064426|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064427|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064428|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
57064429|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064430|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064431|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
57064432|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064433|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57064434|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064435|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
57064436|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57064437|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57064438|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57064439|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
57064440|NCT04610476|Hormones|hormones|mesh-ancestor
57064441|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064442|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57064443|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
57064444|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
57064445|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064446|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57064447|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57064448|NCT04610476|Protective Agents|protective agents|mesh-ancestor
57064449|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57064450|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57064451|NCT04610476|Analgesics|analgesics|mesh-ancestor
57064452|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
57064453|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57064454|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57064455|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57064456|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57064457|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57064458|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064459|NCT03348800|Anesthetics|anesthetics|mesh-list
57064460|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064461|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064462|NCT02314806|Clindamycin|clindamycin|mesh-list
57064463|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
57064464|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
57064465|NCT02314806|Gentamicins|gentamicins|mesh-list
57064466|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57064467|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57064468|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064469|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57064470|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064471|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064472|NCT00709202|Betahistine|betahistine|mesh-list
57064473|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
57064474|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
57064475|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
57064476|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064477|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064478|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064479|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
57064480|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57064481|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57064482|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57064483|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57064484|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064485|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
57064486|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064487|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064488|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57064489|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064490|NCT02321280|Denosumab|denosumab|mesh-list
57064491|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57064492|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064493|NCT04624906|Rituximab|rituximab|mesh-list
57064494|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57064495|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
56746466|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
57064496|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064497|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064498|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
57064499|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064500|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57064501|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57064502|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
57064503|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064504|NCT05016310|Vitamin D|vitamin d|mesh-list
57064505|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
57064506|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
57064507|NCT05016310|Vitamins|vitamins|mesh-list
57064508|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
57064509|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064510|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57064511|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57064512|NCT05527444|Thalidomide|thalidomide|mesh-list
57064513|NCT05527444|Adalimumab|adalimumab|mesh-list
57064514|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57064515|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57064516|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57064517|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064518|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
57064519|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064520|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
57064521|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57064522|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064523|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57064524|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57064525|NCT05527444|Growth Substances|growth substances|mesh-ancestor
57064526|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
57064527|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064528|NCT05439902|Tamsulosin|tamsulosin|mesh-list
57064529|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57064530|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57064531|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57064532|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
57064533|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064534|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064535|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064536|NCT05439902|Urological Agents|urological agents|mesh-ancestor
57064537|NCT02315118|Rituximab|rituximab|mesh-list
57064538|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064539|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064540|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
57064541|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064542|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57064543|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57064544|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
57064545|NCT05521828|Hormones|hormones|mesh-ancestor
57064546|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064547|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064548|NCT05521828|Progestins|progestins|mesh-ancestor
57064549|NCT03122756|Dexamethasone|dexamethasone|mesh-list
57064550|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57064551|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
57064552|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
57064553|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064554|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064555|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57064556|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
57064557|NCT03122756|Hormones|hormones|mesh-ancestor
57064558|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064559|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57064560|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064561|NCT03122678|Thiamine|thiamine|mesh-list
57064562|NCT03122678|Vitamins|vitamins|mesh-ancestor
57064563|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
57064564|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064565|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
57064566|NCT02317770|Lidocaine|lidocaine|mesh-list
57064567|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
57064568|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
57064569|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064570|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064571|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
57064572|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064573|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57064574|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57064575|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57064576|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57064577|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064578|NCT05324852|Midazolam|midazolam|mesh-list
57064579|NCT05324852|Loxapine|loxapine|mesh-list
57064580|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57064581|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57064582|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064583|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064584|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57064585|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57064586|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57064587|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57064588|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
57064589|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
57064590|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
57064591|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
56054810|NCT01902758|Ambrisentan|ambrisentan|mesh-list
57064592|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064593|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064594|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57064595|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57064596|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
57064597|NCT05527054|Diuretics|diuretics|mesh-list
57064598|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
57064599|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064600|NCT04506242|Apatinib|apatinib|mesh-list
57064601|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064602|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57064603|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064604|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064605|NCT05526898|Triamcinolone|triamcinolone|mesh-list
57064606|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57064607|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
57064608|NCT05526898|Hormones|hormones|mesh-ancestor
57064609|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064610|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064611|NCT05526820|Vaccines|vaccines|mesh-list
57064612|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
57064613|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064614|NCT03352076|Danazol|danazol|mesh-list
57064615|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57064616|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
57064617|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064618|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064619|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57064620|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57064621|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57064622|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57064623|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57064624|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
57064625|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064626|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064627|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064628|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
57064629|NCT02738580|Hormones|hormones|mesh-ancestor
57064630|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064631|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064632|NCT03497364|Bupivacaine|bupivacaine|mesh-list
57064633|NCT03497364|Ropivacaine|ropivacaine|mesh-list
57064634|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
57064635|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
57064636|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064637|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064638|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
57064639|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064640|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57064641|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57064642|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064643|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
57064644|NCT05521048|Doxycycline|doxycycline|mesh-list
57064645|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57064646|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064648|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57064649|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57064650|NCT05516446|Chromium|chromium|mesh-list
57064651|NCT05516446|Paclitaxel|paclitaxel|mesh-list
57064652|NCT05516446|Everolimus|everolimus|mesh-list
57064653|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57064654|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064655|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
57064656|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
57064657|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
57064658|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064659|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064660|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
57064661|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064662|NCT05516446|Trace Elements|trace elements|mesh-ancestor
57064663|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
57064664|NCT05232344|Estradiol|estradiol|mesh-list
57064665|NCT05232344|Progesterone|progesterone|mesh-list
57064666|NCT05232344|Estrogens|estrogens|mesh-ancestor
57064667|NCT05232344|Hormones|hormones|mesh-ancestor
55891124|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064668|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064669|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064670|NCT05232344|Progestins|progestins|mesh-ancestor
57064671|NCT02318082|Aldesleukin|aldesleukin|mesh-list
57064672|NCT02318082|Interleukin-2|interleukin-2|mesh-list
57064673|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064674|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57064675|NCT02318082|Analgesics|analgesics|mesh-ancestor
57064676|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
57064677|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064678|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064679|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57064680|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57064681|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
57064682|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064683|NCT05212454|Capecitabine|capecitabine|mesh-list
57064684|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064685|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
57064686|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064687|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064688|NCT03348098|Paclitaxel|paclitaxel|mesh-list
57064689|NCT03348098|Apatinib|apatinib|mesh-list
57064690|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57064691|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064692|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
57064693|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
57064694|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
57064695|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064696|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57064697|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064698|NCT05093296|Naltrexone|naltrexone|mesh-list
57064699|NCT05093296|Oxytocin|oxytocin|mesh-list
57064700|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
57064701|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57064702|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064703|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57064704|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57064705|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
57064706|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064707|NCT03351842|Cisplatin|cisplatin|mesh-list
57064708|NCT03351842|Carboplatin|carboplatin|mesh-list
57064709|NCT03351842|Pemetrexed|pemetrexed|mesh-list
57064710|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064711|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064712|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064713|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57064714|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57064715|NCT02447406|Docetaxel|docetaxel|mesh-list
57064716|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064717|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
57064718|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
57064719|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
57064720|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064721|NCT04505228|Atropine|atropine|mesh-list
57064722|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57064723|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57064724|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57064725|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
57064726|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064727|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064728|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57064729|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
57064730|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
57064731|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
57064732|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57064733|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57064734|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
57064735|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064736|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064737|NCT05584826|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
57064738|NCT05584826|Hallucinogens|hallucinogens|mesh-ancestor
57064739|NCT05584826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064740|NCT05584826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57064741|NCT05584826|Serotonin Agents|serotonin agents|mesh-ancestor
57064742|NCT05584826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064743|NCT05584826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064744|NCT05584826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57064745|NCT05584826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57064746|NCT05584826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57064747|NCT05584826|Adrenergic Agents|adrenergic agents|mesh-ancestor
57064748|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
57064749|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
57064750|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064751|NCT03161028|Protective Agents|protective agents|mesh-ancestor
57064752|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064753|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
57064754|NCT03161028|Vitamins|vitamins|mesh-ancestor
57064755|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
57064756|NCT02322372|Bupivacaine|bupivacaine|mesh-list
57064757|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
57064758|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064759|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064760|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
57064761|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
57064762|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064763|NCT01376804|Valganciclovir|valganciclovir|mesh-list
57064764|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
57064765|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064766|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57064767|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064768|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064769|NCT05526118|Tenofovir|tenofovir|mesh-list
57064770|NCT05526118|Emtricitabine|emtricitabine|mesh-list
57064771|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57064772|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
57064773|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064774|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57064775|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57064776|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064777|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064778|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57064779|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57064780|NCT03122132|Ritonavir|ritonavir|mesh-list
57064781|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57064782|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57064783|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
57064784|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064785|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064786|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57064787|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57064788|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
57064789|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064790|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57064791|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57064792|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
57064793|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57064794|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57064795|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064796|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
57064797|NCT03351686|Coagulants|coagulants|mesh-ancestor
57064798|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
57064799|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57064800|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064801|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
57064802|NCT02319018|Leucovorin|leucovorin|mesh-list
57064803|NCT02319018|Folic Acid|folic acid|mesh-list
57064804|NCT02319018|Fluorouracil|fluorouracil|mesh-list
57064805|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
57064806|NCT02319018|Calcium|calcium|mesh-list
57064807|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
57064808|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57064809|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064810|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57064811|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
57064812|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064813|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064814|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064815|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064816|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
57064817|NCT02319018|Antidotes|antidotes|mesh-ancestor
57064818|NCT02319018|Protective Agents|protective agents|mesh-ancestor
57064819|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
57064820|NCT02319018|Vitamins|vitamins|mesh-ancestor
57064821|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
57064822|NCT02319018|Hematinics|hematinics|mesh-ancestor
57064823|NCT02574520|Bupivacaine|bupivacaine|mesh-list
57064824|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57064825|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
57064826|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
57064827|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064828|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064829|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
57064830|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064831|NCT05043506|Palbociclib|palbociclib|mesh-list
57064832|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57064833|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064834|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57064835|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064836|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064837|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57064838|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57064839|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
57064840|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064841|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064842|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
57064843|NCT04425226|Lenvatinib|lenvatinib|mesh-list
57064844|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064845|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064846|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57064847|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064848|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064849|NCT05520658|Fluorouracil|fluorouracil|mesh-list
57064850|NCT05520658|Digoxin|digoxin|mesh-list
57064851|NCT05520658|Furosemide|furosemide|mesh-list
57064852|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
57064853|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064854|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064855|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064856|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57064857|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
57064858|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064859|NCT05520658|Diuretics|diuretics|mesh-ancestor
57064860|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
57064861|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57064862|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57064863|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57064864|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57064865|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064866|NCT05520658|Protective Agents|protective agents|mesh-ancestor
57064867|NCT03351296|Bevacizumab|bevacizumab|mesh-list
57064868|NCT03351296|Capecitabine|capecitabine|mesh-list
57064869|NCT03351296|Temozolomide|temozolomide|mesh-list
57064870|NCT03351296|Streptozocin|streptozocin|mesh-list
57064871|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57064872|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064873|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57064874|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57064875|NCT03351296|Growth Substances|growth substances|mesh-ancestor
57064876|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064877|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
57064878|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57064879|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
57064880|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064881|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57064882|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
57064883|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57064884|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57064885|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57064886|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064887|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57064888|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
57064889|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064890|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57064891|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57064892|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57064893|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064894|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57064895|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57064896|NCT03452930|Benzimidazole|benzimidazole|mesh-list
57064897|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
57064898|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57064899|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57064900|NCT05135650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57064901|NCT05135650|Antibodies|antibodies|mesh-list
57064902|NCT05135650|Immunoglobulins|immunoglobulins|mesh-list
57064903|NCT05135650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57064904|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
57064905|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064906|NCT05135650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064907|NCT03351062|Tamoxifen|tamoxifen|mesh-list
57064908|NCT03351062|Toremifene|toremifene|mesh-list
57064909|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57064910|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
57064911|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57064912|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064913|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57064914|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57064915|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57064916|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57064917|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57064918|NCT05515978|Metformin|metformin|mesh-list
57064919|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57064920|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064921|NCT03496740|Bupivacaine|bupivacaine|mesh-list
57064922|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
57064923|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
57064924|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064925|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064926|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
57064927|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064928|NCT05515822|Oxycodone|oxycodone|mesh-list
57064929|NCT05515822|Dezocine|dezocine|mesh-list
57064930|NCT05515822|Esketamine|esketamine|mesh-list
57064931|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57064932|NCT05515822|Narcotics|narcotics|mesh-ancestor
57064933|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064934|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064935|NCT05515822|Analgesics|analgesics|mesh-ancestor
57064936|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
57064937|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064938|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
57064939|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57064940|NCT02325024|Nabiximols|nabiximols|mesh-list
57064941|NCT02325024|Analgesics|analgesics|mesh-ancestor
57064942|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
57064943|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064944|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064945|NCT04294654|Vortioxetine|vortioxetine|mesh-list
57064946|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
57064947|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57064948|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57064949|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56746919|NCT00845598|Xhance|xhance|mesh-list
57064950|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064951|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064952|NCT04294654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57064953|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57064954|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57064955|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064956|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064957|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
57064958|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57064959|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57064960|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57064961|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57064962|NCT03496506|Selexipag|selexipag|mesh-list
57064963|NCT03496506|Clopidogrel|clopidogrel|mesh-list
57064964|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57064965|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57064966|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57064967|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57064968|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
57064969|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57064970|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064971|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064972|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57064973|NCT04766684|Lidocaine|lidocaine|mesh-list
57064974|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
57064975|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
57064976|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57064977|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064978|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
57064979|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064980|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57064981|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57064982|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57064983|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57064984|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57064985|NCT02319564|Beclomethasone|beclomethasone|mesh-list
57064986|NCT02319564|Albuterol|albuterol|mesh-list
57064987|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57064988|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
57064989|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57064990|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57064991|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57064992|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
57064993|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
57064994|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57064995|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57064996|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57064997|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57064998|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
57064999|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065000|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065001|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57065002|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
57065003|NCT02319564|Hormones|hormones|mesh-ancestor
57065004|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57065005|NCT05056402|Vaccines|vaccines|mesh-list
57065006|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
57065007|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065008|NCT02911142|Prednisone|prednisone|mesh-list
57065009|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
57065010|NCT02911142|Rituximab|rituximab|mesh-list
57065011|NCT02911142|Doxorubicin|doxorubicin|mesh-list
57065012|NCT02911142|Vincristine|vincristine|mesh-list
57065013|NCT02911142|Lenalidomide|lenalidomide|mesh-list
57065014|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065015|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
57065016|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065017|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065018|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57065019|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
57065020|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065021|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065022|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57065023|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57065024|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57065025|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57065026|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57065028|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57065029|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
57065030|NCT02911142|Hormones|hormones|mesh-ancestor
57065031|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57065032|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57065033|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57065034|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
57065035|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
57065036|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
57065037|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57065038|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57065039|NCT02911142|Growth Substances|growth substances|mesh-ancestor
57065040|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
57065041|NCT02325180|Lumefantrine|lumefantrine|mesh-list
57065042|NCT02325180|Artemether|artemether|mesh-list
57065043|NCT02325180|Piperaquine|piperaquine|mesh-list
57065044|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57065045|NCT02325180|Artenimol|artenimol|mesh-list
57065046|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
57065047|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57065048|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57065049|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065050|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
57065051|NCT00709592|Tacrolimus|tacrolimus|mesh-list
57065052|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
57065053|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57065054|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065055|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
57065056|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065057|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57065058|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065059|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065060|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57065061|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065062|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57065063|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
57065064|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065065|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065066|NCT05515354|Nicotine|nicotine|mesh-list
57065067|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57065068|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
57065069|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065070|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065071|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57065072|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57065073|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
57065074|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065075|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065076|NCT02437370|Gemcitabine|gemcitabine|mesh-list
57065077|NCT02437370|Docetaxel|docetaxel|mesh-list
57065078|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
57065079|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57065080|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
57065081|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065082|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065083|NCT02437370|Antiviral Agents|antiviral agents|mesh-ancestor
57065084|NCT02437370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065085|NCT02437370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065086|NCT02437370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065087|NCT02437370|Immunologic Factors|immunologic factors|mesh-ancestor
57065088|NCT02437370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065089|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
57065090|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
57065091|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
57065092|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57065093|NCT05515120|Aspirin|aspirin|mesh-list
57065094|NCT05515120|Vitamin K|vitamin k|mesh-list
57065095|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
57065096|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
57065097|NCT05515120|Vitamins|vitamins|mesh-ancestor
57065098|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
57065099|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065100|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57065101|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57065103|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
57065104|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065105|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57065106|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065107|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57065108|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57065109|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065110|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57065111|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57065112|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065113|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
57065114|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57065115|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
57065116|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57065117|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
57065118|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
57065119|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57065120|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
57065121|NCT05515120|Coagulants|coagulants|mesh-ancestor
57065122|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
57065123|NCT05114590|Lixisenatide|lixisenatide|mesh-list
57065124|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57065125|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065126|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
57065127|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065128|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
57065129|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065130|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065131|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57065132|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
57065133|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065134|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065135|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57065136|NCT04657640|Iron|iron|mesh-list
57065137|NCT04657640|Trace Elements|trace elements|mesh-list
57065138|NCT04657640|Folic Acid|folic acid|mesh-list
57065139|NCT04657640|Micronutrients|micronutrients|mesh-list
57065140|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
57065141|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065142|NCT04657640|Hematinics|hematinics|mesh-ancestor
57065143|NCT04657640|Vitamins|vitamins|mesh-ancestor
57065144|NCT05042128|Gemcitabine|gemcitabine|mesh-list
57065145|NCT05042128|Paclitaxel|paclitaxel|mesh-list
57065146|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57065147|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065148|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
57065149|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
57065150|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
57065151|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065152|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57065153|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
57065154|NCT05042128|Antiviral Agents|antiviral agents|mesh-ancestor
57065155|NCT05042128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065156|NCT05042128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065157|NCT05042128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065158|NCT05042128|Immunologic Factors|immunologic factors|mesh-ancestor
57065159|NCT05042128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065160|NCT03495804|Mannitol|mannitol|mesh-list
57065161|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57065162|NCT03495804|Diuretics|diuretics|mesh-ancestor
57065163|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
57065164|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065165|NCT05519410|Lenvatinib|lenvatinib|mesh-list
57065166|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065167|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57065168|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065169|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065170|NCT05578586|Meropenem|meropenem|mesh-list
57065171|NCT05578586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065172|NCT05578586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065173|NCT02570074|Fosfomycin|fosfomycin|mesh-list
57065174|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56747146|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065175|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065176|NCT02569996|Rituximab|rituximab|mesh-list
57065177|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57065178|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065179|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
57065180|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065181|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065182|NCT02325882|Fentanyl|fentanyl|mesh-list
57065183|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
57065184|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57065185|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065186|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065187|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57065188|NCT02325882|Analgesics|analgesics|mesh-ancestor
57065189|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
57065190|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065191|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57065192|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57065193|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57065194|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
57065195|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065196|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065197|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57065198|NCT02325882|Narcotics|narcotics|mesh-ancestor
57065199|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57065200|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57065201|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
57065202|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
57065203|NCT00708500|Interferons|interferons|mesh-list
57065204|NCT00708500|Ribavirin|ribavirin|mesh-list
57065205|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
57065206|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
57065207|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57065208|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065209|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
57065210|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065211|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
57065212|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065213|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
57065214|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065215|NCT05144100|Cisplatin|cisplatin|mesh-list
57065216|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065217|NCT02320032|Aripiprazole|aripiprazole|mesh-list
57065218|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
57065219|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
57065220|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57065221|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57065222|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57065223|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065224|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065225|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
57065226|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
57065227|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065228|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065229|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57065230|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57065231|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
57065232|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57065233|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57065234|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57065235|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57065236|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
57065237|NCT05514652|Anesthetics|anesthetics|mesh-list
57065238|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065239|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065240|NCT05514652|Narcotics|narcotics|mesh-ancestor
57065241|NCT05514652|Analgesics|analgesics|mesh-ancestor
57065242|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
57065243|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065244|NCT00673244|Furosemide|furosemide|mesh-list
57065245|NCT00673244|Diuretics|diuretics|mesh-ancestor
57065246|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
57065247|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065248|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57065249|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57065250|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065251|NCT02517788|Interferons|interferons|mesh-list
56747231|NCT02545530|Clonidine|clonidine|mesh-list
57065252|NCT02517788|Interferon-beta|interferon-beta|mesh-list
57065253|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
57065254|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065255|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
57065256|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065257|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
57065258|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065259|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57065260|NCT04599790|Lenvatinib|lenvatinib|mesh-list
57065261|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065262|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57065263|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065264|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065265|NCT03132168|Anesthetics|anesthetics|mesh-list
57065266|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065267|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065268|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
57065269|NCT04937062|Glycerol|glycerol|mesh-list
57065270|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57065271|NCT04937062|Protective Agents|protective agents|mesh-ancestor
57065272|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065273|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065274|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57065275|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57065276|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065277|NCT02324010|Incretins|incretins|mesh-ancestor
57065278|NCT02324010|Hormones|hormones|mesh-ancestor
57065279|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57065280|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57065281|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
57065282|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065283|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065284|NCT02320734|Rocuronium|rocuronium|mesh-list
57065285|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57065286|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57065287|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57065288|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065289|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065290|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
57065291|NCT03346226|Propofol|propofol|mesh-list
57065292|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57065293|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065294|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065295|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57065296|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
57065297|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
57065298|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57065299|NCT03346226|Analgesics|analgesics|mesh-ancestor
57065300|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
56898614|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
57065301|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065302|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57065303|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57065304|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57065305|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
57065306|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065307|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065308|NCT03347240|Baclofen|baclofen|mesh-list
57065309|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57065310|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065311|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57065312|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065313|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57065314|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
57065315|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
57065316|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065317|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065318|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
57065319|NCT02324088|Docetaxel|docetaxel|mesh-list
57065320|NCT02324088|Epirubicin|epirubicin|mesh-list
57065321|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065322|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
57065323|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065324|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065325|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57065326|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
57065327|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065328|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065329|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57065330|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
57065331|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
57065332|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
57065333|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57065334|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57065335|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57065336|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065337|NCT02324166|Cefazolin|cefazolin|mesh-list
57065338|NCT02324166|Lidocaine|lidocaine|mesh-list
57065339|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
57065340|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
57065341|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065342|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065343|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
57065344|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065345|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57065346|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57065347|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57065348|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57065349|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065350|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065351|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065352|NCT03346538|Edaravone|edaravone|mesh-list
57065353|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57065354|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
57065355|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065356|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57065357|NCT03346538|Protective Agents|protective agents|mesh-ancestor
57065358|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065359|NCT02513342|Docetaxel|docetaxel|mesh-list
57065360|NCT02513342|Endostar protein|endostar protein|mesh-list
57065361|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065362|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
57065363|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
57065364|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
57065365|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065366|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57065367|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57065368|NCT02513342|Growth Substances|growth substances|mesh-ancestor
57065369|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065370|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
57065371|NCT03495024|Varenicline|varenicline|mesh-list
57065372|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57065373|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57065374|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
57065375|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065376|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065377|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065378|NCT04188314|Desflurane|desflurane|mesh-list
57065379|NCT04188314|Isoflurane|isoflurane|mesh-list
57065380|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57065381|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
57065382|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
57065383|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065384|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065385|NCT05512780|Letrozole|letrozole|mesh-list
57065386|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065387|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57065388|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57065389|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065390|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065391|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57065392|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
57065393|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57065394|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065395|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57065396|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57065397|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
57065398|NCT02517164|Calcifediol|calcifediol|mesh-list
57065399|NCT02517164|Vitamins|vitamins|mesh-ancestor
57065400|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
57065401|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065402|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57065404|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57065405|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
57065406|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
57065407|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57065408|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065409|NCT05512702|Heparin|heparin|mesh-list
57065410|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57065411|NCT05512702|Plasminogen|plasminogen|mesh-list
57065412|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57065413|NCT05512702|Tinzaparin|tinzaparin|mesh-list
57065414|NCT05512702|Dalteparin|dalteparin|mesh-list
57065415|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
57065416|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57065417|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57065418|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065419|NCT05512546|Aspirin|aspirin|mesh-list
57065420|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57065421|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57065422|NCT05512546|Analgesics|analgesics|mesh-ancestor
57065423|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
57065424|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065425|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065426|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57065427|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065428|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57065429|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57065430|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065431|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57065432|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57065433|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065434|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
57065435|NCT04681482|Apixaban|apixaban|mesh-list
57065436|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57065437|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
57065438|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57065439|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
57065440|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065441|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065442|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
57065443|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
57065444|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57065445|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065446|NCT04770532|Insulin|insulin|mesh-list
57065447|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57065448|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57065449|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065450|NCT02512562|Simeprevir|simeprevir|mesh-list
57065451|NCT02512562|Odalasvir|odalasvir|mesh-list
57065452|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
57065453|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065454|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
57065455|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065456|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065457|NCT02516774|Adalimumab|adalimumab|mesh-list
57065458|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57065459|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065460|NCT05510986|Fentanyl|fentanyl|mesh-list
57065461|NCT05510986|Oxycodone|oxycodone|mesh-list
57065462|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57065463|NCT05510986|Narcotics|narcotics|mesh-ancestor
57065464|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065465|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065466|NCT05510986|Analgesics|analgesics|mesh-ancestor
57065467|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
57065468|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065469|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57065470|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57065471|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
57065472|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
57065473|NCT04872400|Vancomycin|vancomycin|mesh-list
57065474|NCT04872400|Tobramycin|tobramycin|mesh-list
57065475|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065476|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065477|NCT02151084|Gemcitabine|gemcitabine|mesh-list
57065478|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065479|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57065480|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
57065481|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065482|NCT02151084|Antiviral Agents|antiviral agents|mesh-ancestor
57065483|NCT02151084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065484|NCT02151084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065485|NCT02151084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065486|NCT02151084|Immunologic Factors|immunologic factors|mesh-ancestor
57065487|NCT02151084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065488|NCT00101907|Gemcitabine|gemcitabine|mesh-list
57065489|NCT00101907|Panitumumab|panitumumab|mesh-list
57065490|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
57065491|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065492|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57065493|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
57065494|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065495|NCT00101907|Antiviral Agents|antiviral agents|mesh-ancestor
57065496|NCT00101907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065497|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065498|NCT00101907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065499|NCT00101907|Immunologic Factors|immunologic factors|mesh-ancestor
57065500|NCT00101907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065501|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57065502|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57065503|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
57065504|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
57065505|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065506|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065507|NCT04769206|Galantamine|galantamine|mesh-list
57065508|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57065509|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065510|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065511|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
57065512|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065513|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065514|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57065515|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
57065516|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065517|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
57065518|NCT03492996|Delpazolid|delpazolid|mesh-list
57065519|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065520|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065521|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57065522|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065523|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065524|NCT03772028|Cisplatin|cisplatin|mesh-list
57065525|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065526|NCT02161965|Warfarin|warfarin|mesh-list
57065527|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
57065528|NCT02161965|Fluindione|fluindione|mesh-list
57065529|NCT02161965|Phenindione|phenindione|mesh-list
57065530|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
57065531|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57065532|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
57065533|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57065534|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
57065535|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065536|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065537|NCT02050308|Nicotine|nicotine|mesh-list
57065538|NCT02050308|Varenicline|varenicline|mesh-list
57065539|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57065540|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
57065541|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065542|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065543|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57065544|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57065545|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
57065546|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065547|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065548|NCT02516618|Fasinumab|fasinumab|mesh-list
57065549|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57065550|NCT02516618|Analgesics|analgesics|mesh-ancestor
57065551|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
57065552|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065553|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065554|NCT05507554|Analgesics|analgesics|mesh-list
57065555|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
57065556|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065557|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
57065558|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065560|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57065561|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57065562|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065563|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
57065564|NCT04501250|Insulin|insulin|mesh-list
57065565|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57065566|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57065567|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065568|NCT02761629|Interferons|interferons|mesh-list
57065569|NCT02761629|Ribavirin|ribavirin|mesh-list
57065570|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
57065571|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
57065572|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57065573|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065574|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
57065575|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065576|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
57065577|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065578|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
57065579|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065580|NCT03345992|Clarithromycin|clarithromycin|mesh-list
57065581|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065582|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065583|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57065584|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065585|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065586|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57065587|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57065588|NCT02162121|Ketorolac|ketorolac|mesh-list
57065589|NCT02162121|Buprenorphine|buprenorphine|mesh-list
57065590|NCT02162121|Anesthetics|anesthetics|mesh-list
57065591|NCT02162121|Ropivacaine|ropivacaine|mesh-list
57065592|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
57065593|NCT02162121|Mepivacaine|mepivacaine|mesh-list
57065594|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
57065595|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065596|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065597|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
57065598|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065599|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57065600|NCT02162121|Narcotics|narcotics|mesh-ancestor
57065601|NCT02162121|Analgesics|analgesics|mesh-ancestor
57065602|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57065603|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57065604|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57065605|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57065606|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065607|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57065608|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065609|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065610|NCT02511704|Nicotine|nicotine|mesh-list
57065611|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57065612|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
57065613|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065614|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065615|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57065616|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57065617|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
57065618|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065619|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065620|NCT04500704|Carboplatin|carboplatin|mesh-list
57065621|NCT04500704|Pemetrexed|pemetrexed|mesh-list
57065622|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065623|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065624|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065625|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57065626|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57065627|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
57065628|NCT02164773|Analgesics|analgesics|mesh-ancestor
57065629|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
57065630|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065631|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747604|NCT00619476|Gabapentin|gabapentin|mesh-list
57065632|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
57065633|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065634|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57065635|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
57065636|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57065637|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57065638|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065639|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57065640|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
57065641|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57065642|NCT00101439|Ezetimibe|ezetimibe|mesh-list
57065643|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57065644|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57065645|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
57065646|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065647|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57065648|NCT03344822|Choline|choline|mesh-list
57065649|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57065650|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
57065651|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57065652|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
57065653|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065654|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57065655|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57065656|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
57065657|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57065658|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57065659|NCT02506790|Toremifene|toremifene|mesh-list
57065660|NCT02506790|Metformin|metformin|mesh-list
57065661|NCT02506790|Melatonin|melatonin|mesh-list
57065662|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57065663|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065664|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
57065665|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065666|NCT02506790|Protective Agents|protective agents|mesh-ancestor
57065667|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065668|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57065669|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065670|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57065671|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57065672|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
57065673|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57065674|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57065675|NCT04500002|Isoniazid|isoniazid|mesh-list
57065676|NCT04500002|Misoprostol|misoprostol|mesh-list
57065677|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57065678|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
57065679|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57065680|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065681|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57065682|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57065683|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
57065684|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
57065685|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065686|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065687|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57065688|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57065689|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
57065690|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065691|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57065692|NCT02515682|Equol|equol|mesh-list
57065693|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
57065694|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57065695|NCT02515682|Estrogens|estrogens|mesh-ancestor
57065696|NCT02515682|Hormones|hormones|mesh-ancestor
57065697|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57065698|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065699|NCT02515604|Misoprostol|misoprostol|mesh-list
57065700|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57065701|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
57065702|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57065703|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065704|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57065705|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57065706|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
57065707|NCT02510534|Menotropins|menotropins|mesh-list
57065708|NCT02510534|Progesterone|progesterone|mesh-list
57065709|NCT02510534|Progestins|progestins|mesh-ancestor
57065710|NCT02510534|Hormones|hormones|mesh-ancestor
57065711|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57065712|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065713|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57065714|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
57065715|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57065716|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
57065717|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57065718|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065719|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065720|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57065721|NCT02510612|Analgesics|analgesics|mesh-ancestor
57065722|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
57065723|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065724|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57065725|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57065726|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57065727|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
57065728|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065729|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065730|NCT03749616|Acetaminophen|acetaminophen|mesh-list
57065731|NCT03749616|Ibuprofen|ibuprofen|mesh-list
57065732|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57065733|NCT03749616|Analgesics|analgesics|mesh-ancestor
57065734|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
57065735|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065736|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065737|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
57065738|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57065739|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57065740|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065741|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57065742|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065743|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065744|NCT00101283|Gemcitabine|gemcitabine|mesh-list
57065745|NCT00101283|Carboplatin|carboplatin|mesh-list
57065746|NCT00101283|Pemetrexed|pemetrexed|mesh-list
57065747|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891125|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
57065748|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57065749|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
57065750|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065751|NCT00101283|Antiviral Agents|antiviral agents|mesh-ancestor
57065752|NCT00101283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065753|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065754|NCT00101283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065755|NCT00101283|Immunologic Factors|immunologic factors|mesh-ancestor
57065756|NCT00101283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065757|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57065758|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57065759|NCT04532502|Anesthetics|anesthetics|mesh-list
57065760|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
57065761|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065762|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065763|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
57065764|NCT02515526|Tolbutamide|tolbutamide|mesh-list
57065765|NCT02515526|Ethanol|ethanol|mesh-list
57065766|NCT02515526|Digoxin|digoxin|mesh-list
57065767|NCT02515526|Midazolam|midazolam|mesh-list
57065768|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
57065769|NCT02515526|Caffeine|caffeine|mesh-list
57065770|NCT02515526|Omeprazole|omeprazole|mesh-list
57065771|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57065772|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57065773|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065774|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065775|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57065776|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57065777|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57065778|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57065779|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
57065780|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
57065781|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
57065782|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
57065783|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065784|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065785|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57065786|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57065787|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065788|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57065789|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57065790|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
57065791|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57065792|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57065793|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57065794|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57065795|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065796|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57065797|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57065798|NCT02515526|Protective Agents|protective agents|mesh-ancestor
57065799|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
57065800|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
57065801|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57065802|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57065803|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57065804|NCT02515448|Gentamicins|gentamicins|mesh-list
57065805|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065806|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065807|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57065808|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065809|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065810|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
57065811|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57065812|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
57065813|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065814|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
57065815|NCT02170857|Protective Agents|protective agents|mesh-ancestor
57065816|NCT04460820|Doxorubicin|doxorubicin|mesh-list
57065817|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57065818|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57065819|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065820|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57065821|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57065822|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065823|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065824|NCT02170935|Dabigatran|dabigatran|mesh-list
57065825|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
57065826|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57065827|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
57065828|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065829|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065830|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
57065831|NCT03488316|Calcium|calcium|mesh-list
57065832|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57065833|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065834|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
57065835|NCT02510222|Analgesics|analgesics|mesh-ancestor
57065836|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
57065837|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065838|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065839|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
57065840|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065841|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57065842|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
57065843|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57065844|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57065845|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065846|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57065847|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
57065848|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57065849|NCT05100264|Acetic Acid|acetic acid|mesh-list
57065850|NCT05100264|Retinol acetate|retinol acetate|mesh-list
57065851|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065852|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065853|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57065854|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
57065855|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065856|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57065857|NCT05100264|Protective Agents|protective agents|mesh-ancestor
57065858|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747830|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
57065859|NCT02505776|Bimatoprost|bimatoprost|mesh-list
57065860|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57065861|NCT02171013|Dabigatran|dabigatran|mesh-list
57065862|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
57065863|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57065864|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
57065865|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065866|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065867|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
57065868|NCT02167425|Methadone|methadone|mesh-list
57065869|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57065870|NCT02167425|Narcotics|narcotics|mesh-ancestor
57065871|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065872|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065873|NCT02167425|Analgesics|analgesics|mesh-ancestor
57065874|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
57065875|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065876|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
57065877|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
57065878|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
57065879|NCT03111732|Capecitabine|capecitabine|mesh-list
57065880|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
57065881|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57065882|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065883|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57065884|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
57065885|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065886|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
57065887|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065888|NCT02505386|Ertapenem|ertapenem|mesh-list
57065889|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57065890|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065891|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
57065892|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57065893|NCT02514980|Ketamine|ketamine|mesh-list
57065894|NCT02514980|Bupivacaine|bupivacaine|mesh-list
57065895|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
57065896|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
57065897|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065898|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065899|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
57065900|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065901|NCT02514980|Analgesics|analgesics|mesh-ancestor
57065902|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57065903|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57065904|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
57065905|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57065906|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57065907|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57065908|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065909|NCT04920942|Ivermectin|ivermectin|mesh-list
57065910|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57065911|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57065912|NCT02165475|Loperamide|loperamide|mesh-list
57065913|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
57065914|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57065915|NCT04862338|Niacinamide|niacinamide|mesh-list
57065916|NCT04862338|Niacin|niacin|mesh-list
57065917|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
57065918|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
57065919|NCT04862338|Vitamins|vitamins|mesh-ancestor
57065920|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
57065921|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065922|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57065923|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
57065924|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065925|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57065926|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
57065927|NCT02171325|Irinotecan|irinotecan|mesh-list
57065928|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57065929|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57065930|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065931|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065932|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065933|NCT02509286|Leucovorin|leucovorin|mesh-list
57065934|NCT02509286|Paclitaxel|paclitaxel|mesh-list
57065935|NCT02509286|Docetaxel|docetaxel|mesh-list
57065936|NCT02509286|Carboplatin|carboplatin|mesh-list
57065937|NCT02509286|Fluorouracil|fluorouracil|mesh-list
57065938|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
57065939|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57065940|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065941|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
57065942|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
57065943|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
57065944|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065945|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
57065946|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57065947|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57065948|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
57065949|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065950|NCT02509286|Antidotes|antidotes|mesh-ancestor
57065951|NCT02509286|Protective Agents|protective agents|mesh-ancestor
57065952|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
57065953|NCT02509286|Vitamins|vitamins|mesh-ancestor
57065954|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
57065955|NCT03065244|Infliximab|infliximab|mesh-list
57065956|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
57065957|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57065958|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
57065959|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57065960|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
57065961|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065962|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
57065963|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57065964|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57065965|NCT02171481|Dabigatran|dabigatran|mesh-list
57065966|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
57065967|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57065968|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
57065969|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065970|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898630|NCT02524821|Metformin|metformin|mesh-list
57065971|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
57065972|NCT02171559|Enoxaparin|enoxaparin|mesh-list
57065973|NCT02171559|Dabigatran|dabigatran|mesh-list
57065974|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
57065975|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57065976|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57065977|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065978|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
57065979|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57065980|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
57065981|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065982|NCT04901754|Apatinib|apatinib|mesh-list
57065983|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57065984|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57065985|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57065986|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57065987|NCT02509208|Hemostatics|hemostatics|mesh-list
57065988|NCT02509208|Coagulants|coagulants|mesh-ancestor
57065989|NCT02504996|Acetaminophen|acetaminophen|mesh-list
57065990|NCT02504996|Morphine|morphine|mesh-list
57065991|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57065992|NCT02504996|Narcotics|narcotics|mesh-ancestor
57065993|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57065994|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57065995|NCT02504996|Analgesics|analgesics|mesh-ancestor
57065996|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
57065997|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57065998|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57065999|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
57066000|NCT02509052|Leflunomide|leflunomide|mesh-list
57066001|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066002|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066003|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57066004|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
57066005|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066006|NCT00100815|Gemcitabine|gemcitabine|mesh-list
57066007|NCT00100815|Bevacizumab|bevacizumab|mesh-list
57066008|NCT00100815|Capecitabine|capecitabine|mesh-list
57066009|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57066010|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066011|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57066012|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57066013|NCT00100815|Growth Substances|growth substances|mesh-ancestor
57066014|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066015|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
57066016|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57066017|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
57066018|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066019|NCT00100815|Antiviral Agents|antiviral agents|mesh-ancestor
57066020|NCT00100815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066021|NCT00100815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066022|NCT00100815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57066023|NCT00100815|Immunologic Factors|immunologic factors|mesh-ancestor
57066024|NCT00708422|Travoprost|travoprost|mesh-list
57066025|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57066026|NCT00708422|Latanoprost|latanoprost|mesh-list
57066027|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57066028|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57066029|NCT02514200|Riboflavin|riboflavin|mesh-list
57066030|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
57066031|NCT02514200|Vitamins|vitamins|mesh-ancestor
57066032|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
57066033|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066034|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57066035|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
57066036|NCT02504450|Haloperidol|haloperidol|mesh-list
57066037|NCT02504450|Ziprasidone|ziprasidone|mesh-list
57066038|NCT02504450|Loxapine|loxapine|mesh-list
57066039|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
57066040|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
57066041|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066042|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066043|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57066044|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57066045|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57066046|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066047|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57066048|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57066049|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
57066050|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066051|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066052|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57066053|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57066054|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
57066055|NCT02171637|Afatinib|afatinib|mesh-list
57066056|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066057|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57066058|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066059|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066060|NCT02171715|Afatinib|afatinib|mesh-list
57066061|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066062|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57066063|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066064|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066065|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
57066066|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57066067|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066068|NCT02760069|Ondansetron|ondansetron|mesh-list
57066069|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
57066070|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
57066071|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066072|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066073|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57066074|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
57066075|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
57066076|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57066077|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
57066078|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066079|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066080|NCT02760069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57066081|NCT02760069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57066082|NCT02760069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066083|NCT02760069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57066084|NCT02760069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57066085|NCT02504138|Anesthetics|anesthetics|mesh-list
57066086|NCT02504138|Propofol|propofol|mesh-list
57066087|NCT02504138|Desflurane|desflurane|mesh-list
57066088|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066089|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066090|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57066091|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57066092|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
56748065|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
57066093|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57066094|NCT02508584|Antibodies|antibodies|mesh-list
57066095|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
57066096|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066097|NCT02171793|Olodaterol|olodaterol|mesh-list
57066098|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57066099|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
57066100|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066101|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066102|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066103|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066104|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
57066105|NCT02508350|Daptomycin|daptomycin|mesh-list
57066106|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57066107|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066108|NCT02503826|Midazolam|midazolam|mesh-list
57066109|NCT02503826|Sufentanil|sufentanil|mesh-list
57066110|NCT02503826|Dsuvia|dsuvia|mesh-list
57066111|NCT02503826|Propofol|propofol|mesh-list
57066112|NCT02503826|Cisatracurium|cisatracurium|mesh-list
57066113|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57066114|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066115|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066116|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57066117|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
57066118|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
57066119|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57066120|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57066121|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57066122|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57066123|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
57066124|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
57066125|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066126|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066127|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57066128|NCT02503826|Narcotics|narcotics|mesh-ancestor
57066129|NCT02503826|Analgesics|analgesics|mesh-ancestor
57066130|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
57066131|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066132|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57066133|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57066134|NCT03121664|Itraconazole|itraconazole|mesh-list
57066135|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
57066136|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066137|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57066138|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57066139|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066140|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066141|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57066142|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
57066143|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57066144|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066145|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57066146|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57066147|NCT02503904|Metronidazole|metronidazole|mesh-list
57066148|NCT02503904|Lidocaine|lidocaine|mesh-list
57066149|NCT02503904|Epinephrine|epinephrine|mesh-list
57066150|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
57066151|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
57066152|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066153|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066154|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
57066155|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066156|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57066157|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57066158|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57066159|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57066160|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066161|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066162|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57066163|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57066164|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
57066165|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066166|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57066167|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57066168|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
57066169|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066170|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066171|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
57066172|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
57066173|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57066174|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57066175|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57066176|NCT02172105|Olodaterol|olodaterol|mesh-list
57066177|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57066178|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
57066179|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066180|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066181|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066182|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066183|NCT03121352|Paclitaxel|paclitaxel|mesh-list
57066184|NCT03121352|Carboplatin|carboplatin|mesh-list
57066185|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
57066186|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57066187|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066188|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
57066189|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
57066190|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
57066191|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898634|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57066192|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57066193|NCT02513654|Lamotrigine|lamotrigine|mesh-list
57066194|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
57066195|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57066196|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57066197|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066198|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57066199|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066200|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57066201|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57066202|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066203|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57066204|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57066205|NCT02513888|Vitamin D|vitamin d|mesh-list
57066206|NCT02513888|Vitamins|vitamins|mesh-ancestor
57066207|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
57066208|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066209|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57066210|NCT00101595|Dasatinib|dasatinib|mesh-list
57066211|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066212|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57066213|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066214|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066215|NCT02174757|Doxycycline|doxycycline|mesh-list
57066216|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57066217|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066218|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
57066219|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57066220|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57066221|NCT02168127|Methylphenidate|methylphenidate|mesh-list
57066222|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57066223|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066224|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57066225|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57066226|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57066227|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066228|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
57066229|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066230|NCT05233202|Simendan|simendan|mesh-list
57066231|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57066232|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
57066233|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57066234|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57066235|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066236|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066237|NCT05233202|Protective Agents|protective agents|mesh-ancestor
57066238|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066239|NCT02255955|Acetaminophen|acetaminophen|mesh-list
57066240|NCT02255955|Naproxen|naproxen|mesh-list
57066241|NCT02255955|Codeine|codeine|mesh-list
57066242|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57066243|NCT02255955|Analgesics|analgesics|mesh-ancestor
57066244|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
57066245|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066246|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066247|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
57066248|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57066249|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57066250|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57066251|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
57066252|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57066253|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066254|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066255|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57066256|NCT02255955|Narcotics|narcotics|mesh-ancestor
56898642|NCT03854175|Estradiol|estradiol|mesh-list
57066257|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066258|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
57066259|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066260|NCT02172261|Glimepiride|glimepiride|mesh-list
57066261|NCT02172261|Empagliflozin|empagliflozin|mesh-list
57066262|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57066263|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57066264|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066265|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57066266|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
57066267|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57066268|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066269|NCT02501564|Naproxen|naproxen|mesh-list
57066270|NCT02501564|Codeine|codeine|mesh-list
57066271|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57066272|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57066273|NCT02501564|Analgesics|analgesics|mesh-ancestor
57066274|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
57066275|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066276|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066277|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57066278|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57066279|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
57066280|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57066281|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066282|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066283|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57066284|NCT02501564|Narcotics|narcotics|mesh-ancestor
57066285|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066286|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
57066287|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066288|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
57066289|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57066290|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
57066291|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066292|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066293|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066294|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066295|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
57066296|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57066297|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
57066298|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066299|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066300|NCT02172417|Ranitidine|ranitidine|mesh-list
57066301|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
57066302|NCT02172417|Cimetidine|cimetidine|mesh-list
57066303|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
57066304|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57066305|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
57066306|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066307|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066308|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066309|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066310|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
57066311|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57066312|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
57066313|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066314|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066315|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57066316|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57066317|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57066318|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
57066319|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
56748270|NCT00793052|Hormones|hormones|mesh-ancestor
57066320|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57066321|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57066322|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066323|NCT02168205|Pomalidomide|pomalidomide|mesh-list
57066324|NCT02168205|Caffeine|caffeine|mesh-list
57066325|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57066326|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066327|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57066328|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066329|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066330|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57066331|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57066332|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
57066333|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066334|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
57066335|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57066336|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57066337|NCT02168205|Growth Substances|growth substances|mesh-ancestor
57066338|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
57066339|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066340|NCT03343652|Nivolumab|nivolumab|mesh-list
57066341|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57066342|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57066343|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066344|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57066345|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066346|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57066347|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
57066348|NCT02175069|Ropivacaine|ropivacaine|mesh-list
57066349|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
57066350|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
57066351|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066352|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066353|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
57066354|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066355|NCT04498520|Fulvestrant|fulvestrant|mesh-list
57066356|NCT04498520|Palbociclib|palbociclib|mesh-list
57066357|NCT04498520|Abexinostat|abexinostat|mesh-list
57066358|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57066359|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066360|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57066361|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57066362|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
57066363|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57066364|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066365|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57066366|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066367|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066368|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57066369|NCT02172495|Bromides|bromides|mesh-list
57066370|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
57066371|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57066372|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
57066373|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066374|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066375|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066376|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066377|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
57066378|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57066379|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
57066380|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066381|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066382|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
57066383|NCT02172573|Pramipexole|pramipexole|mesh-list
57066384|NCT02172573|Bromocriptine|bromocriptine|mesh-list
57066385|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
57066386|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066387|NCT02172573|Protective Agents|protective agents|mesh-ancestor
57066388|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066389|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57066390|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57066391|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
57066392|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
56748350|NCT00863148|Busulfan|busulfan|mesh-list
57066393|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066394|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
57066395|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57066396|NCT02175381|Gemcitabine|gemcitabine|mesh-list
57066397|NCT02175381|Carboplatin|carboplatin|mesh-list
57066398|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066399|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57066400|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
57066401|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066402|NCT02175381|Antiviral Agents|antiviral agents|mesh-ancestor
57066403|NCT02175381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066404|NCT02175381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066405|NCT02175381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57066406|NCT02175381|Immunologic Factors|immunologic factors|mesh-ancestor
57066407|NCT02175381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066408|NCT03540225|Progesterone|progesterone|mesh-list
57066409|NCT03540225|Progestins|progestins|mesh-ancestor
57066410|NCT03540225|Hormones|hormones|mesh-ancestor
57066411|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57066412|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066413|NCT02507648|Oseltamivir|oseltamivir|mesh-list
57066414|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
57066415|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066416|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066417|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066418|NCT02172729|Lidocaine|lidocaine|mesh-list
57066419|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
57066420|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
57066421|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066422|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066423|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
57066424|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066425|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57066426|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57066427|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57066428|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57066429|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066430|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
57066431|NCT02172807|Oxitropium|oxitropium|mesh-list
57066432|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57066433|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
57066434|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066435|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066436|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066437|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066438|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
57066439|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57066440|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
57066441|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066442|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066443|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
57066444|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
57066445|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066446|NCT02502968|Cytarabine|cytarabine|mesh-list
57066447|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57066448|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
57066449|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066450|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066451|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
57066452|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066453|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57066454|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
57066455|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066456|NCT04557735|Ravulizumab|ravulizumab|mesh-list
57066457|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57066458|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57066459|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
57066460|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066461|NCT02168751|Propofol|propofol|mesh-list
57066462|NCT02168751|Sevoflurane|sevoflurane|mesh-list
57066463|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57066464|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066465|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748423|NCT00570128|Donepezil|donepezil|mesh-list
57066466|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57066467|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
57066468|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
57066469|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57066470|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57066471|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57066472|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066473|NCT03344042|Fentanyl|fentanyl|mesh-list
57066474|NCT03344042|Sufentanil|sufentanil|mesh-list
57066475|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57066476|NCT03344042|Narcotics|narcotics|mesh-ancestor
57066477|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066478|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066479|NCT03344042|Analgesics|analgesics|mesh-ancestor
57066480|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
57066481|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066482|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57066483|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57066484|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
57066485|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
57066486|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57066487|NCT02175927|Amoxicillin|amoxicillin|mesh-list
57066488|NCT02175927|Metronidazole|metronidazole|mesh-list
57066489|NCT02175927|Tetracycline|tetracycline|mesh-list
57066490|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57066491|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
57066492|NCT02175927|Lansoprazole|lansoprazole|mesh-list
57066493|NCT02175927|Bismuth|bismuth|mesh-list
57066494|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57066495|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066496|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066497|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
57066498|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57066499|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57066500|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57066501|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57066502|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066503|NCT02175927|Antacids|antacids|mesh-ancestor
57066504|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57066505|NCT02175927|Diuretics|diuretics|mesh-ancestor
57066506|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
57066507|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066508|NCT02175927|Expectorants|expectorants|mesh-ancestor
57066509|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066510|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
57066511|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
57066512|NCT00707486|Coagulants|coagulants|mesh-ancestor
57066513|NCT02496182|Pirfenidone|pirfenidone|mesh-list
57066514|NCT02496182|Analgesics|analgesics|mesh-ancestor
57066515|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
57066516|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066517|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066518|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57066519|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57066520|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57066521|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57066522|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066523|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
57066524|NCT02168907|Rituximab|rituximab|mesh-list
57066525|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57066526|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57066527|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066528|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
57066529|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066530|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57066531|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57066532|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
57066533|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066534|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
57066535|NCT02168907|Protective Agents|protective agents|mesh-ancestor
57066536|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
57066537|NCT02168907|Vitamins|vitamins|mesh-ancestor
57066538|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
57066539|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
57066540|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57066541|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
57066542|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066543|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066544|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066545|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066546|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56290407|NCT05572723|Remifentanil|remifentanil|mesh-list
57066547|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57066548|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57066549|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
57066550|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066551|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066552|NCT02500940|Leucovorin|leucovorin|mesh-list
57066553|NCT02500940|Fluorouracil|fluorouracil|mesh-list
57066554|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066555|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066556|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
57066557|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066558|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57066559|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57066560|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
57066561|NCT02500940|Antidotes|antidotes|mesh-ancestor
57066562|NCT02500940|Protective Agents|protective agents|mesh-ancestor
57066563|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
57066564|NCT02500940|Vitamins|vitamins|mesh-ancestor
57066565|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
57066566|NCT02495636|Atezolizumab|atezolizumab|mesh-list
57066567|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066568|NCT02169063|Listerine|listerine|mesh-list
57066569|NCT02169063|Fluorides|fluorides|mesh-list
57066570|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
57066571|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
57066572|NCT02169063|Protective Agents|protective agents|mesh-ancestor
57066573|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066574|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57066575|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066576|NCT04496882|Tenofovir|tenofovir|mesh-list
57066577|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
57066578|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066579|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57066580|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57066581|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066582|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066583|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57066584|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57066585|NCT02502500|Celecoxib|celecoxib|mesh-list
57066586|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57066587|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57066588|NCT02502500|Analgesics|analgesics|mesh-ancestor
57066589|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
57066590|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066591|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066592|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57066593|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57066594|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57066595|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57066596|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066597|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066598|NCT02173665|Linagliptin|linagliptin|mesh-list
57066599|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57066600|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066601|NCT02173665|Incretins|incretins|mesh-ancestor
57066602|NCT02173665|Hormones|hormones|mesh-ancestor
57066603|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57066604|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57066605|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
57066606|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066607|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066608|NCT02495324|Valsartan|valsartan|mesh-list
57066609|NCT02495324|Olmesartan|olmesartan|mesh-list
57066610|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
57066611|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57066612|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57066613|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57066614|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066615|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
57066616|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
57066617|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066618|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
57066619|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066620|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066621|NCT04625283|Ketamine|ketamine|mesh-list
57066622|NCT04625283|Analgesics|analgesics|mesh-ancestor
57066623|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
57066624|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066625|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066626|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57066627|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57066628|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
57066629|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
57066630|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066631|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57066632|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57066633|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066634|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066635|NCT02256033|Istradefylline|istradefylline|mesh-list
57066636|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
57066637|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57066638|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57066639|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
57066640|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066641|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066642|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066643|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57066644|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57066645|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57066646|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
57066647|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066648|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57066649|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57066650|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066651|NCT02502344|Metformin|metformin|mesh-list
57066652|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57066653|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066654|NCT02174211|Ranibizumab|ranibizumab|mesh-list
57066655|NCT02174211|Aflibercept|aflibercept|mesh-list
57066656|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57066657|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57066658|NCT02174211|Growth Substances|growth substances|mesh-ancestor
57066659|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066660|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
57066661|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066662|NCT04496492|Tocotrienols|tocotrienols|mesh-list
57066663|NCT04496492|Vitamin E|vitamin e|mesh-list
57066664|NCT04496492|Tocopherols|tocopherols|mesh-list
57066665|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
57066666|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066667|NCT04496492|Protective Agents|protective agents|mesh-ancestor
57066668|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066669|NCT04496492|Vitamins|vitamins|mesh-ancestor
57066670|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
57066671|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57066672|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57066673|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066674|NCT02502032|Cisatracurium|cisatracurium|mesh-list
57066675|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57066676|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57066677|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066678|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066679|NCT02494856|Naproxen|naproxen|mesh-list
57066680|NCT02494856|Esomeprazole|esomeprazole|mesh-list
57066681|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57066682|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57066683|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57066684|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066685|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066686|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57066687|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57066688|NCT02494856|Analgesics|analgesics|mesh-ancestor
57066689|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
57066690|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066691|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066692|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57066693|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57066694|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
57066695|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57066696|NCT04495010|Nivolumab|nivolumab|mesh-list
57066697|NCT04495010|Ipilimumab|ipilimumab|mesh-list
57066698|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57066699|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066700|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57066701|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066702|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57066703|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
57066704|NCT03343418|Coagulants|coagulants|mesh-ancestor
57066705|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57066706|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
57066707|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066708|NCT02501798|Methylphenidate|methylphenidate|mesh-list
57066709|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57066710|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066711|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57066712|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57066713|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57066714|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066715|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
57066716|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066717|NCT02169609|Interleukin-2|interleukin-2|mesh-list
57066718|NCT02169609|Dinutuximab|dinutuximab|mesh-list
57066719|NCT02169609|Isotretinoin|isotretinoin|mesh-list
57066720|NCT02169609|Sargramostim|sargramostim|mesh-list
57066721|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066722|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57066723|NCT02169609|Analgesics|analgesics|mesh-ancestor
57066724|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
57066725|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066726|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066727|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
57066728|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
57066729|NCT02499614|Crizotinib|crizotinib|mesh-list
57066730|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066731|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57066732|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066733|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066734|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
57066735|NCT02169843|Sevoflurane|sevoflurane|mesh-list
57066736|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57066737|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066738|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066739|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57066740|NCT02169843|Analgesics|analgesics|mesh-ancestor
57066741|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
57066742|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066743|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57066744|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57066745|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57066746|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
57066747|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066748|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066749|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57066750|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57066751|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
57066752|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
57066753|NCT03341390|Aspirin|aspirin|mesh-list
57066754|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57066755|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57066756|NCT03341390|Analgesics|analgesics|mesh-ancestor
57066757|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
57066758|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066759|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066760|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57066761|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57066762|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57066763|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56898658|NCT01183611|Vaccines|vaccines|mesh-list
57066764|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066765|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57066766|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57066767|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066768|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
57066769|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
57066770|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066771|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57066772|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066773|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066775|NCT00707174|Tazarotene|tazarotene|mesh-list
57066776|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57066777|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
57066778|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066779|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066780|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
57066781|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
57066782|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
57066783|NCT03341234|Bupivacaine|bupivacaine|mesh-list
57066784|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
57066785|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
57066786|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066787|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066788|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
57066789|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066790|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
57066791|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066792|NCT03120494|Tenofovir|tenofovir|mesh-list
57066793|NCT03120494|Emtricitabine|emtricitabine|mesh-list
57066794|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
57066795|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066796|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57066797|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57066798|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066799|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066800|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57066801|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57066802|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
57066803|NCT03537573|Narcotics|narcotics|mesh-ancestor
57066804|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066805|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066806|NCT03537573|Analgesics|analgesics|mesh-ancestor
57066807|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
57066808|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066809|NCT03120962|Famciclovir|famciclovir|mesh-list
57066810|NCT03120962|Oxycodone|oxycodone|mesh-list
57066811|NCT03120962|Gabapentin|gabapentin|mesh-list
57066812|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57066813|NCT03120962|Narcotics|narcotics|mesh-ancestor
57066814|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57066815|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066816|NCT03120962|Analgesics|analgesics|mesh-ancestor
57066817|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
57066818|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066819|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
57066820|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57066821|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57066822|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57066823|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57066824|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57066825|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066826|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066827|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
57066828|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
57066829|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066830|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57066831|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066832|NCT02178813|Minocycline|minocycline|mesh-list
57066833|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57066834|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066835|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
57066836|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
57066837|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066838|NCT02177253|Bromides|bromides|mesh-list
57066839|NCT02177253|Albuterol|albuterol|mesh-list
56748801|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
57066840|NCT02177253|Ipratropium|ipratropium|mesh-list
57066841|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
57066842|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57066843|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
57066844|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57066845|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066846|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066847|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066848|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
57066849|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57066850|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57066851|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57066852|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57066853|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
57066854|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57066855|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066856|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57066857|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
57066858|NCT02177331|Lacidipine|lacidipine|mesh-list
57066859|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57066860|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57066861|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57066862|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066863|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57066864|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066865|NCT02177409|Amlodipine|amlodipine|mesh-list
57066866|NCT02177409|Telmisartan|telmisartan|mesh-list
57066867|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57066868|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57066869|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57066870|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066871|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57066872|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066873|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
57066874|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57066875|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57066876|NCT02170623|Pantoprazole|pantoprazole|mesh-list
57066877|NCT02170623|Dabigatran|dabigatran|mesh-list
57066878|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57066879|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57066880|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57066881|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066882|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066883|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
57066884|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57066885|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
57066886|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
57066887|NCT02170701|Dabigatran|dabigatran|mesh-list
57066888|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
57066889|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57066890|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
57066891|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066892|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066893|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
57066894|NCT02498756|Ipilimumab|ipilimumab|mesh-list
57066895|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57066896|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066897|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57066898|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066899|NCT03336632|Cyclosporine|cyclosporine|mesh-list
57066900|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
57066901|NCT03336632|Cyclosporins|cyclosporins|mesh-list
57066902|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57066903|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
57066904|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066905|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57066906|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57066907|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
57066908|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066909|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066910|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57066911|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066912|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
57066913|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066914|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
57066915|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57066916|NCT02498288|Isotretinoin|isotretinoin|mesh-list
57066917|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
57066918|NCT02756403|Azithromycin|azithromycin|mesh-list
57066919|NCT02756403|Metronidazole|metronidazole|mesh-list
57066920|NCT02756403|Doxycycline|doxycycline|mesh-list
57066921|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57066922|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066923|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57066924|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57066925|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
57066926|NCT02494466|Montelukast|montelukast|mesh-list
57066927|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57066928|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066929|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57066930|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
57066931|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57066932|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066933|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57066934|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57066935|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066936|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57066937|NCT02177487|Telmisartan|telmisartan|mesh-list
57066938|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
57066939|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57066940|NCT02177487|Diuretics|diuretics|mesh-ancestor
57066941|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
57066942|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066943|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57066944|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57066945|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066946|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57066947|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57066948|NCT02177643|Diacetylrhein|diacetylrhein|mesh-list
57066949|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57066950|NCT03340376|Doxorubicin|doxorubicin|mesh-list
57066951|NCT03340376|Atezolizumab|atezolizumab|mesh-list
57066952|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57066953|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066954|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57066955|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57066956|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066957|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066958|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
57066959|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57066960|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
57066961|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57066962|NCT02182167|Expectorants|expectorants|mesh-ancestor
57066963|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
57066964|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57066965|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
57066966|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066967|NCT02182167|Protective Agents|protective agents|mesh-ancestor
57066968|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066969|NCT02182167|Antidotes|antidotes|mesh-ancestor
57066970|NCT03336242|Cannabidiol|cannabidiol|mesh-list
57066971|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
57066972|NCT02182245|Paclitaxel|paclitaxel|mesh-list
57066973|NCT02182245|Carboplatin|carboplatin|mesh-list
57066974|NCT02182245|Nintedanib|nintedanib|mesh-list
57066975|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57066976|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57066977|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
57066978|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
57066979|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
57066980|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066981|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57066982|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57066983|NCT05233124|Aspirin|aspirin|mesh-list
57066984|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
57066985|NCT05233124|Clopidogrel|clopidogrel|mesh-list
57066986|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57066987|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57066988|NCT05233124|Analgesics|analgesics|mesh-ancestor
57066989|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
57066990|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748950|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
57066991|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57066992|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57066993|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57066994|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57066995|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57066996|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57066997|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57066998|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57066999|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067000|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
57067001|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57067002|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57067003|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57067004|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
57067005|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067006|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57067007|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
57067008|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57067009|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
57067010|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
57067011|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57067012|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57067013|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57067014|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
57067015|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067016|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57067017|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57067018|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067019|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
57067020|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57067021|NCT03339362|Bupivacaine|bupivacaine|mesh-list
57067022|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
57067023|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
57067024|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067025|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067026|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
57067027|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067028|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067029|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
57067030|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
57067031|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57067032|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
57067033|NCT03339362|Hormones|hormones|mesh-ancestor
57067034|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067035|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57067036|NCT03339362|Protective Agents|protective agents|mesh-ancestor
57067037|NCT02497820|Aspirin|aspirin|mesh-list
57067038|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57067039|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57067040|NCT02497820|Analgesics|analgesics|mesh-ancestor
57067041|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
57067042|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067043|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067044|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067045|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067046|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57067047|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57067048|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067049|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57067050|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57067051|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067052|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
57067053|NCT02497508|Nivolumab|nivolumab|mesh-list
57067054|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57067055|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067056|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57067057|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067058|NCT03338426|Atorvastatin|atorvastatin|mesh-list
57067059|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57067060|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57067061|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
57067062|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067063|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57067064|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57067065|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067066|NCT03338348|Azacitidine|azacitidine|mesh-list
57067067|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57067068|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
57067069|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067070|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067071|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067072|NCT03334838|Nifurtimox|nifurtimox|mesh-list
57067073|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57067074|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57067075|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57067076|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067077|NCT02497118|Vinorelbine|vinorelbine|mesh-list
57067078|NCT02497118|Endostatins|endostatins|mesh-list
57067079|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067080|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57067081|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
57067082|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
57067083|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
57067084|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067085|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57067086|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57067087|NCT02497118|Growth Substances|growth substances|mesh-ancestor
57067088|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067089|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
57067090|NCT02496962|Atorvastatin|atorvastatin|mesh-list
57067091|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57067092|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57067093|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
57067094|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067095|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57067096|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57067097|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067098|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
57067099|NCT03334136|Calcifediol|calcifediol|mesh-list
57067100|NCT03334136|Vitamins|vitamins|mesh-ancestor
57067101|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
57067102|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067103|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57067104|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57067105|NCT03120728|Etonogestrel|etonogestrel|mesh-list
57067106|NCT03120728|NuvaRing|nuvaring|mesh-list
57067107|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
57067108|NCT03120728|Estradiol|estradiol|mesh-list
57067109|NCT03120728|Estrogens|estrogens|mesh-ancestor
57067110|NCT03120728|Hormones|hormones|mesh-ancestor
57067111|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067112|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067113|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57067114|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57067115|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57067116|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57067117|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57067118|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
57067119|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067120|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067121|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067122|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57067123|NCT02496650|Analgesics|analgesics|mesh-ancestor
57067124|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
57067125|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067126|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57067127|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57067128|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57067129|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
57067130|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067131|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067132|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57067133|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
57067134|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067135|NCT03342170|Thrombin|thrombin|mesh-list
57067136|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
57067137|NCT03342170|Coagulants|coagulants|mesh-ancestor
57067138|NCT03333824|Midazolam|midazolam|mesh-list
57067139|NCT03333824|Granisetron|granisetron|mesh-list
57067140|NCT03333824|Caffeine|caffeine|mesh-list
57067141|NCT03333824|Omeprazole|omeprazole|mesh-list
57067142|NCT03333824|Adavosertib|adavosertib|mesh-list
57067143|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57067145|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067146|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067147|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57067148|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57067149|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57067150|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067151|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
57067152|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
57067153|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
57067154|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
57067155|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067156|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067157|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57067158|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57067159|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067160|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57067161|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57067162|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
57067163|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57067164|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57067165|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57067166|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
57067167|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
57067168|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067169|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57067170|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
57067171|NCT02496494|Tacrolimus|tacrolimus|mesh-list
57067172|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067173|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
57067174|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067175|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57067176|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067177|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067178|NCT03333278|Vitamins|vitamins|mesh-list
57067179|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
57067180|NCT03333278|Thiamine|thiamine|mesh-list
57067181|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
57067182|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57067183|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
57067184|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067185|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067186|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
57067187|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067188|NCT03333278|Protective Agents|protective agents|mesh-ancestor
57067189|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
57067190|NCT04847596|Ofatumumab|ofatumumab|mesh-list
57067191|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067192|NCT00706628|Nintedanib|nintedanib|mesh-list
57067193|NCT00706628|Afatinib|afatinib|mesh-list
57067194|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067195|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57067196|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067197|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067198|NCT05465330|Propofol|propofol|mesh-list
57067199|NCT05465330|Desflurane|desflurane|mesh-list
57067200|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067201|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067202|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067203|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067204|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
57067205|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
57067206|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57067207|NCT05463614|Propranolol|propranolol|mesh-list
57067208|NCT05463614|Propafenone|propafenone|mesh-list
57067209|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57067210|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57067211|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
57067212|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067213|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067214|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067215|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57067216|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57067217|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
57067218|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57067219|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57067220|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57067222|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57067223|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067224|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
57067225|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067226|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067227|NCT03332732|Metronidazole|metronidazole|mesh-list
57067228|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067229|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57067230|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57067231|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57067232|NCT02492360|Cisplatin|cisplatin|mesh-list
57067233|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067234|NCT02492282|Remifentanil|remifentanil|mesh-list
57067235|NCT02492282|Propofol|propofol|mesh-list
57067236|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067237|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067238|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067239|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067240|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
57067241|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
57067242|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57067243|NCT02492282|Narcotics|narcotics|mesh-ancestor
57067244|NCT02492282|Analgesics|analgesics|mesh-ancestor
57067245|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
57067246|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067247|NCT02492126|Citric Acid|citric acid|mesh-list
57067248|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
57067249|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
57067250|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57067251|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
57067252|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
57067253|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067254|NCT05464862|Lidocaine|lidocaine|mesh-list
57067255|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
57067256|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
57067257|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067258|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067259|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
57067260|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067261|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57067262|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57067263|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57067264|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57067265|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067266|NCT03324776|Insulin|insulin|mesh-list
57067267|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57067268|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57067269|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067270|NCT02561806|Ustekinumab|ustekinumab|mesh-list
57067271|NCT02561806|Ixekizumab|ixekizumab|mesh-list
57067272|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
57067273|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
57067274|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067275|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
57067276|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067277|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067278|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57067279|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
57067280|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067281|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067282|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57067283|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57067284|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
57067285|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
57067286|NCT03330860|Hormones|hormones|mesh-ancestor
57067287|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067288|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067289|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067290|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067291|NCT03324542|Ranibizumab|ranibizumab|mesh-list
57067292|NCT03324542|Aflibercept|aflibercept|mesh-list
57067293|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067294|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749252|NCT00506350|Vaccines|vaccines|mesh-list
57067295|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57067296|NCT03324542|Growth Substances|growth substances|mesh-ancestor
57067297|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067298|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
57067299|NCT03330782|Remifentanil|remifentanil|mesh-list
57067300|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57067301|NCT03330782|Narcotics|narcotics|mesh-ancestor
57067302|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067303|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067304|NCT03330782|Analgesics|analgesics|mesh-ancestor
57067305|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
57067306|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067307|NCT05506462|Ketamine|ketamine|mesh-list
57067308|NCT05506462|Analgesics|analgesics|mesh-ancestor
57067309|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
57067310|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067311|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067312|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57067313|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067314|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
57067315|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
57067316|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067317|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57067318|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57067319|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067320|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067321|NCT04542070|Rilpivirine|rilpivirine|mesh-list
57067322|NCT04542070|Cabotegravir|cabotegravir|mesh-list
57067323|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57067324|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57067325|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067326|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067327|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
57067328|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067329|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57067330|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57067331|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57067332|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57067333|NCT05501704|Tamoxifen|tamoxifen|mesh-list
57067334|NCT05501704|Anastrozole|anastrozole|mesh-list
57067335|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57067336|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
57067337|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067338|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067339|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57067340|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067341|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57067342|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57067343|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57067344|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57067345|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57067346|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067347|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067348|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
57067349|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57067350|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067351|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57067352|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067353|NCT02491268|Cilostazol|cilostazol|mesh-list
57067354|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57067355|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
57067356|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067357|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067358|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57067359|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
57067360|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57067361|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57067362|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067363|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57067364|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
57067365|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57067366|NCT02491268|Protective Agents|protective agents|mesh-ancestor
57067367|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57067368|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57067369|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067370|NCT03323684|Acetaminophen|acetaminophen|mesh-list
57067371|NCT03323684|Ketorolac|ketorolac|mesh-list
57067372|NCT03323684|Fentanyl|fentanyl|mesh-list
57067373|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57067374|NCT03323684|Narcotics|narcotics|mesh-ancestor
57067375|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067376|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067377|NCT03323684|Analgesics|analgesics|mesh-ancestor
57067378|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
57067379|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067380|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57067381|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067382|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
57067383|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
57067384|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57067385|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
57067386|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57067387|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067388|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067389|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57067390|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067391|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067392|NCT02182401|Tolbutamide|tolbutamide|mesh-list
57067393|NCT02182401|Midazolam|midazolam|mesh-list
57067394|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57067395|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067396|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067397|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067398|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57067399|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57067400|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57067401|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067402|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
57067403|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
57067404|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
57067405|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
57067406|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067407|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067408|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57067409|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57067410|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
57067411|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067412|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
57067413|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067414|NCT02177955|Midazolam|midazolam|mesh-list
57067415|NCT02177955|Diazepam|diazepam|mesh-list
57067416|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57067417|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067418|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067419|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067420|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57067421|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57067422|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57067423|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067424|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
57067425|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
57067426|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
57067427|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
57067428|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067429|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067430|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
57067431|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
57067432|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
57067433|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067434|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57067435|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57067436|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57067437|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
57067438|NCT03323528|Benzocaine|benzocaine|mesh-list
57067439|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
57067440|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
57067441|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067442|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067443|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
57067444|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067445|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57067446|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067448|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57067449|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
57067450|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067451|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067452|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57067453|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067454|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57067455|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57067456|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57067457|NCT03537807|Riluzole|riluzole|mesh-list
57067458|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
57067459|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57067460|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57067461|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067462|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067463|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067464|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57067465|NCT03537807|Protective Agents|protective agents|mesh-ancestor
57067466|NCT02182479|Fenoterol|fenoterol|mesh-list
57067467|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57067468|NCT02182479|Ipratropium|ipratropium|mesh-list
57067469|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57067470|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
57067471|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067472|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067473|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57067474|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
57067475|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
57067476|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
57067477|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57067478|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57067479|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57067480|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57067481|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
57067482|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067483|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067484|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57067485|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
57067486|NCT02560558|Abatacept|abatacept|mesh-list
57067487|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57067488|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067489|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067490|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067491|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
57067492|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067493|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067494|NCT03329456|Ropivacaine|ropivacaine|mesh-list
57067495|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
57067496|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
57067497|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067498|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067499|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
57067500|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067501|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57067502|NCT02491736|Ketoprofen|ketoprofen|mesh-list
57067503|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57067504|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57067505|NCT02491736|Analgesics|analgesics|mesh-ancestor
57067506|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
57067507|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067508|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067509|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067510|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067511|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57067512|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067513|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067514|NCT05501080|Spironolactone|spironolactone|mesh-list
57067515|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57067516|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
57067517|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067518|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067519|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57067520|NCT05501080|Diuretics|diuretics|mesh-ancestor
57067521|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
57067522|NCT02491970|Fluticasone|fluticasone|mesh-list
57067524|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
57067525|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57067526|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57067527|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067528|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57067529|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
57067530|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067531|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067532|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57067533|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
57067534|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
57067535|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57067536|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57067537|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57067538|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57067539|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
57067540|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067541|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067542|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
57067543|NCT02491970|Hormones|hormones|mesh-ancestor
57067544|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067545|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
57067546|NCT02182557|Ketotifen|ketotifen|mesh-list
57067547|NCT02182557|Epinastine|epinastine|mesh-list
57067548|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
57067549|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
57067550|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57067551|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
57067552|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
57067553|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067554|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067555|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067556|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57067557|NCT02182635|Oxitropium|oxitropium|mesh-list
57067558|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
57067559|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
57067560|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067561|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067562|NCT02182713|Bromides|bromides|mesh-list
57067563|NCT02182713|Albuterol|albuterol|mesh-list
57067564|NCT02182713|Ipratropium|ipratropium|mesh-list
57067565|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
57067566|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57067567|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
57067568|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067569|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067570|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57067571|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
57067572|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
57067573|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57067574|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57067575|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57067576|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57067577|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
57067578|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067579|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067580|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57067581|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
57067582|NCT03323372|Listerine|listerine|mesh-list
57067583|NCT03323372|Fluorides|fluorides|mesh-list
57067584|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
57067585|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
57067586|NCT03323372|Protective Agents|protective agents|mesh-ancestor
57067587|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067588|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57067589|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067590|NCT02180529|Methylphenidate|methylphenidate|mesh-list
57067591|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57067592|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067593|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57067594|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57067595|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57067596|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067597|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
57067598|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067599|NCT02182791|Nevirapine|nevirapine|mesh-list
57067600|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57067601|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57067602|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067603|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067604|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
57067605|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067606|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57067607|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57067608|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57067609|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57067610|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57067611|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
57067612|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067613|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57067614|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57067615|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067616|NCT02488538|Fluoxetine|fluoxetine|mesh-list
57067617|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
57067618|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
57067619|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
57067620|NCT02488538|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57067621|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57067622|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57067623|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067624|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067625|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
57067626|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067627|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57067628|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
57067629|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57067630|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57067631|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57067632|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067633|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57067634|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56749623|NCT00796796|Sirolimus|sirolimus|mesh-list
57067635|NCT02568046|Leucovorin|leucovorin|mesh-list
57067636|NCT02568046|Fluorouracil|fluorouracil|mesh-list
57067637|NCT02568046|Irinotecan|irinotecan|mesh-list
57067638|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
57067639|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067640|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57067641|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067642|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067643|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
57067644|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067645|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57067646|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57067647|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067648|NCT02568046|Antidotes|antidotes|mesh-ancestor
57067649|NCT02568046|Protective Agents|protective agents|mesh-ancestor
57067650|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
57067651|NCT02568046|Vitamins|vitamins|mesh-ancestor
57067652|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
57067653|NCT03536481|Ensartinib|ensartinib|mesh-list
57067654|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067655|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57067656|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067657|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067658|NCT02488616|Insulin|insulin|mesh-list
57067659|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57067660|NCT02488616|Hormones|hormones|mesh-list
57067661|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57067662|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067663|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067664|NCT02256423|Ibuprofen|ibuprofen|mesh-list
57067665|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57067666|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57067667|NCT02256423|Analgesics|analgesics|mesh-ancestor
57067668|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
57067669|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067670|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067671|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067672|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067673|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57067674|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067675|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067676|NCT03320486|Ketoconazole|ketoconazole|mesh-list
57067677|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
57067678|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067679|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57067680|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57067681|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067682|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067683|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57067684|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
57067685|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067686|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067687|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57067688|NCT02567656|Tenalisib|tenalisib|mesh-list
57067689|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
57067690|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067691|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067692|NCT02185833|Dirithromycin|dirithromycin|mesh-list
57067693|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57067694|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067695|NCT02180997|Tamsulosin|tamsulosin|mesh-list
57067696|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
57067697|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57067698|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57067699|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57067700|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
57067701|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067702|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067703|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067704|NCT02180997|Urological Agents|urological agents|mesh-ancestor
57067705|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57067706|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57067707|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
57067708|NCT02560012|Sirolimus|sirolimus|mesh-list
57067709|NCT02560012|Everolimus|everolimus|mesh-list
57067710|NCT02560012|Sorafenib|sorafenib|mesh-list
57067711|NCT02560012|Sunitinib|sunitinib|mesh-list
57067712|NCT02560012|Axitinib|axitinib|mesh-list
57067713|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067714|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067715|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
57067716|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067717|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57067718|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067719|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067720|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57067721|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57067722|NCT02560012|Growth Substances|growth substances|mesh-ancestor
57067723|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
57067724|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57067725|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067726|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57067727|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
57067728|NCT03320174|Tafenoquine|tafenoquine|mesh-list
57067729|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
57067730|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57067731|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57067732|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067733|NCT03328364|Docetaxel|docetaxel|mesh-list
57067734|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067735|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
57067736|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
57067737|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
57067738|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067739|NCT04515472|Hormones|hormones|mesh-list
57067740|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067741|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067742|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
57067743|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57067744|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
57067745|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57067746|NCT04514302|Antibodies|antibodies|mesh-list
57067747|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
57067748|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067749|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
57067750|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57067751|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067752|NCT03319784|Triamcinolone|triamcinolone|mesh-list
57067753|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57067754|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57067755|NCT03319784|Ketorolac|ketorolac|mesh-list
57067756|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57067757|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067758|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
57067759|NCT03319784|Hormones|hormones|mesh-ancestor
57067760|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067761|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067762|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067763|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
57067764|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067765|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067766|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57067767|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57067768|NCT03319784|Analgesics|analgesics|mesh-ancestor
57067769|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
57067770|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067771|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067772|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57067773|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57067774|NCT05505292|Lifitegrast|lifitegrast|mesh-list
57067775|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57067776|NCT03319706|Olmesartan|olmesartan|mesh-list
57067777|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
57067778|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57067779|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57067780|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57067781|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067782|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
57067783|NCT03322358|Promethazine|promethazine|mesh-list
57067784|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57067785|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067786|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067787|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067788|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
57067789|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
57067790|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
57067791|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067792|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
57067793|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
57067794|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57067795|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57067796|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
57067797|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
57067798|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067799|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067800|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57067801|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
57067802|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
57067803|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
57067805|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
57067806|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067807|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067808|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067809|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067810|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
57067811|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57067812|NCT05045170|Analgesics|analgesics|mesh-ancestor
57067813|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
57067814|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067815|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57067816|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57067817|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57067818|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
57067819|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067820|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067821|NCT05500690|Folic Acid|folic acid|mesh-list
57067822|NCT05500690|Hematinics|hematinics|mesh-ancestor
57067823|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
57067824|NCT05500690|Vitamins|vitamins|mesh-ancestor
57067825|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
57067826|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067827|NCT03322124|Octenidine|octenidine|mesh-list
57067828|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57067829|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57067830|NCT04442984|Leucovorin|leucovorin|mesh-list
57067831|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
57067832|NCT04442984|Irinotecan|irinotecan|mesh-list
57067833|NCT04442984|Fluorouracil|fluorouracil|mesh-list
57067834|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067835|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57067836|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57067837|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067838|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067839|NCT04442984|Antidotes|antidotes|mesh-ancestor
57067840|NCT04442984|Protective Agents|protective agents|mesh-ancestor
57067841|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067842|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
57067843|NCT04442984|Vitamins|vitamins|mesh-ancestor
57067844|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
57067845|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
57067846|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57067847|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067848|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
57067849|NCT03327506|Alprazolam|alprazolam|mesh-list
57067850|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067851|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067852|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067853|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57067854|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57067855|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57067856|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
57067857|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
57067858|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067859|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067860|NCT02487914|Lidocaine|lidocaine|mesh-list
57067861|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
57067862|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
57067863|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067864|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067865|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
57067866|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067867|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57067868|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57067869|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57067870|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57067871|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067872|NCT02487680|Chromium|chromium|mesh-list
57067873|NCT02487680|Picolinic acid|picolinic acid|mesh-list
57067874|NCT02487680|Trace Elements|trace elements|mesh-ancestor
57067875|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
57067876|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067877|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57067878|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
57067879|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
57067880|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067881|NCT03319550|Caseins|caseins|mesh-list
57067882|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
57067883|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
57067884|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067885|NCT04442906|Fentanyl|fentanyl|mesh-list
57067886|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
57067887|NCT04442906|Bupivacaine|bupivacaine|mesh-list
57067888|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
57067889|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
57067890|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067891|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067892|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
57067893|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067894|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067895|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57067896|NCT04442906|Analgesics|analgesics|mesh-ancestor
57067897|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57067898|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57067899|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57067900|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
57067901|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067902|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067903|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57067904|NCT04442906|Narcotics|narcotics|mesh-ancestor
57067905|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57067906|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067907|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
57067908|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
57067909|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
57067910|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067911|NCT03327350|Anticoagulants|anticoagulants|mesh-list
57067912|NCT04695340|Psyllium|psyllium|mesh-list
57067913|NCT04695340|Cathartics|cathartics|mesh-ancestor
57067914|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57067915|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
57067916|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57067917|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57067918|NCT03327272|Prednisolone|prednisolone|mesh-list
57067919|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
57067920|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57067921|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
57067922|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067923|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
57067924|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
57067925|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067926|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067927|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57067928|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
57067929|NCT03327272|Hormones|hormones|mesh-ancestor
57067930|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067931|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57067932|NCT03327272|Protective Agents|protective agents|mesh-ancestor
57067933|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57067934|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067935|NCT05508178|Vaccines|vaccines|mesh-list
57067936|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
57067937|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067938|NCT03327116|Methotrexate|methotrexate|mesh-list
57067939|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57067940|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
57067941|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57067942|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067943|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57067944|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
57067945|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067946|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067947|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
57067948|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57067949|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57067950|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067951|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
57067952|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067953|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57067954|NCT03326960|Propofol|propofol|mesh-list
57067955|NCT03326960|Sevoflurane|sevoflurane|mesh-list
57067956|NCT03326960|Desflurane|desflurane|mesh-list
57067957|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57067958|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067959|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067960|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067961|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
57067962|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
57067963|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57067964|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57067965|NCT03319238|Ketamine|ketamine|mesh-list
57067966|NCT03319238|Analgesics|analgesics|mesh-ancestor
57067967|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
57067968|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57067969|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067970|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57067971|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57067972|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
57067973|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
57067974|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57067975|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57067976|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57067977|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57067978|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067979|NCT03321890|Prednisone|prednisone|mesh-list
57067980|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
57067981|NCT03321890|Methotrexate|methotrexate|mesh-list
57067982|NCT03321890|Etoposide|etoposide|mesh-list
57067983|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57067984|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
57067985|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57067986|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57067987|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57067988|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
57067989|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57067990|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57067991|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57067992|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57067993|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
57067994|NCT03321890|Hormones|hormones|mesh-ancestor
57067995|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57067996|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57067997|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57067998|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
57067999|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57068000|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57068001|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
57068002|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
57068003|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068004|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57068005|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57068006|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57068007|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57068008|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57068009|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
57068010|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56750004|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
57068011|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57068012|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068014|NCT05464394|Coagulants|coagulants|mesh-ancestor
57068015|NCT05499598|Vitamin A|vitamin a|mesh-list
57068016|NCT05499598|Vitamins|vitamins|mesh-ancestor
57068017|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
57068018|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068019|NCT03321734|Caffeine|caffeine|mesh-list
57068020|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57068021|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068022|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57068023|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068024|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068025|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57068026|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57068027|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
57068028|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068029|NCT05504278|Carboplatin|carboplatin|mesh-list
57068030|NCT05504278|Pemetrexed|pemetrexed|mesh-list
57068031|NCT05504278|Cetuximab|cetuximab|mesh-list
57068032|NCT05504278|Cisplatin|cisplatin|mesh-list
57068033|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068034|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068035|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068036|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57068037|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57068038|NCT05504278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57068039|NCT04442750|Bupivacaine|bupivacaine|mesh-list
57068040|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
57068041|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
57068042|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068043|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068044|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
57068045|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068046|NCT02753127|Leucovorin|leucovorin|mesh-list
57068047|NCT02753127|Bevacizumab|bevacizumab|mesh-list
57068048|NCT02753127|Fluorouracil|fluorouracil|mesh-list
57068049|NCT02753127|Irinotecan|irinotecan|mesh-list
57068050|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57068051|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068052|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57068053|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57068054|NCT02753127|Growth Substances|growth substances|mesh-ancestor
57068055|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068056|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
57068057|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
57068058|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068059|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57068060|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57068061|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
57068062|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57068063|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57068064|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068065|NCT02753127|Antidotes|antidotes|mesh-ancestor
57068066|NCT02753127|Protective Agents|protective agents|mesh-ancestor
57068067|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
57068068|NCT02753127|Vitamins|vitamins|mesh-ancestor
57068069|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
57068070|NCT03326258|Nivolumab|nivolumab|mesh-list
57068071|NCT03326258|Ipilimumab|ipilimumab|mesh-list
57068072|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
57068073|NCT03326258|Antibodies|antibodies|mesh-list
57068074|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
57068075|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
57068076|NCT03326258|Immunotoxins|immunotoxins|mesh-list
57068077|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57068078|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
57068079|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068080|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57068081|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068082|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57068083|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068084|NCT03326102|Paclitaxel|paclitaxel|mesh-list
57068085|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57068086|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57068087|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068088|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
57068089|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
57068090|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
57068091|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068092|NCT02487212|Clobetasol|clobetasol|mesh-list
57068093|NCT02487212|Petrolatum|petrolatum|mesh-list
57068094|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068095|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
57068096|NCT02487212|Hormones|hormones|mesh-ancestor
57068097|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068098|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068099|NCT02487212|Emollients|emollients|mesh-ancestor
57068100|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
57068101|NCT04583488|Docetaxel|docetaxel|mesh-list
57068102|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068103|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
57068104|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
57068105|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
57068106|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068107|NCT04578886|Guanfacine|guanfacine|mesh-list
57068108|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57068109|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57068110|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57068111|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57068112|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
57068113|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068114|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068115|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068116|NCT03318536|Granisetron|granisetron|mesh-list
57068117|NCT03318536|Serotonin|serotonin|mesh-list
57068118|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
57068119|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
57068120|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068121|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068122|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068123|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57068124|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
57068125|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068126|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068127|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57068128|NCT03537027|Vitamin D|vitamin d|mesh-list
57068129|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
57068130|NCT03537027|Vitamins|vitamins|mesh-ancestor
57068131|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
57068132|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068133|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57068134|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57068135|NCT02183025|Meloxicam|meloxicam|mesh-list
57068136|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
57068137|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57068138|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57068139|NCT02183025|Analgesics|analgesics|mesh-ancestor
57068140|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
57068141|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068142|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068143|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068144|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068145|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57068146|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57068147|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068148|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068149|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
57068150|NCT04282174|Melphalan|melphalan|mesh-list
57068151|NCT04282174|Busulfan|busulfan|mesh-list
57068152|NCT04282174|Thiotepa|thiotepa|mesh-list
57068153|NCT04282174|Fludarabine|fludarabine|mesh-list
57068154|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57068155|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
57068156|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068157|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068158|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57068159|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
57068160|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068161|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068162|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57068163|NCT02181309|Meloxicam|meloxicam|mesh-list
57068164|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57068165|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57068167|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
57068168|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068169|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068170|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068171|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068172|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57068173|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57068174|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068175|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068176|NCT02186145|Metronidazole|metronidazole|mesh-list
57068177|NCT02186145|Nystatin|nystatin|mesh-list
57068178|NCT02186145|Dexamethasone|dexamethasone|mesh-list
57068179|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068180|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
57068181|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
57068182|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068183|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068184|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068185|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
57068186|NCT02186145|Hormones|hormones|mesh-ancestor
57068187|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068188|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57068189|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068190|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068191|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57068192|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57068193|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57068194|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
57068195|NCT02186145|Ionophores|ionophores|mesh-ancestor
57068196|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57068197|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068198|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
57068199|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57068200|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
57068201|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57068202|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068203|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57068204|NCT02183103|Meloxicam|meloxicam|mesh-list
57068205|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57068206|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57068207|NCT02183103|Analgesics|analgesics|mesh-ancestor
57068208|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
57068209|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068210|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068211|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068212|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068213|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57068214|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57068215|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068216|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068217|NCT03325790|Ebselen|ebselen|mesh-list
57068218|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57068219|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57068220|NCT03325790|Analgesics|analgesics|mesh-ancestor
57068221|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
57068222|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068223|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068224|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068225|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068226|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57068227|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068228|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
57068229|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068230|NCT03325790|Protective Agents|protective agents|mesh-ancestor
57068231|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57068232|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068233|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57068234|NCT02181543|Clonidine|clonidine|mesh-list
57068235|NCT02181543|Analgesics|analgesics|mesh-ancestor
57068236|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
57068237|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068238|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068239|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57068240|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
57068241|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
57068242|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57068243|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57068244|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57068245|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
57068246|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068247|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068248|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
57068249|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57068250|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068251|NCT02490176|Liraglutide|liraglutide|mesh-list
57068252|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57068253|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068254|NCT02490176|Incretins|incretins|mesh-ancestor
57068255|NCT02490176|Hormones|hormones|mesh-ancestor
57068256|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068257|NCT02183181|Meloxicam|meloxicam|mesh-list
57068258|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57068259|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57068260|NCT02183181|Analgesics|analgesics|mesh-ancestor
57068261|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
57068262|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068263|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068264|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068265|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068266|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57068267|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57068268|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068269|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068270|NCT02490098|Insulin|insulin|mesh-list
57068271|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57068272|NCT02490098|Glucagon|glucagon|mesh-list
57068273|NCT02490098|Hormones|hormones|mesh-list
57068274|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57068275|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068276|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068277|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068278|NCT02486822|Oxytocin|oxytocin|mesh-list
57068279|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
57068280|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57068281|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068282|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57068283|NCT02186457|Polymyxins|polymyxins|mesh-list
57068284|NCT02186457|Polymyxin B|polymyxin b|mesh-list
57068285|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068286|NCT02186535|Vitamin D|vitamin d|mesh-list
57068287|NCT02186535|Calcium|calcium|mesh-list
57068288|NCT02186535|Vitamins|vitamins|mesh-ancestor
57068289|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
57068290|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068291|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57068292|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57068293|NCT03325400|Fluorides|fluorides|mesh-list
57068294|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
57068295|NCT03325400|Protective Agents|protective agents|mesh-ancestor
57068296|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068297|NCT02181933|Lamivudine|lamivudine|mesh-list
57068298|NCT02181933|Zidovudine|zidovudine|mesh-list
57068299|NCT02181933|Nevirapine|nevirapine|mesh-list
57068300|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57068301|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57068302|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068303|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068304|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
57068305|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068306|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57068307|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57068308|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
57068309|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57068310|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57068311|NCT02183337|Pioglitazone|pioglitazone|mesh-list
57068312|NCT02183337|Linagliptin|linagliptin|mesh-list
57068313|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57068314|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750300|NCT00978159|Famotidine|famotidine|mesh-list
57068315|NCT02183337|Incretins|incretins|mesh-ancestor
57068316|NCT02183337|Hormones|hormones|mesh-ancestor
57068317|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068318|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57068319|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
57068320|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068321|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068322|NCT02489786|Digoxin|digoxin|mesh-list
57068323|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57068324|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57068325|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068326|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068327|NCT02489786|Protective Agents|protective agents|mesh-ancestor
57068328|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068329|NCT02489864|Terlipressin|terlipressin|mesh-list
57068330|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57068331|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57068332|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57068333|NCT02182011|Tenecteplase|tenecteplase|mesh-list
57068334|NCT02182011|Streptokinase|streptokinase|mesh-list
57068335|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57068336|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57068337|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068338|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57068339|NCT02486744|Hormones|hormones|mesh-ancestor
57068340|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068341|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068342|NCT02186769|Risperidone|risperidone|mesh-list
57068343|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57068344|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
57068345|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068346|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068347|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068348|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57068349|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57068350|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068351|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57068352|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57068353|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
57068354|NCT02486432|Levodopa|levodopa|mesh-list
57068355|NCT02486432|Carbidopa|carbidopa|mesh-list
57068356|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57068357|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57068358|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57068359|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
57068360|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068361|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068362|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068363|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57068364|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068365|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57068366|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
57068367|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
57068368|NCT02489240|Vitamin D|vitamin d|mesh-list
57068369|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
57068370|NCT02489240|Vitamins|vitamins|mesh-ancestor
57068371|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
57068372|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068373|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57068374|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57068375|NCT02183415|Linagliptin|linagliptin|mesh-list
57068376|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57068377|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068378|NCT02183415|Incretins|incretins|mesh-ancestor
57068379|NCT02183415|Hormones|hormones|mesh-ancestor
57068380|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068381|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57068382|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
57068383|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068384|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068385|NCT02486510|Maraviroc|maraviroc|mesh-list
57068386|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57068387|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57068388|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068389|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57068390|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57068391|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
57068392|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068393|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57068394|NCT04493528|Lidocaine|lidocaine|mesh-list
57068395|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
57068396|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
57068397|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068398|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068399|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
57068400|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068401|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57068402|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57068403|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57068404|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57068405|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068406|NCT02183493|Linagliptin|linagliptin|mesh-list
57068407|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57068408|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068409|NCT02183493|Incretins|incretins|mesh-ancestor
57068410|NCT02183493|Hormones|hormones|mesh-ancestor
57068411|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068412|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57068413|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
57068414|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068415|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068416|NCT02187081|Sorafenib|sorafenib|mesh-list
57068417|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068418|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57068419|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068420|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068421|NCT02485106|Rifaximin|rifaximin|mesh-list
57068422|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
57068423|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57068424|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068425|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068426|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57068427|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068428|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068429|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57068430|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57068431|NCT02485106|Protective Agents|protective agents|mesh-ancestor
57068432|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068433|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
57068434|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57068435|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
57068436|NCT02485028|Mirodenafil|mirodenafil|mesh-list
57068437|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57068438|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57068439|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068440|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068441|NCT02183571|Metformin|metformin|mesh-list
57068442|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57068443|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068444|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57068445|NCT03318146|Latanoprost|latanoprost|mesh-list
57068446|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57068447|NCT02183649|Carbetapentane|carbetapentane|mesh-list
57068448|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
57068449|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
57068450|NCT02187315|Cisplatin|cisplatin|mesh-list
57068451|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068452|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
57068453|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
57068454|NCT02256735|Ritobegron|ritobegron|mesh-list
57068455|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57068456|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068457|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57068458|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57068459|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068460|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068461|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068462|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068463|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
57068464|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
57068465|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068466|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
57068467|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57068468|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57068469|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57068470|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
57068471|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068472|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
57068473|NCT02183805|Carboplatin|carboplatin|mesh-list
57068474|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57068475|NCT02183805|Paclitaxel|paclitaxel|mesh-list
57068476|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57068477|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
57068478|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068479|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068480|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57068481|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
57068482|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068483|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068484|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57068485|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57068486|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
57068487|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
57068488|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
57068489|NCT03316352|Bupivacaine|bupivacaine|mesh-list
57068490|NCT03316352|Anesthetics|anesthetics|mesh-list
57068491|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
57068492|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068493|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068494|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
57068495|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068496|NCT02187705|Telmisartan|telmisartan|mesh-list
57068497|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57068498|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57068499|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57068500|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068501|NCT03317912|Lidocaine|lidocaine|mesh-list
57068502|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
57068503|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
57068504|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068505|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068506|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
57068507|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068508|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57068509|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57068510|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57068511|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57068512|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068513|NCT03321110|Ubiquinone|ubiquinone|mesh-list
57068514|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
57068515|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
57068516|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068517|NCT03321110|Vitamins|vitamins|mesh-ancestor
57068518|NCT03317600|Lidocaine|lidocaine|mesh-list
57068519|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
57068520|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
57068521|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068522|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068523|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
57068524|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068525|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56898700|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57068526|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57068527|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57068528|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57068529|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068530|NCT02184117|Adenosine|adenosine|mesh-list
57068531|NCT02184117|Analgesics|analgesics|mesh-ancestor
57068532|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
57068533|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068534|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068535|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57068536|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
57068537|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56750533|NCT00978549|Docetaxel|docetaxel|mesh-list
57068538|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
57068539|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
57068540|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068541|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068542|NCT02184273|Dipyrone|dipyrone|mesh-list
57068543|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57068544|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57068545|NCT02184273|Analgesics|analgesics|mesh-ancestor
57068546|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
57068547|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068548|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068549|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068550|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068551|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
57068552|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
57068553|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068554|NCT02188173|Dexamethasone|dexamethasone|mesh-list
57068555|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068556|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
57068557|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
57068558|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068559|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068560|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068561|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
57068562|NCT02188173|Hormones|hormones|mesh-ancestor
57068563|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068564|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57068565|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068566|NCT02184351|Clotrimazole|clotrimazole|mesh-list
57068567|NCT02184351|Miconazole|miconazole|mesh-list
57068568|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57068569|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068570|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
57068571|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57068572|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57068573|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068574|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068575|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57068576|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
57068577|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068578|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068579|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57068580|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57068581|NCT02184429|PF-06669571|pf-06669571|mesh-list
57068582|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
57068583|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
57068584|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068585|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068586|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068587|NCT02484170|Mannitol|mannitol|mesh-list
57068588|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57068589|NCT02484170|Diuretics|diuretics|mesh-ancestor
57068590|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
57068591|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068592|NCT02188407|Propofol|propofol|mesh-list
57068593|NCT02188407|Sevoflurane|sevoflurane|mesh-list
57068594|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57068595|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068596|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068597|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57068598|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
57068599|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
57068600|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57068601|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57068602|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
57068603|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57068604|NCT03317210|Hematinics|hematinics|mesh-ancestor
57068605|NCT02488694|Pemetrexed|pemetrexed|mesh-list
57068606|NCT02488694|Afatinib|afatinib|mesh-list
57068607|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068608|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068609|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068610|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57068611|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57068612|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57068613|NCT03316898|Memantine|memantine|mesh-list
57068614|NCT03316898|Donepezil|donepezil|mesh-list
57068615|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57068616|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068617|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068618|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
57068619|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068620|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068621|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
57068622|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57068623|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57068624|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
57068625|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57068626|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57068627|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
57068628|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
57068629|NCT02188953|Calcium|calcium|mesh-list
57068630|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57068631|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068632|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57068633|NCT02188953|Antacids|antacids|mesh-ancestor
57068634|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068635|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068636|NCT02184819|Riboflavin|riboflavin|mesh-list
57068637|NCT02184819|Simendan|simendan|mesh-list
57068638|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
57068639|NCT02184819|Vitamins|vitamins|mesh-ancestor
57068640|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
57068641|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068642|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57068643|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
57068644|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57068645|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
57068646|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57068647|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57068648|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068649|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068650|NCT02184819|Protective Agents|protective agents|mesh-ancestor
57068651|NCT05714306|Cyclophosphamide|cyclophosphamide|mesh-list
57068652|NCT05714306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57068653|NCT05714306|Immunologic Factors|immunologic factors|mesh-ancestor
57068654|NCT05714306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068655|NCT05714306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068656|NCT05714306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57068657|NCT05714306|Alkylating Agents|alkylating agents|mesh-ancestor
57068658|NCT05714306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068659|NCT05714306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068660|NCT05714306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57068661|NCT02256813|Vitamin K|vitamin k|mesh-list
57068662|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
57068663|NCT02256813|Midazolam|midazolam|mesh-list
57068664|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
57068665|NCT02256813|Caffeine|caffeine|mesh-list
57068666|NCT02256813|Omeprazole|omeprazole|mesh-list
57068667|NCT02256813|Warfarin|warfarin|mesh-list
57068668|NCT02256813|Vitamins|vitamins|mesh-ancestor
57068669|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
57068670|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068671|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57068672|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56898701|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57068673|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068674|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57068675|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57068676|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57068677|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57068678|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
57068679|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
57068680|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
57068681|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
57068682|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068683|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068684|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
57068685|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57068686|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57068687|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068688|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56750677|NCT00655850|Gemcitabine|gemcitabine|mesh-list
57068689|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57068690|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
57068691|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57068692|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068693|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57068694|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57068695|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57068696|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
57068697|NCT02256813|Coagulants|coagulants|mesh-ancestor
57068698|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
57068699|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
57068700|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57068701|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57068702|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
57068703|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
57068704|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57068705|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57068706|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
57068707|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
57068708|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57068709|NCT02483624|Protective Agents|protective agents|mesh-ancestor
57068710|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068711|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068712|NCT02184897|Lenograstim|lenograstim|mesh-list
57068713|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57068714|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
57068715|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068716|NCT02184975|Hemostatics|hemostatics|mesh-list
57068717|NCT02184975|Coagulants|coagulants|mesh-ancestor
57068718|NCT02189343|Thalidomide|thalidomide|mesh-list
57068719|NCT02189343|Dexamethasone|dexamethasone|mesh-list
57068720|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
57068721|NCT02189343|Pomalidomide|pomalidomide|mesh-list
57068722|NCT02189343|Ricolinostat|ricolinostat|mesh-list
57068723|NCT02189343|BB 1101|bb 1101|mesh-list
57068724|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068725|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
57068726|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
57068727|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068728|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068729|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068730|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
57068731|NCT02189343|Hormones|hormones|mesh-ancestor
57068732|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068733|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57068734|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068735|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
57068736|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068737|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068738|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
57068739|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57068740|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57068741|NCT02189343|Growth Substances|growth substances|mesh-ancestor
57068742|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
57068743|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57068744|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
57068745|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57068746|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068747|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57068748|NCT03535701|Paclitaxel|paclitaxel|mesh-list
57068749|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57068750|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57068751|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068752|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
57068753|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
57068754|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
57068755|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068756|NCT02486276|Cilostazol|cilostazol|mesh-list
57068757|NCT02486276|Sumatriptan|sumatriptan|mesh-list
57068758|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57068759|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
57068760|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068761|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068762|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57068763|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
57068764|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57068765|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57068766|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068767|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57068768|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
57068769|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57068770|NCT02486276|Protective Agents|protective agents|mesh-ancestor
57068771|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57068772|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57068773|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068774|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57068775|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57068776|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57068777|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
57068778|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068779|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
57068780|NCT02189577|Bromides|bromides|mesh-list
57068781|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
57068782|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57068783|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57068784|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57068785|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
57068786|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068787|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068788|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068789|NCT05713994|Bevacizumab|bevacizumab|mesh-list
57068790|NCT05713994|Sorafenib|sorafenib|mesh-list
57068791|NCT05713994|Atezolizumab|atezolizumab|mesh-list
57068792|NCT05713994|Apatinib|apatinib|mesh-list
57068793|NCT05713994|Lenvatinib|lenvatinib|mesh-list
57068794|NCT05713994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57068795|NCT05713994|Antibodies|antibodies|mesh-list
57068796|NCT05713994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57068797|NCT05713994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57068798|NCT05713994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068799|NCT05713994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57068800|NCT05713994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57068801|NCT05713994|Growth Substances|growth substances|mesh-ancestor
57068802|NCT05713994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068803|NCT05713994|Growth Inhibitors|growth inhibitors|mesh-ancestor
57068804|NCT05713994|Immunologic Factors|immunologic factors|mesh-ancestor
57068805|NCT05713994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57068806|NCT05713994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068807|NCT05713994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068808|NCT02189655|Bupivacaine|bupivacaine|mesh-list
57068809|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
57068810|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
57068811|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068812|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068813|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
57068814|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068815|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
57068816|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57068817|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57068818|NCT02193633|Paclitaxel|paclitaxel|mesh-list
57068819|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57068820|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57068821|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068822|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
57068823|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
57068824|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
57068825|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068826|NCT03315338|Prednisone|prednisone|mesh-list
57068827|NCT03315338|Cortisone|cortisone|mesh-list
57068828|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068829|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
57068830|NCT03315338|Hormones|hormones|mesh-ancestor
57068831|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068832|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068833|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57068834|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068835|NCT05713838|Durvalumab|durvalumab|mesh-list
57068836|NCT05713838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57068837|NCT05713838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068838|NCT02483156|Ribavirin|ribavirin|mesh-list
57068839|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
57068840|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
57068841|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068842|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
57068843|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068844|NCT00706004|Lubiprostone|lubiprostone|mesh-list
57068845|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57068846|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57068847|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068848|NCT05713760|Tirbanibulin|tirbanibulin|mesh-list
57068849|NCT05713760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068850|NCT05713760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068851|NCT02485340|Isosorbide|isosorbide|mesh-list
57068852|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57068853|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57068854|NCT02485340|Sumatriptan|sumatriptan|mesh-list
57068855|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57068856|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57068857|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57068858|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
57068859|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068860|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068861|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068862|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57068863|NCT02485340|Diuretics|diuretics|mesh-ancestor
57068864|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
57068865|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
57068866|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57068867|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
57068868|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57068869|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
57068870|NCT02485262|Simeprevir|simeprevir|mesh-list
57068871|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
57068872|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068873|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
57068874|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57068875|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068876|NCT02479490|Prednisone|prednisone|mesh-list
57068877|NCT02479490|Everolimus|everolimus|mesh-list
57068878|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068879|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
57068880|NCT02479490|Hormones|hormones|mesh-ancestor
57068881|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068882|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068883|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57068884|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068885|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57068886|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
57068887|NCT02479256|Tamoxifen|tamoxifen|mesh-list
57068888|NCT02479256|Citric Acid|citric acid|mesh-list
57068889|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
57068890|NCT02479256|Clomiphene|clomiphene|mesh-list
57068891|NCT02479256|Enclomiphene|enclomiphene|mesh-list
57068892|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
57068893|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
57068894|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57068895|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
57068896|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
57068897|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068898|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57068899|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
57068900|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068901|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068902|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57068903|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068904|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57068905|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57068906|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57068907|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57068908|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
57068909|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57068910|NCT02482766|Poractant alfa|poractant alfa|mesh-list
57068911|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
57068912|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
57068913|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
57068914|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
57068915|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068916|NCT02479178|Docetaxel|docetaxel|mesh-list
57068917|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068918|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
57068919|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
57068920|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
57068921|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068923|NCT03314792|Tapentadol|tapentadol|mesh-list
57068924|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57068925|NCT03314792|Narcotics|narcotics|mesh-ancestor
57068926|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57068927|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068928|NCT03314792|Analgesics|analgesics|mesh-ancestor
57068929|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
57068930|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068931|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57068932|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57068933|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57068934|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068935|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
57068936|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57068937|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
57068938|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57068939|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
57068940|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57068941|NCT02476526|Expectorants|expectorants|mesh-ancestor
57068942|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
57068943|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57068944|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
57068945|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57068946|NCT02476526|Protective Agents|protective agents|mesh-ancestor
57068947|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068948|NCT02476526|Antidotes|antidotes|mesh-ancestor
57068949|NCT02479022|Insulin|insulin|mesh-list
57068950|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57068951|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
57068952|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57068953|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068954|NCT03314636|Dexamethasone|dexamethasone|mesh-list
57068955|NCT03314636|Lenalidomide|lenalidomide|mesh-list
57068956|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57068957|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
57068958|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
57068959|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57068960|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57068961|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57068962|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
57068963|NCT03314636|Hormones|hormones|mesh-ancestor
57068964|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57068965|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57068966|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57068967|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
57068968|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56898713|NCT01187589|Albuterol|albuterol|mesh-list
57068969|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57068970|NCT03314636|Growth Substances|growth substances|mesh-ancestor
57068971|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
57068972|NCT02476760|Insulin|insulin|mesh-list
57068973|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57068974|NCT02476760|Metformin|metformin|mesh-list
57068975|NCT02476760|Pioglitazone|pioglitazone|mesh-list
57068976|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57068977|NCT02476760|Liraglutide|liraglutide|mesh-list
57068978|NCT02476760|Exenatide|exenatide|mesh-list
57068979|NCT02476760|Glimepiride|glimepiride|mesh-list
57068980|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
57068981|NCT02476760|Vildagliptin|vildagliptin|mesh-list
57068982|NCT02476760|Saxagliptin|saxagliptin|mesh-list
57068983|NCT02476760|Acarbose|acarbose|mesh-list
57068984|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57068985|NCT02476760|Repaglinide|repaglinide|mesh-list
57068986|NCT02476760|Gliclazide|gliclazide|mesh-list
57068987|NCT02476760|Glipizide|glipizide|mesh-list
57068988|NCT02476760|Biguanides|biguanides|mesh-list
57068989|NCT02476760|Tolbutamide|tolbutamide|mesh-list
57068990|NCT02476760|Voglibose|voglibose|mesh-list
57068991|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
57068992|NCT02476760|Nateglinide|nateglinide|mesh-list
57068993|NCT02476760|Miglitol|miglitol|mesh-list
57068994|NCT02476760|Meglitinide|meglitinide|mesh-list
57068995|NCT02476760|Troglitazone|troglitazone|mesh-list
57068996|NCT02476760|Acetohexamide|acetohexamide|mesh-list
57068997|NCT02476760|Phenformin|phenformin|mesh-list
57068998|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
57068999|NCT02476760|Buformin|buformin|mesh-list
57069000|NCT02476760|Glibornuride|glibornuride|mesh-list
57069001|NCT02476760|Tolazamide|tolazamide|mesh-list
57069002|NCT02476760|Carbutamide|carbutamide|mesh-list
57069003|NCT02476760|Gliquidone|gliquidone|mesh-list
57069004|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57069005|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
57069006|NCT02476760|Incretins|incretins|mesh-list
57069007|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069008|NCT02476760|Hormones|hormones|mesh-ancestor
57069009|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57069010|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
57069011|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069012|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069013|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57069014|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57069015|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069016|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
57069017|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
57069018|NCT05460338|Vitamin D|vitamin d|mesh-list
57069019|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57069020|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069021|NCT05460338|Vitamins|vitamins|mesh-ancestor
57069022|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
57069023|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57069024|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57069025|NCT02476136|Fluoxetine|fluoxetine|mesh-list
57069026|NCT02476136|Paroxetine|paroxetine|mesh-list
57069027|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57069028|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57069029|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57069030|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57069031|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069032|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069033|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069034|NCT02476136|Analgesics|analgesics|mesh-ancestor
57069035|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
57069036|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069037|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
57069038|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57069039|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
57069040|NCT02476136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57069041|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
57069042|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57069043|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57069044|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57069045|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069046|NCT05437094|Itraconazole|itraconazole|mesh-list
57069047|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
57069048|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069049|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57069050|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57069051|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069052|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069053|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57069054|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
57069055|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57069056|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069057|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57069058|NCT05413772|Temocillin|temocillin|mesh-list
57069059|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57069060|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069061|NCT05713292|Pirfenidone|pirfenidone|mesh-list
57069062|NCT05713292|Analgesics|analgesics|mesh-ancestor
57069063|NCT05713292|Sensory System Agents|sensory system agents|mesh-ancestor
57069064|NCT05713292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069065|NCT05713292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069066|NCT05713292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57069067|NCT05713292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069068|NCT05713292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069069|NCT05713292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069070|NCT05713292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069071|NCT02478710|Vancomycin|vancomycin|mesh-list
57069072|NCT02478710|Tobramycin|tobramycin|mesh-list
57069073|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57069074|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069075|NCT02475824|Midazolam|midazolam|mesh-list
57069076|NCT02475824|Meperidine|meperidine|mesh-list
57069077|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
57069078|NCT02475824|Propofol|propofol|mesh-list
57069079|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57069080|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069081|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069082|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57069083|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
57069084|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
57069085|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069086|NCT02475824|Analgesics|analgesics|mesh-ancestor
57069087|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
57069088|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069089|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57069090|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57069091|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57069092|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
57069093|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069094|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069095|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57069096|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57069097|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57069098|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57069099|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
57069100|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
57069101|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57069102|NCT02475824|Narcotics|narcotics|mesh-ancestor
57069103|NCT02478242|Nafamostat|nafamostat|mesh-list
57069104|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57069105|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069106|NCT02478242|Analgesics|analgesics|mesh-ancestor
57069107|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
57069108|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069109|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069110|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069111|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069112|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
57069113|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
57069114|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069115|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069116|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57069117|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57069118|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57069119|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069120|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
57069121|NCT02475746|Itraconazole|itraconazole|mesh-list
57069122|NCT02475746|PF-06372865|pf-06372865|mesh-list
57069123|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
57069124|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069125|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57069126|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57069127|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069128|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069129|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57069130|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
57069131|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57069132|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069133|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57069134|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
57069135|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
57069136|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069137|NCT05715164|Nicotine|nicotine|mesh-list
57069138|NCT05715164|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57069139|NCT05715164|Autonomic Agents|autonomic agents|mesh-ancestor
57069140|NCT05715164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069141|NCT05715164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069142|NCT05715164|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57069143|NCT05715164|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57069144|NCT05715164|Cholinergic Agents|cholinergic agents|mesh-ancestor
57069145|NCT05715164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069146|NCT05715164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069147|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
57069148|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57069149|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
57069150|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57069151|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751125|NCT00810446|Rifabutin|rifabutin|mesh-list
57069152|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57069153|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57069154|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57069155|NCT02480894|Maraviroc|maraviroc|mesh-list
57069156|NCT02480894|Fostemsavir|fostemsavir|mesh-list
57069157|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57069158|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57069159|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069160|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57069161|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57069162|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
57069163|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069164|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57069165|NCT02474654|Ketorolac|ketorolac|mesh-list
57069166|NCT02474654|Epinephrine|epinephrine|mesh-list
57069167|NCT02474654|Racepinephrine|racepinephrine|mesh-list
57069168|NCT02474654|Fentanyl|fentanyl|mesh-list
57069169|NCT02474654|Bupivacaine|bupivacaine|mesh-list
57069170|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
57069171|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
57069172|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
57069173|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069174|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069175|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
57069176|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069177|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57069178|NCT02474654|Narcotics|narcotics|mesh-ancestor
57069179|NCT02474654|Analgesics|analgesics|mesh-ancestor
57069180|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57069181|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57069182|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
57069183|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57069184|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57069185|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
57069186|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069187|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069188|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57069189|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57069190|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
57069191|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57069192|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
57069193|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
57069194|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
57069195|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57069196|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57069197|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069198|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069199|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069200|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57069201|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069202|NCT02477852|Rifampin|rifampin|mesh-list
57069203|NCT02477852|Isoniazid|isoniazid|mesh-list
57069204|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
57069205|NCT02477852|Ethambutol|ethambutol|mesh-list
57069206|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57069207|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
57069208|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57069209|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069210|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
57069211|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57069212|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069213|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069214|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57069215|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57069216|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57069217|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57069218|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57069219|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57069220|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57069221|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57069222|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
57069223|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57069224|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57069225|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57069226|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57069227|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069228|NCT02725268|Paclitaxel|paclitaxel|mesh-list
57069229|NCT02725268|Serabelisib|serabelisib|mesh-list
57069230|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57069231|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069232|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
57069233|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
57069234|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
57069235|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069236|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069237|NCT05038592|Decitabine|decitabine|mesh-list
57069238|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57069239|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
57069240|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069241|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069242|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069243|NCT04977986|Cannabidiol|cannabidiol|mesh-list
57069244|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
57069245|NCT00705536|Insulin|insulin|mesh-list
57069246|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57069247|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
57069248|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57069249|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069250|NCT02724878|Bevacizumab|bevacizumab|mesh-list
57069251|NCT02724878|Atezolizumab|atezolizumab|mesh-list
57069252|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57069253|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069254|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57069255|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57069256|NCT02724878|Growth Substances|growth substances|mesh-ancestor
57069257|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069258|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
57069259|NCT02474420|Amlodipine|amlodipine|mesh-list
57069260|NCT02474420|Deferasirox|deferasirox|mesh-list
57069261|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57069262|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57069263|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57069264|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069265|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57069266|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069267|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
57069268|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57069269|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
57069270|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
57069271|NCT02474186|Paclitaxel|paclitaxel|mesh-list
57069272|NCT02474186|Docetaxel|docetaxel|mesh-list
57069273|NCT02474186|Capecitabine|capecitabine|mesh-list
57069274|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57069275|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069276|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
57069277|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
57069278|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
57069279|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069280|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57069281|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
57069282|NCT02477306|Rabeprazole|rabeprazole|mesh-list
57069283|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57069284|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57069285|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57069286|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069287|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069288|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
57069289|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57069290|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069291|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57069292|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
57069293|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57069294|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069295|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069296|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069297|NCT04862468|Dexamethasone|dexamethasone|mesh-list
57069298|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069299|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
57069300|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
57069301|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069302|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069303|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57069305|NCT04862468|Hormones|hormones|mesh-ancestor
57069306|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57069307|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57069308|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069309|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
57069310|NCT02472626|Cytarabine|cytarabine|mesh-list
57069311|NCT02472626|Daunorubicin|daunorubicin|mesh-list
57069312|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57069313|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
57069314|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069315|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069316|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
57069317|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069318|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069319|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
57069320|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069321|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57069322|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57069323|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57069324|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069325|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
57069326|NCT02472626|Protective Agents|protective agents|mesh-ancestor
57069327|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
57069328|NCT02472626|Vitamins|vitamins|mesh-ancestor
57069329|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
57069330|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
57069331|NCT02472392|Melphalan|melphalan|mesh-list
57069332|NCT02472392|Busulfan|busulfan|mesh-list
57069333|NCT02472392|Fludarabine|fludarabine|mesh-list
57069334|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
57069335|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57069336|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069337|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
57069338|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069339|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069340|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57069341|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
57069342|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069343|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069344|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57069345|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
57069346|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57069347|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069348|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
57069349|NCT02472080|Gemcitabine|gemcitabine|mesh-list
57069350|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
57069351|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57069352|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
57069353|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069354|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069355|NCT02472080|Antiviral Agents|antiviral agents|mesh-ancestor
57069356|NCT02472080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069357|NCT02472080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069358|NCT02472080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069359|NCT02472080|Immunologic Factors|immunologic factors|mesh-ancestor
57069360|NCT02472080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069361|NCT02473562|Varenicline|varenicline|mesh-list
57069362|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57069363|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57069364|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
57069365|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069366|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069367|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069368|NCT02724020|Everolimus|everolimus|mesh-list
57069369|NCT02724020|Serabelisib|serabelisib|mesh-list
57069370|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069371|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069372|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
57069373|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069374|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069375|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069376|NCT02816736|Valsartan|valsartan|mesh-list
57069377|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57069378|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57069379|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57069380|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57069381|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069382|NCT02477072|Heparin|heparin|mesh-list
57069383|NCT02477072|Calcium heparin|calcium heparin|mesh-list
57069384|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
57069385|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57069386|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57069387|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069388|NCT05103410|Aripiprazole|aripiprazole|mesh-list
57069389|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
57069390|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57069391|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57069392|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57069393|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069394|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069395|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
57069396|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
57069397|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069398|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069399|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57069400|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57069401|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
57069402|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57069403|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57069404|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57069405|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57069406|NCT02472236|Digoxin|digoxin|mesh-list
57069407|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57069408|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57069409|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069410|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069411|NCT02472236|Protective Agents|protective agents|mesh-ancestor
57069412|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069413|NCT03108872|Anticoagulants|anticoagulants|mesh-list
57069414|NCT02194491|AS2471907|as2471907|mesh-list
57069415|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57069416|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069417|NCT03487770|Aripiprazole|aripiprazole|mesh-list
57069418|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57069419|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
57069420|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57069421|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57069422|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57069423|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069424|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069425|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
57069426|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
57069427|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069428|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069429|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57069430|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57069431|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
57069432|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57069433|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57069434|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57069435|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57069436|NCT02473328|Ritonavir|ritonavir|mesh-list
57069437|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57069438|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57069439|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57069440|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
57069441|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069442|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069443|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57069444|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57069445|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
57069446|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069447|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57069448|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57069449|NCT02473406|Thymalfasin|thymalfasin|mesh-list
57069450|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57069451|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
57069452|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751428|NCT04589676|Naloxone|naloxone|mesh-list
57069453|NCT02473094|Metformin|metformin|mesh-list
57069454|NCT02473094|Capecitabine|capecitabine|mesh-list
57069455|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57069456|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069457|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57069458|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
57069459|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069460|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069461|NCT03492138|Dexamethasone|dexamethasone|mesh-list
57069462|NCT03492138|Ixazomib|ixazomib|mesh-list
57069463|NCT03492138|TIC10 compound|tic10 compound|mesh-list
57069464|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069465|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
56898740|NCT04951947|Lenvatinib|lenvatinib|mesh-list
57069466|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
57069467|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069468|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069469|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57069470|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
57069471|NCT03492138|Hormones|hormones|mesh-ancestor
57069472|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57069473|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57069474|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069475|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
57069476|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069477|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069478|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57069479|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
57069480|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069481|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
57069482|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069483|NCT03131700|Bevacizumab|bevacizumab|mesh-list
57069484|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57069485|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069486|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57069487|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57069488|NCT03131700|Growth Substances|growth substances|mesh-ancestor
57069489|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069490|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
57069491|NCT04730258|Azacitidine|azacitidine|mesh-list
57069492|NCT04730258|Decitabine|decitabine|mesh-list
57069493|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57069494|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
57069495|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069496|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069497|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069498|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
57069499|NCT04706936|Fludarabine|fludarabine|mesh-list
57069500|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069501|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
57069502|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069503|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069504|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57069505|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
57069506|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069507|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069508|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57069509|NCT02194881|Ivacaftor|ivacaftor|mesh-list
57069510|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57069511|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57069512|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069513|NCT02194179|Nevirapine|nevirapine|mesh-list
57069514|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57069515|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57069516|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069517|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069518|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
57069519|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069520|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57069521|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57069522|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57069523|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57069524|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57069525|NCT02194257|Ambroxol|ambroxol|mesh-list
57069526|NCT02194257|Expectorants|expectorants|mesh-ancestor
57069527|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
57069528|NCT02195115|Amitriptyline|amitriptyline|mesh-list
57069529|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57069530|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
57069531|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57069532|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069533|NCT02195115|Analgesics|analgesics|mesh-ancestor
57069534|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
57069535|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069536|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069537|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57069538|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57069539|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57069540|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069541|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
57069542|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069543|NCT05144529|Nivolumab|nivolumab|mesh-list
57069544|NCT05144529|Ipilimumab|ipilimumab|mesh-list
57069545|NCT05144529|Evolocumab|evolocumab|mesh-list
57069546|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57069547|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069548|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57069549|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069550|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57069551|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57069552|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
57069553|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57069554|NCT02195973|Paclitaxel|paclitaxel|mesh-list
57069555|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57069556|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069557|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
57069558|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
57069559|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
57069560|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069561|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57069562|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
57069563|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069564|NCT02195271|Melatonin|melatonin|mesh-list
57069565|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
57069566|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069567|NCT02195271|Protective Agents|protective agents|mesh-ancestor
57069568|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069569|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069570|NCT02196285|Vaccines|vaccines|mesh-list
57069571|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
57069572|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069573|NCT05096169|Citric Acid|citric acid|mesh-list
57069574|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
57069575|NCT05096169|Clomiphene|clomiphene|mesh-list
57069576|NCT05096169|Enclomiphene|enclomiphene|mesh-list
57069577|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
57069578|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
57069579|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57069580|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
57069581|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
57069582|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069583|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57069584|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
57069585|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57069586|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069587|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57069588|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
57069589|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57069590|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57069591|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57069592|NCT04229979|Cytarabine|cytarabine|mesh-list
57069593|NCT04229979|Azacitidine|azacitidine|mesh-list
57069594|NCT04229979|Decitabine|decitabine|mesh-list
57069595|NCT04229979|Venetoclax|venetoclax|mesh-list
57069596|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57069597|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
57069598|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069599|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069600|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
57069601|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069602|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069603|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
57069604|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069605|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069606|NCT02196441|Bupivacaine|bupivacaine|mesh-list
57069607|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
57069608|NCT02196441|Tetracaine|tetracaine|mesh-list
57069609|NCT02196441|Anesthetics|anesthetics|mesh-list
57069610|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069611|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069612|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
57069613|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069614|NCT02195661|Melatonin|melatonin|mesh-list
57069615|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
57069616|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
57069617|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069618|NCT02195661|Protective Agents|protective agents|mesh-ancestor
57069619|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069620|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069621|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57069622|NCT03534297|Dapansutrile|dapansutrile|mesh-list
57069623|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069624|NCT02195817|Nalmefene|nalmefene|mesh-list
57069625|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57069626|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069627|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
57069628|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069629|NCT02197143|Esomeprazole|esomeprazole|mesh-list
57069630|NCT02197143|Ranitidine|ranitidine|mesh-list
57069631|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
57069632|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57069633|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57069634|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57069635|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069636|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069637|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57069638|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
57069639|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
56898792|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57069640|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069641|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069642|NCT02096874|Bevacizumab|bevacizumab|mesh-list
57069643|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57069644|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069645|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57069646|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57069647|NCT02096874|Growth Substances|growth substances|mesh-ancestor
57069648|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069649|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
57069650|NCT02575794|Masoprocol|masoprocol|mesh-list
57069651|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
57069652|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069653|NCT02575794|Protective Agents|protective agents|mesh-ancestor
57069654|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069655|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
57069656|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069657|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57069658|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57069659|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069660|NCT02575794|Analgesics|analgesics|mesh-ancestor
57069661|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
57069662|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069663|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069664|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069665|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
57069666|NCT02198547|Ropivacaine|ropivacaine|mesh-list
57069667|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
57069668|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
57069669|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069670|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069671|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
57069672|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069673|NCT02198547|Analgesics|analgesics|mesh-ancestor
57069674|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57069675|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
57069676|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57069677|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57069678|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069679|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57069680|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
57069681|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57069682|NCT01024608|Beclomethasone|beclomethasone|mesh-list
57069683|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069684|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
57069685|NCT01024608|Hormones|hormones|mesh-ancestor
57069686|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57069687|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069688|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57069689|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
57069690|NCT03489798|Alprostadil|alprostadil|mesh-list
57069691|NCT03489798|Misoprostol|misoprostol|mesh-list
57069692|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57069693|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
57069694|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57069695|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069696|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57069697|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57069698|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
57069699|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57069700|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
57069701|NCT03489798|Urological Agents|urological agents|mesh-ancestor
57069702|NCT02031081|Prucalopride|prucalopride|mesh-list
57069703|NCT02031081|Laxatives|laxatives|mesh-ancestor
57069704|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57069705|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
57069706|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57069707|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
57069708|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069709|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069710|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069711|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
57069712|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
57069713|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57069714|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069715|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069716|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
57069717|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57069718|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069719|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069720|NCT02199171|Carboplatin|carboplatin|mesh-list
57069721|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069722|NCT00910650|Aldesleukin|aldesleukin|mesh-list
57069723|NCT00910650|Interleukin-2|interleukin-2|mesh-list
57069724|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069725|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069726|NCT00910650|Analgesics|analgesics|mesh-ancestor
57069727|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
57069728|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069729|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069730|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57069731|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57069732|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
57069733|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069734|NCT02199327|Interferons|interferons|mesh-list
57069735|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
57069736|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
57069737|NCT02199327|Mitomycins|mitomycins|mesh-list
57069738|NCT02199327|Mitomycin|mitomycin|mesh-list
57069739|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069740|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
57069741|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069742|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
57069743|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069744|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57069745|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
57069746|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069747|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57069748|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069749|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
57069750|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
57069751|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57069752|NCT02198001|Amoxicillin|amoxicillin|mesh-list
57069753|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
57069754|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
57069755|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57069756|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069757|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57069758|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069759|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069760|NCT05116800|Gemcitabine|gemcitabine|mesh-list
57069761|NCT05116800|Docetaxel|docetaxel|mesh-list
57069762|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57069763|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
57069764|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069765|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069766|NCT05116800|Antiviral Agents|antiviral agents|mesh-ancestor
57069767|NCT05116800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069768|NCT05116800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069769|NCT05116800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069770|NCT05116800|Immunologic Factors|immunologic factors|mesh-ancestor
57069771|NCT05116800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069772|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
57069773|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
57069774|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
57069775|NCT04078737|Aspirin|aspirin|mesh-list
57069776|NCT04078737|Clopidogrel|clopidogrel|mesh-list
57069777|NCT04078737|Ticagrelor|ticagrelor|mesh-list
57069778|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57069779|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069780|NCT04078737|Analgesics|analgesics|mesh-ancestor
57069781|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
57069782|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069783|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069784|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069785|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069786|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57069787|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56898799|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57069788|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069789|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57069790|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57069791|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069792|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
57069793|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57069794|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57069795|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57069796|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
57069797|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069798|NCT03491904|Fasinumab|fasinumab|mesh-list
57069799|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069800|NCT03491904|Analgesics|analgesics|mesh-ancestor
57069801|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
57069802|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069803|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069804|NCT02199951|Piperaquine|piperaquine|mesh-list
57069805|NCT02199951|Artenimol|artenimol|mesh-list
57069806|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
57069807|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57069808|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57069809|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069810|NCT03533361|Lenvatinib|lenvatinib|mesh-list
57069811|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069812|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57069813|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069814|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069815|NCT01433328|Lidocaine|lidocaine|mesh-list
57069816|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
57069817|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
57069818|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069819|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069820|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
57069821|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069822|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57069823|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57069824|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57069825|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57069826|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069827|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
57069828|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57069829|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
57069830|NCT02200185|Morphine|morphine|mesh-list
57069831|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57069832|NCT02200185|Narcotics|narcotics|mesh-ancestor
57069833|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57069834|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069835|NCT02200185|Analgesics|analgesics|mesh-ancestor
57069836|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
57069837|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069838|NCT02201043|Thalidomide|thalidomide|mesh-list
57069839|NCT02201043|Tolnaftate|tolnaftate|mesh-list
57069840|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069841|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
57069842|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069843|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
57069844|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57069845|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069846|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57069847|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57069848|NCT02201043|Growth Substances|growth substances|mesh-ancestor
57069849|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
57069850|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069851|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
57069852|NCT02201121|Phenylephrine|phenylephrine|mesh-list
57069853|NCT02201121|Dopamine|dopamine|mesh-list
57069854|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
57069855|NCT02201121|Ephedrine|ephedrine|mesh-list
57069856|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57069857|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
57069858|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
57069859|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069860|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069861|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
57069862|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57069863|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
57069864|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
57069865|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57069866|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57069867|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57069868|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
57069869|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069870|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069871|NCT02201121|Protective Agents|protective agents|mesh-ancestor
57069872|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57069873|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
57069874|NCT02200575|Telmisartan|telmisartan|mesh-list
57069875|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57069876|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57069877|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57069878|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069879|NCT02201199|Insulin|insulin|mesh-list
57069880|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57069881|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
57069882|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57069883|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069884|NCT02200653|Losartan|losartan|mesh-list
57069885|NCT02200653|Telmisartan|telmisartan|mesh-list
57069886|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57069887|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57069888|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57069889|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57069890|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069891|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
57069892|NCT03999411|Nicotine|nicotine|mesh-list
57069893|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
57069894|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57069895|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57069896|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
57069897|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069898|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069899|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57069900|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57069901|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
57069902|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069903|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751882|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
57069904|NCT05261997|Metformin|metformin|mesh-list
57069905|NCT05261997|Acarbose|acarbose|mesh-list
57069906|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57069907|NCT05261997|Pancreatin|pancreatin|mesh-list
57069908|NCT05261997|Pancrelipase|pancrelipase|mesh-list
57069909|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069910|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57069911|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069912|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069913|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57069914|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
57069915|NCT02206425|Dexamethasone|dexamethasone|mesh-list
57069916|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
57069917|NCT02206425|Prednisone|prednisone|mesh-list
57069918|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
57069919|NCT02206425|Melphalan|melphalan|mesh-list
57069920|NCT02206425|Doxorubicin|doxorubicin|mesh-list
57069921|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57069922|NCT02206425|Lenalidomide|lenalidomide|mesh-list
57069923|NCT02206425|Pomalidomide|pomalidomide|mesh-list
57069924|NCT02206425|BB 1101|bb 1101|mesh-list
57069925|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069926|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
57069927|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069928|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069929|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57069930|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
57069931|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069932|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069933|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57069934|NCT02206425|Vitamins|vitamins|mesh-ancestor
57069935|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
57069936|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069937|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
57069938|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
57069939|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069940|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57069941|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
57069942|NCT02206425|Hormones|hormones|mesh-ancestor
57069943|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57069944|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57069945|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
57069946|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069947|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57069948|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57069949|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57069950|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57069951|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57069952|NCT02206425|Growth Substances|growth substances|mesh-ancestor
57069953|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
57069954|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
57069955|NCT02206425|Protective Agents|protective agents|mesh-ancestor
57069956|NCT02201667|Aspirin|aspirin|mesh-list
57069957|NCT02201667|Clopidogrel|clopidogrel|mesh-list
57069958|NCT02201667|Ticagrelor|ticagrelor|mesh-list
57069959|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57069960|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57069961|NCT02201667|Analgesics|analgesics|mesh-ancestor
57069962|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
57069963|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069964|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069965|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069966|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069967|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57069968|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57069969|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069970|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57069971|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57069972|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57069973|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
57069974|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57069975|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57069976|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57069977|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
57069978|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57069979|NCT02206503|Dexamethasone|dexamethasone|mesh-list
57069980|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
57069981|NCT02206503|Lenalidomide|lenalidomide|mesh-list
57069982|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57069983|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
57069984|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57069985|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57069986|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57069987|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
57069988|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57069989|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57069990|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57069991|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57069993|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
57069994|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57069995|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57069996|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
57069997|NCT02206503|Hormones|hormones|mesh-ancestor
57069998|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57069999|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57070000|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57070001|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57070002|NCT02206503|Growth Substances|growth substances|mesh-ancestor
57070003|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
57070004|NCT02206659|Telmisartan|telmisartan|mesh-list
57070005|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57070006|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57070007|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57070008|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070009|NCT02206737|Nicotine|nicotine|mesh-list
57070010|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57070011|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
57070012|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070013|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070014|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57070015|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57070016|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
57070017|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070018|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070019|NCT02206815|Aspirin|aspirin|mesh-list
57070020|NCT02206815|Warfarin|warfarin|mesh-list
57070021|NCT02206815|Clopidogrel|clopidogrel|mesh-list
57070022|NCT02206815|Ticagrelor|ticagrelor|mesh-list
57070023|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57070024|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57070025|NCT02206815|Analgesics|analgesics|mesh-ancestor
57070026|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
57070027|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070028|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070029|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57070030|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57070031|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57070032|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57070033|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070034|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57070035|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57070036|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070037|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
57070038|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57070039|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57070040|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57070041|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
57070042|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070043|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
57070044|NCT03533127|Bevacizumab|bevacizumab|mesh-list
57070045|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57070046|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070047|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57070048|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57070049|NCT03533127|Growth Substances|growth substances|mesh-ancestor
57070050|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070051|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
57070052|NCT02207361|Paclitaxel|paclitaxel|mesh-list
57070053|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57070054|NCT02207361|Carboplatin|carboplatin|mesh-list
57070055|NCT02207361|Epirubicin|epirubicin|mesh-list
57070056|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57070057|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070058|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
57070059|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
57070060|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
57070061|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070062|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57070063|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57070064|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57070065|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070066|NCT02207439|Nelfinavir|nelfinavir|mesh-list
57070067|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57070068|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57070069|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
57070070|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070071|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070072|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57070073|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57070074|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
57070075|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070076|NCT02202525|Telmisartan|telmisartan|mesh-list
57070077|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57070078|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57070079|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57070080|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070081|NCT02202603|Teriparatide|teriparatide|mesh-list
57070082|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070083|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898803|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57070084|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57070085|NCT02202993|Mibefradil|mibefradil|mesh-list
57070086|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57070087|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57070088|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57070089|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070090|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070091|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070092|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
57070093|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57070094|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57070095|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070096|NCT02190357|Rifaximin|rifaximin|mesh-list
57070097|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070098|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070099|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57070100|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
57070101|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
57070102|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57070103|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
57070104|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57070105|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070106|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57070107|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57070108|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57070109|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57070110|NCT02257671|Estrogens|estrogens|mesh-ancestor
57070111|NCT02257671|Hormones|hormones|mesh-ancestor
57070112|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070113|NCT01460160|Dasatinib|dasatinib|mesh-list
57070114|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070115|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57070116|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070117|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070118|NCT02203227|Turmeric extract|turmeric extract|mesh-list
57070119|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
57070120|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070121|NCT02203227|Protective Agents|protective agents|mesh-ancestor
57070122|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070123|NCT01170702|Ropivacaine|ropivacaine|mesh-list
57070124|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
57070125|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
57070126|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070127|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070128|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
57070129|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070130|NCT02203461|Ritonavir|ritonavir|mesh-list
57070131|NCT02203461|Lopinavir|lopinavir|mesh-list
57070132|NCT02203461|Darunavir|darunavir|mesh-list
57070133|NCT02203461|Tenofovir|tenofovir|mesh-list
57070134|NCT02203461|Emtricitabine|emtricitabine|mesh-list
57070135|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57070136|NCT02203461|Cobicistat|cobicistat|mesh-list
57070137|NCT02203461|Elvitegravir|elvitegravir|mesh-list
57070138|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57070139|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57070140|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
57070141|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070142|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070143|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57070144|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57070145|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
57070146|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070147|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57070148|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57070149|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57070150|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57070151|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57070152|NCT02191059|Docetaxel|docetaxel|mesh-list
57070153|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070154|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
57070155|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
57070156|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
57070157|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070158|NCT02191215|Nevirapine|nevirapine|mesh-list
57070159|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57070160|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57070161|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070162|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070163|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
57070164|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070165|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57070166|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57070167|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57070168|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57070169|NCT02209155|Verapamil|verapamil|mesh-list
57070170|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57070171|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57070172|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57070173|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070174|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070175|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070176|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
57070177|NCT03485118|Rituximab|rituximab|mesh-list
57070178|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57070179|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070180|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
57070181|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070182|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57070183|NCT02191293|Nevirapine|nevirapine|mesh-list
57070184|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57070185|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57070186|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070187|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070188|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
57070189|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070190|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57070191|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57070192|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57070193|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57070194|NCT02880540|Fentanyl|fentanyl|mesh-list
57070195|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
57070196|NCT02880540|Morphine|morphine|mesh-list
57070197|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57070198|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070199|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070200|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57070201|NCT02880540|Analgesics|analgesics|mesh-ancestor
57070202|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
57070203|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070204|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57070205|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57070206|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57070207|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
57070208|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070209|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070210|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57070211|NCT02880540|Narcotics|narcotics|mesh-ancestor
57070212|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57070213|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57070214|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
57070215|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
57070216|NCT02191371|Propofol|propofol|mesh-list
57070217|NCT02191371|Desflurane|desflurane|mesh-list
57070218|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56898810|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57070219|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070220|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070221|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57070222|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
57070223|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
57070224|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57070225|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
57070226|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57070227|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070228|NCT02741388|Gemcitabine|gemcitabine|mesh-list
57070229|NCT02741388|Cytarabine|cytarabine|mesh-list
57070230|NCT02741388|Dexamethasone|dexamethasone|mesh-list
57070231|NCT02741388|Rituximab|rituximab|mesh-list
57070232|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
57070233|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57070234|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070235|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
57070236|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070237|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57070238|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57070239|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
57070240|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
57070241|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070242|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57070243|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
57070244|NCT02741388|Hormones|hormones|mesh-ancestor
57070245|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070246|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57070247|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57070248|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
57070249|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070250|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
57070251|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070252|NCT02741388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070253|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070254|NCT02191527|Chrysarobin|chrysarobin|mesh-list
57070255|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57070256|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57070257|NCT02191527|Analgesics|analgesics|mesh-ancestor
57070258|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
57070259|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070260|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070261|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57070262|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57070263|NCT03484962|Antibodies|antibodies|mesh-list
57070264|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57070265|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
57070266|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070267|NCT01331616|Bevacizumab|bevacizumab|mesh-list
57070268|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57070269|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070270|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57070271|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57070272|NCT01331616|Growth Substances|growth substances|mesh-ancestor
57070273|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070274|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
57070275|NCT02209701|Porfiromycin|porfiromycin|mesh-list
57070276|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57070277|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070278|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57070279|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
57070280|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57070281|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57070283|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070284|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070285|NCT02204397|Ustekinumab|ustekinumab|mesh-list
57070286|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
57070287|NCT02192229|Vitamin D|vitamin d|mesh-list
57070288|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
57070289|NCT02192229|Vitamins|vitamins|mesh-ancestor
57070290|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
57070291|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070292|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57070293|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070294|NCT02192463|Nevirapine|nevirapine|mesh-list
57070295|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57070296|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57070297|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070298|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070299|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
57070300|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070301|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57070302|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57070303|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57070304|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57070305|NCT02204475|Interferons|interferons|mesh-list
57070306|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57070307|NCT02204475|Grazoprevir|grazoprevir|mesh-list
57070308|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
57070309|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070310|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
57070311|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070312|NCT02210169|Vancomycin|vancomycin|mesh-list
57070313|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070314|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070315|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
57070316|NCT02210949|Hematinics|hematinics|mesh-ancestor
57070317|NCT02204553|Panobinostat|panobinostat|mesh-list
57070318|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070319|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57070320|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070321|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070322|NCT01109004|Dexamethasone|dexamethasone|mesh-list
57070323|NCT01109004|Lenalidomide|lenalidomide|mesh-list
57070324|NCT01109004|Bortezomib|bortezomib|mesh-list
57070325|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57070326|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
57070327|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
57070328|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070329|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070330|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57070331|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
57070332|NCT01109004|Hormones|hormones|mesh-ancestor
57070333|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070334|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57070335|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070336|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
57070337|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57070338|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57070339|NCT01109004|Growth Substances|growth substances|mesh-ancestor
57070340|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
57070341|NCT02211729|Azithromycin|azithromycin|mesh-list
57070342|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
57070343|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
57070344|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
57070345|NCT02211729|Amodiaquine|amodiaquine|mesh-list
57070346|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070347|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070348|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
57070349|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57070350|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57070351|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57070352|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070353|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070354|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57070355|NCT02211729|Renal Agents|renal agents|mesh-ancestor
57070356|NCT05151510|Lidocaine|lidocaine|mesh-list
57070357|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
57070358|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
57070359|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070360|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070361|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
57070362|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070363|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57070364|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57070365|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57070366|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57070367|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070368|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
57070369|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57070370|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57070371|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070372|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
57070373|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070374|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070375|NCT03484650|Lidocaine|lidocaine|mesh-list
57070376|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
57070377|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
57070378|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070379|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070380|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
57070381|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070382|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57070383|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57070384|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57070385|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57070386|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070387|NCT02192697|Naquotinib|naquotinib|mesh-list
57070388|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070389|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57070390|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070391|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070392|NCT05153928|Norethindrone|norethindrone|mesh-list
57070393|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
57070394|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57070395|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57070396|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57070397|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
57070398|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57070399|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070400|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57070401|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57070402|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
57070403|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070404|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070405|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57070406|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57070407|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070408|NCT02192853|Incretins|incretins|mesh-ancestor
57070409|NCT02192853|Hormones|hormones|mesh-ancestor
57070410|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070411|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57070412|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
57070413|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070414|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070415|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
57070416|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070417|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
57070418|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
57070419|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
57070420|NCT04574154|Anesthetics|anesthetics|mesh-list
57070421|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070422|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070423|NCT03484416|Vitamin D|vitamin d|mesh-list
57070424|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
57070425|NCT03484416|Calcium|calcium|mesh-list
57070426|NCT03484416|Vitamins|vitamins|mesh-ancestor
57070427|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
57070428|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070429|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070430|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57070431|NCT03484416|Antacids|antacids|mesh-ancestor
57070432|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070433|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57070434|NCT02205255|Azithromycin|azithromycin|mesh-list
57070435|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070436|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070437|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
57070438|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070439|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
57070440|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070441|NCT03476772|Nalbuphine|nalbuphine|mesh-list
57070442|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57070443|NCT03476772|Narcotics|narcotics|mesh-ancestor
57070444|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070445|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070446|NCT03476772|Analgesics|analgesics|mesh-ancestor
57070447|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
57070448|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070449|NCT03535233|Triamcinolone|triamcinolone|mesh-list
57070450|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57070451|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57070452|NCT03535233|Clobetasol|clobetasol|mesh-list
57070453|NCT03535233|Minoxidil|minoxidil|mesh-list
57070454|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57070455|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57070456|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
57070457|NCT03535233|Hormones|hormones|mesh-ancestor
57070458|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070459|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070460|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070461|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
57070462|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070463|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070464|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57070465|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
57070466|NCT02205489|Cetirizine|cetirizine|mesh-list
57070467|NCT02205489|Acyclovir|acyclovir|mesh-list
57070468|NCT02205489|Ibuprofen|ibuprofen|mesh-list
57070469|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
57070470|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57070471|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57070472|NCT02205489|Prednisolone|prednisolone|mesh-list
57070473|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
57070474|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
57070475|NCT02205489|Esomeprazole|esomeprazole|mesh-list
57070476|NCT02205489|Ranitidine|ranitidine|mesh-list
57070477|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57070478|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
57070479|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57070480|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57070481|NCT02205489|Analgesics|analgesics|mesh-ancestor
57070482|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
57070483|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070484|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070485|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57070486|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57070487|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57070488|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070489|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070490|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
57070491|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
57070492|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57070493|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
57070494|NCT02205489|Hormones|hormones|mesh-ancestor
57070495|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070496|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57070497|NCT02205489|Protective Agents|protective agents|mesh-ancestor
57070498|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57070499|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070500|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57070501|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57070502|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57070503|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
57070504|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070505|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57070506|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56752496|NCT02551796|Renal Agents|renal agents|mesh-ancestor
57070507|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57070509|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
57070510|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070511|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57070512|NCT02523846|Morphine|morphine|mesh-list
57070513|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57070514|NCT02523846|Narcotics|narcotics|mesh-ancestor
57070515|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070516|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070517|NCT02523846|Analgesics|analgesics|mesh-ancestor
57070518|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
56898819|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
57070519|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070520|NCT03484260|Testosterone|testosterone|mesh-list
57070521|NCT03484260|Androgens|androgens|mesh-ancestor
57070522|NCT03484260|Hormones|hormones|mesh-ancestor
57070523|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070524|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070525|NCT05195775|Tadalafil|tadalafil|mesh-list
57070526|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
57070527|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57070528|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57070529|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070530|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070531|NCT05195775|Urological Agents|urological agents|mesh-ancestor
57070532|NCT03480906|Latanoprost|latanoprost|mesh-list
57070533|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57070534|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57070535|NCT05262465|Azacitidine|azacitidine|mesh-list
57070536|NCT05262465|Venetoclax|venetoclax|mesh-list
57070537|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57070538|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
57070539|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070540|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070541|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070542|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
57070543|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57070544|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
57070545|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070546|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
57070547|NCT02220621|Protective Agents|protective agents|mesh-ancestor
57070548|NCT04370418|Fluorouracil|fluorouracil|mesh-list
57070549|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
57070550|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070551|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57070552|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070553|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070554|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
57070555|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070556|NCT02220777|Omeprazole|omeprazole|mesh-list
57070557|NCT02220777|ASP8477|asp8477|mesh-list
57070558|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57070559|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57070560|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57070561|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070562|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070563|NCT03476616|Valsartan|valsartan|mesh-list
57070564|NCT03476616|Eplerenone|eplerenone|mesh-list
57070565|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57070566|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57070567|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57070568|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070569|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57070570|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
57070571|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070572|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070573|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57070574|NCT03476616|Diuretics|diuretics|mesh-ancestor
57070575|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
57070576|NCT02205879|Pregabalin|pregabalin|mesh-list
57070577|NCT02205879|Analgesics|analgesics|mesh-ancestor
57070578|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
57070579|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070580|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070581|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
57070582|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57070583|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57070584|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070585|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070586|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57070587|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57070588|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070589|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57070590|NCT03483948|Azacitidine|azacitidine|mesh-list
57070591|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57070592|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
57070593|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070594|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070595|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070596|NCT03483870|Morphine|morphine|mesh-list
57070597|NCT03483870|Granisetron|granisetron|mesh-list
57070598|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57070599|NCT03483870|Narcotics|narcotics|mesh-ancestor
57070600|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070601|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070602|NCT03483870|Analgesics|analgesics|mesh-ancestor
57070603|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
57070604|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070605|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
57070606|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
57070607|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57070608|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57070609|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
57070610|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070611|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070612|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
57070613|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57070614|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070615|NCT03480516|Fluorides|fluorides|mesh-list
57070616|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
57070617|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
57070618|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
57070619|NCT03480516|Protective Agents|protective agents|mesh-ancestor
57070620|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070621|NCT02221401|Metformin|metformin|mesh-list
57070622|NCT02221401|Linagliptin|linagliptin|mesh-list
57070623|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57070624|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070625|NCT02221401|Incretins|incretins|mesh-ancestor
57070626|NCT02221401|Hormones|hormones|mesh-ancestor
57070627|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070628|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57070629|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
57070630|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070631|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070632|NCT03483636|Lemborexant|lemborexant|mesh-list
57070633|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57070634|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070635|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070636|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57070637|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57070638|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070639|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070640|NCT02221479|Plerixafor|plerixafor|mesh-list
57070641|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57070642|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57070643|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
57070644|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070645|NCT02221635|Risperidone|risperidone|mesh-list
57070646|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57070647|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
57070648|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070649|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070650|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070651|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57070652|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57070653|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070654|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57070655|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57070656|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
56752639|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
57070657|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
57070658|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
57070659|NCT03480360|Fludarabine|fludarabine|mesh-list
57070660|NCT03480360|Tacrolimus|tacrolimus|mesh-list
57070661|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070662|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
57070663|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070664|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56898822|NCT03325712|Midazolam|midazolam|mesh-list
57070665|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57070666|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
57070667|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070668|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070669|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57070670|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57070671|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070672|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57070673|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57070674|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
57070675|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070676|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070677|NCT02723864|Veliparib|veliparib|mesh-list
57070678|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070679|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57070680|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070681|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070682|NCT02471690|Oritavancin|oritavancin|mesh-list
57070683|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070684|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070685|NCT02225067|Calcium|calcium|mesh-list
57070686|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070687|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070688|NCT03475758|Goserelin|goserelin|mesh-list
57070689|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57070690|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070691|NCT02231385|Acetic Acid|acetic acid|mesh-list
57070692|NCT02231385|Retinol acetate|retinol acetate|mesh-list
57070693|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070694|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070695|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57070696|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
57070697|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070698|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57070699|NCT02231385|Protective Agents|protective agents|mesh-ancestor
57070700|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070701|NCT02523768|Basiliximab|basiliximab|mesh-list
57070702|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070703|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
57070704|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070705|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57070706|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
57070707|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57070708|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070709|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
57070710|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57070711|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070712|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070713|NCT03203642|XL647|xl647|mesh-list
57070714|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070715|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57070716|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070717|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070718|NCT03475680|Gentamicins|gentamicins|mesh-list
57070719|NCT03475680|Ornidazole|ornidazole|mesh-list
57070720|NCT03475680|Sennosides|sennosides|mesh-list
57070721|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070722|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070723|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57070724|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070725|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070726|NCT03475680|Laxatives|laxatives|mesh-ancestor
57070727|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57070728|NCT03475680|Amebicides|amebicides|mesh-ancestor
57070729|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57070730|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57070731|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57070732|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57070733|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57070735|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57070736|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070737|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
57070738|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57070739|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57070740|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57070741|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57070742|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070743|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
57070744|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070745|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070746|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57070747|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070748|NCT02471846|Atezolizumab|atezolizumab|mesh-list
57070749|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070750|NCT02472782|Teriparatide|teriparatide|mesh-list
57070751|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070752|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070753|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57070754|NCT02258607|Trametinib|trametinib|mesh-list
57070755|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
57070756|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070757|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57070758|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070759|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070760|NCT03792750|Nivolumab|nivolumab|mesh-list
57070761|NCT03792750|Linrodostat|linrodostat|mesh-list
57070762|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57070763|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070764|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57070765|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070766|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070767|NCT02258763|Amoxicillin|amoxicillin|mesh-list
57070768|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
57070769|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
57070770|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57070771|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070772|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070773|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57070774|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070775|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070776|NCT02469974|Busulfan|busulfan|mesh-list
57070777|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
57070778|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070779|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
57070780|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070781|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070782|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57070783|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070784|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57070785|NCT02231931|Metformin|metformin|mesh-list
57070786|NCT02231931|Digoxin|digoxin|mesh-list
57070787|NCT02231931|Furosemide|furosemide|mesh-list
57070788|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57070789|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57070790|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070791|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57070792|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57070793|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
57070794|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070795|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57070796|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57070797|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070798|NCT02231931|Diuretics|diuretics|mesh-ancestor
57070799|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
57070800|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57070801|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57070802|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57070803|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57070804|NCT02231931|Protective Agents|protective agents|mesh-ancestor
57070805|NCT03131622|Coal Tar|coal tar|mesh-list
57070806|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
57070807|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
57070808|NCT03482544|Pregabalin|pregabalin|mesh-list
57070809|NCT03482544|Analgesics|analgesics|mesh-ancestor
57070810|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
57070811|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070812|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070813|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
57070814|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57070815|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57070816|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070817|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070818|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57070819|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57070820|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57070821|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57070822|NCT02750709|Nitisinone|nitisinone|mesh-list
57070823|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070824|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070825|NCT02222649|Vitamin D|vitamin d|mesh-list
57070826|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
57070827|NCT02222649|Vitamins|vitamins|mesh-ancestor
57070828|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
57070829|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070830|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57070831|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57070832|NCT02222727|Donepezil|donepezil|mesh-list
57070833|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57070834|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070835|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070836|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
57070837|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070838|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070839|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
57070840|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
57070841|NCT02723786|Azathioprine|azathioprine|mesh-list
57070842|NCT02723786|Tacrolimus|tacrolimus|mesh-list
57070843|NCT02723786|Basiliximab|basiliximab|mesh-list
57070844|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070845|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
57070846|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070847|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57070848|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070849|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070850|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57070851|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070852|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57070853|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
57070854|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57070855|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070856|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
57070857|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57070858|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57070859|NCT03310736|Hepcidins|hepcidins|mesh-list
57070860|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070861|NCT02226783|Omeprazole|omeprazole|mesh-list
57070862|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57070863|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57070864|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57070865|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070866|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070867|NCT03482232|Acetaminophen|acetaminophen|mesh-list
57070868|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57070869|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57070870|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
57070871|NCT03482232|Ibuprofen|ibuprofen|mesh-list
57070872|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
57070873|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57070874|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
57070875|NCT03482232|Expectorants|expectorants|mesh-list
57070876|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
57070877|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57070878|NCT03482232|Analgesics|analgesics|mesh-ancestor
57070879|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
57070880|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070881|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070882|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57070883|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57070884|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070885|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070886|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
57070887|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
57070888|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57070889|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
57070890|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57070892|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
57070893|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070894|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
57070895|NCT02227173|Digoxin|digoxin|mesh-list
57070896|NCT02227173|Montelukast|montelukast|mesh-list
57070897|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57070898|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
57070899|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57070900|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
57070901|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070902|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070903|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57070904|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57070905|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070906|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57070907|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57070908|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070909|NCT02227173|Protective Agents|protective agents|mesh-ancestor
57070910|NCT02227173|Analgesics|analgesics|mesh-ancestor
57070911|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
57070912|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57070913|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57070914|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57070915|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57070916|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57070917|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57070918|NCT04477850|Luspatercept|luspatercept|mesh-list
57070919|NCT04477850|Hematinics|hematinics|mesh-ancestor
57070920|NCT02469740|Clopidogrel|clopidogrel|mesh-list
57070921|NCT02469740|Ticagrelor|ticagrelor|mesh-list
57070922|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57070923|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57070924|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57070925|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57070926|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
57070927|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57070928|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070929|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070930|NCT04432220|Apixaban|apixaban|mesh-list
57070931|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57070932|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
57070933|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57070934|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
57070935|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070936|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070937|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
57070938|NCT03520842|Methotrexate|methotrexate|mesh-list
57070939|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57070940|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
57070941|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57070942|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070943|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57070944|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
57070945|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070946|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070947|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
57070948|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070949|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57070950|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070951|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
57070952|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57070953|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57070954|NCT04405622|Gemcitabine|gemcitabine|mesh-list
57070955|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57070956|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
57070957|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070958|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070959|NCT04405622|Antiviral Agents|antiviral agents|mesh-ancestor
57070960|NCT04405622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070961|NCT04405622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070962|NCT04405622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57070963|NCT04405622|Immunologic Factors|immunologic factors|mesh-ancestor
57070964|NCT04405622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070965|NCT03481998|Letrozole|letrozole|mesh-list
57070966|NCT03481998|Fulvestrant|fulvestrant|mesh-list
57070967|NCT03481998|Anastrozole|anastrozole|mesh-list
57070968|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070969|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57070970|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57070971|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57070972|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070973|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57070974|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
57070975|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57070976|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070977|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57070978|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57070979|NCT02723084|Ribavirin|ribavirin|mesh-list
57070980|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
57070981|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
57070982|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57070983|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
57070984|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070985|NCT02750943|Fluorides|fluorides|mesh-list
57070986|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
57070987|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
57070988|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
57070989|NCT02750943|Protective Agents|protective agents|mesh-ancestor
57070990|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57070991|NCT03481920|Avelumab|avelumab|mesh-list
57070992|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57070993|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57070994|NCT02227797|Voriconazole|voriconazole|mesh-list
57070995|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
57070996|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57070997|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57070998|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57070999|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071000|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071001|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57071002|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
57071003|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071004|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071005|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57071006|NCT05784311|Metronidazole|metronidazole|mesh-list
57071007|NCT05784311|Cefuroxime|cefuroxime|mesh-list
57071008|NCT05784311|Cefuroxime axetil|cefuroxime axetil|mesh-list
57071009|NCT05784311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071010|NCT05784311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57071011|NCT05784311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57071012|NCT05784311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57071013|NCT05784012|Niraparib|niraparib|mesh-list
57071014|NCT05784012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071015|NCT05784012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57071016|NCT05784012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071017|NCT05784012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071018|NCT05783921|Paclitaxel|paclitaxel|mesh-list
57071019|NCT05783921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57071020|NCT05783921|Cisplatin|cisplatin|mesh-list
57071021|NCT05783921|Carboplatin|carboplatin|mesh-list
57071022|NCT05783921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57071023|NCT05783921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071024|NCT05783921|Tubulin Modulators|tubulin modulators|mesh-ancestor
57071025|NCT05783921|Antimitotic Agents|antimitotic agents|mesh-ancestor
57071026|NCT05783921|Mitosis Modulators|mitosis modulators|mesh-ancestor
57071027|NCT05783921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071028|NCT05783817|Methamphetamine|methamphetamine|mesh-list
57071029|NCT05783817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56753020|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
57071030|NCT05783817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071031|NCT05783817|Sympathomimetics|sympathomimetics|mesh-ancestor
57071032|NCT05783817|Autonomic Agents|autonomic agents|mesh-ancestor
57071033|NCT05783817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071034|NCT05783817|Dopamine Agents|dopamine agents|mesh-ancestor
57071035|NCT05783817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071036|NCT05783817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071037|NCT05783817|Adrenergic Agents|adrenergic agents|mesh-ancestor
57071038|NCT05783817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57071039|NCT05783817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57071040|NCT05783817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57071041|NCT05783817|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57071042|NCT05783778|Testosterone|testosterone|mesh-list
57071043|NCT05783778|Androgens|androgens|mesh-ancestor
57071044|NCT05783778|Hormones|hormones|mesh-ancestor
57071045|NCT05783778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071046|NCT05783778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071047|NCT05783661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57071048|NCT05783661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071049|NCT05783648|Tranexamic Acid|tranexamic acid|mesh-list
57071050|NCT05783648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57071051|NCT05783648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57071052|NCT05783648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071053|NCT05783648|Hemostatics|hemostatics|mesh-ancestor
57071054|NCT05783648|Coagulants|coagulants|mesh-ancestor
57071055|NCT05783609|Rituximab|rituximab|mesh-list
57071056|NCT05783609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071057|NCT05783609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071058|NCT05783609|Immunologic Factors|immunologic factors|mesh-ancestor
57071059|NCT05783609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071060|NCT05783609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071061|NCT05783596|Obinutuzumab|obinutuzumab|mesh-list
57071062|NCT05783596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071063|NCT05783596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071064|NCT05783557|Clevidipine|clevidipine|mesh-list
57071065|NCT05783557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57071066|NCT05783557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57071067|NCT05783557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071068|NCT05783557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57071069|NCT05783557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071070|NCT05783544|Interferons|interferons|mesh-list
57071071|NCT05783544|Interferon-gamma|interferon-gamma|mesh-list
57071072|NCT05783544|Interleukin-4|interleukin-4|mesh-list
57071073|NCT05783544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071074|NCT05783544|Antiviral Agents|antiviral agents|mesh-ancestor
57071075|NCT05783544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071076|NCT05783544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57071077|NCT05783544|Immunologic Factors|immunologic factors|mesh-ancestor
57071078|NCT05783544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071079|NCT05783544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071080|NCT05783518|Propofol|propofol|mesh-list
57071081|NCT05783518|Desflurane|desflurane|mesh-list
57071082|NCT05783518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57071083|NCT05783518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071084|NCT05783518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071085|NCT05783518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57071086|NCT05783518|Anesthetics, General|anesthetics, general|mesh-ancestor
57071087|NCT05783518|Anesthetics|anesthetics|mesh-ancestor
57071088|NCT05783518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57071089|NCT05783492|Ketamine|ketamine|mesh-list
57071090|NCT05783492|Analgesics|analgesics|mesh-ancestor
57071091|NCT05783492|Sensory System Agents|sensory system agents|mesh-ancestor
57071092|NCT05783492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071093|NCT05783492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071094|NCT05783492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57071095|NCT05783492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57071096|NCT05783492|Anesthetics, General|anesthetics, general|mesh-ancestor
57071097|NCT05783492|Anesthetics|anesthetics|mesh-ancestor
57071098|NCT05783492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071099|NCT05783492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57071100|NCT05783492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57071101|NCT05783492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071102|NCT05783492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071103|NCT05783479|Estradiol|estradiol|mesh-list
57071104|NCT05783479|Hyaluronic Acid|hyaluronic acid|mesh-list
57071106|NCT05783479|Hormones|hormones|mesh-ancestor
57071107|NCT05783479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071108|NCT05783479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071109|NCT05783479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57071110|NCT05783479|Immunologic Factors|immunologic factors|mesh-ancestor
57071111|NCT05783479|Viscosupplements|viscosupplements|mesh-ancestor
57071112|NCT05783479|Protective Agents|protective agents|mesh-ancestor
57071113|NCT05783453|Emollients|emollients|mesh-list
57071114|NCT05783453|Dermatologic Agents|dermatologic agents|mesh-ancestor
57071115|NCT05782972|Dapagliflozin|dapagliflozin|mesh-list
57071116|NCT05782972|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57071117|NCT05782972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071118|NCT05782972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57071119|NCT05782972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071120|NCT05782933|Rituximab|rituximab|mesh-list
57071121|NCT05782933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071122|NCT05782933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071123|NCT05782933|Immunologic Factors|immunologic factors|mesh-ancestor
57071124|NCT05782933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071125|NCT05782933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071126|NCT05782920|Hyaluronic Acid|hyaluronic acid|mesh-list
57071127|NCT05782920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57071128|NCT05782920|Immunologic Factors|immunologic factors|mesh-ancestor
57071129|NCT05782920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071130|NCT05782920|Viscosupplements|viscosupplements|mesh-ancestor
57071131|NCT05782920|Protective Agents|protective agents|mesh-ancestor
57071132|NCT05782907|Upadacitinib|upadacitinib|mesh-list
57071133|NCT05782907|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57071134|NCT05782907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57071135|NCT05782907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071136|NCT05782907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071137|NCT05782907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071138|NCT05782881|Glucagon|glucagon|mesh-list
57071139|NCT05782881|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57071140|NCT05782881|Enzyme Inhibitors|enzyme inhibitors|mesh-list
57071141|NCT05782881|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57071142|NCT05782881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57071143|NCT05782881|Hormones|hormones|mesh-ancestor
57071144|NCT05782881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071145|NCT05782881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071146|NCT05782881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071147|NCT05782881|Incretins|incretins|mesh-ancestor
57071148|NCT05782881|Protease Inhibitors|protease inhibitors|mesh-ancestor
57071149|NCT05782816|Oxytocin|oxytocin|mesh-list
57071150|NCT05782816|Oxytocics|oxytocics|mesh-ancestor
57071151|NCT05782816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57071152|NCT05782816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071153|NCT05782777|Ezetimibe|ezetimibe|mesh-list
57071154|NCT05782777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
57071155|NCT05782777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57071156|NCT05782777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57071157|NCT05782777|Antimetabolites|antimetabolites|mesh-ancestor
57071158|NCT05782777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071159|NCT05782777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57071160|NCT05782777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071161|NCT05782764|Endostar protein|endostar protein|mesh-list
57071162|NCT05782764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57071163|NCT05782764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57071164|NCT05782764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57071165|NCT05782764|Growth Substances|growth substances|mesh-ancestor
57071166|NCT05782764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071167|NCT05782764|Growth Inhibitors|growth inhibitors|mesh-ancestor
57071168|NCT05782764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071169|NCT05782764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071170|NCT05782751|Mitogens|mitogens|mesh-list
57071171|NCT05782751|Mitosis Modulators|mitosis modulators|mesh-ancestor
57071172|NCT05782751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071173|NCT05781074|Lenvatinib|lenvatinib|mesh-list
57071174|NCT05781074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071175|NCT05781074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57071176|NCT05781074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071177|NCT05781074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071178|NCT05780879|Venetoclax|venetoclax|mesh-list
57071179|NCT05780879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071180|NCT05780541|Remdesivir|remdesivir|mesh-list
57071181|NCT05780541|Antimetabolites|antimetabolites|mesh-ancestor
57071182|NCT05780541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071183|NCT05780541|Antiviral Agents|antiviral agents|mesh-ancestor
57071184|NCT05780541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071185|NCT05780463|Remdesivir|remdesivir|mesh-list
57071186|NCT05780463|Antimetabolites|antimetabolites|mesh-ancestor
57071187|NCT05780463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071188|NCT05780463|Antiviral Agents|antiviral agents|mesh-ancestor
57071189|NCT05780463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071190|NCT05780281|Remdesivir|remdesivir|mesh-list
57071191|NCT05780281|Antimetabolites|antimetabolites|mesh-ancestor
57071192|NCT05780281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071193|NCT05780281|Antiviral Agents|antiviral agents|mesh-ancestor
57071194|NCT05780281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071195|NCT05780268|Remdesivir|remdesivir|mesh-list
57071196|NCT05780268|Bamlanivimab|bamlanivimab|mesh-list
57071197|NCT05780268|Antimetabolites|antimetabolites|mesh-ancestor
57071198|NCT05780268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071199|NCT05780268|Antiviral Agents|antiviral agents|mesh-ancestor
57071200|NCT05780268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071201|NCT05779657|Midazolam|midazolam|mesh-list
57071202|NCT05779657|Ketamine|ketamine|mesh-list
57071203|NCT05779657|Analgesics|analgesics|mesh-ancestor
57071204|NCT05779657|Sensory System Agents|sensory system agents|mesh-ancestor
57071205|NCT05779657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071206|NCT05779657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071207|NCT05779657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57071208|NCT05779657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57071209|NCT05779657|Anesthetics, General|anesthetics, general|mesh-ancestor
57071210|NCT05779657|Anesthetics|anesthetics|mesh-ancestor
57071211|NCT05779657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071212|NCT05779657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57071213|NCT05779657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57071214|NCT05779657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071215|NCT05779657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071216|NCT05779657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57071217|NCT05779657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57071218|NCT05779657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57071219|NCT05779657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57071220|NCT05779657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57071221|NCT05779657|GABA Modulators|gaba modulators|mesh-ancestor
57071222|NCT05779657|GABA Agents|gaba agents|mesh-ancestor
57071223|NCT05777226|Epalrestat|epalrestat|mesh-list
57071224|NCT05777226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071225|NCT05777226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071226|NCT05776823|Naloxone|naloxone|mesh-list
57071227|NCT05776823|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57071228|NCT05776823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071229|NCT05776823|Sensory System Agents|sensory system agents|mesh-ancestor
57071230|NCT05776823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071231|NCT05774054|Norepinephrine|norepinephrine|mesh-list
57071232|NCT05774054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57071233|NCT05774054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57071234|NCT05774054|Adrenergic Agents|adrenergic agents|mesh-ancestor
57071235|NCT05774054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071236|NCT05774054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071237|NCT05774054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071238|NCT05774054|Sympathomimetics|sympathomimetics|mesh-ancestor
57071239|NCT05774054|Autonomic Agents|autonomic agents|mesh-ancestor
57071240|NCT05774054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071241|NCT05774054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57071242|NCT05773053|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57071243|NCT05773053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57071244|NCT05773053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57071245|NCT05773053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071246|NCT05773053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071247|NCT05773053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57071248|NCT05773053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57071249|NCT05773053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071250|NCT05773053|Cholinergic Agents|cholinergic agents|mesh-ancestor
57071251|NCT05773053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071252|NCT05756673|Listerine|listerine|mesh-list
57071253|NCT05756673|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56753243|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
57071254|NCT05756673|Sodium Fluoride|sodium fluoride|mesh-list
57071255|NCT05756673|Cariostatic Agents|cariostatic agents|mesh-ancestor
57071256|NCT05756673|Protective Agents|protective agents|mesh-ancestor
57071257|NCT05756673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071258|NCT05756673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071259|NCT05751148|Bupivacaine|bupivacaine|mesh-list
57071261|NCT05751148|Anesthetics, Local|anesthetics, local|mesh-ancestor
57071262|NCT05751148|Anesthetics|anesthetics|mesh-ancestor
57071263|NCT05751148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071264|NCT05751148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071265|NCT05751148|Sensory System Agents|sensory system agents|mesh-ancestor
57071266|NCT05751148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071267|NCT05741164|Pembrolizumab|pembrolizumab|mesh-list
57071268|NCT05741164|Propranolol|propranolol|mesh-list
57071269|NCT05741164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071270|NCT05741164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071271|NCT05741164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57071272|NCT05741164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57071273|NCT05741164|Adrenergic Agents|adrenergic agents|mesh-ancestor
57071274|NCT05741164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071275|NCT05741164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071276|NCT05741164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071277|NCT05741164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57071278|NCT05741164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57071279|NCT05741164|Vasodilator Agents|vasodilator agents|mesh-ancestor
57071280|NCT05731492|Macitentan|macitentan|mesh-list
57071281|NCT05731492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57071282|NCT05731492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57071283|NCT05731492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071284|NCT05731492|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57071285|NCT05727176|Futibatinib|futibatinib|mesh-list
57071286|NCT05727176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071287|NCT05711199|Nitroglycerin|nitroglycerin|mesh-list
57071288|NCT05711199|Vasodilator Agents|vasodilator agents|mesh-ancestor
57071289|NCT05706753|Drospirenone|drospirenone|mesh-list
57071290|NCT05706753|Midazolam|midazolam|mesh-list
57071291|NCT05706753|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57071292|NCT05706753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57071293|NCT05706753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57071294|NCT05706753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071295|NCT05706753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071296|NCT05706753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57071297|NCT05706753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57071298|NCT05706753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57071299|NCT05706753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57071300|NCT05706753|Anesthetics, General|anesthetics, general|mesh-ancestor
57071301|NCT05706753|Anesthetics|anesthetics|mesh-ancestor
57071302|NCT05706753|GABA Modulators|gaba modulators|mesh-ancestor
57071303|NCT05706753|GABA Agents|gaba agents|mesh-ancestor
57071304|NCT05706753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071305|NCT05706753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071306|NCT05706753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57071307|NCT05706753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57071308|NCT05706753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57071309|NCT05706753|Contraceptive Agents|contraceptive agents|mesh-ancestor
57071310|NCT05706753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57071311|NCT05706753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57071312|NCT05706753|Estrogens|estrogens|mesh-ancestor
57071313|NCT05706753|Hormones|hormones|mesh-ancestor
57071314|NCT05706753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071315|NCT05706753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57071316|NCT05706753|Hormone Antagonists|hormone antagonists|mesh-ancestor
57071317|NCT05706753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57071318|NCT05706753|Diuretics|diuretics|mesh-ancestor
57071319|NCT05706753|Natriuretic Agents|natriuretic agents|mesh-ancestor
57071320|NCT05704673|Morphine|morphine|mesh-list
57071321|NCT05704673|Nalbuphine|nalbuphine|mesh-list
57071322|NCT05704673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57071323|NCT05704673|Narcotics|narcotics|mesh-ancestor
57071324|NCT05704673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071325|NCT05704673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071326|NCT05704673|Analgesics|analgesics|mesh-ancestor
57071327|NCT05704673|Sensory System Agents|sensory system agents|mesh-ancestor
57071328|NCT05704673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071329|NCT05703971|Atezolizumab|atezolizumab|mesh-list
57071330|NCT05703971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071331|NCT05703074|Niacinamide|niacinamide|mesh-list
57071332|NCT05703074|Niacin|niacin|mesh-list
57071333|NCT05703074|Nicotinic Acids|nicotinic acids|mesh-list
57071334|NCT05703074|Vitamin B Complex|vitamin b complex|mesh-ancestor
57071335|NCT05703074|Vitamins|vitamins|mesh-ancestor
57071336|NCT05703074|Micronutrients|micronutrients|mesh-ancestor
57071337|NCT05703074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071338|NCT05703074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57071339|NCT05703074|Antimetabolites|antimetabolites|mesh-ancestor
57071340|NCT05703074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071341|NCT05703074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57071342|NCT05703074|Vasodilator Agents|vasodilator agents|mesh-ancestor
57071343|NCT05701865|Ethanol|ethanol|mesh-list
57071344|NCT05701865|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57071345|NCT05701865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071346|NCT05701865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071347|NCT05701865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071348|NCT05701345|Antidepressive Agents|antidepressive agents|mesh-list
57071349|NCT05701345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57071350|NCT05696080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57071351|NCT05696080|Immunologic Factors|immunologic factors|mesh-ancestor
57071352|NCT05696080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071353|NCT05687032|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
57071354|NCT05687032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071355|NCT05687032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071356|NCT05687032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57071357|NCT05674721|Ibuprofen|ibuprofen|mesh-list
57071358|NCT05674721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57071359|NCT05674721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57071360|NCT05674721|Analgesics|analgesics|mesh-ancestor
57071361|NCT05674721|Sensory System Agents|sensory system agents|mesh-ancestor
57071362|NCT05674721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071363|NCT05674721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071364|NCT05674721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071365|NCT05674721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071366|NCT05674721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57071367|NCT05674721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071368|NCT05674721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071369|NCT05664464|Sulfasalazine|sulfasalazine|mesh-list
57071370|NCT05664464|Temozolomide|temozolomide|mesh-list
57071371|NCT05664464|Gabapentin|gabapentin|mesh-list
57071372|NCT05664464|Memantine|memantine|mesh-list
57071373|NCT05664464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57071374|NCT05664464|Alkylating Agents|alkylating agents|mesh-ancestor
57071375|NCT05664464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071376|NCT05664464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071377|NCT05664464|Analgesics|analgesics|mesh-ancestor
57071378|NCT05664464|Sensory System Agents|sensory system agents|mesh-ancestor
57071379|NCT05664464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071380|NCT05664464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071381|NCT05664464|Anticonvulsants|anticonvulsants|mesh-ancestor
57071382|NCT05664464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57071383|NCT05664464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57071384|NCT05664464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071385|NCT05664464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57071386|NCT05664464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57071387|NCT05664464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57071388|NCT05664464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071389|NCT05664464|Antimanic Agents|antimanic agents|mesh-ancestor
57071390|NCT05664464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57071391|NCT05664464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57071392|NCT05664464|Dopamine Agents|dopamine agents|mesh-ancestor
57071393|NCT05664464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071394|NCT05664464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57071395|NCT05664464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57071396|NCT05664464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071397|NCT05664464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071398|NCT05664464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57071399|NCT05660538|Pregabalin|pregabalin|mesh-list
57071400|NCT05660538|Analgesics|analgesics|mesh-ancestor
57071401|NCT05660538|Sensory System Agents|sensory system agents|mesh-ancestor
57071402|NCT05660538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071403|NCT05660538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071404|NCT05660538|Anticonvulsants|anticonvulsants|mesh-ancestor
57071405|NCT05660538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57071406|NCT05660538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57071407|NCT05660538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071408|NCT05660538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57071409|NCT05660538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57071410|NCT05660538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57071411|NCT05660538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071412|NCT05660538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57071413|NCT05658497|Interferons|interferons|mesh-list
57071414|NCT05658497|Interferon-beta|interferon-beta|mesh-list
57071415|NCT05658497|Interferon beta-1a|interferon beta-1a|mesh-list
57071416|NCT05658497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57071417|NCT05658497|Natalizumab|natalizumab|mesh-list
57071418|NCT05658497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071419|NCT05658497|Antiviral Agents|antiviral agents|mesh-ancestor
57071420|NCT05658497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071421|NCT05658497|Immunologic Factors|immunologic factors|mesh-ancestor
57071422|NCT05658497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071423|NCT05658497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57071424|NCT05658497|Dermatologic Agents|dermatologic agents|mesh-ancestor
57071425|NCT05658497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57071426|NCT05657457|Tenecteplase|tenecteplase|mesh-list
57071427|NCT05657457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57071428|NCT05657457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57071429|NCT05657457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071430|NCT05646316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57071431|NCT05645757|Ertapenem|ertapenem|mesh-list
57071432|NCT05645757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57071433|NCT05645757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071434|NCT05635344|Pembrolizumab|pembrolizumab|mesh-list
57071435|NCT05635344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071436|NCT05635344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071437|NCT05630989|Hydroxychloroquine|hydroxychloroquine|mesh-list
57071438|NCT05630989|Mitogens|mitogens|mesh-list
57071439|NCT05630989|Antimalarials|antimalarials|mesh-ancestor
57071440|NCT05630989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57071441|NCT05630989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57071442|NCT05630989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071443|NCT05630989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071444|NCT05630989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071445|NCT05630989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071446|NCT05630989|Mitosis Modulators|mitosis modulators|mesh-ancestor
57071447|NCT05626530|Letermovir|letermovir|mesh-list
57071448|NCT05626530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57071449|NCT05626530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071450|NCT05626530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071451|NCT05626530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071452|NCT05626530|Antiviral Agents|antiviral agents|mesh-ancestor
57071453|NCT05626530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071454|NCT05623020|Dexamethasone|dexamethasone|mesh-list
57071455|NCT05623020|Lenalidomide|lenalidomide|mesh-list
57071456|NCT05623020|Daratumumab|daratumumab|mesh-list
57071457|NCT05623020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071458|NCT05623020|Antiemetics|antiemetics|mesh-ancestor
57071459|NCT05623020|Autonomic Agents|autonomic agents|mesh-ancestor
57071460|NCT05623020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071461|NCT05623020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071462|NCT05623020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57071463|NCT05623020|Glucocorticoids|glucocorticoids|mesh-ancestor
57071464|NCT05623020|Hormones|hormones|mesh-ancestor
57071465|NCT05623020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071466|NCT05623020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57071467|NCT05623020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071468|NCT05623020|Immunologic Factors|immunologic factors|mesh-ancestor
57071469|NCT05623020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57071470|NCT05623020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57071471|NCT05623020|Growth Substances|growth substances|mesh-ancestor
57071472|NCT05623020|Growth Inhibitors|growth inhibitors|mesh-ancestor
57071473|NCT05610163|Leucovorin|leucovorin|mesh-list
57071474|NCT05610163|Fluorouracil|fluorouracil|mesh-list
57071475|NCT05610163|Capecitabine|capecitabine|mesh-list
57071476|NCT05610163|Oxaliplatin|oxaliplatin|mesh-list
57071477|NCT05610163|Irinotecan|irinotecan|mesh-list
57071478|NCT05610163|Calcium|calcium|mesh-list
57071479|NCT05610163|Levoleucovorin|levoleucovorin|mesh-list
57071480|NCT05610163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57071481|NCT05610163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071482|NCT05610163|Antimetabolites|antimetabolites|mesh-ancestor
57071483|NCT05610163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071484|NCT05610163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57071485|NCT05610163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071486|NCT05610163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57071487|NCT05610163|Immunologic Factors|immunologic factors|mesh-ancestor
57071488|NCT05610163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57071489|NCT05610163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57071490|NCT05610163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071491|NCT05610163|Antidotes|antidotes|mesh-ancestor
57071492|NCT05610163|Protective Agents|protective agents|mesh-ancestor
57071493|NCT05610163|Vitamin B Complex|vitamin b complex|mesh-ancestor
57071494|NCT05610163|Vitamins|vitamins|mesh-ancestor
57071495|NCT05610163|Micronutrients|micronutrients|mesh-ancestor
57071496|NCT05603104|Lamotrigine|lamotrigine|mesh-list
57071497|NCT05603104|Ketamine|ketamine|mesh-list
57071498|NCT05603104|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57071499|NCT05603104|Valproic Acid|valproic acid|mesh-list
57071500|NCT05603104|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57071501|NCT05603104|Clozapine|clozapine|mesh-list
57071502|NCT05603104|Antipsychotic Agents|antipsychotic agents|mesh-list
57071503|NCT05603104|Citalopram|citalopram|mesh-list
57071504|NCT05603104|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57071505|NCT05603104|Sertraline|sertraline|mesh-list
57071506|NCT05603104|Antidepressive Agents|antidepressive agents|mesh-list
57071507|NCT05603104|Esketamine|esketamine|mesh-list
57071508|NCT05603104|Analgesics|analgesics|mesh-ancestor
57071509|NCT05603104|Sensory System Agents|sensory system agents|mesh-ancestor
57071510|NCT05603104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071511|NCT05603104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071512|NCT05603104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57071513|NCT05603104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57071514|NCT05603104|Anesthetics, General|anesthetics, general|mesh-ancestor
57071515|NCT05603104|Anesthetics|anesthetics|mesh-ancestor
57071516|NCT05603104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071517|NCT05603104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57071518|NCT05603104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57071519|NCT05603104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071520|NCT05603104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071521|NCT05603104|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57071522|NCT05603104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57071523|NCT05603104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57071524|NCT05603104|Serotonin Agents|serotonin agents|mesh-ancestor
57071525|NCT05603104|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57071526|NCT05603104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57071527|NCT05603104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57071528|NCT05603104|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57071529|NCT05603104|Dopamine Agents|dopamine agents|mesh-ancestor
57071530|NCT05603104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071531|NCT05603104|Antimanic Agents|antimanic agents|mesh-ancestor
57071532|NCT05603104|Anticonvulsants|anticonvulsants|mesh-ancestor
57071533|NCT05603104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57071534|NCT05603104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57071535|NCT05603104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57071536|NCT05603104|GABA Agents|gaba agents|mesh-ancestor
57071537|NCT05603104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57071538|NCT05603104|GABA Antagonists|gaba antagonists|mesh-ancestor
57071539|NCT05601674|Anesthetics|anesthetics|mesh-list
57071540|NCT05601674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071541|NCT05601674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071542|NCT05590728|Apramycin|apramycin|mesh-list
57071543|NCT05590728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57071544|NCT05590728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071545|NCT05584657|Amoxicillin|amoxicillin|mesh-list
57071546|NCT05584657|Clavulanic Acid|clavulanic acid|mesh-list
57071547|NCT05584657|Clavulanic Acids|clavulanic acids|mesh-list
57071548|NCT05584657|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57071549|NCT05584657|Lactams|lactams|mesh-list
57071550|NCT05584657|Probenecid|probenecid|mesh-list
57071551|NCT05584657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56898841|NCT01293747|Progesterone|progesterone|mesh-list
57071552|NCT05584657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071553|NCT05584657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57071554|NCT05584657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071555|NCT05584657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071556|NCT05584657|Uricosuric Agents|uricosuric agents|mesh-ancestor
57071557|NCT05584657|Gout Suppressants|gout suppressants|mesh-ancestor
57071558|NCT05584657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071559|NCT05584657|Renal Agents|renal agents|mesh-ancestor
57071560|NCT05570812|Neurosteroids|neurosteroids|mesh-list
57071561|NCT05570812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071562|NCT05570812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071563|NCT05570812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071564|NCT05569954|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57071565|NCT05569954|Immunologic Factors|immunologic factors|mesh-ancestor
57071566|NCT05569954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071567|NCT05567835|Leucovorin|leucovorin|mesh-list
57071568|NCT05567835|Docetaxel|docetaxel|mesh-list
57071569|NCT05567835|Fluorouracil|fluorouracil|mesh-list
57071570|NCT05567835|Oxaliplatin|oxaliplatin|mesh-list
57071571|NCT05567835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071572|NCT05567835|Tubulin Modulators|tubulin modulators|mesh-ancestor
57071573|NCT05567835|Antimitotic Agents|antimitotic agents|mesh-ancestor
57071574|NCT05567835|Mitosis Modulators|mitosis modulators|mesh-ancestor
57071575|NCT05567835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071576|NCT05567835|Antimetabolites|antimetabolites|mesh-ancestor
57071577|NCT05567835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57071578|NCT05567835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57071579|NCT05567835|Immunologic Factors|immunologic factors|mesh-ancestor
57071580|NCT05567835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071581|NCT05567835|Antidotes|antidotes|mesh-ancestor
57071582|NCT05567835|Protective Agents|protective agents|mesh-ancestor
57071583|NCT05567835|Vitamin B Complex|vitamin b complex|mesh-ancestor
57071584|NCT05567835|Vitamins|vitamins|mesh-ancestor
57071585|NCT05567835|Micronutrients|micronutrients|mesh-ancestor
57071586|NCT05564052|Rituximab|rituximab|mesh-list
57071587|NCT05564052|Lenalidomide|lenalidomide|mesh-list
57071588|NCT05564052|Bortezomib|bortezomib|mesh-list
57071589|NCT05564052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071590|NCT05564052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071591|NCT05564052|Immunologic Factors|immunologic factors|mesh-ancestor
57071592|NCT05564052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071593|NCT05564052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071594|NCT05564052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57071595|NCT05564052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57071596|NCT05564052|Growth Substances|growth substances|mesh-ancestor
57071597|NCT05564052|Growth Inhibitors|growth inhibitors|mesh-ancestor
57071598|NCT05563961|Acetaminophen|acetaminophen|mesh-list
57071599|NCT05563961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57071600|NCT05563961|Analgesics|analgesics|mesh-ancestor
57071601|NCT05563961|Sensory System Agents|sensory system agents|mesh-ancestor
57071602|NCT05563961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071603|NCT05563961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071604|NCT05563961|Antipyretics|antipyretics|mesh-ancestor
57071605|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57071606|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57071607|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071608|NCT05552222|Dexamethasone|dexamethasone|mesh-list
57071609|NCT05552222|Lenalidomide|lenalidomide|mesh-list
57071610|NCT05552222|Daratumumab|daratumumab|mesh-list
57071611|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071612|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
57071613|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
57071614|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071615|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071616|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57071617|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
57071618|NCT05552222|Hormones|hormones|mesh-ancestor
57071619|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071620|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57071621|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071622|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
57071623|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57071624|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57071625|NCT05552222|Growth Substances|growth substances|mesh-ancestor
57071626|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
57071627|NCT05551104|Labetalol|labetalol|mesh-list
57071628|NCT05551104|Nifedipine|nifedipine|mesh-list
57071629|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57071630|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57071631|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071632|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56753614|NCT04035798|Memantine|memantine|mesh-list
57071633|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071634|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
57071635|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
57071636|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57071637|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57071638|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57071639|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
57071640|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071641|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57071642|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
57071643|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
57071644|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071645|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57071646|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57071647|NCT05527314|Fentanyl|fentanyl|mesh-list
57071648|NCT05527314|Remifentanil|remifentanil|mesh-list
57071649|NCT05527314|Sevoflurane|sevoflurane|mesh-list
57071650|NCT05527314|Cisatracurium|cisatracurium|mesh-list
57071651|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57071652|NCT05527314|Narcotics|narcotics|mesh-ancestor
57071653|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071654|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071655|NCT05527314|Analgesics|analgesics|mesh-ancestor
57071656|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
57071657|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071658|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57071659|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57071660|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
57071661|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
57071662|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57071663|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57071664|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57071665|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57071666|NCT05521087|Cytarabine|cytarabine|mesh-list
57071667|NCT05521087|Dexamethasone|dexamethasone|mesh-list
57071668|NCT05521087|Fludarabine|fludarabine|mesh-list
57071669|NCT05521087|Vincristine|vincristine|mesh-list
57071670|NCT05521087|Pegaspargase|pegaspargase|mesh-list
57071671|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071672|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
57071673|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
57071674|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071675|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071676|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57071677|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
57071678|NCT05521087|Hormones|hormones|mesh-ancestor
57071679|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071680|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57071681|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071682|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57071683|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
57071684|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071685|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57071686|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
57071687|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
57071688|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071689|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57071690|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
57071691|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
57071692|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
57071693|NCT05517122|Niacinamide|niacinamide|mesh-list
57071694|NCT05517122|Niacin|niacin|mesh-list
57071695|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
57071696|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
57071697|NCT05517122|Vitamins|vitamins|mesh-ancestor
57071698|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
57071699|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071700|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57071701|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
57071702|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071703|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57071704|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
57071705|NCT05509777|Mirikizumab|mirikizumab|mesh-list
57071706|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57071707|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57071708|NCT05509777|Analgesics|analgesics|mesh-ancestor
57071709|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
57071710|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071711|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071712|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071713|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071714|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57071715|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57071716|NCT05498428|Carboplatin|carboplatin|mesh-list
57071717|NCT05498428|Pemetrexed|pemetrexed|mesh-list
57071718|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
57071719|NCT05498428|Heparin|heparin|mesh-list
57071720|NCT05498428|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57071721|NCT05498428|Tinzaparin|tinzaparin|mesh-list
57071722|NCT05498428|Dalteparin|dalteparin|mesh-list
57071723|NCT05498428|Anticoagulants|anticoagulants|mesh-list
57071724|NCT05498428|Lazertinib|lazertinib|mesh-list
57071725|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071726|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071727|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071728|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57071729|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57071730|NCT05498428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57071731|NCT05498428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57071732|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57071733|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071734|NCT05498155|Durvalumab|durvalumab|mesh-list
57071735|NCT05498155|Olaparib|olaparib|mesh-list
57071736|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071737|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071738|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57071739|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071740|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071741|NCT05484505|Nicotine|nicotine|mesh-list
57071742|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57071743|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
57071744|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071745|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071746|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57071747|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57071748|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
57071749|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071750|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071751|NCT05483933|Doxorubicin|doxorubicin|mesh-list
57071752|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57071753|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57071754|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071755|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57071756|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57071757|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071758|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071759|NCT05478161|Fexofenadine|fexofenadine|mesh-list
57071760|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57071761|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57071762|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57071763|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
57071764|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
57071765|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071766|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071767|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071768|NCT05476822|Antibodies|antibodies|mesh-list
57071769|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
57071770|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071771|NCT05473364|Acetazolamide|acetazolamide|mesh-list
57071772|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
57071773|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57071774|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071775|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071776|NCT05473364|Diuretics|diuretics|mesh-ancestor
57071777|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
57071778|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071779|NCT05468489|Carboplatin|carboplatin|mesh-list
57071780|NCT05468489|Etoposide|etoposide|mesh-list
57071781|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
57071782|NCT05468489|Atezolizumab|atezolizumab|mesh-list
57071783|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071784|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57071785|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57071786|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56753760|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
57071787|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071788|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071789|NCT05457972|Estradiol|estradiol|mesh-list
57071790|NCT05457972|Estrogens|estrogens|mesh-ancestor
57071792|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071793|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071794|NCT05455684|Aticaprant|aticaprant|mesh-list
57071795|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57071796|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071797|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
57071798|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071799|NCT05453903|Azacitidine|azacitidine|mesh-list
57071800|NCT05453903|Venetoclax|venetoclax|mesh-list
57071801|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57071802|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
57071803|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071804|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071805|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071806|NCT05441280|Pimavanserin|pimavanserin|mesh-list
57071807|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57071808|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57071809|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57071810|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57071811|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071812|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071813|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57071814|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57071815|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57071816|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
57071817|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071818|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071819|NCT05413811|Fluorouracil|fluorouracil|mesh-list
57071820|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
57071821|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071822|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57071823|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071824|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57071825|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
57071826|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071827|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57071828|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
57071829|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071830|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
57071831|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
57071832|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57071833|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57071834|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57071835|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57071836|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57071837|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071838|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071839|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071840|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57071841|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
57071842|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57071843|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071844|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57071845|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57071846|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57071847|NCT05392608|Fulvestrant|fulvestrant|mesh-list
57071848|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57071849|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071850|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57071851|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57071852|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
57071853|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071854|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071855|NCT05388058|Cannabidiol|cannabidiol|mesh-list
57071856|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
57071857|NCT05382559|Cetuximab|cetuximab|mesh-list
57071858|NCT05382559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071859|NCT05382559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071860|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
57071861|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071862|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
57071863|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57071864|NCT05362058|Insulin|insulin|mesh-list
57071865|NCT05362058|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57071866|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57071867|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071868|NCT05351346|Prednisone|prednisone|mesh-list
57071869|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
57071870|NCT05351346|Rituximab|rituximab|mesh-list
57071871|NCT05351346|Doxorubicin|doxorubicin|mesh-list
57071872|NCT05351346|Vincristine|vincristine|mesh-list
57071873|NCT05351346|Lenalidomide|lenalidomide|mesh-list
57071874|NCT05351346|Decitabine|decitabine|mesh-list
57071875|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57071876|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
57071877|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071878|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071879|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57071880|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
57071881|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071882|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071883|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57071884|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071885|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57071886|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57071887|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57071888|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071889|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071890|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
57071891|NCT05351346|Hormones|hormones|mesh-ancestor
57071892|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071893|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57071894|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57071895|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
57071896|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
57071897|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
57071898|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57071899|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57071900|NCT05351346|Growth Substances|growth substances|mesh-ancestor
57071901|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
57071902|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57071903|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
57071904|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57071905|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071906|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071907|NCT05327010|Talazoparib|talazoparib|mesh-list
56898860|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071908|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57071909|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071910|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071911|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071912|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
57071913|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071914|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071915|NCT05323019|Ketamine|ketamine|mesh-list
57071916|NCT05323019|Esketamine|esketamine|mesh-list
57071917|NCT05323019|Analgesics|analgesics|mesh-ancestor
57071918|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
57071919|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071920|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071921|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57071922|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57071923|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
57071924|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
57071925|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071926|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57071927|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57071928|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57071929|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071930|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
57071931|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57071932|NCT05321420|Pirfenidone|pirfenidone|mesh-list
57071933|NCT05321420|Analgesics|analgesics|mesh-ancestor
57071934|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
57071935|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071936|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071937|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57071938|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57071939|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071940|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071941|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071942|NCT05280743|Oxycodone|oxycodone|mesh-list
57071943|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57071944|NCT05280743|Narcotics|narcotics|mesh-ancestor
57071945|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071946|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071947|NCT05280743|Analgesics|analgesics|mesh-ancestor
57071948|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
57071949|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071950|NCT05276258|Bupivacaine|bupivacaine|mesh-list
57071951|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
57071952|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
57071953|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57071954|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071955|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
57071956|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071957|NCT05261490|Doxorubicin|doxorubicin|mesh-list
57071958|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57071959|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57071960|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071961|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57071962|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57071963|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071964|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071965|NCT05250973|Dexamethasone|dexamethasone|mesh-list
57071966|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
57071967|NCT05250973|Bortezomib|bortezomib|mesh-list
57071968|NCT05250973|Daratumumab|daratumumab|mesh-list
57071969|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57071970|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
57071971|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57071972|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57071973|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57071974|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
57071975|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071976|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071977|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57071978|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57071979|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
57071980|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
56295865|NCT00101335|Celecoxib|celecoxib|mesh-list
57071981|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57071982|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57071983|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
57071984|NCT05250973|Hormones|hormones|mesh-ancestor
57071985|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57071986|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57071987|NCT05249426|Cetuximab|cetuximab|mesh-list
57071988|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57071989|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071990|NCT05233982|Olaparib|olaparib|mesh-list
57071991|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57071992|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57071993|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071994|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57071995|NCT05232071|Empagliflozin|empagliflozin|mesh-list
57071996|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57071997|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57071998|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57071999|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072000|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57072001|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
57072002|NCT05199493|Giapreza|giapreza|mesh-list
57072003|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
57072004|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57072005|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57072006|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
57072007|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072008|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072009|NCT05179876|Selexipag|selexipag|mesh-list
57072010|NCT05179876|Tadalafil|tadalafil|mesh-list
56753996|NCT00819806|Vaccines|vaccines|mesh-list
57072011|NCT05179876|Macitentan|macitentan|mesh-list
57072012|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
57072013|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57072014|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57072015|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072016|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072017|NCT05179876|Urological Agents|urological agents|mesh-ancestor
57072018|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57072019|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57072020|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57072021|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57072022|NCT05176951|Treprostinil|treprostinil|mesh-list
57072023|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57072024|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57072025|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
57072026|NCT05169658|Antibodies|antibodies|mesh-list
57072027|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
57072028|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57072029|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
57072030|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57072031|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
57072032|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072033|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072034|NCT05141305|Clopidogrel|clopidogrel|mesh-list
57072035|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072036|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072037|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57072038|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57072039|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57072040|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57072041|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
57072042|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57072043|NCT05112536|Paclitaxel|paclitaxel|mesh-list
57072044|NCT05112536|Carboplatin|carboplatin|mesh-list
57072045|NCT05112536|Doxorubicin|doxorubicin|mesh-list
57072046|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
57072047|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57072048|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072049|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072050|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072051|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072052|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072053|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57072054|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57072055|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57072056|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072057|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072058|NCT05111626|Nivolumab|nivolumab|mesh-list
57072059|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
57072060|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072061|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072062|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072063|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072064|NCT05111574|Nivolumab|nivolumab|mesh-list
57072065|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072066|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072067|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072068|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072069|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
57072070|NCT05109455|Procyanidin|procyanidin|mesh-list
57072071|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
57072072|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072073|NCT05109455|Protective Agents|protective agents|mesh-ancestor
57072074|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072075|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57072076|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57072077|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072078|NCT05098210|Poly I-C|poly i-c|mesh-list
57072079|NCT05098210|Nivolumab|nivolumab|mesh-list
57072080|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57072081|NCT05098210|Poly ICLC|poly iclc|mesh-list
57072082|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072083|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072084|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072085|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754061|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
57072086|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
57072087|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
57072088|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072089|NCT05098210|Laxatives|laxatives|mesh-ancestor
57072090|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57072091|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
57072092|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072093|NCT05098028|Rifaximin|rifaximin|mesh-list
57072094|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57072095|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072096|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57072097|NCT05079360|Everolimus|everolimus|mesh-list
57072098|NCT05079360|Exemestane|exemestane|mesh-list
57072099|NCT05079360|Estrogens|estrogens|mesh-list
57072100|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
57072101|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
57072102|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072103|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072104|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
57072105|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072106|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57072107|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57072108|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072109|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072110|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57072111|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
57072112|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072113|NCT05079360|Hormones|hormones|mesh-ancestor
57072114|NCT05078060|Vaccines|vaccines|mesh-list
57072115|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
57072116|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072117|NCT05075980|Cisplatin|cisplatin|mesh-list
57072118|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072119|NCT05071053|Ramucirumab|ramucirumab|mesh-list
57072120|NCT05071053|Maytansine|maytansine|mesh-list
57072121|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072122|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57072123|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072124|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072125|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072126|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072127|NCT05067634|Cenobamate|cenobamate|mesh-list
57072128|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
57072129|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
57072130|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072131|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072132|NCT05063786|Capecitabine|capecitabine|mesh-list
57072133|NCT05063786|Trastuzumab|trastuzumab|mesh-list
57072134|NCT05063786|Vinorelbine|vinorelbine|mesh-list
57072135|NCT05063786|Fulvestrant|fulvestrant|mesh-list
57072136|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072137|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
57072138|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072139|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072140|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072141|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57072142|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072143|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072144|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072145|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072146|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57072147|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57072148|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
57072149|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072150|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072151|NCT05037929|Astegolimab|astegolimab|mesh-list
57072152|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57072153|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57072154|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
57072155|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072156|NCT05035836|Tamoxifen|tamoxifen|mesh-list
57072157|NCT05035836|Letrozole|letrozole|mesh-list
57072158|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072159|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57072160|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57072161|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072162|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072163|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57072164|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
57072165|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072166|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072167|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072168|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57072169|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57072170|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57072171|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
57072172|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57072173|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57072174|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57072175|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57072176|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072177|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
57072178|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57072179|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072180|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57072181|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072182|NCT05020236|Dexamethasone|dexamethasone|mesh-list
57072183|NCT05020236|Daratumumab|daratumumab|mesh-list
57072184|NCT05020236|Pomalidomide|pomalidomide|mesh-list
57072185|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57072186|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
57072187|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
57072188|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072189|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072190|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57072191|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
57072192|NCT05020236|Hormones|hormones|mesh-ancestor
57072193|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072194|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072195|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072196|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
57072197|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57072198|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57072199|NCT05020236|Growth Substances|growth substances|mesh-ancestor
57072200|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
57072201|NCT05012787|Vaccines|vaccines|mesh-list
57072202|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
57072203|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
57072204|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072205|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57072206|NCT05005260|Bupivacaine|bupivacaine|mesh-list
57072207|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
57072208|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
57072209|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57072210|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072211|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
57072212|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072213|NCT04990167|Bromides|bromides|mesh-list
57072214|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
57072215|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57072216|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
57072217|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072218|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072219|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57072220|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
57072221|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
57072222|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57072223|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
57072224|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57072225|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072226|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
57072227|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
57072228|NCT04971226|Dasatinib|dasatinib|mesh-list
57072229|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072230|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57072231|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072232|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072233|NCT04965818|Futibatinib|futibatinib|mesh-list
57072234|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072235|NCT04939090|Megestrol|megestrol|mesh-list
57072236|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
56754212|NCT00720941|Sunitinib|sunitinib|mesh-list
57072237|NCT04939090|Olanzapine|olanzapine|mesh-list
57072238|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
57072239|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
57072240|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072241|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072242|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57072243|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57072244|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57072245|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57072246|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57072247|NCT04939090|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57072248|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57072249|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57072250|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072251|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57072252|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
57072253|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57072254|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57072255|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57072256|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
57072257|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57072258|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57072259|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57072260|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072261|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072262|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
57072263|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57072264|NCT04938830|Palivizumab|palivizumab|mesh-list
57072265|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
57072266|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072267|NCT04926181|Androgens|androgens|mesh-list
57072268|NCT04926181|Hormones|hormones|mesh-ancestor
57072269|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072270|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072271|NCT04924322|Enoxaparin|enoxaparin|mesh-list
57072272|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
57072273|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57072274|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57072275|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072276|NCT04919226|Leucovorin|leucovorin|mesh-list
57072277|NCT04919226|Folic Acid|folic acid|mesh-list
57072278|NCT04919226|Fluorouracil|fluorouracil|mesh-list
57072279|NCT04919226|Capecitabine|capecitabine|mesh-list
57072280|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
57072281|NCT04919226|Everolimus|everolimus|mesh-list
57072282|NCT04919226|Temozolomide|temozolomide|mesh-list
57072283|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57072284|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
57072285|NCT04919226|Edotreotide|edotreotide|mesh-list
57072286|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
57072287|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
57072288|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072289|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072290|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072291|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072292|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
57072293|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072294|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57072295|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
57072296|NCT04919226|Antidotes|antidotes|mesh-ancestor
57072297|NCT04919226|Protective Agents|protective agents|mesh-ancestor
57072298|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
57072299|NCT04919226|Vitamins|vitamins|mesh-ancestor
57072300|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
57072301|NCT04919226|Hematinics|hematinics|mesh-ancestor
57072302|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57072303|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
57072304|NCT04918927|Favipiravir|favipiravir|mesh-list
57072305|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57072306|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072307|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
57072308|NCT04907825|Warfarin|warfarin|mesh-list
57072309|NCT04907825|Anticoagulants|anticoagulants|mesh-list
57072310|NCT04907084|Fenofibrate|fenofibrate|mesh-list
57072311|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57072312|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
57072313|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072314|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57072316|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
57072317|NCT04899349|Fulvestrant|fulvestrant|mesh-list
57072318|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57072319|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072320|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57072321|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072322|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072323|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072324|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57072325|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57072326|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
57072327|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072328|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
57072329|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072330|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072331|NCT04893356|Dacarbazine|dacarbazine|mesh-list
57072332|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57072333|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
57072334|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072335|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072336|NCT04892043|Nivolumab|nivolumab|mesh-list
57072337|NCT04892043|Ipilimumab|ipilimumab|mesh-list
57072338|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072339|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072340|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072341|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072342|NCT04884815|Prednisolone|prednisolone|mesh-list
57072343|NCT04884815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57072344|NCT04884815|Glucocorticoids|glucocorticoids|mesh-ancestor
57072345|NCT04884815|Hormones|hormones|mesh-ancestor
57072346|NCT04884815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072347|NCT04884815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072348|NCT04884815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072349|NCT04884815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072350|NCT04858334|Olaparib|olaparib|mesh-list
57072351|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57072352|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072353|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072354|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072355|NCT04857983|Memantine|memantine|mesh-list
57072356|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57072357|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57072358|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
57072359|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57072360|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072361|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072362|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57072363|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57072364|NCT04821622|Talazoparib|talazoparib|mesh-list
57072365|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57072366|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072367|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072368|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072369|NCT04793958|Cetuximab|cetuximab|mesh-list
57072370|NCT04793958|Adagrasib|adagrasib|mesh-list
57072371|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072372|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072373|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
57072374|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072375|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072376|NCT04774094|Ceftazidime|ceftazidime|mesh-list
57072377|NCT04774094|Avibactam|avibactam|mesh-list
57072378|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
57072379|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57072380|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072381|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57072382|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072383|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072384|NCT04763512|Caseins|caseins|mesh-list
57072385|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
57072386|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
56754376|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
57072387|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072389|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072390|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072391|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072392|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072393|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
57072394|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072395|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072396|NCT04704154|Nivolumab|nivolumab|mesh-list
57072397|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072398|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072399|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072400|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072401|NCT04685135|Docetaxel|docetaxel|mesh-list
57072402|NCT04685135|Adagrasib|adagrasib|mesh-list
57072403|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072404|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072405|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072406|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072407|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072408|NCT04671667|Cisplatin|cisplatin|mesh-list
57072409|NCT04671667|Carboplatin|carboplatin|mesh-list
57072410|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
57072411|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072412|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072413|NCT04662944|Ranibizumab|ranibizumab|mesh-list
57072414|NCT04662944|Aflibercept|aflibercept|mesh-list
57072415|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57072416|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57072417|NCT04662944|Growth Substances|growth substances|mesh-ancestor
57072418|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072419|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
57072420|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072421|NCT04658862|Gemcitabine|gemcitabine|mesh-list
57072422|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072423|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072424|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
57072425|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072426|NCT04658862|Antiviral Agents|antiviral agents|mesh-ancestor
57072427|NCT04658862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072428|NCT04658862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072429|NCT04658862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072430|NCT04658862|Immunologic Factors|immunologic factors|mesh-ancestor
57072431|NCT04658862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072432|NCT04626141|Abaloparatide|abaloparatide|mesh-list
57072433|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57072434|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072435|NCT04602117|Paclitaxel|paclitaxel|mesh-list
57072436|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57072437|NCT04602117|Trastuzumab|trastuzumab|mesh-list
57072438|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57072439|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072440|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072441|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072442|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072443|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072444|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072445|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
57072446|NCT04601857|Futibatinib|futibatinib|mesh-list
57072447|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072448|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072449|NCT04590508|Xanthohumol|xanthohumol|mesh-list
57072450|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072451|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57072452|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57072453|NCT04590508|Growth Substances|growth substances|mesh-ancestor
57072454|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072455|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
57072456|NCT04576117|Vinblastine|vinblastine|mesh-list
57072457|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57072458|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072459|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072460|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072461|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072462|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072464|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57072465|NCT04564443|Calcium|calcium|mesh-list
57072466|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57072467|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072468|NCT04543383|Thrombin|thrombin|mesh-list
57072469|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
57072470|NCT04543383|Coagulants|coagulants|mesh-ancestor
57072471|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
57072472|NCT04541355|Cisplatin|cisplatin|mesh-list
57072473|NCT04541355|Antidotes|antidotes|mesh-list
57072474|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072475|NCT04541355|Protective Agents|protective agents|mesh-ancestor
57072476|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072477|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
57072478|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072479|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
57072480|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57072481|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072482|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
57072483|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
57072484|NCT04521231|Blinatumomab|blinatumomab|mesh-list
57072485|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072486|NCT04517396|Fenofibrate|fenofibrate|mesh-list
57072487|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
57072488|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57072489|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
57072490|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072491|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57072492|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57072493|NCT04501978|Remdesivir|remdesivir|mesh-list
57072494|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
57072495|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
57072496|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072497|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
57072498|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072499|NCT04455750|Leuprolide|leuprolide|mesh-list
57072500|NCT04455750|Goserelin|goserelin|mesh-list
57072501|NCT04455750|Rucaparib|rucaparib|mesh-list
57072502|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57072503|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
57072504|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57072505|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072506|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072507|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072508|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57072509|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072510|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072511|NCT04435782|Selexipag|selexipag|mesh-list
57072512|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57072513|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57072514|NCT04382352|Trastuzumab|trastuzumab|mesh-list
57072515|NCT04382352|Antibodies|antibodies|mesh-list
57072516|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
57072517|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57072518|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
57072519|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072520|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072521|NCT04354246|Pembrolizumab|pembrolizumab|mesh-list
57072522|NCT04354246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072523|NCT04354246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072524|NCT04353492|Ofatumumab|ofatumumab|mesh-list
57072525|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072526|NCT04311424|Tirzepatide|tirzepatide|mesh-list
57072527|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57072528|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072529|NCT04311424|Incretins|incretins|mesh-ancestor
57072530|NCT04311424|Hormones|hormones|mesh-ancestor
57072531|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072532|NCT04301765|Testosterone|testosterone|mesh-list
57072533|NCT04301765|Androgens|androgens|mesh-ancestor
57072534|NCT04301765|Hormones|hormones|mesh-ancestor
57072535|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072536|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072537|NCT04296396|Oxycodone|oxycodone|mesh-list
57072538|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57072539|NCT04296396|Narcotics|narcotics|mesh-ancestor
57072540|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57072541|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072542|NCT04296396|Analgesics|analgesics|mesh-ancestor
57072543|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
57072544|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072545|NCT04291456|Minocycline|minocycline|mesh-list
57072546|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57072547|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072548|NCT04273945|Macitentan|macitentan|mesh-list
57072549|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57072550|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57072551|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072552|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57072553|NCT04271475|Macitentan|macitentan|mesh-list
57072554|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57072555|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57072556|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072557|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57072558|NCT04266977|Dexamethasone|dexamethasone|mesh-list
57072559|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57072560|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
57072561|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
57072562|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072563|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072564|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57072565|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
57072566|NCT04266977|Hormones|hormones|mesh-ancestor
57072567|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072568|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072569|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072570|NCT04261439|Spartalizumab|spartalizumab|mesh-list
57072571|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072572|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072573|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072574|NCT04221542|Docetaxel|docetaxel|mesh-list
57072575|NCT04221542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072576|NCT04221542|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072577|NCT04221542|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072578|NCT04221542|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072579|NCT04221542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072580|NCT04216316|Gemcitabine|gemcitabine|mesh-list
57072581|NCT04216316|Carboplatin|carboplatin|mesh-list
57072582|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
57072583|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072584|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072585|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
57072586|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072587|NCT04216316|Antiviral Agents|antiviral agents|mesh-ancestor
57072588|NCT04216316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072589|NCT04216316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072590|NCT04216316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072591|NCT04216316|Immunologic Factors|immunologic factors|mesh-ancestor
57072592|NCT04216316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072593|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072594|NCT04195945|Cytarabine|cytarabine|mesh-list
57072595|NCT04195945|Daunorubicin|daunorubicin|mesh-list
57072596|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
57072597|NCT04195945|Cladribine|cladribine|mesh-list
57072598|NCT04195945|Lenograstim|lenograstim|mesh-list
57072599|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072600|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
57072601|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072602|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072603|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
57072604|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072605|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072606|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
57072607|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072608|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57072609|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57072610|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57072611|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072612|NCT04195945|Analgesics|analgesics|mesh-ancestor
56754581|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57072613|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
57072614|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072615|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57072616|NCT04189445|Futibatinib|futibatinib|mesh-list
57072617|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072618|NCT04185883|Docetaxel|docetaxel|mesh-list
57072619|NCT04185883|Bevacizumab|bevacizumab|mesh-list
57072620|NCT04185883|Carboplatin|carboplatin|mesh-list
57072621|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
57072622|NCT04185883|Pemetrexed|pemetrexed|mesh-list
57072623|NCT04185883|Everolimus|everolimus|mesh-list
57072624|NCT04185883|Atezolizumab|atezolizumab|mesh-list
57072625|NCT04185883|Palbociclib|palbociclib|mesh-list
57072626|NCT04185883|Panitumumab|panitumumab|mesh-list
57072627|NCT04185883|Trametinib|trametinib|mesh-list
57072628|NCT04185883|Afatinib|afatinib|mesh-list
57072629|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072630|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072631|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072632|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072633|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072634|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072635|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57072636|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57072637|NCT04185883|Growth Substances|growth substances|mesh-ancestor
57072638|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072639|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
57072640|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072641|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57072642|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57072643|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072644|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
57072645|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57072646|NCT04172922|Sirolimus|sirolimus|mesh-list
57072647|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57072648|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072649|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57072650|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072651|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
57072652|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072653|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
57072654|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072655|NCT04149899|Timolol|timolol|mesh-list
57072656|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57072657|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57072658|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
57072659|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57072660|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072661|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072662|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57072663|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57072664|NCT04139772|Docetaxel|docetaxel|mesh-list
57072665|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
57072666|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072667|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072668|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072669|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072670|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072671|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57072672|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072673|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
57072674|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072675|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072676|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57072677|NCT04136353|Hormones|hormones|mesh-list
57072678|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
57072679|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072680|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072681|NCT04133636|Dexamethasone|dexamethasone|mesh-list
57072682|NCT04133636|Lenalidomide|lenalidomide|mesh-list
57072683|NCT04133636|Bortezomib|bortezomib|mesh-list
57072684|NCT04133636|Daratumumab|daratumumab|mesh-list
57072685|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57072686|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
57072687|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
57072688|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072689|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072690|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57072691|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
57072692|NCT04133636|Hormones|hormones|mesh-ancestor
57072693|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072694|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072695|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072696|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
57072697|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57072698|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57072699|NCT04133636|Growth Substances|growth substances|mesh-ancestor
57072700|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
57072701|NCT04094688|Vitamin D|vitamin d|mesh-list
57072702|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
57072703|NCT04094688|Leucovorin|leucovorin|mesh-list
57072704|NCT04094688|Bevacizumab|bevacizumab|mesh-list
57072705|NCT04094688|Fluorouracil|fluorouracil|mesh-list
57072706|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
57072707|NCT04094688|Irinotecan|irinotecan|mesh-list
57072708|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
57072709|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072710|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072711|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57072712|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57072713|NCT04094688|Growth Substances|growth substances|mesh-ancestor
57072714|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072715|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
57072716|NCT04094688|Vitamins|vitamins|mesh-ancestor
57072717|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
57072718|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57072719|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57072720|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
57072721|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072722|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072723|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072724|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
57072725|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57072726|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57072727|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072728|NCT04094688|Antidotes|antidotes|mesh-ancestor
57072729|NCT04094688|Protective Agents|protective agents|mesh-ancestor
57072730|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
57072731|NCT04093362|Gemcitabine|gemcitabine|mesh-list
57072732|NCT04093362|Futibatinib|futibatinib|mesh-list
57072733|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072734|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072735|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
57072736|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072737|NCT04093362|Antiviral Agents|antiviral agents|mesh-ancestor
57072738|NCT04093362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072739|NCT04093362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072740|NCT04093362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072741|NCT04093362|Immunologic Factors|immunologic factors|mesh-ancestor
57072742|NCT04093362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072743|NCT04091204|Olaparib|olaparib|mesh-list
57072744|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57072745|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072746|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072747|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072748|NCT04050670|Tirzepatide|tirzepatide|mesh-list
57072749|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57072750|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072751|NCT04050670|Incretins|incretins|mesh-ancestor
57072752|NCT04050670|Hormones|hormones|mesh-ancestor
57072753|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072754|NCT04041050|Celecoxib|celecoxib|mesh-list
57072755|NCT04041050|Navitoclax|navitoclax|mesh-list
57072756|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57072757|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57072758|NCT04041050|Analgesics|analgesics|mesh-ancestor
57072759|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
57072760|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072761|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072762|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57072763|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57072764|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57072765|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56754730|NCT00907764|Regadenoson|regadenoson|mesh-list
57072766|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072767|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072768|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072769|NCT04028245|Spartalizumab|spartalizumab|mesh-list
57072770|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072771|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072772|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072773|NCT04023526|Azacitidine|azacitidine|mesh-list
57072774|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072775|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
57072776|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072777|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072778|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898894|NCT03847623|Curcumin|curcumin|mesh-list
57072779|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57072780|NCT04017650|Nivolumab|nivolumab|mesh-list
57072781|NCT04017650|Cetuximab|cetuximab|mesh-list
57072782|NCT04017650|Antibodies|antibodies|mesh-list
57072783|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
57072784|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57072785|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
57072786|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072787|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072788|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072789|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072790|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
57072791|NCT03988036|Trastuzumab|trastuzumab|mesh-list
57072792|NCT03988036|Pertuzumab|pertuzumab|mesh-list
57072793|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072794|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072795|NCT03975114|Durvalumab|durvalumab|mesh-list
57072796|NCT03975114|Tremelimumab|tremelimumab|mesh-list
57072797|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072798|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072799|NCT03955783|Venetoclax|venetoclax|mesh-list
57072800|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072801|NCT03942211|Selexipag|selexipag|mesh-list
57072802|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57072803|NCT03942120|Ustekinumab|ustekinumab|mesh-list
57072804|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
57072805|NCT03940742|Tirzepatide|tirzepatide|mesh-list
57072806|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57072807|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072808|NCT03940742|Incretins|incretins|mesh-ancestor
57072809|NCT03940742|Hormones|hormones|mesh-ancestor
57072810|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072811|NCT03904693|Tadalafil|tadalafil|mesh-list
57072812|NCT03904693|Macitentan|macitentan|mesh-list
57072813|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
57072814|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57072815|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57072816|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072817|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072818|NCT03904693|Urological Agents|urological agents|mesh-ancestor
57072819|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57072820|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57072821|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57072822|NCT03893240|Antibodies|antibodies|mesh-list
57072823|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
57072824|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
57072825|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072826|NCT03878199|Cytarabine|cytarabine|mesh-list
57072827|NCT03878199|Daunorubicin|daunorubicin|mesh-list
57072828|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
57072829|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072830|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
57072831|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072832|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072833|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
57072834|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072835|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072836|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
57072837|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072838|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57072839|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57072840|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57072841|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072842|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57072843|NCT03878095|Olaparib|olaparib|mesh-list
57072844|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57072845|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072846|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072847|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072848|NCT03875378|Estrogens|estrogens|mesh-list
57072849|NCT03875378|Hormones|hormones|mesh-ancestor
57072850|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072851|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072852|NCT03875274|Morphine|morphine|mesh-list
57072853|NCT03875274|Ropivacaine|ropivacaine|mesh-list
57072854|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57072855|NCT03875274|Narcotics|narcotics|mesh-ancestor
57072856|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57072857|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072858|NCT03875274|Analgesics|analgesics|mesh-ancestor
57072859|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
57072860|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072861|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
57072862|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
57072863|NCT03836040|Erenumab|erenumab|mesh-list
57072864|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57072865|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57072866|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072867|NCT03836040|Analgesics|analgesics|mesh-ancestor
57072868|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
57072869|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072870|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072871|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
57072872|NCT03832998|Erenumab|erenumab|mesh-list
57072873|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57072874|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57072875|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072876|NCT03832998|Analgesics|analgesics|mesh-ancestor
57072877|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
57072878|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072879|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072880|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
57072881|NCT03829501|Atezolizumab|atezolizumab|mesh-list
57072882|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072883|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
57072884|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072885|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072886|NCT03762109|Dantrolene|dantrolene|mesh-list
57072887|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57072888|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072889|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57072890|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072891|NCT03739996|Cabotegravir|cabotegravir|mesh-list
57072892|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
57072893|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57072894|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57072895|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072896|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072897|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57072898|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57072899|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
57072900|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072901|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57072902|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
57072903|NCT03732664|Nivolumab|nivolumab|mesh-list
57072904|NCT03732664|Durvalumab|durvalumab|mesh-list
57072905|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072906|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072907|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57072908|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072909|NCT03725436|Paclitaxel|paclitaxel|mesh-list
57072910|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57072911|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57072912|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072913|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072914|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072915|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072916|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072917|NCT03620032|Vinorelbine|vinorelbine|mesh-list
57072919|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57072920|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072921|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072922|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072923|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072924|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072925|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072926|NCT03582033|Dexamethasone|dexamethasone|mesh-list
57072927|NCT03582033|Pomalidomide|pomalidomide|mesh-list
57072928|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57072929|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
57072930|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
57072931|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57072932|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072933|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57072934|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
57072935|NCT03582033|Hormones|hormones|mesh-ancestor
57072936|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57072937|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57072938|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072939|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
57072940|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57072941|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57072942|NCT03582033|Growth Substances|growth substances|mesh-ancestor
57072943|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
57072944|NCT03504397|Leucovorin|leucovorin|mesh-list
57072945|NCT03504397|Folic Acid|folic acid|mesh-list
57072946|NCT03504397|Fluorouracil|fluorouracil|mesh-list
57072947|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
57072948|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
57072949|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
57072950|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072951|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57072952|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072953|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57072954|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
57072955|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57072956|NCT03504397|Antidotes|antidotes|mesh-ancestor
57072957|NCT03504397|Protective Agents|protective agents|mesh-ancestor
57072958|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
57072959|NCT03504397|Vitamins|vitamins|mesh-ancestor
57072960|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
57072961|NCT03504397|Hematinics|hematinics|mesh-ancestor
57072962|NCT03480191|Daptomycin|daptomycin|mesh-list
57072963|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57072964|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072965|NCT03474107|Paclitaxel|paclitaxel|mesh-list
57072966|NCT03474107|Docetaxel|docetaxel|mesh-list
57072967|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57072968|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072969|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072970|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072971|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072972|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072973|NCT03472560|Avelumab|avelumab|mesh-list
57072974|NCT03472560|Axitinib|axitinib|mesh-list
57072975|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072976|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072977|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57072978|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57072979|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072980|NCT03422328|Macitentan|macitentan|mesh-list
57072981|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57072982|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57072983|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072984|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57072985|NCT03410784|Paclitaxel|paclitaxel|mesh-list
57072986|NCT03410784|Carboplatin|carboplatin|mesh-list
57072987|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
57072988|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57072989|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57072990|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
57072991|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
57072992|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
57072993|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57072994|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57072995|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
57072996|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
57072997|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57072998|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
57072999|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56898901|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57073000|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57073001|NCT03355482|Prednisolone|prednisolone|mesh-list
57073002|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
57073003|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57073004|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
57073005|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57073006|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
57073007|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
57073008|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57073009|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073010|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57073011|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
57073012|NCT03355482|Hormones|hormones|mesh-ancestor
57073013|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57073014|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57073015|NCT03355482|Protective Agents|protective agents|mesh-ancestor
57073016|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57073017|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073018|NCT03340064|Levetiracetam|levetiracetam|mesh-list
57073019|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
57073020|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
57073021|NCT03326921|Vidarabine|vidarabine|mesh-list
57073022|NCT03326921|Fludarabine|fludarabine|mesh-list
57073023|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
57073024|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073025|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073026|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
57073027|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073028|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073029|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
57073030|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073031|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
57073032|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073033|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57073034|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073035|NCT03310619|Nivolumab|nivolumab|mesh-list
57073036|NCT03310619|Durvalumab|durvalumab|mesh-list
57073037|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073038|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073039|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57073040|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073041|NCT03269669|Prednisone|prednisone|mesh-list
57073042|NCT03269669|Cortisone|cortisone|mesh-list
57073043|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
57073044|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57073045|NCT03269669|Doxorubicin|doxorubicin|mesh-list
57073046|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57073047|NCT03269669|Vincristine|vincristine|mesh-list
57073048|NCT03269669|Lenalidomide|lenalidomide|mesh-list
57073049|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
57073050|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073051|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
57073052|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073053|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073054|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57073055|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
57073056|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073057|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073058|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57073059|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57073060|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57073061|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57073062|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073063|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57073064|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
57073065|NCT03269669|Hormones|hormones|mesh-ancestor
57073066|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57073067|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57073068|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073069|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073070|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073072|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57073073|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57073074|NCT03269669|Growth Substances|growth substances|mesh-ancestor
57073075|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
57073076|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073077|NCT03263572|Cytarabine|cytarabine|mesh-list
57073078|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57073079|NCT03263572|Methotrexate|methotrexate|mesh-list
57073080|NCT03263572|Blinatumomab|blinatumomab|mesh-list
57073081|NCT03263572|Ponatinib|ponatinib|mesh-list
57073082|NCT03263572|Antibodies|antibodies|mesh-list
57073083|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
57073084|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57073085|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
57073086|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57073087|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
57073088|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073089|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073090|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57073091|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
57073092|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57073093|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073094|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
57073095|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073096|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
57073097|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073098|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57073099|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073100|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073101|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57073102|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
57073103|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073104|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57073105|NCT03263117|Anesthetics|anesthetics|mesh-list
57073106|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57073107|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073108|NCT03232073|Ponesimod|ponesimod|mesh-list
57073109|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57073110|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073111|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073112|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
57073113|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073114|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
57073115|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
57073116|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073117|NCT03170518|Canagliflozin|canagliflozin|mesh-list
57073118|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57073119|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073120|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57073121|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073122|NCT03093064|Natalizumab|natalizumab|mesh-list
57073123|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
57073124|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073125|NCT03073967|Foscarnet|foscarnet|mesh-list
57073126|NCT03073967|Pritelivir|pritelivir|mesh-list
57073127|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
57073128|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073129|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57073130|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57073131|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073132|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073133|NCT03064126|Paclitaxel|paclitaxel|mesh-list
57073134|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57073135|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073136|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073137|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073138|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073139|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073140|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073141|NCT03060577|Evolocumab|evolocumab|mesh-list
57073142|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57073143|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57073144|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
56755129|NCT00827996|Adalimumab|adalimumab|mesh-list
57073145|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073146|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57073147|NCT02932410|Macitentan|macitentan|mesh-list
57073148|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57073149|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57073150|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073151|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57073152|NCT02797275|Albuterol|albuterol|mesh-list
57073153|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57073154|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
57073155|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57073156|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073157|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57073158|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
57073159|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
57073160|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57073161|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57073162|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57073163|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57073164|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
57073165|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57073166|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073167|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
57073168|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073169|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
57073170|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073171|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073172|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57073173|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
57073174|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073175|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073176|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57073177|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
57073178|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073179|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073180|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
57073181|NCT02750319|Amiodarone|amiodarone|mesh-list
57073182|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57073183|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
57073184|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073185|NCT02750319|Expectorants|expectorants|mesh-ancestor
57073186|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
57073187|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57073188|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
57073189|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073190|NCT02750319|Protective Agents|protective agents|mesh-ancestor
57073191|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073192|NCT02750319|Antidotes|antidotes|mesh-ancestor
57073193|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57073194|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
57073195|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57073196|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57073197|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57073198|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57073199|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57073200|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073201|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57073202|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57073203|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57073204|NCT02734290|Paclitaxel|paclitaxel|mesh-list
57073205|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
57073206|NCT02734290|Capecitabine|capecitabine|mesh-list
57073207|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073208|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073209|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073210|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073211|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073212|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073213|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073214|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073215|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
57073216|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
57073217|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073218|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073219|NCT02633189|Bevacizumab|bevacizumab|mesh-list
57073220|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57073221|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073222|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073223|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57073224|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57073225|NCT02633189|Growth Substances|growth substances|mesh-ancestor
57073226|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073227|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
57073228|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57073229|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073230|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073231|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57073232|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57073233|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57073234|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073235|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073236|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
57073237|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073238|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57073239|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57073240|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
57073241|NCT02601313|Fludarabine|fludarabine|mesh-list
57073242|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073243|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
57073244|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073245|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073246|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57073247|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
57073248|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073249|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073250|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57073251|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
57073252|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57073253|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073254|NCT02514083|Fludarabine|fludarabine|mesh-list
57073255|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073256|NCT02500576|Aldesleukin|aldesleukin|mesh-list
57073257|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
57073258|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
57073259|NCT02500576|Fludarabine|fludarabine|mesh-list
57073260|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
57073261|NCT02500576|Interleukin-2|interleukin-2|mesh-list
57073262|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073263|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
57073264|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073265|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073266|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57073267|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
57073268|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073269|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073270|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57073271|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073272|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073273|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
57073274|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57073275|NCT02500576|Analgesics|analgesics|mesh-ancestor
57073276|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
57073277|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57073278|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57073279|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57073280|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
57073281|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073282|NCT02453282|Gemcitabine|gemcitabine|mesh-list
57073283|NCT02453282|Paclitaxel|paclitaxel|mesh-list
57073284|NCT02453282|Cisplatin|cisplatin|mesh-list
57073285|NCT02453282|Carboplatin|carboplatin|mesh-list
57073286|NCT02453282|Pemetrexed|pemetrexed|mesh-list
57073287|NCT02453282|Durvalumab|durvalumab|mesh-list
57073288|NCT02453282|Tremelimumab|tremelimumab|mesh-list
57073289|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57073290|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073291|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073292|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073293|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073294|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073295|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073296|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073298|NCT02453282|Antiviral Agents|antiviral agents|mesh-ancestor
57073299|NCT02453282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073300|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073301|NCT02453282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073302|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
57073303|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073304|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57073305|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57073306|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073307|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
57073308|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57073309|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073310|NCT02339571|Nivolumab|nivolumab|mesh-list
57073311|NCT02339571|Ipilimumab|ipilimumab|mesh-list
57073312|NCT02339571|Sargramostim|sargramostim|mesh-list
57073313|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073314|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073315|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57073316|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073317|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
57073318|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073319|NCT02214381|Paclitaxel|paclitaxel|mesh-list
57073320|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
57073321|NCT02214381|Doxorubicin|doxorubicin|mesh-list
57073322|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073323|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073324|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073325|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073326|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073327|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073328|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073329|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
57073330|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073331|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073332|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57073333|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
57073334|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57073335|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57073336|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57073337|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57073338|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073339|NCT02185560|Sorafenib|sorafenib|mesh-list
57073340|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073341|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57073342|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073343|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073344|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
57073345|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57073346|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
57073347|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073348|NCT02078427|BAX 855|bax 855|mesh-list
57073349|NCT02078427|Coagulants|coagulants|mesh-ancestor
57073350|NCT02061761|Nivolumab|nivolumab|mesh-list
57073351|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073352|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073353|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57073354|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073355|NCT01974440|Prednisone|prednisone|mesh-list
57073356|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
57073357|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57073358|NCT01974440|Rituximab|rituximab|mesh-list
57073359|NCT01974440|Doxorubicin|doxorubicin|mesh-list
57073360|NCT01974440|Vincristine|vincristine|mesh-list
57073361|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073362|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
57073363|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073364|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073365|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57073366|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
57073367|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073368|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073369|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57073370|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073371|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57073372|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57073373|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57073374|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073375|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57073376|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
57073377|NCT01974440|Hormones|hormones|mesh-ancestor
57073378|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57073379|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57073380|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073381|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073382|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073383|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073384|NCT01927068|Paclitaxel|paclitaxel|mesh-list
57073385|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073386|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073387|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073388|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073389|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073390|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073391|NCT01898104|Capecitabine|capecitabine|mesh-list
57073392|NCT01898104|Valproic Acid|valproic acid|mesh-list
57073393|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073394|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
57073395|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073396|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073397|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
57073398|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073399|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
57073400|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57073401|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073402|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
57073403|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57073404|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57073405|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57073406|NCT01817452|Paclitaxel|paclitaxel|mesh-list
57073407|NCT01817452|Trastuzumab|trastuzumab|mesh-list
57073408|NCT01817452|Pertuzumab|pertuzumab|mesh-list
57073409|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073410|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073411|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073412|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073413|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073414|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073415|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073416|NCT01815242|Gemcitabine|gemcitabine|mesh-list
57073417|NCT01815242|Paclitaxel|paclitaxel|mesh-list
57073418|NCT01815242|Carboplatin|carboplatin|mesh-list
57073419|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073420|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073421|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073422|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073423|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073424|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073425|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073426|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
57073427|NCT01815242|Antiviral Agents|antiviral agents|mesh-ancestor
57073428|NCT01815242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073429|NCT01815242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073430|NCT01815242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073431|NCT01815242|Immunologic Factors|immunologic factors|mesh-ancestor
57073432|NCT01815242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073433|NCT01802749|Gemcitabine|gemcitabine|mesh-list
57073434|NCT01802749|Paclitaxel|paclitaxel|mesh-list
57073435|NCT01802749|Bevacizumab|bevacizumab|mesh-list
57073436|NCT01802749|Carboplatin|carboplatin|mesh-list
57073437|NCT01802749|Doxorubicin|doxorubicin|mesh-list
57073438|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57073439|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073440|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073441|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073442|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
56755404|NCT00933582|Naproxen|naproxen|mesh-list
57073443|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073444|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073445|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073446|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57073447|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57073448|NCT01802749|Growth Substances|growth substances|mesh-ancestor
57073449|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073450|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
57073451|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073452|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
57073453|NCT01802749|Antiviral Agents|antiviral agents|mesh-ancestor
57073454|NCT01802749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073455|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073456|NCT01802749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073457|NCT01802749|Immunologic Factors|immunologic factors|mesh-ancestor
57073458|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57073459|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57073460|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57073461|NCT01801904|Panitumumab|panitumumab|mesh-list
57073462|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073463|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073464|NCT01779206|Paclitaxel|paclitaxel|mesh-list
57073465|NCT01779206|Docetaxel|docetaxel|mesh-list
57073466|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
57073467|NCT01779206|Epirubicin|epirubicin|mesh-list
57073468|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073469|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073470|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073471|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073472|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073473|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073474|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073475|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
57073476|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073477|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073478|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57073479|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
57073480|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57073481|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57073482|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57073483|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57073484|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073485|NCT01745965|Trastuzumab|trastuzumab|mesh-list
57073486|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073487|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073488|NCT01706120|Paclitaxel|paclitaxel|mesh-list
57073489|NCT01706120|Bevacizumab|bevacizumab|mesh-list
57073490|NCT01706120|Carboplatin|carboplatin|mesh-list
57073491|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073492|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073493|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073494|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073495|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073496|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073497|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073498|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57073499|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57073500|NCT01706120|Growth Substances|growth substances|mesh-ancestor
57073501|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073502|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
57073503|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
57073504|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57073505|NCT01682941|Estrogens|estrogens|mesh-ancestor
57073506|NCT01682941|Hormones|hormones|mesh-ancestor
57073507|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57073508|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073509|NCT01656551|Gemcitabine|gemcitabine|mesh-list
57073510|NCT01656551|Pemetrexed|pemetrexed|mesh-list
57073511|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073512|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073513|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
57073514|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073515|NCT01656551|Antiviral Agents|antiviral agents|mesh-ancestor
57073516|NCT01656551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073517|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073518|NCT01656551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073519|NCT01656551|Immunologic Factors|immunologic factors|mesh-ancestor
57073520|NCT01656551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073521|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57073522|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57073523|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
57073524|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
57073525|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57073526|NCT01649674|Cathartics|cathartics|mesh-ancestor
57073527|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57073528|NCT01628211|Leucovorin|leucovorin|mesh-list
57073529|NCT01628211|Folic Acid|folic acid|mesh-list
57073530|NCT01628211|Fluorouracil|fluorouracil|mesh-list
57073531|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
57073532|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
57073533|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
57073534|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073535|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073536|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073537|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073538|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
57073539|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073540|NCT01628211|Antidotes|antidotes|mesh-ancestor
57073541|NCT01628211|Protective Agents|protective agents|mesh-ancestor
57073542|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
57073543|NCT01628211|Vitamins|vitamins|mesh-ancestor
57073544|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
57073545|NCT01628211|Hematinics|hematinics|mesh-ancestor
57073546|NCT01593488|Cytarabine|cytarabine|mesh-list
57073547|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073548|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
57073549|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073550|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073551|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
57073552|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073553|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073554|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
57073555|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073556|NCT01405586|Gemcitabine|gemcitabine|mesh-list
57073557|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073558|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073559|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
57073560|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073561|NCT01405586|Antiviral Agents|antiviral agents|mesh-ancestor
57073562|NCT01405586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073563|NCT01405586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073564|NCT01405586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073565|NCT01405586|Immunologic Factors|immunologic factors|mesh-ancestor
57073566|NCT01405586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073567|NCT01309230|Vaccines|vaccines|mesh-list
57073568|NCT01309230|Immunologic Factors|immunologic factors|mesh-ancestor
57073569|NCT01309230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073570|NCT01294020|Tacrolimus|tacrolimus|mesh-list
57073571|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073572|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
57073573|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073574|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57073575|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073576|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073577|NCT01238692|Rituximab|rituximab|mesh-list
57073578|NCT01238692|Panobinostat|panobinostat|mesh-list
57073579|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073580|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073581|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
57073582|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073583|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073584|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57073585|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073586|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073587|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
57073588|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57073589|NCT01209871|Antibodies|antibodies|mesh-list
57073590|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
56898912|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57073591|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073592|NCT01093326|Ponesimod|ponesimod|mesh-list
57073593|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57073594|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073595|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073596|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
57073597|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073598|NCT01042379|Metformin|metformin|mesh-list
57073599|NCT01042379|Paclitaxel|paclitaxel|mesh-list
57073600|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
57073601|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57073602|NCT01042379|Carboplatin|carboplatin|mesh-list
57073603|NCT01042379|Doxorubicin|doxorubicin|mesh-list
57073604|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
57073605|NCT01042379|Trastuzumab|trastuzumab|mesh-list
57073606|NCT01042379|Irinotecan|irinotecan|mesh-list
57073607|NCT01042379|Durvalumab|durvalumab|mesh-list
57073608|NCT01042379|Letrozole|letrozole|mesh-list
57073609|NCT01042379|Olaparib|olaparib|mesh-list
57073610|NCT01042379|Pertuzumab|pertuzumab|mesh-list
57073611|NCT01042379|Veliparib|veliparib|mesh-list
57073612|NCT01042379|Cemiplimab|cemiplimab|mesh-list
57073613|NCT01042379|Talazoparib|talazoparib|mesh-list
57073614|NCT01042379|Trebananib|trebananib|mesh-list
57073615|NCT01042379|Tucatinib|tucatinib|mesh-list
57073616|NCT01042379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57073617|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073618|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073619|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073620|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073621|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073622|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073623|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57073624|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073625|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57073626|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57073627|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57073628|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073629|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073630|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57073631|NCT01042379|Immunologic Factors|immunologic factors|mesh-ancestor
57073632|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57073633|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57073634|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57073635|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
57073636|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57073637|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57073638|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57073639|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57073640|NCT01042379|Growth Substances|growth substances|mesh-ancestor
57073641|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
57073642|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57073643|NCT00996983|Ziconotide|ziconotide|mesh-list
57073644|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57073645|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57073646|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073647|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57073648|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073649|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57073650|NCT00996983|Protective Agents|protective agents|mesh-ancestor
57073651|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57073652|NCT00996983|Analgesics|analgesics|mesh-ancestor
57073653|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
57073654|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57073655|NCT00660842|Paclitaxel|paclitaxel|mesh-list
57073656|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57073657|NCT00660842|Carboplatin|carboplatin|mesh-list
57073658|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073659|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073660|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073661|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073662|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073663|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073664|NCT00657878|Gemcitabine|gemcitabine|mesh-list
57073665|NCT00657878|Paclitaxel|paclitaxel|mesh-list
57073666|NCT00657878|Carboplatin|carboplatin|mesh-list
57073667|NCT00657878|Doxorubicin|doxorubicin|mesh-list
57073668|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57073669|NCT00657878|Topotecan|topotecan|mesh-list
57073670|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073671|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755627|NCT00832208|Amphotericin B|amphotericin b|mesh-list
57073672|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073673|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073674|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073675|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073676|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57073677|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
57073678|NCT00657878|Antiviral Agents|antiviral agents|mesh-ancestor
57073679|NCT00657878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073680|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073681|NCT00657878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57073682|NCT00657878|Immunologic Factors|immunologic factors|mesh-ancestor
57073683|NCT00657878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073684|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57073685|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57073686|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57073687|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57073688|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
57073689|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57073690|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57073691|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57073692|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073693|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
57073694|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57073695|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073696|NCT00526396|Cisplatin|cisplatin|mesh-list
57073697|NCT00526396|Etoposide|etoposide|mesh-list
57073698|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
57073699|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073700|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073701|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57073702|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57073703|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073704|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073705|NCT00431704|Carboplatin|carboplatin|mesh-list
57073706|NCT00431704|Trastuzumab|trastuzumab|mesh-list
57073707|NCT00431704|Vinorelbine|vinorelbine|mesh-list
57073708|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073709|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57073710|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57073711|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
57073712|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
57073713|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
57073714|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073715|NCT00412022|Tamoxifen|tamoxifen|mesh-list
57073716|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
57073717|NCT00412022|Letrozole|letrozole|mesh-list
57073718|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57073719|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073720|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57073721|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57073722|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073723|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073724|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57073725|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
57073726|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57073727|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073728|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57073729|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57073730|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57073731|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57073732|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
57073733|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57073734|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
57073735|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57073736|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57073737|NCT00324922|Vancomycin|vancomycin|mesh-list
57073738|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57073739|NCT00324922|Trimethoprim|trimethoprim|mesh-list
57073740|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
57073741|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57073742|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073743|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57073744|NCT00324922|Renal Agents|renal agents|mesh-ancestor
57073745|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
57073746|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57073747|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57073748|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57073749|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073750|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073751|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57073752|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57073753|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57073755|NCT03474510|Ropivacaine|ropivacaine|mesh-list
57073756|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
57073757|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
57073758|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57073759|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073760|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
57073761|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57073762|NCT02470832|Itraconazole|itraconazole|mesh-list
57073763|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
57073764|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073765|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57073766|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57073767|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073768|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073769|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57073770|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
57073771|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57073772|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073773|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57073774|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
57073775|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57073776|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
57073777|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073778|NCT05258682|Expectorants|expectorants|mesh-ancestor
57073779|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
57073780|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57073781|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
57073782|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073783|NCT05258682|Protective Agents|protective agents|mesh-ancestor
57073784|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073785|NCT05258682|Antidotes|antidotes|mesh-ancestor
57073786|NCT02228031|Oxytocin|oxytocin|mesh-list
57073787|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
57073788|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57073789|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073790|NCT04458948|Azithromycin|azithromycin|mesh-list
57073791|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
57073792|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57073793|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073794|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
57073795|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57073796|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57073797|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073798|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073799|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073800|NCT02232399|Simendan|simendan|mesh-list
57073801|NCT02232399|Milrinone|milrinone|mesh-list
57073802|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57073803|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
57073804|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57073805|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57073806|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073807|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073808|NCT02232399|Protective Agents|protective agents|mesh-ancestor
57073809|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073810|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57073811|NCT00704522|Ribavirin|ribavirin|mesh-list
57073812|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57073813|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
57073814|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073815|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
57073816|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073817|NCT04458558|Mifepristone|mifepristone|mesh-list
57073818|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57073819|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
57073820|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57073821|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073822|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57073823|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57073824|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57073825|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
57073826|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57073827|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57073828|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
57073829|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57073830|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
57073831|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57073832|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57073833|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
57073834|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
57073835|NCT03930498|Antibodies|antibodies|mesh-list
57073836|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
57073837|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
57073838|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073839|NCT03817554|Dopamine|dopamine|mesh-list
57073840|NCT03817554|Pramipexole|pramipexole|mesh-list
57073841|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
57073842|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
57073843|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073844|NCT03817554|Protective Agents|protective agents|mesh-ancestor
57073845|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073846|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57073847|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57073848|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
57073849|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57073850|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57073851|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
57073852|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
57073853|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57073854|NCT02223819|Crizotinib|crizotinib|mesh-list
57073855|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073856|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57073857|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073858|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073859|NCT03474198|Levofloxacin|levofloxacin|mesh-list
57073860|NCT03474198|Rifampin|rifampin|mesh-list
57073861|NCT03474198|Isoniazid|isoniazid|mesh-list
57073862|NCT03474198|Linezolid|linezolid|mesh-list
57073863|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
57073864|NCT03474198|Ethambutol|ethambutol|mesh-list
57073865|NCT03474198|Rifapentine|rifapentine|mesh-list
57073866|NCT03474198|Bedaquiline|bedaquiline|mesh-list
57073867|NCT03474198|Clofazimine|clofazimine|mesh-list
57073868|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57073869|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073870|NCT03474198|Renal Agents|renal agents|mesh-ancestor
57073871|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57073872|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57073873|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57073874|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073875|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073876|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073877|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57073878|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57073879|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57073880|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
57073881|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
57073882|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57073883|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57073884|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57073885|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57073886|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57073887|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57073888|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57073889|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57073890|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57073891|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
57073892|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57073893|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57073894|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57073895|NCT02723630|Lenvatinib|lenvatinib|mesh-list
57073896|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073897|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57073898|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073899|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073900|NCT02866227|TOL-463|tol-463|mesh-list
57073901|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073902|NCT05258136|Antibodies|antibodies|mesh-list
57073903|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57073904|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
57073905|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073906|NCT04356326|Aspirin|aspirin|mesh-list
57073907|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57073908|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57073909|NCT04356326|Analgesics|analgesics|mesh-ancestor
57073910|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
57073911|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57073912|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073913|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57073914|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073915|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57073916|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57073917|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073918|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57073919|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57073920|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073921|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
57073922|NCT02224131|Aspirin|aspirin|mesh-list
57073923|NCT02224131|Clopidogrel|clopidogrel|mesh-list
57073924|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57073925|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57073926|NCT02224131|Analgesics|analgesics|mesh-ancestor
56898920|NCT03847155|Nicotine|nicotine|mesh-list
57073927|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
57073928|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57073929|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073930|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57073931|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57073932|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57073933|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57073934|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073935|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57073936|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57073937|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073938|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
57073939|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57073940|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57073941|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57073942|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
57073943|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57073944|NCT02068586|Sunitinib|sunitinib|mesh-list
57073945|NCT02068586|Valproic Acid|valproic acid|mesh-list
57073946|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57073947|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57073948|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57073949|NCT02068586|Growth Substances|growth substances|mesh-ancestor
57073950|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073951|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
57073952|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57073953|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073954|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073955|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
57073956|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
57073957|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57073958|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
57073959|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57073960|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57073961|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57073962|NCT04634799|Plasminogen|plasminogen|mesh-list
57073963|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
57073964|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
57073965|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57073966|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57073967|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073968|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57073969|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
57073970|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073971|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57073972|NCT03473964|Hormones|hormones|mesh-ancestor
57073973|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57073974|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073975|NCT03309644|Iodine|iodine|mesh-list
57073976|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57073977|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57073978|NCT03309644|Trace Elements|trace elements|mesh-ancestor
57073979|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
57073980|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073981|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
57073982|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
57073983|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
57073984|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57073985|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073986|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57073987|NCT02008292|Physostigmine|physostigmine|mesh-list
57073988|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57073989|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57073990|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57073991|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
57073992|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57073993|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57073994|NCT02008292|Miotics|miotics|mesh-ancestor
57073995|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
57073996|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57073997|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57073998|NCT03477864|Ipilimumab|ipilimumab|mesh-list
57073999|NCT03477864|Cemiplimab|cemiplimab|mesh-list
57074000|NCT03477864|Antibodies|antibodies|mesh-list
57074001|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
57074002|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57074003|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
57074004|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074005|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074006|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57074007|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074008|NCT02229045|Paclitaxel|paclitaxel|mesh-list
57074009|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57074010|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57074011|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074012|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
57074013|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
57074014|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
57074015|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074016|NCT02229123|Levetiracetam|levetiracetam|mesh-list
57074017|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
57074018|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
57074019|NCT02229201|Propofol|propofol|mesh-list
57074020|NCT02229201|Sevoflurane|sevoflurane|mesh-list
57074021|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57074022|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074023|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074024|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57074025|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
57074026|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
57074027|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57074028|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57074029|NCT02224443|Fentanyl|fentanyl|mesh-list
57074030|NCT02224443|Midazolam|midazolam|mesh-list
57074031|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
57074032|NCT02224443|Remifentanil|remifentanil|mesh-list
57074033|NCT02224443|Propofol|propofol|mesh-list
57074034|NCT02224443|Etomidate|etomidate|mesh-list
57074035|NCT02224443|Sevoflurane|sevoflurane|mesh-list
57074036|NCT02224443|Atracurium|atracurium|mesh-list
57074037|NCT02224443|Cisatracurium|cisatracurium|mesh-list
57074038|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57074039|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074040|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074041|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57074042|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
57074043|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
57074044|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57074045|NCT02224443|Analgesics|analgesics|mesh-ancestor
57074046|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
57074047|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074048|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57074049|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57074050|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57074051|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
57074052|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074053|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074054|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57074055|NCT02224443|Narcotics|narcotics|mesh-ancestor
57074056|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57074057|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57074058|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57074059|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57074060|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
57074061|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
57074062|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57074063|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57074064|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57074065|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57074066|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57074067|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57074068|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57074069|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
57074070|NCT05183126|Paclitaxel|paclitaxel|mesh-list
57074071|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57074072|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57074073|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074074|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
57074075|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
57074076|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
57074077|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074078|NCT01944800|Ticagrelor|ticagrelor|mesh-list
57074079|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57074080|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57074081|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57074082|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57074083|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57074084|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
57074085|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074086|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074087|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074088|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57074089|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57074090|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57074091|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074092|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074093|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57074094|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57074095|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074096|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
57074097|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074098|NCT02470676|Progesterone|progesterone|mesh-list
57074099|NCT02470676|Progestins|progestins|mesh-ancestor
57074100|NCT02470676|Hormones|hormones|mesh-ancestor
57074101|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074102|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074103|NCT01933724|Prednisone|prednisone|mesh-list
57074104|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
57074105|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074106|NCT01933724|Hormones|hormones|mesh-ancestor
57074107|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074108|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074109|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57074110|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074111|NCT02229747|Diclofenac|diclofenac|mesh-list
57074112|NCT02229747|Meloxicam|meloxicam|mesh-list
57074113|NCT02229747|Nimesulide|nimesulide|mesh-list
57074114|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57074115|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57074116|NCT02229747|Analgesics|analgesics|mesh-ancestor
57074117|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
57074118|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074119|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074120|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074121|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57074122|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57074123|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074124|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074125|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57074126|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
57074128|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074129|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57074130|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
57074131|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074132|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074133|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57074134|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57074135|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57074136|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
57074137|NCT03030222|Empagliflozin|empagliflozin|mesh-list
57074138|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57074139|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074140|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57074141|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074142|NCT02232945|Oseltamivir|oseltamivir|mesh-list
57074143|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
57074144|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074145|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074146|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074147|NCT02546622|Factor VIII|factor viii|mesh-list
57074148|NCT02546622|Coagulants|coagulants|mesh-ancestor
57074149|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57074150|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57074151|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57074152|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57074153|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074154|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074155|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074156|NCT02229825|Analgesics|analgesics|mesh-ancestor
57074157|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
57074158|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074159|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
57074160|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57074161|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
57074162|NCT03309566|Tenofovir|tenofovir|mesh-list
57074163|NCT03309566|Emtricitabine|emtricitabine|mesh-list
57074164|NCT03309566|Efavirenz|efavirenz|mesh-list
57074165|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
57074166|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074167|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57074168|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57074169|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074170|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074171|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57074172|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57074173|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57074174|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57074175|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57074176|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57074177|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57074178|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57074179|NCT00735657|Iodine|iodine|mesh-list
57074180|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57074181|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074182|NCT00735657|Trace Elements|trace elements|mesh-ancestor
57074183|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
57074184|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074185|NCT04030143|Aripiprazole|aripiprazole|mesh-list
57074186|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
57074187|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57074188|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57074189|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57074190|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074191|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074192|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
57074193|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
57074194|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074195|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756151|NCT05407155|Growth Substances|growth substances|mesh-ancestor
57074196|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57074197|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57074198|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
57074199|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57074200|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57074201|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57074202|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57074203|NCT02470442|Sevoflurane|sevoflurane|mesh-list
57074204|NCT02470442|Desflurane|desflurane|mesh-list
57074205|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57074206|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57074207|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
57074208|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
57074209|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074210|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074211|NCT01329939|Montelukast|montelukast|mesh-list
57074212|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57074213|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
57074214|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57074215|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
57074216|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074217|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891126|NCT02757885|Thiotepa|thiotepa|mesh-list
57074218|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57074219|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57074220|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074221|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
57074222|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
57074223|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57074224|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
57074225|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074226|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57074227|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57074228|NCT04554693|Metronidazole|metronidazole|mesh-list
57074229|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074230|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57074231|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57074232|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57074233|NCT02230371|Granisetron|granisetron|mesh-list
57074234|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
57074235|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
57074236|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074237|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074238|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074239|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57074240|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
57074241|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074242|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074243|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
57074244|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57074245|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
57074246|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074247|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
57074248|NCT03313934|Protective Agents|protective agents|mesh-ancestor
57074249|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
57074250|NCT03313856|Antacids|antacids|mesh-ancestor
57074251|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074252|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074253|NCT03798626|Leucovorin|leucovorin|mesh-list
57074254|NCT03798626|Paclitaxel|paclitaxel|mesh-list
57074255|NCT03798626|Bevacizumab|bevacizumab|mesh-list
57074256|NCT03798626|Fluorouracil|fluorouracil|mesh-list
57074257|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
57074258|NCT03798626|Irinotecan|irinotecan|mesh-list
57074259|NCT03798626|Ramucirumab|ramucirumab|mesh-list
57074260|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
57074261|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57074262|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074263|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
57074264|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
57074265|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
57074266|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074267|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074268|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57074269|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57074270|NCT03798626|Growth Substances|growth substances|mesh-ancestor
57074271|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074273|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
57074274|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57074275|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57074276|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
57074277|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57074278|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57074279|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074280|NCT03798626|Antidotes|antidotes|mesh-ancestor
57074281|NCT03798626|Protective Agents|protective agents|mesh-ancestor
57074282|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
57074283|NCT03798626|Vitamins|vitamins|mesh-ancestor
57074284|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
57074285|NCT03313544|Nivolumab|nivolumab|mesh-list
57074286|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074287|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074288|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57074289|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074290|NCT05137626|Digoxin|digoxin|mesh-list
57074291|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57074292|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57074293|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074294|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074295|NCT05137626|Protective Agents|protective agents|mesh-ancestor
57074296|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074297|NCT03427125|Sevelamer|sevelamer|mesh-list
57074298|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
57074299|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
57074300|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074301|NCT02233023|Dopamine|dopamine|mesh-list
57074302|NCT02233023|Pramipexole|pramipexole|mesh-list
57074303|NCT02233023|Bromocriptine|bromocriptine|mesh-list
57074304|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
57074305|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
57074306|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074307|NCT02233023|Protective Agents|protective agents|mesh-ancestor
57074308|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074309|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57074310|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57074311|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
57074312|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074313|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57074314|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
57074315|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
57074316|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074317|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
57074318|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074319|NCT03710642|Prazosin|prazosin|mesh-list
57074320|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57074321|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57074322|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57074323|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57074324|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
57074325|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074326|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074327|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074328|NCT02259309|Misoprostol|misoprostol|mesh-list
57074329|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57074330|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
57074331|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57074332|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074333|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57074334|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074335|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
57074336|NCT04459026|Ropivacaine|ropivacaine|mesh-list
57074337|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
57074338|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
57074339|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074340|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074341|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
57074342|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074343|NCT03473418|Ketoconazole|ketoconazole|mesh-list
57074344|NCT03473418|Terconazole|terconazole|mesh-list
57074345|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
56756298|NCT01010308|Nadolol|nadolol|mesh-list
57074346|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074347|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57074348|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57074349|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074350|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074351|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57074352|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
57074353|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074354|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074355|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57074356|NCT04282278|Apatinib|apatinib|mesh-list
57074357|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074358|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57074359|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074360|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074361|NCT00705224|Interferons|interferons|mesh-list
57074362|NCT00705224|Ribavirin|ribavirin|mesh-list
57074363|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074364|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
57074365|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074366|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
57074367|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074368|NCT02457156|Octreotide|octreotide|mesh-list
57074369|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074370|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57074371|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074372|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
57074373|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
57074374|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074375|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
57074376|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
57074377|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074378|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074379|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074380|NCT02523300|Hormones|hormones|mesh-ancestor
57074381|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074382|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57074383|NCT02523300|Protective Agents|protective agents|mesh-ancestor
57074384|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
57074385|NCT02325960|Exenatide|exenatide|mesh-list
57074386|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57074387|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074388|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57074389|NCT02325960|Incretins|incretins|mesh-ancestor
57074390|NCT02325960|Hormones|hormones|mesh-ancestor
57074391|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074392|NCT05265650|Nivolumab|nivolumab|mesh-list
57074393|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074394|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074395|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57074396|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074397|NCT02234349|Pancrelipase|pancrelipase|mesh-list
57074398|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074399|NCT04458636|Prednisolone|prednisolone|mesh-list
57074400|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074401|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
57074402|NCT04458636|Hormones|hormones|mesh-ancestor
57074403|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074404|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074405|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57074406|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074407|NCT03304652|Zaleplon|zaleplon|mesh-list
57074408|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
57074409|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57074410|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074411|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074412|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
57074413|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
57074414|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074415|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074416|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57074417|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56756372|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57074418|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
57074419|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
57074420|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57074421|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074422|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074423|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57074424|NCT02523144|Analgesics|analgesics|mesh-ancestor
57074425|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
57074426|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074427|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57074428|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57074429|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57074430|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
57074431|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074432|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074433|NCT03856047|Liraglutide|liraglutide|mesh-list
57074434|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57074435|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074436|NCT03856047|Incretins|incretins|mesh-ancestor
57074437|NCT03856047|Hormones|hormones|mesh-ancestor
57074438|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074439|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57074440|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57074441|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074442|NCT00704132|Incretins|incretins|mesh-ancestor
57074443|NCT00704132|Hormones|hormones|mesh-ancestor
57074444|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074445|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57074446|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
57074447|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074448|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074449|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
57074450|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57074451|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
57074452|NCT03840837|Rivastigmine|rivastigmine|mesh-list
57074453|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57074454|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074455|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074456|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
57074457|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074458|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074459|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57074460|NCT03840837|Protective Agents|protective agents|mesh-ancestor
57074461|NCT04860141|Gabapentin|gabapentin|mesh-list
57074462|NCT04860141|Analgesics|analgesics|mesh-ancestor
57074463|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
57074464|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074465|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074466|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
57074467|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57074468|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57074469|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074470|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57074471|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57074472|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57074473|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074474|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074475|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
57074476|NCT03527238|Tacrolimus|tacrolimus|mesh-list
57074477|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57074478|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
57074479|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074480|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57074481|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074482|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074483|NCT03832179|Dexamethasone|dexamethasone|mesh-list
57074484|NCT03832179|Bevacizumab|bevacizumab|mesh-list
57074485|NCT03832179|Ranibizumab|ranibizumab|mesh-list
57074486|NCT03832179|Aflibercept|aflibercept|mesh-list
57074487|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074488|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074489|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57074490|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57074491|NCT03832179|Growth Substances|growth substances|mesh-ancestor
57074492|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074493|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
57074494|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074495|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
57074496|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
57074497|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074498|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074499|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
57074500|NCT03832179|Hormones|hormones|mesh-ancestor
57074501|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074502|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57074503|NCT03123783|Nivolumab|nivolumab|mesh-list
57074504|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074505|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074506|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57074507|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074508|NCT05154396|Loperamide|loperamide|mesh-list
57074509|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
57074510|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074511|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57074512|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
57074513|NCT04740645|Coagulants|coagulants|mesh-ancestor
57074514|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57074515|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
57074516|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074517|NCT04735185|Anesthetics|anesthetics|mesh-list
57074518|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
57074519|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074520|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074521|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
57074522|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074523|NCT02802813|Piperaquine|piperaquine|mesh-list
57074524|NCT02802813|Primaquine|primaquine|mesh-list
57074525|NCT02802813|Artenimol|artenimol|mesh-list
57074526|NCT02802813|Artemisinins|artemisinins|mesh-list
57074527|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
57074528|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57074529|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57074530|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074531|NCT05134584|Lactulose|lactulose|mesh-list
57074532|NCT05134584|Linaclotide|linaclotide|mesh-list
57074533|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074534|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57074535|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
57074536|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074537|NCT05633277|Polidocanol|polidocanol|mesh-list
57074538|NCT05633277|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57074539|NCT05633277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57074540|NCT04692831|Pertuzumab|pertuzumab|mesh-list
57074541|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074542|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074543|NCT03312140|Choline|choline|mesh-list
57074544|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
57074545|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57074546|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
57074547|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074548|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074549|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57074550|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
57074551|NCT02233179|Calpastatin|calpastatin|mesh-list
57074552|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
57074553|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
57074554|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074555|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074556|NCT04596657|Vitamin D|vitamin d|mesh-list
57074557|NCT04596657|Vitamins|vitamins|mesh-ancestor
57074558|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
57074559|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074560|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57074561|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57074562|NCT03311984|Dalteparin|dalteparin|mesh-list
57074563|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
57074564|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57074565|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57074566|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756524|NCT00842114|Prednisone|prednisone|mesh-list
57074567|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
57074568|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57074569|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
57074570|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074571|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
57074572|NCT03311906|Protective Agents|protective agents|mesh-ancestor
57074573|NCT04554459|Ponatinib|ponatinib|mesh-list
57074574|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074575|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57074576|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074577|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074578|NCT03311750|Panitumumab|panitumumab|mesh-list
57074579|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074580|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074581|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
57074582|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074583|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074584|NCT03311516|Insulin|insulin|mesh-list
57074585|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57074586|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57074587|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074588|NCT04528329|Dexamethasone|dexamethasone|mesh-list
57074589|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
57074590|NCT04528329|BB 1101|bb 1101|mesh-list
57074591|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074592|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
57074593|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
57074594|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074595|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074596|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074597|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
57074598|NCT04528329|Hormones|hormones|mesh-ancestor
57074599|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074600|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57074601|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074602|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
57074603|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074604|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074605|NCT02811939|Dronabinol|dronabinol|mesh-list
57074606|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
57074607|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074608|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57074609|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57074610|NCT02811939|Analgesics|analgesics|mesh-ancestor
57074611|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
57074612|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074613|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57074614|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57074615|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074616|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074617|NCT02811939|Hormones|hormones|mesh-ancestor
57074618|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074619|NCT01329549|Carboplatin|carboplatin|mesh-list
57074620|NCT01329549|Nintedanib|nintedanib|mesh-list
57074621|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074622|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57074623|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074624|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074625|NCT02234739|Voriconazole|voriconazole|mesh-list
57074626|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
57074627|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074628|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57074629|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57074630|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074631|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074632|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57074633|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
57074634|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074635|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074636|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57074637|NCT02736474|Naltrexone|naltrexone|mesh-list
57074638|NCT02736474|Bupropion|bupropion|mesh-list
57074639|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57074640|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57074641|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074642|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
57074643|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074644|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57074645|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
57074646|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57074647|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57074648|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57074649|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56898970|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
57074650|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074651|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
57074652|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074653|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57074654|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57074655|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074657|NCT03302390|Epinephrine|epinephrine|mesh-list
57074658|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
57074659|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
57074660|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074661|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074662|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
57074663|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074664|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57074665|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57074666|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57074667|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57074668|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074669|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57074670|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57074671|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
57074672|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074673|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57074674|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57074675|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
57074676|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57074677|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
57074678|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
57074679|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
57074680|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57074681|NCT03712371|Chitosan|chitosan|mesh-list
57074682|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57074683|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57074684|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
57074685|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074686|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57074687|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
57074688|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
57074689|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
57074690|NCT03712371|Coagulants|coagulants|mesh-ancestor
57074691|NCT03472950|Ranolazine|ranolazine|mesh-list
57074692|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57074693|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57074694|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074695|NCT03301766|Lidocaine|lidocaine|mesh-list
57074696|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
57074697|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
57074698|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074699|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074700|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
57074701|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074702|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57074703|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57074704|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57074705|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57074706|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074707|NCT03706521|Lorecivivint|lorecivivint|mesh-list
57074708|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074709|NCT02259543|Tetracycline|tetracycline|mesh-list
57074710|NCT02259543|Citric Acid|citric acid|mesh-list
57074711|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
57074712|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57074713|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074714|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57074715|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074716|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074717|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
57074718|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57074719|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
57074720|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
57074722|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57074723|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074724|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
57074725|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
57074726|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
57074727|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074728|NCT04343235|Labetalol|labetalol|mesh-list
57074729|NCT04343235|Furosemide|furosemide|mesh-list
57074730|NCT04343235|Diuretics|diuretics|mesh-ancestor
57074731|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
57074732|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074733|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57074734|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57074735|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074736|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57074737|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57074738|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
57074739|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074740|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57074741|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
57074742|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
57074743|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074744|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57074745|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57074746|NCT05727410|Docetaxel|docetaxel|mesh-list
57074747|NCT05727410|Nivolumab|nivolumab|mesh-list
57074748|NCT05727410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074749|NCT05727410|Tubulin Modulators|tubulin modulators|mesh-ancestor
57074750|NCT05727410|Antimitotic Agents|antimitotic agents|mesh-ancestor
57074751|NCT05727410|Mitosis Modulators|mitosis modulators|mesh-ancestor
57074752|NCT05727410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074753|NCT05727410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074754|NCT05727410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57074755|NCT02467010|Dexamethasone|dexamethasone|mesh-list
57074756|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
57074757|NCT02467010|Bortezomib|bortezomib|mesh-list
57074758|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57074759|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
57074760|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074761|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57074762|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57074763|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
57074764|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074765|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074766|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57074767|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074768|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
57074769|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
57074770|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074771|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074772|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
57074773|NCT02467010|Hormones|hormones|mesh-ancestor
57074774|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074775|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57074776|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57074777|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57074778|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57074779|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57074780|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074781|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074782|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074783|NCT02232555|Analgesics|analgesics|mesh-ancestor
57074784|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
57074785|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074786|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
57074787|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57074788|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
57074789|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
57074790|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57074791|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57074792|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074793|NCT00702650|Testosterone|testosterone|mesh-list
57074794|NCT00702650|Androgens|androgens|mesh-ancestor
57074795|NCT00702650|Hormones|hormones|mesh-ancestor
56298706|NCT00402142|Vaccines|vaccines|mesh-list
57074796|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074797|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074798|NCT03230916|Relebactam|relebactam|mesh-list
57074799|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57074800|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074801|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074802|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57074803|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074804|NCT04210713|Minocycline|minocycline|mesh-list
57074805|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57074806|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57074807|NCT01337115|Ropivacaine|ropivacaine|mesh-list
57074808|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
57074809|NCT01337115|Anesthetics|anesthetics|mesh-list
57074810|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074811|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074812|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
57074813|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074814|NCT03761784|Tretinoin|tretinoin|mesh-list
57074815|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57074816|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
57074817|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074818|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
57074819|NCT05727098|Ketamine|ketamine|mesh-list
57074820|NCT05727098|Bupivacaine|bupivacaine|mesh-list
57074821|NCT05727098|Anesthetics, Local|anesthetics, local|mesh-list
57074822|NCT05727098|Anesthetics|anesthetics|mesh-list
57074823|NCT05727098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074824|NCT05727098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074825|NCT05727098|Sensory System Agents|sensory system agents|mesh-ancestor
57074826|NCT05727098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074827|NCT05727098|Analgesics|analgesics|mesh-ancestor
57074828|NCT05727098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57074829|NCT05727098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57074830|NCT05727098|Anesthetics, General|anesthetics, general|mesh-ancestor
57074831|NCT05727098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57074832|NCT05727098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57074833|NCT05727098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074834|NCT05727098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074835|NCT03300440|Vitamins|vitamins|mesh-list
57074836|NCT03300440|Biotin|biotin|mesh-list
57074837|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
57074838|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
57074839|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074840|NCT02236065|Lenograstim|lenograstim|mesh-list
57074841|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57074842|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
57074843|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074844|NCT02467556|Morphine|morphine|mesh-list
57074845|NCT02467556|Memantine|memantine|mesh-list
57074846|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57074847|NCT02467556|Narcotics|narcotics|mesh-ancestor
57074848|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074849|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074850|NCT02467556|Analgesics|analgesics|mesh-ancestor
57074851|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
57074852|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074853|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57074854|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57074855|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
57074856|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074857|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074858|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57074859|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57074860|NCT02262585|Telmisartan|telmisartan|mesh-list
57074861|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57074862|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57074863|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57074864|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074865|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57074866|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
57074867|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57074869|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57074870|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
57074871|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57074872|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074873|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57074874|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57074875|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57074876|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57074877|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074878|NCT05358639|Olaparib|olaparib|mesh-list
57074879|NCT05358639|Navitoclax|navitoclax|mesh-list
57074880|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57074881|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074882|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074883|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074884|NCT02602353|Loxoprofen|loxoprofen|mesh-list
57074885|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57074886|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57074887|NCT02602353|Analgesics|analgesics|mesh-ancestor
57074888|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
57074889|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074890|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074891|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074892|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57074893|NCT04983498|Ondansetron|ondansetron|mesh-list
57074894|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
57074895|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
57074896|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074897|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074898|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57074899|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
57074900|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
57074901|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57074902|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
57074903|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074904|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074905|NCT04983498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57074906|NCT04983498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57074907|NCT04983498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57074908|NCT04983498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57074909|NCT04983498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57074910|NCT03300362|Vaccines|vaccines|mesh-list
57074911|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
57074912|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074913|NCT02467400|Propranolol|propranolol|mesh-list
57074914|NCT02467400|Atenolol|atenolol|mesh-list
57074915|NCT02467400|Nebivolol|nebivolol|mesh-list
57074916|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57074917|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57074918|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
57074919|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074920|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074921|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074922|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57074923|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57074924|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
57074925|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
57074926|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
57074927|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074928|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57074929|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57074930|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57074931|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57074932|NCT04002141|Letrozole|letrozole|mesh-list
57074933|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074934|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57074935|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57074936|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074937|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074938|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57074939|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
57074940|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756897|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
57074941|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074943|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57074944|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57074945|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
57074946|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074947|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074948|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074949|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
57074950|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
57074951|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074952|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57074953|NCT02262741|Durvalumab|durvalumab|mesh-list
57074954|NCT02262741|Tremelimumab|tremelimumab|mesh-list
57074955|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57074956|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074957|NCT00250341|Beclomethasone|beclomethasone|mesh-list
57074958|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57074959|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57074960|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
57074961|NCT00250341|Hormones|hormones|mesh-ancestor
57074962|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57074963|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074964|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57074965|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
57074966|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57074967|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
57074968|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074969|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
57074970|NCT05156970|Carboplatin|carboplatin|mesh-list
57074971|NCT05156970|Docetaxel|docetaxel|mesh-list
57074972|NCT05156970|Apatinib|apatinib|mesh-list
57074973|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074974|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
57074975|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
57074976|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
57074977|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074978|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57074979|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074980|NCT02233881|Ipratropium|ipratropium|mesh-list
57074981|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57074982|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
57074983|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57074984|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57074985|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57074986|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
57074987|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57074988|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
57074989|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57074990|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074991|NCT02234037|Decitabine|decitabine|mesh-list
57074992|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57074993|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
57074994|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57074995|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57074996|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57074997|NCT02234193|Lidocaine|lidocaine|mesh-list
57074998|NCT02234193|Epinephrine|epinephrine|mesh-list
57074999|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
57075000|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
57075001|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075002|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075003|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
57075004|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075005|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57075006|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57075007|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57075008|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57075009|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075010|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57075011|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57075012|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
57075013|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075014|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57075015|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57075016|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
57075017|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57075018|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
57075019|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
57075020|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
57075021|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57075022|NCT04476459|Apatinib|apatinib|mesh-list
57075023|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075024|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57075025|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075026|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075027|NCT02262897|Paclitaxel|paclitaxel|mesh-list
57075028|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57075029|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075030|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075031|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075032|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075033|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075034|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075035|NCT02723006|Nivolumab|nivolumab|mesh-list
57075036|NCT02723006|Ipilimumab|ipilimumab|mesh-list
57075037|NCT02723006|Vedolizumab|vedolizumab|mesh-list
57075038|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57075039|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075040|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57075041|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075042|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57075043|NCT03308552|Paclitaxel|paclitaxel|mesh-list
57075044|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57075045|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075046|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075047|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075048|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075049|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075050|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075051|NCT03308084|Dexamethasone|dexamethasone|mesh-list
57075052|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
57075053|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57075054|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57075055|NCT03308084|Prednisolone|prednisolone|mesh-list
57075056|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
57075057|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57075058|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
57075059|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57075060|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
57075061|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
57075062|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075063|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075064|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57075065|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
57075066|NCT03308084|Hormones|hormones|mesh-ancestor
57075067|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075068|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57075069|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075070|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57075071|NCT03308084|Protective Agents|protective agents|mesh-ancestor
57075072|NCT00702962|Carboplatin|carboplatin|mesh-list
57075073|NCT00702962|Etoposide|etoposide|mesh-list
57075074|NCT00702962|Vorinostat|vorinostat|mesh-list
57075075|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075076|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075077|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57075078|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57075079|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075080|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075081|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57075082|NCT01379508|Tenofovir|tenofovir|mesh-list
57075083|NCT01379508|Telbivudine|telbivudine|mesh-list
57075084|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
57075085|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075086|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57075087|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57075088|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075089|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075090|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57075091|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57075093|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57075094|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075095|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075096|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57075097|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
57075098|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
57075099|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
57075100|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57075101|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075102|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075103|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57075104|NCT05031026|Analgesics|analgesics|mesh-ancestor
57075105|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
57075106|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075107|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57075108|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57075109|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57075110|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
57075111|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075112|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075113|NCT02264769|Carbetocin|carbetocin|mesh-list
57075114|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
57075115|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57075116|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075117|NCT02264847|Clomiphene|clomiphene|mesh-list
57075118|NCT02264847|Enclomiphene|enclomiphene|mesh-list
57075119|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
57075120|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57075121|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57075122|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
57075123|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075124|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075125|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57075126|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
57075127|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57075128|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57075129|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57075130|NCT04965506|Dulaglutide|dulaglutide|mesh-list
57075131|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57075132|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075133|NCT03469128|Sertraline|sertraline|mesh-list
57075134|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
57075135|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57075136|NCT03469128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57075137|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57075138|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57075139|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075140|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075141|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
57075142|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075143|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
57075144|NCT05161572|Tegafur|tegafur|mesh-list
57075145|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075146|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57075147|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
57075148|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075149|NCT03472170|Lactoferrin|lactoferrin|mesh-list
57075150|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075151|NCT04156698|Docetaxel|docetaxel|mesh-list
57075152|NCT04156698|Capecitabine|capecitabine|mesh-list
57075153|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075154|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075155|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075156|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075157|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075158|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57075159|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
57075160|NCT03108326|Infliximab|infliximab|mesh-list
57075161|NCT03108326|Ustekinumab|ustekinumab|mesh-list
57075162|NCT03108326|Vedolizumab|vedolizumab|mesh-list
57075163|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57075164|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
57075165|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57075166|NCT04964024|Antibodies|antibodies|mesh-list
57075167|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
57075168|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075169|NCT02519439|Ganaxolone|ganaxolone|mesh-list
57075170|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
57075171|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075172|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075173|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075174|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
57075175|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
57075176|NCT02466542|Esmolol|esmolol|mesh-list
57075177|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57075178|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57075179|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57075180|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
57075181|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075182|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075183|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075184|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
57075185|NCT05067270|Treprostinil|treprostinil|mesh-list
57075186|NCT05067270|Citric Acid|citric acid|mesh-list
57075187|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
57075188|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
57075189|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57075190|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
57075191|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
57075192|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075193|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57075194|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075195|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57075196|NCT01437735|Montelukast|montelukast|mesh-list
57075197|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57075198|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
57075199|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57075200|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
57075201|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075202|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075203|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57075204|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57075205|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075206|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
57075207|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57075208|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075209|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075210|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57075211|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57075212|NCT03470610|Estradiol|estradiol|mesh-list
57075213|NCT03470610|Progesterone|progesterone|mesh-list
57075214|NCT03470610|Estrogens|estrogens|mesh-ancestor
57075215|NCT03470610|Hormones|hormones|mesh-ancestor
57075216|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075217|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075218|NCT03470610|Progestins|progestins|mesh-ancestor
57075219|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
57075220|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57075221|NCT03307148|Gemcitabine|gemcitabine|mesh-list
57075222|NCT03307148|Paclitaxel|paclitaxel|mesh-list
57075223|NCT03307148|Tretinoin|tretinoin|mesh-list
57075224|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075225|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075226|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075227|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075228|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075229|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075230|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57075231|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
57075232|NCT03307148|Antiviral Agents|antiviral agents|mesh-ancestor
57075233|NCT03307148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075234|NCT03307148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075235|NCT03307148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57075236|NCT03307148|Immunologic Factors|immunologic factors|mesh-ancestor
57075237|NCT03307148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075238|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
57075239|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
57075240|NCT03984591|Eplerenone|eplerenone|mesh-list
56757200|NCT00852566|Dasatinib|dasatinib|mesh-list
57075241|NCT03984591|Spironolactone|spironolactone|mesh-list
57075242|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57075243|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
57075244|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075245|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075246|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57075247|NCT03984591|Diuretics|diuretics|mesh-ancestor
57075248|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
57075249|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57075250|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57075251|NCT03470532|Epinephrine|epinephrine|mesh-list
57075252|NCT03470532|Racepinephrine|racepinephrine|mesh-list
57075253|NCT03470532|Mepivacaine|mepivacaine|mesh-list
57075254|NCT03470532|Carticaine|carticaine|mesh-list
57075255|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
57075256|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57075257|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57075258|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
57075259|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075260|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075261|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075262|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57075263|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57075264|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
57075265|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075266|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57075267|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
57075268|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
57075269|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
57075270|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57075271|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
57075272|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
57075273|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075274|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
57075275|NCT02502669|Finasteride|finasteride|mesh-list
57075276|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57075277|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57075278|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075279|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075280|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
57075281|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075282|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075283|NCT02502669|Urological Agents|urological agents|mesh-ancestor
57075284|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
57075285|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
57075286|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
57075287|NCT03306836|Heparin|heparin|mesh-list
57075288|NCT03306836|Calcium heparin|calcium heparin|mesh-list
57075289|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
57075290|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57075291|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57075292|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075293|NCT04487145|Piperaquine|piperaquine|mesh-list
57075294|NCT04487145|Artenimol|artenimol|mesh-list
57075295|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
57075296|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57075297|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57075298|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075299|NCT04780568|Osimertinib|osimertinib|mesh-list
57075300|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075301|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57075302|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075303|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075304|NCT00709956|Iloprost|iloprost|mesh-list
57075305|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57075306|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
57075307|NCT02268201|Tacrolimus|tacrolimus|mesh-list
57075308|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57075309|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
57075310|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075311|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57075312|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075313|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075314|NCT03306602|Z 350|z 350|mesh-list
57075315|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57075316|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57075317|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075318|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075319|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
57075320|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075321|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075322|NCT02268279|Solithromycin|solithromycin|mesh-list
57075323|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57075324|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075325|NCT02268357|Propranolol|propranolol|mesh-list
57075326|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57075327|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57075328|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
57075329|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075330|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075331|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075332|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57075333|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57075334|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
57075335|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
57075336|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075337|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57075338|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075339|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075340|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
57075341|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
57075342|NCT02466464|Coagulants|coagulants|mesh-ancestor
57075343|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
57075344|NCT01423149|Combretastatin|combretastatin|mesh-list
57075345|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075346|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075347|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075348|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075349|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075350|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075351|NCT05429762|Maytansine|maytansine|mesh-list
57075352|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075353|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075354|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075355|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075356|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075357|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075358|NCT03470454|Linagliptin|linagliptin|mesh-list
57075359|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57075360|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075361|NCT03470454|Incretins|incretins|mesh-ancestor
57075362|NCT03470454|Hormones|hormones|mesh-ancestor
57075363|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075364|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57075365|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
57075366|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075367|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075368|NCT03130842|Midazolam|midazolam|mesh-list
57075369|NCT03130842|Alprazolam|alprazolam|mesh-list
57075370|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57075371|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57075372|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075373|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075374|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57075375|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57075376|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57075377|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57075378|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
57075379|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
57075380|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
57075381|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
57075382|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075383|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075384|NCT03130764|Durvalumab|durvalumab|mesh-list
57075385|NCT03130764|Tremelimumab|tremelimumab|mesh-list
57075386|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57075387|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075388|NCT01234779|Olanzapine|olanzapine|mesh-list
57075389|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
56757354|NCT00853268|Oxycodone|oxycodone|mesh-list
57075390|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
57075391|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075392|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075393|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57075394|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57075395|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57075396|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075397|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57075398|NCT01234779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57075399|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57075400|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57075401|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075402|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075403|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
57075404|NCT03306446|Adalimumab|adalimumab|mesh-list
57075405|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57075406|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57075407|NCT03223350|Capsaicin|capsaicin|mesh-list
57075408|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
57075409|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
57075410|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
57075411|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075412|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075413|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
57075414|NCT03306368|Narcotics|narcotics|mesh-ancestor
57075415|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075416|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075417|NCT03306368|Analgesics|analgesics|mesh-ancestor
57075418|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
57075419|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075420|NCT02840136|Meropenem|meropenem|mesh-list
57075421|NCT02840136|Tazobactam|tazobactam|mesh-list
57075422|NCT02840136|Piperacillin|piperacillin|mesh-list
57075423|NCT02840136|Ceftazidime|ceftazidime|mesh-list
57075424|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57075425|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57075426|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075427|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57075428|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075429|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075430|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57075431|NCT03306290|Cefoxitin|cefoxitin|mesh-list
57075432|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075433|NCT01616199|Vemurafenib|vemurafenib|mesh-list
57075434|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075435|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57075436|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075437|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075438|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
57075439|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57075440|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57075441|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57075442|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57075443|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075444|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
57075445|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075446|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075447|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57075448|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075449|NCT04506138|Paclitaxel|paclitaxel|mesh-list
57075450|NCT04506138|Carboplatin|carboplatin|mesh-list
57075451|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075452|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075453|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075454|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075455|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075456|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075457|NCT01407003|Licogliflozin|licogliflozin|mesh-list
57075458|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57075459|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075460|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57075461|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075462|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57075463|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
57075464|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075465|NCT01232595|Vancomycin|vancomycin|mesh-list
57075466|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57075467|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075468|NCT01231347|Gemcitabine|gemcitabine|mesh-list
57075469|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57075470|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57075471|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
57075472|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075473|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075474|NCT01231347|Antiviral Agents|antiviral agents|mesh-ancestor
57075475|NCT01231347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075476|NCT01231347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075477|NCT01231347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57075478|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
57075479|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075481|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
57075482|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075483|NCT01228383|Vaccines|vaccines|mesh-list
57075484|NCT01228383|Antibodies|antibodies|mesh-list
57075485|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57075486|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
57075487|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
57075488|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57075489|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57075490|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
57075491|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075492|NCT03305978|Ivermectin|ivermectin|mesh-list
57075493|NCT03305978|Selamectin|selamectin|mesh-list
57075494|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57075495|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075496|NCT01594983|Fenofibrate|fenofibrate|mesh-list
57075497|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57075498|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
57075499|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075500|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57075501|NCT03305510|Vitamin D|vitamin d|mesh-list
57075502|NCT03305510|Vitamins|vitamins|mesh-ancestor
57075503|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
57075504|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075505|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57075506|NCT01224795|Peramivir|peramivir|mesh-list
57075507|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
57075508|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075509|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075510|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075511|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57075512|NCT05263388|Hormones|hormones|mesh-ancestor
57075513|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075514|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075515|NCT01402401|Trastuzumab|trastuzumab|mesh-list
57075516|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57075517|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075518|NCT02720510|Dexamethasone|dexamethasone|mesh-list
57075519|NCT02720510|Lenalidomide|lenalidomide|mesh-list
57075520|NCT02720510|Bortezomib|bortezomib|mesh-list
57075521|NCT02720510|Panobinostat|panobinostat|mesh-list
57075522|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57075523|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
57075524|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
57075525|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075526|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075527|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57075528|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
57075529|NCT02720510|Hormones|hormones|mesh-ancestor
57075530|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075531|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57075532|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075533|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
57075534|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57075535|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57075536|NCT02720510|Growth Substances|growth substances|mesh-ancestor
57075537|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
57075538|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57075539|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075540|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075541|NCT01220271|Temozolomide|temozolomide|mesh-list
57075542|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57075543|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
57075544|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075545|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075547|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57075548|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
57075549|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57075550|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
57075551|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075552|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075553|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
57075554|NCT01205061|Lidocaine|lidocaine|mesh-list
57075555|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
57075556|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
57075557|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075558|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075559|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
57075560|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075561|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57075562|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57075563|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57075564|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57075565|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075566|NCT01204749|Paclitaxel|paclitaxel|mesh-list
57075567|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57075568|NCT01204749|Trebananib|trebananib|mesh-list
57075569|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
57075570|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075571|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075572|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075573|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075574|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075575|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075576|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57075577|NCT01204749|Growth Substances|growth substances|mesh-ancestor
57075578|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075579|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
57075580|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57075581|NCT02466698|Metronidazole|metronidazole|mesh-list
57075582|NCT02466698|Vancomycin|vancomycin|mesh-list
57075583|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57075584|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
57075585|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075586|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
57075587|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57075588|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57075589|NCT02466698|Laxatives|laxatives|mesh-ancestor
57075590|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57075591|NCT02720198|Milnacipran|milnacipran|mesh-list
57075592|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57075593|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
57075594|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
57075595|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57075596|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57075597|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57075598|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075599|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899001|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
57075600|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57075601|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57075602|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57075603|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075604|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075605|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57075606|NCT02720198|Analgesics|analgesics|mesh-ancestor
57075607|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
57075608|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075609|NCT01193361|Interferons|interferons|mesh-list
57075610|NCT01193361|Ribavirin|ribavirin|mesh-list
57075611|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
57075612|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
57075613|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57075614|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075615|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
57075616|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075617|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
57075618|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075619|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
57075620|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075621|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57075622|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57075623|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075624|NCT02263677|Incretins|incretins|mesh-ancestor
57075625|NCT02263677|Hormones|hormones|mesh-ancestor
57075626|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075627|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57075628|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
57075629|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075630|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075631|NCT01390545|Veltuzumab|veltuzumab|mesh-list
57075632|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075633|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
57075634|NCT01591473|Poly I-C|poly i-c|mesh-list
57075635|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
57075636|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075637|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
57075638|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
57075639|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075640|NCT01192035|Ritonavir|ritonavir|mesh-list
57075641|NCT01192035|Lopinavir|lopinavir|mesh-list
57075642|NCT01192035|Nevirapine|nevirapine|mesh-list
57075643|NCT01192035|Efavirenz|efavirenz|mesh-list
57075644|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57075645|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57075646|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
57075647|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075648|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075649|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57075650|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57075651|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
57075652|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075653|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57075654|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57075655|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57075656|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57075657|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57075658|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57075659|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57075660|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57075661|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57075662|NCT01384383|Ledipasvir|ledipasvir|mesh-list
57075663|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
57075664|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075665|NCT01557777|Navitoclax|navitoclax|mesh-list
57075666|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075667|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
57075668|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57075669|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075670|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57075671|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57075672|NCT02268903|Furosemide|furosemide|mesh-list
57075673|NCT02268903|Diuretics|diuretics|mesh-list
57075674|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
57075675|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075676|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57075677|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57075678|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075679|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57075680|NCT01369095|Citalopram|citalopram|mesh-list
57075681|NCT01369095|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57075682|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57075683|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57075684|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075685|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075686|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
57075687|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075688|NCT01369095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57075689|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
57075690|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57075691|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075692|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57075694|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
57075695|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
57075696|NCT02266173|Pertuzumab|pertuzumab|mesh-list
57075697|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57075698|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075699|NCT01168713|Levofloxacin|levofloxacin|mesh-list
57075700|NCT01168713|Ofloxacin|ofloxacin|mesh-list
57075701|NCT01168713|Solithromycin|solithromycin|mesh-list
57075702|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57075703|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075704|NCT01168713|Renal Agents|renal agents|mesh-ancestor
57075705|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57075706|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57075707|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57075708|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075709|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075710|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075711|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57075712|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57075713|NCT02269293|Paclitaxel|paclitaxel|mesh-list
57075714|NCT02269293|Carboplatin|carboplatin|mesh-list
57075715|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075716|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075717|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075718|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075719|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075720|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075721|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57075722|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
57075723|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075724|NCT01366131|Paclitaxel|paclitaxel|mesh-list
57075725|NCT01366131|Bevacizumab|bevacizumab|mesh-list
57075726|NCT01366131|Carboplatin|carboplatin|mesh-list
57075727|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075728|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075729|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075730|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075731|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075732|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075733|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57075734|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57075735|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57075736|NCT01366131|Growth Substances|growth substances|mesh-ancestor
57075737|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075738|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
57075739|NCT01365195|Ketamine|ketamine|mesh-list
57075740|NCT01365195|Analgesics|analgesics|mesh-ancestor
57075741|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
57075742|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075743|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075744|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57075745|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56899004|NCT03942224|Dexamethasone|dexamethasone|mesh-list
57075746|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
57075747|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
57075748|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075749|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57075750|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57075751|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075752|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075753|NCT02269449|Hemostatics|hemostatics|mesh-list
57075754|NCT02269449|Coagulants|coagulants|mesh-ancestor
57075755|NCT01160601|Paclitaxel|paclitaxel|mesh-list
57075756|NCT01160601|Carboplatin|carboplatin|mesh-list
57075757|NCT01160601|Bavituximab|bavituximab|mesh-list
57075758|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075759|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075760|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075761|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075762|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075763|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075764|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57075765|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
57075766|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57075767|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
57075768|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075769|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075770|NCT01356849|Atrasentan|atrasentan|mesh-list
57075771|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075772|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57075773|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57075774|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075775|NCT02266485|Pravastatin|pravastatin|mesh-list
57075776|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57075777|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57075778|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
57075779|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075780|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57075781|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57075782|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075783|NCT02263989|Telmisartan|telmisartan|mesh-list
57075784|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57075785|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57075786|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57075787|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075788|NCT01516203|Rifampin|rifampin|mesh-list
57075789|NCT01516203|Isoniazid|isoniazid|mesh-list
57075790|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
57075791|NCT01516203|Ethambutol|ethambutol|mesh-list
57075792|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57075793|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
57075794|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57075795|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075796|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
57075797|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57075798|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075799|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075800|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57075801|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57075802|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57075803|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57075804|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57075805|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57075806|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57075807|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57075808|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
56899007|NCT03942224|Ixazomib|ixazomib|mesh-list
57075809|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57075810|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
57075811|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
57075812|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075813|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075814|NCT00703118|Ribavirin|ribavirin|mesh-list
57075815|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
57075816|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57075817|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
57075818|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075819|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
57075820|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075821|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075822|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
57075823|NCT01510119|Everolimus|everolimus|mesh-list
57075824|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075825|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57075826|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
57075827|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075828|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
57075829|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57075830|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57075831|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075832|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075833|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075834|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57075835|NCT01150695|Vaccines|vaccines|mesh-list
57075836|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
57075837|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075838|NCT01302249|Timolol|timolol|mesh-list
57075839|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57075840|NCT01302249|Latanoprost|latanoprost|mesh-list
57075841|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57075842|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075843|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57075844|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57075845|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
57075846|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57075847|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075848|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57075849|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57075850|NCT02261636|Mesalamine|mesalamine|mesh-list
57075851|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57075852|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57075853|NCT02261636|Analgesics|analgesics|mesh-ancestor
57075854|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
57075855|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075856|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075857|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57075858|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57075859|NCT05191706|Dexamethasone|dexamethasone|mesh-list
57075860|NCT05191706|Prednisolone|prednisolone|mesh-list
57075861|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57075862|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
57075863|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57075864|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
57075865|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57075866|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
57075867|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57075868|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
57075869|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
57075870|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075871|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075872|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57075873|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
57075874|NCT05191706|Hormones|hormones|mesh-ancestor
57075875|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57075876|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57075877|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075878|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57075879|NCT05191706|Protective Agents|protective agents|mesh-ancestor
57075880|NCT01493505|Paclitaxel|paclitaxel|mesh-list
57075881|NCT01493505|Carboplatin|carboplatin|mesh-list
57075882|NCT01493505|Trebananib|trebananib|mesh-list
57075883|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57075884|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075885|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
57075886|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
57075887|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
57075888|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075889|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57075890|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57075891|NCT01493505|Growth Substances|growth substances|mesh-ancestor
57075892|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075893|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
57075894|NCT01301157|Calcipotriene|calcipotriene|mesh-list
57075895|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
57075896|NCT02264145|Norflurane|norflurane|mesh-list
57075897|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57075898|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
57075899|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075900|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075901|NCT05157464|Losartan|losartan|mesh-list
57075902|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57075903|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57075904|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57075905|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57075906|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075907|NCT02264301|Puerarin|puerarin|mesh-list
57075908|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
57075909|NCT03943875|Vaccines|vaccines|mesh-list
57075910|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
57075911|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075912|NCT04476069|Ibuprofen|ibuprofen|mesh-list
57075913|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57075914|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57075915|NCT04476069|Analgesics|analgesics|mesh-ancestor
57075916|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
57075917|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075918|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075919|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57075921|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57075922|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075923|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075924|NCT01480479|Temozolomide|temozolomide|mesh-list
57075925|NCT01480479|Molgramostim|molgramostim|mesh-list
57075926|NCT01480479|Rindopepimut|rindopepimut|mesh-list
57075927|NCT01480479|Sargramostim|sargramostim|mesh-list
57075928|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57075929|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
57075930|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075931|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075932|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
57075933|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075934|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57075935|NCT01116141|Folic Acid|folic acid|mesh-list
57075936|NCT01116141|Methotrexate|methotrexate|mesh-list
57075937|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57075938|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
57075939|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57075940|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075941|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57075942|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
57075943|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075944|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075945|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
57075946|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075947|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57075948|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57075949|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
57075950|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57075951|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57075952|NCT01116141|Hematinics|hematinics|mesh-ancestor
57075953|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
57075954|NCT01116141|Vitamins|vitamins|mesh-ancestor
57075955|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
57075956|NCT01280565|Dacarbazine|dacarbazine|mesh-list
57075957|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57075958|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
56299872|NCT00020488|Fluorouracil|fluorouracil|mesh-list
57075959|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075960|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075961|NCT05627739|Mycophenolic Acid|mycophenolic acid|mesh-list
57075962|NCT05627739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57075963|NCT05627739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075964|NCT05627739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57075965|NCT05627739|Antitubercular Agents|antitubercular agents|mesh-ancestor
57075966|NCT05627739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57075967|NCT05627739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57075968|NCT05627739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075969|NCT05627739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075970|NCT01113957|Doxorubicin|doxorubicin|mesh-list
57075971|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57075972|NCT01113957|Temozolomide|temozolomide|mesh-list
57075973|NCT01113957|Veliparib|veliparib|mesh-list
57075974|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57075975|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57075976|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57075977|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57075978|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57075979|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075980|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57075981|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
57075982|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57075983|NCT01111773|Lidocaine|lidocaine|mesh-list
57075984|NCT01111773|Tetracaine|tetracaine|mesh-list
57075985|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
57075986|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
57075987|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57075988|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57075989|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
57075990|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57075991|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57075992|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57075993|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57075994|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57075995|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57075996|NCT01280331|Morphine|morphine|mesh-list
57075997|NCT01280331|Oxycodone|oxycodone|mesh-list
57075998|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57075999|NCT01280331|Narcotics|narcotics|mesh-ancestor
57076000|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57076001|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076002|NCT01280331|Analgesics|analgesics|mesh-ancestor
57076003|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
57076004|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076005|NCT01266525|Donepezil|donepezil|mesh-list
57076006|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57076007|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076008|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076009|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
57076010|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076011|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076012|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
57076013|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
57076014|NCT01265901|Sunitinib|sunitinib|mesh-list
57076015|NCT01265901|Molgramostim|molgramostim|mesh-list
57076016|NCT01265901|Sargramostim|sargramostim|mesh-list
57076017|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
57076018|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076019|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076020|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076021|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57076022|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
57076023|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076024|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076025|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57076026|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57076027|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57076028|NCT01265901|Growth Substances|growth substances|mesh-ancestor
57076029|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
57076030|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57076031|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076032|NCT05231382|Leucovorin|leucovorin|mesh-list
57076033|NCT05231382|Fluorouracil|fluorouracil|mesh-list
57076034|NCT05231382|Raltitrexed|raltitrexed|mesh-list
57076035|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
57076036|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
57076037|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076038|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076039|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076040|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076041|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
57076042|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076043|NCT05231382|Antidotes|antidotes|mesh-ancestor
57076044|NCT05231382|Protective Agents|protective agents|mesh-ancestor
57076045|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
57076046|NCT05231382|Vitamins|vitamins|mesh-ancestor
57076047|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
57076048|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57076049|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076050|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57076051|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
57076052|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076053|NCT01460511|Epinephrine|epinephrine|mesh-list
57076054|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57076055|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57076056|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
57076057|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076058|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076059|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076060|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57076061|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57076062|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
57076063|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076064|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57076065|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
56758029|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
57076066|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
57076067|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
57076068|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57076069|NCT03135171|Trastuzumab|trastuzumab|mesh-list
57076071|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076072|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076073|NCT01449591|Metronidazole|metronidazole|mesh-list
57076074|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076075|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57076076|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57076077|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57076078|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
57076079|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57076080|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076081|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
57076082|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57076083|NCT01444365|Analgesics|analgesics|mesh-ancestor
57076084|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
57076085|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076086|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076087|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076088|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076089|NCT01098435|ALKS-33|alks-33|mesh-list
57076090|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57076091|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076092|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
57076093|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076094|NCT00909597|Pioglitazone|pioglitazone|mesh-list
57076095|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57076096|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57076097|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076098|NCT00909597|Incretins|incretins|mesh-ancestor
57076099|NCT00909597|Hormones|hormones|mesh-ancestor
57076100|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57076101|NCT01077297|Tezosentan|tezosentan|mesh-list
57076102|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
57076103|NCT05653245|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
57076104|NCT05653245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076105|NCT05379855|Atropine|atropine|mesh-list
57076106|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57076107|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57076108|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57076109|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57076110|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57076111|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
57076112|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076113|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076114|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57076115|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
57076116|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
57076117|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
57076118|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57076119|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57076120|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
57076121|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076122|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076123|NCT02718326|Aflibercept|aflibercept|mesh-list
57076124|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57076125|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57076126|NCT02718326|Growth Substances|growth substances|mesh-ancestor
57076127|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076128|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
57076129|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076130|NCT03691584|Dimercaprol|dimercaprol|mesh-list
57076131|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
57076132|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
57076133|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076134|NCT04655144|Dexamethasone|dexamethasone|mesh-list
57076135|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076136|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
57076137|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
57076138|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076139|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076140|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076141|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
57076142|NCT04655144|Hormones|hormones|mesh-ancestor
57076143|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57076144|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57076145|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076146|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
57076147|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
57076148|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076150|NCT03600714|Ritonavir|ritonavir|mesh-list
57076151|NCT03600714|Lonafarnib|lonafarnib|mesh-list
57076152|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076153|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
57076154|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076155|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57076156|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57076157|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
57076158|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076159|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076160|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57076161|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57076162|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57076163|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57076164|NCT04590326|Cemiplimab|cemiplimab|mesh-list
57076165|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076166|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076167|NCT05163366|Ketamine|ketamine|mesh-list
57076168|NCT05163366|Morphine|morphine|mesh-list
57076169|NCT05163366|Analgesics|analgesics|mesh-ancestor
57076170|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
57076171|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076172|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076173|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57076174|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57076175|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
57076176|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
57076177|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57076178|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57076179|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57076180|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076181|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076182|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57076183|NCT05163366|Narcotics|narcotics|mesh-ancestor
57076184|NCT00900783|Valacyclovir|valacyclovir|mesh-list
57076185|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
57076186|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076187|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57076188|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57076189|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076190|NCT01035879|Incretins|incretins|mesh-ancestor
57076191|NCT01035879|Hormones|hormones|mesh-ancestor
57076192|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57076193|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57076194|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
57076195|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076196|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076197|NCT04978298|Phenelzine|phenelzine|mesh-list
57076198|NCT04978298|Ozanimod|ozanimod|mesh-list
57076199|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57076200|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076201|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076202|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
57076203|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076204|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
57076205|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57076206|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57076207|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076208|NCT01029873|Cisplatin|cisplatin|mesh-list
57076209|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076210|NCT05391360|Entecavir|entecavir|mesh-list
57076211|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
57076212|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076213|NCT01024101|Paclitaxel|paclitaxel|mesh-list
57076214|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57076215|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076216|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
57076217|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
57076218|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
57076219|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076220|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
57076221|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076222|NCT00818571|Vildagliptin|vildagliptin|mesh-list
57076223|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57076224|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076225|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57076226|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
57076227|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076228|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076229|NCT00818493|Acetaminophen|acetaminophen|mesh-list
57076230|NCT00818493|Morphine|morphine|mesh-list
57076231|NCT00818493|Oxycodone|oxycodone|mesh-list
57076232|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57076233|NCT00818493|Narcotics|narcotics|mesh-ancestor
57076234|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57076235|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076236|NCT00818493|Analgesics|analgesics|mesh-ancestor
57076237|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
57076238|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076239|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57076240|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
57076241|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57076242|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57076243|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57076244|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57076245|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57076246|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076247|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57076248|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076249|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076250|NCT00892203|Sumatriptan|sumatriptan|mesh-list
57076251|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57076252|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57076253|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57076254|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
57076255|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076256|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076257|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076258|NCT05151471|Edaravone|edaravone|mesh-list
57076259|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57076260|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
57076261|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076262|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57076263|NCT05151471|Protective Agents|protective agents|mesh-ancestor
57076264|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076265|NCT04578600|Lenalidomide|lenalidomide|mesh-list
57076266|NCT04578600|Azacitidine|azacitidine|mesh-list
57076267|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
57076268|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
57076269|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076270|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57076271|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57076272|NCT04578600|Growth Substances|growth substances|mesh-ancestor
57076273|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
57076274|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076275|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076276|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
57076277|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076278|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076279|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076280|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
57076281|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076282|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076283|NCT04495478|Ramucirumab|ramucirumab|mesh-list
57076284|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57076285|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076286|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
57076287|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076288|NCT04487444|Thymalfasin|thymalfasin|mesh-list
57076289|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57076290|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
57076291|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076292|NCT03465540|Dexamethasone|dexamethasone|mesh-list
56758308|NCT00992823|Iron|iron|mesh-list
57076293|NCT03465540|Azacitidine|azacitidine|mesh-list
57076294|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076295|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
57076296|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
57076297|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076298|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076299|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076300|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
57076301|NCT03465540|Hormones|hormones|mesh-ancestor
57076302|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57076303|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57076304|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076305|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076306|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
57076307|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076308|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076309|NCT04218786|Colchicine|colchicine|mesh-list
57076310|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
57076311|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076312|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
57076313|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
57076314|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
57076315|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076316|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076317|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
57076318|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076319|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076320|NCT00884715|Octreotide|octreotide|mesh-list
57076321|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076322|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57076323|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076324|NCT03603080|Metformin|metformin|mesh-list
57076325|NCT03603080|Topiramate|topiramate|mesh-list
57076326|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
57076327|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57076328|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076329|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
57076330|NCT01019187|Modafinil|modafinil|mesh-list
57076331|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57076332|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076333|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
57076334|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57076335|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57076336|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076337|NCT05088876|Acetaminophen|acetaminophen|mesh-list
57076338|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57076339|NCT05088876|Analgesics|analgesics|mesh-ancestor
57076340|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
57076341|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076342|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076343|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
57076344|NCT03472274|Durvalumab|durvalumab|mesh-list
57076345|NCT03472274|Tremelimumab|tremelimumab|mesh-list
57076346|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076347|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076348|NCT05084508|Vaccines|vaccines|mesh-list
57076349|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57076350|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
57076351|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076352|NCT01018875|Donepezil|donepezil|mesh-list
57076353|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57076354|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076355|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076356|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
57076357|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076358|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076359|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
57076360|NCT05390736|Vitamin D|vitamin d|mesh-list
57076361|NCT05390736|Vitamins|vitamins|mesh-ancestor
57076362|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
57076363|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076364|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57076365|NCT00806403|Reteplase|reteplase|mesh-list
57076366|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57076367|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57076368|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076370|NCT01007721|Xhance|xhance|mesh-list
57076371|NCT01007721|Montelukast|montelukast|mesh-list
57076372|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076373|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57076374|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
57076375|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076376|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076377|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57076378|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
57076379|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
57076380|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57076381|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57076382|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
57076383|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57076384|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57076385|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57076386|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076387|NCT00701558|Gemcitabine|gemcitabine|mesh-list
57076388|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57076389|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076390|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
57076391|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076392|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076393|NCT00701558|Antiviral Agents|antiviral agents|mesh-ancestor
57076394|NCT00701558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076395|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076396|NCT00701558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076397|NCT00701558|Immunologic Factors|immunologic factors|mesh-ancestor
57076398|NCT00701558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076399|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57076400|NCT03233828|Aldesleukin|aldesleukin|mesh-list
57076401|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076402|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57076403|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57076404|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
57076405|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076406|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
57076407|NCT03882177|Pyridoxal|pyridoxal|mesh-list
57076408|NCT03882177|Pyridoxine|pyridoxine|mesh-list
57076409|NCT03882177|Pravastatin|pravastatin|mesh-list
57076410|NCT03882177|Vitamins|vitamins|mesh-ancestor
57076411|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
57076412|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076413|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
57076414|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57076415|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57076416|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
57076417|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076418|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57076419|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57076420|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076421|NCT01007097|Glimepiride|glimepiride|mesh-list
57076422|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57076423|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57076424|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076425|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076426|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
57076427|NCT05115903|Adalimumab|adalimumab|mesh-list
57076428|NCT05115903|Etanercept|etanercept|mesh-list
57076429|NCT05115903|Golimumab|golimumab|mesh-list
57076430|NCT05115903|Infliximab|infliximab|mesh-list
57076431|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
57076432|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57076433|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076434|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076435|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
57076436|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076437|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57076438|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57076439|NCT05115903|Analgesics|analgesics|mesh-ancestor
57076440|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
57076441|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076442|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758406|NCT00871910|Dexamethasone|dexamethasone|mesh-list
57076443|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076444|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
57076445|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57076446|NCT03695250|Nivolumab|nivolumab|mesh-list
57076447|NCT03695250|Linrodostat|linrodostat|mesh-list
57076448|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076449|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076450|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57076451|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076452|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076453|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
57076454|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57076455|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57076456|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57076457|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57076458|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076459|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
57076460|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076461|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076462|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57076463|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076464|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
57076465|NCT04614636|Fludarabine|fludarabine|mesh-list
57076466|NCT04614636|Daratumumab|daratumumab|mesh-list
57076467|NCT04614636|Elotuzumab|elotuzumab|mesh-list
57076468|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076469|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
57076470|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076471|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076472|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57076473|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
57076474|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076475|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076476|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57076477|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57076478|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
57076479|NCT00869661|Ribavirin|ribavirin|mesh-list
57076480|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
57076481|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076482|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
57076483|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076484|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
57076485|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076486|NCT03192566|Acetaminophen|acetaminophen|mesh-list
57076487|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57076488|NCT03192566|Analgesics|analgesics|mesh-ancestor
57076489|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
57076490|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076491|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076492|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
57076493|NCT03296930|Ritonavir|ritonavir|mesh-list
57076494|NCT03296930|Ribavirin|ribavirin|mesh-list
57076495|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
57076496|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57076497|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57076498|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
57076499|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076500|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076501|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57076502|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57076503|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
57076504|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076505|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57076506|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57076507|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
57076508|NCT04607772|Gemcitabine|gemcitabine|mesh-list
57076509|NCT04607772|Rituximab|rituximab|mesh-list
57076510|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
57076511|NCT04607772|Lenalidomide|lenalidomide|mesh-list
57076512|NCT04607772|Venetoclax|venetoclax|mesh-list
57076513|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57076514|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076515|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076516|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
57076517|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076518|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076519|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076520|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
57076521|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076522|NCT04607772|Antiviral Agents|antiviral agents|mesh-ancestor
57076523|NCT04607772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076524|NCT04607772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076525|NCT04607772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076526|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57076527|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57076528|NCT04607772|Growth Substances|growth substances|mesh-ancestor
57076529|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
57076530|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57076531|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
57076532|NCT01001715|Fasinumab|fasinumab|mesh-list
57076533|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57076534|NCT01001715|Analgesics|analgesics|mesh-ancestor
57076535|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
57076536|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076537|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076538|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
57076539|NCT02464124|Lactulose|lactulose|mesh-list
57076540|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076541|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57076542|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076543|NCT00859521|Levetiracetam|levetiracetam|mesh-list
57076544|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
57076545|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
57076546|NCT05398770|Vitamin D|vitamin d|mesh-list
57076547|NCT05398770|Vitamins|vitamins|mesh-ancestor
57076548|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
57076549|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076550|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57076551|NCT03033914|Doxorubicin|doxorubicin|mesh-list
57076552|NCT03033914|Bleomycin|bleomycin|mesh-list
57076553|NCT03033914|Nivolumab|nivolumab|mesh-list
57076554|NCT03033914|Dacarbazine|dacarbazine|mesh-list
57076555|NCT03033914|Vinblastine|vinblastine|mesh-list
57076556|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57076557|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076558|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57076559|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57076560|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076561|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076562|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076563|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57076564|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57076565|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
57076566|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57076567|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
57076568|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
57076569|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
57076570|NCT00843687|Risperidone|risperidone|mesh-list
57076571|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57076572|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
57076573|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076574|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076575|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076576|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57076577|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57076578|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57076579|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57076580|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57076581|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
57076582|NCT04642131|Caffeine|caffeine|mesh-list
57076583|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57076584|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076585|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57076586|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076587|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076588|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57076589|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57076590|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
57076591|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076592|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
57076593|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57076594|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57076595|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57076596|NCT04513314|Valproic Acid|valproic acid|mesh-list
57076597|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57076598|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
57076599|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57076600|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57076601|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57076602|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57076603|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076604|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
57076605|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076606|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076608|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076609|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
57076610|NCT00789633|Gemcitabine|gemcitabine|mesh-list
57076611|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076612|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
57076613|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076614|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076615|NCT00789633|Antiviral Agents|antiviral agents|mesh-ancestor
57076616|NCT00789633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076617|NCT00789633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076618|NCT00789633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076619|NCT00789633|Immunologic Factors|immunologic factors|mesh-ancestor
57076620|NCT00789633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076621|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
57076622|NCT00788541|Anecortave|anecortave|mesh-list
57076623|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57076624|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57076625|NCT00788541|Growth Substances|growth substances|mesh-ancestor
57076626|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076627|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
57076628|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076629|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076630|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57076631|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57076632|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
57076633|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57076634|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076635|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
57076636|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076637|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57076638|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
57076639|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076640|NCT02320292|Rituximab|rituximab|mesh-list
57076641|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57076642|NCT02320292|Antibodies|antibodies|mesh-list
57076643|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
57076644|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57076645|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
57076646|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076647|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076648|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076649|NCT05514483|Ondansetron|ondansetron|mesh-list
57076650|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
57076651|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
57076652|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076653|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076654|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076655|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
57076656|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
57076657|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57076658|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
57076659|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076660|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076661|NCT05514483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57076662|NCT05514483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57076663|NCT05514483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57076664|NCT05514483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57076665|NCT05514483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57076666|NCT00841815|Amlodipine|amlodipine|mesh-list
57076667|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57076668|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57076669|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57076670|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076671|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57076672|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076673|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
57076675|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076676|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
57076677|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57076678|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57076679|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57076680|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
57076681|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076682|NCT04440280|Expectorants|expectorants|mesh-ancestor
57076683|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
57076684|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57076685|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
57076686|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076687|NCT04440280|Protective Agents|protective agents|mesh-ancestor
57076688|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076689|NCT04440280|Antidotes|antidotes|mesh-ancestor
57076690|NCT00841659|Paroxetine|paroxetine|mesh-list
57076691|NCT00841659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57076692|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57076693|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57076694|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076695|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076696|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
57076697|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076698|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57076699|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
57076700|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57076701|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57076702|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57076703|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076704|NCT04061252|Brodalumab|brodalumab|mesh-list
57076705|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
57076706|NCT05563558|Carboplatin|carboplatin|mesh-list
57076707|NCT05563558|Pembrolizumab|pembrolizumab|mesh-list
57076708|NCT05563558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076709|NCT05563558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076710|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
57076711|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57076712|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076713|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57076714|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076715|NCT01001091|Dexamethasone|dexamethasone|mesh-list
57076716|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57076717|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57076718|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076719|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
57076720|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
57076721|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076722|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076723|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076724|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
57076725|NCT01001091|Hormones|hormones|mesh-ancestor
57076726|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57076727|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57076728|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076729|NCT05076682|Efavirenz|efavirenz|mesh-list
57076730|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
57076731|NCT05076682|Choline|choline|mesh-list
57076732|NCT05076682|Antibodies|antibodies|mesh-list
57076733|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
57076734|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076735|NCT05076682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57076736|NCT05076682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57076737|NCT05076682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076738|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076739|NCT05076682|Antiviral Agents|antiviral agents|mesh-ancestor
57076740|NCT05076682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076741|NCT05076682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57076742|NCT05076682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57076743|NCT05076682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57076744|NCT05076682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57076745|NCT05076682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57076746|NCT05076682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57076747|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
57076748|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57076749|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
57076750|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076751|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57076752|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
57076753|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
57076754|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076755|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57076756|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
57076757|NCT00840879|Meloxicam|meloxicam|mesh-list
57076758|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57076759|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57076760|NCT00840879|Analgesics|analgesics|mesh-ancestor
57076761|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
57076762|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076763|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076764|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076765|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076766|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57076767|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57076768|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076769|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076770|NCT02163434|Gabapentin|gabapentin|mesh-list
57076771|NCT02163434|Metoclopramide|metoclopramide|mesh-list
57076772|NCT02163434|Analgesics|analgesics|mesh-ancestor
57076773|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
57076774|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076775|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076776|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
57076777|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57076778|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57076779|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57076780|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57076781|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57076782|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57076783|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076784|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076785|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
57076786|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
57076787|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
57076788|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57076789|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57076790|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57076791|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
57076792|NCT04015622|Docetaxel|docetaxel|mesh-list
57076793|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076794|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
57076795|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
57076796|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
57076797|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076798|NCT00840411|Clarithromycin|clarithromycin|mesh-list
57076799|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57076800|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076801|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57076802|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076803|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076804|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57076805|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57076806|NCT00840099|Amoxicillin|amoxicillin|mesh-list
57076807|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
57076808|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
57076809|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57076810|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57076811|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076812|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57076813|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076814|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076815|NCT03108248|Doxorubicin|doxorubicin|mesh-list
57076816|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
57076817|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
57076818|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57076819|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076820|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57076821|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57076822|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076823|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076824|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
57076825|NCT03108248|Coagulants|coagulants|mesh-ancestor
57076826|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
57076827|NCT04934722|Androgens|androgens|mesh-list
57076828|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076829|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076830|NCT04934722|Hormones|hormones|mesh-ancestor
57076831|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57076832|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076833|NCT00836901|Amoxicillin|amoxicillin|mesh-list
57076834|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57076835|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
57076836|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
57076837|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57076838|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076839|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57076840|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076841|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076842|NCT04460560|Terlipressin|terlipressin|mesh-list
57076843|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57076844|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57076845|NCT05468697|Palbociclib|palbociclib|mesh-list
57076846|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076847|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57076848|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076849|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076850|NCT04537689|Cyclosporine|cyclosporine|mesh-list
57076851|NCT04537689|Methotrexate|methotrexate|mesh-list
57076852|NCT04537689|Ixekizumab|ixekizumab|mesh-list
57076853|NCT04537689|Acitretin|acitretin|mesh-list
57076854|NCT04537689|Cyclosporins|cyclosporins|mesh-list
57076855|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57076856|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
57076857|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57076858|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076859|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076860|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
57076861|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076862|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076863|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
57076864|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076865|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57076866|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076867|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
57076868|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076869|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57076870|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
57076871|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076872|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57076873|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
57076874|NCT03295760|Ubiquinone|ubiquinone|mesh-list
57076875|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
57076876|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
57076877|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076878|NCT03295760|Vitamins|vitamins|mesh-ancestor
57076879|NCT05563012|Capecitabine|capecitabine|mesh-list
57076880|NCT05563012|Oxaliplatin|oxaliplatin|mesh-list
57076881|NCT05563012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076882|NCT05563012|Antimetabolites|antimetabolites|mesh-ancestor
57076883|NCT05563012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076884|NCT05563012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076885|NCT04501653|Methylphenidate|methylphenidate|mesh-list
57076886|NCT04501653|Psilocybin|psilocybin|mesh-list
57076887|NCT04501653|Psilocin|psilocin|mesh-list
57076888|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57076889|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076890|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57076891|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57076892|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57076893|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076894|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
57076895|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076896|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
57076897|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57076898|NCT04730206|Camostat|camostat|mesh-list
57076899|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
57076900|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076901|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076902|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57076903|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57076904|NCT00990327|Adenosine|adenosine|mesh-list
57076905|NCT00990327|Analgesics|analgesics|mesh-ancestor
57076906|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
57076907|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076908|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076909|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57076910|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
57076911|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57076912|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
57076913|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
57076914|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076915|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076916|NCT03050814|Leucovorin|leucovorin|mesh-list
57076917|NCT03050814|Bevacizumab|bevacizumab|mesh-list
57076918|NCT03050814|Avelumab|avelumab|mesh-list
57076919|NCT03050814|Fluorouracil|fluorouracil|mesh-list
57076920|NCT03050814|Capecitabine|capecitabine|mesh-list
57076921|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
57076922|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57076923|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076924|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57076925|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57076926|NCT03050814|Growth Substances|growth substances|mesh-ancestor
57076927|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076928|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
57076929|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
57076930|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076931|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076932|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076933|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
57076934|NCT03050814|Antidotes|antidotes|mesh-ancestor
57076935|NCT03050814|Protective Agents|protective agents|mesh-ancestor
57076936|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
57076937|NCT03050814|Vitamins|vitamins|mesh-ancestor
57076938|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
57076939|NCT02462174|Ketamine|ketamine|mesh-list
57076940|NCT02462174|Bupivacaine|bupivacaine|mesh-list
57076941|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
57076942|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
57076943|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57076944|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076945|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
57076946|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076947|NCT02462174|Analgesics|analgesics|mesh-ancestor
57076948|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57076949|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57076950|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
57076951|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57076952|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57076953|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57076954|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076955|NCT02564146|Gemcitabine|gemcitabine|mesh-list
57076956|NCT02564146|Paclitaxel|paclitaxel|mesh-list
57076957|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57076958|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57076959|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57076960|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
57076961|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
57076962|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
57076963|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076964|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57076965|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
57076966|NCT02564146|Antiviral Agents|antiviral agents|mesh-ancestor
57076967|NCT02564146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758931|NCT05557721|Lidocaine|lidocaine|mesh-list
57076968|NCT02564146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076969|NCT02564146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076970|NCT02564146|Immunologic Factors|immunologic factors|mesh-ancestor
57076971|NCT02564146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076972|NCT00981357|Naproxen|naproxen|mesh-list
57076973|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57076974|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57076975|NCT00981357|Analgesics|analgesics|mesh-ancestor
57076976|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
57076977|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57076978|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076979|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57076980|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57076981|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
57076982|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57076983|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076984|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076985|NCT02462252|Cyclosporine|cyclosporine|mesh-list
57076986|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
57076987|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57076988|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57076989|NCT02462252|Cyclosporins|cyclosporins|mesh-list
57076990|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57076991|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57076992|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57076993|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57076994|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
57076995|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57076996|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
57076997|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57076998|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
57076999|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57077000|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57077001|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077002|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
57077003|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
57077004|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077005|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57077006|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
57077007|NCT02462252|Hormones|hormones|mesh-ancestor
57077008|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077009|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57077010|NCT02462252|Protective Agents|protective agents|mesh-ancestor
57077011|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57077012|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077013|NCT03130452|Amoxicillin|amoxicillin|mesh-list
57077014|NCT03130452|Metronidazole|metronidazole|mesh-list
57077015|NCT03130452|Clarithromycin|clarithromycin|mesh-list
57077016|NCT03130452|Lansoprazole|lansoprazole|mesh-list
57077017|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
57077018|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57077019|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077020|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57077021|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57077022|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57077023|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077024|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077025|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57077026|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57077027|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57077028|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57077029|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57077030|NCT00979251|Oseltamivir|oseltamivir|mesh-list
57077031|NCT00979251|Amantadine|amantadine|mesh-list
57077032|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
57077033|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077034|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077035|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077036|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57077037|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57077038|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
57077039|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077040|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077041|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57077042|NCT00979251|Analgesics|analgesics|mesh-ancestor
57077043|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
57077044|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077045|NCT04551352|Adalimumab|adalimumab|mesh-list
57077046|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
57077047|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077048|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57077049|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57077050|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077051|NCT05398224|Rituximab|rituximab|mesh-list
57077052|NCT05398224|Methotrexate|methotrexate|mesh-list
57077053|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
57077054|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57077055|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077056|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
57077057|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077058|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57077059|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57077060|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
57077061|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57077062|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57077063|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
57077064|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077065|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
57077066|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077067|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57077068|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57077069|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57077070|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57077071|NCT04542304|Metolazone|metolazone|mesh-list
57077072|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57077073|NCT04542304|Diuretics|diuretics|mesh-ancestor
57077074|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
57077075|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077076|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57077077|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077078|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077079|NCT02463110|Sertraline|sertraline|mesh-list
57077080|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
57077081|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077082|NCT02463110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57077083|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57077084|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077085|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077086|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077087|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
57077088|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077089|NCT04495257|Nivolumab|nivolumab|mesh-list
57077090|NCT04495257|Ipilimumab|ipilimumab|mesh-list
57077091|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57077092|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077093|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57077094|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077095|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
57077096|NCT03930680|Razoxane|razoxane|mesh-list
57077097|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077098|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57077099|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57077100|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57077101|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077102|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077103|NCT03930680|Protective Agents|protective agents|mesh-ancestor
57077104|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077105|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
57077106|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
57077107|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
57077108|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57077109|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077110|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077111|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57077112|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57077113|NCT05502952|Protective Agents|protective agents|mesh-ancestor
57077114|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077115|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
57077116|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57077117|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
57077118|NCT05457855|Fluticasone|fluticasone|mesh-list
57077119|NCT05457855|Montelukast|montelukast|mesh-list
57077120|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077121|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57077122|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
57077123|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077124|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077125|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57077126|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
57077127|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
57077128|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57077129|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57077130|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
57077131|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077132|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57077133|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57077134|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077135|NCT05498116|Montelukast|montelukast|mesh-list
57077136|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57077137|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
57077138|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57077139|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
57077140|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077141|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077142|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57077143|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57077144|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077145|NCT03910244|Pomalidomide|pomalidomide|mesh-list
57077146|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
57077147|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077148|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57077149|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57077150|NCT03910244|Growth Substances|growth substances|mesh-ancestor
57077151|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
57077152|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077153|NCT05497804|Dexamethasone|dexamethasone|mesh-list
57077154|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
57077155|NCT05497804|Lenalidomide|lenalidomide|mesh-list
57077156|NCT05497804|Daratumumab|daratumumab|mesh-list
57077157|NCT05497804|Ichthammol|ichthammol|mesh-list
57077158|NCT05497804|BB 1101|bb 1101|mesh-list
57077159|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077160|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
57077161|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
57077162|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077163|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077164|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57077165|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
57077166|NCT05497804|Hormones|hormones|mesh-ancestor
57077167|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077168|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57077169|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077170|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
57077171|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077172|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077173|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
57077174|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57077175|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57077176|NCT05497804|Growth Substances|growth substances|mesh-ancestor
57077177|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
57077178|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
57077179|NCT00835575|Mirtazapine|mirtazapine|mesh-list
57077180|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
57077181|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077182|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57077183|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
57077184|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
57077185|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077186|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077187|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077188|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57077189|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57077190|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077191|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57077192|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57077193|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57077194|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
56759137|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
57077195|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57077196|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57077197|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
57077198|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57077199|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57077200|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077201|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57077202|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077203|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077204|NCT03295214|Acetaminophen|acetaminophen|mesh-list
57077205|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57077206|NCT03295214|Analgesics|analgesics|mesh-ancestor
57077207|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
57077208|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077209|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077210|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
57077211|NCT04604704|Niacinamide|niacinamide|mesh-list
57077212|NCT04604704|Naltrexone|naltrexone|mesh-list
57077213|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57077214|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57077215|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077216|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
57077217|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077218|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
57077219|NCT04604704|Vitamins|vitamins|mesh-ancestor
57077220|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
57077221|NCT00776373|Cytarabine|cytarabine|mesh-list
57077222|NCT00776373|Sirolimus|sirolimus|mesh-list
57077223|NCT00776373|Etoposide|etoposide|mesh-list
57077224|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57077225|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077226|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57077227|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57077228|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077229|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077230|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57077231|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
57077232|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
57077233|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077234|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57077235|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
57077236|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077237|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57077238|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57077239|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
57077240|NCT00772785|Buprenorphine|buprenorphine|mesh-list
57077241|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57077242|NCT00772785|Narcotics|narcotics|mesh-ancestor
57077243|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077244|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077245|NCT00772785|Analgesics|analgesics|mesh-ancestor
57077246|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
57077247|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077248|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57077249|NCT02461706|Cannabidiol|cannabidiol|mesh-list
57077250|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
57077251|NCT05497570|Tenoxicam|tenoxicam|mesh-list
57077252|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57077253|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57077254|NCT05497570|Analgesics|analgesics|mesh-ancestor
57077255|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
57077256|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077257|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077258|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077259|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57077260|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57077261|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077262|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077263|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57077264|NCT00963885|Lactams|lactams|mesh-list
57077265|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
57077266|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077267|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57077268|NCT05497492|Lidocaine|lidocaine|mesh-list
57077269|NCT05497492|Sufentanil|sufentanil|mesh-list
57077270|NCT05497492|Propofol|propofol|mesh-list
57077271|NCT05497492|Esketamine|esketamine|mesh-list
57077272|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
57077273|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
57077274|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077275|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077276|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
57077277|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077278|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57077279|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57077280|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57077281|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077282|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077283|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57077284|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57077285|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
57077286|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57077287|NCT05497492|Narcotics|narcotics|mesh-ancestor
57077288|NCT05497492|Analgesics|analgesics|mesh-ancestor
57077289|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57077290|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
57077291|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077292|NCT00835497|Metformin|metformin|mesh-list
57077293|NCT00835497|Glipizide|glipizide|mesh-list
57077294|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57077295|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077296|NCT04279054|Morphine|morphine|mesh-list
57077297|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57077298|NCT04279054|Narcotics|narcotics|mesh-ancestor
57077299|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077300|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077301|NCT04279054|Analgesics|analgesics|mesh-ancestor
57077302|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
57077303|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077304|NCT05005689|Fluorides|fluorides|mesh-list
57077305|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
57077306|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077307|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
57077308|NCT05005689|Protective Agents|protective agents|mesh-ancestor
57077309|NCT00763503|Calcitriol|calcitriol|mesh-list
57077310|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57077311|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077312|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57077313|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077314|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077315|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57077316|NCT00763503|Vitamins|vitamins|mesh-ancestor
57077317|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
57077318|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57077319|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57077320|NCT00761709|Latanoprost|latanoprost|mesh-list
57077321|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57077322|NCT00760539|Timolol|timolol|mesh-list
57077323|NCT00760539|Travoprost|travoprost|mesh-list
57077324|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57077325|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57077326|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57077327|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57077328|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
57077329|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077330|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077331|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077332|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57077333|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57077334|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57077335|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57077336|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
57077337|NCT00759135|Finasteride|finasteride|mesh-list
57077338|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57077339|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57077340|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077341|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077342|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
57077343|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077344|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077345|NCT00759135|Urological Agents|urological agents|mesh-ancestor
57077346|NCT00835263|Lamotrigine|lamotrigine|mesh-list
56759289|NCT04080713|Budesonide|budesonide|mesh-list
57077347|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
57077348|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57077349|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077350|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077351|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57077352|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077353|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57077354|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57077355|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077356|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077357|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57077358|NCT02639910|Venetoclax|venetoclax|mesh-list
57077359|NCT02639910|Idelalisib|idelalisib|mesh-list
57077360|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077361|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077362|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077363|NCT04454580|Azacitidine|azacitidine|mesh-list
57077364|NCT04454580|Decitabine|decitabine|mesh-list
57077365|NCT04454580|Venetoclax|venetoclax|mesh-list
57077366|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57077367|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
57077368|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077369|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077370|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077371|NCT00948909|Donepezil|donepezil|mesh-list
57077372|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57077373|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077374|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077375|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
57077376|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077377|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077378|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
57077379|NCT02426892|Nivolumab|nivolumab|mesh-list
57077380|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57077381|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077382|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57077383|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077384|NCT02522910|Docetaxel|docetaxel|mesh-list
57077385|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077386|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
57077387|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
57077388|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
57077389|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077390|NCT00948753|Maraviroc|maraviroc|mesh-list
57077391|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57077392|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57077393|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077394|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57077395|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57077396|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
57077397|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077398|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57077399|NCT05397834|Fluticasone|fluticasone|mesh-list
57077400|NCT05397834|Xhance|xhance|mesh-list
57077401|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077402|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57077403|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
57077404|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077405|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077406|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57077407|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
57077408|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
57077409|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57077410|NCT03134547|Sevoflurane|sevoflurane|mesh-list
57077411|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57077412|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57077413|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
57077414|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
57077415|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077416|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077417|NCT01963208|Ganaxolone|ganaxolone|mesh-list
57077418|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
57077419|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077420|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077421|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077422|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
57077423|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
57077424|NCT00834873|Carvedilol|carvedilol|mesh-list
57077425|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57077426|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57077427|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
57077428|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077429|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077430|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077431|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57077432|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
57077433|NCT00834873|Protective Agents|protective agents|mesh-ancestor
57077434|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57077435|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077436|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57077437|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
57077438|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57077439|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57077440|NCT01377480|Posaconazole|posaconazole|mesh-list
57077441|NCT01377480|Benzonidazole|benzonidazole|mesh-list
57077442|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
57077443|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077444|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57077445|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57077446|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57077447|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57077448|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57077449|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077450|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077451|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57077452|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
57077453|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077454|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077455|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57077456|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
57077457|NCT04263909|Sufentanil|sufentanil|mesh-list
57077458|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57077459|NCT04263909|Narcotics|narcotics|mesh-ancestor
57077460|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077461|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077462|NCT04263909|Analgesics|analgesics|mesh-ancestor
57077463|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
57077464|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077465|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57077466|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57077467|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
57077468|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
57077469|NCT01421264|Gabapentin|gabapentin|mesh-list
57077470|NCT01421264|Analgesics|analgesics|mesh-ancestor
57077471|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
57077472|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077473|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077474|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
57077475|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57077476|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57077477|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077478|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077479|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57077480|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57077481|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077482|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077483|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
57077484|NCT04415840|Acetic Acid|acetic acid|mesh-list
57077485|NCT04415840|Retinol acetate|retinol acetate|mesh-list
57077486|NCT04415840|Lugol's solution|lugol's solution|mesh-list
57077487|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57077488|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077489|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57077490|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
57077491|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077492|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57077493|NCT04415840|Protective Agents|protective agents|mesh-ancestor
57077494|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077495|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
57077496|NCT04415840|Coagulants|coagulants|mesh-ancestor
57077497|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
57077498|NCT04488614|Estrogens|estrogens|mesh-list
57077499|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57077500|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077501|NCT04488614|Hormones|hormones|mesh-ancestor
57077502|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077503|NCT00834795|Carvedilol|carvedilol|mesh-list
57077504|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57077505|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57077506|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
57077507|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077508|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077509|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077510|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57077511|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
57077512|NCT00834795|Protective Agents|protective agents|mesh-ancestor
57077513|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57077514|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077515|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57077516|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
57077517|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57077518|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57077519|NCT00834717|Granisetron|granisetron|mesh-list
57077520|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
57077521|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
57077522|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077523|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077524|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57077525|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57077526|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
57077527|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077528|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077529|NCT00834639|Valproic Acid|valproic acid|mesh-list
57077530|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
57077531|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077532|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077533|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
57077534|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077535|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077536|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
57077537|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57077538|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077539|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077540|NCT00834561|Lamotrigine|lamotrigine|mesh-list
57077541|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
57077542|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57077543|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077544|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077545|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57077546|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077547|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57077548|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57077549|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077550|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077551|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57077552|NCT00754221|Reboxetine|reboxetine|mesh-list
57077553|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
57077554|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077555|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57077556|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57077557|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077558|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077559|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
57077560|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077561|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077562|NCT00834405|Leflunomide|leflunomide|mesh-list
57077563|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077564|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077565|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57077566|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
57077567|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077568|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57077569|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57077570|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57077571|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56301511|NCT00027040|Protective Agents|protective agents|mesh-ancestor
57077572|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077573|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077574|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077575|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57077576|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
57077577|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077579|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57077580|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
57077581|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077582|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077583|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077584|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57077585|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
57077586|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077587|NCT05402397|Losartan|losartan|mesh-list
57077588|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57077589|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57077590|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57077591|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57077592|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077593|NCT00833937|Zolpidem|zolpidem|mesh-list
57077594|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57077595|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57077596|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077597|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077598|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57077599|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
57077600|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
57077601|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077602|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077603|NCT00831051|Morphine|morphine|mesh-list
57077604|NCT00831051|Oxycodone|oxycodone|mesh-list
57077605|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57077606|NCT00831051|Narcotics|narcotics|mesh-ancestor
57077607|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077608|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077609|NCT00831051|Analgesics|analgesics|mesh-ancestor
57077610|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
57077611|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077612|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
57077613|NCT00750633|Dexamethasone|dexamethasone|mesh-list
57077614|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57077615|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57077616|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077617|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
57077618|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
57077619|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077620|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077621|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57077622|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
57077623|NCT00750633|Hormones|hormones|mesh-ancestor
57077624|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077625|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57077626|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077627|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57077628|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077629|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57077630|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57077631|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077632|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077633|NCT00750243|Naproxen|naproxen|mesh-list
57077634|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57077635|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57077636|NCT00750243|Analgesics|analgesics|mesh-ancestor
57077637|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
57077638|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077639|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077640|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077641|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57077642|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
56759601|NCT04293562|Cytarabine|cytarabine|mesh-list
57077643|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57077644|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077645|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077646|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
57077647|NCT00924170|Fludarabine|fludarabine|mesh-list
57077648|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57077649|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
57077650|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077651|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57077652|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57077653|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
57077654|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077655|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077656|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57077657|NCT04809285|Insulin|insulin|mesh-list
57077658|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57077659|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077660|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
57077661|NCT00920985|Gestodene|gestodene|mesh-list
57077662|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
57077663|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57077664|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077665|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57077666|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57077667|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57077668|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57077669|NCT00920985|Progestins|progestins|mesh-ancestor
57077670|NCT00920985|Hormones|hormones|mesh-ancestor
57077671|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077672|NCT05388747|Cefuroxime|cefuroxime|mesh-list
57077673|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
57077674|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57077675|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077676|NCT00828321|Ramipril|ramipril|mesh-list
57077677|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57077678|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
57077679|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077680|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077681|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57077682|NCT01352715|Ritonavir|ritonavir|mesh-list
57077683|NCT01352715|Lopinavir|lopinavir|mesh-list
57077684|NCT01352715|Tenofovir|tenofovir|mesh-list
57077685|NCT01352715|Lamivudine|lamivudine|mesh-list
57077686|NCT01352715|Zidovudine|zidovudine|mesh-list
57077687|NCT01352715|Emtricitabine|emtricitabine|mesh-list
57077688|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
57077689|NCT01352715|Abacavir|abacavir|mesh-list
57077690|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
57077691|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
57077692|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57077693|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57077694|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
57077695|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077696|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077697|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57077698|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57077699|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
57077700|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077701|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57077702|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57077703|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57077704|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57077705|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
57077706|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57077707|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57077708|NCT00743925|Atorvastatin|atorvastatin|mesh-list
57077709|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
57077710|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57077711|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57077712|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
57077713|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077714|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57077715|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57077716|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077717|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
57077718|NCT04221945|Cisplatin|cisplatin|mesh-list
57077720|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077721|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57077722|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57077723|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57077724|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57077725|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077726|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077727|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077728|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077729|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57077730|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
57077731|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077732|NCT00738387|Docetaxel|docetaxel|mesh-list
57077733|NCT00738387|Vadimezan|vadimezan|mesh-list
57077734|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077735|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
57077736|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
57077737|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
57077738|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077739|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
57077740|NCT03710421|Fludarabine|fludarabine|mesh-list
57077741|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57077742|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
57077743|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077744|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57077745|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57077746|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
57077747|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077748|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077749|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57077750|NCT00645177|Paclitaxel|paclitaxel|mesh-list
57077751|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57077752|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077753|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
57077754|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
57077755|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
57077756|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077757|NCT00643383|Acetaminophen|acetaminophen|mesh-list
57077758|NCT00643383|Tramadol|tramadol|mesh-list
57077759|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57077760|NCT00643383|Analgesics|analgesics|mesh-ancestor
57077761|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
57077762|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077763|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077764|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
57077765|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57077766|NCT00643383|Narcotics|narcotics|mesh-ancestor
57077767|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077768|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57077769|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
57077770|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077771|NCT04285450|Vitamin K|vitamin k|mesh-list
57077772|NCT04285450|Vitamins|vitamins|mesh-ancestor
57077773|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
57077774|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077775|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57077776|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57077777|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077778|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
57077779|NCT04285450|Coagulants|coagulants|mesh-ancestor
57077780|NCT05497102|Lenalidomide|lenalidomide|mesh-list
57077781|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
57077782|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077783|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57077784|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57077785|NCT05497102|Growth Substances|growth substances|mesh-ancestor
57077786|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
57077787|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077788|NCT04017442|Morphine|morphine|mesh-list
57077789|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57077790|NCT04017442|Narcotics|narcotics|mesh-ancestor
57077791|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57077792|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077793|NCT04017442|Analgesics|analgesics|mesh-ancestor
57077794|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
57077795|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077796|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57077797|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57077798|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077799|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
57077800|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57077801|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57077802|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077803|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
57077804|NCT05490160|Coagulants|coagulants|mesh-ancestor
57077805|NCT05495620|Dexamethasone|dexamethasone|mesh-list
57077806|NCT05495620|Lenalidomide|lenalidomide|mesh-list
57077807|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077808|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
57077809|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
57077810|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077811|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077812|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57077813|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
57077814|NCT05495620|Hormones|hormones|mesh-ancestor
57077815|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077816|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57077817|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077818|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
57077819|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57077820|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57077821|NCT05495620|Growth Substances|growth substances|mesh-ancestor
57077822|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
57077823|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
57077824|NCT05490082|Mirabegron|mirabegron|mesh-list
57077825|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57077826|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57077827|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
57077828|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077829|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077830|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077831|NCT05490082|Urological Agents|urological agents|mesh-ancestor
57077832|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57077833|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57077834|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57077835|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
57077836|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
57077837|NCT02559310|Linezolid|linezolid|mesh-list
57077838|NCT02559310|Lefamulin|lefamulin|mesh-list
57077839|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57077840|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077841|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57077842|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57077843|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077844|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077845|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077846|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57077847|NCT05489848|Paclitaxel|paclitaxel|mesh-list
57077848|NCT05489848|Carboplatin|carboplatin|mesh-list
57077849|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57077850|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077851|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
57077852|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
57077853|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
57077854|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077855|NCT03517449|Paclitaxel|paclitaxel|mesh-list
57077856|NCT03517449|Doxorubicin|doxorubicin|mesh-list
57077857|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
57077858|NCT03517449|Lenvatinib|lenvatinib|mesh-list
57077859|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57077860|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077861|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
57077862|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
57077863|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
57077864|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077865|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57077866|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57077867|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57077868|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077869|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57077870|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57077871|NCT05489692|Leucovorin|leucovorin|mesh-list
57077872|NCT05489692|Fluorouracil|fluorouracil|mesh-list
57077873|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
57077874|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57077875|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
57077876|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077877|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57077878|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077879|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57077880|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
57077881|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077882|NCT05489692|Antidotes|antidotes|mesh-ancestor
57077883|NCT05489692|Protective Agents|protective agents|mesh-ancestor
57077884|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
57077885|NCT05489692|Vitamins|vitamins|mesh-ancestor
57077886|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
57077887|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57077888|NCT00721695|Mydriatics|mydriatics|mesh-list
57077889|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
57077890|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077891|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077892|NCT00625833|Reboxetine|reboxetine|mesh-list
57077893|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
57077894|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57077895|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57077896|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57077897|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57077898|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077899|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
57077900|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077901|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077902|NCT00670358|Prednisone|prednisone|mesh-list
57077903|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
57077904|NCT00670358|Rituximab|rituximab|mesh-list
57077905|NCT00670358|Doxorubicin|doxorubicin|mesh-list
57077906|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57077907|NCT00670358|Vincristine|vincristine|mesh-list
57077908|NCT00670358|Lenalidomide|lenalidomide|mesh-list
57077909|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57077910|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
57077911|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077912|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57077913|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57077914|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
57077915|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077916|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077917|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57077918|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57077919|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57077920|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57077921|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57077922|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077923|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077924|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
57077925|NCT00670358|Hormones|hormones|mesh-ancestor
57077926|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077927|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57077928|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57077929|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
57077930|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
57077931|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
57077932|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57077933|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57077934|NCT00670358|Growth Substances|growth substances|mesh-ancestor
57077935|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
57077936|NCT03299036|Doxorubicin|doxorubicin|mesh-list
57077937|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57077938|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077939|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57077940|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57077941|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077942|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077943|NCT03290846|Secretin|secretin|mesh-list
57077944|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57077945|NCT03290846|Hormones|hormones|mesh-ancestor
57077946|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077947|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077948|NCT03298958|Sirolimus|sirolimus|mesh-list
57077949|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57077950|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077951|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57077952|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077953|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
57077954|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57077955|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
57077956|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077957|NCT04488926|Palmidrol|palmidrol|mesh-list
57077958|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57077959|NCT04488926|Analgesics|analgesics|mesh-ancestor
57077960|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
57077961|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57077962|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077963|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57077964|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077965|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57077966|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
57077967|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077968|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57077969|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57077970|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57077971|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077972|NCT04488926|Hormones|hormones|mesh-ancestor
57077973|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077974|NCT04328714|Interferons|interferons|mesh-list
57077975|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
57077976|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077977|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
57077978|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57077979|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57077980|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57077981|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077982|NCT03290456|Prednisone|prednisone|mesh-list
57077983|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57077984|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
57077985|NCT03290456|Hormones|hormones|mesh-ancestor
57077986|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57077987|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57077988|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57077989|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57077990|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
57077991|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57077992|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
57077993|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57077994|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
57077995|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57077996|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57077997|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
57077998|NCT03298646|Diclofenac|diclofenac|mesh-list
57077999|NCT03298646|Lidocaine|lidocaine|mesh-list
57078000|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
57078001|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
57078002|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078003|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078004|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
57078005|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078006|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57078007|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57078008|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57078009|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57078010|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078011|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57078012|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57078013|NCT03298646|Analgesics|analgesics|mesh-ancestor
57078014|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078015|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57078016|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57078017|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078018|NCT02460692|Dronabinol|dronabinol|mesh-list
57078019|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
57078020|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078021|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57078022|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57078023|NCT02460692|Analgesics|analgesics|mesh-ancestor
57078024|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
57078025|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078026|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57078027|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57078028|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078029|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078030|NCT02460692|Hormones|hormones|mesh-ancestor
57078031|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078032|NCT05494060|Capecitabine|capecitabine|mesh-list
57078033|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
57078034|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57078035|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
57078036|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078037|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078038|NCT05488990|Calcitriol|calcitriol|mesh-list
57078039|NCT05488990|Calcipotriene|calcipotriene|mesh-list
57078040|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
57078041|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57078042|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078043|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57078044|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57078045|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078046|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57078047|NCT05488990|Vitamins|vitamins|mesh-ancestor
57078048|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
57078049|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57078050|NCT03289520|Clopidogrel|clopidogrel|mesh-list
57078051|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57078052|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57078053|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57078054|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57078055|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
57078056|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078057|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078058|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078059|NCT03293108|Vitamin D|vitamin d|mesh-list
57078060|NCT03293108|Denosumab|denosumab|mesh-list
57078061|NCT03293108|Calcium|calcium|mesh-list
57078062|NCT03293108|Vitamins|vitamins|mesh-ancestor
57078063|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
57078064|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078065|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57078066|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57078067|NCT03292796|Bimatoprost|bimatoprost|mesh-list
57078068|NCT03292796|Latanoprost|latanoprost|mesh-list
57078069|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57078070|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57078071|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57078072|NCT03288896|Ethanol|ethanol|mesh-list
57078073|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57078074|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078075|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078076|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078077|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
57078078|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
57078079|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078080|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57078081|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078082|NCT03292172|Atezolizumab|atezolizumab|mesh-list
57078083|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078084|NCT02461004|Ezetimibe|ezetimibe|mesh-list
57078085|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57078086|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57078087|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
57078088|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078089|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57078090|NCT03288428|Morphine|morphine|mesh-list
57078091|NCT03288428|Nalbuphine|nalbuphine|mesh-list
57078092|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57078093|NCT03288428|Narcotics|narcotics|mesh-ancestor
56760045|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078094|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078095|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078096|NCT03288428|Analgesics|analgesics|mesh-ancestor
57078097|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
57078098|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078099|NCT03288350|Avelumab|avelumab|mesh-list
57078100|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078101|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078102|NCT00003224|Vaccines|vaccines|mesh-list
57078103|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
57078104|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
57078105|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078106|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57078107|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57078108|NCT03288038|Ezetimibe|ezetimibe|mesh-list
57078109|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57078110|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57078111|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
57078112|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078113|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57078114|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57078115|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078116|NCT03287882|Micronutrients|micronutrients|mesh-list
57078117|NCT03287882|Trace Elements|trace elements|mesh-list
57078118|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078119|NCT03291314|Avelumab|avelumab|mesh-list
57078120|NCT03291314|Axitinib|axitinib|mesh-list
57078121|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078122|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078123|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57078124|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078125|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078126|NCT03291158|Minocycline|minocycline|mesh-list
57078127|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57078128|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078129|NCT03283202|Prednisone|prednisone|mesh-list
57078130|NCT03283202|Prednisolone|prednisolone|mesh-list
57078131|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
57078132|NCT03283202|Rituximab|rituximab|mesh-list
57078133|NCT03283202|Vincristine|vincristine|mesh-list
57078134|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57078135|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
57078136|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078137|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57078138|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57078139|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
57078140|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078141|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078142|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57078143|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078144|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078145|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
57078146|NCT03283202|Hormones|hormones|mesh-ancestor
57078147|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078148|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57078149|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57078150|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
57078151|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
57078152|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
57078153|NCT03283046|Dexamethasone|dexamethasone|mesh-list
57078154|NCT03283046|Nivolumab|nivolumab|mesh-list
57078155|NCT03283046|Lenalidomide|lenalidomide|mesh-list
57078156|NCT03283046|Ipilimumab|ipilimumab|mesh-list
57078157|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078158|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
57078159|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
57078160|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078161|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078162|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57078163|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
57078164|NCT03283046|Hormones|hormones|mesh-ancestor
57078165|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078166|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57078167|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078168|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078169|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57078170|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078171|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
57078172|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57078173|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57078174|NCT03283046|Growth Substances|growth substances|mesh-ancestor
57078175|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
57078176|NCT03287180|Buprenorphine|buprenorphine|mesh-list
57078177|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
57078178|NCT03287180|Naloxone|naloxone|mesh-list
57078179|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57078180|NCT03287180|Narcotics|narcotics|mesh-ancestor
57078181|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078182|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078183|NCT03287180|Analgesics|analgesics|mesh-ancestor
57078184|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
57078185|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078186|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57078187|NCT02460146|CXA-10|cxa-10|mesh-list
57078188|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078189|NCT02460302|Progesterone|progesterone|mesh-list
57078190|NCT02460302|Progestins|progestins|mesh-ancestor
57078191|NCT02460302|Hormones|hormones|mesh-ancestor
57078192|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078193|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078194|NCT03282188|Sargramostim|sargramostim|mesh-list
57078195|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
57078196|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078197|NCT03384212|Cytarabine|cytarabine|mesh-list
57078198|NCT03384212|Fludarabine|fludarabine|mesh-list
57078199|NCT03384212|Busulfan|busulfan|mesh-list
57078200|NCT03384212|Cladribine|cladribine|mesh-list
57078201|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078202|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57078203|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
57078204|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078205|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57078206|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
57078207|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078208|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
57078209|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078210|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
57078211|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57078212|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57078213|NCT02460068|Nivolumab|nivolumab|mesh-list
57078214|NCT02460068|Ipilimumab|ipilimumab|mesh-list
57078215|NCT02460068|Fotemustine|fotemustine|mesh-list
57078216|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078217|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078218|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57078219|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078220|NCT03286244|Paclitaxel|paclitaxel|mesh-list
57078221|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57078222|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078223|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
57078224|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
57078225|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
57078226|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078227|NCT03282110|Citalopram|citalopram|mesh-list
57078228|NCT03282110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57078229|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57078230|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57078231|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078232|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078233|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
57078234|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078235|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57078236|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
57078237|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57078238|NCT03269786|Bilirubin|bilirubin|mesh-list
57078239|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
57078240|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078241|NCT03269786|Protective Agents|protective agents|mesh-ancestor
57078242|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078243|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
57078244|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
57078245|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
57078246|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078247|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078248|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
57078249|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57078250|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57078251|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
57078252|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078253|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078254|NCT03269318|Theophylline|theophylline|mesh-list
57078255|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57078256|NCT03269318|Montelukast|montelukast|mesh-list
57078257|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57078258|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
57078259|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078260|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078261|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57078262|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
57078263|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57078264|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57078265|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57078266|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
57078267|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078268|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078269|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57078270|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
57078271|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078272|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57078273|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57078274|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57078275|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078276|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
57078277|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57078278|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57078279|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
57078280|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
57078281|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57078282|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
57078283|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57078284|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
57078285|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078286|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078287|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
57078288|NCT04186598|Nifedipine|nifedipine|mesh-list
57078289|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57078290|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57078291|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078292|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57078293|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078294|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
57078295|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
57078296|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57078297|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57078298|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57078299|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57078300|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078301|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078302|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57078303|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57078304|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078305|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
57078306|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078307|NCT03107858|Dopamine|dopamine|mesh-list
57078308|NCT03107858|Norepinephrine|norepinephrine|mesh-list
57078309|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57078310|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57078311|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
57078312|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078313|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078314|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078315|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
57078316|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
57078317|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760272|NCT01000857|Paroxetine|paroxetine|mesh-list
57078318|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57078319|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57078320|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
57078321|NCT03107858|Protective Agents|protective agents|mesh-ancestor
57078322|NCT03269162|Docetaxel|docetaxel|mesh-list
57078323|NCT03269162|Pemetrexed|pemetrexed|mesh-list
57078324|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078325|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
57078326|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
57078327|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
57078328|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078329|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078330|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57078331|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57078332|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
57078333|NCT03284294|Vitamin D|vitamin d|mesh-list
57078334|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57078335|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078336|NCT03284294|Vitamins|vitamins|mesh-ancestor
57078337|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
57078338|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57078339|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
57078340|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57078341|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078342|NCT03268226|Beclomethasone|beclomethasone|mesh-list
57078343|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
57078344|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
57078345|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57078346|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
57078347|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078348|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078349|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57078350|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
57078351|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57078352|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57078353|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57078354|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
57078355|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078356|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078357|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57078358|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57078359|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57078360|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
57078361|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078362|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
57078363|NCT03268226|Hormones|hormones|mesh-ancestor
57078364|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078365|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57078366|NCT04108858|Trastuzumab|trastuzumab|mesh-list
57078367|NCT04108858|Pertuzumab|pertuzumab|mesh-list
57078368|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
57078369|NCT04108858|Antibodies|antibodies|mesh-list
57078370|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
57078371|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57078372|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
57078373|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078374|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078375|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
57078376|NCT02737475|Nivolumab|nivolumab|mesh-list
57078377|NCT02737475|Ipilimumab|ipilimumab|mesh-list
57078378|NCT02737475|Vaccines|vaccines|mesh-list
57078379|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
57078380|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078381|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57078382|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57078383|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57078384|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
57078385|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078386|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078387|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57078388|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078389|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57078390|NCT02457806|Phenylephrine|phenylephrine|mesh-list
57078391|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
57078392|NCT02457806|Tetracaine|tetracaine|mesh-list
57078393|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
57078394|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
56760351|NCT05228249|Cytarabine|cytarabine|mesh-list
57078395|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078396|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078397|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
57078398|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078399|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57078401|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
57078402|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078403|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078404|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
57078405|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
57078406|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
57078407|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57078408|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
57078409|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57078410|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
57078411|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57078412|NCT02457806|Protective Agents|protective agents|mesh-ancestor
57078413|NCT02459756|Citric Acid|citric acid|mesh-list
57078414|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
57078415|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078416|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
57078417|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57078418|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
57078419|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
57078420|NCT02557672|Thrombin|thrombin|mesh-list
57078421|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
57078422|NCT02557672|Coagulants|coagulants|mesh-ancestor
57078423|NCT02458274|Dimercaprol|dimercaprol|mesh-list
57078424|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
57078425|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
57078426|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078427|NCT02632175|Adalimumab|adalimumab|mesh-list
57078428|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078429|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57078430|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
57078431|NCT02458196|Prednisone|prednisone|mesh-list
57078432|NCT02458196|Prednisolone|prednisolone|mesh-list
57078433|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078434|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
57078435|NCT02458196|Hormones|hormones|mesh-ancestor
57078436|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078437|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078438|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57078439|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078440|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57078441|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57078442|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
57078443|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57078444|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078445|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078446|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078447|NCT05207735|Capecitabine|capecitabine|mesh-list
57078448|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57078449|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
57078450|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078451|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078452|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
57078453|NCT03264638|Cyproterone|cyproterone|mesh-list
57078454|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
57078455|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
57078456|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
57078457|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078458|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078459|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078460|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57078461|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
57078462|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57078463|NCT04502381|Amphotericin B|amphotericin b|mesh-list
57078464|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
57078465|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
57078466|NCT04502381|Amebicides|amebicides|mesh-ancestor
57078467|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57078468|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57078469|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078470|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57078471|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
57078472|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57078473|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57078474|NCT03264794|Gefitinib|gefitinib|mesh-list
57078475|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078476|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57078477|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078478|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078479|NCT02925923|Clopidogrel|clopidogrel|mesh-list
57078480|NCT02925923|Ticagrelor|ticagrelor|mesh-list
57078481|NCT02925923|Eptifibatide|eptifibatide|mesh-list
57078482|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57078483|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57078484|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57078485|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57078486|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
57078487|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078488|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078489|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078490|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
57078491|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
57078492|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57078493|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57078494|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57078495|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57078496|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078497|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
57078498|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078499|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078500|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57078501|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078502|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57078503|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57078504|NCT03280316|Urological Agents|urological agents|mesh-ancestor
57078505|NCT02410343|Hormones|hormones|mesh-list
57078506|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078507|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078508|NCT05234840|Triamcinolone|triamcinolone|mesh-list
57078509|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078510|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
57078511|NCT05234840|Hormones|hormones|mesh-ancestor
57078512|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078513|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078514|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
57078515|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57078516|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57078517|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078518|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57078519|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57078520|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078521|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078522|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078523|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57078524|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
57078525|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57078526|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078527|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57078528|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57078529|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57078530|NCT03434379|Bevacizumab|bevacizumab|mesh-list
57078531|NCT03434379|Sorafenib|sorafenib|mesh-list
57078532|NCT03434379|Atezolizumab|atezolizumab|mesh-list
57078533|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078534|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078535|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57078536|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57078537|NCT03434379|Growth Substances|growth substances|mesh-ancestor
57078538|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078539|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
57078540|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57078541|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078542|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078544|NCT02459288|Ticagrelor|ticagrelor|mesh-list
57078545|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57078546|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57078547|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57078548|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57078549|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
57078550|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078551|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078552|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078553|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
57078554|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
57078555|NCT00734253|Vitamins|vitamins|mesh-ancestor
57078556|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
57078557|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078558|NCT05166239|Lenvatinib|lenvatinib|mesh-list
57078559|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078560|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57078561|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078562|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078563|NCT00730665|Esomeprazole|esomeprazole|mesh-list
57078564|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57078565|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57078566|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57078567|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078568|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078569|NCT00714597|Enoxaparin|enoxaparin|mesh-list
57078570|NCT00714597|Semuloparin|semuloparin|mesh-list
57078571|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
57078572|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
57078573|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57078574|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57078575|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078576|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
57078577|NCT03919526|Fludarabine|fludarabine|mesh-list
57078578|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57078579|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
57078580|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078581|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57078582|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57078583|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
57078584|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078585|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078586|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57078587|NCT03265886|Bupivacaine|bupivacaine|mesh-list
57078588|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
57078589|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
57078590|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078591|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078592|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
57078593|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078594|NCT00728091|Satavaptan|satavaptan|mesh-list
57078595|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57078596|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078597|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
57078598|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078599|NCT03275090|SMOFlipid|smoflipid|mesh-list
57078600|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57078601|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57078602|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57078603|NCT03382821|Dexamethasone|dexamethasone|mesh-list
57078604|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
57078605|NCT03382821|Triamcinolone|triamcinolone|mesh-list
57078606|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57078607|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57078608|NCT03382821|Lidocaine|lidocaine|mesh-list
57078609|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57078610|NCT03382821|BB 1101|bb 1101|mesh-list
57078611|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57078612|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078613|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
57078614|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
57078615|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078616|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078617|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57078618|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
57078619|NCT03382821|Hormones|hormones|mesh-ancestor
57078620|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078621|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57078622|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078623|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
57078624|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078625|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078626|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
57078627|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
57078628|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078629|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
57078630|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57078631|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57078632|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57078633|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57078634|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57078635|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
57078636|NCT03263624|Tazarotene|tazarotene|mesh-list
57078637|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
57078638|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
57078639|NCT00711555|Dexamethasone|dexamethasone|mesh-list
57078640|NCT00711555|Ondansetron|ondansetron|mesh-list
57078641|NCT00711555|Aprepitant|aprepitant|mesh-list
57078642|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078643|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
57078644|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
57078645|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078646|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078647|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57078648|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
57078649|NCT00711555|Hormones|hormones|mesh-ancestor
57078650|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078651|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57078652|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078653|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
57078654|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
57078655|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57078656|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
57078657|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078658|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078659|NCT00711555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57078660|NCT00711555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57078661|NCT00711555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078662|NCT00711555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57078663|NCT00711555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57078664|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57078665|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
57078666|NCT02280993|Dexamethasone|dexamethasone|mesh-list
57078667|NCT02280993|Cisplatin|cisplatin|mesh-list
57078668|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57078669|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078670|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
57078671|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
57078672|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078673|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078674|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57078675|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
57078676|NCT02280993|Hormones|hormones|mesh-ancestor
57078677|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078678|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57078679|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078680|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078681|NCT05488522|Bevacizumab|bevacizumab|mesh-list
57078682|NCT05488522|Atezolizumab|atezolizumab|mesh-list
57078683|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078684|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078685|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57078686|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57078687|NCT05488522|Growth Substances|growth substances|mesh-ancestor
57078688|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078689|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
57078690|NCT05492968|Phenylephrine|phenylephrine|mesh-list
57078691|NCT05492968|Epinephrine|epinephrine|mesh-list
57078692|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
57078694|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57078695|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57078696|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
57078697|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078698|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078699|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078700|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57078701|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57078702|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
57078703|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078704|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57078705|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
57078706|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
57078707|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
57078708|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57078709|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57078710|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
57078711|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57078712|NCT05492968|Protective Agents|protective agents|mesh-ancestor
57078713|NCT02457026|Triamcinolone|triamcinolone|mesh-list
57078714|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57078715|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57078716|NCT02457026|Aflibercept|aflibercept|mesh-list
57078717|NCT02457026|Verteporfin|verteporfin|mesh-list
57078718|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57078719|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078720|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
57078721|NCT02457026|Hormones|hormones|mesh-ancestor
57078722|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078723|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078724|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57078725|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
57078726|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078727|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078728|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57078729|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57078730|NCT02457026|Growth Substances|growth substances|mesh-ancestor
57078731|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
57078732|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078733|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57078734|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
57078735|NCT05492812|Melatonin|melatonin|mesh-list
57078736|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
57078737|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
57078738|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
57078739|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078740|NCT05492812|Protective Agents|protective agents|mesh-ancestor
57078741|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078742|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078743|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
57078744|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
57078745|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57078746|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
57078747|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
57078748|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078749|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57078750|NCT02458118|Secretin|secretin|mesh-list
57078751|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57078752|NCT02458118|Hormones|hormones|mesh-ancestor
57078753|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078754|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078755|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
57078756|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57078757|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078758|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078759|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57078760|NCT05487742|Analgesics|analgesics|mesh-ancestor
57078761|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
57078762|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078763|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57078764|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57078765|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57078766|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
57078767|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078768|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078769|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
57078770|NCT02457650|Fludarabine|fludarabine|mesh-list
57078771|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57078772|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
57078773|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078774|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57078775|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57078776|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
57078777|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078778|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078779|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57078780|NCT02456948|Minocycline|minocycline|mesh-list
57078781|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57078782|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078783|NCT05487508|Dexamethasone|dexamethasone|mesh-list
57078784|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57078785|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
57078786|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
57078787|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078788|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078789|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57078790|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
57078791|NCT05487508|Hormones|hormones|mesh-ancestor
57078792|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57078793|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57078794|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078795|NCT02713490|Bupivacaine|bupivacaine|mesh-list
57078796|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
57078797|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
57078798|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078799|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078800|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
57078801|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078802|NCT03787628|Cannabidiol|cannabidiol|mesh-list
57078803|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
57078804|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
57078805|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57078806|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078807|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57078808|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078809|NCT05491720|Risperidone|risperidone|mesh-list
57078810|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57078811|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
57078812|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078813|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078814|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078815|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57078816|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57078817|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078818|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57078819|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57078820|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
57078821|NCT05387954|Anticoagulants|anticoagulants|mesh-list
57078822|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
57078823|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
57078824|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57078825|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
57078826|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078827|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078828|NCT05486104|Hemay005|hemay005|mesh-list
57078829|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
57078830|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57078831|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57078832|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078833|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078834|NCT03262688|Bupivacaine|bupivacaine|mesh-list
57078835|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
57078836|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
57078837|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078838|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078839|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
57078840|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078841|NCT05486884|Benzocaine|benzocaine|mesh-list
57078842|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
57078843|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
57078844|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078845|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078846|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
57078847|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078848|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57078849|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57078850|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078851|NCT03797924|Ropivacaine|ropivacaine|mesh-list
57078852|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
57078853|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
57078854|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078855|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078856|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
57078857|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078858|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57078859|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078860|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078861|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
57078862|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57078863|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078864|NCT05074628|Renal Agents|renal agents|mesh-ancestor
57078865|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57078866|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
57078867|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57078868|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
57078869|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57078870|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
57078871|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078872|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078873|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
57078874|NCT02458742|Morphine|morphine|mesh-list
57078875|NCT02458742|Bupivacaine|bupivacaine|mesh-list
57078876|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
57078877|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
57078878|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57078879|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078880|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
57078881|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078882|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57078883|NCT02458742|Narcotics|narcotics|mesh-ancestor
57078884|NCT02458742|Analgesics|analgesics|mesh-ancestor
57078885|NCT02403310|Cytarabine|cytarabine|mesh-list
57078886|NCT02403310|Daunorubicin|daunorubicin|mesh-list
57078887|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57078888|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
57078889|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078890|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078891|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
57078892|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078893|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57078894|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
57078895|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078896|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57078897|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57078898|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57078899|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078900|NCT01665274|Capecitabine|capecitabine|mesh-list
57078901|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
57078902|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57078903|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
57078904|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078905|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078906|NCT05387876|Vitamin D|vitamin d|mesh-list
57078907|NCT05387876|Vitamins|vitamins|mesh-ancestor
57078908|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
57078909|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078910|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57078911|NCT04560166|Irinotecan|irinotecan|mesh-list
57078912|NCT04560166|Temozolomide|temozolomide|mesh-list
57078913|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57078914|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57078915|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078916|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078917|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078918|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57078919|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
57078920|NCT03262376|Vitamins|vitamins|mesh-list
57078921|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
57078922|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078923|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57078924|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57078925|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57078926|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57078927|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57078928|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
57078929|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078930|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078931|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078932|NCT05484466|Entecavir|entecavir|mesh-list
57078933|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
57078934|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078935|NCT02456714|Folfirinox|folfirinox|mesh-list
57078936|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078937|NCT03258866|Rituximab|rituximab|mesh-list
57078938|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078939|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078940|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
57078941|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078942|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57078943|NCT03258476|Guanfacine|guanfacine|mesh-list
57078944|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57078945|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57078946|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57078947|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57078948|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
57078949|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078950|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078951|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078952|NCT05484154|Protein C|protein c|mesh-list
57078953|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
57078954|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57078955|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57078956|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078957|NCT03258398|Avelumab|avelumab|mesh-list
57078958|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57078959|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078960|NCT03261596|Mebendazole|mebendazole|mesh-list
57078961|NCT03261596|Piperazine|piperazine|mesh-list
57078962|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
57078963|NCT03261596|DMP 777|dmp 777|mesh-list
57078964|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
57078965|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
57078966|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57078967|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078968|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
57078969|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
57078970|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
57078971|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078972|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57078973|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078974|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57078975|NCT03825874|Amikacin|amikacin|mesh-list
57078976|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57078977|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
57078978|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57078979|NCT03772574|Nicotine|nicotine|mesh-list
57078980|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57078981|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
57078982|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57078983|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078984|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57078985|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57078986|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
57078987|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57078988|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57078989|NCT03694808|Vaccines|vaccines|mesh-list
57078990|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
57078991|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57078992|NCT03261284|Warfarin|warfarin|mesh-list
57078993|NCT03261284|Dabigatran|dabigatran|mesh-list
57078994|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
57078995|NCT03261284|Antithrombins|antithrombins|mesh-ancestor
57078996|NCT03261284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57078997|NCT03261284|Protease Inhibitors|protease inhibitors|mesh-ancestor
57078998|NCT03261284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57078999|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079000|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57079001|NCT02456558|Deferiprone|deferiprone|mesh-list
57079002|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57079003|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
57079004|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
57079005|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079006|NCT05479240|Capecitabine|capecitabine|mesh-list
57079007|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
57079008|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57079009|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
57079010|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079011|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079012|NCT03798080|Insulin|insulin|mesh-list
57079013|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57079014|NCT03798080|Metformin|metformin|mesh-list
57079015|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
57079016|NCT03798080|Lixisenatide|lixisenatide|mesh-list
57079017|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57079018|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079019|NCT03257930|Ethanol|ethanol|mesh-list
57079020|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57079021|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079022|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079023|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079024|NCT03257852|Methotrexate|methotrexate|mesh-list
57079025|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57079026|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
57079027|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57079028|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079029|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57079030|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
57079031|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079032|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079033|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
57079034|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079035|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57079036|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079037|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
57079038|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079039|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57079040|NCT05498896|Paclitaxel|paclitaxel|mesh-list
57079041|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
57079042|NCT05498896|Doxorubicin|doxorubicin|mesh-list
57079043|NCT05498896|Atezolizumab|atezolizumab|mesh-list
57079044|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57079045|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079046|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
57079047|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
57079048|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
56899083|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079049|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079050|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079051|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
57079052|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079053|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079054|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57079055|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
57079056|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57079057|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57079058|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57079059|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57079060|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079061|NCT02743221|Trifluridine|trifluridine|mesh-list
57079062|NCT02743221|Bevacizumab|bevacizumab|mesh-list
57079063|NCT02743221|Capecitabine|capecitabine|mesh-list
57079064|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57079065|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079066|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57079067|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57079068|NCT02743221|Growth Substances|growth substances|mesh-ancestor
57079069|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079070|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
57079071|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57079072|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
57079073|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079075|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079076|NCT03955887|Dimercaprol|dimercaprol|mesh-list
57079077|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
57079078|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
57079079|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079080|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
57079081|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
57079082|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
57079083|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079084|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079085|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
57079086|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079087|NCT03370263|Belimumab|belimumab|mesh-list
57079088|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079089|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
57079090|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079091|NCT00692445|Mecamylamine|mecamylamine|mesh-list
57079092|NCT00692445|Dexetimide|dexetimide|mesh-list
57079093|NCT00692445|Citalopram|citalopram|mesh-list
57079094|NCT00692445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57079095|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57079096|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079097|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079098|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079099|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
57079100|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079101|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57079102|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
57079103|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57079104|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57079105|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57079106|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
57079107|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
57079108|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079109|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57079110|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57079111|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
57079112|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57079113|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
57079114|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57079115|NCT03256292|Testosterone|testosterone|mesh-list
57079116|NCT03256292|Androgens|androgens|mesh-ancestor
57079117|NCT03256292|Hormones|hormones|mesh-ancestor
57079118|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079119|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079120|NCT04473261|Iodine|iodine|mesh-list
57079121|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
57079122|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57079123|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079124|NCT04473261|Trace Elements|trace elements|mesh-ancestor
57079125|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
57079126|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079127|NCT01358968|Gemcitabine|gemcitabine|mesh-list
57079128|NCT01358968|Pemetrexed|pemetrexed|mesh-list
57079129|NCT01358968|Desipramine|desipramine|mesh-list
57079130|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57079131|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
57079132|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079133|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079134|NCT01358968|Antiviral Agents|antiviral agents|mesh-ancestor
57079135|NCT01358968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079136|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079137|NCT01358968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079138|NCT01358968|Immunologic Factors|immunologic factors|mesh-ancestor
57079139|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079140|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57079141|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57079142|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57079143|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
57079144|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57079145|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57079146|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57079147|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079148|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
57079149|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079150|NCT02281305|Colchicine|colchicine|mesh-list
57079151|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
57079152|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079153|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
57079154|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
57079155|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
57079156|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079157|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079158|NCT00624351|Epratuzumab|epratuzumab|mesh-list
57079159|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57079160|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079161|NCT03964090|Cytarabine|cytarabine|mesh-list
57079162|NCT03964090|Isavuconazole|isavuconazole|mesh-list
57079163|NCT03964090|Methotrexate|methotrexate|mesh-list
57079164|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57079165|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
57079166|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57079167|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079168|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57079169|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
57079170|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079171|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079172|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
57079173|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079174|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57079175|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079176|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
57079177|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079178|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57079179|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
57079180|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079181|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
57079182|NCT03251690|Tenofovir|tenofovir|mesh-list
57079183|NCT03251690|Emtricitabine|emtricitabine|mesh-list
57079184|NCT03251690|Efavirenz|efavirenz|mesh-list
57079185|NCT03251690|Rilpivirine|rilpivirine|mesh-list
57079186|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
57079187|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079188|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57079189|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57079190|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079191|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079192|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57079193|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57079194|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57079195|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57079196|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57079197|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57079198|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57079199|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57079200|NCT03251768|Lenograstim|lenograstim|mesh-list
57079201|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57079202|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
57079203|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079204|NCT00687687|Paclitaxel|paclitaxel|mesh-list
57079205|NCT00687687|Carboplatin|carboplatin|mesh-list
57079206|NCT00687687|Iniparib|iniparib|mesh-list
57079207|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57079208|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079209|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
57079210|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
57079211|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
57079212|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079213|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57079214|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079215|NCT00701090|Metformin|metformin|mesh-list
57079216|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57079217|NCT00701090|Glimepiride|glimepiride|mesh-list
57079218|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57079219|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079220|NCT00701090|Incretins|incretins|mesh-ancestor
57079221|NCT00701090|Hormones|hormones|mesh-ancestor
57079222|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079223|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57079224|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
57079225|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079226|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079227|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57079228|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079229|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
57079230|NCT00614601|Vaccines|vaccines|mesh-list
57079231|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
57079232|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079233|NCT02283489|Paclitaxel|paclitaxel|mesh-list
57079234|NCT02283489|Endostatins|endostatins|mesh-list
57079235|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57079236|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079237|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
57079238|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
57079239|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
57079240|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079241|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57079242|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57079243|NCT02283489|Growth Substances|growth substances|mesh-ancestor
57079244|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079245|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
57079246|NCT02455232|Lidocaine|lidocaine|mesh-list
57079247|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
57079248|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
57079249|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079250|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079251|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
57079252|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079253|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57079254|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57079255|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57079256|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079257|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079258|NCT03259958|Donepezil|donepezil|mesh-list
57079259|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57079260|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079261|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079262|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
57079263|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079264|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079265|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
57079266|NCT02923947|Osimertinib|osimertinib|mesh-list
57079267|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079268|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57079269|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079270|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079271|NCT00679731|Methotrexate|methotrexate|mesh-list
57079272|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57079273|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
57079274|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57079275|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079276|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57079277|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
57079278|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079279|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079280|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
57079281|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079282|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57079283|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079284|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
57079285|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079286|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57079287|NCT02455856|Itraconazole|itraconazole|mesh-list
57079288|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
57079289|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079290|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57079291|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57079292|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079293|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079294|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57079295|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
57079296|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079297|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079298|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57079300|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57079301|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
57079302|NCT00602745|Fluorouracil|fluorouracil|mesh-list
57079303|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
57079304|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079305|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57079306|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079307|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079308|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
57079309|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079310|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
57079311|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57079312|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079313|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079314|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57079315|NCT03251222|Analgesics|analgesics|mesh-ancestor
57079316|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
57079317|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079318|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57079319|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57079320|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57079321|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
57079322|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079323|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079324|NCT04487834|Simethicone|simethicone|mesh-list
57079325|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
57079326|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079327|NCT04487834|Emollients|emollients|mesh-ancestor
57079328|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
57079329|NCT03250910|Ribavirin|ribavirin|mesh-list
57079330|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
57079331|NCT03250910|Velpatasvir|velpatasvir|mesh-list
57079332|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57079333|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
57079334|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079335|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
57079336|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079337|NCT02283801|Lamotrigine|lamotrigine|mesh-list
57079338|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
57079339|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
57079340|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57079341|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079342|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079343|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57079344|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079345|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57079346|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57079347|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079348|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57079349|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57079350|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57079351|NCT02455154|Letrozole|letrozole|mesh-list
57079352|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079353|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57079354|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57079355|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079356|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079357|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57079358|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
57079359|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079360|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079361|NCT03254810|Adalimumab|adalimumab|mesh-list
57079362|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57079363|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079364|NCT03255044|Atorvastatin|atorvastatin|mesh-list
57079365|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57079366|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57079367|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56761333|NCT01020292|Nelfinavir|nelfinavir|mesh-list
57079368|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
57079369|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079370|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57079371|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57079372|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079373|NCT00677079|Iniparib|iniparib|mesh-list
57079374|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57079375|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079376|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079377|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079378|NCT03950674|Folic Acid|folic acid|mesh-list
57079379|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
57079380|NCT03950674|Dexamethasone|dexamethasone|mesh-list
57079381|NCT03950674|Carboplatin|carboplatin|mesh-list
57079382|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
57079383|NCT03950674|Pemetrexed|pemetrexed|mesh-list
57079384|NCT03950674|Vitamins|vitamins|mesh-ancestor
57079385|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
57079386|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079387|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57079388|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
57079389|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
57079390|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079391|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57079392|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
57079393|NCT03950674|Hormones|hormones|mesh-ancestor
57079394|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079395|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57079396|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079397|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57079398|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079399|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079400|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57079401|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57079402|NCT03950674|Hematinics|hematinics|mesh-ancestor
57079403|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
57079404|NCT03245996|Atenolol|atenolol|mesh-list
57079405|NCT03245996|Nebivolol|nebivolol|mesh-list
57079406|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57079407|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57079408|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
57079409|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
57079410|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079411|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079412|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57079413|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57079414|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57079415|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
57079416|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079417|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079418|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
57079419|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57079420|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57079421|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57079422|NCT02281929|Amoxicillin|amoxicillin|mesh-list
57079423|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
57079424|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
57079425|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57079426|NCT02281929|Prednisolone|prednisolone|mesh-list
57079427|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57079428|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079429|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57079430|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
57079431|NCT02281929|Hormones|hormones|mesh-ancestor
57079432|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079433|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079434|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57079435|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079436|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079437|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079438|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57079439|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57079440|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079441|NCT05478772|Fluconazole|fluconazole|mesh-list
57079442|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
57079443|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079444|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57079445|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57079446|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079447|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079448|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57079449|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
57079450|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079451|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079452|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57079453|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57079454|NCT02945852|Apatinib|apatinib|mesh-list
57079455|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079456|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57079457|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079458|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079459|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
57079460|NCT03245528|Giapreza|giapreza|mesh-list
57079461|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57079462|NCT00495885|Volinanserin|volinanserin|mesh-list
57079463|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57079464|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
57079465|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079466|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079467|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079468|NCT03254186|Propranolol|propranolol|mesh-list
57079469|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57079470|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57079471|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
57079472|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079473|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079474|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079475|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57079476|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57079477|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
57079478|NCT00589875|Valacyclovir|valacyclovir|mesh-list
57079479|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
57079480|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079481|NCT05483062|Fluorides|fluorides|mesh-list
57079482|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
57079483|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
57079484|NCT05483062|Protective Agents|protective agents|mesh-ancestor
55891143|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
57079485|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079486|NCT02282085|Olanzapine|olanzapine|mesh-list
57079487|NCT02282085|Risperidone|risperidone|mesh-list
57079488|NCT02282085|Aripiprazole|aripiprazole|mesh-list
57079489|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57079490|NCT02282085|Ziprasidone|ziprasidone|mesh-list
57079491|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
57079492|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
57079493|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57079494|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
57079495|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079496|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079497|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079498|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57079499|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079500|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57079501|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57079502|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
57079503|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
57079504|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
57079505|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079506|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57079507|NCT02282085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57079508|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57079509|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079510|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
57079511|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
57079512|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57079513|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57079514|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57079515|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56761486|NCT03713294|Hormones|hormones|mesh-ancestor
57079516|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57079517|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57079518|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57079519|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
57079520|NCT03244592|Minocycline|minocycline|mesh-list
57079521|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57079522|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079523|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
57079524|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57079525|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
57079526|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079527|NCT03253328|Expectorants|expectorants|mesh-ancestor
57079528|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
57079529|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57079530|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
57079531|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079532|NCT03253328|Protective Agents|protective agents|mesh-ancestor
57079533|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079534|NCT03253328|Antidotes|antidotes|mesh-ancestor
57079535|NCT03253250|Tenofovir|tenofovir|mesh-list
57079536|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57079537|NCT03253250|Entecavir|entecavir|mesh-list
57079538|NCT03253250|Adefovir|adefovir|mesh-list
57079539|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
57079540|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079541|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57079542|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57079543|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079544|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079545|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57079546|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57079547|NCT03253562|Metformin|metformin|mesh-list
57079548|NCT03253562|Vildagliptin|vildagliptin|mesh-list
57079549|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57079550|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079551|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57079552|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
57079553|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079554|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079555|NCT03250052|Linagliptin|linagliptin|mesh-list
57079556|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57079557|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079558|NCT03250052|Incretins|incretins|mesh-ancestor
57079559|NCT03250052|Hormones|hormones|mesh-ancestor
57079560|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079561|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57079562|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
57079563|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079564|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079565|NCT05478382|Pregabalin|pregabalin|mesh-list
57079566|NCT05478382|Analgesics|analgesics|mesh-ancestor
57079567|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
57079568|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079569|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079570|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
57079571|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57079572|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079573|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079574|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57079575|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57079576|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57079577|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079578|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57079579|NCT03244358|Epalrestat|epalrestat|mesh-list
57079580|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079581|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079582|NCT03249740|Sunitinib|sunitinib|mesh-list
57079583|NCT03249740|Aflibercept|aflibercept|mesh-list
57079584|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079585|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57079586|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56761564|NCT01077427|Gemcitabine|gemcitabine|mesh-list
57079587|NCT03249740|Growth Substances|growth substances|mesh-ancestor
57079588|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079589|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
57079590|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57079591|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079592|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079593|NCT03057977|Empagliflozin|empagliflozin|mesh-list
57079594|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57079595|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079596|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57079597|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079598|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
57079599|NCT03249506|Empagliflozin|empagliflozin|mesh-list
57079600|NCT03249506|Canagliflozin|canagliflozin|mesh-list
57079601|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
57079602|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57079603|NCT03249506|Glucagon|glucagon|mesh-list
57079604|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57079605|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57079606|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079607|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57079608|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079609|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57079610|NCT03249506|Hormones|hormones|mesh-ancestor
57079611|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079612|NCT03249506|Incretins|incretins|mesh-ancestor
57079613|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
57079614|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079615|NCT03249662|Bupivacaine|bupivacaine|mesh-list
57079616|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
57079617|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
57079618|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079619|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079620|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
57079621|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079622|NCT03249428|Nicotine|nicotine|mesh-list
57079623|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57079624|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
57079625|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079626|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079627|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57079628|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57079629|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
57079630|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079631|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079632|NCT03243500|Lidocaine|lidocaine|mesh-list
57079633|NCT03243500|Bupivacaine|bupivacaine|mesh-list
57079634|NCT03243500|Atracurium|atracurium|mesh-list
57079635|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
57079636|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
57079637|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079638|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079639|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
57079640|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079641|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57079642|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57079643|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57079644|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079645|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079646|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57079647|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57079648|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57079649|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57079650|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57079651|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
57079652|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079653|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
57079654|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57079655|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57079656|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57079657|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079658|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079659|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
57079660|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079661|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079662|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57079663|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079664|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57079665|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
57079666|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
57079667|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079669|NCT04486508|Calcium heparin|calcium heparin|mesh-list
57079670|NCT04486508|Enoxaparin|enoxaparin|mesh-list
57079671|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
57079672|NCT04486508|Atorvastatin|atorvastatin|mesh-list
57079673|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
57079674|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57079675|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57079676|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
57079677|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079678|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57079679|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079680|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
57079681|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56899108|NCT01295073|Trientine|trientine|mesh-list
57079682|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57079683|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
57079684|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079685|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
57079686|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079687|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079688|NCT02454764|Interferons|interferons|mesh-list
57079689|NCT02454764|Tenofovir|tenofovir|mesh-list
57079690|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
57079691|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
57079692|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079693|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
57079694|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079695|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57079696|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57079697|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079698|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079699|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57079700|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57079701|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
57079702|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079703|NCT00685919|Carbidopa|carbidopa|mesh-list
57079704|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57079705|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57079706|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
57079707|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079708|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079709|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079710|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57079711|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079712|NCT03243344|Surgiflo|surgiflo|mesh-list
57079713|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
57079714|NCT03243344|Coagulants|coagulants|mesh-ancestor
57079715|NCT03243032|Ibuprofen|ibuprofen|mesh-list
57079716|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57079717|NCT03243032|Anesthetics|anesthetics|mesh-list
57079718|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
57079719|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079720|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079721|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57079722|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57079723|NCT03243032|Analgesics|analgesics|mesh-ancestor
57079724|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
57079725|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079726|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079727|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57079728|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079729|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079730|NCT03249038|Chrysarobin|chrysarobin|mesh-list
57079731|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57079732|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57079733|NCT03249038|Analgesics|analgesics|mesh-ancestor
57079734|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
57079735|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079736|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079737|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57079738|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079739|NCT03061331|Ivacaftor|ivacaftor|mesh-list
57079740|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57079741|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079742|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079743|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
57079744|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57079745|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079746|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57079747|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57079748|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079749|NCT05213585|Ivermectin|ivermectin|mesh-list
57079750|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57079751|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079752|NCT05482282|Vaccines|vaccines|mesh-list
57079753|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
57079754|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079755|NCT05209529|Durvalumab|durvalumab|mesh-list
57079756|NCT05209529|Olaparib|olaparib|mesh-list
57079757|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57079758|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079759|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57079760|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079761|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079762|NCT04424134|Spironolactone|spironolactone|mesh-list
57079763|NCT04424134|Bromhexine|bromhexine|mesh-list
57079764|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57079765|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
57079766|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079767|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079768|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57079769|NCT04424134|Diuretics|diuretics|mesh-ancestor
57079770|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
57079771|NCT04424134|Expectorants|expectorants|mesh-ancestor
57079772|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
57079773|NCT04486430|Salicylates|salicylates|mesh-list
57079774|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57079775|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57079776|NCT04486430|Analgesics|analgesics|mesh-ancestor
57079777|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
57079778|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079779|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079780|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57079781|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57079782|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57079783|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079784|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079785|NCT03248726|Bisacodyl|bisacodyl|mesh-list
57079786|NCT03248726|Cathartics|cathartics|mesh-ancestor
57079787|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57079788|NCT03248726|Laxatives|laxatives|mesh-ancestor
57079789|NCT05734625|Methylprednisolone|methylprednisolone|mesh-list
57079790|NCT05734625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57079791|NCT05734625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57079792|NCT05734625|Prednisolone|prednisolone|mesh-list
57079793|NCT05734625|Prednisolone acetate|prednisolone acetate|mesh-list
57079794|NCT05734625|Bupivacaine|bupivacaine|mesh-list
57079795|NCT05734625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57079796|NCT05734625|Prednisolone phosphate|prednisolone phosphate|mesh-list
57079797|NCT05734625|Anesthetics, Local|anesthetics, local|mesh-ancestor
57079798|NCT05734625|Anesthetics|anesthetics|mesh-ancestor
57079799|NCT05734625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079800|NCT05734625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079801|NCT05734625|Sensory System Agents|sensory system agents|mesh-ancestor
57079802|NCT05734625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079803|NCT05734625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57079804|NCT05734625|Antiemetics|antiemetics|mesh-ancestor
57079805|NCT05734625|Autonomic Agents|autonomic agents|mesh-ancestor
57079806|NCT05734625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57079807|NCT05734625|Glucocorticoids|glucocorticoids|mesh-ancestor
57079808|NCT05734625|Hormones|hormones|mesh-ancestor
57079809|NCT05734625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079810|NCT05734625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57079811|NCT05734625|Protective Agents|protective agents|mesh-ancestor
57079812|NCT05734625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57079813|NCT05734625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761789|NCT00613574|Bromides|bromides|mesh-list
57079814|NCT03386500|Manganese|manganese|mesh-list
57079815|NCT03386500|Trace Elements|trace elements|mesh-ancestor
57079816|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
57079817|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079818|NCT05209295|Azacitidine|azacitidine|mesh-list
57079819|NCT05209295|Cc-486|cc-486|mesh-list
57079820|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57079821|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
57079822|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079823|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079824|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079825|NCT05208827|Vitamin D|vitamin d|mesh-list
57079826|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
57079827|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
57079828|NCT05208827|Vitamins|vitamins|mesh-list
57079829|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
57079830|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079831|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57079832|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57079833|NCT04947059|Gemcitabine|gemcitabine|mesh-list
57079834|NCT04947059|Epirubicin|epirubicin|mesh-list
57079835|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57079836|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
57079837|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079838|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079839|NCT04947059|Antiviral Agents|antiviral agents|mesh-ancestor
57079840|NCT04947059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079841|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079842|NCT04947059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079843|NCT04947059|Immunologic Factors|immunologic factors|mesh-ancestor
57079844|NCT04947059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079845|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57079846|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57079847|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57079848|NCT05481970|Dexamethasone|dexamethasone|mesh-list
57079849|NCT05481970|Lidocaine|lidocaine|mesh-list
57079850|NCT05481970|Fentanyl|fentanyl|mesh-list
57079851|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
57079852|NCT05481970|Ketamine|ketamine|mesh-list
57079853|NCT05481970|Propofol|propofol|mesh-list
57079854|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57079855|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
57079856|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
57079857|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079858|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079859|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57079860|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
57079861|NCT05481970|Hormones|hormones|mesh-ancestor
57079862|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079863|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57079864|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079865|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079866|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
57079867|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
57079868|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079869|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
57079870|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57079871|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57079872|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57079873|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57079874|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57079875|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57079876|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
57079877|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57079878|NCT05481970|Analgesics|analgesics|mesh-ancestor
57079879|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57079880|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57079881|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57079882|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
57079883|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079884|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57079885|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57079886|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57079887|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57079888|NCT05481970|Narcotics|narcotics|mesh-ancestor
57079889|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57079890|NCT03641560|Androgens|androgens|mesh-list
57079891|NCT03641560|Hormones|hormones|mesh-ancestor
57079892|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079893|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079894|NCT03248648|Ketamine|ketamine|mesh-list
57079895|NCT03248648|Neostigmine|neostigmine|mesh-list
57079896|NCT03248648|Analgesics|analgesics|mesh-ancestor
57079897|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
57079898|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079899|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079900|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57079901|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57079902|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
57079903|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
57079904|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079905|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57079906|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57079907|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079908|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079909|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57079910|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079911|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
57079912|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57079913|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
57079914|NCT03241784|Interleukin-2|interleukin-2|mesh-list
57079915|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079916|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57079917|NCT03241784|Analgesics|analgesics|mesh-ancestor
57079918|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
57079919|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57079920|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079921|NCT05212337|Denosumab|denosumab|mesh-list
57079922|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57079923|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079924|NCT03242096|Sirolimus|sirolimus|mesh-list
57079925|NCT03242096|Paclitaxel|paclitaxel|mesh-list
57079926|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57079927|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079928|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
57079929|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
57079930|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
57079931|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079932|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57079933|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079934|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57079935|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
57079936|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57079937|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
57079938|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079939|NCT03241472|Letrozole|letrozole|mesh-list
57079940|NCT03241472|Clomiphene|clomiphene|mesh-list
57079941|NCT03241472|Enclomiphene|enclomiphene|mesh-list
57079942|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
57079943|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079944|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57079945|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57079946|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57079947|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079948|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57079949|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
57079950|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079951|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079952|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57079953|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
57079954|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57079955|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57079956|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57079957|NCT04313075|Leronlimab|leronlimab|mesh-list
57079958|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57079959|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57079960|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079961|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57079962|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57079963|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
57079964|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079965|NCT03241550|Isavuconazole|isavuconazole|mesh-list
57079966|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
57079967|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079968|NCT03241706|Glucagon|glucagon|mesh-list
57079969|NCT03241706|Somatostatin|somatostatin|mesh-list
57079970|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079971|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57079972|NCT03241706|Hormones|hormones|mesh-ancestor
57079973|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57079974|NCT03237416|Midazolam|midazolam|mesh-list
57079975|NCT03237416|Dabigatran|dabigatran|mesh-list
57079976|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57079977|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57079978|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57079979|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57079980|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57079981|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57079982|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57079983|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57079984|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
57079985|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
57079986|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
57079987|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
57079988|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57079989|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57079990|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
57079991|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57079992|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
57079993|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57079994|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
57079995|NCT05211011|Fosfomycin|fosfomycin|mesh-list
57079996|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57079997|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57079998|NCT03312400|Danazol|danazol|mesh-list
57079999|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57080000|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
57080001|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080002|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080003|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
57080004|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57080005|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57080006|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080007|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
57080008|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080009|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080010|NCT04094519|Digoxin|digoxin|mesh-list
57080011|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57080012|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57080013|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57080014|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
57080015|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080016|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57080017|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57080018|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080019|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57080020|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57080021|NCT04094519|Protective Agents|protective agents|mesh-ancestor
57080022|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080023|NCT02189798|Imidacloprid|imidacloprid|mesh-list
57080024|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
57080025|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080026|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080027|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080028|NCT03107702|Melatonin|melatonin|mesh-list
57080029|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
57080030|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080031|NCT03107702|Protective Agents|protective agents|mesh-ancestor
57080032|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080033|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080034|NCT02554318|Rifampin|rifampin|mesh-list
57080035|NCT02554318|Isoniazid|isoniazid|mesh-list
57080036|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
57080037|NCT02554318|Ethambutol|ethambutol|mesh-list
57080038|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57080039|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
57080040|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57080041|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080042|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
57080043|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57080044|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080045|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080046|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57080047|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57080048|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56304019|NCT00035191|Galantamine|galantamine|mesh-list
57080049|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57080050|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57080051|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57080052|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57080053|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57080054|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
57080055|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57080056|NCT03587662|Gemcitabine|gemcitabine|mesh-list
57080057|NCT03587662|Doxorubicin|doxorubicin|mesh-list
57080058|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57080059|NCT03587662|Daunorubicin|daunorubicin|mesh-list
57080060|NCT03587662|Ixazomib|ixazomib|mesh-list
57080061|NCT03587662|Glycine|glycine|mesh-list
57080062|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57080063|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
57080064|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080065|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080066|NCT03587662|Antiviral Agents|antiviral agents|mesh-ancestor
57080067|NCT03587662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080068|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080069|NCT03587662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57080070|NCT03587662|Immunologic Factors|immunologic factors|mesh-ancestor
57080071|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080072|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57080073|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57080074|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57080075|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
57080076|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
57080077|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080078|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
57080079|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57080080|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
57080081|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080082|NCT03976973|Expectorants|expectorants|mesh-ancestor
57080083|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
57080084|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57080085|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
57080086|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080087|NCT03976973|Protective Agents|protective agents|mesh-ancestor
57080088|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080089|NCT03976973|Antidotes|antidotes|mesh-ancestor
57080090|NCT04066751|Ivacaftor|ivacaftor|mesh-list
57080091|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57080092|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57080093|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080094|NCT02550106|Omalizumab|omalizumab|mesh-list
57080095|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57080096|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57080097|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
57080098|NCT03237260|Vedolizumab|vedolizumab|mesh-list
57080099|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080100|NCT03247400|Atorvastatin|atorvastatin|mesh-list
57080101|NCT03247400|Simvastatin|simvastatin|mesh-list
57080102|NCT03247400|Calcium|calcium|mesh-list
57080103|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57080104|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080105|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57080106|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57080107|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
57080108|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080109|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57080110|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57080111|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080112|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57080113|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
57080114|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080115|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080116|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57080117|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57080118|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
57080119|NCT02453516|Epinephrine|epinephrine|mesh-list
57080120|NCT02453516|Ropivacaine|ropivacaine|mesh-list
57080121|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
57080122|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
56899125|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57080123|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080124|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080125|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
57080126|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080127|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57080128|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57080129|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
57080130|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080131|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080132|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57080133|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57080134|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
57080135|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57080136|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
57080137|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
57080138|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
57080139|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57080140|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
57080141|NCT03716609|Citric Acid|citric acid|mesh-list
57080142|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
57080143|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
57080144|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57080145|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
57080146|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
57080147|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080148|NCT03716609|Cathartics|cathartics|mesh-ancestor
57080149|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080150|NCT03709355|Clarithromycin|clarithromycin|mesh-list
57080151|NCT03709355|Rifampin|rifampin|mesh-list
57080152|NCT03709355|Rifabutin|rifabutin|mesh-list
57080153|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
57080154|NCT03709355|Omeprazole|omeprazole|mesh-list
57080155|NCT03709355|Atorvastatin|atorvastatin|mesh-list
57080156|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
57080157|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57080158|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
57080159|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57080160|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57080161|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
57080162|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080163|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57080164|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57080165|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080166|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57080167|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080168|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57080169|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57080170|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080171|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57080172|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57080173|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57080174|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57080175|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
57080176|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57080177|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080178|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57080179|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57080180|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57080181|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57080182|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
57080183|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
57080184|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57080185|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57080186|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57080187|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57080188|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57080189|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57080190|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57080191|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56762165|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
57080192|NCT03709355|Estrogens|estrogens|mesh-ancestor
57080193|NCT03709355|Hormones|hormones|mesh-ancestor
56899127|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
57080194|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080195|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57080196|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57080197|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
57080198|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57080199|NCT05209217|Ketamine|ketamine|mesh-list
57080200|NCT05209217|Analgesics|analgesics|mesh-ancestor
57080201|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
57080202|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080203|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080204|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57080205|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57080206|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
57080207|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
57080208|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080209|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57080210|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57080211|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080212|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080213|NCT04047953|Paclitaxel|paclitaxel|mesh-list
57080214|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57080215|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
57080216|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57080217|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080218|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
57080219|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
57080220|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
57080221|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080222|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
57080223|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57080224|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57080225|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080226|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080227|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57080228|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57080229|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57080230|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
57080231|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080232|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080233|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57080234|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57080235|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
57080236|NCT00700622|Insulin|insulin|mesh-list
57080237|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57080238|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
57080239|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
57080240|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57080241|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080242|NCT03628625|Letrozole|letrozole|mesh-list
57080243|NCT03628625|Misoprostol|misoprostol|mesh-list
57080244|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080245|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57080246|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57080247|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080248|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080249|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57080250|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
57080251|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080252|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080253|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57080254|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
57080255|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57080256|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57080257|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080258|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
57080259|NCT04469764|Letrozole|letrozole|mesh-list
57080260|NCT04469764|Anastrozole|anastrozole|mesh-list
57080261|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080262|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57080263|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57080264|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080265|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762245|NCT03263429|Irinotecan|irinotecan|mesh-list
57080266|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57080267|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
57080268|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080269|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080270|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57080271|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57080272|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57080273|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080274|NCT02553928|Memantine|memantine|mesh-list
57080275|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57080276|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57080277|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
57080278|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080279|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080280|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080281|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57080282|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57080283|NCT03908255|Vitamins|vitamins|mesh-list
57080284|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
57080285|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080286|NCT03246776|Triclosan|triclosan|mesh-list
57080287|NCT03246776|Halometasone|halometasone|mesh-list
57080288|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57080289|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080290|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57080291|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57080292|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
57080293|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080294|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57080295|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080296|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
57080297|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
57080298|NCT03246776|Hormones|hormones|mesh-ancestor
57080299|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080300|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080301|NCT03246386|Posaconazole|posaconazole|mesh-list
57080302|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
57080303|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080304|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57080305|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57080306|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57080307|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57080308|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57080309|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080310|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080311|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57080312|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
57080313|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080314|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080315|NCT03851081|Vincristine|vincristine|mesh-list
57080316|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
57080317|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57080318|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080319|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
57080320|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
57080321|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
57080322|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080323|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57080324|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57080325|NCT03239600|Methotrexate|methotrexate|mesh-list
57080326|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57080327|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
57080328|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57080329|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080330|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57080331|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
57080332|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080333|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080334|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
56899131|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
57080335|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080336|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57080337|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57080338|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
57080339|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080340|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57080342|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080343|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57080344|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080345|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080346|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
57080347|NCT03229616|Busulfan|busulfan|mesh-list
57080348|NCT03229616|Etoposide|etoposide|mesh-list
57080349|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57080350|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
57080351|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080352|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080353|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57080354|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
57080355|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080356|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080357|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57080358|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57080359|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57080360|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57080361|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080362|NCT03234842|Paclitaxel|paclitaxel|mesh-list
57080363|NCT03234842|Carboplatin|carboplatin|mesh-list
57080364|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57080365|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080366|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
57080367|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
57080368|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
57080369|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080370|NCT03229148|Anesthetics|anesthetics|mesh-list
57080371|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080372|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080373|NCT03228992|Ibuprofen|ibuprofen|mesh-list
57080374|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57080375|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57080376|NCT03228992|Analgesics|analgesics|mesh-ancestor
57080377|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
57080378|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080379|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080380|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080381|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080382|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57080383|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080384|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080385|NCT02627963|Sorafenib|sorafenib|mesh-list
57080386|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080387|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57080388|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080389|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080390|NCT02452502|Atorvastatin|atorvastatin|mesh-list
57080391|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57080392|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57080393|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
57080394|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080395|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57080396|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57080397|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080398|NCT03234296|Metronidazole|metronidazole|mesh-list
57080399|NCT03234296|Levofloxacin|levofloxacin|mesh-list
57080400|NCT03234296|Ertapenem|ertapenem|mesh-list
57080401|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080402|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57080403|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57080404|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57080405|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57080406|NCT03234296|Renal Agents|renal agents|mesh-ancestor
57080407|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56899134|NCT03736785|Insulin|insulin|mesh-list
57080408|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57080409|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080410|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080411|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080412|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57080413|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57080414|NCT05683691|Acetaminophen, aspirin, caffeine drug combination|acetaminophen, aspirin, caffeine drug combination|mesh-list
57080415|NCT05683691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57080416|NCT05683691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57080417|NCT05683691|Analgesics|analgesics|mesh-ancestor
57080418|NCT05683691|Sensory System Agents|sensory system agents|mesh-ancestor
57080419|NCT05683691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080420|NCT05683691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080421|NCT05683691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080422|NCT05683691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080423|NCT03228368|Atezolizumab|atezolizumab|mesh-list
57080424|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080425|NCT03665129|Avdoralimab|avdoralimab|mesh-list
57080426|NCT03665129|Durvalumab|durvalumab|mesh-list
57080427|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57080428|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080429|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080430|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
57080431|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080432|NCT03235700|Nicorandil|nicorandil|mesh-list
57080433|NCT03235700|Adenosine|adenosine|mesh-list
57080434|NCT03235700|Analgesics|analgesics|mesh-ancestor
57080435|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
57080436|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080437|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080438|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57080439|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
57080440|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57080441|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
57080442|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
57080443|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080444|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080445|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57080446|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
57080447|NCT03235700|Vitamins|vitamins|mesh-ancestor
57080448|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
57080449|NCT03234062|Choline|choline|mesh-list
57080450|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
57080451|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57080452|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
57080453|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080454|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080455|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57080456|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
57080457|NCT05702879|Prednisolone|prednisolone|mesh-list
57080458|NCT05702879|Adalimumab|adalimumab|mesh-list
57080459|NCT05702879|Etanercept|etanercept|mesh-list
57080460|NCT05702879|Golimumab|golimumab|mesh-list
57080461|NCT05702879|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
57080462|NCT05702879|Infliximab|infliximab|mesh-list
57080463|NCT05702879|Ustekinumab|ustekinumab|mesh-list
57080464|NCT05702879|Vedolizumab|vedolizumab|mesh-list
57080465|NCT05702879|Ozanimod|ozanimod|mesh-list
57080466|NCT05702879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080467|NCT05702879|Glucocorticoids|glucocorticoids|mesh-ancestor
57080468|NCT05702879|Hormones|hormones|mesh-ancestor
57080469|NCT05702879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080470|NCT05702879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080471|NCT05702879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57080472|NCT05702879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080473|NCT05702879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080474|NCT05702879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080475|NCT05702879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080476|NCT05702879|Dermatologic Agents|dermatologic agents|mesh-ancestor
57080477|NCT05702879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57080478|NCT05702879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57080479|NCT05702879|Analgesics|analgesics|mesh-ancestor
57080480|NCT05702879|Sensory System Agents|sensory system agents|mesh-ancestor
57080481|NCT05702879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57080482|NCT05702879|Immunologic Factors|immunologic factors|mesh-ancestor
56899135|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57080483|NCT05702879|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57080484|NCT05702879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080485|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
57080486|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57080487|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57080488|NCT03235778|Analgesics|analgesics|mesh-ancestor
57080489|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
57080490|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080491|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080492|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080493|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080494|NCT04439513|Hemostatics|hemostatics|mesh-list
57080495|NCT04439513|Coagulants|coagulants|mesh-ancestor
57080496|NCT03077243|Cisplatin|cisplatin|mesh-list
57080497|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080498|NCT02452970|Gemcitabine|gemcitabine|mesh-list
57080499|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080500|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57080501|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
57080502|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080503|NCT02452970|Antiviral Agents|antiviral agents|mesh-ancestor
57080504|NCT02452970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080505|NCT02452970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080506|NCT02452970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57080507|NCT02452970|Immunologic Factors|immunologic factors|mesh-ancestor
57080508|NCT02452970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080509|NCT03227900|Lidocaine|lidocaine|mesh-list
57080510|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
57080511|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
57080512|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080513|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080514|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
57080515|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080516|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57080517|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57080518|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57080519|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57080520|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080521|NCT03120182|Aspirin|aspirin|mesh-list
57080522|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57080523|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57080524|NCT03120182|Analgesics|analgesics|mesh-ancestor
57080525|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
57080526|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080527|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080528|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080529|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080530|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57080531|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57080532|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080533|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57080534|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57080535|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080536|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
57080537|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
57080538|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57080539|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57080540|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080541|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
57080542|NCT02074436|Coagulants|coagulants|mesh-ancestor
57080543|NCT03227432|Dexamethasone|dexamethasone|mesh-list
57080544|NCT03227432|Nivolumab|nivolumab|mesh-list
57080545|NCT03227432|Pomalidomide|pomalidomide|mesh-list
57080546|NCT03227432|Elotuzumab|elotuzumab|mesh-list
57080547|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080548|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
57080549|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
57080550|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080551|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080552|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080553|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
57080554|NCT03227432|Hormones|hormones|mesh-ancestor
57080555|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080556|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57080557|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080558|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57080559|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57080560|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080561|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
57080562|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57080563|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57080564|NCT03227432|Growth Substances|growth substances|mesh-ancestor
57080565|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
57080566|NCT03222518|Acetaminophen|acetaminophen|mesh-list
57080567|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
57080568|NCT03222518|Piroxicam|piroxicam|mesh-list
57080569|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57080570|NCT03222518|Analgesics|analgesics|mesh-ancestor
57080571|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
57080572|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080573|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080574|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
57080575|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080576|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080577|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57080578|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080579|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080580|NCT01750281|Docetaxel|docetaxel|mesh-list
57080581|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080582|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
57080583|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
57080584|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
57080585|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080586|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
57080587|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57080588|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57080589|NCT03222206|Analgesics|analgesics|mesh-ancestor
57080590|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
57080591|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080592|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080593|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080594|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080595|NCT03221816|Folic Acid|folic acid|mesh-list
57080596|NCT03221816|Pyridoxine|pyridoxine|mesh-list
57080597|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
57080598|NCT03221816|Hematinics|hematinics|mesh-ancestor
57080599|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
57080600|NCT03221816|Vitamins|vitamins|mesh-ancestor
57080601|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
57080602|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080603|NCT03119636|Levodopa|levodopa|mesh-list
57080604|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57080605|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57080606|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
57080607|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080608|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080609|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080610|NCT03226340|Niacin|niacin|mesh-list
57080611|NCT03226340|Amlodipine|amlodipine|mesh-list
57080612|NCT03226340|Telmisartan|telmisartan|mesh-list
57080613|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
57080614|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57080615|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57080616|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57080617|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080618|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57080619|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080620|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
57080621|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57080622|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57080623|NCT03226340|Diuretics|diuretics|mesh-ancestor
57080624|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
57080625|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57080626|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57080627|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
57080628|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57080629|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
57080630|NCT03226340|Vitamins|vitamins|mesh-ancestor
57080631|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
57080632|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
57080633|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57080634|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57080635|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
57080636|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080637|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080638|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080639|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
57080641|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080642|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
57080643|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57080644|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
57080645|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
57080646|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
57080647|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080648|NCT03232034|Calcium|calcium|mesh-list
57080649|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57080650|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080651|NCT03225950|Antibodies|antibodies|mesh-list
57080652|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
57080653|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080654|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
57080655|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57080656|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57080657|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080658|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
57080659|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080660|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080661|NCT03232112|Exenatide|exenatide|mesh-list
57080662|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57080663|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080664|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57080665|NCT03232112|Incretins|incretins|mesh-ancestor
57080666|NCT03232112|Hormones|hormones|mesh-ancestor
57080667|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080668|NCT03000569|Levodopa|levodopa|mesh-list
57080669|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
57080670|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57080671|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
57080672|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080673|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080674|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080675|NCT02554786|Fluticasone|fluticasone|mesh-list
57080676|NCT02554786|Xhance|xhance|mesh-list
57080677|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
57080678|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57080679|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080680|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57080681|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
57080682|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080683|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080684|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57080685|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
57080686|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
57080687|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57080688|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57080689|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57080690|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57080691|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
57080692|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080693|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080694|NCT03225326|Carticaine|carticaine|mesh-list
57080695|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
57080696|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
57080697|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080698|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080699|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
57080700|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080701|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
57080702|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57080703|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899140|NCT01295151|Adalimumab|adalimumab|mesh-list
57080704|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080705|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57080706|NCT03220880|Analgesics|analgesics|mesh-ancestor
57080707|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
57080708|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080709|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57080710|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57080711|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57080712|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
57080713|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080714|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080715|NCT02929589|Ibuprofen|ibuprofen|mesh-list
57080716|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
57080717|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57080718|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57080719|NCT02929589|Analgesics|analgesics|mesh-ancestor
57080720|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
57080721|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080722|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080723|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080724|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57080725|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57080726|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080727|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080728|NCT02929589|Narcotics|narcotics|mesh-ancestor
57080729|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080730|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
57080731|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57080732|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080733|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57080734|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57080735|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080736|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080737|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080738|NCT02614547|Brexanolone|brexanolone|mesh-list
57080739|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
57080740|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080741|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080742|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080743|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
57080744|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
57080745|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
57080746|NCT04472481|Vitamin D|vitamin d|mesh-list
57080747|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57080748|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080749|NCT04472481|Vitamins|vitamins|mesh-ancestor
57080750|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
57080751|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57080752|NCT01233297|Azithromycin|azithromycin|mesh-list
57080753|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57080754|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080755|NCT04681079|Albuterol|albuterol|mesh-list
57080756|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57080757|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
57080758|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080759|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080760|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57080761|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
57080762|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
57080763|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57080764|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57080765|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57080766|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57080767|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
57080768|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080769|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080770|NCT00580125|Aripiprazole|aripiprazole|mesh-list
57080771|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
57080772|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57080773|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57080774|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57080775|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080776|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080777|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
57080778|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
57080779|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080780|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080781|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57080782|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57080783|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
57080784|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57080785|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57080786|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56762764|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57080787|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57080788|NCT01179009|Clonidine|clonidine|mesh-list
57080789|NCT01179009|Scopolamine|scopolamine|mesh-list
57080790|NCT01179009|Ketamine|ketamine|mesh-list
57080791|NCT01179009|Lorazepam|lorazepam|mesh-list
57080792|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57080793|NCT01179009|Analgesics|analgesics|mesh-ancestor
57080794|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
57080795|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080796|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080797|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57080798|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57080799|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
57080800|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
57080801|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080802|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57080803|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57080804|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080805|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080806|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57080807|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
57080808|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
57080809|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57080810|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57080811|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57080812|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
57080813|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
57080814|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
57080815|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080816|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57080817|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57080818|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57080819|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57080820|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
57080821|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
57080822|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57080823|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
57080824|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57080825|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
57080826|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57080827|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
57080828|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
57080829|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57080830|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57080831|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080832|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57080833|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57080834|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080835|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080836|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080837|NCT05469178|Carboplatin|carboplatin|mesh-list
57080838|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
57080839|NCT05469178|Pemetrexed|pemetrexed|mesh-list
57080840|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080841|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57080842|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080843|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080844|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57080845|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57080846|NCT00667953|Temozolomide|temozolomide|mesh-list
57080847|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
57080848|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57080849|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
57080850|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080851|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080852|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57080853|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080854|NCT00578955|Azithromycin|azithromycin|mesh-list
57080855|NCT00578955|Dexamethasone|dexamethasone|mesh-list
57080856|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
57080857|NCT00578955|BB 1101|bb 1101|mesh-list
57080858|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080859|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
57080860|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
57080861|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080862|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080863|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762837|NCT00187135|Fentanyl|fentanyl|mesh-list
57080864|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
57080865|NCT00578955|Hormones|hormones|mesh-ancestor
57080866|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080867|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57080868|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080869|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
57080870|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080871|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080872|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57080873|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080874|NCT00576537|Vaccines|vaccines|mesh-list
57080875|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
57080876|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080877|NCT02282241|Melatonin|melatonin|mesh-list
57080878|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
57080879|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080880|NCT02282241|Protective Agents|protective agents|mesh-ancestor
57080881|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080882|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080883|NCT02424851|Thalidomide|thalidomide|mesh-list
57080884|NCT02424851|Dexamethasone|dexamethasone|mesh-list
57080885|NCT02424851|Bortezomib|bortezomib|mesh-list
57080886|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57080887|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57080888|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
57080889|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
57080890|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080891|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080892|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080893|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
57080894|NCT02424851|Hormones|hormones|mesh-ancestor
57080895|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080896|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57080897|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080898|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57080899|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
57080900|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080901|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57080902|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
57080903|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
57080904|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57080905|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080906|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57080907|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57080908|NCT02424851|Growth Substances|growth substances|mesh-ancestor
57080909|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
57080910|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
57080911|NCT02284035|Lamivudine|lamivudine|mesh-list
57080912|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57080913|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57080914|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
57080915|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57080916|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57080917|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57080918|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080919|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080920|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57080921|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57080922|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57080923|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
57080924|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
57080925|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57080926|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080927|NCT00484419|Incretins|incretins|mesh-ancestor
57080928|NCT00484419|Hormones|hormones|mesh-ancestor
57080929|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57080930|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57080931|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
57080932|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080933|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080934|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57080935|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57080936|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
57080937|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57080938|NCT02273895|Scopolamine|scopolamine|mesh-list
57080939|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57080940|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57080941|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
57080942|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
57080943|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080944|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080945|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57080946|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
57080947|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57080948|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
57080949|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080950|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080951|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57080952|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
57080954|NCT00480831|Bevacizumab|bevacizumab|mesh-list
57080955|NCT00480831|Carboplatin|carboplatin|mesh-list
57080956|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57080957|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57080958|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
57080959|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
57080960|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
57080961|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080962|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57080963|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57080964|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57080965|NCT00480831|Growth Substances|growth substances|mesh-ancestor
57080966|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080967|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
57080968|NCT02549092|Levodopa|levodopa|mesh-list
57080969|NCT02549092|Carbidopa|carbidopa|mesh-list
57080970|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57080971|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57080972|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57080973|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
57080974|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57080975|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080976|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899159|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57080977|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57080978|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57080979|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57080980|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
57080981|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
57080982|NCT03220256|Lamotrigine|lamotrigine|mesh-list
57080983|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
57080984|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57080985|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57080986|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57080987|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57080988|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57080989|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57080990|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57080991|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57080992|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57080993|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57080994|NCT03220490|Timolol|timolol|mesh-list
57080995|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57080996|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57080997|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57080998|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
57080999|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081000|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081001|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081002|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57081003|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57081004|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57081005|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57081006|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57081007|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57081008|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57081009|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57081010|NCT02553772|Laxatives|laxatives|mesh-ancestor
57081011|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081012|NCT03119714|Pemirolast|pemirolast|mesh-list
57081013|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
57081014|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
57081015|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081016|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081017|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081018|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57081019|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
57081020|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081021|NCT05468554|Metformin|metformin|mesh-list
57081022|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57081023|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081024|NCT04617821|Gemcitabine|gemcitabine|mesh-list
57081025|NCT04617821|Paclitaxel|paclitaxel|mesh-list
57081026|NCT04617821|Folfirinox|folfirinox|mesh-list
57081027|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57081028|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081029|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
57081030|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
57081031|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
57081032|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081033|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57081034|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
57081035|NCT04617821|Antiviral Agents|antiviral agents|mesh-ancestor
57081036|NCT04617821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081037|NCT04617821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081038|NCT04617821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081039|NCT04617821|Immunologic Factors|immunologic factors|mesh-ancestor
57081040|NCT04617821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081041|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
57081042|NCT03219008|Mirtazapine|mirtazapine|mesh-list
57081043|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
57081044|NCT03219008|Fluoxetine|fluoxetine|mesh-list
57081045|NCT03219008|Bupropion|bupropion|mesh-list
57081046|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
57081047|NCT03219008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57081048|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57081049|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57081050|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081051|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081052|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
57081053|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081054|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57081055|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
57081056|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57081057|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57081058|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57081059|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081060|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
57081061|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57081062|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081063|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57081064|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
57081065|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
57081066|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57081067|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57081068|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57081069|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57081070|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
57081071|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57081072|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57081073|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57081074|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57081075|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57081076|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57081077|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
57081078|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57081079|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57081080|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081081|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
57081082|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
57081083|NCT00562497|Prednisone|prednisone|mesh-list
57081084|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
57081085|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57081086|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
57081087|NCT00562497|Hormones|hormones|mesh-ancestor
57081088|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57081089|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081090|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57081091|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081092|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
57081093|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
57081094|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081095|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081096|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57081097|NCT00562497|Protective Agents|protective agents|mesh-ancestor
57081098|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
57081099|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081100|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57081101|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57081102|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
57081103|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081104|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081105|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57081106|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
57081107|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57081108|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57081109|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57081110|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
57081111|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081112|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081113|NCT01503515|Fluconazole|fluconazole|mesh-list
57081114|NCT01503515|Voriconazole|voriconazole|mesh-list
57081115|NCT01503515|Caspofungin|caspofungin|mesh-list
57081116|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
57081117|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081118|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57081119|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57081120|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081121|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081122|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57081123|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
57081124|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57081125|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081126|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57081127|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57081128|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57081129|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
57081130|NCT00468273|Antibodies|antibodies|mesh-list
57081131|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
57081132|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57081133|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57081134|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
57081135|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081136|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
57081137|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57081138|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
57081139|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081140|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57081141|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081142|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
57081143|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081144|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
57081145|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57081146|NCT03217916|Protective Agents|protective agents|mesh-ancestor
57081147|NCT00468117|Etanercept|etanercept|mesh-list
57081148|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57081149|NCT00468117|Basiliximab|basiliximab|mesh-list
57081150|NCT00468117|Daclizumab|daclizumab|mesh-list
57081151|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57081152|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57081153|NCT00468117|Analgesics|analgesics|mesh-ancestor
57081154|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
57081155|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081156|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081157|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57081158|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57081159|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081160|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081161|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
57081163|NCT00468039|Vildagliptin|vildagliptin|mesh-list
57081164|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57081165|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081166|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57081167|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
57081168|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081169|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081170|NCT02742519|Ivacaftor|ivacaftor|mesh-list
57081171|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57081172|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57081173|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081174|NCT01375010|Vitamin D|vitamin d|mesh-list
57081175|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
57081176|NCT01375010|Vitamins|vitamins|mesh-list
57081177|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
57081178|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081179|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57081180|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57081181|NCT03231176|Capecitabine|capecitabine|mesh-list
57081182|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57081183|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
57081184|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081185|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081186|NCT00467025|Sorafenib|sorafenib|mesh-list
57081187|NCT00467025|Trebananib|trebananib|mesh-list
57081188|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081189|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57081190|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081191|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081192|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57081193|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57081194|NCT00467025|Growth Substances|growth substances|mesh-ancestor
57081195|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081196|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
57081197|NCT03230786|Metformin|metformin|mesh-list
57081198|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57081199|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081200|NCT02451098|Atorvastatin|atorvastatin|mesh-list
57081201|NCT02451098|Ezetimibe|ezetimibe|mesh-list
57081202|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57081203|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57081204|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
57081205|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081206|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57081207|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57081208|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081209|NCT00546273|Vaccines|vaccines|mesh-list
57081210|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
57081211|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081212|NCT02452112|Lidocaine|lidocaine|mesh-list
57081213|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
57081214|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
57081215|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081216|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081217|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
57081218|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081219|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57081220|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57081221|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57081222|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57081223|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081224|NCT00659061|Micronutrients|micronutrients|mesh-list
57081225|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081226|NCT02451956|Paclitaxel|paclitaxel|mesh-list
57081227|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57081228|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081229|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
57081230|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
57081231|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
57081232|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081233|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
57081234|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57081235|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
57081236|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081237|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081238|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57081239|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
57081240|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57081241|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
57081242|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081243|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081244|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57081245|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
57081246|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
57081247|NCT02725372|Protective Agents|protective agents|mesh-ancestor
57081248|NCT02450786|Donepezil|donepezil|mesh-list
57081249|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57081250|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081251|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081252|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
57081253|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081254|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081255|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
57081256|NCT00539721|Ondansetron|ondansetron|mesh-list
57081257|NCT00539721|Rolapitant|rolapitant|mesh-list
57081258|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
57081259|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
57081260|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081261|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081262|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081263|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
57081264|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
57081265|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57081266|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
57081267|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081268|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081269|NCT00539721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57081270|NCT00539721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57081271|NCT00539721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081272|NCT00539721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57081273|NCT00539721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57081274|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57081275|NCT00464061|Volinanserin|volinanserin|mesh-list
57081276|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57081277|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
57081278|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081279|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081280|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081281|NCT03230630|Melatonin|melatonin|mesh-list
57081282|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
57081283|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081284|NCT03230630|Protective Agents|protective agents|mesh-ancestor
57081285|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081286|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081287|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57081288|NCT00460941|Incretins|incretins|mesh-ancestor
57081289|NCT00460941|Hormones|hormones|mesh-ancestor
57081290|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57081291|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081292|NCT00460317|Paclitaxel|paclitaxel|mesh-list
57081293|NCT00460317|Carboplatin|carboplatin|mesh-list
57081294|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
57081295|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57081296|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081297|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
57081298|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
57081299|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
57081300|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081301|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57081302|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081303|NCT03213548|Daminozide|daminozide|mesh-list
57081304|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
57081305|NCT03213548|Growth Substances|growth substances|mesh-ancestor
57081306|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081307|NCT00534027|Conatumumab|conatumumab|mesh-list
57081308|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57081309|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763286|NCT00946374|Cyclosporine|cyclosporine|mesh-list
57081310|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57081311|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
57081312|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081313|NCT02548078|Vaccines|vaccines|mesh-list
57081314|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
57081315|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081316|NCT00532311|Atorvastatin|atorvastatin|mesh-list
57081317|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57081318|NCT00532311|Simvastatin|simvastatin|mesh-list
57081319|NCT00532311|Pravastatin|pravastatin|mesh-list
57081320|NCT00532311|Lovastatin|lovastatin|mesh-list
57081321|NCT00532311|L 647318|l 647318|mesh-list
57081322|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
57081323|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
57081324|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57081325|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57081326|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
57081327|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081328|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57081329|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081330|NCT03230474|Morphine|morphine|mesh-list
57081331|NCT03230474|Naloxone|naloxone|mesh-list
57081332|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57081333|NCT03230474|Narcotics|narcotics|mesh-ancestor
57081334|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081335|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081336|NCT03230474|Analgesics|analgesics|mesh-ancestor
57081337|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
57081338|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081339|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57081340|NCT02671435|Bevacizumab|bevacizumab|mesh-list
57081341|NCT02671435|Cetuximab|cetuximab|mesh-list
57081342|NCT02671435|Durvalumab|durvalumab|mesh-list
57081343|NCT02671435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57081344|NCT02671435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081345|NCT02671435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57081346|NCT02671435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57081347|NCT02671435|Growth Substances|growth substances|mesh-ancestor
57081348|NCT02671435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081349|NCT02671435|Growth Inhibitors|growth inhibitors|mesh-ancestor
57081350|NCT05476354|Amlodipine|amlodipine|mesh-list
57081351|NCT05476354|Irbesartan|irbesartan|mesh-list
57081352|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57081353|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57081354|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57081355|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081356|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57081357|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081358|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
57081359|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57081360|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57081361|NCT00529503|Rituximab|rituximab|mesh-list
57081362|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
57081363|NCT00529503|Carboplatin|carboplatin|mesh-list
57081364|NCT00529503|Etoposide|etoposide|mesh-list
57081365|NCT00529503|Ifosfamide|ifosfamide|mesh-list
57081366|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57081367|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081368|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
57081369|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081370|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57081371|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57081372|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57081373|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57081374|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081375|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081376|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57081377|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
57081378|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57081379|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57081380|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
57081381|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081382|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081383|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57081384|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
57081385|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
57081387|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57081388|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
57081389|NCT05476198|Anesthetics|anesthetics|mesh-list
57081390|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081391|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081392|NCT02280057|Metformin|metformin|mesh-list
57081393|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57081394|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081395|NCT02282709|Asunaprevir|asunaprevir|mesh-list
57081396|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
57081397|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081398|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081399|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
57081400|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57081401|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081402|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081403|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57081404|NCT02282787|Analgesics|analgesics|mesh-ancestor
57081405|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
57081406|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081407|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57081408|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57081409|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57081410|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
57081411|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081412|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081413|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
57081414|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57081415|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081416|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57081417|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57081418|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57081419|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081420|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
57081421|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081422|NCT00458601|Temozolomide|temozolomide|mesh-list
57081423|NCT00458601|Molgramostim|molgramostim|mesh-list
57081424|NCT00458601|Rindopepimut|rindopepimut|mesh-list
57081425|NCT00458601|Sargramostim|sargramostim|mesh-list
57081426|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57081427|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
57081428|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081429|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081430|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
57081431|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081432|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57081433|NCT00658047|Methotrexate|methotrexate|mesh-list
57081434|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57081435|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
57081436|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57081437|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081438|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57081439|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
57081440|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081441|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081442|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
57081443|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081444|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57081445|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081446|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
57081447|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57081448|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57081449|NCT03230162|Heparin|heparin|mesh-list
57081450|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57081451|NCT03230162|Tinzaparin|tinzaparin|mesh-list
57081452|NCT03230162|Dalteparin|dalteparin|mesh-list
57081453|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
57081454|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
57081455|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57081456|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57081457|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081458|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
57081459|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57081460|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57081461|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081462|NCT03230162|Urological Agents|urological agents|mesh-ancestor
57081463|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
57081464|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081465|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57081466|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081467|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081468|NCT02916433|Octreotide|octreotide|mesh-list
57081469|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081470|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57081471|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081472|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57081473|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081474|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57081475|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081476|NCT04059523|Tretinoin|tretinoin|mesh-list
57081477|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081478|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
57081479|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
57081480|NCT00657501|Testosterone|testosterone|mesh-list
57081481|NCT00657501|Androgens|androgens|mesh-ancestor
57081482|NCT00657501|Hormones|hormones|mesh-ancestor
57081483|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57081484|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081485|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
57081486|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
57081487|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57081488|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081489|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
57081490|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57081491|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57081492|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57081493|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081494|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081495|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081496|NCT03229694|Bosentan|bosentan|mesh-list
57081497|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
57081498|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57081499|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081500|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57081501|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57081502|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081503|NCT03209648|Itraconazole|itraconazole|mesh-list
57081504|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
57081505|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081506|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57081507|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57081508|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081509|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081510|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57081511|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
57081512|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57081513|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081514|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57081515|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
57081516|NCT04058899|Nalbuphine|nalbuphine|mesh-list
57081517|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57081518|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081519|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081520|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57081521|NCT04058899|Analgesics|analgesics|mesh-ancestor
57081522|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
57081523|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081524|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57081525|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57081526|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57081527|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
57081528|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081529|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763512|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081530|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57081531|NCT04058899|Narcotics|narcotics|mesh-ancestor
57081532|NCT00657189|Sifalimumab|sifalimumab|mesh-list
57081533|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57081534|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
57081535|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081536|NCT03209180|Carvedilol|carvedilol|mesh-list
57081537|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57081538|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57081539|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
57081540|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081541|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081542|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081543|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57081544|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
57081545|NCT03209180|Protective Agents|protective agents|mesh-ancestor
57081546|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57081547|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57081548|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57081549|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
57081550|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57081551|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57081552|NCT03215017|Loperamide|loperamide|mesh-list
57081553|NCT03215017|Sorbitol|sorbitol|mesh-list
57081554|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
57081555|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081556|NCT03215017|Cathartics|cathartics|mesh-ancestor
57081557|NCT02500849|Busulfan|busulfan|mesh-list
57081558|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
57081559|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081560|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081561|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
57081562|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081563|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57081564|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081565|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57081566|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
57081567|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57081568|NCT02280447|Vaccines|vaccines|mesh-list
57081569|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
57081570|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081571|NCT00528333|Cytarabine|cytarabine|mesh-list
57081572|NCT00528333|Lintuzumab|lintuzumab|mesh-list
57081573|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57081574|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
57081575|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081576|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081577|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
57081578|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081579|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081580|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
57081581|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081582|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57081583|NCT00526227|Clotrimazole|clotrimazole|mesh-list
57081584|NCT00526227|Miconazole|miconazole|mesh-list
57081585|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57081586|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081587|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
57081588|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57081589|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57081590|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081591|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081592|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57081593|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
57081594|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57081595|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081596|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57081597|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57081598|NCT02280603|Minoxidil|minoxidil|mesh-list
57081599|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57081600|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
57081601|NCT00524277|Molgramostim|molgramostim|mesh-list
57081602|NCT00524277|Vaccines|vaccines|mesh-list
57081603|NCT00524277|Sargramostim|sargramostim|mesh-list
57081604|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
57081605|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081606|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081608|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57081609|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57081610|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
57081611|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081612|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57081613|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57081614|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081615|NCT00650949|Carboplatin|carboplatin|mesh-list
57081616|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081617|NCT00520923|Olanzapine|olanzapine|mesh-list
57081618|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
57081619|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
57081620|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081621|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081622|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081623|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57081624|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57081625|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081626|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57081627|NCT00520923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57081628|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57081629|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57081630|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081631|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081632|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
57081633|NCT02283177|Cytarabine|cytarabine|mesh-list
57081634|NCT02283177|Daunorubicin|daunorubicin|mesh-list
57081635|NCT02283177|Idarubicin|idarubicin|mesh-list
57081636|NCT02283177|Crenolanib|crenolanib|mesh-list
57081637|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57081638|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
57081639|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081640|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081641|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
57081642|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081643|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081644|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
57081645|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081646|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57081647|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57081648|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57081649|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081650|NCT00514371|Bortezomib|bortezomib|mesh-list
57081651|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081652|NCT03214510|Fentanyl|fentanyl|mesh-list
57081653|NCT03214510|Hydromorphone|hydromorphone|mesh-list
57081654|NCT03214510|Bupivacaine|bupivacaine|mesh-list
57081655|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
57081656|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
57081657|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081658|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081659|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
57081660|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081661|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57081662|NCT03214510|Narcotics|narcotics|mesh-ancestor
57081663|NCT03214510|Analgesics|analgesics|mesh-ancestor
57081664|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57081665|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57081666|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
57081667|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57081668|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57081669|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57081670|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57081671|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081672|NCT04470531|Renal Agents|renal agents|mesh-ancestor
57081673|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57081674|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
57081675|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57081676|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57081677|NCT02286453|Diclofenac|diclofenac|mesh-list
57081678|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57081679|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57081680|NCT02286453|Analgesics|analgesics|mesh-ancestor
57081681|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
57081682|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081683|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081684|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57081686|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57081687|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081688|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081689|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
57081690|NCT02547454|Hematinics|hematinics|mesh-ancestor
57081691|NCT00385515|Meclocycline|meclocycline|mesh-list
57081692|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57081693|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081694|NCT02286609|Deflazacort|deflazacort|mesh-list
57081695|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57081696|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081697|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
57081698|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081699|NCT00508989|Niacin|niacin|mesh-list
57081700|NCT00508989|Acetylcholine|acetylcholine|mesh-list
57081701|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57081702|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
57081703|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081704|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57081705|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
57081706|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
57081707|NCT00508989|Vitamins|vitamins|mesh-ancestor
57081708|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
57081709|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081710|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57081711|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
57081712|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081713|NCT05457868|Albuterol|albuterol|mesh-list
57081714|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57081715|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
57081716|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081717|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081718|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57081719|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
57081720|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
57081721|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57081722|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57081723|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57081724|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57081725|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
57081726|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081727|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081728|NCT05726097|Ascorbic Acid|ascorbic acid|mesh-list
57081729|NCT05726097|Prucalopride|prucalopride|mesh-list
57081730|NCT05726097|Picosulfate sodium|picosulfate sodium|mesh-list
57081731|NCT05726097|Antioxidants|antioxidants|mesh-ancestor
57081732|NCT05726097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081733|NCT05726097|Protective Agents|protective agents|mesh-ancestor
57081734|NCT05726097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081735|NCT05726097|Vitamins|vitamins|mesh-ancestor
57081736|NCT05726097|Micronutrients|micronutrients|mesh-ancestor
57081737|NCT05726097|Laxatives|laxatives|mesh-ancestor
57081738|NCT05726097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081739|NCT05726097|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
57081740|NCT05726097|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57081741|NCT05726097|Serotonin Agents|serotonin agents|mesh-ancestor
57081742|NCT05726097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081743|NCT05726097|Cathartics|cathartics|mesh-ancestor
57081744|NCT02286687|Talazoparib|talazoparib|mesh-list
57081745|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57081746|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081747|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081748|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081749|NCT03104842|Dexamethasone|dexamethasone|mesh-list
57081750|NCT03104842|Lenalidomide|lenalidomide|mesh-list
57081751|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57081752|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
57081753|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
57081754|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081755|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081756|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081757|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
57081758|NCT03104842|Hormones|hormones|mesh-ancestor
57081759|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57081760|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57081761|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081762|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
57081763|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57081764|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57081765|NCT03104842|Growth Substances|growth substances|mesh-ancestor
57081766|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
57081767|NCT00436683|Sevelamer|sevelamer|mesh-list
57081768|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
57081769|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
57081770|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081771|NCT02498600|Nivolumab|nivolumab|mesh-list
57081772|NCT02498600|Ipilimumab|ipilimumab|mesh-list
57081773|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57081774|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081775|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57081776|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081777|NCT00434811|Sirolimus|sirolimus|mesh-list
57081778|NCT00434811|Etanercept|etanercept|mesh-list
57081779|NCT00434811|Tacrolimus|tacrolimus|mesh-list
57081780|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57081781|NCT00434811|Basiliximab|basiliximab|mesh-list
57081782|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081783|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
57081784|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081785|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57081786|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081787|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081788|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57081789|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081790|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57081791|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081792|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
57081793|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57081794|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57081795|NCT00434811|Analgesics|analgesics|mesh-ancestor
57081796|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
57081797|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081798|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57081799|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57081800|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081801|NCT03519256|Nivolumab|nivolumab|mesh-list
57081802|NCT03519256|Linrodostat|linrodostat|mesh-list
57081803|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57081804|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081805|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57081806|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081807|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081808|NCT03133845|Fentanyl|fentanyl|mesh-list
57081809|NCT03133845|Midazolam|midazolam|mesh-list
57081810|NCT03133845|Morphine|morphine|mesh-list
57081811|NCT03133845|Anesthetics|anesthetics|mesh-list
57081812|NCT03133845|Propofol|propofol|mesh-list
57081813|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57081814|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081815|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57081816|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57081817|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
57081818|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57081819|NCT03133845|Narcotics|narcotics|mesh-ancestor
57081820|NCT03133845|Analgesics|analgesics|mesh-ancestor
57081821|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
57081822|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081823|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57081824|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57081825|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57081826|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57081827|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
57081828|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
57081829|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081830|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081831|NCT00120393|Ritonavir|ritonavir|mesh-list
57081832|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57081833|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57081834|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57081835|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
57081836|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081837|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081838|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57081839|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57081840|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
57081841|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081842|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57081843|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57081844|NCT05726019|Colchicine|colchicine|mesh-list
57081845|NCT05726019|Gout Suppressants|gout suppressants|mesh-ancestor
57081846|NCT05726019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57081847|NCT05726019|Tubulin Modulators|tubulin modulators|mesh-ancestor
57081848|NCT05726019|Antimitotic Agents|antimitotic agents|mesh-ancestor
57081849|NCT05726019|Mitosis Modulators|mitosis modulators|mesh-ancestor
57081850|NCT05726019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081851|NCT05726019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081852|NCT00116415|Lamivudine|lamivudine|mesh-list
57081853|NCT00116415|Efavirenz|efavirenz|mesh-list
57081854|NCT00116415|Didanosine|didanosine|mesh-list
57081855|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57081856|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57081857|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081858|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081859|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
57081860|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081861|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57081862|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57081863|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57081864|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57081865|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57081866|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57081867|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57081868|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57081869|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
57081870|NCT03207698|Metformin|metformin|mesh-list
57081871|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57081872|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081873|NCT03208712|Atezolizumab|atezolizumab|mesh-list
57081874|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081875|NCT03201380|Choline|choline|mesh-list
57081876|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
57081877|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57081878|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
57081879|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081880|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081881|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57081882|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
57081883|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
57081884|NCT03208556|Fludarabine|fludarabine|mesh-list
57081885|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081886|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
57081887|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081888|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57081889|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57081890|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
57081891|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081892|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081893|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57081894|NCT03201146|Cisplatin|cisplatin|mesh-list
57081895|NCT03201146|Carboplatin|carboplatin|mesh-list
57081896|NCT03201146|Pemetrexed|pemetrexed|mesh-list
57081897|NCT03201146|Apatinib|apatinib|mesh-list
57081898|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081899|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081900|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081901|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57081902|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57081903|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57081904|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57081905|NCT00370383|Satraplatin|satraplatin|mesh-list
57081906|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081907|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57081908|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081909|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763888|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
57081910|NCT00367887|Ribavirin|ribavirin|mesh-list
57081912|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57081913|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
57081914|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
57081915|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081916|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
57081917|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57081918|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081919|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
57081920|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081921|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
57081922|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56305928|NCT00039520|Sulindac|sulindac|mesh-list
57081923|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57081924|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
57081925|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081926|NCT03207308|Vitamin A|vitamin a|mesh-list
57081927|NCT03207308|Vitamins|vitamins|mesh-ancestor
57081928|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
57081929|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081930|NCT00366795|Satavaptan|satavaptan|mesh-list
57081931|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57081932|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081933|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
57081934|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081935|NCT00422019|Rilotumumab|rilotumumab|mesh-list
57081936|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57081937|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57081938|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081939|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
57081940|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081941|NCT03207542|Daratumumab|daratumumab|mesh-list
57081942|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081943|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
57081944|NCT00360867|Imetelstat|imetelstat|mesh-list
57081945|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57081946|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081947|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081948|NCT02287389|Mitomycins|mitomycins|mesh-list
57081949|NCT02287389|Mitomycin|mitomycin|mesh-list
57081950|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57081951|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081952|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
57081953|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081954|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57081955|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081956|NCT00057993|Trastuzumab|trastuzumab|mesh-list
57081957|NCT00057993|Exemestane|exemestane|mesh-list
57081958|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57081959|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081960|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57081961|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57081962|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081963|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081964|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57081965|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
57081966|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57081967|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081968|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
57081969|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
57081970|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57081971|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57081972|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57081973|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081974|NCT02284737|Urological Agents|urological agents|mesh-ancestor
57081975|NCT02448290|Docetaxel|docetaxel|mesh-list
57081976|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57081977|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
57081978|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
57081979|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
57081980|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081981|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57081982|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57081983|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56763962|NCT02576015|Lidocaine|lidocaine|mesh-list
57081984|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57081985|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081987|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57081988|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57081989|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
57081990|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
57081991|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57081992|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57081993|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57081994|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
57081995|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57081996|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
57081997|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57081998|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57081999|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57082000|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
57082001|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
57082002|NCT00051129|Anecortave|anecortave|mesh-list
57082003|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57082004|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57082005|NCT00051129|Growth Substances|growth substances|mesh-ancestor
57082006|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082007|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
57082008|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082009|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082010|NCT03200600|Dexamethasone|dexamethasone|mesh-list
57082011|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
57082012|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
57082013|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
57082014|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57082015|NCT03200600|BB 1101|bb 1101|mesh-list
57082016|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082017|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
57082018|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
57082019|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082020|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082021|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57082022|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
57082023|NCT03200600|Hormones|hormones|mesh-ancestor
57082024|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082025|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57082026|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082027|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
57082028|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082029|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082030|NCT03200600|Analgesics|analgesics|mesh-ancestor
57082031|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
57082032|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57082033|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57082034|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082035|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57082036|NCT01491893|Vaccines|vaccines|mesh-list
57082037|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
57082038|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082039|NCT00049959|Verteporfin|verteporfin|mesh-list
57082040|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57082041|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
57082042|NCT03119324|Nimesulide|nimesulide|mesh-list
57082043|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57082044|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57082045|NCT03119324|Analgesics|analgesics|mesh-ancestor
57082046|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
57082047|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082048|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082049|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082050|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082051|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57082052|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082053|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082054|NCT00415623|Amlodipine|amlodipine|mesh-list
57082055|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57082056|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57082057|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57082058|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082059|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57082060|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082061|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
57082063|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
57082064|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082065|NCT03134001|Analgesics|analgesics|mesh-list
57082066|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
57082067|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082068|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082069|NCT01969409|Rituximab|rituximab|mesh-list
57082070|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57082071|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082072|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
57082073|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082074|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082075|NCT05218577|Selenium|selenium|mesh-list
57082076|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
57082077|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082078|NCT05218577|Protective Agents|protective agents|mesh-ancestor
57082079|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082080|NCT05218577|Trace Elements|trace elements|mesh-ancestor
57082081|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
57082082|NCT00150813|Levetiracetam|levetiracetam|mesh-list
57082083|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
57082084|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
57082085|NCT02712788|Milrinone|milrinone|mesh-list
57082086|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57082087|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57082088|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
57082089|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57082090|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57082091|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082092|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082093|NCT02712788|Protective Agents|protective agents|mesh-ancestor
57082094|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082095|NCT00035529|Abatacept|abatacept|mesh-list
57082096|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57082097|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082098|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082099|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082100|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
57082101|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082102|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082103|NCT04470609|Vaccines|vaccines|mesh-list
57082104|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
57082105|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082106|NCT00356109|Insulin|insulin|mesh-list
57082107|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57082108|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
57082109|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57082110|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082111|NCT03206138|Imiquimod|imiquimod|mesh-list
57082112|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57082113|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
57082114|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082115|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082116|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
57082117|NCT04530305|Upadacitinib|upadacitinib|mesh-list
57082118|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57082119|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57082120|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082121|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082122|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082123|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
57082124|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57082125|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
57082126|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082127|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57082128|NCT00006225|Protective Agents|protective agents|mesh-ancestor
57082129|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
57082130|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082131|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
56899205|NCT05671029|Antiviral Agents|antiviral agents|mesh-ancestor
57082132|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
57082133|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082134|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082135|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
57082136|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57082137|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57082138|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
57082139|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082140|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082141|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082142|NCT04477265|Urological Agents|urological agents|mesh-ancestor
57082143|NCT00353457|Capecitabine|capecitabine|mesh-list
57082144|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
57082145|NCT00353457|Cetuximab|cetuximab|mesh-list
57082146|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082147|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
57082148|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082149|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082150|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57082151|NCT00411099|S 20098|s 20098|mesh-list
57082152|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57082153|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57082154|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082155|NCT03195530|Propofol|propofol|mesh-list
57082156|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57082157|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57082158|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082159|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57082160|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
57082161|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
57082162|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
57082163|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
57082164|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57082165|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57082166|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
57082167|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082168|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57082169|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57082170|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082171|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082172|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57082173|NCT00406809|Navitoclax|navitoclax|mesh-list
57082174|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082175|NCT03200210|Febuxostat|febuxostat|mesh-list
57082176|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
57082177|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082178|NCT00004899|Etoposide|etoposide|mesh-list
57082179|NCT00004899|Busulfan|busulfan|mesh-list
57082180|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57082181|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082182|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57082183|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57082184|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082185|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082186|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
57082187|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082188|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
57082189|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082190|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57082191|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57082192|NCT03199976|Fluticasone|fluticasone|mesh-list
57082193|NCT03199976|Xhance|xhance|mesh-list
57082194|NCT03199976|Bromides|bromides|mesh-list
57082195|NCT03199976|Albuterol|albuterol|mesh-list
57082196|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
57082197|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082198|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57082199|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
57082200|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082201|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082202|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57082203|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
57082204|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
57082205|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57082206|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
57082207|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57082208|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
57082209|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082210|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082211|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
57082212|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
57082213|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57082214|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57082215|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57082216|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57082217|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
57082218|NCT00369317|Cytarabine|cytarabine|mesh-list
57082219|NCT00369317|Etoposide|etoposide|mesh-list
57082220|NCT00369317|Daunorubicin|daunorubicin|mesh-list
57082221|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
57082222|NCT00369317|Asparaginase|asparaginase|mesh-list
57082223|NCT00369317|Thioguanine|thioguanine|mesh-list
57082224|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57082225|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082226|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57082227|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57082228|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082229|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082230|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082231|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
57082232|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
57082233|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082234|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082235|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
57082236|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082237|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57082238|NCT02447666|Azacitidine|azacitidine|mesh-list
57082239|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082240|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
57082241|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082242|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082243|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082244|NCT04469829|Methotrexate|methotrexate|mesh-list
57082245|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57082246|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
57082247|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57082248|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082249|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082250|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
57082251|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082252|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082253|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
57082254|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082255|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57082256|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082257|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
57082258|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082259|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57082260|NCT00405951|Docetaxel|docetaxel|mesh-list
57082261|NCT00405951|Obatoclax|obatoclax|mesh-list
57082262|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082263|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
57082264|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
57082265|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
57082266|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082267|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082268|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57082269|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57082270|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082271|NCT03669757|Betamethasone|betamethasone|mesh-list
57082272|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
57082273|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57082274|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
57082275|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57082276|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082277|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
57082278|NCT03669757|Hormones|hormones|mesh-ancestor
57082279|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082280|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082281|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57082282|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
57082283|NCT02303821|Cytarabine|cytarabine|mesh-list
57082284|NCT02303821|Dexamethasone|dexamethasone|mesh-list
57082285|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
57082286|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
56764268|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
57082287|NCT02303821|Methotrexate|methotrexate|mesh-list
57082288|NCT02303821|Vincristine|vincristine|mesh-list
57082289|NCT02303821|Daunorubicin|daunorubicin|mesh-list
57082290|NCT02303821|Asparaginase|asparaginase|mesh-list
57082291|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
57082292|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
57082293|NCT02303821|Pegaspargase|pegaspargase|mesh-list
57082294|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082295|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
57082296|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082297|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082298|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57082299|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
57082300|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082301|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082302|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57082303|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082304|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
57082305|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
57082306|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082307|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57082308|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
57082310|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082311|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57082312|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57082313|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
57082314|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57082315|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082316|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
57082317|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
57082318|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082319|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57082320|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57082321|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
57082322|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082323|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57082324|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
57082325|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
57082326|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
57082327|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57082328|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57082329|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57082330|NCT02303821|Analgesics|analgesics|mesh-ancestor
57082331|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
57082332|NCT03913091|Bupivacaine|bupivacaine|mesh-list
57082333|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
57082334|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
57082335|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57082336|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082337|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
57082338|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082339|NCT00330369|Darusentan|darusentan|mesh-list
57082340|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57082341|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082342|NCT03199664|Tacrolimus|tacrolimus|mesh-list
57082343|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082344|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
57082345|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082346|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57082347|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082348|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082349|NCT02447510|Mitogens|mitogens|mesh-list
57082350|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
57082351|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082352|NCT05674643|Acetaminophen|acetaminophen|mesh-list
57082353|NCT05674643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57082354|NCT05674643|Analgesics|analgesics|mesh-ancestor
57082355|NCT05674643|Sensory System Agents|sensory system agents|mesh-ancestor
57082356|NCT05674643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082357|NCT05674643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082358|NCT05674643|Antipyretics|antipyretics|mesh-ancestor
57082359|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
56764340|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
57082360|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082361|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
57082362|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082363|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082364|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57082365|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
57082366|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57082367|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082368|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
57082370|NCT05216237|Tegafur|tegafur|mesh-list
57082371|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082372|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57082373|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082374|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082375|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082376|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
57082377|NCT00322257|Insulin|insulin|mesh-list
57082378|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57082379|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
57082380|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
57082381|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57082382|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082383|NCT03674671|Ketamine|ketamine|mesh-list
57082384|NCT03674671|Analgesics|analgesics|mesh-ancestor
57082385|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
57082386|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082387|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082388|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57082389|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57082390|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
57082391|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
57082392|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57082393|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57082394|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57082395|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082396|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082397|NCT00312975|Tremelimumab|tremelimumab|mesh-list
57082398|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082399|NCT03199820|Dinoprostone|dinoprostone|mesh-list
57082400|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
57082401|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57082402|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082403|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
57082404|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
57082405|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082406|NCT03199430|Protective Agents|protective agents|mesh-ancestor
57082407|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082408|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
57082409|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57082410|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082411|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57082412|NCT02287857|Tenofovir|tenofovir|mesh-list
57082413|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
57082414|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082415|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57082416|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57082417|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082418|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082419|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57082420|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57082421|NCT01318499|Nepafenac|nepafenac|mesh-list
57082422|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57082423|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57082424|NCT01318499|Analgesics|analgesics|mesh-ancestor
57082425|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
57082426|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082427|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082428|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082429|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082430|NCT00397293|Topotecan|topotecan|mesh-list
57082431|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57082432|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57082433|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082434|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082435|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764418|NCT00468052|Analgesics|analgesics|mesh-ancestor
57082437|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
57082438|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
57082439|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57082440|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082441|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
57082442|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
57082443|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
57082444|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082445|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082446|NCT03204734|Capecitabine|capecitabine|mesh-list
57082447|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082448|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
57082449|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082450|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082451|NCT00396357|Metformin|metformin|mesh-list
57082452|NCT00396357|Vildagliptin|vildagliptin|mesh-list
57082453|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57082454|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082455|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57082456|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
57082457|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082458|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082459|NCT00394563|Tanezumab|tanezumab|mesh-list
57082460|NCT00394563|Analgesics|analgesics|mesh-ancestor
57082461|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
57082462|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082463|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082464|NCT02446730|Clopidogrel|clopidogrel|mesh-list
57082465|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57082466|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57082467|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57082468|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57082469|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
57082470|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082471|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082472|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082473|NCT02449538|Everolimus|everolimus|mesh-list
57082474|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082475|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082476|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
57082477|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082478|NCT02446652|Paclitaxel|paclitaxel|mesh-list
57082479|NCT02446652|Carboplatin|carboplatin|mesh-list
57082480|NCT02446652|Hydralazine|hydralazine|mesh-list
57082481|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57082482|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082483|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
57082484|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
57082485|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
57082486|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082487|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57082488|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
57082489|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
57082490|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57082491|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57082492|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57082493|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082494|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57082495|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57082496|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57082497|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
57082498|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082499|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082500|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57082501|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57082502|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
57082503|NCT00299325|Rimonabant|rimonabant|mesh-list
57082504|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57082505|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
57082506|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57082507|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082508|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082509|NCT00299325|Hormones|hormones|mesh-ancestor
57082510|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082511|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082512|NCT00391209|Insulin|insulin|mesh-list
57082513|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57082514|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57082515|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082516|NCT02446574|Paclitaxel|paclitaxel|mesh-list
57082517|NCT02446574|Cisplatin|cisplatin|mesh-list
57082518|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57082519|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082520|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
57082521|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
57082522|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
57082523|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082524|NCT01775813|Metformin|metformin|mesh-list
57082525|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57082526|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082527|NCT00287547|Abatacept|abatacept|mesh-list
57082528|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57082529|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082530|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082531|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082532|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
57082533|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082534|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082535|NCT03204578|Midazolam|midazolam|mesh-list
57082536|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57082537|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57082538|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57082539|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082540|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57082541|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57082542|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57082543|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57082544|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
57082545|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
57082546|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
57082547|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
57082548|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082549|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082550|NCT01694069|Tazobactam|tazobactam|mesh-list
57082551|NCT01694069|Piperacillin|piperacillin|mesh-list
57082552|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57082553|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57082554|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082555|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57082556|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082557|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082558|NCT03204032|Thalidomide|thalidomide|mesh-list
57082559|NCT03204032|Temozolomide|temozolomide|mesh-list
57082560|NCT03204032|Tegafur|tegafur|mesh-list
57082561|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57082562|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
57082563|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082564|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082565|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082566|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
57082567|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082568|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
57082569|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57082570|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082571|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57082572|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57082573|NCT03204032|Growth Substances|growth substances|mesh-ancestor
57082574|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
57082575|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082576|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
57082577|NCT02285751|Aspirin|aspirin|mesh-list
57082578|NCT02285751|Clopidogrel|clopidogrel|mesh-list
57082579|NCT02285751|Ticagrelor|ticagrelor|mesh-list
57082580|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57082581|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57082582|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57082583|NCT02285751|Analgesics|analgesics|mesh-ancestor
57082584|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
57082585|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082586|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082587|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082589|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57082590|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57082591|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082592|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57082593|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57082594|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082595|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
57082596|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57082597|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57082598|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57082599|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
57082600|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082601|NCT05114915|Docetaxel|docetaxel|mesh-list
57082602|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082603|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
57082604|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
57082605|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
57082606|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082607|NCT03532035|Brincidofovir|brincidofovir|mesh-list
57082608|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
57082609|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082610|NCT05724849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57082611|NCT05724849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57082612|NCT05724849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57082613|NCT05724849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57082614|NCT05724849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082615|NCT05724849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082616|NCT05724849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082617|NCT05724849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57082618|NCT05724849|Antidepressive Agents|antidepressive agents|mesh-ancestor
57082619|NCT05724849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57082620|NCT00282867|Insulin|insulin|mesh-list
57082621|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57082622|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082623|NCT03198338|Bupivacaine|bupivacaine|mesh-list
57082624|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
57082625|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
57082626|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57082627|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082628|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
57082629|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082630|NCT05222633|Ranibizumab|ranibizumab|mesh-list
57082631|NCT05222633|Aflibercept|aflibercept|mesh-list
57082632|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57082633|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57082634|NCT05222633|Growth Substances|growth substances|mesh-ancestor
57082635|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082636|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
57082637|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082638|NCT05222243|Calcium|calcium|mesh-list
57082639|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57082640|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082641|NCT04469283|Caffeine|caffeine|mesh-list
57082642|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57082643|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082644|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57082645|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082646|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082647|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57082648|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57082649|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
57082650|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082651|NCT02285829|Bromides|bromides|mesh-list
57082652|NCT02285829|Rocuronium|rocuronium|mesh-list
57082653|NCT02285829|Cisatracurium|cisatracurium|mesh-list
57082654|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
57082655|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57082656|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57082657|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57082658|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082659|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082661|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
57082662|NCT03203408|Protective Agents|protective agents|mesh-ancestor
57082663|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082664|NCT02285985|Saxagliptin|saxagliptin|mesh-list
57082665|NCT02285985|Incretins|incretins|mesh-ancestor
57082666|NCT02285985|Hormones|hormones|mesh-ancestor
57082667|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082668|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082669|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57082670|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
57082671|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082672|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082673|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57082674|NCT02445872|Dexamethasone|dexamethasone|mesh-list
57082675|NCT02445872|Aprepitant|aprepitant|mesh-list
57082676|NCT02445872|Palonosetron|palonosetron|mesh-list
57082677|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082678|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
57082679|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
57082680|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082681|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082682|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57082683|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
57082684|NCT02445872|Hormones|hormones|mesh-ancestor
57082685|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082686|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57082687|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082688|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57082689|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082690|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082691|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57082692|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57082693|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
57082694|NCT05221775|Lenvatinib|lenvatinib|mesh-list
57082695|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082696|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57082697|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082698|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082699|NCT04700423|Ivermectin|ivermectin|mesh-list
57082700|NCT04700423|Albendazole|albendazole|mesh-list
57082701|NCT04700423|Moxidectin|moxidectin|mesh-list
57082702|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57082703|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082704|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
57082705|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
57082706|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57082707|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57082708|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
57082709|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
57082710|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
57082711|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082712|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082713|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
57082714|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
57082715|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
57082716|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
57082717|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082718|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
57082719|NCT02445716|Testosterone|testosterone|mesh-list
57082720|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
57082721|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
57082722|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57082723|NCT02445716|Androgens|androgens|mesh-ancestor
57082724|NCT02445716|Hormones|hormones|mesh-ancestor
57082725|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082726|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082727|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57082728|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082729|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
57082730|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
57082731|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56764714|NCT00001247|Antifungal Agents|antifungal agents|mesh-ancestor
57082732|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082733|NCT05724381|Phenol|phenol|mesh-list
57082734|NCT05724381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57082735|NCT05724381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082736|NCT05724381|Disinfectants|disinfectants|mesh-ancestor
57082737|NCT05724381|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57082738|NCT05724381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57082739|NCT03194594|Dexamethasone|dexamethasone|mesh-list
57082740|NCT03194594|Ketamine|ketamine|mesh-list
57082741|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082742|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
57082743|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
57082744|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082745|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082746|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57082747|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
57082748|NCT03194594|Hormones|hormones|mesh-ancestor
57082749|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082750|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57082751|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082752|NCT03194594|Analgesics|analgesics|mesh-ancestor
57082753|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
57082754|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57082755|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57082756|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
57082757|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
57082758|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57082759|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57082760|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57082761|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082762|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082763|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
57082764|NCT04407377|Tolperisone|tolperisone|mesh-list
57082765|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57082766|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
57082767|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57082768|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57082769|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082770|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57082771|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082772|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57082773|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57082774|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
57082775|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57082776|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57082777|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57082778|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57082779|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082780|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
57082781|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082782|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082783|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57082784|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082785|NCT00257205|Temozolomide|temozolomide|mesh-list
57082786|NCT00257205|Dacarbazine|dacarbazine|mesh-list
57082787|NCT00257205|Tremelimumab|tremelimumab|mesh-list
57082788|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57082789|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
57082790|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082791|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082792|NCT03194204|Doxycycline|doxycycline|mesh-list
57082793|NCT03194204|Uric Acid|uric acid|mesh-list
57082794|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
57082795|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57082796|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082797|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
57082798|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57082799|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57082800|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
57082801|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082802|NCT03194204|Protective Agents|protective agents|mesh-ancestor
57082803|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082804|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
57082805|NCT04045301|Omalizumab|omalizumab|mesh-list
57082806|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57082807|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57082808|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57082809|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
57082810|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
57082811|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082812|NCT03197480|Aflibercept|aflibercept|mesh-list
57082813|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57082814|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57082815|NCT03197480|Growth Substances|growth substances|mesh-ancestor
57082816|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082817|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
57082818|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082819|NCT00151281|Thalidomide|thalidomide|mesh-list
57082820|NCT00151281|Prednisone|prednisone|mesh-list
57082821|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
57082822|NCT00151281|Rituximab|rituximab|mesh-list
57082823|NCT00151281|Etoposide|etoposide|mesh-list
57082824|NCT00151281|Procarbazine|procarbazine|mesh-list
57082825|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082826|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
57082827|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082828|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082829|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57082830|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
57082831|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082832|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082833|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57082834|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57082835|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082836|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
57082837|NCT00151281|Hormones|hormones|mesh-ancestor
57082838|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082839|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57082840|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57082841|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57082842|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57082843|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082844|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
57082845|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57082846|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082847|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57082848|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57082849|NCT00151281|Growth Substances|growth substances|mesh-ancestor
57082850|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
57082851|NCT03202862|Fulvestrant|fulvestrant|mesh-list
57082852|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57082853|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082854|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57082855|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57082856|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
57082857|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082858|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082859|NCT00255099|Etravirine|etravirine|mesh-list
57082860|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57082861|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57082862|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082863|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082864|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
57082865|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082866|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
57082867|NCT00231153|Povidone|povidone|mesh-list
57082868|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
57082869|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
57082870|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57082871|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082872|NCT03202784|Berotralstat|berotralstat|mesh-list
57082873|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082874|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082875|NCT05220527|Triamcinolone|triamcinolone|mesh-list
57082876|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
57082877|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082878|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
57082879|NCT05220527|Hormones|hormones|mesh-ancestor
57082880|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082881|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082882|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
57082883|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57082884|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
57082885|NCT05220527|Protective Agents|protective agents|mesh-ancestor
57082886|NCT03197402|Caseins|caseins|mesh-list
57082887|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
57082888|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
57082889|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082890|NCT05640245|Adalimumab|adalimumab|mesh-list
57082891|NCT05640245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082892|NCT05640245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082893|NCT05723991|Gemcitabine|gemcitabine|mesh-list
57082894|NCT05723991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082895|NCT05723991|Antimetabolites|antimetabolites|mesh-ancestor
57082896|NCT05723991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082897|NCT05723991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082898|NCT05723991|Antiviral Agents|antiviral agents|mesh-ancestor
57082899|NCT05723991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082900|NCT05723991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082901|NCT05723991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082902|NCT05723991|Immunologic Factors|immunologic factors|mesh-ancestor
57082903|NCT05723991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082904|NCT05681039|Carboplatin|carboplatin|mesh-list
57082905|NCT05681039|Atezolizumab|atezolizumab|mesh-list
57082906|NCT05681039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082907|NCT05607407|Methimazole|methimazole|mesh-list
57082908|NCT05607407|Antithyroid Agents|antithyroid agents|mesh-ancestor
57082909|NCT05607407|Hormone Antagonists|hormone antagonists|mesh-ancestor
57082910|NCT05607407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082911|NCT05607407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082912|NCT04263831|Aldesleukin|aldesleukin|mesh-list
57082913|NCT04263831|Interleukin-2|interleukin-2|mesh-list
57082914|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082915|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57082916|NCT04263831|Analgesics|analgesics|mesh-ancestor
57082917|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
57082918|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082919|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082920|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57082921|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57082922|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
57082923|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082924|NCT01318109|Metformin|metformin|mesh-list
57082925|NCT01318109|Alogliptin|alogliptin|mesh-list
57082926|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57082927|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082928|NCT01318109|Incretins|incretins|mesh-ancestor
57082929|NCT01318109|Hormones|hormones|mesh-ancestor
57082930|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082931|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57082932|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
57082933|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082934|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082935|NCT05721027|Dexamethasone|dexamethasone|mesh-list
57082936|NCT05721027|Ibuprofen|ibuprofen|mesh-list
57082937|NCT05721027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57082938|NCT05721027|Antiemetics|antiemetics|mesh-ancestor
57082939|NCT05721027|Autonomic Agents|autonomic agents|mesh-ancestor
57082940|NCT05721027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082941|NCT05721027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082942|NCT05721027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57082943|NCT05721027|Glucocorticoids|glucocorticoids|mesh-ancestor
57082944|NCT05721027|Hormones|hormones|mesh-ancestor
56306955|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082945|NCT05721027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57082946|NCT05721027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57082947|NCT05721027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082948|NCT05721027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57082949|NCT05721027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57082950|NCT05721027|Analgesics|analgesics|mesh-ancestor
57082951|NCT05721027|Sensory System Agents|sensory system agents|mesh-ancestor
57082952|NCT05721027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57082953|NCT05721027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57082954|NCT05721027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082955|NCT05721027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082956|NCT05720871|Capsaicin|capsaicin|mesh-list
57082957|NCT05720871|Antipruritics|antipruritics|mesh-ancestor
57082958|NCT05720871|Dermatologic Agents|dermatologic agents|mesh-ancestor
57082959|NCT05720871|Sensory System Agents|sensory system agents|mesh-ancestor
57082960|NCT05720871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764957|NCT00467272|Daptomycin|daptomycin|mesh-list
57082961|NCT05720871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082962|NCT05672927|Vaccines|vaccines|mesh-list
57082963|NCT05672927|Immunologic Factors|immunologic factors|mesh-ancestor
57082964|NCT05672927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082965|NCT05636267|Carboplatin|carboplatin|mesh-list
57082966|NCT05636267|Pemetrexed|pemetrexed|mesh-list
57082967|NCT05636267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082968|NCT05636267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082969|NCT05636267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082970|NCT05636267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57082971|NCT05636267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57082972|NCT03873311|Cytarabine|cytarabine|mesh-list
57082973|NCT03873311|Azacitidine|azacitidine|mesh-list
57082974|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57082975|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
57082976|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082977|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57082978|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
57082979|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57082980|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57082981|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
57082982|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082983|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082984|NCT04789499|Theophylline|theophylline|mesh-list
57082985|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57082986|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
57082987|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57082988|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57082989|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57082990|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
57082991|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57082992|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57082993|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57082994|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
57082995|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57082996|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57082997|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
57082998|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57082999|NCT00162279|Abatacept|abatacept|mesh-list
57083000|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57083001|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083002|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083003|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083004|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
57083005|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083006|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083007|NCT00145431|Atorvastatin|atorvastatin|mesh-list
57083008|NCT00145431|Torcetrapib|torcetrapib|mesh-list
57083009|NCT00145431|Fenofibrate|fenofibrate|mesh-list
57083010|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57083011|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57083012|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
57083013|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083014|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57083015|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57083016|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083017|NCT00135369|Lamivudine|lamivudine|mesh-list
57083018|NCT00135369|Efavirenz|efavirenz|mesh-list
57083019|NCT00135369|Stavudine|stavudine|mesh-list
57083020|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57083021|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57083022|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083023|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083024|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
57083025|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083026|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57083027|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57083028|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57083029|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57083030|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57083031|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57083032|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57083033|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57083034|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
57083035|NCT03530319|Azithromycin|azithromycin|mesh-list
57083036|NCT03530319|Doxycycline|doxycycline|mesh-list
57083037|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57083038|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083039|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
57083040|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57083041|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57083042|NCT05726253|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57083043|NCT05726253|Amoxicillin|amoxicillin|mesh-list
57083044|NCT05726253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083045|NCT02445404|Dexamethasone|dexamethasone|mesh-list
57083046|NCT02445404|Prednisone|prednisone|mesh-list
57083047|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
57083048|NCT02445404|Ifosfamide|ifosfamide|mesh-list
57083049|NCT02445404|Carboplatin|carboplatin|mesh-list
57083050|NCT02445404|Etoposide|etoposide|mesh-list
57083051|NCT02445404|Vincristine|vincristine|mesh-list
57083052|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083053|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
57083054|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083055|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083056|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57083057|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
57083058|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083059|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083060|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57083061|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57083062|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
57083063|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
57083064|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083065|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083066|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
57083067|NCT02445404|Hormones|hormones|mesh-ancestor
57083068|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57083069|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57083070|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083071|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57083072|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57083073|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57083074|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
57083075|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
57083076|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
57083077|NCT03530085|Fludarabine|fludarabine|mesh-list
57083078|NCT03530085|Busulfan|busulfan|mesh-list
57083079|NCT03530085|Decitabine|decitabine|mesh-list
57083080|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083081|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57083082|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
57083083|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083084|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083085|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
57083086|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083087|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
57083088|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57083089|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57083090|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307104|NCT00045682|Paclitaxel|paclitaxel|mesh-list
57083091|NCT03196934|Cannabidiol|cannabidiol|mesh-list
57083092|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
57083093|NCT05304351|Vaccines|vaccines|mesh-list
57083094|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
57083095|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083096|NCT03197012|Octreotide|octreotide|mesh-list
57083097|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
57083098|NCT03197012|Edotreotide|edotreotide|mesh-list
57083099|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
57083100|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
57083101|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083102|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57083103|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083104|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57083105|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083106|NCT03530007|Ondansetron|ondansetron|mesh-list
57083107|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
57083108|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
57083109|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083110|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083111|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083112|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
57083113|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
57083114|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57083115|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
57083116|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083117|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083118|NCT03530007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57083119|NCT03530007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57083120|NCT03530007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083121|NCT03530007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57083122|NCT03530007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57083123|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
57083124|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57083125|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57083126|NCT03529929|Prednisolone|prednisolone|mesh-list
57083127|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
57083128|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57083129|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
57083130|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57083131|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
57083132|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
57083133|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083134|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083135|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083136|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
57083137|NCT03529929|Hormones|hormones|mesh-ancestor
57083138|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57083139|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57083140|NCT03529929|Protective Agents|protective agents|mesh-ancestor
57083141|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57083142|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083143|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
57083144|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083145|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
57083146|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083147|NCT03525561|Acetazolamide|acetazolamide|mesh-list
57083148|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
57083149|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57083150|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083151|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083152|NCT03525561|Diuretics|diuretics|mesh-ancestor
57083153|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
57083154|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083155|NCT05696691|Ketamine|ketamine|mesh-list
57083156|NCT05696691|Analgesics|analgesics|mesh-ancestor
57083157|NCT05696691|Sensory System Agents|sensory system agents|mesh-ancestor
57083158|NCT05696691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083159|NCT05696691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083160|NCT05696691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57083161|NCT05696691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57083162|NCT05696691|Anesthetics, General|anesthetics, general|mesh-ancestor
57083163|NCT05696691|Anesthetics|anesthetics|mesh-ancestor
57083164|NCT05696691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083165|NCT05696691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57083166|NCT05696691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57083167|NCT05696691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083168|NCT05696691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083169|NCT03527355|Vaccines|vaccines|mesh-list
57083170|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
57083171|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083172|NCT04458909|Gemcitabine|gemcitabine|mesh-list
57083173|NCT04458909|Cisplatin|cisplatin|mesh-list
57083174|NCT04458909|Carboplatin|carboplatin|mesh-list
57083175|NCT04458909|Nivolumab|nivolumab|mesh-list
57083176|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083177|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57083178|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
57083179|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083180|NCT04458909|Antiviral Agents|antiviral agents|mesh-ancestor
57083181|NCT04458909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083182|NCT04458909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083183|NCT04458909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083184|NCT04458909|Immunologic Factors|immunologic factors|mesh-ancestor
57083185|NCT04458909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083186|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56765162|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
57083187|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57083188|NCT05707169|Lidocaine|lidocaine|mesh-list
57083189|NCT05707169|Epinephrine|epinephrine|mesh-list
57083190|NCT05707169|Racepinephrine|racepinephrine|mesh-list
57083191|NCT05707169|Levobupivacaine|levobupivacaine|mesh-list
57083192|NCT05707169|Epinephryl borate|epinephryl borate|mesh-list
57083193|NCT05707169|Anesthetics, Local|anesthetics, local|mesh-ancestor
57083194|NCT05707169|Anesthetics|anesthetics|mesh-ancestor
57083195|NCT05707169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083196|NCT05707169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083197|NCT05707169|Sensory System Agents|sensory system agents|mesh-ancestor
57083198|NCT05707169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083199|NCT05707169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57083200|NCT05707169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57083201|NCT05707169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57083202|NCT05707169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57083203|NCT05707169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083204|NCT05707169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57083205|NCT05707169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57083206|NCT05707169|Adrenergic Agents|adrenergic agents|mesh-ancestor
57083207|NCT05707169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083208|NCT05707169|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57083209|NCT05707169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57083210|NCT05707169|Autonomic Agents|autonomic agents|mesh-ancestor
57083211|NCT05707169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57083212|NCT05707169|Respiratory System Agents|respiratory system agents|mesh-ancestor
57083213|NCT05707169|Mydriatics|mydriatics|mesh-ancestor
57083214|NCT05707169|Sympathomimetics|sympathomimetics|mesh-ancestor
57083215|NCT05707169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57083216|NCT05052827|Caseins|caseins|mesh-list
57083217|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
57083218|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
57083219|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083220|NCT02712008|Aflibercept|aflibercept|mesh-list
57083221|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57083222|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57083223|NCT02712008|Growth Substances|growth substances|mesh-ancestor
57083224|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083225|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
57083226|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083227|NCT05130515|Niraparib|niraparib|mesh-list
57083228|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57083229|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083230|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083231|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083232|NCT03193814|Apatinib|apatinib|mesh-list
57083233|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083234|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57083235|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083236|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083237|NCT05706779|Cetuximab|cetuximab|mesh-list
57083238|NCT05706779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57083239|NCT05706779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083240|NCT02450084|Fentanyl|fentanyl|mesh-list
57083241|NCT02450084|Ropivacaine|ropivacaine|mesh-list
57083242|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
57083243|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
57083244|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083245|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083246|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
57083247|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083248|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57083249|NCT02450084|Narcotics|narcotics|mesh-ancestor
57083250|NCT02450084|Analgesics|analgesics|mesh-ancestor
57083251|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57083252|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57083253|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
57083254|NCT03201770|Artesunate|artesunate|mesh-list
57083255|NCT03201770|Pyronaridine|pyronaridine|mesh-list
57083256|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
57083257|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57083258|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57083259|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083260|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083261|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
57083262|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
57083263|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56765238|NCT00952302|Iron|iron|mesh-list
57083264|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
57083265|NCT03626831|Evolocumab|evolocumab|mesh-list
57083266|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57083267|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57083268|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
57083269|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083270|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57083271|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57083272|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57083273|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083274|NCT03196466|Topiramate|topiramate|mesh-list
57083275|NCT03196466|Pregabalin|pregabalin|mesh-list
57083276|NCT03196466|Lamotrigine|lamotrigine|mesh-list
57083277|NCT03196466|Zonisamide|zonisamide|mesh-list
57083278|NCT03196466|Lacosamide|lacosamide|mesh-list
57083279|NCT03196466|Carbamazepine|carbamazepine|mesh-list
57083280|NCT03196466|Phenytoin|phenytoin|mesh-list
57083281|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
57083282|NCT03196466|Rufinamide|rufinamide|mesh-list
57083283|NCT03196466|Cannabidiol|cannabidiol|mesh-list
57083284|NCT03196466|Levetiracetam|levetiracetam|mesh-list
57083285|NCT03196466|Valproic Acid|valproic acid|mesh-list
57083286|NCT03196466|Brivaracetam|brivaracetam|mesh-list
57083287|NCT03196466|Phenobarbital|phenobarbital|mesh-list
57083288|NCT03196466|Clobazam|clobazam|mesh-list
57083289|NCT03196466|Ethosuximide|ethosuximide|mesh-list
57083290|NCT03196466|Stiripentol|stiripentol|mesh-list
57083291|NCT03196466|Tiagabine|tiagabine|mesh-list
57083292|NCT03196466|Primidone|primidone|mesh-list
57083293|NCT03196466|Felbamate|felbamate|mesh-list
57083294|NCT03196466|Analgesics|analgesics|mesh-ancestor
57083295|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
57083296|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083297|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083298|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
57083299|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57083300|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57083301|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083302|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57083303|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57083304|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57083305|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083306|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57083307|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57083308|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
57083309|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57083310|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57083311|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083312|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
57083313|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083314|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
57083315|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57083316|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57083317|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57083318|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57083319|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57083320|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57083321|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57083322|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57083323|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
57083324|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57083325|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57083326|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
57083327|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
57083328|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57083329|NCT04204941|Doxorubicin|doxorubicin|mesh-list
57083330|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57083331|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57083332|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083333|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57083334|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57083335|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083336|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083337|NCT04188405|Decitabine|decitabine|mesh-list
57083338|NCT04188405|Venetoclax|venetoclax|mesh-list
57083339|NCT04188405|Ponatinib|ponatinib|mesh-list
57083340|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56765316|NCT00719459|Iron|iron|mesh-list
57083341|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
57083342|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083343|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083344|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083345|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57083347|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083348|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083349|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083350|NCT02449070|Nicorandil|nicorandil|mesh-list
57083351|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57083352|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57083353|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
57083354|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
57083355|NCT02449070|Vitamins|vitamins|mesh-ancestor
57083356|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
57083357|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083358|NCT03529149|Diltiazem|diltiazem|mesh-list
57083359|NCT03529149|Urapidil|urapidil|mesh-list
57083360|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57083361|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57083362|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57083363|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083364|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57083365|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083366|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
57083367|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57083368|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
57083369|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083370|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57083371|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57083372|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57083373|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
57083374|NCT03524937|Melatonin|melatonin|mesh-list
57083375|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
57083376|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083377|NCT03524937|Protective Agents|protective agents|mesh-ancestor
57083378|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083379|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083380|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
57083381|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
57083382|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083383|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57083384|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
57083385|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083386|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083387|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57083388|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57083389|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57083390|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
57083391|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
57083392|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57083393|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
57083394|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57083395|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
57083396|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083397|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083398|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
57083399|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
57083400|NCT02711306|Cathartics|cathartics|mesh-ancestor
57083401|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083402|NCT03193112|S 20098|s 20098|mesh-list
57083403|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57083404|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083405|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083406|NCT03196154|Insulin|insulin|mesh-list
57083407|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57083408|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083409|NCT03193424|Docetaxel|docetaxel|mesh-list
57083410|NCT03193424|Apatinib|apatinib|mesh-list
57083411|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083412|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
57083413|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
57083414|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
57083415|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083416|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57083417|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083418|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
57083419|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57083420|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57083421|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57083422|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57083423|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083424|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
57083425|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083426|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083427|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57083428|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083429|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
57083430|NCT03118076|Ropivacaine|ropivacaine|mesh-list
57083431|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57083432|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083433|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083434|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57083435|NCT03118076|Analgesics|analgesics|mesh-ancestor
57083436|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
57083437|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083438|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57083439|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57083440|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57083441|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
57083442|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083443|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083444|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
57083445|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
57083447|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
57083448|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57083449|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083450|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083451|NCT03192878|Infliximab|infliximab|mesh-list
57083452|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
57083453|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083454|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083455|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
57083456|NCT03241940|Fludarabine|fludarabine|mesh-list
57083457|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
57083458|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083459|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
57083460|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083461|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083462|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57083463|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
57083464|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083465|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083466|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57083467|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57083468|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
57083469|NCT00294320|Imiquimod|imiquimod|mesh-list
57083470|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57083471|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
57083472|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083473|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083474|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
57083475|NCT03526575|Zaleplon|zaleplon|mesh-list
57083476|NCT03526575|Zolpidem|zolpidem|mesh-list
57083477|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57083478|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57083479|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083480|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083481|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57083482|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
57083483|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
57083484|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083485|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083486|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
57083487|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
57083488|NCT00189254|Imiquimod|imiquimod|mesh-list
57083489|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57083490|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
57083491|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083492|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083493|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
57083494|NCT03526419|Bupivacaine|bupivacaine|mesh-list
57083495|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
57083496|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
57083497|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083498|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083499|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
57083500|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083501|NCT03192644|Leucovorin|leucovorin|mesh-list
57083502|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
57083503|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
57083504|NCT03192644|Epirubicin|epirubicin|mesh-list
57083505|NCT03192644|Calcium|calcium|mesh-list
57083506|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
57083507|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083508|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57083509|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083510|NCT03192644|Antidotes|antidotes|mesh-ancestor
57083511|NCT03192644|Protective Agents|protective agents|mesh-ancestor
57083512|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
57083513|NCT03192644|Vitamins|vitamins|mesh-ancestor
57083514|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
57083515|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57083516|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57083517|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57083518|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083519|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083520|NCT03110055|Grazoprevir|grazoprevir|mesh-list
57083521|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
57083522|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
57083523|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083524|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
57083525|NCT04939623|Probenecid|probenecid|mesh-list
57083526|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
57083527|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
57083528|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083529|NCT04939623|Renal Agents|renal agents|mesh-ancestor
57083530|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
57083531|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083532|NCT01190852|Fluticasone|fluticasone|mesh-list
57083533|NCT01190852|Azelastine|azelastine|mesh-list
57083534|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57083535|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57083536|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
57083537|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083538|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083539|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57083540|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
57083541|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
57083542|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57083543|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
57083544|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083545|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083546|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57083547|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57083548|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
57083549|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
57083550|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083551|NCT02710214|Estrogens|estrogens|mesh-list
57083552|NCT02710214|Hormones|hormones|mesh-ancestor
57083553|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57083554|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083555|NCT03782415|Temozolomide|temozolomide|mesh-list
57083556|NCT03782415|Ibudilast|ibudilast|mesh-list
57083557|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57083558|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
57083559|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083560|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083561|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57083562|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
57083563|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083564|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083565|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57083566|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
57083567|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57083568|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083569|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57083570|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
57083571|NCT04858425|Niclosamide|niclosamide|mesh-list
57083573|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57083574|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
57083575|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57083576|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083577|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
57083578|NCT05561205|Methylphenidate|methylphenidate|mesh-list
57083579|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57083580|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083581|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57083582|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57083583|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57083584|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083585|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
57083586|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083587|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
57083588|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
57083589|NCT03052517|Growth Substances|growth substances|mesh-ancestor
57083590|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083591|NCT02443844|Tamsulosin|tamsulosin|mesh-list
57083592|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57083593|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57083594|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57083595|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
57083596|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083597|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083598|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083599|NCT02443844|Urological Agents|urological agents|mesh-ancestor
57083600|NCT02440100|Midazolam|midazolam|mesh-list
57083601|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57083602|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57083603|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083604|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083605|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57083606|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57083607|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57083608|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57083609|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
57083610|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
57083611|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
57083612|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
57083613|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083614|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083615|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
57083616|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
57083617|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083618|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
57083619|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083620|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083621|NCT02439944|Nicotine|nicotine|mesh-list
57083622|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57083623|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
57083624|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083625|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083626|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57083627|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57083628|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
57083629|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083630|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083631|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
57083632|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083633|NCT03190616|Apatinib|apatinib|mesh-list
57083634|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083635|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57083636|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083637|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083638|NCT02443922|Metformin|metformin|mesh-list
57083639|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57083640|NCT02443922|Glimepiride|glimepiride|mesh-list
57083641|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57083642|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083643|NCT02443922|Incretins|incretins|mesh-ancestor
57083644|NCT02443922|Hormones|hormones|mesh-ancestor
57083645|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57083646|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57083647|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
57083648|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083649|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083650|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57083651|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083652|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
57083653|NCT04799847|Catumaxomab|catumaxomab|mesh-list
57083654|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083655|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
57083656|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57083657|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083658|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
57083659|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57083660|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57083661|NCT02439866|Prednisolone|prednisolone|mesh-list
57083662|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
57083663|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57083664|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
57083665|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57083666|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
57083667|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
57083668|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083669|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083670|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083671|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
57083672|NCT02439866|Hormones|hormones|mesh-ancestor
57083673|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57083674|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57083675|NCT02439866|Protective Agents|protective agents|mesh-ancestor
57083676|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57083677|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083678|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
57083679|NCT02439788|Fludarabine|fludarabine|mesh-list
57083680|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083681|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
57083682|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083683|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083684|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57083685|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
57083686|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083687|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083688|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57083689|NCT03188510|Mirikizumab|mirikizumab|mesh-list
57083690|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57083691|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57083692|NCT03188510|Analgesics|analgesics|mesh-ancestor
57083693|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
57083694|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083695|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083696|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57083697|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083698|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57083699|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083700|NCT03188198|Prednisone|prednisone|mesh-list
57083701|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
57083702|NCT03188198|Rituximab|rituximab|mesh-list
57083703|NCT03188198|Doxorubicin|doxorubicin|mesh-list
57083704|NCT03188198|Etoposide|etoposide|mesh-list
57083705|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
57083706|NCT03188198|Vincristine|vincristine|mesh-list
57083707|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083708|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
57083709|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083710|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083711|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57083712|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
57083713|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083714|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083715|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57083716|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57083717|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57083718|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57083719|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57083720|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083721|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57083722|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
57083723|NCT03188198|Hormones|hormones|mesh-ancestor
57083724|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57083725|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57083726|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57083727|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
57083728|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
57083729|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
57083730|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
57083731|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
57083732|NCT03188276|Ledipasvir|ledipasvir|mesh-list
57083733|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
57083734|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083735|NCT03190304|Enalapril|enalapril|mesh-list
57083736|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57083737|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
57083738|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
57083739|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083740|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57083741|NCT02439632|Levofloxacin|levofloxacin|mesh-list
57083742|NCT02439632|Ofloxacin|ofloxacin|mesh-list
57083743|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
57083744|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
57083745|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57083746|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083747|NCT02439632|Renal Agents|renal agents|mesh-ancestor
57083748|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57083749|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57083750|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57083751|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083752|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083753|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083754|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57083755|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57083756|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57083757|NCT02443064|Vancomycin|vancomycin|mesh-list
57083758|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57083759|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57083760|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
57083761|NCT02741271|Prednisone|prednisone|mesh-list
57083762|NCT02741271|Prednisolone|prednisolone|mesh-list
57083763|NCT02741271|Albuterol|albuterol|mesh-list
57083764|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57083765|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
57083766|NCT02741271|Hormones|hormones|mesh-ancestor
56899240|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
57083767|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57083768|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083769|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57083770|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083771|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
57083772|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083773|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57083774|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57083775|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
57083776|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
57083777|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57083778|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57083779|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57083780|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57083781|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
57083782|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083783|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083784|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
57083785|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57083786|NCT02443142|Acetaminophen|acetaminophen|mesh-list
57083787|NCT02443142|Ibuprofen|ibuprofen|mesh-list
57083788|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57083789|NCT02443142|Analgesics|analgesics|mesh-ancestor
57083790|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
57083791|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083792|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083793|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
57083794|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57083795|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765760|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
57083796|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083797|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57083798|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083799|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083800|NCT03524079|Ajmaline|ajmaline|mesh-list
57083801|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57083802|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57083803|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57083804|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57083805|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083806|NCT02438852|Ropivacaine|ropivacaine|mesh-list
57083807|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
57083808|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
57083809|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083810|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083811|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
57083812|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083813|NCT05522673|Rolipram|rolipram|mesh-list
57083814|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
57083815|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57083816|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57083817|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57083818|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083819|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083820|NCT02442674|Tolvaptan|tolvaptan|mesh-list
57083821|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57083822|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083823|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
57083824|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083825|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
57083826|NCT02442752|Lansoprazole|lansoprazole|mesh-list
57083827|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57083828|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083829|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57083830|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083831|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083832|NCT02442362|Paclitaxel|paclitaxel|mesh-list
57083833|NCT02442362|Fluorouracil|fluorouracil|mesh-list
57083834|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
57083835|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57083836|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083837|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
57083838|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
57083839|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
57083840|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083841|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
57083842|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57083843|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57083844|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
57083845|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083846|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
57083847|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57083848|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083849|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083850|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57083851|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57083852|NCT02433860|Nicotine|nicotine|mesh-list
57083853|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57083854|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
57083855|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083856|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083857|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57083858|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57083859|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
57083860|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083861|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083862|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57083863|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083864|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
57083865|NCT03523455|Hematinics|hematinics|mesh-ancestor
57083866|NCT03189836|Rituximab|rituximab|mesh-list
57083867|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57083868|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083869|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
56765836|NCT03537586|Analgesics|analgesics|mesh-ancestor
57083870|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083871|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083872|NCT04466943|Rocuronium|rocuronium|mesh-list
57083873|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57083874|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57083875|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57083876|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083877|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083878|NCT03212469|Durvalumab|durvalumab|mesh-list
57083879|NCT03212469|Tremelimumab|tremelimumab|mesh-list
57083880|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57083881|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57083882|NCT02442440|Anisodamine|anisodamine|mesh-list
57083883|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57083884|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57083885|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
57083886|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083887|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083888|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083889|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57083890|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57083891|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57083892|NCT02442440|Analgesics|analgesics|mesh-ancestor
57083893|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
57083894|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083895|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57083896|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083897|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57083898|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083899|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
57083900|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
57083901|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
57083902|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57083903|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
57083904|NCT02442440|Protective Agents|protective agents|mesh-ancestor
57083905|NCT03187496|Midazolam|midazolam|mesh-list
57083906|NCT03187496|Caffeine|caffeine|mesh-list
57083907|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57083908|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57083909|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57083910|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083911|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083912|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57083913|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57083914|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57083915|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57083916|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
57083917|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
57083918|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
57083919|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
57083920|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083921|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083922|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57083923|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57083924|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
57083925|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57083926|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57083927|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083928|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57083929|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57083930|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57083931|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57083932|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
57083933|NCT02438072|Fexofenadine|fexofenadine|mesh-list
57083934|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
57083935|NCT02438072|Midazolam|midazolam|mesh-list
57083936|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
57083937|NCT02438072|Caffeine|caffeine|mesh-list
57083938|NCT02438072|Bupropion|bupropion|mesh-list
57083939|NCT02438072|Omeprazole|omeprazole|mesh-list
57083940|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57083941|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57083942|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57083943|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083944|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57083945|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57083946|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57083947|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57083948|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
57083949|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
57083950|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
57083951|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
57083952|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083953|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083954|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57083955|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57083956|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57083957|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57083958|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57083959|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
57083960|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57083961|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57083962|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57083963|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57083964|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
57083965|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57083966|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57083967|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57083968|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
57083969|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57083970|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57083971|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
57083972|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
57083973|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57083974|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57083975|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57083976|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57083977|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57083978|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
57083979|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
57083980|NCT02438072|Analgesics|analgesics|mesh-ancestor
57083981|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
57083982|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57083983|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57083984|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57083985|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57083986|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57083987|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57083988|NCT03522987|Citalopram|citalopram|mesh-list
57083989|NCT03522987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57083990|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57083991|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57083992|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57083993|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57083994|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
57083995|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57083996|NCT03522987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57083997|NCT03522987|Antidepressive Agents|antidepressive agents|mesh-ancestor
57083998|NCT03522987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57083999|NCT02433626|Cisplatin|cisplatin|mesh-list
57084000|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084001|NCT02442128|Fentanyl|fentanyl|mesh-list
57084002|NCT02442128|Propofol|propofol|mesh-list
57084003|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57084004|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084005|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084006|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57084007|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
57084008|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
57084009|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57084010|NCT02442128|Narcotics|narcotics|mesh-ancestor
57084011|NCT02442128|Analgesics|analgesics|mesh-ancestor
57084012|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
57084013|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084014|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57084015|NCT04465773|Remifentanil|remifentanil|mesh-list
57084016|NCT04465773|Propofol|propofol|mesh-list
57084017|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
57084018|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084019|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084020|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57084021|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57084022|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
57084023|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57084024|NCT04465773|Narcotics|narcotics|mesh-ancestor
57084025|NCT04465773|Analgesics|analgesics|mesh-ancestor
57084026|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
57084027|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084028|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
57084029|NCT02912559|Leucovorin|leucovorin|mesh-list
57084030|NCT02912559|Folic Acid|folic acid|mesh-list
57084031|NCT02912559|Fluorouracil|fluorouracil|mesh-list
57084032|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
57084033|NCT02912559|Atezolizumab|atezolizumab|mesh-list
57084034|NCT02912559|Calcium|calcium|mesh-list
57084035|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57084036|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
57084037|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57084038|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084039|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57084040|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
57084041|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084042|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57084043|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084044|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57084045|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
57084046|NCT02912559|Antidotes|antidotes|mesh-ancestor
57084047|NCT02912559|Protective Agents|protective agents|mesh-ancestor
57084048|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
57084049|NCT02912559|Vitamins|vitamins|mesh-ancestor
57084050|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
57084051|NCT02912559|Hematinics|hematinics|mesh-ancestor
57084052|NCT02709746|Vortioxetine|vortioxetine|mesh-list
57084053|NCT02709746|Fluoxetine|fluoxetine|mesh-list
57084054|NCT02709746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57084055|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57084056|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57084057|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084058|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084059|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
57084060|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899245|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
57084061|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57084062|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
57084063|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57084064|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57084065|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57084066|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084067|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57084068|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57084069|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084070|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57084071|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57084072|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57084073|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57084074|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
57084075|NCT02441894|Promethazine|promethazine|mesh-list
57084076|NCT02441894|Dexamethasone|dexamethasone|mesh-list
57084077|NCT02441894|Prednisolone|prednisolone|mesh-list
57084078|NCT02441894|Ondansetron|ondansetron|mesh-list
57084079|NCT02441894|Metoclopramide|metoclopramide|mesh-list
57084080|NCT02441894|Granisetron|granisetron|mesh-list
57084081|NCT02441894|Ranitidine|ranitidine|mesh-list
57084082|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
57084083|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084084|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
57084085|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
57084086|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084087|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084088|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084089|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
57084090|NCT02441894|Hormones|hormones|mesh-ancestor
57084091|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084092|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57084093|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084094|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
56766062|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57084095|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
57084096|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57084097|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
57084098|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084099|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084100|NCT02441894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57084101|NCT02441894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57084102|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084103|NCT02441894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57084104|NCT02441894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57084105|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57084106|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57084107|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
57084108|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
57084109|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
57084110|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57084111|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
57084112|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
57084113|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57084114|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57084115|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57084116|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
57084117|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57084118|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57084119|NCT02433704|Cefazolin|cefazolin|mesh-list
57084120|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084121|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084122|NCT05453825|Paclitaxel|paclitaxel|mesh-list
57084123|NCT05453825|Irinotecan|irinotecan|mesh-list
57084124|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57084125|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084126|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
57084127|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
57084128|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
57084129|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084130|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57084131|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57084132|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084133|NCT05555615|Pimavanserin|pimavanserin|mesh-list
57084134|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57084135|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57084136|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57084137|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57084138|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084139|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084140|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57084141|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57084142|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57084143|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
57084144|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084145|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084146|NCT02441816|Aflibercept|aflibercept|mesh-list
57084147|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57084148|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57084149|NCT02441816|Growth Substances|growth substances|mesh-ancestor
57084150|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084151|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
57084152|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084153|NCT02433314|Brexanolone|brexanolone|mesh-list
57084154|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
57084155|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084156|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084157|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084158|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
57084159|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
57084160|NCT02290431|Dexamethasone|dexamethasone|mesh-list
57084161|NCT02290431|Bortezomib|bortezomib|mesh-list
57084162|NCT02290431|Panobinostat|panobinostat|mesh-list
57084163|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084164|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
57084165|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
57084166|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084167|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084168|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084169|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
57084170|NCT02290431|Hormones|hormones|mesh-ancestor
57084171|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084172|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57084173|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084174|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57084175|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084176|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084177|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
57084178|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57084179|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
57084180|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084181|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57084182|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57084183|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
57084184|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084185|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084186|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57084187|NCT02436980|Midazolam|midazolam|mesh-list
57084188|NCT02436980|Tramadol|tramadol|mesh-list
57084189|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57084190|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57084191|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084192|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084193|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57084194|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57084195|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57084196|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57084197|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
57084198|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
57084199|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
57084200|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
57084201|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084202|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084203|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57084204|NCT02436980|Narcotics|narcotics|mesh-ancestor
57084205|NCT02436980|Analgesics|analgesics|mesh-ancestor
57084206|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
57084207|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084208|NCT02436902|Sorafenib|sorafenib|mesh-list
57084209|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
57084210|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084211|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57084212|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084213|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084214|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57084215|NCT02436902|Estrogens|estrogens|mesh-ancestor
57084216|NCT02436902|Hormones|hormones|mesh-ancestor
57084217|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084218|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084219|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57084220|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
57084221|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57084222|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
57084223|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084224|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084225|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57084226|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
57084227|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57084228|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
57084229|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084230|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084231|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57084232|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
57084233|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
57084234|NCT02436512|Protective Agents|protective agents|mesh-ancestor
57084235|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57084236|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57084237|NCT04466241|Ritonavir|ritonavir|mesh-list
57084238|NCT04466241|Lopinavir|lopinavir|mesh-list
57084239|NCT04466241|Telmisartan|telmisartan|mesh-list
57084240|NCT04466241|Atorvastatin|atorvastatin|mesh-list
57084241|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57084242|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57084243|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
57084244|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084245|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57084246|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57084247|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766211|NCT00723515|Calcium|calcium|mesh-list
57084248|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57084249|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57084250|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
57084251|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57084252|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57084253|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
57084254|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084255|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57084256|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57084257|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57084258|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57084259|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57084260|NCT02440880|Dexamethasone|dexamethasone|mesh-list
57084261|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
57084262|NCT02440880|BB 1101|bb 1101|mesh-list
57084263|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084264|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
57084265|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
57084266|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084267|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084268|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084269|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
57084270|NCT02440880|Hormones|hormones|mesh-ancestor
57084271|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084272|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57084273|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084274|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
57084275|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084276|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084277|NCT03186482|Rifampin|rifampin|mesh-list
56308295|NCT00052507|Bortezomib|bortezomib|mesh-list
57084278|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57084279|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57084280|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
57084281|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084282|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084283|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
57084284|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57084285|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084286|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084287|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57084288|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57084289|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57084290|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57084291|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57084292|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57084293|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
57084294|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57084295|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57084296|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57084297|NCT03522207|Trazodone|trazodone|mesh-list
57084298|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57084299|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57084300|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084301|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084302|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57084303|NCT03522207|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57084304|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57084305|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57084306|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084307|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084308|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
57084309|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57084310|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
57084311|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
57084312|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57084313|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084314|NCT03528057|Hemostatics|hemostatics|mesh-list
57084315|NCT03528057|Coagulants|coagulants|mesh-ancestor
57084316|NCT05706233|Analgesics|analgesics|mesh-list
57084317|NCT05706233|Sensory System Agents|sensory system agents|mesh-ancestor
57084318|NCT05706233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084319|NCT05706233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084320|NCT05018273|Atezolizumab|atezolizumab|mesh-list
57084321|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084322|NCT02707952|Ritonavir|ritonavir|mesh-list
57084323|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57084324|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57084325|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
57084326|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084327|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084328|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57084329|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57084330|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
57084331|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084332|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57084333|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57084334|NCT02720445|Nicotine|nicotine|mesh-list
57084335|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57084336|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
57084337|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084338|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084339|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57084340|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57084341|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
57084342|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084343|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084344|NCT02291211|Cisplatin|cisplatin|mesh-list
57084345|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084346|NCT03117998|Volagidemab|volagidemab|mesh-list
57084347|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57084348|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084349|NCT05392101|Deferasirox|deferasirox|mesh-list
57084350|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57084351|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
57084352|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
57084353|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084354|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57084355|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57084356|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57084357|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57084358|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084359|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084360|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084361|NCT02291367|Analgesics|analgesics|mesh-ancestor
57084362|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
57084363|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084364|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
57084365|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57084366|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
57084367|NCT02440958|Folfirinox|folfirinox|mesh-list
57084368|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084369|NCT02432534|Atorvastatin|atorvastatin|mesh-list
57084370|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57084371|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57084372|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
57084373|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084374|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57084375|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57084376|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084377|NCT02432612|Nabiximols|nabiximols|mesh-list
57084378|NCT02432612|Analgesics|analgesics|mesh-ancestor
57084379|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
57084380|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084381|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084382|NCT05705843|Vancomycin|vancomycin|mesh-list
57084383|NCT05705843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084384|NCT05705843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084385|NCT02436044|Leucovorin|leucovorin|mesh-list
57084386|NCT02436044|Fluorouracil|fluorouracil|mesh-list
57084387|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
57084388|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
57084389|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
57084390|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084391|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57084392|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084393|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57084394|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
57084395|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084396|NCT02436044|Antidotes|antidotes|mesh-ancestor
57084397|NCT02436044|Protective Agents|protective agents|mesh-ancestor
57084398|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
57084399|NCT02436044|Vitamins|vitamins|mesh-ancestor
57084400|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
57084401|NCT02435732|Heparin|heparin|mesh-list
57084402|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
57084403|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57084404|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57084405|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084406|NCT02435654|Olanzapine|olanzapine|mesh-list
57084407|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
57084408|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
57084409|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084410|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084411|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084412|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57084413|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57084414|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084415|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57084416|NCT02435654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57084417|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57084418|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57084419|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084420|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084421|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
57084422|NCT03191162|Benzonidazole|benzonidazole|mesh-list
57084423|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57084424|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
57084425|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084426|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57084427|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57084428|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57084429|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084430|NCT05620901|Prednisolone acetate|prednisolone acetate|mesh-list
57084431|NCT05620901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57084432|NCT05620901|Methylprednisolone|methylprednisolone|mesh-list
57084433|NCT05620901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57084434|NCT05620901|Prednisolone|prednisolone|mesh-list
57084435|NCT05620901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57084436|NCT05620901|Prednisolone phosphate|prednisolone phosphate|mesh-list
57084437|NCT05620901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084438|NCT05620901|Antiemetics|antiemetics|mesh-ancestor
57084439|NCT05620901|Autonomic Agents|autonomic agents|mesh-ancestor
57084440|NCT05620901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084441|NCT05620901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084442|NCT05620901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084443|NCT05620901|Glucocorticoids|glucocorticoids|mesh-ancestor
57084444|NCT05620901|Hormones|hormones|mesh-ancestor
57084445|NCT05620901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084446|NCT05620901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57084447|NCT05620901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084448|NCT05620901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57084449|NCT05620901|Protective Agents|protective agents|mesh-ancestor
57084450|NCT05288153|Metformin|metformin|mesh-list
57084451|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57084452|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084453|NCT05571527|Hyaluronic Acid|hyaluronic acid|mesh-list
57084454|NCT05571527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57084455|NCT05571527|Immunologic Factors|immunologic factors|mesh-ancestor
57084456|NCT05571527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084457|NCT05571527|Viscosupplements|viscosupplements|mesh-ancestor
57084458|NCT05571527|Protective Agents|protective agents|mesh-ancestor
57084459|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
57084460|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57084461|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57084462|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
57084463|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084464|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084465|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084466|NCT04825223|Vaccines|vaccines|mesh-list
57084467|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
57084468|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084469|NCT04824599|Ropivacaine|ropivacaine|mesh-list
57084470|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
57084471|NCT04824599|Anesthetics|anesthetics|mesh-list
57084472|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084473|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084474|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
57084475|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084476|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
57084477|NCT02431988|Fludarabine|fludarabine|mesh-list
57084478|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57084479|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
57084480|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084481|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57084482|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57084483|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
57084484|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084485|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084486|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57084487|NCT05233514|Metformin|metformin|mesh-list
57084488|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57084489|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084490|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57084491|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084492|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084493|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57084494|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084495|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084496|NCT02435186|Paclitaxel|paclitaxel|mesh-list
57084497|NCT02435186|Cisplatin|cisplatin|mesh-list
56308511|NCT00053872|Lomustine|lomustine|mesh-list
57084498|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57084499|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084500|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
57084501|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
57084502|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
57084503|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084504|NCT02435108|Crizotinib|crizotinib|mesh-list
57084505|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084506|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57084507|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084508|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084509|NCT05568407|Avelumab|avelumab|mesh-list
57084510|NCT05568407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57084511|NCT05568407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084512|NCT02434952|Piperaquine|piperaquine|mesh-list
57084513|NCT02434952|Primaquine|primaquine|mesh-list
57084514|NCT02434952|Artenimol|artenimol|mesh-list
57084515|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
57084516|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57084517|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57084518|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084519|NCT05702333|Simendan|simendan|mesh-list
57084520|NCT05702333|Dobutamine|dobutamine|mesh-list
57084521|NCT05702333|Dopamine|dopamine|mesh-list
57084522|NCT05702333|Epinephrine|epinephrine|mesh-list
57084523|NCT05702333|Norepinephrine|norepinephrine|mesh-list
57084524|NCT05702333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57084525|NCT05702333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57084526|NCT05702333|Adrenergic Agents|adrenergic agents|mesh-ancestor
57084527|NCT05702333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084528|NCT05702333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084529|NCT05702333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084530|NCT05702333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57084531|NCT05702333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57084532|NCT05702333|Autonomic Agents|autonomic agents|mesh-ancestor
57084533|NCT05702333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084534|NCT05702333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57084535|NCT05702333|Respiratory System Agents|respiratory system agents|mesh-ancestor
57084536|NCT05702333|Mydriatics|mydriatics|mesh-ancestor
57084537|NCT05702333|Sympathomimetics|sympathomimetics|mesh-ancestor
57084538|NCT05702333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57084539|NCT05702333|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57084540|NCT05702333|Vasodilator Agents|vasodilator agents|mesh-ancestor
57084541|NCT05702333|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57084542|NCT05702333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57084543|NCT05702333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084544|NCT05702333|Protective Agents|protective agents|mesh-ancestor
57084545|NCT05702333|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57084546|NCT05702333|Dopamine Agents|dopamine agents|mesh-ancestor
57084547|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
57084548|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57084549|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
57084550|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084551|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084552|NCT03626753|Acetaminophen|acetaminophen|mesh-list
57084553|NCT03626753|Piroxicam|piroxicam|mesh-list
57084554|NCT03626753|Nefopam|nefopam|mesh-list
57084555|NCT03626753|Proroxan|proroxan|mesh-list
57084556|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57084557|NCT03626753|Analgesics|analgesics|mesh-ancestor
57084558|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
57084559|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899256|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57084560|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084561|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
57084562|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57084563|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084564|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57084565|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57084566|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084567|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084568|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57084569|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57084570|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
57084571|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084572|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57084573|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
57084574|NCT02440256|Narcotics|narcotics|mesh-ancestor
57084575|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084576|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084577|NCT02440256|Analgesics|analgesics|mesh-ancestor
57084578|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
57084579|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084580|NCT05157698|Naltrexone|naltrexone|mesh-list
57084581|NCT05157698|Bupropion|bupropion|mesh-list
57084582|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57084583|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57084584|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084585|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
57084586|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084587|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57084588|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
57084589|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57084590|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57084591|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57084592|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57084593|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084594|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
57084595|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084596|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57084597|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57084598|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084599|NCT03185624|Rifaximin|rifaximin|mesh-list
57084600|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084601|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084602|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084603|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
57084604|NCT02707640|Pirfenidone|pirfenidone|mesh-list
57084605|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57084606|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
57084607|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084608|NCT02707640|Expectorants|expectorants|mesh-ancestor
57084609|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
57084610|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57084611|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
57084612|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084613|NCT02707640|Protective Agents|protective agents|mesh-ancestor
57084614|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084615|NCT02707640|Antidotes|antidotes|mesh-ancestor
57084616|NCT02707640|Analgesics|analgesics|mesh-ancestor
57084617|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
57084618|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084619|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57084620|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57084621|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084622|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57084623|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084624|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
57084625|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57084626|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084627|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57084628|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084629|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
57084630|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57084631|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57084632|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57084633|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
57084634|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084635|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084636|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084637|NCT03188978|Atorvastatin|atorvastatin|mesh-list
57084638|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57084639|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57084640|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
57084641|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084642|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57084643|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57084644|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084645|NCT02431286|Dexamethasone|dexamethasone|mesh-list
57084646|NCT02431286|Aprepitant|aprepitant|mesh-list
57084647|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084648|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
57084649|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
57084650|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084651|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084652|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084653|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
57084654|NCT02431286|Hormones|hormones|mesh-ancestor
57084655|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084656|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57084657|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084658|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57084659|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084660|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084661|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
57084662|NCT04579367|Ezetimibe|ezetimibe|mesh-list
57084663|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57084664|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57084665|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
57084666|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084667|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57084668|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084669|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57084670|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084671|NCT02431208|Dexamethasone|dexamethasone|mesh-list
57084672|NCT02431208|Lenalidomide|lenalidomide|mesh-list
57084673|NCT02431208|Atezolizumab|atezolizumab|mesh-list
57084674|NCT02431208|Daratumumab|daratumumab|mesh-list
57084675|NCT02431208|Pomalidomide|pomalidomide|mesh-list
57084676|NCT02431208|Antibodies|antibodies|mesh-list
57084677|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57084678|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
57084679|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084680|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084681|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
57084682|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
57084683|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084684|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084685|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
57084686|NCT02431208|Hormones|hormones|mesh-ancestor
57084687|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084688|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57084689|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084690|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57084691|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57084692|NCT02431208|Growth Substances|growth substances|mesh-ancestor
57084693|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
57084694|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
57084695|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
57084696|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084697|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
57084698|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
56766674|NCT01028482|Sertraline|sertraline|mesh-list
57084699|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084700|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084701|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084702|NCT03107078|Hormones|hormones|mesh-ancestor
57084703|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084704|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57084705|NCT03107078|Protective Agents|protective agents|mesh-ancestor
57084706|NCT02430350|Edaravone|edaravone|mesh-list
57084707|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57084708|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
57084709|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084710|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57084711|NCT02430350|Protective Agents|protective agents|mesh-ancestor
57084712|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084713|NCT02429960|Remifentanil|remifentanil|mesh-list
57084714|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57084715|NCT02429960|Narcotics|narcotics|mesh-ancestor
57084716|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084717|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084718|NCT02429960|Analgesics|analgesics|mesh-ancestor
57084719|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
57084720|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084721|NCT02429804|Listerine|listerine|mesh-list
57084722|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
57084723|NCT02429804|Fluorides|fluorides|mesh-list
57084724|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
57084725|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57084726|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
57084727|NCT02429804|Protective Agents|protective agents|mesh-ancestor
57084728|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084729|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57084730|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084731|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57084732|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084733|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
57084734|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
57084735|NCT03185156|Propofol|propofol|mesh-list
57084736|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57084737|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084738|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084739|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57084740|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
57084741|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
57084742|NCT02429726|Cisplatin|cisplatin|mesh-list
57084743|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084744|NCT02429882|Brodalumab|brodalumab|mesh-list
57084745|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
57084746|NCT02430896|Methylphenidate|methylphenidate|mesh-list
57084747|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57084748|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57084749|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084750|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57084751|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57084752|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57084753|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084754|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
57084755|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084756|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57084757|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
57084758|NCT03184844|Thalidomide|thalidomide|mesh-list
57084759|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57084760|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
57084761|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084762|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
57084763|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084764|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084765|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57084766|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57084767|NCT03184844|Growth Substances|growth substances|mesh-ancestor
57084768|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
57084769|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084770|NCT02425202|Ketamine|ketamine|mesh-list
57084771|NCT02425202|Analgesics|analgesics|mesh-ancestor
57084772|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
57084773|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084774|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084776|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57084777|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
57084778|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
57084779|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084780|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57084781|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57084782|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084783|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084784|NCT03182504|Meropenem|meropenem|mesh-list
57084785|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084786|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084787|NCT02428946|Bromocriptine|bromocriptine|mesh-list
57084788|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57084789|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57084790|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
57084791|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084792|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084793|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
57084794|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
57084795|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084796|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084797|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57084798|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57084799|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084800|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
57084801|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57084802|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57084803|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084804|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
57084805|NCT02428868|Coagulants|coagulants|mesh-ancestor
57084806|NCT03181880|Bromides|bromides|mesh-list
57084807|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
57084808|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57084809|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
57084810|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084811|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084812|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57084813|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
57084814|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57084815|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57084816|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57084817|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
57084818|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084819|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084820|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
57084821|NCT03178994|Ketoconazole|ketoconazole|mesh-list
57084822|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
57084823|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084824|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57084825|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57084826|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084827|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084828|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57084829|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
57084830|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084831|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084832|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57084833|NCT03182114|Bupivacaine|bupivacaine|mesh-list
57084834|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
57084835|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
57084836|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57084837|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084838|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
57084839|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084840|NCT02428322|Vitamin D|vitamin d|mesh-list
57084841|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
57084842|NCT02428322|Vitamins|vitamins|mesh-ancestor
57084843|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
57084844|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084845|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56766811|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57084846|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57084848|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57084849|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084850|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084851|NCT00702338|Hormones|hormones|mesh-list
57084852|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56899271|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084853|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084854|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084855|NCT05484557|Enoxaparin|enoxaparin|mesh-list
57084856|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
57084857|NCT05484557|Apixaban|apixaban|mesh-list
57084858|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
57084859|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57084860|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57084861|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084862|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57084863|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
57084864|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57084865|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
57084866|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084867|NCT02427932|Gentamicins|gentamicins|mesh-list
57084868|NCT02427932|Ampicillin|ampicillin|mesh-list
57084869|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084870|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084871|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57084872|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084873|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084874|NCT03626519|Menthol|menthol|mesh-list
57084875|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
57084876|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
57084877|NCT03184766|Ibuprofen|ibuprofen|mesh-list
57084878|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
57084879|NCT03184766|Ephedrine|ephedrine|mesh-list
57084880|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57084881|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57084882|NCT03184766|Analgesics|analgesics|mesh-ancestor
57084883|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
57084884|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57084885|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084886|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57084887|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57084888|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57084889|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084890|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084891|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57084892|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
57084893|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57084894|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
57084895|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
57084896|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57084897|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57084898|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
57084899|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
57084900|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084901|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
57084902|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
57084903|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57084904|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57084905|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57084906|NCT02420834|Laxatives|laxatives|mesh-ancestor
57084907|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57084908|NCT02423954|Sirolimus|sirolimus|mesh-list
57084909|NCT02423954|Capecitabine|capecitabine|mesh-list
57084910|NCT02423954|Nivolumab|nivolumab|mesh-list
57084911|NCT02423954|Irinotecan|irinotecan|mesh-list
57084912|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57084913|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
57084914|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084915|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084916|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57084917|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57084918|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57084919|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57084920|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084921|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084922|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084923|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57084924|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
57084925|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57084926|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
57084927|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084928|NCT04221503|Niraparib|niraparib|mesh-list
57084929|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57084930|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084931|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084932|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084933|NCT02427308|Miltefosine|miltefosine|mesh-list
57084934|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
57084935|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084936|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084937|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57084938|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57084939|NCT03178292|Levofloxacin|levofloxacin|mesh-list
57084940|NCT03178292|Ofloxacin|ofloxacin|mesh-list
57084941|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57084942|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57084943|NCT03178292|Renal Agents|renal agents|mesh-ancestor
57084944|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57084945|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57084946|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57084947|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084948|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084949|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084950|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57084951|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57084952|NCT02427386|Estradiol|estradiol|mesh-list
57084953|NCT02427386|Estrogens|estrogens|mesh-list
57084954|NCT02427386|Hormones|hormones|mesh-ancestor
57084955|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57084956|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084957|NCT03181178|Micronutrients|micronutrients|mesh-list
57084958|NCT03181178|Trace Elements|trace elements|mesh-list
57084959|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084960|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
57084961|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57084962|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57084963|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57084964|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084965|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
57084966|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57084967|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084968|NCT04523363|Metformin|metformin|mesh-list
57084969|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57084970|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084971|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
57084972|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
57084973|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084974|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57084975|NCT03180944|Lugol's solution|lugol's solution|mesh-list
57084976|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57084977|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
57084978|NCT03180944|Coagulants|coagulants|mesh-ancestor
57084979|NCT04025879|Paclitaxel|paclitaxel|mesh-list
57084980|NCT04025879|Docetaxel|docetaxel|mesh-list
57084981|NCT04025879|Carboplatin|carboplatin|mesh-list
57084982|NCT04025879|Nivolumab|nivolumab|mesh-list
57084983|NCT04025879|Pemetrexed|pemetrexed|mesh-list
57084984|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57084985|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57084986|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
57084987|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
57084988|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
57084989|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57084990|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57084991|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57084992|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57084993|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57084994|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57084995|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
57084996|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57084997|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57084998|NCT04322669|Pidotimod|pidotimod|mesh-list
57084999|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57085000|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
57085001|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085002|NCT03180476|Apatinib|apatinib|mesh-list
57085003|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085004|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57085005|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085006|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085007|NCT03180632|Lorazepam|lorazepam|mesh-list
57085008|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
57085009|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
57085010|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
57085011|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085012|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085013|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085014|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57085015|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085016|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57085017|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57085018|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57085019|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
57085020|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
57085021|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085022|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085023|NCT02420132|Ranibizumab|ranibizumab|mesh-list
57085024|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57085025|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57085026|NCT02420132|Growth Substances|growth substances|mesh-ancestor
57085027|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085028|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
57085029|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085030|NCT04414475|Dexamethasone|dexamethasone|mesh-list
57085031|NCT04414475|Bortezomib|bortezomib|mesh-list
57085032|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085033|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
57085034|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
57085035|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085036|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085037|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085038|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
57085039|NCT04414475|Hormones|hormones|mesh-ancestor
57085040|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085041|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57085042|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085043|NCT03183752|Metformin|metformin|mesh-list
57085044|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57085045|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085046|NCT03183674|Oxytocin|oxytocin|mesh-list
57085047|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
57085048|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57085049|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085050|NCT03117530|Minocycline|minocycline|mesh-list
57085051|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57085052|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085053|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
57085054|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57085055|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
57085056|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085057|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
57085058|NCT03889925|Protective Agents|protective agents|mesh-ancestor
57085059|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
57085060|NCT05103254|Ezetimibe|ezetimibe|mesh-list
57085061|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57085062|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57085063|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
57085064|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085065|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57085066|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085067|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57085068|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085069|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
57085070|NCT02426840|Vitamin D|vitamin d|mesh-list
57085071|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
57085072|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
56767041|NCT00904202|Lidocaine|lidocaine|mesh-list
57085073|NCT02426840|Vitamins|vitamins|mesh-list
57085074|NCT02426840|Calcium|calcium|mesh-list
57085075|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
57085076|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085077|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57085078|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57085079|NCT03178526|Lovastatin|lovastatin|mesh-list
57085080|NCT03178526|L 647318|l 647318|mesh-list
57085081|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
57085082|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57085083|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57085084|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
57085085|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085086|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57085087|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57085088|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085089|NCT03857321|Insulin|insulin|mesh-list
57085090|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57085091|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
57085092|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57085093|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085094|NCT02423642|Heparin|heparin|mesh-list
57085095|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
57085096|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085097|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57085098|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57085099|NCT03180242|Trastuzumab|trastuzumab|mesh-list
57085100|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57085101|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085102|NCT04365257|Prazosin|prazosin|mesh-list
57085103|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
57085104|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
57085105|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57085106|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57085107|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
57085108|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085109|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085110|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085111|NCT00709904|Semuloparin|semuloparin|mesh-list
57085112|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57085113|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57085114|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57085115|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085116|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
57085117|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
57085118|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57085119|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
57085120|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57085121|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
57085122|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085123|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085124|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
57085125|NCT03183596|Dexamethasone|dexamethasone|mesh-list
57085126|NCT03183596|Bupivacaine|bupivacaine|mesh-list
57085127|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085128|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
57085129|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
57085130|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085131|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085132|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085133|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
57085134|NCT03183596|Hormones|hormones|mesh-ancestor
57085135|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085136|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57085137|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085138|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
57085139|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
57085140|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085141|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
57085142|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
57085143|NCT03742505|Vitamin D|vitamin d|mesh-list
57085144|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57085145|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085146|NCT03742505|Vitamins|vitamins|mesh-ancestor
57085147|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
57085148|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57085149|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
57085150|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085151|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
57085152|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
57085153|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
57085155|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57085156|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085157|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
57085158|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
57085159|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57085160|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57085161|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085162|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085163|NCT04325243|Urological Agents|urological agents|mesh-ancestor
57085164|NCT02419820|Aspirin|aspirin|mesh-list
57085165|NCT02419820|Clopidogrel|clopidogrel|mesh-list
57085166|NCT02419820|APD791|apd791|mesh-list
57085167|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57085168|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57085169|NCT02419820|Analgesics|analgesics|mesh-ancestor
57085170|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
57085171|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085172|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085173|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085174|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085175|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57085176|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57085177|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085178|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57085179|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57085180|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085181|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
57085182|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57085183|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57085184|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57085185|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
57085186|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085187|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57085188|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57085189|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
57085190|NCT05692739|Cyclosporine|cyclosporine|mesh-list
57085191|NCT05692739|Lubricant Eye Drops|lubricant eye drops|mesh-list
57085192|NCT05692739|Cyclosporins|cyclosporins|mesh-list
57085193|NCT05692739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085194|NCT05692739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085195|NCT05692739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085196|NCT05692739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085197|NCT05692739|Immunologic Factors|immunologic factors|mesh-ancestor
57085198|NCT05692739|Antifungal Agents|antifungal agents|mesh-ancestor
57085199|NCT05692739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085200|NCT05692739|Dermatologic Agents|dermatologic agents|mesh-ancestor
57085201|NCT05692739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085202|NCT05692739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57085203|NCT05692739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57085204|NCT05692739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57085205|NCT02419352|Atropine|atropine|mesh-list
57085206|NCT02419352|Neostigmine|neostigmine|mesh-list
57085207|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57085208|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57085209|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57085210|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
57085211|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085212|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085213|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57085214|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
57085215|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
57085216|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
57085217|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57085218|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57085219|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
57085220|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085221|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085222|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57085223|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085224|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57085225|NCT03365687|Vitamin D|vitamin d|mesh-list
57085226|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
57085227|NCT03365687|Vitamins|vitamins|mesh-ancestor
57085229|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085230|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57085231|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57085232|NCT02419118|Dexamethasone|dexamethasone|mesh-list
57085233|NCT02419118|Lenalidomide|lenalidomide|mesh-list
57085234|NCT02419118|Daratumumab|daratumumab|mesh-list
57085235|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085236|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
57085237|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
57085238|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085239|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085240|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085241|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
57085242|NCT02419118|Hormones|hormones|mesh-ancestor
57085243|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085244|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57085245|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085246|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
57085247|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57085248|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57085249|NCT02419118|Growth Substances|growth substances|mesh-ancestor
57085250|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
57085251|NCT02426294|Pioglitazone|pioglitazone|mesh-list
57085252|NCT02426294|Glimepiride|glimepiride|mesh-list
57085253|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57085254|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085255|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57085256|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085257|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
57085258|NCT02426450|Leucovorin|leucovorin|mesh-list
57085259|NCT02426450|Fluorouracil|fluorouracil|mesh-list
57085260|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
57085261|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
57085262|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085263|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57085264|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085265|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085266|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
57085267|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085268|NCT02426450|Antidotes|antidotes|mesh-ancestor
57085269|NCT02426450|Protective Agents|protective agents|mesh-ancestor
57085270|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
57085271|NCT02426450|Vitamins|vitamins|mesh-ancestor
57085272|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
57085273|NCT03841097|Tacrolimus|tacrolimus|mesh-list
57085274|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085275|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
57085276|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085277|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57085278|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085279|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085280|NCT03811847|Methylphenidate|methylphenidate|mesh-list
57085281|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57085282|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085283|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57085284|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57085285|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57085286|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085287|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
57085288|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085289|NCT02426060|Warfarin|warfarin|mesh-list
57085290|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
57085291|NCT02422784|Vitamin D|vitamin d|mesh-list
57085292|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
57085293|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
57085294|NCT02422784|Vitamins|vitamins|mesh-list
57085295|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
57085296|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085297|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57085298|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57085299|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
57085300|NCT03740009|Estrogens|estrogens|mesh-list
57085301|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
57085302|NCT03740009|Hormones|hormones|mesh-ancestor
57085303|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085304|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085305|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57085307|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
57085308|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57085309|NCT02418572|Testosterone|testosterone|mesh-list
57085310|NCT02418572|Androgens|androgens|mesh-ancestor
57085311|NCT02418572|Hormones|hormones|mesh-ancestor
57085312|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085313|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085314|NCT05514899|Dronabinol|dronabinol|mesh-list
57085315|NCT05514899|Cannabidiol|cannabidiol|mesh-list
57085316|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
57085317|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
57085318|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085319|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57085320|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57085321|NCT05514899|Analgesics|analgesics|mesh-ancestor
57085322|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
57085323|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085324|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57085325|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57085326|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085327|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085328|NCT05514899|Hormones|hormones|mesh-ancestor
57085329|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085330|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
57085331|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
57085332|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
57085333|NCT03705845|Tocotrienols|tocotrienols|mesh-list
57085334|NCT03705845|Vitamin E|vitamin e|mesh-list
57085335|NCT03705845|Tocopherols|tocopherols|mesh-list
57085336|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
57085337|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085338|NCT03705845|Protective Agents|protective agents|mesh-ancestor
57085339|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085340|NCT03705845|Vitamins|vitamins|mesh-ancestor
57085341|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
57085342|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
57085343|NCT03182894|Azacitidine|azacitidine|mesh-list
57085344|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57085345|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085346|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57085347|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
57085348|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085349|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085350|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57085351|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57085352|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57085353|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
57085354|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085355|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57085356|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57085357|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085358|NCT02423096|Haloperidol|haloperidol|mesh-list
57085359|NCT02423096|Olanzapine|olanzapine|mesh-list
57085360|NCT02423096|Risperidone|risperidone|mesh-list
57085361|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57085362|NCT02423096|Sulpiride|sulpiride|mesh-list
57085363|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57085364|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
57085365|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085366|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085367|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085368|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57085369|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57085370|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085371|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57085372|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57085373|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
57085374|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
57085375|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
57085376|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085377|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085378|NCT02423096|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57085379|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57085380|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57085381|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
57085382|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57085383|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57085384|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
57085385|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57085386|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085387|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085388|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57085389|NCT02423018|Pregabalin|pregabalin|mesh-list
57085390|NCT02423018|Analgesics|analgesics|mesh-ancestor
57085391|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
57085392|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085393|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085394|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
57085395|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57085396|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57085397|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085398|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57085399|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57085400|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57085401|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085402|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57085403|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
57085404|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57085405|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085406|NCT05691959|Calcium|calcium|mesh-list
57085407|NCT05691959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57085408|NCT05691959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085409|NCT02422706|Metronidazole|metronidazole|mesh-list
57085410|NCT02422706|Clarithromycin|clarithromycin|mesh-list
57085411|NCT02422706|Levofloxacin|levofloxacin|mesh-list
57085412|NCT02422706|Ofloxacin|ofloxacin|mesh-list
57085413|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
57085414|NCT02422706|Doxycycline|doxycycline|mesh-list
57085415|NCT02422706|Omeprazole|omeprazole|mesh-list
57085416|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085417|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57085418|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57085419|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57085420|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57085421|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085422|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57085423|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085424|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085425|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57085426|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57085427|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57085428|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57085429|NCT02422706|Renal Agents|renal agents|mesh-ancestor
57085430|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57085431|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57085432|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085433|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57085434|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
57085435|NCT03058757|Mitomycins|mitomycins|mesh-list
57085436|NCT03058757|Mitomycin|mitomycin|mesh-list
57085437|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57085438|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085439|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
57085440|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085441|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57085442|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085443|NCT03138889|Paclitaxel|paclitaxel|mesh-list
57085444|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57085445|NCT03138889|Carboplatin|carboplatin|mesh-list
57085446|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
57085447|NCT03138889|Pemetrexed|pemetrexed|mesh-list
57085448|NCT03138889|Atezolizumab|atezolizumab|mesh-list
57085449|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57085450|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085451|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
57085452|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
57085453|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
57085454|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085455|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57085456|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085457|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57085458|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57085459|NCT01881763|Ketamine|ketamine|mesh-list
57085460|NCT01881763|Methohexital|methohexital|mesh-list
57085461|NCT01881763|Analgesics|analgesics|mesh-ancestor
57085462|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
57085463|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085464|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085465|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57085466|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57085467|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
57085468|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
57085469|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085470|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57085471|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57085472|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085473|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085474|NCT03669601|Gemcitabine|gemcitabine|mesh-list
57085475|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57085476|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
57085477|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085478|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085479|NCT03669601|Antiviral Agents|antiviral agents|mesh-ancestor
57085480|NCT03669601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085481|NCT03669601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085482|NCT03669601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085483|NCT03669601|Immunologic Factors|immunologic factors|mesh-ancestor
57085484|NCT03669601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085485|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
57085486|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57085487|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085488|NCT02416388|Cytarabine|cytarabine|mesh-list
57085489|NCT02416388|Cyclosporine|cyclosporine|mesh-list
57085490|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
57085491|NCT02416388|Dexamethasone|dexamethasone|mesh-list
57085492|NCT02416388|Methotrexate|methotrexate|mesh-list
57085493|NCT02416388|Daunorubicin|daunorubicin|mesh-list
57085494|NCT02416388|Venetoclax|venetoclax|mesh-list
57085495|NCT02416388|Idarubicin|idarubicin|mesh-list
57085496|NCT02416388|Cyclosporins|cyclosporins|mesh-list
57085497|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085498|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
57085499|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
57085500|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085501|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085502|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085503|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
57085504|NCT02416388|Hormones|hormones|mesh-ancestor
57085505|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085506|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57085507|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085508|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57085509|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
57085510|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57085511|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57085512|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
57085513|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085514|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
57085515|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085516|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57085517|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085518|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
57085519|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085520|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57085521|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
57085522|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085523|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
57085524|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57085525|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57085526|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57085527|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57085528|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57085529|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
57085530|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57085531|NCT02886065|Lenalidomide|lenalidomide|mesh-list
57085532|NCT02886065|Poly ICLC|poly iclc|mesh-list
57085533|NCT02886065|Citarinostat|citarinostat|mesh-list
57085534|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
57085535|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085536|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57085537|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57085538|NCT02886065|Growth Substances|growth substances|mesh-ancestor
57085539|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
57085540|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085541|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
57085542|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57085543|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085544|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085545|NCT03392441|Insulin|insulin|mesh-list
57085546|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57085547|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085548|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
57085549|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085550|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
57085551|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57085552|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57085553|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085554|NCT03177824|Urological Agents|urological agents|mesh-ancestor
57085555|NCT02416232|Trametinib|trametinib|mesh-list
57085556|NCT02416232|Dabrafenib|dabrafenib|mesh-list
57085557|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085558|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57085559|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085560|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085561|NCT04482842|Warfarin|warfarin|mesh-list
57085562|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
57085563|NCT02767661|Capecitabine|capecitabine|mesh-list
57085564|NCT02767661|Letrozole|letrozole|mesh-list
57085565|NCT02767661|Anastrozole|anastrozole|mesh-list
57085566|NCT02767661|Exemestane|exemestane|mesh-list
57085567|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57085568|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57085569|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
57085570|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085571|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085572|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57085573|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085574|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57085575|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
57085576|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085577|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085578|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57085579|NCT02415920|Oxytocin|oxytocin|mesh-list
57085580|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
57085581|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57085582|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085583|NCT05691491|Temozolomide|temozolomide|mesh-list
57085584|NCT05691491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57085585|NCT05691491|Alkylating Agents|alkylating agents|mesh-ancestor
57085586|NCT05691491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085587|NCT05691491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085588|NCT03389243|Acetaminophen|acetaminophen|mesh-list
57085589|NCT03389243|Dipyrone|dipyrone|mesh-list
57085590|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57085591|NCT03389243|Analgesics|analgesics|mesh-ancestor
57085592|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
57085593|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085594|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085595|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
57085596|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57085597|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085598|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085599|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
57085600|NCT02421926|Dasatinib|dasatinib|mesh-list
57085601|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899283|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
57085602|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57085603|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085604|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085605|NCT02410460|Lidocaine|lidocaine|mesh-list
57085606|NCT02410460|Clonidine|clonidine|mesh-list
57085607|NCT02410460|Midazolam|midazolam|mesh-list
57085609|NCT02410460|Scopolamine|scopolamine|mesh-list
57085610|NCT02410460|Ketamine|ketamine|mesh-list
57085611|NCT02410460|Ondansetron|ondansetron|mesh-list
57085612|NCT02410460|Metoclopramide|metoclopramide|mesh-list
57085613|NCT02410460|Bupivacaine|bupivacaine|mesh-list
57085614|NCT02410460|Propofol|propofol|mesh-list
57085615|NCT02410460|Sevoflurane|sevoflurane|mesh-list
57085616|NCT02410460|Desflurane|desflurane|mesh-list
57085617|NCT02410460|Famotidine|famotidine|mesh-list
57085618|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57085619|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
57085620|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
57085621|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085622|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085623|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
57085624|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085625|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57085626|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57085627|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57085628|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57085629|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085630|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57085631|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57085632|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
57085633|NCT02410460|Analgesics|analgesics|mesh-ancestor
57085634|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57085635|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57085636|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57085637|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085638|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57085639|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57085640|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57085641|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57085642|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
57085643|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
57085644|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57085645|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57085646|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
57085647|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
57085648|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085649|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
57085650|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
57085651|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57085652|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
57085653|NCT02410460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57085654|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57085655|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
57085656|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57085657|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57085658|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57085659|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
57085660|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57085661|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57085662|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
57085663|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57085664|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57085665|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
57085666|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57085667|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57085668|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
57085669|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
57085670|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
57085671|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
57085672|NCT02410226|Anesthetics|anesthetics|mesh-list
57085673|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085674|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085675|NCT03116672|Ketorolac|ketorolac|mesh-list
57085676|NCT03116672|Diclofenac|diclofenac|mesh-list
57085677|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57085678|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57085679|NCT03116672|Analgesics|analgesics|mesh-ancestor
57085680|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
57085681|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085682|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085683|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085684|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085685|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57085687|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085688|NCT03174860|Diclofenac|diclofenac|mesh-list
57085689|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57085690|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57085691|NCT03174860|Analgesics|analgesics|mesh-ancestor
57085692|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
57085693|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085694|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085695|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085696|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085697|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57085698|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085699|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085700|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
57085701|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57085702|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085703|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57085704|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085705|NCT02417090|Metformin|metformin|mesh-list
57085706|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57085707|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085708|NCT00703820|Cytarabine|cytarabine|mesh-list
57085709|NCT00703820|Etoposide|etoposide|mesh-list
57085710|NCT00703820|Daunorubicin|daunorubicin|mesh-list
57085711|NCT00703820|Clofarabine|clofarabine|mesh-list
57085712|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57085713|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085714|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57085715|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57085716|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085717|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085718|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57085719|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
57085720|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
57085721|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085722|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085723|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
57085724|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085725|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57085726|NCT03177980|Clonidine|clonidine|mesh-list
57085727|NCT03177980|Fentanyl|fentanyl|mesh-list
57085728|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57085729|NCT03177980|Narcotics|narcotics|mesh-ancestor
57085730|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085731|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085732|NCT03177980|Analgesics|analgesics|mesh-ancestor
57085733|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
57085734|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085735|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57085736|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57085737|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
57085738|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
57085739|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57085740|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
57085741|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
57085742|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57085743|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57085744|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57085745|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
57085746|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085747|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085748|NCT03174782|Bupivacaine|bupivacaine|mesh-list
57085749|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
57085750|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
57085751|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57085752|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085753|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
56899285|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
57085754|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085755|NCT02443077|Cytarabine|cytarabine|mesh-list
57085756|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
57085757|NCT02443077|Melphalan|melphalan|mesh-list
57085758|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
57085759|NCT02443077|Carmustine|carmustine|mesh-list
57085760|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
57085761|NCT02443077|Etoposide|etoposide|mesh-list
57085762|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
57085763|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
57085764|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085765|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
57085766|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085767|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085768|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57085769|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
57085770|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085771|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085772|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57085773|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57085774|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57085775|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57085776|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085777|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57085778|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
57085779|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
57085780|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085781|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
57085782|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
57085783|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
57085784|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
57085785|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
57085786|NCT03177434|Lactulose|lactulose|mesh-list
57085787|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085788|NCT02587325|Sirolimus|sirolimus|mesh-list
57085789|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57085790|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085791|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57085792|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085793|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
57085794|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085795|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
57085796|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085797|NCT02414984|Golimumab|golimumab|mesh-list
57085798|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57085799|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085800|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085801|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
57085802|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085803|NCT02415062|Donepezil|donepezil|mesh-list
57085804|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57085805|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085806|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085807|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
57085808|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57085809|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085810|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
57085811|NCT02408978|Naproxen|naproxen|mesh-list
57085812|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57085813|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57085814|NCT02408978|Analgesics|analgesics|mesh-ancestor
57085815|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
57085816|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085817|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085818|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085819|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085820|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
57085821|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57085822|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085823|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085824|NCT02408744|Pirfenidone|pirfenidone|mesh-list
57085825|NCT02408744|Analgesics|analgesics|mesh-ancestor
57085826|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
57085827|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309831|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
57085828|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085829|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57085830|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57085831|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085832|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085833|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085834|NCT03174080|Fluorides|fluorides|mesh-list
57085835|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
57085836|NCT03174080|Protective Agents|protective agents|mesh-ancestor
57085837|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085838|NCT03116516|Amlodipine|amlodipine|mesh-list
57085839|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57085840|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57085841|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57085842|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57085843|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085844|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57085845|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085846|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
57085847|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57085848|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57085849|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
57085850|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57085851|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57085852|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085853|NCT01564537|Dexamethasone|dexamethasone|mesh-list
57085854|NCT01564537|Lenalidomide|lenalidomide|mesh-list
57085855|NCT01564537|Ixazomib|ixazomib|mesh-list
57085856|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085857|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
57085858|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
57085859|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085860|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085861|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57085862|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
57085863|NCT01564537|Hormones|hormones|mesh-ancestor
57085864|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085865|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57085866|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085867|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
57085868|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57085869|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57085870|NCT01564537|Growth Substances|growth substances|mesh-ancestor
57085871|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
57085872|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
57085873|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085874|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085875|NCT02446457|Rituximab|rituximab|mesh-list
57085876|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57085877|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
57085878|NCT02446457|Lenalidomide|lenalidomide|mesh-list
57085879|NCT02446457|Antibodies|antibodies|mesh-list
57085880|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
57085881|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57085882|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
57085883|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085884|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085885|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085886|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57085887|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57085888|NCT02446457|Growth Substances|growth substances|mesh-ancestor
57085889|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
57085890|NCT03174236|Metronidazole|metronidazole|mesh-list
57085891|NCT03174236|Gentamicins|gentamicins|mesh-list
57085892|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
57085893|NCT03174236|Penicillins|penicillins|mesh-list
57085894|NCT03174236|Penicillin G|penicillin g|mesh-list
57085895|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
57085896|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
57085897|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57085898|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57085899|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57085900|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57085901|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57085902|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085903|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085904|NCT03172052|Streptokinase|streptokinase|mesh-list
57085905|NCT03172052|Mesna|mesna|mesh-list
57085906|NCT03172052|Protective Agents|protective agents|mesh-ancestor
57085907|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085908|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57085909|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57085910|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085911|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
57085912|NCT03171818|Hematinics|hematinics|mesh-ancestor
57085913|NCT05672459|Cyclophosphamide|cyclophosphamide|mesh-list
57085914|NCT05672459|Fludarabine|fludarabine|mesh-list
57085915|NCT05672459|Fludarabine phosphate|fludarabine phosphate|mesh-list
57085916|NCT05672459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085917|NCT05672459|Immunologic Factors|immunologic factors|mesh-ancestor
57085918|NCT05672459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085919|NCT05672459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085920|NCT05672459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57085921|NCT05672459|Alkylating Agents|alkylating agents|mesh-ancestor
57085922|NCT05672459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085923|NCT05672459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085924|NCT05672459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57085925|NCT05672459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57085926|NCT05672459|Antimetabolites|antimetabolites|mesh-ancestor
57085927|NCT02408354|Glycerol|glycerol|mesh-list
57085928|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57085929|NCT02408354|Protective Agents|protective agents|mesh-ancestor
57085930|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085931|NCT03176264|Bevacizumab|bevacizumab|mesh-list
57085932|NCT03176264|Spartalizumab|spartalizumab|mesh-list
57085933|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57085934|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085935|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57085936|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57085937|NCT03176264|Growth Substances|growth substances|mesh-ancestor
57085938|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085939|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
57085940|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57085941|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085942|NCT02406170|Paclitaxel|paclitaxel|mesh-list
57085943|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57085944|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085945|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
57085946|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
57085947|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
57085948|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085949|NCT02413658|Phenytoin|phenytoin|mesh-list
57085950|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
57085951|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57085952|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57085953|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57085954|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085955|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57085956|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57085957|NCT02406014|Diclofenac|diclofenac|mesh-list
57085958|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57085959|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57085960|NCT02406014|Analgesics|analgesics|mesh-ancestor
57085961|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
57085962|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57085963|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085964|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085965|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085966|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57085967|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085968|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085969|NCT02406092|Prednisone|prednisone|mesh-list
57085970|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
57085971|NCT02406092|Rituximab|rituximab|mesh-list
57085972|NCT02406092|Doxorubicin|doxorubicin|mesh-list
57085973|NCT02406092|Fludarabine|fludarabine|mesh-list
57085974|NCT02406092|Vincristine|vincristine|mesh-list
57085975|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57085976|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
57085977|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57085978|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57085979|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57085980|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
57085981|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57085982|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57085983|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57085984|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57085985|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57085986|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57085987|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57085988|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57085989|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57085990|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
57085991|NCT02406092|Hormones|hormones|mesh-ancestor
57085992|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57085993|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57085994|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57085995|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
57085996|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
57085997|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
57085998|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
57085999|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
57086000|NCT02405858|Prednisolone|prednisolone|mesh-list
57086001|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
57086002|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086003|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
57086004|NCT02405858|Hormones|hormones|mesh-ancestor
57086005|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086006|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086007|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57086008|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086009|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57086010|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086011|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086012|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
57086013|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57086014|NCT03171740|Midazolam|midazolam|mesh-list
57086015|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
57086016|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57086017|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57086018|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086019|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086020|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086021|NCT03171740|Analgesics|analgesics|mesh-ancestor
57086022|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
57086023|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086024|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57086025|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57086026|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57086027|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
57086028|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086029|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086030|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57086031|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57086032|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57086033|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57086034|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57086035|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
57086036|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
57086037|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
57086038|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
57086039|NCT03176186|Xenon|xenon|mesh-list
57086040|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57086041|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
57086042|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
57086043|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086044|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086045|NCT04482764|Valproic Acid|valproic acid|mesh-list
57086046|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
57086047|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086048|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086049|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
57086050|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086051|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086052|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
57086053|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57086054|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086055|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57086056|NCT02408042|Rituximab|rituximab|mesh-list
57086057|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
57086058|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57086059|NCT02408042|Carboplatin|carboplatin|mesh-list
57086060|NCT02408042|Etoposide|etoposide|mesh-list
57086061|NCT02408042|Ifosfamide|ifosfamide|mesh-list
57086062|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768015|NCT00567398|Icodextrin|icodextrin|mesh-list
57086063|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086064|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
57086065|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086066|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086067|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57086068|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57086069|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57086070|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086071|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086072|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57086073|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
57086074|NCT03172988|Dexamethasone|dexamethasone|mesh-list
57086075|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
57086076|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
57086077|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
57086078|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57086080|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086081|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
57086082|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
57086083|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086084|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086085|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57086086|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
57086087|NCT03172988|Hormones|hormones|mesh-ancestor
57086088|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086089|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57086090|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086091|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
57086092|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086093|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086094|NCT03172988|Analgesics|analgesics|mesh-ancestor
57086095|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
57086096|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57086097|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086098|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086099|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57086100|NCT03042611|Apatinib|apatinib|mesh-list
57086101|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086102|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57086103|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086104|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086105|NCT03171584|Itraconazole|itraconazole|mesh-list
57086106|NCT03171584|Fluconazole|fluconazole|mesh-list
57086107|NCT03171584|Terbinafine|terbinafine|mesh-list
57086108|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
57086109|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086110|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57086111|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57086112|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086113|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086114|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57086115|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
57086116|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086117|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086118|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57086119|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57086120|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57086121|NCT02950259|Indomethacin|indomethacin|mesh-list
57086122|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
57086123|NCT02950259|Omeprazole|omeprazole|mesh-list
57086124|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57086125|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
57086126|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086127|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086128|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57086129|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
57086130|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086131|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086132|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57086133|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57086134|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57086135|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57086136|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086137|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57086138|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086139|NCT02950259|Analgesics|analgesics|mesh-ancestor
57086140|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
57086141|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086142|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086143|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
57086144|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
57086145|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57086146|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57086147|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
57086148|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57086149|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
57086150|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57086151|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086152|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57086153|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57086154|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57086155|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
57086156|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57086157|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57086158|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
57086159|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086160|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086161|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086162|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
57086163|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086164|NCT02412566|SMOFlipid|smoflipid|mesh-list
57086165|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57086166|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57086167|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57086168|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
57086169|NCT02407340|Oxytocin|oxytocin|mesh-list
57086170|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
57086171|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57086172|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086173|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57086174|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086175|NCT02405156|Letrozole|letrozole|mesh-list
57086176|NCT02405156|Misoprostol|misoprostol|mesh-list
57086177|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086178|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57086179|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57086180|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086181|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086182|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57086183|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
57086184|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086185|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086186|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57086187|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
57086188|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57086189|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57086190|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57086191|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
57086192|NCT02411942|Adapalene|adapalene|mesh-list
57086193|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57086194|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086195|NCT02411942|Analgesics|analgesics|mesh-ancestor
57086196|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
57086197|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086198|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086199|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086200|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086201|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
57086202|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57086203|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57086204|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086205|NCT02406950|Incretins|incretins|mesh-ancestor
57086206|NCT02406950|Hormones|hormones|mesh-ancestor
57086207|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086208|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57086209|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
57086211|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086212|NCT02406872|Propofol|propofol|mesh-list
57086213|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57086214|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086215|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086216|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57086217|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
57086218|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
57086219|NCT03172676|Amoxicillin|amoxicillin|mesh-list
57086220|NCT03172676|Clarithromycin|clarithromycin|mesh-list
57086221|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57086222|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57086223|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086224|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57086225|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086226|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086227|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57086228|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57086229|NCT02404844|Tamoxifen|tamoxifen|mesh-list
57086230|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57086231|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
57086232|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086233|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086234|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57086235|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086236|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57086237|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57086238|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57086239|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
57086240|NCT04482296|Astringents|astringents|mesh-ancestor
57086241|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086242|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
57086243|NCT03116282|Ethanol|ethanol|mesh-list
57086244|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57086245|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086246|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086247|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086248|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
57086249|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57086250|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
57086251|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086252|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
57086253|NCT02404454|Protective Agents|protective agents|mesh-ancestor
57086254|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
57086255|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57086256|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086257|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
57086258|NCT02411786|Molgramostim|molgramostim|mesh-list
57086259|NCT02411786|Sargramostim|sargramostim|mesh-list
57086260|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
57086261|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086262|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086263|NCT02404376|Exenatide|exenatide|mesh-list
57086264|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57086265|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086266|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57086267|NCT02404376|Incretins|incretins|mesh-ancestor
57086268|NCT02404376|Hormones|hormones|mesh-ancestor
57086269|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086270|NCT04466085|Vaccines|vaccines|mesh-list
57086271|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
57086272|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086273|NCT03517995|Sulforaphane|sulforaphane|mesh-list
57086274|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57086275|NCT03517995|Protective Agents|protective agents|mesh-ancestor
57086276|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086277|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086278|NCT02411630|Tenofovir|tenofovir|mesh-list
57086279|NCT02411630|Emtricitabine|emtricitabine|mesh-list
57086280|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
57086281|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086282|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57086283|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57086284|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086285|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086286|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57086287|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57086289|NCT02411318|Caffeine|caffeine|mesh-list
57086290|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57086291|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086292|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57086293|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086294|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086295|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57086296|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57086297|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
57086298|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086299|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57086300|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086301|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086302|NCT03133299|Vitamin D|vitamin d|mesh-list
57086303|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
57086304|NCT03133299|Vitamins|vitamins|mesh-ancestor
57086305|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
57086306|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086307|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57086308|NCT03133299|Hormones|hormones|mesh-ancestor
57086309|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086310|NCT04465695|Interferons|interferons|mesh-list
57086311|NCT04465695|Interferon-beta|interferon-beta|mesh-list
57086312|NCT04465695|Clofazimine|clofazimine|mesh-list
57086313|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
57086314|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086315|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
57086316|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086317|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
57086318|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086319|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57086320|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086321|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
57086322|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57086323|NCT03115736|Tenofovir|tenofovir|mesh-list
57086324|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
57086325|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086326|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57086327|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57086328|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086329|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086330|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57086331|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57086332|NCT04465851|Curcumin|curcumin|mesh-list
57086333|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57086334|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086335|NCT04465851|Analgesics|analgesics|mesh-ancestor
57086336|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
57086337|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086338|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086339|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086340|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086341|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086342|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086343|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086344|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
57086345|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
57086346|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086347|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
57086348|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
57086349|NCT02404142|Atracurium|atracurium|mesh-list
57086350|NCT02404142|Curare|curare|mesh-list
57086351|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57086352|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57086353|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57086354|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086355|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086356|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57086357|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57086358|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
57086359|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086360|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086362|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57086363|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086364|NCT03171974|Dexamethasone|dexamethasone|mesh-list
57086365|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086366|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
57086367|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
57086368|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086369|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086370|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57086371|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
57086372|NCT03171974|Hormones|hormones|mesh-ancestor
57086373|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086374|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57086375|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086376|NCT02292069|Amlodipine|amlodipine|mesh-list
57086377|NCT02292069|Atorvastatin|atorvastatin|mesh-list
57086378|NCT02292069|Calcium|calcium|mesh-list
57086379|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57086380|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086381|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57086382|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57086383|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
57086384|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086385|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57086386|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57086387|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086388|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57086389|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57086390|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57086391|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
57086392|NCT02404064|Metronidazole|metronidazole|mesh-list
57086393|NCT02404064|Cefotaxime|cefotaxime|mesh-list
57086394|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086395|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57086396|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57086397|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57086398|NCT02294643|Aspirin|aspirin|mesh-list
57086399|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
57086400|NCT02294643|Clopidogrel|clopidogrel|mesh-list
57086401|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57086402|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086403|NCT02294643|Analgesics|analgesics|mesh-ancestor
57086404|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
57086405|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086406|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086407|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086408|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086409|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57086410|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57086411|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086412|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57086413|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57086414|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086415|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
57086416|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57086417|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57086418|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57086419|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
57086420|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086421|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57086422|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
57086423|NCT02410694|Thalidomide|thalidomide|mesh-list
57086424|NCT02410694|Dexamethasone|dexamethasone|mesh-list
57086425|NCT02410694|Ixazomib|ixazomib|mesh-list
57086426|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086427|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
57086428|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
57086429|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086430|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086431|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57086432|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
57086433|NCT02410694|Hormones|hormones|mesh-ancestor
57086434|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086435|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57086436|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086437|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57086438|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
57086439|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
57086440|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57086441|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086442|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57086443|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57086444|NCT02410694|Growth Substances|growth substances|mesh-ancestor
57086445|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
57086446|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
57086447|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086448|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086449|NCT03521895|Aflibercept|aflibercept|mesh-list
57086450|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57086451|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57086452|NCT03521895|Growth Substances|growth substances|mesh-ancestor
57086453|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086454|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
57086455|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086456|NCT02401880|Empagliflozin|empagliflozin|mesh-list
57086457|NCT02401880|Linagliptin|linagliptin|mesh-list
57086458|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57086459|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086460|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57086461|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086462|NCT02401880|Incretins|incretins|mesh-ancestor
57086463|NCT02401880|Hormones|hormones|mesh-ancestor
57086464|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086465|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57086466|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
57086467|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086468|NCT03170726|Ibuprofen|ibuprofen|mesh-list
57086469|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
57086470|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57086471|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086472|NCT03170726|Analgesics|analgesics|mesh-ancestor
57086473|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
57086474|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086475|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086476|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086477|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086478|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57086479|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086480|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086481|NCT02180867|Doxorubicin|doxorubicin|mesh-list
57086482|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57086483|NCT02180867|Daunorubicin|daunorubicin|mesh-list
57086484|NCT02180867|Ifosfamide|ifosfamide|mesh-list
57086485|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
57086486|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57086487|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086488|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57086489|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57086490|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086491|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086492|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57086493|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
57086494|NCT03175016|Irinotecan|irinotecan|mesh-list
57086495|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57086496|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57086497|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086498|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086499|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086500|NCT03174938|Flutemetamol|flutemetamol|mesh-list
57086501|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57086502|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086503|NCT03520257|Apatinib|apatinib|mesh-list
57086504|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086505|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57086506|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086507|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768462|NCT00566696|Rituximab|rituximab|mesh-list
57086508|NCT02292303|Zinc|zinc|mesh-list
57086509|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
57086510|NCT02292303|Trace Elements|trace elements|mesh-ancestor
57086511|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
57086512|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086513|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
57086514|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
57086515|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57086516|NCT02292303|Protective Agents|protective agents|mesh-ancestor
57086517|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57086518|NCT02581787|Antibodies|antibodies|mesh-list
57086519|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
57086520|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57086521|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
57086522|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
57086523|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086524|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086525|NCT02294955|Amiodarone|amiodarone|mesh-list
57086526|NCT02294955|Sotalol|sotalol|mesh-list
57086527|NCT02294955|Flecainide|flecainide|mesh-list
57086528|NCT02294955|Dronedarone|dronedarone|mesh-list
57086529|NCT02294955|Propafenone|propafenone|mesh-list
57086530|NCT02294955|Disopyramide|disopyramide|mesh-list
57086531|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57086532|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
57086533|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57086534|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57086535|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086536|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57086537|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57086538|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57086539|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086540|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57086541|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57086542|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57086543|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57086544|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57086545|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
57086546|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086547|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086548|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
57086549|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
57086550|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899311|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086551|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57086552|NCT02396888|Insulin|insulin|mesh-list
57086553|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57086554|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086555|NCT05413343|Ceftazidime|ceftazidime|mesh-list
57086556|NCT05413343|Avibactam|avibactam|mesh-list
57086557|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
57086558|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57086559|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086560|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57086561|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086562|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086563|NCT03517683|Methamphetamine|methamphetamine|mesh-list
57086564|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57086565|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086566|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
57086567|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
57086568|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086569|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
57086570|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086571|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086572|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
57086573|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57086574|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57086575|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57086576|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57086577|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
57086578|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57086579|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
57086580|NCT05442515|Fludarabine|fludarabine|mesh-list
57086581|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768538|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086582|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
57086583|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086584|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086585|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57086586|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
57086587|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086588|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086589|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57086590|NCT00801489|Cytarabine|cytarabine|mesh-list
57086591|NCT00801489|Fludarabine|fludarabine|mesh-list
57086592|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
57086593|NCT00801489|Decitabine|decitabine|mesh-list
57086594|NCT00801489|Idarubicin|idarubicin|mesh-list
57086595|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
57086596|NCT00801489|Calicheamicins|calicheamicins|mesh-list
57086597|NCT00801489|Lenograstim|lenograstim|mesh-list
57086598|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086599|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57086600|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
57086601|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086602|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57086603|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
57086604|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086605|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
57086606|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086607|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57086608|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086609|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57086610|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57086611|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57086612|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57086613|NCT02164643|Flutemetamol|flutemetamol|mesh-list
57086614|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57086615|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086616|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
57086617|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57086618|NCT02292459|Laxatives|laxatives|mesh-ancestor
57086619|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57086620|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57086621|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
57086622|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57086623|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57086624|NCT03170336|Amiloride|amiloride|mesh-list
57086625|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57086626|NCT03170336|Diuretics|diuretics|mesh-ancestor
57086627|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
57086628|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086629|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57086630|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57086631|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086632|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
57086633|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57086634|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
57086635|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57086636|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57086637|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57086638|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57086639|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086640|NCT00251433|Docetaxel|docetaxel|mesh-list
57086641|NCT00251433|Trastuzumab|trastuzumab|mesh-list
57086642|NCT00251433|Lapatinib|lapatinib|mesh-list
57086643|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086644|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
57086645|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
57086646|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
57086647|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086648|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57086649|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57086650|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086651|NCT02295189|Triamcinolone|triamcinolone|mesh-list
57086652|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57086653|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57086654|NCT02295189|Ketorolac|ketorolac|mesh-list
57086655|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57086656|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57086657|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086658|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
57086659|NCT02295189|Hormones|hormones|mesh-ancestor
57086660|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086662|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57086663|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
57086664|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086665|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086666|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57086667|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086668|NCT02295189|Analgesics|analgesics|mesh-ancestor
57086669|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
57086670|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086671|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086672|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57086673|NCT04055012|Metformin|metformin|mesh-list
57086674|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57086675|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086676|NCT03519633|Neostigmine|neostigmine|mesh-list
57086677|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57086678|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086679|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086680|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
57086681|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086682|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086683|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57086684|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
57086685|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086686|NCT02289027|Vaccines|vaccines|mesh-list
57086687|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
57086688|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086689|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
57086690|NCT02396030|Analgesics|analgesics|mesh-ancestor
57086691|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
57086692|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086693|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086694|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
57086695|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086696|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57086697|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
57086698|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57086699|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57086700|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086701|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57086702|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
57086703|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57086704|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
57086705|NCT02289261|Morphine|morphine|mesh-list
57086706|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57086707|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086708|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086709|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086710|NCT02289261|Analgesics|analgesics|mesh-ancestor
57086711|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
57086712|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086713|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57086714|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57086715|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57086716|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
57086717|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086718|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086719|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57086720|NCT02289261|Narcotics|narcotics|mesh-ancestor
57086721|NCT03168074|Lenvatinib|lenvatinib|mesh-list
57086722|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086723|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57086724|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086725|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086726|NCT02396108|Paclitaxel|paclitaxel|mesh-list
57086727|NCT02396108|Carboplatin|carboplatin|mesh-list
57086728|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57086729|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086730|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
57086731|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
57086732|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
57086733|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086735|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57086736|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57086737|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086738|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
57086739|NCT02403596|Coagulants|coagulants|mesh-ancestor
57086740|NCT02289495|Ritonavir|ritonavir|mesh-list
57086741|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
57086742|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57086743|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57086744|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
57086745|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086746|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086747|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57086748|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57086749|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
57086750|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086751|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57086752|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57086753|NCT01774721|Gefitinib|gefitinib|mesh-list
57086754|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086755|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57086756|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086757|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086758|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57086759|NCT02395952|Laxatives|laxatives|mesh-ancestor
57086760|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57086761|NCT03516903|Folic Acid|folic acid|mesh-list
57086762|NCT03516903|Methotrexate|methotrexate|mesh-list
57086763|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57086764|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
57086765|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57086766|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086767|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57086768|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
57086769|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086770|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086771|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
57086772|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086773|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57086774|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57086775|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
57086776|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086777|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57086778|NCT03516903|Hematinics|hematinics|mesh-ancestor
57086779|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
57086780|NCT03516903|Vitamins|vitamins|mesh-ancestor
57086781|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
57086782|NCT05504291|Carboplatin|carboplatin|mesh-list
57086783|NCT05504291|Etoposide|etoposide|mesh-list
57086784|NCT05504291|Vincristine|vincristine|mesh-list
57086785|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
57086786|NCT05504291|Melphalan|melphalan|mesh-list
57086787|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
57086788|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
57086789|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
57086790|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086791|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086792|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57086793|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57086794|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57086795|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086796|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086797|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
57086798|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
57086799|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
57086800|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57086801|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
57086802|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57086803|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57086804|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
57086805|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
57086806|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
57086807|NCT03516747|Hormones|hormones|mesh-list
57086808|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
57086809|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57086810|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086811|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57086812|NCT03516669|Amoxicillin|amoxicillin|mesh-list
57086813|NCT03516669|Clarithromycin|clarithromycin|mesh-list
57086814|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57086815|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086816|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57086817|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086818|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086819|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57086820|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57086821|NCT02289807|Cisplatin|cisplatin|mesh-list
57086822|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086823|NCT02298153|Atezolizumab|atezolizumab|mesh-list
57086824|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086825|NCT01275677|Paclitaxel|paclitaxel|mesh-list
57086826|NCT01275677|Docetaxel|docetaxel|mesh-list
57086827|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
57086828|NCT01275677|Doxorubicin|doxorubicin|mesh-list
57086829|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57086830|NCT01275677|Trastuzumab|trastuzumab|mesh-list
57086831|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57086832|NCT01275677|Daunorubicin|daunorubicin|mesh-list
57086833|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
57086834|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57086835|NCT01275677|Antibodies|antibodies|mesh-list
57086836|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
57086837|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57086838|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57086839|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086840|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
57086841|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
57086842|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
57086843|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086844|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57086845|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
57086846|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086847|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086848|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57086849|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
57086850|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57086851|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57086852|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57086853|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57086854|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086855|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57086856|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
57086857|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086858|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
57086859|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57086860|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086861|NCT02296047|Bromides|bromides|mesh-list
57086862|NCT02296047|Albuterol|albuterol|mesh-list
57086863|NCT02296047|Ipratropium|ipratropium|mesh-list
57086864|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
57086865|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57086866|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
57086867|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086868|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086869|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57086870|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
57086871|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
57086872|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57086873|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57086874|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57086875|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57086876|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
57086877|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086878|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086879|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57086880|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
57086881|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
57086882|NCT02293785|Oxycodone|oxycodone|mesh-list
57086883|NCT02293785|Naloxone|naloxone|mesh-list
57086884|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57086885|NCT02293785|Narcotics|narcotics|mesh-ancestor
57086886|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086887|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086888|NCT02293785|Analgesics|analgesics|mesh-ancestor
57086889|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
57086890|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086891|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57086892|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
57086893|NCT01162109|Astringents|astringents|mesh-ancestor
57086894|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086895|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
57086896|NCT02296203|Irinotecan|irinotecan|mesh-list
57086897|NCT02296203|Cetuximab|cetuximab|mesh-list
57086898|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57086899|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57086900|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086901|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086902|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086903|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57086904|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
57086905|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57086906|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086907|NCT02296281|Pirfenidone|pirfenidone|mesh-list
57086908|NCT02296281|Analgesics|analgesics|mesh-ancestor
57086909|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
57086910|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086911|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086912|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57086913|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57086914|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57086915|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086916|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086917|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57086918|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57086919|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57086920|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
57086921|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086922|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57086923|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57086924|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086925|NCT03513549|Loxapine|loxapine|mesh-list
57086926|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57086927|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57086928|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57086929|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086930|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57086931|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57086932|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
57086933|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086934|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086935|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57086936|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57086937|NCT03513393|Velpatasvir|velpatasvir|mesh-list
57086938|NCT03513393|Omeprazole|omeprazole|mesh-list
57086939|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57086940|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57086941|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57086942|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57086943|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086944|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
57086945|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57086946|NCT02299401|Misoprostol|misoprostol|mesh-list
57086947|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57086948|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
57086949|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57086950|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086951|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57086952|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57086953|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
57086954|NCT02699450|Ranibizumab|ranibizumab|mesh-list
57086955|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57086956|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57086957|NCT02699450|Growth Substances|growth substances|mesh-ancestor
57086958|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086959|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
57086960|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086962|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
57086963|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57086964|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57086965|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
57086966|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57086967|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086968|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086969|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
57086970|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
57086971|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57086972|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
57086973|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57086974|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
57086975|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57086976|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
57086977|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57086978|NCT02299557|Protective Agents|protective agents|mesh-ancestor
57086979|NCT02302989|Ranibizumab|ranibizumab|mesh-list
57086980|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57086981|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57086982|NCT02302989|Growth Substances|growth substances|mesh-ancestor
57086983|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086984|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
57086985|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57086986|NCT02296671|Leucovorin|leucovorin|mesh-list
57086987|NCT02296671|Fluorouracil|fluorouracil|mesh-list
57086988|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
57086989|NCT02296671|Pemetrexed|pemetrexed|mesh-list
57086990|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
57086991|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57086992|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57086993|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311016|NCT00071968|Sirolimus|sirolimus|mesh-list
57086994|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57086995|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
57086996|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57086997|NCT02296671|Antidotes|antidotes|mesh-ancestor
57086998|NCT02296671|Protective Agents|protective agents|mesh-ancestor
57086999|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
57087000|NCT02296671|Vitamins|vitamins|mesh-ancestor
57087001|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
57087002|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087003|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57087004|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57087005|NCT02296749|Sirolimus|sirolimus|mesh-list
57087006|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57087007|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087008|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57087009|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087010|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
57087011|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57087012|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
57087013|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087014|NCT04481750|Edaravone|edaravone|mesh-list
57087015|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57087016|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
57087017|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087018|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57087019|NCT04481750|Protective Agents|protective agents|mesh-ancestor
57087020|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087021|NCT02303223|Propofol|propofol|mesh-list
57087022|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57087023|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087024|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087025|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57087026|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
57087027|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
57087028|NCT03168698|Oxytocin|oxytocin|mesh-list
57087029|NCT03168698|Carbetocin|carbetocin|mesh-list
57087030|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
57087031|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087032|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087033|NCT04464135|Acetic Acid|acetic acid|mesh-list
56768985|NCT00697073|Idebenone|idebenone|mesh-list
57087034|NCT04464135|Retinol acetate|retinol acetate|mesh-list
57087035|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57087036|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087037|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57087038|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
57087039|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087040|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57087041|NCT04464135|Protective Agents|protective agents|mesh-ancestor
57087042|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087043|NCT03510351|Tazobactam|tazobactam|mesh-list
57087044|NCT03510351|Ceftolozane|ceftolozane|mesh-list
57087045|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
57087046|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57087047|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087048|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57087049|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087050|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087051|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57087052|NCT03510351|Renal Agents|renal agents|mesh-ancestor
57087053|NCT02403284|Liraglutide|liraglutide|mesh-list
57087054|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57087055|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087056|NCT02403284|Incretins|incretins|mesh-ancestor
57087057|NCT02403284|Hormones|hormones|mesh-ancestor
57087058|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087059|NCT02400866|Olanzapine|olanzapine|mesh-list
57087060|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
57087061|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
57087062|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087063|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087064|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57087065|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57087066|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57087067|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087068|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57087069|NCT02400866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57087070|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57087071|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57087072|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087073|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087074|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
57087075|NCT02400788|Sorafenib|sorafenib|mesh-list
57087076|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087077|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57087078|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087079|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087080|NCT02403128|Aflibercept|aflibercept|mesh-list
57087081|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57087082|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57087083|NCT02403128|Growth Substances|growth substances|mesh-ancestor
57087084|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087085|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
57087086|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087087|NCT02297217|Paclitaxel|paclitaxel|mesh-list
57087088|NCT02297217|Carboplatin|carboplatin|mesh-list
57087089|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57087090|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087091|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
57087092|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
57087093|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
57087094|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087095|NCT03515577|Edetic Acid|edetic acid|mesh-list
57087096|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57087097|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
57087098|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
57087099|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087100|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
57087101|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57087102|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57087103|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
57087104|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57087105|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087106|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087107|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57087108|NCT02300649|Analgesics|analgesics|mesh-ancestor
57087109|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
57087110|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087111|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57087112|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57087113|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57087114|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
57087115|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087116|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087117|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57087118|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57087119|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
57087120|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087121|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087122|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57087123|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57087124|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57087125|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087126|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57087127|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087128|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087129|NCT02303769|Tamsulosin|tamsulosin|mesh-list
57087130|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57087131|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57087132|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57087133|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
57087134|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087135|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087136|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087137|NCT02303769|Urological Agents|urological agents|mesh-ancestor
57087138|NCT02303847|Ketamine|ketamine|mesh-list
57087139|NCT02303847|Analgesics|analgesics|mesh-ancestor
57087140|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
57087141|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087142|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087143|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57087144|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57087145|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
57087146|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
57087147|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087148|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57087149|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57087150|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087151|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087152|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57087153|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
57087154|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57087155|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57087156|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57087157|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087158|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087159|NCT03511833|Ketamine|ketamine|mesh-list
57087160|NCT03511833|Morphine|morphine|mesh-list
57087161|NCT03511833|Analgesics|analgesics|mesh-ancestor
57087162|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
57087163|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087164|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087165|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57087166|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57087167|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
57087168|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
57087169|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087170|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57087171|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57087172|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087173|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087174|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57087175|NCT03511833|Narcotics|narcotics|mesh-ancestor
57087176|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
57087177|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087178|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087179|NCT02696798|Ixekizumab|ixekizumab|mesh-list
57087180|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
57087181|NCT02304081|Saxagliptin|saxagliptin|mesh-list
57087182|NCT02304081|Incretins|incretins|mesh-ancestor
57087183|NCT02304081|Hormones|hormones|mesh-ancestor
57087184|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087185|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087186|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57087187|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
57087188|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087189|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087190|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57087191|NCT02304237|Progesterone|progesterone|mesh-list
57087192|NCT02304237|Progestins|progestins|mesh-ancestor
57087193|NCT02304237|Hormones|hormones|mesh-ancestor
57087194|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087195|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087196|NCT03515187|Bromides|bromides|mesh-list
57087197|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57087198|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57087199|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
57087200|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
57087201|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57087202|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
57087203|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087204|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
57087205|NCT03515187|Protective Agents|protective agents|mesh-ancestor
57087206|NCT04931342|Maytansine|maytansine|mesh-list
57087207|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
57087208|NCT04931342|Bevacizumab|bevacizumab|mesh-list
57087209|NCT04931342|Trastuzumab|trastuzumab|mesh-list
57087210|NCT04931342|Atezolizumab|atezolizumab|mesh-list
57087211|NCT04931342|Letrozole|letrozole|mesh-list
57087212|NCT04931342|Olaparib|olaparib|mesh-list
57087213|NCT04931342|Palbociclib|palbociclib|mesh-list
57087214|NCT04931342|Hormones|hormones|mesh-list
56899324|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57087215|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
57087216|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57087217|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087218|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
57087219|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
57087220|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
57087221|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087222|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087223|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57087224|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57087225|NCT04931342|Growth Substances|growth substances|mesh-ancestor
57087226|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087227|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
57087228|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087229|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57087230|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57087231|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087232|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57087233|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
57087234|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57087235|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57087236|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
57087237|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57087238|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087239|NCT02395016|Gemcitabine|gemcitabine|mesh-list
57087240|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
57087241|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57087242|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
57087243|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087244|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087245|NCT02395016|Antiviral Agents|antiviral agents|mesh-ancestor
57087246|NCT02395016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087247|NCT02395016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087248|NCT02395016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57087249|NCT02395016|Immunologic Factors|immunologic factors|mesh-ancestor
57087250|NCT02395016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087251|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087252|NCT04480268|Gemcitabine|gemcitabine|mesh-list
57087253|NCT04480268|Paclitaxel|paclitaxel|mesh-list
57087254|NCT04480268|Capecitabine|capecitabine|mesh-list
57087255|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57087256|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087257|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
57087258|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
57087259|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
57087260|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087261|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57087262|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
57087263|NCT04480268|Antiviral Agents|antiviral agents|mesh-ancestor
57087264|NCT04480268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087265|NCT04480268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087266|NCT04480268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57087267|NCT04480268|Immunologic Factors|immunologic factors|mesh-ancestor
57087268|NCT04480268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087269|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57087270|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
57087271|NCT03510975|Coagulants|coagulants|mesh-ancestor
57087272|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57087273|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
57087274|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087275|NCT03169790|Leucovorin|leucovorin|mesh-list
57087276|NCT03169790|Paclitaxel|paclitaxel|mesh-list
57087277|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
57087278|NCT03169790|Bevacizumab|bevacizumab|mesh-list
57087279|NCT03169790|Rituximab|rituximab|mesh-list
57087280|NCT03169790|Fluorouracil|fluorouracil|mesh-list
57087281|NCT03169790|Capecitabine|capecitabine|mesh-list
57087282|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
57087283|NCT03169790|Avelumab|avelumab|mesh-list
57087284|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57087285|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087286|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
57087287|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
57087288|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311302|NCT00072943|Antibodies|antibodies|mesh-list
57087289|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087290|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57087291|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
57087292|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087293|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57087294|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57087295|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
57087296|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57087297|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087298|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57087299|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57087300|NCT03169790|Growth Substances|growth substances|mesh-ancestor
57087301|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
57087302|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
57087303|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57087304|NCT03169790|Antidotes|antidotes|mesh-ancestor
57087305|NCT03169790|Protective Agents|protective agents|mesh-ancestor
57087306|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
57087307|NCT03169790|Vitamins|vitamins|mesh-ancestor
57087308|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
57087309|NCT02304393|Atezolizumab|atezolizumab|mesh-list
57087310|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087311|NCT02402972|Leucovorin|leucovorin|mesh-list
57087312|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
57087313|NCT02402972|Floxuridine|floxuridine|mesh-list
57087314|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
57087315|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087316|NCT02402972|Antidotes|antidotes|mesh-ancestor
57087317|NCT02402972|Protective Agents|protective agents|mesh-ancestor
57087318|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087319|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
57087320|NCT02402972|Vitamins|vitamins|mesh-ancestor
57087321|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
57087322|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57087323|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
57087324|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087325|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
57087326|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087327|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57087328|NCT02394470|Protective Agents|protective agents|mesh-ancestor
57087329|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087330|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57087331|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57087332|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57087333|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57087334|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57087335|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57087336|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57087337|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
57087338|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087339|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087340|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087341|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57087342|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57087343|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
57087344|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57087345|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087346|NCT02304627|Insulin|insulin|mesh-list
57087347|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57087348|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087349|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
57087350|NCT02394158|Metformin|metformin|mesh-list
57087351|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57087352|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087353|NCT03508635|Prednisone|prednisone|mesh-list
57087354|NCT03508635|Cortisone|cortisone|mesh-list
57087355|NCT03508635|Mifepristone|mifepristone|mesh-list
57087356|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57087357|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
57087358|NCT03508635|Hormones|hormones|mesh-ancestor
57087359|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087360|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087361|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57087362|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899329|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
57087363|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57087364|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
57087365|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087366|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57087367|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57087368|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57087369|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
57087370|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57087371|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57087372|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
57087373|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
57087374|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57087375|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57087376|NCT04481282|Terbutaline|terbutaline|mesh-list
57087377|NCT04481282|Danazol|danazol|mesh-list
57087378|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57087379|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
57087380|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087381|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087382|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57087383|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
57087384|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
57087385|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
57087386|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087387|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57087388|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57087389|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57087390|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
57087391|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087392|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087393|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57087394|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
57087395|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087396|NCT02541604|Atezolizumab|atezolizumab|mesh-list
57087397|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087398|NCT02393846|Ketoprofen|ketoprofen|mesh-list
57087399|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57087400|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57087401|NCT02393846|Analgesics|analgesics|mesh-ancestor
57087402|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
57087403|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087404|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087405|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57087406|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57087407|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57087408|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087409|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087410|NCT02302209|Oxytocin|oxytocin|mesh-list
57087411|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
57087412|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087413|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087414|NCT02394002|Propofol|propofol|mesh-list
57087415|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57087416|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087417|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087419|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
57087420|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
57087421|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57087422|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57087423|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57087424|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
57087425|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087426|NCT02402348|Metformin|metformin|mesh-list
57087427|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57087428|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087429|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57087430|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
57087431|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
57087432|NCT02399462|Hormones|hormones|mesh-ancestor
57087433|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899330|NCT01196715|Hematinics|hematinics|mesh-ancestor
57087434|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087435|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087436|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087437|NCT02305173|Dexamethasone|dexamethasone|mesh-list
57087438|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57087439|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
57087440|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
57087441|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087442|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087443|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57087444|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
57087445|NCT02305173|Hormones|hormones|mesh-ancestor
57087446|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087447|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57087448|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087449|NCT03505047|Copper|copper|mesh-list
57087450|NCT03505047|Trace Elements|trace elements|mesh-ancestor
57087451|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
57087452|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087453|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
57087454|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57087455|NCT02305485|Everolimus|everolimus|mesh-list
57087456|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087457|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57087458|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
57087459|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087460|NCT02311569|Mirabegron|mirabegron|mesh-list
57087461|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57087462|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57087463|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57087464|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
57087465|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087466|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087467|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087468|NCT02311569|Urological Agents|urological agents|mesh-ancestor
57087469|NCT02393456|Oxytocin|oxytocin|mesh-list
57087470|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
57087471|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087472|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087473|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
57087474|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57087475|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57087476|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087477|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57087478|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57087479|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
57087480|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087481|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087482|NCT02306733|Oxytocin|oxytocin|mesh-list
57087483|NCT02306733|Ergonovine|ergonovine|mesh-list
57087484|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
57087485|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087486|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087487|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57087488|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
57087489|NCT03507465|Capecitabine|capecitabine|mesh-list
57087490|NCT03507465|Letrozole|letrozole|mesh-list
57087491|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57087492|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
57087493|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087494|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087495|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57087496|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57087497|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087498|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57087499|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
57087500|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087501|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087502|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
57087503|NCT05476042|Hematinics|hematinics|mesh-ancestor
57087504|NCT03507387|Phenylephrine|phenylephrine|mesh-list
57087505|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
57087506|NCT03507387|Bupivacaine|bupivacaine|mesh-list
56899333|NCT01189773|Ibuprofen|ibuprofen|mesh-list
57087507|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
57087508|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
57087509|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087510|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087511|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
57087512|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087513|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57087514|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
57087515|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
57087516|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
57087517|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57087518|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
57087519|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
57087520|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57087521|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57087522|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57087523|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
57087524|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087525|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087526|NCT03507387|Protective Agents|protective agents|mesh-ancestor
57087527|NCT05454358|Letrozole|letrozole|mesh-list
57087528|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087529|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57087530|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57087531|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087532|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087533|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57087534|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
57087535|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087536|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087537|NCT02694536|Gemcitabine|gemcitabine|mesh-list
57087538|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57087539|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57087540|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
57087541|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087542|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087543|NCT02694536|Antiviral Agents|antiviral agents|mesh-ancestor
57087544|NCT02694536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087545|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087546|NCT02694536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57087547|NCT02694536|Immunologic Factors|immunologic factors|mesh-ancestor
57087548|NCT02694536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087549|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57087550|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
57087551|NCT02312037|Antibodies|antibodies|mesh-list
57087552|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
57087553|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
57087554|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087555|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087556|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087557|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
57087558|NCT03167918|Metformin|metformin|mesh-list
57087559|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
57087560|NCT03167918|Calcium|calcium|mesh-list
57087561|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57087562|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087563|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57087564|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57087565|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
57087566|NCT03167918|Coagulants|coagulants|mesh-ancestor
57087568|NCT05745818|Gout Suppressants|gout suppressants|mesh-ancestor
57087569|NCT05745818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57087570|NCT05745818|Tubulin Modulators|tubulin modulators|mesh-ancestor
57087571|NCT05745818|Antimitotic Agents|antimitotic agents|mesh-ancestor
57087572|NCT05745818|Mitosis Modulators|mitosis modulators|mesh-ancestor
57087573|NCT05745818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087574|NCT05745818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087575|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
57087576|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57087577|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57087578|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087579|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
57087580|NCT02393300|Coagulants|coagulants|mesh-ancestor
57087581|NCT03106610|Nivolumab|nivolumab|mesh-list
57087582|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087583|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087584|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57087585|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087586|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57087587|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57087588|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087589|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
57087590|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57087591|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57087592|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
57087593|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087594|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57087595|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57087596|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57087597|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57087598|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57087599|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087600|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57087601|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087602|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
57087603|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
57087604|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
57087605|NCT02312115|Furosemide|furosemide|mesh-list
57087606|NCT02312115|Diuretics|diuretics|mesh-ancestor
57087607|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
57087608|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087609|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57087610|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57087611|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087612|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57087613|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57087614|NCT03026140|Celecoxib|celecoxib|mesh-list
57087615|NCT03026140|Nivolumab|nivolumab|mesh-list
57087616|NCT03026140|Ipilimumab|ipilimumab|mesh-list
57087617|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087618|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087619|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57087620|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087621|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57087622|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57087623|NCT03026140|Analgesics|analgesics|mesh-ancestor
57087624|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
57087625|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087626|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087627|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57087628|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57087629|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57087630|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57087631|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087632|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
57087633|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
57087634|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57087635|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
57087636|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57087637|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57087638|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
57087639|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
57087640|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087641|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087642|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57087643|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
57087644|NCT02398994|Hormones|hormones|mesh-ancestor
57087645|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087646|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57087647|NCT02398994|Protective Agents|protective agents|mesh-ancestor
57087648|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
57087649|NCT02306889|Fenofibrate|fenofibrate|mesh-list
57087650|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57087651|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
57087652|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087653|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57087654|NCT02393144|Meperidine|meperidine|mesh-list
57087655|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
57087656|NCT02393144|Analgesics|analgesics|mesh-list
57087657|NCT02393144|Oxytocin|oxytocin|mesh-list
57087658|NCT02393144|Dinoprostone|dinoprostone|mesh-list
57087659|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
57087660|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087661|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087662|NCT02393144|Narcotics|narcotics|mesh-ancestor
57087663|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087664|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
57087665|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087666|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57087667|NCT02306031|Diclofenac|diclofenac|mesh-list
57087668|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
57087669|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57087670|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57087671|NCT02306031|Analgesics|analgesics|mesh-ancestor
57087672|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
57087673|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087674|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087675|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57087676|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57087677|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57087678|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087679|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087680|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57087681|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57087682|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57087683|NCT02392910|Hematinics|hematinics|mesh-ancestor
57087684|NCT02307045|Nicotine|nicotine|mesh-list
57087685|NCT02307045|Varenicline|varenicline|mesh-list
57087686|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57087687|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
57087688|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087689|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087690|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57087691|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57087692|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
57087693|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087694|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087695|NCT03167372|Imidacloprid|imidacloprid|mesh-list
57087696|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
57087697|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087698|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087699|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087700|NCT03504345|Progesterone|progesterone|mesh-list
57087701|NCT03504345|Progestins|progestins|mesh-ancestor
57087702|NCT03504345|Hormones|hormones|mesh-ancestor
57087703|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087704|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087705|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
57087706|NCT02307201|Analgesics|analgesics|mesh-ancestor
57087707|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
57087708|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087709|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087710|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
57087711|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087712|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57087713|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
57087714|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57087715|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57087716|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087717|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57087718|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
57087719|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087720|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
57087721|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57087722|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087723|NCT03167216|Cetirizine|cetirizine|mesh-list
57087724|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
57087725|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57087726|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57087727|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57087728|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
57087729|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
57087730|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087731|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087732|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087733|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
57087734|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
57087735|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57087736|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57087737|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
57087738|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
57087739|NCT02393066|Propofol|propofol|mesh-list
57087740|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57087741|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087742|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087743|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57087744|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
57087745|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
57087746|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57087747|NCT02393066|Analgesics|analgesics|mesh-ancestor
57087748|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
57087749|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087750|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57087751|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57087752|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57087753|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
57087754|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087755|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087756|NCT02398838|Misoprostol|misoprostol|mesh-list
57087757|NCT02398838|Mifepristone|mifepristone|mesh-list
57087758|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57087759|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
57087760|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087761|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087762|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57087763|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57087764|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
57087765|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57087766|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57087767|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57087768|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57087769|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
57087770|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57087771|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57087772|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
57087773|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087774|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
57087775|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57087776|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57087777|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
57087778|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
57087779|NCT02398682|Protective Agents|protective agents|mesh-ancestor
57087780|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087781|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57087782|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
57087783|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087784|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087785|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57087786|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087787|NCT03504033|Desflurane|desflurane|mesh-list
57087788|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57087789|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
57087790|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
57087791|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087792|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087793|NCT03132519|Remifentanil|remifentanil|mesh-list
57087794|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57087795|NCT03132519|Narcotics|narcotics|mesh-ancestor
57087796|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087797|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087798|NCT03132519|Analgesics|analgesics|mesh-ancestor
57087799|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
57087800|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087801|NCT02398448|Allopurinol|allopurinol|mesh-list
57087802|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
57087803|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087804|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087805|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
57087806|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57087807|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57087808|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
57087809|NCT02398448|Protective Agents|protective agents|mesh-ancestor
57087810|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087811|NCT02392520|Cetrorelix|cetrorelix|mesh-list
57087812|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57087813|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
57087814|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57087815|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087816|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
57087817|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087818|NCT02316249|Estradiol|estradiol|mesh-list
57087819|NCT02316249|Hormones|hormones|mesh-ancestor
57087820|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087821|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087822|NCT02316249|Estrogens|estrogens|mesh-ancestor
57087823|NCT02696096|Buprenorphine|buprenorphine|mesh-list
57087824|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
57087825|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57087826|NCT02696096|Narcotics|narcotics|mesh-ancestor
57087827|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087828|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087829|NCT02696096|Analgesics|analgesics|mesh-ancestor
57087830|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
57087831|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087832|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57087833|NCT02316327|Gemcitabine|gemcitabine|mesh-list
57087834|NCT02316327|Bevacizumab|bevacizumab|mesh-list
57087835|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087836|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087837|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57087838|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57087839|NCT02316327|Growth Substances|growth substances|mesh-ancestor
57087840|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087841|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
57087842|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57087843|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
57087844|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087845|NCT02316327|Antiviral Agents|antiviral agents|mesh-ancestor
57087846|NCT02316327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087847|NCT02316327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087848|NCT02316327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57087849|NCT02316327|Immunologic Factors|immunologic factors|mesh-ancestor
57087850|NCT02695628|Misonidazole|misonidazole|mesh-list
57087851|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087852|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57087853|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57087854|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57087855|NCT02392364|Aflibercept|aflibercept|mesh-list
57087856|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57087857|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57087858|NCT02392364|Growth Substances|growth substances|mesh-ancestor
57087859|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087860|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
57087861|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087862|NCT02392676|Olaparib|olaparib|mesh-list
57087863|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57087864|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087865|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087866|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087867|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57087868|NCT03106298|Hematinics|hematinics|mesh-ancestor
57087869|NCT02307591|Amiodarone|amiodarone|mesh-list
57087870|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57087871|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
57087872|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57087873|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56899340|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087874|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087875|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57087876|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57087877|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57087878|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087879|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57087880|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57087881|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57087882|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
57087883|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087884|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087885|NCT02398136|Midazolam|midazolam|mesh-list
57087886|NCT02398136|Ketamine|ketamine|mesh-list
57087887|NCT02398136|Analgesics|analgesics|mesh-ancestor
57087888|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
57087889|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57087890|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087891|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57087892|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57087893|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
57087894|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
57087895|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57087896|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57087897|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57087898|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087899|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087900|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57087901|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57087902|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57087903|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57087904|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57087905|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
57087906|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
57087907|NCT05745584|Mirabegron|mirabegron|mesh-list
57087908|NCT05745584|Cholinergic Antagonists|cholinergic antagonists|mesh-list
57087909|NCT05745584|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57087910|NCT05745584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57087911|NCT05745584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57087912|NCT05745584|Adrenergic Agents|adrenergic agents|mesh-ancestor
57087913|NCT05745584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57087914|NCT05745584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087915|NCT05745584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087916|NCT05745584|Urological Agents|urological agents|mesh-ancestor
57087917|NCT05745584|Cholinergic Agents|cholinergic agents|mesh-ancestor
57087918|NCT02312661|Metformin|metformin|mesh-list
57087919|NCT02312661|Paclitaxel|paclitaxel|mesh-list
57087920|NCT02312661|Carboplatin|carboplatin|mesh-list
57087921|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57087922|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087923|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
57087924|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
57087925|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
57087926|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087927|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57087928|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087929|NCT02398058|Olaparib|olaparib|mesh-list
57087930|NCT02398058|Trabectedin|trabectedin|mesh-list
57087931|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57087932|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087933|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087934|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087935|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57087936|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
57087937|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
57087938|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087939|NCT05745350|Pembrolizumab|pembrolizumab|mesh-list
57087940|NCT05745350|Etoposide|etoposide|mesh-list
57087941|NCT05745350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57087942|NCT05745350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087943|NCT05745350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57087944|NCT05745350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57087945|NCT05745350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57087946|NCT05745350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087947|NCT05745350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087948|NCT03506919|Allopurinol|allopurinol|mesh-list
57087949|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
57087950|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087951|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087952|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
57087953|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57087954|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57087955|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
57087956|NCT03506919|Protective Agents|protective agents|mesh-ancestor
57087957|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087958|NCT02545504|Leucovorin|leucovorin|mesh-list
57087959|NCT02545504|Fluorouracil|fluorouracil|mesh-list
57087960|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
57087961|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
57087962|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087963|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57087964|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087965|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57087966|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
57087967|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087968|NCT02545504|Antidotes|antidotes|mesh-ancestor
57087969|NCT02545504|Protective Agents|protective agents|mesh-ancestor
57087970|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
57087971|NCT02545504|Vitamins|vitamins|mesh-ancestor
57087972|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
57087973|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
57087974|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57087975|NCT03506841|Protective Agents|protective agents|mesh-ancestor
57087976|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087977|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
57087978|NCT02397512|Lactulose|lactulose|mesh-list
57087979|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57087980|NCT02313051|Everolimus|everolimus|mesh-list
57087981|NCT02313051|Letrozole|letrozole|mesh-list
57087982|NCT02313051|Goserelin|goserelin|mesh-list
57087983|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57087984|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57087985|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
57087986|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57087987|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57087988|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57087989|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57087990|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57087991|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57087992|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
57087993|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57087994|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57087995|NCT02397590|Atorvastatin|atorvastatin|mesh-list
57087996|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57087997|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57087998|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
57087999|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088000|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57088001|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57088002|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088003|NCT02397356|Ketamine|ketamine|mesh-list
57088004|NCT02397356|Analgesics|analgesics|mesh-ancestor
57088005|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
57088006|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088007|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088008|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57088009|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57088010|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
57088011|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
57088012|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088013|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57088014|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57088015|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088016|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088017|NCT02307825|Azithromycin|azithromycin|mesh-list
57088018|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57088019|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088020|NCT02540668|Warfarin|warfarin|mesh-list
57088021|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
57088022|NCT03506763|Diclofenac|diclofenac|mesh-list
57088023|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57088024|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57088025|NCT03506763|Analgesics|analgesics|mesh-ancestor
57088026|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
57088027|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088028|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088029|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088030|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57088031|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57088032|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088033|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088034|NCT02441439|Iron|iron|mesh-list
57088035|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
57088036|NCT02441439|Trace Elements|trace elements|mesh-ancestor
57088037|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
57088038|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088039|NCT02441439|Hematinics|hematinics|mesh-ancestor
57088040|NCT02308137|Domperidone|domperidone|mesh-list
57088041|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088042|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
57088043|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
57088044|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088045|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088046|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57088047|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57088048|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
57088049|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088050|NCT03501459|Rituximab|rituximab|mesh-list
57088051|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088052|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088053|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
57088054|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088055|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57088056|NCT02317263|Testosterone|testosterone|mesh-list
57088057|NCT02317263|Androgens|androgens|mesh-ancestor
57088058|NCT02317263|Hormones|hormones|mesh-ancestor
57088059|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088060|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088061|NCT02317341|Midazolam|midazolam|mesh-list
57088062|NCT02317341|Ketamine|ketamine|mesh-list
57088063|NCT02317341|Analgesics|analgesics|mesh-ancestor
57088064|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
57088065|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088066|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088067|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57088068|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57088069|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
57088070|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
57088071|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088072|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57088073|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57088074|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088075|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088076|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57088077|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57088078|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57088079|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57088080|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57088081|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
57088082|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
57088083|NCT02339740|Vitamins|vitamins|mesh-list
57088084|NCT02339740|Vitamin A|vitamin a|mesh-list
57088085|NCT02339740|Cytarabine|cytarabine|mesh-list
57088086|NCT02339740|Dexamethasone|dexamethasone|mesh-list
57088087|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
57088088|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
57088089|NCT02339740|Idarubicin|idarubicin|mesh-list
57088090|NCT02339740|Tretinoin|tretinoin|mesh-list
57088091|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
57088092|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
57088093|NCT02339740|BB 1101|bb 1101|mesh-list
57088094|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
57088095|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088096|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088097|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
57088098|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
57088099|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088100|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57088101|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
57088102|NCT02339740|Hormones|hormones|mesh-ancestor
57088103|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088104|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088105|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088106|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
57088107|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088108|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088109|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57088110|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
57088111|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
57088112|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088113|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57088114|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
57088115|NCT02339740|Analgesics|analgesics|mesh-ancestor
57088116|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
57088117|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57088118|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57088119|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57088120|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
57088121|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
57088122|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
57088123|NCT02339740|Protective Agents|protective agents|mesh-ancestor
57088124|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57088125|NCT02317419|Gemcitabine|gemcitabine|mesh-list
57088126|NCT02317419|Paclitaxel|paclitaxel|mesh-list
57088127|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57088128|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088129|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
57088130|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
57088131|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
57088132|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088133|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57088134|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
57088135|NCT02317419|Antiviral Agents|antiviral agents|mesh-ancestor
57088136|NCT02317419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088137|NCT02317419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088138|NCT02317419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57088139|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
57088140|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088141|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
57088142|NCT02957968|Paclitaxel|paclitaxel|mesh-list
57088143|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
57088144|NCT02957968|Carboplatin|carboplatin|mesh-list
57088145|NCT02957968|Doxorubicin|doxorubicin|mesh-list
57088146|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
57088147|NCT02957968|Decitabine|decitabine|mesh-list
57088148|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57088149|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088150|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
57088151|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
57088152|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
57088153|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088154|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57088155|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
57088156|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088157|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57088158|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57088159|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
57088160|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57088161|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57088162|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57088163|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57088164|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088165|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088166|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57088167|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
57088168|NCT05452174|Mirtazapine|mirtazapine|mesh-list
57088169|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
57088170|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57088171|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57088172|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
57088173|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
57088174|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088175|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088176|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088177|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57088178|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57088179|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088180|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57088181|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57088182|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57088183|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
57088184|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57088185|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57088186|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
57088187|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57088189|NCT03943888|Neostigmine|neostigmine|mesh-list
57088190|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57088191|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57088192|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57088193|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
57088194|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088195|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088196|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57088197|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
57088198|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
57088199|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
57088200|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57088201|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57088202|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
57088203|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088204|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088205|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57088206|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088207|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57088208|NCT00433511|Paclitaxel|paclitaxel|mesh-list
57088209|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
57088210|NCT00433511|Bevacizumab|bevacizumab|mesh-list
57088211|NCT00433511|Doxorubicin|doxorubicin|mesh-list
57088212|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57088213|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57088214|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57088215|NCT00433511|Antibodies|antibodies|mesh-list
57088216|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
57088217|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57088218|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
57088219|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
57088220|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57088221|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088222|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
57088223|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
57088224|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
57088225|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088226|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57088227|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
56899366|NCT01190163|Oxytocin|oxytocin|mesh-list
57088228|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088229|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57088230|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57088231|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
57088232|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57088233|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57088234|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57088235|NCT00433511|Growth Substances|growth substances|mesh-ancestor
57088236|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
57088237|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57088238|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57088239|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57088240|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088241|NCT03502551|Ketamine|ketamine|mesh-list
57088242|NCT03502551|Analgesics|analgesics|mesh-ancestor
57088243|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
57088244|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088245|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088246|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57088247|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57088248|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
57088249|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
57088250|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088251|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57088252|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57088253|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088254|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088255|NCT02314377|Bevacizumab|bevacizumab|mesh-list
57088256|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088257|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088258|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57088259|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57088260|NCT02314377|Growth Substances|growth substances|mesh-ancestor
57088261|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088262|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
57088263|NCT02942290|Azacitidine|azacitidine|mesh-list
57088264|NCT02942290|Venetoclax|venetoclax|mesh-list
57088265|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57088266|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
57088267|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088268|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088269|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088270|NCT02540356|Antibodies|antibodies|mesh-list
57088271|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
57088272|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
57088273|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088274|NCT05463094|Metformin|metformin|mesh-list
57088275|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57088276|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088277|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
57088278|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088279|NCT02392130|Clobetasol|clobetasol|mesh-list
57088280|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088281|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
57088282|NCT02392130|Hormones|hormones|mesh-ancestor
57088283|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088284|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088285|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
57088286|NCT00070499|Dasatinib|dasatinib|mesh-list
57088287|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088288|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57088289|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088290|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088291|NCT05356091|Sevoflurane|sevoflurane|mesh-list
57088292|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57088293|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57088294|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
57088295|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
57088296|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088297|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088298|NCT05351021|Metformin|metformin|mesh-list
57088299|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57088300|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088301|NCT02688764|Calcium|calcium|mesh-list
57088302|NCT02688764|Calcium acetate|calcium acetate|mesh-list
57088303|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57088304|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088305|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
57088306|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
57088307|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088308|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
57088309|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088310|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088311|NCT04544111|Trametinib|trametinib|mesh-list
57088312|NCT04544111|Dabrafenib|dabrafenib|mesh-list
57088313|NCT04544111|Spartalizumab|spartalizumab|mesh-list
57088314|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088315|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57088316|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088317|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088318|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57088319|NCT02688530|Dexamethasone|dexamethasone|mesh-list
57088320|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
57088321|NCT02688530|BB 1101|bb 1101|mesh-list
57088322|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088323|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
57088324|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
57088325|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088326|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088327|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57088328|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
57088329|NCT02688530|Hormones|hormones|mesh-ancestor
57088330|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088331|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088332|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088333|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
57088334|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088335|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088336|NCT05744804|Aspirin|aspirin|mesh-list
57088337|NCT05744804|Rivaroxaban|rivaroxaban|mesh-list
57088338|NCT05744804|Clopidogrel|clopidogrel|mesh-list
57088339|NCT05744804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57088340|NCT05744804|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57088341|NCT05744804|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57088342|NCT05744804|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57088343|NCT05744804|Purinergic Agents|purinergic agents|mesh-ancestor
57088344|NCT05744804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088345|NCT05744804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088346|NCT05744804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088347|NCT05744804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57088348|NCT05744804|Antithrombins|antithrombins|mesh-ancestor
57088349|NCT05744804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57088350|NCT05744804|Protease Inhibitors|protease inhibitors|mesh-ancestor
57088351|NCT05744804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088352|NCT05744804|Anticoagulants|anticoagulants|mesh-ancestor
57088353|NCT05744804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57088354|NCT05744804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57088355|NCT05744804|Analgesics|analgesics|mesh-ancestor
57088356|NCT05744804|Sensory System Agents|sensory system agents|mesh-ancestor
57088357|NCT05744804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088358|NCT05744804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088359|NCT05744804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57088360|NCT05744804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57088361|NCT05744804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57088362|NCT05744804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57088363|NCT05744804|Antipyretics|antipyretics|mesh-ancestor
57088364|NCT05746442|Nicotine|nicotine|mesh-list
57088365|NCT05746442|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57088366|NCT05746442|Autonomic Agents|autonomic agents|mesh-ancestor
57088367|NCT05746442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088368|NCT05746442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088369|NCT05746442|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57088370|NCT05746442|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57088371|NCT05746442|Cholinergic Agents|cholinergic agents|mesh-ancestor
57088372|NCT05746442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088373|NCT05746442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088374|NCT05744726|Bone wax|bone wax|mesh-list
57088375|NCT05744726|Hemostatics|hemostatics|mesh-ancestor
57088376|NCT05744726|Coagulants|coagulants|mesh-ancestor
57088377|NCT02467270|Ponatinib|ponatinib|mesh-list
57088378|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088379|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57088380|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088381|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088382|NCT05369819|Midazolam|midazolam|mesh-list
57088383|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57088384|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57088385|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088386|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088387|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57088388|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57088389|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57088390|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57088391|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
57088392|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
57088393|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
57088394|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
57088395|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088396|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088397|NCT05150795|Pregabalin|pregabalin|mesh-list
57088398|NCT05150795|Fentanyl|fentanyl|mesh-list
57088399|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57088400|NCT05150795|Narcotics|narcotics|mesh-ancestor
57088401|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088402|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088403|NCT05150795|Analgesics|analgesics|mesh-ancestor
57088404|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
57088405|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088406|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57088407|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57088408|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
57088409|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
57088410|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
57088411|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57088412|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57088413|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088414|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57088415|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57088416|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57088417|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57088418|NCT05746208|Pembrolizumab|pembrolizumab|mesh-list
57088419|NCT05746208|Lenvatinib|lenvatinib|mesh-list
57088420|NCT05746208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088421|NCT05746208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088422|NCT05746208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57088423|NCT05746208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088424|NCT05746208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088425|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
57088426|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
57088427|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088428|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57088429|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57088430|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088431|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088432|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
57088433|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088434|NCT05744648|Titanium dioxide|titanium dioxide|mesh-list
57088435|NCT05744648|Sunscreening Agents|sunscreening agents|mesh-ancestor
57088436|NCT05744648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57088437|NCT05744648|Protective Agents|protective agents|mesh-ancestor
57088438|NCT05744648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088439|NCT05744648|Dermatologic Agents|dermatologic agents|mesh-ancestor
57088440|NCT05744648|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57088441|NCT02268448|Clonidine|clonidine|mesh-list
57088442|NCT02268448|Naltrexone|naltrexone|mesh-list
57088443|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57088444|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57088445|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088446|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
57088447|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088448|NCT02268448|Analgesics|analgesics|mesh-ancestor
57088449|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57088450|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
57088451|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
57088452|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57088453|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57088454|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57088455|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
57088456|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088457|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088458|NCT05744570|Anesthetics|anesthetics|mesh-list
57088459|NCT05744570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088460|NCT05744570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088461|NCT05601440|Gemcitabine|gemcitabine|mesh-list
57088462|NCT05601440|Fulvestrant|fulvestrant|mesh-list
57088463|NCT05601440|Niraparib|niraparib|mesh-list
57088464|NCT05601440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57088465|NCT05601440|Antimetabolites|antimetabolites|mesh-ancestor
57088466|NCT05601440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088467|NCT05601440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088468|NCT05601440|Antiviral Agents|antiviral agents|mesh-ancestor
57088469|NCT05601440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088470|NCT05601440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088471|NCT05601440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57088472|NCT05601440|Immunologic Factors|immunologic factors|mesh-ancestor
57088473|NCT05601440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088474|NCT05601440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088475|NCT05601440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57088476|NCT05601440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57088477|NCT05601440|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088478|NCT05601440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088479|NCT05601440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57088480|NCT05600114|Cannabidiol|cannabidiol|mesh-list
57088481|NCT05600114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57088482|NCT05600114|Anticonvulsants|anticonvulsants|mesh-ancestor
57088483|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
57088484|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
57088485|NCT03036839|Ledipasvir|ledipasvir|mesh-list
57088486|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
57088487|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088488|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57088489|NCT04977791|Antibodies|antibodies|mesh-list
57088490|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57088491|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
57088492|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088493|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088494|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088495|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
57088496|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088497|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088498|NCT04862975|Tenofovir|tenofovir|mesh-list
57088499|NCT04862975|Emtricitabine|emtricitabine|mesh-list
57088500|NCT04862975|Efavirenz|efavirenz|mesh-list
57088501|NCT04862975|Dolutegravir|dolutegravir|mesh-list
57088502|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
57088503|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088504|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57088505|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57088506|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088507|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088508|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57088509|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57088510|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57088511|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57088512|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57088513|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57088514|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57088515|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57088516|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57088517|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57088518|NCT03625739|Amoxicillin|amoxicillin|mesh-list
57088519|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
57088520|NCT03625739|Levofloxacin|levofloxacin|mesh-list
57088521|NCT03625739|Isoniazid|isoniazid|mesh-list
57088522|NCT03625739|Cycloserine|cycloserine|mesh-list
57088523|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
57088524|NCT03625739|Imipenem|imipenem|mesh-list
57088525|NCT03625739|Amikacin|amikacin|mesh-list
57088526|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
57088527|NCT03625739|Ethambutol|ethambutol|mesh-list
57088528|NCT03625739|Bedaquiline|bedaquiline|mesh-list
57088529|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57088530|NCT03625739|Clofazimine|clofazimine|mesh-list
57088531|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
57088532|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
57088533|NCT03625739|Streptomycin|streptomycin|mesh-list
57088534|NCT03625739|Ethionamide|ethionamide|mesh-list
57088535|NCT03625739|Kanamycin|kanamycin|mesh-list
57088536|NCT03625739|Capreomycin|capreomycin|mesh-list
57088537|NCT03625739|Thioacetazone|thioacetazone|mesh-list
57088538|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
57088539|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57088540|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088541|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57088542|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57088543|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088544|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088545|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088546|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57088547|NCT03625739|Renal Agents|renal agents|mesh-ancestor
57088548|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57088549|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57088550|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56770492|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
57088551|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
57088552|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57088553|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57088554|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
57088555|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57088556|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57088557|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088558|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57088559|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57088560|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57088561|NCT03904199|Insulin|insulin|mesh-list
57088562|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57088563|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57088564|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088565|NCT03902951|Leuprolide|leuprolide|mesh-list
57088566|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
57088567|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57088568|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
57088569|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57088570|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088571|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088572|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088573|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57088574|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088575|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088576|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088577|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088578|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57088579|NCT01286207|Rizatriptan|rizatriptan|mesh-list
57088580|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57088581|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
57088582|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088583|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088584|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088585|NCT05408026|Dexamethasone|dexamethasone|mesh-list
57088586|NCT05408026|Bortezomib|bortezomib|mesh-list
57088587|NCT05408026|Daratumumab|daratumumab|mesh-list
57088588|NCT05408026|Pomalidomide|pomalidomide|mesh-list
57088589|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088590|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
57088591|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
57088592|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088593|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088594|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57088595|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
57088596|NCT05408026|Hormones|hormones|mesh-ancestor
57088597|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088598|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088599|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088600|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
57088601|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57088602|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57088603|NCT05408026|Growth Substances|growth substances|mesh-ancestor
57088604|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
57088605|NCT02170090|Gemcitabine|gemcitabine|mesh-list
57088606|NCT02170090|Capecitabine|capecitabine|mesh-list
57088607|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088608|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57088609|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
57088610|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088611|NCT02170090|Antiviral Agents|antiviral agents|mesh-ancestor
57088612|NCT02170090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088613|NCT02170090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088614|NCT02170090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57088615|NCT02170090|Immunologic Factors|immunologic factors|mesh-ancestor
57088616|NCT02170090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088617|NCT04423510|Phenol|phenol|mesh-list
57088618|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57088619|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57088620|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
57088621|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57088622|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57088623|NCT00968201|Montelukast|montelukast|mesh-list
57088624|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57088625|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
57088626|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57088627|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088628|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088629|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088630|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57088631|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57088632|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088634|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57088635|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
57088636|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57088637|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088638|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088639|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088640|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57088641|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57088642|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088643|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
57088644|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088645|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
57088646|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57088647|NCT00702845|Hormones|hormones|mesh-list
57088648|NCT00702845|Progesterone|progesterone|mesh-list
57088649|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57088650|NCT00702845|Ganirelix|ganirelix|mesh-list
57088651|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088652|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088653|NCT00702845|Progestins|progestins|mesh-ancestor
57088654|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088655|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57088656|NCT00647933|Lynestrenol|lynestrenol|mesh-list
57088657|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57088658|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57088659|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57088660|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
57088661|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57088662|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088663|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57088664|NCT00647933|Estrogens|estrogens|mesh-ancestor
57088665|NCT00647933|Hormones|hormones|mesh-ancestor
57088666|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088667|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57088668|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
57088669|NCT00641771|Vitamin D|vitamin d|mesh-list
57088670|NCT00641771|Alendronate|alendronate|mesh-list
57088671|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57088672|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088673|NCT00641771|Vitamins|vitamins|mesh-ancestor
57088674|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
57088675|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57088676|NCT03767933|Acetaminophen|acetaminophen|mesh-list
57088677|NCT03767933|Ibuprofen|ibuprofen|mesh-list
57088678|NCT03767933|Hydromorphone|hydromorphone|mesh-list
57088679|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57088680|NCT03767933|Analgesics|analgesics|mesh-ancestor
57088681|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
57088682|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088683|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088684|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
57088685|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57088686|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088687|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57088688|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57088689|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088690|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088691|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57088692|NCT03767933|Narcotics|narcotics|mesh-ancestor
57088693|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088694|NCT00519857|Tibolone|tibolone|mesh-list
57088695|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
57088696|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088697|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088698|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088699|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57088700|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088701|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088702|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57088703|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
57088704|NCT00519857|Hormones|hormones|mesh-ancestor
57088705|NCT00431093|Tibolone|tibolone|mesh-list
57088706|NCT00431093|Estradiol|estradiol|mesh-list
57088707|NCT00431093|Estrogens|estrogens|mesh-ancestor
57088708|NCT00431093|Hormones|hormones|mesh-ancestor
57088709|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088710|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088711|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
57088712|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088713|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57088714|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088715|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088716|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57088717|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
57088718|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
57088719|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088720|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088721|NCT05090033|Ofatumumab|ofatumumab|mesh-list
57088722|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088723|NCT00092963|Rizatriptan|rizatriptan|mesh-list
57088724|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088725|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088726|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088727|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57088728|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
57088729|NCT00092885|Montelukast|montelukast|mesh-list
57088730|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57088731|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
57088732|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57088733|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088734|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088735|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088736|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57088737|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57088738|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088739|NCT03673735|Durvalumab|durvalumab|mesh-list
57088740|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088741|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088742|NCT01272037|Tamoxifen|tamoxifen|mesh-list
57088743|NCT01272037|Letrozole|letrozole|mesh-list
57088744|NCT01272037|Anastrozole|anastrozole|mesh-list
57088745|NCT01272037|Exemestane|exemestane|mesh-list
57088746|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088747|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088748|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57088749|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57088750|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088751|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57088752|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088753|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088754|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088755|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088756|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57088757|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57088758|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57088759|NCT00092105|Montelukast|montelukast|mesh-list
57088760|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57088761|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
57088762|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57088763|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088764|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088765|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088766|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57088767|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57088768|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088769|NCT00092027|Alendronate|alendronate|mesh-list
57088770|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088771|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56770724|NCT03704753|Ropivacaine|ropivacaine|mesh-list
57088772|NCT00076973|Montelukast|montelukast|mesh-list
57088773|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57088774|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
57088775|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57088776|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088777|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088778|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088779|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57088780|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57088781|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088782|NCT03565991|Avelumab|avelumab|mesh-list
57088783|NCT03565991|Talazoparib|talazoparib|mesh-list
57088784|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088785|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088786|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57088787|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088788|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088789|NCT02314533|Fenofibrate|fenofibrate|mesh-list
57088790|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57088791|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
57088792|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088793|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57088794|NCT03502395|Lidocaine|lidocaine|mesh-list
57088795|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
57088796|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
57088797|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088798|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088799|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
57088800|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088801|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57088802|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57088803|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57088804|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57088805|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088806|NCT02318043|Fluticasone|fluticasone|mesh-list
57088807|NCT02318043|Budesonide|budesonide|mesh-list
57088808|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57088809|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57088810|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088811|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57088812|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
57088813|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088814|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088815|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57088816|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
57088817|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
57088818|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57088819|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
57088820|NCT02318043|Hormones|hormones|mesh-ancestor
57088821|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088822|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57088823|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57088824|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57088825|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
57088826|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088827|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088828|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
57088829|NCT05279417|Methotrexate|methotrexate|mesh-list
57088830|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57088831|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
57088832|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57088833|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088834|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57088835|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
57088836|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088837|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088838|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
57088839|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088840|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57088841|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57088842|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
57088843|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57088844|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57088846|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088847|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088848|NCT02318121|Oxytocin|oxytocin|mesh-list
57088849|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
57088850|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57088851|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088852|NCT02318199|Anesthetics|anesthetics|mesh-list
57088853|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57088854|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088855|NCT05225597|Carbachol|carbachol|mesh-list
57088856|NCT05225597|Epinephrine|epinephrine|mesh-list
57088857|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57088858|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57088859|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
57088860|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088861|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088862|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088863|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57088864|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57088865|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
57088866|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088867|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57088868|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
57088869|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
57088870|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
57088871|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57088872|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57088873|NCT05225597|Miotics|miotics|mesh-ancestor
57088874|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57088875|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
57088876|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57088877|NCT05225597|Analgesics|analgesics|mesh-ancestor
57088878|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
57088879|NCT05225597|Protective Agents|protective agents|mesh-ancestor
57088880|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
57088881|NCT03393845|Fulvestrant|fulvestrant|mesh-list
57088882|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57088883|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088884|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088885|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57088886|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57088887|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088888|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088889|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088890|NCT00958633|Citalopram|citalopram|mesh-list
57088891|NCT00958633|Bupropion|bupropion|mesh-list
57088892|NCT00958633|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57088893|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57088894|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57088895|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088896|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088897|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
57088898|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088899|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57088900|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
57088901|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57088902|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57088903|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
57088904|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57088905|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57088906|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088907|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
57088908|NCT03070327|Lenalidomide|lenalidomide|mesh-list
57088909|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57088910|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
57088911|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088912|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57088913|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57088914|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
57088915|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088916|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088917|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57088918|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57088919|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57088920|NCT03070327|Growth Substances|growth substances|mesh-ancestor
57088921|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
57088922|NCT00543127|Fulvestrant|fulvestrant|mesh-list
57088923|NCT00543127|Anastrozole|anastrozole|mesh-list
57088924|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088925|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088926|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57088927|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57088928|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
57088929|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088930|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088931|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57088932|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57088933|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088934|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088935|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
57088936|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57088937|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088938|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088939|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
57088940|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57088941|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088942|NCT03673501|Sunitinib|sunitinib|mesh-list
57088943|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088944|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57088945|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57088946|NCT03673501|Growth Substances|growth substances|mesh-ancestor
57088947|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088948|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
57088949|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57088950|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088951|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088952|NCT02309385|Dexamethasone|dexamethasone|mesh-list
57088953|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
57088954|NCT02309385|Prednisolone|prednisolone|mesh-list
57088955|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57088956|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
57088957|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57088958|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
57088959|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57088960|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
57088961|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57088962|NCT02309385|BB 1101|bb 1101|mesh-list
57088963|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088964|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
57088965|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
57088966|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088967|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088968|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57088969|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
57088970|NCT02309385|Hormones|hormones|mesh-ancestor
57088971|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088972|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57088973|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088974|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
57088975|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57088976|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088977|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57088978|NCT02309385|Protective Agents|protective agents|mesh-ancestor
57088979|NCT02315001|Liraglutide|liraglutide|mesh-list
57088980|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57088981|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088982|NCT02315001|Incretins|incretins|mesh-ancestor
57088983|NCT02315001|Hormones|hormones|mesh-ancestor
57088984|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57088985|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57088986|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57088987|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
57088988|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57088989|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57088990|NCT03500445|Dexamethasone|dexamethasone|mesh-list
56770950|NCT00433966|Paclitaxel|paclitaxel|mesh-list
57088991|NCT03500445|Lenalidomide|lenalidomide|mesh-list
57088992|NCT03500445|Daratumumab|daratumumab|mesh-list
57088993|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57088994|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
57088995|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
57088996|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57088997|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57088998|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57088999|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
57089000|NCT03500445|Hormones|hormones|mesh-ancestor
57089001|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57089002|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57089003|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089004|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
57089005|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57089006|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57089007|NCT03500445|Growth Substances|growth substances|mesh-ancestor
57089008|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
57089009|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
57089010|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089011|NCT03500367|Sirolimus|sirolimus|mesh-list
57089012|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57089013|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089014|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57089015|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089016|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
57089017|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089018|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
56899386|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57089019|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089020|NCT02318433|Dexamethasone|dexamethasone|mesh-list
57089021|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089022|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
57089023|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
57089024|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089025|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089026|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57089027|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
57089028|NCT02318433|Hormones|hormones|mesh-ancestor
57089029|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57089030|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57089031|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089032|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
57089033|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57089034|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
57089035|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089036|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
57089037|NCT02318511|Protective Agents|protective agents|mesh-ancestor
57089038|NCT02315391|Glycine|glycine|mesh-list
57089039|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
57089040|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089041|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089042|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089043|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
57089044|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57089045|NCT03022981|Velpatasvir|velpatasvir|mesh-list
57089046|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
57089047|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089048|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
57089049|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
57089050|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089051|NCT03502005|Tenofovir|tenofovir|mesh-list
57089052|NCT03502005|Emtricitabine|emtricitabine|mesh-list
57089053|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57089054|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
57089055|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089056|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57089057|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57089058|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089059|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089060|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57089061|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57089062|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57089063|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089064|NCT03669445|Dexamethasone|dexamethasone|mesh-list
57089065|NCT03669445|Lenalidomide|lenalidomide|mesh-list
57089066|NCT03669445|Daratumumab|daratumumab|mesh-list
57089067|NCT03669445|Ixazomib|ixazomib|mesh-list
57089068|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089069|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
57089070|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
57089071|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089072|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089073|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57089074|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
57089075|NCT03669445|Hormones|hormones|mesh-ancestor
57089076|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57089077|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57089078|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089079|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
57089080|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57089081|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57089082|NCT03669445|Growth Substances|growth substances|mesh-ancestor
57089083|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
57089084|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
57089085|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089086|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089087|NCT03506061|Ivacaftor|ivacaftor|mesh-list
57089088|NCT03506061|Elexacaftor|elexacaftor|mesh-list
57089089|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57089090|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57089091|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089092|NCT03500133|Cytarabine|cytarabine|mesh-list
57089093|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
57089094|NCT03500133|Cisplatin|cisplatin|mesh-list
57089095|NCT03500133|Etoposide|etoposide|mesh-list
57089096|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089097|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57089098|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
57089099|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089100|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
57089101|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089102|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089103|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
57089104|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089105|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57089106|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57089107|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57089108|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089109|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089110|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
57089111|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
57089112|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089113|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57089114|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
57089115|NCT03500133|Hormones|hormones|mesh-ancestor
57089116|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57089117|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57089118|NCT03500133|Protective Agents|protective agents|mesh-ancestor
57089119|NCT04462809|Talazoparib|talazoparib|mesh-list
57089120|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57089121|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089122|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089123|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089124|NCT02320773|Mirabegron|mirabegron|mesh-list
57089125|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57089126|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57089127|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57089128|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
57089129|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089130|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089131|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089132|NCT02320773|Urological Agents|urological agents|mesh-ancestor
57089133|NCT03377699|Insulin|insulin|mesh-list
57089134|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57089135|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
57089136|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
57089137|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57089138|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089139|NCT04463901|Mitomycins|mitomycins|mesh-list
57089140|NCT04463901|Mitomycin|mitomycin|mesh-list
57089141|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57089142|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089143|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
57089144|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089145|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57089147|NCT01314443|Vitamin E|vitamin e|mesh-list
57089148|NCT01314443|Tocopherols|tocopherols|mesh-list
57089149|NCT01314443|Tocotrienols|tocotrienols|mesh-list
57089150|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
57089151|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
57089152|NCT01314443|Nicotine|nicotine|mesh-list
57089153|NCT01314443|Vitamins|vitamins|mesh-ancestor
57089154|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
57089155|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089156|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57089157|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
57089158|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089159|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57089160|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57089161|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
57089162|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089163|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089164|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
57089165|NCT01314443|Protective Agents|protective agents|mesh-ancestor
57089166|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57089167|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089168|NCT03498417|Antibodies|antibodies|mesh-list
57089169|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
57089170|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089171|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
57089172|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57089173|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089174|NCT02319135|Cytarabine|cytarabine|mesh-list
57089175|NCT02319135|Fludarabine|fludarabine|mesh-list
57089176|NCT02319135|Lenograstim|lenograstim|mesh-list
57089177|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089178|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57089179|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
57089180|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089181|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089182|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
57089183|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089184|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
57089185|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089186|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57089187|NCT04738097|Clopidogrel|clopidogrel|mesh-list
57089188|NCT04738097|Ticagrelor|ticagrelor|mesh-list
57089189|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57089190|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57089191|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57089192|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57089193|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
57089194|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089195|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089196|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089197|NCT03498261|Gabapentin|gabapentin|mesh-list
57089198|NCT03498261|Analgesics|analgesics|mesh-ancestor
57089199|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
57089200|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089201|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089202|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
57089203|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57089204|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57089205|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089206|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57089207|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57089208|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57089209|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089210|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089211|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
57089212|NCT03499743|Celecoxib|celecoxib|mesh-list
57089213|NCT03499743|Scopolamine|scopolamine|mesh-list
57089214|NCT03499743|Bromides|bromides|mesh-list
57089215|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57089216|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57089217|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57089218|NCT03499743|Analgesics|analgesics|mesh-ancestor
57089219|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
57089220|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089221|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089222|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089223|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089224|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57089225|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57089226|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089227|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089228|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
57089229|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57089230|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
57089231|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
57089232|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57089233|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
57089234|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57089235|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
57089236|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089237|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57089238|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
57089239|NCT05223647|Carboplatin|carboplatin|mesh-list
57089240|NCT05223647|Etoposide|etoposide|mesh-list
57089241|NCT05223647|Durvalumab|durvalumab|mesh-list
57089242|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089243|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57089244|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57089245|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57089246|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089247|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089248|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57089249|NCT02310087|Vitamin E|vitamin e|mesh-list
57089250|NCT02310087|Vitamins|vitamins|mesh-ancestor
57089251|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
57089252|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089253|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
57089254|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089255|NCT02310087|Protective Agents|protective agents|mesh-ancestor
57089256|NCT02923921|Leucovorin|leucovorin|mesh-list
57089257|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
57089258|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089259|NCT02923921|Antidotes|antidotes|mesh-ancestor
57089260|NCT02923921|Protective Agents|protective agents|mesh-ancestor
57089261|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089262|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
57089263|NCT02923921|Vitamins|vitamins|mesh-ancestor
57089264|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
57089265|NCT02310243|Palbociclib|palbociclib|mesh-list
57089266|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089267|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57089268|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089269|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089270|NCT05062889|Leucovorin|leucovorin|mesh-list
57089271|NCT05062889|Trifluridine|trifluridine|mesh-list
57089272|NCT05062889|Fluorouracil|fluorouracil|mesh-list
57089273|NCT05062889|Capecitabine|capecitabine|mesh-list
57089274|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
57089275|NCT05062889|Irinotecan|irinotecan|mesh-list
57089276|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
57089277|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
57089278|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089279|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57089280|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089281|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089282|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
57089283|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089284|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57089285|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57089286|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089287|NCT05062889|Antidotes|antidotes|mesh-ancestor
57089288|NCT05062889|Protective Agents|protective agents|mesh-ancestor
57089289|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
57089290|NCT05062889|Vitamins|vitamins|mesh-ancestor
57089291|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
57089292|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
57089293|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089294|NCT03497715|Ibuprofen|ibuprofen|mesh-list
57089295|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57089296|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57089297|NCT03497715|Analgesics|analgesics|mesh-ancestor
57089298|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
57089299|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089300|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089301|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089302|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089303|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57089304|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089305|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089306|NCT02321241|Aflibercept|aflibercept|mesh-list
57089307|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57089308|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57089309|NCT02321241|Growth Substances|growth substances|mesh-ancestor
57089310|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089311|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
57089312|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089313|NCT03583307|Sirolimus|sirolimus|mesh-list
57089314|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57089315|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089316|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57089317|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089318|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
57089319|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089320|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
57089321|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089322|NCT03039023|Choline|choline|mesh-list
57089323|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
57089324|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57089325|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
57089326|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089327|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57089328|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57089329|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
57089330|NCT02321397|Oxycodone|oxycodone|mesh-list
57089331|NCT02321397|Naloxone|naloxone|mesh-list
57089332|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57089333|NCT02321397|Narcotics|narcotics|mesh-ancestor
57089334|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089335|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089336|NCT02321397|Analgesics|analgesics|mesh-ancestor
57089337|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
57089338|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089339|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57089340|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
57089341|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57089342|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57089343|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089344|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
57089345|NCT02319915|Coagulants|coagulants|mesh-ancestor
57089346|NCT04898309|Complement C1s|complement c1s|mesh-list
57089347|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
57089348|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
57089349|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
57089350|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089351|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57089352|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089353|NCT03498963|Dimercaprol|dimercaprol|mesh-list
57089354|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
57089355|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
57089356|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089357|NCT02311101|Mitomycins|mitomycins|mesh-list
57089358|NCT02311101|Mitomycin|mitomycin|mesh-list
57089359|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57089360|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089361|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
57089362|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089363|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57089364|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089365|NCT04620187|Cisplatin|cisplatin|mesh-list
57089366|NCT04620187|Carboplatin|carboplatin|mesh-list
57089367|NCT04620187|Trastuzumab|trastuzumab|mesh-list
57089368|NCT04620187|Maytansine|maytansine|mesh-list
57089369|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089370|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57089371|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57089372|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
57089373|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
57089374|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
56771317|NCT00744419|Pantoprazole|pantoprazole|mesh-list
57089375|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089376|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
57089377|NCT04608487|Fludarabine|fludarabine|mesh-list
57089378|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089379|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
57089380|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089381|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089382|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57089383|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
57089384|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089385|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089386|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57089387|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
57089388|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57089389|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
57089390|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089391|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
57089392|NCT03668665|Protective Agents|protective agents|mesh-ancestor
57089393|NCT04804553|Apremilast|apremilast|mesh-list
57089394|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57089395|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57089396|NCT04804553|Analgesics|analgesics|mesh-ancestor
57089397|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
57089398|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089399|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089400|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089401|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089402|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57089403|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57089404|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089405|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089406|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57089407|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
57089408|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57089409|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
57089410|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089411|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089412|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57089413|NCT03704909|Epinephrine|epinephrine|mesh-list
57089414|NCT03704909|Racepinephrine|racepinephrine|mesh-list
57089415|NCT03704909|Ephedrine|ephedrine|mesh-list
57089416|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
57089417|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57089418|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57089419|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
57089420|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089421|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089422|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089423|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57089424|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57089425|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
57089426|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089427|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57089428|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
57089429|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
57089430|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
57089431|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57089432|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57089433|NCT03704831|Anesthetics|anesthetics|mesh-list
57089434|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
57089435|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089436|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089437|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
57089438|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089439|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
57089440|NCT03494517|Analgesics|analgesics|mesh-ancestor
57089441|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
57089442|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089443|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089444|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
57089445|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089446|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57089447|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
57089448|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57089449|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57089450|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089451|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57089452|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
57089453|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57089454|NCT04912505|Aspirin|aspirin|mesh-list
57089455|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57089456|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57089457|NCT04912505|Analgesics|analgesics|mesh-ancestor
57089458|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
57089459|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089460|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089461|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089462|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089463|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57089464|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57089465|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089466|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57089467|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57089468|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089469|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
57089470|NCT04912427|Dexamethasone|dexamethasone|mesh-list
57089471|NCT04912427|Bortezomib|bortezomib|mesh-list
57089472|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089473|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
57089474|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
57089475|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089476|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089477|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57089478|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
57089479|NCT04912427|Hormones|hormones|mesh-ancestor
57089480|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57089481|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57089482|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089483|NCT02322645|Eszopiclone|eszopiclone|mesh-list
57089484|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57089485|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089486|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089487|NCT04050761|Nivolumab|nivolumab|mesh-list
57089488|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57089489|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089490|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57089491|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089492|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57089493|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57089494|NCT03496389|Acetaminophen|acetaminophen|mesh-list
57089495|NCT03496389|Gabapentin|gabapentin|mesh-list
57089496|NCT03496389|Tramadol|tramadol|mesh-list
57089497|NCT03496389|Analgesics|analgesics|mesh-ancestor
57089498|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
57089499|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089500|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089501|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
57089502|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57089503|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57089504|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089505|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57089506|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57089507|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57089508|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089509|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089510|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
57089511|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57089512|NCT03496389|Narcotics|narcotics|mesh-ancestor
57089513|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57089514|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
57089515|NCT04425447|Anesthetics|anesthetics|mesh-list
57089516|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089517|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089518|NCT03491709|Cetuximab|cetuximab|mesh-list
57089519|NCT03491709|Antibodies|antibodies|mesh-list
57089520|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57089521|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
57089522|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089523|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57089524|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089525|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
57089526|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57089527|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57089528|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089529|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
57089530|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089531|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089532|NCT02323191|Atezolizumab|atezolizumab|mesh-list
57089533|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089534|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57089535|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
57089536|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089537|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
57089538|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089539|NCT02323347|Progesterone|progesterone|mesh-list
57089540|NCT02323347|Progestins|progestins|mesh-ancestor
57089541|NCT02323347|Hormones|hormones|mesh-ancestor
57089542|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57089543|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089544|NCT03495765|Ranibizumab|ranibizumab|mesh-list
57089545|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57089546|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57089547|NCT03495765|Growth Substances|growth substances|mesh-ancestor
57089548|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089549|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
57089550|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089551|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57089552|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57089553|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089554|NCT03491475|Ajmaline|ajmaline|mesh-list
57089555|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57089556|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57089557|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57089558|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57089559|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089560|NCT03499119|Erenumab|erenumab|mesh-list
57089561|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57089562|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089563|NCT03499119|Analgesics|analgesics|mesh-ancestor
57089564|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
57089565|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089566|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089567|NCT03328845|Insulin|insulin|mesh-list
57089568|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57089569|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
57089570|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
57089571|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57089572|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089573|NCT02323737|Cisplatin|cisplatin|mesh-list
57089574|NCT02323737|Irinotecan|irinotecan|mesh-list
57089575|NCT02323737|Etoposide|etoposide|mesh-list
57089576|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089577|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57089578|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57089579|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089580|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089581|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57089582|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57089583|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
57089584|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
57089585|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089586|NCT03491085|Amoxicillin|amoxicillin|mesh-list
57089587|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
57089588|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
57089589|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57089590|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57089591|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089592|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57089593|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089594|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089595|NCT02323971|Ticagrelor|ticagrelor|mesh-list
57089596|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57089597|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57089598|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57089599|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57089600|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
57089601|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089602|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089603|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089604|NCT03148899|Oxytocin|oxytocin|mesh-list
57089605|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
57089606|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57089607|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089608|NCT03495063|Caffeine|caffeine|mesh-list
57089609|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57089610|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089611|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57089612|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089613|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089614|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57089615|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57089616|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
57089617|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089618|NCT03490617|Misoprostol|misoprostol|mesh-list
57089619|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57089620|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
57089621|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57089622|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089623|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57089624|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57089625|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
57089626|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
57089627|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57089628|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57089629|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089630|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57089631|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57089632|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089633|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089634|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089635|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57089636|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
57089637|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57089638|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089639|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57089640|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57089641|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57089642|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
57089643|NCT03490539|Azathioprine|azathioprine|mesh-list
57089644|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57089645|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089646|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57089647|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
57089648|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57089649|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089650|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089651|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089652|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
57089653|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57089654|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089655|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
57089656|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089657|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089658|NCT03493503|Albuterol|albuterol|mesh-list
57089659|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57089660|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
57089661|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089662|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089663|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57089664|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
57089665|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
57089666|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57089667|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57089668|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57089669|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57089670|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
57089671|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089672|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089674|NCT02143414|Cortisone|cortisone|mesh-list
57089675|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57089676|NCT02143414|Methotrexate|methotrexate|mesh-list
57089677|NCT02143414|Vincristine|vincristine|mesh-list
57089678|NCT02143414|Dasatinib|dasatinib|mesh-list
57089679|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
57089680|NCT02143414|Blinatumomab|blinatumomab|mesh-list
57089681|NCT02143414|Antibodies|antibodies|mesh-list
57089682|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
57089683|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57089684|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
57089685|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57089686|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
57089687|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089688|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089689|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089690|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
57089691|NCT02143414|Hormones|hormones|mesh-ancestor
57089692|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899474|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57089693|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57089694|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57089695|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
57089696|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57089697|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57089698|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
57089699|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089700|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
57089701|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089702|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57089703|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089704|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089705|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57089706|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57089707|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
57089708|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
57089709|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
57089710|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57089711|NCT04791761|Acetaminophen|acetaminophen|mesh-list
57089712|NCT04791761|Ibuprofen|ibuprofen|mesh-list
57089713|NCT04791761|Oxycodone|oxycodone|mesh-list
57089714|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
57089715|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57089716|NCT04791761|Analgesics|analgesics|mesh-ancestor
57089717|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
57089718|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089719|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089720|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
57089721|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57089722|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089723|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089724|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57089725|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089726|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089727|NCT04791761|Narcotics|narcotics|mesh-ancestor
57089728|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089729|NCT03667963|Lactulose|lactulose|mesh-list
57089730|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57089731|NCT03489837|Dipropizine|dipropizine|mesh-list
57089732|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
57089733|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
57089734|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57089735|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
57089736|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089737|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089738|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57089739|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089740|NCT04902443|Nivolumab|nivolumab|mesh-list
57089741|NCT04902443|Pomalidomide|pomalidomide|mesh-list
57089742|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57089743|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089744|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57089745|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089746|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
57089747|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089748|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57089749|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57089750|NCT04902443|Growth Substances|growth substances|mesh-ancestor
57089751|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
57089752|NCT03625505|Venetoclax|venetoclax|mesh-list
57089753|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089754|NCT03493269|Midazolam|midazolam|mesh-list
57089755|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57089756|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57089757|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089758|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089759|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57089760|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57089761|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57089762|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57089763|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
57089764|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
57089765|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
57089766|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
57089767|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089768|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089769|NCT04257682|Bupivacaine|bupivacaine|mesh-list
57089770|NCT04257682|Ropivacaine|ropivacaine|mesh-list
57089771|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
57089772|NCT04257682|Mepivacaine|mepivacaine|mesh-list
57089773|NCT04257682|Anesthetics|anesthetics|mesh-list
57089774|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089775|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089776|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
57089777|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089778|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
57089779|NCT05426434|Piperaquine|piperaquine|mesh-list
57089780|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
57089781|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
57089782|NCT05426434|Artenimol|artenimol|mesh-list
57089783|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
57089784|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57089785|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57089786|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089787|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57089788|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089789|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089790|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57089791|NCT05426434|Renal Agents|renal agents|mesh-ancestor
57089792|NCT05404906|Azacitidine|azacitidine|mesh-list
57089793|NCT05404906|Venetoclax|venetoclax|mesh-list
57089794|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57089795|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
57089796|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089797|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089798|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089799|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57089800|NCT03020407|Dopamine|dopamine|mesh-list
57089801|NCT03020407|Epinephrine|epinephrine|mesh-list
57089802|NCT03020407|Norepinephrine|norepinephrine|mesh-list
57089803|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
57089804|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089805|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57089806|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57089807|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
57089808|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089809|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089810|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089811|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57089812|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57089813|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
57089814|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089815|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57089816|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
57089817|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
57089818|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
57089819|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57089820|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
56771784|NCT00749099|Pancreatin|pancreatin|mesh-list
57089821|NCT03020407|Protective Agents|protective agents|mesh-ancestor
57089822|NCT03624959|Itraconazole|itraconazole|mesh-list
57089823|NCT03624959|Rifampin|rifampin|mesh-list
57089824|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
57089825|NCT03624959|Ozanimod|ozanimod|mesh-list
57089826|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
57089827|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57089828|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57089829|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57089830|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089831|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089832|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57089833|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
57089834|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57089835|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089836|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57089837|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57089838|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
57089839|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57089840|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
57089841|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57089842|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57089843|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57089844|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57089845|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57089846|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57089847|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57089848|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57089849|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089850|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
57089851|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57089852|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
57089853|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57089854|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57089855|NCT02536846|Olanzapine|olanzapine|mesh-list
57089856|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
57089857|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
57089858|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089859|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089860|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57089861|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57089862|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57089863|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089864|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57089865|NCT02536846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57089866|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57089867|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57089868|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089869|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089870|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
57089871|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57089872|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089873|NCT02293655|Methylphenidate|methylphenidate|mesh-list
57089874|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57089875|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089876|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57089877|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57089878|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57089879|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089880|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
57089881|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089882|NCT04452214|Carboplatin|carboplatin|mesh-list
57089883|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
57089884|NCT04452214|Pemetrexed|pemetrexed|mesh-list
57089885|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089886|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57089887|NCT04452214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089888|NCT04452214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089889|NCT04452214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57089890|NCT04452214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57089891|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57089892|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57089893|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089894|NCT05439460|Phenylephrine|phenylephrine|mesh-list
57089895|NCT05439460|Vasopressins|vasopressins|mesh-list
57089896|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
57089898|NCT05439460|Racepinephrine|racepinephrine|mesh-list
57089899|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
57089900|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
57089901|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57089902|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57089903|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
57089904|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089905|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089906|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089907|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57089908|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57089909|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
57089910|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089911|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57089912|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
57089913|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
57089914|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
57089915|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57089916|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57089917|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
57089918|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57089919|NCT05439460|Protective Agents|protective agents|mesh-ancestor
57089920|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
57089921|NCT05439460|Coagulants|coagulants|mesh-ancestor
57089922|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57089923|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
57089924|NCT01661140|Methotrexate|methotrexate|mesh-list
57089925|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57089926|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
57089927|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57089928|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089929|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57089930|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
57089931|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089932|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089933|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
57089934|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089935|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57089936|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089937|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
57089938|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089939|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57089940|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57089941|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57089942|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57089943|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
57089944|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089945|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57089946|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57089947|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089948|NCT05399602|Anesthetics|anesthetics|mesh-list
57089949|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089950|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089951|NCT05397886|Propofol|propofol|mesh-list
57089952|NCT05397886|Flumazenil|flumazenil|mesh-list
57089953|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57089954|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089955|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089956|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57089957|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
57089958|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
57089959|NCT05397886|Antidotes|antidotes|mesh-ancestor
57089960|NCT05397886|Protective Agents|protective agents|mesh-ancestor
57089961|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
57089962|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
57089963|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089964|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089965|NCT05436886|Gabapentin|gabapentin|mesh-list
57089966|NCT05436886|Analgesics|analgesics|mesh-ancestor
57089967|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
57089968|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57089969|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089970|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
57089971|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57089972|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57089973|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57089974|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57089975|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57089976|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57089977|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57089978|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089979|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
57089981|NCT01373151|Methotrexate|methotrexate|mesh-list
57089982|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57089983|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
57089984|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57089985|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57089986|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57089987|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
57089988|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57089989|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57089990|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
57089991|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57089992|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57089993|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57089994|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
57089995|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57089996|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57089997|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57089998|NCT05436652|Prednisolone|prednisolone|mesh-list
57089999|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57090000|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
57090001|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57090002|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
57090003|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57090004|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
57090005|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090006|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
57090007|NCT05436652|Hormones|hormones|mesh-ancestor
57090008|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090009|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090010|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57090011|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090012|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
57090013|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
57090014|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090015|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57090016|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57090017|NCT05436652|Protective Agents|protective agents|mesh-ancestor
57090018|NCT01660906|Dasatinib|dasatinib|mesh-list
57090019|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090020|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57090021|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090022|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090023|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
57090024|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090025|NCT03666949|Anesthetics|anesthetics|mesh-list
57090026|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090027|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090028|NCT00886691|Bevacizumab|bevacizumab|mesh-list
57090029|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57090030|NCT00886691|Everolimus|everolimus|mesh-list
57090031|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
57090032|NCT00886691|Antibodies|antibodies|mesh-list
57090033|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
57090034|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57090035|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
57090036|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090037|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57090038|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57090039|NCT00886691|Growth Substances|growth substances|mesh-ancestor
57090040|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090041|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
57090042|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
57090043|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772001|NCT00547248|Vaccines|vaccines|mesh-list
57090044|NCT00960297|Paclitaxel|paclitaxel|mesh-list
57090045|NCT00960297|Bevacizumab|bevacizumab|mesh-list
57090046|NCT00960297|Carboplatin|carboplatin|mesh-list
57090047|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57090048|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090049|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
57090050|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
57090051|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
57090052|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090053|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090054|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57090055|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57090056|NCT00960297|Growth Substances|growth substances|mesh-ancestor
57090057|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090058|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
57090059|NCT05112861|Bevacizumab|bevacizumab|mesh-list
57090060|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090061|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090062|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57090063|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57090064|NCT05112861|Growth Substances|growth substances|mesh-ancestor
57090065|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090066|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
57090067|NCT03012061|Fluticasone|fluticasone|mesh-list
57090068|NCT03012061|Xhance|xhance|mesh-list
57090069|NCT03012061|Albuterol|albuterol|mesh-list
57090070|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090071|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57090072|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
57090073|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090074|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090075|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57090076|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
57090077|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
57090078|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57090079|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
57090080|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57090081|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57090082|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57090083|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57090084|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
57090085|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090086|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090087|NCT00408863|Tibolone|tibolone|mesh-list
57090088|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
57090089|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
57090090|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090091|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090092|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57090093|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57090094|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090095|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57090096|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
57090097|NCT00408863|Hormones|hormones|mesh-ancestor
57090098|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
57090099|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57090100|NCT05085327|Protective Agents|protective agents|mesh-ancestor
57090101|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090102|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
57090103|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
57090104|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
57090105|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57090106|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090107|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090108|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57090109|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57090110|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57090111|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
57090112|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090113|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090114|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57090115|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57090116|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
57090117|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57090118|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57090119|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57090120|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090121|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090122|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57090123|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57090124|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090125|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
57090126|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090127|NCT03131973|Leucovorin|leucovorin|mesh-list
57090128|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
57090129|NCT03131973|Methotrexate|methotrexate|mesh-list
57090130|NCT03131973|Digoxin|digoxin|mesh-list
57090131|NCT03131973|Midazolam|midazolam|mesh-list
57090132|NCT03131973|Caffeine|caffeine|mesh-list
57090133|NCT03131973|Omeprazole|omeprazole|mesh-list
57090134|NCT03131973|Pravastatin|pravastatin|mesh-list
57090135|NCT03131973|Montelukast|montelukast|mesh-list
57090136|NCT03131973|Branebrutinib|branebrutinib|mesh-list
57090137|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57090138|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
57090139|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57090140|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090141|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57090142|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
57090143|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090144|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090145|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
57090146|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090147|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57090148|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57090149|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
57090150|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57090151|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57090152|NCT03131973|Antidotes|antidotes|mesh-ancestor
57090153|NCT03131973|Protective Agents|protective agents|mesh-ancestor
57090154|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
57090155|NCT03131973|Vitamins|vitamins|mesh-ancestor
57090156|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
57090157|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57090158|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57090159|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090160|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57090161|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57090162|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57090163|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57090164|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
57090165|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
57090166|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
57090167|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
57090168|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090169|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57090170|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57090171|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57090172|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57090173|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
57090174|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57090175|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57090176|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57090177|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57090178|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
57090179|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57090180|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
57090181|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090182|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57090183|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57090184|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57090185|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57090186|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57090187|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57090188|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57090189|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57090190|NCT03131973|Analgesics|analgesics|mesh-ancestor
57090191|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
57090192|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314243|NCT04726345|Fexofenadine|fexofenadine|mesh-list
57090193|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57090194|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57090195|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772136|NCT01563068|Calcipotriene|calcipotriene|mesh-list
57090196|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57090197|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57090199|NCT05078931|Lenvatinib|lenvatinib|mesh-list
57090200|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090201|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090202|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57090203|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090204|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090205|NCT04247165|Gemcitabine|gemcitabine|mesh-list
57090206|NCT04247165|Paclitaxel|paclitaxel|mesh-list
57090207|NCT04247165|Nivolumab|nivolumab|mesh-list
57090208|NCT04247165|Ipilimumab|ipilimumab|mesh-list
57090209|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57090210|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090211|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
57090212|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
57090213|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
57090214|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090215|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57090216|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
57090217|NCT04247165|Antiviral Agents|antiviral agents|mesh-ancestor
57090218|NCT04247165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090219|NCT04247165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090220|NCT04247165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57090221|NCT04247165|Immunologic Factors|immunologic factors|mesh-ancestor
57090222|NCT04247165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090223|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090224|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57090225|NCT04825197|Poractant alfa|poractant alfa|mesh-list
57090226|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
57090227|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
57090228|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
57090229|NCT04187105|Fludarabine|fludarabine|mesh-list
57090230|NCT04187105|Tacrolimus|tacrolimus|mesh-list
57090231|NCT04187105|Complement Factor H|complement factor h|mesh-list
57090232|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57090233|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
57090234|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090235|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57090236|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57090237|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
57090238|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090239|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090240|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57090241|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57090242|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090243|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57090244|NCT04703361|Niacin|niacin|mesh-list
57090245|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57090246|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
57090247|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090248|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57090249|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
57090250|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
57090251|NCT04703361|Vitamins|vitamins|mesh-ancestor
57090252|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
57090253|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090254|NCT03010423|Nicorandil|nicorandil|mesh-list
57090255|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57090256|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57090257|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
57090258|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
57090259|NCT03010423|Vitamins|vitamins|mesh-ancestor
57090260|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
57090261|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090262|NCT05576597|Butyric Acid|butyric acid|mesh-list
57090263|NCT05576597|Histamine Antagonists|histamine antagonists|mesh-ancestor
57090264|NCT05576597|Histamine Agents|histamine agents|mesh-ancestor
57090265|NCT05576597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090266|NCT05576597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090267|NCT05576597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090268|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
57090269|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57090270|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772214|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
57090271|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57090272|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090273|NCT03665779|Pyridoxine|pyridoxine|mesh-list
57090274|NCT03665779|Isosorbide|isosorbide|mesh-list
57090275|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57090276|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57090277|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57090278|NCT03665779|Diuretics|diuretics|mesh-ancestor
57090279|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
57090280|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090281|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
57090282|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57090283|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090284|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
57090285|NCT03665779|Vitamins|vitamins|mesh-ancestor
57090286|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
57090287|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57090288|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090289|NCT04944017|Ketamine|ketamine|mesh-list
57090290|NCT04944017|Analgesics|analgesics|mesh-ancestor
57090291|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
57090292|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090293|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090294|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57090295|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57090296|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
57090297|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
57090298|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090299|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57090300|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57090301|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090302|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090303|NCT03703427|Capecitabine|capecitabine|mesh-list
57090304|NCT03703427|Vinorelbine|vinorelbine|mesh-list
57090305|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57090306|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
57090307|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090308|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090309|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57090310|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
57090311|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
57090312|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
57090313|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
57090314|NCT03703349|Analgesics|analgesics|mesh-ancestor
57090315|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
57090316|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090317|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090318|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
57090319|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090320|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57090321|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
57090322|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57090323|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57090324|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090325|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57090326|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
57090327|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57090328|NCT03532139|Enoxaparin|enoxaparin|mesh-list
57090329|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
57090330|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57090331|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57090332|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57090333|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
57090334|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090335|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57090336|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57090337|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090338|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
57090339|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57090340|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57090341|NCT03008005|Dronabinol|dronabinol|mesh-list
57090342|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
56772297|NCT03962803|Vaccines|vaccines|mesh-list
57090343|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090344|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57090345|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57090346|NCT03008005|Analgesics|analgesics|mesh-ancestor
57090347|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
57090348|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090349|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57090350|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57090351|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090352|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090353|NCT03008005|Hormones|hormones|mesh-ancestor
57090354|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090355|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
57090356|NCT03666325|Cetuximab|cetuximab|mesh-list
57090357|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090358|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090359|NCT02440425|Paclitaxel|paclitaxel|mesh-list
57090360|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
57090361|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57090362|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090363|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
57090364|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
57090365|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
57090366|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090367|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090368|NCT04931511|Betamethasone|betamethasone|mesh-list
57090369|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
57090370|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57090371|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
57090372|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57090373|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090374|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
57090375|NCT04931511|Hormones|hormones|mesh-ancestor
57090376|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090377|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090378|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57090379|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
57090380|NCT04182321|Metformin|metformin|mesh-list
57090381|NCT04182321|Entecavir|entecavir|mesh-list
57090382|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57090383|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090384|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
57090385|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090386|NCT03702959|Betamethasone|betamethasone|mesh-list
57090387|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090388|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
57090389|NCT03702959|Hormones|hormones|mesh-ancestor
57090390|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090391|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090392|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57090393|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
57090394|NCT04879823|Acetaminophen|acetaminophen|mesh-list
57090395|NCT04879823|Dexamethasone|dexamethasone|mesh-list
57090396|NCT04879823|Ibuprofen|ibuprofen|mesh-list
57090397|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090398|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
57090399|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
57090400|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090401|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090402|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57090403|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
57090404|NCT04879823|Hormones|hormones|mesh-ancestor
57090405|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090406|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57090407|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090408|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57090409|NCT04879823|Analgesics|analgesics|mesh-ancestor
57090410|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
57090411|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
57090412|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57090413|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57090414|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57090415|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090416|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090417|NCT03001219|Methotrexate|methotrexate|mesh-list
57090418|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57090419|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
56772359|NCT00745511|Bevacizumab|bevacizumab|mesh-list
57090420|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57090421|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090422|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57090423|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
57090424|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090425|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090426|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
57090427|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090428|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57090429|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57090430|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
57090431|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57090432|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57090433|NCT03702803|Alprazolam|alprazolam|mesh-list
57090434|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57090435|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090436|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090437|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57090438|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57090439|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57090440|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
57090441|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
57090442|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090443|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090444|NCT03487809|Budesonide|budesonide|mesh-list
57090445|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090446|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57090447|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
57090448|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090449|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090450|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57090451|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
57090452|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
57090453|NCT03487809|Hormones|hormones|mesh-ancestor
57090454|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090455|NCT03702647|Ropivacaine|ropivacaine|mesh-list
57090456|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
57090457|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
57090458|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090459|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090460|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
57090461|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090462|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
57090463|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57090464|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090465|NCT03000673|Heparin|heparin|mesh-list
57090466|NCT03000673|Enoxaparin|enoxaparin|mesh-list
57090467|NCT03000673|Calcium heparin|calcium heparin|mesh-list
57090468|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
57090469|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57090470|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57090471|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090472|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
57090473|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
57090474|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
57090475|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090476|NCT05423249|Protective Agents|protective agents|mesh-ancestor
57090477|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090478|NCT05423249|Vitamins|vitamins|mesh-ancestor
57090479|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
57090480|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
57090481|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57090482|NCT02912455|Canagliflozin|canagliflozin|mesh-list
57090483|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57090484|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090485|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57090486|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090487|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
57090488|NCT03702491|Apatinib|apatinib|mesh-list
57090489|NCT03702491|Tegafur|tegafur|mesh-list
57090490|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090491|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57090492|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090493|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090494|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57090495|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
57090496|NCT03663751|Decitabine|decitabine|mesh-list
57090497|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57090498|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
57090499|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090500|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090501|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090502|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
57090503|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57090504|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57090505|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090506|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
57090507|NCT04054687|Coagulants|coagulants|mesh-ancestor
57090508|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57090509|NCT05295173|Plasminogen|plasminogen|mesh-list
57090510|NCT05295173|Reteplase|reteplase|mesh-list
57090511|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57090512|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57090513|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090514|NCT03492489|Cemiplimab|cemiplimab|mesh-list
57090515|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090516|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090517|NCT02531698|Vaccines|vaccines|mesh-list
57090518|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
57090519|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090520|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
57090521|NCT04308837|Promethazine|promethazine|mesh-list
57090522|NCT04308837|Dexamethasone|dexamethasone|mesh-list
57090523|NCT04308837|Paclitaxel|paclitaxel|mesh-list
57090524|NCT04308837|Carboplatin|carboplatin|mesh-list
57090525|NCT04308837|Palonosetron|palonosetron|mesh-list
57090526|NCT04308837|Famotidine|famotidine|mesh-list
57090527|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57090528|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090529|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
57090530|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
57090531|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
57090532|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090533|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090534|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
57090535|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
57090536|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090537|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090538|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57090539|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
57090540|NCT04308837|Hormones|hormones|mesh-ancestor
57090541|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090542|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57090543|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57090544|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57090545|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090546|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
57090547|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
57090548|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
57090549|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57090550|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
57090551|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
57090552|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090553|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57090554|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
57090555|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
57090556|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57090557|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57090558|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
57090559|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57090560|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57090561|NCT04692467|Amlodipine|amlodipine|mesh-list
57090562|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57090563|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57090564|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57090565|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090566|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57090567|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090568|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
57090569|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
57090570|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57090571|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57090572|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57090573|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57090574|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090575|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
57090576|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090577|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090578|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57090579|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090580|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
57090581|NCT00403793|Etonogestrel|etonogestrel|mesh-list
57090582|NCT00403793|Testosterone|testosterone|mesh-list
57090583|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
57090584|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
57090585|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57090586|NCT00403793|Androgens|androgens|mesh-ancestor
57090588|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090589|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090590|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57090591|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090592|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
57090593|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57090594|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
57090595|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57090596|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57090597|NCT05597098|Cantharidin|cantharidin|mesh-list
57090598|NCT05597098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090599|NCT05597098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090600|NCT03034577|Neostigmine|neostigmine|mesh-list
57090601|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57090602|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090603|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090604|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
57090605|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090606|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090607|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57090608|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
57090609|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090610|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57090611|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
57090612|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57090613|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57090614|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57090615|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090616|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090617|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090618|NCT04364997|Analgesics|analgesics|mesh-ancestor
57090619|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
57090620|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090621|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
57090622|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57090623|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
57090624|NCT05417386|Leucovorin|leucovorin|mesh-list
57090625|NCT05417386|Fluorouracil|fluorouracil|mesh-list
57090626|NCT05417386|Capecitabine|capecitabine|mesh-list
57090627|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
57090628|NCT05417386|Irinotecan|irinotecan|mesh-list
57090629|NCT05417386|Camptothecin|camptothecin|mesh-list
57090630|NCT05417386|Folfirinox|folfirinox|mesh-list
57090631|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
57090632|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090633|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
57090634|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090635|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57090636|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090637|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57090638|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
57090639|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57090640|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57090641|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090642|NCT05417386|Antidotes|antidotes|mesh-ancestor
57090643|NCT05417386|Protective Agents|protective agents|mesh-ancestor
57090644|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
57090645|NCT05417386|Vitamins|vitamins|mesh-ancestor
57090646|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
57090647|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57090648|NCT04005729|Cangrelor|cangrelor|mesh-list
57090649|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57090650|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57090651|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57090652|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57090653|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
57090654|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090655|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090656|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090657|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
57090658|NCT03487107|Yimitasvir|yimitasvir|mesh-list
57090659|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
57090660|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090661|NCT02997163|Talazoparib|talazoparib|mesh-list
57090662|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57090663|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090664|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090665|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090666|NCT03705065|Bupivacaine|bupivacaine|mesh-list
57090667|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
57090668|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
57090669|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090670|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090671|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
57090672|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090673|NCT03702023|Acetaminophen|acetaminophen|mesh-list
57090674|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57090675|NCT03702023|Analgesics|analgesics|mesh-ancestor
57090676|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
57090677|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090678|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090679|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
57090680|NCT04259944|Capecitabine|capecitabine|mesh-list
57090681|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57090682|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
57090683|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090684|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090685|NCT03698513|Aspirin|aspirin|mesh-list
57090686|NCT03698513|Clopidogrel|clopidogrel|mesh-list
57090687|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57090688|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57090689|NCT03698513|Analgesics|analgesics|mesh-ancestor
57090690|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
57090691|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090692|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090693|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090694|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57090695|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57090696|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57090697|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090698|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57090699|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57090700|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090701|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
57090702|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57090703|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57090704|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57090705|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
57090706|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090707|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
57090708|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57090709|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090710|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090711|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57090712|NCT05389852|Analgesics|analgesics|mesh-ancestor
57090713|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
57090714|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090715|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57090716|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57090717|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57090718|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
57090719|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772657|NCT02976909|Cisplatin|cisplatin|mesh-list
57090720|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090721|NCT03698435|Valganciclovir|valganciclovir|mesh-list
57090722|NCT03698435|Ganciclovir|ganciclovir|mesh-list
57090723|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
57090724|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
57090725|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090726|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57090727|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090728|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090729|NCT01652092|Vidarabine|vidarabine|mesh-list
57090730|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
57090731|NCT01652092|Melphalan|melphalan|mesh-list
57090732|NCT01652092|Busulfan|busulfan|mesh-list
57090733|NCT01652092|Fludarabine|fludarabine|mesh-list
57090734|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
57090735|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
57090736|NCT01652092|Mesna|mesna|mesh-list
57090737|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57090738|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
57090739|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090740|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57090741|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57090742|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
57090743|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090744|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090745|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57090746|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57090747|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
57090748|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
57090749|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090750|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090751|NCT01652092|Protective Agents|protective agents|mesh-ancestor
57090752|NCT04572815|Interleukin-12|interleukin-12|mesh-list
57090753|NCT04572815|Ustekinumab|ustekinumab|mesh-list
57090754|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
57090755|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
57090756|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
57090757|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090758|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
57090759|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57090760|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57090761|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57090762|NCT04572815|Growth Substances|growth substances|mesh-ancestor
57090763|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
57090764|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090765|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57090766|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57090767|NCT03697889|Naproxen|naproxen|mesh-list
57090768|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57090769|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57090770|NCT03697889|Analgesics|analgesics|mesh-ancestor
57090771|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
57090772|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090773|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090774|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090775|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57090776|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
57090777|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57090778|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090779|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090780|NCT03692819|Amoxicillin|amoxicillin|mesh-list
57090781|NCT03692819|Metronidazole|metronidazole|mesh-list
57090782|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57090783|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090784|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57090785|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57090786|NCT00458536|Molgramostim|molgramostim|mesh-list
57090787|NCT00458536|Sargramostim|sargramostim|mesh-list
57090788|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
57090789|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090790|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090791|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57090792|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56772736|NCT00961194|Ketamine|ketamine|mesh-list
57090793|NCT05577364|Prednisone|prednisone|mesh-list
57090794|NCT05577364|Cyclophosphamide|cyclophosphamide|mesh-list
57090795|NCT05577364|Doxorubicin|doxorubicin|mesh-list
57090796|NCT05577364|Vincristine|vincristine|mesh-list
57090797|NCT05577364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57090798|NCT05577364|Immunologic Factors|immunologic factors|mesh-ancestor
57090799|NCT05577364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090800|NCT05577364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57090801|NCT05577364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57090802|NCT05577364|Alkylating Agents|alkylating agents|mesh-ancestor
57090803|NCT05577364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090804|NCT05577364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090805|NCT05577364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57090806|NCT05577364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57090807|NCT05577364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57090808|NCT05577364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57090809|NCT05577364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090810|NCT05577364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090811|NCT05577364|Glucocorticoids|glucocorticoids|mesh-ancestor
57090812|NCT05577364|Hormones|hormones|mesh-ancestor
57090813|NCT05577364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090814|NCT05577364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57090815|NCT05577364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57090816|NCT05577364|Tubulin Modulators|tubulin modulators|mesh-ancestor
57090817|NCT05577364|Antimitotic Agents|antimitotic agents|mesh-ancestor
57090818|NCT05577364|Mitosis Modulators|mitosis modulators|mesh-ancestor
57090819|NCT03697655|Daratumumab|daratumumab|mesh-list
57090820|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090821|NCT03701321|Dexamethasone|dexamethasone|mesh-list
57090822|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
57090823|NCT03701321|Bortezomib|bortezomib|mesh-list
57090824|NCT03701321|Venetoclax|venetoclax|mesh-list
57090825|NCT03701321|Daratumumab|daratumumab|mesh-list
57090826|NCT03701321|Ichthammol|ichthammol|mesh-list
57090827|NCT03701321|BB 1101|bb 1101|mesh-list
57090828|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57090829|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
57090830|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
57090831|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090832|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090833|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57090834|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
57090835|NCT03701321|Hormones|hormones|mesh-ancestor
57090836|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57090837|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57090838|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090839|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
57090840|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090841|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090842|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
57090843|NCT02526550|Vaccines|vaccines|mesh-list
57090844|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
57090845|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090846|NCT05565352|Ketamine|ketamine|mesh-list
57090847|NCT05565352|Analgesics|analgesics|mesh-ancestor
57090848|NCT05565352|Sensory System Agents|sensory system agents|mesh-ancestor
57090849|NCT05565352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090850|NCT05565352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090851|NCT05565352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57090852|NCT05565352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57090853|NCT05565352|Anesthetics, General|anesthetics, general|mesh-ancestor
57090854|NCT05565352|Anesthetics|anesthetics|mesh-ancestor
57090855|NCT05565352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090856|NCT05565352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56899507|NCT04491968|Methadone|methadone|mesh-list
57090857|NCT05565352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57090858|NCT05565352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090859|NCT05565352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090860|NCT04423276|Donepezil|donepezil|mesh-list
57090861|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57090862|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090863|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090864|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
57090865|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090866|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090867|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
57090868|NCT05564416|Atezolizumab|atezolizumab|mesh-list
57090869|NCT05564416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57090870|NCT05564416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090871|NCT05564416|Immunologic Factors|immunologic factors|mesh-ancestor
57090872|NCT05564416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090873|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
57090874|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090875|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090876|NCT03701087|Vitamin D|vitamin d|mesh-list
57090877|NCT03701087|Vitamins|vitamins|mesh-ancestor
57090878|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
57090879|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090880|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57090881|NCT03934372|Ponatinib|ponatinib|mesh-list
57090882|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090883|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57090884|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090885|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090886|NCT03697265|Pregnanolone|pregnanolone|mesh-list
57090887|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
57090888|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090889|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090890|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57090891|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57090892|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
57090893|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090894|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090895|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
57090896|NCT04336943|Durvalumab|durvalumab|mesh-list
57090897|NCT04336943|Olaparib|olaparib|mesh-list
57090898|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57090899|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
57090900|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57090901|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
57090902|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090903|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090904|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
57090905|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090906|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090907|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090908|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
57090909|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57090910|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57090911|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090912|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
57090913|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
57090914|NCT04511039|Trifluridine|trifluridine|mesh-list
57090915|NCT04511039|Talazoparib|talazoparib|mesh-list
57090916|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57090917|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090918|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090919|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090920|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
57090921|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
57090922|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090923|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
57090924|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
57090925|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57090926|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090927|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090928|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
57090929|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57090930|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090931|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090932|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
57090933|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57090934|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57090935|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57090936|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090937|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
57090938|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090939|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090940|NCT03696095|Ropivacaine|ropivacaine|mesh-list
57090941|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
57090942|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
57090943|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57090944|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090945|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
57090946|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57090947|NCT03700229|Rituximab|rituximab|mesh-list
57090948|NCT03700229|Bortezomib|bortezomib|mesh-list
56772882|NCT00966576|Timolol|timolol|mesh-list
57090949|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57090951|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
57090952|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090953|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57090954|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57090955|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57090956|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090957|NCT03695705|Rifaximin|rifaximin|mesh-list
57090958|NCT03695705|Norfloxacin|norfloxacin|mesh-list
57090959|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57090960|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57090961|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57090962|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57090963|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57090964|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57090965|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090966|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090967|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57090968|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57090969|NCT03699839|Vaccines|vaccines|mesh-list
57090970|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
57090971|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090972|NCT04050215|Edetic Acid|edetic acid|mesh-list
57090973|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57090974|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
57090975|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
57090976|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090977|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
57090978|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57090979|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57090980|NCT03691649|Timolol|timolol|mesh-list
57090981|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57090982|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57090983|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57090984|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57090985|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57090986|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
57090987|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57090988|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57090989|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57090990|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57090991|NCT03699449|Paclitaxel|paclitaxel|mesh-list
57090992|NCT03699449|Durvalumab|durvalumab|mesh-list
57090993|NCT03699449|Olaparib|olaparib|mesh-list
57090994|NCT03699449|Tremelimumab|tremelimumab|mesh-list
57090995|NCT03699449|Cediranib|cediranib|mesh-list
57090996|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57090997|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57090998|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57090999|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
57091000|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
57091001|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
57091002|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091003|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57091004|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
57091005|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091006|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57091007|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091008|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57091009|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
57091010|NCT04475939|Niraparib|niraparib|mesh-list
57091011|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57091012|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091013|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57091014|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091015|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091016|NCT03699293|Aspirin|aspirin|mesh-list
57091017|NCT03699293|Celecoxib|celecoxib|mesh-list
57091018|NCT03699293|Naproxen|naproxen|mesh-list
57091019|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57091020|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57091021|NCT03699293|Analgesics|analgesics|mesh-ancestor
57091022|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
56772956|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091023|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091024|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091025|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091026|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091027|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57091028|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57091029|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091030|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57091031|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57091032|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091034|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57091035|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
57091036|NCT03029819|Nicotine|nicotine|mesh-list
57091037|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57091038|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
57091039|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091040|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091041|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57091042|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57091043|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
57091044|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091045|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091046|NCT03105830|Acetaminophen|acetaminophen|mesh-list
57091047|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57091048|NCT03105830|Analgesics|analgesics|mesh-ancestor
57091049|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
57091050|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091051|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091052|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
57091053|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
57091054|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57091055|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57091056|NCT03699215|Simendan|simendan|mesh-list
57091057|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57091058|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
57091059|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57091060|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57091061|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091062|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091063|NCT03699215|Protective Agents|protective agents|mesh-ancestor
57091064|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091065|NCT03694535|Mitomycins|mitomycins|mesh-list
57091066|NCT03694535|Mitomycin|mitomycin|mesh-list
57091067|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57091068|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091069|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
57091070|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091071|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57091072|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091073|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
57091074|NCT05358938|Ipilimumab|ipilimumab|mesh-list
57091075|NCT05358938|Avelumab|avelumab|mesh-list
57091076|NCT05358938|Cemiplimab|cemiplimab|mesh-list
57091077|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57091078|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57091079|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091080|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091081|NCT03115034|Melatonin|melatonin|mesh-list
57091082|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
57091083|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091084|NCT03115034|Protective Agents|protective agents|mesh-ancestor
57091085|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091086|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091087|NCT05563220|Everolimus|everolimus|mesh-list
57091088|NCT05563220|Palbociclib|palbociclib|mesh-list
57091089|NCT05563220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091090|NCT05563220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091091|NCT05563220|Immunologic Factors|immunologic factors|mesh-ancestor
57091092|NCT05563220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091093|NCT05563220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57091094|NCT05563220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091095|NCT05563220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773031|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
57091096|NCT05540522|Vaccines|vaccines|mesh-list
57091097|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
57091098|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091099|NCT05525546|Vaccines|vaccines|mesh-list
57091100|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
57091101|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091102|NCT03027557|Denosumab|denosumab|mesh-list
57091103|NCT03027557|Cinacalcet|cinacalcet|mesh-list
57091104|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57091105|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091106|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57091107|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
57091108|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
57091109|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091110|NCT04423211|Leuprolide|leuprolide|mesh-list
57091111|NCT04423211|Goserelin|goserelin|mesh-list
57091112|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57091113|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
57091114|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57091115|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091116|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57091117|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091118|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57091119|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57091120|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091121|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
57091122|NCT04039607|Nivolumab|nivolumab|mesh-list
57091123|NCT04039607|Ipilimumab|ipilimumab|mesh-list
57091124|NCT04039607|Sorafenib|sorafenib|mesh-list
57091125|NCT04039607|Lenvatinib|lenvatinib|mesh-list
57091126|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57091127|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091128|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57091129|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091130|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57091131|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091132|NCT02691572|Acetaminophen|acetaminophen|mesh-list
57091133|NCT02691572|Ketorolac|ketorolac|mesh-list
57091134|NCT02691572|Fentanyl|fentanyl|mesh-list
57091135|NCT02691572|Bupivacaine|bupivacaine|mesh-list
57091136|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
57091137|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
57091138|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091139|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091140|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
57091141|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091142|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57091143|NCT02691572|Narcotics|narcotics|mesh-ancestor
57091144|NCT02691572|Analgesics|analgesics|mesh-ancestor
57091145|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57091146|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57091147|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
57091148|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57091149|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
57091150|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57091151|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091152|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091153|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57091154|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091155|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091156|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57091157|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57091158|NCT05300048|Paclitaxel|paclitaxel|mesh-list
57091159|NCT05300048|Serabelisib|serabelisib|mesh-list
57091160|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57091161|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091162|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
57091163|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
57091164|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
57091165|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091166|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091167|NCT03693833|Cannabidiol|cannabidiol|mesh-list
57091168|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
57091169|NCT03693599|Carbetocin|carbetocin|mesh-list
57091170|NCT03693599|Syntometrine|syntometrine|mesh-list
57091171|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
56773104|NCT00967434|Atorvastatin|atorvastatin|mesh-list
57091172|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57091173|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091175|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091176|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
57091177|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091178|NCT04270643|Vitamin D|vitamin d|mesh-list
57091179|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
57091180|NCT04270643|Vitamins|vitamins|mesh-ancestor
57091181|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
57091182|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091183|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57091184|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57091185|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
57091186|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57091187|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57091188|NCT02677844|Loperamide|loperamide|mesh-list
57091189|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
57091190|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57091191|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
57091192|NCT03687905|Chloroquine|chloroquine|mesh-list
57091193|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
57091194|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57091195|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57091196|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091197|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091198|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091199|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091200|NCT03687905|Amebicides|amebicides|mesh-ancestor
57091201|NCT03687515|Prednisone|prednisone|mesh-list
57091202|NCT03687515|Budesonide|budesonide|mesh-list
57091203|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091204|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
57091205|NCT03687515|Hormones|hormones|mesh-ancestor
57091206|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091207|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091208|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57091209|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091210|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57091211|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
57091212|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091213|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57091214|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
57091215|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57091216|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57091217|NCT02691494|Norethindrone|norethindrone|mesh-list
57091218|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
57091219|NCT02691494|Estradiol|estradiol|mesh-list
57091220|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57091221|NCT02691494|Estrogens|estrogens|mesh-ancestor
57091222|NCT02691494|Hormones|hormones|mesh-ancestor
57091223|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091224|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091225|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57091226|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
57091227|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57091228|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57091229|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57091230|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57091231|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57091232|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
57091233|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
57091234|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57091235|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57091236|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091237|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091238|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091239|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091240|NCT04140305|Ozanimod|ozanimod|mesh-list
57091241|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57091242|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091243|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091244|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
57091245|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091246|NCT02682602|Tacrine|tacrine|mesh-list
57091247|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57091248|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773179|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57091249|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091250|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
57091251|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091252|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091253|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57091254|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
57091255|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091256|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
57091257|NCT03691337|Bupivacaine|bupivacaine|mesh-list
57091258|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57091259|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
57091260|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
57091261|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091262|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091263|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
57091264|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091265|NCT02681510|Nicotine|nicotine|mesh-list
57091266|NCT02681510|Varenicline|varenicline|mesh-list
57091267|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57091268|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
57091269|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091270|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091271|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57091272|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57091273|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
57091274|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091275|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091276|NCT03690323|Gemcitabine|gemcitabine|mesh-list
57091277|NCT03690323|Paclitaxel|paclitaxel|mesh-list
57091278|NCT03690323|Folfirinox|folfirinox|mesh-list
57091279|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57091280|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091281|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
57091282|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
57091283|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
57091284|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091285|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57091286|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
57091287|NCT03690323|Antiviral Agents|antiviral agents|mesh-ancestor
57091288|NCT03690323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091289|NCT03690323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091290|NCT03690323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091291|NCT03690323|Immunologic Factors|immunologic factors|mesh-ancestor
57091292|NCT03690323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091293|NCT03682211|Fentanyl|fentanyl|mesh-list
57091294|NCT03682211|Morphine|morphine|mesh-list
57091295|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57091296|NCT03682211|Narcotics|narcotics|mesh-ancestor
57091297|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091298|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091299|NCT03682211|Analgesics|analgesics|mesh-ancestor
57091300|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
57091301|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091302|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57091303|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57091304|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
57091305|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
57091306|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
57091307|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
57091308|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57091309|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57091310|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091311|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091312|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091313|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091314|NCT02690714|Plasminogen|plasminogen|mesh-list
57091315|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57091316|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57091317|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091318|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57091319|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57091320|NCT03690167|Mitogens|mitogens|mesh-list
57091321|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
57091322|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091323|NCT03165890|Acetazolamide|acetazolamide|mesh-list
57091324|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
57091325|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57091326|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091327|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091328|NCT03165890|Diuretics|diuretics|mesh-ancestor
57091329|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
57091330|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091331|NCT03681509|Pramipexole|pramipexole|mesh-list
57091332|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
57091333|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091334|NCT03681509|Protective Agents|protective agents|mesh-ancestor
57091335|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091336|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57091337|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57091338|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
57091339|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
57091340|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091341|NCT05712356|Gemcitabine|gemcitabine|mesh-list
57091342|NCT05712356|Paclitaxel|paclitaxel|mesh-list
57091343|NCT05712356|Docetaxel|docetaxel|mesh-list
57091344|NCT05712356|Durvalumab|durvalumab|mesh-list
57091345|NCT05712356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57091346|NCT05712356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091347|NCT05712356|Tubulin Modulators|tubulin modulators|mesh-ancestor
57091348|NCT05712356|Antimitotic Agents|antimitotic agents|mesh-ancestor
57091349|NCT05712356|Mitosis Modulators|mitosis modulators|mesh-ancestor
57091350|NCT05712356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091351|NCT05712356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57091352|NCT05712356|Antimetabolites|antimetabolites|mesh-ancestor
57091353|NCT05712356|Antiviral Agents|antiviral agents|mesh-ancestor
57091354|NCT05712356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091355|NCT05712356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091356|NCT05712356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091357|NCT05712356|Immunologic Factors|immunologic factors|mesh-ancestor
57091358|NCT05712356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091359|NCT05712356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57091360|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
57091361|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
57091362|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57091363|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091364|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091365|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
57091366|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57091367|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091368|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091369|NCT03161210|Anesthetics|anesthetics|mesh-list
56899519|NCT05668455|Povidone|povidone|mesh-list
57091370|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091371|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091372|NCT01898793|Aldesleukin|aldesleukin|mesh-list
57091373|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
57091374|NCT01898793|Fludarabine|fludarabine|mesh-list
57091375|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
57091376|NCT01898793|Interleukin-2|interleukin-2|mesh-list
57091377|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091378|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
57091379|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091380|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091381|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57091382|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
57091383|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091384|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091385|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57091386|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57091387|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
57091388|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
57091389|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091390|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57091391|NCT01898793|Analgesics|analgesics|mesh-ancestor
57091392|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
57091393|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091394|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57091395|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57091396|NCT03164096|Bupivacaine|bupivacaine|mesh-list
57091397|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
57091398|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
57091399|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091400|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091401|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
57091402|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091403|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
57091404|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57091405|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57091406|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091407|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57091408|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57091409|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091410|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
57091411|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
57091412|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57091413|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091414|NCT03681197|Metformin|metformin|mesh-list
57091415|NCT03681197|Clomiphene|clomiphene|mesh-list
57091416|NCT03681197|Enclomiphene|enclomiphene|mesh-list
57091417|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
57091418|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57091419|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091420|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57091421|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
57091422|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091423|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57091424|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
57091425|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57091426|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57091427|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57091428|NCT03485703|Azithromycin|azithromycin|mesh-list
57091429|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57091430|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091431|NCT03165344|Prednisone|prednisone|mesh-list
57091432|NCT03165344|Triamcinolone|triamcinolone|mesh-list
57091433|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57091434|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57091435|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
57091436|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57091437|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57091438|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57091439|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
57091440|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57091441|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091442|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
57091443|NCT03165344|Hormones|hormones|mesh-ancestor
57091444|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091445|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091446|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57091447|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091448|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091449|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
57091450|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091451|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091452|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57091453|NCT03165344|Antacids|antacids|mesh-ancestor
57091454|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57091455|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
57091456|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57091457|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57091458|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
57091459|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091460|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091461|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091462|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
57091463|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
57091464|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091465|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
57091466|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57091467|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
57091468|NCT03689465|Cyclosporine|cyclosporine|mesh-list
57091469|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
57091470|NCT03689465|Methotrexate|methotrexate|mesh-list
57091471|NCT03689465|Cyclosporins|cyclosporins|mesh-list
57091472|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57091473|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
57091474|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57091475|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091476|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57091477|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
57091478|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091479|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091480|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
57091481|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091482|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57091483|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091484|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
57091485|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091486|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57091487|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
57091488|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091489|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57091490|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57091491|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57091492|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
57091493|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57091494|NCT03485625|Acetaminophen|acetaminophen|mesh-list
57091495|NCT03485625|Ketorolac|ketorolac|mesh-list
57091496|NCT03485625|Lidocaine|lidocaine|mesh-list
57091497|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
57091498|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
57091499|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091500|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091501|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
57091502|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091503|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57091504|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57091505|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57091506|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57091507|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091508|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57091509|NCT03485625|Analgesics|analgesics|mesh-ancestor
57091510|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
57091511|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57091512|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091513|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091514|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57091515|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091516|NCT03680885|Lidocaine|lidocaine|mesh-list
57091517|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
57091518|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
57091519|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091520|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091521|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
57091522|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091523|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57091524|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57091525|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57091526|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57091527|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091528|NCT03033069|Sertraline|sertraline|mesh-list
57091529|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
57091530|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
57091531|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57091532|NCT03033069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57091533|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57091534|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57091535|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091536|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091537|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
57091538|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091539|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
57091540|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
57091541|NCT03685409|Metformin|metformin|mesh-list
57091542|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57091543|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091544|NCT03653507|Capecitabine|capecitabine|mesh-list
57091545|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
57091546|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57091547|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
57091548|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091549|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091550|NCT03165500|Midazolam|midazolam|mesh-list
57091551|NCT03165500|Diazepam|diazepam|mesh-list
57091552|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
57091553|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57091554|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57091555|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091556|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091557|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57091558|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57091559|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57091560|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57091561|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
57091562|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
57091563|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
57091564|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
57091565|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091566|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091567|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57091568|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57091569|NCT03165500|Analgesics|analgesics|mesh-ancestor
57091570|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
57091571|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091572|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
57091573|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
57091574|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
57091575|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57091576|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57091577|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57091578|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
57091579|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57091580|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091581|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091582|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57091583|NCT03163238|Analgesics|analgesics|mesh-ancestor
57091584|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
57091585|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091586|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57091587|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57091588|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57091589|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
57091590|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091591|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091592|NCT05127044|Bilirubin|bilirubin|mesh-list
57091593|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
57091594|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091595|NCT05127044|Protective Agents|protective agents|mesh-ancestor
57091596|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091597|NCT03486561|Ranolazine|ranolazine|mesh-list
57091598|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57091599|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57091600|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091601|NCT03680573|Allopurinol|allopurinol|mesh-list
57091602|NCT03680573|Nitroprusside|nitroprusside|mesh-list
57091603|NCT03680573|Nitroarginine|nitroarginine|mesh-list
57091604|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
57091605|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
57091606|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091607|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091608|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
57091609|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091610|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57091611|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
57091612|NCT03680573|Protective Agents|protective agents|mesh-ancestor
57091613|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091614|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57091615|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
57091616|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57091617|NCT03689075|Tacrolimus|tacrolimus|mesh-list
57091618|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091619|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
57091620|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091621|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57091622|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091623|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091624|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
57091625|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57091626|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57091627|NCT03680495|Prednisolone|prednisolone|mesh-list
57091628|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
57091629|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57091630|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
57091631|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091632|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
57091633|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
57091634|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091635|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091636|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57091637|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
57091638|NCT03680495|Hormones|hormones|mesh-ancestor
57091639|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091640|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57091641|NCT03680495|Protective Agents|protective agents|mesh-ancestor
57091642|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57091643|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091644|NCT03647969|Nivolumab|nivolumab|mesh-list
57091645|NCT03647969|Ipilimumab|ipilimumab|mesh-list
57091646|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57091647|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091648|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57091649|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091650|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
57091651|NCT03492255|Prednisone|prednisone|mesh-list
57091652|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
57091653|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
57091654|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091655|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
57091656|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091657|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091658|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57091659|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
57091660|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091661|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091662|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57091663|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091664|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
57091665|NCT03492255|Hormones|hormones|mesh-ancestor
57091666|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091667|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57091668|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57091669|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57091670|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
57091671|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57091672|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091673|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091674|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
57091675|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
57091676|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091677|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57091678|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57091679|NCT03492255|Protective Agents|protective agents|mesh-ancestor
57091680|NCT03684863|Capecitabine|capecitabine|mesh-list
57091681|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57091682|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
57091683|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091684|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091685|NCT03680339|Misoprostol|misoprostol|mesh-list
57091686|NCT03680339|Oxytocin|oxytocin|mesh-list
57091687|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
57091688|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57091689|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091690|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57091691|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
57091692|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57091693|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57091694|NCT03680183|Entecavir|entecavir|mesh-list
57091695|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
57091696|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091697|NCT02136069|Infliximab|infliximab|mesh-list
57091698|NCT02136069|Etrolizumab|etrolizumab|mesh-list
57091699|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
57091700|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57091701|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091702|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
57091703|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091704|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57091705|NCT02917031|Saxagliptin|saxagliptin|mesh-list
57091707|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091708|NCT02917031|Incretins|incretins|mesh-ancestor
57091709|NCT02917031|Hormones|hormones|mesh-ancestor
57091710|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091711|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57091712|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
57091713|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091714|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091715|NCT04460547|Interferons|interferons|mesh-list
57091716|NCT04460547|Interferon-beta|interferon-beta|mesh-list
57091717|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
57091718|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
57091719|NCT04460547|Ivermectin|ivermectin|mesh-list
57091720|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091721|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
57091722|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091723|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
57091724|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57091725|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57091726|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091727|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091728|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57091729|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
57091730|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091731|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57091732|NCT03132051|Triamcinolone|triamcinolone|mesh-list
57091733|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57091734|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57091735|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57091736|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091737|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
57091738|NCT03132051|Hormones|hormones|mesh-ancestor
57091739|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091740|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091741|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091742|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
57091743|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091744|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091745|NCT03684707|Metformin|metformin|mesh-list
57091746|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57091747|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091748|NCT03631199|Paclitaxel|paclitaxel|mesh-list
57091749|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57091750|NCT03631199|Carboplatin|carboplatin|mesh-list
57091751|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
57091752|NCT03631199|Pemetrexed|pemetrexed|mesh-list
57091753|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57091754|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57091755|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091756|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
57091757|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
57091758|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
57091759|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091760|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57091761|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091762|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57091763|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57091764|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
57091765|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091766|NCT01018563|Farletuzumab|farletuzumab|mesh-list
57091767|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091768|NCT02528188|Tanezumab|tanezumab|mesh-list
57091769|NCT02528188|Analgesics|analgesics|mesh-ancestor
57091770|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
57091771|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091772|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091773|NCT03684395|Warfarin|warfarin|mesh-list
57091774|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
57091775|NCT03684395|Dabigatran|dabigatran|mesh-list
57091776|NCT03684395|Apixaban|apixaban|mesh-list
57091777|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
57091778|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57091779|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
57091780|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57091781|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
57091782|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091783|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091785|NCT04460001|Ranibizumab|ranibizumab|mesh-list
57091786|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57091787|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57091788|NCT04460001|Growth Substances|growth substances|mesh-ancestor
57091789|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091790|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
57091791|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091792|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091793|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
57091794|NCT04460001|Hormones|hormones|mesh-ancestor
57091795|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091796|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
57091797|NCT03484845|Lactoferrin|lactoferrin|mesh-list
57091798|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091799|NCT03484845|Trace Elements|trace elements|mesh-ancestor
57091800|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
57091801|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091802|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
57091803|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57091804|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57091805|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091806|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
57091807|NCT03679481|Coagulants|coagulants|mesh-ancestor
57091808|NCT04461249|Travoprost|travoprost|mesh-list
57091809|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57091810|NCT04461249|Latanoprost|latanoprost|mesh-list
57091811|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57091812|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57091813|NCT05151549|Carboplatin|carboplatin|mesh-list
57091814|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091815|NCT05151393|Vitamin D|vitamin d|mesh-list
57091816|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
57091817|NCT05151393|Vitamins|vitamins|mesh-ancestor
57091818|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
57091819|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091820|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57091821|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57091822|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57091823|NCT03484611|Cetrorelix|cetrorelix|mesh-list
57091824|NCT03484611|Menotropins|menotropins|mesh-list
57091825|NCT03484611|Progesterone|progesterone|mesh-list
57091826|NCT03484611|Progestins|progestins|mesh-ancestor
57091827|NCT03484611|Hormones|hormones|mesh-ancestor
57091828|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091829|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091830|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57091831|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57091832|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
57091833|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
57091834|NCT03679325|Vitamin D|vitamin d|mesh-list
57091835|NCT03679325|Vitamins|vitamins|mesh-ancestor
57091836|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
57091837|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091838|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57091839|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
57091840|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57091841|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091842|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
57091843|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
57091844|NCT03623789|Hemostatics|hemostatics|mesh-list
57091845|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57091846|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57091847|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091848|NCT03623789|Coagulants|coagulants|mesh-ancestor
57091849|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
57091850|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57091851|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57091852|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091853|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57091854|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57091855|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091856|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091857|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
57091858|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
57091859|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091860|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
57091861|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091862|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57091864|NCT03623711|Bupropion|bupropion|mesh-list
57091865|NCT03623711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57091866|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57091867|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57091868|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091869|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091870|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
57091871|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091872|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57091873|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
57091874|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57091875|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091876|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57091877|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
57091878|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57091879|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57091880|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091881|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57091882|NCT03623711|Analgesics|analgesics|mesh-ancestor
57091883|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
57091884|NCT05368090|Epinephrine|epinephrine|mesh-list
57091885|NCT05368090|Racepinephrine|racepinephrine|mesh-list
57091886|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
57091887|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57091888|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57091889|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
57091890|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091891|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091892|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091893|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57091894|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57091895|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
57091896|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091897|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57091898|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
57091899|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
57091900|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
57091901|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57091902|NCT05382442|Leucovorin|leucovorin|mesh-list
57091903|NCT05382442|Bevacizumab|bevacizumab|mesh-list
57091904|NCT05382442|Fluorouracil|fluorouracil|mesh-list
57091905|NCT05382442|Capecitabine|capecitabine|mesh-list
57091906|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
57091907|NCT05382442|Irinotecan|irinotecan|mesh-list
57091908|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57091909|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091910|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57091911|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57091912|NCT05382442|Growth Substances|growth substances|mesh-ancestor
57091913|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091914|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
57091915|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
57091916|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091917|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57091918|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091919|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
57091920|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57091921|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57091922|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091923|NCT05382442|Antidotes|antidotes|mesh-ancestor
57091924|NCT05382442|Protective Agents|protective agents|mesh-ancestor
57091925|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
57091926|NCT05382442|Vitamins|vitamins|mesh-ancestor
57091927|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
57091928|NCT05362474|Montelukast|montelukast|mesh-list
57091929|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57091930|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
57091931|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57091932|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
57091933|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091934|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091935|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57091936|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57091937|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091939|NCT05607316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57091940|NCT05607316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091941|NCT05599516|Vaccines|vaccines|mesh-list
57091942|NCT05599516|Immunologic Factors|immunologic factors|mesh-ancestor
57091943|NCT05599516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091944|NCT05380024|Ensartinib|ensartinib|mesh-list
57091945|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091946|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57091947|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091948|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091949|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
57091950|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57091951|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57091952|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091953|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57091954|NCT04251910|Analgesics|analgesics|mesh-ancestor
57091955|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
57091956|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57091957|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57091958|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57091959|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57091960|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
57091961|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57091962|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091963|NCT05342194|Gemcitabine|gemcitabine|mesh-list
57091964|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
57091965|NCT05342194|Lenvatinib|lenvatinib|mesh-list
57091966|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57091967|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57091968|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
57091969|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091970|NCT05342194|Antiviral Agents|antiviral agents|mesh-ancestor
57091971|NCT05342194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57091972|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091973|NCT05342194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091974|NCT05342194|Immunologic Factors|immunologic factors|mesh-ancestor
57091975|NCT05342194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091976|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57091977|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
57091978|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
57091979|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57091980|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57091981|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091982|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
57091983|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091984|NCT05306548|Triamcinolone|triamcinolone|mesh-list
57091985|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57091986|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57091987|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57091988|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57091989|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
57091990|NCT05306548|Hormones|hormones|mesh-ancestor
57091991|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57091992|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57091993|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57091994|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
57091995|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57091996|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57091997|NCT05306470|Lidocaine|lidocaine|mesh-list
57091998|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
57091999|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
57092000|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
57092001|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092002|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092003|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
57092004|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092005|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57092006|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57092007|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56773929|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
57092008|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57092009|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092010|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57092011|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57092012|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092013|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57092014|NCT05507476|Epinephrine|epinephrine|mesh-list
57092015|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57092016|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57092017|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
57092018|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092019|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092020|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092021|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57092022|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57092023|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
57092024|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092025|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57092026|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
57092027|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
57092028|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
57092029|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57092030|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
57092031|NCT05507476|Coagulants|coagulants|mesh-ancestor
57092032|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57092033|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
57092034|NCT05339386|Xenon|xenon|mesh-list
57092035|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57092036|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
57092037|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
57092038|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092039|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092040|NCT05339074|Ketamine|ketamine|mesh-list
57092041|NCT05339074|Analgesics|analgesics|mesh-ancestor
57092042|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
57092043|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092044|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092045|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57092046|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57092047|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
57092048|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
57092049|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092050|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57092051|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57092052|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092053|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092054|NCT05560282|Fenfluramine|fenfluramine|mesh-list
57092055|NCT05560282|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57092056|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57092057|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57092058|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092059|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092060|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
57092061|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092062|NCT03530267|Aflibercept|aflibercept|mesh-list
57092063|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57092064|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57092065|NCT03530267|Growth Substances|growth substances|mesh-ancestor
57092066|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092067|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
57092068|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092069|NCT05338450|Clemastine|clemastine|mesh-list
57092070|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
57092071|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
57092072|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57092073|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
57092074|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
57092075|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092076|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092077|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092078|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57092079|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57092080|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57092081|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57092082|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57092083|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092084|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
57092085|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092086|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092087|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57092088|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57092089|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57092090|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
57092091|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092092|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57092093|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57092094|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092095|NCT03678233|Testosterone|testosterone|mesh-list
57092096|NCT03678233|Androgens|androgens|mesh-ancestor
57092097|NCT03678233|Hormones|hormones|mesh-ancestor
57092098|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092099|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092100|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57092101|NCT03676985|Antibodies|antibodies|mesh-list
57092102|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
57092103|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57092104|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
57092105|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092106|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092107|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
57092109|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
57092110|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092111|NCT02988401|Insulin|insulin|mesh-list
57092112|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57092113|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092114|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57092115|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
57092116|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092117|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
57092118|NCT05331664|Polymyxins|polymyxins|mesh-list
57092119|NCT05331664|Trimethoprim|trimethoprim|mesh-list
57092120|NCT05331664|Prednisolone|prednisolone|mesh-list
57092121|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
57092122|NCT05331664|Triamcinolone|triamcinolone|mesh-list
57092123|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57092124|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57092125|NCT05331664|Atropine|atropine|mesh-list
57092126|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57092127|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57092128|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092129|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
57092130|NCT05331664|Hormones|hormones|mesh-ancestor
57092131|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092132|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092133|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57092134|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092135|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
57092136|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092137|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57092138|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092139|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57092140|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57092141|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092142|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092143|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57092144|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
57092145|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57092146|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57092147|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57092148|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57092149|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57092150|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
57092151|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57092152|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57092153|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57092154|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57092155|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
57092156|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
57092157|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
57092158|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57092159|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57092160|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
57092161|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092162|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57092163|NCT05331664|Renal Agents|renal agents|mesh-ancestor
57092164|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
57092165|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57092166|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57092167|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57092168|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57092169|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57092170|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57092171|NCT05297578|Vaccines|vaccines|mesh-list
57092172|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57092173|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
57092174|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092175|NCT05266924|Hormones|hormones|mesh-list
57092176|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57092177|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092178|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092179|NCT05266456|Vaccines|vaccines|mesh-list
57092180|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57092181|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
57092182|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092183|NCT05486416|Propofol|propofol|mesh-list
57092184|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57092185|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092186|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092187|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57092188|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
57092189|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
57092190|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
57092191|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
57092192|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092193|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092194|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57092195|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57092196|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57092197|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
57092198|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092199|NCT05294146|Clofazimine|clofazimine|mesh-list
57092200|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092201|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
57092202|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57092203|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092204|NCT05293288|Anesthetics|anesthetics|mesh-list
57092205|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092206|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092207|NCT03484221|Fluorouracil|fluorouracil|mesh-list
57092208|NCT03484221|Capecitabine|capecitabine|mesh-list
57092209|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
57092210|NCT03484221|Irinotecan|irinotecan|mesh-list
57092211|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
57092212|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092213|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57092214|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092215|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57092216|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
57092217|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092218|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57092219|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57092220|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092221|NCT03857139|Nicotine|nicotine|mesh-list
57092222|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57092223|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
57092224|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092225|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092226|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57092227|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57092228|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
57092229|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092230|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092231|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
56774155|NCT00098839|Doxorubicin|doxorubicin|mesh-list
57092232|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57092233|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092234|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57092235|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57092236|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092237|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092238|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092240|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
57092241|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
57092242|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092243|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092244|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
57092245|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092246|NCT05322538|Vitamin D|vitamin d|mesh-list
57092247|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
57092248|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
57092249|NCT05322538|Vitamins|vitamins|mesh-list
57092250|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
57092251|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
57092252|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092253|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57092254|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57092255|NCT04965220|Trametinib|trametinib|mesh-list
57092256|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092257|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57092258|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092259|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092260|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
57092261|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092262|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
57092263|NCT05322070|Hormones|hormones|mesh-ancestor
56899540|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57092264|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092265|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092266|NCT03131037|Valacyclovir|valacyclovir|mesh-list
57092267|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
57092268|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092269|NCT03483753|Vasopressins|vasopressins|mesh-list
57092270|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
57092271|NCT03483753|Norepinephrine|norepinephrine|mesh-list
57092272|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57092273|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57092274|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
57092275|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092276|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092277|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092278|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
57092279|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
57092280|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092281|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57092282|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
57092283|NCT03483753|Coagulants|coagulants|mesh-ancestor
57092284|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57092285|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
57092286|NCT03389477|Cisplatin|cisplatin|mesh-list
57092287|NCT03389477|Cetuximab|cetuximab|mesh-list
57092288|NCT03389477|Palbociclib|palbociclib|mesh-list
57092289|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092290|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57092291|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57092292|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092293|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092294|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
57092295|NCT02680574|Hematinics|hematinics|mesh-ancestor
57092296|NCT03672149|Cefazolin|cefazolin|mesh-list
57092297|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57092298|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092299|NCT03672071|Ephedrine|ephedrine|mesh-list
57092300|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
57092301|NCT03672071|Norepinephrine|norepinephrine|mesh-list
57092302|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57092303|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092304|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
57092305|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
57092306|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092307|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57092308|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
57092309|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092310|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092311|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57092312|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57092313|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
57092314|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
57092315|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57092316|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57092317|NCT03480945|Nitroprusside|nitroprusside|mesh-list
57092318|NCT03480945|Serotonin|serotonin|mesh-list
57092319|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57092320|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
57092321|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092322|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092323|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092324|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57092325|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
57092326|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57092327|NCT03483207|Heparin|heparin|mesh-list
57092328|NCT03483207|Warfarin|warfarin|mesh-list
57092329|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
57092330|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57092331|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57092332|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092333|NCT05132985|Carboplatin|carboplatin|mesh-list
57092334|NCT05132985|Pemetrexed|pemetrexed|mesh-list
57092335|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092336|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092337|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092338|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56899541|NCT01191021|Propofol|propofol|mesh-list
57092339|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57092340|NCT05118399|Bupivacaine|bupivacaine|mesh-list
57092341|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
57092342|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
57092343|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092344|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092345|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
57092346|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092347|NCT03908307|Dexamethasone|dexamethasone|mesh-list
57092348|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
57092349|NCT03908307|BB 1101|bb 1101|mesh-list
57092350|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092351|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
57092352|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
57092353|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092354|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092355|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57092356|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
57092357|NCT03908307|Hormones|hormones|mesh-ancestor
57092358|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092359|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57092360|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092361|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
57092362|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092363|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092364|NCT03739593|Dexamethasone|dexamethasone|mesh-list
57092365|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
57092366|NCT03739593|BB 1101|bb 1101|mesh-list
57092367|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092368|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
57092369|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
57092370|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092371|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092372|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57092373|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
57092374|NCT03739593|Hormones|hormones|mesh-ancestor
57092375|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092376|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57092377|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092378|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
57092379|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092380|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092381|NCT05053334|Omalizumab|omalizumab|mesh-list
57092382|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57092383|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57092384|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
57092386|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57092387|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
57092388|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092389|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092390|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
57092391|NCT05254912|Petrolatum|petrolatum|mesh-list
57092392|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57092393|NCT05254912|Protective Agents|protective agents|mesh-ancestor
57092394|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092395|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
57092396|NCT05254912|Emollients|emollients|mesh-ancestor
57092397|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
57092398|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57092399|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092400|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092401|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57092402|NCT03480789|Analgesics|analgesics|mesh-ancestor
57092403|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
57092404|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092405|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57092406|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57092407|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57092408|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
57092409|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092410|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092411|NCT05251636|Aflibercept|aflibercept|mesh-list
57092412|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57092413|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57092414|NCT05251636|Growth Substances|growth substances|mesh-ancestor
57092415|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092416|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
57092417|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092418|NCT03475407|Dexamethasone|dexamethasone|mesh-list
57092419|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
57092420|NCT03475407|BB 1101|bb 1101|mesh-list
57092421|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092422|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
57092423|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
57092424|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092425|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092426|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57092427|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
57092428|NCT03475407|Hormones|hormones|mesh-ancestor
57092429|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092430|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57092431|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092432|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
57092433|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092434|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092435|NCT03655197|Doxycycline|doxycycline|mesh-list
57092436|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57092437|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092438|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
57092439|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57092440|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57092441|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
57092442|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57092443|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57092444|NCT05317624|Prednisolone|prednisolone|mesh-list
57092445|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
57092446|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57092447|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
57092448|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092449|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
57092450|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
57092451|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092452|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092453|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57092454|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
57092455|NCT05317624|Hormones|hormones|mesh-ancestor
57092456|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092457|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57092458|NCT05317624|Protective Agents|protective agents|mesh-ancestor
57092459|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57092460|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092461|NCT03475017|Curcumin|curcumin|mesh-list
57092462|NCT03475017|Piperine|piperine|mesh-list
57092463|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57092464|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57092465|NCT03475017|Analgesics|analgesics|mesh-ancestor
57092466|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
57092467|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092468|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092469|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092470|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57092471|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092472|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092473|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092474|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57092475|NCT03474939|Midazolam|midazolam|mesh-list
57092476|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57092477|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57092478|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092479|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092480|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57092481|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57092482|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57092483|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56899548|NCT01200537|Norinyl|norinyl|mesh-list
57092484|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
57092485|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
57092486|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
57092487|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
57092488|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092489|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092490|NCT03131583|Colchicine|colchicine|mesh-list
57092491|NCT03131583|Febuxostat|febuxostat|mesh-list
57092492|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
57092493|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57092494|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
57092495|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
57092496|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
57092497|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092498|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092499|NCT04672928|Paclitaxel|paclitaxel|mesh-list
57092500|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57092501|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092502|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
57092503|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
57092504|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
57092505|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092506|NCT03480321|Cilostazol|cilostazol|mesh-list
57092507|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57092508|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
57092509|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092510|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092511|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57092512|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
57092513|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57092514|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57092515|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092516|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57092517|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
57092518|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57092519|NCT03480321|Protective Agents|protective agents|mesh-ancestor
57092520|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57092521|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57092522|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092523|NCT04928950|Charcoal|charcoal|mesh-list
57092524|NCT04928950|Antidotes|antidotes|mesh-ancestor
57092525|NCT04928950|Protective Agents|protective agents|mesh-ancestor
57092526|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092527|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
57092528|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092529|NCT02986269|Anesthetics|anesthetics|mesh-list
57092530|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092531|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092532|NCT05313256|Lidocaine|lidocaine|mesh-list
57092533|NCT05313256|Epinephrine|epinephrine|mesh-list
57092534|NCT05313256|Racepinephrine|racepinephrine|mesh-list
57092535|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
57092536|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
57092537|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
57092538|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092539|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092540|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
57092541|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092542|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57092543|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57092544|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57092545|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57092546|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092547|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57092548|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57092549|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
57092550|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092551|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57092552|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57092553|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
57092554|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57092555|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
57092556|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
57092557|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
57092558|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57092559|NCT03474237|Hormones|hormones|mesh-list
57092560|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092561|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092562|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
57092563|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57092564|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092565|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092566|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57092567|NCT05276830|Analgesics|analgesics|mesh-ancestor
57092568|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
57092569|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092570|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57092571|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57092572|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57092573|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
57092574|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092575|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092576|NCT03480165|Parecoxib|parecoxib|mesh-list
57092577|NCT03480165|Ropivacaine|ropivacaine|mesh-list
57092578|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
57092579|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
57092580|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092581|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092582|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
57092583|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092584|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57092585|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57092586|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092587|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092588|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57092589|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57092590|NCT03480165|Analgesics|analgesics|mesh-ancestor
57092591|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092592|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57092593|NCT05311852|Palmidrol|palmidrol|mesh-list
57092594|NCT05311852|Antioxidants|antioxidants|mesh-list
57092595|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092596|NCT05311852|Protective Agents|protective agents|mesh-ancestor
57092597|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092598|NCT05311852|Analgesics|analgesics|mesh-ancestor
57092599|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
57092600|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092601|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57092602|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57092603|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092604|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57092605|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
57092606|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092607|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57092608|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57092609|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092610|NCT05311852|Hormones|hormones|mesh-ancestor
57092611|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092612|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
57092613|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092614|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
57092615|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092616|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092617|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57092618|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
57092619|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57092620|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57092621|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57092622|NCT03671915|Insulin|insulin|mesh-list
57092623|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57092624|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092625|NCT03302195|Heparin|heparin|mesh-list
57092626|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
56899552|NCT01200537|Estradiol|estradiol|mesh-list
57092627|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57092628|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57092629|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092630|NCT02515773|Metformin|metformin|mesh-list
57092631|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57092632|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092633|NCT05275426|Gemcitabine|gemcitabine|mesh-list
57092634|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57092635|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
57092636|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092637|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092638|NCT05275426|Antiviral Agents|antiviral agents|mesh-ancestor
57092639|NCT05275426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092640|NCT05275426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092641|NCT05275426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57092642|NCT05275426|Immunologic Factors|immunologic factors|mesh-ancestor
57092643|NCT05275426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092644|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57092645|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
57092646|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57092647|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
57092648|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092649|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
57092650|NCT03114020|Protective Agents|protective agents|mesh-ancestor
57092651|NCT04460079|Lenograstim|lenograstim|mesh-list
57092652|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57092653|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
57092654|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092655|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
57092656|NCT05239468|Bezafibrate|bezafibrate|mesh-list
57092657|NCT05239468|Cathartics|cathartics|mesh-ancestor
57092658|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57092659|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57092660|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
57092661|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092662|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57092663|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
57092664|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57092665|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092666|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57092667|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
57092668|NCT03676361|Coagulants|coagulants|mesh-ancestor
57092669|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57092670|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
57092671|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092672|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57092673|NCT01712763|Goserelin|goserelin|mesh-list
57092674|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57092675|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57092676|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092677|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
57092678|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57092679|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
57092680|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57092681|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092682|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57092683|NCT02827877|Copper|copper|mesh-list
57092684|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57092685|NCT02827877|Trastuzumab|trastuzumab|mesh-list
57092686|NCT02827877|Pertuzumab|pertuzumab|mesh-list
57092687|NCT02827877|Antibodies|antibodies|mesh-list
57092688|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
57092689|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57092690|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
57092691|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092692|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092693|NCT02827877|Trace Elements|trace elements|mesh-ancestor
57092694|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
57092695|NCT05218486|Isotretinoin|isotretinoin|mesh-list
57092696|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
57092697|NCT02675426|Upadacitinib|upadacitinib|mesh-list
57092698|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57092699|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57092700|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092701|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092702|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57092703|NCT05216770|Bupivacaine|bupivacaine|mesh-list
57092704|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
57092705|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
57092706|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092707|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092708|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
57092709|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092710|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
57092711|NCT05236036|Temozolomide|temozolomide|mesh-list
57092712|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57092713|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092714|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57092715|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
57092716|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57092717|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092718|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092719|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092720|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57092721|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
57092722|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57092723|NCT02781779|Laxatives|laxatives|mesh-ancestor
57092724|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57092725|NCT05270200|Azacitidine|azacitidine|mesh-list
57092726|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57092727|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
57092728|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092729|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092730|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092731|NCT03217565|Tedizolid|tedizolid|mesh-list
57092732|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
57092733|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
57092734|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57092735|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092736|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57092737|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092738|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092739|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
57092740|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57092741|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57092742|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57092743|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
57092744|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092745|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092746|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092747|NCT04953104|Nivolumab|nivolumab|mesh-list
57092748|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57092749|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092750|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57092751|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092752|NCT03671057|Midazolam|midazolam|mesh-list
57092753|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57092754|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57092755|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092756|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092757|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57092758|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57092759|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57092760|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57092761|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
57092762|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
57092763|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
57092764|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
57092765|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092766|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092767|NCT03670901|Rituximab|rituximab|mesh-list
57092768|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57092769|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092770|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
57092771|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092772|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57092773|NCT05166616|Osimertinib|osimertinib|mesh-list
57092774|NCT05166616|Triptolide|triptolide|mesh-list
57092775|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092776|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57092777|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092778|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092779|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57092780|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
57092781|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
57092782|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092783|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57092784|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
57092785|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57092786|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57092787|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
57092788|NCT05213728|Vaccines|vaccines|mesh-list
57092789|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
57092790|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092791|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
57092792|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57092793|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092794|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092795|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57092796|NCT05165836|Analgesics|analgesics|mesh-ancestor
57092797|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
57092798|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092799|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57092800|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57092801|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57092802|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
57092803|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092804|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092805|NCT05213104|Flecainide|flecainide|mesh-list
57092806|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57092807|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57092808|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57092809|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57092810|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092811|NCT04238416|Lactulose|lactulose|mesh-list
57092812|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57092813|NCT05162014|Empagliflozin|empagliflozin|mesh-list
57092814|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57092815|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57092816|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092817|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092818|NCT05226754|Diacetylrhein|diacetylrhein|mesh-list
57092819|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092820|NCT01657162|Alendronate|alendronate|mesh-list
57092821|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57092822|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092823|NCT05211154|Diclofenac|diclofenac|mesh-list
57092824|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57092825|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57092826|NCT05211154|Analgesics|analgesics|mesh-ancestor
57092827|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
57092828|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092829|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092830|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092831|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57092832|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57092833|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092834|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092836|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
57092837|NCT05159752|Afamelanotide|afamelanotide|mesh-list
57092838|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
57092839|NCT05209906|Fentanyl|fentanyl|mesh-list
57092840|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57092841|NCT05209906|Narcotics|narcotics|mesh-ancestor
57092842|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092843|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092844|NCT05209906|Analgesics|analgesics|mesh-ancestor
57092845|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
57092846|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092847|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57092848|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57092849|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
57092850|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
57092851|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
57092852|NCT04422184|Diuretics|diuretics|mesh-ancestor
57092853|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
57092854|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092855|NCT04422184|Expectorants|expectorants|mesh-ancestor
57092856|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
57092857|NCT05633810|Aspirin|aspirin|mesh-list
57092858|NCT05633810|Colchicine|colchicine|mesh-list
57092859|NCT05633810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57092860|NCT05633810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57092861|NCT05633810|Analgesics|analgesics|mesh-ancestor
57092862|NCT05633810|Sensory System Agents|sensory system agents|mesh-ancestor
57092863|NCT05633810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092864|NCT05633810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092865|NCT05633810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57092866|NCT05633810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57092867|NCT05633810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57092868|NCT05633810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57092869|NCT05633810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092870|NCT05633810|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57092871|NCT05633810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57092872|NCT05633810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092873|NCT05633810|Antipyretics|antipyretics|mesh-ancestor
57092874|NCT05633810|Gout Suppressants|gout suppressants|mesh-ancestor
57092875|NCT05633810|Tubulin Modulators|tubulin modulators|mesh-ancestor
57092876|NCT05633810|Antimitotic Agents|antimitotic agents|mesh-ancestor
57092877|NCT05633810|Mitosis Modulators|mitosis modulators|mesh-ancestor
57092878|NCT05633810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092879|NCT05205382|Nicotine|nicotine|mesh-list
57092880|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57092881|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
57092882|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092883|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092884|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57092885|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57092886|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
57092887|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092888|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092889|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57092890|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57092891|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57092892|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57092893|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092894|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57092895|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57092896|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092897|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
57092898|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092899|NCT05203822|Itraconazole|itraconazole|mesh-list
57092900|NCT05203822|Tepotinib|tepotinib|mesh-list
57092901|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
57092902|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092903|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57092904|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57092905|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092906|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092907|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57092908|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
57092909|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092910|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092911|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57092912|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092913|NCT01373294|Lenalidomide|lenalidomide|mesh-list
57092914|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
57092915|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
57092916|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092917|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57092918|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57092919|NCT01373294|Growth Substances|growth substances|mesh-ancestor
57092920|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
57092921|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092922|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57092923|NCT04812548|Azacitidine|azacitidine|mesh-list
57092924|NCT04812548|Venetoclax|venetoclax|mesh-list
57092925|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57092926|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
57092927|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092928|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092929|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092930|NCT05220358|Fostemsavir|fostemsavir|mesh-list
57092931|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57092932|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57092933|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
57092934|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57092935|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57092936|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57092937|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092938|NCT04422028|Desogestrel|desogestrel|mesh-list
57092939|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57092940|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57092941|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57092942|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
57092943|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57092944|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092945|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57092946|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57092947|NCT04422028|Progestins|progestins|mesh-ancestor
57092948|NCT04422028|Hormones|hormones|mesh-ancestor
57092949|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57092950|NCT01656304|Bevacizumab|bevacizumab|mesh-list
57092951|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57092952|NCT01656304|Antibodies|antibodies|mesh-list
57092953|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
57092954|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57092955|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092956|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57092957|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57092958|NCT01656304|Growth Substances|growth substances|mesh-ancestor
57092959|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092960|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
57092961|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
57092962|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
57092963|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57092964|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092965|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092966|NCT04421872|Anesthetics|anesthetics|mesh-list
57092967|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57092968|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092969|NCT05098366|Furosemide|furosemide|mesh-list
57092970|NCT05098366|Diuretics|diuretics|mesh-ancestor
57092971|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
57092972|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092973|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57092974|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57092975|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092976|NCT04227028|Bevacizumab|bevacizumab|mesh-list
57092977|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57092978|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
57092979|NCT04227028|Antibodies|antibodies|mesh-list
57092980|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
57092981|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57092982|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
57092983|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092984|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57092985|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57092986|NCT04227028|Growth Substances|growth substances|mesh-ancestor
57092987|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57092988|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
57092989|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
57092990|NCT03023423|Atezolizumab|atezolizumab|mesh-list
57092991|NCT03023423|Daratumumab|daratumumab|mesh-list
57092992|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57092993|NCT03675191|Orlistat|orlistat|mesh-list
57092994|NCT03675191|Phentermine|phentermine|mesh-list
57092995|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57092996|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57092997|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57092998|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57092999|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57093000|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093001|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
57093002|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
57093003|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
57093004|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093005|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
57093006|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093007|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57093008|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093009|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093010|NCT02635061|Nivolumab|nivolumab|mesh-list
57093011|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093012|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093013|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57093014|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093015|NCT05096728|Nifedipine|nifedipine|mesh-list
57093016|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57093017|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57093018|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093019|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57093020|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093021|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
57093022|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
57093023|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57093024|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
57093025|NCT03190265|Nivolumab|nivolumab|mesh-list
57093026|NCT03190265|Ipilimumab|ipilimumab|mesh-list
57093027|NCT03190265|Pancrelipase|pancrelipase|mesh-list
57093028|NCT03190265|Vaccines|vaccines|mesh-list
57093029|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
57093030|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093031|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093032|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093033|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57093034|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
57093035|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093036|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093037|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57093038|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093039|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57093040|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093041|NCT04421716|Ursolic acid|ursolic acid|mesh-list
57093042|NCT04421716|Curcumin|curcumin|mesh-list
57093043|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57093044|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57093045|NCT04421716|Analgesics|analgesics|mesh-ancestor
57093046|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
57093047|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093048|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093049|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093050|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093051|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093052|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093053|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093054|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093055|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57093056|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57093057|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
57093058|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57093059|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093060|NCT04226950|Interferons|interferons|mesh-list
57093061|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
57093062|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
57093063|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57093064|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093065|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
57093066|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093067|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
57093068|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093069|NCT02521493|Cytarabine|cytarabine|mesh-list
57093070|NCT02521493|Etoposide|etoposide|mesh-list
57093071|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
57093072|NCT02521493|Daunorubicin|daunorubicin|mesh-list
57093073|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
57093074|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
57093075|NCT02521493|Asparaginase|asparaginase|mesh-list
57093076|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
57093077|NCT02521493|Thioguanine|thioguanine|mesh-list
57093078|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
57093079|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57093080|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093081|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57093082|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57093083|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093084|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093085|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57093086|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
57093087|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
57093088|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093089|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093090|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
57093091|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093092|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57093093|NCT02521493|Analgesics|analgesics|mesh-ancestor
57093094|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
57093095|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093096|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57093097|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
57093098|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
57093099|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
57093100|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
57093101|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
57093102|NCT05085574|Celecoxib|celecoxib|mesh-list
57093103|NCT05085574|Famotidine|famotidine|mesh-list
57093104|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57093105|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57093106|NCT05085574|Analgesics|analgesics|mesh-ancestor
57093107|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
57093108|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093109|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093110|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093111|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093112|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57093113|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57093114|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093115|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093116|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57093117|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093118|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57093119|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
57093120|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
57093121|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093122|NCT05085496|Atezolizumab|atezolizumab|mesh-list
57093123|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57093124|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093125|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
57093126|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093127|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
57093128|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
57093129|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
57093130|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
57093131|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57093132|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57093133|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093134|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57093135|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093136|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093137|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57093138|NCT05085340|Renal Agents|renal agents|mesh-ancestor
57093139|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57093140|NCT01126749|Gemcitabine|gemcitabine|mesh-list
57093141|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093142|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57093143|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
56899562|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57093144|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093145|NCT01126749|Antiviral Agents|antiviral agents|mesh-ancestor
57093146|NCT01126749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093147|NCT01126749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093148|NCT01126749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093149|NCT01126749|Immunologic Factors|immunologic factors|mesh-ancestor
57093150|NCT01126749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093151|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
57093152|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
57093153|NCT03674411|Melphalan|melphalan|mesh-list
57093154|NCT03674411|Busulfan|busulfan|mesh-list
57093155|NCT03674411|Fludarabine|fludarabine|mesh-list
57093156|NCT03674411|Tacrolimus|tacrolimus|mesh-list
57093157|NCT03674411|Lenograstim|lenograstim|mesh-list
57093158|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093159|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
57093160|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093161|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093162|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57093163|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
57093164|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093165|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093166|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57093167|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57093168|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093169|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57093170|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57093171|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
57093172|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57093173|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093174|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57093175|NCT03674333|Folic Acid|folic acid|mesh-list
57093176|NCT03674333|Hematinics|hematinics|mesh-ancestor
57093177|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
57093178|NCT03674333|Vitamins|vitamins|mesh-ancestor
57093179|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
57093180|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093181|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
57093182|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57093183|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57093184|NCT03674099|Prednisolone|prednisolone|mesh-list
57093185|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
57093186|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
57093187|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57093188|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
57093189|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093190|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
57093191|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
57093192|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093193|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093194|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093195|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
57093196|NCT03674099|Hormones|hormones|mesh-ancestor
57093197|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57093198|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57093199|NCT03674099|Protective Agents|protective agents|mesh-ancestor
57093200|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57093201|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093202|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57093203|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093204|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093205|NCT05124340|Vaccines|vaccines|mesh-list
57093206|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
57093207|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093208|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
57093209|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093210|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093211|NCT05084404|Guanabenz|guanabenz|mesh-list
57093212|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57093213|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56775148|NCT00682643|Xhance|xhance|mesh-list
57093214|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57093215|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57093216|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
57093217|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093218|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093219|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093220|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
57093221|NCT03473613|Cabergoline|cabergoline|mesh-list
57093222|NCT03473613|Calcium|calcium|mesh-list
57093223|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57093224|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093225|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57093226|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57093227|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57093228|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
57093229|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
57093230|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093231|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093232|NCT03670043|Metformin|metformin|mesh-list
57093233|NCT03670043|Psyllium|psyllium|mesh-list
57093234|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57093235|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093236|NCT03670043|Cathartics|cathartics|mesh-ancestor
57093237|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093238|NCT01701986|Gemcitabine|gemcitabine|mesh-list
57093239|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
57093240|NCT01701986|Rituximab|rituximab|mesh-list
57093241|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57093242|NCT01701986|Busulfan|busulfan|mesh-list
57093243|NCT01701986|Clofarabine|clofarabine|mesh-list
57093244|NCT01701986|Antibodies|antibodies|mesh-list
57093245|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
57093246|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57093247|NCT01701986|Tacrolimus|tacrolimus|mesh-list
57093248|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
57093249|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57093250|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
57093251|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093252|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093253|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093254|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57093255|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
57093256|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093257|NCT01701986|Antiviral Agents|antiviral agents|mesh-ancestor
57093258|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093259|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093260|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093261|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57093262|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57093263|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57093264|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
57093265|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57093266|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
57093267|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57093268|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57093269|NCT05561660|Aspirin|aspirin|mesh-list
57093270|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57093271|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57093272|NCT05561660|Analgesics|analgesics|mesh-ancestor
57093273|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
57093274|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093275|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093276|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093277|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093278|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57093279|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57093280|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093281|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57093282|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57093283|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093284|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
57093285|NCT03042819|Doxorubicin|doxorubicin|mesh-list
57093286|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56775201|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
57093287|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093288|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57093289|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57093290|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093291|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093292|NCT02832687|Acetaminophen|acetaminophen|mesh-list
57093293|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57093294|NCT02832687|Analgesics|analgesics|mesh-ancestor
57093295|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
57093296|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093297|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093298|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
57093299|NCT04372017|Vitamin D|vitamin d|mesh-list
57093300|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
57093301|NCT04372017|Vitamins|vitamins|mesh-ancestor
57093302|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
57093303|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093304|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57093305|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
57093306|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57093307|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57093308|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093309|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093310|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093311|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093312|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
57093313|NCT05233358|Nivolumab|nivolumab|mesh-list
57093314|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57093315|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093316|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093317|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093318|NCT02387918|Dexamethasone|dexamethasone|mesh-list
57093319|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093320|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
57093321|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
57093322|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093323|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093324|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093325|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
57093326|NCT02387918|Hormones|hormones|mesh-ancestor
57093327|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57093328|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57093329|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093330|NCT04312971|Norepinephrine|norepinephrine|mesh-list
57093331|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57093332|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57093333|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
57093334|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093335|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093336|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093337|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
57093338|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
57093339|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093340|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57093341|NCT05231330|Fluorides|fluorides|mesh-list
57093342|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
57093343|NCT05231330|Protective Agents|protective agents|mesh-ancestor
57093344|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093345|NCT05078944|Donepezil|donepezil|mesh-list
57093346|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57093347|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093348|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093349|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
57093350|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093351|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093352|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
57093353|NCT03179475|Oxycodone|oxycodone|mesh-list
57093354|NCT03179475|Naloxone|naloxone|mesh-list
57093355|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57093356|NCT03179475|Narcotics|narcotics|mesh-ancestor
57093357|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57093358|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093359|NCT03179475|Analgesics|analgesics|mesh-ancestor
57093360|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
57093361|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093362|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57093363|NCT03105986|Probenecid|probenecid|mesh-list
57093364|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
57093365|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
57093366|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093367|NCT03105986|Renal Agents|renal agents|mesh-ancestor
57093368|NCT03132129|Manganese|manganese|mesh-list
57093369|NCT03132129|Calcium|calcium|mesh-list
57093370|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57093371|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093372|NCT03132129|Trace Elements|trace elements|mesh-ancestor
57093373|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
57093374|NCT02391662|Gemcitabine|gemcitabine|mesh-list
57093375|NCT02391662|Paclitaxel|paclitaxel|mesh-list
57093376|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57093377|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57093378|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093379|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
57093380|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
57093381|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
57093382|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093383|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57093384|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
57093385|NCT02391662|Antiviral Agents|antiviral agents|mesh-ancestor
57093386|NCT02391662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093387|NCT02391662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093388|NCT02391662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093389|NCT02391662|Immunologic Factors|immunologic factors|mesh-ancestor
57093390|NCT02391662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093391|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
57093392|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57093393|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
57093394|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57093395|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57093396|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093397|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
57093398|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
57093399|NCT04074746|Vidarabine|vidarabine|mesh-list
57093400|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
57093401|NCT04074746|Fludarabine|fludarabine|mesh-list
57093402|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
57093403|NCT04074746|Antibodies|antibodies|mesh-list
57093404|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57093405|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093406|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
57093407|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093408|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093409|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57093410|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
57093411|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093412|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093413|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57093414|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57093415|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
57093416|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
57093417|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093418|NCT05173324|Vaccines|vaccines|mesh-list
57093419|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
57093420|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093421|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
57093422|NCT04029038|Fludarabine|fludarabine|mesh-list
57093423|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093424|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
57093425|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093426|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093427|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57093428|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
57093429|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093430|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093431|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57093432|NCT02898207|Olaparib|olaparib|mesh-list
57093433|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57093434|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093435|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093436|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093437|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
57093438|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57093439|NCT04223518|Antibodies|antibodies|mesh-list
57093440|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
57093441|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093442|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
57093443|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
57093444|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57093445|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57093446|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093447|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093448|NCT02387450|Urological Agents|urological agents|mesh-ancestor
57093449|NCT02390882|Tamsulosin|tamsulosin|mesh-list
57093450|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57093451|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57093452|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57093453|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
57093454|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093455|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093456|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093457|NCT02390882|Urological Agents|urological agents|mesh-ancestor
57093458|NCT05258799|Cytarabine|cytarabine|mesh-list
57093459|NCT05258799|Decitabine|decitabine|mesh-list
57093460|NCT05258799|Aclarubicin|aclarubicin|mesh-list
57093461|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57093462|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
57093463|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093464|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093465|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
57093466|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093467|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093468|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
57093469|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093470|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093471|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57093472|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57093473|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57093474|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
57093475|NCT02387138|Irinotecan|irinotecan|mesh-list
57093476|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093477|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57093478|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57093479|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093480|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093481|NCT02387060|Fentanyl|fentanyl|mesh-list
57093482|NCT02387060|Bupivacaine|bupivacaine|mesh-list
57093483|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
57093484|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
57093485|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57093486|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093487|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
57093488|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093489|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57093490|NCT02387060|Narcotics|narcotics|mesh-ancestor
57093491|NCT02387060|Analgesics|analgesics|mesh-ancestor
57093492|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57093493|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57093494|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
57093495|NCT01365052|Naproxen|naproxen|mesh-list
57093496|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57093497|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57093498|NCT01365052|Analgesics|analgesics|mesh-ancestor
57093499|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
57093500|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093501|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093502|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093503|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093504|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
57093505|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57093506|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093507|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093508|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
57093509|NCT05155215|Fludarabine|fludarabine|mesh-list
57093510|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093511|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
57093512|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093513|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093514|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57093515|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
57093516|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093517|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093518|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56775421|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
57093520|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
57093521|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093522|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57093523|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57093524|NCT03471585|Analgesics|analgesics|mesh-ancestor
57093525|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
57093526|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093527|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57093528|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57093529|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093530|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093531|NCT03471585|Hormones|hormones|mesh-ancestor
57093532|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57093533|NCT05072782|Methotrexate|methotrexate|mesh-list
57093534|NCT05072782|Infliximab|infliximab|mesh-list
57093535|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57093536|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
57093537|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57093538|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093539|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57093540|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
57093541|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093542|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093543|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
57093544|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093545|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57093546|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093547|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
57093548|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093549|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57093550|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093551|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57093552|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
57093553|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
57093554|NCT03379389|Methenamine|methenamine|mesh-list
57093555|NCT03379389|Acriflavine|acriflavine|mesh-list
57093556|NCT03379389|Methylene Blue|methylene blue|mesh-list
57093557|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093558|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093559|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093560|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57093561|NCT03379389|Renal Agents|renal agents|mesh-ancestor
57093562|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57093563|NCT05170438|Paclitaxel|paclitaxel|mesh-list
57093564|NCT05170438|Lenvatinib|lenvatinib|mesh-list
57093565|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57093566|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093567|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
57093568|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
57093569|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
57093570|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093571|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57093572|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093573|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
57093574|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57093575|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093576|NCT03478605|Dexamethasone|dexamethasone|mesh-list
57093577|NCT03478605|Ondansetron|ondansetron|mesh-list
57093578|NCT03478605|Olanzapine|olanzapine|mesh-list
57093579|NCT03478605|Aprepitant|aprepitant|mesh-list
57093580|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093581|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
57093582|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
57093583|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093584|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093585|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093586|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
57093587|NCT03478605|Hormones|hormones|mesh-ancestor
57093588|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57093589|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57093590|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093591|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
57093592|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
57093593|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57093594|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
57093595|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093596|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093597|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57093598|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57093599|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57093600|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57093601|NCT03478605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57093602|NCT03478605|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57093603|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57093604|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57093605|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57093606|NCT05109364|Terazosin|terazosin|mesh-list
57093607|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57093608|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57093609|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57093610|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
57093611|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093612|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093613|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093614|NCT05109364|Urological Agents|urological agents|mesh-ancestor
57093615|NCT02224781|Nivolumab|nivolumab|mesh-list
57093616|NCT02224781|Ipilimumab|ipilimumab|mesh-list
57093617|NCT02224781|Trametinib|trametinib|mesh-list
57093618|NCT02224781|Dabrafenib|dabrafenib|mesh-list
57093619|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
57093620|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093621|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093622|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57093623|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093624|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57093625|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093626|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57093627|NCT02224781|Protective Agents|protective agents|mesh-ancestor
57093628|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093629|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57093630|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
57093631|NCT05053750|Paclitaxel|paclitaxel|mesh-list
57093632|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57093633|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57093634|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093635|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
57093636|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
57093637|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
57093638|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093639|NCT04233892|Estrogens|estrogens|mesh-list
57093640|NCT04233892|Hormones|hormones|mesh-ancestor
57093641|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57093642|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093643|NCT02386358|Benzonidazole|benzonidazole|mesh-list
57093644|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093645|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
57093646|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093647|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57093648|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57093649|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57093650|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093651|NCT03283371|Natalizumab|natalizumab|mesh-list
57093652|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
57093653|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093654|NCT05069350|Bupivacaine|bupivacaine|mesh-list
57093655|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
57093656|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
57093657|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57093658|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093659|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
57093660|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093661|NCT04997902|Tipifarnib|tipifarnib|mesh-list
57093662|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093663|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
57093664|NCT03471351|Tenalisib|tenalisib|mesh-list
57093665|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093666|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093667|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
57093668|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093669|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093670|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
57093671|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57093672|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57093673|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093674|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
57093675|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
57093676|NCT02390258|S66913|s66913|mesh-list
57093677|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57093678|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57093679|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093680|NCT03891446|Bimatoprost|bimatoprost|mesh-list
57093681|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57093682|NCT03059511|Nalbuphine|nalbuphine|mesh-list
57093683|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57093684|NCT03059511|Narcotics|narcotics|mesh-ancestor
57093685|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57093686|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093687|NCT03059511|Analgesics|analgesics|mesh-ancestor
57093688|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
57093689|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093690|NCT04439786|Lidocaine|lidocaine|mesh-list
57093691|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
57093692|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
57093693|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57093694|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093695|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
57093696|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093697|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57093698|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57093699|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57093700|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57093701|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093702|NCT03821792|Prednisone|prednisone|mesh-list
57093703|NCT03821792|Cortisone|cortisone|mesh-list
57093704|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
57093705|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093706|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
57093707|NCT03821792|Hormones|hormones|mesh-ancestor
57093708|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57093709|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093710|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57093711|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093712|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57093713|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093714|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093715|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
57093716|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57093717|NCT02665286|Naproxen|naproxen|mesh-list
57093718|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
57093719|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57093720|NCT02665286|Orphenadrine|orphenadrine|mesh-list
57093721|NCT02665286|Methocarbamol|methocarbamol|mesh-list
57093722|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
57093723|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57093724|NCT02665286|Analgesics|analgesics|mesh-ancestor
57093725|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
57093726|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093727|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093728|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093729|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
57093730|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57093731|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093732|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093733|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
57093734|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093735|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57093736|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57093737|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57093738|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57093739|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
57093740|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
57093741|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57093742|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
57093743|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57093744|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
57093745|NCT02390102|Hematinics|hematinics|mesh-ancestor
57093746|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
57093747|NCT02158091|Rituximab|rituximab|mesh-list
57093748|NCT02158091|Fludarabine|fludarabine|mesh-list
57093749|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093750|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
57093751|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093752|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093753|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57093754|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
57093755|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093756|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093757|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57093758|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093759|NCT02134925|Poly ICLC|poly iclc|mesh-list
57093760|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
57093761|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
57093762|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093763|NCT02910583|Venetoclax|venetoclax|mesh-list
57093764|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093765|NCT03067181|Cisplatin|cisplatin|mesh-list
57093766|NCT03067181|Carboplatin|carboplatin|mesh-list
57093767|NCT03067181|Etoposide|etoposide|mesh-list
57093768|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
57093769|NCT03067181|Bleomycin|bleomycin|mesh-list
57093770|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
57093771|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093772|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57093773|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57093774|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57093775|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093776|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093777|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57093778|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
57093779|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
57093780|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
57093781|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
57093782|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
57093783|NCT03663673|Decanoic acid|decanoic acid|mesh-list
57093784|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
57093785|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093786|NCT04058743|Cobalt|cobalt|mesh-list
57093787|NCT04058743|Chromium|chromium|mesh-list
57093788|NCT04058743|Nickel|nickel|mesh-list
57093789|NCT04058743|Trace Elements|trace elements|mesh-ancestor
57093790|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
57093791|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093792|NCT03664063|Azithromycin|azithromycin|mesh-list
57093793|NCT03664063|Ivermectin|ivermectin|mesh-list
57093794|NCT03664063|Albendazole|albendazole|mesh-list
57093795|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
57093796|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57093797|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093798|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57093799|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
57093800|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
57093801|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57093802|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57093803|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
57093804|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
57093805|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
57093806|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093807|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093808|NCT03664063|Filaricides|filaricides|mesh-ancestor
57093809|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
57093810|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
57093811|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093812|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
57093813|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57093814|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
57093815|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093816|NCT02911285|Expectorants|expectorants|mesh-ancestor
57093817|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
57093818|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57093819|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
57093820|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093821|NCT02911285|Protective Agents|protective agents|mesh-ancestor
57093822|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093823|NCT02911285|Antidotes|antidotes|mesh-ancestor
57093824|NCT01061515|Bevacizumab|bevacizumab|mesh-list
57093825|NCT01061515|Capecitabine|capecitabine|mesh-list
57093826|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
57093827|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093828|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093829|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57093830|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57093831|NCT01061515|Growth Substances|growth substances|mesh-ancestor
57093832|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093833|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
57093834|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57093835|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
57093836|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093837|NCT01069939|Esomeprazole|esomeprazole|mesh-list
57093838|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57093839|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093840|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57093841|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093842|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093843|NCT01069705|Tobramycin|tobramycin|mesh-list
57093844|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57093845|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093846|NCT01996865|Rituximab|rituximab|mesh-list
57093847|NCT01996865|Lenalidomide|lenalidomide|mesh-list
57093848|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093849|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093850|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
57093851|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093852|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093853|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57093854|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57093855|NCT01996865|Growth Substances|growth substances|mesh-ancestor
57093856|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
57093857|NCT01069627|Bevacizumab|bevacizumab|mesh-list
57093858|NCT01069627|Fotemustine|fotemustine|mesh-list
57093859|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57093860|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093861|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57093862|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57093863|NCT01069627|Growth Substances|growth substances|mesh-ancestor
57093864|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093865|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
57093866|NCT04057261|Liraglutide|liraglutide|mesh-list
57093867|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57093868|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093869|NCT04057261|Incretins|incretins|mesh-ancestor
57093870|NCT04057261|Hormones|hormones|mesh-ancestor
57093871|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57093872|NCT01947023|Lapatinib|lapatinib|mesh-list
57093873|NCT01947023|Dabrafenib|dabrafenib|mesh-list
57093874|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093875|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57093876|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093877|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093878|NCT01064245|Mannitol|mannitol|mesh-list
57093879|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
57093880|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57093881|NCT01064245|Diuretics|diuretics|mesh-ancestor
57093882|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
57093883|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093884|NCT01064245|Miotics|miotics|mesh-ancestor
57093885|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
57093886|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093887|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57093888|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
57093889|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
57093890|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57093891|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57093892|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
57093893|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093894|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093895|NCT04615013|Leucovorin|leucovorin|mesh-list
57093896|NCT04615013|Paclitaxel|paclitaxel|mesh-list
57093897|NCT04615013|Docetaxel|docetaxel|mesh-list
57093898|NCT04615013|Carboplatin|carboplatin|mesh-list
57093899|NCT04615013|Fluorouracil|fluorouracil|mesh-list
57093900|NCT04615013|Capecitabine|capecitabine|mesh-list
57093901|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
57093902|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57093903|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57093904|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093905|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
57093906|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
57093907|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
57093908|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093909|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
57093910|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57093911|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57093912|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
57093913|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093914|NCT04615013|Antidotes|antidotes|mesh-ancestor
57093915|NCT04615013|Protective Agents|protective agents|mesh-ancestor
57093916|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
57093917|NCT04615013|Vitamins|vitamins|mesh-ancestor
57093918|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
57093919|NCT04056949|Paclitaxel|paclitaxel|mesh-list
57093920|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57093921|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57093922|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093923|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
57093924|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
57093925|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
57093926|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093927|NCT01946477|Dexamethasone|dexamethasone|mesh-list
57093928|NCT01946477|Daratumumab|daratumumab|mesh-list
57093929|NCT01946477|Pomalidomide|pomalidomide|mesh-list
57093930|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093931|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
57093932|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
57093933|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093934|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093935|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093936|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
57093937|NCT01946477|Hormones|hormones|mesh-ancestor
57093938|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57093939|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57093940|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57093941|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
57093942|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57093943|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57093944|NCT01946477|Growth Substances|growth substances|mesh-ancestor
57093945|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
57093946|NCT03662425|Oxytocin|oxytocin|mesh-list
57093947|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
57093948|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57093949|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093950|NCT03673163|Lidocaine|lidocaine|mesh-list
57093951|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
57093952|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
57093953|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57093954|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093955|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
57093956|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093957|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57093958|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57093959|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57093960|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57093961|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093962|NCT03662269|Indomethacin|indomethacin|mesh-list
57093963|NCT03662269|Omeprazole|omeprazole|mesh-list
57093964|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57093965|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57093966|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57093967|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57093968|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093969|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57093970|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57093971|NCT03662269|Analgesics|analgesics|mesh-ancestor
57093972|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
57093973|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57093974|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093975|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57093976|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57093977|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
57093978|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
57093979|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57093980|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57093981|NCT04056325|Ivermectin|ivermectin|mesh-list
57093982|NCT04056325|Moxidectin|moxidectin|mesh-list
57093983|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57093984|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57093985|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
57093986|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
57093987|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57093988|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57093989|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
57093990|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57093991|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
57093992|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57093993|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57093994|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57093995|NCT01624805|Cyclosporine|cyclosporine|mesh-list
57093996|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
57093997|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57093998|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57093999|NCT01624805|Prednisolone|prednisolone|mesh-list
57094000|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
57094001|NCT01624805|Lenograstim|lenograstim|mesh-list
57094002|NCT01624805|Cyclosporins|cyclosporins|mesh-list
57094003|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
57094004|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57094005|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57094006|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
57094007|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57094008|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
57094009|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094010|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094011|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094012|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094013|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
57094014|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094015|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
57094016|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094017|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57094018|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094019|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
57094020|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
57094021|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094022|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094023|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
57094024|NCT01624805|Hormones|hormones|mesh-ancestor
57094025|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57094026|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57094027|NCT01624805|Protective Agents|protective agents|mesh-ancestor
57094028|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57094029|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094030|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
57094031|NCT01585025|Cathartics|cathartics|mesh-ancestor
57094032|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094033|NCT00328653|Cyclosporine|cyclosporine|mesh-list
57094034|NCT00328653|Cyclosporins|cyclosporins|mesh-list
57094035|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094036|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094037|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094038|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
57094039|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094040|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
57094041|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094042|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
57094043|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094044|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57094045|NCT03662113|Domperidone|domperidone|mesh-list
57094046|NCT03662113|Simethicone|simethicone|mesh-list
57094047|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
57094048|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
57094049|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094050|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094051|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094052|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57094053|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
57094054|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094055|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775987|NCT00974792|Vitamins|vitamins|mesh-ancestor
57094056|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
57094058|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
57094059|NCT03662035|Apatinib|apatinib|mesh-list
57094060|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094061|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57094062|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094063|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094064|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
57094065|NCT05158647|Analgesics|analgesics|mesh-ancestor
57094066|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
57094067|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094068|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094069|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
57094070|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094071|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57094072|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
57094073|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57094074|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57094075|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094076|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57094077|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
57094078|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57094079|NCT03471117|Pioglitazone|pioglitazone|mesh-list
57094080|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094081|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094082|NCT02738151|Insulin|insulin|mesh-list
57094083|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57094084|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
57094085|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57094086|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094087|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
57094088|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
57094089|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
57094090|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57094091|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094092|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57094093|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
57094094|NCT03471039|Growth Substances|growth substances|mesh-ancestor
57094095|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094096|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
57094097|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094098|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094099|NCT03472677|Capsaicin|capsaicin|mesh-list
57094100|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
57094101|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
57094102|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
57094103|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094104|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094105|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57094106|NCT02673567|Antibodies|antibodies|mesh-list
57094107|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
57094108|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57094109|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
57094110|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094111|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094112|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57094113|NCT00702195|Hormones|hormones|mesh-ancestor
57094114|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57094115|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094116|NCT02993731|Gemcitabine|gemcitabine|mesh-list
57094117|NCT02993731|Paclitaxel|paclitaxel|mesh-list
57094118|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57094119|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094120|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
57094121|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
57094122|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
57094123|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094124|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57094125|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
57094126|NCT02993731|Antiviral Agents|antiviral agents|mesh-ancestor
57094127|NCT02993731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094128|NCT02993731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094129|NCT02993731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094130|NCT02993731|Immunologic Factors|immunologic factors|mesh-ancestor
57094131|NCT02993731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094133|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57094134|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094135|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094136|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094137|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
57094138|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094139|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094140|NCT03669263|Fentanyl|fentanyl|mesh-list
57094141|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57094142|NCT03669263|Narcotics|narcotics|mesh-ancestor
57094143|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094144|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094145|NCT03669263|Analgesics|analgesics|mesh-ancestor
57094146|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
57094147|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094148|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57094149|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57094150|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
57094151|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
57094152|NCT01012817|Topotecan|topotecan|mesh-list
57094153|NCT01012817|Veliparib|veliparib|mesh-list
57094154|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57094155|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57094156|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094157|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094158|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094159|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57094160|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
57094161|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094162|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094163|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
57094164|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094165|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094166|NCT02385656|Modafinil|modafinil|mesh-list
57094167|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57094168|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094169|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
57094170|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57094171|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57094172|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094173|NCT02389868|Lovastatin|lovastatin|mesh-list
57094174|NCT02389868|L 647318|l 647318|mesh-list
57094175|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
57094176|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57094177|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57094178|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
57094179|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094180|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57094181|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57094182|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094183|NCT03623087|Gemcitabine|gemcitabine|mesh-list
57094184|NCT03623087|Dexamethasone|dexamethasone|mesh-list
57094185|NCT03623087|Etoposide|etoposide|mesh-list
57094186|NCT03623087|Asparaginase|asparaginase|mesh-list
57094187|NCT03623087|Ifosfamide|ifosfamide|mesh-list
57094188|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094189|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
57094190|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
57094191|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094192|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094193|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094194|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
57094195|NCT03623087|Hormones|hormones|mesh-ancestor
57094196|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57094197|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57094198|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094199|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57094200|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
57094201|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094202|NCT03623087|Antiviral Agents|antiviral agents|mesh-ancestor
57094203|NCT03623087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776117|NCT00972842|Vorinostat|vorinostat|mesh-list
57094204|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094205|NCT03623087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094206|NCT03623087|Immunologic Factors|immunologic factors|mesh-ancestor
57094207|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57094208|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57094209|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57094210|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57094211|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
57094212|NCT05420636|Paclitaxel|paclitaxel|mesh-list
57094213|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57094214|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094215|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
57094216|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
57094217|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
57094218|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094219|NCT05066308|Cannabidiol|cannabidiol|mesh-list
57094220|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
57094221|NCT03714308|Aflibercept|aflibercept|mesh-list
57094222|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57094223|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57094224|NCT03714308|Growth Substances|growth substances|mesh-ancestor
57094225|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094226|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
57094227|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094228|NCT03113396|Baclofen|baclofen|mesh-list
57094229|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57094230|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094231|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57094232|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094233|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57094234|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
57094235|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
57094236|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094237|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094238|NCT05065372|Metformin|metformin|mesh-list
57094239|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094240|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094241|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
57094242|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094243|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
57094244|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094245|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094246|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57094247|NCT05065216|Kallikreins|kallikreins|mesh-list
57094248|NCT05065216|Coagulants|coagulants|mesh-ancestor
57094249|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
57094250|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
57094251|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57094252|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094253|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
57094254|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57094255|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
57094256|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094257|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57094258|NCT03693170|Cetuximab|cetuximab|mesh-list
57094259|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094260|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094261|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
57094262|NCT05062954|Procyanidin|procyanidin|mesh-list
57094263|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
57094264|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094265|NCT05062954|Protective Agents|protective agents|mesh-ancestor
57094266|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094267|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57094268|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57094269|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094270|NCT05048524|Leucovorin|leucovorin|mesh-list
57094271|NCT05048524|Gemcitabine|gemcitabine|mesh-list
57094272|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
57094273|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57094274|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
57094275|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094276|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094277|NCT05048524|Antiviral Agents|antiviral agents|mesh-ancestor
57094278|NCT05048524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094279|NCT05048524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094280|NCT05048524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094281|NCT05048524|Immunologic Factors|immunologic factors|mesh-ancestor
57094282|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094283|NCT05048524|Antidotes|antidotes|mesh-ancestor
57094284|NCT05048524|Protective Agents|protective agents|mesh-ancestor
57094285|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
57094286|NCT05048524|Vitamins|vitamins|mesh-ancestor
57094287|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
57094288|NCT02389400|Methotrexate|methotrexate|mesh-list
57094289|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57094290|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
57094291|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57094292|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094293|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57094294|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
57094295|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094296|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094297|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
57094298|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094299|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57094300|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094301|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
57094302|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094303|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57094304|NCT05048212|Nivolumab|nivolumab|mesh-list
57094305|NCT05048212|Ipilimumab|ipilimumab|mesh-list
57094306|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094307|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094308|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57094309|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094310|NCT03581240|Eflornithine|eflornithine|mesh-list
57094311|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094312|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57094313|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57094314|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57094315|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094316|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
57094317|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094318|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094319|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
57094320|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57094321|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
57094322|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094323|NCT05059600|Pregnanolone|pregnanolone|mesh-list
57094324|NCT05059600|Brexanolone|brexanolone|mesh-list
57094325|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
57094326|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094327|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094328|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
57094329|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094330|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094331|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
57094332|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
57094333|NCT03669029|Golimumab|golimumab|mesh-list
57094334|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57094335|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57094336|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094337|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094338|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
57094339|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094340|NCT03668015|Sorbitol|sorbitol|mesh-list
57094341|NCT03668015|Cathartics|cathartics|mesh-ancestor
57094342|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094343|NCT02385734|Mitogens|mitogens|mesh-list
57094344|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
57094345|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094346|NCT02385500|Fesoterodine|fesoterodine|mesh-list
57094347|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57094348|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57094349|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
57094350|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094351|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094352|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094353|NCT02385500|Urological Agents|urological agents|mesh-ancestor
57094354|NCT05058976|Vitamin D|vitamin d|mesh-list
57094355|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
57094356|NCT05058976|Calcium|calcium|mesh-list
57094357|NCT05058976|Vitamins|vitamins|mesh-ancestor
57094358|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
57094359|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094360|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57094361|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57094362|NCT02385422|Propranolol|propranolol|mesh-list
57094363|NCT02385422|Carvedilol|carvedilol|mesh-list
57094364|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57094365|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57094366|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
57094367|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094368|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094369|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094370|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57094371|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57094372|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
57094373|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
57094374|NCT02385422|Protective Agents|protective agents|mesh-ancestor
57094375|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57094376|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57094377|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57094378|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57094379|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57094380|NCT02520388|Methylphenidate|methylphenidate|mesh-list
57094381|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57094382|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094383|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57094384|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57094385|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57094386|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094387|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
57094388|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094389|NCT03579446|Oxymorphone|oxymorphone|mesh-list
57094390|NCT03579446|Morphine|morphine|mesh-list
57094391|NCT03579446|Oxycodone|oxycodone|mesh-list
57094392|NCT03579446|Hydromorphone|hydromorphone|mesh-list
57094393|NCT03579446|Hydrocodone|hydrocodone|mesh-list
57094394|NCT03579446|Levorphanol|levorphanol|mesh-list
57094395|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57094396|NCT03579446|Narcotics|narcotics|mesh-ancestor
57094397|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094398|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094399|NCT03579446|Analgesics|analgesics|mesh-ancestor
57094400|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
57094401|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094402|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
57094403|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
57094404|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57094405|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57094406|NCT03667937|Laxatives|laxatives|mesh-ancestor
57094407|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094408|NCT05045794|Liver Extracts|liver extracts|mesh-list
57094409|NCT05045794|Hematinics|hematinics|mesh-ancestor
57094410|NCT02385266|Cycloserine|cycloserine|mesh-list
57094411|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57094412|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094413|NCT02385266|Renal Agents|renal agents|mesh-ancestor
57094414|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57094415|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
57094416|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57094417|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
57094418|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094419|NCT03667235|Glutaral|glutaral|mesh-list
57094420|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
57094421|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094422|NCT02668640|Adalimumab|adalimumab|mesh-list
57094423|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094424|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094425|NCT05043766|Naltrexone|naltrexone|mesh-list
57094426|NCT05043766|Oxycodone|oxycodone|mesh-list
57094427|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57094428|NCT05043766|Narcotics|narcotics|mesh-ancestor
57094429|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094430|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094431|NCT05043766|Analgesics|analgesics|mesh-ancestor
57094432|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
57094433|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094434|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57094436|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
57094437|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57094438|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
57094439|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57094440|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094441|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094442|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094443|NCT03011333|Epinephrine|epinephrine|mesh-list
57094444|NCT03011333|Bupivacaine|bupivacaine|mesh-list
57094445|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
57094446|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
57094447|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094448|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094449|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
57094450|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094451|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57094452|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57094453|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
57094454|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094455|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094456|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57094457|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57094458|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
57094459|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57094460|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
57094461|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
57094462|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
57094463|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57094464|NCT04570397|Ravulizumab|ravulizumab|mesh-list
57094465|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57094466|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094467|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
57094468|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094469|NCT02385188|Acetaminophen|acetaminophen|mesh-list
57094470|NCT02385188|Imiquimod|imiquimod|mesh-list
57094471|NCT02385188|Lidocaine|lidocaine|mesh-list
57094472|NCT02385188|Petrolatum|petrolatum|mesh-list
57094473|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
57094474|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
57094475|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094476|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094477|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
57094478|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094479|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57094480|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57094481|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57094482|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57094483|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094484|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57094485|NCT02385188|Analgesics|analgesics|mesh-ancestor
57094486|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
57094487|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57094488|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
57094489|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094490|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
57094491|NCT02385188|Emollients|emollients|mesh-ancestor
57094492|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
57094493|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
57094494|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57094495|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094496|NCT02384954|Rituximab|rituximab|mesh-list
57094497|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094498|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094499|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
57094500|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094501|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094502|NCT02384876|Ephedrine|ephedrine|mesh-list
57094503|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
57094504|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57094505|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57094506|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094507|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
56776423|NCT02897076|Betamethasone|betamethasone|mesh-list
57094508|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
57094509|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094510|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57094511|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
57094512|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094513|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094514|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57094515|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57094516|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
57094517|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
57094518|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
57094519|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
57094520|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094521|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094522|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57094523|NCT02377388|Saxagliptin|saxagliptin|mesh-list
57094524|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094525|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094526|NCT02377388|Incretins|incretins|mesh-ancestor
57094527|NCT02377388|Hormones|hormones|mesh-ancestor
57094528|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57094529|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57094530|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
57094531|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094532|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094533|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
57094534|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
57094535|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
57094536|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094537|NCT02382146|Dexamethasone|dexamethasone|mesh-list
57094538|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
57094539|NCT02382146|Ondansetron|ondansetron|mesh-list
57094540|NCT02382146|BB 1101|bb 1101|mesh-list
57094541|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094542|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
57094543|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
57094544|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094545|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094546|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094547|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
57094548|NCT02382146|Hormones|hormones|mesh-ancestor
57094549|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57094550|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57094551|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094552|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
57094553|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094554|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094555|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
57094556|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
57094557|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57094558|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
57094559|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094560|NCT02382146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57094561|NCT02382146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57094562|NCT02382146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094563|NCT02382146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57094564|NCT02382146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57094565|NCT02382068|Dexamethasone|dexamethasone|mesh-list
57094566|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094567|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
57094568|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
57094569|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094570|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094571|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094572|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
57094573|NCT02382068|Hormones|hormones|mesh-ancestor
57094574|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57094575|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57094576|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094577|NCT04731272|Dulaglutide|dulaglutide|mesh-list
57094578|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094579|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094580|NCT02381600|Vitamin D|vitamin d|mesh-list
57094581|NCT02381600|Vitamins|vitamins|mesh-ancestor
57094582|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
57094583|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094584|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57094585|NCT03113084|Heparin|heparin|mesh-list
57094586|NCT03113084|Calcium heparin|calcium heparin|mesh-list
57094587|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
57094588|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57094589|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57094590|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094591|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
57094592|NCT02377076|Calcium|calcium|mesh-list
57094593|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57094594|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094595|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57094596|NCT04439474|Vitamin D|vitamin d|mesh-list
57094597|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
57094598|NCT04439474|Vitamins|vitamins|mesh-ancestor
57094599|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
57094600|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094601|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57094602|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57094603|NCT04990258|Infliximab|infliximab|mesh-list
57094604|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
57094605|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094606|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094607|NCT02662556|Sufentanil|sufentanil|mesh-list
57094608|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57094609|NCT02662556|Narcotics|narcotics|mesh-ancestor
57094610|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094611|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094612|NCT02662556|Analgesics|analgesics|mesh-ancestor
57094613|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
57094614|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094615|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57094616|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57094617|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
57094618|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
57094619|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
57094620|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
57094621|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57094622|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
57094623|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094624|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
57094625|NCT04262336|Protective Agents|protective agents|mesh-ancestor
57094626|NCT04262336|Antidotes|antidotes|mesh-ancestor
57094627|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
57094628|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094629|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
57094630|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57094631|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094632|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
57094633|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
57094634|NCT05054374|Fulvestrant|fulvestrant|mesh-list
57094635|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57094636|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094637|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57094638|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57094639|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
57094640|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57094641|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094642|NCT02376452|Leucovorin|leucovorin|mesh-list
57094643|NCT02376452|Fluorouracil|fluorouracil|mesh-list
57094644|NCT02376452|Raltitrexed|raltitrexed|mesh-list
57094645|NCT02376452|Irinotecan|irinotecan|mesh-list
57094646|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
57094647|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094648|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57094649|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094650|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094651|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
57094652|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094653|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57094654|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57094655|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094656|NCT02376452|Antidotes|antidotes|mesh-ancestor
57094657|NCT02376452|Protective Agents|protective agents|mesh-ancestor
57094658|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
57094659|NCT02376452|Vitamins|vitamins|mesh-ancestor
57094660|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
57094661|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57094662|NCT02516098|Scopolamine|scopolamine|mesh-list
57094663|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57094664|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57094665|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
57094666|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
57094667|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094668|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094669|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094670|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
57094671|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57094672|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
57094673|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094674|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094675|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57094676|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
57094677|NCT02372318|Nalmefene|nalmefene|mesh-list
57094678|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57094679|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094680|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
57094681|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094682|NCT03105674|Anesthetics|anesthetics|mesh-list
57094683|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
57094684|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094685|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094686|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
57094687|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094688|NCT02380898|Ketorolac|ketorolac|mesh-list
57094689|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57094690|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57094691|NCT02380898|Analgesics|analgesics|mesh-ancestor
57094692|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
57094693|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094694|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094695|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094696|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094697|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57094698|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094699|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094701|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57094702|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
57094703|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094704|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
57094705|NCT04098068|Antibodies|antibodies|mesh-list
57094706|NCT04098068|Immunologic Factors|immunologic factors|mesh-ancestor
57094707|NCT04098068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094708|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094709|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094710|NCT02376296|Docetaxel|docetaxel|mesh-list
57094711|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094712|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
57094713|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
57094714|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
57094715|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094716|NCT01364428|Insulin|insulin|mesh-list
57094717|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57094718|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
57094719|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094720|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094721|NCT02380586|Anesthetics|anesthetics|mesh-list
57094722|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094723|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094724|NCT02375828|Glyburide|glyburide|mesh-list
57094725|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094726|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094727|NCT02371226|Insulin|insulin|mesh-list
57094728|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57094729|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094730|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094731|NCT02371304|Capecitabine|capecitabine|mesh-list
57094732|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57094733|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
57094734|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094735|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094736|NCT02380352|Amoxicillin|amoxicillin|mesh-list
56776631|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57094737|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57094738|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094740|NCT02380118|Haloperidol|haloperidol|mesh-list
57094741|NCT02380118|Olanzapine|olanzapine|mesh-list
57094742|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
57094743|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57094744|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57094745|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094746|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094747|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57094748|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57094749|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57094750|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57094751|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
57094752|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
57094753|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
57094754|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
57094755|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094756|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094757|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
57094758|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
57094759|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094760|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57094761|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57094762|NCT02380118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57094763|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57094764|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57094765|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
57094766|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57094767|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
57094768|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57094769|NCT03113708|Heparin|heparin|mesh-list
57094770|NCT03113708|Calcium heparin|calcium heparin|mesh-list
57094771|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
57094772|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57094773|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57094774|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094775|NCT02371148|Rituximab|rituximab|mesh-list
57094776|NCT02371148|Bortezomib|bortezomib|mesh-list
57094777|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57094778|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094779|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094780|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
57094781|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094782|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094783|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57094784|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
57094785|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094786|NCT02370680|Aspirin|aspirin|mesh-list
57094787|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57094788|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57094789|NCT02370680|Analgesics|analgesics|mesh-ancestor
57094790|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
57094791|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094792|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094793|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094794|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094795|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57094796|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57094797|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094798|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57094799|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57094800|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094801|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
57094802|NCT02370758|Valganciclovir|valganciclovir|mesh-list
57094803|NCT02370758|Ganciclovir|ganciclovir|mesh-list
57094804|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
57094805|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
57094806|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094807|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57094808|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094809|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094810|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
57094811|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
57094812|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57094813|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57094814|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094815|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094816|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094817|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094818|NCT04661150|Capecitabine|capecitabine|mesh-list
57094819|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
57094820|NCT04661150|Trastuzumab|trastuzumab|mesh-list
57094821|NCT04661150|Atezolizumab|atezolizumab|mesh-list
57094822|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57094823|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
57094824|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094825|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094826|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094827|NCT04613492|Durvalumab|durvalumab|mesh-list
57094828|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094829|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094830|NCT02379026|Vitamin D|vitamin d|mesh-list
57094831|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
57094832|NCT02379026|Vitamins|vitamins|mesh-ancestor
57094833|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
57094834|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094835|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57094836|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57094837|NCT02991859|Fluticasone|fluticasone|mesh-list
57094838|NCT02991859|Xhance|xhance|mesh-list
57094839|NCT02991859|Budesonide|budesonide|mesh-list
57094840|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094841|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57094842|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
57094843|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094844|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094845|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57094846|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
57094847|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
57094848|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57094849|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
57094850|NCT02991859|Hormones|hormones|mesh-ancestor
57094851|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57094852|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
57094853|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57094854|NCT02374736|Antibodies|antibodies|mesh-list
57094855|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
57094856|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
57094857|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094858|NCT02369978|Benzonidazole|benzonidazole|mesh-list
57094859|NCT02369978|Nifurtimox|nifurtimox|mesh-list
57094860|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094861|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
57094862|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094863|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57094864|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57094865|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57094866|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094867|NCT03661489|Propofol|propofol|mesh-list
57094868|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57094869|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094870|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094871|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57094872|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
57094873|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
57094874|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57094875|NCT04056169|Ezetimibe|ezetimibe|mesh-list
57094876|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57094877|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57094878|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
57094879|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094880|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57094881|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57094882|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094883|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
57094884|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57094885|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57094886|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094887|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
57094888|NCT04947514|Coagulants|coagulants|mesh-ancestor
57094889|NCT05030194|Nicotine|nicotine|mesh-list
57094890|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57094891|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
57094892|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094893|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094894|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57094895|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57094896|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
57094897|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094898|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094899|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
57094900|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57094901|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
57094902|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094903|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57094904|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094905|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57094906|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094907|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
57094908|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
57094910|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57094911|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
57094912|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57094913|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57094914|NCT03008915|Analgesics|analgesics|mesh-ancestor
57094915|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
57094916|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094917|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094918|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094919|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094920|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57094921|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57094922|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094923|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57094924|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57094925|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094926|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
57094927|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57094928|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57094929|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
57094930|NCT03622489|Acetaminophen|acetaminophen|mesh-list
57094931|NCT03622489|Dipyrone|dipyrone|mesh-list
57094932|NCT03622489|Ibuprofen|ibuprofen|mesh-list
57094933|NCT03622489|Morphine|morphine|mesh-list
57094934|NCT03622489|Tramadol|tramadol|mesh-list
57094935|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57094936|NCT03622489|Narcotics|narcotics|mesh-ancestor
57094937|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094938|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094939|NCT03622489|Analgesics|analgesics|mesh-ancestor
57094940|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
57094941|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094942|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57094943|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
57094944|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57094945|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57094946|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57094947|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57094948|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57094949|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094950|NCT03667001|Lidocaine|lidocaine|mesh-list
57094951|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
57094952|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
57094953|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094954|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094955|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
57094956|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094957|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57094958|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57094959|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57094960|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57094961|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094962|NCT03666299|Lidocaine|lidocaine|mesh-list
57094963|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
57094964|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
57094965|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57094966|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094967|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
57094968|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094969|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57094970|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57094971|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57094972|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57094973|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094974|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
57094975|NCT03591380|Belimumab|belimumab|mesh-list
57094976|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57094977|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
57094978|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094979|NCT04057469|Tulobuterol|tulobuterol|mesh-list
57094980|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57094981|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57094982|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
57094983|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57094984|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57094985|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57094986|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57094987|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
57094988|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57094989|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57094990|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
57094991|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
57094992|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57094993|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57094994|NCT03658291|Levofloxacin|levofloxacin|mesh-list
57094995|NCT03658291|Ofloxacin|ofloxacin|mesh-list
57094996|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57094997|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57094998|NCT03658291|Renal Agents|renal agents|mesh-ancestor
57094999|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57095000|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57095001|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57095002|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319086|NCT00023907|Paclitaxel|paclitaxel|mesh-list
57095003|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095004|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095005|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57095006|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57095007|NCT03658213|Goserelin|goserelin|mesh-list
57095008|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095009|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095010|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
57095011|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57095012|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095013|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095014|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
57095015|NCT03006887|Lenvatinib|lenvatinib|mesh-list
57095016|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095017|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095018|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57095019|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095020|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095021|NCT02377856|Interferons|interferons|mesh-list
57095022|NCT02377856|Ribavirin|ribavirin|mesh-list
57095023|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
57095024|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
57095025|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57095026|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095027|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
57095028|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095029|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
57095030|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095031|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
57095032|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095033|NCT02377778|Thiopental|thiopental|mesh-list
57095034|NCT02377778|Propofol|propofol|mesh-list
57095035|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57095036|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095037|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095038|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57095039|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
57095041|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
57095042|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
57095043|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
57095044|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095045|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095046|NCT02514772|Rituximab|rituximab|mesh-list
57095047|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095048|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095049|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
57095050|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095051|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57095052|NCT03658057|Rocuronium|rocuronium|mesh-list
57095053|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57095054|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57095055|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57095056|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095057|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095058|NCT03657979|Ropivacaine|ropivacaine|mesh-list
57095059|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
57095060|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
57095061|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095062|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095063|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
57095064|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095065|NCT03659851|Simendan|simendan|mesh-list
57095066|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57095067|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
57095068|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57095069|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57095070|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095071|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095072|NCT03659851|Protective Agents|protective agents|mesh-ancestor
57095073|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095074|NCT04551521|Trastuzumab|trastuzumab|mesh-list
57095075|NCT04551521|Pertuzumab|pertuzumab|mesh-list
57095076|NCT04551521|Atezolizumab|atezolizumab|mesh-list
57095077|NCT04551521|Vemurafenib|vemurafenib|mesh-list
57095078|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57095079|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095080|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095081|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
57095082|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095083|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57095084|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095085|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095086|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57095087|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095088|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57095089|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
57095090|NCT02368730|Coagulants|coagulants|mesh-ancestor
57095091|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57095092|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
57095093|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095094|NCT03659305|Bevacizumab|bevacizumab|mesh-list
57095095|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095096|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095097|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57095098|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57095099|NCT03659305|Growth Substances|growth substances|mesh-ancestor
57095100|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095101|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
57095102|NCT02788981|Paclitaxel|paclitaxel|mesh-list
57095103|NCT02788981|Mifepristone|mifepristone|mesh-list
57095104|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57095105|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095106|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
57095107|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
57095108|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
57095109|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095110|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57095111|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
57095112|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57095113|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095114|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57095115|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57095116|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57095117|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
57095118|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57095119|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57095120|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
57095121|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095122|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
57095123|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57095124|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57095125|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57095126|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57095127|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
57095128|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57095129|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
57095130|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57095131|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095132|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57095133|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095134|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095136|NCT02373722|Mineral Oil|mineral oil|mesh-list
57095137|NCT02373722|Emollients|emollients|mesh-ancestor
57095138|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
57095139|NCT03000179|Avelumab|avelumab|mesh-list
57095140|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095141|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095142|NCT04493060|Niraparib|niraparib|mesh-list
57095143|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
57095144|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
57095145|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
57095146|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095147|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57095148|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095149|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095150|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095151|NCT03658993|Rifaximin|rifaximin|mesh-list
57095152|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57095153|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095154|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095155|NCT02373410|Bupivacaine|bupivacaine|mesh-list
57095156|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
57095157|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
57095158|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095159|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095160|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
57095161|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095162|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57095163|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095164|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
57095165|NCT02920177|Hormones|hormones|mesh-ancestor
57095166|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095167|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095168|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57095169|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
57095170|NCT03006341|Telmisartan|telmisartan|mesh-list
57095171|NCT03006341|Warfarin|warfarin|mesh-list
57095172|NCT03006341|Dabigatran|dabigatran|mesh-list
57095173|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
57095174|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57095175|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57095176|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57095177|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095178|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
57095179|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57095180|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
57095181|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095182|NCT05022784|Nintedanib|nintedanib|mesh-list
57095183|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095184|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57095185|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095186|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095187|NCT04413799|Lidocaine|lidocaine|mesh-list
57095188|NCT04413799|Ketamine|ketamine|mesh-list
57095189|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
57095190|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
57095191|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095192|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095193|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
57095194|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095195|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57095196|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57095197|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57095198|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57095199|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095200|NCT04413799|Analgesics|analgesics|mesh-ancestor
57095201|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57095202|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57095203|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
57095204|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57095205|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57095206|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095207|NCT03665753|Ketorolac|ketorolac|mesh-list
57095208|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57095209|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57095210|NCT03665753|Analgesics|analgesics|mesh-ancestor
57095211|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
57095212|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095213|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095214|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095215|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57095216|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57095217|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095218|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095219|NCT02368652|Amlodipine|amlodipine|mesh-list
57095220|NCT02368652|Candesartan|candesartan|mesh-list
57095221|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
57095222|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57095223|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57095224|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56319310|NCT00025389|Carboplatin|carboplatin|mesh-list
57095225|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095226|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57095227|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095228|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
57095229|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57095230|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57095231|NCT02512042|Brinzolamide|brinzolamide|mesh-list
57095232|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57095233|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095234|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095235|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
57095236|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57095237|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095238|NCT03923270|Durvalumab|durvalumab|mesh-list
57095239|NCT03923270|Olaparib|olaparib|mesh-list
57095240|NCT03923270|Tremelimumab|tremelimumab|mesh-list
57095241|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57095242|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095243|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095244|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57095245|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095246|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095247|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
57095248|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095249|NCT04386746|Gemcitabine|gemcitabine|mesh-list
57095250|NCT04386746|Docetaxel|docetaxel|mesh-list
57095251|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57095252|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
57095253|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095254|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095255|NCT04386746|Antiviral Agents|antiviral agents|mesh-ancestor
57095256|NCT04386746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095257|NCT04386746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095258|NCT04386746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57095259|NCT04386746|Immunologic Factors|immunologic factors|mesh-ancestor
57095260|NCT04386746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095261|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
57095262|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
57095263|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
57095264|NCT01066897|Pramipexole|pramipexole|mesh-list
57095265|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
57095266|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095267|NCT01066897|Protective Agents|protective agents|mesh-ancestor
57095268|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095269|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57095270|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57095271|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
57095272|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
57095273|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095274|NCT02373254|Acetaminophen|acetaminophen|mesh-list
57095275|NCT02373254|Ibuprofen|ibuprofen|mesh-list
57095276|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
57095277|NCT02373254|Hydrocodone|hydrocodone|mesh-list
57095278|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57095279|NCT02373254|Analgesics|analgesics|mesh-ancestor
57095280|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
57095281|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095282|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095283|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
57095284|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57095285|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095286|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57095287|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57095288|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095289|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095290|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57095291|NCT02373254|Narcotics|narcotics|mesh-ancestor
57095292|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095293|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
57095294|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
57095295|NCT03657355|Zolpidem|zolpidem|mesh-list
57095296|NCT03657355|Suvorexant|suvorexant|mesh-list
57095297|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57095298|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57095299|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095300|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095301|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57095302|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
57095303|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
57095304|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095305|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095306|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57095307|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
57095308|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57095309|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
57095310|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57095311|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095312|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57095313|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57095314|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57095315|NCT02365532|Dofetilide|dofetilide|mesh-list
57095316|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57095317|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57095318|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57095319|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095320|NCT03113162|Cytarabine|cytarabine|mesh-list
57095321|NCT03113162|Etoposide|etoposide|mesh-list
57095322|NCT03113162|Melphalan|melphalan|mesh-list
57095323|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57095324|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095325|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57095326|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57095327|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095328|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095329|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57095330|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
57095331|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
57095332|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095333|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57095334|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
57095335|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095336|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57095337|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
57095338|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57095339|NCT02356705|Lidocaine|lidocaine|mesh-list
57095340|NCT02356705|Midazolam|midazolam|mesh-list
57095341|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57095342|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57095343|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095344|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095345|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57095346|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57095347|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57095348|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57095349|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
57095350|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
57095351|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
57095352|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
57095353|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095354|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095355|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
57095356|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
57095357|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095358|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57095359|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57095360|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57095361|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57095362|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
57095363|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
57095364|NCT03541850|Hormones|hormones|mesh-list
57095365|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
57095366|NCT03541850|Androgens|androgens|mesh-list
57095367|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
57095368|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899610|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095369|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095370|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
57095371|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095372|NCT03541850|Protective Agents|protective agents|mesh-ancestor
57095373|NCT03541850|Vitamins|vitamins|mesh-ancestor
57095374|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
57095375|NCT03541850|Estrogens|estrogens|mesh-ancestor
57095376|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095377|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095378|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
57095379|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
57095380|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
57095381|NCT02511184|Crizotinib|crizotinib|mesh-list
57095382|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095383|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095384|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57095385|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095386|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095387|NCT02542657|Clarithromycin|clarithromycin|mesh-list
57095388|NCT02542657|Dexamethasone|dexamethasone|mesh-list
57095389|NCT02542657|Pomalidomide|pomalidomide|mesh-list
57095390|NCT02542657|Ixazomib|ixazomib|mesh-list
57095391|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095392|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
57095393|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
57095394|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095395|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095396|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095397|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
57095398|NCT02542657|Hormones|hormones|mesh-ancestor
57095399|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095400|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095401|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095402|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095403|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57095404|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095405|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57095406|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095407|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57095408|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57095409|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
57095410|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57095411|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57095412|NCT02542657|Growth Substances|growth substances|mesh-ancestor
57095413|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
57095414|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
57095415|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
57095416|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57095417|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57095419|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
57095420|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57095421|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
57095422|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095423|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
57095424|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
57095425|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095426|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095427|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095428|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
57095429|NCT02367560|Hormones|hormones|mesh-ancestor
57095430|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095431|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57095432|NCT02367560|Protective Agents|protective agents|mesh-ancestor
57095433|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095434|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095435|NCT02372942|Progesterone|progesterone|mesh-list
57095436|NCT02372942|Progestins|progestins|mesh-ancestor
57095437|NCT02372942|Hormones|hormones|mesh-ancestor
57095438|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095439|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095440|NCT02364986|Interferons|interferons|mesh-list
57095441|NCT02364986|Interferon-beta|interferon-beta|mesh-list
57095442|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
57095443|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095444|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
56319529|NCT00026364|Leucovorin|leucovorin|mesh-list
57095445|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095446|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
57095447|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095448|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57095449|NCT03506360|Dexamethasone|dexamethasone|mesh-list
57095450|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
57095451|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
57095452|NCT03506360|Ixazomib|ixazomib|mesh-list
57095453|NCT03506360|Ichthammol|ichthammol|mesh-list
57095454|NCT03506360|BB 1101|bb 1101|mesh-list
57095455|NCT03506360|Glycine|glycine|mesh-list
57095456|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095457|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
57095458|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
57095459|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095460|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095461|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095462|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
57095463|NCT03506360|Hormones|hormones|mesh-ancestor
57095464|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095465|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095466|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095467|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
57095468|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095469|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095470|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095471|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
57095472|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
57095473|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095474|NCT02372786|Lidocaine|lidocaine|mesh-list
57095475|NCT02372786|Tetracaine|tetracaine|mesh-list
57095476|NCT02372786|Prilocaine|prilocaine|mesh-list
57095477|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
57095478|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
57095479|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095480|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095481|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
57095482|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095483|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57095484|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56777348|NCT00538902|Adalimumab|adalimumab|mesh-list
57095485|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57095486|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57095487|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095488|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57095489|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57095490|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57095491|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57095492|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095493|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095494|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095495|NCT02367404|Analgesics|analgesics|mesh-ancestor
57095496|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
57095497|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095498|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
57095499|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57095500|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
57095501|NCT03715946|Nivolumab|nivolumab|mesh-list
57095502|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095503|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095504|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57095505|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095506|NCT02367248|Deferoxamine|deferoxamine|mesh-list
57095507|NCT02367248|Siderophores|siderophores|mesh-ancestor
57095508|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57095509|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
57095510|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
57095511|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095512|NCT03656965|Acyclovir|acyclovir|mesh-list
57095513|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
57095514|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095515|NCT02384239|Tamoxifen|tamoxifen|mesh-list
57095516|NCT02384239|Fulvestrant|fulvestrant|mesh-list
57095517|NCT02384239|Palbociclib|palbociclib|mesh-list
57095518|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57095519|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
57095520|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095521|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095522|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095523|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095524|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57095525|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57095526|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57095527|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57095528|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57095529|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095530|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095531|NCT02364752|Diuretics|diuretics|mesh-list
57095532|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
57095533|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
57095534|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095535|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57095536|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095537|NCT04617002|TIC10 compound|tic10 compound|mesh-list
57095538|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095539|NCT02372240|Dexamethasone|dexamethasone|mesh-list
57095540|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095541|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
57095542|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
57095543|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095544|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095545|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095546|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
57095547|NCT02372240|Hormones|hormones|mesh-ancestor
57095548|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095549|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095550|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095551|NCT02364206|Temozolomide|temozolomide|mesh-list
57095552|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57095553|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
57095554|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095555|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095556|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
57095557|NCT02366546|Fludarabine|fludarabine|mesh-list
57095558|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57095559|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
57095560|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095561|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57095562|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57095563|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
57095564|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095565|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095566|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57095567|NCT03029702|Metformin|metformin|mesh-list
57095568|NCT03029702|Glyburide|glyburide|mesh-list
57095569|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57095570|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095571|NCT02364362|Docetaxel|docetaxel|mesh-list
57095572|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095573|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
57095574|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
57095575|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
57095576|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095577|NCT04384484|Gemcitabine|gemcitabine|mesh-list
57095578|NCT04384484|Rituximab|rituximab|mesh-list
57095579|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
57095580|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
57095581|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095582|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095583|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
57095584|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095585|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57095586|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57095587|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
57095588|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095589|NCT04384484|Antiviral Agents|antiviral agents|mesh-ancestor
57095590|NCT04384484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095591|NCT04384484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095592|NCT04384484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57095593|NCT03004469|Finasteride|finasteride|mesh-list
57095594|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57095595|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57095596|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095597|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095598|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
57095599|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095600|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095601|NCT03004469|Urological Agents|urological agents|mesh-ancestor
57095602|NCT02358824|Amlodipine|amlodipine|mesh-list
57095603|NCT02358824|Telmisartan|telmisartan|mesh-list
57095604|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57095605|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57095606|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57095607|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095608|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57095609|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095610|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
57095611|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57095612|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57095613|NCT02359136|Epinephrine|epinephrine|mesh-list
57095614|NCT02359136|Analgesics|analgesics|mesh-list
57095615|NCT02359136|Anesthetics|anesthetics|mesh-list
57095616|NCT02359136|Ropivacaine|ropivacaine|mesh-list
57095617|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095618|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095619|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
57095620|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
57095621|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095622|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57095623|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57095624|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
57095625|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095626|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095627|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57095628|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57095629|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
57095630|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57095631|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
57095632|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
57095633|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
57095634|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57095635|NCT02998151|Minocycline|minocycline|mesh-list
57095636|NCT02998151|Acamprosate|acamprosate|mesh-list
57095637|NCT02998151|Baclofen|baclofen|mesh-list
57095638|NCT02998151|Lovastatin|lovastatin|mesh-list
57095639|NCT02998151|L 647318|l 647318|mesh-list
57095640|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
57095641|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57095642|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095643|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57095644|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095645|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57095646|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095647|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57095648|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
57095649|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
57095650|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095651|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095652|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57095653|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57095654|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
57095655|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57095656|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57095657|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095658|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57095659|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57095660|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57095661|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
57095662|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095663|NCT04057937|Apremilast|apremilast|mesh-list
57095664|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57095665|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57095666|NCT04057937|Analgesics|analgesics|mesh-ancestor
57095667|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
57095668|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095669|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095670|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095671|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57095672|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57095673|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57095674|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095675|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095676|NCT01069523|Guanfacine|guanfacine|mesh-list
57095677|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57095678|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57095679|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57095680|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57095681|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
57095682|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095683|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095684|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095685|NCT01069289|Budesonide|budesonide|mesh-list
57095686|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
57095687|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
57095688|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095689|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57095690|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
57095691|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095692|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095693|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57095694|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
57095695|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
57095696|NCT01069289|Hormones|hormones|mesh-ancestor
57095697|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095698|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57095699|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57095700|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57095701|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
57095702|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095703|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095704|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
57095705|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57095706|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095707|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57095708|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
57095709|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57095710|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095712|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095713|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
57095714|NCT03266783|Apixaban|apixaban|mesh-list
57095715|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57095716|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
57095717|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57095718|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
57095719|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095720|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095721|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
57095722|NCT02510794|Ranibizumab|ranibizumab|mesh-list
57095723|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57095724|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57095725|NCT02510794|Growth Substances|growth substances|mesh-ancestor
57095726|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095727|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
57095728|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095729|NCT04056923|Methylene Blue|methylene blue|mesh-list
57095730|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095731|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095732|NCT03664115|Itraconazole|itraconazole|mesh-list
57095733|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
57095734|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095735|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57095736|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57095737|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095738|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095739|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57095740|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
57095741|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095742|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095743|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57095744|NCT02937818|Carboplatin|carboplatin|mesh-list
57095745|NCT02937818|Durvalumab|durvalumab|mesh-list
57095746|NCT02937818|Olaparib|olaparib|mesh-list
57095747|NCT02937818|Tremelimumab|tremelimumab|mesh-list
57095748|NCT02937818|Adavosertib|adavosertib|mesh-list
57095749|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095750|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57095751|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57095752|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095753|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095754|NCT03664037|Dexamethasone|dexamethasone|mesh-list
57095755|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57095756|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095757|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
57095758|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
57095759|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095760|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095761|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095762|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
57095763|NCT03664037|Hormones|hormones|mesh-ancestor
57095764|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095765|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095766|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095767|NCT04056845|Acetaminophen|acetaminophen|mesh-list
57095768|NCT04056845|Diclofenac|diclofenac|mesh-list
57095769|NCT04056845|Analgesics|analgesics|mesh-list
57095770|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57095771|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57095772|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
57095773|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095774|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095775|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095776|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57095777|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57095778|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095779|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095780|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
57095781|NCT02510014|Buprenorphine|buprenorphine|mesh-list
57095782|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
57095783|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57095784|NCT02510014|Narcotics|narcotics|mesh-ancestor
57095785|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095786|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095787|NCT02510014|Analgesics|analgesics|mesh-ancestor
57095788|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
57095789|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095790|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57095791|NCT02509312|Ketorolac|ketorolac|mesh-list
57095792|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57095793|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57095794|NCT02509312|Analgesics|analgesics|mesh-ancestor
57095795|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
57095796|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095797|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095798|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095799|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57095800|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57095801|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095802|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095803|NCT02362958|Capecitabine|capecitabine|mesh-list
57095804|NCT02362958|Vinorelbine|vinorelbine|mesh-list
57095805|NCT02362958|Lapatinib|lapatinib|mesh-list
57095806|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57095807|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
57095808|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095809|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095810|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57095811|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
57095812|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
57095813|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
57095814|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57095815|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095816|NCT04973800|Simvastatin|simvastatin|mesh-list
57095817|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57095818|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57095819|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
57095820|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095821|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57095822|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57095823|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095824|NCT05020522|Phenobarbital|phenobarbital|mesh-list
57095825|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
57095826|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57095827|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095828|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095829|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57095830|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57095831|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095832|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095833|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
57095834|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
57095835|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57095836|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57095837|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57095838|NCT02519842|Dexamethasone|dexamethasone|mesh-list
57095839|NCT02519842|Ondansetron|ondansetron|mesh-list
57095840|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
57095841|NCT02519842|Aprepitant|aprepitant|mesh-list
57095842|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
57095843|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095844|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
57095845|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
57095846|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095847|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095848|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095849|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
57095850|NCT02519842|Hormones|hormones|mesh-ancestor
57095851|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095852|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57095853|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095854|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
57095855|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
57095856|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57095857|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
57095858|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777731|NCT00086515|Metformin|metformin|mesh-list
57095859|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095860|NCT02519842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57095861|NCT02519842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57095862|NCT02519842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095863|NCT02519842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57095864|NCT02519842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57095865|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57095866|NCT02509078|Cisatracurium|cisatracurium|mesh-list
57095867|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57095868|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57095869|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095870|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095871|NCT02993783|Vedolizumab|vedolizumab|mesh-list
57095872|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095873|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
57095874|NCT03661775|Analgesics|analgesics|mesh-ancestor
57095875|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
57095876|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095877|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095878|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
57095879|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095880|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57095881|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
57095882|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57095883|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57095884|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095885|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57095886|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
57095887|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57095888|NCT03660761|Apatinib|apatinib|mesh-list
57095889|NCT03660761|Temozolomide|temozolomide|mesh-list
57095890|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095891|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57095892|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095893|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095894|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57095895|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
57095896|NCT02993471|Vitamin K|vitamin k|mesh-list
57095897|NCT02993471|Midazolam|midazolam|mesh-list
57095898|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
57095899|NCT02993471|Caffeine|caffeine|mesh-list
57095900|NCT02993471|Ixekizumab|ixekizumab|mesh-list
57095901|NCT02993471|Omeprazole|omeprazole|mesh-list
57095902|NCT02993471|Warfarin|warfarin|mesh-list
57095903|NCT02993471|Vitamins|vitamins|mesh-ancestor
57095904|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
57095905|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095906|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57095907|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57095908|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57095909|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57095910|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57095911|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57095912|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57095913|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
57095914|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
57095915|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
57095916|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
57095917|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57095918|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095919|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
57095920|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57095921|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57095922|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095923|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57095924|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57095925|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
57095926|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57095927|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095928|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57095929|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57095930|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57095931|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
57095932|NCT02993471|Coagulants|coagulants|mesh-ancestor
57095933|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
57095934|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
56777801|NCT04004234|Manganese|manganese|mesh-list
57095935|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57095936|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57095937|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
57095938|NCT01068743|Metformin|metformin|mesh-list
57095939|NCT01068743|Saxagliptin|saxagliptin|mesh-list
57095940|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57095941|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095942|NCT01068743|Incretins|incretins|mesh-ancestor
57095943|NCT01068743|Hormones|hormones|mesh-ancestor
57095944|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57095945|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57095946|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
57095947|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095948|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095949|NCT03622541|Sorafenib|sorafenib|mesh-list
57095950|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57095951|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57095952|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095953|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095954|NCT03658733|Amoxicillin|amoxicillin|mesh-list
57095955|NCT03658733|Tetracycline|tetracycline|mesh-list
57095956|NCT03658733|Furazolidone|furazolidone|mesh-list
57095957|NCT03658733|Esomeprazole|esomeprazole|mesh-list
57095958|NCT03658733|Rabeprazole|rabeprazole|mesh-list
57095959|NCT03658733|Bismuth|bismuth|mesh-list
57095960|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57095961|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57095962|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57095963|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57095964|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57095965|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095966|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095967|NCT03658733|Antacids|antacids|mesh-ancestor
57095968|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57095969|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57095970|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57095971|NCT03658733|Renal Agents|renal agents|mesh-ancestor
57095972|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57095973|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57095974|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57095975|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57095976|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
57095977|NCT04056143|Apixaban|apixaban|mesh-list
57095978|NCT04056143|Edoxaban|edoxaban|mesh-list
57095979|NCT04056143|Dabigatran|dabigatran|mesh-list
57095980|NCT04056143|Thromboplastin|thromboplastin|mesh-list
57095981|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57095982|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
57095983|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57095984|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
57095985|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57095986|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57095987|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
57095988|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
57095989|NCT04056143|Coagulants|coagulants|mesh-ancestor
57095990|NCT03661463|Aspirin|aspirin|mesh-list
57095991|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57095992|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57095993|NCT03661463|Analgesics|analgesics|mesh-ancestor
57095994|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
57095995|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57095996|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57095997|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57095998|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57095999|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57096000|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57096001|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096002|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57096003|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57096004|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096005|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
57096006|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
57096007|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57096008|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
57096009|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096010|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096011|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57096012|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
57096013|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57096015|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096016|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096017|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57096018|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
57096019|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
57096020|NCT03661385|Protective Agents|protective agents|mesh-ancestor
57096021|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
57096022|NCT03658421|Morphine|morphine|mesh-list
57096023|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57096024|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096025|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096026|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57096027|NCT03658421|Analgesics|analgesics|mesh-ancestor
57096028|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
57096029|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096030|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57096031|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57096032|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57096033|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
57096034|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096035|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096036|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57096037|NCT03658421|Narcotics|narcotics|mesh-ancestor
57096038|NCT03660293|Captopril|captopril|mesh-list
57096039|NCT03660293|Atorvastatin|atorvastatin|mesh-list
57096040|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57096041|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57096042|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
57096043|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096044|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57096045|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57096046|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096047|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57096048|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
57096049|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57096050|NCT02986139|Etanercept|etanercept|mesh-list
57096051|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57096052|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57096053|NCT02986139|Analgesics|analgesics|mesh-ancestor
57096054|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
57096055|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096056|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096057|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57096058|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096059|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57096060|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57096061|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
57096062|NCT02906917|Insulin|insulin|mesh-list
57096063|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57096064|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
57096065|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
57096066|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
57096067|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
57096068|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57096069|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096070|NCT01066585|Ivermectin|ivermectin|mesh-list
57096071|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57096072|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096073|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
57096074|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57096075|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
57096076|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096077|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096078|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57096079|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
57096080|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096081|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096082|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57096083|NCT02980783|Lidocaine|lidocaine|mesh-list
57096084|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
57096085|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
57096086|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777950|NCT05589896|Fludarabine|fludarabine|mesh-list
57096087|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096088|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
57096089|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096090|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57096091|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57096092|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57096093|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57096094|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096095|NCT02923115|Enoxaparin|enoxaparin|mesh-list
57096096|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
57096097|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57096098|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57096099|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096100|NCT02989649|Metformin|metformin|mesh-list
57096101|NCT02989649|Pioglitazone|pioglitazone|mesh-list
57096102|NCT02989649|Alogliptin|alogliptin|mesh-list
57096103|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57096104|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096105|NCT02989649|Incretins|incretins|mesh-ancestor
57096106|NCT02989649|Hormones|hormones|mesh-ancestor
57096107|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57096108|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57096109|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
57096110|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096111|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096112|NCT03659435|Rivastigmine|rivastigmine|mesh-list
57096113|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57096114|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096115|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096116|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
57096117|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096118|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096119|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57096120|NCT03659435|Protective Agents|protective agents|mesh-ancestor
57096121|NCT01067339|Darapladib|darapladib|mesh-list
57096122|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
57096123|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096124|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096125|NCT04484675|Milrinone|milrinone|mesh-list
57096126|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57096127|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57096128|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
57096129|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57096130|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57096131|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096132|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096133|NCT04484675|Protective Agents|protective agents|mesh-ancestor
57096134|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096135|NCT03658109|Lidocaine|lidocaine|mesh-list
57096136|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
57096137|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
57096138|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096139|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096140|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
57096141|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096142|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57096143|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57096144|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57096145|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57096146|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096147|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
57096148|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57096149|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096150|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57096151|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096152|NCT03660917|Riluzole|riluzole|mesh-list
57096153|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
57096154|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57096155|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57096156|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096157|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096158|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096159|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57096160|NCT03660917|Protective Agents|protective agents|mesh-ancestor
57096161|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
57096162|NCT02977507|Hydroquinone|hydroquinone|mesh-list
57096163|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57096164|NCT02977507|Protective Agents|protective agents|mesh-ancestor
57096165|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096166|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
57096167|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
57096168|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096169|NCT04471415|Atezolizumab|atezolizumab|mesh-list
57096170|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096171|NCT02976103|Analgesics|analgesics|mesh-list
57096172|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
57096173|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096174|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096175|NCT02897375|Carboplatin|carboplatin|mesh-list
57096176|NCT02897375|Palbociclib|palbociclib|mesh-list
57096177|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096178|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57096179|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096180|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096181|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
57096182|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57096183|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096184|NCT03653845|Epinephrine|epinephrine|mesh-list
57096185|NCT03653845|Racepinephrine|racepinephrine|mesh-list
57096186|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
57096187|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57096188|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57096189|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
57096190|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096191|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096192|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096193|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57096194|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57096195|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
57096196|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096197|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57096198|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
57096199|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
57096200|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
57096201|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57096202|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57096203|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
57096204|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096205|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57096206|NCT01066039|Bisoprolol|bisoprolol|mesh-list
57096207|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57096208|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
57096209|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
57096210|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096211|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096212|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57096213|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57096214|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57096215|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
57096216|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096217|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096218|NCT04217967|Lenalidomide|lenalidomide|mesh-list
57096219|NCT04217967|Ixazomib|ixazomib|mesh-list
57096220|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
57096221|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096222|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57096223|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57096224|NCT04217967|Growth Substances|growth substances|mesh-ancestor
57096225|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
57096226|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096227|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
57096228|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096229|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096230|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57096231|NCT02919761|Hormones|hormones|mesh-ancestor
57096232|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57096233|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096234|NCT02910167|Acetaminophen|acetaminophen|mesh-list
57096235|NCT02910167|Scopolamine|scopolamine|mesh-list
57096236|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57096237|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57096238|NCT02910167|Analgesics|analgesics|mesh-ancestor
57096239|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
55891144|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096240|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096241|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096242|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
57096243|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57096244|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
57096245|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
57096246|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57096247|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
57096248|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57096249|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
57096250|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096251|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096252|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57096253|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
57096254|NCT04458285|Valsartan|valsartan|mesh-list
57096255|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57096256|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57096257|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57096258|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57096259|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096260|NCT05156541|Interferons|interferons|mesh-list
57096261|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
57096262|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096263|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
57096264|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096265|NCT01067105|Ciclesonide|ciclesonide|mesh-list
57096266|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
57096267|NCT01067105|Hormones|hormones|mesh-ancestor
57096268|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57096269|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096270|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57096271|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
57096272|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57096273|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
57096274|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
57096275|NCT03470649|Hematinics|hematinics|mesh-ancestor
57096276|NCT02910011|Doxycycline|doxycycline|mesh-list
57096277|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57096278|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096279|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
57096280|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57096281|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57096282|NCT04456803|Sevelamer|sevelamer|mesh-list
57096283|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
57096284|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
57096285|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096286|NCT02908529|Oxybutynin|oxybutynin|mesh-list
57096287|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57096288|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57096289|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57096290|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57096291|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096292|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
57096293|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096294|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096295|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
57096296|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
57096297|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096298|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57096299|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57096300|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
57096301|NCT02908529|Urological Agents|urological agents|mesh-ancestor
57096302|NCT03469557|Capecitabine|capecitabine|mesh-list
57096303|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
57096304|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096305|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57096306|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
57096307|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096308|NCT04768569|Zonisamide|zonisamide|mesh-list
57096309|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
57096310|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57096311|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57096312|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096313|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57096314|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096315|NCT02643381|Ketamine|ketamine|mesh-list
57096316|NCT02643381|Etomidate|etomidate|mesh-list
57096317|NCT02643381|Analgesics|analgesics|mesh-ancestor
57096318|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
57096319|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096320|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096321|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57096322|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57096323|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
57096324|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
57096325|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096326|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57096327|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57096328|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096329|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096330|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57096331|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
57096332|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
57096333|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
57096334|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57096335|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57096336|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096337|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096338|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096339|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096340|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
57096341|NCT04328961|Protective Agents|protective agents|mesh-ancestor
57096342|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096343|NCT04328961|Vitamins|vitamins|mesh-ancestor
57096344|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
57096345|NCT00455403|Chloroquine|chloroquine|mesh-list
57096346|NCT00455403|Amebicides|amebicides|mesh-ancestor
57096347|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57096348|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57096349|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096350|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
57096351|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096352|NCT03470337|Wobenzym|wobenzym|mesh-list
57096353|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57096354|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
57096355|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096356|NCT03576261|Polygeline|polygeline|mesh-list
57096357|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
57096358|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
57096359|NCT03469323|Succinylcholine|succinylcholine|mesh-list
57096360|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
57096361|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57096362|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57096363|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096364|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096365|NCT05160285|Nivolumab|nivolumab|mesh-list
57096366|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57096367|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096368|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57096369|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096370|NCT05160051|FAPI-46|fapi-46|mesh-list
57096371|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57096372|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096373|NCT03471819|Serotonin|serotonin|mesh-list
57096374|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57096375|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
57096376|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096377|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096378|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096379|NCT03618693|Anesthetics|anesthetics|mesh-list
57096380|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096381|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096382|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
57096383|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57096384|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57096385|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096386|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
57096387|NCT01064167|Coagulants|coagulants|mesh-ancestor
57096389|NCT04205305|Nicardipine|nicardipine|mesh-list
57096390|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57096391|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57096392|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
57096393|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096394|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096395|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096396|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57096397|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
57096398|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
57096399|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096400|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57096401|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57096402|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57096403|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57096404|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57096405|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
57096406|NCT03470103|Aflibercept|aflibercept|mesh-list
57096407|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57096408|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57096409|NCT03470103|Growth Substances|growth substances|mesh-ancestor
57096410|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096411|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
57096412|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096413|NCT01064947|Retapamulin|retapamulin|mesh-list
57096414|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57096415|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096416|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
57096417|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57096418|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57096419|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096420|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
57096421|NCT03469947|Coagulants|coagulants|mesh-ancestor
57096422|NCT05157087|Omalizumab|omalizumab|mesh-list
57096423|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57096424|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57096425|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
57096426|NCT05163249|Osimertinib|osimertinib|mesh-list
57096427|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096428|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57096429|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096430|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096431|NCT04054063|Etomidate|etomidate|mesh-list
57096432|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57096433|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096434|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096435|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57096436|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
57096437|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
57096438|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57096439|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57096440|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096441|NCT05097651|Cannabidiol|cannabidiol|mesh-list
57096442|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
57096443|NCT02918071|Benralizumab|benralizumab|mesh-list
57096444|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57096445|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
57096446|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
57096447|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
57096448|NCT05162625|Cefazolin|cefazolin|mesh-list
57096449|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57096450|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57096451|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57096452|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096453|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57096454|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57096455|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096456|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096457|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096458|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57096459|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57096460|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56778330|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
57096461|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
57096462|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096463|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57096464|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57096465|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
57096466|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096467|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096468|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57096469|NCT02506816|Olaparib|olaparib|mesh-list
57096470|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57096471|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096472|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096473|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096474|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
57096475|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
57096476|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096477|NCT05009901|Protective Agents|protective agents|mesh-ancestor
57096478|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096479|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
57096480|NCT05009901|Vitamins|vitamins|mesh-ancestor
57096481|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
57096482|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
57096483|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57096484|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096485|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096486|NCT05162001|Disulfiram|disulfiram|mesh-list
57096487|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57096488|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
57096489|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096490|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096491|NCT03469167|Epinephrine|epinephrine|mesh-list
57096492|NCT03469167|CEGP-003|cegp-003|mesh-list
57096493|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57096494|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57096495|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
57096496|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096497|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096498|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096499|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57096500|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57096501|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
57096502|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096503|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57096504|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
57096505|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
57096506|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
57096507|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57096508|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
57096509|NCT03469167|Coagulants|coagulants|mesh-ancestor
57096510|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57096511|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57096512|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57096513|NCT04587687|Antibodies|antibodies|mesh-list
57096514|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
57096515|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57096516|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
57096517|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
57096518|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096519|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096520|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57096521|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
57096522|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096523|NCT01063153|Methylphenidate|methylphenidate|mesh-list
57096524|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57096525|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096526|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57096527|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57096528|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57096529|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096530|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
57096531|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096532|NCT05161221|Acetaminophen|acetaminophen|mesh-list
57096533|NCT05161221|Naproxen|naproxen|mesh-list
56778406|NCT04049201|Midazolam|midazolam|mesh-list
57096534|NCT05161221|Oxycodone|oxycodone|mesh-list
57096535|NCT05161221|Bupivacaine|bupivacaine|mesh-list
57096536|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
57096537|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
57096538|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096539|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096540|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
57096541|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096542|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57096543|NCT05161221|Narcotics|narcotics|mesh-ancestor
57096544|NCT05161221|Analgesics|analgesics|mesh-ancestor
57096545|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57096546|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57096547|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57096548|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096549|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
57096550|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57096551|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096552|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096553|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
57096554|NCT02505334|Liraglutide|liraglutide|mesh-list
57096555|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57096556|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096557|NCT02505334|Incretins|incretins|mesh-ancestor
57096558|NCT02505334|Hormones|hormones|mesh-ancestor
57096559|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57096560|NCT03469089|Ketamine|ketamine|mesh-list
57096561|NCT03469089|Modafinil|modafinil|mesh-list
57096562|NCT03469089|Analgesics|analgesics|mesh-ancestor
57096563|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
57096564|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096565|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096566|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57096567|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57096568|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
57096569|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
57096570|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096571|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57096572|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57096573|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096574|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096575|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57096576|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
57096577|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57096578|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57096579|NCT04969510|Pramoxine|pramoxine|mesh-list
57096580|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
57096581|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
57096582|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096583|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096584|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
57096585|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096586|NCT02504320|Febuxostat|febuxostat|mesh-list
57096587|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
57096588|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096589|NCT05014516|Xenon|xenon|mesh-list
57096590|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57096591|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
57096592|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
57096593|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096594|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096595|NCT01061671|Simvastatin|simvastatin|mesh-list
57096596|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57096597|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57096598|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
57096599|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096600|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57096601|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57096602|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096603|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57096604|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57096605|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57096606|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096607|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096608|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57096609|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57096610|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096611|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
57096612|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096613|NCT04969120|Metoclopramide|metoclopramide|mesh-list
57096614|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
57096615|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
57096616|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096617|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096618|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57096619|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57096620|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57096621|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
57096622|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096623|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096624|NCT00709995|Sunitinib|sunitinib|mesh-list
57096625|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096626|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57096627|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57096628|NCT00709995|Growth Substances|growth substances|mesh-ancestor
57096629|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096630|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
57096631|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57096632|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096633|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096634|NCT02503540|Aflibercept|aflibercept|mesh-list
57096635|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57096636|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57096637|NCT02503540|Growth Substances|growth substances|mesh-ancestor
57096638|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096639|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
57096640|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096641|NCT04053985|Lenvatinib|lenvatinib|mesh-list
57096642|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096643|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57096644|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096645|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096646|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
57096647|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57096648|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
57096649|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096650|NCT04455243|Expectorants|expectorants|mesh-ancestor
57096651|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
57096652|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57096653|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
57096654|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096655|NCT04455243|Protective Agents|protective agents|mesh-ancestor
57096656|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096657|NCT04455243|Antidotes|antidotes|mesh-ancestor
57096658|NCT04966702|Ivermectin|ivermectin|mesh-list
57096659|NCT04966702|Albendazole|albendazole|mesh-list
57096660|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57096661|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096662|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
57096663|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
57096664|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57096665|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57096666|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
57096667|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
57096668|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
57096669|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096670|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096671|NCT04454775|Protein C|protein c|mesh-list
57096672|NCT04454775|Antithrombins|antithrombins|mesh-list
57096673|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
57096674|NCT04454775|Protein S|protein s|mesh-list
57096675|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57096676|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
57096677|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096678|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096679|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
57096680|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56899644|NCT01198665|Hormones|hormones|mesh-ancestor
57096681|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57096682|NCT03651661|Insulin|insulin|mesh-list
57096683|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57096684|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57096685|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096686|NCT01060111|Topiramate|topiramate|mesh-list
57096687|NCT01060111|Propranolol|propranolol|mesh-list
57096688|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57096689|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57096690|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
57096691|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096692|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096693|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096694|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57096695|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57096696|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
57096697|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
57096698|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57096699|NCT02969863|Pancrelipase|pancrelipase|mesh-list
57096700|NCT02969863|Pancreatin|pancreatin|mesh-list
57096701|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57096702|NCT03651427|Estradiol|estradiol|mesh-list
57096703|NCT03651427|Estrogens|estrogens|mesh-ancestor
57096704|NCT03651427|Hormones|hormones|mesh-ancestor
57096705|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57096706|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096707|NCT05285293|Vitamin A|vitamin a|mesh-list
57096708|NCT05285293|Vitamins|vitamins|mesh-ancestor
57096709|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
57096710|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096711|NCT03650257|Temozolomide|temozolomide|mesh-list
57096712|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57096713|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
57096714|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096715|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096716|NCT03649243|Propolis|propolis|mesh-list
57096717|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096718|NCT03649165|Acetaminophen|acetaminophen|mesh-list
57096719|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57096720|NCT03649165|Analgesics|analgesics|mesh-ancestor
57096721|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
57096722|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096723|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096724|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
57096725|NCT03649009|Thiamine|thiamine|mesh-list
57096726|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
57096727|NCT03649009|Metoclopramide|metoclopramide|mesh-list
57096728|NCT03649009|Vitamins|vitamins|mesh-ancestor
57096729|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
57096730|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096731|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57096732|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
57096733|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
57096734|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
57096735|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096736|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57096737|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57096738|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57096739|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
57096740|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096741|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096742|NCT03650023|Chitosan|chitosan|mesh-list
57096743|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57096744|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57096745|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
57096746|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096747|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57096748|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
57096749|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
57096750|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
57096751|NCT03650023|Coagulants|coagulants|mesh-ancestor
57096752|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
57096753|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
57096754|NCT04054999|Methylene Blue|methylene blue|mesh-list
57096755|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096756|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096757|NCT04054999|Hematinics|hematinics|mesh-ancestor
57096758|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
57096759|NCT04054999|Vitamins|vitamins|mesh-ancestor
57096760|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
57096761|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096762|NCT03649945|Docetaxel|docetaxel|mesh-list
57096763|NCT03649945|Endostar protein|endostar protein|mesh-list
57096764|NCT03649945|Nedaplatin|nedaplatin|mesh-list
57096765|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096766|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
57096767|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
57096768|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
57096769|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096770|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57096771|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57096772|NCT03649945|Growth Substances|growth substances|mesh-ancestor
57096773|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096774|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
57096775|NCT03650881|Adapalene|adapalene|mesh-list
57096776|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57096777|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
57096778|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57096779|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57096780|NCT03650881|Analgesics|analgesics|mesh-ancestor
57096781|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
57096782|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096783|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096784|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57096785|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096786|NCT02904265|Acetazolamide|acetazolamide|mesh-list
57096787|NCT02904265|Diazepam|diazepam|mesh-list
57096788|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
57096789|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57096790|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096791|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096792|NCT02904265|Diuretics|diuretics|mesh-ancestor
57096793|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
57096794|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096795|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57096796|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
57096797|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
57096798|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096799|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57096800|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57096801|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096802|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57096803|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57096804|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57096805|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57096806|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57096807|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57096808|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
57096809|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
57096810|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
57096811|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
57096812|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096813|NCT03648229|Timolol|timolol|mesh-list
57096814|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57096815|NCT03648229|Latanoprost|latanoprost|mesh-list
57096816|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57096817|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57096818|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57096819|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
57096820|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096821|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096822|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096823|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57096824|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57096825|NCT05285449|Cannabidiol|cannabidiol|mesh-list
57096826|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
57096827|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
57096828|NCT03648697|Fludarabine|fludarabine|mesh-list
57096829|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57096830|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
57096831|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096832|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096833|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57096834|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
57096835|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096836|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096837|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57096838|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57096839|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
57096840|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096841|NCT02967679|Biotin|biotin|mesh-list
57096842|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
56778700|NCT01037140|Vitamin D|vitamin d|mesh-list
57096844|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
57096845|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096846|NCT04838301|Pregnanolone|pregnanolone|mesh-list
57096847|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
57096848|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096849|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096850|NCT04447053|Belimumab|belimumab|mesh-list
57096851|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57096852|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
57096853|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096854|NCT04361799|Insulin|insulin|mesh-list
57096855|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57096856|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096857|NCT04450173|Venetoclax|venetoclax|mesh-list
57096858|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
57096859|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096860|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57096861|NCT05390073|Hormones|hormones|mesh-list
57096862|NCT05390073|Mitogens|mitogens|mesh-list
57096863|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096864|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57096865|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
57096866|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096867|NCT04328727|Cyclosporine|cyclosporine|mesh-list
57096868|NCT04328727|Cyclosporins|cyclosporins|mesh-list
57096869|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57096870|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
57096871|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096872|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096873|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57096874|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
57096875|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096876|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
57096877|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096878|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
57096879|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096880|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57096881|NCT03647839|Nivolumab|nivolumab|mesh-list
57096882|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57096883|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096884|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57096885|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096886|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57096887|NCT04454307|Tramadol|tramadol|mesh-list
57096888|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57096889|NCT04454307|Narcotics|narcotics|mesh-ancestor
57096890|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096891|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096892|NCT04454307|Analgesics|analgesics|mesh-ancestor
57096893|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
57096894|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096895|NCT05388123|Rituximab|rituximab|mesh-list
57096896|NCT05388123|Vemurafenib|vemurafenib|mesh-list
57096897|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57096898|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096899|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
57096900|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096901|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096902|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57096903|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096904|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096905|NCT04455711|Lidocaine|lidocaine|mesh-list
57096906|NCT04455711|Remifentanil|remifentanil|mesh-list
57096907|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
57096908|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
57096909|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57096910|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096911|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
57096912|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096913|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57096914|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57096915|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57096916|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57096917|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096918|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57096919|NCT04455711|Narcotics|narcotics|mesh-ancestor
57096920|NCT04455711|Analgesics|analgesics|mesh-ancestor
57096921|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
57096922|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57096923|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57096924|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57096925|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57096926|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096927|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
57096928|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57096929|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096930|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57096931|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096932|NCT04062669|Vaccines|vaccines|mesh-list
57096933|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
57096934|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096935|NCT05387967|Valsartan|valsartan|mesh-list
57096936|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57096937|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
57096938|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57096939|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57096940|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096941|NCT03856359|Rifaximin|rifaximin|mesh-list
57096942|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57096943|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57096944|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57096945|NCT04052659|Azacitidine|azacitidine|mesh-list
57096946|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57096947|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
57096948|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096949|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096950|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096951|NCT02964247|Liraglutide|liraglutide|mesh-list
57096952|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57096953|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096954|NCT02964247|Incretins|incretins|mesh-ancestor
57096955|NCT02964247|Hormones|hormones|mesh-ancestor
57096956|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57096957|NCT03896503|Topotecan|topotecan|mesh-list
57096958|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57096959|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57096960|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096961|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096962|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57096963|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
57096964|NCT03654729|Edetic Acid|edetic acid|mesh-list
57096965|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
57096966|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57096967|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
57096968|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
57096969|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096970|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
57096971|NCT03654729|Vitamins|vitamins|mesh-ancestor
57096972|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
57096973|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096974|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
57096975|NCT04052269|Tadalafil|tadalafil|mesh-list
57096976|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
57096977|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57096978|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57096979|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096980|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096981|NCT04052269|Urological Agents|urological agents|mesh-ancestor
57096982|NCT01377987|Acetazolamide|acetazolamide|mesh-list
57096983|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
57096984|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57096985|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57096986|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57096987|NCT01377987|Diuretics|diuretics|mesh-ancestor
57096988|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
57096989|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096990|NCT03645187|Celecoxib|celecoxib|mesh-list
57096991|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57096992|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57096994|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
57096995|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57096996|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57096997|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57096998|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57096999|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57097000|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57097001|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097002|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097003|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
57097004|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
57097005|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097006|NCT03278925|Protective Agents|protective agents|mesh-ancestor
57097007|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097008|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
57097009|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57097010|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097011|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57097012|NCT03258567|Nivolumab|nivolumab|mesh-list
57097013|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097014|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097015|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57097016|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097017|NCT03645109|Vitamin D|vitamin d|mesh-list
57097018|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
57097019|NCT03645109|Vitamins|vitamins|mesh-ancestor
57097020|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
57097021|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097022|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57097023|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57097024|NCT04455555|Rotigotine|rotigotine|mesh-list
57097025|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
57097026|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
57097027|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097028|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097029|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097030|NCT02898259|Rituximab|rituximab|mesh-list
57097031|NCT02898259|Lenalidomide|lenalidomide|mesh-list
57097032|NCT02898259|Ixazomib|ixazomib|mesh-list
57097033|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097034|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097035|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
57097036|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097037|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097038|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57097039|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57097040|NCT02898259|Growth Substances|growth substances|mesh-ancestor
57097041|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
57097042|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
57097043|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097044|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097045|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
57097046|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57097047|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
57097048|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097049|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097050|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097051|NCT02963935|Liraglutide|liraglutide|mesh-list
57097052|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57097053|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097054|NCT02963935|Incretins|incretins|mesh-ancestor
57097055|NCT02963935|Hormones|hormones|mesh-ancestor
57097056|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57097057|NCT02899195|Durvalumab|durvalumab|mesh-list
57097058|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097059|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097060|NCT03644641|Propofol|propofol|mesh-list
57097061|NCT03644641|Desflurane|desflurane|mesh-list
57097062|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57097063|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097064|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097065|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56778925|NCT01757626|Molgramostim|molgramostim|mesh-list
57097066|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
57097067|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
57097068|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57097069|NCT05283421|Estrogens|estrogens|mesh-list
57097070|NCT05283421|Hormones|hormones|mesh-ancestor
57097071|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57097072|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097073|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
57097074|NCT03630991|Edetic Acid|edetic acid|mesh-list
57097075|NCT03630991|Calcium|calcium|mesh-list
57097076|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
57097077|NCT03630991|Succimer|succimer|mesh-list
57097078|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097079|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57097080|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57097081|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
57097082|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57097083|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
57097084|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
57097085|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097086|NCT03630991|Antidotes|antidotes|mesh-ancestor
57097087|NCT03630991|Protective Agents|protective agents|mesh-ancestor
57097088|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57097089|NCT02963701|Ibuprofen|ibuprofen|mesh-list
57097090|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
57097091|NCT02963701|Ephedrine|ephedrine|mesh-list
57097092|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57097093|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57097094|NCT02963701|Analgesics|analgesics|mesh-ancestor
57097095|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
57097096|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097097|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097098|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57097099|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097100|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57097101|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097102|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097103|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57097104|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
57097105|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57097106|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
57097107|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
57097108|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57097109|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57097110|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
57097111|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
57097112|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097113|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
57097114|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57097115|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097116|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57097117|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57097118|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097119|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097120|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097121|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57097122|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57097123|NCT03643549|Temozolomide|temozolomide|mesh-list
57097124|NCT03643549|Bortezomib|bortezomib|mesh-list
57097125|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57097126|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
56899652|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
57097127|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097128|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097129|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
57097130|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
57097131|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097132|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097133|NCT05262205|Anesthetics|anesthetics|mesh-list
57097134|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097135|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097136|NCT03641053|Iodine|iodine|mesh-list
57097137|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
57097138|NCT03641053|Povidone|povidone|mesh-list
57097139|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57097140|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097141|NCT03641053|Trace Elements|trace elements|mesh-ancestor
57097142|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
57097143|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097144|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
57097145|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
57097146|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
57097147|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
57097148|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097149|NCT05345691|Denosumab|denosumab|mesh-list
57097150|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57097151|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097152|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57097153|NCT03468777|Lansoprazole|lansoprazole|mesh-list
57097154|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
57097155|NCT03468777|Ranitidine|ranitidine|mesh-list
57097156|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
57097157|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57097158|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57097159|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57097160|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097161|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097162|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57097163|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
57097164|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
57097165|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097166|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097167|NCT03640377|Praziquantel|praziquantel|mesh-list
57097168|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
57097169|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57097170|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097171|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
57097172|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57097173|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57097174|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097175|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
57097176|NCT05323149|Coagulants|coagulants|mesh-ancestor
57097177|NCT05303805|Sevoflurane|sevoflurane|mesh-list
57097178|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57097179|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57097180|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
57097181|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
57097182|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097183|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097184|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57097185|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
57097186|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097187|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
57097188|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
57097189|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57097190|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097191|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097192|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
57097193|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57097194|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097195|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097196|NCT03632187|Abatacept|abatacept|mesh-list
57097197|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57097198|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097199|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097200|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097201|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
57097202|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097203|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097204|NCT05110209|Bevacizumab|bevacizumab|mesh-list
57097205|NCT05110209|Ranibizumab|ranibizumab|mesh-list
57097206|NCT05110209|Aflibercept|aflibercept|mesh-list
57097207|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097208|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097209|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57097210|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57097211|NCT05110209|Growth Substances|growth substances|mesh-ancestor
57097212|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097213|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
57097214|NCT04454151|Azithromycin|azithromycin|mesh-list
57097215|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57097216|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097217|NCT02297139|Dasatinib|dasatinib|mesh-list
56779079|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
57097218|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097219|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57097220|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097221|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097222|NCT05272683|Itraconazole|itraconazole|mesh-list
57097223|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
57097224|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097225|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57097226|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57097227|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097228|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097229|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57097230|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
57097231|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57097232|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097233|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57097234|NCT05661201|Doxorubicin|doxorubicin|mesh-list
57097235|NCT05661201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57097236|NCT05661201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097237|NCT05661201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57097238|NCT05661201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57097239|NCT05661201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097240|NCT05661201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097241|NCT03934671|Antioxidants|antioxidants|mesh-list
57097242|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097243|NCT03934671|Protective Agents|protective agents|mesh-ancestor
57097244|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097245|NCT03130179|Nicotine|nicotine|mesh-list
57097246|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57097247|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
57097248|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097249|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097250|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57097251|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57097252|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
57097253|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097254|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097255|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
57097256|NCT03466983|Hematinics|hematinics|mesh-ancestor
57097257|NCT05439213|Epinephrine|epinephrine|mesh-list
57097258|NCT05439213|Racepinephrine|racepinephrine|mesh-list
57097259|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57097260|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
57097261|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57097262|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57097263|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
57097264|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097265|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097266|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097267|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57097268|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57097269|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
57097270|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097271|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56321389|NCT00034905|Risperidone|risperidone|mesh-list
57097272|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
57097273|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
57097274|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
57097275|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57097276|NCT05398653|Cyclosporine|cyclosporine|mesh-list
57097277|NCT05398653|Cyclosporins|cyclosporins|mesh-list
57097278|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097279|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097280|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097281|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
57097282|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097283|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
57097284|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097285|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
57097286|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097287|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57097288|NCT03466749|Paclitaxel|paclitaxel|mesh-list
57097289|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57097290|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097291|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
57097292|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
57097293|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
57097294|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097295|NCT03466437|Methamphetamine|methamphetamine|mesh-list
57097296|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57097297|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097298|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
57097299|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
57097300|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097301|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
57097302|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097303|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097304|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
57097305|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57097306|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57097307|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57097308|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57097309|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
57097310|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097311|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097312|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
57097313|NCT01909245|Gastrins|gastrins|mesh-list
57097314|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
57097315|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097316|NCT01909245|Hormones|hormones|mesh-ancestor
57097317|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57097318|NCT04481919|Diuretics|diuretics|mesh-list
57097319|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
57097320|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097321|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
57097322|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097323|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097324|NCT03465969|Tacrolimus|tacrolimus|mesh-list
57097325|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097326|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
57097327|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097328|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57097329|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097330|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097331|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57097332|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57097333|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
57097334|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57097335|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
57097336|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57097337|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097338|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57097339|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57097340|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097341|NCT02889159|Imiquimod|imiquimod|mesh-list
57097342|NCT02889159|Histamine|histamine|mesh-list
57097343|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
57097344|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57097345|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
57097346|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097347|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097348|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
57097349|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
57097350|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
57097351|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097352|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097353|NCT03130101|Insulin|insulin|mesh-list
57097354|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57097355|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097356|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
57097357|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
57097358|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57097359|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
57097360|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097361|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097362|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097363|NCT04311489|Ularitide|ularitide|mesh-list
57097364|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57097365|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
57097366|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097367|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097368|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57097369|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
57097370|NCT04311489|Diuretics|diuretics|mesh-ancestor
57097371|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
57097372|NCT02735577|Disulfiram|disulfiram|mesh-list
57097373|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57097374|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
57097375|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097376|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097377|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57097378|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57097379|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
57097380|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57097381|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57097382|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097383|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
57097384|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
57097385|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57097386|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
57097387|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097388|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097389|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57097390|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
57097391|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
57097392|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57097393|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
57097394|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097395|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097396|NCT05396937|Bevacizumab|bevacizumab|mesh-list
57097397|NCT05396937|Atezolizumab|atezolizumab|mesh-list
57097398|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097399|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097400|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57097401|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57097402|NCT05396937|Growth Substances|growth substances|mesh-ancestor
57097403|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097404|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
57097405|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57097406|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57097407|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097408|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
57097409|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57097410|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097411|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57097412|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097413|NCT03642145|Deflazacort|deflazacort|mesh-list
57097414|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57097415|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097416|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
57097417|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097418|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
57097419|NCT01064791|Tacrolimus|tacrolimus|mesh-list
57097420|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097421|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
57097422|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097423|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57097424|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097425|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097426|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57097427|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097428|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57097429|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
57097430|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57097431|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097432|NCT03465423|Propofol|propofol|mesh-list
57097433|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
57097434|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097435|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097436|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57097437|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57097438|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
57097439|NCT05161351|Vitamin D|vitamin d|mesh-list
57097440|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
57097441|NCT05161351|Baclofen|baclofen|mesh-list
57097443|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
57097444|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097445|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57097446|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57097447|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57097448|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57097449|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097450|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
57097451|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
57097452|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
57097453|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097454|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097455|NCT03465345|Metformin|metformin|mesh-list
57097456|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
57097457|NCT03465345|Procyanidin|procyanidin|mesh-list
57097458|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57097459|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097460|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
57097461|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097462|NCT03465345|Protective Agents|protective agents|mesh-ancestor
57097463|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57097464|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57097465|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097466|NCT04563507|Letrozole|letrozole|mesh-list
57097467|NCT04563507|Palbociclib|palbociclib|mesh-list
57097468|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097469|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57097470|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57097471|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097472|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097473|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57097474|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
57097475|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57097476|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097477|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57097478|NCT02983799|Olaparib|olaparib|mesh-list
57097479|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57097480|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097481|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097482|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097483|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
57097484|NCT05389527|Lenvatinib|lenvatinib|mesh-list
57097485|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097486|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097487|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57097488|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097489|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097490|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
57097491|NCT05385705|Trastuzumab|trastuzumab|mesh-list
57097492|NCT05385705|Interleukin-2|interleukin-2|mesh-list
57097493|NCT05385705|Pertuzumab|pertuzumab|mesh-list
57097494|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097495|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
57097496|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097497|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097498|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57097499|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
57097500|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097501|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097502|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57097503|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097504|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57097505|NCT05385705|Analgesics|analgesics|mesh-ancestor
57097506|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
57097507|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097508|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
57097509|NCT03912831|Fludarabine|fludarabine|mesh-list
57097510|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097511|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
57097512|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097513|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097514|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57097515|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
57097516|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097517|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097518|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57097520|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57097521|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097522|NCT02186847|Metformin|metformin|mesh-list
57097523|NCT02186847|Paclitaxel|paclitaxel|mesh-list
57097524|NCT02186847|Carboplatin|carboplatin|mesh-list
57097525|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57097526|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097527|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
57097528|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
57097529|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
57097530|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097531|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57097532|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097533|NCT01938261|Acetaminophen|acetaminophen|mesh-list
57097534|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57097535|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57097536|NCT01938261|Analgesics|analgesics|mesh-ancestor
57097537|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
57097538|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097539|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097540|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
57097541|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
57097542|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57097543|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097544|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097545|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57097546|NCT05274789|Analgesics|analgesics|mesh-ancestor
57097547|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
57097548|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097549|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57097550|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57097551|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57097552|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
57097553|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097554|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097555|NCT02353247|Norethindrone|norethindrone|mesh-list
57097556|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
57097557|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57097558|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57097559|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57097560|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
57097561|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57097562|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097563|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57097564|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57097565|NCT04343651|Leronlimab|leronlimab|mesh-list
57097566|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57097567|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57097568|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097569|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57097570|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57097571|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
57097572|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097573|NCT03343431|Tenofovir|tenofovir|mesh-list
57097574|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
57097575|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097576|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57097577|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57097578|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097579|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097580|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57097581|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57097582|NCT05226897|Metformin|metformin|mesh-list
57097583|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
57097584|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57097585|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097586|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57097587|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097588|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
57097589|NCT04453761|Vitamins|vitamins|mesh-ancestor
57097590|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
57097591|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097592|NCT03225417|Sirolimus|sirolimus|mesh-list
57097593|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
57097594|NCT03225417|Ixazomib|ixazomib|mesh-list
57097595|NCT03225417|Tacrolimus|tacrolimus|mesh-list
57097596|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57097597|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097598|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
57097599|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097600|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097601|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57097602|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
57097603|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097604|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097605|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57097606|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57097607|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097608|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57097609|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097610|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57097611|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
57097612|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
57097613|NCT03463317|Aspirin|aspirin|mesh-list
57097614|NCT03463317|Warfarin|warfarin|mesh-list
57097615|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
57097616|NCT03463317|Dabigatran|dabigatran|mesh-list
57097617|NCT03463317|Apixaban|apixaban|mesh-list
57097618|NCT03463317|Edoxaban|edoxaban|mesh-list
57097619|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
57097620|NCT03463317|Clopidogrel|clopidogrel|mesh-list
57097621|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57097622|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57097623|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57097624|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57097625|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
57097626|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097627|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097628|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097629|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
57097630|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57097631|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
57097632|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57097633|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
57097634|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097635|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57097636|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57097637|NCT03463317|Analgesics|analgesics|mesh-ancestor
57097638|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
57097639|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097640|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57097641|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097642|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57097643|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57097644|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57097645|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
57097646|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
57097647|NCT05049213|Povidone|povidone|mesh-list
57097648|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
57097649|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
57097650|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57097651|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097652|NCT05033769|Paclitaxel|paclitaxel|mesh-list
57097653|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57097654|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57097655|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097656|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
57097657|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
57097658|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
57097659|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097660|NCT02906579|Praliciguat|praliciguat|mesh-list
57097661|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57097662|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
57097663|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097664|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57097665|NCT04975347|Naloxone|naloxone|mesh-list
57097666|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779528|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57097667|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57097668|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
57097669|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097670|NCT03463083|Fentanyl|fentanyl|mesh-list
57097671|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
57097672|NCT03463083|Bupivacaine|bupivacaine|mesh-list
57097673|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
57097674|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
57097675|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097676|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097677|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
57097678|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097679|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57097680|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57097681|NCT03463083|Analgesics|analgesics|mesh-ancestor
57097682|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57097683|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57097684|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57097685|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
57097686|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097687|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097688|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57097689|NCT03463083|Narcotics|narcotics|mesh-ancestor
57097690|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57097691|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57097692|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
57097693|NCT04971837|Cannabidiol|cannabidiol|mesh-list
57097694|NCT04971837|Sorbitol|sorbitol|mesh-list
57097695|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
57097696|NCT04971837|Cathartics|cathartics|mesh-ancestor
57097697|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57097698|NCT01328535|Temozolomide|temozolomide|mesh-list
57097699|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57097700|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
57097701|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097702|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097703|NCT03463005|Propolis|propolis|mesh-list
57097704|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097705|NCT02522169|Infliximab|infliximab|mesh-list
57097706|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
57097707|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57097708|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097709|NCT03656393|Carboplatin|carboplatin|mesh-list
57097710|NCT03656393|Vinorelbine|vinorelbine|mesh-list
57097711|NCT03656393|Gefitinib|gefitinib|mesh-list
57097712|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097713|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57097714|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
57097715|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
57097716|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
57097717|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097718|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57097719|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097720|NCT02979197|Celecoxib|celecoxib|mesh-list
57097721|NCT02979197|Amlodipine|amlodipine|mesh-list
57097722|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57097723|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57097724|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57097725|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097726|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57097727|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097728|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
57097729|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57097730|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57097731|NCT02979197|Analgesics|analgesics|mesh-ancestor
57097732|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
57097733|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097734|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57097735|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57097736|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57097737|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57097738|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097739|NCT01837277|Efavirenz|efavirenz|mesh-list
57097740|NCT01837277|Dolutegravir|dolutegravir|mesh-list
57097741|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57097742|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57097743|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097744|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097745|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
57097746|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097747|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57097748|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57097749|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57097750|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57097751|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57097752|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57097753|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57097754|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57097755|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57097756|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57097758|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57097759|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097760|NCT03654365|Caffeine|caffeine|mesh-list
57097761|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57097762|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097763|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57097764|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097765|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097766|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57097767|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57097768|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
57097769|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097770|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
57097771|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57097772|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097773|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097774|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57097775|NCT03655847|Analgesics|analgesics|mesh-ancestor
57097776|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
57097777|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097778|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57097779|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57097780|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57097781|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
57097782|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097783|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097784|NCT03655457|Poractant alfa|poractant alfa|mesh-list
57097785|NCT03655457|Beractant|beractant|mesh-list
57097786|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
57097787|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
57097788|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57097789|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57097790|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
57097791|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097792|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57097793|NCT04453371|Plasminogen|plasminogen|mesh-list
57097794|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57097795|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57097796|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097797|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
57097798|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
57097799|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
57097800|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57097801|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
57097802|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57097803|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57097804|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097805|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57097806|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57097807|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097808|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097809|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097810|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097811|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57097812|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
57097813|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
57097814|NCT02980523|Protective Agents|protective agents|mesh-ancestor
57097815|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
57097816|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
56779676|NCT00393484|Lamivudine|lamivudine|mesh-list
57097817|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57097818|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57097819|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
57097820|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097821|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097822|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097823|NCT03468465|Urological Agents|urological agents|mesh-ancestor
57097824|NCT03460743|Vaccines|vaccines|mesh-list
57097825|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
57097826|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
57097827|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097828|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
57097829|NCT02980133|Fluticasone|fluticasone|mesh-list
57097830|NCT02980133|Xhance|xhance|mesh-list
57097831|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57097832|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57097833|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57097834|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
57097835|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097836|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097837|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57097838|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
57097839|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
57097840|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57097841|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57097842|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57097843|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57097844|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
57097845|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097846|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097847|NCT03653663|Simvastatin|simvastatin|mesh-list
57097848|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57097849|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57097850|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
57097851|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097852|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57097853|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57097854|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097855|NCT04864743|Factor VIII|factor viii|mesh-list
57097856|NCT04864743|Coagulants|coagulants|mesh-ancestor
57097857|NCT02979431|Gontivimab|gontivimab|mesh-list
57097858|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
57097859|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097860|NCT03460275|Osimertinib|osimertinib|mesh-list
57097861|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097862|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57097863|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899667|NCT01566669|Parecoxib|parecoxib|mesh-list
57097864|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097865|NCT03468231|Leucovorin|leucovorin|mesh-list
57097866|NCT03468231|Fluorouracil|fluorouracil|mesh-list
57097867|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
57097868|NCT03468231|Sorafenib|sorafenib|mesh-list
57097869|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
57097870|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097871|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57097872|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097873|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57097874|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
57097875|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097876|NCT03468231|Antidotes|antidotes|mesh-ancestor
57097877|NCT03468231|Protective Agents|protective agents|mesh-ancestor
57097878|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
57097879|NCT03468231|Vitamins|vitamins|mesh-ancestor
57097880|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
57097881|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57097882|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097883|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
57097884|NCT03460041|Bupivacaine|bupivacaine|mesh-list
57097885|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
57097886|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
57097887|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097888|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097889|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
57097890|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097891|NCT03460041|Analgesics|analgesics|mesh-ancestor
57097892|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57097893|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
57097894|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57097895|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57097896|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097897|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57097898|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
57097899|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57097900|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
57097901|NCT02522013|Aminophylline|aminophylline|mesh-list
57097902|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57097903|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
57097904|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097905|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097906|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57097907|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
57097908|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57097909|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57097910|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097911|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097912|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57097913|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57097914|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
57097915|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097916|NCT02522013|Protective Agents|protective agents|mesh-ancestor
57097917|NCT02978417|Naltrexone|naltrexone|mesh-list
57097918|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57097919|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57097920|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097921|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
57097922|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097923|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
57097924|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57097925|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097926|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57097927|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097928|NCT03457467|Apatinib|apatinib|mesh-list
57097929|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57097930|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57097931|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097932|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097933|NCT05191875|Doxycycline|doxycycline|mesh-list
57097934|NCT05191875|Furazolidone|furazolidone|mesh-list
57097935|NCT05191875|Bismuth|bismuth|mesh-list
57097936|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57097937|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097938|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
57097939|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57097940|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57097941|NCT05191875|Antacids|antacids|mesh-ancestor
57097942|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097943|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57097944|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57097945|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57097946|NCT05191875|Renal Agents|renal agents|mesh-ancestor
57097947|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57097948|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57097949|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57097950|NCT04370145|Meropenem|meropenem|mesh-list
57097951|NCT04370145|Tinidazole|tinidazole|mesh-list
57097952|NCT04370145|Teicoplanin|teicoplanin|mesh-list
57097953|NCT04370145|Sulperazone|sulperazone|mesh-list
57097954|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57097955|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57097956|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
57097957|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097958|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57097959|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57097960|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57097961|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57097962|NCT04370145|Renal Agents|renal agents|mesh-ancestor
57097963|NCT03453723|Lidocaine|lidocaine|mesh-list
57097964|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
57097965|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
57097966|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097967|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097968|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
57097969|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097970|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57097971|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57097972|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57097973|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57097974|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097975|NCT04368429|Vaccines|vaccines|mesh-list
57097976|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
57097977|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097978|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
57097979|NCT04774965|Promethazine|promethazine|mesh-list
57097980|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57097981|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57097982|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57097983|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57097984|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
57097985|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
57097986|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
57097987|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57097988|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
57097989|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
57097990|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57097991|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57097992|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
57097993|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
57097994|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57097995|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57097996|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57097997|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
57097998|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
57097999|NCT03452553|Doxorubicin|doxorubicin|mesh-list
57098000|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57098001|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098002|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57098003|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57098004|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098005|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098006|NCT03452475|Lumefantrine|lumefantrine|mesh-list
57098007|NCT03452475|Artemether|artemether|mesh-list
57098008|NCT03452475|Piperaquine|piperaquine|mesh-list
57098009|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57098010|NCT03452475|Mefloquine|mefloquine|mesh-list
57098011|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
57098012|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57098013|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57098014|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098015|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57098016|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
57098017|NCT03451227|Remifentanil|remifentanil|mesh-list
57098018|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57098019|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098020|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098021|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57098022|NCT03451227|Analgesics|analgesics|mesh-ancestor
57098023|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
57098024|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098025|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57098026|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57098027|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57098028|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
57098029|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098030|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098031|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57098032|NCT03451227|Narcotics|narcotics|mesh-ancestor
57098033|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
57098034|NCT02529813|Fludarabine|fludarabine|mesh-list
57098035|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
57098036|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57098037|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
57098038|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098039|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57098040|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57098041|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
57098042|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098043|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098044|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57098045|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57098046|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
57098047|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57098048|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57098049|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
57098051|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098052|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098053|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
57098054|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57098055|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
57098056|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57098057|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57098058|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57098059|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098060|NCT02417103|Liraglutide|liraglutide|mesh-list
57098061|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57098062|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098063|NCT02417103|Incretins|incretins|mesh-ancestor
57098064|NCT02417103|Hormones|hormones|mesh-ancestor
57098065|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098066|NCT02382549|Vaccines|vaccines|mesh-list
57098067|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
57098068|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098069|NCT02097225|Trametinib|trametinib|mesh-list
57098070|NCT02097225|Dabrafenib|dabrafenib|mesh-list
57098071|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098072|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098073|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098074|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098075|NCT02958865|PF-06700841|pf-06700841|mesh-list
57098076|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098077|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098078|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098079|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
57098080|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57098081|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098082|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098083|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57098084|NCT05321121|Analgesics|analgesics|mesh-ancestor
57098085|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
57098086|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098087|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57098088|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57098089|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57098090|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
57098091|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098092|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098093|NCT02501902|Paclitaxel|paclitaxel|mesh-list
57098094|NCT02501902|Palbociclib|palbociclib|mesh-list
57098095|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57098096|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098097|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
57098098|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
57098099|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
57098100|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098101|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098102|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098103|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
57098104|NCT04205968|Leucovorin|leucovorin|mesh-list
57098105|NCT04205968|Folic Acid|folic acid|mesh-list
57098106|NCT04205968|Paclitaxel|paclitaxel|mesh-list
57098107|NCT04205968|Camptothecin|camptothecin|mesh-list
57098108|NCT04205968|Fluorouracil|fluorouracil|mesh-list
57098109|NCT04205968|Irinotecan|irinotecan|mesh-list
57098110|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57098111|NCT04205968|Ramucirumab|ramucirumab|mesh-list
57098112|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57098113|NCT04205968|Antibodies|antibodies|mesh-list
57098114|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
57098115|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57098116|NCT04205968|Lexatumumab|lexatumumab|mesh-list
57098117|NCT04205968|Calcium|calcium|mesh-list
57098118|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
57098119|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57098120|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098121|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
56779981|NCT00995306|Capsaicin|capsaicin|mesh-list
57098122|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
57098123|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
57098124|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098125|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
57098126|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098127|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57098128|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57098129|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
57098130|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57098131|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57098132|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57098133|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57098134|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098135|NCT04205968|Antidotes|antidotes|mesh-ancestor
57098136|NCT04205968|Protective Agents|protective agents|mesh-ancestor
57098137|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
57098138|NCT04205968|Vitamins|vitamins|mesh-ancestor
57098139|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
57098140|NCT04205968|Hematinics|hematinics|mesh-ancestor
57098141|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
57098142|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098143|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098144|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098145|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098146|NCT03448731|Doxycycline|doxycycline|mesh-list
57098147|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57098148|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098149|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
57098150|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57098151|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57098152|NCT04452669|Epoprostenol|epoprostenol|mesh-list
57098153|NCT04452669|Tezosentan|tezosentan|mesh-list
57098154|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57098155|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57098156|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
57098157|NCT03719001|Clevidipine|clevidipine|mesh-list
57098158|NCT03719001|Phenylephrine|phenylephrine|mesh-list
57098159|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
57098160|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
57098161|NCT03719001|Calcium|calcium|mesh-list
57098162|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57098163|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098164|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57098165|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098166|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57098167|NCT03719001|Analgesics|analgesics|mesh-ancestor
57098168|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
57098169|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098170|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57098171|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57098172|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57098173|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
57098174|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098175|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098176|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57098177|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
57098178|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
57098179|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
57098180|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57098181|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
57098182|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
57098183|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57098184|NCT03719001|Protective Agents|protective agents|mesh-ancestor
57098185|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57098186|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098187|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57098188|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57098189|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57098190|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098191|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098192|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
57098193|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098194|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098195|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
57098196|NCT03129555|Apixaban|apixaban|mesh-list
57098197|NCT03129555|Edoxaban|edoxaban|mesh-list
57098198|NCT03129555|Dabigatran|dabigatran|mesh-list
57098199|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57098200|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
57098201|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57098202|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
57098203|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098204|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098205|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
57098206|NCT04965064|Capecitabine|capecitabine|mesh-list
57098207|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57098208|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
57098209|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098210|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098211|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
57098212|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57098213|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098214|NCT04964128|Insulin|insulin|mesh-list
57098215|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57098216|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098217|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
57098218|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098219|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098220|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
57098221|NCT03205605|Oxybutynin|oxybutynin|mesh-list
57098222|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
57098223|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
57098224|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098225|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098226|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57098227|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57098228|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
57098229|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098230|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098231|NCT03205605|Urological Agents|urological agents|mesh-ancestor
57098232|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57098233|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098234|NCT03205605|Renal Agents|renal agents|mesh-ancestor
57098235|NCT05006638|Atropine|atropine|mesh-list
57098236|NCT05006638|Ondansetron|ondansetron|mesh-list
57098237|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
57098238|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
57098239|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
57098240|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
57098241|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098242|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098243|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57098244|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
57098245|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
57098246|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57098247|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
57098248|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098249|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098250|NCT05006638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57098251|NCT05006638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57098252|NCT05006638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098253|NCT05006638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57098254|NCT05006638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57098255|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57098256|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57098257|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57098258|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57098259|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
57098260|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
57098261|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
57098262|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57098263|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57098264|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
57098265|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57098266|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57098267|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
57098268|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
57098269|NCT02498236|Oxytocin|oxytocin|mesh-list
57098270|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
57098271|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57098272|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098273|NCT01283997|Minocycline|minocycline|mesh-list
57098274|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57098275|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098276|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
57098277|NCT02496676|Analgesics|analgesics|mesh-ancestor
57098278|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
57098279|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098280|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098281|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
57098282|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098283|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57098284|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
57098285|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57098286|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098287|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098288|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57098289|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
57098290|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57098292|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098293|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098294|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098295|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098296|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57098297|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
57098298|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57098299|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57098300|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
57098301|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098302|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098303|NCT03800602|Metformin|metformin|mesh-list
57098304|NCT03800602|Nivolumab|nivolumab|mesh-list
57098305|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57098306|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098307|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57098308|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098309|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55891145|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57098310|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098311|NCT01160211|Trastuzumab|trastuzumab|mesh-list
57098312|NCT01160211|Lapatinib|lapatinib|mesh-list
57098313|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57098314|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57098315|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098316|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098317|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098318|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098319|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57098320|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57098321|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
57098322|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098323|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098324|NCT03443271|Bupivacaine|bupivacaine|mesh-list
57098325|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
57098326|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
57098327|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098328|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098329|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
57098330|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098331|NCT01064687|Metformin|metformin|mesh-list
57098332|NCT01064687|Pioglitazone|pioglitazone|mesh-list
57098333|NCT01064687|Exenatide|exenatide|mesh-list
57098334|NCT01064687|Dulaglutide|dulaglutide|mesh-list
57098335|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57098336|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098337|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57098338|NCT01064687|Incretins|incretins|mesh-ancestor
57098339|NCT01064687|Hormones|hormones|mesh-ancestor
57098340|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098341|NCT03447873|Lamivudine|lamivudine|mesh-list
57098342|NCT03447873|Cobicistat|cobicistat|mesh-list
57098343|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57098344|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57098345|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098346|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098347|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
57098348|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098349|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57098350|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57098351|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57098352|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57098353|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
57098354|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57098355|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57098356|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57098357|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098358|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098359|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
57098360|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098361|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098362|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57098363|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098364|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
57098365|NCT00740805|Doxorubicin|doxorubicin|mesh-list
57098366|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57098367|NCT00740805|Veliparib|veliparib|mesh-list
57098368|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57098369|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
57098370|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098371|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57098372|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57098373|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
57098374|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098375|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098376|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57098377|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57098378|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57098379|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57098380|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098381|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57098382|NCT03621995|Catalase|catalase|mesh-list
57098383|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
57098384|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098385|NCT03621995|Protective Agents|protective agents|mesh-ancestor
57098386|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098387|NCT03443037|Amantadine|amantadine|mesh-list
57098388|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57098389|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57098390|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
57098391|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098392|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
57098393|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098394|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098395|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098396|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57098397|NCT03443037|Analgesics|analgesics|mesh-ancestor
57098398|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
57098399|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098400|NCT03442491|Hemostatics|hemostatics|mesh-list
57098401|NCT03442491|Coagulants|coagulants|mesh-ancestor
57098402|NCT02918279|Liraglutide|liraglutide|mesh-list
57098403|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57098404|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098405|NCT02918279|Incretins|incretins|mesh-ancestor
57098406|NCT02918279|Hormones|hormones|mesh-ancestor
57098407|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098408|NCT02956837|Vaccines|vaccines|mesh-list
57098409|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
57098410|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098411|NCT03447093|Methimazole|methimazole|mesh-list
57098412|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
57098413|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
57098414|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
57098415|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098416|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098417|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
57098418|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098419|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57098420|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57098421|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
56780280|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098422|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57098424|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098425|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
57098426|NCT03640351|Protective Agents|protective agents|mesh-ancestor
57098427|NCT03640273|Loratadine|loratadine|mesh-list
57098428|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
57098429|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
57098430|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57098431|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57098432|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57098433|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
57098434|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
57098435|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098436|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098437|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098438|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
57098439|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57098440|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57098441|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098442|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
57098443|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
57098444|NCT01063283|Bevacizumab|bevacizumab|mesh-list
57098445|NCT01063283|Carboplatin|carboplatin|mesh-list
57098446|NCT01063283|Pemetrexed|pemetrexed|mesh-list
57098447|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57098448|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098449|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57098450|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57098451|NCT01063283|Growth Substances|growth substances|mesh-ancestor
57098452|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098453|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
57098454|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098455|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098456|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57098457|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57098458|NCT01062971|Timolol|timolol|mesh-list
57098459|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57098460|NCT01062971|Dorzolamide|dorzolamide|mesh-list
57098461|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57098462|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57098463|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
57098464|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098465|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098466|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098467|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57098468|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57098469|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57098470|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57098471|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57098472|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57098473|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098474|NCT03446937|Dexamethasone|dexamethasone|mesh-list
57098475|NCT03446937|Betamethasone|betamethasone|mesh-list
57098476|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
57098477|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57098478|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
57098479|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
57098480|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57098481|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57098482|NCT03446937|BB 1101|bb 1101|mesh-list
57098483|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57098484|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
57098485|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
57098486|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098487|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098488|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57098489|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
57098490|NCT03446937|Hormones|hormones|mesh-ancestor
57098491|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098492|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57098493|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098494|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57098495|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
57098496|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
57098497|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098498|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098500|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098501|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
57098502|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57098503|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57098504|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
57098505|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57098506|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098507|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57098508|NCT02493868|Citalopram|citalopram|mesh-list
57098509|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57098510|NCT02493868|Sertraline|sertraline|mesh-list
57098511|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
57098512|NCT02493868|Esketamine|esketamine|mesh-list
57098513|NCT02493868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57098514|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57098515|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098516|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098517|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098518|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
57098519|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098520|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57098521|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57098522|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098523|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57098524|NCT02493868|Analgesics|analgesics|mesh-ancestor
57098525|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
57098526|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
57098527|NCT03619057|Anesthetics|anesthetics|mesh-list
57098528|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098529|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098530|NCT04451655|Insulin|insulin|mesh-list
57098531|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57098532|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098533|NCT03446625|Resveratrol|resveratrol|mesh-list
57098534|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
57098535|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098536|NCT03446625|Protective Agents|protective agents|mesh-ancestor
57098537|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098538|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098539|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57098540|NCT04594005|Paclitaxel|paclitaxel|mesh-list
57098541|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57098542|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098543|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
57098544|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
57098545|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
57098546|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098547|NCT02516410|Ivacaftor|ivacaftor|mesh-list
57098548|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57098549|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098550|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098551|NCT04580277|Tofacitinib|tofacitinib|mesh-list
57098552|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098553|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098554|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098555|NCT02493712|Mesalamine|mesalamine|mesh-list
57098556|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57098557|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57098558|NCT02493712|Analgesics|analgesics|mesh-ancestor
57098559|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
57098560|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098561|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098562|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57098563|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57098564|NCT03446547|Durvalumab|durvalumab|mesh-list
57098565|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57098566|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098567|NCT02516332|Citalopram|citalopram|mesh-list
57098568|NCT02516332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57098569|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57098570|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098571|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098572|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098574|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098575|NCT02516332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57098576|NCT02516332|Antidepressive Agents|antidepressive agents|mesh-ancestor
57098577|NCT02516332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57098578|NCT03437655|Eugenol|eugenol|mesh-list
57098579|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
57098580|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
57098581|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
57098582|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57098583|NCT03437655|Protective Agents|protective agents|mesh-ancestor
57098584|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098585|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098586|NCT01062425|Temozolomide|temozolomide|mesh-list
57098587|NCT01062425|Cediranib|cediranib|mesh-list
57098588|NCT01062425|Maleic acid|maleic acid|mesh-list
57098589|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57098590|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
57098591|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098592|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098593|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098594|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098595|NCT03437187|Analgesics|analgesics|mesh-list
57098596|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098597|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
57098598|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098599|NCT02491684|Interferons|interferons|mesh-list
57098600|NCT02491684|Interferon-beta|interferon-beta|mesh-list
57098601|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
57098602|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098603|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
57098604|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098605|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
57098606|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098607|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57098608|NCT04752813|Vitamin K|vitamin k|mesh-list
57098609|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
57098610|NCT04752813|Temozolomide|temozolomide|mesh-list
57098611|NCT04752813|Vitamins|vitamins|mesh-ancestor
57098612|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
57098613|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098614|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57098615|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
57098616|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098617|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098618|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57098619|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57098620|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
57098621|NCT04752813|Coagulants|coagulants|mesh-ancestor
57098622|NCT03445611|Lidocaine|lidocaine|mesh-list
57098623|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57098624|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
57098625|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
57098626|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098627|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098628|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
57098629|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098630|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57098631|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57098632|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57098633|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098634|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098635|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
57098636|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57098637|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57098638|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098639|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
57098640|NCT04360629|Coagulants|coagulants|mesh-ancestor
57098641|NCT04727229|Bupivacaine|bupivacaine|mesh-list
57098642|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
57098643|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
56780512|NCT00783107|Cyclosporine|cyclosporine|mesh-list
57098644|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098645|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098646|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
57098647|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098648|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57098649|NCT03436719|Metronidazole|metronidazole|mesh-list
57098650|NCT03436719|Erythromycin|erythromycin|mesh-list
57098651|NCT03436719|Cefoperazone|cefoperazone|mesh-list
57098652|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57098653|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098654|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
57098655|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57098656|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57098657|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57098658|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57098659|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098660|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098661|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
57098662|NCT01061333|Nedocromil|nedocromil|mesh-list
57098663|NCT01061333|Montelukast|montelukast|mesh-list
57098664|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57098665|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
57098666|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57098667|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
57098668|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098669|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098670|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57098671|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57098672|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098673|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57098674|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
57098675|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57098676|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
57098677|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
57098678|NCT02489968|Empagliflozin|empagliflozin|mesh-list
57098679|NCT02489968|Linagliptin|linagliptin|mesh-list
57098680|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57098681|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098682|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57098683|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098684|NCT02489968|Incretins|incretins|mesh-ancestor
57098685|NCT02489968|Hormones|hormones|mesh-ancestor
57098686|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098687|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57098688|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
57098689|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098690|NCT03436173|Fluoxetine|fluoxetine|mesh-list
57098691|NCT03436173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57098692|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57098693|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098694|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098695|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098696|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
57098697|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098698|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57098699|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
57098700|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57098701|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57098702|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57098703|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098704|NCT03444831|Buspirone|buspirone|mesh-list
57098705|NCT03444831|Omeprazole|omeprazole|mesh-list
57098706|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57098707|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57098708|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57098709|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098710|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098711|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57098712|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57098713|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098714|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098715|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57098716|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57098717|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
57098718|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098719|NCT02481934|Lenalidomide|lenalidomide|mesh-list
57098720|NCT02481934|Bortezomib|bortezomib|mesh-list
57098721|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
57098722|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098723|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57098724|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57098725|NCT02481934|Growth Substances|growth substances|mesh-ancestor
57098726|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
57098727|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098728|NCT03444519|Mannitol|mannitol|mesh-list
57098729|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57098730|NCT03444519|Diuretics|diuretics|mesh-ancestor
57098731|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
57098732|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098733|NCT03129009|Anesthetics|anesthetics|mesh-list
57098734|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098735|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098736|NCT02489500|Bortezomib|bortezomib|mesh-list
57098737|NCT02489500|Melphalan|melphalan|mesh-list
57098738|NCT02489500|Lenograstim|lenograstim|mesh-list
57098739|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098740|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57098741|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
57098742|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098743|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57098744|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57098745|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
57098746|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098747|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57098748|NCT04053959|Insulin|insulin|mesh-list
57098749|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57098750|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57098751|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098752|NCT03652571|Nortriptyline|nortriptyline|mesh-list
57098753|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57098754|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
57098755|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57098756|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57098757|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57098758|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098759|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098760|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
57098761|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098762|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098763|NCT03652103|Bupivacaine|bupivacaine|mesh-list
57098764|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
57098765|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
57098766|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098767|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098768|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
57098769|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098770|NCT03651947|Denosumab|denosumab|mesh-list
57098771|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57098772|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098773|NCT03651557|Salicylates|salicylates|mesh-list
57098774|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57098775|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57098776|NCT03651557|Analgesics|analgesics|mesh-ancestor
57098777|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
57098778|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098779|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098780|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57098781|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57098782|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57098783|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098784|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098785|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
57098786|NCT03432975|Povidone|povidone|mesh-list
57098787|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
57098788|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
57098789|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57098790|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098791|NCT04953130|Vaccines|vaccines|mesh-list
57098792|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
57098793|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098794|NCT02488330|Bevacizumab|bevacizumab|mesh-list
57098795|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57098796|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57098797|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098798|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57098799|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57098800|NCT02488330|Growth Substances|growth substances|mesh-ancestor
57098801|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098802|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
57098803|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098804|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098805|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098806|NCT03432663|Amiodarone|amiodarone|mesh-list
57098807|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57098808|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
57098809|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57098810|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57098811|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098812|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57098813|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57098814|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57098815|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098816|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57098817|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57098818|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57098819|NCT04266795|Azacitidine|azacitidine|mesh-list
57098820|NCT04266795|Venetoclax|venetoclax|mesh-list
57098821|NCT04266795|Pevonedistat|pevonedistat|mesh-list
57098822|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57098823|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
57098824|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098825|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098826|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098827|NCT03432273|Nicotine|nicotine|mesh-list
57098828|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57098829|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
57098830|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098831|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098832|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57098833|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57098834|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
57098835|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098836|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098837|NCT02481310|Cytarabine|cytarabine|mesh-list
57098838|NCT02481310|Prednisone|prednisone|mesh-list
57098839|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
57098840|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57098841|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57098842|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57098843|NCT02481310|Cortisone|cortisone|mesh-list
57098844|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
57098845|NCT02481310|Rituximab|rituximab|mesh-list
57098846|NCT02481310|Doxorubicin|doxorubicin|mesh-list
57098847|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57098848|NCT02481310|Methotrexate|methotrexate|mesh-list
57098849|NCT02481310|Etoposide|etoposide|mesh-list
57098850|NCT02481310|Vincristine|vincristine|mesh-list
57098851|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
57098852|NCT02481310|Ixazomib|ixazomib|mesh-list
57098853|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
57098854|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57098855|NCT02481310|Antibodies|antibodies|mesh-list
57098856|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
57098857|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57098858|NCT02481310|Glycine|glycine|mesh-list
57098859|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57098860|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
57098861|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098862|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57098863|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57098864|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
57098865|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098866|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098867|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57098868|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57098869|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57098870|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57098871|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098872|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57098873|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
57098874|NCT02481310|Hormones|hormones|mesh-ancestor
57098875|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098876|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57098877|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57098878|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
57098879|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57098880|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57098881|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
57098882|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
57098883|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57098884|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57098885|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57098886|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
57098887|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098888|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
57098889|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
57098890|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
57098891|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
57098892|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
57098893|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
57098894|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098895|NCT03432195|Donepezil|donepezil|mesh-list
57098896|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57098897|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098898|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098899|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
57098900|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098901|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098902|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
57098903|NCT03431961|Triamcinolone|triamcinolone|mesh-list
57098904|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57098905|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57098906|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57098907|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57098908|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
57098909|NCT03431961|Hormones|hormones|mesh-ancestor
57098910|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098911|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098912|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57098913|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
57098914|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098915|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098916|NCT02480764|Valsartan|valsartan|mesh-list
57098917|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
57098918|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57098919|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57098920|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57098921|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098922|NCT03434691|Remifentanil|remifentanil|mesh-list
57098923|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57098924|NCT03434691|Narcotics|narcotics|mesh-ancestor
57098925|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098926|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098927|NCT03434691|Analgesics|analgesics|mesh-ancestor
57098928|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
57098929|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57098930|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57098931|NCT03434613|Ezetimibe|ezetimibe|mesh-list
57098932|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57098933|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57098934|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
57098935|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098936|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57098937|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57098938|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098939|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
57098940|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098941|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57098942|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098943|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098944|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
57098945|NCT03428685|Progestins|progestins|mesh-ancestor
57098946|NCT03428685|Hormones|hormones|mesh-ancestor
57098947|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098948|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098949|NCT05665647|Ritonavir|ritonavir|mesh-list
57098950|NCT05665647|Itraconazole|itraconazole|mesh-list
57098951|NCT05665647|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
57098952|NCT05665647|Rifampin|rifampin|mesh-list
57098953|NCT05665647|Midazolam|midazolam|mesh-list
57098954|NCT05665647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57098955|NCT05665647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57098956|NCT05665647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57098957|NCT05665647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57098958|NCT05665647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57098959|NCT05665647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57098960|NCT05665647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57098961|NCT05665647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57098962|NCT05665647|Anesthetics, General|anesthetics, general|mesh-ancestor
57098963|NCT05665647|Anesthetics|anesthetics|mesh-ancestor
57098964|NCT05665647|GABA Modulators|gaba modulators|mesh-ancestor
57098965|NCT05665647|GABA Agents|gaba agents|mesh-ancestor
57098966|NCT05665647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57098967|NCT05665647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098968|NCT05665647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57098969|NCT05665647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57098970|NCT05665647|Protease Inhibitors|protease inhibitors|mesh-ancestor
57098971|NCT05665647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098972|NCT05665647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57098973|NCT05665647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57098974|NCT05665647|Antiviral Agents|antiviral agents|mesh-ancestor
57098975|NCT05665647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57098976|NCT05665647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57098977|NCT05665647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57098978|NCT05665647|Antifungal Agents|antifungal agents|mesh-ancestor
57098979|NCT05665647|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57098980|NCT05665647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57098981|NCT05665647|Hormone Antagonists|hormone antagonists|mesh-ancestor
57098982|NCT05665647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57098983|NCT05665647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57098984|NCT05665647|Antitubercular Agents|antitubercular agents|mesh-ancestor
57098985|NCT05665647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57098986|NCT05665647|Leprostatic Agents|leprostatic agents|mesh-ancestor
57098987|NCT05665647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57098988|NCT05665647|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57098989|NCT05665647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57098990|NCT05665647|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57098991|NCT05665647|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57098992|NCT05665647|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57098993|NCT05665647|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57098994|NCT03943173|Olaparib|olaparib|mesh-list
57098995|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57098996|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57098997|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57098998|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57098999|NCT04941196|Ticagrelor|ticagrelor|mesh-list
57099000|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57099001|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57099002|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57099003|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57099004|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
57099005|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099006|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099007|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099008|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
57099009|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57099010|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57099011|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099012|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
57099013|NCT03431805|Coagulants|coagulants|mesh-ancestor
57099014|NCT03428607|Olaparib|olaparib|mesh-list
57099015|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57099016|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099017|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099018|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099019|NCT02521233|Losartan|losartan|mesh-list
57099020|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57099021|NCT02521233|Candesartan|candesartan|mesh-list
57099022|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
57099023|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
57099024|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57099025|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57099026|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57099027|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57099028|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099029|NCT02521233|Diuretics|diuretics|mesh-ancestor
57099030|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
57099031|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099032|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57099033|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57099034|NCT03428529|Fluorouracil|fluorouracil|mesh-list
57099035|NCT03428529|Capecitabine|capecitabine|mesh-list
57099036|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
57099037|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099038|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57099039|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099040|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57099041|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
57099042|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099043|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
57099044|NCT03431649|Beraprost|beraprost|mesh-list
57099045|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099046|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
57099047|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57099048|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57099049|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099050|NCT03431649|Urological Agents|urological agents|mesh-ancestor
57099051|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57099052|NCT04450095|Ambrisentan|ambrisentan|mesh-list
57099053|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57099054|NCT03101475|Durvalumab|durvalumab|mesh-list
57099055|NCT03101475|Tremelimumab|tremelimumab|mesh-list
57099056|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099057|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099058|NCT01060007|Leucovorin|leucovorin|mesh-list
57099059|NCT01060007|Fluorouracil|fluorouracil|mesh-list
57099060|NCT01060007|Capecitabine|capecitabine|mesh-list
57099061|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
57099062|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
57099063|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099064|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57099065|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099066|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57099067|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
57099068|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099069|NCT01060007|Antidotes|antidotes|mesh-ancestor
57099070|NCT01060007|Protective Agents|protective agents|mesh-ancestor
57099071|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
57099072|NCT01060007|Vitamins|vitamins|mesh-ancestor
57099073|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
57099074|NCT04175925|Famotidine|famotidine|mesh-list
57099075|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57099076|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57099077|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57099078|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
57099079|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
57099080|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099081|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099082|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099083|NCT02971007|Fluconazole|fluconazole|mesh-list
57099084|NCT02971007|Amphotericin B|amphotericin b|mesh-list
57099085|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
57099086|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
57099087|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099088|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57099089|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57099090|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099091|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099092|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57099093|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
57099094|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57099095|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099096|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57099097|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57099098|NCT02971007|Amebicides|amebicides|mesh-ancestor
57099099|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57099100|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57099101|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57099102|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
57099103|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
57099104|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57099105|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57099106|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099107|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099108|NCT02983461|Urological Agents|urological agents|mesh-ancestor
57099109|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
57099110|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
57099111|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099112|NCT03428139|Protective Agents|protective agents|mesh-ancestor
57099113|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099114|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
57099115|NCT03428139|Vitamins|vitamins|mesh-ancestor
57099116|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
57099117|NCT03650543|Amoxicillin|amoxicillin|mesh-list
57099118|NCT03650543|Clarithromycin|clarithromycin|mesh-list
57099119|NCT03650543|Omeprazole|omeprazole|mesh-list
57099120|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57099121|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099122|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57099123|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57099124|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57099125|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099126|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099127|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57099128|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57099129|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57099130|NCT03650777|Warfarin|warfarin|mesh-list
57099131|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
57099132|NCT02970305|Pimavanserin|pimavanserin|mesh-list
57099133|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57099134|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57099135|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57099136|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57099137|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099138|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099139|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57099140|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57099141|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57099142|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
57099143|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099144|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099145|NCT03649763|Lidocaine|lidocaine|mesh-list
57099146|NCT03649763|Bupivacaine|bupivacaine|mesh-list
57099147|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
57099148|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
57099149|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099150|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099151|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
57099152|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099153|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57099154|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57099155|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57099156|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57099157|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099158|NCT03427437|Epinephrine|epinephrine|mesh-list
57099159|NCT03427437|Racepinephrine|racepinephrine|mesh-list
57099160|NCT03427437|Bupivacaine|bupivacaine|mesh-list
57099161|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
57099162|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
57099163|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
57099164|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099165|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099166|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
57099167|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099168|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57099169|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57099171|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099172|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099173|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57099174|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57099175|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
57099176|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57099177|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
57099178|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
57099179|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
57099180|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57099181|NCT03427359|Capecitabine|capecitabine|mesh-list
57099182|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099183|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57099184|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
57099185|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099186|NCT05053659|Venetoclax|venetoclax|mesh-list
57099187|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
57099188|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099189|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099190|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57099191|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57099192|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099193|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
57099194|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099195|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
57099196|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
57099197|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
57099198|NCT03423225|Tacrolimus|tacrolimus|mesh-list
57099199|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57099200|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
57099201|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099202|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57099203|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099204|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099205|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
57099206|NCT02521077|Vitamins|vitamins|mesh-ancestor
57099207|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
57099208|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099209|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
57099210|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099211|NCT02521077|Protective Agents|protective agents|mesh-ancestor
57099212|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
57099213|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57099214|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099215|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099216|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57099217|NCT03564093|Analgesics|analgesics|mesh-ancestor
57099218|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
57099219|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099220|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57099221|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57099222|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57099223|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
57099224|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099225|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099226|NCT03429621|Simethicone|simethicone|mesh-list
57099227|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
57099228|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099229|NCT03429621|Emollients|emollients|mesh-ancestor
57099230|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
57099231|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
57099232|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
57099233|NCT03426969|Melphalan|melphalan|mesh-list
57099234|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
57099235|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
57099236|NCT03426969|Fludarabine|fludarabine|mesh-list
57099237|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
57099238|NCT03426969|Tacrolimus|tacrolimus|mesh-list
57099239|NCT03426969|Lenograstim|lenograstim|mesh-list
57099240|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57099241|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
57099242|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099243|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57099244|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57099245|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
57099246|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099247|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099248|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57099249|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57099251|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57099252|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099253|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57099254|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57099255|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57099256|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
57099257|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57099258|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099259|NCT03422445|Temozolomide|temozolomide|mesh-list
57099260|NCT03422445|Apatinib|apatinib|mesh-list
57099261|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57099262|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
56899692|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57099263|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099264|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099265|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57099266|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099267|NCT03429309|Propofol|propofol|mesh-list
57099268|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57099269|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099270|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099271|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57099272|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
57099273|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
57099274|NCT03429075|Citalopram|citalopram|mesh-list
57099275|NCT03429075|Psilocybin|psilocybin|mesh-list
57099276|NCT03429075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57099277|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57099278|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57099279|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099280|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099281|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
57099282|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099283|NCT03429075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57099284|NCT03429075|Antidepressive Agents|antidepressive agents|mesh-ancestor
57099285|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57099286|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
57099287|NCT03422289|Folic Acid|folic acid|mesh-list
57099288|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
57099289|NCT03422289|Inositol|inositol|mesh-list
57099290|NCT03422289|Hematinics|hematinics|mesh-ancestor
57099291|NCT03422289|Vitamins|vitamins|mesh-ancestor
57099292|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
57099293|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099294|NCT03422055|Fucoidan|fucoidan|mesh-list
57099295|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57099296|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57099297|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
57099298|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099299|NCT04449471|Naproxen|naproxen|mesh-list
57099300|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57099301|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57099302|NCT04449471|Analgesics|analgesics|mesh-ancestor
57099303|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
57099304|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099305|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099306|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57099307|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57099308|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
57099309|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57099310|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099311|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099312|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
57099313|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57099314|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
57099315|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
57099316|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099317|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099318|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57099319|NCT03127371|Analgesics|analgesics|mesh-ancestor
57099320|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
56781201|NCT01095211|Vitamins|vitamins|mesh-ancestor
57099321|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099322|NCT03421821|Ropivacaine|ropivacaine|mesh-list
57099323|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
57099324|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
57099325|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099326|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099327|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
57099328|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099329|NCT03421743|Molgramostim|molgramostim|mesh-list
57099330|NCT03421743|Sargramostim|sargramostim|mesh-list
57099331|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099332|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
57099333|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099334|NCT01103349|Montelukast|montelukast|mesh-list
57099335|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57099336|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
57099337|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57099338|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
57099339|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57099340|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099341|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57099342|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57099343|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099344|NCT03421275|Fentanyl|fentanyl|mesh-list
57099345|NCT03421275|Esketamine|esketamine|mesh-list
57099346|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57099347|NCT03421275|Narcotics|narcotics|mesh-ancestor
57099348|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099349|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099350|NCT03421275|Analgesics|analgesics|mesh-ancestor
57099351|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
57099352|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099353|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57099354|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57099355|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
57099356|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
57099357|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
57099358|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57099359|NCT03416517|Irinotecan|irinotecan|mesh-list
57099360|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57099361|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57099362|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099363|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099364|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099365|NCT03421119|Insulin|insulin|mesh-list
57099366|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57099367|NCT03421119|Metformin|metformin|mesh-list
57099368|NCT03421119|Liraglutide|liraglutide|mesh-list
57099369|NCT03421119|Secretagogues|secretagogues|mesh-list
57099370|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57099371|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099372|NCT03421119|Incretins|incretins|mesh-ancestor
57099373|NCT03421119|Hormones|hormones|mesh-ancestor
57099374|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57099375|NCT03426033|Warfarin|warfarin|mesh-list
57099376|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
57099377|NCT02451423|Atezolizumab|atezolizumab|mesh-list
57099378|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099379|NCT02432547|Aflibercept|aflibercept|mesh-list
57099380|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57099381|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57099382|NCT02432547|Growth Substances|growth substances|mesh-ancestor
57099383|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099384|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
57099385|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099386|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57099387|NCT02345733|Amoxicillin|amoxicillin|mesh-list
57099388|NCT02345733|Metronidazole|metronidazole|mesh-list
57099389|NCT02345733|Doxycycline|doxycycline|mesh-list
57099390|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099391|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57099392|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57099393|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
57099394|NCT03415269|Ambroxol|ambroxol|mesh-list
57099395|NCT03415269|Expectorants|expectorants|mesh-ancestor
57099396|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
57099397|NCT03618589|Pregabalin|pregabalin|mesh-list
57099398|NCT03618589|Analgesics|analgesics|mesh-ancestor
57099399|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
57099400|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099401|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099402|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
57099403|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57099404|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57099405|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099406|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57099407|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57099408|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57099409|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099410|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57099411|NCT03127449|Aflutinib|aflutinib|mesh-list
57099412|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57099413|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099414|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099415|NCT02521155|Fenbendazole|fenbendazole|mesh-list
57099416|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
57099417|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
57099418|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57099419|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099420|NCT03415191|Ketamine|ketamine|mesh-list
57099421|NCT03415191|Analgesics|analgesics|mesh-ancestor
57099422|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
57099423|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099424|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099425|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57099426|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57099427|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
57099428|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
57099429|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099430|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57099431|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57099432|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099433|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099434|NCT01337089|Nabiximols|nabiximols|mesh-list
57099435|NCT01337089|Analgesics|analgesics|mesh-ancestor
57099436|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
57099437|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099438|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099439|NCT03419949|Pregabalin|pregabalin|mesh-list
57099440|NCT03419949|Lamotrigine|lamotrigine|mesh-list
57099441|NCT03419949|Analgesics|analgesics|mesh-ancestor
57099442|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
57099443|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099444|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099445|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
57099446|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57099447|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57099448|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099449|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57099450|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57099451|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57099452|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099453|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57099454|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57099455|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57099456|NCT03414879|Lidocaine|lidocaine|mesh-list
57099457|NCT03414879|Ketamine|ketamine|mesh-list
57099458|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
57099459|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
57099460|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099461|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099462|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
57099463|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099464|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57099465|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57099466|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57099467|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57099468|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099469|NCT03414879|Analgesics|analgesics|mesh-ancestor
57099470|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57099471|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57099472|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
56781358|NCT00038467|Tamoxifen|tamoxifen|mesh-list
57099473|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57099474|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57099475|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099476|NCT03419715|Bimatoprost|bimatoprost|mesh-list
57099477|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57099479|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57099480|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099481|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57099482|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099483|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
57099484|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57099485|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
57099486|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099487|NCT04448457|Sufentanil|sufentanil|mesh-list
57099488|NCT04448457|Oxycodone|oxycodone|mesh-list
57099489|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57099490|NCT04448457|Narcotics|narcotics|mesh-ancestor
57099491|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099492|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099493|NCT04448457|Analgesics|analgesics|mesh-ancestor
57099494|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
57099495|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099496|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57099497|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57099498|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
57099499|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
57099500|NCT05384743|Rituximab|rituximab|mesh-list
57099501|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099502|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099503|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
57099504|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099505|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57099506|NCT03414333|Hormones|hormones|mesh-list
57099507|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57099508|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099509|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
57099510|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099511|NCT03616639|Morphine|morphine|mesh-list
57099512|NCT03616639|Oxycodone|oxycodone|mesh-list
57099513|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57099514|NCT03616639|Narcotics|narcotics|mesh-ancestor
57099515|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099516|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099517|NCT03616639|Analgesics|analgesics|mesh-ancestor
57099518|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
57099519|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099520|NCT03616561|Apremilast|apremilast|mesh-list
57099521|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57099522|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57099523|NCT03616561|Analgesics|analgesics|mesh-ancestor
57099524|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
57099525|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099526|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099527|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57099528|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57099529|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57099530|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57099531|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099532|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099533|NCT03615313|Antibodies|antibodies|mesh-list
57099534|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
57099535|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099536|NCT03617575|Lactoferrin|lactoferrin|mesh-list
57099537|NCT03617575|Fesoterodine|fesoterodine|mesh-list
57099538|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099539|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57099540|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57099541|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
57099542|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099543|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099544|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099545|NCT03617575|Urological Agents|urological agents|mesh-ancestor
57099546|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
57099547|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099548|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099549|NCT03616405|Amoxicillin|amoxicillin|mesh-list
57099550|NCT03616405|Tetracycline|tetracycline|mesh-list
57099551|NCT03616405|Furazolidone|furazolidone|mesh-list
57099552|NCT03616405|Rabeprazole|rabeprazole|mesh-list
57099553|NCT03616405|Bismuth|bismuth|mesh-list
57099554|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57099555|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099556|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57099557|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57099558|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57099559|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099560|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099561|NCT03616405|Antacids|antacids|mesh-ancestor
57099562|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57099563|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57099564|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57099565|NCT03616405|Renal Agents|renal agents|mesh-ancestor
57099566|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57099567|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57099568|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57099569|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57099570|NCT03419559|Durvalumab|durvalumab|mesh-list
57099571|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099572|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099573|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
57099574|NCT02873689|Lansoprazole|lansoprazole|mesh-list
57099575|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57099576|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57099577|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57099578|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099579|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099580|NCT02873377|Nicotine|nicotine|mesh-list
57099581|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57099582|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
57099583|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099584|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099585|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57099586|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57099587|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
57099588|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099589|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099590|NCT03647579|Midazolam|midazolam|mesh-list
57099591|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
57099592|NCT03647579|Ketamine|ketamine|mesh-list
57099593|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57099594|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099595|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099596|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57099597|NCT03647579|Analgesics|analgesics|mesh-ancestor
57099598|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
57099599|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099600|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57099601|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57099602|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57099603|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
57099604|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099605|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099606|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57099607|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57099608|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
57099609|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
57099610|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57099611|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57099612|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57099613|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57099614|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57099615|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57099616|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
57099617|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
57099618|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
57099619|NCT04046861|Vitamins|vitamins|mesh-ancestor
56781479|NCT00795899|Trastuzumab|trastuzumab|mesh-list
57099620|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
57099621|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099622|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
57099623|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099624|NCT04046861|Protective Agents|protective agents|mesh-ancestor
57099625|NCT02236741|Pramipexole|pramipexole|mesh-list
57099626|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
57099627|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099628|NCT02236741|Protective Agents|protective agents|mesh-ancestor
57099629|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099630|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57099631|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57099632|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
57099633|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
57099634|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099635|NCT03648671|Rasagiline|rasagiline|mesh-list
57099636|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57099637|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099638|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099639|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57099640|NCT03648671|Protective Agents|protective agents|mesh-ancestor
57099641|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099642|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
57099643|NCT03647423|Cetuximab|cetuximab|mesh-list
57099644|NCT03647423|Avelumab|avelumab|mesh-list
57099645|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57099646|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
57099647|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099648|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57099649|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57099650|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
57099651|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099652|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099653|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57099654|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099655|NCT04052711|Minocycline|minocycline|mesh-list
57099656|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57099657|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099658|NCT03291847|Buprenorphine|buprenorphine|mesh-list
57099659|NCT03291847|Methadone|methadone|mesh-list
57099660|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
57099661|NCT03291847|Naloxone|naloxone|mesh-list
57099662|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57099663|NCT03291847|Narcotics|narcotics|mesh-ancestor
57099664|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099665|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099666|NCT03291847|Analgesics|analgesics|mesh-ancestor
57099667|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
57099668|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099669|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57099670|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
57099671|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
57099672|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
57099673|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099674|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099675|NCT03621683|Antioxidants|antioxidants|mesh-list
57099676|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099677|NCT03621683|Protective Agents|protective agents|mesh-ancestor
57099678|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099679|NCT03614065|Endostar protein|endostar protein|mesh-list
57099680|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
57099681|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57099682|NCT03614065|Growth Substances|growth substances|mesh-ancestor
57099683|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099684|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
57099685|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099686|NCT03621527|Remifentanil|remifentanil|mesh-list
57099687|NCT03621527|Anesthetics|anesthetics|mesh-list
57099688|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099689|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099690|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57099691|NCT03621527|Narcotics|narcotics|mesh-ancestor
57099692|NCT03621527|Analgesics|analgesics|mesh-ancestor
57099693|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
57099694|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099695|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57099696|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57099697|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099698|NCT03646721|Incretins|incretins|mesh-ancestor
57099699|NCT03646721|Hormones|hormones|mesh-ancestor
57099700|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57099701|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57099702|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
57099703|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099704|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099705|NCT03613753|Irinotecan|irinotecan|mesh-list
57099706|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57099707|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57099708|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099709|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099710|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099711|NCT03267433|Rituximab|rituximab|mesh-list
57099712|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099713|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099714|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
57099715|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099716|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57099717|NCT04051853|Sorafenib|sorafenib|mesh-list
57099718|NCT04051853|Midazolam|midazolam|mesh-list
57099719|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57099720|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57099721|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099722|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099723|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57099724|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57099725|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57099726|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57099727|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
57099728|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
57099729|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
57099730|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
57099731|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099732|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099733|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099734|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57099735|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099736|NCT03605927|Sirolimus|sirolimus|mesh-list
57099737|NCT03605927|Tacrolimus|tacrolimus|mesh-list
57099738|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57099739|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
57099740|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099741|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57099742|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099743|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099744|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57099745|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099746|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57099747|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099748|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
57099749|NCT03643757|Bupivacaine|bupivacaine|mesh-list
57099750|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
57099751|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
57099752|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57099753|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099754|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
57099755|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099756|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
57099757|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57099758|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
57099759|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099760|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099761|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57099762|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
57099763|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57099764|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
56899718|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57099765|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099766|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099767|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57099768|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
57099769|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
57099770|NCT03718793|Protective Agents|protective agents|mesh-ancestor
57099771|NCT02962739|Tenofovir|tenofovir|mesh-list
57099772|NCT02962739|Emtricitabine|emtricitabine|mesh-list
57099773|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
57099774|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099775|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57099776|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57099777|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099778|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099779|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57099780|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57099781|NCT01344629|Telmisartan|telmisartan|mesh-list
57099782|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57099783|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57099784|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57099785|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099786|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57099787|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57099788|NCT03642665|Estradiol|estradiol|mesh-list
57099789|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57099790|NCT03642665|Progesterone|progesterone|mesh-list
57099791|NCT03642665|Estrogens|estrogens|mesh-ancestor
57099792|NCT03642665|Hormones|hormones|mesh-ancestor
57099793|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57099794|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099795|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57099796|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
57099797|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57099798|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57099799|NCT03642665|Progestins|progestins|mesh-ancestor
57099800|NCT05233163|Empagliflozin|empagliflozin|mesh-list
57099801|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57099802|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099803|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57099804|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099805|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
57099806|NCT03642509|Apixaban|apixaban|mesh-list
57099807|NCT03642509|Edoxaban|edoxaban|mesh-list
57099808|NCT03642509|Dabigatran|dabigatran|mesh-list
57099809|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57099810|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
57099811|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57099812|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
57099813|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099814|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099815|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
57099816|NCT03642353|Listerine|listerine|mesh-list
57099817|NCT03642353|Triclosan|triclosan|mesh-list
57099818|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
57099819|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
57099820|NCT03642353|Protective Agents|protective agents|mesh-ancestor
57099821|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099822|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57099823|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099824|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57099825|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57099826|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
57099827|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099828|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57099829|NCT03424707|Eperisone|eperisone|mesh-list
57099830|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
57099831|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57099832|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57099833|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099834|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57099835|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099836|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57099837|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57099838|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099839|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
57099840|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
57099841|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
57099842|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
57099843|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57099844|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
57099845|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57099846|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099847|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099848|NCT03418935|Niacinamide|niacinamide|mesh-list
57099849|NCT03418935|Niacin|niacin|mesh-list
57099850|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
57099851|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
56781706|NCT00797693|Misoprostol|misoprostol|mesh-list
57099852|NCT03418935|Vitamins|vitamins|mesh-ancestor
57099853|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
57099854|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099855|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57099856|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
57099857|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099858|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57099859|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
57099860|NCT03413319|Tilavonemab|tilavonemab|mesh-list
57099861|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
57099862|NCT03424629|Methotrexate|methotrexate|mesh-list
57099863|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57099864|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
57099865|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57099866|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099867|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57099868|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
57099869|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099870|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099871|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
57099872|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099873|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57099874|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57099875|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
57099876|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57099877|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57099878|NCT03424473|Tucatinib|tucatinib|mesh-list
57099879|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099880|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57099881|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099882|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099883|NCT04448379|Osimertinib|osimertinib|mesh-list
57099884|NCT04448379|Afatinib|afatinib|mesh-list
57099885|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099886|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57099887|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099888|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099889|NCT04448223|Latanoprost|latanoprost|mesh-list
57099890|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57099891|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57099892|NCT03644147|Acetaminophen|acetaminophen|mesh-list
57099893|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57099894|NCT03644147|Analgesics|analgesics|mesh-ancestor
57099895|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
57099896|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099897|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099898|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
57099899|NCT02743923|Paclitaxel|paclitaxel|mesh-list
57099900|NCT02743923|Bevacizumab|bevacizumab|mesh-list
57099901|NCT02743923|Carboplatin|carboplatin|mesh-list
57099902|NCT02743923|Pemetrexed|pemetrexed|mesh-list
57099903|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57099904|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099905|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
57099906|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
57099907|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
57099908|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099909|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099910|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57099911|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57099912|NCT02743923|Growth Substances|growth substances|mesh-ancestor
57099913|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099914|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
57099915|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099916|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57099917|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57099918|NCT01065779|Alendronate|alendronate|mesh-list
57099919|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57099920|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099921|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57099922|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099923|NCT03570359|Interferons|interferons|mesh-list
57099924|NCT03570359|Interferon-beta|interferon-beta|mesh-list
57099925|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
57099926|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099927|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
57099928|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099929|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
57099930|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099931|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57099933|NCT02358200|Carboplatin|carboplatin|mesh-list
57099934|NCT02358200|Talazoparib|talazoparib|mesh-list
57099935|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57099936|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099937|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
57099938|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
57099939|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
57099940|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099941|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57099942|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099943|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
57099944|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
57099945|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099946|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
57099947|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099948|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099949|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57099950|NCT03112538|Insulin|insulin|mesh-list
57099951|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57099952|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57099953|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099954|NCT05283551|Famciclovir|famciclovir|mesh-list
57099955|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
57099956|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099957|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57099958|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099959|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099960|NCT02357732|Nivolumab|nivolumab|mesh-list
57099961|NCT02357732|Trametinib|trametinib|mesh-list
57099962|NCT02357732|Dabrafenib|dabrafenib|mesh-list
57099963|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57099964|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099965|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57099966|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099967|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57099968|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099969|NCT02109081|Dexamethasone|dexamethasone|mesh-list
57099970|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57099971|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
57099972|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
57099973|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57099974|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57099975|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57099976|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
57099977|NCT02109081|Hormones|hormones|mesh-ancestor
57099978|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57099979|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57099980|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099981|NCT03160040|Minocycline|minocycline|mesh-list
57099982|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57099983|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099984|NCT03112148|Tofacitinib|tofacitinib|mesh-list
57099985|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57099986|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899723|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57099987|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099988|NCT03423849|Gemcitabine|gemcitabine|mesh-list
57099989|NCT03423849|Capecitabine|capecitabine|mesh-list
57099990|NCT03423849|Vinorelbine|vinorelbine|mesh-list
57099991|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57099992|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57099993|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
57099994|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57099995|NCT03423849|Antiviral Agents|antiviral agents|mesh-ancestor
57099996|NCT03423849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57099997|NCT03423849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57099998|NCT03423849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57099999|NCT03423849|Immunologic Factors|immunologic factors|mesh-ancestor
57100000|NCT03423849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100001|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57100002|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
57100003|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
57100004|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
57100005|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57100006|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
57100007|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100008|NCT02362256|Clonidine|clonidine|mesh-list
57100009|NCT02362256|Naltrexone|naltrexone|mesh-list
57100010|NCT02362256|Lorazepam|lorazepam|mesh-list
57100011|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57100012|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57100013|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100014|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
57100015|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100016|NCT02362256|Analgesics|analgesics|mesh-ancestor
57100017|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57100018|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
57100019|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
57100020|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57100021|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57100022|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57100023|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
57100024|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100025|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100026|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
57100027|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
57100028|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100029|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57100030|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100031|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57100032|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57100033|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57100034|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
57100035|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
57100036|NCT03412305|Amoxicillin|amoxicillin|mesh-list
57100037|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57100038|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100039|NCT04259996|Estradiol|estradiol|mesh-list
57100040|NCT04259996|Progesterone|progesterone|mesh-list
57100041|NCT04259996|Estrogens|estrogens|mesh-ancestor
57100042|NCT04259996|Hormones|hormones|mesh-ancestor
57100043|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57100044|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100045|NCT04259996|Progestins|progestins|mesh-ancestor
57100046|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57100047|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57100048|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57100049|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
57100050|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
57100051|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
57100052|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57100053|NCT03397875|Protective Agents|protective agents|mesh-ancestor
57100054|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100055|NCT02362022|Morphine|morphine|mesh-list
57100056|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57100057|NCT02362022|Narcotics|narcotics|mesh-ancestor
57100058|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100059|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100060|NCT02362022|Analgesics|analgesics|mesh-ancestor
57100061|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
57100062|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100063|NCT03412071|Metronidazole|metronidazole|mesh-list
57100064|NCT03412071|Clindamycin|clindamycin|mesh-list
57100065|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
57100066|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
57100067|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57100068|NCT03412071|Tinidazole|tinidazole|mesh-list
57100069|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100070|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57100071|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57100072|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57100073|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57100074|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100075|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100076|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57100077|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
57100078|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
57100079|NCT03397797|Rocuronium|rocuronium|mesh-list
57100080|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57100081|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56781927|NCT01583959|Vitamins|vitamins|mesh-ancestor
57100082|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57100083|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100084|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100085|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57100086|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100087|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100088|NCT02351882|Nabilone|nabilone|mesh-list
57100089|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
57100090|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
57100091|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100092|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100093|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100094|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57100095|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57100096|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100097|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57100098|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
57100099|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
57100100|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
57100101|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100102|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100103|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
57100104|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100105|NCT05169801|Paclitaxel|paclitaxel|mesh-list
57100106|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57100107|NCT05169801|Carboplatin|carboplatin|mesh-list
57100108|NCT05169801|Bevacizumab|bevacizumab|mesh-list
57100109|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57100110|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100111|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
57100112|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
57100113|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
57100114|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100115|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57100116|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57100117|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57100118|NCT05169801|Growth Substances|growth substances|mesh-ancestor
57100119|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100120|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
57100121|NCT04447443|Loperamide|loperamide|mesh-list
57100122|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
57100123|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100124|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57100125|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57100126|NCT01345253|Belimumab|belimumab|mesh-list
57100127|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57100128|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
57100129|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100130|NCT03150134|Cyclosporine|cyclosporine|mesh-list
57100131|NCT03150134|Cyclosporins|cyclosporins|mesh-list
57100132|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
57100133|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100134|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100135|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
57100136|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100137|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
57100138|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100139|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
57100140|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57100141|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57100142|NCT03411369|Vitamins|vitamins|mesh-list
57100143|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
57100144|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100145|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57100146|NCT02351804|Dexamethasone|dexamethasone|mesh-list
57100147|NCT02351804|Ropivacaine|ropivacaine|mesh-list
57100148|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57100149|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
57100150|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
57100151|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100152|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100153|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100154|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
57100155|NCT02351804|Hormones|hormones|mesh-ancestor
57100156|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57100157|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57100158|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100159|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
57100160|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
57100161|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100162|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
57100163|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57100164|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57100165|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57100166|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57100167|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100168|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100169|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100170|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57100171|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
57100172|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57100173|NCT03640403|Artesunate|artesunate|mesh-list
57100174|NCT03640403|Piperaquine|piperaquine|mesh-list
57100175|NCT03640403|Amodiaquine|amodiaquine|mesh-list
57100176|NCT03640403|Artenimol|artenimol|mesh-list
57100177|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
57100178|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57100179|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57100180|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100181|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100182|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
57100183|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
57100184|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57100185|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
57100186|NCT02355938|Vancomycin|vancomycin|mesh-list
57100187|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
57100188|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57100189|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100190|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
57100191|NCT03397173|Azacitidine|azacitidine|mesh-list
57100192|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57100193|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
57100194|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100195|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100196|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100197|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
57100198|NCT03397173|Protective Agents|protective agents|mesh-ancestor
57100199|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100200|NCT03397173|Vitamins|vitamins|mesh-ancestor
57100201|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
57100202|NCT03640247|Acetaminophen|acetaminophen|mesh-list
57100203|NCT03640247|Ibuprofen|ibuprofen|mesh-list
57100204|NCT03640247|Oxycodone|oxycodone|mesh-list
57100205|NCT03640247|Tramadol|tramadol|mesh-list
57100206|NCT03640247|Hydrocodone|hydrocodone|mesh-list
57100207|NCT03640247|Narcotics|narcotics|mesh-list
57100208|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57100209|NCT03640247|Analgesics|analgesics|mesh-ancestor
57100210|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
57100211|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100212|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100213|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
57100214|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57100215|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57100216|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57100217|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57100218|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100219|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100220|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57100221|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100222|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
57100223|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
57100224|NCT03394131|Insulin|insulin|mesh-list
57100225|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57100226|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57100227|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100228|NCT02360618|Metformin|metformin|mesh-list
57100229|NCT02360618|Simvastatin|simvastatin|mesh-list
57100230|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57100231|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100232|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57100233|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57100234|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
57100235|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100236|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57100237|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57100238|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100239|NCT05214183|Rituximab|rituximab|mesh-list
57100240|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
57100241|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57100242|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100243|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
57100244|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100245|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57100246|NCT01344161|Vitamin D|vitamin d|mesh-list
57100247|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
57100248|NCT01344161|Vitamins|vitamins|mesh-ancestor
57100249|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
57100250|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100251|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57100252|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57100253|NCT02451358|Vaccines|vaccines|mesh-list
57100254|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
57100255|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100256|NCT02360384|Linaclotide|linaclotide|mesh-list
57100257|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57100258|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
57100259|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100260|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100261|NCT03396861|Aflibercept|aflibercept|mesh-list
57100262|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57100263|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57100264|NCT03396861|Growth Substances|growth substances|mesh-ancestor
57100265|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100266|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
57100267|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100268|NCT02749721|Vortioxetine|vortioxetine|mesh-list
57100269|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
57100270|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57100271|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57100272|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57100273|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100274|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100275|NCT02749721|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57100276|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57100277|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57100278|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100279|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100280|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
57100281|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57100282|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57100283|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57100284|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57100285|NCT02351102|Valacyclovir|valacyclovir|mesh-list
57100286|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
57100287|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100288|NCT02351024|Naproxen|naproxen|mesh-list
57100289|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57100290|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57100291|NCT02351024|Analgesics|analgesics|mesh-ancestor
57100292|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
57100293|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100294|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100295|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57100296|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57100297|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
57100298|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57100299|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100300|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100301|NCT02355704|Atorvastatin|atorvastatin|mesh-list
57100302|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57100303|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57100304|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
57100305|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100306|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57100307|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57100308|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100309|NCT03396393|Artenimol|artenimol|mesh-list
57100310|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
57100311|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57100312|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57100313|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100315|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
57100316|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57100317|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100318|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100319|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100320|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
57100321|NCT03393507|Apatinib|apatinib|mesh-list
57100322|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100323|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57100324|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100325|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100326|NCT01348139|AZD-3199|azd-3199|mesh-list
57100327|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57100328|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57100329|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57100330|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
57100331|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100332|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100333|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100334|NCT02355236|Celecoxib|celecoxib|mesh-list
57100335|NCT02355236|Naproxen|naproxen|mesh-list
57100336|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57100337|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57100338|NCT02355236|Analgesics|analgesics|mesh-ancestor
57100339|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
57100340|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100341|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100342|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57100343|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57100344|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57100345|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57100346|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100347|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100348|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
57100349|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57100350|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100351|NCT02359604|Esomeprazole|esomeprazole|mesh-list
57100352|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57100353|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100354|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57100355|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100356|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100357|NCT03410511|Nicotine|nicotine|mesh-list
57100358|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57100359|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
57100360|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100361|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100362|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57100363|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57100364|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
57100365|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100366|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100367|NCT05169021|Folic Acid|folic acid|mesh-list
57100368|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
57100369|NCT05169021|Amlodipine|amlodipine|mesh-list
57100370|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
57100371|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57100372|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57100373|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100374|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57100375|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100376|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
57100377|NCT05169021|Hematinics|hematinics|mesh-ancestor
57100378|NCT05169021|Vitamins|vitamins|mesh-ancestor
57100379|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
57100380|NCT02359292|Charcoal|charcoal|mesh-list
57100381|NCT02359292|Antidotes|antidotes|mesh-ancestor
57100382|NCT02359292|Protective Agents|protective agents|mesh-ancestor
57100383|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782230|NCT00800267|Latanoprost|latanoprost|mesh-list
57100384|NCT05168787|Valsartan|valsartan|mesh-list
57100385|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57100386|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57100387|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57100388|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57100389|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100390|NCT02359214|Vitamin D|vitamin d|mesh-list
57100391|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
57100392|NCT02359214|Vitamins|vitamins|mesh-ancestor
57100393|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
57100394|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100395|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57100396|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57100397|NCT02359370|Lidocaine|lidocaine|mesh-list
57100398|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
57100399|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
57100400|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
57100401|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100402|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100403|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
57100404|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100405|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57100406|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57100407|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57100408|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57100409|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100410|NCT02359370|Analgesics|analgesics|mesh-ancestor
57100411|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
57100412|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57100413|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57100414|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
57100415|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57100416|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
57100417|NCT03396315|Alendronate|alendronate|mesh-list
57100418|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57100419|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100420|NCT02359448|Melatonin|melatonin|mesh-list
57100421|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
57100422|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100423|NCT02359448|Protective Agents|protective agents|mesh-ancestor
57100424|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100425|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100426|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
57100427|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57100428|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
57100429|NCT02359526|Hormones|hormones|mesh-ancestor
57100430|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57100431|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100432|NCT03618953|Atezolizumab|atezolizumab|mesh-list
57100433|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100434|NCT02354768|Lanreotide|lanreotide|mesh-list
57100435|NCT02354768|Loperamide|loperamide|mesh-list
57100436|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
57100437|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100438|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100439|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
57100440|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57100441|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57100442|NCT02354612|Bevacizumab|bevacizumab|mesh-list
57100443|NCT02354612|Capecitabine|capecitabine|mesh-list
57100444|NCT02354612|Axitinib|axitinib|mesh-list
57100445|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57100446|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100447|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57100448|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57100449|NCT02354612|Growth Substances|growth substances|mesh-ancestor
57100450|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100451|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
57100452|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57100453|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
57100454|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100455|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57100456|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100457|NCT02348450|Irinotecan|irinotecan|mesh-list
57100458|NCT02348450|Etoposide|etoposide|mesh-list
56782370|NCT02552459|Dsuvia|dsuvia|mesh-list
57100459|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100460|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57100461|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57100462|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100463|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100464|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57100465|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57100466|NCT03393273|Elotuzumab|elotuzumab|mesh-list
57100467|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100468|NCT03613597|Etoposide|etoposide|mesh-list
57100469|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
57100470|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100471|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57100472|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57100473|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57100474|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100475|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100476|NCT02348372|Glycine|glycine|mesh-list
57100477|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
57100478|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100479|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100480|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100481|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57100482|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
57100483|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100484|NCT03614533|Vaccines|vaccines|mesh-list
57100485|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
57100486|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100487|NCT03147404|Avelumab|avelumab|mesh-list
57100488|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57100489|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100490|NCT03614455|Itraconazole|itraconazole|mesh-list
57100491|NCT03614455|Posaconazole|posaconazole|mesh-list
57100492|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
57100493|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
57100494|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100495|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57100496|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57100497|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100498|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100499|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57100500|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
56899738|NCT03090165|Bicalutamide|bicalutamide|mesh-list
57100501|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57100502|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100503|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57100504|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57100505|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57100506|NCT03393117|Narcotics|narcotics|mesh-list
57100507|NCT03393117|Bupivacaine|bupivacaine|mesh-list
57100508|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
57100509|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
57100510|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100511|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100512|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
57100513|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100514|NCT03393117|Analgesics|analgesics|mesh-ancestor
57100515|NCT02032303|Ticagrelor|ticagrelor|mesh-list
57100516|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57100517|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57100518|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57100519|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57100520|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57100521|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
57100522|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100523|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100524|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100525|NCT04297293|Ramosetron|ramosetron|mesh-list
57100526|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
57100527|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
57100528|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100529|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100530|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100531|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57100532|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
57100533|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100534|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100535|NCT03392961|Insulin|insulin|mesh-list
57100536|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57100537|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100538|NCT02350946|Oxytocin|oxytocin|mesh-list
57100539|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
57100540|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57100541|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100542|NCT00000371|Cycloserine|cycloserine|mesh-list
57100543|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57100544|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100545|NCT00000371|Renal Agents|renal agents|mesh-ancestor
57100546|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57100547|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
57100548|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57100549|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
57100550|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100551|NCT02350712|Carboplatin|carboplatin|mesh-list
57100552|NCT02350712|Cetuximab|cetuximab|mesh-list
57100553|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100554|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57100555|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57100556|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57100557|NCT03618797|Fenofibrate|fenofibrate|mesh-list
57100558|NCT03618797|Pitavastatin|pitavastatin|mesh-list
57100559|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57100560|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
57100561|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100562|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57100563|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57100564|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57100565|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100566|NCT03149432|Gabapentin|gabapentin|mesh-list
57100567|NCT03149432|Analgesics|analgesics|mesh-ancestor
57100568|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
57100569|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100570|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100571|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
57100572|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57100573|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57100574|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100575|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57100576|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57100577|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57100578|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100579|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100580|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
57100581|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
57100582|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57100583|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57100584|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57100585|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
57100586|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100587|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100588|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100589|NCT05384483|Cariprazine|cariprazine|mesh-list
57100590|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57100591|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57100592|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100593|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100594|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57100595|NCT03610061|Durvalumab|durvalumab|mesh-list
57100596|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57100597|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100598|NCT05061563|Esomeprazole|esomeprazole|mesh-list
57100599|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57100600|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100601|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57100602|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100603|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100604|NCT03147092|Losartan|losartan|mesh-list
57100605|NCT03147092|Atenolol|atenolol|mesh-list
57100606|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57100607|NCT03147092|Clonidine|clonidine|mesh-list
57100608|NCT03147092|Captopril|captopril|mesh-list
57100609|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57100610|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57100611|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57100612|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57100613|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100614|NCT03147092|Diuretics|diuretics|mesh-ancestor
57100615|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
57100616|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100617|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57100618|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57100619|NCT03147092|Analgesics|analgesics|mesh-ancestor
57100620|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
57100621|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100622|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
57100623|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
57100624|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57100625|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57100626|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57100627|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
57100628|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100629|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57100630|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57100631|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57100632|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57100633|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
57100634|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100635|NCT03149588|Propofol|propofol|mesh-list
57100636|NCT03149588|Sevoflurane|sevoflurane|mesh-list
57100637|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57100638|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100639|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100640|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57100641|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
57100642|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
57100643|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57100644|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57100645|NCT03613207|Lidocaine|lidocaine|mesh-list
57100646|NCT03613207|Prilocaine|prilocaine|mesh-list
57100647|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
57100648|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
57100649|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100650|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100651|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
57100652|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100653|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57100654|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57100655|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57100656|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57100657|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100658|NCT03612739|Azacitidine|azacitidine|mesh-list
57100659|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57100660|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
57100661|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100662|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100663|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100664|NCT02350400|Irinotecan|irinotecan|mesh-list
57100665|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57100666|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57100667|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100668|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100669|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100670|NCT03612817|Timolol|timolol|mesh-list
57100671|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57100672|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57100673|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
57100674|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100675|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100676|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100677|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57100678|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57100679|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
57100680|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100681|NCT03612349|Menthol|menthol|mesh-list
57100682|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
57100683|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
57100685|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
57100686|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57100687|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57100688|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100689|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57100690|NCT03408405|Hormones|hormones|mesh-ancestor
57100691|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57100692|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100693|NCT03408093|Interferons|interferons|mesh-list
57100694|NCT03408093|Interferon-beta|interferon-beta|mesh-list
57100695|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
57100696|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100697|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
57100698|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100699|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
57100700|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100701|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57100702|NCT04679623|Midazolam|midazolam|mesh-list
57100703|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57100704|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57100705|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100706|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100707|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57100708|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57100709|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57100710|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57100711|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
57100712|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
57100713|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
57100714|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
57100715|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100716|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100717|NCT02353988|Bicalutamide|bicalutamide|mesh-list
57100718|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
57100719|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
57100720|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57100721|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100722|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100723|NCT03392571|Gemcitabine|gemcitabine|mesh-list
57100724|NCT03392571|Paclitaxel|paclitaxel|mesh-list
57100725|NCT03392571|Cisplatin|cisplatin|mesh-list
57100726|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57100727|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100728|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
57100729|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
57100730|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
57100731|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100732|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57100733|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
57100734|NCT03392571|Antiviral Agents|antiviral agents|mesh-ancestor
57100735|NCT03392571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100736|NCT03392571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100737|NCT03392571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57100738|NCT03392571|Immunologic Factors|immunologic factors|mesh-ancestor
57100739|NCT03392571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100740|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
57100741|NCT04656067|Ethamsylate|ethamsylate|mesh-list
57100742|NCT04656067|Oxytocin|oxytocin|mesh-list
57100743|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
57100744|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57100745|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100746|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57100747|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57100748|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100749|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
57100750|NCT04656067|Coagulants|coagulants|mesh-ancestor
57100751|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
57100752|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
57100753|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100754|NCT03612037|Protective Agents|protective agents|mesh-ancestor
57100755|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100756|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
57100757|NCT03612037|Vitamins|vitamins|mesh-ancestor
57100758|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
57100759|NCT04447209|Chrysarobin|chrysarobin|mesh-list
57100760|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57100761|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57100762|NCT04447209|Analgesics|analgesics|mesh-ancestor
57100763|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
57100764|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100765|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100766|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57100767|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57100768|NCT04199624|Omeprazole|omeprazole|mesh-list
57100769|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100770|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57100771|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57100772|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57100773|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100774|NCT03611491|Lidocaine|lidocaine|mesh-list
57100775|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
57100776|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
57100777|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100778|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100779|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
57100780|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100781|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57100782|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57100783|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57100784|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57100785|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100786|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57100787|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
57100788|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100789|NCT03611179|Bevacizumab|bevacizumab|mesh-list
57100790|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57100791|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100792|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57100793|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57100794|NCT03611179|Growth Substances|growth substances|mesh-ancestor
57100795|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100796|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
57100797|NCT03126123|Acetic Acid|acetic acid|mesh-list
57100798|NCT03126123|Retinol acetate|retinol acetate|mesh-list
57100799|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57100800|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100801|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57100802|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
57100803|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100804|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57100805|NCT03126123|Protective Agents|protective agents|mesh-ancestor
57100806|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100807|NCT02353676|Bupivacaine|bupivacaine|mesh-list
57100808|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
57100809|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
57100810|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100811|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100812|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
57100813|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100814|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57100815|NCT04184869|Belinostat|belinostat|mesh-list
57100816|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57100817|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57100818|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
57100819|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100820|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100821|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57100822|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57100823|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
57100824|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100825|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100826|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57100827|NCT03617471|Acetaminophen|acetaminophen|mesh-list
57100828|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57100829|NCT03617471|Analgesics|analgesics|mesh-ancestor
57100830|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
57100831|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100832|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100833|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
57100834|NCT04162873|Celecoxib|celecoxib|mesh-list
57100836|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57100837|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57100838|NCT04162873|Analgesics|analgesics|mesh-ancestor
57100839|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
57100840|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100841|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100842|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57100843|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57100844|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57100845|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57100846|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100847|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100848|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57100849|NCT05168007|Cariprazine|cariprazine|mesh-list
57100850|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57100851|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57100852|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100853|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100854|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57100855|NCT02032927|Acetaminophen|acetaminophen|mesh-list
57100856|NCT02032927|Oxycodone|oxycodone|mesh-list
57100857|NCT02032927|Codeine|codeine|mesh-list
57100858|NCT02032927|Naloxone|naloxone|mesh-list
57100859|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57100860|NCT02032927|Analgesics|analgesics|mesh-ancestor
57100861|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
57100862|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100863|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100864|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
57100865|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57100866|NCT02032927|Narcotics|narcotics|mesh-ancestor
57100867|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57100868|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57100869|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
57100870|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
57100871|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57100872|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
57100873|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100874|NCT03395223|Methylene Blue|methylene blue|mesh-list
57100875|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100876|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100877|NCT03392103|Raltitrexed|raltitrexed|mesh-list
57100878|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57100879|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
57100880|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100881|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100882|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57100883|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100884|NCT03610945|Fluconazole|fluconazole|mesh-list
57100885|NCT03610945|Quinidine|quinidine|mesh-list
57100886|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
57100887|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100888|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57100889|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57100890|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100891|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100892|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57100893|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
57100894|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57100895|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100896|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57100897|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57100898|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57100899|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57100900|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
57100901|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100902|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57100903|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
57100904|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57100905|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57100906|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57100907|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57100908|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
57100909|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57100910|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57100911|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57100912|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57100913|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
57100914|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
57100915|NCT05167851|Lazertinib|lazertinib|mesh-list
57100916|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57100917|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100918|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100919|NCT02236715|Ipratropium|ipratropium|mesh-list
57100920|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57100921|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
57100922|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100923|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100924|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57100925|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
57100926|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57100927|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
57100928|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100929|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100930|NCT03823365|Blinatumomab|blinatumomab|mesh-list
57100931|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100932|NCT03616691|Bevacizumab|bevacizumab|mesh-list
57100933|NCT03616691|Atezolizumab|atezolizumab|mesh-list
57100934|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57100935|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57100936|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891146|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
57100937|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57100938|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57100939|NCT03616691|Growth Substances|growth substances|mesh-ancestor
57100940|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100941|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
57100942|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
57100943|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
57100944|NCT03158168|Astringents|astringents|mesh-ancestor
57100945|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100946|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
57100947|NCT03334253|Atropine|atropine|mesh-list
57100948|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57100949|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57100950|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57100951|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57100952|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
57100953|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100954|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100955|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57100956|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
57100957|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
57100958|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
57100959|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57100960|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57100961|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
57100962|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57100963|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100964|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57100965|NCT02865499|Acarbose|acarbose|mesh-list
57100966|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57100967|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100968|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100969|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57100970|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100971|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
57100972|NCT03156062|Salicylates|salicylates|mesh-list
57100973|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57100974|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
57100975|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
57100976|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
57100977|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57100978|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57100979|NCT03156062|Analgesics|analgesics|mesh-ancestor
57100980|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
57100981|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57100982|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100983|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57100984|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57100985|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57100986|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57100987|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57100988|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57100989|NCT02568553|Lenalidomide|lenalidomide|mesh-list
57100990|NCT02568553|Blinatumomab|blinatumomab|mesh-list
57100991|NCT02568553|Antibodies|antibodies|mesh-list
57100992|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
57100993|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57100994|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
57100995|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57100996|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
57100997|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57100998|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57100999|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57101000|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57101001|NCT02568553|Growth Substances|growth substances|mesh-ancestor
57101002|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
57101003|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101004|NCT03404739|Ceftazidime|ceftazidime|mesh-list
57101005|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57101006|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101007|NCT02031965|Dexamethasone|dexamethasone|mesh-list
57101008|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101009|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
57101010|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
57101011|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101012|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101013|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101014|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
57101015|NCT02031965|Hormones|hormones|mesh-ancestor
57101016|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101017|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101018|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101019|NCT03149120|Nivolumab|nivolumab|mesh-list
57101020|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57101021|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101022|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57101023|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101024|NCT04849325|Sirolimus|sirolimus|mesh-list
57101025|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57101026|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101027|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57101028|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101029|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
57101030|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101031|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
57101032|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101033|NCT03403023|Cyclosporine|cyclosporine|mesh-list
57101034|NCT03403023|Cyclosporins|cyclosporins|mesh-list
57101035|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101036|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101037|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101038|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
57101039|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101040|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
57101041|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101042|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
57101043|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101044|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57101045|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
57101046|NCT02864407|Olodaterol|olodaterol|mesh-list
57101047|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57101048|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
57101049|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101050|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101051|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57101052|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
57101053|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
57101054|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57101055|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
57101056|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101057|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101058|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56782915|NCT00372424|Docetaxel|docetaxel|mesh-list
57101059|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57101060|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101061|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57101062|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101063|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101064|NCT03394989|Fluticasone|fluticasone|mesh-list
57101065|NCT03394989|Xhance|xhance|mesh-list
57101066|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57101067|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57101068|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101069|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57101070|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
57101071|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101072|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101073|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57101074|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
57101075|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
57101076|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57101077|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57101078|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57101079|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57101080|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
57101081|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101082|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101083|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
57101084|NCT03394989|Hormones|hormones|mesh-ancestor
57101085|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101086|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
57101087|NCT02033239|Insulin|insulin|mesh-list
57101088|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57101089|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
57101090|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
57101091|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
57101092|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57101093|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101094|NCT02486302|Etanercept|etanercept|mesh-list
57101095|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57101096|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57101097|NCT02486302|Analgesics|analgesics|mesh-ancestor
57101098|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
57101099|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101100|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101101|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101102|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101103|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101104|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101105|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
57101106|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57101107|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101108|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57101109|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101110|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101111|NCT03615833|Vitamin D|vitamin d|mesh-list
57101112|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
57101113|NCT03615833|Vitamins|vitamins|mesh-ancestor
57101114|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
57101115|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101116|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57101117|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57101118|NCT02747875|Fentanyl|fentanyl|mesh-list
57101119|NCT02747875|Methadone|methadone|mesh-list
57101120|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57101121|NCT02747875|Narcotics|narcotics|mesh-ancestor
57101122|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101123|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101124|NCT02747875|Analgesics|analgesics|mesh-ancestor
57101125|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
57101126|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101127|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57101128|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57101129|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
57101130|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
57101131|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
57101132|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
57101133|NCT03394833|Polygeline|polygeline|mesh-list
57101134|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
57101136|NCT02347358|Plasminogen|plasminogen|mesh-list
57101137|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57101138|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57101139|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57101140|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101141|NCT03610321|Gefarnate|gefarnate|mesh-list
57101142|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57101143|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101144|NCT02236793|Becaplermin|becaplermin|mesh-list
57101145|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
57101146|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
57101147|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57101148|NCT02236793|Growth Substances|growth substances|mesh-ancestor
57101149|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101150|NCT02347046|Dotinurad|dotinurad|mesh-list
57101151|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
57101152|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
57101153|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101154|NCT02347046|Renal Agents|renal agents|mesh-ancestor
57101155|NCT03391245|Vitamin D|vitamin d|mesh-list
57101156|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
57101157|NCT03391245|Calcifediol|calcifediol|mesh-list
57101158|NCT03391245|Vitamins|vitamins|mesh-ancestor
57101159|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
57101160|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101161|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57101162|NCT03401619|Vitamin D|vitamin d|mesh-list
57101163|NCT03401619|Calcitonin|calcitonin|mesh-list
57101164|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
57101165|NCT03401619|Diphosphonates|diphosphonates|mesh-list
57101166|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
57101167|NCT03401619|Katacalcin|katacalcin|mesh-list
57101168|NCT03401619|Vitamins|vitamins|mesh-ancestor
57101169|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
57101170|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101171|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57101172|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57101173|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
57101174|NCT03399903|Mesalamine|mesalamine|mesh-list
57101175|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57101176|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57101177|NCT03399903|Analgesics|analgesics|mesh-ancestor
57101178|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
57101179|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101180|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101181|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101182|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101183|NCT03146468|Nivolumab|nivolumab|mesh-list
57101184|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57101185|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101186|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57101187|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101188|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
57101189|NCT02636725|Axitinib|axitinib|mesh-list
57101190|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57101191|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101192|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57101193|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101194|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101195|NCT02353130|Memantine|memantine|mesh-list
57101196|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57101197|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57101198|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
57101199|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101200|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101201|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101202|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57101203|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57101204|NCT02033551|Paclitaxel|paclitaxel|mesh-list
57101205|NCT02033551|Carboplatin|carboplatin|mesh-list
57101206|NCT02033551|Veliparib|veliparib|mesh-list
57101207|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57101208|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101209|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
57101210|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
57101211|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
57101212|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101213|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57101214|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101215|NCT02450578|Atovaquone|atovaquone|mesh-list
57101216|NCT02450578|Proguanil|proguanil|mesh-list
57101217|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
57101218|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101219|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
57101220|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57101221|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57101222|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101223|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101224|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
57101225|NCT02346890|Sevelamer|sevelamer|mesh-list
57101226|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
57101227|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
57101228|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101229|NCT03146390|Listerine|listerine|mesh-list
57101230|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
57101231|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57101232|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101233|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
57101234|NCT03146390|Protective Agents|protective agents|mesh-ancestor
57101235|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101236|NCT02859415|Plicamycin|plicamycin|mesh-list
57101237|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57101238|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101239|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57101240|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101241|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57101242|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101243|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101244|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57101245|NCT02871791|Everolimus|everolimus|mesh-list
57101246|NCT02871791|Palbociclib|palbociclib|mesh-list
57101247|NCT02871791|Exemestane|exemestane|mesh-list
57101248|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101249|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101250|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
57101251|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101252|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57101253|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101254|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101255|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57101256|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57101257|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57101258|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
57101259|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101260|NCT02346578|Flutamide|flutamide|mesh-list
57101261|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
57101262|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
57101263|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101264|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101265|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101266|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101267|NCT04933721|Berotralstat|berotralstat|mesh-list
57101268|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101269|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101270|NCT03112382|Vitamins|vitamins|mesh-list
57101271|NCT03112382|Vitamin A|vitamin a|mesh-list
57101272|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
57101273|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
57101274|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101275|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
57101276|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101277|NCT03112382|Protective Agents|protective agents|mesh-ancestor
57101278|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57101279|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101280|NCT03399669|Gefitinib|gefitinib|mesh-list
57101281|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101282|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57101283|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101284|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101285|NCT03148574|Misoprostol|misoprostol|mesh-list
57101286|NCT03148574|Oxytocin|oxytocin|mesh-list
57101287|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
57101288|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57101289|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101290|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57101291|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
57101292|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57101293|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101294|NCT02343536|Prednisone|prednisone|mesh-list
57101295|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
57101296|NCT02343536|Rituximab|rituximab|mesh-list
57101297|NCT02343536|Vincristine|vincristine|mesh-list
57101298|NCT02343536|Azacitidine|azacitidine|mesh-list
57101299|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101300|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
57101301|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101302|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101303|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57101304|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
57101305|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101306|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101307|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57101308|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57101309|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101310|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
57101311|NCT02343536|Hormones|hormones|mesh-ancestor
57101312|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101313|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101314|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57101315|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
57101316|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
57101317|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
57101318|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57101319|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
57101320|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101321|NCT02343614|Celecoxib|celecoxib|mesh-list
57101322|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57101323|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57101324|NCT02343614|Analgesics|analgesics|mesh-ancestor
57101325|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
57101326|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101327|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101328|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101329|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101330|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57101331|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57101332|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101333|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101334|NCT02871635|Adalimumab|adalimumab|mesh-list
57101335|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101336|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101337|NCT03390465|Amlodipine|amlodipine|mesh-list
57101338|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57101339|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57101340|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57101341|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57101342|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101343|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57101344|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101345|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
57101346|NCT03390465|Diuretics|diuretics|mesh-ancestor
57101347|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
57101348|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57101349|NCT03390387|Dexamethasone|dexamethasone|mesh-list
57101350|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
57101351|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
57101352|NCT03390387|Bortezomib|bortezomib|mesh-list
57101353|NCT03390387|Daunorubicin|daunorubicin|mesh-list
57101354|NCT03390387|Idarubicin|idarubicin|mesh-list
57101355|NCT03390387|BB 1101|bb 1101|mesh-list
57101356|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101357|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
57101358|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
57101359|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101360|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101361|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101362|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
57101363|NCT03390387|Hormones|hormones|mesh-ancestor
57101364|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101365|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101366|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101367|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
57101368|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101369|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101370|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57101371|NCT03390387|Protective Agents|protective agents|mesh-ancestor
57101372|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57101373|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57101374|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57101376|NCT03146000|Lidocaine|lidocaine|mesh-list
57101377|NCT03146000|Prilocaine|prilocaine|mesh-list
57101378|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
57101379|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
57101380|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
57101381|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56325561|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
57101382|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101383|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
57101384|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101385|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57101386|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57101387|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57101388|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57101389|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101390|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57101391|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57101392|NCT03146000|Analgesics|analgesics|mesh-ancestor
57101393|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101394|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101395|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57101396|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57101397|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101398|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
57101399|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
57101400|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
57101401|NCT02346188|Trace Elements|trace elements|mesh-ancestor
57101402|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
57101403|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101404|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
57101405|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
57101406|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57101407|NCT02346188|Protective Agents|protective agents|mesh-ancestor
57101408|NCT02477332|Omalizumab|omalizumab|mesh-list
57101409|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57101410|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57101411|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
57101412|NCT02346110|Dexamethasone|dexamethasone|mesh-list
57101413|NCT02346110|Epinephrine|epinephrine|mesh-list
57101414|NCT02346110|Racepinephrine|racepinephrine|mesh-list
57101415|NCT02346110|Bupivacaine|bupivacaine|mesh-list
57101416|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
57101417|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101418|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
57101419|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
57101420|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101421|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101422|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101423|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
57101424|NCT02346110|Hormones|hormones|mesh-ancestor
57101425|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101426|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101427|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101428|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
57101429|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
57101430|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101431|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
57101432|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57101433|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57101434|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
57101435|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101436|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101437|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56783300|NCT00382720|Docetaxel|docetaxel|mesh-list
57101438|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57101439|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57101440|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
57101441|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
57101442|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
57101443|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57101444|NCT02348528|Dexamethasone|dexamethasone|mesh-list
57101445|NCT02348528|Lenalidomide|lenalidomide|mesh-list
57101446|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101447|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
57101448|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
57101449|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101450|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101451|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101452|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
57101453|NCT02348528|Hormones|hormones|mesh-ancestor
57101454|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101455|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101456|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101457|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
57101458|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57101459|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57101460|NCT02348528|Growth Substances|growth substances|mesh-ancestor
57101461|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
57101462|NCT02342600|Trametinib|trametinib|mesh-list
57101463|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101464|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57101465|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101466|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101467|NCT03147638|Warfarin|warfarin|mesh-list
57101468|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
57101469|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
57101470|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57101471|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57101472|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
57101473|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
57101474|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101475|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101476|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
57101477|NCT02862535|Nivolumab|nivolumab|mesh-list
57101478|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101479|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57101480|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57101481|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101482|NCT02033707|Scopolamine|scopolamine|mesh-list
57101483|NCT02033707|Hallucinogens|hallucinogens|mesh-list
57101484|NCT02033707|Nicotine|nicotine|mesh-list
57101485|NCT02033707|Histamine Antagonists|histamine antagonists|mesh-list
57101486|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57101487|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
57101488|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101489|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101490|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57101491|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57101492|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
57101493|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101494|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101495|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57101496|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
57101497|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101498|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
57101499|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57101500|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57101501|NCT02033707|Histamine Agents|histamine agents|mesh-ancestor
57101502|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57101503|NCT02039336|Docetaxel|docetaxel|mesh-list
57101504|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101505|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
57101506|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
57101507|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
57101508|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101509|NCT04935476|Dapsone|dapsone|mesh-list
57101510|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101511|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
57101512|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57101513|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57101514|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57101515|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101516|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101517|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
57101518|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57101519|NCT02476006|Atorvastatin|atorvastatin|mesh-list
57101520|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57101521|NCT02476006|Simvastatin|simvastatin|mesh-list
57101522|NCT02476006|Ezetimibe|ezetimibe|mesh-list
57101523|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57101524|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57101525|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
57101526|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101527|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57101528|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57101529|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101530|NCT02344940|Tamoxifen|tamoxifen|mesh-list
57101531|NCT02344940|Toremifene|toremifene|mesh-list
57101532|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57101533|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
57101534|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101535|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101536|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101537|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101538|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57101539|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57101540|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57101541|NCT03615677|Esomeprazole|esomeprazole|mesh-list
57101542|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57101543|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101544|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57101545|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101546|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101547|NCT02344862|Dotinurad|dotinurad|mesh-list
57101548|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
57101549|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
57101550|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101551|NCT02344862|Renal Agents|renal agents|mesh-ancestor
57101552|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
57101553|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57101554|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101555|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
57101556|NCT03614273|Epinephrine|epinephrine|mesh-list
57101557|NCT03614273|Racepinephrine|racepinephrine|mesh-list
57101558|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
57101559|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57101560|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57101561|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
57101562|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101563|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101564|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101565|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57101566|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57101567|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
57101568|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101569|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57101570|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
57101571|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
57101572|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
57101573|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57101574|NCT02336984|Trastuzumab|trastuzumab|mesh-list
57101575|NCT02336984|Pertuzumab|pertuzumab|mesh-list
57101576|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57101577|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101578|NCT03145610|Triclosan|triclosan|mesh-list
57101579|NCT03145610|Fluorides|fluorides|mesh-list
57101580|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
57101581|NCT03145610|Protective Agents|protective agents|mesh-ancestor
57101582|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101583|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57101584|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101585|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57101586|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57101587|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
57101588|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101589|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57101590|NCT02341586|Iron|iron|mesh-list
57101591|NCT02341586|Trace Elements|trace elements|mesh-ancestor
56783459|NCT02551133|Hormones|hormones|mesh-ancestor
57101593|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101594|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
57101595|NCT02336906|Laxatives|laxatives|mesh-ancestor
57101596|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101597|NCT03613961|Anesthetics|anesthetics|mesh-list
57101598|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101599|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101600|NCT02341352|Fluorides|fluorides|mesh-list
57101601|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
57101602|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
57101603|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57101604|NCT02341352|Antibodies|antibodies|mesh-list
57101605|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
57101606|NCT02341352|Protective Agents|protective agents|mesh-ancestor
57101607|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101608|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
57101609|NCT02344550|Everolimus|everolimus|mesh-list
57101610|NCT02344550|Letrozole|letrozole|mesh-list
57101611|NCT02344550|Leuprolide|leuprolide|mesh-list
57101612|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101613|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101614|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
57101615|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101616|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57101617|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57101618|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101619|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101620|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57101621|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
57101622|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101623|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57101624|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
57101625|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57101626|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101627|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
57101628|NCT02419612|Glimepiride|glimepiride|mesh-list
57101629|NCT02419612|Saxagliptin|saxagliptin|mesh-list
57101630|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57101631|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101632|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57101633|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101634|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57101635|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101636|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
57101637|NCT02419612|Incretins|incretins|mesh-ancestor
57101638|NCT02419612|Hormones|hormones|mesh-ancestor
57101639|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101640|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57101641|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
57101642|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101643|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
57101644|NCT03612947|Bupivacaine|bupivacaine|mesh-list
57101645|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
57101646|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
57101647|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101648|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101649|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
57101650|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101651|NCT03612947|Analgesics|analgesics|mesh-ancestor
57101652|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57101653|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
57101654|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57101655|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57101656|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101657|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57101658|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
57101659|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57101660|NCT02344784|Methylphenidate|methylphenidate|mesh-list
57101661|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57101662|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101663|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57101664|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57101665|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57101666|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101667|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
57101668|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101670|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101671|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
57101672|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101673|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57101674|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101675|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101676|NCT02447848|Sufentanil|sufentanil|mesh-list
57101677|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57101678|NCT02447848|Narcotics|narcotics|mesh-ancestor
57101679|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101680|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101681|NCT02447848|Analgesics|analgesics|mesh-ancestor
57101682|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
57101683|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101684|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57101685|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57101686|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
57101687|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
57101688|NCT02336516|Azithromycin|azithromycin|mesh-list
57101689|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57101690|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101691|NCT03114527|Everolimus|everolimus|mesh-list
57101692|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101693|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101694|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
57101695|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101696|NCT03055013|Nivolumab|nivolumab|mesh-list
57101697|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57101698|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101699|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57101700|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101701|NCT05254652|Pregabalin|pregabalin|mesh-list
57101702|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57101703|NCT05254652|Analgesics|analgesics|mesh-ancestor
57101704|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
57101705|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101706|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101707|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
57101708|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57101709|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57101710|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101711|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57101712|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57101713|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57101714|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101715|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57101716|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57101717|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57101718|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101719|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
57101720|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
57101721|NCT02343926|Metformin|metformin|mesh-list
57101722|NCT02343926|Vildagliptin|vildagliptin|mesh-list
57101723|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57101724|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101725|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57101726|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
57101727|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101728|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101729|NCT05254574|Diclofenac|diclofenac|mesh-list
57101730|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57101731|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57101732|NCT05254574|Analgesics|analgesics|mesh-ancestor
57101733|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
57101734|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101735|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101736|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101737|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101738|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56783597|NCT01047748|Digoxin|digoxin|mesh-list
57101739|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101740|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101742|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
57101743|NCT03112226|Estrogens|estrogens|mesh-ancestor
57101744|NCT03112226|Hormones|hormones|mesh-ancestor
57101745|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101746|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101747|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
57101748|NCT02343692|Pancrelipase|pancrelipase|mesh-list
57101749|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101750|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
57101751|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57101752|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57101753|NCT02332616|Prednisolone|prednisolone|mesh-list
57101754|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
57101755|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57101756|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
57101757|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101758|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
57101759|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
57101760|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101761|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101762|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101763|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
57101764|NCT02332616|Hormones|hormones|mesh-ancestor
57101765|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101766|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57101767|NCT02332616|Protective Agents|protective agents|mesh-ancestor
57101768|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101769|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101770|NCT03345173|Ketamine|ketamine|mesh-list
57101771|NCT03345173|Analgesics|analgesics|mesh-ancestor
57101772|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
57101773|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101774|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101775|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57101776|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57101777|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
57101778|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
57101779|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101780|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57101781|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57101782|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101783|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101784|NCT03618173|Dexamethasone|dexamethasone|mesh-list
57101785|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
57101786|NCT03618173|BB 1101|bb 1101|mesh-list
57101787|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101788|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
57101789|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
57101790|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101791|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101792|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57101793|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
57101794|NCT03618173|Hormones|hormones|mesh-ancestor
57101795|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101796|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57101797|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101798|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
57101799|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101800|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101801|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
57101802|NCT02336048|Chlorambucil|chlorambucil|mesh-list
57101803|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57101804|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101805|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57101806|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
57101807|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101808|NCT03612401|Mirabegron|mirabegron|mesh-list
57101809|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57101810|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57101811|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57101812|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
57101813|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101814|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101815|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101816|NCT03612401|Urological Agents|urological agents|mesh-ancestor
57101817|NCT03612323|Piroxicam|piroxicam|mesh-list
57101818|NCT03612323|Carticaine|carticaine|mesh-list
57101819|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
57101820|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
57101821|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101822|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101823|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
57101824|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101825|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57101826|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57101827|NCT03612323|Analgesics|analgesics|mesh-ancestor
57101828|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57101829|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57101830|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57101831|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101832|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101833|NCT02994719|Amantadine|amantadine|mesh-list
57101834|NCT02994719|Levodopa|levodopa|mesh-list
57101835|NCT02994719|Carbidopa|carbidopa|mesh-list
57101836|NCT02994719|Pramipexole|pramipexole|mesh-list
57101837|NCT02994719|Ropinirole|ropinirole|mesh-list
57101838|NCT02994719|Entacapone|entacapone|mesh-list
57101839|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57101840|NCT02994719|Tolcapone|tolcapone|mesh-list
57101841|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57101842|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57101843|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
57101844|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101845|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101846|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101847|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57101848|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101849|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
57101850|NCT02994719|Protective Agents|protective agents|mesh-ancestor
57101851|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
57101852|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
57101853|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101854|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57101855|NCT02994719|Analgesics|analgesics|mesh-ancestor
57101856|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
57101857|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101858|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
57101859|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57101860|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
57101861|NCT04356638|Midazolam|midazolam|mesh-list
57101862|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
57101863|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57101864|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101865|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101866|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57101867|NCT04356638|Analgesics|analgesics|mesh-ancestor
57101868|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
57101869|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101870|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57101871|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57101872|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57101873|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
57101874|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101875|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101876|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57101877|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57101878|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57101879|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57101880|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57101881|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
57101882|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
57101883|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
57101884|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
57101885|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
57101886|NCT04346108|Antibodies|antibodies|mesh-list
57101887|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
57101888|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57101889|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57101890|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
57101891|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
57101892|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101893|NCT02335736|Cetrorelix|cetrorelix|mesh-list
57101894|NCT02335736|Hormones|hormones|mesh-list
57101895|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
57101896|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57101897|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101898|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57101899|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
57101900|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57101901|NCT03613259|Alovudine|alovudine|mesh-list
57101902|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
57101903|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101904|NCT02032355|Anesthetics|anesthetics|mesh-list
57101905|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101906|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101907|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
57101908|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57101909|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
57101910|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101911|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101912|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57101913|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
57101914|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
57101915|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57101916|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
57101917|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101918|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101919|NCT03612557|Penicillins|penicillins|mesh-list
57101920|NCT03612557|Penicillin G|penicillin g|mesh-list
57101921|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
57101922|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
57101923|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57101924|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101925|NCT02340182|Metronidazole|metronidazole|mesh-list
57101926|NCT02340182|Vancomycin|vancomycin|mesh-list
57101927|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
57101928|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101929|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57101930|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57101931|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57101932|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57101933|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57101934|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101935|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101936|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101937|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57101938|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57101939|NCT02339714|Loratadine|loratadine|mesh-list
57101940|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
57101941|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
57101942|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57101943|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57101944|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57101945|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
57101946|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
57101947|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57101948|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101949|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101950|NCT02335190|Lidocaine|lidocaine|mesh-list
57101951|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
57101952|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
57101953|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57101954|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101955|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
57101956|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57101957|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57101958|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57101959|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57101960|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57101961|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101962|NCT02339324|Interferons|interferons|mesh-list
57101963|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
57101965|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
57101966|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57101967|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101968|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
57101969|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101970|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
57101971|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101972|NCT02418754|Aflibercept|aflibercept|mesh-list
57101973|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57101974|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56326162|NCT01314118|Hormones|hormones|mesh-ancestor
57101975|NCT02418754|Growth Substances|growth substances|mesh-ancestor
57101976|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101977|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
57101978|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101979|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
57101980|NCT02334488|Everolimus|everolimus|mesh-list
57101981|NCT02334488|Tacrolimus|tacrolimus|mesh-list
57101982|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57101983|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
57101984|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57101985|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57101986|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57101987|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57101988|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57101989|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57101990|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57101991|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
57101992|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57101993|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57101994|NCT02862457|Paclitaxel|paclitaxel|mesh-list
57101995|NCT02862457|Cisplatin|cisplatin|mesh-list
57101996|NCT02862457|Carboplatin|carboplatin|mesh-list
57101997|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
57101998|NCT02862457|Pemetrexed|pemetrexed|mesh-list
57101999|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57102000|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102001|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
57102002|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
57102003|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
57102004|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102005|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57102006|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102007|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57102008|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57102009|NCT02334254|Warfarin|warfarin|mesh-list
57102010|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
57102011|NCT02334254|Clopidogrel|clopidogrel|mesh-list
57102012|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57102013|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57102014|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57102015|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57102016|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
57102017|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102018|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102019|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102020|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
57102021|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57102022|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
57102023|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57102024|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
57102025|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102026|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
57102027|NCT02331602|Dabigatran|dabigatran|mesh-list
57102028|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57102029|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
57102030|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57102031|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
57102032|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102033|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102034|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
57102035|NCT02338934|Vitamin D|vitamin d|mesh-list
57102036|NCT02338934|Cinacalcet|cinacalcet|mesh-list
57102037|NCT02338934|Vitamins|vitamins|mesh-ancestor
57102038|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
57102039|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102040|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57102041|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57102043|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
57102044|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102045|NCT03861039|Tirzepatide|tirzepatide|mesh-list
57102046|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57102047|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102048|NCT03861039|Incretins|incretins|mesh-ancestor
57102049|NCT03861039|Hormones|hormones|mesh-ancestor
57102050|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102051|NCT02334176|Lidocaine|lidocaine|mesh-list
57102052|NCT02334176|Epinephrine|epinephrine|mesh-list
57102053|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
57102054|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
57102055|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102056|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102057|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
57102058|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102059|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57102060|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57102061|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57102062|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57102063|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102064|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57102065|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57102066|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102067|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102068|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57102069|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57102070|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
57102071|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57102072|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
57102073|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
57102074|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
57102075|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57102076|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
57102077|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102078|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57102079|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57102080|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102081|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102082|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
57102083|NCT03609307|Bevacizumab|bevacizumab|mesh-list
57102084|NCT03609307|Propranolol|propranolol|mesh-list
57102085|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57102086|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102087|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57102088|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57102089|NCT03609307|Growth Substances|growth substances|mesh-ancestor
57102090|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102091|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
57102092|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57102093|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57102094|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102095|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102096|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102097|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57102098|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57102099|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
57102100|NCT03399435|Epinephrine|epinephrine|mesh-list
57102101|NCT03399435|Racepinephrine|racepinephrine|mesh-list
57102102|NCT03399435|Bupivacaine|bupivacaine|mesh-list
57102103|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
57102104|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
57102105|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
57102106|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
57102107|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102108|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102109|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
57102110|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102111|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57102112|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57102113|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102114|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102115|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102116|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57102117|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57102118|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
57102119|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57102120|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
57102121|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
57102122|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
57102123|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57102124|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57102125|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57102126|NCT01936688|Etanercept|etanercept|mesh-list
57102127|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57102128|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57102129|NCT01936688|Analgesics|analgesics|mesh-ancestor
57102130|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
57102131|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102132|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102133|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57102134|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102135|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57102136|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57102137|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
57102138|NCT02338544|Adapalene|adapalene|mesh-list
57102139|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57102140|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
57102141|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57102142|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57102143|NCT02338544|Analgesics|analgesics|mesh-ancestor
57102144|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
57102145|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102146|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102147|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57102148|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102149|NCT04446663|Paclitaxel|paclitaxel|mesh-list
57102150|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57102151|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57102152|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102153|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
57102154|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
57102155|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
57102156|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102157|NCT01861496|Cisplatin|cisplatin|mesh-list
57102158|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102159|NCT02520219|Endostar protein|endostar protein|mesh-list
57102160|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57102161|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57102162|NCT02520219|Growth Substances|growth substances|mesh-ancestor
57102163|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102164|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
57102165|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102166|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57102167|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57102168|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102169|NCT03394287|Apatinib|apatinib|mesh-list
57102170|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102171|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57102172|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102173|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102174|NCT02338622|Olaparib|olaparib|mesh-list
57102175|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57102176|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102177|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102178|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102179|NCT02338466|Tenecteplase|tenecteplase|mesh-list
57102180|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57102181|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57102182|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102183|NCT03394209|Oseltamivir|oseltamivir|mesh-list
57102184|NCT03394209|Favipiravir|favipiravir|mesh-list
57102185|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
57102186|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102187|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102188|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102189|NCT03399201|Anesthetics|anesthetics|mesh-list
57102190|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102191|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102192|NCT02520453|Durvalumab|durvalumab|mesh-list
57102193|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57102194|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102195|NCT03389763|Remifentanil|remifentanil|mesh-list
57102196|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57102197|NCT03389763|Narcotics|narcotics|mesh-ancestor
57102198|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102199|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102200|NCT03389763|Analgesics|analgesics|mesh-ancestor
57102201|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
57102202|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102203|NCT02866175|Vitamin K|vitamin k|mesh-list
57102204|NCT02866175|Edoxaban|edoxaban|mesh-list
57102205|NCT02866175|Clopidogrel|clopidogrel|mesh-list
57102206|NCT02866175|Ticagrelor|ticagrelor|mesh-list
57102207|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57102208|NCT02866175|Vitamins|vitamins|mesh-ancestor
57102209|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
57102210|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102211|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57102212|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57102213|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57102214|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57102215|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
57102216|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102217|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102218|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57102219|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57102220|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
57102221|NCT02866175|Coagulants|coagulants|mesh-ancestor
57102222|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57102223|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
57102224|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57102225|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
57102226|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102227|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
57102228|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
57102229|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57102230|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
57102231|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102232|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
57102233|NCT02330822|Protective Agents|protective agents|mesh-ancestor
57102234|NCT02338310|Letrozole|letrozole|mesh-list
57102235|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57102236|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102237|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57102238|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102239|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102240|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57102241|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
57102242|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102243|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102244|NCT03389607|Anesthetics|anesthetics|mesh-list
57102245|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102246|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102247|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
57102248|NCT02817789|Clopidogrel|clopidogrel|mesh-list
57102249|NCT02817789|Ticagrelor|ticagrelor|mesh-list
57102250|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57102251|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57102252|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57102253|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57102254|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
57102255|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102256|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102257|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102258|NCT02817789|Analgesics|analgesics|mesh-ancestor
57102259|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
57102260|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102261|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57102262|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57102263|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57102264|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102265|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57102266|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102267|NCT05383625|Vaccines|vaccines|mesh-list
57102268|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
57102269|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102270|NCT02926859|Cannabidiol|cannabidiol|mesh-list
57102271|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
57102272|NCT03389451|Edetic Acid|edetic acid|mesh-list
57102273|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57102274|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
57102275|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
57102276|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102277|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
57102278|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57102279|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57102280|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57102281|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57102282|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57102283|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
57102284|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102285|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102286|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
57102287|NCT02330120|Propofol|propofol|mesh-list
57102288|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57102289|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102290|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102291|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57102292|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
57102293|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
57102294|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57102295|NCT02330120|Analgesics|analgesics|mesh-ancestor
57102296|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
57102297|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102298|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57102299|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57102300|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57102301|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102302|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102303|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102304|NCT03389295|Cisplatin|cisplatin|mesh-list
57102305|NCT03389295|Docetaxel|docetaxel|mesh-list
57102306|NCT03389295|Fluorouracil|fluorouracil|mesh-list
57102307|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102308|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
57102309|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
57102310|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
57102311|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102312|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
57102313|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57102314|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57102315|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
57102316|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102317|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
57102318|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57102319|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102320|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57102321|NCT03398811|Etonogestrel|etonogestrel|mesh-list
57102322|NCT03398811|Desogestrel|desogestrel|mesh-list
57102323|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
57102324|NCT03398811|Progesterone|progesterone|mesh-list
57102325|NCT03398811|Progestins|progestins|mesh-ancestor
57102326|NCT03398811|Hormones|hormones|mesh-ancestor
57102327|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102328|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102329|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57102330|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
57102331|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57102332|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57102333|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57102334|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57102335|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57102336|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57102337|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57102338|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102339|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
57102340|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57102341|NCT01300143|Estrogens|estrogens|mesh-ancestor
57102342|NCT01300143|Hormones|hormones|mesh-ancestor
57102343|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102344|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102345|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57102346|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102347|NCT01336205|Naloxegol|naloxegol|mesh-list
57102348|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57102349|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102350|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
57102351|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102352|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
57102353|NCT03610685|Prednisolone|prednisolone|mesh-list
57102354|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57102355|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
57102356|NCT03610685|Hormones|hormones|mesh-ancestor
57102357|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102358|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102359|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57102360|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102361|NCT02327234|Ibuprofen|ibuprofen|mesh-list
57102362|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57102363|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57102364|NCT02327234|Analgesics|analgesics|mesh-ancestor
57102365|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
57102366|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102367|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102368|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57102369|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102370|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57102371|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102372|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102373|NCT01123707|Aripiprazole|aripiprazole|mesh-list
57102374|NCT01123707|Citalopram|citalopram|mesh-list
57102375|NCT01123707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57102376|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57102377|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57102378|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102379|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102380|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
57102381|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102382|NCT01123707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57102383|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
57102384|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57102385|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57102386|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57102387|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102388|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
57102389|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
57102390|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57102391|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57102392|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57102393|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57102394|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57102395|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57102396|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
57102397|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
57102398|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57102399|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
57102400|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102401|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102402|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57102403|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
57102404|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57102405|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57102406|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57102407|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102408|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102409|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102410|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57102411|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
57102412|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57102413|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
57102414|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57102415|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102416|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102417|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57102418|NCT02327156|Analgesics|analgesics|mesh-ancestor
57102419|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
57102420|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102421|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57102422|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57102423|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57102424|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102425|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102426|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102427|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57102428|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
57102429|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57102430|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
57102431|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102432|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
57102433|NCT02039804|Protective Agents|protective agents|mesh-ancestor
57102434|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57102436|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
57102437|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57102438|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57102439|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57102440|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57102441|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102442|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
57102443|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102444|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102445|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57102446|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102447|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102448|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57102449|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102450|NCT02327000|Pregabalin|pregabalin|mesh-list
57102451|NCT02327000|Analgesics|analgesics|mesh-ancestor
57102452|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
57102453|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102454|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102455|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
57102456|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57102457|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57102458|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102459|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57102460|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57102461|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57102462|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102463|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57102464|NCT02033603|Ropivacaine|ropivacaine|mesh-list
57102465|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
57102466|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
57102467|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102468|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102469|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
57102470|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102471|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
57102472|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57102473|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
57102474|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57102475|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102476|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57102477|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57102478|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57102479|NCT02327078|Nivolumab|nivolumab|mesh-list
57102480|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57102481|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899778|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102482|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57102483|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102484|NCT00862251|Atorvastatin|atorvastatin|mesh-list
57102485|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56784354|NCT01027923|Analgesics|analgesics|mesh-ancestor
57102486|NCT00862251|Simvastatin|simvastatin|mesh-list
57102487|NCT00862251|Ezetimibe|ezetimibe|mesh-list
57102488|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57102489|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57102490|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
57102491|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102492|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57102493|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57102494|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102495|NCT03389139|Anesthetics|anesthetics|mesh-list
57102496|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102497|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102498|NCT00885963|Sapacitabine|sapacitabine|mesh-list
57102499|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102500|NCT00725127|Aspirin|aspirin|mesh-list
57102501|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57102502|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57102503|NCT00725127|Analgesics|analgesics|mesh-ancestor
57102504|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
57102505|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102506|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102507|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57102508|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102509|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57102510|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57102511|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102512|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57102513|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57102514|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102515|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
57102516|NCT02328950|Cytarabine|cytarabine|mesh-list
57102517|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
57102518|NCT02328950|Busulfan|busulfan|mesh-list
57102519|NCT02328950|Fludarabine|fludarabine|mesh-list
57102520|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57102521|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
57102522|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102523|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102524|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57102525|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
57102526|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102527|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102528|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57102529|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57102530|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
57102531|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
57102532|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102533|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
57102534|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57102535|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102536|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57102537|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102538|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
57102539|NCT03389061|Velpatasvir|velpatasvir|mesh-list
57102540|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57102541|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
57102542|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102543|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
57102544|NCT05078138|Hematinics|hematinics|mesh-ancestor
57102545|NCT02038868|Tamsulosin|tamsulosin|mesh-list
57102546|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57102547|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57102548|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57102549|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102550|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102551|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102552|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102553|NCT02038868|Urological Agents|urological agents|mesh-ancestor
57102554|NCT02328794|Varenicline|varenicline|mesh-list
57102555|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57102556|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57102557|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
57102558|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102559|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102560|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102561|NCT03388827|Misoprostol|misoprostol|mesh-list
57102562|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57102563|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
57102564|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57102565|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102566|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57102567|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57102568|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
57102569|NCT02328716|Cisplatin|cisplatin|mesh-list
57102570|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102571|NCT00445107|Montelukast|montelukast|mesh-list
57102572|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57102573|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
57102574|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57102575|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
57102576|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102577|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102578|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57102579|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57102580|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102581|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
57102582|NCT05077592|Povidone|povidone|mesh-list
57102583|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
57102584|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
57102585|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57102586|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102587|NCT00038727|Metformin|metformin|mesh-list
57102588|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57102589|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102590|NCT02864381|Nivolumab|nivolumab|mesh-list
57102591|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57102592|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102593|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57102594|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102595|NCT05230472|Simvastatin|simvastatin|mesh-list
57102596|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57102597|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57102598|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
57102599|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102600|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57102601|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57102602|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102603|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
57102604|NCT03398031|Antacids|antacids|mesh-ancestor
57102605|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102606|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57102607|NCT02039960|Bupropion|bupropion|mesh-list
57102608|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57102609|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
57102610|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57102611|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57102612|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57102613|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57102614|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102615|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
57102616|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102617|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102618|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57102619|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57102620|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102621|NCT05383313|Midazolam|midazolam|mesh-list
57102622|NCT05383313|Ketamine|ketamine|mesh-list
57102623|NCT05383313|Psilocybin|psilocybin|mesh-list
57102624|NCT05383313|Analgesics|analgesics|mesh-ancestor
57102625|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
57102626|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102627|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102628|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57102629|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57102630|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
57102631|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
57102632|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102633|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57102634|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57102635|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102636|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102637|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57102638|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57102639|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57102640|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57102641|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57102642|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
57102643|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
57102644|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
57102645|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57102646|NCT03144128|Vitamin D|vitamin d|mesh-list
57102647|NCT03144128|Vitamins|vitamins|mesh-ancestor
57102648|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
57102649|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102650|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57102651|NCT02484443|Dinutuximab|dinutuximab|mesh-list
57102652|NCT02484443|Sargramostim|sargramostim|mesh-list
57102653|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
57102654|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102655|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102656|NCT02326610|Hormones|hormones|mesh-list
57102657|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102658|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102659|NCT00409773|Atorvastatin|atorvastatin|mesh-list
57102660|NCT00409773|Simvastatin|simvastatin|mesh-list
57102661|NCT00409773|Ezetimibe|ezetimibe|mesh-list
57102662|NCT00409773|Calcium|calcium|mesh-list
57102663|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57102664|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102665|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57102666|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57102667|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
57102668|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102669|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57102670|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57102671|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102672|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57102673|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102674|NCT02034422|Antioxidants|antioxidants|mesh-list
57102675|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102676|NCT02034422|Protective Agents|protective agents|mesh-ancestor
57102677|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102678|NCT02325986|Fluorouracil|fluorouracil|mesh-list
57102679|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102680|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
57102681|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102682|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57102683|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57102684|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
57102685|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102686|NCT00398151|Montelukast|montelukast|mesh-list
57102687|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57102688|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
57102689|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57102690|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
57102691|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102692|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102693|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57102694|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57102695|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102696|NCT03610139|Vitamin D|vitamin d|mesh-list
57102697|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
57102698|NCT03610139|Vitamins|vitamins|mesh-ancestor
57102699|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
57102700|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102701|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57102702|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57102703|NCT02327624|Clopidogrel|clopidogrel|mesh-list
57102704|NCT02327624|Ticagrelor|ticagrelor|mesh-list
57102705|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57102706|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57102707|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57102708|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57102709|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
57102710|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102711|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102712|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102713|NCT03388671|Bupivacaine|bupivacaine|mesh-list
57102714|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
57102715|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
57102716|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102717|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102718|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
57102719|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102720|NCT02327936|Fesoterodine|fesoterodine|mesh-list
57102721|NCT02327936|Oxybutynin|oxybutynin|mesh-list
57102722|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57102723|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57102724|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
57102725|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102726|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102727|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102728|NCT02327936|Urological Agents|urological agents|mesh-ancestor
57102729|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
57102730|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
57102731|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102732|NCT04531943|Progesterone|progesterone|mesh-list
57102733|NCT04531943|Estrogens|estrogens|mesh-list
57102734|NCT04531943|Progestins|progestins|mesh-ancestor
57102735|NCT04531943|Hormones|hormones|mesh-ancestor
57102736|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102737|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102738|NCT03609827|Melphalan|melphalan|mesh-list
57102739|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57102740|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
57102741|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102742|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102743|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57102744|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57102745|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
57102746|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102747|NCT02858401|Vesatolimod|vesatolimod|mesh-list
57102748|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
57102749|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102750|NCT03144596|Tamsulosin|tamsulosin|mesh-list
57102751|NCT03144596|Alfuzosin|alfuzosin|mesh-list
57102752|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57102753|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57102754|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57102755|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102756|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102757|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102758|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102759|NCT03144596|Urological Agents|urological agents|mesh-ancestor
57102760|NCT00127647|Montelukast|montelukast|mesh-list
57102761|NCT00127647|Pranlukast|pranlukast|mesh-list
57102762|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57102763|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
57102764|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57102765|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
57102766|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102767|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102768|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57102769|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57102770|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102771|NCT02408549|Lacosamide|lacosamide|mesh-list
57102772|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
57102773|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57102774|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57102775|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57102776|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102777|NCT03111446|Anesthetics|anesthetics|mesh-list
57102778|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102779|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102780|NCT02034071|Diazoxide|diazoxide|mesh-list
57102781|NCT02034071|Choline|choline|mesh-list
57102782|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
57102784|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
57102785|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102786|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57102787|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57102788|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
57102789|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57102790|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
57102791|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
57102792|NCT03609359|Lenvatinib|lenvatinib|mesh-list
57102793|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57102794|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102795|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57102796|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102797|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102798|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57102799|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57102800|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57102801|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
57102802|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102803|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57102804|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57102805|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102806|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
57102807|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57102808|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57102809|NCT04822376|Ansuvimab|ansuvimab|mesh-list
57102810|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
57102811|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102812|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
57102813|NCT05173545|Analgesics|analgesics|mesh-ancestor
57102814|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
57102815|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102816|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102817|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102818|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57102819|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57102820|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102821|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102822|NCT05383183|Choline|choline|mesh-list
57102823|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
57102824|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57102825|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
57102826|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102827|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57102828|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57102829|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
57102830|NCT02327702|Emtricitabine|emtricitabine|mesh-list
57102831|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
57102832|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102833|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57102834|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57102835|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102836|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102837|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57102838|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57102839|NCT03609775|Ethanol|ethanol|mesh-list
57102840|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56899794|NCT01202331|Azithromycin|azithromycin|mesh-list
57102841|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102842|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102843|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102844|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
57102845|NCT03690765|Progestins|progestins|mesh-ancestor
57102846|NCT03690765|Hormones|hormones|mesh-ancestor
57102847|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102848|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102849|NCT02033941|Phenol|phenol|mesh-list
57102850|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57102851|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102852|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
57102853|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57102854|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57102855|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
57102856|NCT03143972|Remifentanil|remifentanil|mesh-list
57102857|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57102858|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102859|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102860|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57102861|NCT03143972|Analgesics|analgesics|mesh-ancestor
57102862|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
57102863|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102864|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57102865|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57102866|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57102867|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102868|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102869|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102870|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57102871|NCT03143972|Narcotics|narcotics|mesh-ancestor
57102872|NCT02237027|Tenofovir|tenofovir|mesh-list
57102873|NCT02237027|Emtricitabine|emtricitabine|mesh-list
57102874|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57102875|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
57102876|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102877|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57102878|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57102879|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102880|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102881|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57102882|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57102883|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57102884|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57102885|NCT03143738|Anesthetics|anesthetics|mesh-list
57102886|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57102887|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102888|NCT04393753|Avelumab|avelumab|mesh-list
57102889|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57102890|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102891|NCT04647903|Amphetamine|amphetamine|mesh-list
57102892|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
57102893|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57102894|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102895|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
57102896|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
57102897|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102898|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
57102899|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57102900|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102901|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
57102902|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57102903|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57102904|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57102905|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57102906|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
57102907|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57102908|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
57102909|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102910|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102911|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57102912|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
57102913|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102914|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102915|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57102916|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57102917|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57102918|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57102919|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102920|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102921|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
57102922|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102923|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57102924|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57102925|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
57102926|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57102927|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57102928|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57102929|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57102931|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102932|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102933|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57102934|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57102935|NCT03380325|Iloprost|iloprost|mesh-list
57102936|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57102937|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
57102938|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57102939|NCT02237053|Octreotide|octreotide|mesh-list
57102940|NCT02237053|Glucagon|glucagon|mesh-list
57102941|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102942|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57102943|NCT02237053|Hormones|hormones|mesh-ancestor
57102944|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57102945|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57102946|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102947|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
57102948|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
57102949|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
57102950|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57102951|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102952|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57102953|NCT04997174|Celecoxib|celecoxib|mesh-list
57102954|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57102955|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57102956|NCT04997174|Analgesics|analgesics|mesh-ancestor
57102957|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
57102958|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57102959|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102960|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57102961|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102962|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57102963|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57102964|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57102965|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102966|NCT02237209|Vaccines|vaccines|mesh-list
57102967|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
57102968|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102969|NCT03387111|Leucovorin|leucovorin|mesh-list
57102970|NCT03387111|Paclitaxel|paclitaxel|mesh-list
57102971|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
57102972|NCT03387111|Bevacizumab|bevacizumab|mesh-list
57102973|NCT03387111|Fluorouracil|fluorouracil|mesh-list
57102974|NCT03387111|Capecitabine|capecitabine|mesh-list
57102975|NCT03387111|Cetuximab|cetuximab|mesh-list
57102976|NCT03387111|Avelumab|avelumab|mesh-list
57102977|NCT03387111|Necitumumab|necitumumab|mesh-list
57102978|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57102979|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57102980|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
57102981|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
57102982|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
57102983|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57102984|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57102985|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
57102986|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57102987|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57102988|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57102989|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
57102990|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57102991|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57102992|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57102993|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57102994|NCT03387111|Growth Substances|growth substances|mesh-ancestor
57102995|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
57102996|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
57102997|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57102998|NCT03387111|Antidotes|antidotes|mesh-ancestor
57102999|NCT03387111|Protective Agents|protective agents|mesh-ancestor
57103000|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
57103001|NCT03387111|Vitamins|vitamins|mesh-ancestor
57103002|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
57103003|NCT03608293|Dimercaprol|dimercaprol|mesh-list
57103004|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
57103005|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
57103006|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103007|NCT03608501|Thalidomide|thalidomide|mesh-list
57103008|NCT03608501|Dexamethasone|dexamethasone|mesh-list
57103009|NCT03608501|Ixazomib|ixazomib|mesh-list
57103010|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103011|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
57103012|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
57103013|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103014|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103015|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57103016|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
57103017|NCT03608501|Hormones|hormones|mesh-ancestor
57103018|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103019|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57103020|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103021|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103022|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103023|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
57103024|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
57103025|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57103026|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103027|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57103028|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57103029|NCT03608501|Growth Substances|growth substances|mesh-ancestor
57103030|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
57103031|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
57103032|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103033|NCT03608761|Rebamipide|rebamipide|mesh-list
57103034|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57103035|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57103036|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
57103037|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103038|NCT03608761|Protective Agents|protective agents|mesh-ancestor
57103039|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103040|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103041|NCT04554836|Cetuximab|cetuximab|mesh-list
57103042|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57103043|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103044|NCT04536272|Heparin|heparin|mesh-list
57103045|NCT04536272|Calcium heparin|calcium heparin|mesh-list
57103046|NCT04536272|Enoxaparin|enoxaparin|mesh-list
57103047|NCT04536272|Nadroparin|nadroparin|mesh-list
57103048|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
57103049|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57103050|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57103051|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103052|NCT02731131|Ribavirin|ribavirin|mesh-list
57103053|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57103054|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
57103055|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103056|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
57103057|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103058|NCT04585724|Palbociclib|palbociclib|mesh-list
57103059|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103060|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57103061|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103062|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103063|NCT02237261|Prednisone|prednisone|mesh-list
57103064|NCT02237261|Bortezomib|bortezomib|mesh-list
57103065|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57103066|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103067|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
57103068|NCT02237261|Hormones|hormones|mesh-ancestor
57103069|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103070|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103071|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57103072|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103073|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57103074|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
57103075|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103076|NCT03386643|Clobetasol|clobetasol|mesh-list
57103077|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103078|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
57103079|NCT03386643|Hormones|hormones|mesh-ancestor
57103080|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103081|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103082|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
57103083|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57103084|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103085|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103086|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57103087|NCT05171985|Analgesics|analgesics|mesh-ancestor
57103088|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
57103089|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103090|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57103091|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57103092|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57103093|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
57103094|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103095|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103096|NCT02237365|Aspirin|aspirin|mesh-list
57103097|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57103098|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57103099|NCT02237365|Analgesics|analgesics|mesh-ancestor
57103100|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
57103101|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103102|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103103|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103104|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57103105|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57103106|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57103107|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103108|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57103109|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57103110|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103111|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
57103112|NCT03383367|TEMPO|tempo|mesh-list
57103113|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
57103114|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103115|NCT03383367|Protective Agents|protective agents|mesh-ancestor
57103116|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103117|NCT02856113|Alogliptin|alogliptin|mesh-list
57103118|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57103119|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103120|NCT02856113|Incretins|incretins|mesh-ancestor
57103121|NCT02856113|Hormones|hormones|mesh-ancestor
57103122|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103123|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57103124|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
57103125|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103126|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103127|NCT03386565|Lidocaine|lidocaine|mesh-list
57103128|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57103129|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103130|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
57103131|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103132|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103133|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
57103134|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899798|NCT01201551|Latanoprost|latanoprost|mesh-list
57103135|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57103136|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57103137|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57103138|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103139|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103140|NCT02237339|Allopurinol|allopurinol|mesh-list
57103141|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
57103142|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103143|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103144|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
57103145|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57103146|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57103147|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
57103148|NCT02237339|Protective Agents|protective agents|mesh-ancestor
57103149|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103150|NCT05171751|Octreotide|octreotide|mesh-list
57103151|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57103152|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57103153|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103154|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
57103155|NCT03971084|Caseins|caseins|mesh-list
57103156|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57103157|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
57103158|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103159|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103160|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103161|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
57103162|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
57103163|NCT03379779|Dimercaprol|dimercaprol|mesh-list
57103164|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
57103165|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
57103166|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103167|NCT04083014|Bortezomib|bortezomib|mesh-list
57103168|NCT04083014|Antibodies|antibodies|mesh-list
57103169|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
57103170|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103171|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103172|NCT03563066|Benralizumab|benralizumab|mesh-list
57103173|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57103174|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
57103175|NCT03140384|Misoprostol|misoprostol|mesh-list
57103176|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57103177|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
57103178|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57103179|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103180|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57103181|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57103182|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
57103183|NCT05117307|Bupivacaine|bupivacaine|mesh-list
57103184|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103185|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
57103186|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103187|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103188|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
57103189|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103190|NCT03739268|Sevelamer|sevelamer|mesh-list
57103191|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
57103192|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
57103193|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103194|NCT02787590|Simvastatin|simvastatin|mesh-list
57103195|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57103196|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57103197|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
57103198|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103199|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57103200|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57103201|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103202|NCT03971474|Gemcitabine|gemcitabine|mesh-list
57103203|NCT03971474|Docetaxel|docetaxel|mesh-list
57103204|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
57103205|NCT03971474|Pemetrexed|pemetrexed|mesh-list
57103206|NCT03971474|Ramucirumab|ramucirumab|mesh-list
57103207|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57103208|NCT03971474|Antibodies|antibodies|mesh-list
57103209|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
57103210|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57103211|NCT03971474|Lexatumumab|lexatumumab|mesh-list
57103212|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
57103213|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103214|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57103215|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
57103216|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103217|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103218|NCT03971474|Antiviral Agents|antiviral agents|mesh-ancestor
57103219|NCT03971474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103220|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103221|NCT03971474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103222|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
57103223|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
57103224|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
57103225|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57103226|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57103227|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
57103228|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
57103229|NCT03382743|Lidocaine|lidocaine|mesh-list
56785104|NCT03894540|Paclitaxel|paclitaxel|mesh-list
57103230|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103231|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
57103232|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103233|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103234|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
57103235|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103236|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57103237|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57103238|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57103239|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103240|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103241|NCT02854631|Prednisolone|prednisolone|mesh-list
57103242|NCT02854631|Selonsertib|selonsertib|mesh-list
57103243|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103244|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
57103245|NCT02854631|Hormones|hormones|mesh-ancestor
57103246|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103247|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103248|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57103249|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103250|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57103251|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103252|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103253|NCT03607643|Leucovorin|leucovorin|mesh-list
57103254|NCT03607643|Gemcitabine|gemcitabine|mesh-list
57103255|NCT03607643|Bevacizumab|bevacizumab|mesh-list
57103256|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
57103257|NCT03607643|Irinotecan|irinotecan|mesh-list
57103258|NCT03607643|Temozolomide|temozolomide|mesh-list
57103259|NCT03607643|Bortezomib|bortezomib|mesh-list
57103260|NCT03607643|Cannabidiol|cannabidiol|mesh-list
57103261|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57103262|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103263|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57103264|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57103265|NCT03607643|Growth Substances|growth substances|mesh-ancestor
57103266|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103267|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
57103268|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57103269|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
57103270|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103271|NCT03607643|Antiviral Agents|antiviral agents|mesh-ancestor
57103272|NCT03607643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103273|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103274|NCT03607643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103275|NCT03607643|Immunologic Factors|immunologic factors|mesh-ancestor
57103276|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57103277|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57103278|NCT03607643|Antidotes|antidotes|mesh-ancestor
57103279|NCT03607643|Protective Agents|protective agents|mesh-ancestor
57103280|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
57103281|NCT03607643|Vitamins|vitamins|mesh-ancestor
57103282|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
57103283|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57103284|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
57103285|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
57103286|NCT02855359|Prednisone|prednisone|mesh-list
57103287|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
57103288|NCT02855359|Rituximab|rituximab|mesh-list
57103289|NCT02855359|Doxorubicin|doxorubicin|mesh-list
57103290|NCT02855359|Vincristine|vincristine|mesh-list
57103291|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103292|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
57103293|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103294|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57103295|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57103296|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
57103297|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103298|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103299|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57103300|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57103301|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57103302|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57103303|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57103304|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103305|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103306|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
57103307|NCT02855359|Hormones|hormones|mesh-ancestor
57103308|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103309|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57103310|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57103312|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
57103313|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
57103314|NCT05084456|Docetaxel|docetaxel|mesh-list
57103315|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103316|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
57103317|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
57103318|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
57103319|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103320|NCT03607903|Adalimumab|adalimumab|mesh-list
57103321|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103322|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57103323|NCT04438850|Ivermectin|ivermectin|mesh-list
57103324|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57103325|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103326|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
57103327|NCT03385863|Poractant alfa|poractant alfa|mesh-list
57103328|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
57103329|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
57103330|NCT03939026|Fludarabine|fludarabine|mesh-list
57103331|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103332|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
57103333|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103334|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57103335|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57103336|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
57103337|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103338|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103339|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57103340|NCT03382587|Aflibercept|aflibercept|mesh-list
57103341|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57103342|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57103343|NCT03382587|Growth Substances|growth substances|mesh-ancestor
57103344|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103345|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
57103346|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103347|NCT03382431|PC-786|pc-786|mesh-list
57103348|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
57103349|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103350|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103351|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103352|NCT03141632|Dulaglutide|dulaglutide|mesh-list
57103353|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57103354|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103355|NCT04282239|Lidocaine|lidocaine|mesh-list
57103356|NCT04282239|Epinephrine|epinephrine|mesh-list
57103357|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
57103358|NCT04282239|Ropivacaine|ropivacaine|mesh-list
57103359|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103360|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
57103361|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103362|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103363|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
57103364|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103365|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57103366|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57103367|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57103368|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103369|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103370|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57103371|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57103372|NCT04282239|Analgesics|analgesics|mesh-ancestor
57103373|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57103374|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57103375|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57103376|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
57103377|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103378|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57103379|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57103380|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
57103381|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57103382|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
57103383|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
57103384|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
57103386|NCT03605173|Vitamin D|vitamin d|mesh-list
57103387|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
57103388|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
57103389|NCT03605173|Vitamins|vitamins|mesh-list
57103390|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
57103391|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103392|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57103393|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57103394|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
57103395|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
57103396|NCT03382275|Iron|iron|mesh-list
57103397|NCT03382275|Ferric maltol|ferric maltol|mesh-list
57103398|NCT03382275|Trace Elements|trace elements|mesh-ancestor
57103399|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
57103400|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103401|NCT03382275|Hematinics|hematinics|mesh-ancestor
57103402|NCT05080478|Clopidogrel|clopidogrel|mesh-list
57103403|NCT05080478|Ticagrelor|ticagrelor|mesh-list
57103404|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57103405|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57103406|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57103407|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57103408|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
57103409|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103410|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103411|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103412|NCT03604627|Calcium|calcium|mesh-list
57103413|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57103414|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103415|NCT05082974|Varenicline|varenicline|mesh-list
57103416|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57103417|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57103418|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
57103419|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103420|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103421|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103422|NCT03604471|Atorvastatin|atorvastatin|mesh-list
57103423|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57103424|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57103425|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
57103426|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103427|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57103428|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57103429|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103430|NCT03757130|Liraglutide|liraglutide|mesh-list
57103431|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57103432|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103433|NCT03757130|Incretins|incretins|mesh-ancestor
57103434|NCT03757130|Hormones|hormones|mesh-ancestor
57103435|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103436|NCT02237443|Bromides|bromides|mesh-list
57103437|NCT02237443|Rocuronium|rocuronium|mesh-list
57103438|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
57103439|NCT02237443|Succinylcholine|succinylcholine|mesh-list
57103440|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
57103441|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57103442|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57103443|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57103444|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103445|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103446|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
57103447|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57103448|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57103449|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
57103450|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103451|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103452|NCT03141398|Pancrelipase|pancrelipase|mesh-list
57103453|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57103454|NCT03733418|Vitamin D|vitamin d|mesh-list
57103455|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
57103456|NCT03733418|Vitamins|vitamins|mesh-ancestor
57103457|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
57103458|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103459|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56785350|NCT01001130|Xhance|xhance|mesh-list
57103460|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57103461|NCT03607331|Citalopram|citalopram|mesh-list
57103462|NCT03607331|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57103463|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57103464|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103465|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103466|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103467|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
57103468|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103469|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57103470|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
57103471|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57103472|NCT05082896|Anesthetics|anesthetics|mesh-list
57103473|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103474|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103475|NCT03607955|Paclitaxel|paclitaxel|mesh-list
57103476|NCT03607955|Carboplatin|carboplatin|mesh-list
57103477|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57103478|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103479|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
57103480|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
57103481|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
57103482|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103483|NCT02067975|Tryptophan|tryptophan|mesh-list
57103484|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57103485|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
57103486|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57103487|NCT03143036|Thalidomide|thalidomide|mesh-list
57103488|NCT03143036|Dexamethasone|dexamethasone|mesh-list
57103489|NCT03143036|Daratumumab|daratumumab|mesh-list
57103490|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103491|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
57103492|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
57103493|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103494|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103495|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57103496|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
57103497|NCT03143036|Hormones|hormones|mesh-ancestor
57103498|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103499|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57103500|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103501|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103502|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
57103503|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
57103504|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57103505|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103506|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57103507|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57103508|NCT03143036|Growth Substances|growth substances|mesh-ancestor
57103509|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
57103510|NCT03607175|Triamcinolone|triamcinolone|mesh-list
57103511|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57103512|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103513|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
57103514|NCT03607175|Hormones|hormones|mesh-ancestor
57103515|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103516|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103517|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103518|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
57103519|NCT05082662|Diclofenac|diclofenac|mesh-list
57103520|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57103521|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57103522|NCT05082662|Analgesics|analgesics|mesh-ancestor
57103523|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
57103524|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103525|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103526|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103527|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57103528|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57103529|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103530|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103531|NCT05080010|Carboplatin|carboplatin|mesh-list
57103532|NCT05080010|Etoposide|etoposide|mesh-list
57103533|NCT05080010|Vincristine|vincristine|mesh-list
56785398|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57103534|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103535|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57103536|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57103537|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57103538|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103539|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103540|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
57103541|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
57103542|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
57103543|NCT03385551|Estradiol|estradiol|mesh-list
57103544|NCT03385551|Estrogens|estrogens|mesh-ancestor
57103545|NCT03385551|Hormones|hormones|mesh-ancestor
57103546|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103547|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103548|NCT03606473|Amphetamine|amphetamine|mesh-list
57103549|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
57103550|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57103551|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103552|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
57103553|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
57103554|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103555|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
57103556|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103557|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103558|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
57103559|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57103560|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57103561|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103562|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57103563|NCT03316274|Nivolumab|nivolumab|mesh-list
57103564|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57103565|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103566|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57103567|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103568|NCT03252626|Alprostadil|alprostadil|mesh-list
57103569|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57103570|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
57103571|NCT03252626|Urological Agents|urological agents|mesh-ancestor
57103572|NCT05072054|Atorvastatin|atorvastatin|mesh-list
57103573|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57103574|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57103575|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57103576|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
57103577|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103578|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57103579|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57103580|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103581|NCT03142880|Ropivacaine|ropivacaine|mesh-list
57103582|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103583|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
57103584|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103585|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103586|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
57103587|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103588|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
57103589|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103590|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
57103591|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57103592|NCT05049902|Amoxicillin|amoxicillin|mesh-list
57103593|NCT05049902|Metronidazole|metronidazole|mesh-list
57103594|NCT05049902|Clarithromycin|clarithromycin|mesh-list
57103595|NCT05049902|Tetracycline|tetracycline|mesh-list
57103596|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
57103597|NCT05049902|Bismuth|bismuth|mesh-list
57103598|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103599|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57103600|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103601|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57103602|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57103603|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57103604|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103605|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57103606|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57103607|NCT05049902|Antacids|antacids|mesh-ancestor
57103608|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57103610|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
57103611|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103612|NCT05049902|Expectorants|expectorants|mesh-ancestor
57103613|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
57103614|NCT05379803|Aflutinib|aflutinib|mesh-list
57103615|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57103616|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103617|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103618|NCT03381495|Sufentanil|sufentanil|mesh-list
57103619|NCT03381495|Ropivacaine|ropivacaine|mesh-list
57103620|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103621|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
57103622|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103623|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103624|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
57103625|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103626|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57103627|NCT03381495|Narcotics|narcotics|mesh-ancestor
57103628|NCT03381495|Analgesics|analgesics|mesh-ancestor
57103629|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57103630|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57103631|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
57103632|NCT03059498|Bupivacaine|bupivacaine|mesh-list
57103633|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103634|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
57103635|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103636|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103637|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
57103638|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103639|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57103640|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57103641|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103642|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
57103643|NCT03142646|Fludarabine|fludarabine|mesh-list
57103644|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103645|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
57103646|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103647|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57103648|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57103649|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
57103650|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103651|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103652|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57103653|NCT03541083|Blinatumomab|blinatumomab|mesh-list
57103654|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103655|NCT04962230|Ritonavir|ritonavir|mesh-list
57103656|NCT04962230|Carbamazepine|carbamazepine|mesh-list
57103657|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57103658|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57103659|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
57103660|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103661|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103662|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57103663|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57103664|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
57103665|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103666|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57103667|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57103668|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
57103669|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
57103670|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57103671|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103672|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103673|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57103674|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57103675|NCT04962230|Analgesics|analgesics|mesh-ancestor
57103676|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
57103677|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103678|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57103679|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103680|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57103681|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57103682|NCT03602027|Gefitinib|gefitinib|mesh-list
57103683|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785562|NCT00436917|Letrozole|letrozole|mesh-list
57103684|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57103685|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103686|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103688|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
57103689|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57103690|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103691|NCT03601871|Thalidomide|thalidomide|mesh-list
57103692|NCT03601871|Dexamethasone|dexamethasone|mesh-list
57103693|NCT03601871|Palonosetron|palonosetron|mesh-list
56899810|NCT01204125|Iniparib|iniparib|mesh-list
57103694|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
57103695|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103696|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
57103697|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
57103698|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103699|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103700|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57103701|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
57103702|NCT03601871|Hormones|hormones|mesh-ancestor
57103703|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57103704|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57103705|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103706|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103707|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
57103708|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
57103709|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57103710|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103711|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57103712|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57103713|NCT03601871|Growth Substances|growth substances|mesh-ancestor
57103714|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
57103715|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57103716|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
57103717|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103718|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103719|NCT03380949|Remifentanil|remifentanil|mesh-list
57103720|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
57103721|NCT03380949|Narcotics|narcotics|mesh-ancestor
57103722|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103723|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103724|NCT03380949|Analgesics|analgesics|mesh-ancestor
57103725|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
57103726|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103727|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57103728|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57103729|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103730|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57103731|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57103732|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
57103733|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103734|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103735|NCT05078372|Midazolam|midazolam|mesh-list
57103736|NCT05078372|Ropivacaine|ropivacaine|mesh-list
57103737|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103738|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
57103739|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103740|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103741|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
57103742|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103743|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57103744|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57103745|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57103746|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57103747|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57103748|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57103749|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
57103750|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
57103751|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
57103752|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103753|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103754|NCT03380871|Carboplatin|carboplatin|mesh-list
57103755|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
57103756|NCT03380871|Pemetrexed|pemetrexed|mesh-list
57103757|NCT03380871|Poly ICLC|poly iclc|mesh-list
56785622|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57103758|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103759|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57103760|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103761|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103762|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57103763|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57103764|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
57103765|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
57103766|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103767|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
57103768|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57103769|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103770|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103771|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57103772|NCT02237495|Analgesics|analgesics|mesh-ancestor
57103773|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
57103774|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103775|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57103776|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57103777|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57103778|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
57103779|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103780|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103781|NCT02486666|Enoxaparin|enoxaparin|mesh-list
57103782|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
57103783|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
57103784|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57103785|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57103786|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103787|NCT02237807|Dirithromycin|dirithromycin|mesh-list
57103788|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57103789|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103790|NCT03125187|Heparin|heparin|mesh-list
57103791|NCT03125187|Calcium heparin|calcium heparin|mesh-list
57103792|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
57103793|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57103794|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57103795|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103796|NCT02038946|Nivolumab|nivolumab|mesh-list
57103797|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57103798|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103799|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57103800|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103801|NCT03377907|Lidocaine|lidocaine|mesh-list
57103802|NCT03377907|Ketamine|ketamine|mesh-list
57103803|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103804|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
57103805|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103806|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103807|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
57103808|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103809|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57103810|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57103811|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57103812|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103813|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103814|NCT03377907|Analgesics|analgesics|mesh-ancestor
57103815|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57103816|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57103817|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
57103818|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57103819|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57103820|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103821|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
57103822|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
57103823|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57103824|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103825|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
57103826|NCT03369795|Methotrexate|methotrexate|mesh-list
57103827|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57103828|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
57103829|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57103830|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103831|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57103832|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
57103833|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103834|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103835|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
57103836|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103837|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57103838|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103839|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
57103840|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57103841|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57103842|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
57103843|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
57103844|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57103845|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57103846|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103847|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103848|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57103849|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57103850|NCT05393414|Acetaminophen|acetaminophen|mesh-list
57103851|NCT05393414|Ketorolac|ketorolac|mesh-list
57103852|NCT05393414|Morphine|morphine|mesh-list
57103853|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
57103854|NCT05393414|Narcotics|narcotics|mesh-ancestor
57103855|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103856|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103857|NCT05393414|Analgesics|analgesics|mesh-ancestor
57103858|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
57103859|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103860|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57103861|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
57103862|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57103863|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57103864|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57103865|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57103866|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103867|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103868|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
57103869|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
57103870|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103871|NCT02034500|Vaccines|vaccines|mesh-list
57103872|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
57103873|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103874|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57103875|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
57103876|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
57103877|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103878|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57103879|NCT03955640|Olaparib|olaparib|mesh-list
57103880|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57103881|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103882|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103883|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103884|NCT03369093|Amoxicillin|amoxicillin|mesh-list
57103885|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57103886|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103887|NCT03369015|Amphetamine|amphetamine|mesh-list
57103888|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
57103889|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57103890|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103891|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
57103892|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
57103893|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103894|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
57103895|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103896|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103897|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
57103898|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57103899|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57103900|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103901|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57103902|NCT03890744|Docetaxel|docetaxel|mesh-list
57103903|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103904|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
57103905|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
57103906|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
57103907|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103908|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
57103909|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57103910|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57103911|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57103912|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57103914|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
57103915|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57103916|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
57103917|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103918|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103919|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
57103920|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57103921|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57103922|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
57103923|NCT05392166|Calcium|calcium|mesh-list
57103924|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57103925|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103926|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
57103927|NCT02853331|Sunitinib|sunitinib|mesh-list
57103928|NCT02853331|Axitinib|axitinib|mesh-list
57103929|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57103930|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103931|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57103932|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57103933|NCT02853331|Growth Substances|growth substances|mesh-ancestor
57103934|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103935|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
57103936|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57103937|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57103938|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103939|NCT03136640|Docetaxel|docetaxel|mesh-list
57103940|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103941|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
57103942|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
57103943|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
57103944|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103945|NCT02675439|Ipilimumab|ipilimumab|mesh-list
57103946|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57103947|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57103948|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57103949|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103950|NCT03604003|Losartan|losartan|mesh-list
57103951|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57103952|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57103953|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57103954|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57103955|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103956|NCT03368547|Edetic Acid|edetic acid|mesh-list
57103957|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57103958|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
57103959|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
57103960|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103961|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
57103962|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57103963|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57103964|NCT03368391|Lidocaine|lidocaine|mesh-list
57103965|NCT03368391|Phenylephrine|phenylephrine|mesh-list
57103966|NCT03368391|Epinephrine|epinephrine|mesh-list
57103967|NCT03368391|Racepinephrine|racepinephrine|mesh-list
57103968|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
57103969|NCT03368391|Tetracaine|tetracaine|mesh-list
57103970|NCT03368391|Mepivacaine|mepivacaine|mesh-list
57103971|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
57103972|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
57103973|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
57103974|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57103975|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57103976|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
57103977|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57103978|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57103979|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57103980|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57103981|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57103982|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57103983|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57103984|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57103985|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
57103986|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57103987|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57103988|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57103990|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57103991|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
57103992|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
57103993|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
57103994|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57103995|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
57103996|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57103997|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57103998|NCT03368391|Protective Agents|protective agents|mesh-ancestor
57103999|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57104000|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57104001|NCT03373305|Lenalidomide|lenalidomide|mesh-list
57104002|NCT03373305|Piperidine|piperidine|mesh-list
57104003|NCT03373305|Antibodies|antibodies|mesh-list
57104004|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
57104005|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57104006|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
57104007|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
57104008|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104009|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104010|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57104011|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57104012|NCT03373305|Growth Substances|growth substances|mesh-ancestor
57104013|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
57104014|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57104015|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57104016|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104017|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57104018|NCT03376737|Pemetrexed|pemetrexed|mesh-list
57104019|NCT03376737|Apatinib|apatinib|mesh-list
57104020|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104021|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104022|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104023|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57104024|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57104025|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57104026|NCT03373227|Tacrolimus|tacrolimus|mesh-list
57104027|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104028|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
57104029|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104030|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57104031|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104032|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104033|NCT02484716|Timolol|timolol|mesh-list
57104034|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57104035|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57104036|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
57104037|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104038|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104039|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104040|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57104041|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57104042|NCT03373149|Hormones|hormones|mesh-list
57104043|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
57104044|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104045|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104046|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
57104047|NCT05386784|Vitamin D|vitamin d|mesh-list
57104048|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
57104049|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57104050|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104051|NCT05386784|Vitamins|vitamins|mesh-ancestor
57104052|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
57104053|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57104054|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57104055|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
57104056|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104057|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57104058|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57104059|NCT03602287|Lidocaine|lidocaine|mesh-list
57104060|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
57104061|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
57104062|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104063|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104064|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
57104065|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104066|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57104067|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57104068|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57104069|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57104070|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104071|NCT03137498|Ketorolac|ketorolac|mesh-list
57104072|NCT03137498|Lidocaine|lidocaine|mesh-list
57104073|NCT03137498|Prilocaine|prilocaine|mesh-list
57104074|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
57104075|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
57104076|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104077|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104078|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
57104079|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104080|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57104081|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57104082|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57104083|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57104084|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104085|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57104086|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57104087|NCT03137498|Analgesics|analgesics|mesh-ancestor
57104088|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57104089|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57104090|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57104091|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104092|NCT03372837|Rituximab|rituximab|mesh-list
57104093|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57104094|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104095|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
57104096|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104097|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57104098|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57104099|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104100|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
57104101|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57104102|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104103|NCT03602131|Gemcitabine|gemcitabine|mesh-list
57104104|NCT03602131|Busulfan|busulfan|mesh-list
57104105|NCT03602131|Cladribine|cladribine|mesh-list
57104106|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57104107|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
57104108|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104109|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104110|NCT03602131|Antiviral Agents|antiviral agents|mesh-ancestor
57104111|NCT03602131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104112|NCT03602131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104113|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104114|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
57104115|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104116|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
57104117|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57104118|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57104119|NCT03606577|Dexamethasone|dexamethasone|mesh-list
57104120|NCT03606577|Lenalidomide|lenalidomide|mesh-list
57104121|NCT03606577|Daratumumab|daratumumab|mesh-list
57104122|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57104123|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
57104124|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
57104125|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104126|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104127|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57104128|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
57104129|NCT03606577|Hormones|hormones|mesh-ancestor
57104130|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104131|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57104132|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104133|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
57104134|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57104135|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57104136|NCT03606577|Growth Substances|growth substances|mesh-ancestor
57104137|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
57104138|NCT03601975|Gemcitabine|gemcitabine|mesh-list
57104139|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104140|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57104141|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
57104142|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104143|NCT03601975|Antiviral Agents|antiviral agents|mesh-ancestor
57104144|NCT03601975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104145|NCT03601975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104146|NCT03601975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104147|NCT03601975|Immunologic Factors|immunologic factors|mesh-ancestor
57104148|NCT03601975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104149|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57104150|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57104151|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104152|NCT03137186|Metformin|metformin|mesh-list
57104153|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57104154|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104155|NCT03601897|Paclitaxel|paclitaxel|mesh-list
57104156|NCT03601897|Rebastinib|rebastinib|mesh-list
57104157|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57104158|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104159|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
57104160|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
57104161|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
57104162|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104163|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57104164|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104165|NCT03137030|Acetaminophen|acetaminophen|mesh-list
57104166|NCT03137030|Hydrocodone|hydrocodone|mesh-list
57104167|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57104168|NCT03137030|Analgesics|analgesics|mesh-ancestor
57104169|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
57104170|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104171|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104172|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
57104173|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57104174|NCT03137030|Narcotics|narcotics|mesh-ancestor
57104175|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104176|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
57104177|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
57104178|NCT03596749|Sevelamer|sevelamer|mesh-list
57104179|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
57104180|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
57104181|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104182|NCT01595061|Gemcitabine|gemcitabine|mesh-list
57104183|NCT01595061|Cisplatin|cisplatin|mesh-list
57104184|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104185|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57104186|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
57104187|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104188|NCT01595061|Antiviral Agents|antiviral agents|mesh-ancestor
57104189|NCT01595061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104190|NCT01595061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104191|NCT01595061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104192|NCT01595061|Immunologic Factors|immunologic factors|mesh-ancestor
57104193|NCT01595061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104194|NCT03122522|Nivolumab|nivolumab|mesh-list
57104195|NCT03122522|Ipilimumab|ipilimumab|mesh-list
57104196|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57104197|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104198|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57104199|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104200|NCT03367143|Carboplatin|carboplatin|mesh-list
57104201|NCT03367143|Etoposide|etoposide|mesh-list
57104202|NCT03367143|Lenalidomide|lenalidomide|mesh-list
57104203|NCT03367143|Ifosfamide|ifosfamide|mesh-list
57104204|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104205|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57104206|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57104207|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57104208|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104209|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104210|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
57104211|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104212|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57104213|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57104214|NCT03367143|Growth Substances|growth substances|mesh-ancestor
57104215|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
57104216|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57104217|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
57104218|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
57104219|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57104220|NCT04762316|Pyridoxal|pyridoxal|mesh-list
57104221|NCT04762316|Pyridoxine|pyridoxine|mesh-list
57104222|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
57104223|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
57104224|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
57104225|NCT04762316|Vitamins|vitamins|mesh-ancestor
57104226|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
57104227|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104228|NCT03372447|Thiamine|thiamine|mesh-list
57104229|NCT03372447|Pyridoxine|pyridoxine|mesh-list
57104230|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
57104231|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
57104232|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
57104233|NCT03372447|Vitamins|vitamins|mesh-ancestor
57104234|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
57104235|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104236|NCT03372447|Hematinics|hematinics|mesh-ancestor
57104237|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
57104238|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57104239|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57104240|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104241|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
57104242|NCT04651166|Coagulants|coagulants|mesh-ancestor
57104243|NCT03376191|Apatinib|apatinib|mesh-list
57104244|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104245|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57104246|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104247|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104248|NCT03366597|Sevoflurane|sevoflurane|mesh-list
57104249|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57104250|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57104251|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
57104252|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
57104253|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104254|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104255|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
57104256|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57104257|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
57104258|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
57104259|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104260|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104261|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
57104262|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104263|NCT03109886|Maleic acid|maleic acid|mesh-list
57104264|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104265|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104266|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
57104267|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57104268|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57104269|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57104270|NCT03110198|Mesalamine|mesalamine|mesh-list
57104271|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57104272|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57104273|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57104274|NCT03110198|Analgesics|analgesics|mesh-ancestor
57104275|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
57104276|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104277|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104278|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57104279|NCT04460781|Vaccines|vaccines|mesh-list
57104280|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
57104281|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104282|NCT04427241|Amantadine|amantadine|mesh-list
57104283|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
57104284|NCT04427241|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57104285|NCT04427241|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57104286|NCT04427241|Antiviral Agents|antiviral agents|mesh-ancestor
57104288|NCT04427241|Dopamine Agents|dopamine agents|mesh-ancestor
57104289|NCT04427241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104290|NCT04427241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104291|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104292|NCT04427241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57104293|NCT04427241|Analgesics|analgesics|mesh-ancestor
57104294|NCT04427241|Sensory System Agents|sensory system agents|mesh-ancestor
57104295|NCT04427241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104296|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57104297|NCT04427241|Protective Agents|protective agents|mesh-ancestor
57104298|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
57104299|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57104300|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
57104301|NCT04262024|Cabergoline|cabergoline|mesh-list
57104302|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57104303|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57104304|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
57104305|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
57104306|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104307|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104308|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104309|NCT03371589|Dexamethasone|dexamethasone|mesh-list
57104310|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57104311|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
57104312|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
57104313|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104314|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104315|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57104316|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
57104317|NCT03371589|Hormones|hormones|mesh-ancestor
57104318|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104319|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57104320|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104321|NCT03365817|Fentanyl|fentanyl|mesh-list
57104322|NCT03365817|Morphine|morphine|mesh-list
57104323|NCT03365817|Oxycodone|oxycodone|mesh-list
57104324|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
57104325|NCT03365817|Tramadol|tramadol|mesh-list
57104326|NCT03365817|Methadone|methadone|mesh-list
57104327|NCT03365817|Narcotics|narcotics|mesh-ancestor
57104328|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104329|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104330|NCT03365817|Analgesics|analgesics|mesh-ancestor
57104331|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
57104332|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104333|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57104334|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57104335|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
57104336|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
57104337|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
57104338|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
57104339|NCT02852005|Vaccines|vaccines|mesh-list
57104340|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
57104341|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104342|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
57104343|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57104344|NCT03365115|Fentanyl|fentanyl|mesh-list
57104345|NCT03365115|Morphine|morphine|mesh-list
56899866|NCT01566825|Analgesics|analgesics|mesh-ancestor
57104346|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57104347|NCT03365115|Narcotics|narcotics|mesh-ancestor
57104348|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104349|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104350|NCT03365115|Analgesics|analgesics|mesh-ancestor
57104351|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
57104352|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104353|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57104354|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57104355|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
57104356|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
57104357|NCT02237755|Citric Acid|citric acid|mesh-list
57104358|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
57104359|NCT02237755|Clomiphene|clomiphene|mesh-list
57104360|NCT02237755|Enclomiphene|enclomiphene|mesh-list
57104361|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
57104362|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
57104363|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57104364|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
57104365|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
57104366|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104367|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57104368|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
57104369|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104370|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104371|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57104372|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
57104373|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57104374|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57104375|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57104376|NCT04524897|Triamcinolone|triamcinolone|mesh-list
57104377|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57104378|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57104379|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57104380|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57104381|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
57104382|NCT04524897|Hormones|hormones|mesh-ancestor
57104383|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104384|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104385|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104386|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
57104387|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104388|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104389|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
57104390|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57104391|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57104392|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104393|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
57104394|NCT03364569|Coagulants|coagulants|mesh-ancestor
57104395|NCT03363477|Enoxaparin|enoxaparin|mesh-list
57104396|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
57104397|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
57104398|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57104399|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57104400|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104401|NCT02879318|Gemcitabine|gemcitabine|mesh-list
57104402|NCT02879318|Paclitaxel|paclitaxel|mesh-list
57104403|NCT02879318|Durvalumab|durvalumab|mesh-list
57104404|NCT02879318|Tremelimumab|tremelimumab|mesh-list
57104405|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57104406|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104407|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
57104408|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
57104409|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
57104410|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104411|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57104412|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
57104413|NCT02879318|Antiviral Agents|antiviral agents|mesh-ancestor
57104414|NCT02879318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104415|NCT02879318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104416|NCT02879318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104417|NCT02879318|Immunologic Factors|immunologic factors|mesh-ancestor
57104418|NCT02879318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104419|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57104420|NCT03593707|Metformin|metformin|mesh-list
57104421|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57104422|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104423|NCT03592537|Fentanyl|fentanyl|mesh-list
57104424|NCT03592537|Midazolam|midazolam|mesh-list
57104425|NCT03592537|Bupivacaine|bupivacaine|mesh-list
57104426|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
57104427|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
57104428|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104429|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104430|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
57104431|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104432|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57104433|NCT03592537|Narcotics|narcotics|mesh-ancestor
57104434|NCT03592537|Analgesics|analgesics|mesh-ancestor
57104435|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57104436|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57104437|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
57104438|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57104439|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57104440|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57104441|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57104442|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
57104443|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
57104444|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104445|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104446|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
57104447|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57104448|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104449|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57104450|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57104451|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104452|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104453|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104454|NCT02849743|Oxytocin|oxytocin|mesh-list
57104455|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
57104456|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57104457|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104458|NCT05063006|Methamphetamine|methamphetamine|mesh-list
57104459|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57104460|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104461|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
57104462|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
57104463|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104464|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
57104465|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104466|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104467|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
57104468|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57104469|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57104470|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57104471|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57104472|NCT03587077|Isosorbide|isosorbide|mesh-list
57104473|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57104474|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57104475|NCT03587077|Misoprostol|misoprostol|mesh-list
57104476|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57104477|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
57104478|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57104479|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104480|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57104481|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57104482|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
57104483|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57104484|NCT03587077|Diuretics|diuretics|mesh-ancestor
57104485|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
57104486|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
57104487|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57104488|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104489|NCT02238457|Losartan|losartan|mesh-list
57104490|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57104491|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57104492|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57104493|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57104494|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104495|NCT02238535|Iloprost|iloprost|mesh-list
57104496|NCT02238535|Warfarin|warfarin|mesh-list
57104497|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
57104498|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57104499|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
57104500|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57104501|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104502|NCT03909074|Vaccines|vaccines|mesh-list
57104503|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
57104504|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104505|NCT03138668|Ropivacaine|ropivacaine|mesh-list
57104506|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
57104507|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
57104508|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104509|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104510|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
57104511|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104512|NCT03371043|Analgesics|analgesics|mesh-list
57104513|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
57104514|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104515|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104516|NCT03600961|Sirolimus|sirolimus|mesh-list
56786385|NCT02549261|Etoposide|etoposide|mesh-list
57104517|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57104518|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104519|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57104520|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104521|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
57104522|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104523|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
57104524|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104525|NCT05013242|Goserelin|goserelin|mesh-list
57104526|NCT05013242|Dienogest|dienogest|mesh-list
57104527|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57104528|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104529|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57104530|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
57104531|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57104532|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104533|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57104534|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57104535|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57104536|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57104537|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
57104538|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104539|NCT05089604|Tacrolimus|tacrolimus|mesh-list
57104540|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104541|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
57104542|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104543|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57104544|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104545|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104546|NCT03590275|Folfirinox|folfirinox|mesh-list
57104547|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104548|NCT05089448|Amlodipine|amlodipine|mesh-list
57104549|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57104550|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57104551|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57104552|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104553|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57104554|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104555|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
57104556|NCT00601003|Nifurtimox|nifurtimox|mesh-list
57104557|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
57104558|NCT00601003|Topotecan|topotecan|mesh-list
57104559|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104560|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
57104561|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104562|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57104563|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57104564|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
57104565|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104566|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104567|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57104568|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57104569|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57104570|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104571|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57104572|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57104573|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57104574|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104575|NCT02849509|Vitamin K|vitamin k|mesh-list
57104576|NCT02849509|Dabigatran|dabigatran|mesh-list
57104577|NCT02849509|Vitamins|vitamins|mesh-ancestor
57104578|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
57104579|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104580|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
57104581|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57104582|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
57104583|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104584|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104585|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
57104586|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57104587|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57104588|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
57104589|NCT02849509|Coagulants|coagulants|mesh-ancestor
57104590|NCT00151424|Olanzapine|olanzapine|mesh-list
57104591|NCT00151424|Asenapine|asenapine|mesh-list
57104592|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
57104593|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
57104594|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104595|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104596|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57104597|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57104598|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57104599|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104600|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57104601|NCT00151424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57104602|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57104603|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57104604|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104605|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104606|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
57104607|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
57104609|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57104610|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104611|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104612|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57104613|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
57104614|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
57104615|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57104616|NCT03600727|Analgesics|analgesics|mesh-ancestor
57104617|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
57104618|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104619|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57104620|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57104621|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57104622|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
57104623|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104624|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104625|NCT02733133|Testosterone|testosterone|mesh-list
57104626|NCT02733133|Androgens|androgens|mesh-ancestor
57104627|NCT02733133|Hormones|hormones|mesh-ancestor
57104628|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104629|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104630|NCT03464942|Atezolizumab|atezolizumab|mesh-list
57104631|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104632|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
57104633|NCT03584893|Provitamins|provitamins|mesh-ancestor
57104634|NCT03584893|Vitamins|vitamins|mesh-ancestor
57104635|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
57104636|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104637|NCT03362073|Ketamine|ketamine|mesh-list
57104638|NCT03362073|Analgesics|analgesics|mesh-ancestor
57104639|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
57104640|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104641|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104642|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57104643|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57104644|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
57104645|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
57104646|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104647|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57104648|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57104649|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104650|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104651|NCT03582865|Tamoxifen|tamoxifen|mesh-list
57104652|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57104653|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
57104654|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104655|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104656|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57104657|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104658|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57104659|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57104660|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57104661|NCT03136406|Leucovorin|leucovorin|mesh-list
57104662|NCT03136406|Paclitaxel|paclitaxel|mesh-list
57104663|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
57104664|NCT03136406|Bevacizumab|bevacizumab|mesh-list
57104665|NCT03136406|Fluorouracil|fluorouracil|mesh-list
57104666|NCT03136406|Capecitabine|capecitabine|mesh-list
57104667|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
57104668|NCT03136406|Avelumab|avelumab|mesh-list
57104669|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57104670|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104671|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
57104672|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
57104673|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
57104674|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104675|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104676|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
57104677|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104678|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57104679|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57104680|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
57104681|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57104682|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57104683|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57104684|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57104685|NCT03136406|Growth Substances|growth substances|mesh-ancestor
57104686|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
57104687|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
57104688|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57104689|NCT03136406|Antidotes|antidotes|mesh-ancestor
57104690|NCT03136406|Protective Agents|protective agents|mesh-ancestor
57104691|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
57104692|NCT03136406|Vitamins|vitamins|mesh-ancestor
57104693|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
57104694|NCT03590197|Melatonin|melatonin|mesh-list
57104695|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
57104696|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104697|NCT03590197|Protective Agents|protective agents|mesh-ancestor
57104698|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104699|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104700|NCT05057468|Cyclosporine|cyclosporine|mesh-list
57104701|NCT05057468|Rituximab|rituximab|mesh-list
57104702|NCT05057468|Cyclosporins|cyclosporins|mesh-list
57104703|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57104704|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104705|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
57104706|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104707|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57104708|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104709|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104710|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104711|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
57104712|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104713|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
57104714|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57104715|NCT02518503|Atorvastatin|atorvastatin|mesh-list
57104716|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57104717|NCT02518503|Simvastatin|simvastatin|mesh-list
57104718|NCT02518503|Pravastatin|pravastatin|mesh-list
57104719|NCT02518503|Lovastatin|lovastatin|mesh-list
57104720|NCT02518503|L 647318|l 647318|mesh-list
57104721|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
57104722|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57104723|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57104724|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
57104725|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104726|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57104727|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57104728|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104729|NCT03600493|Lidocaine|lidocaine|mesh-list
57104730|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
57104731|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
57104732|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
57104733|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104734|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104735|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
57104736|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104737|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57104738|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57104739|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57104740|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57104741|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104742|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57104743|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57104744|NCT03600493|Analgesics|analgesics|mesh-ancestor
57104745|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57104746|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57104747|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57104748|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
57104749|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104750|NCT03138356|Metformin|metformin|mesh-list
57104751|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
57104752|NCT03138356|Saxagliptin|saxagliptin|mesh-list
57104753|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57104754|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104755|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57104756|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104757|NCT03138356|Incretins|incretins|mesh-ancestor
57104758|NCT03138356|Hormones|hormones|mesh-ancestor
57104759|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104760|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57104761|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
57104762|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104763|NCT03137966|Deferoxamine|deferoxamine|mesh-list
57104764|NCT03137966|Siderophores|siderophores|mesh-ancestor
57104765|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57104766|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
57104767|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
57104768|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104769|NCT02853305|Gemcitabine|gemcitabine|mesh-list
57104770|NCT02853305|Carboplatin|carboplatin|mesh-list
57104771|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
57104772|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104773|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57104774|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
57104775|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104776|NCT02853305|Antiviral Agents|antiviral agents|mesh-ancestor
57104777|NCT02853305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104778|NCT02853305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104779|NCT02853305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104780|NCT02853305|Immunologic Factors|immunologic factors|mesh-ancestor
57104781|NCT02853305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104782|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57104783|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
57104784|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57104785|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
57104786|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104787|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
57104788|NCT04521387|Protective Agents|protective agents|mesh-ancestor
57104789|NCT03579979|Methylene Blue|methylene blue|mesh-list
57104790|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104791|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104792|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
57104793|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57104794|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57104795|NCT04509219|Prednisolone|prednisolone|mesh-list
57104796|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
57104797|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57104798|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
57104799|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57104800|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
57104801|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
57104802|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104803|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104804|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57104805|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
57104806|NCT04509219|Hormones|hormones|mesh-ancestor
57104807|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57104808|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57104809|NCT04509219|Protective Agents|protective agents|mesh-ancestor
57104810|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57104811|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104812|NCT04444635|Fentanyl|fentanyl|mesh-list
57104813|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57104814|NCT04444635|Narcotics|narcotics|mesh-ancestor
57104815|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104816|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104817|NCT04444635|Analgesics|analgesics|mesh-ancestor
57104818|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
57104819|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104820|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57104821|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57104822|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
57104823|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
57104824|NCT03033446|Nivolumab|nivolumab|mesh-list
57104825|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57104826|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104827|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57104828|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104829|NCT03579823|Adalimumab|adalimumab|mesh-list
57104830|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57104831|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57104832|NCT04444011|Amoxicillin|amoxicillin|mesh-list
57104833|NCT04444011|Clarithromycin|clarithromycin|mesh-list
57104834|NCT04444011|Bismuth|bismuth|mesh-list
57104835|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57104836|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104837|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57104838|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104839|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104840|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57104841|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57104842|NCT04444011|Antacids|antacids|mesh-ancestor
57104843|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57104844|NCT04443387|Vitamin D|vitamin d|mesh-list
57104845|NCT04443387|Vitamins|vitamins|mesh-ancestor
57104846|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
57104847|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104848|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57104849|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
57104850|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57104851|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104852|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104853|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57104854|NCT02316236|Analgesics|analgesics|mesh-ancestor
57104855|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
57104856|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104857|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57104858|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57104859|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57104860|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
57104861|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104862|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104863|NCT04521075|Nivolumab|nivolumab|mesh-list
57104864|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57104865|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104866|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57104867|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104868|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
57104869|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57104870|NCT03601091|Midazolam|midazolam|mesh-list
57104871|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
57104872|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57104873|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104874|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104875|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57104876|NCT03601091|Analgesics|analgesics|mesh-ancestor
57104877|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
57104878|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104879|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57104880|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57104881|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57104882|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
57104883|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104884|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104885|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57104886|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57104887|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57104888|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57104889|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57104890|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
57104891|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
57104892|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
57104893|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
57104894|NCT04508829|Antibodies|antibodies|mesh-list
57104895|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57104896|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
57104897|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104898|NCT04521309|Antibodies|antibodies|mesh-list
57104899|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
57104900|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104901|NCT02267252|Antibodies|antibodies|mesh-list
57104902|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
57104903|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104904|NCT04521153|Apatinib|apatinib|mesh-list
57104905|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104906|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57104907|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104908|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104909|NCT04362566|Bupivacaine|bupivacaine|mesh-list
57104910|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
57104911|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
57104912|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104913|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104914|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
57104915|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104916|NCT03579589|Neostigmine|neostigmine|mesh-list
57104917|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57104918|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104919|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104920|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
57104921|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57104922|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104923|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57104924|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
57104925|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104926|NCT03600857|Misoprostol|misoprostol|mesh-list
57104927|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57104928|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
57104929|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57104930|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104931|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57104932|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57104933|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
57104934|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
57104935|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57104936|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57104937|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104938|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
57104939|NCT02229968|Coagulants|coagulants|mesh-ancestor
57104940|NCT03600623|Gemcitabine|gemcitabine|mesh-list
57104941|NCT03600623|Paclitaxel|paclitaxel|mesh-list
57104942|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57104943|NCT03600623|Fluorouracil|fluorouracil|mesh-list
57104944|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
57104945|NCT03600623|Irinotecan|irinotecan|mesh-list
57104946|NCT03600623|Folfirinox|folfirinox|mesh-list
57104947|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57104948|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104949|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
57104950|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
57104951|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
57104952|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104953|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57104954|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
57104955|NCT03600623|Antiviral Agents|antiviral agents|mesh-ancestor
57104956|NCT03600623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57104957|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104958|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57104959|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
57104960|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104961|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57104962|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57104963|NCT02848729|Acetaminophen|acetaminophen|mesh-list
57104964|NCT02848729|Morphine|morphine|mesh-list
57104965|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57104966|NCT02848729|Narcotics|narcotics|mesh-ancestor
57104967|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104968|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104969|NCT02848729|Analgesics|analgesics|mesh-ancestor
57104970|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
57104971|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104972|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57104973|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
56786842|NCT00833807|Paclitaxel|paclitaxel|mesh-list
57104974|NCT03600467|Seviteronel|seviteronel|mesh-list
57104975|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104976|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57104977|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57104978|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57104979|NCT05737784|Pramoxine|pramoxine|mesh-list
57104980|NCT05737784|Anesthetics, Local|anesthetics, local|mesh-ancestor
57104981|NCT05737784|Anesthetics|anesthetics|mesh-ancestor
57104982|NCT05737784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104983|NCT05737784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104984|NCT05737784|Sensory System Agents|sensory system agents|mesh-ancestor
57104985|NCT05737784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57104986|NCT04520919|Anesthetics|anesthetics|mesh-list
57104987|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57104988|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104989|NCT05737628|Rituximab|rituximab|mesh-list
57104990|NCT05737628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57104991|NCT05737628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57104992|NCT05737628|Immunologic Factors|immunologic factors|mesh-ancestor
57104993|NCT05737628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57104994|NCT05737628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57104995|NCT03600311|Vitamin D|vitamin d|mesh-list
57104996|NCT03600311|Calcium|calcium|mesh-list
57104997|NCT03600311|Vitamins|vitamins|mesh-ancestor
57104998|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
57104999|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105000|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57105001|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57105002|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
57105003|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57105004|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
57105005|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
57105006|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
57105007|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
57105008|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57105009|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57105010|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105011|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105012|NCT03603119|Dexamethasone|dexamethasone|mesh-list
57105013|NCT03603119|Midazolam|midazolam|mesh-list
57105014|NCT03603119|Ondansetron|ondansetron|mesh-list
57105015|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105016|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
57105017|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
57105018|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105019|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105020|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105021|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
57105022|NCT03603119|Hormones|hormones|mesh-ancestor
57105023|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105024|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57105025|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105026|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57105027|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57105028|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105029|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57105030|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57105031|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57105032|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57105033|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
57105034|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
57105035|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
57105036|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
57105037|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105038|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105039|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
57105040|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
57105041|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57105042|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
57105043|NCT03603119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57105044|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
57105045|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57105046|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105047|NCT03356769|Aspirin|aspirin|mesh-list
56786914|NCT01055938|Valproic Acid|valproic acid|mesh-list
57105048|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
57105049|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57105050|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57105051|NCT03356769|Analgesics|analgesics|mesh-ancestor
57105052|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
57105053|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105054|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105055|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105056|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57105057|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57105058|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57105059|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105060|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57105061|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57105062|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105063|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
57105064|NCT04508439|Heparin|heparin|mesh-list
57105065|NCT04508439|Enoxaparin|enoxaparin|mesh-list
57105066|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57105067|NCT04508439|Tinzaparin|tinzaparin|mesh-list
57105068|NCT04508439|Dalteparin|dalteparin|mesh-list
57105069|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
57105070|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57105071|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57105072|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105073|NCT02237651|Anesthetics|anesthetics|mesh-list
57105074|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105075|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105076|NCT02237729|Adalimumab|adalimumab|mesh-list
57105077|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105078|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57105079|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
57105080|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
57105081|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57105082|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
57105083|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105084|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105085|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57105086|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
57105087|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57105088|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57105089|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57105090|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
57105091|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105092|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105093|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
57105094|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57105095|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
57105096|NCT03354117|Meloxicam|meloxicam|mesh-list
57105097|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
57105098|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57105099|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57105100|NCT03354117|Analgesics|analgesics|mesh-ancestor
57105101|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
57105102|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105103|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105104|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105105|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57105106|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57105107|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57105108|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105109|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105110|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57105111|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
57105112|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57105113|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57105114|NCT03360981|Incretins|incretins|mesh-list
57105115|NCT03360981|Hormones|hormones|mesh-ancestor
57105116|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105117|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105118|NCT03597815|Aflibercept|aflibercept|mesh-list
57105119|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57105120|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57105121|NCT03597815|Growth Substances|growth substances|mesh-ancestor
57105122|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105123|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
56786974|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
57105124|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105125|NCT03595085|Streptokinase|streptokinase|mesh-list
57105126|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57105127|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57105128|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105129|NCT00158756|Vaccines|vaccines|mesh-list
57105130|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
57105131|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105132|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57105133|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
57105134|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57105135|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
57105136|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57105137|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105138|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57105139|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57105140|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105141|NCT03885713|Adalimumab|adalimumab|mesh-list
57105142|NCT03885713|Golimumab|golimumab|mesh-list
57105143|NCT03885713|Infliximab|infliximab|mesh-list
57105144|NCT03885713|Ustekinumab|ustekinumab|mesh-list
57105145|NCT03885713|Vedolizumab|vedolizumab|mesh-list
57105146|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105147|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57105148|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
57105149|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105150|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57105151|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57105152|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
57105153|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105154|NCT04519125|Tenofovir|tenofovir|mesh-list
57105155|NCT04519125|Emtricitabine|emtricitabine|mesh-list
57105156|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
57105157|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105158|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57105159|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57105160|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105161|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105162|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57105163|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57105164|NCT02730195|Pioglitazone|pioglitazone|mesh-list
57105165|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57105166|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105167|NCT03360279|Paclitaxel|paclitaxel|mesh-list
57105168|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57105169|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105170|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
57105171|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
57105172|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
57105173|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105174|NCT03353103|Listerine|listerine|mesh-list
57105175|NCT03353103|Fluorides|fluorides|mesh-list
57105176|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
57105177|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
57105178|NCT03353103|Protective Agents|protective agents|mesh-ancestor
57105179|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105180|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57105181|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105182|NCT03360123|Midazolam|midazolam|mesh-list
57105183|NCT03360123|Triazolam|triazolam|mesh-list
57105184|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57105185|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57105186|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105187|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105188|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57105189|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57105190|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57105191|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57105192|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
57105193|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
57105194|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
57105195|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
57105196|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105197|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105198|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
56787049|NCT00528996|Bromides|bromides|mesh-list
57105199|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
57105200|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57105201|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57105202|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105203|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
57105204|NCT03360045|Coagulants|coagulants|mesh-ancestor
57105205|NCT03353025|Dopamine|dopamine|mesh-list
57105206|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
57105207|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57105208|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
57105209|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
57105210|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105211|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105212|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
57105213|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105214|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105215|NCT03353025|Protective Agents|protective agents|mesh-ancestor
57105216|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57105217|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57105218|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105219|NCT04506957|Chrysarobin|chrysarobin|mesh-list
57105220|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57105221|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57105222|NCT04506957|Analgesics|analgesics|mesh-ancestor
57105223|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
57105224|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105225|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105226|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105227|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57105228|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57105229|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57105230|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105231|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
57105232|NCT03352947|Trametinib|trametinib|mesh-list
57105233|NCT03352947|Dabrafenib|dabrafenib|mesh-list
57105234|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105235|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57105236|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105237|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105238|NCT02730351|Fluticasone|fluticasone|mesh-list
57105239|NCT02730351|Xhance|xhance|mesh-list
57105240|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105241|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57105242|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
57105243|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105244|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105245|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57105246|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
57105247|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
57105248|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57105249|NCT03359655|Scopolamine|scopolamine|mesh-list
57105250|NCT03359655|Bromides|bromides|mesh-list
57105251|NCT03359655|Misoprostol|misoprostol|mesh-list
57105252|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57105253|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57105254|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
57105255|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57105256|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105257|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57105258|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105259|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
57105260|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
57105261|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57105262|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
57105263|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
57105264|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105265|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
57105266|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57105267|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
57105268|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105269|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105270|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57105271|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
57105272|NCT03352869|Metformin|metformin|mesh-list
57105273|NCT03352869|Exenatide|exenatide|mesh-list
57105274|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57105275|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105276|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57105277|NCT03352869|Incretins|incretins|mesh-ancestor
57105279|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105280|NCT03359499|Trimebutine|trimebutine|mesh-list
57105281|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105282|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
57105283|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
57105284|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105285|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105286|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
57105287|NCT03352479|Narcotics|narcotics|mesh-ancestor
57105288|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105289|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105290|NCT03352479|Analgesics|analgesics|mesh-ancestor
57105291|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
57105292|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105293|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
57105294|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57105295|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105296|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105297|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57105298|NCT03355053|Analgesics|analgesics|mesh-ancestor
57105299|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
57105300|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105301|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57105302|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57105303|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57105304|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
57105305|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105306|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105307|NCT03354897|Torsemide|torsemide|mesh-list
57105308|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57105309|NCT03354897|Diuretics|diuretics|mesh-ancestor
57105310|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
57105311|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105312|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57105313|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57105314|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105315|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
57105316|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57105317|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105318|NCT03358953|Nicotine|nicotine|mesh-list
57105319|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57105320|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
57105321|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105322|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105323|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57105324|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57105325|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
57105326|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105327|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105328|NCT04509999|Bicalutamide|bicalutamide|mesh-list
57105329|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
57105330|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
57105331|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105332|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105333|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105334|NCT04505943|Isoniazid|isoniazid|mesh-list
57105335|NCT04505943|Misoprostol|misoprostol|mesh-list
57105336|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57105337|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
57105338|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57105339|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105340|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57105341|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105342|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
57105343|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
57105344|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57105345|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105346|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57105347|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57105348|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
57105349|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787196|NCT01008384|Vitamins|vitamins|mesh-ancestor
57105350|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57105351|NCT03358719|Poly I-C|poly i-c|mesh-list
57105352|NCT03358719|Nivolumab|nivolumab|mesh-list
57105353|NCT03358719|Decitabine|decitabine|mesh-list
57105354|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57105355|NCT03358719|Poly ICLC|poly iclc|mesh-list
57105356|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57105357|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105358|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57105359|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105360|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57105361|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
57105362|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105363|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
57105364|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
57105365|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105366|NCT03358719|Laxatives|laxatives|mesh-ancestor
57105367|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105368|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
57105369|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105370|NCT04505475|Hemostatics|hemostatics|mesh-list
57105371|NCT04505475|Coagulants|coagulants|mesh-ancestor
57105372|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
57105373|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57105374|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
57105375|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105376|NCT03350373|Dotinurad|dotinurad|mesh-list
57105377|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
57105378|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
57105379|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57105380|NCT03350373|Renal Agents|renal agents|mesh-ancestor
57105381|NCT03350295|Nifurtimox|nifurtimox|mesh-list
57105382|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57105383|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57105384|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57105385|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105386|NCT03349827|Apatinib|apatinib|mesh-list
57105387|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105388|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57105389|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105390|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105391|NCT04503915|Estrogens|estrogens|mesh-list
57105392|NCT04503915|Hormones|hormones|mesh-ancestor
57105393|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105394|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105395|NCT04504851|Rifampin|rifampin|mesh-list
57105396|NCT04504851|Isoniazid|isoniazid|mesh-list
57105397|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
57105398|NCT04504851|Ethambutol|ethambutol|mesh-list
57105399|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57105400|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57105401|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57105402|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
57105403|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105404|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57105405|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57105406|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105407|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57105408|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
57105409|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57105410|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105411|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
57105412|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57105413|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57105414|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57105415|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57105416|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57105417|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57105418|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57105419|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57105420|NCT05509257|Naltrexone|naltrexone|mesh-list
57105421|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57105422|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57105423|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105424|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
57105425|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105426|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
57105427|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
57105428|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105429|NCT03072147|Teriparatide|teriparatide|mesh-list
57105430|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57105431|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105432|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57105433|NCT03030261|Dexamethasone|dexamethasone|mesh-list
57105434|NCT03030261|Pomalidomide|pomalidomide|mesh-list
57105435|NCT03030261|Elotuzumab|elotuzumab|mesh-list
57105436|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105437|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
57105438|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
57105439|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105440|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105441|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105442|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
57105443|NCT03030261|Hormones|hormones|mesh-ancestor
57105444|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105445|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57105446|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105447|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
57105448|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57105449|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57105450|NCT03030261|Growth Substances|growth substances|mesh-ancestor
57105451|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
57105452|NCT02176161|Metformin|metformin|mesh-list
57105453|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57105454|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105455|NCT03348735|Lidocaine|lidocaine|mesh-list
57105456|NCT03348735|Pregabalin|pregabalin|mesh-list
57105457|NCT03348735|Capsaicin|capsaicin|mesh-list
57105458|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
57105459|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
57105460|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105461|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105462|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
57105463|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105464|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57105465|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57105466|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57105467|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57105468|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105469|NCT03348735|Analgesics|analgesics|mesh-ancestor
57105470|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
57105471|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57105472|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57105473|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57105474|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57105475|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57105476|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
57105477|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
57105478|NCT01700673|Azacitidine|azacitidine|mesh-list
57105479|NCT01700673|Sargramostim|sargramostim|mesh-list
57105480|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57105481|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
57105482|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105483|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105484|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105485|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
57105486|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105487|NCT05647551|Lidocaine|lidocaine|mesh-list
57105488|NCT05647551|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57105489|NCT05647551|Anesthetics, Local|anesthetics, local|mesh-ancestor
57105490|NCT05647551|Anesthetics|anesthetics|mesh-ancestor
57105491|NCT05647551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105492|NCT05647551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105493|NCT05647551|Sensory System Agents|sensory system agents|mesh-ancestor
57105494|NCT05647551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105495|NCT05647551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57105496|NCT05647551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57105497|NCT05647551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57105498|NCT05647551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57105499|NCT05647551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105500|NCT05647551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57105501|NCT05647551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57105502|NCT05647551|Cholinergic Agents|cholinergic agents|mesh-ancestor
57105503|NCT05647551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105504|NCT03348423|Fentanyl|fentanyl|mesh-list
57105505|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57105506|NCT03348423|Narcotics|narcotics|mesh-ancestor
57105507|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105508|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105509|NCT03348423|Analgesics|analgesics|mesh-ancestor
57105510|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
57105511|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105512|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57105513|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57105514|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
57105515|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
57105516|NCT03898154|Dexamethasone|dexamethasone|mesh-list
57105517|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
57105518|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57105519|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57105520|NCT03898154|Prednisolone|prednisolone|mesh-list
57105521|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
57105522|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57105523|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
57105524|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105525|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
57105526|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
57105527|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899892|NCT03298412|Blinatumomab|blinatumomab|mesh-list
57105528|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105529|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105530|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
57105531|NCT03898154|Hormones|hormones|mesh-ancestor
57105532|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105533|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57105534|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105535|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57105536|NCT03898154|Protective Agents|protective agents|mesh-ancestor
57105537|NCT02517957|Loperamide|loperamide|mesh-list
57105538|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
57105539|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105540|NCT03348267|Caseins|caseins|mesh-list
57105541|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
57105542|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
57105543|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105544|NCT03136796|Meropenem|meropenem|mesh-list
57105545|NCT03136796|Piperacillin|piperacillin|mesh-list
57105546|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57105547|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105548|NCT05243745|Fluorides|fluorides|mesh-list
57105549|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
57105550|NCT05243745|Protective Agents|protective agents|mesh-ancestor
57105551|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105552|NCT04500717|Carboplatin|carboplatin|mesh-list
57105553|NCT04500717|Pemetrexed|pemetrexed|mesh-list
57105554|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105555|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105556|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105557|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57105558|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57105559|NCT01680458|Fluconazole|fluconazole|mesh-list
57105560|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
57105561|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105562|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57105563|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57105564|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105565|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105566|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57105567|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
57105568|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105569|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105570|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57105571|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57105572|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57105573|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57105574|NCT03346317|Estradiol|estradiol|mesh-list
57105575|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57105576|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
57105577|NCT03346317|Estrogens|estrogens|mesh-ancestor
57105578|NCT03346317|Hormones|hormones|mesh-ancestor
57105579|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105580|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105581|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57105582|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
57105583|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57105584|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57105585|NCT03346317|Progestins|progestins|mesh-ancestor
57105586|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
57105587|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57105588|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
57105589|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105590|NCT01550432|Expectorants|expectorants|mesh-ancestor
57105591|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
57105592|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57105593|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
57105594|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105595|NCT01550432|Protective Agents|protective agents|mesh-ancestor
57105596|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105597|NCT01550432|Antidotes|antidotes|mesh-ancestor
57105598|NCT04502277|Fluconazole|fluconazole|mesh-list
57105599|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
57105600|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105601|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57105602|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57105603|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105604|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105605|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57105606|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
57105607|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105608|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105609|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57105610|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57105611|NCT05730608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57105612|NCT05730608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57105613|NCT05730608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105614|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
57105615|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105616|NCT05585151|Evolocumab|evolocumab|mesh-list
57105617|NCT05585151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57105618|NCT05585151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57105619|NCT05585151|Antimetabolites|antimetabolites|mesh-ancestor
57105620|NCT05585151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105621|NCT05585151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57105622|NCT04850144|Bromides|bromides|mesh-list
57105623|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
57105624|NCT04850144|Charcoal|charcoal|mesh-list
57105625|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57105626|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
57105627|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105628|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105629|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57105630|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
57105631|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
57105632|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57105633|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
57105634|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105635|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105636|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
57105637|NCT04850144|Antidotes|antidotes|mesh-ancestor
57105638|NCT04850144|Protective Agents|protective agents|mesh-ancestor
57105639|NCT04590794|Plasminogen|plasminogen|mesh-list
57105640|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57105641|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57105642|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105643|NCT00709761|Paclitaxel|paclitaxel|mesh-list
57105644|NCT00709761|Lapatinib|lapatinib|mesh-list
57105645|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57105646|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105647|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
57105648|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
57105649|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
57105650|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105651|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57105652|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105653|NCT03346083|Betrixaban|betrixaban|mesh-list
57105654|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57105655|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
57105656|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57105657|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
57105658|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105659|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105660|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
57105661|NCT00547196|Cyclosporine|cyclosporine|mesh-list
57105662|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
57105663|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
57105664|NCT00547196|Melphalan|melphalan|mesh-list
57105665|NCT00547196|Busulfan|busulfan|mesh-list
57105666|NCT00547196|Fludarabine|fludarabine|mesh-list
57105667|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
57105668|NCT00547196|Cyclosporins|cyclosporins|mesh-list
57105669|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57105670|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
57105671|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105672|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57105673|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57105674|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
57105675|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105676|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105677|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57105678|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57105679|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
57105680|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105681|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
57105682|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105683|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
57105684|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57105685|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57105686|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57105687|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
57105688|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57105689|NCT05584683|Amoxicillin|amoxicillin|mesh-list
57105690|NCT05584683|Clavulanic Acid|clavulanic acid|mesh-list
57105691|NCT05584683|Clavulanic Acids|clavulanic acids|mesh-list
57105692|NCT05584683|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57105693|NCT05584683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57105694|NCT05584683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105695|NCT05584683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57105696|NCT05584683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105697|NCT05584683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105698|NCT02358031|Carboplatin|carboplatin|mesh-list
57105699|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
57105700|NCT02358031|Cetuximab|cetuximab|mesh-list
57105701|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105702|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57105703|NCT02516631|Misoprostol|misoprostol|mesh-list
57105704|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57105705|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
57105706|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57105707|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105708|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57105709|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105710|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
57105711|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
57105712|NCT02516475|Astringents|astringents|mesh-ancestor
57105713|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105714|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
57105715|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57105716|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57105717|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57105718|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105719|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105720|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57105721|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57105722|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105723|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
57105724|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105725|NCT03423680|Aripiprazole|aripiprazole|mesh-list
57105726|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
57105727|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57105728|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57105729|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57105730|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105731|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105732|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
57105733|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
57105734|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105735|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105736|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57105737|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57105738|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
57105739|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57105740|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57105741|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57105742|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57105744|NCT00588991|Topotecan|topotecan|mesh-list
57105745|NCT00588991|Veliparib|veliparib|mesh-list
57105746|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105747|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57105748|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57105749|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105750|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105751|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57105752|NCT04443543|Fluorouracil|fluorouracil|mesh-list
57105753|NCT04443543|Capecitabine|capecitabine|mesh-list
57105754|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
57105755|NCT04443543|Irinotecan|irinotecan|mesh-list
57105756|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
57105757|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105758|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57105759|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105760|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57105761|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
57105762|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105763|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57105764|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57105765|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105766|NCT02516085|Metformin|metformin|mesh-list
57105767|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57105768|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105769|NCT00061568|Sirolimus|sirolimus|mesh-list
57105770|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
57105771|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57105772|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105773|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57105774|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105775|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
57105776|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57105777|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
57105778|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105779|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57105780|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
57105781|NCT02515929|Procyanidin|procyanidin|mesh-list
57105782|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
57105783|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105784|NCT02515929|Protective Agents|protective agents|mesh-ancestor
57105785|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105786|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57105787|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57105788|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105789|NCT03347721|Lidocaine|lidocaine|mesh-list
57105790|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
57105791|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
57105792|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105793|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105794|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
57105795|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105796|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57105797|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57105798|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57105799|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57105800|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105801|NCT02848651|Atezolizumab|atezolizumab|mesh-list
57105802|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105803|NCT00709059|Ribavirin|ribavirin|mesh-list
56787698|NCT00527826|Xhance|xhance|mesh-list
57105804|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57105805|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
57105806|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
57105807|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105808|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
57105809|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105810|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
57105811|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105812|NCT05584137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57105813|NCT05584137|Antibodies|antibodies|mesh-list
57105814|NCT05584137|Immunoglobulins|immunoglobulins|mesh-list
57105815|NCT05584137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57105816|NCT05584137|Immunologic Factors|immunologic factors|mesh-ancestor
57105817|NCT05584137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105818|NCT05584137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105819|NCT04500561|Gemcitabine|gemcitabine|mesh-list
57105820|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
57105821|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57105822|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
57105823|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105824|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105825|NCT04500561|Antiviral Agents|antiviral agents|mesh-ancestor
57105826|NCT04500561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105827|NCT04500561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105828|NCT04500561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57105829|NCT04500561|Immunologic Factors|immunologic factors|mesh-ancestor
57105830|NCT04500561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105831|NCT04968015|Cytarabine|cytarabine|mesh-list
57105832|NCT04968015|Venetoclax|venetoclax|mesh-list
57105833|NCT04968015|Idarubicin|idarubicin|mesh-list
57105834|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57105835|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
57105836|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105837|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105838|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
57105839|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105840|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57105841|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
57105842|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105843|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57105844|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57105845|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57105846|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105847|NCT05094596|Montelukast|montelukast|mesh-list
57105848|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57105849|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
57105850|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57105851|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
57105852|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105853|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105854|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57105855|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57105856|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105857|NCT02133872|Minocycline|minocycline|mesh-list
57105858|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57105859|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105860|NCT01678820|Metformin|metformin|mesh-list
57105861|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57105862|NCT01678820|Glimepiride|glimepiride|mesh-list
57105863|NCT01678820|Simvastatin|simvastatin|mesh-list
57105864|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57105865|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105866|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57105867|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57105868|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
57105869|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105870|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57105871|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57105872|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105873|NCT01678820|Incretins|incretins|mesh-ancestor
57105874|NCT01678820|Hormones|hormones|mesh-ancestor
57105875|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105876|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57105877|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
56787724|NCT03998670|Methamphetamine|methamphetamine|mesh-list
57105878|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57105879|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57105880|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
57105881|NCT02515695|Interferons|interferons|mesh-list
57105882|NCT02515695|Interferon-beta|interferon-beta|mesh-list
57105883|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
57105884|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105885|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
57105886|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105887|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
57105888|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105889|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57105890|NCT04788615|Interferons|interferons|mesh-list
57105891|NCT04788615|Interferon-beta|interferon-beta|mesh-list
57105892|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
57105893|NCT04788615|Teriflunomide|teriflunomide|mesh-list
57105894|NCT04788615|Ofatumumab|ofatumumab|mesh-list
57105895|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
57105896|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57105897|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
57105898|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105899|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
57105900|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105901|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
57105902|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105903|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57105904|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
57105905|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57105906|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57105907|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57105908|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57105909|NCT04788615|Analgesics|analgesics|mesh-ancestor
57105910|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
57105911|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105912|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57105913|NCT03346629|Misoprostol|misoprostol|mesh-list
57105914|NCT03346629|Mifepristone|mifepristone|mesh-list
57105915|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57105916|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
57105917|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57105918|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105919|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57105920|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57105921|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
57105922|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57105923|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57105924|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57105925|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57105926|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
57105927|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57105928|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57105929|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
57105930|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57105931|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
57105932|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57105933|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57105934|NCT04501965|Azithromycin|azithromycin|mesh-list
57105935|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
57105936|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57105937|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105938|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
57105939|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57105940|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57105941|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105942|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105943|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57105944|NCT04437836|Rifampin|rifampin|mesh-list
57105945|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57105946|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
57105947|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57105948|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57105949|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
57105950|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57105951|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57105952|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787799|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57105953|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57105954|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57105955|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57105956|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57105957|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57105958|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57105960|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
57105961|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57105962|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105963|NCT04536194|Dopamine|dopamine|mesh-list
57105964|NCT04536194|Norepinephrine|norepinephrine|mesh-list
57105965|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57105966|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57105967|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
57105968|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57105969|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105970|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105971|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
57105972|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
57105973|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57105974|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57105975|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57105976|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
57105977|NCT04536194|Protective Agents|protective agents|mesh-ancestor
57105978|NCT03122769|Metformin|metformin|mesh-list
57105979|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57105980|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105981|NCT03121833|Endostar protein|endostar protein|mesh-list
57105982|NCT03121833|Endostatins|endostatins|mesh-list
57105983|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57105984|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57105985|NCT03121833|Growth Substances|growth substances|mesh-ancestor
57105986|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105987|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
57105988|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105989|NCT03121521|Melatonin|melatonin|mesh-list
57105990|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
57105991|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57105992|NCT03121521|Protective Agents|protective agents|mesh-ancestor
57105993|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57105994|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57105995|NCT03046862|Gemcitabine|gemcitabine|mesh-list
57105996|NCT03046862|Durvalumab|durvalumab|mesh-list
57105997|NCT03046862|Tremelimumab|tremelimumab|mesh-list
57105998|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57105999|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57106000|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
57106001|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106002|NCT03046862|Antiviral Agents|antiviral agents|mesh-ancestor
57106003|NCT03046862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106004|NCT03046862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106005|NCT03046862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106006|NCT03046862|Immunologic Factors|immunologic factors|mesh-ancestor
57106007|NCT03046862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106008|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106009|NCT05590923|Dexamethasone|dexamethasone|mesh-list
57106010|NCT05590923|Olanzapine|olanzapine|mesh-list
57106011|NCT05590923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106012|NCT05590923|Antiemetics|antiemetics|mesh-ancestor
57106013|NCT05590923|Autonomic Agents|autonomic agents|mesh-ancestor
57106014|NCT05590923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106015|NCT05590923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106016|NCT05590923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106017|NCT05590923|Glucocorticoids|glucocorticoids|mesh-ancestor
57106018|NCT05590923|Hormones|hormones|mesh-ancestor
57106019|NCT05590923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57106020|NCT05590923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57106021|NCT05590923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106022|NCT05590923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57106023|NCT05590923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57106024|NCT05590923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106025|NCT05590923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57106026|NCT05590923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57106027|NCT05590923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57106028|NCT05590923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57106029|NCT05590923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106030|NCT05590923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106031|NCT05590923|Serotonin Agents|serotonin agents|mesh-ancestor
57106033|NCT00770809|Trastuzumab|trastuzumab|mesh-list
57106034|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57106035|NCT00770809|Lapatinib|lapatinib|mesh-list
57106036|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
57106037|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57106038|NCT00770809|Antibodies|antibodies|mesh-list
57106039|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
57106040|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57106041|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57106042|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106043|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
57106044|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
57106045|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
57106046|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106047|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
57106048|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106049|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57106050|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106051|NCT02643056|Panitumumab|panitumumab|mesh-list
57106052|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106053|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106054|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
57106055|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57106056|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106057|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
57106058|NCT04263896|Laxatives|laxatives|mesh-ancestor
57106059|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106060|NCT04578639|Rituximab|rituximab|mesh-list
57106061|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
57106062|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106063|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106064|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
57106065|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106066|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57106067|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
57106068|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106069|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106070|NCT02238145|Ipratropium|ipratropium|mesh-list
57106071|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57106072|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
57106073|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106074|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106075|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57106076|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
57106077|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57106078|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
57106079|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106080|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106081|NCT04550637|Apixaban|apixaban|mesh-list
57106082|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57106083|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
57106084|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57106085|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
57106086|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106087|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106088|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
57106089|NCT03345303|Bortezomib|bortezomib|mesh-list
57106090|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106091|NCT03574909|Aspirin|aspirin|mesh-list
57106092|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57106093|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57106094|NCT03574909|Analgesics|analgesics|mesh-ancestor
57106095|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
57106096|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106097|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106098|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106099|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57106100|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57106101|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57106102|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106103|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57106104|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57106105|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106106|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
57106107|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
57106108|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106109|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106110|NCT03579043|Cocaine|cocaine|mesh-list
57106111|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
57106112|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
57106113|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106114|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106115|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
57106116|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106117|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57106118|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57106119|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57106120|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57106121|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106122|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
57106123|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106124|NCT02187991|Paclitaxel|paclitaxel|mesh-list
57106125|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57106126|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106127|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
57106128|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
57106129|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
57106130|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106131|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
57106132|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57106133|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57106134|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
57106135|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57106136|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57106137|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106138|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
57106139|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106140|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106141|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57106142|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106143|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
57106144|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
57106145|NCT03576469|Complement C1s|complement c1s|mesh-list
57106146|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
57106147|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
57106148|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
57106149|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106150|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57106151|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106152|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
57106153|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57106154|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106155|NCT05097950|Acetaminophen|acetaminophen|mesh-list
57106156|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57106157|NCT05097950|Analgesics|analgesics|mesh-ancestor
57106158|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
57106159|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106160|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106161|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
57106162|NCT05097248|Doxorubicin|doxorubicin|mesh-list
57106163|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57106164|NCT05097248|Losartan|losartan|mesh-list
57106165|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57106166|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106167|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57106168|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57106169|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106170|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106171|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57106172|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57106173|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57106174|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57106175|NCT01603394|Pregabalin|pregabalin|mesh-list
57106176|NCT01603394|Analgesics|analgesics|mesh-ancestor
57106177|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
57106178|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106179|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106180|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
57106181|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57106182|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57106183|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106184|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57106185|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57106186|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57106187|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106188|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57106189|NCT04682522|Metronidazole|metronidazole|mesh-list
57106190|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106191|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57106192|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57106193|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57106194|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
57106195|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57106196|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57106197|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57106198|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106199|NCT02729025|Evolocumab|evolocumab|mesh-list
57106200|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57106201|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57106202|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
57106203|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106204|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57106205|NCT05599971|Fluorouracil|fluorouracil|mesh-list
57106206|NCT05599971|Digoxin|digoxin|mesh-list
57106207|NCT05599971|Furosemide|furosemide|mesh-list
57106208|NCT05599971|Antimetabolites|antimetabolites|mesh-ancestor
57106209|NCT05599971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106210|NCT05599971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57106211|NCT05599971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106212|NCT05599971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106213|NCT05599971|Immunologic Factors|immunologic factors|mesh-ancestor
57106214|NCT05599971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106215|NCT05599971|Diuretics|diuretics|mesh-ancestor
57106216|NCT05599971|Natriuretic Agents|natriuretic agents|mesh-ancestor
57106217|NCT05599971|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57106218|NCT05599971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57106219|NCT05599971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57106220|NCT05599971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57106221|NCT05599971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106222|NCT05599971|Protective Agents|protective agents|mesh-ancestor
57106223|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
57106224|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57106225|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106226|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106227|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106228|NCT02511795|Olaparib|olaparib|mesh-list
57106229|NCT02511795|Adavosertib|adavosertib|mesh-list
57106230|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57106231|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106232|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106233|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106234|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
57106235|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
57106236|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106237|NCT04796636|Protective Agents|protective agents|mesh-ancestor
57106238|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106239|NCT04796636|Vitamins|vitamins|mesh-ancestor
57106240|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
57106241|NCT04501809|Misoprostol|misoprostol|mesh-list
57106242|NCT04501809|Oxytocin|oxytocin|mesh-list
57106243|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
57106244|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57106245|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106246|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57106247|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
57106248|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57106249|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106250|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
57106251|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
57106252|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57106253|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
57106254|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57106255|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106256|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57106257|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57106258|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57106260|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106261|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57106262|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57106263|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106264|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106265|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106266|NCT02514681|Gemcitabine|gemcitabine|mesh-list
57106267|NCT02514681|Paclitaxel|paclitaxel|mesh-list
57106268|NCT02514681|Vinorelbine|vinorelbine|mesh-list
57106269|NCT02514681|Docetaxel|docetaxel|mesh-list
57106270|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57106271|NCT02514681|Capecitabine|capecitabine|mesh-list
57106272|NCT02514681|Trastuzumab|trastuzumab|mesh-list
57106273|NCT02514681|Pertuzumab|pertuzumab|mesh-list
57106274|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57106275|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106276|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
57106277|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
57106278|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
57106279|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106280|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57106281|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
57106282|NCT02514681|Antiviral Agents|antiviral agents|mesh-ancestor
57106283|NCT02514681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106284|NCT02514681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106285|NCT02514681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106286|NCT02514681|Immunologic Factors|immunologic factors|mesh-ancestor
57106287|NCT02514681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106288|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106289|NCT02511639|Everolimus|everolimus|mesh-list
57106290|NCT02511639|Letrozole|letrozole|mesh-list
57106291|NCT02511639|Anastrozole|anastrozole|mesh-list
57106292|NCT02511639|Exemestane|exemestane|mesh-list
57106293|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57106294|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106295|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106296|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
57106297|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106298|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57106299|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106300|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106301|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57106302|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
57106303|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57106304|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57106305|NCT02511483|Propranolol|propranolol|mesh-list
57106306|NCT02511483|Morphine|morphine|mesh-list
57106307|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57106308|NCT02511483|Narcotics|narcotics|mesh-ancestor
57106309|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106310|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106311|NCT02511483|Analgesics|analgesics|mesh-ancestor
57106312|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
57106313|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106314|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57106315|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57106316|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
57106317|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106318|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106319|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57106320|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57106321|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
57106322|NCT03060434|Acetaminophen|acetaminophen|mesh-list
57106323|NCT03060434|Ibuprofen|ibuprofen|mesh-list
57106324|NCT03060434|Pregabalin|pregabalin|mesh-list
57106325|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
57106326|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57106327|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57106328|NCT03060434|Analgesics|analgesics|mesh-ancestor
57106329|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
57106330|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106331|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106332|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106333|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57106334|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57106335|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106336|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106337|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
57106338|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57106339|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57106340|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57106341|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57106342|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57106343|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106344|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57106345|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
57106346|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57106347|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57106348|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57106349|NCT03060434|Protective Agents|protective agents|mesh-ancestor
57106350|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
57106351|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57106352|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
57106353|NCT04429802|Prucalopride|prucalopride|mesh-list
57106354|NCT04429802|Laxatives|laxatives|mesh-ancestor
57106355|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106356|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
57106357|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57106358|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
57106359|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106360|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106361|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106362|NCT02511405|Bevacizumab|bevacizumab|mesh-list
57106363|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106364|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106365|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57106366|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57106367|NCT02511405|Growth Substances|growth substances|mesh-ancestor
57106368|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106369|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
57106370|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
57106371|NCT04387760|Favipiravir|favipiravir|mesh-list
57106372|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
57106373|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57106374|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57106375|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106376|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106377|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106378|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57106379|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
57106380|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
57106381|NCT05091086|Denosumab|denosumab|mesh-list
57106382|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57106383|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106384|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
57106385|NCT05091008|Ledipasvir|ledipasvir|mesh-list
57106386|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
57106387|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
57106388|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106389|NCT02918084|Letrozole|letrozole|mesh-list
57106390|NCT02918084|Anastrozole|anastrozole|mesh-list
57106391|NCT02918084|Exemestane|exemestane|mesh-list
57106392|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106393|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57106394|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57106395|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106396|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106397|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57106398|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
57106399|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57106400|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788257|NCT03998436|Esmolol|esmolol|mesh-list
57106401|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57106402|NCT01603082|Clopidogrel|clopidogrel|mesh-list
57106403|NCT01603082|Ticagrelor|ticagrelor|mesh-list
57106404|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57106406|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57106407|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57106408|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
57106409|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106410|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106411|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106412|NCT04499313|Dexamethasone|dexamethasone|mesh-list
57106413|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
57106414|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57106415|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57106416|NCT04499313|Prednisolone|prednisolone|mesh-list
57106417|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
57106418|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57106419|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
57106420|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106421|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
57106422|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
57106423|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106424|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106425|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106426|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
57106427|NCT04499313|Hormones|hormones|mesh-ancestor
57106428|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57106429|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57106430|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106431|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57106432|NCT04499313|Protective Agents|protective agents|mesh-ancestor
57106433|NCT04134884|Talazoparib|talazoparib|mesh-list
57106434|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57106435|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106436|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106437|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106438|NCT04331756|Anesthetics|anesthetics|mesh-list
57106439|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106440|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106441|NCT04112199|Terlipressin|terlipressin|mesh-list
57106442|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57106443|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57106444|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
57106445|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
57106446|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
57106447|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106448|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106449|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
57106450|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106451|NCT02510781|Carboplatin|carboplatin|mesh-list
57106452|NCT02510781|Docetaxel|docetaxel|mesh-list
57106453|NCT02510781|Trastuzumab|trastuzumab|mesh-list
57106454|NCT02510781|Epirubicin|epirubicin|mesh-list
57106455|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106456|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
57106457|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
57106458|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
57106459|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106460|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106461|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57106462|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57106463|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57106464|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106465|NCT03121599|Alovudine|alovudine|mesh-list
57106466|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
57106467|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106468|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
57106469|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106470|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
57106471|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
57106472|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
57106473|NCT04181606|Esmolol|esmolol|mesh-list
57106474|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57106475|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57106476|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57106477|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
57106478|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788322|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57106479|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106480|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106481|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
57106482|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106483|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
57106484|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57106485|NCT02510469|Apatinib|apatinib|mesh-list
57106486|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106487|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57106488|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106489|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106490|NCT05375630|Vitamin K|vitamin k|mesh-list
57106491|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
57106492|NCT05375630|Vitamins|vitamins|mesh-ancestor
57106493|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
57106494|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106495|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57106496|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57106497|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106498|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
57106499|NCT05375630|Coagulants|coagulants|mesh-ancestor
57106500|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
57106501|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57106502|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
57106503|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106504|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
57106505|NCT02510235|Protective Agents|protective agents|mesh-ancestor
57106506|NCT05081336|Ezetimibe|ezetimibe|mesh-list
57106507|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57106508|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57106509|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
57106510|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106511|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57106512|NCT03834519|Prednisone|prednisone|mesh-list
57106513|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
57106514|NCT03834519|Olaparib|olaparib|mesh-list
57106515|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
57106516|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106517|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106518|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106519|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
57106520|NCT03834519|Hormones|hormones|mesh-ancestor
57106521|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57106522|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106523|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57106524|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57106525|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106526|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106527|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57106528|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
57106529|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57106530|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57106531|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57106532|NCT03710876|Gemcitabine|gemcitabine|mesh-list
57106533|NCT03710876|Celecoxib|celecoxib|mesh-list
57106534|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57106535|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
57106536|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106537|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106538|NCT03710876|Antiviral Agents|antiviral agents|mesh-ancestor
57106539|NCT03710876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106540|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106541|NCT03710876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106542|NCT03710876|Immunologic Factors|immunologic factors|mesh-ancestor
57106543|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106544|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57106545|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57106546|NCT03710876|Analgesics|analgesics|mesh-ancestor
57106547|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
57106548|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106549|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106550|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57106551|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57106552|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56788397|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
57106553|NCT02513433|Bupivacaine|bupivacaine|mesh-list
57106554|NCT02513433|Ropivacaine|ropivacaine|mesh-list
57106555|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
57106556|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
57106557|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
57106558|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106559|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106560|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
57106561|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106562|NCT02510157|Dexamethasone|dexamethasone|mesh-list
57106563|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106564|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
57106565|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
57106566|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106567|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106568|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106569|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
57106570|NCT02510157|Hormones|hormones|mesh-ancestor
57106571|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57106572|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57106573|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106574|NCT03345147|Vitamins|vitamins|mesh-list
57106575|NCT03345147|Vitamin A|vitamin a|mesh-list
57106576|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
57106577|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
57106578|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106579|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
57106580|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106581|NCT03345147|Protective Agents|protective agents|mesh-ancestor
57106582|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57106583|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106584|NCT03662919|Adalimumab|adalimumab|mesh-list
57106585|NCT03662919|Infliximab|infliximab|mesh-list
57106586|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57106587|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57106588|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
57106589|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106590|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
57106591|NCT05375240|Propranolol|propranolol|mesh-list
57106592|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57106593|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57106594|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
57106595|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106596|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106597|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106598|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57106599|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57106600|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
57106601|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57106602|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106603|NCT00406393|Sirolimus|sirolimus|mesh-list
57106604|NCT00406393|Methotrexate|methotrexate|mesh-list
57106605|NCT00406393|Tacrolimus|tacrolimus|mesh-list
57106606|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57106607|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
57106608|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57106609|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106610|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57106611|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
57106612|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106613|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106614|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
57106615|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106616|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57106617|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106618|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
57106619|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57106620|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57106621|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57106622|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57106623|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106624|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57106625|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
57106626|NCT02513355|Cisplatin|cisplatin|mesh-list
56788475|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
57106627|NCT02513355|Endostar protein|endostar protein|mesh-list
57106628|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106629|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57106630|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57106631|NCT02513355|Growth Substances|growth substances|mesh-ancestor
57106632|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106633|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
57106635|NCT03329378|Docetaxel|docetaxel|mesh-list
57106636|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57106637|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
57106638|NCT03329378|Carboplatin|carboplatin|mesh-list
57106639|NCT03329378|Doxorubicin|doxorubicin|mesh-list
57106640|NCT03329378|Trastuzumab|trastuzumab|mesh-list
57106641|NCT03329378|Pertuzumab|pertuzumab|mesh-list
57106642|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57106643|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106644|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
57106645|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
57106646|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
57106647|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106648|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106649|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
57106650|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106651|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57106652|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57106653|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
57106654|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57106655|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57106656|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57106657|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57106658|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106659|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106660|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
57106661|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57106662|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57106663|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106664|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57106665|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57106666|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
57106667|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106668|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106669|NCT02509923|Rabeprazole|rabeprazole|mesh-list
57106670|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57106671|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106672|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57106673|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106674|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106675|NCT03578263|Oxytocin|oxytocin|mesh-list
57106676|NCT03578263|Carbetocin|carbetocin|mesh-list
57106677|NCT03578263|Ergonovine|ergonovine|mesh-list
57106678|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
57106679|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57106680|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106681|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57106682|NCT05099198|Glimepiride|glimepiride|mesh-list
57106683|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57106684|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106685|NCT05099198|Incretins|incretins|mesh-ancestor
57106686|NCT05099198|Hormones|hormones|mesh-ancestor
57106687|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57106688|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57106689|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
57106690|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106691|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106692|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57106693|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106694|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
57106695|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57106696|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
57106697|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57106698|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57106699|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57106700|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106701|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106702|NCT03425331|Nivolumab|nivolumab|mesh-list
57106703|NCT03425331|Ipilimumab|ipilimumab|mesh-list
57106704|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106705|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106707|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106708|NCT02845375|Neostigmine|neostigmine|mesh-list
57106709|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57106710|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106711|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106712|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
57106713|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106714|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106715|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57106716|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
57106717|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106718|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
57106719|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57106720|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57106721|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
57106722|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106723|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106724|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106725|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
57106726|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
57106727|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106728|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
57106729|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57106730|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
57106731|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
57106732|NCT03344679|Adenosine|adenosine|mesh-list
57106733|NCT03344679|Bupivacaine|bupivacaine|mesh-list
57106734|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
57106735|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
57106736|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106737|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106738|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
57106739|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106740|NCT03344679|Analgesics|analgesics|mesh-ancestor
57106741|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57106742|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
57106743|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57106744|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57106745|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106746|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57106747|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
57106748|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57106749|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
57106750|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57106751|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
57106752|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
57106753|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106754|NCT02259829|Amlodipine|amlodipine|mesh-list
57106755|NCT02259829|Telmisartan|telmisartan|mesh-list
57106756|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
57106757|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57106758|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57106759|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57106760|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106761|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57106762|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106763|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
57106764|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57106765|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56054811|NCT01902758|Theophylline|theophylline|mesh-list
57106766|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
57106767|NCT03344523|Hematinics|hematinics|mesh-ancestor
57106768|NCT02658734|Trastuzumab|trastuzumab|mesh-list
57106769|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
57106770|NCT02658734|Maytansine|maytansine|mesh-list
57106771|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106772|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106773|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57106774|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
57106775|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
57106776|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
57106777|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106778|NCT03344445|Anesthetics|anesthetics|mesh-list
57106779|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106780|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106781|NCT04501107|Insulin|insulin|mesh-list
57106782|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57106783|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
57106784|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57106785|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106786|NCT03143985|Pomalidomide|pomalidomide|mesh-list
57106787|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
57106788|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106789|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57106790|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57106791|NCT03143985|Growth Substances|growth substances|mesh-ancestor
57106792|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
57106793|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106794|NCT02605148|Vitamin D|vitamin d|mesh-list
57106795|NCT02605148|Vitamins|vitamins|mesh-ancestor
57106796|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
57106797|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106798|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57106799|NCT04497831|Morphine|morphine|mesh-list
57106800|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57106801|NCT04497831|Narcotics|narcotics|mesh-ancestor
57106802|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106803|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106804|NCT04497831|Analgesics|analgesics|mesh-ancestor
57106805|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
57106806|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106807|NCT02395640|Capecitabine|capecitabine|mesh-list
57106808|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
57106809|NCT02395640|Epirubicin|epirubicin|mesh-list
57106810|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57106811|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
57106812|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106813|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106814|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57106815|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57106816|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57106817|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106818|NCT02509143|Ramosetron|ramosetron|mesh-list
57106819|NCT02509143|Antiemetics|antiemetics|mesh-list
57106820|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
57106821|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106822|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106823|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106824|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57106825|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
57106826|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106827|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106828|NCT05100446|Amoxicillin|amoxicillin|mesh-list
57106829|NCT05100446|Esomeprazole|esomeprazole|mesh-list
57106830|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57106831|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106832|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57106833|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106834|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57106835|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106836|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106837|NCT02506803|Gemcitabine|gemcitabine|mesh-list
57106838|NCT02506803|Paclitaxel|paclitaxel|mesh-list
57106839|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57106840|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106841|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
57106842|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
57106843|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
57106844|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106845|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57106846|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
57106847|NCT02506803|Antiviral Agents|antiviral agents|mesh-ancestor
57106848|NCT02506803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106849|NCT02506803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106850|NCT02506803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106851|NCT02506803|Immunologic Factors|immunologic factors|mesh-ancestor
57106852|NCT02506803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106854|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106855|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57106856|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106857|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106858|NCT04531592|Valproic Acid|valproic acid|mesh-list
57106859|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
57106860|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106861|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106862|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
57106863|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106864|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106865|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
57106866|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57106867|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106868|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57106869|NCT03571711|Meropenem|meropenem|mesh-list
57106870|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57106871|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106872|NCT03570541|Acetaminophen|acetaminophen|mesh-list
57106873|NCT03570541|Morphine|morphine|mesh-list
57106874|NCT03570541|Ropivacaine|ropivacaine|mesh-list
57106875|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57106876|NCT03570541|Narcotics|narcotics|mesh-ancestor
57106877|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106878|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106879|NCT03570541|Analgesics|analgesics|mesh-ancestor
57106880|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
57106881|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57106882|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
57106883|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
57106884|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57106885|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
57106886|NCT00708435|Protein C|protein c|mesh-list
57106887|NCT00708435|Protein S|protein s|mesh-list
57106888|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
57106889|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57106890|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57106891|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106892|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
57106893|NCT02508753|Tazobactam|tazobactam|mesh-list
57106894|NCT02508753|Ceftolozane|ceftolozane|mesh-list
57106895|NCT02508753|Cephalosporins|cephalosporins|mesh-list
57106896|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57106897|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106898|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57106899|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57106900|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106901|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106902|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106903|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57106904|NCT02506647|Insulin|insulin|mesh-list
57106905|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57106906|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
57106907|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57106908|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106909|NCT02571530|Trastuzumab|trastuzumab|mesh-list
57106910|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106911|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106912|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
57106913|NCT04379024|Estrogens|estrogens|mesh-list
57106914|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
57106915|NCT04379024|Hormones|hormones|mesh-ancestor
57106916|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57106917|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106918|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57106919|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57106920|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
57106921|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57106922|NCT04498689|Gemcitabine|gemcitabine|mesh-list
57106923|NCT04498689|Paclitaxel|paclitaxel|mesh-list
57106924|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57106925|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106926|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
57106927|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
57106928|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
57106929|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106930|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57106931|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
57106932|NCT04498689|Antiviral Agents|antiviral agents|mesh-ancestor
57106933|NCT04498689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106934|NCT04498689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57106935|NCT04498689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57106936|NCT04498689|Immunologic Factors|immunologic factors|mesh-ancestor
57106937|NCT04498689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106939|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57106940|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
57106941|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57106942|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106943|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57106944|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106945|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
57106946|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57106947|NCT04272008|Estradiol|estradiol|mesh-list
57106948|NCT04272008|Estrogens|estrogens|mesh-ancestor
57106949|NCT04272008|Hormones|hormones|mesh-ancestor
57106950|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57106951|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106952|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57106953|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
57106954|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57106955|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57106956|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57106957|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57106958|NCT05103020|Bevacizumab|bevacizumab|mesh-list
57106959|NCT05103020|Cetuximab|cetuximab|mesh-list
57106960|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
57106961|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57106962|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57106963|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57106964|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57106965|NCT05103020|Growth Substances|growth substances|mesh-ancestor
57106966|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106967|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
57106968|NCT02501109|Aripiprazole|aripiprazole|mesh-list
57106969|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
57106970|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57106971|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57106972|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57106973|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106974|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106975|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
57106976|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
57106977|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57106978|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57106979|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57106980|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57106981|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
57106982|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57106983|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57106984|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57106985|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57106986|NCT05060666|Ivermectin|ivermectin|mesh-list
57106987|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57106988|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57106989|NCT02506335|Cholic Acids|cholic acids|mesh-list
57106990|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57106991|NCT04725032|Propofol|propofol|mesh-list
57106992|NCT04725032|Sevoflurane|sevoflurane|mesh-list
57106993|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57106994|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57106995|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57106996|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57106997|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
57106998|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
57106999|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57107000|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57107001|NCT01353859|Methotrexate|methotrexate|mesh-list
57107002|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57107003|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
57107004|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57107005|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107006|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57107007|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
57107008|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107009|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107010|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
57107011|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107012|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57107013|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57107014|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
57107015|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57107016|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57107018|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57107019|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
57107020|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107021|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107022|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57107023|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107024|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57107025|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
57107026|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107027|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107028|NCT03571321|Cytarabine|cytarabine|mesh-list
57107029|NCT03571321|Dexamethasone|dexamethasone|mesh-list
57107030|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
57107031|NCT03571321|Rituximab|rituximab|mesh-list
57107032|NCT03571321|Doxorubicin|doxorubicin|mesh-list
57107033|NCT03571321|Methotrexate|methotrexate|mesh-list
57107034|NCT03571321|Vincristine|vincristine|mesh-list
57107035|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
57107036|NCT03571321|Pegaspargase|pegaspargase|mesh-list
57107037|NCT03571321|Thioguanine|thioguanine|mesh-list
57107038|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57107039|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
57107040|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107041|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57107042|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57107043|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
57107044|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107045|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107046|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57107047|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107048|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57107049|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
57107050|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
57107051|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107052|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57107053|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
57107054|NCT03571321|Hormones|hormones|mesh-ancestor
57107055|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57107056|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57107057|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57107058|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57107059|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57107060|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107061|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57107062|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
57107063|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57107064|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57107065|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
57107066|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
57107067|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57107068|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57107069|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
57107070|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107071|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57107072|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
57107073|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
57107074|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
57107075|NCT03592199|Sunitinib|sunitinib|mesh-list
57107076|NCT03592199|Axitinib|axitinib|mesh-list
57107077|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107078|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57107079|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57107080|NCT03592199|Growth Substances|growth substances|mesh-ancestor
57107081|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107082|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
57107083|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57107084|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107085|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107087|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57107088|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
57107089|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107090|NCT03139916|Temozolomide|temozolomide|mesh-list
57107091|NCT03139916|Bavituximab|bavituximab|mesh-list
57107092|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57107093|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
57107094|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107095|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107096|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107097|NCT02507583|Insulin|insulin|mesh-list
57107098|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57107099|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107100|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
57107101|NCT02298959|Aflibercept|aflibercept|mesh-list
57107102|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
57107103|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107104|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107105|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57107106|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57107107|NCT02298959|Growth Substances|growth substances|mesh-ancestor
57107108|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107109|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
57107110|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
57107111|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
57107112|NCT02506023|Coagulants|coagulants|mesh-ancestor
57107113|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57107114|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
57107115|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107116|NCT02246179|Lidocaine|lidocaine|mesh-list
57107117|NCT02246179|Epinephrine|epinephrine|mesh-list
57107118|NCT02246179|Prilocaine|prilocaine|mesh-list
57107119|NCT02246179|Carticaine|carticaine|mesh-list
57107120|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
57107121|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
57107122|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
57107123|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107124|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107125|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
57107126|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107127|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107128|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57107129|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57107130|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57107131|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107132|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57107133|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57107134|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
57107135|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107136|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57107137|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57107138|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
57107139|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57107140|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107141|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
57107142|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
57107143|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57107144|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
57107145|NCT02238275|Telmisartan|telmisartan|mesh-list
57107146|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57107147|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57107148|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57107149|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107150|NCT04655222|Interferons|interferons|mesh-list
57107151|NCT04655222|Interferon-beta|interferon-beta|mesh-list
57107152|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107153|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
57107154|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107155|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
57107156|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107157|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
57107158|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57107159|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107160|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107161|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57107162|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57107164|NCT04394117|Valsartan|valsartan|mesh-list
57107165|NCT04394117|Telmisartan|telmisartan|mesh-list
57107166|NCT04394117|Candesartan|candesartan|mesh-list
57107167|NCT04394117|Olmesartan|olmesartan|mesh-list
57107168|NCT04394117|Irbesartan|irbesartan|mesh-list
57107169|NCT04394117|Eprosartan|eprosartan|mesh-list
57107170|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
57107171|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57107172|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57107173|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107174|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107175|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
57107176|NCT02500563|Caseins|caseins|mesh-list
57107177|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
57107178|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
57107179|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107180|NCT02500329|Acarbose|acarbose|mesh-list
57107181|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57107182|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107183|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107184|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57107185|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107186|NCT02243137|Aspirin|aspirin|mesh-list
57107187|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
57107188|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
57107189|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57107190|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57107191|NCT02243137|Analgesics|analgesics|mesh-ancestor
57107192|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
57107193|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107194|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107195|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57107196|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57107197|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57107198|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57107199|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107200|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57107201|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57107202|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107203|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
57107204|NCT03343977|Docetaxel|docetaxel|mesh-list
57107205|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107206|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
57107207|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
57107208|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
57107209|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107210|NCT02850965|Adalimumab|adalimumab|mesh-list
57107211|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57107212|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57107213|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57107214|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57107215|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57107216|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
57107217|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107218|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57107219|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57107220|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107221|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
57107222|NCT01375959|Resveratrol|resveratrol|mesh-list
57107223|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
57107224|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107225|NCT01375959|Protective Agents|protective agents|mesh-ancestor
57107226|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107227|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107228|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57107229|NCT02238353|Fluticasone|fluticasone|mesh-list
57107230|NCT02238353|Azelastine|azelastine|mesh-list
57107231|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789066|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
57107232|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57107233|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
57107234|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107235|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107236|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57107237|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107238|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
57107239|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57107240|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
57107241|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107242|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107243|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57107244|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57107245|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
57107246|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
57107247|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107249|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
57107250|NCT04482686|Vitamins|vitamins|mesh-list
57107251|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
57107252|NCT04482686|Zinc|zinc|mesh-list
57107253|NCT04482686|Doxycycline|doxycycline|mesh-list
57107254|NCT04482686|Ivermectin|ivermectin|mesh-list
57107255|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
57107256|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
57107257|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107258|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57107259|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57107260|NCT04482686|Trace Elements|trace elements|mesh-ancestor
57107261|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
57107262|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107263|NCT04482686|Protective Agents|protective agents|mesh-ancestor
57107264|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57107265|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107266|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
57107267|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57107268|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57107269|NCT04482686|Astringents|astringents|mesh-ancestor
57107270|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
57107271|NCT03580889|Atropine|atropine|mesh-list
57107272|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
57107273|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57107274|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107275|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57107276|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
57107277|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107278|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107279|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57107280|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107281|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
57107282|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
57107283|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57107284|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57107285|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
56331739|NCT00028496|Vaccines|vaccines|mesh-list
57107286|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107287|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107288|NCT02500017|Melatonin|melatonin|mesh-list
57107289|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
57107290|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107291|NCT02500017|Protective Agents|protective agents|mesh-ancestor
57107292|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107293|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107294|NCT02505633|Lidocaine|lidocaine|mesh-list
57107295|NCT02505633|Epinephrine|epinephrine|mesh-list
57107296|NCT02505633|Racepinephrine|racepinephrine|mesh-list
57107297|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
57107298|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
57107299|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
57107300|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107301|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107302|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
57107303|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107304|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107305|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57107306|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57107307|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57107308|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107309|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57107310|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57107311|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
57107312|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107313|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57107314|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57107315|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
57107316|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57107317|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107318|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
57107319|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
57107320|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57107321|NCT03587441|Neostigmine|neostigmine|mesh-list
57107322|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57107323|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107324|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107325|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
57107326|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107327|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107328|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57107329|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
57107330|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107331|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
57107332|NCT05102396|Oxybutynin|oxybutynin|mesh-list
57107333|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
57107334|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
57107335|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107336|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107337|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57107338|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57107339|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
57107340|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107341|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107342|NCT05102396|Urological Agents|urological agents|mesh-ancestor
57107343|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57107344|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107345|NCT05102396|Renal Agents|renal agents|mesh-ancestor
57107346|NCT01165645|Ritonavir|ritonavir|mesh-list
57107347|NCT01165645|Lopinavir|lopinavir|mesh-list
57107348|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57107349|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57107350|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
57107351|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107352|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107353|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57107354|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57107355|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
57107356|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107357|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57107358|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57107359|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
57107360|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
57107361|NCT03579875|Busulfan|busulfan|mesh-list
57107362|NCT03579875|Rituximab|rituximab|mesh-list
57107363|NCT03579875|Fludarabine|fludarabine|mesh-list
57107364|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57107365|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
57107366|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107367|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57107368|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57107369|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
57107370|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107371|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107372|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57107373|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107374|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57107375|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
57107376|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
57107377|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107378|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57107379|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
57107380|NCT03579875|Hormones|hormones|mesh-ancestor
57107381|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57107382|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57107383|NCT03579875|Protective Agents|protective agents|mesh-ancestor
56789214|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
57107384|NCT03569995|Cytarabine|cytarabine|mesh-list
57107385|NCT03569995|Rituximab|rituximab|mesh-list
57107387|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107388|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107389|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
57107390|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107391|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57107392|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57107393|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
57107394|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57107395|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57107396|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
57107397|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107398|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
57107399|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107400|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57107401|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57107402|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57107403|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
57107404|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107405|NCT02238431|Leuprolide|leuprolide|mesh-list
57107406|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57107407|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
57107408|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57107409|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107410|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57107411|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107412|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
57107413|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107414|NCT02238509|Trastuzumab|trastuzumab|mesh-list
57107415|NCT02238509|Lapatinib|lapatinib|mesh-list
57107416|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107417|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107418|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57107419|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107420|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107421|NCT03579914|Metoprolol|metoprolol|mesh-list
57107422|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107423|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57107424|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
57107425|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
57107426|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107427|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107428|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57107429|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57107430|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57107431|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
57107432|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107433|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107434|NCT03573037|Anticoagulants|anticoagulants|mesh-list
57107435|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57107436|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107437|NCT03585413|Micronutrients|micronutrients|mesh-list
57107438|NCT03585413|Trace Elements|trace elements|mesh-list
57107439|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107440|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
57107441|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57107442|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
57107443|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107444|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
57107445|NCT03569683|Protective Agents|protective agents|mesh-ancestor
57107446|NCT00708201|Alvimopan|alvimopan|mesh-list
57107447|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57107448|NCT03572959|Triamcinolone|triamcinolone|mesh-list
57107449|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57107450|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57107451|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57107452|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57107453|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
57107454|NCT03572959|Hormones|hormones|mesh-ancestor
57107455|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57107456|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107457|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57107458|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
57107459|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789303|NCT00875927|Zinc|zinc|mesh-list
57107460|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107462|NCT05708755|Antiviral Agents|antiviral agents|mesh-ancestor
57107463|NCT05708755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107464|NCT02500251|Rituximab|rituximab|mesh-list
57107465|NCT02500251|Bortezomib|bortezomib|mesh-list
57107466|NCT02500251|Belimumab|belimumab|mesh-list
57107467|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107468|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107469|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
57107470|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107471|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57107472|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57107473|NCT03568513|Curcumin|curcumin|mesh-list
57107474|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57107475|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57107476|NCT03568513|Analgesics|analgesics|mesh-ancestor
57107477|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
57107478|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107479|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107480|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57107481|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57107482|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107483|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107484|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107485|NCT02982668|Metoclopramide|metoclopramide|mesh-list
57107486|NCT02982668|Mosapride|mosapride|mesh-list
57107487|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
57107488|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
57107489|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107490|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107491|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57107492|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57107493|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57107494|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
57107495|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107496|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107497|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57107498|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
57107499|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
57107500|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57107501|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
57107502|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107503|NCT02505477|Expectorants|expectorants|mesh-ancestor
57107504|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107505|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57107506|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
57107507|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107508|NCT02505477|Protective Agents|protective agents|mesh-ancestor
57107509|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107510|NCT02505477|Antidotes|antidotes|mesh-ancestor
57107511|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57107512|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107513|NCT05354479|Acetaminophen|acetaminophen|mesh-list
57107514|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57107515|NCT05354479|Analgesics|analgesics|mesh-ancestor
57107516|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
57107517|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107518|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107519|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
57107520|NCT02505399|Clopidogrel|clopidogrel|mesh-list
57107521|NCT02505399|Ticagrelor|ticagrelor|mesh-list
57107522|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57107523|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57107524|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57107525|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57107526|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
57107527|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107528|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107529|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107530|NCT02728089|Tazobactam|tazobactam|mesh-list
57107531|NCT02728089|Ceftolozane|ceftolozane|mesh-list
57107532|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57107533|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107534|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57107535|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107536|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107537|NCT05110118|Bevacizumab|bevacizumab|mesh-list
57107538|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
57107539|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107540|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107541|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57107542|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57107543|NCT05110118|Growth Substances|growth substances|mesh-ancestor
57107544|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107545|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
57107546|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
57107547|NCT03572647|Hematinics|hematinics|mesh-ancestor
57107548|NCT02495181|Aflibercept|aflibercept|mesh-list
57107549|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57107550|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57107551|NCT02495181|Growth Substances|growth substances|mesh-ancestor
57107552|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107553|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
57107554|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107555|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57107556|NCT05109650|Antibodies|antibodies|mesh-list
57107557|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
57107558|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
57107559|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107560|NCT02499861|Decitabine|decitabine|mesh-list
57107561|NCT02499861|Genistein|genistein|mesh-list
57107562|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57107563|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
57107564|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107565|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107566|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107567|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57107568|NCT02499861|Protective Agents|protective agents|mesh-ancestor
57107569|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107570|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57107571|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
57107572|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57107573|NCT02499861|Estrogens|estrogens|mesh-ancestor
57107574|NCT02499861|Hormones|hormones|mesh-ancestor
57107575|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57107576|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57107577|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
57107578|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57107579|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57107580|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57107581|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
57107582|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57107583|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107584|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57107585|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57107586|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57107587|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57107588|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107589|NCT02840461|Ivermectin|ivermectin|mesh-list
57107590|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57107591|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107592|NCT05108714|Lidocaine|lidocaine|mesh-list
57107593|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
57107594|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
57107595|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107596|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107597|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
57107598|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107599|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107600|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57107601|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57107602|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57107603|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107604|NCT02495415|Fenretinide|fenretinide|mesh-list
57107605|NCT02495415|Retinamide|retinamide|mesh-list
57107606|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107607|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57107608|NCT02495415|Protective Agents|protective agents|mesh-ancestor
57107609|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107610|NCT02505009|Tenofovir|tenofovir|mesh-list
57107611|NCT02505009|Entecavir|entecavir|mesh-list
57107612|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
57107613|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107614|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57107615|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57107616|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107617|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107618|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57107619|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57107620|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
57107621|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57107622|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57107623|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57107624|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57107625|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
57107626|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107627|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107628|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107629|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57107630|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57107631|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
57107632|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57107633|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107634|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57107635|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57107636|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57107637|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107638|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
57107639|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57107640|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
57107641|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107642|NCT02505087|Expectorants|expectorants|mesh-ancestor
57107643|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107644|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57107645|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
57107646|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107647|NCT02505087|Protective Agents|protective agents|mesh-ancestor
57107648|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107649|NCT02505087|Antidotes|antidotes|mesh-ancestor
57107650|NCT02839681|Maytansine|maytansine|mesh-list
57107651|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57107652|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107653|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
57107654|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
57107655|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
55891147|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
57107656|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107657|NCT02504463|Naltrexone|naltrexone|mesh-list
57107658|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57107659|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57107660|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107661|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
57107662|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107663|NCT03566329|Lidocaine|lidocaine|mesh-list
57107664|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
57107665|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
57107666|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
57107667|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107668|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107669|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
57107670|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107671|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107672|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57107673|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57107674|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57107675|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107676|NCT03566329|Analgesics|analgesics|mesh-ancestor
57107677|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
57107678|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57107679|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57107680|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
57107681|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57107682|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
57107683|NCT02499237|Denosumab|denosumab|mesh-list
57107684|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57107685|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107686|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
57107687|NCT02499393|Analgesics|analgesics|mesh-ancestor
57107688|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
57107689|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107690|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107691|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
57107692|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107693|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107694|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
57107695|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57107696|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57107697|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107698|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57107699|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
57107700|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57107701|NCT02504307|Sirolimus|sirolimus|mesh-list
57107702|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57107703|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107704|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57107705|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107706|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
57107707|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57107708|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
57107709|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107710|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
57107711|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107712|NCT03567343|Melatonin|melatonin|mesh-list
57107713|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
57107714|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107715|NCT03567343|Protective Agents|protective agents|mesh-ancestor
57107716|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107717|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107718|NCT04595864|Leucovorin|leucovorin|mesh-list
57107719|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
57107720|NCT04595864|Calcium|calcium|mesh-list
57107721|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
57107722|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57107723|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107724|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107725|NCT04595864|Antidotes|antidotes|mesh-ancestor
57107726|NCT04595864|Protective Agents|protective agents|mesh-ancestor
57107727|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
57107728|NCT04595864|Vitamins|vitamins|mesh-ancestor
57107729|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
57107730|NCT04583462|Metformin|metformin|mesh-list
57107731|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57107732|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107733|NCT04456322|Cisplatin|cisplatin|mesh-list
57107734|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
57107735|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107736|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107737|NCT02503761|Meropenem|meropenem|mesh-list
57107738|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57107739|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107740|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
57107741|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
57107742|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
57107743|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107744|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57107745|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57107746|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107747|NCT04305548|Trabectedin|trabectedin|mesh-list
57107748|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57107749|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
57107750|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107751|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107752|NCT04097912|Aspirin|aspirin|mesh-list
57107753|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57107754|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57107755|NCT04097912|Analgesics|analgesics|mesh-ancestor
57107756|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
57107757|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107758|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107759|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57107760|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57107761|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57107762|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57107763|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107764|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57107765|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57107766|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107767|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
57107768|NCT04966676|Nivolumab|nivolumab|mesh-list
57107769|NCT04966676|Ipilimumab|ipilimumab|mesh-list
57107770|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107771|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107772|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57107773|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107774|NCT03340779|Dobutamine|dobutamine|mesh-list
57107775|NCT03340779|Norepinephrine|norepinephrine|mesh-list
57107776|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57107777|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57107778|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
57107779|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107780|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107781|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107782|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
57107783|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
57107784|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107785|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57107786|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57107787|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57107788|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57107789|NCT03340779|Protective Agents|protective agents|mesh-ancestor
57107790|NCT04040738|Anesthetics|anesthetics|mesh-list
57107791|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107792|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107793|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
57107794|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57107795|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107796|NCT05087732|Lidocaine|lidocaine|mesh-list
57107797|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
57107798|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
57107799|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107800|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107801|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
57107802|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107803|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107804|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57107805|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57107806|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57107807|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107808|NCT03340701|Progesterone|progesterone|mesh-list
57107809|NCT03340701|Progestins|progestins|mesh-ancestor
57107810|NCT03340701|Hormones|hormones|mesh-ancestor
57107811|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57107812|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107813|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
57107814|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57107815|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
57107816|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107817|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107818|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57107819|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107820|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57107821|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
57107822|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107823|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107824|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57107825|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
57107826|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
57107827|NCT02498535|Protective Agents|protective agents|mesh-ancestor
57107828|NCT04727138|Midazolam|midazolam|mesh-list
57107829|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57107830|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57107831|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107832|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107833|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57107834|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57107835|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57107837|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
57107838|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
57107839|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
57107840|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
57107841|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107842|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107843|NCT02498457|Calcium|calcium|mesh-list
57107844|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57107845|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107846|NCT02498301|Rifaximin|rifaximin|mesh-list
57107847|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57107848|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107849|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57107850|NCT03343665|Nivolumab|nivolumab|mesh-list
57107851|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107852|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107853|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57107854|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107855|NCT02733614|SRX246|srx246|mesh-list
57107856|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57107857|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107858|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
57107859|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107860|NCT04674254|Bevacizumab|bevacizumab|mesh-list
57107861|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57107862|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107863|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57107864|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57107865|NCT04674254|Growth Substances|growth substances|mesh-ancestor
57107866|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107867|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
57107868|NCT03342807|Insulin|insulin|mesh-list
57107869|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57107870|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107871|NCT02570672|Metformin|metformin|mesh-list
57107872|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57107873|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107874|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
57107875|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56904684|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
57107876|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57107877|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107878|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
57107879|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107880|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107881|NCT04593914|Protective Agents|protective agents|mesh-list
57107882|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107883|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
57107884|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57107885|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107886|NCT03342651|Vitamin D|vitamin d|mesh-list
57107887|NCT03342651|Vitamins|vitamins|mesh-ancestor
57107888|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
57107889|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107890|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57107891|NCT04819568|Terlipressin|terlipressin|mesh-list
57107892|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57107893|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57107894|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
57107895|NCT02502981|Spironolactone|spironolactone|mesh-list
57107896|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
57107897|NCT02502981|Diuretics|diuretics|mesh-list
57107898|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
57107899|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
57107900|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
57107901|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57107902|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107903|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57107904|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
57107905|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57107906|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57107907|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107908|NCT02502981|Hormones|hormones|mesh-ancestor
57107909|NCT04230746|Trimethoprim|trimethoprim|mesh-list
57107910|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57107912|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57107913|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107914|NCT04230746|Renal Agents|renal agents|mesh-ancestor
57107915|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
57107916|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57107917|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57107918|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57107919|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57107920|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107921|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57107922|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57107923|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57107924|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57107925|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
57107926|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57107927|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
57107928|NCT05111444|Paclitaxel|paclitaxel|mesh-list
57107929|NCT05111444|Capecitabine|capecitabine|mesh-list
57107930|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
57107931|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57107932|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107933|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
57107934|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
57107935|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
57107936|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107937|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57107938|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
57107939|NCT03769688|Metronidazole|metronidazole|mesh-list
57107940|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107941|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57107942|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57107943|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57107944|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
57107945|NCT02502825|Miotics|miotics|mesh-ancestor
57107946|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
57107947|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107948|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107949|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57107950|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
57107951|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107952|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57107953|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57107954|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
57107955|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107956|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107957|NCT04495868|Lidocaine|lidocaine|mesh-list
57107958|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
57107959|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
57107960|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107961|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107962|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
57107963|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107964|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57107965|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57107966|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57107967|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57107968|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107969|NCT02498145|Nicotine|nicotine|mesh-list
57107970|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57107971|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
57107972|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107973|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107974|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57107975|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57107976|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
57107977|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57107978|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57107979|NCT02497911|Bupivacaine|bupivacaine|mesh-list
57107980|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
57107981|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
57107982|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57107983|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57107984|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
57107985|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57107986|NCT02497833|Tretinoin|tretinoin|mesh-list
57107987|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57107988|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
57107989|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
57107990|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
57107991|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57107992|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
57107993|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
57107994|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57107995|NCT02493933|Expectorants|expectorants|mesh-ancestor
57107996|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
57107997|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57107998|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
57107999|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108000|NCT02493933|Protective Agents|protective agents|mesh-ancestor
57108001|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108002|NCT02493933|Antidotes|antidotes|mesh-ancestor
57108003|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57108004|NCT02493933|Estrogens|estrogens|mesh-ancestor
57108005|NCT02493933|Hormones|hormones|mesh-ancestor
57108006|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108007|NCT04153604|Doxycycline|doxycycline|mesh-list
57108008|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108009|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108010|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
57108011|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57108012|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57108013|NCT03338205|Ketamine|ketamine|mesh-list
57108014|NCT03338205|Analgesics|analgesics|mesh-ancestor
57108015|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
57108016|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108017|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108018|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57108019|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57108020|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
57108021|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
57108022|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108023|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57108024|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57108025|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108026|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108027|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
57108028|NCT04314050|Tramadol|tramadol|mesh-list
57108029|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108030|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108031|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108032|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108033|NCT04314050|Analgesics|analgesics|mesh-ancestor
57108034|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
57108035|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108036|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57108037|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57108038|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57108039|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
57108040|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108041|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108042|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57108043|NCT04314050|Narcotics|narcotics|mesh-ancestor
57108044|NCT03343509|Metronidazole|metronidazole|mesh-list
57108045|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108046|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108047|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57108048|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57108049|NCT04516148|Clindamycin|clindamycin|mesh-list
57108050|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
57108051|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
57108052|NCT04516148|Cefazolin|cefazolin|mesh-list
57108053|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108054|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108055|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57108056|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108057|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108058|NCT04522622|Teriparatide|teriparatide|mesh-list
56789892|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108059|NCT04522622|Listerine|listerine|mesh-list
57108060|NCT04522622|Fluorides|fluorides|mesh-list
57108061|NCT04522622|Sodium Fluoride|sodium fluoride|mesh-list
57108062|NCT04522622|Cariostatic Agents|cariostatic agents|mesh-ancestor
57108063|NCT04522622|Protective Agents|protective agents|mesh-ancestor
57108064|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108065|NCT04522622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57108066|NCT04522622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108067|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57108068|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57108069|NCT02497365|Cefazolin|cefazolin|mesh-list
57108070|NCT02497365|Tobramycin|tobramycin|mesh-list
57108071|NCT02497365|Besifloxacin|besifloxacin|mesh-list
57108072|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108073|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108074|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57108075|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57108076|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108077|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108078|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108079|NCT02497053|Pemetrexed|pemetrexed|mesh-list
57108080|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108081|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108082|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108083|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57108084|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57108085|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57108086|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108087|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
57108088|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
57108089|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57108090|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108091|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108092|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
57108093|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57108094|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108095|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108096|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
57108097|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108098|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108099|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108100|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108101|NCT03337581|Analgesics|analgesics|mesh-ancestor
57108102|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
57108103|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108104|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57108105|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57108106|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57108107|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
57108108|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108109|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108110|NCT02496975|Cyclosporine|cyclosporine|mesh-list
57108111|NCT02496975|Cyclosporins|cyclosporins|mesh-list
57108112|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108113|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108114|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57108115|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
57108116|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108117|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
57108118|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108119|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
57108120|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108121|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57108122|NCT03337503|Dronabinol|dronabinol|mesh-list
57108123|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
57108124|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108125|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57108126|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108127|NCT03337503|Analgesics|analgesics|mesh-ancestor
57108128|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
57108129|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108130|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57108131|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57108132|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108133|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108134|NCT03337503|Hormones|hormones|mesh-ancestor
57108135|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108136|NCT01675622|Morphine|morphine|mesh-list
57108137|NCT01675622|Oxycodone|oxycodone|mesh-list
57108138|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57108139|NCT01675622|Narcotics|narcotics|mesh-ancestor
57108140|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108141|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108142|NCT01675622|Analgesics|analgesics|mesh-ancestor
57108143|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
57108144|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108145|NCT02496741|Metformin|metformin|mesh-list
57108146|NCT02496741|Chloroquine|chloroquine|mesh-list
57108147|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57108148|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108149|NCT02496741|Amebicides|amebicides|mesh-ancestor
57108150|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57108151|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57108152|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108153|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
57108154|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108155|NCT04496037|Rituximab|rituximab|mesh-list
57108156|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57108157|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108158|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
57108159|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108160|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108161|NCT04169828|Leucovorin|leucovorin|mesh-list
57108162|NCT04169828|Folic Acid|folic acid|mesh-list
57108163|NCT04169828|Methotrexate|methotrexate|mesh-list
57108164|NCT04169828|Ondansetron|ondansetron|mesh-list
57108165|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
57108166|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57108167|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
57108168|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57108169|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108170|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57108171|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
57108172|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108173|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108174|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
57108175|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108176|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57108177|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57108178|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
57108179|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108180|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57108181|NCT04169828|Antidotes|antidotes|mesh-ancestor
57108182|NCT04169828|Protective Agents|protective agents|mesh-ancestor
57108183|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
57108184|NCT04169828|Vitamins|vitamins|mesh-ancestor
57108185|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
57108186|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
57108187|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
57108188|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108189|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57108190|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
57108191|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57108192|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
57108193|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108194|NCT04169828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57108195|NCT04169828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57108196|NCT04169828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108197|NCT04169828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57108198|NCT04169828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57108199|NCT04169828|Hematinics|hematinics|mesh-ancestor
57108200|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57108201|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57108202|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108203|NCT04495881|Incretins|incretins|mesh-ancestor
57108204|NCT04495881|Hormones|hormones|mesh-ancestor
57108205|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108206|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57108207|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
57108208|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108209|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108210|NCT02493465|Everolimus|everolimus|mesh-list
56790053|NCT00883883|Cefdinir|cefdinir|mesh-list
57108211|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108212|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57108213|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
57108214|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108215|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
57108216|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108217|NCT04495569|Antibodies|antibodies|mesh-list
57108218|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57108219|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
57108220|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108221|NCT03337191|Morphine|morphine|mesh-list
57108222|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
57108223|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57108224|NCT03337191|Narcotics|narcotics|mesh-ancestor
57108225|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108226|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108227|NCT03337191|Analgesics|analgesics|mesh-ancestor
57108228|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
57108229|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108230|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
57108231|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
57108232|NCT04494243|Rabeprazole|rabeprazole|mesh-list
57108233|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57108234|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57108235|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57108236|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108237|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108238|NCT03337035|Oxytocin|oxytocin|mesh-list
57108239|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
57108240|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57108241|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108242|NCT03330717|Anesthetics|anesthetics|mesh-list
57108243|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108244|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108245|NCT02655224|Relugolix|relugolix|mesh-list
57108246|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
57108247|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
57108248|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108249|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108250|NCT04494321|Budesonide|budesonide|mesh-list
57108251|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
57108252|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108253|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57108254|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
57108255|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108256|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108257|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57108258|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
57108259|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
57108260|NCT04494321|Hormones|hormones|mesh-ancestor
57108261|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108262|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57108263|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57108264|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57108265|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
57108266|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108267|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108268|NCT03330171|Vaccines|vaccines|mesh-list
57108269|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
57108270|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108271|NCT05118542|Methimazole|methimazole|mesh-list
57108272|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
57108273|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
57108274|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
57108275|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108276|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108277|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
57108278|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108279|NCT03336801|Propofol|propofol|mesh-list
57108280|NCT03336801|Sevoflurane|sevoflurane|mesh-list
57108281|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108282|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108283|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108284|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57108285|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
57108286|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
57108287|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57108288|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57108289|NCT05115578|Midazolam|midazolam|mesh-list
57108290|NCT05115578|Remifentanil|remifentanil|mesh-list
57108291|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57108292|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108293|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108294|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108295|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57108296|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57108297|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57108298|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57108299|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
57108300|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
57108301|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
57108302|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
57108303|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108304|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108305|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57108306|NCT05115578|Narcotics|narcotics|mesh-ancestor
57108307|NCT05115578|Analgesics|analgesics|mesh-ancestor
57108308|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
57108309|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108310|NCT02636036|Nivolumab|nivolumab|mesh-list
57108311|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57108312|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108313|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57108314|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108315|NCT03329781|Curcumin|curcumin|mesh-list
57108316|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57108317|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108318|NCT03329781|Analgesics|analgesics|mesh-ancestor
57108319|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
57108320|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108321|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108322|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108323|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108324|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108325|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108326|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108327|NCT02437604|Fluticasone|fluticasone|mesh-list
57108328|NCT02437604|Xhance|xhance|mesh-list
57108329|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57108330|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57108331|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108332|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57108333|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
57108334|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108335|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108336|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57108337|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
57108338|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
57108339|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57108340|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57108341|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57108342|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57108343|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
57108344|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108345|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108346|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
57108347|NCT02437604|Hormones|hormones|mesh-ancestor
57108348|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108349|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
57108350|NCT03329547|Cefixime|cefixime|mesh-list
57108351|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108352|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108353|NCT05463627|Metformin|metformin|mesh-list
57108354|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57108355|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108356|NCT01975298|Interferons|interferons|mesh-list
57108357|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
57108358|NCT01975298|Interferon-beta|interferon-beta|mesh-list
57108359|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108360|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
57108361|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790194|NCT00887003|Bupivacaine|bupivacaine|mesh-list
57108362|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57108363|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
57108364|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108366|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57108367|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57108368|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108369|NCT05084534|Midodrine|midodrine|mesh-list
56899973|NCT01202487|Lidocaine|lidocaine|mesh-list
57108370|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
57108371|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
57108372|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108373|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108374|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57108375|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57108376|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57108377|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57108378|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
57108379|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108380|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108381|NCT04645316|Propofol|propofol|mesh-list
57108382|NCT04645316|Sevoflurane|sevoflurane|mesh-list
57108383|NCT04645316|Desflurane|desflurane|mesh-list
57108384|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108385|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108386|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108387|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57108388|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
57108389|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
57108390|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57108391|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57108392|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57108393|NCT00659126|Hematinics|hematinics|mesh-ancestor
57108394|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57108395|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57108396|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
57108397|NCT04594382|Narcotics|narcotics|mesh-ancestor
57108398|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108399|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108400|NCT04594382|Analgesics|analgesics|mesh-ancestor
57108401|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
57108402|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108403|NCT02491515|Denosumab|denosumab|mesh-list
57108404|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57108405|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108406|NCT05113628|Methylene Blue|methylene blue|mesh-list
57108407|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108408|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108409|NCT04247750|Sirolimus|sirolimus|mesh-list
57108410|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108411|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108412|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57108413|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108414|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
57108415|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57108416|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
57108417|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108418|NCT04513808|Anesthetics|anesthetics|mesh-list
57108419|NCT04513808|Propofol|propofol|mesh-list
57108420|NCT04513808|Sevoflurane|sevoflurane|mesh-list
57108421|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108422|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108423|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108424|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57108425|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
57108426|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57108427|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57108428|NCT02493231|Ketamine|ketamine|mesh-list
57108429|NCT02493231|Nefopam|nefopam|mesh-list
57108430|NCT02493231|Analgesics|analgesics|mesh-ancestor
57108431|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
57108432|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108433|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108434|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57108435|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57108436|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
57108437|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
57108438|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108439|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57108440|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57108441|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108442|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899974|NCT01202487|Epinephrine|epinephrine|mesh-list
57108443|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108444|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57108445|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57108446|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57108447|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57108449|NCT05112692|Menotropins|menotropins|mesh-list
57108450|NCT05112692|Estradiol|estradiol|mesh-list
57108451|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57108452|NCT05112692|Progesterone|progesterone|mesh-list
57108453|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
57108454|NCT05112692|Estrogens|estrogens|mesh-ancestor
57108455|NCT05112692|Hormones|hormones|mesh-ancestor
57108456|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108457|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108458|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57108459|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
57108460|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57108461|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57108462|NCT05112692|Progestins|progestins|mesh-ancestor
57108463|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
57108464|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57108465|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108466|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57108467|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
57108468|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
57108469|NCT03328533|Phenylephrine|phenylephrine|mesh-list
57108470|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
57108471|NCT03328533|Norepinephrine|norepinephrine|mesh-list
57108472|NCT03328533|Bupivacaine|bupivacaine|mesh-list
57108473|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
57108474|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
57108475|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108476|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108477|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
57108478|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108479|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57108480|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
57108481|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
57108482|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
57108483|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57108484|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
57108485|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
57108486|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57108487|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57108488|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57108489|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
57108490|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108491|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108492|NCT03328533|Protective Agents|protective agents|mesh-ancestor
57108493|NCT03324243|Cytarabine|cytarabine|mesh-list
57108494|NCT03324243|Fludarabine|fludarabine|mesh-list
57108495|NCT03324243|Crenolanib|crenolanib|mesh-list
57108496|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108497|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57108498|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
57108499|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108500|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57108501|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
57108502|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108503|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
57108504|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108505|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
57108506|NCT03328299|Bupivacaine|bupivacaine|mesh-list
57108507|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
57108508|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
57108509|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108510|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108511|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
57108512|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108513|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108514|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108515|NCT03328299|Analgesics|analgesics|mesh-ancestor
57108516|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57108517|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57108518|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57108519|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
57108520|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108521|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108523|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108524|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108525|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57108526|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57108527|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
57108528|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108529|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108530|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57108531|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57108532|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108533|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108534|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108535|NCT03327987|Vaccines|vaccines|mesh-list
57108536|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
57108537|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108538|NCT03335241|Doxorubicin|doxorubicin|mesh-list
57108539|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57108540|NCT03335241|Fludarabine|fludarabine|mesh-list
57108541|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57108542|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108543|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57108544|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57108545|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108546|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108547|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57108548|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57108549|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
57108550|NCT03120663|Amoxicillin|amoxicillin|mesh-list
57108551|NCT03120663|Clindamycin|clindamycin|mesh-list
57108552|NCT03120663|Meropenem|meropenem|mesh-list
57108553|NCT03120663|Tazobactam|tazobactam|mesh-list
57108554|NCT03120663|Piperacillin|piperacillin|mesh-list
57108555|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
57108556|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
57108557|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57108558|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57108559|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108560|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108561|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57108562|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108563|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108564|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57108565|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
57108566|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57108567|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57108568|NCT02578394|Prednisolone|prednisolone|mesh-list
57108569|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
57108570|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57108571|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57108572|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
57108573|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108574|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
57108575|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
57108576|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108577|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108578|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57108579|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
57108580|NCT02578394|Hormones|hormones|mesh-ancestor
57108581|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108582|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57108583|NCT02578394|Protective Agents|protective agents|mesh-ancestor
57108584|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57108585|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108586|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108587|NCT04493229|Oxytocin|oxytocin|mesh-list
57108588|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
57108589|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57108590|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108591|NCT03120273|Lansoprazole|lansoprazole|mesh-list
57108592|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
57108593|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57108594|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57108595|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57108596|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108597|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108598|NCT02122718|Allopurinol|allopurinol|mesh-list
57108599|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
57108600|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108601|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108602|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
57108603|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108604|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57108605|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
57108606|NCT02122718|Protective Agents|protective agents|mesh-ancestor
57108607|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108608|NCT04513652|Carticaine|carticaine|mesh-list
57108609|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
57108610|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
57108611|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108612|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108613|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
57108614|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108615|NCT00706797|Etanercept|etanercept|mesh-list
57108616|NCT00706797|Methotrexate|methotrexate|mesh-list
57108617|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57108618|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
57108619|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57108620|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108621|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57108622|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
57108623|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108624|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108625|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
57108626|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108627|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57108628|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57108629|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
57108630|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108631|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57108632|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57108633|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108634|NCT00706797|Analgesics|analgesics|mesh-ancestor
57108635|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
57108636|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108637|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108638|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57108639|NCT03323697|Citalopram|citalopram|mesh-list
57108640|NCT03323697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57108641|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57108642|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57108643|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108644|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108645|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
57108646|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108647|NCT03323697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57108648|NCT03323697|Antidepressive Agents|antidepressive agents|mesh-ancestor
57108649|NCT03323697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57108650|NCT00706641|Dasatinib|dasatinib|mesh-list
57108651|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108652|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57108653|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108654|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108655|NCT03335085|Oxytocin|oxytocin|mesh-list
57108656|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
57108657|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57108658|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108659|NCT03323619|Anesthetics|anesthetics|mesh-list
57108660|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108661|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108662|NCT03323541|Lenograstim|lenograstim|mesh-list
57108663|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57108664|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
57108665|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790497|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
57108667|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57108668|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108669|NCT03335007|Analgesics|analgesics|mesh-ancestor
57108670|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
57108671|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108672|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108673|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108674|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108675|NCT01362530|Ondansetron|ondansetron|mesh-list
57108676|NCT01362530|Aprepitant|aprepitant|mesh-list
57108677|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
57108678|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
57108679|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
57108680|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108681|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108682|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57108683|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
57108684|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
57108685|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57108686|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
57108687|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108688|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108689|NCT01362530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57108690|NCT01362530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57108691|NCT01362530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108692|NCT01362530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57108693|NCT01362530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57108694|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57108695|NCT04494399|Interferons|interferons|mesh-list
57108696|NCT04494399|Ribavirin|ribavirin|mesh-list
57108697|NCT04494399|Interferon-beta|interferon-beta|mesh-list
57108698|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
57108699|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108700|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
57108701|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108702|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
57108703|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108704|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
57108705|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108706|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57108707|NCT03323385|Meloxicam|meloxicam|mesh-list
57108708|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57108709|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108710|NCT03323385|Analgesics|analgesics|mesh-ancestor
57108711|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
57108712|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108713|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108714|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108715|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108716|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57108717|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57108718|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108719|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108720|NCT01758614|Aspirin|aspirin|mesh-list
57108721|NCT01758614|Clopidogrel|clopidogrel|mesh-list
57108722|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57108723|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57108724|NCT01758614|Analgesics|analgesics|mesh-ancestor
57108725|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
57108726|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108727|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108728|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108729|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108730|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57108731|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57108732|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108733|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57108734|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57108735|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108736|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
57108737|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57108738|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57108739|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57108740|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
57108741|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108742|NCT02490657|Iloprost|iloprost|mesh-list
57108743|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57108744|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
57108745|NCT04520048|Acetylcholine|acetylcholine|mesh-list
57108746|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
57108747|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57108748|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
57108749|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108750|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108751|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108752|NCT04442919|Morphine|morphine|mesh-list
57108753|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
57108754|NCT04442919|Ticagrelor|ticagrelor|mesh-list
57108755|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57108756|NCT04442919|Narcotics|narcotics|mesh-ancestor
57108757|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108758|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108759|NCT04442919|Analgesics|analgesics|mesh-ancestor
57108760|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
57108761|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108762|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57108763|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57108764|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57108765|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57108766|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
57108767|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108768|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108769|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57108770|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
57108771|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
57108772|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57108773|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57108774|NCT02654054|Norethindrone|norethindrone|mesh-list
57108775|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
57108776|NCT02654054|Estradiol|estradiol|mesh-list
57108777|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57108778|NCT02654054|Estrogens|estrogens|mesh-ancestor
57108779|NCT02654054|Hormones|hormones|mesh-ancestor
57108780|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108781|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108782|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57108783|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
57108784|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57108785|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57108786|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57108787|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57108788|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57108789|NCT04323566|Rituximab|rituximab|mesh-list
57108790|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57108791|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108792|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
57108793|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108794|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108795|NCT03109119|Propofol|propofol|mesh-list
57108796|NCT03109119|Sevoflurane|sevoflurane|mesh-list
57108797|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108798|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108799|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108800|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57108801|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
57108802|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
57108803|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57108804|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57108805|NCT05070104|Bevacizumab|bevacizumab|mesh-list
57108806|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57108807|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108808|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57108809|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57108810|NCT05070104|Growth Substances|growth substances|mesh-ancestor
57108811|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108812|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
57108813|NCT03326661|Clindamycin|clindamycin|mesh-list
57108814|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
57108815|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
56790648|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57108816|NCT03326661|Penicillins|penicillins|mesh-list
57108817|NCT03326661|Penicillin V|penicillin v|mesh-list
57108818|NCT03326661|Metronidazole|metronidazole|mesh-list
57108819|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108820|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108821|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57108822|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108823|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108824|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57108825|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57108826|NCT05119712|Terbinafine|terbinafine|mesh-list
57108827|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
57108828|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108829|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108830|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108831|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
57108832|NCT03186404|Atorvastatin|atorvastatin|mesh-list
57108833|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57108834|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57108835|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
57108836|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108837|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57108838|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57108839|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108841|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108842|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
57108843|NCT02492373|Hormones|hormones|mesh-ancestor
57108844|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108845|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108846|NCT03073070|Biotin|biotin|mesh-list
57108847|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
57108848|NCT03073070|Vitamins|vitamins|mesh-ancestor
57108849|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
57108850|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108851|NCT02905214|Sirolimus|sirolimus|mesh-list
57108852|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57108853|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108854|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57108855|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108856|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
57108857|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57108858|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
57108859|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108860|NCT03333603|Esomeprazole|esomeprazole|mesh-list
57108861|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57108862|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57108863|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57108864|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108865|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108866|NCT03333525|Insulin|insulin|mesh-list
57108867|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57108868|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108869|NCT05463861|Lemborexant|lemborexant|mesh-list
57108870|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57108871|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108872|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108873|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57108874|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108875|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108876|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108877|NCT03333369|Levodopa|levodopa|mesh-list
57108878|NCT03333369|Benserazide|benserazide|mesh-list
57108879|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57108880|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57108881|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
57108882|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108883|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108884|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108885|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108886|NCT03325803|Lidocaine|lidocaine|mesh-list
57108887|NCT03325803|Prilocaine|prilocaine|mesh-list
57108888|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
57108889|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
57108890|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
56790726|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
57108891|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108892|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108893|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
57108894|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108895|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57108896|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57108897|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57108898|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57108899|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108900|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
57108901|NCT03325491|Acipimox|acipimox|mesh-list
57108902|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57108903|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
57108904|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108905|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57108906|NCT04150562|Avelumab|avelumab|mesh-list
57108907|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57108908|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108909|NCT03325413|Anesthetics|anesthetics|mesh-list
57108910|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108911|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108912|NCT03325335|Midazolam|midazolam|mesh-list
57108913|NCT03325335|Remifentanil|remifentanil|mesh-list
57108914|NCT03325335|Propofol|propofol|mesh-list
57108915|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57108916|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108917|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108918|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57108919|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
57108920|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
57108921|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57108922|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57108923|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57108924|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57108925|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
57108926|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
57108927|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57108928|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108929|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57108930|NCT03325335|Narcotics|narcotics|mesh-ancestor
57108931|NCT03325335|Analgesics|analgesics|mesh-ancestor
57108932|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
57108933|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108934|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57108935|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
57108936|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
57108937|NCT05114720|Docetaxel|docetaxel|mesh-list
57108938|NCT05114720|Doxorubicin|doxorubicin|mesh-list
57108939|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57108940|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57108941|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57108942|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
57108943|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108944|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57108945|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57108946|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
57108947|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108948|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108949|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57108950|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
57108951|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
57108952|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
57108953|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57108954|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57108955|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57108956|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57108957|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57108958|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57108959|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
57108960|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57108961|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57108962|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57108963|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57108964|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
56790800|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
57108965|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57108966|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57108968|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
57108969|NCT04493463|Ropivacaine|ropivacaine|mesh-list
57108970|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57108971|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
57108972|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
57108973|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
57108974|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57108975|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108976|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
57108977|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57108978|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57108979|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
57108980|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
57108981|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57108982|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
57108983|NCT04493463|Hormones|hormones|mesh-ancestor
57108984|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57108985|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57108986|NCT04493463|Protective Agents|protective agents|mesh-ancestor
57108987|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57108988|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108989|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
57108990|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
57108991|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57108992|NCT04493073|Mitomycins|mitomycins|mesh-list
57108993|NCT04493073|Mitomycin|mitomycin|mesh-list
57108994|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57108995|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57108996|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
57108997|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57108998|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57108999|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109000|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
57109001|NCT00950846|Busulfan|busulfan|mesh-list
57109002|NCT00950846|Fludarabine|fludarabine|mesh-list
57109003|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109004|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
57109005|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109006|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57109007|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57109008|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
57109009|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109010|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109011|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57109012|NCT00748904|Rifaximin|rifaximin|mesh-list
57109013|NCT00748904|Lactulose|lactulose|mesh-list
57109014|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57109015|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109016|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57109017|NCT03321903|Charcoal|charcoal|mesh-list
57109018|NCT03321903|Antidotes|antidotes|mesh-ancestor
57109019|NCT03321903|Protective Agents|protective agents|mesh-ancestor
57109020|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109021|NCT04984616|Atorvastatin|atorvastatin|mesh-list
57109022|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57109023|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57109024|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
57109025|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109026|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57109027|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57109028|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109029|NCT04411550|Pertuzumab|pertuzumab|mesh-list
57109030|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57109031|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109032|NCT03321825|Lidocaine|lidocaine|mesh-list
57109033|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
57109034|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
57109035|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
57109036|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891148|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57109037|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109038|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
57109039|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109040|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57109041|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57109042|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57109043|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57109044|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109045|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57109046|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
57109047|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
57109048|NCT03321825|Protective Agents|protective agents|mesh-ancestor
57109049|NCT02492217|Adalimumab|adalimumab|mesh-list
57109050|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57109051|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57109052|NCT05229536|Vaccines|vaccines|mesh-list
57109053|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
57109054|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109055|NCT04810910|Molgramostim|molgramostim|mesh-list
57109056|NCT04810910|Sargramostim|sargramostim|mesh-list
57109057|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
57109058|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109059|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109060|NCT04562558|Leucovorin|leucovorin|mesh-list
57109061|NCT04562558|Dactinomycin|dactinomycin|mesh-list
57109062|NCT04562558|Methotrexate|methotrexate|mesh-list
57109063|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109064|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57109065|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
57109066|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57109067|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57109068|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
57109069|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109070|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109071|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
57109072|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109073|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57109074|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109075|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
57109076|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57109077|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57109078|NCT04562558|Antidotes|antidotes|mesh-ancestor
57109079|NCT04562558|Protective Agents|protective agents|mesh-ancestor
57109080|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
57109081|NCT04562558|Vitamins|vitamins|mesh-ancestor
57109082|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
57109083|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57109084|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109085|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57109086|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57109087|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
57109088|NCT03320187|Dinoprostone|dinoprostone|mesh-list
57109089|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
57109090|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
57109091|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57109092|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109093|NCT03320109|Vitamin D|vitamin d|mesh-list
57109094|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
57109095|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
57109096|NCT03320109|Vitamins|vitamins|mesh-list
57109097|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
57109098|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109099|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57109100|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57109101|NCT04529876|Abatacept|abatacept|mesh-list
57109102|NCT04529876|Tofacitinib|tofacitinib|mesh-list
57109103|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57109104|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109105|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109106|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109107|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
57109108|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109109|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57109110|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57109111|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109112|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
57109113|NCT03320031|Linagliptin|linagliptin|mesh-list
57109114|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57109115|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109116|NCT03320031|Incretins|incretins|mesh-ancestor
57109117|NCT03320031|Hormones|hormones|mesh-ancestor
57109118|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57109119|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57109120|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
57109121|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109122|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109123|NCT04510922|Droxidopa|droxidopa|mesh-list
57109124|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57109125|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57109126|NCT05465031|Valsartan|valsartan|mesh-list
57109127|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57109128|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57109129|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57109130|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57109131|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109132|NCT04510844|Evolocumab|evolocumab|mesh-list
57109133|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57109134|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57109135|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
57109136|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109137|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57109138|NCT05464953|Triamcinolone|triamcinolone|mesh-list
57109139|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57109140|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57109141|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57109142|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57109143|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
57109144|NCT05464953|Hormones|hormones|mesh-ancestor
57109145|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57109146|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109147|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109148|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
57109149|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109150|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109151|NCT02491749|Anesthetics|anesthetics|mesh-list
57109152|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109153|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109154|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
57109155|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57109156|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109157|NCT02490345|Gabapentin|gabapentin|mesh-list
57109158|NCT02490345|Analgesics|analgesics|mesh-ancestor
57109159|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
57109160|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109161|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109162|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
57109163|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57109164|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57109165|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109166|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57109167|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57109168|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57109169|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109170|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109171|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
57109172|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
57109173|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57109174|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57109175|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109176|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
57109177|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
57109178|NCT03319563|Epinephrine|epinephrine|mesh-list
57109179|NCT03319563|Anesthetics|anesthetics|mesh-list
57109180|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
57109181|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109182|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109183|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57109184|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57109185|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
57109186|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109187|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109188|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57109189|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57109190|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
57109191|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109192|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57109193|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
57109194|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
57109195|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
57109196|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57109197|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
57109198|NCT02484573|Propranolol|propranolol|mesh-list
57109199|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57109200|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57109201|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
57109202|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109203|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109204|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109205|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57109206|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57109207|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
57109208|NCT02489955|Tobramycin|tobramycin|mesh-list
57109209|NCT02489955|Amikacin|amikacin|mesh-list
57109210|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57109211|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109212|NCT03734744|Vitamin D|vitamin d|mesh-list
57109213|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
57109214|NCT03734744|Vitamins|vitamins|mesh-ancestor
57109215|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
57109216|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109217|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57109218|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57109219|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
57109220|NCT03576716|Calcifediol|calcifediol|mesh-list
57109221|NCT03576716|Vitamins|vitamins|mesh-ancestor
57109222|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
57109223|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109224|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57109225|NCT03436862|Nivolumab|nivolumab|mesh-list
57109226|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57109227|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109228|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57109229|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109230|NCT02487381|Dronabinol|dronabinol|mesh-list
57109231|NCT02487381|Cannabidiol|cannabidiol|mesh-list
57109232|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
57109233|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
57109234|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109235|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57109236|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57109237|NCT02487381|Analgesics|analgesics|mesh-ancestor
57109238|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
57109239|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109240|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57109241|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57109242|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109243|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109244|NCT02487381|Hormones|hormones|mesh-ancestor
57109245|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57109246|NCT02487849|Carboplatin|carboplatin|mesh-list
57109247|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109248|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57109249|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109250|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
57109251|NCT04021550|Telmisartan|telmisartan|mesh-list
57109252|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57109253|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57109254|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57109255|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109256|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
57109257|NCT04021550|Protective Agents|protective agents|mesh-ancestor
56899989|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
57109258|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109259|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
57109260|NCT04021550|Vitamins|vitamins|mesh-ancestor
57109261|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
57109262|NCT02489487|Ritonavir|ritonavir|mesh-list
57109263|NCT02489487|Darunavir|darunavir|mesh-list
57109264|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
57109265|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57109266|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57109267|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
57109268|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109269|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109271|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57109272|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
57109273|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109274|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57109275|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57109276|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57109277|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57109278|NCT02096354|Irinotecan|irinotecan|mesh-list
57109279|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109280|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57109281|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57109282|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109283|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109284|NCT02487069|Cyclosporine|cyclosporine|mesh-list
57109285|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
57109286|NCT02487069|Methotrexate|methotrexate|mesh-list
57109287|NCT02487069|Cyclosporins|cyclosporins|mesh-list
57109288|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57109289|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57109290|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
57109291|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57109292|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109293|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57109294|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
57109295|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109296|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109297|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
57109298|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109299|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57109300|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109301|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
57109302|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57109303|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57109304|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
57109305|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109306|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57109307|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57109308|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57109309|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
57109310|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57109311|NCT03177746|Tadalafil|tadalafil|mesh-list
57109312|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
57109313|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57109314|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57109315|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109316|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109317|NCT03177746|Urological Agents|urological agents|mesh-ancestor
57109318|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57109319|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57109320|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57109321|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
57109322|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109323|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57109324|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57109325|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109326|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57109327|NCT02483715|Amoxicillin|amoxicillin|mesh-list
57109328|NCT02483715|Metronidazole|metronidazole|mesh-list
57109329|NCT02483715|Tetracycline|tetracycline|mesh-list
57109330|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57109331|NCT02483715|Rabeprazole|rabeprazole|mesh-list
57109332|NCT02483715|Bismuth|bismuth|mesh-list
57109333|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57109334|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109335|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
57109336|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57109337|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57109338|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57109339|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57109340|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109341|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109342|NCT02483715|Antacids|antacids|mesh-ancestor
57109343|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57109345|NCT02483793|Oxybutynin|oxybutynin|mesh-list
57109346|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57109347|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57109348|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57109349|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
57109350|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109351|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109352|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109353|NCT02483793|Urological Agents|urological agents|mesh-ancestor
57109354|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
57109355|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
57109356|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109357|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57109358|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57109359|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
57109360|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
57109361|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57109362|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
57109363|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109364|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
57109365|NCT03200288|Protective Agents|protective agents|mesh-ancestor
57109366|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
57109367|NCT03318471|Analgesics|analgesics|mesh-ancestor
57109368|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
57109369|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109370|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109371|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
57109372|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109373|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57109374|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
57109375|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57109376|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57109377|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109378|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57109379|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
57109380|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57109381|NCT04234022|Pomalidomide|pomalidomide|mesh-list
57109382|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
57109383|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109384|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57109385|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57109386|NCT04234022|Growth Substances|growth substances|mesh-ancestor
57109387|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
57109388|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109389|NCT02489409|Gemcitabine|gemcitabine|mesh-list
57109390|NCT02489409|Vinorelbine|vinorelbine|mesh-list
57109391|NCT02489409|Endostatins|endostatins|mesh-list
57109392|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57109393|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
57109394|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109395|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109396|NCT02489409|Antiviral Agents|antiviral agents|mesh-ancestor
57109397|NCT02489409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109398|NCT02489409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109399|NCT02489409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109400|NCT02489409|Immunologic Factors|immunologic factors|mesh-ancestor
57109401|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109402|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57109403|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
57109404|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
57109405|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
57109406|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57109407|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57109408|NCT02489409|Growth Substances|growth substances|mesh-ancestor
57109409|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
57109410|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
57109411|NCT03930602|BMS-986165|bms-986165|mesh-list
57109412|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57109413|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57109414|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109415|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109416|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57109417|NCT03930602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57109418|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57109419|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57109420|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109421|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109422|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
57109423|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57109424|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
57109425|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57109426|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57109427|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109428|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57109429|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
57109430|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57109431|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57109432|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57109433|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57109434|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
57109435|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109436|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57109437|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57109438|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109439|NCT02489019|Fentanyl|fentanyl|mesh-list
57109440|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57109441|NCT02489019|Narcotics|narcotics|mesh-ancestor
57109442|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109443|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109444|NCT02489019|Analgesics|analgesics|mesh-ancestor
57109445|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
57109446|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109447|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57109448|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57109449|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
57109450|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
57109451|NCT02604446|Oxycodone|oxycodone|mesh-list
57109452|NCT02604446|Tapentadol|tapentadol|mesh-list
57109453|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57109454|NCT02604446|Narcotics|narcotics|mesh-ancestor
57109455|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109456|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109457|NCT02604446|Analgesics|analgesics|mesh-ancestor
57109458|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
57109459|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109460|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57109461|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57109462|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57109463|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109464|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
57109465|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109466|NCT02847637|Factor VIII|factor viii|mesh-list
57109467|NCT02847637|Coagulants|coagulants|mesh-ancestor
57109468|NCT02652260|Tenofovir|tenofovir|mesh-list
57109469|NCT02652260|Lamivudine|lamivudine|mesh-list
57109470|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57109471|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
57109472|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109473|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57109474|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57109475|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109476|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109477|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57109478|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57109479|NCT01710176|Gemcitabine|gemcitabine|mesh-list
57109480|NCT01710176|Docetaxel|docetaxel|mesh-list
57109481|NCT01710176|Etoposide|etoposide|mesh-list
57109482|NCT01710176|Epirubicin|epirubicin|mesh-list
57109483|NCT01710176|Ifosfamide|ifosfamide|mesh-list
57109484|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
57109485|NCT01710176|Dacarbazine|dacarbazine|mesh-list
57109486|NCT01710176|Trabectedin|trabectedin|mesh-list
57109487|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57109488|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
57109489|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109490|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109491|NCT01710176|Antiviral Agents|antiviral agents|mesh-ancestor
57109492|NCT01710176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109493|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109494|NCT01710176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109495|NCT01710176|Immunologic Factors|immunologic factors|mesh-ancestor
57109496|NCT01710176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109497|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
57109498|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
57109499|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
57109500|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57109501|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57109502|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57109503|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57109504|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57109505|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
57109507|NCT00584246|Analgesics|analgesics|mesh-ancestor
57109508|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
57109509|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109510|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109511|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
57109512|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57109513|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57109514|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109515|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57109516|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57109517|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57109518|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109519|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57109520|NCT05124314|Misoprostol|misoprostol|mesh-list
57109521|NCT05124314|Mifepristone|mifepristone|mesh-list
57109522|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57109523|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
57109524|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57109525|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109526|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57109527|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57109528|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
57109529|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57109530|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57109531|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57109532|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57109533|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
57109534|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57109535|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57109536|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
57109537|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57109538|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
57109539|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57109540|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57109541|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
57109542|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
57109543|NCT03320967|Coagulants|coagulants|mesh-ancestor
57109544|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57109545|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57109546|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
57109547|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109548|NCT02483325|Fludarabine|fludarabine|mesh-list
57109549|NCT02483325|Busulfan|busulfan|mesh-list
57109550|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
57109551|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899998|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57109552|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109553|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109554|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
57109555|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109556|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
57109557|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57109558|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57109559|NCT04212026|Nivolumab|nivolumab|mesh-list
57109560|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57109561|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109562|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57109563|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109564|NCT04211090|Carboplatin|carboplatin|mesh-list
57109565|NCT04211090|Pemetrexed|pemetrexed|mesh-list
56791404|NCT00515216|Vitamins|vitamins|mesh-ancestor
57109566|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109567|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109568|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109569|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57109570|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57109572|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57109573|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
57109574|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57109575|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
57109576|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109577|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109578|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
57109579|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
57109580|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57109581|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109582|NCT04538534|Nicardipine|nicardipine|mesh-list
57109583|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57109584|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57109585|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57109586|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109587|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57109588|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109589|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
57109590|NCT03318159|Posaconazole|posaconazole|mesh-list
57109591|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
57109592|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109593|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57109594|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57109595|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57109596|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57109597|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57109598|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109599|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109600|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57109601|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
57109602|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57109603|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109604|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
57109605|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
57109606|NCT02724410|Amoxicillin|amoxicillin|mesh-list
57109607|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
57109608|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
57109609|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57109610|NCT02724410|Ertapenem|ertapenem|mesh-list
57109611|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57109612|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109613|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57109614|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109615|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109616|NCT02486601|Paclitaxel|paclitaxel|mesh-list
57109617|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57109618|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109619|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
57109620|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
57109621|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
57109622|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109623|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
57109624|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109625|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109626|NCT03317847|Dexamethasone|dexamethasone|mesh-list
57109627|NCT03317847|Bromfenac|bromfenac|mesh-list
57109628|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57109629|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57109630|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
57109631|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
57109632|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109633|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109634|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57109635|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
57109636|NCT03317847|Hormones|hormones|mesh-ancestor
57109637|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57109638|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57109639|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109640|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57109641|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57109642|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57109643|NCT03317847|Analgesics|analgesics|mesh-ancestor
57109644|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
57109645|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57109646|NCT01342081|Timolol|timolol|mesh-list
57109647|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57109648|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57109649|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57109650|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57109651|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
57109652|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109653|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109654|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109655|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57109656|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57109657|NCT03563833|Anesthetics|anesthetics|mesh-list
57109658|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109659|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109660|NCT02483169|Aspirin|aspirin|mesh-list
57109661|NCT02483169|Cilostazol|cilostazol|mesh-list
57109662|NCT02483169|Probucol|probucol|mesh-list
57109663|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57109664|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57109665|NCT02483169|Analgesics|analgesics|mesh-ancestor
57109666|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
57109667|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109668|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109669|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57109670|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57109671|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57109672|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57109673|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109674|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57109675|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57109676|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109677|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
57109678|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57109679|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
57109680|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57109681|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
57109682|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
57109683|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57109684|NCT02483169|Protective Agents|protective agents|mesh-ancestor
57109685|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57109686|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57109687|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57109688|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57109689|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
57109690|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57109691|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
57109692|NCT02256800|Leucovorin|leucovorin|mesh-list
57109693|NCT02256800|Bevacizumab|bevacizumab|mesh-list
57109694|NCT02256800|Irinotecan|irinotecan|mesh-list
57109695|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57109696|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109697|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57109698|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57109699|NCT02256800|Growth Substances|growth substances|mesh-ancestor
57109700|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109701|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
57109702|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57109703|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57109704|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109705|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109706|NCT02256800|Antidotes|antidotes|mesh-ancestor
57109707|NCT02256800|Protective Agents|protective agents|mesh-ancestor
57109708|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
57109709|NCT02256800|Vitamins|vitamins|mesh-ancestor
57109710|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
57109711|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
57109712|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57109713|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
57109714|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
57109715|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109716|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109717|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57109719|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
57109720|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109721|NCT02203682|Doxycycline|doxycycline|mesh-list
57109722|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57109723|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109724|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
57109725|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57109726|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57109727|NCT01611116|Sirolimus|sirolimus|mesh-list
57109728|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57109729|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109730|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57109731|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109732|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
57109733|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109734|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
57109735|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109736|NCT01341457|Gemcitabine|gemcitabine|mesh-list
57109737|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57109738|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
57109739|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109740|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109741|NCT01341457|Antiviral Agents|antiviral agents|mesh-ancestor
57109742|NCT01341457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109743|NCT01341457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109744|NCT01341457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109745|NCT01341457|Immunologic Factors|immunologic factors|mesh-ancestor
57109746|NCT01341457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109747|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
57109748|NCT02488473|Ropivacaine|ropivacaine|mesh-list
57109749|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57109750|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109751|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109752|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57109753|NCT02488473|Analgesics|analgesics|mesh-ancestor
57109754|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
57109755|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109756|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57109757|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57109758|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57109759|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
57109760|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109761|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109762|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
57109763|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
57109764|NCT05128292|Selenium|selenium|mesh-list
57109765|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
57109766|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109767|NCT05128292|Protective Agents|protective agents|mesh-ancestor
57109768|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109769|NCT05128292|Trace Elements|trace elements|mesh-ancestor
57109770|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
57109771|NCT05127980|Antibodies|antibodies|mesh-list
57109772|NCT05127980|Autoantibodies|autoantibodies|mesh-list
57109773|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
57109774|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109775|NCT03971708|Lidocaine|lidocaine|mesh-list
57109776|NCT03971708|Ropivacaine|ropivacaine|mesh-list
57109777|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
57109778|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
57109779|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109780|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109781|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
57109782|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109783|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57109784|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57109785|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57109786|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57109787|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109788|NCT02832037|BI 425809|bi 425809|mesh-list
57109789|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
57109790|NCT03966014|Amoxicillin|amoxicillin|mesh-list
57109791|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57109792|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109794|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57109795|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57109796|NCT02482857|Analgesics|analgesics|mesh-ancestor
57109797|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
57109798|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109799|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109800|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57109801|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57109802|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57109803|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57109804|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109805|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57109806|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57109807|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109808|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
57109809|NCT05463393|Xanthohumol|xanthohumol|mesh-list
57109810|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109811|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57109812|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57109813|NCT05463393|Growth Substances|growth substances|mesh-ancestor
57109814|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109815|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
57109816|NCT03955172|Everolimus|everolimus|mesh-list
57109817|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109818|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109819|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
57109820|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109821|NCT04200248|Aflibercept|aflibercept|mesh-list
57109822|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57109823|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57109824|NCT04200248|Growth Substances|growth substances|mesh-ancestor
57109825|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109826|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
57109827|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109828|NCT02480049|Montelukast|montelukast|mesh-list
57109829|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57109830|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
57109831|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57109832|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
57109833|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57109834|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109835|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57109836|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57109837|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109838|NCT02620046|Vedolizumab|vedolizumab|mesh-list
57109839|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57109840|NCT02479971|Clindamycin|clindamycin|mesh-list
57109841|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
57109842|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
57109843|NCT02479971|Gentamicins|gentamicins|mesh-list
57109844|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57109845|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109846|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57109847|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109848|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109849|NCT02486133|Ritonavir|ritonavir|mesh-list
57109850|NCT02486133|Darunavir|darunavir|mesh-list
57109851|NCT02486133|Tenofovir|tenofovir|mesh-list
57109852|NCT02486133|Lamivudine|lamivudine|mesh-list
57109853|NCT02486133|Emtricitabine|emtricitabine|mesh-list
57109854|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57109855|NCT02486133|Dolutegravir|dolutegravir|mesh-list
57109856|NCT02486133|Abacavir|abacavir|mesh-list
57109857|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57109858|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57109859|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
57109860|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109861|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109862|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57109863|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57109864|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
57109865|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109866|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57109867|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57109868|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57109869|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57109870|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57109871|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57109872|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
57109873|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
57109874|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109875|NCT02486055|Vitamins|vitamins|mesh-ancestor
57109876|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
57109877|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
57109878|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
57109879|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109880|NCT02485821|Misoprostol|misoprostol|mesh-list
57109881|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57109882|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57109883|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57109884|NCT02485821|Estradiol|estradiol|mesh-list
57109885|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57109886|NCT02485821|Estrogens|estrogens|mesh-ancestor
57109887|NCT02485821|Hormones|hormones|mesh-ancestor
57109888|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57109889|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109890|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57109891|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
57109892|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57109893|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57109894|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57109895|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
57109896|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57109897|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57109898|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
57109899|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57109900|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57109901|NCT05127746|Donepezil|donepezil|mesh-list
57109902|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57109903|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109904|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109905|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
57109906|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109907|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109908|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
57109909|NCT02479815|Micronutrients|micronutrients|mesh-list
57109910|NCT02479815|Trace Elements|trace elements|mesh-list
57109911|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109912|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
57109913|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
57109914|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57109915|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109916|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
57109917|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109918|NCT04049786|Metoprolol|metoprolol|mesh-list
57109919|NCT04049786|Carvedilol|carvedilol|mesh-list
57109920|NCT04049786|Midazolam|midazolam|mesh-list
57109921|NCT04049786|Simvastatin|simvastatin|mesh-list
57109922|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57109923|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57109924|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57109925|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109926|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57109927|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57109928|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57109929|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57109930|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
57109931|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
57109932|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
57109933|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
57109934|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57109935|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109936|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57109937|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57109938|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
57109939|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57109940|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57109941|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791785|NCT03249012|Vitamins|vitamins|mesh-ancestor
57109942|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57109943|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57109944|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
57109945|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
57109946|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109947|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57109948|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57109949|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57109950|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
57109951|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
57109952|NCT04049786|Protective Agents|protective agents|mesh-ancestor
57109953|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57109954|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57109955|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57109956|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
57109957|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57109958|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57109959|NCT02482311|Adavosertib|adavosertib|mesh-list
57109960|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109961|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109962|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
57109963|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
57109964|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109965|NCT03316599|Gemcitabine|gemcitabine|mesh-list
57109966|NCT03316599|Paclitaxel|paclitaxel|mesh-list
57109967|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57109968|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57109969|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
57109970|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
57109971|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
57109972|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109973|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57109974|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
57109975|NCT03316599|Antiviral Agents|antiviral agents|mesh-ancestor
57109976|NCT03316599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57109977|NCT03316599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109978|NCT03316599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57109979|NCT03316599|Immunologic Factors|immunologic factors|mesh-ancestor
57109980|NCT03316599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109981|NCT02482155|Ibuprofen|ibuprofen|mesh-list
57109982|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57109983|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57109984|NCT02482155|Analgesics|analgesics|mesh-ancestor
57109985|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
57109986|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57109987|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57109988|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57109989|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57109990|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57109991|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109992|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109993|NCT01675154|Orlistat|orlistat|mesh-list
57109994|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57109995|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57109996|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57109997|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57109998|NCT02485431|Deflazacort|deflazacort|mesh-list
57109999|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57110000|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57110001|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
57110002|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110003|NCT02744755|Adalimumab|adalimumab|mesh-list
57110004|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57110005|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57110006|NCT03314493|Spironolactone|spironolactone|mesh-list
57110007|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57110008|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
57110009|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110010|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110011|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57110012|NCT03314493|Diuretics|diuretics|mesh-ancestor
57110013|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
57110014|NCT03829514|Fenofibrate|fenofibrate|mesh-list
57110015|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57110016|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
57110017|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110018|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57110019|NCT03801200|Apatinib|apatinib|mesh-list
57110020|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110021|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57110022|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110023|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110024|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
57110025|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57110026|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57110027|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110028|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
57110029|NCT03801122|Coagulants|coagulants|mesh-ancestor
57110030|NCT02485041|Mirodenafil|mirodenafil|mesh-list
57110031|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57110032|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57110033|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110034|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110035|NCT02484885|Xenon|xenon|mesh-list
57110036|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57110037|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
57110038|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
57110039|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110040|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110041|NCT02484963|Zolpidem|zolpidem|mesh-list
57110042|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57110043|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57110044|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110045|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110046|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57110047|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
57110048|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
57110049|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110050|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110051|NCT05713773|Caffeine|caffeine|mesh-list
57110052|NCT05713773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57110053|NCT05713773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110054|NCT05713773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57110055|NCT05713773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110056|NCT05713773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110057|NCT05713773|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57110058|NCT05713773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57110059|NCT05713773|Purinergic Agents|purinergic agents|mesh-ancestor
57110060|NCT05713773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110061|NCT05708053|Metformin|metformin|mesh-list
57110062|NCT05708053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57110063|NCT05708053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110064|NCT02829775|Interferons|interferons|mesh-list
57110065|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
57110066|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
57110067|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57110068|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110069|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
57110070|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110071|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
57110072|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110073|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
57110074|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57110075|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
57110076|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110077|NCT02476773|Antacids|antacids|mesh-ancestor
57110078|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110079|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110080|NCT04500860|Tadalafil|tadalafil|mesh-list
57110081|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
57110082|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
57110083|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57110084|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57110085|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110086|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110087|NCT04500860|Urological Agents|urological agents|mesh-ancestor
57110088|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57110089|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57110090|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
57110091|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110092|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110093|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57110094|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110095|NCT02479581|Floxacillin|floxacillin|mesh-list
57110096|NCT02479581|Dexamethasone|dexamethasone|mesh-list
57110097|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
57110098|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57110099|NCT02479581|Scopolamine|scopolamine|mesh-list
57110100|NCT02479581|Morphine|morphine|mesh-list
57110101|NCT02479581|Anesthetics|anesthetics|mesh-list
57110102|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57110103|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
57110104|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
57110105|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110106|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110107|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110108|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
57110109|NCT02479581|Hormones|hormones|mesh-ancestor
57110110|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110111|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57110112|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110113|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110114|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110115|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57110116|NCT02479581|Narcotics|narcotics|mesh-ancestor
57110117|NCT02479581|Analgesics|analgesics|mesh-ancestor
57110118|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
57110119|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57110120|NCT02479581|Protective Agents|protective agents|mesh-ancestor
57110121|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57110122|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
57110123|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57110124|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
57110125|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110126|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57110127|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57110128|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110129|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
57110130|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
57110131|NCT02479347|Povidone|povidone|mesh-list
57110132|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57110133|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110134|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
57110135|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
57110136|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
57110137|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57110138|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57110139|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
57110140|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57110141|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
57110142|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57110143|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
57110144|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110145|NCT02481609|Expectorants|expectorants|mesh-ancestor
57110146|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
57110147|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57110148|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
57110149|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110150|NCT02481609|Protective Agents|protective agents|mesh-ancestor
57110151|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110152|NCT02481609|Antidotes|antidotes|mesh-ancestor
57110153|NCT05373225|Acetic Acid|acetic acid|mesh-list
57110154|NCT05373225|Retinol acetate|retinol acetate|mesh-list
57110155|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57110156|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110157|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57110158|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
57110159|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110160|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57110161|NCT05373225|Protective Agents|protective agents|mesh-ancestor
57110162|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110163|NCT01355575|Rifaximin|rifaximin|mesh-list
57110164|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57110165|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110166|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110167|NCT05125640|Progesterone|progesterone|mesh-list
57110168|NCT05125640|Progestins|progestins|mesh-ancestor
56792012|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57110169|NCT05125640|Hormones|hormones|mesh-ancestor
57110170|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110171|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110172|NCT03314259|Tamsulosin|tamsulosin|mesh-list
57110173|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57110174|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57110175|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57110176|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
57110177|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110178|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110179|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110180|NCT03314259|Urological Agents|urological agents|mesh-ancestor
57110181|NCT05125328|Remifentanil|remifentanil|mesh-list
57110182|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57110183|NCT05125328|Narcotics|narcotics|mesh-ancestor
57110184|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110185|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110186|NCT05125328|Analgesics|analgesics|mesh-ancestor
57110187|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
57110188|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110189|NCT02481453|Sirolimus|sirolimus|mesh-list
57110190|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57110191|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110192|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57110193|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110194|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
57110195|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57110196|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
57110197|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110198|NCT02825251|Insulin|insulin|mesh-list
57110199|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57110200|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
57110201|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
57110202|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
57110203|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57110204|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110205|NCT03563365|Adapalene|adapalene|mesh-list
57110206|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57110207|NCT03563365|Resveratrol|resveratrol|mesh-list
57110208|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
57110209|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110210|NCT03563365|Protective Agents|protective agents|mesh-ancestor
57110211|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110212|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110213|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57110214|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
57110215|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57110216|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57110217|NCT03563365|Analgesics|analgesics|mesh-ancestor
57110218|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
57110219|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110220|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57110221|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57110222|NCT02475915|Tenofovir|tenofovir|mesh-list
57110223|NCT02475915|Emtricitabine|emtricitabine|mesh-list
57110224|NCT02475915|Efavirenz|efavirenz|mesh-list
57110225|NCT02475915|Maraviroc|maraviroc|mesh-list
57110226|NCT02475915|Darunavir|darunavir|mesh-list
57110227|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
57110228|NCT02475915|Vorinostat|vorinostat|mesh-list
57110229|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
57110230|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110231|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57110232|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57110233|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110234|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110235|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57110236|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57110237|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
57110238|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57110239|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57110240|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57110241|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57110242|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57110243|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57110244|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57110245|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57110246|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57110247|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110248|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57110249|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57110250|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57110251|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57110252|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57110253|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57110254|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
57110255|NCT05124457|Insulin|insulin|mesh-list
57110256|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57110257|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
57110258|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
57110259|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
57110260|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
57110261|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57110262|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110263|NCT03833323|Treprostinil|treprostinil|mesh-list
57110264|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57110265|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
57110266|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57110267|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
57110268|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57110269|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57110270|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110271|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55891149|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110272|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110273|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57110274|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110275|NCT02824627|Oxytocin|oxytocin|mesh-list
57110276|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
57110277|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57110278|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110279|NCT05384847|Hormones|hormones|mesh-list
57110280|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110281|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110282|NCT05020327|Amoxicillin|amoxicillin|mesh-list
57110283|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57110284|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110285|NCT02478879|Teriparatide|teriparatide|mesh-list
57110286|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
57110287|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110288|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57110289|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57110290|NCT02478645|Ramosetron|ramosetron|mesh-list
57110291|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
57110292|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
57110293|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110294|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110295|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110296|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57110297|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
57110298|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110299|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110300|NCT03829579|Esketamine|esketamine|mesh-list
57110301|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
57110302|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57110303|NCT03070951|OBE2109|obe2109|mesh-list
57110304|NCT03070951|Hormone Antagonists|hormone antagonists|mesh-ancestor
57110305|NCT03070951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110306|NCT03070951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110307|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57110308|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57110309|NCT01362296|Docetaxel|docetaxel|mesh-list
57110310|NCT01362296|Trametinib|trametinib|mesh-list
57110311|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110312|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
57110313|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
57110314|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
57110315|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110316|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57110317|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110318|NCT01338415|Bosentan|bosentan|mesh-list
57110319|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57110320|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56792167|NCT03601637|Ivacaftor|ivacaftor|mesh-list
57110321|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110322|NCT04353128|Melatonin|melatonin|mesh-list
57110323|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
57110324|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110325|NCT04353128|Protective Agents|protective agents|mesh-ancestor
57110326|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110327|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110328|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
57110329|NCT04263350|Cobicistat|cobicistat|mesh-list
57110330|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57110331|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57110332|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
57110333|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110334|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110335|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57110336|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57110337|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
57110338|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110339|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57110340|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57110341|NCT03562585|Antibodies|antibodies|mesh-list
57110342|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57110343|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
56900035|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
57110344|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110345|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
57110346|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
57110347|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110348|NCT04574713|Candesartan|candesartan|mesh-list
57110349|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
57110350|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57110351|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57110352|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57110353|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110354|NCT05124938|Hormones|hormones|mesh-list
57110355|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110356|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110357|NCT02259985|Itasetron|itasetron|mesh-list
57110358|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
57110359|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
57110360|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110361|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110362|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110363|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57110364|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57110365|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
57110366|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110367|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110368|NCT03131726|Simvastatin|simvastatin|mesh-list
57110369|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57110370|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57110371|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
57110372|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110373|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57110374|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57110375|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110376|NCT01371643|Octreotide|octreotide|mesh-list
57110377|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110378|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57110379|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110380|NCT03023462|Droperidol|droperidol|mesh-list
57110381|NCT03023462|Oxycodone|oxycodone|mesh-list
57110382|NCT03023462|Ondansetron|ondansetron|mesh-list
57110383|NCT03023462|Ropivacaine|ropivacaine|mesh-list
57110384|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
57110385|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
57110386|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110387|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110388|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
57110389|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110390|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57110391|NCT03023462|Narcotics|narcotics|mesh-ancestor
57110392|NCT03023462|Analgesics|analgesics|mesh-ancestor
57110393|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
57110394|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
57110395|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110396|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
57110397|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
57110398|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57110399|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
57110400|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110401|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110402|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57110403|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57110404|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57110405|NCT03023462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57110406|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57110407|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57110408|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57110409|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
57110410|NCT02824952|Osimertinib|osimertinib|mesh-list
57110411|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110412|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57110413|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110414|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110415|NCT01371565|Mifepristone|mifepristone|mesh-list
57110416|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57110417|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
57110418|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57110419|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110420|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57110421|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57110422|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57110423|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
57110424|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57110425|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57110426|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
57110427|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110428|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
57110429|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57110430|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57110431|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
57110432|NCT02821819|Hormones|hormones|mesh-ancestor
57110433|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110434|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110435|NCT04500548|Nivolumab|nivolumab|mesh-list
57110436|NCT04500548|Ipilimumab|ipilimumab|mesh-list
57110437|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110438|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110439|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57110440|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110441|NCT05707819|Antibodies|antibodies|mesh-list
57110442|NCT05707819|Immunologic Factors|immunologic factors|mesh-ancestor
57110443|NCT05707819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110444|NCT03034538|Zonisamide|zonisamide|mesh-list
57110445|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
57110446|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57110447|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57110448|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110449|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57110450|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110451|NCT02468180|Polidocanol|polidocanol|mesh-list
57110452|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57110453|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57110454|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
57110455|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57110456|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57110457|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110458|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57110459|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57110460|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
57110461|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110462|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
57110463|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110464|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110465|NCT00094016|Beclomethasone|beclomethasone|mesh-list
57110466|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57110467|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
57110468|NCT00094016|Hormones|hormones|mesh-ancestor
57110469|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110470|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110471|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57110472|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
57110473|NCT05134298|Meropenem|meropenem|mesh-list
57110474|NCT05134298|Tazobactam|tazobactam|mesh-list
57110475|NCT05134298|Piperacillin|piperacillin|mesh-list
57110476|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57110477|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57110478|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110479|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57110480|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110481|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110482|NCT05134220|Calcium|calcium|mesh-list
57110483|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57110484|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110485|NCT03910387|Gemcitabine|gemcitabine|mesh-list
57110486|NCT03910387|Paclitaxel|paclitaxel|mesh-list
57110487|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57110488|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57110489|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110490|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
57110491|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
57110492|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
57110493|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110494|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57110495|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
57110496|NCT03910387|Antiviral Agents|antiviral agents|mesh-ancestor
57110497|NCT03910387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110498|NCT03910387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110499|NCT03910387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57110500|NCT03910387|Immunologic Factors|immunologic factors|mesh-ancestor
57110501|NCT03910387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110502|NCT03562507|Nivolumab|nivolumab|mesh-list
57110503|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110504|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110505|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57110506|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110507|NCT03954379|Dexamethasone|dexamethasone|mesh-list
57110508|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
57110509|NCT03954379|Analgesics|analgesics|mesh-list
57110510|NCT03954379|Anesthetics|anesthetics|mesh-list
57110511|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
57110512|NCT03954379|BB 1101|bb 1101|mesh-list
57110513|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57110514|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
57110515|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
57110516|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110517|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110518|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110519|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
57110520|NCT03954379|Hormones|hormones|mesh-ancestor
57110521|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110522|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57110523|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110524|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
57110525|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110526|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110527|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110528|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
57110529|NCT03843463|Dexetimide|dexetimide|mesh-list
57110530|NCT03843463|Citalopram|citalopram|mesh-list
57110531|NCT03843463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57110532|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57110533|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57110534|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110535|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110536|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
57110537|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110538|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57110539|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
57110540|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57110541|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57110542|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57110543|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
57110544|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
57110545|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110547|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57110548|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
57110549|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
57110550|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57110551|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57110552|NCT02036125|Prednisolone|prednisolone|mesh-list
57110553|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
57110554|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57110555|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
57110556|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57110557|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
57110558|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
57110559|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110560|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110561|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110562|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
57110563|NCT02036125|Hormones|hormones|mesh-ancestor
57110564|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110565|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57110566|NCT02036125|Protective Agents|protective agents|mesh-ancestor
57110567|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57110568|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110569|NCT02818777|Cannabidiol|cannabidiol|mesh-list
57110570|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
57110571|NCT05128916|Terbinafine|terbinafine|mesh-list
57110572|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
57110573|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110574|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110575|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110576|NCT05133050|Ramipril|ramipril|mesh-list
57110577|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57110578|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
57110579|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110580|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110581|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57110582|NCT02817841|Drospirenone|drospirenone|mesh-list
57110583|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57110584|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
57110585|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110586|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110587|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57110588|NCT02817841|Diuretics|diuretics|mesh-ancestor
57110589|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
57110590|NCT05704933|Nivolumab|nivolumab|mesh-list
57110591|NCT05704933|Ipilimumab|ipilimumab|mesh-list
57110592|NCT05704933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110593|NCT05704933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110594|NCT05704933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57110595|NCT05704933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110596|NCT05132270|Thalidomide|thalidomide|mesh-list
57110597|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
57110598|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57110599|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
57110600|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110601|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
57110602|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57110603|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110604|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57110605|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57110606|NCT05132270|Growth Substances|growth substances|mesh-ancestor
57110607|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
57110608|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110609|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
57110610|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110611|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110612|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57110613|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
57110614|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57110615|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
57110616|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57110617|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57110618|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110619|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57110620|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110621|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57110622|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110623|NCT05121038|Leucovorin|leucovorin|mesh-list
57110624|NCT05121038|Fluorouracil|fluorouracil|mesh-list
57110625|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
57110626|NCT05121038|Irinotecan|irinotecan|mesh-list
57110627|NCT05121038|Panitumumab|panitumumab|mesh-list
57110628|NCT05121038|Folfirinox|folfirinox|mesh-list
57110629|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
57110630|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110631|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57110632|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110633|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57110634|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
57110635|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110636|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57110637|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57110638|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110639|NCT05121038|Antidotes|antidotes|mesh-ancestor
57110640|NCT05121038|Protective Agents|protective agents|mesh-ancestor
57110641|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
57110642|NCT05121038|Vitamins|vitamins|mesh-ancestor
57110643|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
57110644|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110645|NCT05097794|Indapamide|indapamide|mesh-list
57110646|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57110647|NCT05097794|Diuretics|diuretics|mesh-ancestor
57110648|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
57110649|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110650|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57110651|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57110652|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110653|NCT02036281|Substance P|substance p|mesh-list
57110654|NCT02036281|Neurokinin A|neurokinin a|mesh-list
57110655|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110656|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110657|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110658|NCT02036359|Docetaxel|docetaxel|mesh-list
57110659|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57110660|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110661|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
57110662|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
57110663|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
57110664|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110665|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57110666|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110667|NCT04635644|Morphine|morphine|mesh-list
57110668|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57110669|NCT04635644|Narcotics|narcotics|mesh-ancestor
57110670|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110671|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110672|NCT04635644|Analgesics|analgesics|mesh-ancestor
57110673|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
57110674|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110675|NCT02036437|Misoprostol|misoprostol|mesh-list
57110676|NCT02036437|Dinoprostone|dinoprostone|mesh-list
57110677|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57110678|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
57110679|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57110680|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110681|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57110682|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57110683|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
57110684|NCT05027360|Nitroprusside|nitroprusside|mesh-list
57110685|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57110686|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
57110687|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57110688|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110689|NCT02036983|Anesthetics|anesthetics|mesh-list
57110690|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
57110691|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110692|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110693|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
57110694|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110695|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
56792553|NCT00903227|Xhance|xhance|mesh-list
57110696|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110697|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
57110698|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110699|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110700|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57110701|NCT05689177|Vaccines|vaccines|mesh-list
57110702|NCT05689177|Immunologic Factors|immunologic factors|mesh-ancestor
57110703|NCT05689177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110704|NCT04818320|Favipiravir|favipiravir|mesh-list
57110705|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
57110706|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110707|NCT02475135|Tenofovir|tenofovir|mesh-list
57110708|NCT02475135|Emtricitabine|emtricitabine|mesh-list
57110709|NCT02475135|Darunavir|darunavir|mesh-list
57110710|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57110711|NCT02475135|Cobicistat|cobicistat|mesh-list
57110712|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57110713|NCT02475135|Elvitegravir|elvitegravir|mesh-list
57110714|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
57110715|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
57110716|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57110717|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57110718|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57110719|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110720|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110721|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57110722|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57110723|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57110724|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57110725|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
57110726|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57110727|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57110728|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57110729|NCT05161754|Hemostatics|hemostatics|mesh-list
57110730|NCT05161754|Coagulants|coagulants|mesh-ancestor
57110731|NCT05137262|Cisplatin|cisplatin|mesh-list
57110732|NCT05137262|Doxorubicin|doxorubicin|mesh-list
57110733|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57110734|NCT05137262|Methotrexate|methotrexate|mesh-list
57110735|NCT05137262|Durvalumab|durvalumab|mesh-list
57110736|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
57110737|NCT05137262|Vinblastine|vinblastine|mesh-list
57110738|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110739|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57110740|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57110741|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57110742|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110743|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110744|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57110745|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
57110746|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57110747|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110748|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57110749|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
57110750|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
57110751|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57110752|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57110753|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
57110754|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57110755|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57110756|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110757|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57110758|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
57110759|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110760|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57110761|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57110762|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
57110763|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
57110764|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
57110765|NCT05714631|Lidocaine|lidocaine|mesh-list
57110766|NCT05714631|Anesthetics, Local|anesthetics, local|mesh-ancestor
57110767|NCT05714631|Anesthetics|anesthetics|mesh-ancestor
57110768|NCT05714631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110769|NCT05714631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110770|NCT05714631|Sensory System Agents|sensory system agents|mesh-ancestor
57110771|NCT05714631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110772|NCT05714631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57110773|NCT05714631|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57110774|NCT05714631|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57110775|NCT05714631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57110776|NCT05714631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110777|NCT05118620|Bupivacaine|bupivacaine|mesh-list
57110778|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
57110779|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
57110780|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110781|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110782|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
57110783|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110784|NCT02814643|Benralizumab|benralizumab|mesh-list
57110785|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57110786|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
57110787|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
57110788|NCT05080790|Interleukin-2|interleukin-2|mesh-list
57110789|NCT05080790|Dinutuximab|dinutuximab|mesh-list
57110790|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110791|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57110792|NCT05080790|Analgesics|analgesics|mesh-ancestor
57110793|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
57110794|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110795|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110796|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57110797|NCT02036827|Bromides|bromides|mesh-list
57110798|NCT02036827|Rocuronium|rocuronium|mesh-list
57110799|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
57110800|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57110801|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57110802|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57110803|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110804|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110805|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
57110806|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110807|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110808|NCT05714553|Leucovorin|leucovorin|mesh-list
57110809|NCT05714553|Docetaxel|docetaxel|mesh-list
57110810|NCT05714553|Pembrolizumab|pembrolizumab|mesh-list
57110811|NCT05714553|Levoleucovorin|levoleucovorin|mesh-list
57110812|NCT05714553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110813|NCT05714553|Tubulin Modulators|tubulin modulators|mesh-ancestor
57110814|NCT05714553|Antimitotic Agents|antimitotic agents|mesh-ancestor
57110815|NCT05714553|Mitosis Modulators|mitosis modulators|mesh-ancestor
57110816|NCT05714553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110817|NCT05714553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110818|NCT05714553|Antidotes|antidotes|mesh-ancestor
57110819|NCT05714553|Protective Agents|protective agents|mesh-ancestor
57110820|NCT05714553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110821|NCT05714553|Vitamin B Complex|vitamin b complex|mesh-ancestor
57110822|NCT05714553|Vitamins|vitamins|mesh-ancestor
57110823|NCT05714553|Micronutrients|micronutrients|mesh-ancestor
57110824|NCT05328440|Fulvestrant|fulvestrant|mesh-list
57110825|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57110826|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110827|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57110828|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57110829|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
57110830|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110831|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110832|NCT05256056|Bupivacaine|bupivacaine|mesh-list
57110833|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
57110834|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
57110835|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110836|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110837|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
57110838|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110839|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
57110840|NCT05360511|Hematinics|hematinics|mesh-ancestor
57110841|NCT02724111|Rocuronium|rocuronium|mesh-list
57110842|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57110843|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57110844|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57110845|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110846|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110847|NCT02480751|Beraprost|beraprost|mesh-list
57110848|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57110849|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
57110850|NCT05346159|Androgens|androgens|mesh-list
57110851|NCT05346159|Hormones|hormones|mesh-ancestor
57110852|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110853|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110854|NCT04227314|Apremilast|apremilast|mesh-list
57110855|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57110856|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57110857|NCT04227314|Analgesics|analgesics|mesh-ancestor
57110858|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
57110859|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110860|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110861|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57110862|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57110863|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57110864|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57110865|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110866|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110867|NCT04223648|Nivolumab|nivolumab|mesh-list
57110868|NCT04223648|Ipilimumab|ipilimumab|mesh-list
57110869|NCT04223648|Durvalumab|durvalumab|mesh-list
57110870|NCT04223648|Tremelimumab|tremelimumab|mesh-list
57110871|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110872|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110873|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57110874|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110875|NCT02814175|Adalimumab|adalimumab|mesh-list
57110876|NCT02814175|Methotrexate|methotrexate|mesh-list
57110877|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57110878|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
57110879|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57110880|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110881|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57110882|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
57110883|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110884|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110885|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
57110886|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110887|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57110888|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57110889|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
57110890|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57110891|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57110892|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57110893|NCT02475057|Hormones|hormones|mesh-list
57110894|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
57110895|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57110896|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110897|NCT05312151|Psilocybin|psilocybin|mesh-list
57110898|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
57110899|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110900|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57110901|NCT02474667|Mitogens|mitogens|mesh-list
57110902|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
57110903|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110904|NCT05053737|Atezolizumab|atezolizumab|mesh-list
57110905|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110906|NCT03096080|XL647|xl647|mesh-list
57110907|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110908|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57110909|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110910|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110911|NCT01335997|Niacin|niacin|mesh-list
57110912|NCT01335997|Niacinamide|niacinamide|mesh-list
57110913|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
57110914|NCT01335997|Simvastatin|simvastatin|mesh-list
57110915|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57110916|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57110917|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
57110918|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110919|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57110920|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57110921|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110922|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
57110923|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
57110924|NCT01335997|Vitamins|vitamins|mesh-ancestor
57110925|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
57110926|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110927|NCT02048215|Ephedrine|ephedrine|mesh-list
57110928|NCT02048215|Caffeine|caffeine|mesh-list
57110929|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57110930|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110931|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57110932|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57110933|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110934|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57110935|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57110936|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
57110937|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110938|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
57110939|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
57110940|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110941|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57110942|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
57110943|NCT04849832|Fesoterodine|fesoterodine|mesh-list
57110944|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57110945|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57110946|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
57110947|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57110948|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110949|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110950|NCT04849832|Urological Agents|urological agents|mesh-ancestor
57110951|NCT02048293|Remifentanil|remifentanil|mesh-list
57110952|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57110953|NCT02048293|Narcotics|narcotics|mesh-ancestor
57110954|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110955|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110956|NCT02048293|Analgesics|analgesics|mesh-ancestor
57110957|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
57110958|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57110959|NCT02050009|Metformin|metformin|mesh-list
57110960|NCT02050009|Paclitaxel|paclitaxel|mesh-list
57110961|NCT02050009|Carboplatin|carboplatin|mesh-list
57110962|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57110963|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110964|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
57110965|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
57110966|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
57110967|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110968|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57110969|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110970|NCT04495088|Leucovorin|leucovorin|mesh-list
57110971|NCT04495088|Folic Acid|folic acid|mesh-list
57110972|NCT04495088|Capecitabine|capecitabine|mesh-list
57110973|NCT04495088|Fluorouracil|fluorouracil|mesh-list
57110974|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
57110975|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
57110976|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57110977|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
57110978|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110979|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110980|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57110981|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
57110982|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110983|NCT04495088|Antidotes|antidotes|mesh-ancestor
57110984|NCT04495088|Protective Agents|protective agents|mesh-ancestor
57110985|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
57110986|NCT04495088|Vitamins|vitamins|mesh-ancestor
57110987|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
57110988|NCT04495088|Hematinics|hematinics|mesh-ancestor
57110989|NCT04717154|Nivolumab|nivolumab|mesh-list
57110990|NCT04717154|Ipilimumab|ipilimumab|mesh-list
57110991|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57110992|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57110993|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57110994|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57110995|NCT02474511|Anesthetics|anesthetics|mesh-list
57110996|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57110997|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57110998|NCT03108963|Metformin|metformin|mesh-list
57110999|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57111000|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111001|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
57111002|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
57111003|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57111004|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57111005|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111006|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111007|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111008|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111010|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57111011|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
57111012|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57111013|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111014|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57111015|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57111016|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
57111017|NCT04812002|Bevacizumab|bevacizumab|mesh-list
57111018|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57111019|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111020|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111021|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57111022|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57111023|NCT04812002|Growth Substances|growth substances|mesh-ancestor
57111024|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111025|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
57111026|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111027|NCT03424460|Hemostatics|hemostatics|mesh-list
57111028|NCT03424460|Coagulants|coagulants|mesh-ancestor
57111029|NCT05712837|Salicylic Acid|salicylic acid|mesh-list
57111030|NCT05712837|Salicylates|salicylates|mesh-list
57111031|NCT05712837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111032|NCT05712837|Antifungal Agents|antifungal agents|mesh-ancestor
57111033|NCT05712837|Keratolytic Agents|keratolytic agents|mesh-ancestor
57111034|NCT05712837|Dermatologic Agents|dermatologic agents|mesh-ancestor
57111035|NCT05712837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57111036|NCT05712837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57111037|NCT05712837|Analgesics|analgesics|mesh-ancestor
57111038|NCT05712837|Sensory System Agents|sensory system agents|mesh-ancestor
57111039|NCT05712837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111040|NCT05712837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111041|NCT05712837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111042|NCT05712837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111043|NCT05712837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57111044|NCT05712837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111045|NCT05712837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111046|NCT02472249|Norepinephrine|norepinephrine|mesh-list
57111047|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57111048|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57111049|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
57111050|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111051|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111052|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111053|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
57111054|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
57111055|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111056|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57111057|NCT02313194|Buspirone|buspirone|mesh-list
57111058|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57111059|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57111060|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111061|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111062|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57111063|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57111064|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
57111065|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111066|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111067|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
57111068|NCT04821141|Estrogens|estrogens|mesh-list
57111069|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
57111070|NCT04821141|Hormones|hormones|mesh-ancestor
57111071|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111072|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111073|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57111074|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57111076|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57111077|NCT04435652|Paclitaxel|paclitaxel|mesh-list
57111078|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57111079|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57111080|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111081|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
57111082|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
57111083|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
57111084|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111085|NCT02473887|Ondansetron|ondansetron|mesh-list
57111086|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
57111087|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
57111088|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111089|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111090|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57111091|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
57111092|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
57111093|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57111094|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
57111095|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111096|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111097|NCT02473887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57111098|NCT02473887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57111099|NCT02473887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111100|NCT02473887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57111101|NCT02473887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57111102|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
57111103|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111104|NCT00071552|Fluticasone|fluticasone|mesh-list
57111105|NCT00071552|Xhance|xhance|mesh-list
57111106|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111107|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57111108|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
57111109|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111110|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111111|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57111112|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
57111113|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
57111114|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57111115|NCT05164263|Empagliflozin|empagliflozin|mesh-list
57111116|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57111117|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111118|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57111119|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111120|NCT04767711|Prednisolone|prednisolone|mesh-list
57111121|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111122|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
57111123|NCT04767711|Hormones|hormones|mesh-ancestor
57111124|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111125|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111126|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57111127|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111128|NCT02473809|Liraglutide|liraglutide|mesh-list
57111129|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57111130|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111131|NCT02473809|Incretins|incretins|mesh-ancestor
57111132|NCT02473809|Hormones|hormones|mesh-ancestor
57111133|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111134|NCT03976934|Tamsulosin|tamsulosin|mesh-list
57111135|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57111136|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57111137|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57111138|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
57111139|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111140|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111141|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111142|NCT03976934|Urological Agents|urological agents|mesh-ancestor
57111143|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57111144|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57111145|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
57111146|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792987|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
57111147|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111148|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57111149|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
57111150|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
57111151|NCT02416180|Hormones|hormones|mesh-ancestor
57111152|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111153|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
57111154|NCT05130398|Vaccines|vaccines|mesh-list
57111155|NCT05130398|Immunologic Factors|immunologic factors|mesh-ancestor
57111156|NCT05130398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111157|NCT02473575|Caffeine|caffeine|mesh-list
57111158|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57111159|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111160|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57111161|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111162|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111163|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57111164|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57111165|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
57111166|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111167|NCT03770546|Betamethasone|betamethasone|mesh-list
57111168|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111169|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
57111170|NCT03770546|Hormones|hormones|mesh-ancestor
57111171|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111172|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111173|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57111174|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
57111175|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
57111176|NCT05114421|Lenvatinib|lenvatinib|mesh-list
57111177|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111178|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111179|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57111180|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111181|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111182|NCT04646967|Acetaminophen|acetaminophen|mesh-list
57111183|NCT04646967|Ibuprofen|ibuprofen|mesh-list
57111184|NCT04646967|Ketorolac|ketorolac|mesh-list
57111185|NCT04646967|Bupivacaine|bupivacaine|mesh-list
57111186|NCT04646967|Sevoflurane|sevoflurane|mesh-list
57111187|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
57111188|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
57111189|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111190|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111191|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
57111192|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111193|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57111194|NCT04646967|Analgesics|analgesics|mesh-ancestor
57111195|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
57111196|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57111197|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111198|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111199|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57111200|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111201|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111202|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57111203|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57111204|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
57111205|NCT05341323|Ketamine|ketamine|mesh-list
57111206|NCT05341323|Bupivacaine|bupivacaine|mesh-list
57111207|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
57111208|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
57111209|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111210|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111211|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
57111212|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111213|NCT05341323|Analgesics|analgesics|mesh-ancestor
57111214|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57111215|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57111216|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
57111217|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57111218|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57111219|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111220|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793061|NCT00566501|Donepezil|donepezil|mesh-list
57111221|NCT04622865|Quercetin|quercetin|mesh-list
57111222|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
57111223|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111224|NCT04622865|Protective Agents|protective agents|mesh-ancestor
57111225|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111226|NCT02473185|Methylphenidate|methylphenidate|mesh-list
57111227|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57111228|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111229|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57111230|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57111231|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57111232|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111233|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
57111234|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111235|NCT02445586|Docetaxel|docetaxel|mesh-list
57111236|NCT02445586|Trastuzumab|trastuzumab|mesh-list
57111237|NCT02445586|Pertuzumab|pertuzumab|mesh-list
57111238|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111239|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
57111240|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
57111241|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
57111242|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111243|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111244|NCT02471547|Mitomycins|mitomycins|mesh-list
57111245|NCT02471547|Mitomycin|mitomycin|mesh-list
57111246|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57111247|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111248|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
57111249|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111250|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57111251|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111252|NCT02477631|Deferiprone|deferiprone|mesh-list
57111253|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57111254|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
57111255|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
57111256|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111257|NCT01674062|Trastuzumab|trastuzumab|mesh-list
57111258|NCT01674062|Pertuzumab|pertuzumab|mesh-list
57111259|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111260|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111261|NCT02472873|Ethanol|ethanol|mesh-list
57111262|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57111263|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111264|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111265|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111266|NCT03370172|Factor VIII|factor viii|mesh-list
57111267|NCT03370172|Coagulants|coagulants|mesh-ancestor
57111268|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
57111269|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
57111270|NCT02472886|Ledipasvir|ledipasvir|mesh-list
57111271|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
57111272|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111273|NCT04570839|Nivolumab|nivolumab|mesh-list
57111274|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111275|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111276|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57111277|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111278|NCT05283356|Ticagrelor|ticagrelor|mesh-list
57111279|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57111280|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57111281|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57111282|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57111283|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
57111284|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111285|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111286|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111287|NCT02472652|Aripiprazole|aripiprazole|mesh-list
57111288|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
57111289|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57111290|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57111291|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57111292|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111293|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111294|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
57111295|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
57111296|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111297|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111298|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57111299|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57111300|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
57111301|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57111302|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57111303|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57111304|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57111305|NCT05243186|Methylphenidate|methylphenidate|mesh-list
57111306|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57111307|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111308|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57111309|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57111310|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57111311|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111312|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
57111313|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111314|NCT02808182|Niacin|niacin|mesh-list
57111315|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
57111316|NCT02808182|Niacinamide|niacinamide|mesh-list
57111317|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57111318|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
57111319|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111320|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57111321|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
57111322|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
57111323|NCT02808182|Vitamins|vitamins|mesh-ancestor
57111324|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
57111325|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111326|NCT04695704|Montelukast|montelukast|mesh-list
57111327|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57111328|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57111329|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
57111330|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
57111331|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111332|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111333|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57111334|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57111335|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111336|NCT02051569|Tryptophan|tryptophan|mesh-list
57111337|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57111338|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
57111339|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57111340|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
57111341|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
57111342|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111343|NCT05217758|Mifepristone|mifepristone|mesh-list
57111344|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57111345|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
57111346|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57111347|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111348|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57111349|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57111350|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57111351|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
57111352|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57111353|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57111354|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
57111355|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111356|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
57111357|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57111358|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57111359|NCT02051023|Fluorometholone|fluorometholone|mesh-list
57111360|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
57111361|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57111362|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57111363|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111364|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
57111365|NCT02051023|Hormones|hormones|mesh-ancestor
57111366|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111367|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111368|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57111369|NCT02415556|Insulin|insulin|mesh-list
57111370|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57111371|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57111372|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111373|NCT05192798|Paclitaxel|paclitaxel|mesh-list
57111374|NCT05192798|Bevacizumab|bevacizumab|mesh-list
57111375|NCT05192798|Apatinib|apatinib|mesh-list
57111376|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57111377|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57111378|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111379|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
57111380|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
57111381|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
57111382|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111383|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111384|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57111385|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57111386|NCT05192798|Growth Substances|growth substances|mesh-ancestor
57111387|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111388|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
57111389|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57111390|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111391|NCT02048683|Sevoflurane|sevoflurane|mesh-list
57111392|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57111393|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57111394|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
57111395|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
57111396|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111397|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111398|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
57111399|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57111400|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57111401|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111402|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
57111403|NCT03108807|Coagulants|coagulants|mesh-ancestor
57111404|NCT02048761|Metformin|metformin|mesh-list
57111405|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57111406|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111407|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
57111408|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
57111409|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57111410|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57111411|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57111412|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111413|NCT02048917|Bupropion|bupropion|mesh-list
57111414|NCT02048917|Varenicline|varenicline|mesh-list
57111415|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57111416|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
57111417|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57111418|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57111419|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57111420|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57111421|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111422|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
57111423|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111424|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111425|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57111426|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57111427|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111428|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57111429|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57111430|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
57111431|NCT02472717|Liraglutide|liraglutide|mesh-list
57111432|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57111433|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111434|NCT02472717|Incretins|incretins|mesh-ancestor
57111435|NCT02472717|Hormones|hormones|mesh-ancestor
57111436|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111437|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
57111438|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57111439|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57111440|NCT02049073|Prednisolone|prednisolone|mesh-list
57111441|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
57111442|NCT02049073|Zonisamide|zonisamide|mesh-list
57111443|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57111444|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
57111445|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111446|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
57111447|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
57111448|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111449|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111450|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57111451|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
57111453|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111454|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57111455|NCT02049073|Protective Agents|protective agents|mesh-ancestor
57111456|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57111457|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111458|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
57111459|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57111460|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57111461|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111462|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57111463|NCT04518345|Azacitidine|azacitidine|mesh-list
57111464|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57111465|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
57111466|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111467|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111468|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111469|NCT02260063|Epinastine|epinastine|mesh-list
57111470|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57111471|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
57111472|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
57111473|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111474|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111475|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111476|NCT04398914|Paclitaxel|paclitaxel|mesh-list
57111477|NCT04398914|Trastuzumab|trastuzumab|mesh-list
57111478|NCT04398914|Pertuzumab|pertuzumab|mesh-list
57111479|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57111480|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111481|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
57111482|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
57111483|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
57111484|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111485|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111486|NCT03561649|Adalimumab|adalimumab|mesh-list
57111487|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111488|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111489|NCT02807623|Ibuprofen|ibuprofen|mesh-list
57111490|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57111491|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57111492|NCT02807623|Analgesics|analgesics|mesh-ancestor
57111493|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
57111494|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111495|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111496|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111497|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111498|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57111499|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111500|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111501|NCT05137964|Vitamin D|vitamin d|mesh-list
57111502|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
57111503|NCT05137964|Vitamins|vitamins|mesh-ancestor
57111504|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
57111505|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111506|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57111507|NCT04374578|Dulaglutide|dulaglutide|mesh-list
57111508|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57111509|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111510|NCT02470923|Nicotine|nicotine|mesh-list
57111511|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57111512|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
57111513|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111514|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111515|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56793366|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
57111516|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57111518|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111519|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111520|NCT02049229|Everolimus|everolimus|mesh-list
57111521|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111522|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57111523|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
57111524|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111525|NCT02805907|Calcifediol|calcifediol|mesh-list
57111526|NCT02805907|Vitamins|vitamins|mesh-ancestor
57111527|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
57111528|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111529|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57111530|NCT02477397|Fluticasone|fluticasone|mesh-list
57111531|NCT02477397|Xhance|xhance|mesh-list
57111532|NCT02477397|Budesonide|budesonide|mesh-list
57111533|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
57111534|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57111535|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57111536|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
57111537|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111538|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57111539|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
57111540|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111541|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111542|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57111543|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
57111544|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
57111545|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57111546|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
57111547|NCT02477397|Hormones|hormones|mesh-ancestor
57111548|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111549|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57111550|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57111551|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57111552|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
57111553|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111554|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111555|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
57111556|NCT03278691|Ketorolac|ketorolac|mesh-list
57111557|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57111558|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57111559|NCT03278691|Analgesics|analgesics|mesh-ancestor
57111560|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
57111561|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111562|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111563|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111564|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111565|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57111566|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111567|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111568|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57111569|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57111570|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57111571|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57111572|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111573|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111574|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111575|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57111576|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
57111577|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57111578|NCT02470767|Anticoagulants|anticoagulants|mesh-list
57111579|NCT02049541|Rituximab|rituximab|mesh-list
57111580|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111581|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111582|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
57111583|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111584|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111585|NCT02470611|Alendronate|alendronate|mesh-list
57111586|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57111587|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111588|NCT05305898|Metformin|metformin|mesh-list
57111589|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57111590|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111591|NCT05580861|Sulfasalazine|sulfasalazine|mesh-list
57111592|NCT05580861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111593|NCT05580861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57111594|NCT05580861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57111595|NCT05580861|Analgesics|analgesics|mesh-ancestor
57111596|NCT05580861|Sensory System Agents|sensory system agents|mesh-ancestor
57111597|NCT05580861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111598|NCT05580861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111599|NCT05580861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111600|NCT05580861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111601|NCT05580861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57111602|NCT02469831|Rocuronium|rocuronium|mesh-list
57111603|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57111604|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57111605|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57111606|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111607|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111608|NCT02995005|Tenofovir|tenofovir|mesh-list
57111609|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
57111610|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111611|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57111612|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57111613|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111614|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111615|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57111616|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57111617|NCT03561415|Posaconazole|posaconazole|mesh-list
57111618|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
57111619|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111620|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57111621|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57111622|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57111623|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57111624|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57111625|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111626|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111627|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57111628|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
57111629|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111630|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111631|NCT02477007|Acetaminophen|acetaminophen|mesh-list
57111632|NCT02477007|Ibuprofen|ibuprofen|mesh-list
57111633|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57111634|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57111635|NCT02477007|Analgesics|analgesics|mesh-ancestor
57111636|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
57111637|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111638|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111639|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111640|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111641|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57111642|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111643|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111644|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
57111645|NCT02052973|Propolis|propolis|mesh-list
57111646|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111647|NCT04347434|Atorvastatin|atorvastatin|mesh-list
57111648|NCT04347434|Ezetimibe|ezetimibe|mesh-list
57111649|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57111650|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57111651|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
57111652|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111653|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57111654|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57111655|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111656|NCT02053519|Vitamin D|vitamin d|mesh-list
57111657|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
57111658|NCT02053519|Vitamins|vitamins|mesh-ancestor
57111659|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
57111660|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111661|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57111662|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57111663|NCT02053597|Paclitaxel|paclitaxel|mesh-list
57111664|NCT02053597|Doxorubicin|doxorubicin|mesh-list
57111665|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57111666|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111667|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
57111668|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
57111669|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
57111670|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111671|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57111672|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57111673|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57111674|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111675|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
57111676|NCT05054348|Cemiplimab|cemiplimab|mesh-list
57111677|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111678|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111679|NCT04163900|Gemcitabine|gemcitabine|mesh-list
57111680|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111681|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57111682|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
57111683|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111684|NCT04163900|Antiviral Agents|antiviral agents|mesh-ancestor
57111685|NCT04163900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111686|NCT04163900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111687|NCT04163900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57111688|NCT04163900|Immunologic Factors|immunologic factors|mesh-ancestor
57111689|NCT04163900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111690|NCT02801617|Latanoprost|latanoprost|mesh-list
57111691|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57111692|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57111693|NCT02056249|Norepinephrine|norepinephrine|mesh-list
57111694|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57111695|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57111696|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
57111697|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111698|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111699|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111700|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
57111701|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
57111702|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111703|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57111704|NCT04140968|Progesterone|progesterone|mesh-list
57111705|NCT04140968|Progestins|progestins|mesh-ancestor
57111706|NCT04140968|Hormones|hormones|mesh-ancestor
57111707|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111708|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111709|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
57111710|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111711|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111712|NCT01334515|Isotretinoin|isotretinoin|mesh-list
57111713|NCT01334515|Sargramostim|sargramostim|mesh-list
57111714|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111715|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
57111716|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
57111717|NCT02415400|Aspirin|aspirin|mesh-list
57111718|NCT02415400|Vitamin K|vitamin k|mesh-list
57111719|NCT02415400|Apixaban|apixaban|mesh-list
57111720|NCT02415400|Vitamins|vitamins|mesh-ancestor
57111721|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
57111722|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111723|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57111724|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57111725|NCT02415400|Analgesics|analgesics|mesh-ancestor
57111726|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
57111727|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111728|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111729|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111730|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57111731|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57111732|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111733|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57111734|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57111735|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111736|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
57111737|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57111738|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
57111739|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57111740|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
56793615|NCT00930839|Niacin|niacin|mesh-list
57111742|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57111743|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
57111744|NCT02415400|Coagulants|coagulants|mesh-ancestor
57111745|NCT02053675|Vasopressins|vasopressins|mesh-list
57111746|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
57111747|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
57111748|NCT02053675|Coagulants|coagulants|mesh-ancestor
57111749|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57111750|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57111751|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
57111752|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111753|NCT02037997|Docetaxel|docetaxel|mesh-list
57111754|NCT02037997|Pemetrexed|pemetrexed|mesh-list
57111755|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57111756|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111757|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
57111758|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
57111759|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
57111760|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111761|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111762|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57111763|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57111764|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57111765|NCT02056405|Mosapride|mosapride|mesh-list
57111766|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57111767|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57111768|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
57111769|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111770|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111771|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111772|NCT02056717|Dexamethasone|dexamethasone|mesh-list
57111773|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57111774|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
57111775|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
57111776|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111777|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111778|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57111779|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
57111780|NCT02056717|Hormones|hormones|mesh-ancestor
57111781|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111782|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57111783|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111784|NCT02802865|Letrozole|letrozole|mesh-list
57111785|NCT02802865|Clomiphene|clomiphene|mesh-list
57111786|NCT02802865|Enclomiphene|enclomiphene|mesh-list
57111787|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
57111788|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111789|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111790|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57111791|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57111792|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111793|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57111794|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
57111795|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57111796|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111797|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57111798|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
57111799|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57111800|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57111801|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57111802|NCT02414932|Midazolam|midazolam|mesh-list
57111803|NCT02414932|Ketamine|ketamine|mesh-list
57111804|NCT02414932|Analgesics|analgesics|mesh-ancestor
57111805|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
57111806|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111807|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111808|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57111809|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57111810|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
56793687|NCT00931073|Omeprazole|omeprazole|mesh-list
57111811|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
57111812|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111813|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57111814|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57111815|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111816|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111817|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57111818|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57111819|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57111820|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57111821|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57111822|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
57111823|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
57111824|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
57111825|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57111826|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
57111827|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
57111828|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111829|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111830|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57111831|NCT02476929|Analgesics|analgesics|mesh-ancestor
57111832|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
57111833|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111834|NCT02726997|Paclitaxel|paclitaxel|mesh-list
57111835|NCT02726997|Carboplatin|carboplatin|mesh-list
57111836|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57111837|NCT02726997|Durvalumab|durvalumab|mesh-list
57111838|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
57111839|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57111840|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
57111841|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57111842|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111843|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
57111844|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
57111845|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
57111846|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111847|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111848|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
57111849|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111850|NCT02057107|Docetaxel|docetaxel|mesh-list
57111851|NCT02057107|Cetuximab|cetuximab|mesh-list
57111852|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111853|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
57111854|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
57111855|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
57111856|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111857|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57111858|NCT02473497|Crizotinib|crizotinib|mesh-list
57111859|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111860|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57111861|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111862|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111863|NCT02054143|Sevoflurane|sevoflurane|mesh-list
57111864|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57111865|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57111866|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
57111867|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
57111868|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57111869|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111870|NCT02058667|Paclitaxel|paclitaxel|mesh-list
57111871|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57111872|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111873|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
57111874|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
57111875|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
57111876|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111877|NCT02470455|Atorvastatin|atorvastatin|mesh-list
57111878|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57111879|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57111880|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
57111881|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111882|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57111883|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57111884|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111885|NCT02057263|Alendronate|alendronate|mesh-list
57111886|NCT02057263|Diphosphonates|diphosphonates|mesh-list
57111887|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57111888|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111889|NCT05550909|Artesunate|artesunate|mesh-list
57111890|NCT05550909|Lumefantrine|lumefantrine|mesh-list
57111891|NCT05550909|Artemether|artemether|mesh-list
57111892|NCT05550909|Primaquine|primaquine|mesh-list
57111893|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57111894|NCT05550909|Amodiaquine|amodiaquine|mesh-list
57111895|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
57111896|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
57111897|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57111898|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57111899|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111900|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111901|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
57111902|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
57111903|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57111904|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
57111905|NCT02054299|Thiamine|thiamine|mesh-list
57111906|NCT02054299|Proguanil|proguanil|mesh-list
57111907|NCT02054299|Sumatriptan|sumatriptan|mesh-list
57111908|NCT02054299|Amitriptyline|amitriptyline|mesh-list
57111909|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
57111910|NCT02054299|Fenoterol|fenoterol|mesh-list
57111911|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57111912|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57111913|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57111914|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
57111915|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57111916|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111917|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111918|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57111919|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
57111920|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57111921|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57111922|NCT02054299|Analgesics|analgesics|mesh-ancestor
57111923|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
57111924|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111925|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57111926|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57111927|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57111928|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
57111929|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
57111930|NCT02054299|Vitamins|vitamins|mesh-ancestor
57111931|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
57111932|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57111933|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
57111934|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57111935|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57111936|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57111937|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
57111938|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57111939|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
57111940|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57111941|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
57111942|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
57111943|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
57111944|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57111945|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57111946|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57111947|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57111948|NCT02058823|Amlodipine|amlodipine|mesh-list
57111949|NCT02058823|Valsartan|valsartan|mesh-list
57111950|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57111951|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57111952|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57111953|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111954|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57111955|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111956|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
57111957|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57111958|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57111959|NCT00704535|Ezetimibe|ezetimibe|mesh-list
57111960|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57111961|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57111962|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
57111963|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111964|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57111965|NCT02058901|Sunitinib|sunitinib|mesh-list
57111966|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793824|NCT00936143|Infliximab|infliximab|mesh-list
57111967|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57111968|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57111969|NCT02058901|Growth Substances|growth substances|mesh-ancestor
57111970|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111971|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
57111972|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57111973|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57111974|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111975|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
57111977|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57111978|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
57111979|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111980|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57111981|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57111982|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
57111983|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57111984|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57111985|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57111986|NCT03909165|Atropine|atropine|mesh-list
57111987|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
57111988|NCT03909165|Neostigmine|neostigmine|mesh-list
57111989|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57111990|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57111991|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57111992|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
57111993|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57111994|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57111995|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57111996|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
57111997|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
57111998|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
57111999|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57112000|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57112001|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
57112002|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112003|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112004|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57112005|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112006|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57112007|NCT01955499|Lenalidomide|lenalidomide|mesh-list
57112008|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
57112009|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112010|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57112011|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57112012|NCT01955499|Growth Substances|growth substances|mesh-ancestor
57112013|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
57112014|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112015|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57112016|NCT02058979|Cefazolin|cefazolin|mesh-list
57112017|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112018|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57112019|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
57112020|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112021|NCT03893955|Paclitaxel|paclitaxel|mesh-list
57112022|NCT03893955|Carboplatin|carboplatin|mesh-list
57112023|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57112024|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112025|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
57112026|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
57112027|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
57112028|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112029|NCT02648204|Dulaglutide|dulaglutide|mesh-list
57112030|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57112031|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112032|NCT03310749|Metformin|metformin|mesh-list
57112033|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57112034|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112035|NCT01217931|Bevacizumab|bevacizumab|mesh-list
57112036|NCT01217931|Everolimus|everolimus|mesh-list
57112037|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57112038|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112039|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57112040|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57112041|NCT01217931|Growth Substances|growth substances|mesh-ancestor
57112042|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112043|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
57112044|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112045|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
57112046|NCT05291325|Linaclotide|linaclotide|mesh-list
57112047|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57112048|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
57112049|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112050|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57112051|NCT03310593|Cannabidiol|cannabidiol|mesh-list
57112052|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
57112053|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
57112054|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57112055|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112056|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
57112057|NCT03810807|Osimertinib|osimertinib|mesh-list
57112058|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112059|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57112060|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112061|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112062|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
57112063|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57112064|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
57112065|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57112066|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
57112067|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112068|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112069|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
57112070|NCT02058277|Aprepitant|aprepitant|mesh-list
57112071|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
57112072|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
57112073|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112074|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112075|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57112076|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57112077|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112078|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112079|NCT04813562|Vaccines|vaccines|mesh-list
57112080|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
57112081|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112082|NCT03314025|Tamsulosin|tamsulosin|mesh-list
57112083|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57112084|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57112085|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57112086|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
57112087|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112088|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112089|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112090|NCT03314025|Urological Agents|urological agents|mesh-ancestor
57112091|NCT02055079|Sirolimus|sirolimus|mesh-list
57112092|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57112093|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112094|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57112095|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112096|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
57112097|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112098|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
57112099|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112100|NCT02470065|Afatinib|afatinib|mesh-list
57112101|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112102|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57112103|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112104|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112105|NCT03313869|Vitamin E|vitamin e|mesh-list
57112106|NCT03313869|Selenium|selenium|mesh-list
57112107|NCT03313869|Vitamins|vitamins|mesh-ancestor
57112108|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
57112109|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112110|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
57112111|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112112|NCT03313869|Protective Agents|protective agents|mesh-ancestor
57112113|NCT03313869|Trace Elements|trace elements|mesh-ancestor
57112114|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
57112115|NCT00705159|Tobramycin|tobramycin|mesh-list
57112116|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57112117|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112118|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57112119|NCT01673984|Goserelin|goserelin|mesh-list
57112120|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57112121|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57112122|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112123|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
57112124|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57112125|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
57112126|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57112127|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112128|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57112130|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
57112131|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
57112132|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112133|NCT05303090|Lenvatinib|lenvatinib|mesh-list
57112134|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112135|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57112136|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112137|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112138|NCT03310047|Lidocaine|lidocaine|mesh-list
57112139|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
57112140|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
57112141|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112142|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112143|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
57112144|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112145|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57112146|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57112147|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57112148|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57112149|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112150|NCT03313557|Adavosertib|adavosertib|mesh-list
57112151|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112152|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112153|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
57112154|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57112155|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112156|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
57112157|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57112158|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112159|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112160|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57112161|NCT03313479|Analgesics|analgesics|mesh-ancestor
57112162|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
57112163|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112164|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57112165|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57112166|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57112167|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
57112168|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112169|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112170|NCT04079738|Ixazomib|ixazomib|mesh-list
57112171|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112172|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
57112173|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112174|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112175|NCT03313401|Aflibercept|aflibercept|mesh-list
57112176|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57112177|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57112178|NCT03313401|Growth Substances|growth substances|mesh-ancestor
57112179|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112180|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
57112181|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112182|NCT05278065|Nicotine|nicotine|mesh-list
57112183|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57112184|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
57112185|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112186|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112187|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57112188|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57112189|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
57112190|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112191|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112192|NCT03313323|Ipilimumab|ipilimumab|mesh-list
56794027|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
57112193|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57112194|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112195|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57112196|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112197|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57112198|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
57112199|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57112200|NCT05302232|Prednisolone|prednisolone|mesh-list
57112201|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
57112202|NCT05302232|Lidocaine|lidocaine|mesh-list
57112203|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57112204|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
57112205|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
57112206|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
57112207|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112208|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112209|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
57112210|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112211|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57112212|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57112213|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57112214|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57112215|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112216|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57112217|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
57112218|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
57112219|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57112220|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
57112221|NCT05302232|Hormones|hormones|mesh-ancestor
57112222|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57112223|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57112224|NCT05302232|Protective Agents|protective agents|mesh-ancestor
57112225|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57112226|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112227|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57112228|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112229|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57112230|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112231|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112232|NCT03304431|Lidocaine|lidocaine|mesh-list
57112233|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
57112234|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
57112235|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112236|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112237|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
57112238|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112239|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57112240|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57112241|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57112242|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57112243|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112244|NCT04741334|Anticoagulants|anticoagulants|mesh-list
57112245|NCT04741334|Dicumarol|dicumarol|mesh-list
57112246|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
57112247|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112248|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112249|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
57112250|NCT03309735|Progesterone|progesterone|mesh-list
57112251|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
57112252|NCT03309735|Progestins|progestins|mesh-ancestor
57112253|NCT03309735|Hormones|hormones|mesh-ancestor
57112254|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57112255|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112256|NCT04335968|Melatonin|melatonin|mesh-list
57112257|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
57112258|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112259|NCT04335968|Protective Agents|protective agents|mesh-ancestor
57112260|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112261|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112262|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
57112263|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
57112264|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112265|NCT02926586|Cytarabine|cytarabine|mesh-list
57112266|NCT02926586|Fludarabine|fludarabine|mesh-list
57112268|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57112269|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
57112270|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112271|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112272|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
57112273|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112274|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
57112275|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112276|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
57112277|NCT04490967|Salicylates|salicylates|mesh-list
57112278|NCT04490967|Silybin|silybin|mesh-list
57112279|NCT04490967|Silymarin|silymarin|mesh-list
57112280|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
57112281|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112282|NCT04490967|Protective Agents|protective agents|mesh-ancestor
57112283|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112284|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112285|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
57112286|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
57112287|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
57112288|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57112289|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57112290|NCT04490967|Analgesics|analgesics|mesh-ancestor
57112291|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
57112292|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112293|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57112294|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57112295|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57112296|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112297|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57112298|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112299|NCT04214834|Morphine|morphine|mesh-list
57112300|NCT04214834|Methadone|methadone|mesh-list
57112301|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57112302|NCT04214834|Narcotics|narcotics|mesh-ancestor
57112303|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112304|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112305|NCT04214834|Analgesics|analgesics|mesh-ancestor
57112306|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
57112307|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112308|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
57112309|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
57112310|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
57112311|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
57112312|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112313|NCT03312777|Tramadol|tramadol|mesh-list
57112314|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57112315|NCT03312777|Narcotics|narcotics|mesh-ancestor
57112316|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112317|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112318|NCT03312777|Analgesics|analgesics|mesh-ancestor
57112319|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
57112320|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112321|NCT02332928|Melatonin|melatonin|mesh-list
57112322|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
57112323|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112324|NCT02332928|Protective Agents|protective agents|mesh-ancestor
57112325|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112326|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112327|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57112328|NCT03738878|Valsartan|valsartan|mesh-list
57112329|NCT03738878|Bradykinin|bradykinin|mesh-list
57112330|NCT03738878|Kininogens|kininogens|mesh-list
57112331|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57112332|NCT03738878|Substance P|substance p|mesh-list
57112333|NCT03738878|Neurokinin A|neurokinin a|mesh-list
57112334|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57112335|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112336|NCT03738878|Incretins|incretins|mesh-ancestor
57112337|NCT03738878|Hormones|hormones|mesh-ancestor
57112338|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57112339|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57112340|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
57112341|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794188|NCT00522392|Bortezomib|bortezomib|mesh-list
57112342|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112343|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57112344|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57112345|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57112346|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
57112347|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
57112348|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112349|NCT04682834|Probenecid|probenecid|mesh-list
57112350|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
57112351|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
57112352|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57112353|NCT04682834|Renal Agents|renal agents|mesh-ancestor
57112354|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
57112355|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
57112356|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57112357|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112358|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112359|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
57112360|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57112361|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112362|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112363|NCT05426252|Sirolimus|sirolimus|mesh-list
57112364|NCT05426252|Abatacept|abatacept|mesh-list
57112365|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57112366|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112367|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57112368|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112369|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
56401533|NCT02081755|Everolimus|everolimus|mesh-list
57112370|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112371|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
57112372|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112373|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57112374|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112375|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57112376|NCT01506986|Metronidazole|metronidazole|mesh-list
57112377|NCT01506986|Clarithromycin|clarithromycin|mesh-list
57112378|NCT01506986|Lansoprazole|lansoprazole|mesh-list
57112379|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
57112380|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112381|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57112382|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57112383|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57112384|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57112385|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112386|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112387|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57112388|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57112389|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57112390|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57112391|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57112392|NCT05422664|Lacosamide|lacosamide|mesh-list
57112393|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
57112394|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57112395|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57112396|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57112397|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112398|NCT02714894|Clozapine|clozapine|mesh-list
57112399|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57112400|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
57112401|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112402|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112403|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112404|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57112405|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57112406|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112407|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57112408|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
57112409|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
57112410|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
57112411|NCT03303651|Narcotics|narcotics|mesh-ancestor
57112412|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112413|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112414|NCT03303651|Analgesics|analgesics|mesh-ancestor
57112415|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
57112416|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112417|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
57112418|NCT03312153|Eusol|eusol|mesh-list
57112419|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
57112420|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112421|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
57112422|NCT03303573|Hematinics|hematinics|mesh-ancestor
57112423|NCT03303495|Leucovorin|leucovorin|mesh-list
57112424|NCT03303495|Bevacizumab|bevacizumab|mesh-list
57112425|NCT03303495|Fluorouracil|fluorouracil|mesh-list
57112426|NCT03303495|Irinotecan|irinotecan|mesh-list
57112427|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57112428|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112429|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57112430|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57112431|NCT03303495|Growth Substances|growth substances|mesh-ancestor
57112432|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112433|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
57112434|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
57112435|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112436|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57112437|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112438|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
57112439|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57112440|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57112441|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112442|NCT03303495|Antidotes|antidotes|mesh-ancestor
57112443|NCT03303495|Protective Agents|protective agents|mesh-ancestor
57112444|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
57112445|NCT03303495|Vitamins|vitamins|mesh-ancestor
56900187|NCT03537651|Ivacaftor|ivacaftor|mesh-list
57112446|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
56900333|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
57112447|NCT03308955|Tramadol|tramadol|mesh-list
57112448|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57112449|NCT03308955|Narcotics|narcotics|mesh-ancestor
56900788|NCT02047552|Hormones|hormones|mesh-ancestor
56900868|NCT02049970|Bupivacaine|bupivacaine|mesh-list
57112450|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112451|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112452|NCT03308955|Analgesics|analgesics|mesh-ancestor
57112453|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
56901165|NCT03796533|Posaconazole|posaconazole|mesh-list
56901307|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57112454|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112455|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
57112456|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
57112457|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112458|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57112459|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57112460|NCT03308643|Oxytocin|oxytocin|mesh-list
57112461|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
57112462|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57112463|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112464|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
57112465|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57112466|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57112467|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57112468|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57112469|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112470|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
57112471|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112472|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112473|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57112474|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112475|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
57112476|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57112477|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112478|NCT03308487|Vitamin D|vitamin d|mesh-list
57112479|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
57112480|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
57112481|NCT03308487|Vitamins|vitamins|mesh-list
57112482|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
57112483|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112484|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57112485|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57112486|NCT03308331|Nicotine|nicotine|mesh-list
57112487|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57112488|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
57112489|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112490|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112491|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57112492|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57112493|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
57112494|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112495|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112496|NCT02414854|Albuterol|albuterol|mesh-list
57112497|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57112498|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
57112499|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112500|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112501|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57112502|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
57112503|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
57112504|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57112505|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57112506|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57112507|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57112508|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
57112509|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112510|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112511|NCT03308253|Vancomycin|vancomycin|mesh-list
57112512|NCT03308253|Tobramycin|tobramycin|mesh-list
57112513|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57112514|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112515|NCT02467023|Lidocaine|lidocaine|mesh-list
57112516|NCT02467023|Fentanyl|fentanyl|mesh-list
57112517|NCT02467023|Midazolam|midazolam|mesh-list
57112518|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
57112519|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
57112520|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112521|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112522|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
57112523|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112524|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57112525|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57112526|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57112527|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57112528|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112529|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57112530|NCT02467023|Narcotics|narcotics|mesh-ancestor
57112531|NCT02467023|Analgesics|analgesics|mesh-ancestor
57112532|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57112533|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57112534|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
57112535|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57112536|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57112537|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57112538|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57112539|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
57112540|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
57112541|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112542|NCT02055703|Itraconazole|itraconazole|mesh-list
57112543|NCT02055703|Rifampin|rifampin|mesh-list
57112544|NCT02055703|Digoxin|digoxin|mesh-list
57112545|NCT02055703|Donepezil|donepezil|mesh-list
57112546|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
57112547|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112548|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57112549|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57112550|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112551|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112552|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57112553|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
57112554|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57112555|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112556|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57112557|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57112558|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
57112559|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112560|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
57112561|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57112562|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
57112563|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57112564|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
57112565|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57112566|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57112567|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57112568|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56794408|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112569|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57112570|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57112571|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57112572|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57112573|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57112574|NCT02055703|Protective Agents|protective agents|mesh-ancestor
57112575|NCT02058433|Paclitaxel|paclitaxel|mesh-list
57112576|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57112577|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57112578|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112579|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
57112580|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
57112581|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
57112582|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112583|NCT03561181|Vaccines|vaccines|mesh-list
57112584|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
57112585|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112586|NCT02060149|Minocycline|minocycline|mesh-list
57112587|NCT02060149|Sulbactam|sulbactam|mesh-list
57112588|NCT02060149|Cefoperazone|cefoperazone|mesh-list
57112589|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57112590|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57112591|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112592|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56901614|NCT03788889|Ketamine|ketamine|mesh-list
57112593|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112594|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112595|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
57112596|NCT03302403|Fludarabine|fludarabine|mesh-list
57112597|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112598|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
57112599|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112600|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57112601|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57112602|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
57112603|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112604|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112605|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57112606|NCT02038621|Paclitaxel|paclitaxel|mesh-list
57112607|NCT02038621|Capecitabine|capecitabine|mesh-list
57112608|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
57112609|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57112610|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112611|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
57112612|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
57112613|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
57112614|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112615|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57112616|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
57112617|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
57112618|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57112619|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112620|NCT05727969|Dexmedetomidine|dexmedetomidine|mesh-list
57112621|NCT05727969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57112622|NCT05727969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112623|NCT05727969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112624|NCT05727969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57112625|NCT05727969|Analgesics|analgesics|mesh-ancestor
57112626|NCT05727969|Sensory System Agents|sensory system agents|mesh-ancestor
57112627|NCT05727969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112628|NCT05727969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57112629|NCT05727969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57112630|NCT05727969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57112631|NCT05727969|Adrenergic Agents|adrenergic agents|mesh-ancestor
57112632|NCT05727969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112633|NCT05727969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112634|NCT01334125|Metformin|metformin|mesh-list
57112635|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57112636|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112637|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57112638|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57112639|NCT01333501|Interferons|interferons|mesh-list
57112640|NCT01333501|Interferon-beta|interferon-beta|mesh-list
57112641|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57112642|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
57112643|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112644|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
57112645|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112646|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
57112647|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112648|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57112649|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112650|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112651|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57112652|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
57112653|NCT01362140|Hematinics|hematinics|mesh-ancestor
57112654|NCT03307941|Fluorouracil|fluorouracil|mesh-list
57112655|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
57112656|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
57112657|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112658|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57112659|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112660|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112661|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
57112662|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112663|NCT03307863|Topiramate|topiramate|mesh-list
57112664|NCT03307863|Carbamazepine|carbamazepine|mesh-list
57112665|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
57112666|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57112667|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112668|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
57112669|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57112670|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112671|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57112672|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57112673|NCT03307863|Analgesics|analgesics|mesh-ancestor
57112674|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
57112675|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112676|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57112677|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57112678|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112679|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57112680|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57112681|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
57112682|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57112683|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112684|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112685|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57112686|NCT04656470|Analgesics|analgesics|mesh-ancestor
57112687|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
57112688|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112689|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57112690|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57112691|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57112692|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
57112693|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112694|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112695|NCT05391074|Vitamins|vitamins|mesh-list
57112696|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
57112697|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112698|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
57112699|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57112700|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112701|NCT05727579|Ertugliflozin|ertugliflozin|mesh-list
57112702|NCT05727579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57112703|NCT05727579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112704|NCT05727579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57112705|NCT05727579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112706|NCT02467647|Thalidomide|thalidomide|mesh-list
57112707|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112708|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
57112709|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112710|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
57112711|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57112712|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112713|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57112714|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57112715|NCT02467647|Growth Substances|growth substances|mesh-ancestor
57112716|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
57112717|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112719|NCT03263936|Fludarabine|fludarabine|mesh-list
57112720|NCT03263936|Decitabine|decitabine|mesh-list
57112721|NCT03263936|Vorinostat|vorinostat|mesh-list
57112722|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112723|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57112724|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
57112725|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112726|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112727|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
57112728|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112729|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
57112730|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112731|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112732|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57112733|NCT03307551|Propofol|propofol|mesh-list
57112734|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57112735|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112736|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112737|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57112738|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
57112739|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
57112740|NCT02060305|Bevacizumab|bevacizumab|mesh-list
57112741|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57112742|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112743|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57112744|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57112745|NCT02060305|Growth Substances|growth substances|mesh-ancestor
57112746|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112747|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
57112748|NCT03497143|Lamotrigine|lamotrigine|mesh-list
57112749|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
57112750|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57112751|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57112752|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112753|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57112754|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112755|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57112756|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57112757|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112758|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57112759|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57112760|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57112761|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57112762|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112763|NCT02059759|Aldesleukin|aldesleukin|mesh-list
57112764|NCT02059759|Interleukin-2|interleukin-2|mesh-list
57112765|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112766|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57112767|NCT02059759|Analgesics|analgesics|mesh-ancestor
57112768|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
57112769|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112770|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112771|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57112772|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57112773|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
57112774|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112775|NCT03103022|Acetaminophen|acetaminophen|mesh-list
57112776|NCT03103022|Ibuprofen|ibuprofen|mesh-list
57112777|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57112778|NCT03103022|Analgesics|analgesics|mesh-ancestor
57112779|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
57112780|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112781|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112782|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
57112783|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57112784|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57112785|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57112786|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57112787|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112788|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112789|NCT00702507|Miconazole|miconazole|mesh-list
57112790|NCT00702507|Clotrimazole|clotrimazole|mesh-list
57112791|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
57112792|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794633|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
57112793|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57112794|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57112795|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112796|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112797|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57112798|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
57112799|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57112800|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112801|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57112802|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57112803|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57112804|NCT03324932|Denosumab|denosumab|mesh-list
57112805|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57112806|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112807|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
57112808|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57112809|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112810|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
57112811|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57112812|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57112813|NCT03301233|Estradiol|estradiol|mesh-list
57112814|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57112815|NCT03301233|Estrogens|estrogens|mesh-ancestor
57112816|NCT03301233|Hormones|hormones|mesh-ancestor
57112817|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57112818|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112819|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57112820|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
57112821|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57112822|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57112823|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
57112824|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57112825|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57112826|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112827|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112828|NCT03301233|Urological Agents|urological agents|mesh-ancestor
57112829|NCT02581748|Trastuzumab|trastuzumab|mesh-list
57112830|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57112831|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112832|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
57112833|NCT02501096|Lenvatinib|lenvatinib|mesh-list
57112834|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57112835|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112836|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57112837|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112838|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112839|NCT01003028|Remifentanil|remifentanil|mesh-list
57112840|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57112841|NCT01003028|Narcotics|narcotics|mesh-ancestor
57112842|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57112843|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112844|NCT01003028|Analgesics|analgesics|mesh-ancestor
57112845|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
57112846|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112847|NCT03113942|Thalidomide|thalidomide|mesh-list
57112848|NCT03113942|Pomalidomide|pomalidomide|mesh-list
57112849|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
57112850|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112851|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57112852|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57112853|NCT03113942|Growth Substances|growth substances|mesh-ancestor
57112854|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
57112855|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112856|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112857|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
57112858|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57112859|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112860|NCT04786340|Pirenzepine|pirenzepine|mesh-list
57112861|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57112862|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57112863|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57112864|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57112865|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57112866|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
57112867|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112868|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112869|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112870|NCT03104270|Dexamethasone|dexamethasone|mesh-list
57112871|NCT03104270|Pomalidomide|pomalidomide|mesh-list
57112872|NCT03104270|Elotuzumab|elotuzumab|mesh-list
57112873|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57112874|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
57112875|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
57112876|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112877|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112878|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57112879|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
57112880|NCT03104270|Hormones|hormones|mesh-ancestor
57112881|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57112882|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57112883|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112884|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
57112885|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57112886|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57112887|NCT03104270|Growth Substances|growth substances|mesh-ancestor
57112888|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
57112889|NCT03300765|Apatinib|apatinib|mesh-list
57112890|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112891|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57112892|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57112893|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112894|NCT04064918|Timolol|timolol|mesh-list
57112895|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112896|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57112897|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57112898|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
57112899|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112900|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112901|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57112902|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57112903|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57112904|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57112905|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57112906|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
57112907|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112908|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112909|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57112910|NCT04688294|Valsartan|valsartan|mesh-list
57112911|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57112912|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57112913|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57112914|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57112915|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112916|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
57112917|NCT03300609|Leucovorin|leucovorin|mesh-list
57112918|NCT03300609|Folic Acid|folic acid|mesh-list
57112919|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
57112920|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
57112921|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57112922|NCT03300609|Panitumumab|panitumumab|mesh-list
57112923|NCT03300609|Fluorouracil|fluorouracil|mesh-list
57112924|NCT03300609|Capecitabine|capecitabine|mesh-list
57112925|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
57112926|NCT03300609|Antibodies|antibodies|mesh-list
57112927|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
57112928|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57112929|NCT03300609|Calcium|calcium|mesh-list
57112930|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
57112931|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
57112932|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112933|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57112934|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57112935|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57112936|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
57112937|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112938|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57112939|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57112940|NCT03300609|Antidotes|antidotes|mesh-ancestor
57112941|NCT03300609|Protective Agents|protective agents|mesh-ancestor
57112942|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
57112943|NCT03300609|Vitamins|vitamins|mesh-ancestor
57112944|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
57112945|NCT03300609|Hematinics|hematinics|mesh-ancestor
57112946|NCT00583778|Ipratropium|ipratropium|mesh-list
57112947|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57112948|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
57112949|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112950|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112951|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57112952|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
57112953|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57112954|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
57112955|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112956|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112957|NCT03300531|Betamethasone|betamethasone|mesh-list
57112958|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57112959|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
57112960|NCT03300531|Hormones|hormones|mesh-ancestor
57112961|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57112962|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112963|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57112964|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
57112965|NCT02467335|Fostemsavir|fostemsavir|mesh-list
57112966|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57112967|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57112968|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
57112969|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57112970|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57112971|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57112972|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112973|NCT02809820|Metoprolol|metoprolol|mesh-list
57112974|NCT02809820|Carvedilol|carvedilol|mesh-list
57112975|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
57112976|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57112977|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57112978|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
57112979|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
57112980|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112981|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57112982|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57112983|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57112984|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
57112985|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57112986|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57112987|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
57112988|NCT02809820|Protective Agents|protective agents|mesh-ancestor
57112989|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57112990|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57112991|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57112992|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
57112993|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57112994|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57112995|NCT05717049|Theophylline|theophylline|mesh-list
57112996|NCT05717049|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57112997|NCT05717049|Autonomic Agents|autonomic agents|mesh-ancestor
57112998|NCT05717049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57112999|NCT05717049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113000|NCT05717049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57113001|NCT05717049|Respiratory System Agents|respiratory system agents|mesh-ancestor
57113002|NCT05717049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57113003|NCT05717049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113004|NCT05717049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113005|NCT05717049|Vasodilator Agents|vasodilator agents|mesh-ancestor
57113006|NCT05717049|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57113007|NCT05717049|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57113008|NCT05717049|Purinergic Agents|purinergic agents|mesh-ancestor
57113009|NCT05717049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113010|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
57113011|NCT04491357|Calcium|calcium|mesh-list
57113012|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57113013|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113014|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56794863|NCT01013402|Insulin|insulin|mesh-list
57113016|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57113017|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57113018|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113019|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
56901639|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
57113020|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113021|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57113022|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57113023|NCT02786498|Vitamin D|vitamin d|mesh-list
57113024|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
57113025|NCT02786498|Vitamins|vitamins|mesh-ancestor
57113026|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
57113027|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113028|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57113029|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57113030|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57113031|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57113032|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113033|NCT02597660|Hormones|hormones|mesh-list
57113034|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57113035|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113036|NCT02419664|Edotreotide|edotreotide|mesh-list
57113037|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57113038|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113039|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
57113040|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57113041|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113042|NCT03841058|Abaloparatide|abaloparatide|mesh-list
57113043|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57113044|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113045|NCT04435574|Lactoferrin|lactoferrin|mesh-list
57113046|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113047|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
57113048|NCT03104426|Hematinics|hematinics|mesh-ancestor
57113049|NCT02163356|Ketoconazole|ketoconazole|mesh-list
57113050|NCT02163356|Vincristine|vincristine|mesh-list
57113051|NCT02163356|Fenretinide|fenretinide|mesh-list
57113052|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57113053|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113054|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
57113055|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
57113056|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
57113057|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113058|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
57113059|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113060|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57113061|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57113062|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113063|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57113064|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
57113065|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57113066|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113067|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57113068|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57113069|NCT02163356|Protective Agents|protective agents|mesh-ancestor
57113070|NCT02021006|Amoxicillin|amoxicillin|mesh-list
57113071|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
57113072|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
57113073|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57113074|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
57113075|NCT02021006|Cefixime|cefixime|mesh-list
57113076|NCT02021006|Trimethoprim|trimethoprim|mesh-list
57113077|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
57113078|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57113079|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113080|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57113081|NCT02021006|Renal Agents|renal agents|mesh-ancestor
57113082|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
57113083|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57113084|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57113085|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57113086|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113087|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113088|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56794973|NCT00565409|Etanercept|etanercept|mesh-list
57113089|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57113090|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57113091|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57113093|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57113094|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
57113095|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
57113096|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113097|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113098|NCT03867110|Atorvastatin|atorvastatin|mesh-list
57113099|NCT03867110|Ezetimibe|ezetimibe|mesh-list
57113100|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57113101|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57113102|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
57113103|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113104|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57113105|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57113106|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113107|NCT03865082|Nivolumab|nivolumab|mesh-list
57113108|NCT03865082|Ipilimumab|ipilimumab|mesh-list
57113109|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57113110|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113111|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57113112|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113113|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
57113114|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
57113115|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57113116|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57113117|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113118|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113119|NCT03102398|Urological Agents|urological agents|mesh-ancestor
57113120|NCT01187810|Cytarabine|cytarabine|mesh-list
57113121|NCT01187810|Methotrexate|methotrexate|mesh-list
57113122|NCT01187810|Fenretinide|fenretinide|mesh-list
57113123|NCT01187810|Retinamide|retinamide|mesh-list
57113124|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57113125|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
57113126|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57113127|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113128|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57113129|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
57113130|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113131|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113132|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
57113133|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113134|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57113135|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57113136|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
57113137|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57113138|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57113139|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
57113140|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113141|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57113142|NCT01187810|Protective Agents|protective agents|mesh-ancestor
57113143|NCT03104036|Mesalamine|mesalamine|mesh-list
57113144|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57113145|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57113146|NCT03104036|Analgesics|analgesics|mesh-ancestor
57113147|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
57113148|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113149|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113150|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57113151|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57113152|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
57113153|NCT03449888|Calcium|calcium|mesh-list
57113154|NCT03449888|Regadenoson|regadenoson|mesh-list
57113155|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57113156|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113157|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57113158|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
57113159|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57113160|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
57113161|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
57113162|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113163|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113165|NCT03308396|Guadecitabine|guadecitabine|mesh-list
57113166|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57113167|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113168|NCT03102242|Atezolizumab|atezolizumab|mesh-list
57113169|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113170|NCT01333033|Leucovorin|leucovorin|mesh-list
57113171|NCT01333033|Paclitaxel|paclitaxel|mesh-list
57113172|NCT01333033|Carboplatin|carboplatin|mesh-list
57113173|NCT01333033|Fluorouracil|fluorouracil|mesh-list
57113174|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
57113175|NCT01333033|Calcium|calcium|mesh-list
57113176|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
57113177|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57113178|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113179|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
57113180|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
57113181|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
57113182|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113183|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57113184|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113185|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
57113186|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57113187|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57113188|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
57113189|NCT01333033|Antidotes|antidotes|mesh-ancestor
57113190|NCT01333033|Protective Agents|protective agents|mesh-ancestor
57113191|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
57113192|NCT01333033|Vitamins|vitamins|mesh-ancestor
57113193|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
57113194|NCT02720523|Upadacitinib|upadacitinib|mesh-list
57113195|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57113196|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57113197|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113198|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113199|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57113200|NCT02646332|Amoxicillin|amoxicillin|mesh-list
57113201|NCT02646332|Metronidazole|metronidazole|mesh-list
57113202|NCT02646332|Clarithromycin|clarithromycin|mesh-list
57113203|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
57113204|NCT02646332|Lansoprazole|lansoprazole|mesh-list
57113205|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57113206|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113207|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57113208|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57113209|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57113210|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113211|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113212|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57113213|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57113214|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57113215|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57113216|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57113217|NCT00015002|Betamethasone|betamethasone|mesh-list
57113218|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57113219|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
57113220|NCT00015002|Hormones|hormones|mesh-ancestor
57113221|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57113222|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113223|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57113224|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
57113225|NCT03103412|Tofacitinib|tofacitinib|mesh-list
57113226|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57113227|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113228|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113229|NCT02061007|Misonidazole|misonidazole|mesh-list
57113230|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113231|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57113232|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57113233|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113234|NCT02086604|Lenalidomide|lenalidomide|mesh-list
57113235|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
57113236|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
57113237|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113238|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57113239|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57113240|NCT02086604|Growth Substances|growth substances|mesh-ancestor
57113241|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
57113242|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113243|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57113244|NCT03103568|Tolbutamide|tolbutamide|mesh-list
57113245|NCT03103568|Metoprolol|metoprolol|mesh-list
57113246|NCT03103568|Furosemide|furosemide|mesh-list
57113247|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
57113248|NCT03103568|Nitisinone|nitisinone|mesh-list
57113249|NCT03103568|Diuretics|diuretics|mesh-ancestor
57113250|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
57113251|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113252|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57113253|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57113254|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113255|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57113256|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57113257|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
57113258|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
57113259|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113260|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57113261|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57113262|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57113263|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
57113264|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113265|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57113266|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113267|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57113268|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57113269|NCT05654467|Vaccines|vaccines|mesh-list
57113270|NCT05654467|Immunologic Factors|immunologic factors|mesh-ancestor
57113271|NCT05654467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113272|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57113273|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57113274|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113275|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
57113276|NCT02925195|Vitamin D|vitamin d|mesh-list
57113277|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
57113278|NCT02925195|Vitamins|vitamins|mesh-ancestor
57113279|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
57113280|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113281|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57113282|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57113283|NCT03103646|Itraconazole|itraconazole|mesh-list
57113284|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
57113285|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
57113286|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113287|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57113288|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57113289|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113290|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113291|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57113292|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
57113293|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57113294|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113295|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57113296|NCT01554410|Gemcitabine|gemcitabine|mesh-list
57113297|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113298|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57113299|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
57113300|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113301|NCT01554410|Antiviral Agents|antiviral agents|mesh-ancestor
57113302|NCT01554410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113303|NCT01554410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113304|NCT01554410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57113305|NCT01554410|Immunologic Factors|immunologic factors|mesh-ancestor
57113306|NCT01554410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113307|NCT05608369|Vorinostat|vorinostat|mesh-list
57113308|NCT05608369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113309|NCT05608369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57113310|NCT05608369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113311|NCT05608369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113312|NCT01499888|Sirolimus|sirolimus|mesh-list
57113313|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
57113314|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57113316|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57113317|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113318|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
57113319|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57113320|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
57113321|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113322|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57113323|NCT03299829|Trientine|trientine|mesh-list
57113324|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
57113325|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
57113326|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113327|NCT04968158|Acetaminophen|acetaminophen|mesh-list
57113328|NCT04968158|Etoricoxib|etoricoxib|mesh-list
57113329|NCT04968158|Tramadol|tramadol|mesh-list
57113330|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57113331|NCT04968158|Analgesics|analgesics|mesh-ancestor
57113332|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
57113333|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113334|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113335|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
57113336|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57113337|NCT04968158|Narcotics|narcotics|mesh-ancestor
57113338|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113339|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57113340|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57113341|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57113342|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57113343|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57113344|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113345|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113346|NCT02059915|Oxycodone|oxycodone|mesh-list
57113347|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57113348|NCT02059915|Narcotics|narcotics|mesh-ancestor
57113349|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113350|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113351|NCT02059915|Analgesics|analgesics|mesh-ancestor
57113352|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
57113353|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113354|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
57113355|NCT02471404|Glimepiride|glimepiride|mesh-list
57113356|NCT02471404|Saxagliptin|saxagliptin|mesh-list
57113357|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57113358|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113359|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57113360|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113361|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57113362|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57113363|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
57113364|NCT02471404|Incretins|incretins|mesh-ancestor
57113365|NCT02471404|Hormones|hormones|mesh-ancestor
57113366|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57113367|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57113368|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
57113369|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113370|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
57113371|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57113372|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
57113373|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57113374|NCT02061475|Lidocaine|lidocaine|mesh-list
57113375|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
57113376|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
57113377|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113378|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113379|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
57113380|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113381|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57113382|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57113383|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57113384|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57113385|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113386|NCT03100994|Bupivacaine|bupivacaine|mesh-list
57113387|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
57113388|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
56795245|NCT00393939|Docetaxel|docetaxel|mesh-list
57113389|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113390|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113391|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
57113392|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113393|NCT04160936|Bupivacaine|bupivacaine|mesh-list
57113394|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
57113395|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
57113396|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113397|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113398|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
57113399|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113400|NCT03103334|Methotrexate|methotrexate|mesh-list
57113401|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57113402|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
57113403|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57113404|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113405|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57113406|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
57113407|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113408|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113409|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
57113410|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113411|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57113412|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57113413|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
57113414|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57113415|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57113416|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57113417|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
57113418|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113419|NCT00795158|Desloratadine|desloratadine|mesh-list
57113420|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57113421|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
57113422|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113423|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113424|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113425|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57113426|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57113427|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
57113428|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
57113429|NCT02063269|Rivastigmine|rivastigmine|mesh-list
57113430|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57113431|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113432|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113433|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
57113434|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113435|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113436|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57113437|NCT02063269|Protective Agents|protective agents|mesh-ancestor
57113438|NCT00794846|Cetirizine|cetirizine|mesh-list
57113439|NCT00794846|Desloratadine|desloratadine|mesh-list
57113440|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57113441|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57113442|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57113443|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
57113444|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
57113445|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113446|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113447|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113448|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57113449|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
57113450|NCT00794768|Fexofenadine|fexofenadine|mesh-list
57113451|NCT00794768|Desloratadine|desloratadine|mesh-list
57113452|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57113453|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
57113454|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113455|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113456|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113457|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57113458|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57113459|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
57113460|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
57113461|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57113463|NCT02060851|Trace Elements|trace elements|mesh-ancestor
57113464|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
57113465|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113466|NCT00779636|Desloratadine|desloratadine|mesh-list
57113467|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57113468|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
57113469|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113470|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113471|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113472|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57113473|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57113474|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
57113475|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
57113476|NCT02060929|Esketamine|esketamine|mesh-list
57113477|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
57113478|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57113479|NCT00757562|Desloratadine|desloratadine|mesh-list
57113480|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57113481|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
57113482|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113483|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113484|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113485|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57113486|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57113487|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
57113488|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
57113489|NCT03299517|Lidocaine|lidocaine|mesh-list
57113490|NCT03299517|Amiodarone|amiodarone|mesh-list
57113491|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
57113492|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
57113493|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
57113494|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113495|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113496|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
57113497|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113498|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57113499|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57113500|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57113501|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113502|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
57113503|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57113504|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57113505|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57113506|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113507|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57113508|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57113509|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57113510|NCT00651404|Ezetimibe|ezetimibe|mesh-list
57113511|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57113512|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57113513|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
57113514|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113515|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57113516|NCT00651014|Ezetimibe|ezetimibe|mesh-list
57113517|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57113518|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57113519|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
57113520|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113521|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57113522|NCT04435418|Apixaban|apixaban|mesh-list
57113523|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57113524|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
57113525|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57113526|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
57113527|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113528|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113529|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
57113530|NCT04563338|Bevacizumab|bevacizumab|mesh-list
57113531|NCT04563338|Atezolizumab|atezolizumab|mesh-list
57113532|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57113533|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113534|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57113535|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57113536|NCT04563338|Growth Substances|growth substances|mesh-ancestor
57113537|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113538|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
57113539|NCT02062255|Aspirin|aspirin|mesh-list
57113540|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57113541|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57113542|NCT02062255|Analgesics|analgesics|mesh-ancestor
57113543|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
57113544|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113545|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113546|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57113547|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57113548|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57113549|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57113550|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113551|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57113552|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57113553|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113554|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
57113555|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57113556|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
57113557|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57113558|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
57113559|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113560|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
57113561|NCT05547243|Vaccines|vaccines|mesh-list
57113562|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
57113563|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113564|NCT03100604|Sevoflurane|sevoflurane|mesh-list
57113565|NCT03100604|Desflurane|desflurane|mesh-list
57113566|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57113567|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57113568|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
57113569|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
57113570|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113571|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113572|NCT00398294|Simvastatin|simvastatin|mesh-list
57113573|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57113574|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57113575|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
57113576|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113577|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57113578|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57113579|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113580|NCT04823403|Nivolumab|nivolumab|mesh-list
57113581|NCT04823403|Ipilimumab|ipilimumab|mesh-list
57113582|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57113583|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113584|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57113585|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113586|NCT03493646|Azacitidine|azacitidine|mesh-list
57113587|NCT03493646|Cc-486|cc-486|mesh-list
57113588|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57113589|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
57113590|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113591|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113592|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113593|NCT05500443|Vitamin K|vitamin k|mesh-list
57113594|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
57113595|NCT05500443|Vitamin MK 7|vitamin mk 7|mesh-list
57113596|NCT05500443|Vitamins|vitamins|mesh-ancestor
57113597|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
56901661|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
57113598|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113599|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57113600|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57113601|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113602|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
57113603|NCT05500443|Coagulants|coagulants|mesh-ancestor
57113604|NCT05244200|Insulin|insulin|mesh-list
57113605|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57113606|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113607|NCT03451370|Bevacizumab|bevacizumab|mesh-list
57113608|NCT03451370|Capecitabine|capecitabine|mesh-list
57113609|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
57113610|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57113611|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113612|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57113613|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57113614|NCT03451370|Growth Substances|growth substances|mesh-ancestor
57113615|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113616|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
57113617|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57113618|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
57113619|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113620|NCT03991832|Durvalumab|durvalumab|mesh-list
57113621|NCT03991832|Olaparib|olaparib|mesh-list
57113622|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57113623|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113624|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57113625|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113626|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113627|NCT01361594|Insulin|insulin|mesh-list
57113628|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57113629|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57113630|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113631|NCT04435028|Ketotifen|ketotifen|mesh-list
57113632|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
57113633|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
57113634|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57113635|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
57113636|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
57113637|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113638|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113639|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113640|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57113641|NCT03945812|Lenograstim|lenograstim|mesh-list
57113642|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57113643|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
57113644|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113645|NCT05060198|Lumefantrine|lumefantrine|mesh-list
57113646|NCT05060198|Artemether|artemether|mesh-list
57113647|NCT05060198|Piperaquine|piperaquine|mesh-list
57113648|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57113649|NCT05060198|Artenimol|artenimol|mesh-list
57113650|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
57113651|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57113652|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57113653|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113654|NCT04478084|Vaccines|vaccines|mesh-list
57113655|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
57113656|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57113657|NCT04478084|Antibodies|antibodies|mesh-list
57113658|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
57113659|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113660|NCT03098888|Dimercaprol|dimercaprol|mesh-list
57113661|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
57113662|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
57113663|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113664|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
57113665|NCT03098810|Astringents|astringents|mesh-ancestor
57113666|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113667|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
57113668|NCT02464761|Verteporfin|verteporfin|mesh-list
57113669|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57113670|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
57113671|NCT02462889|Aflibercept|aflibercept|mesh-list
57113672|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57113673|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57113674|NCT02462889|Growth Substances|growth substances|mesh-ancestor
57113675|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113676|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
57113677|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113678|NCT02462577|Morphine|morphine|mesh-list
57113679|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57113680|NCT02462577|Narcotics|narcotics|mesh-ancestor
57113681|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113682|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113683|NCT02462577|Analgesics|analgesics|mesh-ancestor
57113684|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
57113685|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113686|NCT02462499|Eplerenone|eplerenone|mesh-list
57113687|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57113688|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
57113689|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57113690|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113691|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57113692|NCT02462499|Diuretics|diuretics|mesh-ancestor
57113693|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
57113694|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57113695|NCT02464683|Vitamin D|vitamin d|mesh-list
57113696|NCT02464683|Vitamins|vitamins|mesh-ancestor
57113697|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
57113698|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113699|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57113700|NCT02061631|Dexamethasone|dexamethasone|mesh-list
57113701|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
57113702|NCT02061631|Docetaxel|docetaxel|mesh-list
57113703|NCT02061631|BB 1101|bb 1101|mesh-list
57113704|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57113705|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
57113706|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
57113707|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113708|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113709|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57113710|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
57113711|NCT02061631|Hormones|hormones|mesh-ancestor
57113712|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57113713|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57113714|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113715|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
57113716|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113717|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113718|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
57113719|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
57113720|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
57113721|NCT03098342|Amorolfine|amorolfine|mesh-list
57113722|NCT03098342|Methylene Blue|methylene blue|mesh-list
57113723|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113724|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113725|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
57113726|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113727|NCT05059418|Clonazepam|clonazepam|mesh-list
57113728|NCT05059418|Capsaicin|capsaicin|mesh-list
57113729|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
57113730|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
57113731|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
57113732|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113733|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113734|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
57113735|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
57113736|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
57113737|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113738|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113739|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
57113740|NCT02062333|Esmolol|esmolol|mesh-list
57113741|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57113742|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113743|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113744|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57113745|NCT02062333|Analgesics|analgesics|mesh-ancestor
57113746|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
57113747|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113748|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57113749|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57113750|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57113751|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
57113752|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113753|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113754|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57113755|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57113756|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57113757|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
57113758|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57113759|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
57113760|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113761|NCT05010668|Lenvatinib|lenvatinib|mesh-list
57113762|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113763|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57113764|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113765|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113766|NCT02063425|Fluoxetine|fluoxetine|mesh-list
57113767|NCT02063425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57113768|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57113769|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57113770|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113771|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113772|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
57113773|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113774|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57113775|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
57113776|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57113777|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57113778|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57113779|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113780|NCT05071118|Pregabalin|pregabalin|mesh-list
57113781|NCT05071118|Analgesics|analgesics|mesh-ancestor
57113782|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
57113783|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113784|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113785|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
57113786|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57113787|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57113788|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113789|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57113790|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57113791|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57113792|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113793|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57113794|NCT03559400|Gentamicins|gentamicins|mesh-list
57113795|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57113796|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113797|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57113798|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113799|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113800|NCT03464019|Etripamil|etripamil|mesh-list
57113801|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57113802|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57113803|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113804|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57113805|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113806|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
57113807|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
57113808|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57113809|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113810|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113811|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
57113812|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57113813|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113814|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113815|NCT05069870|Itraconazole|itraconazole|mesh-list
57113816|NCT05069870|Rifampin|rifampin|mesh-list
57113817|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
57113818|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
57113819|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113820|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57113821|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57113822|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113823|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113824|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57113825|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
57113826|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57113827|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113828|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57113829|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57113830|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
57113831|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57113832|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
57113833|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57113834|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57113835|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57113836|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57113837|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57113838|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57113839|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57113840|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57113841|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
57113842|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57113843|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57113844|NCT03080883|Apixaban|apixaban|mesh-list
57113845|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57113846|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
57113847|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57113848|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
57113849|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113850|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113851|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
57113852|NCT03031821|Metformin|metformin|mesh-list
57113853|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57113854|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113855|NCT05275491|Calcium|calcium|mesh-list
57113856|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
57113857|NCT05275491|Hormones|hormones|mesh-list
57113858|NCT05275491|Mitogens|mitogens|mesh-list
57113859|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57113860|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113861|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57113862|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
57113863|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113864|NCT04584255|Niraparib|niraparib|mesh-list
57113865|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57113866|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113867|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113868|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113869|NCT02976753|Factor VIII|factor viii|mesh-list
57113870|NCT02976753|Coagulants|coagulants|mesh-ancestor
57113871|NCT04559529|Levetiracetam|levetiracetam|mesh-list
57113872|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
57113873|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
57113874|NCT04490421|Etoposide|etoposide|mesh-list
57113875|NCT04490421|Apatinib|apatinib|mesh-list
57113876|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113877|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57113878|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57113879|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57113880|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113881|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113882|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57113883|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
57113884|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57113885|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113886|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57113887|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113888|NCT02462109|Lorazepam|lorazepam|mesh-list
57113889|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
57113890|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
57113891|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
57113892|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113893|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113894|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57113895|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57113896|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113897|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57113898|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57113899|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57113900|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
57113901|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
57113902|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113903|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113904|NCT02056899|Gabapentin|gabapentin|mesh-list
57113905|NCT02056899|Analgesics|analgesics|mesh-ancestor
57113906|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
57113907|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113908|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795770|NCT00470262|Pioglitazone|pioglitazone|mesh-list
57113909|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
57113910|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57113911|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57113912|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57113913|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57113914|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57113915|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57113916|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113917|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113918|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
57113920|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
57113921|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113922|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113923|NCT02462265|Analgesics|analgesics|mesh-ancestor
57113924|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
57113925|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113926|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57113927|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57113928|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113929|NCT02461875|Cabergoline|cabergoline|mesh-list
57113930|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57113931|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57113932|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
57113933|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
57113934|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113935|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113936|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113937|NCT02461719|Cyclosporine|cyclosporine|mesh-list
57113938|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57113939|NCT02461719|Cyclosporins|cyclosporins|mesh-list
57113940|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113941|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113942|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57113943|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
57113944|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113945|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
57113946|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113947|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
57113948|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57113949|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57113950|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57113951|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
57113952|NCT04322643|Nivolumab|nivolumab|mesh-list
57113953|NCT04322643|Durvalumab|durvalumab|mesh-list
57113954|NCT04322643|Avelumab|avelumab|mesh-list
57113955|NCT04322643|Atezolizumab|atezolizumab|mesh-list
57113956|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57113957|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113958|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57113959|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113960|NCT01682187|Lomustine|lomustine|mesh-list
57113961|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57113962|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
57113963|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113964|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113965|NCT02796391|Nicotine|nicotine|mesh-list
57113966|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57113967|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
57113968|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57113969|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113970|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57113971|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57113972|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
57113973|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57113974|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113975|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
57113976|NCT02064049|Velpatasvir|velpatasvir|mesh-list
57113977|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57113978|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
57113979|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57113980|NCT02064829|Paclitaxel|paclitaxel|mesh-list
57113981|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57113982|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57113983|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57113984|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
57113985|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
57113986|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
57113987|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113989|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57113990|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57113991|NCT02067949|Simvastatin|simvastatin|mesh-list
57113992|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57113993|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57113994|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
57113995|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57113996|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57113997|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57113998|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57113999|NCT02068339|Oltipraz|oltipraz|mesh-list
57114000|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
57114001|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114002|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
57114003|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57114004|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
57114005|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57114006|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57114007|NCT02068339|Protective Agents|protective agents|mesh-ancestor
57114008|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114009|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114010|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57114011|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57114012|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114013|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114014|NCT02065843|Midazolam|midazolam|mesh-list
57114015|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57114016|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57114017|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114018|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114019|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57114020|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57114021|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57114022|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57114023|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
57114024|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
57114025|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
57114026|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
57114027|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114028|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114029|NCT02066077|Propofol|propofol|mesh-list
57114030|NCT02066077|Etomidate|etomidate|mesh-list
57114031|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57114032|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114033|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114034|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57114035|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
57114036|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
57114037|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57114038|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
57114039|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114040|NCT02065063|Palbociclib|palbociclib|mesh-list
57114041|NCT02065063|Trametinib|trametinib|mesh-list
57114042|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114043|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57114044|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114045|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114046|NCT02069197|Orlistat|orlistat|mesh-list
57114047|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114048|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114049|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57114050|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57114051|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
57114052|NCT00813423|Sunitinib|sunitinib|mesh-list
57114053|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114054|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57114055|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57114056|NCT00813423|Growth Substances|growth substances|mesh-ancestor
57114057|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114058|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
57114059|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57114060|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795941|NCT00486720|Vorinostat|vorinostat|mesh-list
57114061|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114062|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
57114063|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57114064|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57114065|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114066|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114067|NCT05120349|Osimertinib|osimertinib|mesh-list
57114068|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114069|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57114070|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114071|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114072|NCT02069431|Oxytocin|oxytocin|mesh-list
57114073|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
57114074|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57114075|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114076|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
57114077|NCT01652872|Hematinics|hematinics|mesh-ancestor
57114078|NCT02065219|Bupivacaine|bupivacaine|mesh-list
57114079|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
57114080|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
57114081|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114082|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114083|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
57114084|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114085|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
57114086|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57114087|NCT03560011|Antibodies|antibodies|mesh-list
57114088|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
57114089|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114090|NCT02069665|Ribavirin|ribavirin|mesh-list
57114091|NCT02069665|Ibuprofen|ibuprofen|mesh-list
57114092|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
57114093|NCT02069665|Albuterol|albuterol|mesh-list
57114094|NCT02069665|Guaifenesin|guaifenesin|mesh-list
57114095|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
57114096|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
57114097|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114098|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
57114099|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114100|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57114101|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57114102|NCT02069665|Analgesics|analgesics|mesh-ancestor
57114103|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
57114104|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114105|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114106|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114107|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114108|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57114109|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114110|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57114111|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
57114112|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57114113|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
57114114|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
57114115|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57114116|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57114117|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57114118|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57114119|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
57114120|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114121|NCT02069665|Expectorants|expectorants|mesh-ancestor
57114122|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57114123|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
57114124|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57114125|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
57114126|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
57114127|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57114128|NCT04938856|Lamotrigine|lamotrigine|mesh-list
57114129|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
57114130|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57114131|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57114132|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114133|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57114134|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114135|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57114136|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57114137|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114138|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57114139|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57114141|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
57114142|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
57114143|NCT02463825|Pimozide|pimozide|mesh-list
57114144|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57114145|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57114146|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114147|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114148|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57114149|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57114150|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
57114151|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114152|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114153|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57114154|NCT02069977|Aripiprazole|aripiprazole|mesh-list
57114155|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
57114156|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57114157|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57114158|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57114159|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114160|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114161|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
57114162|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
57114163|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114164|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114165|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57114166|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57114167|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
57114168|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57114169|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57114170|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57114171|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57114172|NCT04490031|Ketamine|ketamine|mesh-list
57114173|NCT04490031|Analgesics|analgesics|mesh-ancestor
57114174|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
57114175|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114176|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114177|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57114178|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57114179|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
57114180|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
57114181|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114182|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57114183|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57114184|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114185|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114186|NCT02443402|Insulin|insulin|mesh-list
57114187|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57114188|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
57114189|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57114190|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
57114191|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
57114192|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57114193|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114194|NCT02443402|Incretins|incretins|mesh-ancestor
57114195|NCT02443402|Hormones|hormones|mesh-ancestor
57114196|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114197|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57114198|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
57114199|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114200|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114201|NCT02067013|Ranibizumab|ranibizumab|mesh-list
57114202|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57114203|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57114204|NCT02067013|Growth Substances|growth substances|mesh-ancestor
57114205|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114206|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
57114207|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114208|NCT03298581|Clobetasol|clobetasol|mesh-list
57114209|NCT03298581|Halobetasol|halobetasol|mesh-list
57114210|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57114211|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114212|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
57114213|NCT03298581|Hormones|hormones|mesh-ancestor
57114214|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114215|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114216|NCT02412670|Gemcitabine|gemcitabine|mesh-list
57114217|NCT02412670|Cisplatin|cisplatin|mesh-list
57114218|NCT02412670|Carboplatin|carboplatin|mesh-list
57114219|NCT02412670|Doxorubicin|doxorubicin|mesh-list
57114220|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57114221|NCT02412670|Methotrexate|methotrexate|mesh-list
57114222|NCT02412670|Vinblastine|vinblastine|mesh-list
57114223|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114224|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57114225|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
57114226|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114227|NCT02412670|Antiviral Agents|antiviral agents|mesh-ancestor
57114228|NCT02412670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114229|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114230|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57114231|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
57114232|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114233|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57114234|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57114235|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57114236|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57114237|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
57114238|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57114239|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
57114240|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57114241|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114242|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57114243|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57114244|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
57114245|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
57114246|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
57114247|NCT01370005|Empagliflozin|empagliflozin|mesh-list
57114248|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57114249|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114250|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57114251|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114252|NCT02070133|Simvastatin|simvastatin|mesh-list
57114253|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57114254|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57114255|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
57114256|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114257|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57114258|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57114259|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114260|NCT02070289|PF-06372865|pf-06372865|mesh-list
57114261|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
57114262|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
57114263|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114264|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114265|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114266|NCT02071927|Azacitidine|azacitidine|mesh-list
57114267|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57114268|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
57114269|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114270|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114271|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114272|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
57114273|NCT02072083|Ketamine|ketamine|mesh-list
57114274|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57114275|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114276|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114277|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57114278|NCT02072083|Analgesics|analgesics|mesh-ancestor
57114279|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
57114280|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114281|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57114282|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57114283|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57114284|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
57114285|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796145|NCT00401973|Metformin|metformin|mesh-list
57114286|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114287|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57114288|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57114289|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
57114290|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
57114291|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57114292|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57114293|NCT02070679|Vitamin E|vitamin e|mesh-list
57114294|NCT02070679|Tocopherols|tocopherols|mesh-list
57114295|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
57114296|NCT02070679|Vitamins|vitamins|mesh-ancestor
57114297|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
57114298|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114299|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
57114300|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114301|NCT02070679|Protective Agents|protective agents|mesh-ancestor
57114302|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57114303|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
57114304|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57114305|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57114306|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57114307|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
57114308|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57114309|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114310|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57114311|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57114312|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57114313|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57114314|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114315|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57114316|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57114317|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114318|NCT02072317|Raltitrexed|raltitrexed|mesh-list
57114319|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57114320|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
57114321|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114322|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114323|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57114324|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114325|NCT01651000|Calcifediol|calcifediol|mesh-list
57114326|NCT01651000|Vitamins|vitamins|mesh-ancestor
57114327|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
57114328|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114329|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57114330|NCT02469610|Bupivacaine|bupivacaine|mesh-list
57114331|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
57114332|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
57114333|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114334|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114335|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
57114336|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114337|NCT02071069|Fluorouracil|fluorouracil|mesh-list
57114338|NCT02071069|Irinotecan|irinotecan|mesh-list
57114339|NCT02071069|Cetuximab|cetuximab|mesh-list
57114340|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
57114341|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114342|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57114343|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114344|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57114345|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
57114346|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114347|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57114348|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57114349|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114350|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57114351|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
57114352|NCT02076373|Hematinics|hematinics|mesh-ancestor
57114353|NCT02072785|Vincristine|vincristine|mesh-list
57114354|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57114355|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114356|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
57114357|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
57114358|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
57114359|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114360|NCT02469298|Oseltamivir|oseltamivir|mesh-list
57114361|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
57114362|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114363|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114364|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114365|NCT02076451|DS-8273a|ds-8273a|mesh-list
57114366|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57114367|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114368|NCT02071303|Celecoxib|celecoxib|mesh-list
57114369|NCT02071303|Tramadol|tramadol|mesh-list
57114370|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57114371|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57114372|NCT02071303|Analgesics|analgesics|mesh-ancestor
57114373|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
57114374|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114375|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114376|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114377|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114378|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57114379|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57114380|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114381|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114382|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57114383|NCT02071303|Narcotics|narcotics|mesh-ancestor
57114384|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114385|NCT02076529|Ramosetron|ramosetron|mesh-list
57114386|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
57114387|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
57114388|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114389|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114390|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57114391|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57114392|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
57114393|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114394|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114395|NCT02411578|Glucagon|glucagon|mesh-list
57114396|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57114397|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57114398|NCT02411578|Hormones|hormones|mesh-ancestor
57114399|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114400|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114401|NCT02411578|Incretins|incretins|mesh-ancestor
57114402|NCT02076685|Isoniazid|isoniazid|mesh-list
57114403|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
57114404|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57114405|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114406|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57114407|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57114408|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
57114409|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114410|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57114411|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
57114412|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
57114413|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
57114414|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114415|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114416|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57114417|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
57114418|NCT02071459|Droxidopa|droxidopa|mesh-list
57114419|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57114420|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57114421|NCT02463747|Vancomycin|vancomycin|mesh-list
57114422|NCT02463747|Meropenem|meropenem|mesh-list
57114423|NCT02463747|Tazobactam|tazobactam|mesh-list
57114424|NCT02463747|Piperacillin|piperacillin|mesh-list
57114425|NCT02463747|Ceftazidime|ceftazidime|mesh-list
57114426|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57114427|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57114428|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114429|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57114430|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114431|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114432|NCT02071537|Gemcitabine|gemcitabine|mesh-list
57114433|NCT02071537|Chloroquine|chloroquine|mesh-list
57114434|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
57114435|NCT02071537|Carboplatin|carboplatin|mesh-list
57114436|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114437|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796309|NCT00331630|Paclitaxel|paclitaxel|mesh-list
57114438|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
57114439|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114440|NCT02071537|Antiviral Agents|antiviral agents|mesh-ancestor
57114441|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114442|NCT02071537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114443|NCT02071537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57114444|NCT02071537|Immunologic Factors|immunologic factors|mesh-ancestor
57114445|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114446|NCT02071537|Amebicides|amebicides|mesh-ancestor
57114447|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57114448|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57114449|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
57114450|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114451|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57114452|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57114453|NCT02071537|Analgesics|analgesics|mesh-ancestor
57114454|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
57114455|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114456|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114457|NCT02071537|Filaricides|filaricides|mesh-ancestor
57114458|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
57114459|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
57114460|NCT02076841|Interferons|interferons|mesh-list
57114461|NCT02076841|Interferon-beta|interferon-beta|mesh-list
57114462|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
57114463|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114464|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
57114465|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114466|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
57114467|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114468|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57114469|NCT02442310|Deferiprone|deferiprone|mesh-list
57114470|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57114471|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
57114472|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
57114473|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114474|NCT02071615|Caffeine|caffeine|mesh-list
57114475|NCT02071615|Methylphenidate|methylphenidate|mesh-list
57114476|NCT02071615|Modafinil|modafinil|mesh-list
57114477|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57114478|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114479|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57114480|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114481|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114482|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57114483|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57114484|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
57114485|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114486|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57114487|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57114488|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57114489|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
57114490|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
57114491|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57114492|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57114493|NCT02077231|Vitamins|vitamins|mesh-list
57114494|NCT02077231|Vitamin A|vitamin a|mesh-list
57114495|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
57114496|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
57114497|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114498|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
57114499|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114500|NCT02077231|Protective Agents|protective agents|mesh-ancestor
57114501|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57114502|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114503|NCT02077309|Linagliptin|linagliptin|mesh-list
57114504|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57114505|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114506|NCT02077309|Incretins|incretins|mesh-ancestor
57114507|NCT02077309|Hormones|hormones|mesh-ancestor
57114508|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114509|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57114510|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
57114511|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114512|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114513|NCT01369849|Rituximab|rituximab|mesh-list
57114514|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57114516|NCT01369849|Antibodies|antibodies|mesh-list
57114517|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
57114518|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57114519|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
57114520|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114521|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114522|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114523|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57114524|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
57114525|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114526|NCT02716779|Interferons|interferons|mesh-list
57114527|NCT02716779|Ribavirin|ribavirin|mesh-list
57114528|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114529|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
57114530|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114531|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
57114532|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114533|NCT02074189|Gemcitabine|gemcitabine|mesh-list
57114534|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114535|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57114536|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
57114537|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114538|NCT02074189|Antiviral Agents|antiviral agents|mesh-ancestor
57114539|NCT02074189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114540|NCT02074189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114541|NCT02074189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57114542|NCT02074189|Immunologic Factors|immunologic factors|mesh-ancestor
57114543|NCT02074189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114544|NCT02463591|Thrombin|thrombin|mesh-list
57114545|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
57114546|NCT02463591|Coagulants|coagulants|mesh-ancestor
57114547|NCT02079961|Micronutrients|micronutrients|mesh-list
57114548|NCT02079961|Trace Elements|trace elements|mesh-list
57114549|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114550|NCT03298347|Caffeine|caffeine|mesh-list
57114551|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57114552|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114553|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57114554|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114555|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114556|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57114557|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57114558|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
57114559|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114560|NCT02074267|Gabapentin|gabapentin|mesh-list
57114561|NCT02074267|Analgesics|analgesics|mesh-ancestor
57114562|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
57114563|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114564|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114565|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
57114566|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57114567|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57114568|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114569|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57114570|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57114571|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57114572|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114573|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114574|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
57114575|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
57114576|NCT02077777|Mesalamine|mesalamine|mesh-list
57114577|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57114578|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57114579|NCT02077777|Analgesics|analgesics|mesh-ancestor
57114580|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
57114581|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114582|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114583|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114584|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114585|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
57114586|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57114587|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114588|NCT05036421|Empagliflozin|empagliflozin|mesh-list
57114589|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57114590|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114591|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57114592|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114593|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
57114594|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
57114595|NCT03298191|Ritodrine|ritodrine|mesh-list
57114596|NCT03298191|Calcium|calcium|mesh-list
57114597|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57114598|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114599|NCT03298191|Analgesics|analgesics|mesh-ancestor
57114600|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
57114601|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114602|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
57114603|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114604|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57114605|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
57114606|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57114607|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114608|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
57114609|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57114610|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
57114611|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
57114612|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57114613|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57114614|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57114615|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
57114616|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114617|NCT01369615|Oxycodone|oxycodone|mesh-list
57114618|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57114619|NCT01369615|Narcotics|narcotics|mesh-ancestor
57114620|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114621|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114622|NCT01369615|Analgesics|analgesics|mesh-ancestor
57114623|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
57114624|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114625|NCT02077933|Everolimus|everolimus|mesh-list
57114626|NCT02077933|Exemestane|exemestane|mesh-list
57114627|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114628|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57114629|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
57114630|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114631|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57114632|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57114633|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114634|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114635|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57114636|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
57114637|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114638|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
57114639|NCT02078089|Morphine|morphine|mesh-list
57114640|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57114641|NCT02078089|Narcotics|narcotics|mesh-ancestor
57114642|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114643|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114644|NCT02078089|Analgesics|analgesics|mesh-ancestor
57114645|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
57114646|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114647|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
57114648|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57114649|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57114650|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57114651|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114652|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57114653|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57114654|NCT02074891|Tenofovir|tenofovir|mesh-list
57114655|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
57114656|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114657|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57114658|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57114659|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114660|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114661|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57114662|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57114664|NCT02078167|Red yeast rice|red yeast rice|mesh-list
57114665|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57114666|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57114667|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57114668|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
57114669|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114670|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114671|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57114672|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57114673|NCT02078323|Linaclotide|linaclotide|mesh-list
57114674|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57114675|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
57114676|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114677|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57114678|NCT02075749|Triamcinolone|triamcinolone|mesh-list
57114679|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57114680|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57114681|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57114682|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114683|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
57114684|NCT02075749|Hormones|hormones|mesh-ancestor
57114685|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114686|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114687|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57114688|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
57114689|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114690|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114691|NCT02081287|Inositol|inositol|mesh-list
57114692|NCT02081287|Lamotrigine|lamotrigine|mesh-list
57114693|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
57114694|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57114695|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57114696|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114697|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57114698|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114699|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57114700|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57114701|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114702|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57114703|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57114704|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
57114705|NCT02081287|Vitamins|vitamins|mesh-ancestor
57114706|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
57114707|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57114708|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57114709|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57114710|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114711|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114712|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57114713|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57114714|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114715|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
57114716|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114717|NCT04918069|Capsaicin|capsaicin|mesh-list
57114718|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
57114719|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
57114720|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
57114721|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114722|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114723|NCT02078869|Progesterone|progesterone|mesh-list
57114724|NCT02078869|Progestins|progestins|mesh-ancestor
57114725|NCT02078869|Hormones|hormones|mesh-ancestor
57114726|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114727|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114728|NCT02083315|Morphine|morphine|mesh-list
57114729|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57114730|NCT02083315|Narcotics|narcotics|mesh-ancestor
57114731|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114732|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114733|NCT02083315|Analgesics|analgesics|mesh-ancestor
57114734|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
57114735|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114736|NCT03559387|Lenograstim|lenograstim|mesh-list
57114737|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57114738|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
57114739|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114740|NCT05519059|Paclitaxel|paclitaxel|mesh-list
57114741|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57114742|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114743|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
57114744|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
57114745|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
57114746|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114747|NCT02079337|Rocuronium|rocuronium|mesh-list
57114748|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57114749|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57114750|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57114751|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114752|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114753|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
57114754|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57114755|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57114756|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57114757|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
57114758|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114759|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57114760|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57114761|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114762|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57114763|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114764|NCT02079727|Celecoxib|celecoxib|mesh-list
57114765|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57114766|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57114767|NCT02079727|Analgesics|analgesics|mesh-ancestor
57114768|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
57114769|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114770|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114771|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114772|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114773|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57114774|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57114775|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114776|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114777|NCT02082067|Ketorolac|ketorolac|mesh-list
57114778|NCT02082067|Morphine|morphine|mesh-list
57114779|NCT02082067|Anesthetics|anesthetics|mesh-list
57114780|NCT02082067|Ropivacaine|ropivacaine|mesh-list
57114781|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
57114782|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
57114783|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114784|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114785|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57114786|NCT02082067|Narcotics|narcotics|mesh-ancestor
57114787|NCT02082067|Analgesics|analgesics|mesh-ancestor
57114788|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
57114789|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114790|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57114791|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57114792|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114793|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114794|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57114795|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114796|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114797|NCT02084563|Cytarabine|cytarabine|mesh-list
57114798|NCT02084563|Decitabine|decitabine|mesh-list
57114799|NCT02084563|Daunorubicin|daunorubicin|mesh-list
57114800|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57114801|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
57114802|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114803|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114804|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
57114805|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114806|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57114807|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
57114808|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796665|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
57114809|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57114810|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57114811|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57114812|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114814|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
57114815|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114816|NCT02084875|Tofacitinib|tofacitinib|mesh-list
57114817|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57114818|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114819|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114820|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
57114821|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57114822|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114823|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
57114824|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57114825|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114826|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57114827|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57114828|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114829|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114830|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114831|NCT02082613|Polidocanol|polidocanol|mesh-list
57114832|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57114833|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57114834|NCT02085109|Theobromine|theobromine|mesh-list
57114835|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57114836|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
57114837|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114838|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114839|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57114840|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
57114841|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
57114842|NCT03557983|Fenofibrate|fenofibrate|mesh-list
57114843|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57114844|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
57114845|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114846|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57114847|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
57114848|NCT03558919|Mirabegron|mirabegron|mesh-list
57114849|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57114850|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57114851|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
57114852|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114853|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114854|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114855|NCT03558919|Urological Agents|urological agents|mesh-ancestor
57114856|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57114857|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57114858|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57114859|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
57114860|NCT02085577|Acetaminophen|acetaminophen|mesh-list
57114861|NCT02085577|Sufentanil|sufentanil|mesh-list
57114862|NCT02085577|Ketamine|ketamine|mesh-list
57114863|NCT02085577|Morphine|morphine|mesh-list
57114864|NCT02085577|Dsuvia|dsuvia|mesh-list
57114865|NCT02085577|Ondansetron|ondansetron|mesh-list
57114866|NCT02085577|Analgesics|analgesics|mesh-ancestor
57114867|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
57114868|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114869|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114870|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57114871|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57114872|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
57114873|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
57114874|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114875|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57114876|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57114877|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114878|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114879|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57114880|NCT02085577|Narcotics|narcotics|mesh-ancestor
57114881|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57114882|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
57114883|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
57114884|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
57114885|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57114886|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
56796745|NCT00949949|Everolimus|everolimus|mesh-list
57114888|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57114889|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
57114890|NCT02085577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57114891|NCT02085577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57114892|NCT02085577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57114893|NCT02085577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57114894|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57114895|NCT02085655|Gemcitabine|gemcitabine|mesh-list
57114896|NCT02085655|Thalidomide|thalidomide|mesh-list
57114897|NCT02085655|Dexamethasone|dexamethasone|mesh-list
57114898|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
57114899|NCT02085655|Methotrexate|methotrexate|mesh-list
57114900|NCT02085655|Pegaspargase|pegaspargase|mesh-list
57114901|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57114902|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
57114903|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
57114904|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57114905|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114906|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57114907|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
57114908|NCT02085655|Hormones|hormones|mesh-ancestor
57114909|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114910|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57114911|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114912|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57114913|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
57114914|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114915|NCT02085655|Antiviral Agents|antiviral agents|mesh-ancestor
57114916|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114917|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114918|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57114919|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
57114920|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57114921|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
57114922|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57114923|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
57114924|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57114925|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57114926|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57114927|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
57114928|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57114929|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57114930|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57114931|NCT02085655|Growth Substances|growth substances|mesh-ancestor
57114932|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
57114933|NCT02085967|Itraconazole|itraconazole|mesh-list
57114934|NCT02085967|Rifampin|rifampin|mesh-list
57114935|NCT02085967|Midazolam|midazolam|mesh-list
57114936|NCT02085967|Bupropion|bupropion|mesh-list
57114937|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57114938|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57114939|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57114940|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114941|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57114942|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57114943|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57114944|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57114945|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
57114946|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
57114947|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
57114948|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
57114949|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57114950|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57114951|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57114952|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
57114953|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57114954|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57114955|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57114956|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
57114957|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57114958|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57114959|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114960|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
57114961|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57114962|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57114963|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57114964|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
57114965|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114966|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57114967|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57114968|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
57114969|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57114970|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
57114971|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57114972|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57114973|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57114974|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57114975|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57114976|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57114977|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57114978|NCT02091505|Ranibizumab|ranibizumab|mesh-list
57114979|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57114980|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57114981|NCT02091505|Growth Substances|growth substances|mesh-ancestor
57114982|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114983|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
57114984|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57114985|NCT02091817|Oxytocin|oxytocin|mesh-list
57114986|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
57114987|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57114988|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114989|NCT02086279|Hormones|hormones|mesh-list
57114990|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57114991|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114992|NCT02091973|Everolimus|everolimus|mesh-list
57114993|NCT02091973|Tacrolimus|tacrolimus|mesh-list
57114994|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57114995|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
57114996|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57114997|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57114998|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57114999|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115000|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115001|NCT03558295|Anticoagulants|anticoagulants|mesh-list
57115002|NCT02089399|Olmesartan|olmesartan|mesh-list
57115003|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57115004|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57115005|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115006|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
57115007|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115008|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115009|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57115010|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115011|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57115012|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57115013|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57115014|NCT03557437|Amoxicillin|amoxicillin|mesh-list
57115015|NCT03557437|Metronidazole|metronidazole|mesh-list
57115016|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
57115017|NCT03557437|Esomeprazole|esomeprazole|mesh-list
57115018|NCT03557437|Bismuth|bismuth|mesh-list
57115019|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115020|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56404184|NCT00548509|Vitamin K|vitamin k|mesh-list
57115021|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115022|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57115023|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57115024|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57115025|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115026|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57115027|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115028|NCT03557437|Antacids|antacids|mesh-ancestor
57115029|NCT03557437|Diuretics|diuretics|mesh-ancestor
57115030|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
57115031|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115032|NCT03557437|Expectorants|expectorants|mesh-ancestor
57115033|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
57115034|NCT02089633|BCT-100|bct-100|mesh-list
57115035|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796891|NCT00385827|Analgesics|analgesics|mesh-ancestor
57115036|NCT02086747|Acetaminophen|acetaminophen|mesh-list
57115037|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57115039|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
57115040|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115041|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115042|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
57115043|NCT02086825|Rifaximin|rifaximin|mesh-list
57115044|NCT02086825|Lactulose|lactulose|mesh-list
57115045|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57115046|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115047|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115048|NCT02086903|Clopidogrel|clopidogrel|mesh-list
57115049|NCT02086903|Ticagrelor|ticagrelor|mesh-list
57115050|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57115051|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57115052|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57115053|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57115054|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
57115055|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115056|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115057|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115058|NCT02087215|Boron|boron|mesh-list
57115059|NCT02087215|Trace Elements|trace elements|mesh-ancestor
57115060|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
57115061|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115062|NCT02087527|Dexamethasone|dexamethasone|mesh-list
57115063|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57115064|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
57115065|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
57115066|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115067|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115068|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115069|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
57115070|NCT02087527|Hormones|hormones|mesh-ancestor
57115071|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115072|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57115073|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115074|NCT02087683|Vitamin D|vitamin d|mesh-list
57115075|NCT02087683|Vitamins|vitamins|mesh-ancestor
57115076|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
57115077|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115078|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57115079|NCT02092363|Paclitaxel|paclitaxel|mesh-list
57115080|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57115081|NCT02092363|Carboplatin|carboplatin|mesh-list
57115082|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
57115083|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57115084|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115085|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
57115086|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
57115087|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
57115088|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115089|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
57115090|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115091|NCT03558139|Avelumab|avelumab|mesh-list
57115092|NCT03558139|Magrolimab|magrolimab|mesh-list
57115093|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57115094|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115095|NCT02089867|Ezetimibe|ezetimibe|mesh-list
57115096|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57115097|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115098|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
57115099|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115100|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115101|NCT02092597|Exenatide|exenatide|mesh-list
57115102|NCT02092597|Linagliptin|linagliptin|mesh-list
57115103|NCT02092597|Gliclazide|gliclazide|mesh-list
57115104|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57115105|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115106|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57115107|NCT02092597|Incretins|incretins|mesh-ancestor
57115108|NCT02092597|Hormones|hormones|mesh-ancestor
56796962|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
57115109|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115110|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57115111|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
57115112|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115113|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115114|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57115115|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57115116|NCT02093143|Remifentanil|remifentanil|mesh-list
57115117|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57115118|NCT02093143|Narcotics|narcotics|mesh-ancestor
57115119|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57115120|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115121|NCT02093143|Analgesics|analgesics|mesh-ancestor
57115122|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
57115123|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115124|NCT02093299|Clopidogrel|clopidogrel|mesh-list
57115125|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57115126|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57115127|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57115128|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57115129|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
57115130|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115131|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115132|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115133|NCT00454753|Dasatinib|dasatinib|mesh-list
57115134|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115135|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57115136|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115137|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115138|NCT02093533|Eculizumab|eculizumab|mesh-list
57115139|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57115140|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57115141|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
57115142|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115143|NCT03297879|Metformin|metformin|mesh-list
57115144|NCT03297879|Exenatide|exenatide|mesh-list
57115145|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57115146|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115147|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57115148|NCT03297879|Incretins|incretins|mesh-ancestor
57115149|NCT03297879|Hormones|hormones|mesh-ancestor
57115150|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115151|NCT02093845|Everolimus|everolimus|mesh-list
57115152|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115153|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57115154|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
57115155|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115156|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
57115157|NCT04489797|Rabeprazole|rabeprazole|mesh-list
57115158|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57115159|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115160|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57115161|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115162|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115163|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115164|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57115165|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57115166|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115167|NCT02096419|Clopidogrel|clopidogrel|mesh-list
57115168|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57115169|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57115170|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57115171|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57115172|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
57115173|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115174|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115175|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115176|NCT02094157|Heparin|heparin|mesh-list
57115177|NCT02094157|Calcium heparin|calcium heparin|mesh-list
57115178|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57115179|NCT02094157|Tinzaparin|tinzaparin|mesh-list
57115180|NCT02094157|Dalteparin|dalteparin|mesh-list
57115181|NCT02094157|Warfarin|warfarin|mesh-list
57115182|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
57115183|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57115184|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57115185|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115186|NCT02094313|Atorvastatin|atorvastatin|mesh-list
57115187|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
57115188|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115189|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
57115190|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115191|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115192|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57115193|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115194|NCT02094391|Ipilimumab|ipilimumab|mesh-list
57115195|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57115196|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115197|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57115198|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115199|NCT02094469|Cilostazol|cilostazol|mesh-list
57115200|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57115201|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
57115202|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115203|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115204|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57115205|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
57115206|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57115207|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57115208|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115209|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57115210|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
57115211|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57115212|NCT02094469|Protective Agents|protective agents|mesh-ancestor
56901764|NCT01307475|Analgesics|analgesics|mesh-ancestor
57115213|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57115214|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57115215|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115216|NCT02094703|Levofloxacin|levofloxacin|mesh-list
57115217|NCT02094703|Ofloxacin|ofloxacin|mesh-list
57115218|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
57115219|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57115220|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115221|NCT02094703|Renal Agents|renal agents|mesh-ancestor
57115222|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57115223|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57115224|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57115225|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115226|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115227|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115228|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57115229|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57115230|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57115231|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57115232|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
57115233|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115234|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115235|NCT02094703|Urological Agents|urological agents|mesh-ancestor
57115236|NCT02098837|Dolutegravir|dolutegravir|mesh-list
57115237|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57115238|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57115239|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115240|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115241|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57115242|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57115243|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
57115244|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115245|NCT02098915|Metoclopramide|metoclopramide|mesh-list
57115246|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
57115247|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
57115248|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115249|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115250|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115251|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57115252|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57115253|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
57115254|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115255|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115256|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
57115257|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57115258|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115259|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57115260|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115262|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57115263|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115264|NCT02095405|Caffeine|caffeine|mesh-list
57115265|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57115266|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115267|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57115268|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115269|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115270|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57115271|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57115272|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
57115273|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115274|NCT04434482|Temozolomide|temozolomide|mesh-list
57115275|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57115276|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
57115277|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115278|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115279|NCT02096965|Tolvaptan|tolvaptan|mesh-list
57115280|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57115281|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115282|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
57115283|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115284|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
57115285|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57115286|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115287|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
57115288|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57115289|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115290|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
57115291|NCT02095717|Curcumin|curcumin|mesh-list
57115292|NCT02095717|Docetaxel|docetaxel|mesh-list
57115293|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115294|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
57115295|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
57115296|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
57115297|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115298|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57115299|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57115300|NCT02095717|Analgesics|analgesics|mesh-ancestor
57115301|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
57115302|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115303|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115304|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57115305|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57115306|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115307|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
57115308|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
57115309|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115310|NCT03099824|Protective Agents|protective agents|mesh-ancestor
57115311|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115312|NCT02718417|Paclitaxel|paclitaxel|mesh-list
57115313|NCT02718417|Carboplatin|carboplatin|mesh-list
57115314|NCT02718417|Avelumab|avelumab|mesh-list
57115315|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57115316|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57115317|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115318|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
57115319|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
57115320|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
57115321|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115322|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57115323|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
57115324|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115325|NCT05067530|Paclitaxel|paclitaxel|mesh-list
57115326|NCT05067530|Carboplatin|carboplatin|mesh-list
57115327|NCT05067530|Palbociclib|palbociclib|mesh-list
57115328|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57115329|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115330|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
57115331|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
57115332|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
57115333|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115334|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57115335|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115336|NCT02640404|Vaccines|vaccines|mesh-list
57115337|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
57115338|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115339|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
57115340|NCT05003895|Fludarabine|fludarabine|mesh-list
57115341|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57115342|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
57115343|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115344|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57115345|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57115346|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
57115347|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115348|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115349|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57115350|NCT03097406|Imidacloprid|imidacloprid|mesh-list
57115351|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
57115352|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115353|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115354|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115355|NCT03099590|Puerarin|puerarin|mesh-list
57115356|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
57115357|NCT04999761|Futibatinib|futibatinib|mesh-list
57115358|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115359|NCT05054426|Methotrexate|methotrexate|mesh-list
57115360|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57115361|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
57115362|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57115363|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115364|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57115365|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
57115366|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115367|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115368|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
57115369|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115370|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57115371|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57115372|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
57115373|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57115374|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57115375|NCT00701727|Ezetimibe|ezetimibe|mesh-list
57115376|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57115377|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115378|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
57115379|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115380|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115381|NCT02463513|Vitamins|vitamins|mesh-list
57115382|NCT02463513|Riboflavin|riboflavin|mesh-list
57115383|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
57115384|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
57115385|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115386|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57115387|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
57115388|NCT04990323|Vidarabine|vidarabine|mesh-list
57115389|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
57115390|NCT04990323|Busulfan|busulfan|mesh-list
57115391|NCT04990323|Thiotepa|thiotepa|mesh-list
57115392|NCT04990323|Fludarabine|fludarabine|mesh-list
57115393|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
57115394|NCT04990323|Clofarabine|clofarabine|mesh-list
57115395|NCT04990323|Tacrolimus|tacrolimus|mesh-list
57115396|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57115397|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
57115398|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115399|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57115400|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57115401|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
57115402|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115403|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115404|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57115405|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57115406|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
56797257|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57115407|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
57115408|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115409|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57115410|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115411|NCT04155008|Dexamethasone|dexamethasone|mesh-list
57115413|NCT04155008|Mirtazapine|mirtazapine|mesh-list
57115414|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57115415|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
57115416|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
57115417|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115418|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115419|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115420|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
57115421|NCT04155008|Hormones|hormones|mesh-ancestor
57115422|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115423|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57115424|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115425|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
57115426|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57115427|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57115428|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
57115429|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
57115430|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115431|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115432|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57115433|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57115434|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57115435|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57115436|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57115437|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57115438|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
57115439|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57115440|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57115441|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
57115442|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57115443|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
57115444|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57115445|NCT04155008|Analgesics|analgesics|mesh-ancestor
57115446|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
57115447|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57115448|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57115449|NCT05044364|Clevidipine|clevidipine|mesh-list
57115450|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57115451|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57115452|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115453|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57115454|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115455|NCT03993717|Vaccines|vaccines|mesh-list
57115456|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
57115457|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115458|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
57115459|NCT04150640|Nivolumab|nivolumab|mesh-list
57115460|NCT04150640|Trastuzumab|trastuzumab|mesh-list
57115461|NCT04150640|Fluorouracil|fluorouracil|mesh-list
57115462|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
57115463|NCT04150640|Irinotecan|irinotecan|mesh-list
57115464|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57115465|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115466|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
57115467|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115468|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57115469|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57115470|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
57115471|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115472|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57115473|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57115474|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57115475|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115476|NCT04959981|Osimertinib|osimertinib|mesh-list
57115477|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115478|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57115479|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115480|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115481|NCT05054114|Interferons|interferons|mesh-list
57115482|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
57115483|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115484|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
57115485|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115486|NCT04665531|Ropivacaine|ropivacaine|mesh-list
57115487|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
57115488|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
57115489|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57115490|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115491|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
57115492|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115493|NCT01369069|Insulin|insulin|mesh-list
57115494|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57115495|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57115496|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115497|NCT02097511|Metoprolol|metoprolol|mesh-list
57115498|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
57115499|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57115500|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57115501|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
57115502|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
57115503|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901788|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115504|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115505|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57115506|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57115507|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57115508|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
57115509|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115510|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115511|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57115512|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57115513|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57115514|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57115515|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
57115516|NCT03957681|Brodalumab|brodalumab|mesh-list
57115517|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
57115518|NCT05043740|Evolocumab|evolocumab|mesh-list
57115519|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57115520|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115521|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
57115522|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115523|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115524|NCT03928275|Aldesleukin|aldesleukin|mesh-list
57115525|NCT03928275|Interleukin-2|interleukin-2|mesh-list
57115526|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
57115527|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115528|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57115529|NCT03928275|Analgesics|analgesics|mesh-ancestor
57115530|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
57115531|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115532|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115533|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57115534|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57115535|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
57115536|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115537|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57115538|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
57115539|NCT05043896|Tadalafil|tadalafil|mesh-list
57115540|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
57115541|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57115542|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57115543|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115544|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115545|NCT05043896|Urological Agents|urological agents|mesh-ancestor
57115546|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
57115547|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57115548|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57115549|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
57115550|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115551|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115552|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115553|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
57115554|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
57115555|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115556|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
57115557|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57115558|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
57115559|NCT03096704|Vitamin D|vitamin d|mesh-list
57115560|NCT03096704|Vitamins|vitamins|mesh-ancestor
57115561|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
57115562|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115563|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57115564|NCT02099695|Oxybutynin|oxybutynin|mesh-list
57115565|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
57115566|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
57115567|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115568|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115569|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57115570|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57115571|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
57115572|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115573|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115574|NCT02099695|Urological Agents|urological agents|mesh-ancestor
57115575|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
57115576|NCT05066516|Linagliptin|linagliptin|mesh-list
57115577|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57115578|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115579|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57115580|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115581|NCT05066516|Incretins|incretins|mesh-ancestor
57115582|NCT05066516|Hormones|hormones|mesh-ancestor
57115583|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115584|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57115585|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
57115586|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115587|NCT02097589|Atorvastatin|atorvastatin|mesh-list
57115588|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57115589|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
57115590|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115591|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57115592|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115593|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
57115594|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115595|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115596|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57115597|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115598|NCT03836001|Serlopitant|serlopitant|mesh-list
57115599|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57115600|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115601|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115602|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115603|NCT02465866|Promethazine|promethazine|mesh-list
57115604|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
57115605|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
57115606|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57115607|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
57115608|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
57115609|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115610|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115611|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115612|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57115613|NCT05052008|Erenumab|erenumab|mesh-list
57115614|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57115615|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115616|NCT05052008|Analgesics|analgesics|mesh-ancestor
57115617|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
57115618|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115619|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115620|NCT04727307|Bevacizumab|bevacizumab|mesh-list
57115621|NCT04727307|Atezolizumab|atezolizumab|mesh-list
57115622|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56901804|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57115623|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57115624|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115625|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57115626|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57115627|NCT04727307|Growth Substances|growth substances|mesh-ancestor
57115628|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115629|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
57115630|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
57115631|NCT05066360|Hormones|hormones|mesh-list
57115632|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115633|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797476|NCT00374907|Hormones|hormones|mesh-ancestor
57115634|NCT02439970|Valganciclovir|valganciclovir|mesh-list
57115635|NCT02439970|Brincidofovir|brincidofovir|mesh-list
57115636|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
57115637|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115638|NCT03290859|Propofol|propofol|mesh-list
57115639|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57115640|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57115641|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115642|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57115643|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
57115644|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
57115645|NCT05065658|Posaconazole|posaconazole|mesh-list
57115646|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
57115647|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115648|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57115649|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57115650|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57115651|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57115652|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57115653|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115654|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115655|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57115656|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
57115657|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115658|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115659|NCT02102815|Dexamethasone|dexamethasone|mesh-list
57115660|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57115661|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
57115662|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
57115663|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115664|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115665|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115666|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
57115667|NCT02102815|Hormones|hormones|mesh-ancestor
57115668|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115669|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57115670|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115671|NCT04935112|Pantoprazole|pantoprazole|mesh-list
57115672|NCT04935112|Famotidine|famotidine|mesh-list
57115673|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57115674|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115675|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57115676|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115677|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115678|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57115679|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
57115680|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
57115681|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115682|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115683|NCT02102971|Liver Extracts|liver extracts|mesh-list
57115684|NCT02102971|Hematinics|hematinics|mesh-ancestor
57115685|NCT05043350|Loratadine|loratadine|mesh-list
57115686|NCT05043350|Famotidine|famotidine|mesh-list
57115687|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57115688|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115689|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57115690|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
57115691|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
57115692|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115693|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115694|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115695|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
57115696|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
57115697|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57115698|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57115699|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57115700|NCT03555487|Choline|choline|mesh-list
57115701|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
57115702|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115703|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
57115704|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115705|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115706|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115707|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
57115708|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
57115709|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56797550|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
57115710|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115711|NCT02103049|Ezetimibe|ezetimibe|mesh-list
57115712|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57115713|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115714|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
57115715|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115716|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115717|NCT03099278|Ezetimibe|ezetimibe|mesh-list
57115718|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57115719|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115720|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
57115721|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115722|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115723|NCT02172651|Vitamin D|vitamin d|mesh-list
57115724|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
57115725|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
57115726|NCT02172651|Vitamins|vitamins|mesh-list
57115727|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
57115728|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115729|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57115730|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57115731|NCT02103205|Iron|iron|mesh-list
57115732|NCT02103205|Lactoferrin|lactoferrin|mesh-list
57115733|NCT02103205|Trace Elements|trace elements|mesh-ancestor
57115734|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
57115735|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115736|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115737|NCT03290703|Rabeprazole|rabeprazole|mesh-list
57115738|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57115739|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115740|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57115741|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115742|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115743|NCT02408068|Dexamethasone|dexamethasone|mesh-list
57115744|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
56901836|NCT01308255|Methotrexate|methotrexate|mesh-list
57115745|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
57115746|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
57115747|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
57115748|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57115749|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
57115750|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
57115751|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115752|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115753|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115754|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
57115755|NCT02408068|Hormones|hormones|mesh-ancestor
57115756|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115757|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57115758|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115759|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
57115760|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57115761|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
57115762|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115763|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
57115764|NCT02465853|Protective Agents|protective agents|mesh-ancestor
57115765|NCT02465385|Linaclotide|linaclotide|mesh-list
57115766|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57115767|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
57115768|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115769|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115770|NCT05050604|Choline|choline|mesh-list
57115771|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
57115772|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57115773|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
57115774|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115775|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115776|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57115777|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
57115778|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
57115779|NCT03290625|Ketamine|ketamine|mesh-list
57115780|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57115781|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57115782|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115783|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57115784|NCT03290625|Analgesics|analgesics|mesh-ancestor
57115785|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
57115786|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115787|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57115788|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57115789|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57115790|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
57115791|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115792|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115793|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57115794|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57115795|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
57115796|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
57115797|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57115798|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57115799|NCT02250781|TIC10 compound|tic10 compound|mesh-list
57115800|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115801|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
57115802|NCT03099122|Prednisone|prednisone|mesh-list
57115803|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
57115804|NCT03099122|Tacrolimus|tacrolimus|mesh-list
57115805|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
57115806|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57115807|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
57115808|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57115809|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
57115810|NCT03099122|Hormones|hormones|mesh-ancestor
57115811|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115812|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115813|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57115814|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115815|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57115816|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
57115817|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57115818|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115819|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115820|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57115821|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57115822|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
57115823|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57115824|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115825|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
57115826|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
57115827|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115828|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115829|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57115830|NCT03099122|Protective Agents|protective agents|mesh-ancestor
57115831|NCT02103361|Ustekinumab|ustekinumab|mesh-list
57115832|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
57115833|NCT04335201|Defibrotide|defibrotide|mesh-list
57115834|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57115835|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57115836|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115837|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57115838|NCT03295851|Iron|iron|mesh-list
57115839|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
57115840|NCT03295851|Trace Elements|trace elements|mesh-ancestor
57115841|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
57115842|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115843|NCT03096470|Anesthetics|anesthetics|mesh-list
57115844|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57115845|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115846|NCT05050448|Diclofenac|diclofenac|mesh-list
57115847|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57115848|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57115849|NCT05050448|Analgesics|analgesics|mesh-ancestor
57115850|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
57115851|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115852|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115853|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57115854|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57115855|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57115856|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115857|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115858|NCT02100553|Itraconazole|itraconazole|mesh-list
57115859|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
57115860|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
57115861|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115862|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57115863|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57115864|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115865|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115866|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57115867|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
57115868|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115869|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115870|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57115871|NCT05389813|Pregabalin|pregabalin|mesh-list
57115872|NCT05389813|Oxycodone|oxycodone|mesh-list
57115873|NCT05389813|Analgesics|analgesics|mesh-ancestor
57115874|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
57115875|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115876|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115877|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
57115878|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57115879|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57115880|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115881|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57115882|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57115883|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57115884|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57115885|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57115886|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57115887|NCT05389813|Narcotics|narcotics|mesh-ancestor
57115888|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57115889|NCT02100787|Laxatives|laxatives|mesh-ancestor
57115890|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115891|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57115892|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57115893|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115894|NCT04718805|Darunavir|darunavir|mesh-list
57115895|NCT04718805|Cobicistat|cobicistat|mesh-list
57115896|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
57115897|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57115898|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57115899|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
57115900|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115901|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115902|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57115903|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57115904|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
57115905|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115906|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57115907|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57115908|NCT05042336|Lenvatinib|lenvatinib|mesh-list
57115909|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115910|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57115911|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115912|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115913|NCT03096392|Insulin|insulin|mesh-list
57115914|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57115915|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
57115916|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57115917|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115918|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
57115919|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
57115920|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57115921|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57115922|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115923|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115924|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57115925|NCT02460393|Antibodies|antibodies|mesh-list
57115926|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
57115927|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57115928|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
57115929|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115930|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115931|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57115932|NCT02250859|Minocycline|minocycline|mesh-list
57115933|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115934|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
56797777|NCT00463866|Hormones|hormones|mesh-ancestor
57115935|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57115936|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115937|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
57115938|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
57115939|NCT03295383|Rituximab|rituximab|mesh-list
57115940|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57115941|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
57115942|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115943|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57115944|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57115945|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
57115946|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115947|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115948|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57115949|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57115950|NCT02101255|Fluorides|fluorides|mesh-list
57115951|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
57115952|NCT02101255|Protective Agents|protective agents|mesh-ancestor
57115953|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115954|NCT05063318|Itraconazole|itraconazole|mesh-list
57115955|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
57115956|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57115957|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57115958|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57115959|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57115960|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57115961|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57115962|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
57115963|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57115964|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115965|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57115966|NCT02104297|Remifentanil|remifentanil|mesh-list
57115967|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57115968|NCT02104297|Narcotics|narcotics|mesh-ancestor
57115969|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57115970|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115971|NCT02104297|Analgesics|analgesics|mesh-ancestor
57115972|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
57115973|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115974|NCT02106481|Ropivacaine|ropivacaine|mesh-list
57115975|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
57115976|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
57115977|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57115978|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115979|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
57115980|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115981|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
57115982|NCT02106559|Trioxsalen|trioxsalen|mesh-list
57115983|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57115984|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
57115985|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57115986|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
57115987|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57115988|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57115989|NCT05047874|Prednisolone|prednisolone|mesh-list
57115990|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
57115991|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57115992|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
57115993|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57115994|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
57115995|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
57115996|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57115997|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57115998|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57115999|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
57116000|NCT05047874|Hormones|hormones|mesh-ancestor
57116001|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116002|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57116003|NCT05047874|Protective Agents|protective agents|mesh-ancestor
57116004|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57116005|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116006|NCT04488705|Albuterol|albuterol|mesh-list
57116007|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57116008|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
57116009|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797857|NCT00299104|Hormones|hormones|mesh-ancestor
57116010|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116011|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57116012|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
57116013|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
57116014|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57116015|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57116016|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57116017|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57116018|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
57116019|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116020|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116021|NCT02106637|Varenicline|varenicline|mesh-list
57116022|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57116023|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57116024|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
57116025|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116026|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116027|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116028|NCT05062304|Fluticasone|fluticasone|mesh-list
57116029|NCT05062304|Xhance|xhance|mesh-list
57116030|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116031|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57116032|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
57116033|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116034|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116035|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57116036|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
57116037|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
57116038|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57116039|NCT05047328|Inolimomab|inolimomab|mesh-list
57116040|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116041|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
57116042|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116043|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
57116044|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57116045|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
57116046|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57116047|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116048|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57116049|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57116050|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57116051|NCT02106793|Mitomycins|mitomycins|mesh-list
57116052|NCT02106793|Mitomycin|mitomycin|mesh-list
57116053|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57116054|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116055|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
57116056|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116057|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57116058|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116059|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57116060|NCT02104843|Asunaprevir|asunaprevir|mesh-list
57116061|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57116062|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57116063|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
57116064|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116065|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57116066|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57116067|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116068|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
57116069|NCT05041790|Choline|choline|mesh-list
57116070|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
57116071|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57116072|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
57116073|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116074|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57116075|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57116076|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
57116077|NCT02105077|Anesthetics|anesthetics|mesh-list
57116078|NCT02105077|Xenon|xenon|mesh-list
57116079|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116080|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116081|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57116082|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
57116083|NCT02101567|Oxytocin|oxytocin|mesh-list
57116084|NCT02101567|Carbetocin|carbetocin|mesh-list
57116085|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
57116086|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57116087|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116089|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
57116090|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57116091|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57116092|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116093|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116094|NCT02106871|Urological Agents|urological agents|mesh-ancestor
57116095|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
57116096|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116097|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
57116098|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
57116099|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
57116100|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57116101|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57116102|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116103|NCT02105155|Tacrolimus|tacrolimus|mesh-list
57116104|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116105|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
57116106|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116107|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56901855|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
57116108|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116109|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116110|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57116111|NCT03294525|Mirtazapine|mirtazapine|mesh-list
57116112|NCT03294525|Citalopram|citalopram|mesh-list
57116113|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
57116114|NCT03294525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57116115|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57116116|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57116117|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116118|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116119|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
57116120|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116121|NCT03294525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57116122|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57116123|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116124|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57116125|NCT03294525|Analgesics|analgesics|mesh-ancestor
57116126|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
57116127|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
57116128|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57116129|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
57116130|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
57116131|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57116132|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57116133|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116134|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57116135|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57116136|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57116137|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
57116138|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57116139|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57116140|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57116141|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
57116142|NCT05036174|Promethazine|promethazine|mesh-list
57116143|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57116144|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57116145|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116146|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116147|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
57116148|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
57116149|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
57116150|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116151|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
57116152|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
57116153|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57116154|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57116155|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
57116156|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
57116157|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116158|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116159|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57116160|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
57116161|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
57116162|NCT03283059|Donepezil|donepezil|mesh-list
57116163|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57116164|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116165|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116166|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
57116167|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116168|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116169|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
57116170|NCT05060822|Pirfenidone|pirfenidone|mesh-list
57116171|NCT05060822|Analgesics|analgesics|mesh-ancestor
57116172|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
57116173|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116174|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116175|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57116176|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57116177|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116178|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57116179|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116180|NCT05060588|Valsartan|valsartan|mesh-list
57116181|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57116182|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57116183|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57116184|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57116185|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116186|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
57116187|NCT02105311|Travoprost|travoprost|mesh-list
57116188|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57116189|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57116190|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116191|NCT03554395|Antibodies|antibodies|mesh-list
57116192|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57116193|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
57116194|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116195|NCT03282825|Paclitaxel|paclitaxel|mesh-list
57116196|NCT03282825|Decitabine|decitabine|mesh-list
57116197|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57116198|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116199|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
57116200|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
57116201|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
57116202|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116203|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57116204|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
57116205|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116206|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57116207|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57116208|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57116209|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
57116210|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116211|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57116212|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57116213|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116214|NCT05356897|Trifluridine|trifluridine|mesh-list
57116215|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57116216|NCT05356897|Trastuzumab|trastuzumab|mesh-list
57116217|NCT05356897|Tucatinib|tucatinib|mesh-list
57116218|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
57116219|NCT05356897|Antibodies|antibodies|mesh-list
57116220|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
57116221|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57116222|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
57116223|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116224|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116225|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
57116226|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116227|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
57116228|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116229|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57116230|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116231|NCT05039606|Nedaplatin|nedaplatin|mesh-list
57116232|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116233|NCT03288051|Dobutamine|dobutamine|mesh-list
57116234|NCT03288051|Norepinephrine|norepinephrine|mesh-list
57116235|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57116236|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57116237|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
57116238|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116239|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116240|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116241|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
57116242|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
57116243|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116244|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57116245|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57116246|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57116247|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57116248|NCT03288051|Protective Agents|protective agents|mesh-ancestor
57116249|NCT05035472|Phenylephrine|phenylephrine|mesh-list
57116250|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
57116251|NCT05035472|Norepinephrine|norepinephrine|mesh-list
57116252|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
57116253|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57116254|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
57116255|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
57116256|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116257|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116258|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
57116259|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
57116260|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
57116261|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57116262|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57116263|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57116264|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
57116265|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116266|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116267|NCT05035472|Protective Agents|protective agents|mesh-ancestor
57116268|NCT02460627|Lidocaine|lidocaine|mesh-list
57116269|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
57116270|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
57116271|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116272|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116273|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
57116274|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116275|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57116276|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57116277|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57116278|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57116279|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116280|NCT02107729|Lidocaine|lidocaine|mesh-list
57116281|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
57116282|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
57116283|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116284|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116285|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
57116286|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116287|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57116288|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57116289|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57116290|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57116291|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116292|NCT02437318|Fulvestrant|fulvestrant|mesh-list
57116293|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57116294|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116295|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57116296|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57116297|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
57116298|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116299|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116300|NCT03282513|Ivosidenib|ivosidenib|mesh-list
57116301|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116302|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116303|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116304|NCT02107807|Lactitol|lactitol|mesh-list
57116305|NCT02107807|Vaccines|vaccines|mesh-list
57116306|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
57116307|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116308|NCT02107807|Cathartics|cathartics|mesh-ancestor
57116309|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57116310|NCT01673282|Lacosamide|lacosamide|mesh-list
57116311|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
57116312|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57116313|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57116314|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57116315|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116316|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57116317|NCT02113735|Hormones|hormones|mesh-ancestor
57116318|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116319|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116320|NCT02113813|Naquotinib|naquotinib|mesh-list
57116321|NCT02113813|Midazolam|midazolam|mesh-list
57116322|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57116323|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56901860|NCT01308255|Hormones|hormones|mesh-ancestor
57116324|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116325|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116326|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57116327|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57116328|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57116329|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57116330|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
57116331|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
57116332|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
57116333|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
57116334|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116335|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116336|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116337|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57116338|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116339|NCT03095144|Anesthetics|anesthetics|mesh-list
57116340|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116341|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116342|NCT03095222|Ketamine|ketamine|mesh-list
57116343|NCT03095222|Analgesics|analgesics|mesh-ancestor
57116344|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
57116345|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116346|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116347|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57116348|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57116349|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
57116350|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
57116351|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116352|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57116353|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57116354|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116355|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116356|NCT02113891|Eculizumab|eculizumab|mesh-list
57116357|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57116358|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116359|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
57116360|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116361|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
57116362|NCT03095378|Tetracycline|tetracycline|mesh-list
57116363|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57116364|NCT03095378|Citric Acid|citric acid|mesh-list
57116365|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
57116366|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57116367|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116368|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116369|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
57116370|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57116371|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
57116372|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
57116373|NCT05025098|Azacitidine|azacitidine|mesh-list
57116374|NCT05025098|Venetoclax|venetoclax|mesh-list
57116375|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57116376|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
57116377|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116378|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116379|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116380|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
57116381|NCT05038202|Bromides|bromides|mesh-list
57116382|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
57116383|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116384|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
57116385|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57116386|NCT02114359|Cisplatin|cisplatin|mesh-list
57116387|NCT02114359|Fluorouracil|fluorouracil|mesh-list
57116388|NCT02114359|Capecitabine|capecitabine|mesh-list
57116389|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
57116390|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116391|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
57116392|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116393|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57116394|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116395|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
57116396|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116397|NCT02110303|Ticagrelor|ticagrelor|mesh-list
57116398|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57116399|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57116400|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57116401|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57116402|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
57116403|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116404|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116405|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116406|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
57116407|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
57116408|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
57116409|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116410|NCT02108353|Melatonin|melatonin|mesh-list
57116411|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
57116412|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116413|NCT02108353|Protective Agents|protective agents|mesh-ancestor
57116414|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116415|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116416|NCT04157751|Empagliflozin|empagliflozin|mesh-list
57116417|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57116418|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116419|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57116420|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116421|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
57116422|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57116423|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116424|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57116425|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57116426|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116427|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116428|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116429|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57116430|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57116431|NCT02110459|Murepavadin|murepavadin|mesh-list
57116432|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57116433|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116434|NCT03287505|Aripiprazole|aripiprazole|mesh-list
57116435|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
57116436|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57116437|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57116438|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57116439|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116440|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116441|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
57116442|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
57116443|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116444|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116445|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57116446|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57116447|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
57116448|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57116449|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57116450|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57116451|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57116452|NCT03090698|Triamcinolone|triamcinolone|mesh-list
57116453|NCT03090698|Hylan|hylan|mesh-list
57116454|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116455|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
57116456|NCT03090698|Hormones|hormones|mesh-ancestor
57116457|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116458|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116460|NCT03090698|Protective Agents|protective agents|mesh-ancestor
57116461|NCT03293511|Oxytocin|oxytocin|mesh-list
57116462|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
57116463|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57116464|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116465|NCT02251171|Ritonavir|ritonavir|mesh-list
57116466|NCT02251171|Tipranavir|tipranavir|mesh-list
57116467|NCT02251171|Rifabutin|rifabutin|mesh-list
57116468|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57116469|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57116470|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
57116471|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116472|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116473|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57116474|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57116475|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
57116476|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116477|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57116478|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57116479|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57116480|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57116481|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
57116482|NCT02110537|Flecainide|flecainide|mesh-list
57116483|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57116484|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57116485|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57116486|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57116487|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116488|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
57116489|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57116490|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116491|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116492|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57116493|NCT03293277|Analgesics|analgesics|mesh-ancestor
57116494|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
57116495|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116496|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57116497|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57116498|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57116499|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
57116500|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116501|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116502|NCT02108743|Albuterol|albuterol|mesh-list
57116503|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57116504|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
57116505|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116506|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116507|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57116508|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
57116509|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
57116510|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57116511|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57116512|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57116513|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57116514|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
57116515|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116516|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116517|NCT03292965|Neostigmine|neostigmine|mesh-list
57116518|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57116519|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116520|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116521|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
57116522|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116523|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116524|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57116525|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
57116526|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116527|NCT05032118|Ketamine|ketamine|mesh-list
57116528|NCT05032118|Propofol|propofol|mesh-list
57116529|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57116530|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116531|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798375|NCT03996252|Fluorouracil|fluorouracil|mesh-list
57116533|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
57116534|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
57116535|NCT05032118|Analgesics|analgesics|mesh-ancestor
57116536|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
57116537|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116538|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57116539|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57116540|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57116541|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116542|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116543|NCT05024084|Anesthetics|anesthetics|mesh-list
57116544|NCT05024084|Sevoflurane|sevoflurane|mesh-list
57116545|NCT05024084|Desflurane|desflurane|mesh-list
57116546|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116547|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116548|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57116549|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57116550|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
57116551|NCT02109289|Etanercept|etanercept|mesh-list
57116552|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57116553|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57116554|NCT02109289|Analgesics|analgesics|mesh-ancestor
57116555|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
57116556|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116557|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116558|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116559|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57116560|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57116561|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116562|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
57116563|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
57116564|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
57116565|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57116566|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
57116567|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116568|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116569|NCT03292731|Progestins|progestins|mesh-ancestor
57116570|NCT03292731|Hormones|hormones|mesh-ancestor
57116571|NCT03553303|Valsartan|valsartan|mesh-list
57116572|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57116573|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57116574|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57116575|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57116576|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116577|NCT03286959|Calcium|calcium|mesh-list
57116578|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57116579|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116580|NCT03292575|Anticoagulants|anticoagulants|mesh-list
57116581|NCT02115529|Nabilone|nabilone|mesh-list
57116582|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
57116583|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
57116584|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116585|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116586|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57116587|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57116588|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57116589|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116590|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57116591|NCT01652716|Exenatide|exenatide|mesh-list
57116592|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57116593|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116594|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57116595|NCT01652716|Incretins|incretins|mesh-ancestor
57116596|NCT01652716|Hormones|hormones|mesh-ancestor
57116597|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116598|NCT02459613|Annexin A5|annexin a5|mesh-list
57116599|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116600|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116601|NCT02251249|Acetaminophen|acetaminophen|mesh-list
57116602|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57116603|NCT02251249|Analgesics|analgesics|mesh-ancestor
57116604|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
57116605|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116606|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116608|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
57116609|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57116610|NCT03292263|Nivolumab|nivolumab|mesh-list
57116611|NCT03292263|Melphalan|melphalan|mesh-list
57116612|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57116613|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116614|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57116615|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116616|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57116617|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
57116618|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57116619|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116620|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
57116621|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116622|NCT02115763|Caffeine|caffeine|mesh-list
57116623|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57116624|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116625|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57116626|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116627|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116628|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57116629|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57116630|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
57116631|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116632|NCT03286803|Vaccines|vaccines|mesh-list
57116633|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
57116634|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116635|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
57116636|NCT05017454|Valproic Acid|valproic acid|mesh-list
57116637|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116638|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
57116639|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57116640|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
57116641|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116642|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116643|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
57116644|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116645|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116646|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
57116647|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57116648|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116649|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57116650|NCT03292185|Insulin|insulin|mesh-list
57116651|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57116652|NCT03292185|Liraglutide|liraglutide|mesh-list
57116653|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
57116654|NCT03292185|Xultophy|xultophy|mesh-list
57116655|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57116656|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116657|NCT03292185|Incretins|incretins|mesh-ancestor
57116658|NCT03292185|Hormones|hormones|mesh-ancestor
57116659|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116660|NCT04239339|Citalopram|citalopram|mesh-list
57116661|NCT04239339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57116662|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57116663|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57116664|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116665|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116666|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
57116667|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116668|NCT04239339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57116669|NCT04239339|Antidepressive Agents|antidepressive agents|mesh-ancestor
57116670|NCT04239339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57116671|NCT02109679|Metformin|metformin|mesh-list
57116672|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57116673|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116674|NCT05023304|Prednisolone|prednisolone|mesh-list
57116675|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116676|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
57116677|NCT05023304|Hormones|hormones|mesh-ancestor
57116678|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116679|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798531|NCT03824704|Nivolumab|nivolumab|mesh-list
57116680|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57116681|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116682|NCT02109913|Everolimus|everolimus|mesh-list
57116683|NCT02109913|Exemestane|exemestane|mesh-list
56901876|NCT03781947|Antarelix|antarelix|mesh-list
57116684|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116685|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116686|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
57116687|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116688|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57116689|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57116690|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116691|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116692|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57116693|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
57116694|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116695|NCT02116231|Cisplatin|cisplatin|mesh-list
57116696|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116697|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
57116698|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57116699|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
57116700|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
57116701|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57116702|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
57116703|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116704|NCT02116465|Levodopa|levodopa|mesh-list
57116705|NCT02116465|Carbidopa|carbidopa|mesh-list
57116706|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57116707|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57116708|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57116709|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
57116710|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116711|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116712|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116713|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57116714|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116715|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57116716|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
57116717|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
57116718|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57116719|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57116720|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
57116721|NCT02119117|Vitamins|vitamins|mesh-ancestor
57116722|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
57116723|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116724|NCT05016128|Ketamine|ketamine|mesh-list
57116725|NCT05016128|Esketamine|esketamine|mesh-list
57116726|NCT05016128|Analgesics|analgesics|mesh-ancestor
57116727|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
57116728|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116729|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116730|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57116731|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57116732|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
57116733|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
57116734|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116735|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57116736|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57116737|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116738|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116739|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
57116740|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57116741|NCT02111317|Verapamil|verapamil|mesh-list
57116742|NCT02111317|Peficitinib|peficitinib|mesh-list
57116743|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57116744|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57116745|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57116746|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116747|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57116748|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116749|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
57116750|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116751|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116752|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
56798653|NCT03867383|Calcium|calcium|mesh-list
57116753|NCT03553615|Ivermectin|ivermectin|mesh-list
57116754|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57116755|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116756|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
57116757|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57116758|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57116759|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116760|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57116761|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57116762|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116763|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116764|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116765|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57116766|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
57116767|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57116768|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116769|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57116770|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57116771|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57116772|NCT02111473|Testosterone|testosterone|mesh-list
57116773|NCT02111473|Androgens|androgens|mesh-ancestor
57116774|NCT02111473|Hormones|hormones|mesh-ancestor
57116775|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116776|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116777|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
57116778|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57116779|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57116780|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
57116781|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116782|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116783|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116784|NCT02119273|Prednisone|prednisone|mesh-list
57116785|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116786|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
57116787|NCT02119273|Hormones|hormones|mesh-ancestor
57116788|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116789|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116790|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57116791|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116792|NCT05029076|Liraglutide|liraglutide|mesh-list
57116793|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57116794|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116795|NCT05029076|Incretins|incretins|mesh-ancestor
57116796|NCT05029076|Hormones|hormones|mesh-ancestor
57116797|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116798|NCT05016440|Lisinopril|lisinopril|mesh-list
57116799|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57116800|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
57116801|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116802|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116803|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57116804|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57116805|NCT05016440|Protective Agents|protective agents|mesh-ancestor
57116806|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116807|NCT02111629|Fluconazole|fluconazole|mesh-list
57116808|NCT02111629|Secnidazole|secnidazole|mesh-list
57116809|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
57116810|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116811|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57116812|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57116813|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116814|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116815|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57116816|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
57116817|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116818|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901880|NCT03781869|Cisplatin|cisplatin|mesh-list
57116819|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57116820|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57116821|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57116822|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57116823|NCT02111707|Indomethacin|indomethacin|mesh-list
57116824|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57116825|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57116826|NCT02111707|Analgesics|analgesics|mesh-ancestor
57116827|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
57116828|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116829|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116830|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116831|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57116832|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
57116833|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
57116834|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57116835|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57116836|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116837|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116838|NCT03552601|Methamphetamine|methamphetamine|mesh-list
57116839|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57116840|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116841|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
57116842|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
57116843|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116844|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
57116845|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116846|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116847|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
57116848|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57116849|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57116850|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57116851|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57116852|NCT05021588|Anticoagulants|anticoagulants|mesh-list
57116853|NCT02989597|Dexamethasone|dexamethasone|mesh-list
57116854|NCT02989597|Sufentanil|sufentanil|mesh-list
57116855|NCT02989597|Ketamine|ketamine|mesh-list
57116856|NCT02989597|Remifentanil|remifentanil|mesh-list
57116857|NCT02989597|Methadone|methadone|mesh-list
57116858|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116859|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
57116860|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
57116861|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116862|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116863|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57116864|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
57116865|NCT02989597|Hormones|hormones|mesh-ancestor
57116866|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116867|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57116868|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116869|NCT02989597|Analgesics|analgesics|mesh-ancestor
57116870|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
57116871|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57116872|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57116873|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
57116874|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
57116875|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116876|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57116877|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57116878|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116879|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116880|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57116881|NCT02989597|Narcotics|narcotics|mesh-ancestor
57116882|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57116883|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
57116884|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
57116885|NCT03087890|Trimethoprim|trimethoprim|mesh-list
57116886|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57116887|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
57116888|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57116889|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57116890|NCT03087890|Renal Agents|renal agents|mesh-ancestor
57116891|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
57116892|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57116893|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57116894|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57116895|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116896|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116897|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57116898|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57116899|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57116900|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57116901|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
57116902|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116904|NCT02117401|Ketamine|ketamine|mesh-list
57116905|NCT02117401|Remifentanil|remifentanil|mesh-list
57116906|NCT02117401|Propofol|propofol|mesh-list
57116907|NCT02117401|Mivacurium|mivacurium|mesh-list
57116908|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57116909|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57116910|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116911|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57116912|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
57116913|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
57116914|NCT02117401|Analgesics|analgesics|mesh-ancestor
57116915|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
57116916|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116917|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57116918|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57116919|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57116920|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57116921|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116922|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57116923|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57116924|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57116925|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57116926|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
57116927|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
57116928|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57116929|NCT02117401|Narcotics|narcotics|mesh-ancestor
57116930|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57116931|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57116932|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57116933|NCT04434404|Silymarin|silymarin|mesh-list
57116934|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
57116935|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116936|NCT04434404|Protective Agents|protective agents|mesh-ancestor
57116937|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116938|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
57116939|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57116940|NCT02251483|Antibodies|antibodies|mesh-list
57116941|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
57116942|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116943|NCT02117869|Furocoumarins|furocoumarins|mesh-list
57116944|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
57116945|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57116946|NCT02120599|Folic Acid|folic acid|mesh-list
57116947|NCT02120599|Hematinics|hematinics|mesh-ancestor
57116948|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
57116949|NCT02120599|Vitamins|vitamins|mesh-ancestor
57116950|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
57116951|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116952|NCT02112097|Etanercept|etanercept|mesh-list
57116953|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57116954|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57116955|NCT02112097|Analgesics|analgesics|mesh-ancestor
57116956|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
57116957|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57116958|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116959|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116960|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57116961|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57116962|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116963|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
57116964|NCT02112175|Lenalidomide|lenalidomide|mesh-list
57116965|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
57116966|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116967|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57116968|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57116969|NCT02112175|Growth Substances|growth substances|mesh-ancestor
57116970|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
57116971|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116972|NCT03553537|Prednisone|prednisone|mesh-list
57116973|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
57116974|NCT03553537|Doxorubicin|doxorubicin|mesh-list
57116975|NCT03553537|Vincristine|vincristine|mesh-list
57116976|NCT03553537|Decitabine|decitabine|mesh-list
57116977|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57116978|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
57116979|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57116980|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57116981|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57116982|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
57116983|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57116984|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57116985|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57116986|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57116987|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57116988|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57116989|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57116990|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57116991|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
57116992|NCT03553537|Hormones|hormones|mesh-ancestor
57116993|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57116994|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57116995|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57116996|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
57116997|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
57116998|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
57116999|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57117000|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
57117001|NCT04434170|Valsartan|valsartan|mesh-list
57117002|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57117003|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57117004|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57117005|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57117006|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117007|NCT03086174|Antibodies|antibodies|mesh-list
57117008|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57117009|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
57117010|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117011|NCT03085784|Aflibercept|aflibercept|mesh-list
57117012|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57117013|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57117014|NCT03085784|Growth Substances|growth substances|mesh-ancestor
57117015|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117016|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
57117017|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117018|NCT05021276|Basiliximab|basiliximab|mesh-list
57117019|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57117020|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
57117021|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117022|NCT05014490|Etoricoxib|etoricoxib|mesh-list
57117023|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57117024|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117025|NCT05014490|Analgesics|analgesics|mesh-ancestor
57117026|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
57117027|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117028|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117029|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117030|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117031|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57117032|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57117033|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117034|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117035|NCT05020964|Trastuzumab|trastuzumab|mesh-list
57117036|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57117037|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117038|NCT05014100|Lenalidomide|lenalidomide|mesh-list
57117039|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
57117040|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117041|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57117042|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57117043|NCT05014100|Growth Substances|growth substances|mesh-ancestor
57117044|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
57117045|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117046|NCT05027126|Folic Acid|folic acid|mesh-list
57117047|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
57117048|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
57117049|NCT05027126|Vitamins|vitamins|mesh-ancestor
57117050|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
57117051|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117052|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57117053|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117054|NCT05027126|Analgesics|analgesics|mesh-ancestor
57117055|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
57117056|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117057|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117058|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117059|NCT05027126|Hematinics|hematinics|mesh-ancestor
57117060|NCT02120677|Itraconazole|itraconazole|mesh-list
57117061|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
57117062|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117063|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57117064|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57117065|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117066|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117067|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57117068|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
57117069|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117070|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117071|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57117072|NCT02120911|Trastuzumab|trastuzumab|mesh-list
57117073|NCT02120911|Pertuzumab|pertuzumab|mesh-list
57117074|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57117075|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117076|NCT02112487|Macitentan|macitentan|mesh-list
57117077|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57117078|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57117079|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117080|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57117081|NCT03094442|Dexamethasone|dexamethasone|mesh-list
57117082|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117083|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
57117084|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
57117085|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117086|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117087|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57117088|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
57117089|NCT03094442|Hormones|hormones|mesh-ancestor
57117090|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117091|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57117092|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117093|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
57117094|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57117095|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117096|NCT02112643|Selenium|selenium|mesh-list
57117097|NCT02112643|Selenic Acid|selenic acid|mesh-list
57117098|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
57117099|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117100|NCT02112643|Protective Agents|protective agents|mesh-ancestor
57117101|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117102|NCT02112643|Trace Elements|trace elements|mesh-ancestor
57117103|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
57117104|NCT02112721|Vitamin D|vitamin d|mesh-list
57117105|NCT02112721|Vitamins|vitamins|mesh-ancestor
57117106|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
57117107|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117108|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57117109|NCT04434248|Ritonavir|ritonavir|mesh-list
57117110|NCT04434248|Lopinavir|lopinavir|mesh-list
57117111|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
57117112|NCT04434248|Chloroquine|chloroquine|mesh-list
57117113|NCT04434248|Favipiravir|favipiravir|mesh-list
57117114|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57117115|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57117116|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
57117117|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117118|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117119|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57117120|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57117121|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
57117122|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117123|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57117124|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57117125|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
57117126|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57117127|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57117128|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117129|NCT04434248|Amebicides|amebicides|mesh-ancestor
57117130|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57117131|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
57117132|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117133|NCT02122939|Citalopram|citalopram|mesh-list
57117134|NCT02122939|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57117135|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57117136|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57117137|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117138|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117139|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
57117140|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117141|NCT02122939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57117142|NCT02122939|Antidepressive Agents|antidepressive agents|mesh-ancestor
57117143|NCT02122939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57117144|NCT02121457|Selenium|selenium|mesh-list
57117145|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
57117146|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117147|NCT02121457|Protective Agents|protective agents|mesh-ancestor
57117148|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117149|NCT02121457|Trace Elements|trace elements|mesh-ancestor
57117150|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
57117151|NCT02251795|Aspirin|aspirin|mesh-list
57117152|NCT02251795|Ritonavir|ritonavir|mesh-list
57117153|NCT02251795|Darunavir|darunavir|mesh-list
57117154|NCT02251795|Tipranavir|tipranavir|mesh-list
57117155|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57117156|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117157|NCT02251795|Analgesics|analgesics|mesh-ancestor
57117158|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
57117159|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117160|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117161|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117162|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117163|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57117164|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57117165|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117166|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57117167|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57117168|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117169|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
57117170|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57117171|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57117172|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
57117173|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57117174|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57117175|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
57117176|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117177|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57117178|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57117179|NCT05013164|Leucovorin|leucovorin|mesh-list
57117180|NCT05013164|Folic Acid|folic acid|mesh-list
57117181|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
57117182|NCT05013164|Antidotes|antidotes|mesh-ancestor
57117183|NCT05013164|Protective Agents|protective agents|mesh-ancestor
57117184|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117185|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
57117186|NCT05013164|Vitamins|vitamins|mesh-ancestor
57117187|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
57117188|NCT05013164|Hematinics|hematinics|mesh-ancestor
57117189|NCT02251951|Paclitaxel|paclitaxel|mesh-list
57117190|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57117191|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117192|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
57117193|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
57117194|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
57117195|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117196|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57117197|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57117198|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
57117199|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117200|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57117201|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57117202|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
57117203|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
57117204|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117205|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799052|NCT00959621|Analgesics|analgesics|mesh-ancestor
57117206|NCT02121613|Tamsulosin|tamsulosin|mesh-list
57117207|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
57117208|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57117209|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57117210|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57117211|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117212|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117213|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117214|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117215|NCT02121613|Urological Agents|urological agents|mesh-ancestor
57117216|NCT03091712|Insulin|insulin|mesh-list
57117217|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57117218|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117219|NCT03552211|Biotin|biotin|mesh-list
57117220|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
57117221|NCT03552211|Vitamins|vitamins|mesh-ancestor
57117222|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
57117223|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117224|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
57117225|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117226|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
57117227|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57117228|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
57117229|NCT03281187|Testosterone|testosterone|mesh-list
57117230|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
57117231|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
57117232|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57117233|NCT03281187|Androgens|androgens|mesh-ancestor
57117234|NCT03281187|Hormones|hormones|mesh-ancestor
57117235|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117236|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117237|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57117238|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117239|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
57117240|NCT05009342|Calpastatin|calpastatin|mesh-list
57117241|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
57117242|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
57117243|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117244|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117245|NCT03291249|Omeprazole|omeprazole|mesh-list
57117246|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57117247|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57117248|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57117249|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117250|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117251|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
57117252|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
57117253|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57117254|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117255|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117256|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117257|NCT05013320|Analgesics|analgesics|mesh-ancestor
57117258|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
57117259|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117260|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57117261|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57117262|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57117263|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117264|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117265|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117266|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57117267|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57117268|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57117269|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
57117270|NCT02437162|Golimumab|golimumab|mesh-list
57117271|NCT02437162|Ustekinumab|ustekinumab|mesh-list
57117272|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
57117273|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
57117274|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117275|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57117276|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
57117277|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117278|NCT03291093|Flutemetamol|flutemetamol|mesh-list
57117279|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57117280|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117281|NCT02123563|Listerine|listerine|mesh-list
57117282|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57117283|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117285|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117286|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57117287|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117288|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117289|NCT03079388|Azithromycin|azithromycin|mesh-list
57117290|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
57117291|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
57117292|NCT03079388|Albendazole|albendazole|mesh-list
57117293|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
57117294|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57117295|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117296|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
57117297|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57117298|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57117299|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57117300|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117301|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117302|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57117303|NCT03079388|Renal Agents|renal agents|mesh-ancestor
57117304|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
57117305|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
57117306|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57117307|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
57117308|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
57117309|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
57117310|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117311|NCT03079544|Asparaginase|asparaginase|mesh-list
57117312|NCT03079544|Pegaspargase|pegaspargase|mesh-list
57117313|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117314|NCT03286101|Ivermectin|ivermectin|mesh-list
57117315|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57117316|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117317|NCT02437084|Atorvastatin|atorvastatin|mesh-list
57117318|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57117319|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57117320|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
57117321|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117322|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57117323|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57117324|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117325|NCT05009498|Vitamin D|vitamin d|mesh-list
57117326|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
57117327|NCT05009498|Vitamins|vitamins|mesh-ancestor
57117328|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
57117329|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117330|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57117331|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57117332|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
57117333|NCT02406586|Carvedilol|carvedilol|mesh-list
57117334|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
57117335|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57117336|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57117337|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117338|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117339|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117340|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117341|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57117342|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
57117343|NCT02406586|Protective Agents|protective agents|mesh-ancestor
57117344|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57117345|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57117346|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57117347|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
57117348|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57117349|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57117350|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57117351|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57117352|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57117353|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57117354|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117355|NCT02406586|Analgesics|analgesics|mesh-ancestor
57117356|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
57117357|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117358|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117359|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117360|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
57117361|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57117362|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117363|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117364|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117365|NCT03091166|Analgesics|analgesics|mesh-ancestor
57117366|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
57117367|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117368|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57117369|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57117370|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57117371|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117372|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117373|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117374|NCT02122393|Sertraline|sertraline|mesh-list
57117375|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
57117376|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57117377|NCT02122393|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57117378|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57117379|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57117380|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117381|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117382|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
57117383|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117384|NCT03821883|Aspirin|aspirin|mesh-list
57117385|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57117386|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117387|NCT03821883|Analgesics|analgesics|mesh-ancestor
57117388|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
57117389|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117390|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117391|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117392|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117393|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57117394|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57117395|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117396|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57117397|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57117398|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117399|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
57117400|NCT03080480|Pioglitazone|pioglitazone|mesh-list
57117401|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57117402|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117403|NCT02126761|Vaccines|vaccines|mesh-list
57117404|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
57117405|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117406|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57117407|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57117408|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57117409|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57117410|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117411|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117412|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117413|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117414|NCT03280641|Warfarin|warfarin|mesh-list
57117415|NCT03280641|Dabigatran|dabigatran|mesh-list
57117416|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
57117417|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
57117418|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57117419|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
57117420|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117421|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117422|NCT03285165|Propofol|propofol|mesh-list
57117423|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57117424|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117425|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117426|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57117427|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
57117428|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
57117429|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
57117430|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57117431|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117432|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117433|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117434|NCT03285087|Analgesics|analgesics|mesh-ancestor
57117435|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
57117436|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117437|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57117438|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57117439|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57117440|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117441|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117442|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117443|NCT02122627|Vitamin D|vitamin d|mesh-list
57117444|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
57117445|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
57117446|NCT02122627|Vitamins|vitamins|mesh-list
57117447|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
57117448|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117449|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57117450|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57117451|NCT02122705|Remifentanil|remifentanil|mesh-list
57117452|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57117453|NCT02122705|Narcotics|narcotics|mesh-ancestor
57117454|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117455|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117456|NCT02122705|Analgesics|analgesics|mesh-ancestor
57117457|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
57117458|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117459|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57117460|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57117461|NCT03384225|Cytarabine|cytarabine|mesh-list
57117462|NCT03384225|Fludarabine|fludarabine|mesh-list
57117463|NCT03384225|Busulfan|busulfan|mesh-list
57117464|NCT03384225|Cladribine|cladribine|mesh-list
57117465|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117466|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57117467|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
57117468|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117469|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57117470|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
57117471|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117472|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
57117473|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117474|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
57117475|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57117476|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57117477|NCT05019326|Andrographolide|andrographolide|mesh-list
57117478|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117479|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57117480|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117481|NCT05019326|Analgesics|analgesics|mesh-ancestor
57117482|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
57117483|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117484|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117485|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117486|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57117487|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57117488|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117489|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
57117490|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57117491|NCT05008250|Metoprolol|metoprolol|mesh-list
57117492|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57117493|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57117494|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
57117495|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
57117496|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117497|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117498|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57117499|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57117500|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57117501|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117502|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117503|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117504|NCT03079076|Bupivacaine|bupivacaine|mesh-list
57117505|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
57117506|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
56799355|NCT00968903|Prednisolone|prednisolone|mesh-list
57117507|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117508|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117509|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
57117510|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117511|NCT03271749|Anesthetics|anesthetics|mesh-list
57117512|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117513|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117514|NCT03280407|Leucovorin|leucovorin|mesh-list
57117515|NCT03280407|Capecitabine|capecitabine|mesh-list
57117516|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
57117517|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
57117518|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57117519|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
57117520|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117521|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117522|NCT03280407|Antidotes|antidotes|mesh-ancestor
57117523|NCT03280407|Protective Agents|protective agents|mesh-ancestor
57117524|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117525|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
57117526|NCT03280407|Vitamins|vitamins|mesh-ancestor
57117527|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
57117528|NCT03078842|Zinc|zinc|mesh-list
57117529|NCT03078842|Trace Elements|trace elements|mesh-ancestor
57117530|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
57117531|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117532|NCT05007860|Vaccines|vaccines|mesh-list
57117533|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
57117534|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117535|NCT03270033|Dexamethasone|dexamethasone|mesh-list
57117536|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
57117537|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
57117538|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57117539|NCT03270033|BB 1101|bb 1101|mesh-list
57117540|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117541|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
57117542|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
57117543|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117544|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117545|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57117546|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
57117547|NCT03270033|Hormones|hormones|mesh-ancestor
57117548|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117549|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57117550|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117551|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
57117552|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117553|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117554|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57117555|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117556|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117557|NCT03270033|Analgesics|analgesics|mesh-ancestor
57117558|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
57117559|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57117560|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57117561|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57117562|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117563|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117564|NCT04959812|Sufentanil|sufentanil|mesh-list
57117565|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57117566|NCT04959812|Narcotics|narcotics|mesh-ancestor
57117567|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117568|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117569|NCT04959812|Analgesics|analgesics|mesh-ancestor
57117570|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
57117571|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117572|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57117573|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57117574|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
57117575|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
57117576|NCT03280095|Acetaminophen|acetaminophen|mesh-list
57117577|NCT03280095|Codeine|codeine|mesh-list
57117578|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117579|NCT03280095|Analgesics|analgesics|mesh-ancestor
56799425|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
57117580|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
57117581|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117582|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117583|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
57117584|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57117585|NCT03280095|Narcotics|narcotics|mesh-ancestor
57117586|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117587|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
57117588|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
57117589|NCT04463030|Vitamins|vitamins|mesh-list
57117590|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
57117591|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
57117592|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117593|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
57117594|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117595|NCT04463030|Protective Agents|protective agents|mesh-ancestor
57117596|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
57117597|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
57117598|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117599|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
57117600|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117601|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117602|NCT05010434|Bevacizumab|bevacizumab|mesh-list
57117603|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57117604|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117605|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57117606|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57117607|NCT05010434|Growth Substances|growth substances|mesh-ancestor
57117608|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117609|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
57117610|NCT05010356|Insulin|insulin|mesh-list
57117611|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57117612|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117613|NCT03269955|Thrombin|thrombin|mesh-list
57117614|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
57117615|NCT03269955|Coagulants|coagulants|mesh-ancestor
57117616|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
57117617|NCT05006846|Narcotics|narcotics|mesh-ancestor
57117618|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117619|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117620|NCT05006846|Analgesics|analgesics|mesh-ancestor
57117621|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
57117622|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117623|NCT05001074|Tacrolimus|tacrolimus|mesh-list
57117624|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57117625|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
57117626|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117627|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57117628|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117629|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117630|NCT02457520|Isotretinoin|isotretinoin|mesh-list
57117631|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
57117632|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
57117633|NCT02457585|Infliximab|infliximab|mesh-list
57117634|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
57117635|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57117636|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117637|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117638|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
57117639|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
57117640|NCT02457507|Vitamins|vitamins|mesh-ancestor
57117641|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
57117642|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117643|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
57117644|NCT02457507|Hematinics|hematinics|mesh-ancestor
57117645|NCT03265197|Lidocaine|lidocaine|mesh-list
57117646|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
57117647|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
57117648|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117649|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117650|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
57117651|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117652|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57117653|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57117654|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57117655|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57117656|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117657|NCT03078374|Warfarin|warfarin|mesh-list
57117658|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
56799501|NCT00971165|Losartan|losartan|mesh-list
57117659|NCT04944836|Clomiphene|clomiphene|mesh-list
57117660|NCT04944836|Enclomiphene|enclomiphene|mesh-list
57117661|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
57117662|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57117663|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
57117664|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117665|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117666|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57117667|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
57117668|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57117669|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57117670|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57117671|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
57117672|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57117673|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
57117674|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
57117675|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117676|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117677|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117678|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117679|NCT04940390|Analgesics|analgesics|mesh-ancestor
57117680|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
57117681|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117682|NCT02788279|Atezolizumab|atezolizumab|mesh-list
57117683|NCT02788279|Antibodies|antibodies|mesh-list
57117684|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
57117685|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117686|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117687|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
57117688|NCT03264651|Anastrozole|anastrozole|mesh-list
57117689|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57117690|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117691|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57117692|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57117693|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117694|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117695|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57117696|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
57117697|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117698|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117699|NCT03078062|Dexamethasone|dexamethasone|mesh-list
57117700|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117701|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
57117702|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
57117703|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117704|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117705|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57117706|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
57117707|NCT03078062|Hormones|hormones|mesh-ancestor
57117708|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117709|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57117710|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117711|NCT02435992|Ozanimod|ozanimod|mesh-list
57117712|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57117713|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117714|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57117715|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
57117716|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117717|NCT02457351|Itraconazole|itraconazole|mesh-list
57117718|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
57117719|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117720|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57117721|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57117722|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117723|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117724|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57117725|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
57117726|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117727|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117728|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57117729|NCT02788513|BI 425809|bi 425809|mesh-list
57117730|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
57117731|NCT03077828|Carboplatin|carboplatin|mesh-list
57117732|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
56799574|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117733|NCT03077828|Etoposide|etoposide|mesh-list
57117734|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
57117735|NCT03077828|Ifosfamide|ifosfamide|mesh-list
57117736|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
57117737|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
57117738|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117739|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57117740|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57117741|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57117742|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57117743|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117744|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117745|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57117746|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
57117747|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
57117748|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
57117749|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
57117750|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
57117751|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
57117752|NCT02126995|Metadoxine|metadoxine|mesh-list
57117753|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57117754|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
57117755|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57117756|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
57117757|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117758|NCT04459052|Expectorants|expectorants|mesh-ancestor
57117759|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
57117760|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57117761|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
57117762|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117763|NCT04459052|Protective Agents|protective agents|mesh-ancestor
57117764|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117765|NCT04459052|Antidotes|antidotes|mesh-ancestor
57117766|NCT05257291|Melatonin|melatonin|mesh-list
57117767|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
57117768|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117769|NCT05257291|Protective Agents|protective agents|mesh-ancestor
57117770|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117771|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117772|NCT04930900|Epinephrine|epinephrine|mesh-list
57117773|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57117774|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57117775|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117776|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117777|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117778|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117779|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57117780|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57117781|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
57117782|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117783|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57117784|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
57117785|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
57117786|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
57117787|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57117788|NCT02458209|Bococizumab|bococizumab|mesh-list
57117789|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57117790|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57117791|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
57117792|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117793|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57117794|NCT02127151|Talazoparib|talazoparib|mesh-list
57117795|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57117796|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117797|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117798|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117799|NCT03077516|Meloxicam|meloxicam|mesh-list
57117800|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57117801|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117802|NCT03077516|Analgesics|analgesics|mesh-ancestor
57117803|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
57117804|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117805|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117806|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799652|NCT00366249|Ertapenem|ertapenem|mesh-list
57117807|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117808|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57117809|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57117810|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117811|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117812|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57117813|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57117814|NCT04993040|Paclitaxel|paclitaxel|mesh-list
57117815|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57117816|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117817|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
57117818|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
57117819|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
56407027|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
57117820|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117821|NCT05300035|Antibodies|antibodies|mesh-list
57117822|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57117823|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
57117824|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117825|NCT03072992|Curcumin|curcumin|mesh-list
57117826|NCT03072992|Paclitaxel|paclitaxel|mesh-list
57117827|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57117828|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117829|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
57117830|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
57117831|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
57117832|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117833|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57117834|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57117835|NCT03072992|Analgesics|analgesics|mesh-ancestor
57117836|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
57117837|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117838|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117839|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117840|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117841|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117842|NCT03267771|Progesterone|progesterone|mesh-list
57117843|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
57117844|NCT03267771|Progestins|progestins|mesh-ancestor
57117845|NCT03267771|Hormones|hormones|mesh-ancestor
57117846|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117847|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117848|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57117849|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
57117850|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57117851|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57117852|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117853|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
57117854|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
57117855|NCT02456961|Riboflavin|riboflavin|mesh-list
57117856|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
57117857|NCT02456961|Vitamins|vitamins|mesh-ancestor
57117858|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
57117859|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117860|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57117861|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
57117862|NCT03551197|Budesonide|budesonide|mesh-list
57117863|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
57117864|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57117865|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57117866|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
57117867|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117868|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117869|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57117870|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
57117871|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
57117872|NCT03551197|Hormones|hormones|mesh-ancestor
57117873|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117874|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57117875|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57117876|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57117877|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
57117878|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117879|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117880|NCT02435836|Aripiprazole|aripiprazole|mesh-list
57117881|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
57117882|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57117883|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57117884|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57117885|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117886|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117887|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
57117888|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
57117889|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117890|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117891|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57117892|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57117893|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
57117894|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57117895|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57117896|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57117897|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57117898|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57117899|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57117900|NCT05075265|Methadone|methadone|mesh-list
57117901|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57117902|NCT05075265|Narcotics|narcotics|mesh-ancestor
57117903|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57117904|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117905|NCT05075265|Analgesics|analgesics|mesh-ancestor
57117906|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
57117907|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117908|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
57117909|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
57117910|NCT02127541|Exenatide|exenatide|mesh-list
57117911|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57117912|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117913|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57117914|NCT02127541|Incretins|incretins|mesh-ancestor
57117915|NCT02127541|Hormones|hormones|mesh-ancestor
57117916|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117917|NCT03263871|Micronutrients|micronutrients|mesh-list
57117918|NCT03263871|Trace Elements|trace elements|mesh-list
57117919|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117920|NCT04992182|Vaccines|vaccines|mesh-list
57117921|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
57117922|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117923|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
57117924|NCT02124655|Listerine|listerine|mesh-list
57117925|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57117926|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117927|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
57117928|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
57117929|NCT03263715|Hormones|hormones|mesh-ancestor
57117930|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57117931|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117932|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
57117933|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57117934|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
57117935|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117936|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57117937|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57117938|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
57117939|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117940|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117941|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57117942|NCT03266991|Isoniazid|isoniazid|mesh-list
57117943|NCT03266991|Rifapentine|rifapentine|mesh-list
57117944|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
57117945|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57117946|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117947|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57117948|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57117949|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
57117950|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117951|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57117952|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57117953|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
57117954|NCT02456740|Erenumab|erenumab|mesh-list
57117955|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57117956|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117957|NCT02456740|Analgesics|analgesics|mesh-ancestor
57117958|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
57117959|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57117960|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117961|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57117962|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57117963|NCT03266601|Interferons|interferons|mesh-list
57117964|NCT03266601|Ribavirin|ribavirin|mesh-list
57117965|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117966|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
57117967|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57117968|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
57117969|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117970|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57117971|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57117972|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
57117973|NCT05003648|Pramipexole|pramipexole|mesh-list
57117974|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
57117975|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117976|NCT05003648|Protective Agents|protective agents|mesh-ancestor
57117977|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57117978|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57117979|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57117980|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
57117981|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
57117982|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57117983|NCT02458755|Atorvastatin|atorvastatin|mesh-list
57117984|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57117985|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57117986|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57117987|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
57117988|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117989|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57117990|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57117991|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57117992|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
57117993|NCT04462406|Nivolumab|nivolumab|mesh-list
57117994|NCT04462406|Ipilimumab|ipilimumab|mesh-list
57117995|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57117996|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57117997|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57117998|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57117999|NCT02400580|Acetaminophen|acetaminophen|mesh-list
57118000|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57118001|NCT02400580|Analgesics|analgesics|mesh-ancestor
57118002|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
57118003|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118004|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118005|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
57118006|NCT03262857|Lidocaine|lidocaine|mesh-list
57118007|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
57118008|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
57118009|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
57118010|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118011|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118012|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
57118013|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118014|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57118015|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57118016|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57118017|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57118018|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118019|NCT03262857|Analgesics|analgesics|mesh-ancestor
57118020|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
57118021|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57118022|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57118023|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
57118024|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57118025|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
57118026|NCT02127697|Albuterol|albuterol|mesh-list
57118027|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57118028|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
57118029|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118030|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118031|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57118032|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
56799884|NCT00975767|Docetaxel|docetaxel|mesh-list
57118033|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
57118034|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57118035|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57118036|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57118037|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57118038|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
57118039|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118040|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118041|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57118042|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57118043|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57118044|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
57118045|NCT02127775|Lesinurad|lesinurad|mesh-list
57118046|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
57118047|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57118048|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
57118049|NCT02127775|Renal Agents|renal agents|mesh-ancestor
57118050|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
57118051|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57118052|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
57118053|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118054|NCT02252341|Expectorants|expectorants|mesh-ancestor
57118055|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
57118056|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57118057|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
57118058|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118059|NCT02252341|Protective Agents|protective agents|mesh-ancestor
57118060|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118061|NCT02252341|Antidotes|antidotes|mesh-ancestor
57118062|NCT02127853|Gabapentin|gabapentin|mesh-list
57118063|NCT02127853|Analgesics|analgesics|mesh-ancestor
57118064|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
57118065|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118066|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118067|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
57118068|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57118069|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57118070|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118071|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57118072|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57118073|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57118074|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118075|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118076|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
57118077|NCT03266445|Buprenorphine|buprenorphine|mesh-list
57118078|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
57118079|NCT03266445|Naloxone|naloxone|mesh-list
57118080|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57118081|NCT03266445|Narcotics|narcotics|mesh-ancestor
57118082|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118083|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118084|NCT03266445|Analgesics|analgesics|mesh-ancestor
57118085|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
57118086|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118087|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57118088|NCT01367119|Ketamine|ketamine|mesh-list
57118089|NCT01367119|Methohexital|methohexital|mesh-list
57118090|NCT01367119|Analgesics|analgesics|mesh-ancestor
57118091|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
57118092|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118093|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118094|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57118095|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57118096|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
57118097|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
57118098|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118099|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57118100|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57118101|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118102|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118103|NCT02252107|Decitabine|decitabine|mesh-list
57118104|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57118105|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
57118106|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118107|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118108|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118109|NCT03262545|Apatinib|apatinib|mesh-list
57118110|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118111|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57118112|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118113|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118114|NCT03262077|Methylene Blue|methylene blue|mesh-list
57118115|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118116|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118117|NCT03265899|Lactitol|lactitol|mesh-list
57118118|NCT03265899|Oxytocin|oxytocin|mesh-list
57118119|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
57118120|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57118121|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118122|NCT03265899|Cathartics|cathartics|mesh-ancestor
57118123|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57118124|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
57118125|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
57118126|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118127|NCT03934905|Sulforaphane|sulforaphane|mesh-list
57118128|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57118129|NCT03934905|Protective Agents|protective agents|mesh-ancestor
57118130|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118131|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118132|NCT02125201|Fentanyl|fentanyl|mesh-list
57118133|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57118134|NCT02125201|Narcotics|narcotics|mesh-ancestor
57118135|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118136|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118137|NCT02125201|Analgesics|analgesics|mesh-ancestor
57118138|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
57118139|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118140|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57118141|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57118142|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
57118143|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
57118144|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
57118145|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118146|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57118147|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118148|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118149|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
57118150|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118151|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118152|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57118153|NCT03074942|Reslizumab|reslizumab|mesh-list
57118154|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57118155|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
57118156|NCT02458911|Paclitaxel|paclitaxel|mesh-list
57118157|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57118158|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118159|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
57118160|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
57118161|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
57118162|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118163|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
57118164|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
57118165|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118166|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
57118167|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118168|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118169|NCT04998344|Vaccines|vaccines|mesh-list
57118170|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
57118171|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118172|NCT02128243|Leucovorin|leucovorin|mesh-list
57118173|NCT02128243|Cisplatin|cisplatin|mesh-list
57118174|NCT02128243|Docetaxel|docetaxel|mesh-list
57118175|NCT02128243|Fluorouracil|fluorouracil|mesh-list
57118176|NCT02128243|Capecitabine|capecitabine|mesh-list
57118177|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
57118178|NCT02128243|Epirubicin|epirubicin|mesh-list
57118179|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
57118180|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118181|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
57118182|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
57118183|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
57118184|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118185|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
57118186|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57118187|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57118188|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
57118189|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118190|NCT02128243|Antidotes|antidotes|mesh-ancestor
57118191|NCT02128243|Protective Agents|protective agents|mesh-ancestor
57118192|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
57118193|NCT02128243|Vitamins|vitamins|mesh-ancestor
57118194|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
57118195|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57118196|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57118197|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57118198|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118199|NCT04998500|Hormones|hormones|mesh-list
57118200|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118201|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118202|NCT03072290|Triamcinolone|triamcinolone|mesh-list
57118203|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57118204|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57118205|NCT03072290|Lidocaine|lidocaine|mesh-list
57118206|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57118207|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
57118208|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
57118209|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118210|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118211|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
57118212|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118213|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57118214|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57118215|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57118216|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57118217|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118218|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118219|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
57118220|NCT03072290|Hormones|hormones|mesh-ancestor
57118221|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118222|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57118223|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
57118224|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118225|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57118226|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
57118227|NCT02132689|Heparin|heparin|mesh-list
57118228|NCT02132689|Calcium heparin|calcium heparin|mesh-list
57118229|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57118230|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118231|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
57118232|NCT02128321|Repaglinide|repaglinide|mesh-list
57118233|NCT02128321|Isavuconazole|isavuconazole|mesh-list
57118234|NCT02128321|Caffeine|caffeine|mesh-list
57118235|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57118236|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118237|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57118238|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118239|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118240|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57118241|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57118242|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
57118243|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118244|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57118245|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
57118246|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118247|NCT02457975|Ranibizumab|ranibizumab|mesh-list
57118248|NCT02457975|Aflibercept|aflibercept|mesh-list
57118249|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118250|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57118251|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57118252|NCT02457975|Growth Substances|growth substances|mesh-ancestor
57118253|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118254|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
57118255|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57118256|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118257|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57118258|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118259|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118260|NCT02125903|Ropivacaine|ropivacaine|mesh-list
57118261|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
57118262|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
57118263|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118264|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118265|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
57118266|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118267|NCT04997564|Tenofovir|tenofovir|mesh-list
57118268|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
57118269|NCT04997564|Velpatasvir|velpatasvir|mesh-list
57118270|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57118271|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
57118272|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118273|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57118274|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57118275|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118276|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118277|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57118278|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57118279|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
57118280|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57118281|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57118282|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118283|NCT02126137|Ezetimibe|ezetimibe|mesh-list
57118284|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57118285|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57118286|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
57118287|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118288|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57118289|NCT02126293|Zinc|zinc|mesh-list
57118290|NCT02126293|Trace Elements|trace elements|mesh-ancestor
57118291|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
57118292|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118293|NCT03261921|Dexamethasone|dexamethasone|mesh-list
57118294|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
57118295|NCT03261921|Bupivacaine|bupivacaine|mesh-list
57118296|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118297|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
57118298|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
57118299|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118300|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118301|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57118302|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
57118303|NCT03261921|Hormones|hormones|mesh-ancestor
57118304|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118305|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57118306|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118307|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
57118308|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
57118309|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118310|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
57118311|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57118312|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57118313|NCT03261921|Analgesics|analgesics|mesh-ancestor
56901969|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
57118314|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57118315|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57118316|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57118317|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
57118318|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118319|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118320|NCT02635724|Peramivir|peramivir|mesh-list
57118321|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
57118322|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118323|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118324|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118325|NCT02133469|Vaccines|vaccines|mesh-list
57118326|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57118327|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
57118328|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118329|NCT03905265|Moxidectin|moxidectin|mesh-list
57118330|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
57118331|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57118332|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118333|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
57118334|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
57118335|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118336|NCT02126527|Sirolimus|sirolimus|mesh-list
56800175|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
57118337|NCT02126527|Auranofin|auranofin|mesh-list
57118338|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57118339|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118340|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57118341|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118342|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
57118343|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57118344|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
57118345|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118346|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57118347|NCT02133625|Pioglitazone|pioglitazone|mesh-list
57118348|NCT02133625|Carboplatin|carboplatin|mesh-list
57118349|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118350|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57118351|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118352|NCT02260687|Aflibercept|aflibercept|mesh-list
57118353|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57118354|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57118355|NCT02260687|Growth Substances|growth substances|mesh-ancestor
57118356|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118357|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
57118358|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118359|NCT03071822|Gemcitabine|gemcitabine|mesh-list
57118360|NCT03071822|Dexamethasone|dexamethasone|mesh-list
57118362|NCT03071822|Asparaginase|asparaginase|mesh-list
57118363|NCT03071822|Ifosfamide|ifosfamide|mesh-list
57118364|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118365|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
57118366|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
57118367|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118368|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118369|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57118370|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
57118371|NCT03071822|Hormones|hormones|mesh-ancestor
57118372|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118373|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57118374|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118375|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57118376|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
57118377|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118378|NCT03071822|Antiviral Agents|antiviral agents|mesh-ancestor
57118379|NCT03071822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118380|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118381|NCT03071822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57118382|NCT03071822|Immunologic Factors|immunologic factors|mesh-ancestor
57118383|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57118384|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57118385|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57118386|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57118387|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
57118388|NCT04991012|Triamcinolone|triamcinolone|mesh-list
57118389|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57118390|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57118391|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57118392|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118393|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
57118394|NCT04991012|Hormones|hormones|mesh-ancestor
57118395|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118396|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118397|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57118398|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
57118399|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118400|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118401|NCT02252731|Warfarin|warfarin|mesh-list
57118402|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
57118403|NCT02128633|Listerine|listerine|mesh-list
57118404|NCT02128633|Fluorides|fluorides|mesh-list
57118405|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
57118406|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
57118407|NCT02128633|Protective Agents|protective agents|mesh-ancestor
57118408|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118409|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57118410|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118411|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
57118412|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
57118413|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57118414|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57118415|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118416|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118417|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118418|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57118419|NCT04930094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57118420|NCT04930094|Immunologic Factors|immunologic factors|mesh-ancestor
57118421|NCT04930094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118422|NCT03252561|Anesthetics|anesthetics|mesh-list
57118423|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
57118424|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118425|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118426|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
57118427|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118428|NCT02252263|Elotuzumab|elotuzumab|mesh-list
57118429|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118430|NCT04996550|Metoprolol|metoprolol|mesh-list
57118431|NCT04996550|Carvedilol|carvedilol|mesh-list
57118432|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57118433|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57118434|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
57118435|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
57118436|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118437|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118438|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57118439|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57118440|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57118441|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
57118442|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118443|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118444|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
57118445|NCT04996550|Protective Agents|protective agents|mesh-ancestor
57118446|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57118447|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57118448|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57118449|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
57118450|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57118451|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57118452|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57118453|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
57118454|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118455|NCT02135965|Caffeine|caffeine|mesh-list
57118456|NCT02135965|Albuterol|albuterol|mesh-list
57118457|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57118458|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118459|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57118460|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118461|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118462|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57118463|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57118464|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
57118465|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118466|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57118467|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
57118468|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118469|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57118470|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
57118471|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
57118472|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57118473|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57118474|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57118475|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57118476|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
57118477|NCT02455401|Remifentanil|remifentanil|mesh-list
57118478|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57118479|NCT02455401|Narcotics|narcotics|mesh-ancestor
57118480|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118481|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118482|NCT02455401|Analgesics|analgesics|mesh-ancestor
57118483|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
57118484|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118485|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
57118486|NCT03260829|Vitamins|vitamins|mesh-ancestor
57118487|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
57118488|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118489|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
57118490|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118491|NCT03260829|Protective Agents|protective agents|mesh-ancestor
57118493|NCT02134093|Sufentanil|sufentanil|mesh-list
57118494|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
57118495|NCT02134093|Remifentanil|remifentanil|mesh-list
57118496|NCT02134093|Anesthetics|anesthetics|mesh-list
57118497|NCT02134093|Propofol|propofol|mesh-list
57118498|NCT02134093|Etomidate|etomidate|mesh-list
57118499|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
57118500|NCT02134093|Rocuronium|rocuronium|mesh-list
57118501|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118502|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118503|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57118504|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57118505|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
57118506|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57118507|NCT02134093|Analgesics|analgesics|mesh-ancestor
57118508|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
57118509|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118510|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57118511|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57118512|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57118513|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
57118514|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118515|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118516|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57118517|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57118518|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57118519|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57118520|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
57118521|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
57118522|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57118523|NCT02134093|Narcotics|narcotics|mesh-ancestor
57118524|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57118525|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57118526|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57118527|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57118528|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57118529|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
57118530|NCT03074786|Tenofovir|tenofovir|mesh-list
57118531|NCT03074786|Emtricitabine|emtricitabine|mesh-list
57118532|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57118533|NCT03074786|Dapivirine|dapivirine|mesh-list
57118534|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
57118535|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118536|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57118537|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57118538|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118539|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118540|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57118541|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57118542|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
57118543|NCT00408005|Leucovorin|leucovorin|mesh-list
57118544|NCT00408005|Folic Acid|folic acid|mesh-list
57118545|NCT00408005|Cytarabine|cytarabine|mesh-list
57118546|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
57118547|NCT00408005|Dexamethasone|dexamethasone|mesh-list
57118548|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
57118549|NCT00408005|Prednisone|prednisone|mesh-list
57118550|NCT00408005|Cortisone|cortisone|mesh-list
57118551|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
57118552|NCT00408005|Doxorubicin|doxorubicin|mesh-list
57118553|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57118554|NCT00408005|Methotrexate|methotrexate|mesh-list
57118555|NCT00408005|Vincristine|vincristine|mesh-list
57118556|NCT00408005|Daunorubicin|daunorubicin|mesh-list
57118557|NCT00408005|Asparaginase|asparaginase|mesh-list
57118558|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
57118559|NCT00408005|Pegaspargase|pegaspargase|mesh-list
57118560|NCT00408005|Thioguanine|thioguanine|mesh-list
57118561|NCT00408005|BB 1101|bb 1101|mesh-list
57118562|NCT00408005|Calcium|calcium|mesh-list
57118563|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
57118564|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
57118565|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57118566|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
57118567|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118568|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57118569|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57118570|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
57118571|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118572|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118573|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57118574|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118575|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
57118576|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
57118577|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118578|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57118579|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
57118580|NCT00408005|Hormones|hormones|mesh-ancestor
57118581|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118582|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57118583|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
57118584|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118585|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57118586|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57118587|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57118588|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57118589|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57118590|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57118591|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
57118592|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57118593|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57118594|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
57118595|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
57118596|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57118597|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57118598|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
57118599|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118600|NCT00408005|Antidotes|antidotes|mesh-ancestor
57118601|NCT00408005|Protective Agents|protective agents|mesh-ancestor
57118602|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
57118603|NCT00408005|Vitamins|vitamins|mesh-ancestor
57118604|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
57118605|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57118606|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
57118607|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
57118608|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
57118609|NCT00408005|Hematinics|hematinics|mesh-ancestor
57118610|NCT03377049|Acetazolamide|acetazolamide|mesh-list
57118611|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
57118612|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57118613|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118614|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118615|NCT03377049|Diuretics|diuretics|mesh-ancestor
57118616|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
57118617|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118618|NCT03070028|Phenol|phenol|mesh-list
57118619|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57118620|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118621|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
57118622|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
57118623|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57118624|NCT03260439|Tramadol|tramadol|mesh-list
57118625|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57118626|NCT03260439|Narcotics|narcotics|mesh-ancestor
57118627|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118628|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118629|NCT03260439|Analgesics|analgesics|mesh-ancestor
57118630|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
57118631|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118632|NCT02634788|Buprenorphine|buprenorphine|mesh-list
57118633|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57118634|NCT02634788|Narcotics|narcotics|mesh-ancestor
57118635|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118636|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118637|NCT02634788|Analgesics|analgesics|mesh-ancestor
57118638|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
57118639|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118640|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57118641|NCT03251859|Ticagrelor|ticagrelor|mesh-list
57118642|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57118643|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57118644|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57118645|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57118646|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
57118647|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118648|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118649|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118650|NCT03260283|Fentanyl|fentanyl|mesh-list
57118651|NCT03260283|Meperidine|meperidine|mesh-list
57118652|NCT03260283|Ropivacaine|ropivacaine|mesh-list
57118653|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
57118654|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
57118655|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118656|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118657|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
57118658|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118659|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57118660|NCT03260283|Narcotics|narcotics|mesh-ancestor
57118661|NCT03260283|Analgesics|analgesics|mesh-ancestor
57118662|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57118663|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57118664|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
57118665|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
57118666|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57118667|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57118668|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118669|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
57118670|NCT03251469|Coagulants|coagulants|mesh-ancestor
57118671|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
57118672|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57118673|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
57118674|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118675|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
57118676|NCT04986644|Protective Agents|protective agents|mesh-ancestor
57118677|NCT02785939|Docetaxel|docetaxel|mesh-list
57118678|NCT02785939|Palbociclib|palbociclib|mesh-list
57118679|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118680|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
57118681|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
57118682|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
57118683|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118684|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57118685|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118686|NCT03583229|Aspirin|aspirin|mesh-list
57118687|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57118688|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57118689|NCT03583229|Analgesics|analgesics|mesh-ancestor
57118690|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
57118691|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118692|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118693|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118694|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57118695|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57118696|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57118697|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118698|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57118699|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57118700|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118701|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
57118702|NCT02259803|Amlodipine|amlodipine|mesh-list
57118703|NCT02259803|Telmisartan|telmisartan|mesh-list
57118704|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
57118705|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57118706|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57118707|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57118708|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118709|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57118710|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118711|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
57118712|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57118713|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57118714|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
57118715|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118716|NCT03069950|Leucovorin|leucovorin|mesh-list
57118717|NCT03069950|Dexamethasone|dexamethasone|mesh-list
57118718|NCT03069950|Fluorouracil|fluorouracil|mesh-list
57118719|NCT03069950|Irinotecan|irinotecan|mesh-list
57118720|NCT03069950|Panitumumab|panitumumab|mesh-list
57118721|NCT03069950|Floxuridine|floxuridine|mesh-list
57118722|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56800561|NCT02535039|Prednisolone|prednisolone|mesh-list
57118723|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
57118724|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
57118725|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118726|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118727|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57118728|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
57118729|NCT03069950|Hormones|hormones|mesh-ancestor
57118730|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118731|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57118732|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118733|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
57118734|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118735|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57118736|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57118737|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
57118738|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57118739|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57118740|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118741|NCT03069950|Antidotes|antidotes|mesh-ancestor
57118742|NCT03069950|Protective Agents|protective agents|mesh-ancestor
57118743|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
57118744|NCT03069950|Vitamins|vitamins|mesh-ancestor
57118745|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
57118746|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57118747|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
57118748|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118749|NCT03577457|Oxytocin|oxytocin|mesh-list
57118750|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
57118751|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57118752|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118753|NCT02455245|Carboplatin|carboplatin|mesh-list
57118754|NCT02455245|Vincristine|vincristine|mesh-list
57118755|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118756|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57118757|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
57118758|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
57118759|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
57118760|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118761|NCT03537599|Daratumumab|daratumumab|mesh-list
57118762|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118763|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57118764|NCT04986254|Meropenem|meropenem|mesh-list
57118765|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
57118766|NCT04986254|Tazobactam|tazobactam|mesh-list
57118767|NCT04986254|Piperacillin|piperacillin|mesh-list
57118768|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
57118769|NCT04986254|Penicillin G|penicillin g|mesh-list
57118770|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
57118771|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
57118772|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118773|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57118774|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118775|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118776|NCT03257943|Ivermectin|ivermectin|mesh-list
57118777|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57118778|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118779|NCT04996160|Dexamethasone|dexamethasone|mesh-list
57118780|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
57118781|NCT04996160|Doxorubicin|doxorubicin|mesh-list
57118782|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57118783|NCT04996160|Bortezomib|bortezomib|mesh-list
57118784|NCT04996160|Palbociclib|palbociclib|mesh-list
57118785|NCT04996160|BB 1101|bb 1101|mesh-list
57118786|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118787|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
57118788|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
57118789|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118790|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118791|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57118792|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
57118793|NCT04996160|Hormones|hormones|mesh-ancestor
57118794|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118795|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57118796|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118797|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
57118798|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800643|NCT01047891|Sorafenib|sorafenib|mesh-list
57118799|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118800|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57118801|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57118802|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57118803|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57118804|NCT04986098|Paclitaxel|paclitaxel|mesh-list
57118805|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57118806|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118807|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
57118808|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
57118809|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
57118810|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118811|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
57118812|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
57118813|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57118814|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118815|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118816|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57118817|NCT02239445|Analgesics|analgesics|mesh-ancestor
57118818|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
57118819|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118820|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57118821|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57118822|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57118823|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
57118824|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118825|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118826|NCT03071042|Docetaxel|docetaxel|mesh-list
57118827|NCT03071042|Apatinib|apatinib|mesh-list
57118828|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118829|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
57118830|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
57118831|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
57118832|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118833|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57118834|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118835|NCT03582605|Amoxicillin|amoxicillin|mesh-list
57118836|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57118837|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57118838|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
57118839|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
57118840|NCT04989140|Dexamethasone|dexamethasone|mesh-list
57118841|NCT04989140|Pomalidomide|pomalidomide|mesh-list
57118842|NCT04989140|Ixazomib|ixazomib|mesh-list
57118843|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118844|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
57118845|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
57118846|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118847|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118848|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57118849|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
57118850|NCT04989140|Hormones|hormones|mesh-ancestor
57118851|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57118852|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57118853|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118854|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
57118855|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57118856|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57118857|NCT04989140|Growth Substances|growth substances|mesh-ancestor
57118858|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
57118859|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
57118860|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118861|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118862|NCT03246009|Lenograstim|lenograstim|mesh-list
57118863|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57118864|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
57118865|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118866|NCT03246399|Lorecivivint|lorecivivint|mesh-list
57118867|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118868|NCT02134249|Cabergoline|cabergoline|mesh-list
57118869|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57118870|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57118871|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
57118872|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
57118873|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118874|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118875|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118877|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
57118878|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
57118879|NCT03245853|Vitamins|vitamins|mesh-ancestor
57118880|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
57118881|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118882|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57118883|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
57118884|NCT03574649|Paclitaxel|paclitaxel|mesh-list
57118885|NCT03574649|Docetaxel|docetaxel|mesh-list
57118886|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
57118887|NCT03574649|Carboplatin|carboplatin|mesh-list
57118888|NCT03574649|Fluorouracil|fluorouracil|mesh-list
57118889|NCT03574649|Avelumab|avelumab|mesh-list
57118890|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57118891|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118892|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
57118893|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
57118894|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
57118895|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118896|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57118897|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
57118898|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118899|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57118900|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57118901|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
57118902|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57118903|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
57118904|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57118905|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57118906|NCT02128945|Fludarabine|fludarabine|mesh-list
57118907|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118908|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57118909|NCT03073928|Ropivacaine|ropivacaine|mesh-list
57118910|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
57118911|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
57118912|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118913|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118914|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
57118915|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118916|NCT02134327|Midazolam|midazolam|mesh-list
57118917|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
57118918|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57118919|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57118920|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118921|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57118922|NCT02134327|Analgesics|analgesics|mesh-ancestor
57118923|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
57118924|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118925|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57118926|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57118927|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57118928|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
57118929|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57118930|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118931|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57118932|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57118933|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57118934|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57118935|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57118936|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
57118937|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
57118938|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
57118939|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
57118940|NCT02134405|Esomeprazole|esomeprazole|mesh-list
57118941|NCT02134405|Rebamipide|rebamipide|mesh-list
57118942|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57118943|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57118944|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57118945|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118946|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118947|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
57118948|NCT02134405|Protective Agents|protective agents|mesh-ancestor
57118949|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118950|NCT02456025|Tacrolimus|tacrolimus|mesh-list
57118951|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57118952|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
57118953|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118954|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57118955|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118956|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118957|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
57118958|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57118959|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118960|NCT03576911|Ubiquinone|ubiquinone|mesh-list
57118961|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
57118962|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
57118963|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118964|NCT03576911|Vitamins|vitamins|mesh-ancestor
57118965|NCT02136511|Rituximab|rituximab|mesh-list
57118966|NCT02136511|Idelalisib|idelalisib|mesh-list
57118967|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57118968|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118969|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
57118970|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118971|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57118972|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118973|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118974|NCT02136589|Diclofenac|diclofenac|mesh-list
57118975|NCT02136589|Travoprost|travoprost|mesh-list
57118976|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57118977|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57118978|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57118979|NCT02136589|Analgesics|analgesics|mesh-ancestor
57118980|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
57118981|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57118982|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57118983|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57118984|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57118985|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57118986|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118987|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118988|NCT02134639|Edotreotide|edotreotide|mesh-list
57118989|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57118990|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118991|NCT02129101|Azacitidine|azacitidine|mesh-list
57118992|NCT02129101|Decitabine|decitabine|mesh-list
57118993|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57118994|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
57118995|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57118996|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57118997|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57118998|NCT02134717|Maraviroc|maraviroc|mesh-list
57118999|NCT02134717|Dimercaprol|dimercaprol|mesh-list
57119000|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57119001|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57119002|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119003|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57119004|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57119005|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
57119006|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119007|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57119008|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
57119009|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
57119010|NCT03245385|Halobetasol|halobetasol|mesh-list
57119011|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57119012|NCT02136823|Isradipine|isradipine|mesh-list
57119013|NCT02136823|Riluzole|riluzole|mesh-list
57119014|NCT02136823|Memantine|memantine|mesh-list
57119015|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57119016|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57119017|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
57119018|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119019|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119020|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119021|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57119022|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57119023|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
57119024|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57119025|NCT02136823|Protective Agents|protective agents|mesh-ancestor
57119026|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57119027|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57119028|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119029|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57119030|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
57119031|NCT03250143|Cyclosporine|cyclosporine|mesh-list
57119032|NCT03250143|Azathioprine|azathioprine|mesh-list
57119033|NCT03250143|Cyclosporins|cyclosporins|mesh-list
57119034|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119035|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119036|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57119037|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
57119038|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119039|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
57119040|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119041|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
57119042|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57119043|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57119044|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
57119045|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57119046|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119047|NCT03073850|Anticoagulants|anticoagulants|mesh-list
57119048|NCT03073850|Edoxaban|edoxaban|mesh-list
57119049|NCT03073850|Clopidogrel|clopidogrel|mesh-list
57119050|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119051|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119052|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57119053|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119054|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57119055|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57119056|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57119057|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
57119058|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119059|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57119060|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
57119061|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57119062|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
57119063|NCT03257319|Morphine|morphine|mesh-list
57119064|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57119065|NCT03257319|Narcotics|narcotics|mesh-ancestor
57119066|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119067|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119068|NCT03257319|Analgesics|analgesics|mesh-ancestor
57119069|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
57119070|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119071|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
57119072|NCT03070574|Mesalamine|mesalamine|mesh-list
57119073|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57119074|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57119075|NCT03070574|Analgesics|analgesics|mesh-ancestor
57119076|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
57119077|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119078|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119079|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57119080|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57119081|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
57119082|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57119083|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119084|NCT03257241|Cytarabine|cytarabine|mesh-list
57119085|NCT03257241|Fludarabine|fludarabine|mesh-list
57119086|NCT03257241|Daunorubicin|daunorubicin|mesh-list
57119087|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
57119088|NCT03257241|Idarubicin|idarubicin|mesh-list
57119089|NCT03257241|Cladribine|cladribine|mesh-list
57119090|NCT03257241|Lenograstim|lenograstim|mesh-list
57119091|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119092|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57119093|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
57119094|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119095|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57119096|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
57119097|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119098|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
57119099|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119100|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57119101|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57119102|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57119103|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57119104|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119105|NCT03257241|Analgesics|analgesics|mesh-ancestor
57119106|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
57119107|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119108|NCT02129179|Glucagon|glucagon|mesh-list
57119109|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57119110|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57119111|NCT02129179|Hormones|hormones|mesh-ancestor
57119112|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57119113|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119114|NCT02129179|Incretins|incretins|mesh-ancestor
57119115|NCT02129257|Leucovorin|leucovorin|mesh-list
57119116|NCT02129257|Folic Acid|folic acid|mesh-list
57119117|NCT02129257|Fluorouracil|fluorouracil|mesh-list
57119118|NCT02129257|Irinotecan|irinotecan|mesh-list
57119119|NCT02129257|Aflibercept|aflibercept|mesh-list
57119120|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
57119121|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
57119122|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119123|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57119124|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119125|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57119126|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
57119127|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119128|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57119129|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57119130|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119131|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57119132|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57119133|NCT02129257|Growth Substances|growth substances|mesh-ancestor
57119134|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
57119135|NCT02129257|Antidotes|antidotes|mesh-ancestor
57119136|NCT02129257|Protective Agents|protective agents|mesh-ancestor
57119137|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
57119138|NCT02129257|Vitamins|vitamins|mesh-ancestor
57119139|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
57119140|NCT02129257|Hematinics|hematinics|mesh-ancestor
57119141|NCT03245307|Apatinib|apatinib|mesh-list
57119142|NCT03245307|Nifedipine|nifedipine|mesh-list
57119143|NCT03245307|Warfarin|warfarin|mesh-list
57119144|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
57119145|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119146|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56902051|NCT03779685|Anesthetics|anesthetics|mesh-list
57119147|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119148|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119149|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57119150|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119151|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57119152|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119153|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
57119154|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
57119155|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57119156|NCT02136979|Propofol|propofol|mesh-list
57119157|NCT02136979|Sevoflurane|sevoflurane|mesh-list
57119158|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57119159|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119160|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119161|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57119162|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
57119163|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
57119164|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57119165|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57119166|NCT04983836|Anesthetics|anesthetics|mesh-list
57119167|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119168|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119169|NCT02455011|Volagidemab|volagidemab|mesh-list
57119170|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57119171|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119172|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57119173|NCT03249285|Perindopril|perindopril|mesh-list
57119174|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57119175|NCT03249285|Diuretics|diuretics|mesh-ancestor
57119176|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
57119177|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119178|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57119179|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119180|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119181|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57119182|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
57119183|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119184|NCT03249519|Cisplatin|cisplatin|mesh-list
57119185|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119186|NCT04983524|Propolis|propolis|mesh-list
57119187|NCT04983524|Calcium|calcium|mesh-list
57119188|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57119189|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119190|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119191|NCT02634320|Aripiprazole|aripiprazole|mesh-list
57119192|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
57119193|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
57119194|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57119195|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57119196|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57119197|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119198|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119199|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
57119200|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
57119201|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119202|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119203|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57119204|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57119205|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
57119206|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57119207|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57119208|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57119209|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57119210|NCT02435680|Gemcitabine|gemcitabine|mesh-list
57119211|NCT02435680|Carboplatin|carboplatin|mesh-list
57119212|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119213|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57119214|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
57119215|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119216|NCT02435680|Antiviral Agents|antiviral agents|mesh-ancestor
57119217|NCT02435680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119218|NCT02435680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902059|NCT02059330|Palbociclib|palbociclib|mesh-list
57119219|NCT02435680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57119220|NCT02435680|Immunologic Factors|immunologic factors|mesh-ancestor
57119221|NCT02435680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119222|NCT04988048|Vaccines|vaccines|mesh-list
57119223|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
57119224|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119225|NCT04982900|Aflutinib|aflutinib|mesh-list
57119226|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57119227|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119228|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119229|NCT03256071|Decitabine|decitabine|mesh-list
57119230|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57119231|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
57119232|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119233|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119234|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119235|NCT04912856|Ezogabine|ezogabine|mesh-list
57119236|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
57119237|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119238|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119239|NCT03248817|Phenylephrine|phenylephrine|mesh-list
57119240|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
57119241|NCT03248817|Bupivacaine|bupivacaine|mesh-list
57119242|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
57119243|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
57119244|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119245|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119246|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
57119247|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119248|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57119249|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
57119250|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
57119251|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
57119252|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57119253|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
57119254|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
57119255|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57119256|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57119257|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57119258|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
57119259|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119260|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119261|NCT03248817|Protective Agents|protective agents|mesh-ancestor
57119262|NCT03647774|Naltrexone|naltrexone|mesh-list
57119263|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57119264|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57119265|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119266|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
57119267|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119268|NCT03248973|Ampicillin|ampicillin|mesh-list
57119269|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57119270|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119271|NCT05635916|Bupivacaine|bupivacaine|mesh-list
57119272|NCT05635916|Anesthetics, Local|anesthetics, local|mesh-ancestor
57119273|NCT05635916|Anesthetics|anesthetics|mesh-ancestor
57119274|NCT05635916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119275|NCT05635916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119276|NCT05635916|Sensory System Agents|sensory system agents|mesh-ancestor
57119277|NCT05635916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119278|NCT02832531|Aspirin|aspirin|mesh-list
57119279|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
57119280|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57119281|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57119282|NCT02832531|Analgesics|analgesics|mesh-ancestor
57119283|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
57119284|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119285|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119286|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57119287|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57119288|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57119289|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57119290|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119291|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57119292|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57119293|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119294|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
57119295|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57119296|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
57119297|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57119298|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
57119299|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
57119300|NCT03582488|Corticosterone|corticosterone|mesh-list
57119301|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57119302|NCT03248427|Paclitaxel|paclitaxel|mesh-list
57119303|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
57119304|NCT03248427|Doxorubicin|doxorubicin|mesh-list
57119305|NCT03248427|Letrozole|letrozole|mesh-list
57119306|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57119307|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119308|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
57119309|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
57119310|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
57119311|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119312|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57119313|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
57119314|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119315|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57119316|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57119317|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
57119318|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57119319|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57119320|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57119321|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57119322|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119323|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57119324|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57119325|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57119326|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
57119327|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57119328|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57119329|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119330|NCT05635370|Cilostazol|cilostazol|mesh-list
56801160|NCT01017380|Celecoxib|celecoxib|mesh-list
57119331|NCT05635370|Pentoxifylline|pentoxifylline|mesh-list
57119332|NCT05635370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57119333|NCT05635370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119334|NCT05635370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119335|NCT05635370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57119336|NCT05635370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57119337|NCT05635370|Protective Agents|protective agents|mesh-ancestor
57119338|NCT05635370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119339|NCT05635370|Vasodilator Agents|vasodilator agents|mesh-ancestor
57119340|NCT05635370|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57119341|NCT05635370|Antioxidants|antioxidants|mesh-ancestor
57119342|NCT05635370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57119343|NCT05635370|Autonomic Agents|autonomic agents|mesh-ancestor
57119344|NCT05635370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119345|NCT05635370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57119346|NCT05635370|Respiratory System Agents|respiratory system agents|mesh-ancestor
57119347|NCT05635370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57119348|NCT05635370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57119349|NCT05635370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57119350|NCT05635370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57119351|NCT05371886|Midazolam|midazolam|mesh-list
57119352|NCT05371886|Morphine|morphine|mesh-list
57119353|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57119354|NCT05371886|Narcotics|narcotics|mesh-ancestor
57119355|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119356|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119357|NCT05371886|Analgesics|analgesics|mesh-ancestor
57119358|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
57119359|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119360|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57119361|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57119362|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57119363|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57119364|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57119365|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57119366|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
57119367|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
57119368|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
57119369|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
57119370|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119371|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119372|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
57119373|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
57119374|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
57119375|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57119376|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
57119377|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57119378|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57119379|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
57119380|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119381|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119382|NCT03243903|Insulin|insulin|mesh-list
57119383|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57119384|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57119385|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119386|NCT03576677|Simendan|simendan|mesh-list
57119387|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57119388|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
57119389|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57119390|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57119391|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119392|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119393|NCT03576677|Protective Agents|protective agents|mesh-ancestor
57119394|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119395|NCT03247257|Lidocaine|lidocaine|mesh-list
57119396|NCT03247257|Anesthetics|anesthetics|mesh-list
57119397|NCT03247257|Propofol|propofol|mesh-list
57119398|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
57119399|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119400|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119401|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
57119402|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119403|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57119404|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57119405|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57119406|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56801233|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
57119407|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119408|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57119409|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57119410|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
57119411|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
57119412|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57119413|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119415|NCT02239835|Saquinavir|saquinavir|mesh-list
57119416|NCT02239835|Tipranavir|tipranavir|mesh-list
57119417|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57119418|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57119419|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
57119420|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119421|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119422|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57119423|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57119424|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
57119425|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119426|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57119427|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57119428|NCT02239913|Topiramate|topiramate|mesh-list
57119429|NCT02239913|Phentermine|phentermine|mesh-list
57119430|NCT02239913|Cocaine|cocaine|mesh-list
57119431|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
57119432|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57119433|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119434|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
57119435|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
57119436|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119437|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
57119438|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119439|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57119440|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57119441|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57119442|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119443|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119444|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
57119445|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119446|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57119447|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
57119448|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57119449|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
57119450|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
57119451|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
57119452|NCT03576287|Apremilast|apremilast|mesh-list
57119453|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57119454|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57119455|NCT03576287|Analgesics|analgesics|mesh-ancestor
57119456|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
57119457|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119458|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119459|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57119460|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57119461|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57119462|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57119463|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119464|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119465|NCT02455869|Alendronate|alendronate|mesh-list
57119466|NCT02455869|Atorvastatin|atorvastatin|mesh-list
57119467|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57119468|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57119469|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
57119470|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119471|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57119472|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57119473|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119474|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57119475|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119476|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57119477|NCT03246555|Perindopril|perindopril|mesh-list
57119478|NCT03246555|Indapamide|indapamide|mesh-list
57119479|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57119480|NCT03246555|Diuretics|diuretics|mesh-ancestor
57119481|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
57119482|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119483|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57119484|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119485|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119486|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57119487|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
57119488|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119489|NCT03576053|Lidocaine|lidocaine|mesh-list
57119490|NCT03576053|Serotonin|serotonin|mesh-list
57119491|NCT03576053|Histamine|histamine|mesh-list
57119492|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
57119493|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
57119494|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119495|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119496|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
57119497|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119498|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57119499|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57119500|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57119501|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119502|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119503|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57119504|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
57119505|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119506|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
57119507|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
57119508|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
57119509|NCT03242967|Hematinics|hematinics|mesh-ancestor
57119510|NCT03239457|Mitogens|mitogens|mesh-list
57119511|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
57119512|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119513|NCT00075803|Fluconazole|fluconazole|mesh-list
57119514|NCT00075803|Voriconazole|voriconazole|mesh-list
57119515|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
57119516|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119517|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57119518|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57119519|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119520|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119521|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57119522|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
57119523|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57119524|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119525|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57119526|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57119527|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57119528|NCT03242499|Lovastatin|lovastatin|mesh-list
57119529|NCT03242499|L 647318|l 647318|mesh-list
57119530|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
57119531|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57119532|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57119533|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
57119534|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119535|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57119536|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57119537|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119538|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
57119539|NCT02523911|Simethicone|simethicone|mesh-list
57119540|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
57119541|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57119542|NCT02523911|Analgesics|analgesics|mesh-ancestor
57119543|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
57119544|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119545|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119546|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
57119547|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119548|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57119549|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
57119550|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57119551|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119552|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119553|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57119554|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
57119555|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57119557|NCT02523911|Emollients|emollients|mesh-ancestor
57119558|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
57119559|NCT02523911|Cathartics|cathartics|mesh-ancestor
57119560|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57119561|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
57119562|NCT03572231|Mirabegron|mirabegron|mesh-list
57119563|NCT03572231|Fesoterodine|fesoterodine|mesh-list
57119564|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
57119565|NCT03572231|Oxybutynin|oxybutynin|mesh-list
57119566|NCT03572231|Darifenacin|darifenacin|mesh-list
57119567|NCT03572231|Propiverine|propiverine|mesh-list
57119568|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57119569|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57119570|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
57119571|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119572|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119573|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119574|NCT03572231|Urological Agents|urological agents|mesh-ancestor
57119575|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57119576|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57119577|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57119578|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
57119579|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
57119580|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
57119581|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119582|NCT02135029|Atorvastatin|atorvastatin|mesh-list
57119583|NCT02135029|Bococizumab|bococizumab|mesh-list
57119584|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57119585|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57119586|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
57119587|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119588|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57119589|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57119590|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119591|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
57119592|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57119593|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57119594|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119595|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
57119596|NCT03573245|Coagulants|coagulants|mesh-ancestor
57119597|NCT02241161|Bacteriocins|bacteriocins|mesh-list
57119598|NCT02241161|Antioxidants|antioxidants|mesh-list
57119599|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119600|NCT02241161|Protective Agents|protective agents|mesh-ancestor
57119601|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119602|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57119603|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119604|NCT02135263|Enalapril|enalapril|mesh-list
57119605|NCT02135263|Methylphenidate|methylphenidate|mesh-list
57119606|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57119607|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119608|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57119609|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57119610|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119611|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119612|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
57119613|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119614|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57119615|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
57119616|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119617|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57119618|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
57119619|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57119620|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57119621|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57119622|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57119623|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119624|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119625|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
57119626|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119627|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119628|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56801456|NCT00282256|Tacrolimus|tacrolimus|mesh-list
56902094|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57119629|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119630|NCT02239523|Denosumab|denosumab|mesh-list
57119631|NCT02239523|Teriparatide|teriparatide|mesh-list
57119632|NCT02239523|Diphosphonates|diphosphonates|mesh-list
57119633|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57119634|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119635|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57119636|NCT02137213|Naloxone|naloxone|mesh-list
57119637|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57119638|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119639|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
57119640|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119641|NCT03571919|Lidocaine|lidocaine|mesh-list
57119642|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
57119643|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
57119644|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119645|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119646|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
57119647|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119648|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57119649|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57119650|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57119651|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119652|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119653|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
57119654|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57119655|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57119656|NCT02252809|Prednisolone|prednisolone|mesh-list
57119657|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
57119658|NCT02252809|Adalimumab|adalimumab|mesh-list
57119659|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57119660|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
57119661|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57119662|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
57119663|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
57119664|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119665|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119666|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57119667|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
57119668|NCT02252809|Hormones|hormones|mesh-ancestor
57119669|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57119670|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57119671|NCT02252809|Protective Agents|protective agents|mesh-ancestor
57119672|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57119673|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119674|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57119675|NCT02137525|Fentanyl|fentanyl|mesh-list
57119676|NCT02137525|Morphine|morphine|mesh-list
57119677|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57119678|NCT02137525|Narcotics|narcotics|mesh-ancestor
57119679|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119680|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119681|NCT02137525|Analgesics|analgesics|mesh-ancestor
57119682|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
57119683|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119684|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57119685|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57119686|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
57119687|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
57119688|NCT02137681|Rituximab|rituximab|mesh-list
57119689|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57119690|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119691|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
57119692|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119693|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57119694|NCT02842073|Naltrexone|naltrexone|mesh-list
57119695|NCT02842073|Bupropion|bupropion|mesh-list
57119696|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57119697|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57119698|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119699|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
57119700|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119701|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57119702|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
57119703|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57119704|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57119705|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57119706|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119707|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119708|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
57119709|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119710|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57119711|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57119712|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119714|NCT02135887|Folic Acid|folic acid|mesh-list
57119715|NCT02135887|Fluorouracil|fluorouracil|mesh-list
57119716|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
57119717|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
57119718|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
57119719|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119720|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57119721|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119722|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57119723|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
57119724|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119725|NCT02135887|Antidotes|antidotes|mesh-ancestor
57119726|NCT02135887|Protective Agents|protective agents|mesh-ancestor
57119727|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
57119728|NCT02135887|Vitamins|vitamins|mesh-ancestor
57119729|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
57119730|NCT02135887|Hematinics|hematinics|mesh-ancestor
57119731|NCT02137759|Temozolomide|temozolomide|mesh-list
57119732|NCT02137759|Belinostat|belinostat|mesh-list
57119733|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57119734|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
57119735|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119736|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119737|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57119738|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119739|NCT02137993|Olanzapine|olanzapine|mesh-list
57119740|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
57119741|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
57119742|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119743|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119744|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57119745|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57119746|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57119747|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119748|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57119749|NCT02137993|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57119750|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57119751|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119752|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119753|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119754|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
57119755|NCT05579119|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57119756|NCT05579119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57119757|NCT05579119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119758|NCT05579119|Incretins|incretins|mesh-ancestor
57119759|NCT05579119|Hormones|hormones|mesh-ancestor
56902117|NCT02059564|Incretins|incretins|mesh-ancestor
57119760|NCT05579119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57119761|NCT05579119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57119762|NCT05579119|Protease Inhibitors|protease inhibitors|mesh-ancestor
57119763|NCT05579119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119764|NCT05579119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119765|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
57119766|NCT02245841|Hormones|hormones|mesh-ancestor
57119767|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57119768|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119769|NCT05709041|Anesthetics|anesthetics|mesh-list
57119770|NCT05709041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119771|NCT05709041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119772|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
57119773|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57119774|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57119775|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57119776|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801612|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
57119777|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
57119778|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119779|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119780|NCT03570281|Enoxaparin|enoxaparin|mesh-list
57119781|NCT03570281|Edoxaban|edoxaban|mesh-list
57119782|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
57119783|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57119784|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57119785|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119786|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57119787|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
57119788|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57119789|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
57119790|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119791|NCT02242799|Artesunate|artesunate|mesh-list
57119792|NCT02242799|Lumefantrine|lumefantrine|mesh-list
57119793|NCT02242799|Artemether|artemether|mesh-list
57119794|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57119795|NCT02242799|Amodiaquine|amodiaquine|mesh-list
57119796|NCT02242799|Dolutegravir|dolutegravir|mesh-list
57119797|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
57119798|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57119799|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57119800|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119801|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119802|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
57119803|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
57119804|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57119805|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
57119806|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57119807|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57119808|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119809|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119810|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57119811|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57119812|NCT02138383|Gemcitabine|gemcitabine|mesh-list
57119813|NCT02138383|Paclitaxel|paclitaxel|mesh-list
57119814|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57119815|NCT02138383|Androgens|androgens|mesh-list
57119816|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57119817|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119818|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
57119819|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
57119820|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
57119821|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119822|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57119823|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
57119824|NCT02138383|Antiviral Agents|antiviral agents|mesh-ancestor
57119825|NCT02138383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119826|NCT02138383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119827|NCT02138383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57119828|NCT02138383|Immunologic Factors|immunologic factors|mesh-ancestor
57119829|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119830|NCT02138383|Hormones|hormones|mesh-ancestor
57119831|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57119832|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
57119833|NCT02243735|Trace Elements|trace elements|mesh-ancestor
57119834|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
57119835|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119836|NCT02138539|Hydroquinone|hydroquinone|mesh-list
57119837|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
57119838|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119839|NCT02138539|Protective Agents|protective agents|mesh-ancestor
57119840|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119841|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57119842|NCT02252419|Acetaminophen|acetaminophen|mesh-list
57119843|NCT02252419|Dexamethasone|dexamethasone|mesh-list
57119844|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57119845|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
57119846|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
57119847|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119848|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119849|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57119850|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
57119851|NCT02252419|Hormones|hormones|mesh-ancestor
57119852|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57119853|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57119854|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119855|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57119856|NCT02252419|Analgesics|analgesics|mesh-ancestor
57119857|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
57119858|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
57119859|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
57119860|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57119861|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57119862|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119863|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
57119864|NCT02252497|Coagulants|coagulants|mesh-ancestor
57119865|NCT02138773|Tamsulosin|tamsulosin|mesh-list
57119866|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57119867|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57119868|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57119869|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
57119870|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119871|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119872|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119873|NCT02138773|Urological Agents|urological agents|mesh-ancestor
57119874|NCT01367275|Irinotecan|irinotecan|mesh-list
57119875|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57119876|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57119877|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119878|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119879|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119880|NCT02138929|Everolimus|everolimus|mesh-list
57119881|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57119882|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57119883|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
57119884|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119885|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
57119886|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57119887|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119888|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119889|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57119890|NCT02253199|Analgesics|analgesics|mesh-ancestor
57119891|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
57119892|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119893|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57119894|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57119895|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57119896|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
57119897|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119898|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119899|NCT02842853|Vaccines|vaccines|mesh-list
57119900|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
57119901|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119902|NCT02139241|Ramosetron|ramosetron|mesh-list
57119903|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
57119904|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
57119905|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119906|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119907|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57119908|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57119909|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
57119910|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119911|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119912|NCT03569579|Memantine|memantine|mesh-list
57119913|NCT03569579|Donepezil|donepezil|mesh-list
57119914|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57119915|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119916|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119917|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
57119918|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119919|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119920|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
57119921|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57119922|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57119923|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
57119924|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57119925|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57119926|NCT02130661|Itraconazole|itraconazole|mesh-list
57119927|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
57119928|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119929|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57119930|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57119931|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119932|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119933|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57119934|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
57119935|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57119936|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119937|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57119938|NCT02130739|Fentanyl|fentanyl|mesh-list
57119939|NCT02130739|Propofol|propofol|mesh-list
57119940|NCT02130739|Ropivacaine|ropivacaine|mesh-list
57119941|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
57119942|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119943|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119944|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57119945|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57119946|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
57119947|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
57119948|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
57119949|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119950|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57119951|NCT02130739|Narcotics|narcotics|mesh-ancestor
57119952|NCT02130739|Analgesics|analgesics|mesh-ancestor
57119953|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57119954|NCT02248493|Acetaminophen|acetaminophen|mesh-list
57119955|NCT02248493|Ketoprofen|ketoprofen|mesh-list
57119956|NCT02248493|Morphine|morphine|mesh-list
57119957|NCT02248493|Tramadol|tramadol|mesh-list
57119958|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57119959|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57119960|NCT02248493|Narcotics|narcotics|mesh-ancestor
57119961|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119962|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119963|NCT02248493|Analgesics|analgesics|mesh-ancestor
57119964|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
57119965|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119966|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57119967|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
57119968|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57119969|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57119970|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57119971|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57119972|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119973|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119974|NCT05577871|Dexmedetomidine|dexmedetomidine|mesh-list
57119975|NCT05577871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57119976|NCT05577871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57119977|NCT05577871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57119978|NCT05577871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57119979|NCT05577871|Analgesics|analgesics|mesh-ancestor
57119980|NCT05577871|Sensory System Agents|sensory system agents|mesh-ancestor
57119981|NCT05577871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57119982|NCT05577871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57119983|NCT05577871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57119984|NCT05577871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57119985|NCT05577871|Adrenergic Agents|adrenergic agents|mesh-ancestor
57119986|NCT05577871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57119987|NCT05577871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119988|NCT03140423|Mupirocin|mupirocin|mesh-list
57119989|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57119990|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57119991|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57119992|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57119993|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57119994|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
57119995|NCT02130817|Dexamethasone|dexamethasone|mesh-list
57119996|NCT02130817|Prednisone|prednisone|mesh-list
57119997|NCT02130817|Abatacept|abatacept|mesh-list
57119998|NCT02130817|Tacrolimus|tacrolimus|mesh-list
57119999|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
57120000|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57120001|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
57120002|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57120003|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
57120004|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
57120005|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57120006|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57120007|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
57120008|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
57120009|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120010|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120011|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57120012|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
57120013|NCT02130817|Hormones|hormones|mesh-ancestor
57120014|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120015|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57120016|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120017|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120018|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120019|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57120020|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
57120021|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57120022|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57120023|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57120024|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
57120025|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57120026|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120027|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57120028|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57120029|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
57120030|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
57120031|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57120032|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120033|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120034|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
57120035|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
57120036|NCT02130973|Denosumab|denosumab|mesh-list
57120037|NCT02130973|Teriparatide|teriparatide|mesh-list
57120038|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57120039|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120040|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57120041|NCT02456662|Ondansetron|ondansetron|mesh-list
57120042|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
57120043|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
57120044|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120045|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120046|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57120047|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
57120048|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
57120049|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57120050|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
57120051|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409251|NCT01877395|Vaccines|vaccines|mesh-list
57120052|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120053|NCT02456662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57120054|NCT02456662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57120055|NCT02456662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120056|NCT02456662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57120057|NCT02456662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57120058|NCT05577481|Antidepressive Agents|antidepressive agents|mesh-list
57120059|NCT05577481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57120060|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
57120061|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
57120062|NCT03548311|Vitamins|vitamins|mesh-ancestor
57120063|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
57120064|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120065|NCT01653262|Brivaracetam|brivaracetam|mesh-list
57120066|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
57120067|NCT02455336|Fenofibrate|fenofibrate|mesh-list
57120068|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57120069|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
57120070|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120071|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57120072|NCT02253121|Insulin|insulin|mesh-list
57120073|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57120074|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
57120075|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57120076|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120077|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57120078|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120079|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
57120080|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57120081|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
57120082|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120083|NCT03568721|Acetaminophen|acetaminophen|mesh-list
57120084|NCT03568721|Ibuprofen|ibuprofen|mesh-list
57120085|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57120086|NCT03568721|Analgesics|analgesics|mesh-ancestor
57120087|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
57120088|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120089|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120090|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
57120091|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57120092|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57120093|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57120094|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57120095|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120096|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120097|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
57120098|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57120099|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120100|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120101|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57120102|NCT03566303|Vitamin K|vitamin k|mesh-list
57120103|NCT03566303|Warfarin|warfarin|mesh-list
57120104|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
57120105|NCT03566303|Vitamins|vitamins|mesh-ancestor
57120106|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
57120107|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120108|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
57120109|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57120110|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
57120111|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57120112|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
57120113|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120114|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120115|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57120116|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57120117|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
57120118|NCT03566303|Coagulants|coagulants|mesh-ancestor
57120119|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57120120|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120121|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57120122|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120123|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120124|NCT03567941|Acetaminophen|acetaminophen|mesh-list
57120125|NCT03567941|Hydrocodone|hydrocodone|mesh-list
57120126|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57120127|NCT03567941|Analgesics|analgesics|mesh-ancestor
57120128|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
57120129|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120130|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120131|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
57120132|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57120133|NCT03567941|Narcotics|narcotics|mesh-ancestor
57120134|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120135|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
57120136|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
57120137|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57120138|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57120139|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57120140|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
57120141|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120142|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57120143|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57120144|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120145|NCT03566225|Metformin|metformin|mesh-list
57120146|NCT03566225|Pioglitazone|pioglitazone|mesh-list
57120147|NCT03566225|Clomiphene|clomiphene|mesh-list
57120148|NCT03566225|Enclomiphene|enclomiphene|mesh-list
57120149|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
57120150|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57120151|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120152|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57120153|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
57120154|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120155|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57120156|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
57120157|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56801990|NCT04004507|Phentolamine|phentolamine|mesh-list
57120158|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57120159|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57120160|NCT02397694|Dolutegravir|dolutegravir|mesh-list
57120161|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57120162|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57120163|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120164|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120165|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57120166|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57120167|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
57120168|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120169|NCT03566069|Oxytocin|oxytocin|mesh-list
57120170|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
57120171|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57120172|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120173|NCT04916548|Ketamine|ketamine|mesh-list
57120174|NCT04916548|Analgesics|analgesics|mesh-ancestor
57120175|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
57120176|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120177|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120178|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57120179|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57120180|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
57120181|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
57120182|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120183|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57120184|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57120185|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57120186|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120187|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
57120188|NCT03567629|Leucovorin|leucovorin|mesh-list
57120189|NCT03567629|Bevacizumab|bevacizumab|mesh-list
57120190|NCT03567629|Cetuximab|cetuximab|mesh-list
57120191|NCT03567629|Fluorouracil|fluorouracil|mesh-list
57120192|NCT03567629|Capecitabine|capecitabine|mesh-list
57120193|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
57120194|NCT03567629|Irinotecan|irinotecan|mesh-list
57120195|NCT03567629|Calcium|calcium|mesh-list
57120196|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
57120197|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120198|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409390|NCT00407927|Epinastine|epinastine|mesh-list
57120199|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57120200|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57120201|NCT03567629|Growth Substances|growth substances|mesh-ancestor
57120202|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120203|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
57120204|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57120205|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57120206|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
57120207|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120208|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57120209|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57120210|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
57120211|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57120212|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57120213|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120214|NCT03567629|Antidotes|antidotes|mesh-ancestor
57120215|NCT03567629|Protective Agents|protective agents|mesh-ancestor
57120216|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
57120217|NCT03567629|Vitamins|vitamins|mesh-ancestor
57120218|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
57120219|NCT02783599|Doxorubicin|doxorubicin|mesh-list
57120220|NCT02783599|Olaratumab|olaratumab|mesh-list
57120221|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57120222|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120223|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57120224|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57120225|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120226|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120227|NCT03567395|Melatonin|melatonin|mesh-list
57120228|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
57120229|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120230|NCT03567395|Protective Agents|protective agents|mesh-ancestor
56802134|NCT04573673|Emodin|emodin|mesh-list
57120231|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120232|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120233|NCT03565133|Quinine|quinine|mesh-list
57120234|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
57120235|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57120236|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57120237|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120238|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57120239|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120240|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57120241|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120242|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57120243|NCT03565133|Analgesics|analgesics|mesh-ancestor
57120244|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
57120245|NCT05353283|Tenofovir|tenofovir|mesh-list
57120246|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
57120247|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120248|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57120249|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57120250|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120251|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120252|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57120253|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57120254|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57120255|NCT05353673|Danazol|danazol|mesh-list
57120256|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57120257|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120258|NCT05353673|Incretins|incretins|mesh-ancestor
57120259|NCT05353673|Hormones|hormones|mesh-ancestor
57120260|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120261|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57120262|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
57120263|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120264|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120265|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57120266|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
57120267|NCT05353205|HH-GV-678|hh-gv-678|mesh-list
57120268|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57120269|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120270|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120271|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
57120272|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57120273|NCT03564509|Hormones|hormones|mesh-ancestor
57120274|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120275|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120276|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57120277|NCT02935634|Nivolumab|nivolumab|mesh-list
57120278|NCT02935634|Ipilimumab|ipilimumab|mesh-list
57120279|NCT02935634|Rucaparib|rucaparib|mesh-list
57120280|NCT02935634|Linrodostat|linrodostat|mesh-list
57120281|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120282|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120283|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57120284|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120285|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57120286|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120287|NCT03068234|Pirfenidone|pirfenidone|mesh-list
57120288|NCT03068234|Analgesics|analgesics|mesh-ancestor
57120289|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
57120290|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120291|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120292|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57120293|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57120294|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57120295|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57120296|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120297|NCT05339399|Oxytocin|oxytocin|mesh-list
57120298|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
57120299|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57120300|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120301|NCT04092179|Venetoclax|venetoclax|mesh-list
57120302|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120303|NCT05634824|Immunoglobulins|immunoglobulins|mesh-list
57120304|NCT05634824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57120305|NCT05634824|Antibodies|antibodies|mesh-list
57120306|NCT05634824|gamma-Globulins|gamma-globulins|mesh-list
57120307|NCT05634824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57120308|NCT05634824|Immunologic Factors|immunologic factors|mesh-ancestor
57120309|NCT05634824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120310|NCT02454478|Everolimus|everolimus|mesh-list
57120311|NCT02454478|Lenvatinib|lenvatinib|mesh-list
57120312|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120313|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57120314|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
57120315|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120316|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57120317|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120318|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120319|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57120320|NCT02359097|Hematinics|hematinics|mesh-ancestor
57120321|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57120322|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57120323|NCT04078295|Nivolumab|nivolumab|mesh-list
57120324|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120325|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120326|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57120327|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120328|NCT05284214|Ipilimumab|ipilimumab|mesh-list
57120329|NCT05284214|Sargramostim|sargramostim|mesh-list
57120330|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120331|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120332|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57120333|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120334|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
57120335|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120336|NCT03563963|Lidocaine|lidocaine|mesh-list
57120337|NCT03563963|Ropivacaine|ropivacaine|mesh-list
57120338|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57120339|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
57120340|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
57120341|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120342|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120343|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
57120344|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120345|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57120346|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57120347|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57120348|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57120349|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120350|NCT03066518|Melatonin|melatonin|mesh-list
57120351|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
57120352|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120353|NCT03066518|Protective Agents|protective agents|mesh-ancestor
57120354|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120355|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120356|NCT03069248|Interferons|interferons|mesh-list
57120357|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
57120358|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
57120359|NCT03069248|Rituximab|rituximab|mesh-list
57120360|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120361|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120362|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
57120363|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120364|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57120365|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
57120366|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120367|NCT05730062|Oxycodone|oxycodone|mesh-list
57120368|NCT05730062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57120369|NCT05730062|Narcotics|narcotics|mesh-ancestor
57120370|NCT05730062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120371|NCT05730062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120372|NCT05730062|Analgesics|analgesics|mesh-ancestor
57120373|NCT05730062|Sensory System Agents|sensory system agents|mesh-ancestor
57120374|NCT05730062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120375|NCT03068936|Cisplatin|cisplatin|mesh-list
57120376|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120377|NCT05017610|Lomustine|lomustine|mesh-list
57120378|NCT05017610|Methimazole|methimazole|mesh-list
57120379|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57120380|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
57120381|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120382|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120383|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
57120384|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
56802216|NCT00358917|Ritonavir|ritonavir|mesh-list
57120385|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120386|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120387|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
57120388|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57120389|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
57120390|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120391|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120392|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
57120393|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120394|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120396|NCT05004116|Temozolomide|temozolomide|mesh-list
57120397|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57120398|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57120399|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120400|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120401|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120402|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57120403|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
57120404|NCT02452762|Vitamin D|vitamin d|mesh-list
57120405|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
57120406|NCT02452762|Vitamins|vitamins|mesh-ancestor
57120407|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
57120408|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120409|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57120410|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57120411|NCT04977830|Xenon|xenon|mesh-list
57120412|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57120413|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
57120414|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
57120415|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120416|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120417|NCT04972292|Dipyrone|dipyrone|mesh-list
57120418|NCT04972292|Codeine|codeine|mesh-list
57120419|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57120420|NCT04972292|Narcotics|narcotics|mesh-ancestor
57120421|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120422|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120423|NCT04972292|Analgesics|analgesics|mesh-ancestor
57120424|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
57120425|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120426|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
57120427|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
57120428|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57120429|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57120430|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57120431|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57120432|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
57120433|NCT04943900|Nivolumab|nivolumab|mesh-list
57120434|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120435|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120436|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57120437|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120438|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
57120439|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57120440|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120441|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
57120442|NCT05633420|Artesunate|artesunate|mesh-list
57120443|NCT05633420|Pyronaridine|pyronaridine|mesh-list
57120444|NCT05633420|Antimalarials|antimalarials|mesh-ancestor
57120445|NCT05633420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57120446|NCT05633420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57120447|NCT05633420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120448|NCT05633420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120449|NCT05633420|Antiviral Agents|antiviral agents|mesh-ancestor
57120450|NCT05633420|Schistosomicides|schistosomicides|mesh-ancestor
57120451|NCT05633420|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57120452|NCT05633420|Anthelmintics|anthelmintics|mesh-ancestor
57120453|NCT05729594|Bimatoprost|bimatoprost|mesh-list
57120454|NCT05729594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57120455|NCT05729282|Diazoxide|diazoxide|mesh-list
57120456|NCT05729282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57120457|NCT05729282|Vasodilator Agents|vasodilator agents|mesh-ancestor
57120458|NCT02631746|Nivolumab|nivolumab|mesh-list
57120459|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120460|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120461|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57120462|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120463|NCT04699058|Antibodies|antibodies|mesh-list
57120464|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
57120465|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120466|NCT04626128|Aflibercept|aflibercept|mesh-list
57120467|NCT04626128|Axitinib|axitinib|mesh-list
57120468|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57120469|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57120470|NCT04626128|Growth Substances|growth substances|mesh-ancestor
57120471|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120472|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
57120473|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120474|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57120475|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120476|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120477|NCT05487092|Letrozole|letrozole|mesh-list
57120478|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120479|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57120480|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57120481|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120482|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120483|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57120484|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
57120485|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120486|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120487|NCT05728892|Melatonin|melatonin|mesh-list
57120488|NCT05728892|Antioxidants|antioxidants|mesh-ancestor
57120489|NCT05728892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120490|NCT05728892|Protective Agents|protective agents|mesh-ancestor
57120491|NCT05728892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120492|NCT05728892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120493|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
57120494|NCT05478278|Psilocybin|psilocybin|mesh-list
57120495|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57120496|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120497|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57120498|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57120499|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120500|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120501|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120502|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120503|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
57120504|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57120505|NCT03067688|Amlodipine|amlodipine|mesh-list
57120506|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
57120507|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57120508|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57120509|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57120510|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57120511|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120512|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57120513|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120514|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
57120515|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57120516|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57120517|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
57120518|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57120519|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57120520|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120521|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57120522|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57120523|NCT02396758|Plasminogen|plasminogen|mesh-list
57120524|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57120525|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57120526|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57120527|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120528|NCT05728424|Amoxicillin|amoxicillin|mesh-list
57120529|NCT05728424|Levofloxacin|levofloxacin|mesh-list
57120530|NCT05728424|Ofloxacin|ofloxacin|mesh-list
57120531|NCT05728424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57120532|NCT05728424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120533|NCT05728424|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57120534|NCT05728424|Renal Agents|renal agents|mesh-ancestor
56802360|NCT02534337|Leucovorin|leucovorin|mesh-list
57120535|NCT05728424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57120536|NCT05728424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57120537|NCT05728424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120538|NCT05728424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120539|NCT05728424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120540|NCT05728424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57120541|NCT05728424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57120542|NCT05728346|Hyaluronic Acid|hyaluronic acid|mesh-list
57120543|NCT05728346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57120544|NCT05728346|Immunologic Factors|immunologic factors|mesh-ancestor
57120545|NCT05728346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120546|NCT05728346|Viscosupplements|viscosupplements|mesh-ancestor
57120547|NCT05728346|Protective Agents|protective agents|mesh-ancestor
57120548|NCT05515796|Trastuzumab|trastuzumab|mesh-list
57120549|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120550|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120551|NCT05728268|Paclitaxel|paclitaxel|mesh-list
57120552|NCT05728268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57120553|NCT05728268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120554|NCT05728268|Tubulin Modulators|tubulin modulators|mesh-ancestor
57120555|NCT05728268|Antimitotic Agents|antimitotic agents|mesh-ancestor
57120556|NCT05728268|Mitosis Modulators|mitosis modulators|mesh-ancestor
57120557|NCT05728268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120558|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
57120559|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
57120560|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120561|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57120562|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120563|NCT04926844|Midazolam|midazolam|mesh-list
57120564|NCT04926844|Levetiracetam|levetiracetam|mesh-list
57120565|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57120566|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57120567|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120568|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120569|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57120570|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57120571|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57120572|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57120573|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
57120574|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
57120575|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
57120576|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
57120577|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57120578|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120579|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
57120580|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
57120581|NCT05482256|Listerine|listerine|mesh-list
57120582|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
57120583|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
57120584|NCT05482256|Protective Agents|protective agents|mesh-ancestor
57120585|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120586|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57120587|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120588|NCT01651936|Methotrexate|methotrexate|mesh-list
57120589|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57120590|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
57120591|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57120592|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120593|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57120594|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
57120595|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120596|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120597|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
57120598|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120599|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57120600|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57120601|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
57120602|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57120603|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57120604|NCT04225598|Buprenorphine|buprenorphine|mesh-list
57120605|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57120606|NCT04225598|Narcotics|narcotics|mesh-ancestor
57120607|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120608|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802448|NCT00541775|Metformin|metformin|mesh-list
57120609|NCT04225598|Analgesics|analgesics|mesh-ancestor
57120610|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
57120611|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120612|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57120613|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
57120614|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
57120615|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120616|NCT03065504|Turmeric extract|turmeric extract|mesh-list
57120617|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
57120618|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120619|NCT03065504|Protective Agents|protective agents|mesh-ancestor
57120620|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120621|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57120622|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
57120623|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57120624|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
57120625|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57120626|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120627|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57120628|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57120629|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120630|NCT02630966|Vedolizumab|vedolizumab|mesh-list
57120631|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57120632|NCT05724212|Interferons|interferons|mesh-list
57120633|NCT05724212|Interferon-gamma|interferon-gamma|mesh-list
57120634|NCT05724212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120635|NCT05724212|Antiviral Agents|antiviral agents|mesh-ancestor
57120636|NCT05724212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120637|NCT05723588|Nicotine|nicotine|mesh-list
57120638|NCT05723588|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57120639|NCT05723588|Autonomic Agents|autonomic agents|mesh-ancestor
57120640|NCT05723588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120641|NCT05723588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120642|NCT05723588|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57120643|NCT05723588|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57120644|NCT05723588|Cholinergic Agents|cholinergic agents|mesh-ancestor
57120645|NCT05723588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57120646|NCT05723588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120647|NCT01651780|Heparin|heparin|mesh-list
57120648|NCT01651780|Calcium heparin|calcium heparin|mesh-list
57120649|NCT01651780|Bivalirudin|bivalirudin|mesh-list
57120650|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
57120651|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57120652|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57120653|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120654|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
57120655|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57120656|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
57120657|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120658|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57120659|NCT05403476|Hormones|hormones|mesh-ancestor
57120660|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120661|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120662|NCT02394730|Vorapaxar|vorapaxar|mesh-list
57120663|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57120664|NCT05376878|Copper|copper|mesh-list
57120665|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57120666|NCT05376878|Trastuzumab|trastuzumab|mesh-list
57120667|NCT05376878|Camptothecin|camptothecin|mesh-list
57120668|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
57120669|NCT05376878|Antibodies|antibodies|mesh-list
57120670|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
57120671|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57120672|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
57120673|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
57120674|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120675|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120676|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120677|NCT05376878|Trace Elements|trace elements|mesh-ancestor
57120678|NCT05376878|Micronutrients|micronutrients|mesh-ancestor
57120679|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57120680|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57120681|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57120682|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120683|NCT05362760|Fulvestrant|fulvestrant|mesh-list
57120684|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
57120685|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57120686|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120687|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57120688|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57120689|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
57120690|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120691|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120692|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57120693|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120694|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120695|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57120696|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
57120697|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57120698|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
57120699|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120700|NCT05357612|Pimavanserin|pimavanserin|mesh-list
57120701|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57120702|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57120703|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57120704|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57120705|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120706|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120707|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57120708|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57120709|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57120710|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
57120711|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57120712|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120713|NCT02394340|Luliconazole|luliconazole|mesh-list
57120714|NCT02394340|Omeprazole|omeprazole|mesh-list
57120715|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57120716|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57120717|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57120718|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120719|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120720|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
57120721|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120722|NCT01672736|Dexamethasone|dexamethasone|mesh-list
57120723|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
57120724|NCT01672736|Bortezomib|bortezomib|mesh-list
57120725|NCT01672736|BB 1101|bb 1101|mesh-list
57120726|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57120727|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
57120728|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
57120729|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120730|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120731|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57120732|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
57120733|NCT01672736|Hormones|hormones|mesh-ancestor
57120734|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120735|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57120736|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120737|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
57120738|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120739|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120740|NCT05645900|Vaccines|vaccines|mesh-list
57120741|NCT05645900|Immunologic Factors|immunologic factors|mesh-ancestor
57120742|NCT05645900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120743|NCT03065660|Mifepristone|mifepristone|mesh-list
57120744|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57120745|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
57120746|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57120747|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120748|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57120749|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57120750|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57120751|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
57120752|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57120753|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57120754|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
57120755|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120756|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
56802588|NCT02404337|Betaine|betaine|mesh-list
57120757|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57120758|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57120759|NCT03893630|Aspirin|aspirin|mesh-list
57120760|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57120761|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57120762|NCT03893630|Analgesics|analgesics|mesh-ancestor
57120763|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
57120764|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120765|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120766|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57120767|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57120768|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57120769|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57120770|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120771|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57120772|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57120773|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120774|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
57120775|NCT03866174|Niacin|niacin|mesh-list
57120776|NCT03866174|Psilocybin|psilocybin|mesh-list
57120777|NCT03866174|Vitamins|vitamins|mesh-ancestor
57120778|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
57120779|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120780|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
57120781|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57120782|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
57120783|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120784|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57120785|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
57120786|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
57120787|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57120788|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
57120789|NCT03065816|Antacids|antacids|mesh-ancestor
57120790|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120791|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57120792|NCT05633654|Pembrolizumab|pembrolizumab|mesh-list
57120793|NCT05633654|Capecitabine|capecitabine|mesh-list
57120794|NCT05633654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120795|NCT05633654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120796|NCT05633654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57120797|NCT05633654|Antimetabolites|antimetabolites|mesh-ancestor
57120798|NCT05633654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120799|NCT05289908|Folic Acid|folic acid|mesh-list
57120800|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
57120801|NCT05289908|Dexamethasone|dexamethasone|mesh-list
57120802|NCT05289908|Pemetrexed|pemetrexed|mesh-list
57120803|NCT05289908|Vitamins|vitamins|mesh-ancestor
57120804|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
57120805|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120806|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57120807|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
57120808|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
57120809|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120810|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57120811|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
57120812|NCT05289908|Hormones|hormones|mesh-ancestor
57120813|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120814|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57120815|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120816|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120817|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120818|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57120819|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57120820|NCT05289908|Hematinics|hematinics|mesh-ancestor
57120821|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
57120822|NCT05619848|Midazolam|midazolam|mesh-list
57120823|NCT05619848|Remifentanil|remifentanil|mesh-list
57120824|NCT05619848|Bromides|bromides|mesh-list
57120825|NCT05619848|Propofol|propofol|mesh-list
57120826|NCT05619848|Etomidate|etomidate|mesh-list
57120827|NCT05619848|Rocuronium|rocuronium|mesh-list
57120828|NCT05619848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57120829|NCT05619848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120830|NCT05619848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120831|NCT05619848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57120832|NCT05619848|Anesthetics, General|anesthetics, general|mesh-ancestor
57120833|NCT05619848|Anesthetics|anesthetics|mesh-ancestor
57120834|NCT05619848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57120835|NCT05619848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57120836|NCT05619848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57120837|NCT05619848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57120838|NCT05619848|GABA Modulators|gaba modulators|mesh-ancestor
57120839|NCT05619848|GABA Agents|gaba agents|mesh-ancestor
57120840|NCT05619848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57120841|NCT05619848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120842|NCT05619848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57120843|NCT05619848|Narcotics|narcotics|mesh-ancestor
57120844|NCT05619848|Analgesics|analgesics|mesh-ancestor
57120845|NCT05619848|Sensory System Agents|sensory system agents|mesh-ancestor
57120846|NCT05619848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120847|NCT05619848|Anticonvulsants|anticonvulsants|mesh-ancestor
57120848|NCT05619848|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57120849|NCT05619848|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57120850|NCT05619848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57120851|NCT01560637|Treprostinil|treprostinil|mesh-list
57120852|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57120853|NCT04447352|Leucovorin|leucovorin|mesh-list
57120854|NCT04447352|Docetaxel|docetaxel|mesh-list
57120855|NCT04447352|Fluorouracil|fluorouracil|mesh-list
57120856|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
57120857|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120858|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
57120859|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
57120860|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
57120861|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120862|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
57120863|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57120864|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57120865|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
57120866|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120867|NCT04447352|Antidotes|antidotes|mesh-ancestor
57120868|NCT04447352|Protective Agents|protective agents|mesh-ancestor
57120869|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
57120870|NCT04447352|Vitamins|vitamins|mesh-ancestor
57120871|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
57120872|NCT04157036|Ibuprofen|ibuprofen|mesh-list
57120873|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
57120874|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57120875|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57120876|NCT04157036|Prednisolone|prednisolone|mesh-list
57120877|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
57120878|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57120879|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
57120880|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57120881|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57120882|NCT04157036|Analgesics|analgesics|mesh-ancestor
57120883|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
57120884|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57120885|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120886|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57120887|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57120888|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57120889|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120890|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120891|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
57120892|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
57120893|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57120894|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
57120895|NCT04157036|Hormones|hormones|mesh-ancestor
57120896|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57120897|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57120898|NCT04157036|Protective Agents|protective agents|mesh-ancestor
57120899|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57120900|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120901|NCT03547375|Apatinib|apatinib|mesh-list
57120902|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120903|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57120904|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120905|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120906|NCT01353911|Interferons|interferons|mesh-list
57120907|NCT01353911|Ribavirin|ribavirin|mesh-list
57120908|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
57120909|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
56802743|NCT00367341|Citalopram|citalopram|mesh-list
57120910|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57120911|NCT01353911|Grazoprevir|grazoprevir|mesh-list
57120912|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120913|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
57120914|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120915|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
57120916|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120917|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
57120918|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120919|NCT05575297|Rifampin|rifampin|mesh-list
57120920|NCT05575297|Methotrexate|methotrexate|mesh-list
57120921|NCT05575297|Febuxostat|febuxostat|mesh-list
57120922|NCT05575297|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57120923|NCT05575297|Abortifacient Agents|abortifacient agents|mesh-ancestor
57120924|NCT05575297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57120925|NCT05575297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120926|NCT05575297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57120927|NCT05575297|Antimetabolites|antimetabolites|mesh-ancestor
57120928|NCT05575297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120929|NCT05575297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120930|NCT05575297|Dermatologic Agents|dermatologic agents|mesh-ancestor
57120931|NCT05575297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120932|NCT05575297|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57120933|NCT05575297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57120934|NCT05575297|Immunologic Factors|immunologic factors|mesh-ancestor
57120935|NCT05575297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57120936|NCT05575297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57120937|NCT05575297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57120938|NCT05575297|Antitubercular Agents|antitubercular agents|mesh-ancestor
57120939|NCT05575297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57120940|NCT05575297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57120941|NCT05575297|Leprostatic Agents|leprostatic agents|mesh-ancestor
57120942|NCT05575297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57120943|NCT05575297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57120944|NCT05575297|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57120945|NCT05575297|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57120946|NCT05575297|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57120947|NCT05575297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57120948|NCT05575297|Gout Suppressants|gout suppressants|mesh-ancestor
57120949|NCT01671488|Mitomycins|mitomycins|mesh-list
57120950|NCT01671488|Mitomycin|mitomycin|mesh-list
57120951|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57120952|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120953|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
57120954|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120955|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57120956|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120957|NCT05400889|Tofacitinib|tofacitinib|mesh-list
57120958|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57120959|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120960|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120961|NCT05395117|Digoxin|digoxin|mesh-list
57120962|NCT05395117|Midazolam|midazolam|mesh-list
57120963|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57120964|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57120965|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57120966|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57120967|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120968|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57120969|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57120970|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57120971|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57120972|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
57120973|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
57120974|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
57120975|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
57120976|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57120977|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57120978|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57120979|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57120980|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
57120981|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57120982|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57120983|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57120984|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57120985|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57120986|NCT05395117|Protective Agents|protective agents|mesh-ancestor
57120987|NCT05325229|Bevacizumab|bevacizumab|mesh-list
57120988|NCT05325229|Docetaxel|docetaxel|mesh-list
57120989|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57120990|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57120991|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57120992|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57120993|NCT05325229|Growth Substances|growth substances|mesh-ancestor
57120994|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57120995|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
57120996|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
57120997|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
57120998|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
57120999|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121000|NCT05573581|Botulinum Toxins|botulinum toxins|mesh-list
57121001|NCT05573581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57121002|NCT05573581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57121003|NCT05573581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57121004|NCT05573581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57121005|NCT05573581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121006|NCT05573581|Cholinergic Agents|cholinergic agents|mesh-ancestor
57121007|NCT05573581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121008|NCT05573581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121009|NCT05573581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57121010|NCT05573581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121011|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
57121012|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57121013|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57121014|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57121015|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121016|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57121017|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57121018|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57121019|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57121020|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
57121021|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121022|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121023|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57121024|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57121025|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
57121026|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57121027|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57121028|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
57121029|NCT05573425|Tazarotene|tazarotene|mesh-list
57121030|NCT05573425|Dermatologic Agents|dermatologic agents|mesh-ancestor
57121031|NCT05573425|Keratolytic Agents|keratolytic agents|mesh-ancestor
57121032|NCT02253901|Ritonavir|ritonavir|mesh-list
57121033|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57121034|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57121035|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57121036|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
57121037|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121038|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121039|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57121040|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57121041|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
57121042|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121043|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57121044|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57121045|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57121046|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57121047|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
57121048|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57121049|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57121050|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121051|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121052|NCT03546283|Protective Agents|protective agents|mesh-ancestor
57121053|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121054|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57121055|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57121056|NCT04940546|Bevacizumab|bevacizumab|mesh-list
57121057|NCT04940546|Capecitabine|capecitabine|mesh-list
57121058|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
57121059|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57121060|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121061|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57121062|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57121063|NCT04940546|Growth Substances|growth substances|mesh-ancestor
57121064|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121065|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
57121066|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121067|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
57121068|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121069|NCT03547219|Citalopram|citalopram|mesh-list
57121070|NCT03547219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57121071|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57121072|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57121073|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121074|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121075|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
57121076|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121077|NCT03547219|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57121078|NCT03547219|Antidepressive Agents|antidepressive agents|mesh-ancestor
57121079|NCT03547219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57121080|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
57121081|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57121082|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
57121083|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121084|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
57121085|NCT05188898|Protective Agents|protective agents|mesh-ancestor
57121086|NCT04116320|Poly ICLC|poly iclc|mesh-list
57121087|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
57121088|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
57121089|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121090|NCT04069819|Cilostazol|cilostazol|mesh-list
57121091|NCT04069819|Citalopram|citalopram|mesh-list
57121092|NCT04069819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57121093|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57121094|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57121095|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121096|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121097|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
57121098|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121099|NCT04069819|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57121100|NCT04069819|Antidepressive Agents|antidepressive agents|mesh-ancestor
57121101|NCT04069819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57121102|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
57121103|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121104|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57121105|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57121106|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
57121107|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57121108|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57121109|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57121110|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
57121111|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57121112|NCT04069819|Protective Agents|protective agents|mesh-ancestor
57121113|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57121114|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57121115|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121116|NCT04084496|Folfirinox|folfirinox|mesh-list
57121117|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121118|NCT04433156|Prednisone|prednisone|mesh-list
57121119|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
57121120|NCT04433156|Rituximab|rituximab|mesh-list
57121121|NCT04433156|Bortezomib|bortezomib|mesh-list
57121122|NCT04433156|Epirubicin|epirubicin|mesh-list
57121123|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121124|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
57121125|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121126|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121127|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57121128|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
57121129|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121130|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121131|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57121132|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57121133|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57121134|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
57121135|NCT04433156|Hormones|hormones|mesh-ancestor
57121136|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121137|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121138|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57121139|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57121140|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57121141|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121142|NCT02831855|Methotrexate|methotrexate|mesh-list
57121143|NCT02831855|Tofacitinib|tofacitinib|mesh-list
57121144|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57121145|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
57121146|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57121147|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121148|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121149|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
57121150|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121151|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121152|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
57121153|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121154|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57121155|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121156|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
57121157|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121158|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57121159|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57121160|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
57121161|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57121162|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121163|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57121164|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121165|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
57121166|NCT01356407|Cathartics|cathartics|mesh-ancestor
57121167|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121168|NCT05289323|Neostigmine|neostigmine|mesh-list
57121169|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57121170|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121171|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121172|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
57121173|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121174|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121175|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57121176|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
57121177|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121178|NCT00109837|Leucovorin|leucovorin|mesh-list
57121179|NCT00109837|Cytarabine|cytarabine|mesh-list
57121180|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57121181|NCT00109837|Dexamethasone|dexamethasone|mesh-list
57121182|NCT00109837|Prednisone|prednisone|mesh-list
57121183|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
57121184|NCT00109837|Doxorubicin|doxorubicin|mesh-list
57121185|NCT00109837|Methotrexate|methotrexate|mesh-list
57121186|NCT00109837|Vincristine|vincristine|mesh-list
57121187|NCT00109837|Daunorubicin|daunorubicin|mesh-list
57121188|NCT00109837|Asparaginase|asparaginase|mesh-list
57121189|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
57121190|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
57121191|NCT00109837|Thioguanine|thioguanine|mesh-list
57121192|NCT00109837|Allopurinol|allopurinol|mesh-list
57121193|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121194|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
57121195|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121196|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121197|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57121198|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
57121199|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121200|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121201|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57121202|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57121203|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
57121204|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
57121205|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902171|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
57121206|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121207|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
57121208|NCT00109837|Hormones|hormones|mesh-ancestor
57121209|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121210|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121211|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57121212|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57121213|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57121214|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121215|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57121216|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
57121217|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57121218|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121219|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
57121220|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
57121221|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57121222|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57121223|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
57121224|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121225|NCT00109837|Antidotes|antidotes|mesh-ancestor
57121226|NCT00109837|Protective Agents|protective agents|mesh-ancestor
57121227|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
57121228|NCT00109837|Vitamins|vitamins|mesh-ancestor
57121229|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
57121230|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57121231|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
57121232|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
57121233|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121234|NCT00109837|Analgesics|analgesics|mesh-ancestor
57121235|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
57121236|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
57121237|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57121238|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
57121239|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57121240|NCT00109837|Renal Agents|renal agents|mesh-ancestor
57121241|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57121242|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
57121243|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57121244|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57121245|NCT05229445|Insulin|insulin|mesh-list
57121246|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57121247|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121248|NCT01671332|Suramin|suramin|mesh-list
57121249|NCT01671332|Docetaxel|docetaxel|mesh-list
57121250|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121251|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
57121252|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
57121253|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121254|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121255|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
57121256|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
57121257|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57121258|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121259|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57121260|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57121261|NCT03063242|Sargramostim|sargramostim|mesh-list
57121262|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
57121263|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121264|NCT04824092|Prednisone|prednisone|mesh-list
57121265|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
57121266|NCT04824092|Rituximab|rituximab|mesh-list
57121267|NCT04824092|Doxorubicin|doxorubicin|mesh-list
57121268|NCT04824092|Vincristine|vincristine|mesh-list
57121269|NCT04824092|Lenalidomide|lenalidomide|mesh-list
57121270|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121271|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
57121272|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121273|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121274|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57121275|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
57121276|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121277|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121278|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57121279|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57121280|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56902173|NCT01316445|Midazolam|midazolam|mesh-list
57121281|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57121282|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57121283|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121284|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57121285|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
57121286|NCT04824092|Hormones|hormones|mesh-ancestor
57121287|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121288|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121289|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57121290|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
57121291|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
57121292|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121293|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57121294|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57121295|NCT04824092|Growth Substances|growth substances|mesh-ancestor
57121296|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
57121298|NCT05085002|Fulvestrant|fulvestrant|mesh-list
57121299|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121300|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57121301|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57121302|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121303|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121304|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57121305|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
57121306|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121307|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121308|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121309|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57121310|NCT03897062|Suvorexant|suvorexant|mesh-list
57121311|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57121312|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57121313|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57121314|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121315|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57121316|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121317|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121318|NCT05048264|Dexamethasone|dexamethasone|mesh-list
57121319|NCT05048264|Methylprednisolone|methylprednisolone|mesh-list
57121320|NCT05048264|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57121321|NCT05048264|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57121322|NCT05048264|Prednisolone|prednisolone|mesh-list
57121323|NCT05048264|Prednisolone acetate|prednisolone acetate|mesh-list
57121324|NCT05048264|Triamcinolone|triamcinolone|mesh-list
57121325|NCT05048264|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57121326|NCT05048264|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57121327|NCT05048264|Betamethasone|betamethasone|mesh-list
57121328|NCT05048264|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57121329|NCT05048264|Prednisolone phosphate|prednisolone phosphate|mesh-list
57121330|NCT05048264|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57121331|NCT05048264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57121332|NCT05048264|Antiemetics|antiemetics|mesh-ancestor
57121333|NCT05048264|Autonomic Agents|autonomic agents|mesh-ancestor
57121334|NCT05048264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121335|NCT05048264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121336|NCT05048264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121337|NCT05048264|Glucocorticoids|glucocorticoids|mesh-ancestor
57121338|NCT05048264|Hormones|hormones|mesh-ancestor
57121339|NCT05048264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121340|NCT05048264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121341|NCT05048264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121342|NCT05048264|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57121343|NCT05048264|Protective Agents|protective agents|mesh-ancestor
57121344|NCT05048264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121345|NCT05048264|Immunologic Factors|immunologic factors|mesh-ancestor
57121346|NCT05048264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121347|NCT05048264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121348|NCT05048264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57121349|NCT05048264|Respiratory System Agents|respiratory system agents|mesh-ancestor
57121350|NCT05046314|Vincristine|vincristine|mesh-list
57121351|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57121352|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121353|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
57121354|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
57121355|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121356|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121357|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
57121358|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57121359|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121360|NCT00100802|Temozolomide|temozolomide|mesh-list
57121361|NCT00100802|Lomustine|lomustine|mesh-list
57121362|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57121363|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
57121364|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121365|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121366|NCT01355159|Folic Acid|folic acid|mesh-list
57121367|NCT01355159|Hematinics|hematinics|mesh-ancestor
57121368|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
57121369|NCT01355159|Vitamins|vitamins|mesh-ancestor
57121370|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
57121371|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121372|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
57121373|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57121374|NCT04703036|Glycine|glycine|mesh-list
57121375|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
57121376|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121377|NCT04703036|Expectorants|expectorants|mesh-ancestor
57121378|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
57121379|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57121380|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
57121381|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121382|NCT04703036|Protective Agents|protective agents|mesh-ancestor
57121383|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121384|NCT04703036|Antidotes|antidotes|mesh-ancestor
57121385|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
57121386|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121387|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
57121388|NCT04661852|Topotecan|topotecan|mesh-list
57121389|NCT04661852|Mitogens|mitogens|mesh-list
57121390|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121391|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
57121392|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121393|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121394|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57121395|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
57121396|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121397|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121398|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57121399|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57121400|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57121401|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121402|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121403|NCT02630186|Atezolizumab|atezolizumab|mesh-list
57121404|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121405|NCT00002462|Cobalt|cobalt|mesh-list
57121406|NCT00002462|Prednisone|prednisone|mesh-list
57121407|NCT00002462|Doxorubicin|doxorubicin|mesh-list
57121408|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57121409|NCT00002462|Bleomycin|bleomycin|mesh-list
57121410|NCT00002462|Vincristine|vincristine|mesh-list
57121411|NCT00002462|Vinblastine|vinblastine|mesh-list
57121412|NCT00002462|Procarbazine|procarbazine|mesh-list
57121413|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
57121414|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57121415|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121416|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57121417|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57121418|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121419|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121420|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57121421|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
57121422|NCT00002462|Hormones|hormones|mesh-ancestor
57121423|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121424|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121425|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121426|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57121427|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
57121428|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
57121429|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121430|NCT00002462|Trace Elements|trace elements|mesh-ancestor
57121431|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
57121432|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
57121433|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57121434|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
57121435|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
56803281|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
57121436|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
57121437|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57121438|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
57121439|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57121440|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121441|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121442|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
57121443|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121444|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57121445|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57121446|NCT01995578|Azacitidine|azacitidine|mesh-list
57121447|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121448|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
57121449|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121450|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121451|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121452|NCT04440176|Vaccines|vaccines|mesh-list
57121453|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
57121454|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121455|NCT03595592|Paclitaxel|paclitaxel|mesh-list
57121456|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57121457|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
57121458|NCT03595592|Carboplatin|carboplatin|mesh-list
57121459|NCT03595592|Doxorubicin|doxorubicin|mesh-list
57121460|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57121461|NCT03595592|Trastuzumab|trastuzumab|mesh-list
57121462|NCT03595592|Atezolizumab|atezolizumab|mesh-list
57121463|NCT03595592|Pertuzumab|pertuzumab|mesh-list
57121464|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57121465|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121466|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
57121467|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
57121468|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121469|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121470|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121471|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
57121472|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121473|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121474|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57121475|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
57121476|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57121477|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57121478|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57121479|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57121480|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121481|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57121482|NCT01355081|Vortioxetine|vortioxetine|mesh-list
57121483|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
57121484|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57121485|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57121486|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57121487|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57121488|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121489|NCT01355081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57121490|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57121491|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57121492|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121493|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121494|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
57121495|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57121496|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57121497|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57121498|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57121499|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57121500|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
57121501|NCT02259959|Olodaterol|olodaterol|mesh-list
57121502|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57121503|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
57121504|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121505|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121506|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57121507|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
57121508|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
57121509|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57121510|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
57121511|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121512|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121513|NCT03062462|Clopidogrel|clopidogrel|mesh-list
57121514|NCT03062462|Ticagrelor|ticagrelor|mesh-list
57121515|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57121516|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57121517|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57121518|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57121519|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
57121520|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121521|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121522|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121523|NCT04433078|Doxycycline|doxycycline|mesh-list
57121524|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57121525|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121526|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
57121527|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57121528|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57121529|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
57121530|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121531|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57121532|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121533|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121534|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
57121535|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121536|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121537|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57121538|NCT05212571|Ketamine|ketamine|mesh-list
57121539|NCT05212571|Esketamine|esketamine|mesh-list
57121540|NCT05212571|Analgesics|analgesics|mesh-ancestor
57121541|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
57121542|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121543|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121544|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57121545|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57121546|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
57121547|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
57121548|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57121549|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57121550|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57121551|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121552|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121553|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
57121554|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57121555|NCT04368533|Fluorides|fluorides|mesh-list
57121556|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
57121557|NCT04368533|Protective Agents|protective agents|mesh-ancestor
57121558|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121559|NCT04002271|Propofol|propofol|mesh-list
57121560|NCT04002271|Sevoflurane|sevoflurane|mesh-list
57121561|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
57121562|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57121563|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121564|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57121565|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57121566|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
57121567|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57121568|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57121569|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57121570|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57121571|NCT02627144|Interferons|interferons|mesh-list
57121572|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
57121573|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
57121574|NCT02627144|Bevacizumab|bevacizumab|mesh-list
57121575|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57121576|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121577|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57121578|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57121579|NCT02627144|Growth Substances|growth substances|mesh-ancestor
57121580|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121581|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
57121582|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
57121583|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121584|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
57121585|NCT04586335|Olaparib|olaparib|mesh-list
57121586|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57121587|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803424|NCT04002635|Progestins|progestins|mesh-ancestor
57121588|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121589|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121590|NCT04981886|Bimatoprost|bimatoprost|mesh-list
57121591|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57121592|NCT03900637|Letrozole|letrozole|mesh-list
57121593|NCT03900637|Leuprolide|leuprolide|mesh-list
57121594|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121595|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57121596|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57121597|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121598|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121599|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57121600|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
57121601|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121602|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121603|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57121604|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
57121605|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57121606|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121607|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57121608|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
57121609|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121610|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
57121611|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
57121612|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
57121613|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57121614|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121615|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
57121616|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121617|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
57121618|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57121619|NCT03493178|Glycine|glycine|mesh-list
57121620|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
57121621|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121622|NCT03493178|Expectorants|expectorants|mesh-ancestor
57121623|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
57121624|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57121625|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
57121626|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121627|NCT03493178|Protective Agents|protective agents|mesh-ancestor
57121628|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121629|NCT03493178|Antidotes|antidotes|mesh-ancestor
57121630|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
57121631|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121632|NCT04548440|Paclitaxel|paclitaxel|mesh-list
57121633|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57121634|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57121635|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121636|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
57121637|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
57121638|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121639|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121640|NCT03742921|Romidepsin|romidepsin|mesh-list
57121641|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57121642|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121643|NCT02626520|Gemcitabine|gemcitabine|mesh-list
57121644|NCT02626520|Paclitaxel|paclitaxel|mesh-list
57121645|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57121646|NCT02626520|Fluorouracil|fluorouracil|mesh-list
57121647|NCT02626520|Irinotecan|irinotecan|mesh-list
57121648|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57121649|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121650|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
57121651|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
57121652|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121653|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121654|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121655|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
57121656|NCT02626520|Antiviral Agents|antiviral agents|mesh-ancestor
57121657|NCT02626520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121658|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121659|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121660|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
57121661|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121662|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57121663|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57121665|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57121666|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121667|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121668|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121669|NCT04585711|Etanercept|etanercept|mesh-list
57121670|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57121671|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57121672|NCT04585711|Analgesics|analgesics|mesh-ancestor
57121673|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
57121674|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121675|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121676|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57121677|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121678|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121679|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121680|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
57121681|NCT05084521|Famotidine|famotidine|mesh-list
57121682|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57121683|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121684|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57121685|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
57121686|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
57121687|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121688|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121689|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121690|NCT05069857|Apatinib|apatinib|mesh-list
57121691|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57121692|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121693|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57121694|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121695|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121696|NCT02971891|Furosemide|furosemide|mesh-list
57121697|NCT02971891|Diuretics|diuretics|mesh-ancestor
57121698|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
57121699|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121700|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57121701|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57121702|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121703|NCT05063851|Memantine|memantine|mesh-list
57121704|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57121705|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57121706|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
57121707|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121708|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121709|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121710|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57121711|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57121712|NCT04392037|Dexamethasone|dexamethasone|mesh-list
57121713|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
57121714|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121715|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
57121716|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121717|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121718|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57121719|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
57121720|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121721|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121722|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57121723|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57121724|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
57121725|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
57121726|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121727|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121728|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
57121729|NCT04392037|Hormones|hormones|mesh-ancestor
57121730|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121731|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121732|NCT03359161|Furosemide|furosemide|mesh-list
57121733|NCT03359161|Diuretics|diuretics|mesh-ancestor
57121734|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
57121735|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121736|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57121737|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57121738|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121740|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
57121741|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57121742|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57121743|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121744|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121745|NCT05030623|Urological Agents|urological agents|mesh-ancestor
57121746|NCT04986631|Topiramate|topiramate|mesh-list
57121747|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
57121748|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57121749|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121750|NCT03277339|Paroxetine|paroxetine|mesh-list
57121751|NCT03277339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57121752|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57121753|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57121754|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121755|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121756|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
57121757|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121758|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57121759|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
57121760|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57121761|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57121762|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57121763|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121764|NCT03145675|Enoxaparin|enoxaparin|mesh-list
57121765|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
57121766|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
57121767|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57121768|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57121769|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121770|NCT04251715|Leucovorin|leucovorin|mesh-list
57121771|NCT04251715|Dexamethasone|dexamethasone|mesh-list
57121772|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
57121773|NCT04251715|Fluorouracil|fluorouracil|mesh-list
57121774|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
57121775|NCT04251715|Irinotecan|irinotecan|mesh-list
57121776|NCT04251715|Floxuridine|floxuridine|mesh-list
57121777|NCT04251715|BB 1101|bb 1101|mesh-list
57121778|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
57121779|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57121780|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
57121781|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
57121782|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121783|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121784|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121785|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
57121786|NCT04251715|Hormones|hormones|mesh-ancestor
57121787|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121788|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121789|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121790|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
57121791|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121792|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121793|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
57121794|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121795|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121796|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
57121797|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57121798|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57121799|NCT04251715|Antidotes|antidotes|mesh-ancestor
57121800|NCT04251715|Protective Agents|protective agents|mesh-ancestor
57121801|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
57121802|NCT04251715|Vitamins|vitamins|mesh-ancestor
57121803|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
57121804|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
57121805|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57121806|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57121807|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121808|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57121809|NCT04042727|Analgesics|analgesics|mesh-ancestor
56803640|NCT00428220|Sunitinib|sunitinib|mesh-list
57121810|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
57121811|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57121812|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57121813|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57121814|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57121815|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
57121816|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121817|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121818|NCT02035943|Insulin|insulin|mesh-list
57121819|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57121820|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57121821|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121822|NCT03819413|Antibodies|antibodies|mesh-list
57121823|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
57121824|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
57121825|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121826|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57121827|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121828|NCT02394028|Etrolizumab|etrolizumab|mesh-list
57121829|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121830|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
57121831|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121832|NCT04239703|Antibodies|antibodies|mesh-list
57121833|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
57121834|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121835|NCT04079621|Primaquine|primaquine|mesh-list
57121836|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
57121837|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57121838|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57121839|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121840|NCT04940299|Nivolumab|nivolumab|mesh-list
57121841|NCT04940299|Ipilimumab|ipilimumab|mesh-list
57121842|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
57121843|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
57121844|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57121845|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121846|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57121847|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121848|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
57121849|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121850|NCT02819297|Laxatives|laxatives|mesh-list
57121851|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121852|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
57121853|NCT05134441|Calcium|calcium|mesh-list
57121854|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57121855|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121856|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57121857|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
57121858|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
57121859|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
57121860|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
57121861|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57121862|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121863|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
57121864|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121865|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
57121866|NCT04925557|Siponimod|siponimod|mesh-list
57121867|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
57121868|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121869|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57121870|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121871|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121872|NCT03063788|Copper|copper|mesh-list
57121873|NCT03063788|Trace Elements|trace elements|mesh-ancestor
57121874|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
57121875|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121876|NCT02821715|Flecainide|flecainide|mesh-list
57121877|NCT02821715|Modafinil|modafinil|mesh-list
57121878|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57121879|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121880|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
57121881|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57121882|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57121883|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121884|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57121885|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57121886|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57121887|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57121888|NCT04158739|Cytarabine|cytarabine|mesh-list
57121889|NCT04158739|Antibodies|antibodies|mesh-list
57121890|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
57121891|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57121892|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
57121893|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121894|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121895|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
57121896|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121897|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121898|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
57121899|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57121900|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121901|NCT04377932|Cyclophosphamide|cyclophosphamide|mesh-list
57121902|NCT04377932|Fludarabine|fludarabine|mesh-list
57121903|NCT04377932|Fludarabine phosphate|fludarabine phosphate|mesh-list
57121904|NCT04377932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121905|NCT04377932|Immunologic Factors|immunologic factors|mesh-ancestor
57121906|NCT04377932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121907|NCT04377932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57121908|NCT04377932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57121909|NCT04377932|Alkylating Agents|alkylating agents|mesh-ancestor
57121910|NCT04377932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121911|NCT04377932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121912|NCT04377932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57121913|NCT04377932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121914|NCT04377932|Antimetabolites|antimetabolites|mesh-ancestor
57121915|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
57121916|NCT03545347|Nandrolone|nandrolone|mesh-list
57121917|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
57121918|NCT03545347|Androgens|androgens|mesh-ancestor
57121919|NCT03545347|Hormones|hormones|mesh-ancestor
57121920|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121921|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121922|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
57121923|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57121924|NCT02815397|Metformin|metformin|mesh-list
57121925|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57121926|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121927|NCT04980404|Decitabine|decitabine|mesh-list
57121928|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121929|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
57121930|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121931|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121932|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121933|NCT02427958|Leuprolide|leuprolide|mesh-list
57121934|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57121935|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
57121936|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57121937|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121938|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121939|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121940|NCT03715127|Psilocybin|psilocybin|mesh-list
57121941|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
57121942|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121943|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57121944|NCT02260037|Epinastine|epinastine|mesh-list
57121945|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57121946|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
57121947|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
57121948|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57121949|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121950|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121951|NCT02036489|Prednisone|prednisone|mesh-list
57121952|NCT02036489|Vincristine|vincristine|mesh-list
57121953|NCT02036489|Daunorubicin|daunorubicin|mesh-list
57121954|NCT02036489|Asparaginase|asparaginase|mesh-list
57121955|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
57121956|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57121957|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
57121958|NCT02036489|Hormones|hormones|mesh-ancestor
57121959|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121960|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121961|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121962|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121963|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57121964|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
57121965|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
57121966|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
57121967|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121968|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57121969|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57121970|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57121971|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121972|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
57121973|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57121974|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57121975|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
57121976|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57121977|NCT02392624|Omalizumab|omalizumab|mesh-list
57121978|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57121979|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57121980|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
57121981|NCT02047565|Edoxaban|edoxaban|mesh-list
57121982|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57121983|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
57121984|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57121985|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
57121986|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57121987|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57121988|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
57121989|NCT05701241|Octreotide|octreotide|mesh-list
57121990|NCT05701241|Lanreotide|lanreotide|mesh-list
57121991|NCT05701241|Somatostatin|somatostatin|mesh-list
57121992|NCT05701241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57121993|NCT05701241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57121994|NCT05701241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57121995|NCT05701241|Hormones|hormones|mesh-ancestor
57121996|NCT05701241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57121997|NCT05701241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57121998|NCT03063866|Fentanyl|fentanyl|mesh-list
57121999|NCT03063866|Midazolam|midazolam|mesh-list
57122000|NCT03063866|Propofol|propofol|mesh-list
57122001|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57122002|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122003|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122004|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57122005|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
57122006|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
57122007|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57122008|NCT03063866|Narcotics|narcotics|mesh-ancestor
57122009|NCT03063866|Analgesics|analgesics|mesh-ancestor
57122010|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
57122011|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122012|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57122013|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57122014|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57122015|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57122016|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
57122017|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
57122018|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122019|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122020|NCT02037191|Methotrexate|methotrexate|mesh-list
57122021|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57122022|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
57122023|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57122024|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122025|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57122026|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
57122027|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122028|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122029|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
57122030|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122031|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57122032|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57122033|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
57122034|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122035|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57122036|NCT04980170|Amoxicillin|amoxicillin|mesh-list
57122037|NCT04980170|Clindamycin|clindamycin|mesh-list
57122038|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
57122039|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
57122040|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57122041|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
57122043|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57122044|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122045|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57122046|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122047|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122048|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57122049|NCT03006068|Upadacitinib|upadacitinib|mesh-list
57122050|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57122051|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57122052|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122053|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122054|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122055|NCT02387164|Vitamin D|vitamin d|mesh-list
57122056|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
57122057|NCT02387164|Vitamins|vitamins|mesh-ancestor
57122058|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
57122059|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122060|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57122061|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57122062|NCT02047799|Calcitriol|calcitriol|mesh-list
57122063|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57122064|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122065|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57122066|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122067|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122068|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57122069|NCT02047799|Vitamins|vitamins|mesh-ancestor
57122070|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
57122071|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57122072|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
57122073|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57122074|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122075|NCT02392234|Ivacaftor|ivacaftor|mesh-list
57122076|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
57122077|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122078|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122079|NCT02036723|Bevacizumab|bevacizumab|mesh-list
57122080|NCT02036723|Ranibizumab|ranibizumab|mesh-list
57122081|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57122082|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122083|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57122084|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57122085|NCT02036723|Growth Substances|growth substances|mesh-ancestor
57122086|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122087|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
57122088|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57122089|NCT02036879|Norethindrone|norethindrone|mesh-list
57122090|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
57122091|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
57122092|NCT02036879|Estradiol|estradiol|mesh-list
57122093|NCT02036879|Estrogens|estrogens|mesh-ancestor
57122094|NCT02036879|Hormones|hormones|mesh-ancestor
57122095|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122096|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122097|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57122098|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
57122099|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57122100|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57122101|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57122102|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57122103|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57122104|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57122105|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
57122106|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57122107|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
57122108|NCT02963090|Topotecan|topotecan|mesh-list
57122109|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57122110|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122111|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57122112|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57122113|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803945|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122114|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122115|NCT02048423|Ketamine|ketamine|mesh-list
57122116|NCT02048423|Analgesics|analgesics|mesh-ancestor
57122117|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
57122118|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122119|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122120|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57122121|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57122122|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
57122123|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
57122124|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122125|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57122126|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57122127|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122128|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122129|NCT02037035|Ketamine|ketamine|mesh-list
57122130|NCT02037035|Analgesics|analgesics|mesh-ancestor
57122131|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
57122132|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122133|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122134|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57122135|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57122136|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
57122137|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
57122138|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122139|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57122140|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57122141|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122142|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122143|NCT04979468|Lamivudine|lamivudine|mesh-list
57122144|NCT04979468|Dolutegravir|dolutegravir|mesh-list
57122145|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57122146|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57122147|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122148|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122149|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
57122150|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122151|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57122152|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57122153|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57122154|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57122155|NCT03562169|Thalidomide|thalidomide|mesh-list
57122156|NCT03562169|Dexamethasone|dexamethasone|mesh-list
57122157|NCT03562169|Ixazomib|ixazomib|mesh-list
57122158|NCT03562169|Glycine|glycine|mesh-list
57122159|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57122160|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
57122161|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
57122162|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122163|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122164|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57122165|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
57122166|NCT03562169|Hormones|hormones|mesh-ancestor
57122167|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122168|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57122169|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122170|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57122171|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
57122172|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
57122173|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57122174|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122175|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57122176|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57122177|NCT03562169|Growth Substances|growth substances|mesh-ancestor
57122178|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
57122179|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
57122180|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122181|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122182|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
57122183|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122184|NCT02427802|Gentamicins|gentamicins|mesh-list
57122185|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57122186|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122187|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57122188|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122189|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122190|NCT02050529|Hydralazine|hydralazine|mesh-list
57122191|NCT02050529|Labetalol|labetalol|mesh-list
57122192|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57122193|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
57122194|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57122195|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57122196|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
57122197|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122198|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122199|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122200|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
57122201|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
57122202|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122203|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57122204|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57122205|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57122206|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57122207|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
57122208|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57122209|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57122210|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122211|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122212|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57122213|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122214|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122215|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
57122216|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122217|NCT02048969|Flumazenil|flumazenil|mesh-list
57122218|NCT02048969|Antidotes|antidotes|mesh-ancestor
57122219|NCT02048969|Protective Agents|protective agents|mesh-ancestor
57122220|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122221|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
57122222|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
57122223|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122224|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122225|NCT03561935|Propafenone|propafenone|mesh-list
57122226|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56902197|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122227|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57122228|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57122229|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122230|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122231|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
57122232|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57122233|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57122234|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122235|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122236|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57122237|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57122238|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57122239|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57122240|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
57122241|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122242|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122243|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57122244|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57122245|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
57122246|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57122247|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57122248|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
57122249|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
57122250|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57122251|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
57122252|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57122253|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122254|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57122255|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
57122256|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122257|NCT02620280|Paclitaxel|paclitaxel|mesh-list
57122258|NCT02620280|Carboplatin|carboplatin|mesh-list
57122259|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57122260|NCT02620280|Atezolizumab|atezolizumab|mesh-list
57122261|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56804142|NCT00995657|Xhance|xhance|mesh-list
57122262|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122263|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
57122264|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
57122265|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
57122266|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122268|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57122269|NCT02806973|Hormones|hormones|mesh-ancestor
57122270|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122271|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122272|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
57122273|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
57122274|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122275|NCT02037737|Abatacept|abatacept|mesh-list
57122276|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57122277|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122278|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122279|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57122280|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
57122281|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122282|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122283|NCT02037503|Ketamine|ketamine|mesh-list
57122284|NCT02037503|Analgesics|analgesics|mesh-ancestor
57122285|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
57122286|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122287|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122288|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57122289|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57122290|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
57122291|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
57122292|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122293|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57122294|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57122295|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122296|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122297|NCT02049671|Hormones|hormones|mesh-list
57122298|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122299|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122300|NCT02037815|Mannitol|mannitol|mesh-list
57122301|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57122302|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57122303|NCT02037815|Diuretics|diuretics|mesh-ancestor
57122304|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
57122305|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122306|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
57122307|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57122308|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
57122309|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122310|NCT02053727|Abatacept|abatacept|mesh-list
57122311|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57122312|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122313|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122314|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57122315|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
57122316|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122317|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122318|NCT02051153|Modafinil|modafinil|mesh-list
57122319|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57122320|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122321|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
57122322|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57122323|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57122324|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122325|NCT02807363|Leuprolide|leuprolide|mesh-list
57122326|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57122327|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
57122328|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57122329|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122330|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57122331|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122332|NCT02051231|Oxytocin|oxytocin|mesh-list
56804177|NCT00994253|Diuretics|diuretics|mesh-ancestor
57122333|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
57122334|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57122335|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122336|NCT02051387|Cannabidiol|cannabidiol|mesh-list
57122337|NCT02051387|Olanzapine|olanzapine|mesh-list
57122338|NCT02051387|Risperidone|risperidone|mesh-list
57122339|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57122340|NCT02051387|Amisulpride|amisulpride|mesh-list
57122341|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57122342|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
57122343|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122344|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122345|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122346|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57122347|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57122348|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122349|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57122350|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57122351|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
57122352|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
57122353|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
57122354|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122355|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57122356|NCT02051387|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57122357|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57122358|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122359|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
57122360|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
57122361|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57122362|NCT02426086|Niacinamide|niacinamide|mesh-list
57122363|NCT02426086|Imetelstat|imetelstat|mesh-list
57122364|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
57122365|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122366|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122367|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57122368|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
57122369|NCT02426086|Vitamins|vitamins|mesh-ancestor
57122370|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
57122371|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122372|NCT02052167|Methotrexate|methotrexate|mesh-list
57122373|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57122374|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
57122375|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57122376|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122377|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57122378|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
57122379|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122380|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122381|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
57122382|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122383|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57122384|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57122385|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
57122386|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122387|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57122388|NCT03573947|Paclitaxel|paclitaxel|mesh-list
57122389|NCT03573947|Nivolumab|nivolumab|mesh-list
57122390|NCT03573947|Ipilimumab|ipilimumab|mesh-list
57122391|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57122392|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122393|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
57122394|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
57122395|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
57122396|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122397|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57122398|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57122399|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
57122400|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57122401|NCT03524417|Antibodies|antibodies|mesh-list
57122402|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
57122403|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122404|NCT02054429|Insulin|insulin|mesh-list
57122405|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57122406|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57122407|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122408|NCT03806543|Vancomycin|vancomycin|mesh-list
57122409|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57122410|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122412|NCT02052323|Mefloquine|mefloquine|mesh-list
57122413|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
57122414|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57122415|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57122416|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122417|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122418|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
57122419|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
57122420|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57122421|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
57122422|NCT02056223|Acetaminophen|acetaminophen|mesh-list
57122423|NCT02056223|Ibuprofen|ibuprofen|mesh-list
57122424|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57122425|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57122426|NCT02056223|Analgesics|analgesics|mesh-ancestor
57122427|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
57122428|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122429|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122430|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57122431|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122432|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57122433|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122434|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122435|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
57122436|NCT02056379|Dexamethasone|dexamethasone|mesh-list
57122437|NCT02056379|Budesonide|budesonide|mesh-list
57122438|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57122439|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
57122440|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
57122441|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122442|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122443|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57122444|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
57122445|NCT02056379|Hormones|hormones|mesh-ancestor
57122446|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122447|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57122448|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122449|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57122450|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57122451|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
57122452|NCT02383966|Carboplatin|carboplatin|mesh-list
57122453|NCT02383966|Fluorouracil|fluorouracil|mesh-list
57122454|NCT02383966|Cetuximab|cetuximab|mesh-list
57122455|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122456|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
57122457|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122458|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57122459|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57122460|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
57122461|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122462|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57122463|NCT02054663|Clopidogrel|clopidogrel|mesh-list
57122464|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57122465|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57122466|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57122467|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57122468|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
57122469|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122470|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122471|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122472|NCT02054975|Vitamin D|vitamin d|mesh-list
57122473|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
57122474|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
57122475|NCT02054975|Vitamins|vitamins|mesh-list
57122476|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
57122477|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122478|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57122479|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57122480|NCT02055131|Aspirin|aspirin|mesh-list
57122481|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57122482|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57122483|NCT02055131|Analgesics|analgesics|mesh-ancestor
57122484|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
57122485|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122486|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122487|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57122488|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122489|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57122490|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57122491|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122492|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57122493|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57122494|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122495|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
57122496|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
57122497|NCT02056847|Pitavastatin|pitavastatin|mesh-list
57122499|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57122500|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122501|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57122502|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57122503|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57122504|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57122505|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
57122506|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122507|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122508|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57122509|NCT02052713|Tamsulosin|tamsulosin|mesh-list
57122510|NCT02052713|Dutasteride|dutasteride|mesh-list
57122511|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57122512|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57122513|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57122514|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
57122515|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122516|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122517|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122518|NCT02052713|Urological Agents|urological agents|mesh-ancestor
57122519|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57122520|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57122521|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122522|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
57122523|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122524|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
57122525|NCT02057003|Grazoprevir|grazoprevir|mesh-list
57122526|NCT02057003|Ledipasvir|ledipasvir|mesh-list
57122527|NCT02057003|Velpatasvir|velpatasvir|mesh-list
57122528|NCT02057003|Simeprevir|simeprevir|mesh-list
57122529|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
57122530|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122531|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
57122532|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122533|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122534|NCT02055911|Ranibizumab|ranibizumab|mesh-list
57122535|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57122536|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57122537|NCT02055911|Growth Substances|growth substances|mesh-ancestor
57122538|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122539|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
57122540|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122541|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57122542|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
57122543|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122544|NCT02390362|Rituximab|rituximab|mesh-list
57122545|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57122546|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122547|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
57122548|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122549|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122550|NCT02389816|Vortioxetine|vortioxetine|mesh-list
57122551|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
57122552|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57122553|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57122554|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57122555|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122556|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122557|NCT02389816|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57122558|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56804411|NCT01060683|Chrysarobin|chrysarobin|mesh-list
57122559|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122560|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122561|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122562|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
57122563|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57122564|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57122565|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57122566|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57122568|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
57122569|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57122570|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57122571|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57122572|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122573|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122574|NCT02382640|Febuxostat|febuxostat|mesh-list
57122575|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
57122576|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122577|NCT02801669|Edoxaban|edoxaban|mesh-list
57122578|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57122579|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
57122580|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57122581|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
57122582|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122583|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122584|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
57122585|NCT02804399|Rifampin|rifampin|mesh-list
57122586|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57122587|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
57122588|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57122589|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122590|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
57122591|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57122592|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122593|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122594|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57122595|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57122596|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57122597|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57122598|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57122599|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57122600|NCT05614037|Felodipine|felodipine|mesh-list
57122601|NCT05614037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57122602|NCT05614037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57122603|NCT05614037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57122604|NCT05614037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122605|NCT05614037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122606|NCT05614037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57122607|NCT05614037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122608|NCT05614037|Vasodilator Agents|vasodilator agents|mesh-ancestor
57122609|NCT02058875|Cyclosporine|cyclosporine|mesh-list
57122610|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
57122611|NCT02058875|Prednisone|prednisone|mesh-list
57122612|NCT02058875|Cyclosporins|cyclosporins|mesh-list
57122613|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57122614|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
57122615|NCT02058875|Hormones|hormones|mesh-ancestor
57122616|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122617|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122618|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57122619|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122620|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122621|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122622|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57122623|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
57122624|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
57122625|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122626|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
57122627|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122628|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57122629|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57122630|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57122631|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
57122632|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57122633|NCT02059031|Cabotegravir|cabotegravir|mesh-list
57122634|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57122635|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57122636|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122637|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122638|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57122639|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57122640|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
57122641|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122642|NCT01333865|Memantine|memantine|mesh-list
57122643|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57122644|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57122645|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
57122646|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122647|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122648|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122649|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57122650|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57122651|NCT04978688|Relugolix|relugolix|mesh-list
57122652|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
57122653|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
57122654|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122655|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122656|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
57122657|NCT04434326|Vorolanib|vorolanib|mesh-list
57122658|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57122659|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122660|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122661|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
57122662|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57122663|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57122664|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57122665|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122666|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122667|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
57122668|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122669|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122670|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57122671|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122672|NCT02172872|Decitabine|decitabine|mesh-list
57122673|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57122674|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
57122675|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122676|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122677|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122678|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
57122679|NCT02059655|Bimatoprost|bimatoprost|mesh-list
57122680|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57122681|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57122682|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57122683|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57122684|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122685|NCT05636501|Prednisolone|prednisolone|mesh-list
57122686|NCT05636501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57122687|NCT05636501|Glucocorticoids|glucocorticoids|mesh-ancestor
57122688|NCT05636501|Hormones|hormones|mesh-ancestor
57122689|NCT05636501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122690|NCT05636501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122691|NCT05636501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57122692|NCT05636501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122693|NCT02058173|Chloroquine|chloroquine|mesh-list
57122694|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
57122695|NCT02058173|Amebicides|amebicides|mesh-ancestor
57122696|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57122697|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57122698|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122699|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
57122700|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122701|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57122702|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57122703|NCT02058173|Analgesics|analgesics|mesh-ancestor
57122704|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
57122705|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122706|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122707|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57122708|NCT02058173|Filaricides|filaricides|mesh-ancestor
57122709|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
57122710|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
57122711|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
57122712|NCT02060201|Saxagliptin|saxagliptin|mesh-list
57122713|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57122714|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122715|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57122716|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122717|NCT02060201|Incretins|incretins|mesh-ancestor
57122718|NCT02060201|Hormones|hormones|mesh-ancestor
57122719|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122720|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57122721|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
57122722|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122723|NCT03561233|Omeprazole|omeprazole|mesh-list
57122724|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57122725|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57122726|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57122727|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122728|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122729|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57122730|NCT02058485|Midazolam|midazolam|mesh-list
57122731|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
57122732|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57122733|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122734|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122735|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57122736|NCT02058485|Analgesics|analgesics|mesh-ancestor
57122737|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
57122738|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122739|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57122740|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57122741|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57122742|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
57122743|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122744|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122745|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57122746|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57122747|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57122748|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57122749|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57122750|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
57122751|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
57122752|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
57122753|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
57122754|NCT02060279|Carotenoids|carotenoids|mesh-list
57122755|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
57122756|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122757|NCT02060279|Protective Agents|protective agents|mesh-ancestor
57122758|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122759|NCT02058641|Darapladib|darapladib|mesh-list
57122760|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
57122761|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122762|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122763|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
57122764|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57122765|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57122766|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122767|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
57122768|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
57122769|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122770|NCT02059967|Paclitaxel|paclitaxel|mesh-list
57122771|NCT02059967|Carboplatin|carboplatin|mesh-list
57122772|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57122773|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122774|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
57122775|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
57122776|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
57122777|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122778|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57122779|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57122780|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122781|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57122782|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
57122783|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122784|NCT02061449|Romidepsin|romidepsin|mesh-list
57122785|NCT02061449|Poly ICLC|poly iclc|mesh-list
57122786|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
57122787|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
57122788|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122789|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57122790|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122791|NCT02060591|Bupivacaine|bupivacaine|mesh-list
57122792|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
57122793|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
57122794|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122795|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122796|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
57122797|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122798|NCT02060669|Capecitabine|capecitabine|mesh-list
57122799|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57122800|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
57122801|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122802|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122803|NCT04428008|Thymalfasin|thymalfasin|mesh-list
57122804|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57122805|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
57122806|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122807|NCT02046590|Propofol|propofol|mesh-list
57122808|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
57122809|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122810|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122811|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57122812|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57122813|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
57122814|NCT02796755|Riluzole|riluzole|mesh-list
57122815|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
57122816|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57122817|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57122818|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122819|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122820|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122821|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57122822|NCT02796755|Protective Agents|protective agents|mesh-ancestor
57122823|NCT02061917|Lobeline|lobeline|mesh-list
57122824|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57122825|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
57122826|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122827|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122828|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57122829|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57122830|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
57122831|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122832|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122833|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
57122834|NCT03560375|Empagliflozin|empagliflozin|mesh-list
57122835|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57122836|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122837|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57122838|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122839|NCT02382016|Macitentan|macitentan|mesh-list
57122840|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
57122841|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57122842|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122843|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57122844|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57122845|NCT02422186|Citalopram|citalopram|mesh-list
57122846|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57122847|NCT02422186|Sertraline|sertraline|mesh-list
57122848|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
57122849|NCT02422186|Esketamine|esketamine|mesh-list
57122850|NCT02422186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57122851|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57122852|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122853|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804691|NCT05223335|Clopidogrel|clopidogrel|mesh-list
57122854|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122855|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
57122856|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122857|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57122858|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57122859|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122860|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57122861|NCT02422186|Analgesics|analgesics|mesh-ancestor
57122862|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
57122863|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
57122865|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
57122866|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
57122867|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57122868|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
57122869|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122870|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122871|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57122872|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
57122873|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57122874|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57122875|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57122876|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
57122877|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122878|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122879|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
57122880|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57122881|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
57122882|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
57122883|NCT02007512|Exemestane|exemestane|mesh-list
57122884|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122885|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57122886|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57122887|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122888|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122889|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57122890|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
57122891|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57122892|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122893|NCT04973462|Oseltamivir|oseltamivir|mesh-list
57122894|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
57122895|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57122896|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122897|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122898|NCT02378506|Etanercept|etanercept|mesh-list
57122899|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57122900|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57122901|NCT02378506|Analgesics|analgesics|mesh-ancestor
57122902|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
57122903|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122904|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122905|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57122906|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57122907|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57122908|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57122909|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
57122910|NCT02794883|Durvalumab|durvalumab|mesh-list
57122911|NCT02794883|Ipilimumab|ipilimumab|mesh-list
57122912|NCT02794883|Tremelimumab|tremelimumab|mesh-list
57122913|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
57122914|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57122915|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
57122916|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57122917|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57122918|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
57122919|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122920|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57122921|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122922|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
57122923|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57122924|NCT02063789|Antibodies|antibodies|mesh-list
57122925|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
57122926|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122927|NCT02063945|Risperidone|risperidone|mesh-list
57122928|NCT02063945|Methylphenidate|methylphenidate|mesh-list
57122929|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57122930|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
57122931|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122932|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122933|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122934|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57122935|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56902235|NCT02057770|Busulfan|busulfan|mesh-list
57122936|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57122937|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57122938|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57122939|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
57122940|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57122941|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57122942|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57122943|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57122944|NCT02064023|Insulin|insulin|mesh-list
57122945|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57122946|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57122947|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122948|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
57122949|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
57122950|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
57122951|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122952|NCT01370603|Atorvastatin|atorvastatin|mesh-list
57122953|NCT01370603|Ezetimibe|ezetimibe|mesh-list
57122954|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57122955|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57122956|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
57122957|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122958|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57122959|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57122960|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122961|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
57122962|NCT02659397|Atorvastatin|atorvastatin|mesh-list
57122963|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57122964|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57122965|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
57122966|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122967|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57122968|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57122969|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57122970|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57122971|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122972|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
57122973|NCT02347072|Bromides|bromides|mesh-list
57122974|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
57122975|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
57122976|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57122977|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
57122978|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57122979|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57122980|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57122981|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
57122982|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57122983|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57122984|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57122985|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
57122986|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57122987|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57122988|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
57122989|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57122990|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
57122991|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
57122992|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57122993|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57122994|NCT02064491|Paclitaxel|paclitaxel|mesh-list
57122995|NCT02064491|Docetaxel|docetaxel|mesh-list
57122996|NCT02064491|Cisplatin|cisplatin|mesh-list
57122997|NCT02064491|Carboplatin|carboplatin|mesh-list
57122998|NCT02064491|Pemetrexed|pemetrexed|mesh-list
57122999|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57123000|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57123001|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123002|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
57123003|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
57123004|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
57123005|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123006|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123007|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57123008|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123009|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123010|NCT02064881|Metformin|metformin|mesh-list
57123011|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57123012|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123013|NCT02346370|Docetaxel|docetaxel|mesh-list
57123014|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123015|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
57123016|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
57123017|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
57123018|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123019|NCT02065739|Itraconazole|itraconazole|mesh-list
57123020|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
57123021|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
57123022|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123023|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57123024|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57123025|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123026|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123027|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57123028|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
57123029|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57123030|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123031|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57123032|NCT02068079|Vemurafenib|vemurafenib|mesh-list
57123033|NCT02068079|Trientine|trientine|mesh-list
57123034|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123035|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123036|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123037|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123038|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
57123039|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
57123040|NCT02793947|Epinephrine|epinephrine|mesh-list
57123041|NCT02793947|Morphine|morphine|mesh-list
57123042|NCT02793947|Ropivacaine|ropivacaine|mesh-list
57123043|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57123044|NCT02793947|Narcotics|narcotics|mesh-ancestor
57123045|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123046|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123047|NCT02793947|Analgesics|analgesics|mesh-ancestor
57123048|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
57123049|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123050|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
57123051|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
57123052|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57123053|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57123054|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
57123055|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123056|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123057|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57123058|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57123059|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
57123060|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57123061|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
57123062|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
57123063|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
57123064|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57123065|NCT02068235|Ponesimod|ponesimod|mesh-list
57123066|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57123067|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123068|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123069|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
57123070|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123071|NCT01370213|Interleukin-2|interleukin-2|mesh-list
57123072|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57123073|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123074|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57123075|NCT01370213|Analgesics|analgesics|mesh-ancestor
57123076|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
57123077|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123078|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123079|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
57123080|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123081|NCT02066207|Atorvastatin|atorvastatin|mesh-list
57123082|NCT02066207|Fenofibrate|fenofibrate|mesh-list
57123083|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57123084|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57123085|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
57123086|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123087|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57123088|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57123089|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123090|NCT01370525|Esomeprazole|esomeprazole|mesh-list
57123091|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57123092|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57123093|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57123094|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123095|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123096|NCT02065349|ASP8477|asp8477|mesh-list
57123097|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123098|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123099|NCT02068625|Rasagiline|rasagiline|mesh-list
57123100|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57123101|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123102|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123103|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57123104|NCT02068625|Protective Agents|protective agents|mesh-ancestor
57123105|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123106|NCT02068859|Diclofenac|diclofenac|mesh-list
57123107|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57123108|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57123109|NCT02068859|Analgesics|analgesics|mesh-ancestor
57123110|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
57123111|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123112|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123113|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123114|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123115|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57123116|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123117|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123118|NCT02068937|Furosemide|furosemide|mesh-list
57123119|NCT02068937|Diuretics|diuretics|mesh-ancestor
57123120|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
57123121|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123122|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57123123|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57123124|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123125|NCT02066675|Trabectedin|trabectedin|mesh-list
57123126|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57123127|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
57123128|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123129|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123130|NCT02072135|Bupivacaine|bupivacaine|mesh-list
57123131|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
57123132|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
57123133|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123134|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123135|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
57123136|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123137|NCT02067065|Propofol|propofol|mesh-list
57123138|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57123139|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123140|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123141|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57123142|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
57123143|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
57123144|NCT02067143|Cytarabine|cytarabine|mesh-list
57123145|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57123146|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
57123147|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123148|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123149|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
57123150|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123151|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123152|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
57123153|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123155|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57123156|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57123157|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57123158|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
57123159|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123160|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123161|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123162|NCT02072213|Urological Agents|urological agents|mesh-ancestor
57123163|NCT02072291|Nifedipine|nifedipine|mesh-list
57123164|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57123165|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57123166|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123167|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57123168|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123169|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
57123170|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
57123171|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57123172|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57123173|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
57123174|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123175|NCT03059888|Abatacept|abatacept|mesh-list
57123176|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57123177|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123178|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123179|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123180|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
57123181|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123182|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123183|NCT04976816|Triamcinolone|triamcinolone|mesh-list
57123184|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57123185|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57123186|NCT04976816|Betamethasone|betamethasone|mesh-list
57123187|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
57123188|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57123189|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
57123190|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57123191|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57123192|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123193|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
57123194|NCT04976816|Hormones|hormones|mesh-ancestor
57123195|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57123196|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123197|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123198|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
57123199|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123200|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123201|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57123202|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
57123203|NCT03061838|Rituximab|rituximab|mesh-list
57123204|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57123205|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123206|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
57123207|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123208|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123209|NCT04964180|Indomethacin|indomethacin|mesh-list
57123210|NCT04964180|Lidocaine|lidocaine|mesh-list
57123211|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
57123212|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
57123213|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123214|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123215|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
57123216|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123217|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57123218|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57123219|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57123220|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57123221|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123222|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57123223|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57123224|NCT04964180|Analgesics|analgesics|mesh-ancestor
57123225|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123226|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123227|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
57123228|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
57123229|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57123230|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57123231|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123232|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
57123233|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57123234|NCT02067377|Antibodies|antibodies|mesh-list
57123235|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
57123236|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123237|NCT02073149|Iron|iron|mesh-list
57123238|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
57123239|NCT02073149|Trace Elements|trace elements|mesh-ancestor
57123240|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
57123241|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123242|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57123243|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
57123244|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
57123245|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123246|NCT02625974|Nifurtimox|nifurtimox|mesh-list
57123247|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57123248|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57123249|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57123250|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123251|NCT02067767|Lamivudine|lamivudine|mesh-list
57123252|NCT02067767|Abacavir|abacavir|mesh-list
57123253|NCT02067767|Dolutegravir|dolutegravir|mesh-list
57123254|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57123255|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123256|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123257|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123258|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
57123259|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123260|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57123261|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57123262|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57123263|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57123264|NCT02073227|Metformin|metformin|mesh-list
57123265|NCT02073227|Canagliflozin|canagliflozin|mesh-list
57123266|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57123267|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123268|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57123269|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123270|NCT03060044|Fluticasone|fluticasone|mesh-list
57123271|NCT03060044|Xhance|xhance|mesh-list
57123272|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57123273|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57123274|NCT03060044|Charcoal|charcoal|mesh-list
57123275|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123276|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57123277|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
57123278|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123279|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123280|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57123281|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
57123282|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
57123283|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57123284|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57123285|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57123286|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57123287|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
57123288|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123289|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123290|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
57123291|NCT03060044|Hormones|hormones|mesh-ancestor
57123292|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57123293|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
57123294|NCT03060044|Antidotes|antidotes|mesh-ancestor
57123295|NCT03060044|Protective Agents|protective agents|mesh-ancestor
57123296|NCT02070653|Ticagrelor|ticagrelor|mesh-list
57123297|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57123298|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57123299|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57123300|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57123301|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
57123302|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123303|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123304|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123305|NCT04831892|Isosorbide|isosorbide|mesh-list
57123306|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57123307|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57123308|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57123309|NCT04831892|Diuretics|diuretics|mesh-ancestor
57123310|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
57123311|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123312|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
57123313|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57123314|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123315|NCT02073773|Levodopa|levodopa|mesh-list
57123316|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57123317|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57123318|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
57123319|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123320|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123321|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123322|NCT03062150|Cycloserine|cycloserine|mesh-list
57123323|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
57123324|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57123325|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123326|NCT03062150|Renal Agents|renal agents|mesh-ancestor
57123327|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57123328|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
57123329|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57123330|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
57123331|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123332|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123333|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
57123334|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57123335|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57123336|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123337|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
57123338|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
57123339|NCT02076659|Methotrexate|methotrexate|mesh-list
57123340|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57123341|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
57123342|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57123343|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123344|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57123345|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
57123346|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123347|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123348|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
57123349|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123350|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57123351|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123352|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
57123353|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123354|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123355|NCT04975724|Citalopram|citalopram|mesh-list
57123356|NCT04975724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57123357|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57123358|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57123359|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123360|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123361|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
57123362|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123363|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57123364|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
57123365|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57123366|NCT02076815|Anagrelide|anagrelide|mesh-list
57123367|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57123368|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57123369|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123370|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57123371|NCT02071043|Capecitabine|capecitabine|mesh-list
57123372|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
57123373|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57123374|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
57123375|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123376|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123377|NCT02076893|Ibuprofen|ibuprofen|mesh-list
57123378|NCT02076893|Gabapentin|gabapentin|mesh-list
57123379|NCT02076893|Tramadol|tramadol|mesh-list
57123380|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57123381|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57123382|NCT02076893|Analgesics|analgesics|mesh-ancestor
57123383|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
57123384|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123385|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123386|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123387|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123388|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57123389|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123390|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123391|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
57123392|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57123393|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57123394|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123395|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57123396|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57123397|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57123398|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123399|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
57123400|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57123401|NCT02076893|Narcotics|narcotics|mesh-ancestor
57123402|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57123403|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57123404|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57123405|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123406|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123407|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57123408|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57123409|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123410|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
57123411|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123412|NCT04963088|Capecitabine|capecitabine|mesh-list
57123413|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
57123414|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57123415|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
57123416|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123417|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123418|NCT04970576|Warfarin|warfarin|mesh-list
57123419|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
57123420|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
57123421|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57123422|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
57123423|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57123424|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
57123425|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123426|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123427|NCT02074319|Methotrexate|methotrexate|mesh-list
57123428|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57123429|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
57123430|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57123431|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123432|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57123433|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
57123434|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123435|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123436|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
57123437|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123438|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57123439|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123440|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
57123441|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123442|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123443|NCT04975022|Insulin|insulin|mesh-list
57123444|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57123445|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123446|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57123447|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
57123448|NCT03061604|Octreotide|octreotide|mesh-list
57123449|NCT03061604|Hemostatics|hemostatics|mesh-list
57123450|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123451|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57123452|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57123453|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123454|NCT03061604|Coagulants|coagulants|mesh-ancestor
57123455|NCT04974944|Paclitaxel|paclitaxel|mesh-list
57123456|NCT04974944|Bevacizumab|bevacizumab|mesh-list
57123457|NCT04974944|Carboplatin|carboplatin|mesh-list
57123458|NCT04974944|Apatinib|apatinib|mesh-list
57123459|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57123460|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123461|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
57123462|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
57123463|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
57123464|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123465|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57123466|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57123467|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57123468|NCT04974944|Growth Substances|growth substances|mesh-ancestor
57123469|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123470|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
57123471|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123472|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123473|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57123474|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57123475|NCT04962386|Hormones|hormones|mesh-list
57123476|NCT04962386|Estradiol|estradiol|mesh-list
57123477|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57123478|NCT04962386|Progesterone|progesterone|mesh-list
57123479|NCT04962386|Estrogens|estrogens|mesh-list
57123480|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57123481|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123482|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57123483|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
57123484|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57123485|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57123486|NCT04962386|Progestins|progestins|mesh-ancestor
57123487|NCT02071355|Simeprevir|simeprevir|mesh-list
57123488|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
57123489|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123490|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
57123491|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123492|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123493|NCT02071433|Iodine|iodine|mesh-list
57123494|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57123495|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123496|NCT02071433|Trace Elements|trace elements|mesh-ancestor
57123497|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
57123498|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123499|NCT04962308|Vaccines|vaccines|mesh-list
57123500|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
57123501|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123502|NCT02071589|Nifedipine|nifedipine|mesh-list
57123503|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57123504|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57123505|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123506|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57123507|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123508|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
57123509|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
57123510|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57123511|NCT04970342|Alprazolam|alprazolam|mesh-list
57123512|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123513|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57123514|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123515|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123516|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57123517|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123518|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57123519|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57123520|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
57123521|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
57123522|NCT02077751|Biotin|biotin|mesh-list
57123523|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
57123524|NCT02077751|Vitamins|vitamins|mesh-ancestor
57123525|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
57123526|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805366|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57123527|NCT04961684|Amorolfine|amorolfine|mesh-list
57123528|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
57123529|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123530|NCT03061058|Docetaxel|docetaxel|mesh-list
57123531|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
57123532|NCT03061058|Irinotecan|irinotecan|mesh-list
57123533|NCT03061058|Pemetrexed|pemetrexed|mesh-list
57123534|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123535|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
57123536|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
57123537|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
57123538|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123539|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57123540|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57123541|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123542|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57123543|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123544|NCT04961918|Durvalumab|durvalumab|mesh-list
57123545|NCT04961918|Lenvatinib|lenvatinib|mesh-list
57123546|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57123547|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123548|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123549|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123550|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123551|NCT04954040|Azithromycin|azithromycin|mesh-list
57123552|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
57123553|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57123554|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123555|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
57123556|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57123557|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57123558|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123559|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123560|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123561|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
57123562|NCT04424654|Testosterone|testosterone|mesh-list
57123563|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
57123564|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
57123565|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
57123566|NCT04424654|Androgens|androgens|mesh-ancestor
57123567|NCT04424654|Hormones|hormones|mesh-ancestor
57123568|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57123569|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123570|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57123571|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123572|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
57123573|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
57123574|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
57123575|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57123576|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123577|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123578|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57123579|NCT04968392|Analgesics|analgesics|mesh-ancestor
57123580|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
57123581|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123582|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57123583|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57123584|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57123585|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
57123586|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123587|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123588|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
57123589|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
57123590|NCT02792699|Rituximab|rituximab|mesh-list
57123591|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57123592|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123593|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
57123594|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123595|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123596|NCT04968002|Apatinib|apatinib|mesh-list
57123597|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123598|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123599|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123600|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123601|NCT04961138|Lenvatinib|lenvatinib|mesh-list
57123602|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123603|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123604|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123605|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123606|NCT03061136|Clonazepam|clonazepam|mesh-list
57123607|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
57123608|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
57123609|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
57123610|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123611|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123612|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123613|NCT04952792|Apixaban|apixaban|mesh-list
57123614|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57123615|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
57123616|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57123617|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
57123618|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123619|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123620|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
57123621|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57123622|NCT02080169|Fentanyl|fentanyl|mesh-list
57123623|NCT02080169|Midazolam|midazolam|mesh-list
57123624|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
57123625|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57123626|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123627|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123628|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57123629|NCT02080169|Analgesics|analgesics|mesh-ancestor
57123630|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
57123631|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123632|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57123633|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57123634|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57123635|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
57123636|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123637|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123638|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57123639|NCT02080169|Narcotics|narcotics|mesh-ancestor
57123640|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57123641|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57123642|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
57123643|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
57123644|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57123645|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57123646|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57123647|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
57123648|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
57123649|NCT02078063|Mepivacaine|mepivacaine|mesh-list
57123650|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
57123651|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
57123652|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123653|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123654|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
57123655|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123656|NCT04951856|Evolocumab|evolocumab|mesh-list
57123657|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57123658|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57123659|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
57123660|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123661|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57123662|NCT04951232|Cinepazide|cinepazide|mesh-list
57123663|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
57123664|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
57123665|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
57123666|NCT04959578|Hematinics|hematinics|mesh-ancestor
57123667|NCT04959500|Temozolomide|temozolomide|mesh-list
57123668|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57123669|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
57123670|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123671|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123672|NCT04950530|Emtricitabine|emtricitabine|mesh-list
57123673|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
57123674|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123675|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57123676|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123677|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123678|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123679|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57123680|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57123681|NCT02076191|Decitabine|decitabine|mesh-list
57123682|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57123683|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
57123684|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123685|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123686|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123687|NCT02080715|Tolcapone|tolcapone|mesh-list
57123688|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57123689|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57123690|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
57123691|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123692|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123693|NCT04965662|Tenofovir|tenofovir|mesh-list
57123694|NCT04965662|Emtricitabine|emtricitabine|mesh-list
57123695|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57123696|NCT04965662|Maraviroc|maraviroc|mesh-list
57123697|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
57123698|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123699|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57123700|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123701|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123702|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123703|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57123704|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57123705|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57123706|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57123707|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
57123708|NCT02078609|Midostaurin|midostaurin|mesh-list
57123709|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123710|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123711|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123712|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123713|NCT04957940|SMOFlipid|smoflipid|mesh-list
57123714|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
57123715|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57123716|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57123717|NCT03060278|Nicotine|nicotine|mesh-list
57123718|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57123719|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
57123720|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123721|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123722|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57123723|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57123724|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
57123725|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123726|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123727|NCT02083991|Prednisolone|prednisolone|mesh-list
57123728|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
57123729|NCT02083991|Basiliximab|basiliximab|mesh-list
57123730|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123731|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
57123732|NCT02083991|Hormones|hormones|mesh-ancestor
57123733|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57123734|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123735|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57123736|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123737|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
57123738|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123739|NCT02081027|Riluzole|riluzole|mesh-list
57123740|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
57123741|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57123742|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57123743|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123744|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123745|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123746|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57123747|NCT02081027|Protective Agents|protective agents|mesh-ancestor
57123748|NCT04947956|Apatinib|apatinib|mesh-list
57123749|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123750|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123751|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123752|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123753|NCT03254511|Enoxaparin|enoxaparin|mesh-list
56805590|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
57123754|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
57123755|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
57123756|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57123757|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57123758|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123759|NCT04947566|Ibuprofen|ibuprofen|mesh-list
57123760|NCT04947566|Naproxen|naproxen|mesh-list
57123761|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57123762|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57123763|NCT04947566|Analgesics|analgesics|mesh-ancestor
57123764|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
57123765|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123766|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123767|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123768|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123769|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57123770|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123771|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123772|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
57123773|NCT03241875|Pregabalin|pregabalin|mesh-list
57123774|NCT03241875|Gabapentin|gabapentin|mesh-list
57123775|NCT03241875|Analgesics|analgesics|mesh-ancestor
57123776|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
57123777|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123778|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123779|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
57123780|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57123781|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57123782|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123783|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57123784|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57123785|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57123786|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123787|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57123788|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57123789|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57123790|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123791|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
57123792|NCT03058094|Pemetrexed|pemetrexed|mesh-list
57123793|NCT03058094|Abivertinib|abivertinib|mesh-list
57123794|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123795|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123796|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123797|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57123798|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123799|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123800|NCT04413266|Curcumin|curcumin|mesh-list
57123801|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57123802|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57123803|NCT04413266|Analgesics|analgesics|mesh-ancestor
57123804|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
57123805|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123806|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123807|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123808|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123809|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123810|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123811|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123812|NCT04944524|Methotrexate|methotrexate|mesh-list
57123813|NCT04944524|Tofacitinib|tofacitinib|mesh-list
57123814|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57123815|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
57123816|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57123817|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123818|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57123819|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
57123820|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123821|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123822|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
57123823|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123824|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57123825|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123826|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
57123827|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123828|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123829|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57123830|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57123831|NCT04412876|Imipramine|imipramine|mesh-list
57123832|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57123833|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57123834|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57123835|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123836|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123837|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123838|NCT04412876|Analgesics|analgesics|mesh-ancestor
57123839|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
57123840|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123841|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
57123842|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57123843|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
57123844|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57123845|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57123846|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
57123847|NCT03241563|Triamcinolone|triamcinolone|mesh-list
57123848|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
57123849|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57123850|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
57123851|NCT03241563|Hormones|hormones|mesh-ancestor
57123852|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57123853|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123854|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57123855|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57123856|NCT03241641|Tenofovir|tenofovir|mesh-list
57123857|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
57123858|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123859|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57123860|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57123861|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123862|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123863|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57123864|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57123865|NCT04486521|Siltuximab|siltuximab|mesh-list
57123866|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123867|NCT04955834|Insulin|insulin|mesh-list
57123868|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57123869|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123870|NCT03241407|Triclosan|triclosan|mesh-list
57123871|NCT03241407|Fluorides|fluorides|mesh-list
57123872|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
57123873|NCT03241407|Protective Agents|protective agents|mesh-ancestor
57123874|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123875|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57123876|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123877|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57123878|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57123879|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
57123880|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123881|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57123882|NCT03238131|Ivermectin|ivermectin|mesh-list
57123883|NCT03238131|Albendazole|albendazole|mesh-list
57123884|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57123885|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123886|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
57123887|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
57123888|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57123889|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57123890|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
57123891|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
57123892|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
57123893|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123894|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123895|NCT01369433|Sirolimus|sirolimus|mesh-list
57123896|NCT01369433|Paclitaxel|paclitaxel|mesh-list
57123897|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57123898|NCT01369433|Capecitabine|capecitabine|mesh-list
57123899|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57123900|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123901|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
57123902|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
57123903|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
57123904|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123905|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57123907|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57123908|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123909|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57123910|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
57123911|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123912|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
57123913|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123914|NCT04946162|Tadalafil|tadalafil|mesh-list
57123915|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
57123916|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57123917|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57123918|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123919|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123920|NCT04946162|Urological Agents|urological agents|mesh-ancestor
57123921|NCT02084225|Lidocaine|lidocaine|mesh-list
57123922|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
57123923|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
57123924|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123925|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123926|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
57123927|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123928|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57123929|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57123930|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57123931|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57123932|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123933|NCT04945694|Fentanyl|fentanyl|mesh-list
57123934|NCT04945694|Propofol|propofol|mesh-list
57123935|NCT04945694|Sevoflurane|sevoflurane|mesh-list
57123936|NCT04945694|Atracurium|atracurium|mesh-list
57123937|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57123938|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123939|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123940|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57123941|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
57123942|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
57123943|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57123944|NCT04945694|Narcotics|narcotics|mesh-ancestor
57123945|NCT04945694|Analgesics|analgesics|mesh-ancestor
57123946|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
57123947|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57123948|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57123949|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57123950|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57123951|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57123952|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57123953|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57123954|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
57123955|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57123956|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
57123957|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123958|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123959|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57123960|NCT02084303|Hematinics|hematinics|mesh-ancestor
57123961|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57123962|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57123963|NCT02420847|Gemcitabine|gemcitabine|mesh-list
57123964|NCT02420847|Doxorubicin|doxorubicin|mesh-list
57123965|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57123966|NCT02420847|Ixazomib|ixazomib|mesh-list
57123967|NCT02420847|Glycine|glycine|mesh-list
57123968|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57123969|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
57123970|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123971|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57123972|NCT02420847|Antiviral Agents|antiviral agents|mesh-ancestor
57123973|NCT02420847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123974|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123975|NCT02420847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57123976|NCT02420847|Immunologic Factors|immunologic factors|mesh-ancestor
57123977|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805814|NCT01025882|Gemcitabine|gemcitabine|mesh-list
57123978|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57123979|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57123980|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57123981|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
57123982|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
57123983|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57123984|NCT03253887|Ethanol|ethanol|mesh-list
57123985|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57123986|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123987|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57123988|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57123989|NCT02453607|Infliximab|infliximab|mesh-list
57123990|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
57123991|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57123992|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57123993|NCT02453529|Nafithromycin|nafithromycin|mesh-list
57123994|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57123995|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57123996|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57123997|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57123998|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57123999|NCT03241017|Durvalumab|durvalumab|mesh-list
57124000|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124001|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124002|NCT03237741|Rabeprazole|rabeprazole|mesh-list
57124003|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57124004|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124005|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57124006|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124007|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124008|NCT03240939|Tadalafil|tadalafil|mesh-list
57124009|NCT03240939|Dutasteride|dutasteride|mesh-list
57124010|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
57124011|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57124012|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57124013|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124014|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124015|NCT03240939|Urological Agents|urological agents|mesh-ancestor
57124016|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57124017|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57124018|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
57124019|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57124020|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124021|NCT02624492|Rituximab|rituximab|mesh-list
57124022|NCT02624492|BI 836826|bi 836826|mesh-list
57124023|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124024|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124025|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
57124026|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124027|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57124028|NCT03240783|Dexamethasone|dexamethasone|mesh-list
57124029|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
57124030|NCT03240783|Betamethasone|betamethasone|mesh-list
57124031|NCT03240783|BB 1101|bb 1101|mesh-list
57124032|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57124033|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
57124034|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
57124035|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124036|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124037|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124038|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
57124039|NCT03240783|Hormones|hormones|mesh-ancestor
56902252|NCT05615025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124040|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57124041|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57124042|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124043|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
57124044|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124045|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124046|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57124047|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
57124048|NCT03237507|Paclitaxel|paclitaxel|mesh-list
57124049|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
57124050|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57124051|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124052|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
57124053|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
57124054|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
57124055|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124056|NCT04945226|Finasteride|finasteride|mesh-list
57124057|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57124058|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57124059|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124060|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124061|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
57124062|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57124063|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124064|NCT04945226|Urological Agents|urological agents|mesh-ancestor
57124066|NCT01975831|Tremelimumab|tremelimumab|mesh-list
57124067|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124068|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124069|NCT04945070|Insulin|insulin|mesh-list
57124070|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57124071|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124072|NCT03240471|Calpastatin|calpastatin|mesh-list
57124073|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
57124074|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
57124075|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124076|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124077|NCT04942652|Itraconazole|itraconazole|mesh-list
57124078|NCT04942652|Esomeprazole|esomeprazole|mesh-list
57124079|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57124080|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124081|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57124082|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124083|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124084|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
57124085|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124086|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57124087|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57124088|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57124089|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
57124090|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57124091|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124092|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57124093|NCT03240549|Bevacizumab|bevacizumab|mesh-list
57124094|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124095|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124096|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57124097|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57124098|NCT03240549|Growth Substances|growth substances|mesh-ancestor
57124099|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124100|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
57124101|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
57124102|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
57124103|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57124104|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57124105|NCT04933292|Prednisolone|prednisolone|mesh-list
57124106|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
57124107|NCT04933292|Azathioprine|azathioprine|mesh-list
57124108|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57124109|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
57124110|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57124111|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124112|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57124113|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
57124114|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57124115|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124116|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124117|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124118|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57124119|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
57124120|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
57124121|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124122|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124123|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124124|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
57124125|NCT04933292|Hormones|hormones|mesh-ancestor
56805961|NCT01026428|Levodopa|levodopa|mesh-list
57124126|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57124127|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57124128|NCT04933292|Protective Agents|protective agents|mesh-ancestor
57124129|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57124131|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57124132|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57124133|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
57124134|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57124135|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
57124136|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57124137|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57124138|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124139|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
57124140|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
57124141|NCT04941872|FAPI-46|fapi-46|mesh-list
57124142|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57124143|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124144|NCT03237117|Hormones|hormones|mesh-list
57124145|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57124146|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124147|NCT03239691|ACT-709478|act-709478|mesh-list
57124148|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57124149|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124150|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124151|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57124152|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124153|NCT04944602|Omalizumab|omalizumab|mesh-list
57124154|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57124155|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57124156|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
57124157|NCT03253107|Trastuzumab|trastuzumab|mesh-list
57124158|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124159|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124160|NCT03236883|Gemcitabine|gemcitabine|mesh-list
57124161|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57124162|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
57124163|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124164|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124165|NCT03236883|Antiviral Agents|antiviral agents|mesh-ancestor
57124166|NCT03236883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124167|NCT03236883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124168|NCT03236883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57124169|NCT03236883|Immunologic Factors|immunologic factors|mesh-ancestor
57124170|NCT03236883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124171|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
57124172|NCT03236961|Metronidazole|metronidazole|mesh-list
57124173|NCT03236961|Levofloxacin|levofloxacin|mesh-list
57124174|NCT03236961|Ertapenem|ertapenem|mesh-list
57124175|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57124176|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124177|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57124178|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57124179|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124180|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124181|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124182|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57124183|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57124184|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57124185|NCT03236961|Renal Agents|renal agents|mesh-ancestor
57124186|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57124187|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57124188|NCT05234619|Ketorolac|ketorolac|mesh-list
57124189|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57124190|NCT05234619|Lidocaine|lidocaine|mesh-list
57124191|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
57124192|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
57124193|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124194|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124195|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
57124196|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124197|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57124198|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57124199|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57124200|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124201|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124202|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57124203|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57124204|NCT05234619|Analgesics|analgesics|mesh-ancestor
57124205|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57124206|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57124207|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57124208|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124209|NCT04921904|Ramucirumab|ramucirumab|mesh-list
57124210|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124211|NCT02622386|Riboflavin|riboflavin|mesh-list
57124212|NCT02622386|Vitamins|vitamins|mesh-ancestor
57124213|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
57124214|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124215|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
57124216|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57124217|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
57124218|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
57124219|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57124220|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57124221|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124222|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
57124223|NCT04427618|Coagulants|coagulants|mesh-ancestor
57124224|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
57124225|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57124226|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124227|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124228|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57124229|NCT03236727|Analgesics|analgesics|mesh-ancestor
57124230|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
57124231|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124232|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57124233|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57124234|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57124235|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
57124236|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124237|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124238|NCT03236493|PF-06700841|pf-06700841|mesh-list
57124239|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57124240|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124241|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124242|NCT04921124|Teriparatide|teriparatide|mesh-list
57124243|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57124244|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124245|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57124246|NCT04921046|Lidocaine|lidocaine|mesh-list
57124247|NCT04921046|Midazolam|midazolam|mesh-list
57124248|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57124249|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57124250|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124251|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124252|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57124253|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57124254|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57124255|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57124256|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
57124257|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
57124258|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
57124259|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
57124260|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124261|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124262|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
57124263|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
57124264|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124265|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57124266|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57124267|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57124268|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124269|NCT02792231|Teriflunomide|teriflunomide|mesh-list
57124270|NCT02792231|Ofatumumab|ofatumumab|mesh-list
57124271|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57124272|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124273|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
57124274|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124275|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57124277|NCT02792231|Analgesics|analgesics|mesh-ancestor
57124278|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
57124279|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124280|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57124281|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57124282|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57124283|NCT04930952|Ethanol|ethanol|mesh-list
57124284|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57124285|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124286|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124287|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124288|NCT04920968|Rituximab|rituximab|mesh-list
57124289|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
57124290|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124291|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124292|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
57124293|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124294|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57124295|NCT00700401|Ribavirin|ribavirin|mesh-list
57124296|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57124297|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
57124298|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124299|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
57124300|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124301|NCT04931108|Atenolol|atenolol|mesh-list
57124302|NCT04931108|Nitrendipine|nitrendipine|mesh-list
57124303|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57124304|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57124305|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
57124306|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
57124307|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124308|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124309|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57124310|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57124311|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57124312|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
57124313|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124314|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124315|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57124316|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124317|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57124318|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
57124319|NCT04930562|Belumosudil|belumosudil|mesh-list
57124320|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57124321|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124322|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124323|NCT04920500|Cytarabine|cytarabine|mesh-list
57124324|NCT04920500|Daunorubicin|daunorubicin|mesh-list
57124325|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57124326|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
57124327|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124328|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124329|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
57124330|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124331|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57124332|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
57124333|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124334|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57124335|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57124336|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57124337|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124338|NCT02084615|Aspirin|aspirin|mesh-list
57124339|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57124340|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57124341|NCT02084615|Analgesics|analgesics|mesh-ancestor
57124342|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
57124343|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124344|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124345|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57124346|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57124347|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57124348|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57124349|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124350|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57124351|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57124352|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124353|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
57124354|NCT03559751|Nicotine|nicotine|mesh-list
57124355|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57124356|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
57124357|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124358|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124359|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57124360|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57124361|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
57124362|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124363|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124364|NCT03234699|Midazolam|midazolam|mesh-list
57124365|NCT03234699|Cenobamate|cenobamate|mesh-list
57124366|NCT03234699|Bupropion|bupropion|mesh-list
57124367|NCT03234699|Omeprazole|omeprazole|mesh-list
57124368|NCT03234699|Warfarin|warfarin|mesh-list
57124369|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57124370|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57124371|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124372|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124373|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57124374|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57124375|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57124376|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57124377|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
57124378|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
57124379|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
57124380|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
57124381|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124382|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124383|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
57124384|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57124385|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124386|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57124387|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124388|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57124389|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
57124390|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57124391|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57124392|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124393|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
57124394|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57124395|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57124396|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
57124397|NCT03559673|Lacosamide|lacosamide|mesh-list
57124398|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
56902270|NCT02055586|Fluorides|fluorides|mesh-list
57124399|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57124400|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57124401|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124402|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124403|NCT03228771|Atorvastatin|atorvastatin|mesh-list
57124404|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57124405|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57124406|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
57124407|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124408|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57124409|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57124410|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124411|NCT02081339|Ranibizumab|ranibizumab|mesh-list
57124412|NCT02081339|Aflibercept|aflibercept|mesh-list
57124413|NCT02081339|Verteporfin|verteporfin|mesh-list
57124414|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57124415|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57124416|NCT02081339|Growth Substances|growth substances|mesh-ancestor
57124417|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124418|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
57124419|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124420|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57124421|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
57124422|NCT04939766|Insulin|insulin|mesh-list
57124423|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57124424|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124425|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57124426|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
57124427|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124429|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124430|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
57124431|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57124432|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
57124433|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124434|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124435|NCT03235947|Trimethoprim|trimethoprim|mesh-list
57124436|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
57124437|NCT03235947|Fosfomycin|fosfomycin|mesh-list
57124438|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57124439|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124440|NCT03235947|Renal Agents|renal agents|mesh-ancestor
57124441|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
57124442|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57124443|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57124444|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57124445|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124446|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124447|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57124448|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57124449|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57124450|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57124451|NCT03057470|Insulin|insulin|mesh-list
57124452|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57124453|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57124454|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124455|NCT02871401|Valganciclovir|valganciclovir|mesh-list
57124456|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
57124457|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124458|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
57124459|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124460|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57124461|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124462|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124463|NCT02085005|Capecitabine|capecitabine|mesh-list
57124464|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
57124465|NCT02085005|Aflibercept|aflibercept|mesh-list
57124466|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57124467|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
57124468|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124469|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124470|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57124471|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56413694|NCT00183911|Leucovorin|leucovorin|mesh-list
57124472|NCT02085005|Growth Substances|growth substances|mesh-ancestor
57124473|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124474|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
57124475|NCT03235869|Durvalumab|durvalumab|mesh-list
57124476|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124477|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124478|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57124479|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
57124480|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124481|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
57124482|NCT03057314|Calcium|calcium|mesh-list
57124483|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57124484|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124485|NCT03057314|Antacids|antacids|mesh-ancestor
57124486|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124487|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124488|NCT02576509|Nivolumab|nivolumab|mesh-list
57124489|NCT02576509|Sorafenib|sorafenib|mesh-list
57124490|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124491|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124492|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57124493|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124494|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57124495|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124496|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57124497|NCT02081495|Doxorubicin|doxorubicin|mesh-list
57124498|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57124499|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124500|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57124501|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57124502|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124503|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124505|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124506|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57124507|NCT03056846|Renal Agents|renal agents|mesh-ancestor
57124508|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
57124509|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57124510|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57124511|NCT03227679|Bupropion|bupropion|mesh-list
57124512|NCT03227679|Nicotine|nicotine|mesh-list
57124513|NCT03227679|Varenicline|varenicline|mesh-list
57124514|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57124515|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
57124516|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124517|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124518|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57124519|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57124520|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
57124521|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124522|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124523|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57124524|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
57124525|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57124526|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57124527|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57124528|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124529|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
57124530|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57124531|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57124532|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124533|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57124534|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57124535|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57124536|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124537|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124538|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
57124539|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124540|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124541|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57124542|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124543|NCT04937894|Tigecycline|tigecycline|mesh-list
57124544|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57124545|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124546|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57124547|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124548|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124549|NCT04919252|Vedolizumab|vedolizumab|mesh-list
57124550|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124551|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
57124552|NCT04919174|Remifentanil|remifentanil|mesh-list
57124553|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57124554|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124555|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124556|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57124557|NCT04919174|Analgesics|analgesics|mesh-ancestor
57124558|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
57124559|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124560|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57124561|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57124562|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57124563|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
57124564|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124565|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124566|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57124567|NCT04919174|Narcotics|narcotics|mesh-ancestor
57124568|NCT02085239|Lidocaine|lidocaine|mesh-list
57124569|NCT02085239|Ropivacaine|ropivacaine|mesh-list
57124570|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
57124571|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
57124572|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124573|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124574|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
57124575|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124576|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57124577|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57124578|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57124579|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124580|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124581|NCT05143489|Lidocaine|lidocaine|mesh-list
57124582|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
57124583|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
57124584|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124585|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124586|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
57124587|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124588|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57124589|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57124590|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57124591|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124592|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124593|NCT02085317|Nitroprusside|nitroprusside|mesh-list
57124594|NCT02085317|Acetylcholine|acetylcholine|mesh-list
57124595|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57124596|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
57124597|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57124598|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124599|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57124600|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
57124601|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124602|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124603|NCT03234153|Durvalumab|durvalumab|mesh-list
57124604|NCT03234153|Tremelimumab|tremelimumab|mesh-list
57124605|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
57124606|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124607|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124608|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124609|NCT03056924|Vaccines|vaccines|mesh-list
57124610|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
57124611|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124612|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
57124613|NCT04929626|Albuterol|albuterol|mesh-list
57124614|NCT04929626|Analgesics|analgesics|mesh-ancestor
57124615|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
57124616|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124617|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124618|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
56902274|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
57124619|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124620|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57124621|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
57124622|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57124623|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124624|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124625|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57124626|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
57124627|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57124628|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57124629|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
57124630|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57124631|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
57124632|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57124633|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57124634|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57124635|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
57124636|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124637|NCT05523401|Psilocybin|psilocybin|mesh-list
57124638|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
57124639|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
57124640|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
57124641|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124642|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57124643|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
57124644|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124645|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124646|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57124647|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57124648|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124650|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57124651|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57124652|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57124653|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
57124654|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57124655|NCT04918862|Granisetron|granisetron|mesh-list
57124656|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
57124657|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
57124658|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124659|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124660|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124661|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57124662|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
57124663|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124664|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124665|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
57124666|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57124667|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124668|NCT02081885|Chitosan|chitosan|mesh-list
57124669|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57124670|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57124671|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
57124672|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124673|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57124674|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
57124675|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
57124676|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
57124677|NCT02081885|Coagulants|coagulants|mesh-ancestor
57124678|NCT04431206|Oxytocin|oxytocin|mesh-list
57124679|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
57124680|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57124681|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124682|NCT03235245|Nivolumab|nivolumab|mesh-list
57124683|NCT03235245|Ipilimumab|ipilimumab|mesh-list
57124684|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124685|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124686|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57124687|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124688|NCT02452281|Ipilimumab|ipilimumab|mesh-list
57124689|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124690|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124691|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57124692|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124693|NCT02452125|Nicotine|nicotine|mesh-list
57124694|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57124695|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
57124696|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124697|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124698|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57124699|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57124700|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
57124701|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124702|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124703|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
57124704|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
57124705|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57124706|NCT02619812|Antibodies|antibodies|mesh-list
57124707|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
57124708|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124709|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57124710|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57124711|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
57124712|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124713|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57124714|NCT04928066|Prednisone|prednisone|mesh-list
57124715|NCT04928066|Tofacitinib|tofacitinib|mesh-list
57124716|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57124717|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
57124718|NCT04928066|Hormones|hormones|mesh-ancestor
57124719|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57124720|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806566|NCT01030094|Topiramate|topiramate|mesh-list
57124721|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57124722|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124723|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57124724|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124725|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124726|NCT03222765|Metformin|metformin|mesh-list
57124727|NCT03222765|Linagliptin|linagliptin|mesh-list
57124728|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57124729|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124730|NCT03222765|Incretins|incretins|mesh-ancestor
57124731|NCT03222765|Hormones|hormones|mesh-ancestor
57124732|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57124733|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57124734|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
57124735|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124736|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124737|NCT04485585|Tamsulosin|tamsulosin|mesh-list
57124738|NCT04485585|Mirabegron|mirabegron|mesh-list
57124739|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57124740|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57124741|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57124742|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
57124743|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124744|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124745|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124746|NCT04485585|Urological Agents|urological agents|mesh-ancestor
57124747|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57124748|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57124749|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57124750|NCT03222687|Prednisone|prednisone|mesh-list
57124751|NCT03222687|Tacrolimus|tacrolimus|mesh-list
57124752|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57124753|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
57124754|NCT03222687|Hormones|hormones|mesh-ancestor
57124755|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57124756|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124757|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57124758|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124759|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57124760|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
57124761|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57124762|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124763|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124764|NCT03055442|Inositol|inositol|mesh-list
57124765|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
57124766|NCT03055442|Vitamins|vitamins|mesh-ancestor
57124767|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
57124768|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124769|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
57124770|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
57124771|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124772|NCT03226431|Protective Agents|protective agents|mesh-ancestor
57124773|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124774|NCT03226431|Vitamins|vitamins|mesh-ancestor
57124775|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
57124776|NCT02451579|Cetirizine|cetirizine|mesh-list
57124777|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
57124778|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
57124779|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57124780|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57124781|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
57124782|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124783|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124784|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124785|NCT04935788|Caseins|caseins|mesh-list
57124786|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
57124787|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
57124788|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124789|NCT03233295|Vitamin D|vitamin d|mesh-list
57124790|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
57124791|NCT03233295|Vitamins|vitamins|mesh-ancestor
57124792|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
57124793|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124794|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57124795|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57124796|NCT04917458|Vitamin D|vitamin d|mesh-list
57124797|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
57124798|NCT04917458|Vitamins|vitamins|mesh-ancestor
57124799|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
57124800|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124801|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57124802|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57124803|NCT03225963|Temozolomide|temozolomide|mesh-list
57124804|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57124805|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
57124806|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124807|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124808|NCT03221907|Pregabalin|pregabalin|mesh-list
57124809|NCT03221907|Analgesics|analgesics|mesh-ancestor
57124810|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
57124811|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124812|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124813|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
57124814|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57124815|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124816|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124817|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57124818|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57124819|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57124820|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124821|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57124822|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57124823|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
57124824|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57124825|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
57124826|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124827|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124828|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124829|NCT03107481|Acetaminophen|acetaminophen|mesh-list
57124830|NCT03107481|Hydromorphone|hydromorphone|mesh-list
57124831|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57124832|NCT03107481|Analgesics|analgesics|mesh-ancestor
55896990|NCT02387554|Losartan|losartan|mesh-list
57124833|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
57124834|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124835|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124836|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
57124837|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57124838|NCT03107481|Narcotics|narcotics|mesh-ancestor
57124839|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124840|NCT04934852|Ephedrine|ephedrine|mesh-list
57124841|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
57124842|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57124843|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124844|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
57124845|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
57124846|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124847|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57124848|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
57124849|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124850|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124851|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57124852|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57124853|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
57124854|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
57124855|NCT04934618|Irinotecan|irinotecan|mesh-list
57124856|NCT04934618|Apatinib|apatinib|mesh-list
57124857|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57124858|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57124859|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124860|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124861|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124862|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57124863|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57124864|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57124865|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124866|NCT04916522|Colchicine|colchicine|mesh-list
57124867|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
57124868|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57124869|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
56806726|NCT01030796|Caffeine|caffeine|mesh-list
57124870|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
57124871|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
57124872|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124873|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124875|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
57124876|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57124877|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124878|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57124879|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124880|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
57124881|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57124882|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57124883|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
57124884|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124885|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57124886|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57124887|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124888|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124889|NCT03220815|Methamphetamine|methamphetamine|mesh-list
57124890|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57124891|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124892|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
57124893|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
57124894|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124895|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
57124896|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124897|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124898|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
57124899|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57124900|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57124901|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57124902|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57124903|NCT01529593|Metformin|metformin|mesh-list
57124904|NCT01529593|Sirolimus|sirolimus|mesh-list
57124905|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57124906|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124907|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57124908|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124909|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57124910|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124911|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
57124912|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57124913|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
57124914|NCT04913402|Sufentanil|sufentanil|mesh-list
57124915|NCT04913402|Dsuvia|dsuvia|mesh-list
57124916|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57124917|NCT04913402|Narcotics|narcotics|mesh-ancestor
57124918|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57124919|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124920|NCT04913402|Analgesics|analgesics|mesh-ancestor
57124921|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
57124922|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124923|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57124924|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57124925|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
57124926|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
57124927|NCT04912934|Insulin|insulin|mesh-list
57124928|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57124929|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124930|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57124931|NCT04915586|Plasminogen|plasminogen|mesh-list
57124932|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57124933|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57124934|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124935|NCT01446133|Rituximab|rituximab|mesh-list
57124936|NCT01446133|Lenalidomide|lenalidomide|mesh-list
57124937|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124938|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124939|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
57124940|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124941|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57124942|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57124943|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57124944|NCT01446133|Growth Substances|growth substances|mesh-ancestor
56806799|NCT03011684|Tamoxifen|tamoxifen|mesh-list
57124945|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
57124946|NCT03232125|Ramosetron|ramosetron|mesh-list
57124947|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
57124948|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
57124949|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124950|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124951|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124952|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57124953|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
57124954|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57124955|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124956|NCT03224637|Acetaminophen|acetaminophen|mesh-list
57124957|NCT03224637|Ketorolac|ketorolac|mesh-list
57124958|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57124959|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57124960|NCT03224637|Analgesics|analgesics|mesh-ancestor
57124961|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
57124962|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57124963|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124964|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
57124965|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57124966|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57124967|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57124968|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57124969|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57124970|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124971|NCT04912700|Vaccines|vaccines|mesh-list
57124972|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
57124973|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124974|NCT03224871|Aldesleukin|aldesleukin|mesh-list
57124975|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
57124976|NCT03224871|Nivolumab|nivolumab|mesh-list
57124977|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57124978|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57124979|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57124980|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57124981|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57124982|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57124983|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
57124984|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57124985|NCT03220425|Insulin|insulin|mesh-list
57124986|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57124987|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
57124988|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
57124989|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
57124990|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
57124991|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57124992|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57124993|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
57124994|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57124995|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124996|NCT04402346|Pancrelipase|pancrelipase|mesh-list
57124997|NCT04402346|Pancreatin|pancreatin|mesh-list
57124998|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57124999|NCT03220191|Palbociclib|palbociclib|mesh-list
57125000|NCT03220191|Rabeprazole|rabeprazole|mesh-list
57125001|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125002|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57125003|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125004|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125005|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57125006|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125007|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57125008|NCT03220113|Thiamine|thiamine|mesh-list
57125009|NCT03220113|Dexamethasone|dexamethasone|mesh-list
57125010|NCT03220113|Lidocaine|lidocaine|mesh-list
57125011|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57125012|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
57125013|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
57125014|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125015|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125016|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125017|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
57125018|NCT03220113|Hormones|hormones|mesh-ancestor
57125019|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806882|NCT01024712|Paclitaxel|paclitaxel|mesh-list
57125020|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57125021|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125022|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
57125023|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
57125024|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125025|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
57125026|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57125027|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57125028|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57125029|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57125030|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125031|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
57125032|NCT03220113|Vitamins|vitamins|mesh-ancestor
57125033|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
57125034|NCT02254525|Ibuprofen|ibuprofen|mesh-list
57125035|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57125036|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57125037|NCT02254525|Analgesics|analgesics|mesh-ancestor
57125038|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
57125039|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125040|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125041|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57125042|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57125043|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57125044|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125045|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125046|NCT03231813|Emollients|emollients|mesh-list
57125047|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
57125048|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
57125049|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
57125050|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57125051|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125052|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125053|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
57125054|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57125055|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125056|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125057|NCT02143531|Haloperidol|haloperidol|mesh-list
57125058|NCT02143531|Ondansetron|ondansetron|mesh-list
57125059|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
57125060|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
57125061|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
57125062|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125063|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125064|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125065|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
57125066|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
57125067|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57125068|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
57125069|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125070|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125071|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57125072|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57125073|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125074|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57125075|NCT02143531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57125076|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57125077|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
57125078|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57125079|NCT04485117|Anesthetics|anesthetics|mesh-list
57125080|NCT04485117|Propofol|propofol|mesh-list
57125081|NCT04485117|Sevoflurane|sevoflurane|mesh-list
57125082|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125083|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125084|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57125085|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57125086|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
57125087|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57125088|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57125089|NCT00803569|Sargramostim|sargramostim|mesh-list
57125090|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
57125091|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125092|NCT02143687|Sevoflurane|sevoflurane|mesh-list
57125093|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57125094|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57125095|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
57125096|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
57125097|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125098|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125100|NCT02143765|Mitiglinide|mitiglinide|mesh-list
57125101|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57125102|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125103|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125104|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57125105|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125106|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
57125107|NCT02148367|Hematinics|hematinics|mesh-ancestor
57125108|NCT00482833|Methotrexate|methotrexate|mesh-list
57125109|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
57125110|NCT00482833|Idarubicin|idarubicin|mesh-list
57125111|NCT00482833|Tretinoin|tretinoin|mesh-list
57125112|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
57125113|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57125114|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
57125115|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57125116|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125117|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57125118|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
57125119|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125120|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125121|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
57125122|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125123|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57125124|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125125|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
57125126|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57125127|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57125128|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57125129|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57125130|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57125131|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
57125132|NCT02451033|Hormones|hormones|mesh-list
57125133|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57125134|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125135|NCT00390793|Cytarabine|cytarabine|mesh-list
57125136|NCT00390793|Dexamethasone|dexamethasone|mesh-list
57125137|NCT00390793|Prednisone|prednisone|mesh-list
57125138|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
57125139|NCT00390793|Cortisone|cortisone|mesh-list
57125140|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
57125141|NCT00390793|Doxorubicin|doxorubicin|mesh-list
57125142|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57125143|NCT00390793|Methotrexate|methotrexate|mesh-list
57125144|NCT00390793|Vincristine|vincristine|mesh-list
57125145|NCT00390793|Daunorubicin|daunorubicin|mesh-list
57125146|NCT00390793|Dasatinib|dasatinib|mesh-list
57125147|NCT00390793|BB 1101|bb 1101|mesh-list
57125148|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125149|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
57125150|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125151|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57125152|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57125153|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
57125154|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125155|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125156|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57125157|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57125158|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
57125159|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
57125160|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125161|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125162|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
57125163|NCT00390793|Hormones|hormones|mesh-ancestor
57125164|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57125165|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57125166|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57125167|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57125168|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57125169|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125170|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57125171|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
57125172|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57125173|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56807021|NCT00410124|Everolimus|everolimus|mesh-list
57125174|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
57125175|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
57125176|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57125177|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57125178|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
57125179|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125180|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57125181|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
57125182|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
57125183|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
57125184|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57125185|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
57125186|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
57125187|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57125188|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57125189|NCT04485429|Prednisolone|prednisolone|mesh-list
57125190|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
57125191|NCT04485429|Heparin|heparin|mesh-list
57125192|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57125193|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
57125194|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57125195|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
57125196|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
57125197|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125198|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125199|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125200|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
57125201|NCT04485429|Hormones|hormones|mesh-ancestor
57125202|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57125203|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57125204|NCT04485429|Protective Agents|protective agents|mesh-ancestor
57125205|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57125206|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125207|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
57125208|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57125209|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57125210|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125211|NCT00112957|Vaccines|vaccines|mesh-list
57125212|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
57125213|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125214|NCT02140801|Clopidogrel|clopidogrel|mesh-list
57125215|NCT02140801|Ticagrelor|ticagrelor|mesh-list
57125216|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57125217|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57125218|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57125219|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57125220|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
57125221|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125222|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125223|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125224|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57125225|NCT02148601|Vancomycin|vancomycin|mesh-list
57125226|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125227|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
57125228|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
57125229|NCT02141035|Vitamins|vitamins|mesh-ancestor
57125230|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
57125231|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125232|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
57125233|NCT03214653|Propofol|propofol|mesh-list
57125234|NCT03214653|Sevoflurane|sevoflurane|mesh-list
57125235|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57125236|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125237|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125238|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57125239|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
57125240|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
57125241|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57125242|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57125243|NCT02450877|Azacitidine|azacitidine|mesh-list
57125244|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57125245|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
57125246|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125247|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125248|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125249|NCT02141113|Guanfacine|guanfacine|mesh-list
57125250|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57125251|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57125252|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57125253|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57125254|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
57125255|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125256|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125257|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125258|NCT03213639|Esomeprazole|esomeprazole|mesh-list
57125259|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57125260|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125261|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57125262|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125263|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125264|NCT03231033|Pioglitazone|pioglitazone|mesh-list
57125265|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57125266|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125267|NCT02141347|Durvalumab|durvalumab|mesh-list
57125268|NCT02141347|Tremelimumab|tremelimumab|mesh-list
57125269|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57125270|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125271|NCT02254759|Midazolam|midazolam|mesh-list
57125272|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57125273|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57125274|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125275|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125276|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57125277|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57125278|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57125279|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57125280|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
57125281|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
56902293|NCT03778593|Vitamins|vitamins|mesh-ancestor
57125282|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
57125283|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
57125284|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125285|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125286|NCT03208257|Esmolol|esmolol|mesh-list
57125287|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57125288|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57125289|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57125290|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
57125291|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125292|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125293|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125294|NCT02141425|Peficitinib|peficitinib|mesh-list
57125295|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125296|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125297|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125298|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
57125299|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125300|NCT02148913|Melphalan|melphalan|mesh-list
57125301|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57125302|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57125303|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
57125304|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125305|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125306|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57125307|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125308|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
57125309|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125310|NCT03208101|Vaccines|vaccines|mesh-list
57125311|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
57125312|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125313|NCT02149225|Poly I-C|poly i-c|mesh-list
57125314|NCT02149225|Molgramostim|molgramostim|mesh-list
57125315|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
57125316|NCT02149225|Vaccines|vaccines|mesh-list
57125317|NCT02149225|Sargramostim|sargramostim|mesh-list
57125318|NCT02149225|Poly ICLC|poly iclc|mesh-list
57125319|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
57125320|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125321|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125322|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
57125323|NCT02149225|Laxatives|laxatives|mesh-ancestor
57125324|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125325|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
57125326|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125327|NCT03208335|Endostatins|endostatins|mesh-list
57125328|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125329|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57125330|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57125331|NCT03208335|Growth Substances|growth substances|mesh-ancestor
57125332|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125333|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
57125334|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
57125335|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57125336|NCT03211065|Antibodies|antibodies|mesh-list
57125337|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
57125338|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125339|NCT02149459|Metformin|metformin|mesh-list
57125340|NCT02149459|Biguanides|biguanides|mesh-list
57125341|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57125342|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125343|NCT02376790|Etanercept|etanercept|mesh-list
57125344|NCT02376790|Methotrexate|methotrexate|mesh-list
57125345|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57125346|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
57125347|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57125348|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125349|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57125350|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
57125351|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125352|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125353|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
57125354|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125355|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57125356|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125357|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
57125358|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57125359|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57125360|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57125361|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57125362|NCT02376790|Analgesics|analgesics|mesh-ancestor
57125363|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
57125364|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125365|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57125366|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125367|NCT02141737|Lidocaine|lidocaine|mesh-list
57125368|NCT02141737|Fentanyl|fentanyl|mesh-list
57125369|NCT02141737|Midazolam|midazolam|mesh-list
57125370|NCT02141737|Etomidate|etomidate|mesh-list
57125371|NCT02141737|Rocuronium|rocuronium|mesh-list
57125372|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
57125373|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
57125374|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125375|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125376|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
57125377|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125378|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57125379|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57125380|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57125381|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57125382|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125383|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57125384|NCT02141737|Narcotics|narcotics|mesh-ancestor
57125385|NCT02141737|Analgesics|analgesics|mesh-ancestor
57125386|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57125387|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57125388|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
57125389|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57125390|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57125391|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57125392|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57125393|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
57125394|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
57125395|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125396|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57125397|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57125398|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57125399|NCT02254447|Candesartan|candesartan|mesh-list
57125400|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
57125401|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57125402|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57125403|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57125404|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125406|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57125407|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125408|NCT03207165|Dobutamine|dobutamine|mesh-list
57125409|NCT03207165|Milrinone|milrinone|mesh-list
57125410|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
57125411|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57125412|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
57125413|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
57125414|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125415|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125416|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57125417|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57125418|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57125419|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
57125420|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125421|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125422|NCT03207165|Protective Agents|protective agents|mesh-ancestor
57125423|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57125424|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
57125425|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57125426|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125427|NCT02142205|Natalizumab|natalizumab|mesh-list
57125428|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
57125429|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125430|NCT03209427|Morphine|morphine|mesh-list
57125431|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57125432|NCT03209427|Narcotics|narcotics|mesh-ancestor
57125433|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125434|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125435|NCT03209427|Analgesics|analgesics|mesh-ancestor
57125436|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
57125437|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125438|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
57125439|NCT03544723|Nivolumab|nivolumab|mesh-list
57125440|NCT03544723|Durvalumab|durvalumab|mesh-list
57125441|NCT03544723|Atezolizumab|atezolizumab|mesh-list
57125442|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57125443|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125444|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57125445|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125446|NCT03209661|Menthol|menthol|mesh-list
57125447|NCT03209661|Nicotine|nicotine|mesh-list
57125448|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57125449|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
57125450|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125451|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125452|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57125453|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57125454|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
57125455|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125456|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125457|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
57125458|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
57125459|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57125460|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
57125461|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125462|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
57125463|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
57125464|NCT03209115|Calcium|calcium|mesh-list
57125465|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57125466|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125467|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57125468|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57125469|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125470|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
57125471|NCT03209193|Sevoflurane|sevoflurane|mesh-list
57125472|NCT03209193|Desflurane|desflurane|mesh-list
57125473|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57125474|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57125475|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
57125476|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
57125477|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125478|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125479|NCT02142595|Midazolam|midazolam|mesh-list
57125480|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
57125481|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57125482|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125483|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125484|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57125485|NCT02142595|Analgesics|analgesics|mesh-ancestor
57125486|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
57125487|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125488|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57125489|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57125490|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57125491|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
57125492|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125493|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125494|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57125495|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57125496|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57125497|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57125498|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57125499|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
57125500|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
57125501|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
57125502|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
57125503|NCT04898374|Gemcitabine|gemcitabine|mesh-list
57125504|NCT04898374|Cisplatin|cisplatin|mesh-list
57125505|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125506|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57125507|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
57125508|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125509|NCT04898374|Antiviral Agents|antiviral agents|mesh-ancestor
57125510|NCT04898374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125511|NCT04898374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125512|NCT04898374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125513|NCT04898374|Immunologic Factors|immunologic factors|mesh-ancestor
57125514|NCT04898374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125515|NCT02521311|Clemastine|clemastine|mesh-list
57125516|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
57125517|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
57125518|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57125519|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
57125520|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
57125521|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125522|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125523|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125524|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57125525|NCT03207477|Mydriatics|mydriatics|mesh-list
57125526|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
57125527|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125528|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125529|NCT02452515|Fulacimstat|fulacimstat|mesh-list
57125530|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125531|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125532|NCT03206931|Selitrectinib|selitrectinib|mesh-list
57125533|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125534|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125535|NCT02344342|Diuretics|diuretics|mesh-list
57125536|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
57125537|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125538|NCT02452437|Oxycodone|oxycodone|mesh-list
57125539|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57125540|NCT02452437|Narcotics|narcotics|mesh-ancestor
57125541|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125542|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125543|NCT02452437|Analgesics|analgesics|mesh-ancestor
57125544|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
57125545|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125546|NCT03208413|Thalidomide|thalidomide|mesh-list
57125547|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125548|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
57125549|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125550|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
57125551|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57125552|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125553|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57125554|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57125555|NCT03208413|Growth Substances|growth substances|mesh-ancestor
57125556|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
57125557|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125558|NCT03201159|Pentamidine|pentamidine|mesh-list
57125559|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
57125560|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125561|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57125562|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57125563|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
57125564|NCT02149927|Sevoflurane|sevoflurane|mesh-list
57125565|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57125566|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57125567|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
57125568|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
57125569|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125570|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125571|NCT02142751|Meropenem|meropenem|mesh-list
57125572|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
57125573|NCT02142751|Fosfomycin|fosfomycin|mesh-list
57125574|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57125575|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57125576|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125577|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
57125578|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57125579|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125580|NCT02142829|Bupivacaine|bupivacaine|mesh-list
57125581|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
57125582|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
57125583|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125584|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125585|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
57125586|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125587|NCT03200691|Antibodies|antibodies|mesh-list
57125588|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
57125589|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125590|NCT02150161|Lidocaine|lidocaine|mesh-list
57125591|NCT02150161|Fentanyl|fentanyl|mesh-list
57125592|NCT02150161|Ketamine|ketamine|mesh-list
57125593|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
57125594|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
57125595|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125596|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125597|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
57125598|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125599|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57125600|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57125601|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57125602|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57125603|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125604|NCT02150161|Analgesics|analgesics|mesh-ancestor
57125605|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57125606|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57125607|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
57125608|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57125609|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57125610|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125611|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57125612|NCT02150161|Narcotics|narcotics|mesh-ancestor
57125613|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57125614|NCT03200613|Heparin|heparin|mesh-list
57125615|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57125616|NCT03200613|Tinzaparin|tinzaparin|mesh-list
57125617|NCT03200613|Dalteparin|dalteparin|mesh-list
57125618|NCT03200613|Apixaban|apixaban|mesh-list
57125619|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
57125620|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57125621|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57125622|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125623|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57125624|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
57125625|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57125626|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
57125627|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125628|NCT02150317|Sorafenib|sorafenib|mesh-list
57125629|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
57125630|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125631|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57125632|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125633|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125634|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57125635|NCT02150317|Estrogens|estrogens|mesh-ancestor
57125636|NCT02150317|Hormones|hormones|mesh-ancestor
57125637|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57125638|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125639|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57125640|NCT02310568|PF-06372865|pf-06372865|mesh-list
57125641|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
57125642|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
57125643|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125644|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125645|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125646|NCT02448069|Argatroban|argatroban|mesh-list
57125647|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
57125648|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57125649|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
57125650|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125651|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125652|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
57125653|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57125654|NCT02449941|Rabeprazole|rabeprazole|mesh-list
57125655|NCT02449941|Pantoprazole|pantoprazole|mesh-list
57125656|NCT02449941|Lansoprazole|lansoprazole|mesh-list
57125657|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
57125658|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57125659|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57125660|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125661|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125662|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125663|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
57125664|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57125665|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
57125666|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57125667|NCT03199989|Capecitabine|capecitabine|mesh-list
57125668|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
57125669|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57125670|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
57125671|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125672|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125673|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
57125674|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57125675|NCT03195543|Thrombin|thrombin|mesh-list
57125676|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
57125677|NCT03195543|Coagulants|coagulants|mesh-ancestor
57125678|NCT03204669|Trace Elements|trace elements|mesh-list
57125679|NCT03204669|Micronutrients|micronutrients|mesh-list
57125680|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125681|NCT03199677|Apatinib|apatinib|mesh-list
57125682|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125683|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57125684|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125685|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125686|NCT02780167|Abrocitinib|abrocitinib|mesh-list
57125687|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57125688|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125689|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125690|NCT02447757|Remifentanil|remifentanil|mesh-list
57125691|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57125692|NCT02447757|Narcotics|narcotics|mesh-ancestor
57125693|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125694|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125695|NCT02447757|Analgesics|analgesics|mesh-ancestor
57125696|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
57125697|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125698|NCT02447835|Olanzapine|olanzapine|mesh-list
57125699|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
57125700|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
57125701|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125702|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125703|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57125704|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57125705|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57125706|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125707|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57125708|NCT02447835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57125709|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57125710|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57125711|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125712|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125713|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
57125714|NCT02447679|Tegafur|tegafur|mesh-list
57125715|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57125716|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
57125717|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125718|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125719|NCT03203967|Morphine|morphine|mesh-list
57125720|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57125721|NCT03203967|Narcotics|narcotics|mesh-ancestor
57125722|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56414922|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125723|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125724|NCT03203967|Analgesics|analgesics|mesh-ancestor
57125725|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
57125726|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125727|NCT03204045|Fentanyl|fentanyl|mesh-list
57125728|NCT03204045|Oxycodone|oxycodone|mesh-list
57125729|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57125730|NCT03204045|Narcotics|narcotics|mesh-ancestor
57125731|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125732|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125733|NCT03204045|Analgesics|analgesics|mesh-ancestor
57125734|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
57125735|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125736|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57125737|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57125738|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
57125739|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
57125740|NCT03199521|Thrombin|thrombin|mesh-list
57125741|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
57125742|NCT03199521|Coagulants|coagulants|mesh-ancestor
57125743|NCT03195153|Allopurinol|allopurinol|mesh-list
57125744|NCT03195153|Atorvastatin|atorvastatin|mesh-list
57125745|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57125746|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57125747|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
57125748|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125749|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57125750|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57125751|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125752|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
57125753|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57125754|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57125755|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
57125756|NCT03195153|Protective Agents|protective agents|mesh-ancestor
57125757|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125758|NCT03195309|Fentanyl|fentanyl|mesh-list
57125759|NCT03195309|Ropivacaine|ropivacaine|mesh-list
57125760|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
57125761|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
57125762|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125763|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125764|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
57125765|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125766|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57125767|NCT03195309|Narcotics|narcotics|mesh-ancestor
57125768|NCT03195309|Analgesics|analgesics|mesh-ancestor
57125769|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57125770|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57125771|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
57125772|NCT03198819|Cefotaxime|cefotaxime|mesh-list
57125773|NCT03198819|Cefoxitin|cefoxitin|mesh-list
57125774|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57125775|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125776|NCT02447601|Simvastatin|simvastatin|mesh-list
57125777|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57125778|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57125779|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
57125780|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125781|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57125782|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57125783|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125784|NCT03118713|Metformin|metformin|mesh-list
57125785|NCT03118713|Glimepiride|glimepiride|mesh-list
57125786|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
57125787|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57125788|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125789|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57125790|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125791|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
57125792|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57125793|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125794|NCT03198585|Empagliflozin|empagliflozin|mesh-list
57125795|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57125796|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125797|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57125798|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125799|NCT02447289|Midazolam|midazolam|mesh-list
57125800|NCT02447289|Ketamine|ketamine|mesh-list
57125801|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57125802|NCT02447289|Analgesics|analgesics|mesh-ancestor
57125803|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
57125804|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57125805|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125806|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57125807|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57125808|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
57125809|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
57125810|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125811|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57125812|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57125813|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125814|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125815|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57125816|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57125817|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57125818|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57125819|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57125820|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
57125821|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
57125822|NCT02447211|Doxepin|doxepin|mesh-list
57125823|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57125824|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57125825|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125826|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125827|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57125828|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
57125829|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57125830|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
57125831|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
57125832|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125833|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125834|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
57125835|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125836|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
57125837|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125838|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57125839|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57125840|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
57125841|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125842|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125843|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57125844|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
57125845|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
57125846|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57125847|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
57125848|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125849|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125850|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
57125851|NCT03203031|Anesthetics|anesthetics|mesh-list
57125852|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57125853|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125854|NCT03118479|Anastrozole|anastrozole|mesh-list
57125855|NCT03118479|Testosterone|testosterone|mesh-list
57125856|NCT03118479|Androgens|androgens|mesh-ancestor
57125857|NCT03118479|Hormones|hormones|mesh-ancestor
57125858|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57125859|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125860|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57125861|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125862|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56807691|NCT01072786|Vaccines|vaccines|mesh-list
57125863|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57125864|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125865|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125866|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57125867|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
57125868|NCT03197961|Tenofovir|tenofovir|mesh-list
57125869|NCT03197961|Emtricitabine|emtricitabine|mesh-list
57125870|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
57125871|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
57125872|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
57125873|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125874|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57125875|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57125876|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125877|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125878|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57125879|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57125880|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57125881|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57125882|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57125883|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
57125884|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57125885|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125886|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57125887|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57125888|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57125889|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57125890|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125891|NCT03202875|Insulin|insulin|mesh-list
57125892|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57125893|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
57125894|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
57125895|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
57125896|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57125897|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125898|NCT03197571|Leucovorin|leucovorin|mesh-list
57125899|NCT03197571|Paclitaxel|paclitaxel|mesh-list
57125900|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
57125901|NCT03197571|Bevacizumab|bevacizumab|mesh-list
57125902|NCT03197571|Fluorouracil|fluorouracil|mesh-list
57125903|NCT03197571|Capecitabine|capecitabine|mesh-list
57125904|NCT03197571|Fulvestrant|fulvestrant|mesh-list
57125905|NCT03197571|Avelumab|avelumab|mesh-list
57125906|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57125907|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125908|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
57125909|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
57125910|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
57125911|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125912|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125913|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
57125914|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125915|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57125916|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57125917|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
57125918|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57125919|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57125920|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57125921|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57125922|NCT03197571|Growth Substances|growth substances|mesh-ancestor
57125923|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
57125924|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
57125925|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57125926|NCT03197571|Antidotes|antidotes|mesh-ancestor
57125927|NCT03197571|Protective Agents|protective agents|mesh-ancestor
57125928|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
57125929|NCT03197571|Vitamins|vitamins|mesh-ancestor
57125930|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
57125931|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57125932|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57125933|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57125934|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
57125935|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57125936|NCT02446977|Riboflavin|riboflavin|mesh-list
57125937|NCT02446977|Vitamins|vitamins|mesh-ancestor
57125938|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
57125939|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125940|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
57125941|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57125942|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
57125943|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
57125944|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
57125945|NCT02447055|Melphalan|melphalan|mesh-list
57125946|NCT02447055|Fludarabine|fludarabine|mesh-list
57125947|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
57125948|NCT02447055|Tacrolimus|tacrolimus|mesh-list
57125949|NCT02447055|Lenograstim|lenograstim|mesh-list
57125950|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125951|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
57125952|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125953|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57125954|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57125955|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
57125956|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125957|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125958|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57125959|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57125960|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
57125961|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57125962|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125963|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57125964|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57125965|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57125966|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
57125967|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57125968|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57125969|NCT03202563|Metformin|metformin|mesh-list
57125970|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
57125971|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57125972|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125973|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57125974|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125975|NCT03197493|Levodopa|levodopa|mesh-list
57125976|NCT03197493|Carbidopa|carbidopa|mesh-list
57125977|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
57125978|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57125979|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57125980|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
57125981|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57125982|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125983|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125984|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
57125985|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125986|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57125987|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
57125988|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
57125989|NCT02450175|Everolimus|everolimus|mesh-list
57125990|NCT02450175|Letrozole|letrozole|mesh-list
57125991|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57125992|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57125993|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
57125994|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57125995|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57125996|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57125997|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57125998|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57125999|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57126000|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
57126001|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57126002|NCT03202719|Vaccines|vaccines|mesh-list
57126003|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
57126004|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126005|NCT03202407|Calcium|calcium|mesh-list
57126006|NCT03202407|Sevelamer|sevelamer|mesh-list
57126007|NCT03202407|Calcium acetate|calcium acetate|mesh-list
57126008|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57126009|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126010|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
57126011|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
57126012|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126013|NCT02779855|Paclitaxel|paclitaxel|mesh-list
57126014|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57126015|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57126016|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126017|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
57126018|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
57126019|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
57126020|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126021|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57126022|NCT02261077|Scopolamine|scopolamine|mesh-list
57126023|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57126024|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57126025|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
57126026|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
57126027|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126028|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126029|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57126030|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
57126031|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57126032|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
57126033|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126034|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126035|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57126036|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
57126037|NCT03196869|Cisplatin|cisplatin|mesh-list
57126038|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126039|NCT02150473|Adalimumab|adalimumab|mesh-list
57126040|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126041|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126042|NCT02446431|Sirolimus|sirolimus|mesh-list
57126043|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
57126044|NCT02446431|Bevacizumab|bevacizumab|mesh-list
57126045|NCT02446431|Valproic Acid|valproic acid|mesh-list
57126046|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126047|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
57126048|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126049|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126050|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57126051|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
57126052|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126053|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126054|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57126055|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57126056|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57126057|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57126058|NCT02446431|Growth Substances|growth substances|mesh-ancestor
57126059|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
57126060|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57126061|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126062|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57126063|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
57126064|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
57126065|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126066|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
57126067|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126068|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
57126069|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57126070|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57126071|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57126072|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
57126073|NCT02446353|Megestrol|megestrol|mesh-list
57126074|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57126075|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126076|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
57126077|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57126078|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126079|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57126080|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57126081|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57126082|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
57126083|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57126084|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57126085|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57126086|NCT02144389|Praziquantel|praziquantel|mesh-list
57126087|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
57126088|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57126089|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126090|NCT04484259|Aspirin|aspirin|mesh-list
57126091|NCT04484259|Clopidogrel|clopidogrel|mesh-list
57126092|NCT04484259|Ticagrelor|ticagrelor|mesh-list
57126093|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57126094|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126095|NCT04484259|Analgesics|analgesics|mesh-ancestor
57126096|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
57126097|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126098|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126099|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126100|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126101|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57126102|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57126103|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126104|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57126105|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57126106|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126107|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
57126108|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57126109|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57126110|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57126111|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
57126112|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126113|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
57126114|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57126115|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
57126116|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126117|NCT03197103|Expectorants|expectorants|mesh-ancestor
57126118|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
57126119|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57126120|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
57126121|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126122|NCT03197103|Protective Agents|protective agents|mesh-ancestor
57126123|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126124|NCT03197103|Antidotes|antidotes|mesh-ancestor
57126125|NCT02144623|Valproic Acid|valproic acid|mesh-list
57126126|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
57126127|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126128|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126129|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
57126130|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126131|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126132|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
57126133|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57126134|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57126135|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57126136|NCT03201861|Paclitaxel|paclitaxel|mesh-list
57126137|NCT03201861|Docetaxel|docetaxel|mesh-list
57126138|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57126139|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57126140|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126141|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
57126142|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
57126143|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
57126144|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126145|NCT03194685|FF-10101|ff-10101|mesh-list
57126146|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57126147|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126148|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126149|NCT00105079|Ritonavir|ritonavir|mesh-list
57126150|NCT00105079|Lopinavir|lopinavir|mesh-list
57126151|NCT00105079|Saquinavir|saquinavir|mesh-list
57126152|NCT00105079|Tenofovir|tenofovir|mesh-list
57126153|NCT00105079|Emtricitabine|emtricitabine|mesh-list
57126154|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57126155|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57126156|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57126157|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
57126158|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126159|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126160|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57126161|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57126162|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
57126163|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126164|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57126165|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56808002|NCT03982173|Durvalumab|durvalumab|mesh-list
57126166|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55896991|NCT02387554|Amlodipine|amlodipine|mesh-list
57126167|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57126169|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57126170|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126171|NCT02150707|Liraglutide|liraglutide|mesh-list
57126172|NCT02150707|Exenatide|exenatide|mesh-list
57126173|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57126174|NCT02150707|Glucagon|glucagon|mesh-list
57126175|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57126176|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57126177|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126178|NCT02150707|Incretins|incretins|mesh-ancestor
57126179|NCT02150707|Hormones|hormones|mesh-ancestor
57126180|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57126181|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57126182|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57126183|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
57126184|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126185|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126186|NCT03196479|Ketamine|ketamine|mesh-list
57126187|NCT03196479|Propofol|propofol|mesh-list
57126188|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57126189|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57126190|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126191|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57126192|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
57126193|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
57126194|NCT03196479|Analgesics|analgesics|mesh-ancestor
57126195|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
57126196|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126197|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57126198|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57126199|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57126200|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126201|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126202|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
57126203|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
57126204|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57126205|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126206|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126207|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
57126208|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57126209|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57126210|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126211|NCT02151721|Gefitinib|gefitinib|mesh-list
57126212|NCT02151721|Vorinostat|vorinostat|mesh-list
57126213|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126214|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57126215|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126216|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126217|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57126218|NCT03201393|Acetaminophen|acetaminophen|mesh-list
57126219|NCT03201393|Naltrexone|naltrexone|mesh-list
57126220|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126221|NCT03201393|Analgesics|analgesics|mesh-ancestor
57126222|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
57126223|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126224|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126225|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
57126226|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57126227|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57126228|NCT03192969|Abatacept|abatacept|mesh-list
57126229|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
57126230|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57126231|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126232|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126233|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126234|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
57126235|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126236|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126237|NCT03192969|Hormones|hormones|mesh-ancestor
57126238|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57126239|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
57126240|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
57126241|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126242|NCT03194139|Protective Agents|protective agents|mesh-ancestor
57126243|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126244|NCT03118167|Antioxidants|antioxidants|mesh-list
57126245|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126246|NCT03118167|Protective Agents|protective agents|mesh-ancestor
57126247|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126248|NCT00189267|Imiquimod|imiquimod|mesh-list
57126249|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57126250|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
57126251|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126252|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126253|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
57126254|NCT02444949|Cisplatin|cisplatin|mesh-list
57126255|NCT02444949|Endostar protein|endostar protein|mesh-list
57126256|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126257|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57126258|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57126259|NCT02444949|Growth Substances|growth substances|mesh-ancestor
57126260|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126261|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
57126262|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57126263|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57126264|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57126265|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
57126266|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126267|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57126268|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57126269|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126270|NCT03192657|Basiliximab|basiliximab|mesh-list
57126271|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
57126272|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126273|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
57126274|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126275|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126276|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126277|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
57126278|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57126279|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
57126280|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126281|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
57126282|NCT02444169|Protective Agents|protective agents|mesh-ancestor
57126283|NCT03194061|Cisplatin|cisplatin|mesh-list
57126284|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126285|NCT02343406|Temozolomide|temozolomide|mesh-list
57126286|NCT02343406|Lomustine|lomustine|mesh-list
57126287|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57126288|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
57126289|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126290|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126291|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
57126292|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126293|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
57126294|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126295|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126296|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57126297|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
57126298|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126299|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126300|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57126301|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
57126302|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57126303|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
57126304|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126305|NCT03193749|Amiodarone|amiodarone|mesh-list
57126306|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57126307|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
57126308|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
57126309|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57126310|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126311|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57126312|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57126313|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57126314|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126315|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57126316|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57126317|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57126319|NCT02444013|Uric Acid|uric acid|mesh-list
57126320|NCT02444013|Hematinics|hematinics|mesh-ancestor
57126321|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
57126322|NCT02444013|Vitamins|vitamins|mesh-ancestor
57126323|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
57126324|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126325|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
57126326|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126327|NCT02444013|Protective Agents|protective agents|mesh-ancestor
57126328|NCT02444637|Rivastigmine|rivastigmine|mesh-list
57126329|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57126330|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126331|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126332|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
57126333|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126334|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126335|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57126336|NCT02444637|Protective Agents|protective agents|mesh-ancestor
57126337|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
57126338|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57126339|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
57126340|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57126341|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126342|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57126343|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57126344|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57126345|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57126346|NCT02710071|Nebivolol|nebivolol|mesh-list
57126347|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57126348|NCT02710071|Diuretics|diuretics|mesh-ancestor
57126349|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
57126350|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126351|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57126352|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57126353|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126354|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
57126355|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
57126356|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57126357|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57126358|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
57126359|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126360|NCT02443545|Deferiprone|deferiprone|mesh-list
57126361|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57126362|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
57126363|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
57126364|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126365|NCT02439489|Carboplatin|carboplatin|mesh-list
57126366|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126367|NCT02444481|Polymyxins|polymyxins|mesh-list
57126368|NCT02444481|Neomycin|neomycin|mesh-list
57126369|NCT02444481|Nystatin|nystatin|mesh-list
57126370|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57126371|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126372|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57126373|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126374|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126375|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
57126376|NCT02444481|Ionophores|ionophores|mesh-ancestor
57126377|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57126378|NCT02444559|Clonidine|clonidine|mesh-list
57126379|NCT02444559|Ropivacaine|ropivacaine|mesh-list
57126380|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
57126381|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
57126382|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57126383|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126384|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
57126385|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126386|NCT02444559|Analgesics|analgesics|mesh-ancestor
57126387|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57126388|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
56808215|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
57126389|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
57126390|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57126391|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57126392|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57126393|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
57126394|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126395|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126396|NCT03190239|Pemetrexed|pemetrexed|mesh-list
57126397|NCT03190239|Apatinib|apatinib|mesh-list
57126398|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126399|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126400|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126401|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57126402|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57126403|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57126404|NCT02439411|Trametinib|trametinib|mesh-list
57126405|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126406|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57126407|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126408|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126409|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
57126410|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126411|NCT02443311|Betamethasone|betamethasone|mesh-list
57126412|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
57126413|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
57126414|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
57126415|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
57126416|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
57126417|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126418|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
57126419|NCT02443311|Hormones|hormones|mesh-ancestor
57126420|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57126421|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126422|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57126423|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
57126424|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57126425|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126426|NCT02443311|Analgesics|analgesics|mesh-ancestor
57126427|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
57126428|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126429|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126430|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
57126431|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126432|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
57126433|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57126434|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126435|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126436|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
57126437|NCT02373202|Mizoribine|mizoribine|mesh-list
57126438|NCT02373202|Bucillamine|bucillamine|mesh-list
57126439|NCT02373202|Tacrolimus|tacrolimus|mesh-list
57126440|NCT02373202|Leflunomide|leflunomide|mesh-list
57126441|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126442|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
57126443|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126444|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57126445|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126446|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126447|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126448|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57126449|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126450|NCT02373202|Analgesics|analgesics|mesh-ancestor
57126451|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
57126452|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126453|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126454|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126455|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57126456|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
57126457|NCT02373202|Protective Agents|protective agents|mesh-ancestor
57126458|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57126459|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57126460|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126461|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
57126462|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57126463|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57126464|NCT03192111|Entinostat|entinostat|mesh-list
57126465|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126466|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57126467|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126468|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126469|NCT02622074|Paclitaxel|paclitaxel|mesh-list
57126470|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57126471|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
57126472|NCT02622074|Carboplatin|carboplatin|mesh-list
57126473|NCT02622074|Doxorubicin|doxorubicin|mesh-list
57126474|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
57126475|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57126476|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126477|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
57126478|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
57126479|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
57126480|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126481|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126482|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
57126483|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126484|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126485|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57126486|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
57126487|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57126488|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57126489|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57126490|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57126491|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126492|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57126493|NCT02438709|Etoricoxib|etoricoxib|mesh-list
57126494|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
57126495|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57126496|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126497|NCT02438709|Analgesics|analgesics|mesh-ancestor
57126498|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
57126499|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126500|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126501|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126502|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126503|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57126504|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126505|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126506|NCT05438758|Ketamine|ketamine|mesh-list
57126507|NCT05438758|Esketamine|esketamine|mesh-list
57126508|NCT05438758|Analgesics|analgesics|mesh-ancestor
57126509|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
57126510|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126511|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126512|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57126513|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57126514|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
57126515|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
57126516|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57126517|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57126518|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57126519|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126520|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126521|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
57126522|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57126523|NCT02442921|Colchicine|colchicine|mesh-list
57126524|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
57126525|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126526|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
57126527|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
57126528|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
57126529|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126530|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126531|NCT02438865|Epirubicin|epirubicin|mesh-list
57126532|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57126533|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126534|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57126535|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57126536|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126537|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126538|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
56808358|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57126540|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126541|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
57126542|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
57126543|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
57126544|NCT02342704|Natalizumab|natalizumab|mesh-list
57126545|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57126546|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
57126547|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126548|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57126549|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126550|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126551|NCT02442453|Turmeric extract|turmeric extract|mesh-list
57126552|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
57126553|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126554|NCT02442453|Protective Agents|protective agents|mesh-ancestor
57126555|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126556|NCT02438397|Insulin|insulin|mesh-list
57126557|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57126558|NCT02438397|Metformin|metformin|mesh-list
57126559|NCT02438397|Acarbose|acarbose|mesh-list
57126560|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57126561|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126562|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57126563|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126564|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126565|NCT01359956|Interferons|interferons|mesh-list
57126566|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
57126567|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
57126568|NCT01359956|Dacarbazine|dacarbazine|mesh-list
57126569|NCT01359956|Fotemustine|fotemustine|mesh-list
57126570|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126571|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
57126572|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126573|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
57126574|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126575|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57126576|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
57126577|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126578|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
57126579|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57126580|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57126581|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57126582|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57126583|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126584|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
57126585|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126586|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126587|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57126588|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126589|NCT02442531|Docetaxel|docetaxel|mesh-list
57126590|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126591|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
57126592|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
57126593|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
57126594|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126595|NCT03193203|Etanercept|etanercept|mesh-list
57126596|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57126597|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126598|NCT03193203|Analgesics|analgesics|mesh-ancestor
57126599|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
57126600|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126601|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126602|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126603|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126604|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57126605|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126606|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
57126607|NCT02442063|Paclitaxel|paclitaxel|mesh-list
57126608|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
57126609|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57126610|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126611|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
57126612|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
57126613|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
57126614|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126615|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
57126616|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57126617|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57126618|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
57126619|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126620|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126621|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57126622|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
57126623|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57126624|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
57126625|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57126626|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126627|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126628|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57126629|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126630|NCT03054662|Hemostatics|hemostatics|mesh-list
57126631|NCT03054662|Coagulants|coagulants|mesh-ancestor
57126632|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
57126633|NCT04922996|Calcium|calcium|mesh-list
57126634|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57126635|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126636|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
57126637|NCT04922996|Coagulants|coagulants|mesh-ancestor
57126638|NCT04913480|Durvalumab|durvalumab|mesh-list
57126639|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57126640|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126641|NCT02441907|Aflibercept|aflibercept|mesh-list
57126642|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57126643|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57126644|NCT02441907|Growth Substances|growth substances|mesh-ancestor
57126645|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126646|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
57126647|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126648|NCT02437461|Triamcinolone|triamcinolone|mesh-list
57126649|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57126650|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57126651|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57126652|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126653|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
57126654|NCT02437461|Hormones|hormones|mesh-ancestor
57126655|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57126656|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126657|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57126658|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
57126659|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126660|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126661|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
57126662|NCT04910594|Hematinics|hematinics|mesh-ancestor
57126663|NCT02441673|Ephedrine|ephedrine|mesh-list
57126664|NCT02441673|Meperidine|meperidine|mesh-list
57126665|NCT02441673|Tramadol|tramadol|mesh-list
57126666|NCT02441673|Nefopam|nefopam|mesh-list
57126667|NCT02441673|Metoclopramide|metoclopramide|mesh-list
57126668|NCT02441673|Ranitidine|ranitidine|mesh-list
57126669|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
57126670|NCT02441673|Oxytocin|oxytocin|mesh-list
57126671|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
57126672|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57126673|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126674|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57126675|NCT02441673|Narcotics|narcotics|mesh-ancestor
57126676|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57126677|NCT02441673|Analgesics|analgesics|mesh-ancestor
57126678|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
56415852|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
57126679|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126680|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
57126681|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
57126682|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57126683|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57126684|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57126685|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
57126686|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126687|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126688|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57126689|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
57126690|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57126691|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
57126692|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57126693|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57126694|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
57126695|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
57126696|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57126697|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126698|NCT04910126|Doxorubicin|doxorubicin|mesh-list
57126699|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57126700|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57126701|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126702|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57126703|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57126704|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126705|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126706|NCT04922450|Paclitaxel|paclitaxel|mesh-list
57126707|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57126708|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57126709|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126710|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
57126711|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
57126712|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
57126713|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126714|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
57126715|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
57126716|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126717|NCT04903808|Protective Agents|protective agents|mesh-ancestor
57126718|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126719|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57126720|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126721|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57126722|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126723|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
57126724|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
57126725|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126726|NCT02436993|Paclitaxel|paclitaxel|mesh-list
57126727|NCT02436993|Bevacizumab|bevacizumab|mesh-list
57126728|NCT02436993|Carboplatin|carboplatin|mesh-list
57126729|NCT02436993|Trastuzumab|trastuzumab|mesh-list
57126730|NCT02436993|Pertuzumab|pertuzumab|mesh-list
57126731|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57126732|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126733|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
57126734|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
57126735|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
57126736|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126737|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57126738|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57126739|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57126740|NCT02436993|Growth Substances|growth substances|mesh-ancestor
57126741|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126742|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
57126743|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
57126744|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57126745|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57126746|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126747|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
57126748|NCT04902950|Coagulants|coagulants|mesh-ancestor
57126749|NCT04893980|Aldesleukin|aldesleukin|mesh-list
57126750|NCT04893980|Interleukin-2|interleukin-2|mesh-list
57126751|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126752|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126753|NCT04893980|Analgesics|analgesics|mesh-ancestor
57126754|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
57126755|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126756|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126757|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57126758|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57126759|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
57126760|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126761|NCT04149470|Omeprazole|omeprazole|mesh-list
57126762|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57126763|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57126764|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57126765|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126766|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126767|NCT04902638|Dexamethasone|dexamethasone|mesh-list
57126768|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126769|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
57126770|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
57126771|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126772|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126773|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57126774|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
57126775|NCT04902638|Hormones|hormones|mesh-ancestor
57126776|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57126777|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57126778|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126779|NCT02617628|Naltrexone|naltrexone|mesh-list
57126780|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57126781|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57126782|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126783|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
57126784|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126785|NCT03053414|Vitamin D|vitamin d|mesh-list
57126786|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
57126787|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
57126788|NCT03053414|Vitamins|vitamins|mesh-ancestor
57126789|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
57126790|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126791|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57126792|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57126793|NCT04892732|Budesonide|budesonide|mesh-list
57126794|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
57126795|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126796|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57126797|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
57126798|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126799|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126800|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57126801|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
57126802|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
57126803|NCT04892732|Hormones|hormones|mesh-ancestor
57126804|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57126805|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57126806|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57126807|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57126808|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
57126809|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126810|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126811|NCT02308540|Vaccines|vaccines|mesh-list
57126812|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57126813|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
57126814|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126815|NCT02308228|Metformin|metformin|mesh-list
57126816|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57126817|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126818|NCT03051932|Acetaminophen|acetaminophen|mesh-list
57126819|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126820|NCT03051932|Analgesics|analgesics|mesh-ancestor
57126821|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
57126822|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126823|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126824|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
57126825|NCT04900532|Tocotrienols|tocotrienols|mesh-list
57126826|NCT04900532|Vitamin E|vitamin e|mesh-list
57126827|NCT04900532|Tocopherols|tocopherols|mesh-list
57126828|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
57126829|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126830|NCT04900532|Protective Agents|protective agents|mesh-ancestor
57126831|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126832|NCT04900532|Vitamins|vitamins|mesh-ancestor
57126833|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
57126834|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
57126835|NCT04900766|Analgesics|analgesics|mesh-ancestor
57126836|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
57126837|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126838|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126839|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126840|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57126841|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57126842|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126843|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126844|NCT04908566|Folfirinox|folfirinox|mesh-list
57126845|NCT04908566|Antibodies|antibodies|mesh-list
57126846|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
57126847|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
57126848|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126849|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126850|NCT04892654|Dolutegravir|dolutegravir|mesh-list
57126851|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57126852|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57126853|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126854|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126855|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57126856|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57126857|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
57126858|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126859|NCT04899674|Bupropion|bupropion|mesh-list
57126860|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57126861|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
57126862|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57126863|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57126864|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57126865|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57126866|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126867|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
57126868|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126869|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126870|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57126871|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57126872|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126873|NCT04907708|Metformin|metformin|mesh-list
57126874|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57126875|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126876|NCT04890626|Tenofovir|tenofovir|mesh-list
57126877|NCT04890626|Emtricitabine|emtricitabine|mesh-list
57126878|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57126879|NCT04890626|Dexamethasone|dexamethasone|mesh-list
57126880|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
57126881|NCT04890626|BB 1101|bb 1101|mesh-list
57126882|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126883|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
57126884|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
57126885|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126886|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126887|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57126888|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
57126889|NCT04890626|Hormones|hormones|mesh-ancestor
57126890|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57126891|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57126892|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126893|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
57126894|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126895|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126896|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
57126897|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126898|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57126899|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57126900|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57126901|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57126902|NCT04907864|Ibuprofen|ibuprofen|mesh-list
57126903|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57126904|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126905|NCT04907864|Analgesics|analgesics|mesh-ancestor
57126906|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
57126907|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126908|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126909|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57126910|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57126911|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57126912|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126913|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126914|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56808740|NCT01046058|Simeprevir|simeprevir|mesh-list
57126915|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57126916|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126917|NCT04907474|Phenylephrine|phenylephrine|mesh-list
57126918|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
57126919|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57126920|NCT04907474|Tropicamide|tropicamide|mesh-list
57126921|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57126922|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57126923|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
57126924|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
57126925|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126926|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126927|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
57126928|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57126929|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
57126930|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
57126931|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57126932|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57126933|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57126934|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
57126935|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126936|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126937|NCT04907474|Protective Agents|protective agents|mesh-ancestor
57126938|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57126939|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57126940|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
57126941|NCT04899050|Cannabidiol|cannabidiol|mesh-list
57126942|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
57126943|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
57126944|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57126945|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126946|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
57126947|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
57126948|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57126949|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126950|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126951|NCT02616614|Clindamycin|clindamycin|mesh-list
57126952|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
57126953|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
57126954|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
57126955|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57126956|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57126957|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57126958|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57126959|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126960|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
57126961|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
57126963|NCT04906772|Propofol|propofol|mesh-list
57126964|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57126965|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57126966|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57126967|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57126968|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
57126969|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
57126970|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57126971|NCT04906772|Analgesics|analgesics|mesh-ancestor
57126972|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
57126973|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57126974|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57126975|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57126976|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57126977|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
57126978|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57126979|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126980|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57126981|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57126982|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57126983|NCT04404140|Docetaxel|docetaxel|mesh-list
57126984|NCT04404140|Atezolizumab|atezolizumab|mesh-list
57126985|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126986|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
57126987|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
56808807|NCT00413660|Tofacitinib|tofacitinib|mesh-list
57126988|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
57126989|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126990|NCT04898504|Floxuridine|floxuridine|mesh-list
57126991|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57126992|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
57126993|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57126994|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57126995|NCT04890470|Vasopressins|vasopressins|mesh-list
57126996|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
57126997|NCT04890470|Oxytocin|oxytocin|mesh-list
57126998|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
57126999|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57127000|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127001|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
57127002|NCT04890470|Coagulants|coagulants|mesh-ancestor
57127003|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57127004|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57127005|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
57127006|NCT04889768|Antibodies|antibodies|mesh-list
57127007|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
57127008|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127009|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
57127010|NCT04898270|Flupenthixol|flupenthixol|mesh-list
57127011|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
57127012|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57127013|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127014|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127015|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57127016|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57127017|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
57127018|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127019|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127020|NCT04897958|Leuprolide|leuprolide|mesh-list
57127021|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57127022|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
57127023|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57127024|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127025|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57127026|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127027|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
57127028|NCT04906304|Cyclosporine|cyclosporine|mesh-list
57127029|NCT04906304|Everolimus|everolimus|mesh-list
57127030|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127031|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57127032|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
57127033|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127034|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57127035|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57127036|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
57127037|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57127038|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127039|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127040|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127041|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
57127042|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
57127043|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57127044|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57127045|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57127046|NCT03051698|Metronidazole|metronidazole|mesh-list
57127047|NCT03051698|Vancomycin|vancomycin|mesh-list
57127048|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
57127049|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
57127050|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127051|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57127052|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57127053|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57127054|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57127055|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127056|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127057|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127058|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57127059|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57127060|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57127061|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57127062|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
57127063|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127064|NCT04896164|Curcumin|curcumin|mesh-list
57127065|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57127066|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57127068|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
57127069|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127070|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127071|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57127072|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57127073|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127074|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127075|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127076|NCT04887818|Lidocaine|lidocaine|mesh-list
57127077|NCT04887818|Diltiazem|diltiazem|mesh-list
57127078|NCT04887818|Nifedipine|nifedipine|mesh-list
57127079|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
57127080|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
57127081|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127082|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127083|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
57127084|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127085|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57127086|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57127087|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57127088|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57127089|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127090|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57127091|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57127092|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
57127093|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
57127094|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57127095|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57127096|NCT04883996|Pilocarpine|pilocarpine|mesh-list
57127097|NCT04883996|Miotics|miotics|mesh-ancestor
57127098|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
57127099|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127100|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127101|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57127102|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57127103|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
57127104|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127105|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127106|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
57127107|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57127108|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
57127109|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57127110|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127111|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
57127112|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
57127113|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57127114|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
57127115|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127116|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
57127117|NCT04884464|Protective Agents|protective agents|mesh-ancestor
57127118|NCT05028608|Carbamazepine|carbamazepine|mesh-list
57127119|NCT05028608|Midazolam|midazolam|mesh-list
57127120|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57127121|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57127122|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902340|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
57127123|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127124|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57127125|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57127126|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57127127|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57127128|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
57127129|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
57127130|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
57127131|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
57127132|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127133|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127134|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
57127135|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
57127136|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57127137|NCT05028608|Analgesics|analgesics|mesh-ancestor
57127138|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
57127139|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127140|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56808963|NCT03976713|Bromides|bromides|mesh-list
57127141|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57127142|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57127143|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57127144|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
57127145|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
57127146|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57127147|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57127148|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127149|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127150|NCT04882826|Urological Agents|urological agents|mesh-ancestor
57127151|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
57127152|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57127153|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
57127154|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127155|NCT04481048|Expectorants|expectorants|mesh-ancestor
57127156|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
57127157|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57127158|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
57127159|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127160|NCT04481048|Protective Agents|protective agents|mesh-ancestor
57127161|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127162|NCT04481048|Antidotes|antidotes|mesh-ancestor
57127163|NCT04309916|Esomeprazole|esomeprazole|mesh-list
57127164|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57127165|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57127166|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57127167|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127168|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127169|NCT01596062|Cyclosporine|cyclosporine|mesh-list
57127170|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
57127171|NCT01596062|Everolimus|everolimus|mesh-list
57127172|NCT01596062|Cyclosporins|cyclosporins|mesh-list
57127173|NCT01596062|Basiliximab|basiliximab|mesh-list
57127174|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127175|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127176|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57127177|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
57127178|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127179|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
57127180|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127181|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
57127182|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57127183|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57127184|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127185|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57127186|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57127187|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
57127188|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57127189|NCT02614898|Eculizumab|eculizumab|mesh-list
57127190|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57127191|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57127192|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
57127193|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127194|NCT02145091|Psilocybin|psilocybin|mesh-list
57127195|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
57127196|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
57127197|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127198|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57127199|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57127200|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
57127201|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127202|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127203|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57127204|NCT03352934|Avelumab|avelumab|mesh-list
57127205|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57127206|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127207|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
57127208|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
57127209|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57127210|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127211|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57127212|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
57127213|NCT04881110|Liraglutide|liraglutide|mesh-list
57127214|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57127215|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127216|NCT04881110|Incretins|incretins|mesh-ancestor
57127217|NCT04881110|Hormones|hormones|mesh-ancestor
57127218|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57127220|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
57127221|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57127222|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57127223|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127224|NCT02145559|Metformin|metformin|mesh-list
57127225|NCT02145559|Sirolimus|sirolimus|mesh-list
57127226|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57127227|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127228|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57127229|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127230|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57127231|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127232|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
57127233|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57127234|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
57127235|NCT02145637|Afatinib|afatinib|mesh-list
57127236|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127237|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57127238|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127239|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127240|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
57127241|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57127242|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
57127243|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127244|NCT03154580|Expectorants|expectorants|mesh-ancestor
57127245|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
57127246|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57127247|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
57127248|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127249|NCT03154580|Protective Agents|protective agents|mesh-ancestor
57127250|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127251|NCT03154580|Antidotes|antidotes|mesh-ancestor
57127252|NCT02145715|Thalidomide|thalidomide|mesh-list
57127253|NCT02145715|Dexamethasone|dexamethasone|mesh-list
57127254|NCT02145715|Bortezomib|bortezomib|mesh-list
57127255|NCT02145715|Panobinostat|panobinostat|mesh-list
57127256|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57127257|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
57127258|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
57127259|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127260|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127261|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57127262|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
57127263|NCT02145715|Hormones|hormones|mesh-ancestor
57127264|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57127265|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57127266|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127267|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57127268|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
57127269|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
57127270|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57127271|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127272|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56902344|NCT02059876|Carboplatin|carboplatin|mesh-list
57127273|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57127274|NCT02145715|Growth Substances|growth substances|mesh-ancestor
57127275|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
57127276|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57127277|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127278|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127279|NCT04871750|Caseins|caseins|mesh-list
57127280|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
57127281|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
57127282|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127283|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
57127284|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57127285|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57127286|NCT01838174|Prednisolone|prednisolone|mesh-list
57127287|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
57127288|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57127289|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
57127290|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57127291|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
57127292|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
57127293|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127294|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127295|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57127296|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
57127297|NCT01838174|Hormones|hormones|mesh-ancestor
57127298|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57127299|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57127300|NCT01838174|Protective Agents|protective agents|mesh-ancestor
57127301|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57127302|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127303|NCT02152579|Isosorbide|isosorbide|mesh-list
57127304|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
57127305|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
57127306|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57127307|NCT02152579|Diuretics|diuretics|mesh-ancestor
57127308|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
57127309|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127310|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
57127311|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57127312|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127313|NCT02155777|Norinyl|norinyl|mesh-list
57127314|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57127315|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57127316|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57127317|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
57127318|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57127319|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127320|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57127321|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57127322|NCT02145949|Tryptophan|tryptophan|mesh-list
57127323|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57127324|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
57127325|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57127326|NCT01243190|Ofatumumab|ofatumumab|mesh-list
57127327|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127328|NCT00806390|Metoprolol|metoprolol|mesh-list
57127329|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57127330|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57127331|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
57127332|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
57127333|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127334|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127335|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57127336|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57127337|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57127338|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
57127339|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127340|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127341|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
57127342|NCT00566618|Dasatinib|dasatinib|mesh-list
57127343|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127344|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57127345|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127346|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127347|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57127348|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127349|NCT02769481|Glimepiride|glimepiride|mesh-list
57127350|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
57127351|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57127352|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57127353|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127354|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57127355|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
57127356|NCT04877210|Insulin|insulin|mesh-list
57127357|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57127358|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57127359|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127360|NCT02152969|Amlodipine|amlodipine|mesh-list
57127361|NCT02152969|Telmisartan|telmisartan|mesh-list
57127362|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
57127363|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57127364|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56809175|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
57127365|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57127366|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127367|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57127368|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127369|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
57127370|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57127371|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57127372|NCT02152969|Diuretics|diuretics|mesh-ancestor
57127373|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
57127374|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57127375|NCT04879004|Ropivacaine|ropivacaine|mesh-list
57127376|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
57127377|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
57127378|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127379|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127380|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
57127381|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127382|NCT02153125|Eplerenone|eplerenone|mesh-list
57127383|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57127384|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
57127385|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57127386|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127387|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57127388|NCT02153125|Diuretics|diuretics|mesh-ancestor
57127389|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
57127390|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57127391|NCT04878926|Midazolam|midazolam|mesh-list
57127392|NCT04878926|Propofol|propofol|mesh-list
57127393|NCT04878926|Anesthetics|anesthetics|mesh-list
57127394|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
57127395|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57127396|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127397|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127398|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57127399|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
57127400|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57127401|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57127402|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57127403|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57127404|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
57127405|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
57127406|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127407|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127408|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
57127409|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127410|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57127411|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
57127412|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127413|NCT04862767|Aldesleukin|aldesleukin|mesh-list
57127414|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127415|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57127416|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57127417|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
57127418|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127419|NCT02146261|Quetmolimab|quetmolimab|mesh-list
57127420|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57127421|NCT02153281|Phenelzine|phenelzine|mesh-list
57127422|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
57127423|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57127424|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
57127425|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127426|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127427|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
57127428|NCT03542851|Convulsants|convulsants|mesh-ancestor
57127429|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57127430|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127431|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
57127432|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
57127433|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127434|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127435|NCT02769247|Naproxen|naproxen|mesh-list
57127436|NCT02769247|Lidocaine|lidocaine|mesh-list
57127437|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
57127438|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
57127439|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127440|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127441|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
57127442|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127443|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57127444|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57127445|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57127446|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57127447|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127448|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57127449|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57127450|NCT02769247|Analgesics|analgesics|mesh-ancestor
57127451|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57127452|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57127453|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
57127454|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57127455|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127456|NCT02153437|Sotalol|sotalol|mesh-list
57127457|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57127458|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57127459|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
57127460|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127461|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127462|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127463|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57127464|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
57127465|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
57127466|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127467|NCT02146651|Insulin|insulin|mesh-list
57127468|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57127469|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
57127470|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57127471|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127472|NCT03542149|Tocopherols|tocopherols|mesh-list
57127473|NCT03542149|Vitamin E|vitamin e|mesh-list
57127474|NCT03542149|Tocotrienols|tocotrienols|mesh-list
57127475|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
57127476|NCT03542149|Piperaquine|piperaquine|mesh-list
57127477|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
57127478|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57127479|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57127480|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127481|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
57127482|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127483|NCT03542149|Protective Agents|protective agents|mesh-ancestor
57127484|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127485|NCT03542149|Vitamins|vitamins|mesh-ancestor
57127486|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
57127487|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
57127488|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
57127489|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57127490|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57127491|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127492|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
57127493|NCT02153593|Coagulants|coagulants|mesh-ancestor
57127494|NCT02154217|Timolol|timolol|mesh-list
57127495|NCT02154217|Bimatoprost|bimatoprost|mesh-list
57127496|NCT02154217|Latanoprost|latanoprost|mesh-list
57127497|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57127498|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57127499|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
57127500|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127501|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127502|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127503|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57127504|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57127505|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57127506|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57127507|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
57127508|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
57127509|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127510|NCT02147041|Protective Agents|protective agents|mesh-ancestor
57127511|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127512|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
57127513|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
57127514|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127515|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57127516|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
57127517|NCT02767765|Hematinics|hematinics|mesh-ancestor
57127518|NCT00103207|Cetuximab|cetuximab|mesh-list
57127519|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57127520|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127521|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
57127522|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57127523|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
57127524|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127526|NCT02157181|Cladribine|cladribine|mesh-list
57127527|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57127528|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127529|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
57127530|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127531|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57127532|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57127533|NCT02159287|Heparin|heparin|mesh-list
57127534|NCT02159287|Calcium heparin|calcium heparin|mesh-list
57127535|NCT02159287|Enoxaparin|enoxaparin|mesh-list
57127536|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
57127537|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
57127538|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57127539|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57127540|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127541|NCT03738553|Trastuzumab|trastuzumab|mesh-list
57127542|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57127543|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127544|NCT05005273|Nivolumab|nivolumab|mesh-list
57127545|NCT05005273|Ipilimumab|ipilimumab|mesh-list
57127546|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57127547|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127548|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57127549|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127550|NCT02157337|Atorvastatin|atorvastatin|mesh-list
57127551|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57127552|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57127553|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
57127554|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127555|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57127556|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57127557|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127558|NCT02159599|Ritonavir|ritonavir|mesh-list
57127559|NCT02159599|Darunavir|darunavir|mesh-list
57127560|NCT02159599|Tenofovir|tenofovir|mesh-list
57127561|NCT02159599|Lamivudine|lamivudine|mesh-list
57127562|NCT02159599|Emtricitabine|emtricitabine|mesh-list
57127563|NCT02159599|Abacavir|abacavir|mesh-list
57127564|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57127565|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57127566|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
57127567|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902352|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57127568|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127569|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57127570|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57127571|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
57127572|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127573|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57127574|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57127575|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57127576|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57127577|NCT03541681|Anesthetics|anesthetics|mesh-list
57127578|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
57127579|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127580|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127581|NCT03541681|Hormones|hormones|mesh-ancestor
57127582|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57127583|NCT02157415|Polihexanide|polihexanide|mesh-list
57127584|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
57127585|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127586|NCT02157571|Levofloxacin|levofloxacin|mesh-list
57127587|NCT02157571|Ofloxacin|ofloxacin|mesh-list
57127588|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
57127589|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
57127590|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57127591|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127592|NCT02157571|Renal Agents|renal agents|mesh-ancestor
57127593|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57127594|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57127595|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57127596|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127597|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127598|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127599|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57127600|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57127601|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57127602|NCT01369355|Ustekinumab|ustekinumab|mesh-list
57127603|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
57127604|NCT03541993|Resveratrol|resveratrol|mesh-list
57127605|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
57127606|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127607|NCT03541993|Protective Agents|protective agents|mesh-ancestor
57127608|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127609|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127610|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57127611|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
57127612|NCT02157649|Codeine|codeine|mesh-list
57127613|NCT02157649|Guaifenesin|guaifenesin|mesh-list
57127614|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
57127615|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57127616|NCT02157649|Narcotics|narcotics|mesh-ancestor
57127617|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127618|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127619|NCT02157649|Analgesics|analgesics|mesh-ancestor
57127620|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
57127621|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127622|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
57127623|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
57127624|NCT02157649|Expectorants|expectorants|mesh-ancestor
57127625|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57127626|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57127627|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
57127628|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127629|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127630|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
57127631|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57127632|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
57127633|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
57127634|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
57127635|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57127636|NCT02159911|Misoprostol|misoprostol|mesh-list
57127637|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57127638|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
57127639|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56902354|NCT03777423|Chromium|chromium|mesh-list
57127640|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127641|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57127642|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57127643|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
57127644|NCT03542617|Dexamethasone|dexamethasone|mesh-list
57127645|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57127646|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
57127647|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
57127648|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127649|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127650|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57127651|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
57127652|NCT03542617|Hormones|hormones|mesh-ancestor
57127653|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57127654|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57127655|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127656|NCT04878770|Cyclosporine|cyclosporine|mesh-list
57127657|NCT04878770|Cyclosporins|cyclosporins|mesh-list
57127658|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127659|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127660|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57127661|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
57127662|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127663|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
57127664|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127665|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
57127666|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57127667|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57127668|NCT02086019|Ramipril|ramipril|mesh-list
57127669|NCT02086019|Bisoprolol|bisoprolol|mesh-list
57127670|NCT02086019|Heparin|heparin|mesh-list
57127671|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57127672|NCT02086019|Tinzaparin|tinzaparin|mesh-list
56809500|NCT00207142|Ritonavir|ritonavir|mesh-list
57127673|NCT02086019|Dalteparin|dalteparin|mesh-list
57127674|NCT02086019|Clopidogrel|clopidogrel|mesh-list
57127675|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
57127676|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127677|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127678|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57127679|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57127680|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127681|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57127682|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127683|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57127684|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57127685|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57127686|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
57127687|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127688|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
57127689|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
57127690|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57127691|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57127692|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57127693|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
57127694|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
57127695|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
57127696|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57127697|NCT02086097|Ibuprofen|ibuprofen|mesh-list
57127698|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
57127699|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57127700|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57127701|NCT02086097|Analgesics|analgesics|mesh-ancestor
57127702|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
57127703|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127704|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127705|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57127706|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57127707|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57127708|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127709|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127710|NCT02307682|Aflibercept|aflibercept|mesh-list
57127711|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57127712|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56902358|NCT05654662|Listerine|listerine|mesh-list
57127713|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57127714|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57127715|NCT02307682|Growth Substances|growth substances|mesh-ancestor
57127716|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127717|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
57127718|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127719|NCT02088515|Docetaxel|docetaxel|mesh-list
57127720|NCT02088515|Nedaplatin|nedaplatin|mesh-list
57127721|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127722|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
57127723|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
57127724|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
57127725|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127726|NCT02086253|BQ 788|bq 788|mesh-list
57127727|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57127728|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57127729|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127730|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
57127731|NCT04870502|Clomiphene|clomiphene|mesh-list
57127732|NCT04870502|Enclomiphene|enclomiphene|mesh-list
57127733|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
57127734|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57127735|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
57127736|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57127737|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127738|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57127739|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
57127740|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57127741|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57127742|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57127743|NCT02088671|Propofol|propofol|mesh-list
57127744|NCT02088671|Desflurane|desflurane|mesh-list
57127745|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57127746|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127747|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127748|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57127750|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
57127751|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57127752|NCT04870190|Osimertinib|osimertinib|mesh-list
57127753|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127754|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57127755|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127756|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127757|NCT03049046|Caffeic acid|caffeic acid|mesh-list
57127758|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
57127759|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127760|NCT03049046|Protective Agents|protective agents|mesh-ancestor
57127761|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127762|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
57127763|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
57127764|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
57127765|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127766|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127767|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
57127768|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127769|NCT04874246|Vasopressins|vasopressins|mesh-list
57127770|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
57127771|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
57127772|NCT04874246|Coagulants|coagulants|mesh-ancestor
57127773|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57127774|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
57127775|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
57127776|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127777|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57127778|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127779|NCT03048110|Itraconazole|itraconazole|mesh-list
57127780|NCT03048110|Rifampin|rifampin|mesh-list
57127781|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
57127782|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127783|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57127784|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57127785|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127786|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127787|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57127788|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
57127789|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57127790|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127791|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57127792|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57127793|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
57127794|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57127795|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
57127796|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57127797|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57127798|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57127799|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57127800|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57127801|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57127802|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57127803|NCT05256758|Fenofibrate|fenofibrate|mesh-list
57127804|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57127805|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
57127806|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127807|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57127808|NCT02791763|Glycine|glycine|mesh-list
57127809|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
57127810|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127811|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127812|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127813|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
57127814|NCT02086409|Vitamin D|vitamin d|mesh-list
57127815|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
57127816|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
57127817|NCT02086409|Vitamins|vitamins|mesh-list
57127818|NCT02086409|Calcium|calcium|mesh-list
57127819|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
57127820|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127821|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57127822|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57127823|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
57127824|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
57127825|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127826|NCT02613572|Protective Agents|protective agents|mesh-ancestor
57127827|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127828|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
57127829|NCT02613572|Vitamins|vitamins|mesh-ancestor
57127830|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
57127831|NCT02088983|Choline|choline|mesh-list
57127832|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
57127833|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
57127834|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57127835|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
57127836|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127837|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57127838|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57127839|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
57127840|NCT02089061|Atorvastatin|atorvastatin|mesh-list
57127841|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57127842|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57127843|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57127844|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
57127845|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127846|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57127847|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57127848|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127849|NCT02082665|Dabrafenib|dabrafenib|mesh-list
57127850|NCT02082665|Midazolam|midazolam|mesh-list
57127851|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57127852|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57127853|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57127854|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127855|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127856|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57127857|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57127858|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57127859|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57127860|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
57127861|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
57127862|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
57127863|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
57127864|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127865|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127866|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57127867|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57127868|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
57127869|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57127870|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57127871|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127872|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127873|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57127874|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
57127875|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57127876|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
57127877|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127878|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
57127879|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57127880|NCT02341456|Paclitaxel|paclitaxel|mesh-list
57127881|NCT02341456|Carboplatin|carboplatin|mesh-list
57127882|NCT02341456|Adavosertib|adavosertib|mesh-list
57127883|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57127884|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127885|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
57127886|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
57127887|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
57127888|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127889|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127890|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
57127891|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
57127892|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57127893|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127894|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127895|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57127896|NCT02083055|Analgesics|analgesics|mesh-ancestor
57127897|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
57127898|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127899|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57127900|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57127902|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
57127903|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127904|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127905|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
57127906|NCT02089295|Oxycodone|oxycodone|mesh-list
57127907|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57127908|NCT02089295|Narcotics|narcotics|mesh-ancestor
57127909|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127910|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127911|NCT02089295|Analgesics|analgesics|mesh-ancestor
57127912|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
57127913|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127914|NCT02370784|Atorvastatin|atorvastatin|mesh-list
57127915|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57127916|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57127917|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
57127918|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127919|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56902363|NCT05654662|Protective Agents|protective agents|mesh-ancestor
57127920|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57127921|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127922|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
57127923|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57127924|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127925|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
57127926|NCT01595438|Ceftazidime|ceftazidime|mesh-list
57127927|NCT01595438|Avibactam|avibactam|mesh-list
57127928|NCT01595438|Doripenem|doripenem|mesh-list
57127929|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57127930|NCT01595438|Trimethoprim|trimethoprim|mesh-list
57127931|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
57127932|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57127933|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57127934|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57127935|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57127936|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127937|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127938|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57127939|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57127940|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57127941|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57127942|NCT01595438|Renal Agents|renal agents|mesh-ancestor
57127943|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
57127944|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57127945|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57127946|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57127947|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57127948|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57127949|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57127950|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
57127951|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57127952|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127953|NCT02340520|Theophylline|theophylline|mesh-list
57127954|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57127955|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
57127956|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127957|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127958|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57127959|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
57127960|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57127961|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57127962|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127963|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
57127964|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57127965|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57127966|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
57127967|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127968|NCT02087579|Olanzapine|olanzapine|mesh-list
57127969|NCT02087579|Risperidone|risperidone|mesh-list
57127970|NCT02087579|Aripiprazole|aripiprazole|mesh-list
57127971|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
57127972|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56809774|NCT00422942|Rituximab|rituximab|mesh-list
57127973|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57127974|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
57127975|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57127976|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57127977|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57127978|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57127979|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57127980|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57127981|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57127982|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57127983|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
57127984|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
57127985|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
57127986|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57127987|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57127988|NCT02087579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57127989|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57127990|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57127991|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
57127992|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
57127993|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57127994|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57127995|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57127996|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57127997|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
57127998|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57127999|NCT02339584|Brinzolamide|brinzolamide|mesh-list
57128000|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57128001|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57128002|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57128003|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57128004|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57128005|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
57128006|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128007|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128008|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128009|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57128010|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128011|NCT02339506|Cosyntropin|cosyntropin|mesh-list
57128013|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128014|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128015|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
57128016|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57128017|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
57128018|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57128019|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
57128020|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57128021|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
57128022|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
57128023|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128024|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128025|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57128026|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
57128027|NCT02087813|Hormones|hormones|mesh-ancestor
57128028|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128029|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57128030|NCT02087813|Protective Agents|protective agents|mesh-ancestor
57128031|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57128032|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128033|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128034|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128035|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57128036|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57128037|NCT02089529|Ibuprofen|ibuprofen|mesh-list
57128038|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57128039|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57128040|NCT02089529|Analgesics|analgesics|mesh-ancestor
57128041|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
57128042|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128043|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128044|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56809846|NCT01047072|Fludarabine|fludarabine|mesh-list
57128045|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57128046|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57128047|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128048|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128050|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57128051|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57128052|NCT02090933|Analgesics|analgesics|mesh-ancestor
57128053|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
57128054|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128055|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128056|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57128057|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57128058|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57128059|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57128060|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128061|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128062|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
57128063|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56902382|NCT02060032|Simvastatin|simvastatin|mesh-list
57128064|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128065|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128066|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57128067|NCT03046238|Analgesics|analgesics|mesh-ancestor
57128068|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
57128069|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128070|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57128071|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57128072|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57128073|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
57128074|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128075|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128076|NCT02089763|BCT-100|bct-100|mesh-list
57128077|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128078|NCT04884802|Phenylephrine|phenylephrine|mesh-list
57128079|NCT04884802|Norepinephrine|norepinephrine|mesh-list
57128080|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
57128081|NCT04884802|Propofol|propofol|mesh-list
57128082|NCT04884802|Etomidate|etomidate|mesh-list
57128083|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57128084|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128085|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128086|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57128087|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
57128088|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
57128089|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57128090|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
57128091|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
57128092|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128093|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
57128094|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
57128095|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
57128096|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57128097|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57128098|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57128099|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
57128100|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128101|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128102|NCT04884802|Protective Agents|protective agents|mesh-ancestor
57128103|NCT02089841|Lumefantrine|lumefantrine|mesh-list
57128104|NCT02089841|Artemether|artemether|mesh-list
57128105|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57128106|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
57128107|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57128108|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57128109|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128110|NCT03045770|Leucovorin|leucovorin|mesh-list
57128111|NCT03045770|Paclitaxel|paclitaxel|mesh-list
57128112|NCT03045770|Fluorouracil|fluorouracil|mesh-list
57128113|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
57128114|NCT03045770|Irinotecan|irinotecan|mesh-list
57128115|NCT03045770|Calcium|calcium|mesh-list
57128116|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
57128117|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57128118|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809923|NCT00267969|Ustekinumab|ustekinumab|mesh-list
57128119|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
57128120|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
57128121|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
57128122|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128123|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57128124|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128125|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
57128126|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57128127|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57128128|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
57128129|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57128130|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57128131|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128132|NCT03045770|Antidotes|antidotes|mesh-ancestor
57128133|NCT03045770|Protective Agents|protective agents|mesh-ancestor
57128134|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
57128136|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
57128137|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
56902385|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
57128138|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128139|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57128140|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128141|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128142|NCT02095847|Proflavine|proflavine|mesh-list
57128143|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57128144|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128145|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
57128146|NCT02091401|Analgesics|analgesics|mesh-ancestor
57128147|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
57128148|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128149|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128150|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
57128151|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128152|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57128153|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
57128154|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57128155|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57128156|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128157|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57128158|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
57128159|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57128160|NCT01594970|Bimatoprost|bimatoprost|mesh-list
57128161|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57128162|NCT04869176|Caffeine|caffeine|mesh-list
57128163|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
57128164|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128165|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57128166|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128167|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57128168|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128169|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57128170|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57128171|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
57128172|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128173|NCT03557255|Simendan|simendan|mesh-list
57128174|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57128175|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
57128176|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57128177|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57128178|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128179|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128180|NCT03557255|Protective Agents|protective agents|mesh-ancestor
57128181|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128182|NCT04868552|Naloxone|naloxone|mesh-list
57128183|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57128184|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128185|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
57128186|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128187|NCT02090153|Leucovorin|leucovorin|mesh-list
57128188|NCT02090153|Tegafur|tegafur|mesh-list
57128189|NCT02090153|Antidotes|antidotes|mesh-ancestor
57128190|NCT02090153|Protective Agents|protective agents|mesh-ancestor
57128191|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128192|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
57128193|NCT02090153|Vitamins|vitamins|mesh-ancestor
57128194|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
57128195|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57128196|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
57128197|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128198|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128199|NCT00358163|Paclitaxel|paclitaxel|mesh-list
57128200|NCT00358163|Vatalanib|vatalanib|mesh-list
57128201|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57128202|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128203|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
57128204|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
57128205|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
57128206|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128207|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57128208|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128209|NCT02096315|Murepavadin|murepavadin|mesh-list
57128210|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57128211|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128212|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
57128213|NCT02337946|Leucovorin|leucovorin|mesh-list
57128214|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
57128215|NCT02337946|Fluorouracil|fluorouracil|mesh-list
57128216|NCT02337946|Panitumumab|panitumumab|mesh-list
57128217|NCT02337946|Calcium|calcium|mesh-list
57128218|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
57128219|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57128220|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128221|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57128222|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128223|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
57128224|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128225|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57128226|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57128227|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
57128228|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57128229|NCT02337946|Antidotes|antidotes|mesh-ancestor
57128230|NCT02337946|Protective Agents|protective agents|mesh-ancestor
57128231|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
57128232|NCT02337946|Vitamins|vitamins|mesh-ancestor
57128233|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
57128234|NCT04865510|Heparin|heparin|mesh-list
57128235|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
57128236|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128237|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57128238|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57128239|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
57128240|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57128241|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
57128242|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57128243|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
57128244|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128245|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
57128246|NCT03047096|Protective Agents|protective agents|mesh-ancestor
57128247|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
57128248|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
57128249|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57128250|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
57128251|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57128252|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
57128253|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128254|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128255|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
57128256|NCT02093195|Bosentan|bosentan|mesh-list
57128257|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
57128258|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57128259|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
57128260|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57128261|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
57128262|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128263|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
57128264|NCT03555617|Itraconazole|itraconazole|mesh-list
57128265|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
57128266|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128267|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57128268|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57128269|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128270|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128271|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57128272|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
57128273|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128274|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128275|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57128276|NCT02098889|Scopolamine|scopolamine|mesh-list
57128277|NCT02098889|Bromides|bromides|mesh-list
57128278|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
57128279|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
57128280|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57128281|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
57128282|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
57128283|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128284|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128285|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57128286|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
57128287|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57128288|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
57128289|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128290|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128291|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57128292|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
57128293|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57128294|NCT01369199|Entecavir|entecavir|mesh-list
57128295|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
57128296|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128297|NCT02097017|Lidocaine|lidocaine|mesh-list
57128298|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
57128299|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
57128300|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128301|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128302|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
57128303|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128304|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57128305|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57128306|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57128307|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57128308|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128309|NCT02097173|Methotrexate|methotrexate|mesh-list
57128310|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57128311|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
57128312|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57128313|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128314|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57128315|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
57128316|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128317|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128318|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
57128319|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128320|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57128321|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57128322|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
57128323|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57128324|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57128325|NCT02097329|Palbociclib|palbociclib|mesh-list
57128326|NCT02097329|Rabeprazole|rabeprazole|mesh-list
57128327|NCT02097329|Famotidine|famotidine|mesh-list
57128328|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
57128329|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
57128330|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
57128331|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
57128332|NCT02097329|Antacids|antacids|mesh-list
57128333|NCT02097329|TEMPO|tempo|mesh-list
57128334|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128335|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57128336|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128337|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128338|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57128339|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57128340|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57128341|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
57128342|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
57128343|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128344|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128345|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
57128346|NCT02097329|Protective Agents|protective agents|mesh-ancestor
57128347|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57128348|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
57128350|NCT02093585|Abacavir|abacavir|mesh-list
57128351|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
57128352|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128353|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57128354|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57128355|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128356|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128357|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57128358|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57128359|NCT02099357|Vitamin D|vitamin d|mesh-list
57128360|NCT02099357|Vitamins|vitamins|mesh-ancestor
57128361|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
57128362|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128363|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57128364|NCT02093741|Factor VIII|factor viii|mesh-list
57128365|NCT02093741|Coagulants|coagulants|mesh-ancestor
57128366|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
57128367|NCT02097407|Propofol|propofol|mesh-list
57128368|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57128369|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128370|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128371|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57128372|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
57128373|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
57128374|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57128375|NCT02097407|Analgesics|analgesics|mesh-ancestor
57128376|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
57128377|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128378|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57128379|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57128380|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57128381|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
57128382|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128383|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128384|NCT02250599|Paclitaxel|paclitaxel|mesh-list
57128385|NCT02250599|Bevacizumab|bevacizumab|mesh-list
57128386|NCT02250599|Carboplatin|carboplatin|mesh-list
57128387|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57128388|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128389|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
57128390|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
57128391|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
57128392|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128393|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57128394|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57128395|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57128396|NCT02250599|Growth Substances|growth substances|mesh-ancestor
57128397|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128398|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
57128399|NCT02094053|Donepezil|donepezil|mesh-list
57128400|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57128401|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128402|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128403|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
57128404|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128405|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128406|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
57128407|NCT03555929|Dexamethasone|dexamethasone|mesh-list
57128408|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57128409|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
57128410|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
57128411|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128412|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128413|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57128414|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
57128415|NCT03555929|Hormones|hormones|mesh-ancestor
57128416|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128417|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57128418|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128419|NCT02099825|Cycloserine|cycloserine|mesh-list
57128420|NCT02099825|Mifepristone|mifepristone|mesh-list
57128421|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
57128422|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
57128423|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57128424|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128425|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57128426|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57128427|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57128428|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
57128429|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
57128430|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
57128431|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
57128432|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128433|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
57128434|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57128435|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
57128436|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57128437|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128438|NCT02099825|Renal Agents|renal agents|mesh-ancestor
57128439|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57128440|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
57128441|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57128442|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
57128443|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128444|NCT02099981|Pimagedine|pimagedine|mesh-list
57128445|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128446|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128447|NCT02250209|Capecitabine|capecitabine|mesh-list
57128448|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
57128449|NCT02250209|Trastuzumab|trastuzumab|mesh-list
57128450|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57128451|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
57128452|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128453|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128454|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57128455|NCT02097953|Rifampin|rifampin|mesh-list
57128456|NCT02097953|Daptomycin|daptomycin|mesh-list
57128457|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57128458|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
57128459|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57128460|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128461|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
57128462|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57128463|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128464|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128465|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57128466|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57128467|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57128468|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57128469|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57128470|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57128471|NCT02094287|Dimethindene|dimethindene|mesh-list
57128472|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
57128473|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
57128474|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57128475|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
57128476|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
57128477|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128478|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128479|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128480|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57128481|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
57128482|NCT02100293|Analgesics|analgesics|mesh-ancestor
57128483|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
57128484|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128485|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128486|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
57128487|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128488|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57128489|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
57128490|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57128491|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57128492|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128493|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57128494|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
57128495|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57128496|NCT02094599|Dronabinol|dronabinol|mesh-list
57128497|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
57128498|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128499|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57128500|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57128501|NCT02094599|Analgesics|analgesics|mesh-ancestor
57128502|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
57128503|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128504|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57128505|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57128506|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128507|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128508|NCT02094599|Hormones|hormones|mesh-ancestor
57128509|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128510|NCT02094833|Vaccines|vaccines|mesh-list
57128511|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
57128512|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128513|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
57128514|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
57128515|NCT02100605|Ephedrine|ephedrine|mesh-list
57128516|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57128517|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
57128518|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57128519|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128520|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
57128521|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
57128522|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128523|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
57128524|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128525|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128526|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57128527|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57128528|NCT02100761|Voriconazole|voriconazole|mesh-list
57128529|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
57128530|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128531|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57128532|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57128533|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128534|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128535|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57128536|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
57128537|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128538|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128539|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57128540|NCT02100917|Trastuzumab|trastuzumab|mesh-list
57128541|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57128542|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128543|NCT02098421|Oxytocin|oxytocin|mesh-list
57128544|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
57128545|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57128546|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128547|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
57128548|NCT02098499|Promethazine|promethazine|mesh-list
57128549|NCT02098499|Haloperidol|haloperidol|mesh-list
57128550|NCT02098499|Metoclopramide|metoclopramide|mesh-list
57128551|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
57128552|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57128553|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57128554|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128555|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128556|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
57128557|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
57128558|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
57128559|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128560|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
57128561|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
57128562|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57128563|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57128564|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
57128565|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
57128566|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128567|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128568|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57128569|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
57128570|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
57128571|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57128572|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57128573|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57128574|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57128575|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
57128576|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57128577|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57128578|NCT03555383|Hemostatics|hemostatics|mesh-list
56902390|NCT03783273|Vitamin D|vitamin d|mesh-list
57128579|NCT03555383|Coagulants|coagulants|mesh-ancestor
57128580|NCT02101151|Vitamin D|vitamin d|mesh-list
57128581|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
57128582|NCT02101151|Vitamins|vitamins|mesh-ancestor
57128583|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
57128584|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128585|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57128586|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57128587|NCT02101229|Insulin|insulin|mesh-list
57128588|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57128589|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57128590|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128591|NCT02102555|Acetaminophen|acetaminophen|mesh-list
57128592|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57128593|NCT02102555|Analgesics|analgesics|mesh-ancestor
57128594|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
57128595|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128596|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128597|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
57128598|NCT02102633|Dabigatran|dabigatran|mesh-list
57128599|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
57128600|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57128601|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
57128602|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128603|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128604|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
57128605|NCT02102711|Vitamin A|vitamin a|mesh-list
57128606|NCT02102711|Vitamins|vitamins|mesh-ancestor
57128607|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
57128608|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128609|NCT02106767|Rifampin|rifampin|mesh-list
57128610|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57128611|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57128612|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57128613|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
57128614|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128615|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57128616|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57128617|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128618|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57128619|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
57128620|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57128621|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128622|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
57128623|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57128624|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57128625|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57128626|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57128627|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57128628|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57128629|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57128630|NCT02103023|Imiquimod|imiquimod|mesh-list
57128631|NCT02103023|Vaccines|vaccines|mesh-list
57128632|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
57128633|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128634|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57128635|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128636|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
57128637|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
57128638|NCT02101931|Levulinic acid|levulinic acid|mesh-list
57128639|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57128640|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810443|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
57128641|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128642|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128643|NCT02106845|Digoxin|digoxin|mesh-list
57128644|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57128645|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57128646|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57128647|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
57128648|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128649|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57128650|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57128651|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128652|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57128653|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57128654|NCT02106845|Protective Agents|protective agents|mesh-ancestor
57128655|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128656|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
57128657|NCT03554447|Dexetimide|dexetimide|mesh-list
57128658|NCT03554447|Citalopram|citalopram|mesh-list
57128659|NCT03554447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57128660|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57128661|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57128662|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128663|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128664|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
57128665|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128666|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57128667|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
57128668|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57128669|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57128670|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57128671|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
57128672|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
57128673|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128674|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57128675|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57128676|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
57128677|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57128678|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128679|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57128680|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57128681|NCT03554447|Protective Agents|protective agents|mesh-ancestor
57128682|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
57128683|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57128684|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
57128685|NCT02103335|Dexamethasone|dexamethasone|mesh-list
57128686|NCT02103335|Pomalidomide|pomalidomide|mesh-list
57128687|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57128688|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
57128689|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
57128690|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128691|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128692|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57128693|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
57128694|NCT02103335|Hormones|hormones|mesh-ancestor
57128695|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128696|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57128697|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128698|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
57128699|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57128700|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57128701|NCT02103335|Growth Substances|growth substances|mesh-ancestor
57128702|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
57128703|NCT02610140|Vinorelbine|vinorelbine|mesh-list
57128704|NCT02610140|Maytansine|maytansine|mesh-list
57128705|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57128706|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128707|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
57128708|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
57128709|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
57128710|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128711|NCT02102321|Albendazole|albendazole|mesh-list
57128712|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
57128713|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57128714|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128715|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
57128716|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57128717|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57128718|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
57128719|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
57128720|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
57128721|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128722|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128723|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57128724|NCT02103569|Norethindrone|norethindrone|mesh-list
57128725|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
57128726|NCT02103569|Estradiol|estradiol|mesh-list
57128727|NCT02103569|Asunaprevir|asunaprevir|mesh-list
57128728|NCT02103569|Estrogens|estrogens|mesh-ancestor
57128729|NCT02103569|Hormones|hormones|mesh-ancestor
57128730|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128731|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128732|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57128733|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
57128734|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57128735|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57128736|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57128737|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57128738|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57128739|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
57128740|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128741|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128742|NCT02103647|Pregabalin|pregabalin|mesh-list
57128743|NCT02103647|Analgesics|analgesics|mesh-ancestor
57128744|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
57128745|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128746|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128747|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
57128748|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57128749|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57128750|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128751|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57128752|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57128753|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57128754|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128755|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57128756|NCT02109965|Midazolam|midazolam|mesh-list
57128757|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
57128758|NCT02109965|Propofol|propofol|mesh-list
57128759|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57128760|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128761|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128762|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57128763|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
57128764|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
57128765|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57128766|NCT02109965|Analgesics|analgesics|mesh-ancestor
57128767|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
57128768|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128769|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57128770|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57128771|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57128772|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
57128773|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128774|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128775|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57128776|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57128777|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57128778|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57128779|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
57128780|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
57128781|NCT02789657|Paclitaxel|paclitaxel|mesh-list
57128782|NCT02789657|Carboplatin|carboplatin|mesh-list
57128783|NCT02789657|Trastuzumab|trastuzumab|mesh-list
57128784|NCT02789657|Pertuzumab|pertuzumab|mesh-list
57128785|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57128786|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128787|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
57128788|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
57128789|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
57128790|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128791|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57128792|NCT03555071|Vaccines|vaccines|mesh-list
57128793|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
57128794|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128795|NCT02609984|Atezolizumab|atezolizumab|mesh-list
57128796|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128797|NCT02107079|Melatonin|melatonin|mesh-list
57128798|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
57128799|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128800|NCT02107079|Protective Agents|protective agents|mesh-ancestor
57128801|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128802|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128803|NCT02107235|ON 01910|on 01910|mesh-list
57128804|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128805|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57128806|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128807|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128808|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
57128809|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57128810|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57128811|NCT02103725|Analgesics|analgesics|mesh-ancestor
57128812|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
57128813|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128814|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128815|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57128816|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57128817|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
57128818|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57128819|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
57128820|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57128821|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128822|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128823|NCT03042260|Trimethoprim|trimethoprim|mesh-list
57128824|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57128825|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
57128826|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57128827|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128828|NCT03042260|Renal Agents|renal agents|mesh-ancestor
57128829|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
57128830|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57128831|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57128832|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57128833|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128834|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128835|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57128836|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57128837|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57128838|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57128839|NCT02110355|Trametinib|trametinib|mesh-list
57128840|NCT02110355|Dabrafenib|dabrafenib|mesh-list
57128841|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128842|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57128843|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128844|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128845|NCT02107391|Leuprolide|leuprolide|mesh-list
57128846|NCT02107391|Goserelin|goserelin|mesh-list
57128847|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57128848|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
57128849|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57128850|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128851|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57128852|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128853|NCT02103881|Ketamine|ketamine|mesh-list
57128854|NCT02103881|Haloperidol|haloperidol|mesh-list
57128855|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
57128856|NCT02103881|Analgesics|analgesics|mesh-ancestor
57128857|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
57128858|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128859|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128860|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57128861|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57128862|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
57128863|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
57128864|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128865|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57128866|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57128867|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128868|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128869|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
57128870|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
56810701|NCT00203476|Niacin|niacin|mesh-list
57128871|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56902397|NCT03777345|Cobalt|cobalt|mesh-list
57128872|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57128873|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57128874|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57128875|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57128876|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
57128877|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57128878|NCT03554915|Midazolam|midazolam|mesh-list
57128879|NCT03554915|Ketamine|ketamine|mesh-list
57128880|NCT03554915|Analgesics|analgesics|mesh-ancestor
57128881|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
57128882|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128883|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128884|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57128885|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57128886|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
57128887|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
57128888|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128889|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57128890|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57128891|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128892|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128893|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57128894|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57128895|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57128896|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57128897|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57128898|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
57128899|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
57128900|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
57128901|NCT03044522|Narcotics|narcotics|mesh-ancestor
57128902|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128903|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128904|NCT03044522|Analgesics|analgesics|mesh-ancestor
57128905|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
57128906|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128907|NCT03044366|Anesthetics|anesthetics|mesh-list
57128908|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128909|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128910|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
57128911|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57128912|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
57128913|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57128914|NCT04864496|Expectorants|expectorants|mesh-ancestor
57128915|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
57128916|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57128917|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
57128918|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128919|NCT04864496|Protective Agents|protective agents|mesh-ancestor
57128920|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128921|NCT04864496|Antidotes|antidotes|mesh-ancestor
57128922|NCT02250833|Amlodipine|amlodipine|mesh-list
57128923|NCT02250833|Telmisartan|telmisartan|mesh-list
57128924|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57128925|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57128926|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57128927|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128928|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57128929|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128930|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
57128931|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57128932|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57128933|NCT02110745|Propofol|propofol|mesh-list
57128934|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57128935|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128936|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128937|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57128938|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
57128939|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
57128940|NCT04857320|Insulin|insulin|mesh-list
57128941|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57128942|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57128943|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128944|NCT03041948|Acetaminophen|acetaminophen|mesh-list
57128945|NCT03041948|Dexamethasone|dexamethasone|mesh-list
56810752|NCT00256282|Docetaxel|docetaxel|mesh-list
57128946|NCT03041948|Ketorolac|ketorolac|mesh-list
57128948|NCT03041948|Remifentanil|remifentanil|mesh-list
57128949|NCT03041948|Ondansetron|ondansetron|mesh-list
57128950|NCT03041948|Propofol|propofol|mesh-list
57128951|NCT03041948|Sevoflurane|sevoflurane|mesh-list
57128952|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57128953|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
57128954|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
57128955|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57128956|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57128957|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57128958|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
57128959|NCT03041948|Hormones|hormones|mesh-ancestor
57128960|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57128961|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57128962|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57128963|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57128964|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57128965|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57128966|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
57128967|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
57128968|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57128969|NCT03041948|Narcotics|narcotics|mesh-ancestor
57128970|NCT03041948|Analgesics|analgesics|mesh-ancestor
57128971|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
57128972|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57128973|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
57128974|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57128975|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57128976|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
57128977|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
57128978|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57128979|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
57128980|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57128981|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128982|NCT03041948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57128983|NCT03041948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57128984|NCT03041948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57128985|NCT03041948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57128986|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57128987|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57128988|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57128989|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128990|NCT02104193|Simvastatin|simvastatin|mesh-list
57128991|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57128992|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57128993|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
57128994|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57128995|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57128996|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57128997|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57128998|NCT03042182|Vaccines|vaccines|mesh-list
57128999|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
57129000|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129001|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
57129002|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
57129003|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57129004|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57129005|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57129006|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129007|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57129008|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57129009|NCT02611778|Ranibizumab|ranibizumab|mesh-list
57129010|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57129011|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57129012|NCT02611778|Growth Substances|growth substances|mesh-ancestor
57129013|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129014|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
57129015|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129016|NCT04867226|Colchicine|colchicine|mesh-list
57129017|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
57129018|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129019|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
57129020|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
56810819|NCT00278889|Cediranib|cediranib|mesh-list
57129021|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
57129022|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129023|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129024|NCT04856852|Iodine|iodine|mesh-list
57129025|NCT04856852|Temozolomide|temozolomide|mesh-list
57129026|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57129027|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
57129028|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129029|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129030|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57129031|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129032|NCT04856852|Trace Elements|trace elements|mesh-ancestor
57129033|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
57129034|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129035|NCT02711553|Gemcitabine|gemcitabine|mesh-list
57129036|NCT02711553|Ramucirumab|ramucirumab|mesh-list
57129037|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129038|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129039|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
57129040|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129041|NCT02711553|Antiviral Agents|antiviral agents|mesh-ancestor
57129042|NCT02711553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129043|NCT02711553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129044|NCT02711553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129045|NCT02711553|Immunologic Factors|immunologic factors|mesh-ancestor
57129046|NCT02711553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129047|NCT01453179|Diclofenac|diclofenac|mesh-list
57129048|NCT01453179|Imiquimod|imiquimod|mesh-list
57129049|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57129050|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57129051|NCT01453179|Analgesics|analgesics|mesh-ancestor
57129052|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
57129053|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129054|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129055|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129056|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129057|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57129058|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129059|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129060|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57129061|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
57129062|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129063|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
57129064|NCT03192033|Hemostatics|hemostatics|mesh-list
57129065|NCT03192033|Coagulants|coagulants|mesh-ancestor
57129066|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
57129067|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
57129068|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
57129069|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
57129070|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129071|NCT03188445|Protective Agents|protective agents|mesh-ancestor
57129072|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129073|NCT03188445|Vitamins|vitamins|mesh-ancestor
57129074|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
57129075|NCT03188445|Trace Elements|trace elements|mesh-ancestor
57129076|NCT03188445|Hematinics|hematinics|mesh-ancestor
57129077|NCT04483635|Vitamin D|vitamin d|mesh-list
57129078|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
57129079|NCT04483635|Vitamins|vitamins|mesh-ancestor
57129080|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
57129081|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129082|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57129083|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57129084|NCT04865900|Antibodies|antibodies|mesh-list
57129085|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
57129086|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129087|NCT03191721|Triclosan|triclosan|mesh-list
57129088|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
57129089|NCT03191721|Fluorides|fluorides|mesh-list
57129090|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
57129091|NCT03191721|Protective Agents|protective agents|mesh-ancestor
57129092|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129093|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57129094|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57129095|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57129096|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
57129097|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129098|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57129099|NCT03188289|Chitosan|chitosan|mesh-list
57129100|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
57129101|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57129102|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
57129103|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129104|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
57129105|NCT03188289|Protective Agents|protective agents|mesh-ancestor
57129106|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57129107|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57129108|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
57129109|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129110|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57129111|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
57129112|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
57129113|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
57129114|NCT03188289|Coagulants|coagulants|mesh-ancestor
57129115|NCT03044912|Mirabegron|mirabegron|mesh-list
57129116|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57129117|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57129118|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57129119|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
57129120|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129121|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129122|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129123|NCT03044912|Urological Agents|urological agents|mesh-ancestor
57129124|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
57129125|NCT03041012|Romidepsin|romidepsin|mesh-list
57129126|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
57129127|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
57129128|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129129|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57129130|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129131|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
57129132|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129133|NCT03187899|Ropivacaine|ropivacaine|mesh-list
57129134|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
57129135|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
57129136|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129137|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129138|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
57129139|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129140|NCT01648582|Metformin|metformin|mesh-list
57129141|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
57129142|NCT01648582|Dulaglutide|dulaglutide|mesh-list
57129143|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57129144|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129145|NCT02440347|Anesthetics|anesthetics|mesh-list
57129146|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129147|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129148|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
57129149|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57129150|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
57129151|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57129152|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129153|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57129154|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57129155|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57129156|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
57129157|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
57129158|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129159|NCT04854668|Bevacizumab|bevacizumab|mesh-list
57129160|NCT04854668|Capecitabine|capecitabine|mesh-list
57129161|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
57129162|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57129163|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129164|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57129165|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57129166|NCT04854668|Growth Substances|growth substances|mesh-ancestor
57129167|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129168|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
57129169|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129170|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
56902403|NCT01318005|Norinyl|norinyl|mesh-list
57129171|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129172|NCT03189069|Warfarin|warfarin|mesh-list
57129173|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
56810975|NCT00251745|Lansoprazole|lansoprazole|mesh-list
57129175|NCT03189069|Apixaban|apixaban|mesh-list
57129176|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
57129177|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57129178|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
57129179|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57129180|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
57129181|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129182|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129183|NCT03040934|Sirolimus|sirolimus|mesh-list
57129184|NCT03040934|Everolimus|everolimus|mesh-list
57129185|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129186|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129187|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
57129188|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129189|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57129190|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129191|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57129192|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
57129193|NCT04861142|Denosumab|denosumab|mesh-list
57129194|NCT04861142|Alendronate|alendronate|mesh-list
57129195|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57129196|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129197|NCT03117855|Capecitabine|capecitabine|mesh-list
57129198|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129199|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
57129200|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129201|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129202|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
57129203|NCT02607800|Velpatasvir|velpatasvir|mesh-list
57129204|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
57129205|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129206|NCT02304484|Evolocumab|evolocumab|mesh-list
57129207|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57129208|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57129209|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
57129210|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129211|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57129212|NCT02434029|Budesonide|budesonide|mesh-list
57129213|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129214|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57129215|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
57129216|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129217|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129218|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57129219|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
57129220|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
57129221|NCT02434029|Hormones|hormones|mesh-ancestor
57129222|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57129223|NCT03043430|Midazolam|midazolam|mesh-list
57129224|NCT03043430|Ketamine|ketamine|mesh-list
57129225|NCT03043430|Analgesics|analgesics|mesh-ancestor
57129226|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
57129227|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129228|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129229|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57129230|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57129231|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
57129232|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
57129233|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129234|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57129235|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57129236|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129237|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129238|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57129239|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57129240|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57129241|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57129242|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57129243|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
57129244|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
57129245|NCT02708355|Esomeprazole|esomeprazole|mesh-list
57129246|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57129247|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57129248|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57129249|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129250|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129251|NCT04854044|TIC10 compound|tic10 compound|mesh-list
57129252|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129253|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
57129254|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57129255|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129256|NCT02337478|Vincristine|vincristine|mesh-list
57129257|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57129258|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129259|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
57129260|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
57129261|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
57129262|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129263|NCT02434653|Chrysarobin|chrysarobin|mesh-list
57129264|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57129265|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57129266|NCT02434653|Analgesics|analgesics|mesh-ancestor
57129267|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
57129268|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129269|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129270|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129271|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129272|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57129273|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57129274|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57129275|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
57129276|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129277|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57129278|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57129279|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129280|NCT03188835|Glycerol|glycerol|mesh-list
57129281|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57129282|NCT03188835|Protective Agents|protective agents|mesh-ancestor
57129283|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129284|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
57129285|NCT04847024|Parecoxib|parecoxib|mesh-list
57129286|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57129287|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57129288|NCT04847024|Analgesics|analgesics|mesh-ancestor
57129289|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
57129290|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129291|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129292|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129293|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129294|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57129295|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57129296|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129297|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129298|NCT04860674|Carboplatin|carboplatin|mesh-list
57129299|NCT04860674|Etoposide|etoposide|mesh-list
57129300|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57129301|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129302|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57129303|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57129304|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57129305|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129306|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129307|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
57129308|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57129309|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129310|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
57129311|NCT02430363|Dactolisib|dactolisib|mesh-list
57129312|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57129313|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129314|NCT02429973|Gemcitabine|gemcitabine|mesh-list
57129315|NCT02429973|Sirolimus|sirolimus|mesh-list
57129316|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129317|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
57129318|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129319|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129320|NCT02429973|Antiviral Agents|antiviral agents|mesh-ancestor
57129321|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129322|NCT02429973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129323|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129324|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
57129325|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129326|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57129327|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57129328|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
57129330|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
57129331|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57129332|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57129333|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129334|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129335|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129336|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129337|NCT04846634|Gemcitabine|gemcitabine|mesh-list
57129338|NCT04846634|Paclitaxel|paclitaxel|mesh-list
57129339|NCT04846634|Docetaxel|docetaxel|mesh-list
57129340|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57129341|NCT04846634|Cisplatin|cisplatin|mesh-list
57129342|NCT04846634|Carboplatin|carboplatin|mesh-list
57129343|NCT04846634|Pemetrexed|pemetrexed|mesh-list
57129344|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57129345|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129346|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
57129347|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
57129348|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
57129349|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129350|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129351|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
57129352|NCT04846634|Antiviral Agents|antiviral agents|mesh-ancestor
57129353|NCT04846634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129354|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129355|NCT04846634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129356|NCT04846634|Immunologic Factors|immunologic factors|mesh-ancestor
57129357|NCT04846634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129358|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57129359|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57129360|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
57129361|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57129362|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57129363|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129364|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129365|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57129366|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57129367|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57129368|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
57129369|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129370|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129371|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57129372|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57129373|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
57129374|NCT02429817|Edetic Acid|edetic acid|mesh-list
57129375|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
57129376|NCT02429817|Antidotes|antidotes|mesh-ancestor
57129377|NCT02429817|Protective Agents|protective agents|mesh-ancestor
57129378|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129379|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
57129380|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
57129381|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129382|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57129383|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
57129384|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57129385|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
57129386|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57129387|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
57129388|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129389|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
57129390|NCT04851548|Protective Agents|protective agents|mesh-ancestor
57129391|NCT02706951|Methotrexate|methotrexate|mesh-list
57129392|NCT02706951|Upadacitinib|upadacitinib|mesh-list
57129393|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57129394|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
57129395|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57129396|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129397|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129398|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
57129399|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129400|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129401|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
57129402|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129403|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57129404|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129405|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
57129406|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129407|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57129408|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
57129409|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57129410|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
57129411|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129412|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129413|NCT04851392|Dronabinol|dronabinol|mesh-list
57129414|NCT04851392|Cannabidiol|cannabidiol|mesh-list
57129415|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
57129416|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
57129417|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129418|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57129419|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57129420|NCT04851392|Analgesics|analgesics|mesh-ancestor
57129421|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
57129422|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129423|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57129424|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57129425|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129426|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129427|NCT04851392|Hormones|hormones|mesh-ancestor
57129428|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57129429|NCT02429193|Prednisone|prednisone|mesh-list
57129430|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
57129431|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129432|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
57129433|NCT02429193|Hormones|hormones|mesh-ancestor
57129434|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57129435|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129436|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57129437|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129438|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57129439|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129440|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129441|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
57129442|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57129443|NCT04859738|Lidocaine|lidocaine|mesh-list
57129444|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
57129445|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
57129446|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129447|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129448|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
57129449|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129450|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57129451|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57129452|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57129453|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57129454|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129455|NCT02429271|Clopidogrel|clopidogrel|mesh-list
57129456|NCT02429271|Ticagrelor|ticagrelor|mesh-list
57129457|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57129458|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57129459|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57129460|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57129461|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
57129462|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129463|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129464|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129465|NCT02429505|Miltefosine|miltefosine|mesh-list
57129466|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
57129467|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129468|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129469|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57129470|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57129471|NCT04851002|Mitogens|mitogens|mesh-list
57129472|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
57129473|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129474|NCT04844996|Ezetimibe|ezetimibe|mesh-list
57129475|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57129476|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57129477|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
57129478|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129479|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57129481|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129482|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
57129483|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129484|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129485|NCT02425137|Antiviral Agents|antiviral agents|mesh-ancestor
57129486|NCT02425137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129487|NCT02425137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129488|NCT02425137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129489|NCT02425137|Immunologic Factors|immunologic factors|mesh-ancestor
57129490|NCT02425137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129491|NCT04841018|Dexamethasone|dexamethasone|mesh-list
57129492|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
57129493|NCT04841018|BB 1101|bb 1101|mesh-list
57129494|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129495|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
57129496|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
57129497|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129498|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129499|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57129500|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
57129501|NCT04841018|Hormones|hormones|mesh-ancestor
57129502|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57129503|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57129504|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129505|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
57129506|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129507|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129508|NCT04840550|Lansoprazole|lansoprazole|mesh-list
57129509|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
57129510|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57129511|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57129512|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57129513|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129514|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129515|NCT03182595|Acetaminophen|acetaminophen|mesh-list
57129516|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57129517|NCT03182595|Analgesics|analgesics|mesh-ancestor
57129518|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
57129519|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129520|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129521|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
57129522|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
57129523|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
57129524|NCT02429037|Cisplatin|cisplatin|mesh-list
57129525|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129526|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
57129527|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57129528|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129529|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57129530|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57129531|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57129532|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129533|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129534|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57129535|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57129536|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129537|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
57129538|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129539|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
57129540|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57129541|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129542|NCT04833218|Propranolol|propranolol|mesh-list
57129543|NCT04833218|Clonidine|clonidine|mesh-list
57129544|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57129545|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57129546|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
57129547|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129548|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129549|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129550|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57129551|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57129552|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
57129553|NCT04833218|Analgesics|analgesics|mesh-ancestor
57129554|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
57129555|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129556|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
57129557|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
57129558|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57129559|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57129560|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57129561|NCT04833374|Prednisone|prednisone|mesh-list
57129562|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
57129563|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57129564|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57129565|NCT04833374|Prednisolone|prednisolone|mesh-list
57129566|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
57129567|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57129568|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
57129569|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129570|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
57129571|NCT04833374|Hormones|hormones|mesh-ancestor
57129572|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57129573|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129574|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57129575|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129576|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
57129577|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
57129578|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129579|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57129580|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57129581|NCT04833374|Protective Agents|protective agents|mesh-ancestor
57129582|NCT04843982|Esketamine|esketamine|mesh-list
57129583|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
57129584|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57129585|NCT02707965|Topiramate|topiramate|mesh-list
57129586|NCT02707965|Lamotrigine|lamotrigine|mesh-list
57129587|NCT02707965|Zonisamide|zonisamide|mesh-list
57129588|NCT02707965|Carbamazepine|carbamazepine|mesh-list
57129589|NCT02707965|Phenytoin|phenytoin|mesh-list
57129590|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
57129591|NCT02707965|Levetiracetam|levetiracetam|mesh-list
57129592|NCT02707965|Valproic Acid|valproic acid|mesh-list
57129593|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
57129594|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57129595|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129596|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
57129597|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57129598|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57129599|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129600|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57129601|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57129602|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57129603|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129604|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57129605|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57129606|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
57129607|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57129608|NCT02707965|Analgesics|analgesics|mesh-ancestor
57129609|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
57129610|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129611|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57129612|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57129613|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129614|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
57129615|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129616|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57129617|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57129618|NCT04839536|Sevoflurane|sevoflurane|mesh-list
57129619|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57129620|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57129621|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
57129622|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
57129623|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129624|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129625|NCT02428257|Ephedrine|ephedrine|mesh-list
57129626|NCT02428257|Bupivacaine|bupivacaine|mesh-list
57129627|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
57129629|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129630|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129631|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
57129632|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129633|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57129634|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
57129635|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
57129636|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57129637|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
57129638|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129639|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129640|NCT04839224|Phenylephrine|phenylephrine|mesh-list
57129641|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
57129642|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57129643|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
57129644|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
57129645|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129646|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129647|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
57129648|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57129649|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
57129650|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
57129651|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57129652|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57129653|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57129654|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
57129655|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129656|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129657|NCT04839224|Protective Agents|protective agents|mesh-ancestor
57129658|NCT03036644|Nicotine|nicotine|mesh-list
57129659|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
57129660|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
57129661|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129662|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129663|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
57129664|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57129665|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
57129666|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129667|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129668|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
57129669|NCT02424201|Misoprostol|misoprostol|mesh-list
57129670|NCT02424201|Vitamins|vitamins|mesh-ancestor
57129671|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
57129672|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129673|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57129674|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
57129675|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57129676|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57129677|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57129678|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
57129679|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
57129680|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129681|NCT02424201|Protective Agents|protective agents|mesh-ancestor
57129682|NCT02432781|Insulin|insulin|mesh-list
57129683|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57129684|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129685|NCT01667900|Dulaglutide|dulaglutide|mesh-list
57129686|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57129687|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129688|NCT04843280|Coal Tar|coal tar|mesh-list
57129689|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
57129690|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
57129691|NCT04833296|Ropivacaine|ropivacaine|mesh-list
57129692|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
57129693|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
57129694|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129695|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129696|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
57129697|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129698|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
57129699|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57129700|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
57129701|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57129702|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811512|NCT01075438|Vaccines|vaccines|mesh-list
57129703|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57129704|NCT00702273|Progesterone|progesterone|mesh-list
57129705|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57129706|NCT00702273|Ganirelix|ganirelix|mesh-list
57129707|NCT00702273|Progestins|progestins|mesh-ancestor
57129708|NCT00702273|Hormones|hormones|mesh-ancestor
57129709|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57129710|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129711|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
57129712|NCT02433795|Rituximab|rituximab|mesh-list
57129713|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57129714|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57129715|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129716|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
57129717|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129718|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129719|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57129720|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
57129721|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129722|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
57129723|NCT03038516|Vitamin D|vitamin d|mesh-list
57129724|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57129725|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129726|NCT03038516|Vitamins|vitamins|mesh-ancestor
57129727|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
57129728|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57129729|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
57129730|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57129731|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57129732|NCT02424435|Prednisolone|prednisolone|mesh-list
57129733|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
57129734|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57129735|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
57129736|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129737|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
57129738|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
57129739|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129740|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129741|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57129742|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
57129743|NCT02424435|Hormones|hormones|mesh-ancestor
57129744|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57129745|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57129746|NCT02424435|Protective Agents|protective agents|mesh-ancestor
57129747|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57129748|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129749|NCT04842968|Methylene Blue|methylene blue|mesh-list
57129750|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129751|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129752|NCT04832204|Apatinib|apatinib|mesh-list
57129753|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129754|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57129755|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129756|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129757|NCT03038282|Chromium|chromium|mesh-list
57129758|NCT03038282|Chromous chloride|chromous chloride|mesh-list
57129759|NCT03038282|Trace Elements|trace elements|mesh-ancestor
57129760|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
57129761|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129762|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
56902408|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57129763|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129764|NCT03038282|Protective Agents|protective agents|mesh-ancestor
57129765|NCT02424045|Dexamethasone|dexamethasone|mesh-list
57129766|NCT02424045|Carboplatin|carboplatin|mesh-list
57129767|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57129768|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129769|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
57129770|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
57129771|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129772|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129773|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57129774|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
57129775|NCT02424045|Hormones|hormones|mesh-ancestor
57129776|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57129777|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57129778|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129779|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57129780|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
57129781|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129782|NCT03037970|Becaplermin|becaplermin|mesh-list
57129783|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
57129784|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
57129785|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57129786|NCT03037970|Growth Substances|growth substances|mesh-ancestor
57129787|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129788|NCT04841720|Metformin|metformin|mesh-list
57129789|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57129790|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129791|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
57129792|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57129793|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129794|NCT03039842|Valproic Acid|valproic acid|mesh-list
57129795|NCT03039842|Memantine|memantine|mesh-list
57129796|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
57129797|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57129798|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57129799|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
57129800|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129801|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129802|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129803|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57129804|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57129805|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
57129806|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
57129807|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
57129808|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129809|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
57129810|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
57129811|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57129812|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129813|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57129814|NCT03181815|Cytarabine|cytarabine|mesh-list
57129815|NCT03181815|Cladribine|cladribine|mesh-list
57129816|NCT03181815|Aclarubicin|aclarubicin|mesh-list
57129817|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
57129818|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129819|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
57129820|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129821|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129822|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
57129823|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129824|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129825|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
57129826|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129827|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57129828|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57129829|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57129830|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129831|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57129832|NCT03038048|Ranibizumab|ranibizumab|mesh-list
57129833|NCT03038048|Aflibercept|aflibercept|mesh-list
57129834|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57129835|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57129836|NCT03038048|Growth Substances|growth substances|mesh-ancestor
57129837|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129838|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
57129839|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129840|NCT03185871|Celecoxib|celecoxib|mesh-list
57129841|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57129842|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57129843|NCT03185871|Analgesics|analgesics|mesh-ancestor
57129844|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
57129845|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129846|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129847|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129848|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129849|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57129850|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57129851|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129852|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129853|NCT04830878|Methotrexate|methotrexate|mesh-list
57129854|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57129855|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
57129856|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57129857|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129858|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129859|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
57129860|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129861|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129862|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
57129863|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129864|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57129865|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129866|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
57129867|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129868|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57129869|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57129870|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
57129871|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
57129872|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129873|NCT03180957|Adalimumab|adalimumab|mesh-list
57129874|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129875|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129876|NCT02427165|Albuterol|albuterol|mesh-list
57129877|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57129878|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
57129879|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129880|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129881|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57129882|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
57129883|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
57129884|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57129885|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57129886|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57129887|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57129888|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
57129889|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129890|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129891|NCT03037736|Bevacizumab|bevacizumab|mesh-list
57129892|NCT03037736|Fluorouracil|fluorouracil|mesh-list
57129893|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57129894|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129895|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57129896|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57129897|NCT03037736|Growth Substances|growth substances|mesh-ancestor
57129898|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129899|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
57129900|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
57129901|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129902|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57129903|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129904|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
57129905|NCT04838132|Ropivacaine|ropivacaine|mesh-list
57129906|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
57129907|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
57129908|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129909|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129910|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
57129911|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129912|NCT03037892|Fentanyl|fentanyl|mesh-list
57129913|NCT03037892|Midazolam|midazolam|mesh-list
57129914|NCT03037892|Remifentanil|remifentanil|mesh-list
57129915|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57129916|NCT03037892|Narcotics|narcotics|mesh-ancestor
57129917|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129918|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129919|NCT03037892|Analgesics|analgesics|mesh-ancestor
57129920|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
57129921|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129922|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57129923|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57129924|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
57129925|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
57129926|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57129927|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57129928|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57129929|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57129930|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
57129931|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
57129932|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57129933|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129934|NCT03183843|Warfarin|warfarin|mesh-list
57129935|NCT03183843|Dabigatran|dabigatran|mesh-list
57129936|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
57129937|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
57129938|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57129939|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
57129940|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129941|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129942|NCT03180879|Ibuprofen|ibuprofen|mesh-list
57129943|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57129944|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57129945|NCT03180879|Analgesics|analgesics|mesh-ancestor
57129946|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
57129947|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129948|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129949|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129950|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129951|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57129952|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129953|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129954|NCT03180723|Cyclosporine|cyclosporine|mesh-list
57129955|NCT03180723|Rituximab|rituximab|mesh-list
57129956|NCT03180723|Cyclosporins|cyclosporins|mesh-list
57129957|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57129958|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57129959|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
57129960|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129961|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57129962|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129963|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129964|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129965|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
57129966|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57129967|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
57129968|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57129969|NCT04841096|Metformin|metformin|mesh-list
57129970|NCT04841096|Glimepiride|glimepiride|mesh-list
57129971|NCT04841096|Vildagliptin|vildagliptin|mesh-list
57129972|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57129973|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129974|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57129975|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57129976|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
57129977|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57129978|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
57129979|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57129980|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57129981|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57129982|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
57129983|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129984|NCT02426697|Fentanyl|fentanyl|mesh-list
57129985|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57129986|NCT02426697|Narcotics|narcotics|mesh-ancestor
57129987|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57129988|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57129989|NCT02426697|Analgesics|analgesics|mesh-ancestor
57129990|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
57129991|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57129992|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57129993|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57129994|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
57129995|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
57129996|NCT03039608|Prednisone|prednisone|mesh-list
57129997|NCT03039608|Triamcinolone|triamcinolone|mesh-list
57129998|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57129999|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
57130000|NCT03039608|Hormones|hormones|mesh-ancestor
57130001|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130002|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130003|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57130004|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130005|NCT02423811|Fursultiamin|fursultiamin|mesh-list
57130006|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
57130007|NCT02423811|Vitamins|vitamins|mesh-ancestor
57130008|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
57130009|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130010|NCT04837664|Nystatin|nystatin|mesh-list
57130011|NCT04837664|Curcumin|curcumin|mesh-list
57130012|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57130013|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57130014|NCT04837664|Analgesics|analgesics|mesh-ancestor
57130015|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
57130016|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130017|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130018|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130019|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57130020|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130021|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130022|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130023|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57130024|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130025|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
57130026|NCT04837664|Ionophores|ionophores|mesh-ancestor
57130027|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130028|NCT01331837|Etanercept|etanercept|mesh-list
57130029|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57130030|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57130031|NCT01331837|Analgesics|analgesics|mesh-ancestor
57130032|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
57130033|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130034|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130035|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130036|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57130037|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57130038|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57130039|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
57130040|NCT02706483|Plecanatide|plecanatide|mesh-list
57130041|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57130042|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
57130043|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130044|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57130045|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
57130046|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130047|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
57130048|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130049|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130050|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57130051|NCT03183297|Fexofenadine|fexofenadine|mesh-list
57130052|NCT03183297|Naproxen|naproxen|mesh-list
57130053|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57130054|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57130055|NCT03183297|Analgesics|analgesics|mesh-ancestor
57130056|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
57130057|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130058|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130059|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130060|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57130061|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
57130062|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57130063|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130064|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130065|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57130066|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57130067|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57130068|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
57130069|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
57130070|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130071|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57130072|NCT02426619|Fluorides|fluorides|mesh-list
57130073|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
57130074|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
57130075|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
57130076|NCT02426619|Protective Agents|protective agents|mesh-ancestor
57130077|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130078|NCT02108483|Dapsone|dapsone|mesh-list
57130079|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130080|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
57130081|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57130082|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57130083|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57130084|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130085|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130086|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
57130087|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57130088|NCT01648348|Bevacizumab|bevacizumab|mesh-list
57130089|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57130090|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
57130091|NCT01648348|Antibodies|antibodies|mesh-list
57130092|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
57130093|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57130094|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
57130095|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130096|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57130097|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57130098|NCT01648348|Growth Substances|growth substances|mesh-ancestor
57130099|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130100|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
57130101|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
57130102|NCT03180255|Dexamethasone|dexamethasone|mesh-list
57130103|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
57130104|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57130105|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130106|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
57130107|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
57130108|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130109|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130110|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57130111|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
57130112|NCT03180255|Hormones|hormones|mesh-ancestor
57130113|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130114|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55896992|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
57130115|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130116|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
57130117|NCT02431221|Perhexiline|perhexiline|mesh-list
57130118|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57130119|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130120|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130121|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57130122|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130123|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
57130124|NCT02108639|Asunaprevir|asunaprevir|mesh-list
57130125|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
57130126|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130127|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130128|NCT03180099|Bupivacaine|bupivacaine|mesh-list
57130129|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
57130130|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
57130131|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130132|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130133|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
57130134|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130135|NCT04770272|Paclitaxel|paclitaxel|mesh-list
57130136|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
57130137|NCT04770272|Carboplatin|carboplatin|mesh-list
57130138|NCT04770272|Atezolizumab|atezolizumab|mesh-list
57130139|NCT04770272|Epirubicin|epirubicin|mesh-list
57130140|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57130141|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57130142|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130143|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
57130144|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
57130145|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
57130146|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130147|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57130148|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
57130149|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130150|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57130151|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57130152|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
57130153|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57130154|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57130155|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57130156|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57130157|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130158|NCT02251145|Ritonavir|ritonavir|mesh-list
57130159|NCT02251145|Tenofovir|tenofovir|mesh-list
57130160|NCT02251145|Tipranavir|tipranavir|mesh-list
57130161|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57130162|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57130163|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
57130164|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130165|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130166|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57130167|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57130168|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
57130169|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130170|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57130171|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57130172|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57130173|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57130174|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57130175|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
57130176|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130177|NCT00709371|Zonisamide|zonisamide|mesh-list
57130178|NCT00709371|Bupropion|bupropion|mesh-list
57130179|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57130180|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
57130181|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57130182|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57130183|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57130184|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130185|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130186|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
57130187|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130188|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130189|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57130190|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57130191|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130192|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
57130193|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57130194|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57130195|NCT02426463|Oxycodone|oxycodone|mesh-list
57130196|NCT02426463|Propofol|propofol|mesh-list
57130197|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57130198|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130199|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130200|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57130201|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
57130202|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
57130203|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57130204|NCT02426463|Narcotics|narcotics|mesh-ancestor
57130205|NCT02426463|Analgesics|analgesics|mesh-ancestor
57130206|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
57130207|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130208|NCT02426229|Dabigatran|dabigatran|mesh-list
57130209|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
57130210|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57130211|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
57130212|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130213|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130214|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
57130215|NCT01648270|Buprenorphine|buprenorphine|mesh-list
57130216|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57130217|NCT01648270|Narcotics|narcotics|mesh-ancestor
57130218|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130219|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130220|NCT01648270|Analgesics|analgesics|mesh-ancestor
57130221|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
57130222|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130223|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57130224|NCT02108795|Remifentanil|remifentanil|mesh-list
57130225|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57130226|NCT02108795|Narcotics|narcotics|mesh-ancestor
57130227|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130228|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130229|NCT02108795|Analgesics|analgesics|mesh-ancestor
57130230|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
57130231|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130232|NCT02431143|Miltefosine|miltefosine|mesh-list
57130233|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
57130234|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130235|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130236|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57130237|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57130238|NCT02302846|Ixazomib|ixazomib|mesh-list
57130239|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130240|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
57130241|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130242|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130243|NCT02431065|Ropivacaine|ropivacaine|mesh-list
57130244|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
57130245|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
57130246|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130247|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130248|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
57130249|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130250|NCT04836806|Cetirizine|cetirizine|mesh-list
57130251|NCT04836806|Famotidine|famotidine|mesh-list
57130252|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57130253|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57130254|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57130255|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
57130256|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
57130257|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130258|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130259|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130260|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57130261|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
57130262|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57130263|NCT04836728|Paclitaxel|paclitaxel|mesh-list
57130264|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57130265|NCT04836728|Carboplatin|carboplatin|mesh-list
57130266|NCT04836728|Pemetrexed|pemetrexed|mesh-list
57130267|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57130268|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57130269|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130270|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
57130271|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
57130272|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
57130273|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130274|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130275|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57130276|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57130277|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
57130278|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130279|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
57130280|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57130281|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
57130282|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57130283|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
57130284|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130285|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57130286|NCT02105675|Docetaxel|docetaxel|mesh-list
57130287|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130288|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
57130289|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
57130290|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
57130291|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130292|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
57130293|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130294|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
57130295|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130296|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57130297|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
57130298|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130299|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57130300|NCT04824404|Buprenorphine|buprenorphine|mesh-list
57130301|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57130302|NCT04824404|Narcotics|narcotics|mesh-ancestor
57130303|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130304|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130305|NCT04824404|Analgesics|analgesics|mesh-ancestor
57130306|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
57130307|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130308|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57130309|NCT02109341|Paclitaxel|paclitaxel|mesh-list
57130310|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57130311|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57130312|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130313|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
57130314|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
57130315|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
57130316|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130317|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
57130318|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
57130320|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130321|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57130322|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130323|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130324|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57130325|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
57130326|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130327|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57130328|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57130329|NCT04827134|Triumeq|triumeq|mesh-list
57130330|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57130331|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57130332|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
57130333|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130334|NCT04367168|Colchicine|colchicine|mesh-list
57130335|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
57130336|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57130337|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
57130338|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
57130339|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
56902441|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57130340|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130341|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130342|NCT02113943|Citalopram|citalopram|mesh-list
57130343|NCT02113943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57130344|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57130345|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130346|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130347|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130348|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
57130349|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130350|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57130351|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
57130352|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57130353|NCT02114021|Betamethasone|betamethasone|mesh-list
57130354|NCT02114021|Lidocaine|lidocaine|mesh-list
57130355|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
57130356|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
57130357|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130358|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130359|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
57130360|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130361|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57130362|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57130363|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57130364|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130365|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130366|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130367|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
57130368|NCT02114021|Hormones|hormones|mesh-ancestor
57130369|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130370|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57130371|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
57130372|NCT04826822|Dexamethasone|dexamethasone|mesh-list
57130373|NCT04826822|Spironolactone|spironolactone|mesh-list
57130374|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130375|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
57130376|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
57130377|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130378|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130379|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57130380|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
57130381|NCT04826822|Hormones|hormones|mesh-ancestor
57130382|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130383|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57130384|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130385|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57130386|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
57130387|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57130389|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
57130390|NCT02251457|Ranolazine|ranolazine|mesh-list
57130391|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57130392|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130393|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130394|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
57130395|NCT02112305|Analgesics|analgesics|mesh-ancestor
57130396|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
57130397|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130398|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130399|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
57130400|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130401|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57130402|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
57130403|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57130404|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130405|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130406|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57130407|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
57130408|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57130409|NCT02114099|Atorvastatin|atorvastatin|mesh-list
57130410|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57130411|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57130412|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
57130413|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130414|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57130415|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57130416|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130417|NCT02251223|Ritonavir|ritonavir|mesh-list
57130418|NCT02251223|Tipranavir|tipranavir|mesh-list
57130419|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57130420|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57130421|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
57130422|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130423|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130424|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57130425|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57130426|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
57130427|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130428|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57130429|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57130430|NCT02114333|Vaccines|vaccines|mesh-list
57130431|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
57130432|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130433|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
57130434|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57130435|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130436|NCT02114645|Leuprolide|leuprolide|mesh-list
57130437|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57130438|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57130439|NCT02114645|Estradiol|estradiol|mesh-list
57130440|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57130441|NCT02114645|Progesterone|progesterone|mesh-list
57130442|NCT02114645|Estrogens|estrogens|mesh-ancestor
57130443|NCT02114645|Hormones|hormones|mesh-ancestor
57130444|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130445|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130446|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57130447|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
57130448|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57130449|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57130450|NCT02114645|Progestins|progestins|mesh-ancestor
57130451|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57130452|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
57130453|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57130454|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130455|NCT02112695|Diprenorphine|diprenorphine|mesh-list
57130456|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57130457|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130458|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
56812244|NCT01046240|Palonosetron|palonosetron|mesh-list
57130459|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130460|NCT02603432|Avelumab|avelumab|mesh-list
57130461|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57130462|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57130463|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130464|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
57130465|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130466|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
57130467|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57130468|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130469|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130470|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57130471|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130472|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130473|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
57130474|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130475|NCT04361162|Nivolumab|nivolumab|mesh-list
57130476|NCT04361162|Ipilimumab|ipilimumab|mesh-list
57130477|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57130478|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130479|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57130480|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130481|NCT04826198|Olaparib|olaparib|mesh-list
57130482|NCT04826198|Niraparib|niraparib|mesh-list
57130483|NCT04826198|Rucaparib|rucaparib|mesh-list
57130484|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57130485|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130486|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130487|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130488|NCT04823390|Fentanyl|fentanyl|mesh-list
57130489|NCT04823390|Midazolam|midazolam|mesh-list
57130490|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57130491|NCT04823390|Narcotics|narcotics|mesh-ancestor
57130492|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130493|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130494|NCT04823390|Analgesics|analgesics|mesh-ancestor
57130495|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
57130496|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130497|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57130498|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57130499|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
57130500|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
57130501|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57130502|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57130503|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57130504|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57130505|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
57130506|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
57130507|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130508|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130509|NCT04826432|Pasireotide|pasireotide|mesh-list
57130510|NCT04826432|Hormones|hormones|mesh-ancestor
57130511|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130512|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130513|NCT05618912|Petrolatum|petrolatum|mesh-list
57130514|NCT05618912|Emollients|emollients|mesh-ancestor
57130515|NCT05618912|Dermatologic Agents|dermatologic agents|mesh-ancestor
57130516|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
57130517|NCT04826510|Perospirone|perospirone|mesh-list
57130518|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
57130519|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57130520|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130521|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130522|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
57130523|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57130524|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130525|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130526|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57130527|NCT03036800|Liraglutide|liraglutide|mesh-list
57130528|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57130529|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130530|NCT03036800|Incretins|incretins|mesh-ancestor
57130531|NCT03036800|Hormones|hormones|mesh-ancestor
57130532|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130533|NCT02301988|Paclitaxel|paclitaxel|mesh-list
57130534|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57130535|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812318|NCT01046708|Progesterone|progesterone|mesh-list
57130536|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
57130537|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
57130538|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
57130539|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130540|NCT04326920|Sargramostim|sargramostim|mesh-list
57130541|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
57130542|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130544|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57130545|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
57130546|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
57130547|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130548|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130549|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
57130550|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57130551|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130552|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57130553|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57130554|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130555|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130556|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920408|NCT03456882|RNS60|rns60|mesh-list
57130557|NCT02115035|Vemurafenib|vemurafenib|mesh-list
57130558|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130559|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57130560|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130561|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130562|NCT02113319|Dasatinib|dasatinib|mesh-list
57130563|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130564|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57130565|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130566|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130567|NCT02113397|Tobramycin|tobramycin|mesh-list
57130568|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57130569|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130570|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
57130571|NCT04822064|Ketamine|ketamine|mesh-list
57130572|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
57130573|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57130574|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130575|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130576|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57130577|NCT04822064|Analgesics|analgesics|mesh-ancestor
57130578|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
57130579|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130580|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57130581|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57130582|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57130583|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
57130584|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130585|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130586|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57130587|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57130588|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
57130589|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
57130590|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57130591|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57130592|NCT03553433|Apremilast|apremilast|mesh-list
57130593|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57130594|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57130595|NCT03553433|Analgesics|analgesics|mesh-ancestor
57130596|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
57130597|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130598|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130599|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130600|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57130601|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57130602|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57130603|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130604|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130605|NCT02604212|Tenofovir|tenofovir|mesh-list
57130606|NCT02604212|Entecavir|entecavir|mesh-list
57130607|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
57130608|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
57130609|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
56812432|NCT01047098|Iron|iron|mesh-list
57130610|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130611|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57130612|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57130613|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130614|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130615|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57130616|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57130617|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
57130618|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130619|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130620|NCT02115659|Triptolide|triptolide|mesh-list
57130621|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
57130622|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130623|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57130624|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
57130625|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57130626|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57130627|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
57130628|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57130629|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
57130630|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130631|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130632|NCT02113631|Interferons|interferons|mesh-list
57130633|NCT02113631|Ribavirin|ribavirin|mesh-list
57130634|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
57130635|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
57130636|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57130637|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130638|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
57130639|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130640|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
57130641|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130642|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
57130643|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130644|NCT02123069|Nitroprusside|nitroprusside|mesh-list
57130645|NCT02123069|Phenylephrine|phenylephrine|mesh-list
57130646|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
57130647|NCT02123069|Norepinephrine|norepinephrine|mesh-list
57130648|NCT02123069|Acetylcholine|acetylcholine|mesh-list
57130649|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57130650|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
57130651|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
57130652|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130653|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130654|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
57130655|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57130656|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
57130657|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
57130658|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57130659|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57130660|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57130661|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
57130662|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130663|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130664|NCT02123069|Protective Agents|protective agents|mesh-ancestor
57130665|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57130666|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
57130667|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
57130668|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57130669|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
57130670|NCT04428632|Berotralstat|berotralstat|mesh-list
57130671|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130672|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130673|NCT05618210|Anesthetics|anesthetics|mesh-list
57130674|NCT05618210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130675|NCT05618210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130676|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
57130677|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
57130678|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57130679|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57130680|NCT02789111|Alvimopan|alvimopan|mesh-list
57130681|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57130682|NCT04807166|Paclitaxel|paclitaxel|mesh-list
57130683|NCT04807166|Carboplatin|carboplatin|mesh-list
56812471|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130684|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57130686|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
57130687|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
57130688|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
57130689|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130690|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57130691|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57130692|NCT02251925|Estradiol|estradiol|mesh-list
57130693|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57130694|NCT02251925|Estrogens|estrogens|mesh-ancestor
57130695|NCT02251925|Hormones|hormones|mesh-ancestor
57130696|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130697|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130698|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57130699|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
57130700|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57130701|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57130702|NCT03552653|Vitamin D|vitamin d|mesh-list
57130703|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
57130704|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
57130705|NCT03552653|Vitamins|vitamins|mesh-list
57130706|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
57130707|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130708|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57130709|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57130710|NCT03552575|Valsartan|valsartan|mesh-list
57130711|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57130712|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57130713|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57130714|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57130715|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130716|NCT01359644|Ribavirin|ribavirin|mesh-list
57130717|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
57130718|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
57130719|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130720|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
57130721|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130722|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
57130723|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
57130724|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57130725|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130726|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130727|NCT04806230|Mirtazapine|mirtazapine|mesh-list
57130728|NCT04806230|Citalopram|citalopram|mesh-list
57130729|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57130730|NCT04806230|Sertraline|sertraline|mesh-list
57130731|NCT04806230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57130732|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57130733|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130734|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130735|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130736|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
57130737|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130738|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57130739|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
57130740|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57130741|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57130742|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57130743|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
57130744|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
57130745|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57130746|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57130747|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130748|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57130749|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57130750|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57130751|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
57130752|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57130753|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57130754|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
57130755|NCT02603120|Tenofovir|tenofovir|mesh-list
57130756|NCT02603120|Emtricitabine|emtricitabine|mesh-list
57130757|NCT02603120|Lamivudine|lamivudine|mesh-list
57130758|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
57130759|NCT02603120|Triumeq|triumeq|mesh-list
57130760|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
57130761|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130762|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57130763|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57130764|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130765|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130766|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57130767|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57130768|NCT04815200|Copper|copper|mesh-list
57130769|NCT04815200|Nickel|nickel|mesh-list
57130770|NCT04815200|Trace Elements|trace elements|mesh-ancestor
57130771|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
57130772|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130773|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57130774|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130775|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130776|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57130777|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130778|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130779|NCT04412252|Tofacitinib|tofacitinib|mesh-list
57130780|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57130781|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130782|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130783|NCT04813952|Sevoflurane|sevoflurane|mesh-list
57130784|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57130785|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57130786|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
57130787|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
57130788|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130789|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130790|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
57130791|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57130792|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
57130793|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
57130794|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130795|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130796|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57130797|NCT04813874|Analgesics|analgesics|mesh-ancestor
57130798|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
57130799|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130800|NCT04803500|Simvastatin|simvastatin|mesh-list
57130801|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57130802|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57130803|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
57130804|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130805|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57130806|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57130807|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130808|NCT01331681|Aflibercept|aflibercept|mesh-list
57130809|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57130810|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57130811|NCT01331681|Growth Substances|growth substances|mesh-ancestor
57130812|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130813|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
57130814|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130815|NCT02120339|Carvedilol|carvedilol|mesh-list
57130816|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57130817|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57130818|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
57130819|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57130820|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130821|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130822|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57130823|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
57130824|NCT02120339|Protective Agents|protective agents|mesh-ancestor
57130825|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57130826|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130827|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57130828|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
57130829|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57130830|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57130831|NCT02123381|Cetuximab|cetuximab|mesh-list
57130832|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57130833|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130834|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
57130835|NCT02123615|Antibodies|antibodies|mesh-list
57130836|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
57130837|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57130838|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57130839|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
57130840|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
57130841|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130842|NCT02120651|Hemostatics|hemostatics|mesh-list
57130843|NCT02120651|Coagulants|coagulants|mesh-ancestor
57130844|NCT02117219|Azacitidine|azacitidine|mesh-list
57130845|NCT02117219|Durvalumab|durvalumab|mesh-list
57130846|NCT02117219|Tremelimumab|tremelimumab|mesh-list
57130847|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57130848|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
57130849|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130850|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130851|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902449|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130852|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57130853|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57130854|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57130855|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57130856|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
57130857|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130858|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57130859|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57130860|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130861|NCT02124005|Bupivacaine|bupivacaine|mesh-list
57130862|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
57130863|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
57130864|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130865|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130866|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
57130867|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130868|NCT03551873|Plecanatide|plecanatide|mesh-list
57130869|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
57130870|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
57130871|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130872|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57130873|NCT02117765|Ustekinumab|ustekinumab|mesh-list
57130874|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
57130875|NCT02121119|Lidocaine|lidocaine|mesh-list
57130876|NCT02121119|Bupivacaine|bupivacaine|mesh-list
57130877|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
57130878|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
57130879|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130880|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130881|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
57130882|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130883|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57130884|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57130885|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57130886|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57130887|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130888|NCT02121197|Dexamethasone|dexamethasone|mesh-list
57130889|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130890|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
57130891|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
57130892|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130893|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130894|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57130895|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
57130896|NCT02121197|Hormones|hormones|mesh-ancestor
57130897|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130898|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57130899|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130900|NCT02124317|Paclitaxel|paclitaxel|mesh-list
57130901|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57130902|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57130903|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130904|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812695|NCT00170950|Amlodipine|amlodipine|mesh-list
57130905|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
57130906|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
57130907|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130908|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
57130909|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130910|NCT02121353|Ranibizumab|ranibizumab|mesh-list
57130911|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57130912|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57130913|NCT02121353|Growth Substances|growth substances|mesh-ancestor
57130914|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130915|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
57130916|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130917|NCT05617430|Leucovorin|leucovorin|mesh-list
57130918|NCT05617430|Bevacizumab|bevacizumab|mesh-list
57130919|NCT05617430|Fluorouracil|fluorouracil|mesh-list
57130920|NCT05617430|Oxaliplatin|oxaliplatin|mesh-list
57130921|NCT05617430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57130922|NCT05617430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902450|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
57130923|NCT05617430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57130924|NCT05617430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57130925|NCT05617430|Growth Substances|growth substances|mesh-ancestor
57130926|NCT05617430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130927|NCT05617430|Growth Inhibitors|growth inhibitors|mesh-ancestor
57130928|NCT05617430|Antimetabolites|antimetabolites|mesh-ancestor
57130929|NCT05617430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130930|NCT05617430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57130931|NCT05617430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57130932|NCT05617430|Immunologic Factors|immunologic factors|mesh-ancestor
57130933|NCT05617430|Antidotes|antidotes|mesh-ancestor
57130934|NCT05617430|Protective Agents|protective agents|mesh-ancestor
57130935|NCT05617430|Vitamin B Complex|vitamin b complex|mesh-ancestor
57130936|NCT05617430|Vitamins|vitamins|mesh-ancestor
57130937|NCT05617430|Micronutrients|micronutrients|mesh-ancestor
57130938|NCT02251691|Tacrolimus|tacrolimus|mesh-list
57130939|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57130940|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
57130941|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130942|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57130943|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130944|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130945|NCT02595398|Triamcinolone|triamcinolone|mesh-list
57130946|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57130947|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57130948|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57130949|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57130950|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
57130951|NCT02595398|Hormones|hormones|mesh-ancestor
57130952|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57130953|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130954|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57130955|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
57130956|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130957|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130958|NCT02251769|Ritonavir|ritonavir|mesh-list
57130959|NCT02251769|Tipranavir|tipranavir|mesh-list
57130960|NCT02251769|Clarithromycin|clarithromycin|mesh-list
57130961|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57130962|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57130963|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
57130964|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130965|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130966|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57130967|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57130968|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
57130969|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130970|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57130971|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57130972|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57130973|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57130974|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
57130975|NCT02118311|Fludarabine|fludarabine|mesh-list
57130976|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57130977|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
57130978|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130979|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57130980|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57130981|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
56812769|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57130982|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57130983|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57130984|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57130985|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57130986|NCT01368497|Entecavir|entecavir|mesh-list
57130987|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
57130988|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57130989|NCT04812860|Tramadol|tramadol|mesh-list
57130990|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57130991|NCT04812860|Narcotics|narcotics|mesh-ancestor
57130992|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57130993|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57130994|NCT04812860|Analgesics|analgesics|mesh-ancestor
57130995|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
57130996|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57130997|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
57130998|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57130999|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57131000|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131001|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
57131002|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
57131003|NCT04427540|Oxytocin|oxytocin|mesh-list
57131004|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
57131005|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57131006|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131007|NCT04801940|Apixaban|apixaban|mesh-list
57131008|NCT04801940|Atorvastatin|atorvastatin|mesh-list
57131009|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57131010|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57131011|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
57131012|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131013|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57131014|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57131015|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131016|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57131017|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
57131018|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57131019|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
57131020|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
57131021|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57131022|NCT02251847|Ezetimibe|ezetimibe|mesh-list
57131023|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57131024|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57131025|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
57131026|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131027|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57131028|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57131029|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131030|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57131031|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57131032|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131033|NCT02127047|Incretins|incretins|mesh-ancestor
57131034|NCT02127047|Hormones|hormones|mesh-ancestor
57131035|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131036|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57131037|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
57131038|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131039|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131040|NCT02122055|Fentanyl|fentanyl|mesh-list
57131041|NCT02122055|Midazolam|midazolam|mesh-list
57131042|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
57131043|NCT02122055|Propofol|propofol|mesh-list
57131044|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57131045|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57131046|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131047|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57131048|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
57131049|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
57131050|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57131051|NCT02122055|Analgesics|analgesics|mesh-ancestor
57131052|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
57131053|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131054|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57131055|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57131056|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57131057|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
56812846|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
57131058|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131059|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131060|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57131061|NCT02122055|Narcotics|narcotics|mesh-ancestor
57131062|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57131063|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57131064|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57131065|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57131066|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
57131067|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
57131069|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57131070|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57131071|NCT02125409|Analgesics|analgesics|mesh-ancestor
57131072|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
57131073|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131074|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131075|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57131076|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57131077|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57131078|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57131079|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131080|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57131081|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57131082|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131083|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
57131084|NCT04816838|Osimertinib|osimertinib|mesh-list
57131085|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131086|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57131087|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131088|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131089|NCT02788175|Vedolizumab|vedolizumab|mesh-list
57131090|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57131091|NCT03551171|Niraparib|niraparib|mesh-list
57131092|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57131093|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131094|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131095|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131096|NCT02787083|Mirabegron|mirabegron|mesh-list
57131097|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57131098|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57131099|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57131100|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
57131101|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131102|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131103|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131104|NCT02787083|Urological Agents|urological agents|mesh-ancestor
57131105|NCT02122211|Betaine|betaine|mesh-list
57131106|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57131107|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
57131108|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57131109|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
57131110|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131111|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57131112|NCT02125565|Lidocaine|lidocaine|mesh-list
57131113|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
57131114|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
57131115|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57131116|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131117|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
57131118|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131119|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57131120|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57131121|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57131122|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57131123|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131124|NCT02125643|Caffeine|caffeine|mesh-list
57131125|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57131126|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131127|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57131128|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131129|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131130|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57131131|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57131132|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
57131133|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131134|NCT02127437|Lanreotide|lanreotide|mesh-list
57131135|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131136|NCT05319587|Cytarabine|cytarabine|mesh-list
57131137|NCT05319587|Annamycin|annamycin|mesh-list
57131138|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57131139|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
57131140|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131141|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131142|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
57131143|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131144|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57131145|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
57131146|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131147|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57131148|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
57131149|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57131150|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
57131151|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131152|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
57131153|NCT02122601|Protective Agents|protective agents|mesh-ancestor
57131154|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
57131155|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
57131156|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
57131157|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57131158|NCT02127593|Norgestimate|norgestimate|mesh-list
57131159|NCT02127593|Norgestrel|norgestrel|mesh-list
57131160|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
57131161|NCT02127593|Estradiol|estradiol|mesh-list
57131162|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
57131163|NCT02127593|Estrogens|estrogens|mesh-ancestor
57131164|NCT02127593|Hormones|hormones|mesh-ancestor
57131165|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131166|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131167|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57131168|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
57131169|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57131170|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57131171|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57131172|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57131173|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57131174|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57131175|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131176|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57131177|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57131178|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131179|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131180|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131181|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
57131182|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
57131183|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57131184|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57131185|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131186|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
57131187|NCT02122679|Coagulants|coagulants|mesh-ancestor
57131188|NCT04810754|Daratumumab|daratumumab|mesh-list
57131189|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131190|NCT02127749|Metronidazole|metronidazole|mesh-list
57131191|NCT02127749|Vancomycin|vancomycin|mesh-list
57131192|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
57131193|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131194|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57131195|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57131196|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57131197|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57131198|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57131199|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131200|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131201|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131202|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57131203|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57131204|NCT04797338|Nafarelin|nafarelin|mesh-list
57131205|NCT04797338|Progesterone|progesterone|mesh-list
56902462|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57131206|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
57131207|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
57131208|NCT04797338|Estradiol|estradiol|mesh-list
57131209|NCT04797338|Progestins|progestins|mesh-ancestor
57131210|NCT04797338|Hormones|hormones|mesh-ancestor
57131211|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131212|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131213|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57131214|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
57131215|NCT04797338|Estrogens|estrogens|mesh-ancestor
57131216|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57131217|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57131218|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
57131219|NCT05272865|Dronabinol|dronabinol|mesh-list
57131220|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
57131221|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131222|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57131223|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57131224|NCT05272865|Analgesics|analgesics|mesh-ancestor
57131225|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
57131226|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131227|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57131228|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57131229|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131230|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131231|NCT05272865|Hormones|hormones|mesh-ancestor
57131232|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131233|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57131234|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
57131235|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131236|NCT04809818|Aspirin|aspirin|mesh-list
57131237|NCT04809818|Dabigatran|dabigatran|mesh-list
57131238|NCT04809818|Apixaban|apixaban|mesh-list
57131239|NCT04809818|Clopidogrel|clopidogrel|mesh-list
57131240|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57131241|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57131242|NCT04809818|Analgesics|analgesics|mesh-ancestor
57131243|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
57131244|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131245|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131246|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57131247|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57131248|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57131249|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57131250|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131251|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57131252|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57131253|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131254|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
57131255|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57131256|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57131257|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57131258|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
57131259|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131260|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
57131261|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57131262|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
57131263|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
57131264|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57131265|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
57131266|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
57131267|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131268|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
57131269|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131270|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57131271|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
57131272|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
57131273|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
57131274|NCT02126267|Azithromycin|azithromycin|mesh-list
57131275|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57131276|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131277|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
57131278|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
57131279|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57131280|NCT02128061|Rituximab|rituximab|mesh-list
57131281|NCT02128061|Lenalidomide|lenalidomide|mesh-list
57131282|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57131283|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131284|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
57131285|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131286|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57131287|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57131288|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57131289|NCT02128061|Growth Substances|growth substances|mesh-ancestor
57131290|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
57131292|NCT05615636|Immunologic Factors|immunologic factors|mesh-ancestor
57131293|NCT05615636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131294|NCT05615636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57131295|NCT05615636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57131296|NCT05615636|Growth Substances|growth substances|mesh-ancestor
57131297|NCT05615636|Growth Inhibitors|growth inhibitors|mesh-ancestor
57131298|NCT05615636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131299|NCT02596958|Bevacizumab|bevacizumab|mesh-list
57131300|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57131301|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131302|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57131303|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57131304|NCT02596958|Growth Substances|growth substances|mesh-ancestor
57131305|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131306|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
57131307|NCT02126579|Poly ICLC|poly iclc|mesh-list
57131308|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
57131309|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
57131310|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131311|NCT04808648|Itraconazole|itraconazole|mesh-list
57131312|NCT04808648|Rifampin|rifampin|mesh-list
57131313|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
57131314|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131315|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57131316|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57131317|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131318|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131319|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57131320|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
57131321|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131322|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131323|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57131324|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57131325|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
57131326|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57131327|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
57131328|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57131329|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57131330|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57131331|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57131332|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57131333|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57131334|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57131335|NCT02126657|Glycolic acid|glycolic acid|mesh-list
57131336|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
57131337|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
57131338|NCT02128451|Fentanyl|fentanyl|mesh-list
57131339|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57131340|NCT02128451|Narcotics|narcotics|mesh-ancestor
57131341|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57131342|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131343|NCT02128451|Analgesics|analgesics|mesh-ancestor
57131344|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
57131345|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131346|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57131347|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57131348|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
57131349|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
57131350|NCT04785716|Niraparib|niraparib|mesh-list
57131351|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57131352|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131353|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131354|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131355|NCT01367249|Bromfenac|bromfenac|mesh-list
56813146|NCT04754945|Ichthammol|ichthammol|mesh-list
57131356|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57131357|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57131358|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57131359|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57131360|NCT01367249|Analgesics|analgesics|mesh-ancestor
57131361|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
57131362|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131363|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131364|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57131365|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57131366|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
57131367|NCT02128685|Progestins|progestins|mesh-ancestor
57131368|NCT02128685|Hormones|hormones|mesh-ancestor
57131369|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131370|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131371|NCT02252627|Phenylephrine|phenylephrine|mesh-list
57131372|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
57131373|NCT02252627|Ephedrine|ephedrine|mesh-list
57131374|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57131375|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
57131376|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
57131377|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131378|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131379|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
57131380|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57131381|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
57131382|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
57131383|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57131384|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57131385|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57131386|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
57131387|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131388|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131389|NCT02252627|Protective Agents|protective agents|mesh-ancestor
57131390|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57131391|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
57131392|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57131393|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
57131394|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57131395|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
57131396|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131397|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131398|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
57131399|NCT03550859|Telmisartan|telmisartan|mesh-list
57131400|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57131401|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57131402|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57131403|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
57131404|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131405|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57131406|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57131407|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131408|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57131409|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57131410|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57131411|NCT03550781|Prednisone|prednisone|mesh-list
57131412|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
57131413|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57131414|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
57131415|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131416|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57131417|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57131418|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
57131419|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131420|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131421|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57131422|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57131423|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
57131424|NCT03550781|Hormones|hormones|mesh-ancestor
57131425|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131426|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57131427|NCT02260661|Fulvestrant|fulvestrant|mesh-list
57131428|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57131429|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131430|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57131432|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
57131433|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131434|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131435|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
57131436|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
57131437|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57131438|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57131439|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131440|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131441|NCT02136329|Urological Agents|urological agents|mesh-ancestor
57131442|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
57131443|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57131444|NCT02129231|Simvastatin|simvastatin|mesh-list
57131445|NCT02129231|Ezetimibe|ezetimibe|mesh-list
57131446|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
57131447|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57131448|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57131449|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
57131450|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131451|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57131452|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57131453|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131454|NCT02129231|Antacids|antacids|mesh-ancestor
57131455|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57131456|NCT02136641|Fentanyl|fentanyl|mesh-list
57131457|NCT02136641|Midazolam|midazolam|mesh-list
57131458|NCT02136641|Ketamine|ketamine|mesh-list
57131459|NCT02136641|Analgesics|analgesics|mesh-ancestor
57131460|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
57131461|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131462|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131463|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57131464|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57131465|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
57131466|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
57131467|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57131468|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57131469|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57131470|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131471|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131472|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57131473|NCT02136641|Narcotics|narcotics|mesh-ancestor
57131474|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57131475|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57131476|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57131477|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57131478|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57131479|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
57131480|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
57131481|NCT03549689|Tenofovir|tenofovir|mesh-list
57131482|NCT03549689|Lamivudine|lamivudine|mesh-list
57131483|NCT03549689|Dolutegravir|dolutegravir|mesh-list
57131484|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
57131485|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131486|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57131487|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57131488|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131489|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131490|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57131491|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57131492|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57131493|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57131494|NCT02129621|Spironolactone|spironolactone|mesh-list
57131495|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57131496|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
57131497|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131498|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131499|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57131500|NCT02129621|Diuretics|diuretics|mesh-ancestor
57131501|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
57131502|NCT02129699|Denosumab|denosumab|mesh-list
57131503|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57131504|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131505|NCT03549923|Esmolol|esmolol|mesh-list
57131506|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57131507|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57131508|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57131509|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
57131510|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131511|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131512|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131513|NCT02136875|Fluticasone|fluticasone|mesh-list
57131514|NCT02136875|Xhance|xhance|mesh-list
57131515|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57131516|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57131517|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57131518|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
57131519|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131520|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131521|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57131522|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
57131523|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
57131524|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57131525|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57131526|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57131527|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57131528|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
57131529|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131530|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131531|NCT02129933|Bevacizumab|bevacizumab|mesh-list
57131532|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57131533|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131534|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57131535|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57131536|NCT02129933|Growth Substances|growth substances|mesh-ancestor
57131537|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131538|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
57131539|NCT02132897|Carbamazepine|carbamazepine|mesh-list
57131540|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
57131541|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
57131542|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57131543|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57131544|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131545|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57131546|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57131547|NCT02132897|Analgesics|analgesics|mesh-ancestor
57131548|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
57131549|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131550|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57131551|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57131552|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131553|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57131554|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57131555|NCT02133053|Beclomethasone|beclomethasone|mesh-list
57131556|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57131557|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
57131558|NCT02133053|Hormones|hormones|mesh-ancestor
57131559|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131560|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131561|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57131562|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
57131563|NCT02137109|Natalizumab|natalizumab|mesh-list
57131564|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
57131565|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131566|NCT02130167|Atropine|atropine|mesh-list
57131567|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57131568|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57131569|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57131570|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
57131571|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131572|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902471|NCT03308786|Interleukin-2|interleukin-2|mesh-list
57131573|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57131574|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
57131575|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
57131576|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
57131577|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57131578|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57131579|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
57131580|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131581|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131582|NCT02130323|Imiquimod|imiquimod|mesh-list
57131583|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57131584|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
57131585|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131586|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131587|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
57131588|NCT03549611|Acetaminophen|acetaminophen|mesh-list
57131589|NCT03549611|Celecoxib|celecoxib|mesh-list
57131590|NCT03549611|Oxycodone|oxycodone|mesh-list
57131591|NCT03549611|Gabapentin|gabapentin|mesh-list
57131592|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57131593|NCT03549611|Analgesics|analgesics|mesh-ancestor
57131594|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
57131595|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131596|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131597|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
57131598|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57131599|NCT03549611|Narcotics|narcotics|mesh-ancestor
57131600|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57131601|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57131602|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57131603|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57131604|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57131605|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57131606|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131607|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131608|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
57131609|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57131610|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57131611|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57131612|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57131613|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57131614|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131615|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
57131616|NCT02133287|Sirolimus|sirolimus|mesh-list
57131617|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
57131618|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57131619|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131620|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57131621|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131622|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
57131623|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57131624|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
57131625|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131626|NCT02137265|Clomiphene|clomiphene|mesh-list
57131627|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57131628|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
57131629|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131630|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131631|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57131632|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
57131633|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57131634|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57131635|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57131636|NCT02592434|Tofacitinib|tofacitinib|mesh-list
57131637|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57131638|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131639|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131640|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
57131641|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57131642|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131643|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57131644|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131645|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131646|NCT02137421|Resveratrol|resveratrol|mesh-list
57131647|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
57131648|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131649|NCT02137421|Protective Agents|protective agents|mesh-ancestor
57131650|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131651|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131652|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57131653|NCT02133677|Temozolomide|temozolomide|mesh-list
57131654|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57131655|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
57131656|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131657|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131658|NCT02137733|Carvedilol|carvedilol|mesh-list
57131659|NCT02137733|Bisoprolol|bisoprolol|mesh-list
57131660|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57131661|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57131662|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
57131663|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131664|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131665|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131666|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57131667|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
57131668|NCT02137733|Protective Agents|protective agents|mesh-ancestor
57131669|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57131670|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57131671|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57131672|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
57131673|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57131674|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57131675|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
57131676|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
57131677|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131678|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57131679|NCT02133755|Bromocriptine|bromocriptine|mesh-list
57131680|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57131681|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57131682|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
57131683|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131684|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131685|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
57131686|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
57131687|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131688|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131689|NCT02130869|Cytarabine|cytarabine|mesh-list
57131690|NCT02130869|Aldesleukin|aldesleukin|mesh-list
57131691|NCT02130869|Carboplatin|carboplatin|mesh-list
57131692|NCT02130869|Etoposide|etoposide|mesh-list
57131693|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
57131694|NCT02130869|Melphalan|melphalan|mesh-list
57131695|NCT02130869|Busulfan|busulfan|mesh-list
57131696|NCT02130869|Interleukin-2|interleukin-2|mesh-list
57131697|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57131698|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
57131699|NCT02130869|Sargramostim|sargramostim|mesh-list
57131700|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131701|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57131702|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57131703|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57131704|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131705|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131706|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57131707|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
57131708|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
57131709|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131710|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57131711|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
57131712|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131713|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57131714|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
57131715|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57131716|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57131717|NCT02130869|Analgesics|analgesics|mesh-ancestor
57131718|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
57131719|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131720|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57131721|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57131722|NCT02133911|Ranolazine|ranolazine|mesh-list
57131723|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57131724|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57131725|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131726|NCT02133989|Ticlopidine|ticlopidine|mesh-list
57131727|NCT02133989|Clopidogrel|clopidogrel|mesh-list
57131728|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57131729|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57131730|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57131731|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57131732|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
57131733|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131734|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131735|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131736|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57131737|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57131738|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57131739|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57131740|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131741|NCT04341350|Analgesics|analgesics|mesh-list
57131742|NCT04341350|Propofol|propofol|mesh-list
57131743|NCT04341350|Isoflurane|isoflurane|mesh-list
57131744|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57131745|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57131746|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131747|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57131748|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
57131749|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
57131750|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
57131751|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131752|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57131753|NCT02138045|Liraglutide|liraglutide|mesh-list
57131754|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57131755|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131756|NCT02138045|Incretins|incretins|mesh-ancestor
57131757|NCT02138045|Hormones|hormones|mesh-ancestor
57131758|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131759|NCT02134067|Paclitaxel|paclitaxel|mesh-list
57131760|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57131761|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131762|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
57131763|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
57131764|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
57131765|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131766|NCT04091126|Dexamethasone|dexamethasone|mesh-list
57131767|NCT04091126|Lenalidomide|lenalidomide|mesh-list
57131768|NCT04091126|Bortezomib|bortezomib|mesh-list
57131769|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57131770|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
57131771|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
57131772|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131773|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131774|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57131775|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
57131776|NCT04091126|Hormones|hormones|mesh-ancestor
57131777|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131778|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57131779|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131780|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
57131781|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57131782|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57131783|NCT04091126|Growth Substances|growth substances|mesh-ancestor
57131784|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
57131785|NCT04026776|Allopurinol|allopurinol|mesh-list
57131786|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
57131787|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131788|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131789|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
57131790|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57131791|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57131792|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
57131793|NCT04026776|Protective Agents|protective agents|mesh-ancestor
57131794|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131795|NCT04348292|Sirolimus|sirolimus|mesh-list
57131796|NCT04348292|Durvalumab|durvalumab|mesh-list
57131797|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
57131798|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57131799|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
57131800|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57131801|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131802|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57131803|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131804|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
57131805|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56813592|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
57131806|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
57131807|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131808|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57131809|NCT03962114|Niacinamide|niacinamide|mesh-list
57131810|NCT03962114|Niacin|niacin|mesh-list
57131811|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
57131812|NCT03962114|Vitamins|vitamins|mesh-ancestor
57131813|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
57131814|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131815|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
57131816|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57131817|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
57131818|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131819|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57131820|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
57131821|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
57131822|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
57131823|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
57131824|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131825|NCT05472896|Epirubicin|epirubicin|mesh-list
57131826|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57131827|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131828|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57131829|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57131830|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131831|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131832|NCT02138357|Buprenorphine|buprenorphine|mesh-list
57131833|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57131834|NCT02138357|Narcotics|narcotics|mesh-ancestor
57131835|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57131836|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131837|NCT02138357|Analgesics|analgesics|mesh-ancestor
57131838|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
57131839|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131840|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57131841|NCT03596918|Vincristine|vincristine|mesh-list
57131842|NCT03596918|Bleomycin|bleomycin|mesh-list
57131843|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57131844|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131845|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
57131846|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
57131847|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
57131848|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131849|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57131850|NCT03535298|Interferons|interferons|mesh-list
57131851|NCT03535298|Interferon-beta|interferon-beta|mesh-list
57131852|NCT03535298|Teriflunomide|teriflunomide|mesh-list
57131853|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
57131854|NCT03535298|Ofatumumab|ofatumumab|mesh-list
57131855|NCT03535298|Cladribine|cladribine|mesh-list
57131856|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
57131857|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
57131858|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
57131859|NCT03535298|Natalizumab|natalizumab|mesh-list
57131860|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57131861|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
57131862|NCT03535298|Ozanimod|ozanimod|mesh-list
57131863|NCT03535298|Ponesimod|ponesimod|mesh-list
57131864|NCT03535298|Siponimod|siponimod|mesh-list
57131865|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57131866|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131867|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
57131868|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131869|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57131870|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
57131871|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131872|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57131873|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57131874|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131875|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
57131876|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57131877|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57131878|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57131879|NCT03535298|Analgesics|analgesics|mesh-ancestor
57131880|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
56813677|NCT00136084|Hormones|hormones|mesh-ancestor
57131881|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131882|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57131883|NCT02134379|Clotrimazole|clotrimazole|mesh-list
57131885|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57131886|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131887|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
57131888|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57131889|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57131890|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131891|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131892|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57131893|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
57131894|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57131895|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131896|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57131897|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57131898|NCT03511118|Metformin|metformin|mesh-list
57131899|NCT03511118|Topiramate|topiramate|mesh-list
57131900|NCT03511118|Azithromycin|azithromycin|mesh-list
57131901|NCT03511118|Doxycycline|doxycycline|mesh-list
57131902|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
57131903|NCT03511118|Levofloxacin|levofloxacin|mesh-list
57131904|NCT03511118|Clindamycin|clindamycin|mesh-list
57131905|NCT03511118|Valganciclovir|valganciclovir|mesh-list
57131906|NCT03511118|Remdesivir|remdesivir|mesh-list
57131907|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
57131908|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
57131909|NCT03511118|Verapamil|verapamil|mesh-list
57131910|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57131911|NCT03511118|Labetalol|labetalol|mesh-list
57131912|NCT03511118|Nifedipine|nifedipine|mesh-list
57131913|NCT03511118|Furosemide|furosemide|mesh-list
57131914|NCT03511118|Sumatriptan|sumatriptan|mesh-list
57131915|NCT03511118|Oxycodone|oxycodone|mesh-list
57131916|NCT03511118|Gabapentin|gabapentin|mesh-list
57131917|NCT03511118|Ondansetron|ondansetron|mesh-list
57131918|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
57131919|NCT03511118|Trazodone|trazodone|mesh-list
57131920|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
57131921|NCT03511118|Methylphenidate|methylphenidate|mesh-list
57131922|NCT03511118|Citalopram|citalopram|mesh-list
57131923|NCT03511118|Sertraline|sertraline|mesh-list
57131924|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
57131925|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
57131926|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57131927|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57131928|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57131929|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57131930|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57131931|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
57131932|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57131933|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57131934|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57131935|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57131936|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57131937|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57131938|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57131939|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57131940|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
57131941|NCT03511118|Coagulants|coagulants|mesh-ancestor
57131942|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57131943|NCT03511118|Narcotics|narcotics|mesh-ancestor
57131944|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57131945|NCT03511118|Analgesics|analgesics|mesh-ancestor
57131946|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
57131947|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57131948|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
57131949|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57131950|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57131951|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57131952|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57131953|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57131954|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57131955|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
57131956|NCT03511118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57131957|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57131958|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57131959|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
57131960|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57131961|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
57131962|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
57131963|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57131964|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57131965|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
57131966|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
57131967|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57131968|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
57131969|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
57131970|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57131971|NCT03511118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57131972|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57131973|NCT03511118|Diuretics|diuretics|mesh-ancestor
57131974|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
57131975|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57131976|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
57131977|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57131978|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57131979|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57131980|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57131981|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57131982|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57131983|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57131984|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57131985|NCT03511118|Renal Agents|renal agents|mesh-ancestor
57131986|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57131987|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57131988|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57131989|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
57131990|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57131991|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57131992|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57131993|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
57131994|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
57131995|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57131996|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57131997|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57131998|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57131999|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57132000|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
57132001|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57132002|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57132003|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57132004|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57132005|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
57132006|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
57132007|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57132008|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57132009|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57132010|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57132011|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57132012|NCT02134457|Ranibizumab|ranibizumab|mesh-list
57132013|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57132014|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57132015|NCT02134457|Growth Substances|growth substances|mesh-ancestor
57132016|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132017|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
57132018|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132019|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
57132020|NCT04090190|Fesoterodine|fesoterodine|mesh-list
57132021|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
57132023|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57132024|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57132025|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
57132026|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132027|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132028|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132029|NCT04090190|Urological Agents|urological agents|mesh-ancestor
57132030|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
57132031|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
57132032|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132033|NCT04792034|Cocaine|cocaine|mesh-list
57132034|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
57132035|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
57132036|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132037|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132038|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
57132039|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132040|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57132041|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57132042|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57132043|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57132044|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132045|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
57132046|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132047|NCT02253095|Micronutrients|micronutrients|mesh-list
57132048|NCT02253095|Trace Elements|trace elements|mesh-list
57132049|NCT02253095|Albendazole|albendazole|mesh-list
57132050|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
57132051|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57132052|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132053|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
57132054|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57132055|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57132056|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
57132057|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
57132058|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
57132059|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132060|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132061|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132062|NCT03358706|Vitamin K|vitamin k|mesh-list
57132063|NCT03358706|Midazolam|midazolam|mesh-list
57132064|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
57132065|NCT03358706|Caffeine|caffeine|mesh-list
57132066|NCT03358706|Ustekinumab|ustekinumab|mesh-list
57132067|NCT03358706|Omeprazole|omeprazole|mesh-list
57132068|NCT03358706|Warfarin|warfarin|mesh-list
57132069|NCT03358706|Vitamins|vitamins|mesh-ancestor
57132070|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
57132071|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132072|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57132073|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57132074|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132075|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57132076|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57132077|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57132078|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57132079|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
57132080|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
57132081|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
57132082|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
57132083|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132084|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132085|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
57132086|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57132087|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57132088|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132089|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57132090|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57132091|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
57132092|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57132093|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57132094|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57132095|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
57132096|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57132097|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57132098|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
57132099|NCT03358706|Coagulants|coagulants|mesh-ancestor
57132100|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
57132101|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
57132102|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57132103|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57132104|NCT04791332|Aticaprant|aticaprant|mesh-list
57132105|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57132106|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132107|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
57132108|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132109|NCT05461820|Methimazole|methimazole|mesh-list
57132110|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
57132111|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
57132112|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132113|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132114|NCT04791020|Lidocaine|lidocaine|mesh-list
57132115|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
57132116|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
57132117|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132118|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132119|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
57132120|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132121|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57132122|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57132123|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57132124|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57132125|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132126|NCT02531906|Oxycodone|oxycodone|mesh-list
57132127|NCT02531906|Methadone|methadone|mesh-list
57132128|NCT02531906|Gabapentin|gabapentin|mesh-list
57132129|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57132130|NCT02531906|Narcotics|narcotics|mesh-ancestor
57132131|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132132|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132133|NCT02531906|Analgesics|analgesics|mesh-ancestor
57132134|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
57132135|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132136|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
57132137|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57132138|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57132139|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57132140|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57132141|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57132142|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132143|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132144|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
57132145|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
57132146|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
57132147|NCT02783729|Zolpidem|zolpidem|mesh-list
57132148|NCT02783729|Lemborexant|lemborexant|mesh-list
57132149|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
57132150|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57132151|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132152|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132153|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57132154|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
57132155|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
57132156|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132157|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132158|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
57132159|NCT02227940|Gemcitabine|gemcitabine|mesh-list
57132160|NCT02227940|Paclitaxel|paclitaxel|mesh-list
57132161|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57132162|NCT02227940|Cisplatin|cisplatin|mesh-list
57132163|NCT02227940|Ceritinib|ceritinib|mesh-list
57132164|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57132165|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132166|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
57132167|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
57132168|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
57132169|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132170|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57132171|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
57132172|NCT02227940|Antiviral Agents|antiviral agents|mesh-ancestor
57132173|NCT02227940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132174|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132175|NCT02227940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57132176|NCT02227940|Immunologic Factors|immunologic factors|mesh-ancestor
57132177|NCT02227940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132178|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57132179|NCT02072486|Sorafenib|sorafenib|mesh-list
57132180|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132181|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57132182|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132183|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132184|NCT00988364|Simvastatin|simvastatin|mesh-list
57132185|NCT00988364|Ezetimibe|ezetimibe|mesh-list
57132186|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
57132187|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57132188|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57132189|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
57132190|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132191|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57132192|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57132193|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132194|NCT05578001|Pilocarpine|pilocarpine|mesh-list
57132195|NCT05578001|Miotics|miotics|mesh-ancestor
57132196|NCT05578001|Autonomic Agents|autonomic agents|mesh-ancestor
57132197|NCT05578001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132198|NCT05578001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132199|NCT05578001|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
57132200|NCT05578001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
57132201|NCT05578001|Cholinergic Agents|cholinergic agents|mesh-ancestor
57132202|NCT05578001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132203|NCT05578001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132204|NCT05577923|Trastuzumab|trastuzumab|mesh-list
57132205|NCT05577923|Fulvestrant|fulvestrant|mesh-list
57132206|NCT05577923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57132207|NCT05577923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132208|NCT05577923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57132209|NCT05577923|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57132210|NCT05577923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57132211|NCT05577923|Hormone Antagonists|hormone antagonists|mesh-ancestor
57132212|NCT05577923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132213|NCT05577923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132214|NCT04790708|Octreotide|octreotide|mesh-list
57132215|NCT04790708|Edotreotide|edotreotide|mesh-list
57132216|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
57132217|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57132218|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132219|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57132220|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57132221|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132222|NCT05615012|Metformin|metformin|mesh-list
57132223|NCT05615012|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57132224|NCT05615012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57132225|NCT05615012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132226|NCT05615012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57132227|NCT05615012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57132228|NCT05615012|Antimetabolites|antimetabolites|mesh-ancestor
57132229|NCT05615012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132230|NCT05615012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57132231|NCT05615012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57132232|NCT05615012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132233|NCT05614934|Clarithromycin|clarithromycin|mesh-list
57132234|NCT05614934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57132235|NCT05614934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132236|NCT05614934|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57132237|NCT05614934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902488|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57132238|NCT05614934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132239|NCT05614934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57132240|NCT05614934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57132241|NCT02135393|Folic Acid|folic acid|mesh-list
57132242|NCT02135393|Hematinics|hematinics|mesh-ancestor
57132243|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
57132244|NCT02135393|Vitamins|vitamins|mesh-ancestor
57132245|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
57132246|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132247|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
57132248|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57132249|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57132250|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57132251|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57132252|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132253|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57132254|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132255|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57132256|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57132257|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132258|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57132259|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57132260|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
57132261|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132262|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
57132263|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57132264|NCT02139761|Analgesics|analgesics|mesh-ancestor
57132265|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
57132266|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132267|NCT05614778|Zoledronic Acid|zoledronic acid|mesh-list
57132268|NCT05614778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57132269|NCT05614778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132270|NCT05474924|Prednisolone|prednisolone|mesh-list
57132272|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57132273|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
57132274|NCT05474924|Hormones|hormones|mesh-ancestor
57132275|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132276|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132277|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57132278|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132279|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
57132280|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132281|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57132282|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57132283|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
57132284|NCT02135627|Epinephrine|epinephrine|mesh-list
57132285|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57132286|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57132287|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
57132288|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132289|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132290|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132291|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57132292|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57132293|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
57132294|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132295|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57132296|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
57132297|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
57132298|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
57132299|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57132300|NCT05613140|Valsartan|valsartan|mesh-list
57132301|NCT05613140|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
57132302|NCT05613140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57132303|NCT05613140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57132304|NCT05613140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57132305|NCT05613140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132306|NCT05613062|Oren gedoku to|oren gedoku to|mesh-list
57132307|NCT05613062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57132308|NCT05613062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57132309|NCT05613062|Analgesics|analgesics|mesh-ancestor
57132310|NCT05613062|Sensory System Agents|sensory system agents|mesh-ancestor
57132311|NCT05613062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132312|NCT05613062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132313|NCT05613062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57132314|NCT05613062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57132315|NCT05614622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57132316|NCT05614622|Cyclopentolate|cyclopentolate|mesh-list
57132317|NCT05614622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57132318|NCT05614622|Mydriatics|mydriatics|mesh-ancestor
57132319|NCT05614622|Autonomic Agents|autonomic agents|mesh-ancestor
57132320|NCT05614622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132321|NCT05614622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132322|NCT05614622|Parasympatholytics|parasympatholytics|mesh-ancestor
57132323|NCT05614622|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57132324|NCT05614622|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57132325|NCT05614622|Cholinergic Agents|cholinergic agents|mesh-ancestor
57132326|NCT05614622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132327|NCT05614622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132328|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57132329|NCT03548129|Fosfomycin|fosfomycin|mesh-list
57132330|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
57132331|NCT02140073|Domperidone|domperidone|mesh-list
57132332|NCT02140073|Omeprazole|omeprazole|mesh-list
57132333|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57132334|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57132335|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57132336|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814129|NCT00524303|Paclitaxel|paclitaxel|mesh-list
57132337|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132338|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
57132339|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
57132340|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132341|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132342|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57132343|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
57132344|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132345|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
57132346|NCT05474690|Carboplatin|carboplatin|mesh-list
57132347|NCT05474690|Docetaxel|docetaxel|mesh-list
57132348|NCT05474690|Trastuzumab|trastuzumab|mesh-list
57132349|NCT05474690|Epirubicin|epirubicin|mesh-list
57132350|NCT05474690|Pertuzumab|pertuzumab|mesh-list
57132351|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57132352|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
57132353|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132354|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57132355|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57132356|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
57132357|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132358|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132359|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57132360|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
57132361|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
57132362|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
57132363|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57132364|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57132365|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57132366|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57132367|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132368|NCT05575973|Rituximab|rituximab|mesh-list
57132369|NCT05575973|Lenalidomide|lenalidomide|mesh-list
57132370|NCT05575973|Mitoxantrone|mitoxantrone|mesh-list
57132371|NCT05575973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57132372|NCT05575973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132373|NCT05575973|Immunologic Factors|immunologic factors|mesh-ancestor
57132374|NCT05575973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132375|NCT05575973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57132376|NCT05575973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57132377|NCT05575973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57132378|NCT05575973|Growth Substances|growth substances|mesh-ancestor
57132379|NCT05575973|Growth Inhibitors|growth inhibitors|mesh-ancestor
57132380|NCT05575973|Analgesics|analgesics|mesh-ancestor
57132381|NCT05575973|Sensory System Agents|sensory system agents|mesh-ancestor
57132382|NCT05575973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132383|NCT05575973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57132384|NCT05575973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57132385|NCT05575973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132386|NCT05575973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132387|NCT03547895|Vitamin K|vitamin k|mesh-list
57132388|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
57132389|NCT03547895|Ribavirin|ribavirin|mesh-list
57132390|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
57132391|NCT03547895|Furosemide|furosemide|mesh-list
57132392|NCT03547895|Spironolactone|spironolactone|mesh-list
57132393|NCT03547895|Silymarin|silymarin|mesh-list
57132394|NCT03547895|Vitamins|vitamins|mesh-ancestor
57132395|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
57132396|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132397|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
57132398|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132399|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
57132400|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132401|NCT03547895|Diuretics|diuretics|mesh-ancestor
57132402|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
57132403|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57132404|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57132405|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57132406|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
57132407|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132408|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57132409|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56814204|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
57132410|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57132411|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
57132412|NCT03547895|Coagulants|coagulants|mesh-ancestor
57132413|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
57132414|NCT03547895|Protective Agents|protective agents|mesh-ancestor
57132415|NCT01359254|Fludarabine|fludarabine|mesh-list
57132416|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
57132417|NCT01359254|Melphalan|melphalan|mesh-list
57132418|NCT01359254|Busulfan|busulfan|mesh-list
57132419|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
57132420|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132421|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57132422|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
57132423|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132424|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57132425|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
57132426|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132427|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57132428|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
57132429|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57132430|NCT05575739|Antioxidants|antioxidants|mesh-list
57132431|NCT05575739|Superoxide Dismutase|superoxide dismutase|mesh-list
57132432|NCT05575739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132433|NCT05575739|Protective Agents|protective agents|mesh-ancestor
57132434|NCT05575739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132435|NCT05575739|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57132436|NCT05035862|Interferons|interferons|mesh-list
57132437|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
57132438|NCT05035862|Prednisone|prednisone|mesh-list
57132439|NCT05035862|Albuterol|albuterol|mesh-list
57132440|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57132441|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
57132442|NCT05035862|Hormones|hormones|mesh-ancestor
57132443|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132444|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132445|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57132446|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132447|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
57132448|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132449|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57132450|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
57132451|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132452|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57132453|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
57132454|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
57132455|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57132456|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57132457|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57132458|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57132459|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
57132460|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132461|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132462|NCT03549221|Ketorolac|ketorolac|mesh-list
57132463|NCT03549221|Epinephrine|epinephrine|mesh-list
57132464|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
57132465|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57132466|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57132467|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
57132468|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132469|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132470|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132471|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57132472|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57132473|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
57132474|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132475|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57132476|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
57132477|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
57132478|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
57132479|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57132480|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57132481|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57132482|NCT03549221|Analgesics|analgesics|mesh-ancestor
57132483|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
57132484|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57132485|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57132486|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57132487|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132488|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
57132489|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
57132490|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132491|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
57132492|NCT05013632|Remdesivir|remdesivir|mesh-list
57132493|NCT05013632|Antibodies|antibodies|mesh-list
57132494|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57132495|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
57132496|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132497|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132498|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
57132499|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132500|NCT05614544|Propofol|propofol|mesh-list
57132501|NCT05614544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57132502|NCT05614544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132503|NCT05614544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132504|NCT05614544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57132505|NCT05614544|Anesthetics, General|anesthetics, general|mesh-ancestor
57132506|NCT05614544|Anesthetics|anesthetics|mesh-ancestor
57132507|NCT05185505|Bevacizumab|bevacizumab|mesh-list
57132508|NCT05185505|Atezolizumab|atezolizumab|mesh-list
57132509|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57132510|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132511|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57132512|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57132513|NCT05185505|Growth Substances|growth substances|mesh-ancestor
57132514|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132515|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
57132516|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57132517|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
57132518|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132519|NCT05575271|Norepinephrine|norepinephrine|mesh-list
57132520|NCT05575271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57132521|NCT05575271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57132522|NCT05575271|Adrenergic Agents|adrenergic agents|mesh-ancestor
57132523|NCT05575271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132524|NCT05575271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132525|NCT05575271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132526|NCT05575271|Sympathomimetics|sympathomimetics|mesh-ancestor
57132527|NCT05575271|Autonomic Agents|autonomic agents|mesh-ancestor
57132528|NCT05575271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132529|NCT05575271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57132530|NCT04750460|Teriparatide|teriparatide|mesh-list
57132531|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57132532|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132533|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57132534|NCT05575037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57132535|NCT05575037|Immunologic Factors|immunologic factors|mesh-ancestor
57132536|NCT05575037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132537|NCT05574881|Trastuzumab|trastuzumab|mesh-list
57132538|NCT05574881|Pertuzumab|pertuzumab|mesh-list
57132539|NCT05574881|Fulvestrant|fulvestrant|mesh-list
57132540|NCT05574881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57132541|NCT05574881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132542|NCT05574881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57132543|NCT05574881|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57132544|NCT05574881|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57132545|NCT05574881|Hormone Antagonists|hormone antagonists|mesh-ancestor
57132546|NCT05574881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132547|NCT05574881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132548|NCT05612984|Aspirin|aspirin|mesh-list
57132549|NCT05612984|Folic Acid|folic acid|mesh-list
57132550|NCT05612984|Micronutrients|micronutrients|mesh-list
57132551|NCT05612984|Trace Elements|trace elements|mesh-list
57132552|NCT05612984|Calcium|calcium|mesh-list
57132553|NCT05612984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57132554|NCT05612984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132555|NCT05612984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57132556|NCT05612984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57132557|NCT05612984|Analgesics|analgesics|mesh-ancestor
57132558|NCT05612984|Sensory System Agents|sensory system agents|mesh-ancestor
57132559|NCT05612984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132560|NCT05612984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57132561|NCT05612984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57132562|NCT05612984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57132563|NCT05612984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57132564|NCT05612984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814350|NCT00112294|Cetuximab|cetuximab|mesh-list
57132565|NCT05612984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57132566|NCT05612984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57132567|NCT05612984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132568|NCT05612984|Antipyretics|antipyretics|mesh-ancestor
57132569|NCT05612984|Hematinics|hematinics|mesh-ancestor
57132570|NCT05612984|Vitamin B Complex|vitamin b complex|mesh-ancestor
57132571|NCT05612984|Vitamins|vitamins|mesh-ancestor
57132572|NCT04787510|Heparin|heparin|mesh-list
57132573|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
57132574|NCT04787510|Tinzaparin|tinzaparin|mesh-list
57132575|NCT04787510|Dalteparin|dalteparin|mesh-list
57132576|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
57132577|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57132578|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57132579|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132580|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
57132581|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
57132582|NCT05424263|Calcium|calcium|mesh-list
57132583|NCT05424263|Calcium acetate|calcium acetate|mesh-list
57132584|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57132585|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132586|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57132587|NCT05424263|Antacids|antacids|mesh-ancestor
57132588|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132589|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57132590|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
57132591|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
57132592|NCT05398757|Midazolam|midazolam|mesh-list
57132593|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
57132594|NCT05398757|Propofol|propofol|mesh-list
57132595|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57132596|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132597|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132598|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57132599|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
57132600|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
57132601|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57132602|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57132603|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57132604|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57132605|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
57132606|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
57132607|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132608|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132609|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57132610|NCT05398757|Analgesics|analgesics|mesh-ancestor
57132611|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
57132612|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132613|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57132614|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57132615|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57132616|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
57132617|NCT05574101|Cemiplimab|cemiplimab|mesh-list
57132618|NCT05574101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57132619|NCT05574101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132620|NCT04787276|Rifaximin|rifaximin|mesh-list
57132621|NCT04787276|Lactulose|lactulose|mesh-list
57132622|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57132623|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132624|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57132625|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
57132626|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57132627|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57132628|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57132629|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57132630|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132631|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
57132632|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132633|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132634|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57132635|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132636|NCT04618016|Vitamins|vitamins|mesh-list
57132637|NCT04618016|Vitamin E|vitamin e|mesh-list
57132638|NCT04618016|Tocopherols|tocopherols|mesh-list
57132639|NCT04618016|Tocotrienols|tocotrienols|mesh-list
57132640|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
57132641|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
57132642|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132643|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
57132644|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132645|NCT04618016|Protective Agents|protective agents|mesh-ancestor
57132646|NCT05612594|Ertugliflozin|ertugliflozin|mesh-list
57132647|NCT05612594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57132648|NCT05612594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132649|NCT05612594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57132650|NCT05612594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132651|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
57132652|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
57132653|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
57132654|NCT03547505|Protective Agents|protective agents|mesh-ancestor
57132655|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132656|NCT05279183|Erythritol|erythritol|mesh-list
57132657|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
57132658|NCT05184842|Decitabine|decitabine|mesh-list
57132659|NCT05184842|Venetoclax|venetoclax|mesh-list
57132660|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57132661|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
57132662|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132663|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132664|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132665|NCT04462952|Adavosertib|adavosertib|mesh-list
57132666|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132667|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132668|NCT04429022|Acetaminophen|acetaminophen|mesh-list
57132669|NCT04429022|Celecoxib|celecoxib|mesh-list
57132670|NCT04429022|Ketorolac|ketorolac|mesh-list
57132671|NCT04429022|Oxycodone|oxycodone|mesh-list
57132672|NCT04429022|Gabapentin|gabapentin|mesh-list
57132673|NCT04429022|Hydromorphone|hydromorphone|mesh-list
57132674|NCT04429022|Ropivacaine|ropivacaine|mesh-list
57132675|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
57132676|NCT04429022|Anesthetics|anesthetics|mesh-list
57132677|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132678|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132679|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
57132680|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132681|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57132682|NCT04429022|Analgesics|analgesics|mesh-ancestor
57132683|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
57132684|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57132685|NCT04429022|Narcotics|narcotics|mesh-ancestor
57132686|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57132687|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57132688|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57132689|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57132690|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57132691|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132692|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132693|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
57132694|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57132695|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57132696|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57132697|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57132698|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57132699|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132700|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
57132701|NCT02253485|Telbivudine|telbivudine|mesh-list
57132702|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
57132703|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132704|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57132705|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132706|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132707|NCT05612516|Hydrogen Peroxide|hydrogen peroxide|mesh-list
57132708|NCT05612516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57132709|NCT05612516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132710|NCT05700812|Levonorgestrel|levonorgestrel|mesh-list
57132711|NCT05700812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57132712|NCT05700812|Contraceptive Agents|contraceptive agents|mesh-ancestor
57132713|NCT05700812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57132714|NCT05700812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132715|NCT05700812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57132716|NCT05700812|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57132717|NCT05700812|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57132718|NCT02589626|Empagliflozin|empagliflozin|mesh-list
57132719|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57132720|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132721|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57132722|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132723|NCT04976036|Nintedanib|nintedanib|mesh-list
57132724|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132725|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57132726|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132727|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132728|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57132729|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
57132730|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57132731|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
57132732|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57132733|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132734|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57132735|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57132736|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132737|NCT05557136|Ether|ether|mesh-list
57132738|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57132739|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
57132740|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
57132741|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132742|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132743|NCT05556200|Apatinib|apatinib|mesh-list
57132744|NCT05556200|Antibodies|antibodies|mesh-list
57132745|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57132746|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
57132747|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132748|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132749|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57132750|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132751|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132752|NCT05556122|Betamethasone|betamethasone|mesh-list
57132753|NCT05556122|Ropivacaine|ropivacaine|mesh-list
57132754|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
57132755|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
57132756|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132757|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132758|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
57132759|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132760|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57132761|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
57132762|NCT05556122|Hormones|hormones|mesh-ancestor
57132763|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132764|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57132765|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
57132766|NCT05611268|Pentoxifylline|pentoxifylline|mesh-list
57132767|NCT05611268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57132768|NCT05611268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132769|NCT05611268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132770|NCT05611268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57132771|NCT05611268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57132772|NCT05611268|Protective Agents|protective agents|mesh-ancestor
57132773|NCT05611268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132774|NCT05611268|Vasodilator Agents|vasodilator agents|mesh-ancestor
57132775|NCT05611268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57132776|NCT05611268|Antioxidants|antioxidants|mesh-ancestor
57132777|NCT05549570|Metformin|metformin|mesh-list
57132778|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
57132779|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57132780|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132781|NCT05549570|Incretins|incretins|mesh-ancestor
57132782|NCT05549570|Hormones|hormones|mesh-ancestor
57132783|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132784|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57132785|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
57132786|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132787|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132788|NCT05549492|Buprenorphine|buprenorphine|mesh-list
57132789|NCT05549492|Ropivacaine|ropivacaine|mesh-list
57132790|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
57132791|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
57132792|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132793|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814594|NCT03540485|Melatonin|melatonin|mesh-list
57132794|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
57132795|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132796|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57132797|NCT05549492|Narcotics|narcotics|mesh-ancestor
57132798|NCT05549492|Analgesics|analgesics|mesh-ancestor
57132799|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57132800|NCT04331132|Tolvaptan|tolvaptan|mesh-list
57132801|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
57132802|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132803|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
57132804|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132805|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57132806|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132807|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132808|NCT04759274|Diuretics|diuretics|mesh-list
57132809|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
57132810|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132811|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57132812|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57132813|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132814|NCT01666730|Leucovorin|leucovorin|mesh-list
57132815|NCT01666730|Metformin|metformin|mesh-list
57132816|NCT01666730|Fluorouracil|fluorouracil|mesh-list
57132817|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
57132818|NCT01666730|Calcium|calcium|mesh-list
57132819|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
57132820|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57132821|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132822|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57132823|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
57132824|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132825|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57132826|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132827|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57132828|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
57132829|NCT01666730|Antidotes|antidotes|mesh-ancestor
57132830|NCT01666730|Protective Agents|protective agents|mesh-ancestor
57132831|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
57132832|NCT01666730|Vitamins|vitamins|mesh-ancestor
57132833|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
57132834|NCT05554094|Psilocybin|psilocybin|mesh-list
57132835|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
57132836|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132837|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57132838|NCT04434560|Nivolumab|nivolumab|mesh-list
57132839|NCT04434560|Ipilimumab|ipilimumab|mesh-list
57132840|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57132841|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132842|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57132843|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132844|NCT05700656|Capecitabine|capecitabine|mesh-list
57132845|NCT05700656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57132846|NCT05700656|Antimetabolites|antimetabolites|mesh-ancestor
57132847|NCT05700656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132848|NCT05700656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132849|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
57132850|NCT00103285|Leucovorin|leucovorin|mesh-list
57132851|NCT00103285|Folic Acid|folic acid|mesh-list
57132852|NCT00103285|Cytarabine|cytarabine|mesh-list
57132853|NCT00103285|Dexamethasone|dexamethasone|mesh-list
57132854|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
57132855|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
57132856|NCT00103285|Doxorubicin|doxorubicin|mesh-list
57132857|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57132858|NCT00103285|Methotrexate|methotrexate|mesh-list
57132859|NCT00103285|Vincristine|vincristine|mesh-list
57132860|NCT00103285|Asparaginase|asparaginase|mesh-list
57132861|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
57132862|NCT00103285|Pegaspargase|pegaspargase|mesh-list
57132863|NCT00103285|Thioguanine|thioguanine|mesh-list
57132864|NCT00103285|BB 1101|bb 1101|mesh-list
57132865|NCT00103285|Calcium|calcium|mesh-list
57132866|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
57132867|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
57132868|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57132869|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
57132870|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132871|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57132872|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57132873|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
57132874|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132875|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132876|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57132877|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57132879|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
57132880|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132881|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57132882|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
57132883|NCT00103285|Hormones|hormones|mesh-ancestor
57132884|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132885|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57132886|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
57132887|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132888|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57132889|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57132890|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57132891|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57132892|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57132893|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57132894|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
57132895|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57132896|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57132897|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
57132898|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
57132899|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57132900|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57132901|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
57132902|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132903|NCT00103285|Antidotes|antidotes|mesh-ancestor
57132904|NCT00103285|Protective Agents|protective agents|mesh-ancestor
57132905|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
57132906|NCT00103285|Vitamins|vitamins|mesh-ancestor
57132907|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
57132908|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57132909|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
57132910|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
57132911|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
57132912|NCT00103285|Hematinics|hematinics|mesh-ancestor
57132913|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
57132914|NCT03541915|Analgesics|analgesics|mesh-ancestor
57132915|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
57132916|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132917|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132918|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
57132919|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132920|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57132921|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
57132922|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57132923|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57132924|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132925|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57132926|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
57132927|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57132928|NCT03541837|Ropivacaine|ropivacaine|mesh-list
57132929|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
57132930|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
57132931|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132932|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132933|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
57132934|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132935|NCT02158117|Naloxone|naloxone|mesh-list
57132936|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57132937|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132938|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
57132939|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132940|NCT03541603|Simendan|simendan|mesh-list
57132941|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57132942|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
57132943|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
57132944|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57132945|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132946|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132947|NCT03541603|Protective Agents|protective agents|mesh-ancestor
57132948|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132949|NCT02160223|Neostigmine|neostigmine|mesh-list
57132950|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57132951|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132952|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132953|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
57132954|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57132955|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132956|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
57132957|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
57132958|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132959|NCT04802837|Vancomycin|vancomycin|mesh-list
57132960|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57132961|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57132962|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
57132963|NCT05256797|Apixaban|apixaban|mesh-list
57132964|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57132965|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
57132966|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57132967|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
57132968|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132969|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57132970|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
57132971|NCT02160301|Acetaminophen|acetaminophen|mesh-list
57132972|NCT02160301|Dexamethasone|dexamethasone|mesh-list
57132973|NCT02160301|Celecoxib|celecoxib|mesh-list
57132974|NCT02160301|Oxycodone|oxycodone|mesh-list
57132975|NCT02160301|Gabapentin|gabapentin|mesh-list
57132976|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57132977|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
57132978|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
57132979|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57132980|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57132981|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57132982|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
57132983|NCT02160301|Hormones|hormones|mesh-ancestor
57132984|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57132985|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57132986|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57132987|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57132988|NCT02160301|Analgesics|analgesics|mesh-ancestor
57132989|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
57132990|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
57132991|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57132992|NCT02160301|Narcotics|narcotics|mesh-ancestor
57132993|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57132994|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57132995|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57132996|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57132997|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57132998|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57132999|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133000|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
57133001|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57133002|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57133003|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57133004|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57133005|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57133006|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133007|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
57133008|NCT04756427|Citric Acid|citric acid|mesh-list
57133009|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
57133010|NCT04756427|Anticoagulants|anticoagulants|mesh-list
57133011|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57133012|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
57133013|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
57133014|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133015|NCT03541759|Hydromorphone|hydromorphone|mesh-list
57133016|NCT03541759|Pirinitramide|pirinitramide|mesh-list
57133017|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57133018|NCT03541759|Narcotics|narcotics|mesh-ancestor
57133019|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133020|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133021|NCT03541759|Analgesics|analgesics|mesh-ancestor
56814807|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
57133022|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
57133023|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133024|NCT05206955|Tadalafil|tadalafil|mesh-list
57133025|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
57133026|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
57133027|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57133028|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133029|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133030|NCT05206955|Urological Agents|urological agents|mesh-ancestor
57133031|NCT05159453|Insulin|insulin|mesh-list
57133032|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57133033|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57133034|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133035|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
57133036|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
57133037|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57133038|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
57133039|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133040|NCT01666652|Antacids|antacids|mesh-ancestor
57133041|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133042|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57133043|NCT03998813|Ropivacaine|ropivacaine|mesh-list
57133044|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
57133045|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
57133046|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133047|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133048|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
57133049|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133050|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57133051|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
57133052|NCT05174585|Antibodies|antibodies|mesh-list
57133053|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
57133054|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57133055|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
57133056|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133057|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133058|NCT04428086|Metformin|metformin|mesh-list
57133059|NCT04428086|Apatinib|apatinib|mesh-list
57133060|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57133061|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57133062|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133063|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57133064|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57133065|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
57133066|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133067|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57133068|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57133069|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133070|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133071|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57133072|NCT05132231|Brodalumab|brodalumab|mesh-list
57133073|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
57133074|NCT05125055|Paclitaxel|paclitaxel|mesh-list
57133075|NCT05125055|Docetaxel|docetaxel|mesh-list
57133076|NCT05125055|Fluorouracil|fluorouracil|mesh-list
57133077|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57133078|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133079|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
57133080|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
57133081|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
57133082|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133083|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
57133084|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57133085|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133086|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
57133087|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133088|NCT04355858|Paclitaxel|paclitaxel|mesh-list
57133089|NCT04355858|Capecitabine|capecitabine|mesh-list
57133090|NCT04355858|Everolimus|everolimus|mesh-list
57133091|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57133092|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133093|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
57133094|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
57133095|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
57133096|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814880|NCT03367871|Growth Substances|growth substances|mesh-ancestor
57133097|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57133098|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
57133099|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133100|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
57133101|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133103|NCT05610956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57133104|NCT05610956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133105|NCT05610956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57133106|NCT05610956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133107|NCT00109733|Hormones|hormones|mesh-list
57133108|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57133109|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133110|NCT05699876|Gabapentin|gabapentin|mesh-list
57133111|NCT05699876|Melatonin|melatonin|mesh-list
57133112|NCT05699876|Analgesics|analgesics|mesh-ancestor
57133113|NCT05699876|Sensory System Agents|sensory system agents|mesh-ancestor
57133114|NCT05699876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133115|NCT05699876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133116|NCT05699876|Anticonvulsants|anticonvulsants|mesh-ancestor
57133117|NCT05699876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57133118|NCT05699876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57133119|NCT05699876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133120|NCT05699876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57133121|NCT05699876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57133122|NCT05699876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57133123|NCT05699876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133124|NCT05699876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133125|NCT05699876|Antimanic Agents|antimanic agents|mesh-ancestor
57133126|NCT05699876|Antioxidants|antioxidants|mesh-ancestor
57133127|NCT05699876|Protective Agents|protective agents|mesh-ancestor
57133128|NCT05610878|Curcumin|curcumin|mesh-list
57133129|NCT05610878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57133130|NCT05610878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57133131|NCT05610878|Analgesics|analgesics|mesh-ancestor
57133132|NCT05610878|Sensory System Agents|sensory system agents|mesh-ancestor
57133133|NCT05610878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133134|NCT05610878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133135|NCT05610878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133136|NCT05610878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133137|NCT05610878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133138|NCT05610878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133139|NCT05610878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133140|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
57133141|NCT02706405|Fludarabine|fludarabine|mesh-list
57133142|NCT02706405|Durvalumab|durvalumab|mesh-list
57133143|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
57133144|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57133145|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
57133146|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133147|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
57133148|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133149|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133150|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57133151|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
57133152|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133153|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133154|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57133155|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133156|NCT02254031|Maytansine|maytansine|mesh-list
57133157|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
57133158|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57133159|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133160|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
57133161|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
57133162|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
57133163|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133164|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133165|NCT04174352|Tamoxifen|tamoxifen|mesh-list
57133166|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57133167|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
57133168|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57133169|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133170|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57133171|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133172|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56814954|NCT01074645|Tenofovir|tenofovir|mesh-list
57133173|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57133174|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57133175|NCT03545711|Irinotecan|irinotecan|mesh-list
57133176|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57133177|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57133178|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902529|NCT02764268|Apatinib|apatinib|mesh-list
57133179|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133180|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133181|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
57133182|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57133183|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57133184|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133185|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
57133186|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133187|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133188|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
57133189|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57133190|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57133191|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133192|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133193|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57133194|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
57133195|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57133196|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57133197|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
57133198|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133199|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133200|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57133201|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57133202|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
57133203|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57133204|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57133205|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
57133206|NCT02253953|Ritonavir|ritonavir|mesh-list
57133207|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57133208|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57133209|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
57133210|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133211|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133212|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57133213|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57133214|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
57133215|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133216|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57133217|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57133218|NCT03546803|Protective Agents|protective agents|mesh-list
57133219|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133220|NCT02422953|Micronutrients|micronutrients|mesh-list
57133221|NCT02422953|Trace Elements|trace elements|mesh-list
57133222|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133223|NCT04053140|Penicillins|penicillins|mesh-list
57133224|NCT04053140|Penicillin G|penicillin g|mesh-list
57133225|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
57133226|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
57133227|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57133228|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133229|NCT03733535|Benralizumab|benralizumab|mesh-list
57133230|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57133231|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
57133232|NCT03713879|Indomethacin|indomethacin|mesh-list
57133233|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57133234|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57133235|NCT03713879|Analgesics|analgesics|mesh-ancestor
57133236|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
57133237|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133238|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133239|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133240|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133241|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
57133242|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
57133243|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57133244|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57133245|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815028|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57133246|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133248|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56902534|NCT01320111|Paclitaxel|paclitaxel|mesh-list
57133249|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133250|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
57133251|NCT03661307|Decitabine|decitabine|mesh-list
57133252|NCT03661307|Venetoclax|venetoclax|mesh-list
57133253|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57133254|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
57133255|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133256|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133257|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133258|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
57133259|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133260|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133261|NCT02425605|Sorafenib|sorafenib|mesh-list
57133262|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133263|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57133264|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133265|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133266|NCT02422563|Paclitaxel|paclitaxel|mesh-list
57133267|NCT02422563|Carboplatin|carboplatin|mesh-list
57133268|NCT02422563|Ifosfamide|ifosfamide|mesh-list
57133269|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57133270|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133271|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
57133272|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
57133273|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
57133274|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133275|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57133276|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
57133277|NCT03185403|Sufentanil|sufentanil|mesh-list
57133278|NCT03185403|Ropivacaine|ropivacaine|mesh-list
57133279|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
57133280|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
57133281|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133282|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133283|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
57133284|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133285|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57133286|NCT03185403|Narcotics|narcotics|mesh-ancestor
57133287|NCT03185403|Analgesics|analgesics|mesh-ancestor
57133288|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57133289|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57133290|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
57133291|NCT04329806|Amlodipine|amlodipine|mesh-list
57133292|NCT04329806|Moxonidine|moxonidine|mesh-list
57133293|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57133294|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57133295|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57133296|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133297|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57133298|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133299|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
57133300|NCT03635021|Bevacizumab|bevacizumab|mesh-list
57133301|NCT03635021|Panitumumab|panitumumab|mesh-list
57133302|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133303|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133304|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57133305|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57133306|NCT03635021|Growth Substances|growth substances|mesh-ancestor
57133307|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133308|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
57133309|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
57133310|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57133311|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57133312|NCT02422485|Analgesics|analgesics|mesh-ancestor
57133313|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
57133314|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133315|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133316|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133317|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133318|NCT05551910|Remifentanil|remifentanil|mesh-list
57133319|NCT05551910|Propofol|propofol|mesh-list
57133320|NCT05551910|Esketamine|esketamine|mesh-list
57133321|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57133322|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133323|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133324|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57133325|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
57133326|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
57133327|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57133328|NCT05551910|Narcotics|narcotics|mesh-ancestor
57133329|NCT05551910|Analgesics|analgesics|mesh-ancestor
57133330|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
57133331|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133332|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
57133333|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57133334|NCT05699720|Magnesium Sulfate|magnesium sulfate|mesh-list
57133335|NCT05699720|Analgesics|analgesics|mesh-ancestor
57133336|NCT05699720|Sensory System Agents|sensory system agents|mesh-ancestor
57133337|NCT05699720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133338|NCT05699720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133339|NCT05699720|Anesthetics|anesthetics|mesh-ancestor
57133340|NCT05699720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133341|NCT05699720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57133342|NCT05699720|Anticonvulsants|anticonvulsants|mesh-ancestor
57133343|NCT05699720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57133344|NCT05699720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57133345|NCT05699720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133346|NCT05699720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57133347|NCT05699720|Tocolytic Agents|tocolytic agents|mesh-ancestor
57133348|NCT05699720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57133349|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
57133350|NCT05546762|Povidone|povidone|mesh-list
57133351|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
57133352|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
57133353|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57133354|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133355|NCT03863288|Oxytocin|oxytocin|mesh-list
57133356|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
57133357|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57133358|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133359|NCT03535883|Anticoagulants|anticoagulants|mesh-list
57133360|NCT03535883|Coagulants|coagulants|mesh-list
57133361|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
57133362|NCT05551598|Analgesics|analgesics|mesh-ancestor
57133363|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
57133364|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133365|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133366|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133367|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57133368|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57133369|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133370|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133371|NCT03810794|Donepezil|donepezil|mesh-list
57133372|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57133373|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133374|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133375|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
57133376|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133377|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133378|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
57133379|NCT03185793|Benzbromarone|benzbromarone|mesh-list
57133380|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
57133381|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
57133382|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133383|NCT03185793|Renal Agents|renal agents|mesh-ancestor
57133384|NCT03660488|Penicillins|penicillins|mesh-list
57133385|NCT03660488|Cefixime|cefixime|mesh-list
57133386|NCT03660488|Penicillin G|penicillin g|mesh-list
57133387|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
57133388|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
57133389|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57133390|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133391|NCT02422017|Timolol|timolol|mesh-list
57133392|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57133393|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57133394|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
57133395|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133396|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133397|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133398|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57133399|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57133400|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
57133401|NCT02761915|Fludarabine|fludarabine|mesh-list
57133402|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133403|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
57133404|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133405|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133406|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57133407|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
57133408|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133409|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133410|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57133411|NCT05699408|Insulin Glargine|insulin glargine|mesh-list
57133412|NCT05699408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57133413|NCT05699408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133414|NCT03464084|Melatonin|melatonin|mesh-list
57133415|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
57133416|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133417|NCT03464084|Protective Agents|protective agents|mesh-ancestor
57133418|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133419|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133420|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
57133421|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57133422|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133423|NCT05551208|Bevacizumab|bevacizumab|mesh-list
57133424|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133425|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133426|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57133427|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57133428|NCT05551208|Growth Substances|growth substances|mesh-ancestor
57133429|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133430|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
57133431|NCT03334682|Doxycycline|doxycycline|mesh-list
57133432|NCT03334682|Spironolactone|spironolactone|mesh-list
57133433|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57133434|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133435|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
57133436|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57133437|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57133438|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
57133439|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
57133440|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57133441|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133442|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
57133443|NCT03334682|Diuretics|diuretics|mesh-ancestor
57133444|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
57133445|NCT02764333|Durvalumab|durvalumab|mesh-list
57133446|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133447|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133448|NCT05700344|Avelumab|avelumab|mesh-list
57133449|NCT05700344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133450|NCT05700344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133451|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
57133452|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57133453|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57133454|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57133455|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57133456|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133457|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
57133458|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133459|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133460|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57133461|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133462|NCT02161237|Tacrolimus|tacrolimus|mesh-list
57133463|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133464|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
57133465|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133466|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57133467|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133468|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133469|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57133470|NCT03173066|Hematinics|hematinics|mesh-ancestor
57133471|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57133472|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57133473|NCT05546060|Dexamethasone|dexamethasone|mesh-list
57133474|NCT05546060|Etoposide|etoposide|mesh-list
57133475|NCT05546060|Venetoclax|venetoclax|mesh-list
57133476|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133477|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
57133478|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
57133479|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133480|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133481|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57133482|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
57133483|NCT05546060|Hormones|hormones|mesh-ancestor
57133484|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57133485|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57133486|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133487|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57133488|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57133489|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57133490|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133491|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133492|NCT02416869|Dexamethasone|dexamethasone|mesh-list
57133493|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
57133494|NCT02416869|BB 1101|bb 1101|mesh-list
57133495|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133496|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
57133497|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
57133498|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133499|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133500|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57133501|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
57133502|NCT02416869|Hormones|hormones|mesh-ancestor
57133503|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57133504|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57133505|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133506|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
57133507|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133508|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133509|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
57133510|NCT02588612|Fludarabine|fludarabine|mesh-list
57133511|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133512|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
57133513|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133514|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133515|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57133516|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
57133517|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133518|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133519|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57133520|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
57133521|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
57133522|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133523|NCT03540979|Letrozole|letrozole|mesh-list
57133524|NCT03540979|Progesterone|progesterone|mesh-list
57133525|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133526|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57133527|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57133528|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133529|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133530|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57133531|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
57133532|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57133533|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133534|NCT03540979|Progestins|progestins|mesh-ancestor
57133535|NCT03540979|Hormones|hormones|mesh-ancestor
57133536|NCT02946788|Minocycline|minocycline|mesh-list
57133537|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57133538|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133539|NCT02159131|Cabotegravir|cabotegravir|mesh-list
57133540|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
57133541|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57133542|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
57133543|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57133544|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133545|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57133546|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57133547|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57133548|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57133549|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57133550|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133551|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133552|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57133553|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57133554|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
57133555|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133556|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
57133557|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
57133558|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57133559|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57133560|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133561|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133562|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133563|NCT05550506|Analgesics|analgesics|mesh-ancestor
57133564|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
57133565|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133566|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
57133567|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57133568|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
57133569|NCT03174795|Meropenem|meropenem|mesh-list
57133570|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57133571|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133572|NCT02163655|Furosemide|furosemide|mesh-list
57133573|NCT02163655|Diuretics|diuretics|mesh-ancestor
57133574|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
57133575|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133576|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57133577|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57133578|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133579|NCT02410083|Aspirin|aspirin|mesh-list
57133580|NCT02410083|Clopidogrel|clopidogrel|mesh-list
57133581|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57133582|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57133583|NCT02410083|Analgesics|analgesics|mesh-ancestor
57133584|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
57133585|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133586|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133587|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133588|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133589|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57133590|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57133591|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133592|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57133593|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57133594|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133595|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
57133596|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57133597|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57133598|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57133599|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
57133600|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133601|NCT05545670|Allopurinol|allopurinol|mesh-list
57133602|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
57133603|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133604|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133605|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
57133606|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133607|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57133608|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
57133609|NCT05545670|Protective Agents|protective agents|mesh-ancestor
57133610|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133611|NCT02416245|Micronutrients|micronutrients|mesh-list
57133612|NCT02416245|Trace Elements|trace elements|mesh-list
57133613|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133614|NCT02416167|Dotinurad|dotinurad|mesh-list
57133615|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
57133616|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
57133617|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133618|NCT02416167|Renal Agents|renal agents|mesh-ancestor
57133619|NCT01463072|Paclitaxel|paclitaxel|mesh-list
57133620|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57133621|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57133622|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133623|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
57133624|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
57133625|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
57133626|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133627|NCT02166853|Midazolam|midazolam|mesh-list
57133628|NCT02166853|Sevoflurane|sevoflurane|mesh-list
57133629|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57133630|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57133631|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133632|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133633|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57133634|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57133635|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57133636|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57133637|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
57133638|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
57133639|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
57133640|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
57133641|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133642|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133643|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57133644|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57133645|NCT02162251|Donepezil|donepezil|mesh-list
57133646|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
57133647|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133648|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133649|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
57133650|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133651|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133652|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
57133653|NCT02164045|Fostemsavir|fostemsavir|mesh-list
57133654|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57133655|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57133656|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
57133657|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133658|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
57133659|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
57133660|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133661|NCT02410005|Calcitriol|calcitriol|mesh-list
57133662|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
57133663|NCT02410005|Losartan|losartan|mesh-list
57133664|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57133665|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57133666|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57133667|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57133668|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133669|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57133670|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133671|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
57133672|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57133673|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57133674|NCT02410005|Vitamins|vitamins|mesh-ancestor
57133675|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
57133676|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57133677|NCT05543330|Cisplatin|cisplatin|mesh-list
57133678|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133679|NCT03174561|Choline|choline|mesh-list
57133680|NCT03174561|Silymarin|silymarin|mesh-list
57133681|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
57133682|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57133683|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
57133684|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133685|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57133686|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57133687|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
57133688|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
57133689|NCT03174561|Protective Agents|protective agents|mesh-ancestor
57133690|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133691|NCT05545592|Estrogens|estrogens|mesh-list
57133692|NCT05545592|Hormones|hormones|mesh-ancestor
57133693|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57133694|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133695|NCT05545436|Capecitabine|capecitabine|mesh-list
57133696|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
57133697|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57133698|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
57133699|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133700|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133702|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57133703|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57133704|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133705|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133706|NCT02167165|Protective Agents|protective agents|mesh-ancestor
57133707|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133708|NCT02409849|Octreotide|octreotide|mesh-list
57133709|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57133710|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57133711|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133712|NCT00664040|Aspirin|aspirin|mesh-list
57133713|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57133714|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57133715|NCT00664040|Analgesics|analgesics|mesh-ancestor
57133716|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
57133717|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133718|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133719|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133720|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133721|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57133722|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57133723|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133724|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57133725|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57133726|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133727|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
57133728|NCT02162407|Insulin|insulin|mesh-list
57133729|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57133730|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
57133731|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57133732|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133733|NCT02162485|Fluticasone|fluticasone|mesh-list
57133734|NCT02162485|Xhance|xhance|mesh-list
57133735|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57133736|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
57133737|NCT02162485|Charcoal|charcoal|mesh-list
57133738|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133739|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57133740|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
57133741|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133742|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133743|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57133744|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
57133745|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
57133746|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57133747|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57133748|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57133749|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57133750|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
57133751|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133752|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133753|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
57133754|NCT02162485|Hormones|hormones|mesh-ancestor
57133755|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57133756|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
57133757|NCT02162485|Antidotes|antidotes|mesh-ancestor
57133758|NCT02162485|Protective Agents|protective agents|mesh-ancestor
57133759|NCT02415777|Riboflavin|riboflavin|mesh-list
57133760|NCT02415777|Thiamine|thiamine|mesh-list
57133761|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
57133762|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
57133763|NCT02415777|Vitamins|vitamins|mesh-ancestor
57133764|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
57133765|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133766|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57133767|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
57133768|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
57133769|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57133770|NCT05544968|Antibodies|antibodies|mesh-list
57133771|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57133772|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
57133773|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133774|NCT03178539|Ketorolac|ketorolac|mesh-list
57133775|NCT03178539|Diclofenac|diclofenac|mesh-list
57133776|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57133777|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57133778|NCT03178539|Analgesics|analgesics|mesh-ancestor
57133779|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
57133780|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133781|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133782|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133783|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133784|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57133785|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133786|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133787|NCT03174483|Fluticasone|fluticasone|mesh-list
57133788|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133789|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57133790|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
57133791|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133792|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133793|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57133794|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
57133795|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
57133796|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57133797|NCT05699174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57133798|NCT05699174|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57133799|NCT05699174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133800|NCT05699174|Antitubercular Agents|antitubercular agents|mesh-ancestor
57133801|NCT04320914|Ibuprofen|ibuprofen|mesh-list
57133802|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57133803|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57133804|NCT04320914|Analgesics|analgesics|mesh-ancestor
57133805|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
57133806|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133807|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133808|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133809|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133810|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57133811|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133812|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133813|NCT05544812|Cetuximab|cetuximab|mesh-list
57133814|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133815|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133816|NCT02415699|Leucovorin|leucovorin|mesh-list
57133817|NCT02415699|Fluorouracil|fluorouracil|mesh-list
57133818|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
57133819|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
57133820|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133821|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57133822|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133823|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133824|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
57133825|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133826|NCT02415699|Antidotes|antidotes|mesh-ancestor
57133827|NCT02415699|Protective Agents|protective agents|mesh-ancestor
57133828|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
57133829|NCT02415699|Vitamins|vitamins|mesh-ancestor
57133830|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
57133831|NCT05544656|Tolperisone|tolperisone|mesh-list
57133832|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
57133833|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133834|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57133835|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133836|NCT02409537|Resveratrol|resveratrol|mesh-list
57133837|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
57133838|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133839|NCT02409537|Protective Agents|protective agents|mesh-ancestor
57133840|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133841|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133842|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57133843|NCT05542394|Curcumin|curcumin|mesh-list
57133844|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57133845|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57133846|NCT05542394|Analgesics|analgesics|mesh-ancestor
57133847|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
57133848|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815625|NCT01010243|Hormones|hormones|mesh-ancestor
57133849|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133850|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133851|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133852|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133853|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133854|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133855|NCT03177993|Ivermectin|ivermectin|mesh-list
57133856|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57133857|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133858|NCT04425590|Aspirin|aspirin|mesh-list
57133859|NCT04425590|Atorvastatin|atorvastatin|mesh-list
57133860|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57133861|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57133862|NCT04425590|Analgesics|analgesics|mesh-ancestor
57133863|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
57133864|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133865|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133866|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133867|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133868|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57133869|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57133870|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133871|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57133872|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57133873|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133874|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
57133875|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57133876|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57133877|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
57133878|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57133879|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57133880|NCT00707889|Leucovorin|leucovorin|mesh-list
57133881|NCT00707889|Folic Acid|folic acid|mesh-list
57133882|NCT00707889|Bevacizumab|bevacizumab|mesh-list
57133883|NCT00707889|Fluorouracil|fluorouracil|mesh-list
57133884|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
57133885|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
57133886|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133887|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133888|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57133889|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57133890|NCT00707889|Growth Substances|growth substances|mesh-ancestor
57133891|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133892|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
57133893|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
57133894|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133895|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57133896|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133897|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
57133898|NCT00707889|Antidotes|antidotes|mesh-ancestor
57133899|NCT00707889|Protective Agents|protective agents|mesh-ancestor
57133900|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
57133901|NCT00707889|Vitamins|vitamins|mesh-ancestor
57133902|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
57133903|NCT00707889|Hematinics|hematinics|mesh-ancestor
57133904|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
57133905|NCT00109031|Etoposide|etoposide|mesh-list
57133906|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133907|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
57133908|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133909|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57133910|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57133911|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
57133912|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133913|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133914|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57133915|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57133916|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57133917|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57133918|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57133919|NCT02419443|Gabapentin|gabapentin|mesh-list
57133920|NCT02419443|Analgesics|analgesics|mesh-ancestor
57133921|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
57133922|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57133923|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133924|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
57133925|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57133926|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57133927|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57133929|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57133930|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57133931|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57133932|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133933|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
57133934|NCT02409147|Nystatin|nystatin|mesh-list
57133935|NCT02409147|Prednisone|prednisone|mesh-list
57133936|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
57133937|NCT02409147|Basiliximab|basiliximab|mesh-list
57133938|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57133939|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
57133940|NCT02409147|Hormones|hormones|mesh-ancestor
57133941|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57133942|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133943|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57133944|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133945|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133946|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133947|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
57133948|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57133949|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133950|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
57133951|NCT02409147|Ionophores|ionophores|mesh-ancestor
57133952|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57133953|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57133954|NCT05017103|Antibodies|antibodies|mesh-list
57133955|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
57133956|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57133957|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
57133958|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133959|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133960|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
57133961|NCT02414919|Etonogestrel|etonogestrel|mesh-list
57133962|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57133963|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
57133964|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57133965|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133966|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57133967|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
57133968|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57133969|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
57133970|NCT05005559|Paraproteins|paraproteins|mesh-list
57133971|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
57133972|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133973|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57133974|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57133975|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57133976|NCT02408679|Vitamin D|vitamin d|mesh-list
57133977|NCT02408679|Vitamins|vitamins|mesh-ancestor
57133978|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
57133979|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133980|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57133981|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
57133982|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57133983|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133984|NCT05089565|Interferons|interferons|mesh-list
57133985|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
57133986|NCT05089565|Antibodies|antibodies|mesh-list
57133987|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
57133988|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
57133989|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133990|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133991|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
57133992|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57133993|NCT03174171|Everolimus|everolimus|mesh-list
57133994|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57133995|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57133996|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
57133997|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57133998|NCT02414529|Vitamin D|vitamin d|mesh-list
57133999|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
57134000|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
57134001|NCT02414529|Vitamins|vitamins|mesh-list
57134002|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
57134003|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134004|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57134005|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57134007|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57134008|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134009|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
57134010|NCT03743402|Narcotics|narcotics|mesh-ancestor
57134011|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134012|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134013|NCT03743402|Analgesics|analgesics|mesh-ancestor
57134014|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
57134015|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134016|NCT02414685|Paclitaxel|paclitaxel|mesh-list
57134017|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57134018|NCT02414685|Cisplatin|cisplatin|mesh-list
57134019|NCT02414685|Ifosfamide|ifosfamide|mesh-list
57134020|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
57134021|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57134022|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134023|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
57134024|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
57134025|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
57134026|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134027|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57134028|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
57134029|NCT04425824|Rituximab|rituximab|mesh-list
57134030|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57134031|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134032|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
57134033|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134034|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134035|NCT02414451|Propranolol|propranolol|mesh-list
57134036|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57134037|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57134038|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
57134039|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134040|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134041|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134042|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57134043|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57134044|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
57134045|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
57134046|NCT02408289|Procyanidin|procyanidin|mesh-list
57134047|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
57134048|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134049|NCT02408289|Protective Agents|protective agents|mesh-ancestor
57134050|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134051|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57134052|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57134053|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134054|NCT02417883|Furosemide|furosemide|mesh-list
57134055|NCT02417883|Diuretics|diuretics|mesh-ancestor
57134056|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
57134057|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134058|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57134059|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57134060|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134061|NCT01664624|Exenatide|exenatide|mesh-list
57134062|NCT01664624|Alogliptin|alogliptin|mesh-list
57134063|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57134064|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134065|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57134066|NCT01664624|Incretins|incretins|mesh-ancestor
57134067|NCT01664624|Hormones|hormones|mesh-ancestor
57134068|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57134069|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57134070|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
57134071|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134072|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134073|NCT03173781|Droxidopa|droxidopa|mesh-list
57134074|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57134075|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57134076|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57134077|NCT05540834|Plasminogen|plasminogen|mesh-list
56815847|NCT00098254|Sorafenib|sorafenib|mesh-list
57134078|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57134079|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57134080|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134081|NCT05696132|Povidone-Iodine|povidone-iodine|mesh-list
57134082|NCT05696132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57134083|NCT05696132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134084|NCT02407899|Vitamin D|vitamin d|mesh-list
57134085|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
57134086|NCT02407899|Insulin|insulin|mesh-list
57134087|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57134088|NCT02407899|Metformin|metformin|mesh-list
57134089|NCT02407899|Saxagliptin|saxagliptin|mesh-list
57134090|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
57134091|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57134092|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134093|NCT02407899|Vitamins|vitamins|mesh-ancestor
57134094|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
57134095|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57134096|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57134097|NCT02407899|Incretins|incretins|mesh-ancestor
57134098|NCT02407899|Hormones|hormones|mesh-ancestor
57134099|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57134100|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
57134101|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134102|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134103|NCT02417493|Epinephrine|epinephrine|mesh-list
57134104|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57134105|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57134106|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
57134107|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134108|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134109|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134110|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57134111|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57134112|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
57134113|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134114|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57134115|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
57134116|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
57134117|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
57134118|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57134119|NCT05540600|Digoxin|digoxin|mesh-list
57134120|NCT05540600|Bisoprolol|bisoprolol|mesh-list
57134121|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57134122|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57134123|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134124|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134125|NCT05540600|Protective Agents|protective agents|mesh-ancestor
57134126|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134127|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57134128|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
57134129|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
57134130|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134131|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57134132|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57134133|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57134134|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
57134135|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134136|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
57134137|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57134138|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
57134139|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134140|NCT03265574|Enalapril|enalapril|mesh-list
57134141|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57134142|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
57134143|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134144|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134145|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57134146|NCT03177837|Acetazolamide|acetazolamide|mesh-list
57134147|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
57134148|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
57134149|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134150|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134151|NCT03177837|Diuretics|diuretics|mesh-ancestor
57134152|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
56815929|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
57134153|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134154|NCT02414373|Bupivacaine|bupivacaine|mesh-list
57134155|NCT02414373|Ropivacaine|ropivacaine|mesh-list
57134156|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
57134157|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
57134158|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134159|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134160|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
57134161|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134162|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
57134163|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134164|NCT03173235|Vitamin D|vitamin d|mesh-list
57134165|NCT03173235|Vitamins|vitamins|mesh-ancestor
57134166|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
57134167|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134168|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57134169|NCT05697692|Heparin|heparin|mesh-list
57134170|NCT05697692|Calcium heparin|calcium heparin|mesh-list
57134171|NCT05697692|Anticoagulants|anticoagulants|mesh-ancestor
57134172|NCT05697692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57134173|NCT05697692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57134174|NCT05697692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134175|NCT02761057|Sunitinib|sunitinib|mesh-list
57134176|NCT02761057|Crizotinib|crizotinib|mesh-list
57134177|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134178|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57134179|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57134180|NCT02761057|Growth Substances|growth substances|mesh-ancestor
57134181|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134182|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
57134183|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57134184|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134185|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134186|NCT02407821|Citalopram|citalopram|mesh-list
57134187|NCT02407821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57134188|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57134189|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57134190|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134191|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134192|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
57134193|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134194|NCT02407821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57134195|NCT02407821|Antidepressive Agents|antidepressive agents|mesh-ancestor
57134196|NCT02407821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57134197|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
57134198|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57134199|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134200|NCT02417337|Acetaminophen|acetaminophen|mesh-list
57134201|NCT02417337|Ibuprofen|ibuprofen|mesh-list
57134202|NCT02417337|Diclofenac|diclofenac|mesh-list
57134203|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
57134204|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57134205|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57134206|NCT02417337|Analgesics|analgesics|mesh-ancestor
57134207|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
57134208|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134209|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134210|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57134211|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134212|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57134213|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134214|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134215|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
57134216|NCT02167321|Leucovorin|leucovorin|mesh-list
57134217|NCT02167321|Fluorouracil|fluorouracil|mesh-list
57134218|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
57134219|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
57134220|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134221|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57134222|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134223|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57134224|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
57134225|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134226|NCT02167321|Antidotes|antidotes|mesh-ancestor
57134227|NCT02167321|Protective Agents|protective agents|mesh-ancestor
56816006|NCT00227721|Gemcitabine|gemcitabine|mesh-list
57134228|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
57134230|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
57134231|NCT02162797|Zinc|zinc|mesh-list
57134232|NCT02162797|Trace Elements|trace elements|mesh-ancestor
57134233|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
57134234|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134235|NCT02162875|Praziquantel|praziquantel|mesh-list
57134236|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
57134237|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57134238|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134239|NCT02167633|Pantoprazole|pantoprazole|mesh-list
57134240|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57134241|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
57134242|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57134243|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57134244|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134245|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134246|NCT02167633|Hormones|hormones|mesh-ancestor
57134247|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57134248|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134249|NCT02413281|Buprenorphine|buprenorphine|mesh-list
57134250|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57134251|NCT02413281|Narcotics|narcotics|mesh-ancestor
57134252|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134253|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134254|NCT02413281|Analgesics|analgesics|mesh-ancestor
57134255|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
57134256|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134257|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57134258|NCT02170909|Dabigatran|dabigatran|mesh-list
57134259|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
57134260|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57134261|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
57134262|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134263|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134264|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
57134265|NCT02164825|Morphine|morphine|mesh-list
57134266|NCT02164825|Ropivacaine|ropivacaine|mesh-list
57134267|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57134268|NCT02164825|Narcotics|narcotics|mesh-ancestor
57134269|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134270|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134271|NCT02164825|Analgesics|analgesics|mesh-ancestor
57134272|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
57134273|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134274|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
57134275|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
57134276|NCT02584634|Avelumab|avelumab|mesh-list
57134277|NCT02584634|Crizotinib|crizotinib|mesh-list
57134278|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57134279|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134280|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57134281|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134282|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134283|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
57134284|NCT02170987|Dabigatran|dabigatran|mesh-list
57134285|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57134286|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134287|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57134288|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57134289|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134290|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134291|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134292|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
57134293|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57134294|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
57134295|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
57134296|NCT03176121|Oxycodone|oxycodone|mesh-list
57134297|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57134298|NCT03176121|Narcotics|narcotics|mesh-ancestor
57134299|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134300|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134301|NCT03176121|Analgesics|analgesics|mesh-ancestor
57134302|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
56816080|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
57134303|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134304|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
57134305|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134306|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134307|NCT03176199|Oxycodone|oxycodone|mesh-list
57134308|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57134309|NCT03176199|Narcotics|narcotics|mesh-ancestor
57134310|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134311|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134312|NCT03176199|Analgesics|analgesics|mesh-ancestor
57134313|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
57134314|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134315|NCT05697614|Lamotrigine|lamotrigine|mesh-list
57134316|NCT05697614|Carbamazepine|carbamazepine|mesh-list
57134317|NCT05697614|Phenytoin|phenytoin|mesh-list
57134318|NCT05697614|Oxcarbazepine|oxcarbazepine|mesh-list
57134319|NCT05697614|Valproic Acid|valproic acid|mesh-list
57134320|NCT05697614|Clobazam|clobazam|mesh-list
57134321|NCT05697614|Anticonvulsants|anticonvulsants|mesh-ancestor
57134322|NCT05697614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57134323|NCT05697614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57134324|NCT05697614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134325|NCT05697614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57134326|NCT05697614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134327|NCT05697614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57134328|NCT05697614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57134329|NCT05697614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134330|NCT05697614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57134331|NCT05697614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57134332|NCT05697614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134333|NCT05697614|GABA Agents|gaba agents|mesh-ancestor
57134334|NCT05697614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134335|NCT05697614|Antimanic Agents|antimanic agents|mesh-ancestor
57134336|NCT05697614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57134337|NCT05697614|Analgesics|analgesics|mesh-ancestor
57134338|NCT05697614|Sensory System Agents|sensory system agents|mesh-ancestor
57134339|NCT05697614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134340|NCT05697614|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57134341|NCT05697614|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57134342|NCT05697614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57134343|NCT05697614|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57134344|NCT05697614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57134345|NCT05697614|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57134346|NCT05697614|GABA Agonists|gaba agonists|mesh-ancestor
57134347|NCT02171221|DFP-11207|dfp-11207|mesh-list
57134348|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57134349|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
56902570|NCT03775395|Sorafenib|sorafenib|mesh-list
57134350|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134351|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134352|NCT02413515|Nifedipine|nifedipine|mesh-list
57134353|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57134354|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57134355|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134356|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57134357|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134358|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
57134359|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
57134360|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57134361|NCT03194906|Memantine|memantine|mesh-list
57134362|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57134363|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57134364|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
57134365|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134366|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134367|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134368|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57134369|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57134370|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
57134371|NCT03171987|Lidocaine|lidocaine|mesh-list
57134372|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
57134373|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
57134374|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134375|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134376|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
57134377|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134378|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57134379|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57134380|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57134381|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57134382|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134383|NCT03171987|Analgesics|analgesics|mesh-ancestor
57134384|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57134385|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57134386|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57134387|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134388|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57134389|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134390|NCT05540288|Nalmefene|nalmefene|mesh-list
57134391|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57134392|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134393|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
57134394|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134395|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
57134396|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57134397|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134398|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134399|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57134400|NCT03172065|Analgesics|analgesics|mesh-ancestor
57134401|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
57134402|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134403|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57134404|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57134405|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57134406|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
57134407|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134408|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134409|NCT02171299|Ropivacaine|ropivacaine|mesh-list
57134410|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
57134411|NCT02171299|Anesthetics|anesthetics|mesh-list
57134412|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134413|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134414|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
57134415|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134416|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
57134417|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
57134418|NCT03171831|Busulfan|busulfan|mesh-list
57134419|NCT03171831|Methotrexate|methotrexate|mesh-list
57134420|NCT03171831|Fludarabine|fludarabine|mesh-list
57134421|NCT03171831|Tacrolimus|tacrolimus|mesh-list
57134422|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
57134423|NCT03171831|Basiliximab|basiliximab|mesh-list
57134424|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57134425|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
57134426|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134427|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134428|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57134429|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
57134430|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134431|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134432|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57134433|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57134434|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
57134435|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57134436|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57134437|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
57134438|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
57134439|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134440|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57134441|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57134442|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57134443|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57134444|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57134445|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
57134446|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57134447|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134448|NCT02967692|Trametinib|trametinib|mesh-list
57134449|NCT02967692|Dabrafenib|dabrafenib|mesh-list
57134450|NCT02967692|Spartalizumab|spartalizumab|mesh-list
57134451|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134452|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57134453|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134454|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134455|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57134456|NCT02171455|Dabigatran|dabigatran|mesh-list
57134457|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
57134458|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57134459|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
57134460|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134461|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134462|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
57134463|NCT02171533|Verapamil|verapamil|mesh-list
57134464|NCT02171533|Dabigatran|dabigatran|mesh-list
57134465|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
57134466|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57134467|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
57134468|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134469|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134470|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
57134471|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57134472|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57134473|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57134474|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57134475|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134476|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
57134477|NCT04482543|Methotrexate|methotrexate|mesh-list
57134478|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57134479|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
57134480|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57134481|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134482|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57134483|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
57134484|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134485|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134486|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
57134487|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134488|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57134489|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57134490|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
57134491|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134492|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57134493|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
57134494|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57134495|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134496|NCT04728230|Carboplatin|carboplatin|mesh-list
57134497|NCT04728230|Etoposide|etoposide|mesh-list
57134498|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
57134499|NCT04728230|Durvalumab|durvalumab|mesh-list
57134500|NCT04728230|Olaparib|olaparib|mesh-list
57134501|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
57134502|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
57134503|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57134504|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
57134505|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134506|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57134507|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57134508|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57134509|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134510|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134511|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57134512|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
57134513|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134514|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57134515|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
57134516|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
57134517|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
57134518|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
57134519|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
57134520|NCT02406183|Ipilimumab|ipilimumab|mesh-list
57134521|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57134522|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134523|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57134524|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134525|NCT04723472|Cefuroxime|cefuroxime|mesh-list
57134526|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
56816303|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
57134527|NCT04723472|Bismuth|bismuth|mesh-list
57134528|NCT04723472|Antacids|antacids|mesh-ancestor
57134529|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134530|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57134531|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57134532|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134534|NCT02412813|Trace Elements|trace elements|mesh-ancestor
57134535|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
57134536|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134537|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
57134538|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57134539|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134540|NCT03116295|Opicapone|opicapone|mesh-list
57134541|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
57134542|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134543|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134544|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57134545|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57134546|NCT02405715|Oxytocin|oxytocin|mesh-list
57134547|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
57134548|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57134549|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134550|NCT00082706|Leucovorin|leucovorin|mesh-list
57134551|NCT00082706|Gemcitabine|gemcitabine|mesh-list
57134552|NCT00082706|Cisplatin|cisplatin|mesh-list
57134553|NCT00082706|Fluorouracil|fluorouracil|mesh-list
57134554|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134555|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57134556|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
57134557|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134558|NCT00082706|Antiviral Agents|antiviral agents|mesh-ancestor
57134559|NCT00082706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134560|NCT00082706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134561|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57134562|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
57134563|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134564|NCT00082706|Antidotes|antidotes|mesh-ancestor
57134565|NCT00082706|Protective Agents|protective agents|mesh-ancestor
57134566|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
57134567|NCT00082706|Vitamins|vitamins|mesh-ancestor
57134568|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
57134569|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
57134570|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57134571|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
57134572|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134573|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134574|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57134575|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
57134576|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134577|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134578|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57134579|NCT02412345|Alprostadil|alprostadil|mesh-list
57134580|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57134581|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
57134582|NCT02412345|Urological Agents|urological agents|mesh-ancestor
57134583|NCT05679050|Folfirinox|folfirinox|mesh-list
57134584|NCT05679050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134585|NCT02412267|Carboplatin|carboplatin|mesh-list
57134586|NCT02412267|Etoposide|etoposide|mesh-list
57134587|NCT02412267|Ifosfamide|ifosfamide|mesh-list
57134588|NCT02412267|Ofatumumab|ofatumumab|mesh-list
57134589|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134590|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57134591|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57134592|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57134593|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134594|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134595|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57134596|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
57134597|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
57134598|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
57134599|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57134600|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
57134601|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134602|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134603|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
57134604|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
57134605|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
57134606|NCT05698394|Esketamine|esketamine|mesh-list
57134607|NCT05698394|Antidepressive Agents|antidepressive agents|mesh-ancestor
57134608|NCT05698394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57134610|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134611|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
57134612|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134613|NCT02405793|Meloxicam|meloxicam|mesh-list
57134614|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57134615|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57134616|NCT02405793|Analgesics|analgesics|mesh-ancestor
57134617|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
57134618|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134619|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134620|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57134621|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134622|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57134623|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57134624|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134625|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134626|NCT05695664|Ibuprofen|ibuprofen|mesh-list
57134627|NCT05695664|Ketorolac|ketorolac|mesh-list
57134628|NCT05695664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57134629|NCT05695664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57134630|NCT05695664|Analgesics|analgesics|mesh-ancestor
57134631|NCT05695664|Sensory System Agents|sensory system agents|mesh-ancestor
57134632|NCT05695664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134633|NCT05695664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134634|NCT05695664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57134635|NCT05695664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134636|NCT05695664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57134637|NCT05695664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134638|NCT05695664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134639|NCT02412189|Norepinephrine|norepinephrine|mesh-list
57134640|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57134641|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57134642|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
57134643|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134644|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134645|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134646|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
57134647|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
57134648|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134649|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57134650|NCT03172299|Aflibercept|aflibercept|mesh-list
57134651|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57134652|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57134653|NCT03172299|Growth Substances|growth substances|mesh-ancestor
57134654|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134655|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
57134656|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134657|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
57134658|NCT02411955|Tazarotene|tazarotene|mesh-list
57134659|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
57134660|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
57134661|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
57134662|NCT02411955|Vitamins|vitamins|mesh-ancestor
57134663|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
57134664|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134665|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
57134666|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
57134667|NCT05517668|Fomepizole|fomepizole|mesh-list
57134668|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
57134669|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134670|NCT05517668|Expectorants|expectorants|mesh-ancestor
57134671|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
57134672|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57134673|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
57134674|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134675|NCT05517668|Protective Agents|protective agents|mesh-ancestor
57134676|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134677|NCT05517668|Antidotes|antidotes|mesh-ancestor
57134678|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134679|NCT03172533|Dienogest|dienogest|mesh-list
57134680|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56816515|NCT00503009|Xhance|xhance|mesh-list
57134681|NCT03172533|Estradiol|estradiol|mesh-list
57134682|NCT03172533|Estrogens|estrogens|mesh-ancestor
57134683|NCT03172533|Hormones|hormones|mesh-ancestor
57134684|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57134685|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134686|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57134687|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
57134688|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57134689|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57134690|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57134691|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57134692|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57134693|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
57134694|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57134695|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134696|NCT05497778|Gemcitabine|gemcitabine|mesh-list
57134697|NCT05497778|Paclitaxel|paclitaxel|mesh-list
57134698|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57134699|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57134700|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134701|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
57134702|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
57134703|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
57134704|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134705|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57134706|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
57134707|NCT05497778|Antiviral Agents|antiviral agents|mesh-ancestor
57134708|NCT05497778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134709|NCT05497778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134710|NCT05497778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57134711|NCT05497778|Immunologic Factors|immunologic factors|mesh-ancestor
57134712|NCT05497778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134713|NCT02412033|Misoprostol|misoprostol|mesh-list
57134714|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57134715|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
57134716|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57134717|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134718|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57134719|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57134720|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
57134721|NCT02401971|Thalidomide|thalidomide|mesh-list
57134722|NCT02401971|Irinotecan|irinotecan|mesh-list
57134723|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57134724|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57134725|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134726|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134727|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134728|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57134729|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
57134730|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134731|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
57134732|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57134733|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134734|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57134735|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57134736|NCT02401971|Growth Substances|growth substances|mesh-ancestor
57134737|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
57134738|NCT00701883|Atorvastatin|atorvastatin|mesh-list
57134739|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57134740|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57134741|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
57134742|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134743|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57134744|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57134745|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134746|NCT05678738|Antioxidants|antioxidants|mesh-list
57134747|NCT05678738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134748|NCT05678738|Protective Agents|protective agents|mesh-ancestor
57134749|NCT05678738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134750|NCT03175653|Oxycodone|oxycodone|mesh-list
57134751|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57134752|NCT03175653|Narcotics|narcotics|mesh-ancestor
57134753|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134754|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134755|NCT03175653|Analgesics|analgesics|mesh-ancestor
57134756|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
57134757|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134759|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
57134760|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134761|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
57134762|NCT03175341|Vitamins|vitamins|mesh-ancestor
57134763|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
57134764|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134765|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
57134766|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134767|NCT03175341|Protective Agents|protective agents|mesh-ancestor
57134768|NCT05538026|Mesalamine|mesalamine|mesh-list
57134769|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57134770|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57134771|NCT05538026|Analgesics|analgesics|mesh-ancestor
57134772|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
57134773|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134774|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134775|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57134776|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134777|NCT02401425|Letrozole|letrozole|mesh-list
57134778|NCT02401425|Misoprostol|misoprostol|mesh-list
57134779|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134780|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57134781|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57134782|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134783|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134784|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57134785|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
57134786|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57134787|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134788|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57134789|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
57134790|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57134791|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57134792|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57134793|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
57134794|NCT05537948|Pitavastatin|pitavastatin|mesh-list
57134795|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57134796|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57134797|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57134798|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
56902574|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134799|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134800|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134801|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57134802|NCT02759185|Dronabinol|dronabinol|mesh-list
57134803|NCT02759185|Cannabidiol|cannabidiol|mesh-list
57134804|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
57134805|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
57134806|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134807|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57134808|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57134809|NCT02759185|Analgesics|analgesics|mesh-ancestor
57134810|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
57134811|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134812|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57134813|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57134814|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134815|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134816|NCT02759185|Hormones|hormones|mesh-ancestor
57134817|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57134818|NCT02401269|Aspirin|aspirin|mesh-list
57134819|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57134820|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57134821|NCT02401269|Analgesics|analgesics|mesh-ancestor
57134822|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
57134823|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134824|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134825|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57134826|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57134827|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57134828|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57134829|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816615|NCT01013675|Vaccines|vaccines|mesh-list
57134830|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57134831|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57134832|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134833|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
57134834|NCT04480827|Cholic Acids|cholic acids|mesh-list
57134835|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57134836|NCT02582684|Lamivudine|lamivudine|mesh-list
57134837|NCT02582684|Dolutegravir|dolutegravir|mesh-list
57134838|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57134839|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57134840|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134841|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134842|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
57134843|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134844|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57134845|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57134846|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57134847|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57134848|NCT02411877|Clotrimazole|clotrimazole|mesh-list
57134849|NCT02411877|Miconazole|miconazole|mesh-list
57134850|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57134851|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134852|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
57134853|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57134854|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57134855|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134856|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134857|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57134858|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
57134859|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57134860|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134861|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57134862|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57134863|NCT04903119|Trametinib|trametinib|mesh-list
57134864|NCT04903119|Dabrafenib|dabrafenib|mesh-list
57134865|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134866|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57134867|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134868|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134869|NCT03169569|Hemostatics|hemostatics|mesh-list
57134870|NCT03169569|Coagulants|coagulants|mesh-ancestor
57134871|NCT02585960|Factor VIII|factor viii|mesh-list
57134872|NCT02585960|BAX 855|bax 855|mesh-list
57134873|NCT02585960|Coagulants|coagulants|mesh-ancestor
57134874|NCT03169413|Adenosine|adenosine|mesh-list
57134875|NCT03169413|Analgesics|analgesics|mesh-ancestor
57134876|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
57134877|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134878|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134879|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57134880|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
57134881|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
57134882|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
57134883|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
57134884|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134885|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134886|NCT03169335|Paclitaxel|paclitaxel|mesh-list
57134887|NCT03169335|Bevacizumab|bevacizumab|mesh-list
57134888|NCT03169335|Carboplatin|carboplatin|mesh-list
57134889|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57134890|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134891|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
57134892|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
57134893|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
57134894|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134895|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57134896|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57134897|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57134898|NCT03169335|Growth Substances|growth substances|mesh-ancestor
57134899|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134900|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
57134901|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
57134902|NCT03106623|Mirabegron|mirabegron|mesh-list
56816677|NCT00484679|Hormones|hormones|mesh-ancestor
57134903|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57134904|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57134905|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
57134906|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134907|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134908|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134909|NCT03106623|Urological Agents|urological agents|mesh-ancestor
57134910|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57134911|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57134912|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57134913|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
57134914|NCT02411175|Ethanol|ethanol|mesh-list
57134915|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57134916|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134917|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134918|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134919|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
57134920|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57134921|NCT02411331|Ethanol|ethanol|mesh-list
57134922|NCT02411331|Enoxaparin|enoxaparin|mesh-list
57134923|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
57134924|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57134925|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57134926|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134927|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57134928|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134929|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134930|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134931|NCT00100789|Gemcitabine|gemcitabine|mesh-list
57134932|NCT00100789|Paclitaxel|paclitaxel|mesh-list
57134933|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57134934|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134935|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
57134936|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
57134937|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
57134938|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134939|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57134940|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
57134941|NCT00100789|Antiviral Agents|antiviral agents|mesh-ancestor
57134942|NCT00100789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134943|NCT00100789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134944|NCT00100789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57134945|NCT00100789|Immunologic Factors|immunologic factors|mesh-ancestor
57134946|NCT00100789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134947|NCT02410863|Trametinib|trametinib|mesh-list
57134948|NCT02410863|Dabrafenib|dabrafenib|mesh-list
57134949|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57134950|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57134951|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57134952|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134953|NCT05678192|Hormones|hormones|mesh-list
57134954|NCT05678192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57134955|NCT05678192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134956|NCT00708123|Listerine|listerine|mesh-list
57134957|NCT00708123|Fluorides|fluorides|mesh-list
57134958|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
57134959|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
57134960|NCT00708123|Protective Agents|protective agents|mesh-ancestor
57134961|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134962|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57134963|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57134964|NCT05678114|Inositol|inositol|mesh-list
57134965|NCT05678114|Vitamin B Complex|vitamin b complex|mesh-ancestor
57134966|NCT05678114|Vitamins|vitamins|mesh-ancestor
57134967|NCT05678114|Micronutrients|micronutrients|mesh-ancestor
57134968|NCT05678114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134969|NCT05678036|Analgesics, Opioid|analgesics, opioid|mesh-list
57134970|NCT05678036|Narcotics|narcotics|mesh-ancestor
57134971|NCT05678036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134972|NCT05678036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134973|NCT05678036|Analgesics|analgesics|mesh-ancestor
57134974|NCT05678036|Sensory System Agents|sensory system agents|mesh-ancestor
57134975|NCT05678036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57134976|NCT05537090|Midazolam|midazolam|mesh-list
57134977|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57134978|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57134979|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134980|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816746|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
57134981|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57134982|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57134983|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57134984|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57134985|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
57134986|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
57134987|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
57134988|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
57134989|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57134990|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57134991|NCT02400879|Sufentanil|sufentanil|mesh-list
57134992|NCT02400879|Remifentanil|remifentanil|mesh-list
57134993|NCT02400879|Sevoflurane|sevoflurane|mesh-list
57134994|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57134995|NCT02400879|Narcotics|narcotics|mesh-ancestor
57134996|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57134997|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57134998|NCT02400879|Analgesics|analgesics|mesh-ancestor
57134999|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
57135000|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135001|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57135002|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57135003|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
57135004|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
57135005|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57135006|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57135007|NCT04133480|Cannabidiol|cannabidiol|mesh-list
57135008|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
57135009|NCT02400645|Ketorolac|ketorolac|mesh-list
57135010|NCT02400645|Bupivacaine|bupivacaine|mesh-list
57135011|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
57135012|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
57135013|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135014|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135015|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
57135016|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135017|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57135018|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57135019|NCT02400645|Analgesics|analgesics|mesh-ancestor
56902577|NCT02797522|Tenofovir|tenofovir|mesh-list
57135020|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57135021|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57135022|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57135023|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135024|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135025|NCT02165215|Etrolizumab|etrolizumab|mesh-list
57135026|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57135027|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
57135028|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135029|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
57135030|NCT02400801|Dienogest|dienogest|mesh-list
57135031|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
57135032|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
57135033|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
57135034|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
57135035|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57135036|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135037|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
57135038|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57135039|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135040|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
57135041|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
57135042|NCT02400801|Estrogens|estrogens|mesh-ancestor
57135043|NCT02400801|Hormones|hormones|mesh-ancestor
57135044|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135045|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
57135046|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
57135047|NCT02168569|Artesunate|artesunate|mesh-list
57135048|NCT02168569|Lumefantrine|lumefantrine|mesh-list
57135049|NCT02168569|Artemether|artemether|mesh-list
57135050|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57135051|NCT02168569|Amodiaquine|amodiaquine|mesh-list
57135052|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
57135053|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57135054|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57135055|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135056|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135057|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
57135058|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
57135059|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
57135060|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
57135061|NCT02400255|Crenolanib|crenolanib|mesh-list
57135062|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135063|NCT02171689|Afatinib|afatinib|mesh-list
57135064|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135065|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57135066|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135067|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135068|NCT02171767|Afatinib|afatinib|mesh-list
57135069|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135070|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57135071|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135072|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135073|NCT02400021|Progesterone|progesterone|mesh-list
57135074|NCT02400021|Progestins|progestins|mesh-ancestor
57135075|NCT02400021|Hormones|hormones|mesh-ancestor
57135076|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135077|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135078|NCT05677490|Calcium, Dietary|calcium, dietary|mesh-list
57135079|NCT05677490|Leucovorin|leucovorin|mesh-list
57135080|NCT05677490|Tetrahydrofolates|tetrahydrofolates|mesh-list
57135081|NCT05677490|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
57135082|NCT05677490|Fluorouracil|fluorouracil|mesh-list
57135083|NCT05677490|Oxaliplatin|oxaliplatin|mesh-list
57135084|NCT05677490|Nivolumab|nivolumab|mesh-list
57135085|NCT05677490|Irinotecan|irinotecan|mesh-list
57135086|NCT05677490|Calcium|calcium|mesh-list
57135087|NCT05677490|Levoleucovorin|levoleucovorin|mesh-list
57135088|NCT05677490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57135089|NCT05677490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135090|NCT05677490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57135091|NCT05677490|Antimetabolites|antimetabolites|mesh-ancestor
57135092|NCT05677490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135093|NCT05677490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57135094|NCT05677490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135095|NCT05677490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57135096|NCT05677490|Immunologic Factors|immunologic factors|mesh-ancestor
57135097|NCT05677490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57135098|NCT05677490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57135099|NCT05677490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57135100|NCT05677490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57135101|NCT05677490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135102|NCT05677490|Antidotes|antidotes|mesh-ancestor
57135103|NCT05677490|Protective Agents|protective agents|mesh-ancestor
57135104|NCT05677490|Vitamin B Complex|vitamin b complex|mesh-ancestor
57135105|NCT05677490|Vitamins|vitamins|mesh-ancestor
57135106|NCT05677490|Micronutrients|micronutrients|mesh-ancestor
57135107|NCT02165449|Ketamine|ketamine|mesh-list
57135108|NCT02165449|Analgesics|analgesics|mesh-ancestor
57135109|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
57135110|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135111|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135112|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57135113|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57135114|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
57135115|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
57135116|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135117|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57135118|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57135119|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135120|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135121|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
57135122|NCT02172001|Hematinics|hematinics|mesh-ancestor
57135123|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
57135124|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57135125|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
57135126|NCT05535998|Estrogens|estrogens|mesh-ancestor
57135127|NCT05535998|Hormones|hormones|mesh-ancestor
57135128|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135129|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135130|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57135131|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135132|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135133|NCT05531942|Aspirin|aspirin|mesh-list
57135134|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57135135|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57135136|NCT05531942|Analgesics|analgesics|mesh-ancestor
57135137|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
57135138|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135139|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135140|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57135141|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57135142|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57135143|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57135144|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135145|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57135146|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57135147|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135148|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
57135149|NCT03540199|Antibodies|antibodies|mesh-list
57135150|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57135151|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
57135152|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135153|NCT05677334|Insulin|insulin|mesh-list
57135154|NCT05677334|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57135155|NCT05677334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57135156|NCT05677334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135157|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
57135158|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57135159|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
57135160|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135161|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
57135162|NCT02165917|Protective Agents|protective agents|mesh-ancestor
57135163|NCT02168881|Misoprostol|misoprostol|mesh-list
57135164|NCT02168881|Dinoprostone|dinoprostone|mesh-list
57135165|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57135166|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
57135167|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57135168|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135169|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57135170|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57135171|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
57135172|NCT02168959|Bupivacaine|bupivacaine|mesh-list
57135173|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
57135174|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
57135175|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135176|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135177|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
57135178|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135179|NCT05696678|Morphine|morphine|mesh-list
57135180|NCT05696678|Ropivacaine|ropivacaine|mesh-list
57135181|NCT05696678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57135182|NCT05696678|Narcotics|narcotics|mesh-ancestor
57135183|NCT05696678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135184|NCT05696678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135185|NCT05696678|Analgesics|analgesics|mesh-ancestor
57135186|NCT05696678|Sensory System Agents|sensory system agents|mesh-ancestor
57135187|NCT05696678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135188|NCT05696678|Anesthetics, Local|anesthetics, local|mesh-ancestor
57135189|NCT05696678|Anesthetics|anesthetics|mesh-ancestor
57135190|NCT05450822|Lamotrigine|lamotrigine|mesh-list
57135191|NCT05450822|Levetiracetam|levetiracetam|mesh-list
57135192|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
57135193|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
57135194|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57135195|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57135196|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135197|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57135198|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135199|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57135200|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57135201|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135202|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57135203|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57135204|NCT02172157|Olodaterol|olodaterol|mesh-list
57135205|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57135206|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
57135207|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135208|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135209|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56816979|NCT01054508|Niacin|niacin|mesh-list
57135210|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
57135211|NCT02172235|Pioglitazone|pioglitazone|mesh-list
57135212|NCT02172235|Empagliflozin|empagliflozin|mesh-list
57135213|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57135214|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135215|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57135216|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135217|NCT02166229|Valproic Acid|valproic acid|mesh-list
57135218|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
57135219|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135220|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135221|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
57135222|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135223|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135224|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
57135225|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57135226|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135227|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57135228|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
57135229|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57135230|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135231|NCT05297864|Niraparib|niraparib|mesh-list
57135232|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57135233|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135234|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135235|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135236|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
57135237|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57135238|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135239|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135240|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57135241|NCT02757625|Analgesics|analgesics|mesh-ancestor
57135242|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
57135243|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135244|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57135245|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57135246|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57135247|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
57135248|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135249|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135250|NCT05691920|Fentanyl|fentanyl|mesh-list
57135251|NCT05691920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57135252|NCT05691920|Narcotics|narcotics|mesh-ancestor
57135253|NCT05691920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135254|NCT05691920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135255|NCT05691920|Analgesics|analgesics|mesh-ancestor
57135256|NCT05691920|Sensory System Agents|sensory system agents|mesh-ancestor
57135257|NCT05691920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135258|NCT05691920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57135259|NCT05691920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57135260|NCT05691920|Anesthetics, General|anesthetics, general|mesh-ancestor
57135261|NCT05691920|Anesthetics|anesthetics|mesh-ancestor
57135262|NCT05696366|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
57135263|NCT05696366|Volagidemab|volagidemab|mesh-list
57135264|NCT05696366|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57135265|NCT05696366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135266|NCT05696366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57135267|NCT05696366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135268|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57135269|NCT04394624|Ramucirumab|ramucirumab|mesh-list
57135270|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135271|NCT05613842|Copper|copper|mesh-list
57135272|NCT05613842|Bombesin|bombesin|mesh-list
57135273|NCT05613842|Trace Elements|trace elements|mesh-ancestor
57135274|NCT05613842|Micronutrients|micronutrients|mesh-ancestor
57135275|NCT05613842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135276|NCT05613842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135277|NCT05613842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135278|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
57135279|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57135280|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
57135281|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135282|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135283|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57135284|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
57135285|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
57135286|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57135287|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
57135288|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135289|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135290|NCT00109681|Iloprost|iloprost|mesh-list
57135291|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57135292|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
57135293|NCT02172469|Bromides|bromides|mesh-list
57135294|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
57135295|NCT02172469|Ipratropium|ipratropium|mesh-list
57135296|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57135297|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
57135298|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135299|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135300|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57135301|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
57135302|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
57135303|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57135304|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
57135305|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135306|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135307|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
57135308|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
57135309|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57135310|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
57135311|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135312|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135313|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57135314|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
57135315|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
57135316|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57135317|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
57135318|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135319|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135320|NCT02174887|Gemcitabine|gemcitabine|mesh-list
57135321|NCT02174887|Paclitaxel|paclitaxel|mesh-list
57135322|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57135323|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135324|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
57135325|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
57135326|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
57135327|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135328|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57135329|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
57135330|NCT02174887|Antiviral Agents|antiviral agents|mesh-ancestor
57135331|NCT02174887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135332|NCT02174887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135333|NCT02174887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57135334|NCT02174887|Immunologic Factors|immunologic factors|mesh-ancestor
57135335|NCT02174887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135336|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
57135337|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
57135338|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
57135339|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135340|NCT05142319|Vaccines|vaccines|mesh-list
57135341|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
57135342|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135343|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
57135344|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135345|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135346|NCT05576792|Ranibizumab|ranibizumab|mesh-list
57135347|NCT05576792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57135348|NCT05576792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57135349|NCT05576792|Growth Substances|growth substances|mesh-ancestor
57135350|NCT05576792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135351|NCT05576792|Growth Inhibitors|growth inhibitors|mesh-ancestor
57135352|NCT05576792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135353|NCT04298528|Dronabinol|dronabinol|mesh-list
57135354|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
57135355|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135356|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57135357|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57135358|NCT04298528|Analgesics|analgesics|mesh-ancestor
57135359|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
57135360|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135361|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57135362|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57135363|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135364|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135365|NCT04298528|Hormones|hormones|mesh-ancestor
57135366|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135367|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
57135368|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135369|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57135370|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
57135371|NCT02581202|Ritonavir|ritonavir|mesh-list
57135372|NCT02581202|Lopinavir|lopinavir|mesh-list
57135373|NCT02581202|Lamivudine|lamivudine|mesh-list
57135374|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57135375|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57135376|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
57135377|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135378|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135379|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57135380|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57135381|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
57135382|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135383|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57135384|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57135385|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57135386|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57135387|NCT02758171|Empagliflozin|empagliflozin|mesh-list
57135388|NCT02758171|Linagliptin|linagliptin|mesh-list
57135389|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57135390|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135391|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57135392|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135393|NCT02758171|Incretins|incretins|mesh-ancestor
57135394|NCT02758171|Hormones|hormones|mesh-ancestor
57135395|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135396|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57135397|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
57135398|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135399|NCT00101101|Aldesleukin|aldesleukin|mesh-list
57135400|NCT00101101|Dexamethasone|dexamethasone|mesh-list
57135401|NCT00101101|Prednisone|prednisone|mesh-list
57135402|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
57135403|NCT00101101|Doxorubicin|doxorubicin|mesh-list
57135404|NCT00101101|Vincristine|vincristine|mesh-list
57135405|NCT00101101|Interleukin-2|interleukin-2|mesh-list
57135406|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57135407|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
57135408|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135409|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57135410|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57135411|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
57135412|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135413|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135414|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57135415|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57135416|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
57135417|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
57135418|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135419|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57135420|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
57135421|NCT00101101|Hormones|hormones|mesh-ancestor
57135422|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135423|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57135424|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57135425|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57135426|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57135427|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135428|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57135429|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
57135430|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
57135431|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
57135432|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57135433|NCT00101101|Analgesics|analgesics|mesh-ancestor
57135434|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
57135435|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57135436|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57135437|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
57135438|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135439|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
57135440|NCT02172781|Ipratropium|ipratropium|mesh-list
57135441|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57135442|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
57135443|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135444|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135445|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57135446|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
57135447|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
57135448|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57135449|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
57135450|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135451|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135452|NCT02173093|Aldesleukin|aldesleukin|mesh-list
57135453|NCT02173093|Interleukin-2|interleukin-2|mesh-list
57135454|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135455|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57135456|NCT02173093|Analgesics|analgesics|mesh-ancestor
57135457|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
57135458|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424603|NCT04611958|Bupivacaine|bupivacaine|mesh-list
57135459|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135460|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57135461|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57135462|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
57135463|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135464|NCT01465100|Liver Extracts|liver extracts|mesh-list
57135465|NCT01465100|Hematinics|hematinics|mesh-ancestor
57135466|NCT05142085|Mineral Oil|mineral oil|mesh-list
57135467|NCT05142085|Emollients|emollients|mesh-ancestor
57135468|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
57135469|NCT00103831|Taxane|taxane|mesh-list
57135470|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135471|NCT03538483|Bupivacaine|bupivacaine|mesh-list
57135472|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
57135473|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
57135474|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135475|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135476|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
57135477|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135478|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
57135479|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57135480|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135481|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57135482|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135483|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57135484|NCT02175355|Telmisartan|telmisartan|mesh-list
57135485|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57135486|NCT02175355|Diuretics|diuretics|mesh-ancestor
57135487|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
57135488|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135489|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57135490|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57135491|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135492|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57135493|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57135494|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
57135495|NCT04231214|Olodaterol|olodaterol|mesh-list
57135496|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57135497|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
57135498|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135499|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135500|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57135501|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
57135502|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
57135503|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57135504|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
57135505|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135506|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135507|NCT03538327|Silybin|silybin|mesh-list
57135508|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57135509|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135510|NCT03538327|Protective Agents|protective agents|mesh-ancestor
57135511|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135512|NCT02170597|Dabigatran|dabigatran|mesh-list
57135513|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
57135514|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57135515|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
57135516|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135517|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135518|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
57135519|NCT02170675|Ketoconazole|ketoconazole|mesh-list
57135520|NCT02170675|Dabigatran|dabigatran|mesh-list
57135521|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
57135522|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57135523|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
57135524|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135525|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135526|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
57135527|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
57135528|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135529|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57135530|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57135531|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57135532|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
57135533|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135534|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135535|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57135536|NCT04154150|Ketamine|ketamine|mesh-list
57135537|NCT04154150|Analgesics|analgesics|mesh-ancestor
57135538|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
57135539|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135540|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135541|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57135542|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57135543|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
57135544|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
57135545|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135546|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57135547|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57135548|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135549|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135550|NCT00521846|Cimetidine|cimetidine|mesh-list
57135551|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57135552|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57135553|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57135554|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
57135555|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
57135556|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135557|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135558|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135559|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57135560|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57135561|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135562|NCT02170831|Dabigatran|dabigatran|mesh-list
57135563|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
57135564|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57135565|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
57135566|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135567|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135568|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
57135569|NCT02175589|Colchicine|colchicine|mesh-list
57135570|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
57135571|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57135572|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
57135573|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
57135574|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
57135575|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135576|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135577|NCT05438186|Liraglutide|liraglutide|mesh-list
57135578|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57135579|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135580|NCT05438186|Incretins|incretins|mesh-ancestor
57135581|NCT05438186|Hormones|hormones|mesh-ancestor
57135582|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817347|NCT00327444|Growth Substances|growth substances|mesh-ancestor
57135583|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
57135584|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135585|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57135587|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135588|NCT02173639|Metformin|metformin|mesh-list
57135589|NCT02173639|Linagliptin|linagliptin|mesh-list
57135590|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57135591|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135592|NCT02173639|Incretins|incretins|mesh-ancestor
57135593|NCT02173639|Hormones|hormones|mesh-ancestor
57135594|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135595|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57135596|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
57135597|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135598|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135599|NCT02173717|Rifampin|rifampin|mesh-list
57135600|NCT02173717|Dabigatran|dabigatran|mesh-list
57135601|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
57135602|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57135603|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
57135604|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424741|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135605|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135606|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
57135607|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57135608|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
57135609|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57135610|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135611|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
57135612|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57135613|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
57135614|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57135615|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
57135616|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
57135617|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
57135618|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57135619|NCT04516447|Gemcitabine|gemcitabine|mesh-list
57135620|NCT04516447|Paclitaxel|paclitaxel|mesh-list
57135621|NCT04516447|Carboplatin|carboplatin|mesh-list
57135622|NCT04516447|Doxorubicin|doxorubicin|mesh-list
57135623|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57135624|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57135625|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135626|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
57135627|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
57135628|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
57135629|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135630|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57135631|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
57135632|NCT04516447|Antiviral Agents|antiviral agents|mesh-ancestor
57135633|NCT04516447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135634|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135635|NCT04516447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57135636|NCT04516447|Immunologic Factors|immunologic factors|mesh-ancestor
57135637|NCT04516447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135638|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57135639|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57135640|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57135641|NCT04067648|Sufentanil|sufentanil|mesh-list
57135642|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57135643|NCT04067648|Narcotics|narcotics|mesh-ancestor
57135644|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135645|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135646|NCT04067648|Analgesics|analgesics|mesh-ancestor
57135647|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
57135648|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135649|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57135650|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57135651|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
57135652|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
57135653|NCT02173795|Fenoterol|fenoterol|mesh-list
57135654|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57135655|NCT02173795|Ipratropium|ipratropium|mesh-list
57135656|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57135657|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
57135658|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135659|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135661|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
57135662|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
57135663|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
57135664|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57135665|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57135666|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57135667|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57135668|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
57135669|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135670|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135671|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57135672|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
57135673|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57135674|NCT02175901|Amoxicillin|amoxicillin|mesh-list
57135675|NCT02175901|Metronidazole|metronidazole|mesh-list
57135676|NCT02175901|Clarithromycin|clarithromycin|mesh-list
57135677|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
57135678|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
57135679|NCT02175901|Lansoprazole|lansoprazole|mesh-list
57135680|NCT02175901|Bismuth|bismuth|mesh-list
57135681|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
57135682|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135683|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135684|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
57135685|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57135686|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57135687|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57135688|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135689|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57135690|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57135691|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57135692|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57135693|NCT02175901|Antacids|antacids|mesh-ancestor
57135694|NCT02175901|Diuretics|diuretics|mesh-ancestor
57135695|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
57135696|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135697|NCT02175901|Expectorants|expectorants|mesh-ancestor
57135698|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
57135699|NCT05534750|Linezolid|linezolid|mesh-list
57135700|NCT05534750|Tedizolid|tedizolid|mesh-list
57135701|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
57135702|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57135703|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135704|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57135705|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135706|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135707|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
57135708|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57135709|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
57135710|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135711|NCT02173873|Aflibercept|aflibercept|mesh-list
57135712|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57135713|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57135714|NCT02173873|Growth Substances|growth substances|mesh-ancestor
57135715|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135716|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
57135717|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135718|NCT02176057|Azithromycin|azithromycin|mesh-list
57135719|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57135720|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135721|NCT02173951|Deferiprone|deferiprone|mesh-list
57135722|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57135723|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
57135724|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
57135725|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135726|NCT02176135|Auranofin|auranofin|mesh-list
57135727|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57135728|NCT02176213|Dexamethasone|dexamethasone|mesh-list
57135729|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
57135730|NCT02176213|Pomalidomide|pomalidomide|mesh-list
57135731|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57135732|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
57135733|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135734|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57135735|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57135736|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
57135737|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135738|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135739|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57135740|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57135741|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
57135742|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
57135743|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135744|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57135745|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
57135746|NCT02176213|Hormones|hormones|mesh-ancestor
57135747|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135748|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57135749|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57135750|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57135751|NCT02176213|Growth Substances|growth substances|mesh-ancestor
57135752|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
57135753|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
57135754|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
57135755|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
57135756|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57135757|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135758|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135759|NCT04305002|Exenatide|exenatide|mesh-list
57135760|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57135761|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135762|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57135763|NCT04305002|Incretins|incretins|mesh-ancestor
57135764|NCT04305002|Hormones|hormones|mesh-ancestor
57135765|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57135766|NCT02253797|Ritonavir|ritonavir|mesh-list
57135767|NCT02253797|Tipranavir|tipranavir|mesh-list
57135768|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57135769|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57135770|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
57135771|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135772|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135773|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57135774|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57135775|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
57135776|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135777|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57135778|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57135779|NCT04620746|Penicillins|penicillins|mesh-list
57135780|NCT04620746|Penicillin G|penicillin g|mesh-list
57135781|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57135782|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135783|NCT02253875|Ritonavir|ritonavir|mesh-list
57135784|NCT02253875|Tipranavir|tipranavir|mesh-list
57135785|NCT02253875|Omeprazole|omeprazole|mesh-list
57135786|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57135787|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57135788|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
57135789|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135790|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135791|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57135792|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57135793|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
57135794|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135795|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57135796|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57135797|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57135798|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57135799|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57135800|NCT05534672|Sirolimus|sirolimus|mesh-list
57135801|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57135802|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135803|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57135804|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135805|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
57135806|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57135807|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
57135808|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135809|NCT04414943|Ketamine|ketamine|mesh-list
57135810|NCT04414943|Esketamine|esketamine|mesh-list
57135811|NCT04414943|Analgesics|analgesics|mesh-ancestor
57135812|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
57135813|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135814|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135815|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57135816|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57135817|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
57135818|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
57135819|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135820|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57135821|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57135822|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135823|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135824|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
57135825|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57135826|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
57135827|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897222|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
57135828|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135830|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
57135831|NCT04597268|Ketamine|ketamine|mesh-list
57135832|NCT04597268|Propofol|propofol|mesh-list
57135833|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57135834|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135835|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135836|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57135837|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
57135838|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
57135839|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57135840|NCT04597268|Analgesics|analgesics|mesh-ancestor
57135841|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
57135842|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135843|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57135844|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57135845|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57135846|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
57135847|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135848|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135849|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57135850|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57135851|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57135852|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57135853|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57135854|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57135855|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57135856|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
57135857|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
57135858|NCT04976543|Nadroparin|nadroparin|mesh-list
57135859|NCT04976543|Warfarin|warfarin|mesh-list
57135860|NCT04976543|Calcium|calcium|mesh-list
57135861|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57135862|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135863|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
57135864|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57135865|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57135866|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135867|NCT04310930|Azithromycin|azithromycin|mesh-list
57135868|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
57135869|NCT04310930|Clarithromycin|clarithromycin|mesh-list
57135870|NCT04310930|Doxycycline|doxycycline|mesh-list
57135871|NCT04310930|Linezolid|linezolid|mesh-list
57135872|NCT04310930|Imipenem|imipenem|mesh-list
57135873|NCT04310930|Amikacin|amikacin|mesh-list
57135874|NCT04310930|Ethambutol|ethambutol|mesh-list
57135875|NCT04310930|Rifabutin|rifabutin|mesh-list
57135876|NCT04310930|Tigecycline|tigecycline|mesh-list
57135877|NCT04310930|Bedaquiline|bedaquiline|mesh-list
57135878|NCT04310930|Clofazimine|clofazimine|mesh-list
57135879|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
57135880|NCT04310930|Cefoxitin|cefoxitin|mesh-list
57135881|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57135882|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135883|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57135884|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57135885|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135886|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135887|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817652|NCT01063920|Naproxen|naproxen|mesh-list
57135888|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57135889|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57135890|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57135891|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
57135892|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57135893|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57135894|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
57135895|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57135896|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57135897|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
57135898|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57135899|NCT04310930|Renal Agents|renal agents|mesh-ancestor
57135900|NCT05533892|Lenvatinib|lenvatinib|mesh-list
57135901|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
57135902|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135903|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57135904|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902593|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57135905|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135906|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57135907|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
57135908|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135909|NCT02924441|Lidocaine|lidocaine|mesh-list
57135910|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
57135911|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
57135912|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135913|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135914|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
57135915|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135916|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57135917|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57135918|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57135919|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57135920|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135921|NCT04526288|Cytarabine|cytarabine|mesh-list
57135922|NCT04526288|Daunorubicin|daunorubicin|mesh-list
57135923|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57135924|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
57135925|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135926|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135927|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
57135928|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135929|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57135930|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
57135931|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135932|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57135933|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57135934|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57135935|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135936|NCT05631626|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
57135937|NCT05631626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57135938|NCT05631626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135939|NCT05631626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57135940|NCT05631626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57135941|NCT05631626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57135942|NCT05631626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135943|NCT05631626|Dopamine Agents|dopamine agents|mesh-ancestor
57135944|NCT05631626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57135945|NCT00109967|Sirolimus|sirolimus|mesh-list
57135946|NCT00109967|Rituximab|rituximab|mesh-list
57135947|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57135948|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57135949|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
57135950|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135951|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57135952|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57135953|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57135954|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57135955|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
57135956|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57135957|NCT02579096|Allopurinol|allopurinol|mesh-list
57135958|NCT02579096|Febuxostat|febuxostat|mesh-list
57135959|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
57135960|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135961|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135962|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
57135963|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57135964|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57135965|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
57135966|NCT02579096|Protective Agents|protective agents|mesh-ancestor
57135967|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135968|NCT02578862|Propofol|propofol|mesh-list
57135969|NCT02578862|Sevoflurane|sevoflurane|mesh-list
57135970|NCT02578862|Isoflurane|isoflurane|mesh-list
57135971|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57135972|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57135973|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135974|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57135975|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
57135976|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
57135977|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57135978|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57135979|NCT02578706|Aspirin|aspirin|mesh-list
57135980|NCT02578706|Clopidogrel|clopidogrel|mesh-list
57135981|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57135982|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57135983|NCT02578706|Analgesics|analgesics|mesh-ancestor
57135984|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
57135985|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57135986|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57135987|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57135988|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57135989|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57135990|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57135991|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57135992|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57135993|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57135994|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57135995|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
57135996|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57135997|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57135998|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57135999|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
57136000|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136001|NCT04503668|Dexamethasone|dexamethasone|mesh-list
57136002|NCT04503668|Ondansetron|ondansetron|mesh-list
57136003|NCT04503668|Olanzapine|olanzapine|mesh-list
57136004|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
57136005|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
57136006|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
57136007|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136008|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
57136009|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
57136010|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136011|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136012|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57136013|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
57136014|NCT04503668|Hormones|hormones|mesh-ancestor
57136015|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136016|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57136017|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136018|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
57136019|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
57136020|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57136021|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
57136022|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136023|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136024|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57136025|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57136026|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57136027|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57136028|NCT04503668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57136029|NCT04503668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57136030|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57136031|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57136032|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57136033|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
57136034|NCT03455504|Venetoclax|venetoclax|mesh-list
57136035|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817795|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57136036|NCT00108953|Doxorubicin|doxorubicin|mesh-list
57136037|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57136038|NCT00108953|Sorafenib|sorafenib|mesh-list
57136039|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57136040|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136041|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57136042|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57136043|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136044|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136045|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57136046|NCT04464980|Naltrexone|naltrexone|mesh-list
57136047|NCT04464980|Buprenorphine|buprenorphine|mesh-list
57136048|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57136049|NCT04464980|Narcotics|narcotics|mesh-ancestor
57136050|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57136051|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136052|NCT04464980|Analgesics|analgesics|mesh-ancestor
57136053|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
57136054|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136055|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
57136056|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
57136057|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57136058|NCT04457258|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
57136059|NCT04457258|FAPI-46|fapi-46|mesh-list
57136060|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
57136061|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136062|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57136063|NCT03365882|Trastuzumab|trastuzumab|mesh-list
57136064|NCT03365882|Cetuximab|cetuximab|mesh-list
57136065|NCT03365882|Pertuzumab|pertuzumab|mesh-list
57136066|NCT03365882|Irinotecan|irinotecan|mesh-list
57136067|NCT03365882|Camptothecin|camptothecin|mesh-list
57136068|NCT03365882|Antibodies|antibodies|mesh-list
57136069|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
57136070|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57136071|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
57136072|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136073|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136074|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57136075|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57136076|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136077|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136078|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57136079|NCT03054896|Venetoclax|venetoclax|mesh-list
57136080|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136081|NCT05593328|Bevacizumab|bevacizumab|mesh-list
57136082|NCT05593328|Onvansertib|onvansertib|mesh-list
57136083|NCT05593328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136084|NCT05593328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136085|NCT05593328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57136086|NCT05593328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57136087|NCT05593328|Growth Substances|growth substances|mesh-ancestor
57136088|NCT05593328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136089|NCT05593328|Growth Inhibitors|growth inhibitors|mesh-ancestor
57136090|NCT05593328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57136091|NCT05593328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136092|NCT05593328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136093|NCT02578316|Lenvatinib|lenvatinib|mesh-list
57136094|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136095|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57136096|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136097|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136098|NCT05532878|Apixaban|apixaban|mesh-list
57136099|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
57136100|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
57136101|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57136102|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
57136103|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136104|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136105|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
57136106|NCT05498792|Nivolumab|nivolumab|mesh-list
57136107|NCT05498792|Ipilimumab|ipilimumab|mesh-list
57136108|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136109|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136110|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57136111|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136112|NCT03025880|Gemcitabine|gemcitabine|mesh-list
57136113|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
57136114|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57136115|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
57136116|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136117|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136118|NCT03025880|Antiviral Agents|antiviral agents|mesh-ancestor
57136119|NCT03025880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57136120|NCT03025880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136121|NCT03025880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57136122|NCT03025880|Immunologic Factors|immunologic factors|mesh-ancestor
57136123|NCT03025880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136124|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136125|NCT02576678|Apremilast|apremilast|mesh-list
56902596|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136126|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57136127|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57136128|NCT02576678|Analgesics|analgesics|mesh-ancestor
57136129|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
57136130|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136131|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136132|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136133|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57136134|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
57136135|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57136136|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136137|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136138|NCT05532332|Fluoxetine|fluoxetine|mesh-list
57136139|NCT05532332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57136140|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57136141|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57136142|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136143|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136144|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
57136145|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136146|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57136147|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
57136148|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57136149|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57136150|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57136151|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136152|NCT05215418|Topiramate|topiramate|mesh-list
57136153|NCT05215418|Phentermine|phentermine|mesh-list
57136154|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
57136155|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57136156|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136157|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57136158|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
57136159|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
57136160|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
57136161|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
57136162|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136163|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
57136164|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136165|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136166|NCT05532254|Aripiprazole|aripiprazole|mesh-list
57136167|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
57136168|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57136169|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57136170|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57136171|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57136172|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136173|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
57136174|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
57136175|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136176|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136177|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57136178|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57136179|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
57136180|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57136181|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57136182|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57136183|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57136184|NCT05471648|Pertuzumab|pertuzumab|mesh-list
57136185|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136186|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136187|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
57136188|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136189|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136190|NCT00108745|Paclitaxel|paclitaxel|mesh-list
57136191|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57136192|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
57136193|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57136194|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136195|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
57136196|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
57136197|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
57136198|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136199|NCT05532020|Diazoxide|diazoxide|mesh-list
57136200|NCT05532020|Choline|choline|mesh-list
57136201|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
57136202|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57136203|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
57136204|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136205|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57136206|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57136207|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
57136208|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57136209|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
57136210|NCT02098343|Carboplatin|carboplatin|mesh-list
57136211|NCT02098343|Doxorubicin|doxorubicin|mesh-list
57136212|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57136213|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136214|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57136215|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57136216|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57136217|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136218|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136219|NCT02581982|Paclitaxel|paclitaxel|mesh-list
57136220|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
57136221|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57136222|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57136223|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136224|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
57136225|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
57136226|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
57136227|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136228|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136229|NCT02176369|Vinorelbine|vinorelbine|mesh-list
57136230|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57136231|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136232|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
57136233|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
57136234|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
57136235|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136236|NCT02716805|Melphalan|melphalan|mesh-list
57136237|NCT02716805|Durvalumab|durvalumab|mesh-list
57136238|NCT02716805|Tremelimumab|tremelimumab|mesh-list
57136239|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57136240|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
57136241|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136242|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136243|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57136244|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57136245|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
57136246|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136247|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136248|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
57136249|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
57136250|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
57136251|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136252|NCT04152473|Proglumide|proglumide|mesh-list
57136253|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57136254|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57136255|NCT04099355|Dronabinol|dronabinol|mesh-list
57136256|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
57136257|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136258|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57136259|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56818020|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
57136260|NCT04099355|Analgesics|analgesics|mesh-ancestor
57136261|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
57136262|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136263|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
57136264|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
57136265|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136266|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136267|NCT04099355|Hormones|hormones|mesh-ancestor
57136268|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136269|NCT02174575|Sevoflurane|sevoflurane|mesh-list
57136270|NCT02174575|Desflurane|desflurane|mesh-list
57136271|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57136272|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57136273|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
57136274|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
57136275|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57136276|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136277|NCT03751397|Cystatins|cystatins|mesh-list
57136278|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
57136279|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
57136280|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136281|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136282|NCT02176681|Vildagliptin|vildagliptin|mesh-list
57136283|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57136284|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136285|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57136286|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
57136287|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136288|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136289|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
57136290|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57136291|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57136292|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57136293|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136294|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
57136295|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136296|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136297|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57136298|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136299|NCT02254577|Progesterone|progesterone|mesh-list
57136300|NCT02254577|Progestins|progestins|mesh-ancestor
57136301|NCT02254577|Hormones|hormones|mesh-ancestor
57136302|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136303|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136304|NCT02176759|Citric Acid|citric acid|mesh-list
57136305|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
57136306|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
57136307|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
57136308|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
57136309|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
57136310|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136311|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
57136312|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136313|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136314|NCT03538171|Exemestane|exemestane|mesh-list
57136315|NCT03538171|Entinostat|entinostat|mesh-list
57136316|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136317|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57136318|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57136319|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136320|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136321|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57136322|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
57136323|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136324|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136325|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57136326|NCT05312216|Durvalumab|durvalumab|mesh-list
57136327|NCT05312216|Lenvatinib|lenvatinib|mesh-list
57136328|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136329|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136330|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57136331|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136332|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136333|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
57136334|NCT02256319|Propofol|propofol|mesh-list
57136335|NCT02256319|Imidazole|imidazole|mesh-list
56818094|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57136336|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57136337|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57136338|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136339|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57136340|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
57136341|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
57136342|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57136343|NCT02256319|Analgesics|analgesics|mesh-ancestor
57136344|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
57136345|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136346|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57136347|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57136348|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57136349|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
57136350|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136351|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136352|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136353|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
57136354|NCT04510285|Trastuzumab|trastuzumab|mesh-list
57136355|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136356|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136357|NCT05450432|Ketamine|ketamine|mesh-list
57136358|NCT05450432|Esketamine|esketamine|mesh-list
57136359|NCT05450432|Analgesics|analgesics|mesh-ancestor
57136360|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
57136361|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136362|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136363|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
57136364|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57136365|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
57136366|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
57136367|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57136368|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
57136369|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
57136370|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136371|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136372|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
57136373|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57136374|NCT02179255|Hormones|hormones|mesh-list
57136375|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
57136376|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136377|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136378|NCT02182063|Nintedanib|nintedanib|mesh-list
57136379|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136380|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57136381|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136382|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136383|NCT02182141|Nintedanib|nintedanib|mesh-list
57136384|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136385|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57136386|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136387|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136388|NCT02182219|Nintedanib|nintedanib|mesh-list
57136389|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136390|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57136391|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136392|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136393|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
57136394|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
57136395|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136396|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57136397|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136398|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
57136399|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57136400|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57136401|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
57136402|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57136403|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
57136404|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57136405|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136406|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136407|NCT02179567|Bevacizumab|bevacizumab|mesh-list
57136408|NCT02179567|Docetaxel|docetaxel|mesh-list
57136409|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136410|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136411|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57136412|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57136413|NCT02179567|Growth Substances|growth substances|mesh-ancestor
56425559|NCT00565981|Fludarabine|fludarabine|mesh-list
57136414|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136415|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
57136416|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
57136417|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
57136418|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
57136419|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136420|NCT02182453|Empagliflozin|empagliflozin|mesh-list
57136421|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57136422|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136423|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57136424|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136425|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
57136426|NCT02182531|Ephedrine|ephedrine|mesh-list
57136427|NCT02182531|Epinastine|epinastine|mesh-list
57136428|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57136429|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
57136430|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136431|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136432|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57136433|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
57136434|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
57136435|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57136436|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57136437|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
57136438|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
57136439|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136440|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136441|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57136442|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
57136443|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
57136444|NCT01990352|Doxorubicin|doxorubicin|mesh-list
57136445|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57136446|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57136447|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136448|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57136449|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57136450|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136451|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136452|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57136453|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
57136454|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57136455|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
57136456|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136457|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136458|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57136459|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
57136460|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
57136461|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57136462|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
57136463|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136464|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136465|NCT02182765|Nevirapine|nevirapine|mesh-list
57136466|NCT02182765|Abacavir|abacavir|mesh-list
57136467|NCT02182765|Amprenavir|amprenavir|mesh-list
57136468|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57136469|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57136470|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136471|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136472|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
57136473|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57136474|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57136475|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57136476|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57136477|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57136478|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57136479|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
57136480|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57136481|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57136482|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57136483|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
57136484|NCT02179645|Celecoxib|celecoxib|mesh-list
57136485|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57136486|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57136487|NCT02179645|Analgesics|analgesics|mesh-ancestor
57136488|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
57136489|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136490|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136491|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136492|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57136493|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57136494|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57136495|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136496|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136497|NCT03537157|Rifaximin|rifaximin|mesh-list
57136498|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57136499|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57136500|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57136501|NCT01606202|Nabiximols|nabiximols|mesh-list
57136502|NCT01606202|Analgesics|analgesics|mesh-ancestor
57136503|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
57136504|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136505|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136506|NCT05529290|Acetaminophen|acetaminophen|mesh-list
57136507|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
57136508|NCT05529290|Ketoprofen|ketoprofen|mesh-list
57136509|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57136510|NCT05529290|Analgesics|analgesics|mesh-ancestor
57136511|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
57136512|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136513|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136514|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
57136515|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57136516|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136517|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57136518|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57136519|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136520|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136521|NCT02756611|Venetoclax|venetoclax|mesh-list
57136522|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136523|NCT05528588|Furosemide|furosemide|mesh-list
57136524|NCT05528588|Diuretics|diuretics|mesh-ancestor
57136525|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
57136526|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136527|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
57136528|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57136529|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136530|NCT03536611|Warfarin|warfarin|mesh-list
57136531|NCT03536611|Dabigatran|dabigatran|mesh-list
57136532|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
57136533|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
57136534|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57136535|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
57136536|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136537|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136538|NCT02630459|Erenumab|erenumab|mesh-list
57136539|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57136540|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57136541|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136542|NCT02630459|Analgesics|analgesics|mesh-ancestor
57136543|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
57136544|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136545|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136546|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
57136547|NCT02183077|Meloxicam|meloxicam|mesh-list
57136548|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57136549|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57136550|NCT02183077|Analgesics|analgesics|mesh-ancestor
57136551|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
57136552|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136553|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136554|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136555|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57136556|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57136557|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57136558|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902603|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136559|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136561|NCT02183155|Meloxicam|meloxicam|mesh-list
57136562|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57136563|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57136564|NCT02183155|Analgesics|analgesics|mesh-ancestor
57136565|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
57136566|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136567|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136568|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136569|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57136570|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
57136571|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
57136572|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57136573|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57136574|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136575|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136576|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57136577|NCT02177461|Telmisartan|telmisartan|mesh-list
57136578|NCT02177461|Clonidine|clonidine|mesh-list
57136579|NCT02177461|Enalapril|enalapril|mesh-list
57136580|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57136581|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57136582|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57136583|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136584|NCT02177461|Analgesics|analgesics|mesh-ancestor
57136585|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
57136586|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136587|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136588|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
57136589|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
57136590|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57136591|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57136592|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57136593|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
57136594|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136595|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
57136596|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
57136597|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136598|NCT03545243|Pantoprazole|pantoprazole|mesh-list
57136599|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57136600|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57136601|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57136602|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136603|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136604|NCT02183311|Linagliptin|linagliptin|mesh-list
57136605|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57136606|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136607|NCT02183311|Incretins|incretins|mesh-ancestor
57136608|NCT02183311|Hormones|hormones|mesh-ancestor
57136609|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136610|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57136611|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
57136612|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136613|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136614|NCT05518526|Annamycin|annamycin|mesh-list
57136615|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57136616|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136617|NCT01464593|Doxorubicin|doxorubicin|mesh-list
57136618|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
57136619|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57136620|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136621|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57136622|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57136623|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136624|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136625|NCT02183389|Linagliptin|linagliptin|mesh-list
57136626|NCT02183389|Warfarin|warfarin|mesh-list
57136627|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
57136628|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57136629|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136630|NCT02183389|Incretins|incretins|mesh-ancestor
57136631|NCT02183389|Hormones|hormones|mesh-ancestor
57136632|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136633|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57136635|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136636|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136637|NCT02177539|Phenylephrine|phenylephrine|mesh-list
57136638|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
57136639|NCT02177539|Tropicamide|tropicamide|mesh-list
57136640|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
57136641|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
57136642|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
57136643|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
57136644|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136645|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136646|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
57136647|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
57136648|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
57136649|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
57136650|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
57136651|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57136652|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57136653|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
57136654|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136655|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136656|NCT02177539|Protective Agents|protective agents|mesh-ancestor
57136657|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57136658|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57136659|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
57136660|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
57136661|NCT05528198|Montelukast|montelukast|mesh-list
57136662|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57136663|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
57136664|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
57136665|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
57136666|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136667|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136668|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57136669|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57136670|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136671|NCT05527808|Carboplatin|carboplatin|mesh-list
57136672|NCT05527808|Pemetrexed|pemetrexed|mesh-list
57136673|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136674|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136675|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136676|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57136677|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57136678|NCT04141904|Tofacitinib|tofacitinib|mesh-list
57136679|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57136680|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136681|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136682|NCT05523986|Vitamin D|vitamin d|mesh-list
57136683|NCT05523986|Vitamins|vitamins|mesh-ancestor
57136684|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
57136685|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136686|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57136687|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57136688|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
57136689|NCT01361711|Ofatumumab|ofatumumab|mesh-list
57136690|NCT01361711|Antibodies|antibodies|mesh-list
57136691|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
57136692|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57136693|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
57136694|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136695|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136696|NCT05527418|Dasatinib|dasatinib|mesh-list
57136697|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136698|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57136699|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136700|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136701|NCT04614974|Famotidine|famotidine|mesh-list
57136702|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57136703|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57136704|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
57136705|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
57136706|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
57136707|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136708|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136709|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136710|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57136711|NCT05527340|Dexamethasone|dexamethasone|mesh-list
57136712|NCT05527340|Daratumumab|daratumumab|mesh-list
57136713|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136714|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
57136715|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
57136716|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136717|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136718|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57136719|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
57136720|NCT05527340|Hormones|hormones|mesh-ancestor
57136721|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136722|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57136723|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136724|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
57136725|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
57136726|NCT05527106|Vitamins|vitamins|mesh-ancestor
57136727|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
57136728|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136729|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
57136730|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136731|NCT05527106|Protective Agents|protective agents|mesh-ancestor
57136732|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
57136733|NCT05526794|Analgesics|analgesics|mesh-list
57136734|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
57136735|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136736|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136737|NCT05522894|Paclitaxel|paclitaxel|mesh-list
57136738|NCT05522894|Cisplatin|cisplatin|mesh-list
57136739|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57136740|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136741|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
57136742|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
57136743|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
57136744|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136745|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
57136746|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136747|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136748|NCT02573870|Fluticasone|fluticasone|mesh-list
57136749|NCT02573870|Xhance|xhance|mesh-list
57136750|NCT02573870|Albuterol|albuterol|mesh-list
57136751|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136752|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57136753|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
57136754|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136755|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136756|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57136757|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
57136758|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
57136759|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57136760|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
57136761|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57136762|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57136763|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57136764|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57136765|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
57136766|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136767|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136768|NCT05149898|Cannabidiol|cannabidiol|mesh-list
57136769|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
57136770|NCT05148026|Heparin|heparin|mesh-list
57136771|NCT05148026|Calcium heparin|calcium heparin|mesh-list
57136772|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
57136773|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
57136774|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57136775|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57136776|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136777|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57136778|NCT05522270|Mitogens|mitogens|mesh-list
57136779|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
57136780|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136781|NCT05522192|Venetoclax|venetoclax|mesh-list
56818545|NCT01058252|Letrozole|letrozole|mesh-list
57136782|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
57136783|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136784|NCT05522192|Analgesics|analgesics|mesh-ancestor
57136785|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
57136786|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136787|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136788|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57136789|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57136790|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136791|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136792|NCT04991480|Niraparib|niraparib|mesh-list
57136793|NCT04991480|Talazoparib|talazoparib|mesh-list
57136794|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
57136795|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136796|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136797|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136798|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
57136799|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
57136800|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
57136801|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
57136802|NCT05515874|Hematinics|hematinics|mesh-ancestor
57136803|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
57136804|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57136805|NCT05525234|Thalidomide|thalidomide|mesh-list
57136806|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57136807|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
57136808|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136809|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
57136810|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57136811|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57136812|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57136813|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57136814|NCT05525234|Growth Substances|growth substances|mesh-ancestor
57136815|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
57136816|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136817|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57136818|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57136819|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136820|NCT04300790|Metformin|metformin|mesh-list
57136821|NCT04300790|Letrozole|letrozole|mesh-list
57136822|NCT04300790|Fulvestrant|fulvestrant|mesh-list
57136823|NCT04300790|Exemestane|exemestane|mesh-list
57136824|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57136825|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136826|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136827|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57136828|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57136829|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136830|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136831|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57136832|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
57136833|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136834|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57136835|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57136836|NCT04295330|Lidocaine|lidocaine|mesh-list
57136837|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
57136838|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
57136839|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57136840|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136841|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
57136842|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136843|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57136844|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57136845|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57136846|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57136847|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136848|NCT05525156|Aspirin|aspirin|mesh-list
57136849|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57136850|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57136851|NCT05525156|Analgesics|analgesics|mesh-ancestor
57136852|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
57136853|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136854|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136855|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136856|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57136857|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57136858|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57136859|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136860|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57136861|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57136862|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136863|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
57136864|NCT05512364|Tamoxifen|tamoxifen|mesh-list
57136865|NCT05512364|Letrozole|letrozole|mesh-list
57136866|NCT05512364|Anastrozole|anastrozole|mesh-list
57136867|NCT05512364|Exemestane|exemestane|mesh-list
57136868|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136869|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57136870|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57136871|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136872|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136873|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57136874|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
57136875|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136876|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136877|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57136878|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
57136879|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
57136880|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57136881|NCT04424641|Antibodies|antibodies|mesh-list
57136882|NCT04424641|Immunoglobulins|immunoglobulins|mesh-list
57136883|NCT04424641|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57136884|NCT04424641|Immunoglobulin G|immunoglobulin g|mesh-list
57136885|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
57136886|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
57136887|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136888|NCT05512130|Empagliflozin|empagliflozin|mesh-list
57136889|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57136890|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136891|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57136892|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136893|NCT04898894|Cytarabine|cytarabine|mesh-list
57136894|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
57136895|NCT04898894|Methotrexate|methotrexate|mesh-list
57136896|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
57136897|NCT04898894|Fludarabine|fludarabine|mesh-list
57136898|NCT04898894|Venetoclax|venetoclax|mesh-list
57136899|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57136900|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
57136901|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57136902|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136903|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57136904|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
57136905|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136906|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136907|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
57136908|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136909|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57136910|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57136911|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
57136912|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57136913|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57136914|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
57136915|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57136916|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136917|NCT02180425|Adapalene|adapalene|mesh-list
57136918|NCT02180425|Tretinoin|tretinoin|mesh-list
57136919|NCT02180425|Isotretinoin|isotretinoin|mesh-list
57136920|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
57136921|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57136922|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57136923|NCT02180425|Analgesics|analgesics|mesh-ancestor
57136924|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
57136925|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136926|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136927|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57136928|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57136929|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136930|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
57136931|NCT02183467|Linagliptin|linagliptin|mesh-list
57136932|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
57136933|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57136934|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57136935|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57136936|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57136937|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136938|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136939|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57136940|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136941|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57136942|NCT02183467|Incretins|incretins|mesh-ancestor
57136943|NCT02183467|Hormones|hormones|mesh-ancestor
57136944|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136945|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57136946|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
57136947|NCT02180503|Linagliptin|linagliptin|mesh-list
57136948|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57136949|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136950|NCT02180503|Incretins|incretins|mesh-ancestor
57136951|NCT02180503|Hormones|hormones|mesh-ancestor
57136952|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57136953|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57136954|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
57136955|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57136956|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136957|NCT02177851|Iron|iron|mesh-list
57136958|NCT02177851|Trace Elements|trace elements|mesh-ancestor
57136959|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
57136960|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136961|NCT05075876|Granisetron|granisetron|mesh-list
57136962|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
57136963|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
57136964|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136965|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136966|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57136967|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57136968|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
57136969|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136970|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136971|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
57136972|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57136973|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57136974|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136975|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57136976|NCT02180737|Analgesics|analgesics|mesh-ancestor
57136977|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
57136978|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57136979|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57136980|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57136981|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57136982|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
57136983|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136984|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136985|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
57136986|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
57136987|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
57136988|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
57136989|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
57136990|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
57136991|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57136992|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57136993|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57136994|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57136995|NCT02183623|Linagliptin|linagliptin|mesh-list
57136996|NCT02183623|Simvastatin|simvastatin|mesh-list
57136997|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57136998|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57136999|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
57137000|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137001|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56902612|NCT02060656|Rituximab|rituximab|mesh-list
57137002|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57137003|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137004|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57137005|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137006|NCT02183623|Incretins|incretins|mesh-ancestor
57137007|NCT02183623|Hormones|hormones|mesh-ancestor
57137008|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57137009|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
57137010|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
57137012|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57137013|NCT02183701|Telmisartan|telmisartan|mesh-list
57137014|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57137015|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57137016|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57137017|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57137018|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137019|NCT02183701|Diuretics|diuretics|mesh-ancestor
57137020|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
57137021|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137022|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57137023|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137024|NCT02183779|Fluconazole|fluconazole|mesh-list
57137025|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
57137026|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137027|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
57137028|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57137029|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137030|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137031|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57137032|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
57137033|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57137034|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137035|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
57137036|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57137037|NCT02184091|Nevirapine|nevirapine|mesh-list
57137038|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57137039|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57137040|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137041|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137042|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
57137043|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137044|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57137045|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57137046|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57137047|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57137048|NCT02184247|Theophylline|theophylline|mesh-list
57137049|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57137050|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
57137051|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137052|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137053|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57137054|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
57137055|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57137056|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137057|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137058|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
57137059|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57137060|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57137061|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
57137062|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57137063|NCT04292756|Triamcinolone|triamcinolone|mesh-list
57137064|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57137065|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57137066|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57137067|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137068|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
57137069|NCT04292756|Hormones|hormones|mesh-ancestor
56902615|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137070|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57137071|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137072|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57137073|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
57137074|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137075|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137076|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
57137077|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
57137078|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57137079|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57137080|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137081|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137082|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137083|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137084|NCT05074706|Antibodies|antibodies|mesh-list
57137085|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
57137086|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
57137087|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137088|NCT02181205|Bupivacaine|bupivacaine|mesh-list
57137089|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
57137090|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
57137091|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137092|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137093|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
57137094|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137095|NCT02184559|Ropivacaine|ropivacaine|mesh-list
57137096|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
57137097|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
57137098|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137099|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137100|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
57137101|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137102|NCT02185651|Miglustat|miglustat|mesh-list
57137103|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137104|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137105|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57137106|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57137107|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
57137108|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137109|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
57137110|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57137111|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137112|NCT02181361|Aspirin|aspirin|mesh-list
57137113|NCT02181361|Hirudins|hirudins|mesh-list
57137114|NCT02181361|Warfarin|warfarin|mesh-list
57137115|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57137116|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137117|NCT02181361|Analgesics|analgesics|mesh-ancestor
57137118|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
57137119|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137120|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137121|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137122|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137123|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57137124|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57137125|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137126|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57137127|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57137128|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137129|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
57137130|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
57137131|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
57137132|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
57137133|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
57137134|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
57137135|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
57137136|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137137|NCT02184637|Lumefantrine|lumefantrine|mesh-list
57137138|NCT02184637|Artemether|artemether|mesh-list
57137139|NCT02184637|Piperaquine|piperaquine|mesh-list
57137140|NCT02184637|Artenimol|artenimol|mesh-list
57137141|NCT02184637|Tafenoquine|tafenoquine|mesh-list
57137142|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
57137143|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
57137144|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57137145|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57137146|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137147|NCT04870424|Colchicine|colchicine|mesh-list
57137148|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
57137149|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137150|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
57137151|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
57137152|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
56818922|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
57137153|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137154|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137155|NCT03536845|Vitamin D|vitamin d|mesh-list
57137156|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
57137157|NCT03536845|Vitamins|vitamins|mesh-ancestor
57137158|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
57137159|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137160|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57137161|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57137162|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57137163|NCT02181985|Heparin|heparin|mesh-list
57137164|NCT02181985|Enoxaparin|enoxaparin|mesh-list
57137165|NCT02181985|Tenecteplase|tenecteplase|mesh-list
57137166|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
57137167|NCT02181985|Abciximab|abciximab|mesh-list
57137168|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
57137169|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57137170|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57137171|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137172|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57137173|NCT05514080|Insulin|insulin|mesh-list
57137174|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57137175|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137176|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57137177|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57137178|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57137179|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
57137180|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137181|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57137182|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57137183|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137184|NCT05513924|Fluorouracil|fluorouracil|mesh-list
57137185|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57137186|NCT05513924|Latanoprost|latanoprost|mesh-list
57137187|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
57137188|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137189|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57137190|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137191|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57137192|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
57137193|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137194|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57137195|NCT02186119|Ranibizumab|ranibizumab|mesh-list
57137196|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57137197|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57137198|NCT02186119|Growth Substances|growth substances|mesh-ancestor
57137199|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137200|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
57137201|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137202|NCT02185261|Interferons|interferons|mesh-list
57137203|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
57137204|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
57137205|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137206|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
57137207|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137208|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
57137209|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137210|NCT02573012|Prednisone|prednisone|mesh-list
57137211|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137212|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
57137213|NCT02573012|Hormones|hormones|mesh-ancestor
57137214|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57137215|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137216|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57137217|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137218|NCT04128176|Omalizumab|omalizumab|mesh-list
57137219|NCT04128176|Rituximab|rituximab|mesh-list
57137220|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57137221|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137222|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
57137223|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137224|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137225|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57137226|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57137227|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
57137228|NCT02186275|Vitamin D|vitamin d|mesh-list
57137229|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
56818996|NCT00302952|Lovastatin|lovastatin|mesh-list
57137230|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
57137231|NCT02186275|Vitamins|vitamins|mesh-list
57137232|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
57137233|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137234|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57137235|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57137236|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
57137237|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
57137238|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
57137239|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137240|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137241|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
57137242|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137243|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
57137244|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57137245|NCT05519072|Cephalexin|cephalexin|mesh-list
57137246|NCT05519072|Fosfomycin|fosfomycin|mesh-list
57137247|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
57137248|NCT05519072|Trimethoprim|trimethoprim|mesh-list
57137249|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
57137250|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57137251|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137252|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57137253|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57137254|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137255|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137256|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137257|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57137258|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57137259|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
57137260|NCT05519072|Renal Agents|renal agents|mesh-ancestor
57137261|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
57137262|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57137263|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57137264|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57137265|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57137266|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
57137267|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57137268|NCT04411706|Capecitabine|capecitabine|mesh-list
57137269|NCT04411706|Apatinib|apatinib|mesh-list
57137270|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57137271|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
57137272|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137273|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137274|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57137275|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137276|NCT05518994|Bevacizumab|bevacizumab|mesh-list
57137277|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57137278|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137279|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57137280|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57137281|NCT05518994|Growth Substances|growth substances|mesh-ancestor
57137282|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137283|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
57137284|NCT02256943|Amitriptyline|amitriptyline|mesh-list
57137285|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
57137286|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
57137287|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
57137288|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
57137289|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57137290|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137291|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137292|NCT02256943|Urological Agents|urological agents|mesh-ancestor
57137293|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
57137294|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
57137295|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57137296|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137297|NCT02256943|Analgesics|analgesics|mesh-ancestor
57137298|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
57137299|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137300|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
57137301|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57137302|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137303|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
57137304|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57137305|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819094|NCT00289848|Hormones|hormones|mesh-ancestor
57137306|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137307|NCT02186899|Anesthetics|anesthetics|mesh-list
57137308|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137309|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137310|NCT02752633|Allopurinol|allopurinol|mesh-list
57137311|NCT02752633|Febuxostat|febuxostat|mesh-list
57137312|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
57137313|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137314|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137315|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
57137316|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137317|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57137318|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
57137319|NCT02752633|Protective Agents|protective agents|mesh-ancestor
57137320|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137321|NCT02191189|Nevirapine|nevirapine|mesh-list
57137322|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57137323|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57137324|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137325|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137326|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
57137327|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137328|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57137329|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57137330|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57137331|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57137332|NCT05512520|Capecitabine|capecitabine|mesh-list
57137333|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57137334|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
57137335|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137336|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137337|NCT02187133|Rituximab|rituximab|mesh-list
57137338|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
57137339|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57137340|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137341|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
57137342|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137343|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137344|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57137345|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
57137346|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137347|NCT04411862|Choline|choline|mesh-list
57137348|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
57137349|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57137350|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
57137351|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137352|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57137353|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57137354|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
57137355|NCT02187211|Minocycline|minocycline|mesh-list
57137356|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57137357|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137358|NCT04766996|Aspirin|aspirin|mesh-list
57137359|NCT04766996|Acetaminophen|acetaminophen|mesh-list
57137360|NCT04766996|Prednisone|prednisone|mesh-list
57137361|NCT04766996|Meloxicam|meloxicam|mesh-list
57137362|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
57137363|NCT04766996|Diclofenac|diclofenac|mesh-list
57137364|NCT04766996|Lidocaine|lidocaine|mesh-list
57137365|NCT04766996|Pregabalin|pregabalin|mesh-list
57137366|NCT04766996|Tramadol|tramadol|mesh-list
57137367|NCT04766996|Bupivacaine|bupivacaine|mesh-list
57137368|NCT04766996|Propofol|propofol|mesh-list
57137369|NCT04766996|Omeprazole|omeprazole|mesh-list
57137370|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
57137371|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
57137372|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
57137373|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137374|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137375|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
57137376|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137377|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57137378|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57137379|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57137380|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137381|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137382|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137383|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
57137384|NCT04766996|Hormones|hormones|mesh-ancestor
57137385|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57137386|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57137387|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137388|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57137389|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57137390|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
57137391|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57137392|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137393|NCT04766996|Analgesics|analgesics|mesh-ancestor
57137394|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137395|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57137396|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57137397|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57137398|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57137399|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137400|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
57137401|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57137402|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
57137403|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57137404|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57137405|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57137406|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57137407|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57137408|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
57137409|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
57137410|NCT04766996|Coagulants|coagulants|mesh-ancestor
57137411|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57137412|NCT04766996|Narcotics|narcotics|mesh-ancestor
57137413|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57137414|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57137415|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57137416|NCT02191423|Oxytocin|oxytocin|mesh-list
57137417|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
57137418|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57137419|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137420|NCT05509946|Celecoxib|celecoxib|mesh-list
57137421|NCT05509946|Pregabalin|pregabalin|mesh-list
57137422|NCT05509946|Analgesics|analgesics|mesh-ancestor
57137423|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
57137424|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137425|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137426|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
57137427|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57137428|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137429|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137430|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57137431|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57137432|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57137433|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137434|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57137435|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57137436|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137437|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137438|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137439|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57137440|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57137441|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137442|NCT04304209|Capecitabine|capecitabine|mesh-list
57137443|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
57137444|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57137445|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
57137446|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137447|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137448|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
57137449|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57137450|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
57137451|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137452|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137453|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57137454|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
57137455|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137456|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137457|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57137458|NCT02187445|Budesonide|budesonide|mesh-list
57137459|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137460|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57137461|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
57137462|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137463|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137464|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57137465|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
57137466|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
57137467|NCT02187445|Hormones|hormones|mesh-ancestor
57137468|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57137469|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
57137470|NCT02187523|Telmisartan|telmisartan|mesh-list
57137471|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57137472|NCT02187523|Diuretics|diuretics|mesh-ancestor
57137473|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
57137474|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137475|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
57137476|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137477|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137478|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57137479|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57137480|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
57137481|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
57137482|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
57137483|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137484|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137485|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
57137486|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57137487|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137488|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57137489|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137490|NCT05507606|Bevacizumab|bevacizumab|mesh-list
57137491|NCT05507606|Carboplatin|carboplatin|mesh-list
57137492|NCT05507606|Pemetrexed|pemetrexed|mesh-list
57137493|NCT05507606|Osimertinib|osimertinib|mesh-list
57137494|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57137495|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137496|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57137497|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57137498|NCT05507606|Growth Substances|growth substances|mesh-ancestor
57137499|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137500|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
57137501|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137502|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137503|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57137504|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57137505|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57137506|NCT02191657|Deferiprone|deferiprone|mesh-list
57137507|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57137508|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
57137509|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
57137510|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137511|NCT02191891|Afatinib|afatinib|mesh-list
57137512|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137513|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57137514|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137515|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137516|NCT05507372|Pimozide|pimozide|mesh-list
57137517|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57137518|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57137519|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137520|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137521|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57137522|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57137523|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
57137524|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57137525|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137526|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57137527|NCT02192203|Diclofenac|diclofenac|mesh-list
57137528|NCT02192203|Menthol|menthol|mesh-list
57137529|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57137530|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137531|NCT02192203|Analgesics|analgesics|mesh-ancestor
56819298|NCT00287586|Hormones|hormones|mesh-ancestor
57137532|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
57137533|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137534|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137535|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137536|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137537|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57137538|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137539|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137540|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
57137541|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
57137542|NCT02257021|Ritonavir|ritonavir|mesh-list
57137543|NCT02257021|Tipranavir|tipranavir|mesh-list
57137544|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57137545|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57137546|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
57137547|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137548|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137549|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57137550|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57137551|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
57137552|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137553|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57137554|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57137555|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
57137556|NCT03536065|Narcotics|narcotics|mesh-ancestor
57137557|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137558|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137559|NCT03536065|Analgesics|analgesics|mesh-ancestor
57137560|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
57137561|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137562|NCT02192827|Dexamethasone|dexamethasone|mesh-list
57137563|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
57137564|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57137565|NCT02192827|BB 1101|bb 1101|mesh-list
57137566|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137567|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
57137568|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
57137569|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137570|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137571|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57137572|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
57137573|NCT02192827|Hormones|hormones|mesh-ancestor
57137574|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57137575|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57137576|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137577|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
57137578|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137579|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137580|NCT02188225|Fluoxetine|fluoxetine|mesh-list
57137581|NCT02188225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57137582|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57137583|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137584|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137585|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57137586|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
57137587|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137588|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57137589|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
57137590|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57137591|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
57137592|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57137593|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137594|NCT04535089|Lidocaine|lidocaine|mesh-list
57137595|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
57137596|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
57137597|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
57137598|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137599|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137600|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
57137601|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137602|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57137603|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57137604|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57137605|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137606|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137607|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57137608|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137609|NCT04535089|Analgesics|analgesics|mesh-ancestor
57137610|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57137611|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57137612|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57137613|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
57137614|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57137615|NCT02188537|Nelfinavir|nelfinavir|mesh-list
57137616|NCT02188537|Dexamethasone|dexamethasone|mesh-list
57137617|NCT02188537|Bortezomib|bortezomib|mesh-list
57137618|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137619|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
57137620|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
57137621|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137622|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137623|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57137624|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
57137625|NCT02188537|Hormones|hormones|mesh-ancestor
57137626|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57137627|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57137628|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137629|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57137630|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57137631|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
57137632|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137633|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137634|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57137635|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57137636|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
57137637|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137638|NCT03535051|Tacrolimus|tacrolimus|mesh-list
57137639|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57137640|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
57137641|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137642|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57137643|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137644|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137645|NCT02188615|Vinorelbine|vinorelbine|mesh-list
57137646|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137647|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57137648|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
57137649|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
57137650|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
57137651|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137652|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
57137653|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57137654|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
57137655|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137656|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
57137657|NCT02188771|Protective Agents|protective agents|mesh-ancestor
57137658|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
57137659|NCT02194075|Methylphenidate|methylphenidate|mesh-list
57137660|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57137661|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137662|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57137663|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57137664|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137665|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137666|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
57137667|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57137668|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57137669|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57137670|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137671|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57137672|NCT02194075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
57137673|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
57137674|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
57137675|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
57137676|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
57137677|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57137678|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137679|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
57137681|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57137682|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57137683|NCT04270747|Growth Substances|growth substances|mesh-ancestor
57137684|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137685|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
57137686|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137687|NCT02562716|Gemcitabine|gemcitabine|mesh-list
57137688|NCT02562716|Paclitaxel|paclitaxel|mesh-list
57137689|NCT02562716|Camptothecin|camptothecin|mesh-list
57137690|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
57137691|NCT02562716|Fluorouracil|fluorouracil|mesh-list
57137692|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
57137693|NCT02562716|Irinotecan|irinotecan|mesh-list
57137694|NCT02562716|Pancrelipase|pancrelipase|mesh-list
57137695|NCT02562716|Pancreatin|pancreatin|mesh-list
57137696|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57137697|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137698|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
57137699|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
57137700|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
57137701|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137702|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57137703|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
57137704|NCT02562716|Antiviral Agents|antiviral agents|mesh-ancestor
57137705|NCT02562716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137706|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137707|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57137708|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
57137709|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137710|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57137711|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57137712|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57137713|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57137714|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57137715|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137716|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57137717|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
57137718|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137719|NCT03534973|Caffeine|caffeine|mesh-list
57137720|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57137721|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137722|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
57137723|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137724|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137725|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
57137726|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57137727|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
57137728|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57137729|NCT03534895|Midazolam|midazolam|mesh-list
57137730|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
57137731|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137732|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137733|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57137734|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57137735|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57137736|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57137737|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57137738|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57137739|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
57137740|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
57137741|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
57137742|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57137743|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137744|NCT03535753|Decitabine|decitabine|mesh-list
57137745|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57137746|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
57137747|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137748|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137749|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137750|NCT02189395|Insulin|insulin|mesh-list
57137751|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
57137752|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57137753|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57137754|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137755|NCT03535519|Methotrexate|methotrexate|mesh-list
57137756|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57137757|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
57137758|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57137759|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137760|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57137761|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
57137762|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137763|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137764|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
57137765|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137766|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57137767|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57137768|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
57137769|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137770|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57137771|NCT02194153|Tenecteplase|tenecteplase|mesh-list
57137772|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57137773|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57137774|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137775|NCT02194231|Trabectedin|trabectedin|mesh-list
57137776|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57137777|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
57137778|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137779|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137780|NCT04292054|Cefazolin|cefazolin|mesh-list
57137781|NCT04292054|Tazobactam|tazobactam|mesh-list
57137782|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57137783|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137784|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57137785|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137786|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137787|NCT04291508|Acetaminophen|acetaminophen|mesh-list
57137788|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137789|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137790|NCT04291508|Analgesics|analgesics|mesh-ancestor
57137791|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
57137792|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137793|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
57137794|NCT02933671|Ropivacaine|ropivacaine|mesh-list
57137795|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
57137796|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
57137797|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137798|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137799|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
57137800|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137801|NCT05509478|Lenvatinib|lenvatinib|mesh-list
57137802|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
57137803|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137804|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57137805|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137806|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137807|NCT02194309|Amlodipine|amlodipine|mesh-list
57137808|NCT02194309|Telmisartan|telmisartan|mesh-list
57137809|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57137810|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57137811|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57137812|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137813|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57137814|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137815|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
57137816|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57137817|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57137818|NCT04392505|Durvalumab|durvalumab|mesh-list
57137819|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57137820|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137821|NCT05502458|Propofol|propofol|mesh-list
57137822|NCT05502458|Desflurane|desflurane|mesh-list
57137823|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57137824|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137825|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137826|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57137827|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
57137828|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
57137829|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
57137830|NCT03534037|Febuxostat|febuxostat|mesh-list
57137831|NCT03534037|Benzbromarone|benzbromarone|mesh-list
57137832|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
57137833|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137834|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
57137835|NCT03534037|Renal Agents|renal agents|mesh-ancestor
57137836|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57137837|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137838|NCT02567708|Nemiralisib|nemiralisib|mesh-list
57137839|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57137840|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137841|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137842|NCT05509244|Acetaminophen|acetaminophen|mesh-list
57137843|NCT05509244|Ibuprofen|ibuprofen|mesh-list
57137844|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137845|NCT05509244|Analgesics|analgesics|mesh-ancestor
57137846|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
57137847|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137848|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137849|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
57137850|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57137851|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137852|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137853|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57137854|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137855|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137856|NCT05502068|Vitamin D|vitamin d|mesh-list
57137857|NCT05502068|Vitamins|vitamins|mesh-ancestor
57137858|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
57137859|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137860|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57137861|NCT02030977|Resveratrol|resveratrol|mesh-list
57137862|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
57137863|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137864|NCT02030977|Protective Agents|protective agents|mesh-ancestor
57137865|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137866|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137867|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57137868|NCT02194855|Rocuronium|rocuronium|mesh-list
57137869|NCT02194855|Cisatracurium|cisatracurium|mesh-list
57137870|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57137871|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57137872|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57137873|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137874|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137875|NCT03534661|Teduglutide|teduglutide|mesh-list
57137876|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
57137877|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137878|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137879|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57137880|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
57137881|NCT03534661|Protective Agents|protective agents|mesh-ancestor
57137882|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137883|NCT02031211|Etanercept|etanercept|mesh-list
57137884|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57137885|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137886|NCT02031211|Analgesics|analgesics|mesh-ancestor
57137887|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
57137888|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137889|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137890|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137891|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137892|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57137893|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57137894|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
57137895|NCT02195089|Vaccines|vaccines|mesh-list
57137896|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
57137897|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137898|NCT02031289|Folic Acid|folic acid|mesh-list
57137899|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
57137900|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
57137901|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
57137902|NCT02031289|Vitamins|vitamins|mesh-ancestor
57137903|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
57137904|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137905|NCT02031289|Hematinics|hematinics|mesh-ancestor
57137906|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
57137907|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
57137908|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57137909|NCT02197741|Narcotics|narcotics|mesh-ancestor
57137910|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137911|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137912|NCT02197741|Analgesics|analgesics|mesh-ancestor
57137913|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
57137914|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137915|NCT02196493|Azithromycin|azithromycin|mesh-list
57137916|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57137917|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137918|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
57137919|NCT03533803|Indomethacin|indomethacin|mesh-list
57137920|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57137921|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137922|NCT03533803|Analgesics|analgesics|mesh-ancestor
57137923|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
57137924|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137925|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137926|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137927|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137928|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
57137929|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
57137930|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57137931|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57137932|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137933|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137934|NCT02198209|Liraglutide|liraglutide|mesh-list
57137935|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57137936|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137937|NCT02198209|Incretins|incretins|mesh-ancestor
57137938|NCT02198209|Hormones|hormones|mesh-ancestor
57137939|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57137940|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57137941|NCT02195557|Hylan|hylan|mesh-list
57137942|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
57137943|NCT02195557|Protective Agents|protective agents|mesh-ancestor
57137944|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137945|NCT02195635|Octreotide|octreotide|mesh-list
57137946|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57137947|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57137948|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57137949|NCT03534505|Ketorolac|ketorolac|mesh-list
57137950|NCT03534505|Bupivacaine|bupivacaine|mesh-list
57137951|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
57137952|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
57137953|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57137954|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137955|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
57137956|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57137957|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57137958|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57137959|NCT03534505|Analgesics|analgesics|mesh-ancestor
57137960|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57137961|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57137962|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57137963|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137964|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137965|NCT02195791|Pioglitazone|pioglitazone|mesh-list
57137966|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57137967|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137968|NCT02196805|Probucol|probucol|mesh-list
57137969|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57137970|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57137971|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
57137972|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137973|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57137974|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
57137975|NCT02196805|Protective Agents|protective agents|mesh-ancestor
57137976|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57137977|NCT02198443|Ritonavir|ritonavir|mesh-list
57137978|NCT02198443|Lopinavir|lopinavir|mesh-list
57137979|NCT02198443|Tenofovir|tenofovir|mesh-list
57137980|NCT02198443|Emtricitabine|emtricitabine|mesh-list
57137981|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57137982|NCT02198443|Cobicistat|cobicistat|mesh-list
57137983|NCT02198443|Elvitegravir|elvitegravir|mesh-list
57137984|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57137985|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57137986|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
57137987|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57137988|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57137989|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57137990|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57137991|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
57137992|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57137993|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57137994|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57137995|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57137996|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57137997|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
57137998|NCT03533179|Glucagon|glucagon|mesh-list
57137999|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
57138000|NCT03533179|Esmolol|esmolol|mesh-list
57138001|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57138002|NCT03533179|Hormones|hormones|mesh-ancestor
57138003|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138004|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138005|NCT03533179|Incretins|incretins|mesh-ancestor
57138006|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57138007|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57138008|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57138009|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
57138010|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138011|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138012|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
57138013|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
57138014|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138015|NCT05261971|Etodolac|etodolac|mesh-list
57138016|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57138017|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57138018|NCT05261971|Analgesics|analgesics|mesh-ancestor
57138019|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
57138020|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138021|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138022|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138023|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57138024|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
57138025|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57138026|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902632|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
57138027|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138028|NCT02201563|Minocycline|minocycline|mesh-list
57138029|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57138030|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138031|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
57138032|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
57138033|NCT02206477|Protective Agents|protective agents|mesh-ancestor
57138034|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138035|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57138036|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
57138037|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138038|NCT02201641|Calcium|calcium|mesh-list
57138039|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57138040|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138041|NCT02206555|Tenofovir|tenofovir|mesh-list
57138042|NCT02206555|Emtricitabine|emtricitabine|mesh-list
57138043|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
57138044|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
57138045|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138046|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57138047|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57138048|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138049|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138050|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57138051|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57138052|NCT02206711|BMS-955176|bms-955176|mesh-list
57138053|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57138054|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57138055|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
57138056|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138057|NCT02206789|Cyclosporine|cyclosporine|mesh-list
57138058|NCT02206789|Prednisolone|prednisolone|mesh-list
57138059|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
57138060|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
57138061|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
57138062|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
57138063|NCT02206789|Cyclosporins|cyclosporins|mesh-list
57138064|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
57138065|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
57138066|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138067|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138068|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57138069|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
57138070|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138071|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
57138072|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138073|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
57138074|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57138075|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
57138076|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138077|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
57138078|NCT02206789|Hormones|hormones|mesh-ancestor
57138079|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138080|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57138081|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138082|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
57138083|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
57138084|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138085|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57138086|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
57138087|NCT02206789|Protective Agents|protective agents|mesh-ancestor
57138088|NCT03892369|Ethanol|ethanol|mesh-list
57138089|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57138090|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138091|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138092|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138093|NCT02206867|Adalimumab|adalimumab|mesh-list
57138094|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138095|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57138096|NCT02751931|Mirabegron|mirabegron|mesh-list
57138097|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
57138098|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57138099|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57138100|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
57138101|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138102|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138103|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138104|NCT02751931|Urological Agents|urological agents|mesh-ancestor
57138105|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57138106|NCT05261581|Analgesics|analgesics|mesh-list
57138107|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
57138108|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138109|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138110|NCT02199223|Panitumumab|panitumumab|mesh-list
57138111|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57138112|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138113|NCT02207335|Gemcitabine|gemcitabine|mesh-list
57138114|NCT02207335|Carboplatin|carboplatin|mesh-list
57138115|NCT02207335|Capecitabine|capecitabine|mesh-list
57138116|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138117|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57138118|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
57138119|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138120|NCT02207335|Antiviral Agents|antiviral agents|mesh-ancestor
57138121|NCT02207335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138122|NCT02207335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138123|NCT02207335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57138124|NCT02207335|Immunologic Factors|immunologic factors|mesh-ancestor
57138125|NCT02207335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138126|NCT02561078|Insulin|insulin|mesh-list
57138127|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
57138128|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57138129|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138130|NCT02202889|Calcium|calcium|mesh-list
57138131|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56819888|NCT00303446|Dutasteride|dutasteride|mesh-list
57138132|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138134|NCT04058197|Siderophores|siderophores|mesh-ancestor
57138135|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
57138136|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
57138137|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
57138138|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138139|NCT02202967|Misoprostol|misoprostol|mesh-list
57138140|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57138141|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
57138142|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57138143|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138144|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57138145|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57138146|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
57138147|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
57138148|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
57138149|NCT03532867|Protective Agents|protective agents|mesh-ancestor
57138150|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138151|NCT02207959|Proflavine|proflavine|mesh-list
57138152|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57138153|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138154|NCT02567552|Progesterone|progesterone|mesh-list
57138155|NCT02567552|Progestins|progestins|mesh-ancestor
57138156|NCT02567552|Hormones|hormones|mesh-ancestor
57138157|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138158|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138159|NCT02208427|Isoniazid|isoniazid|mesh-list
57138160|NCT02208427|Rifapentine|rifapentine|mesh-list
57138161|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
57138162|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57138163|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138164|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
57138165|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57138166|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
57138167|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138168|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57138169|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
57138170|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
57138171|NCT05508620|Sirolimus|sirolimus|mesh-list
57138172|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57138173|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138174|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57138175|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138176|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
57138177|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57138178|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
57138179|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138180|NCT03803605|Vorinostat|vorinostat|mesh-list
57138181|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138182|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
57138183|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138184|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138185|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
57138186|NCT02208505|Remifentanil|remifentanil|mesh-list
57138187|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57138188|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138189|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138190|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57138191|NCT02208505|Analgesics|analgesics|mesh-ancestor
57138192|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
57138193|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138194|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57138195|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57138196|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57138197|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
57138198|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138199|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138200|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57138201|NCT02208505|Narcotics|narcotics|mesh-ancestor
57138202|NCT02208583|Prednisone|prednisone|mesh-list
57138203|NCT02208583|Cisplatin|cisplatin|mesh-list
57138204|NCT02208583|Docetaxel|docetaxel|mesh-list
57138205|NCT02208583|Etoposide|etoposide|mesh-list
57138206|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
57138207|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138208|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
57138209|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
57138210|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
57138211|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138212|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138213|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
57138214|NCT02208583|Hormones|hormones|mesh-ancestor
57138215|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138216|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138217|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57138218|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57138219|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57138220|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57138221|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138222|NCT05501288|Pholcodine|pholcodine|mesh-list
57138223|NCT05501288|Analgesics|analgesics|mesh-ancestor
57138224|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
57138225|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138226|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138227|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
57138228|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
57138229|NCT04738292|Fulvestrant|fulvestrant|mesh-list
57138230|NCT04738292|Onapristone|onapristone|mesh-list
57138231|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57138232|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138233|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
57138234|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57138235|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
57138236|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138237|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138238|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57138239|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
57138240|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57138241|NCT02199379|Lenvatinib|lenvatinib|mesh-list
57138242|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138243|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57138244|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138245|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138246|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57138247|NCT05508152|Amoxicillin|amoxicillin|mesh-list
57138248|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
57138249|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
57138250|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
57138251|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
57138252|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138253|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
57138254|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138255|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138256|NCT03532711|Leucovorin|leucovorin|mesh-list
57138257|NCT03532711|Fluorouracil|fluorouracil|mesh-list
57138258|NCT03532711|Capecitabine|capecitabine|mesh-list
57138259|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
57138260|NCT03532711|Irinotecan|irinotecan|mesh-list
57138261|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
57138262|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138263|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
57138264|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138265|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57138266|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138267|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57138268|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
57138269|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
57138270|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57138271|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138272|NCT03532711|Antidotes|antidotes|mesh-ancestor
57138273|NCT03532711|Protective Agents|protective agents|mesh-ancestor
57138274|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
57138275|NCT03532711|Vitamins|vitamins|mesh-ancestor
57138276|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
57138277|NCT04729322|Metronidazole|metronidazole|mesh-list
57138278|NCT04729322|Vancomycin|vancomycin|mesh-list
57138279|NCT04729322|Neomycin|neomycin|mesh-list
57138280|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
57138281|NCT04729322|Nivolumab|nivolumab|mesh-list
57138282|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57138283|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138284|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57138285|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138286|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138287|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57138288|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
57138289|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57138290|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57138291|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138292|NCT04714112|Dexamethasone|dexamethasone|mesh-list
57138293|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
57138294|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
57138295|NCT04714112|BB 1101|bb 1101|mesh-list
57138296|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138297|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
57138298|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
57138299|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138300|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138301|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57138302|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
57138303|NCT04714112|Hormones|hormones|mesh-ancestor
57138304|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138305|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57138306|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138307|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
57138308|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138309|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138310|NCT02199613|Darunavir|darunavir|mesh-list
57138311|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57138312|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57138313|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
57138314|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138315|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138316|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57138317|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57138318|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
57138319|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138320|NCT02209441|Sorafenib|sorafenib|mesh-list
57138321|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138322|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57138323|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138324|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138325|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
57138326|NCT04772222|Morphine|morphine|mesh-list
57138327|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57138328|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138329|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138330|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57138331|NCT04772222|Analgesics|analgesics|mesh-ancestor
57138332|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
57138333|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138334|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57138335|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57138336|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57138337|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
57138338|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138339|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138340|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57138341|NCT04772222|Narcotics|narcotics|mesh-ancestor
57138342|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
57138343|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
57138344|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
57138345|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
57138346|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138347|NCT03338647|Doxorubicin|doxorubicin|mesh-list
57138348|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57138349|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138350|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57138351|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57138352|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138353|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138354|NCT05500742|Selenium|selenium|mesh-list
57138355|NCT05500742|Ubiquinone|ubiquinone|mesh-list
57138356|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
57138357|NCT05500742|Resveratrol|resveratrol|mesh-list
57138358|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
57138359|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138360|NCT05500742|Protective Agents|protective agents|mesh-ancestor
57138361|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138363|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57138364|NCT05500742|Trace Elements|trace elements|mesh-ancestor
57138365|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
57138366|NCT05500742|Vitamins|vitamins|mesh-ancestor
57138367|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
57138368|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
57138369|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57138370|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138371|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
57138372|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
57138373|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
57138374|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57138375|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138376|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138377|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57138378|NCT02200159|Analgesics|analgesics|mesh-ancestor
57138379|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
57138380|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138381|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57138382|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57138383|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57138384|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
57138385|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138386|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138387|NCT02204527|Vitamin D|vitamin d|mesh-list
57138388|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
57138389|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
57138390|NCT02204527|Vitamins|vitamins|mesh-list
57138391|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
57138392|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138393|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57138394|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57138395|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
57138396|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
57138397|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
57138398|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138399|NCT02200237|Antacids|antacids|mesh-ancestor
57138400|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138401|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57138402|NCT02209831|Pantoprazole|pantoprazole|mesh-list
57138403|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57138404|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57138405|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
57138406|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138407|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138408|NCT01663532|Aripiprazole|aripiprazole|mesh-list
57138409|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
57138410|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57138411|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57138412|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57138413|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138414|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138415|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
57138416|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
57138417|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138418|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138419|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
57138420|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
57138421|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
57138422|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
57138423|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
57138424|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
57138425|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
57138426|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
57138427|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
57138428|NCT05215106|Durvalumab|durvalumab|mesh-list
57138429|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57138430|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138431|NCT02204683|Aflibercept|aflibercept|mesh-list
57138432|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57138433|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57138434|NCT02204683|Growth Substances|growth substances|mesh-ancestor
57138435|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138436|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
57138437|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138438|NCT02204839|Insulin|insulin|mesh-list
57138439|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
57138440|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
57138441|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57138442|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138443|NCT02209909|Aspirin|aspirin|mesh-list
57138444|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57138445|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57138446|NCT02209909|Analgesics|analgesics|mesh-ancestor
57138447|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
57138448|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138449|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138450|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138451|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57138452|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57138453|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57138454|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138455|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57138456|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57138457|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138458|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
57138459|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57138460|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
57138461|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138462|NCT02205151|Amlodipine|amlodipine|mesh-list
57138463|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57138464|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57138465|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054995|NCT00832299|Fluorouracil|fluorouracil|mesh-list
57138466|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138467|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57138468|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138469|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
57138470|NCT05262985|Durvalumab|durvalumab|mesh-list
57138471|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57138472|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138473|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
57138474|NCT05504720|Trastuzumab|trastuzumab|mesh-list
57138475|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57138476|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138477|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
57138478|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57138479|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
57138480|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138481|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138482|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57138483|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
57138484|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57138485|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
57138486|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138487|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138488|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57138489|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
57138490|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
57138491|NCT04476992|Protective Agents|protective agents|mesh-ancestor
57138492|NCT05504642|Nivolumab|nivolumab|mesh-list
57138493|NCT05504642|Ipilimumab|ipilimumab|mesh-list
57138494|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
57138495|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57138496|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138497|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57138498|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138499|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138500|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
57138501|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
57138502|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138503|NCT02220673|Protective Agents|protective agents|mesh-ancestor
57138504|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138505|NCT05499572|Minocycline|minocycline|mesh-list
57138506|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57138507|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138508|NCT02220751|Doxycycline|doxycycline|mesh-list
57138509|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57138510|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138511|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
57138513|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
57138514|NCT02205541|Eculizumab|eculizumab|mesh-list
57138515|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
57138516|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57138517|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
57138518|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138519|NCT02205619|Glycine|glycine|mesh-list
57138520|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
57138521|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138522|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138523|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138524|NCT05504330|Aspirin|aspirin|mesh-list
57138525|NCT05504330|Clopidogrel|clopidogrel|mesh-list
57138526|NCT05504330|Atorvastatin|atorvastatin|mesh-list
57138527|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57138528|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57138529|NCT05504330|Analgesics|analgesics|mesh-ancestor
57138530|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
57138531|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138532|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138533|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138534|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57138535|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
57138536|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
57138537|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138538|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57138539|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57138540|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138541|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
57138542|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57138543|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57138544|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
57138545|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57138546|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57138547|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
57138548|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
57138549|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
57138550|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
57138551|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138552|NCT02220829|Silodosin|silodosin|mesh-list
57138553|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
57138554|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
57138555|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57138556|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
57138557|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138558|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138559|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138560|NCT02220829|Urological Agents|urological agents|mesh-ancestor
57138561|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
57138562|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57138563|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57138564|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
57138565|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138566|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57138567|NCT02215213|Vitamin D|vitamin d|mesh-list
57138568|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
57138569|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
57138570|NCT02215213|Vitamins|vitamins|mesh-list
57138571|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
57138572|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138573|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57138574|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57138575|NCT05564546|Nitric Oxide|nitric oxide|mesh-list
57138576|NCT05564546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57138577|NCT05564546|Autonomic Agents|autonomic agents|mesh-ancestor
57138578|NCT05564546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138579|NCT05564546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138580|NCT05564546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57138581|NCT05564546|Respiratory System Agents|respiratory system agents|mesh-ancestor
57138582|NCT05564546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
57138583|NCT05564546|Antioxidants|antioxidants|mesh-ancestor
57138584|NCT05564546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138585|NCT05564546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138586|NCT05564546|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
57138587|NCT05564546|Vasodilator Agents|vasodilator agents|mesh-ancestor
57138588|NCT05564546|Gasotransmitters|gasotransmitters|mesh-ancestor
57138589|NCT05564546|Protective Agents|protective agents|mesh-ancestor
57138590|NCT04419272|Methylphenidate|methylphenidate|mesh-list
57138591|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
57138592|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138593|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
57138594|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
57138595|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57138596|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138597|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
57138598|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138599|NCT02205775|Atorvastatin|atorvastatin|mesh-list
57138600|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
57138601|NCT02205775|Ezetimibe|ezetimibe|mesh-list
57138602|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57138603|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57138604|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
57138605|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138606|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57138607|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57138608|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138609|NCT02217787|PF-06372865|pf-06372865|mesh-list
57138610|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
57138611|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
57138612|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138613|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138614|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138615|NCT02205931|Topiramate|topiramate|mesh-list
57138616|NCT02205931|Lamotrigine|lamotrigine|mesh-list
57138617|NCT02205931|Zonisamide|zonisamide|mesh-list
57138618|NCT02205931|Carbamazepine|carbamazepine|mesh-list
57138619|NCT02205931|Phenytoin|phenytoin|mesh-list
57138620|NCT02205931|Rufinamide|rufinamide|mesh-list
57138621|NCT02205931|Levetiracetam|levetiracetam|mesh-list
57138622|NCT02205931|Valproic Acid|valproic acid|mesh-list
57138623|NCT02205931|Clonazepam|clonazepam|mesh-list
57138624|NCT02205931|Vigabatrin|vigabatrin|mesh-list
57138625|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
57138626|NCT02205931|Clobazam|clobazam|mesh-list
57138627|NCT02205931|Ethosuximide|ethosuximide|mesh-list
57138628|NCT02205931|Stiripentol|stiripentol|mesh-list
57138629|NCT02205931|Nitrazepam|nitrazepam|mesh-list
57138630|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57138631|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138632|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
57138633|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
57138634|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57138635|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138636|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57138637|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
57138638|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57138639|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138640|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57138641|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
57138642|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138643|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
57138644|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138645|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
57138646|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57138647|NCT02205931|Analgesics|analgesics|mesh-ancestor
57138648|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
57138649|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138650|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
57138651|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
57138652|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
57138653|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
57138654|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
57138655|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57138656|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
57138657|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
57138658|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57138659|NCT04528004|Niacinamide|niacinamide|mesh-list
57138660|NCT04528004|Niacin|niacin|mesh-list
57138661|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
57138662|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
57138663|NCT04528004|Vitamins|vitamins|mesh-ancestor
57138664|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
57138665|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138666|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57138667|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
57138668|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138669|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57138670|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
57138672|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
57138673|NCT02221063|Vitamins|vitamins|mesh-ancestor
57138674|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
57138675|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138676|NCT02220049|Bortezomib|bortezomib|mesh-list
57138677|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138678|NCT01351805|Vitamin D|vitamin d|mesh-list
57138679|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
57138680|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
57138681|NCT01351805|Vitamins|vitamins|mesh-list
57138682|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
57138683|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138684|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57138685|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57138686|NCT02206165|Amlodipine|amlodipine|mesh-list
57138687|NCT02206165|Candesartan|candesartan|mesh-list
57138688|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
57138689|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57138690|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56902653|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
57138691|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
57138692|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138693|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57138694|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138695|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
57138696|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57138697|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57138698|NCT04356950|Thrombin|thrombin|mesh-list
57138699|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
57138700|NCT04356950|Coagulants|coagulants|mesh-ancestor
57138701|NCT01295645|Cidofovir|cidofovir|mesh-list
57138702|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
57138703|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138704|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138705|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138706|NCT02425943|Mannitol|mannitol|mesh-list
57138707|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
57138708|NCT02425943|Diuretics|diuretics|mesh-ancestor
57138709|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
57138710|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138711|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
57138712|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57138713|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
57138714|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138715|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138716|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57138717|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
57138718|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
57138719|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
57138720|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57138721|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
57138722|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138723|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138724|NCT05563610|Amoxicillin|amoxicillin|mesh-list
57138725|NCT05563610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
57138726|NCT05563610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138727|NCT01198067|Pomalidomide|pomalidomide|mesh-list
57138728|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
57138729|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138730|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57138731|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57138732|NCT01198067|Growth Substances|growth substances|mesh-ancestor
57138733|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
57138734|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138735|NCT05503706|Selenium|selenium|mesh-list
57138736|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
57138737|NCT05503706|Salicylates|salicylates|mesh-list
57138738|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
57138739|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
57138740|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138741|NCT05503706|Protective Agents|protective agents|mesh-ancestor
57138742|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138743|NCT05503706|Trace Elements|trace elements|mesh-ancestor
57138744|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
57138745|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138746|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
57138747|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
57138748|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
57138749|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57138750|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57138751|NCT05503706|Analgesics|analgesics|mesh-ancestor
57138752|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
57138753|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138754|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138755|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57138756|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
57138757|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138759|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
57138760|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138761|NCT02174861|Analgesics|analgesics|mesh-ancestor
57138762|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
57138763|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138764|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138765|NCT02221375|Ciclesonide|ciclesonide|mesh-list
57138766|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
57138767|NCT02221375|Hormones|hormones|mesh-ancestor
57138768|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138769|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138770|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
57138771|NCT02399709|Simvastatin|simvastatin|mesh-list
57138772|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
57138773|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
57138774|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
57138775|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138776|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
57138777|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
57138778|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138779|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
57138780|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57138781|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138782|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138783|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57138784|NCT02220361|Analgesics|analgesics|mesh-ancestor
57138785|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
57138786|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138787|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57138788|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57138789|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57138790|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
57138791|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138792|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138793|NCT05175001|Betamethasone|betamethasone|mesh-list
57138794|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
57138795|NCT05175001|Ropivacaine|ropivacaine|mesh-list
57138796|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
57138797|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
57138798|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138799|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138800|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
57138801|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138802|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138803|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
57138804|NCT05175001|Hormones|hormones|mesh-ancestor
57138805|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138806|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57138807|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
57138808|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
57138809|NCT00140855|Ipilimumab|ipilimumab|mesh-list
57138810|NCT00140855|Antibodies|antibodies|mesh-list
57138811|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
57138812|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
57138813|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
56820572|NCT01021475|Domperidone|domperidone|mesh-list
57138814|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138815|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138816|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
57138817|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138818|NCT02399397|Fentanyl|fentanyl|mesh-list
57138819|NCT02399397|Midazolam|midazolam|mesh-list
57138820|NCT02399397|Anesthetics|anesthetics|mesh-list
57138821|NCT02399397|Propofol|propofol|mesh-list
57138822|NCT02399397|Rocuronium|rocuronium|mesh-list
57138823|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138824|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138825|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57138826|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57138827|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
57138828|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
57138829|NCT02399397|Narcotics|narcotics|mesh-ancestor
57138830|NCT02399397|Analgesics|analgesics|mesh-ancestor
57138831|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
57138832|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138833|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57138834|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57138835|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57138836|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57138837|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
57138838|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
57138839|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138840|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138841|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
57138842|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
57138843|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
57138844|NCT02221453|Triamcinolone|triamcinolone|mesh-list
57138845|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
57138846|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
57138847|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
57138848|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138849|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
57138850|NCT02221453|Hormones|hormones|mesh-ancestor
57138851|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138852|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138853|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57138854|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
57138855|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138856|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138857|NCT03106545|Bupivacaine|bupivacaine|mesh-list
57138858|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
57138859|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
57138860|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57138861|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138862|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
57138863|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138864|NCT02221531|Carbetocin|carbetocin|mesh-list
57138865|NCT02221531|Oxytocin|oxytocin|mesh-list
57138866|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
57138867|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57138868|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138869|NCT02231125|Losartan|losartan|mesh-list
57138870|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
57138871|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57138872|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
57138873|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
57138874|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138875|NCT02396433|Carboplatin|carboplatin|mesh-list
57138876|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
57138877|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138878|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138879|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138880|NCT02231203|Tocopherols|tocopherols|mesh-list
57138881|NCT02231203|Antioxidants|antioxidants|mesh-list
57138882|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138883|NCT02231203|Protective Agents|protective agents|mesh-ancestor
57138884|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138885|NCT02231203|Vitamins|vitamins|mesh-ancestor
57138886|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
57138887|NCT02231281|Ritonavir|ritonavir|mesh-list
57138888|NCT02231281|Lopinavir|lopinavir|mesh-list
57138889|NCT02231281|Tenofovir|tenofovir|mesh-list
57138890|NCT02231281|Lamivudine|lamivudine|mesh-list
57138892|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
57138893|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
57138894|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
57138895|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138896|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138897|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
57138898|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
57138899|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
57138900|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138901|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
57138902|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
57138903|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
57138904|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57138905|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
57138906|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57138907|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57138908|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
57138909|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138910|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138911|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57138912|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
57138913|NCT02780687|Afatinib|afatinib|mesh-list
57138914|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138915|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
57138916|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138917|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138918|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
57138919|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
57138920|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
57138921|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138922|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138923|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
57138924|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
57138925|NCT02147873|Azacitidine|azacitidine|mesh-list
57138926|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57138927|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
57138928|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138929|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138930|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138931|NCT02398929|Bisoprolol|bisoprolol|mesh-list
57138932|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
57138933|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
57138934|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
57138935|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138936|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138937|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
57138938|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
57138939|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
57138940|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
57138941|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57138942|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138943|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
57138944|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57138945|NCT02221765|Hormones|hormones|mesh-ancestor
57138946|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138947|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138948|NCT05069129|Vaccines|vaccines|mesh-list
57138949|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
57138950|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138951|NCT02396043|Cytarabine|cytarabine|mesh-list
57138952|NCT02396043|Dexamethasone|dexamethasone|mesh-list
57138953|NCT02396043|Prednisone|prednisone|mesh-list
57138954|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
57138955|NCT02396043|Methotrexate|methotrexate|mesh-list
57138956|NCT02396043|Vincristine|vincristine|mesh-list
57138957|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
57138958|NCT02396043|Pegaspargase|pegaspargase|mesh-list
57138959|NCT02396043|Asparaginase|asparaginase|mesh-list
57138960|NCT02396043|Pirarubicin|pirarubicin|mesh-list
57138961|NCT02396043|Doxorubicin|doxorubicin|mesh-list
57138962|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57138963|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
57138964|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57138965|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57138966|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
57138967|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
57138968|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57138969|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57138970|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
57138971|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57138972|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
57138973|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
57138974|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57138975|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57138976|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
57138977|NCT02396043|Hormones|hormones|mesh-ancestor
57138978|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57138979|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57138980|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57138981|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57138982|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
57138983|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57138984|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57138985|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
57138986|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
57138987|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
57138988|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
57138989|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
57138990|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57138991|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57138992|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
57138993|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
57138994|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
57138995|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
57138996|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
57138997|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
57138998|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
57138999|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57139000|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139001|NCT03544073|Leuprolide|leuprolide|mesh-list
57139002|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
57139003|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
57139004|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57139005|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139006|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
57139007|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139008|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
57139009|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139010|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
57139011|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
57139012|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57139013|NCT02781311|Finasteride|finasteride|mesh-list
57139014|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
57139015|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57139016|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139017|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139018|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
57139019|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139020|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139021|NCT02781311|Urological Agents|urological agents|mesh-ancestor
57139022|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
57139023|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57139024|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139025|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
57139026|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
57139027|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139028|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57139029|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
57139030|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139031|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
57139032|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
57139033|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139034|NCT02221999|Paclitaxel|paclitaxel|mesh-list
57139035|NCT02221999|Letrozole|letrozole|mesh-list
57139036|NCT02221999|Hormones|hormones|mesh-list
57139037|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56820786|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
57139038|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139039|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
57139040|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
57139041|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
57139042|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139043|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139044|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139045|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
57139046|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
57139047|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
57139048|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
57139049|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
57139050|NCT02564198|Ramucirumab|ramucirumab|mesh-list
57139051|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139052|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
57139053|NCT02398539|Triamcinolone|triamcinolone|mesh-list
57139054|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139055|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
57139056|NCT02398539|Hormones|hormones|mesh-ancestor
57139057|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
57139058|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139059|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
57139060|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139061|NCT02144753|Psyllium|psyllium|mesh-list
57139062|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
57139063|NCT02144753|Cathartics|cathartics|mesh-ancestor
57139064|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57139065|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
57139066|NCT02231905|Pramipexole|pramipexole|mesh-list
57139067|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
57139068|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139069|NCT02231905|Protective Agents|protective agents|mesh-ancestor
57139070|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139071|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
57139072|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
57139073|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
57139074|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
57139075|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139076|NCT02141087|Pirfenidone|pirfenidone|mesh-list
57139077|NCT02141087|Analgesics|analgesics|mesh-ancestor
57139078|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
57139079|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139080|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139081|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
57139082|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57139083|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
57139084|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
57139085|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139086|NCT02698293|Vitamin D|vitamin d|mesh-list
57139087|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
57139088|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
57139089|NCT02698293|Vitamins|vitamins|mesh-list
57139090|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
57139091|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139092|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
57139093|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
57139094|NCT02226289|Bevacizumab|bevacizumab|mesh-list
57139095|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
57139096|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139097|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
57139098|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
57139099|NCT02226289|Growth Substances|growth substances|mesh-ancestor
57139100|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139101|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
57139102|NCT04480593|Propolis|propolis|mesh-list
57139103|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
57139104|NCT05079217|Vaccines|vaccines|mesh-list
57139105|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
57139106|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820861|NCT02531568|Warfarin|warfarin|mesh-list
57139108|NCT02141321|Misoprostol|misoprostol|mesh-list
57139109|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
57139110|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
57139111|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
57139112|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139113|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
57139114|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57139115|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
57139116|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
57139117|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
57139118|NCT02141321|Urological Agents|urological agents|mesh-ancestor
57139119|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
57139120|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
57139121|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
57139122|NCT02141477|Decitabine|decitabine|mesh-list
57139123|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
57139124|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
57139125|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
57139126|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139127|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
57139128|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054996|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
57139129|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57139130|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
57139131|NCT02232139|Midazolam|midazolam|mesh-list
57139132|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
57139133|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57139134|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139135|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139136|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
57139137|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
57139138|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
57139139|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
57139140|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
57139141|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
57139142|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
57139143|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
57139144|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139145|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139146|NCT04288778|Metformin|metformin|mesh-list
57139147|NCT04288778|Canagliflozin|canagliflozin|mesh-list
57139148|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
57139149|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139150|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
57139151|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139152|NCT02226601|Aprepitant|aprepitant|mesh-list
57139153|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
57139154|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
57139155|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139156|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139157|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
57139158|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
57139159|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139160|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139161|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
57139162|NCT02397603|Bupivacaine|bupivacaine|mesh-list
57139163|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
57139164|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
57139165|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
57139166|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
57139167|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
57139168|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
57139169|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
57139170|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
57139171|NCT02397603|Analgesics|analgesics|mesh-ancestor
57139172|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
57139173|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
57139174|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
57139175|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
57139176|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
57139177|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
57139178|NCT02145065|Paclitaxel|paclitaxel|mesh-list
57139179|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
57139180|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820941|NCT01072812|Phenserine|phenserine|mesh-list
56821010|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56821011|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56821012|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56821013|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56821014|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
56821015|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
56821016|NCT03812380|Cathartics|cathartics|mesh-ancestor
56821017|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821018|NCT01085422|Temozolomide|temozolomide|mesh-list
56821019|NCT01085422|Veliparib|veliparib|mesh-list
56821020|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56821021|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
56821022|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821023|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821024|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56821025|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821026|NCT01085656|Combretastatin|combretastatin|mesh-list
56821027|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56821028|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821029|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
56821030|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
56821031|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
56821032|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821033|NCT01087138|Calcium|calcium|mesh-list
56821034|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56821035|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821036|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56821037|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
56821038|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821039|NCT00464087|Heparin|heparin|mesh-list
56821040|NCT00464087|Calcium heparin|calcium heparin|mesh-list
56821041|NCT00464087|PENTA|penta|mesh-list
56821042|NCT00464087|Bivalirudin|bivalirudin|mesh-list
56821043|NCT00464087|Fondaparinux|fondaparinux|mesh-list
56821044|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
56821045|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56821046|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56821047|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821048|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
56821049|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56821050|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
56821051|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821052|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56821053|NCT00452699|Fluticasone|fluticasone|mesh-list
56821054|NCT00452699|Xhance|xhance|mesh-list
56821055|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56821056|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821057|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56821058|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
56821059|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821060|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821061|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56821062|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
56821063|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
56821064|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56821065|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56821066|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56821067|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56821068|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
56821069|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821070|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821071|NCT00069784|Insulin|insulin|mesh-list
56821072|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56821073|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
56821074|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56821075|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821076|NCT00090610|Carboplatin|carboplatin|mesh-list
56821077|NCT00090610|Docetaxel|docetaxel|mesh-list
56821078|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821079|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56821080|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56821081|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56821082|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821083|NCT01326988|Anesthetics|anesthetics|mesh-list
56821084|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920142|NCT01212367|Interferons|interferons|mesh-list
56531952|NCT02878707|Analgesics|analgesics|mesh-ancestor
56821085|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821086|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
56821088|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56821089|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821090|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
56821091|NCT03962296|Coagulants|coagulants|mesh-ancestor
56821092|NCT01086046|Heparin|heparin|mesh-list
56821093|NCT01086046|Enoxaparin|enoxaparin|mesh-list
56821094|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56821095|NCT01086046|Tinzaparin|tinzaparin|mesh-list
56821096|NCT01086046|Dalteparin|dalteparin|mesh-list
56821097|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
56821098|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56821099|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56821100|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821101|NCT01090648|Etravirine|etravirine|mesh-list
56821102|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56821103|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56821104|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821105|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821106|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
56821107|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821108|NCT03741244|Temozolomide|temozolomide|mesh-list
56821109|NCT03741244|Apatinib|apatinib|mesh-list
56821110|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56821111|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
56821112|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821113|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821114|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56821115|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821116|NCT00463385|Thalidomide|thalidomide|mesh-list
56821117|NCT00463385|Prednisone|prednisone|mesh-list
56821118|NCT00463385|Pomalidomide|pomalidomide|mesh-list
56821119|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821120|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
56821121|NCT00463385|Hormones|hormones|mesh-ancestor
56821122|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56821123|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821124|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56821125|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821126|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
56821127|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56821128|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56821129|NCT00463385|Growth Substances|growth substances|mesh-ancestor
56821130|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
56821131|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821132|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
56821133|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56821134|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821135|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
56821136|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56821137|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56821138|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56821139|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56821140|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821141|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
56821142|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821143|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821144|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56821145|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821146|NCT00068692|Leucovorin|leucovorin|mesh-list
56821147|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
56821148|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56821149|NCT00068692|Fluorouracil|fluorouracil|mesh-list
56821150|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
56821151|NCT00068692|Irinotecan|irinotecan|mesh-list
56821152|NCT00068692|Camptothecin|camptothecin|mesh-list
56821153|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
56821154|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821155|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
56821156|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821157|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56821158|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821159|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532030|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
56335528|NCT00204919|Vitamins|vitamins|mesh-ancestor
56821169|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56821170|NCT00463151|Rebamipide|rebamipide|mesh-list
56821171|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56821172|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821173|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
56821174|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821175|NCT00463151|Protective Agents|protective agents|mesh-ancestor
56821176|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821177|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821178|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
56821179|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821180|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56821181|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821182|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821183|NCT00067990|Losartan|losartan|mesh-list
56821184|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56821185|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56821186|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56902667|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
56821187|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56821188|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821189|NCT00263328|Tacrolimus|tacrolimus|mesh-list
56821190|NCT00263328|Tofacitinib|tofacitinib|mesh-list
56821191|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821192|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
56821193|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821194|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56821195|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821196|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821197|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56821198|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56821199|NCT03741660|Cathartics|cathartics|mesh-ancestor
56821200|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821201|NCT00262860|Gemcitabine|gemcitabine|mesh-list
56821202|NCT00262860|Bortezomib|bortezomib|mesh-list
56821203|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56821204|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
56821205|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821206|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821207|NCT00262860|Antiviral Agents|antiviral agents|mesh-ancestor
56821208|NCT00262860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821209|NCT00262860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821210|NCT00262860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821211|NCT00262860|Immunologic Factors|immunologic factors|mesh-ancestor
56821212|NCT00262860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821213|NCT00236184|Rabeprazole|rabeprazole|mesh-list
56821214|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56821215|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821216|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56821217|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821218|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821219|NCT00296504|Ritonavir|ritonavir|mesh-list
56821220|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
56821221|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56821222|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56821223|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
56821224|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821225|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821226|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56557563|NCT02801188|Analgesics|analgesics|mesh-ancestor
56821227|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56821228|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
56821229|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821230|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56821231|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56821232|NCT00313820|Pregabalin|pregabalin|mesh-list
56821233|NCT00313820|Analgesics|analgesics|mesh-ancestor
56821234|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
56821235|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821236|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821237|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
56821238|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56821239|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56821240|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821241|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56821242|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56821243|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56821244|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821245|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56821246|NCT03781817|Ketamine|ketamine|mesh-list
56821247|NCT03781817|Analgesics|analgesics|mesh-ancestor
56821248|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
56821249|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821250|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821251|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56821252|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56821253|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
56821254|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
56821255|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821256|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56821257|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56821258|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821259|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821260|NCT00235872|Adalimumab|adalimumab|mesh-list
56821261|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821262|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56821263|NCT00461981|Vaccines|vaccines|mesh-list
56821264|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
56821265|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821266|NCT00296036|Pyridoxine|pyridoxine|mesh-list
56821267|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
56821268|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
56821269|NCT00296036|Vitamins|vitamins|mesh-ancestor
56821270|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
56821271|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821272|NCT01072890|Sirolimus|sirolimus|mesh-list
56821273|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56821274|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821275|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56821276|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821277|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
56821278|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821279|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
56821280|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821281|NCT00089674|Denosumab|denosumab|mesh-list
56821282|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56821283|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821284|NCT01090882|Bupivacaine|bupivacaine|mesh-list
56821285|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
56821286|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
56821287|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821288|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821289|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
56821290|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821291|NCT01067066|Temozolomide|temozolomide|mesh-list
56821292|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56821293|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
56821294|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821295|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821296|NCT00313586|Azacitidine|azacitidine|mesh-list
56821297|NCT00313586|Entinostat|entinostat|mesh-list
56821298|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56821299|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56821300|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
56821301|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821302|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821303|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821304|NCT01069328|Paclitaxel|paclitaxel|mesh-list
56821305|NCT01069328|Bevacizumab|bevacizumab|mesh-list
56821306|NCT01069328|Carboplatin|carboplatin|mesh-list
56821307|NCT01069328|Sorafenib|sorafenib|mesh-list
56821308|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56821309|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821310|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
56821311|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
56821312|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
56532185|NCT00977938|Aspirin|aspirin|mesh-list
56821313|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821314|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821315|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56821316|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56821317|NCT01069328|Growth Substances|growth substances|mesh-ancestor
56821318|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821319|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
56821320|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56821321|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821322|NCT01067222|Modafinil|modafinil|mesh-list
56821323|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56821324|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821325|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56821326|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56821327|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56821328|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821329|NCT00312572|Buprenorphine|buprenorphine|mesh-list
56821330|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56821331|NCT00312572|Narcotics|narcotics|mesh-ancestor
56821332|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821333|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821334|NCT00312572|Analgesics|analgesics|mesh-ancestor
56821335|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
56821336|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821337|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56821338|NCT00290732|Doxorubicin|doxorubicin|mesh-list
56821339|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56821340|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56821341|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821342|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56821343|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56821344|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821345|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821346|NCT00312494|Ziprasidone|ziprasidone|mesh-list
56821347|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56821348|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
56821349|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821350|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821351|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821352|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56821353|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56821354|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821355|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56821356|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56821357|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
56821358|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
56821359|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56821360|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56821361|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821362|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56821363|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56821364|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821365|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821366|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821367|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56821368|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
56821369|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56821370|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821371|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56821372|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56821373|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56821374|NCT00290498|Cytarabine|cytarabine|mesh-list
56821376|NCT00290498|Prednisone|prednisone|mesh-list
56821377|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
56821378|NCT00290498|Rituximab|rituximab|mesh-list
56821379|NCT00290498|Doxorubicin|doxorubicin|mesh-list
56821380|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56821381|NCT00290498|Methotrexate|methotrexate|mesh-list
56821382|NCT00290498|Vincristine|vincristine|mesh-list
56821383|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821384|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
56821385|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821386|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532252|NCT02437279|Nivolumab|nivolumab|mesh-list
56821387|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56821388|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
56821389|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821390|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821391|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56821392|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821393|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821394|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
56821395|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
56821396|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821397|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821398|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
56821399|NCT00290498|Hormones|hormones|mesh-ancestor
56821400|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56821401|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56821402|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56821403|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56821404|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56821405|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821406|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56821407|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
56821408|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56821409|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56821410|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
56821411|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
56821412|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56821413|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56821414|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
56821415|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821416|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56821417|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
56821418|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
56821419|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
56821420|NCT01069796|Paclitaxel|paclitaxel|mesh-list
56821421|NCT01069796|Bevacizumab|bevacizumab|mesh-list
56821422|NCT01069796|Capecitabine|capecitabine|mesh-list
56821423|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56821424|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821425|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
56821426|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
56821427|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
56821428|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821429|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821430|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56821431|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56821432|NCT01069796|Growth Substances|growth substances|mesh-ancestor
56821433|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821434|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
56821435|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56821436|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
56821437|NCT01067534|Albuterol|albuterol|mesh-list
56821438|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56821439|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
56821440|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821441|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821442|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56821443|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
56821444|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
56821445|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56821446|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56821447|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56821448|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56821451|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821452|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
56821453|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56821454|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
56821455|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
56821456|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821457|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
56821458|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821459|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56532329|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
56821460|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56821461|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56821462|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56821463|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56821464|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821465|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
56821466|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56821467|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821468|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
56821469|NCT01069874|Vitamin D|vitamin d|mesh-list
56821470|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
56821471|NCT01069874|Vitamins|vitamins|mesh-ancestor
56821472|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
56821473|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821474|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56821475|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56821477|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
56821478|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56821479|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
56821480|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56821481|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821482|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56821483|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56821484|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56821485|NCT01022645|Trace Elements|trace elements|mesh-ancestor
56821486|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
56821487|NCT01025765|Metformin|metformin|mesh-list
56821488|NCT01025765|Pioglitazone|pioglitazone|mesh-list
56821489|NCT01025765|Acarbose|acarbose|mesh-list
56821490|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56821491|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821492|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56821493|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821494|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821495|NCT03824912|Ketoconazole|ketoconazole|mesh-list
56821496|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
56821497|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821498|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56821499|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56821500|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821501|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821502|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56821503|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
56821504|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56821505|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821506|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56821507|NCT01062776|Furosemide|furosemide|mesh-list
56821508|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56821509|NCT01062776|Diuretics|diuretics|mesh-ancestor
56821510|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
56821511|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821512|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56821513|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56821514|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821515|NCT01025921|Colistin|colistin|mesh-list
56821516|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56821517|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821518|NCT01070030|Amlodipine|amlodipine|mesh-list
56821519|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56821520|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56821521|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56821522|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56821523|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821524|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56821525|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821526|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
56821527|NCT01070030|Diuretics|diuretics|mesh-ancestor
56821528|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
56821529|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56821530|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56821531|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
56821532|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56532410|NCT04075474|Listerine|listerine|mesh-list
56821533|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56821534|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821535|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821536|NCT00461123|Urological Agents|urological agents|mesh-ancestor
56821537|NCT00290342|Edetic Acid|edetic acid|mesh-list
56821538|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
56821539|NCT00290342|Antidotes|antidotes|mesh-ancestor
56821540|NCT00290342|Protective Agents|protective agents|mesh-ancestor
56821541|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821542|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
56821543|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
56821544|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821545|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56821546|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
56821547|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56821548|NCT00460811|Linaclotide|linaclotide|mesh-list
56821549|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56821550|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
56821551|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821552|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821553|NCT01070108|Ketamine|ketamine|mesh-list
56821554|NCT01070108|Analgesics|analgesics|mesh-ancestor
56821555|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
56821556|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821557|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821558|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56821559|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56821560|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
56821561|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
56821562|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821563|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56821564|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56821565|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821566|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821567|NCT01067690|Indinavir|indinavir|mesh-list
56821568|NCT01067690|Bleomycin|bleomycin|mesh-list
56821569|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56821570|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56821571|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
56821572|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821573|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821574|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56821575|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56821576|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
56821577|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821578|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56821579|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821580|NCT03977012|Buprenorphine|buprenorphine|mesh-list
56821581|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56821582|NCT03977012|Narcotics|narcotics|mesh-ancestor
56821583|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821584|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821585|NCT03977012|Analgesics|analgesics|mesh-ancestor
56821586|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
56821587|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821588|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56821589|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
56821590|NCT03982004|Imiquimod|imiquimod|mesh-list
56821591|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821592|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821593|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56821594|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
56821596|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
56821597|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56821598|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821599|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821600|NCT01062932|Cycloserine|cycloserine|mesh-list
56821601|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56821602|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821603|NCT01062932|Renal Agents|renal agents|mesh-ancestor
56821604|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56821605|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
56821606|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56821607|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
56920143|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
56821608|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821609|NCT01026311|Ubiquinone|ubiquinone|mesh-list
56821610|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
56821611|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
56821612|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821613|NCT01026311|Vitamins|vitamins|mesh-ancestor
56821614|NCT01063010|Bevacizumab|bevacizumab|mesh-list
56821615|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821616|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821617|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56821618|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56821619|NCT01063010|Growth Substances|growth substances|mesh-ancestor
56821620|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821621|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
56821622|NCT00460577|Bromides|bromides|mesh-list
56821623|NCT00460577|Fenoterol|fenoterol|mesh-list
56821624|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
56821625|NCT00460577|Ipratropium|ipratropium|mesh-list
56821626|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56821627|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
56821628|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821629|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821630|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56821631|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
56821632|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56821633|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56821634|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56821635|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
56821636|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821637|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821638|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
56821639|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56821640|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
56821641|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
56821642|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
56821643|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56821644|NCT01581320|Vitamin D|vitamin d|mesh-list
56821645|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
56821646|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
56821647|NCT01581320|Vitamins|vitamins|mesh-ancestor
56821648|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
56821649|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821650|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56821651|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56821652|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56821653|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821654|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821655|NCT00288704|Rilonacept|rilonacept|mesh-list
56821656|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821657|NCT00288626|Cytarabine|cytarabine|mesh-list
56821658|NCT00288626|Prednisone|prednisone|mesh-list
56821659|NCT00288626|Etoposide|etoposide|mesh-list
56821660|NCT00288626|Melphalan|melphalan|mesh-list
56821661|NCT00288626|Carmustine|carmustine|mesh-list
56821662|NCT00288626|Lenograstim|lenograstim|mesh-list
56821663|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821664|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
56821665|NCT00288626|Hormones|hormones|mesh-ancestor
56821666|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56821667|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821668|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56821669|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821670|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56821673|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821674|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821675|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56821676|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
56821677|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
56821678|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821679|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821680|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
56821681|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56821682|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
56821683|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56821684|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56821685|NCT00087490|Vancomycin|vancomycin|mesh-list
56821686|NCT00087490|Linezolid|linezolid|mesh-list
56821687|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56821688|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821689|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56821690|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821691|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821692|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
56821693|NCT00087178|Doxorubicin|doxorubicin|mesh-list
56821694|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56821695|NCT00087178|Fluorouracil|fluorouracil|mesh-list
56821696|NCT00087178|Epirubicin|epirubicin|mesh-list
56821697|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821698|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
56821699|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821700|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56821701|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56821702|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
56821703|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821704|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821705|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56821706|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56821707|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56821708|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56821709|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821710|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
56821711|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56821712|NCT00288080|Dexamethasone|dexamethasone|mesh-list
56821713|NCT00288080|Prednisone|prednisone|mesh-list
56821714|NCT00288080|Docetaxel|docetaxel|mesh-list
56821715|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
56821716|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821717|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
56821718|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
56821719|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821720|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821721|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821722|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
56821723|NCT00288080|Hormones|hormones|mesh-ancestor
56821724|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56821725|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56821726|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821727|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
56821728|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
56821729|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
56821730|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821731|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56821732|NCT01068392|Prednisolone|prednisolone|mesh-list
56821733|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
56821734|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821735|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821736|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
56821737|NCT01068392|Hormones|hormones|mesh-ancestor
56821738|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56821739|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821740|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56821741|NCT01086826|Cisplatin|cisplatin|mesh-list
56821742|NCT01086826|Docetaxel|docetaxel|mesh-list
56821743|NCT01086826|Fluorouracil|fluorouracil|mesh-list
56821744|NCT01086826|Cetuximab|cetuximab|mesh-list
56821745|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821746|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
56821747|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
56821748|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
56821749|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821750|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
56821751|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56821752|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821753|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
56821754|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821755|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821756|NCT00287690|Genistein|genistein|mesh-list
56821757|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56821758|NCT00287690|Protective Agents|protective agents|mesh-ancestor
56821759|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821760|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821761|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56821762|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821763|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821764|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
56821765|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56821766|NCT00287690|Estrogens|estrogens|mesh-ancestor
56821767|NCT00287690|Hormones|hormones|mesh-ancestor
56821768|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56821769|NCT01070186|Sunitinib|sunitinib|mesh-list
56821770|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821771|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56821772|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56821773|NCT01070186|Growth Substances|growth substances|mesh-ancestor
56821774|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821775|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
56821776|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56821777|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821778|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821779|NCT00066742|Etoposide|etoposide|mesh-list
56821780|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
56821781|NCT00066742|Tirapazamine|tirapazamine|mesh-list
56821782|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821783|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56821784|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56821785|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56821786|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821787|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821788|NCT01026467|Carboplatin|carboplatin|mesh-list
56821789|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821790|NCT01094158|Cholic Acids|cholic acids|mesh-list
56821791|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821792|NCT00460109|Rituximab|rituximab|mesh-list
56821793|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
56821794|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821795|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821796|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
56821797|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821798|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56821799|NCT03956212|Doxycycline|doxycycline|mesh-list
56821800|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56821801|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821802|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
56821803|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56821804|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56821805|NCT01091818|Midazolam|midazolam|mesh-list
56821806|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
56821807|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56821808|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821809|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821810|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56821811|NCT01091818|Analgesics|analgesics|mesh-ancestor
56821812|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
56821813|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821814|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56821815|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56821816|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56821817|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
56821818|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821819|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821820|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56821823|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56821824|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56821825|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
56821826|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
56821827|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
56821828|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
56821829|NCT01091896|Bevacizumab|bevacizumab|mesh-list
56821830|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821831|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821832|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56821833|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56821834|NCT01091896|Growth Substances|growth substances|mesh-ancestor
56821835|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821836|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56821837|NCT00065260|Cyclosporine|cyclosporine|mesh-list
56821838|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
56821839|NCT00065260|Cyclosporins|cyclosporins|mesh-list
56821840|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
56821841|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56821842|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821843|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821844|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56821845|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
56821846|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821847|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
56821848|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821849|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
56821850|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56821851|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56821852|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56821853|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821854|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
56821856|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56821857|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821858|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56821859|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56821860|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821861|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821862|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821863|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56821864|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56821865|NCT01094626|Secretin|secretin|mesh-list
56821866|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821867|NCT01094626|Hormones|hormones|mesh-ancestor
56821868|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56821869|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821870|NCT03956134|Tapentadol|tapentadol|mesh-list
56821871|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56821872|NCT03956134|Narcotics|narcotics|mesh-ancestor
56821873|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821874|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821875|NCT03956134|Analgesics|analgesics|mesh-ancestor
56821876|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
56821877|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821878|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56821879|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56821880|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56821881|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821882|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
56821883|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821884|NCT00460031|Ketoconazole|ketoconazole|mesh-list
56821885|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
56821886|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56821887|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56821888|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56821889|NCT00460031|Lenalidomide|lenalidomide|mesh-list
56821890|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
56821891|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821892|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56821893|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56821894|NCT00460031|Growth Substances|growth substances|mesh-ancestor
56821895|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
56821896|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821897|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821898|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
56821899|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56821900|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56821901|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56821902|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821903|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821904|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56821905|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
56821906|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56821907|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56821908|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
56821909|NCT00451217|Neostigmine|neostigmine|mesh-list
56821910|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56821911|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821912|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821913|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
56821914|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821915|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821916|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56821917|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
56821918|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821919|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56821920|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56821921|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56821922|NCT00459953|Nicotine|nicotine|mesh-list
56821923|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56821924|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
56821925|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821926|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821927|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56821928|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56821929|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
56821930|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56821931|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821932|NCT00459875|Sunitinib|sunitinib|mesh-list
56821933|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821934|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56821935|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56821936|NCT00459875|Growth Substances|growth substances|mesh-ancestor
56821937|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821938|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
56821939|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56821940|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821941|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821942|NCT00311402|Aspirin|aspirin|mesh-list
56821943|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56821944|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56821945|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56821946|NCT00311402|Analgesics|analgesics|mesh-ancestor
56821947|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
56821948|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56821949|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821950|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821951|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56821952|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56821953|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56821954|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821955|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56821956|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56821957|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821958|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
56821959|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56821960|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56821961|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56821962|NCT00450749|Lycopene|lycopene|mesh-list
56821963|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56821964|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
56821965|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821966|NCT00450749|Protective Agents|protective agents|mesh-ancestor
56821967|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821968|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56821969|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56821970|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821971|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56821972|NCT00292370|Paroxetine|paroxetine|mesh-list
56821973|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
56821974|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56821975|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56821976|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56821977|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56821978|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56821979|NCT00292370|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56821980|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56821981|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56821982|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821983|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532860|NCT05331781|Morphine|morphine|mesh-list
56821984|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
56821985|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56821986|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56821987|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56821988|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821989|NCT00065182|Docetaxel|docetaxel|mesh-list
56821990|NCT00065182|Topotecan|topotecan|mesh-list
56821991|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56821992|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
56821993|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
56821994|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
56821995|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821996|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56821997|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56821998|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821999|NCT01026701|Bortezomib|bortezomib|mesh-list
56822000|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822001|NCT01092130|Vitamin D|vitamin d|mesh-list
56822002|NCT01092130|Vitamins|vitamins|mesh-ancestor
56822003|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
56822004|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822005|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56822006|NCT00064792|Simvastatin|simvastatin|mesh-list
56822007|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56822008|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56822009|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
56822010|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822011|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56822012|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56822013|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822014|NCT01095016|Fenoterol|fenoterol|mesh-list
56822015|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56822016|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
56822017|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822018|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822019|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56822020|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
56822021|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
56822022|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
56822023|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56822024|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56822025|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56822026|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56822027|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
56822028|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822029|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822030|NCT01095172|Prednisolone|prednisolone|mesh-list
56822031|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56822032|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
56822033|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56822034|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
56822035|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
56822036|NCT01095172|Rituximab|rituximab|mesh-list
56822037|NCT01095172|Tacrolimus|tacrolimus|mesh-list
56822038|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56822039|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
56822040|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822041|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822042|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
56822044|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822045|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822046|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56822047|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822048|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822049|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822050|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
56822051|NCT01095172|Hormones|hormones|mesh-ancestor
56822052|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822053|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56822054|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
56822055|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
56822056|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822057|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822058|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56822059|NCT01095172|Protective Agents|protective agents|mesh-ancestor
56822060|NCT00286442|Metformin|metformin|mesh-list
56822061|NCT00286442|Alogliptin|alogliptin|mesh-list
56822062|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56822063|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822064|NCT00286442|Incretins|incretins|mesh-ancestor
56822065|NCT00286442|Hormones|hormones|mesh-ancestor
56822066|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822067|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56822068|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
56822069|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822070|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822071|NCT00063934|Docetaxel|docetaxel|mesh-list
56822072|NCT00063934|Doxorubicin|doxorubicin|mesh-list
56822073|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56822074|NCT00063934|Oblimersen|oblimersen|mesh-list
56822075|NCT00063934|Lenograstim|lenograstim|mesh-list
56822076|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822077|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
56822078|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
56822079|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
56822080|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822081|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56822082|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56822083|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56822084|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822085|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56822086|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
56822087|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822088|NCT00063154|Pertuzumab|pertuzumab|mesh-list
56822089|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822090|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822091|NCT01092520|Gabapentin|gabapentin|mesh-list
56822092|NCT01092520|Analgesics|analgesics|mesh-ancestor
56822093|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
56822094|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822095|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822096|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
56822097|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56822098|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56822099|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56822100|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56822101|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56822102|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56822103|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822104|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822105|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
56822106|NCT00458705|Thalidomide|thalidomide|mesh-list
56822107|NCT00458705|Dexamethasone|dexamethasone|mesh-list
56822108|NCT00458705|Doxorubicin|doxorubicin|mesh-list
56822109|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56822110|NCT00458705|Bortezomib|bortezomib|mesh-list
56822111|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822112|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
56822113|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
56822114|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822115|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822116|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822117|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
56822118|NCT00458705|Hormones|hormones|mesh-ancestor
56822119|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822120|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56822121|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822122|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56822123|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56822124|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56822125|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822126|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822127|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822128|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
56822129|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
56822130|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56822131|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822132|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56533003|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
56822133|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56822134|NCT00458705|Growth Substances|growth substances|mesh-ancestor
56822135|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
56822137|NCT00062374|Alovudine|alovudine|mesh-list
56822138|NCT00062374|Cisplatin|cisplatin|mesh-list
56822139|NCT00062374|Irinotecan|irinotecan|mesh-list
56822140|NCT00062374|Camptothecin|camptothecin|mesh-list
56822141|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56822142|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822143|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56822144|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56822145|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822146|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822147|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56822148|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56822149|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
56822150|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
56822151|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822152|NCT00285818|Mifepristone|mifepristone|mesh-list
56822153|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56822154|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
56822155|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56822156|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822157|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56822158|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56822159|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56822160|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
56822161|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56822162|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56822163|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
56822164|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822165|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
56822166|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56822167|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56822168|NCT01023347|Paclitaxel|paclitaxel|mesh-list
56822169|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56822170|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56822171|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822172|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
56822173|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
56822174|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
56822175|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822176|NCT01023425|Donepezil|donepezil|mesh-list
56822177|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56822178|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822179|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822180|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
56822181|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822182|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822183|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
56822184|NCT00285584|Bupropion|bupropion|mesh-list
56822185|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56822186|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
56822187|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56822188|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56822189|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56822190|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56822191|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822193|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822194|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822195|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56822196|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56822197|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822198|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56822199|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822200|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822201|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822202|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56822203|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
56822204|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822205|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
56822206|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822207|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533080|NCT04413253|Dexamethasone|dexamethasone|mesh-list
56822208|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56822209|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56822210|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56822211|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822212|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822213|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
56902692|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
56822214|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822215|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56822216|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56822217|NCT03955354|Apatinib|apatinib|mesh-list
56822218|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822219|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822220|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822221|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822222|NCT01095484|Rotigotine|rotigotine|mesh-list
56822223|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
56822224|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
56822225|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822226|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822227|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822228|NCT01063478|Everolimus|everolimus|mesh-list
56822229|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822230|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822231|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
56822232|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822233|NCT01327144|Acyclovir|acyclovir|mesh-list
56822234|NCT01327144|Famciclovir|famciclovir|mesh-list
56822235|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
56822236|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822237|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56822238|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822239|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822240|NCT01323101|Doxycycline|doxycycline|mesh-list
56822241|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56822242|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822243|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
56822244|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56822245|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56822246|NCT00310856|Vaccines|vaccines|mesh-list
56822247|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
56822248|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822249|NCT03670355|Tenofovir|tenofovir|mesh-list
56822250|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
56822251|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822252|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56822253|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56822254|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822255|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822256|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56822257|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56822258|NCT02532062|Vitamin D|vitamin d|mesh-list
56822259|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
56822260|NCT02532062|Vitamins|vitamins|mesh-ancestor
56822261|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
56822262|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822263|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56822266|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
56822267|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822268|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822269|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56822270|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
56822271|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822272|NCT00449033|Gemcitabine|gemcitabine|mesh-list
56822273|NCT00449033|Sorafenib|sorafenib|mesh-list
56822274|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822275|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56822276|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
56822277|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822278|NCT00449033|Antiviral Agents|antiviral agents|mesh-ancestor
56822279|NCT00449033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822280|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822281|NCT00449033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822282|NCT00449033|Immunologic Factors|immunologic factors|mesh-ancestor
56822283|NCT00449033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822284|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822285|NCT01024205|Sunitinib|sunitinib|mesh-list
56822286|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822287|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56822288|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56822289|NCT01024205|Growth Substances|growth substances|mesh-ancestor
56822290|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822291|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
56902693|NCT05435313|Irinotecan|irinotecan|mesh-list
56822292|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822293|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822294|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822295|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
56822296|NCT00448019|Bevacizumab|bevacizumab|mesh-list
56822297|NCT00448019|Rituximab|rituximab|mesh-list
56822298|NCT00448019|Fludarabine|fludarabine|mesh-list
56822299|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
56822300|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822301|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
56822302|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822303|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822304|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56822305|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
56822306|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822307|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822308|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56822309|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822310|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56822311|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56822312|NCT00448019|Growth Substances|growth substances|mesh-ancestor
56822313|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
56822314|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56822315|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
56822316|NCT00457691|Leucovorin|leucovorin|mesh-list
56822317|NCT00457691|Fluorouracil|fluorouracil|mesh-list
56822318|NCT00457691|Irinotecan|irinotecan|mesh-list
56822319|NCT00457691|Sunitinib|sunitinib|mesh-list
56822320|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
56822321|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
56822322|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822323|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56822324|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822325|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822326|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
56822327|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822328|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56822329|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56822330|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822331|NCT00457691|Antidotes|antidotes|mesh-ancestor
56822332|NCT00457691|Protective Agents|protective agents|mesh-ancestor
56822333|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
56822334|NCT00457691|Vitamins|vitamins|mesh-ancestor
56822335|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
56822336|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56822337|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56822338|NCT00457691|Growth Substances|growth substances|mesh-ancestor
56822342|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822343|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822344|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822345|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822346|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
56822347|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
56822348|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56822349|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822350|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822351|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
56822352|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56822353|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56822354|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822355|NCT00446849|Mesalamine|mesalamine|mesh-list
56822356|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56533225|NCT01074255|Aprepitant|aprepitant|mesh-list
56822357|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56822358|NCT00446849|Analgesics|analgesics|mesh-ancestor
56822359|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
56822360|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822361|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822362|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822363|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822365|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822366|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822367|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56822368|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822369|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
56822370|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56822371|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822372|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56822373|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
56822374|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56822375|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822376|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822377|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822378|NCT00456599|Gemcitabine|gemcitabine|mesh-list
56822379|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
56822380|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56822381|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
56822382|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822383|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822384|NCT00456599|Antiviral Agents|antiviral agents|mesh-ancestor
56822385|NCT00456599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822386|NCT00456599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822387|NCT00456599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822388|NCT00456599|Immunologic Factors|immunologic factors|mesh-ancestor
56822389|NCT00456599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822390|NCT00456521|Naltrexone|naltrexone|mesh-list
56822391|NCT00456521|Bupropion|bupropion|mesh-list
56822392|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56822393|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56822394|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822395|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
56822396|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822397|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56822398|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
56822399|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56822400|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56822401|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56822402|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56822403|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822404|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
56822405|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822406|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56822407|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56822408|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822409|NCT00456365|Pravastatin|pravastatin|mesh-list
56822412|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
56822413|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822414|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56822415|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56822416|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822417|NCT03843047|Nicotine|nicotine|mesh-list
56822418|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56822419|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
56822420|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822421|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822422|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56822423|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56822424|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
56822425|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822426|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822427|NCT00455741|Estradiol|estradiol|mesh-list
56822428|NCT00455741|Progesterone|progesterone|mesh-list
56822429|NCT00455741|Estrogens|estrogens|mesh-ancestor
56822430|NCT00455741|Hormones|hormones|mesh-ancestor
56822431|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822432|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822433|NCT00455741|Progestins|progestins|mesh-ancestor
56822434|NCT00445679|Paroxetine|paroxetine|mesh-list
56822435|NCT00445679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56822436|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56822437|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56822438|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822439|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822440|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
56822441|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822442|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56822443|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
56822444|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56822445|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56822446|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56822447|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822448|NCT00445601|Gemcitabine|gemcitabine|mesh-list
56822449|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56822450|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
56822451|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822452|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822453|NCT00445601|Antiviral Agents|antiviral agents|mesh-ancestor
56822454|NCT00445601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822455|NCT00445601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822456|NCT00445601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822457|NCT00445601|Immunologic Factors|immunologic factors|mesh-ancestor
56822458|NCT00445601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822459|NCT00444587|Trastuzumab|trastuzumab|mesh-list
56822460|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822461|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822462|NCT03841331|Serlopitant|serlopitant|mesh-list
56822463|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56822464|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822465|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822466|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822467|NCT00235716|Vitamins|vitamins|mesh-list
56822468|NCT00235716|Vitamin E|vitamin e|mesh-list
56822469|NCT00235716|Tocopherols|tocopherols|mesh-list
56822470|NCT00235716|Tocotrienols|tocotrienols|mesh-list
56822471|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
56822472|NCT00235716|Memantine|memantine|mesh-list
56822473|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
56822474|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822475|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
56822476|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822477|NCT00235716|Protective Agents|protective agents|mesh-ancestor
56822478|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56822479|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56822480|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
56822481|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822482|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56822483|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56822484|NCT00274742|Blinatumomab|blinatumomab|mesh-list
56822485|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56822486|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822487|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
56822488|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822489|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
56822490|NCT03970044|Exenatide|exenatide|mesh-list
56822491|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56822492|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822493|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56822494|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822495|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56822496|NCT03970044|Incretins|incretins|mesh-ancestor
56822497|NCT03970044|Hormones|hormones|mesh-ancestor
56822498|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822499|NCT00444275|Esomeprazole|esomeprazole|mesh-list
56822500|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56822501|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822502|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56822503|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822504|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822505|NCT00454805|Fulvestrant|fulvestrant|mesh-list
56822506|NCT00454805|Cediranib|cediranib|mesh-list
56822507|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56822508|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822509|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56822510|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56822511|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
56822512|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822513|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822514|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822515|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822516|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822517|NCT00283244|Gemcitabine|gemcitabine|mesh-list
56822518|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56822519|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56822520|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
56822521|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822522|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822523|NCT00283244|Antiviral Agents|antiviral agents|mesh-ancestor
56822524|NCT00283244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822525|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822526|NCT00283244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822527|NCT00283244|Immunologic Factors|immunologic factors|mesh-ancestor
56822528|NCT00283244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822529|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822530|NCT00282464|Ziprasidone|ziprasidone|mesh-list
56822531|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56822532|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
56822533|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822534|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822535|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822536|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56822537|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56822538|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56822539|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56822540|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56822541|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
56822542|NCT00262080|Ecallantide|ecallantide|mesh-list
56822543|NCT00262080|Analgesics|analgesics|mesh-ancestor
56822544|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
56822545|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822546|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822547|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56822548|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56822549|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822550|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822551|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
56822552|NCT01073904|Norgestrel|norgestrel|mesh-list
56822553|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56822554|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
56822555|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56822556|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822558|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56822559|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56822560|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56822561|NCT00282308|Rituximab|rituximab|mesh-list
56822562|NCT00282308|Methotrexate|methotrexate|mesh-list
56822563|NCT00282308|Vaccines|vaccines|mesh-list
56822564|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56822565|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56822566|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
56822567|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822568|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822569|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822570|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822571|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56822572|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
56822573|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56822574|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56822575|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
56822576|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822577|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
56822578|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822579|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56920144|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
56533447|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
56822580|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822581|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56822582|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56822583|NCT00281840|Bevacizumab|bevacizumab|mesh-list
56822584|NCT00281840|Docetaxel|docetaxel|mesh-list
56822585|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822586|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822587|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56822588|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56822589|NCT00281840|Growth Substances|growth substances|mesh-ancestor
56822590|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822591|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
56822592|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
56822593|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
56822594|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
56822595|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822596|NCT00272792|Verapamil|verapamil|mesh-list
56822597|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56822598|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56822599|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56822600|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822601|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56822602|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822603|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
56822604|NCT01069094|Leuprolide|leuprolide|mesh-list
56822605|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56822606|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
56822607|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56822608|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822609|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56822610|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822611|NCT00048568|Methotrexate|methotrexate|mesh-list
56822612|NCT00048568|Abatacept|abatacept|mesh-list
56822613|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56822614|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
56822615|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56822616|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822617|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56822618|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
56822619|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822620|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822621|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
56822622|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822623|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56822624|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822625|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
56822626|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822627|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56822628|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56822630|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
56822631|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822632|NCT01584076|Donepezil|donepezil|mesh-list
56822633|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56822634|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822635|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822636|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
56822637|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822638|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822639|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
56822640|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
56822641|NCT03954964|Narcotics|narcotics|mesh-ancestor
56822642|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56822643|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822644|NCT03954964|Analgesics|analgesics|mesh-ancestor
56822645|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
56822646|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822647|NCT00281528|Paclitaxel|paclitaxel|mesh-list
56822648|NCT00281528|Bevacizumab|bevacizumab|mesh-list
56822649|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56822650|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56822651|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822652|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
56822653|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
56822654|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
56822655|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822656|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822657|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56822658|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56822659|NCT00281528|Growth Substances|growth substances|mesh-ancestor
56822660|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822661|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
56822662|NCT01095640|Adapalene|adapalene|mesh-list
56822663|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56822664|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56822665|NCT01095640|Analgesics|analgesics|mesh-ancestor
56822666|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
56822667|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822668|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822669|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822670|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822671|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
56822672|NCT00280748|Pemetrexed|pemetrexed|mesh-list
56822673|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822674|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822675|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822676|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56822677|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56822678|NCT03975374|Tobramycin|tobramycin|mesh-list
56822679|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56822680|NCT03975374|Dexamethasone|dexamethasone|mesh-list
56822681|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56822682|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822683|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
56822684|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
56822685|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822686|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822687|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822688|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
56822689|NCT03975374|Hormones|hormones|mesh-ancestor
56822690|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822691|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56822692|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822693|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56822694|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822695|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56822696|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
56822697|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822698|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822699|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56822700|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
56822701|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
56822702|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822704|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822705|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56822706|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56822707|NCT03976544|Estradiol|estradiol|mesh-list
56822708|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56822709|NCT03976544|Progesterone|progesterone|mesh-list
56822710|NCT03976544|Estrogens|estrogens|mesh-ancestor
56822711|NCT03976544|Hormones|hormones|mesh-ancestor
56822712|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822713|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822714|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56822715|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
56822716|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56822717|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56822718|NCT03976544|Progestins|progestins|mesh-ancestor
56822719|NCT01093300|Paclitaxel|paclitaxel|mesh-list
56822720|NCT01093300|Everolimus|everolimus|mesh-list
56822721|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56822722|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822723|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
56822724|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
56822725|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
56822726|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822727|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822728|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
56822729|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822730|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56822731|NCT03741686|Cathartics|cathartics|mesh-ancestor
56822732|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822733|NCT00279812|Selenium|selenium|mesh-list
56822734|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
56822735|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822736|NCT00279812|Protective Agents|protective agents|mesh-ancestor
56822737|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822738|NCT00279812|Trace Elements|trace elements|mesh-ancestor
56822739|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
56822740|NCT01070732|Acetaminophen|acetaminophen|mesh-list
56822741|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56822742|NCT01070732|Analgesics|analgesics|mesh-ancestor
56822743|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
56822744|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822745|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822746|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
56822747|NCT00207714|Golimumab|golimumab|mesh-list
56822748|NCT00207714|Infliximab|infliximab|mesh-list
56822749|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
56822750|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822751|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822752|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56822753|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822754|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822755|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
56822756|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822757|NCT00207090|Rifampin|rifampin|mesh-list
56822758|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56822759|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
56822760|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56822761|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822762|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
56822763|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56822764|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822765|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822766|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56822767|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56822768|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56822769|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56822770|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56822771|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56822772|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
56822773|NCT00059332|Analgesics|analgesics|mesh-ancestor
56822774|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
56822775|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822776|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822777|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
56822780|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
56822781|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56822782|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56822783|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822784|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56822785|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
56822786|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56822787|NCT00233454|Midostaurin|midostaurin|mesh-list
56822788|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822789|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822790|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822791|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822792|NCT00047320|Carboplatin|carboplatin|mesh-list
56822793|NCT00047320|Etoposide|etoposide|mesh-list
56822794|NCT00047320|Ifosfamide|ifosfamide|mesh-list
56822795|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
56822796|NCT00047320|Thiotepa|thiotepa|mesh-list
56822797|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822798|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56822799|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56822800|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56822801|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822802|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822803|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56822804|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
56822805|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56822806|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822807|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
56822808|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822809|NCT00233064|Palivizumab|palivizumab|mesh-list
56822810|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
56822811|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822812|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
56822813|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56822814|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56822815|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822816|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822817|NCT03973086|Protective Agents|protective agents|mesh-ancestor
56822818|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822819|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
56822820|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56822821|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822822|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56822823|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
56822824|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56822825|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822826|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822827|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822828|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
56822829|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56822830|NCT00278954|Antibodies|antibodies|mesh-list
56822831|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
56822832|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56822833|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
56822834|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822835|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
56822836|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56822837|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56822838|NCT00278564|Prednisolone|prednisolone|mesh-list
56822839|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
56822840|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
56822841|NCT00278564|Rituximab|rituximab|mesh-list
56822842|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56822843|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
56822844|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822845|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
56822846|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822847|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822848|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56822849|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
56822850|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822852|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56822853|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822854|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822856|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
56822857|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822858|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822859|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
56822860|NCT00278564|Hormones|hormones|mesh-ancestor
56822861|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822862|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56822863|NCT00278564|Protective Agents|protective agents|mesh-ancestor
56822864|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56822865|NCT01071564|R04929097|r04929097|mesh-list
56822866|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822867|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822868|NCT00268346|Gefitinib|gefitinib|mesh-list
56822869|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822870|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822871|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822872|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822873|NCT00250718|Levofloxacin|levofloxacin|mesh-list
56822874|NCT00250718|Ofloxacin|ofloxacin|mesh-list
56822875|NCT00250718|Dexamethasone|dexamethasone|mesh-list
56822876|NCT00250718|Rituximab|rituximab|mesh-list
56822877|NCT00250718|Etoposide|etoposide|mesh-list
56822878|NCT00250718|Vincristine|vincristine|mesh-list
56822879|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822880|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822881|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
56822882|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822883|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822884|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822885|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
56822886|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
56822887|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822888|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822889|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
56822890|NCT00250718|Hormones|hormones|mesh-ancestor
56822891|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56822892|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56822893|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56822894|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56822895|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56822896|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822897|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822898|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
56822899|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
56822900|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
56822901|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56822902|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822903|NCT00250718|Renal Agents|renal agents|mesh-ancestor
56822904|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56822905|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56822906|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56822907|NCT00276614|Bortezomib|bortezomib|mesh-list
56822908|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822909|NCT00276458|Atorvastatin|atorvastatin|mesh-list
56822910|NCT00276458|Ezetimibe|ezetimibe|mesh-list
56822911|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56822912|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56822913|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
56822914|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822915|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56822916|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56822917|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822918|NCT00276380|Aspirin|aspirin|mesh-list
56822919|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56822920|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56822921|NCT00276380|Analgesics|analgesics|mesh-ancestor
56822922|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
56822923|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557582|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56822924|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822925|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56822926|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56822927|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56822928|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56822929|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822930|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56822931|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56822932|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822934|NCT02531984|Azithromycin|azithromycin|mesh-list
56822935|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56822936|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822937|NCT00267956|Ustekinumab|ustekinumab|mesh-list
56822938|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
56822939|NCT00267488|Topotecan|topotecan|mesh-list
56822940|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56822941|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56822942|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822943|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822944|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822945|NCT01073696|Granisetron|granisetron|mesh-list
56822946|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
56822947|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
56822948|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56822949|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822950|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56822951|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56822952|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
56822953|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56822954|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822955|NCT00046930|Cytarabine|cytarabine|mesh-list
56533821|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
56822956|NCT00046930|Daunorubicin|daunorubicin|mesh-list
56822957|NCT00046930|Molgramostim|molgramostim|mesh-list
56822958|NCT00046930|Lenograstim|lenograstim|mesh-list
56822959|NCT00046930|Sargramostim|sargramostim|mesh-list
56822960|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56822961|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
56822962|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822963|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822964|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
56822965|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56822966|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56822967|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
56822968|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822969|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56822970|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56822971|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56822972|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56822973|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822974|NCT00058552|Pertuzumab|pertuzumab|mesh-list
56822975|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56822976|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822977|NCT01093768|Vasopressins|vasopressins|mesh-list
56822978|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
56822979|NCT01093768|Oxytocin|oxytocin|mesh-list
56822980|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
56822981|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56822982|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822983|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
56822984|NCT01093768|Coagulants|coagulants|mesh-ancestor
56822985|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56822986|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56822987|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
56822988|NCT00044512|Sorafenib|sorafenib|mesh-list
56822989|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56822990|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56822991|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56822992|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56822993|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
56822994|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
56822995|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
56822996|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56822997|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56822998|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
56557584|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
56822999|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823001|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
56823002|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56823003|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823004|NCT03953716|Desogestrel|desogestrel|mesh-list
56823005|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56823006|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56823007|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56823008|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
56823009|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56823010|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823011|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56823012|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56823013|NCT03953716|Progestins|progestins|mesh-ancestor
56823014|NCT03953716|Hormones|hormones|mesh-ancestor
56823015|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823016|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
56823017|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56823018|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
56823019|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56823020|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823021|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56823022|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56823023|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56823024|NCT00147537|Paclitaxel|paclitaxel|mesh-list
56823025|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56823026|NCT00147537|Carboplatin|carboplatin|mesh-list
56823027|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56823028|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56823029|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56823030|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823031|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
56823032|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
56823033|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
56823034|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823035|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56823036|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823037|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
56823038|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823040|NCT00222729|Pemetrexed|pemetrexed|mesh-list
56823041|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823042|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823043|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823044|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823045|NCT00222729|Growth Substances|growth substances|mesh-ancestor
56823046|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823047|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823048|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823049|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823050|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56823051|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56823052|NCT00147225|Carboplatin|carboplatin|mesh-list
56823053|NCT00147225|Doxorubicin|doxorubicin|mesh-list
56823054|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56823055|NCT00147225|Ifosfamide|ifosfamide|mesh-list
56823056|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823057|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56823058|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56823059|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56823060|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823061|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823062|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56823063|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
56823064|NCT00222105|Thalidomide|thalidomide|mesh-list
56823065|NCT00222105|Dexamethasone|dexamethasone|mesh-list
56823066|NCT00222105|Doxorubicin|doxorubicin|mesh-list
56823067|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56823068|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823069|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
56823070|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
56823071|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823072|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823073|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56337466|NCT00216931|Iloprost|iloprost|mesh-list
56823076|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823077|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56823078|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823079|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56823080|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56823081|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56823082|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823083|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823084|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823085|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
56823086|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
56823087|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56823088|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823089|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823090|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823091|NCT00222105|Growth Substances|growth substances|mesh-ancestor
56823092|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823093|NCT00247676|Sunitinib|sunitinib|mesh-list
56823094|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823095|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823096|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823097|NCT00247676|Growth Substances|growth substances|mesh-ancestor
56823098|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823099|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823100|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56823101|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823102|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823103|NCT00267020|Gemcitabine|gemcitabine|mesh-list
56823104|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56823105|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
56533969|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56823106|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823107|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823108|NCT00267020|Antiviral Agents|antiviral agents|mesh-ancestor
56823109|NCT00267020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823110|NCT00267020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823111|NCT00267020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823112|NCT00267020|Immunologic Factors|immunologic factors|mesh-ancestor
56823113|NCT00267020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823114|NCT03975062|Dabigatran|dabigatran|mesh-list
56823115|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
56823116|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56823117|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
56823118|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823119|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823120|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
56823121|NCT03970772|Glucagon|glucagon|mesh-list
56823122|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56823123|NCT03970772|Hormones|hormones|mesh-ancestor
56823124|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823125|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823126|NCT00242216|Ritonavir|ritonavir|mesh-list
56823127|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56823128|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
56823129|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56823130|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56823131|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
56823132|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823133|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823134|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56823135|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56823136|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
56823137|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823138|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56823139|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56823140|NCT00240110|Valproic Acid|valproic acid|mesh-list
56823141|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
56823142|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
56823143|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56823144|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823145|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823147|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56823148|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823149|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823150|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
56823151|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
56823152|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823153|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
56823154|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
56823155|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823156|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823157|NCT02532140|Cefepime|cefepime|mesh-list
56823158|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56823159|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823160|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
56823161|NCT00266864|Testosterone|testosterone|mesh-list
56823162|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
56823163|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
56823164|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56823165|NCT00266864|Androgens|androgens|mesh-ancestor
56823166|NCT00266864|Hormones|hormones|mesh-ancestor
56823167|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823168|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823169|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56823170|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823171|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
56823172|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
56823173|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
56823174|NCT00266708|Diphosphonates|diphosphonates|mesh-list
56902716|NCT01321905|Vitamin D|vitamin d|mesh-list
56823175|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56823176|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56823177|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823178|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56534047|NCT02839135|Scopolamine|scopolamine|mesh-list
56823179|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823180|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56823182|NCT00266630|Valproic Acid|valproic acid|mesh-list
56823183|NCT00266630|Olanzapine|olanzapine|mesh-list
56823184|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
56823185|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
56823186|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823187|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823188|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56823189|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56823190|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56823191|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823192|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56823193|NCT00266630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56823194|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56823195|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56823196|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823197|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823198|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
56823199|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823200|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
56823201|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
56823202|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
56823203|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56823204|NCT00266630|Analgesics|analgesics|mesh-ancestor
56823205|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
56823206|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56823207|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56823208|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56823209|NCT02531672|Choline|choline|mesh-list
56823210|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
56823211|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56823212|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
56823213|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823214|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56823215|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56823216|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
56823217|NCT00129129|Vaccines|vaccines|mesh-list
56823218|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
56823219|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823220|NCT00221403|Valproic Acid|valproic acid|mesh-list
56823221|NCT00221403|Risperidone|risperidone|mesh-list
56823223|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56823224|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
56823225|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823226|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823227|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823228|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56823229|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56823230|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823231|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56823232|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56823233|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
56823234|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
56823235|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823236|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
56823237|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
56823238|NCT00145977|Vitamin D|vitamin d|mesh-list
56823239|NCT00145977|Alendronate|alendronate|mesh-list
56823240|NCT00145977|Calcium|calcium|mesh-list
56823241|NCT00145977|Vitamins|vitamins|mesh-ancestor
56823242|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
56823243|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823244|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56823245|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56823246|NCT00238238|Rituximab|rituximab|mesh-list
56823247|NCT00238238|Lenalidomide|lenalidomide|mesh-list
56823248|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823249|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823250|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
56823251|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823252|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823253|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823254|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823255|NCT00238238|Growth Substances|growth substances|mesh-ancestor
56823256|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823257|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
56823258|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
56823259|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56823260|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56823261|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823262|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823263|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823264|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823265|NCT01071122|Valsartan|valsartan|mesh-list
56823266|NCT01071122|Nifedipine|nifedipine|mesh-list
56823267|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56823268|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56823269|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56823270|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823271|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56823272|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56823273|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56823274|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823275|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
56823276|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
56823277|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56823278|NCT01072604|Aspirin|aspirin|mesh-list
56823279|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56823280|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56823281|NCT01072604|Analgesics|analgesics|mesh-ancestor
56823282|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
56823283|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823284|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823285|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823286|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823287|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56823288|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56823289|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823290|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56823291|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56823292|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823293|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
56823294|NCT00128661|Vaccines|vaccines|mesh-list
56823295|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
56823296|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823298|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56823299|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56823300|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823301|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823302|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56823304|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
56823305|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56823306|NCT03965949|Hormones|hormones|mesh-list
56823307|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823308|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823309|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
56823310|NCT00220779|Antibodies|antibodies|mesh-list
56823311|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
56823312|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56823313|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56823314|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
56823315|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
56823316|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823317|NCT00207740|Golimumab|golimumab|mesh-list
56823318|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56823319|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823320|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823321|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
56823322|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823323|NCT00265382|Ziprasidone|ziprasidone|mesh-list
56823324|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56823325|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
56823326|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823327|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823328|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823329|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56823330|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56823331|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823332|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56534196|NCT01228175|Riboflavin|riboflavin|mesh-list
56823333|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56823334|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
56823335|NCT03974984|Anesthetics|anesthetics|mesh-list
56823336|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823337|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823338|NCT00206726|Fludarabine|fludarabine|mesh-list
56823339|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
56823340|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823341|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823342|NCT00237458|Lacosamide|lacosamide|mesh-list
56823343|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
56823344|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56823345|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56823346|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56823347|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823348|NCT01581788|Valproic Acid|valproic acid|mesh-list
56823349|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
56823350|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823351|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823352|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
56823353|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823354|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823355|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
56823356|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56823357|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823358|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56823359|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
56823360|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56823361|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823362|NCT00043186|Denosumab|denosumab|mesh-list
56823363|NCT00043186|Alendronate|alendronate|mesh-list
56823364|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56823365|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823366|NCT00041470|Paclitaxel|paclitaxel|mesh-list
56823367|NCT00041470|Vinorelbine|vinorelbine|mesh-list
56823368|NCT00041470|Trastuzumab|trastuzumab|mesh-list
56823369|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56823370|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823371|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56823374|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823375|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823376|NCT03953950|Losartan|losartan|mesh-list
56823377|NCT03953950|Spironolactone|spironolactone|mesh-list
56823378|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56823379|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56823380|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56823381|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56823382|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823383|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56823384|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
56823385|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823386|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823387|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56823388|NCT03953950|Diuretics|diuretics|mesh-ancestor
56823389|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
56823390|NCT00206102|Risperidone|risperidone|mesh-list
56823391|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56823392|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56823393|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
56823394|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823395|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823396|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823397|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56823398|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56823399|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823400|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56823401|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56823402|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
56823403|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
56823404|NCT03954262|Propofol|propofol|mesh-list
56823405|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56823406|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920145|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56823408|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56823409|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
56823410|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
56823411|NCT00041080|Tamoxifen|tamoxifen|mesh-list
56823412|NCT00041080|Thalidomide|thalidomide|mesh-list
56823413|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56823414|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56823415|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823416|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823417|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56823418|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823419|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56823420|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56823421|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56823422|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823423|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
56823424|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
56823425|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56823426|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823427|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823428|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823429|NCT00041080|Growth Substances|growth substances|mesh-ancestor
56823430|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823431|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
56823432|NCT00205712|Ketamine|ketamine|mesh-list
56823433|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56823434|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823435|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823436|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56823437|NCT00205712|Analgesics|analgesics|mesh-ancestor
56823438|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
56823439|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823440|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56823441|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56823442|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56823443|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
56823445|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823446|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56823447|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56823448|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
56823450|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56823451|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56823452|NCT03969758|Metronidazole|metronidazole|mesh-list
56823453|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
56823454|NCT03969758|Cefixime|cefixime|mesh-list
56823455|NCT03969758|Liver Extracts|liver extracts|mesh-list
56823456|NCT03969758|Hematinics|hematinics|mesh-ancestor
56823457|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823458|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56823459|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56823460|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56823461|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56823462|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56823463|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823464|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823465|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823466|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56823467|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56823468|NCT00203294|Triamcinolone|triamcinolone|mesh-list
56823469|NCT00203294|Lidocaine|lidocaine|mesh-list
56823470|NCT00203294|Bupivacaine|bupivacaine|mesh-list
56823471|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
56823472|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
56823473|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56823474|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823475|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
56823476|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902719|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
56823477|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56823478|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56823479|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56823480|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56823481|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823482|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823483|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
56823485|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823486|NCT01074086|Everolimus|everolimus|mesh-list
56823487|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823488|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823489|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
56823490|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823491|NCT00264290|Valganciclovir|valganciclovir|mesh-list
56823492|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
56823493|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823494|NCT00234494|Gemcitabine|gemcitabine|mesh-list
56823495|NCT00234494|Bevacizumab|bevacizumab|mesh-list
56823496|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823497|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823498|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823499|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823500|NCT00234494|Growth Substances|growth substances|mesh-ancestor
56823501|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823502|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823503|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56823504|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
56823505|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823506|NCT00234494|Antiviral Agents|antiviral agents|mesh-ancestor
56823507|NCT00234494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823508|NCT00234494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823509|NCT00234494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823510|NCT00234494|Immunologic Factors|immunologic factors|mesh-ancestor
56823511|NCT00234104|Tolvaptan|tolvaptan|mesh-list
56823512|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56823513|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823514|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
56823515|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823516|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
56823517|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823519|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823520|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823521|NCT00195338|Etanercept|etanercept|mesh-list
56823522|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56823523|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56823524|NCT00195338|Analgesics|analgesics|mesh-ancestor
56823525|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
56823526|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823527|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823528|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823529|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823530|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56823531|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823532|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
56823533|NCT00039130|Leucovorin|leucovorin|mesh-list
56823534|NCT00039130|Cytarabine|cytarabine|mesh-list
56823535|NCT00039130|Dexamethasone|dexamethasone|mesh-list
56823536|NCT00039130|Prednisone|prednisone|mesh-list
56823537|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
56823538|NCT00039130|Ifosfamide|ifosfamide|mesh-list
56823539|NCT00039130|Rituximab|rituximab|mesh-list
56823540|NCT00039130|Doxorubicin|doxorubicin|mesh-list
56823541|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56823542|NCT00039130|Methotrexate|methotrexate|mesh-list
56823543|NCT00039130|Etoposide|etoposide|mesh-list
56823544|NCT00039130|Vincristine|vincristine|mesh-list
56823545|NCT00039130|Allopurinol|allopurinol|mesh-list
56823546|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
56823547|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823548|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
56823549|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823550|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823551|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56823552|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
56823553|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823554|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823555|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56823556|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823557|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823558|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
56823559|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
56823560|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823561|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56823562|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
56823563|NCT00039130|Hormones|hormones|mesh-ancestor
56823564|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823565|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56823566|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56823567|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56823568|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56823569|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823570|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56823571|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
56823572|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56823573|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56823574|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
56823575|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
56823576|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56823577|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56823578|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56823579|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
56823580|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823581|NCT00039130|Antidotes|antidotes|mesh-ancestor
56823582|NCT00039130|Protective Agents|protective agents|mesh-ancestor
56823583|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
56823584|NCT00039130|Vitamins|vitamins|mesh-ancestor
56823585|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
56823586|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
56823587|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
56823588|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
56823589|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
56823590|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56823591|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
56823592|NCT01096654|Epinephrine|epinephrine|mesh-list
56823593|NCT01096654|Racepinephrine|racepinephrine|mesh-list
56823594|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
56823595|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56823597|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
56823598|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823599|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823600|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823601|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56823602|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56823603|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
56823604|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823605|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56823606|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
56823607|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
56823608|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
56823609|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56823610|NCT00035932|Ritonavir|ritonavir|mesh-list
56823611|NCT00035932|Lopinavir|lopinavir|mesh-list
56823612|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56823613|NCT00035932|Saquinavir|saquinavir|mesh-list
56823614|NCT00035932|Tenofovir|tenofovir|mesh-list
56823615|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56823616|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56823617|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
56823618|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823619|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823620|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56823621|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56823622|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
56823623|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823624|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56823625|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56823626|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56823627|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56823628|NCT03953326|Nitroprusside|nitroprusside|mesh-list
56823629|NCT03953326|Acetylcholine|acetylcholine|mesh-list
56823630|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56823631|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
56823632|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56823633|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823634|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56823635|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
56823636|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823637|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823638|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
56823640|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56823641|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823642|NCT01097278|Vitamins|vitamins|mesh-ancestor
56823643|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
56823644|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56823645|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
56823646|NCT00022516|Methotrexate|methotrexate|mesh-list
56823647|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823648|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
56823649|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823650|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823651|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56823652|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
56823653|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823654|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823655|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56823656|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56823657|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
56823658|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56823659|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56823660|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
56823661|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
56823662|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823663|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56823664|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56823665|NCT01097512|Gemcitabine|gemcitabine|mesh-list
56823666|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56823667|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
56823668|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823669|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823670|NCT01097512|Antiviral Agents|antiviral agents|mesh-ancestor
56823673|NCT01097512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823674|NCT01097512|Immunologic Factors|immunologic factors|mesh-ancestor
56823675|NCT01097512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823676|NCT00033514|Trastuzumab|trastuzumab|mesh-list
56823677|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56823678|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823679|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823680|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56823681|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823682|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823683|NCT00006916|Bleomycin|bleomycin|mesh-list
56823684|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56823685|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823686|NCT02529982|Curcumin|curcumin|mesh-list
56823687|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56823688|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56823689|NCT02529982|Analgesics|analgesics|mesh-ancestor
56823690|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
56823691|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823692|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823693|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823694|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823695|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823696|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823697|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823698|NCT00454649|Gemcitabine|gemcitabine|mesh-list
56823699|NCT00454649|Paclitaxel|paclitaxel|mesh-list
56823700|NCT00454649|Docetaxel|docetaxel|mesh-list
56823701|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56823702|NCT00454649|Cisplatin|cisplatin|mesh-list
56823703|NCT00454649|Carboplatin|carboplatin|mesh-list
56823704|NCT00454649|Capecitabine|capecitabine|mesh-list
56823705|NCT00454649|Pemetrexed|pemetrexed|mesh-list
56823706|NCT00454649|Axitinib|axitinib|mesh-list
56823707|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56823708|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823709|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
56823710|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
56823711|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
56823712|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823713|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56823714|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
56823715|NCT00454649|Antiviral Agents|antiviral agents|mesh-ancestor
56823716|NCT00454649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823717|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823718|NCT00454649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823719|NCT00454649|Immunologic Factors|immunologic factors|mesh-ancestor
56823720|NCT00454649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823721|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56823722|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56823723|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56823724|NCT00454571|Leuprolide|leuprolide|mesh-list
56823725|NCT00454571|Goserelin|goserelin|mesh-list
56823726|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56823727|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
56823728|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56823729|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823730|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56823731|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823732|NCT01323257|Ritonavir|ritonavir|mesh-list
56823733|NCT01323257|Darunavir|darunavir|mesh-list
56823734|NCT01323257|Erythromycin|erythromycin|mesh-list
56823735|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
56823736|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56823737|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
56823738|NCT01323257|Simeprevir|simeprevir|mesh-list
56823739|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56823740|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56823741|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
56823742|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823743|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823744|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56823745|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56823746|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
56823747|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823748|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56823749|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56823750|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56823751|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56823752|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56823753|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56823754|NCT01323335|Rasburicase|rasburicase|mesh-list
56823756|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
56823757|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823758|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
56823759|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823760|NCT01323335|Protective Agents|protective agents|mesh-ancestor
56823761|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823762|NCT03836729|Tenofovir|tenofovir|mesh-list
56823763|NCT03836729|Emtricitabine|emtricitabine|mesh-list
56823764|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
56823765|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823766|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56823767|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56823768|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823769|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823770|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56823771|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56823772|NCT01027481|Ranibizumab|ranibizumab|mesh-list
56823773|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823774|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823775|NCT01027481|Growth Substances|growth substances|mesh-ancestor
56823776|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823777|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823778|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823779|NCT00443729|Ritonavir|ritonavir|mesh-list
56823780|NCT00443729|Lopinavir|lopinavir|mesh-list
56823781|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
56823782|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56823783|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56823784|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
56823785|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823786|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823787|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56823788|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56823789|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
56823790|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823791|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56823792|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56823793|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56823794|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56823795|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56823796|NCT00443651|Rituximab|rituximab|mesh-list
56823797|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823798|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823799|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
56823800|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823801|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823802|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
56823803|NCT03567473|Dexamethasone|dexamethasone|mesh-list
56823804|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
56823805|NCT03567473|Epinephrine|epinephrine|mesh-list
56823806|NCT03567473|Racepinephrine|racepinephrine|mesh-list
56823807|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
56823808|NCT03567473|BB 1101|bb 1101|mesh-list
56823809|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823810|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
56823811|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
56823812|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823813|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823814|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56823815|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
56823816|NCT03567473|Hormones|hormones|mesh-ancestor
56823817|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823818|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56823819|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823820|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
56823821|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823822|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823824|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56823825|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
56823826|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823827|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56823828|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56823829|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56823830|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
56823831|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
56823832|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
56823833|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56823834|NCT00443261|Azacitidine|azacitidine|mesh-list
56823835|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823836|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56823837|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
56823838|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823839|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823840|NCT00439517|Cetuximab|cetuximab|mesh-list
56823841|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823842|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823843|NCT01028261|CKD732|ckd732|mesh-list
56823844|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823845|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823846|NCT01028261|Growth Substances|growth substances|mesh-ancestor
56823847|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823848|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823849|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823850|NCT01028339|Mannitol|mannitol|mesh-list
56823851|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56823852|NCT01028339|Diuretics|diuretics|mesh-ancestor
56823853|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
56823854|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823855|NCT01031459|Interferons|interferons|mesh-list
56823856|NCT01031459|Interferon-beta|interferon-beta|mesh-list
56823857|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
56823858|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823859|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
56823860|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823861|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
56823862|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823863|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56823864|NCT00438815|Complement C1s|complement c1s|mesh-list
56823865|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56823866|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56823867|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
56823868|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823869|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56823870|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823871|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
56823872|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823873|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
56823874|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56823875|NCT01028495|Gemcitabine|gemcitabine|mesh-list
56823876|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56823877|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
56823878|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823879|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823880|NCT01028495|Antiviral Agents|antiviral agents|mesh-ancestor
56823881|NCT01028495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823882|NCT01028495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823883|NCT01028495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823884|NCT01028495|Immunologic Factors|immunologic factors|mesh-ancestor
56823885|NCT01028495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823886|NCT00437645|Amlodipine|amlodipine|mesh-list
56823887|NCT00437645|Valsartan|valsartan|mesh-list
56823888|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56823889|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56823890|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56823891|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823892|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56823893|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823894|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
56823895|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56823896|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56823897|NCT03995147|Prednisone|prednisone|mesh-list
56823898|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
56823899|NCT03995147|Doxorubicin|doxorubicin|mesh-list
56823900|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
56823901|NCT03995147|Vincristine|vincristine|mesh-list
56823902|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823903|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
56823904|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823905|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56823906|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56823907|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
56823908|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823909|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823910|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56823911|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56823912|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56823913|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56823914|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56823915|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823916|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56823917|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
56823918|NCT03995147|Hormones|hormones|mesh-ancestor
56823919|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823920|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56823921|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56823922|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
56823923|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
56823924|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
56823925|NCT00437489|Insulin|insulin|mesh-list
56823926|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56823927|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56823928|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823929|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56823930|NCT01028573|Laxatives|laxatives|mesh-ancestor
56823931|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56823932|NCT04683575|Selenium|selenium|mesh-list
56823933|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
56823934|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823935|NCT04683575|Protective Agents|protective agents|mesh-ancestor
56823936|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823937|NCT04683575|Trace Elements|trace elements|mesh-ancestor
56823938|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
56823939|NCT00442559|Montelukast|montelukast|mesh-list
56534800|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823940|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56823941|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
56823942|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56823943|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
56823944|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56823945|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823946|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56823947|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56823948|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823949|NCT01323491|Nicotine|nicotine|mesh-list
56823950|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56823951|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
56823952|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56823953|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823954|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56823955|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56823956|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
56823957|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56823958|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823959|NCT00441545|Sevelamer|sevelamer|mesh-list
56823960|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
56823961|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
56823962|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823963|NCT00436553|Ranibizumab|ranibizumab|mesh-list
56823964|NCT00436553|Verteporfin|verteporfin|mesh-list
56823965|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823966|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823967|NCT00436553|Growth Substances|growth substances|mesh-ancestor
56823968|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823969|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823970|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823971|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56823973|NCT01028729|Gemcitabine|gemcitabine|mesh-list
56823974|NCT01028729|Endostar protein|endostar protein|mesh-list
56823975|NCT01028729|Endostatins|endostatins|mesh-list
56823976|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56823977|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56823978|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
56823979|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823980|NCT01028729|Antiviral Agents|antiviral agents|mesh-ancestor
56823981|NCT01028729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823982|NCT01028729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823983|NCT01028729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56823984|NCT01028729|Immunologic Factors|immunologic factors|mesh-ancestor
56823985|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56823986|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56823987|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56823988|NCT01028729|Growth Substances|growth substances|mesh-ancestor
56823989|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
56823990|NCT03357419|Clindamycin|clindamycin|mesh-list
56823991|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
56823992|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
56823993|NCT03357419|Cephalexin|cephalexin|mesh-list
56823994|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56823995|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56823996|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56823997|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56823998|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56823999|NCT01031927|Glycine|glycine|mesh-list
56824000|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
56824001|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824002|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824003|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824004|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
56824005|NCT03331289|Exenatide|exenatide|mesh-list
56824006|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56824007|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824008|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56824009|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824010|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56824011|NCT03331289|Incretins|incretins|mesh-ancestor
56824012|NCT03331289|Hormones|hormones|mesh-ancestor
56824013|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824014|NCT01032083|Citalopram|citalopram|mesh-list
56824015|NCT01032083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56824016|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56824017|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56824018|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824019|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824020|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
56824021|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824022|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56824023|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
56824024|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56824025|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56824026|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
56824027|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824028|NCT01028963|Pioglitazone|pioglitazone|mesh-list
56824029|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56824030|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824031|NCT00006604|Ritonavir|ritonavir|mesh-list
56824032|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56824033|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56824034|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
56824035|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824036|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824037|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56824038|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56824039|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
56824040|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824041|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56824042|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56824043|NCT00006478|Sargramostim|sargramostim|mesh-list
56824044|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56824045|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
56824050|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56824051|NCT01097902|Analgesics|analgesics|mesh-ancestor
56824052|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
56824053|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824054|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824055|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824056|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824057|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56824058|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824059|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824060|NCT00436007|Vaccines|vaccines|mesh-list
56824061|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
56824062|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824063|NCT00435461|Fluticasone|fluticasone|mesh-list
56824065|NCT00435461|Fexofenadine|fexofenadine|mesh-list
56824066|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824067|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56824068|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
56824069|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824070|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824071|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56824072|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
56824073|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
56824074|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56824075|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56824076|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56824077|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
56824078|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
56824079|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824080|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824081|NCT00006436|Prednisone|prednisone|mesh-list
56824082|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
56824083|NCT00006436|Rituximab|rituximab|mesh-list
56824084|NCT00006436|Doxorubicin|doxorubicin|mesh-list
56824085|NCT00006436|Etoposide|etoposide|mesh-list
56824086|NCT00006436|Vincristine|vincristine|mesh-list
56824087|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56824088|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824089|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
56824090|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824091|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824092|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56824093|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
56824094|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824095|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824096|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56824097|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56824098|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56824099|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56824100|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56824101|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824102|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824103|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
56824104|NCT00006436|Hormones|hormones|mesh-ancestor
56824105|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824106|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56824107|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56824108|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
56824109|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
56824110|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
56824111|NCT01097980|Trazodone|trazodone|mesh-list
56824112|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56824113|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56824114|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56824115|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824116|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56557594|NCT02689960|Hormones|hormones|mesh-ancestor
56824118|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56824119|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56824120|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824121|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824122|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
56824123|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56824124|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
56824125|NCT01029275|Octreotide|octreotide|mesh-list
56824126|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56824127|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56824128|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824129|NCT04829903|Liraglutide|liraglutide|mesh-list
56824130|NCT04829903|Dulaglutide|dulaglutide|mesh-list
56824131|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56824132|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824133|NCT04829903|Incretins|incretins|mesh-ancestor
56824134|NCT04829903|Hormones|hormones|mesh-ancestor
56824135|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824136|NCT01323569|Nabiximols|nabiximols|mesh-list
56824137|NCT01323569|Dronabinol|dronabinol|mesh-list
56902750|NCT04068597|Venetoclax|venetoclax|mesh-list
56824138|NCT01323569|Analgesics|analgesics|mesh-ancestor
56824139|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
56824140|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824141|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824142|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
56824143|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56824144|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56824145|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56824146|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56824147|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824148|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824149|NCT01323569|Hormones|hormones|mesh-ancestor
56824150|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824151|NCT00440999|Artesunate|artesunate|mesh-list
56824152|NCT00440999|Chloroquine|chloroquine|mesh-list
56824153|NCT00440999|Pyronaridine|pyronaridine|mesh-list
56824154|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
56824155|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56824156|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56824157|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824158|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824159|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
56824160|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
56824161|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56824162|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
56824163|NCT00440999|Amebicides|amebicides|mesh-ancestor
56824164|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824165|NCT00434213|Methylphenidate|methylphenidate|mesh-list
56824166|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56824167|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824168|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56824169|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56824170|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56824171|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824172|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
56824173|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824174|NCT01029743|Aspirin|aspirin|mesh-list
56824175|NCT01029743|PENTA|penta|mesh-list
56824176|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
56824177|NCT01029743|Fondaparinux|fondaparinux|mesh-list
56824178|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56824179|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56824180|NCT01029743|Analgesics|analgesics|mesh-ancestor
56824181|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
56824182|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824183|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824184|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824185|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824186|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56824187|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56824188|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824189|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56824190|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56824192|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
56824193|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56824194|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
56824195|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56824196|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
56824197|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
56824198|NCT01029821|Heparin|heparin|mesh-list
56824199|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56824200|NCT01029821|Tinzaparin|tinzaparin|mesh-list
56824201|NCT01029821|Dalteparin|dalteparin|mesh-list
56824202|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
56824203|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56824204|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56824205|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824206|NCT00006184|Cyclosporine|cyclosporine|mesh-list
56824207|NCT00006184|Prednisone|prednisone|mesh-list
56824208|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
56824209|NCT00006184|Doxorubicin|doxorubicin|mesh-list
56824210|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56824211|NCT00006184|Methotrexate|methotrexate|mesh-list
56824212|NCT00006184|Fludarabine|fludarabine|mesh-list
56824213|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
56824214|NCT00006184|Etoposide|etoposide|mesh-list
56824215|NCT00006184|Vincristine|vincristine|mesh-list
56824216|NCT00006184|Bortezomib|bortezomib|mesh-list
56824217|NCT00006184|Molgramostim|molgramostim|mesh-list
56824218|NCT00006184|Cyclosporins|cyclosporins|mesh-list
56824219|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
56824220|NCT00006184|Lenograstim|lenograstim|mesh-list
56824221|NCT00006184|Sargramostim|sargramostim|mesh-list
56824222|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56824223|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824224|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
56824225|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824226|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824227|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56824228|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
56824229|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824230|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824231|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56824232|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56824233|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56824234|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56824235|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824236|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824237|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
56824238|NCT00006184|Hormones|hormones|mesh-ancestor
56824239|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824240|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56824241|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56824242|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
56824243|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56824244|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56824245|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
56824246|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
56824247|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56824248|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56824249|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56824250|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
56824251|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
56824252|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
56824253|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
56824254|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824255|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56824256|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56824257|NCT00433199|Testosterone|testosterone|mesh-list
56824258|NCT00433199|Androgens|androgens|mesh-ancestor
56824259|NCT00433199|Hormones|hormones|mesh-ancestor
56824260|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824261|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824262|NCT00006046|Antibodies|antibodies|mesh-list
56824263|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56824264|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
56824265|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824266|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56824267|NCT01098448|Amoxicillin|amoxicillin|mesh-list
56824268|NCT01098448|Metronidazole|metronidazole|mesh-list
56824269|NCT01098448|Tetracycline|tetracycline|mesh-list
56824271|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56824272|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56824273|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56824274|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824275|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824276|NCT01098526|Efavirenz|efavirenz|mesh-list
56824277|NCT01098526|Dolutegravir|dolutegravir|mesh-list
56824278|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56824279|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56824280|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824281|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824282|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
56824283|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824284|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56824285|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56824286|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56824287|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56824288|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56824289|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56824290|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56824291|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56824292|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56824293|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56824294|NCT00005908|Tamoxifen|tamoxifen|mesh-list
56824295|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
56824296|NCT00005908|Docetaxel|docetaxel|mesh-list
56824297|NCT00005908|Doxorubicin|doxorubicin|mesh-list
56824298|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56824299|NCT00005908|Capecitabine|capecitabine|mesh-list
56824300|NCT00005908|Anastrozole|anastrozole|mesh-list
56824301|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824302|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
56824303|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824304|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824305|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56824306|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
56824307|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824308|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824309|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56824310|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
56824311|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
56824312|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
56824313|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56824314|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56824315|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56824316|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824317|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56824318|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
56824319|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56824320|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
56824321|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824322|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56824323|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56824324|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56824325|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56824326|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56824327|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56824328|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
56824329|NCT03160079|Blinatumomab|blinatumomab|mesh-list
56824330|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56824331|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824332|NCT00004978|Aldesleukin|aldesleukin|mesh-list
56824333|NCT00004978|Interleukin-2|interleukin-2|mesh-list
56824334|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824335|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56824336|NCT00004978|Analgesics|analgesics|mesh-ancestor
56824337|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
56824338|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824339|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824340|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56824341|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56824342|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
56824343|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824345|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
56824346|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56824347|NCT01030601|BB 1101|bb 1101|mesh-list
56824348|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824349|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
56824350|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
56824351|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824352|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824353|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56824354|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
56824355|NCT01030601|Hormones|hormones|mesh-ancestor
56824356|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824357|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56824358|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824359|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
56824360|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824361|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824362|NCT00430937|Vancomycin|vancomycin|mesh-list
56824363|NCT00430937|Daptomycin|daptomycin|mesh-list
56824364|NCT00430937|Teicoplanin|teicoplanin|mesh-list
56824365|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56824366|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824367|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
56824368|NCT01101412|Ethanol|ethanol|mesh-list
56824369|NCT01101412|Trimethoprim|trimethoprim|mesh-list
56824370|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
56824371|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56824372|NCT01101412|Edetic Acid|edetic acid|mesh-list
56824373|NCT01101412|Calcium|calcium|mesh-list
56824374|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
56824375|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56824376|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824377|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56824378|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56824379|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824380|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56824381|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56824382|NCT01101412|Renal Agents|renal agents|mesh-ancestor
56824383|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
56824384|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56824385|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56824386|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56824387|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824388|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824389|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56824390|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56824391|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56824392|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56824393|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
56824394|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56824395|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
56824396|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
56824397|NCT01101412|Antidotes|antidotes|mesh-ancestor
56824398|NCT01101412|Protective Agents|protective agents|mesh-ancestor
56824399|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56824400|NCT03122717|Gefitinib|gefitinib|mesh-list
56824401|NCT03122717|Osimertinib|osimertinib|mesh-list
56824402|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824403|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56824404|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824405|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824406|NCT00004888|Docetaxel|docetaxel|mesh-list
56824407|NCT00004888|Doxorubicin|doxorubicin|mesh-list
56824408|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56824409|NCT00004888|Trastuzumab|trastuzumab|mesh-list
56824410|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824411|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56824412|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56824413|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56824414|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824415|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56824416|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56824417|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56824418|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824419|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56824421|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824422|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56824423|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824424|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824425|NCT03950830|Disulfiram|disulfiram|mesh-list
56824426|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56824427|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56824428|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824429|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824430|NCT00430781|Lapatinib|lapatinib|mesh-list
56824431|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824432|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56824433|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824434|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824435|NCT01033097|Betamethasone|betamethasone|mesh-list
56824436|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824437|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
56824438|NCT01033097|Hormones|hormones|mesh-ancestor
56824439|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824440|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824441|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56824442|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
56824443|NCT00429299|Paclitaxel|paclitaxel|mesh-list
56824444|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
56824445|NCT00429299|Fluorouracil|fluorouracil|mesh-list
56824446|NCT00429299|Trastuzumab|trastuzumab|mesh-list
56824447|NCT00429299|Lapatinib|lapatinib|mesh-list
56824448|NCT00429299|Epirubicin|epirubicin|mesh-list
56824449|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56824450|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824451|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
56824452|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
56824453|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
56824454|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824455|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824456|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
56824457|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824458|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824459|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56824460|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
56824461|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56824462|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
56824463|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56824464|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56824465|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56824466|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824467|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56824468|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56824469|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56824470|NCT01033877|Vaccines|vaccines|mesh-list
56824471|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
56824472|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824473|NCT00428597|Sunitinib|sunitinib|mesh-list
56824474|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824475|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56824476|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56824477|NCT00428597|Growth Substances|growth substances|mesh-ancestor
56824478|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824479|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
56824480|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56824481|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824482|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824483|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56824484|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56824485|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56824486|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
56824487|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824488|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56824489|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56824490|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824491|NCT00428441|Warfarin|warfarin|mesh-list
56824492|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
56824493|NCT03994211|Itraconazole|itraconazole|mesh-list
56824494|NCT03994211|Rifampin|rifampin|mesh-list
56824496|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824497|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56824498|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56824499|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824500|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824501|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56824502|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
56824503|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824504|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824505|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56824506|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56824507|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
56824508|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56824509|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
56824510|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56824511|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56824512|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56824513|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56824514|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56824515|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56824516|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56824517|NCT02488967|Paclitaxel|paclitaxel|mesh-list
56824518|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
56824519|NCT02488967|Carboplatin|carboplatin|mesh-list
56824520|NCT02488967|Doxorubicin|doxorubicin|mesh-list
56824521|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56824522|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56824523|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56824524|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824525|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
56824526|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
56824527|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
56824528|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824529|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824530|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
56824531|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824532|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824533|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56824534|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
56824535|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56824536|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56824537|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56824538|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56824539|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824540|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
56824541|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56824542|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
56824543|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824544|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824545|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56824546|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
56824547|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
56824548|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56824549|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
56824550|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824551|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824552|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
56824553|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56824554|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
56824555|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824556|NCT03967665|Expectorants|expectorants|mesh-ancestor
56824557|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
56824558|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56824559|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
56824560|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824561|NCT03967665|Protective Agents|protective agents|mesh-ancestor
56824562|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824563|NCT03967665|Antidotes|antidotes|mesh-ancestor
56824564|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
56824565|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56824566|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56824567|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824568|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56824569|NCT00127803|Vaccines|vaccines|mesh-list
56824570|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
56824571|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824572|NCT01077999|Paclitaxel|paclitaxel|mesh-list
56824573|NCT01077999|Carboplatin|carboplatin|mesh-list
56824574|NCT01077999|Panitumumab|panitumumab|mesh-list
56824575|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56824576|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824577|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
56824578|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
56824579|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
56824580|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824581|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56824582|NCT01033409|Vaccines|vaccines|mesh-list
56824583|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
56824584|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824585|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
56824586|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56824587|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
56824588|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824589|NCT01037465|Expectorants|expectorants|mesh-ancestor
56824590|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
56824591|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56824592|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
56824593|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824594|NCT01037465|Protective Agents|protective agents|mesh-ancestor
56824595|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824596|NCT01037465|Antidotes|antidotes|mesh-ancestor
56824597|NCT01582425|Isavuconazole|isavuconazole|mesh-list
56824598|NCT01582425|Methadone|methadone|mesh-list
56824599|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56824600|NCT01582425|Narcotics|narcotics|mesh-ancestor
56824601|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56824602|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824603|NCT01582425|Analgesics|analgesics|mesh-ancestor
56824604|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
56824605|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824606|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
56824607|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
56824608|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
56824609|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824610|NCT00143403|Leucovorin|leucovorin|mesh-list
56824611|NCT00143403|Folic Acid|folic acid|mesh-list
56824612|NCT00143403|Irinotecan|irinotecan|mesh-list
56824613|NCT00143403|Fluorouracil|fluorouracil|mesh-list
56824614|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
56824615|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56824616|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56824617|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824618|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824619|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824620|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
56824621|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56824622|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824623|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
56824624|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824625|NCT00143403|Antidotes|antidotes|mesh-ancestor
56824626|NCT00143403|Protective Agents|protective agents|mesh-ancestor
56824627|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
56824628|NCT00143403|Vitamins|vitamins|mesh-ancestor
56824629|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
56824630|NCT00143403|Hematinics|hematinics|mesh-ancestor
56824631|NCT00220701|Dexetimide|dexetimide|mesh-list
56824632|NCT00220701|Citalopram|citalopram|mesh-list
56824633|NCT00220701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56824634|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56824635|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56824636|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824637|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824638|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
56824639|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824640|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56824641|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
56824642|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56824643|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56824644|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56824645|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
56824646|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
56824647|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824648|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56824649|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56824650|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
56824652|NCT00127101|Bexarotene|bexarotene|mesh-list
56824653|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824654|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56824655|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824656|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824657|NCT00126555|Gefitinib|gefitinib|mesh-list
56824658|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824659|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56824660|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824661|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824662|NCT00004228|Leucovorin|leucovorin|mesh-list
56824663|NCT00004228|Cytarabine|cytarabine|mesh-list
56824664|NCT00004228|Dexamethasone|dexamethasone|mesh-list
56824665|NCT00004228|Prednisone|prednisone|mesh-list
56824666|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
56824667|NCT00004228|Doxorubicin|doxorubicin|mesh-list
56824668|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56824669|NCT00004228|Methotrexate|methotrexate|mesh-list
56824670|NCT00004228|Vincristine|vincristine|mesh-list
56824671|NCT00004228|Daunorubicin|daunorubicin|mesh-list
56824672|NCT00004228|Asparaginase|asparaginase|mesh-list
56824673|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
56824674|NCT00004228|Thioguanine|thioguanine|mesh-list
56824675|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
56824676|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824677|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
56824678|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824679|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824680|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56824681|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
56824682|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824683|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824684|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56824685|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824686|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
56824687|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
56824688|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824689|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56824690|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
56824691|NCT00004228|Hormones|hormones|mesh-ancestor
56824692|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56824693|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56824694|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56824695|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56824696|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56824697|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824698|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56824699|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
56824700|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56824701|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56824702|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
56824703|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56824704|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56824705|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56824706|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
56824707|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824708|NCT00004228|Antidotes|antidotes|mesh-ancestor
56824709|NCT00004228|Protective Agents|protective agents|mesh-ancestor
56824710|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
56824711|NCT00004228|Vitamins|vitamins|mesh-ancestor
56824712|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
56824713|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56824714|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
56824715|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
56824716|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
56824717|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56824718|NCT01101568|Simvastatin|simvastatin|mesh-list
56824719|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56824720|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56824721|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
56824722|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824724|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56824725|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824727|NCT01087840|Emtricitabine|emtricitabine|mesh-list
56824728|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
56824729|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
56824730|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824731|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56824732|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56824733|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824734|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824735|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56824736|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56824737|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56824738|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56824739|NCT01098994|Vitamin E|vitamin e|mesh-list
56824740|NCT01098994|Tocopherols|tocopherols|mesh-list
56824741|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
56824742|NCT01098994|Vitamins|vitamins|mesh-ancestor
56824743|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
56824744|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824745|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
56824746|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824747|NCT01098994|Protective Agents|protective agents|mesh-ancestor
56824748|NCT01099072|Methylphenidate|methylphenidate|mesh-list
56824749|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56824750|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824751|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56824752|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56824753|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56824754|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824755|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
56824756|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824757|NCT00031486|Valacyclovir|valacyclovir|mesh-list
56824758|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
56824759|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824760|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
56824761|NCT01099150|Procyanidin|procyanidin|mesh-list
56824762|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
56824763|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824764|NCT01099150|Protective Agents|protective agents|mesh-ancestor
56824765|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824766|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56824767|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56824768|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824769|NCT02530060|Tenofovir|tenofovir|mesh-list
56824770|NCT02530060|Emtricitabine|emtricitabine|mesh-list
56824771|NCT02530060|Rilpivirine|rilpivirine|mesh-list
56824772|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
56824773|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824774|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56824775|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56824776|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824777|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824778|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56824779|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56824780|NCT01101646|Rabeprazole|rabeprazole|mesh-list
56824781|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56824782|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56824783|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56824784|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824785|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824786|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
56824787|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56824788|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824789|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56824790|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
56824791|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56824792|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824793|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824794|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824795|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56824796|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824798|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824799|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56824800|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
56824801|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56824802|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56824803|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824804|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
56824805|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824806|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824808|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56824809|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56824810|NCT01099462|Analgesics|analgesics|mesh-ancestor
56824811|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
56824812|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824813|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824814|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824815|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824816|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56824817|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824818|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824819|NCT00003298|Leucovorin|leucovorin|mesh-list
56824820|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
56824821|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56824822|NCT00003298|Paclitaxel|paclitaxel|mesh-list
56824823|NCT00003298|Cisplatin|cisplatin|mesh-list
56824824|NCT00003298|Fluorouracil|fluorouracil|mesh-list
56824825|NCT00003298|Calcium|calcium|mesh-list
56824826|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
56824827|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56824828|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824829|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
56824830|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
56824831|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
56824832|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824833|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56824834|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824835|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
56824836|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56824837|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824838|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
56824839|NCT00003298|Antidotes|antidotes|mesh-ancestor
56824840|NCT00003298|Protective Agents|protective agents|mesh-ancestor
56824841|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
56824842|NCT00003298|Vitamins|vitamins|mesh-ancestor
56824843|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
56824844|NCT03961360|Aspirin|aspirin|mesh-list
56824845|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56824846|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56824847|NCT03961360|Analgesics|analgesics|mesh-ancestor
56824848|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
56824849|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824850|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824851|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824852|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824853|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56824854|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56824855|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824856|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56824857|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56824858|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824860|NCT03960970|Azithromycin|azithromycin|mesh-list
56824861|NCT03960970|Cefoxitin|cefoxitin|mesh-list
56824862|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56824863|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824864|NCT00002842|Leucovorin|leucovorin|mesh-list
56824865|NCT00002842|Fluorouracil|fluorouracil|mesh-list
56824866|NCT00002842|Floxuridine|floxuridine|mesh-list
56824867|NCT00002842|Calcium|calcium|mesh-list
56824868|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
56824869|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56824870|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824871|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
56904601|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56824872|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824873|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56824875|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824876|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
56824877|NCT00002842|Antidotes|antidotes|mesh-ancestor
56824878|NCT00002842|Protective Agents|protective agents|mesh-ancestor
56824879|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
56824880|NCT00002842|Vitamins|vitamins|mesh-ancestor
56824881|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
56824882|NCT00143247|Insulin|insulin|mesh-list
56824883|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56824884|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824885|NCT00125853|Atenolol|atenolol|mesh-list
56824886|NCT00125853|Nebivolol|nebivolol|mesh-list
56824887|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56824888|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56824889|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
56824890|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
56824891|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824892|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824893|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56824894|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56824895|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56902764|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
56824896|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
56824897|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56824898|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824899|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
56824900|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56824901|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56824902|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56824903|NCT00219141|Losartan|losartan|mesh-list
56824904|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56824905|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56824906|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56824907|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56824908|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824909|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
56824910|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
56824911|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824912|NCT00233948|Nelfinavir|nelfinavir|mesh-list
56824913|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56824914|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56824915|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
56824916|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824917|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824918|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56824919|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56824920|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
56824921|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824922|NCT00233480|Atorvastatin|atorvastatin|mesh-list
56824923|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56824924|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56824925|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
56535773|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56824926|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824927|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56824928|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56824929|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824930|NCT03801928|Infliximab|infliximab|mesh-list
56824931|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
56824932|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56824933|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824934|NCT02530918|Ranibizumab|ranibizumab|mesh-list
56824935|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56824936|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56824937|NCT02530918|Growth Substances|growth substances|mesh-ancestor
56824938|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824939|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
56824940|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824941|NCT03950518|Levamisole|levamisole|mesh-list
56824942|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56824943|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
56824944|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824945|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
56824947|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56824948|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56824949|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824950|NCT01100164|Eszopiclone|eszopiclone|mesh-list
56824951|NCT01100164|Zopiclone|zopiclone|mesh-list
56824952|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56824953|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56824954|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824955|NCT01102114|Vaccines|vaccines|mesh-list
56824956|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
56824957|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824958|NCT01327222|Bevacizumab|bevacizumab|mesh-list
56824959|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56824960|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824961|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56824962|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56824963|NCT01327222|Growth Substances|growth substances|mesh-ancestor
56824964|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824965|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56824966|NCT03950362|Avelumab|avelumab|mesh-list
56824967|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56824968|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824969|NCT00263588|Lapatinib|lapatinib|mesh-list
56824970|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824971|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56824972|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824973|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824974|NCT00213135|Cladribine|cladribine|mesh-list
56824975|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824976|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56824977|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
56824978|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824979|NCT00077974|Sunitinib|sunitinib|mesh-list
56824980|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56824981|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56824982|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56824983|NCT00077974|Growth Substances|growth substances|mesh-ancestor
56824984|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824985|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
56824986|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56824987|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56824988|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56824989|NCT00141921|Etanercept|etanercept|mesh-list
56824990|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56824991|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56824992|NCT00141921|Analgesics|analgesics|mesh-ancestor
56824993|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
56824994|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56824995|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56824996|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56824997|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56824998|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56824999|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825000|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
56825001|NCT01088620|Pemetrexed|pemetrexed|mesh-list
56825002|NCT01088620|Panitumumab|panitumumab|mesh-list
56535849|NCT04303767|Calcium|calcium|mesh-list
56825003|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825004|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825005|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825006|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56825007|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56825008|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825009|NCT00026494|Temozolomide|temozolomide|mesh-list
56825010|NCT00026494|Vinorelbine|vinorelbine|mesh-list
56825011|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56825012|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
56825013|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825014|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825015|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56825016|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825017|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825018|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825019|NCT03950050|Ambroxol|ambroxol|mesh-list
56825021|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56825022|NCT05627596|Nicotine|nicotine|mesh-list
56825023|NCT05627596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56825024|NCT05627596|Autonomic Agents|autonomic agents|mesh-ancestor
56825025|NCT05627596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825026|NCT05627596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825027|NCT05627596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56825028|NCT05627596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56825029|NCT05627596|Cholinergic Agents|cholinergic agents|mesh-ancestor
56825030|NCT05627596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825031|NCT05627596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825032|NCT00023764|Bortezomib|bortezomib|mesh-list
56825033|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825034|NCT03961126|Clobetasol|clobetasol|mesh-list
56825035|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56825036|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
56825037|NCT03961126|Hormones|hormones|mesh-ancestor
56825038|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56825039|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825040|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
56825041|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
56825042|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825043|NCT00189488|Methotrexate|methotrexate|mesh-list
56825044|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56825045|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
56825046|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56825047|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825048|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56825049|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
56825050|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825051|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825052|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
56825053|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825054|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56825055|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825056|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
56825057|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825058|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56825059|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56825060|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
56825061|NCT00023452|Isoniazid|isoniazid|mesh-list
56825062|NCT00023452|Rifapentine|rifapentine|mesh-list
56825063|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
56825064|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56825065|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825066|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56825067|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56825068|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
56825069|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825070|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56825071|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56825072|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
56825073|NCT01088932|SRX246|srx246|mesh-list
56825074|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56825075|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535923|NCT05296629|Doxycycline|doxycycline|mesh-list
56825076|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
56825077|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825078|NCT03961048|Ropivacaine|ropivacaine|mesh-list
56825079|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56825080|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
56825081|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
56825082|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56825083|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825084|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
56825085|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825086|NCT00022672|Trastuzumab|trastuzumab|mesh-list
56825087|NCT00022672|Anastrozole|anastrozole|mesh-list
56825088|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825089|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825090|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56825091|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56825092|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56825094|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825095|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56825096|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
56825097|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56825098|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825099|NCT00141453|Olmesartan|olmesartan|mesh-list
56825100|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56825101|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56825102|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56825103|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56825104|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825105|NCT00076570|Sirolimus|sirolimus|mesh-list
56825106|NCT00076570|Tacrolimus|tacrolimus|mesh-list
56825107|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825108|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
56825109|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825110|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56825111|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825112|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825113|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56825114|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825115|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56825116|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825117|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
56825118|NCT00124449|Abatacept|abatacept|mesh-list
56825119|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56825120|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825121|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825122|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825123|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
56825124|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825125|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825126|NCT00076336|Lamivudine|lamivudine|mesh-list
56825127|NCT00076336|Telbivudine|telbivudine|mesh-list
56825128|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56825129|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56825130|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825131|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825132|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
56825133|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825134|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56825135|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56825136|NCT00185588|Gemcitabine|gemcitabine|mesh-list
56825137|NCT00185588|Vatalanib|vatalanib|mesh-list
56825138|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56825139|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
56825140|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825141|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825142|NCT00185588|Antiviral Agents|antiviral agents|mesh-ancestor
56825143|NCT00185588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825144|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825145|NCT00185588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825146|NCT00185588|Immunologic Factors|immunologic factors|mesh-ancestor
56825147|NCT00185588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825148|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56535999|NCT01045707|Insulin|insulin|mesh-list
56825150|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825151|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56825152|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
56825153|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825154|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
56825155|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56825156|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825157|NCT00076102|Pirfenidone|pirfenidone|mesh-list
56825158|NCT00076102|Analgesics|analgesics|mesh-ancestor
56825159|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
56825160|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825161|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825162|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56825163|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56825164|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56825165|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825166|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825167|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
56825168|NCT03968588|Tacrolimus|tacrolimus|mesh-list
56825169|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825170|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
56825171|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825172|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56825173|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825174|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825175|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56825176|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825177|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56825178|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
56825179|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56825180|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825181|NCT01582646|Terbutaline|terbutaline|mesh-list
56825182|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56825183|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
56825184|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825185|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825186|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56825187|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
56825188|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
56825189|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
56825190|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56825191|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56825192|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56825193|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56825194|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
56825195|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825196|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825197|NCT03974360|Erenumab|erenumab|mesh-list
56825198|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56825199|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825200|NCT03974360|Analgesics|analgesics|mesh-ancestor
56825201|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
56825202|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825203|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825204|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
56825205|NCT00184028|Docetaxel|docetaxel|mesh-list
56825206|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825207|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825208|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825209|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825210|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825211|NCT00183872|Docetaxel|docetaxel|mesh-list
56825212|NCT00183872|Irinotecan|irinotecan|mesh-list
56825213|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825214|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825215|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825216|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825217|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825218|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56825219|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56825220|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825221|NCT03815175|Aspirin|aspirin|mesh-list
56825222|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56825223|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56825224|NCT03815175|Analgesics|analgesics|mesh-ancestor
56825225|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
56825226|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825227|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825228|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56825229|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825230|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56825231|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56825232|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825233|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56825234|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56825235|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825236|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
56825237|NCT01080027|Interferons|interferons|mesh-list
56825238|NCT01080027|Interferon-beta|interferon-beta|mesh-list
56825239|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
56825240|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825242|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825244|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825245|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56825246|NCT00262028|Vaccines|vaccines|mesh-list
56825247|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
56825248|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825249|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
56825250|NCT00183248|Sirolimus|sirolimus|mesh-list
56825251|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
56825252|NCT00183248|Tacrolimus|tacrolimus|mesh-list
56825253|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825254|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
56825255|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825256|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56825257|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825258|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825259|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56825260|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825261|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56825262|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
56825263|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56825264|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825265|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
56825266|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825267|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
56825268|NCT00230282|Fludarabine|fludarabine|mesh-list
56825269|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
56825270|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825271|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
56825272|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825273|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825274|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56825275|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
56825276|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825277|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825278|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56825279|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825280|NCT00261950|Cinacalcet|cinacalcet|mesh-list
56825281|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56825282|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825283|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56825284|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
56825285|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56825286|NCT00229658|Pramlintide|pramlintide|mesh-list
56825287|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56825288|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825289|NCT00182078|Sertraline|sertraline|mesh-list
56825290|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
56825291|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56825292|NCT00182078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56825293|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56825294|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56825295|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825296|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825297|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
56825298|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825300|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
56825301|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56825302|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56825303|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825304|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56825305|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825306|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56825307|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56825308|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56825309|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56825310|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56825311|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56825312|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56825313|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56825315|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825317|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825318|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825319|NCT00180674|Warfarin|warfarin|mesh-list
56825320|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
56825321|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56825322|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56825323|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56825324|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56825325|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825326|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56825327|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56825328|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56825329|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56825330|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
56825331|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825332|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825333|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56825334|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56825335|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
56825336|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56825337|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56825338|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
56825339|NCT00076024|Docetaxel|docetaxel|mesh-list
56825340|NCT00076024|Axitinib|axitinib|mesh-list
56825341|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825342|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825343|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825344|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825345|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825346|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56825347|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825348|NCT01103050|Cetirizine|cetirizine|mesh-list
56825349|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56825350|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56825351|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56825352|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
56825353|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
56825354|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825355|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825356|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825357|NCT00075478|Cyclosporine|cyclosporine|mesh-list
56825358|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
56825359|NCT00075478|Fludarabine|fludarabine|mesh-list
56825360|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
56825361|NCT00075478|Cyclosporins|cyclosporins|mesh-list
56825362|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825363|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56825364|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
56825365|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825366|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825367|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
56825368|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825369|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825370|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
56825371|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825372|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56825373|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825374|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56825375|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56825376|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56825377|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
56825378|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56825379|NCT00175916|Brivaracetam|brivaracetam|mesh-list
56825380|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
56825381|NCT01089088|Gemcitabine|gemcitabine|mesh-list
56825382|NCT01089088|Sunitinib|sunitinib|mesh-list
56825383|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825384|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56825385|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
56825386|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825390|NCT01089088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825391|NCT01089088|Immunologic Factors|immunologic factors|mesh-ancestor
56825392|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825393|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56825394|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56825395|NCT01089088|Growth Substances|growth substances|mesh-ancestor
56825396|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
56825397|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56825398|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
56825399|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825400|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56825401|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825402|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825403|NCT01103206|Cinacalcet|cinacalcet|mesh-list
56825404|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56825405|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825406|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56825407|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
56825408|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56825409|NCT00228566|Modafinil|modafinil|mesh-list
56825410|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56825411|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825412|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56825413|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56825414|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56825415|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825416|NCT05625724|Aspirin|aspirin|mesh-list
56825417|NCT05625724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56825418|NCT05625724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56825419|NCT05625724|Analgesics|analgesics|mesh-ancestor
56825420|NCT05625724|Sensory System Agents|sensory system agents|mesh-ancestor
56825421|NCT05625724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825422|NCT05625724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825423|NCT05625724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56825424|NCT05625724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825425|NCT05625724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56825426|NCT05625724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56825427|NCT05625724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825428|NCT05625724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56825429|NCT05625724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56825430|NCT05625724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825431|NCT05625724|Antipyretics|antipyretics|mesh-ancestor
56825432|NCT01089166|Metformin|metformin|mesh-list
56825433|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56825434|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825435|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
56825436|NCT00203502|Bevacizumab|bevacizumab|mesh-list
56825437|NCT00203502|Docetaxel|docetaxel|mesh-list
56825438|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825439|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
56825440|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825441|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825442|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56825443|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
56825444|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825445|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825446|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56825447|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825448|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56825449|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56825451|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
56825452|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825453|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825454|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825455|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
56825456|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56825457|NCT01103518|Estradiol|estradiol|mesh-list
56825458|NCT01103518|Cyproterone|cyproterone|mesh-list
56825459|NCT01103518|Estrogens|estrogens|mesh-ancestor
56825461|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56825462|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825463|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56825465|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56825466|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56825467|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56825468|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56825469|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
56825470|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
56825471|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825472|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56825473|NCT01327534|Clopidogrel|clopidogrel|mesh-list
56825474|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56825475|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56825476|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56825477|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56825478|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56825479|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
56825480|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825481|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825482|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825483|NCT00232596|Ezogabine|ezogabine|mesh-list
56825484|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
56825485|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56825486|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825487|NCT00073918|Iodine|iodine|mesh-list
56825488|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
56825489|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
56825490|NCT00073918|Etoposide|etoposide|mesh-list
56825491|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
56825492|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
56825493|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56825494|NCT00073918|Antibodies|antibodies|mesh-list
56825495|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
56825496|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56825497|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825498|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
56825499|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825500|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825501|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56825502|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
56825503|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825504|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825505|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56825506|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56825507|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56825508|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56825509|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825510|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56825511|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825512|NCT00073918|Trace Elements|trace elements|mesh-ancestor
56825513|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
56825514|NCT00231894|Pioglitazone|pioglitazone|mesh-list
56825515|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56825516|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825517|NCT00203424|Bevacizumab|bevacizumab|mesh-list
56825518|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56825519|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825520|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825521|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56825522|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56825523|NCT00203424|Growth Substances|growth substances|mesh-ancestor
56825524|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825525|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
56825526|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56825527|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825528|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825529|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
56825530|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56825531|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
56825532|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
56825534|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825535|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825536|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56825537|NCT00203268|Analgesics|analgesics|mesh-ancestor
56825538|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
56825539|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825540|NCT00168818|Enoxaparin|enoxaparin|mesh-list
56825541|NCT00168818|Dabigatran|dabigatran|mesh-list
56825542|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
56825543|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56825544|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56825545|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825546|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
56825547|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56825548|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
56825549|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825550|NCT00260832|Cytarabine|cytarabine|mesh-list
56825551|NCT00260832|Decitabine|decitabine|mesh-list
56825552|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56825553|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
56825554|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825555|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825556|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
56825557|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825558|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825559|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
56825560|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825561|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825562|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
56825563|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56825564|NCT00168038|Antibodies|antibodies|mesh-list
56825565|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
56825566|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825567|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
56825568|NCT00166712|Sirolimus|sirolimus|mesh-list
56825569|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
56825570|NCT00166712|Tacrolimus|tacrolimus|mesh-list
56825571|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825572|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
56825573|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825574|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56825575|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825576|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825577|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56825578|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825579|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56825580|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
56825581|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56825582|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825583|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
56825584|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825585|NCT00073528|Letrozole|letrozole|mesh-list
56825586|NCT00073528|Lapatinib|lapatinib|mesh-list
56825587|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825588|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56825589|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56825590|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825591|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825592|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56536456|NCT02090998|Lidocaine|lidocaine|mesh-list
56825593|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
56825594|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56825595|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825596|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56825598|NCT03801148|Lansoprazole|lansoprazole|mesh-list
56825599|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56825600|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56825601|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56825602|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825603|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825604|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
56825605|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56825606|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825607|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
56825610|NCT01103830|Piperaquine|piperaquine|mesh-list
56825611|NCT01103830|Artenimol|artenimol|mesh-list
56825612|NCT01103830|Artemisinins|artemisinins|mesh-list
56825613|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56825614|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56825615|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56825616|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825617|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56825618|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56825619|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825620|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825621|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825622|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56825623|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
56825624|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56825625|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432862|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
56825626|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56825627|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56825628|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56825629|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
56825630|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56825631|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56825632|NCT05562466|Budesonide|budesonide|mesh-list
56825633|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56825634|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56825635|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
56825636|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825637|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825638|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56825639|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
56825640|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
56825641|NCT05562466|Hormones|hormones|mesh-ancestor
56825642|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56825643|NCT00072280|Dactinomycin|dactinomycin|mesh-list
56825644|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
56825645|NCT00072280|Ifosfamide|ifosfamide|mesh-list
56825646|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
56825647|NCT00072280|Etoposide|etoposide|mesh-list
56825648|NCT00072280|Vincristine|vincristine|mesh-list
56825649|NCT00072280|Lenograstim|lenograstim|mesh-list
56825650|NCT00072280|Mesna|mesna|mesh-list
56825651|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825652|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
56825653|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825654|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825655|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56825656|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
56825657|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825658|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825659|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56825660|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56825661|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56825662|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56825663|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825664|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56825665|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825666|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825667|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825668|NCT00072280|Protective Agents|protective agents|mesh-ancestor
56825669|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56825670|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825671|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56825672|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56825673|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56825674|NCT05527834|Ceftibuten|ceftibuten|mesh-list
56825675|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56825676|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825677|NCT01106716|Lidocaine|lidocaine|mesh-list
56825678|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
56825679|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
56825680|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56825681|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825682|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
56825685|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56825686|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56825687|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56825688|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825689|NCT00071812|Belimumab|belimumab|mesh-list
56825690|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825691|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
56825692|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825693|NCT01104298|Doxorubicin|doxorubicin|mesh-list
56825694|NCT01104298|Trabectedin|trabectedin|mesh-list
56825695|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56825696|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825697|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56825698|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56825699|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825700|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825701|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56825702|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
56825703|NCT01106872|Gemcitabine|gemcitabine|mesh-list
56825704|NCT01106872|Bevacizumab|bevacizumab|mesh-list
56825705|NCT01106872|Docetaxel|docetaxel|mesh-list
56825706|NCT01106872|Valproic Acid|valproic acid|mesh-list
56825707|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825708|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825709|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56825710|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56825711|NCT01106872|Growth Substances|growth substances|mesh-ancestor
56825712|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825713|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
56825714|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56825715|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
56825716|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825717|NCT01106872|Antiviral Agents|antiviral agents|mesh-ancestor
56825718|NCT01106872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825719|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825720|NCT01106872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825721|NCT01106872|Immunologic Factors|immunologic factors|mesh-ancestor
56825722|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825723|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825724|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825725|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
56825726|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
56825727|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825728|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
56825729|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56825730|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56825731|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56825732|NCT03960268|Brodalumab|brodalumab|mesh-list
56825733|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
56825734|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
56825735|NCT05485480|Narcotics|narcotics|mesh-ancestor
56825736|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56825737|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825738|NCT05485480|Analgesics|analgesics|mesh-ancestor
56825739|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
56825740|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825741|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
56825742|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825743|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
56825744|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825745|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825746|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56825747|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
56825748|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56825749|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
56825750|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56825751|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825752|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56825753|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
56825754|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
56825755|NCT00259610|Etanercept|etanercept|mesh-list
56825756|NCT00259610|Methotrexate|methotrexate|mesh-list
56825757|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56825758|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
56825759|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56825760|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825761|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56825762|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
56825763|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825764|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825765|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
56825766|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825767|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56825768|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825769|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
56825770|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825771|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56825772|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
56825773|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56825774|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56825775|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56825776|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56825777|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56825778|NCT00259610|Analgesics|analgesics|mesh-ancestor
56825779|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
56825780|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825781|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56825782|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56825783|NCT05371132|Deferoxamine|deferoxamine|mesh-list
56825784|NCT05371132|Siderophores|siderophores|mesh-ancestor
56825785|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56825786|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
56825787|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
56825788|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825789|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
56825790|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
56825791|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56825792|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56825793|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56825794|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56825795|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825796|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
56825797|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825798|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825799|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56825800|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825801|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56825802|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
56825803|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825804|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
56825805|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56825806|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56825807|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825808|NCT00165698|Vitamins|vitamins|mesh-ancestor
56825809|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
56825810|NCT01075022|Vitamin D|vitamin d|mesh-list
56825811|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
56825812|NCT01075022|Vitamins|vitamins|mesh-ancestor
56825813|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
56825814|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825815|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56825816|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56825817|NCT00225758|Lapatinib|lapatinib|mesh-list
56825818|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825819|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56825820|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825821|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825822|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56825824|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56825825|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825826|NCT01104532|Incretins|incretins|mesh-ancestor
56825827|NCT01104532|Hormones|hormones|mesh-ancestor
56825828|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56825829|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56825830|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
56825831|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904602|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825832|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825833|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56825834|NCT01107574|Gabapentin|gabapentin|mesh-list
56825835|NCT01107574|Analgesics|analgesics|mesh-ancestor
56825836|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
56825837|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825838|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825839|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
56825840|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56825841|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56825842|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56825843|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56825844|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56825845|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56825846|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825847|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825848|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
56825849|NCT03971500|Ticagrelor|ticagrelor|mesh-list
56825850|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825851|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825852|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56825853|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56825854|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56825855|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56825856|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
56825857|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825858|NCT00259298|Teriparatide|teriparatide|mesh-list
56825859|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56825860|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825861|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56825862|NCT01108744|Mannitol|mannitol|mesh-list
56825863|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56825864|NCT01108744|Diuretics|diuretics|mesh-ancestor
56825865|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
56825866|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825867|NCT01581866|Ziprasidone|ziprasidone|mesh-list
56825868|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56825869|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
56825870|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825871|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825872|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825873|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56825874|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56825875|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56825876|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56825877|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56825878|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
56825879|NCT03892642|Avelumab|avelumab|mesh-list
56825880|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825881|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825882|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
56825883|NCT01107808|Vitamin D|vitamin d|mesh-list
56825884|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
56825885|NCT01107808|Metformin|metformin|mesh-list
56825886|NCT01107808|Calcium|calcium|mesh-list
56825887|NCT01107808|Vitamins|vitamins|mesh-ancestor
56825888|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
56825889|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825890|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56825891|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56825892|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56825893|NCT01104844|Acetaminophen|acetaminophen|mesh-list
56825894|NCT01104844|Ibuprofen|ibuprofen|mesh-list
56825895|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56825896|NCT01104844|Analgesics|analgesics|mesh-ancestor
56825897|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
56825898|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825899|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825900|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
56825901|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56825902|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56825903|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56825904|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56825905|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825906|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825907|NCT03750136|Furosemide|furosemide|mesh-list
56825908|NCT03750136|Diuretics|diuretics|mesh-ancestor
56825909|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
56825910|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825911|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56825912|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56825913|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825914|NCT01108042|Docetaxel|docetaxel|mesh-list
56825915|NCT01108042|Fluorouracil|fluorouracil|mesh-list
56825916|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825917|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825918|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825919|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825920|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825921|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
56825922|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56825923|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56825924|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
56825925|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825926|NCT01105234|Vitamin D|vitamin d|mesh-list
56825927|NCT01105234|Calcipotriene|calcipotriene|mesh-list
56825928|NCT01105234|Vitamins|vitamins|mesh-ancestor
56825929|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
56825930|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825931|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56825932|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
56825933|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
56825934|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56825935|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
56825936|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56825937|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
56825938|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
56825939|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56825940|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56825941|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825942|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825943|NCT01108900|Urological Agents|urological agents|mesh-ancestor
56825944|NCT01105390|Pemetrexed|pemetrexed|mesh-list
56825945|NCT01105390|Rilotumumab|rilotumumab|mesh-list
56825946|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56825947|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825948|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56825949|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825950|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56825951|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56825952|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825953|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
56825954|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825955|NCT03947242|Trastuzumab|trastuzumab|mesh-list
56825956|NCT03947242|Vinorelbine|vinorelbine|mesh-list
56825957|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56825958|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825959|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56825960|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825961|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825962|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825963|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825964|NCT03944980|Docetaxel|docetaxel|mesh-list
56825965|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56825966|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
56825967|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
56825968|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
56825969|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825970|NCT03576664|Carvedilol|carvedilol|mesh-list
56825971|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56825972|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56825974|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56825975|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825976|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825977|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56825978|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
56825979|NCT03576664|Protective Agents|protective agents|mesh-ancestor
56825980|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56825981|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56825982|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56825984|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56825985|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56825987|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56825988|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56825989|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56825990|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56825991|NCT01108588|Aspirin|aspirin|mesh-list
56825992|NCT01108588|Clopidogrel|clopidogrel|mesh-list
56825993|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56825994|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56825995|NCT01108588|Analgesics|analgesics|mesh-ancestor
56825996|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
56825997|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56825998|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56825999|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826000|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826001|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56826002|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56826003|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826004|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56826005|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56826006|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826007|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
56826008|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56826009|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56826010|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56826011|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
56826012|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826013|NCT01208740|Metformin|metformin|mesh-list
56826014|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56826015|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826016|NCT01208818|Dexamethasone|dexamethasone|mesh-list
56826017|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
56826018|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
56826019|NCT01208818|Bortezomib|bortezomib|mesh-list
56826020|NCT01208818|BB 1101|bb 1101|mesh-list
56826021|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56826022|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
56826023|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826024|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826025|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56826026|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
56826027|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826028|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826029|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56826030|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826031|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
56826032|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
56826033|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826034|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56826035|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
56826036|NCT01208818|Hormones|hormones|mesh-ancestor
56826037|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56826038|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56826039|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
56826040|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826041|NCT05078866|Vaccines|vaccines|mesh-list
56826042|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
56826043|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826044|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
56826045|NCT01111630|Hematinics|hematinics|mesh-ancestor
56826046|NCT03942796|Pregabalin|pregabalin|mesh-list
56826047|NCT03942796|Analgesics|analgesics|mesh-ancestor
56826048|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
56826049|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826050|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826051|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
56826052|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56826053|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826054|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826055|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56340432|NCT00132535|Chloroquine|chloroquine|mesh-list
56826057|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56826058|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826059|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56826061|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826062|NCT01109212|Bindarit|bindarit|mesh-list
56826063|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826064|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56826065|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826066|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826067|NCT01111864|Micronutrients|micronutrients|mesh-list
56826068|NCT01111864|Trace Elements|trace elements|mesh-list
56826069|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826070|NCT01111942|Cisplatin|cisplatin|mesh-list
56826071|NCT01111942|Carboplatin|carboplatin|mesh-list
56826072|NCT01111942|Docetaxel|docetaxel|mesh-list
56826073|NCT01111942|Fluorouracil|fluorouracil|mesh-list
56826074|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826075|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
56826076|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
56826077|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
56826078|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826079|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
56826080|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56826081|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56826082|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
56826083|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826084|NCT01211860|Diazoxide|diazoxide|mesh-list
56826085|NCT01211860|Choline|choline|mesh-list
56826086|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
56826087|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56826088|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
56826089|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826090|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56826091|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56826092|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
56826093|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56826094|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
56826095|NCT01211938|Cetuximab|cetuximab|mesh-list
56826096|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56826097|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826098|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
56826099|NCT02947438|Hematinics|hematinics|mesh-ancestor
56826100|NCT01209130|Rituximab|rituximab|mesh-list
56826101|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56826102|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826103|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
56826104|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826105|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826106|NCT01209208|Budesonide|budesonide|mesh-list
56826107|NCT01209208|Mesalamine|mesalamine|mesh-list
56826108|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826109|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56826110|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
56826111|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826112|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826113|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56826114|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
56826115|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
56826116|NCT01209208|Hormones|hormones|mesh-ancestor
56826117|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56826118|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56826119|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56826120|NCT01209208|Analgesics|analgesics|mesh-ancestor
56826121|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
56826122|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826123|NCT01114750|Dextrans|dextrans|mesh-list
56826124|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
56826125|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
56826126|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
56826127|NCT01328470|Cilostazol|cilostazol|mesh-list
56826128|NCT01328470|Clopidogrel|clopidogrel|mesh-list
56826129|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56826130|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56826131|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56826132|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56826133|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
56826134|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826135|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826136|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826137|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56826139|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826140|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56826141|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
56826142|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56826143|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56826144|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
56826145|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56826146|NCT01328470|Protective Agents|protective agents|mesh-ancestor
56826147|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56826148|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56826149|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826150|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56826151|NCT03940378|Levamisole|levamisole|mesh-list
56433369|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826152|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56826153|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
56826154|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826155|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
56826156|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
56826157|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56826158|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56826159|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826160|NCT01115062|Lidocaine|lidocaine|mesh-list
56826161|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
56826162|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
56826163|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826164|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826165|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
56826166|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826167|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56826168|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56826169|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56826170|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826171|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826172|NCT01115140|Folic Acid|folic acid|mesh-list
56826173|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
56826174|NCT01115140|Metformin|metformin|mesh-list
56826175|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56826176|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826177|NCT01115140|Hematinics|hematinics|mesh-ancestor
56826178|NCT01115140|Vitamins|vitamins|mesh-ancestor
56826179|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
56826180|NCT01112644|Oxycodone|oxycodone|mesh-list
56826181|NCT01112644|Naloxone|naloxone|mesh-list
56826182|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56826183|NCT01112644|Narcotics|narcotics|mesh-ancestor
56826184|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826185|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826186|NCT01112644|Analgesics|analgesics|mesh-ancestor
56826187|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
56826188|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826189|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56826190|NCT01112722|Histamine|histamine|mesh-list
56826191|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
56826192|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
56826193|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826194|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826195|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826196|NCT01015222|Paclitaxel|paclitaxel|mesh-list
56826197|NCT01015222|Bevacizumab|bevacizumab|mesh-list
56826198|NCT01015222|Dasatinib|dasatinib|mesh-list
56826199|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56826200|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826201|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
56826203|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
56826204|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826205|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56826206|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56826207|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56826208|NCT01015222|Growth Substances|growth substances|mesh-ancestor
56826209|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557612|NCT01149863|Plerixafor|plerixafor|mesh-list
56826211|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56826212|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826213|NCT01212250|Carvedilol|carvedilol|mesh-list
56826214|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56826215|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56826216|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
56826217|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826218|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826219|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826220|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56826221|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
56826222|NCT01212250|Protective Agents|protective agents|mesh-ancestor
56826223|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56826224|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826225|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56902796|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
56826226|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
56826227|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56826228|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56826229|NCT01209988|Tamsulosin|tamsulosin|mesh-list
56826230|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56826231|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56826232|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56826233|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
56826234|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826235|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826236|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826237|NCT01209988|Urological Agents|urological agents|mesh-ancestor
56826238|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
56826239|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56826240|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
56826241|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826242|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
56826243|NCT03943186|Protective Agents|protective agents|mesh-ancestor
56826244|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56826245|NCT01210066|Fentanyl|fentanyl|mesh-list
56826246|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
56826247|NCT01210066|Narcotics|narcotics|mesh-ancestor
56826248|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826249|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826250|NCT01210066|Analgesics|analgesics|mesh-ancestor
56826251|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
56826252|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826253|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56826254|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56826255|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
56826256|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
56826257|NCT01112878|Clonidine|clonidine|mesh-list
56826258|NCT01112878|Gabapentin|gabapentin|mesh-list
56826259|NCT01112878|Analgesics|analgesics|mesh-ancestor
56826260|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
56826261|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826262|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826263|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
56826264|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56826265|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56826266|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826267|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56826268|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56826269|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56826270|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826271|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826272|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
56826273|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56826274|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
56826275|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
56826276|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56826277|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56826278|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56826279|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
56826280|NCT01212406|Vitamin D|vitamin d|mesh-list
56826281|NCT01212406|Vitamins|vitamins|mesh-ancestor
56826282|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
56826283|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826284|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56826286|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56826287|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
56826288|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826289|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56826290|NCT01328236|Dexamethasone|dexamethasone|mesh-list
56826291|NCT01328236|Doxorubicin|doxorubicin|mesh-list
56826292|NCT01328236|Bortezomib|bortezomib|mesh-list
56826293|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826294|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
56826295|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
56826296|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826297|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826298|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56826299|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
56826300|NCT01328236|Hormones|hormones|mesh-ancestor
56902800|NCT03768609|Cyclosporine|cyclosporine|mesh-list
56826301|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56826302|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56826303|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826304|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56826305|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56826306|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56826307|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826308|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826309|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
56826310|NCT01328392|Lansoprazole|lansoprazole|mesh-list
56826311|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56826312|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56826313|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56826314|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826315|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826316|NCT01115842|Vitamin D|vitamin d|mesh-list
56826317|NCT01115842|Vitamins|vitamins|mesh-ancestor
56826318|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
56826319|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826320|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56826321|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
56826322|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
56826323|NCT01116154|Lenalidomide|lenalidomide|mesh-list
56826324|NCT01116154|Vorinostat|vorinostat|mesh-list
56826325|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
56826326|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826327|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56826328|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56826329|NCT01116154|Growth Substances|growth substances|mesh-ancestor
56826330|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
56826331|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826332|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56826333|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826334|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826335|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
56826336|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56826337|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
56826338|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56826339|NCT01210456|Expectorants|expectorants|mesh-ancestor
56826340|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
56826341|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56826342|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
56826343|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826344|NCT01210456|Protective Agents|protective agents|mesh-ancestor
56826345|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826346|NCT01210456|Antidotes|antidotes|mesh-ancestor
56826347|NCT01116310|Glycine|glycine|mesh-list
56826348|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
56826349|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537218|NCT02792491|Hormones|hormones|mesh-ancestor
56826350|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826351|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826352|NCT01116388|Caseins|caseins|mesh-list
56826353|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
56826354|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
56826355|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826356|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56826357|NCT01116622|Bexarotene|bexarotene|mesh-list
56826358|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826359|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56826360|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826361|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826362|NCT01211002|Endostatins|endostatins|mesh-list
56826363|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826364|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56826365|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56826366|NCT01211002|Growth Substances|growth substances|mesh-ancestor
56826367|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826368|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
56826369|NCT01211080|Propranolol|propranolol|mesh-list
56826370|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56826371|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56826372|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
56826373|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826374|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826375|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826376|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56826377|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56826378|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
56826379|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
56826380|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56826381|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826382|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826383|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56826384|NCT01116700|Analgesics|analgesics|mesh-ancestor
56826385|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
56826386|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826387|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56826388|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56826389|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56826390|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
56826391|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826392|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826393|NCT01113424|Nicotine|nicotine|mesh-list
56826394|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56826395|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
56826396|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826397|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826398|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56826399|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56826400|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
56826401|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826402|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826403|NCT01211158|Ketamine|ketamine|mesh-list
56826404|NCT01211158|Propofol|propofol|mesh-list
56826405|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56826406|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826407|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826408|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56826409|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
56826410|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
56826411|NCT01211158|Analgesics|analgesics|mesh-ancestor
56826412|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
56826413|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826414|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56826415|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56826416|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56826417|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826418|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826419|NCT01110226|Cisplatin|cisplatin|mesh-list
56826420|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
56826421|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826422|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826423|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537280|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56826424|NCT03789292|Adalimumab|adalimumab|mesh-list
56826425|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826426|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826428|NCT01211314|Lercanidipine|lercanidipine|mesh-list
56826429|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56826430|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
56826431|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826432|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826433|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56826434|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56826435|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826436|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56826437|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826438|NCT01110304|Analgesics|analgesics|mesh-list
56826439|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
56826440|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826441|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826442|NCT02529514|Baclofen|baclofen|mesh-list
56826443|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56826444|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826445|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56826446|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826447|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56826448|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
56826449|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
56826450|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826451|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826452|NCT01211470|Daptomycin|daptomycin|mesh-list
56826453|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56826454|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56826455|NCT01114048|Thalidomide|thalidomide|mesh-list
56826456|NCT01114048|Dexamethasone|dexamethasone|mesh-list
56826457|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
56826458|NCT01114048|Bortezomib|bortezomib|mesh-list
56826459|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56826460|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
56826461|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826462|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826463|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56826464|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
56826465|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826466|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826467|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56826468|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826469|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
56826470|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
56826471|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826472|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56826473|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
56826474|NCT01114048|Hormones|hormones|mesh-ancestor
56826475|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56826476|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56826477|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
56826478|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56826479|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56826480|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56826481|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56826482|NCT01114048|Growth Substances|growth substances|mesh-ancestor
56826483|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
56826484|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
56826485|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826486|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56826487|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56826488|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56826489|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826490|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826491|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56826492|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56826493|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56826494|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
56826495|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826496|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826497|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56537360|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
56826498|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56826499|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
56826500|NCT02529670|Lidocaine|lidocaine|mesh-list
56826501|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
56826502|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
56826503|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826504|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826505|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
56826506|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826507|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56826508|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56826509|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56826510|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826511|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826512|NCT01117636|Aspirin|aspirin|mesh-list
56826513|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56826514|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56826515|NCT01117636|Analgesics|analgesics|mesh-ancestor
56826516|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
56826517|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826518|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826519|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826520|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826521|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56826522|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56826523|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826524|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56826525|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56826526|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826527|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
56826528|NCT03938740|Insulin|insulin|mesh-list
56826529|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56826530|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
56826531|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
56826532|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56826533|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826534|NCT01110616|Lorazepam|lorazepam|mesh-list
56826535|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
56826536|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
56826537|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
56826538|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826539|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826540|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56826541|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56826542|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826543|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56826544|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56826545|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56826546|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
56826547|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
56826548|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826549|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826550|NCT03938662|Choline|choline|mesh-list
56826551|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
56826552|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56826553|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
56826554|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826555|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56826556|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56826557|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
56826558|NCT01213498|Atorvastatin|atorvastatin|mesh-list
56826559|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56826560|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56826561|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
56826562|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826563|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56826564|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56826565|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826566|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56826567|NCT01111084|Hormones|hormones|mesh-ancestor
56826568|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56826569|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826570|NCT01118260|Anesthetics|anesthetics|mesh-list
56826571|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826572|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826573|NCT01121770|PENTA|penta|mesh-list
56826574|NCT01121770|Fondaparinux|fondaparinux|mesh-list
56826575|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56826576|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
56826577|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56826578|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
56826579|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826580|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826581|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
56826582|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56826584|NCT01121848|Leucovorin|leucovorin|mesh-list
56826585|NCT01121848|Fluorouracil|fluorouracil|mesh-list
56826586|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
56826587|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
56826588|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826589|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56826590|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826591|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56826592|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
56826593|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826594|NCT01121848|Antidotes|antidotes|mesh-ancestor
56826595|NCT01121848|Protective Agents|protective agents|mesh-ancestor
56826596|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
56826597|NCT01121848|Vitamins|vitamins|mesh-ancestor
56826598|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
56826599|NCT01122004|Pregabalin|pregabalin|mesh-list
56826600|NCT01122004|Analgesics|analgesics|mesh-ancestor
56826601|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
56826602|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826603|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826604|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
56826605|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56826606|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826607|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826608|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56826609|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56826610|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56826611|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826612|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56826613|NCT03933982|Vinorelbine|vinorelbine|mesh-list
56826614|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56826615|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826616|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
56826617|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
56826618|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
56826619|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826620|NCT01118572|Celecoxib|celecoxib|mesh-list
56826621|NCT01118572|Etodolac|etodolac|mesh-list
56826622|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56826623|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56826624|NCT01118572|Analgesics|analgesics|mesh-ancestor
56826625|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
56826626|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826627|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826628|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826629|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826630|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56826631|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56826632|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826633|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826634|NCT03937648|Lasmiditan|lasmiditan|mesh-list
56826635|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56826636|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
56826637|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826638|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826639|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826640|NCT01219036|Budesonide|budesonide|mesh-list
56826641|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56826642|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56826643|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
56826644|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826645|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826646|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56826647|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
56826648|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
56826650|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56826651|NCT03936010|Canagliflozin|canagliflozin|mesh-list
56826652|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56826653|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56826654|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826655|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56826656|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826657|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
56826658|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826659|NCT01124500|Methylphenidate|methylphenidate|mesh-list
56826660|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56826661|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826662|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56902810|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826663|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56826664|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826665|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826666|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
56826667|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826668|NCT01118884|Promethazine|promethazine|mesh-list
56826669|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
56826670|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
56826671|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
56826672|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56826673|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
56826674|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
56826675|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826676|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826677|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826678|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56826679|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56826680|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56826681|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826682|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
56826683|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
56826684|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
56826685|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826686|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
56826687|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
56826688|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56826689|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
56826690|NCT01119196|Icodextrin|icodextrin|mesh-list
56826691|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56826692|NCT01213888|Trientine|trientine|mesh-list
56826693|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
56826694|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
56826695|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826696|NCT01119430|Fluoxetine|fluoxetine|mesh-list
56826697|NCT01119430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56826698|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56826699|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826700|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826701|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826702|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
56826703|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826704|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56826705|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
56826706|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56826707|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56826708|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56826709|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826710|NCT02529124|Caseins|caseins|mesh-list
56826711|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
56826712|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
56826713|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826714|NCT03780244|Mannitol|mannitol|mesh-list
56826715|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56826716|NCT03780244|Diuretics|diuretics|mesh-ancestor
56826717|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
56826718|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826719|NCT01119742|Butenafine|butenafine|mesh-list
56826720|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
56826721|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56826722|NCT01216696|Ipilimumab|ipilimumab|mesh-list
56826723|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56826724|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826725|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56826726|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826727|NCT03937258|Probenecid|probenecid|mesh-list
56826728|NCT03937258|Abrocitinib|abrocitinib|mesh-list
56826729|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
56826730|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
56826731|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826732|NCT03937258|Renal Agents|renal agents|mesh-ancestor
56826734|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826735|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826736|NCT01124656|Pioglitazone|pioglitazone|mesh-list
56826737|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56826738|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56826739|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826740|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56826741|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56826742|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826743|NCT01122472|Lenalidomide|lenalidomide|mesh-list
56826744|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
56826745|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826746|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56826747|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56826748|NCT01122472|Growth Substances|growth substances|mesh-ancestor
56826749|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
56826750|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826751|NCT01214122|Warfarin|warfarin|mesh-list
56826752|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
56826753|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
56826754|NCT03935152|Progestins|progestins|mesh-ancestor
56826755|NCT03935152|Hormones|hormones|mesh-ancestor
56826756|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56826757|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826758|NCT01216852|Losartan|losartan|mesh-list
56826759|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56826760|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56826761|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56826762|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56826763|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826764|NCT03933748|Teicoplanin|teicoplanin|mesh-list
56826765|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56826766|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56826767|NCT01120366|Methotrexate|methotrexate|mesh-list
56826768|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56826769|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
56826770|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56826771|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826772|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56826773|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
56826774|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826775|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826776|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
56826777|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826778|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56826779|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56826780|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
56826781|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826782|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56826783|NCT01217086|Infliximab|infliximab|mesh-list
56826784|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
56826785|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56826786|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826787|NCT01120444|Insulin|insulin|mesh-list
56826788|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56826789|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826790|NCT01217398|Bevacizumab|bevacizumab|mesh-list
56826791|NCT01217398|Temozolomide|temozolomide|mesh-list
56826792|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56826793|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826794|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56826795|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56826796|NCT01217398|Growth Substances|growth substances|mesh-ancestor
56826797|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826798|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
56826799|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56826800|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
56826801|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826802|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
56826803|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56826804|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56826805|NCT01214746|Atorvastatin|atorvastatin|mesh-list
56826807|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56826808|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
56826809|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826810|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56902814|NCT03269552|Antibodies|antibodies|mesh-list
56826811|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56826812|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826813|NCT03935074|Melphalan|melphalan|mesh-list
56826814|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56826815|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
56826816|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826817|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826818|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56826819|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56826820|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
56826821|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826822|NCT01217632|Entecavir|entecavir|mesh-list
56826823|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
56826824|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56826825|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
56826826|NCT03933280|Nalbuphine|nalbuphine|mesh-list
56826827|NCT03933280|Propofol|propofol|mesh-list
56826828|NCT03933280|Benoxinate|benoxinate|mesh-list
56826829|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56826830|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56826831|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826832|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826833|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56826834|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
56826835|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
56826836|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56826837|NCT03933280|Analgesics|analgesics|mesh-ancestor
56826838|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
56826839|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826840|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56826841|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56826842|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56826843|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
56826844|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826845|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826846|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56826847|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56826848|NCT03933280|Narcotics|narcotics|mesh-ancestor
56826849|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
56826850|NCT01120912|Insulin|insulin|mesh-list
56826851|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56826852|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826853|NCT01219582|Metformin|metformin|mesh-list
56826854|NCT01219582|Acarbose|acarbose|mesh-list
56826855|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56826856|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826857|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56826858|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826859|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826860|NCT03933358|Hormones|hormones|mesh-list
56826861|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56826862|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826863|NCT01122940|Phenytoin|phenytoin|mesh-list
56826864|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
56826865|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56826866|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56826867|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826868|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826869|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56826870|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56826871|NCT01219816|Epratuzumab|epratuzumab|mesh-list
56537726|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
56826872|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56826873|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826875|NCT01215136|Everolimus|everolimus|mesh-list
56826876|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56826877|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826878|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
56826879|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
56826881|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826882|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56826883|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
56826884|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826885|NCT01218022|Losartan|losartan|mesh-list
56826886|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56826887|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56826888|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56826889|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56826890|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826891|NCT01121458|Clevidipine|clevidipine|mesh-list
56826892|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56826893|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826894|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826895|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56826896|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826897|NCT01215214|Midazolam|midazolam|mesh-list
56826898|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56826899|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56826900|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826901|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826902|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56826903|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56826904|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56826905|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56826906|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
56826907|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
56826908|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
56826909|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
56826910|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826911|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826912|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56826913|NCT01125670|Darexaban|darexaban|mesh-list
56826914|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56826915|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
56826916|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56826917|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
56826918|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826919|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826920|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
56826921|NCT03934450|Primaquine|primaquine|mesh-list
56826922|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
56826923|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56826924|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56826925|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56826926|NCT01215682|Vitamin D|vitamin d|mesh-list
56826927|NCT01215682|Vitamins|vitamins|mesh-ancestor
56826928|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
56826929|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826930|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56826931|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56826932|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56826933|NCT01123408|Haloperidol|haloperidol|mesh-list
56826934|NCT01123408|Olanzapine|olanzapine|mesh-list
56826935|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
56826936|NCT01123408|Clozapine|clozapine|mesh-list
56826937|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
56826938|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
56826939|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826940|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826941|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56434155|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
56826942|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56826943|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56826944|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537860|NCT02780479|Prednisone|prednisone|mesh-list
56826945|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56826946|NCT01123408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56826947|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56826948|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56826949|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826950|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56826951|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
56826952|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56826953|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
56826955|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56826956|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
56826957|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
56826958|NCT00141297|Palbociclib|palbociclib|mesh-list
56826959|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826960|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56826961|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56826962|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826963|NCT01123486|Hydromorphone|hydromorphone|mesh-list
56826964|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56826965|NCT01123486|Narcotics|narcotics|mesh-ancestor
56826966|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56826967|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826968|NCT01123486|Analgesics|analgesics|mesh-ancestor
56826969|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
56826970|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56826971|NCT01123564|Ranibizumab|ranibizumab|mesh-list
56826972|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56826973|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56826974|NCT01123564|Growth Substances|growth substances|mesh-ancestor
56826975|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826976|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
56826977|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826978|NCT01222312|Docetaxel|docetaxel|mesh-list
56826979|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
56826980|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826981|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
56826982|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
56826983|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
56826984|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826985|NCT03932266|Docetaxel|docetaxel|mesh-list
56826986|NCT03932266|Endostar protein|endostar protein|mesh-list
56826987|NCT03932266|Endostatins|endostatins|mesh-list
56826988|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56826989|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
56826990|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
56826991|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
56826992|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56826993|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56826994|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56826995|NCT03932266|Growth Substances|growth substances|mesh-ancestor
56826996|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56826997|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
56826998|NCT00141219|Pregabalin|pregabalin|mesh-list
56826999|NCT00141219|Analgesics|analgesics|mesh-ancestor
56827000|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
56827001|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827002|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827003|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
56827004|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56827005|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56827006|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827007|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56827008|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56827009|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56827010|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827011|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56827012|NCT01222468|Nabilone|nabilone|mesh-list
56827013|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
56827014|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
56827015|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827016|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827017|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827018|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56827019|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56827020|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827021|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56537893|NCT02779387|Goserelin|goserelin|mesh-list
56827022|NCT01220284|Vinorelbine|vinorelbine|mesh-list
56827023|NCT01220284|Satraplatin|satraplatin|mesh-list
56827024|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56827025|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827026|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
56827027|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
56827028|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
56827031|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
56827032|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
56827033|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827034|NCT01222780|Vincristine|vincristine|mesh-list
56827035|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56827036|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827037|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
56827038|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
56827039|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
56827040|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827041|NCT01222936|Panobinostat|panobinostat|mesh-list
56827042|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827043|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56827044|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827045|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827046|NCT01125904|Crizotinib|crizotinib|mesh-list
56827047|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827048|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56827049|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827050|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827051|NCT01125982|Propofol|propofol|mesh-list
56827052|NCT01125982|Desflurane|desflurane|mesh-list
56827053|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56827054|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827055|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827056|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56827057|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
56827058|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
56827059|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56827060|NCT01220362|Fentanyl|fentanyl|mesh-list
56827061|NCT01220362|Bupivacaine|bupivacaine|mesh-list
56827062|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
56827063|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
56827064|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827065|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827066|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
56827067|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827068|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56827069|NCT01220362|Narcotics|narcotics|mesh-ancestor
56827070|NCT01220362|Analgesics|analgesics|mesh-ancestor
56827071|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56827072|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56827073|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
56827074|NCT01220440|Methylphenidate|methylphenidate|mesh-list
56827075|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
56827076|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56827077|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827078|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56827079|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56827080|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56827081|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827082|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
56827083|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827084|NCT01123876|Veliparib|veliparib|mesh-list
56827085|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56827086|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827087|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827088|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827089|NCT01124032|Methylphenidate|methylphenidate|mesh-list
56827090|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56827091|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827092|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56827093|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56827094|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56827095|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827096|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
56827097|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827098|NCT03934294|Metoclopramide|metoclopramide|mesh-list
56827099|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
56827100|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
56827101|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827102|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827103|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827104|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56827105|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56827107|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827108|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827109|NCT01126138|Docetaxel|docetaxel|mesh-list
56827110|NCT01126138|Capecitabine|capecitabine|mesh-list
56827111|NCT01126138|Vinorelbine|vinorelbine|mesh-list
56827112|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827113|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
56827114|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
56827115|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
56827116|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827117|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56827118|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
56827119|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56827120|NCT01218568|Rifaximin|rifaximin|mesh-list
56827121|NCT01218568|Lactulose|lactulose|mesh-list
56827122|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56827123|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827124|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827125|NCT01127542|Lenalidomide|lenalidomide|mesh-list
56827126|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
56827127|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827128|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56827129|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56827130|NCT01127542|Growth Substances|growth substances|mesh-ancestor
56827131|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
56827132|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827133|NCT01127620|Cetirizine|cetirizine|mesh-list
56827134|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56827135|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56827136|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56827137|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
56827138|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
56827139|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827140|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827141|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827142|NCT01220518|Infliximab|infliximab|mesh-list
56827143|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
56827144|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827145|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56827146|NCT01220596|Interferons|interferons|mesh-list
56827147|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56827148|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
56827149|NCT01220596|Entecavir|entecavir|mesh-list
56827150|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827151|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
56827152|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827153|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
56827154|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827155|NCT01218724|Losartan|losartan|mesh-list
56827156|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56827157|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56827158|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56827159|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56827160|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56827161|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827162|NCT01218724|Diuretics|diuretics|mesh-ancestor
56827163|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
56827164|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827165|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56827166|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56827167|NCT01126216|Paclitaxel|paclitaxel|mesh-list
56827168|NCT01126216|Cisplatin|cisplatin|mesh-list
56827169|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56827170|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827171|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
56827172|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
56827173|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
56827174|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827175|NCT01329016|Metformin|metformin|mesh-list
56827176|NCT01329016|Glyburide|glyburide|mesh-list
56827177|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56827178|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827179|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
56827180|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56827181|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
56827182|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827183|NCT01223326|Expectorants|expectorants|mesh-ancestor
56827184|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
56827185|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56827186|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
56827187|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827188|NCT01223326|Protective Agents|protective agents|mesh-ancestor
56827189|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827190|NCT01223326|Antidotes|antidotes|mesh-ancestor
56827191|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
56827192|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56827193|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827194|NCT01126294|Melatonin|melatonin|mesh-list
56827195|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
56827196|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827197|NCT01126294|Protective Agents|protective agents|mesh-ancestor
56827198|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827199|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827200|NCT00162266|Abatacept|abatacept|mesh-list
56827201|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56827202|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827203|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827204|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56827205|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
56827206|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827207|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56827208|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56827209|NCT01126450|Cetuximab|cetuximab|mesh-list
56827210|NCT01126450|Lenalidomide|lenalidomide|mesh-list
56827211|NCT01126450|Antibodies|antibodies|mesh-list
56827212|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
56827213|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56827214|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
56827215|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827216|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827217|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56827218|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56827219|NCT01126450|Growth Substances|growth substances|mesh-ancestor
56827220|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
56827221|NCT01073384|Beclomethasone|beclomethasone|mesh-list
56827222|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56827223|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
56827224|NCT01073384|Hormones|hormones|mesh-ancestor
56827225|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56827226|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827227|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56827228|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
56827229|NCT01126528|Vitamin D|vitamin d|mesh-list
56827230|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
56827231|NCT01126528|Vitamins|vitamins|mesh-ancestor
56827232|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
56827233|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827234|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56827235|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56827236|NCT00225212|Rituximab|rituximab|mesh-list
56827237|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56827238|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827239|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
56827240|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827241|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56827242|NCT03853330|Bupivacaine|bupivacaine|mesh-list
56827243|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
56827244|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
56827245|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827246|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827247|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
56827248|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827249|NCT01581944|Goserelin|goserelin|mesh-list
56827250|NCT01581944|Hormones|hormones|mesh-list
56827251|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56827252|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827253|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56827254|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827255|NCT01226056|Everolimus|everolimus|mesh-list
56827256|NCT01226056|Sorafenib|sorafenib|mesh-list
56827257|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827258|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56827259|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
56827260|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827261|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56827262|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827263|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827264|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56827265|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56827266|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827267|NCT01126606|Glycerol|glycerol|mesh-list
56827268|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56827269|NCT01126606|Protective Agents|protective agents|mesh-ancestor
56827270|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827271|NCT01329406|Milnacipran|milnacipran|mesh-list
56827272|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
56827273|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56827274|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56827275|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56827276|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827277|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827278|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827279|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56827280|NCT01329406|Analgesics|analgesics|mesh-ancestor
56827281|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
56827282|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827283|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
56827284|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56827285|NCT01126684|Atorvastatin|atorvastatin|mesh-list
56827286|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56827287|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56827288|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
56827289|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827290|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56827291|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56827292|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827293|NCT01224028|Tacrolimus|tacrolimus|mesh-list
56827294|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56827295|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
56827296|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827297|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56827298|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827299|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827300|NCT01226212|Sulfalene|sulfalene|mesh-list
56827301|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827302|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56827303|NCT01226212|Renal Agents|renal agents|mesh-ancestor
56827304|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
56827305|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56827306|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56827307|NCT01075490|Clonidine|clonidine|mesh-list
56827308|NCT01075490|Analgesics|analgesics|mesh-ancestor
56827309|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
56827310|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827311|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827312|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56827313|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
56827314|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
56827315|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56827316|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56827317|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56827318|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
56827319|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827320|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827321|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56827322|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56827323|NCT03930706|Estradiol|estradiol|mesh-list
56827324|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56827325|NCT03930706|Estrogens|estrogens|mesh-ancestor
56827326|NCT03930706|Hormones|hormones|mesh-ancestor
56904603|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
56827327|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56827328|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827329|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56827331|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56827332|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56827333|NCT03932578|Atropine|atropine|mesh-list
56827334|NCT03932578|Metoclopramide|metoclopramide|mesh-list
56827335|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56827336|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56827337|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56827338|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
56827339|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827340|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827341|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56827342|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
56827343|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
56827344|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
56827345|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56827346|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56827347|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
56827348|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827349|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827350|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
56827351|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827352|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56827353|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56827354|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
56827355|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
56827356|NCT00258440|Hematinics|hematinics|mesh-ancestor
56827357|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
56827358|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56827359|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827360|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56827361|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56827362|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827363|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827364|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827365|NCT00224120|Silodosin|silodosin|mesh-list
56827366|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56827367|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56827368|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56827369|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
56827370|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827371|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827372|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827373|NCT00224120|Urological Agents|urological agents|mesh-ancestor
56827374|NCT01226446|Vitamin D|vitamin d|mesh-list
56827375|NCT01226446|Vitamins|vitamins|mesh-ancestor
56827376|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
56827377|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827378|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56827379|NCT01224418|Tacrolimus|tacrolimus|mesh-list
56827380|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56827381|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
56827382|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827383|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56827384|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827385|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827386|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
56827387|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56827388|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56827389|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56827390|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56827391|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827392|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
56827393|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827394|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827395|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56827396|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827397|NCT01129180|Azacitidine|azacitidine|mesh-list
56827398|NCT01129180|Bortezomib|bortezomib|mesh-list
56827399|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56827400|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
56827402|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827403|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827404|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
56827405|NCT00224042|Hematinics|hematinics|mesh-ancestor
56827406|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
56827407|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827408|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827409|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
56827410|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827411|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56827412|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827413|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827414|NCT01224652|Paclitaxel|paclitaxel|mesh-list
56827415|NCT01224652|Irinotecan|irinotecan|mesh-list
56827416|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56827417|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827418|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
56827419|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
56827420|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
56827421|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827422|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56827423|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56827424|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827425|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
56827426|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56827427|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
56827428|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827429|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56827430|NCT03928210|Digoxin|digoxin|mesh-list
56827431|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56827432|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56827433|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827434|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827435|NCT03928210|Protective Agents|protective agents|mesh-ancestor
56827436|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827437|NCT01226602|Ticagrelor|ticagrelor|mesh-list
56827438|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56827439|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56827440|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56827441|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56827442|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
56827443|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827444|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827445|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827446|NCT01226680|Tofacitinib|tofacitinib|mesh-list
56827447|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56827448|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827449|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827450|NCT00257192|Ziprasidone|ziprasidone|mesh-list
56827451|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56827452|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
56827453|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827454|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827455|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827456|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56827457|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56827458|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827459|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56827460|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56827461|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
56827462|NCT01224964|Montelukast|montelukast|mesh-list
56827463|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56827464|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
56827465|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56827466|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
56827467|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56827468|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827469|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56538327|NCT04756063|Vitamins|vitamins|mesh-ancestor
56827470|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56827471|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827473|NCT03967964|Testosterone|testosterone|mesh-list
56827474|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
56827475|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
56827476|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56827477|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56827478|NCT03967964|Androgens|androgens|mesh-ancestor
56827479|NCT03967964|Hormones|hormones|mesh-ancestor
56827480|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56827481|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827482|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56827483|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827484|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
56827485|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56827486|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
56827487|NCT01129414|Omeprazole|omeprazole|mesh-list
56827488|NCT01129414|Clopidogrel|clopidogrel|mesh-list
56827489|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56827490|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56827491|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56827492|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56827493|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
56827494|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827495|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827496|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827497|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56827498|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827499|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56827500|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827501|NCT03967886|Esomeprazole|esomeprazole|mesh-list
56827502|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56827503|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827504|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56827505|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827506|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827507|NCT03968042|Thiamine|thiamine|mesh-list
56827508|NCT03968042|Edaravone|edaravone|mesh-list
56827509|NCT03968042|Mitogens|mitogens|mesh-list
56827510|NCT03968042|Vitamins|vitamins|mesh-ancestor
56827511|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
56827512|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827513|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56827514|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827515|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
56827516|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56827517|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
56827518|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56827519|NCT03968042|Protective Agents|protective agents|mesh-ancestor
56827520|NCT01128322|Niacin|niacin|mesh-list
56827521|NCT01128322|Amlodipine|amlodipine|mesh-list
56827522|NCT01128322|Telmisartan|telmisartan|mesh-list
56827523|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56827524|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56827525|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56827526|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827527|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56827528|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827529|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
56827530|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56827531|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56827532|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56827533|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
56827534|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56827535|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
56827536|NCT01128322|Vitamins|vitamins|mesh-ancestor
56827537|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
56827538|NCT01129570|Silybin|silybin|mesh-list
56827539|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56827540|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827541|NCT01129570|Protective Agents|protective agents|mesh-ancestor
56827542|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827543|NCT01073540|Cephalexin|cephalexin|mesh-list
56827544|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56827545|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827546|NCT03740386|Phentolamine|phentolamine|mesh-list
56827548|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56827549|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
56827550|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827551|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827552|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827553|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56827554|NCT03927352|Adalimumab|adalimumab|mesh-list
56827555|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56827556|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56827557|NCT01225198|Vitamins|vitamins|mesh-list
56827558|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
56827559|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827560|NCT01226992|Vancomycin|vancomycin|mesh-list
56827561|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56827562|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827563|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
56827564|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56827565|NCT03740464|Lenograstim|lenograstim|mesh-list
56827566|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56827567|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
56827568|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827569|NCT03927118|Dexamethasone|dexamethasone|mesh-list
56827570|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
56827571|NCT03927118|BB 1101|bb 1101|mesh-list
56827572|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56827573|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
56827574|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
56827575|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827576|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827577|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827578|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
56827579|NCT03927118|Hormones|hormones|mesh-ancestor
56827580|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56827581|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56827582|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827583|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
56827584|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827585|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827586|NCT01227148|Insulin|insulin|mesh-list
56827587|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56827588|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827589|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
56827590|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56827591|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56827592|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
56827593|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56827594|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827595|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56827596|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827597|NCT01128712|Pregabalin|pregabalin|mesh-list
56827598|NCT01128712|Analgesics|analgesics|mesh-ancestor
56827599|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
56827600|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827601|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827602|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
56827603|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56827604|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56827605|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827606|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56827607|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56827608|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56902846|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
56827609|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827610|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56827611|NCT01127386|Lenalidomide|lenalidomide|mesh-list
56827612|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
56827613|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827614|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56827615|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56827616|NCT01127386|Growth Substances|growth substances|mesh-ancestor
56827617|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
56827618|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827619|NCT01130194|Procarbazine|procarbazine|mesh-list
56827620|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538483|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
56827623|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
56827624|NCT01225744|Irinotecan|irinotecan|mesh-list
56827625|NCT01225744|Cetuximab|cetuximab|mesh-list
56827626|NCT01225744|Tegafur|tegafur|mesh-list
56827627|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827628|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56827629|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56827630|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827631|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827632|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56827633|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56827634|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
56827635|NCT03926806|Vitamins|vitamins|mesh-list
56827636|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
56827637|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
56827638|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827639|NCT03926962|Nafithromycin|nafithromycin|mesh-list
56827640|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56827641|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827642|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56827643|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827644|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827645|NCT01228240|Metformin|metformin|mesh-list
56827646|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56827647|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827648|NCT03919786|Anesthetics|anesthetics|mesh-list
56827649|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827650|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827651|NCT03924544|Mitomycins|mitomycins|mesh-list
56827652|NCT03924544|Mitomycin|mitomycin|mesh-list
56827653|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56827654|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827655|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
56827656|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827657|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56827658|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827659|NCT01131364|Doxorubicin|doxorubicin|mesh-list
56827660|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56827661|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827662|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56827663|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56827664|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827665|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827666|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
56827667|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56827668|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56827669|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827670|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56827671|NCT02529202|Analgesics|analgesics|mesh-ancestor
56827672|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
56827673|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827674|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56827675|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56827676|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56827677|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
56827678|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827679|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827680|NCT00154310|Cyclosporine|cyclosporine|mesh-list
56827681|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
56827682|NCT00154310|Everolimus|everolimus|mesh-list
56827683|NCT00154310|Cyclosporins|cyclosporins|mesh-list
56827684|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434888|NCT00274170|Octreotide|octreotide|mesh-list
56827685|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827686|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56827687|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
56827688|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827689|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
56827690|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827691|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
56827692|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56827693|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56827694|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827696|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56827697|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
56827698|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56827699|NCT03770728|Metformin|metformin|mesh-list
56827700|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
56827701|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56827702|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827703|NCT01132222|Ibuprofen|ibuprofen|mesh-list
56827704|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
56827705|NCT01132222|Ephedrine|ephedrine|mesh-list
56827706|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56827707|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56827708|NCT01132222|Analgesics|analgesics|mesh-ancestor
56827709|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
56827710|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827711|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827712|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56827713|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56827714|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56827715|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827716|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827717|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56827718|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
56827719|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56827720|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
56827721|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
56827722|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56827723|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56827724|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
56827725|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
56827726|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827727|NCT03926182|Aflutinib|aflutinib|mesh-list
56827728|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56827729|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827730|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827731|NCT01130506|Cytarabine|cytarabine|mesh-list
56827732|NCT01130506|Decitabine|decitabine|mesh-list
56827733|NCT01130506|Vorinostat|vorinostat|mesh-list
56827734|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56827735|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
56827736|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827737|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827738|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
56827739|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827740|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56827741|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
56827742|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827743|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827744|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56827745|NCT01130662|Decitabine|decitabine|mesh-list
56827746|NCT01130662|Midostaurin|midostaurin|mesh-list
56827747|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56827748|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
56827749|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827750|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827751|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827752|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56827753|NCT03919552|Cisplatin|cisplatin|mesh-list
56827754|NCT03919552|Carboplatin|carboplatin|mesh-list
56827755|NCT03919552|Docetaxel|docetaxel|mesh-list
56827756|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827757|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
56827758|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
56827759|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
56902848|NCT03768531|Nivolumab|nivolumab|mesh-list
56827760|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827761|NCT03925714|Metformin|metformin|mesh-list
56827762|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56827763|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827764|NCT01228552|Ketoprofen|ketoprofen|mesh-list
56827765|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56827766|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56827767|NCT01228552|Analgesics|analgesics|mesh-ancestor
56827768|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
56827769|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827770|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827771|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56827772|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56827773|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56827774|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827775|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827777|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56827778|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
56827779|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827780|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827781|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56827782|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56827783|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
56827784|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827785|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827786|NCT03923842|Denosumab|denosumab|mesh-list
56827787|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56827788|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827789|NCT01132768|Atenolol|atenolol|mesh-list
56827790|NCT01132768|Olmesartan|olmesartan|mesh-list
56827791|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56827792|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56827793|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56827794|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56827795|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827796|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56827797|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
56827798|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
56827799|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827800|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827801|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56827802|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56827803|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56827804|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
56827805|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827806|NCT01230034|Ramipril|ramipril|mesh-list
56827807|NCT01230034|Imidapril|imidapril|mesh-list
56827808|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56827809|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
56827810|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827811|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827812|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56827813|NCT03918616|Dopamine|dopamine|mesh-list
56827814|NCT03918616|Memantine|memantine|mesh-list
56827815|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
56827816|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56827817|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56827818|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
56827819|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827820|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827821|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827822|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56827823|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56827824|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56827825|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
56827826|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
56827827|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827828|NCT03918616|Protective Agents|protective agents|mesh-ancestor
56827829|NCT01228630|Loratadine|loratadine|mesh-list
56827830|NCT01228630|Fexofenadine|fexofenadine|mesh-list
56827831|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
56827832|NCT01228630|Ephedrine|ephedrine|mesh-list
56827833|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
56827834|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
56827835|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56827836|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56827837|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56827838|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
56827839|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
56827840|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827841|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827842|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827843|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56827844|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
56342228|NCT00150553|Carbamazepine|carbamazepine|mesh-list
56827846|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56827847|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
56827848|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
56827849|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56827850|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56827852|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
56827853|NCT01134406|Hylan|hylan|mesh-list
56827854|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
56827855|NCT01134406|Protective Agents|protective agents|mesh-ancestor
56827856|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827857|NCT01231828|Lactulose|lactulose|mesh-list
56827858|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827859|NCT03923218|Vitamin D|vitamin d|mesh-list
56827860|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
56827861|NCT03923218|Vitamins|vitamins|mesh-ancestor
56827862|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
56827863|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827864|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56827865|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56827866|NCT03923140|Tranilast|tranilast|mesh-list
56827867|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56827868|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56827869|NCT03923140|Analgesics|analgesics|mesh-ancestor
56827870|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
56827871|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827872|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827873|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56827874|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56827875|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56827876|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56827877|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827878|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56827879|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56827880|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
56827881|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
56827882|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827883|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56827884|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56827885|NCT01133080|Minocycline|minocycline|mesh-list
56827886|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56827887|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827888|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56827889|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56827890|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
56827891|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
56827892|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827893|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827894|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827895|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56827896|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56827897|NCT01585792|Glimepiride|glimepiride|mesh-list
56827898|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56827899|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56827900|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827901|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56827902|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
56827903|NCT01134484|Thalidomide|thalidomide|mesh-list
56827904|NCT01134484|Dexamethasone|dexamethasone|mesh-list
56827905|NCT01134484|Bortezomib|bortezomib|mesh-list
56827906|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56827907|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
56827908|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
56827909|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827910|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827911|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827912|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
56827913|NCT01134484|Hormones|hormones|mesh-ancestor
56827914|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56827915|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56827916|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827917|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56827918|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
56827919|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
56827920|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56827921|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827922|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56827923|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56827924|NCT01134484|Growth Substances|growth substances|mesh-ancestor
56827925|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
56827927|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
56827928|NCT01133470|Ephedrine|ephedrine|mesh-list
56827929|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56827930|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
56827931|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56827932|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827933|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56827934|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
56827935|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
56827936|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56827937|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56827938|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
56827939|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
56827940|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827941|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827942|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56827943|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56827944|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56827945|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
56827946|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
56827947|NCT01134718|Simeprevir|simeprevir|mesh-list
56827948|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
56827949|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827950|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
56827951|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56827952|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827953|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
56827954|NCT03917758|Empagliflozin|empagliflozin|mesh-list
56827955|NCT03917758|Canagliflozin|canagliflozin|mesh-list
56827956|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56827957|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827958|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56827959|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827960|NCT01230736|Timolol|timolol|mesh-list
56827961|NCT01230736|Travoprost|travoprost|mesh-list
56827962|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56827963|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56827964|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56827965|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56827966|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
56827967|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56827968|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56827969|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827970|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56827971|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56827972|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
56827973|NCT01133548|Testosterone|testosterone|mesh-list
56827974|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
56827975|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
56827976|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56827977|NCT01133548|Androgens|androgens|mesh-ancestor
56827978|NCT01133548|Hormones|hormones|mesh-ancestor
56827979|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56827980|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827981|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56827982|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56827983|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
56827984|NCT03917134|Metronidazole|metronidazole|mesh-list
56827985|NCT03917134|Cephalosporins|cephalosporins|mesh-list
56827986|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827987|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56827988|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56827989|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56827990|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56827991|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56827992|NCT01231126|Misoprostol|misoprostol|mesh-list
56827993|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56827994|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
56827995|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56557623|NCT01149473|Losartan|losartan|mesh-list
56827996|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56827998|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56827999|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
56828000|NCT03769090|Budesonide|budesonide|mesh-list
56538856|NCT05346588|Anesthetics|anesthetics|mesh-list
56828001|NCT03769090|Albuterol|albuterol|mesh-list
56828002|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828003|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56828004|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
56828005|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828006|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828007|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56828008|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
56828009|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
56828010|NCT03769090|Hormones|hormones|mesh-ancestor
56828011|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828012|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
56828013|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56828014|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56828015|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56828016|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56828017|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
56828018|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828019|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828020|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56828021|NCT03921736|Perindopril|perindopril|mesh-list
56828022|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56828023|NCT03921736|Diuretics|diuretics|mesh-ancestor
56828024|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
56828025|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828026|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56828027|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56828028|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828029|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56828030|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
56828031|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828032|NCT05401006|Acitretin|acitretin|mesh-list
56828033|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
56828034|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
56828035|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
56828036|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828037|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828038|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
56828039|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56828040|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828041|NCT01131754|Heparin|heparin|mesh-list
56828042|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
56828043|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56828044|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56828045|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828046|NCT01231594|Trametinib|trametinib|mesh-list
56828047|NCT01231594|Dabrafenib|dabrafenib|mesh-list
56828048|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
56828049|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828050|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828051|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828052|NCT01136278|Clonidine|clonidine|mesh-list
56828053|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56828054|NCT01136278|Analgesics|analgesics|mesh-ancestor
56828055|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
56828056|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828057|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828058|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56828059|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
56828060|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
56828061|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56828062|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56828063|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56828064|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
56828065|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828066|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828067|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
56828068|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56828069|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
56828070|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56828071|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56828072|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56828074|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
56828075|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828076|NCT05480488|Midazolam|midazolam|mesh-list
56828077|NCT05480488|Warfarin|warfarin|mesh-list
56828078|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56828079|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56828080|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828081|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828082|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56828083|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56828084|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56828085|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56828086|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
56828087|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
56828088|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
56828089|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
56828090|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828091|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828092|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
56828093|NCT01229332|Carbidopa|carbidopa|mesh-list
56828094|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56828095|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56828096|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
56828097|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828098|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828099|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828100|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56828101|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828102|NCT03921034|Ropivacaine|ropivacaine|mesh-list
56828103|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
56828104|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
56828105|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828106|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828107|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
56828108|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828109|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
56828110|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56828111|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56828112|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828113|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
56828114|NCT01136590|Coagulants|coagulants|mesh-ancestor
56828115|NCT03920878|Aflibercept|aflibercept|mesh-list
56828116|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56828117|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56828118|NCT03920878|Growth Substances|growth substances|mesh-ancestor
56828119|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828120|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
56828121|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828122|NCT03920644|Scopolamine|scopolamine|mesh-list
56828123|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56828124|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56828125|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
56828126|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
56828127|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828128|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828129|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56828130|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
56828131|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56828132|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
56828133|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828134|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828135|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56828136|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
56828137|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
56828138|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828139|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828140|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828141|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828142|NCT01137994|Paclitaxel|paclitaxel|mesh-list
56828143|NCT01137994|Vinorelbine|vinorelbine|mesh-list
56828144|NCT01137994|Docetaxel|docetaxel|mesh-list
56828145|NCT01137994|Trastuzumab|trastuzumab|mesh-list
56828148|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828149|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
56828150|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
56828151|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
56828152|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828153|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828154|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828155|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828156|NCT01138072|Atorvastatin|atorvastatin|mesh-list
56828157|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56828158|NCT01138072|Simvastatin|simvastatin|mesh-list
56828159|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56828160|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56828161|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
56828162|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828163|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56828164|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56828165|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828166|NCT01131910|Vaccines|vaccines|mesh-list
56828167|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
56828168|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828169|NCT03739606|Antibodies|antibodies|mesh-list
56828170|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
56828171|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56828172|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56828173|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
56828174|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828175|NCT01138384|Lapatinib|lapatinib|mesh-list
56828176|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828177|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828178|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828179|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828180|NCT05533372|Methotrexate|methotrexate|mesh-list
56828181|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56828182|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
56828183|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56828184|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828185|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56828186|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
56828187|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828188|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828189|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
56828190|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828191|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56828192|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56828193|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
56828194|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828195|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56828196|NCT01233622|Vildagliptin|vildagliptin|mesh-list
56828197|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56828198|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828199|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56828200|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
56828201|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828202|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828203|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
56828204|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
56828205|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828206|NCT01138774|Protective Agents|protective agents|mesh-ancestor
56828207|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828208|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
56828209|NCT01138774|Vitamins|vitamins|mesh-ancestor
56828210|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
56828211|NCT01131988|Tacrolimus|tacrolimus|mesh-list
56828212|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56828213|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
56828214|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828215|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56828216|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828217|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828218|NCT01138852|Ampicillin|ampicillin|mesh-list
56828220|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
56828221|NCT01138852|Sulbactam|sulbactam|mesh-list
56828222|NCT01138852|Sultamicillin|sultamicillin|mesh-list
56828223|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56828224|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828225|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56828226|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828227|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828228|NCT05487196|Clonidine|clonidine|mesh-list
56828229|NCT05487196|Fentanyl|fentanyl|mesh-list
56828230|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
56828231|NCT05487196|Ropivacaine|ropivacaine|mesh-list
56828232|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56828233|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828234|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828235|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56828236|NCT05487196|Analgesics|analgesics|mesh-ancestor
56828237|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
56828238|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828239|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56828240|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56828241|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56828242|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
56828243|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828244|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828245|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
56828246|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
56828247|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56828248|NCT05487196|Narcotics|narcotics|mesh-ancestor
56828249|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56828250|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56828251|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
56828252|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56828253|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
56828254|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
56828255|NCT01585870|Sorafenib|sorafenib|mesh-list
56828256|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828257|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828258|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828259|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828260|NCT05210140|Citalopram|citalopram|mesh-list
56828261|NCT05210140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56828262|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56828263|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56828264|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828265|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828266|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
56828267|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828268|NCT05210140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56828269|NCT05210140|Antidepressive Agents|antidepressive agents|mesh-ancestor
56828270|NCT05210140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56828271|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
56828272|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56828273|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56828274|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
56828275|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
56828276|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828277|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828278|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828279|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
56828280|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
56828281|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56828282|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56828283|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56828284|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828285|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56828286|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56828287|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828288|NCT05195944|Incretins|incretins|mesh-ancestor
56828289|NCT05195944|Hormones|hormones|mesh-ancestor
56828290|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828291|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56828292|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56828293|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828294|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828296|NCT01236586|R04929097|r04929097|mesh-list
56828297|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828298|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
56828299|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
56828300|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828301|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828302|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56828303|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
56828305|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828306|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56828307|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828308|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828309|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828310|NCT01234792|Nicotine|nicotine|mesh-list
56828311|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56828312|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
56828313|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828314|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828315|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56828316|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56828317|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
56828318|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828319|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828320|NCT03513328|Thiotepa|thiotepa|mesh-list
56828321|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56828322|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
56828323|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828324|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828325|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56828326|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56828327|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
56828328|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828329|NCT03467932|Insulin|insulin|mesh-list
56828330|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56828331|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56828332|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828333|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56828334|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
56828335|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56828336|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
56828337|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56828338|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828339|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56828340|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56828341|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828342|NCT05109052|Bevacizumab|bevacizumab|mesh-list
56828343|NCT05109052|Atezolizumab|atezolizumab|mesh-list
56828344|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828345|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828346|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56828347|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56828348|NCT05109052|Growth Substances|growth substances|mesh-ancestor
56828349|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828350|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
56828351|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
56828352|NCT03414502|Minocycline|minocycline|mesh-list
56828353|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
56828354|NCT03414502|Adalimumab|adalimumab|mesh-list
56828355|NCT03414502|Etanercept|etanercept|mesh-list
56828356|NCT03414502|Golimumab|golimumab|mesh-list
56828357|NCT03414502|Rituximab|rituximab|mesh-list
56828358|NCT03414502|Methotrexate|methotrexate|mesh-list
56828359|NCT03414502|Abatacept|abatacept|mesh-list
56828360|NCT03414502|Azathioprine|azathioprine|mesh-list
56828361|NCT03414502|Infliximab|infliximab|mesh-list
56828362|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
56828363|NCT03414502|Leflunomide|leflunomide|mesh-list
56828364|NCT03414502|Tofacitinib|tofacitinib|mesh-list
56828365|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828366|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828367|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
56828368|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828369|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828370|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56828373|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56828374|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
56828375|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828376|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
56828377|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828378|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56828379|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56828380|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56828381|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828382|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
56828383|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56828384|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56828385|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828386|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56828387|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56828388|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56828389|NCT03414502|Analgesics|analgesics|mesh-ancestor
56828390|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
56828391|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828392|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56828393|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56828394|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828395|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56828396|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
56828397|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
56828398|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56828399|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56828400|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828401|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828402|NCT03199612|Urological Agents|urological agents|mesh-ancestor
56828403|NCT01140100|Thiopental|thiopental|mesh-list
56828404|NCT01140100|Propofol|propofol|mesh-list
56828405|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56828406|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828407|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828408|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56828409|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
56828410|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
56828411|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
56828412|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
56828413|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
56828414|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828415|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828416|NCT01141036|Midazolam|midazolam|mesh-list
56828417|NCT01141036|Propofol|propofol|mesh-list
56828418|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56828419|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828420|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828421|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56828422|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
56828423|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
56828424|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56828425|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56828426|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56828427|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56828428|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
56828429|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
56828430|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828431|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828432|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
56828433|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56828434|NCT04983940|Testosterone|testosterone|mesh-list
56828435|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
56828436|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
56828437|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56828438|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828439|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
56828440|NCT04983940|Hormones|hormones|mesh-ancestor
56828441|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828442|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828443|NCT04983940|Androgens|androgens|mesh-ancestor
56828444|NCT02902198|Quinine|quinine|mesh-list
56828446|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56828447|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56828448|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828449|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56828450|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828451|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56828452|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828453|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56828454|NCT02902198|Analgesics|analgesics|mesh-ancestor
56828455|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
56828456|NCT04917406|Dexamethasone|dexamethasone|mesh-list
56828457|NCT04917406|Lidocaine|lidocaine|mesh-list
56828458|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828459|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
56828460|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
56828461|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828462|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828463|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56828464|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
56828465|NCT04917406|Hormones|hormones|mesh-ancestor
56828466|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828467|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56828468|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828469|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
56828470|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
56828471|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828472|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
56828473|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56828474|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56828475|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56828476|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56828477|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828478|NCT02685826|Dexamethasone|dexamethasone|mesh-list
56828479|NCT02685826|Lenalidomide|lenalidomide|mesh-list
56828480|NCT02685826|Durvalumab|durvalumab|mesh-list
56828481|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828482|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
56828483|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
56828484|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828485|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828486|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56828487|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
56828488|NCT02685826|Hormones|hormones|mesh-ancestor
56828489|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828490|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56828491|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828492|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
56828493|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56828494|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56828495|NCT02685826|Growth Substances|growth substances|mesh-ancestor
56828496|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
56828497|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828498|NCT04906720|Colchicine|colchicine|mesh-list
56828499|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
56828500|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828501|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
56828502|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
56828503|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
56828504|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828505|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828506|NCT01141192|Vitamin D|vitamin d|mesh-list
56828507|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
56828508|NCT01141192|Vitamins|vitamins|mesh-ancestor
56828509|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
56828510|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828511|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56828512|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56828513|NCT01144000|Daptomycin|daptomycin|mesh-list
56828514|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56828515|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828516|NCT01140412|Ritonavir|ritonavir|mesh-list
56828517|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
56828518|NCT01140412|Maraviroc|maraviroc|mesh-list
56828519|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56828520|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56828521|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
56828522|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828523|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828524|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56828525|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56828526|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
56828527|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828528|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56828529|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56828530|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56828531|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56539396|NCT00602680|Donepezil|donepezil|mesh-list
56828532|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56828533|NCT01234324|Cisplatin|cisplatin|mesh-list
56828534|NCT01234324|Capecitabine|capecitabine|mesh-list
56828535|NCT01234324|Epirubicin|epirubicin|mesh-list
56828536|NCT01234324|Panitumumab|panitumumab|mesh-list
56828537|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828538|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56828539|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
56828540|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828541|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56828542|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56828543|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56828544|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828545|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828546|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
56828547|NCT02334124|Floxacillin|floxacillin|mesh-list
56828548|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56828549|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828550|NCT01144156|Adalimumab|adalimumab|mesh-list
56828551|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828552|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828553|NCT01235260|Becaplermin|becaplermin|mesh-list
56828554|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
56828555|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56828556|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56828557|NCT01235260|Growth Substances|growth substances|mesh-ancestor
56828558|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828559|NCT01144312|Fentanyl|fentanyl|mesh-list
56828560|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56828561|NCT01144312|Narcotics|narcotics|mesh-ancestor
56828562|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828563|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828564|NCT01144312|Analgesics|analgesics|mesh-ancestor
56828565|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
56828566|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828567|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56828568|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56828569|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
56828570|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
56828571|NCT01144390|Methadone|methadone|mesh-list
56828572|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56828573|NCT01144390|Narcotics|narcotics|mesh-ancestor
56828574|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828575|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828576|NCT01144390|Analgesics|analgesics|mesh-ancestor
56828577|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
56828578|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828579|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
56828580|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
56828581|NCT01329640|Paclitaxel|paclitaxel|mesh-list
56828582|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
56828583|NCT01329640|Trastuzumab|trastuzumab|mesh-list
56828584|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56828585|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828586|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
56828587|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
56828588|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
56828589|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828590|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56828591|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
56828592|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828593|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828594|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56828595|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
56828596|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56828597|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828599|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
56828600|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828601|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56828602|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56828603|NCT05335018|Growth Substances|growth substances|mesh-ancestor
56828604|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
56828605|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828606|NCT00114777|Cyclosporine|cyclosporine|mesh-list
56828607|NCT00114777|Abatacept|abatacept|mesh-list
56828608|NCT00114777|Cyclosporins|cyclosporins|mesh-list
56828609|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828610|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828611|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56828612|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
56828613|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828614|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
56828615|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828616|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
56828617|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828618|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56828619|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56828620|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828621|NCT00139737|Ziprasidone|ziprasidone|mesh-list
56828622|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56828623|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
56828624|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828625|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828626|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828627|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56828628|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56828629|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828630|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56828631|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56828632|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
56828633|NCT00139659|Insulin|insulin|mesh-list
56828634|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56828635|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56828636|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828637|NCT01076439|Fluticasone|fluticasone|mesh-list
56828638|NCT01076439|Xhance|xhance|mesh-list
56828639|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56828640|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828641|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56828642|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
56828643|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828644|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828645|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56828646|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
56828647|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
56828648|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56828649|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56828650|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56828651|NCT01076439|Analgesics|analgesics|mesh-ancestor
56828652|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
56828653|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828654|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56828655|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56828656|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
56828657|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
56828658|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902869|NCT01322061|Protective Agents|protective agents|mesh-ancestor
56828659|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828660|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
56828661|NCT03965637|Vitamins|vitamins|mesh-ancestor
56828662|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
56828663|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828664|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
56828665|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828666|NCT03965637|Protective Agents|protective agents|mesh-ancestor
56828667|NCT01078779|Chloroquine|chloroquine|mesh-list
56828668|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56828669|NCT01078779|Amebicides|amebicides|mesh-ancestor
56828670|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56828671|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56828672|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828675|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56828676|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56828677|NCT01078779|Analgesics|analgesics|mesh-ancestor
56828678|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
56828679|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828680|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828681|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828682|NCT01078779|Filaricides|filaricides|mesh-ancestor
56828683|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
56828684|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
56828685|NCT00114231|Capecitabine|capecitabine|mesh-list
56828686|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
56828687|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56828688|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
56828689|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828690|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828691|NCT00113919|Busulfan|busulfan|mesh-list
56828692|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
56828693|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828694|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56828695|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
56828696|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828697|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56828698|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828699|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56828700|NCT00113841|Curcumin|curcumin|mesh-list
56828701|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56828702|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56828703|NCT00113841|Analgesics|analgesics|mesh-ancestor
56828704|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
56828705|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828706|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828707|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828708|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828709|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828710|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828711|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828712|NCT00113607|Dexamethasone|dexamethasone|mesh-list
56828713|NCT00113607|Trabectedin|trabectedin|mesh-list
56828714|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828715|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
56828716|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
56828717|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828718|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828719|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56828720|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
56828721|NCT00113607|Hormones|hormones|mesh-ancestor
56828722|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828723|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56828724|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828725|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56828726|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
56828727|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828728|NCT00113529|Sunitinib|sunitinib|mesh-list
56828729|NCT00113529|Gefitinib|gefitinib|mesh-list
56828730|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828731|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56828732|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56902870|NCT02062996|Phenylephrine|phenylephrine|mesh-list
56828733|NCT00113529|Growth Substances|growth substances|mesh-ancestor
56828734|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828735|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
56828736|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828737|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828738|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828739|NCT01079013|Treosulfan|treosulfan|mesh-list
56828740|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56828741|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
56828742|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828743|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828744|NCT00134901|Memantine|memantine|mesh-list
56828745|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56828746|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56828747|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
56828748|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828749|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828750|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828751|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56828752|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56828753|NCT01076595|Interferons|interferons|mesh-list
56828754|NCT01076595|Interferon-beta|interferon-beta|mesh-list
56828755|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
56828756|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828757|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
56828758|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828759|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
56828760|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828762|NCT00113373|Lapatinib|lapatinib|mesh-list
56828763|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828764|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828765|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828766|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828767|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56828768|NCT00113295|Paroxetine|paroxetine|mesh-list
56828769|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
56828770|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56828771|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56828772|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56828773|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828774|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828775|NCT00113295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56828776|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56828777|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56828778|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828779|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828780|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
56828781|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56828782|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56828783|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56828784|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828785|NCT00112905|Sorafenib|sorafenib|mesh-list
56828786|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828787|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828788|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828789|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828790|NCT00427895|Vaccines|vaccines|mesh-list
56828791|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56828792|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
56828793|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828794|NCT00427349|Octreotide|octreotide|mesh-list
56828795|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
56828796|NCT00427349|Imetelstat|imetelstat|mesh-list
56828797|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56828798|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56828799|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828800|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828801|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828802|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828803|NCT01034189|Paclitaxel|paclitaxel|mesh-list
56828804|NCT01034189|Cetuximab|cetuximab|mesh-list
56828805|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56828806|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828807|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
56828808|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
56828809|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
56828810|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828811|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828812|NCT00425945|Pycnogenols|pycnogenols|mesh-list
56828813|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56828814|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
56828815|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828816|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
56828817|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828818|NCT00425945|Protective Agents|protective agents|mesh-ancestor
56828819|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56828820|NCT00121641|Metformin|metformin|mesh-list
56828822|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56828823|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828824|NCT00121641|Incretins|incretins|mesh-ancestor
56828826|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828827|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56828828|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
56828829|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828830|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828831|NCT00425555|Panobinostat|panobinostat|mesh-list
56828832|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539690|NCT01032837|Oseltamivir|oseltamivir|mesh-list
56828833|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56828834|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828835|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828837|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828838|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56828839|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828840|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828841|NCT01034345|Sirolimus|sirolimus|mesh-list
56828842|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56828843|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56828844|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828845|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56828846|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828847|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
56828848|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56828849|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
56828850|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828851|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828852|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828853|NCT01763866|Atorvastatin|atorvastatin|mesh-list
56828854|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56828855|NCT01763866|Simvastatin|simvastatin|mesh-list
56828856|NCT01763866|Ezetimibe|ezetimibe|mesh-list
56828857|NCT01763866|Evolocumab|evolocumab|mesh-list
56828858|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56828859|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56828860|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56828861|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
56828862|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828863|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56828864|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56828865|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828866|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
56828867|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828868|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
56828869|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56828870|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56828871|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
56828872|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
56828873|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828874|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828875|NCT01588925|Dexamethasone|dexamethasone|mesh-list
56828876|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
56828877|NCT01588925|BB 1101|bb 1101|mesh-list
56828878|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
56828879|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56828880|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
56828881|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
56828882|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828883|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828884|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56828885|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
56828886|NCT01588925|Hormones|hormones|mesh-ancestor
56828887|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56828888|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56828889|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828890|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
56828891|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828892|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828893|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56828894|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
56828895|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
56828896|NCT01588925|Protective Agents|protective agents|mesh-ancestor
56828897|NCT01238146|Rituximab|rituximab|mesh-list
56828898|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56828899|NCT01238146|Obatoclax|obatoclax|mesh-list
56828900|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828901|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828902|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
56828903|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828904|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56828905|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56828906|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
56828907|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828908|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828909|NCT01141894|Phenylephrine|phenylephrine|mesh-list
56828911|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
56828912|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56828913|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56828914|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
56828915|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
56828916|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828917|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828918|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
56828919|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56828920|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
56828921|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
56828922|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56828923|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56828924|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56828925|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
56828926|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56828927|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828928|NCT01141894|Protective Agents|protective agents|mesh-ancestor
56828929|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56828930|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56828931|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
56828932|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
56828933|NCT01238224|Tadalafil|tadalafil|mesh-list
56828934|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
56828935|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56828936|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56828937|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828938|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828939|NCT01238224|Urological Agents|urological agents|mesh-ancestor
56828940|NCT01237444|Ritonavir|ritonavir|mesh-list
56828941|NCT01237444|Lopinavir|lopinavir|mesh-list
56828942|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56828943|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56828944|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
56828945|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828946|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828947|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56828948|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56828949|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
56828950|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828951|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56828952|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56828953|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
56828954|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56828955|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828956|NCT01141972|Vitamin D|vitamin d|mesh-list
56828957|NCT01141972|Vitamins|vitamins|mesh-ancestor
56828958|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
56828959|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828960|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56828961|NCT04316806|Rifaximin|rifaximin|mesh-list
56828962|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56828963|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828964|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56828965|NCT01145326|Lidocaine|lidocaine|mesh-list
56828966|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
56828967|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
56828968|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56828969|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828970|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
56828971|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56828973|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56828974|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56828975|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56828976|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828978|NCT01144702|Mefloquine|mefloquine|mesh-list
56828979|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
56828980|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56828981|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56828982|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56828983|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828984|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
56828985|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
56828986|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56828987|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
56828988|NCT01145404|Capecitabine|capecitabine|mesh-list
56828990|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56828991|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
56828992|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56828993|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56828994|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56828995|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56828996|NCT01237522|Metformin|metformin|mesh-list
56828997|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56828998|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56828999|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
56829000|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56829001|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829002|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829003|NCT04246996|Gentamicins|gentamicins|mesh-list
56829004|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56829005|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829006|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56829007|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829008|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829009|NCT00424463|Edaravone|edaravone|mesh-list
56829010|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56829011|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
56829012|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829013|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56829014|NCT00424463|Protective Agents|protective agents|mesh-ancestor
56829015|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829016|NCT01324115|Nitroarginine|nitroarginine|mesh-list
56829017|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829018|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829019|NCT01037621|Valacyclovir|valacyclovir|mesh-list
56829020|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
56829021|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829022|NCT00424385|Sorafenib|sorafenib|mesh-list
56829023|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
56829024|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829025|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56829026|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829027|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829028|NCT03994055|Antioxidants|antioxidants|mesh-list
56829029|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829030|NCT03994055|Protective Agents|protective agents|mesh-ancestor
56829031|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829032|NCT01037699|Hormones|hormones|mesh-list
56829033|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56829034|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56829035|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829036|NCT00423917|Bevacizumab|bevacizumab|mesh-list
56829037|NCT00423917|Fulvestrant|fulvestrant|mesh-list
56829038|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56829039|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829040|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56829041|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56829042|NCT00423917|Growth Substances|growth substances|mesh-ancestor
56829043|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829044|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
56829045|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56829046|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56829047|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56829048|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
56829049|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56829050|NCT00845026|Olanzapine|olanzapine|mesh-list
56829051|NCT00845026|Risperidone|risperidone|mesh-list
56829052|NCT00845026|Aripiprazole|aripiprazole|mesh-list
56829053|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56829054|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
56829055|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829056|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829057|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829058|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56829059|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56829060|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829061|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56829062|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56829063|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
56829064|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
56829065|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
56829066|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829067|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56829068|NCT00845026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56829069|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56829070|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56829071|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
56829072|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
56829073|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56829074|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56829075|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56829076|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56829077|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56829078|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
56829079|NCT02445131|Idelalisib|idelalisib|mesh-list
56829080|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56829081|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
56829082|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829083|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829084|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56829085|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829086|NCT00003838|Cyclosporine|cyclosporine|mesh-list
56829087|NCT00003838|Methotrexate|methotrexate|mesh-list
56829088|NCT00003838|Cyclosporins|cyclosporins|mesh-list
56829089|NCT00003838|Lenograstim|lenograstim|mesh-list
56829090|NCT00003838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56829091|NCT00003838|Abortifacient Agents|abortifacient agents|mesh-ancestor
56829092|NCT00003838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56829093|NCT00003838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829094|NCT00003838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56829095|NCT00003838|Antimetabolites|antimetabolites|mesh-ancestor
56829096|NCT00003838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829097|NCT00003838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829098|NCT00003838|Dermatologic Agents|dermatologic agents|mesh-ancestor
56829099|NCT00003838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829100|NCT00003838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56829101|NCT00003838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829102|NCT00003838|Immunologic Factors|immunologic factors|mesh-ancestor
56829103|NCT00003838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829104|NCT00003838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56829105|NCT00003838|Antifungal Agents|antifungal agents|mesh-ancestor
56829106|NCT00003838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829107|NCT00003838|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56829108|NCT00003838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56829109|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
56829110|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829111|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
56829112|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829113|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829114|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56829115|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
56829116|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829117|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829118|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56829119|NCT01145950|Etanercept|etanercept|mesh-list
56829121|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56829122|NCT01145950|Analgesics|analgesics|mesh-ancestor
56829123|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
56829124|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829125|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829126|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56829127|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829128|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56829129|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829130|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
56829131|NCT01238926|Vitamins|vitamins|mesh-list
56829132|NCT01238926|Folic Acid|folic acid|mesh-list
56829133|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
56829134|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
56829135|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
56829136|NCT01238926|Pyridoxal|pyridoxal|mesh-list
56829137|NCT01238926|Pyridoxine|pyridoxine|mesh-list
56829138|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
56829139|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
56829140|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829141|NCT01238926|Hematinics|hematinics|mesh-ancestor
56829142|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56829143|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56829144|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56829145|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
56829146|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829147|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56829148|NCT05161156|Bromides|bromides|mesh-list
56829149|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
56829150|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56829151|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
56829152|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829153|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829154|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56829155|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
56829156|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
56829157|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56829158|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
56829159|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829160|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829161|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
56829162|NCT04006288|Aspirin|aspirin|mesh-list
56829163|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
56829164|NCT04006288|Clopidogrel|clopidogrel|mesh-list
56829165|NCT04006288|Ticagrelor|ticagrelor|mesh-list
56829166|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56829167|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56829168|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56829169|NCT04006288|Analgesics|analgesics|mesh-ancestor
56829170|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
56829171|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829172|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829173|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56829174|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829175|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56829176|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56829177|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829178|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56829179|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56829180|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829181|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
56829182|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56829183|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56829184|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56829185|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
56829186|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829187|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56829188|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
56829189|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56829190|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
56829191|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
56829192|NCT03942328|Vaccines|vaccines|mesh-list
56829193|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
56829194|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829195|NCT01142518|Interferons|interferons|mesh-list
56829196|NCT01142518|Interferon-beta|interferon-beta|mesh-list
56829199|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
56829200|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829201|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
56829202|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829203|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56829204|NCT00423449|Gemcitabine|gemcitabine|mesh-list
56829205|NCT00423449|Vorinostat|vorinostat|mesh-list
56829206|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56540069|NCT02750917|Etoricoxib|etoricoxib|mesh-list
56829207|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
56829208|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829209|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829210|NCT00423449|Antiviral Agents|antiviral agents|mesh-ancestor
56829211|NCT00423449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829212|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829213|NCT00423449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829214|NCT00423449|Immunologic Factors|immunologic factors|mesh-ancestor
56829215|NCT00423449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829216|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56829217|NCT00423293|Fluorouracil|fluorouracil|mesh-list
56829218|NCT00423293|Mitomycins|mitomycins|mesh-list
56829219|NCT00423293|Mitomycin|mitomycin|mesh-list
56829220|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
56829221|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829222|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56829223|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829224|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829225|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
56829226|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829227|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56829228|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
56829229|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56829230|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829231|NCT00422903|Letrozole|letrozole|mesh-list
56829232|NCT00422903|Lapatinib|lapatinib|mesh-list
56829233|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829234|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56829235|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56829236|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829237|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829238|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56829239|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
56829240|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56829241|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829242|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56829243|NCT00422591|Cytarabine|cytarabine|mesh-list
56829244|NCT00422591|Idarubicin|idarubicin|mesh-list
56829245|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56829246|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
56829247|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829248|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829249|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
56829250|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829251|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829252|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
56829253|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829254|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56829255|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56829256|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56829257|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829258|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
56829259|NCT00422513|Hematinics|hematinics|mesh-ancestor
56829260|NCT00202878|Simvastatin|simvastatin|mesh-list
56829261|NCT00202878|Ezetimibe|ezetimibe|mesh-list
56829262|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56829263|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56829264|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56829265|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
56829266|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829267|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56829268|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56829269|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829270|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
56829271|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
56829272|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56829273|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829274|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56829275|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56829276|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829277|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829278|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829279|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56829280|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56829281|NCT00260208|Cyclosporine|cyclosporine|mesh-list
56829282|NCT00260208|Tacrolimus|tacrolimus|mesh-list
56540144|NCT02750137|Tetracaine|tetracaine|mesh-list
56829283|NCT00260208|Cyclosporins|cyclosporins|mesh-list
56829284|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829285|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
56829286|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829287|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56829288|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829289|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829290|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
56829291|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829292|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
56829293|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829294|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
56829295|NCT00202644|Anagrelide|anagrelide|mesh-list
56829296|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829297|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
56829298|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829299|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829300|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56829301|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56829302|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56829303|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56829304|NCT00259740|Denosumab|denosumab|mesh-list
56829305|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56829306|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829307|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56829308|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56829309|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56829310|NCT01236040|Vaccines|vaccines|mesh-list
56829311|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
56829312|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829313|NCT03812224|Erenumab|erenumab|mesh-list
56902898|NCT02065414|Listerine|listerine|mesh-list
56829314|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56829315|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829316|NCT03812224|Analgesics|analgesics|mesh-ancestor
56829317|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
56829318|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829319|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829320|NCT01146028|Tizanidine|tizanidine|mesh-list
56829321|NCT01146028|Analgesics|analgesics|mesh-ancestor
56829322|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
56829323|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829324|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829325|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
56829326|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56829327|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56829328|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
56829329|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
56829330|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56829331|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56829332|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56829333|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
56829334|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829335|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829336|NCT03530800|Dronabinol|dronabinol|mesh-list
56829337|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
56829338|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829339|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56829340|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56829341|NCT03530800|Analgesics|analgesics|mesh-ancestor
56829342|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
56829343|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829344|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56829346|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829347|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829348|NCT03530800|Hormones|hormones|mesh-ancestor
56829349|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56829350|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
56829351|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56829352|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
56829353|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829354|NCT04982146|Expectorants|expectorants|mesh-ancestor
56829355|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
56829356|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56829357|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
56829358|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829359|NCT04982146|Protective Agents|protective agents|mesh-ancestor
56829360|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829362|NCT04958746|Propofol|propofol|mesh-list
56829363|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56829364|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829365|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829366|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56829367|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
56829368|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
56829369|NCT01146106|Pravastatin|pravastatin|mesh-list
56829370|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56829371|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56829372|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
56829373|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829374|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56829375|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56829376|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829377|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
56829378|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56829379|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
56829380|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829381|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
56829382|NCT03431584|Protective Agents|protective agents|mesh-ancestor
56829383|NCT04916392|Bupivacaine|bupivacaine|mesh-list
56829384|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
56829385|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
56829386|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829387|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829388|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
56829389|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829390|NCT00259272|Olanzapine|olanzapine|mesh-list
56829391|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
56829392|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
56829393|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829394|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829395|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56829396|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56829397|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56829398|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829399|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56829400|NCT00259272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56829401|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56829402|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56829403|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829404|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829405|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
56829406|NCT03172624|Nivolumab|nivolumab|mesh-list
56829407|NCT03172624|Ipilimumab|ipilimumab|mesh-list
56829408|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56829409|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829410|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56829411|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829412|NCT03106324|Lenalidomide|lenalidomide|mesh-list
56829413|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
56829414|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829415|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56829416|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56829417|NCT03106324|Growth Substances|growth substances|mesh-ancestor
56829418|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
56829419|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829421|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56829422|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829423|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56829424|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
56829425|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829426|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829427|NCT01239940|Paclitaxel|paclitaxel|mesh-list
56829428|NCT01239940|Everolimus|everolimus|mesh-list
56829429|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56829430|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829431|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
56829432|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
56829433|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
56829434|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829435|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829436|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
56829437|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829438|NCT02526004|Tobramycin|tobramycin|mesh-list
56829439|NCT02526004|Ceftazidime|ceftazidime|mesh-list
56829440|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56829441|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829442|NCT00421889|Paclitaxel|paclitaxel|mesh-list
56829443|NCT00421889|Carboplatin|carboplatin|mesh-list
56829444|NCT00421889|Belinostat|belinostat|mesh-list
56829445|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56829446|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829447|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
56829448|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
56829449|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
56829450|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829451|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56829452|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829453|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
56829454|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
56829455|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829456|NCT03913468|Protective Agents|protective agents|mesh-ancestor
56829457|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829458|NCT03913468|Vitamins|vitamins|mesh-ancestor
56829459|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
56829460|NCT01147354|Selenium|selenium|mesh-list
56829461|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
56829462|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829463|NCT01147354|Protective Agents|protective agents|mesh-ancestor
56829464|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829465|NCT01147354|Trace Elements|trace elements|mesh-ancestor
56829466|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
56829467|NCT04744480|Anesthetics|anesthetics|mesh-list
56829468|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829469|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829470|NCT01147432|Capsaicin|capsaicin|mesh-list
56829471|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
56829472|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
56829473|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
56829474|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829475|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829476|NCT03916510|Capecitabine|capecitabine|mesh-list
56829477|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56829478|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
56829479|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829480|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829481|NCT01147510|Montelukast|montelukast|mesh-list
56829482|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56829483|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
56829484|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56829485|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
56829486|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56829487|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829488|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56829489|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56829490|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829491|NCT03916432|Sirolimus|sirolimus|mesh-list
56829492|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343864|NCT00051896|Vanoxerine|vanoxerine|mesh-list
56829493|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829494|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56829495|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829496|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
56829497|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829498|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
56829499|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829500|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
56829501|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56829502|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829503|NCT00421733|Vitamins|vitamins|mesh-ancestor
56829504|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
56829505|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56829506|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
56829507|NCT00421343|Vitamin D|vitamin d|mesh-list
56829508|NCT00421343|Alendronate|alendronate|mesh-list
56829509|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
56829511|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56829512|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829513|NCT00421343|Vitamins|vitamins|mesh-ancestor
56829514|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
56829515|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56829516|NCT00421343|Antacids|antacids|mesh-ancestor
56829517|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829518|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56829519|NCT01147588|Esomeprazole|esomeprazole|mesh-list
56829520|NCT01147588|Omeprazole|omeprazole|mesh-list
56829521|NCT01147588|Lansoprazole|lansoprazole|mesh-list
56829522|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
56829523|NCT01147588|Clopidogrel|clopidogrel|mesh-list
56829524|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56829525|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56829526|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56829527|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56829528|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
56829529|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829530|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829531|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829532|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56829533|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56829534|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56829535|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829536|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
56829537|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829538|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829539|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829540|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56829541|NCT00230178|Allopurinol|allopurinol|mesh-list
56829542|NCT00230178|Rasburicase|rasburicase|mesh-list
56829543|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
56829544|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829545|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829546|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
56829547|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829548|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56829549|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
56829550|NCT00230178|Protective Agents|protective agents|mesh-ancestor
56829551|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829552|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
56829553|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56829554|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56829555|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56829556|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56829557|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829558|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
56829559|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829560|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829561|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56829562|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829563|NCT01251172|Melphalan|melphalan|mesh-list
56829564|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
56829565|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56829566|NCT01251172|R04929097|r04929097|mesh-list
56829567|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56829568|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
56829569|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829571|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56829572|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829573|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
56829574|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829575|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829576|NCT00413777|Tolvaptan|tolvaptan|mesh-list
56829577|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56829578|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829579|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
56829580|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829581|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56829582|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56829583|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56829584|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56829585|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56829586|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
56829587|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829588|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829589|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829590|NCT01074060|Plerixafor|plerixafor|mesh-list
56829591|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
56829592|NCT01074060|Lenograstim|lenograstim|mesh-list
56829593|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829594|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
56829595|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829596|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829597|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56829598|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
56829599|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829600|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829601|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56829602|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56829603|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56829604|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56829605|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
56829606|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829607|NCT03915340|Propafenone|propafenone|mesh-list
56829608|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56902906|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
56829609|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56829610|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56829611|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56829612|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829613|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
56829614|NCT00258960|Doxorubicin|doxorubicin|mesh-list
56829615|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56829616|NCT00258960|Trastuzumab|trastuzumab|mesh-list
56829617|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829618|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
56829619|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829620|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829621|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56829622|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
56829623|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829624|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829625|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56829626|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56829627|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56829628|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56829629|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829630|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56829631|NCT01581918|Carbamazepine|carbamazepine|mesh-list
56829632|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
56829633|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
56829634|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56829635|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829636|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829637|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56829638|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56829639|NCT01581918|Analgesics|analgesics|mesh-ancestor
56829640|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
56829641|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829642|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56829643|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56829644|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829645|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56829646|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56829647|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56829648|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
56829649|NCT01582542|Coagulants|coagulants|mesh-ancestor
56829650|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56829651|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
56829652|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829653|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
56829654|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
56829655|NCT03912766|Coagulants|coagulants|mesh-ancestor
56829656|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56829657|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56829658|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
56829659|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829660|NCT01251328|Anesthetics|anesthetics|mesh-list
56829661|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829662|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829663|NCT00420641|Paroxetine|paroxetine|mesh-list
56829664|NCT00420641|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56829665|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56829666|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56829667|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829668|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829669|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
56829670|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829671|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56829672|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
56829673|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56829674|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56829675|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56829676|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829677|NCT00257556|Menotropins|menotropins|mesh-list
56829678|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56829679|NCT00257556|Hormones|hormones|mesh-ancestor
56829680|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56829681|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829682|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56829683|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
56829684|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56829685|NCT03906916|Micafungin|micafungin|mesh-list
56829686|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
56829687|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829688|NCT03741426|Durvalumab|durvalumab|mesh-list
56829689|NCT03741426|Olaparib|olaparib|mesh-list
56829690|NCT03741426|Cediranib|cediranib|mesh-list
56829691|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56829692|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829693|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56829694|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829695|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829696|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56829697|NCT01250470|Sargramostim|sargramostim|mesh-list
56829698|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56829699|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
56829700|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829701|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56829702|NCT01250548|Apremilast|apremilast|mesh-list
56829703|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56829704|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56829705|NCT01250548|Analgesics|analgesics|mesh-ancestor
56829706|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
56829707|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829708|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829709|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56829710|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829711|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56829712|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56829713|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829714|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829715|NCT03906838|Ropivacaine|ropivacaine|mesh-list
56829716|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
56829719|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829720|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
56829721|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829722|NCT01251484|Nintedanib|nintedanib|mesh-list
56829723|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829724|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56829725|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829726|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829727|NCT03914638|Albuterol|albuterol|mesh-list
56829728|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56829729|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
56829730|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829731|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540594|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
56829732|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56829733|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
56829734|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
56829735|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56829736|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56829737|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56829738|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56829739|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
56829740|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829741|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829742|NCT01148446|Prednisone|prednisone|mesh-list
56829743|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
56829744|NCT01148446|Rituximab|rituximab|mesh-list
56829745|NCT01148446|Doxorubicin|doxorubicin|mesh-list
56829746|NCT01148446|Vincristine|vincristine|mesh-list
56829747|NCT01148446|Epirubicin|epirubicin|mesh-list
56829748|NCT01148446|Vinblastine|vinblastine|mesh-list
56829749|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829750|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
56829751|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829752|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829753|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56829754|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
56829755|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829756|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829757|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56829758|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56829759|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56829760|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56829761|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56829762|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829763|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56829764|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
56829765|NCT01148446|Hormones|hormones|mesh-ancestor
56829766|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56829767|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56829768|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56829769|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
56829770|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
56829771|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
56829772|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
56829773|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
56829774|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829775|NCT03914404|Protective Agents|protective agents|mesh-ancestor
56829776|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829777|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
56829778|NCT03914404|Vitamins|vitamins|mesh-ancestor
56829779|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
56829780|NCT01251640|Gemcitabine|gemcitabine|mesh-list
56829781|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56829782|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
56829783|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829784|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829785|NCT01251640|Antiviral Agents|antiviral agents|mesh-ancestor
56829786|NCT01251640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829787|NCT01251640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829788|NCT01251640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829789|NCT01251640|Immunologic Factors|immunologic factors|mesh-ancestor
56829791|NCT00257166|Ziprasidone|ziprasidone|mesh-list
56829792|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56829793|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
56829794|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829795|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829796|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829797|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56829798|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56829799|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829800|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56829801|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56829802|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
56829803|NCT03914092|Triamcinolone|triamcinolone|mesh-list
56829804|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56829805|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56829806|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56829807|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56829808|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
56829809|NCT03914092|Hormones|hormones|mesh-ancestor
56829810|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56829811|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829812|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829813|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
56829814|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829815|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829816|NCT01251718|Donepezil|donepezil|mesh-list
56829817|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56829818|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902910|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829819|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829820|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
56829821|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829822|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829823|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
56829824|NCT03913858|Anesthetics|anesthetics|mesh-list
56829825|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829826|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829827|NCT00227370|Valganciclovir|valganciclovir|mesh-list
56829828|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
56829829|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829830|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56829831|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829832|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56829833|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829834|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829835|NCT01251874|Alovudine|alovudine|mesh-list
56829836|NCT01251874|Carboplatin|carboplatin|mesh-list
56829837|NCT01251874|Veliparib|veliparib|mesh-list
56829838|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829839|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56829840|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829841|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829842|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
56829843|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829844|NCT03911440|Azithromycin|azithromycin|mesh-list
56829845|NCT03911440|Doxycycline|doxycycline|mesh-list
56829846|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56829847|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829848|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
56829849|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56829850|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56829851|NCT00191100|Gemcitabine|gemcitabine|mesh-list
56829852|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829853|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56829854|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
56829855|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829856|NCT00191100|Antiviral Agents|antiviral agents|mesh-ancestor
56829857|NCT00191100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829858|NCT00191100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829859|NCT00191100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56829860|NCT00191100|Immunologic Factors|immunologic factors|mesh-ancestor
56829861|NCT00191100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829862|NCT03902782|Dexamethasone|dexamethasone|mesh-list
56829863|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
56829864|NCT03902782|Epinephrine|epinephrine|mesh-list
56829866|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56829867|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
56829868|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
56829869|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829870|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829871|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56829872|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
56829873|NCT03902782|Hormones|hormones|mesh-ancestor
56829874|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56829875|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56829876|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829877|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
56829878|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
56829879|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829880|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
56829881|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56829882|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56829883|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
56829884|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829885|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829886|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56829887|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56829888|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56829889|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
56829890|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
56829891|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
56829892|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56829893|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
56829894|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56829895|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829896|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829897|NCT01252342|Oxytocin|oxytocin|mesh-list
56829898|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
56829899|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56829900|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829901|NCT01254994|Entecavir|entecavir|mesh-list
56829902|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
56829903|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56829904|NCT03904732|Aspirin|aspirin|mesh-list
56829905|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56829906|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56829907|NCT03904732|Analgesics|analgesics|mesh-ancestor
56829908|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
56829909|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829910|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829911|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56829912|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56829913|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56829914|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56829915|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829916|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56829917|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56829918|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829919|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
56829920|NCT01252420|Enoxaparin|enoxaparin|mesh-list
56829921|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
56829922|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56829923|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56829924|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829925|NCT01149304|Enoxaparin|enoxaparin|mesh-list
56829926|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
56829927|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56829928|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
56829929|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56829930|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56829931|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829932|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56829933|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56829934|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56829935|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56829936|NCT01149304|Protective Agents|protective agents|mesh-ancestor
56829937|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829938|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
56829939|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56829941|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56829942|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56829943|NCT01254526|Paclitaxel|paclitaxel|mesh-list
56829944|NCT01254526|Bevacizumab|bevacizumab|mesh-list
56829945|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56829946|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829947|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
56829948|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
56829949|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
56829950|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829951|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56829952|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56829953|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56829954|NCT01254526|Growth Substances|growth substances|mesh-ancestor
56829955|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829956|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
56829957|NCT01148992|Lofexidine|lofexidine|mesh-list
56540818|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56829958|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56829959|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56829960|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829961|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
56829962|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829963|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56829964|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56829965|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56829966|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
56829967|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829968|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829969|NCT03901612|Ropivacaine|ropivacaine|mesh-list
56829970|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
56829971|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
56829972|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56829973|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829974|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
56829975|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829976|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
56829977|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
56829978|NCT03903952|Vitamins|vitamins|mesh-ancestor
56829979|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
56829980|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829981|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
56829982|NCT03903952|Hematinics|hematinics|mesh-ancestor
56829983|NCT00257010|Almotriptan|almotriptan|mesh-list
56829984|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56829985|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
56829986|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56829987|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56829988|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829989|NCT03901768|Dexamethasone|dexamethasone|mesh-list
56829990|NCT03901768|Triamcinolone|triamcinolone|mesh-list
56829991|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56829992|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
56829993|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
56829994|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56829995|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56829996|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56829997|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
56829998|NCT03901768|Hormones|hormones|mesh-ancestor
56829999|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56830000|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56830001|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830002|NCT03903718|Oseltamivir|oseltamivir|mesh-list
56830003|NCT03903718|MEDI8852|medi8852|mesh-list
56830004|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
56830005|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830006|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830007|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830008|NCT03910504|Rocuronium|rocuronium|mesh-list
56830009|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56830010|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56830011|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56830012|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830013|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830017|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830018|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830019|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
56830020|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
56830021|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56830022|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830023|NCT00256854|Ropinirole|ropinirole|mesh-list
56830024|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56830025|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56830026|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
56830027|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
56830028|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830029|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830030|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830031|NCT00189462|Montelukast|montelukast|mesh-list
56540894|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56830032|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56830033|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
56830034|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56830035|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
56830036|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56830037|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830038|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56830039|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56830040|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830042|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56830043|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830044|NCT01150318|Trace Elements|trace elements|mesh-ancestor
56830045|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
56830046|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830047|NCT01256632|Ranibizumab|ranibizumab|mesh-list
56830048|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56830049|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56830050|NCT01256632|Growth Substances|growth substances|mesh-ancestor
56830051|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830052|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
56830053|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830054|NCT00256698|Fulvestrant|fulvestrant|mesh-list
56830055|NCT00256698|Anastrozole|anastrozole|mesh-list
56830056|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56830057|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830058|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56830059|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56830060|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
56830061|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56830062|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830063|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56830064|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56830065|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830066|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830067|NCT01150630|Gemcitabine|gemcitabine|mesh-list
56830068|NCT01150630|Capecitabine|capecitabine|mesh-list
56830069|NCT01150630|Epirubicin|epirubicin|mesh-list
56830070|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830071|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56830072|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
56830073|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830074|NCT01150630|Antiviral Agents|antiviral agents|mesh-ancestor
56830075|NCT01150630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830076|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830077|NCT01150630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830078|NCT01150630|Immunologic Factors|immunologic factors|mesh-ancestor
56830079|NCT01150630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830080|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56830081|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56830082|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56830083|NCT00189306|Imiquimod|imiquimod|mesh-list
56830084|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56830085|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
56830087|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830088|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
56830089|NCT03898336|Micronutrients|micronutrients|mesh-list
56830090|NCT03898336|Trace Elements|trace elements|mesh-list
56830091|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830092|NCT03972462|Sirolimus|sirolimus|mesh-list
56830093|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56830094|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830095|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56830096|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830097|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
56830098|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830099|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
56830100|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830101|NCT01150786|Selenium|selenium|mesh-list
56830102|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
56830103|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830104|NCT01150786|Protective Agents|protective agents|mesh-ancestor
56830105|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830106|NCT01150786|Trace Elements|trace elements|mesh-ancestor
56830107|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
56830108|NCT03909724|Sunitinib|sunitinib|mesh-list
56830109|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830110|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56830111|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56830112|NCT03909724|Growth Substances|growth substances|mesh-ancestor
56830113|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830114|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
56830115|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56830116|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830117|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830118|NCT03909646|Fluorouracil|fluorouracil|mesh-list
56830119|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56830120|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56830121|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
56830122|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830123|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56830124|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830125|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830126|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
56830127|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830128|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56830129|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
56830130|NCT01256866|Midazolam|midazolam|mesh-list
56830131|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
56830132|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56830133|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830134|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830135|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56830136|NCT01256866|Analgesics|analgesics|mesh-ancestor
56830137|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
56830138|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830139|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56830140|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56830141|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56830142|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
56830143|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830144|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830145|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56830146|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56830147|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56830148|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56830149|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56830150|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
56830151|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
56830152|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
56830153|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
56830154|NCT03908944|Methadone|methadone|mesh-list
56830155|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56830156|NCT03908944|Narcotics|narcotics|mesh-ancestor
56830157|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830158|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830159|NCT03908944|Analgesics|analgesics|mesh-ancestor
56830160|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
56830161|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830163|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
56830164|NCT03899506|Midazolam|midazolam|mesh-list
56830165|NCT03899506|Olanzapine|olanzapine|mesh-list
56830166|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56830167|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56830168|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830169|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830170|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56830171|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56830172|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56830173|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56830174|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
56830175|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
56830176|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
56830177|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
56830178|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830179|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830180|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
56830181|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
56830182|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830183|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56830184|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56830185|NCT03899506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56830186|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56830187|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56830188|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
56830189|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
56830190|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56830191|NCT03896932|Antibodies|antibodies|mesh-list
56830192|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
56830193|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56830194|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
56830195|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830196|NCT01257334|Empagliflozin|empagliflozin|mesh-list
56830197|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56830198|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830199|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56830200|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830201|NCT01151176|Insulin|insulin|mesh-list
56830202|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56830203|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56830204|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830205|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
56830206|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56830207|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830208|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56830209|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830210|NCT01257490|Bupropion|bupropion|mesh-list
56830211|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56830212|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
56830213|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56830214|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56830215|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56830216|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56830217|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830218|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
56830219|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830220|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830221|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56830222|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56830223|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830224|NCT03894280|Fluticasone|fluticasone|mesh-list
56830225|NCT03894280|Xhance|xhance|mesh-list
56830226|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56830227|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56830228|NCT03894280|Charcoal|charcoal|mesh-list
56830229|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56830230|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56830231|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
56830232|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830233|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830234|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56830235|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
56830236|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
56830237|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56830238|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56830239|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56830240|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56830241|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
56830242|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830243|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830244|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
56830246|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56830247|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
56830248|NCT03894280|Antidotes|antidotes|mesh-ancestor
56830249|NCT03894280|Protective Agents|protective agents|mesh-ancestor
56830250|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
56830251|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56830252|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56830253|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830254|NCT01150162|Omeprazole|omeprazole|mesh-list
56830255|NCT01150162|Rebamipide|rebamipide|mesh-list
56830256|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56830257|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56830258|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56830259|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830260|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830261|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
56830262|NCT01150162|Protective Agents|protective agents|mesh-ancestor
56830263|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830264|NCT03893734|Methadone|methadone|mesh-list
56830265|NCT03893734|Hydromorphone|hydromorphone|mesh-list
56830266|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56830267|NCT03893734|Narcotics|narcotics|mesh-ancestor
56830268|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830269|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830270|NCT03893734|Analgesics|analgesics|mesh-ancestor
56830271|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
56830272|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830273|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
56830274|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
56830275|NCT03899194|Citalopram|citalopram|mesh-list
56830276|NCT03899194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56830277|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56830278|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56830279|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830280|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830281|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
56830282|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830283|NCT03899194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56830284|NCT03899194|Antidepressive Agents|antidepressive agents|mesh-ancestor
56830285|NCT03899194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56830286|NCT01151800|Benzocaine|benzocaine|mesh-list
56830287|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
56830288|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
56830289|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830290|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830291|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
56830292|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830293|NCT03896074|Bevacizumab|bevacizumab|mesh-list
56830294|NCT03896074|Atezolizumab|atezolizumab|mesh-list
56830295|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56830296|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830297|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56830298|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56830299|NCT03896074|Growth Substances|growth substances|mesh-ancestor
56830300|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830301|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
56830302|NCT03899038|Anesthetics|anesthetics|mesh-list
56830303|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830304|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830305|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56830306|NCT01151878|Cathartics|cathartics|mesh-ancestor
56830307|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56830308|NCT03898882|Oxytocin|oxytocin|mesh-list
56830309|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
56830310|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56830311|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830312|NCT01151254|Propofol|propofol|mesh-list
56830313|NCT01151254|Sevoflurane|sevoflurane|mesh-list
56830314|NCT01151254|Isoflurane|isoflurane|mesh-list
56830315|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56830316|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830317|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830318|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56830319|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
56830320|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
56830321|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56830322|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56830323|NCT01255774|Ranibizumab|ranibizumab|mesh-list
56830324|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56830325|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56830326|NCT01255774|Growth Substances|growth substances|mesh-ancestor
56830327|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830328|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
56830329|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830330|NCT01255852|Atorvastatin|atorvastatin|mesh-list
56830331|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56830332|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56541190|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
56830333|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
56830334|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830335|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56830336|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56830337|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830338|NCT03895528|Lonafarnib|lonafarnib|mesh-list
56830339|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830340|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830341|NCT01257958|Vitamin D|vitamin d|mesh-list
56830342|NCT01257958|Vitamins|vitamins|mesh-ancestor
56830343|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
56830344|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830345|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56830346|NCT03893032|Modafinil|modafinil|mesh-list
56830347|NCT03893032|Amphetamine|amphetamine|mesh-list
56830348|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56830349|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830350|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56830351|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56830352|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56830353|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830354|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
56830355|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
56830356|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830357|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
56830358|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830359|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
56830360|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56830361|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56830362|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56830363|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56830364|NCT01258036|Hormones|hormones|mesh-list
56830365|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56830366|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830367|NCT03889366|Aprepitant|aprepitant|mesh-list
56830368|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
56830369|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
56830370|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830371|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830372|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56830373|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56830374|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830375|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830376|NCT03894826|Vorinostat|vorinostat|mesh-list
56830377|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830378|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56830379|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830380|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830381|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
56830382|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56830384|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56830385|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56830386|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830387|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
56830388|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830389|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830390|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56830391|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830392|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
56830393|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830394|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56830395|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830396|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830397|NCT03888664|Interferons|interferons|mesh-list
56830398|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
56830399|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830400|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
56830401|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830402|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
56830403|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830404|NCT01153828|Mupirocin|mupirocin|mesh-list
56830405|NCT01153828|Retapamulin|retapamulin|mesh-list
56830406|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
56830407|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56830408|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830409|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56830410|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830411|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830412|NCT01151722|Bevacizumab|bevacizumab|mesh-list
56830413|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56830414|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830415|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56830416|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56830417|NCT01151722|Growth Substances|growth substances|mesh-ancestor
56830418|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830419|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
56830420|NCT01258192|Paclitaxel|paclitaxel|mesh-list
56830421|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56830422|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56830423|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830424|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
56830425|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
56830426|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
56830427|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830428|NCT01326078|Propofol|propofol|mesh-list
56830429|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56830430|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830431|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830432|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56830433|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
56830434|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
56830435|NCT01260376|Acipimox|acipimox|mesh-list
56830436|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56830437|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
56830438|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830439|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56830440|NCT01259050|Copper|copper|mesh-list
56830441|NCT01259050|Trace Elements|trace elements|mesh-ancestor
56830442|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
56830443|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830444|NCT00255840|Ritonavir|ritonavir|mesh-list
56830445|NCT00255840|Lopinavir|lopinavir|mesh-list
56830446|NCT00255840|Lamivudine|lamivudine|mesh-list
56830447|NCT00255840|Nevirapine|nevirapine|mesh-list
56830448|NCT00255840|Stavudine|stavudine|mesh-list
56830449|NCT00255840|Efavirenz|efavirenz|mesh-list
56830450|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56830451|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56830452|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
56830453|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830454|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830455|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56830456|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56830457|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
56830458|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344833|NCT00164749|Analgesics|analgesics|mesh-ancestor
56830460|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56830461|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56830462|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56830463|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56830464|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56830465|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56830466|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56830467|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56830469|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
56830470|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
56830471|NCT00224874|Etanercept|etanercept|mesh-list
56830472|NCT00224874|Pentostatin|pentostatin|mesh-list
56830473|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
56830474|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56830475|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830476|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56830477|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
56830478|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56830479|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830480|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830481|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541306|NCT05269537|Oxytocin|oxytocin|mesh-list
56830482|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56830484|NCT00224874|Analgesics|analgesics|mesh-ancestor
56830485|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
56830486|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830487|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830488|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56830489|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56830490|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56830491|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830492|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
56830493|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56830494|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
56830495|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
56830496|NCT03892330|Doxorubicin|doxorubicin|mesh-list
56830497|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56830498|NCT03892330|Vincristine|vincristine|mesh-list
56830499|NCT03892330|Pirarubicin|pirarubicin|mesh-list
56830500|NCT03892330|Epirubicin|epirubicin|mesh-list
56830501|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830502|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
56830503|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830504|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56830505|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56830506|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
56830507|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830508|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830509|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56830510|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56830511|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56830512|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56830513|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830514|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56830515|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
56830516|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
56830517|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
56830518|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56830519|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830520|NCT00186186|Valproic Acid|valproic acid|mesh-list
56830521|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
56830522|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830523|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830524|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
56830525|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830526|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830527|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
56830528|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56830529|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830530|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56830531|NCT00185640|Cyclosporine|cyclosporine|mesh-list
56830533|NCT00185640|Lenograstim|lenograstim|mesh-list
56830534|NCT00185640|Cyclosporins|cyclosporins|mesh-list
56830535|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
56830536|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56830537|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56830538|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
56830539|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830540|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830541|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830542|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830543|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
56830544|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830545|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
56830546|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56830547|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56830548|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56830549|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830550|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56830551|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
56830552|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56830553|NCT03885388|Dactinomycin|dactinomycin|mesh-list
56830554|NCT03885388|Methotrexate|methotrexate|mesh-list
56830555|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56830556|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
56830557|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56830558|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830559|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56830560|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
56830561|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830562|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830563|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
56830564|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830565|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56830566|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830567|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
56830568|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56830569|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56830570|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56830571|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830572|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56830573|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56830574|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
56830575|NCT03968640|Vitamins|vitamins|mesh-ancestor
56830576|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
56830577|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830578|NCT01152346|Azacitidine|azacitidine|mesh-list
56830579|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56830580|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
56830581|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830582|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830583|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830584|NCT01260610|Tenofovir|tenofovir|mesh-list
56830585|NCT01260610|Telbivudine|telbivudine|mesh-list
56830586|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
56830587|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830588|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56830589|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56830590|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830591|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830592|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56830593|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56830594|NCT01155700|Omalizumab|omalizumab|mesh-list
56830595|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56902974|NCT02064010|Calcium|calcium|mesh-list
56830596|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56830597|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
56830598|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56830599|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56830600|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
56830601|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830602|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56830603|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56830604|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
56830605|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
56830606|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830607|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830608|NCT03887650|Dexamethasone|dexamethasone|mesh-list
56830609|NCT03887650|Epinephrine|epinephrine|mesh-list
56830610|NCT03887650|Bupivacaine|bupivacaine|mesh-list
56830611|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56830612|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
56830613|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
56830614|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830615|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830616|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56830617|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
56830619|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56830620|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56830621|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830622|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830623|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
56830624|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
56830625|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830626|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
56830627|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56830628|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56830629|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
56830630|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830631|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56830632|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56830633|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56830634|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
56830635|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
56830636|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
56830637|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56830638|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
56830639|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56830640|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830641|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
56830642|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
56830643|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56830644|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830645|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56830646|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830647|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56830648|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
56830649|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830650|NCT03891472|Fluorouracil|fluorouracil|mesh-list
56830651|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
56830652|NCT03891472|Irinotecan|irinotecan|mesh-list
56830653|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
56830654|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830655|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56830656|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830657|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830658|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
56830659|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830660|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56830661|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56830662|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830663|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
56830664|NCT01262482|Sorafenib|sorafenib|mesh-list
56830665|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830666|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56830667|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830668|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830669|NCT01261078|Epinephrine|epinephrine|mesh-list
56830670|NCT01261078|Racepinephrine|racepinephrine|mesh-list
56830671|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
56830672|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56830673|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56830674|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
56830675|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830676|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830677|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830678|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56830679|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56830680|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
56830681|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830683|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
56830684|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
56830685|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
56830686|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56830687|NCT01155934|Risperidone|risperidone|mesh-list
56830688|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56830689|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
56830690|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830691|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830692|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830693|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56830694|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56830695|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830696|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56830697|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56830698|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
56830699|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56830700|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
56541535|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
56541536|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56541537|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
56830701|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830702|NCT01261156|Diltiazem|diltiazem|mesh-list
56830703|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56830704|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56830705|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56830706|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830707|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56830708|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830709|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
56830710|NCT03884530|Aspirin|aspirin|mesh-list
56830711|NCT03884530|Ticagrelor|ticagrelor|mesh-list
56830712|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56830713|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56830714|NCT03884530|Analgesics|analgesics|mesh-ancestor
56830715|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
56830716|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830717|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830718|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56830719|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56830720|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56830721|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56830722|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830723|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56830724|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56830725|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830726|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
56830727|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56830728|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56830729|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56830730|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
56830731|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830732|NCT03891316|Sevoflurane|sevoflurane|mesh-list
56830733|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56830734|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56830735|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
56830736|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
56830737|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830738|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830739|NCT03887260|Fentanyl|fentanyl|mesh-list
56830740|NCT03887260|Morphine|morphine|mesh-list
56830741|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56830742|NCT03887260|Narcotics|narcotics|mesh-ancestor
56830743|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830744|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830745|NCT03887260|Analgesics|analgesics|mesh-ancestor
56830746|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
56830747|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830748|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56830749|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56830750|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
56830751|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
56830752|NCT03883984|Cysteamine|cysteamine|mesh-list
56830753|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56830755|NCT01586494|Tramadol|tramadol|mesh-list
56830756|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56830757|NCT01586494|Narcotics|narcotics|mesh-ancestor
56830758|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830759|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830760|NCT01586494|Analgesics|analgesics|mesh-ancestor
56830761|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
56830762|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830763|NCT03886948|Mirikizumab|mirikizumab|mesh-list
56830764|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56830765|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56830766|NCT03886948|Analgesics|analgesics|mesh-ancestor
56830767|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
56830768|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830769|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830770|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56830771|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56830772|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56830773|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56830774|NCT01259362|Cocaine|cocaine|mesh-list
56830775|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
56830776|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
56830777|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830778|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830779|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
56830780|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830781|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56830782|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56830783|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56830784|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56830785|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830786|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
56830787|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830788|NCT03891238|Avelumab|avelumab|mesh-list
56830789|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56830790|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830791|NCT01261234|Cilostazol|cilostazol|mesh-list
56830792|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56830793|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
56830794|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830795|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830796|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56902985|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
56830797|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
56830798|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56830799|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56830800|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830801|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56830802|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
56830803|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56830804|NCT01261234|Protective Agents|protective agents|mesh-ancestor
56830805|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56830806|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56830807|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830808|NCT01152736|Nicotine|nicotine|mesh-list
56830809|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56830810|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
56830811|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830812|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830813|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56830814|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56830815|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
56830816|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830817|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830818|NCT01154764|Ketoconazole|ketoconazole|mesh-list
56830819|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
56830820|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830821|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56830822|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56830823|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830824|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830825|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56830827|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56830828|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830829|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56830830|NCT01261546|Dexamethasone|dexamethasone|mesh-list
56830831|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56830832|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
56830833|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
56830834|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830835|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830836|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56830837|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
56830838|NCT01261546|Hormones|hormones|mesh-ancestor
56830839|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56830840|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56830841|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830842|NCT03883360|Cannabidiol|cannabidiol|mesh-list
56830843|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
56830844|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
56830845|NCT01261702|Analgesics|analgesics|mesh-ancestor
56830846|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
56830847|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830848|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830849|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
56830850|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830851|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56830852|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
56830853|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56830854|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56830855|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830856|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56830857|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
56830858|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56830860|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
56830861|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56830862|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830863|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56830864|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830865|NCT03890770|BMS-986165|bms-986165|mesh-list
56830866|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
56830867|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56830868|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438036|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
56830869|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830870|NCT03883204|Risperidone|risperidone|mesh-list
56830871|NCT03883204|Aripiprazole|aripiprazole|mesh-list
56830872|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56830873|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
56830874|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56830875|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830876|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830877|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56830878|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56830879|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830880|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56830881|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56830882|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
56830883|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
56830884|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
56830885|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56830886|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56830887|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56830888|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56830889|NCT01263418|Ofatumumab|ofatumumab|mesh-list
56830890|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830891|NCT03882814|Meperidine|meperidine|mesh-list
56830892|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56830893|NCT03882814|Narcotics|narcotics|mesh-ancestor
56830894|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830895|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830896|NCT03882814|Analgesics|analgesics|mesh-ancestor
56830897|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
56830898|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830899|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56830902|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830903|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56830904|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56830905|NCT03647566|Listerine|listerine|mesh-list
56830906|NCT03647566|Fluorides|fluorides|mesh-list
56830907|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
56830908|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
56830909|NCT03647566|Protective Agents|protective agents|mesh-ancestor
56830910|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830911|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56830912|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830913|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
56830914|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
56830915|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56830916|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56830917|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830918|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830919|NCT01156636|Urological Agents|urological agents|mesh-ancestor
56830920|NCT03889288|Analgesics|analgesics|mesh-list
56830921|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
56830922|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56830923|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830924|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
56830925|NCT01153204|Citric Acid|citric acid|mesh-list
56830926|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
56830927|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
56541760|NCT00605020|Insulin|insulin|mesh-list
56830928|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56830929|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
56830930|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
56830931|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830932|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
56830933|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56830934|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56830935|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830936|NCT01153204|Urological Agents|urological agents|mesh-ancestor
56830937|NCT03760666|Ribavirin|ribavirin|mesh-list
56830938|NCT03760666|Brequinar|brequinar|mesh-list
56830939|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
56830940|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830941|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
56830942|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830943|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830944|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56830945|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56830946|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
56830947|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830948|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
56830949|NCT01263574|Ethanol|ethanol|mesh-list
56830950|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56830951|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56830952|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56830953|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830954|NCT03464734|Paclitaxel|paclitaxel|mesh-list
56830955|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
56830956|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56830957|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56830958|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830959|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56830960|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56830961|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56830962|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830963|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56830964|NCT01156948|Misoprostol|misoprostol|mesh-list
56830965|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56830966|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
56830967|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56830968|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830969|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56830970|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56830971|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
56830972|NCT01157026|Tamoxifen|tamoxifen|mesh-list
56830973|NCT01157026|Tocotrienols|tocotrienols|mesh-list
56830974|NCT01157026|Vitamin E|vitamin e|mesh-list
56830977|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
56830978|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56830979|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56830980|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56830981|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56830982|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56830983|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56830984|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56830985|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
56830986|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56830987|NCT01157026|Protective Agents|protective agents|mesh-ancestor
56830988|NCT01157026|Vitamins|vitamins|mesh-ancestor
56830989|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
56830990|NCT01263652|Dipyrone|dipyrone|mesh-list
56830991|NCT01263652|Diclofenac|diclofenac|mesh-list
56830992|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
56830993|NCT01263652|Tramadol|tramadol|mesh-list
56830994|NCT01263652|Orphenadrine|orphenadrine|mesh-list
56830995|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56830996|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56830997|NCT01263652|Analgesics|analgesics|mesh-ancestor
56830998|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
56830999|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831000|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831001|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831002|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831003|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56831004|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831005|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831006|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56831008|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831009|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
56831010|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56831011|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56831012|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56831013|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56831014|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
56831015|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
56831016|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56831017|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56831018|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
56831019|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831020|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
56831021|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56831022|NCT03881644|Sumatriptan|sumatriptan|mesh-list
56831023|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
56831024|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56831025|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56831026|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56831027|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
56831028|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831029|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831030|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831031|NCT03881644|Growth Substances|growth substances|mesh-ancestor
56831032|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
56831033|NCT01259830|Etoricoxib|etoricoxib|mesh-list
56831034|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56831035|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56831036|NCT01259830|Analgesics|analgesics|mesh-ancestor
56831037|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
56831038|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831039|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831040|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831041|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831042|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56831043|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56831044|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831045|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831046|NCT00224484|Vaccines|vaccines|mesh-list
56557641|NCT02794714|Rocuronium|rocuronium|mesh-list
56831048|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831049|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
56831050|NCT01265680|Hematinics|hematinics|mesh-ancestor
56831051|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
56831052|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56831053|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831054|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56831055|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56831056|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831057|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831058|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831059|NCT01157572|Metoprolol|metoprolol|mesh-list
56831060|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56831061|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56831062|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
56831063|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
56831064|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831065|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831066|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56831067|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56831068|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56831069|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
56831070|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831071|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831072|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56831073|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56831074|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831075|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56541905|NCT00936598|Zolpidem|zolpidem|mesh-list
56831076|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831077|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831078|NCT00254982|Infliximab|infliximab|mesh-list
56831079|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
56831080|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831081|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831082|NCT01586572|Vaccines|vaccines|mesh-list
56831083|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
56831084|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831085|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
56831086|NCT00224016|Oxybutynin|oxybutynin|mesh-list
56831087|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
56831088|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
56831089|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831090|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831091|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56831092|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56831093|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
56831094|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831095|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831096|NCT00224016|Urological Agents|urological agents|mesh-ancestor
56831097|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56831098|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831099|NCT00224016|Renal Agents|renal agents|mesh-ancestor
56831100|NCT02527174|Cytarabine|cytarabine|mesh-list
56831101|NCT02527174|Idarubicin|idarubicin|mesh-list
56831102|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56831103|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
56831104|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831105|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831106|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
56831107|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831108|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831109|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
56831110|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831111|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56831112|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56831113|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56831114|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831115|NCT01161940|Nizatidine|nizatidine|mesh-list
56831116|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56831117|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831118|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56831119|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
56831120|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
56831121|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831122|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831123|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831125|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56831126|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831127|NCT01266694|Colchicine|colchicine|mesh-list
56831128|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
56831129|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831130|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
56831131|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
56831132|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
56831133|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831134|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831135|NCT03876886|Paclitaxel|paclitaxel|mesh-list
56831136|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56831137|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
56831138|NCT03876886|Carboplatin|carboplatin|mesh-list
56831139|NCT03876886|Epirubicin|epirubicin|mesh-list
56831140|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56831141|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831142|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
56831143|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
56831144|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
56831145|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831146|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831147|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
56831148|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831149|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831150|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56831151|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
56831152|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56831153|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56831154|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56831155|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56831156|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831157|NCT01266772|Budesonide|budesonide|mesh-list
56831158|NCT01266772|Montelukast|montelukast|mesh-list
56831159|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831160|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56831161|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
56831162|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831163|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831164|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56831165|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
56831166|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
56831167|NCT01266772|Hormones|hormones|mesh-ancestor
56831168|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831169|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56831170|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
56831171|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56831172|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56831173|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831174|NCT01264354|Adefovir|adefovir|mesh-list
56831175|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56831176|NCT01264354|Clevudine|clevudine|mesh-list
56831177|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
56831178|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831179|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56831180|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56831181|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831182|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831183|NCT01264432|Veliparib|veliparib|mesh-list
56831184|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56831185|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831186|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831187|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831188|NCT02527096|Lamivudine|lamivudine|mesh-list
56831189|NCT02527096|Dolutegravir|dolutegravir|mesh-list
56831190|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56831191|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56831192|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831193|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831194|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
56831196|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56831197|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56831198|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56831199|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56831200|NCT01160302|Curcumin|curcumin|mesh-list
56831201|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56831202|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56831203|NCT01160302|Analgesics|analgesics|mesh-ancestor
56831204|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
56831205|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831206|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831207|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831208|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831209|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831210|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831211|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831212|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
56831213|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56831214|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56831215|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
56831216|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831217|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831218|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831219|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
56831220|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
56831221|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831222|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
56831223|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56831224|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
56831225|NCT01268176|Vitamin D|vitamin d|mesh-list
56542057|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831226|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
56831227|NCT01268176|Vitamins|vitamins|mesh-ancestor
56831228|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
56831229|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831230|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56831231|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56831232|NCT01264588|Calcium|calcium|mesh-list
56831233|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56831234|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831235|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
56831236|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56831237|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56831238|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831239|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
56831240|NCT05075200|Coagulants|coagulants|mesh-ancestor
56831241|NCT01158274|Capecitabine|capecitabine|mesh-list
56831242|NCT01158274|R04929097|r04929097|mesh-list
56831243|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56831244|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
56831245|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831246|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831247|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831248|NCT01267084|Ketoconazole|ketoconazole|mesh-list
56831249|NCT01267084|Dexamethasone|dexamethasone|mesh-list
56831250|NCT01267084|Trabectedin|trabectedin|mesh-list
56831251|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831252|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
56831253|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
56831254|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831255|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831256|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831257|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
56831258|NCT01267084|Hormones|hormones|mesh-ancestor
56831259|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831260|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56831261|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831262|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
56831263|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831264|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56831265|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56831266|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831267|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831270|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56831271|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56831272|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
56831273|NCT01264822|Rabeprazole|rabeprazole|mesh-list
56831274|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56831275|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831276|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56831277|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831278|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831279|NCT01160926|Cediranib|cediranib|mesh-list
56831280|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831281|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56831282|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831283|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831284|NCT03876574|Gemcitabine|gemcitabine|mesh-list
56831285|NCT03876574|Dexamethasone|dexamethasone|mesh-list
56831286|NCT03876574|Floxuridine|floxuridine|mesh-list
56831287|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831288|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
56831289|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
56831290|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831291|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831292|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831293|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
56831294|NCT03876574|Hormones|hormones|mesh-ancestor
56831295|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903026|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56831296|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56831297|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831298|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56831299|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
56920146|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831300|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831301|NCT03876574|Antiviral Agents|antiviral agents|mesh-ancestor
56831302|NCT03876574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831303|NCT03876574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831304|NCT03876574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831305|NCT03876574|Immunologic Factors|immunologic factors|mesh-ancestor
56831306|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
56831307|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
56831308|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
56831309|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831310|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831311|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
56831312|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831313|NCT01267396|Sertraline|sertraline|mesh-list
56831314|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
56831315|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56831316|NCT01267396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56831317|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56831318|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56831319|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831320|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831321|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
56831322|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831323|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
56831324|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56831325|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56831326|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
56831327|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831328|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56831329|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56831330|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831331|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831332|NCT01161316|Cetuximab|cetuximab|mesh-list
56831333|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56831334|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831335|NCT01161550|Cytarabine|cytarabine|mesh-list
56831336|NCT01161550|Tretinoin|tretinoin|mesh-list
56831337|NCT01161550|Cladribine|cladribine|mesh-list
56831338|NCT01161550|Midostaurin|midostaurin|mesh-list
56831339|NCT01161550|Lenograstim|lenograstim|mesh-list
56831340|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56831342|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831344|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
56831345|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831346|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831347|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
56831348|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831349|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56831350|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
56831351|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56831352|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56831353|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831354|NCT01159210|Thrombin|thrombin|mesh-list
56831355|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
56831356|NCT01159210|Coagulants|coagulants|mesh-ancestor
56831357|NCT03879460|Naltrexone|naltrexone|mesh-list
56831358|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56831359|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56831360|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831361|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
56831362|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831363|NCT03877120|Diazepam|diazepam|mesh-list
56831364|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
56831365|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56831366|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831367|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831368|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56831369|NCT03877120|Analgesics|analgesics|mesh-ancestor
56831370|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
56903029|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56831371|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831372|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56831373|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56831374|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56831375|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
56831376|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831377|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831378|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56831379|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
56831380|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
56831381|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
56831382|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831383|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56831384|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56831385|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56831386|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56831387|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56831388|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56831389|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
56831390|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
56831391|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
56831392|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
56831393|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
56831394|NCT03879382|Fludarabine|fludarabine|mesh-list
56831395|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831396|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
56831397|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831398|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831399|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56831400|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
56831401|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831402|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831403|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56831404|NCT01166932|Amoxicillin|amoxicillin|mesh-list
56831405|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
56831406|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
56831407|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
56831408|NCT01166932|Oxacillin|oxacillin|mesh-list
56831409|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56831410|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831411|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831412|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831413|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56831414|NCT01167010|Budesonide|budesonide|mesh-list
56831415|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
56831416|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831417|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56831418|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
56831419|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831420|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831421|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56831422|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
56831423|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
56831425|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831426|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56831427|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56831428|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56831429|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
56831430|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831431|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831432|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56831433|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
56831434|NCT01280188|Coagulants|coagulants|mesh-ancestor
56831435|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56831436|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
56831437|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831438|NCT03871972|Sirolimus|sirolimus|mesh-list
56831439|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56831440|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831441|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56831442|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831443|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
56831444|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831445|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
56831446|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831447|NCT01165060|Bezafibrate|bezafibrate|mesh-list
56831448|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56831449|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
56831450|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831451|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56831452|NCT01165294|Ketamine|ketamine|mesh-list
56831453|NCT01165294|Analgesics|analgesics|mesh-ancestor
56831454|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
56831455|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831456|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831457|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56831458|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56831459|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
56831460|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
56831461|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831462|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56831463|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56831464|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831465|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831466|NCT01165372|Artesunate|artesunate|mesh-list
56831467|NCT01165372|Piperaquine|piperaquine|mesh-list
56831468|NCT01165372|Artenimol|artenimol|mesh-list
56831469|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
56831470|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56831471|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56831472|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831473|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831474|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
56831475|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
56831476|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56831477|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
56831478|NCT01280734|Melatonin|melatonin|mesh-list
56831479|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
56831480|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831481|NCT01280734|Protective Agents|protective agents|mesh-ancestor
56831482|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831483|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831484|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56831485|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56831486|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831487|NCT01587430|Cytarabine|cytarabine|mesh-list
56831488|NCT01587430|Daunorubicin|daunorubicin|mesh-list
56831489|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
56831490|NCT01587430|Idarubicin|idarubicin|mesh-list
56831491|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56831492|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
56831493|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831494|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831496|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831497|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831498|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
56831499|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831500|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56831501|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56831502|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56831503|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831504|NCT01587430|Analgesics|analgesics|mesh-ancestor
56831505|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
56831506|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831507|NCT03874000|Metformin|metformin|mesh-list
56831508|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56831509|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831510|NCT03757234|Levofloxacin|levofloxacin|mesh-list
56831511|NCT03757234|Ofloxacin|ofloxacin|mesh-list
56831512|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56831513|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831514|NCT03757234|Renal Agents|renal agents|mesh-ancestor
56831515|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56831516|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56831517|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56831518|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831519|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831520|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831521|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56831522|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56831523|NCT03874156|Atorvastatin|atorvastatin|mesh-list
56831524|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56831525|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56831526|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
56831527|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831528|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56920147|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
56831529|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56831530|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831531|NCT01167478|Caffeine|caffeine|mesh-list
56831532|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56831533|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831534|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56831535|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831536|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831537|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56831538|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56831539|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
56831540|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831541|NCT01587196|Naltrexone|naltrexone|mesh-list
56831542|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56831543|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56831544|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831545|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
56831546|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831547|NCT01281514|Carboplatin|carboplatin|mesh-list
56831548|NCT01281514|Doxorubicin|doxorubicin|mesh-list
56831549|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56831550|NCT01281514|Everolimus|everolimus|mesh-list
56831551|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831552|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56831553|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56831554|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56831555|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831556|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831557|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831558|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
56831559|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831560|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56831561|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
56831562|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831563|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56831564|NCT00223080|Antacids|antacids|mesh-ancestor
56904604|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831565|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831566|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831567|NCT03971604|Vitamins|vitamins|mesh-list
56831568|NCT03971604|Vitamin E|vitamin e|mesh-list
56831569|NCT03971604|Vitamin A|vitamin a|mesh-list
56831570|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
56831571|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831572|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
56831573|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831574|NCT03971604|Protective Agents|protective agents|mesh-ancestor
56831575|NCT02531490|Labetalol|labetalol|mesh-list
56831576|NCT02531490|Methyldopa|methyldopa|mesh-list
56831577|NCT02531490|Nifedipine|nifedipine|mesh-list
56831578|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56831579|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56831580|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831581|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56831582|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831583|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
56831584|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
56831585|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56831586|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56831587|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56831588|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
56831589|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831590|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56831591|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
56831592|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
56831593|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831594|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56831595|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56831596|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
56831597|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56831598|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56831599|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56831600|NCT03871114|Triamcinolone|triamcinolone|mesh-list
56831601|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56831602|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56831603|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56831604|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831605|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
56831606|NCT03871114|Hormones|hormones|mesh-ancestor
56831607|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831608|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831609|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831610|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
56831611|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831612|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831613|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
56831614|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56831615|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56831616|NCT01281748|Prednisolone|prednisolone|mesh-list
56831617|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
56831618|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56831619|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
56831620|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831621|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
56831622|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
56831623|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831624|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831625|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831626|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
56831627|NCT01281748|Hormones|hormones|mesh-ancestor
56831628|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831629|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56831630|NCT01281748|Protective Agents|protective agents|mesh-ancestor
56831631|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56831632|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831633|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
56831634|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56831635|NCT00220740|Antibodies|antibodies|mesh-list
56831636|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
56831637|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56831638|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
56831639|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
56831640|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831642|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
56831643|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56831644|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
56831645|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831646|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
56831647|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56831648|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
56831649|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831650|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831651|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56831652|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
56831653|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56831654|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
56831655|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831656|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831657|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56831658|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
56831659|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
56831660|NCT03873298|Protective Agents|protective agents|mesh-ancestor
56831661|NCT00184002|Prednisone|prednisone|mesh-list
56831662|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
56831663|NCT00184002|Doxorubicin|doxorubicin|mesh-list
56831664|NCT00184002|Vincristine|vincristine|mesh-list
56831665|NCT00184002|Rituximab|rituximab|mesh-list
56831666|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831667|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
56831668|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831669|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831670|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56831671|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
56831672|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831673|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831674|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56831675|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56831676|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56831677|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56831678|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831679|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831680|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
56831681|NCT00184002|Hormones|hormones|mesh-ancestor
56831682|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831683|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56831684|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56831685|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
56831686|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
56831687|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
56831688|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56831689|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
56831690|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56831691|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56831692|NCT01167946|Prednisolone|prednisolone|mesh-list
56831693|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
56831694|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56831695|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
56831696|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831697|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
56831698|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
56831699|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831700|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831701|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831702|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
56831703|NCT01167946|Hormones|hormones|mesh-ancestor
56831704|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831705|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56831706|NCT01167946|Protective Agents|protective agents|mesh-ancestor
56831707|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56831708|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831709|NCT01275508|Adalimumab|adalimumab|mesh-list
56831710|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831711|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831712|NCT01073670|Acetaminophen|acetaminophen|mesh-list
56831713|NCT01073670|Indomethacin|indomethacin|mesh-list
56831714|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56831715|NCT01073670|Analgesics|analgesics|mesh-ancestor
56831716|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
56831717|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831718|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831720|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56831721|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831722|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831723|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
56831724|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
56831725|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56831726|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56831727|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831728|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831729|NCT03971370|Vaccines|vaccines|mesh-list
56831730|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
56831731|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831732|NCT01168336|Betahistine|betahistine|mesh-list
56831733|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
56831734|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
56831735|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
56831736|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831737|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831738|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831739|NCT00165672|Rabeprazole|rabeprazole|mesh-list
56831740|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56831741|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831742|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56831743|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831744|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831745|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
56831746|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56831747|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
56831748|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831749|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
56831750|NCT03870646|Protective Agents|protective agents|mesh-ancestor
56831751|NCT01168492|Ketamine|ketamine|mesh-list
56831752|NCT01168492|Analgesics|analgesics|mesh-ancestor
56831753|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
56831754|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831755|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831756|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56831757|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56831758|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
56831759|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
56831760|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831761|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56831762|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56831763|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831764|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831765|NCT03870490|Cefepime|cefepime|mesh-list
56831766|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56831767|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831768|NCT01278082|Budesonide|budesonide|mesh-list
56831769|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831770|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56831771|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
56831772|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831773|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831774|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56831775|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
56831776|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
56831777|NCT01278082|Hormones|hormones|mesh-ancestor
56831778|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831779|NCT03870256|Misoprostol|misoprostol|mesh-list
56831780|NCT03870256|Carbetocin|carbetocin|mesh-list
56831781|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56831782|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
56831783|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56831784|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831785|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56831786|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831787|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
56831788|NCT01166542|Paclitaxel|paclitaxel|mesh-list
56831789|NCT01166542|Carboplatin|carboplatin|mesh-list
56831790|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56831791|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831793|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
56831794|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
56831795|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831796|NCT00169104|Trastuzumab|trastuzumab|mesh-list
56831797|NCT00169104|Vinorelbine|vinorelbine|mesh-list
56831798|NCT00169104|Lenograstim|lenograstim|mesh-list
56831799|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56831800|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831801|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56831802|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
56831803|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831804|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56831805|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
56831806|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
56831807|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
56831808|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831809|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
56831810|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56831811|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56831812|NCT03872830|Analgesics|analgesics|mesh-ancestor
56831813|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
56831814|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831815|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831816|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831817|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831818|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56831819|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
56831820|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56831821|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
56831822|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831823|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56831824|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
56831825|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56831826|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56831827|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56831828|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831829|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831830|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56831831|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56831832|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56831833|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
56831834|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831835|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831836|NCT00163020|Progestins|progestins|mesh-ancestor
56831837|NCT00163020|Hormones|hormones|mesh-ancestor
56831838|NCT01168804|Dexamethasone|dexamethasone|mesh-list
56831839|NCT01168804|Bortezomib|bortezomib|mesh-list
56831840|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56831841|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831842|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
56831843|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
56831844|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831845|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831846|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831847|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
56831848|NCT01168804|Hormones|hormones|mesh-ancestor
56831849|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831850|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56831851|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831852|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56831853|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
56831854|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831855|NCT03873532|Capecitabine|capecitabine|mesh-list
56831856|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56831857|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
56831858|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831859|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831860|NCT01282528|Infliximab|infliximab|mesh-list
56831861|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
56831862|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831863|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831864|NCT01169506|Silicon|silicon|mesh-list
56831865|NCT01169506|Trace Elements|trace elements|mesh-ancestor
56831867|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831868|NCT01169740|Bilirubin|bilirubin|mesh-list
56831869|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
56831870|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831871|NCT01169740|Protective Agents|protective agents|mesh-ancestor
56831872|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831873|NCT01169584|Molgramostim|molgramostim|mesh-list
56831874|NCT01169584|Sargramostim|sargramostim|mesh-list
56831875|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
56831876|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831877|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831878|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
56831879|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56831880|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831881|NCT01282762|Vaccines|vaccines|mesh-list
56831882|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
56831883|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831884|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56831885|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56831886|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56831887|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
56831888|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831889|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831890|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831891|NCT01282840|Urological Agents|urological agents|mesh-ancestor
56831892|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
56831893|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831894|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56831895|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831896|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831897|NCT01172626|Valproic Acid|valproic acid|mesh-list
56831898|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
56831899|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831900|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831901|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
56831902|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831903|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831904|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
56831905|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56831906|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831907|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56831908|NCT01172782|Hydromorphone|hydromorphone|mesh-list
56831909|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56831910|NCT01172782|Narcotics|narcotics|mesh-ancestor
56831911|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831912|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831913|NCT01172782|Analgesics|analgesics|mesh-ancestor
56831914|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
56831915|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831916|NCT03866746|Aflibercept|aflibercept|mesh-list
56831917|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56831918|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56831919|NCT03866746|Growth Substances|growth substances|mesh-ancestor
56831920|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831921|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
56831922|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831923|NCT03869398|Calcitriol|calcitriol|mesh-list
56831924|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56831925|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831926|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56831927|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56831928|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831929|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56831930|NCT03869398|Vitamins|vitamins|mesh-ancestor
56831931|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
56831932|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56831933|NCT01170052|Sirolimus|sirolimus|mesh-list
56831934|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56831935|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56831936|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
56831937|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831938|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831939|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56831940|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56831941|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56831942|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
56831943|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831944|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
56831945|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831947|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56831948|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
56831949|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
56831950|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831951|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831952|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56831953|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
56831954|NCT01284478|Hormones|hormones|mesh-ancestor
56831955|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56831956|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56831957|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831958|NCT00252720|Candesartan|candesartan|mesh-list
56831959|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56831960|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56831961|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56831962|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831963|NCT01284556|Phenobarbital|phenobarbital|mesh-list
56831964|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
56831965|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56831966|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831967|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831968|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56831969|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56831970|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56831971|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831972|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
56831973|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
56831974|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56831975|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56831976|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56831977|NCT01170130|Lidocaine|lidocaine|mesh-list
56831978|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
56831979|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
56831980|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56831981|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831982|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
56831983|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56831984|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56831985|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56831986|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56831987|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56831988|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831989|NCT03868852|Apatinib|apatinib|mesh-list
56831990|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56831991|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56831992|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56831993|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56831994|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
56831995|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56831996|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
56831997|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56831998|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56831999|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56832000|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
56832001|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832002|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832003|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56832004|NCT01163500|Ubiquinone|ubiquinone|mesh-list
56832005|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
56832006|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
56832007|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832008|NCT01163500|Vitamins|vitamins|mesh-ancestor
56832009|NCT01163734|Ranolazine|ranolazine|mesh-list
56832010|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56832011|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346418|NCT00174733|Hormones|hormones|mesh-ancestor
56832013|NCT01284868|Propranolol|propranolol|mesh-list
56832014|NCT01284868|Bisoprolol|bisoprolol|mesh-list
56832015|NCT01284868|Mirabegron|mirabegron|mesh-list
56832016|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56832017|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56832018|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
56832019|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832020|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832021|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832022|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56832023|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56832024|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
56832025|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56832026|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56832027|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56832028|NCT01284868|Urological Agents|urological agents|mesh-ancestor
56832029|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
56832030|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
56832031|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832032|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56832033|NCT01170442|Vitamin D|vitamin d|mesh-list
56832034|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
56832035|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
56832036|NCT01170442|Vitamins|vitamins|mesh-list
56832037|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
56832038|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832039|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56832040|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56832041|NCT00252564|Leucovorin|leucovorin|mesh-list
56832042|NCT00252564|Bevacizumab|bevacizumab|mesh-list
56832043|NCT00252564|Cetuximab|cetuximab|mesh-list
56832044|NCT00252564|Fluorouracil|fluorouracil|mesh-list
56832045|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
56832046|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56832047|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832048|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56832049|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56832050|NCT00252564|Growth Substances|growth substances|mesh-ancestor
56832051|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832052|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
56832053|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
56832054|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542893|NCT02704507|Triamcinolone|triamcinolone|mesh-list
56832055|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56832056|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832057|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
56832059|NCT00252564|Protective Agents|protective agents|mesh-ancestor
56832060|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
56832061|NCT00252564|Vitamins|vitamins|mesh-ancestor
56832062|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
56832063|NCT01284946|Deferasirox|deferasirox|mesh-list
56832064|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56832065|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
56832066|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
56832067|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832068|NCT01173562|Mebendazole|mebendazole|mesh-list
56832069|NCT01173562|Piperazine|piperazine|mesh-list
56832070|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
56832071|NCT01173562|DMP 777|dmp 777|mesh-list
56832072|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
56832073|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
56832074|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56832075|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832076|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
56832077|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
56832078|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
56832079|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832080|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832081|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832082|NCT00166296|Citalopram|citalopram|mesh-list
56832083|NCT00166296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56832084|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56832085|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56832086|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832087|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832089|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832090|NCT00166296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56832092|NCT00166296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56832093|NCT01173640|Midazolam|midazolam|mesh-list
56832094|NCT01173640|Resveratrol|resveratrol|mesh-list
56832095|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56832096|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56832097|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832098|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832099|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56832100|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56832101|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56832102|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56832103|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
56832104|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
56832105|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
56832106|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
56832107|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832108|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832109|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
56832110|NCT01173640|Protective Agents|protective agents|mesh-ancestor
56832111|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832112|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56832113|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56832114|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
56832115|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832116|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56832117|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
56832118|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832119|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832120|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56832121|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56832122|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56832123|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
56832124|NCT03868306|Chrysarobin|chrysarobin|mesh-list
56832125|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56832126|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56832127|NCT03868306|Analgesics|analgesics|mesh-ancestor
56832128|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
56832129|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542967|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
56832130|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832131|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832132|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832134|NCT01164046|Heparin|heparin|mesh-list
56832135|NCT01164046|Enoxaparin|enoxaparin|mesh-list
56832136|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56832137|NCT01164046|Tinzaparin|tinzaparin|mesh-list
56832138|NCT01164046|Dalteparin|dalteparin|mesh-list
56832139|NCT01164046|Nadroparin|nadroparin|mesh-list
56832140|NCT01164046|Reviparin|reviparin|mesh-list
56832141|NCT01164046|Warfarin|warfarin|mesh-list
56832142|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
56832143|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
56832144|NCT01164046|Bemiparin|bemiparin|mesh-list
56832145|NCT01164046|Certoparin|certoparin|mesh-list
56832146|NCT01164046|Vitamins|vitamins|mesh-ancestor
56832147|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
56832148|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832149|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
56832150|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56832151|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56832152|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832153|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56832154|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
56832155|NCT01164046|Coagulants|coagulants|mesh-ancestor
56832156|NCT01075464|Paclitaxel|paclitaxel|mesh-list
56832157|NCT01075464|Bevacizumab|bevacizumab|mesh-list
56832158|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56832159|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832160|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
56832161|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
56832162|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
56832163|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832164|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56832166|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56832167|NCT01075464|Growth Substances|growth substances|mesh-ancestor
56832168|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832169|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
56832170|NCT01074996|Leucovorin|leucovorin|mesh-list
56832171|NCT01074996|Antidotes|antidotes|mesh-ancestor
56832172|NCT01074996|Protective Agents|protective agents|mesh-ancestor
56832173|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832174|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
56832175|NCT01074996|Vitamins|vitamins|mesh-ancestor
56832176|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
56832177|NCT00160680|Levocetirizine|levocetirizine|mesh-list
56832178|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56832179|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56832180|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
56832181|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
56832182|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832183|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832184|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832185|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
56832186|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832187|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
56832188|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832189|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832190|NCT01077570|Repaglinide|repaglinide|mesh-list
56832191|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56832192|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832193|NCT01075698|Telmisartan|telmisartan|mesh-list
56832194|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56832195|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56832196|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56832197|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832198|NCT00159822|Voriconazole|voriconazole|mesh-list
56832199|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
56832200|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832201|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56832202|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56832203|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543035|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
56832204|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832205|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56832206|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
56832207|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56832208|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832209|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56832210|NCT00158262|Propranolol|propranolol|mesh-list
56832211|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56832212|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56832213|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
56832214|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832215|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832216|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832217|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56832218|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56832219|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
56832220|NCT03868072|Tofacitinib|tofacitinib|mesh-list
56832221|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56832222|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832223|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832224|NCT02526394|Vaccines|vaccines|mesh-list
56832225|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
56832226|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832227|NCT01283932|Pantoprazole|pantoprazole|mesh-list
56832228|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56832229|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832230|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56832231|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832232|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832233|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56832234|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832235|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832237|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56832238|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832239|NCT01171378|Ofatumumab|ofatumumab|mesh-list
56832240|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832241|NCT01171456|Metformin|metformin|mesh-list
56832242|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56832243|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832244|NCT03865888|Cyclosporine|cyclosporine|mesh-list
56832245|NCT03865888|Tacrolimus|tacrolimus|mesh-list
56832246|NCT03865888|Cyclosporins|cyclosporins|mesh-list
56832247|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832248|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
56832249|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832250|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56832251|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832252|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832253|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
56832254|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832255|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
56832256|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832257|NCT01284166|Timolol|timolol|mesh-list
56832258|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56832259|NCT01284166|Dorzolamide|dorzolamide|mesh-list
56832260|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56832261|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56832262|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56832263|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56832264|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
56832265|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832266|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832267|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832268|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56832269|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56832270|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56832271|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56832272|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56832273|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56832274|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832275|NCT01285414|Temozolomide|temozolomide|mesh-list
56832276|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56832277|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
56832278|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832279|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832280|NCT01172002|Azathioprine|azathioprine|mesh-list
56832281|NCT01172002|Leflunomide|leflunomide|mesh-list
56832282|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
56832283|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832284|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56832285|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832286|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832287|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
56832288|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832289|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832290|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832291|NCT03867994|Carvedilol|carvedilol|mesh-list
56832292|NCT03867994|Atorvastatin|atorvastatin|mesh-list
56832293|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56832294|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56832295|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
56832296|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832297|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56832298|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56832299|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832300|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56832301|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56832302|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
56832303|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832304|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832305|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56832306|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
56832307|NCT03867994|Protective Agents|protective agents|mesh-ancestor
56832308|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56832309|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346700|NCT00176449|Bupropion|bupropion|mesh-list
56832310|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56832311|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
56832312|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56832313|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56832315|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832316|NCT02525848|Dexamethasone|dexamethasone|mesh-list
56832317|NCT02525848|Gabapentin|gabapentin|mesh-list
56832318|NCT02525848|Aprepitant|aprepitant|mesh-list
56832319|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832320|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
56832321|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
56832322|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832323|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832324|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832325|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
56832326|NCT02525848|Hormones|hormones|mesh-ancestor
56832327|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56832328|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56832329|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832330|NCT02525848|Analgesics|analgesics|mesh-ancestor
56832331|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
56832332|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
56832333|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56832334|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56832335|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832336|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56832337|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56832338|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56832339|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832340|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832341|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
56832342|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56832343|NCT01269112|Citric Acid|citric acid|mesh-list
56832344|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
56832345|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
56832346|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56832347|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
56832348|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
56832349|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832350|NCT01174420|Mitomycins|mitomycins|mesh-list
56832351|NCT01174420|Mitomycin|mitomycin|mesh-list
56832352|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56832353|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832354|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
56543204|NCT02701933|Ketamine|ketamine|mesh-list
56832355|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832356|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56832357|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832359|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56832360|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56832361|NCT01164826|Analgesics|analgesics|mesh-ancestor
56832362|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
56832363|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832364|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832365|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832366|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832367|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56832368|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56832369|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832370|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832371|NCT03867370|Lenvatinib|lenvatinib|mesh-list
56832372|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832373|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56832374|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832375|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832376|NCT03867214|Tranexamic Acid|tranexamic acid|mesh-list
56832377|NCT03867214|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56832378|NCT03867214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56832379|NCT03867214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832380|NCT03867214|Hemostatics|hemostatics|mesh-ancestor
56832381|NCT03867214|Coagulants|coagulants|mesh-ancestor
56832382|NCT01172392|Interferons|interferons|mesh-list
56832383|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
56832384|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
56832385|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56832386|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832387|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
56832388|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832389|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
56832390|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832392|NCT01172470|Carboplatin|carboplatin|mesh-list
56832393|NCT01172470|Pemetrexed|pemetrexed|mesh-list
56832394|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832395|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56832396|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
56832397|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832398|NCT01172470|Antiviral Agents|antiviral agents|mesh-ancestor
56832399|NCT01172470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832400|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832401|NCT01172470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832402|NCT01172470|Immunologic Factors|immunologic factors|mesh-ancestor
56832403|NCT01172470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832404|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56832405|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56832406|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
56832407|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56832408|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832409|NCT03864016|Sufentanil|sufentanil|mesh-list
56832410|NCT03864016|Dsuvia|dsuvia|mesh-list
56832411|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
56832412|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832413|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832414|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56832415|NCT03864016|Narcotics|narcotics|mesh-ancestor
56832416|NCT03864016|Analgesics|analgesics|mesh-ancestor
56832417|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
56832418|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832419|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56832420|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56832421|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
56832422|NCT03860662|Baclofen|baclofen|mesh-list
56832423|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56832424|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832425|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56832426|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832427|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56832428|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
56832429|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
56832430|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832431|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832432|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
56832433|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
56832434|NCT01177852|Promethazine|promethazine|mesh-list
56832435|NCT01177852|Brompheniramine|brompheniramine|mesh-list
56832436|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
56832437|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
56832439|NCT01177852|Dipropizine|dipropizine|mesh-list
56832440|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832441|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56832442|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56832443|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832444|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832445|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
56832446|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
56832447|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
56832448|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832449|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
56832450|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
56832451|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832452|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56832453|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
56832454|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
56832455|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832456|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56832457|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
56832458|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56832459|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56832460|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56832461|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
56557647|NCT01148771|Ertapenem|ertapenem|mesh-list
56832464|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56832465|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
56832466|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
56832467|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
56832468|NCT03863392|Misoprostol|misoprostol|mesh-list
56832469|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56832470|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
56832471|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56832472|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832473|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56832474|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832475|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
56832476|NCT01175200|Lansoprazole|lansoprazole|mesh-list
56832477|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
56832478|NCT01175200|Clopidogrel|clopidogrel|mesh-list
56832479|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56832480|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56832481|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56832482|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56832483|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56832484|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
56832485|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832486|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832487|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832488|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56832489|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832490|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56832491|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832492|NCT03863626|Furosemide|furosemide|mesh-list
56832493|NCT03863626|Diuretics|diuretics|mesh-ancestor
56832494|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
56832495|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832496|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56832497|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56832498|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832499|NCT01288378|Caspofungin|caspofungin|mesh-list
56832500|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
56832501|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832502|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832503|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832504|NCT01178320|Niacin|niacin|mesh-list
56832505|NCT01178320|Niacinamide|niacinamide|mesh-list
56832506|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
56832507|NCT01178320|Simvastatin|simvastatin|mesh-list
56832508|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56832509|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56832510|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
56832511|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832512|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56832513|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56832514|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832515|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
56832516|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
56832517|NCT01178320|Vitamins|vitamins|mesh-ancestor
56832518|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
56832519|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832520|NCT01175512|Naltrexone|naltrexone|mesh-list
56832521|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56832522|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56832523|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832524|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
56832525|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832526|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
56832527|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56832528|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832529|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832530|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56832531|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56832532|NCT03859570|Protective Agents|protective agents|mesh-ancestor
56832533|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832534|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
56832536|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
56832537|NCT01286584|Varenicline|varenicline|mesh-list
56832538|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56832539|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56832540|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
56832541|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832542|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832543|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832544|NCT03743038|Minocycline|minocycline|mesh-list
56832545|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56832546|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832547|NCT03864250|Prednisone|prednisone|mesh-list
56832548|NCT03864250|Tacrolimus|tacrolimus|mesh-list
56832549|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832550|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
56832551|NCT03864250|Hormones|hormones|mesh-ancestor
56832552|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56832553|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832554|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56832555|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832556|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832557|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
56832558|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56832559|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832560|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832561|NCT01175746|Nicardipine|nicardipine|mesh-list
56832562|NCT01175746|Remifentanil|remifentanil|mesh-list
56832563|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56832564|NCT01175746|Narcotics|narcotics|mesh-ancestor
56832565|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832566|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832567|NCT01175746|Analgesics|analgesics|mesh-ancestor
56832568|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
56832569|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832570|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56832571|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56832572|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56832573|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832574|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56832575|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
56832576|NCT01174810|Exenatide|exenatide|mesh-list
56832577|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56832578|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832579|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56832580|NCT01174810|Incretins|incretins|mesh-ancestor
56832581|NCT01174810|Hormones|hormones|mesh-ancestor
56832582|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56832584|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56832585|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56832586|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
56832587|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832588|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56832589|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56832590|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832591|NCT01174888|Cytarabine|cytarabine|mesh-list
56832592|NCT01174888|Etoposide|etoposide|mesh-list
56832593|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
56832594|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
56832595|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
56832596|NCT01174888|Bortezomib|bortezomib|mesh-list
56832597|NCT01174888|Midostaurin|midostaurin|mesh-list
56832598|NCT01174888|Staurosporine|staurosporine|mesh-list
56832599|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56832600|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832601|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56832602|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56832603|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832604|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832605|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56832606|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
56832607|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
56832608|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832609|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832610|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
56832612|NCT01174888|Analgesics|analgesics|mesh-ancestor
56832613|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
56832614|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832615|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
56832616|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
56832617|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56832618|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56832619|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56832620|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56832621|NCT01178788|Progesterone|progesterone|mesh-list
56832622|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56832623|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56832624|NCT01178788|Progestins|progestins|mesh-ancestor
56832625|NCT01178788|Hormones|hormones|mesh-ancestor
56832626|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56832627|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832628|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56832629|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
56832630|NCT00153816|Vitamin D|vitamin d|mesh-list
56832631|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
56832632|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
56832633|NCT00153816|Calcium|calcium|mesh-list
56832634|NCT00153816|Vitamins|vitamins|mesh-ancestor
56832635|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
56832636|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832637|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56832638|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56832639|NCT00153816|Antacids|antacids|mesh-ancestor
56832640|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832641|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832642|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56832643|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
56832644|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832645|NCT01077648|Trastuzumab|trastuzumab|mesh-list
56832646|NCT01077648|Lapatinib|lapatinib|mesh-list
56832647|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56832648|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832649|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56832650|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832651|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832652|NCT00151476|Celecoxib|celecoxib|mesh-list
56832653|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56832654|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56832655|NCT00151476|Analgesics|analgesics|mesh-ancestor
56832656|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
56832657|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832658|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543484|NCT02700217|Heroin|heroin|mesh-list
56832660|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832661|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56832662|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56832663|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832664|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832665|NCT01077726|Capecitabine|capecitabine|mesh-list
56832666|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56832667|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
56832668|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832669|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832670|NCT01179100|Lidocaine|lidocaine|mesh-list
56832671|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
56832672|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
56832673|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832674|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832675|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
56832676|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832677|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56832678|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56832679|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56832680|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56832681|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832682|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
56832683|NCT03864172|Calcium|calcium|mesh-list
56557651|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56832684|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56832685|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832686|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56832688|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832689|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
56832690|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56832691|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56832692|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832693|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56832694|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832695|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832696|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56832697|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56832698|NCT02525302|Growth Substances|growth substances|mesh-ancestor
56832699|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832700|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
56832701|NCT01286194|Rabeprazole|rabeprazole|mesh-list
56832702|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56832703|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832704|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56832705|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832706|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832707|NCT01179256|Curcumin|curcumin|mesh-list
56832708|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56832709|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56832710|NCT01179256|Analgesics|analgesics|mesh-ancestor
56832711|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
56832712|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832713|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832714|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832715|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832716|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832717|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832718|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832719|NCT01179412|Iodine|iodine|mesh-list
56832720|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
56832721|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
56832722|NCT01179412|Povidone|povidone|mesh-list
56832723|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56832724|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832725|NCT01179412|Trace Elements|trace elements|mesh-ancestor
56832726|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
56832727|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832728|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
56832729|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
56832730|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56832731|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56832732|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832734|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
56832735|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832736|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56832737|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56832738|NCT03862768|Growth Substances|growth substances|mesh-ancestor
56832739|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832740|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
56832741|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56832742|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832743|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832744|NCT03862456|Azithromycin|azithromycin|mesh-list
56832745|NCT03862456|Metronidazole|metronidazole|mesh-list
56832746|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56832747|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832748|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56832749|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56832750|NCT03859102|Acetaminophen|acetaminophen|mesh-list
56832751|NCT03859102|Dexamethasone|dexamethasone|mesh-list
56832752|NCT03859102|Gabapentin|gabapentin|mesh-list
56832753|NCT03859102|Ondansetron|ondansetron|mesh-list
56832754|NCT03859102|Anesthetics|anesthetics|mesh-list
56832755|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
56832756|NCT03859102|Lansoprazole|lansoprazole|mesh-list
56832757|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
56832758|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832759|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
56832760|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
56832761|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832762|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832764|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
56832765|NCT03859102|Hormones|hormones|mesh-ancestor
56832766|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56832767|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56832768|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832769|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56832770|NCT03859102|Analgesics|analgesics|mesh-ancestor
56832771|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
56832772|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
56832773|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832774|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
56832775|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56832776|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56832777|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56832778|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56832779|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56832780|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832781|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832782|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
56832783|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
56832784|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
56832785|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56832786|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
56832787|NCT03859102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56832788|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56832789|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56832790|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832791|NCT00149994|Cyclosporine|cyclosporine|mesh-list
56832792|NCT00149994|Prednisone|prednisone|mesh-list
56832793|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
56832794|NCT00149994|Tacrolimus|tacrolimus|mesh-list
56832795|NCT00149994|Cyclosporins|cyclosporins|mesh-list
56832796|NCT00149994|Basiliximab|basiliximab|mesh-list
56832797|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832798|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
56832799|NCT00149994|Hormones|hormones|mesh-ancestor
56894842|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832800|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56832801|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832802|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56832803|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832804|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832805|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
56832806|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56832807|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832808|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832809|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
56832810|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832811|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
56832812|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832813|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
56832814|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
56832815|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832816|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832817|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56832818|NCT00149994|Protective Agents|protective agents|mesh-ancestor
56832819|NCT01179646|Pantoprazole|pantoprazole|mesh-list
56832820|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56832821|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832822|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56832823|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832824|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832825|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
56832826|NCT01075776|Acetylcholine|acetylcholine|mesh-list
56832827|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
56832828|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56832829|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
56832830|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832831|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832832|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832833|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
56832834|NCT01079910|Fluorides|fluorides|mesh-list
56832835|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
56832836|NCT01079910|Protective Agents|protective agents|mesh-ancestor
56832839|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832840|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56832841|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56832842|NCT01286896|Growth Substances|growth substances|mesh-ancestor
56832843|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832844|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56832845|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56832846|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832847|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832848|NCT03857854|Pirfenidone|pirfenidone|mesh-list
56832849|NCT03857854|Analgesics|analgesics|mesh-ancestor
56832850|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
56832851|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832852|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832853|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56832854|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56832855|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832856|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832857|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832858|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
56832859|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56832860|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
56832861|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
56832862|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832863|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832864|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56832865|NCT01287052|Analgesics|analgesics|mesh-ancestor
56832866|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
56832867|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832868|NCT01288924|Parecoxib|parecoxib|mesh-list
56832869|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56832870|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56832871|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832872|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832873|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56832874|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56832875|NCT01288924|Analgesics|analgesics|mesh-ancestor
56832876|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
56832877|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832878|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832879|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832880|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832881|NCT01179724|Pantoprazole|pantoprazole|mesh-list
56832882|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56543715|NCT01204697|Docetaxel|docetaxel|mesh-list
56832883|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56832884|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832885|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832886|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832887|NCT03862612|Anesthetics|anesthetics|mesh-list
56832888|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832889|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832891|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56832892|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832893|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
56832894|NCT00149214|Docetaxel|docetaxel|mesh-list
56832895|NCT00149214|Doxorubicin|doxorubicin|mesh-list
56832896|NCT00149214|Pemetrexed|pemetrexed|mesh-list
56832897|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832898|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
56832899|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832900|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56832901|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56832902|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
56832903|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832904|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832905|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56832906|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
56832907|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
56832908|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
56832909|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56832910|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56832911|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56832912|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832913|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56832914|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56832915|NCT03034018|Suvorexant|suvorexant|mesh-list
56832916|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56832917|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56832918|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56832919|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832920|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56832921|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832922|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832923|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56832924|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
56832925|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56832926|NCT02525458|Protective Agents|protective agents|mesh-ancestor
56832927|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832928|NCT02555254|Methamphetamine|methamphetamine|mesh-list
56832929|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56832930|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832931|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
56832932|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
56832933|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832934|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
56832935|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56832936|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832937|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
56832938|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56832939|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56832940|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56832941|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56832942|NCT00114972|Paclitaxel|paclitaxel|mesh-list
56832943|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56832944|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56832945|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832946|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
56832947|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
56832948|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
56832949|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832950|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
56832951|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
56832952|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
56832953|NCT02444728|Azathioprine|azathioprine|mesh-list
56832954|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56832955|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
56832956|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56832957|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56543777|NCT04212403|Levofloxacin|levofloxacin|mesh-list
56832958|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56832959|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
56832960|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832961|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56832962|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56832963|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832964|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
56832965|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
56832966|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56832967|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56832968|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
56832969|NCT02444728|Hormones|hormones|mesh-ancestor
56832970|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56832971|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56832972|NCT02444728|Protective Agents|protective agents|mesh-ancestor
56832973|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
56832974|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56832975|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56832976|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56832977|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832978|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
56832979|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56832980|NCT00129402|Simvastatin|simvastatin|mesh-list
56832981|NCT00129402|Ezetimibe|ezetimibe|mesh-list
56832982|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56832983|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56832984|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
56832985|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56832986|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56832987|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56832988|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56832989|NCT03739528|Levofloxacin|levofloxacin|mesh-list
56832991|NCT03739528|Tobramycin|tobramycin|mesh-list
56832992|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56832993|NCT03739528|Dexamethasone|dexamethasone|mesh-list
56832994|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
56832995|NCT03739528|BB 1101|bb 1101|mesh-list
56832996|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56832997|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
56832998|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
56832999|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833000|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833001|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56833002|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
56833003|NCT03739528|Hormones|hormones|mesh-ancestor
56833004|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56833005|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56833006|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833007|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
56833008|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833009|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833010|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56833011|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833012|NCT03739528|Renal Agents|renal agents|mesh-ancestor
56833013|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56833014|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56833015|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56833016|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56833017|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56833018|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56833019|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56833020|NCT03857386|Anesthetics|anesthetics|mesh-list
56833021|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833022|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833023|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56833024|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
56833025|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833026|NCT01289236|Milnacipran|milnacipran|mesh-list
56833027|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
56833028|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56833029|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56833030|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833031|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543853|NCT00619333|Hormones|hormones|mesh-ancestor
56833032|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833033|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833034|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56833035|NCT01289236|Analgesics|analgesics|mesh-ancestor
56833036|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
56833037|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833038|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
56833039|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56833040|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
56833041|NCT01289938|Promethazine|promethazine|mesh-list
56833042|NCT01289938|Metoclopramide|metoclopramide|mesh-list
56833043|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56833044|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56833045|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833046|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833047|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
56833048|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
56833049|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
56833050|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833051|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
56833052|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
56833053|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56833054|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56833055|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
56833056|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
56347440|NCT00183001|Vitamin K|vitamin k|mesh-list
56833058|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833059|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56833060|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
56833061|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
56833062|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56833063|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56833064|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
56833065|NCT00114738|Rituximab|rituximab|mesh-list
56833066|NCT00114738|Bortezomib|bortezomib|mesh-list
56833067|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56833068|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833069|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
56833070|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833071|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833072|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
56833073|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56833074|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56833075|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56833076|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833077|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833078|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
56833079|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833080|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833081|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56833082|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833083|NCT01180426|Tosedostat|tosedostat|mesh-list
56833084|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833085|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833086|NCT00148122|Docetaxel|docetaxel|mesh-list
56833087|NCT00148122|Capecitabine|capecitabine|mesh-list
56833088|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833089|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
56833090|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
56833091|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
56833092|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833093|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56833094|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
56833095|NCT01182142|Capecitabine|capecitabine|mesh-list
56833096|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56833097|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
56833098|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833099|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833100|NCT01180816|Temozolomide|temozolomide|mesh-list
56833101|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56833102|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
56833103|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833104|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543943|NCT00618397|Ketamine|ketamine|mesh-list
56833105|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
56833106|NCT01287598|Midazolam|midazolam|mesh-list
56833107|NCT01287598|Omeprazole|omeprazole|mesh-list
56833108|NCT01287598|Warfarin|warfarin|mesh-list
56833109|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56833110|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56833111|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833112|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833113|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56833114|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56833115|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56833116|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56833117|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
56833118|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
56833119|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
56833120|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
56833121|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833122|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833123|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
56833124|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56833125|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56833126|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56833127|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833128|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56833129|NCT03862144|Palonosetron|palonosetron|mesh-list
56833130|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
56833131|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
56833132|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833133|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833134|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56833135|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56833136|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56833138|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833139|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833140|NCT01290172|Somatostatin|somatostatin|mesh-list
56833141|NCT01290172|Hormones|hormones|mesh-ancestor
56833142|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56833143|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833144|NCT03861598|Carvedilol|carvedilol|mesh-list
56833145|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56833146|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56833147|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
56833148|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833149|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833150|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833151|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56833152|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
56833153|NCT03861598|Protective Agents|protective agents|mesh-ancestor
56833154|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56833155|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833156|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56833157|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
56833158|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56833159|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56833160|NCT01184482|Cetuximab|cetuximab|mesh-list
56833161|NCT01184482|Lapatinib|lapatinib|mesh-list
56833162|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56833163|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833164|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56833165|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833166|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833167|NCT01184560|Orlistat|orlistat|mesh-list
56833168|NCT01184560|Sibutramine|sibutramine|mesh-list
56833169|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833170|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833171|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56833172|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56833173|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
56833174|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56833175|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
56833176|NCT01184638|Propofol|propofol|mesh-list
56833177|NCT01184638|Sevoflurane|sevoflurane|mesh-list
56833178|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56833179|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833180|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833181|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56833182|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
56833183|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
56833184|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56833185|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56833186|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
56833187|NCT01290328|Hematinics|hematinics|mesh-ancestor
56833188|NCT01184716|Vitamin D|vitamin d|mesh-list
56833189|NCT01184716|Vitamins|vitamins|mesh-ancestor
56833190|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
56833191|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833192|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56833193|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
56833194|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
56833195|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
56833196|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833197|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833198|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
56833199|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833200|NCT01587508|Meloxicam|meloxicam|mesh-list
56833201|NCT01587508|Amitriptyline|amitriptyline|mesh-list
56833202|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
56833203|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56833204|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56833205|NCT01587508|Analgesics|analgesics|mesh-ancestor
56833206|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
56833207|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833208|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833209|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833210|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833211|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56833212|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56833213|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833214|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833215|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56833216|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
56833217|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56833218|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56833219|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56833220|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56833221|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833222|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56894843|NCT03909477|Xenon|xenon|mesh-list
56833223|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56833224|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833225|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
56833226|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833227|NCT00147498|Tofacitinib|tofacitinib|mesh-list
56833228|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56833229|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833230|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833231|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56833232|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
56833233|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833234|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833235|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56833236|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833238|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56833239|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833240|NCT01185184|Tofacitinib|tofacitinib|mesh-list
56833241|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56833242|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833243|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833244|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
56833245|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56833246|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56833247|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833248|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
56833249|NCT00113568|Coagulants|coagulants|mesh-ancestor
56833250|NCT01185262|Rituximab|rituximab|mesh-list
56833251|NCT01185262|Lenalidomide|lenalidomide|mesh-list
56833252|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56833253|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833254|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
56833255|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833256|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833257|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56833258|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56833259|NCT01185262|Growth Substances|growth substances|mesh-ancestor
56833260|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56833261|NCT00113490|Palivizumab|palivizumab|mesh-list
56833262|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
56833263|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833264|NCT00146640|Prednisone|prednisone|mesh-list
56833265|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833266|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
56833267|NCT00146640|Hormones|hormones|mesh-ancestor
56833268|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56833269|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833270|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56833271|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833272|NCT01185418|Haloperidol|haloperidol|mesh-list
56833273|NCT01185418|Risperidone|risperidone|mesh-list
56833274|NCT01185418|Aripiprazole|aripiprazole|mesh-list
56833275|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
56833276|NCT01185418|Amisulpride|amisulpride|mesh-list
56833277|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56833278|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
56833279|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833280|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833281|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833282|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56833283|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56833284|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833285|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56833286|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56833288|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
56833289|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
56833290|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56833291|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56833292|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56833293|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56833294|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
56833295|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
56833296|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833297|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56833298|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56833299|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56833300|NCT01185574|Vitamin D|vitamin d|mesh-list
56833301|NCT01185574|Vitamins|vitamins|mesh-ancestor
56833302|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
56833303|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833304|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56833305|NCT03861364|Propofol|propofol|mesh-list
56833306|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56833307|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833308|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833309|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56833310|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
56833311|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
56833312|NCT01185808|Vitamin D|vitamin d|mesh-list
56833313|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
56833314|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
56833315|NCT01185808|Vitamins|vitamins|mesh-list
56833316|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
56833317|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833318|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56833319|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56833320|NCT01183624|Analgesics|analgesics|mesh-list
56833321|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
56833322|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833323|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833324|NCT01291186|Epinephrine|epinephrine|mesh-list
56833325|NCT01291186|Racepinephrine|racepinephrine|mesh-list
56833326|NCT01291186|Bupivacaine|bupivacaine|mesh-list
56833327|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
56833328|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
56833329|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
56833330|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833331|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833332|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
56833333|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833334|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56833335|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56833336|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
56833337|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833338|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833339|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56833340|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56833341|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
56833342|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56833343|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
56833344|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
56833345|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
56833346|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56833347|NCT04979338|Bupivacaine|bupivacaine|mesh-list
56833348|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
56833349|NCT04979338|Anesthetics|anesthetics|mesh-list
56833350|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833351|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833352|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
56833353|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833354|NCT01177306|Guanfacine|guanfacine|mesh-list
56833355|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56833356|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56833359|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
56833360|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833361|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833362|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833363|NCT01290406|Dactolisib|dactolisib|mesh-list
56833364|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833365|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
56833366|NCT03854812|Fentanyl|fentanyl|mesh-list
56833367|NCT03854812|Propofol|propofol|mesh-list
56833368|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56833369|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833370|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833371|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56833372|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
56833373|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
56440530|NCT00263393|Atenolol|atenolol|mesh-list
56833374|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56833375|NCT03854812|Narcotics|narcotics|mesh-ancestor
56833376|NCT03854812|Analgesics|analgesics|mesh-ancestor
56833377|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
56833378|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833379|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56833380|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56833381|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
56833382|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56833383|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833384|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833385|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56833386|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
56833387|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56833388|NCT01186120|Umirolimus|umirolimus|mesh-list
56833389|NCT01186120|Everolimus|everolimus|mesh-list
56833390|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833391|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56833392|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
56833393|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833394|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833395|NCT03855826|Amiodarone|amiodarone|mesh-list
56833396|NCT03855826|Nifekalant|nifekalant|mesh-list
56833397|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56833398|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
56833399|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56833400|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833401|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833402|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56833403|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56833404|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56833405|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833406|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56833407|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56833408|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56544222|NCT05662189|Incretins|incretins|mesh-ancestor
56833409|NCT01184404|Bosentan|bosentan|mesh-list
56833410|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56833411|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56833412|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833413|NCT01186588|Canagliflozin|canagliflozin|mesh-list
56833414|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56833415|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833416|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56833417|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833418|NCT03854266|Heparin|heparin|mesh-list
56833419|NCT03854266|Calcium heparin|calcium heparin|mesh-list
56833420|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56833421|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
56833422|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56833423|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56833424|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833425|NCT01187992|Atorvastatin|atorvastatin|mesh-list
56833426|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56833427|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56833428|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
56833429|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833431|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56833432|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833433|NCT01191034|Imiquimod|imiquimod|mesh-list
56833434|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56833435|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
56833436|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833437|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833438|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
56833439|NCT01188148|Memantine|memantine|mesh-list
56833440|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56833441|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56833442|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
56833443|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894844|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56833444|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833445|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833446|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56833447|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56833448|NCT03852628|Naltrexone|naltrexone|mesh-list
56833449|NCT03852628|Buprenorphine|buprenorphine|mesh-list
56833450|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56833451|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56833452|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833453|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
56833454|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833455|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56833456|NCT03852628|Narcotics|narcotics|mesh-ancestor
56833457|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833458|NCT03852628|Analgesics|analgesics|mesh-ancestor
56833459|NCT01187212|Cisplatin|cisplatin|mesh-list
56833460|NCT01187212|Capecitabine|capecitabine|mesh-list
56833461|NCT01187212|Sorafenib|sorafenib|mesh-list
56833462|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833463|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56833464|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
56833465|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833466|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56833467|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833468|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
56833469|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56833470|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
56833471|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
56833472|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833473|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833474|NCT03849508|Phenylephrine|phenylephrine|mesh-list
56833475|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
56833476|NCT03849508|Norepinephrine|norepinephrine|mesh-list
56833477|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56833478|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
56833479|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
56833480|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833481|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833482|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
56833483|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56833484|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
56544305|NCT05368051|Antibodies|antibodies|mesh-list
56833485|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
56833486|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56833487|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56833488|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56833489|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
56833490|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833491|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833492|NCT03849508|Protective Agents|protective agents|mesh-ancestor
56833493|NCT03849664|Riboflavin|riboflavin|mesh-list
56833494|NCT03849664|Niacinamide|niacinamide|mesh-list
56833495|NCT03849664|Niacin|niacin|mesh-list
56833496|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
56833497|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
56833498|NCT03849664|Povidone|povidone|mesh-list
56833499|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56833500|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833501|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
56833502|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
56833503|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
56833504|NCT03849664|Vitamins|vitamins|mesh-ancestor
56833505|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
56833506|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56833507|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
56833508|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56833509|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
56833510|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833511|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56833512|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
56833513|NCT04912492|Ethanol|ethanol|mesh-list
56833514|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56833515|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833516|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833517|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833518|NCT01293838|Citalopram|citalopram|mesh-list
56833519|NCT01293838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56833520|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56833521|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833522|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833523|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833524|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
56833525|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833526|NCT01293838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56833527|NCT01293838|Antidepressive Agents|antidepressive agents|mesh-ancestor
56833528|NCT01293838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56833529|NCT01188304|Aspirin|aspirin|mesh-list
56833530|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56833531|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56833532|NCT01188304|Analgesics|analgesics|mesh-ancestor
56833533|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
56833534|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833535|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833536|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833537|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833538|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56833539|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56833540|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833541|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56833542|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56833543|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833544|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
56833545|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
56833546|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
56833547|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56833548|NCT02524444|Mefloquine|mefloquine|mesh-list
56833549|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
56833550|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56833551|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56833552|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833553|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56833554|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833555|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833556|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56833557|NCT02524444|Renal Agents|renal agents|mesh-ancestor
56833558|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
56833559|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56544373|NCT04205643|Infliximab|infliximab|mesh-list
56833560|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
56833561|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833562|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833563|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56833564|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
56833565|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56833566|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
56833567|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833568|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833569|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56833570|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
56833571|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
56833572|NCT03853642|Protective Agents|protective agents|mesh-ancestor
56833574|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
56833575|NCT02296918|Venetoclax|venetoclax|mesh-list
56833576|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
56833577|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56833578|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833579|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
56833582|NCT01294072|Curcumin|curcumin|mesh-list
56833583|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56833584|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56833585|NCT01294072|Analgesics|analgesics|mesh-ancestor
56833586|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
56833587|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833588|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833589|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833590|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833591|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833592|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833593|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833594|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
56833595|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56833596|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
56833597|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833598|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833599|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56833600|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
56833601|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56833602|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56833603|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56833604|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
56833605|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833606|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833607|NCT01291654|Acetaminophen|acetaminophen|mesh-list
56833608|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56833609|NCT01291654|Analgesics|analgesics|mesh-ancestor
56833610|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
56833611|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833612|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833613|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
56833614|NCT03853096|Cefazolin|cefazolin|mesh-list
56833615|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56833616|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833617|NCT05671276|Aspirin|aspirin|mesh-list
56833618|NCT05671276|Rivaroxaban|rivaroxaban|mesh-list
56833619|NCT05671276|Clopidogrel|clopidogrel|mesh-list
56833620|NCT05671276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56833621|NCT05671276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56833622|NCT05671276|Analgesics|analgesics|mesh-ancestor
56833623|NCT05671276|Sensory System Agents|sensory system agents|mesh-ancestor
56833624|NCT05671276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833625|NCT05671276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833626|NCT05671276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833627|NCT05671276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833628|NCT05671276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56833629|NCT05671276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56833630|NCT05671276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833631|NCT05671276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56833632|NCT05671276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56833633|NCT05671276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544448|NCT02605993|Ravulizumab|ravulizumab|mesh-list
56833634|NCT05671276|Antipyretics|antipyretics|mesh-ancestor
56833635|NCT05671276|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56833636|NCT05671276|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56833637|NCT05671276|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56833638|NCT05671276|Purinergic Agents|purinergic agents|mesh-ancestor
56833639|NCT05671276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833640|NCT05671276|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56833641|NCT05671276|Antithrombins|antithrombins|mesh-ancestor
56833642|NCT05671276|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56833643|NCT05671276|Protease Inhibitors|protease inhibitors|mesh-ancestor
56833644|NCT05671276|Anticoagulants|anticoagulants|mesh-ancestor
56833645|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56833646|NCT03852160|Mirtazapine|mirtazapine|mesh-list
56833647|NCT03852160|Trazodone|trazodone|mesh-list
56833648|NCT03852160|S 20098|s 20098|mesh-list
56833649|NCT03852160|Citalopram|citalopram|mesh-list
56833650|NCT03852160|Bupropion|bupropion|mesh-list
56833651|NCT03852160|Sertraline|sertraline|mesh-list
56833652|NCT03852160|Esketamine|esketamine|mesh-list
56833653|NCT03852160|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56833654|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56833656|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833657|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833658|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
56833659|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833660|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56833661|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
56833662|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56833663|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833664|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56833665|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
56833666|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56833667|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56833668|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833669|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56833670|NCT03852160|Analgesics|analgesics|mesh-ancestor
56833671|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
56833672|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56833673|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
56833674|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
56833675|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56833676|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56833677|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833678|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56833679|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56833680|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56833681|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
56833682|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56833683|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56833684|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56833685|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56833686|NCT02524210|Omeprazole|omeprazole|mesh-list
56833687|NCT02524210|Rabeprazole|rabeprazole|mesh-list
56833688|NCT02524210|Dabigatran|dabigatran|mesh-list
56833689|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56833690|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56833691|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56833692|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833693|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833694|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
56833695|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56833696|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
56833697|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
56833698|NCT03847792|Dexamethasone|dexamethasone|mesh-list
56833699|NCT03847792|Fentanyl|fentanyl|mesh-list
56833700|NCT03847792|Bupivacaine|bupivacaine|mesh-list
56833701|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833702|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
56833703|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
56833704|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833705|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833706|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56833707|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
56544523|NCT04360681|Lofexidine|lofexidine|mesh-list
56833708|NCT03847792|Hormones|hormones|mesh-ancestor
56833709|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56833710|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56833711|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833712|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
56833713|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
56833714|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833715|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
56833716|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56833717|NCT03847792|Narcotics|narcotics|mesh-ancestor
56833718|NCT03847792|Analgesics|analgesics|mesh-ancestor
56833719|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56833720|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56833721|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
56833722|NCT01294618|Interferons|interferons|mesh-list
56833723|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833724|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
56833725|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833726|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
56833727|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
56833729|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56833730|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833731|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833732|NCT01194232|Urological Agents|urological agents|mesh-ancestor
56833733|NCT01296334|Morphine|morphine|mesh-list
56833734|NCT01296334|Buprenorphine|buprenorphine|mesh-list
56833735|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56833736|NCT01296334|Narcotics|narcotics|mesh-ancestor
56833737|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833738|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833739|NCT01296334|Analgesics|analgesics|mesh-ancestor
56833740|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
56833741|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833742|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56833743|NCT03847558|Hormones|hormones|mesh-list
56833744|NCT03847558|Testosterone|testosterone|mesh-list
56833745|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56833746|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56833747|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833748|NCT03847558|Androgens|androgens|mesh-ancestor
56833749|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
56833750|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
56833751|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
56833752|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56833753|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56833754|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833755|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833756|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833757|NCT01292356|Cetuximab|cetuximab|mesh-list
56833758|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56833759|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833760|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56833761|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
56833762|NCT03847246|Entecavir|entecavir|mesh-list
56833763|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
56833764|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833765|NCT03849196|Bisacodyl|bisacodyl|mesh-list
56833766|NCT03849196|Cathartics|cathartics|mesh-ancestor
56833767|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56833768|NCT03849196|Laxatives|laxatives|mesh-ancestor
56833769|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56833770|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56833771|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56833772|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
56833773|NCT01296802|Fenfluramine|fenfluramine|mesh-list
56833774|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
56833775|NCT01296802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56833776|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56833777|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833778|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833779|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833780|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
56833781|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833782|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56833783|NCT01296958|Niclosamide|niclosamide|mesh-list
56833784|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
56833785|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56833786|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
56833787|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56833788|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833789|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
56833790|NCT01295086|Docetaxel|docetaxel|mesh-list
56833791|NCT01295086|Capecitabine|capecitabine|mesh-list
56833792|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
56833793|NCT01295086|Trastuzumab|trastuzumab|mesh-list
56833794|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833795|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
56833796|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
56833797|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
56833798|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833799|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56833800|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
56894845|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
56833801|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56833802|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56833804|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
56833805|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833806|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833807|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56833808|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
56833809|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
56833810|NCT01194700|Hormones|hormones|mesh-ancestor
56833811|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56833812|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
56833813|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56833814|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
56833815|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56833816|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56833817|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56833818|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833819|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833820|NCT01194778|Vitamins|vitamins|mesh-list
56833821|NCT01194778|Vitamin K|vitamin k|mesh-list
56833822|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
56833823|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
56833824|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
56833825|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833826|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56833827|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56833828|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833829|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
56833830|NCT01194778|Coagulants|coagulants|mesh-ancestor
56833831|NCT01194934|Lenograstim|lenograstim|mesh-list
56833832|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56833833|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
56833834|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833835|NCT01297036|Donepezil|donepezil|mesh-list
56833836|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56833837|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833838|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833839|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
56833840|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56833841|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833842|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
56833843|NCT03848806|Calcitriol|calcitriol|mesh-list
56833844|NCT03848806|Calcipotriene|calcipotriene|mesh-list
56833845|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
56833846|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56833847|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833848|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56833849|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56833850|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833851|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56833852|NCT03848806|Vitamins|vitamins|mesh-ancestor
56833853|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
56833854|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56833855|NCT03737110|Rilonacept|rilonacept|mesh-list
56833856|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833857|NCT01189864|Diclofenac|diclofenac|mesh-list
56833858|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
56833859|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56833860|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
56833861|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56833862|NCT01189864|Prednisolone|prednisolone|mesh-list
56833863|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56833864|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
56833865|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56833866|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56833868|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
56833869|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833870|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833871|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833872|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833873|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56833874|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833875|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833876|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
56833877|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
56833878|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56833880|NCT01189864|Hormones|hormones|mesh-ancestor
56833881|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56833882|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56833883|NCT01189864|Protective Agents|protective agents|mesh-ancestor
56833884|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56833885|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833886|NCT01195246|Vaccines|vaccines|mesh-list
56833887|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
56833888|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833889|NCT01191892|Gemcitabine|gemcitabine|mesh-list
56833890|NCT01191892|Carboplatin|carboplatin|mesh-list
56833891|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833892|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56833893|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
56833894|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833895|NCT01191892|Antiviral Agents|antiviral agents|mesh-ancestor
56833896|NCT01191892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56833897|NCT01191892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833898|NCT01191892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56833899|NCT01191892|Immunologic Factors|immunologic factors|mesh-ancestor
56833900|NCT01191892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833901|NCT05594680|Methotrexate|methotrexate|mesh-list
56833902|NCT05594680|Cilostazol|cilostazol|mesh-list
56833903|NCT05594680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56833904|NCT05594680|Abortifacient Agents|abortifacient agents|mesh-ancestor
56833905|NCT05594680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56833906|NCT05594680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833907|NCT05594680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56833908|NCT05594680|Antimetabolites|antimetabolites|mesh-ancestor
56833909|NCT05594680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833910|NCT05594680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833911|NCT05594680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56833912|NCT05594680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833913|NCT05594680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56833914|NCT05594680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56833915|NCT05594680|Immunologic Factors|immunologic factors|mesh-ancestor
56833916|NCT05594680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833917|NCT05594680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56833918|NCT05594680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56833919|NCT05594680|Autonomic Agents|autonomic agents|mesh-ancestor
56833920|NCT05594680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833921|NCT05594680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56833922|NCT05594680|Respiratory System Agents|respiratory system agents|mesh-ancestor
56833923|NCT05594680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56833924|NCT05594680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56833925|NCT05594680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56833926|NCT05594680|Vasodilator Agents|vasodilator agents|mesh-ancestor
56833927|NCT05594680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56833928|NCT05594680|Protective Agents|protective agents|mesh-ancestor
56833929|NCT05594680|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56833930|NCT05594680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56833931|NCT01293058|Naloxone|naloxone|mesh-list
56833932|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56833933|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833934|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
56833935|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833936|NCT01195324|Canagliflozin|canagliflozin|mesh-list
56833937|NCT01195324|Warfarin|warfarin|mesh-list
56833938|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
56833939|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56833940|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833941|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56833942|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833943|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
56833944|NCT01293136|Narcotics|narcotics|mesh-ancestor
56833945|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56833946|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833947|NCT01293136|Analgesics|analgesics|mesh-ancestor
56833948|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
56833949|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833950|NCT01293292|Teriparatide|teriparatide|mesh-list
56894846|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
56833951|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56833952|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833953|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56833955|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56833956|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56833957|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833958|NCT01195714|Ofatumumab|ofatumumab|mesh-list
56833959|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833960|NCT01190722|Diclofenac|diclofenac|mesh-list
56833961|NCT01190722|Etoricoxib|etoricoxib|mesh-list
56833962|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56833963|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56833964|NCT01190722|Analgesics|analgesics|mesh-ancestor
56833965|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
56833966|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56833967|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833968|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56833969|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56833970|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56833971|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56833972|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833973|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56833974|NCT01196260|Capecitabine|capecitabine|mesh-list
56833975|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
56833976|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56833977|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
56833978|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833979|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833980|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
56833981|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833982|NCT05412082|Leucovorin|leucovorin|mesh-list
56833983|NCT05412082|Fluorouracil|fluorouracil|mesh-list
56833984|NCT05412082|Capecitabine|capecitabine|mesh-list
56833985|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
56833986|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
56833987|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56833988|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56833989|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56833990|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56833991|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
56833992|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56833993|NCT05412082|Antidotes|antidotes|mesh-ancestor
56833994|NCT05412082|Protective Agents|protective agents|mesh-ancestor
56833995|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
56833996|NCT05412082|Vitamins|vitamins|mesh-ancestor
56833997|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
56833998|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56833999|NCT01193296|Vildagliptin|vildagliptin|mesh-list
56834000|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56834001|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834002|NCT01193296|Incretins|incretins|mesh-ancestor
56834003|NCT01193296|Hormones|hormones|mesh-ancestor
56834004|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834005|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56834006|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
56834007|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834008|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834009|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
56834010|NCT01197040|Prednisone|prednisone|mesh-list
56834011|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834012|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
56544824|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834013|NCT01197040|Hormones|hormones|mesh-ancestor
56834014|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834015|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834016|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56834017|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834018|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56834019|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56834020|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
56834021|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834022|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834023|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834024|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834025|NCT05440864|Durvalumab|durvalumab|mesh-list
56834026|NCT05440864|Tremelimumab|tremelimumab|mesh-list
56834030|NCT01193452|Fluorouracil|fluorouracil|mesh-list
56834031|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
56834032|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
56834033|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834034|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56834035|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834036|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56834037|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
56834038|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834039|NCT01193452|Antidotes|antidotes|mesh-ancestor
56834040|NCT01193452|Protective Agents|protective agents|mesh-ancestor
56834041|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
56834042|NCT01193452|Vitamins|vitamins|mesh-ancestor
56834043|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
56834044|NCT05670886|Carbetocin|carbetocin|mesh-list
56834045|NCT05670886|Oxytocics|oxytocics|mesh-ancestor
56834046|NCT05670886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56834047|NCT05670886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834048|NCT03844594|Eptifibatide|eptifibatide|mesh-list
56834049|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56834050|NCT03848182|Gemcitabine|gemcitabine|mesh-list
56834051|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56834052|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
56834053|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834054|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834055|NCT03848182|Antiviral Agents|antiviral agents|mesh-ancestor
56834056|NCT03848182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834057|NCT03848182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834058|NCT03848182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56834059|NCT03848182|Immunologic Factors|immunologic factors|mesh-ancestor
56834060|NCT03848182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834061|NCT00146328|Tipranavir|tipranavir|mesh-list
56834062|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56834063|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56834064|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
56834065|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834066|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
56834067|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
56834068|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56834069|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
56834070|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834071|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834072|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56834073|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
56834074|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56834075|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
56834076|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834077|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834078|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56834079|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
56834080|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
56834081|NCT01295866|Protective Agents|protective agents|mesh-ancestor
56834082|NCT03848104|Cefoxitin|cefoxitin|mesh-list
56834083|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834084|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834085|NCT03345784|Cisplatin|cisplatin|mesh-list
56834086|NCT03345784|Adavosertib|adavosertib|mesh-list
56834087|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834088|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834089|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834090|NCT05670808|Epinephrine|epinephrine|mesh-list
56834091|NCT05670808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56834092|NCT05670808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56834093|NCT05670808|Adrenergic Agents|adrenergic agents|mesh-ancestor
56834094|NCT05670808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834095|NCT05670808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834096|NCT05670808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834097|NCT05670808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56834098|NCT05670808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56834099|NCT05670808|Autonomic Agents|autonomic agents|mesh-ancestor
56834100|NCT05670808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834102|NCT05670808|Respiratory System Agents|respiratory system agents|mesh-ancestor
56834104|NCT05670808|Sympathomimetics|sympathomimetics|mesh-ancestor
56834105|NCT05670808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56834106|NCT01197664|Fluorouracil|fluorouracil|mesh-list
56834107|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
56834108|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834109|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56834110|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834111|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56834112|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
56834113|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834115|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56834116|NCT01199458|Narcotics|narcotics|mesh-ancestor
56834117|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834118|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834119|NCT01199458|Analgesics|analgesics|mesh-ancestor
56834120|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
56834121|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834122|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56834123|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
56834124|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
56834125|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
56834126|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834127|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56834128|NCT01588522|Calcitriol|calcitriol|mesh-list
56834129|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56834130|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834131|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56834132|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56834133|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834134|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56834135|NCT01588522|Vitamins|vitamins|mesh-ancestor
56834136|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
56834137|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56834138|NCT01296178|Idarubicin|idarubicin|mesh-list
56834139|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56834140|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834141|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56834142|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56834143|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834144|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834145|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56834146|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56834147|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
56834148|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834149|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834150|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56834151|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
56834152|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834153|NCT03730012|Atezolizumab|atezolizumab|mesh-list
56834154|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834155|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
56834156|NCT03844360|Bortezomib|bortezomib|mesh-list
56834157|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
56834158|NCT03844360|Dasatinib|dasatinib|mesh-list
56834159|NCT03844360|Pegaspargase|pegaspargase|mesh-list
56834160|NCT03844360|Lenograstim|lenograstim|mesh-list
56834161|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834162|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56834163|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834164|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834165|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56834166|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
56834167|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834168|NCT01198054|Lenalidomide|lenalidomide|mesh-list
56834169|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
56834170|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834171|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56834172|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56834173|NCT01198054|Growth Substances|growth substances|mesh-ancestor
56834174|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
56834176|NCT01202032|Bevacizumab|bevacizumab|mesh-list
56834177|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56834178|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834179|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56834180|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56834181|NCT01202032|Growth Substances|growth substances|mesh-ancestor
56834182|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834183|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
56834186|NCT03844984|Ketamine|ketamine|mesh-list
56834187|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
56834188|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
56834189|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834190|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834191|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
56834192|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834193|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56834194|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56834195|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56834196|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56834197|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834198|NCT03844984|Analgesics|analgesics|mesh-ancestor
56834199|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56834200|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56834201|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
56834202|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56834203|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56834204|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834205|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56834206|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56834207|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56834208|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56834209|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56834210|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
56834211|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
56834212|NCT03842020|Amiodarone|amiodarone|mesh-list
56834213|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56834214|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
56834215|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56834216|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56834217|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834218|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56834219|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56834220|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56834221|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834222|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56834223|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56834224|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56834225|NCT01200004|Lenalidomide|lenalidomide|mesh-list
56834226|NCT01200004|Azacitidine|azacitidine|mesh-list
56834227|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
56834228|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834229|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56834230|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56834231|NCT01200004|Growth Substances|growth substances|mesh-ancestor
56834232|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
56834233|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834234|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56834235|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
56834236|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834237|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834238|NCT01198210|Dexamethasone|dexamethasone|mesh-list
56834240|NCT01198210|Ketamine|ketamine|mesh-list
56834241|NCT01198210|BB 1101|bb 1101|mesh-list
56834242|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834243|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
56834244|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
56834245|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834246|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834247|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56834248|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
56834249|NCT01198210|Hormones|hormones|mesh-ancestor
56557662|NCT00693433|Sirolimus|sirolimus|mesh-list
56834251|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56834252|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834253|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
56834254|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834255|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834256|NCT01198210|Analgesics|analgesics|mesh-ancestor
56834257|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
56834258|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56834259|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56834260|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
56834261|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
56834262|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834263|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56834264|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56834265|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834266|NCT03843736|Drospirenone|drospirenone|mesh-list
56834267|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
56834268|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56834269|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
56834270|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56834271|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56834272|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834273|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56834274|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56834275|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56834276|NCT03843736|Estrogens|estrogens|mesh-ancestor
56834277|NCT03843736|Hormones|hormones|mesh-ancestor
56834278|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834279|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56834280|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
56834281|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56834282|NCT03843736|Diuretics|diuretics|mesh-ancestor
56834283|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
56834284|NCT01200472|Apremilast|apremilast|mesh-list
56834285|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56834286|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56834287|NCT01200472|Analgesics|analgesics|mesh-ancestor
56834288|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
56834289|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834290|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834291|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834292|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56834293|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56834294|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56834295|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834296|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834297|NCT04638790|Dexamethasone|dexamethasone|mesh-list
56834298|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
56834299|NCT04638790|Dacarbazine|dacarbazine|mesh-list
56834300|NCT04638790|Doxorubicin|doxorubicin|mesh-list
56834301|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56834302|NCT04638790|Etoposide|etoposide|mesh-list
56834303|NCT04638790|Vincristine|vincristine|mesh-list
56834304|NCT04638790|Bleomycin|bleomycin|mesh-list
56834305|NCT04638790|Vinblastine|vinblastine|mesh-list
56834306|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56834307|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
56834308|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834309|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56834310|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56834311|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
56834312|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834313|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834314|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56834315|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834316|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
56834317|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
56834318|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834319|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56834320|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
56834321|NCT04638790|Hormones|hormones|mesh-ancestor
56834322|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834323|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56834324|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56834325|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56834326|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56834327|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834328|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56834329|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
56834330|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
56834331|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56834333|NCT03249142|Tremelimumab|tremelimumab|mesh-list
56834334|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56834335|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56834336|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834337|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
56834338|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834339|NCT01200706|Amoxicillin|amoxicillin|mesh-list
56834340|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834341|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834342|NCT01200784|Niacinamide|niacinamide|mesh-list
56834343|NCT01200784|Niacin|niacin|mesh-list
56834344|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
56834345|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
56834346|NCT01200784|Vitamins|vitamins|mesh-ancestor
56834347|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
56834348|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834349|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56834350|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
56834351|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834352|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56834353|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
56834354|NCT05132920|Dexamethasone|dexamethasone|mesh-list
56834355|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834356|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
56834357|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
56834358|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834359|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834360|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56834361|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
56834362|NCT05132920|Hormones|hormones|mesh-ancestor
56834363|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834364|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56834365|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834366|NCT03841474|Citalopram|citalopram|mesh-list
56834367|NCT03841474|Sertraline|sertraline|mesh-list
56834368|NCT03841474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56834369|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56834370|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56834371|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834372|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834373|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
56834374|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834375|NCT03841474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56834376|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
56834377|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56834378|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56834379|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56834380|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834381|NCT05670184|Ethanol|ethanol|mesh-list
56834382|NCT05670184|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
56834383|NCT05670184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56834384|NCT05670184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834385|NCT05670184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834386|NCT05670184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834387|NCT05670184|Hallucinogens|hallucinogens|mesh-ancestor
56834388|NCT05670184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56545198|NCT02683837|Remifentanil|remifentanil|mesh-list
56834389|NCT05670184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56834390|NCT05670184|Serotonin Agents|serotonin agents|mesh-ancestor
56834391|NCT05670184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834392|NCT05670184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834393|NCT05670184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56834394|NCT05084248|Vitamin D|vitamin d|mesh-list
56834395|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
56834396|NCT05084248|Vitamins|vitamins|mesh-ancestor
56348792|NCT00191347|Pemetrexed|pemetrexed|mesh-list
56834397|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
56834398|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903121|NCT01321671|Analgesics|analgesics|mesh-ancestor
56834399|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56834400|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56834401|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
56834402|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56834403|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56834404|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834405|NCT04429516|Morphine|morphine|mesh-list
56834406|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56834407|NCT04429516|Narcotics|narcotics|mesh-ancestor
56834408|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834409|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834410|NCT04429516|Analgesics|analgesics|mesh-ancestor
56834411|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
56834412|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834413|NCT03842800|Ketamine|ketamine|mesh-list
56834414|NCT03842800|Analgesics|analgesics|mesh-ancestor
56834415|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
56834416|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834417|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834418|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56834419|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56834420|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
56834421|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
56834422|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834423|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56834424|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56834425|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834426|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834427|NCT01202422|Pregabalin|pregabalin|mesh-list
56834428|NCT01202422|Analgesics|analgesics|mesh-ancestor
56834429|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
56834430|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834431|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834432|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
56834433|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56834434|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56834435|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834436|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56834437|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56834438|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56834439|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834440|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56834441|NCT03892018|Paclitaxel|paclitaxel|mesh-list
56834442|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56834443|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834444|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56834445|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56834446|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56834447|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834448|NCT01198912|Doxycycline|doxycycline|mesh-list
56834449|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834450|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834451|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
56834452|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56834453|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56834454|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
56834455|NCT03842488|Darunavir|darunavir|mesh-list
56834456|NCT03842488|Cobicistat|cobicistat|mesh-list
56834457|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56834458|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56834459|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
56834460|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834461|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56834462|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56834463|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920148|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834464|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834465|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56834466|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56834467|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
56834468|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56834469|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56834470|NCT04256824|Triclosan|triclosan|mesh-list
56834472|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834473|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56834474|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56834475|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
56834476|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834477|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56834478|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
56834479|NCT03842254|Hematinics|hematinics|mesh-ancestor
56834480|NCT01201642|Prednisolone|prednisolone|mesh-list
56834481|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834482|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
56834483|NCT01201642|Hormones|hormones|mesh-ancestor
56834484|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834485|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834486|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56834487|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834488|NCT05004064|Rituximab|rituximab|mesh-list
56834489|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
56834490|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56834491|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834492|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
56834493|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834494|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56834495|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56834496|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56834497|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
56834498|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834499|NCT01202734|Methylphenidate|methylphenidate|mesh-list
56834500|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56834501|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834502|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56834503|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56834504|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56834505|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834506|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
56834507|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834508|NCT03173092|Dexamethasone|dexamethasone|mesh-list
56834509|NCT03173092|Lenalidomide|lenalidomide|mesh-list
56834510|NCT03173092|Ixazomib|ixazomib|mesh-list
56834511|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834512|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
56834513|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
56834514|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834515|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834516|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56834517|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
56834518|NCT03173092|Hormones|hormones|mesh-ancestor
56834519|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834520|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56834521|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834522|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
56834523|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56834524|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56834525|NCT03173092|Growth Substances|growth substances|mesh-ancestor
56834526|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
56834527|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
56834528|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834529|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834530|NCT02966314|Omalizumab|omalizumab|mesh-list
56834531|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56834532|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56834533|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
56834534|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56834535|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56834536|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56834537|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
56545346|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
56834538|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834539|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56834540|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56834541|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834542|NCT01202890|Bevacizumab|bevacizumab|mesh-list
56834543|NCT01202890|Lenalidomide|lenalidomide|mesh-list
56834544|NCT01202890|Doxorubicin|doxorubicin|mesh-list
56441724|NCT00269126|Xhance|xhance|mesh-list
56834545|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56834546|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56834547|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834548|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56834549|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56834550|NCT01202890|Growth Substances|growth substances|mesh-ancestor
56834551|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834552|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
56834553|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56834554|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56834555|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56834556|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834557|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834558|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
56834559|NCT03743428|Bevacizumab|bevacizumab|mesh-list
56834560|NCT03743428|Apatinib|apatinib|mesh-list
56834561|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56834562|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834563|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56834564|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56834565|NCT03743428|Growth Substances|growth substances|mesh-ancestor
56834566|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834567|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
56834568|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56834569|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834570|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834571|NCT01199224|Veliparib|veliparib|mesh-list
56834572|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56834573|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834574|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834575|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834576|NCT01204138|Apremilast|apremilast|mesh-list
56834577|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56834578|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56834579|NCT01204138|Analgesics|analgesics|mesh-ancestor
56834580|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
56834581|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834582|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834583|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834584|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56834585|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56834586|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56834587|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834588|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834589|NCT02927392|Leuprolide|leuprolide|mesh-list
56834590|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56834591|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
56834592|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56834593|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834594|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56834595|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834597|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
56834598|NCT01204216|Vitamins|vitamins|mesh-ancestor
56834599|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
56834600|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834601|NCT01204372|Gemcitabine|gemcitabine|mesh-list
56834602|NCT01204372|Trastuzumab|trastuzumab|mesh-list
56834603|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56834604|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56834605|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
56834606|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834607|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834608|NCT01204372|Antiviral Agents|antiviral agents|mesh-ancestor
56834609|NCT01204372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834610|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545433|NCT02869035|Analgesics|analgesics|mesh-ancestor
56834611|NCT01204372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56834612|NCT01204372|Immunologic Factors|immunologic factors|mesh-ancestor
56834613|NCT01204372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834614|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56834615|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56834617|NCT01204450|Valproic Acid|valproic acid|mesh-list
56834618|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834652|NCT02605486|Bicalutamide|bicalutamide|mesh-list
56834653|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834654|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56834655|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834656|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834657|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
56834658|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
56834659|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834660|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834661|NCT03834454|Bupivacaine|bupivacaine|mesh-list
56834662|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
56834663|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
56834664|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834665|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834666|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
56834667|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834668|NCT02428270|Trametinib|trametinib|mesh-list
56834669|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834670|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56834671|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834672|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834673|NCT03829930|Entinostat|entinostat|mesh-list
56834674|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834675|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56834676|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834677|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834678|NCT01203202|Clomipramine|clomipramine|mesh-list
56834679|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56834680|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
56834681|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56834682|NCT01203202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56834683|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56834684|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56834685|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834686|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834687|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
56834688|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834689|NCT02047474|Leucovorin|leucovorin|mesh-list
56834690|NCT02047474|Fluorouracil|fluorouracil|mesh-list
56834691|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
56834693|NCT02047474|Calcium|calcium|mesh-list
56834694|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
56834695|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56834696|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834697|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
56834698|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834699|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56834700|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834701|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56834702|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
56834703|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56834704|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56834705|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834706|NCT02047474|Antidotes|antidotes|mesh-ancestor
56834707|NCT02047474|Protective Agents|protective agents|mesh-ancestor
56834708|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
56834709|NCT02047474|Vitamins|vitamins|mesh-ancestor
56834710|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
56834711|NCT01298284|Propranolol|propranolol|mesh-list
56834712|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56834713|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56834714|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
56834715|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834716|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834717|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834718|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56834719|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56834720|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
56834721|NCT01204840|Hormones|hormones|mesh-list
56834722|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834723|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834724|NCT01203358|Beractant|beractant|mesh-list
56834725|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56834726|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
56834727|NCT05669560|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56834728|NCT05669560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56834729|NCT05669560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834730|NCT03832426|Ritonavir|ritonavir|mesh-list
56834731|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56834732|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56834733|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
56834734|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834735|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834736|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56834737|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56834738|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
56834739|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834740|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56834741|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56834742|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
56834743|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56834744|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
56834745|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834746|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
56834747|NCT03840070|Protective Agents|protective agents|mesh-ancestor
56834748|NCT03272698|Ketamine|ketamine|mesh-list
56834749|NCT03272698|Analgesics|analgesics|mesh-ancestor
56834750|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
56834751|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834752|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834753|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56834754|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56834755|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
56834756|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
56834757|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834758|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56834759|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56834760|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834761|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834762|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
56834763|NCT01203514|Hematinics|hematinics|mesh-ancestor
56834764|NCT01204996|Gemcitabine|gemcitabine|mesh-list
56834765|NCT01204996|Paclitaxel|paclitaxel|mesh-list
56834766|NCT01204996|Docetaxel|docetaxel|mesh-list
56834767|NCT01204996|Carboplatin|carboplatin|mesh-list
56834770|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56834771|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834772|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
56834773|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
56834774|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
56834775|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834776|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56834777|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
56834778|NCT01204996|Antiviral Agents|antiviral agents|mesh-ancestor
56834779|NCT01204996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834780|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834781|NCT01204996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56834782|NCT01204996|Immunologic Factors|immunologic factors|mesh-ancestor
56834783|NCT01204996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834784|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56834785|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56834786|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56834787|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
56834788|NCT01297192|Mirabegron|mirabegron|mesh-list
56834789|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56834790|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56834791|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
56834792|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834793|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834794|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834795|NCT01297192|Urological Agents|urological agents|mesh-ancestor
56834796|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56834797|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56834798|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56834799|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
56834800|NCT01205074|Ethanol|ethanol|mesh-list
56834801|NCT01205074|Propranolol|propranolol|mesh-list
56834802|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56834803|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56834804|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
56834805|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834806|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834807|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834808|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56834809|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56834810|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
56834811|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56834812|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834813|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834814|NCT05667376|Curcumin|curcumin|mesh-list
56834815|NCT05667376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56834816|NCT05667376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56834817|NCT05667376|Analgesics|analgesics|mesh-ancestor
56834818|NCT05667376|Sensory System Agents|sensory system agents|mesh-ancestor
56834819|NCT05667376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834820|NCT05667376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834821|NCT05667376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834822|NCT05667376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56834823|NCT05667376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56834824|NCT05667376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834825|NCT05667376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834826|NCT03722524|Amlodipine|amlodipine|mesh-list
56834827|NCT03722524|Perindopril|perindopril|mesh-list
56834828|NCT03722524|Indapamide|indapamide|mesh-list
56834829|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
56834830|NCT03722524|Diuretics|diuretics|mesh-list
56834831|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56834832|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56834833|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56834834|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56920149|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
56545649|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
56834835|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834836|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56834837|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834839|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
56834840|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
56834841|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834842|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56834843|NCT05667220|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56834844|NCT05667220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56834845|NCT05667220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834846|NCT05667220|Incretins|incretins|mesh-ancestor
56834847|NCT05667220|Hormones|hormones|mesh-ancestor
56834848|NCT05667220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834849|NCT05667220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56834850|NCT05667220|Protease Inhibitors|protease inhibitors|mesh-ancestor
56834851|NCT05667220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834852|NCT05667220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834853|NCT01203592|Albuterol|albuterol|mesh-list
56834854|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56834855|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
56834856|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834857|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834858|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56834859|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
56834860|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
56834861|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56834862|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56834863|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56834864|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56834865|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
56834866|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834867|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834868|NCT05281276|Celecoxib|celecoxib|mesh-list
56834869|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56834870|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56834871|NCT05281276|Analgesics|analgesics|mesh-ancestor
56834872|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
56834873|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834874|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834875|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834876|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56834877|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56834878|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56834879|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834880|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834881|NCT03829150|Amoxicillin|amoxicillin|mesh-list
56834882|NCT03829150|Metronidazole|metronidazole|mesh-list
56834883|NCT03829150|Clarithromycin|clarithromycin|mesh-list
56834884|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
56834885|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834886|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834887|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56834888|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56834889|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56834890|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834891|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834892|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56834893|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56834894|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56834895|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56834896|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56834897|NCT01205464|Doxycycline|doxycycline|mesh-list
56834898|NCT01205464|Tetracycline|tetracycline|mesh-list
56834899|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834900|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834901|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
56834902|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56834903|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56834904|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56834905|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834906|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834907|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
56834908|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56834909|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834910|NCT03819010|Letrozole|letrozole|mesh-list
56834911|NCT03819010|Palbociclib|palbociclib|mesh-list
56834913|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56834914|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56834915|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834916|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834917|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56834918|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
56834919|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56834920|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834921|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56834922|NCT03818932|Acetaminophen|acetaminophen|mesh-list
56834923|NCT03818932|Celecoxib|celecoxib|mesh-list
56834924|NCT03818932|Ketorolac|ketorolac|mesh-list
56834925|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56834926|NCT03818932|Diazepam|diazepam|mesh-list
56834927|NCT03818932|Gabapentin|gabapentin|mesh-list
56834928|NCT03818932|Hydrocodone|hydrocodone|mesh-list
56834929|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56834930|NCT03818932|Analgesics|analgesics|mesh-ancestor
56834931|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
56834932|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834933|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834934|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
56834935|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56834936|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834937|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56834938|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56834939|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56834940|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834941|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834942|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
56834943|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56834944|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56834945|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56834946|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56834947|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56834948|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56834949|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56834950|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
56834951|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56834952|NCT03818932|Narcotics|narcotics|mesh-ancestor
56834953|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
56834954|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
56834955|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56834956|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
56834957|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
56834958|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56834959|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56834960|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56834961|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56834962|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56834963|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
56834964|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
56834965|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
56834966|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
56834967|NCT01205932|Enoxaparin|enoxaparin|mesh-list
56834968|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
56834969|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56834970|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
56834971|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56834972|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
56834973|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834974|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834975|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
56834976|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56834977|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56834978|NCT01300780|Etoricoxib|etoricoxib|mesh-list
56834979|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56834980|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56834981|NCT01300780|Analgesics|analgesics|mesh-ancestor
56834982|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
56834983|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56834984|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56834985|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56834986|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56834987|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56834989|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56834990|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56834991|NCT01297816|Minocycline|minocycline|mesh-list
56834992|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834993|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834995|NCT01297894|Fosfomycin|fosfomycin|mesh-list
56834996|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56834997|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56834998|NCT05666362|Benoxinate|benoxinate|mesh-list
56834999|NCT05666362|Anesthetics, Local|anesthetics, local|mesh-ancestor
56835000|NCT05666362|Anesthetics|anesthetics|mesh-ancestor
56835001|NCT05666362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835002|NCT05666362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835003|NCT05666362|Sensory System Agents|sensory system agents|mesh-ancestor
56835004|NCT05666362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835005|NCT01206010|Varenicline|varenicline|mesh-list
56835006|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56835007|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56835008|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
56835009|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835010|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835011|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835012|NCT05665114|Cytarabine|cytarabine|mesh-list
56835013|NCT05665114|Cyclophosphamide|cyclophosphamide|mesh-list
56835014|NCT05665114|Fludarabine|fludarabine|mesh-list
56835015|NCT05665114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835016|NCT05665114|Immunologic Factors|immunologic factors|mesh-ancestor
56835017|NCT05665114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835018|NCT05665114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835019|NCT05665114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56835020|NCT05665114|Alkylating Agents|alkylating agents|mesh-ancestor
56835021|NCT05665114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835022|NCT05665114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835023|NCT05665114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56835024|NCT05665114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56835025|NCT05665114|Antimetabolites|antimetabolites|mesh-ancestor
56835026|NCT05665114|Antiviral Agents|antiviral agents|mesh-ancestor
56835027|NCT05665114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835028|NCT05345002|Tretinoin|tretinoin|mesh-list
56835029|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835030|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
56835031|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
56835032|NCT05618314|Probenecid|probenecid|mesh-list
56835033|NCT05618314|Uricosuric Agents|uricosuric agents|mesh-ancestor
56835034|NCT05618314|Gout Suppressants|gout suppressants|mesh-ancestor
56835035|NCT05618314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835036|NCT05618314|Renal Agents|renal agents|mesh-ancestor
56835037|NCT03814642|Esomeprazole|esomeprazole|mesh-list
56835038|NCT03814642|Clopidogrel|clopidogrel|mesh-list
56835039|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56835040|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56835041|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56835042|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56835043|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
56835044|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835045|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835046|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835047|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56835048|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835049|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56835050|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835051|NCT01299220|Acitretin|acitretin|mesh-list
56835052|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
56835053|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
56835054|NCT03813784|Capecitabine|capecitabine|mesh-list
56835055|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
56835056|NCT03813784|Apatinib|apatinib|mesh-list
56835057|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56835058|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
56835059|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835060|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835061|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56835062|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835063|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
56835064|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56835066|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
56835067|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835068|NCT03827044|Avelumab|avelumab|mesh-list
56835069|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56835070|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835071|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
56835072|NCT00145626|Melphalan|melphalan|mesh-list
56835073|NCT00145626|Thiotepa|thiotepa|mesh-list
56835074|NCT00145626|Fludarabine|fludarabine|mesh-list
56835075|NCT00145626|Antibodies|antibodies|mesh-list
56835076|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835077|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
56835078|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835079|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835080|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56835081|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
56835082|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835083|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835084|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56835085|NCT01206946|Betamethasone|betamethasone|mesh-list
56835086|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835087|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
56835088|NCT01206946|Hormones|hormones|mesh-ancestor
56835089|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835090|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835091|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56835092|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
56835093|NCT03813940|Vaccines|vaccines|mesh-list
56835094|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
56835095|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835096|NCT03967938|Olaparib|olaparib|mesh-list
56835097|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56835098|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835099|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835100|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835101|NCT01299298|Mipomersen|mipomersen|mesh-list
56835102|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56835103|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56835104|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
56835105|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835106|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56835107|NCT00153062|Telmisartan|telmisartan|mesh-list
56835108|NCT00153062|Clopidogrel|clopidogrel|mesh-list
56835109|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56835110|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56835111|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56835112|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56835113|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56835114|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
56835115|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835116|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835117|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835118|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56835119|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56835120|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56835121|NCT05264974|Vaccines|vaccines|mesh-list
56835122|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
56835123|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835124|NCT00145470|Asenapine|asenapine|mesh-list
56835125|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56835126|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56835127|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835128|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835129|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56835130|NCT03813394|Bevacizumab|bevacizumab|mesh-list
56835131|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
56835132|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56835133|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835134|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56835135|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56835136|NCT03813394|Growth Substances|growth substances|mesh-ancestor
56835137|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835139|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56835140|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
56835141|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56835142|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56835143|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56835144|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835145|NCT03813316|Incretins|incretins|mesh-ancestor
56835146|NCT03813316|Hormones|hormones|mesh-ancestor
56835147|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835148|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
56835149|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835150|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835151|NCT01301248|Cisplatin|cisplatin|mesh-list
56835152|NCT01301248|Cetuximab|cetuximab|mesh-list
56835153|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835154|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56835155|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
56835156|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56835157|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835158|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56835159|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835160|NCT01302106|Clofarabine|clofarabine|mesh-list
56835161|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56835162|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
56835163|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835164|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835165|NCT00152516|Levetiracetam|levetiracetam|mesh-list
56835166|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
56835167|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
56835168|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56835169|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56835170|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
56835171|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835172|NCT05624008|Methamphetamine|methamphetamine|mesh-list
56903134|NCT03770013|Clonidine|clonidine|mesh-list
56835173|NCT05624008|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56835174|NCT05624008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835175|NCT05624008|Sympathomimetics|sympathomimetics|mesh-ancestor
56835176|NCT05624008|Autonomic Agents|autonomic agents|mesh-ancestor
56835177|NCT05624008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835178|NCT05624008|Dopamine Agents|dopamine agents|mesh-ancestor
56835179|NCT05624008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835180|NCT05624008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835181|NCT05624008|Adrenergic Agents|adrenergic agents|mesh-ancestor
56835182|NCT05624008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56835183|NCT05624008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56835184|NCT05624008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56835185|NCT05624008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56835186|NCT05623852|Fucoidan|fucoidan|mesh-list
56835187|NCT05623852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56835188|NCT05623852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835189|NCT05623852|Anticoagulants|anticoagulants|mesh-ancestor
56835190|NCT05623852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835191|NCT01302340|Dronabinol|dronabinol|mesh-list
56835192|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
56835193|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835194|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56835195|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56835196|NCT01302340|Analgesics|analgesics|mesh-ancestor
56835197|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
56835198|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835199|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56835200|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56835201|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835202|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835203|NCT01302340|Hormones|hormones|mesh-ancestor
56835204|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835205|NCT00150800|Brivaracetam|brivaracetam|mesh-list
56835206|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
56835207|NCT03812770|Leucovorin|leucovorin|mesh-list
56835208|NCT03812770|Fluorouracil|fluorouracil|mesh-list
56835209|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
56835210|NCT03812770|Sorafenib|sorafenib|mesh-list
56835211|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
56349592|NCT00196378|Estrogens|estrogens|mesh-list
56835213|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56835214|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835215|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835216|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
56835217|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835218|NCT03812770|Antidotes|antidotes|mesh-ancestor
56835219|NCT03812770|Protective Agents|protective agents|mesh-ancestor
56835220|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
56835221|NCT03812770|Vitamins|vitamins|mesh-ancestor
56835222|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
56835223|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56835224|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835225|NCT00144300|Pramipexole|pramipexole|mesh-list
56835226|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
56835227|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835228|NCT00144300|Protective Agents|protective agents|mesh-ancestor
56835229|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835230|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56835231|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56835232|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
56835233|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
56835234|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835235|NCT00149630|Disulfiram|disulfiram|mesh-list
56835236|NCT00149630|Methadone|methadone|mesh-list
56835237|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56835238|NCT00149630|Narcotics|narcotics|mesh-ancestor
56835239|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835240|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835241|NCT00149630|Analgesics|analgesics|mesh-ancestor
56835242|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
56835243|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835244|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
56835245|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
56835246|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56835247|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56835248|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835249|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835250|NCT01302496|Ipilimumab|ipilimumab|mesh-list
56835251|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56835252|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835253|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56835254|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835255|NCT00127842|Etanercept|etanercept|mesh-list
56835256|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56835257|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56835258|NCT00127842|Analgesics|analgesics|mesh-ancestor
56835259|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
56835260|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835261|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835262|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835263|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835264|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835265|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835266|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
56835267|NCT01075802|Tamoxifen|tamoxifen|mesh-list
56835268|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56835269|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
56835270|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835271|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835272|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56835273|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835274|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56835275|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56835276|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56835277|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
56835278|NCT03816592|Anesthetics|anesthetics|mesh-list
56835279|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835280|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835281|NCT03816592|Narcotics|narcotics|mesh-ancestor
56835282|NCT03816592|Analgesics|analgesics|mesh-ancestor
56835283|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
56835284|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835286|NCT01078038|Everolimus|everolimus|mesh-list
56835287|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835288|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835289|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
56835290|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835291|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56835292|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835293|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56835294|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
56835295|NCT00223496|Aripiprazole|aripiprazole|mesh-list
56835296|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
56835297|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56835298|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56835299|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56835300|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835301|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835302|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
56835303|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
56835304|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835305|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835306|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56835307|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56835308|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
56835309|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56835310|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56835311|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56835312|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56835313|NCT02531412|Spironolactone|spironolactone|mesh-list
56835314|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56835315|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
56835316|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835317|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835318|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56835319|NCT02531412|Diuretics|diuretics|mesh-ancestor
56835320|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
56835321|NCT00126672|Sirolimus|sirolimus|mesh-list
56835322|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56835323|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835324|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56835325|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835326|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
56835327|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835328|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
56835329|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835330|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56835331|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56835332|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56835333|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
56835334|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835335|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56835336|NCT05034562|Edetic Acid|edetic acid|mesh-list
56835337|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56835338|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
56835339|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
56835340|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835341|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
56835342|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56835343|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56835344|NCT00145496|Olanzapine|olanzapine|mesh-list
56835345|NCT00145496|Asenapine|asenapine|mesh-list
56835346|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
56835347|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
56835348|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835349|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835350|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835351|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56835352|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56835353|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835354|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56835355|NCT00145496|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56835356|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56835357|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56835358|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835359|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835360|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
56835361|NCT01299922|Cyclosporine|cyclosporine|mesh-list
56835362|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
56546230|NCT02683369|Iron|iron|mesh-list
56835363|NCT01299922|Cyclosporins|cyclosporins|mesh-list
56835364|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835365|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835366|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835367|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
56835368|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835369|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
56835370|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835371|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
56835372|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835373|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56835374|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56835375|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835376|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56835377|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
56835378|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56835379|NCT05030818|Aspirin|aspirin|mesh-list
56835380|NCT05030818|Ramipril|ramipril|mesh-list
56835381|NCT05030818|Atorvastatin|atorvastatin|mesh-list
56835382|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56835383|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56835384|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
56835385|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835386|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56835387|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56835388|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835389|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56835390|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56835391|NCT05030818|Analgesics|analgesics|mesh-ancestor
56835392|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
56835393|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835394|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835395|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835396|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835397|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56835398|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56835399|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56835400|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56835401|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
56835402|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56835403|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
56835404|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56835405|NCT01582022|Bupivacaine|bupivacaine|mesh-list
56835406|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
56835407|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
56835408|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835409|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835410|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
56835411|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835412|NCT01582412|Isavuconazole|isavuconazole|mesh-list
56835413|NCT01582412|Digoxin|digoxin|mesh-list
56835414|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56835415|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56835416|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835417|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835418|NCT01582412|Protective Agents|protective agents|mesh-ancestor
56835419|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835420|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
56835421|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835422|NCT04979806|Meropenem|meropenem|mesh-list
56835423|NCT04979806|Cefepime|cefepime|mesh-list
56835424|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56835425|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835426|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
56835427|NCT00255164|Lansoprazole|lansoprazole|mesh-list
56835428|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56835429|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835430|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56835431|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835432|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835433|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
56835434|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835436|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
56835437|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
56835438|NCT00126594|Sorafenib|sorafenib|mesh-list
56835439|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835440|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
56835441|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835442|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56835443|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835444|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835445|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
56835446|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835447|NCT01080456|Tacrolimus|tacrolimus|mesh-list
56835448|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835449|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
56835450|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835451|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56835452|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835453|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835454|NCT03811054|Apatinib|apatinib|mesh-list
56835455|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835456|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56835457|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835458|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835459|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56835460|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835461|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835462|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835463|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56835464|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56835465|NCT01075854|Hormones|hormones|mesh-ancestor
56835466|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835467|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835468|NCT03967392|Lidocaine|lidocaine|mesh-list
56835469|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
56835470|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
56835471|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835472|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835473|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
56835474|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835475|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56835476|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56835477|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56835478|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56835479|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835480|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
56835481|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835482|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
56835483|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56835484|NCT00142584|Metoprolol|metoprolol|mesh-list
56835485|NCT00142584|Nebivolol|nebivolol|mesh-list
56835486|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56835487|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56835488|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
56835489|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
56835490|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835491|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835492|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56835493|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56835494|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56835495|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
56835496|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835497|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835498|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
56835499|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56835500|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56835501|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56835502|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
56835503|NCT04848064|Fludarabine|fludarabine|mesh-list
56835504|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
56835505|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
56835506|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
56835507|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835508|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
56835510|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835511|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56835512|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
56920150|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835513|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835514|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835515|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56835516|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
56835517|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56835518|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56835519|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56835520|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56835521|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835522|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
56835523|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835524|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835525|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56835526|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835527|NCT01080534|Tacrolimus|tacrolimus|mesh-list
56835528|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835529|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
56835530|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835531|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56835532|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835533|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835534|NCT00125190|Mecasermin|mecasermin|mesh-list
56835535|NCT00125190|Growth Substances|growth substances|mesh-ancestor
56835536|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835537|NCT00141726|Etanercept|etanercept|mesh-list
56835538|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56835539|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56835540|NCT00141726|Analgesics|analgesics|mesh-ancestor
56835541|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
56835542|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835543|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835544|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835545|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835546|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835547|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56835548|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
56835549|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56835550|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56835551|NCT01301716|Paclitaxel|paclitaxel|mesh-list
56835552|NCT01301716|Bevacizumab|bevacizumab|mesh-list
56835553|NCT01301716|Carboplatin|carboplatin|mesh-list
56835554|NCT01301716|Pemetrexed|pemetrexed|mesh-list
56835555|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56835556|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835557|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
56835558|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
56835559|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
56835560|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835561|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56835562|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56835563|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56835564|NCT01301716|Growth Substances|growth substances|mesh-ancestor
56835565|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835566|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
56835567|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835568|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56835569|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56835570|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
56835571|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
56835572|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56835573|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835574|NCT01300312|Diclofenac|diclofenac|mesh-list
56835575|NCT01300312|Eperisone|eperisone|mesh-list
56835576|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56835577|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56835578|NCT01300312|Analgesics|analgesics|mesh-ancestor
56835579|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
56835580|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835582|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835583|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835584|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56835585|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835586|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835587|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
56835588|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56835589|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56835590|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56835591|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56835592|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56835593|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
56835594|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
56835595|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
56835597|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835598|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835599|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835600|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56835601|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56835602|NCT01080612|Pregabalin|pregabalin|mesh-list
56835603|NCT01080612|Analgesics|analgesics|mesh-ancestor
56835604|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
56835605|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835606|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835607|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
56835608|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56835609|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56835610|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835611|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56835612|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56835613|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56835614|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835615|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56835616|NCT03815344|Misoprostol|misoprostol|mesh-list
56835617|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56835618|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
56835619|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56835620|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835621|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56835622|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835623|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
56835624|NCT03819790|Insulin|insulin|mesh-list
56835625|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56835626|NCT03819790|Metformin|metformin|mesh-list
56835627|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
56835628|NCT03819790|Lixisenatide|lixisenatide|mesh-list
56835629|NCT03819790|Gliclazide|gliclazide|mesh-list
56835630|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56835631|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835632|NCT01560442|Buprenorphine|buprenorphine|mesh-list
56835633|NCT01560442|Methadone|methadone|mesh-list
56835634|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56835635|NCT01560442|Narcotics|narcotics|mesh-ancestor
56835636|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835637|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835638|NCT01560442|Analgesics|analgesics|mesh-ancestor
56835639|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
56835640|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835641|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56835642|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
56835643|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56835644|NCT04484818|Leuprolide|leuprolide|mesh-list
56835645|NCT04484818|Goserelin|goserelin|mesh-list
56835646|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56835647|NCT04484818|Tryptophan|tryptophan|mesh-list
56835648|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
56835649|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835650|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835651|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56835652|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
56835653|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56835654|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56835655|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835656|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
56835659|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56835660|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56835661|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
56835662|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56835663|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
56835664|NCT00110994|Sorafenib|sorafenib|mesh-list
56835665|NCT00110994|Dacarbazine|dacarbazine|mesh-list
56835666|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835667|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56835668|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835669|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835670|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56835671|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
56835672|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
56835673|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56835674|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56835675|NCT01560052|Prednisolone|prednisolone|mesh-list
56835676|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
56835677|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56835678|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
56835679|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835680|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
56835681|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
56835682|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835683|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835684|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835685|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
56835686|NCT01560052|Hormones|hormones|mesh-ancestor
56835687|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835688|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56835689|NCT01560052|Protective Agents|protective agents|mesh-ancestor
56835690|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56835691|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835692|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
56835693|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56442772|NCT00314457|Bupivacaine|bupivacaine|mesh-list
56835694|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835695|NCT04356352|Lidocaine|lidocaine|mesh-list
56835696|NCT04356352|Esmolol|esmolol|mesh-list
56835697|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
56835698|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
56835699|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835700|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835701|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
56835702|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835703|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56835704|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56835705|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56835706|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56835707|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835708|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56835709|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56835710|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56835711|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
56835712|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835713|NCT05622994|Rimonabant|rimonabant|mesh-list
56835714|NCT05622994|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56835715|NCT05622994|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56835716|NCT05622994|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56835717|NCT05622994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835718|NCT05622994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835719|NCT05622994|Hormones|hormones|mesh-ancestor
56835720|NCT05622994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835721|NCT05622994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835722|NCT05622916|Ethanol|ethanol|mesh-list
56835723|NCT05622916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56835724|NCT05622916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835725|NCT05622916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835726|NCT05622916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835727|NCT03819556|Caseins|caseins|mesh-list
56835728|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
56835729|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
56835730|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835731|NCT03804034|Molybdenum|molybdenum|mesh-list
56835732|NCT03804034|Trace Elements|trace elements|mesh-ancestor
56835733|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
56835734|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835735|NCT04246762|Vitamin K|vitamin k|mesh-list
56835736|NCT04246762|Midazolam|midazolam|mesh-list
56546590|NCT00975195|Xhance|xhance|mesh-list
56835737|NCT04246762|Caffeine|caffeine|mesh-list
56835738|NCT04246762|Omeprazole|omeprazole|mesh-list
56835739|NCT04246762|Warfarin|warfarin|mesh-list
56835740|NCT04246762|Vitamins|vitamins|mesh-ancestor
56835741|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
56835742|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835743|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56835744|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56835745|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835746|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56835747|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56835748|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56835749|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56835750|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
56835751|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
56835752|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
56835753|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
56835754|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835755|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835756|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
56835757|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56835758|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56835759|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835760|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56835761|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56835762|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
56835763|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56835764|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903145|NCT03770013|Analgesics|analgesics|mesh-ancestor
56835765|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56835766|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56835767|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56835768|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
56835769|NCT04246762|Coagulants|coagulants|mesh-ancestor
56835770|NCT03799120|Tamsulosin|tamsulosin|mesh-list
56835771|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56835772|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56835773|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56835774|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
56835775|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835776|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835777|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835778|NCT03799120|Urological Agents|urological agents|mesh-ancestor
56835779|NCT03792724|Nivolumab|nivolumab|mesh-list
56835780|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56835781|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835782|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56835783|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835784|NCT00144170|Ritonavir|ritonavir|mesh-list
56835785|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56835786|NCT00144170|Tipranavir|tipranavir|mesh-list
56835787|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
56835788|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56835789|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835790|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835791|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56835792|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56835793|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
56835794|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835795|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56835796|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56835797|NCT00255086|Memantine|memantine|mesh-list
56835798|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56835799|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56835800|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
56835801|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835802|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835803|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835804|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56835806|NCT00110214|Prednisone|prednisone|mesh-list
56835807|NCT00110214|Bevacizumab|bevacizumab|mesh-list
56835808|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56835809|NCT00110214|Docetaxel|docetaxel|mesh-list
56835810|NCT00110214|Antibodies|antibodies|mesh-list
56835811|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
56835812|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56835813|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835814|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56835815|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56835816|NCT00110214|Growth Substances|growth substances|mesh-ancestor
56835817|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835818|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
56835819|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
56835820|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
56835821|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
56835822|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
56835823|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835824|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835825|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
56835826|NCT00110214|Hormones|hormones|mesh-ancestor
56835827|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835828|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56835829|NCT04176172|Nicotine|nicotine|mesh-list
56835830|NCT04176172|Varenicline|varenicline|mesh-list
56835831|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56835832|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
56835833|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835834|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835835|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56835836|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56835837|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
56835838|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835839|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835840|NCT05625334|Aspirin|aspirin|mesh-list
56835841|NCT05625334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56835842|NCT05625334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56835843|NCT05625334|Analgesics|analgesics|mesh-ancestor
56835844|NCT05625334|Sensory System Agents|sensory system agents|mesh-ancestor
56835845|NCT05625334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835846|NCT05625334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835847|NCT05625334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835848|NCT05625334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56835849|NCT05625334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56835850|NCT05625334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56835851|NCT05625334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835852|NCT05625334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56835853|NCT05625334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56835854|NCT05625334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835855|NCT05625334|Antipyretics|antipyretics|mesh-ancestor
56835856|NCT03795844|Liver Extracts|liver extracts|mesh-list
56835857|NCT03795844|Hematinics|hematinics|mesh-ancestor
56835858|NCT05669170|Methylphenidate|methylphenidate|mesh-list
56835859|NCT05669170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56835860|NCT05669170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835861|NCT05669170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56835862|NCT05669170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56835863|NCT05669170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56835864|NCT05669170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835865|NCT05669170|Dopamine Agents|dopamine agents|mesh-ancestor
56835866|NCT05669170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835867|NCT03798106|Durvalumab|durvalumab|mesh-list
56835868|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56835869|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835870|NCT03799822|Vitamin K|vitamin k|mesh-list
56835871|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
56835872|NCT03799822|Vitamins|vitamins|mesh-ancestor
56835873|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
56835874|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835875|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56835876|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
56835877|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56835878|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
56835879|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835880|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835882|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56835883|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56835884|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
56835885|NCT03799822|Coagulants|coagulants|mesh-ancestor
56835886|NCT05589688|Acyclovir|acyclovir|mesh-list
56835887|NCT05589688|Antiviral Agents|antiviral agents|mesh-ancestor
56835888|NCT05589688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835889|NCT03799900|Ketamine|ketamine|mesh-list
56835890|NCT03799900|Analgesics|analgesics|mesh-ancestor
56835891|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
56835892|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835893|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835894|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56835895|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56835896|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
56835897|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
56835898|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835899|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56835900|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56835901|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835902|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835903|NCT05624866|Triamcinolone|triamcinolone|mesh-list
56835904|NCT05624866|Dexmedetomidine|dexmedetomidine|mesh-list
56835905|NCT05624866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56835906|NCT05624866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835907|NCT05624866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835908|NCT05624866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56835909|NCT05624866|Analgesics|analgesics|mesh-ancestor
56835910|NCT05624866|Sensory System Agents|sensory system agents|mesh-ancestor
56835911|NCT05624866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835912|NCT05624866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56835913|NCT05624866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56835914|NCT05624866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56835915|NCT05624866|Adrenergic Agents|adrenergic agents|mesh-ancestor
56835916|NCT05624866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835917|NCT05624866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835918|NCT05624866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56835919|NCT05624866|Glucocorticoids|glucocorticoids|mesh-ancestor
56835920|NCT05624866|Hormones|hormones|mesh-ancestor
56835921|NCT05624866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56835922|NCT01304602|Irinotecan|irinotecan|mesh-list
56835923|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56835924|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56835925|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835926|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835927|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835928|NCT01304134|Morphine|morphine|mesh-list
56835929|NCT01304134|Oxycodone|oxycodone|mesh-list
56835930|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56835931|NCT01304134|Narcotics|narcotics|mesh-ancestor
56835932|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835933|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835934|NCT01304134|Analgesics|analgesics|mesh-ancestor
56835935|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
56835936|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835937|NCT00124020|Vancomycin|vancomycin|mesh-list
56835938|NCT00124020|Telavancin|telavancin|mesh-list
56835939|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56835940|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835941|NCT05630794|TIC10 compound|tic10 compound|mesh-list
56835942|NCT05630794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56835943|NCT01080846|Misoprostol|misoprostol|mesh-list
56835944|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56835945|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
56835946|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56835947|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835948|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56835949|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835950|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
56835951|NCT01076322|Albuterol|albuterol|mesh-list
56835952|NCT01076322|Procaterol|procaterol|mesh-list
56835953|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56835954|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
56835955|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835956|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835957|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56835958|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
56835959|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
56835960|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56835961|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56835962|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56835963|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56835964|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
56920151|NCT01216111|Paclitaxel|paclitaxel|mesh-list
56835965|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56835966|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835967|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
56835968|NCT03966066|Erythromycin|erythromycin|mesh-list
56835969|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
56835970|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56835971|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
56835972|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56835973|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56835974|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56835975|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56835976|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56835977|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56835978|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56835979|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
56835981|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56835982|NCT01304212|Epinephrine|epinephrine|mesh-list
56835983|NCT01304212|Racepinephrine|racepinephrine|mesh-list
56835984|NCT01304212|Morphine|morphine|mesh-list
56835985|NCT01304212|Ropivacaine|ropivacaine|mesh-list
56835986|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
56835987|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56835988|NCT01304212|Narcotics|narcotics|mesh-ancestor
56835989|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56835990|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56835991|NCT01304212|Analgesics|analgesics|mesh-ancestor
56835992|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
56835993|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56835994|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
56835995|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
56835996|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56835997|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56835998|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56835999|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56836000|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836001|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56836002|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56836003|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
56836004|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56836005|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
56836006|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
56836007|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
56836008|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56836009|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56836010|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836011|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836012|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836013|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56836014|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836015|NCT00143390|Anastrozole|anastrozole|mesh-list
56836016|NCT00143390|Exemestane|exemestane|mesh-list
56836017|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56836018|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836019|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56836020|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56836021|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836022|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836023|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56836024|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
56836025|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56836026|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836027|NCT03238534|Omeprazole|omeprazole|mesh-list
56836028|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56836029|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56836030|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56836031|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836032|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836033|NCT03800134|Gemcitabine|gemcitabine|mesh-list
56836034|NCT03800134|Paclitaxel|paclitaxel|mesh-list
56836035|NCT03800134|Cisplatin|cisplatin|mesh-list
56836036|NCT03800134|Carboplatin|carboplatin|mesh-list
56836037|NCT03800134|Pemetrexed|pemetrexed|mesh-list
56836038|NCT03800134|Durvalumab|durvalumab|mesh-list
56836039|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56836040|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836041|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
56836042|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
56836043|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
56836044|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836045|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56836046|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
56836047|NCT03800134|Antiviral Agents|antiviral agents|mesh-ancestor
56836048|NCT03800134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836049|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836050|NCT03800134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836051|NCT03800134|Immunologic Factors|immunologic factors|mesh-ancestor
56836052|NCT03800134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836053|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56836054|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56836055|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56836056|NCT00141102|Celecoxib|celecoxib|mesh-list
56836057|NCT00141102|Diclofenac|diclofenac|mesh-list
56836058|NCT00141102|Omeprazole|omeprazole|mesh-list
56836059|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56836060|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836061|NCT00141102|Analgesics|analgesics|mesh-ancestor
56836062|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
56836063|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836064|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836065|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836066|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836067|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56836068|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56836069|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836070|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836071|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56836072|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56836073|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56836074|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56836075|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56836076|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836077|NCT01078428|Petrolatum|petrolatum|mesh-list
56836078|NCT01078428|Emollients|emollients|mesh-ancestor
56836079|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
56836080|NCT01081002|Lidocaine|lidocaine|mesh-list
56836081|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
56836082|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
56836083|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56836084|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836085|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
56836086|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836087|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56836088|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56836089|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56836090|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56836091|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836092|NCT03789058|Ibuprofen|ibuprofen|mesh-list
56836093|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56836094|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836095|NCT03789058|Analgesics|analgesics|mesh-ancestor
56836096|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
56836097|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836098|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836099|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836100|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836101|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56836102|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836103|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836104|NCT03788902|Methylphenidate|methylphenidate|mesh-list
56836105|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56836106|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836108|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56836109|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56836110|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836111|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
56836112|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56836113|NCT05669092|Capecitabine|capecitabine|mesh-list
56836114|NCT05669092|Oxaliplatin|oxaliplatin|mesh-list
56836115|NCT05669092|Irinotecan|irinotecan|mesh-list
56836116|NCT05669092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56836117|NCT05669092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56836118|NCT05669092|Antimetabolites|antimetabolites|mesh-ancestor
56836119|NCT05669092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836120|NCT05669092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836121|NCT05669092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56836122|NCT05669092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56836123|NCT05669092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836125|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56836126|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
56836127|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
56836128|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836129|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
56836130|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836131|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
56836132|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836133|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56836134|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
56836135|NCT03714022|Abatacept|abatacept|mesh-list
56836136|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56836137|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836138|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836139|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836140|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
56836141|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836142|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836143|NCT00143312|Voriconazole|voriconazole|mesh-list
56836144|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
56836145|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836146|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56836147|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56836148|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836149|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836150|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56836151|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
56836152|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56836153|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836154|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56836155|NCT04833946|Andrographolide|andrographolide|mesh-list
56836156|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836157|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56836158|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836159|NCT04833946|Analgesics|analgesics|mesh-ancestor
56836160|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
56836161|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836162|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836163|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836164|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56836165|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56836166|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836167|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
56836168|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56836169|NCT01077206|Simvastatin|simvastatin|mesh-list
56836170|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56836171|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56836172|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
56836173|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836174|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56836175|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56836176|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836177|NCT05623540|Diphosphonates|diphosphonates|mesh-list
56836178|NCT05623540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56557677|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56836181|NCT05622838|Protein C Inhibitor|protein c inhibitor|mesh-list
56836182|NCT05622838|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56836183|NCT05622838|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56836184|NCT05622838|Protease Inhibitors|protease inhibitors|mesh-ancestor
56836185|NCT05622838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836186|NCT05622838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836187|NCT01306318|Diclofenac|diclofenac|mesh-list
56836188|NCT01306318|Eperisone|eperisone|mesh-list
56836189|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56836190|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836191|NCT01306318|Analgesics|analgesics|mesh-ancestor
56836192|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
56836193|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836194|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836195|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836196|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836197|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56836198|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836199|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836200|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
56836201|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56836202|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56836203|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56836204|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56836205|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56836206|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
56836207|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
56836208|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
56836209|NCT00254540|Sunitinib|sunitinib|mesh-list
56836210|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836211|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56836212|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56836213|NCT00254540|Growth Substances|growth substances|mesh-ancestor
56836214|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836215|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
56836216|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56836217|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836218|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836219|NCT01326494|Prednisone|prednisone|mesh-list
56836220|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836221|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
56836222|NCT01326494|Hormones|hormones|mesh-ancestor
56836223|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56836224|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836225|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56836226|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836227|NCT05316220|Mesalamine|mesalamine|mesh-list
56836228|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56836229|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836230|NCT05316220|Analgesics|analgesics|mesh-ancestor
56836231|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
56836232|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836233|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836234|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836235|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836236|NCT01305850|Losartan|losartan|mesh-list
56836237|NCT01305850|Enalapril|enalapril|mesh-list
56836238|NCT01305850|Enalaprilat|enalaprilat|mesh-list
56836239|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56836240|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56836241|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56836242|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56836243|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836244|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56836245|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
56836246|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836247|NCT01306630|Capecitabine|capecitabine|mesh-list
56836248|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56836249|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
56836250|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836252|NCT01306708|Amitriptyline|amitriptyline|mesh-list
56836253|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56836254|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
56836255|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56836256|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836257|NCT01306708|Analgesics|analgesics|mesh-ancestor
56836258|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
56836259|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836260|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836261|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56920152|NCT01216111|Docetaxel|docetaxel|mesh-list
56836262|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56836263|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56836264|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836265|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
56836266|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56836267|NCT03794518|Pioglitazone|pioglitazone|mesh-list
56836268|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56836269|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836270|NCT05566288|Moxifloxacin|moxifloxacin|mesh-list
56836271|NCT05566288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56836272|NCT05566288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836273|NCT05566288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56836274|NCT05566288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56836275|NCT05566288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836276|NCT05566288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836277|NCT05566288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836278|NCT03790540|Benzocaine|benzocaine|mesh-list
56836279|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
56836280|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
56836281|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56836282|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836283|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
56836284|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836285|NCT03794596|Aspirin|aspirin|mesh-list
56836286|NCT03794596|Avelumab|avelumab|mesh-list
56836287|NCT03794596|Lansoprazole|lansoprazole|mesh-list
56836288|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
56836289|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56836290|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56836291|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836292|NCT03794596|Analgesics|analgesics|mesh-ancestor
56836293|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
56836294|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836295|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836296|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836297|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836298|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56836299|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56836300|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836301|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56836302|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56836303|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836304|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
56836305|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56836306|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836307|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56836308|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56836309|NCT05571748|Thioctic Acid|thioctic acid|mesh-list
56836310|NCT05571748|Antioxidants|antioxidants|mesh-ancestor
56836311|NCT05571748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836312|NCT05571748|Protective Agents|protective agents|mesh-ancestor
56836313|NCT05571748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836314|NCT05571748|Vitamin B Complex|vitamin b complex|mesh-ancestor
56836315|NCT05571748|Vitamins|vitamins|mesh-ancestor
56836316|NCT05571748|Micronutrients|micronutrients|mesh-ancestor
56836317|NCT03790618|Methamphetamine|methamphetamine|mesh-list
56836318|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56836319|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
56836320|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836321|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56836322|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
56836323|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904605|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56836325|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56836326|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56836327|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56836328|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
56836329|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56836330|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
56836331|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
56836332|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836333|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
56836334|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56836335|NCT03790228|Carboplatin|carboplatin|mesh-list
56836337|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836338|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836339|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836340|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56836341|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56836342|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
56836343|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
56836344|NCT01304836|Prednisolone|prednisolone|mesh-list
56836346|NCT01304836|Basiliximab|basiliximab|mesh-list
56836347|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836348|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
56836349|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836350|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56836351|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836352|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836353|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56836354|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836355|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56836356|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
56836357|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56836358|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836359|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836360|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
56836361|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
56836362|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836363|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56836364|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
56836365|NCT01304836|Hormones|hormones|mesh-ancestor
56836366|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56836367|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56836368|NCT01304836|Protective Agents|protective agents|mesh-ancestor
56836369|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56836370|NCT01306864|Hemostatics|hemostatics|mesh-list
56836371|NCT01306864|Coagulants|coagulants|mesh-ancestor
56836372|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
56836373|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56836374|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836375|NCT03790384|Mitomycins|mitomycins|mesh-list
56836376|NCT03790384|Mitomycin|mitomycin|mesh-list
56836377|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
56836378|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56836379|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836380|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
56836381|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836382|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56836383|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836384|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56836385|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
56836386|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836387|NCT01307488|Ritonavir|ritonavir|mesh-list
56836388|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56836389|NCT01307488|Lamivudine|lamivudine|mesh-list
56836390|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56836391|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56836392|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
56836393|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836394|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836395|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56836396|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56836397|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
56836398|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836399|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56836400|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56836401|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56836402|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56836404|NCT03790072|Fludarabine|fludarabine|mesh-list
56836405|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836406|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
56836407|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836408|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836409|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56836410|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
56836411|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836412|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836413|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56836415|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
56836416|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836417|NCT03794440|Sorafenib|sorafenib|mesh-list
56836418|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836419|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56836420|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836421|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836422|NCT00139776|Celecoxib|celecoxib|mesh-list
56836423|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56836424|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836425|NCT00139776|Analgesics|analgesics|mesh-ancestor
56836426|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
56836427|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836428|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836429|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836430|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836431|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56836432|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56836433|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836434|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836435|NCT00413699|Tofacitinib|tofacitinib|mesh-list
56836436|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56836437|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836438|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836439|NCT03713320|Vorinostat|vorinostat|mesh-list
56836440|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836441|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56836442|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836443|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836444|NCT00420407|Vasopressins|vasopressins|mesh-list
56836445|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
56836446|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
56836447|NCT00420407|Coagulants|coagulants|mesh-ancestor
56836448|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56836449|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56836450|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
56836451|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836452|NCT03789370|Propofol|propofol|mesh-list
56836453|NCT03789370|Sevoflurane|sevoflurane|mesh-list
56836454|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56836455|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56836456|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836457|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56836458|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
56836459|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
56836460|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56836461|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56836462|NCT00420095|Insulin|insulin|mesh-list
56836463|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56836464|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
56836465|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56836466|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836467|NCT04904692|Dimercaprol|dimercaprol|mesh-list
56836468|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
56836469|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
56836470|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836471|NCT01038089|Resveratrol|resveratrol|mesh-list
56836472|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
56836473|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836477|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56836478|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
56836479|NCT05495464|Rituximab|rituximab|mesh-list
56836480|NCT05495464|Fludarabine|fludarabine|mesh-list
56836481|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
56836482|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
56836483|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836484|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
56836485|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836486|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836487|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56836488|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
56836489|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836490|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836491|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56836492|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56836493|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56836494|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
56836495|NCT00419393|Levetiracetam|levetiracetam|mesh-list
56836496|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
56836497|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
56836498|NCT01038167|Cyclosporine|cyclosporine|mesh-list
56836499|NCT01038167|Tacrolimus|tacrolimus|mesh-list
56836500|NCT01038167|Cyclosporins|cyclosporins|mesh-list
56836501|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836502|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
56836503|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836504|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56836505|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836506|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836507|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
56836508|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836509|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
56836510|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836511|NCT03787030|Vitamin E|vitamin e|mesh-list
56836512|NCT03787030|Tocopherols|tocopherols|mesh-list
56836513|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
56836514|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
56836515|NCT03787030|Vitamins|vitamins|mesh-ancestor
56836516|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
56836517|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836518|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
56836519|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836520|NCT03787030|Protective Agents|protective agents|mesh-ancestor
56836521|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
56836522|NCT02174549|Tirapazamine|tirapazamine|mesh-list
56836523|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836524|NCT03786562|Morphine|morphine|mesh-list
56836525|NCT03786562|Nalbuphine|nalbuphine|mesh-list
56836526|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56836527|NCT03786562|Narcotics|narcotics|mesh-ancestor
56836528|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56836529|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836530|NCT03786562|Analgesics|analgesics|mesh-ancestor
56836531|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
56836532|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836533|NCT05694364|Cyclophosphamide|cyclophosphamide|mesh-list
56836534|NCT05694364|Fludarabine|fludarabine|mesh-list
56836535|NCT05694364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836536|NCT05694364|Immunologic Factors|immunologic factors|mesh-ancestor
56836537|NCT05694364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836538|NCT05694364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836539|NCT05694364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56836540|NCT05694364|Alkylating Agents|alkylating agents|mesh-ancestor
56836541|NCT05694364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836542|NCT05694364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836543|NCT05694364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56836544|NCT05694286|Hyaluronic Acid|hyaluronic acid|mesh-list
56836545|NCT05694286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56836546|NCT05694286|Immunologic Factors|immunologic factors|mesh-ancestor
56836547|NCT05694286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836548|NCT05694286|Viscosupplements|viscosupplements|mesh-ancestor
56836550|NCT01305148|Warfarin|warfarin|mesh-list
56836551|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
56836552|NCT01305226|Streptokinase|streptokinase|mesh-list
56836553|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56836554|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56836555|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836556|NCT01308268|Ivermectin|ivermectin|mesh-list
56836557|NCT01308268|Albendazole|albendazole|mesh-list
56836558|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56836559|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836560|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
56836561|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
56836562|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56836563|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56836564|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
56836565|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
56836566|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
56836567|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836568|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836570|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836571|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836572|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
56836573|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836574|NCT05694130|Prednisolone|prednisolone|mesh-list
56836575|NCT05694130|Tacrolimus|tacrolimus|mesh-list
56836576|NCT05694130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836577|NCT05694130|Immunologic Factors|immunologic factors|mesh-ancestor
56836578|NCT05694130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836579|NCT05694130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56836580|NCT05694130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836581|NCT05694130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836582|NCT05694130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836583|NCT05694130|Glucocorticoids|glucocorticoids|mesh-ancestor
56836584|NCT05694130|Hormones|hormones|mesh-ancestor
56836585|NCT05694130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56836586|NCT05694130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56836587|NCT05694130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836588|NCT00419159|Everolimus|everolimus|mesh-list
56836589|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836590|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836591|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
56836592|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836593|NCT03717064|Pitavastatin|pitavastatin|mesh-list
56903158|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836594|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56836595|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56836596|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56836597|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
56836598|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836599|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836600|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56836601|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
56836602|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
56836603|NCT02113163|Metformin|metformin|mesh-list
56836604|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56836605|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56836606|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836607|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56836608|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56836609|NCT00413153|Ritonavir|ritonavir|mesh-list
56836610|NCT00413153|Lopinavir|lopinavir|mesh-list
56836611|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56836612|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56836613|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56836614|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
56836615|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836616|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836617|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56836618|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56836619|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
56836620|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836621|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56836622|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56836623|NCT02107937|Paclitaxel|paclitaxel|mesh-list
56836624|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56836625|NCT02107937|Carboplatin|carboplatin|mesh-list
56836627|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836628|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
56836629|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
56836630|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
56836631|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836632|NCT01312402|Brinzolamide|brinzolamide|mesh-list
56836633|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56836634|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836635|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836636|NCT05693428|Propofol|propofol|mesh-list
56836637|NCT05693428|Sevoflurane|sevoflurane|mesh-list
56836638|NCT05693428|Isoflurane|isoflurane|mesh-list
56836639|NCT05693428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56836640|NCT05693428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56836641|NCT05693428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836642|NCT05693428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56836643|NCT05693428|Anesthetics, General|anesthetics, general|mesh-ancestor
56836644|NCT05693428|Anesthetics|anesthetics|mesh-ancestor
56836645|NCT05693428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56836646|NCT05693428|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56836647|NCT01035281|Nabilone|nabilone|mesh-list
56836648|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
56836649|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
56836650|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836651|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836652|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56836653|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56836654|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56836655|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56836656|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56836657|NCT01561066|Octreotide|octreotide|mesh-list
56836658|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56836659|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56836660|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56836661|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836662|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
56836663|NCT01561066|Coagulants|coagulants|mesh-ancestor
56836664|NCT00419003|Lamotrigine|lamotrigine|mesh-list
56836665|NCT00419003|Ketamine|ketamine|mesh-list
56836666|NCT00419003|Riluzole|riluzole|mesh-list
56836667|NCT00419003|Analgesics|analgesics|mesh-ancestor
56836668|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
56836669|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836670|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836671|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56836672|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56836673|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
56836674|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
56836675|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56836676|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56836677|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56836678|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56836679|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836680|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
56836681|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56836682|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56836683|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56836684|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56836685|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56836686|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56836687|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56836688|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56836689|NCT00419003|Protective Agents|protective agents|mesh-ancestor
56836690|NCT00418691|Methylphenidate|methylphenidate|mesh-list
56836691|NCT00418691|Modafinil|modafinil|mesh-list
56836692|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56836693|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836694|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56836695|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56836696|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56836697|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836698|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
56836699|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56836701|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56836702|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56836704|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
56836705|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56836706|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56836707|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56836708|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56836709|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836710|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56836711|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56836712|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56836713|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
56836714|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56836715|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836716|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56836717|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56836718|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
56836719|NCT01308658|Ritonavir|ritonavir|mesh-list
56836720|NCT01308658|Darunavir|darunavir|mesh-list
56836721|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56836722|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56836723|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
56836724|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836725|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836726|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56836727|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56836728|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
56836729|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836730|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56836731|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56836732|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56836733|NCT03777514|Hematinics|hematinics|mesh-ancestor
56836734|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56836735|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56836736|NCT03777124|Carboplatin|carboplatin|mesh-list
56836737|NCT03777124|Pemetrexed|pemetrexed|mesh-list
56836738|NCT03777124|Apatinib|apatinib|mesh-list
56836739|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836740|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836741|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836742|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56836743|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56443804|NCT00281255|Dobutamine|dobutamine|mesh-list
56836744|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56836745|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
56836746|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836747|NCT03780556|Lornoxicam|lornoxicam|mesh-list
56836748|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56836749|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56836750|NCT03780556|Analgesics|analgesics|mesh-ancestor
56836751|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
56836752|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836753|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836754|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836755|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836756|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
56836757|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56836758|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56836759|NCT00418145|Prednisolone|prednisolone|mesh-list
56836760|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
56836761|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56836762|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
56836763|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836764|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
56836765|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
56836766|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836767|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836768|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56836769|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
56836770|NCT00418145|Hormones|hormones|mesh-ancestor
56836771|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56836772|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56836773|NCT00418145|Protective Agents|protective agents|mesh-ancestor
56836774|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56836775|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836776|NCT03780634|Sorafenib|sorafenib|mesh-list
56836777|NCT03780634|Antibodies|antibodies|mesh-list
56836778|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
56836779|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
56836780|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836781|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836782|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56836783|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836784|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836785|NCT03777280|Cobalt|cobalt|mesh-list
56836786|NCT03777280|Chromium|chromium|mesh-list
56836787|NCT03777280|Trace Elements|trace elements|mesh-ancestor
56836788|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
56836789|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836790|NCT02043587|Leucovorin|leucovorin|mesh-list
56836791|NCT02043587|Cytarabine|cytarabine|mesh-list
56836792|NCT02043587|Prednisone|prednisone|mesh-list
56836793|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
56836794|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56836795|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56836796|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56836797|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
56836798|NCT02043587|Rituximab|rituximab|mesh-list
56836799|NCT02043587|Methotrexate|methotrexate|mesh-list
56836800|NCT02043587|Etoposide|etoposide|mesh-list
56836801|NCT02043587|Vincristine|vincristine|mesh-list
56836802|NCT02043587|Daunorubicin|daunorubicin|mesh-list
56836803|NCT02043587|Asparaginase|asparaginase|mesh-list
56836804|NCT02043587|Dasatinib|dasatinib|mesh-list
56836805|NCT02043587|Pegaspargase|pegaspargase|mesh-list
56836806|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836807|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
56836808|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836809|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836810|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56836811|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
56836812|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836813|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836814|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56836815|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56836816|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836817|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
56836818|NCT02043587|Hormones|hormones|mesh-ancestor
56836819|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56836820|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56836821|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56836822|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
56836823|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56836824|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56836825|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
56836826|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
56836827|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836828|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56836829|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56836830|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56836831|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56836832|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56836833|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
56836834|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836835|NCT02043587|Antidotes|antidotes|mesh-ancestor
56836836|NCT02043587|Protective Agents|protective agents|mesh-ancestor
56836837|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
56836838|NCT02043587|Vitamins|vitamins|mesh-ancestor
56836839|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
56836840|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56836841|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56836842|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
56836843|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56836844|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56836845|NCT01561222|Calcitriol|calcitriol|mesh-list
56836846|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56836847|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836848|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56836849|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56836850|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836851|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56836854|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56836855|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
56836856|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56836857|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56836858|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56836860|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56836861|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836862|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836863|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
56836864|NCT01039025|Melphalan|melphalan|mesh-list
56836865|NCT01039025|Topotecan|topotecan|mesh-list
56836866|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836867|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
56836868|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836869|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56836870|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56836871|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
56836872|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836873|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836874|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56836875|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56836876|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56836877|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836878|NCT03779776|Vitamins|vitamins|mesh-list
56836879|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
56836880|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836881|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56836882|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836883|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56836884|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836885|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836886|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56836887|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56836888|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836889|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
56836890|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836891|NCT01317784|Antibodies|antibodies|mesh-list
56836892|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
56836893|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
56836894|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
56836895|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836896|NCT03779464|Gemcitabine|gemcitabine|mesh-list
56836897|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56836898|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
56836899|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836900|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836901|NCT03779464|Antiviral Agents|antiviral agents|mesh-ancestor
56836902|NCT03779464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836903|NCT03779464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836904|NCT03779464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836905|NCT03779464|Immunologic Factors|immunologic factors|mesh-ancestor
56836906|NCT03779464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836907|NCT01309126|Cetuximab|cetuximab|mesh-list
56836908|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56836909|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836910|NCT03784378|Agerafenib|agerafenib|mesh-list
56836911|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56836912|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836913|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836914|NCT01314898|Spironolactone|spironolactone|mesh-list
56836915|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56836916|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
56836917|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56836918|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836919|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56836920|NCT01314898|Diuretics|diuretics|mesh-ancestor
56836921|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
56836922|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
56836923|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56836924|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
56836925|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56836926|NCT01315912|Letrozole|letrozole|mesh-list
56836927|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836928|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56836929|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56836930|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836931|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836932|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56836933|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
56836934|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56836935|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836936|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
56836937|NCT03778450|Analgesics|analgesics|mesh-list
56836938|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56836939|NCT03778450|Narcotics|narcotics|mesh-ancestor
56836940|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56836941|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836942|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
56547760|NCT02886299|Simvastatin|simvastatin|mesh-list
56836943|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56836945|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
56836946|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56836947|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836948|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
56836949|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56836950|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836951|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836952|NCT03778138|Pemetrexed|pemetrexed|mesh-list
56836953|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56836954|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836955|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836956|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56836957|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56836958|NCT04933552|Siponimod|siponimod|mesh-list
56836959|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56836960|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836961|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56836962|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
56836963|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836964|NCT03783754|Amlodipine|amlodipine|mesh-list
56836965|NCT03783754|Telmisartan|telmisartan|mesh-list
56836966|NCT03783754|Indapamide|indapamide|mesh-list
56836967|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56836968|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56836969|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56836970|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836971|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56836972|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56836973|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
56836974|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56836975|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56836976|NCT03783754|Diuretics|diuretics|mesh-ancestor
56836977|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
56836978|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56836979|NCT01309438|Erythromycin|erythromycin|mesh-list
56836980|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
56836981|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56836982|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
56836983|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
56836984|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56836985|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
56836986|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56836987|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
56836988|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56836989|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56836990|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
56836991|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56836992|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836993|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56836994|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56836995|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
56836996|NCT03776032|Hematinics|hematinics|mesh-ancestor
56836998|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56836999|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
56837000|NCT03775876|Propofol|propofol|mesh-list
56837001|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56837002|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837003|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837004|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56837005|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
56837006|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
56837007|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56837008|NCT03775876|Analgesics|analgesics|mesh-ancestor
56837009|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
56837010|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837011|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56837012|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56837013|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56837014|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
56837015|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837016|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837017|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56837018|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
56837019|NCT01320514|Coagulants|coagulants|mesh-ancestor
56837020|NCT03773536|Artesunate|artesunate|mesh-list
56837021|NCT03773536|Primaquine|primaquine|mesh-list
56837022|NCT03773536|Amodiaquine|amodiaquine|mesh-list
56837023|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
56837024|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56837025|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56837026|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837027|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837028|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
56837029|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
56837030|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56837031|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
56837032|NCT01320592|Paclitaxel|paclitaxel|mesh-list
56837033|NCT01320592|Palbociclib|palbociclib|mesh-list
56837034|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56837035|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837036|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
56837037|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
56837038|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
56837039|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837040|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56837041|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837042|NCT03783676|Remifentanil|remifentanil|mesh-list
56837043|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56837044|NCT03783676|Narcotics|narcotics|mesh-ancestor
56837045|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837046|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837047|NCT03783676|Analgesics|analgesics|mesh-ancestor
56837048|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
56837049|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837050|NCT04905316|Durvalumab|durvalumab|mesh-list
56837051|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56837052|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837053|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56837055|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
56837056|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837057|NCT01320982|Aspirin|aspirin|mesh-list
56837058|NCT01320982|Minocycline|minocycline|mesh-list
56837059|NCT01320982|Pramipexole|pramipexole|mesh-list
56837060|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56837061|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56837062|NCT01320982|Analgesics|analgesics|mesh-ancestor
56837063|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
56837064|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837065|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837066|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837067|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56837068|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56837069|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56837070|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837071|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56837072|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56837073|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837075|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56837076|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837077|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
56837078|NCT01320982|Protective Agents|protective agents|mesh-ancestor
56837079|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56837080|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56837081|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
56837082|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
56837083|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837084|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
56837085|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56837086|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56837087|NCT01321138|Morphine|morphine|mesh-list
56837088|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56837089|NCT01321138|Narcotics|narcotics|mesh-ancestor
56837090|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837091|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837092|NCT01321138|Analgesics|analgesics|mesh-ancestor
56837093|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
56837094|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837095|NCT04628572|Ceftazidime|ceftazidime|mesh-list
56837096|NCT04628572|Avibactam|avibactam|mesh-list
56837097|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
56837098|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56837099|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837100|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56837101|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837102|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837103|NCT03772990|Calcium|calcium|mesh-list
56837104|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56837105|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837106|NCT03782662|Itraconazole|itraconazole|mesh-list
56837107|NCT03782662|Rifampin|rifampin|mesh-list
56837108|NCT03782662|Verapamil|verapamil|mesh-list
56837109|NCT03782662|Midazolam|midazolam|mesh-list
56837110|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56837111|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56837112|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837113|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837114|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56837115|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56837116|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56837117|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56903167|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
56837118|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
56837119|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
56837120|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
56837121|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
56837122|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837123|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837124|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
56837125|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837126|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56837127|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56837128|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837129|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56837130|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
56837131|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837132|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56837133|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56837134|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
56837135|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56837136|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
56837137|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56837138|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56837139|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56837140|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56837141|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56837142|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56837143|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56837144|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56837145|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56837146|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56837147|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56837148|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
56837149|NCT01309984|Propofol|propofol|mesh-list
56837150|NCT01309984|Fospropofol|fospropofol|mesh-list
56837151|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56837152|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837153|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837154|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56837155|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
56837156|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
56837157|NCT03772054|Propofol|propofol|mesh-list
56837158|NCT03772054|Sevoflurane|sevoflurane|mesh-list
56837159|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56837160|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837161|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837162|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56837163|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
56837164|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
56837165|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56837166|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56837167|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
56837168|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56837169|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547984|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
56837170|NCT05531890|Betamethasone|betamethasone|mesh-list
56837171|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
56837172|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56837173|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
56837174|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56837175|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56837176|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837177|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
56837178|NCT05531890|Hormones|hormones|mesh-ancestor
56837179|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837180|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837181|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56837182|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
56837183|NCT00123474|Dasatinib|dasatinib|mesh-list
56837184|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837185|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56837186|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837187|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837188|NCT00142298|Telbivudine|telbivudine|mesh-list
56837189|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
56837190|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837191|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56837192|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837193|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837194|NCT03774706|Misoprostol|misoprostol|mesh-list
56837195|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
56837196|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56837197|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56837198|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837199|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
56837200|NCT03774706|Coagulants|coagulants|mesh-ancestor
56837201|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56837202|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
56837203|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56837204|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837205|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56837206|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56837207|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
56837208|NCT03967496|Metformin|metformin|mesh-list
56837209|NCT03967496|Amlodipine|amlodipine|mesh-list
56837210|NCT03967496|Lisinopril|lisinopril|mesh-list
56837211|NCT03967496|Bisoprolol|bisoprolol|mesh-list
56837212|NCT03967496|Hydralazine|hydralazine|mesh-list
56837213|NCT03967496|Anesthetics|anesthetics|mesh-list
56837214|NCT03967496|Atorvastatin|atorvastatin|mesh-list
56837215|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56837216|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837217|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837218|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56837219|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56837220|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
56837221|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837222|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56837223|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56837246|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
56837247|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837248|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56837249|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56837250|NCT03964350|Ethanol|ethanol|mesh-list
56837251|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56837252|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837253|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837254|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837255|NCT01310452|Insulin|insulin|mesh-list
56837256|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56837257|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
56837258|NCT01310452|Protamines|protamines|mesh-list
56837259|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56837260|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837261|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
56837262|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837263|NCT01310452|Coagulants|coagulants|mesh-ancestor
56837264|NCT01035671|Vitamin E|vitamin e|mesh-list
56837265|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
56837266|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
56837267|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56837268|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
56837269|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837270|NCT01035671|Protective Agents|protective agents|mesh-ancestor
56837271|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837272|NCT01035671|Vitamins|vitamins|mesh-ancestor
56837273|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
56837274|NCT04560868|Nicotine|nicotine|mesh-list
56837275|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56837276|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
56837277|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837278|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837279|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56837280|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56837281|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
56837282|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837283|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837285|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
56837286|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
56837287|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837288|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837289|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
56837290|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837291|NCT03769402|Citric Acid|citric acid|mesh-list
56837292|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
56837293|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
56837294|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56837295|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
56837296|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
56837297|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837298|NCT00411671|Sorafenib|sorafenib|mesh-list
56837299|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837300|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56837301|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837302|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837303|NCT01035983|Frovatriptan|frovatriptan|mesh-list
56837304|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56837305|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
56837306|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837307|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837308|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837309|NCT03770806|Acetaminophen|acetaminophen|mesh-list
56837310|NCT03770806|Celecoxib|celecoxib|mesh-list
56837311|NCT03770806|Oxycodone|oxycodone|mesh-list
56837312|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56837313|NCT03770806|Analgesics|analgesics|mesh-ancestor
56837314|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
56837315|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837316|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837317|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
56837318|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56837319|NCT03770806|Narcotics|narcotics|mesh-ancestor
56837320|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837321|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56837322|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837323|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56837324|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56837325|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56837326|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837327|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837328|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
56837329|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56837330|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56837331|NCT01039103|Prednisolone|prednisolone|mesh-list
56837332|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
56837333|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56837334|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
56837335|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837336|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
56837337|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
56837338|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837339|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837340|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56837341|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
56837342|NCT01039103|Hormones|hormones|mesh-ancestor
56837343|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837344|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56837345|NCT01039103|Protective Agents|protective agents|mesh-ancestor
56837346|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56837347|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837348|NCT01039181|Vitamin D|vitamin d|mesh-list
56837349|NCT01039181|Calcitriol|calcitriol|mesh-list
56837350|NCT01039181|Vitamins|vitamins|mesh-ancestor
56837351|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
56351727|NCT00096369|Tamoxifen|tamoxifen|mesh-list
56837352|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837353|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56837354|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56837355|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56837356|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56837357|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837358|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56837359|NCT03770026|Clomiphene|clomiphene|mesh-list
56837360|NCT03770026|Enclomiphene|enclomiphene|mesh-list
56837361|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
56837362|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56837363|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
56837364|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837365|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837366|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56837367|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
56837368|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56837369|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56837370|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56837371|NCT03769870|Atorvastatin|atorvastatin|mesh-list
56837372|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56837373|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56837374|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
56837375|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837376|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56837377|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56837378|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837379|NCT01589081|Nicotine|nicotine|mesh-list
56837380|NCT01589081|Progesterone|progesterone|mesh-list
56837381|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56837382|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
56837383|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837384|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837385|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56837386|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56837387|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
56837388|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837389|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837390|NCT01589081|Progestins|progestins|mesh-ancestor
56837391|NCT01589081|Hormones|hormones|mesh-ancestor
56837392|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837393|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56837394|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56837395|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837396|NCT01567540|Incretins|incretins|mesh-ancestor
56837398|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837399|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56837400|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
56837401|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837402|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837403|NCT04047472|Aflibercept|aflibercept|mesh-list
56837404|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56837405|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56837406|NCT04047472|Growth Substances|growth substances|mesh-ancestor
56837407|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837408|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
56837409|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837410|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56837411|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
56837412|NCT01036841|Coagulants|coagulants|mesh-ancestor
56837413|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56837414|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
56837415|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837416|NCT03709576|Azacitidine|azacitidine|mesh-list
56837417|NCT03709576|Pevonedistat|pevonedistat|mesh-list
56837418|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56837419|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
56837420|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837421|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837422|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837423|NCT00122460|Cisplatin|cisplatin|mesh-list
56837424|NCT00122460|Carboplatin|carboplatin|mesh-list
56837425|NCT00122460|Fluorouracil|fluorouracil|mesh-list
56837426|NCT00122460|Cetuximab|cetuximab|mesh-list
56837429|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837430|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56837431|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56837432|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
56837433|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837434|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56837435|NCT03763396|Ketoconazole|ketoconazole|mesh-list
56837436|NCT03763396|Posaconazole|posaconazole|mesh-list
56837437|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
56837438|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837439|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56837440|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56837441|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837442|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837443|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56837444|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
56837445|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837446|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837447|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56837448|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56837449|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56837450|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56837451|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56837452|NCT01320436|Curcumin|curcumin|mesh-list
56837453|NCT01320436|Mesalamine|mesalamine|mesh-list
56837454|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56837455|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56837456|NCT01320436|Analgesics|analgesics|mesh-ancestor
56837457|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
56837458|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837459|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837460|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837461|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56837462|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837463|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837464|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837465|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
56837466|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56837467|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837468|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
56837469|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837470|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56837471|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837472|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837473|NCT03763084|Acetaminophen|acetaminophen|mesh-list
56837474|NCT03763084|Sufentanil|sufentanil|mesh-list
56837475|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56837476|NCT03763084|Analgesics|analgesics|mesh-ancestor
56837477|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
56837478|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837479|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837480|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
56837481|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56837482|NCT03763084|Narcotics|narcotics|mesh-ancestor
56837483|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837484|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56837485|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56837486|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
56837487|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
56837488|NCT01567618|Docetaxel|docetaxel|mesh-list
56837489|NCT01567618|Fluorouracil|fluorouracil|mesh-list
56837490|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837491|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
56837492|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
56837493|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
56837494|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837495|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
56837496|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56837497|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56837498|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
56837499|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837501|NCT03762928|Midazolam|midazolam|mesh-list
56837502|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56837503|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56837504|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837505|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837506|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56837507|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56837508|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56837509|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56837510|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
56837511|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
56837512|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
56837513|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
56837514|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837515|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837516|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56837517|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56837518|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837519|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
56837520|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837521|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56837522|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56837523|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56837524|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56837525|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56837526|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56837527|NCT01561456|Docetaxel|docetaxel|mesh-list
56837528|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837529|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
56837530|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
56837531|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
56837532|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837533|NCT00137436|Prednisone|prednisone|mesh-list
56837534|NCT00137436|Docetaxel|docetaxel|mesh-list
56837535|NCT00137436|Sunitinib|sunitinib|mesh-list
56837536|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837537|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
56837538|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
56837539|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
56837540|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837541|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837542|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
56837543|NCT00137436|Hormones|hormones|mesh-ancestor
56837544|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837545|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837546|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56837547|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56837548|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56837549|NCT00137436|Growth Substances|growth substances|mesh-ancestor
56837550|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
56837551|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56837552|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837553|NCT03762538|Propofol|propofol|mesh-list
56837554|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56837555|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837556|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837557|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56837558|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
56837559|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
56837560|NCT03762382|Tenofovir|tenofovir|mesh-list
56837561|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
56837562|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
56837563|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837564|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56837565|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56837566|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837567|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837568|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56837569|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56837570|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56837571|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
56837572|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56837573|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837575|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56837576|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56837577|NCT04005352|Aflibercept|aflibercept|mesh-list
56837578|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56837579|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56837580|NCT04005352|Growth Substances|growth substances|mesh-ancestor
56837581|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837582|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
56837583|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837584|NCT03767920|Dexamethasone|dexamethasone|mesh-list
56837585|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
56837586|NCT03767920|Bupivacaine|bupivacaine|mesh-list
56837587|NCT03767920|BB 1101|bb 1101|mesh-list
56837588|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837589|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
56837590|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
56837591|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837592|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837593|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56837594|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
56837595|NCT03767920|Hormones|hormones|mesh-ancestor
56837596|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837597|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56837598|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837599|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
56837600|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837601|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837602|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
56837603|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
56837604|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837605|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
56837606|NCT03834623|Nivolumab|nivolumab|mesh-list
56837607|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56837608|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837609|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56837610|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837611|NCT03762148|Vitamins|vitamins|mesh-list
56837612|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
56837613|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
56837614|NCT03762148|Iron|iron|mesh-list
56837615|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
56837616|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837617|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
56837618|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837619|NCT03762148|Protective Agents|protective agents|mesh-ancestor
56837620|NCT03762148|Trace Elements|trace elements|mesh-ancestor
56837621|NCT01589159|Capecitabine|capecitabine|mesh-list
56837622|NCT01589159|Etoposide|etoposide|mesh-list
56920153|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
56837623|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56837624|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
56837625|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837626|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837627|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56837628|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56837629|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56837630|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837631|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56837632|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837633|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
56837634|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56837635|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837636|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
56837637|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56837638|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837639|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837640|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56837641|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56837642|NCT03625648|Protective Agents|protective agents|mesh-ancestor
56837643|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837644|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
56837645|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56837646|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
56837647|NCT03767296|Phenylephrine|phenylephrine|mesh-list
56837649|NCT03767296|Ephedrine|ephedrine|mesh-list
56837650|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
56837651|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56837652|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
56837653|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
56837654|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837655|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837656|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
56837657|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56837658|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
56837659|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
56837660|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56837661|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56837662|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56837663|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
56837664|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837665|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837666|NCT03767296|Protective Agents|protective agents|mesh-ancestor
56837667|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56837668|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56837669|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56837670|NCT00410813|Dasatinib|dasatinib|mesh-list
56837671|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837672|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56837673|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837674|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837675|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56837676|NCT03767218|Hormones|hormones|mesh-ancestor
56837677|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837678|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837679|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
56837680|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56837681|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837682|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837683|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56837684|NCT03760978|Analgesics|analgesics|mesh-ancestor
56837685|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
56837686|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837687|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56837688|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56837689|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56837690|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
56837691|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837692|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837693|NCT03766984|Diclofenac|diclofenac|mesh-list
56837694|NCT03766984|Tramadol|tramadol|mesh-list
56837695|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56837696|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56837697|NCT03766984|Analgesics|analgesics|mesh-ancestor
56837698|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
56837699|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837700|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837701|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837702|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56837703|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56837704|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837705|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837706|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56837707|NCT03766984|Narcotics|narcotics|mesh-ancestor
56837708|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837709|NCT00405821|Acyclovir|acyclovir|mesh-list
56837710|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
56837711|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837712|NCT01322464|Nabiximols|nabiximols|mesh-list
56837713|NCT01322464|Analgesics|analgesics|mesh-ancestor
56837714|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
56837715|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837716|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837717|NCT03928600|Misoprostol|misoprostol|mesh-list
56837718|NCT03928600|Dinoprostone|dinoprostone|mesh-list
56837719|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56837720|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
56837721|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56837722|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837724|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56837725|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
56837726|NCT03924856|Gemcitabine|gemcitabine|mesh-list
56837727|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
56837728|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837729|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56837730|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
56837731|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837732|NCT03924856|Antiviral Agents|antiviral agents|mesh-ancestor
56837733|NCT03924856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837734|NCT03924856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837735|NCT03924856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56837736|NCT03924856|Immunologic Factors|immunologic factors|mesh-ancestor
56837737|NCT03924856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837738|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56837739|NCT03760822|Paclitaxel|paclitaxel|mesh-list
56837740|NCT03760822|Ramucirumab|ramucirumab|mesh-list
56837741|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56837742|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837743|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
56837744|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
56837745|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
56837746|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837747|NCT01322152|Capecitabine|capecitabine|mesh-list
56837748|NCT01322152|Irinotecan|irinotecan|mesh-list
56837749|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56837750|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
56837751|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837752|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837753|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56837754|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56837755|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837756|NCT01446016|Paclitaxel|paclitaxel|mesh-list
56837757|NCT01446016|Docetaxel|docetaxel|mesh-list
56837758|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56837759|NCT01446016|Taxane|taxane|mesh-list
56837760|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56837761|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837762|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
56837763|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
56837764|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
56837765|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837766|NCT00137046|Insulin|insulin|mesh-list
56837767|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56837768|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56837769|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837770|NCT03456076|Gemcitabine|gemcitabine|mesh-list
56837771|NCT03456076|Carboplatin|carboplatin|mesh-list
56837772|NCT03456076|Pemetrexed|pemetrexed|mesh-list
56548591|NCT01217060|Dexamethasone|dexamethasone|mesh-list
56837773|NCT03456076|Vinorelbine|vinorelbine|mesh-list
56837774|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837775|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56837776|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
56837777|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837778|NCT03456076|Antiviral Agents|antiviral agents|mesh-ancestor
56837779|NCT03456076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837780|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837781|NCT03456076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56837782|NCT03456076|Immunologic Factors|immunologic factors|mesh-ancestor
56837783|NCT03456076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837784|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56837785|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56837786|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56837787|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
56837788|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
56837789|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
56837790|NCT03383458|Nivolumab|nivolumab|mesh-list
56837791|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56837792|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837793|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56837794|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837795|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
56837796|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56837797|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56837799|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
56837800|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56837801|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
56837802|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837803|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
56837804|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
56837805|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837806|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837807|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56837808|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
56837809|NCT03760354|Hormones|hormones|mesh-ancestor
56837810|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837811|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56837812|NCT03760354|Protective Agents|protective agents|mesh-ancestor
56837813|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56837814|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837815|NCT03760276|Voriconazole|voriconazole|mesh-list
56837816|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
56837817|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837818|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56837819|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56837820|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837821|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837822|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56837823|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
56837824|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837825|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837826|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56837827|NCT03766594|Folic Acid|folic acid|mesh-list
56837828|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
56837829|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837830|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
56837831|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56837832|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56837833|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837834|NCT03766594|Urological Agents|urological agents|mesh-ancestor
56837835|NCT03766594|Hematinics|hematinics|mesh-ancestor
56837836|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
56837837|NCT03766594|Vitamins|vitamins|mesh-ancestor
56837838|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
56837839|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837840|NCT03923374|Buprenorphine|buprenorphine|mesh-list
56837841|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56837842|NCT03923374|Narcotics|narcotics|mesh-ancestor
56837843|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56837844|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837845|NCT03923374|Analgesics|analgesics|mesh-ancestor
56837846|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
56837847|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837848|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56837849|NCT03280030|Midostaurin|midostaurin|mesh-list
56837850|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837851|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56837852|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837853|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837854|NCT00122382|Methotrexate|methotrexate|mesh-list
56837855|NCT00122382|Abatacept|abatacept|mesh-list
56837856|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56837857|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
56837858|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56837859|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837860|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56837861|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
56837862|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837863|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837864|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56837865|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837866|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56837867|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56837868|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
56837869|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904606|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
56837870|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56837871|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56837872|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
56837873|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
56837874|NCT01028716|Fludarabine|fludarabine|mesh-list
56837875|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
56837876|NCT01028716|Tacrolimus|tacrolimus|mesh-list
56837877|NCT01028716|Lenograstim|lenograstim|mesh-list
56837878|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56837879|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
56837880|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837881|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56837882|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56837883|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
56837884|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837885|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837886|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56837887|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56837888|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
56837889|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56837890|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837891|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56837892|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56837893|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56837894|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
56837895|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56837896|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837897|NCT02531724|Simendan|simendan|mesh-list
56837898|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56837899|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
56837900|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56837901|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56837902|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837903|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837904|NCT02531724|Protective Agents|protective agents|mesh-ancestor
56837905|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837906|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56837907|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56837908|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837909|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837910|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56837911|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56837912|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837913|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
56837914|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837915|NCT00106704|Pioglitazone|pioglitazone|mesh-list
56837916|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56837917|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56837918|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837919|NCT00106704|Incretins|incretins|mesh-ancestor
56837920|NCT00106704|Hormones|hormones|mesh-ancestor
56837921|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56837922|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56837923|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
56837924|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837925|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837926|NCT03759886|Metronidazole|metronidazole|mesh-list
56837927|NCT03759886|Paromomycin|paromomycin|mesh-list
56837928|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837929|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56837930|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56837931|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56837932|NCT01081158|Ritonavir|ritonavir|mesh-list
56837933|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56837934|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
56837935|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56837936|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56837937|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
56837938|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837939|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837940|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56837941|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56837942|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
56837943|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56837944|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56054095|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
56837945|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56837947|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837948|NCT00105066|Metformin|metformin|mesh-list
56837949|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56837950|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837951|NCT01322308|Pioglitazone|pioglitazone|mesh-list
56837952|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56837953|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837954|NCT05208268|Rabeprazole|rabeprazole|mesh-list
56837955|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56837956|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56837957|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56837958|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837959|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837960|NCT03165292|Topotecan|topotecan|mesh-list
56837961|NCT03165292|Thiotepa|thiotepa|mesh-list
56837962|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56837963|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56837964|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56837965|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837966|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837967|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56837968|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
56837969|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56837970|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56837971|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
56837972|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837973|NCT03109288|Pioglitazone|pioglitazone|mesh-list
56837974|NCT03109288|Clemastine|clemastine|mesh-list
56837975|NCT03109288|Pirfenidone|pirfenidone|mesh-list
56837976|NCT03109288|Dantrolene|dantrolene|mesh-list
56837977|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56837978|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56837979|NCT03109288|Analgesics|analgesics|mesh-ancestor
56837980|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
56837981|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56837982|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56837983|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56837984|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56837985|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56837986|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56837987|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
56837988|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
56837989|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56837990|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
56837991|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
56837992|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56837993|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56837994|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56837995|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56837996|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56837997|NCT03759262|Vitamin D|vitamin d|mesh-list
56837998|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
56838000|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
56838001|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838002|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56838003|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56838004|NCT00135330|Exenatide|exenatide|mesh-list
56838005|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
56838006|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838007|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838008|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56838009|NCT00135330|Incretins|incretins|mesh-ancestor
56838010|NCT00135330|Hormones|hormones|mesh-ancestor
56838011|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56838012|NCT01076478|Cilostazol|cilostazol|mesh-list
56838013|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56838014|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
56838015|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838016|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838017|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56838018|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
56838019|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56838020|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56904607|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
56838021|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838022|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56838023|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
56838024|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56838025|NCT01076478|Protective Agents|protective agents|mesh-ancestor
56838026|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56838027|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56838028|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838029|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
56838030|NCT01076556|Rituximab|rituximab|mesh-list
56838031|NCT01076556|Alvocidib|alvocidib|mesh-list
56838032|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56838033|NCT01076556|Antibodies|antibodies|mesh-list
56838034|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
56838035|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56838036|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838037|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
56838038|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838039|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56838040|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56838041|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
56838042|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838043|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838044|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56838045|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
56838046|NCT01076556|Growth Substances|growth substances|mesh-ancestor
56838047|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56838048|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838049|NCT03965442|Esmolol|esmolol|mesh-list
56838050|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56838051|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56838052|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56838053|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56838054|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838055|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838056|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838057|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
56838058|NCT00134082|Rituximab|rituximab|mesh-list
56838059|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838060|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
56838061|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838062|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56838063|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56838064|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
56838065|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838066|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838067|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56838068|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56838069|NCT01326312|Leuprolide|leuprolide|mesh-list
56838070|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56548892|NCT00648817|Tenofovir|tenofovir|mesh-list
56838071|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
56838072|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56838073|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838074|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56838075|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838076|NCT03765346|Oxycodone|oxycodone|mesh-list
56838077|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56838078|NCT03765346|Narcotics|narcotics|mesh-ancestor
56838079|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838080|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838081|NCT03765346|Analgesics|analgesics|mesh-ancestor
56838082|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
56838083|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838084|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
56838085|NCT01078818|Trace Elements|trace elements|mesh-ancestor
56838086|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
56838087|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838088|NCT01079052|Famotidine|famotidine|mesh-list
56838089|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56838090|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56838091|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56838092|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
56838093|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
56838094|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904608|NCT02086474|Protective Agents|protective agents|mesh-ancestor
56838095|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838096|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838098|NCT01326468|Cisplatin|cisplatin|mesh-list
56838099|NCT01326468|Cetuximab|cetuximab|mesh-list
56838100|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838101|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56838102|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56838103|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838104|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56838105|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
56838106|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838107|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
56838108|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838109|NCT01076634|Insulin|insulin|mesh-list
56838110|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56838111|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
56838112|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838113|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838114|NCT00132678|Risperidone|risperidone|mesh-list
56838115|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56838116|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
56838117|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838118|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838119|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838120|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56838121|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56838122|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838123|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56838124|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56838125|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
56838126|NCT01081548|Atorvastatin|atorvastatin|mesh-list
56838127|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56838128|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56838129|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
56838130|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838131|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56838132|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56838133|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838134|NCT00101400|Sorafenib|sorafenib|mesh-list
56838135|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838136|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56838137|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838138|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838139|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
56838140|NCT00121992|Docetaxel|docetaxel|mesh-list
56838141|NCT00121992|Doxorubicin|doxorubicin|mesh-list
56838142|NCT00121992|Fluorouracil|fluorouracil|mesh-list
56838143|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838144|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
56548958|NCT01215032|Metformin|metformin|mesh-list
56838145|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838146|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56838147|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56838148|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
56838149|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838150|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838151|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56838152|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56838153|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56838154|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56838155|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56838156|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56838157|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56838158|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838159|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
56838160|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56838161|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
56838162|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56838163|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838164|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838165|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56838166|NCT01076790|Analgesics|analgesics|mesh-ancestor
56838167|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
56838168|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838169|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56838170|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56838171|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56838172|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
56838173|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838174|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838175|NCT01582932|Calcipotriene|calcipotriene|mesh-list
56838176|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
56838178|NCT03965286|Ledipasvir|ledipasvir|mesh-list
56838179|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56838180|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
56838181|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838182|NCT01079286|Sirolimus|sirolimus|mesh-list
56838183|NCT01079286|Nelfinavir|nelfinavir|mesh-list
56838184|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56838185|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838186|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56838187|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838188|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
56838189|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838190|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
56838191|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838192|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56838193|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56838194|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
56838195|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838196|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838197|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56838198|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56838199|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
56838200|NCT01081704|Ustekinumab|ustekinumab|mesh-list
56838201|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
56838202|NCT00141518|Levodopa|levodopa|mesh-list
56838203|NCT00141518|Carbidopa|carbidopa|mesh-list
56838204|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56838205|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56838206|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56838207|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
56838208|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838209|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838210|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838211|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56838212|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838213|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56838214|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
56838215|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
56838216|NCT01075880|Interferons|interferons|mesh-list
56838217|NCT01075880|Interferon-beta|interferon-beta|mesh-list
56838218|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
56838219|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838220|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
56838221|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838222|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
56838223|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838224|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56838225|NCT00098748|Maraviroc|maraviroc|mesh-list
56838226|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56838227|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56838228|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838229|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56838230|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56838231|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
56838232|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838233|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56838234|NCT00130520|Bevacizumab|bevacizumab|mesh-list
56838235|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56838236|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56838237|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838238|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56838239|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56838240|NCT00130520|Growth Substances|growth substances|mesh-ancestor
56838241|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838242|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
56838243|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56838244|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838245|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838246|NCT00130442|Dacarbazine|dacarbazine|mesh-list
56838247|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56838248|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
56838249|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838250|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838251|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56838252|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
56838253|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56838254|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
56838255|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838256|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56838257|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56838258|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56838259|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838260|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838261|NCT00253370|Cisplatin|cisplatin|mesh-list
56838262|NCT00253370|Docetaxel|docetaxel|mesh-list
56838263|NCT00253370|Sorafenib|sorafenib|mesh-list
56838264|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838265|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
56838266|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
56838267|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
56838268|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838269|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56838270|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838271|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56838272|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
56838273|NCT00140426|Risperidone|risperidone|mesh-list
56838274|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56838275|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
56838276|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838277|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838278|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838279|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56838280|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56838281|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838282|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56838283|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56838284|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
56838285|NCT03966560|Timolol|timolol|mesh-list
56838286|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56838287|NCT03966560|Bimatoprost|bimatoprost|mesh-list
56838288|NCT03966560|Travoprost|travoprost|mesh-list
56838289|NCT03966560|Dorzolamide|dorzolamide|mesh-list
56838290|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56838291|NCT03966560|Latanoprost|latanoprost|mesh-list
56838292|NCT03966560|Brinzolamide|brinzolamide|mesh-list
56838293|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56838294|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838295|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838296|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56838297|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56838298|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
56838299|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838300|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838301|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56838302|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56838303|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56838304|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56838305|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56838306|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56838307|NCT01072058|Adalimumab|adalimumab|mesh-list
56838308|NCT01072058|Etanercept|etanercept|mesh-list
56838309|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56838310|NCT01072058|Infliximab|infliximab|mesh-list
56838311|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56838312|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56838313|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
56838314|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56838315|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56838316|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56838317|NCT01072058|Analgesics|analgesics|mesh-ancestor
56838318|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
56838319|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838320|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838322|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
56838323|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
56838324|NCT00121134|Bevacizumab|bevacizumab|mesh-list
56838325|NCT00121134|Capecitabine|capecitabine|mesh-list
56838326|NCT00121134|Methotrexate|methotrexate|mesh-list
56838327|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838328|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
56838329|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838330|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56838331|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56838332|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
56838333|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838334|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838335|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56838336|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56838337|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56838338|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56838339|NCT00121134|Growth Substances|growth substances|mesh-ancestor
56838340|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
56838341|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56838342|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
56838343|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56838344|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
56838345|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56838346|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
56838347|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838348|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56838349|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56838350|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
56838351|NCT03966378|Calcium|calcium|mesh-list
56838352|NCT03966378|Caseins|caseins|mesh-list
56838353|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56838354|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838355|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
56838356|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
56838357|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838358|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56838359|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838360|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
56838361|NCT03966378|Protective Agents|protective agents|mesh-ancestor
56838362|NCT02657434|Carboplatin|carboplatin|mesh-list
56838363|NCT02657434|Pemetrexed|pemetrexed|mesh-list
56838364|NCT02657434|Atezolizumab|atezolizumab|mesh-list
56838365|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838366|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838367|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838368|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56838369|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56838370|NCT02652052|Dasatinib|dasatinib|mesh-list
56838371|NCT02652052|Quercetin|quercetin|mesh-list
56838372|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838373|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56838374|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838375|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838376|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
56838377|NCT02652052|Protective Agents|protective agents|mesh-ancestor
56838378|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838379|NCT00119262|Tamoxifen|tamoxifen|mesh-list
56838380|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
56838381|NCT00119262|Bevacizumab|bevacizumab|mesh-list
56838382|NCT00119262|Doxorubicin|doxorubicin|mesh-list
56838383|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56838384|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56838385|NCT00119262|Antibodies|antibodies|mesh-list
56838386|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
56838387|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56838388|NCT00119262|Lenograstim|lenograstim|mesh-list
56838389|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56838390|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838391|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838392|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838393|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
56838394|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838395|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904609|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
56838396|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56838397|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
56838398|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56838399|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56838400|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56838401|NCT00119262|Growth Substances|growth substances|mesh-ancestor
56838402|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56838403|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56838404|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56838405|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56838406|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838407|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56838408|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56838409|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
56838410|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56838411|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56838412|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56838413|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56838414|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56838415|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56838416|NCT00131664|Metformin|metformin|mesh-list
56838417|NCT00131664|Glimepiride|glimepiride|mesh-list
56838418|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
56838419|NCT00131664|Maleic acid|maleic acid|mesh-list
56838420|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838421|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838422|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838423|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838424|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56838425|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838426|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
56838427|NCT05050318|Vaccines|vaccines|mesh-list
56838428|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
56838429|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838430|NCT03778996|Sirolimus|sirolimus|mesh-list
56838431|NCT03778996|Phenytoin|phenytoin|mesh-list
56838432|NCT03778996|Methoxsalen|methoxsalen|mesh-list
56838433|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
56838434|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56838435|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838436|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56838437|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838438|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
56838439|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838440|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
56838441|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838442|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
56838443|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56838444|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56838445|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56838446|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838447|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56838448|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56838449|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56838450|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
56838451|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838452|NCT03764722|Simendan|simendan|mesh-list
56838453|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56838454|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
56838455|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56838456|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56838457|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838458|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838459|NCT03764722|Protective Agents|protective agents|mesh-ancestor
56838460|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838462|NCT05024734|Docetaxel|docetaxel|mesh-list
56838463|NCT05024734|Epirubicin|epirubicin|mesh-list
56838464|NCT05024734|Mitomycins|mitomycins|mesh-list
56838465|NCT05024734|Mitomycin|mitomycin|mesh-list
56838466|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56838467|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
56838468|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838469|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838470|NCT05024734|Antiviral Agents|antiviral agents|mesh-ancestor
56838471|NCT05024734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838472|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838473|NCT05024734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838474|NCT05024734|Immunologic Factors|immunologic factors|mesh-ancestor
56838475|NCT05024734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838476|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56838477|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56838478|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56838479|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56838480|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56838481|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56838482|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
56838483|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56838484|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
56838485|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56838486|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838487|NCT03756298|Capecitabine|capecitabine|mesh-list
56838488|NCT03756298|Atezolizumab|atezolizumab|mesh-list
56838489|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56838490|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
56838491|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838492|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838493|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
56838495|NCT03756220|Vitamins|vitamins|mesh-ancestor
56838496|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
56838497|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838498|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
56838499|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838500|NCT03756220|Protective Agents|protective agents|mesh-ancestor
56838501|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
56838502|NCT04980040|Alogliptin|alogliptin|mesh-list
56838503|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838504|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838505|NCT04980040|Incretins|incretins|mesh-ancestor
56838506|NCT04980040|Hormones|hormones|mesh-ancestor
56838507|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56838508|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56838509|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
56838510|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838511|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838512|NCT04647916|Camptothecin|camptothecin|mesh-list
56838513|NCT04647916|Irinotecan|irinotecan|mesh-list
56838514|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
56838515|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
56838516|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838517|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56838518|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838519|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56838520|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56838521|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838522|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838523|NCT00131352|Hylan|hylan|mesh-list
56838524|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
56838525|NCT00131352|Protective Agents|protective agents|mesh-ancestor
56838526|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838527|NCT00136916|Insulin|insulin|mesh-list
56838528|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56838529|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838530|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838531|NCT04633564|Bevacizumab|bevacizumab|mesh-list
56838532|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56838533|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838534|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56838535|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56838536|NCT04633564|Growth Substances|growth substances|mesh-ancestor
56838537|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838538|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
56838539|NCT03756064|Carboplatin|carboplatin|mesh-list
56838540|NCT03756064|Docetaxel|docetaxel|mesh-list
56838541|NCT03756064|Trastuzumab|trastuzumab|mesh-list
56838542|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838543|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
56838544|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
56838545|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
56838546|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352932|NCT00234676|Hormones|hormones|mesh-ancestor
56838549|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
56838551|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56838552|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
56838553|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838554|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838555|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838556|NCT03764020|Melatonin|melatonin|mesh-list
56838557|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
56838558|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838559|NCT03764020|Protective Agents|protective agents|mesh-ancestor
56838560|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838561|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838562|NCT00135512|Bupropion|bupropion|mesh-list
56838563|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56838564|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
56838565|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56838566|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56838567|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56838568|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56838569|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838570|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
56838571|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838572|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838573|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56838574|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56838575|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838576|NCT00130728|Bevacizumab|bevacizumab|mesh-list
56838577|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56838578|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56838579|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838580|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56838581|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56838582|NCT00130728|Growth Substances|growth substances|mesh-ancestor
56838583|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838584|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
56838585|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56838586|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838587|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838588|NCT00129974|Gemcitabine|gemcitabine|mesh-list
56838589|NCT00129974|Pemetrexed|pemetrexed|mesh-list
56838590|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56838591|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
56838592|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838593|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838594|NCT00129974|Antiviral Agents|antiviral agents|mesh-ancestor
56838595|NCT00129974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838596|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838597|NCT00129974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838598|NCT00129974|Immunologic Factors|immunologic factors|mesh-ancestor
56838599|NCT00129974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838600|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56838601|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56838602|NCT03966326|Fentanyl|fentanyl|mesh-list
56838603|NCT03966326|Anesthetics|anesthetics|mesh-list
56838604|NCT03966326|Sevoflurane|sevoflurane|mesh-list
56838605|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838606|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838607|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56838608|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56838609|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
56838610|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56838611|NCT03966326|Narcotics|narcotics|mesh-ancestor
56838612|NCT03966326|Analgesics|analgesics|mesh-ancestor
56838613|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
56838614|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838615|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56838616|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56838617|NCT00119106|Tenofovir|tenofovir|mesh-list
56838618|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
56838619|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838620|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56838621|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56838622|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838623|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838624|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56838625|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56838627|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56838628|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
56838629|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838630|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838631|NCT00135356|Ritonavir|ritonavir|mesh-list
56838632|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56838633|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56838634|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56838635|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
56838636|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56838637|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838638|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838639|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56838640|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56838641|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
56838642|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838643|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56838644|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56838645|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56838646|NCT00118716|Fluticasone|fluticasone|mesh-list
56838647|NCT00118716|Xhance|xhance|mesh-list
56838648|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56838649|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56838650|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56838651|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
56838652|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838653|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838654|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56838655|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
56838656|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
56838657|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56838658|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56838659|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56838660|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56838661|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
56838662|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838663|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838664|NCT04907032|Mirabegron|mirabegron|mesh-list
56838665|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56838666|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56838667|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56838668|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
56838669|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838670|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838671|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838672|NCT04907032|Urological Agents|urological agents|mesh-ancestor
56838673|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
56549481|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56838674|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56838675|NCT03966950|Melatonin|melatonin|mesh-list
56838676|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
56838677|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838678|NCT03966950|Protective Agents|protective agents|mesh-ancestor
56838679|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838680|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838681|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
56838682|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56838683|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56838684|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838685|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56838686|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56838687|NCT01076582|Desogestrel|desogestrel|mesh-list
56838688|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56838689|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56838690|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56353082|NCT00235729|Lofexidine|lofexidine|mesh-list
56838691|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
56838692|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56838693|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838694|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56838696|NCT01076582|Hormones|hormones|mesh-ancestor
56838697|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56838698|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56838699|NCT01076582|Progestins|progestins|mesh-ancestor
56838700|NCT01081938|Insulin|insulin|mesh-list
56838701|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56838702|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
56838703|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
56838704|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838705|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838706|NCT01082796|Glipizide|glipizide|mesh-list
56838707|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838708|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838709|NCT03763786|Cetrorelix|cetrorelix|mesh-list
56838710|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56838711|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
56838712|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56838713|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838714|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
56838715|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56838716|NCT01079364|Insulin|insulin|mesh-list
56838717|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56838718|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
56838719|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
56838720|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
56838721|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56838722|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838723|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838724|NCT01077752|Acetaminophen|acetaminophen|mesh-list
56838725|NCT01077752|Lidocaine|lidocaine|mesh-list
56838726|NCT01077752|Morphine|morphine|mesh-list
56838727|NCT01077752|Ropivacaine|ropivacaine|mesh-list
56838728|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
56838729|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
56838730|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838731|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838732|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
56838733|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838734|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56838735|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56838736|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56838737|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56838738|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838739|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56838740|NCT01077752|Narcotics|narcotics|mesh-ancestor
56838741|NCT01077752|Analgesics|analgesics|mesh-ancestor
56838742|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56838743|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
56838744|NCT00129272|Bupropion|bupropion|mesh-list
56838745|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56838746|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
56838747|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56838748|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56838749|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56838750|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56838751|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838752|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
56838753|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838754|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838755|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56838756|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56838757|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838758|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
56838759|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56838760|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838761|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
56838762|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56838763|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
56838764|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838765|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838767|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
56838768|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56838769|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
56838770|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838771|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838772|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56838773|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
56838774|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
56838775|NCT03963648|Protective Agents|protective agents|mesh-ancestor
56838776|NCT04899232|Antithrombins|antithrombins|mesh-list
56838777|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
56838778|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56838779|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
56838780|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838781|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838782|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
56838783|NCT00096174|Cisplatin|cisplatin|mesh-list
56838784|NCT00096174|Cetuximab|cetuximab|mesh-list
56838785|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838786|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56838787|NCT03757858|Antibodies|antibodies|mesh-list
56838788|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
56838789|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838790|NCT01079676|Lenograstim|lenograstim|mesh-list
56838791|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56838792|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
56838793|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838794|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56838795|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56838796|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56838797|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838798|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838799|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56838800|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56838801|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56838802|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56838803|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
56838804|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838805|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838806|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56838807|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56838808|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
56838809|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56838810|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56838811|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
56838812|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
56838813|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838814|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838815|NCT03965208|Heparin|heparin|mesh-list
56838816|NCT03965208|Calcium heparin|calcium heparin|mesh-list
56838817|NCT03965208|Bivalirudin|bivalirudin|mesh-list
56838818|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
56838819|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56838820|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56838821|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838822|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
56838823|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56838824|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
56838825|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838826|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
56838827|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
56838828|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838829|NCT04555096|Protective Agents|protective agents|mesh-ancestor
56838830|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838831|NCT00097500|Metformin|metformin|mesh-list
56838832|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
56838833|NCT00097500|Exenatide|exenatide|mesh-list
56838834|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56838835|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838836|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56838837|NCT00097500|Incretins|incretins|mesh-ancestor
56838838|NCT00097500|Hormones|hormones|mesh-ancestor
56838839|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353241|NCT00097968|Everolimus|everolimus|mesh-list
56838840|NCT01082484|Treprostinil|treprostinil|mesh-list
56838841|NCT01082484|Iloprost|iloprost|mesh-list
56838842|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56838843|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56838844|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
56838845|NCT05459974|Colchicine|colchicine|mesh-list
56838846|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
56838847|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56838848|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
56838849|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
56838850|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
56838851|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838852|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838853|NCT03754816|Anesthetics|anesthetics|mesh-list
56838854|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
56838855|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838856|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838857|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
56838858|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
56838859|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838860|NCT04542694|Favipiravir|favipiravir|mesh-list
56838861|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
56838862|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838863|NCT01083264|Gestodene|gestodene|mesh-list
56838864|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56838865|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56838866|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56838867|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
56838868|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56838869|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838870|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56838871|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56838872|NCT01083264|Progestins|progestins|mesh-ancestor
56838873|NCT01083264|Hormones|hormones|mesh-ancestor
56838874|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56838875|NCT00129116|Vaccines|vaccines|mesh-list
56838876|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
56838877|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838878|NCT00117156|Rituximab|rituximab|mesh-list
56838879|NCT00117156|Fludarabine|fludarabine|mesh-list
56838880|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56838881|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838882|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
56838883|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838884|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56838885|NCT01083420|Minocycline|minocycline|mesh-list
56838886|NCT01083420|Dexamethasone|dexamethasone|mesh-list
56838887|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56838888|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
56838889|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
56838890|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56838891|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838892|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56838893|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
56838894|NCT01083420|Hormones|hormones|mesh-ancestor
56838895|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56838896|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56838897|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838898|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56838899|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838900|NCT00096954|Omalizumab|omalizumab|mesh-list
56838901|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56838902|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56838903|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
56838904|NCT00096486|Everolimus|everolimus|mesh-list
56838905|NCT00096486|Gefitinib|gefitinib|mesh-list
56838906|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838907|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56838908|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
56838909|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838910|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56838911|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838912|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838913|NCT00116844|Valacyclovir|valacyclovir|mesh-list
56838914|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
56838915|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838916|NCT03963336|Acetazolamide|acetazolamide|mesh-list
56838917|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
56838918|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56838919|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838920|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838922|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
56838923|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838924|NCT00132314|Risperidone|risperidone|mesh-list
56838925|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
56838926|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56838927|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
56838928|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56838929|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838930|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838931|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56838932|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838933|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56838934|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56838935|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
56838936|NCT04539262|Remdesivir|remdesivir|mesh-list
56838937|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
56838938|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838939|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
56838940|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838941|NCT04537234|Vaccines|vaccines|mesh-list
56838942|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
56838943|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838944|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56838945|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
56838946|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
56838947|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56838948|NCT04537078|Cetrorelix|cetrorelix|mesh-list
56838949|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56838950|NCT04537078|Progesterone|progesterone|mesh-list
56838951|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
56838952|NCT04537078|Estradiol|estradiol|mesh-list
56838953|NCT04537078|Progestins|progestins|mesh-ancestor
56838954|NCT04537078|Hormones|hormones|mesh-ancestor
56838955|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56838956|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838957|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56838958|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56838959|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
56838960|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56838961|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56838962|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56838963|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56838964|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
56838965|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
56838966|NCT04537078|Estrogens|estrogens|mesh-ancestor
56838967|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
56838968|NCT04532164|Clotrimazole|clotrimazole|mesh-list
56838969|NCT04532164|Miconazole|miconazole|mesh-list
56838970|NCT04532164|Butenafine|butenafine|mesh-list
56838971|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838972|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56838973|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56838974|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56838975|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56838976|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838977|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56838978|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
56838979|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56838980|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838981|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56838982|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56838983|NCT04531540|Butenafine|butenafine|mesh-list
56838984|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
56838985|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56838986|NCT04799782|Mirtazapine|mirtazapine|mesh-list
56838987|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
56838988|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56838989|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56838990|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
56838991|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
56838992|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353386|NCT00237523|Iodine|iodine|mesh-list
56838993|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56838994|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56838995|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56838996|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56838997|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56838998|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56838999|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56839000|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56839001|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
56839002|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56839003|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56839004|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
56839005|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56839006|NCT04790812|Acetaminophen|acetaminophen|mesh-list
56839007|NCT04790812|Celecoxib|celecoxib|mesh-list
56839008|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839009|NCT04790812|Analgesics|analgesics|mesh-ancestor
56839010|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
56839011|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839012|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839013|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
56839014|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56839015|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839016|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839017|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56839018|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56839019|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839020|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839021|NCT03697252|Xanomeline|xanomeline|mesh-list
56839022|NCT03697252|Trospium chloride|trospium chloride|mesh-list
56839023|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
56839024|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
56839025|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839026|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839027|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56839028|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56839029|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
56839030|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839031|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839032|NCT03697252|Urological Agents|urological agents|mesh-ancestor
56839033|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56839034|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56839035|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56839036|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56839037|NCT03701074|Acetaminophen|acetaminophen|mesh-list
56839038|NCT03701074|Ibuprofen|ibuprofen|mesh-list
56839039|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839040|NCT03701074|Analgesics|analgesics|mesh-ancestor
56839041|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
56839042|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839043|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839044|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
56839045|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56839046|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839047|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839048|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56839049|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839050|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839051|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56839052|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56839053|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56839054|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56549856|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
56839055|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
56839056|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839057|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56839058|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56839059|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839060|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56839061|NCT03757156|Aspirin|aspirin|mesh-list
56839062|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56839063|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839064|NCT03757156|Analgesics|analgesics|mesh-ancestor
56839065|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
56839066|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839067|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839069|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839070|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56839071|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56839072|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839073|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56839074|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56839075|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839076|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
56839077|NCT03750916|Docetaxel|docetaxel|mesh-list
56839078|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839079|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
56839080|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
56839081|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
56839082|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839083|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
56839084|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839085|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
56839086|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839087|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839088|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56839089|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
56839090|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839091|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839092|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56839093|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56839094|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56839095|NCT03750760|Atorvastatin|atorvastatin|mesh-list
56839096|NCT03750760|Ezetimibe|ezetimibe|mesh-list
56839097|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56839098|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56839099|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
56839100|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839101|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56839102|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56839103|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839104|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
56839105|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56839106|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839107|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839108|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839109|NCT01076816|Analgesics|analgesics|mesh-ancestor
56839110|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
56839111|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839112|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56839113|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56839114|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56839115|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
56839116|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839117|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839118|NCT01076894|Anesthetics|anesthetics|mesh-list
56839119|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839120|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839121|NCT00130832|Vaccines|vaccines|mesh-list
56839122|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
56839123|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839124|NCT00096018|Thalidomide|thalidomide|mesh-list
56839125|NCT00096018|Fludarabine|fludarabine|mesh-list
56839126|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
56839127|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839128|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56839129|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
56839130|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839131|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839132|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
56839133|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839134|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
56839135|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56839136|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839137|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56839138|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56839140|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
56839142|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
56839143|NCT01079754|Narcotics|narcotics|mesh-ancestor
56839144|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839145|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839146|NCT01079754|Analgesics|analgesics|mesh-ancestor
56839147|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
56839148|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839149|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
56839150|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
56839151|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839152|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
56839153|NCT01322776|Fludarabine|fludarabine|mesh-list
56839154|NCT01322776|Bortezomib|bortezomib|mesh-list
56839155|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839156|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
56839157|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839158|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839159|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56839160|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
56839161|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839162|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839163|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56839164|NCT03933202|Cladribine|cladribine|mesh-list
56839165|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839166|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839167|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
56839168|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839169|NCT00128102|Vorinostat|vorinostat|mesh-list
56839170|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839171|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56839172|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839173|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839174|NCT03965858|Esketamine|esketamine|mesh-list
56839175|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
56839176|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56839177|NCT04668274|Resveratrol|resveratrol|mesh-list
56839178|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
56839179|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839180|NCT04668274|Protective Agents|protective agents|mesh-ancestor
56839181|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839182|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839183|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56839184|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
56839185|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839186|NCT04406194|Favipiravir|favipiravir|mesh-list
56839187|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
56839188|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839189|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
56839190|NCT03822884|Hematinics|hematinics|mesh-ancestor
56839191|NCT03822416|Nicotine|nicotine|mesh-list
56839192|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56839193|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
56839194|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839195|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839196|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56839197|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56839198|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
56839199|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839200|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839201|NCT00127712|Amiodarone|amiodarone|mesh-list
56839202|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56839203|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
56839204|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56839205|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56920154|NCT01216111|Fluorouracil|fluorouracil|mesh-list
56839206|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903212|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
56839207|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56839208|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56839209|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56839210|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839211|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56839212|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56839214|NCT01082744|Sufentanil|sufentanil|mesh-list
56839215|NCT01082744|Ropivacaine|ropivacaine|mesh-list
56839216|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
56839217|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
56839218|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839219|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839220|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
56839221|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839222|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56839223|NCT01082744|Narcotics|narcotics|mesh-ancestor
56839224|NCT01082744|Analgesics|analgesics|mesh-ancestor
56839225|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56839226|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56839227|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
56839228|NCT00096356|Vitamins|vitamins|mesh-list
56839229|NCT00096356|Vitamin E|vitamin e|mesh-list
56839230|NCT00096356|Tocopherols|tocopherols|mesh-list
56839231|NCT00096356|Tocotrienols|tocotrienols|mesh-list
56839232|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
56839233|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
56839234|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839235|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
56839236|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839237|NCT00096356|Protective Agents|protective agents|mesh-ancestor
56839238|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
56839239|NCT03749590|Analgesics|analgesics|mesh-ancestor
56839240|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
56839241|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839242|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839243|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
56839244|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839245|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56839246|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
56839247|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56839248|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56839249|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839250|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56839251|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
56839252|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56839253|NCT04391842|Diclofenac|diclofenac|mesh-list
56839254|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56839255|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839256|NCT04391842|Analgesics|analgesics|mesh-ancestor
56839257|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
56839258|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839259|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839260|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839261|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839262|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56839263|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839264|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839265|NCT03777982|Prednisone|prednisone|mesh-list
56839266|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
56839267|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839268|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
56839269|NCT03777982|Hormones|hormones|mesh-ancestor
56839270|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56839271|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839272|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56839273|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839274|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56839275|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839276|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839277|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
56839278|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56839279|NCT03749356|Tacrolimus|tacrolimus|mesh-list
56839280|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839281|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
56839282|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839283|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56839284|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839285|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839287|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
56839288|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56839289|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839290|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
56839291|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56839292|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56839293|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839294|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839295|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839296|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
56839297|NCT00096278|Leucovorin|leucovorin|mesh-list
56839298|NCT00096278|Folic Acid|folic acid|mesh-list
56839299|NCT00096278|Bevacizumab|bevacizumab|mesh-list
56839300|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56839301|NCT00096278|Fluorouracil|fluorouracil|mesh-list
56839302|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
56839303|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
56839304|NCT00096278|Antibodies|antibodies|mesh-list
56839305|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
56839306|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56839307|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
56839308|NCT00096278|Calcium|calcium|mesh-list
56839309|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
56839310|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839311|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56839312|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56839313|NCT00096278|Growth Substances|growth substances|mesh-ancestor
56839314|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839315|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
56839316|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
56839317|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56839318|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56839319|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
56839320|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839321|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56839322|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839323|NCT00096278|Antidotes|antidotes|mesh-ancestor
56839324|NCT00096278|Protective Agents|protective agents|mesh-ancestor
56839325|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
56839326|NCT00096278|Vitamins|vitamins|mesh-ancestor
56839327|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
56839328|NCT00096278|Hematinics|hematinics|mesh-ancestor
56839329|NCT00095940|Lapatinib|lapatinib|mesh-list
56839330|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839331|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56839332|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839333|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839334|NCT00114218|Gemcitabine|gemcitabine|mesh-list
56839335|NCT00114218|Docetaxel|docetaxel|mesh-list
56839336|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56839337|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
56839338|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839339|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839340|NCT00114218|Antiviral Agents|antiviral agents|mesh-ancestor
56839341|NCT00114218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839342|NCT00114218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839343|NCT00114218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839344|NCT00114218|Immunologic Factors|immunologic factors|mesh-ancestor
56839345|NCT00114218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839346|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
56839347|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
56839348|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
56839349|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
56839350|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839351|NCT01077986|Capecitabine|capecitabine|mesh-list
56839352|NCT01077986|Cetuximab|cetuximab|mesh-list
56839353|NCT01077986|Everolimus|everolimus|mesh-list
56839354|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56839355|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
56839356|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839357|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839358|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56839359|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839360|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
56839361|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839362|NCT03963024|Treosulfan|treosulfan|mesh-list
56839363|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56839364|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
56839365|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839366|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839367|NCT01082718|Artesunate|artesunate|mesh-list
56839368|NCT01082718|Mefloquine|mefloquine|mesh-list
56839369|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
56839370|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56839371|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56839372|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839373|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839374|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
56839375|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
56839376|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56839377|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
56839378|NCT04380142|Levodopa|levodopa|mesh-list
56839379|NCT04380142|Carbidopa|carbidopa|mesh-list
56839380|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56839381|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56839382|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
56839383|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839384|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839385|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839386|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56839387|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839388|NCT04336228|Dexetimide|dexetimide|mesh-list
56839389|NCT04336228|Citalopram|citalopram|mesh-list
56839390|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839391|NCT04336228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56839392|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56839393|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56839394|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839395|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839396|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
56839397|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56839398|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
56839399|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56839400|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56839401|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56839402|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
56839403|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
56839404|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839405|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56839406|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56839407|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
56839408|NCT03917446|Propofol|propofol|mesh-list
56839409|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56839410|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839411|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839412|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56839413|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
56839414|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
56839415|NCT04332874|Dactinomycin|dactinomycin|mesh-list
56839416|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
56839417|NCT04332874|Melphalan|melphalan|mesh-list
56839418|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56839419|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839420|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56839421|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
56839422|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839423|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56839424|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839425|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
56839426|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839427|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56839428|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839429|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56839430|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56839431|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839432|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56839433|NCT03748108|Lidocaine|lidocaine|mesh-list
56839434|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
56839435|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
56839436|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839437|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839438|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
56839439|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839440|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56839441|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56839442|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56839443|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56839444|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839446|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839447|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839448|NCT04167670|Amoxicillin|amoxicillin|mesh-list
56839449|NCT04167670|Clarithromycin|clarithromycin|mesh-list
56839450|NCT04167670|Lansoprazole|lansoprazole|mesh-list
56839451|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
56839452|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56839453|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839454|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56839455|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839456|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839457|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56839458|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56839459|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56839460|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56839461|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56839462|NCT00113516|Paclitaxel|paclitaxel|mesh-list
56839463|NCT00113516|Carboplatin|carboplatin|mesh-list
56839464|NCT00113516|Sunitinib|sunitinib|mesh-list
56839465|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56839466|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839467|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
56839468|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
56839469|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
56839470|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839471|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56839472|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56839473|NCT00113516|Growth Substances|growth substances|mesh-ancestor
56839474|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839475|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
56839476|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56839477|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839478|NCT04142242|Vaccines|vaccines|mesh-list
56839479|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
56839480|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839481|NCT03251326|Propranolol|propranolol|mesh-list
56839482|NCT03251326|Nabilone|nabilone|mesh-list
56839483|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56839484|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56839485|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
56839486|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839487|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839488|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839489|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56839490|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56839491|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
56839492|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
56839493|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
56839494|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839495|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56839496|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56839497|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56839498|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839499|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56839500|NCT04140292|Vitamin D|vitamin d|mesh-list
56839501|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
56839502|NCT04140292|Vitamins|vitamins|mesh-ancestor
56839503|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
56839504|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839505|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56839506|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56839507|NCT00127166|Fluticasone|fluticasone|mesh-list
56839508|NCT00127166|Xhance|xhance|mesh-list
56839509|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56839510|NCT00127166|Montelukast|montelukast|mesh-list
56839511|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839512|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56839513|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
56839514|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839515|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839516|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56839517|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
56839518|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
56839519|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56839520|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56839521|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56839522|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56839523|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
56839524|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839525|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839526|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56839527|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
56839528|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56839529|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56839530|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56839531|NCT00125138|Metylperon|metylperon|mesh-list
56839532|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56839533|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56839534|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839535|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839536|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56839537|NCT04132336|Naproxen|naproxen|mesh-list
56839538|NCT04132336|Caffeine|caffeine|mesh-list
56839539|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56839540|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839541|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56839542|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839543|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839544|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56839545|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56839546|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
56839547|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839548|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56839549|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839550|NCT04132336|Analgesics|analgesics|mesh-ancestor
56839551|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
56839552|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839553|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839554|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839555|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
56839556|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56839557|NCT04131556|Maribavir|maribavir|mesh-list
56839558|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
56839559|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839560|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56839561|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
56839562|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
56839563|NCT03691948|Narcotics|narcotics|mesh-ancestor
56839564|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839565|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839566|NCT03691948|Analgesics|analgesics|mesh-ancestor
56839567|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
56839568|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839569|NCT04124926|Lansoprazole|lansoprazole|mesh-list
56839570|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
56839571|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56839572|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56839573|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56839574|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839575|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839576|NCT03746158|Curcumin|curcumin|mesh-list
56839577|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56839578|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839579|NCT03746158|Analgesics|analgesics|mesh-ancestor
56839580|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
56839581|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839582|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550381|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839583|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839584|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839585|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839586|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839587|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839588|NCT03747094|Fentanyl|fentanyl|mesh-list
56839589|NCT03747094|Ketamine|ketamine|mesh-list
56839590|NCT03747094|Analgesics|analgesics|mesh-ancestor
56839591|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
56839594|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56839595|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56839596|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
56839597|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
56839598|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839599|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56839600|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56839601|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839602|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839603|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56839604|NCT03747094|Narcotics|narcotics|mesh-ancestor
56839605|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56839606|NCT04105972|Ivacaftor|ivacaftor|mesh-list
56839607|NCT04105972|Elexacaftor|elexacaftor|mesh-list
56839608|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56839609|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56839610|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839611|NCT00124982|Abatacept|abatacept|mesh-list
56839612|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
56839613|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56839614|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839615|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839616|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839617|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
56839618|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839619|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
56839620|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56839621|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839622|NCT04249336|Listerine|listerine|mesh-list
56839623|NCT04249336|Calcium|calcium|mesh-list
56839624|NCT04249336|Fluorides|fluorides|mesh-list
56839625|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
56839626|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56839627|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839628|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
56839629|NCT04249336|Protective Agents|protective agents|mesh-ancestor
56839630|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56839631|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839632|NCT03752476|Lactams|lactams|mesh-list
56839633|NCT03752476|beta-Lactams|beta-lactams|mesh-list
56839634|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56839635|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839636|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56839637|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56839638|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
56839639|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
56839640|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839641|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56839642|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839643|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839644|NCT01078142|Sirolimus|sirolimus|mesh-list
56839645|NCT01078142|Rituximab|rituximab|mesh-list
56839646|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56839647|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56839648|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839649|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
56839650|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839651|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839652|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56839653|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
56839654|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839655|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56839656|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839657|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56839658|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
56839659|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839661|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56839662|NCT04060654|Narcotics|narcotics|mesh-ancestor
56839663|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839664|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839666|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
56839667|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839668|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56839669|NCT00096200|Paclitaxel|paclitaxel|mesh-list
56839670|NCT00096200|Carboplatin|carboplatin|mesh-list
56839671|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56839672|NCT00096200|Sorafenib|sorafenib|mesh-list
56839673|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56839674|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839675|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56839676|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56839677|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56839678|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839679|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56839680|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839681|NCT00096044|Rituximab|rituximab|mesh-list
56839682|NCT00096044|Lenalidomide|lenalidomide|mesh-list
56839683|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56839684|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839685|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
56839686|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839687|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839688|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56839689|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56839690|NCT00096044|Growth Substances|growth substances|mesh-ancestor
56839691|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
56839692|NCT03963128|Vitamin D|vitamin d|mesh-list
56839693|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
56839694|NCT03963128|Vitamins|vitamins|mesh-ancestor
56839695|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
56839696|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839697|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56839698|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56839699|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
56839700|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56839701|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
56839702|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839703|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56839704|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56839705|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56839706|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839707|NCT01083290|Spironolactone|spironolactone|mesh-list
56839708|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56839709|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
56839710|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56839711|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839712|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56839713|NCT01083290|Diuretics|diuretics|mesh-ancestor
56839714|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
56839715|NCT01326650|Vitamin D|vitamin d|mesh-list
56839716|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
56839717|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
56839718|NCT01326650|Vitamins|vitamins|mesh-list
56839719|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56839720|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
56839721|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839722|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56839723|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56839724|NCT03689374|Insulin|insulin|mesh-list
56839725|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56839726|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
56839727|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
56839728|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56839729|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839730|NCT00113360|Everolimus|everolimus|mesh-list
56839731|NCT00113360|Octreotide|octreotide|mesh-list
56839732|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839733|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839734|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
56839735|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839736|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56839737|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56839738|NCT03745300|Atorvastatin|atorvastatin|mesh-list
56839739|NCT03745300|Simvastatin|simvastatin|mesh-list
56839740|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56839741|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56839743|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839744|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56839745|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56839746|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839748|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56839749|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839750|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56839751|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839752|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839753|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56839754|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839755|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56839756|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
56839757|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839758|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
56839759|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839760|NCT04052620|Diclofenac|diclofenac|mesh-list
56839761|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56839762|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839763|NCT04052620|Analgesics|analgesics|mesh-ancestor
56839764|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
56839765|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839766|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839767|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839768|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839769|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56839770|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839771|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839772|NCT00112580|Ipilimumab|ipilimumab|mesh-list
56839773|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56839774|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839775|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56839776|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839777|NCT04238650|Bevacizumab|bevacizumab|mesh-list
56839778|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56839779|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839780|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56839781|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56839782|NCT04238650|Growth Substances|growth substances|mesh-ancestor
56839783|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839784|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
56839785|NCT00095498|Denosumab|denosumab|mesh-list
56839786|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56839787|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839788|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
56839789|NCT04237792|Propofol|propofol|mesh-list
56839790|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56839791|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839792|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839793|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56839794|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
56839795|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
56839796|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839797|NCT04237792|Analgesics|analgesics|mesh-ancestor
56839798|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
56839799|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839800|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56839801|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56839802|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56839803|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
56839804|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839805|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839806|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
56839807|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56920155|NCT01216111|Epirubicin|epirubicin|mesh-list
56839808|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56839809|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839810|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
56839811|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
56839812|NCT03414034|Prednisone|prednisone|mesh-list
56839813|NCT03414034|Onvansertib|onvansertib|mesh-list
56839815|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
56839816|NCT03414034|Hormones|hormones|mesh-ancestor
56839817|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56839818|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839819|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56839820|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839821|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56839822|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839823|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839824|NCT04489732|Interferons|interferons|mesh-list
56839825|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
56839826|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839827|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
56839828|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839829|NCT03744988|Androgens|androgens|mesh-list
56839830|NCT03744988|Hormones|hormones|mesh-ancestor
56839831|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56839832|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839833|NCT03746782|Thrombin|thrombin|mesh-list
56839834|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
56839835|NCT03746782|Coagulants|coagulants|mesh-ancestor
56839836|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
56839837|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56839838|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56839839|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839840|NCT04024228|Vaccines|vaccines|mesh-list
56839841|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
56839842|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
56839843|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839844|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
56839845|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
56839846|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56839847|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839848|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
56839849|NCT04018612|Acetaminophen|acetaminophen|mesh-list
56839850|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839851|NCT04018612|Analgesics|analgesics|mesh-ancestor
56839852|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
56839853|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839854|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839855|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
56839856|NCT03395080|Paclitaxel|paclitaxel|mesh-list
56839857|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56839858|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839859|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
56839860|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
56839861|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
56839862|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839863|NCT04207840|Epinephrine|epinephrine|mesh-list
56839864|NCT04207840|Racepinephrine|racepinephrine|mesh-list
56839865|NCT04207840|Albuterol|albuterol|mesh-list
56839866|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
56839867|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56839868|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56839869|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
56839870|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839871|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839872|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839873|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56839874|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56839875|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
56839876|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839877|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56839878|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
56839879|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
56839880|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
56839881|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56839882|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
56839883|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56839884|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56839886|NCT04195828|Apatinib|apatinib|mesh-list
56839887|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56839888|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839889|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
56839890|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
56839891|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
56839892|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839893|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56839894|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839896|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
56839897|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839898|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56839899|NCT03744364|Misoprostol|misoprostol|mesh-list
56839900|NCT03744364|Dinoprostone|dinoprostone|mesh-list
56839901|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56839902|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
56839903|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56839904|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839905|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56839906|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56839907|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
56839908|NCT03744208|Antibodies|antibodies|mesh-list
56839909|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56839910|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
56839911|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839912|NCT05069896|Mirikizumab|mirikizumab|mesh-list
56839913|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56839914|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839915|NCT05069896|Analgesics|analgesics|mesh-ancestor
56839916|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
56839917|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839918|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839919|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839920|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839921|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56839922|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56839923|NCT01562626|Flucytosine|flucytosine|mesh-list
56839924|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
56839925|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56839926|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
56839927|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839928|NCT04470622|Aprepitant|aprepitant|mesh-list
56839929|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
56839930|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
56839931|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839932|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839933|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56839934|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56839935|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56839936|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839937|NCT04465396|Teduglutide|teduglutide|mesh-list
56839938|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56839939|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56839940|NCT04465396|Protective Agents|protective agents|mesh-ancestor
56839941|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839942|NCT03996694|Oxycodone|oxycodone|mesh-list
56839943|NCT03996694|Buprenorphine|buprenorphine|mesh-list
56839944|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56839945|NCT03996694|Narcotics|narcotics|mesh-ancestor
56839946|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839947|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839948|NCT03996694|Analgesics|analgesics|mesh-ancestor
56839949|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
56839950|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839951|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56839952|NCT03743896|Capsaicin|capsaicin|mesh-list
56839953|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
56839954|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
56839955|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
56839956|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839957|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839958|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56839959|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839960|NCT03751228|BMS-986165|bms-986165|mesh-list
56550757|NCT00654121|Insulin|insulin|mesh-list
56839961|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56839962|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56839963|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839964|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839965|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56839967|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56839968|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839970|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56839971|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56839972|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56839973|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839974|NCT01329796|Lidocaine|lidocaine|mesh-list
56839975|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
56839976|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
56839977|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56839978|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839979|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
56839980|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839981|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56839982|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56839983|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56839984|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56839985|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56839986|NCT04428502|Etanercept|etanercept|mesh-list
56839987|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56839988|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56839989|NCT04428502|Analgesics|analgesics|mesh-ancestor
56839990|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
56839991|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56839992|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56839993|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56839994|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56839995|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56839996|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56839997|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
56839998|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
56839999|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56840000|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840001|NCT04428424|Etanercept|etanercept|mesh-list
56840002|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56840003|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56840004|NCT04428424|Analgesics|analgesics|mesh-ancestor
56840005|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
56840006|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840007|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840008|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840009|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840010|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56840011|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840012|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
56840013|NCT00095238|Irbesartan|irbesartan|mesh-list
56840014|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56447035|NCT00298025|Cetrorelix|cetrorelix|mesh-list
56840015|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56840016|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56840017|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840018|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
56840019|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56840020|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840021|NCT01084044|Urinastatin|urinastatin|mesh-list
56840022|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56840023|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56840024|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
56840025|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840026|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840027|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
56840028|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840029|NCT01090596|Naproxen|naproxen|mesh-list
56840030|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56840031|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56840032|NCT01090596|Analgesics|analgesics|mesh-ancestor
56550836|NCT05657171|Contraceptive Agents|contraceptive agents|mesh-ancestor
56840033|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
56840034|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840035|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840036|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840038|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
56840039|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56840040|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840041|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840042|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56840043|NCT01084122|Hematinics|hematinics|mesh-ancestor
56840044|NCT01084200|Propofol|propofol|mesh-list
56840045|NCT01084200|Sevoflurane|sevoflurane|mesh-list
56840046|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56840047|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56840048|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840049|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56840050|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
56840051|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
56840052|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56840053|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56840054|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56840055|NCT00094770|Glipizide|glipizide|mesh-list
56840056|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56840057|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840058|NCT00094770|Incretins|incretins|mesh-ancestor
56840059|NCT00094770|Hormones|hormones|mesh-ancestor
56840060|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840061|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56840062|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
56840063|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840064|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840065|NCT01087398|Cyclosporine|cyclosporine|mesh-list
56840066|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
56840067|NCT01087398|Busulfan|busulfan|mesh-list
56840068|NCT01087398|Methotrexate|methotrexate|mesh-list
56840069|NCT01087398|Fludarabine|fludarabine|mesh-list
56840070|NCT01087398|Cyclosporins|cyclosporins|mesh-list
56840071|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
56840072|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840073|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
56840074|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840075|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840076|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56840077|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
56840078|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840079|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840080|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56840081|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56840082|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
56840083|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56840084|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840085|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
56840086|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840087|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840088|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56840089|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56840090|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
56840091|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840092|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56840093|NCT01087476|Doxycycline|doxycycline|mesh-list
56840094|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56840095|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840096|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
56840097|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56840098|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56840099|NCT00069108|Leucovorin|leucovorin|mesh-list
56840100|NCT00069108|Capecitabine|capecitabine|mesh-list
56840101|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
56840102|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840103|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
56840104|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840105|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840106|NCT00069108|Antidotes|antidotes|mesh-ancestor
56840107|NCT00069108|Protective Agents|protective agents|mesh-ancestor
56840108|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840109|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
56840110|NCT00069108|Vitamins|vitamins|mesh-ancestor
56840111|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
56840112|NCT00405587|Vemurafenib|vemurafenib|mesh-list
56840113|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840114|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840115|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840116|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840118|NCT01040429|Analgesics|analgesics|mesh-ancestor
56840119|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
56840120|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840121|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840122|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56840123|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
56840124|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
56840125|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56840126|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56840127|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56840128|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
56840129|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56840130|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840131|NCT01039883|Albaconazole|albaconazole|mesh-list
56840132|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
56840133|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840134|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
56840135|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
56840136|NCT00405275|Etanercept|etanercept|mesh-list
56840137|NCT00405275|Methotrexate|methotrexate|mesh-list
56840138|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56840139|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
56840140|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56840141|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840142|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840143|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
56840144|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840145|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840146|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840147|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840148|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56840149|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840150|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
56840151|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840152|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56840153|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
56840154|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56840155|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56840156|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840157|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56840158|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56840159|NCT00405275|Analgesics|analgesics|mesh-ancestor
56840160|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
56840161|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840162|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840163|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56840164|NCT00404651|Vaccines|vaccines|mesh-list
56840165|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
56840166|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840167|NCT00404495|Irinotecan|irinotecan|mesh-list
56840168|NCT00404495|Temozolomide|temozolomide|mesh-list
56840169|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56840170|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56840171|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840172|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840173|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840174|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56840175|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
56840176|NCT00409331|Amifostine|amifostine|mesh-list
56840177|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56840178|NCT00409331|Protective Agents|protective agents|mesh-ancestor
56840179|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840180|NCT00362219|Morphine|morphine|mesh-list
56840181|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56840182|NCT00362219|Narcotics|narcotics|mesh-ancestor
56840183|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56840184|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550986|NCT02567253|Cisplatin|cisplatin|mesh-list
56840185|NCT00362219|Analgesics|analgesics|mesh-ancestor
56840186|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
56840187|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840188|NCT01040585|Linezolid|linezolid|mesh-list
56840190|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840191|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56840193|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840194|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56840195|NCT00215813|Poly I-C|poly i-c|mesh-list
56840196|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
56840197|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840198|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
56840199|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
56840200|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840201|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
56840202|NCT01040195|Methotrexate|methotrexate|mesh-list
56840203|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56840204|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
56840205|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56840206|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840207|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840208|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
56840209|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840210|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840211|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840212|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840213|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56840214|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840215|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
56840216|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840217|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56840218|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
56840219|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56840220|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56840221|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840222|NCT01040273|Bupivacaine|bupivacaine|mesh-list
56840223|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
56840224|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
56840225|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56840226|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840227|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
56840228|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840229|NCT00408629|Adalimumab|adalimumab|mesh-list
56840230|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840231|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840232|NCT00408317|Pancrelipase|pancrelipase|mesh-list
56840233|NCT00408317|Pancreatin|pancreatin|mesh-list
56840234|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56840235|NCT00112502|Thalidomide|thalidomide|mesh-list
56840236|NCT00112502|Celecoxib|celecoxib|mesh-list
56840237|NCT00112502|Temozolomide|temozolomide|mesh-list
56840238|NCT00112502|Isotretinoin|isotretinoin|mesh-list
56840239|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56840240|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
56840241|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840242|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840243|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56840244|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56840245|NCT00112502|Analgesics|analgesics|mesh-ancestor
56840246|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
56840247|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840248|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840249|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840250|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840251|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56840252|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56840253|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840254|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840255|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
56840256|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
56840257|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56840258|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840259|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56840260|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551064|NCT02638831|Ketorolac|ketorolac|mesh-list
56840261|NCT00112502|Growth Substances|growth substances|mesh-ancestor
56840262|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
56840264|NCT03965546|Sorafenib|sorafenib|mesh-list
56840265|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840266|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840267|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840268|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840269|NCT01083992|Vitamin D|vitamin d|mesh-list
56840270|NCT01083992|Vildagliptin|vildagliptin|mesh-list
56840271|NCT01083992|Vitamins|vitamins|mesh-ancestor
56840272|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
56840273|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840274|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56840275|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56840276|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56840277|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
56840278|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840279|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840280|NCT03822182|Dexamethasone|dexamethasone|mesh-list
56840281|NCT03822182|Bupivacaine|bupivacaine|mesh-list
56840282|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840283|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
56840284|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
56840285|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840286|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840287|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56840288|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
56840289|NCT03822182|Hormones|hormones|mesh-ancestor
56840290|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840291|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56840292|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840293|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
56840294|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
56840295|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56840296|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
56840297|NCT01078610|Adalimumab|adalimumab|mesh-list
56840298|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840299|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840300|NCT01080482|Tacrolimus|tacrolimus|mesh-list
56840301|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840302|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
56840303|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840304|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56840305|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840306|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840307|NCT03965624|Ixazomib|ixazomib|mesh-list
56840308|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840309|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
56840310|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840311|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840312|NCT01080560|Cyclosporine|cyclosporine|mesh-list
56840313|NCT01080560|Cyclosporins|cyclosporins|mesh-list
56840314|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840315|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840316|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840317|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
56840318|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840319|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
56840320|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840321|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840322|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840323|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56840324|NCT00094328|Anastrozole|anastrozole|mesh-list
56840325|NCT00094328|Bicalutamide|bicalutamide|mesh-list
56840326|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56840327|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840328|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56840329|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56840330|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840331|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840332|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56840333|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
56840334|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840335|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840336|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
56840337|NCT00094172|Atorvastatin|atorvastatin|mesh-list
56840339|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56840341|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840342|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56840343|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56840344|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840345|NCT00094094|Axitinib|axitinib|mesh-list
56840346|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840347|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840348|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840349|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840350|NCT03962816|Vaccines|vaccines|mesh-list
56840351|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
56840352|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840353|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
56840354|NCT01080638|Abciximab|abciximab|mesh-list
56840355|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
56840356|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56840357|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56840358|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
56840359|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840360|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56840361|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840362|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
56840363|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840364|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
56840365|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56840366|NCT01080638|Protective Agents|protective agents|mesh-ancestor
56840367|NCT00110396|Interferons|interferons|mesh-list
56840368|NCT00110396|Interferon-beta|interferon-beta|mesh-list
56840369|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
56840370|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840371|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
56840372|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840373|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
56840374|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840375|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56840376|NCT00093470|Tipifarnib|tipifarnib|mesh-list
56840377|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840378|NCT00407537|Amlodipine|amlodipine|mesh-list
56840379|NCT00407537|Atorvastatin|atorvastatin|mesh-list
56840380|NCT00407537|Calcium|calcium|mesh-list
56840381|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56840382|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840383|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56840384|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56840385|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
56840386|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840387|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56840388|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56840389|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840390|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56840391|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56840392|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56840393|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
56840394|NCT00094458|Azathioprine|azathioprine|mesh-list
56840395|NCT00094458|Infliximab|infliximab|mesh-list
56840396|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840397|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56840398|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840399|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
56840400|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840401|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840402|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840403|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840404|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
56840405|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840406|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56840407|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56840408|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840409|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840410|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56840411|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56840413|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
56840414|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56840415|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
56840416|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
56840417|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840418|NCT03961464|Cycloserine|cycloserine|mesh-list
56840419|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56840420|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840421|NCT03961464|Renal Agents|renal agents|mesh-ancestor
56840422|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56840423|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
56840424|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56840425|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
56840426|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840427|NCT01087554|Sirolimus|sirolimus|mesh-list
56840428|NCT01087554|Everolimus|everolimus|mesh-list
56840429|NCT01087554|Vorinostat|vorinostat|mesh-list
56840430|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840431|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840432|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
56840433|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840434|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56840435|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840436|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56840437|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
56840438|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56840439|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840440|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840441|NCT01087632|Folic Acid|folic acid|mesh-list
56840442|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
56840443|NCT01087632|Policosanol|policosanol|mesh-list
56840444|NCT01087632|Red yeast rice|red yeast rice|mesh-list
56840445|NCT01087632|Hematinics|hematinics|mesh-ancestor
56840446|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
56840447|NCT01087632|Vitamins|vitamins|mesh-ancestor
56840448|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
56840449|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840450|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56840451|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56840452|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56840453|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
56840454|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840455|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840456|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56840457|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56840458|NCT00394589|Infliximab|infliximab|mesh-list
56840459|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840460|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56840461|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840462|NCT00068406|Cisplatin|cisplatin|mesh-list
56840463|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840464|NCT00403559|Ketoconazole|ketoconazole|mesh-list
56840465|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
56840466|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
56840467|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840468|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56840469|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56840470|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840471|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840472|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56840473|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
56840474|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840475|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840476|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56840477|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56840478|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56840479|NCT00403559|Analgesics|analgesics|mesh-ancestor
56840480|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
56840481|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840482|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840483|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840484|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840485|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840488|NCT01087710|Vitamins|vitamins|mesh-list
56840489|NCT01087710|Antioxidants|antioxidants|mesh-list
56840490|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
56840491|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840492|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840493|NCT01087710|Protective Agents|protective agents|mesh-ancestor
56840494|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56840495|NCT00403481|Olmesartan|olmesartan|mesh-list
56840496|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56840497|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56840498|NCT00403481|Diuretics|diuretics|mesh-ancestor
56840499|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
56840500|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840501|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56840502|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56840503|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840504|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56840505|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56840506|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56840507|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840508|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840509|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840510|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840511|NCT00394433|Bevacizumab|bevacizumab|mesh-list
56840512|NCT00394433|Cisplatin|cisplatin|mesh-list
56840513|NCT00394433|Docetaxel|docetaxel|mesh-list
56840514|NCT00394433|Irinotecan|irinotecan|mesh-list
56840515|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56840516|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840517|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56840518|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56840519|NCT00394433|Growth Substances|growth substances|mesh-ancestor
56840520|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840521|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
56840522|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
56840523|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
56840524|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
56840525|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840526|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56840527|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56840528|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840529|NCT00092534|Vaccines|vaccines|mesh-list
56840530|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
56840531|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840532|NCT00068250|Rituximab|rituximab|mesh-list
56840533|NCT00068250|Methotrexate|methotrexate|mesh-list
56840534|NCT00068250|Temozolomide|temozolomide|mesh-list
56840535|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56840536|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840537|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
56840538|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840539|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840540|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56840541|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
56840542|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56840543|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840544|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
56840545|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840546|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840547|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840548|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56840549|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840550|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56840551|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56840552|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
56840553|NCT03957720|Penicillamine|penicillamine|mesh-list
56840554|NCT03957720|Succimer|succimer|mesh-list
56840555|NCT03957720|Antidotes|antidotes|mesh-ancestor
56840556|NCT03957720|Protective Agents|protective agents|mesh-ancestor
56840557|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840558|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
56840559|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
56840560|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840562|NCT00393029|Aldesleukin|aldesleukin|mesh-list
56840563|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
56840564|NCT00393029|Fludarabine|fludarabine|mesh-list
56840565|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
56840566|NCT00393029|Interleukin-2|interleukin-2|mesh-list
56840567|NCT00393029|Lenograstim|lenograstim|mesh-list
56840568|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840569|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
56840570|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840571|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840572|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56840573|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
56840574|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840575|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840576|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56840577|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840578|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
56840579|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56840580|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56840581|NCT00393029|Analgesics|analgesics|mesh-ancestor
56840582|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
56840583|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840584|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56840585|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56840586|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
56840587|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840588|NCT00402233|Pramipexole|pramipexole|mesh-list
56840589|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
56840590|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840591|NCT00402233|Protective Agents|protective agents|mesh-ancestor
56840592|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840593|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56840594|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56840595|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
56840596|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
56840597|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56840598|NCT03993431|Methamphetamine|methamphetamine|mesh-list
56840599|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56840600|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840601|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
56840602|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
56840603|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840604|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
56840605|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56840606|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840607|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
56840608|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56840609|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56840610|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56840611|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56840612|NCT00401843|Dexamethasone|dexamethasone|mesh-list
56840613|NCT00401843|Bortezomib|bortezomib|mesh-list
56840614|NCT00401843|Siltuximab|siltuximab|mesh-list
56840615|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840616|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
56840617|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
56840618|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840619|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840620|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56840621|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
56840622|NCT00401843|Hormones|hormones|mesh-ancestor
56840623|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840624|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56840625|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840626|NCT00401531|Vaccines|vaccines|mesh-list
56840627|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56840628|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
56840629|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840630|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
56840631|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56840632|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840633|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
56840634|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840636|NCT00400517|Sargramostim|sargramostim|mesh-list
56840637|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840638|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
56840639|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840640|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
56840641|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56840642|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840643|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56840644|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56840645|NCT00400517|Growth Substances|growth substances|mesh-ancestor
56840646|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
56840647|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840648|NCT01044095|Vaccines|vaccines|mesh-list
56840649|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
56840650|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840651|NCT00392171|Temozolomide|temozolomide|mesh-list
56840652|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56840653|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
56840654|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840655|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840656|NCT00091832|Denosumab|denosumab|mesh-list
56840657|NCT00091832|Diphosphonates|diphosphonates|mesh-list
56840658|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56840659|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840660|NCT00391391|Vaccines|vaccines|mesh-list
56840661|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
56840662|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840663|NCT01044251|Frovatriptan|frovatriptan|mesh-list
56840664|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56840665|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
56840666|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56840667|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840668|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840669|NCT01044329|Triamcinolone|triamcinolone|mesh-list
56840670|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56840671|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56840672|NCT01044329|Bevacizumab|bevacizumab|mesh-list
56840673|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56840674|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56840675|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840676|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56840677|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56840678|NCT01044329|Growth Substances|growth substances|mesh-ancestor
56840679|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840680|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
56840681|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840682|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
56840683|NCT01044329|Hormones|hormones|mesh-ancestor
56840684|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840685|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840686|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
56840687|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840688|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840689|NCT00091442|Docetaxel|docetaxel|mesh-list
56840690|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56840691|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840692|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56840693|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56840694|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56840695|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840696|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56840697|NCT00390689|Pramipexole|pramipexole|mesh-list
56840698|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
56840699|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840700|NCT00390689|Protective Agents|protective agents|mesh-ancestor
56840701|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840702|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56840703|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56840704|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
56840705|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
56840706|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56840707|NCT01079078|Acetaminophen|acetaminophen|mesh-list
56840708|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56840709|NCT01079078|Analgesics|analgesics|mesh-ancestor
56840711|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840712|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840714|NCT00390455|Fulvestrant|fulvestrant|mesh-list
56840715|NCT00390455|Lapatinib|lapatinib|mesh-list
56840716|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56840717|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840718|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56840719|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56840720|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
56840721|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840722|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840723|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840724|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840725|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840726|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56840727|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56840728|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840729|NCT01583114|Perindopril|perindopril|mesh-list
56840730|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56840731|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
56840732|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840733|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840734|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56840735|NCT04258046|Trametinib|trametinib|mesh-list
56840736|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840737|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840738|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840739|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840740|NCT01079312|Fentanyl|fentanyl|mesh-list
56840741|NCT01079312|Remifentanil|remifentanil|mesh-list
56840742|NCT01079312|Propofol|propofol|mesh-list
56840743|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56840744|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56840745|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840746|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56840747|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
56840748|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
56840749|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56840750|NCT01079312|Narcotics|narcotics|mesh-ancestor
56840751|NCT01079312|Analgesics|analgesics|mesh-ancestor
56840752|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
56840753|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56840754|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56840755|NCT01044485|Docetaxel|docetaxel|mesh-list
56840756|NCT01044485|Lapatinib|lapatinib|mesh-list
56840757|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840758|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
56840759|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
56840760|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
56840761|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840762|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840763|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840764|NCT00119678|Prednisone|prednisone|mesh-list
56840765|NCT00119678|Abatacept|abatacept|mesh-list
56840766|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56840767|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
56840768|NCT00119678|Hormones|hormones|mesh-ancestor
56840769|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840770|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840771|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56840772|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840773|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56840774|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840775|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840776|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
56840777|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840778|NCT00110084|Gemcitabine|gemcitabine|mesh-list
56840779|NCT00110084|Paclitaxel|paclitaxel|mesh-list
56840780|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56840781|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56840782|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840783|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
56840785|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
56840786|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840787|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840788|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
56840789|NCT00110084|Antiviral Agents|antiviral agents|mesh-ancestor
56840790|NCT00110084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840791|NCT00110084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840792|NCT00110084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840793|NCT00110084|Immunologic Factors|immunologic factors|mesh-ancestor
56840794|NCT00110084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840796|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840797|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
56840798|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840799|NCT00389831|Rotigotine|rotigotine|mesh-list
56840800|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
56840801|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
56840802|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56840803|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840804|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840805|NCT00389519|Ramipril|ramipril|mesh-list
56840806|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56840807|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
56840808|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840809|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840810|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56840811|NCT00389441|Axitinib|axitinib|mesh-list
56840812|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840813|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840814|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840815|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840816|NCT00118898|Ritonavir|ritonavir|mesh-list
56840817|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56840818|NCT00118898|Tenofovir|tenofovir|mesh-list
56840819|NCT00118898|Lamivudine|lamivudine|mesh-list
56840820|NCT00118898|Emtricitabine|emtricitabine|mesh-list
56840821|NCT00118898|Abacavir|abacavir|mesh-list
56840822|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56840823|NCT00118898|Efavirenz|efavirenz|mesh-list
56840824|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
56840825|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56840826|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56840827|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
56840828|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840829|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840830|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56840831|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56840832|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
56840833|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840834|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56840835|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56840836|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56840837|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56840838|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56840839|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56840840|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56840841|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56840842|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56840843|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
56840844|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
56840845|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56840846|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
56840847|NCT01085552|Hematinics|hematinics|mesh-ancestor
56840848|NCT01085708|Rabeprazole|rabeprazole|mesh-list
56840849|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56840850|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56840851|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56840852|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840853|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840854|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56840855|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56840856|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56840857|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
56840858|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56840859|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840860|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840862|NCT01079624|Glucagon|glucagon|mesh-list
56840863|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56840864|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56840865|NCT01079624|Hormones|hormones|mesh-ancestor
56840866|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840867|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840868|NCT01079624|Incretins|incretins|mesh-ancestor
56840869|NCT01086020|Atorvastatin|atorvastatin|mesh-list
56840870|NCT01086020|Ezetimibe|ezetimibe|mesh-list
56840871|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56840872|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56840873|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
56840874|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840875|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56840876|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56840877|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840878|NCT03670810|Lasmiditan|lasmiditan|mesh-list
56840879|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56840880|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
56840881|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56840882|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840883|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840884|NCT01086254|Gemcitabine|gemcitabine|mesh-list
56840885|NCT01086254|Iniparib|iniparib|mesh-list
56840886|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840887|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840888|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
56840889|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840890|NCT01086254|Antiviral Agents|antiviral agents|mesh-ancestor
56840891|NCT01086254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840892|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840893|NCT01086254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840894|NCT01086254|Immunologic Factors|immunologic factors|mesh-ancestor
56840895|NCT01086254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840896|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56840897|NCT01086332|Gemcitabine|gemcitabine|mesh-list
56840898|NCT01086332|Nelfinavir|nelfinavir|mesh-list
56840899|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840900|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
56840901|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840902|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840903|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
56840904|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840905|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903259|NCT03753477|Amlodipine|amlodipine|mesh-list
56840906|NCT01086332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840907|NCT01086332|Immunologic Factors|immunologic factors|mesh-ancestor
56840908|NCT01086332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840909|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56840910|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56840911|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
56840912|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56840913|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56840914|NCT01811368|Cyclosporine|cyclosporine|mesh-list
56840915|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
56840916|NCT01811368|Rituximab|rituximab|mesh-list
56840917|NCT01811368|Cyclosporins|cyclosporins|mesh-list
56840918|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
56840919|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56840920|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
56840921|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56840922|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840923|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
56840924|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840925|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56840926|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840927|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840928|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840929|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
56840930|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840931|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56840932|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56840933|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56840934|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56840935|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
56840936|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56840938|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840939|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56840940|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56840941|NCT00089648|Growth Substances|growth substances|mesh-ancestor
56840942|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840943|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
56840944|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840945|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840946|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840947|NCT01079702|Capecitabine|capecitabine|mesh-list
56840948|NCT01079702|Everolimus|everolimus|mesh-list
56840949|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56840950|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
56840951|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840952|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840953|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56840954|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
56840955|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840956|NCT00118040|Genistein|genistein|mesh-list
56840957|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56840958|NCT00118040|Protective Agents|protective agents|mesh-ancestor
56840959|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840960|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56840961|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56840962|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840963|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840964|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
56840965|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56840966|NCT00118040|Estrogens|estrogens|mesh-ancestor
56840967|NCT00118040|Hormones|hormones|mesh-ancestor
56840968|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56840969|NCT03961958|Propofol|propofol|mesh-list
56840970|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56840971|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56840972|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840973|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56840974|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
56840975|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
56840976|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56840977|NCT00389207|Nevirapine|nevirapine|mesh-list
56840978|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56840979|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56840980|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
56840981|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56840982|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56840983|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56840984|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56840985|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
56840986|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56840987|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56840988|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56840989|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56840990|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56840991|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56840992|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
56840993|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56840994|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56840995|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56840996|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56840997|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56840998|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
56840999|NCT00085202|Vincristine|vincristine|mesh-list
56841000|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841001|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
56841002|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841003|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841004|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56841005|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
56841006|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841007|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841008|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56841009|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56841010|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
56841011|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
56841012|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
56841014|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
56841015|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841016|NCT00117572|Docetaxel|docetaxel|mesh-list
56841017|NCT00117572|Fluorouracil|fluorouracil|mesh-list
56841018|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
56841019|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841020|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
56841021|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
56841022|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
56841023|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841024|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
56841025|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841026|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841027|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
56841028|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841029|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
56841030|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841031|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56841032|NCT00388505|Tobramycin|tobramycin|mesh-list
56841033|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841034|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841035|NCT00388349|Gemcitabine|gemcitabine|mesh-list
56841036|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
56841037|NCT00388349|Carmustine|carmustine|mesh-list
56841038|NCT00388349|Etoposide|etoposide|mesh-list
56841039|NCT00388349|Vinorelbine|vinorelbine|mesh-list
56841040|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841041|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
56841042|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841043|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841044|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56841045|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
56841046|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841047|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841048|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56841049|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841050|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
56841051|NCT00388349|Antiviral Agents|antiviral agents|mesh-ancestor
56841052|NCT00388349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841053|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841054|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56841055|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56841056|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56841057|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
56841058|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
56841059|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
56841060|NCT00117338|Montelukast|montelukast|mesh-list
56841061|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56841062|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
56841063|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56841064|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
56841065|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841066|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841067|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56841068|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56841069|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841070|NCT00388037|Sunitinib|sunitinib|mesh-list
56841071|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841072|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56841073|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56841074|NCT00388037|Growth Substances|growth substances|mesh-ancestor
56841075|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841076|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
56841077|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56841078|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841079|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841080|NCT00387881|Naproxen|naproxen|mesh-list
56841081|NCT00387881|Sumatriptan|sumatriptan|mesh-list
56841082|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56841085|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
56841086|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841087|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841088|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841089|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841090|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
56841091|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56841092|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841093|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841094|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56841095|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56841096|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56841097|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
56841098|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56841099|NCT00084656|Ipilimumab|ipilimumab|mesh-list
56841100|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841101|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841102|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56841103|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841104|NCT03123029|Venetoclax|venetoclax|mesh-list
56841105|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841106|NCT00387647|Azacitidine|azacitidine|mesh-list
56841107|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841108|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
56841109|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841110|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841111|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841112|NCT00386009|Tadalafil|tadalafil|mesh-list
56841113|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
56841114|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56841115|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56841116|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841117|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841118|NCT00386009|Urological Agents|urological agents|mesh-ancestor
56841119|NCT01045889|Prednisone|prednisone|mesh-list
56841120|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
56841121|NCT01045889|Melphalan|melphalan|mesh-list
56841122|NCT01045889|Rituximab|rituximab|mesh-list
56841123|NCT01045889|Etoposide|etoposide|mesh-list
56841124|NCT01045889|Vincristine|vincristine|mesh-list
56841125|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841126|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
56841127|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841128|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841129|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56841130|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
56841131|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841132|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841133|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56841134|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841135|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841136|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
56841137|NCT01045889|Hormones|hormones|mesh-ancestor
56841138|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841139|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56841140|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56841141|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56841142|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56841143|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841144|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
56841145|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
56841146|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
56841147|NCT00373685|Celecoxib|celecoxib|mesh-list
56841148|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56841149|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56841150|NCT00373685|Analgesics|analgesics|mesh-ancestor
56841151|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
56841152|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841153|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841154|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841155|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841158|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841159|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841160|NCT00373529|Clofarabine|clofarabine|mesh-list
56841161|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841162|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
56841163|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841164|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551965|NCT02848612|Heparin|heparin|mesh-list
56841165|NCT00373295|Baclofen|baclofen|mesh-list
56841166|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56841167|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841168|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56841169|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841170|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56841171|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
56841172|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
56841173|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56841174|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841175|NCT00385541|Morphine|morphine|mesh-list
56841176|NCT00385541|Hydromorphone|hydromorphone|mesh-list
56841177|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56841178|NCT00385541|Narcotics|narcotics|mesh-ancestor
56841179|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56841180|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841181|NCT00385541|Analgesics|analgesics|mesh-ancestor
56841182|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
56841183|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841184|NCT01046045|Everolimus|everolimus|mesh-list
56841185|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841186|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841187|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
56841188|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841189|NCT01044719|Meropenem|meropenem|mesh-list
56841190|NCT01044719|Tobramycin|tobramycin|mesh-list
56841191|NCT01044719|Ceftazidime|ceftazidime|mesh-list
56841192|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841193|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841194|NCT01045109|Vitamin D|vitamin d|mesh-list
56841195|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
56841196|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
56841197|NCT01045109|Vitamins|vitamins|mesh-list
56841198|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
56841199|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841200|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56903276|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841201|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56841202|NCT00094302|Spironolactone|spironolactone|mesh-list
56841203|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56841204|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
56841205|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841206|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841207|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56841208|NCT00094302|Diuretics|diuretics|mesh-ancestor
56841209|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
56841210|NCT00372905|Rituximab|rituximab|mesh-list
56841211|NCT00372905|Bortezomib|bortezomib|mesh-list
56841212|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56841213|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841214|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841215|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
56841216|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841217|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841218|NCT00384839|Azacitidine|azacitidine|mesh-list
56841219|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841220|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
56841221|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841222|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841223|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841224|NCT01046279|Bevacizumab|bevacizumab|mesh-list
56841225|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841226|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841227|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56841228|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56841229|NCT01046279|Growth Substances|growth substances|mesh-ancestor
56841230|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841231|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
56841232|NCT00384293|Niacin|niacin|mesh-list
56841233|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56841234|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
56841235|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841236|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56841237|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
56841238|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
56841239|NCT00384293|Vitamins|vitamins|mesh-ancestor
56841240|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
56841241|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841242|NCT01087866|Metformin|metformin|mesh-list
56841243|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56841244|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841245|NCT01090830|Paclitaxel|paclitaxel|mesh-list
56841246|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56841247|NCT01090830|Bevacizumab|bevacizumab|mesh-list
56841248|NCT01090830|Carboplatin|carboplatin|mesh-list
56841249|NCT01090830|Belinostat|belinostat|mesh-list
56841250|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56841251|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841252|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
56841253|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
56841254|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
56841255|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841256|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841257|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56841258|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56841259|NCT01090830|Growth Substances|growth substances|mesh-ancestor
56841260|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841261|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
56841262|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56841263|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841264|NCT01084824|Cantharidin|cantharidin|mesh-list
56841265|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841266|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841267|NCT01088022|Dexamethasone|dexamethasone|mesh-list
56841268|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
56841269|NCT01088022|Aprepitant|aprepitant|mesh-list
56841270|NCT01088022|Palonosetron|palonosetron|mesh-list
56841271|NCT01088022|BB 1101|bb 1101|mesh-list
56841272|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841273|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
56841274|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
56841275|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841276|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841277|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56841278|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
56841279|NCT01088022|Hormones|hormones|mesh-ancestor
56841280|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841281|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56841282|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841283|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
56841284|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841285|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841286|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56841287|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56841288|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56841289|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56841290|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
56841291|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
56841292|NCT00067002|Melphalan|melphalan|mesh-list
56841293|NCT00067002|Thiotepa|thiotepa|mesh-list
56841294|NCT00067002|Rituximab|rituximab|mesh-list
56841295|NCT00067002|Fludarabine|fludarabine|mesh-list
56841296|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
56841297|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841298|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
56841299|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841300|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841301|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56841302|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
56841303|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841304|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841305|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56841306|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841307|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841308|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
56841310|NCT03961698|Bevacizumab|bevacizumab|mesh-list
56841311|NCT03961698|Atezolizumab|atezolizumab|mesh-list
56841312|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56841313|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841314|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
56841315|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
56841316|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
56841317|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841318|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841319|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56841320|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56841321|NCT03961698|Growth Substances|growth substances|mesh-ancestor
56841322|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841323|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
56841324|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56841325|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841326|NCT01084902|Latanoprost|latanoprost|mesh-list
56841327|NCT01084902|Brinzolamide|brinzolamide|mesh-list
56841328|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56841329|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56841330|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56841331|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841332|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841333|NCT01084980|Tacrolimus|tacrolimus|mesh-list
56841334|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841335|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
56841336|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841337|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56841338|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841339|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841340|NCT01085058|Lenograstim|lenograstim|mesh-list
56841341|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56841342|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
56841343|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841344|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
56841345|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56841346|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
56841347|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56841348|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841349|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56841350|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56841351|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56841352|NCT01088256|Etoricoxib|etoricoxib|mesh-list
56841353|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56841354|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56841355|NCT01088256|Analgesics|analgesics|mesh-ancestor
56841356|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
56841357|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841358|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841359|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841360|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841361|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56841362|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56841363|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841364|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841365|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56841366|NCT01326858|Ketotifen|ketotifen|mesh-list
56841367|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56841368|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56841369|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56841370|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56841371|NCT01326858|Analgesics|analgesics|mesh-ancestor
56841372|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
56841373|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841374|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841375|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841376|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841377|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56841378|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56355764|NCT00252811|Gefitinib|gefitinib|mesh-list
56841380|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
56841381|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
56841382|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56841383|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841384|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
56841385|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
56841386|NCT00091572|Temozolomide|temozolomide|mesh-list
56841387|NCT00091572|Dacarbazine|dacarbazine|mesh-list
56841388|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56841389|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
56841390|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841391|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841392|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
56841393|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841394|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
56841395|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841396|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841398|NCT00084266|Linezolid|linezolid|mesh-list
56841399|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841400|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841401|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56841402|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841403|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841404|NCT01086878|Trimethoprim|trimethoprim|mesh-list
56841405|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56841406|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
56841407|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56841408|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841409|NCT01086878|Renal Agents|renal agents|mesh-ancestor
56841410|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
56841411|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56841412|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56841413|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56841414|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841415|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841416|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56841417|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56903283|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841418|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56841419|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841420|NCT01086956|Sufentanil|sufentanil|mesh-list
56841421|NCT01086956|Ropivacaine|ropivacaine|mesh-list
56841422|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
56841423|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
56841424|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56841425|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841426|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
56841427|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841428|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56841429|NCT01086956|Narcotics|narcotics|mesh-ancestor
56841430|NCT01086956|Analgesics|analgesics|mesh-ancestor
56841431|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56841432|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56841433|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
56841434|NCT00091026|Gemcitabine|gemcitabine|mesh-list
56841435|NCT00091026|Bevacizumab|bevacizumab|mesh-list
56841436|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56841437|NCT00091026|Cetuximab|cetuximab|mesh-list
56841438|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56841439|NCT00091026|Antibodies|antibodies|mesh-list
56841440|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
56841441|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56841442|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841443|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56841444|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56841445|NCT00091026|Growth Substances|growth substances|mesh-ancestor
56841446|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841447|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
56841448|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
56841449|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841450|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
56841451|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841452|NCT00091026|Antiviral Agents|antiviral agents|mesh-ancestor
56841453|NCT00091026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841455|NCT00091026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841456|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56841457|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56841458|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841459|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56841460|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841461|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841462|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
56841463|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56841464|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
56841465|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56841466|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
56841467|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841468|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
56841469|NCT00100178|Daclizumab|daclizumab|mesh-list
56841470|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56841471|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841472|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56841473|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
56841474|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841475|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841476|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841477|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841478|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841479|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
56841480|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841481|NCT00099632|Ritonavir|ritonavir|mesh-list
56841482|NCT00099632|Lopinavir|lopinavir|mesh-list
56841483|NCT00099632|Tenofovir|tenofovir|mesh-list
56841484|NCT00099632|Lamivudine|lamivudine|mesh-list
56841485|NCT00099632|Zidovudine|zidovudine|mesh-list
56841486|NCT00099632|Emtricitabine|emtricitabine|mesh-list
56841487|NCT00099632|Nevirapine|nevirapine|mesh-list
56841488|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56841489|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56841490|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56841491|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56841492|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
56841493|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903287|NCT03758469|Rifampin|rifampin|mesh-list
56841494|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841495|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56841496|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56841497|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
56841498|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841499|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56841500|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56841501|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56841502|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56841503|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
56841504|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56841505|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56841506|NCT01087190|Isoniazid|isoniazid|mesh-list
56841507|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
56841508|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841509|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841510|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56841511|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56841512|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
56841513|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841514|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56841515|NCT01090466|Gemcitabine|gemcitabine|mesh-list
56841516|NCT01090466|Sirolimus|sirolimus|mesh-list
56841517|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841518|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841519|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
56841520|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841521|NCT01090466|Antiviral Agents|antiviral agents|mesh-ancestor
56841522|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841523|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841524|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841525|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
56841526|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841527|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841535|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841536|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56841538|NCT04116398|Hormones|hormones|mesh-ancestor
56841539|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841540|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56841541|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841542|NCT00098774|Leucovorin|leucovorin|mesh-list
56841543|NCT00098774|Cytarabine|cytarabine|mesh-list
56841544|NCT00098774|Rituximab|rituximab|mesh-list
56552336|NCT00902044|Fludarabine|fludarabine|mesh-list
56841545|NCT00098774|Methotrexate|methotrexate|mesh-list
56841546|NCT00098774|Etoposide|etoposide|mesh-list
56841547|NCT00098774|Temozolomide|temozolomide|mesh-list
56841548|NCT00098774|Calcium|calcium|mesh-list
56841549|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
56841550|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841551|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841552|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
56841553|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841554|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841555|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56841556|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56841557|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
56841558|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56841559|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841560|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
56841561|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841562|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
56841563|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841564|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56841565|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841566|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56841567|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56841568|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56841569|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56841570|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
56841571|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841572|NCT00098774|Antidotes|antidotes|mesh-ancestor
56841573|NCT00098774|Protective Agents|protective agents|mesh-ancestor
56841574|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
56841575|NCT00098774|Vitamins|vitamins|mesh-ancestor
56841576|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
56841577|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56841578|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
56841579|NCT01081652|Progesterone|progesterone|mesh-list
56841580|NCT01081652|Progestins|progestins|mesh-ancestor
56841581|NCT01081652|Hormones|hormones|mesh-ancestor
56841582|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841583|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841584|NCT01087580|Prednisone|prednisone|mesh-list
56841585|NCT01087580|Docetaxel|docetaxel|mesh-list
56841586|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841587|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
56841588|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
56841589|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
56841590|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841591|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841592|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
56841593|NCT01087580|Hormones|hormones|mesh-ancestor
56841594|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841595|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557735|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
56841597|NCT01087658|Calcium|calcium|mesh-list
56841598|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56841599|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841600|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56841601|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56841602|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841603|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
56841604|NCT01081730|Ustekinumab|ustekinumab|mesh-list
56841605|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
56841606|NCT01090700|Simeprevir|simeprevir|mesh-list
56841607|NCT01090700|Dexetimide|dexetimide|mesh-list
56841608|NCT01090700|Citalopram|citalopram|mesh-list
56841609|NCT01090700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56841610|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56841611|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56841612|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841613|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56841614|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
56841615|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841616|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56841617|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
56841618|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56841619|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56841620|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56841621|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
56841622|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
56841623|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841624|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56841625|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56841626|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
56841627|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
56841628|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841629|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
56841630|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841631|NCT03957902|Aspirin|aspirin|mesh-list
56841632|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56841633|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56841634|NCT03957902|Analgesics|analgesics|mesh-ancestor
56841635|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
56841636|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841637|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841638|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841639|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841640|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56841641|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56841642|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841643|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56841644|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56841645|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841646|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
56841647|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56841648|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
56841649|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841650|NCT01046435|Amoxicillin|amoxicillin|mesh-list
56841651|NCT01046435|Metronidazole|metronidazole|mesh-list
56841652|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841653|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841654|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56841655|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56841656|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
56841657|NCT00858364|Hematinics|hematinics|mesh-ancestor
56841658|NCT00382733|Topotecan|topotecan|mesh-list
56841659|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56841660|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56841661|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841662|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841663|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841664|NCT03992885|Pemetrexed|pemetrexed|mesh-list
56841665|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841666|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841667|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841668|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56841669|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56841671|NCT03739294|Xhance|xhance|mesh-list
56841672|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841673|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56841674|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
56841675|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841676|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841677|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56841678|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
56841679|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
56841680|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56841681|NCT03732508|Fluorouracil|fluorouracil|mesh-list
56841682|NCT03732508|Irinotecan|irinotecan|mesh-list
56841683|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
56841684|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841685|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841686|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841687|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841688|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
56841689|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841690|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56841691|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56841692|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841693|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56552487|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
56841694|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
56841695|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841696|NCT00112437|Vitamin D|vitamin d|mesh-list
56841697|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
56841698|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
56841699|NCT00112437|Calcium|calcium|mesh-list
56841700|NCT00112437|Vitamins|vitamins|mesh-ancestor
56841701|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
56841702|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841703|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56841704|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56841705|NCT00112437|Antacids|antacids|mesh-ancestor
56841706|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841707|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56841708|NCT03653416|Bupivacaine|bupivacaine|mesh-list
56841709|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
56841710|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
56841711|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56841712|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841713|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
56841714|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841715|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
56841716|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56841717|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
56841718|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841719|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
56841720|NCT01076673|Protective Agents|protective agents|mesh-ancestor
56841721|NCT00119379|Tenofovir|tenofovir|mesh-list
56841722|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
56841723|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841724|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56841725|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56841726|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841727|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841728|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56841729|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56841730|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
56841731|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56841732|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841733|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56841734|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
56841735|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841736|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841737|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841738|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841739|NCT01079481|Everolimus|everolimus|mesh-list
56841740|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841741|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841742|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
56841743|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841744|NCT03964779|Antibodies|antibodies|mesh-list
56841745|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
56841746|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
56841747|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841748|NCT00131937|Sorafenib|sorafenib|mesh-list
56841749|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841750|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56841751|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841752|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841753|NCT01079559|Tobramycin|tobramycin|mesh-list
56841754|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841755|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841756|NCT00131469|Teriparatide|teriparatide|mesh-list
56841757|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56841758|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841759|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56841760|NCT00372593|Cytarabine|cytarabine|mesh-list
56841761|NCT00372593|Etoposide|etoposide|mesh-list
56841762|NCT00372593|Daunorubicin|daunorubicin|mesh-list
56841763|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
56841764|NCT00372593|Asparaginase|asparaginase|mesh-list
56841765|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
56841766|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56841767|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841768|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56841769|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56841770|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841771|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552563|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
56841772|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841773|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
56841774|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
56841775|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841776|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841777|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
56841778|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841779|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56841780|NCT00372593|Analgesics|analgesics|mesh-ancestor
56841781|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
56841782|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841783|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841784|NCT01324583|Prednisolone|prednisolone|mesh-list
56841785|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841786|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
56841787|NCT01324583|Hormones|hormones|mesh-ancestor
56841788|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841789|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841790|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56841791|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841792|NCT00382109|Sirolimus|sirolimus|mesh-list
56841793|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
56841794|NCT00382109|Thiotepa|thiotepa|mesh-list
56841795|NCT00382109|Methotrexate|methotrexate|mesh-list
56841796|NCT00382109|Tacrolimus|tacrolimus|mesh-list
56841797|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56841798|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
56841799|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841800|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841801|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56841802|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
56841803|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841804|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841805|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56841806|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56841807|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
56841808|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56841809|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56841810|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
56841811|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
56841812|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841813|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56841814|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56841815|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56841816|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56841817|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841818|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56841819|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
56841821|NCT00381797|Bevacizumab|bevacizumab|mesh-list
56841822|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56841823|NCT00381797|Irinotecan|irinotecan|mesh-list
56841824|NCT00381797|Camptothecin|camptothecin|mesh-list
56841825|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
56841826|NCT00381797|Antibodies|antibodies|mesh-list
56841827|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
56841828|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56841829|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
56841830|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56841831|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841832|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56841833|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56841834|NCT00381797|Growth Substances|growth substances|mesh-ancestor
56841835|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841836|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
56841837|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
56841838|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56841839|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56841840|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841841|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841842|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56841843|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56841844|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
56841845|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
56841846|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841847|NCT03665038|Brexanolone|brexanolone|mesh-list
56841848|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
56841849|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56841850|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841851|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841852|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
56841853|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
56841854|NCT03664024|Carboplatin|carboplatin|mesh-list
56841855|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
56841856|NCT03664024|Pemetrexed|pemetrexed|mesh-list
56841857|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841858|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56841859|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841860|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841861|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56841862|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56841863|NCT00381641|Sunitinib|sunitinib|mesh-list
56841864|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841865|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56841866|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56841867|NCT00381641|Growth Substances|growth substances|mesh-ancestor
56841868|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841869|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
56841870|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56841871|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841872|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841873|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
56841874|NCT03624946|Antibodies|antibodies|mesh-list
56841875|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
56841876|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56841877|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56841878|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
56841879|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
56841880|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841881|NCT03735082|Paclitaxel|paclitaxel|mesh-list
56841882|NCT03735082|Carboplatin|carboplatin|mesh-list
56841883|NCT03735082|Apatinib|apatinib|mesh-list
56841884|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56841885|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841886|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
56841887|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
56841888|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
56841889|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841890|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56841891|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841892|NCT00381095|Pregabalin|pregabalin|mesh-list
56841893|NCT00381095|Analgesics|analgesics|mesh-ancestor
56841894|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
56841895|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841896|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841899|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56841900|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841901|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56841902|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56841903|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56841904|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56841905|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56841906|NCT03737656|Progesterone|progesterone|mesh-list
56841907|NCT03737656|Progestins|progestins|mesh-ancestor
56841908|NCT03737656|Hormones|hormones|mesh-ancestor
56841909|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841910|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841911|NCT00112047|Tenofovir|tenofovir|mesh-list
56841912|NCT00112047|Lamivudine|lamivudine|mesh-list
56841913|NCT00112047|Zidovudine|zidovudine|mesh-list
56841914|NCT00112047|Emtricitabine|emtricitabine|mesh-list
56841915|NCT00112047|Efavirenz|efavirenz|mesh-list
56841916|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56841917|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
56841918|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841919|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56841920|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56841921|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841922|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841923|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56552719|NCT02153632|Analgesics|analgesics|mesh-ancestor
56841924|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56841925|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
56841926|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56841927|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56841928|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56841929|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56841930|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56841931|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56841932|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56841933|NCT03658876|Hematinics|hematinics|mesh-ancestor
56841934|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
56841935|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56841936|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841937|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
56841938|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56841939|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56841940|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841941|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841942|NCT03734614|Aspirin|aspirin|mesh-list
56841943|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56841944|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56841945|NCT03734614|Analgesics|analgesics|mesh-ancestor
56841946|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
56841947|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56841948|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841949|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841950|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56841951|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56841952|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56841953|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841954|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56841955|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56841956|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56841957|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
56841958|NCT00380393|Vaccines|vaccines|mesh-list
56841959|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
56841960|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841961|NCT00380081|Zolpidem|zolpidem|mesh-list
56841962|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56841963|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56841964|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56841965|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841966|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56841967|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
56841968|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
56841969|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56841970|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841972|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56841973|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
56841974|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56841975|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841976|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841977|NCT03732040|Fluorides|fluorides|mesh-list
56841978|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
56841979|NCT03732040|Protective Agents|protective agents|mesh-ancestor
56841980|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841981|NCT00098306|Maraviroc|maraviroc|mesh-list
56841982|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56841983|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56841984|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56841985|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56841986|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56841987|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
56841988|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841989|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56841990|NCT03615040|Astegolimab|astegolimab|mesh-list
56841991|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56841992|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56841993|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
56841994|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56841995|NCT01090778|Hormones|hormones|mesh-list
56841996|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56841997|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56841998|NCT00068588|Capecitabine|capecitabine|mesh-list
56841999|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56842000|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
56842001|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842002|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842003|NCT01088282|Dipivefrin|dipivefrin|mesh-list
56842004|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56842005|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
56842006|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842007|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842008|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842009|NCT03963752|Megestrol|megestrol|mesh-list
56842010|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
56842011|NCT03963752|Leuprolide|leuprolide|mesh-list
56842012|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56842013|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56842014|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56842015|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
56842016|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56842017|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842018|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56842019|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56842020|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56842021|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842022|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
56842023|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56842024|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56842025|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
56842026|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
56842027|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
56842028|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842029|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842030|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842031|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
56842032|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
56842033|NCT01310296|Lofexidine|lofexidine|mesh-list
56842034|NCT01310296|Clonidine|clonidine|mesh-list
56842035|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56842036|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56842037|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842038|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
56842039|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842040|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56842041|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56842042|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56842043|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
56842044|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842045|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842046|NCT01310296|Analgesics|analgesics|mesh-ancestor
56842047|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
56842048|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
56842049|NCT03734068|Doxorubicin|doxorubicin|mesh-list
56842050|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56842051|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842052|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56842053|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56842054|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842055|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842056|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
56842057|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56842058|NCT03575806|Estrogens|estrogens|mesh-ancestor
56842059|NCT03575806|Hormones|hormones|mesh-ancestor
56842060|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842061|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842062|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56842063|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842064|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
56842065|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
56842066|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842067|NCT03729310|Triamcinolone|triamcinolone|mesh-list
56842068|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842069|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
56842070|NCT03729310|Hormones|hormones|mesh-ancestor
56842071|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842072|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842073|NCT03731494|Nickel|nickel|mesh-list
56842074|NCT03731494|Trace Elements|trace elements|mesh-ancestor
56842075|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
56842076|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842077|NCT00111813|Bortezomib|bortezomib|mesh-list
56842078|NCT00111813|Vorinostat|vorinostat|mesh-list
56842079|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842080|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56842081|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842082|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842083|NCT00118287|Etanercept|etanercept|mesh-list
56842084|NCT00118287|Azacitidine|azacitidine|mesh-list
56842085|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56842086|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
56842087|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842088|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842089|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842090|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56842091|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56842092|NCT00118287|Analgesics|analgesics|mesh-ancestor
56842093|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
56842094|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842095|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842096|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842097|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842098|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56842099|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56842100|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
56842101|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
56842102|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
56842103|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56842104|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842105|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842106|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
56842107|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56842108|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56842109|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842110|NCT01079715|Propranolol|propranolol|mesh-list
56842111|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56842112|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56842113|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
56842114|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842115|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842116|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842117|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56842118|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56842119|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
56842120|NCT00130689|Cetuximab|cetuximab|mesh-list
56842121|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56842122|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842123|NCT01326585|Dexamethasone|dexamethasone|mesh-list
56842124|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
56842125|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56842126|NCT01326585|BB 1101|bb 1101|mesh-list
56842127|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842128|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
56842129|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
56842130|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842131|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842132|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56842133|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
56842134|NCT01326585|Hormones|hormones|mesh-ancestor
56842135|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842136|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56842137|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842138|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
56842139|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842140|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842141|NCT03964935|Minocycline|minocycline|mesh-list
56842142|NCT03964935|Lycopene|lycopene|mesh-list
56842143|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56842144|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842145|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842146|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
56552939|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842147|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842148|NCT03964935|Protective Agents|protective agents|mesh-ancestor
56842149|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842150|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56842151|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56842152|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842154|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
56842155|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842156|NCT00117507|Deferasirox|deferasirox|mesh-list
56842157|NCT00117507|Chelating Agents|chelating agents|mesh-list
56842158|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56842159|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
56842160|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842161|NCT03621046|Zolpidem|zolpidem|mesh-list
56842162|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56903302|NCT04646109|Azithromycin|azithromycin|mesh-list
56842163|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56842164|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56842165|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842166|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56842167|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
56842168|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
56842169|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842170|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842171|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
56842172|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56842173|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842174|NCT03603496|Nicotine|nicotine|mesh-list
56842175|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56842176|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
56842177|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842178|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842179|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56842180|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56842181|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
56842182|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842183|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842184|NCT00096135|Leucovorin|leucovorin|mesh-list
56842185|NCT00096135|Cytarabine|cytarabine|mesh-list
56842186|NCT00096135|Dexamethasone|dexamethasone|mesh-list
56842187|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
56842188|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56842189|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56842190|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56842191|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
56842192|NCT00096135|Methotrexate|methotrexate|mesh-list
56842193|NCT00096135|Etoposide|etoposide|mesh-list
56842194|NCT00096135|Vincristine|vincristine|mesh-list
56842196|NCT00096135|Asparaginase|asparaginase|mesh-list
56842197|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
56842198|NCT00096135|Pegaspargase|pegaspargase|mesh-list
56842199|NCT00096135|Lenograstim|lenograstim|mesh-list
56842200|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
56842201|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56842202|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
56842203|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842204|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842205|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56842206|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
56842207|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842208|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842209|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56842210|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842211|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
56842212|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
56842213|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842214|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56842215|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
56842216|NCT00096135|Hormones|hormones|mesh-ancestor
56842217|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842218|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56842219|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56842220|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
56842221|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56842222|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56842223|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
56842224|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
56842225|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842226|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56842227|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56842228|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56842229|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56842230|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56842232|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842233|NCT00096135|Antidotes|antidotes|mesh-ancestor
56842234|NCT00096135|Protective Agents|protective agents|mesh-ancestor
56842235|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
56842236|NCT00096135|Vitamins|vitamins|mesh-ancestor
56842237|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
56842238|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56842239|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
56842240|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
56842241|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
56842242|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56842243|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56842244|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56842245|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56842246|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56842247|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842248|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842249|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
56842250|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842251|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56842252|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56842253|NCT00116649|Imiquimod|imiquimod|mesh-list
56842254|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56842255|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
56842256|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842257|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842258|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
56842259|NCT01080651|Voriconazole|voriconazole|mesh-list
56842260|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
56842261|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842262|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56842263|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56842264|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842265|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842266|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56842267|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
56842268|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842269|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842270|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56842272|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56842273|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842274|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842275|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
56842276|NCT03962907|Mupirocin|mupirocin|mesh-list
56842277|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56842278|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842279|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
56842280|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56842281|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56842282|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842283|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842284|NCT00083889|Interferons|interferons|mesh-list
56842285|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
56842286|NCT00083889|Sunitinib|sunitinib|mesh-list
56842287|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842288|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
56842289|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842290|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
56842291|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842292|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56842293|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56842294|NCT00083889|Growth Substances|growth substances|mesh-ancestor
56842295|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
56842296|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56842297|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553092|NCT02633839|Carbidopa|carbidopa|mesh-list
56842298|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842299|NCT03639532|Tacrine|tacrine|mesh-list
56842300|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56842301|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842302|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842303|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
56842304|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842305|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842306|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56842307|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
56842308|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842309|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
56842310|NCT03571516|Teduglutide|teduglutide|mesh-list
56842311|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56842312|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56842313|NCT03571516|Protective Agents|protective agents|mesh-ancestor
56842314|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842315|NCT03600376|Dantrolene|dantrolene|mesh-list
56842316|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56842317|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842318|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56842319|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842320|NCT03961659|Metformin|metformin|mesh-list
56842321|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
56842322|NCT03961659|Acarbose|acarbose|mesh-list
56842323|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56842324|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842325|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56842326|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842327|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56842328|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842329|NCT03599362|Nivolumab|nivolumab|mesh-list
56842330|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56842331|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842332|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56842333|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842334|NCT03741309|Calcium|calcium|mesh-list
56842335|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56842336|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842337|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
56842338|NCT00082407|Exenatide|exenatide|mesh-list
56842339|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
56842340|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56842341|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842342|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56842343|NCT00082407|Incretins|incretins|mesh-ancestor
56842345|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842347|NCT01080963|Cefuroxime|cefuroxime|mesh-list
56842348|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
56842349|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56842350|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842351|NCT01083381|Risperidone|risperidone|mesh-list
56842352|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56842353|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
56842354|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842355|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842356|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842357|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56842358|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56842359|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56842360|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56842361|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56842362|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
56842363|NCT01087359|Melatonin|melatonin|mesh-list
56842364|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
56842365|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842366|NCT01087359|Protective Agents|protective agents|mesh-ancestor
56842367|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842368|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56842369|NCT01087437|Calcium|calcium|mesh-list
56842370|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56842371|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842372|NCT01083537|Paclitaxel|paclitaxel|mesh-list
56842373|NCT01083537|Cisplatin|cisplatin|mesh-list
56842374|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56842375|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842376|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
56842377|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
56842378|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
56842379|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842380|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
56842381|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
56842382|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
56842383|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
56842384|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842385|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
56842386|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56842387|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56842388|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895037|NCT03242460|Dexamethasone|dexamethasone|mesh-list
56842389|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56842390|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
56842391|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842392|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56842393|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
56842394|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
56842395|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56842396|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56842397|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
56842398|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56842399|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56842400|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842401|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
56842402|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842403|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842404|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56842405|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842406|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
56842407|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
56842408|NCT03727282|Dobutamine|dobutamine|mesh-list
56842409|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56842410|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
56842411|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
56842412|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842413|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842414|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56842415|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56842416|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56842417|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
56842419|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842420|NCT03727282|Protective Agents|protective agents|mesh-ancestor
56842421|NCT00110019|Paclitaxel|paclitaxel|mesh-list
56842422|NCT00110019|Carboplatin|carboplatin|mesh-list
56842423|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56842424|NCT00110019|Sorafenib|sorafenib|mesh-list
56842425|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56842426|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842427|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
56842428|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
56842429|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
56842430|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842431|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56842432|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842433|NCT03642262|Guaifenesin|guaifenesin|mesh-list
56842434|NCT03642262|Expectorants|expectorants|mesh-ancestor
56842435|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
56842436|NCT03727048|Ketorolac|ketorolac|mesh-list
56842437|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56842438|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56842439|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56842440|NCT03727048|Analgesics|analgesics|mesh-ancestor
56842441|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
56842442|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842443|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842444|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842445|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842446|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56842447|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842448|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842449|NCT00095979|Epothilones|epothilones|mesh-list
56842450|NCT00095979|Epothilone B|epothilone b|mesh-list
56842451|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56842452|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56842453|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56842454|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842455|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842456|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56842457|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56842458|NCT01087593|Estradiol|estradiol|mesh-list
56842459|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56842460|NCT01087593|Estrogens|estrogens|mesh-ancestor
56842461|NCT01087593|Hormones|hormones|mesh-ancestor
56842462|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842463|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842464|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56842465|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
56842466|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56842467|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56842468|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
56842469|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56842470|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842471|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56842472|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56842473|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842474|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842475|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842476|NCT01087749|Losartan|losartan|mesh-list
56842477|NCT01087749|Propranolol|propranolol|mesh-list
56842478|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56842479|NCT01087749|Eprosartan|eprosartan|mesh-list
56842480|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56842481|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56842482|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56842483|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56842484|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842485|NCT01087749|Diuretics|diuretics|mesh-ancestor
56842486|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
56842487|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842488|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56842489|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56842490|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56842491|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56842493|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842494|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
56842495|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
56842496|NCT03568318|Upadacitinib|upadacitinib|mesh-list
56842497|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56842498|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56842499|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842500|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842501|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842502|NCT00108069|Tamoxifen|tamoxifen|mesh-list
56842503|NCT00108069|Bortezomib|bortezomib|mesh-list
56842504|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842505|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56842506|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
56842507|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842508|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842509|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56842510|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56842511|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56842512|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56842513|NCT00079274|Leucovorin|leucovorin|mesh-list
56842514|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56842515|NCT00079274|Cetuximab|cetuximab|mesh-list
56842516|NCT00079274|Fluorouracil|fluorouracil|mesh-list
56842517|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
56842518|NCT00079274|Irinotecan|irinotecan|mesh-list
56842519|NCT00079274|Antibodies|antibodies|mesh-list
56842520|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
56842521|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56842522|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
56842523|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
56842524|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842525|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842526|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
56842527|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842528|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56842529|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56842530|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56842531|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56842532|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842533|NCT00079274|Antidotes|antidotes|mesh-ancestor
56842534|NCT00079274|Protective Agents|protective agents|mesh-ancestor
56842535|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
56842536|NCT00079274|Vitamins|vitamins|mesh-ancestor
56842537|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
56842538|NCT01081964|Levofloxacin|levofloxacin|mesh-list
56842539|NCT01081964|Ofloxacin|ofloxacin|mesh-list
56842540|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
56842541|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56842542|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842543|NCT01081964|Renal Agents|renal agents|mesh-ancestor
56842544|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56842545|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56842546|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56842547|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842548|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842549|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842550|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56842551|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56842552|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56842553|NCT00079040|Bevacizumab|bevacizumab|mesh-list
56842554|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56842555|NCT00079040|Etoposide|etoposide|mesh-list
56842556|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
56842557|NCT00079040|Antibodies|antibodies|mesh-list
56842558|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
56842559|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56842560|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842561|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56842562|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56842563|NCT00079040|Growth Substances|growth substances|mesh-ancestor
56842564|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842565|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
56842566|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
56842567|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56842569|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56842570|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842571|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842572|NCT01088516|Ritonavir|ritonavir|mesh-list
56842573|NCT01088516|Lopinavir|lopinavir|mesh-list
56842574|NCT01088516|Zidovudine|zidovudine|mesh-list
56842575|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56842576|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56842577|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
56842578|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842579|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842580|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56842581|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56842582|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
56842583|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842584|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56842585|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56842586|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
56842587|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56842588|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56842589|NCT00078806|Etanercept|etanercept|mesh-list
56842590|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56842591|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56842592|NCT00078806|Analgesics|analgesics|mesh-ancestor
56842593|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
56842594|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842595|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842596|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842597|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842598|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56842599|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56842600|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
56842601|NCT00078338|Interferons|interferons|mesh-list
56842602|NCT00078338|Interferon-beta|interferon-beta|mesh-list
56842603|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
56842604|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
56842605|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
56842606|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842607|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
56842608|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842609|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
56842610|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842611|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56842612|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56842613|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842614|NCT01088594|Pioglitazone|pioglitazone|mesh-list
56842615|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
56842616|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56842617|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842618|NCT01082120|Pioglitazone|pioglitazone|mesh-list
56842619|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56842620|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842621|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56842622|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56842623|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
56842624|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56842625|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56842626|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842627|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56842628|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56842629|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842630|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842631|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842632|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56842633|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
56842634|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56842635|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842636|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56842637|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56842638|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56842639|NCT03961334|Aspirin|aspirin|mesh-list
56842640|NCT03961334|Dabigatran|dabigatran|mesh-list
56842641|NCT03961334|Apixaban|apixaban|mesh-list
56842642|NCT03961334|Edoxaban|edoxaban|mesh-list
56842643|NCT03961334|Clopidogrel|clopidogrel|mesh-list
56842644|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56842646|NCT03961334|Analgesics|analgesics|mesh-ancestor
56842647|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
56842648|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842649|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842650|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842651|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842652|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56842653|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56842654|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842655|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56842656|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56842657|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842658|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
56842659|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56842660|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56842661|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56842662|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
56842663|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842664|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
56842665|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56842666|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
56842667|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
56842668|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56842669|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56842670|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
56842671|NCT00077636|Ribavirin|ribavirin|mesh-list
56842672|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
56842673|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842674|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
56842675|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842676|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
56842677|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842679|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56842680|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
56842681|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842682|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56842683|NCT01088750|Prednisolone|prednisolone|mesh-list
56842684|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
56842685|NCT01088750|Vinblastine|vinblastine|mesh-list
56842686|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56842687|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
56842688|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842689|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842690|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56842691|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
56842692|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842693|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842694|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56842695|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842696|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
56842697|NCT01088750|Hormones|hormones|mesh-ancestor
56842698|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842699|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56842700|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56842701|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
56842702|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
56842703|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
56842704|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
56842705|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
56842706|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56842707|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56842708|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842709|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842710|NCT01091012|Urological Agents|urological agents|mesh-ancestor
56842711|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56842712|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56842713|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56842714|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56842715|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842716|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56842717|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56842718|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56842720|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
56842721|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842722|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842723|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56842724|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56842725|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
56842726|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56842727|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56842728|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
56842729|NCT01088906|Pemetrexed|pemetrexed|mesh-list
56842730|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842731|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842732|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842733|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56842734|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56842735|NCT00095199|Docetaxel|docetaxel|mesh-list
56842736|NCT00095199|Pemetrexed|pemetrexed|mesh-list
56842737|NCT00095199|Cetuximab|cetuximab|mesh-list
56842738|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842739|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
56842740|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
56842741|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
56842742|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842743|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842744|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56842745|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56842746|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56842747|NCT00075764|Fulvestrant|fulvestrant|mesh-list
56842748|NCT00075764|Anastrozole|anastrozole|mesh-list
56842749|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56553549|NCT00658255|Budesonide|budesonide|mesh-list
56842750|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842751|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56842753|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
56842754|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842755|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842756|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56842757|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56842758|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894847|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56842759|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842760|NCT03567616|Dexamethasone|dexamethasone|mesh-list
56842761|NCT03567616|Venetoclax|venetoclax|mesh-list
56842762|NCT03567616|Pomalidomide|pomalidomide|mesh-list
56842763|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842764|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
56842765|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
56842766|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842767|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842768|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56842769|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
56842770|NCT03567616|Hormones|hormones|mesh-ancestor
56842771|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56842772|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56842773|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842774|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
56842775|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56842776|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56842777|NCT03567616|Growth Substances|growth substances|mesh-ancestor
56842778|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
56842779|NCT03567382|Tenofovir|tenofovir|mesh-list
56842780|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
56842781|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842782|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56842783|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56842784|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842785|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842786|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56842787|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56842788|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56842789|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56842790|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56357177|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
56842791|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56842792|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56842793|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
56842794|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842795|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842796|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842797|NCT03730714|Epinephrine|epinephrine|mesh-list
56842798|NCT03730714|Racepinephrine|racepinephrine|mesh-list
56842799|NCT03730714|Morphine|morphine|mesh-list
56842800|NCT03730714|Anesthetics|anesthetics|mesh-list
56842801|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
56842802|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
56842803|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56842804|NCT03730714|Narcotics|narcotics|mesh-ancestor
56842805|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56842806|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842807|NCT03730714|Analgesics|analgesics|mesh-ancestor
56842808|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
56842809|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842810|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56842811|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56842812|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
56842813|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842814|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842815|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56842816|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56842817|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
56842818|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56842819|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
56842820|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
56842821|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
56842822|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56842823|NCT00106353|Sirolimus|sirolimus|mesh-list
56842824|NCT00106353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56842825|NCT00106353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842826|NCT00106353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56842827|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842828|NCT00106353|Antifungal Agents|antifungal agents|mesh-ancestor
56842829|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56842830|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
56842831|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842832|NCT01087983|Metformin|metformin|mesh-list
56842833|NCT01087983|Sirolimus|sirolimus|mesh-list
56842834|NCT01087983|Lapatinib|lapatinib|mesh-list
56842835|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56842836|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842837|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56842838|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842839|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56842840|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842841|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
56842842|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56842843|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
56842844|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56842845|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842846|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842847|NCT00080301|Capecitabine|capecitabine|mesh-list
56842848|NCT00080301|Epothilones|epothilones|mesh-list
56842849|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56842850|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
56842851|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842852|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842853|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
56842854|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
56842855|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
56842856|NCT03961503|Vancomycin|vancomycin|mesh-list
56842857|NCT03961503|Daptomycin|daptomycin|mesh-list
56842858|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56842859|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842860|NCT00079677|Modafinil|modafinil|mesh-list
56842861|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56842862|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842863|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56842864|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56842865|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56842866|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842867|NCT01081353|Aspirin|aspirin|mesh-list
56842868|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56842870|NCT01081353|Analgesics|analgesics|mesh-ancestor
56842871|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
56842872|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842873|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842874|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56842875|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56842876|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56842877|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56842878|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842879|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56842880|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56842881|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842882|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
56842883|NCT00095121|Lamivudine|lamivudine|mesh-list
56842884|NCT00095121|Adefovir|adefovir|mesh-list
56842885|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56842886|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56842887|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56842888|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842889|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842890|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
56842891|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56842892|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56842893|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56842894|NCT01081431|Lenalidomide|lenalidomide|mesh-list
56842895|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
56842896|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842897|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56842898|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56842899|NCT01081431|Growth Substances|growth substances|mesh-ancestor
56842900|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
56842901|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842902|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
56842903|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56842904|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
56842905|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842906|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842907|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842908|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
56842909|NCT01084473|Morphine|morphine|mesh-list
56842910|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56842911|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56842912|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842913|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56842914|NCT01084473|Analgesics|analgesics|mesh-ancestor
56842915|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
56842916|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56842917|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56842918|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56842919|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56842920|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
56842921|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56842922|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842923|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56842924|NCT01084473|Narcotics|narcotics|mesh-ancestor
56842925|NCT01088373|Lenalidomide|lenalidomide|mesh-list
56842926|NCT01088373|Azacitidine|azacitidine|mesh-list
56842927|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
56842928|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842929|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56842930|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56842931|NCT01088373|Growth Substances|growth substances|mesh-ancestor
56842932|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
56842933|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842934|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56842935|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
56842936|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842937|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842938|NCT01088451|Insulin|insulin|mesh-list
56842939|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56842940|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842941|NCT00075218|Sunitinib|sunitinib|mesh-list
56842943|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56842944|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56842945|NCT00075218|Growth Substances|growth substances|mesh-ancestor
56842946|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842947|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
56842948|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56842949|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56842950|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842951|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
56842952|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56842953|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56842954|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842955|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
56842956|NCT01089140|Coagulants|coagulants|mesh-ancestor
56842957|NCT00094653|Ipilimumab|ipilimumab|mesh-list
56842958|NCT00094653|Vaccines|vaccines|mesh-list
56842959|NCT00094653|Antibodies|antibodies|mesh-list
56842960|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56842961|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
56842962|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842963|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56842964|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842965|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56842966|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842967|NCT00104247|Verapamil|verapamil|mesh-list
56842968|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56842969|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56842970|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56842971|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842972|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56842973|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842974|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
56842975|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56842976|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
55895038|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
56842977|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842978|NCT05665348|Bevacizumab|bevacizumab|mesh-list
56842979|NCT05665348|Ipilimumab|ipilimumab|mesh-list
56842980|NCT05665348|Atezolizumab|atezolizumab|mesh-list
56842981|NCT05665348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56842982|NCT05665348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56842983|NCT05665348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842984|NCT05665348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56842985|NCT05665348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56842986|NCT05665348|Growth Substances|growth substances|mesh-ancestor
56842987|NCT05665348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56842988|NCT05665348|Growth Inhibitors|growth inhibitors|mesh-ancestor
56842989|NCT05665348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56842990|NCT05665348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842991|NCT05665348|Immunologic Factors|immunologic factors|mesh-ancestor
56842992|NCT03726736|Docetaxel|docetaxel|mesh-list
56842993|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56842994|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
56842995|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
56842996|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
56842997|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56842998|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56842999|NCT03591406|Hematinics|hematinics|mesh-ancestor
56843000|NCT03726580|Propofol|propofol|mesh-list
56843001|NCT03726580|Sevoflurane|sevoflurane|mesh-list
56843002|NCT03726580|Isoflurane|isoflurane|mesh-list
56843003|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56843004|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843005|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843006|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56843007|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
56843008|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
56843009|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56843010|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56843011|NCT03730558|Aflibercept|aflibercept|mesh-list
56843012|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56843013|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56843014|NCT03730558|Growth Substances|growth substances|mesh-ancestor
56843015|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843016|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
56843017|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843018|NCT03588910|Acetaminophen|acetaminophen|mesh-list
56843019|NCT03588910|Ibuprofen|ibuprofen|mesh-list
56843020|NCT03588910|Oxycodone|oxycodone|mesh-list
56843021|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56843022|NCT03588910|Analgesics|analgesics|mesh-ancestor
56843023|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
56843024|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843025|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843026|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
56843027|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56843028|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56843029|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56843030|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56843031|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843032|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843033|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56843034|NCT03588910|Narcotics|narcotics|mesh-ancestor
56843035|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843036|NCT03730402|Bupivacaine|bupivacaine|mesh-list
56843037|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
56843038|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
56843039|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843040|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843041|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
56843042|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843043|NCT00103857|Metformin|metformin|mesh-list
56843044|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56843045|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56843046|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843047|NCT00103857|Incretins|incretins|mesh-ancestor
56843048|NCT00103857|Hormones|hormones|mesh-ancestor
56843049|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450005|NCT00310934|Analgesics|analgesics|mesh-ancestor
56843050|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56553849|NCT02630095|Nadroparin|nadroparin|mesh-list
56843051|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
56843052|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843053|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843054|NCT03587584|Bupivacaine|bupivacaine|mesh-list
56843055|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
56843056|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
56843057|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843058|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843059|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
56843060|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843061|NCT03586726|Rifampin|rifampin|mesh-list
56843062|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56843063|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
56843064|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56843065|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56843066|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
56843067|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56843068|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843069|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843070|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56843071|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56843072|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56843073|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56843074|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56843075|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56843076|NCT03725878|Folic Acid|folic acid|mesh-list
56843077|NCT03725878|Hematinics|hematinics|mesh-ancestor
56843078|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
56843079|NCT03725878|Vitamins|vitamins|mesh-ancestor
56843080|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
56843081|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843082|NCT03721900|Ketamine|ketamine|mesh-list
56843083|NCT03721900|Analgesics|analgesics|mesh-ancestor
56843084|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
56843085|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843086|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843087|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56843088|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56843089|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
56843090|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
56843092|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56843093|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56843094|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843095|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843096|NCT03585712|Norgestrel|norgestrel|mesh-list
56843097|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56843098|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56843099|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56843100|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
56843101|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56843102|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843103|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56843104|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56843105|NCT01082510|Tegafur|tegafur|mesh-list
56843106|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56843107|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
56843108|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843109|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843110|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56843111|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56843112|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56843113|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
56843114|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843115|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843116|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843117|NCT03583372|Urological Agents|urological agents|mesh-ancestor
56843118|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
56843119|NCT00074282|Rituximab|rituximab|mesh-list
56843120|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
56843121|NCT00074282|Pentostatin|pentostatin|mesh-list
56843122|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843123|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
56843124|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843125|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56843126|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56843127|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
56843128|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843129|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843130|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56843131|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843132|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56843133|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843134|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
56843135|NCT01091324|Silymarin|silymarin|mesh-list
56843136|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
56843137|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
56843138|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56843139|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56843140|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843141|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843142|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843143|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
56843144|NCT01091324|Protective Agents|protective agents|mesh-ancestor
56843145|NCT05782608|Ibuprofen|ibuprofen|mesh-list
56843146|NCT05782608|Ketorolac|ketorolac|mesh-list
56843147|NCT05782608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56843148|NCT05782608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56843149|NCT05782608|Analgesics|analgesics|mesh-ancestor
56843150|NCT05782608|Sensory System Agents|sensory system agents|mesh-ancestor
56843151|NCT05782608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843152|NCT05782608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843153|NCT05782608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56843154|NCT05782608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56843155|NCT05782608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56843156|NCT05782608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843157|NCT05782608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843158|NCT05782426|Paclitaxel|paclitaxel|mesh-list
56843159|NCT05782426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56843160|NCT05782426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843161|NCT05782426|Tubulin Modulators|tubulin modulators|mesh-ancestor
56843162|NCT05782426|Antimitotic Agents|antimitotic agents|mesh-ancestor
56843171|NCT05782348|Cariostatic Agents|cariostatic agents|mesh-ancestor
56843172|NCT05782348|Protective Agents|protective agents|mesh-ancestor
56843173|NCT05782348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843174|NCT05782348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56843175|NCT05782348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56843176|NCT05782244|Sildenafil Citrate|sildenafil citrate|mesh-list
56843177|NCT05782244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843178|NCT05782244|Vasodilator Agents|vasodilator agents|mesh-ancestor
56843179|NCT05782244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56843180|NCT05782244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56843181|NCT05782244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843182|NCT05782244|Urological Agents|urological agents|mesh-ancestor
56843183|NCT05782192|Alogliptin|alogliptin|mesh-list
56843184|NCT05782192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56843185|NCT05782192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843186|NCT05782192|Incretins|incretins|mesh-ancestor
56843187|NCT05782192|Hormones|hormones|mesh-ancestor
56843188|NCT05782192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843189|NCT05782192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56843190|NCT05782192|Protease Inhibitors|protease inhibitors|mesh-ancestor
56843191|NCT05782192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843192|NCT05782192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843193|NCT05782127|Venetoclax|venetoclax|mesh-list
56843194|NCT05782127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843195|NCT05781997|Mydriatics|mydriatics|mesh-list
56843196|NCT05781997|Autonomic Agents|autonomic agents|mesh-ancestor
56843197|NCT05781997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843198|NCT05781997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843199|NCT05781854|Dexmedetomidine|dexmedetomidine|mesh-list
56553996|NCT05657015|Simvastatin|simvastatin|mesh-list
56843201|NCT05781854|Anesthetics, Local|anesthetics, local|mesh-ancestor
56843202|NCT05781854|Anesthetics|anesthetics|mesh-ancestor
56904700|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56843203|NCT05781854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843204|NCT05781854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843205|NCT05781854|Sensory System Agents|sensory system agents|mesh-ancestor
56843206|NCT05781854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843207|NCT05781854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56843208|NCT05781854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56843209|NCT05781854|Analgesics|analgesics|mesh-ancestor
56843210|NCT05781854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56843211|NCT05781854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56843212|NCT05781854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56843213|NCT05781854|Adrenergic Agents|adrenergic agents|mesh-ancestor
56843214|NCT05781854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843215|NCT05781854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843216|NCT05781711|Metformin|metformin|mesh-list
56843217|NCT05781711|Levodopa|levodopa|mesh-list
56843218|NCT05781711|Carbidopa|carbidopa|mesh-list
56843219|NCT05781711|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56843220|NCT05781711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56843221|NCT05781711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843222|NCT05781711|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56843223|NCT05781711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56843224|NCT05781711|Dopamine Agents|dopamine agents|mesh-ancestor
56843225|NCT05781711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843226|NCT05781711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843227|NCT05781711|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56843228|NCT05781711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843229|NCT05781711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56843230|NCT05781711|Immunologic Factors|immunologic factors|mesh-ancestor
56843231|NCT05781711|Dopamine Agonists|dopamine agonists|mesh-ancestor
56843232|NCT05781698|Mesalamine|mesalamine|mesh-list
56843233|NCT05781698|Fenofibrate|fenofibrate|mesh-list
56843234|NCT05781698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56843235|NCT05781698|Antimetabolites|antimetabolites|mesh-ancestor
56843236|NCT05781698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843237|NCT05781698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56843239|NCT05781698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56843240|NCT05781698|Analgesics|analgesics|mesh-ancestor
56843241|NCT05781698|Sensory System Agents|sensory system agents|mesh-ancestor
56843242|NCT05781698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843243|NCT05781698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843244|NCT05781698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56843245|NCT05781698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56843246|NCT05781685|Testosterone|testosterone|mesh-list
56843247|NCT05781685|Androgens|androgens|mesh-ancestor
56843248|NCT05781685|Hormones|hormones|mesh-ancestor
56843249|NCT05781685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843250|NCT05781685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843251|NCT05781633|Bevacizumab|bevacizumab|mesh-list
56843252|NCT05781633|Etoposide|etoposide|mesh-list
56843253|NCT05781633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843254|NCT05781633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843255|NCT05781633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56843256|NCT05781633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56843257|NCT05781633|Growth Substances|growth substances|mesh-ancestor
56843258|NCT05781633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843259|NCT05781633|Growth Inhibitors|growth inhibitors|mesh-ancestor
56843260|NCT05781633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56843261|NCT05781633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56843262|NCT05781633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56843263|NCT05781633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843264|NCT05781633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843265|NCT05781620|Vitamin D|vitamin d|mesh-list
56843266|NCT05781620|Vitamins|vitamins|mesh-ancestor
56843267|NCT05781620|Micronutrients|micronutrients|mesh-ancestor
56843268|NCT05781620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843269|NCT05781620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56843270|NCT05781542|MEDI9197|medi9197|mesh-list
56843271|NCT05781542|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56843272|NCT05781542|Immunologic Factors|immunologic factors|mesh-ancestor
56843273|NCT05781542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843274|NCT05781529|Hyaluronic Acid|hyaluronic acid|mesh-list
56903329|NCT03752931|Celiprolol|celiprolol|mesh-list
56843275|NCT05781529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56843276|NCT05781529|Immunologic Factors|immunologic factors|mesh-ancestor
56843277|NCT05781529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843278|NCT05781529|Viscosupplements|viscosupplements|mesh-ancestor
56843279|NCT05781529|Protective Agents|protective agents|mesh-ancestor
56843281|NCT05781308|Bevacizumab|bevacizumab|mesh-list
56843282|NCT05781308|Atezolizumab|atezolizumab|mesh-list
56843283|NCT05781308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56843284|NCT05781308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843285|NCT05781308|Tubulin Modulators|tubulin modulators|mesh-ancestor
56843286|NCT05781308|Antimitotic Agents|antimitotic agents|mesh-ancestor
56843287|NCT05781308|Mitosis Modulators|mitosis modulators|mesh-ancestor
56843288|NCT05781308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843289|NCT05781308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843290|NCT05781308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56843291|NCT05781308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56843292|NCT05781308|Growth Substances|growth substances|mesh-ancestor
56843293|NCT05781308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843294|NCT05781308|Growth Inhibitors|growth inhibitors|mesh-ancestor
56843295|NCT05781217|Goserelin|goserelin|mesh-list
56843296|NCT05781217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56843297|NCT05781217|Leuprolide|leuprolide|mesh-list
56843298|NCT05781217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56843299|NCT05781217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843300|NCT05781217|Luteolytic Agents|luteolytic agents|mesh-ancestor
56843301|NCT05781217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56843302|NCT05781217|Contraceptive Agents|contraceptive agents|mesh-ancestor
56843303|NCT05781217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56843304|NCT05781217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843305|NCT05781217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56843306|NCT05781217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56843307|NCT05781217|Fertility Agents|fertility agents|mesh-ancestor
56843308|NCT05781152|Adalimumab|adalimumab|mesh-list
56843309|NCT05781152|Infliximab|infliximab|mesh-list
56843310|NCT05781152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56843311|NCT05781152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56843312|NCT05781152|Dermatologic Agents|dermatologic agents|mesh-ancestor
56843313|NCT05781152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56843315|NCT05781035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843316|NCT05781035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843317|NCT05781035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56843318|NCT05781035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56843319|NCT05781035|Analgesics|analgesics|mesh-ancestor
56843320|NCT05781035|Sensory System Agents|sensory system agents|mesh-ancestor
56843321|NCT05781035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843322|NCT05781035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56843323|NCT05781035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56843324|NCT05781035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56843325|NCT05781035|Adrenergic Agents|adrenergic agents|mesh-ancestor
56843326|NCT05781035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843327|NCT05781035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843328|NCT05780801|Glycerol|glycerol|mesh-list
56843329|NCT05780801|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56843330|NCT05780801|Protective Agents|protective agents|mesh-ancestor
56843331|NCT05780801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843332|NCT05780554|Cyclophosphamide|cyclophosphamide|mesh-list
56843333|NCT05780554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843334|NCT05780554|Immunologic Factors|immunologic factors|mesh-ancestor
56843335|NCT05780554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843336|NCT05780554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56843337|NCT05780554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56843338|NCT05780554|Alkylating Agents|alkylating agents|mesh-ancestor
56843339|NCT05780554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843340|NCT05780554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843341|NCT05780554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56843342|NCT05766501|Islatravir|islatravir|mesh-list
56843343|NCT05766501|Antiviral Agents|antiviral agents|mesh-ancestor
56843344|NCT05766501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56843345|NCT05766501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843346|NCT05766501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843347|NCT05766501|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56843348|NCT05766501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56554137|NCT00893464|Ixazomib|ixazomib|mesh-list
56843349|NCT05766501|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56843350|NCT05758948|Formaldehyde|formaldehyde|mesh-list
56843351|NCT05758948|Disinfectants|disinfectants|mesh-ancestor
56843352|NCT05758948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56843353|NCT05743946|Ivacaftor|ivacaftor|mesh-list
56843354|NCT05743946|Elexacaftor|elexacaftor|mesh-list
56843355|NCT05743946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56843356|NCT05743946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56843357|NCT05743946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843358|NCT05739292|Vaccines|vaccines|mesh-list
56843359|NCT05739292|Immunologic Factors|immunologic factors|mesh-ancestor
56843360|NCT05739292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843361|NCT05710081|Broncho-Vaxom|broncho-vaxom|mesh-list
56843362|NCT05710081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56843363|NCT05710081|Immunologic Factors|immunologic factors|mesh-ancestor
56843364|NCT05710081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843365|NCT05703191|Nitric Oxide|nitric oxide|mesh-list
56843366|NCT05703191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56843367|NCT05703191|Autonomic Agents|autonomic agents|mesh-ancestor
56843368|NCT05703191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843369|NCT05703191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843370|NCT05703191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56843371|NCT05703191|Respiratory System Agents|respiratory system agents|mesh-ancestor
56843372|NCT05703191|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56843373|NCT05703191|Antioxidants|antioxidants|mesh-ancestor
56843374|NCT05703191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843375|NCT05703191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843376|NCT05703191|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56843377|NCT05703191|Vasodilator Agents|vasodilator agents|mesh-ancestor
56843378|NCT05703191|Gasotransmitters|gasotransmitters|mesh-ancestor
56843379|NCT05703191|Protective Agents|protective agents|mesh-ancestor
56843380|NCT05689424|Insulin Lispro|insulin lispro|mesh-list
56843381|NCT05689424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56843382|NCT05689424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843383|NCT05687071|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56843384|NCT05687071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56843385|NCT05687071|Antimetabolites|antimetabolites|mesh-ancestor
56557748|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
56843386|NCT05687071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843387|NCT05687071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56843388|NCT05687071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843389|NCT05687071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56843390|NCT05687071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843391|NCT05681611|Rocuronium|rocuronium|mesh-list
56843392|NCT05681611|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56843393|NCT05681611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56843394|NCT05681611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56843395|NCT05681611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843396|NCT05681611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843397|NCT05679908|Oxytocin|oxytocin|mesh-list
56843398|NCT05679908|Oxytocics|oxytocics|mesh-ancestor
56843399|NCT05679908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56843400|NCT05679908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843401|NCT05657470|Tenecteplase|tenecteplase|mesh-list
56843402|NCT05657470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56843403|NCT05657470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56843404|NCT05657470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843405|NCT05649059|Cannabidiol|cannabidiol|mesh-list
56843406|NCT05649059|Anticonvulsants|anticonvulsants|mesh-ancestor
56843407|NCT05639686|Remifentanil|remifentanil|mesh-list
56843408|NCT05639686|Anesthetics|anesthetics|mesh-list
56843409|NCT05639686|Propofol|propofol|mesh-list
56843410|NCT05639686|Isoflurane|isoflurane|mesh-list
56843411|NCT05639686|Tranexamic Acid|tranexamic acid|mesh-list
56843412|NCT05639686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843413|NCT05639686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843414|NCT05639686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56843415|NCT05639686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56843416|NCT05639686|Anesthetics, General|anesthetics, general|mesh-ancestor
56843417|NCT05639686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56843418|NCT05639686|Narcotics|narcotics|mesh-ancestor
56843419|NCT05639686|Analgesics|analgesics|mesh-ancestor
56843420|NCT05639686|Sensory System Agents|sensory system agents|mesh-ancestor
56843421|NCT05639686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843422|NCT05639686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56843423|NCT05639686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56843424|NCT05639686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843425|NCT05639686|Hemostatics|hemostatics|mesh-ancestor
56843426|NCT05639686|Coagulants|coagulants|mesh-ancestor
56843427|NCT05639686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56843428|NCT05639647|Aztreonam|aztreonam|mesh-list
56843429|NCT05639647|Avibactam|avibactam|mesh-list
56843430|NCT05639647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56843431|NCT05639647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56843432|NCT05639647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56843433|NCT05639647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843434|NCT05639647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843435|NCT05633576|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56843436|NCT05633576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56843437|NCT05629585|Pembrolizumab|pembrolizumab|mesh-list
56843438|NCT05629585|Durvalumab|durvalumab|mesh-list
56843439|NCT05629585|Capecitabine|capecitabine|mesh-list
56843440|NCT05629585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843441|NCT05629585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843442|NCT05629585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56843443|NCT05629585|Antimetabolites|antimetabolites|mesh-ancestor
56843444|NCT05629585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843445|NCT05608005|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56843446|NCT05608005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56843447|NCT05608005|Immunologic Factors|immunologic factors|mesh-ancestor
56843448|NCT05608005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843449|NCT05607004|Exemestane|exemestane|mesh-list
56843450|NCT05607004|Goserelin|goserelin|mesh-list
56843451|NCT05607004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843452|NCT05607004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56843453|NCT05607004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56843454|NCT05607004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843455|NCT05607004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843456|NCT05607004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56843457|NCT05607004|Hormone Antagonists|hormone antagonists|mesh-ancestor
56843458|NCT05607004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843459|NCT05607004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843460|NCT05607004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56843461|NCT05590234|Dexmedetomidine|dexmedetomidine|mesh-list
56843463|NCT05590234|Anesthetics, Local|anesthetics, local|mesh-ancestor
56843464|NCT05590234|Anesthetics|anesthetics|mesh-ancestor
56843465|NCT05590234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843466|NCT05590234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843467|NCT05590234|Sensory System Agents|sensory system agents|mesh-ancestor
56843468|NCT05590234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843469|NCT05590234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56843470|NCT05590234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56843471|NCT05590234|Analgesics|analgesics|mesh-ancestor
56843472|NCT05590234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56843473|NCT05590234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56843474|NCT05590234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56843475|NCT05590234|Adrenergic Agents|adrenergic agents|mesh-ancestor
56843476|NCT05590234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843477|NCT05590234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843478|NCT05586074|Cytarabine|cytarabine|mesh-list
56843479|NCT05586074|Fludarabine|fludarabine|mesh-list
56843480|NCT05586074|Azacitidine|azacitidine|mesh-list
56843481|NCT05586074|Decitabine|decitabine|mesh-list
56843482|NCT05586074|Idarubicin|idarubicin|mesh-list
56843483|NCT05586074|Lenograstim|lenograstim|mesh-list
56843484|NCT05586074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843485|NCT05586074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56843486|NCT05586074|Antimetabolites|antimetabolites|mesh-ancestor
56843487|NCT05586074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843488|NCT05586074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56843489|NCT05586074|Immunologic Factors|immunologic factors|mesh-ancestor
56843490|NCT05586074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843491|NCT05586074|Antiviral Agents|antiviral agents|mesh-ancestor
56843492|NCT05586074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56843493|NCT05586074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843494|NCT05586074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56843495|NCT05586074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56843496|NCT05586074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56843497|NCT05586074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56843498|NCT05568615|Edaravone|edaravone|mesh-list
56843499|NCT05568615|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56843500|NCT05568615|Antioxidants|antioxidants|mesh-ancestor
56920156|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56843501|NCT05568615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843502|NCT05568615|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56843503|NCT05568615|Protective Agents|protective agents|mesh-ancestor
56843504|NCT05568615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843505|NCT05565937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56843507|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56843508|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843509|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56843510|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56843511|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
56843512|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56843513|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843514|NCT05554328|Olaparib|olaparib|mesh-list
56843515|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56843516|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843517|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843518|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843519|NCT05553522|Capecitabine|capecitabine|mesh-list
56843520|NCT05553522|Trastuzumab|trastuzumab|mesh-list
56843521|NCT05553522|Tucatinib|tucatinib|mesh-list
56843522|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56843523|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
56843524|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843525|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843526|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56843527|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56843528|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843529|NCT05552859|Insulin|insulin|mesh-list
56843530|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56843531|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
56843532|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56843533|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843534|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
56843535|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843536|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
56843537|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843538|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843539|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56843541|NCT05541146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56843542|NCT05541146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56843543|NCT05541146|Tubulin Modulators|tubulin modulators|mesh-ancestor
56843544|NCT05541146|Antimitotic Agents|antimitotic agents|mesh-ancestor
56843545|NCT05541146|Mitosis Modulators|mitosis modulators|mesh-ancestor
56843546|NCT05541146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843547|NCT05537935|Naltrexone|naltrexone|mesh-list
56843548|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56843549|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56843550|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843551|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
56843552|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843553|NCT05532358|Midazolam|midazolam|mesh-list
56843554|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
56843555|NCT05532358|Caffeine|caffeine|mesh-list
56843556|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56843557|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56843558|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56843559|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843560|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56843561|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56843562|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56843563|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56843564|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
56843565|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
56843566|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
56843567|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
56843568|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843569|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843570|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56843571|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56843572|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843573|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56843574|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56843575|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
56843576|NCT05532358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56843577|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56843578|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56843579|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
56843580|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56843581|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
56843582|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56843583|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56843584|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56843585|NCT05525416|Propranolol|propranolol|mesh-list
56843586|NCT05525416|Nitroprusside|nitroprusside|mesh-list
56843587|NCT05525416|Phentolamine|phentolamine|mesh-list
56843588|NCT05525416|Phenylephrine|phenylephrine|mesh-list
56843589|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
56843590|NCT05525416|Norepinephrine|norepinephrine|mesh-list
56843591|NCT05525416|Synephrine|synephrine|mesh-list
56843592|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56843593|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56843594|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
56843595|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56843596|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56843597|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56843598|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56843599|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56843600|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
56843601|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56843602|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
56843603|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
56843604|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56843605|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
56843606|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56843607|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
56843608|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
56843609|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56843610|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56557749|NCT02793544|Sirolimus|sirolimus|mesh-list
56843646|NCT05477576|Growth Substances|growth substances|mesh-ancestor
56843647|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
56554442|NCT00889720|Varenicline|varenicline|mesh-list
56843648|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56843649|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56843650|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845543|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845544|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845545|NCT03478696|Budesonide|budesonide|mesh-list
56845546|NCT03478696|Albuterol|albuterol|mesh-list
56845547|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
56845548|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
56845549|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56845550|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56845551|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56845552|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
56845553|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845554|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845555|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56845556|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
56845557|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
56845558|NCT03478696|Hormones|hormones|mesh-ancestor
56845559|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845560|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56845561|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56845562|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56845563|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
56845564|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56845565|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845566|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
56845567|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56845568|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
56845569|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
56845570|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56845571|NCT00072176|Sirolimus|sirolimus|mesh-list
56845572|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56845573|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845574|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56845575|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845576|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
56845577|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845578|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
56845579|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845580|NCT00071396|Rituximab|rituximab|mesh-list
56845581|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
56845582|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845583|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845584|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
56845585|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845586|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845587|NCT03472534|Diacetylrhein|diacetylrhein|mesh-list
56845588|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56845589|NCT03725020|Fluorides|fluorides|mesh-list
56845590|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
56845591|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
56845592|NCT03725020|Protective Agents|protective agents|mesh-ancestor
56845593|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845594|NCT03721432|Pregabalin|pregabalin|mesh-list
56845595|NCT03721432|Analgesics|analgesics|mesh-ancestor
56845596|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
56845597|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845598|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845599|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
56845600|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56845601|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56845602|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845603|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56845604|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56845605|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56845606|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845607|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56845608|NCT03469336|Betamethasone|betamethasone|mesh-list
56845609|NCT03469336|Calcipotriene|calcipotriene|mesh-list
56845610|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56845611|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
56845612|NCT03469336|Hormones|hormones|mesh-ancestor
56845613|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845614|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845615|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56845616|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
56845618|NCT03719560|Cytarabine|cytarabine|mesh-list
56845619|NCT03719560|Methotrexate|methotrexate|mesh-list
56845620|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56845621|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
56845622|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56845623|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845624|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845625|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
56845626|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845627|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845628|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
56845629|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845630|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56845631|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845632|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
56845633|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845634|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56845635|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
56845636|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845637|NCT03469258|Pancrelipase|pancrelipase|mesh-list
56845638|NCT03469258|Pancreatin|pancreatin|mesh-list
56845639|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56845640|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
56845641|NCT00066170|Modafinil|modafinil|mesh-list
56845642|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56845643|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845644|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56845645|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56845646|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56845647|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845648|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56845649|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56845650|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
56845651|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
56845652|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845653|NCT00065468|Interferons|interferons|mesh-list
56845654|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
56845655|NCT00065468|Sirolimus|sirolimus|mesh-list
56845656|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845657|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
56845658|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845659|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
56845660|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845661|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56845662|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56845663|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
56845664|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845665|NCT00071006|Axitinib|axitinib|mesh-list
56845666|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845667|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56845668|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845669|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845670|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56845671|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56845672|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845673|NCT00094107|Axitinib|axitinib|mesh-list
56845674|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845675|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56845676|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845677|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845678|NCT00102063|Aripiprazole|aripiprazole|mesh-list
56845679|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
56845680|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56845681|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56845682|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56845683|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845684|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845685|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
56845687|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56845688|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845689|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56845690|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56845691|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
56845692|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56845693|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56845694|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56845696|NCT00065156|Lenalidomide|lenalidomide|mesh-list
56845697|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
56845698|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845699|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56845700|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56845701|NCT00065156|Growth Substances|growth substances|mesh-ancestor
56845702|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
56845703|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845704|NCT01094210|Fluorides|fluorides|mesh-list
56845705|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
56845706|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
56845707|NCT01094210|Protective Agents|protective agents|mesh-ancestor
56845708|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845709|NCT01094444|Vitamin K|vitamin k|mesh-list
56845710|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
56845711|NCT01094444|Vitamins|vitamins|mesh-ancestor
56845712|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
56845713|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845714|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56845715|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56845716|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845717|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
56845718|NCT01094444|Coagulants|coagulants|mesh-ancestor
56845719|NCT00078819|Etanercept|etanercept|mesh-list
56845720|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56845721|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56845722|NCT00078819|Analgesics|analgesics|mesh-ancestor
56845723|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
56845724|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845725|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845726|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56845727|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845728|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56845729|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845730|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
56845731|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56845732|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56845733|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56845734|NCT00098865|Thalidomide|thalidomide|mesh-list
56845735|NCT00098865|Temozolomide|temozolomide|mesh-list
56845736|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56845737|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
56845738|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845739|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845740|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845741|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
56845742|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845743|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
56845744|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56845745|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845746|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56845747|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56845748|NCT00098865|Growth Substances|growth substances|mesh-ancestor
56845749|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
56845750|NCT00098787|Leucovorin|leucovorin|mesh-list
56845751|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
56845752|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56845753|NCT00098787|Bevacizumab|bevacizumab|mesh-list
56845754|NCT00098787|Fluorouracil|fluorouracil|mesh-list
56845755|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
56845756|NCT00098787|Irinotecan|irinotecan|mesh-list
56845757|NCT00098787|Camptothecin|camptothecin|mesh-list
56556533|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
56845758|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
56845759|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845760|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845761|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56845762|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56845763|NCT00098787|Growth Substances|growth substances|mesh-ancestor
56845764|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845765|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
56845766|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
56845767|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845769|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845770|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
56845771|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56845772|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56845773|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845775|NCT00098787|Protective Agents|protective agents|mesh-ancestor
56845776|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
56845777|NCT00098787|Vitamins|vitamins|mesh-ancestor
56845778|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
56845779|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56845780|NCT01084863|Paclitaxel|paclitaxel|mesh-list
56845781|NCT01084863|Trastuzumab|trastuzumab|mesh-list
56845782|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56845783|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845784|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
56845785|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
56845786|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
56845787|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845788|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845789|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
56845790|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56845791|NCT03719404|Eusol|eusol|mesh-list
56845792|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56845793|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845794|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
56845795|NCT03720886|Teriparatide|teriparatide|mesh-list
56845796|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56845797|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845798|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56845799|NCT00077649|Ribavirin|ribavirin|mesh-list
56845800|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56845801|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
56845802|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
56845803|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56845804|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
56845805|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845806|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
56845807|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845808|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
56845809|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845810|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845811|NCT00038948|Cyclosporine|cyclosporine|mesh-list
56845812|NCT00038948|Sirolimus|sirolimus|mesh-list
56845813|NCT00038948|Tacrolimus|tacrolimus|mesh-list
56845814|NCT00038948|Cyclosporins|cyclosporins|mesh-list
56845815|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845816|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
56845817|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845818|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56845819|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845820|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845821|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
56845822|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845823|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
56845824|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845825|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56845826|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56845827|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845828|NCT01096940|Simvastatin|simvastatin|mesh-list
56845829|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56845830|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56845831|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
56845832|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845833|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56556610|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
56845834|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56845835|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845836|NCT02530424|Trastuzumab|trastuzumab|mesh-list
56845837|NCT02530424|Pertuzumab|pertuzumab|mesh-list
56845838|NCT02530424|Fulvestrant|fulvestrant|mesh-list
56845839|NCT02530424|Palbociclib|palbociclib|mesh-list
56845840|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845841|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845842|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56845844|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56845845|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
56845846|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845847|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845848|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56845849|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845850|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845851|NCT01088763|Dexamethasone|dexamethasone|mesh-list
56845852|NCT01088763|R04929097|r04929097|mesh-list
56845853|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56845854|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
56845855|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
56845856|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845857|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845858|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56845859|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
56845860|NCT01088763|Hormones|hormones|mesh-ancestor
56845861|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845862|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56845863|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845864|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845865|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845866|NCT01094600|Secretin|secretin|mesh-list
56845867|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56845868|NCT01094600|Hormones|hormones|mesh-ancestor
56845869|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845870|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845871|NCT01097252|Cisplatin|cisplatin|mesh-list
56845872|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845873|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
56845874|NCT02530502|Temozolomide|temozolomide|mesh-list
56845875|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56845876|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845877|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56845878|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
56845879|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845880|NCT00054704|Riluzole|riluzole|mesh-list
56845881|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
56845882|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56845883|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56845884|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56845885|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845886|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845887|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56845888|NCT00054704|Protective Agents|protective agents|mesh-ancestor
56845889|NCT01092572|Simvastatin|simvastatin|mesh-list
56845890|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56845891|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56845892|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
56845893|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845894|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56845895|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56845896|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845897|NCT03956966|Dexamethasone|dexamethasone|mesh-list
56845898|NCT03956966|Bupivacaine|bupivacaine|mesh-list
56845899|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56845900|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
56845901|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
56845902|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845903|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845904|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56845905|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
56845906|NCT03956966|Hormones|hormones|mesh-ancestor
56845907|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56845908|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56556682|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
56845909|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845910|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
56845911|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
56845912|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845913|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
56845914|NCT00031694|Paclitaxel|paclitaxel|mesh-list
56845916|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56845917|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845918|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
56845919|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
56845920|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
56845921|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845922|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56845923|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
56845924|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845925|NCT03953066|Melatonin|melatonin|mesh-list
56845926|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
56845927|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845928|NCT03953066|Protective Agents|protective agents|mesh-ancestor
56845929|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845930|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845931|NCT00093795|Gemcitabine|gemcitabine|mesh-list
56845932|NCT00093795|Paclitaxel|paclitaxel|mesh-list
56845933|NCT00093795|Docetaxel|docetaxel|mesh-list
56845934|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
56845935|NCT00093795|Doxorubicin|doxorubicin|mesh-list
56845936|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56845937|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845938|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
56845939|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
56845940|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
56845941|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845942|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845943|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
56845944|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845945|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845946|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56845947|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
56845948|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56845949|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56845950|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
56845951|NCT00093795|Antiviral Agents|antiviral agents|mesh-ancestor
56845952|NCT00093795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845953|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845954|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56845955|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56845956|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56845957|NCT01092806|Tacrolimus|tacrolimus|mesh-list
56845958|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845959|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
56845960|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845961|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56845962|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845963|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845964|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
56845965|NCT01094912|Narcotics|narcotics|mesh-ancestor
56845966|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56845967|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845968|NCT01094912|Analgesics|analgesics|mesh-ancestor
56845969|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
56845970|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56845971|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
56845972|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
56845973|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56845974|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
56845975|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845976|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56845977|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56845978|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
56845979|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845980|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56845981|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56845982|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56845983|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56845984|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
56845985|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56845986|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56845987|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56845988|NCT03802994|Vaccines|vaccines|mesh-list
56360348|NCT00286585|Propofol|propofol|mesh-list
56845989|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56845990|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
56845991|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56845992|NCT01088919|Pioglitazone|pioglitazone|mesh-list
56845993|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
56845994|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56845995|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895039|NCT03242460|Pomalidomide|pomalidomide|mesh-list
56845996|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56845997|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56845998|NCT03802916|Deferiprone|deferiprone|mesh-list
56845999|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56846000|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
56846001|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
56846002|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846004|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846005|NCT01094990|Dexamethasone|dexamethasone|mesh-list
56846006|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846007|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
56846008|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
56846009|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846010|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846011|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846012|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
56846013|NCT01094990|Hormones|hormones|mesh-ancestor
56846014|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846015|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56846016|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846017|NCT01584050|Folic Acid|folic acid|mesh-list
56846018|NCT01584050|Hematinics|hematinics|mesh-ancestor
56846019|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
56846020|NCT01584050|Vitamins|vitamins|mesh-ancestor
56846021|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
56846022|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846023|NCT03952832|Leflunomide|leflunomide|mesh-list
56846024|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846025|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846026|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846027|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
56846028|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846029|NCT01311076|Insulin|insulin|mesh-list
56846030|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56846031|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
56846032|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56846033|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846034|NCT01098344|Gemcitabine|gemcitabine|mesh-list
56846035|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56846036|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
56846037|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846038|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846039|NCT01098344|Antiviral Agents|antiviral agents|mesh-ancestor
56846040|NCT01098344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846041|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846042|NCT01098344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846043|NCT01098344|Immunologic Factors|immunologic factors|mesh-ancestor
56846044|NCT01098344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846045|NCT01098656|Lenalidomide|lenalidomide|mesh-list
56846046|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
56846047|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846048|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56846049|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56846050|NCT01098656|Growth Substances|growth substances|mesh-ancestor
56846051|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
56846052|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846053|NCT00076011|Mitogens|mitogens|mesh-list
56846054|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
56846055|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
56846056|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846057|NCT00076011|Growth Substances|growth substances|mesh-ancestor
56846058|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846059|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
56846060|NCT03465436|Lasmiditan|lasmiditan|mesh-list
56846061|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56846062|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846063|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56846064|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56846066|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846068|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846069|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56846070|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
56846071|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846072|NCT01098890|Plasminogen|plasminogen|mesh-list
55895110|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
56846073|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56846074|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56846075|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56846076|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846077|NCT00053846|Buspirone|buspirone|mesh-list
56846078|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56846079|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56846080|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56846081|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846082|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56846083|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56846084|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
56846085|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846086|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846087|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
56846088|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56846089|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56846090|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56846091|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846092|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
56846093|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846094|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56846095|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846096|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846097|NCT03489304|Zaleplon|zaleplon|mesh-list
56846098|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
56846099|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56846100|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56846101|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846102|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
56846103|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
56846104|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846105|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846106|NCT03718624|Paclitaxel|paclitaxel|mesh-list
56846107|NCT03718624|Apatinib|apatinib|mesh-list
56846108|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56846109|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846110|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
56846111|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
56846112|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
56846113|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846114|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56846115|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846116|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
56846117|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
56846118|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846119|NCT03485950|Meropenem|meropenem|mesh-list
56846120|NCT03485950|Tazobactam|tazobactam|mesh-list
56846121|NCT03485950|Piperacillin|piperacillin|mesh-list
56846122|NCT03485950|Cefepime|cefepime|mesh-list
56846123|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56846124|NCT03485950|Ceftolozane|ceftolozane|mesh-list
56846125|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56846126|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846127|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56846128|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846129|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846130|NCT00060944|Dexamethasone|dexamethasone|mesh-list
56846131|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
56846132|NCT00060944|Trabectedin|trabectedin|mesh-list
56846133|NCT00060944|BB 1101|bb 1101|mesh-list
56556909|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
56846134|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846135|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
56846136|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
56846137|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846140|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
56846141|NCT00060944|Hormones|hormones|mesh-ancestor
56846142|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846143|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56846144|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846145|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56846146|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846147|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846148|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56846149|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
56846150|NCT03956732|Vitamin D|vitamin d|mesh-list
56846151|NCT03956732|Caseins|caseins|mesh-list
56846152|NCT03956732|Vitamins|vitamins|mesh-ancestor
56846153|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
56846154|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846155|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56846156|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
56846157|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
56846158|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846159|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
56846160|NCT01093274|Cathartics|cathartics|mesh-ancestor
56846161|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846162|NCT01584206|Ezetimibe|ezetimibe|mesh-list
56846163|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56846164|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56846165|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
56846166|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846167|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56846168|NCT03541252|Cisplatin|cisplatin|mesh-list
56846169|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846170|NCT00031460|Acyclovir|acyclovir|mesh-list
56846171|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
56846172|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846173|NCT03540160|Serlopitant|serlopitant|mesh-list
56846174|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56846175|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846176|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846177|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846178|NCT01095302|Docetaxel|docetaxel|mesh-list
56846179|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846180|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
56846181|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
56846182|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
56846183|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846184|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56846185|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
56846186|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56846187|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56846188|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
56846189|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846190|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846191|NCT03457636|Doxycycline|doxycycline|mesh-list
56846192|NCT03457636|Adapalene|adapalene|mesh-list
56846193|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56846194|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56846195|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56846196|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846197|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
56846198|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56846199|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56846200|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56846201|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56846202|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56846203|NCT03457636|Analgesics|analgesics|mesh-ancestor
56846204|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
56846205|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846206|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846207|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846208|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846209|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
56846210|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
56556978|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846212|NCT01099436|Doxorubicin|doxorubicin|mesh-list
56846213|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56846214|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846215|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
56846216|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846217|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846218|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56846219|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
56846220|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846221|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451244|NCT00317447|Prednisone|prednisone|mesh-list
56846222|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56846223|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
56846224|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
56846225|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
56846226|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56846227|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56846228|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56846229|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846230|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56846231|NCT05659810|Gabapentin|gabapentin|mesh-list
56846232|NCT05659810|Analgesics|analgesics|mesh-ancestor
56846233|NCT05659810|Sensory System Agents|sensory system agents|mesh-ancestor
56846234|NCT05659810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846235|NCT05659810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846236|NCT05659810|Anticonvulsants|anticonvulsants|mesh-ancestor
56846237|NCT05659810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56846238|NCT05659810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56846239|NCT05659810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56846240|NCT05659810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56846241|NCT05659810|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56846242|NCT05659810|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56846243|NCT05659810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846244|NCT05659810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846245|NCT05659810|Antimanic Agents|antimanic agents|mesh-ancestor
56846246|NCT01099592|Citalopram|citalopram|mesh-list
56846247|NCT01099592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56846248|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56846249|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56846250|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846251|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846252|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
56846253|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846254|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56846255|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
56846256|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56846257|NCT01099748|Methadone|methadone|mesh-list
56846258|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56846259|NCT01099748|Narcotics|narcotics|mesh-ancestor
56846260|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56846261|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846262|NCT01099748|Analgesics|analgesics|mesh-ancestor
56846263|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
56846264|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846265|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
56846266|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
56846267|NCT03481816|Vaccines|vaccines|mesh-list
56846268|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
56846269|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846270|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
56846271|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56846272|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
56846273|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846274|NCT03956888|Expectorants|expectorants|mesh-ancestor
56846275|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
56903375|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
56846276|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56846277|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
56846278|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846279|NCT03956888|Protective Agents|protective agents|mesh-ancestor
56846280|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846281|NCT03956888|Antidotes|antidotes|mesh-ancestor
56846282|NCT03955406|Anesthetics|anesthetics|mesh-list
56846283|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56846284|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568043|NCT01190930|BB 1101|bb 1101|mesh-list
56846287|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
56846288|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56846289|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56846290|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846291|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846292|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846293|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56846294|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
56846295|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846296|NCT00050960|Paclitaxel|paclitaxel|mesh-list
56846297|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56846298|NCT00050960|Carboplatin|carboplatin|mesh-list
56846299|NCT00050960|Bexarotene|bexarotene|mesh-list
56846300|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56846301|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846302|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
56846303|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
56846304|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
56846305|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846306|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
56846307|NCT00097773|Tobramycin|tobramycin|mesh-list
56846308|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56846309|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846310|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56846311|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56846312|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846313|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846314|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846315|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56846316|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56846317|NCT03480022|Liraglutide|liraglutide|mesh-list
56846318|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56846319|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846320|NCT03480022|Incretins|incretins|mesh-ancestor
56846321|NCT03480022|Hormones|hormones|mesh-ancestor
56846322|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846323|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
56846324|NCT01093820|Hematinics|hematinics|mesh-ancestor
56846325|NCT00049322|Bevacizumab|bevacizumab|mesh-list
56846326|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56846327|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846328|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56846329|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56846330|NCT00049322|Growth Substances|growth substances|mesh-ancestor
56846331|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846332|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
56846333|NCT00008138|Paclitaxel|paclitaxel|mesh-list
56846334|NCT00008138|Carboplatin|carboplatin|mesh-list
56846335|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56846336|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846337|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
56846338|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
56846339|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
56846340|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846341|NCT01100060|Azithromycin|azithromycin|mesh-list
56846342|NCT01100060|Chloroquine|chloroquine|mesh-list
56846343|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56846344|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56846345|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846346|NCT01100060|Amebicides|amebicides|mesh-ancestor
56846347|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56846348|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56846349|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
56846350|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846351|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56846352|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56846353|NCT01100060|Analgesics|analgesics|mesh-ancestor
56846354|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
56846355|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846356|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846357|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846358|NCT01100060|Filaricides|filaricides|mesh-ancestor
56846360|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
56846361|NCT01100216|Nicotine|nicotine|mesh-list
56846362|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56846363|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
56846364|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846365|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846366|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56846367|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56846368|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
56846369|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846370|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846371|NCT01100294|Vaccines|vaccines|mesh-list
56846372|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
56846373|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846374|NCT03436420|Calcium|calcium|mesh-list
56846375|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56846376|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846377|NCT01100372|Gemcitabine|gemcitabine|mesh-list
56846378|NCT01100372|Doxorubicin|doxorubicin|mesh-list
56846379|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56846380|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56846381|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
56846382|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846383|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846384|NCT01100372|Antiviral Agents|antiviral agents|mesh-ancestor
56846385|NCT01100372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846386|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846387|NCT01100372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846388|NCT01100372|Immunologic Factors|immunologic factors|mesh-ancestor
56846389|NCT01100372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846390|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56846391|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56846392|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56846393|NCT00027560|Cyclosporine|cyclosporine|mesh-list
56846394|NCT00027560|Fludarabine|fludarabine|mesh-list
56846395|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
56846396|NCT00027560|Melphalan|melphalan|mesh-list
56846397|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
56846398|NCT00027560|Cyclosporins|cyclosporins|mesh-list
56846399|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846400|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56846401|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
56846402|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846403|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846404|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
56846405|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846406|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846407|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
56846408|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846409|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
56846410|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846411|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56846412|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56846413|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
56846414|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56846415|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56846416|NCT02529878|Paclitaxel|paclitaxel|mesh-list
56846417|NCT02529878|Apatinib|apatinib|mesh-list
56846418|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56846419|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903396|NCT04578015|Metronidazole|metronidazole|mesh-list
56846420|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
56846421|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
56846422|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
56846423|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846424|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56846425|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846426|NCT03451006|Metformin|metformin|mesh-list
56846427|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56846428|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846429|NCT05625854|Cocaine|cocaine|mesh-list
56846430|NCT05625854|Anesthetics, Local|anesthetics, local|mesh-ancestor
56846431|NCT05625854|Anesthetics|anesthetics|mesh-ancestor
56846432|NCT05625854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557205|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568046|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
56846435|NCT05625854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846436|NCT05625854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56846437|NCT05625854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56846438|NCT05625854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56846439|NCT05625854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56846440|NCT05625854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846441|NCT05625854|Dopamine Agents|dopamine agents|mesh-ancestor
56846442|NCT05625854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846443|NCT01327118|Dinoprost|dinoprost|mesh-list
56846444|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
56846445|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56846446|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
56846447|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56846448|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846449|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
56846450|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
56846451|NCT03449758|Chloroquine|chloroquine|mesh-list
56846452|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
56846453|NCT03449758|Methotrexate|methotrexate|mesh-list
56846454|NCT03449758|Azathioprine|azathioprine|mesh-list
56846455|NCT03449758|Leflunomide|leflunomide|mesh-list
56846456|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56846457|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
56846458|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56846459|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846460|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56846461|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
56846462|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846463|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846464|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
56846465|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846466|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56846467|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846468|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
56846469|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846470|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56846471|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
56846472|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56846473|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56846474|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846475|NCT03449758|Amebicides|amebicides|mesh-ancestor
56846476|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56846477|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56846478|NCT03449758|Analgesics|analgesics|mesh-ancestor
56846479|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
56846480|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846481|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846482|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846483|NCT03449446|Firsocostat|firsocostat|mesh-list
56846484|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846485|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846486|NCT05664958|Bupivacaine|bupivacaine|mesh-list
56846487|NCT05664958|Anesthetics, Local|anesthetics, local|mesh-ancestor
56846488|NCT05664958|Anesthetics|anesthetics|mesh-ancestor
56846489|NCT05664958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56846490|NCT05664958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846491|NCT05664958|Sensory System Agents|sensory system agents|mesh-ancestor
56846492|NCT05664958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846493|NCT03716596|Antibodies|antibodies|mesh-list
56846494|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
56846495|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846496|NCT05650840|Calcium Carbonate|calcium carbonate|mesh-list
56846497|NCT05650840|Calcium|calcium|mesh-list
56846498|NCT05650840|Charcoal|charcoal|mesh-list
56846499|NCT05650840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56846500|NCT05650840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846501|NCT05650840|Antacids|antacids|mesh-ancestor
56846502|NCT05650840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846503|NCT05650840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846504|NCT05650840|Antidotes|antidotes|mesh-ancestor
56846505|NCT05650840|Protective Agents|protective agents|mesh-ancestor
56846506|NCT03722914|Benzonatate|benzonatate|mesh-list
56846508|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
56846509|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
56846510|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56846511|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56846512|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846513|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
56846514|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846515|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846516|NCT03444766|Nivolumab|nivolumab|mesh-list
56846517|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56846518|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846519|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56846520|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846521|NCT03526432|Bevacizumab|bevacizumab|mesh-list
56846522|NCT03526432|Atezolizumab|atezolizumab|mesh-list
56846523|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56846524|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846525|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56846526|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56846527|NCT03526432|Growth Substances|growth substances|mesh-ancestor
56846528|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846529|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
56846530|NCT01310842|Nicotine|nicotine|mesh-list
56846531|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56846532|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
56846533|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846534|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846535|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56846536|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56846537|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
56846538|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846539|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846540|NCT03722290|Metformin|metformin|mesh-list
56846541|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56846542|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846543|NCT03523156|Azithromycin|azithromycin|mesh-list
56846544|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56846545|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846546|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56846547|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56846548|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56846549|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56846550|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846551|NCT03717688|Incretins|incretins|mesh-ancestor
56846552|NCT03717688|Hormones|hormones|mesh-ancestor
56846553|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846554|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
56846555|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846556|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846557|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56846558|NCT02953678|Prednisone|prednisone|mesh-list
56846559|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
56846560|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56846561|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56846562|NCT02953678|Prednisolone|prednisolone|mesh-list
56846563|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
56846564|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56846565|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
56846566|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846567|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
56846568|NCT02953678|Hormones|hormones|mesh-ancestor
56846569|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846570|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846571|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56846572|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846573|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
56846574|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
56846575|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846576|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846577|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56846578|NCT02953678|Protective Agents|protective agents|mesh-ancestor
56846579|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
56846580|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
56846581|NCT00090753|Hematinics|hematinics|mesh-ancestor
56846582|NCT00048932|Abatacept|abatacept|mesh-list
56846583|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56846584|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846585|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846586|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557361|NCT05502250|Gemcitabine|gemcitabine|mesh-list
56846587|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
56846588|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846589|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846590|NCT00073983|Gemcitabine|gemcitabine|mesh-list
56846591|NCT00073983|Docetaxel|docetaxel|mesh-list
56846592|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56846593|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
56846594|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846595|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846596|NCT00073983|Antiviral Agents|antiviral agents|mesh-ancestor
56846597|NCT00073983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846598|NCT00073983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846599|NCT00073983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846600|NCT00073983|Immunologic Factors|immunologic factors|mesh-ancestor
56846601|NCT00073983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846602|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
56846603|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
56846604|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
56846605|NCT02952820|Lemborexant|lemborexant|mesh-list
56846606|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56846607|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846608|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846609|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56846610|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56846611|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56846612|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846613|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
56846614|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846615|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
56846616|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
56846617|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56846618|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
56846619|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56846620|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846621|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56846622|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56846623|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56846624|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56846625|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846626|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
56846627|NCT01085487|Coagulants|coagulants|mesh-ancestor
56846628|NCT01089309|Spironolactone|spironolactone|mesh-list
56846629|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56846630|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
56846631|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846632|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846633|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56846634|NCT01089309|Diuretics|diuretics|mesh-ancestor
56846635|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
56846636|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
56846637|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
56846638|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
56846639|NCT01085721|Ephedrine|ephedrine|mesh-list
56846640|NCT01085721|Guaifenesin|guaifenesin|mesh-list
56846641|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56846642|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56846643|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56846644|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
56846645|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846646|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846647|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56846648|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
56846649|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
56846650|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56846651|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56846652|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
56846653|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
56846655|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846657|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56846658|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56846659|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
56846660|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56846661|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56846662|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
56846663|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
56846664|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
56846665|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
56846666|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56846667|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
56846668|NCT00006392|Vitamins|vitamins|mesh-list
56846669|NCT00006392|Vitamin E|vitamin e|mesh-list
56846670|NCT00006392|Tocopherols|tocopherols|mesh-list
56846671|NCT00006392|Tocotrienols|tocotrienols|mesh-list
56846672|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
56846673|NCT00006392|Selenium|selenium|mesh-list
56846674|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
56846675|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846676|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
56846677|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846678|NCT00006392|Protective Agents|protective agents|mesh-ancestor
56846679|NCT00006392|Trace Elements|trace elements|mesh-ancestor
56846680|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56846681|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56846682|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56846683|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56846684|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846685|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846686|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846687|NCT01089621|Analgesics|analgesics|mesh-ancestor
56846688|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
56846689|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846690|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
56846691|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56846692|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
56846693|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56846694|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56846695|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56846696|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56846697|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846698|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846699|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846700|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
56846701|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56846702|NCT00379769|Metformin|metformin|mesh-list
56846703|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
56846704|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56846705|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846706|NCT00006164|Ribavirin|ribavirin|mesh-list
56846707|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56846708|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
56846709|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
56846710|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846711|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
56846712|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846713|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
56846714|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846715|NCT00378599|Interferons|interferons|mesh-list
56846716|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
56846717|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
56846718|NCT00378599|Ribavirin|ribavirin|mesh-list
56846719|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56846720|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846721|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
56846722|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846723|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
56846724|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846725|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
56846726|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846727|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56846728|NCT01046981|Metronidazole|metronidazole|mesh-list
56846729|NCT01046981|Cefazolin|cefazolin|mesh-list
56846730|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56846731|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846732|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
56846733|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56846734|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56846735|NCT00378209|Dexamethasone|dexamethasone|mesh-list
56846736|NCT00378209|Lenalidomide|lenalidomide|mesh-list
56846737|NCT00378209|Bortezomib|bortezomib|mesh-list
56846738|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846739|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
56846740|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
56846741|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846742|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846743|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846744|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
56846745|NCT00378209|Hormones|hormones|mesh-ancestor
56846746|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846747|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56846748|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846749|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
56846750|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56846751|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56846752|NCT00378209|Growth Substances|growth substances|mesh-ancestor
56846753|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
56846754|NCT01047059|Bevacizumab|bevacizumab|mesh-list
56846755|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56846756|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56846757|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846758|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56846759|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56846760|NCT01047059|Growth Substances|growth substances|mesh-ancestor
56846761|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846762|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
56846763|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56846764|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846765|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846766|NCT00377819|Denosumab|denosumab|mesh-list
56846767|NCT00377819|Alendronate|alendronate|mesh-list
56846768|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56846769|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846770|NCT00377429|Catumaxomab|catumaxomab|mesh-list
56846771|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846772|NCT01047215|Aripiprazole|aripiprazole|mesh-list
56846773|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56846774|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
56846775|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56846776|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56846777|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56846778|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56846779|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846780|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
56846781|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
56846782|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846783|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846784|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56846785|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56846786|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
56846787|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56846788|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56846789|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56846790|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56846791|NCT03715582|Trimetazidine|trimetazidine|mesh-list
56846792|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
56846793|NCT00376961|Prednisone|prednisone|mesh-list
56846794|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
56846795|NCT00376961|Rituximab|rituximab|mesh-list
56846796|NCT00376961|Doxorubicin|doxorubicin|mesh-list
56846797|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56846798|NCT00376961|Vincristine|vincristine|mesh-list
56846799|NCT00376961|Bortezomib|bortezomib|mesh-list
56846800|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846801|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
56846802|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846803|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846804|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56846805|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
56846806|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846808|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56846809|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56846810|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56846811|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56846812|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56846813|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846814|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846815|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
56846816|NCT00376961|Hormones|hormones|mesh-ancestor
56846817|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846818|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56846819|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56846820|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
56846821|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
56846822|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
56846823|NCT00376259|Adefovir|adefovir|mesh-list
56846824|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56846825|NCT00376259|Telbivudine|telbivudine|mesh-list
56846826|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
56846827|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846828|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56846829|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56846830|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846831|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846832|NCT03715348|Thrombin|thrombin|mesh-list
56846833|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
56846834|NCT03715348|Coagulants|coagulants|mesh-ancestor
56846835|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
56846836|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56846837|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56846838|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56846839|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846840|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846841|NCT00365105|Vitamin D|vitamin d|mesh-list
56846842|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
56846843|NCT00365105|Calcium|calcium|mesh-list
56846844|NCT00365105|Vitamins|vitamins|mesh-ancestor
56846845|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
56846846|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846847|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56846848|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56846849|NCT01049633|Aspirin|aspirin|mesh-list
56846850|NCT01049633|Sirolimus|sirolimus|mesh-list
56846851|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56846852|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
56846853|NCT01049633|Clotrimazole|clotrimazole|mesh-list
56846854|NCT01049633|Miconazole|miconazole|mesh-list
56846855|NCT01049633|Trimethoprim|trimethoprim|mesh-list
56846856|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
56846857|NCT01049633|Valganciclovir|valganciclovir|mesh-list
56846858|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
56846859|NCT01049633|Heparin|heparin|mesh-list
56846860|NCT01049633|Enoxaparin|enoxaparin|mesh-list
56846861|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
56846862|NCT01049633|Tacrolimus|tacrolimus|mesh-list
56846863|NCT01049633|Basiliximab|basiliximab|mesh-list
56846864|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56846865|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56846866|NCT01049633|Analgesics|analgesics|mesh-ancestor
56846867|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
56846868|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56846869|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846870|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846871|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846872|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56846873|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56846874|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846875|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56846876|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56846877|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846878|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
56846879|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846880|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
56846881|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56846882|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846884|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846886|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56846887|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56846888|NCT01049633|Protective Agents|protective agents|mesh-ancestor
56846889|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
56846890|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56846891|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
56846892|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56846893|NCT01049633|Renal Agents|renal agents|mesh-ancestor
56846894|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
56846895|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56846896|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56846897|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56846898|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56846899|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56846900|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56846901|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56846902|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56846903|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56846904|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
56846905|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846906|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56846907|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56846909|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846910|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56846911|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846912|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
56846913|NCT01049711|Hematinics|hematinics|mesh-ancestor
56846914|NCT00048542|Adalimumab|adalimumab|mesh-list
56846915|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56846916|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846917|NCT03814590|Vaccines|vaccines|mesh-list
56846918|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
56846919|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846920|NCT01583244|Abatacept|abatacept|mesh-list
56846921|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56846922|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846923|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846924|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56846925|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
56846926|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846927|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56846928|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
56846929|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846930|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
56846931|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56846932|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846933|NCT01102946|Ranibizumab|ranibizumab|mesh-list
56846934|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56846935|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56846936|NCT01102946|Growth Substances|growth substances|mesh-ancestor
56903415|NCT03752229|Diazepam|diazepam|mesh-list
56846937|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846938|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
56846939|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846940|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56846941|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
56846942|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846943|NCT01101386|Voriconazole|voriconazole|mesh-list
56846944|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
56846945|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846946|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56846947|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56846948|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846949|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846950|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56846951|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
56846952|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846953|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846954|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56846955|NCT00005906|Octreotide|octreotide|mesh-list
56846956|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56846957|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56846958|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846960|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56846961|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56846962|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
56846963|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
56846964|NCT01103336|Vitamins|vitamins|mesh-ancestor
56846965|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
56846966|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846967|NCT03950960|Itraconazole|itraconazole|mesh-list
56846968|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
56846969|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56846970|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56846971|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56846972|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56846973|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846974|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56846975|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
56846976|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846977|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846978|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56846979|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
56846980|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56846981|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56846982|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846983|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
56846984|NCT03954860|Coagulants|coagulants|mesh-ancestor
56846985|NCT00066690|Tamoxifen|tamoxifen|mesh-list
56846986|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56846987|NCT00066690|Exemestane|exemestane|mesh-list
56846988|NCT00066690|Tryptophan|tryptophan|mesh-list
56846989|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56846990|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56846991|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56846992|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56846993|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
56846994|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56846995|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56846996|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56846997|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56846998|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56846999|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56847000|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56847001|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847002|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
56847003|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56847004|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
56847005|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56847006|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56847007|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56847008|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
56847009|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56847010|NCT03409276|Vaccines|vaccines|mesh-list
56847011|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
56847012|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847013|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56847014|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56847015|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56847016|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56847017|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
56847018|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
56847019|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847020|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847021|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847022|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
56847023|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
56847024|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847025|NCT00004088|Pamidronate|pamidronate|mesh-list
56847026|NCT00004088|Interferons|interferons|mesh-list
56847027|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
56847028|NCT00004088|Thalidomide|thalidomide|mesh-list
56361395|NCT00130156|Doxazosin|doxazosin|mesh-list
56847031|NCT00004088|Busulfan|busulfan|mesh-list
56847032|NCT00004088|Lenograstim|lenograstim|mesh-list
56847033|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847034|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
56847035|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847036|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847037|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56847038|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
56847039|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847040|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847041|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56847042|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
56847043|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847044|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56847045|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
56847046|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56847047|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56847048|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56847049|NCT00004088|Growth Substances|growth substances|mesh-ancestor
56847050|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
56847051|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56847052|NCT03439072|Glucagon|glucagon|mesh-list
56847053|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56847054|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56847055|NCT03439072|Hormones|hormones|mesh-ancestor
56847056|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56847057|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847058|NCT03439072|Incretins|incretins|mesh-ancestor
56847059|NCT00078312|Modafinil|modafinil|mesh-list
56847060|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56847061|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847062|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56847063|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56847064|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56847065|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847066|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56847067|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847068|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56847069|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847070|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847071|NCT00003896|Paclitaxel|paclitaxel|mesh-list
56847072|NCT00003896|Doxorubicin|doxorubicin|mesh-list
56847073|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56847074|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56847075|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847076|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
56847077|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
56847078|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
56847079|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847080|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56847081|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56847082|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56847083|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847084|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56847085|NCT03712540|Rifampin|rifampin|mesh-list
56847086|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56847087|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
56847088|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56847089|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847090|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
56847091|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56847092|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847093|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847094|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56847095|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56847096|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56847097|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56847098|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56847099|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56847100|NCT05472220|Carboplatin|carboplatin|mesh-list
56847101|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
56847102|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847103|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847104|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847105|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
56847106|NCT00003782|Docetaxel|docetaxel|mesh-list
56847107|NCT00003782|Doxorubicin|doxorubicin|mesh-list
56847108|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847109|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
56847110|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847111|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847112|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56847113|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
56557881|NCT00697021|Aspirin|aspirin|mesh-list
56847114|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847115|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847116|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56847117|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
56847118|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
56847119|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
56847120|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56847121|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56847122|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56847123|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847124|NCT03389308|Diacetylrhein|diacetylrhein|mesh-list
56847125|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847126|NCT03714490|Capecitabine|capecitabine|mesh-list
56847127|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
56847128|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56847129|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
56847130|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847131|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847132|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
56847133|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847134|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847135|NCT01103648|Simvastatin|simvastatin|mesh-list
56847136|NCT01103648|Ezetimibe|ezetimibe|mesh-list
56847137|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
56847138|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56847139|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56847140|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
56847141|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847142|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56847143|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847144|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
56847145|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56847146|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847147|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847148|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
56847149|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847150|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56847151|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56847152|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
56847153|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847154|NCT01095926|Doxorubicin|doxorubicin|mesh-list
56847155|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56847156|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847157|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56847158|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56847159|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847160|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847161|NCT05617118|Baclofen|baclofen|mesh-list
56847162|NCT05617118|Botulinum Toxins|botulinum toxins|mesh-list
56847163|NCT05617118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56847164|NCT05617118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56847165|NCT05617118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56847166|NCT05617118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56847167|NCT05617118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847168|NCT05617118|Cholinergic Agents|cholinergic agents|mesh-ancestor
56847169|NCT05617118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847170|NCT05617118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847171|NCT05617118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56847172|NCT05617118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847173|NCT05617118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56847174|NCT05617118|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56847177|NCT00003656|Interferons|interferons|mesh-list
56847178|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
56847179|NCT00003656|Tretinoin|tretinoin|mesh-list
56847180|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847181|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
56847182|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847183|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
56847184|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847185|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
56847186|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
56847187|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
56847188|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847189|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
56847190|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847191|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847192|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56847193|NCT03948620|Penicillins|penicillins|mesh-list
56847194|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56847195|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847196|NCT03416374|Dexamethasone|dexamethasone|mesh-list
56847197|NCT03416374|Lenalidomide|lenalidomide|mesh-list
56847198|NCT03416374|Bortezomib|bortezomib|mesh-list
56847199|NCT03416374|Ixazomib|ixazomib|mesh-list
56847200|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847201|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
56847202|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
56847203|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847204|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847205|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56847206|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
56847207|NCT03416374|Hormones|hormones|mesh-ancestor
56847208|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56847209|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56847210|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847211|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
56847212|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56847213|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56847214|NCT03416374|Growth Substances|growth substances|mesh-ancestor
56847215|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
56847216|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
56847217|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847218|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847219|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
56847220|NCT00077766|Hematinics|hematinics|mesh-ancestor
56847221|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
56847222|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
56847223|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56847224|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847225|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847226|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
56847227|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56847228|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56847229|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847230|NCT03388138|Ketotifen|ketotifen|mesh-list
56847231|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
56847232|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
56847233|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56847234|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
56847235|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
56847236|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847237|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847238|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847239|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56847240|NCT01101620|Simendan|simendan|mesh-list
56847241|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56847242|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
56847243|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56847244|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56847245|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847246|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847247|NCT01101620|Protective Agents|protective agents|mesh-ancestor
56847248|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847249|NCT02952898|Diclofenac|diclofenac|mesh-list
56568052|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
56847250|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56847252|NCT02952898|Analgesics|analgesics|mesh-ancestor
56847253|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
56847254|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847255|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847256|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847257|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847258|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56847259|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847260|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847261|NCT01101698|Vitamin D|vitamin d|mesh-list
56847262|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
56847263|NCT01101698|Vitamins|vitamins|mesh-list
56847264|NCT01101698|Vitamin K|vitamin k|mesh-list
56847265|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
56847266|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
56847267|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847268|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56847269|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56847270|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56847271|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56847272|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847273|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
56847274|NCT01101698|Coagulants|coagulants|mesh-ancestor
56847275|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
56847276|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847277|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56847278|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847279|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847280|NCT05513768|Protein C|protein c|mesh-list
56847281|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
56847282|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56847283|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56847284|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847285|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
56847286|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56847287|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56847288|NCT03387046|Prednisolone|prednisolone|mesh-list
56847289|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
56847290|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56847291|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
56847292|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847293|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
56847294|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
56847295|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847296|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847297|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56847298|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
56847299|NCT03387046|Hormones|hormones|mesh-ancestor
56847300|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56847301|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56847302|NCT03387046|Protective Agents|protective agents|mesh-ancestor
56847303|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56847304|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847305|NCT01101776|Interferons|interferons|mesh-list
56847306|NCT01101776|Interferon-beta|interferon-beta|mesh-list
56847307|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
56847308|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847309|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
56847310|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847311|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
56847312|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847313|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56847314|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56847315|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847316|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56847317|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847318|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847319|NCT03353740|Edetic Acid|edetic acid|mesh-list
56847320|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56847321|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
56847322|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
56847323|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847324|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
56847326|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56847327|NCT04814602|Proglumide|proglumide|mesh-list
56847328|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56847329|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56847330|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
56847331|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56847332|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56847333|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847334|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
56847335|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
56847336|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56847337|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56847338|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558108|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
56847339|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56847340|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847341|NCT00399035|Leucovorin|leucovorin|mesh-list
56847342|NCT00399035|Fluorouracil|fluorouracil|mesh-list
56847343|NCT00399035|Capecitabine|capecitabine|mesh-list
56847344|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
56847345|NCT00399035|Cediranib|cediranib|mesh-list
56847346|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
56847347|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
56847348|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847349|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56847350|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847351|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847352|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
56847353|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847354|NCT00399035|Antidotes|antidotes|mesh-ancestor
56847355|NCT00399035|Protective Agents|protective agents|mesh-ancestor
56847356|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
56847357|NCT00399035|Vitamins|vitamins|mesh-ancestor
56847358|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
56847359|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56847360|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847361|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56847362|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847363|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847364|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56847365|NCT03960801|Remifentanil|remifentanil|mesh-list
56847366|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56847367|NCT03960801|Narcotics|narcotics|mesh-ancestor
56847368|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56847369|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847370|NCT03960801|Analgesics|analgesics|mesh-ancestor
56847371|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
56847372|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847373|NCT01583439|Ritonavir|ritonavir|mesh-list
56847374|NCT01583439|Lopinavir|lopinavir|mesh-list
56847375|NCT01583439|Tenofovir|tenofovir|mesh-list
56847376|NCT01583439|Lamivudine|lamivudine|mesh-list
56847377|NCT01583439|Zidovudine|zidovudine|mesh-list
56847378|NCT01583439|Emtricitabine|emtricitabine|mesh-list
56847379|NCT01583439|Efavirenz|efavirenz|mesh-list
56847380|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56847381|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56847382|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56847383|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
56847384|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847385|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847386|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56847387|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
56847388|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847389|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56847390|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56847391|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56847392|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56847393|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
56847394|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56847395|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56847396|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56847397|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56847398|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56847401|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847402|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56847403|NCT00398567|Trastuzumab|trastuzumab|mesh-list
56847404|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847405|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847406|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56847407|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56847408|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56847409|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56847410|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847411|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56847412|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56847413|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56847414|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56847415|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
56847416|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847417|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847418|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56847419|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56847420|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
56847421|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56847422|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56847423|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
56847425|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56847426|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56847427|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56847428|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56847429|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
56847430|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847431|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847432|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847433|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
56847434|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56847435|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847436|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56847437|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56847438|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847439|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847440|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847441|NCT03352414|Alvimopan|alvimopan|mesh-list
56847442|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56847443|NCT00364793|Emtricitabine|emtricitabine|mesh-list
56847444|NCT00364793|Efavirenz|efavirenz|mesh-list
56847445|NCT00364793|Didanosine|didanosine|mesh-list
56847446|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
56847447|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847448|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56847449|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56847450|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847451|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847452|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56847453|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56847454|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56847455|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56847456|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56847457|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56847458|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56847459|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56847460|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
56847461|NCT03351478|Empagliflozin|empagliflozin|mesh-list
56847462|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56847463|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56847464|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847465|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56847466|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847467|NCT00363545|Vaccines|vaccines|mesh-list
56847468|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
56847470|NCT03351244|BI 409306|bi 409306|mesh-list
56847471|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56847472|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847473|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847474|NCT03386032|Desonide|desonide|mesh-list
56847475|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847476|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
56847477|NCT00077610|Hematinics|hematinics|mesh-ancestor
56847478|NCT00066222|Etoposide|etoposide|mesh-list
56847479|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847480|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56847481|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56847482|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56847483|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847484|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847485|NCT00397943|Vaccines|vaccines|mesh-list
56847486|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
56558258|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
56847487|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847488|NCT00066066|Amoxicillin|amoxicillin|mesh-list
56847489|NCT00066066|Metronidazole|metronidazole|mesh-list
56847490|NCT00066066|Doxycycline|doxycycline|mesh-list
56847491|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56847492|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847493|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56847494|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56847495|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
56847496|NCT00363467|Busulfan|busulfan|mesh-list
56847497|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
56847498|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847499|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847500|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
56847501|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847502|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56847503|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847504|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56847505|NCT00397631|Pioglitazone|pioglitazone|mesh-list
56847506|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56847507|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56847508|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847509|NCT00397631|Incretins|incretins|mesh-ancestor
56847510|NCT00397631|Hormones|hormones|mesh-ancestor
56847511|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56847512|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56847513|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
56847514|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847515|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847516|NCT00077376|Carboplatin|carboplatin|mesh-list
56847517|NCT00077376|Trastuzumab|trastuzumab|mesh-list
56847518|NCT00077376|Epothilone B|epothilone b|mesh-list
56847519|NCT00077376|Epothilones|epothilones|mesh-list
56847520|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847521|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847522|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
56847523|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
56847524|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
56847525|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847526|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
56847527|NCT01088724|Rituximab|rituximab|mesh-list
56847528|NCT01088724|Doxorubicin|doxorubicin|mesh-list
56847529|NCT01088724|Fludarabine|fludarabine|mesh-list
56847530|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847531|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
56847532|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847533|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847534|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56847535|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
56847536|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847537|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847538|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56847539|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847540|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56847541|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56847542|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56847545|NCT03957174|Reboxetine|reboxetine|mesh-list
56847546|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56847547|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847548|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847549|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
56847550|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847551|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847552|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56847553|NCT03957174|Protective Agents|protective agents|mesh-ancestor
56847554|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
56847555|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56847556|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56847557|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56847558|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56847559|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
56847560|NCT03406156|Venetoclax|venetoclax|mesh-list
56847561|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56847562|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
56847563|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847564|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56847565|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
56847566|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847567|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847569|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56847570|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56847571|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847572|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847573|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
56847574|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56847575|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847576|NCT00362609|Pantoprazole|pantoprazole|mesh-list
56847577|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56847578|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56847579|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56847580|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847581|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847582|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
56847583|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
56847584|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847585|NCT02534753|Protective Agents|protective agents|mesh-ancestor
56847586|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847587|NCT02534753|Vitamins|vitamins|mesh-ancestor
56847588|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
56847589|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
56847590|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56847591|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847592|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56847593|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
56847594|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56847595|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847596|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847597|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847598|NCT00362297|Valacyclovir|valacyclovir|mesh-list
56847599|NCT00362297|Acyclovir|acyclovir|mesh-list
56847600|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
56847601|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847602|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
56847603|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847604|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
56847605|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
56847606|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847607|NCT00090402|Protective Agents|protective agents|mesh-ancestor
56847608|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847609|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
56847610|NCT00090402|Vitamins|vitamins|mesh-ancestor
56847611|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
56847612|NCT00361283|Atorvastatin|atorvastatin|mesh-list
56847613|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56847614|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56847615|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
56847616|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847618|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56847619|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847620|NCT00077064|Captopril|captopril|mesh-list
56847621|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56847622|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
56847623|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847624|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847625|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56847626|NCT00396383|Plerixafor|plerixafor|mesh-list
56847627|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56847628|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56847629|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
56847630|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847631|NCT02534363|Aripiprazole|aripiprazole|mesh-list
56847632|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56847633|NCT02534363|Ziprasidone|ziprasidone|mesh-list
56847634|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
56847635|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56847636|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56847637|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56847638|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56847639|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847640|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
56847641|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
56847642|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847643|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847644|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56847645|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56847646|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
56847647|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56847648|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56847649|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56847650|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56847651|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
56847652|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56847653|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847654|NCT01088958|Micronutrients|micronutrients|mesh-list
56847655|NCT01088958|Trace Elements|trace elements|mesh-list
56847656|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847657|NCT03404518|Acetaminophen|acetaminophen|mesh-list
56847658|NCT03404518|Ibuprofen|ibuprofen|mesh-list
56847659|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56847660|NCT03404518|Hydrocodone|hydrocodone|mesh-list
56847661|NCT03404518|Narcotics|narcotics|mesh-list
56903438|NCT05359731|Bupivacaine|bupivacaine|mesh-list
56847662|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56847663|NCT03404518|Analgesics|analgesics|mesh-ancestor
56847664|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
56847665|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847666|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847667|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
56847668|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56847669|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847670|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847671|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56847672|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847673|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847674|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56847675|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56847676|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
56847677|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
56847678|NCT03404206|Ibuprofen|ibuprofen|mesh-list
56847679|NCT03404206|Naproxen|naproxen|mesh-list
56847680|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56847681|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56847682|NCT03404206|Analgesics|analgesics|mesh-ancestor
56847683|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
56847684|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847685|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847686|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847687|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847688|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56847689|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568057|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
56847691|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
56847692|NCT00394901|Pregabalin|pregabalin|mesh-list
56847693|NCT00394901|Analgesics|analgesics|mesh-ancestor
56847694|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
56847695|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847696|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847697|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
56847698|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56847699|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56847700|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847701|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56847702|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56847703|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56847704|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56847705|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56847706|NCT03349060|Abrocitinib|abrocitinib|mesh-list
56847707|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56847708|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847709|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847710|NCT03348904|Gemcitabine|gemcitabine|mesh-list
56847711|NCT03348904|Paclitaxel|paclitaxel|mesh-list
56847712|NCT03348904|Carboplatin|carboplatin|mesh-list
56847713|NCT03348904|Nivolumab|nivolumab|mesh-list
56847714|NCT03348904|Pemetrexed|pemetrexed|mesh-list
56847715|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56847716|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847717|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
56847718|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
56847719|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
56847720|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847721|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56847722|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
56847723|NCT03348904|Antiviral Agents|antiviral agents|mesh-ancestor
56847724|NCT03348904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847725|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847726|NCT03348904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847727|NCT03348904|Immunologic Factors|immunologic factors|mesh-ancestor
56847728|NCT03348904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847729|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847730|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56847731|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56847732|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56847733|NCT00359021|Etravirine|etravirine|mesh-list
56847734|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56847735|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56847736|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847737|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847738|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
56847739|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847740|NCT00064350|Sorafenib|sorafenib|mesh-list
56847741|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847742|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56847743|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847744|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847745|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56847746|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56847747|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56847748|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56847749|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847750|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
56847751|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847752|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847753|NCT01052597|Curcumin|curcumin|mesh-list
56847754|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56847755|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56847756|NCT01052597|Analgesics|analgesics|mesh-ancestor
56847757|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
56847758|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847759|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847760|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56362135|NCT00292201|Atorvastatin|atorvastatin|mesh-list
56847763|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847764|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847765|NCT01051115|Dasatinib|dasatinib|mesh-list
56847766|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847767|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56847768|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847769|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847770|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
56847771|NCT00076752|Promethazine|promethazine|mesh-list
56847772|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
56847773|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
56847774|NCT00076752|Rituximab|rituximab|mesh-list
56847775|NCT00076752|Fludarabine|fludarabine|mesh-list
56847776|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
56847777|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847778|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
56847779|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847780|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847781|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56847782|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
56847783|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847784|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847785|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56847786|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847787|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56847789|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847790|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
56847791|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
56847792|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847793|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56847794|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
56847795|NCT00076752|Hormones|hormones|mesh-ancestor
56847796|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56847797|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56847798|NCT00076752|Protective Agents|protective agents|mesh-ancestor
56847799|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56847800|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56847801|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56847802|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
56847803|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
56847804|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
56847805|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56847806|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
56847807|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
56847808|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847809|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56847810|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
56847811|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
56847812|NCT03384940|Trastuzumab|trastuzumab|mesh-list
56847813|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847814|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847815|NCT00075582|Dactinomycin|dactinomycin|mesh-list
56847816|NCT00075582|Cactinomycin|cactinomycin|mesh-list
56847817|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
56847818|NCT00075582|Vincristine|vincristine|mesh-list
56847819|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847820|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
56847821|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847822|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847823|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56847824|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
56847825|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847826|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847827|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56847828|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56847829|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56847830|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56847831|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56847832|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56847833|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847834|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56847835|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56847837|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56847838|NCT00063258|Paclitaxel|paclitaxel|mesh-list
56847839|NCT00063258|Carboplatin|carboplatin|mesh-list
56847840|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56847841|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56847842|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847843|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
56847844|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
56847845|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
56847846|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847847|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56847848|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847849|NCT00088530|Gemcitabine|gemcitabine|mesh-list
56847850|NCT00088530|Prednisone|prednisone|mesh-list
56847851|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
56847852|NCT00088530|Rituximab|rituximab|mesh-list
56847853|NCT00088530|Etoposide|etoposide|mesh-list
56847854|NCT00088530|Vincristine|vincristine|mesh-list
56847855|NCT00088530|Vinorelbine|vinorelbine|mesh-list
56847856|NCT00088530|Pixantrone|pixantrone|mesh-list
56847857|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847858|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
56847859|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847860|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847861|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56847862|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
56847863|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847864|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847865|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56847866|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847867|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56847869|NCT00088530|Antiviral Agents|antiviral agents|mesh-ancestor
56847870|NCT00088530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847871|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847872|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847873|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
56847874|NCT00088530|Hormones|hormones|mesh-ancestor
56847875|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56847876|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56847877|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56847878|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56847879|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56847880|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
56847881|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
56847882|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
56847883|NCT00359801|Insulin|insulin|mesh-list
56847884|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56847885|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55895111|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
56847886|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847887|NCT03990701|Metomidate|metomidate|mesh-list
56847888|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56847889|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56847890|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847891|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
56847892|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
56847893|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56847894|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56847895|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56847896|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847897|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56847898|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56847899|NCT01051271|Midazolam|midazolam|mesh-list
56847900|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56847901|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56847902|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56847903|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847904|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56847905|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56847906|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56847907|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56847908|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
56847909|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
56847910|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
56847911|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
56362290|NCT00120081|Antacids|antacids|mesh-ancestor
56847913|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847914|NCT01051427|Hemostatics|hemostatics|mesh-list
56847915|NCT01051427|Surgiflo|surgiflo|mesh-list
56847916|NCT01051427|Coagulants|coagulants|mesh-ancestor
56847917|NCT01052909|Glimepiride|glimepiride|mesh-list
56847918|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56847919|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56847920|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847921|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847922|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
56847923|NCT00045032|Trastuzumab|trastuzumab|mesh-list
56847924|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847925|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847926|NCT01052987|Tranilast|tranilast|mesh-list
56847927|NCT01052987|Allopurinol|allopurinol|mesh-list
56847928|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
56847929|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847930|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847931|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
56847932|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56847933|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56847934|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
56847935|NCT01052987|Protective Agents|protective agents|mesh-ancestor
56847936|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847937|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56847938|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56847939|NCT01052987|Analgesics|analgesics|mesh-ancestor
56847940|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
56847941|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56847942|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56847943|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56847944|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56847945|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56847946|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56847947|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
56847948|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
56847949|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56847950|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56847951|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56847952|NCT02533973|Calcipotriene|calcipotriene|mesh-list
56847953|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
56847954|NCT01053065|Atorvastatin|atorvastatin|mesh-list
56847955|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
56847956|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
56847957|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56847958|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56847959|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
56903455|NCT03695367|Ibuprofen|ibuprofen|mesh-list
56847960|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56847961|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56847962|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56847963|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847964|NCT01051583|Bevacizumab|bevacizumab|mesh-list
56847965|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56847966|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56847967|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56847968|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56847969|NCT01051583|Growth Substances|growth substances|mesh-ancestor
56847970|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847971|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
56847972|NCT05386706|Metformin|metformin|mesh-list
56847973|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56847974|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847975|NCT03950804|Eculizumab|eculizumab|mesh-list
56847976|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56847977|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56847978|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
56847979|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847980|NCT00356915|Itraconazole|itraconazole|mesh-list
56847981|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56847982|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
56847983|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56847984|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56847985|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56847986|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56847988|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56847989|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
56847990|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56847991|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56847992|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56847993|NCT00356759|Warfarin|warfarin|mesh-list
56847994|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
56847995|NCT00356603|Sumatriptan|sumatriptan|mesh-list
56847996|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56847997|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56847998|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56847999|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
56848000|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848001|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848002|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848003|NCT01052051|Vitamin D|vitamin d|mesh-list
56848004|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
56848005|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
56848006|NCT01052051|Calcium|calcium|mesh-list
56848007|NCT01052051|Vitamins|vitamins|mesh-ancestor
56848008|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
56848009|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848010|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56848011|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56558783|NCT01293682|Vitamins|vitamins|mesh-ancestor
56848012|NCT01052051|Antacids|antacids|mesh-ancestor
56848013|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848014|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56848015|NCT00002558|Paclitaxel|paclitaxel|mesh-list
56848016|NCT00002558|Etoposide|etoposide|mesh-list
56848017|NCT00002558|Carboplatin|carboplatin|mesh-list
56848018|NCT00002558|Ifosfamide|ifosfamide|mesh-list
56848019|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56848020|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848021|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
56848022|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
56848023|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
56848024|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848025|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56848026|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56848027|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848028|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56848029|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
56848030|NCT00001880|Cyclosporine|cyclosporine|mesh-list
56848031|NCT00001880|Methotrexate|methotrexate|mesh-list
56848032|NCT00001880|Cyclosporins|cyclosporins|mesh-list
56848033|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56848034|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
56848035|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56848036|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848037|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56848038|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
56848039|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848040|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848041|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
56848042|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848043|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56848044|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848045|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
56848046|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56848047|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56848048|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
56848049|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848050|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56848051|NCT01096472|Octenidine|octenidine|mesh-list
56848052|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848053|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56848054|NCT05627648|Mitogens|mitogens|mesh-list
56848055|NCT05627648|Mitosis Modulators|mitosis modulators|mesh-ancestor
56848056|NCT05627648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848057|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
56848058|NCT05296772|Antibodies|antibodies|mesh-list
56848059|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
56848060|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
56848061|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848062|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848063|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848064|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
56848065|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56848066|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56848067|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848068|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56848069|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56848070|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
56848071|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848072|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848073|NCT01104896|Nicotine|nicotine|mesh-list
56848074|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56848075|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
56848076|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848077|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848078|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56848079|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56848080|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
56848081|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848082|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848083|NCT00043550|Sertraline|sertraline|mesh-list
56848084|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56848085|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
56848086|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56848087|NCT00043550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56848088|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56848089|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56848090|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848091|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848092|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
56848093|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848094|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56848095|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56848096|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56848097|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848098|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56848099|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848100|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
56848101|NCT01102244|Hormones|hormones|mesh-ancestor
56848102|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848103|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848104|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56848105|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56848106|NCT01105208|Cephalexin|cephalexin|mesh-list
56848107|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56848108|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848109|NCT01105286|Vitamin D|vitamin d|mesh-list
56848110|NCT01105286|Calcipotriene|calcipotriene|mesh-list
56848111|NCT01105286|Vitamins|vitamins|mesh-ancestor
56848112|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
56848113|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848114|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56848115|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
56848116|NCT00041132|Leucovorin|leucovorin|mesh-list
56848117|NCT00041132|Cytarabine|cytarabine|mesh-list
56848118|NCT00041132|Dexamethasone|dexamethasone|mesh-list
56848119|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
56848120|NCT00041132|Rituximab|rituximab|mesh-list
56848121|NCT00041132|Doxorubicin|doxorubicin|mesh-list
56848122|NCT00041132|Methotrexate|methotrexate|mesh-list
56848123|NCT00041132|Vincristine|vincristine|mesh-list
56848124|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
56848125|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848126|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
56848127|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848128|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56848129|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56848130|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
56848131|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848132|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848133|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56848134|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848135|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848136|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
56848137|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
56848138|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848139|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56848140|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
56848141|NCT00041132|Hormones|hormones|mesh-ancestor
56848142|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848143|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56848144|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56848145|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56848146|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56848147|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848148|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56848149|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
56848150|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56848151|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56848152|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
56848153|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
56848154|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56848155|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56848156|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
56848157|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848158|NCT00041132|Antidotes|antidotes|mesh-ancestor
56848159|NCT00041132|Protective Agents|protective agents|mesh-ancestor
56848160|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
56848161|NCT00041132|Vitamins|vitamins|mesh-ancestor
56848162|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
56848163|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56848164|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
56848165|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
56848166|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
56848168|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
56848169|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56848170|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56848171|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
56848172|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848173|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848174|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56848175|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56848176|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
56848177|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848178|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56848179|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56848180|NCT02952586|Avelumab|avelumab|mesh-list
56848181|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848182|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848183|NCT05098574|Drospirenone|drospirenone|mesh-list
56848184|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56848185|NCT05098574|Estradiol|estradiol|mesh-list
56848186|NCT05098574|Estrogens|estrogens|mesh-ancestor
56848187|NCT05098574|Hormones|hormones|mesh-ancestor
56848188|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848189|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848190|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56848191|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
56848192|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56848193|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56848194|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56848195|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56848196|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56848197|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
56848198|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56848199|NCT05098574|Diuretics|diuretics|mesh-ancestor
56848200|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
56848201|NCT01096706|Aspirin|aspirin|mesh-list
56848202|NCT01096706|Fluconazole|fluconazole|mesh-list
56848203|NCT01096706|Substance P|substance p|mesh-list
56848204|NCT01096706|Neurokinin A|neurokinin a|mesh-list
56848205|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56848206|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56848207|NCT01096706|Analgesics|analgesics|mesh-ancestor
56848208|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
56848209|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848210|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848211|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848212|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56848214|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56848215|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848216|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56848217|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56848218|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848219|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
56848220|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
56848221|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848222|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56848223|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56848224|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56848225|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
56848226|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848227|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56848228|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56848229|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848230|NCT01102478|Losartan|losartan|mesh-list
56848231|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56848232|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56848233|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56848234|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56848235|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56848236|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848237|NCT01102478|Diuretics|diuretics|mesh-ancestor
56848239|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848240|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56848241|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56848242|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56848243|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56848244|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
56848245|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848246|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56848247|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848248|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56848249|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848250|NCT03384316|Vaccines|vaccines|mesh-list
56848251|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
56848252|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848253|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
56848254|NCT03994172|Vitamin D|vitamin d|mesh-list
56848255|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
56848256|NCT03994172|Teriparatide|teriparatide|mesh-list
56848257|NCT03994172|Citric Acid|citric acid|mesh-list
56848258|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
56848259|NCT03994172|Calcium|calcium|mesh-list
56848260|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
56848261|NCT03994172|Cinacalcet|cinacalcet|mesh-list
56848262|NCT03994172|Hormones|hormones|mesh-list
56848263|NCT03994172|Vitamins|vitamins|mesh-ancestor
56848264|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
56848265|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848266|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56848267|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56848268|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
56848269|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56848270|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
56848271|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
56848272|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848273|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848274|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56848275|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
56848276|NCT01105832|Teriparatide|teriparatide|mesh-list
56848277|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56848278|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848279|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56848280|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56848281|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
56848282|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56848283|NCT03856658|Floxuridine|floxuridine|mesh-list
56848284|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56848285|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
56362659|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
56848287|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848288|NCT03383692|Ritonavir|ritonavir|mesh-list
56848289|NCT03383692|Itraconazole|itraconazole|mesh-list
56848290|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56848291|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56848292|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
56848293|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848294|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848295|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56848296|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56848297|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
56848298|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848299|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56848300|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56848301|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
56848302|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56848303|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56848304|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
56848305|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848306|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848307|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
56848308|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848309|NCT00356525|Gemcitabine|gemcitabine|mesh-list
56848310|NCT00356525|Carboplatin|carboplatin|mesh-list
56848311|NCT00356525|Pemetrexed|pemetrexed|mesh-list
56848312|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848313|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56848315|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848316|NCT00356525|Antiviral Agents|antiviral agents|mesh-ancestor
56848317|NCT00356525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848318|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848319|NCT00356525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848320|NCT00356525|Immunologic Factors|immunologic factors|mesh-ancestor
56848321|NCT00356525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848322|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56848323|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56848324|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
56848325|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848326|NCT01052129|Naproxen|naproxen|mesh-list
56848327|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56848328|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56848329|NCT01052129|Analgesics|analgesics|mesh-ancestor
56848330|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
56848331|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848332|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848333|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848334|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56848335|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
56848336|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56848337|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848338|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848339|NCT01053377|Oseltamivir|oseltamivir|mesh-list
56848340|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
56848341|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848342|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848343|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848344|NCT03991559|Manganese|manganese|mesh-list
56848345|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56848346|NCT03991559|Antibodies|antibodies|mesh-list
56848347|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
56848348|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
56848349|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848350|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848351|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848352|NCT03991559|Trace Elements|trace elements|mesh-ancestor
56848353|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
56848354|NCT03949634|Paclitaxel|paclitaxel|mesh-list
56848355|NCT03949634|Docetaxel|docetaxel|mesh-list
56848356|NCT03949634|Doxorubicin|doxorubicin|mesh-list
56848357|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56848358|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848359|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
56848360|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
56848362|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848363|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56848364|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56848365|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56848366|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848367|NCT01108874|Metaraminol|metaraminol|mesh-list
56848368|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
56848369|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
56848370|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848371|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848372|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56848373|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56848374|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56848375|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56848376|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
56848377|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848378|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848379|NCT03383614|Emodepside|emodepside|mesh-list
56848380|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56848381|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848382|NCT03403036|Brodalumab|brodalumab|mesh-list
56848383|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
56848384|NCT00356135|Clopidogrel|clopidogrel|mesh-list
56848385|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56848386|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56848387|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56848388|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56848389|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56848390|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
56848391|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848392|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848393|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848394|NCT01052363|Bevacizumab|bevacizumab|mesh-list
56848395|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848396|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848397|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56848398|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56848399|NCT01052363|Growth Substances|growth substances|mesh-ancestor
56848400|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848401|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
56848402|NCT01053611|Remifentanil|remifentanil|mesh-list
56848403|NCT01053611|Propofol|propofol|mesh-list
56848404|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56848405|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56848406|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848407|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56848408|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
56848409|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
56848410|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56848411|NCT01053611|Narcotics|narcotics|mesh-ancestor
56848412|NCT01053611|Analgesics|analgesics|mesh-ancestor
56848413|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
56848414|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848415|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
56848416|NCT00350519|Hematinics|hematinics|mesh-ancestor
56848417|NCT01053689|Glimepiride|glimepiride|mesh-list
56848418|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56848419|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56848420|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848421|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848422|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
56848423|NCT01111448|Sirolimus|sirolimus|mesh-list
56848424|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56848425|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848426|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56848427|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848428|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
56848429|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848430|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
56848431|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848432|NCT03382912|Nivolumab|nivolumab|mesh-list
56848433|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848434|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848435|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56848438|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56848439|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848440|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56848441|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848442|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
56848443|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848444|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
56848445|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848446|NCT00350207|Bromides|bromides|mesh-list
56848447|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
56848448|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56848449|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56848450|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
56848451|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848452|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848453|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56848454|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
56848455|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
56848456|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56848457|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
56848458|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848459|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848460|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56848461|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56848462|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56848463|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
56848464|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
56848465|NCT03946826|Halometasone|halometasone|mesh-list
56848466|NCT03946826|Petrolatum|petrolatum|mesh-list
56848467|NCT03946826|Emollients|emollients|mesh-ancestor
56848468|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
56848469|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848470|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
56848471|NCT03946826|Hormones|hormones|mesh-ancestor
56848472|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848473|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848474|NCT01311622|Warfarin|warfarin|mesh-list
56848475|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
56848476|NCT01109030|Pioglitazone|pioglitazone|mesh-list
56848477|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
56848478|NCT01109030|Dexetimide|dexetimide|mesh-list
56848479|NCT01109030|Citalopram|citalopram|mesh-list
56848480|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56848481|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848482|NCT01109030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56848483|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56848484|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56848485|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848486|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848487|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
56848488|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56848489|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
56848490|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56848491|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56848492|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56848493|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
56848494|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
56848495|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848496|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56848497|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56848498|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
56848499|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56848500|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56848501|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56848502|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56848503|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56848504|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
56848505|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
56848506|NCT04542824|Gemcitabine|gemcitabine|mesh-list
56848507|NCT04542824|Prednisone|prednisone|mesh-list
56848508|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
56848509|NCT04542824|Rituximab|rituximab|mesh-list
56848510|NCT04542824|Doxorubicin|doxorubicin|mesh-list
56848511|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
56848513|NCT04542824|Lenalidomide|lenalidomide|mesh-list
56848514|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848515|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
56848516|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848517|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56848518|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56848519|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
56848520|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848521|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848522|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56848523|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848524|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56848525|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
56848526|NCT04542824|Antiviral Agents|antiviral agents|mesh-ancestor
56848527|NCT04542824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848528|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848529|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56848530|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56848531|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56848532|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848533|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
56848534|NCT04542824|Hormones|hormones|mesh-ancestor
56848535|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848536|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56848537|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56848538|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
56848539|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
56848540|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
56559303|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56848541|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56848542|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56848543|NCT04542824|Growth Substances|growth substances|mesh-ancestor
56848544|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
56848545|NCT00349973|Dipyridamole|dipyridamole|mesh-list
56848546|NCT00349973|Olanzapine|olanzapine|mesh-list
56848547|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
56848548|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
56848549|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848550|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848551|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56848552|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56848553|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56848554|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56848555|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56848556|NCT00349973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56848557|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56848558|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56848559|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848560|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848561|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
56848562|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56848563|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848564|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56848565|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
56848566|NCT01111682|Mannitol|mannitol|mesh-list
56848567|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56848568|NCT01111682|Diuretics|diuretics|mesh-ancestor
56848569|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
56848570|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848571|NCT03946514|Losartan|losartan|mesh-list
56848572|NCT03946514|Amlodipine|amlodipine|mesh-list
56848573|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56848574|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56848575|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56848576|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56848577|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848578|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56848579|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848580|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
56848581|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56848582|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56848583|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56848584|NCT03946514|Diuretics|diuretics|mesh-ancestor
56848585|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
56848586|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56848588|NCT04464122|Hormones|hormones|mesh-ancestor
56848589|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848590|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848591|NCT01111994|Clindamycin|clindamycin|mesh-list
56848592|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
56848593|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
56848594|NCT01111994|Tretinoin|tretinoin|mesh-list
56848595|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56848596|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848597|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56848598|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848599|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848600|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848601|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
56848602|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
56848603|NCT03187262|Daratumumab|daratumumab|mesh-list
56848604|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848605|NCT03944252|Cetuximab|cetuximab|mesh-list
56848606|NCT03944252|Avelumab|avelumab|mesh-list
56848607|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848608|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848609|NCT01209026|Fluticasone|fluticasone|mesh-list
56848610|NCT01209026|Xhance|xhance|mesh-list
56848611|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
56848612|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56848613|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848614|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56848615|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
56848616|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848617|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848618|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56848619|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
56848620|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
56848621|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56848622|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56848623|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848624|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56848625|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56848626|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848627|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848628|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848629|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56848630|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
56848631|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56848632|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56848633|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56848634|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56848635|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56848636|NCT01107470|Hormones|hormones|mesh-ancestor
56848637|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848638|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848639|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56848640|NCT01109264|Chlorambucil|chlorambucil|mesh-list
56848641|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56848642|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
56848643|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848644|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848645|NCT01311700|Metoprolol|metoprolol|mesh-list
56848646|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56848647|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56848648|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
56848649|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
56848650|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848651|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848652|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56848653|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56848654|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56848655|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
56848656|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848657|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363051|NCT00304993|Niacin|niacin|mesh-list
56848659|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
56848660|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56848661|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56848662|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848663|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848664|NCT01107782|Urological Agents|urological agents|mesh-ancestor
56848665|NCT01107938|Esomeprazole|esomeprazole|mesh-list
56848666|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56848667|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56848668|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56848669|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848670|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848671|NCT02950558|Ropivacaine|ropivacaine|mesh-list
56848672|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
56848673|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
56848674|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56848675|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848676|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
56848677|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848678|NCT02791334|Ramucirumab|ramucirumab|mesh-list
56848679|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848680|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
56848681|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56848682|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
56848683|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848684|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848685|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56848686|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
56848687|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
56848688|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56559454|NCT02778178|Clonidine|clonidine|mesh-list
56848689|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
56848690|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848691|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848693|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848694|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848695|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56848696|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56848697|NCT05497726|Growth Substances|growth substances|mesh-ancestor
56848698|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848699|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
56848700|NCT01209416|Acipimox|acipimox|mesh-list
56848701|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56848702|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
56848703|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848704|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56848705|NCT00349349|Ofatumumab|ofatumumab|mesh-list
56848706|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848707|NCT01112462|Acetaminophen|acetaminophen|mesh-list
56848708|NCT01112462|Phenylephrine|phenylephrine|mesh-list
56848709|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
56848710|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56848711|NCT01112462|Analgesics|analgesics|mesh-ancestor
56848712|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
56848713|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848714|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848715|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
56848716|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56848717|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
56848718|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
56848719|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
56848720|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56848721|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
56848722|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
56848723|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56848724|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56848725|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56848726|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
56848727|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848728|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848729|NCT01112462|Protective Agents|protective agents|mesh-ancestor
56848730|NCT02950480|Zafirlukast|zafirlukast|mesh-list
56848731|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56848732|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
56848734|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
56848735|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848736|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848737|NCT05494528|Entecavir|entecavir|mesh-list
56848738|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
56848739|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848740|NCT03987815|Nivolumab|nivolumab|mesh-list
56848741|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848742|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848743|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56848744|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848745|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
56848746|NCT00348881|Vaccines|vaccines|mesh-list
56848747|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
56848748|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848749|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
56848750|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56848751|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56848752|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848753|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
56848754|NCT02257580|Coagulants|coagulants|mesh-ancestor
56848755|NCT01055795|Bevacizumab|bevacizumab|mesh-list
56848756|NCT01055795|Everolimus|everolimus|mesh-list
56848757|NCT01055795|Panobinostat|panobinostat|mesh-list
56848758|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848759|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848760|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56848761|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56848762|NCT01055795|Growth Substances|growth substances|mesh-ancestor
56848763|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559542|NCT02777788|Paclitaxel|paclitaxel|mesh-list
56848764|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
56848765|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848766|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
56848767|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56848768|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848769|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848770|NCT03943784|Propranolol|propranolol|mesh-list
56848771|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56848772|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56848773|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
56848774|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56848775|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848776|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848777|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56848778|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56848779|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
56848780|NCT00347009|Adefovir|adefovir|mesh-list
56848781|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56848782|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
56848783|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848784|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56848785|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56848786|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848787|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848788|NCT01209650|Afatinib|afatinib|mesh-list
56848789|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848790|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56848791|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848792|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848793|NCT01947140|Romidepsin|romidepsin|mesh-list
56848794|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56848795|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848796|NCT00346775|Beclomethasone|beclomethasone|mesh-list
56848797|NCT00346775|Flunisolide|flunisolide|mesh-list
56848798|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848799|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
56848800|NCT00346775|Hormones|hormones|mesh-ancestor
56848801|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848802|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848803|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56848804|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
56848805|NCT01108562|Lidocaine|lidocaine|mesh-list
56848807|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
56848808|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56848809|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848810|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
56848811|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848812|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56848813|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56848814|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56848815|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56848816|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848817|NCT01112540|Morphine|morphine|mesh-list
56848818|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56848819|NCT01112540|Narcotics|narcotics|mesh-ancestor
56848820|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56848821|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848822|NCT01112540|Analgesics|analgesics|mesh-ancestor
56848823|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
56848824|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848825|NCT03400852|Cosyntropin|cosyntropin|mesh-list
56848826|NCT03400852|Hormones|hormones|mesh-ancestor
56848827|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848828|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848829|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
56848830|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
56848831|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848832|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
56848833|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
56848834|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848835|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559603|NCT02777320|Acetaminophen|acetaminophen|mesh-list
56848837|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
56848838|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848839|NCT01056497|Protective Agents|protective agents|mesh-ancestor
56848840|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848841|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
56848842|NCT01056497|Vitamins|vitamins|mesh-ancestor
56848843|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
56848844|NCT03398356|Metformin|metformin|mesh-list
56848845|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56848846|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848847|NCT00346151|Sirolimus|sirolimus|mesh-list
56848848|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
56848849|NCT00346151|Abatacept|abatacept|mesh-list
56848850|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
56848851|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56848852|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
56848853|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
56848854|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56848855|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848856|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56848857|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848858|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
56848859|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848860|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
56848861|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848862|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56848863|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
56848864|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
56848865|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848866|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56848867|NCT00346151|Hormones|hormones|mesh-ancestor
56848868|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848869|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56848870|NCT00346151|Protective Agents|protective agents|mesh-ancestor
56848871|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56848872|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848873|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56848874|NCT03940976|Afatinib|afatinib|mesh-list
56848875|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848876|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56848877|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848878|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848879|NCT01109498|Cyclosporine|cyclosporine|mesh-list
56848880|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
56848881|NCT01109498|Cyclosporins|cyclosporins|mesh-list
56848882|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848883|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848884|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848885|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
56848886|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848887|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
56848888|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848889|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
56848890|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56848891|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56848892|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56848893|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848894|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56848895|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
56848896|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56848897|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
56848898|NCT00130286|Hormones|hormones|mesh-list
56848899|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848900|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848901|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56848902|NCT03940664|Formaldehyde|formaldehyde|mesh-list
56848903|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
56848904|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848905|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
56848906|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
56848907|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56848908|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
56848909|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
56559678|NCT00944697|Analgesics|analgesics|mesh-ancestor
56848910|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56848911|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848912|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56848913|NCT03941990|Analgesics|analgesics|mesh-ancestor
56848914|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
56848915|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848916|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
56848917|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56848918|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848919|NCT01209728|Ethanol|ethanol|mesh-list
56848920|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56848921|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56848922|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56848923|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848924|NCT00076310|Cisplatin|cisplatin|mesh-list
56848925|NCT00076310|Docetaxel|docetaxel|mesh-list
56848926|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56848927|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848928|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
56848929|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
56848930|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
56848931|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848932|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56848933|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848934|NCT00345683|Vaccines|vaccines|mesh-list
56848935|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
56848936|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848937|NCT01211912|Acetaminophen|acetaminophen|mesh-list
56848938|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56848939|NCT01211912|Analgesics|analgesics|mesh-ancestor
56848940|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
56848941|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56848942|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848943|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
56848944|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
56848945|NCT03943472|Fludarabine|fludarabine|mesh-list
56848946|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56848947|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
56848948|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848949|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56848950|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56848951|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
56848952|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848953|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56848954|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56848955|NCT01114490|Anacetrapib|anacetrapib|mesh-list
56848957|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56848958|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
56848959|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848960|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56848961|NCT01209806|Simethicone|simethicone|mesh-list
56848962|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
56848963|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56848964|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
56848965|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
56848966|NCT01209806|TEMPO|tempo|mesh-list
56848967|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
56848968|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848969|NCT01209806|Emollients|emollients|mesh-ancestor
56848970|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
56848971|NCT01209806|Antacids|antacids|mesh-ancestor
56848972|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56848973|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56848974|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
56848975|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848976|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
56848977|NCT01209806|Protective Agents|protective agents|mesh-ancestor
56848978|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
56848979|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56848980|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848981|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56848982|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848983|NCT01109654|Cetrorelix|cetrorelix|mesh-list
56848984|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56848985|NCT01109654|Hormones|hormones|mesh-ancestor
56848986|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56848987|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56848988|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56848989|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
56848990|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56848991|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
56848992|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
56848993|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
56848994|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56848995|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56848996|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56848997|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56848998|NCT01054001|Urological Agents|urological agents|mesh-ancestor
56848999|NCT01057355|Ethanol|ethanol|mesh-list
56849000|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56849001|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849002|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849003|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849004|NCT01057511|Progesterone|progesterone|mesh-list
56849005|NCT01057511|Progestins|progestins|mesh-ancestor
56849006|NCT01057511|Hormones|hormones|mesh-ancestor
56849007|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849008|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849009|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56849010|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849011|NCT01210040|Folic Acid|folic acid|mesh-list
56849012|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
56849013|NCT01210040|Hematinics|hematinics|mesh-ancestor
56849014|NCT01210040|Vitamins|vitamins|mesh-ancestor
56849015|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
56849016|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849017|NCT01054313|Sirolimus|sirolimus|mesh-list
56849018|NCT01054313|Prednisone|prednisone|mesh-list
56849019|NCT01054313|Docetaxel|docetaxel|mesh-list
56849020|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849021|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
56849022|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
56849023|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
56849024|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849025|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849026|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
56849027|NCT01054313|Hormones|hormones|mesh-ancestor
56849028|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849029|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849032|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849033|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56849034|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
56849035|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56849036|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
56849037|NCT01114958|Cisplatin|cisplatin|mesh-list
56849038|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849039|NCT03742115|Dexamethasone|dexamethasone|mesh-list
56849040|NCT03742115|Etoposide|etoposide|mesh-list
56849041|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
56849042|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849043|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
56849044|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
56849045|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849046|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849047|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849048|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
56849049|NCT03742115|Hormones|hormones|mesh-ancestor
56849050|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849051|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56849052|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849053|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56849054|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56849055|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56849056|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849057|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849058|NCT01115036|Panobinostat|panobinostat|mesh-list
56849059|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559826|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56849060|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56849061|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849062|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849063|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56849064|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56849065|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56849066|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849067|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849068|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
56849069|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849070|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849071|NCT03942068|Paclitaxel|paclitaxel|mesh-list
56849072|NCT03942068|Apatinib|apatinib|mesh-list
56849073|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56849074|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56849075|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849076|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
56849077|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
56849078|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
56849079|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849080|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56849081|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920157|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920158|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
56920159|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
56920160|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
56920161|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920162|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56920163|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
56920164|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920165|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56920166|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56920167|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
56920168|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56920169|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
56920170|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56920171|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56920172|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56920173|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56920174|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920175|NCT01216267|Lansoprazole|lansoprazole|mesh-list
56920177|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56920178|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56920179|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56920180|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920181|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920182|NCT01216345|Gemcitabine|gemcitabine|mesh-list
56920183|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
56920184|NCT01216345|Cetuximab|cetuximab|mesh-list
56920185|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56920186|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
56920187|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920188|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920189|NCT01216345|Antiviral Agents|antiviral agents|mesh-ancestor
56920190|NCT01216345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920191|NCT01216345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920192|NCT01216345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56920193|NCT01216345|Immunologic Factors|immunologic factors|mesh-ancestor
56920194|NCT01216345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920195|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920196|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
56920197|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
56920198|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
56920199|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56920200|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56920201|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920202|NCT01212523|Propofol|propofol|mesh-list
56920203|NCT01212523|Isoflurane|isoflurane|mesh-list
56920204|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56920205|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920206|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920207|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56920208|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
56920209|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
56920210|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56920211|NCT01122121|Leuprolide|leuprolide|mesh-list
56849082|NCT01112852|Terlipressin|terlipressin|mesh-list
56849083|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56849084|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56849085|NCT01112852|Somatostatin|somatostatin|mesh-list
56849086|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56849087|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849088|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849089|NCT01112852|Hormones|hormones|mesh-ancestor
56849090|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849091|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849092|NCT01054469|Ropivacaine|ropivacaine|mesh-list
56849093|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
56849094|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
56849095|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849096|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849097|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
56849098|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849099|NCT03940430|Lactoferrin|lactoferrin|mesh-list
56849100|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849101|NCT00355121|Vaccines|vaccines|mesh-list
56849102|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
56849103|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849104|NCT02533349|Pantoprazole|pantoprazole|mesh-list
56849105|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56849106|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849107|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56849108|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849109|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849110|NCT01115426|Losartan|losartan|mesh-list
56849111|NCT01115426|Ramipril|ramipril|mesh-list
56849112|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56849113|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56849114|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56849115|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56849116|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849117|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56849118|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
56849119|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849120|NCT03942458|Clopidogrel|clopidogrel|mesh-list
56849122|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56849123|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56849124|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56849125|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
56849126|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849127|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849128|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849129|NCT01115504|Thiamine|thiamine|mesh-list
56849130|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
56849131|NCT01115504|Vitamins|vitamins|mesh-ancestor
56849132|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
56849133|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849134|NCT00343889|Vaccines|vaccines|mesh-list
56849135|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
56849136|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849137|NCT03939884|Diclofenac|diclofenac|mesh-list
56849138|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56849139|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56849140|NCT03939884|Analgesics|analgesics|mesh-ancestor
56849141|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
56849142|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849143|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849144|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849145|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56849146|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56849147|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849148|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849149|NCT01054547|Anesthetics|anesthetics|mesh-list
56849150|NCT01054547|Ropivacaine|ropivacaine|mesh-list
56849151|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849152|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849153|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
56849154|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
56849155|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849156|NCT01115894|Naltrexone|naltrexone|mesh-list
56849157|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56849158|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56849159|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849160|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
56849161|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849163|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56849164|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56849165|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56849166|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849167|NCT01116050|Misoprostol|misoprostol|mesh-list
56849168|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56849169|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
56849170|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56849171|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849172|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56849173|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849174|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
56849175|NCT03343054|Talazoparib|talazoparib|mesh-list
56849176|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56849177|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849178|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849179|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849180|NCT01054781|Rituximab|rituximab|mesh-list
56849181|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56849182|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849183|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
56849184|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849185|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56849186|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
56849187|NCT01311778|Fentanyl|fentanyl|mesh-list
56849188|NCT01311778|Cannabidiol|cannabidiol|mesh-list
56849189|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56849190|NCT01311778|Narcotics|narcotics|mesh-ancestor
56849191|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849192|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849193|NCT01311778|Analgesics|analgesics|mesh-ancestor
56849194|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
56849196|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56849197|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56849198|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
56849199|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
56849200|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
56849201|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
56849202|NCT00354341|Hematinics|hematinics|mesh-ancestor
56849203|NCT03708718|Prednisolone|prednisolone|mesh-list
56849204|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849205|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
56849206|NCT03708718|Hormones|hormones|mesh-ancestor
56849207|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849208|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849209|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56849210|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849211|NCT00354107|Cytarabine|cytarabine|mesh-list
56849212|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
56849213|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56849214|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56849215|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56849216|NCT00354107|Carboplatin|carboplatin|mesh-list
56849217|NCT00354107|Methotrexate|methotrexate|mesh-list
56849218|NCT00354107|Etoposide|etoposide|mesh-list
56849219|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
56849220|NCT00354107|Ifosfamide|ifosfamide|mesh-list
56849221|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56849222|NCT00354107|Antibodies|antibodies|mesh-list
56849223|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56849224|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
56849225|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849226|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849227|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56849228|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
56849229|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56849230|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56849231|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
56849232|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849233|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
56849234|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849235|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56849236|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56849237|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56849238|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56849239|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56849240|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56849241|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56849242|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
56849243|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849244|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849245|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56849246|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
56849247|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56849248|NCT00354029|Ketamine|ketamine|mesh-list
56849249|NCT00354029|Analgesics|analgesics|mesh-ancestor
56849250|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
56849251|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849252|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849253|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56849254|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56849255|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
56849256|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
56849257|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849258|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56849259|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56849260|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849261|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849262|NCT00353873|Fluticasone|fluticasone|mesh-list
56849263|NCT00353873|Xhance|xhance|mesh-list
56849264|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56849265|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849266|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56849267|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
56849268|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849269|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849271|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
56849272|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
56849273|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56849274|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56849275|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56849276|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56849277|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
56849278|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849279|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849280|NCT01058057|Atorvastatin|atorvastatin|mesh-list
56849281|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56849282|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56849283|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
56849284|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849285|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56849286|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56849287|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849288|NCT03796676|Abrocitinib|abrocitinib|mesh-list
56849289|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56849290|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849291|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849292|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56849293|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56849294|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56849295|NCT00339833|Analgesics|analgesics|mesh-ancestor
56849296|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
56849297|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849298|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849299|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849300|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56849301|NCT01058291|Apomorphine|apomorphine|mesh-list
56849303|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849304|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
56849305|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849306|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849307|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
56849308|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
56849309|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849310|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849311|NCT01055249|Ibuprofen|ibuprofen|mesh-list
56849312|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
56849313|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56849314|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56849315|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56849316|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56849317|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56849318|NCT01055249|Analgesics|analgesics|mesh-ancestor
56849319|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
56849320|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849321|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849322|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849323|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56849324|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56849325|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849326|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849327|NCT01055327|Lamotrigine|lamotrigine|mesh-list
56849328|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
56849329|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56849330|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849331|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849332|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56849333|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849334|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56849335|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56849336|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849337|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56849338|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56849339|NCT03793556|Omeprazole|omeprazole|mesh-list
56849340|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56849341|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849342|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56849343|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849344|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849346|NCT01113164|Sertraline|sertraline|mesh-list
56849347|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
56849348|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
56849349|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849350|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849351|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849352|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
56849353|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
56849354|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56849355|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
56849356|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849357|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849358|NCT01113164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56849359|NCT01113164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56849360|NCT01113164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903511|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
56849361|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56849362|NCT01113164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56849363|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
56849364|NCT01113164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56849365|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56849366|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849367|NCT01210430|Vitamins|vitamins|mesh-list
56849368|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
56849369|NCT01210430|Losartan|losartan|mesh-list
56849370|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
56849371|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849372|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56849373|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56849374|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56849375|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56849376|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849377|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
56849378|NCT01210430|Protective Agents|protective agents|mesh-ancestor
56849379|NCT01210742|Hylan|hylan|mesh-list
56849380|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
56849381|NCT01210742|Protective Agents|protective agents|mesh-ancestor
56849382|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849384|NCT01116128|Melphalan|melphalan|mesh-list
56849385|NCT01116128|Dasatinib|dasatinib|mesh-list
56849386|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849387|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
56849388|NCT01116128|Hormones|hormones|mesh-ancestor
56849389|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849390|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849391|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56849392|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849393|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56849394|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
56849395|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849396|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56849397|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56849398|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
56849399|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56849400|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849401|NCT03390166|Vaccines|vaccines|mesh-list
56849402|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
56849403|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849404|NCT01116206|Prucalopride|prucalopride|mesh-list
56849405|NCT01116206|Laxatives|laxatives|mesh-ancestor
56849406|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849407|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56849408|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56849409|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
56849410|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849411|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849412|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849413|NCT01210976|Simendan|simendan|mesh-list
56849414|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56849415|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
56849416|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56849417|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56849419|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849420|NCT01210976|Protective Agents|protective agents|mesh-ancestor
56849421|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849422|NCT03828539|Topiramate|topiramate|mesh-list
56849423|NCT03828539|Erenumab|erenumab|mesh-list
56849424|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56849425|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
56849426|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56849427|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849428|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56849429|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849430|NCT03828539|Analgesics|analgesics|mesh-ancestor
56849431|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
56849432|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849433|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
56849434|NCT01109888|Cetrorelix|cetrorelix|mesh-list
56849435|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56849436|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
56849437|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56849438|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849439|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
56849440|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849441|NCT03336502|Posaconazole|posaconazole|mesh-list
56849442|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
56849443|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849444|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56849445|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56849446|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56849447|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56849448|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56849449|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849450|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849451|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56849452|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
56849453|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849454|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849455|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
56849456|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56849457|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56849458|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
56849459|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849460|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56849461|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56849462|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849463|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849464|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
56849465|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
56849466|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56849467|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56849468|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849469|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849470|NCT01055405|Urological Agents|urological agents|mesh-ancestor
56849471|NCT02949934|Tolcapone|tolcapone|mesh-list
56849472|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56849473|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56849474|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56849475|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849476|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849477|NCT01055483|Panobinostat|panobinostat|mesh-list
56849478|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849479|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56849480|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849481|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849482|NCT03370510|Oxytocin|oxytocin|mesh-list
56849483|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
56849484|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56849485|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849486|NCT03985865|Quinine|quinine|mesh-list
56849487|NCT03985865|Denatonium|denatonium|mesh-list
56849488|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
56849489|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56849490|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56849492|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56849493|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849494|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56849495|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849496|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56849497|NCT03985865|Analgesics|analgesics|mesh-ancestor
56849498|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
56849499|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
56849500|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849501|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
56849502|NCT01116596|Acetaminophen|acetaminophen|mesh-list
56849503|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56849504|NCT01116596|Analgesics|analgesics|mesh-ancestor
56849505|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
56849506|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903523|NCT05280873|Prednisolone|prednisolone|mesh-list
56849507|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849508|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
56849509|NCT00351611|Pregabalin|pregabalin|mesh-list
56849510|NCT00351611|Analgesics|analgesics|mesh-ancestor
56849511|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
56849512|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849513|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849514|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
56849515|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56849516|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849517|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849518|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56849519|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56849520|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56849521|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849522|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56849523|NCT01211210|Fluorouracil|fluorouracil|mesh-list
56849524|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
56849525|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
56849526|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849527|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56849528|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560354|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
56849529|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56849530|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
56849531|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849532|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
56849533|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56849534|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849535|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849536|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56849537|NCT03789110|Nivolumab|nivolumab|mesh-list
56849538|NCT03789110|Ipilimumab|ipilimumab|mesh-list
56849539|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56849540|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849541|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56849542|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849543|NCT01208012|Liraglutide|liraglutide|mesh-list
56849544|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56849545|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849546|NCT01208012|Incretins|incretins|mesh-ancestor
56849547|NCT01208012|Hormones|hormones|mesh-ancestor
56849548|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849549|NCT03939806|Oxytocin|oxytocin|mesh-list
56849550|NCT03939806|Carbetocin|carbetocin|mesh-list
56849551|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
56849552|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56849553|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849554|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
56849555|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56849556|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849557|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56849558|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
56849559|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56849560|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849561|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849562|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849563|NCT00337727|Dexamethasone|dexamethasone|mesh-list
56849565|NCT00337727|Ondansetron|ondansetron|mesh-list
56849566|NCT00337727|Aprepitant|aprepitant|mesh-list
56849567|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
56849568|NCT00337727|BB 1101|bb 1101|mesh-list
56849569|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849570|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
56849571|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
56849572|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849573|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849574|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849575|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
56849576|NCT00337727|Hormones|hormones|mesh-ancestor
56849577|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56849578|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56849579|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849580|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
56202491|NCT01534585|Paclitaxel|paclitaxel|mesh-list
56849581|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849582|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849583|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
56849584|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
56849585|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56849586|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
56849587|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849588|NCT00337727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56849589|NCT00337727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56849590|NCT00337727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849591|NCT00337727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56849592|NCT00337727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56849593|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56849594|NCT03987893|Lactulose|lactulose|mesh-list
56849595|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56849596|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849597|NCT03987893|Laxatives|laxatives|mesh-ancestor
56849598|NCT01208480|Carboplatin|carboplatin|mesh-list
56849599|NCT01208480|Docetaxel|docetaxel|mesh-list
56849600|NCT01208480|Bevacizumab|bevacizumab|mesh-list
56849601|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849602|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
56849603|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
56849604|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
56849605|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849606|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56849607|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56849608|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56849609|NCT01208480|Growth Substances|growth substances|mesh-ancestor
56849610|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849611|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
56849612|NCT02949700|Metformin|metformin|mesh-list
56849613|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56849614|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849615|NCT04774120|Propofol|propofol|mesh-list
56849616|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56849617|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849618|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849619|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56849620|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
56849621|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
56849622|NCT01117220|Ziprasidone|ziprasidone|mesh-list
56849623|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56849624|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
56849625|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849626|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849627|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849628|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56849629|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56849630|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849631|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56849632|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56849633|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
56849634|NCT05236972|Capecitabine|capecitabine|mesh-list
56849635|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
56849636|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56849637|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
56849638|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849639|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849643|NCT01114100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56849644|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56849645|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849646|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849647|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849648|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
56849649|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849650|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56849651|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
56849652|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56849653|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56849654|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849655|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849656|NCT01110590|Urological Agents|urological agents|mesh-ancestor
56849658|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
56849659|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56849660|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56849661|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849662|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849663|NCT01117298|Urological Agents|urological agents|mesh-ancestor
56849664|NCT01117376|Erythromycin|erythromycin|mesh-list
56849665|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
56849666|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56849667|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
56849668|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
56849669|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56849670|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849671|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849672|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56849673|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849674|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849675|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56849676|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849677|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
56849678|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849679|NCT01213238|Bevacizumab|bevacizumab|mesh-list
56849680|NCT01213238|Capecitabine|capecitabine|mesh-list
56849681|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
56849682|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56849683|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849684|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56849685|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56849686|NCT01213238|Growth Substances|growth substances|mesh-ancestor
56849687|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849688|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
56849689|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56849690|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
56849691|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849692|NCT01110824|Carvedilol|carvedilol|mesh-list
56849693|NCT01110824|Enalapril|enalapril|mesh-list
56849694|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56849695|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56849696|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
56849697|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849698|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849699|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849700|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56849701|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
56849702|NCT01110824|Protective Agents|protective agents|mesh-ancestor
56849703|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56849704|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849705|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56849706|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
56849707|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56849708|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56849709|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56849712|NCT03936140|Iloprost|iloprost|mesh-list
56849713|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56849714|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
56849715|NCT01117610|Ropivacaine|ropivacaine|mesh-list
56849716|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
56849717|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
56849718|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849719|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849720|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
56849721|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849722|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
56849723|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56849724|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849725|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849726|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56849727|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849728|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56849729|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
56849730|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56849731|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849732|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56849733|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
56849734|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56849735|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849736|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849737|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849738|NCT01121744|Sirolimus|sirolimus|mesh-list
56849739|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56849740|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849741|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56849742|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849743|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
56849744|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56849745|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
56849746|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849747|NCT01121822|Vaccines|vaccines|mesh-list
56849748|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
56849749|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849750|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
56849751|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56849752|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56560582|NCT02762812|Infliximab|infliximab|mesh-list
56849753|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849754|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
56849755|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56849756|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56849757|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849758|NCT01216046|Ivacaftor|ivacaftor|mesh-list
56849759|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56849760|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849761|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849762|NCT01216124|Docetaxel|docetaxel|mesh-list
56849763|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
56849764|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849765|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
56849766|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
56849767|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
56849768|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849769|NCT01219010|Siltuximab|siltuximab|mesh-list
56849770|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849771|NCT01118234|Rituximab|rituximab|mesh-list
56849772|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56849773|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849774|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
56849775|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849776|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56849777|NCT00324155|Ipilimumab|ipilimumab|mesh-list
56849778|NCT00324155|Dacarbazine|dacarbazine|mesh-list
56849779|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56849780|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849781|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56904612|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56849783|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56849785|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
56849786|NCT03937544|Fludarabine|fludarabine|mesh-list
56849787|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56849788|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
56849789|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849790|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56849791|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56849792|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
56849793|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849794|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849795|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56849796|NCT01122056|Interferons|interferons|mesh-list
56849797|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
56849798|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849799|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
56849800|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849801|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56849802|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
56849803|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849804|NCT01219088|Morphine|morphine|mesh-list
56849805|NCT01219088|Bupivacaine|bupivacaine|mesh-list
56849806|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
56849807|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
56849808|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849809|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849810|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
56849811|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849812|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56849813|NCT01219088|Narcotics|narcotics|mesh-ancestor
56849814|NCT01219088|Analgesics|analgesics|mesh-ancestor
56849815|NCT01122134|Artesunate|artesunate|mesh-list
56849816|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
56849817|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56849818|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56849819|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849820|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849821|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
56849822|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
56849823|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56849824|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
56849825|NCT01118702|Methylphenidate|methylphenidate|mesh-list
56849826|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56849827|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560656|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
56849828|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56849829|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56849830|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849831|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849833|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849834|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
56849835|NCT01118936|Antacids|antacids|mesh-ancestor
56849836|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849837|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849838|NCT01119014|Aripiprazole|aripiprazole|mesh-list
56849839|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56849840|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
56849841|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56849842|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56849843|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56849844|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849845|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849846|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
56849847|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
56849848|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849849|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849850|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56849851|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56849852|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
56849853|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56849854|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56849855|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56849857|NCT01219244|Resveratrol|resveratrol|mesh-list
56849858|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
56849859|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849860|NCT01219244|Protective Agents|protective agents|mesh-ancestor
56849861|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849862|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849863|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56849864|NCT01119482|Vaccines|vaccines|mesh-list
56849865|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
56849866|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849867|NCT01119638|Risperidone|risperidone|mesh-list
56849868|NCT01119638|Citalopram|citalopram|mesh-list
56849869|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56849870|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
56849871|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849872|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849873|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849874|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56849875|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56849876|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56849877|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56849878|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56849879|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
56849880|NCT01119638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56903529|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
56849881|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56849882|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56849883|NCT01119638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56849884|NCT01119638|Antidepressive Agents|antidepressive agents|mesh-ancestor
56849885|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56849886|NCT03338998|Siponimod|siponimod|mesh-list
56849887|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56849888|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849889|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56849890|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
56849891|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849892|NCT03935984|Calcitonin|calcitonin|mesh-list
56849893|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
56849894|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56849895|NCT03935984|Katacalcin|katacalcin|mesh-list
56849896|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56849897|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849898|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56849899|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
56849900|NCT01219400|Vildagliptin|vildagliptin|mesh-list
56560743|NCT01182194|Diuretics|diuretics|mesh-ancestor
56849901|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56849902|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849903|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56849904|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
56849905|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849906|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849908|NCT01124630|Fluorouracil|fluorouracil|mesh-list
56849909|NCT01124630|Irinotecan|irinotecan|mesh-list
56849910|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
56849911|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849912|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56849913|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849914|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56849915|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
56849916|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849917|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56849918|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56849919|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849920|NCT01124630|Antidotes|antidotes|mesh-ancestor
56849921|NCT01124630|Protective Agents|protective agents|mesh-ancestor
56849922|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
56849923|NCT01124630|Vitamins|vitamins|mesh-ancestor
56849924|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
56849925|NCT05683054|Adalimumab|adalimumab|mesh-list
56849926|NCT05683054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849927|NCT05683054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56849928|NCT01120106|Simendan|simendan|mesh-list
56849929|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56849930|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
56849931|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56849932|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56849933|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849934|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849935|NCT01120106|Protective Agents|protective agents|mesh-ancestor
56849936|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849938|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
56849939|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849940|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
56849941|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
56849942|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
56849943|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849944|NCT01216826|Everolimus|everolimus|mesh-list
56849945|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849946|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56849947|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
56849948|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849949|NCT01120340|Mesalamine|mesalamine|mesh-list
56849950|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56849951|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56849952|NCT01120340|Analgesics|analgesics|mesh-ancestor
56849953|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
56849954|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849955|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849956|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56849957|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56849958|NCT01120418|Besifloxacin|besifloxacin|mesh-list
56849959|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56849960|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849961|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56849962|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56849963|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849964|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849965|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849966|NCT01214408|Pantoprazole|pantoprazole|mesh-list
56849967|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56849968|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56849969|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56849970|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849971|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849972|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
56849973|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56849974|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56849975|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
56849976|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56849977|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56849978|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56849979|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56849980|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849981|NCT01216904|Nicotine|nicotine|mesh-list
56849982|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56849983|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
56849984|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56849985|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56849986|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56849987|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56849988|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
56849989|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56849990|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849991|NCT01125020|Gemcitabine|gemcitabine|mesh-list
56849992|NCT01125020|Doxorubicin|doxorubicin|mesh-list
56849993|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
56849994|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56849995|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56849996|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
56849997|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56849998|NCT01125020|Antiviral Agents|antiviral agents|mesh-ancestor
56849999|NCT01125020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850000|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850001|NCT01125020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850002|NCT01125020|Immunologic Factors|immunologic factors|mesh-ancestor
56850003|NCT01125020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364446|NCT05567081|Triamcinolone|triamcinolone|mesh-list
56850005|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56850006|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56850007|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
56850008|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850010|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56850011|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56850012|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56850013|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850014|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56850015|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850016|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
56850017|NCT03710434|Lansoprazole|lansoprazole|mesh-list
56850018|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
56850019|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56850020|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56850021|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56850022|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850023|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850024|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56850025|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
56850026|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56850027|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56850028|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850029|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850030|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
56850031|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850032|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56850033|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56850034|NCT01217138|Epinephrine|epinephrine|mesh-list
56850035|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56850036|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56850037|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
56850038|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850039|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850040|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850041|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56850042|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56850043|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
56850044|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850045|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56850046|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
56850047|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
56850048|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
56850049|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56850050|NCT03710356|Danazol|danazol|mesh-list
56850051|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56850052|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
56850053|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850054|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850055|NCT01217294|Morphine|morphine|mesh-list
56850056|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56850057|NCT01217294|Narcotics|narcotics|mesh-ancestor
56850058|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850059|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850060|NCT01217294|Analgesics|analgesics|mesh-ancestor
56850061|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
56850062|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850063|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
56850064|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56850065|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850066|NCT01121042|Ondansetron|ondansetron|mesh-list
56850067|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
56850068|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
56850069|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850070|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850071|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56850072|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
56850073|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
56850074|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56850075|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
56850076|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850077|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850078|NCT01121042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56850079|NCT01121042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56850080|NCT01121042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850081|NCT01121042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56850082|NCT01121042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56850083|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56850084|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56850085|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
56850086|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56850087|NCT01217450|Cetuximab|cetuximab|mesh-list
56850088|NCT01217450|Antibodies|antibodies|mesh-list
56850089|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
56850090|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56850091|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
56850092|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850093|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850094|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56850095|NCT01219556|Olmesartan|olmesartan|mesh-list
56850096|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56850097|NCT01219556|Diuretics|diuretics|mesh-ancestor
56850098|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
56850099|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850100|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56850101|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56850102|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850103|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56850104|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56850105|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
56850106|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56850107|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850108|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56850109|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850110|NCT01121276|Insulin|insulin|mesh-list
56850111|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56850112|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
56850113|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
56850114|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56850115|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56850116|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850117|NCT05175508|Azacitidine|azacitidine|mesh-list
56850118|NCT05175508|Tretinoin|tretinoin|mesh-list
56850119|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56850120|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
56850121|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560951|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56850122|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850123|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850124|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
56850125|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
56850126|NCT01125410|Clindamycin|clindamycin|mesh-list
56850127|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
56850128|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
56850129|NCT01125410|Dequalinium|dequalinium|mesh-list
56850130|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56850131|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850132|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56850133|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850134|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850135|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56850136|NCT01328834|Tacrolimus|tacrolimus|mesh-list
56850137|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850138|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
56850139|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850140|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56850141|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850142|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850143|NCT01121354|Cefazolin|cefazolin|mesh-list
56850144|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56850145|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850146|NCT01122602|Aspirin|aspirin|mesh-list
56850147|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56850148|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56850149|NCT01122602|Analgesics|analgesics|mesh-ancestor
56850150|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
56850152|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850153|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56850154|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850155|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56850156|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56850157|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850158|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56850159|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56850160|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850161|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
56850162|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56850163|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56850164|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850165|NCT03359590|Incretins|incretins|mesh-ancestor
56850166|NCT03359590|Hormones|hormones|mesh-ancestor
56850167|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850168|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56850169|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
56850170|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850171|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850172|NCT01219712|Simendan|simendan|mesh-list
56850173|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56850174|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
56850175|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56850176|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56850177|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850178|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850179|NCT01219712|Protective Agents|protective agents|mesh-ancestor
56850180|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850181|NCT05378464|Trastuzumab|trastuzumab|mesh-list
56850182|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56850183|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850184|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56850185|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56850186|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850187|NCT03936062|Incretins|incretins|mesh-ancestor
56850188|NCT03936062|Hormones|hormones|mesh-ancestor
56850189|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850190|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56850191|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
56850192|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850193|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850194|NCT01215266|Sorafenib|sorafenib|mesh-list
56850195|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850196|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56850197|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850198|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850199|NCT05682196|Rituximab|rituximab|mesh-list
56850200|NCT05682196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56850201|NCT05682196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850202|NCT05682196|Immunologic Factors|immunologic factors|mesh-ancestor
56850203|NCT05682196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850204|NCT05682196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850205|NCT03936374|Omeprazole|omeprazole|mesh-list
56850206|NCT03936374|Linrodostat|linrodostat|mesh-list
56850207|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56850208|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56850209|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56850210|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850211|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850212|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56850213|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
56850214|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56850215|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
56850216|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56850217|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850218|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56850219|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56850220|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850221|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
56850222|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56850224|NCT01215578|Sunitinib|sunitinib|mesh-list
56850225|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850226|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56850227|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56850228|NCT01215578|Growth Substances|growth substances|mesh-ancestor
56850229|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850230|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
56850231|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56850232|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850233|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850234|NCT05577988|Aspirin|aspirin|mesh-list
56850235|NCT05577988|Clopidogrel|clopidogrel|mesh-list
56850236|NCT05577988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56850237|NCT05577988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56850238|NCT05577988|Analgesics|analgesics|mesh-ancestor
56850239|NCT05577988|Sensory System Agents|sensory system agents|mesh-ancestor
56850240|NCT05577988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850241|NCT05577988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850242|NCT05577988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56850243|NCT05577988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850244|NCT05577988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56850245|NCT05577988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56850246|NCT05577988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850247|NCT05577988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56850248|NCT05577988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56850249|NCT05577988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850250|NCT05577988|Antipyretics|antipyretics|mesh-ancestor
56850251|NCT05577988|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56850252|NCT05577988|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56850253|NCT05577988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56850254|NCT05577988|Purinergic Agents|purinergic agents|mesh-ancestor
56850255|NCT05577988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850256|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
56850257|NCT01222052|Docetaxel|docetaxel|mesh-list
56850258|NCT01222052|Fluorouracil|fluorouracil|mesh-list
56850259|NCT01222052|Epirubicin|epirubicin|mesh-list
56850260|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850261|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
56850262|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850263|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850264|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56850265|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
56850266|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850267|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850268|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56850269|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
56850270|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
56850271|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
56850272|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
56850273|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56850274|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56850275|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56850276|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56850277|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850279|NCT03710044|Cyclosporins|cyclosporins|mesh-list
56850280|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850281|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850282|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850283|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
56850284|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850285|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
56850286|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850287|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
56850288|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850289|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56850290|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
56850291|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
56850292|NCT03706300|Ephedrine|ephedrine|mesh-list
56850293|NCT03706300|Guaifenesin|guaifenesin|mesh-list
56850294|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56850295|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56850296|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
56850297|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850298|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850300|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
56850301|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
56850302|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56850303|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56850304|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
56850305|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
56850306|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850307|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850308|NCT03706300|Expectorants|expectorants|mesh-ancestor
56850309|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56850310|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56850311|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
56850312|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56850313|NCT05155540|Plasminogen|plasminogen|mesh-list
56850314|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56850315|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56850316|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56850317|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850318|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56850319|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850320|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
56850321|NCT01222442|AZD-3199|azd-3199|mesh-list
56850322|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56850323|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850324|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56850325|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56850326|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850327|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850328|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850329|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850330|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56850331|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56850332|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56850333|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56850334|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850335|NCT03706222|Grazoprevir|grazoprevir|mesh-list
56850336|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56850337|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
56850338|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850339|NCT01222676|Gemcitabine|gemcitabine|mesh-list
56850340|NCT01222676|Sorafenib|sorafenib|mesh-list
56850341|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56850342|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850343|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56850344|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
56850345|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850346|NCT01222676|Antiviral Agents|antiviral agents|mesh-ancestor
56850347|NCT01222676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561173|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
56850348|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850349|NCT01222676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850350|NCT01222676|Immunologic Factors|immunologic factors|mesh-ancestor
56850351|NCT01222676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850352|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56850353|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56850354|NCT05681728|Paclitaxel|paclitaxel|mesh-list
56850355|NCT05681728|Cyclophosphamide|cyclophosphamide|mesh-list
56850356|NCT05681728|Pembrolizumab|pembrolizumab|mesh-list
56850357|NCT05681728|Epirubicin|epirubicin|mesh-list
56850358|NCT05681728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56850359|NCT05681728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850360|NCT05681728|Tubulin Modulators|tubulin modulators|mesh-ancestor
56850361|NCT05681728|Antimitotic Agents|antimitotic agents|mesh-ancestor
56850362|NCT05681728|Mitosis Modulators|mitosis modulators|mesh-ancestor
56850363|NCT05681728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850364|NCT05681728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850365|NCT05681728|Immunologic Factors|immunologic factors|mesh-ancestor
56850366|NCT05681728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850367|NCT05681728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850368|NCT05681728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56850369|NCT05681728|Alkylating Agents|alkylating agents|mesh-ancestor
56850370|NCT05681728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56364819|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
56850372|NCT05681728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56850373|NCT05681728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56850374|NCT05681728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56850375|NCT05681728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850376|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
56850378|NCT05535166|Methotrexate|methotrexate|mesh-list
56850379|NCT05535166|Etoposide|etoposide|mesh-list
56850380|NCT05535166|Vincristine|vincristine|mesh-list
56850381|NCT05535166|Topotecan|topotecan|mesh-list
56850382|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850383|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
56850384|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850385|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850386|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56850387|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
56850388|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850389|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850390|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56850391|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56850392|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
56850393|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56850394|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56850395|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
56850396|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
56850397|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850398|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56850399|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56850400|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56850401|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56850402|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56850403|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
56850404|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
56850405|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
56850406|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56850407|NCT03931928|Tamoxifen|tamoxifen|mesh-list
56850408|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56850409|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
56850410|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850411|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850412|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56850413|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850414|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56850415|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56850416|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56850417|NCT05681572|Midazolam|midazolam|mesh-list
56850418|NCT05681572|Dexmedetomidine|dexmedetomidine|mesh-list
56850419|NCT05681572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56850420|NCT05681572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561247|NCT04221256|Citalopram|citalopram|mesh-list
56850421|NCT05681572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850422|NCT05681572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56850423|NCT05681572|Analgesics|analgesics|mesh-ancestor
56850424|NCT05681572|Sensory System Agents|sensory system agents|mesh-ancestor
56850425|NCT05681572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850426|NCT05681572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56850427|NCT05681572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56850428|NCT05681572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56850429|NCT05681572|Adrenergic Agents|adrenergic agents|mesh-ancestor
56850430|NCT05681572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850431|NCT05681572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850432|NCT05681572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56850433|NCT05681572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56850434|NCT05681572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56850435|NCT05681572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56850436|NCT05681572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56850437|NCT05681572|Anesthetics, General|anesthetics, general|mesh-ancestor
56850438|NCT05681572|Anesthetics|anesthetics|mesh-ancestor
56850439|NCT05681572|GABA Modulators|gaba modulators|mesh-ancestor
56850440|NCT05681572|GABA Agents|gaba agents|mesh-ancestor
56850441|NCT01220102|Adapalene|adapalene|mesh-list
56850442|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56850443|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
56850444|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56850446|NCT01220102|Analgesics|analgesics|mesh-ancestor
56850447|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
56850448|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850449|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850450|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56850451|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850452|NCT05133310|Simvastatin|simvastatin|mesh-list
56850453|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56850454|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56850455|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
56850456|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850457|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56850458|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56850459|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850460|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56850461|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56850462|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850463|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850464|NCT01222910|Valacyclovir|valacyclovir|mesh-list
56850465|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
56850466|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850467|NCT04533568|Ibuprofen|ibuprofen|mesh-list
56850468|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56850469|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56850470|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56850471|NCT04533568|Analgesics|analgesics|mesh-ancestor
56850472|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
56850473|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850474|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850475|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56850476|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850477|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56850478|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850479|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850480|NCT03932864|Plerixafor|plerixafor|mesh-list
56850481|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56850482|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56850483|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
56850484|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850485|NCT05268562|Ketamine|ketamine|mesh-list
56850486|NCT05268562|Propofol|propofol|mesh-list
56850487|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56850488|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850489|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850490|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56850491|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
56850492|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
56850493|NCT05268562|Analgesics|analgesics|mesh-ancestor
56850494|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
56850495|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850496|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56850497|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56850498|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56850499|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850500|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850501|NCT05245552|Vaccines|vaccines|mesh-list
56850502|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
56850503|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850504|NCT01312324|Docetaxel|docetaxel|mesh-list
56850505|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850506|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
56850507|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
56850508|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
56850509|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850510|NCT05482516|Bevacizumab|bevacizumab|mesh-list
56850511|NCT05482516|Atezolizumab|atezolizumab|mesh-list
56850512|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56850513|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850514|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56850515|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56850516|NCT05482516|Growth Substances|growth substances|mesh-ancestor
56850517|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850519|NCT01127594|Temozolomide|temozolomide|mesh-list
56850520|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56850521|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
56850522|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850523|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850524|NCT01127672|Betamethasone|betamethasone|mesh-list
56850525|NCT01127672|Lidocaine|lidocaine|mesh-list
56850526|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56850527|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
56850528|NCT01127672|Hormones|hormones|mesh-ancestor
56850529|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850530|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850531|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56850532|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
56850533|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
56850534|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
56850535|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850536|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
56850537|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850538|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56850539|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56850540|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56850541|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56850542|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850543|NCT01220258|Azithromycin|azithromycin|mesh-list
56850544|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56850545|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56850546|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56850547|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850548|NCT01223534|Isoniazid|isoniazid|mesh-list
56850549|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
56850550|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56850551|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850552|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56850553|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56850554|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
56850555|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850556|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56850557|NCT01223612|Ranibizumab|ranibizumab|mesh-list
56850558|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56850559|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56850560|NCT01223612|Growth Substances|growth substances|mesh-ancestor
56850561|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850562|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
56850563|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850564|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56850565|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56850566|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850567|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850568|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
56850569|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850570|NCT02946580|Naloxegol|naloxegol|mesh-list
56561398|NCT00942357|Paclitaxel|paclitaxel|mesh-list
56850571|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56850572|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850573|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
56850574|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850575|NCT01223690|Clarithromycin|clarithromycin|mesh-list
56850576|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56850577|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850578|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56850579|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850580|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850581|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56850582|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56850583|NCT05381350|Vaccines|vaccines|mesh-list
56850584|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
56850585|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850586|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
56850587|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
56850588|NCT01223768|Vitamins|vitamins|mesh-ancestor
56850589|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
56850590|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850592|NCT01126112|Panitumumab|panitumumab|mesh-list
56850593|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56850594|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850595|NCT05024032|Tirzepatide|tirzepatide|mesh-list
56850596|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56850597|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850598|NCT05024032|Incretins|incretins|mesh-ancestor
56850599|NCT05024032|Hormones|hormones|mesh-ancestor
56850600|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850601|NCT04724668|Melatonin|melatonin|mesh-list
56850602|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
56850603|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850604|NCT04724668|Protective Agents|protective agents|mesh-ancestor
56850605|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850606|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850607|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
56850608|NCT01123538|Progesterone|progesterone|mesh-list
56850609|NCT01123538|Progestins|progestins|mesh-ancestor
56850610|NCT01123538|Hormones|hormones|mesh-ancestor
56850611|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850612|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850613|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
56850614|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
56850615|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56850616|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56850617|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56850618|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
56850619|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56850620|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56850621|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56850622|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
56850623|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56850624|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850625|NCT04524910|Aflibercept|aflibercept|mesh-list
56850626|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56850627|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56850628|NCT04524910|Growth Substances|growth substances|mesh-ancestor
56850629|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850630|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
56850631|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850632|NCT01220570|Sirolimus|sirolimus|mesh-list
56850633|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56850634|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56850635|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850636|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56850637|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850638|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
56850639|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850640|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
56850641|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850642|NCT04682860|Scopolamine|scopolamine|mesh-list
56850643|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56850644|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56850645|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
56850646|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
56850647|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850648|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850649|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56850650|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
56850651|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56850652|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
56850653|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850654|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850655|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56850656|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
56850657|NCT01127906|Oxycodone|oxycodone|mesh-list
56850658|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56850659|NCT01127906|Narcotics|narcotics|mesh-ancestor
56850660|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850661|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850662|NCT01127906|Analgesics|analgesics|mesh-ancestor
56850663|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
56365114|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850664|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850665|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56850666|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
56850667|NCT01127984|Coagulants|coagulants|mesh-ancestor
56850668|NCT01220648|Interferons|interferons|mesh-list
56850669|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
56850670|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850671|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
56850672|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850673|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
56850674|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850675|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56850676|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56850677|NCT01218386|Estradiol|estradiol|mesh-list
56850678|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56850679|NCT01218386|Estrogens|estrogens|mesh-ancestor
56850680|NCT01218386|Hormones|hormones|mesh-ancestor
56850681|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850682|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850683|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56850684|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
56850685|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56850686|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56850687|NCT03933098|Vaccines|vaccines|mesh-list
56850688|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
56850689|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850690|NCT05111314|Edetic Acid|edetic acid|mesh-list
56850691|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56850692|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
56850693|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
56850694|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850695|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
56850696|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56850697|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56850698|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
56850699|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56850700|NCT01224392|Capecitabine|capecitabine|mesh-list
56850701|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56850702|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
56850703|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850704|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850705|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
56850706|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56850707|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850708|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850709|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56850710|NCT01224470|Analgesics|analgesics|mesh-ancestor
56850711|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
56850712|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850713|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56850714|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56850715|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56850716|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
56850717|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850718|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850719|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56850720|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56850721|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
56850722|NCT03740516|Apremilast|apremilast|mesh-list
56850723|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56850724|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56850725|NCT03740516|Analgesics|analgesics|mesh-ancestor
56850726|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
56850727|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850728|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850729|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56850730|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850731|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56850732|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56850733|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850734|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850735|NCT03933956|Empagliflozin|empagliflozin|mesh-list
56894848|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850736|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56850737|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850738|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56850740|NCT01218620|Tolbutamide|tolbutamide|mesh-list
56850741|NCT01218620|Rifampin|rifampin|mesh-list
56850742|NCT01218620|Ketoconazole|ketoconazole|mesh-list
56850743|NCT01218620|Midazolam|midazolam|mesh-list
56850744|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
56850745|NCT01218620|Omeprazole|omeprazole|mesh-list
56850746|NCT01218620|R04929097|r04929097|mesh-list
56850747|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56850748|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56850749|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850750|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850751|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56850752|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56850753|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56850754|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56850755|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
56850756|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
56850757|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
56850758|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
56850759|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850760|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850761|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56850762|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56850763|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56850764|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850765|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56850766|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
56850767|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56850768|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850769|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
56850770|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56850771|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56850772|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56850773|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56850774|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56850775|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56850776|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56850777|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
56850778|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56850779|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56850780|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56850781|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
56850782|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850783|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56850784|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
56850785|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
56850786|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56850787|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56850788|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56850789|NCT00323297|Bosentan|bosentan|mesh-list
56850790|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
56850791|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850792|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
56850793|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56850794|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56850795|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850796|NCT00323297|Urological Agents|urological agents|mesh-ancestor
56850797|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56850798|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56850799|NCT01218698|Losartan|losartan|mesh-list
56850800|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56850801|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56850802|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56850803|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56850804|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850805|NCT01224860|Losartan|losartan|mesh-list
56850806|NCT01224860|Telmisartan|telmisartan|mesh-list
56850807|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56850808|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56850809|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56850810|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56904613|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56850811|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850813|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
56850814|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56850815|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
56850816|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850817|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850818|NCT00323063|Antiviral Agents|antiviral agents|mesh-ancestor
56850819|NCT00323063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850820|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850821|NCT00323063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850822|NCT00323063|Immunologic Factors|immunologic factors|mesh-ancestor
56850823|NCT00323063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850824|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56850825|NCT03983057|Antibodies|antibodies|mesh-list
56850826|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56850827|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
56850828|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850829|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
56850830|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
56850831|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56850832|NCT01328990|Amodiaquine|amodiaquine|mesh-list
56850833|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
56850834|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56850835|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56850836|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850837|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56850838|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850839|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850840|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56850841|NCT01328990|Renal Agents|renal agents|mesh-ancestor
56850842|NCT01225094|Curcumin|curcumin|mesh-list
56850843|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56850844|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56850845|NCT01225094|Analgesics|analgesics|mesh-ancestor
56850846|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
56850847|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850848|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850849|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56850850|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850851|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850852|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850853|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850854|NCT03930212|Progesterone|progesterone|mesh-list
56850855|NCT03930212|Progestins|progestins|mesh-ancestor
56850856|NCT03930212|Hormones|hormones|mesh-ancestor
56850857|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850858|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850859|NCT00322049|Vaccines|vaccines|mesh-list
56850860|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
56850861|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850862|NCT01124240|Temozolomide|temozolomide|mesh-list
56850863|NCT01124240|Procarbazine|procarbazine|mesh-list
56850864|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56850865|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
56850866|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850867|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850868|NCT01124318|Lactulose|lactulose|mesh-list
56850869|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56850870|NCT01221116|Simendan|simendan|mesh-list
56850871|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56850872|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
56850873|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56850874|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56850875|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850876|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850877|NCT01221116|Protective Agents|protective agents|mesh-ancestor
56850878|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850879|NCT03929744|Midazolam|midazolam|mesh-list
56850880|NCT03929744|Atorvastatin|atorvastatin|mesh-list
56850881|NCT03929744|Simvastatin|simvastatin|mesh-list
56850882|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56850883|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56850884|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850885|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850886|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56850887|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56850888|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56850889|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56850890|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
56850891|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
56850892|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
56850893|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
56850894|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850895|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850896|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56850897|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56850898|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
56850899|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56850900|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56850901|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850902|NCT01225406|Tenofovir|tenofovir|mesh-list
56850903|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
56850904|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850905|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56850906|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56850907|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850908|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850909|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56850910|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56850911|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
56850912|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850913|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56850914|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850915|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850916|NCT01225484|Ropivacaine|ropivacaine|mesh-list
56850917|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
56850918|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
56850919|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56850920|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850921|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
56850922|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850923|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56850924|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56850925|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56850926|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56850927|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850928|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
56850929|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56850930|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850931|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56850932|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850933|NCT01128998|Sorafenib|sorafenib|mesh-list
56850934|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850935|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56850936|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850937|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850938|NCT00321893|Budesonide|budesonide|mesh-list
56850939|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56850940|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56850941|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
56850942|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850943|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850944|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56850945|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
56850947|NCT00321893|Hormones|hormones|mesh-ancestor
56850948|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850949|NCT01225874|Cytarabine|cytarabine|mesh-list
56850950|NCT01225874|Dexamethasone|dexamethasone|mesh-list
56850951|NCT01225874|Prednisone|prednisone|mesh-list
56850952|NCT01225874|Methotrexate|methotrexate|mesh-list
56850953|NCT01225874|Vincristine|vincristine|mesh-list
56850954|NCT01225874|Daunorubicin|daunorubicin|mesh-list
56850955|NCT01225874|Asparaginase|asparaginase|mesh-list
56850956|NCT01225874|Pegaspargase|pegaspargase|mesh-list
56850957|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56850958|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
56850959|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
56850960|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56850961|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850962|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56850964|NCT01225874|Hormones|hormones|mesh-ancestor
56850965|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56850966|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56850967|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850968|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56850969|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
56850970|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56850971|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56850972|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
56850973|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850974|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
56850975|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850976|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56850977|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56850978|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
56850979|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56850980|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56850981|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
56850982|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56850983|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56850984|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
56850985|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
56850986|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
56850987|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56850988|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56850989|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56850990|NCT03928340|Metformin|metformin|mesh-list
56850991|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56850992|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56850993|NCT00371345|Dasatinib|dasatinib|mesh-list
56850994|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56850995|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56850996|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56850997|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56850998|NCT01226186|Morphine|morphine|mesh-list
56850999|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56851000|NCT01226186|Narcotics|narcotics|mesh-ancestor
56851001|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851002|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851003|NCT01226186|Analgesics|analgesics|mesh-ancestor
56851004|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
56851005|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851006|NCT01228214|Aspirin|aspirin|mesh-list
56851007|NCT01228214|Amiloride|amiloride|mesh-list
56851008|NCT01228214|Clopidogrel|clopidogrel|mesh-list
56851009|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56851010|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56851011|NCT01228214|Analgesics|analgesics|mesh-ancestor
56851012|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
56851013|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851014|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851015|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851016|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851017|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56851018|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56851019|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851020|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56851021|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56851022|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851024|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56851025|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56851026|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56851027|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
56851028|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851029|NCT01228214|Diuretics|diuretics|mesh-ancestor
56851030|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
56851031|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56851032|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56851033|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56851034|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56851035|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56851036|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
56851038|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56851039|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851040|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56851041|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851042|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851044|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56851045|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
56851046|NCT03740438|Chrysarobin|chrysarobin|mesh-list
56851047|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56851048|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56851049|NCT03740438|Analgesics|analgesics|mesh-ancestor
56851050|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
56851051|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851052|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851053|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851054|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851055|NCT01129154|Panitumumab|panitumumab|mesh-list
56851056|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56851057|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851058|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56851059|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
56851060|NCT02309645|Coagulants|coagulants|mesh-ancestor
56851061|NCT01047995|Ritonavir|ritonavir|mesh-list
56851062|NCT01047995|Darunavir|darunavir|mesh-list
56851063|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
56851064|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56851065|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56851066|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
56851067|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851068|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851069|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56851070|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56851071|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
56851072|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851073|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56851074|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56851075|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56851076|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56851077|NCT01129310|Capecitabine|capecitabine|mesh-list
56851078|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
56851079|NCT01129310|Irinotecan|irinotecan|mesh-list
56851080|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56851081|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
56851082|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851083|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851084|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56851085|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56851086|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851087|NCT01129388|Omeprazole|omeprazole|mesh-list
56851088|NCT01129388|Clopidogrel|clopidogrel|mesh-list
56851089|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56851090|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56851091|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56851092|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56851093|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
56851094|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851095|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851096|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851097|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56851098|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851099|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56851100|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851101|NCT01228292|Heparin|heparin|mesh-list
56851102|NCT01228292|Calcium heparin|calcium heparin|mesh-list
56851103|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
56851104|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56851105|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56851106|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851107|NCT03924596|Boswellic acid|boswellic acid|mesh-list
56851108|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56851109|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56851110|NCT03924596|Analgesics|analgesics|mesh-ancestor
56851111|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
56851113|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851114|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851115|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851116|NCT00320801|Buprenorphine|buprenorphine|mesh-list
56851117|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56851118|NCT00320801|Narcotics|narcotics|mesh-ancestor
56851119|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851120|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851121|NCT00320801|Analgesics|analgesics|mesh-ancestor
56851122|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
56851123|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851124|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56851125|NCT01127204|Lamivudine|lamivudine|mesh-list
56851126|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56851127|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56851128|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851129|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851130|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
56851131|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851132|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56851133|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56851134|NCT01228370|Silodosin|silodosin|mesh-list
56851135|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56851136|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56851137|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56851138|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
56851139|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851140|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851141|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851142|NCT01228370|Urological Agents|urological agents|mesh-ancestor
56851143|NCT01221740|Milnacipran|milnacipran|mesh-list
56851144|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
56851145|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56851146|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56851147|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56851148|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851149|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851150|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851151|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56851152|NCT01221740|Analgesics|analgesics|mesh-ancestor
56851153|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
56851154|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851155|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
56851156|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56851157|NCT00320489|Olanzapine|olanzapine|mesh-list
56851158|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
56851159|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
56851160|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851161|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851162|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851163|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56851164|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56851165|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851166|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56851167|NCT00320489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56851168|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56851169|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56851170|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851171|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851172|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
56851173|NCT01127282|Vitamins|vitamins|mesh-list
56851174|NCT01127282|Vitamin A|vitamin a|mesh-list
56851175|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
56851176|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851177|NCT01127360|Bevacizumab|bevacizumab|mesh-list
56851178|NCT01127360|Ranibizumab|ranibizumab|mesh-list
56851179|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56851180|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851181|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56851182|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56851183|NCT01127360|Growth Substances|growth substances|mesh-ancestor
56851184|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851185|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
56851186|NCT01228604|Methylphenidate|methylphenidate|mesh-list
56851187|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56851188|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851189|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56851190|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56851191|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56851192|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851193|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
56851194|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851195|NCT01228682|Tolvaptan|tolvaptan|mesh-list
56851196|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56851197|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851198|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
56851199|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851200|NCT01221896|Choline|choline|mesh-list
56851201|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
56851202|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56851203|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
56851204|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851205|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851206|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56851207|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
56851208|NCT03923114|Exenatide|exenatide|mesh-list
56851209|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56851210|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851211|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56851212|NCT03923114|Incretins|incretins|mesh-ancestor
56851213|NCT03923114|Hormones|hormones|mesh-ancestor
56851214|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56851215|NCT00320411|Lapatinib|lapatinib|mesh-list
56851216|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851217|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56851218|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851219|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851220|NCT01132040|Primidone|primidone|mesh-list
56851221|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
56851222|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
56851223|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
56851224|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851225|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851226|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851227|NCT01226966|Liraglutide|liraglutide|mesh-list
56851228|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56851229|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851230|NCT01226966|Incretins|incretins|mesh-ancestor
56851231|NCT01226966|Hormones|hormones|mesh-ancestor
56851232|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56851233|NCT03923036|Cetuximab|cetuximab|mesh-list
56851234|NCT03923036|Panitumumab|panitumumab|mesh-list
56851235|NCT03923036|Aflibercept|aflibercept|mesh-list
56851236|NCT03923036|Capecitabine|capecitabine|mesh-list
56851237|NCT03923036|Irinotecan|irinotecan|mesh-list
56851238|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
56851239|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56851240|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56851241|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56851242|NCT03923036|Growth Substances|growth substances|mesh-ancestor
56851243|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851244|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
56562099|NCT04216888|Ketamine|ketamine|mesh-list
56851245|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56851247|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851248|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56851249|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56851250|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851251|NCT01129856|Dexamethasone|dexamethasone|mesh-list
56851252|NCT01129856|Citric Acid|citric acid|mesh-list
56851253|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
56851254|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56851255|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56851256|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56851257|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851258|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
56851259|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
56851260|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851262|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851263|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
56851264|NCT01129856|Hormones|hormones|mesh-ancestor
56851265|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56851266|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56851267|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851268|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
56851269|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56851270|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
56851271|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
56851272|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851273|NCT01129934|Promethazine|promethazine|mesh-list
56851274|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
56851275|NCT01129934|Morphine|morphine|mesh-list
56851276|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56851277|NCT01129934|Narcotics|narcotics|mesh-ancestor
56851278|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851279|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851280|NCT01129934|Analgesics|analgesics|mesh-ancestor
56851281|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
56851282|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851283|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
56851284|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
56851285|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56851286|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
56851287|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
56851288|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851289|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851290|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56851291|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56851292|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56851293|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
56851294|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
56851295|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
56851296|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
56851297|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851298|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
56851299|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56851300|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
56851301|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851302|NCT01131572|Expectorants|expectorants|mesh-ancestor
56851303|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
56851304|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56851305|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
56851306|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851307|NCT01131572|Protective Agents|protective agents|mesh-ancestor
56851308|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851309|NCT01131572|Antidotes|antidotes|mesh-ancestor
56851310|NCT01132196|Valproic Acid|valproic acid|mesh-list
56851311|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
56851312|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851313|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851314|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
56851315|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851316|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851317|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
56851318|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56851319|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851320|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56851321|NCT01228994|Baclofen|baclofen|mesh-list
56851322|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56851323|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851324|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56851325|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851326|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56851327|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
56851328|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
56851329|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851330|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851331|NCT03927170|Metformin|metformin|mesh-list
56851332|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56851333|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56851334|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851335|NCT03927170|Incretins|incretins|mesh-ancestor
56851336|NCT03927170|Hormones|hormones|mesh-ancestor
56851337|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56851338|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56851340|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851341|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851342|NCT01227200|Tramadol|tramadol|mesh-list
56851343|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56851344|NCT01227200|Narcotics|narcotics|mesh-ancestor
56851345|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851346|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851347|NCT01227200|Analgesics|analgesics|mesh-ancestor
56851348|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
56851349|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851350|NCT01227356|Interferons|interferons|mesh-list
56851351|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
56851352|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851353|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
56851354|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851355|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56851356|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851357|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851358|NCT01132352|Levetiracetam|levetiracetam|mesh-list
56851359|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
56851360|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
56851361|NCT01131728|Naproxen|naproxen|mesh-list
56851362|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
56851363|NCT01131728|Ephedrine|ephedrine|mesh-list
56851364|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56851365|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56851366|NCT01131728|Analgesics|analgesics|mesh-ancestor
56851367|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
56851368|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851369|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851370|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851371|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851372|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
56851373|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56851374|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851375|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851376|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56851377|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
56851378|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56851379|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
56851380|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
56851381|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56851382|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56851383|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
56851384|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
56851385|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851386|NCT01132586|Cytarabine|cytarabine|mesh-list
56851387|NCT01132586|Lenalidomide|lenalidomide|mesh-list
56851388|NCT01132586|Idarubicin|idarubicin|mesh-list
56851389|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56851390|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
56851391|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851392|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851393|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
56851394|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851395|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56851396|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
56851397|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851398|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56851399|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56851400|NCT01132586|Growth Substances|growth substances|mesh-ancestor
56851401|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
56851402|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56851403|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56851404|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56851405|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851406|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
56851407|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56851408|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851409|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851410|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
56851411|NCT01227590|Ritonavir|ritonavir|mesh-list
56851413|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56851414|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56851415|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
56851416|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851417|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851418|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56851419|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56851420|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
56851421|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851422|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56851423|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56851424|NCT03927248|Nivolumab|nivolumab|mesh-list
56851425|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56851426|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851427|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56851428|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851429|NCT03926780|Warfarin|warfarin|mesh-list
56851430|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
56851431|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
56851432|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56851433|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
56851434|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56851435|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
56851436|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851437|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851438|NCT03919448|Bevacizumab|bevacizumab|mesh-list
56851439|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56851440|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851441|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56851442|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56851443|NCT03919448|Growth Substances|growth substances|mesh-ancestor
56851444|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851445|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
56851446|NCT03926936|Fulvestrant|fulvestrant|mesh-list
56851447|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56851448|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851449|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56851450|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56851451|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
56851452|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56851453|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851454|NCT03920618|Tenofovir|tenofovir|mesh-list
56851455|NCT03920618|Entecavir|entecavir|mesh-list
56851456|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
56851457|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851458|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56851459|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56851460|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851461|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851462|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56851463|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56851464|NCT01131806|Fluticasone|fluticasone|mesh-list
56851465|NCT01131806|Xhance|xhance|mesh-list
56851466|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56851467|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56851468|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851469|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56851470|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
56851471|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920212|NCT01122121|Flutamide|flutamide|mesh-list
56851472|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851473|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56851474|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
56851475|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
56851476|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56851477|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56851478|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56851479|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56851480|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
56851481|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851482|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903589|NCT04493931|Midazolam|midazolam|mesh-list
56851483|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
56904614|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851485|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56851486|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
56851487|NCT01229930|Paclitaxel|paclitaxel|mesh-list
56851488|NCT01229930|Carboplatin|carboplatin|mesh-list
56851489|NCT01229930|Cediranib|cediranib|mesh-list
56851490|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56851491|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851492|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
56851493|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
56851494|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
56851495|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851496|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851497|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56851498|NCT03805100|Ranibizumab|ranibizumab|mesh-list
56851499|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56851500|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56851501|NCT03805100|Growth Substances|growth substances|mesh-ancestor
56851502|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851503|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
56851504|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851505|NCT03920150|Vitamin D|vitamin d|mesh-list
56851506|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
56851507|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
56851508|NCT03920150|Vitamins|vitamins|mesh-list
56851509|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
56851510|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851511|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56851512|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56851513|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
56851514|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56851515|NCT01130324|Telavancin|telavancin|mesh-list
56851516|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56851517|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851518|NCT01229774|Diclofenac|diclofenac|mesh-list
56851519|NCT01229774|Etoricoxib|etoricoxib|mesh-list
56851520|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56851521|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56851522|NCT01229774|Analgesics|analgesics|mesh-ancestor
56851523|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
56851524|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851525|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851526|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851527|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851528|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56851529|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851530|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851531|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56851532|NCT03918590|Nepafenac|nepafenac|mesh-list
56851533|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56851534|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56851535|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56851536|NCT03918590|Analgesics|analgesics|mesh-ancestor
56851537|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
56851538|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851539|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851540|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851541|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851542|NCT03918590|Laxatives|laxatives|mesh-ancestor
56851543|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851544|NCT00320255|Apixaban|apixaban|mesh-list
56851545|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56851546|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
56562378|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56851548|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
56851549|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851550|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851551|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
56851552|NCT01231802|Leucovorin|leucovorin|mesh-list
56851553|NCT01231802|Fluorouracil|fluorouracil|mesh-list
56851554|NCT01231802|Capecitabine|capecitabine|mesh-list
56851555|NCT01231802|Eniluracil|eniluracil|mesh-list
56851556|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
56851557|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851558|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56851559|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851560|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56851561|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
56851562|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851563|NCT01231802|Antidotes|antidotes|mesh-ancestor
56851564|NCT01231802|Protective Agents|protective agents|mesh-ancestor
56851565|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
56851566|NCT01231802|Vitamins|vitamins|mesh-ancestor
56851567|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
56851568|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851569|NCT01329614|Nicotine|nicotine|mesh-list
56851570|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56851571|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
56851572|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851573|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851574|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56851575|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56851576|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
56851577|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851578|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851579|NCT01231880|Piperaquine|piperaquine|mesh-list
56851580|NCT01231880|Artenimol|artenimol|mesh-list
56851581|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
56851582|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56851583|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56851584|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851585|NCT01232036|Metformin|metformin|mesh-list
56851586|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56851587|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851588|NCT01130636|Oseltamivir|oseltamivir|mesh-list
56851589|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
56851590|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851591|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851592|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851593|NCT03926156|Warfarin|warfarin|mesh-list
56851594|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
56851595|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
56851596|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56851597|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
56851598|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56851599|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
56851600|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851601|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851602|NCT01134536|Tapentadol|tapentadol|mesh-list
56851603|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56851604|NCT01134536|Narcotics|narcotics|mesh-ancestor
56851605|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851606|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851607|NCT01134536|Analgesics|analgesics|mesh-ancestor
56851608|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
56851609|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851610|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56851611|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56851612|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56851613|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851614|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
56851615|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851616|NCT01134692|Norfloxacin|norfloxacin|mesh-list
56851617|NCT01134692|Propranolol|propranolol|mesh-list
56851618|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56851619|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56562467|NCT00703651|Vaccines|vaccines|mesh-list
56851620|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
56851621|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851622|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851623|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851624|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56851625|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56851626|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
56851627|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56851628|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851629|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56851630|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56851631|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851632|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851633|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56851634|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56851635|NCT01134848|Morphine|morphine|mesh-list
56851636|NCT01134848|Secretin|secretin|mesh-list
56851637|NCT01134848|Neostigmine|neostigmine|mesh-list
56851638|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56851640|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851642|NCT01134848|Analgesics|analgesics|mesh-ancestor
56851643|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
56851644|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851645|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56851646|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851647|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851648|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
56851649|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851650|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56851651|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
56851652|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851653|NCT01134848|Hormones|hormones|mesh-ancestor
56851654|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56851655|NCT03926000|Pregabalin|pregabalin|mesh-list
56851656|NCT03926000|Analgesics|analgesics|mesh-ancestor
56851657|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
56851658|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851659|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851660|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
56851661|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56851662|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56851663|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851664|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56851665|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56851666|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56851667|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851668|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56851669|NCT01134926|Misoprostol|misoprostol|mesh-list
56851670|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56851671|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
56851672|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56851673|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851674|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56851675|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851676|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
56851677|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
56851678|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56851679|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56851680|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851681|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
56851682|NCT01228136|Coagulants|coagulants|mesh-ancestor
56851683|NCT03140176|Sunitinib|sunitinib|mesh-list
56851684|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851685|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56851686|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56851687|NCT03140176|Growth Substances|growth substances|mesh-ancestor
56851688|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851689|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
56851690|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56851691|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851692|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851693|NCT04259164|Mometasone Furoate|mometasone furoate|mesh-list
56851694|NCT04259164|Glycopyrrolate|glycopyrrolate|mesh-list
56851695|NCT04259164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851696|NCT04259164|Dermatologic Agents|dermatologic agents|mesh-ancestor
56851697|NCT04259164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56851698|NCT04259164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56851699|NCT04259164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56851700|NCT04259164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56851701|NCT04259164|Cholinergic Agents|cholinergic agents|mesh-ancestor
56851702|NCT04259164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851703|NCT04259164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851704|NCT04259164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851705|NCT01230476|Cetuximab|cetuximab|mesh-list
56851706|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56851707|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851708|NCT01135472|Esomeprazole|esomeprazole|mesh-list
56851709|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56851710|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851711|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56851716|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56851717|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851718|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56851719|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56851720|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
56851721|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851722|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56851723|NCT01135550|Dexamethasone|dexamethasone|mesh-list
56851724|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
56851725|NCT01135550|BB 1101|bb 1101|mesh-list
56851726|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851727|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
56851728|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
56851729|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851730|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851731|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851732|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
56851733|NCT01135550|Hormones|hormones|mesh-ancestor
56851734|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56851735|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56851736|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851737|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
56851738|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851739|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851740|NCT05401370|Methylene Blue|methylene blue|mesh-list
56851741|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851742|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851743|NCT01131026|Amoxicillin|amoxicillin|mesh-list
56851744|NCT01131026|Levofloxacin|levofloxacin|mesh-list
56851745|NCT01131026|Ofloxacin|ofloxacin|mesh-list
56851746|NCT01131026|Lansoprazole|lansoprazole|mesh-list
56851747|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
56851748|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56851749|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851750|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56851751|NCT01131026|Renal Agents|renal agents|mesh-ancestor
56851752|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56851753|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56851754|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851755|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851756|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851757|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56851758|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56851759|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56851760|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851761|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56851762|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56851763|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56851764|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851765|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
56851766|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
56851767|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56851768|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851769|NCT01133366|Warfarin|warfarin|mesh-list
56851770|NCT01133366|Mipomersen|mipomersen|mesh-list
56851771|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
56851772|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56851773|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56851774|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
56851775|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851776|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56851777|NCT01232270|Propofol|propofol|mesh-list
56851778|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56851779|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851780|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851781|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56851782|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
56851783|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
56851785|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851786|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56851787|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851788|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851789|NCT01233206|Metformin|metformin|mesh-list
56851790|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56851791|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851792|NCT00369941|Tenofovir|tenofovir|mesh-list
56851793|NCT00369941|Emtricitabine|emtricitabine|mesh-list
56851794|NCT00369941|Efavirenz|efavirenz|mesh-list
56851795|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
56851796|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56851797|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
56851798|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851799|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56851800|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56851801|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851802|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851803|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56851804|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56851805|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56851806|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56851807|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56851808|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56851809|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56851810|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56851811|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56851812|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56851813|NCT01133444|Finasteride|finasteride|mesh-list
56851814|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56851815|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56851816|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851817|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851818|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
56851819|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56851820|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851821|NCT01133444|Urological Agents|urological agents|mesh-ancestor
56851822|NCT01137656|Acetylcholine|acetylcholine|mesh-list
56851823|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
56851824|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56851825|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
56851826|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851827|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851828|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851829|NCT00369785|Donepezil|donepezil|mesh-list
56851830|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56851831|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851832|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851833|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
56851834|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851835|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851836|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
56851837|NCT01136252|Adalimumab|adalimumab|mesh-list
56851838|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56851839|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851840|NCT05597462|Minocycline|minocycline|mesh-list
56851841|NCT05597462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56851842|NCT05597462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851843|NCT00369707|Rituximab|rituximab|mesh-list
56851844|NCT00369707|Bortezomib|bortezomib|mesh-list
56851845|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56851846|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851847|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
56851848|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851849|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851851|NCT04973254|Cabotegravir|cabotegravir|mesh-list
56851852|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56851853|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56851854|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851855|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851856|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
56851857|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851864|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56851865|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56851866|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851867|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851868|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851869|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56851870|NCT04749628|Cannabidiol|cannabidiol|mesh-list
56851871|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
56851872|NCT01233362|Vaccines|vaccines|mesh-list
56851873|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
56851874|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851875|NCT01136642|Nicotine|nicotine|mesh-list
56851876|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56851877|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
56851878|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851879|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851880|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56851881|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56851882|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
56851883|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851884|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851885|NCT03917420|Tenofovir|tenofovir|mesh-list
56851886|NCT03917420|Emtricitabine|emtricitabine|mesh-list
56851887|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56851888|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
56851889|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851890|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56851891|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56851892|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851893|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851894|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56851895|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56851896|NCT00369629|Gemcitabine|gemcitabine|mesh-list
56851897|NCT00369629|Pemetrexed|pemetrexed|mesh-list
56851898|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56851899|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
56851900|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851901|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851902|NCT00369629|Antiviral Agents|antiviral agents|mesh-ancestor
56851903|NCT00369629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851904|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851905|NCT00369629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56851906|NCT00369629|Immunologic Factors|immunologic factors|mesh-ancestor
56851907|NCT00369629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851908|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56851909|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56851910|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
56851911|NCT01133600|Vancomycin|vancomycin|mesh-list
56851912|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56851913|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851919|NCT01133912|Gemcitabine|gemcitabine|mesh-list
56851920|NCT01133912|Paclitaxel|paclitaxel|mesh-list
56851921|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56851922|NCT01133912|Lapatinib|lapatinib|mesh-list
56851923|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56851924|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851925|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
56851926|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
56851927|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
56851928|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851929|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56851930|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
56851931|NCT01133912|Antiviral Agents|antiviral agents|mesh-ancestor
56851932|NCT01133912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851933|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851935|NCT01133912|Immunologic Factors|immunologic factors|mesh-ancestor
56851936|NCT01133912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851937|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56851938|NCT05320094|Sorbitol|sorbitol|mesh-list
56851939|NCT05320094|Charcoal|charcoal|mesh-list
56851940|NCT05320094|Antidotes|antidotes|mesh-ancestor
56851941|NCT05320094|Protective Agents|protective agents|mesh-ancestor
56851942|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851943|NCT05320094|Cathartics|cathartics|mesh-ancestor
56851944|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56851945|NCT01233752|Morphine|morphine|mesh-list
56903600|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
56851946|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56851947|NCT01233752|Narcotics|narcotics|mesh-ancestor
56851948|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851949|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851950|NCT01233752|Analgesics|analgesics|mesh-ancestor
56851951|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
56851952|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851953|NCT01140620|Ketamine|ketamine|mesh-list
56851954|NCT01140620|Risperidone|risperidone|mesh-list
56851955|NCT01140620|Analgesics|analgesics|mesh-ancestor
56851956|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
56851957|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56851958|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851959|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56851960|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56851961|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
56851962|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
56851963|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851964|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56851965|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56851966|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56851967|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851968|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56851969|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
56851970|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56851971|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56851972|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56851973|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56851974|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
56851975|NCT03917186|Sevoflurane|sevoflurane|mesh-list
56851976|NCT03917186|Desflurane|desflurane|mesh-list
56851977|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56851978|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56851979|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
56851980|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
56851981|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56851982|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851983|NCT04713098|Coal Tar|coal tar|mesh-list
56851984|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
56851985|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
56851986|NCT04630730|Gemcitabine|gemcitabine|mesh-list
56851987|NCT04630730|Atezolizumab|atezolizumab|mesh-list
56851988|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
56851989|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56851990|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56851991|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
56851992|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56851993|NCT04630730|Antiviral Agents|antiviral agents|mesh-ancestor
56851994|NCT04630730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56851995|NCT04630730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56851996|NCT04630730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56851997|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
56851998|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56851999|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56852000|NCT01140932|Prednisolone|prednisolone|mesh-list
56852001|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56852003|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56852004|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
56852005|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56852006|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
56852007|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56852008|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
56852009|NCT01140932|Hormones|hormones|mesh-ancestor
56852010|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56852011|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852013|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852014|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
56852015|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
56852016|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852017|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56852018|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56852019|NCT01140932|Protective Agents|protective agents|mesh-ancestor
56852020|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
56852021|NCT01138904|Irinotecan|irinotecan|mesh-list
56852022|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852023|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56903601|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
56852024|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56852025|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852026|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852027|NCT04582448|Insulin|insulin|mesh-list
56852028|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852029|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852030|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
56852031|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852032|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852033|NCT01139138|Irinotecan|irinotecan|mesh-list
56852034|NCT01139138|Everolimus|everolimus|mesh-list
56852035|NCT01139138|Panitumumab|panitumumab|mesh-list
56852036|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56852037|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56852038|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852039|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852040|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852041|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852042|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
56852043|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852044|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852045|NCT04528082|Apremilast|apremilast|mesh-list
56852046|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56852047|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56852048|NCT04528082|Analgesics|analgesics|mesh-ancestor
56852049|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
56852050|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852051|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852052|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56852053|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56852054|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56852055|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56852056|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852057|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852058|NCT01134224|Insulin|insulin|mesh-list
56852059|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56852060|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
56852061|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
56852062|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56852063|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
56852064|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56852065|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
56852066|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852067|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852068|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56852069|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56852070|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852071|NCT04703920|Talazoparib|talazoparib|mesh-list
56852072|NCT04703920|Belinostat|belinostat|mesh-list
56852073|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56852074|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562900|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56852075|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852076|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852077|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56852079|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56852080|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56852081|NCT01231490|Analgesics|analgesics|mesh-ancestor
56852082|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
56852083|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852084|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852087|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
56852088|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56852089|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852090|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852091|NCT01141244|Sirolimus|sirolimus|mesh-list
56852092|NCT01141244|Irinotecan|irinotecan|mesh-list
56852093|NCT01141244|Temozolomide|temozolomide|mesh-list
56852094|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56852095|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56852096|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852097|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852098|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852099|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56852100|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
56852101|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56852102|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852103|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56852104|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
56852105|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852106|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
56852107|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852108|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56852109|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56852110|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56852111|NCT04003636|Gemcitabine|gemcitabine|mesh-list
56852112|NCT04003636|Cisplatin|cisplatin|mesh-list
56852113|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
56852114|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852115|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56852116|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
56852117|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852118|NCT04003636|Antiviral Agents|antiviral agents|mesh-ancestor
56852119|NCT04003636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852120|NCT04003636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852121|NCT04003636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852122|NCT04003636|Immunologic Factors|immunologic factors|mesh-ancestor
56852123|NCT04003636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852124|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852125|NCT01141556|Selenium|selenium|mesh-list
56852126|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
56852127|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852128|NCT01141556|Protective Agents|protective agents|mesh-ancestor
56852129|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852130|NCT01141556|Trace Elements|trace elements|mesh-ancestor
56852131|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
56852132|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56852133|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
56852134|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56852135|NCT03638440|Naloxegol|naloxegol|mesh-list
56852136|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56852137|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852138|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
56852139|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852140|NCT01719640|Insulin|insulin|mesh-list
56852141|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852142|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852143|NCT02439658|Sotalol|sotalol|mesh-list
56852144|NCT02439658|Dofetilide|dofetilide|mesh-list
56852145|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56852146|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56852147|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
56852148|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852149|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852150|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852151|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56852153|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
56852154|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852155|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56852156|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852157|NCT05191394|Antibodies|antibodies|mesh-list
56852158|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
56852159|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852161|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56852162|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56852163|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56852164|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
56852165|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852166|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56852167|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852168|NCT00318461|Metformin|metformin|mesh-list
56852169|NCT00318461|Liraglutide|liraglutide|mesh-list
56852170|NCT00318461|Glimepiride|glimepiride|mesh-list
56852171|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852172|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852173|NCT00318461|Incretins|incretins|mesh-ancestor
56852174|NCT00318461|Hormones|hormones|mesh-ancestor
56852175|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56852176|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56852177|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852178|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
56852179|NCT02243878|Ranibizumab|ranibizumab|mesh-list
56852180|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56852181|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56852182|NCT02243878|Growth Substances|growth substances|mesh-ancestor
56852183|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852184|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
56852185|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852186|NCT04734652|Tenofovir|tenofovir|mesh-list
56852187|NCT04734652|Lamivudine|lamivudine|mesh-list
56852188|NCT04734652|Dolutegravir|dolutegravir|mesh-list
56852189|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
56852190|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852191|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56852192|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56852193|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852194|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852195|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56852196|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56852197|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56852198|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56852199|NCT01142258|Trazodone|trazodone|mesh-list
56852200|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56852201|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56852202|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852203|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852204|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56852205|NCT01142258|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56852206|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56852207|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852208|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852209|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852210|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
56852211|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56852212|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
56852213|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
56852214|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56852215|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852216|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852217|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852218|NCT01139840|Vitamin D|vitamin d|mesh-list
56852219|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
56852220|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
56852221|NCT01139840|Vitamins|vitamins|mesh-list
56852222|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
56852223|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852224|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56852225|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56852227|NCT02945410|Calcium|calcium|mesh-list
56852228|NCT02945410|Vitamins|vitamins|mesh-ancestor
56852229|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
56852230|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852231|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56852232|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56852233|NCT03727724|Cetuximab|cetuximab|mesh-list
56852234|NCT03727724|Afatinib|afatinib|mesh-list
56852235|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852237|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56852238|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852239|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852240|NCT05032508|Lidocaine|lidocaine|mesh-list
56852241|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
56852242|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
56852243|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852244|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852245|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
56852246|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852247|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56852248|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56852249|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56852250|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852251|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852252|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
56852253|NCT01140074|Astringents|astringents|mesh-ancestor
56852254|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852255|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
56852256|NCT04578652|Metformin|metformin|mesh-list
56852257|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852258|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852259|NCT03913442|Colchicine|colchicine|mesh-list
56852260|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
56852261|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56852262|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56852263|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56852264|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56852265|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852266|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852267|NCT01142414|Fluorouracil|fluorouracil|mesh-list
56852268|NCT01142414|Panitumumab|panitumumab|mesh-list
56852269|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852270|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
56852271|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852272|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56852273|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852274|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
56852275|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852276|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852277|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
56852278|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852279|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852280|NCT01236482|Oxytocin|oxytocin|mesh-list
56852281|NCT01236482|Ergonovine|ergonovine|mesh-list
56852282|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
56852283|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56894849|NCT03907371|Donepezil|donepezil|mesh-list
56852284|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852285|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
56852286|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56852287|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
56852288|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56852289|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852290|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56852291|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56852292|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56852293|NCT01142492|Interferons|interferons|mesh-list
56852294|NCT01142492|Interferon-beta|interferon-beta|mesh-list
56852295|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
56852296|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852297|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
56852298|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563125|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
56852299|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
56852300|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852301|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56852302|NCT03958474|Remifentanil|remifentanil|mesh-list
56852303|NCT03958474|Oxycodone|oxycodone|mesh-list
56852304|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56852305|NCT03958474|Narcotics|narcotics|mesh-ancestor
56852306|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852307|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852308|NCT03958474|Analgesics|analgesics|mesh-ancestor
56852309|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
56366794|NCT00328939|PENTA|penta|mesh-list
56852311|NCT04956692|Paclitaxel|paclitaxel|mesh-list
56852312|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56852313|NCT04956692|Carboplatin|carboplatin|mesh-list
56852314|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
56852315|NCT04956692|Pemetrexed|pemetrexed|mesh-list
56852316|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56852317|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852318|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
56852319|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
56852320|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
56852321|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852322|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852323|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852324|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56852325|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56852326|NCT01234142|Varenicline|varenicline|mesh-list
56852327|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56852328|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56852329|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
56852330|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852331|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852332|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852333|NCT01140308|Ubiquinone|ubiquinone|mesh-list
56852334|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
56852335|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
56852336|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852337|NCT01140308|Vitamins|vitamins|mesh-ancestor
56852338|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
56852339|NCT01142648|Neostigmine|neostigmine|mesh-list
56852340|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56852341|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852342|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852343|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
56852344|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852345|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852346|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56852347|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
56852348|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852349|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56852350|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56852351|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56852352|NCT02143726|Everolimus|everolimus|mesh-list
56852353|NCT02143726|Sorafenib|sorafenib|mesh-list
56852354|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852355|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852356|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
56852357|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852358|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56852359|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852360|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852361|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
56852362|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852363|NCT02088112|Durvalumab|durvalumab|mesh-list
56852364|NCT02088112|Gefitinib|gefitinib|mesh-list
56852365|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852366|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852367|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56852368|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852369|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852370|NCT04700176|Dexamethasone|dexamethasone|mesh-list
56852371|NCT04700176|Daratumumab|daratumumab|mesh-list
56852372|NCT04700176|Pomalidomide|pomalidomide|mesh-list
56852373|NCT04700176|Tretinoin|tretinoin|mesh-list
56852374|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56852375|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
56852376|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
56852377|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852379|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56852380|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
56852381|NCT04700176|Hormones|hormones|mesh-ancestor
56852382|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56852383|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56852384|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852385|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
56852386|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56852395|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852396|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852397|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56852398|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56852399|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
56852400|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56852401|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56852402|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
56852403|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852404|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852405|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56852406|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56852407|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852408|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56852409|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56852410|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852411|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852412|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
56852413|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852414|NCT05308342|Hormones|hormones|mesh-list
56852415|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56852416|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852417|NCT03332212|Empagliflozin|empagliflozin|mesh-list
56852418|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56852419|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852420|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852421|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852422|NCT03417284|Melphalan|melphalan|mesh-list
56852423|NCT03417284|Lenograstim|lenograstim|mesh-list
56852424|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56852425|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
56852426|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852427|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56852428|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
56852429|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852430|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852431|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56852432|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852433|NCT01144988|Bevacizumab|bevacizumab|mesh-list
56852434|NCT01144988|Irinotecan|irinotecan|mesh-list
56852435|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852436|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852437|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56852438|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56852439|NCT01144988|Growth Substances|growth substances|mesh-ancestor
56852440|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852441|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
56852442|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56852443|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56852444|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852445|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852446|NCT03331666|Evolocumab|evolocumab|mesh-list
56852447|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56852448|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56852449|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
56852450|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852451|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56852461|NCT04828538|Vitamin D|vitamin d|mesh-list
56852462|NCT04828538|Vitamins|vitamins|mesh-list
56852463|NCT04828538|Folic Acid|folic acid|mesh-list
56852464|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
56852465|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
56852466|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852467|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56852468|NCT04828538|Hematinics|hematinics|mesh-ancestor
56852469|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56852470|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56852471|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
56852472|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852473|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
56852474|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56852475|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852476|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56852477|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56852478|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
56852479|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852480|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852481|NCT04786210|Triamcinolone|triamcinolone|mesh-list
56852482|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56852483|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56852484|NCT04786210|Fluorouracil|fluorouracil|mesh-list
56852485|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56852486|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
56852487|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852488|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56852489|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852490|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852491|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
56852492|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852493|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56852494|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
56852495|NCT04786210|Hormones|hormones|mesh-ancestor
56852496|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56852497|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852498|NCT01234454|Olanzapine|olanzapine|mesh-list
56852499|NCT01234454|Risperidone|risperidone|mesh-list
56852500|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56852501|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
56852502|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852503|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852504|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852505|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56852506|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56852507|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852508|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56852509|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56852510|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
56852511|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
56852512|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
56852513|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852514|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56852515|NCT01234454|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56852516|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56852517|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852518|NCT01145456|Gemcitabine|gemcitabine|mesh-list
56852519|NCT01145456|R04929097|r04929097|mesh-list
56852520|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56852521|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
56852522|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852523|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852524|NCT01145456|Antiviral Agents|antiviral agents|mesh-ancestor
56852525|NCT01145456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852526|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852527|NCT01145456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852528|NCT01145456|Immunologic Factors|immunologic factors|mesh-ancestor
56852529|NCT01145456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852531|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
56852532|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
56852533|NCT04939636|Vitamins|vitamins|mesh-list
56852534|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
56852535|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852536|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56852537|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56852539|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56852540|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852541|NCT01145534|Glyburide|glyburide|mesh-list
56852542|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852543|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852544|NCT01145612|Losartan|losartan|mesh-list
56852545|NCT01145612|Atenolol|atenolol|mesh-list
56852546|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56852547|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56852548|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56852549|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56852550|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852551|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
56852552|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
56852553|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852554|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852555|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56852556|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56852557|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56852558|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
56852559|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852560|NCT03572764|Cytarabine|cytarabine|mesh-list
56852561|NCT03572764|Daunorubicin|daunorubicin|mesh-list
56852562|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56852563|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
56852564|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852565|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852566|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
56852567|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852568|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852569|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
56852570|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852571|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56852572|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56852573|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56852574|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852575|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
56852576|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56852577|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
56852578|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852579|NCT01143584|Dopamine|dopamine|mesh-list
56852580|NCT01143584|Cabergoline|cabergoline|mesh-list
56852581|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
56852582|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56852583|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
56852584|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
56852585|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852586|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852587|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
56852588|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852589|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852590|NCT01143584|Protective Agents|protective agents|mesh-ancestor
56852591|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56852592|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56852593|NCT01145846|Cytarabine|cytarabine|mesh-list
56852594|NCT01145846|Daunorubicin|daunorubicin|mesh-list
56852595|NCT01145846|Idarubicin|idarubicin|mesh-list
56852596|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56852597|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
56852598|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563426|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
56852599|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852600|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
56852601|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852602|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852603|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
56852604|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852605|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56852606|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56852607|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56852608|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852609|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
56852610|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852611|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852614|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852616|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56852617|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852618|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852619|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56852620|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
56852621|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
56852622|NCT01146548|Fluoxetine|fluoxetine|mesh-list
56852623|NCT01146548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56852624|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56852625|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852626|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852627|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852628|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
56852629|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852630|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56852631|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
56852632|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56852633|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56852634|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56852635|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852636|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
56852637|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852638|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852639|NCT03478930|Omalizumab|omalizumab|mesh-list
56852640|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56852641|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56852642|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
56852643|NCT01312714|Vitamin D|vitamin d|mesh-list
56852644|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
56852645|NCT01312714|Vitamins|vitamins|mesh-ancestor
56852646|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
56852647|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852648|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56852649|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56852650|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
56852651|NCT04188028|Paroxetine|paroxetine|mesh-list
56852652|NCT04188028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56852653|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56852654|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852655|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852656|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852657|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
56852658|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852659|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56852660|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
56852661|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56852662|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56852663|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56852664|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852665|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
56852666|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
56852667|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56852668|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56852669|NCT01312792|Ampicillin|ampicillin|mesh-list
56852670|NCT01312792|Cephradine|cephradine|mesh-list
56852671|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56852672|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563499|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56852673|NCT03523000|Fentanyl|fentanyl|mesh-list
56852674|NCT03523000|Bupivacaine|bupivacaine|mesh-list
56852675|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
56852676|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
56852677|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852678|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852679|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
56852680|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852681|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56852682|NCT03523000|Narcotics|narcotics|mesh-ancestor
56852683|NCT03523000|Analgesics|analgesics|mesh-ancestor
56852684|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56852685|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56852686|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
56852688|NCT04705480|Gabapentin|gabapentin|mesh-list
56852689|NCT04705480|Analgesics|analgesics|mesh-ancestor
56852690|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
56852691|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852692|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852693|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
56852694|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56852695|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852696|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852697|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56852698|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56852699|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56852700|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852701|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56852702|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56852703|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56852704|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852705|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
56852706|NCT01238978|Vildagliptin|vildagliptin|mesh-list
56852707|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852708|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852709|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56852710|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
56852711|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852712|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852713|NCT00318149|Vaccines|vaccines|mesh-list
56852714|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
56852715|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852716|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
56852717|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56852718|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852719|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852720|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852721|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56852722|NCT04648696|Vancomycin|vancomycin|mesh-list
56852723|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56852724|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852725|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
56852726|NCT01236716|Gemcitabine|gemcitabine|mesh-list
56852727|NCT01236716|Paclitaxel|paclitaxel|mesh-list
56852728|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56852729|NCT01236716|Carboplatin|carboplatin|mesh-list
56852730|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56852731|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852732|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
56903661|NCT03755037|Estradiol|estradiol|mesh-list
56852733|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
56852734|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
56852735|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852736|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56852737|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
56852738|NCT01236716|Antiviral Agents|antiviral agents|mesh-ancestor
56852739|NCT01236716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852740|NCT01236716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852741|NCT01236716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852742|NCT01236716|Immunologic Factors|immunologic factors|mesh-ancestor
56852743|NCT01236716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852744|NCT04154800|Itraconazole|itraconazole|mesh-list
56852745|NCT04154800|Diltiazem|diltiazem|mesh-list
56852746|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
56563577|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
56852747|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852748|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56852749|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56852750|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852751|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852752|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56852753|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
56852754|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56852755|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367222|NCT00093288|Bupropion|bupropion|mesh-list
56852757|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56852758|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56852759|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852760|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56852761|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
56852762|NCT01048229|Pramipexole|pramipexole|mesh-list
56852764|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
56852765|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852766|NCT01048229|Protective Agents|protective agents|mesh-ancestor
56852767|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852768|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56852769|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56852770|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
56852771|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
56852772|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852773|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56852774|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852775|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56852776|NCT01048307|Polihexanide|polihexanide|mesh-list
56852777|NCT01048307|Betaine|betaine|mesh-list
56852778|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56852779|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56852780|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
56852781|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56852782|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
56852783|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852784|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56852785|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
56852786|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852787|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56852788|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852789|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852790|NCT04017832|Incretins|incretins|mesh-ancestor
56852791|NCT04017832|Hormones|hormones|mesh-ancestor
56852792|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56852793|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56852794|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
56852795|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852796|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852797|NCT02049905|Gemcitabine|gemcitabine|mesh-list
56852798|NCT02049905|Docetaxel|docetaxel|mesh-list
56852799|NCT02049905|Doxorubicin|doxorubicin|mesh-list
56852800|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56852801|NCT02049905|Ifosfamide|ifosfamide|mesh-list
56852802|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
56852803|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56852804|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
56852805|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852806|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852807|NCT02049905|Antiviral Agents|antiviral agents|mesh-ancestor
56852808|NCT02049905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852809|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852810|NCT02049905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852811|NCT02049905|Immunologic Factors|immunologic factors|mesh-ancestor
56852812|NCT02049905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852813|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
56852814|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
56852815|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
56852816|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56852817|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56852818|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56852819|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56852820|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
56852821|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56852822|NCT01062191|Laxatives|laxatives|mesh-ancestor
56852823|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56852824|NCT01058759|Enoxaparin|enoxaparin|mesh-list
56852825|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
56852826|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
56852827|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56852828|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56852829|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852830|NCT01239368|Sirolimus|sirolimus|mesh-list
56852833|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56852834|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852835|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
56852836|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852837|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
56852838|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852839|NCT01146002|Guanfacine|guanfacine|mesh-list
56852840|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56852841|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56852842|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56852843|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56852844|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
56852845|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852846|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852847|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852848|NCT01146626|Vitamin D|vitamin d|mesh-list
56852849|NCT01146626|Ribavirin|ribavirin|mesh-list
56852850|NCT01146626|Vitamins|vitamins|mesh-ancestor
56852851|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
56852852|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852853|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56852854|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
56852855|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852856|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
56852857|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852858|NCT02924324|Propofol|propofol|mesh-list
56852859|NCT02924324|Ropivacaine|ropivacaine|mesh-list
56852860|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56852861|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852862|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852863|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56852864|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
56852865|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
56852866|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
56852867|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
56852868|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852869|NCT03518606|Durvalumab|durvalumab|mesh-list
56852870|NCT03518606|Vinorelbine|vinorelbine|mesh-list
56852871|NCT03518606|Tremelimumab|tremelimumab|mesh-list
56852872|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56852873|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852874|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56852875|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
56852876|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
56852877|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
56852878|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852879|NCT05137574|Ketamine|ketamine|mesh-list
56852880|NCT05137574|Propofol|propofol|mesh-list
56852881|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56852882|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852883|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852884|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56852885|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
56852886|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
56852887|NCT05137574|Analgesics|analgesics|mesh-ancestor
56852888|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
56852889|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852890|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56852891|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56852892|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56852893|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852894|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852895|NCT02842424|Ramipril|ramipril|mesh-list
56852896|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56852897|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
56852898|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852899|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852900|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56852901|NCT01236950|Listerine|listerine|mesh-list
56852902|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56852903|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56852904|NCT04971746|Pirfenidone|pirfenidone|mesh-list
56852906|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852907|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56852908|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852909|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852910|NCT04971746|Analgesics|analgesics|mesh-ancestor
56852911|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
56852912|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56852913|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852914|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56852915|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56852916|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56852917|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56852919|NCT00369161|Tacrolimus|tacrolimus|mesh-list
56852920|NCT00369161|Basiliximab|basiliximab|mesh-list
56852921|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852922|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
56852923|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852924|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56852925|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852926|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852927|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852928|NCT01143974|Pemetrexed|pemetrexed|mesh-list
56852929|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852930|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852931|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852932|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56852933|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56852934|NCT00337571|Aripiprazole|aripiprazole|mesh-list
56852935|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
56852936|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56852937|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56852938|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56852939|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56852940|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852941|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
56852942|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
56852943|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56852944|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852945|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56852946|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56852947|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
56852948|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56852949|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56852950|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56852951|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56852952|NCT01247870|Metformin|metformin|mesh-list
56852953|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852954|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852955|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
56852956|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56852957|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852958|NCT03985319|Esomeprazole|esomeprazole|mesh-list
56852959|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56852960|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56852961|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56852962|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852963|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852964|NCT01237028|Calcitriol|calcitriol|mesh-list
56852965|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56852966|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852967|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56852968|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56852969|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852970|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56852971|NCT01237028|Vitamins|vitamins|mesh-ancestor
56852972|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
56852973|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56563797|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
56852974|NCT01240850|Prednisone|prednisone|mesh-list
56852975|NCT01240850|Methotrexate|methotrexate|mesh-list
56852976|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56852977|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
56852979|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56852980|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56852981|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56852982|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56852983|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56852984|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
56852985|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56852986|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56852987|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
56852988|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56852989|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
56852990|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56852991|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56852992|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56852993|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
56852994|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56852995|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56852996|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
56852997|NCT04813016|Tramadol|tramadol|mesh-list
56852998|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56852999|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853000|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853001|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56853002|NCT04813016|Analgesics|analgesics|mesh-ancestor
56853003|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
56853004|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853005|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56853006|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56853007|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56853008|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
56853009|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853010|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853011|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56853012|NCT04813016|Narcotics|narcotics|mesh-ancestor
56853013|NCT00368927|Sulindac|sulindac|mesh-list
56853014|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56853015|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56853016|NCT00368927|Analgesics|analgesics|mesh-ancestor
56853017|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
56853018|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853019|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853020|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56853021|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853022|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853023|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56853024|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853025|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853026|NCT01242410|Silicon|silicon|mesh-list
56853027|NCT01242410|Trace Elements|trace elements|mesh-ancestor
56853028|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
56853029|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853030|NCT02655692|Ketamine|ketamine|mesh-list
56853031|NCT02655692|Analgesics|analgesics|mesh-ancestor
56853032|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
56853033|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853034|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853035|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56853036|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56853037|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
56853038|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
56853039|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853040|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56853041|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56853042|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853043|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853044|NCT01237262|Adalimumab|adalimumab|mesh-list
56853045|NCT01237262|Etanercept|etanercept|mesh-list
56853046|NCT01237262|Infliximab|infliximab|mesh-list
56853047|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56563878|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
56853048|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853049|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
56853050|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56853051|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56853052|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56853054|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
56853055|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853056|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853057|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853058|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
56853059|NCT01329770|Vitamins|vitamins|mesh-list
56853060|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
56853061|NCT01329770|Vitamin E|vitamin e|mesh-list
56853062|NCT01329770|Tocopherols|tocopherols|mesh-list
56853063|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
56853064|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
56853065|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853066|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
56853067|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853068|NCT01329770|Protective Agents|protective agents|mesh-ancestor
56853069|NCT01048385|Ubiquinone|ubiquinone|mesh-list
56853070|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
56853071|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
56853072|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853073|NCT01048385|Vitamins|vitamins|mesh-ancestor
56853074|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
56853075|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56853076|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853077|NCT03916250|Petrolatum|petrolatum|mesh-list
56853078|NCT03916250|PF-06700841|pf-06700841|mesh-list
56853079|NCT03916250|Emollients|emollients|mesh-ancestor
56853080|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56853081|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56853082|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853083|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853084|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
56853085|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56853086|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853087|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56853088|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56853089|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
56853090|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56853091|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853092|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56853093|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56853094|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56853095|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853096|NCT03916406|Midazolam|midazolam|mesh-list
56853097|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56853098|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56853099|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853100|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853101|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56853102|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56853103|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853104|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56853105|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
56853106|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
56853107|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
56853108|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
56853109|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853110|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853111|NCT01147016|Paclitaxel|paclitaxel|mesh-list
56853112|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
56853113|NCT01147016|Doxorubicin|doxorubicin|mesh-list
56853114|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56853115|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56853116|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853117|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
56853118|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
56853119|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
56853120|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853121|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853122|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
56563948|NCT00606411|Topiramate|topiramate|mesh-list
56853123|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853124|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853125|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568091|NCT01190930|Hematinics|hematinics|mesh-ancestor
56853128|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56853129|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56853130|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56853131|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853132|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
56853133|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56853134|NCT00316277|Narcotics|narcotics|mesh-ancestor
56853135|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853136|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853137|NCT00316277|Analgesics|analgesics|mesh-ancestor
56853138|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
56853139|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853140|NCT01249352|Fluorouracil|fluorouracil|mesh-list
56853141|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
56853142|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853143|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
56853144|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853145|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56853146|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853147|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
56853148|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853149|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56853151|NCT03912974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56853152|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56853153|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853154|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853155|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853156|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
56853157|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853158|NCT03912974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56853159|NCT03912974|Antidepressive Agents|antidepressive agents|mesh-ancestor
56853160|NCT03912974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853161|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56853162|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56853163|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56853164|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853165|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853166|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
56853167|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853168|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853169|NCT01144676|Dapivirine|dapivirine|mesh-list
56853170|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56853171|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56853172|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
56853173|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853174|NCT00316199|Gemcitabine|gemcitabine|mesh-list
56853175|NCT00316199|Paclitaxel|paclitaxel|mesh-list
56853176|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56853177|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853178|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
56853179|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
56853180|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
56853181|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853182|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56853183|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
56853184|NCT00316199|Antiviral Agents|antiviral agents|mesh-ancestor
56853185|NCT00316199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853186|NCT00316199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853187|NCT00316199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853188|NCT00316199|Immunologic Factors|immunologic factors|mesh-ancestor
56853189|NCT00316199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853190|NCT01147718|Digoxin|digoxin|mesh-list
56853191|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
56853192|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56853193|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56853194|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853195|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853196|NCT01147718|Protective Agents|protective agents|mesh-ancestor
56853197|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853200|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56853201|NCT03913052|Viscosupplements|viscosupplements|mesh-list
56853202|NCT03913052|Protective Agents|protective agents|mesh-ancestor
56853203|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853205|NCT03915938|Analgesics|analgesics|mesh-ancestor
56853206|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
56853207|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853208|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853209|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56853210|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56853211|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
56853212|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
56853213|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853214|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56853215|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56853216|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853217|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853218|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56853219|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
56853220|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853221|NCT01251458|Sirolimus|sirolimus|mesh-list
56853222|NCT01251458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56853223|NCT01251458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853224|NCT01251458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56853225|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853226|NCT01251458|Antifungal Agents|antifungal agents|mesh-ancestor
56853227|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853228|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
56853229|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853230|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
56853231|NCT03912740|Remifentanil|remifentanil|mesh-list
56853232|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56853233|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853234|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853235|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56853236|NCT03912740|Analgesics|analgesics|mesh-ancestor
56853237|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
56853238|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853239|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56853240|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56853241|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56853242|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56853243|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853244|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853245|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56853246|NCT03912740|Narcotics|narcotics|mesh-ancestor
56853247|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56853248|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56853249|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56853250|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
56853251|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853252|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56853253|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56853254|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853255|NCT01144754|Rituximab|rituximab|mesh-list
56853256|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56853257|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853258|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
56853259|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853260|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853261|NCT01144832|Ebastine|ebastine|mesh-list
56853262|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56853263|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
56853264|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
56853265|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853266|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853267|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853268|NCT01251848|Ritonavir|ritonavir|mesh-list
56853269|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
56853270|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56853272|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
56853273|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853274|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853276|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56853277|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
56853278|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853279|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56853280|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56853281|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56853283|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56853284|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853285|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56853286|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56853287|NCT01251926|Growth Substances|growth substances|mesh-ancestor
56853288|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853289|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
56853290|NCT03911648|Lidocaine|lidocaine|mesh-list
56853291|NCT03911648|Bupivacaine|bupivacaine|mesh-list
56853292|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
56853293|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
56853294|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853295|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853296|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
56853297|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853298|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56853299|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56853300|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56853301|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853302|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853303|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56853304|NCT01237730|Cefuroxime|cefuroxime|mesh-list
56853305|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
56853306|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853307|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56853308|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853309|NCT01252160|Capsaicin|capsaicin|mesh-list
56853310|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
56853311|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
56853312|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
56853313|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853314|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853315|NCT00337103|Capecitabine|capecitabine|mesh-list
56853316|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56853317|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
56853318|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853319|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853320|NCT03911570|Acetaminophen|acetaminophen|mesh-list
56853321|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56853322|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56853323|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56853324|NCT03911570|Analgesics|analgesics|mesh-ancestor
56853325|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
56853326|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853327|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853328|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
56853329|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853330|NCT01250366|Ribavirin|ribavirin|mesh-list
56853331|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
56853332|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853333|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
56853334|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853335|NCT00075504|Gemcitabine|gemcitabine|mesh-list
56853336|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56853337|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
56853338|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853339|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853340|NCT00075504|Antiviral Agents|antiviral agents|mesh-ancestor
56853341|NCT00075504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853342|NCT00075504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853343|NCT00075504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853344|NCT00075504|Immunologic Factors|immunologic factors|mesh-ancestor
56853346|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
56853347|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56853348|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56853349|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
56853350|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853351|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853352|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853353|NCT01092624|Urological Agents|urological agents|mesh-ancestor
56853354|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
56853355|NCT00321464|Denosumab|denosumab|mesh-list
56853356|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56853357|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853358|NCT02889796|Adalimumab|adalimumab|mesh-list
56853359|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56853360|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853361|NCT01237808|Cytarabine|cytarabine|mesh-list
56853362|NCT01237808|Etoposide|etoposide|mesh-list
56853363|NCT01237808|Tretinoin|tretinoin|mesh-list
56853364|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56853365|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853366|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56853367|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56853368|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853369|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853370|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56853371|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
56853372|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
56853373|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853374|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853375|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
56853376|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853377|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
56853378|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
56853379|NCT03910634|Carboplatin|carboplatin|mesh-list
56853380|NCT03910634|Fluorouracil|fluorouracil|mesh-list
56853381|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853382|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
56853383|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853384|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56853385|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853386|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
56853387|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853388|NCT03910712|Trastuzumab|trastuzumab|mesh-list
56853389|NCT03910712|Letrozole|letrozole|mesh-list
56853390|NCT03910712|Anastrozole|anastrozole|mesh-list
56853391|NCT03910712|Exemestane|exemestane|mesh-list
56853392|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56853393|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56853394|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853395|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56853396|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853397|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853398|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56853399|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
56853400|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56853401|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853402|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56853403|NCT03910556|Propofol|propofol|mesh-list
56853404|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56853405|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853406|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853407|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56853408|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
56853409|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
56853410|NCT03659578|Thymalfasin|thymalfasin|mesh-list
56853411|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56853412|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
56853413|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853414|NCT03877354|Anesthetics|anesthetics|mesh-list
56853415|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853416|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853417|NCT02889562|Warfarin|warfarin|mesh-list
56853418|NCT02889562|Apixaban|apixaban|mesh-list
56853419|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
56853421|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
56853422|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56853423|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
56853424|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853425|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853426|NCT03323164|Timolol|timolol|mesh-list
56853427|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56853428|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853429|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56853430|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56853431|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
56853432|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853433|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853434|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56853435|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56853436|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56853437|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56853438|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56853439|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
56853440|NCT03914690|Hematinics|hematinics|mesh-ancestor
56853441|NCT03914534|Valproic Acid|valproic acid|mesh-list
56853442|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
56853443|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853444|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853445|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
56853446|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853447|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853448|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
56853449|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56853450|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853451|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853452|NCT03910088|Acetaminophen|acetaminophen|mesh-list
56853453|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
56853454|NCT03910088|Diclofenac|diclofenac|mesh-list
56853455|NCT03910088|Pregabalin|pregabalin|mesh-list
56853456|NCT03910088|Caffeine|caffeine|mesh-list
56853457|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56853458|NCT03910088|Analgesics|analgesics|mesh-ancestor
56853459|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
56853460|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853461|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853462|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
56853463|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
56853464|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56853465|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853466|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853467|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56853468|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56853469|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56853470|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853471|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853472|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903682|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853473|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56853474|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56853475|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853476|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56853477|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56853478|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
56853479|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853480|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56853481|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853482|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56853483|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56853484|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56853485|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853486|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56853487|NCT03908372|Docetaxel|docetaxel|mesh-list
56853488|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853489|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
56853490|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
56853491|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
56853492|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853493|NCT05617664|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56853496|NCT05617664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56853497|NCT05617664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56853498|NCT05617664|Adrenergic Agents|adrenergic agents|mesh-ancestor
56853499|NCT05617664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853500|NCT05617664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853501|NCT05617664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853502|NCT05617664|Urological Agents|urological agents|mesh-ancestor
56853503|NCT05617664|Hemostatics|hemostatics|mesh-ancestor
56853504|NCT05617664|Coagulants|coagulants|mesh-ancestor
56853505|NCT05617664|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56853506|NCT05617664|Natriuretic Agents|natriuretic agents|mesh-ancestor
56853507|NCT03909776|Cisplatin|cisplatin|mesh-list
56853508|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853509|NCT01148264|Olanzapine|olanzapine|mesh-list
56853510|NCT01148264|Metoclopramide|metoclopramide|mesh-list
56853511|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
56853512|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
56853513|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853514|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853515|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56853516|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56853517|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56853518|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853519|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853520|NCT01148264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56853521|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56853522|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853523|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853524|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853525|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
56853526|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56853527|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56853528|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
56853529|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56853530|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56853531|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853532|NCT00086580|Vidarabine|vidarabine|mesh-list
56853533|NCT00086580|Fludarabine|fludarabine|mesh-list
56853534|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
56853535|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
56853536|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853537|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56853538|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
56853539|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853540|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853541|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
56853542|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853543|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
56853544|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853545|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56853546|NCT03321526|Norepinephrine|norepinephrine|mesh-list
56853547|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56853548|NCT03321526|Serotonin|serotonin|mesh-list
56853549|NCT03321526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56853550|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
56853551|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853552|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56853553|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56853554|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853555|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853556|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56853557|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56853558|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56853559|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853560|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853561|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
56853562|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
56853563|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853564|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56853565|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56853566|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
56853567|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56853569|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
56853570|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
56853571|NCT03908528|Doxorubicin|doxorubicin|mesh-list
56853572|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56853573|NCT03908528|Paclitaxel|paclitaxel|mesh-list
56853574|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56853575|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853576|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
56853577|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853578|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853579|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56853580|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
56853581|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853582|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853583|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56853584|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56853585|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56853586|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56853587|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853588|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56853589|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
56853590|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
56853591|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
56853592|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
56853593|NCT03908528|Protective Agents|protective agents|mesh-ancestor
56853594|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
56853595|NCT03908528|Vitamins|vitamins|mesh-ancestor
56853596|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
56853597|NCT03903458|Nivolumab|nivolumab|mesh-list
56853598|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56853599|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853600|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56853601|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853602|NCT00086502|Metformin|metformin|mesh-list
56853603|NCT00086502|Pioglitazone|pioglitazone|mesh-list
56853604|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56853605|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56853606|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853607|NCT00086502|Incretins|incretins|mesh-ancestor
56853608|NCT00086502|Hormones|hormones|mesh-ancestor
56853609|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56853610|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56853611|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
56853612|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853613|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853614|NCT03903302|Valproic Acid|valproic acid|mesh-list
56853615|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
56853616|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853617|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853618|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
56853619|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853620|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853621|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
56853622|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56853623|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853624|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853625|NCT03636542|Bupivacaine|bupivacaine|mesh-list
56853626|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
56853627|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
56853628|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853629|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853630|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
56853631|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853632|NCT00086190|Paroxetine|paroxetine|mesh-list
56853633|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56853634|NCT00086190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56853635|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56853636|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853637|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853638|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853639|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
56853640|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853641|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56853642|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
56853643|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853644|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56853645|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56853646|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853647|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56564468|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
56853649|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56853650|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56853651|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853652|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
56853653|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853654|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56853655|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
56853656|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853657|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853658|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
56853659|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853660|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853661|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56853662|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56853663|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853664|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
56853665|NCT03557242|Aspirin|aspirin|mesh-list
56853666|NCT03557242|Warfarin|warfarin|mesh-list
56853667|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56853668|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56853669|NCT03557242|Analgesics|analgesics|mesh-ancestor
56853670|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
56853671|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853672|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853673|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56853674|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853675|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56853676|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56853677|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853678|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56853679|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56853680|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853681|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
56853682|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
56853683|NCT04774666|Antibodies|antibodies|mesh-list
56853684|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
56853685|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853686|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56853687|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56853688|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56853689|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853690|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853691|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853692|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56853693|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56853694|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
56853695|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853696|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853697|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56853698|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56853699|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
56853700|NCT03898466|Fluticasone|fluticasone|mesh-list
56853701|NCT03898466|Xhance|xhance|mesh-list
56853702|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56853703|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56853704|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
56853705|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853706|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853707|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56853708|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
56853709|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
56853710|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56853711|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
56853712|NCT02527772|Leucovorin|leucovorin|mesh-list
56853713|NCT02527772|Gemcitabine|gemcitabine|mesh-list
56853714|NCT02527772|Fluorouracil|fluorouracil|mesh-list
56853715|NCT02527772|Doxorubicin|doxorubicin|mesh-list
56853717|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
56853718|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56853719|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
56853720|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853721|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853722|NCT02527772|Antiviral Agents|antiviral agents|mesh-ancestor
56853723|NCT02527772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853724|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853725|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56853726|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
56853727|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853728|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56853729|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56853730|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56853731|NCT02527772|Antidotes|antidotes|mesh-ancestor
56853732|NCT02527772|Protective Agents|protective agents|mesh-ancestor
56853733|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
56853734|NCT02527772|Vitamins|vitamins|mesh-ancestor
56853735|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
56853736|NCT03273946|Fluticasone|fluticasone|mesh-list
56853737|NCT03273946|Xhance|xhance|mesh-list
56853738|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56853739|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56853740|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
56853741|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853742|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853743|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56853744|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
56853745|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56853746|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56853747|NCT00660218|Paclitaxel|paclitaxel|mesh-list
56853748|NCT00660218|Cetuximab|cetuximab|mesh-list
56853749|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56853750|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56853751|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853752|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
56853753|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
56853754|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
56853755|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853756|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56853757|NCT00314951|Vancomycin|vancomycin|mesh-list
56853758|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
56853759|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56853760|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853761|NCT00085644|Adalimumab|adalimumab|mesh-list
56853762|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56853763|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853764|NCT01257074|Acyclovir|acyclovir|mesh-list
56853765|NCT01257074|Penciclovir|penciclovir|mesh-list
56853766|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
56853767|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853768|NCT01149278|Benzocaine|benzocaine|mesh-list
56853769|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
56853770|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
56853771|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853772|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853773|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
56853774|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853775|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56853776|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
56853777|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56853778|NCT03902522|Leronlimab|leronlimab|mesh-list
56853779|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56853780|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56853781|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853782|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56853783|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56853784|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
56853785|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853786|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
56853787|NCT01092858|Testosterone|testosterone|mesh-list
56853788|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
56853789|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
56853790|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56853791|NCT01092858|Androgens|androgens|mesh-ancestor
56853792|NCT01092858|Hormones|hormones|mesh-ancestor
56904615|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853793|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56853795|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56853796|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853797|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
56853798|NCT00314327|Risperidone|risperidone|mesh-list
56853799|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56853800|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
56853801|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853802|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853803|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853804|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56853805|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56853806|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853807|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853808|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56853809|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
56853811|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56853812|NCT03897452|Narcotics|narcotics|mesh-ancestor
56853813|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853814|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853815|NCT03897452|Analgesics|analgesics|mesh-ancestor
56853816|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
56853817|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853818|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56853819|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56853820|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
56853821|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
56853822|NCT01151072|Insulin|insulin|mesh-list
56853823|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56853824|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853825|NCT01257386|Mesalamine|mesalamine|mesh-list
56853826|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56853827|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56853828|NCT01257386|Analgesics|analgesics|mesh-ancestor
56853829|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
56853830|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853831|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853832|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56853833|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56853834|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56853835|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56853836|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56853837|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853838|NCT01257464|Incretins|incretins|mesh-ancestor
56853839|NCT01257464|Hormones|hormones|mesh-ancestor
56853840|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56853841|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
56853842|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853843|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853844|NCT01255046|Donepezil|donepezil|mesh-list
56853845|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56853846|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458795|NCT00469599|Vitamins|vitamins|mesh-ancestor
56853847|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853848|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
56853849|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853850|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853851|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
56853852|NCT01149356|Exemestane|exemestane|mesh-list
56853853|NCT01149356|Goserelin|goserelin|mesh-list
56853854|NCT01149356|R04929097|r04929097|mesh-list
56853855|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853856|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56853857|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56853858|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853859|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853860|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56853861|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
56853862|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56853863|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853864|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56853865|NCT01148576|Vitamin E|vitamin e|mesh-list
56853866|NCT01148576|Entecavir|entecavir|mesh-list
56853867|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
56853871|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
56853872|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853873|NCT01148576|Protective Agents|protective agents|mesh-ancestor
56853874|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
56853875|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853876|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56853877|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
56853878|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56853879|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56853880|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
56853881|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56853882|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56853883|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
56853884|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56853885|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56853886|NCT03905486|Pregabalin|pregabalin|mesh-list
56853887|NCT03905486|Analgesics|analgesics|mesh-ancestor
56853888|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
56853889|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853890|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853891|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
56853892|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56853893|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853894|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853895|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56853896|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56853897|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56853898|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56853899|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56853900|NCT03901118|Paclitaxel|paclitaxel|mesh-list
56853901|NCT03901118|Etoposide|etoposide|mesh-list
56853902|NCT03901118|Chiauranib|chiauranib|mesh-list
56853903|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56853904|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853905|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56853906|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56853907|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56853908|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853909|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56853910|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56853911|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853912|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56853913|NCT03895892|Caffeine|caffeine|mesh-list
56853914|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56853915|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853916|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56853917|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853918|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853919|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56853920|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56853921|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
56853922|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853923|NCT01151306|Simvastatin|simvastatin|mesh-list
56853924|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56853925|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56853926|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
56853927|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853928|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56853929|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56853930|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853931|NCT05570786|Gestrinone|gestrinone|mesh-list
56853932|NCT05570786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56853933|NCT05570786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56853934|NCT05570786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56853935|NCT05570786|Contraceptive Agents|contraceptive agents|mesh-ancestor
56853936|NCT05570786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56853937|NCT05570786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853938|NCT05570786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56853939|NCT05570786|Progestins|progestins|mesh-ancestor
56853941|NCT05570786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56853942|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
56853943|NCT03895970|Lenvatinib|lenvatinib|mesh-list
56853944|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56853945|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853946|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56853947|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56853948|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853949|NCT00336479|Interferons|interferons|mesh-list
56853950|NCT00336479|Ribavirin|ribavirin|mesh-list
56853951|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
56853952|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
56853953|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56853954|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853955|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
56853956|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56853957|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
56853958|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853959|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
56853960|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853961|NCT03905564|Pyridoxine|pyridoxine|mesh-list
56853962|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
56853963|NCT03905564|Doxylamine|doxylamine|mesh-list
56853964|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
56853965|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
56853966|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
56853967|NCT03905564|Vitamins|vitamins|mesh-ancestor
56853968|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
56853969|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853970|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
56853971|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
56853972|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56853973|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56853974|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56853975|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
56853976|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
56853977|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853978|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853979|NCT01151384|Docetaxel|docetaxel|mesh-list
56853980|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56853981|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
56853982|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
56853983|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
56853984|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853985|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
56853986|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56853987|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56853988|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853989|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
56853990|NCT01258010|Coagulants|coagulants|mesh-ancestor
56853991|NCT00314249|Milnacipran|milnacipran|mesh-list
56853992|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
56853993|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56853994|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56853995|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56853996|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56853997|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56853998|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56853999|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56854000|NCT00314249|Analgesics|analgesics|mesh-ancestor
56854001|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
56854002|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854003|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
56854004|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56854005|NCT03905018|Tadalafil|tadalafil|mesh-list
56854006|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
56854007|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56854008|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56854009|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854010|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854011|NCT03905018|Urological Agents|urological agents|mesh-ancestor
56854012|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
56854013|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56854014|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854017|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56854018|NCT03894800|Narcotics|narcotics|mesh-ancestor
56854019|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854020|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854021|NCT03894800|Analgesics|analgesics|mesh-ancestor
56854022|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
56854023|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854024|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56854025|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56854026|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
56854027|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
56854028|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56854029|NCT03900026|Evolocumab|evolocumab|mesh-list
56854030|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56854031|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56854032|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
56854033|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854034|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56854035|NCT01149668|Abexinostat|abexinostat|mesh-list
56854036|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56854037|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854038|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854039|NCT01149746|Tamsulosin|tamsulosin|mesh-list
56854040|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56854041|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56854042|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56854043|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
56854044|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854045|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854046|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854047|NCT01149746|Urological Agents|urological agents|mesh-ancestor
56854048|NCT01149824|Salvinorin A|salvinorin a|mesh-list
56854049|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
56854050|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854051|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56854052|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
56854053|NCT01149902|Docetaxel|docetaxel|mesh-list
56854054|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56854055|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
56854056|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854057|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56854058|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56854059|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
56854060|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854061|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854062|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56854063|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
56854064|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
56854065|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
56854066|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
56854067|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
56854068|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
56854069|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56854070|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
56854071|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
56854072|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854073|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854074|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854075|NCT01149980|Dexetimide|dexetimide|mesh-list
56854076|NCT01149980|Citalopram|citalopram|mesh-list
56854077|NCT01149980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56854078|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56854079|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854080|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854081|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854082|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
56854083|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854084|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56854085|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
56854086|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56854087|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56854088|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56854090|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
56854091|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854092|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56854093|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56854094|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
56854096|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56854097|NCT03644186|Trastuzumab|trastuzumab|mesh-list
56854098|NCT03644186|Letrozole|letrozole|mesh-list
56854099|NCT03644186|Palbociclib|palbociclib|mesh-list
56854100|NCT03644186|Pertuzumab|pertuzumab|mesh-list
56854101|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56854102|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854103|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
56854104|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
56854105|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
56854106|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854107|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56854108|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56854109|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56854110|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854111|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56854112|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
56854113|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56854114|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854115|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56854116|NCT01258322|Pioglitazone|pioglitazone|mesh-list
56854117|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56854118|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854119|NCT01255358|Dexamethasone|dexamethasone|mesh-list
56854120|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
56854121|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56854122|NCT01255358|BB 1101|bb 1101|mesh-list
56854123|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56854124|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
56854125|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
56854126|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854127|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854128|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56854129|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
56854130|NCT01255358|Hormones|hormones|mesh-ancestor
56854131|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56854132|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56854133|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854134|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
56854135|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854136|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854137|NCT03899246|Capsaicin|capsaicin|mesh-list
56854138|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
56854139|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
56854140|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
56854141|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854142|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854143|NCT03893864|Ubiquinone|ubiquinone|mesh-list
56854144|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
56854145|NCT03893864|Antioxidants|antioxidants|mesh-list
56903699|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
56854146|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854147|NCT03893864|Protective Agents|protective agents|mesh-ancestor
56854148|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854149|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
56854150|NCT03893864|Vitamins|vitamins|mesh-ancestor
56854151|NCT03899324|Bumetanide|bumetanide|mesh-list
56854152|NCT03899324|Diuretics|diuretics|mesh-ancestor
56854153|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
56854154|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854155|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56854156|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854157|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854158|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56854159|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56854160|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
56854161|NCT01258634|Leucovorin|leucovorin|mesh-list
56854162|NCT01258634|Doxorubicin|doxorubicin|mesh-list
56854163|NCT01258634|Etoposide|etoposide|mesh-list
56854164|NCT01258634|Ifosfamide|ifosfamide|mesh-list
56854165|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
56854166|NCT01258634|Razoxane|razoxane|mesh-list
56854167|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854168|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56854169|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56854170|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56854171|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854172|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854173|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56854174|NCT01258634|Antidotes|antidotes|mesh-ancestor
56854175|NCT01258634|Protective Agents|protective agents|mesh-ancestor
56854176|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854177|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
56854178|NCT01258634|Vitamins|vitamins|mesh-ancestor
56854179|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
56854180|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56854181|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
56854182|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56854183|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
56854184|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
56854185|NCT01258712|Methotrexate|methotrexate|mesh-list
56854186|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56854187|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
56854188|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56854189|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854190|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56854191|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
56854192|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854193|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854194|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
56854195|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854196|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56854197|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56854198|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
56854199|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56854200|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56854201|NCT01258868|Celecoxib|celecoxib|mesh-list
56854202|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56854203|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56854204|NCT01258868|Analgesics|analgesics|mesh-ancestor
56854205|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
56854206|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854207|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854208|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56854209|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56854210|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56854211|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56854212|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854213|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854214|NCT01254578|Lenalidomide|lenalidomide|mesh-list
56854215|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
56854216|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854217|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56854218|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56854219|NCT01254578|Growth Substances|growth substances|mesh-ancestor
56854220|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
56854221|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854222|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
56854223|NCT03892928|Propofol|propofol|mesh-list
56854224|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56854225|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854226|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854227|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56854228|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
56854229|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
56854230|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56854231|NCT03892928|Analgesics|analgesics|mesh-ancestor
56854232|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
56854233|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854234|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56854235|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56854236|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56854237|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
56854238|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854239|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854241|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56854242|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854243|NCT03341806|Avelumab|avelumab|mesh-list
56854244|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56854245|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854246|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
56854247|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56854248|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854249|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854250|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
56854251|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854252|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854253|NCT01149122|Gemcitabine|gemcitabine|mesh-list
56854254|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
56854255|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56565071|NCT03761134|Metformin|metformin|mesh-list
56854256|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56854257|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
56854258|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854259|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854260|NCT01149122|Antiviral Agents|antiviral agents|mesh-ancestor
56854261|NCT01149122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854262|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854263|NCT01149122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56854264|NCT01149122|Immunologic Factors|immunologic factors|mesh-ancestor
56854265|NCT01149122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854266|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56854267|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56854268|NCT03892148|Furosemide|furosemide|mesh-list
56854269|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56854270|NCT03892148|Diuretics|diuretics|mesh-ancestor
56854271|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
56854272|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854273|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56854274|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854275|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854276|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56854277|NCT01152476|Remifentanil|remifentanil|mesh-list
56854278|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56854279|NCT01152476|Narcotics|narcotics|mesh-ancestor
56854280|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854281|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854282|NCT01152476|Analgesics|analgesics|mesh-ancestor
56854283|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
56854284|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854285|NCT03892070|Mannitol|mannitol|mesh-list
56854286|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56854287|NCT03892070|Diuretics|diuretics|mesh-ancestor
56854288|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
56854289|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854290|NCT01155440|Lidocaine|lidocaine|mesh-list
56854291|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
56854292|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
56903701|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56854293|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854294|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854295|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
56854296|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854297|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56854298|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56854299|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56854300|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854301|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854302|NCT01259336|Itraconazole|itraconazole|mesh-list
56854303|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
56854304|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854305|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56854306|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56854307|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854308|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854309|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56854310|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
56904616|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854311|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56854312|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854313|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56854314|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
56854315|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854316|NCT03314662|Vaccines|vaccines|mesh-list
56854317|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56854318|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
56854319|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854320|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56854321|NCT01152710|Capecitabine|capecitabine|mesh-list
56854322|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56854323|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
56854324|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854325|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854326|NCT03271528|Lacosamide|lacosamide|mesh-list
56854327|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
56854328|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56854329|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56854330|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854331|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854332|NCT04480372|Gemcitabine|gemcitabine|mesh-list
56854333|NCT04480372|Atezolizumab|atezolizumab|mesh-list
56854334|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56854335|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
56854336|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854337|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854338|NCT04480372|Antiviral Agents|antiviral agents|mesh-ancestor
56854339|NCT04480372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854340|NCT04480372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854341|NCT04480372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56854342|NCT04480372|Immunologic Factors|immunologic factors|mesh-ancestor
56854343|NCT04480372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854344|NCT04462276|Atezolizumab|atezolizumab|mesh-list
56854345|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854346|NCT03890510|Anesthetics|anesthetics|mesh-list
56854347|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854348|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854349|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56854350|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56854351|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854352|NCT01153568|Vitamin D|vitamin d|mesh-list
56854353|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
56854354|NCT01153568|Vitamins|vitamins|mesh-ancestor
56854355|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
56854356|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854357|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56854358|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56854359|NCT03889808|Antitoxins|antitoxins|mesh-list
56854360|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
56854361|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854362|NCT03890042|Dienogest|dienogest|mesh-list
56459309|NCT00463008|Methotrexate|methotrexate|mesh-list
56854363|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56854364|NCT03890042|Gestodene|gestodene|mesh-list
56854365|NCT03890042|Femovan|femovan|mesh-list
56854366|NCT03890042|Estradiol|estradiol|mesh-list
56854367|NCT03890042|Estrogens|estrogens|mesh-ancestor
56854368|NCT03890042|Hormones|hormones|mesh-ancestor
56854369|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56854370|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854371|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56854372|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
56854373|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56854374|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56854375|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56854376|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56854377|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56854378|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
56854379|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56854380|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854381|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56854382|NCT03890042|Progestins|progestins|mesh-ancestor
56854383|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56854384|NCT01153802|Dopamine|dopamine|mesh-list
56854385|NCT01153802|Norepinephrine|norepinephrine|mesh-list
56854386|NCT01153802|Serotonin|serotonin|mesh-list
56854387|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
56854388|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56854389|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56854390|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
56854391|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854392|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854393|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
56854394|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
56854395|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854396|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56854397|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56854398|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
56854399|NCT01153802|Protective Agents|protective agents|mesh-ancestor
56854400|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56854401|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
56854402|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
56565216|NCT02330926|Ibuprofen|ibuprofen|mesh-list
56854403|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56854404|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854405|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
56854406|NCT01153256|Analgesics|analgesics|mesh-ancestor
56854407|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
56854408|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854409|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854410|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
56854411|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854412|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56854413|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
56854414|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56854415|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854416|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854417|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56854418|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
56854419|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56854420|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56854421|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56854422|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56854423|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
56854424|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854425|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56854426|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56854427|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854428|NCT01153880|Mupirocin|mupirocin|mesh-list
56854429|NCT01153880|Retapamulin|retapamulin|mesh-list
56854430|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56854431|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854432|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56854433|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854434|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854435|NCT01260506|Bevacizumab|bevacizumab|mesh-list
56854436|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56854437|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854438|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56854439|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56854440|NCT01260506|Growth Substances|growth substances|mesh-ancestor
56854441|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854442|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
56854443|NCT03884972|Venetoclax|venetoclax|mesh-list
56854444|NCT03884972|Trabectedin|trabectedin|mesh-list
56854445|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854446|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56854447|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
56854448|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854449|NCT01154114|Darapladib|darapladib|mesh-list
56854450|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56854451|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854452|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854453|NCT01157312|Citric Acid|citric acid|mesh-list
56854454|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
56854455|NCT01157312|Clomiphene|clomiphene|mesh-list
56854456|NCT01157312|Enclomiphene|enclomiphene|mesh-list
56854457|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
56854458|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
56854459|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56854460|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
56854461|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
56854462|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854463|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56854464|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
56854465|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56854466|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854467|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56854469|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56854470|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56854471|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56854472|NCT01157546|Lidocaine|lidocaine|mesh-list
56854473|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
56854474|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
56854475|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854476|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854477|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
56854478|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854479|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56854480|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56854481|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56854482|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854483|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854484|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56854485|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56854486|NCT01263860|Ribavirin|ribavirin|mesh-list
56854487|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56854488|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
56854489|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
56854490|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854491|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
56854492|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854493|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
56854494|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854495|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
56854496|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854497|NCT01154348|Metformin|metformin|mesh-list
56854498|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56854499|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854500|NCT00075270|Paclitaxel|paclitaxel|mesh-list
56854501|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56854502|NCT00075270|Lapatinib|lapatinib|mesh-list
56854503|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56854504|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854505|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
56854506|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
56854507|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
56854508|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854509|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56854510|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854511|NCT01264094|Clevudine|clevudine|mesh-list
56854512|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
56854513|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854514|NCT03884348|Amoxicillin|amoxicillin|mesh-list
56854515|NCT03884348|Metronidazole|metronidazole|mesh-list
56854516|NCT03884348|Clarithromycin|clarithromycin|mesh-list
56854517|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56854518|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56854519|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854520|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56854521|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56854522|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56854523|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854524|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854525|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56854526|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56854527|NCT01154426|Gemcitabine|gemcitabine|mesh-list
56854528|NCT01154426|Veliparib|veliparib|mesh-list
56854529|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56854530|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
56854531|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854532|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854533|NCT01154426|Antiviral Agents|antiviral agents|mesh-ancestor
56854534|NCT01154426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854535|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854537|NCT01154426|Immunologic Factors|immunologic factors|mesh-ancestor
56854538|NCT01154426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854539|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56854540|NCT01589744|Hemostatics|hemostatics|mesh-list
56854541|NCT01589744|Coagulants|coagulants|mesh-ancestor
56854542|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
56854543|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56854544|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56854545|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
56854546|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854547|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854548|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56854549|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
56854550|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56854551|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
56854552|NCT01154504|Protective Agents|protective agents|mesh-ancestor
56854553|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56565359|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
56854554|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56854555|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56854556|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854557|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854558|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854559|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854561|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
56854562|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854563|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
56854564|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56854565|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
56854566|NCT01155908|Amlodipine|amlodipine|mesh-list
56854567|NCT01155908|Benazepril|benazepril|mesh-list
56854568|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56854569|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56854570|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854571|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854572|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56854573|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854574|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
56854575|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56854576|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
56854577|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854578|NCT03880448|Metronidazole|metronidazole|mesh-list
56854579|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854580|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56854581|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56854582|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56854583|NCT03298984|Cytarabine|cytarabine|mesh-list
56854584|NCT03298984|Daunorubicin|daunorubicin|mesh-list
56854585|NCT03298984|Alvocidib|alvocidib|mesh-list
56854586|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56854587|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
56854588|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854589|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854590|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
56854591|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854592|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56854593|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
56854594|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854595|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56854596|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56854597|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56854598|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854599|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
56854600|NCT03298984|Growth Substances|growth substances|mesh-ancestor
56854601|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56854602|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56854603|NCT03883880|Capsaicin|capsaicin|mesh-list
56854604|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
56854605|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
56854606|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
56854607|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854608|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854609|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
56854611|NCT03883880|Protective Agents|protective agents|mesh-ancestor
56854612|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56854613|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56854614|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854615|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56854616|NCT03887858|Tamsulosin|tamsulosin|mesh-list
56854617|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56854618|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56854619|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56854620|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
56854621|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854622|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854623|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854624|NCT03887858|Urological Agents|urological agents|mesh-ancestor
56854625|NCT02940574|Oxytocin|oxytocin|mesh-list
56854626|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
56854627|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56854628|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854629|NCT01264328|Paclitaxel|paclitaxel|mesh-list
56854630|NCT01264328|Panitumumab|panitumumab|mesh-list
56854631|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56854632|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854633|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
56854634|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
56854635|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
56854636|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854637|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56854638|NCT01157858|Everolimus|everolimus|mesh-list
56854639|NCT01157858|Octreotide|octreotide|mesh-list
56854640|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854641|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56854642|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
56854643|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854644|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56854645|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56854646|NCT01157936|Allopurinol|allopurinol|mesh-list
56854647|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
56854648|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854649|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854650|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
56854651|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56854652|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56854653|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
56854654|NCT01157936|Protective Agents|protective agents|mesh-ancestor
56854655|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854656|NCT01264484|Imidacloprid|imidacloprid|mesh-list
56854657|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
56854658|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854659|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854660|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854661|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
56854662|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56854663|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56854664|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854665|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
56854666|NCT01260818|Coagulants|coagulants|mesh-ancestor
56854667|NCT01262612|Cediranib|cediranib|mesh-list
56854668|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854669|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56854670|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854671|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854672|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56854673|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
56854674|NCT01158014|Coagulants|coagulants|mesh-ancestor
56854675|NCT03884036|Vitamin D|vitamin d|mesh-list
56854676|NCT03884036|Vitamins|vitamins|mesh-ancestor
56854677|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
56854678|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854679|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56854680|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56854681|NCT01158170|Gefitinib|gefitinib|mesh-list
56854682|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854683|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56854684|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854685|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854687|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
56854688|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854689|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854690|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854691|NCT01264640|Aspirin|aspirin|mesh-list
56854692|NCT01264640|Clopidogrel|clopidogrel|mesh-list
56854693|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56854694|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56854695|NCT01264640|Analgesics|analgesics|mesh-ancestor
56854696|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
56854697|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854698|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854699|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56854700|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56854701|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56854702|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56854703|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854704|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56854705|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56854706|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854707|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
56854708|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56854709|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56854710|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56854711|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
56854712|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854713|NCT01155986|Lidocaine|lidocaine|mesh-list
56854714|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
56854715|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
56854716|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854717|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854718|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
56854719|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854720|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56854721|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56854722|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56854723|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854724|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854725|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56854726|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56854727|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
56854728|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854729|NCT01261130|Antacids|antacids|mesh-ancestor
56854730|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854731|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56854732|NCT01158248|Panitumumab|panitumumab|mesh-list
56854733|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854734|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56854735|NCT01264874|Vitamin D|vitamin d|mesh-list
56854736|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
56854737|NCT01264874|Vitamins|vitamins|mesh-ancestor
56854738|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
56854739|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854740|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56854741|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56854742|NCT01262924|Vaccines|vaccines|mesh-list
56854743|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
56854744|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854745|NCT01158560|Vitamin D|vitamin d|mesh-list
56854746|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
56854747|NCT01158560|Vitamins|vitamins|mesh-ancestor
56854748|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
56854749|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854750|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56854751|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56854752|NCT03879746|Paroxetine|paroxetine|mesh-list
56854753|NCT03879746|Tamsulosin|tamsulosin|mesh-list
56854754|NCT03879746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56854755|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56854756|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854757|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854759|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
56854760|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854761|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56854762|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
56854763|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56854764|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56854765|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56854766|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854767|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56854768|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56854769|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56854770|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
56854771|NCT03879746|Urological Agents|urological agents|mesh-ancestor
56854772|NCT03879590|Budesonide|budesonide|mesh-list
56854773|NCT03879590|Doxofylline|doxofylline|mesh-list
56854774|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56854775|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56854776|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
56854777|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854778|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854779|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56854780|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
56854781|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
56854782|NCT03879590|Hormones|hormones|mesh-ancestor
56854783|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56854784|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
56854785|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56854786|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854787|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854788|NCT01265108|Iron|iron|mesh-list
56854789|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56854790|NCT01265108|Trace Elements|trace elements|mesh-ancestor
56854791|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
56854792|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854793|NCT01265108|Hematinics|hematinics|mesh-ancestor
56854794|NCT01154738|Lidocaine|lidocaine|mesh-list
56854795|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
56854796|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
56854797|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854798|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854799|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
56854800|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854801|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56854802|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56854803|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56854804|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854805|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854806|NCT01263002|Adefovir|adefovir|mesh-list
56854807|NCT01263002|Clevudine|clevudine|mesh-list
56854808|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
56854809|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854810|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56854811|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56854812|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854813|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854814|NCT01261286|Verapamil|verapamil|mesh-list
56854815|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56854816|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56854817|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56854818|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854819|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56854820|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854821|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
56854822|NCT01263080|Folic Acid|folic acid|mesh-list
56854823|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
56854824|NCT01263080|Mirtazapine|mirtazapine|mesh-list
56854825|NCT01263080|Vitamins|vitamins|mesh-ancestor
56854826|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
56854827|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854828|NCT01263080|Hematinics|hematinics|mesh-ancestor
56854829|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
56854830|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56854831|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56854834|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854835|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854836|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56854837|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56854838|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854839|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56854840|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56854841|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56854842|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
56854843|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56854844|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56854845|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
56854846|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56854847|NCT01263158|Oxytocin|oxytocin|mesh-list
56854848|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
56854849|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56854850|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854851|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
56854852|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56854853|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
56854854|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854855|NCT03879356|Expectorants|expectorants|mesh-ancestor
56854856|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
56854857|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56854858|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
56854859|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854860|NCT03879356|Protective Agents|protective agents|mesh-ancestor
56854861|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854862|NCT03879356|Antidotes|antidotes|mesh-ancestor
56854863|NCT01159418|Paclitaxel|paclitaxel|mesh-list
56854864|NCT01159418|Carboplatin|carboplatin|mesh-list
56854865|NCT01159418|Panobinostat|panobinostat|mesh-list
56854866|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56854867|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854868|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
56854869|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
56854870|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
56854871|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854872|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56854873|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854874|NCT03886766|Efavirenz|efavirenz|mesh-list
56854875|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56854876|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56854877|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854878|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854879|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
56854880|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854881|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56854882|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56854883|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56854884|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56854885|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56854886|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56854887|NCT01265342|Beclomethasone|beclomethasone|mesh-list
56854888|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56854889|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
56854890|NCT01265342|Hormones|hormones|mesh-ancestor
56854891|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56854892|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854893|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56854894|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
56854895|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
56854896|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56854897|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
56854898|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854899|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
56854900|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854901|NCT01265576|Etodolac|etodolac|mesh-list
56854902|NCT01265576|Sorafenib|sorafenib|mesh-list
56854903|NCT01265576|Propranolol|propranolol|mesh-list
56854904|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56854906|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854907|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854908|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56854909|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56854910|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
56854911|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854912|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854913|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56854914|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56854915|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
56854916|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56854917|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56854918|NCT01265576|Analgesics|analgesics|mesh-ancestor
56854919|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
56854920|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854921|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56854922|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56854923|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56854924|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56854925|NCT03883022|Vancomycin|vancomycin|mesh-list
56854926|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56854927|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56854928|NCT01159652|Zaleplon|zaleplon|mesh-list
56854929|NCT01159652|Zolpidem|zolpidem|mesh-list
56854930|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56854931|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56854932|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854933|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854934|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56854935|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
56854936|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
56854937|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854938|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854939|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
56854940|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
56854941|NCT01261832|Cilostazol|cilostazol|mesh-list
56854942|NCT01261832|Clopidogrel|clopidogrel|mesh-list
56854943|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56854944|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56854945|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56854946|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56854947|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
56854948|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854949|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854950|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854951|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56854952|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
56854953|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854954|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56459883|NCT00464919|Tegafur|tegafur|mesh-list
56854955|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
56854956|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56854957|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56854958|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
56854959|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56854960|NCT01261832|Protective Agents|protective agents|mesh-ancestor
56854961|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56854962|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56854963|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56854964|NCT01265810|Calcium|calcium|mesh-list
56854965|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56854966|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854967|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
56854968|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56854969|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
56854970|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56854971|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854972|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56854973|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
56854974|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56854975|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
56854976|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56854977|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56854980|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
56854981|NCT01265888|Protective Agents|protective agents|mesh-ancestor
56854982|NCT01155206|Glucagon|glucagon|mesh-list
56854983|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56854984|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56854985|NCT01155206|Hormones|hormones|mesh-ancestor
56854986|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56854987|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854988|NCT01155206|Incretins|incretins|mesh-ancestor
56854989|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
56854990|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
56854991|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
56854992|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854993|NCT03878888|Bupivacaine|bupivacaine|mesh-list
56854994|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
56854995|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
56854996|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56854997|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56854998|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
56854999|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855000|NCT03882710|Metoprolol|metoprolol|mesh-list
56855001|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56855002|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56855003|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
56855004|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
56855005|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855006|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855007|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56855008|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56855009|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56855010|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
56855011|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855012|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855013|NCT01161836|Iniparib|iniparib|mesh-list
56855014|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56855015|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855016|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855017|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855018|NCT01266434|Simvastatin|simvastatin|mesh-list
56855019|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56855020|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56855021|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
56855022|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855023|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56855024|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56855025|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855026|NCT01266512|Docetaxel|docetaxel|mesh-list
56855027|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855028|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
56855029|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
56855030|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
56855031|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855032|NCT01160042|Metformin|metformin|mesh-list
56855033|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56855034|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855035|NCT03882788|Fentanyl|fentanyl|mesh-list
56855036|NCT03882788|Isoflurane|isoflurane|mesh-list
56855037|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56855038|NCT03882788|Narcotics|narcotics|mesh-ancestor
56855039|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855040|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855041|NCT03882788|Analgesics|analgesics|mesh-ancestor
56855042|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
56855043|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855044|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56855045|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56855046|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
56855047|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
56855048|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56855049|NCT01156688|Misoprostol|misoprostol|mesh-list
56855050|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56855051|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
56855052|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56855053|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855054|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56855055|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855057|NCT03876704|Vitamins|vitamins|mesh-list
56855058|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
56855059|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855060|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56855061|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
56855062|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855063|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56855064|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855065|NCT03878264|Cortisone|cortisone|mesh-list
56855066|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56855067|NCT03882164|Tacrolimus|tacrolimus|mesh-list
56855068|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56855069|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
56855070|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855071|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56855072|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855073|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855074|NCT01160276|Cyclosporine|cyclosporine|mesh-list
56855075|NCT01160276|Colchicine|colchicine|mesh-list
56855076|NCT01160276|Tacrolimus|tacrolimus|mesh-list
56855077|NCT01160276|Cyclosporins|cyclosporins|mesh-list
56565881|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
56855078|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56855079|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
56855080|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855081|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56855082|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855083|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855084|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
56855085|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855086|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
56855087|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56855088|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
56855089|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
56855090|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
56855091|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
56855092|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855093|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56855094|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56855095|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855096|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56855097|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56855098|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855099|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855100|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
56855101|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855103|NCT01160432|Naloxone|naloxone|mesh-list
56855104|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56855105|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855106|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
56855107|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855108|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56855109|NCT01160432|Narcotics|narcotics|mesh-ancestor
56855110|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855111|NCT01160432|Analgesics|analgesics|mesh-ancestor
56855112|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
56855113|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
56855114|NCT03877718|Promethazine|promethazine|mesh-list
56855115|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
56855116|NCT03877718|Sumatriptan|sumatriptan|mesh-list
56855117|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56855118|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56855119|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56855120|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
56855121|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855122|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855123|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855124|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
56855125|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
56855126|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56855127|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
56855128|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
56855129|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56855130|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56855131|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56855132|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855133|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
56855134|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
56855135|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
56855136|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855137|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
56855138|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
56855139|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855140|NCT01267058|Vaccines|vaccines|mesh-list
56855141|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
56855142|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855143|NCT02526914|Vasopressins|vasopressins|mesh-list
56855144|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
56855145|NCT02526914|Oxytocin|oxytocin|mesh-list
56855146|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
56855147|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56855148|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855149|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
56855150|NCT02526914|Coagulants|coagulants|mesh-ancestor
56855151|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56855152|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56855153|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
56855154|NCT03876938|Olanzapine|olanzapine|mesh-list
56855155|NCT03876938|Aprepitant|aprepitant|mesh-list
56855156|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
56855157|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
56855158|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855159|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855160|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855161|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56855162|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56855163|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855164|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56855165|NCT03876938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56855166|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56855167|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855168|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855169|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855170|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
56855171|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56855172|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56855173|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
56855174|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56855175|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56855176|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855177|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855179|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56855180|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855181|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855182|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56855183|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
56855184|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855185|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56855186|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
56855187|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56855188|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
56855189|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855190|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
56855191|NCT01267214|Protective Agents|protective agents|mesh-ancestor
56855192|NCT01156922|Rituximab|rituximab|mesh-list
56855193|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56855194|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855195|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
56855196|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855197|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56855198|NCT03877874|Terbutaline|terbutaline|mesh-list
56855199|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56855200|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
56855201|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855202|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855203|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56855206|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
56855207|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56855208|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56855209|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56855210|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56855211|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
56855212|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855213|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855214|NCT01160588|Sertraline|sertraline|mesh-list
56855215|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
56855216|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56855217|NCT01160588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56855218|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56855219|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855220|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855221|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855222|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
56855223|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855224|NCT03877562|Olanzapine|olanzapine|mesh-list
56855225|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
56855226|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
56855227|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855228|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855229|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855230|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56855231|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56855232|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855233|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56855234|NCT03877562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56855235|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56855236|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855237|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855238|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855240|NCT01160666|Belimumab|belimumab|mesh-list
56855241|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56855242|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
56855243|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855244|NCT03876548|Iodine|iodine|mesh-list
56855245|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
56855246|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56855247|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855248|NCT03876548|Trace Elements|trace elements|mesh-ancestor
56855249|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
56855250|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855251|NCT03760250|Imiquimod|imiquimod|mesh-list
56855252|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56855253|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
56855254|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855255|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855256|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
56855257|NCT01157000|Canagliflozin|canagliflozin|mesh-list
56855258|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56855259|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855260|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56855261|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855262|NCT01160900|Bivalirudin|bivalirudin|mesh-list
56855263|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56855264|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56855265|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
56855266|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56855267|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
56855268|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855269|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855270|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
56855271|NCT01160978|Simvastatin|simvastatin|mesh-list
56855272|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56855273|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56855274|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
56855275|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855276|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56369734|NCT00089804|Abetimus|abetimus|mesh-list
56855277|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56855278|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855280|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56855281|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56855282|NCT01161134|Analgesics|analgesics|mesh-ancestor
56855283|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
56855284|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855285|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855286|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56855287|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56855288|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56855289|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56855290|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855291|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855292|NCT01268384|Gemcitabine|gemcitabine|mesh-list
56855293|NCT01268384|Capecitabine|capecitabine|mesh-list
56855294|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56855295|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
56855296|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855297|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855298|NCT01268384|Antiviral Agents|antiviral agents|mesh-ancestor
56855299|NCT01268384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855300|NCT01268384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855301|NCT01268384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56566111|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
56855302|NCT01268384|Immunologic Factors|immunologic factors|mesh-ancestor
56855303|NCT01268384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855304|NCT01267448|Metformin|metformin|mesh-list
56855305|NCT01267448|Saxagliptin|saxagliptin|mesh-list
56855306|NCT01267448|Glipizide|glipizide|mesh-list
56855307|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56855308|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855309|NCT01267448|Incretins|incretins|mesh-ancestor
56855310|NCT01267448|Hormones|hormones|mesh-ancestor
56855311|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56855312|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56855313|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
56855314|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855315|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855316|NCT01269476|Fluorides|fluorides|mesh-list
56855317|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
56855318|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
56855319|NCT01269476|Protective Agents|protective agents|mesh-ancestor
56855320|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855321|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56855322|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855323|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855324|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
56855325|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855326|NCT01267604|Inositol|inositol|mesh-list
56855327|NCT01267604|Melatonin|melatonin|mesh-list
56855328|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
56855329|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855330|NCT01267604|Protective Agents|protective agents|mesh-ancestor
56855331|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855332|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855333|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
56855334|NCT01267604|Vitamins|vitamins|mesh-ancestor
56855335|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
56855336|NCT01161368|Vinorelbine|vinorelbine|mesh-list
56855337|NCT01161368|Lapatinib|lapatinib|mesh-list
56855338|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56855339|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855340|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56855341|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56855342|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56855343|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855344|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56855345|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855346|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
56855347|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56855348|NCT01280162|Piperaquine|piperaquine|mesh-list
56855349|NCT01280162|Artenimol|artenimol|mesh-list
56855350|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
56369816|NCT00344149|Rituximab|rituximab|mesh-list
56855353|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855354|NCT01167062|Tamsulosin|tamsulosin|mesh-list
56855355|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56855356|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56855357|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56855358|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
56855359|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855360|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855361|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855362|NCT01167062|Urological Agents|urological agents|mesh-ancestor
56855363|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56855364|NCT01280240|Hematinics|hematinics|mesh-ancestor
56855365|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
56855366|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56855367|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855368|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56855369|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855370|NCT03874364|Lidocaine|lidocaine|mesh-list
56855371|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
56855372|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
56566182|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56855373|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855374|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855375|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
56855376|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855377|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56855378|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56855379|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56855380|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855381|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855382|NCT01163396|Leucovorin|leucovorin|mesh-list
56855383|NCT01163396|Bevacizumab|bevacizumab|mesh-list
56855384|NCT01163396|Fluorouracil|fluorouracil|mesh-list
56855385|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
56855386|NCT01163396|Irinotecan|irinotecan|mesh-list
56855387|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56855388|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855389|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56855390|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56855391|NCT01163396|Growth Substances|growth substances|mesh-ancestor
56855392|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855393|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
56855394|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
56855395|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855396|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56855397|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56855398|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
56855399|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56855400|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56855401|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855402|NCT01163396|Antidotes|antidotes|mesh-ancestor
56855403|NCT01163396|Protective Agents|protective agents|mesh-ancestor
56855404|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
56855405|NCT01163396|Vitamins|vitamins|mesh-ancestor
56855406|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
56855407|NCT01269788|Fluoxetine|fluoxetine|mesh-list
56855408|NCT01269788|Omeprazole|omeprazole|mesh-list
56855409|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56855410|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855411|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56855412|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855413|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855414|NCT01269788|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56855415|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56855416|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855417|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855418|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
56855419|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855420|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56855421|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
56855422|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56855424|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56855425|NCT01163630|Esomeprazole|esomeprazole|mesh-list
56855426|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56855427|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855428|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56855429|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855430|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855431|NCT03874130|Scopolamine|scopolamine|mesh-list
56855432|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56855433|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56855434|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
56855435|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
56855436|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855437|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855438|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855439|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
56855440|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56855441|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
56855442|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855443|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855444|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56855445|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
56855446|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56855447|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56855448|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56855449|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855450|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855451|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855452|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855453|NCT01269866|Analgesics|analgesics|mesh-ancestor
56855454|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
56855455|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855456|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
56855457|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56855458|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
56855459|NCT05387642|Pramoxine|pramoxine|mesh-list
56855460|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
56855461|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
56855462|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855463|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855464|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
56855465|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855466|NCT03871322|Vitamin D|vitamin d|mesh-list
56855467|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
56855468|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
56855469|NCT03871322|Vitamins|vitamins|mesh-list
56855470|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
56855471|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855472|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56855473|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56855474|NCT00313781|Prednisone|prednisone|mesh-list
56855475|NCT00313781|Docetaxel|docetaxel|mesh-list
56855476|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855477|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
56855478|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
56855479|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
56855480|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855481|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56855482|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
56855483|NCT00313781|Hormones|hormones|mesh-ancestor
56855484|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56855485|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855486|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56855487|NCT03871478|Lidocaine|lidocaine|mesh-list
56855488|NCT03871478|Bupivacaine|bupivacaine|mesh-list
56855489|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
56855490|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
56855491|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855492|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855493|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
56855494|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855495|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56855497|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56855498|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855499|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855501|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56855502|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855503|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56855504|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
56855505|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855506|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855507|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855508|NCT00368537|Ampicillin|ampicillin|mesh-list
56855509|NCT00368537|Tigecycline|tigecycline|mesh-list
56855510|NCT00368537|Sulbactam|sulbactam|mesh-list
56855511|NCT00368537|Sultamicillin|sultamicillin|mesh-list
56855512|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56855513|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855514|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56855515|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855516|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855517|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56855518|NCT01165580|Valganciclovir|valganciclovir|mesh-list
56855519|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
56855520|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855521|NCT01048619|ON 01910|on 01910|mesh-list
56855522|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855523|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56855524|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855525|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855526|NCT01281800|Gemcitabine|gemcitabine|mesh-list
56855527|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56855528|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
56855529|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855530|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855531|NCT01281800|Antiviral Agents|antiviral agents|mesh-ancestor
56855532|NCT01281800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855533|NCT01281800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855534|NCT01281800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56855535|NCT01281800|Immunologic Factors|immunologic factors|mesh-ancestor
56855536|NCT01281800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855537|NCT03982121|Nivolumab|nivolumab|mesh-list
56855538|NCT03982121|Ipilimumab|ipilimumab|mesh-list
56855539|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56855540|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855541|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56855542|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855543|NCT01167530|Everolimus|everolimus|mesh-list
56855544|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855545|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56855546|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
56855547|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855548|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
56855549|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56855550|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56855551|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855552|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
56855553|NCT01167764|Coagulants|coagulants|mesh-ancestor
56855554|NCT01164176|Everolimus|everolimus|mesh-list
56855555|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855556|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56855557|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
56855558|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855559|NCT00313313|Metformin|metformin|mesh-list
56855560|NCT00313313|Saxagliptin|saxagliptin|mesh-list
56855561|NCT00313313|Glyburide|glyburide|mesh-list
56855562|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56855563|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855564|NCT00313313|Incretins|incretins|mesh-ancestor
56855565|NCT00313313|Hormones|hormones|mesh-ancestor
56855566|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56855567|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56855568|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
56855569|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855570|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855571|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
56855572|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
56855573|NCT01167920|Diuretics|diuretics|mesh-list
56855574|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56855575|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56855576|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855577|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
56855578|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
56855579|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855580|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855581|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56855582|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855583|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
56855584|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
56855585|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
56855586|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855587|NCT01268930|Hemostatics|hemostatics|mesh-list
56855588|NCT01268930|Coagulants|coagulants|mesh-ancestor
56855589|NCT02526758|Budesonide|budesonide|mesh-list
56855590|NCT02526758|Beclomethasone|beclomethasone|mesh-list
56855591|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
56855592|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56855593|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56855594|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
56855595|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855596|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855597|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56855598|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
56855599|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
56855600|NCT02526758|Hormones|hormones|mesh-ancestor
56855601|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566404|NCT02612545|Mefloquine|mefloquine|mesh-list
56855602|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56855603|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56855604|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56855605|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56855606|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855607|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855608|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
56855609|NCT01281878|Pyridoxal|pyridoxal|mesh-list
56855610|NCT01281878|Pyridoxine|pyridoxine|mesh-list
56855611|NCT01281878|Vitamins|vitamins|mesh-ancestor
56855612|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
56855613|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855614|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
56855615|NCT01164488|Ritonavir|ritonavir|mesh-list
56855616|NCT01164488|Ketoconazole|ketoconazole|mesh-list
56855617|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56855618|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56855619|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
56855620|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855621|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855622|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56855623|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56855624|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
56855625|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855626|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56855627|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56855628|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
56855629|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56855630|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56855631|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
56855632|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56855633|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855634|NCT00312845|Rituximab|rituximab|mesh-list
56855635|NCT00312845|Bortezomib|bortezomib|mesh-list
56855636|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56855637|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855638|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
56855639|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855640|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56855641|NCT01168544|Vitamin D|vitamin d|mesh-list
56855642|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
56855643|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
56855644|NCT01168544|Vitamins|vitamins|mesh-list
56855645|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
56855647|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56855648|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56855649|NCT00368069|Levetiracetam|levetiracetam|mesh-list
56855650|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
56855651|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
56855652|NCT01165814|Naproxen|naproxen|mesh-list
56855653|NCT01165814|Tramadol|tramadol|mesh-list
56855654|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56855655|NCT01165814|Narcotics|narcotics|mesh-ancestor
56855656|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855657|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855658|NCT01165814|Analgesics|analgesics|mesh-ancestor
56855659|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
56855660|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855661|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56855662|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56855663|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56855664|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56855665|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
56855666|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56855667|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855668|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855669|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
56855670|NCT00367991|Hematinics|hematinics|mesh-ancestor
56855671|NCT00367835|Guanfacine|guanfacine|mesh-list
56855672|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56855673|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56855674|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56566480|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
56855675|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56855676|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
56855677|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855678|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855679|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855680|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
56855681|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56855682|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
56855683|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
56855684|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855685|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855686|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855687|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56855688|NCT03874832|Analgesics|analgesics|mesh-ancestor
56855689|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
56855690|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855691|NCT01164800|Trandolapril|trandolapril|mesh-list
56855692|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56855693|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
56855694|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855695|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855696|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56855697|NCT01169012|Clofarabine|clofarabine|mesh-list
56855698|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56855699|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
56855700|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855701|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855702|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56855703|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56855704|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855705|NCT01169090|Incretins|incretins|mesh-ancestor
56855706|NCT01169090|Hormones|hormones|mesh-ancestor
56855707|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56855708|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56855709|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
56855710|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855711|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855712|NCT01282502|Midostaurin|midostaurin|mesh-list
56855713|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855714|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56855715|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855716|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855717|NCT01269242|Bindarit|bindarit|mesh-list
56855720|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855721|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855722|NCT01169792|Tamoxifen|tamoxifen|mesh-list
56855723|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56855724|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
56855725|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56855726|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855727|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56855728|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855729|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56855730|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56855731|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56855732|NCT01169402|Fluconazole|fluconazole|mesh-list
56855733|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
56855734|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855735|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56855736|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56855737|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855738|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855739|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56855740|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
56855741|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56855742|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855743|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56855744|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56855745|NCT01274780|Ritonavir|ritonavir|mesh-list
56855746|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56855747|NCT01274780|Darunavir|darunavir|mesh-list
56855748|NCT01274780|Tenofovir|tenofovir|mesh-list
56566562|NCT01104701|Exenatide|exenatide|mesh-list
56855750|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56855751|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56855752|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
56855753|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855754|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855755|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56855756|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56855757|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
56855758|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855759|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56855760|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56855761|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56855762|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56855763|NCT01169870|Paclitaxel|paclitaxel|mesh-list
56855764|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56855765|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855766|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
56855767|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
56855768|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
56855769|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855770|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56855771|NCT01165970|Laxatives|laxatives|mesh-ancestor
56855772|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855773|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56855774|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56855775|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56855776|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855777|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855778|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855779|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855780|NCT01166048|Analgesics|analgesics|mesh-ancestor
56855781|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
56855782|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855783|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
56855784|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56855785|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
56855786|NCT03869762|Denosumab|denosumab|mesh-list
56855787|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56855788|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855789|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56855790|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855791|NCT01283048|Bevacizumab|bevacizumab|mesh-list
56855792|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56855793|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855794|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56855795|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56855796|NCT01283048|Growth Substances|growth substances|mesh-ancestor
56855797|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855798|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
56855799|NCT03873740|Vaccines|vaccines|mesh-list
56855800|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
56855801|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855802|NCT01172756|Riociguat|riociguat|mesh-list
56855803|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
56855804|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855805|NCT02525822|Tazarotene|tazarotene|mesh-list
56855806|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
56855807|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
56855808|NCT01172912|Dexamethasone|dexamethasone|mesh-list
56855809|NCT01172912|Carboplatin|carboplatin|mesh-list
56855810|NCT01172912|Etoposide|etoposide|mesh-list
56855811|NCT01172912|Ifosfamide|ifosfamide|mesh-list
56855812|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56855813|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
56855814|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
56855815|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855816|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855817|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855818|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
56855819|NCT01172912|Hormones|hormones|mesh-ancestor
56855820|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56855821|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56855822|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855823|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56855824|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56855825|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56855826|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855827|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855828|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56855829|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
56855830|NCT01283204|Leucovorin|leucovorin|mesh-list
56855831|NCT01283204|Paclitaxel|paclitaxel|mesh-list
56855832|NCT01283204|Docetaxel|docetaxel|mesh-list
56855833|NCT01283204|Cisplatin|cisplatin|mesh-list
56855834|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
56855835|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
56855836|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56855837|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855838|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
56855839|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
56855840|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
56855841|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855842|NCT01283204|Antidotes|antidotes|mesh-ancestor
56855843|NCT01283204|Protective Agents|protective agents|mesh-ancestor
56855844|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855845|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
56855846|NCT01283204|Vitamins|vitamins|mesh-ancestor
56855847|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
56855848|NCT03869528|Lidocaine|lidocaine|mesh-list
56855849|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
56855850|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
56855851|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855852|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855853|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
56855854|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855855|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56855856|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56855857|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56855858|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855859|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855860|NCT01283360|Tenofovir|tenofovir|mesh-list
56855861|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
56855862|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855863|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56904617|NCT02621398|Paclitaxel|paclitaxel|mesh-list
56855865|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855866|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855867|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56855868|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56855869|NCT01173068|Ertapenem|ertapenem|mesh-list
56855870|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56855871|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855872|NCT03267940|Atezolizumab|atezolizumab|mesh-list
56855873|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855874|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
56855875|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56855876|NCT01170104|Sorafenib|sorafenib|mesh-list
56855877|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855878|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56855879|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855880|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855881|NCT01284764|Mosapride|mosapride|mesh-list
56855882|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855883|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56855884|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
56855885|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855886|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855887|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855888|NCT01170182|Omeprazole|omeprazole|mesh-list
56855889|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56855890|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855891|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56855892|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855893|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855894|NCT01170260|Ethanol|ethanol|mesh-list
56855895|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56855896|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855897|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566703|NCT02872818|Estrogens|estrogens|mesh-ancestor
56855898|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855899|NCT00312377|Docetaxel|docetaxel|mesh-list
56855900|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855901|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
56855902|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
56855903|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
56855904|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855905|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
56855906|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56855907|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855908|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56855909|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56855910|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855911|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855912|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855913|NCT01580891|Naftifine|naftifine|mesh-list
56855914|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
56855915|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56855916|NCT01059383|Esomeprazole|esomeprazole|mesh-list
56855917|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56855918|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56855919|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56855920|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56855921|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855922|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56855923|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56855924|NCT01166594|Bevacizumab|bevacizumab|mesh-list
56855925|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56855926|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56855927|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56855928|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56855929|NCT01166594|Growth Substances|growth substances|mesh-ancestor
56855930|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855931|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56855932|NCT01170338|Varenicline|varenicline|mesh-list
56855933|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56855934|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56855935|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
56855936|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855937|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855938|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855939|NCT00312221|Oxycodone|oxycodone|mesh-list
56855940|NCT00312221|Buprenorphine|buprenorphine|mesh-list
56855941|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56855942|NCT00312221|Narcotics|narcotics|mesh-ancestor
56855943|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855944|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855945|NCT00312221|Analgesics|analgesics|mesh-ancestor
56855946|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
56855947|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855948|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56855949|NCT03872570|Phenylephrine|phenylephrine|mesh-list
56855950|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
56855951|NCT03872570|Norepinephrine|norepinephrine|mesh-list
56855952|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56855953|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
56855954|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
56855955|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56855956|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855957|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
56855958|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56855959|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
56855960|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
56855961|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56855962|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56855963|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56855964|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
56855965|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855966|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855967|NCT03872570|Protective Agents|protective agents|mesh-ancestor
56855968|NCT01173926|Insulin|insulin|mesh-list
56855969|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56855970|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
56855971|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
56855972|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56855973|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56855974|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855976|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56855977|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
56855978|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
56855979|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56855980|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855981|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
56855982|NCT01170494|Vitamin D|vitamin d|mesh-list
56855983|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
56855984|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56855985|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855986|NCT01170494|Vitamins|vitamins|mesh-ancestor
56855987|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
56855988|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56855989|NCT01587326|Citalopram|citalopram|mesh-list
56855990|NCT01587326|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56855991|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56855992|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56855993|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56855994|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56855995|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
56855996|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56855997|NCT01587326|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56855998|NCT01587326|Antidepressive Agents|antidepressive agents|mesh-ancestor
56855999|NCT01587326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56856000|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56856001|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56856002|NCT03294538|Estradiol|estradiol|mesh-list
56856003|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56856004|NCT03294538|Estrogens|estrogens|mesh-ancestor
56856005|NCT03294538|Hormones|hormones|mesh-ancestor
56856006|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856007|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856008|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56856009|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
56856010|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56856011|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56856012|NCT03872336|Labetalol|labetalol|mesh-list
56904618|NCT02621398|Carboplatin|carboplatin|mesh-list
56856013|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56856014|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56856015|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
56856016|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856017|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856018|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856019|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56856020|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
56856021|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
56856022|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856023|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56856024|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56856025|NCT02987530|Tenofovir|tenofovir|mesh-list
56856026|NCT02987530|Emtricitabine|emtricitabine|mesh-list
56856027|NCT02987530|Dolutegravir|dolutegravir|mesh-list
56856028|NCT02987530|Darunavir|darunavir|mesh-list
56856029|NCT02987530|Cobicistat|cobicistat|mesh-list
56856030|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56856031|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
56856032|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856033|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56856034|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56856035|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856036|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856037|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56856038|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56856039|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56856040|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56856041|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56856042|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56856043|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
56856044|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56856045|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56856046|NCT03865550|Ketamine|ketamine|mesh-list
56856047|NCT03865550|Analgesics|analgesics|mesh-ancestor
56856048|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
56856049|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856050|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856051|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56856052|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56856053|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
56856054|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
56856055|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856056|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56856057|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56856058|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856059|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856060|NCT02965690|Cimetidine|cimetidine|mesh-list
56856061|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56856062|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56856063|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56856064|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
56856065|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
56856066|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856067|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856068|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856069|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56856070|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56856071|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856072|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
56856073|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856074|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56856075|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56856076|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856077|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856078|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
56856079|NCT01285466|Paclitaxel|paclitaxel|mesh-list
56856080|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56856081|NCT01285466|Trastuzumab|trastuzumab|mesh-list
56856082|NCT01285466|Dactolisib|dactolisib|mesh-list
56856083|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56856084|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856085|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
56856086|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
56856087|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
56856088|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856089|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56856090|NCT01285544|Atorvastatin|atorvastatin|mesh-list
56856091|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56856092|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56856093|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
56856094|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856095|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56856096|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56856097|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856098|NCT01174394|Fluoxetine|fluoxetine|mesh-list
56856099|NCT01174394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56856100|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56856101|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856102|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856103|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856104|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
56856105|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856106|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56856107|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
56856108|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56856109|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56856110|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56856111|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856112|NCT01174472|Paclitaxel|paclitaxel|mesh-list
56856113|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56856114|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856115|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56856116|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56856117|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56856118|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856119|NCT00335153|Levodopa|levodopa|mesh-list
56566928|NCT00832117|Epothilones|epothilones|mesh-list
56856120|NCT00335153|Carbidopa|carbidopa|mesh-list
56856121|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56856122|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56856123|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56856124|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
56856125|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856126|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903747|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56856127|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856128|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56856129|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856130|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56856131|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
56856132|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
56856133|NCT01170806|Orlistat|orlistat|mesh-list
56856134|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856135|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856136|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56856137|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56856138|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
56856139|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56856140|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
56856141|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
56856142|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856143|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856144|NCT01280006|Celecoxib|celecoxib|mesh-list
56856145|NCT01280006|Indomethacin|indomethacin|mesh-list
56856146|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56856147|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56856148|NCT01280006|Analgesics|analgesics|mesh-ancestor
56856149|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
56856150|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856151|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856152|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856153|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856154|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56856155|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56856156|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856157|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856158|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
56856159|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
56856160|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56856161|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56856162|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856163|NCT03865160|Atropine|atropine|mesh-list
56856164|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56856165|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56856166|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56856167|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56856168|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56856169|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
56856170|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856171|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856172|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56856173|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
56856174|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
56856175|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
56856176|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56856177|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56856178|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
56856179|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856180|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856181|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
56856182|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56856183|NCT01059461|Protective Agents|protective agents|mesh-ancestor
56856184|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856185|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
56856186|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56856187|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
56856188|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856189|NCT01286246|Progesterone|progesterone|mesh-list
56856190|NCT01286246|Progestins|progestins|mesh-ancestor
56856191|NCT01286246|Hormones|hormones|mesh-ancestor
56856192|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856193|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856194|NCT03981887|Nafithromycin|nafithromycin|mesh-list
56856195|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56856196|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856197|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56856198|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903748|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
56856199|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856200|NCT01063127|Insulin|insulin|mesh-list
56856201|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56856202|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856203|NCT03865004|Acetaminophen|acetaminophen|mesh-list
56856204|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56856205|NCT03865004|Morphine|morphine|mesh-list
56856206|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56856207|NCT03865004|Narcotics|narcotics|mesh-ancestor
56856208|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856209|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856210|NCT03865004|Analgesics|analgesics|mesh-ancestor
56856211|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
56856212|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856213|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56856214|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
56856215|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56856216|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856217|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856218|NCT00334295|Fulvestrant|fulvestrant|mesh-list
56856219|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56856220|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856221|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56856222|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56856223|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
56856224|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856225|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856226|NCT01285778|Panitumumab|panitumumab|mesh-list
56856227|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56856228|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856229|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
56856230|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56856231|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
56856232|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856233|NCT01063205|Expectorants|expectorants|mesh-ancestor
56856234|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
56856235|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56856237|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856238|NCT01063205|Protective Agents|protective agents|mesh-ancestor
56856239|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856240|NCT01063205|Antidotes|antidotes|mesh-ancestor
56856241|NCT01175096|Everolimus|everolimus|mesh-list
56856242|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856243|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856244|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
56856245|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856246|NCT01285934|Insulin|insulin|mesh-list
56856247|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56856248|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856249|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
56856250|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56856251|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56856252|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856253|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
56856254|NCT01060163|Coagulants|coagulants|mesh-ancestor
56856255|NCT01063439|Cytarabine|cytarabine|mesh-list
56856256|NCT01063439|Etoposide|etoposide|mesh-list
56856257|NCT01063439|Melphalan|melphalan|mesh-list
56856258|NCT01063439|Busulfan|busulfan|mesh-list
56856259|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56856260|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856261|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56856262|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56856263|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856264|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856265|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56856266|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
56856267|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
56856268|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567076|NCT05010876|Icatibant|icatibant|mesh-list
56856269|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856270|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
56856271|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856272|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56856273|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
56856274|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56856275|NCT05275270|Oxytocin|oxytocin|mesh-list
56856276|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
56856277|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56856278|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856279|NCT02884648|Bevacizumab|bevacizumab|mesh-list
56856280|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56856281|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856282|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56856283|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56856284|NCT02884648|Growth Substances|growth substances|mesh-ancestor
56856285|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856286|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
56856287|NCT03868124|Travoprost|travoprost|mesh-list
56856288|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56856289|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56856290|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56856291|NCT03868202|Estradiol|estradiol|mesh-list
56856292|NCT03868202|Progesterone|progesterone|mesh-list
56856293|NCT03868202|Estrogens|estrogens|mesh-ancestor
56856294|NCT03868202|Hormones|hormones|mesh-ancestor
56856295|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856296|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856297|NCT03868202|Progestins|progestins|mesh-ancestor
56856298|NCT00311363|Gabapentin|gabapentin|mesh-list
56856299|NCT00311363|Analgesics|analgesics|mesh-ancestor
56856300|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
56856301|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856302|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856303|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
56856304|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56856305|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56856306|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856307|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56856308|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56856309|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56856310|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856312|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
56856313|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56856314|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56856315|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56856316|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56856317|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56856318|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56856319|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
56856321|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56856322|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56856323|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56856324|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
56856325|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856326|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856327|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856328|NCT00310817|Vaccines|vaccines|mesh-list
56856329|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
56856330|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856331|NCT03783286|Ivacaftor|ivacaftor|mesh-list
56856332|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56856333|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856334|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856335|NCT03863366|Prucalopride|prucalopride|mesh-list
56856336|NCT03863366|Laxatives|laxatives|mesh-ancestor
56856337|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56856338|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56856339|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56856340|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
56856341|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856342|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856343|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856344|NCT01175486|Pioglitazone|pioglitazone|mesh-list
56567152|NCT04786275|Analgesics|analgesics|mesh-ancestor
56856345|NCT01175486|Acarbose|acarbose|mesh-list
56856346|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56856347|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903752|NCT02072278|Vortioxetine|vortioxetine|mesh-list
56856348|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56856349|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856350|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856351|NCT01177904|Progesterone|progesterone|mesh-list
56856352|NCT01177904|Progestins|progestins|mesh-ancestor
56856353|NCT01177904|Hormones|hormones|mesh-ancestor
56856354|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856355|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856356|NCT02940886|Iron|iron|mesh-list
56856357|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56856358|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56856359|NCT02940886|Trace Elements|trace elements|mesh-ancestor
56856360|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
56856361|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856362|NCT02940886|Hematinics|hematinics|mesh-ancestor
56856363|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
56856364|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56856365|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56856366|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856367|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856368|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56856369|NCT05216614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56856370|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56856371|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856372|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856373|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856374|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
56856375|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56856376|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
56856377|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56856378|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56856379|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856380|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56856381|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56856383|NCT03860636|Estradiol|estradiol|mesh-list
56856384|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56856385|NCT03860636|Progesterone|progesterone|mesh-list
56856386|NCT03860636|Estrogens|estrogens|mesh-ancestor
56856387|NCT03860636|Hormones|hormones|mesh-ancestor
56856388|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856389|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856390|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56856391|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
56856392|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56856393|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56856394|NCT03860636|Progestins|progestins|mesh-ancestor
56856395|NCT03860480|Bupivacaine|bupivacaine|mesh-list
56856396|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
56856397|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
56856398|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856399|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856400|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
56856401|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856402|NCT03285646|Fasinumab|fasinumab|mesh-list
56856403|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56856404|NCT03285646|Analgesics|analgesics|mesh-ancestor
56856405|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
56856406|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856407|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856408|NCT03860012|Folic Acid|folic acid|mesh-list
56856409|NCT03860012|Hematinics|hematinics|mesh-ancestor
56856410|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
56856411|NCT03860012|Vitamins|vitamins|mesh-ancestor
56856412|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
56856413|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856414|NCT03859934|Melatonin|melatonin|mesh-list
56856415|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
56856416|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856417|NCT03859934|Protective Agents|protective agents|mesh-ancestor
56856418|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856419|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856420|NCT01178372|Lactulose|lactulose|mesh-list
56856421|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56856422|NCT01178450|Cinacalcet|cinacalcet|mesh-list
56856423|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56856424|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856425|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56856426|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
56856427|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856428|NCT00074490|Prednisone|prednisone|mesh-list
56856429|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
56856430|NCT00074490|Rituximab|rituximab|mesh-list
56856431|NCT00074490|Doxorubicin|doxorubicin|mesh-list
56856432|NCT00074490|Fludarabine|fludarabine|mesh-list
56856433|NCT00074490|Etoposide|etoposide|mesh-list
56856434|NCT00074490|Vincristine|vincristine|mesh-list
56856435|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856436|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
56856437|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856438|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856439|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56856440|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
56856441|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856442|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856443|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56856444|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56856445|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56856446|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56856447|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56856448|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856449|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856450|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
56856451|NCT00074490|Hormones|hormones|mesh-ancestor
56856452|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856453|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56856454|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56856455|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
56856456|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
56856457|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
56856458|NCT03859856|Hormones|hormones|mesh-list
56856459|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856460|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856461|NCT01094028|Oxytocin|oxytocin|mesh-list
56856462|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
56856463|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56856464|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856465|NCT01288508|Psyllium|psyllium|mesh-list
56856466|NCT01288508|Cathartics|cathartics|mesh-ancestor
56856467|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56856468|NCT01175954|Lacosamide|lacosamide|mesh-list
56856469|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
56856470|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56856471|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56856472|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856473|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856474|NCT01288664|Tacrolimus|tacrolimus|mesh-list
56856475|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856476|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
56856477|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856478|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56856479|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856480|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856481|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
56856482|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856483|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856484|NCT02525276|Hormones|hormones|mesh-list
56856485|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856486|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856487|NCT01172444|Mesalamine|mesalamine|mesh-list
56856488|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56856489|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56856490|NCT01172444|Analgesics|analgesics|mesh-ancestor
56856491|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
56856492|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856493|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856494|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461416|NCT00478101|Oxycodone|oxycodone|mesh-list
56856495|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856496|NCT01288742|Simeprevir|simeprevir|mesh-list
56856497|NCT01288742|Digoxin|digoxin|mesh-list
56856498|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56856499|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56856500|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56856501|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
56856502|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856503|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56856504|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56856505|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856506|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56856507|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56856508|NCT01288742|Protective Agents|protective agents|mesh-ancestor
56856509|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856510|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
56856511|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856512|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
56856513|NCT01178996|Ribavirin|ribavirin|mesh-list
56856514|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56856515|NCT01178996|Thymalfasin|thymalfasin|mesh-list
56856516|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
56856517|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856518|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
56856519|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856520|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56856521|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
56856522|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856523|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
56856524|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56856525|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
56856526|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856527|NCT03862586|Expectorants|expectorants|mesh-ancestor
56856528|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
56856529|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56856530|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
56856531|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856532|NCT03862586|Protective Agents|protective agents|mesh-ancestor
56856534|NCT03862586|Antidotes|antidotes|mesh-ancestor
56856535|NCT01180946|Vitamin D|vitamin d|mesh-list
56856536|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
56856537|NCT01180946|Vitamins|vitamins|mesh-ancestor
56856538|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
56856539|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856540|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56856541|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56856542|NCT01179152|Budesonide|budesonide|mesh-list
56856543|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
56856544|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856545|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56856546|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
56856547|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856548|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856549|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56856550|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
56856551|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
56856552|NCT01179152|Hormones|hormones|mesh-ancestor
56856553|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856554|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56856555|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56856556|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56856557|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
56856558|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856559|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856560|NCT01179230|Dipyridamole|dipyridamole|mesh-list
56856561|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56856562|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856563|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856564|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56856565|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
56856566|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
56856567|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56856568|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
56856569|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56856570|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856571|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56856572|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56856573|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56856575|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856576|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856577|NCT03088826|Acetaminophen|acetaminophen|mesh-list
56856578|NCT03088826|Morphine|morphine|mesh-list
56856579|NCT03088826|Oxycodone|oxycodone|mesh-list
56856580|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56856581|NCT03088826|Narcotics|narcotics|mesh-ancestor
56856582|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856583|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856584|NCT03088826|Analgesics|analgesics|mesh-ancestor
56856585|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
56856586|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856587|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56856588|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
56856589|NCT00367133|Triamcinolone|triamcinolone|mesh-list
56856590|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56856591|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56856592|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56856593|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856594|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
56856595|NCT00367133|Hormones|hormones|mesh-ancestor
56856596|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856597|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856598|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856599|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
56856600|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856601|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856602|NCT01179464|Simvastatin|simvastatin|mesh-list
56856603|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56856604|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56856605|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
56856606|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856607|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56856609|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856610|NCT01179620|Certoparin|certoparin|mesh-list
56856611|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
56856612|NCT01288820|Artesunate|artesunate|mesh-list
56856613|NCT01288820|Primaquine|primaquine|mesh-list
56856614|NCT01288820|Piperaquine|piperaquine|mesh-list
56856615|NCT01288820|Amodiaquine|amodiaquine|mesh-list
56856616|NCT01288820|Artenimol|artenimol|mesh-list
56856617|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
56856618|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56856619|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56856620|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856621|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856622|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
56856623|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
56856624|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56856625|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
56856626|NCT00367055|Metformin|metformin|mesh-list
56856627|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
56856628|NCT00367055|Gliclazide|gliclazide|mesh-list
56856629|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56856630|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856631|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
56856632|NCT00057330|Vaccines|vaccines|mesh-list
56856633|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
56856634|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
56856635|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856636|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56856637|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56856638|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856639|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
56856640|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856641|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
56856642|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56856643|NCT00057330|Protective Agents|protective agents|mesh-ancestor
56856644|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56856645|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856646|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856647|NCT03283696|Doxorubicin|doxorubicin|mesh-list
56856648|NCT03283696|Ifosfamide|ifosfamide|mesh-list
56856649|NCT03283696|Olaratumab|olaratumab|mesh-list
56856650|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56856651|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856652|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56856653|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56856654|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856655|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856656|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56856657|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
56856659|NCT01176344|Vitamins|vitamins|mesh-ancestor
56856660|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
56856661|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856662|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56856663|NCT02530788|Selenium|selenium|mesh-list
56856664|NCT02530788|Selenious Acid|selenious acid|mesh-list
56856665|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
56856666|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
56856667|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856668|NCT02530788|Protective Agents|protective agents|mesh-ancestor
56856669|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856670|NCT02530788|Trace Elements|trace elements|mesh-ancestor
56856671|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
56856672|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
56856673|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56856674|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856675|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56856676|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856677|NCT01089192|Metformin|metformin|mesh-list
56856678|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56856679|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856680|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
56856681|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56856682|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856683|NCT01093092|Calcitriol|calcitriol|mesh-list
56856684|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56856685|NCT01093092|Gemcitabine|gemcitabine|mesh-list
56856686|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856687|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56856688|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
56856689|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856690|NCT01093092|Antiviral Agents|antiviral agents|mesh-ancestor
56856691|NCT01093092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856692|NCT01093092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856693|NCT01093092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856694|NCT01093092|Immunologic Factors|immunologic factors|mesh-ancestor
56856695|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856696|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56856697|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56856698|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856699|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56856700|NCT01093092|Vitamins|vitamins|mesh-ancestor
56856701|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
56856702|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56856703|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
56856704|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856705|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56856706|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856707|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856708|NCT01179776|Iloprost|iloprost|mesh-list
56856709|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56856710|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
56856711|NCT00062010|Interferons|interferons|mesh-list
56856712|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
56856713|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
56856714|NCT00062010|Paclitaxel|paclitaxel|mesh-list
56856715|NCT00062010|Tretinoin|tretinoin|mesh-list
56856716|NCT00062010|Isotretinoin|isotretinoin|mesh-list
56856717|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56856718|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461638|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
56856719|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
56856720|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
56856721|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
56856722|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856723|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
56856724|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856725|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
56856726|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856727|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
56856728|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
56856729|NCT01181414|Amiodarone|amiodarone|mesh-list
56856730|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56856731|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56856732|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
56856733|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856734|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856735|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856736|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56856737|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
56856738|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56856739|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856740|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56856741|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56856742|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56856743|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856744|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56856745|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56856746|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56856747|NCT01094340|Thalidomide|thalidomide|mesh-list
56856748|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856749|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
56856750|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856751|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
56856752|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56856753|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856754|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56856755|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56856756|NCT01094340|Growth Substances|growth substances|mesh-ancestor
56856757|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
56856758|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856759|NCT00056862|Ribavirin|ribavirin|mesh-list
56856760|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56856761|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
56856763|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856764|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
56856765|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856766|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
56856767|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856768|NCT01289132|Candesartan|candesartan|mesh-list
56856769|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
56856770|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56856771|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56856772|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56856773|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56856774|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856775|NCT01287260|Nifedipine|nifedipine|mesh-list
56856776|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56856777|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856778|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856779|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56856780|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856781|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
56856782|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
56856783|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56856784|NCT01181570|Adalimumab|adalimumab|mesh-list
56856785|NCT01181570|Mannitol|mannitol|mesh-list
56856786|NCT01181570|Citric Acid|citric acid|mesh-list
56856787|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
56856788|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
56856789|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56856790|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
56856791|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
56856792|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856793|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856794|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856795|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56856796|NCT01181570|Diuretics|diuretics|mesh-ancestor
56856797|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
56856798|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856799|NCT05200312|Prednisone|prednisone|mesh-list
56856800|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
56856801|NCT05200312|Rituximab|rituximab|mesh-list
56856802|NCT05200312|Doxorubicin|doxorubicin|mesh-list
56856803|NCT05200312|Vincristine|vincristine|mesh-list
56856804|NCT05200312|Lenalidomide|lenalidomide|mesh-list
56856805|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
56856806|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856807|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
56856808|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856809|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856810|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56856811|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
56856812|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856813|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856814|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56856815|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56856816|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56856817|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56856818|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56856819|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856820|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856821|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
56856822|NCT05200312|Hormones|hormones|mesh-ancestor
56856823|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856824|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56856825|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56856826|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
56856827|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
56856828|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
56856829|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56856830|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56856831|NCT05200312|Growth Substances|growth substances|mesh-ancestor
56856832|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
56856833|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56856834|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
56856835|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56904619|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
56856837|NCT02940730|Dalbavancin|dalbavancin|mesh-list
56856838|NCT02940730|Teicoplanin|teicoplanin|mesh-list
56856839|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56856840|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856841|NCT01587638|Metoprolol|metoprolol|mesh-list
56856842|NCT01587638|Atenolol|atenolol|mesh-list
56856843|NCT01587638|Carvedilol|carvedilol|mesh-list
56856844|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
56856845|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56856846|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56856847|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
56856848|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
56856849|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856850|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856851|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56856852|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56856853|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
56856854|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856855|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856856|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
56856857|NCT01587638|Protective Agents|protective agents|mesh-ancestor
56856858|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56856859|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856860|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56856861|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
56856862|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56461782|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
56856863|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56856864|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56856865|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56856866|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56856867|NCT01287338|Analgesics|analgesics|mesh-ancestor
56856868|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
56856869|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856870|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856871|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856872|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856873|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56856874|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56856875|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56856876|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
56856877|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
56856878|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856879|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856881|NCT01180322|Etoposide|etoposide|mesh-list
56856882|NCT01180322|Idarubicin|idarubicin|mesh-list
56856883|NCT01180322|Azacitidine|azacitidine|mesh-list
56856884|NCT01180322|Lenograstim|lenograstim|mesh-list
56856885|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56856886|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856887|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56856888|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56856889|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856890|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856891|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56856892|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
56856893|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
56856894|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856895|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856896|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
56856897|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856898|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56856899|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56856900|NCT01287494|Sertraline|sertraline|mesh-list
56856901|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
56856902|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56856903|NCT01287494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56856904|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56856905|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856906|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856907|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856908|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
56856909|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856910|NCT02524964|Tanshinone|tanshinone|mesh-list
56856912|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56856913|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56856914|NCT02524964|Analgesics|analgesics|mesh-ancestor
56856915|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
56856916|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856917|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856918|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856919|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856920|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
56856921|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56856922|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56856923|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56856924|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
56856925|NCT02639702|Clozapine|clozapine|mesh-list
56856926|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56856927|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
56856928|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856929|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856930|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856931|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56856932|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56856933|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856934|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56856935|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
56856936|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
56856937|NCT01289756|Clarithromycin|clarithromycin|mesh-list
56856938|NCT01289756|Paroxetine|paroxetine|mesh-list
56856939|NCT01289756|Clomiphene|clomiphene|mesh-list
56856940|NCT01289756|Enclomiphene|enclomiphene|mesh-list
56856941|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
56856942|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56856943|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56856944|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56856945|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856946|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856947|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56856948|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56856949|NCT01289756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56856950|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56856951|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56856952|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856953|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
56856954|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856955|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56856956|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
56856957|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56856958|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56856959|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56856960|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
56856961|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56856962|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56856963|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
56856964|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56856965|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56856966|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56856967|NCT01181882|Aspirin|aspirin|mesh-list
56856968|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56856969|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56856970|NCT01181882|Analgesics|analgesics|mesh-ancestor
56856971|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
56856972|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56856973|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856974|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56856975|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56856976|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56856977|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56856978|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856979|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56856980|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56856981|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56856982|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
56856983|NCT01181960|Risperidone|risperidone|mesh-list
56856985|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
56856986|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56856987|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
56856988|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56856989|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56856990|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56856991|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56856992|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56856993|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56856994|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56856995|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
56856996|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56856997|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56856999|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56857000|NCT03858062|Pancrelipase|pancrelipase|mesh-list
56857001|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56857002|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857003|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857004|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
56857005|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
56857006|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857007|NCT04994444|Nicotine|nicotine|mesh-list
56857008|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56857009|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
56857010|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857011|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857012|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56857013|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56857014|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
56857015|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857016|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857017|NCT03307252|Metformin|metformin|mesh-list
56857018|NCT03307252|Rifampin|rifampin|mesh-list
56857019|NCT03307252|Probenecid|probenecid|mesh-list
56857020|NCT03307252|Digoxin|digoxin|mesh-list
56857021|NCT03307252|Verapamil|verapamil|mesh-list
56857022|NCT03307252|Furosemide|furosemide|mesh-list
56857023|NCT03307252|Cimetidine|cimetidine|mesh-list
56857024|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56857025|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56857026|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857027|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56857028|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56857029|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
56857030|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857031|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56857032|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56857033|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857034|NCT03307252|Diuretics|diuretics|mesh-ancestor
56857035|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
56857036|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56857037|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56857038|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56857039|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
56857040|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56857041|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857042|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
56857043|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56857044|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56857045|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56857046|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56857047|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56857048|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56857049|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56857050|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56857051|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56857052|NCT03307252|Protective Agents|protective agents|mesh-ancestor
56857053|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56857054|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56857055|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
56857056|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
56857057|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
56857059|NCT03307252|Renal Agents|renal agents|mesh-ancestor
56857060|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56857061|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857062|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56857063|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
56857064|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
56857065|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857066|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56857067|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56857068|NCT03307174|Fentanyl|fentanyl|mesh-list
56857069|NCT03307174|Bupivacaine|bupivacaine|mesh-list
56857070|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
56857071|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
56857072|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857073|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857074|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
56857075|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857076|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56857077|NCT03307174|Narcotics|narcotics|mesh-ancestor
56857078|NCT03307174|Analgesics|analgesics|mesh-ancestor
56857079|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56857080|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56857081|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
56857082|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
56857083|NCT03448978|Fludarabine|fludarabine|mesh-list
56857084|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857085|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
56857086|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857087|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857088|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56857089|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
56857090|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857091|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857092|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56857093|NCT01290926|Sorafenib|sorafenib|mesh-list
56857094|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857095|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56857096|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857097|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857098|NCT01185158|Gefitinib|gefitinib|mesh-list
56857099|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857100|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56857102|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857103|NCT01185236|Atorvastatin|atorvastatin|mesh-list
56857104|NCT01185236|Simvastatin|simvastatin|mesh-list
56857105|NCT01185236|Ezetimibe|ezetimibe|mesh-list
56857106|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56857107|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56857108|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
56857109|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857110|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56857111|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56857112|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857113|NCT02524652|Ropivacaine|ropivacaine|mesh-list
56857114|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
56857115|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
56857116|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857117|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857118|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
56857119|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857120|NCT01182272|Sorafenib|sorafenib|mesh-list
56857121|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857122|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56857123|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857124|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857125|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56857126|NCT01185470|Morphine|morphine|mesh-list
56857127|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56857128|NCT01185470|Narcotics|narcotics|mesh-ancestor
56857129|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857130|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857131|NCT01185470|Analgesics|analgesics|mesh-ancestor
56857132|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
56857133|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857135|NCT00056160|Lenalidomide|lenalidomide|mesh-list
56857136|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857137|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
56857138|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
56857139|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857140|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857141|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857142|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
56857143|NCT00056160|Hormones|hormones|mesh-ancestor
56857144|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857145|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56857146|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857147|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
56857148|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56857149|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56857150|NCT00056160|Growth Substances|growth substances|mesh-ancestor
56857151|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
56857152|NCT01290146|Simendan|simendan|mesh-list
56857153|NCT01290146|Diuretics|diuretics|mesh-list
56857154|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
56857155|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857156|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56857157|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
56857158|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56857159|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56857160|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857161|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857162|NCT01290146|Protective Agents|protective agents|mesh-ancestor
56857163|NCT00061932|Irinotecan|irinotecan|mesh-list
56857164|NCT00061932|Bortezomib|bortezomib|mesh-list
56857165|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56857166|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56857167|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857168|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857169|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857170|NCT03856970|Glyburide|glyburide|mesh-list
56857171|NCT03856970|Digoxin|digoxin|mesh-list
56857172|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56857173|NCT03856970|Norethindrone|norethindrone|mesh-list
56857174|NCT03856970|Estradiol|estradiol|mesh-list
56857175|NCT03856970|Estrogens|estrogens|mesh-ancestor
56857176|NCT03856970|Hormones|hormones|mesh-ancestor
56567981|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
56857177|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857178|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857179|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56857180|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
56857181|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56857182|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56857183|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56857184|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56857185|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56857186|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56857187|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857188|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857189|NCT03856970|Protective Agents|protective agents|mesh-ancestor
56857190|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56857191|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56857192|NCT01089348|Metronidazole|metronidazole|mesh-list
56857193|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857194|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56857195|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56857196|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56857197|NCT01291316|Clonazepam|clonazepam|mesh-list
56857198|NCT01291316|Clobazam|clobazam|mesh-list
56857199|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56857200|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56857201|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56857202|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
56857203|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857204|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857205|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857206|NCT01291316|Urological Agents|urological agents|mesh-ancestor
56857207|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
56857208|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
56857209|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
56857211|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56857212|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857213|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56857214|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56857215|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
56857216|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
56857217|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56857218|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
56857219|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857220|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857221|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56857222|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
56857223|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56857224|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
56857225|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857226|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857227|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56857228|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
56857229|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
56857230|NCT00060840|Protective Agents|protective agents|mesh-ancestor
56857231|NCT01185860|Ritonavir|ritonavir|mesh-list
56857232|NCT01185860|Ribavirin|ribavirin|mesh-list
56857233|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56857234|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56857235|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56857236|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
56857237|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857238|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857239|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56857240|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56857241|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
56857242|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857243|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56857244|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56857245|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
56857246|NCT01290302|Azacitidine|azacitidine|mesh-list
56857247|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56857248|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
56857249|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857250|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857251|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857252|NCT01089660|Vaccines|vaccines|mesh-list
56857253|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
56857254|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857255|NCT01182662|Cyclosporine|cyclosporine|mesh-list
56857256|NCT01182662|Cyclosporins|cyclosporins|mesh-list
56857257|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857258|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857259|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857260|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
56857261|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857262|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
56857263|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857264|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56857265|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857266|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56857267|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56857268|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56857269|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56857270|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
56857271|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857272|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56857273|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56857274|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857275|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56857276|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56857277|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857278|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
56857279|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56857280|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56857281|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56857282|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56857283|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857285|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857286|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857287|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56857288|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857289|NCT03854942|Naltrexone|naltrexone|mesh-list
56857290|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56857291|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56857292|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857293|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
56857294|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857295|NCT03278626|Paclitaxel|paclitaxel|mesh-list
56857296|NCT03278626|Carboplatin|carboplatin|mesh-list
56857297|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56857298|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857299|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56857300|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56857301|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56857302|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857303|NCT01186094|Sirolimus|sirolimus|mesh-list
56857304|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56857305|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857306|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56857307|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857308|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
56857309|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857310|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
56857311|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857312|NCT01287806|Urinastatin|urinastatin|mesh-list
56857313|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56857314|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56857315|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
56857316|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857317|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857318|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56857319|NCT01186172|Ethanol|ethanol|mesh-list
56857320|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857321|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56857322|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857323|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857324|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
56857325|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857326|NCT03854708|Hormones|hormones|mesh-ancestor
56857327|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857328|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857329|NCT03860870|Clenbuterol|clenbuterol|mesh-list
56857330|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56857331|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56857332|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
56857333|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857334|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857335|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857336|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56857337|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
56857338|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857339|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56857340|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
56857341|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
56857342|NCT01177514|Gabapentin|gabapentin|mesh-list
56857343|NCT01177514|Analgesics|analgesics|mesh-ancestor
56857344|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
56857345|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857346|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857347|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
56857348|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56857349|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56857350|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857351|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56857352|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56857353|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56857354|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857355|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857356|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
56857357|NCT00073008|Lapatinib|lapatinib|mesh-list
56857359|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56857360|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857361|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857363|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56857364|NCT01182974|Analgesics|analgesics|mesh-ancestor
56857365|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
56857366|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857367|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857368|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
56857369|NCT03856502|Dexamethasone|dexamethasone|mesh-list
56857370|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
56857371|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
56857372|NCT03856502|BB 1101|bb 1101|mesh-list
56857373|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857374|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
56857375|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
56857376|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857377|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857378|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857379|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
56857380|NCT03856502|Hormones|hormones|mesh-ancestor
56857381|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857382|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56857383|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857384|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
56857385|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857386|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857387|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
56857388|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
56857389|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857390|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
56857391|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56857392|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56857393|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857394|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857395|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56857396|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56857397|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857398|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
56857399|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857400|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56857401|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56857402|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
56857403|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857404|NCT01093638|Insulin|insulin|mesh-list
56857405|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56857406|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857407|NCT01287962|Apatinib|apatinib|mesh-list
56857408|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857409|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56857410|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857411|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857412|NCT00058422|Prednisone|prednisone|mesh-list
56857413|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
56857414|NCT00058422|Rituximab|rituximab|mesh-list
56857415|NCT00058422|Doxorubicin|doxorubicin|mesh-list
56857416|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56857417|NCT00058422|Vincristine|vincristine|mesh-list
56857418|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
56857419|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56857420|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857421|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
56857422|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857423|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857424|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56857425|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
56857426|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857427|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857428|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56857429|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56857430|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56371919|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
56857432|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56857433|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857434|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857435|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
56857436|NCT00058422|Hormones|hormones|mesh-ancestor
56857437|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857438|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56857439|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56857440|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
56857441|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
56857442|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
56857443|NCT00058422|Hematinics|hematinics|mesh-ancestor
56857444|NCT01094964|Interferons|interferons|mesh-list
56857445|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
56857446|NCT01094964|Epirubicin|epirubicin|mesh-list
56857447|NCT01094964|Mitomycins|mitomycins|mesh-list
56857448|NCT01094964|Mitomycin|mitomycin|mesh-list
56857449|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857450|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
56857451|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857452|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
56857453|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857454|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56857455|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56857456|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56857457|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857458|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857459|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
56857460|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56857461|NCT01291472|Ketorolac|ketorolac|mesh-list
56857462|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56857463|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56857464|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56857465|NCT01291472|Analgesics|analgesics|mesh-ancestor
56857466|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
56857467|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857468|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857469|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857470|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857471|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56857472|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857473|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568283|NCT02697058|Vitamins|vitamins|mesh-ancestor
56857474|NCT02530632|Propofol|propofol|mesh-list
56857475|NCT02530632|Sevoflurane|sevoflurane|mesh-list
56857476|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
56857477|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857478|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857479|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56857480|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56857482|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56857483|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56857484|NCT01183364|Docetaxel|docetaxel|mesh-list
56857485|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857486|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
56857487|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
56857488|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
56857489|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857490|NCT00072384|Carboplatin|carboplatin|mesh-list
56857491|NCT00072384|Etoposide|etoposide|mesh-list
56857492|NCT00072384|Vincristine|vincristine|mesh-list
56857493|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
56857494|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857495|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56857496|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56857497|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56857498|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857499|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857500|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
56857501|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
56857502|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
56857503|NCT01183442|Vitamin D|vitamin d|mesh-list
56857504|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
56857505|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
56857506|NCT01183442|Vitamins|vitamins|mesh-list
56857508|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857509|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56857510|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56857511|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
56857512|NCT01187108|Acetazolamide|acetazolamide|mesh-list
56857513|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56857514|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
56857515|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857516|NCT01187108|Expectorants|expectorants|mesh-ancestor
56857517|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
56857518|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56857519|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
56857520|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857521|NCT01187108|Protective Agents|protective agents|mesh-ancestor
56857522|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857523|NCT01187108|Antidotes|antidotes|mesh-ancestor
56857524|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
56857525|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56857526|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857527|NCT01187108|Diuretics|diuretics|mesh-ancestor
56857528|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
56857529|NCT01187888|Rasagiline|rasagiline|mesh-list
56857530|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56857531|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857532|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857533|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56857534|NCT01187888|Protective Agents|protective agents|mesh-ancestor
56857535|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857536|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
56857537|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56857538|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857539|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56857540|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857541|NCT00054132|Bevacizumab|bevacizumab|mesh-list
56857542|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56857543|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56857544|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
56857545|NCT00054132|Antibodies|antibodies|mesh-list
56857546|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
56857547|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56857548|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
56857549|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857550|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56857551|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56857552|NCT00054132|Growth Substances|growth substances|mesh-ancestor
56857553|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857554|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
56857555|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
56857556|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56857557|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857558|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857559|NCT01187264|Methotrexate|methotrexate|mesh-list
56857560|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56857561|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
56857562|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56857563|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857564|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56857565|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
56857566|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857567|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857568|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
56857569|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857570|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56857571|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857572|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
56857573|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857574|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56857575|NCT01183676|Valproic Acid|valproic acid|mesh-list
56857576|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
56857577|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857578|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857579|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
56857580|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857581|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857583|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56857584|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857585|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56857586|NCT03856112|Dexamethasone|dexamethasone|mesh-list
56857587|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
56857588|NCT03856112|Venetoclax|venetoclax|mesh-list
56857589|NCT03856112|Ixazomib|ixazomib|mesh-list
56857590|NCT03856112|Ichthammol|ichthammol|mesh-list
56857591|NCT03856112|BB 1101|bb 1101|mesh-list
56857592|NCT03856112|Glycine|glycine|mesh-list
56857593|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857594|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
56857595|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
56857596|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857597|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857598|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857599|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
56857600|NCT03856112|Hormones|hormones|mesh-ancestor
56857601|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857602|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56857603|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857604|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857605|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
56857606|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857607|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
56857608|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857609|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
56857610|NCT01290380|Vadimezan|vadimezan|mesh-list
56857611|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857612|NCT00071760|Ritonavir|ritonavir|mesh-list
56857613|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
56857614|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56857615|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56857616|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
56857617|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857618|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857619|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56857620|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56857621|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
56857622|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857623|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56857624|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56857625|NCT00057954|Cyclosporine|cyclosporine|mesh-list
56857626|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
56857627|NCT00057954|Methotrexate|methotrexate|mesh-list
56857628|NCT00057954|Pentostatin|pentostatin|mesh-list
56857629|NCT00057954|Cyclosporins|cyclosporins|mesh-list
56857630|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56857631|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
56857632|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56857633|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857634|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56857636|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857637|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857638|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
56857639|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857640|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56857641|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857642|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
56857643|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857644|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56857645|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
56857646|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857647|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56857648|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56857649|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56857650|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
56857651|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56857652|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56857653|NCT00057876|Gemcitabine|gemcitabine|mesh-list
56857654|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56857655|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
56857656|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857657|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857659|NCT00057876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857660|NCT00057876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857661|NCT00057876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857662|NCT00057876|Immunologic Factors|immunologic factors|mesh-ancestor
56857663|NCT00057876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857664|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
56857665|NCT01183910|Calcium|calcium|mesh-list
56857666|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56857667|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857668|NCT01183910|Antacids|antacids|mesh-ancestor
56857669|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857670|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857671|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
56857672|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56857673|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
56857674|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857675|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
56857676|NCT03852914|Protective Agents|protective agents|mesh-ancestor
56857677|NCT05234684|Prednisone|prednisone|mesh-list
56857678|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
56857679|NCT05234684|Vincristine|vincristine|mesh-list
56857680|NCT05234684|Rituximab|rituximab|mesh-list
56857681|NCT05234684|Doxorubicin|doxorubicin|mesh-list
56857682|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857683|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
56857684|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857685|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857686|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56857687|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
56857688|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857689|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857690|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56857691|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857692|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
56857693|NCT05234684|Hormones|hormones|mesh-ancestor
56857694|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857695|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56857696|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56857697|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
56857698|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
56857699|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
56857700|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56857701|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56857702|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56568521|NCT01193842|Prednisone|prednisone|mesh-list
56857703|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56857704|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857705|NCT03853538|Petrolatum|petrolatum|mesh-list
56857706|NCT03853538|Emollients|emollients|mesh-ancestor
56857707|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
56857708|NCT03853304|Folic Acid|folic acid|mesh-list
56857709|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
56857710|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
56857711|NCT03853304|Vitamins|vitamins|mesh-ancestor
56857712|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
56857713|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857714|NCT03853304|Hematinics|hematinics|mesh-ancestor
56857715|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
56857716|NCT01290458|Vitamins|vitamins|mesh-list
56857717|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
56857718|NCT01290458|Vitamin E|vitamin e|mesh-list
56857719|NCT01290458|Tocopherols|tocopherols|mesh-list
56857720|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
56857721|NCT01290458|Antioxidants|antioxidants|mesh-list
56857722|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
56857723|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857724|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857725|NCT01290458|Protective Agents|protective agents|mesh-ancestor
56857726|NCT01184144|Pioglitazone|pioglitazone|mesh-list
56857727|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56857728|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857729|NCT01291628|Copper|copper|mesh-list
56857730|NCT01291628|Trace Elements|trace elements|mesh-ancestor
56857731|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
56857732|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857733|NCT00053898|Tamoxifen|tamoxifen|mesh-list
56857734|NCT00053898|Anastrozole|anastrozole|mesh-list
56857735|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857737|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
56857738|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857739|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857740|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56857741|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857742|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56857743|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56857744|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56857745|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56857746|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56857747|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857749|NCT01293734|Theophylline|theophylline|mesh-list
56857750|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857751|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56857752|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
56857753|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857754|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857755|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56857756|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
56857757|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
56857758|NCT01293734|Hormones|hormones|mesh-ancestor
56857759|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857760|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56857761|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857762|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857763|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
56857764|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56857765|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56857766|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
56857767|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857768|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56857769|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56857770|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
56857771|NCT01188278|Dasatinib|dasatinib|mesh-list
56857772|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857773|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56857774|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857775|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857776|NCT03850028|Atezolizumab|atezolizumab|mesh-list
56857777|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857778|NCT01184378|Caseins|caseins|mesh-list
56857779|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
56857780|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
56857781|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857782|NCT03852602|Analgesics|analgesics|mesh-list
56857783|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
56857784|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857785|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857786|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56857787|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
56857788|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56857789|NCT02459392|Prednisolone|prednisolone|mesh-list
56857790|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
56857791|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
56857792|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56857793|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
56857794|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56857795|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
56857796|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857797|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
56857798|NCT02459392|Protective Agents|protective agents|mesh-ancestor
56857799|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857800|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
56857801|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
56857802|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857803|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857804|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
56857805|NCT02459392|Hormones|hormones|mesh-ancestor
56857806|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857807|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56857808|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56857810|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
56857811|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56857812|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56857813|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56857814|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
56857815|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857816|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857817|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857818|NCT03852446|Tryptophan|tryptophan|mesh-list
56857819|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56857820|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
56857821|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56857822|NCT05117710|Ebselen|ebselen|mesh-list
56857823|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56857824|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56857825|NCT05117710|Analgesics|analgesics|mesh-ancestor
56857826|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
56857827|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857828|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857829|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857830|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857831|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56857832|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56857833|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
56857834|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857835|NCT05117710|Protective Agents|protective agents|mesh-ancestor
56857836|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56857837|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857838|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56857839|NCT03637582|Lidocaine|lidocaine|mesh-list
56857840|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
56857841|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
56857842|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857843|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857844|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
56857845|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857846|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56857847|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56857848|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56857849|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56857850|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857851|NCT00053352|Etoposide|etoposide|mesh-list
56857852|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
56857853|NCT00053352|Bleomycin|bleomycin|mesh-list
56857854|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568665|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
56857855|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56857856|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56857857|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56857858|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857859|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857860|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56857861|NCT01193816|Loxapine|loxapine|mesh-list
56857862|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56857863|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56857864|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857865|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857866|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56857867|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56857868|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
56857869|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857870|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857871|NCT05571202|Anesthetics|anesthetics|mesh-list
56857872|NCT05571202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857873|NCT05571202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857874|NCT03245398|Mebendazole|mebendazole|mesh-list
56857875|NCT03245398|Piperazine|piperazine|mesh-list
56857876|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
56857877|NCT03245398|DMP 777|dmp 777|mesh-list
56857878|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
56857879|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
56857880|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56857881|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857883|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
56857884|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
56857885|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857886|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857887|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857888|NCT01291940|Petrolatum|petrolatum|mesh-list
56857889|NCT01291940|Emollients|emollients|mesh-ancestor
56857890|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
56857891|NCT03244618|Fluorides|fluorides|mesh-list
56857892|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
56857893|NCT03244618|Protective Agents|protective agents|mesh-ancestor
56857894|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857895|NCT05571046|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
56857896|NCT05571046|Glucocorticoids|glucocorticoids|mesh-list
56857897|NCT05571046|Hormones|hormones|mesh-ancestor
56857898|NCT05571046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56857899|NCT05571046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857900|NCT05571046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857901|NCT03849404|Adalimumab|adalimumab|mesh-list
56857902|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56857903|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857904|NCT00051636|Vitamin D|vitamin d|mesh-list
56857905|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
56857906|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
56857907|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
56857908|NCT00051636|Calcium|calcium|mesh-list
56857909|NCT00051636|Vitamins|vitamins|mesh-ancestor
56857910|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
56903785|NCT04534491|Oxybutynin|oxybutynin|mesh-list
56857911|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857912|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56857913|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56857914|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56857915|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56857916|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857917|NCT01294826|Cetuximab|cetuximab|mesh-list
56857918|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56857919|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857920|NCT03847922|Lidocaine|lidocaine|mesh-list
56857921|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
56857922|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
56857923|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
56857924|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56857925|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857926|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
56857927|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56857928|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56857929|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56857930|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56857931|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56857932|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857933|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56857934|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
56857935|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56857936|NCT03847922|Analgesics|analgesics|mesh-ancestor
56857937|NCT01194284|Mifamurtide|mifamurtide|mesh-list
56857938|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56857939|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
56857940|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857941|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56857942|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56857943|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857944|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
56857945|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857946|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
56857947|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56857948|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56857949|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857950|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
56857951|NCT01191554|Coagulants|coagulants|mesh-ancestor
56857952|NCT01296464|Carbidopa|carbidopa|mesh-list
56857953|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56857954|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56857955|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
56857956|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56857958|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857959|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56857960|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857961|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
56857962|NCT00038142|Doxorubicin|doxorubicin|mesh-list
56857963|NCT00038142|Vincristine|vincristine|mesh-list
56857964|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
56857965|NCT00038142|Razoxane|razoxane|mesh-list
56857966|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56857967|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
56857968|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857969|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56857970|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56857971|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
56857972|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857973|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56857974|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56857975|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56857976|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56857977|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56857978|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857979|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56857980|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
56857981|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
56857982|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
56857983|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56857984|NCT00038142|Protective Agents|protective agents|mesh-ancestor
56857985|NCT00366899|Vaccines|vaccines|mesh-list
56857986|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56857987|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
56857988|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56857989|NCT03847376|Rilpivirine|rilpivirine|mesh-list
56857990|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56857991|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56857992|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56857993|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56857994|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
56857995|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56857996|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56857997|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56857998|NCT01090128|Paclitaxel|paclitaxel|mesh-list
56857999|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
56858000|NCT01090128|Doxorubicin|doxorubicin|mesh-list
56858001|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56858002|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56858003|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858004|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
56858005|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
56858006|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
56858007|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858008|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858009|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
56858010|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858011|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56858012|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56858013|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
56858014|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56858015|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56858016|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56858017|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56858018|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858019|NCT01292174|Ibalizumab|ibalizumab|mesh-list
56858020|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56858021|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56858022|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56858023|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
56858024|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858025|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
56858026|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858027|NCT01090206|Vitamin D|vitamin d|mesh-list
56858028|NCT01090206|Calcium|calcium|mesh-list
56858029|NCT01090206|Vitamins|vitamins|mesh-ancestor
56858030|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
56858031|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858033|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56858034|NCT04728646|Dexamethasone|dexamethasone|mesh-list
56858035|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56858036|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
56858037|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
56858038|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858039|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858040|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858041|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
56858043|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858044|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56858045|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858046|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56858047|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
56858048|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858049|NCT01295138|Lactulose|lactulose|mesh-list
56858050|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858051|NCT01188824|Cilostazol|cilostazol|mesh-list
56858052|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56858053|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
56858054|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858055|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858056|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56858057|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
56858058|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56858059|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56858060|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858061|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56858062|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
56858063|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56858064|NCT01188824|Protective Agents|protective agents|mesh-ancestor
56858065|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56858066|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56858067|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858068|NCT01060475|Tacrolimus|tacrolimus|mesh-list
56858069|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858070|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
56858071|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858072|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56858073|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858074|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858075|NCT01060631|Propofol|propofol|mesh-list
56858076|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56858077|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858078|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858079|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56858080|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
56858081|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
56568917|NCT02688400|Celecoxib|celecoxib|mesh-list
56858082|NCT03254134|Warfarin|warfarin|mesh-list
56858083|NCT03254134|Dabigatran|dabigatran|mesh-list
56858084|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
56858085|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
56858086|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56858087|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
56858088|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858089|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858090|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
56858091|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
56858092|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
56858093|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56858094|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56858095|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858096|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
56858097|NCT01295294|Coagulants|coagulants|mesh-ancestor
56858098|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56858099|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
56858100|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56858101|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858102|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56858103|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56858104|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56858106|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56858107|NCT01295294|Analgesics|analgesics|mesh-ancestor
56858108|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
56858109|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858110|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56858111|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56858112|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56858113|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858114|NCT01191710|Progesterone|progesterone|mesh-list
56858115|NCT01191710|Progestins|progestins|mesh-ancestor
56858116|NCT01191710|Hormones|hormones|mesh-ancestor
56858117|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858118|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858119|NCT04367740|Antibodies|antibodies|mesh-list
56858120|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
56858121|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
56858122|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858123|NCT03852056|Fluorides|fluorides|mesh-list
56858124|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
56858125|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
56858126|NCT03852056|Protective Agents|protective agents|mesh-ancestor
56858127|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858128|NCT03242434|Mannitol|mannitol|mesh-list
56858129|NCT03242434|Lactulose|lactulose|mesh-list
56858130|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56858131|NCT03242434|Diuretics|diuretics|mesh-ancestor
56858132|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
56858133|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858134|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858135|NCT04222426|Atezolizumab|atezolizumab|mesh-list
56858136|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858137|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
56858138|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
56858139|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56858140|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56858141|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858142|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858143|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858144|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56858145|NCT01295372|Risperidone|risperidone|mesh-list
56858146|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56858147|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
56858148|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858149|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858150|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858151|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56858152|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56858153|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858154|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56858155|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56568968|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56858156|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
56858157|NCT05283278|Lactoferrin|lactoferrin|mesh-list
56858158|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858159|NCT05179018|Autoantibodies|autoantibodies|mesh-list
56858160|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
56858161|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858162|NCT01295450|Vitamins|vitamins|mesh-list
56858163|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
56858164|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858165|NCT01297010|Dexamethasone|dexamethasone|mesh-list
56858166|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
56858167|NCT01297010|BB 1101|bb 1101|mesh-list
56858168|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56858169|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
56858170|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
56858171|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858172|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858173|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858174|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
56858175|NCT01297010|Hormones|hormones|mesh-ancestor
56858176|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858177|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56858178|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858179|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
56858180|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858182|NCT03851432|Metformin|metformin|mesh-list
56858183|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56858184|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858185|NCT01192490|Lidocaine|lidocaine|mesh-list
56858186|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
56858187|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
56858188|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858189|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858190|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
56858191|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858192|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56858193|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56858194|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56858195|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56858196|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858197|NCT01295606|Cefazolin|cefazolin|mesh-list
56858198|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56858199|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858200|NCT01192724|Aspirin|aspirin|mesh-list
56858201|NCT01192724|Cilostazol|cilostazol|mesh-list
56858202|NCT01192724|Clopidogrel|clopidogrel|mesh-list
56858203|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56858204|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56858205|NCT01192724|Analgesics|analgesics|mesh-ancestor
56858206|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
56858207|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858208|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858209|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56858210|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56858211|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56858212|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56858213|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895175|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
56858214|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56858215|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56858216|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858217|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
56858218|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56858219|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56858220|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56858221|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
56858222|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858223|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56858224|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
56858225|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56858226|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
56858227|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
56858228|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56858229|NCT01192724|Protective Agents|protective agents|mesh-ancestor
56858230|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56858231|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56858232|NCT01192802|Albendazole|albendazole|mesh-list
56858233|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
56858234|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56858235|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858236|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
56858237|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56858238|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56858239|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
56858240|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
56858241|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
56858242|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858243|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858244|NCT01292720|Vitamin D|vitamin d|mesh-list
56858245|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
56858246|NCT01292720|Vitamins|vitamins|mesh-ancestor
56858247|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
56858248|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858249|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56858250|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56858251|NCT05671172|Bupivacaine|bupivacaine|mesh-list
56858252|NCT05671172|Anesthetics, Local|anesthetics, local|mesh-ancestor
56858253|NCT05671172|Anesthetics|anesthetics|mesh-ancestor
56858254|NCT05671172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858272|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858273|NCT01193270|Vitamin E|vitamin e|mesh-list
56858274|NCT01193270|Vitamins|vitamins|mesh-ancestor
56858275|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
56858276|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858277|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
56858278|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858279|NCT01193270|Protective Agents|protective agents|mesh-ancestor
56858280|NCT01189214|Memantine|memantine|mesh-list
56858281|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56858282|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56858283|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
56858284|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858285|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858286|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858287|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56858288|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56858289|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56858290|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
56858291|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56858292|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
56858293|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56858294|NCT01193504|Prednisolone|prednisolone|mesh-list
56858295|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56858296|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
56858297|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56858298|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
56858299|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
56858300|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858301|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858302|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858303|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
56858304|NCT01193504|Hormones|hormones|mesh-ancestor
56858305|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463181|NCT03273296|Vancomycin|vancomycin|mesh-list
56858306|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56858307|NCT01193504|Protective Agents|protective agents|mesh-ancestor
56858308|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56858309|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569123|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
56858310|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56858311|NCT03848780|Desflurane|desflurane|mesh-list
56858312|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56858314|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
56858315|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858316|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858317|NCT05599802|Vaccines|vaccines|mesh-list
56858318|NCT05599802|Immunologic Factors|immunologic factors|mesh-ancestor
56858319|NCT05599802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858320|NCT00051558|Alendronate|alendronate|mesh-list
56858321|NCT00051558|Teriparatide|teriparatide|mesh-list
56858322|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56858323|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858324|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56858325|NCT03848234|Estradiol|estradiol|mesh-list
56858326|NCT03848234|Estrogens|estrogens|mesh-ancestor
56858327|NCT03848234|Hormones|hormones|mesh-ancestor
56858328|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858329|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858330|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56858331|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858332|NCT01195298|Bevacizumab|bevacizumab|mesh-list
56858333|NCT01195298|Capecitabine|capecitabine|mesh-list
56858334|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56858335|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858336|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56858337|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56858338|NCT01195298|Growth Substances|growth substances|mesh-ancestor
56858339|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858340|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
56858341|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56858342|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
56858343|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858344|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56858345|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56858346|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
56858347|NCT01296074|Hormones|hormones|mesh-ancestor
56858348|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858349|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858350|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56858351|NCT01296074|Protective Agents|protective agents|mesh-ancestor
56858352|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56858353|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858354|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
56858355|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
56858356|NCT01189448|Spiramycin|spiramycin|mesh-list
56858357|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
56858358|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56858359|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56858360|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858361|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56858362|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858363|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858364|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56858365|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
56858366|NCT01195376|Dactolisib|dactolisib|mesh-list
56858367|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858368|NCT01189526|Ranibizumab|ranibizumab|mesh-list
56858369|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56858370|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56858371|NCT01189526|Growth Substances|growth substances|mesh-ancestor
56858372|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858373|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
56858374|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858375|NCT01296230|Hormones|hormones|mesh-list
56858376|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858377|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858378|NCT01580696|Molgramostim|molgramostim|mesh-list
56858379|NCT01580696|Vaccines|vaccines|mesh-list
56858380|NCT01580696|Sargramostim|sargramostim|mesh-list
56858381|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
56858382|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858383|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569193|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
56858384|NCT01197014|Losartan|losartan|mesh-list
56858385|NCT01197014|Amlodipine|amlodipine|mesh-list
56858386|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56858387|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56858389|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858390|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56858391|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858392|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
56858393|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56858394|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56858395|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56858396|NCT01195454|Insulin|insulin|mesh-list
56858397|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56858398|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
56858399|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56858400|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858401|NCT01197170|Bevacizumab|bevacizumab|mesh-list
56858402|NCT01197170|Everolimus|everolimus|mesh-list
56858403|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56858404|NCT01197170|Sorafenib|sorafenib|mesh-list
56858405|NCT01197170|Anastrozole|anastrozole|mesh-list
56858406|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56858407|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858408|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56858409|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56858410|NCT01197170|Growth Substances|growth substances|mesh-ancestor
56858411|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858412|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
56858413|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858414|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
56858415|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56858416|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858417|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858418|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56858419|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56858420|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56858421|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56858422|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
56858423|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858424|NCT05516966|Dulaglutide|dulaglutide|mesh-list
56858425|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56858426|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858427|NCT01195766|Ofatumumab|ofatumumab|mesh-list
56858428|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858429|NCT03850886|Niacinamide|niacinamide|mesh-list
56858430|NCT03850886|Niacin|niacin|mesh-list
56858431|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
56858432|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56858433|NCT03850886|Vitamins|vitamins|mesh-ancestor
56858434|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
56858435|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858436|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
56858437|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56858438|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
56858439|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858440|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56858441|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
56858442|NCT03251482|Apixaban|apixaban|mesh-list
56858443|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56858444|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
56858445|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56858446|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
56858447|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858448|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858449|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
56858450|NCT03732248|Sirolimus|sirolimus|mesh-list
56858451|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56858452|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858453|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56858454|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858455|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
56858456|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858457|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
56858458|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858459|NCT00310037|Bortezomib|bortezomib|mesh-list
56858460|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569283|NCT00641212|Budesonide|budesonide|mesh-list
56858461|NCT01196234|Paclitaxel|paclitaxel|mesh-list
56372953|NCT00132444|UC-781|uc-781|mesh-list
56858474|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56858475|NCT03007030|Antibodies|antibodies|mesh-list
56858476|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
56858477|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56858478|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
56858479|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
56858480|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858481|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858493|NCT05668286|Triamcinolone|triamcinolone|mesh-list
56858494|NCT05668286|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56858495|NCT05668286|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56858496|NCT05668286|Prilocaine|prilocaine|mesh-list
56858497|NCT05668286|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56858498|NCT05668286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56858499|NCT05668286|Glucocorticoids|glucocorticoids|mesh-ancestor
56858500|NCT05668286|Hormones|hormones|mesh-ancestor
56858501|NCT05668286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858502|NCT05668286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858503|NCT05668286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858504|NCT05668286|Immunologic Factors|immunologic factors|mesh-ancestor
56858505|NCT05668286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858506|NCT05668286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858507|NCT05668286|Anesthetics, Local|anesthetics, local|mesh-ancestor
56858508|NCT05668286|Anesthetics|anesthetics|mesh-ancestor
56858509|NCT05668286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858510|NCT05668286|Sensory System Agents|sensory system agents|mesh-ancestor
56858511|NCT05668286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858512|NCT03992261|Halobetasol|halobetasol|mesh-list
56858513|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56858514|NCT00309959|Paclitaxel|paclitaxel|mesh-list
56858515|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56858516|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56858517|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858518|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
56858519|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
56858520|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
56858521|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858522|NCT03238924|Oxytocin|oxytocin|mesh-list
56858523|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
56858524|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56858525|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858526|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
56858527|NCT01190384|Antioxidants|antioxidants|mesh-list
56858528|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858529|NCT01190384|Protective Agents|protective agents|mesh-ancestor
56858530|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858531|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56858532|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858533|NCT02532413|Entecavir|entecavir|mesh-list
56858534|NCT02532413|Poly I-C|poly i-c|mesh-list
56858535|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
56858536|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858538|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
56858539|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858542|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56858543|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858544|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56858545|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56858546|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
56903807|NCT03694821|Prednisolone|prednisolone|mesh-list
56858547|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858548|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56858549|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56858550|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858551|NCT01198106|Cinnarizine|cinnarizine|mesh-list
56858552|NCT01198106|Scopolamine|scopolamine|mesh-list
56858553|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56858554|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56858555|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
56858556|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
56858557|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858558|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858559|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858560|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
56858561|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56858562|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
56858563|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858564|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858565|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56858566|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
56858567|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56858568|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56858569|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56858570|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56858571|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
56858572|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
56858573|NCT02918500|Nicotine|nicotine|mesh-list
56858574|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56858575|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
56858576|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858577|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858578|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56858579|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56858580|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
56858581|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858582|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858583|NCT03850652|Iron|iron|mesh-list
56858584|NCT03850652|Trace Elements|trace elements|mesh-ancestor
56858585|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
56858586|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858587|NCT05559814|Peppermint oil|peppermint oil|mesh-list
56858588|NCT05559814|Antiemetics|antiemetics|mesh-ancestor
56858589|NCT05559814|Autonomic Agents|autonomic agents|mesh-ancestor
56858590|NCT05559814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858591|NCT05559814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858592|NCT05559814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858593|NCT05559814|Parasympatholytics|parasympatholytics|mesh-ancestor
56858594|NCT01198184|Sirolimus|sirolimus|mesh-list
56858595|NCT01198184|R04929097|r04929097|mesh-list
56858596|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56858597|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858598|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56858599|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858600|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
56858601|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858602|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
56858603|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858604|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858605|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858606|NCT00333359|Gabapentin|gabapentin|mesh-list
56858607|NCT00333359|Analgesics|analgesics|mesh-ancestor
56858608|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
56858609|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858610|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858611|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
56568153|NCT01101191|Oxycodone|oxycodone|mesh-list
56858613|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56858614|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858615|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56858616|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56858617|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56858618|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858619|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858620|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
56858621|NCT03246724|Midazolam|midazolam|mesh-list
56858622|NCT03246724|Triazolam|triazolam|mesh-list
56858623|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56858624|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56858625|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858626|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858627|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56858628|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56858629|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56858630|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56858631|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
56858632|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
56858633|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
56858634|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
56858635|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858636|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858637|NCT01196546|Metformin|metformin|mesh-list
56858638|NCT01196546|Vildagliptin|vildagliptin|mesh-list
56858639|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56858640|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858641|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56858642|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
56858643|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858644|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858645|NCT05671562|Lycopene|lycopene|mesh-list
56858646|NCT05671562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56858647|NCT05671562|Antioxidants|antioxidants|mesh-ancestor
56858648|NCT05671562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858649|NCT05671562|Protective Agents|protective agents|mesh-ancestor
56858650|NCT05671562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858651|NCT05671562|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56858652|NCT05671562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56858653|NCT05671562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858654|NCT01293266|Propofol|propofol|mesh-list
56858655|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56858656|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858657|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858658|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56858659|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
56858660|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
56858661|NCT03948646|Bromides|bromides|mesh-list
56858662|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
56858663|NCT01198340|Ropivacaine|ropivacaine|mesh-list
56858664|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
56858665|NCT01198340|Anesthetics|anesthetics|mesh-list
56858666|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858667|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858668|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
56858669|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858670|NCT01347112|Varenicline|varenicline|mesh-list
56858671|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56858672|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56858673|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
56858674|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858675|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858676|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858677|NCT00308711|Misoprostol|misoprostol|mesh-list
56858678|NCT00308711|Dinoprostone|dinoprostone|mesh-list
56858679|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56858680|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
56858681|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56858682|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858683|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56858684|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858685|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
56858686|NCT05487586|Ceftazidime|ceftazidime|mesh-list
56858687|NCT05487586|Avibactam|avibactam|mesh-list
56858688|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
56858689|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56858690|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858691|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56858692|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858693|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858694|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56858696|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
56858697|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
56858698|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858699|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858700|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858701|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56858702|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56858703|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858704|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56858705|NCT01198496|Losartan|losartan|mesh-list
56858706|NCT01198496|Amlodipine|amlodipine|mesh-list
56858707|NCT01198496|Valsartan|valsartan|mesh-list
56858708|NCT01198496|Telmisartan|telmisartan|mesh-list
56858709|NCT01198496|Candesartan|candesartan|mesh-list
56858710|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
56858711|NCT01198496|Olmesartan|olmesartan|mesh-list
56858712|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56858713|NCT01198496|Spironolactone|spironolactone|mesh-list
56858714|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56858715|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56858716|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56858717|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858718|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56858719|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858720|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
56858721|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56858722|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56858723|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56858724|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56858725|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
56858726|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858727|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56858728|NCT01198496|Diuretics|diuretics|mesh-ancestor
56858729|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
56858730|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
56858731|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56858732|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
56858733|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858734|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858735|NCT03719326|Paclitaxel|paclitaxel|mesh-list
56858736|NCT03719326|Doxorubicin|doxorubicin|mesh-list
56858737|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56858738|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56858739|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56858740|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858741|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56858742|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56858743|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56858744|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858745|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56858746|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56858747|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56858748|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858749|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
56858750|NCT03846284|Bupivacaine|bupivacaine|mesh-list
56858751|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
56858752|NCT03846284|Anesthetics|anesthetics|mesh-list
56858753|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
56858754|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858755|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858756|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
56858757|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858758|NCT03846284|Analgesics|analgesics|mesh-ancestor
56858759|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56858760|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
56858761|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56858762|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56858763|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858765|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
56858766|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56858767|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56858768|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56858769|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858770|NCT01066169|Lactitol|lactitol|mesh-list
56858771|NCT01066169|Cathartics|cathartics|mesh-ancestor
56858772|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56858773|NCT05572060|Metformin|metformin|mesh-list
56858774|NCT05572060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56858775|NCT05572060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858776|NCT05431244|Gemcitabine|gemcitabine|mesh-list
56858777|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
56858778|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56858779|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
56858780|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858781|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858782|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858783|NCT05431244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858784|NCT05431244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858785|NCT05431244|Immunologic Factors|immunologic factors|mesh-ancestor
56858786|NCT05431244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858787|NCT03172754|Nivolumab|nivolumab|mesh-list
56858788|NCT03172754|Axitinib|axitinib|mesh-list
56858789|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56858790|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858791|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56858792|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858793|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56858794|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858795|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
56858796|NCT01199432|Fluorouracil|fluorouracil|mesh-list
56858797|NCT01199432|Epirubicin|epirubicin|mesh-list
56858798|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858799|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
56858800|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858801|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56858802|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56858803|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
56858804|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858805|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858806|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56858807|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
56858808|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56858809|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56858810|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56858811|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56858812|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858813|NCT05064020|Tenofovir|tenofovir|mesh-list
56858814|NCT05064020|Emtricitabine|emtricitabine|mesh-list
56858815|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56858816|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
56858817|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858818|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56858819|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56858820|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858821|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858822|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56858823|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56858824|NCT01293422|Rifampin|rifampin|mesh-list
56858825|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56858826|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
56858827|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56858828|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858829|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
56858830|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56858831|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858832|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858833|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56858834|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56858835|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56858836|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56858837|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56858838|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56858840|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
56858841|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903815|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
56858842|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858843|NCT01566734|Cefazolin|cefazolin|mesh-list
56858844|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56858845|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858846|NCT00050778|Interferons|interferons|mesh-list
56858847|NCT00050778|Interferon-beta|interferon-beta|mesh-list
56858848|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
56858849|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
56858850|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858851|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
56858852|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858853|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56858854|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
56858855|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858856|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56858857|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56858858|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
56858859|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56858860|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
56858861|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56858862|NCT00050622|Methylphenidate|methylphenidate|mesh-list
56858863|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56858864|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858865|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56858866|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56858867|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56858868|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858869|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
56858870|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858871|NCT00308087|Rituximab|rituximab|mesh-list
56858872|NCT00308087|Molgramostim|molgramostim|mesh-list
56858873|NCT00308087|Sargramostim|sargramostim|mesh-list
56858874|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56858875|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56858876|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
56858877|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858878|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56858879|NCT04942184|Complement Factor H|complement factor h|mesh-list
56858880|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56858881|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858882|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
56858883|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858884|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
56858885|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56858886|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
56858887|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858888|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56858889|NCT01097148|Atracurium|atracurium|mesh-list
56858890|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56858891|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56858892|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56858893|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858894|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858895|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56858896|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56858897|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
56858898|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858899|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858900|NCT01199276|Sevoflurane|sevoflurane|mesh-list
56858901|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56858902|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56858903|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
56858904|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
56858905|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858906|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858907|NCT01202084|Fluticasone|fluticasone|mesh-list
56858908|NCT01202084|Xhance|xhance|mesh-list
56858909|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
56373385|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
56858912|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
56858913|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56858914|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858915|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56858916|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
56858917|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
56858918|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56858919|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56858920|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56858921|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56858922|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
56858923|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56858924|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858925|NCT04133792|Simvastatin|simvastatin|mesh-list
56858926|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56858927|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56858928|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
56858929|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858930|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56858931|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56858932|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858933|NCT01202240|Ketoconazole|ketoconazole|mesh-list
56858934|NCT01202240|Tofacitinib|tofacitinib|mesh-list
56858935|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
56858936|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858937|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56858938|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56858939|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858940|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858941|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56858942|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
56858943|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858944|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858945|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56858946|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56858947|NCT01204112|Rifampin|rifampin|mesh-list
56858948|NCT01204112|Tofacitinib|tofacitinib|mesh-list
56858949|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56858950|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
56858951|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56858952|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56858953|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
56858954|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56858955|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56858956|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858957|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56858958|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56858959|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56858960|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56858961|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56858962|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56858963|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56858964|NCT01204190|Gestodene|gestodene|mesh-list
56858965|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56858966|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56858967|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56858968|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
56858969|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56858970|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858971|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56858972|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56858973|NCT01204190|Progestins|progestins|mesh-ancestor
56858974|NCT01204190|Hormones|hormones|mesh-ancestor
56858975|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56858976|NCT01204268|Sevoflurane|sevoflurane|mesh-list
56858977|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56858978|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56858979|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
56858981|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56858982|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858983|NCT02965898|Vitamin D|vitamin d|mesh-list
56858984|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
56858985|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
56858986|NCT02965898|Vitamins|vitamins|mesh-list
56858987|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
56858988|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858989|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56858990|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56858991|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
56858992|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
56858993|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56858994|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56858995|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56858996|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56858997|NCT03844178|Tetracaine|tetracaine|mesh-list
56858998|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
56858999|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
56859000|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859001|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859002|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
56859003|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859004|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56859005|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
56859006|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859007|NCT00307151|Ritonavir|ritonavir|mesh-list
56859008|NCT00307151|Lopinavir|lopinavir|mesh-list
56859009|NCT00307151|Lamivudine|lamivudine|mesh-list
56859010|NCT00307151|Zidovudine|zidovudine|mesh-list
56859011|NCT00307151|Nevirapine|nevirapine|mesh-list
56859012|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56859013|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56859014|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
56859015|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859016|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859017|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56859018|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56859019|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
56859020|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859021|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56859022|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56859023|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56859024|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56859025|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
56859026|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56859027|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56859028|NCT03981029|Folic Acid|folic acid|mesh-list
56859029|NCT03981029|Hematinics|hematinics|mesh-ancestor
56859030|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
56859031|NCT03981029|Vitamins|vitamins|mesh-ancestor
56859032|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
56859033|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859034|NCT02654132|Dexamethasone|dexamethasone|mesh-list
56859035|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
56859036|NCT02654132|Pomalidomide|pomalidomide|mesh-list
56859037|NCT02654132|Elotuzumab|elotuzumab|mesh-list
56859038|NCT02654132|BB 1101|bb 1101|mesh-list
56859039|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56859040|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
56859041|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
56859042|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859043|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859044|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56859045|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
56859046|NCT02654132|Hormones|hormones|mesh-ancestor
56859047|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859048|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56859049|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859050|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
56859051|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859052|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859053|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
56859054|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56859055|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56373532|NCT00136110|Valproic Acid|valproic acid|mesh-list
56859058|NCT01064141|Vaccines|vaccines|mesh-list
56859059|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
56859060|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859061|NCT03837470|Furosemide|furosemide|mesh-list
56859062|NCT03837470|Diuretics|diuretics|mesh-ancestor
56859063|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
56859064|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895237|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
56859065|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56859066|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859067|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859068|NCT05307874|Aldesleukin|aldesleukin|mesh-list
56859069|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859070|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56859071|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56859072|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
56859073|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859074|NCT01199900|Prednisone|prednisone|mesh-list
56859075|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56859076|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
56859077|NCT01199900|Hormones|hormones|mesh-ancestor
56859078|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859079|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859080|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56859081|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859082|NCT01200056|Atorvastatin|atorvastatin|mesh-list
56859083|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56859084|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56859085|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
56859086|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859087|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56859088|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56859089|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859090|NCT03841526|Glucagon|glucagon|mesh-list
56859091|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56859092|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56859093|NCT03841526|Hormones|hormones|mesh-ancestor
56859094|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859095|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859096|NCT03841526|Incretins|incretins|mesh-ancestor
56859097|NCT01200212|Bevacizumab|bevacizumab|mesh-list
56859098|NCT01200212|Taxane|taxane|mesh-list
56859099|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859100|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859101|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56859102|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56859103|NCT01200212|Growth Substances|growth substances|mesh-ancestor
56859104|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859105|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
56859106|NCT03978845|Lidocaine|lidocaine|mesh-list
56859107|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
56859108|NCT03978845|Anesthetics|anesthetics|mesh-list
56859109|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859110|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859111|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
56859112|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859113|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56859114|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56859115|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56859116|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859117|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859118|NCT02387996|Nivolumab|nivolumab|mesh-list
56859119|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859120|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859121|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56859122|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859123|NCT01204580|Metformin|metformin|mesh-list
56859124|NCT01204580|Glimepiride|glimepiride|mesh-list
56859125|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56859126|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859127|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56859128|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859130|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
56859131|NCT03850366|Bortezomib|bortezomib|mesh-list
56859132|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859133|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
56859134|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859135|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56859136|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56859137|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
56859138|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859139|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859140|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56859141|NCT05181592|Luspatercept|luspatercept|mesh-list
56859142|NCT05181592|Hematinics|hematinics|mesh-ancestor
56859143|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56859144|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56859145|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56859146|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56859147|NCT05669846|Pembrolizumab|pembrolizumab|mesh-list
56859148|NCT05669846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859149|NCT05669846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859150|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
56859151|NCT03229486|Neostigmine|neostigmine|mesh-list
56859152|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56859153|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859154|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859155|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
56859156|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859157|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859158|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56859159|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
56859160|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859161|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56859162|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56859163|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56859164|NCT05153668|Everolimus|everolimus|mesh-list
56859165|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859166|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859167|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
56859168|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859169|NCT03833570|Melatonin|melatonin|mesh-list
56859170|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
56859171|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859172|NCT03833570|Protective Agents|protective agents|mesh-ancestor
56859173|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859174|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859175|NCT01779050|Paclitaxel|paclitaxel|mesh-list
56859176|NCT01779050|Docetaxel|docetaxel|mesh-list
56859177|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
56859178|NCT01779050|Carboplatin|carboplatin|mesh-list
56859179|NCT01779050|Doxorubicin|doxorubicin|mesh-list
56859180|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56859181|NCT01779050|Fluorouracil|fluorouracil|mesh-list
56859182|NCT01779050|Trastuzumab|trastuzumab|mesh-list
56859183|NCT01779050|Epirubicin|epirubicin|mesh-list
56859184|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56859185|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859186|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
56859187|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
56859188|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
56859189|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859190|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859191|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
56859192|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859193|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56859194|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56859195|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
56859196|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56859197|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56859198|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56859199|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56859200|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859201|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
56859202|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56859203|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859204|NCT03841136|Etoposide|etoposide|mesh-list
56859206|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859207|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56859208|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56859209|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859210|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859212|NCT05669768|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56859213|NCT05669768|Hormone Antagonists|hormone antagonists|mesh-ancestor
56859214|NCT05669768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859215|NCT05669768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859216|NCT05669768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56859217|NCT05669768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859218|NCT05669768|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56859219|NCT05669768|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56859220|NCT05669768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56859222|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
56859223|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859224|NCT01066247|Midazolam|midazolam|mesh-list
56859225|NCT01066247|Morphine|morphine|mesh-list
56859226|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56859227|NCT01066247|Narcotics|narcotics|mesh-ancestor
56859228|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859229|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859230|NCT01066247|Analgesics|analgesics|mesh-ancestor
56859231|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
56859232|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859233|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56859234|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56859235|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56859236|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56859237|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56859238|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56859239|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
56859240|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
56859241|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
56859242|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
56859243|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859244|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859245|NCT00306293|Valacyclovir|valacyclovir|mesh-list
56859246|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
56859247|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859248|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
56859249|NCT03980951|Narcotics|narcotics|mesh-ancestor
56859250|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859251|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859252|NCT03980951|Analgesics|analgesics|mesh-ancestor
56859253|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
56859254|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859255|NCT02532491|Risperidone|risperidone|mesh-list
56859256|NCT02532491|Aripiprazole|aripiprazole|mesh-list
56859257|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56859258|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
56859259|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859260|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859261|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859262|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56859263|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56859264|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859265|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56859266|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56859267|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
56859268|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
56859269|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
56859270|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56859271|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56859272|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56859273|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56859274|NCT01066403|Pergolide|pergolide|mesh-list
56859275|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
56859276|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
56859277|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859278|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859281|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56859282|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859283|NCT00294671|Diflunisal|diflunisal|mesh-list
56859284|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56859285|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56859286|NCT00294671|Analgesics|analgesics|mesh-ancestor
56859287|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
56859288|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859289|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859290|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56859291|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56859292|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56859293|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859294|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859295|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56859296|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56859297|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859298|NCT03980249|Carvedilol|carvedilol|mesh-list
56859299|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56859300|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56859301|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
56859302|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859303|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859304|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859305|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56859306|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
56859307|NCT03980249|Protective Agents|protective agents|mesh-ancestor
56859308|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56859309|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859310|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56859311|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
56859312|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56859313|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56859314|NCT01495598|Pomalidomide|pomalidomide|mesh-list
56859315|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
56859316|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859317|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56859318|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56859319|NCT01495598|Growth Substances|growth substances|mesh-ancestor
56859320|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
56859321|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859322|NCT01297166|Calcitriol|calcitriol|mesh-list
56859323|NCT01297166|Calcipotriene|calcipotriene|mesh-list
56859324|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
56859325|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56859326|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859327|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56859328|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859329|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859330|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56859331|NCT01297166|Vitamins|vitamins|mesh-ancestor
56859332|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
56859333|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56859334|NCT01202474|Insulin|insulin|mesh-list
56859335|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56859336|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
56859337|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
56859338|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56859339|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859340|NCT05667818|Norfloxacin|norfloxacin|mesh-list
56859341|NCT05667818|Amlodipine|amlodipine|mesh-list
56859342|NCT05667818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56859343|NCT05667818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56859344|NCT05667818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859345|NCT05667818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859346|NCT05667818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56859347|NCT05667818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859348|NCT05667818|Vasodilator Agents|vasodilator agents|mesh-ancestor
56859349|NCT05667818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56859351|NCT05667818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56859352|NCT05667818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56859353|NCT05667818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859354|NCT05667818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859355|NCT05667818|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56859356|NCT05667818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56859357|NCT01205204|Clonidine|clonidine|mesh-list
56859358|NCT01205204|Fentanyl|fentanyl|mesh-list
56859359|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56859360|NCT01205204|Narcotics|narcotics|mesh-ancestor
56859361|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859362|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859363|NCT01205204|Analgesics|analgesics|mesh-ancestor
56859364|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
56859365|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859366|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56859367|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56859368|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
56859370|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56859371|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
56859372|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
56859373|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56859374|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56859375|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56859376|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
56859377|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859378|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859379|NCT01205282|Pioglitazone|pioglitazone|mesh-list
56859380|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56859381|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859382|NCT03902912|Prednisolone|prednisolone|mesh-list
56859383|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56859384|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
56859385|NCT03902912|Hormones|hormones|mesh-ancestor
56859386|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859387|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859388|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56859389|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859390|NCT01205360|Fentanyl|fentanyl|mesh-list
56859391|NCT01205360|Bupivacaine|bupivacaine|mesh-list
56859392|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
56859393|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
56859394|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859395|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859396|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
56859397|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859398|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56859399|NCT01205360|Narcotics|narcotics|mesh-ancestor
56859400|NCT01205360|Analgesics|analgesics|mesh-ancestor
56859401|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56859402|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56859403|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
56859404|NCT01200914|Heparin|heparin|mesh-list
56859405|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
56859406|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56859407|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56859408|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859409|NCT01205516|Morphine|morphine|mesh-list
56859410|NCT01205516|Methadone|methadone|mesh-list
56859411|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56859412|NCT01205516|Narcotics|narcotics|mesh-ancestor
56859413|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859414|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859415|NCT01205516|Analgesics|analgesics|mesh-ancestor
56859416|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
56859417|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859418|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
56859419|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
56859420|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
56859421|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56859422|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56859423|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56859424|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859425|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859427|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859428|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859429|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56859430|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859431|NCT01201070|Antithrombins|antithrombins|mesh-list
56859432|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
56859433|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56859434|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
56859435|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859436|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859437|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
56859438|NCT01205672|Metformin|metformin|mesh-list
56859439|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56859440|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859441|NCT03817970|Ondansetron|ondansetron|mesh-list
56859442|NCT03817970|Palonosetron|palonosetron|mesh-list
56859443|NCT03817970|Granisetron|granisetron|mesh-list
56859444|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
56859445|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
56859446|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859447|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859448|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56859449|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
56859450|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
56859451|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56859452|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
56859453|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859454|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859455|NCT03817970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56859456|NCT03817970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56859457|NCT03817970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859458|NCT03817970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56859459|NCT03817970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56859460|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56859461|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
56859462|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56859463|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859464|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859465|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56859466|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859467|NCT01205750|Insulin|insulin|mesh-list
56859468|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56859469|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56859470|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859471|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
56859472|NCT03012386|Citric Acid|citric acid|mesh-list
56859473|NCT03012386|Sodium Citrate|sodium citrate|mesh-list
56859474|NCT03012386|Anticoagulants|anticoagulants|mesh-ancestor
56859475|NCT03012386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56859476|NCT03012386|Chelating Agents|chelating agents|mesh-ancestor
56859477|NCT03012386|Sequestering Agents|sequestering agents|mesh-ancestor
56859478|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859479|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
56859480|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56859481|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56859482|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859483|NCT03012386|Urological Agents|urological agents|mesh-ancestor
56859484|NCT01202552|Vaccines|vaccines|mesh-list
56859485|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
56859486|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859487|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56859488|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
56859489|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56859490|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56859491|NCT01205984|Prednisolone|prednisolone|mesh-list
56859492|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
56859493|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56859494|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
56859495|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56859496|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
56859497|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
56859498|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859499|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859500|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56859501|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
56859504|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56859505|NCT01205984|Protective Agents|protective agents|mesh-ancestor
56859506|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56859507|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859508|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56859509|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859510|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56859511|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859512|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859513|NCT01297946|Hormones|hormones|mesh-list
56903833|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859514|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920213|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56859515|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859516|NCT03211858|Insulin|insulin|mesh-list
56859517|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56859518|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
56859519|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
56859520|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
56859521|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56859522|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56859523|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859524|NCT01298180|Hormones|hormones|mesh-list
56859525|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859526|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859527|NCT03211156|Amoxicillin|amoxicillin|mesh-list
56859528|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56859529|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859530|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
56859531|NCT01298336|Clarithromycin|clarithromycin|mesh-list
56859532|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56859533|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859534|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56859535|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56859536|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859537|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859538|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859539|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56859540|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56859541|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56859542|NCT04472494|Abatacept|abatacept|mesh-list
56859543|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56859544|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859545|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859546|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859547|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
56859548|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859549|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56859550|NCT04568200|Paclitaxel|paclitaxel|mesh-list
56859551|NCT04568200|Carboplatin|carboplatin|mesh-list
56859552|NCT04568200|Durvalumab|durvalumab|mesh-list
56859553|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56859554|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859555|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56859556|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56859557|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56859558|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859559|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859560|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
56859561|NCT03236506|Grazoprevir|grazoprevir|mesh-list
56859562|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56859563|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
56859564|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859565|NCT01298882|Diacetylrhein|diacetylrhein|mesh-list
56859566|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56859567|NCT01206530|Leucovorin|leucovorin|mesh-list
56859568|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
56859569|NCT01206530|Bevacizumab|bevacizumab|mesh-list
56859570|NCT01206530|Fluorouracil|fluorouracil|mesh-list
56859571|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
56859572|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859573|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859576|NCT01206530|Growth Substances|growth substances|mesh-ancestor
56859577|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859578|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
56859579|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
56859580|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859581|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56859582|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859583|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
56859584|NCT01206530|Antidotes|antidotes|mesh-ancestor
56859585|NCT01206530|Protective Agents|protective agents|mesh-ancestor
56859586|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
56859587|NCT01206530|Vitamins|vitamins|mesh-ancestor
56859588|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
56859589|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
56859590|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56859591|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56859592|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859593|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859594|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56859596|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56859597|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
56859598|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56859599|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859600|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56859601|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859602|NCT05282420|Ranibizumab|ranibizumab|mesh-list
56859603|NCT05282420|Aflibercept|aflibercept|mesh-list
56859604|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56859605|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56859606|NCT05282420|Growth Substances|growth substances|mesh-ancestor
56859607|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859608|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
56859609|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859610|NCT01203020|Fludarabine|fludarabine|mesh-list
56859611|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
56859612|NCT01203020|Busulfan|busulfan|mesh-list
56859613|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859614|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56859615|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
56859616|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859617|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859618|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
56859619|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859620|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
56859621|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56859622|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56859623|NCT00304031|Temozolomide|temozolomide|mesh-list
56859624|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56859625|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
56859626|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859627|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859628|NCT01567124|Moxonidine|moxonidine|mesh-list
56859629|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56859630|NCT03617666|Avelumab|avelumab|mesh-list
56859631|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859632|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859633|NCT01299194|Atorvastatin|atorvastatin|mesh-list
56859634|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56859635|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56859636|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
56859637|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859638|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56859639|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56859640|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859641|NCT03827408|Midazolam|midazolam|mesh-list
56859642|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
56859643|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56859644|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859645|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859646|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56859647|NCT03827408|Analgesics|analgesics|mesh-ancestor
56859648|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
56859652|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56859653|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
56859654|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859655|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859656|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56859657|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56859658|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56859659|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56859660|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56859661|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
56859662|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
56859663|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
56859664|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
56859665|NCT03556904|Docetaxel|docetaxel|mesh-list
56859666|NCT03556904|Hormones|hormones|mesh-list
56859667|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859668|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
56859669|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
56859670|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
56859671|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859672|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859673|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859675|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56859676|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56859677|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859678|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859679|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56859680|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859681|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
56859682|NCT01206998|Progesterone|progesterone|mesh-list
56859683|NCT01206998|Progestins|progestins|mesh-ancestor
56859684|NCT01206998|Hormones|hormones|mesh-ancestor
56859685|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859686|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859687|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56859688|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56859689|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56859690|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859691|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859692|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859693|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859694|NCT00331799|Analgesics|analgesics|mesh-ancestor
56859695|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
56859696|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859697|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
56859698|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56859699|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
56859700|NCT03826940|Lovastatin|lovastatin|mesh-list
56859701|NCT03826940|L 647318|l 647318|mesh-list
56859702|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
56859703|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56859704|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56859705|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
56859706|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859707|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56859708|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56859709|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859710|NCT00303953|Belinostat|belinostat|mesh-list
56859711|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859712|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56859713|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859714|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859715|NCT01201694|Curcumin|curcumin|mesh-list
56859716|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56859717|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56859718|NCT01201694|Analgesics|analgesics|mesh-ancestor
56568166|NCT01812616|Nabiximols|nabiximols|mesh-list
56859720|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859721|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859722|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56859723|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56859724|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859725|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859726|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859728|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56859729|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859730|NCT00303719|Cyclosporine|cyclosporine|mesh-list
56859731|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
56859732|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
56859733|NCT00303719|Fludarabine|fludarabine|mesh-list
56859734|NCT00303719|Cyclosporins|cyclosporins|mesh-list
56859735|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56859736|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859737|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
56859738|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859739|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56859740|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56859741|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
56859742|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859743|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859744|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56859745|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859746|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
56859747|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859748|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
56859749|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56859750|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56859751|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56859752|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
56859753|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56859754|NCT01207310|Nicotine|nicotine|mesh-list
56859755|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56859756|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
56859757|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859758|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859759|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56859760|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56859761|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
56859762|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859763|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859764|NCT05622812|Lidocaine|lidocaine|mesh-list
56859765|NCT05622812|Anesthetics, Local|anesthetics, local|mesh-ancestor
56859766|NCT05622812|Anesthetics|anesthetics|mesh-ancestor
56859767|NCT05622812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859768|NCT05622812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859769|NCT05622812|Sensory System Agents|sensory system agents|mesh-ancestor
56859770|NCT05622812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859771|NCT05622812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56859772|NCT05622812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56859773|NCT05622812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56859774|NCT05622812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859775|NCT05622812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859776|NCT00331409|Everolimus|everolimus|mesh-list
56859777|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
56859778|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859779|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859780|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
56859781|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859782|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56859783|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859784|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859785|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56859786|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56859787|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56859788|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
56859789|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859790|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56859791|NCT01064921|Vorinostat|vorinostat|mesh-list
56859793|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56859794|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859795|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859796|NCT01299662|Poly ICLC|poly iclc|mesh-list
56859797|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
56859798|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
56859799|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859800|NCT00303485|Vitamin D|vitamin d|mesh-list
56859801|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
56859802|NCT00303485|Calcium|calcium|mesh-list
56859803|NCT00303485|Vitamins|vitamins|mesh-ancestor
56859804|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
56859805|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859806|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56859807|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56859808|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
56859809|NCT03983915|Remifentanil|remifentanil|mesh-list
56859810|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56859811|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859812|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859813|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56859814|NCT03983915|Analgesics|analgesics|mesh-ancestor
56859815|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
56464629|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
56859816|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859817|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56859818|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56859819|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56859820|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
56859821|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859822|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859823|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56859824|NCT03983915|Narcotics|narcotics|mesh-ancestor
56859825|NCT01300754|Lidocaine|lidocaine|mesh-list
56859826|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
56859827|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
56859828|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859829|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859830|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
56859831|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859832|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56859833|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56859834|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56859835|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859836|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859837|NCT03840122|Anesthetics|anesthetics|mesh-list
56859838|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
56859839|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859840|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859841|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
56859842|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859843|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
56859844|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56859845|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
56859846|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859847|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
56859848|NCT03723590|Protective Agents|protective agents|mesh-ancestor
56859849|NCT04343872|Metformin|metformin|mesh-list
56859850|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56859851|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859852|NCT01314274|Bevacizumab|bevacizumab|mesh-list
56859853|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859854|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859855|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56859856|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56859857|NCT01314274|Growth Substances|growth substances|mesh-ancestor
56859858|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859859|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
56859860|NCT04303390|Cefazolin|cefazolin|mesh-list
56859861|NCT04303390|Cefuroxime|cefuroxime|mesh-list
56859862|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
56859863|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56859864|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859865|NCT02935894|Ibuprofen|ibuprofen|mesh-list
56859866|NCT02935894|Pilocarpine|pilocarpine|mesh-list
56859867|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56859868|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56859870|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
56859871|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859872|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859873|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56859874|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56859875|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56859876|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859877|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859878|NCT02935894|Miotics|miotics|mesh-ancestor
56859879|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
56859880|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56859881|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56859882|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
56859883|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859884|NCT04170946|Talazoparib|talazoparib|mesh-list
56859885|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56859886|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859887|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859888|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859889|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
56859890|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56859891|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859892|NCT03224182|Apaziquone|apaziquone|mesh-list
56859893|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859894|NCT03821480|Fluconazole|fluconazole|mesh-list
56859895|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
56859896|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56859897|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56859898|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56859899|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859900|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859901|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56859902|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
56859903|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56859904|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859905|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56859906|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56859907|NCT01203488|Vitamin A|vitamin a|mesh-list
56859908|NCT01203488|Vitamins|vitamins|mesh-ancestor
56859909|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
56859910|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859911|NCT03697720|Naproxen|naproxen|mesh-list
56859912|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56859913|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56859914|NCT03697720|Analgesics|analgesics|mesh-ancestor
56859915|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
56859916|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859917|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859918|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56859919|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56859920|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
56859921|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56859922|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56859923|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859924|NCT01314352|Desloratadine|desloratadine|mesh-list
56859925|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56859926|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
56859927|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859928|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859929|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859930|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56859931|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56859932|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
56859933|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
56859934|NCT03818282|Paclitaxel|paclitaxel|mesh-list
56859935|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56859936|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859937|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
56859938|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
56859939|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
56859941|NCT01300364|Citalopram|citalopram|mesh-list
56859942|NCT01300364|Reboxetine|reboxetine|mesh-list
56859943|NCT01300364|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56859944|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56859945|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56859946|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859947|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859948|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
56859949|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859950|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56859951|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
56859952|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56859953|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56859954|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
56859955|NCT03221842|Complement C1s|complement c1s|mesh-list
56859956|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56859957|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56859958|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
56859959|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859960|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56859961|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56859962|NCT05622890|Maytansine|maytansine|mesh-list
56859963|NCT05622890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56859964|NCT05622890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859965|NCT05622890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56859966|NCT05622890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56859967|NCT05622890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56859968|NCT05622890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859969|NCT00303329|Deferasirox|deferasirox|mesh-list
56859970|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56859971|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
56859972|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
56859973|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859974|NCT01300988|Aprepitant|aprepitant|mesh-list
56859975|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
56859976|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
56859977|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
56859978|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56859979|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859980|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56859981|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56859982|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56859983|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859984|NCT01064999|Capecitabine|capecitabine|mesh-list
56859985|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
56859986|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56859987|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
56859988|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56859989|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56859990|NCT03818048|Propofol|propofol|mesh-list
56859991|NCT03818048|Sevoflurane|sevoflurane|mesh-list
56859992|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56859993|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56859994|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56859995|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56859996|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
56859997|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
56859998|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56859999|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56860000|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56860001|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56860002|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56860003|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860004|NCT00329849|Vaccines|vaccines|mesh-list
56860005|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
56860006|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860007|NCT05655806|Aminophylline|aminophylline|mesh-list
56860008|NCT05655806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56860009|NCT05655806|Autonomic Agents|autonomic agents|mesh-ancestor
56860010|NCT05655806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860011|NCT05655806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860012|NCT05655806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56860013|NCT05655806|Respiratory System Agents|respiratory system agents|mesh-ancestor
56860014|NCT05655806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56860015|NCT05655806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56860016|NCT05655806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860017|NCT05655806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860018|NCT05655806|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56860019|NCT05655806|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56860020|NCT05655806|Purinergic Agents|purinergic agents|mesh-ancestor
56860021|NCT05655806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860022|NCT05655806|Protective Agents|protective agents|mesh-ancestor
56860024|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
56860025|NCT01300676|Estrogens|estrogens|mesh-ancestor
56860026|NCT01300676|Hormones|hormones|mesh-ancestor
56860027|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860028|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860029|NCT01300676|Progestins|progestins|mesh-ancestor
56860030|NCT03113968|Ketamine|ketamine|mesh-list
56860031|NCT03113968|Analgesics|analgesics|mesh-ancestor
56860032|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
56860033|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860034|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860035|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56860036|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56860037|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
56860038|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
56860039|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56860040|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56860041|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56860042|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860043|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860044|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
56860045|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860046|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
56860047|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860048|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56860049|NCT03806816|Melatonin|melatonin|mesh-list
56860050|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
56860051|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860052|NCT03806816|Protective Agents|protective agents|mesh-ancestor
56860053|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860054|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56860055|NCT02960230|Nivolumab|nivolumab|mesh-list
56860056|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56860057|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860058|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56860059|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860060|NCT01301222|Octreotide|octreotide|mesh-list
56860061|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860062|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860063|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860064|NCT02864992|Tepotinib|tepotinib|mesh-list
56860065|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860066|NCT02532569|Vaccines|vaccines|mesh-list
56860067|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
56860068|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860069|NCT01302002|Metformin|metformin|mesh-list
56860070|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56860071|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860072|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56860073|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
56860074|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
56860075|NCT03814616|Artesunate|artesunate|mesh-list
56860076|NCT03814616|Pyronaridine|pyronaridine|mesh-list
56860077|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
56860078|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56860079|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56860080|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860081|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860082|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
56860083|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
56860084|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56860085|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
56860086|NCT00302159|Temozolomide|temozolomide|mesh-list
56860087|NCT00302159|Valproic Acid|valproic acid|mesh-list
56860088|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56860095|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860096|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860097|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
56860098|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56860099|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56860100|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56860101|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
56860102|NCT03814226|Growth Substances|growth substances|mesh-ancestor
56860103|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860104|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
56860105|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860106|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860107|NCT00302081|Ribavirin|ribavirin|mesh-list
56860108|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56860109|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
56860110|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
56860111|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860112|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
56570921|NCT00601354|Orlistat|orlistat|mesh-list
56860113|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860114|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
56464924|NCT00501111|Donepezil|donepezil|mesh-list
56860115|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860116|NCT00302003|Cytarabine|cytarabine|mesh-list
56860117|NCT00302003|Dexamethasone|dexamethasone|mesh-list
56860118|NCT00302003|Prednisone|prednisone|mesh-list
56860119|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
56860120|NCT00302003|Ifosfamide|ifosfamide|mesh-list
56860121|NCT00302003|Doxorubicin|doxorubicin|mesh-list
56860122|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56860123|NCT00302003|Etoposide|etoposide|mesh-list
56860124|NCT00302003|Vincristine|vincristine|mesh-list
56860125|NCT00302003|Vinorelbine|vinorelbine|mesh-list
56860126|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
56860127|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860128|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
56860129|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860130|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56860131|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56860132|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
56860133|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860134|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860135|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56860136|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56860137|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
56860138|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
56860139|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860140|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860141|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
56860142|NCT00302003|Hormones|hormones|mesh-ancestor
56860143|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860144|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860145|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56860146|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56860147|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56860148|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860149|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56860150|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860151|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
56860152|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
56860153|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860154|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
56860155|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
56860156|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
56860157|NCT00036270|Tamoxifen|tamoxifen|mesh-list
56860158|NCT00036270|Exemestane|exemestane|mesh-list
56568171|NCT00618358|Thrombin|thrombin|mesh-list
56860160|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
56860161|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860162|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860163|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860164|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860165|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56860166|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56860167|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56860168|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56860169|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56860170|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860171|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860173|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56860174|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56860175|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56860176|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860177|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56860178|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
56860179|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
56860180|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860181|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860182|NCT00049530|Interferons|interferons|mesh-list
56860183|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
56860184|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
56860185|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56860186|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860187|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
56570995|NCT01170962|Ribavirin|ribavirin|mesh-list
56860188|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860189|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
56860190|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860192|NCT00301067|Temozolomide|temozolomide|mesh-list
56860193|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56860194|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
56860195|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860196|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860197|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56860198|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860199|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56860200|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56860201|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56860202|NCT00301067|Vitamins|vitamins|mesh-ancestor
56860203|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
56860204|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56860205|NCT03979859|Nafithromycin|nafithromycin|mesh-list
56860206|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56860207|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860208|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56860209|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860210|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860211|NCT03955458|Bupivacaine|bupivacaine|mesh-list
56860212|NCT03955458|Ropivacaine|ropivacaine|mesh-list
56860213|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
56860214|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
56860215|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56860216|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860217|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
56860218|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860219|NCT00007020|Cholic Acids|cholic acids|mesh-list
56860220|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860221|NCT00300755|Pantoprazole|pantoprazole|mesh-list
56860222|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56860223|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860224|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56860225|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860226|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860227|NCT00033540|Gemcitabine|gemcitabine|mesh-list
56860228|NCT00033540|Capecitabine|capecitabine|mesh-list
56860229|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860230|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
56904620|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56860231|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860233|NCT00033540|Antiviral Agents|antiviral agents|mesh-ancestor
56860234|NCT00033540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860235|NCT00033540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860236|NCT00033540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860237|NCT00033540|Immunologic Factors|immunologic factors|mesh-ancestor
56860238|NCT00033540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860239|NCT00300365|Aspirin|aspirin|mesh-list
56860240|NCT00300365|Niacin|niacin|mesh-list
56860241|NCT00300365|Pioglitazone|pioglitazone|mesh-list
56860242|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56860243|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56860244|NCT00300365|Analgesics|analgesics|mesh-ancestor
56860245|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
56860246|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860247|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860248|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56860249|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56860250|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56860251|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56860252|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860253|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56860254|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56860255|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860256|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
56860257|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56860258|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56860259|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
56860260|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56860261|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
56860262|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
56571088|NCT01155284|Hormones|hormones|mesh-ancestor
56860263|NCT00300365|Vitamins|vitamins|mesh-ancestor
56860264|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
56860265|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56860266|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860267|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
56860268|NCT00048048|Hematinics|hematinics|mesh-ancestor
56860269|NCT03953118|Azithromycin|azithromycin|mesh-list
56860270|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56860271|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860272|NCT01101204|Metformin|metformin|mesh-list
56860273|NCT01101204|Simvastatin|simvastatin|mesh-list
56860274|NCT01101204|Fenofibrate|fenofibrate|mesh-list
56860275|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56860276|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860277|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56860278|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56860279|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
56860280|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860281|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56860282|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56860283|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860284|NCT01095822|Valsartan|valsartan|mesh-list
56860285|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56860286|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56860287|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56860288|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860289|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
56860290|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56860291|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56860292|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860293|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
56860294|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860295|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860296|NCT00300053|Lenograstim|lenograstim|mesh-list
56860297|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56860298|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
56860299|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860300|NCT01098084|Decitabine|decitabine|mesh-list
56860301|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860302|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
56860303|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860304|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860306|NCT03952572|Prednisone|prednisone|mesh-list
56860307|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
56860308|NCT03952572|Doxorubicin|doxorubicin|mesh-list
56860309|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56860310|NCT03952572|Vincristine|vincristine|mesh-list
56860311|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860312|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
56860313|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860314|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56860315|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56860316|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
56860317|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860318|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860319|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56860320|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56860321|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56860322|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56860323|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860324|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56860325|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
56860326|NCT03952572|Hormones|hormones|mesh-ancestor
56860327|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860328|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860329|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56860330|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
56860331|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
56860332|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
56860333|NCT03954756|Apatinib|apatinib|mesh-list
56860334|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860335|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860336|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860337|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860338|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
56860339|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56860340|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56860341|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860343|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56860344|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
56860345|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860346|NCT00326885|Catumaxomab|catumaxomab|mesh-list
56860347|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860348|NCT00326495|Cetuximab|cetuximab|mesh-list
56860349|NCT00326495|Sorafenib|sorafenib|mesh-list
56860350|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56860351|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860352|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860353|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860354|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860355|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
56860356|NCT00326417|Fludarabine|fludarabine|mesh-list
56860357|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860358|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
56860359|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860360|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56860361|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56860362|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
56860363|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860364|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860365|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56860366|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56860367|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56860368|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
56860369|NCT01060787|Hormones|hormones|mesh-ancestor
56860370|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860371|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860372|NCT01065467|Panobinostat|panobinostat|mesh-list
56860373|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860374|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56860375|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860376|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860377|NCT01065545|Clofarabine|clofarabine|mesh-list
56860378|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860379|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
56860380|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860382|NCT03979469|Fentanyl|fentanyl|mesh-list
56860383|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
56860384|NCT03979469|Ketamine|ketamine|mesh-list
56860385|NCT03979469|Remifentanil|remifentanil|mesh-list
56860386|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56860387|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56860388|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860389|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56860390|NCT03979469|Analgesics|analgesics|mesh-ancestor
56860391|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
56860392|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860393|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56860394|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56860395|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56860396|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
56860397|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860398|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860399|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56860400|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56860401|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
56860402|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
56860403|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56860404|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56860405|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56860406|NCT03979469|Narcotics|narcotics|mesh-ancestor
56860407|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56860408|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
56860409|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56860410|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571219|NCT00839527|Hormones|hormones|mesh-ancestor
56860411|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860412|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56860414|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
56860415|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860416|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56860417|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56860418|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56860419|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
56860420|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860421|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860422|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
56860423|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860424|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
56860425|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860426|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860427|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56860428|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
56860429|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
56860430|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
56860431|NCT01065857|Citric Acid|citric acid|mesh-list
56860432|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
56860433|NCT01065857|Cathartics|cathartics|mesh-ancestor
56860434|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860435|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
56860436|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56860437|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
56860438|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
56860439|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860440|NCT01065857|Antacids|antacids|mesh-ancestor
56860441|NCT00297479|Nicotine|nicotine|mesh-list
56860442|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56860443|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
56860444|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860445|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860446|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56860447|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56860448|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
56860449|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860450|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860451|NCT00688870|Vaccines|vaccines|mesh-list
56860452|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56860453|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
56568181|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
56860454|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860455|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56860456|NCT02532335|Cathartics|cathartics|mesh-ancestor
56860457|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860459|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860460|NCT03216226|Hormones|hormones|mesh-ancestor
56860461|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860462|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860463|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
56860464|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
56860465|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860466|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860467|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860468|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860469|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
56860470|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56860471|NCT00290693|Docetaxel|docetaxel|mesh-list
56860472|NCT00290693|Capecitabine|capecitabine|mesh-list
56860473|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860474|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
56860475|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
56860476|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
56860477|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860478|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860479|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
56860480|NCT00274469|Fulvestrant|fulvestrant|mesh-list
56860481|NCT00274469|Anastrozole|anastrozole|mesh-list
56860482|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860483|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860484|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56860485|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56860486|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
56571293|NCT00600886|Octreotide|octreotide|mesh-list
56860487|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860488|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860489|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56860490|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56860491|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860492|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860493|NCT01556776|Lenalidomide|lenalidomide|mesh-list
56860494|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
56860495|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860496|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56860497|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56860498|NCT01556776|Growth Substances|growth substances|mesh-ancestor
56860499|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
56860500|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860501|NCT02422498|Cisplatin|cisplatin|mesh-list
56860502|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860503|NCT01314976|Metronidazole|metronidazole|mesh-list
56860504|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860505|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56860506|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56860507|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56860508|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
56860509|NCT02379520|Nivolumab|nivolumab|mesh-list
56860510|NCT02379520|Fludarabine|fludarabine|mesh-list
56860511|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860512|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
56860513|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860514|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56860515|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56860516|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
56860517|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860518|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860519|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56860520|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56860521|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56860522|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
56860523|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56860524|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56860525|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860526|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56860527|NCT01973452|Analgesics|analgesics|mesh-ancestor
56860528|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
56860529|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860530|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56860531|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56860532|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56860533|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
56860534|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860535|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860536|NCT04504942|Leronlimab|leronlimab|mesh-list
56860537|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56860538|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56860539|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860540|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56860541|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56860542|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
56860543|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860544|NCT01882816|Doxorubicin|doxorubicin|mesh-list
56860545|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56860546|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860547|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56860548|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56860549|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860550|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860551|NCT03648892|Raclopride|raclopride|mesh-list
56860552|NCT03648892|Fallypride|fallypride|mesh-list
56860553|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56860554|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56860555|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56860556|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860557|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56860558|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56860559|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
56860560|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571375|NCT00838903|Metformin|metformin|mesh-list
56860561|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860562|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56860563|NCT00272987|Paclitaxel|paclitaxel|mesh-list
56860564|NCT00272987|Trastuzumab|trastuzumab|mesh-list
56860565|NCT00272987|Lapatinib|lapatinib|mesh-list
56860566|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56860567|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860568|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
56860569|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
56860570|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
56860571|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860572|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56860573|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860574|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860575|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56860576|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860577|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860578|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860579|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860580|NCT01070927|R04929097|r04929097|mesh-list
56860581|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860582|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860583|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56860584|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860585|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56860586|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
56860587|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860588|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
56860589|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860590|NCT01730950|Bevacizumab|bevacizumab|mesh-list
56860591|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56860592|NCT01730950|Antibodies|antibodies|mesh-list
56860593|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
56860594|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56860595|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860596|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56860597|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56860598|NCT01730950|Growth Substances|growth substances|mesh-ancestor
56860599|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860600|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
56860601|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
56860603|NCT00271505|Carboplatin|carboplatin|mesh-list
56860604|NCT00271505|Docetaxel|docetaxel|mesh-list
56860605|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56860606|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860607|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56860608|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56860609|NCT00271505|Growth Substances|growth substances|mesh-ancestor
56860610|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860611|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
56860612|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
56860613|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
56860614|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
56860615|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860616|NCT01642186|Everolimus|everolimus|mesh-list
56860617|NCT01642186|Letrozole|letrozole|mesh-list
56860618|NCT01642186|Leuprolide|leuprolide|mesh-list
56860619|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860620|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860621|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
56860622|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860623|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56860624|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56860625|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860626|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860627|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56860628|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
56860629|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860630|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56860631|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
56860632|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56860633|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860634|NCT04500574|Latanoprost|latanoprost|mesh-list
56571444|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
56860635|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56860636|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56860637|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
56860638|NCT00423514|Melphalan|melphalan|mesh-list
56860639|NCT00423514|Thiotepa|thiotepa|mesh-list
56860640|NCT00423514|Clofarabine|clofarabine|mesh-list
56860641|NCT00423514|Tacrolimus|tacrolimus|mesh-list
56860642|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860643|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
56860644|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860645|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56860646|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860647|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860648|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56860649|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860650|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56860651|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
56860652|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56860653|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860654|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56860655|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
56860656|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56860657|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860658|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
56860659|NCT03132454|Dexamethasone|dexamethasone|mesh-list
56860660|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
56860661|NCT03132454|Sorafenib|sorafenib|mesh-list
56860662|NCT03132454|Decitabine|decitabine|mesh-list
56860663|NCT03132454|Palbociclib|palbociclib|mesh-list
56860664|NCT03132454|Ichthammol|ichthammol|mesh-list
56860665|NCT03132454|BB 1101|bb 1101|mesh-list
56860666|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56860667|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
56860668|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
56860669|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860670|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860671|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860672|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
56860673|NCT03132454|Hormones|hormones|mesh-ancestor
56860674|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860675|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860676|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860677|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
56860678|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860679|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860680|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860681|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860682|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
56860683|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
56860684|NCT00120952|Cobalt|cobalt|mesh-list
56860685|NCT00120952|Chromium|chromium|mesh-list
56860686|NCT00120952|Trace Elements|trace elements|mesh-ancestor
56860687|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
56860688|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860689|NCT00289991|Itraconazole|itraconazole|mesh-list
56860690|NCT00289991|Voriconazole|voriconazole|mesh-list
56860691|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
56860692|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860693|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56860694|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56860695|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860696|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860697|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56860698|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
56860699|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860700|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860701|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56860702|NCT00270413|Sunitinib|sunitinib|mesh-list
56860703|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860704|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56860705|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56860706|NCT00270413|Growth Substances|growth substances|mesh-ancestor
56860707|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860708|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
56860709|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860710|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920214|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
56860711|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860712|NCT00270257|Buprenorphine|buprenorphine|mesh-list
56860713|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56860714|NCT00270257|Naloxone|naloxone|mesh-list
56860715|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56860716|NCT00270257|Narcotics|narcotics|mesh-ancestor
56860717|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56860718|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860719|NCT00270257|Analgesics|analgesics|mesh-ancestor
56860720|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
56860721|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860722|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56860723|NCT00269399|Vancomycin|vancomycin|mesh-list
56860724|NCT00269399|Rifaximin|rifaximin|mesh-list
56860725|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56860726|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860727|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860728|NCT00269087|Fluticasone|fluticasone|mesh-list
56860729|NCT00269087|Xhance|xhance|mesh-list
56860730|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56860731|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56860732|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56860733|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
56860734|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860735|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860736|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56860737|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
56860738|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
56860739|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56860740|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56860741|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56860742|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56860743|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
56860744|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860745|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860746|NCT00288587|Diuretics|diuretics|mesh-list
56860747|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56860748|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
56860749|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860750|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56904621|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56860752|NCT00268463|Capecitabine|capecitabine|mesh-list
56860753|NCT00268463|Floxuridine|floxuridine|mesh-list
56860754|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
56860755|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860756|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
56860757|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860758|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860759|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
56860760|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56860761|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56860762|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56860763|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56860764|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860765|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
56860766|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860767|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860768|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56860769|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860770|NCT01071005|Leuprolide|leuprolide|mesh-list
56860771|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56860772|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
56860773|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56860774|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860775|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860776|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860777|NCT03976037|Misoprostol|misoprostol|mesh-list
56860778|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56860779|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
56860780|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56860781|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860782|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56860783|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860784|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
56860785|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
56860786|NCT00265889|Melphalan|melphalan|mesh-list
56860787|NCT00265889|Busulfan|busulfan|mesh-list
56860788|NCT00265889|Etoposide|etoposide|mesh-list
56860789|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860790|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
56860791|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860792|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56860793|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56860794|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
56860795|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860796|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860797|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56860798|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56860799|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56860800|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56860801|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860802|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
56860803|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860804|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860805|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860806|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860807|NCT01333696|Pemetrexed|pemetrexed|mesh-list
56860808|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860809|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860810|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860811|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56860812|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56860813|NCT01333774|Acarbose|acarbose|mesh-list
56860814|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56860815|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860816|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860817|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56860818|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860819|NCT01333852|Metformin|metformin|mesh-list
56860820|NCT01333852|Paclitaxel|paclitaxel|mesh-list
56860821|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56860822|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860823|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
56860824|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
56860825|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
56860826|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860827|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56860828|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860830|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56860831|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56860832|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
56860833|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860834|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860835|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860836|NCT03206788|Losartan|losartan|mesh-list
56860837|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56860838|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56860839|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56860840|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56860841|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860842|NCT03205150|Licogliflozin|licogliflozin|mesh-list
56860843|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56860844|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860845|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56860846|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860847|NCT04936984|Abaloparatide|abaloparatide|mesh-list
56860848|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
56860849|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56860850|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860851|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56860852|NCT02931838|BMS-986165|bms-986165|mesh-list
56860853|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
56860854|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56860855|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860856|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860857|NCT03201562|Tropicamide|tropicamide|mesh-list
56571681|NCT00650182|Fentanyl|fentanyl|mesh-list
56860859|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
56860860|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
56860861|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860862|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860863|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56860864|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56860865|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
56860866|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56860867|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860868|NCT03201562|Miotics|miotics|mesh-ancestor
56860869|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56860870|NCT03290950|Dexamethasone|dexamethasone|mesh-list
56860871|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
56860872|NCT03290950|Lenalidomide|lenalidomide|mesh-list
56860873|NCT03290950|Daratumumab|daratumumab|mesh-list
56860874|NCT03290950|BB 1101|bb 1101|mesh-list
56860875|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56860876|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
56860877|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
56860878|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860879|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860880|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860881|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
56860882|NCT03290950|Hormones|hormones|mesh-ancestor
56860883|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860884|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860885|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860886|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
56860887|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860888|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860889|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
56860890|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56860891|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56860892|NCT03290950|Growth Substances|growth substances|mesh-ancestor
56860893|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
56860894|NCT03200860|Empagliflozin|empagliflozin|mesh-list
56860895|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56860896|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860897|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56860898|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860900|NCT01314508|Growth Substances|growth substances|mesh-ancestor
56860901|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860902|NCT03268954|Azacitidine|azacitidine|mesh-list
56860903|NCT03268954|Pevonedistat|pevonedistat|mesh-list
56860904|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860905|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
56860906|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860907|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860908|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860909|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
56860910|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
56860911|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56860912|NCT01314586|Estrogens|estrogens|mesh-ancestor
56860913|NCT01314586|Hormones|hormones|mesh-ancestor
56860914|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860915|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860916|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
56860917|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860918|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
56860919|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860920|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56860921|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56860922|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
56860923|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860924|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860925|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56860926|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
56860927|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56860928|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860929|NCT03180736|Dexamethasone|dexamethasone|mesh-list
56860930|NCT03180736|Daratumumab|daratumumab|mesh-list
56860931|NCT03180736|Pomalidomide|pomalidomide|mesh-list
56860932|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56860933|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
56860934|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
56860935|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56860936|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860937|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56860938|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
56860939|NCT03180736|Hormones|hormones|mesh-ancestor
56860940|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860941|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56860942|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860943|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
56860944|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56860945|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56860946|NCT03180736|Growth Substances|growth substances|mesh-ancestor
56860947|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
56860948|NCT03178942|Permethrin|permethrin|mesh-list
56860949|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860950|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860951|NCT03093922|Gemcitabine|gemcitabine|mesh-list
56860952|NCT03093922|Atezolizumab|atezolizumab|mesh-list
56860953|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860954|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56860955|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
56860956|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860957|NCT03093922|Antiviral Agents|antiviral agents|mesh-ancestor
56860958|NCT03093922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56860959|NCT03093922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860960|NCT03093922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56860961|NCT03093922|Immunologic Factors|immunologic factors|mesh-ancestor
56860962|NCT03093922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860963|NCT03175198|Dabigatran|dabigatran|mesh-list
56860964|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
56860965|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56860966|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
56860967|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56860968|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860969|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
56860970|NCT03087448|Trametinib|trametinib|mesh-list
56860971|NCT03087448|Ceritinib|ceritinib|mesh-list
56860972|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860975|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56860977|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56860978|NCT03175120|Liraglutide|liraglutide|mesh-list
56860979|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
56860980|NCT03175120|Xultophy|xultophy|mesh-list
56860981|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56860982|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860983|NCT03175120|Incretins|incretins|mesh-ancestor
56860984|NCT03175120|Hormones|hormones|mesh-ancestor
56860985|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56860986|NCT04942210|Vaccines|vaccines|mesh-list
56860987|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
56860988|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860989|NCT03054766|Ranibizumab|ranibizumab|mesh-list
56860990|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56860991|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56860992|NCT03054766|Growth Substances|growth substances|mesh-ancestor
56860993|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56860994|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
56860995|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860996|NCT05118724|Atezolizumab|atezolizumab|mesh-list
56860997|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56860998|NCT03036748|Amiloride|amiloride|mesh-list
56860999|NCT03036748|Diuretics|diuretics|mesh-ancestor
56861000|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
56861001|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861002|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56861003|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56861004|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861005|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861006|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56861007|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56861008|NCT03167242|Lumefantrine|lumefantrine|mesh-list
56861009|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56861010|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
56861011|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56861012|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56861013|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861015|NCT05441410|Pyronaridine|pyronaridine|mesh-list
56861016|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
56861017|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56861018|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56861019|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861020|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861021|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
56861022|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
56861023|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56861024|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
56861025|NCT03636178|Daminozide|daminozide|mesh-list
56861026|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56861027|NCT03636178|Growth Substances|growth substances|mesh-ancestor
56861028|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861029|NCT04874194|Venetoclax|venetoclax|mesh-list
56861030|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
56861031|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861032|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56861033|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56861034|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861035|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861036|NCT01952782|Naloxone|naloxone|mesh-list
56861037|NCT01952782|Hormones|hormones|mesh-list
56861038|NCT01952782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861039|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861040|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56861041|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
56861042|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861043|NCT01330654|Metoprolol|metoprolol|mesh-list
56861044|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56861045|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56861046|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
56861047|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
56861049|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861050|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56861051|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56861052|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56861053|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
56861054|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861055|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861056|NCT01330810|Curcumin|curcumin|mesh-list
56861057|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56861058|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56861059|NCT01330810|Analgesics|analgesics|mesh-ancestor
56861060|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
56861061|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861062|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861063|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861064|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861065|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861066|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861067|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861068|NCT01331122|Droxidopa|droxidopa|mesh-list
56861069|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56861070|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56861071|NCT01320280|Afatinib|afatinib|mesh-list
56861072|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861073|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56861074|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861075|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861076|NCT01331434|Exemestane|exemestane|mesh-list
56861077|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861078|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56861079|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56861080|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861081|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861082|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56861083|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
56861084|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861085|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861086|NCT01331590|Dexamethasone|dexamethasone|mesh-list
56861087|NCT01331590|Etoposide|etoposide|mesh-list
56861088|NCT01331590|Ifosfamide|ifosfamide|mesh-list
56861089|NCT01331590|Lenograstim|lenograstim|mesh-list
56861090|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861091|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
56861092|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
56861093|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861094|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861095|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56861096|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
56861097|NCT01331590|Hormones|hormones|mesh-ancestor
56861098|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861099|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56861100|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861101|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56861102|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56861103|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56861104|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861105|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861106|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56861107|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
56861108|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56861109|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
56861110|NCT04447846|Cannabidiol|cannabidiol|mesh-list
56861111|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
56861112|NCT01331902|Nicorandil|nicorandil|mesh-list
56861113|NCT01331902|Adenosine|adenosine|mesh-list
56861114|NCT01331902|Analgesics|analgesics|mesh-ancestor
56861115|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
56861116|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861117|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861118|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56861119|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
56861120|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56861123|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861124|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861125|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56861126|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
56861127|NCT01331902|Vitamins|vitamins|mesh-ancestor
56861128|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
56861129|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56861130|NCT04245748|Citalopram|citalopram|mesh-list
56861131|NCT04245748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56861132|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56861133|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861134|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861135|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861136|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
56861137|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861138|NCT04245748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56861139|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
56861140|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56861141|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861142|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56861143|NCT04245748|Analgesics|analgesics|mesh-ancestor
56861144|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
56861145|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
56861146|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56861147|NCT04245436|Citalopram|citalopram|mesh-list
56861148|NCT04245436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56861149|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56861150|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861151|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861152|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861153|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
56861154|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861155|NCT04245436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56861156|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
56861157|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56861158|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861159|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56861160|NCT04245436|Analgesics|analgesics|mesh-ancestor
56861161|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
56861162|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
56861163|NCT01332370|Metformin|metformin|mesh-list
56861164|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56861165|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
56861166|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56861167|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861168|NCT01332370|Incretins|incretins|mesh-ancestor
56861169|NCT01332370|Hormones|hormones|mesh-ancestor
56861170|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861171|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56861172|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
56861173|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861174|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861175|NCT01332448|Orlistat|orlistat|mesh-list
56861176|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861177|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861178|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56861179|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56861180|NCT04484428|Menthol|menthol|mesh-list
56861181|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
56861182|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
56861183|NCT01332604|Bevacizumab|bevacizumab|mesh-list
56861184|NCT01332604|Capecitabine|capecitabine|mesh-list
56861185|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56861186|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861187|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56861188|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56861189|NCT01332604|Growth Substances|growth substances|mesh-ancestor
56861190|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861191|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
56861192|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56861200|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
56861201|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861202|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861203|NCT01333150|Propranolol|propranolol|mesh-list
56861204|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56861205|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56861206|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
56861207|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861208|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861209|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861210|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56861211|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56861212|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
56861213|NCT02913664|Losartan|losartan|mesh-list
56861214|NCT02913664|Amlodipine|amlodipine|mesh-list
56861215|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
56861216|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
56861217|NCT02913664|Giapreza|giapreza|mesh-list
56861218|NCT02913664|Calcium|calcium|mesh-list
56861219|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56861220|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
56861221|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56861222|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861223|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56861224|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861225|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861226|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
56861227|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56861228|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56861229|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56861230|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56861231|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
56861232|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572044|NCT02640898|Docetaxel|docetaxel|mesh-list
56861233|NCT02818582|Remdesivir|remdesivir|mesh-list
56861235|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861236|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
56861237|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861238|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56861239|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56861240|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56861241|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861242|NCT01337440|Incretins|incretins|mesh-ancestor
56861243|NCT01337440|Hormones|hormones|mesh-ancestor
56861244|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861245|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56861246|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
56861247|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861248|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861249|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56861250|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56861251|NCT01337518|Androgens|androgens|mesh-list
56861252|NCT01337518|Hormones|hormones|mesh-ancestor
56861253|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861254|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861255|NCT05186194|Vitamin D|vitamin d|mesh-list
56861256|NCT05186194|Calcium|calcium|mesh-list
56861257|NCT05186194|Vitamins|vitamins|mesh-ancestor
56861258|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
56861259|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568187|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
56861261|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56861262|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
56861263|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56861264|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56861265|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861266|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
56861267|NCT01338454|Coagulants|coagulants|mesh-ancestor
56861268|NCT02882152|Morphine|morphine|mesh-list
56861269|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56861270|NCT02882152|Narcotics|narcotics|mesh-ancestor
56861271|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861272|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861273|NCT02882152|Analgesics|analgesics|mesh-ancestor
56861274|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
56861275|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861276|NCT05185804|Enoxaparin|enoxaparin|mesh-list
56861277|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
56861278|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
56861279|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56861280|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56861281|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861282|NCT01338844|Inositol|inositol|mesh-list
56861283|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
56861284|NCT01338844|Vitamins|vitamins|mesh-ancestor
56861285|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
56861286|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861287|NCT01338922|Insulin|insulin|mesh-list
56861288|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56861289|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861290|NCT01339312|Vaccines|vaccines|mesh-list
56861291|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
56861292|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861293|NCT01339468|Tacrolimus|tacrolimus|mesh-list
56861294|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56861295|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
56861296|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861297|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56861298|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903877|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861299|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861300|NCT01339624|Ketorolac|ketorolac|mesh-list
56861301|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56861302|NCT01339624|Fentanyl|fentanyl|mesh-list
56861303|NCT01339624|Morphine|morphine|mesh-list
56861304|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56861305|NCT01339624|Narcotics|narcotics|mesh-ancestor
56861306|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861307|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861308|NCT01339624|Analgesics|analgesics|mesh-ancestor
56861309|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
56572115|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
56861310|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861311|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56861312|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56861313|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
56861314|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
56861315|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56861316|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56861317|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861318|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861319|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56861320|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861321|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861323|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56861324|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56861325|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
56861326|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861327|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861328|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861329|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56861330|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
56861331|NCT01340248|Protective Agents|protective agents|mesh-ancestor
56861332|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56861333|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861334|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56861336|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56861337|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56861338|NCT01340326|Valsartan|valsartan|mesh-list
56861339|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56861340|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56861341|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56861342|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861343|NCT00286091|Denosumab|denosumab|mesh-list
56861344|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56861345|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861346|NCT01340950|Tenofovir|tenofovir|mesh-list
56861347|NCT01340950|Lamivudine|lamivudine|mesh-list
56861348|NCT01340950|Zidovudine|zidovudine|mesh-list
56861349|NCT01340950|Efavirenz|efavirenz|mesh-list
56861350|NCT01340950|Nevirapine|nevirapine|mesh-list
56861351|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56861352|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
56861353|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861354|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56861355|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56861356|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861357|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861358|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56861359|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56861360|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
56861361|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56861362|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56861363|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56861364|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56861365|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56861366|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56861367|NCT01341106|Entecavir|entecavir|mesh-list
56861368|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
56861369|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861370|NCT01341184|Rifampin|rifampin|mesh-list
56861371|NCT01341184|Rifabutin|rifabutin|mesh-list
56861372|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56861373|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
56861374|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56861375|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861376|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
56861377|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56861378|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861379|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861380|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56861381|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56572195|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861382|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56861383|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56861384|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56861385|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56861386|NCT00285857|Lovastatin|lovastatin|mesh-list
56861387|NCT00285857|L 647318|l 647318|mesh-list
56861388|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
56861389|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56861390|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
56861391|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861392|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56861393|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56861394|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56861395|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861396|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
56861397|NCT01341262|Thalidomide|thalidomide|mesh-list
56861398|NCT01341262|Dexamethasone|dexamethasone|mesh-list
56861399|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
56861400|NCT01341262|Melphalan|melphalan|mesh-list
56861401|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56861402|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
56861403|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861404|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861405|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56861406|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
56904622|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861408|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861409|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56861410|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861411|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
56861412|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
56861413|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861414|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56861415|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
56861416|NCT01341262|Hormones|hormones|mesh-ancestor
56861417|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861418|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56861419|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
56861420|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56861421|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861422|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56861423|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56861424|NCT01341262|Growth Substances|growth substances|mesh-ancestor
56861425|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56861426|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56861427|NCT01341340|Everolimus|everolimus|mesh-list
56861428|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861429|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56861430|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
56861431|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861432|NCT01341496|Celecoxib|celecoxib|mesh-list
56861433|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
56861434|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56861435|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
56861436|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861437|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861438|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56861439|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
56861440|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861441|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861442|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56861443|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56861444|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56861445|NCT01341496|Analgesics|analgesics|mesh-ancestor
56861446|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
56861447|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861448|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861449|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56861450|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56861451|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861452|NCT00284141|Aflibercept|aflibercept|mesh-list
56861453|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56861454|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56861455|NCT00284141|Growth Substances|growth substances|mesh-ancestor
56861456|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861457|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
56861458|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861459|NCT05182138|Zinc|zinc|mesh-list
56861460|NCT05182138|Trace Elements|trace elements|mesh-ancestor
56861461|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
56861462|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861463|NCT04901494|Serotonin|serotonin|mesh-list
56861464|NCT04901494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56861465|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56861466|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
56861467|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861468|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861469|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861470|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56861471|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861472|NCT01315990|Cetuximab|cetuximab|mesh-list
56861473|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56861474|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861475|NCT00265343|Olanzapine|olanzapine|mesh-list
56861476|NCT00265343|Asenapine|asenapine|mesh-list
56861477|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
56861478|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
56861479|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861480|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861481|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56861483|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56861484|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861485|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56861486|NCT00265343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56861487|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56861488|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861489|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861490|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861491|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
56861492|NCT01341886|Metformin|metformin|mesh-list
56861493|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56861494|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861495|NCT00283595|Hormones|hormones|mesh-list
56861496|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861497|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861498|NCT01341964|Aspirin|aspirin|mesh-list
56861499|NCT01341964|Clopidogrel|clopidogrel|mesh-list
56861500|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56861501|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56861502|NCT01341964|Analgesics|analgesics|mesh-ancestor
56861503|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
56861504|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861505|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861506|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861507|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861508|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56861509|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56861510|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861511|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56861512|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56861513|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861514|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
56861515|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56861516|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56861517|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56466300|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
56861518|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
56861519|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861520|NCT00265109|Levetiracetam|levetiracetam|mesh-list
56861521|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
56861522|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
56861523|NCT01342198|Erythromycin|erythromycin|mesh-list
56861524|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
56861525|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56861526|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
56861527|NCT01342198|Pregabalin|pregabalin|mesh-list
56861528|NCT01342198|Analgesics|analgesics|mesh-ancestor
56861529|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
56861530|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861531|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861532|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
56861533|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56861534|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861535|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861536|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56861537|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56861538|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56861539|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861540|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56861541|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56861542|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861543|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56861544|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56861545|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861546|NCT01342744|Metformin|metformin|mesh-list
56861547|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56861548|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861549|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
56861550|NCT05150782|Curcumin|curcumin|mesh-list
56861551|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
56861552|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861553|NCT05150782|Protective Agents|protective agents|mesh-ancestor
56861554|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861557|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56861558|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56861559|NCT05150782|Analgesics|analgesics|mesh-ancestor
56861560|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
56861561|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861562|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861563|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861564|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861565|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861566|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56861567|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
56861568|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56861569|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
56861570|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861571|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56861572|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56861573|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56861574|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56861575|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861576|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56861577|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56861578|NCT00283049|Insulin|insulin|mesh-list
56861579|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56861580|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
56861581|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
56861582|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56861583|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861584|NCT00264875|Pregabalin|pregabalin|mesh-list
56861585|NCT00264875|Analgesics|analgesics|mesh-ancestor
56861586|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
56861587|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861588|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861589|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
56861590|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56861591|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861592|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861593|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56861594|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56861595|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56861596|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861597|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56861598|NCT03635398|Midazolam|midazolam|mesh-list
56861599|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56861600|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56861601|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861602|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861603|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56861604|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56861605|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56861606|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56861607|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
56861608|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
56861609|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
56861610|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
56861611|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861612|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861613|NCT03151408|Azacitidine|azacitidine|mesh-list
56861614|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56861615|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
56861616|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861617|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861618|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861619|NCT05226442|Heparin|heparin|mesh-list
56861620|NCT05226442|Calcium heparin|calcium heparin|mesh-list
56861621|NCT05226442|Argatroban|argatroban|mesh-list
56861622|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
56861623|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56861624|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56861625|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861626|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
56861627|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56861628|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
56568197|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
56861631|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
56861632|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861633|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56861634|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861635|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861636|NCT05198128|Calcium|calcium|mesh-list
56861637|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56861638|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861639|NCT02121184|Oxytocin|oxytocin|mesh-list
56861640|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
56861641|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56861642|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861643|NCT01485874|Doxorubicin|doxorubicin|mesh-list
56861644|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56861645|NCT01485874|Nintedanib|nintedanib|mesh-list
56861646|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56861647|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861648|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56861649|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56861650|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861651|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861652|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56861653|NCT05000710|Durvalumab|durvalumab|mesh-list
56861654|NCT05000710|Tremelimumab|tremelimumab|mesh-list
56861655|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56861656|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861657|NCT04786756|Bupivacaine|bupivacaine|mesh-list
56861658|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
56861659|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
56861660|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861661|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861662|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
56861663|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861664|NCT05073250|Rituximab|rituximab|mesh-list
56861665|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56861666|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861667|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
56861668|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861669|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861670|NCT00546754|Losartan|losartan|mesh-list
56861671|NCT00546754|Valsartan|valsartan|mesh-list
56861672|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56861673|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56861674|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56861675|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56861676|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861677|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56861678|NCT00546754|Diuretics|diuretics|mesh-ancestor
56861679|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
56861680|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861681|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56861682|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861683|NCT04768426|Capecitabine|capecitabine|mesh-list
56861684|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56861685|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
56861686|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861687|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861688|NCT04473508|Ropivacaine|ropivacaine|mesh-list
56861689|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
56861690|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
56861691|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861692|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861693|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
56861694|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861695|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
56861696|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56861697|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861698|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861699|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56861700|NCT04471402|Analgesics|analgesics|mesh-ancestor
56861701|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
56861703|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56861704|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56861706|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56861707|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861708|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861709|NCT00282347|Acetaminophen|acetaminophen|mesh-list
56861710|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
56861711|NCT00282347|Promethazine|promethazine|mesh-list
56861712|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
56861713|NCT00282347|Prednisone|prednisone|mesh-list
56861714|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
56861715|NCT00282347|Rituximab|rituximab|mesh-list
56861716|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56861717|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861718|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
56861719|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861720|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861721|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861722|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
56861723|NCT00282347|Hormones|hormones|mesh-ancestor
56861724|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861725|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56861726|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56861727|NCT00282347|Analgesics|analgesics|mesh-ancestor
56861728|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
56861729|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861730|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
56861731|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56861732|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56861733|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
56861734|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56861735|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861736|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861737|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861738|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
56861739|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
56861740|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56861741|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56861742|NCT00282347|Protective Agents|protective agents|mesh-ancestor
56861743|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56861744|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56861745|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861746|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
56861747|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
56861748|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56861749|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
56861750|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
56861751|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861752|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56861753|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
56861754|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
56861755|NCT01334632|Morphine|morphine|mesh-list
56861756|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56861757|NCT01334632|Narcotics|narcotics|mesh-ancestor
56861758|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861759|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861760|NCT01334632|Analgesics|analgesics|mesh-ancestor
56861761|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
56861762|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861763|NCT00405964|Desloratadine|desloratadine|mesh-list
56861764|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56861765|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
56861766|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861767|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861768|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861769|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56861770|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56861771|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
56861772|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
56861773|NCT00264797|Methylphenidate|methylphenidate|mesh-list
56861774|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56861775|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861777|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56861778|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861779|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861780|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
56861781|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861782|NCT03148756|Dalbavancin|dalbavancin|mesh-list
56861783|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56861784|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861785|NCT01343680|Heparin|heparin|mesh-list
56861786|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
56861787|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56861788|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56861789|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861790|NCT00281957|Sirolimus|sirolimus|mesh-list
56861791|NCT00281957|Sorafenib|sorafenib|mesh-list
56861792|NCT00281957|Tipifarnib|tipifarnib|mesh-list
56861793|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861794|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56861795|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861796|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861797|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56861798|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861799|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56861800|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
56861801|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56861802|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
56861803|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861804|NCT01071161|Azithromycin|azithromycin|mesh-list
56861805|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56861806|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861807|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
56861808|NCT01070225|Propranolol|propranolol|mesh-list
56861809|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861810|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56861811|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56861812|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
56861813|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861814|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861815|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861816|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56861817|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56861818|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
56861819|NCT01070615|Prucalopride|prucalopride|mesh-list
56861820|NCT01070615|Laxatives|laxatives|mesh-ancestor
56861821|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56861822|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56861823|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56861824|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
56861825|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861826|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861827|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861828|NCT00262925|Leucovorin|leucovorin|mesh-list
56861829|NCT00262925|Dexamethasone|dexamethasone|mesh-list
56861830|NCT00262925|Methotrexate|methotrexate|mesh-list
56861831|NCT00262925|Vincristine|vincristine|mesh-list
56861832|NCT00262925|Asparaginase|asparaginase|mesh-list
56861833|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
56861834|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
56861835|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56861836|NCT00262925|Antibodies|antibodies|mesh-list
56861837|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
56861838|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56861839|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
56861840|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
56861841|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861842|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861843|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
56861844|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
56861845|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861846|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56861847|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
56861848|NCT00262925|Hormones|hormones|mesh-ancestor
56861849|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861850|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56861851|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861853|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
56861854|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56861855|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56861856|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
56861857|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861858|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
56861859|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861860|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56861861|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56861862|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861863|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56861864|NCT00262925|Antidotes|antidotes|mesh-ancestor
56861865|NCT00262925|Protective Agents|protective agents|mesh-ancestor
56861866|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
56861867|NCT00262925|Vitamins|vitamins|mesh-ancestor
56861868|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
56861869|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56861870|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
56861871|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
56861872|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
56861873|NCT01581515|Everolimus|everolimus|mesh-list
56861874|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861875|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56861876|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
56861877|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861878|NCT03720470|Abrocitinib|abrocitinib|mesh-list
56861879|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56861880|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861881|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861882|NCT00262847|Paclitaxel|paclitaxel|mesh-list
56861883|NCT00262847|Bevacizumab|bevacizumab|mesh-list
56861884|NCT00262847|Carboplatin|carboplatin|mesh-list
56861885|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56861886|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56861887|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
56861888|NCT00262847|Antibodies|antibodies|mesh-list
56861889|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
56861890|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56861891|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
56861892|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56861893|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861894|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
56861895|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
56861896|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
56861897|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861898|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56861899|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56861900|NCT00262847|Growth Substances|growth substances|mesh-ancestor
56861901|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861902|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
56861903|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
56861904|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
56861905|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56861906|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572715|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56861907|NCT01303640|Everolimus|everolimus|mesh-list
56861908|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861909|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56861910|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
56861911|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861912|NCT03817268|Capecitabine|capecitabine|mesh-list
56861913|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56861914|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
56861915|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861916|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861917|NCT00280397|Lenvatinib|lenvatinib|mesh-list
56861918|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861919|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56861920|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861921|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861922|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
56861923|NCT03817112|Propofol|propofol|mesh-list
56861924|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56861925|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56861926|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861928|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
56861929|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
56861930|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56861931|NCT03817112|Analgesics|analgesics|mesh-ancestor
56861932|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
56861933|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861934|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56861935|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56861936|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56861937|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
56861938|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56861939|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861940|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56861941|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56861942|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56861943|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
56861944|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861945|NCT03814148|Indapamide|indapamide|mesh-list
56861946|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56861947|NCT03814148|Diuretics|diuretics|mesh-ancestor
56861948|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
56861949|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861950|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56861951|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56861952|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861953|NCT00279305|Rituximab|rituximab|mesh-list
56861954|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56861955|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861956|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
56861957|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861958|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56861959|NCT04224272|Fulvestrant|fulvestrant|mesh-list
56861960|NCT04224272|Palbociclib|palbociclib|mesh-list
56466734|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
56861961|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56861962|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861963|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56861964|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56861965|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
56861966|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861967|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861968|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56861969|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56861970|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56861971|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
56861972|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56861973|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
56861974|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861975|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
56861976|NCT03800810|Protective Agents|protective agents|mesh-ancestor
56861977|NCT03974867|Prednisone|prednisone|mesh-list
56861978|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
56861979|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56861980|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56861981|NCT03974867|Prednisolone|prednisolone|mesh-list
56861982|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
56861983|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56861984|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
56861985|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56861987|NCT03974867|Hormones|hormones|mesh-ancestor
56861988|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56861989|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56861990|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56861991|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56861992|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
56861993|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
56861994|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56861995|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56861996|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56861997|NCT03974867|Protective Agents|protective agents|mesh-ancestor
56861998|NCT03799406|Vitamin D|vitamin d|mesh-list
56861999|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
56862000|NCT03799406|Vitamins|vitamins|mesh-ancestor
56862002|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862003|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56862004|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56862005|NCT03799172|Echinocandins|echinocandins|mesh-list
56862006|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
56862007|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862008|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
56862009|NCT03799094|Vitamins|vitamins|mesh-ancestor
56862010|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
56862011|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862012|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
56862013|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862014|NCT03799094|Protective Agents|protective agents|mesh-ancestor
56862015|NCT00277355|Minocycline|minocycline|mesh-list
56862016|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56862017|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862018|NCT05593094|Trastuzumab|trastuzumab|mesh-list
56862019|NCT05593094|Pertuzumab|pertuzumab|mesh-list
56862020|NCT05593094|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56862021|NCT05593094|Maytansine|maytansine|mesh-list
56862022|NCT05593094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862023|NCT05593094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862024|NCT05593094|Tubulin Modulators|tubulin modulators|mesh-ancestor
56862025|NCT05593094|Antimitotic Agents|antimitotic agents|mesh-ancestor
56862026|NCT05593094|Mitosis Modulators|mitosis modulators|mesh-ancestor
56862027|NCT05593094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862028|NCT05593094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56862029|NCT00262223|Sertraline|sertraline|mesh-list
56862030|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
56862031|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56862032|NCT00262223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56862033|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56862034|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56862035|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862036|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862037|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
56862038|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862039|NCT05575700|Ibuprofen|ibuprofen|mesh-list
56862040|NCT05575700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56862041|NCT05575700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56862042|NCT05575700|Analgesics|analgesics|mesh-ancestor
56862043|NCT05575700|Sensory System Agents|sensory system agents|mesh-ancestor
56862044|NCT05575700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862045|NCT05575700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862046|NCT05575700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862047|NCT05575700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56862048|NCT05575700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56862049|NCT05575700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862050|NCT05575700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862051|NCT00276419|Diclofenac|diclofenac|mesh-list
56862052|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56862053|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56862054|NCT00276419|Analgesics|analgesics|mesh-ancestor
56862055|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
56862056|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862057|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862058|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862059|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56572877|NCT02708836|Anesthetics|anesthetics|mesh-list
56862060|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56862061|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862062|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862063|NCT05216432|Fulvestrant|fulvestrant|mesh-list
56862064|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56862065|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862066|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56862067|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56862068|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
56862069|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56862070|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862071|NCT03798392|Anesthetics|anesthetics|mesh-list
56862072|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862073|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862074|NCT03816020|Niacinamide|niacinamide|mesh-list
56862076|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
56862077|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
56862078|NCT03816020|Vitamins|vitamins|mesh-ancestor
56862079|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
56862080|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862081|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56862082|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
56862083|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862084|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56862085|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
56862086|NCT03815864|Antibodies|antibodies|mesh-list
56862087|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
56862088|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
56862089|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862090|NCT03815942|Nivolumab|nivolumab|mesh-list
56862091|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862092|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862093|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56862094|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862095|NCT01303874|Etanercept|etanercept|mesh-list
56862096|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56862097|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56862098|NCT01303874|Analgesics|analgesics|mesh-ancestor
56862099|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
56862100|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862101|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862102|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862103|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56862104|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862105|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56862106|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
56862107|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56862108|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
56862109|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56862110|NCT04140266|Tenofovir|tenofovir|mesh-list
56862111|NCT04140266|Emtricitabine|emtricitabine|mesh-list
56862112|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56862113|NCT04140266|Dapivirine|dapivirine|mesh-list
56862114|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
56862115|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862116|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56862117|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56862118|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862119|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862120|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56862121|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56862122|NCT04109924|Trifluridine|trifluridine|mesh-list
56862123|NCT04109924|Bevacizumab|bevacizumab|mesh-list
56862124|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56862125|NCT04109924|Irinotecan|irinotecan|mesh-list
56862126|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
56862127|NCT04109924|Antibodies|antibodies|mesh-list
56862128|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
56862129|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56862130|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862131|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56862132|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56862133|NCT04109924|Growth Substances|growth substances|mesh-ancestor
56862134|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862135|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
56862136|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
56862137|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56862138|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56862139|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862140|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862141|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
56862142|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
56862143|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862144|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56862145|NCT04070768|Venetoclax|venetoclax|mesh-list
56862146|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
56862147|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862148|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862149|NCT01301612|Cisplatin|cisplatin|mesh-list
56862150|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
56862151|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862152|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862153|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56862154|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56862155|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862157|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56862158|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56862159|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
56862160|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862161|NCT03970616|Durvalumab|durvalumab|mesh-list
56862162|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862163|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862164|NCT03815474|Epirubicin|epirubicin|mesh-list
56862165|NCT03815474|Ifosfamide|ifosfamide|mesh-list
56862166|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56862167|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862168|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56862169|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56862170|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862171|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862172|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56862173|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
56862174|NCT01302158|Glimepiride|glimepiride|mesh-list
56862175|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
56862176|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56862177|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56862178|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862179|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56862180|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
56862181|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56862182|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862183|NCT01302236|Eplerenone|eplerenone|mesh-list
56862184|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56862185|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
56862186|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56862187|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862188|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56862189|NCT01302236|Diuretics|diuretics|mesh-ancestor
56862190|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
56862191|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56862192|NCT01304264|Maleic acid|maleic acid|mesh-list
56862193|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862194|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862195|NCT01304342|Fentanyl|fentanyl|mesh-list
56862196|NCT01304342|Remifentanil|remifentanil|mesh-list
56862197|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56862198|NCT01304342|Narcotics|narcotics|mesh-ancestor
56862199|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862200|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862201|NCT01304342|Analgesics|analgesics|mesh-ancestor
56862202|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
56862203|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862204|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56862205|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56862206|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
56862207|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
56862208|NCT05651282|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56862209|NCT05651282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56862210|NCT05651282|Contraceptive Agents|contraceptive agents|mesh-ancestor
56862211|NCT05651282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56862212|NCT05651282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862213|NCT05651282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56862214|NCT05651282|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56862215|NCT05651282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56862216|NCT05651282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862217|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56862218|NCT03653546|Gefitinib|gefitinib|mesh-list
56862219|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862220|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56862221|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862222|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862223|NCT03812354|Nicotine|nicotine|mesh-list
56862226|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862227|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862228|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56862229|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56862230|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
56862231|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862232|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862233|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56862234|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
56862235|NCT03812120|Coagulants|coagulants|mesh-ancestor
56862236|NCT03796364|Endostar protein|endostar protein|mesh-list
56862237|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56862238|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56862239|NCT03796364|Growth Substances|growth substances|mesh-ancestor
56862240|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862241|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
56862242|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862243|NCT03483038|Irinotecan|irinotecan|mesh-list
56862244|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56862245|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56862246|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862247|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862248|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862249|NCT03795584|Hemostatics|hemostatics|mesh-list
56862250|NCT03795584|Coagulants|coagulants|mesh-ancestor
56862251|NCT03792776|Lidocaine|lidocaine|mesh-list
56862252|NCT03792776|Anesthetics|anesthetics|mesh-list
56862253|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
56862254|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862255|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862256|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
56862257|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862258|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56862259|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56862260|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56862261|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56862262|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862263|NCT03795272|Rucaparib|rucaparib|mesh-list
56862264|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56862265|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862266|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862267|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862268|NCT00980954|Paclitaxel|paclitaxel|mesh-list
56862269|NCT00980954|Carboplatin|carboplatin|mesh-list
56862270|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56862271|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862272|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
56862273|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
56862274|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
56862275|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862276|NCT00956930|Doxorubicin|doxorubicin|mesh-list
56862277|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56862278|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56862279|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862280|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56862281|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56862282|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862283|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862284|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56862285|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56862286|NCT00080756|Estradiol|estradiol|mesh-list
56862287|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56862288|NCT00080756|Testosterone|testosterone|mesh-list
56862289|NCT00080756|Deslorelin|deslorelin|mesh-list
56862290|NCT00080756|Estrogens|estrogens|mesh-ancestor
56862291|NCT00080756|Hormones|hormones|mesh-ancestor
56862292|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56862293|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862294|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56862295|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
56862296|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56862298|NCT00080756|Androgens|androgens|mesh-ancestor
56862299|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862300|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862301|NCT03792620|Daratumumab|daratumumab|mesh-list
56862302|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862303|NCT05027594|Dexamethasone|dexamethasone|mesh-list
56862304|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862305|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
56862306|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
56862307|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862308|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862309|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862310|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
56862311|NCT05027594|Hormones|hormones|mesh-ancestor
56862312|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56862313|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56862314|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862315|NCT03811418|Docetaxel|docetaxel|mesh-list
56862316|NCT03811418|Trastuzumab|trastuzumab|mesh-list
56862317|NCT03811418|Vinorelbine|vinorelbine|mesh-list
56862318|NCT03811418|Pertuzumab|pertuzumab|mesh-list
56862319|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862320|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
56862321|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
56862322|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
56862323|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862324|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862325|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56862326|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
56862327|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
56862328|NCT03794492|Prednisolone|prednisolone|mesh-list
56862329|NCT03794492|Tacrolimus|tacrolimus|mesh-list
56862330|NCT03794492|Basiliximab|basiliximab|mesh-list
56862331|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56862332|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
56862333|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862334|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56862335|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862336|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862337|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56862338|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862339|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56862340|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
56862341|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56862342|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862343|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862344|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
56862345|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
56862346|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862347|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862348|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
56862349|NCT03794492|Hormones|hormones|mesh-ancestor
56862350|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56862351|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56862352|NCT03794492|Protective Agents|protective agents|mesh-ancestor
56862353|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56862354|NCT05624996|Paclitaxel|paclitaxel|mesh-list
56862355|NCT05624996|Etoposide|etoposide|mesh-list
56862356|NCT05624996|Podophyllotoxin|podophyllotoxin|mesh-list
56862357|NCT05624996|Cisplatin|cisplatin|mesh-list
56862358|NCT05624996|Carboplatin|carboplatin|mesh-list
56862359|NCT05624996|Pemetrexed|pemetrexed|mesh-list
56862360|NCT05624996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56862361|NCT05624996|Etoposide phosphate|etoposide phosphate|mesh-list
56862362|NCT05624996|Durvalumab|durvalumab|mesh-list
56862363|NCT05624996|Immunoglobulins|immunoglobulins|mesh-list
56862365|NCT05624996|Immunoglobulin G|immunoglobulin g|mesh-list
56862366|NCT05624996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56862367|NCT05624996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862368|NCT05624996|Tubulin Modulators|tubulin modulators|mesh-ancestor
56862369|NCT05624996|Antimitotic Agents|antimitotic agents|mesh-ancestor
56862370|NCT05624996|Mitosis Modulators|mitosis modulators|mesh-ancestor
56862371|NCT05624996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862372|NCT05624996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56862373|NCT05624996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56862374|NCT05624996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862375|NCT05624996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56862376|NCT05624996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56862377|NCT05624996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862378|NCT05624996|Immunologic Factors|immunologic factors|mesh-ancestor
56862379|NCT05624996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862380|NCT05624996|Keratolytic Agents|keratolytic agents|mesh-ancestor
56862381|NCT05624996|Dermatologic Agents|dermatologic agents|mesh-ancestor
56862382|NCT03792152|Warfarin|warfarin|mesh-list
56862383|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
56862384|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
56862385|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56862386|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
56862387|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56862388|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
56862389|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862390|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862391|NCT00262067|Bevacizumab|bevacizumab|mesh-list
56862392|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862393|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862394|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56862395|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56862396|NCT00262067|Growth Substances|growth substances|mesh-ancestor
56862397|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862398|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
56862399|NCT00275561|Fluticasone|fluticasone|mesh-list
56862400|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862401|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56862402|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
56862403|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862404|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862405|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56862406|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
56862407|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
56862408|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56862409|NCT03810872|Paclitaxel|paclitaxel|mesh-list
56862410|NCT03810872|Afatinib|afatinib|mesh-list
56862411|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56862412|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862413|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
56862414|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
56862415|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
56862416|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862417|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56862418|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862419|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
56862420|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862421|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
56862422|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862423|NCT00274937|Cisplatin|cisplatin|mesh-list
56862424|NCT00274937|Fluorouracil|fluorouracil|mesh-list
56862425|NCT00274937|Amifostine|amifostine|mesh-list
56862426|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862427|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
56862428|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862429|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56862430|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56862431|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
56862432|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862433|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56862434|NCT00274937|Protective Agents|protective agents|mesh-ancestor
56862435|NCT03792074|Paclitaxel|paclitaxel|mesh-list
56862436|NCT03792074|Bevacizumab|bevacizumab|mesh-list
56573245|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56862437|NCT03792074|Carboplatin|carboplatin|mesh-list
56862438|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56862439|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862440|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
56862441|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
56862442|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
56862443|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862444|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862445|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56862446|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56862447|NCT03792074|Growth Substances|growth substances|mesh-ancestor
56862448|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862449|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
56862452|NCT05624528|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56862453|NCT05624528|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56862454|NCT05624528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862455|NCT05624528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862456|NCT00251693|Lansoprazole|lansoprazole|mesh-list
56862457|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
56862458|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56862459|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862460|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56862461|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862462|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862463|NCT03791918|Lenvatinib|lenvatinib|mesh-list
56862464|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
56862465|NCT03791918|Antibodies|antibodies|mesh-list
56862466|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
56862467|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
56862468|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862469|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862470|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56862471|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862472|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862473|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56862474|NCT03791918|Estrogens|estrogens|mesh-ancestor
56862475|NCT03791918|Hormones|hormones|mesh-ancestor
56862476|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56862477|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56862478|NCT00250835|Celecoxib|celecoxib|mesh-list
56862479|NCT00250835|Capecitabine|capecitabine|mesh-list
56862480|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
56862481|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56862482|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
56862483|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862484|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862485|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56862486|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56862487|NCT00250835|Analgesics|analgesics|mesh-ancestor
56862488|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
56862489|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903906|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
56862490|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862491|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862492|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56862493|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56862494|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56862495|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862496|NCT01303094|Trabectedin|trabectedin|mesh-list
56862497|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56862498|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
56862499|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862500|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862501|NCT04785326|Ustekinumab|ustekinumab|mesh-list
56862502|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
56862503|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56862504|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
56862505|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56862506|NCT03791762|Protective Agents|protective agents|mesh-ancestor
56862507|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862508|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
56862509|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56862510|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
56862511|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56862512|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862513|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56862514|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56862515|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56862516|NCT03789032|Rabeprazole|rabeprazole|mesh-list
56862517|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56862518|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862519|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56862520|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862521|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862522|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
56862523|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56862524|NCT01306370|Hemostatics|hemostatics|mesh-list
56862525|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56862526|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56862527|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862528|NCT01306370|Coagulants|coagulants|mesh-ancestor
56862529|NCT03716024|Linezolid|linezolid|mesh-list
56862530|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56862531|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862532|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56862533|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862534|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862535|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
56862536|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56862537|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
56862538|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862539|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862540|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56862541|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
56862542|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56862543|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56862544|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56862545|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
56862546|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862547|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862548|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
56862549|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
56862550|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56862551|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
56862552|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862553|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
56862554|NCT03791294|Protective Agents|protective agents|mesh-ancestor
56862555|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
56862556|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56862557|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
56862558|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56862559|NCT01567358|Infliximab|infliximab|mesh-list
56862560|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
56862561|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862562|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56862563|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
56862564|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56862565|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862566|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862567|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56862568|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56862569|NCT01308242|Sevelamer|sevelamer|mesh-list
56862570|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
56862571|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
56862572|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862573|NCT01308320|Fentanyl|fentanyl|mesh-list
56862574|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56862575|NCT01308320|Narcotics|narcotics|mesh-ancestor
56862576|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862577|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862578|NCT01308320|Analgesics|analgesics|mesh-ancestor
56862579|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
56862580|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862581|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56862582|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56862583|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
56862584|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
56862585|NCT01306760|Ketamine|ketamine|mesh-list
56862586|NCT01306760|Propofol|propofol|mesh-list
56862587|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56862588|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862589|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862590|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56862591|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
56862592|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
56862593|NCT01306760|Analgesics|analgesics|mesh-ancestor
56862594|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
56862595|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862596|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56862597|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56862598|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56862599|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904623|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
56862602|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
56862603|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56862604|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862605|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56862606|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56862607|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
56862608|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862609|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56862610|NCT03788018|Lidocaine|lidocaine|mesh-list
56862611|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
56862612|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
56862613|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
56862614|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862615|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862616|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
56862617|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862618|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56862619|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56862620|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56862621|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56862622|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862623|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56862624|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56862625|NCT03788018|Analgesics|analgesics|mesh-ancestor
56862626|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56862627|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56862628|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56862629|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
56862630|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862631|NCT03785756|Ibuprofen|ibuprofen|mesh-list
56862632|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56862633|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56862634|NCT03785756|Analgesics|analgesics|mesh-ancestor
56862635|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
56862636|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862637|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862638|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862639|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56862640|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56862641|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862642|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862643|NCT03788174|Apatinib|apatinib|mesh-list
56862644|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862645|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56862646|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862647|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862648|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56862649|NCT03787550|Analgesics|analgesics|mesh-list
56862650|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56862651|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862652|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
56862653|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862654|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862655|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862656|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
56862657|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
56862658|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862659|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56862660|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56862661|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
56573471|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
56862662|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862663|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862664|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56862665|NCT03789890|Itraconazole|itraconazole|mesh-list
56862666|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
56862667|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862668|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56862669|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56862670|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862671|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862672|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56862673|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
56862674|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56862675|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862676|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56862677|NCT01308554|Bupivacaine|bupivacaine|mesh-list
56862678|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
56862679|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
56862680|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862681|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862682|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
56862683|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862684|NCT05693402|Analgesics, Opioid|analgesics, opioid|mesh-list
56862685|NCT05693402|Anesthetics|anesthetics|mesh-list
56862686|NCT05693402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862687|NCT05693402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862688|NCT05693402|Narcotics|narcotics|mesh-ancestor
56862689|NCT05693402|Analgesics|analgesics|mesh-ancestor
56862690|NCT05693402|Sensory System Agents|sensory system agents|mesh-ancestor
56862691|NCT05693402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862692|NCT05694728|Vaccines|vaccines|mesh-list
56862693|NCT05694728|Immunologic Factors|immunologic factors|mesh-ancestor
56862694|NCT05694728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862695|NCT01308632|Irinotecan|irinotecan|mesh-list
56862696|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56862697|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56862698|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862699|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862700|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862701|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
56862702|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56862703|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862704|NCT03785522|Insulin|insulin|mesh-list
56862705|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56862706|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862707|NCT05694416|Etoposide|etoposide|mesh-list
56862708|NCT05694416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862709|NCT05694416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56862710|NCT05694416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56862711|NCT05694416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56862712|NCT05694416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862713|NCT05694416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862714|NCT03789422|Cetirizine|cetirizine|mesh-list
56862715|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
56862716|NCT03789422|Levocetirizine|levocetirizine|mesh-list
56862717|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56862718|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56862719|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862720|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
56862721|NCT03789422|Coagulants|coagulants|mesh-ancestor
56862722|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56862723|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56862724|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
56862725|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
56862726|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862727|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862728|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56862729|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56862730|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
56862731|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
56862732|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862733|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862734|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56862735|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56862736|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
56862737|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862738|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862739|NCT05690048|Vancomycin|vancomycin|mesh-list
56862740|NCT05690048|Bevacizumab|bevacizumab|mesh-list
56862741|NCT05690048|Atezolizumab|atezolizumab|mesh-list
56862742|NCT05690048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862743|NCT05690048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862744|NCT05690048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56862745|NCT05690048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56862747|NCT05690048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862748|NCT05690048|Growth Inhibitors|growth inhibitors|mesh-ancestor
56862749|NCT05690048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56862750|NCT05690048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862751|NCT01308086|Leucovorin|leucovorin|mesh-list
56862752|NCT01308086|Fluorouracil|fluorouracil|mesh-list
56862753|NCT01308086|Capecitabine|capecitabine|mesh-list
56862754|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
56862755|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
56862756|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
56862757|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862758|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56862759|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862760|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56862761|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
56862762|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862763|NCT01308086|Antidotes|antidotes|mesh-ancestor
56862764|NCT01308086|Protective Agents|protective agents|mesh-ancestor
56862765|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
56862766|NCT01308086|Vitamins|vitamins|mesh-ancestor
56862767|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
56862768|NCT05443802|Insulin|insulin|mesh-list
56862769|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56862770|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56862771|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862772|NCT01308944|Propranolol|propranolol|mesh-list
56862773|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56862774|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56862775|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
56862776|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862777|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862778|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862779|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56862780|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56862781|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
56862782|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
56862783|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56862784|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56862785|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862786|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
56862787|NCT03777488|Coagulants|coagulants|mesh-ancestor
56862788|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
56862789|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56862790|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56862791|NCT03777254|Growth Substances|growth substances|mesh-ancestor
56862792|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862793|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
56862794|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862795|NCT01312298|Bupivacaine|bupivacaine|mesh-list
56862796|NCT01312298|Anesthetics|anesthetics|mesh-list
56862797|NCT01312298|Propofol|propofol|mesh-list
56862798|NCT01312298|Succinylcholine|succinylcholine|mesh-list
56862799|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
56862800|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862801|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862802|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
56862803|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862804|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56862805|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56862806|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
56862807|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56862808|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56862809|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56862810|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
56862811|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573620|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862812|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862813|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
56862814|NCT01309022|Sirolimus|sirolimus|mesh-list
56862815|NCT01309022|Tacrolimus|tacrolimus|mesh-list
56862816|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56862817|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
56862818|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862819|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56862820|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862821|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862822|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56862823|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862824|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56862825|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
56862826|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56862827|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862828|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
56862829|NCT00261443|Valproic Acid|valproic acid|mesh-list
56862830|NCT00261443|Aripiprazole|aripiprazole|mesh-list
56862831|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
56862832|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
56862833|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56862834|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56862835|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56862836|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862837|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862838|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
56862839|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
56862840|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862841|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862842|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56862843|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56862844|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
56862845|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56862846|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56862847|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56862848|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56862849|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862850|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
56862851|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
56862852|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
56862853|NCT01560962|Azithromycin|azithromycin|mesh-list
56862855|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
56862856|NCT01560962|Povidone|povidone|mesh-list
56862857|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56862858|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862859|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
56862860|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
56862861|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56862862|NCT05401058|Droperidol|droperidol|mesh-list
56862863|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56862864|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
56862865|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
56862866|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862867|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862868|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862869|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56862870|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56862871|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56862872|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56862873|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56862874|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56862875|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
56862876|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862877|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862878|NCT03781466|Progesterone|progesterone|mesh-list
56862879|NCT03781466|Progestins|progestins|mesh-ancestor
56862880|NCT03781466|Hormones|hormones|mesh-ancestor
56862881|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56862882|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862883|NCT01318928|Metronidazole|metronidazole|mesh-list
56862884|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862885|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56862886|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56862887|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56573708|NCT00820027|Ibuprofen|ibuprofen|mesh-list
56862888|NCT01309178|Mannitol|mannitol|mesh-list
56862889|NCT01309178|Amitriptyline|amitriptyline|mesh-list
56862890|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56862891|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
56862892|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56862893|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56862894|NCT01309178|Analgesics|analgesics|mesh-ancestor
56862895|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
56862896|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862897|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862898|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56862899|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56862900|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56862901|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862902|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
56862903|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862904|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56862905|NCT01309178|Diuretics|diuretics|mesh-ancestor
56862906|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
56862907|NCT01335334|Metronidazole|metronidazole|mesh-list
56862908|NCT01335334|Tetracycline|tetracycline|mesh-list
56862909|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56862911|NCT01335334|Bismuth|bismuth|mesh-list
56862912|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56862913|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56862914|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56862915|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56862916|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56862917|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862918|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56862919|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862920|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862921|NCT01335334|Antacids|antacids|mesh-ancestor
56862922|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56862923|NCT01344304|Aprepitant|aprepitant|mesh-list
56862924|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
56862925|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
56862926|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
56862927|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862928|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862929|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862930|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56862931|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862932|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862933|NCT01320020|Catumaxomab|catumaxomab|mesh-list
56862934|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862935|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56862936|NCT05312762|Chitosan|chitosan|mesh-list
56862937|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56862938|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56862939|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
56862940|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862941|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56862942|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
56862943|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
56862944|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
56862945|NCT05312762|Coagulants|coagulants|mesh-ancestor
56862946|NCT05312762|Laxatives|laxatives|mesh-ancestor
56862947|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56862948|NCT00379288|Fluticasone|fluticasone|mesh-list
56862949|NCT00379288|Xhance|xhance|mesh-list
56862950|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
56862951|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56862952|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56862953|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56862954|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56862955|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
56862956|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56862957|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862958|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56862959|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56862960|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
56862961|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56862962|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56862963|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56862964|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56862965|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
56862966|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862967|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862968|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
56862969|NCT00379288|Hormones|hormones|mesh-ancestor
56862970|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56862971|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
56862972|NCT03784040|Nivolumab|nivolumab|mesh-list
56862973|NCT03784040|Ipilimumab|ipilimumab|mesh-list
56862974|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862976|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56862977|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862979|NCT00243503|Sunitinib|sunitinib|mesh-list
56862980|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56862981|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56862982|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56862983|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56862984|NCT00243503|Growth Substances|growth substances|mesh-ancestor
56467752|NCT00484068|Enalapril|enalapril|mesh-list
56862985|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862986|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
56862987|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56862988|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56862989|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862990|NCT03780686|Dopamine|dopamine|mesh-list
56862991|NCT03780686|Norepinephrine|norepinephrine|mesh-list
56862992|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56862993|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56862994|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
56862995|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56862996|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56862997|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56862998|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
56862999|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
56863000|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863001|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56863002|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56863003|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
56863004|NCT03780686|Protective Agents|protective agents|mesh-ancestor
56863005|NCT00338260|Atenolol|atenolol|mesh-list
56863006|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
56863007|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863008|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863009|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863010|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
56863011|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863012|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56863013|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56863014|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
56863015|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56863016|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56863017|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56863018|NCT03775928|Capecitabine|capecitabine|mesh-list
56863019|NCT03775928|Apatinib|apatinib|mesh-list
56863020|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56863021|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
56863022|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863023|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863024|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56863025|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863026|NCT03775538|Dopamine|dopamine|mesh-list
56863027|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56863028|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
56863029|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
56863030|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863031|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863032|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
56863033|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863034|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863035|NCT03775538|Protective Agents|protective agents|mesh-ancestor
56863036|NCT00259649|Eletriptan|eletriptan|mesh-list
56863037|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56863038|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
56863039|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920215|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56863040|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863041|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863042|NCT05668988|Carboplatin|carboplatin|mesh-list
56863043|NCT05668988|Pemetrexed|pemetrexed|mesh-list
56863044|NCT05668988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863045|NCT05668988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863046|NCT05668988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863048|NCT05668988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56863049|NCT01320176|Vaccines|vaccines|mesh-list
56863050|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
56863051|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863052|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56863053|NCT01335646|Analgesics|analgesics|mesh-list
56903946|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
56863054|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
56863055|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863056|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863057|NCT01309412|Siltuximab|siltuximab|mesh-list
56863058|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863059|NCT00307060|Losartan|losartan|mesh-list
56863060|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56863061|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56863062|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56863063|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56863064|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56863065|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863066|NCT00307060|Diuretics|diuretics|mesh-ancestor
56863067|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
56863068|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863069|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56863070|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56863071|NCT01320254|Gemcitabine|gemcitabine|mesh-list
56863072|NCT01320254|Cisplatin|cisplatin|mesh-list
56863073|NCT01320254|Panitumumab|panitumumab|mesh-list
56863074|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56863075|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863076|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56863077|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
56863078|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863079|NCT01320254|Antiviral Agents|antiviral agents|mesh-ancestor
56863080|NCT01320254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863081|NCT01320254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863082|NCT01320254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56863083|NCT01320254|Immunologic Factors|immunologic factors|mesh-ancestor
56863084|NCT01320254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863085|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56863086|NCT00092638|Ezetimibe|ezetimibe|mesh-list
56863087|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56863088|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863089|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
56863090|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863091|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863092|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
56863093|NCT03775382|Vitamins|vitamins|mesh-ancestor
56863094|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
56863095|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863096|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
56863097|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863098|NCT03775382|Protective Agents|protective agents|mesh-ancestor
56863099|NCT03783728|Pyridoxine|pyridoxine|mesh-list
56863100|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
56863101|NCT03783728|Isoniazid|isoniazid|mesh-list
56863102|NCT03783728|Rifapentine|rifapentine|mesh-list
56863103|NCT03783728|Vitamins|vitamins|mesh-ancestor
56863104|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
56863105|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863106|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
56863107|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
56863108|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56863109|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863110|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56863111|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863112|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
56863113|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863114|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863115|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56863116|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
56863117|NCT03620422|Mannitol|mannitol|mesh-list
56863118|NCT03620422|Albuterol|albuterol|mesh-list
56863119|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56863120|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
56863121|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863122|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863123|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56863124|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56863125|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
56863126|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56863127|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56863128|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56863129|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56863130|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
56863131|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863132|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863133|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56863134|NCT03620422|Diuretics|diuretics|mesh-ancestor
56863135|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
56863137|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
56863138|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863139|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
56863140|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863141|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56863142|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56863143|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863144|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
56863145|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863146|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863147|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56863148|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863149|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
56863150|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863151|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56863152|NCT03783494|Propofol|propofol|mesh-list
56863153|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56863154|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863155|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863156|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56863157|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
56863158|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
56863159|NCT03774836|Morphine|morphine|mesh-list
56863160|NCT03774836|Tramadol|tramadol|mesh-list
56863161|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56863162|NCT03774836|Narcotics|narcotics|mesh-ancestor
56863163|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863164|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863165|NCT03774836|Analgesics|analgesics|mesh-ancestor
56863166|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
56863167|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863168|NCT03774680|Cetuximab|cetuximab|mesh-list
56863169|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56863170|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863171|NCT03783338|Vitamin D|vitamin d|mesh-list
56863172|NCT03783338|Vitamins|vitamins|mesh-ancestor
56863173|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
56863174|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863175|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56863176|NCT03774524|Misoprostol|misoprostol|mesh-list
56863177|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56863178|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
56863179|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56863180|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863181|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56863182|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56863183|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
56863184|NCT03774446|Roscovitine|roscovitine|mesh-list
56863185|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863186|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
56863187|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863188|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56863189|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863190|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863191|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
56863192|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
56863193|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56863194|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
56863195|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863196|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56863197|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56863198|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
56863199|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863200|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863201|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56863202|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56863204|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
56863205|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
56863206|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863207|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863208|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
56863209|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863210|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56863211|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56863212|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56863213|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56863214|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863215|NCT03779594|Acetazolamide|acetazolamide|mesh-list
56863216|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
56863217|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56863218|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863219|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863220|NCT03779594|Diuretics|diuretics|mesh-ancestor
56863221|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
56863222|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863223|NCT03779672|Memantine|memantine|mesh-list
56863224|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56863225|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56863226|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
56863227|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863228|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863229|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863230|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56863231|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56863232|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
56863233|NCT03779282|Ketamine|ketamine|mesh-list
56863234|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56863235|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863236|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863237|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56863238|NCT03779282|Analgesics|analgesics|mesh-ancestor
56863239|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
56863240|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863241|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56863242|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56863243|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56863244|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
56863245|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863246|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863247|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56863248|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56863249|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
56863250|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
56863251|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56863252|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56863253|NCT03773588|Propofol|propofol|mesh-list
56863254|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56863255|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863256|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863257|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56863258|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
56863259|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
56863260|NCT03773510|Trabectedin|trabectedin|mesh-list
56863261|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56863262|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
56863263|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863264|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863265|NCT03779360|Clindamycin|clindamycin|mesh-list
56863267|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
56863268|NCT03779360|Erythromycin|erythromycin|mesh-list
56863269|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
56863270|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56863271|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
56863272|NCT03779360|Prednisolone|prednisolone|mesh-list
56863273|NCT03779360|Clobetasol|clobetasol|mesh-list
56863274|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56863275|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
56863276|NCT03779360|Hormones|hormones|mesh-ancestor
56863277|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56863278|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863279|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56863280|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863281|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56863282|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56863283|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863284|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56863285|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863286|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863287|NCT01320878|Iloprost|iloprost|mesh-list
56863288|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56863289|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56863290|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
56863291|NCT01321034|Niacin|niacin|mesh-list
56863292|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863293|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
56863294|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863295|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863296|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
56863297|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
56863298|NCT01321034|Vitamins|vitamins|mesh-ancestor
56863299|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
56863300|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863301|NCT05254184|Nivolumab|nivolumab|mesh-list
56863302|NCT05254184|Ipilimumab|ipilimumab|mesh-list
56863303|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56863304|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863305|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56863306|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863307|NCT03773042|Propofol|propofol|mesh-list
56863308|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56863309|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863310|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863311|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56863312|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
56863313|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
56863314|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56863315|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56863316|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
56863317|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863318|NCT03712280|Rifaximin|rifaximin|mesh-list
56863319|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
56863320|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56863321|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863322|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56863323|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56863324|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
56863325|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863326|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863327|NCT01561508|Butyric Acid|butyric acid|mesh-list
56863328|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
56863329|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
56863330|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863331|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863332|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863333|NCT04673942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56863334|NCT04673942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863335|NCT04673942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863336|NCT03772262|Metformin|metformin|mesh-list
56863337|NCT03772262|Furosemide|furosemide|mesh-list
56863338|NCT03772262|Midazolam|midazolam|mesh-list
56863339|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56863340|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56574145|NCT01120184|Trastuzumab|trastuzumab|mesh-list
56863341|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863342|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56863343|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56863344|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863345|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56863346|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56863347|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56863348|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56863350|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
56863351|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
56863352|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
56863353|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863354|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863355|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56863356|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863357|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
56863358|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863359|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56863360|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863361|NCT03772262|Diuretics|diuretics|mesh-ancestor
56863362|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
56863363|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56863364|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56863365|NCT03772106|Propofol|propofol|mesh-list
56863366|NCT03772106|Sevoflurane|sevoflurane|mesh-list
56863367|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56863368|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863369|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863370|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56863371|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
56863372|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
56863373|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56863374|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56863375|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
56863376|NCT03778502|Apixaban|apixaban|mesh-list
56863377|NCT03778502|Edoxaban|edoxaban|mesh-list
56863378|NCT03778502|Dabigatran|dabigatran|mesh-list
56863379|NCT03778502|Anticoagulants|anticoagulants|mesh-list
56863380|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56863381|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
56863382|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56863383|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
56863384|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863385|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863386|NCT01345240|Vaccines|vaccines|mesh-list
56863387|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
56863388|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863389|NCT03771638|Tenofovir|tenofovir|mesh-list
56863390|NCT03771638|Emtricitabine|emtricitabine|mesh-list
56863391|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
56863392|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863393|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56863394|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56863395|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863396|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863397|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56863398|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56863399|NCT00092560|Ezetimibe|ezetimibe|mesh-list
56863400|NCT00092560|Fenofibrate|fenofibrate|mesh-list
56863401|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56863402|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863403|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
56863404|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863405|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863406|NCT03769064|Methylphenidate|methylphenidate|mesh-list
56863407|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56863408|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863409|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56863410|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56863411|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56863412|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863413|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
56863414|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863415|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56863416|NCT00090298|Simvastatin|simvastatin|mesh-list
56863417|NCT00090298|Ezetimibe|ezetimibe|mesh-list
56863418|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56863419|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863420|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
56863421|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863422|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56904624|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
56863424|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863425|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
56863426|NCT03771092|Hematinics|hematinics|mesh-ancestor
56863427|NCT02765854|Dexamethasone|dexamethasone|mesh-list
56863428|NCT02765854|Lenalidomide|lenalidomide|mesh-list
56863429|NCT02765854|Ixazomib|ixazomib|mesh-list
56863430|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56863431|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
56863432|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
56863433|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863434|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863435|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56863436|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
56863437|NCT02765854|Hormones|hormones|mesh-ancestor
56863438|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56863439|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56863440|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863441|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
56863442|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56863443|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56863444|NCT02765854|Growth Substances|growth substances|mesh-ancestor
56863445|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
56863446|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863447|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
56863448|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863449|NCT03768908|Artesunate|artesunate|mesh-list
56863450|NCT03768908|Lumefantrine|lumefantrine|mesh-list
56863451|NCT03768908|Artemether|artemether|mesh-list
56863452|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56863453|NCT03768908|Amodiaquine|amodiaquine|mesh-list
56863454|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
56863455|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56863456|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56863457|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863458|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863459|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
56863460|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
56863461|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56863462|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
56863463|NCT03777878|Oxytocin|oxytocin|mesh-list
56863464|NCT03777878|Carbetocin|carbetocin|mesh-list
56863465|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
56863466|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56863467|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863468|NCT03246958|Nivolumab|nivolumab|mesh-list
56863469|NCT03246958|Ipilimumab|ipilimumab|mesh-list
56863470|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56863471|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863472|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56863473|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863474|NCT01321268|Beta Carotene|beta carotene|mesh-list
56863475|NCT01321268|Lycopene|lycopene|mesh-list
56863476|NCT01321268|Resveratrol|resveratrol|mesh-list
56863477|NCT01321268|Carotenoids|carotenoids|mesh-list
56863478|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
56863479|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863480|NCT01321268|Protective Agents|protective agents|mesh-ancestor
56863481|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863482|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863483|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56863484|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56863485|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56863486|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56863487|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863488|NCT01321268|Provitamins|provitamins|mesh-ancestor
56863489|NCT01321268|Vitamins|vitamins|mesh-ancestor
56574298|NCT00972504|Cetirizine|cetirizine|mesh-list
56863490|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
56863491|NCT01561274|Bupivacaine|bupivacaine|mesh-list
56863492|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
56863493|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
56863494|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863495|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863496|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
56863497|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863498|NCT02882854|Guanfacine|guanfacine|mesh-list
56863499|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56863500|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56863501|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56863503|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
56863504|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863505|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863506|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863507|NCT03770936|Candesartan|candesartan|mesh-list
56863508|NCT03770936|Ramipril|ramipril|mesh-list
56863509|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56863510|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56863511|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56863512|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863513|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56863514|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
56863515|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863516|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
56863517|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56863518|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863519|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56863520|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56863521|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863522|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863523|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863524|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56863525|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56863526|NCT01321346|Cytarabine|cytarabine|mesh-list
56863527|NCT01321346|Panobinostat|panobinostat|mesh-list
56863528|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56863529|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
56863530|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863531|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863532|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
56863533|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863534|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56863535|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
56863536|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863537|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56863538|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863539|NCT04058366|Ivacaftor|ivacaftor|mesh-list
56863540|NCT04058366|Elexacaftor|elexacaftor|mesh-list
56863541|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56863542|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56863543|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863544|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
56863545|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56863546|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56863547|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56863548|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56863549|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863550|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56863551|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863552|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56863553|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56863554|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863555|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56863556|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56863557|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
56863558|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863559|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
56863560|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56863561|NCT02118610|Analgesics|analgesics|mesh-ancestor
56863562|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
56863563|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863564|NCT01561742|Minocycline|minocycline|mesh-list
56863565|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56863566|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863567|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56863568|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863569|NCT01345708|Prednisone|prednisone|mesh-list
56863570|NCT01345708|Rituximab|rituximab|mesh-list
56863571|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56863573|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
56863574|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863575|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56863576|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56863577|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
56863579|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56863580|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56863581|NCT01345864|Scopolamine|scopolamine|mesh-list
56863582|NCT01345864|Donepezil|donepezil|mesh-list
56863583|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56863584|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56863585|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863586|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863587|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
56863588|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863589|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863590|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
56863591|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56863592|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
56863593|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
56863594|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863595|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56863596|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
56863597|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56863598|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56863599|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
56863600|NCT04320602|Eculizumab|eculizumab|mesh-list
56863601|NCT04320602|Ravulizumab|ravulizumab|mesh-list
56863602|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56863603|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56863604|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
56863605|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863606|NCT03948022|Progesterone|progesterone|mesh-list
56863607|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
56863608|NCT03948022|Progestins|progestins|mesh-ancestor
56863609|NCT03948022|Hormones|hormones|mesh-ancestor
56863610|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56863611|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863612|NCT03777644|Morphine|morphine|mesh-list
56863613|NCT03777644|Ropivacaine|ropivacaine|mesh-list
56863614|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56863615|NCT03777644|Narcotics|narcotics|mesh-ancestor
56863616|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863617|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863618|NCT03777644|Analgesics|analgesics|mesh-ancestor
56863619|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
56863620|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863621|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
56863622|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
56863623|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
56863624|NCT04345666|Testosterone|testosterone|mesh-list
56863625|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
56863626|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
56863627|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56863628|NCT04345666|Androgens|androgens|mesh-ancestor
56863629|NCT04345666|Hormones|hormones|mesh-ancestor
56863630|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56863631|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863632|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56863633|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863634|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
56863635|NCT01336192|Gemcitabine|gemcitabine|mesh-list
56863636|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56863637|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
56863638|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863639|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863640|NCT01336192|Antiviral Agents|antiviral agents|mesh-ancestor
56574447|NCT05779943|Cariostatic Agents|cariostatic agents|mesh-ancestor
56863641|NCT01336192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863642|NCT01336192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863643|NCT01336192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56863644|NCT01336192|Immunologic Factors|immunologic factors|mesh-ancestor
56863645|NCT01336192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863646|NCT04296890|Maytansine|maytansine|mesh-list
56863647|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56863649|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56863650|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56863651|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56863652|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863653|NCT04459234|Ketamine|ketamine|mesh-list
56863654|NCT04459234|Analgesics|analgesics|mesh-ancestor
56863655|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
56863656|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863657|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863658|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56863659|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56863660|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
56863661|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
56863662|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863663|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56863664|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56863665|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863666|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863667|NCT01336348|Tirofiban|tirofiban|mesh-list
56863668|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56863669|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56863670|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56863671|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56863672|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863673|NCT01346254|Pioglitazone|pioglitazone|mesh-list
56863674|NCT01346254|Vildagliptin|vildagliptin|mesh-list
56863675|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56863676|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863677|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56863678|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
56863679|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863680|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863681|NCT04592536|Alprazolam|alprazolam|mesh-list
56863682|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56863683|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863684|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863685|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56863686|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56863687|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56863688|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
56863689|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
56863690|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863691|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863692|NCT01336582|Docetaxel|docetaxel|mesh-list
56863693|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863694|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56863695|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56863696|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56863697|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863698|NCT03149848|Rifabutin|rifabutin|mesh-list
56863699|NCT03149848|Cabotegravir|cabotegravir|mesh-list
56863700|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56863701|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863702|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56863703|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
56863704|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56863705|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56863706|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863707|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863708|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56863709|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56863710|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
56863711|NCT01346800|Ritonavir|ritonavir|mesh-list
56863712|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56863713|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56863714|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56863715|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
56863716|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863717|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863718|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56863719|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56863720|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
56863722|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56863723|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56863725|NCT03902314|Lidocaine|lidocaine|mesh-list
56863726|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
56863727|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
56863728|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863729|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863730|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
56863731|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863732|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56863733|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56863734|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56863735|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56863736|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863737|NCT01336660|Antivenins|antivenins|mesh-list
56863738|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
56863739|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863740|NCT03768518|Exenatide|exenatide|mesh-list
56863741|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56863742|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863743|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56863744|NCT03768518|Incretins|incretins|mesh-ancestor
56863745|NCT03768518|Hormones|hormones|mesh-ancestor
56863746|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56863747|NCT04276376|Atezolizumab|atezolizumab|mesh-list
56863748|NCT04276376|Rucaparib|rucaparib|mesh-list
56863749|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863750|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56863751|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863752|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863753|NCT04254692|Bupivacaine|bupivacaine|mesh-list
56863754|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
56863755|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
56863756|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56863757|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863758|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
56863759|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863760|NCT03770000|Romidepsin|romidepsin|mesh-list
56863761|NCT03770000|Tenalisib|tenalisib|mesh-list
56863762|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56863763|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863764|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
56863765|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863766|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863767|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56863768|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56863769|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863770|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
56863771|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863772|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863773|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863774|NCT03158272|Nivolumab|nivolumab|mesh-list
56863775|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56863776|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863777|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56863778|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863779|NCT01431508|Losartan|losartan|mesh-list
56863780|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56863781|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56863782|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56863783|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56863784|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863785|NCT01321502|Famciclovir|famciclovir|mesh-list
56863786|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
56903974|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
56863787|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863788|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56863789|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920216|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574593|NCT05755997|Cerebrolysin|cerebrolysin|mesh-list
56863808|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863809|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
56863811|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56863812|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
56863813|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56863814|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863815|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
56863816|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56863817|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863818|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863819|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56863820|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56863821|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56863822|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56863823|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56863824|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56863825|NCT00654628|Simvastatin|simvastatin|mesh-list
56863826|NCT00654628|Ezetimibe|ezetimibe|mesh-list
56863827|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56863828|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863829|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
56863830|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863831|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863832|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56863833|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863834|NCT00536380|Loratadine|loratadine|mesh-list
56863835|NCT00536380|Desloratadine|desloratadine|mesh-list
56863836|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56863837|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
56863838|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863839|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863840|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863841|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56863842|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56863843|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
56863844|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
56863846|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
56863847|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56863849|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56863850|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56863851|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863852|NCT03762824|Vaccines|vaccines|mesh-list
56863853|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56863854|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
56863855|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863856|NCT00496834|Losartan|losartan|mesh-list
56863857|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56863858|NCT00496834|Carvedilol|carvedilol|mesh-list
56863859|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56863860|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56863861|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56863862|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56863863|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863864|NCT00496834|Diuretics|diuretics|mesh-ancestor
56863865|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
56863866|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863867|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56863868|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56863869|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56863870|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56863871|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
56863872|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863873|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
56863874|NCT00496834|Protective Agents|protective agents|mesh-ancestor
56863875|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56863876|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56863877|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
56863878|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56863879|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56863880|NCT00189280|Imiquimod|imiquimod|mesh-list
56863881|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56863882|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
56863883|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863884|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863885|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
56863886|NCT01352494|Gemcitabine|gemcitabine|mesh-list
56863887|NCT01352494|Docetaxel|docetaxel|mesh-list
56863888|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56863889|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
56863890|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863891|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863892|NCT01352494|Antiviral Agents|antiviral agents|mesh-ancestor
56863893|NCT01352494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56863894|NCT01352494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863895|NCT01352494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56863896|NCT01352494|Immunologic Factors|immunologic factors|mesh-ancestor
56863897|NCT01352494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863898|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
56863899|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
56863900|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
56863901|NCT01347814|Domperidone|domperidone|mesh-list
56863902|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
56863903|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
56863904|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863905|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863906|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56863907|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56863908|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
56863909|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863910|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863911|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56863912|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56863913|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863914|NCT01348126|Docetaxel|docetaxel|mesh-list
56863915|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56863916|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
56863917|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
56863918|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
56568235|NCT04315688|Insulin|insulin|mesh-list
56863919|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863921|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
56863922|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863923|NCT01348204|Protective Agents|protective agents|mesh-ancestor
56863924|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863925|NCT00166504|Atorvastatin|atorvastatin|mesh-list
56863926|NCT00166504|Simvastatin|simvastatin|mesh-list
56863928|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56863929|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56863930|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
56863931|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863932|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56863933|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56863934|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863935|NCT01348282|Rivastigmine|rivastigmine|mesh-list
56863936|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863937|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863939|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56863940|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
56863941|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863942|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56863943|NCT01348282|Protective Agents|protective agents|mesh-ancestor
56863944|NCT03137992|Bromides|bromides|mesh-list
56863945|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
56863946|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56863947|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
56863948|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56863949|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863950|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56863951|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
56863952|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
56863953|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56863954|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
56863955|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863956|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863957|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
56863958|NCT04470778|Famotidine|famotidine|mesh-list
56863959|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56863960|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56863961|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56863962|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
56863963|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
56863964|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863965|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863966|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863967|NCT01352572|Milnacipran|milnacipran|mesh-list
56863968|NCT01352572|Mirtazapine|mirtazapine|mesh-list
56863969|NCT01352572|Sertraline|sertraline|mesh-list
56863970|NCT01352572|Fluoxetine|fluoxetine|mesh-list
56863971|NCT01352572|Paroxetine|paroxetine|mesh-list
56863972|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56863973|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
56863974|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
56863975|NCT01352572|Nortriptyline|nortriptyline|mesh-list
56863976|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56863977|NCT01352572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56863978|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56863979|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56863980|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56863981|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56863982|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
56863983|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56863984|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56863985|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56863986|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56863987|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56863988|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56863989|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56863990|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
56863991|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
56863992|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56863993|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56864002|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56864003|NCT01352572|Analgesics|analgesics|mesh-ancestor
56864004|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
56864005|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864006|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56864007|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56864008|NCT01352650|Plerixafor|plerixafor|mesh-list
56864009|NCT01352650|Decitabine|decitabine|mesh-list
56864010|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56864011|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
56864012|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864013|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864014|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864015|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56864016|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56864017|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
56864018|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864019|NCT01352728|Axitinib|axitinib|mesh-list
56864020|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864021|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864022|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864023|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864024|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
56864025|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56864026|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864027|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
56864028|NCT03602612|Fludarabine|fludarabine|mesh-list
56864029|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864030|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
56864031|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864032|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864033|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56864034|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
56864035|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864036|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864037|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56864038|NCT03767660|Sirolimus|sirolimus|mesh-list
56864039|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56864040|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864041|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56864042|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864043|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
56864044|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864045|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
56864046|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864047|NCT03767504|Thymol|thymol|mesh-list
56864048|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864049|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56864050|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
56864051|NCT01343290|Canagliflozin|canagliflozin|mesh-list
56864052|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56864053|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864054|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56864055|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864056|NCT03761264|Amoxicillin|amoxicillin|mesh-list
56864057|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
56864058|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904625|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
56864059|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56864060|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864061|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
56864062|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
56864063|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56864064|NCT03761264|Protective Agents|protective agents|mesh-ancestor
56864066|NCT05096312|Adapalene|adapalene|mesh-list
56864067|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56864068|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56864069|NCT05096312|Trace Elements|trace elements|mesh-ancestor
56864070|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
56864071|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864072|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56864073|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56864074|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56864075|NCT05096312|Analgesics|analgesics|mesh-ancestor
56864076|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
56864077|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864078|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864079|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864080|NCT05089916|Osimertinib|osimertinib|mesh-list
56864081|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864082|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864083|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864084|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864085|NCT05004662|Nicotine|nicotine|mesh-list
56864086|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56864087|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
56864088|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864089|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864090|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56864091|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56864092|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
56864093|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864094|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864095|NCT03767036|Ketorolac|ketorolac|mesh-list
56864096|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56864097|NCT03767036|Tramadol|tramadol|mesh-list
56864098|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56864099|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56864100|NCT03767036|Analgesics|analgesics|mesh-ancestor
56864101|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
56864102|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864103|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864104|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864105|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864106|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56864107|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864108|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864109|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56864110|NCT03767036|Narcotics|narcotics|mesh-ancestor
56864111|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864112|NCT03758144|Rifaximin|rifaximin|mesh-list
56864113|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56864114|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864115|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56864116|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
56864117|NCT03766724|Empagliflozin|empagliflozin|mesh-list
56864118|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56864119|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864120|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56864121|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864122|NCT04860518|Dexamethasone|dexamethasone|mesh-list
56864123|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864124|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
56864125|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
56864126|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864127|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864128|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56864129|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
56864130|NCT04860518|Hormones|hormones|mesh-ancestor
56864131|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56864132|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56864133|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864134|NCT03110380|Dolutegravir|dolutegravir|mesh-list
56864135|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56864136|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56864137|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56864138|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864139|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864140|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56864141|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56864142|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
56864143|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864144|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56864145|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56864146|NCT03757910|Corticosterone|corticosterone|mesh-list
56864147|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864148|NCT01322204|Codeine|codeine|mesh-list
56864149|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56864150|NCT01322204|Narcotics|narcotics|mesh-ancestor
56864151|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864152|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864153|NCT01322204|Analgesics|analgesics|mesh-ancestor
56864154|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
56864155|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864156|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
56864157|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
56864158|NCT03766490|Gefitinib|gefitinib|mesh-list
56864159|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864160|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864161|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574965|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864162|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864163|NCT01348984|Fentanyl|fentanyl|mesh-list
56864164|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56864165|NCT01348984|Narcotics|narcotics|mesh-ancestor
56864166|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864167|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864168|NCT01348984|Analgesics|analgesics|mesh-ancestor
56864169|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
56864170|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864171|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56864172|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56864173|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
56864174|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
56864175|NCT01567670|Naloxone|naloxone|mesh-list
56864176|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56864177|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864178|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
56864179|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864180|NCT04848662|Budesonide|budesonide|mesh-list
56864181|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864182|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56864183|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
56864184|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864185|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864186|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56864187|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
56864188|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
56864189|NCT04848662|Hormones|hormones|mesh-ancestor
56864190|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56864191|NCT04351256|Durvalumab|durvalumab|mesh-list
56864192|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56864193|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864194|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
56864195|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56864196|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864197|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56864198|NCT03700892|Protective Agents|protective agents|mesh-ancestor
56864199|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864200|NCT01322282|Cetirizine|cetirizine|mesh-list
56864201|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56864202|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56864203|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56864204|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
56864205|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
56864206|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864207|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864208|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864211|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
56864212|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56864213|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864214|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56864215|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
56864216|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864217|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864218|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
56864219|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864220|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56864221|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864222|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
56864223|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864224|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56864225|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
56864226|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56864227|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864228|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
56864230|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
56864231|NCT04737278|Vitamins|vitamins|mesh-ancestor
56864232|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
56864233|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864234|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56864235|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
56864236|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864237|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56864238|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
56864239|NCT03759860|Ranibizumab|ranibizumab|mesh-list
56864240|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56864241|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56864242|NCT03759860|Growth Substances|growth substances|mesh-ancestor
56864243|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864244|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
56864245|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864246|NCT03759782|Tenofovir|tenofovir|mesh-list
56864247|NCT03759782|Ribavirin|ribavirin|mesh-list
56864248|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
56864249|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864250|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56864251|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56864252|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864253|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864254|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56864255|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56864256|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
56864257|NCT03757052|Amoxicillin|amoxicillin|mesh-list
56864258|NCT03757052|Penicillins|penicillins|mesh-list
56864259|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56864260|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864261|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
56864262|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56864263|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864264|NCT03765944|Sirolimus|sirolimus|mesh-list
56864265|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56864266|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864267|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56864268|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864269|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
56864270|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864271|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
56864272|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864273|NCT04684394|Aflibercept|aflibercept|mesh-list
56864274|NCT04684394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56864275|NCT04684394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56864276|NCT04684394|Growth Substances|growth substances|mesh-ancestor
56864277|NCT04684394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864278|NCT04684394|Growth Inhibitors|growth inhibitors|mesh-ancestor
56864279|NCT04684394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864280|NCT03765554|PF-06700841|pf-06700841|mesh-list
56864281|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864282|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864283|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864285|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56864286|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56864287|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864288|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864289|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56864290|NCT04668950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56864291|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56864292|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56864293|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864294|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864295|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
56864296|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56864297|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
56864298|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56864299|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56864300|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864301|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56864302|NCT03078478|Insulin|insulin|mesh-list
56864303|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56864304|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
56864305|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56864306|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864307|NCT01349296|Everolimus|everolimus|mesh-list
56864308|NCT01349296|Nintedanib|nintedanib|mesh-list
56864309|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864310|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864311|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
56864312|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864313|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864314|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864315|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864316|NCT03522844|Citalopram|citalopram|mesh-list
56864317|NCT03522844|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56864318|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56864319|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56864320|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864321|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864322|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
56864323|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894850|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56864324|NCT03522844|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56864325|NCT03522844|Antidepressive Agents|antidepressive agents|mesh-ancestor
56864326|NCT03522844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56864327|NCT00045942|Itraconazole|itraconazole|mesh-list
56864328|NCT00045942|Midostaurin|midostaurin|mesh-list
56864329|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
56864330|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864331|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56864332|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56864333|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864334|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864335|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56864336|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
56864337|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56864338|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864339|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56864340|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864341|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864342|NCT04386616|Astegolimab|astegolimab|mesh-list
56864343|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56864344|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864345|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
56864346|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864347|NCT00045708|Epothilones|epothilones|mesh-list
56864348|NCT00045708|Epothilone B|epothilone b|mesh-list
56864349|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
56864350|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56864351|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56864352|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56864353|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864354|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864355|NCT01349452|Ganciclovir|ganciclovir|mesh-list
56864357|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
56864358|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56864359|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56864360|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
56864361|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864362|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56864363|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864364|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864365|NCT00045630|Gemcitabine|gemcitabine|mesh-list
56864366|NCT00045630|Paclitaxel|paclitaxel|mesh-list
56864367|NCT00045630|Carboplatin|carboplatin|mesh-list
56864368|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56864369|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864370|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
56864371|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
56864372|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
56864373|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864374|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56864375|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
56864376|NCT00045630|Antiviral Agents|antiviral agents|mesh-ancestor
56864377|NCT00045630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864378|NCT00045630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864379|NCT00045630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864380|NCT00045630|Immunologic Factors|immunologic factors|mesh-ancestor
56864381|NCT00045630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864382|NCT01357252|Vildagliptin|vildagliptin|mesh-list
56864383|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56864384|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864385|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56575193|NCT05023070|Cannabidiol|cannabidiol|mesh-list
56864386|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
56864387|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864388|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864389|NCT03465280|Interferons|interferons|mesh-list
56864390|NCT03465280|Acyclovir|acyclovir|mesh-list
56864391|NCT03465280|Cidofovir|cidofovir|mesh-list
56864392|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
56864393|NCT03465280|Artemisinins|artemisinins|mesh-list
56864394|NCT03465280|Artemisinin|artemisinin|mesh-list
56864395|NCT03465280|Celecoxib|celecoxib|mesh-list
56864396|NCT03465280|Methotrexate|methotrexate|mesh-list
56864397|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
56864398|NCT03465280|Isotretinoin|isotretinoin|mesh-list
56864399|NCT03465280|Cimetidine|cimetidine|mesh-list
56864400|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864401|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864402|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56864403|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
56864404|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56864405|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56864406|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
56864407|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864408|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
56864409|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864410|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56864411|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864412|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
56864413|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864414|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56864415|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
56864416|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864417|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56864418|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56864419|NCT03465280|Analgesics|analgesics|mesh-ancestor
56864420|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
56864421|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864422|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864423|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56864424|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56864425|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56864426|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56864427|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56864428|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
56864429|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
56864430|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864431|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56864432|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56864433|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
56864434|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56864435|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56864436|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56864437|NCT03465280|Protective Agents|protective agents|mesh-ancestor
56864439|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
56864440|NCT01349764|Vitamins|vitamins|mesh-ancestor
56864441|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
56864442|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864443|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56864444|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56864445|NCT02924272|Ixazomib|ixazomib|mesh-list
56864446|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864447|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
56864448|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864449|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864450|NCT01353742|Lamivudine|lamivudine|mesh-list
56864451|NCT01353742|Adefovir|adefovir|mesh-list
56864452|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56864453|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56864454|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56864455|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864456|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864457|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
56864458|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864459|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56864460|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56864461|NCT00003702|Dactinomycin|dactinomycin|mesh-list
56864462|NCT00003702|Cactinomycin|cactinomycin|mesh-list
56864463|NCT00003702|Methotrexate|methotrexate|mesh-list
56864464|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56864465|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
56864466|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56864467|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864468|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56864469|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
56864470|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864471|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864472|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
56864473|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864474|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56864475|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864476|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
56864477|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864478|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56864479|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56864480|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864481|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56864482|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56864483|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
56864484|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
56864485|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56864486|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56864487|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864488|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864489|NCT01350154|Urological Agents|urological agents|mesh-ancestor
56864490|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
56864491|NCT00031590|Lomustine|lomustine|mesh-list
56864492|NCT00031590|Etoposide|etoposide|mesh-list
56864493|NCT00031590|Vincristine|vincristine|mesh-list
56864494|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864495|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
56864496|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864497|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864498|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56864499|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
56864500|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864501|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864502|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56864503|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56864504|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56864505|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56864507|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
56864508|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
56864509|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
56864511|NCT01318096|Lamivudine|lamivudine|mesh-list
56864512|NCT01318096|Efavirenz|efavirenz|mesh-list
56864513|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
56864514|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
56864515|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864516|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56864517|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56864518|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864519|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864520|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56864521|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56864522|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56864523|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56864524|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56864525|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56864526|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56864527|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56864528|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56864529|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56864530|NCT02530320|Palbociclib|palbociclib|mesh-list
56864531|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864532|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864533|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864534|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864535|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56864536|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56864537|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56864539|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864540|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56864541|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56864542|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864543|NCT00238433|Melphalan|melphalan|mesh-list
56864544|NCT00238433|Busulfan|busulfan|mesh-list
56864545|NCT00238433|Thiotepa|thiotepa|mesh-list
56864546|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
56894851|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864547|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864548|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56864549|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
56864550|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864551|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864552|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56864553|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864554|NCT02532023|Curcumin|curcumin|mesh-list
56864555|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56864556|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56864557|NCT02532023|Analgesics|analgesics|mesh-ancestor
56864558|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
56864559|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864560|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864561|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864562|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864563|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864564|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864565|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864566|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
56864567|NCT01354522|Docetaxel|docetaxel|mesh-list
56864568|NCT01354522|Doxorubicin|doxorubicin|mesh-list
56864569|NCT01354522|Capecitabine|capecitabine|mesh-list
56864570|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864571|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
56864572|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864573|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864574|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56864575|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
56864576|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864577|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864578|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56864579|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
56864583|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56864584|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56864585|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864586|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56864587|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
56864588|NCT00045162|Irinotecan|irinotecan|mesh-list
56864589|NCT00045162|Etoposide|etoposide|mesh-list
56864590|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864591|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56864592|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56864593|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864594|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864595|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56864596|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56864597|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56864598|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56864599|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56864600|NCT00238121|Sorafenib|sorafenib|mesh-list
56864601|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864602|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864603|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864604|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864605|NCT01350622|Diclofenac|diclofenac|mesh-list
56864606|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
56864607|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56864608|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56864609|NCT01350622|Analgesics|analgesics|mesh-ancestor
56864610|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
56864611|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864612|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864613|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864614|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864615|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56864616|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864617|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864619|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56864620|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56864621|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
56864622|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
56864623|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864624|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864625|NCT03139240|Oxycodone|oxycodone|mesh-list
56864626|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56864627|NCT03139240|Narcotics|narcotics|mesh-ancestor
56864628|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864629|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864630|NCT03139240|Analgesics|analgesics|mesh-ancestor
56864631|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
56864632|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864633|NCT01350856|Artesunate|artesunate|mesh-list
56864634|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
56864635|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56864636|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56864637|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864638|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864639|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
56864640|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
56864641|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56864642|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
56864643|NCT03973775|Permethrin|permethrin|mesh-list
56864644|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864645|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864646|NCT01351168|Levodopa|levodopa|mesh-list
56864647|NCT01351168|Zolpidem|zolpidem|mesh-list
56864648|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56864649|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56864650|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
56864651|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864652|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864653|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864656|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864657|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56864658|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
56864659|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
56864660|NCT01351636|Arotinolol|arotinolol|mesh-list
56864661|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56864662|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56864663|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
56864664|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864665|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864666|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864667|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56864668|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56864669|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56864670|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
56864671|NCT03952260|Anesthetics|anesthetics|mesh-list
56864672|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864673|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864674|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56864675|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56864676|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
56864677|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864678|NCT01351948|Antacids|antacids|mesh-ancestor
56864679|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864680|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56864681|NCT01352026|Metformin|metformin|mesh-list
56864682|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56864683|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864684|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
56864685|NCT03136198|Diuretics|diuretics|mesh-list
56864686|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56864687|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
56864688|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864689|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56864690|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864691|NCT01357486|Sorafenib|sorafenib|mesh-list
56864692|NCT01357486|Pravastatin|pravastatin|mesh-list
56864693|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864694|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864695|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864696|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864697|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56864698|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56864699|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
56864700|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56864701|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56864702|NCT01318564|Metformin|metformin|mesh-list
56864703|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56864704|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864705|NCT00042432|Cinacalcet|cinacalcet|mesh-list
56864706|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56864707|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864708|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56864709|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
56864710|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56864711|NCT01352338|Prednisone|prednisone|mesh-list
56864712|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
56864713|NCT01352338|Lenalidomide|lenalidomide|mesh-list
56864714|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864715|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
56864716|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864717|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864718|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56864719|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
56864720|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864721|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864722|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56864723|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864724|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
56864725|NCT01352338|Hormones|hormones|mesh-ancestor
56864726|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56864727|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56864728|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56864729|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56864730|NCT01352338|Growth Substances|growth substances|mesh-ancestor
56864731|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
56864732|NCT01542736|Carboplatin|carboplatin|mesh-list
56864733|NCT01542736|Vincristine|vincristine|mesh-list
56864734|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864735|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56864736|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
56864737|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
56864738|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
56864739|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864740|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56864741|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56864742|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56864743|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56864744|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
56864745|NCT01481974|Treprostinil|treprostinil|mesh-list
56864746|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56864747|NCT01361542|Etanercept|etanercept|mesh-list
56864748|NCT01361542|Infliximab|infliximab|mesh-list
56864749|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
56864750|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56864751|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864752|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56864753|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56864754|NCT01361542|Analgesics|analgesics|mesh-ancestor
56864755|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
56864756|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864757|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864758|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864759|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575570|NCT04047706|Nivolumab|nivolumab|mesh-list
56864760|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
56864762|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56864763|NCT03950700|Bupivacaine|bupivacaine|mesh-list
56864764|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56864765|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
56864766|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
56864767|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864768|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864769|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
56864770|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864771|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56864772|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56864773|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
56864774|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864775|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864776|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56864777|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56864778|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
56864779|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56864780|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
56864781|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
56864782|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
56864783|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
56864784|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864785|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56864786|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864787|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864788|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
56864789|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56864790|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56864791|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56864792|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56864793|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864794|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
56864795|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864796|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864797|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56864798|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864799|NCT00003222|Aldesleukin|aldesleukin|mesh-list
56864801|NCT00003222|Sargramostim|sargramostim|mesh-list
56864802|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
56864803|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864804|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56864805|NCT00003222|Analgesics|analgesics|mesh-ancestor
56864806|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
56864807|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864808|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864809|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
56864810|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56864811|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56864812|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
56864813|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864814|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56864815|NCT01357876|Metformin|metformin|mesh-list
56864816|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56864817|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864818|NCT02877082|Bortezomib|bortezomib|mesh-list
56864819|NCT02877082|Tacrolimus|tacrolimus|mesh-list
56864820|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
56864821|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56864822|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864823|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
56864824|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864825|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56864826|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864827|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864828|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864829|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56864830|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56864831|NCT03951558|Diuretics|diuretics|mesh-ancestor
56864832|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
56864833|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864834|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56864835|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56864836|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864837|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56864838|NCT01362010|Minocycline|minocycline|mesh-list
56864839|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864840|NCT04775680|Antibodies|antibodies|mesh-list
56864841|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
56864842|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864843|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
56864844|NCT00003138|Lenograstim|lenograstim|mesh-list
56864845|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56864846|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
56864847|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864848|NCT00003138|Hematinics|hematinics|mesh-ancestor
56864849|NCT02875366|Ivacaftor|ivacaftor|mesh-list
56864850|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56864851|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56864852|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864853|NCT01362400|Docetaxel|docetaxel|mesh-list
56864854|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864855|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
56864856|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
56864857|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
56864858|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864859|NCT00003102|Antibodies|antibodies|mesh-list
56864860|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56864861|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
56864862|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864863|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
56864864|NCT00002850|Ofloxacin|ofloxacin|mesh-list
56864865|NCT00002850|Trimethoprim|trimethoprim|mesh-list
56864866|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
56864867|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56864868|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864869|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56864870|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56864871|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864872|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864873|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864874|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56864875|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56379381|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
56864876|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56864878|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
56864879|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56864880|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56864881|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56864882|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56864883|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56864884|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
56864885|NCT04234906|Amiodarone|amiodarone|mesh-list
56864886|NCT04234906|Procainamide|procainamide|mesh-list
56864887|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
56864888|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56864889|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56864890|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864891|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56864892|NCT04234906|Analgesics|analgesics|mesh-ancestor
56864893|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
56864894|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864895|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56864896|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56864897|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56864898|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
56864899|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864900|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864901|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
56864902|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56864903|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
56864904|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56864905|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56864906|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56864907|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
56864908|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56864909|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
56864910|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56864911|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56864912|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56864913|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56864914|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864915|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56864916|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56864917|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56864918|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56864919|NCT00002766|Cytarabine|cytarabine|mesh-list
56864920|NCT00002766|Dactinomycin|dactinomycin|mesh-list
56864921|NCT00002766|Prednisone|prednisone|mesh-list
56864922|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
56864923|NCT00002766|Carmustine|carmustine|mesh-list
56864924|NCT00002766|Doxorubicin|doxorubicin|mesh-list
56864925|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56864926|NCT00002766|Methotrexate|methotrexate|mesh-list
56864927|NCT00002766|Etoposide|etoposide|mesh-list
56864928|NCT00002766|Vincristine|vincristine|mesh-list
56864929|NCT00002766|Daunorubicin|daunorubicin|mesh-list
56864930|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
56864931|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
56864932|NCT00002766|Pegaspargase|pegaspargase|mesh-list
56864933|NCT00002766|Sargramostim|sargramostim|mesh-list
56864934|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56864935|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
56864936|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864937|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864938|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56864939|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
56864940|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864941|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56864942|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56864943|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56864944|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56864945|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56864946|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56864947|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864948|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
56864949|NCT00002766|Hormones|hormones|mesh-ancestor
56864950|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56864951|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56864952|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56864954|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56864955|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56864956|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
56864957|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
56864958|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56864959|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56864960|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56864961|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
56864962|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56864963|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
56864964|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
56864965|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
56864966|NCT00002766|Analgesics|analgesics|mesh-ancestor
56864967|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
56864968|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864969|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56864970|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56864971|NCT01355380|Iloprost|iloprost|mesh-list
56864972|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56864973|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
56864974|NCT01355614|Infliximab|infliximab|mesh-list
56864975|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
56864976|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56864977|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56864978|NCT01584492|Beclomethasone|beclomethasone|mesh-list
56864979|NCT01584492|Albuterol|albuterol|mesh-list
56864980|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
56864981|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56864982|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
56864983|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56864984|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56864985|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56864986|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
56864987|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56864988|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56864989|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56864990|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
56864991|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56864992|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56864993|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56864994|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
56864995|NCT01584492|Hormones|hormones|mesh-ancestor
56864996|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56864997|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
56864998|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56864999|NCT00001962|Daclizumab|daclizumab|mesh-list
56865000|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865001|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
56865002|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865003|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56865004|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56865005|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
56865006|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56865007|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
56865008|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865009|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
56865010|NCT01101984|Protective Agents|protective agents|mesh-ancestor
56865011|NCT01103154|Nadolol|nadolol|mesh-list
56865012|NCT01103154|Carvedilol|carvedilol|mesh-list
56865013|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56865014|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56865015|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
56865016|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56865017|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865018|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865019|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56865020|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
56865021|NCT01103154|Protective Agents|protective agents|mesh-ancestor
56865022|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56865023|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56865024|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56865025|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
56865026|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56865029|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
56865030|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
56865031|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865032|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56865033|NCT01100346|Hormones|hormones|mesh-ancestor
56865034|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865035|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865036|NCT01103388|Rituximab|rituximab|mesh-list
56865037|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56865038|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865039|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
56865040|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865041|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865042|NCT01327326|Naltrexone|naltrexone|mesh-list
56865043|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56865044|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56865045|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865046|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
56865047|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865048|NCT03950544|Meropenem|meropenem|mesh-list
56865049|NCT03950544|Fosfomycin|fosfomycin|mesh-list
56865050|NCT03950544|Tigecycline|tigecycline|mesh-list
56865051|NCT03950544|Polymyxins|polymyxins|mesh-list
56865052|NCT03950544|Polymyxin B|polymyxin b|mesh-list
56865053|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865054|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865055|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56865056|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865057|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865058|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
56865059|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865060|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56865061|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865062|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575877|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
56865063|NCT00256997|Risperidone|risperidone|mesh-list
56865064|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
56865065|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56865066|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
56865067|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56865068|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865069|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865070|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56865071|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865072|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56865073|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56865074|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
56865075|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
56865076|NCT00027846|Carboplatin|carboplatin|mesh-list
56865077|NCT00027846|Etoposide|etoposide|mesh-list
56865078|NCT00027846|Vincristine|vincristine|mesh-list
56865079|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
56865080|NCT00027846|Lenograstim|lenograstim|mesh-list
56865081|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865082|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
56865083|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865084|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865085|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56865086|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
56865087|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865088|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865089|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56865090|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56865091|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56865092|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865093|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865094|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56865095|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
56865096|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56865097|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
56865098|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
56865099|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
56865100|NCT00027378|Fluoxetine|fluoxetine|mesh-list
56865102|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56865103|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56865104|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865105|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56865106|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
56865107|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865108|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56865109|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
56865110|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56865111|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56865112|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56865113|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865114|NCT03950154|Bevacizumab|bevacizumab|mesh-list
56865115|NCT03950154|Capecitabine|capecitabine|mesh-list
56865116|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
56865117|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56865118|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865119|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56865120|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56865121|NCT03950154|Growth Substances|growth substances|mesh-ancestor
56865122|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865123|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
56865124|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56865125|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
56865126|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865127|NCT03949062|Rituximab|rituximab|mesh-list
56865128|NCT03949062|Lenalidomide|lenalidomide|mesh-list
56865129|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56865130|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865131|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
56865132|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865133|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865134|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56904011|NCT03559504|Sevoflurane|sevoflurane|mesh-list
56865135|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56865136|NCT03949062|Growth Substances|growth substances|mesh-ancestor
56865137|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
56865138|NCT00235391|Deferasirox|deferasirox|mesh-list
56865139|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56865140|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
56865141|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
56865142|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865143|NCT01103622|Digoxin|digoxin|mesh-list
56865144|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56865145|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56865146|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865147|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865148|NCT01103622|Protective Agents|protective agents|mesh-ancestor
56865149|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865150|NCT01072955|Heparin|heparin|mesh-list
56865151|NCT01072955|Calcium heparin|calcium heparin|mesh-list
56865152|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
56865153|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56865154|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56865155|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865156|NCT00026208|Prednisone|prednisone|mesh-list
56865157|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
56865158|NCT00026208|Doxorubicin|doxorubicin|mesh-list
56865159|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56865160|NCT00026208|Etoposide|etoposide|mesh-list
56865161|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
56865162|NCT00026208|Vincristine|vincristine|mesh-list
56865163|NCT00026208|Bleomycin|bleomycin|mesh-list
56865164|NCT00026208|Vinblastine|vinblastine|mesh-list
56865165|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865166|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
56865167|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865168|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865169|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56865170|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
56865171|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865172|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865173|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56865174|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56865176|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865177|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865178|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865179|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
56865180|NCT00026208|Hormones|hormones|mesh-ancestor
56865181|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865182|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56865183|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56865184|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
56865185|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
56865186|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
56865187|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
56865188|NCT02955290|Nivolumab|nivolumab|mesh-list
56865189|NCT02955290|Vaccines|vaccines|mesh-list
56865190|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56865191|NCT02955290|Mitogens|mitogens|mesh-list
56865192|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
56865193|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865194|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56865195|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865196|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56865197|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865198|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
56904015|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
56865199|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56865200|NCT00025662|Interleukin-2|interleukin-2|mesh-list
56865201|NCT00025662|Immunotoxins|immunotoxins|mesh-list
56865202|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865203|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56865204|NCT00025662|Analgesics|analgesics|mesh-ancestor
56865205|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
56865206|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865207|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865208|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
56865209|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
56865210|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56865211|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
56865212|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865213|NCT03759158|Expectorants|expectorants|mesh-ancestor
56576043|NCT02582008|Bupropion|bupropion|mesh-list
56865214|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
56865215|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56865216|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
56865217|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865218|NCT03759158|Protective Agents|protective agents|mesh-ancestor
56865219|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865220|NCT03759158|Antidotes|antidotes|mesh-ancestor
56865221|NCT02922764|Carboplatin|carboplatin|mesh-list
56865222|NCT02922764|Docetaxel|docetaxel|mesh-list
56865223|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
56865224|NCT02922764|Pemetrexed|pemetrexed|mesh-list
56865225|NCT02922764|Ipilimumab|ipilimumab|mesh-list
56865226|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865227|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
56865228|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
56865229|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
56865230|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865231|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56865232|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865233|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56865234|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56865235|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56865236|NCT00025506|Thalidomide|thalidomide|mesh-list
56865237|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865238|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
56865239|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865240|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
56865241|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865242|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865243|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56865244|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56865245|NCT00025506|Growth Substances|growth substances|mesh-ancestor
56865246|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
56865247|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865248|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
56865249|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865250|NCT03756272|Bupivacaine|bupivacaine|mesh-list
56865252|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
56865253|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865254|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865255|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
56865256|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865257|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56865258|NCT03756116|Epinephrine|epinephrine|mesh-list
56865259|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56865260|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56865261|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
56865262|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56865263|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865264|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865265|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56865266|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56865267|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
56865268|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865269|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56865270|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
56865271|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
56865272|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
56865273|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56865274|NCT00023712|Bortezomib|bortezomib|mesh-list
56865275|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865276|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56865277|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
56865278|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865279|NCT04640168|Remdesivir|remdesivir|mesh-list
56865280|NCT04640168|Dexamethasone|dexamethasone|mesh-list
56865281|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865282|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
56865283|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
56865284|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865285|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865286|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56865287|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
56865288|NCT04640168|Hormones|hormones|mesh-ancestor
56865289|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865290|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56865291|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865292|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
56865293|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865294|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
56865295|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865296|NCT00022698|Capecitabine|capecitabine|mesh-list
56865297|NCT00022698|Irinotecan|irinotecan|mesh-list
56865298|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56865299|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
56865300|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865301|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865302|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56865303|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865304|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865305|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
56865306|NCT03951402|Tapentadol|tapentadol|mesh-list
56865307|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56865308|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865309|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865310|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56865311|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865312|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865313|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865314|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865315|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56865316|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
56865317|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56865318|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865319|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56865320|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56865321|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56865322|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56865323|NCT03951402|Narcotics|narcotics|mesh-ancestor
56865324|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865326|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
56865327|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865328|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56865329|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56865330|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56865331|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56865332|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56865333|NCT01100736|Bosentan|bosentan|mesh-list
56865334|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
56865335|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56865336|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56865337|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865338|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
56865339|NCT01584726|Analgesics|analgesics|mesh-ancestor
56865340|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
56865341|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865342|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865343|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
56865344|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865345|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56865346|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
56865347|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56865348|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56865349|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865350|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56865351|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
56865352|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56865353|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
56865354|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
56865355|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
56865356|NCT01105494|Hematinics|hematinics|mesh-ancestor
56865357|NCT03949686|Bupivacaine|bupivacaine|mesh-list
56865358|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
56865359|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
56865360|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865361|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865362|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
56865363|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865364|NCT03949842|Fluticasone|fluticasone|mesh-list
56865365|NCT03949842|Xhance|xhance|mesh-list
56865366|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
56865367|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
56865368|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56865369|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865370|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56865372|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865373|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865374|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56865375|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
56865376|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
56865377|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56865378|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56865379|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865380|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56865381|NCT01102608|Ifosfamide|ifosfamide|mesh-list
56865382|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56865383|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
56865384|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865385|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865386|NCT01102686|Leucovorin|leucovorin|mesh-list
56865387|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
56865388|NCT01102686|Antidotes|antidotes|mesh-ancestor
56865389|NCT01102686|Protective Agents|protective agents|mesh-ancestor
56865390|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865391|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
56865392|NCT01102686|Vitamins|vitamins|mesh-ancestor
56865393|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
56865394|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
56865395|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56865396|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56865397|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865398|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56865399|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865400|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865402|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56865403|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56865404|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
56865405|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865406|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56865407|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56865408|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865409|NCT05626140|Diclofenac|diclofenac|mesh-list
56865410|NCT05626140|Lacosamide|lacosamide|mesh-list
56865411|NCT05626140|Codeine|codeine|mesh-list
56865412|NCT05626140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56865413|NCT05626140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56865414|NCT05626140|Analgesics|analgesics|mesh-ancestor
56865415|NCT05626140|Sensory System Agents|sensory system agents|mesh-ancestor
56865416|NCT05626140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865417|NCT05626140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865418|NCT05626140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865419|NCT05626140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865420|NCT05626140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56865421|NCT05626140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865422|NCT05626140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865423|NCT05626140|Anticonvulsants|anticonvulsants|mesh-ancestor
56865424|NCT05626140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56865425|NCT05626140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56865426|NCT05626140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56865427|NCT05626140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56865428|NCT05626140|Narcotics|narcotics|mesh-ancestor
56865429|NCT05626140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865430|NCT05626140|Antitussive Agents|antitussive agents|mesh-ancestor
56865431|NCT05626140|Respiratory System Agents|respiratory system agents|mesh-ancestor
56865432|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56865433|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56865434|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865435|NCT04813614|Lidocaine|lidocaine|mesh-list
56865436|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
56865437|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
56865438|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865439|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865440|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
56576254|NCT01131182|Metformin|metformin|mesh-list
56865441|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865442|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56865443|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56865444|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56865445|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56865446|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865447|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56865448|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
56865449|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56865450|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56865451|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865452|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865453|NCT01106118|Urological Agents|urological agents|mesh-ancestor
56865454|NCT00234065|Aspirin|aspirin|mesh-list
56865455|NCT00234065|Cilostazol|cilostazol|mesh-list
56865456|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56865457|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56865458|NCT00234065|Analgesics|analgesics|mesh-ancestor
56865459|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
56865460|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865461|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865462|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865463|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865464|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56865465|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56865466|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865467|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56865468|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56865469|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865470|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
56865471|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56865472|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
56865473|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56865474|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
56865475|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
56865476|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56865477|NCT00234065|Protective Agents|protective agents|mesh-ancestor
56865478|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56865479|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56865480|NCT01108848|Complement C1s|complement c1s|mesh-list
56865481|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56865482|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56865483|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
56865484|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865485|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56865486|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865487|NCT04660812|Bevacizumab|bevacizumab|mesh-list
56865488|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56865489|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865490|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56865491|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56865492|NCT04660812|Growth Substances|growth substances|mesh-ancestor
56865493|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865494|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
56865495|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
56865497|NCT00233987|Carmustine|carmustine|mesh-list
56865498|NCT00233987|Etoposide|etoposide|mesh-list
55895238|NCT00734877|Doxorubicin|doxorubicin|mesh-list
56865499|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865500|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
56865501|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865502|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865503|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56865504|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
56865505|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865506|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865507|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56865508|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56865509|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56865510|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865511|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865512|NCT01108926|Tenofovir|tenofovir|mesh-list
56865513|NCT01108926|Emtricitabine|emtricitabine|mesh-list
56865514|NCT01108926|Efavirenz|efavirenz|mesh-list
56865515|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56865517|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865518|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56865519|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56865520|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865521|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865522|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56865523|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56865524|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56865525|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56865526|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56865527|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56865528|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56865529|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56865530|NCT05321394|Ritonavir|ritonavir|mesh-list
56865531|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56865532|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56865533|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
56865534|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865535|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865536|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56865537|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56865538|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
56865539|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865540|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56865541|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56865542|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56865543|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
56865544|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865545|NCT00233363|Rebamipide|rebamipide|mesh-list
56380054|NCT00475969|Analgesics|analgesics|mesh-ancestor
56865547|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56865548|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
56865549|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865550|NCT00233363|Protective Agents|protective agents|mesh-ancestor
56865551|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865552|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865553|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
56865554|NCT01147666|Hematinics|hematinics|mesh-ancestor
56865555|NCT01073111|Sirolimus|sirolimus|mesh-list
56865556|NCT01073111|Everolimus|everolimus|mesh-list
56865557|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865558|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865559|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
56865560|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865561|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865562|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865563|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56865564|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
56865565|NCT01325987|Vitamin D|vitamin d|mesh-list
56865566|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
56865567|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
56865568|NCT01325987|Vitamins|vitamins|mesh-list
56865569|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
56865570|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865571|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56865572|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56865573|NCT00256295|Gemcitabine|gemcitabine|mesh-list
56865574|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
56865575|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56865576|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
56865577|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865578|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865579|NCT00256295|Antiviral Agents|antiviral agents|mesh-ancestor
56865580|NCT00256295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865581|NCT00256295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865582|NCT00256295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865583|NCT00256295|Immunologic Factors|immunologic factors|mesh-ancestor
56865584|NCT00256295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865585|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
56865586|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
56865587|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56865588|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56865589|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865590|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865591|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865592|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865593|NCT01109160|Azithromycin|azithromycin|mesh-list
56865594|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865595|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865596|NCT01363336|Nifedipine|nifedipine|mesh-list
56865597|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56865598|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56865599|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865600|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56865601|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865602|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
56865603|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
56865604|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56865605|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
56865606|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56865607|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
56865608|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865609|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
56865610|NCT01363414|Protective Agents|protective agents|mesh-ancestor
56865611|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
56865612|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56865613|NCT02223520|Mupirocin|mupirocin|mesh-list
56865614|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56865615|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865616|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
56865617|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
56865618|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865619|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56865620|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865621|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865624|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865625|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865626|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
56865627|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865628|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865629|NCT02122198|Leuprolide|leuprolide|mesh-list
56865630|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56865631|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
56865632|NCT02122198|Estradiol|estradiol|mesh-list
56865633|NCT02122198|Estrogens|estrogens|mesh-ancestor
56865634|NCT02122198|Hormones|hormones|mesh-ancestor
56865635|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865636|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865637|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56904035|NCT05459649|Cyclosporine|cyclosporine|mesh-list
56865638|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
56865639|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56865640|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56865641|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56865642|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
56865643|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56865644|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865645|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56865646|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56865647|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56865648|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56865649|NCT01363570|Ranibizumab|ranibizumab|mesh-list
56865650|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56865651|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56865652|NCT01363570|Growth Substances|growth substances|mesh-ancestor
56865653|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865654|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
56865655|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865656|NCT04608500|Minocycline|minocycline|mesh-list
56865657|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865658|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865659|NCT01363648|Choline|choline|mesh-list
56865660|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
56865661|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56865662|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
56865663|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576482|NCT01142726|Abatacept|abatacept|mesh-list
56865664|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56865665|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56865666|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
56865667|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
56865668|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865669|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865670|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56865671|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865672|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865673|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865674|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865675|NCT03944070|Ranibizumab|ranibizumab|mesh-list
56865676|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56865677|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56865678|NCT03944070|Growth Substances|growth substances|mesh-ancestor
56865679|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865680|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
56865681|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865682|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56865683|NCT03764462|AD 101|ad 101|mesh-list
56865684|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56865685|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
56865686|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865687|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865688|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56865689|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56865690|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56865691|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56865692|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865693|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56865694|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56865698|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56865699|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56865701|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
56865702|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865703|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865704|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865705|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865706|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56865707|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56865708|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865709|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56865710|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56865711|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865712|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
56865713|NCT01364194|Bupivacaine|bupivacaine|mesh-list
56865714|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
56865715|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
56865716|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865717|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865718|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
56865719|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865720|NCT04575038|Brequinar|brequinar|mesh-list
56865721|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865722|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865723|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865724|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865725|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
56865726|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865727|NCT03066622|Olanzapine|olanzapine|mesh-list
56865728|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
56865729|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
56865730|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865731|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865732|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56865733|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56865734|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56865735|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865736|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56865737|NCT03066622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56865738|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56865739|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56865740|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865741|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56865742|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
56865743|NCT01364974|Peficitinib|peficitinib|mesh-list
56865744|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865745|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865746|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865747|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
56865748|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865749|NCT05323214|Fentanyl|fentanyl|mesh-list
56865750|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
56865751|NCT05323214|Analgesics|analgesics|mesh-list
56865752|NCT05323214|Bupivacaine|bupivacaine|mesh-list
56865753|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
56865754|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
56865755|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56865756|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865757|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
56865758|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865759|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56865760|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56865761|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56865762|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56865763|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56865764|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
56865765|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904722|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865767|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56865768|NCT05323214|Narcotics|narcotics|mesh-ancestor
56865769|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56865770|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56865771|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
56865772|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
56865773|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56865774|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865775|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56865776|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865777|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865778|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865779|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865780|NCT05366816|Sunitinib|sunitinib|mesh-list
56865781|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865782|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56865783|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56865784|NCT05366816|Growth Substances|growth substances|mesh-ancestor
56865785|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865786|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
56865787|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56865788|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865789|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865790|NCT02060188|Nivolumab|nivolumab|mesh-list
56865791|NCT02060188|Ipilimumab|ipilimumab|mesh-list
56865792|NCT02060188|Daratumumab|daratumumab|mesh-list
56865793|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56865794|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865795|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56865796|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865797|NCT01356862|Pasireotide|pasireotide|mesh-list
56865798|NCT01356862|Hormones|hormones|mesh-ancestor
56865799|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865800|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865801|NCT03763760|Dexamethasone|dexamethasone|mesh-list
56865802|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865803|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
56865804|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
56865805|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865806|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865807|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56865808|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
56865809|NCT03763760|Hormones|hormones|mesh-ancestor
56865810|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865811|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56865812|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865813|NCT04501952|Remdesivir|remdesivir|mesh-list
56865814|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
56865815|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865816|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
56865817|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865818|NCT00321100|Bevacizumab|bevacizumab|mesh-list
56865820|NCT00321100|Capecitabine|capecitabine|mesh-list
56865821|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
56865822|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56865823|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865824|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56865825|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56865826|NCT00321100|Growth Substances|growth substances|mesh-ancestor
56865827|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865828|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
56865829|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56865830|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
56865831|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865832|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56865833|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865834|NCT01365598|Primaquine|primaquine|mesh-list
56865835|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
56865836|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56865837|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56865838|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865839|NCT01365676|Hypericin|hypericin|mesh-list
56568259|NCT01189604|Propofol|propofol|mesh-list
56865842|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865844|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865845|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865846|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865847|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865848|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
56865849|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865850|NCT03754712|Vitamin D|vitamin d|mesh-list
56865851|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
56865852|NCT03754712|Vitamins|vitamins|mesh-ancestor
56865853|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
56865854|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865855|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56865856|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56865857|NCT03754634|Diacetylrhein|diacetylrhein|mesh-list
56865858|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865859|NCT04498832|Vaccines|vaccines|mesh-list
56865860|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
56865861|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865862|NCT00070018|Prednisone|prednisone|mesh-list
56865863|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
56865864|NCT00070018|Rituximab|rituximab|mesh-list
56865865|NCT00070018|Doxorubicin|doxorubicin|mesh-list
56865866|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56865867|NCT00070018|Vincristine|vincristine|mesh-list
56865868|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56865869|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865870|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
56865871|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865872|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56865873|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56865874|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
56865875|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865876|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865877|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56865878|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56865879|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56865880|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56865881|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865882|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865883|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865884|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
56865885|NCT00070018|Hormones|hormones|mesh-ancestor
56865886|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865887|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56865888|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56865889|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56865890|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56865891|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56865892|NCT03991988|Montelukast|montelukast|mesh-list
56865893|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56865894|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
56865895|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56865896|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
56865897|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865898|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865899|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56865900|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56865901|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865902|NCT01073189|Fenoldopam|fenoldopam|mesh-list
56865903|NCT01073189|Furosemide|furosemide|mesh-list
56865904|NCT01073189|Diuretics|diuretics|mesh-ancestor
56865905|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
56865906|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865907|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56865908|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56865909|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865910|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56865911|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
56865913|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
56865914|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56865915|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
56865916|NCT03750656|Tamsulosin|tamsulosin|mesh-list
56865917|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56865918|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56865919|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56865920|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
56865921|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56865922|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865923|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865924|NCT03750656|Urological Agents|urological agents|mesh-ancestor
56865925|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56865926|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56865927|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56865928|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
56865929|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865930|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56865931|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
56865932|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
56865933|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
56865934|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56865935|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56865936|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
56865937|NCT00229931|Triamcinolone|triamcinolone|mesh-list
56865938|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56865939|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56865940|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56865941|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865942|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
56865943|NCT00229931|Hormones|hormones|mesh-ancestor
56865944|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865945|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865946|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865947|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
56865948|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865949|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865950|NCT03752294|Dabigatran|dabigatran|mesh-list
56865951|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
56865952|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56865953|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
56865954|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865955|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865956|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
56865957|NCT03135028|Cytarabine|cytarabine|mesh-list
56865958|NCT03135028|Daunorubicin|daunorubicin|mesh-list
56865959|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56865960|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
56865961|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865962|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865963|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
56865964|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56865965|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56865966|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
56865967|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865968|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56865969|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56865970|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865971|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865972|NCT03752138|Decitabine|decitabine|mesh-list
56865973|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56865974|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
56865975|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865976|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865977|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865978|NCT01370434|Dexamethasone|dexamethasone|mesh-list
56865979|NCT01370434|Doxorubicin|doxorubicin|mesh-list
56865980|NCT01370434|Vincristine|vincristine|mesh-list
56865981|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56865982|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
56865983|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
56865984|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56865985|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56865986|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56865988|NCT01370434|Hormones|hormones|mesh-ancestor
56865989|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56865990|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56865991|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56865992|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56865993|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56865994|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56865995|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56865996|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56865997|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56865998|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
56865999|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
56866000|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
56866001|NCT05190952|Dexamethasone|dexamethasone|mesh-list
56866002|NCT05190952|Ketamine|ketamine|mesh-list
56866003|NCT05190952|Bupivacaine|bupivacaine|mesh-list
56866004|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866005|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
56866006|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
56866007|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866008|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866009|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866010|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
56866011|NCT05190952|Hormones|hormones|mesh-ancestor
56866012|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866013|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56866014|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866015|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
56866016|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
56866017|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866018|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
56866019|NCT05190952|Analgesics|analgesics|mesh-ancestor
56866020|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56866021|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56866022|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
56866023|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56866024|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56866025|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866026|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866027|NCT03972683|Atropine|atropine|mesh-list
56866028|NCT03972683|Adenosine|adenosine|mesh-list
56866029|NCT03972683|Nitroprusside|nitroprusside|mesh-list
56866030|NCT03972683|Phenylephrine|phenylephrine|mesh-list
56866031|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
56866032|NCT03972683|Acetylcholine|acetylcholine|mesh-list
56866033|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56866034|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
56866035|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
56866036|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866037|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866038|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
56866039|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56866040|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
56866041|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
56866042|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56866043|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56866044|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56866045|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
56866046|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866047|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866048|NCT03972683|Protective Agents|protective agents|mesh-ancestor
56866049|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56866050|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56866051|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56866052|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56866053|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
56866054|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56866055|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56866056|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
56866057|NCT03972683|Analgesics|analgesics|mesh-ancestor
56866058|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
56866059|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
56866060|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56866061|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
56866063|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56866064|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56866065|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56866066|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
56866067|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
56866068|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866069|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
56866070|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56866071|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
56866072|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866073|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
56866074|NCT03754010|Protective Agents|protective agents|mesh-ancestor
56866075|NCT00227591|Prednisone|prednisone|mesh-list
56866076|NCT00227591|Lenalidomide|lenalidomide|mesh-list
56866077|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866078|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
56866079|NCT00227591|Hormones|hormones|mesh-ancestor
56866080|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866081|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866082|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56866083|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866084|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
56866085|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56866086|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56866087|NCT00227591|Growth Substances|growth substances|mesh-ancestor
56866088|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
56866089|NCT01358344|Pantoprazole|pantoprazole|mesh-list
56866090|NCT01358344|Vorapaxar|vorapaxar|mesh-list
56866091|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56866092|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866093|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56866094|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866095|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866096|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56866097|NCT01366300|Lidocaine|lidocaine|mesh-list
56866098|NCT01366300|Propofol|propofol|mesh-list
56866099|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
56866100|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
56866101|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866102|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866103|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
56866104|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866105|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56866106|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56866107|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56866108|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866109|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866110|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56866111|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56866112|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
56866113|NCT00226811|Sunitinib|sunitinib|mesh-list
56866114|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866115|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56866116|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56866117|NCT00226811|Growth Substances|growth substances|mesh-ancestor
56866118|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866119|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
56866120|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56866121|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866122|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866123|NCT02951052|Rilpivirine|rilpivirine|mesh-list
56866124|NCT02951052|Cabotegravir|cabotegravir|mesh-list
56866125|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56866126|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56866127|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866128|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866129|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
56866130|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866131|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56866132|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56866133|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56866134|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56866135|NCT03936218|Goserelin|goserelin|mesh-list
56866136|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56866138|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
56866139|NCT05261516|Analgesics|analgesics|mesh-ancestor
56866140|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
56866141|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866142|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866143|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
56866144|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866145|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56866146|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
56866147|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56866148|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866149|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866150|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56866151|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
56866152|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56866153|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
56866154|NCT00226655|Hormones|hormones|mesh-ancestor
56866155|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866156|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866157|NCT03691376|Aldesleukin|aldesleukin|mesh-list
56866158|NCT03691376|Melphalan|melphalan|mesh-list
56866159|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
56866160|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56866161|NCT03691376|Interleukin-2|interleukin-2|mesh-list
56866162|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56866163|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
56866164|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866165|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866166|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56866167|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56866168|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
56866169|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866170|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56866171|NCT03691376|Analgesics|analgesics|mesh-ancestor
56866172|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
56866173|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866174|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56866175|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56866176|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
56866177|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866178|NCT01371058|Clopidogrel|clopidogrel|mesh-list
56866179|NCT01371058|Policosanol|policosanol|mesh-list
56866180|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56866181|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56866182|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56866183|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56866184|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
56866185|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866186|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866187|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866188|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56866189|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56866190|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
56866191|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56866192|NCT01105338|Lycopene|lycopene|mesh-list
56866193|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866194|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
56866195|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866196|NCT01105338|Protective Agents|protective agents|mesh-ancestor
56866197|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866198|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56866199|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56866200|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866201|NCT03747614|Fluorometholone|fluorometholone|mesh-list
56866202|NCT03747614|Tacrolimus|tacrolimus|mesh-list
56866203|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56866204|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
56866205|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866206|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56866207|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866208|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866209|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866212|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866213|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56866215|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866216|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56866217|NCT05347004|BI 425809|bi 425809|mesh-list
56866218|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
56866219|NCT05171166|Leucovorin|leucovorin|mesh-list
56866220|NCT05171166|Fluorouracil|fluorouracil|mesh-list
56866221|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
56866222|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
56866223|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
56866224|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866225|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56866226|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866227|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56866228|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
56866229|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866230|NCT05171166|Antidotes|antidotes|mesh-ancestor
56866231|NCT05171166|Protective Agents|protective agents|mesh-ancestor
56866232|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
56866233|NCT05171166|Vitamins|vitamins|mesh-ancestor
56866234|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
56866235|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56866236|NCT05171166|Estrogens|estrogens|mesh-ancestor
56866237|NCT05171166|Hormones|hormones|mesh-ancestor
56866238|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866239|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56866240|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56866241|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56866242|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
56866243|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866244|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866245|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
56866246|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866247|NCT05190562|Astringents|astringents|mesh-ancestor
56866248|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
56866249|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
56866250|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56866251|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866252|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
56866253|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866254|NCT03747536|Bromides|bromides|mesh-list
56866255|NCT03747536|Ipratropium|ipratropium|mesh-list
56866256|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
56866257|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56866258|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
56866259|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866260|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866261|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56866262|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
56866263|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56866264|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
56866265|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866266|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577063|NCT01126580|Metformin|metformin|mesh-list
56866267|NCT04734080|Dronabinol|dronabinol|mesh-list
56866268|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
56866269|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866270|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56866271|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56866272|NCT04734080|Analgesics|analgesics|mesh-ancestor
56866273|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
56866274|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866275|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56866276|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56866277|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866278|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866279|NCT04734080|Hormones|hormones|mesh-ancestor
56866280|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866281|NCT01358500|Fentanyl|fentanyl|mesh-list
56866282|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56866283|NCT01358500|Narcotics|narcotics|mesh-ancestor
56866285|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866287|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
56866288|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866289|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56866290|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56866291|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
56866292|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
56866293|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
56866294|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
56866295|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866296|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866297|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866298|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
56866299|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
56866300|NCT01208766|Dexamethasone|dexamethasone|mesh-list
56866301|NCT01208766|Prednisone|prednisone|mesh-list
56866302|NCT01208766|Lenalidomide|lenalidomide|mesh-list
56866303|NCT01208766|Bortezomib|bortezomib|mesh-list
56866304|NCT01208766|Melphalan|melphalan|mesh-list
56470936|NCT00509184|Rituximab|rituximab|mesh-list
56866305|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866306|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
56866307|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
56866308|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866309|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866310|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866311|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
56866312|NCT01208766|Hormones|hormones|mesh-ancestor
56866313|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866314|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56866315|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866316|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
56866317|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56866318|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56866319|NCT01208766|Growth Substances|growth substances|mesh-ancestor
56866320|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
56866321|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56866322|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
56866323|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866324|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56866325|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56866326|NCT03751514|Azithromycin|azithromycin|mesh-list
56866327|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56866328|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866329|NCT03615664|Gemcitabine|gemcitabine|mesh-list
56866330|NCT03615664|Dexamethasone|dexamethasone|mesh-list
56866331|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56866332|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866333|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
56866334|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
56866335|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866336|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866337|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866338|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
56866339|NCT03615664|Hormones|hormones|mesh-ancestor
56866340|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866341|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56866342|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866343|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56866344|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
56866345|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866346|NCT03615664|Antiviral Agents|antiviral agents|mesh-ancestor
56866347|NCT03615664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866348|NCT03615664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866349|NCT03615664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56866350|NCT03615664|Immunologic Factors|immunologic factors|mesh-ancestor
56866351|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56866352|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
56866353|NCT03513250|Scopolamine|scopolamine|mesh-list
56866354|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56866355|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56866356|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
56866357|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
56568267|NCT02697058|Leucovorin|leucovorin|mesh-list
56866358|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866359|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866360|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866362|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56866363|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
56866364|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866365|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866366|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56866367|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
56866368|NCT01358812|Panitumumab|panitumumab|mesh-list
56866369|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56866370|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866371|NCT01107522|Temozolomide|temozolomide|mesh-list
56866372|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56866373|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
56866374|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866375|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866376|NCT01371448|Paroxetine|paroxetine|mesh-list
56866377|NCT01371448|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56866378|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56866379|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866380|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866381|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866382|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
56866383|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866384|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56866385|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
56866386|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56866387|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56866388|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56866389|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866390|NCT01371526|Cosyntropin|cosyntropin|mesh-list
56866391|NCT01371526|Hormones|hormones|mesh-ancestor
56866392|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866393|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866394|NCT03943992|Esomeprazole|esomeprazole|mesh-list
56866395|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56866396|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866397|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56866398|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866399|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866400|NCT01371604|Ribavirin|ribavirin|mesh-list
56866401|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56866402|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
56866403|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866404|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
56866405|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866406|NCT01371682|Ropinirole|ropinirole|mesh-list
56866407|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56866408|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56866409|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
56866410|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
56866411|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866412|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866413|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866414|NCT01107756|Lenograstim|lenograstim|mesh-list
56866415|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56866416|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
56866417|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866418|NCT03127384|Lidocaine|lidocaine|mesh-list
56866419|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
56866420|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
56866421|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866422|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866423|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
56866424|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866425|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56866426|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56866427|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56866428|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866429|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866430|NCT01111656|Interferons|interferons|mesh-list
56866431|NCT01111656|Interferon-beta|interferon-beta|mesh-list
56866432|NCT01111656|Atorvastatin|atorvastatin|mesh-list
56866433|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
56866434|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866435|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
56866436|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866437|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56866438|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56866439|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
56866440|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866441|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56866442|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56866443|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866444|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
56866445|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866446|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56866447|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
56866448|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56866449|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866451|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56866452|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56866453|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
56866454|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866455|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866456|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866457|NCT02523274|Resveratrol|resveratrol|mesh-list
56866458|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
56866459|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866460|NCT02523274|Protective Agents|protective agents|mesh-ancestor
56866461|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866462|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866463|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56866464|NCT02432560|Sirolimus|sirolimus|mesh-list
56866465|NCT02432560|Everolimus|everolimus|mesh-list
56866466|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866467|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56866468|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
56866469|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866470|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56866471|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866472|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56866473|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
56866474|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
56866475|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56866476|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866477|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
56866478|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866479|NCT01111734|Expectorants|expectorants|mesh-ancestor
56866480|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
56866481|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56866482|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
56866483|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866484|NCT01111734|Protective Agents|protective agents|mesh-ancestor
56866485|NCT01111734|Antidotes|antidotes|mesh-ancestor
56866486|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56866487|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56866488|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56866489|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866490|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866491|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56866492|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866493|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866494|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
56866495|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866496|NCT01111890|Timolol|timolol|mesh-list
56866497|NCT01111890|Dorzolamide|dorzolamide|mesh-list
56866498|NCT01111890|Brinzolamide|brinzolamide|mesh-list
56866499|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56866500|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56866501|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
56866502|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866503|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866504|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866507|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56866508|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866510|NCT00745134|Capecitabine|capecitabine|mesh-list
56866511|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56866512|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
56866513|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866514|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866515|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56866516|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56866517|NCT00745134|Analgesics|analgesics|mesh-ancestor
56866518|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
56866519|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866520|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866521|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866522|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56866523|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866524|NCT01111968|Vaccines|vaccines|mesh-list
56866525|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
56866526|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866527|NCT04398134|Entecavir|entecavir|mesh-list
56866528|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
56866529|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866530|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
56866531|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56866532|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866533|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56866534|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56866535|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866536|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866537|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866538|NCT04253262|Rucaparib|rucaparib|mesh-list
56866539|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56866540|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866541|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866542|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866543|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
56866544|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56866545|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56866546|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56866547|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866548|NCT01108302|Oxytocin|oxytocin|mesh-list
56866549|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
56866550|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56866551|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866552|NCT03122860|Lorecivivint|lorecivivint|mesh-list
56866553|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866554|NCT01319188|Ranibizumab|ranibizumab|mesh-list
56866555|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56866556|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56866557|NCT01319188|Growth Substances|growth substances|mesh-ancestor
56866558|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866559|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
56866560|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866561|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
56866562|NCT05167084|Metyrapone|metyrapone|mesh-list
56866563|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866564|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
56866565|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866566|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866567|NCT00867178|Vitamin A|vitamin a|mesh-list
56866568|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
56866569|NCT00867178|Thiotepa|thiotepa|mesh-list
56866570|NCT00867178|Cisplatin|cisplatin|mesh-list
56866571|NCT00867178|Carboplatin|carboplatin|mesh-list
56866572|NCT00867178|Etoposide|etoposide|mesh-list
56866573|NCT00867178|Vincristine|vincristine|mesh-list
56866574|NCT00867178|Vorinostat|vorinostat|mesh-list
56866575|NCT00867178|Tretinoin|tretinoin|mesh-list
56866576|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
56866577|NCT00867178|Isotretinoin|isotretinoin|mesh-list
56866578|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56866579|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
56866580|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866582|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56866583|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
56866584|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866585|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866586|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56866587|NCT00867178|Vitamins|vitamins|mesh-ancestor
56866588|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
56866589|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56866590|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56866591|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56866592|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866593|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
56866594|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
56866595|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
56866596|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56866597|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
56866598|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56866599|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
56866600|NCT03945396|Antacids|antacids|mesh-ancestor
56866601|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866602|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866603|NCT01109784|Clopidogrel|clopidogrel|mesh-list
56866604|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56866605|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56866606|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56866607|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56866608|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56866609|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
56866610|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866611|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866612|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866613|NCT01328340|Methamphetamine|methamphetamine|mesh-list
56866614|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56866615|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866616|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
56866617|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
56866618|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866619|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
56866620|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866621|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866622|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
56866623|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56866624|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56866625|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866626|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56866627|NCT03796728|Lidocaine|lidocaine|mesh-list
56866628|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
56866629|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
56866630|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866631|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866632|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
56866633|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866634|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56866635|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56866636|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56866637|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866638|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866639|NCT00352534|Dactinomycin|dactinomycin|mesh-list
56866640|NCT00352534|Cactinomycin|cactinomycin|mesh-list
56866641|NCT00352534|Doxorubicin|doxorubicin|mesh-list
56866642|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56866643|NCT00352534|Vincristine|vincristine|mesh-list
56866644|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56866645|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866646|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56866647|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56866648|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866649|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866650|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56866651|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
56866652|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
56866654|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56866655|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866656|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56866657|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56866659|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866660|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56866661|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866662|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866664|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56866665|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866666|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
56866667|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56866668|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866669|NCT03749642|Gabapentin|gabapentin|mesh-list
56866670|NCT03749642|Trazodone|trazodone|mesh-list
56866671|NCT03749642|Analgesics|analgesics|mesh-ancestor
56866672|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
56866673|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866674|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866675|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
56866676|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56866677|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56866678|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866679|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56866680|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56866681|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56866682|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866683|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866684|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
56866685|NCT03749642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56866686|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56866687|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866688|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
56866689|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56866690|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
56866691|NCT03751358|Anesthetics|anesthetics|mesh-list
56866692|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
56866693|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866694|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866695|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
56866696|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866697|NCT04097028|Trifluridine|trifluridine|mesh-list
56866698|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
56866699|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866700|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
56866701|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866702|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
56866703|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866704|NCT05193292|Trastuzumab|trastuzumab|mesh-list
56866705|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56866706|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866707|NCT05193214|Antibodies|antibodies|mesh-list
56866708|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56866709|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
56866710|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866711|NCT02529774|Leucovorin|leucovorin|mesh-list
56866712|NCT02529774|Dexamethasone|dexamethasone|mesh-list
56866713|NCT02529774|Capecitabine|capecitabine|mesh-list
56866714|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
56866715|NCT02529774|Fluorouracil|fluorouracil|mesh-list
56866716|NCT02529774|Floxuridine|floxuridine|mesh-list
56866717|NCT02529774|Heparin|heparin|mesh-list
56866718|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
56866719|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866720|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
56866721|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
56866722|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866723|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866724|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866725|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
56866726|NCT02529774|Hormones|hormones|mesh-ancestor
56866727|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904723|NCT00191477|Antiviral Agents|antiviral agents|mesh-ancestor
56866730|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56866731|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
56866732|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866733|NCT02529774|Antidotes|antidotes|mesh-ancestor
56866734|NCT02529774|Protective Agents|protective agents|mesh-ancestor
56866735|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
56866736|NCT02529774|Vitamins|vitamins|mesh-ancestor
56866737|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
56866738|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56866739|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
56866740|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
56866741|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56866742|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56866743|NCT04459598|Efavirenz|efavirenz|mesh-list
56866744|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56866745|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56866746|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866747|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866748|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
56866749|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866750|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56866751|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56866752|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56866753|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56866754|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56866755|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56866756|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
56866757|NCT03942354|Linezolid|linezolid|mesh-list
56866758|NCT03942354|Bedaquiline|bedaquiline|mesh-list
56866759|NCT03942354|Clofazimine|clofazimine|mesh-list
56866760|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56866761|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866762|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56866763|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56866764|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866765|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866766|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866767|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56866768|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
56866769|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866770|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
56866771|NCT05165992|Fentanyl|fentanyl|mesh-list
56866772|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56866773|NCT05165992|Narcotics|narcotics|mesh-ancestor
56866774|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866775|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866776|NCT05165992|Analgesics|analgesics|mesh-ancestor
56866777|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
56866778|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866779|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56866780|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56866781|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
56866782|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
56866783|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56866784|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
56866785|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56866786|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866787|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
56866788|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866789|NCT01367626|Letrozole|letrozole|mesh-list
56866790|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866791|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56866792|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56866793|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866794|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866795|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56866796|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
56866797|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866798|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866799|NCT01112748|Lidocaine|lidocaine|mesh-list
56866800|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
56866802|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866803|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866805|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866806|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56866807|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56866808|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56866809|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866810|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866811|NCT05192902|Anesthetics|anesthetics|mesh-list
56866812|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866813|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866814|NCT01211808|Diltiazem|diltiazem|mesh-list
56866815|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56866816|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56866817|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866818|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866819|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56866820|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866821|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
56866822|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56866823|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56866824|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56866825|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
56866826|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56866827|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866828|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56866829|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56866830|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56866831|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56866832|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56866833|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56866834|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56866835|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56866836|NCT05191888|Amoxicillin|amoxicillin|mesh-list
56866837|NCT05191888|Metronidazole|metronidazole|mesh-list
56866838|NCT05191888|Clarithromycin|clarithromycin|mesh-list
56866839|NCT05191888|Rabeprazole|rabeprazole|mesh-list
56866840|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56866841|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866842|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56866843|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56866844|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56866845|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866846|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866847|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56866848|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56866849|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56866850|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866851|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56866852|NCT01112826|Capecitabine|capecitabine|mesh-list
56866853|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56866854|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
56866855|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866856|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866857|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
56866858|NCT01210014|Astringents|astringents|mesh-ancestor
56866859|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866860|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
56866861|NCT05118256|Pirfenidone|pirfenidone|mesh-list
56866862|NCT05118256|Analgesics|analgesics|mesh-ancestor
56866863|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
56866864|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866865|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866866|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56866867|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56866868|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866869|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56866870|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866883|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866884|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866886|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56866887|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56866888|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866889|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56866890|NCT03941886|Aspirin|aspirin|mesh-list
56866891|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56866892|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56866893|NCT03941886|Analgesics|analgesics|mesh-ancestor
56866894|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
56866895|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866896|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866897|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866898|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56866899|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56866900|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56866901|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866902|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56866903|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56866904|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866905|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
56866906|NCT01359436|Antibodies|antibodies|mesh-list
56866907|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
56866908|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866909|NCT01359514|Pregabalin|pregabalin|mesh-list
56866910|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
56866911|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56866912|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56866913|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866914|NCT01359514|Analgesics|analgesics|mesh-ancestor
56866915|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
56866916|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866917|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
56866918|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56866919|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866920|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56866921|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56866922|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56866923|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56866924|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56866925|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56866926|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866927|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
56866928|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
56866929|NCT01368016|Nicotine|nicotine|mesh-list
56866930|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56866931|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
56866932|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866935|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56866936|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
56866937|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56866938|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866939|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
56866940|NCT03634852|Dexamethasone|dexamethasone|mesh-list
56866942|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56866943|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56866944|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56866945|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56866946|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56866947|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56866948|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
56866949|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
56866950|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56866951|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866952|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56866953|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
56866954|NCT03634852|Hormones|hormones|mesh-ancestor
56866955|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56866956|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56866957|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866958|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56866959|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56866960|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56866961|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56866962|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866963|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866964|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56866965|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
56866966|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56866967|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56866968|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56866969|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56866970|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56866971|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
56866972|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56866973|NCT01208454|Vitamin A|vitamin a|mesh-list
56866974|NCT01208454|Vorinostat|vorinostat|mesh-list
56866975|NCT01208454|Tretinoin|tretinoin|mesh-list
56866976|NCT01208454|Isotretinoin|isotretinoin|mesh-list
56866977|NCT01208454|Vitamins|vitamins|mesh-ancestor
56866978|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
56866979|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56866980|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866981|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56866982|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866983|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866984|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
56866985|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
56866986|NCT01110486|Carboplatin|carboplatin|mesh-list
56866987|NCT01110486|Docetaxel|docetaxel|mesh-list
56866988|NCT01110486|Ilorasertib|ilorasertib|mesh-list
56866989|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56866990|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
56866991|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
56866992|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
56866993|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56866994|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56866995|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866996|NCT01372306|Galantamine|galantamine|mesh-list
56866997|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56866998|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56866999|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867000|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
56867001|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867002|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867003|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56867004|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
56867005|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867006|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
56867007|NCT01114854|Topiramate|topiramate|mesh-list
56867010|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867011|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
56867012|NCT01359670|Tadalafil|tadalafil|mesh-list
56867013|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867014|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56867015|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56867016|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867017|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867018|NCT01359670|Urological Agents|urological agents|mesh-ancestor
56867019|NCT05188768|Mitogens|mitogens|mesh-list
56867020|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
56867021|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867022|NCT01368328|Chromium|chromium|mesh-list
56867023|NCT01368328|Niacin|niacin|mesh-list
56867024|NCT01368328|Trace Elements|trace elements|mesh-ancestor
56867025|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
56867026|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867027|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56867028|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
56867029|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867030|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56867031|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867032|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
56867033|NCT01368328|Vitamins|vitamins|mesh-ancestor
56867034|NCT01110642|Lovastatin|lovastatin|mesh-list
56867035|NCT01110642|L 647318|l 647318|mesh-list
56867036|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
56867037|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56867038|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56867039|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
56867040|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867041|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56867042|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56867043|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867044|NCT02929498|Azacitidine|azacitidine|mesh-list
56867045|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56867046|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
56867047|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867048|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867049|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867050|NCT01359826|Milnacipran|milnacipran|mesh-list
56867051|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
56867052|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56867053|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56867054|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867055|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867056|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867057|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867058|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56867059|NCT01359826|Analgesics|analgesics|mesh-ancestor
56867060|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
56867061|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867062|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
56867063|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56867064|NCT03792672|Ketamine|ketamine|mesh-list
56867065|NCT03792672|Analgesics|analgesics|mesh-ancestor
56867066|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
56867067|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867068|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867069|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56867070|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56867071|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
56867072|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
56867073|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867074|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56867075|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56867076|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867077|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867078|NCT01372540|Filanesib|filanesib|mesh-list
56867079|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
56867080|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
56568293|NCT01008696|Rabeprazole|rabeprazole|mesh-list
56867081|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867082|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867083|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
56867084|NCT01113138|Analgesics|analgesics|mesh-ancestor
56867085|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
56867086|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867087|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867088|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
56867089|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867090|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56867091|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
56867092|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56867093|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867094|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867095|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56867097|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56867098|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
56867100|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
56867101|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
56867102|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
56867103|NCT01115322|Vitamins|vitamins|mesh-ancestor
56867104|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
56867105|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867106|NCT01111188|Bortezomib|bortezomib|mesh-list
56867107|NCT01111188|Palbociclib|palbociclib|mesh-list
56867108|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867109|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56867110|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867111|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867112|NCT01210482|Sirolimus|sirolimus|mesh-list
56867113|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56867114|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867115|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56867116|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867117|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
56867118|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56867119|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
56867120|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867121|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
56867122|NCT01360060|Analgesics|analgesics|mesh-ancestor
56867123|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
56867124|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867125|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867126|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
56867127|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867128|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56867129|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
56867130|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56867131|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867132|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867133|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56867134|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
56867135|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56867136|NCT01210638|Oxymorphone|oxymorphone|mesh-list
56867137|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56867138|NCT01210638|Narcotics|narcotics|mesh-ancestor
56867139|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867140|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867141|NCT01210638|Analgesics|analgesics|mesh-ancestor
56867142|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
56867143|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867144|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56867145|NCT03120676|Atezolizumab|atezolizumab|mesh-list
56867146|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867147|NCT01115478|Vitamin A|vitamin a|mesh-list
56867148|NCT01115478|Vitamins|vitamins|mesh-ancestor
56867149|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
56867150|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867151|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
56867152|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56867153|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
56867154|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867155|NCT01111422|Expectorants|expectorants|mesh-ancestor
56867156|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56867157|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56867159|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867160|NCT01111422|Protective Agents|protective agents|mesh-ancestor
56867161|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867162|NCT01111422|Antidotes|antidotes|mesh-ancestor
56867164|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56867165|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867166|NCT01213368|Dronedarone|dronedarone|mesh-list
56867167|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56867168|NCT01369186|Morphine|morphine|mesh-list
56867169|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56867170|NCT01369186|Narcotics|narcotics|mesh-ancestor
56867171|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867172|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867173|NCT01369186|Analgesics|analgesics|mesh-ancestor
56867174|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
56867175|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867176|NCT01115712|Pioglitazone|pioglitazone|mesh-list
56867177|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56867178|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867179|NCT01117662|Rituximab|rituximab|mesh-list
56867180|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56867181|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867182|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
56867183|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867184|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56867185|NCT01319266|Hydrocodone|hydrocodone|mesh-list
56867186|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56867187|NCT01319266|Narcotics|narcotics|mesh-ancestor
56867188|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867189|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867190|NCT01319266|Analgesics|analgesics|mesh-ancestor
56867191|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
56867192|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867193|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
56867194|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
56867195|NCT01115946|Enalapril|enalapril|mesh-list
56867196|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56867197|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
56867198|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867199|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867200|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56867201|NCT01113372|Clopidogrel|clopidogrel|mesh-list
56867202|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56867203|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56867204|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56867205|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56867206|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
56867207|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867208|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867209|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867210|NCT03120520|Plecanatide|plecanatide|mesh-list
56867211|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56867212|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
56867213|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867214|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56867215|NCT03941340|Aflutinib|aflutinib|mesh-list
56867216|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56867217|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867218|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867219|NCT01372930|Etanercept|etanercept|mesh-list
56867220|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56867221|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56867222|NCT01372930|Analgesics|analgesics|mesh-ancestor
56867223|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
56867224|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867225|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867226|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56867227|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56867228|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56867229|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56867230|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
56867231|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
56867233|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56867234|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867235|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867236|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56867237|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56867238|NCT01373008|Beclomethasone|beclomethasone|mesh-list
56867239|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56867240|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
56867241|NCT01373008|Hormones|hormones|mesh-ancestor
56920217|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56578034|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56867242|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867243|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867244|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56867245|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
56867246|NCT01116180|Candesartan|candesartan|mesh-list
56867247|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
56867248|NCT01116180|Giapreza|giapreza|mesh-list
56867249|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56867250|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
56867251|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56867252|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56867253|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867254|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56867255|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56867256|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
56867257|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867258|NCT05067166|Ansuvimab|ansuvimab|mesh-list
56867259|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
56867260|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867261|NCT01113528|Aspirin|aspirin|mesh-list
56867262|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56867263|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56867264|NCT01113528|Analgesics|analgesics|mesh-ancestor
56867265|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
56867266|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867267|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867268|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56867269|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56867270|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56867271|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56867272|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867273|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56867274|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56867275|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867276|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
56867277|NCT01369576|Zopiclone|zopiclone|mesh-list
56867278|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56867279|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867280|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867281|NCT01113762|Cimetidine|cimetidine|mesh-list
56867282|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56867283|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56867284|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56867285|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
56867286|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
56867287|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867288|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867289|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867290|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56867291|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56867292|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867293|NCT01212666|Ropivacaine|ropivacaine|mesh-list
56867294|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
56867295|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
56867296|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867297|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867298|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
56867299|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867300|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56867301|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867302|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56867303|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867305|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56867306|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
56867307|NCT01213680|Hematinics|hematinics|mesh-ancestor
56867308|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
56867309|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56867310|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867311|NCT01211496|Methamphetamine|methamphetamine|mesh-list
56867312|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56867313|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867314|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
56867315|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
56867316|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867317|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
56867318|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867319|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867320|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
56867321|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56867322|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56867323|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867324|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56867325|NCT01118286|Nifedipine|nifedipine|mesh-list
56867326|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56867327|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867328|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867329|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56867330|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867331|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867332|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
56867333|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56867334|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56867335|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
56867336|NCT01585350|Poly ICLC|poly iclc|mesh-list
56867337|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56867338|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
56867339|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867340|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
56867341|NCT03936036|Linagliptin|linagliptin|mesh-list
56867342|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56867343|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867344|NCT03936036|Incretins|incretins|mesh-ancestor
56867345|NCT03936036|Hormones|hormones|mesh-ancestor
56867346|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867347|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56867348|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
56867349|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867350|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867351|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
56867352|NCT01118598|Niacin|niacin|mesh-list
56867353|NCT01118598|Niacinamide|niacinamide|mesh-list
56867354|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
56867355|NCT01118598|Vitamins|vitamins|mesh-ancestor
56867356|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
56867357|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867358|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56867359|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
56867360|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867361|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56867362|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867363|NCT01216020|Cisplatin|cisplatin|mesh-list
56867364|NCT01216020|Cetuximab|cetuximab|mesh-list
56867365|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867366|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56867367|NCT01121796|Vitamin D|vitamin d|mesh-list
56867368|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
56867369|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
56867370|NCT01121796|Vitamins|vitamins|mesh-list
56867371|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
56867372|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867373|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56867374|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56867375|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56867376|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
56867377|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867379|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56867380|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867381|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
56867382|NCT01119144|Calcium|calcium|mesh-list
56867383|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56867384|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867385|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56867386|NCT01117038|Amlodipine|amlodipine|mesh-list
56867387|NCT01117038|Enalapril|enalapril|mesh-list
56867388|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56867389|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56578184|NCT00680602|Sertraline|sertraline|mesh-list
56867390|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867391|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867392|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56867393|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867394|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867395|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56867396|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
56867397|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867398|NCT01119534|Camphor|camphor|mesh-list
56867399|NCT01119534|Eucalyptol|eucalyptol|mesh-list
56867400|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
56867401|NCT01119534|Menthol|menthol|mesh-list
56867402|NCT01119534|Guaifenesin|guaifenesin|mesh-list
56867403|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56867404|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
56867405|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
56867406|NCT01119534|Expectorants|expectorants|mesh-ancestor
56867407|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
56867408|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56867409|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56867410|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
56867411|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867412|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867413|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867414|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
56867415|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56867416|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
56867417|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
56867418|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867419|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
56867420|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56867421|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56867422|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867423|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
56867424|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
56867425|NCT01119534|Protective Agents|protective agents|mesh-ancestor
56867426|NCT01117116|Fluticasone|fluticasone|mesh-list
56867427|NCT01117116|Xhance|xhance|mesh-list
56867428|NCT01117116|Budesonide|budesonide|mesh-list
56867429|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
56867430|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56867431|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56867432|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56867433|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
56867434|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867435|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867436|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56867437|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
56867438|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
56867439|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56867440|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
56867441|NCT01117116|Hormones|hormones|mesh-ancestor
56867442|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867443|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56867444|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56867445|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56867446|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
56867447|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867448|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867449|NCT01216488|Lidocaine|lidocaine|mesh-list
56867450|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
56867451|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
56867452|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867453|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867454|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
56867455|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867456|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56867457|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56867458|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56867459|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867460|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867462|NCT01122342|Testosterone|testosterone|mesh-list
56867463|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
56867464|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
56867465|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56867466|NCT01122342|Androgens|androgens|mesh-ancestor
56867467|NCT01122342|Hormones|hormones|mesh-ancestor
56867468|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867469|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867470|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56867471|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867472|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
56867473|NCT01213992|Iron|iron|mesh-list
56867474|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56867475|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
56867476|NCT01213992|Trace Elements|trace elements|mesh-ancestor
56867477|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
56867478|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867479|NCT01213992|Hematinics|hematinics|mesh-ancestor
56867480|NCT03963414|Carboplatin|carboplatin|mesh-list
56867481|NCT03963414|Etoposide|etoposide|mesh-list
56867482|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
56867483|NCT03963414|Durvalumab|durvalumab|mesh-list
56867484|NCT03963414|Tremelimumab|tremelimumab|mesh-list
56867485|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56867486|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867487|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56867488|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56867489|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56867490|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867491|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867492|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56867493|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
56867494|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867495|NCT01216644|Leucovorin|leucovorin|mesh-list
56867496|NCT01216644|Docetaxel|docetaxel|mesh-list
56867497|NCT01216644|Fluorouracil|fluorouracil|mesh-list
56867498|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
56867499|NCT01216644|Epirubicin|epirubicin|mesh-list
56867500|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867501|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
56867502|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
56867503|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
56867504|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867505|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
56867506|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56867507|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56867508|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
56867509|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867510|NCT01216644|Antidotes|antidotes|mesh-ancestor
56867511|NCT01216644|Protective Agents|protective agents|mesh-ancestor
56867512|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
56867513|NCT01216644|Vitamins|vitamins|mesh-ancestor
56867514|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
56867515|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56867516|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56867517|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56867518|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867519|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
56867520|NCT04816162|Ketamine|ketamine|mesh-list
56867521|NCT04816162|Propofol|propofol|mesh-list
56867522|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56867523|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867524|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867525|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56867526|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
56867527|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
56867528|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56867530|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
56867531|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867532|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56867533|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56867534|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56867535|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
56867536|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867537|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867538|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56867539|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56578330|NCT04935229|Nivolumab|nivolumab|mesh-list
56867540|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56867541|NCT04959760|Antibodies|antibodies|mesh-list
56867542|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
56867543|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
56867544|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
56867545|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867547|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56867548|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867549|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867550|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56867551|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56867552|NCT01214226|Protective Agents|protective agents|mesh-ancestor
56867553|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867554|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867555|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56867556|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
56867557|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
56867558|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56867559|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867560|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
56867561|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867562|NCT01219062|Morphine|morphine|mesh-list
56867563|NCT01219062|Bupivacaine|bupivacaine|mesh-list
56867564|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
56867565|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
56867566|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867567|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867568|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
56867569|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867570|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56867571|NCT01219062|Narcotics|narcotics|mesh-ancestor
56867572|NCT01219062|Analgesics|analgesics|mesh-ancestor
56867573|NCT01120158|Paclitaxel|paclitaxel|mesh-list
56867574|NCT01120158|Bevacizumab|bevacizumab|mesh-list
56867575|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56867576|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867577|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
56867578|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
56867579|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
56867580|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867581|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56867582|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56867583|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56867584|NCT01120158|Growth Substances|growth substances|mesh-ancestor
56867585|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867586|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
56867587|NCT01373398|Apaziquone|apaziquone|mesh-list
56867588|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867589|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
56867590|NCT01124526|Rituximab|rituximab|mesh-list
56867591|NCT01124526|Fludarabine|fludarabine|mesh-list
56867592|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56867593|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
56867594|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867595|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56867596|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56867597|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
56867598|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867599|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867600|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56867601|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56867602|NCT01120314|Otamixaban|otamixaban|mesh-list
56867603|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56867605|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56867606|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
56867607|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867608|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867609|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
56867610|NCT03633994|Heparin|heparin|mesh-list
56867611|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
56867612|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56867613|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56867614|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867615|NCT01328886|Omalizumab|omalizumab|mesh-list
56867616|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56867617|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56867618|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
56867619|NCT01216878|Losartan|losartan|mesh-list
56867620|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56867621|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56867622|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56867623|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56867624|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867625|NCT04624984|Gemcitabine|gemcitabine|mesh-list
56867626|NCT04624984|Doxorubicin|doxorubicin|mesh-list
56867627|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56867628|NCT04624984|Vinorelbine|vinorelbine|mesh-list
56867629|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56867630|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56867631|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
56867632|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867633|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867634|NCT04624984|Antiviral Agents|antiviral agents|mesh-ancestor
56867635|NCT04624984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867636|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867637|NCT04624984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56867638|NCT04624984|Immunologic Factors|immunologic factors|mesh-ancestor
56867639|NCT04624984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867640|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56867641|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56867642|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56867643|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56867644|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
56867645|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
56867646|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
56867647|NCT01214382|Sertraline|sertraline|mesh-list
56867648|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
56867649|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56867650|NCT01214382|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56867651|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56867652|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867653|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867654|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867655|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
56867656|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867657|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
56867658|NCT01216956|Niacin|niacin|mesh-list
56867659|NCT01216956|Niacinamide|niacinamide|mesh-list
56867660|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
56867661|NCT01216956|Vitamins|vitamins|mesh-ancestor
56867662|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
56867663|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867664|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56867665|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
56867666|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867667|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56867668|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867669|NCT01217034|Sorafenib|sorafenib|mesh-list
56867670|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
56867671|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867672|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56867673|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867674|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867675|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56867676|NCT01217034|Estrogens|estrogens|mesh-ancestor
56867677|NCT01217034|Hormones|hormones|mesh-ancestor
56867678|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867680|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56867681|NCT01373554|Oltipraz|oltipraz|mesh-list
56867682|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
56867683|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867684|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
56867685|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56867686|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
56867687|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56867688|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56867689|NCT01373554|Protective Agents|protective agents|mesh-ancestor
56867690|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867691|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867692|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56867693|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56867694|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867695|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867696|NCT01319344|Eplerenone|eplerenone|mesh-list
56867697|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56867698|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
56867699|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867700|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867701|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56867702|NCT01319344|Diuretics|diuretics|mesh-ancestor
56867703|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
56867704|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56867705|NCT01373632|Sirolimus|sirolimus|mesh-list
56867706|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56867707|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867708|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56867709|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867710|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
56867711|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56867712|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
56867713|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867714|NCT01124760|Ketoconazole|ketoconazole|mesh-list
56867715|NCT01124760|Diltiazem|diltiazem|mesh-list
56867716|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
56867717|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867718|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56867719|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56867720|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867721|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867722|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56867723|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
56867724|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867725|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867726|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56867727|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56867728|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56867729|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867730|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56867731|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867732|NCT01214772|Heparin|heparin|mesh-list
56867733|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
56867734|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56867735|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56867736|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867737|NCT01217580|Ropivacaine|ropivacaine|mesh-list
56867738|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
56867739|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
56867740|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867741|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867742|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
56867743|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867744|NCT01125150|Metformin|metformin|mesh-list
56867745|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56867746|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867747|NCT01373710|Trastuzumab|trastuzumab|mesh-list
56867748|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56867749|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867750|NCT03935256|Paclitaxel|paclitaxel|mesh-list
56867751|NCT03935256|Carboplatin|carboplatin|mesh-list
56867753|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867754|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56867755|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56867756|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56867757|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867758|NCT04055116|Lidocaine|lidocaine|mesh-list
56867759|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
56867760|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
56867761|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867762|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867763|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
56867764|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867765|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56867766|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56867767|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56867768|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867769|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867770|NCT03869866|Vaccines|vaccines|mesh-list
56867771|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
56867772|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867773|NCT03783702|Acetaminophen|acetaminophen|mesh-list
56867774|NCT03783702|Ibuprofen|ibuprofen|mesh-list
56867775|NCT03783702|Oxycodone|oxycodone|mesh-list
56867776|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56867777|NCT03783702|Analgesics|analgesics|mesh-ancestor
56867778|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
56867779|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867780|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867781|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
56867782|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56867783|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56867784|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56867785|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56867786|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867787|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867788|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56867789|NCT03783702|Narcotics|narcotics|mesh-ancestor
56867790|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56867791|NCT01319734|Glyburide|glyburide|mesh-list
56867792|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867793|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56867794|NCT01121016|Montelukast|montelukast|mesh-list
56867795|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56867796|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
56867797|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56867798|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
56867799|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867800|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867801|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56867802|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56867803|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867804|NCT03575572|Colchicine|colchicine|mesh-list
56867805|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
56867806|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56867807|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
56867808|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
56867809|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
56867810|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867811|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867812|NCT01214928|Vitamin D|vitamin d|mesh-list
56867813|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
56867814|NCT01214928|Vitamins|vitamins|mesh-ancestor
56867815|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
56867816|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867817|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56867818|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56867819|NCT01122966|Bevacizumab|bevacizumab|mesh-list
56867820|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56867821|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867822|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56867823|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56867824|NCT01122966|Growth Substances|growth substances|mesh-ancestor
56867827|NCT01219686|Pindolol|pindolol|mesh-list
56867828|NCT01219686|Dexetimide|dexetimide|mesh-list
56867829|NCT01219686|Citalopram|citalopram|mesh-list
56867830|NCT01219686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56867831|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56867832|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867833|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867834|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867835|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
56867836|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867837|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56867838|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
56867839|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56867840|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56867841|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56578631|NCT02607943|Insulin|insulin|mesh-list
56867842|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
56867843|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
56867844|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867845|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56867846|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56867847|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
56867848|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56867849|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56867850|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
56867851|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56867852|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56867853|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867854|NCT01219764|Amoxicillin|amoxicillin|mesh-list
56867855|NCT01219764|Metronidazole|metronidazole|mesh-list
56867856|NCT01219764|Clarithromycin|clarithromycin|mesh-list
56867857|NCT01219764|Rabeprazole|rabeprazole|mesh-list
56867858|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56867859|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867860|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56867861|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56867862|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56867863|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867864|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867865|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56867866|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56867867|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56867868|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56867869|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56867870|NCT03936426|Copper|copper|mesh-list
56867871|NCT03936426|Trace Elements|trace elements|mesh-ancestor
56867872|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
56867873|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867874|NCT01217970|Ibudilast|ibudilast|mesh-list
56867875|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56867876|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
56867877|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56867878|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867879|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56867880|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
56867881|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56867882|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867883|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867884|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56867885|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
56867886|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
56867887|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56867888|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56867889|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867890|NCT01125696|Ritonavir|ritonavir|mesh-list
56867891|NCT01125696|Lopinavir|lopinavir|mesh-list
56867892|NCT01125696|Tenofovir|tenofovir|mesh-list
56867893|NCT01125696|Lamivudine|lamivudine|mesh-list
56867894|NCT01125696|Zidovudine|zidovudine|mesh-list
56867895|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56867896|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56867897|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
56867898|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867900|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56867901|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56867902|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
56867903|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867904|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56867905|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56867906|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56867907|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56867908|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
56867909|NCT03932916|Donepezil|donepezil|mesh-list
56867910|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56867911|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867912|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867913|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
56867914|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56867915|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578706|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867916|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
56867917|NCT03116152|Paclitaxel|paclitaxel|mesh-list
56867918|NCT03116152|Irinotecan|irinotecan|mesh-list
56867919|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56867920|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867921|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
56867922|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
56867923|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
56867924|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867925|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56867926|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56867927|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867928|NCT01123278|Testosterone|testosterone|mesh-list
56867929|NCT01123278|Androgens|androgens|mesh-ancestor
56867930|NCT01123278|Hormones|hormones|mesh-ancestor
56867931|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867932|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867933|NCT01219920|Leucovorin|leucovorin|mesh-list
56867934|NCT01219920|Irinotecan|irinotecan|mesh-list
56867935|NCT01219920|Antidotes|antidotes|mesh-ancestor
56867936|NCT01219920|Protective Agents|protective agents|mesh-ancestor
56867937|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867938|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
56867939|NCT01219920|Vitamins|vitamins|mesh-ancestor
56867940|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
56867941|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867942|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867943|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56867944|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56867945|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867946|NCT01400776|Estradiol|estradiol|mesh-list
56867947|NCT01400776|Estrogens|estrogens|mesh-ancestor
56867948|NCT01400776|Hormones|hormones|mesh-ancestor
56867949|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867950|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867951|NCT01220076|Tamoxifen|tamoxifen|mesh-list
56867952|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56867953|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
56867954|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56867955|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867956|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56867957|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867958|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56867959|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56867960|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56867961|NCT01220154|Paclitaxel|paclitaxel|mesh-list
56867962|NCT01220154|Bevacizumab|bevacizumab|mesh-list
56867963|NCT01220154|Carboplatin|carboplatin|mesh-list
56867964|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56867965|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867966|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
56867967|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
56867968|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
56867969|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867970|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56867971|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56867972|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56867973|NCT01220154|Growth Substances|growth substances|mesh-ancestor
56867974|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867975|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
56867976|NCT01182766|Topiramate|topiramate|mesh-list
56867977|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
56867978|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56867979|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56867980|NCT01220232|Lamivudine|lamivudine|mesh-list
56867981|NCT01220232|Abacavir|abacavir|mesh-list
56867982|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
56867983|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56867984|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56867985|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56867986|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867987|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
56867988|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56867989|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56867990|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56867991|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
56578781|NCT00804193|Ciclopirox|ciclopirox|mesh-list
56867992|NCT01126008|Docetaxel|docetaxel|mesh-list
56867993|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56867994|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56867995|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56867996|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56867997|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56867998|NCT03934710|Serotonin|serotonin|mesh-list
56867999|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
56868000|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
56868001|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868002|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868003|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868004|NCT05169424|Fluticasone|fluticasone|mesh-list
56868006|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
56868007|NCT05169424|Olodaterol|olodaterol|mesh-list
55895239|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56868008|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868009|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56868010|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
56868011|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868012|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868013|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56868014|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
56868015|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
56868016|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56868017|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
56868018|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56868019|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
56868020|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868021|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868022|NCT03117010|Dexamethasone|dexamethasone|mesh-list
56868023|NCT03117010|Etoposide|etoposide|mesh-list
56868024|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868025|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
56868026|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
56868027|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868028|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868029|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56868030|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
56868031|NCT03117010|Hormones|hormones|mesh-ancestor
56868032|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868033|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56868034|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868035|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868036|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868037|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56868038|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56868039|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56868040|NCT01123824|Clopidogrel|clopidogrel|mesh-list
56868041|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56868042|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56868043|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56868044|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56868045|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
56868046|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868048|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868049|NCT01126086|Otamixaban|otamixaban|mesh-list
56868050|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56868051|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
56868052|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56868053|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
56868054|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868055|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868056|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
56868057|NCT03009838|Letrozole|letrozole|mesh-list
56868058|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868059|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56868060|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56868061|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868062|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868063|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56868064|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
56868065|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868066|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868068|NCT01124058|Calcium heparin|calcium heparin|mesh-list
56868069|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56868070|NCT01124058|Tinzaparin|tinzaparin|mesh-list
56868071|NCT01124058|Dalteparin|dalteparin|mesh-list
56868072|NCT01124058|Warfarin|warfarin|mesh-list
56868073|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
56868074|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56868075|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56868076|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868077|NCT01375972|Gemcitabine|gemcitabine|mesh-list
56868078|NCT01375972|Cisplatin|cisplatin|mesh-list
56868079|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868080|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56868081|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
56868082|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868083|NCT01375972|Antiviral Agents|antiviral agents|mesh-ancestor
56868084|NCT01375972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868085|NCT01375972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868086|NCT01375972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56868087|NCT01375972|Immunologic Factors|immunologic factors|mesh-ancestor
56868088|NCT01375972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868089|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56868090|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
56868091|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868092|NCT01220622|Nimodipine|nimodipine|mesh-list
56868093|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56868094|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56868095|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56868096|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868097|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56868098|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868099|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
56868100|NCT05123170|Lidocaine|lidocaine|mesh-list
56868101|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
56868102|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
56868103|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
56868104|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56868105|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868106|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
56868107|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868108|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56868109|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56868110|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56868111|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56868112|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868113|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56868114|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56868115|NCT05123170|Analgesics|analgesics|mesh-ancestor
56868116|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56868117|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56868118|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56868119|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
56382678|NCT00495781|Iron|iron|mesh-list
56868122|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56868123|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56868124|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56868125|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
56868126|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868127|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868128|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868129|NCT01215708|Urological Agents|urological agents|mesh-ancestor
56868130|NCT01222026|Vitamin D|vitamin d|mesh-list
56868131|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
56868132|NCT01222026|Vitamins|vitamins|mesh-ancestor
56868133|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
56868134|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868135|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56868136|NCT00225251|Bupropion|bupropion|mesh-list
56868137|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56868138|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
56868139|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56868140|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56868141|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56868142|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56868143|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868144|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
56868145|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868146|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868147|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56868148|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56868149|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868150|NCT01376128|Paroxetine|paroxetine|mesh-list
56868151|NCT01376128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56868152|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56868153|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56868154|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868155|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868156|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
56868157|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868158|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56868159|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
56868160|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56868161|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56868162|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56868163|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868164|NCT01376206|Fluticasone|fluticasone|mesh-list
56868165|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868166|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56868167|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
56868168|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868169|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868170|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56868171|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
56868172|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
56868173|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56868174|NCT01073501|Pregabalin|pregabalin|mesh-list
56868175|NCT01073501|Analgesics|analgesics|mesh-ancestor
56868176|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
56868177|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868178|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868179|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
56868180|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56868181|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56868182|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868183|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56868184|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56868185|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56868186|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56868187|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56868188|NCT05005312|Ritonavir|ritonavir|mesh-list
56868189|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56868190|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56868193|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868194|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56868195|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56868196|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
56868197|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868198|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56868199|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56868200|NCT01222182|Atorvastatin|atorvastatin|mesh-list
56868201|NCT01222182|Simvastatin|simvastatin|mesh-list
56868202|NCT01222182|Pravastatin|pravastatin|mesh-list
56868203|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56868204|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56868205|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
56868206|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868207|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56868208|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56868209|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868210|NCT03633604|HBOC 201|hboc 201|mesh-list
56868211|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
56868212|NCT01218750|Bevacizumab|bevacizumab|mesh-list
56579012|NCT00907335|Tretinoin|tretinoin|mesh-list
56868213|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56868214|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868215|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56868216|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56868217|NCT01218750|Growth Substances|growth substances|mesh-ancestor
56868218|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868219|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
56868220|NCT01376284|Dutasteride|dutasteride|mesh-list
56868221|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56868222|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56868223|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868224|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868225|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
56868226|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868227|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868228|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56868229|NCT01376440|Eusol|eusol|mesh-list
56868230|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
56868231|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868232|NCT01329042|Citric Acid|citric acid|mesh-list
56868233|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
56868234|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
56868235|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56868236|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
56868237|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
56868238|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868239|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56868240|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
56868241|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868242|NCT00253643|Protective Agents|protective agents|mesh-ancestor
56868243|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868244|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56868245|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56868246|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868247|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56868248|NCT01222650|Silodosin|silodosin|mesh-list
56868249|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56868250|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56868251|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56868252|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
56868253|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868254|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868255|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868256|NCT01222650|Urological Agents|urological agents|mesh-ancestor
56868257|NCT04856488|Lugol's solution|lugol's solution|mesh-list
56868258|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56868259|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
56868260|NCT04856488|Coagulants|coagulants|mesh-ancestor
56868261|NCT01073579|Vigabatrin|vigabatrin|mesh-list
56868262|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
56868263|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868265|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
56868266|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868267|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868268|NCT00221195|Thrombin|thrombin|mesh-list
56868269|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
56868270|NCT00221195|Coagulants|coagulants|mesh-ancestor
56868271|NCT04646590|Vaccines|vaccines|mesh-list
56868272|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
56868273|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868274|NCT03931668|Maleic acid|maleic acid|mesh-list
56868275|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868276|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868277|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
56868278|NCT00220805|Antibodies|antibodies|mesh-list
56904148|NCT04428411|Etanercept|etanercept|mesh-list
56868279|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
56868280|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56868281|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56868282|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
56868283|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
56868284|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579082|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56868285|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
56868286|NCT00220727|Antibodies|antibodies|mesh-list
56868287|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
56868288|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56868289|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56868290|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
56868291|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
56868292|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868293|NCT01072097|Atorvastatin|atorvastatin|mesh-list
56868294|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56868295|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56868296|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
56868297|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868298|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56868299|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56868300|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868301|NCT05760430|Bevacizumab|bevacizumab|mesh-list
56868302|NCT05760430|Apatinib|apatinib|mesh-list
56868303|NCT05760430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56868304|NCT05760430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868305|NCT05760430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56868306|NCT05760430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56868307|NCT05760430|Growth Substances|growth substances|mesh-ancestor
56868308|NCT05760430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868309|NCT05760430|Growth Inhibitors|growth inhibitors|mesh-ancestor
56868310|NCT05760430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56868311|NCT05760430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868312|NCT05760430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868314|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56868315|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
56868316|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868317|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56868318|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
56868319|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
56868320|NCT01221402|Vitamins|vitamins|mesh-ancestor
56868321|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
56868322|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868323|NCT04214860|Azacitidine|azacitidine|mesh-list
56868324|NCT04214860|Venetoclax|venetoclax|mesh-list
56868325|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56868326|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
56868327|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868328|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868329|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868330|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56868331|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56868332|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56868333|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56868334|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868335|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868336|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868338|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
56868339|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868340|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
56868341|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56868342|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
56868343|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56868344|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
56868345|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56868346|NCT01126866|Bevacizumab|bevacizumab|mesh-list
56868347|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56868348|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868349|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56868350|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56868351|NCT01126866|Growth Substances|growth substances|mesh-ancestor
56868352|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868353|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
56868354|NCT04103554|Valsartan|valsartan|mesh-list
56868355|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56868356|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56868357|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56868358|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56868359|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868360|NCT03740568|Progesterone|progesterone|mesh-list
56579161|NCT03522831|Albuterol|albuterol|mesh-list
56868361|NCT03740568|Progestins|progestins|mesh-ancestor
56868363|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868364|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868365|NCT00252239|Plasminogen|plasminogen|mesh-list
56868366|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56868367|NCT00252239|Tenecteplase|tenecteplase|mesh-list
56868368|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56868369|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56868370|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868371|NCT01127022|Choline|choline|mesh-list
56868372|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
56868373|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56868374|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
56868375|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868376|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56868377|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56868378|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
56868379|NCT01221558|Lycopene|lycopene|mesh-list
56868380|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868381|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
56868382|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868383|NCT01221558|Protective Agents|protective agents|mesh-ancestor
56868384|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868385|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56868386|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56868387|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868388|NCT01221636|Abatacept|abatacept|mesh-list
56868389|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56868390|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868391|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868392|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56868393|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
56868394|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868395|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56868396|NCT05731804|Ritonavir|ritonavir|mesh-list
56868397|NCT05731804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56868398|NCT05731804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56868399|NCT05731804|Protease Inhibitors|protease inhibitors|mesh-ancestor
56868400|NCT05731804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868401|NCT05731804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868402|NCT05731804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56868403|NCT05731804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56868404|NCT05731804|Antiviral Agents|antiviral agents|mesh-ancestor
56868405|NCT05731804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868406|NCT05731804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56868407|NCT05731804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56868408|NCT01127568|Propranolol|propranolol|mesh-list
56868409|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56568310|NCT01955980|Hormones|hormones|mesh-ancestor
56868419|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56868421|NCT01127100|Fentanyl|fentanyl|mesh-list
56868422|NCT01127100|Gabapentin|gabapentin|mesh-list
56868423|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56868424|NCT01127100|Narcotics|narcotics|mesh-ancestor
56868425|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56868426|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868427|NCT01127100|Analgesics|analgesics|mesh-ancestor
56868428|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
56868429|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868430|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56868431|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56868432|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
56868433|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
56868434|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
56868435|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56868436|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56868437|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56868438|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56868439|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56868440|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868441|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868442|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
56868443|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
56868444|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56868445|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868446|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868447|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868448|NCT01221792|Carvedilol|carvedilol|mesh-list
56868449|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56868450|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56868451|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
56868452|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868453|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868454|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868455|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56868456|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
56868457|NCT01221792|Protective Agents|protective agents|mesh-ancestor
56868458|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56868459|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56868460|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56868461|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
56868462|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56868463|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56868464|NCT03932526|Apatinib|apatinib|mesh-list
56868465|NCT03932526|Vinorelbine|vinorelbine|mesh-list
56868466|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868467|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56868468|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868469|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868470|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56868471|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
56868472|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
56868495|NCT05675098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868496|NCT05675098|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56868497|NCT05675098|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56868498|NCT05675098|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56868499|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
56868500|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
56868501|NCT01223742|Vitamins|vitamins|mesh-ancestor
56868502|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
56868503|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868504|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
56868505|NCT01129518|Vaccines|vaccines|mesh-list
56868506|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
56868507|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868508|NCT01223820|Capsaicin|capsaicin|mesh-list
56868509|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
56868510|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
56868511|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
56868512|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868513|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868514|NCT01131234|Cediranib|cediranib|mesh-list
56868515|NCT01131234|R04929097|r04929097|mesh-list
56868516|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868517|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868518|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868519|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56868520|NCT01129596|Donepezil|donepezil|mesh-list
56868521|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56868522|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868523|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868524|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
56868525|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868526|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868527|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
56868529|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868530|NCT01127880|Clindamycin|clindamycin|mesh-list
56868531|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
56868532|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
56868533|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56868534|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868535|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56868536|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868537|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868538|NCT01228344|Lumefantrine|lumefantrine|mesh-list
56868539|NCT01228344|Artemether|artemether|mesh-list
56868540|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56868541|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
56868542|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56868543|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56868544|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868545|NCT03927456|Fulvestrant|fulvestrant|mesh-list
56868546|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56868547|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868548|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56868549|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56868550|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
56868551|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868552|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868553|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56868554|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56868555|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
56868556|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868557|NCT01228422|Interferons|interferons|mesh-list
56868558|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
56868559|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
56868560|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868561|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
56868562|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868563|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
56868564|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868565|NCT01319422|Pomalidomide|pomalidomide|mesh-list
56868566|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
56868567|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868568|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56868569|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56868570|NCT01319422|Growth Substances|growth substances|mesh-ancestor
56868571|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
56868572|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868573|NCT01227174|Propofol|propofol|mesh-list
56868574|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56868575|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56868576|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868577|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56868578|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
56868579|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
56868580|NCT05615974|Rituximab|rituximab|mesh-list
56868581|NCT05615974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56868582|NCT05615974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868583|NCT05615974|Immunologic Factors|immunologic factors|mesh-ancestor
56868584|NCT05615974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868585|NCT05615974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56868586|NCT03924492|Pregnanolone|pregnanolone|mesh-list
56868588|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
56868589|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868590|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868591|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868592|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
56868593|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
56868594|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
56868595|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56868596|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56868597|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56868598|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
56868599|NCT01224366|Vildagliptin|vildagliptin|mesh-list
56868600|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56868601|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868602|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56868603|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
56868604|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868605|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868606|NCT05415826|Dexamethasone|dexamethasone|mesh-list
56868607|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868608|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
56868609|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
56868610|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868611|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868612|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56868613|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
56868614|NCT05415826|Hormones|hormones|mesh-ancestor
56868615|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868616|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56868617|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868618|NCT05415748|Tamsulosin|tamsulosin|mesh-list
56868619|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56868620|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56868621|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56868622|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
56868623|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868624|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868625|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868626|NCT05415748|Urological Agents|urological agents|mesh-ancestor
56868627|NCT03774576|Itraconazole|itraconazole|mesh-list
56868628|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
56868629|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868630|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56868631|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56868632|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868633|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868634|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56868635|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
56868636|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868637|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868638|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56868639|NCT05415436|Propofol|propofol|mesh-list
56868640|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56868641|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56868642|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868643|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56868644|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
56868645|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
56868646|NCT01227408|Paclitaxel|paclitaxel|mesh-list
56868647|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
56868648|NCT01227408|Doxorubicin|doxorubicin|mesh-list
56868649|NCT01227408|Capecitabine|capecitabine|mesh-list
56868650|NCT01227408|Methotrexate|methotrexate|mesh-list
56868651|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56868652|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56868653|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868654|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56868655|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56868656|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56868657|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868658|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56868659|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
56868660|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868661|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56868662|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56868663|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
56868664|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56868665|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56868666|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56868667|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56868668|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868669|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56868670|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
56868671|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56868672|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
56868673|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56868674|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
56868675|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56868676|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56868677|NCT03773796|Nabilone|nabilone|mesh-list
56868679|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
56868680|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868681|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868682|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56868683|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56868684|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56868685|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56868686|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56868687|NCT02927938|Cytarabine|cytarabine|mesh-list
56868688|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56868689|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
56868690|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868691|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868692|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
56868693|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868694|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56868695|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
56868696|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868697|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
56868698|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56868699|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56868700|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868701|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
56868702|NCT05370820|Coagulants|coagulants|mesh-ancestor
56868703|NCT03923166|Capecitabine|capecitabine|mesh-list
56868704|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56868705|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
56868706|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868707|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868708|NCT01224756|Tinoridine|tinoridine|mesh-list
56868709|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56868710|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56868711|NCT01224756|Analgesics|analgesics|mesh-ancestor
56868712|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
56868713|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868714|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868715|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868716|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56868717|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
56868718|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56868719|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868720|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
56868721|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56868722|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868723|NCT01130298|Testosterone|testosterone|mesh-list
56868724|NCT01130298|Androgens|androgens|mesh-ancestor
56868725|NCT01130298|Hormones|hormones|mesh-ancestor
56868726|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868727|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868728|NCT01227720|Nicotine|nicotine|mesh-list
56868729|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56868730|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
56868731|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868732|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868733|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56868734|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56868736|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868737|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868738|NCT03175978|Methotrexate|methotrexate|mesh-list
56868739|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868740|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56868741|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
56868742|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56868743|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56868744|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
56868745|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868746|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868747|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56868748|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868749|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56868750|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56868751|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
56868752|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56868753|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56868755|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
56868756|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868757|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56868758|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56868759|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868760|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868761|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56868762|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
56868763|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868764|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868765|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56868766|NCT01227798|Interferons|interferons|mesh-list
56868767|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
56868768|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868769|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
56868770|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868771|NCT01130376|Aldesleukin|aldesleukin|mesh-list
56868772|NCT01130376|Interleukin-2|interleukin-2|mesh-list
56868773|NCT01130376|Hormones|hormones|mesh-list
56868774|NCT01130376|Sargramostim|sargramostim|mesh-list
56868775|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868776|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868777|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868778|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56868779|NCT01130376|Analgesics|analgesics|mesh-ancestor
56868780|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
56868781|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868782|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
56868783|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56868784|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56868785|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
56868786|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868787|NCT03740178|Donepezil|donepezil|mesh-list
56868788|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56868789|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868790|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868791|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
56868792|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868793|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868794|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
56868795|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
56868796|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56868797|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
56868798|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868799|NCT01131468|Expectorants|expectorants|mesh-ancestor
56868800|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
56868801|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56868802|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
56868803|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868804|NCT01131468|Protective Agents|protective agents|mesh-ancestor
56868805|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868806|NCT01131468|Antidotes|antidotes|mesh-ancestor
56868807|NCT01225224|Peficitinib|peficitinib|mesh-list
56868808|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868809|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868810|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56868811|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
56868812|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868814|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56868815|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56868816|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56868817|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868818|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56868819|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868820|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
56868821|NCT01225302|Paclitaxel|paclitaxel|mesh-list
56868822|NCT01225302|Carboplatin|carboplatin|mesh-list
56868823|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56868824|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868825|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
56868826|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
56868827|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
56868828|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868830|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
56868831|NCT01229046|Ticarcillin|ticarcillin|mesh-list
56868832|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
56868833|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56868834|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868835|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868836|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868837|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56868838|NCT03921684|Capecitabine|capecitabine|mesh-list
56868839|NCT03921684|Nivolumab|nivolumab|mesh-list
56868840|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56868841|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
56868842|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868843|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868844|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56868845|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56868846|NCT03929094|Gemcitabine|gemcitabine|mesh-list
56868847|NCT03929094|Paclitaxel|paclitaxel|mesh-list
56868848|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56868849|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56868850|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868851|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
56868852|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
56868853|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
56868854|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868855|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56868856|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
56868857|NCT03929094|Antiviral Agents|antiviral agents|mesh-ancestor
56868858|NCT03929094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868859|NCT03929094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868860|NCT03929094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56868861|NCT03929094|Immunologic Factors|immunologic factors|mesh-ancestor
56868862|NCT03929094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868863|NCT01131702|Ranitidine|ranitidine|mesh-list
56868864|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56868865|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56868866|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56868867|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56868868|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
56868869|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
56868870|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868871|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868872|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868873|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
56868874|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868875|NCT03925818|Metronidazole|metronidazole|mesh-list
56868876|NCT03925818|Tetracycline|tetracycline|mesh-list
56868877|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56868878|NCT03925818|Pantoprazole|pantoprazole|mesh-list
56868879|NCT03925818|Bismuth|bismuth|mesh-list
56868880|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868881|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56868882|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56868883|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56868884|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56868885|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56868886|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56868887|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868888|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868889|NCT03925818|Antacids|antacids|mesh-ancestor
56868890|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56868891|NCT03925740|Listerine|listerine|mesh-list
56868892|NCT03925740|Fluorides|fluorides|mesh-list
56868893|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
56868894|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
56868895|NCT03925740|Protective Agents|protective agents|mesh-ancestor
56868896|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868897|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56868898|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868899|NCT01130688|Zileuton|zileuton|mesh-list
56868900|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56868901|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56868902|NCT01130688|Analgesics|analgesics|mesh-ancestor
56868903|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
56868912|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
56868913|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56868914|NCT03925662|Mebendazole|mebendazole|mesh-list
56868915|NCT03925662|Piperazine|piperazine|mesh-list
56868916|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
56868917|NCT03925662|Bevacizumab|bevacizumab|mesh-list
56868918|NCT03925662|DMP 777|dmp 777|mesh-list
56868919|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56868920|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868921|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56868922|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56868923|NCT03925662|Growth Substances|growth substances|mesh-ancestor
56868924|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868925|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
56868926|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
56868927|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
56868928|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56868929|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868930|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
56868931|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
56868932|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
56868933|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868934|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868935|NCT01229202|Bevacizumab|bevacizumab|mesh-list
56868936|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56868937|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868938|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56868939|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56868940|NCT01229202|Growth Substances|growth substances|mesh-ancestor
56868941|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868942|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
56868943|NCT01229280|Darifenacin|darifenacin|mesh-list
56868944|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56868945|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
56868946|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56868947|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868948|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868949|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868950|NCT01229280|Urological Agents|urological agents|mesh-ancestor
56868951|NCT01131780|Ibuprofen|ibuprofen|mesh-list
56868952|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
56868953|NCT01131780|Ephedrine|ephedrine|mesh-list
56868954|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56868955|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56868956|NCT01131780|Analgesics|analgesics|mesh-ancestor
56868957|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
56868958|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868959|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868960|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868961|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56868962|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56868963|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868964|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868965|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56868966|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
56868967|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56868968|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
56868969|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
56568342|NCT00619996|Docetaxel|docetaxel|mesh-list
56868972|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
56868973|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
56868974|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56868975|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
56868976|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56868977|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56868978|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56868979|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56868980|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56868981|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56868982|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56868983|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56868984|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56868985|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
56868986|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56868987|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868988|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56868989|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56868990|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56868991|NCT01131000|Ibuprofen|ibuprofen|mesh-list
56868992|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56868993|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56868994|NCT01131000|Analgesics|analgesics|mesh-ancestor
56868995|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
56868996|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56868997|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56868998|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56868999|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869000|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56869001|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869002|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869003|NCT01132170|Valproic Acid|valproic acid|mesh-list
56869004|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
56869005|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869006|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869007|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
56869008|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869009|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869010|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
56869011|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56869012|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869013|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56869014|NCT03925428|Entinostat|entinostat|mesh-list
56869015|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56869016|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869017|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869018|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869019|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56869020|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56869021|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869022|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
56869023|NCT03919812|Vitamin D|vitamin d|mesh-list
56869024|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56869025|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869026|NCT03919812|Vitamins|vitamins|mesh-ancestor
56869027|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
56869028|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56869029|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
56869030|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56869031|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869032|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56869033|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869034|NCT01132248|Mefloquine|mefloquine|mesh-list
56869035|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
56869036|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56869037|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56869038|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869039|NCT01229592|Ethanol|ethanol|mesh-list
56869040|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56869041|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869042|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869043|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869044|NCT01131936|Amlodipine|amlodipine|mesh-list
56869045|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56869046|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56869047|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56869048|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869049|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56904175|NCT03751059|Analgesics|analgesics|mesh-ancestor
56869050|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869051|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
56869052|NCT01132404|Leuprolide|leuprolide|mesh-list
56869053|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56869054|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
56869055|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56869056|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869057|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56869058|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869059|NCT01231854|Cyclosporine|cyclosporine|mesh-list
56869060|NCT01231854|Alitretinoin|alitretinoin|mesh-list
56869061|NCT01231854|Cyclosporins|cyclosporins|mesh-list
56869062|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869063|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869064|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56869065|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
56869066|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869067|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
56869068|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869069|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
56869070|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869071|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56869072|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869073|NCT01132638|Esomeprazole|esomeprazole|mesh-list
56869074|NCT01132638|Pantoprazole|pantoprazole|mesh-list
56869075|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56869076|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869077|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56869078|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869079|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869080|NCT05402124|Aspirin|aspirin|mesh-list
56869081|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56869082|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56869083|NCT05402124|Analgesics|analgesics|mesh-ancestor
56869084|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
56869085|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869086|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869087|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56869088|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869089|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56869090|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56869091|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869092|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56869093|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56869094|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869095|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
56869096|NCT01134432|Prednisolone|prednisolone|mesh-list
56869097|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56869098|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
56869099|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56869100|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
56869101|NCT01134432|Rituximab|rituximab|mesh-list
56869102|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56869103|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
56869104|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56869105|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869106|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
56869107|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869108|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869109|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56869110|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
56869111|NCT01134432|Hormones|hormones|mesh-ancestor
56869112|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869113|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56869114|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
56869115|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
56869116|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869117|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869118|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56869119|NCT01134432|Protective Agents|protective agents|mesh-ancestor
56869121|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56869122|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56869123|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869124|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869125|NCT01132716|Valacyclovir|valacyclovir|mesh-list
56869126|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
56869127|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869128|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
56869129|NCT05401812|Hormones|hormones|mesh-ancestor
56869130|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869131|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869132|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
56869133|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56869134|NCT01137708|Tofacitinib|tofacitinib|mesh-list
56869135|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56869136|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
56869137|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56869138|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869139|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56869140|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56869141|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56869142|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56869143|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869144|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869145|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56869146|NCT01137708|Estrogens|estrogens|mesh-ancestor
56869147|NCT01137708|Hormones|hormones|mesh-ancestor
56869148|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869149|NCT03765138|Pramipexole|pramipexole|mesh-list
56869150|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
56869151|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869152|NCT03765138|Protective Agents|protective agents|mesh-ancestor
56869153|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869154|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56869155|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56869156|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
56869157|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
56869158|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869159|NCT01134666|Cetuximab|cetuximab|mesh-list
56869160|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56869161|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869162|NCT03739788|BMS-986165|bms-986165|mesh-list
56869163|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
56869164|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56869165|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869166|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869167|NCT01137942|Metronidazole|metronidazole|mesh-list
56869168|NCT01137942|Clarithromycin|clarithromycin|mesh-list
56869169|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56869170|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869171|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56869172|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56869173|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56869174|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56869175|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869176|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869177|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56869178|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56869179|NCT01233492|Mannitol|mannitol|mesh-list
56869180|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56869181|NCT01233492|Diuretics|diuretics|mesh-ancestor
56869182|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
56869183|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869185|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869186|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56869187|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869188|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869189|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
56869190|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56869191|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869192|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869193|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56869194|NCT01132794|Analgesics|analgesics|mesh-ancestor
56869195|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
56869196|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869197|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56869198|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56869199|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56869200|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
56869201|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869202|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869203|NCT01135212|Candesartan|candesartan|mesh-list
56869204|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
56869205|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56869206|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56869207|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56869208|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869209|NCT01233570|Tacrolimus|tacrolimus|mesh-list
56869210|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56869211|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
56869212|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869213|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56869214|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869215|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869216|NCT01135290|Petrolatum|petrolatum|mesh-list
56869217|NCT01135290|Emollients|emollients|mesh-ancestor
56869218|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
56869219|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
56869220|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56869221|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869222|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56869223|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869224|NCT01135602|Topiramate|topiramate|mesh-list
56869225|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
56869226|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56869227|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869228|NCT05308212|Vaccines|vaccines|mesh-list
56869229|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
56869230|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869231|NCT01138488|Insulin|insulin|mesh-list
56869232|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
56869233|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56869234|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869235|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
56869236|NCT01135680|Glycerol|glycerol|mesh-list
56869237|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56869238|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869239|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56869240|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56869241|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869242|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869243|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869244|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869245|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56869246|NCT01135680|Protective Agents|protective agents|mesh-ancestor
56869247|NCT01135758|Ketamine|ketamine|mesh-list
56869248|NCT01135758|Analgesics|analgesics|mesh-ancestor
56869249|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
56869250|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869251|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869252|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56869253|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56869254|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
56869255|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
56869256|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869257|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56869258|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56869259|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869260|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869262|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56869263|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56869264|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56869265|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
56383781|NCT00503659|Miotics|miotics|mesh-ancestor
56869267|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869268|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869269|NCT05401032|Urological Agents|urological agents|mesh-ancestor
56869270|NCT03768726|Ziprasidone|ziprasidone|mesh-list
56869271|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56869272|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
56869273|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869274|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869275|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869276|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56869277|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56869278|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869279|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56869280|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56869281|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
56869282|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
56869283|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56869284|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
56869285|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869286|NCT01138956|Expectorants|expectorants|mesh-ancestor
56869287|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
56869288|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56869289|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
56869290|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869291|NCT01138956|Protective Agents|protective agents|mesh-ancestor
56869292|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869293|NCT01138956|Antidotes|antidotes|mesh-ancestor
56869294|NCT03917940|Glimepiride|glimepiride|mesh-list
56869295|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56869296|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56869297|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869298|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56869299|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
56869300|NCT05291598|Ketorolac|ketorolac|mesh-list
56869301|NCT05291598|Meloxicam|meloxicam|mesh-list
56869302|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56869303|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56869304|NCT05291598|Analgesics|analgesics|mesh-ancestor
56869305|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
56869306|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869307|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869308|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56869309|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869310|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56869311|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869312|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869313|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56869314|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56869315|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869316|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869317|NCT01232244|Glucagon|glucagon|mesh-list
56869318|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56869319|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869320|NCT01232244|Hormones|hormones|mesh-ancestor
56869321|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869322|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869323|NCT01232244|Incretins|incretins|mesh-ancestor
56869324|NCT03917784|Curcumin|curcumin|mesh-list
56869325|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56869326|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56869327|NCT03917784|Analgesics|analgesics|mesh-ancestor
56869328|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
56869329|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869330|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580128|NCT04956302|Daratumumab|daratumumab|mesh-list
56869331|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56869332|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869333|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869334|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869335|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869336|NCT01133496|Alendronate|alendronate|mesh-list
56869337|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56869338|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869340|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56869341|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56869342|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56869343|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
56869344|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904180|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869345|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869346|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869347|NCT02528760|Erythromycin|erythromycin|mesh-list
56869348|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
56869349|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56869350|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
56869351|NCT02528760|Metoclopramide|metoclopramide|mesh-list
56869352|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
56869353|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
56869354|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869355|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869356|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869357|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56869358|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56869359|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
56869360|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869361|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869362|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56869363|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869364|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56869365|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869366|NCT05594472|Gentamicins|gentamicins|mesh-list
56869367|NCT05594472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56869368|NCT05594472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869369|NCT05594472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56869370|NCT05594472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869371|NCT05594472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869372|NCT01136538|Valacyclovir|valacyclovir|mesh-list
56869373|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
56869374|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869375|NCT03917628|Adalimumab|adalimumab|mesh-list
56869376|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56869377|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869378|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56869379|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869380|NCT01136850|Azithromycin|azithromycin|mesh-list
56869381|NCT01136850|Chloroquine|chloroquine|mesh-list
56869382|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
56869383|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
56869384|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56869385|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56869386|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869387|NCT01136850|Amebicides|amebicides|mesh-ancestor
56869388|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56869389|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56869390|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
56869391|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869392|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56869393|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869394|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869395|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56869396|NCT01136850|Renal Agents|renal agents|mesh-ancestor
56869397|NCT05088252|Propofol|propofol|mesh-list
56869398|NCT05088252|Desflurane|desflurane|mesh-list
56869399|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56869400|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869401|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869402|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56869403|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
56869404|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
56869405|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56580204|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
56869406|NCT01234116|Tenofovir|tenofovir|mesh-list
56869407|NCT01234116|Emtricitabine|emtricitabine|mesh-list
56869408|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56869409|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
56869410|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869411|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56869412|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56869413|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869414|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869415|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56869416|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56869418|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
56869419|NCT03916926|Fluorides|fluorides|mesh-list
56869420|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
56869421|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
56869422|NCT03916926|Protective Agents|protective agents|mesh-ancestor
56869423|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869424|NCT01230996|Cisplatin|cisplatin|mesh-list
56869425|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869426|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
56869427|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56869428|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56869429|NCT01137084|Prednisolone|prednisolone|mesh-list
56869430|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
56869431|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56869432|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
56869433|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56869434|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
56869435|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
56869436|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869437|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869438|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869439|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
56869440|NCT01137084|Hormones|hormones|mesh-ancestor
56869441|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869442|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56869443|NCT01137084|Protective Agents|protective agents|mesh-ancestor
56869444|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56869445|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869446|NCT01133886|Decitabine|decitabine|mesh-list
56869447|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56869448|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
56869449|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869450|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869451|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869452|NCT03917082|Tamoxifen|tamoxifen|mesh-list
56869453|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56869454|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869455|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56869456|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
56869457|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869458|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869459|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56869460|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869461|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56869462|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56869463|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56869464|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56869465|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869466|NCT01140126|UB-421|ub-421|mesh-list
56869467|NCT01140126|Antibodies|antibodies|mesh-list
56869468|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
56869469|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869470|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56869471|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
56869472|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869473|NCT01231074|Metformin|metformin|mesh-list
56869474|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56869475|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869476|NCT03917394|Iron|iron|mesh-list
56869477|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56869478|NCT03917394|Trace Elements|trace elements|mesh-ancestor
56869479|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
56869480|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580282|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
56869481|NCT03917394|Hematinics|hematinics|mesh-ancestor
56869482|NCT03769896|Nabilone|nabilone|mesh-list
56869483|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
56869484|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
56869485|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869486|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869487|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869488|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56384019|NCT00405444|Fentanyl|fentanyl|mesh-list
56869490|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869491|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56869492|NCT01234194|Remifentanil|remifentanil|mesh-list
56869493|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56869494|NCT01234194|Narcotics|narcotics|mesh-ancestor
56869495|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869496|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869497|NCT01234194|Analgesics|analgesics|mesh-ancestor
56869498|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
56869499|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869500|NCT04913922|Nivolumab|nivolumab|mesh-list
56869501|NCT04913922|Azacitidine|azacitidine|mesh-list
56869502|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56869503|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869504|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56869505|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869506|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56869507|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
56869508|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869509|NCT04910022|Lomustine|lomustine|mesh-list
56869510|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56869511|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
56869512|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869513|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869514|NCT05485662|Listerine|listerine|mesh-list
56869515|NCT05485662|Fluorides|fluorides|mesh-list
56869516|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
56869517|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
56869518|NCT05485662|Protective Agents|protective agents|mesh-ancestor
56869519|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869520|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56869521|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869522|NCT01234272|Morphine|morphine|mesh-list
56869523|NCT01234272|Ropivacaine|ropivacaine|mesh-list
56869524|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56869525|NCT01234272|Narcotics|narcotics|mesh-ancestor
56869526|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869527|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869528|NCT01234272|Analgesics|analgesics|mesh-ancestor
56869529|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
56869530|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869531|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
56869532|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
56869533|NCT01140438|Metformin|metformin|mesh-list
56869534|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56869535|NCT01140438|Repaglinide|repaglinide|mesh-list
56869536|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
56869537|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
56869538|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
56869539|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56869540|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869541|NCT01140438|Incretins|incretins|mesh-ancestor
56869542|NCT01140438|Hormones|hormones|mesh-ancestor
56869543|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869544|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56869545|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
56869546|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869547|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869548|NCT01234506|Vitamin D|vitamin d|mesh-list
56869549|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
56869550|NCT01234506|Vitamins|vitamins|mesh-ancestor
56869551|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
56869552|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869553|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56869554|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
56580354|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56869555|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56869556|NCT01234506|Estrogens|estrogens|mesh-ancestor
56869557|NCT01234506|Hormones|hormones|mesh-ancestor
56920218|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869558|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869559|NCT04751604|Niacinamide|niacinamide|mesh-list
56869560|NCT04751604|Niacin|niacin|mesh-list
56869561|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
56869562|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
56869563|NCT04751604|Vitamins|vitamins|mesh-ancestor
56869565|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869566|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56869567|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
56869568|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869569|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56869570|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
56869571|NCT01231542|Rifampin|rifampin|mesh-list
56869572|NCT01231542|Rifabutin|rifabutin|mesh-list
56869573|NCT01231542|Dolutegravir|dolutegravir|mesh-list
56869574|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56869575|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
56869576|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56869577|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869578|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
56869579|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56869580|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869581|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869582|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56869583|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56869584|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56869585|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56869586|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56869587|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56869588|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56869589|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56869590|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56869591|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56869592|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
56869593|NCT01231698|Esmolol|esmolol|mesh-list
56869594|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56869595|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56869596|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56869597|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
56869598|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869599|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869600|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869601|NCT01142778|Bevacizumab|bevacizumab|mesh-list
56869602|NCT01142778|Trastuzumab|trastuzumab|mesh-list
56869603|NCT01142778|Docetaxel|docetaxel|mesh-list
56869604|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56869605|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869606|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56869607|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56869608|NCT01142778|Growth Substances|growth substances|mesh-ancestor
56869609|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869610|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
56869611|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56869612|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56869613|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56869614|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869615|NCT03739710|Docetaxel|docetaxel|mesh-list
56869616|NCT03739710|Ipilimumab|ipilimumab|mesh-list
56869617|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869618|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
56869619|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
56869620|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
56869621|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869622|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56869623|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56869624|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
56869625|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56869626|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56869627|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869628|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
56869629|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
56869630|NCT04722978|Gemcitabine|gemcitabine|mesh-list
56869631|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
56869632|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56869633|NCT04722978|Carboplatin|carboplatin|mesh-list
56869634|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56869635|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869636|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56869637|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
56869639|NCT04722978|Antiviral Agents|antiviral agents|mesh-ancestor
56869640|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869641|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869642|NCT04722978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56869643|NCT04722978|Immunologic Factors|immunologic factors|mesh-ancestor
56869644|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869645|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56869646|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56869647|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56869648|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
56869649|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56869650|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56869651|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56869652|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56869653|NCT01140828|Rabeprazole|rabeprazole|mesh-list
56869654|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56869655|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869656|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56869657|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869658|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869659|NCT01234740|Bafetinib|bafetinib|mesh-list
56869660|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56869661|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869662|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869663|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
56869664|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56869665|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
56869666|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56869667|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869668|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56869669|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56869670|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56869671|NCT03720990|Cholic Acids|cholic acids|mesh-list
56869672|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869673|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
56869674|NCT03714594|Saxagliptin|saxagliptin|mesh-list
56869675|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56869676|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869677|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56869678|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869679|NCT03714594|Incretins|incretins|mesh-ancestor
56869680|NCT03714594|Hormones|hormones|mesh-ancestor
56869681|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869682|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56869683|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
56869684|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869685|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
56869686|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56869687|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56869688|NCT04624776|Prednisolone|prednisolone|mesh-list
56869689|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
56869690|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56869691|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
56869692|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56869693|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
56869694|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
56869695|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869696|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869697|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869698|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
56869699|NCT04624776|Hormones|hormones|mesh-ancestor
56869700|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869701|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56869702|NCT04624776|Protective Agents|protective agents|mesh-ancestor
56869703|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56869704|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580502|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
56869705|NCT01234896|Nicotine|nicotine|mesh-list
56869706|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56869707|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
56869708|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869709|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869711|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56869712|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
56869713|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869714|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869715|NCT01238094|Simvastatin|simvastatin|mesh-list
56869716|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56869717|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56869718|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
56869719|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869720|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56869721|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56869722|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869723|NCT01236612|Chloroquine|chloroquine|mesh-list
56869724|NCT01236612|Proguanil|proguanil|mesh-list
56869725|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56869726|NCT01236612|Amebicides|amebicides|mesh-ancestor
56869727|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56869728|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56869729|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869730|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
56869731|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869732|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
56869733|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869734|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
56869735|NCT03633630|Antacids|antacids|mesh-ancestor
56869736|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869737|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869738|NCT01234974|Everolimus|everolimus|mesh-list
56869739|NCT01234974|Pasireotide|pasireotide|mesh-list
56869740|NCT01234974|Somatostatin|somatostatin|mesh-list
56869741|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869742|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56869743|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
56869744|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869745|NCT01234974|Hormones|hormones|mesh-ancestor
56869746|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869747|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
56869748|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56869749|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56869750|NCT01140984|Prednisolone|prednisolone|mesh-list
56869751|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
56869752|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56869753|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
56869754|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56869755|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
56869756|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
56869757|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869758|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869759|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869760|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
56869761|NCT01140984|Hormones|hormones|mesh-ancestor
56869762|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869763|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56869764|NCT01140984|Protective Agents|protective agents|mesh-ancestor
56869765|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56869766|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869767|NCT01145430|Doxorubicin|doxorubicin|mesh-list
56869768|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56869769|NCT01145430|Veliparib|veliparib|mesh-list
56869770|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56869771|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869772|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56869773|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56869774|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869775|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869776|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56869777|NCT03389724|Captopril|captopril|mesh-list
56869778|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56869779|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
56869780|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869781|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869782|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56869783|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
56869784|NCT01586052|Hematinics|hematinics|mesh-ancestor
56869785|NCT03684564|Warfarin|warfarin|mesh-list
56869786|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
56869787|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
56869788|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56869789|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
56869790|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56869791|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
56869792|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869793|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869794|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
56869795|NCT04478292|Cisplatin|cisplatin|mesh-list
56869796|NCT04478292|Carboplatin|carboplatin|mesh-list
56869797|NCT04478292|Doxorubicin|doxorubicin|mesh-list
56869798|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56869799|NCT04478292|Fluorouracil|fluorouracil|mesh-list
56869800|NCT04478292|Irinotecan|irinotecan|mesh-list
56869801|NCT04478292|Vincristine|vincristine|mesh-list
56869802|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869803|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56869804|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56869805|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56869806|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869807|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869808|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
56869809|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56869810|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56869811|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
56869812|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869813|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56869814|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56869815|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
56869816|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
56869817|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
56869818|NCT04478292|Antidotes|antidotes|mesh-ancestor
56869819|NCT04478292|Protective Agents|protective agents|mesh-ancestor
56869820|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
56869821|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
56869822|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56869823|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869824|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
56869825|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
56869826|NCT01141296|Fenofibrate|fenofibrate|mesh-list
56869827|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56869828|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
56869829|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869830|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56869831|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
56869832|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56869833|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56869834|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
56869835|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869836|NCT01238406|Pancrelipase|pancrelipase|mesh-list
56869837|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869838|NCT03724890|Avelumab|avelumab|mesh-list
56869839|NCT03724890|Peposertib|peposertib|mesh-list
56869840|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56869841|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869842|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56869843|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869844|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869845|NCT01141452|Fluticasone|fluticasone|mesh-list
56869846|NCT01141452|Xhance|xhance|mesh-list
56869847|NCT01141452|Beclomethasone|beclomethasone|mesh-list
56869848|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56869849|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56869850|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
56869851|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869852|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580650|NCT04268394|Methotrexate|methotrexate|mesh-list
56869853|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56869854|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
56869855|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
56869856|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56869857|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
56869858|NCT01141452|Hormones|hormones|mesh-ancestor
56869859|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869860|NCT00219557|Gemcitabine|gemcitabine|mesh-list
56869861|NCT00219557|Axitinib|axitinib|mesh-list
56869862|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56869864|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869865|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869866|NCT00219557|Antiviral Agents|antiviral agents|mesh-ancestor
56869867|NCT00219557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869868|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869869|NCT00219557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56869870|NCT00219557|Immunologic Factors|immunologic factors|mesh-ancestor
56869871|NCT00219557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869872|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56869873|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
56869874|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56869875|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56869876|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56869877|NCT05282940|Estradiol|estradiol|mesh-list
56869878|NCT05282940|Estrogens|estrogens|mesh-ancestor
56869879|NCT05282940|Hormones|hormones|mesh-ancestor
56869880|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56869881|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869882|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56869883|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
56869884|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56869885|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56869886|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56869887|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56869888|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56869889|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56869890|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56869891|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56869892|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56869893|NCT01238562|Lenograstim|lenograstim|mesh-list
56869894|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56869895|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
56869896|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869897|NCT01329666|Vitamin D|vitamin d|mesh-list
56869898|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
56869899|NCT01329666|Vitamins|vitamins|mesh-ancestor
56869900|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
56869901|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869902|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56869903|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56869904|NCT05255484|Antibodies|antibodies|mesh-list
56869905|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
56869906|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869907|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
56869908|NCT01141998|Vitamin D|vitamin d|mesh-list
56869909|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
56869910|NCT01141998|Calcium|calcium|mesh-list
56869911|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56869912|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869913|NCT01141998|Vitamins|vitamins|mesh-ancestor
56869914|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
56869915|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56869916|NCT01238718|Lidocaine|lidocaine|mesh-list
56869917|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
56869918|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
56869919|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869920|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869921|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
56869922|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869923|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56869924|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56869925|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56869926|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56869927|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869928|NCT01238796|Telavancin|telavancin|mesh-list
56869929|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56869930|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56869931|NCT01143948|Insulin|insulin|mesh-list
56869932|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56869933|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56869934|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869935|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
56869936|NCT01145976|Fludarabine|fludarabine|mesh-list
56869938|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56869939|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56869940|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
56869941|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869942|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56869943|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56869944|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
56869945|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869946|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869947|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56869948|NCT01238952|Carboplatin|carboplatin|mesh-list
56869949|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56869950|NCT05158998|Propofol|propofol|mesh-list
56869951|NCT05158998|Sevoflurane|sevoflurane|mesh-list
56869952|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56869953|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869954|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869955|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56869956|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
56869957|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
56869958|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56869959|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56869960|NCT02282358|Mocetinostat|mocetinostat|mesh-list
56869961|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56869962|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869963|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869964|NCT01144260|Bafetinib|bafetinib|mesh-list
56869965|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56869966|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56869967|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869968|NCT01239498|Lidocaine|lidocaine|mesh-list
56869969|NCT01239498|Epinephrine|epinephrine|mesh-list
56869970|NCT01239498|Racepinephrine|racepinephrine|mesh-list
56869971|NCT01239498|Anesthetics|anesthetics|mesh-list
56869972|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
56869973|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
56869974|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56869975|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56869976|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
56869977|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56869978|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56869979|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56869980|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56869981|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56869982|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56869983|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56869984|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56869985|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
56869986|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56869987|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56869988|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56869989|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
56869990|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56869991|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
56869992|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
56869993|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
56869994|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56869995|NCT00251927|Esomeprazole|esomeprazole|mesh-list
56869996|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56869997|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56869998|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56869999|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870000|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870001|NCT03790800|Urapidil|urapidil|mesh-list
56870002|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56870003|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
56870004|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56870005|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
56870006|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870007|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870008|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870009|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56870010|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56870011|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56870012|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
56870013|NCT03971201|Sorafenib|sorafenib|mesh-list
56870014|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870015|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56870016|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870017|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870018|NCT01236144|Plerixafor|plerixafor|mesh-list
56870019|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56870020|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56870021|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
56870022|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870023|NCT02528526|Inositol|inositol|mesh-list
56870024|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
56870025|NCT02528526|Vitamins|vitamins|mesh-ancestor
56870026|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
56870027|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870028|NCT03971279|Dexamethasone|dexamethasone|mesh-list
56870029|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56870030|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
56870031|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
56870032|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870033|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870034|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56870035|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
56870036|NCT03971279|Hormones|hormones|mesh-ancestor
56870037|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870038|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56870039|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870040|NCT01329744|Mecasermin|mecasermin|mesh-list
56870041|NCT01329744|Growth Substances|growth substances|mesh-ancestor
56870042|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870043|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
56870044|NCT00165503|Pemetrexed|pemetrexed|mesh-list
56870045|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870046|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870047|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870048|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56870049|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56870050|NCT00165503|Antidotes|antidotes|mesh-ancestor
56870051|NCT00165503|Protective Agents|protective agents|mesh-ancestor
56870052|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870053|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
56870054|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
56870055|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56870056|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870057|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
56870058|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
56870059|NCT01144650|Dapsone|dapsone|mesh-list
56870060|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870061|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
56870062|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56870063|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56870064|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56870065|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870066|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870067|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
56870068|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56870069|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
56870070|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
56870071|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870072|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
56870073|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870074|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870075|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56870076|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
56870077|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870078|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870079|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56870080|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870081|NCT00162773|Omalizumab|omalizumab|mesh-list
56870082|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56870083|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56870084|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
56870085|NCT03970577|Prednisone|prednisone|mesh-list
56870086|NCT03970577|Rituximab|rituximab|mesh-list
56920219|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
56870088|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870089|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
56870090|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870091|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870092|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56870093|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
56870095|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870096|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56870097|NCT01073813|Minocycline|minocycline|mesh-list
56870098|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56870099|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870100|NCT03823391|Adalimumab|adalimumab|mesh-list
56870101|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56870102|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870103|NCT00161213|Gemcitabine|gemcitabine|mesh-list
56870104|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
56870105|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56870106|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
56870107|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870108|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870109|NCT00161213|Antiviral Agents|antiviral agents|mesh-ancestor
56870110|NCT00161213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870111|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870112|NCT00161213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870113|NCT00161213|Immunologic Factors|immunologic factors|mesh-ancestor
56870114|NCT00161213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870115|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56870116|NCT01075529|Fluoxetine|fluoxetine|mesh-list
56870117|NCT01075529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56870118|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56870119|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56870120|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870121|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870122|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
56870123|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870124|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56870125|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
56870126|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56870127|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56870128|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56870129|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870130|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
56870131|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56870132|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56870133|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870134|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56870135|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56870136|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870137|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870138|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870139|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56870140|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
56870141|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56870142|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870143|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56870144|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56870145|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56870146|NCT00209027|Aripiprazole|aripiprazole|mesh-list
56870147|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
56870148|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56870149|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56870150|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56870151|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56870152|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870153|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
56870154|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
56870155|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870156|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870157|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56870160|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56870161|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56870162|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56870163|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56870164|NCT00160667|Brivaracetam|brivaracetam|mesh-list
56870165|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
56870166|NCT00206375|Hormones|hormones|mesh-list
56870167|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870168|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870169|NCT00160199|Progesterone|progesterone|mesh-list
56870170|NCT00160199|Progestins|progestins|mesh-ancestor
56870171|NCT00160199|Hormones|hormones|mesh-ancestor
56870172|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870173|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870174|NCT00157157|Factor VIII|factor viii|mesh-list
56870175|NCT00157157|Coagulants|coagulants|mesh-ancestor
56870176|NCT00203411|Bevacizumab|bevacizumab|mesh-list
56870177|NCT00203411|Capecitabine|capecitabine|mesh-list
56870178|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870179|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870180|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870181|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870182|NCT00203411|Growth Substances|growth substances|mesh-ancestor
56870183|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870184|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870185|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56870186|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
56870187|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870188|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
56870189|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
56870190|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56870191|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
56870192|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870193|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870194|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870195|NCT00201851|Tamoxifen|tamoxifen|mesh-list
56870196|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56870197|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
56870198|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870199|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870200|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56870201|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870202|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56870203|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56870204|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56870205|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
56870206|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56870207|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870208|NCT01074281|Enalapril|enalapril|mesh-list
56870209|NCT01074281|Enalaprilat|enalaprilat|mesh-list
56870210|NCT01074281|Nitrendipine|nitrendipine|mesh-list
56870211|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870212|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870213|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56870214|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
56870215|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56870216|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56870217|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56870218|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56870219|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870220|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
56870221|NCT03129100|Ixekizumab|ixekizumab|mesh-list
56870222|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
56870223|NCT03100006|Nivolumab|nivolumab|mesh-list
56870224|NCT03100006|Oregovomab|oregovomab|mesh-list
56870225|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870226|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870227|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56870228|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870229|NCT03099538|Ixekizumab|ixekizumab|mesh-list
56870230|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
56870232|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870233|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581025|NCT00687466|Insulin|insulin|mesh-list
56870234|NCT00883480|Gemcitabine|gemcitabine|mesh-list
56870235|NCT00883480|Docetaxel|docetaxel|mesh-list
56870236|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56870237|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870238|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56870239|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
56870240|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870241|NCT00883480|Antiviral Agents|antiviral agents|mesh-ancestor
56870242|NCT00883480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870243|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870244|NCT00883480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870245|NCT00883480|Immunologic Factors|immunologic factors|mesh-ancestor
56870246|NCT00883480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870247|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
56870248|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
56870249|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
56870250|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56870251|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
56870252|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56870253|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870254|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56870255|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870256|NCT03097588|Palonosetron|palonosetron|mesh-list
56870257|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
56870258|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
56870259|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870260|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870261|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56870262|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56870263|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56870264|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
56870265|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870266|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870267|NCT05418556|Aspirin|aspirin|mesh-list
56870268|NCT05418556|Clopidogrel|clopidogrel|mesh-list
56870269|NCT05418556|Ticagrelor|ticagrelor|mesh-list
56870270|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56870271|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56870272|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56870273|NCT05418556|Analgesics|analgesics|mesh-ancestor
56870274|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
56870275|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870276|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870277|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56870278|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870279|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56870280|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56870281|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870282|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56870283|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56870284|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870285|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
56870286|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56870287|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56870288|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56870289|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
56870290|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870291|NCT04956640|Carboplatin|carboplatin|mesh-list
56870292|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
56870293|NCT04956640|Pemetrexed|pemetrexed|mesh-list
56870294|NCT04956640|Cetuximab|cetuximab|mesh-list
56870295|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870296|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870297|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870298|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870299|NCT04956640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56870300|NCT04956640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56870301|NCT04939792|Vitamin D|vitamin d|mesh-list
56870302|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
56870303|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
56870304|NCT04939792|Vitamins|vitamins|mesh-list
56870307|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56581113|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
56920220|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
56870308|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56870309|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
56870310|NCT04900792|Temozolomide|temozolomide|mesh-list
56870311|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56870312|NCT04900792|Vitamins|vitamins|mesh-ancestor
56870313|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
56870314|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870315|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56870316|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
56870317|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870318|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870319|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
56870320|NCT04900792|Protective Agents|protective agents|mesh-ancestor
56870321|NCT04900792|Hematinics|hematinics|mesh-ancestor
56870322|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56870323|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56870324|NCT05418244|Ondansetron|ondansetron|mesh-list
56870325|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
56870326|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
56870327|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870328|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870329|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56870330|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
56870331|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
56870332|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56870333|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
56870334|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870335|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870336|NCT05418244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56870337|NCT05418244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56870338|NCT05418244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56870339|NCT05418244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56870340|NCT05418244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56870341|NCT05418166|Evolocumab|evolocumab|mesh-list
56870342|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56870343|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56870344|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
56870345|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870346|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56870347|NCT04738942|Vedolizumab|vedolizumab|mesh-list
56870348|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56870349|NCT01631214|Alendronate|alendronate|mesh-list
56870350|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56870351|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56870352|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870353|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
56870354|NCT01567774|Atorvastatin|atorvastatin|mesh-list
56870355|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56870356|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56870357|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56870358|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
56870359|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870360|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56870361|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56870362|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870363|NCT04663750|Aflibercept|aflibercept|mesh-list
56870364|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56870365|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870366|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870367|NCT04663750|Growth Substances|growth substances|mesh-ancestor
56870368|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870369|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870370|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870371|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56870372|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56870373|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870374|NCT01567930|Sirolimus|sirolimus|mesh-list
56870375|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56870376|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870388|NCT01142622|Ropivacaine|ropivacaine|mesh-list
56870389|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
56870390|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
56870391|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56870392|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870393|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
56870394|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870395|NCT01142700|Ribavirin|ribavirin|mesh-list
56870396|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56870397|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
56870398|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870399|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
56870400|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870409|NCT01144728|Metformin|metformin|mesh-list
56870410|NCT01144728|Glimepiride|glimepiride|mesh-list
56870411|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56870412|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870413|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56870414|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870415|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
56870416|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
56870417|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56870418|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
56870419|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870420|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
56870421|NCT01239810|Protective Agents|protective agents|mesh-ancestor
56870422|NCT01239888|Tibolone|tibolone|mesh-list
56870423|NCT01239888|Oxytocin|oxytocin|mesh-list
56870424|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
56870425|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56870426|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870427|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
56870428|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
56870429|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870430|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56870431|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56870432|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870433|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56870434|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
56870435|NCT01239888|Hormones|hormones|mesh-ancestor
56870436|NCT01318486|Heparin|heparin|mesh-list
56870437|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
56870438|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56870439|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56870440|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870441|NCT03436108|Bisphenol A|bisphenol a|mesh-list
56870442|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56870443|NCT03436108|Estrogens|estrogens|mesh-ancestor
56870444|NCT03436108|Hormones|hormones|mesh-ancestor
56870445|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870446|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870447|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56870448|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
56870450|NCT03436108|Protective Agents|protective agents|mesh-ancestor
56870451|NCT02870218|Nicotine|nicotine|mesh-list
56870452|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56870453|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
56870454|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870455|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870456|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56581257|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
56870457|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56870458|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
56870459|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870460|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870461|NCT02614690|Calpastatin|calpastatin|mesh-list
56870462|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56870463|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
56870464|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870465|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870466|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56870467|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56870468|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870469|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870470|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
56870471|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870472|NCT00468130|Aripiprazole|aripiprazole|mesh-list
56870473|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
56870474|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56870475|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56870476|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56870477|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56870478|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870479|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
56870480|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
56904201|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
56870481|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870482|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870483|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56870484|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56870485|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
56870486|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56870487|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56870488|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56870489|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56870490|NCT05196256|Sufentanil|sufentanil|mesh-list
56870491|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
56870492|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56870493|NCT05196256|Narcotics|narcotics|mesh-ancestor
56870494|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56870495|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870496|NCT05196256|Analgesics|analgesics|mesh-ancestor
56870497|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
56870498|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870499|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56870500|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56870501|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
56870502|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
56870503|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
56870504|NCT01375348|Remifentanil|remifentanil|mesh-list
56870505|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56870506|NCT01375348|Narcotics|narcotics|mesh-ancestor
56870507|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56870508|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870509|NCT01375348|Analgesics|analgesics|mesh-ancestor
56870510|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
56870511|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870512|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
56870513|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
56870514|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870515|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
56870516|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870517|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870518|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56870519|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
56904724|NCT00191477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870521|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870522|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56870523|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56870524|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56870525|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
56870526|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56870527|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870528|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870529|NCT05194852|Anesthetics|anesthetics|mesh-list
56870530|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
56870531|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56870532|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870533|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
56870534|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870535|NCT01375426|Amoxicillin|amoxicillin|mesh-list
56870536|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56870537|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870538|NCT05193838|Allopurinol|allopurinol|mesh-list
56870539|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
56870540|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870541|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870542|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
56870543|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870544|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56870545|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
56870546|NCT05193838|Protective Agents|protective agents|mesh-ancestor
56870547|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870548|NCT05193604|Gemcitabine|gemcitabine|mesh-list
56870549|NCT05193604|Paclitaxel|paclitaxel|mesh-list
56870550|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56870551|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870552|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
56870553|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
56870554|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
56870555|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870556|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56870557|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
56870558|NCT05193604|Antiviral Agents|antiviral agents|mesh-ancestor
56870559|NCT05193604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870560|NCT05193604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870561|NCT05193604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870562|NCT05193604|Immunologic Factors|immunologic factors|mesh-ancestor
56870563|NCT05193604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870564|NCT01375816|Leucovorin|leucovorin|mesh-list
56870565|NCT01375816|Bevacizumab|bevacizumab|mesh-list
56870566|NCT01375816|Fluorouracil|fluorouracil|mesh-list
56870567|NCT01375816|Irinotecan|irinotecan|mesh-list
56870568|NCT01375816|Calcium|calcium|mesh-list
56870569|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
56870570|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870571|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870572|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870573|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870574|NCT01375816|Growth Substances|growth substances|mesh-ancestor
56870575|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870576|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870577|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56870578|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
56870579|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870580|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56870581|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870582|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
56870583|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56870584|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56870585|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870586|NCT01375816|Antidotes|antidotes|mesh-ancestor
56870587|NCT01375816|Protective Agents|protective agents|mesh-ancestor
56870588|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
56870589|NCT01375816|Vitamins|vitamins|mesh-ancestor
56870590|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
56870591|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
56870592|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56870593|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56870594|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870595|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
56870596|NCT03632824|Coagulants|coagulants|mesh-ancestor
56870597|NCT00911820|Bevacizumab|bevacizumab|mesh-list
56870598|NCT00911820|Cisplatin|cisplatin|mesh-list
56870599|NCT00911820|Docetaxel|docetaxel|mesh-list
56870600|NCT00911820|Irinotecan|irinotecan|mesh-list
56870601|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870602|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870603|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870604|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870605|NCT00911820|Growth Substances|growth substances|mesh-ancestor
56581401|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56870606|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870607|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870609|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
56870610|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
56870611|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870612|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56870613|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56870614|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870615|NCT05348122|Dulaglutide|dulaglutide|mesh-list
56870616|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56870617|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56870618|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870619|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
56870620|NCT05125276|Aspirin|aspirin|mesh-list
56870621|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56870622|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56870623|NCT05125276|Analgesics|analgesics|mesh-ancestor
56870624|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
56870625|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870626|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870627|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56870628|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870629|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56870630|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56870631|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870632|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56870633|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56870634|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870635|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
56870636|NCT05054842|Metformin|metformin|mesh-list
56870637|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56870638|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870639|NCT05038618|Somatomedin B|somatomedin b|mesh-list
56870640|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56870641|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56870642|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
56870643|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870644|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870645|NCT01244880|Ketamine|ketamine|mesh-list
56870646|NCT01244880|Analgesics|analgesics|mesh-ancestor
56870647|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
56870648|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870649|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870650|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56870651|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56870652|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
56870653|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
56870654|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56870655|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56870656|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56870657|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870658|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870659|NCT01244958|Rituximab|rituximab|mesh-list
56870660|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870661|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870662|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
56870663|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870664|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870665|NCT00246324|Interferons|interferons|mesh-list
56870666|NCT00246324|Interferon-beta|interferon-beta|mesh-list
56870667|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
56870668|NCT00246324|Doxycycline|doxycycline|mesh-list
56870669|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870670|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
56904725|NCT00191477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870671|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870672|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56870673|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
56870674|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56870675|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56870676|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
56870677|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870678|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56870679|NCT01237782|Propolis|propolis|mesh-list
56870680|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56870681|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581475|NCT04136470|Nivolumab|nivolumab|mesh-list
56870682|NCT01245660|Lapatinib|lapatinib|mesh-list
56870683|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870684|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56870685|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870686|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870687|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
56870688|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870689|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56870690|NCT03913806|Bevacizumab|bevacizumab|mesh-list
56870691|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870692|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870693|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870694|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870695|NCT03913806|Growth Substances|growth substances|mesh-ancestor
56870696|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870697|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870698|NCT01250808|Dexamethasone|dexamethasone|mesh-list
56870699|NCT01250808|Bortezomib|bortezomib|mesh-list
56870700|NCT01250808|Melphalan|melphalan|mesh-list
56870701|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56870702|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
56870703|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
56870704|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870705|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870706|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56870707|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
56870708|NCT01250808|Hormones|hormones|mesh-ancestor
56870709|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870710|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56870711|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870712|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56870713|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
56870714|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870715|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56870716|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870717|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
56870718|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
56870719|NCT01146678|Lixisenatide|lixisenatide|mesh-list
56870720|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56870721|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870722|NCT05429866|Nivolumab|nivolumab|mesh-list
56870723|NCT05429866|Durvalumab|durvalumab|mesh-list
56870724|NCT05429866|Avelumab|avelumab|mesh-list
56870725|NCT05429866|Cemiplimab|cemiplimab|mesh-list
56870726|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56870727|NCT05429866|Atezolizumab|atezolizumab|mesh-list
56870728|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870729|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870730|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870731|NCT04778982|Fulvestrant|fulvestrant|mesh-list
56870732|NCT04778982|Palbociclib|palbociclib|mesh-list
56870733|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56870734|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870735|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56870736|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56870737|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
56870738|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870739|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870740|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56870741|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870742|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870743|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56870744|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
56870745|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
56870747|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870749|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
56870750|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870751|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870752|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
56870753|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56870754|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56870755|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
56870756|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56870757|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56870758|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56870760|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56870761|NCT03632590|Cathartics|cathartics|mesh-ancestor
56870762|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56870763|NCT03632590|Antacids|antacids|mesh-ancestor
56870764|NCT05376670|Gentamicins|gentamicins|mesh-list
56870765|NCT05376670|Tobramycin|tobramycin|mesh-list
56870766|NCT05376670|Amikacin|amikacin|mesh-list
56870767|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56870768|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870769|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56870770|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870771|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870772|NCT01242774|Panobinostat|panobinostat|mesh-list
56870773|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870774|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56870775|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870776|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870777|NCT01243086|Dexamethasone|dexamethasone|mesh-list
56870778|NCT01243086|Ranibizumab|ranibizumab|mesh-list
56870779|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56870780|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
56870781|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
56870782|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870783|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870784|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56870785|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
56870786|NCT01243086|Hormones|hormones|mesh-ancestor
56870787|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870788|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56870789|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870790|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870791|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870792|NCT01243086|Growth Substances|growth substances|mesh-ancestor
56870793|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870794|NCT03908814|Antibodies|antibodies|mesh-list
56870795|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
56870796|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870797|NCT01253382|Ecallantide|ecallantide|mesh-list
56870798|NCT01253382|Analgesics|analgesics|mesh-ancestor
56870799|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
56870800|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56870801|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870802|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56870803|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56870804|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56870805|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56870806|NCT01148160|Voriconazole|voriconazole|mesh-list
56870807|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
56870808|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870809|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56870810|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56870811|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870812|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870813|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56870814|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
56870815|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870816|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870817|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56870818|NCT01147692|Simvastatin|simvastatin|mesh-list
56870819|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
56870825|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56870827|NCT01147692|Incretins|incretins|mesh-ancestor
56870828|NCT01147692|Hormones|hormones|mesh-ancestor
56870829|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870830|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870831|NCT03913182|Apatinib|apatinib|mesh-list
56870832|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870833|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56870834|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870835|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870837|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870838|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56870839|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870840|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870841|NCT02713386|Paclitaxel|paclitaxel|mesh-list
56870842|NCT02713386|Carboplatin|carboplatin|mesh-list
56870843|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56870844|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56870845|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870846|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
56870847|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
56870848|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
56870849|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870850|NCT02671890|Gemcitabine|gemcitabine|mesh-list
56870851|NCT02671890|Disulfiram|disulfiram|mesh-list
56870852|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56870853|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
56870854|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870855|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870856|NCT02671890|Antiviral Agents|antiviral agents|mesh-ancestor
56870857|NCT02671890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870858|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904207|NCT04940338|Hormones|hormones|mesh-ancestor
56870859|NCT02671890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870860|NCT02671890|Immunologic Factors|immunologic factors|mesh-ancestor
56870861|NCT02671890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870862|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56870863|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56870864|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
56870865|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56870866|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
56870867|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870868|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
56870869|NCT02287428|Temozolomide|temozolomide|mesh-list
56870870|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870871|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870872|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56870873|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
56870874|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870875|NCT01967238|Vaccines|vaccines|mesh-list
56870876|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
56870877|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870878|NCT05616000|Folic Acid|folic acid|mesh-list
56870879|NCT05616000|Acetylcarnitine|acetylcarnitine|mesh-list
56870880|NCT05616000|Hematinics|hematinics|mesh-ancestor
56870881|NCT05616000|Vitamin B Complex|vitamin b complex|mesh-ancestor
56870882|NCT05616000|Vitamins|vitamins|mesh-ancestor
56870883|NCT05616000|Micronutrients|micronutrients|mesh-ancestor
56870884|NCT05616000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870885|NCT05616000|Nootropic Agents|nootropic agents|mesh-ancestor
56870886|NCT00999804|Trastuzumab|trastuzumab|mesh-list
56870887|NCT00999804|Letrozole|letrozole|mesh-list
56870888|NCT00999804|Lapatinib|lapatinib|mesh-list
56870889|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870890|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870892|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56870893|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870894|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870895|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56870896|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
56870897|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870898|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870899|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56870901|NCT03912402|Bevacizumab|bevacizumab|mesh-list
56870902|NCT03912402|Carboplatin|carboplatin|mesh-list
56870903|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56870904|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870905|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
56870906|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
56870907|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
56870908|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870909|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870910|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870911|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870912|NCT03912402|Growth Substances|growth substances|mesh-ancestor
56870913|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870914|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870915|NCT01147770|Progesterone|progesterone|mesh-list
56870916|NCT01147770|Progestins|progestins|mesh-ancestor
56870917|NCT01147770|Hormones|hormones|mesh-ancestor
56870918|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56870919|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870920|NCT01148316|Fluoxetine|fluoxetine|mesh-list
56870921|NCT01148316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56870922|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56870923|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56870924|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870925|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56870926|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
56870927|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870928|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56870929|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
56870930|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56870931|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56870932|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56870933|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870934|NCT01249638|Bevacizumab|bevacizumab|mesh-list
56870935|NCT01249638|Capecitabine|capecitabine|mesh-list
56870936|NCT01249638|Irinotecan|irinotecan|mesh-list
56870937|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56870938|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870939|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870940|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870941|NCT01249638|Growth Substances|growth substances|mesh-ancestor
56870942|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870943|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870944|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56870945|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
56870946|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870947|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56870948|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56870949|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870950|NCT03907098|Endostar protein|endostar protein|mesh-list
56870951|NCT03907098|Endostatins|endostatins|mesh-list
56870952|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56870953|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870954|NCT03907098|Growth Substances|growth substances|mesh-ancestor
56870955|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870956|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870957|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870958|NCT01251822|Prucalopride|prucalopride|mesh-list
56870959|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56870960|NCT01251822|Laxatives|laxatives|mesh-ancestor
56870961|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56870962|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56870970|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56870971|NCT01253694|Growth Substances|growth substances|mesh-ancestor
56870972|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870973|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
56870974|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870976|NCT03915444|Paclitaxel|paclitaxel|mesh-list
56870977|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56870978|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56870979|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
56870980|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
56870981|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
56870982|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870983|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56870985|NCT03915444|Antiviral Agents|antiviral agents|mesh-ancestor
56870986|NCT03915444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56870987|NCT03915444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870988|NCT03915444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56870989|NCT03915444|Immunologic Factors|immunologic factors|mesh-ancestor
56870990|NCT03915444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56870991|NCT01148004|Ritonavir|ritonavir|mesh-list
56870992|NCT01148004|Lopinavir|lopinavir|mesh-list
56870993|NCT01148004|Fenofibrate|fenofibrate|mesh-list
56870994|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56870995|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56870996|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
56870997|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56870998|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56870999|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56871000|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56871001|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
56871002|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871003|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56871004|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56871005|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56871006|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
56871007|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56871008|NCT01252056|Cilostazol|cilostazol|mesh-list
56871009|NCT01252056|Probucol|probucol|mesh-list
56871010|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56871011|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
56871012|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871013|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871014|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56871015|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
56871016|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56871017|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56871018|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871019|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56871020|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
56871021|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56871022|NCT01252056|Protective Agents|protective agents|mesh-ancestor
56871023|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56871024|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56871025|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871026|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56871027|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56871028|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
56871029|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56871030|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
56871031|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
56871033|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56871034|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56871035|NCT01148472|Citalopram|citalopram|mesh-list
56871036|NCT01148472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56871037|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56871038|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871039|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871040|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871041|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
56871042|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871043|NCT01148472|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56871044|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
56871045|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871046|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871047|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56871048|NCT01148472|Analgesics|analgesics|mesh-ancestor
56871049|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
56871050|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
56871051|NCT01147146|Fentanyl|fentanyl|mesh-list
56871052|NCT01147146|Midazolam|midazolam|mesh-list
56871053|NCT01147146|Bupivacaine|bupivacaine|mesh-list
56871054|NCT01147146|Propofol|propofol|mesh-list
56871055|NCT01147146|Atracurium|atracurium|mesh-list
56871056|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
56871057|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
56871058|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871059|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871060|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
56871061|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871062|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56871063|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56871064|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
56871065|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56871066|NCT01147146|Narcotics|narcotics|mesh-ancestor
56871067|NCT01147146|Analgesics|analgesics|mesh-ancestor
56871068|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56871069|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56871070|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56871071|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871072|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
56871073|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
56871074|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871075|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871076|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56871077|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56871078|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56871079|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56871080|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56871081|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
56871082|NCT01250340|Aspirin|aspirin|mesh-list
56871083|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56871084|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871085|NCT01250340|Analgesics|analgesics|mesh-ancestor
56871086|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
56871087|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871088|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871089|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56871090|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56871091|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56871092|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56871093|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871094|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56871095|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56871096|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871097|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
56871098|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
56871099|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56871100|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871101|NCT01250652|Cetirizine|cetirizine|mesh-list
56871102|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
56871103|NCT01250652|Levocetirizine|levocetirizine|mesh-list
56871104|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56871105|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56871106|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
56871121|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871123|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56871124|NCT01252524|Cathartics|cathartics|mesh-ancestor
56871125|NCT03914352|Antibodies|antibodies|mesh-list
56871126|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
56871127|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871128|NCT01254006|Thiamine|thiamine|mesh-list
56871129|NCT01254006|Vitamins|vitamins|mesh-ancestor
56871130|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
56871131|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871132|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
56871133|NCT03914118|Modafinil|modafinil|mesh-list
56871134|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56871135|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871136|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56871137|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56871138|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56871139|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871140|NCT02528136|Oxytocin|oxytocin|mesh-list
56871141|NCT02528136|Carbetocin|carbetocin|mesh-list
56871142|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
56871143|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56871144|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871145|NCT01252680|Vaccines|vaccines|mesh-list
56871146|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
56871147|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871148|NCT01252758|Albuterol|albuterol|mesh-list
56871149|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56871150|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
56871151|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871152|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871153|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56871154|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
56871155|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
56871156|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56871157|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56871158|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56871159|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56871160|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56871161|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871162|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871163|NCT03913884|Mitogens|mitogens|mesh-list
56871164|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
56871165|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871166|NCT01147224|Ciclesonide|ciclesonide|mesh-list
56871167|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
56871168|NCT01147224|Hormones|hormones|mesh-ancestor
56568374|NCT00890266|Riboflavin|riboflavin|mesh-list
56871184|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
56871185|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
56871186|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871187|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871188|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56871189|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
56871190|NCT02874742|Hormones|hormones|mesh-ancestor
56871191|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871192|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56871193|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871194|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
56871195|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56871196|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56871197|NCT02874742|Growth Substances|growth substances|mesh-ancestor
56871198|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
56871199|NCT01149174|Mitomycins|mitomycins|mesh-list
56871200|NCT01149174|Mitomycin|mitomycin|mesh-list
56871201|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56871202|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871203|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
56871204|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871205|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56871206|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871207|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56871208|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56871209|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581996|NCT00696514|Vitamin D|vitamin d|mesh-list
56871210|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871211|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
56871212|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871213|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871215|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871216|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56871217|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
56871218|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871219|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56871220|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
56871221|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871222|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56871223|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56871224|NCT03909594|Ketamine|ketamine|mesh-list
56871225|NCT03909594|Bupivacaine|bupivacaine|mesh-list
56871226|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
56871227|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
56871228|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871229|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871233|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56871234|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56871235|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
56871236|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56871237|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56871238|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871239|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871240|NCT04492072|Misoprostol|misoprostol|mesh-list
56871241|NCT04492072|Oxytocin|oxytocin|mesh-list
56871242|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
56871243|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56871244|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871245|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56871246|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
56871247|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56871248|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56871249|NCT04181008|Amiloride|amiloride|mesh-list
56871250|NCT04181008|Diuretics|diuretics|mesh-ancestor
56871251|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
56871252|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871253|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56871254|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56871255|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871256|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871257|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56871258|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56871259|NCT04421248|Methylphenidate|methylphenidate|mesh-list
56871260|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56871261|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871262|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56871263|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56871264|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871265|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871266|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
56871267|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871268|NCT04160494|Atezolizumab|atezolizumab|mesh-list
56871269|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
56871270|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871271|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
56871272|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871273|NCT03629340|Metformin|metformin|mesh-list
56871274|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56871275|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871276|NCT03904836|Tobramycin|tobramycin|mesh-list
56871277|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56871278|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871279|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56871280|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56871281|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871282|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582083|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
56871283|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56871284|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871285|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871286|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
56871287|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871288|NCT03904680|Vitamin D|vitamin d|mesh-list
56871289|NCT03904680|Methotrexate|methotrexate|mesh-list
56871290|NCT03904680|Vitamins|vitamins|mesh-ancestor
56871291|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
56871292|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871293|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56871294|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56871295|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
56871296|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56871297|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56871298|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
56904726|NCT00191477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56871300|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871301|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56871302|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871303|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56871304|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56871305|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
56871306|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56871307|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56871308|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56871309|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56871310|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56871311|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871312|NCT04415944|Carboplatin|carboplatin|mesh-list
56871313|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871314|NCT01256268|Paclitaxel|paclitaxel|mesh-list
56871315|NCT01256268|Carboplatin|carboplatin|mesh-list
56871316|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56871317|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871318|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
56871319|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
56871320|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
56871321|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871322|NCT03902106|Albuterol|albuterol|mesh-list
56871323|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56871324|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
56871325|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871326|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871327|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56871328|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
56871329|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
56871330|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56871331|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56871332|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56871333|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56871334|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
56871335|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871336|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871337|NCT03902340|Analgesics|analgesics|mesh-list
56871338|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
56871339|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871340|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871341|NCT05285566|Lidocaine|lidocaine|mesh-list
56871342|NCT05285566|Bupivacaine|bupivacaine|mesh-list
56871343|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
56871344|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
56871345|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871346|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871347|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
56871348|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871349|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56871350|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56871351|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56871352|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871353|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582151|NCT00869050|Capecitabine|capecitabine|mesh-list
56871354|NCT01149330|Adapalene|adapalene|mesh-list
56871355|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56871356|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871358|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
56871359|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871360|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871361|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56871362|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56871363|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
56871364|NCT03984214|Dronabinol|dronabinol|mesh-list
56871365|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
56871366|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871367|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871368|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871369|NCT03984214|Analgesics|analgesics|mesh-ancestor
56871370|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
56904727|NCT00191477|Immunologic Factors|immunologic factors|mesh-ancestor
56871377|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871379|NCT01150344|Atovaquone|atovaquone|mesh-list
56871380|NCT01150344|Proguanil|proguanil|mesh-list
56871381|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56871382|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
56871383|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56871384|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56871385|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871386|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871387|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871388|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
56871389|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56871390|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
56871391|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
56871392|NCT05125224|Calcium|calcium|mesh-list
56871393|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56871394|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871395|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56871396|NCT05125224|Diuretics|diuretics|mesh-ancestor
56871397|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
56871398|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56871399|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871400|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871401|NCT01256580|Dexamethasone|dexamethasone|mesh-list
56871402|NCT01256580|Bevacizumab|bevacizumab|mesh-list
56871403|NCT01256580|Verteporfin|verteporfin|mesh-list
56871404|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56871405|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871406|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56871407|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56871408|NCT01256580|Growth Substances|growth substances|mesh-ancestor
56871409|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871410|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
56871411|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56871412|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
56871413|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
56871414|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871415|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56871416|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
56871417|NCT01256580|Hormones|hormones|mesh-ancestor
56871418|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871419|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56871420|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56871421|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
56871422|NCT03901716|Fentanyl|fentanyl|mesh-list
56871423|NCT03901716|Midazolam|midazolam|mesh-list
56871424|NCT03901716|Sufentanil|sufentanil|mesh-list
56871425|NCT03901716|Remifentanil|remifentanil|mesh-list
56871426|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56871427|NCT03901716|Narcotics|narcotics|mesh-ancestor
56871428|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871429|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871430|NCT03901716|Analgesics|analgesics|mesh-ancestor
56871431|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
56871433|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56871434|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56871435|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
56871436|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
56871437|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56871438|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56871439|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56871440|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871447|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56871448|NCT04113538|Growth Substances|growth substances|mesh-ancestor
56871449|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871450|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
56871451|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871452|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56871453|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56871454|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871455|NCT03922750|Insulin|insulin|mesh-list
56871456|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56871457|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
56871458|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56871459|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871460|NCT03898128|Immunotoxins|immunotoxins|mesh-list
56871461|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
56871462|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871463|NCT03604978|Nivolumab|nivolumab|mesh-list
56871464|NCT03604978|Ipilimumab|ipilimumab|mesh-list
56871465|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56871466|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871467|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56871468|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871469|NCT01149408|Decitabine|decitabine|mesh-list
56871470|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56871471|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
56871472|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871473|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871474|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871475|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
56871476|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56871477|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
56871478|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
56871479|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871480|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871481|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871482|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871483|NCT03901482|Analgesics|analgesics|mesh-ancestor
56871484|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
56871485|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871486|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56871487|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56871488|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871489|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871490|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
56871491|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871492|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871493|NCT01149018|Dronabinol|dronabinol|mesh-list
56871494|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
56871495|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871496|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871497|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871498|NCT01149018|Analgesics|analgesics|mesh-ancestor
56871499|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
56871500|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871501|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56871502|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56871503|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871504|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871505|NCT01149018|Hormones|hormones|mesh-ancestor
56871506|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871508|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56871509|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56871521|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871522|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
56871523|NCT03897660|Coagulants|coagulants|mesh-ancestor
56871525|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871526|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56871527|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56871528|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871529|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871530|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56871531|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
56871532|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871533|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871534|NCT03900858|Isoniazid|isoniazid|mesh-list
56871535|NCT03900858|Rifapentine|rifapentine|mesh-list
56871536|NCT03900858|Rifampin|rifampin|mesh-list
56871537|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
56871538|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56871539|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871540|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56871541|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56871542|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
56871543|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871544|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56871545|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56871546|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
56871547|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56871548|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871549|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56871550|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56871551|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56871552|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56871553|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56871554|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56871555|NCT01149564|Ibuprofen|ibuprofen|mesh-list
56871556|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56871557|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871558|NCT01149564|Analgesics|analgesics|mesh-ancestor
56871559|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
56871560|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871561|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871562|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56871563|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56871564|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56871565|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871566|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871567|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
56871568|NCT02527746|Epirubicin|epirubicin|mesh-list
56871569|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56871570|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
56871571|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871572|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56871573|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56871594|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56871595|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
56871596|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871597|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871598|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56871599|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
56871600|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
56871601|NCT01257048|Hormones|hormones|mesh-ancestor
56871602|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871603|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56871604|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56871605|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56871606|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56871607|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871608|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871609|NCT01258296|Fentanyl|fentanyl|mesh-list
56871610|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56871611|NCT01258296|Narcotics|narcotics|mesh-ancestor
56871612|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871613|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871614|NCT01258296|Analgesics|analgesics|mesh-ancestor
56871615|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
56871616|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871617|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56871618|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56871619|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
56871620|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
56871621|NCT01257126|Diclofenac|diclofenac|mesh-list
56871622|NCT01257126|Nimesulide|nimesulide|mesh-list
56871623|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56871624|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871625|NCT01257126|Analgesics|analgesics|mesh-ancestor
56871626|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
56871627|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871628|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568429|NCT00622648|Enoxaparin|enoxaparin|mesh-list
56871632|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871633|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871635|NCT02527824|Irinotecan|irinotecan|mesh-list
56871636|NCT02527824|Tegafur|tegafur|mesh-list
56871637|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871638|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56871639|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56871640|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871641|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871642|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56871643|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
56871644|NCT01586208|Phenytoin|phenytoin|mesh-list
56871645|NCT01586208|Valproic Acid|valproic acid|mesh-list
56871646|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
56871647|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871648|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871649|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
56871650|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871651|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871652|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
56871653|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56871654|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871655|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871656|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56871657|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56871658|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871659|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56871660|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56871661|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56871662|NCT03893526|Valsartan|valsartan|mesh-list
56871663|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56871664|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56871665|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871666|NCT03893526|Incretins|incretins|mesh-ancestor
56871667|NCT03893526|Hormones|hormones|mesh-ancestor
56871668|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871669|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56871670|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
56871671|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871672|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871673|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56871674|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56871675|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56871676|NCT01149798|Cisplatin|cisplatin|mesh-list
56871677|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56871678|NCT01149798|Paclitaxel|paclitaxel|mesh-list
56871679|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871680|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56871681|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
56871682|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
56871683|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
56871684|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871685|NCT01257360|Panitumumab|panitumumab|mesh-list
56871686|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56871687|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871688|NCT01257516|Pregabalin|pregabalin|mesh-list
56871689|NCT01257516|Analgesics|analgesics|mesh-ancestor
56871690|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
56871691|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871692|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871693|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
56871694|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56871695|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871696|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871697|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56568450|NCT01005966|Listerine|listerine|mesh-list
56871699|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56871700|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871701|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871702|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56871703|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871704|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56871705|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871706|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871707|NCT01149954|Ibuprofen|ibuprofen|mesh-list
56871708|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56871709|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871710|NCT01149954|Analgesics|analgesics|mesh-ancestor
56871711|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
56871712|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871713|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871714|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56871715|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56871716|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56871717|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871718|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871719|NCT03899610|Durvalumab|durvalumab|mesh-list
56871720|NCT03899610|Tremelimumab|tremelimumab|mesh-list
56871721|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56871722|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871723|NCT02527668|Vitamin D|vitamin d|mesh-list
56871724|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
56871725|NCT02527668|Calcifediol|calcifediol|mesh-list
56871726|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56871728|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
56871729|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871730|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56871731|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56871732|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
56871733|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
56871734|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
56871735|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871736|NCT03896256|Ketamine|ketamine|mesh-list
56871737|NCT03896256|Analgesics|analgesics|mesh-ancestor
56871738|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
56871739|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871740|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871741|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56871742|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56871743|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
56871744|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
56871745|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871746|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56871747|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56871748|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871749|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871750|NCT03893136|Leflunomide|leflunomide|mesh-list
56871751|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904227|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871752|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871753|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56871754|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
56871755|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871756|NCT01258530|Oseltamivir|oseltamivir|mesh-list
56871757|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
56871758|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871759|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871760|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871761|NCT01255410|Vaccines|vaccines|mesh-list
56871762|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
56871763|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871764|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
56871765|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871766|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
56871767|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
56871768|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
56871769|NCT01257672|Ondansetron|ondansetron|mesh-list
56871770|NCT01257672|Domperidone|domperidone|mesh-list
56871771|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
56871772|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
56568454|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
56871774|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871776|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
56871777|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
56871778|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56871779|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
56871780|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871781|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871782|NCT01257672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56871783|NCT01257672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56871784|NCT01257672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871785|NCT01257672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871786|NCT01257672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56871787|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56871788|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
56871789|NCT01258686|Silymarin|silymarin|mesh-list
56871790|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
56871791|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871792|NCT01258686|Protective Agents|protective agents|mesh-ancestor
56871793|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871794|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56871795|NCT01258764|Lisinopril|lisinopril|mesh-list
56871796|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56871797|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56871798|NCT01258764|Diuretics|diuretics|mesh-ancestor
56871799|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
56871800|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871801|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56871802|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56871803|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871804|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
56871805|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871806|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56871807|NCT01258764|Protective Agents|protective agents|mesh-ancestor
56871808|NCT03895788|Niraparib|niraparib|mesh-list
56871809|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56871810|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871811|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871812|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871813|NCT01257828|Riluzole|riluzole|mesh-list
56871814|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
56871815|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56871816|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56871817|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871818|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871819|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871820|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56871821|NCT01257828|Protective Agents|protective agents|mesh-ancestor
56871822|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
56871823|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56871824|NCT03899142|Antibodies|antibodies|mesh-list
56871825|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
56871826|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871827|NCT03892902|Zopiclone|zopiclone|mesh-list
56871828|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56871829|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871830|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871831|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
56871832|NCT03892668|Oxytocin|oxytocin|mesh-list
56871833|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
56871834|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56871835|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871836|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56871837|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56871838|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871839|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
56871840|NCT03892668|Coagulants|coagulants|mesh-ancestor
56871841|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56871842|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56871843|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56871844|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56568455|NCT01005966|Protective Agents|protective agents|mesh-ancestor
56871845|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871847|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56871848|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56871849|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
56871850|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871851|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871852|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56871853|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56871854|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
56871855|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
56871856|NCT03898752|Vitamins|vitamins|mesh-ancestor
56871857|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
56871858|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871859|NCT01255644|Valganciclovir|valganciclovir|mesh-list
56871860|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
56871861|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871862|NCT01255800|Cetuximab|cetuximab|mesh-list
56871863|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56871864|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871865|NCT01257906|Tretinoin|tretinoin|mesh-list
56871866|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871867|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
56871868|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56871869|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
56871870|NCT03892512|Esmolol|esmolol|mesh-list
56871871|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56871872|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871873|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871874|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871875|NCT03892512|Analgesics|analgesics|mesh-ancestor
56871876|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
56871877|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871878|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56871879|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56871880|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56871881|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
56871882|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871883|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871884|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56871885|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56871886|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56871888|NCT01255878|Analgesics|analgesics|mesh-ancestor
56871889|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
56871890|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871891|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871892|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
56871893|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56871894|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56871895|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871896|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56871897|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56871898|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56871899|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871900|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871901|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
56871902|NCT01255956|Sirolimus|sirolimus|mesh-list
56871903|NCT01255956|Paclitaxel|paclitaxel|mesh-list
56871904|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56871905|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871906|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
56871907|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
56871908|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
56871909|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871910|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56871911|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871912|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56871913|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
56871914|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56871915|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
56871916|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871917|NCT03892434|Dexamethasone|dexamethasone|mesh-list
56871918|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
56871919|NCT03892434|Bevacizumab|bevacizumab|mesh-list
56871920|NCT03892434|BB 1101|bb 1101|mesh-list
56871922|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871923|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56871924|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56871925|NCT03892434|Growth Substances|growth substances|mesh-ancestor
56871926|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871927|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
56871928|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56871929|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
56871930|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
56871931|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56871932|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56871933|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
56871934|NCT03892434|Hormones|hormones|mesh-ancestor
56871935|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56871936|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56871937|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
56871938|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871939|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871940|NCT03889626|Capecitabine|capecitabine|mesh-list
56871941|NCT03889626|Apatinib|apatinib|mesh-list
56871942|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56871943|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
56871944|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871945|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871946|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56871947|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56871948|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
56871949|NCT03892122|Propofol|propofol|mesh-list
56871950|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56871951|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56871952|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871953|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56871954|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
56871955|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
56871956|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56871957|NCT03892122|Analgesics|analgesics|mesh-ancestor
56871958|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
56871959|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904231|NCT02080624|Sirolimus|sirolimus|mesh-list
56871960|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56871961|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56871962|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56871963|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
56871964|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56871965|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56871966|NCT01589562|Megestrol|megestrol|mesh-list
56871967|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
56871968|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56871969|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56871970|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56871971|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
56871972|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56871973|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871974|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56871975|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56871976|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56871977|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871978|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
56871979|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56871980|NCT01152372|Insulin|insulin|mesh-list
56871981|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56871982|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871983|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56871984|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
56871985|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56871986|NCT01259934|Interferons|interferons|mesh-list
56871987|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
56871988|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
56871989|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56871990|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
56871991|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56871992|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
56871993|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56871994|NCT01153386|Treprostinil|treprostinil|mesh-list
56872018|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
56872019|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56872020|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
56872021|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872022|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872023|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56872024|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872025|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56582818|NCT04134052|Midazolam|midazolam|mesh-list
56872026|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56872027|NCT03888846|Protective Agents|protective agents|mesh-ancestor
56872028|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872030|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56872031|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
56872032|NCT03891420|Galidesivir|galidesivir|mesh-list
56872033|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
56872034|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872035|NCT01153542|Ivacaftor|ivacaftor|mesh-list
56872036|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56872037|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56872038|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872039|NCT01152606|Trastuzumab|trastuzumab|mesh-list
56872040|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56872041|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872047|NCT01153854|Racecadotril|racecadotril|mesh-list
56872048|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
56872049|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56872050|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
56568459|NCT00628680|Heparin|heparin|mesh-list
56872059|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56872060|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
56872061|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872062|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872064|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872065|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
56872066|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872067|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872068|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
56872069|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56872070|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872071|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872072|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56872073|NCT03885804|Analgesics|analgesics|mesh-ancestor
56872074|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
56872075|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872076|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56872077|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56872078|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56872079|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
56872080|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872081|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872082|NCT03885258|Melatonin|melatonin|mesh-list
56872083|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
56872084|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872085|NCT03885258|Protective Agents|protective agents|mesh-ancestor
56872086|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872087|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872088|NCT01262196|Chrysarobin|chrysarobin|mesh-list
56872089|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56872090|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56872091|NCT01262196|Analgesics|analgesics|mesh-ancestor
56872092|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
56872093|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872094|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872095|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56872096|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56872097|NCT03885180|Warfarin|warfarin|mesh-list
56872098|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
56872099|NCT03888144|Ketorolac|ketorolac|mesh-list
56872100|NCT03888144|Oxycodone|oxycodone|mesh-list
56872101|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56872102|NCT03888144|Narcotics|narcotics|mesh-ancestor
56872103|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872104|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872105|NCT03888144|Analgesics|analgesics|mesh-ancestor
56872106|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
56872107|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872108|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56872109|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56872110|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56872111|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56872112|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56872113|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872114|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872115|NCT03890406|Rocuronium|rocuronium|mesh-list
56872116|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56872117|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56872118|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56872119|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872120|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872121|NCT01154400|Caseins|caseins|mesh-list
56872122|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
56872123|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
56872124|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872125|NCT01152840|Everolimus|everolimus|mesh-list
56872126|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872127|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872128|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
56872129|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872130|NCT01262274|Anastrozole|anastrozole|mesh-list
56872131|NCT01262274|Tegafur|tegafur|mesh-list
56872132|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56872133|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872134|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56872135|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56872136|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872137|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872138|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56872139|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
56872140|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872141|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872142|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56872143|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
56872144|NCT01260558|Sirolimus|sirolimus|mesh-list
56872145|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56872146|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872147|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56872148|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872149|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
56872150|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872151|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
56872152|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872153|NCT01260714|Etoposide|etoposide|mesh-list
56872154|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
56872155|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
56872156|NCT01260714|Azacitidine|azacitidine|mesh-list
56872157|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
56872158|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56872159|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872160|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56872161|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56872162|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872163|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872164|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56872165|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
56872166|NCT01260714|Analgesics|analgesics|mesh-ancestor
56872167|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
56872168|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872169|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872170|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
56872171|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
56872172|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
56872173|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
56872174|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
56872175|NCT03890094|Sufentanil|sufentanil|mesh-list
56872176|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56872177|NCT03890094|Narcotics|narcotics|mesh-ancestor
56872178|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872179|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872180|NCT03890094|Analgesics|analgesics|mesh-ancestor
56872181|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
56872182|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872183|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56872184|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56872185|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
56872186|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
56872187|NCT03887754|Risperidone|risperidone|mesh-list
56872188|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56872189|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
56872190|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872191|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872192|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872194|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56872195|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872196|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56872197|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56872198|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
56872199|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
56872200|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
56872201|NCT01262586|Glimepiride|glimepiride|mesh-list
56872202|NCT01262586|Vildagliptin|vildagliptin|mesh-list
56872203|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56872204|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56872205|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872206|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872207|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
56872208|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56872209|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
56872210|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872211|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872212|NCT01157052|Capecitabine|capecitabine|mesh-list
56872213|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
56872214|NCT01157052|Calcium|calcium|mesh-list
56872215|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56872216|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872217|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56872218|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
56872219|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872220|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872221|NCT03887130|Gemcitabine|gemcitabine|mesh-list
56872222|NCT03887130|Paclitaxel|paclitaxel|mesh-list
56872223|NCT03887130|Vinorelbine|vinorelbine|mesh-list
56872224|NCT03887130|Docetaxel|docetaxel|mesh-list
56872225|NCT03887130|Capecitabine|capecitabine|mesh-list
56872226|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56872227|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872228|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
56872229|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
56872230|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
56872231|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872232|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56872233|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
56872234|NCT03887130|Antiviral Agents|antiviral agents|mesh-ancestor
56872235|NCT03887130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872236|NCT03887130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872237|NCT03887130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872238|NCT03887130|Immunologic Factors|immunologic factors|mesh-ancestor
56872239|NCT03887130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872240|NCT01155960|Anastrozole|anastrozole|mesh-list
56872241|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56872242|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872243|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56872244|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56872245|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872246|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872247|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56872248|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
56872249|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872250|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583047|NCT02618824|Tryptophan|tryptophan|mesh-list
56872251|NCT03883776|Octreotide|octreotide|mesh-list
56872252|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
56872253|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56872254|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56872255|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872256|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56872257|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872258|NCT03886896|Lidocaine|lidocaine|mesh-list
56872259|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
56872260|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
56872261|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872262|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872263|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
56872264|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872265|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56872266|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56872267|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56872268|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56872269|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872271|NCT03881904|Gestodene|gestodene|mesh-list
56872272|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56872273|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56872274|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56872275|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
56872276|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56872277|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872278|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56872279|NCT03881904|Estrogens|estrogens|mesh-ancestor
56872280|NCT03881904|Hormones|hormones|mesh-ancestor
56872281|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872282|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56872283|NCT03881904|Progestins|progestins|mesh-ancestor
56872284|NCT01262742|Carbetocin|carbetocin|mesh-list
56872285|NCT01262742|Oxytocin|oxytocin|mesh-list
56872286|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
56872287|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56872288|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872289|NCT01261416|Levetiracetam|levetiracetam|mesh-list
56872290|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
56872291|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
56872292|NCT03617172|Misoprostol|misoprostol|mesh-list
56872293|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56872294|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
56872295|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56872296|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872297|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56872298|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56872299|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
56872300|NCT01154790|Naproxen|naproxen|mesh-list
56872301|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56872302|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56872303|NCT01154790|Analgesics|analgesics|mesh-ancestor
56872304|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
56872305|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872306|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872307|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56872308|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56872309|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
56872310|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56872311|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872312|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872313|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
56872314|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
56872315|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872316|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56872317|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
56872318|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872319|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
56872320|NCT01263288|Vitamin D|vitamin d|mesh-list
56872321|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56872322|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872323|NCT01263288|Vitamins|vitamins|mesh-ancestor
56872324|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
56872325|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56872326|NCT01263834|Bevacizumab|bevacizumab|mesh-list
56872327|NCT01263834|Mitomycins|mitomycins|mesh-list
56872328|NCT01263834|Mitomycin|mitomycin|mesh-list
56872329|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56872330|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872331|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56872332|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56872333|NCT01263834|Growth Substances|growth substances|mesh-ancestor
56872334|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872335|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
56872336|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56872337|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
56872338|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872339|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56386860|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
56872342|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56872344|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
56872345|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872346|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872347|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872348|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
56872349|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
56872350|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872351|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56872352|NCT01155102|Anastrozole|anastrozole|mesh-list
56872353|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56872354|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872355|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56872356|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56872357|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872358|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872359|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56872360|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
56872361|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872362|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872363|NCT01156350|Fludarabine|fludarabine|mesh-list
56872364|NCT01156350|Busulfan|busulfan|mesh-list
56872365|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872366|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872367|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872368|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
56872369|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872370|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
56872371|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56872372|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56872373|NCT03886662|LB100|lb100|mesh-list
56872374|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872375|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872376|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872377|NCT01155258|Sirolimus|sirolimus|mesh-list
56872378|NCT01155258|Vinorelbine|vinorelbine|mesh-list
56872379|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56872380|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872381|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56872382|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872383|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
56872384|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872385|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
56872386|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872387|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56872388|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
56872389|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
56872390|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
56872391|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872392|NCT01156584|Flucytosine|flucytosine|mesh-list
56872393|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
56872394|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872395|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
56872396|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872397|NCT03879174|Tamoxifen|tamoxifen|mesh-list
56872398|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
56872399|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56872400|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872401|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56872402|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
56872403|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872404|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872405|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56872406|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56872407|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56872408|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56872409|NCT01159548|Promethazine|promethazine|mesh-list
56872410|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
56872411|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
56872412|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
56872426|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872428|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
56872429|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56872430|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56872431|NCT01156740|Amoxicillin|amoxicillin|mesh-list
56872432|NCT01156740|Penicillins|penicillins|mesh-list
56872433|NCT01156740|beta-Lactams|beta-lactams|mesh-list
56872434|NCT01156740|Penicillin G|penicillin g|mesh-list
56872435|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56872436|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
56872437|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872438|NCT03880968|Etanercept|etanercept|mesh-list
56872439|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56872440|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56872441|NCT03880968|Analgesics|analgesics|mesh-ancestor
56872442|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
56872443|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872444|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872445|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56872446|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56872447|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56872448|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872449|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
56872450|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
56872451|NCT03880734|Vitamin D|vitamin d|mesh-list
56872452|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56872453|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872454|NCT03880734|Vitamins|vitamins|mesh-ancestor
56872455|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
56476867|NCT00525200|Docetaxel|docetaxel|mesh-list
56872456|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56872457|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
56872458|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56872459|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
56872460|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56872461|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872462|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56872463|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56872464|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56872465|NCT01265940|Vinblastine|vinblastine|mesh-list
56872466|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56872467|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872468|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
56872469|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
56872470|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
56872471|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872472|NCT01264302|Finasteride|finasteride|mesh-list
56872473|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56872474|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56872479|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872480|NCT01264302|Urological Agents|urological agents|mesh-ancestor
56872481|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56872482|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
56872483|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872485|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56872486|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56872487|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56872489|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872490|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872491|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872492|NCT01266174|Eltoprazine|eltoprazine|mesh-list
56872493|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56872494|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
56872495|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872496|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872497|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872498|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
56872499|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56872500|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872501|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872502|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56872503|NCT01266252|Analgesics|analgesics|mesh-ancestor
56872504|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
56872505|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872506|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56872507|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56872508|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56872509|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
56872510|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872511|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872512|NCT01266486|Metformin|metformin|mesh-list
56872513|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56872514|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872515|NCT01161888|Imiquimod|imiquimod|mesh-list
56872516|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56872517|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
56872518|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872519|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872520|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
56872521|NCT03759366|Eculizumab|eculizumab|mesh-list
56872522|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56872523|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872524|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
56872525|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872526|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
56872527|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56872528|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872529|NCT03759600|Niraparib|niraparib|mesh-list
56872530|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56872531|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872532|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872533|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872534|NCT01161966|Zonisamide|zonisamide|mesh-list
56872535|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
56872536|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56872537|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56872538|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872539|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56872540|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872541|NCT01158144|Paclitaxel|paclitaxel|mesh-list
56872542|NCT01158144|Carboplatin|carboplatin|mesh-list
56872544|NCT01158144|Endostatins|endostatins|mesh-list
56872545|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56872546|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872547|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
56872548|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
56872549|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
56872550|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872551|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56872552|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56872553|NCT01158144|Growth Substances|growth substances|mesh-ancestor
56872554|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872555|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
56872556|NCT01264536|Lactoferrin|lactoferrin|mesh-list
56872557|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872558|NCT01160172|Vaccines|vaccines|mesh-list
56872559|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
56872560|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872561|NCT03878784|Sumatriptan|sumatriptan|mesh-list
56872562|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56872563|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56872564|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56872565|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
56872566|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872567|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872568|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872569|NCT01266720|Gemcitabine|gemcitabine|mesh-list
56872570|NCT01266720|Immunologic Factors|immunologic factors|mesh-ancestor
56872571|NCT01266720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872572|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56872573|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
56872574|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872575|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872576|NCT01266720|Antiviral Agents|antiviral agents|mesh-ancestor
56872577|NCT01266720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872578|NCT01266720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872579|NCT01266720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872580|NCT01589952|Interferons|interferons|mesh-list
56872581|NCT01589952|Entecavir|entecavir|mesh-list
56872582|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872583|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
56872584|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872585|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
56872586|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56872587|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56872588|NCT03876444|Prednisolone|prednisolone|mesh-list
56872589|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
56872590|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56872591|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
56872592|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56872593|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
56872594|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
56872595|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872596|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872597|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56872598|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
56872599|NCT03876444|Hormones|hormones|mesh-ancestor
56872600|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872601|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56872602|NCT03876444|Protective Agents|protective agents|mesh-ancestor
56872603|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56872604|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872605|NCT01264692|Amlodipine|amlodipine|mesh-list
56872606|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56872607|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56872608|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55895240|NCT00734877|Bortezomib|bortezomib|mesh-list
56872609|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872610|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56872611|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872612|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
56872613|NCT01160328|Leuprolide|leuprolide|mesh-list
56872614|NCT01160328|Testosterone|testosterone|mesh-list
56872615|NCT01160328|Androgens|androgens|mesh-ancestor
56872616|NCT01160328|Hormones|hormones|mesh-ancestor
56872617|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872619|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56872620|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872621|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56872622|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
56872623|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56583417|NCT03679611|Neostigmine|neostigmine|mesh-list
56872624|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
56872625|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872626|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56872627|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872628|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872629|NCT01162746|Dexamethasone|dexamethasone|mesh-list
56872630|NCT01162746|Ranibizumab|ranibizumab|mesh-list
56872631|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56872632|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
56872633|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
56872634|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872635|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872636|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56872637|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
56872638|NCT01162746|Hormones|hormones|mesh-ancestor
56872639|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872640|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56872641|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872642|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56872643|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56872644|NCT01162746|Growth Substances|growth substances|mesh-ancestor
56872645|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
56872646|NCT01268202|Pravastatin|pravastatin|mesh-list
56872647|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56872648|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56872649|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
56872650|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872651|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56872652|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56872653|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872654|NCT01162824|Adenosine|adenosine|mesh-list
56872655|NCT01162824|Acetylcholine|acetylcholine|mesh-list
56872656|NCT01162824|Analgesics|analgesics|mesh-ancestor
56872657|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
56872658|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872659|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872660|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56872661|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
56872662|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56872663|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
56872664|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
56872665|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872666|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872667|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56872668|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
56872669|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56872670|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
56872671|NCT01265004|Coagulants|coagulants|mesh-ancestor
56872672|NCT01162902|Candesartan|candesartan|mesh-list
56872673|NCT01162902|Bisoprolol|bisoprolol|mesh-list
56872674|NCT01162902|Diltiazem|diltiazem|mesh-list
56872675|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56872676|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56872677|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56872678|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872679|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
56872680|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
56872681|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872682|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904258|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
56872683|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56872684|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56872685|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56872686|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
56872687|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872688|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56872689|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56872690|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56872692|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56872693|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56872694|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56872695|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
56872696|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872697|NCT02526888|Diltiazem|diltiazem|mesh-list
56872698|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56872699|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56872700|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56872701|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872702|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56872703|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872705|NCT01158612|Hormones|hormones|mesh-list
56872706|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872707|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872708|NCT03877692|Labetalol|labetalol|mesh-list
56872709|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56872710|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56872711|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
56872712|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872713|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872714|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872715|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56872716|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
56872717|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
56872718|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872719|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56872720|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56872721|NCT01158846|Bivalirudin|bivalirudin|mesh-list
56872722|NCT01158846|Abciximab|abciximab|mesh-list
56872723|NCT01158846|Clopidogrel|clopidogrel|mesh-list
56872724|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56872725|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56872726|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56872727|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56872728|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56872729|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
56872730|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872731|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872732|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872733|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
56872734|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56872735|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
56872736|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872737|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
56872738|NCT01268670|Ibuprofen|ibuprofen|mesh-list
56872739|NCT01268670|Oxycodone|oxycodone|mesh-list
56872740|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56872741|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56872742|NCT01268670|Analgesics|analgesics|mesh-ancestor
56872743|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
56872744|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872745|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872746|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56872747|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56872748|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56872749|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872750|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872751|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56872752|NCT01268670|Narcotics|narcotics|mesh-ancestor
56872753|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872754|NCT01160718|Fulvestrant|fulvestrant|mesh-list
56872755|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56872756|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872757|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56872758|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56872759|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
56872760|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872761|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872762|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
56872779|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56872780|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56872781|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872782|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872783|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56872784|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
56872785|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872786|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872787|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56872788|NCT01159158|Nateglinide|nateglinide|mesh-list
56872789|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56872790|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872792|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
56872793|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872794|NCT01161108|Protective Agents|protective agents|mesh-ancestor
56872795|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872796|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872797|NCT01161186|Gemcitabine|gemcitabine|mesh-list
56872798|NCT01161186|Paclitaxel|paclitaxel|mesh-list
56872799|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56872800|NCT01161186|Capecitabine|capecitabine|mesh-list
56872801|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56872802|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872803|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
56872804|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
56872805|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
56872806|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872807|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56872808|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
56872809|NCT01161186|Antiviral Agents|antiviral agents|mesh-ancestor
56872810|NCT01161186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872811|NCT01161186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872812|NCT01161186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872813|NCT01161186|Immunologic Factors|immunologic factors|mesh-ancestor
56872814|NCT01161186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872815|NCT01159236|Paclitaxel|paclitaxel|mesh-list
56872816|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
56872817|NCT01159236|Bevacizumab|bevacizumab|mesh-list
56872818|NCT01159236|Doxorubicin|doxorubicin|mesh-list
56872819|NCT01159236|Fluorouracil|fluorouracil|mesh-list
56872820|NCT01159236|Epirubicin|epirubicin|mesh-list
56872821|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56872822|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872823|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
56872824|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
56872825|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
56872826|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872827|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872828|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
56872829|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872830|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56872831|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56872832|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
56872833|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56872834|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56872835|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56872836|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56872837|NCT01159236|Growth Substances|growth substances|mesh-ancestor
56872838|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
56872839|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56872840|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56872841|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56872842|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872843|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
56872844|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56872846|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
56872847|NCT01267344|Cetuximab|cetuximab|mesh-list
56872848|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56872849|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
56872850|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872851|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872852|NCT01267344|Antiviral Agents|antiviral agents|mesh-ancestor
56872853|NCT01267344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872854|NCT01267344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872855|NCT01267344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872856|NCT01267344|Immunologic Factors|immunologic factors|mesh-ancestor
56872857|NCT01267344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872858|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56872859|NCT03879564|Ketamine|ketamine|mesh-list
56872860|NCT03879564|Analgesics|analgesics|mesh-ancestor
56872861|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
56872862|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872863|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872864|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56872865|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56872866|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
56872867|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
56872868|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56872869|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56872870|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56872871|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872872|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872873|NCT01581840|Panitumumab|panitumumab|mesh-list
56872874|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56872875|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872876|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
56872877|NCT03879486|Formaldehyde|formaldehyde|mesh-list
56872878|NCT03879486|Povidone|povidone|mesh-list
56872879|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
56872880|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
56872881|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56872882|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872883|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
56872884|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
56872885|NCT01269294|Simeprevir|simeprevir|mesh-list
56872886|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56872887|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56872888|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872889|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56872890|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56872891|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872892|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872893|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872894|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56872895|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
56872896|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56872897|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872901|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
56872902|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
56872903|NCT01163994|Doxycycline|doxycycline|mesh-list
56872904|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
56872905|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56872906|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56872907|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
56872908|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56872909|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56872910|NCT01267734|Everolimus|everolimus|mesh-list
56872911|NCT01267734|Clopidogrel|clopidogrel|mesh-list
56872912|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56872913|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56872914|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
56872915|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872916|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56872917|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56872918|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56872919|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56872920|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
56872921|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872922|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872923|NCT01164306|Nicotine|nicotine|mesh-list
56904260|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56872924|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56872925|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
56872926|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872927|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872928|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56872929|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56872930|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
56872931|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872932|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872933|NCT01269450|Progesterone|progesterone|mesh-list
56872934|NCT01269450|Progestins|progestins|mesh-ancestor
56872935|NCT01269450|Hormones|hormones|mesh-ancestor
56872936|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872937|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872938|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
56872939|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
56872940|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56872941|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
56872942|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56872943|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872944|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56872945|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
56872946|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56872947|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
56872948|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872949|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872950|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56872951|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
56872952|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
56872953|NCT01269528|Protective Agents|protective agents|mesh-ancestor
56872954|NCT01269528|Miotics|miotics|mesh-ancestor
56872955|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56872956|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56872957|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56872958|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56872959|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
56872960|NCT01268904|Valproic Acid|valproic acid|mesh-list
56872961|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
56872962|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872963|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872964|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
56872965|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56872966|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872967|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
56872968|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56872969|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56568522|NCT01193842|Cortisone|cortisone|mesh-list
56872970|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56872972|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56872973|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
56872974|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
56872975|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56872976|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56872977|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872978|NCT03872232|Telmisartan|telmisartan|mesh-list
56872979|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56872980|NCT03872232|Ezetimibe|ezetimibe|mesh-list
56872981|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56872982|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56872983|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
56872984|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56872985|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56872986|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56872987|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56872988|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56872989|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56872990|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56872991|NCT01280214|Triamcinolone|triamcinolone|mesh-list
56872992|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56872993|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
56583794|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56872994|NCT01280214|Hormones|hormones|mesh-ancestor
56904261|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
56872995|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56872996|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56872997|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56872998|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56872999|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56873000|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56873001|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56873002|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
56873003|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873004|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56873005|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56873006|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873007|NCT01269684|Everolimus|everolimus|mesh-list
56873008|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873009|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873010|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
56873011|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873012|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56873013|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
56873014|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56873015|NCT01280526|Romidepsin|romidepsin|mesh-list
56873016|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56873017|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873018|NCT01164774|Ramipril|ramipril|mesh-list
56873019|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56873020|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
56873021|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873022|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873023|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56873024|NCT01269138|Thrombin|thrombin|mesh-list
56873025|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
56873026|NCT01269138|Coagulants|coagulants|mesh-ancestor
56873027|NCT02526810|Insulin|insulin|mesh-list
56873028|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56873029|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
56873030|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
56873031|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56873032|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873033|NCT01280682|Rituximab|rituximab|mesh-list
56873034|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56873035|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873036|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
56873037|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873038|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56873039|NCT01269216|Leucovorin|leucovorin|mesh-list
56873040|NCT01269216|Irinotecan|irinotecan|mesh-list
56873041|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56873042|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56873043|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904728|NCT00191477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873053|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56873054|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
56873055|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
56873056|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873057|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873058|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
56873059|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873060|NCT01165476|Treprostinil|treprostinil|mesh-list
56873061|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56873062|NCT01169922|Ethanol|ethanol|mesh-list
56873063|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56873064|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873065|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873066|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873067|NCT01283100|Dolutegravir|dolutegravir|mesh-list
56873068|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56873069|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56873070|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873071|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873072|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56873073|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56873074|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
56873075|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873077|NCT01269996|Gliclazide|gliclazide|mesh-list
56873078|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56873079|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873080|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56873081|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56873082|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873083|NCT01281150|Paclitaxel|paclitaxel|mesh-list
56873084|NCT01281150|Carboplatin|carboplatin|mesh-list
56873085|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56873086|NCT01281150|Veliparib|veliparib|mesh-list
56873087|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56873088|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873089|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
56873090|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
56873091|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
56873092|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873093|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56873094|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873095|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
56873096|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56873097|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
56873098|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873099|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
56873100|NCT03871218|Protective Agents|protective agents|mesh-ancestor
56873101|NCT01281228|Exenatide|exenatide|mesh-list
56873102|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56873103|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873104|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56873105|NCT01281228|Incretins|incretins|mesh-ancestor
56873106|NCT01281228|Hormones|hormones|mesh-ancestor
56873107|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56873108|NCT01283256|Zonisamide|zonisamide|mesh-list
56873109|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
56873110|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56873111|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56568525|NCT01193842|Doxorubicin|doxorubicin|mesh-list
56873113|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56873114|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873116|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56873117|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56873118|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873119|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
56873120|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
56873121|NCT03874260|Fenofibrate|fenofibrate|mesh-list
56873122|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56873123|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
56873124|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873125|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56873126|NCT01281540|Cisapride|cisapride|mesh-list
56873127|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56873128|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56873129|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56873130|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
56873131|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873132|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873133|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873134|NCT03874026|Cetuximab|cetuximab|mesh-list
56873135|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56873136|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873137|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
56873138|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56873139|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873140|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873141|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56873142|NCT01283412|Analgesics|analgesics|mesh-ancestor
56873143|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
56873144|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873145|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56873146|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56873147|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56873148|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
56873149|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873150|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873151|NCT01271478|Telmisartan|telmisartan|mesh-list
56873152|NCT01271478|Captopril|captopril|mesh-list
56873153|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56873154|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56873155|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56873156|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873157|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56873158|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
56873159|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873160|NCT03871062|Anesthetics|anesthetics|mesh-list
56873161|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873162|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873163|NCT01281696|Bevacizumab|bevacizumab|mesh-list
56873164|NCT01281696|Methotrexate|methotrexate|mesh-list
56873165|NCT01281696|Etoposide|etoposide|mesh-list
56873166|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56873167|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873168|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56873169|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56873170|NCT01281696|Growth Substances|growth substances|mesh-ancestor
56873171|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873172|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
56873173|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56873174|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
56873175|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56873176|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56873177|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
56873178|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873179|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
56873180|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873181|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56873182|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873184|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56873185|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56873186|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56873187|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56873188|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56873189|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
56873190|NCT01170078|Hematinics|hematinics|mesh-ancestor
56873191|NCT01283646|Vitamins|vitamins|mesh-list
56873192|NCT01283646|Folic Acid|folic acid|mesh-list
56873193|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
56873194|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
56873195|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873196|NCT01283646|Hematinics|hematinics|mesh-ancestor
56873197|NCT01283724|Dienogest|dienogest|mesh-list
56873198|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56873199|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
56873200|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56873201|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873202|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56873203|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56873204|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56873205|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56873206|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
56873207|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56873208|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56873209|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873210|NCT01586442|Eplerenone|eplerenone|mesh-list
56873211|NCT01586442|Spironolactone|spironolactone|mesh-list
56873212|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56873213|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
56873214|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56873215|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873216|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56873217|NCT01586442|Diuretics|diuretics|mesh-ancestor
56873218|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
56873219|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56873220|NCT01587066|Valproic Acid|valproic acid|mesh-list
56873221|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56873222|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
56873223|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56873224|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56873225|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56873226|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56904266|NCT03936933|Goserelin|goserelin|mesh-list
56873227|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873228|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
56873229|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873230|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873231|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
56873232|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873233|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
56873234|NCT01587144|Lucanthone|lucanthone|mesh-list
56873235|NCT01587144|Temozolomide|temozolomide|mesh-list
56873236|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56873237|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
56873238|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873239|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873240|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
56873241|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56873242|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
56873243|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56873244|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873245|NCT01587222|Octreotide|octreotide|mesh-list
56873246|NCT01587222|Midodrine|midodrine|mesh-list
56873247|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56873248|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56873249|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873250|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
56873251|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
56873252|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873253|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873254|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56873255|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56873256|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56873257|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56873259|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873260|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873261|NCT01167738|Metformin|metformin|mesh-list
56873262|NCT01167738|Gemcitabine|gemcitabine|mesh-list
56873263|NCT01167738|Capecitabine|capecitabine|mesh-list
56873264|NCT01167738|Epirubicin|epirubicin|mesh-list
56873265|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873266|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56873267|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
56873268|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873269|NCT01167738|Antiviral Agents|antiviral agents|mesh-ancestor
56873270|NCT01167738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873271|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873272|NCT01167738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873273|NCT01167738|Immunologic Factors|immunologic factors|mesh-ancestor
56873274|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873275|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56873276|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56873277|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56873278|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56873279|NCT01167816|Azacitidine|azacitidine|mesh-list
56873280|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56873281|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
56873282|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873283|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873284|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873285|NCT01167894|Simvastatin|simvastatin|mesh-list
56873286|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56873287|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56873288|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
56873289|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873290|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56873291|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56873292|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873293|NCT03870828|Dimercaprol|dimercaprol|mesh-list
56873294|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
56873295|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
56873296|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873297|NCT03870594|Chrysarobin|chrysarobin|mesh-list
56873298|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56873299|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56873300|NCT03870594|Analgesics|analgesics|mesh-ancestor
56873301|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
56873302|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873303|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873304|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56873305|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56873306|NCT01165866|Ondansetron|ondansetron|mesh-list
56873307|NCT01165866|Metoclopramide|metoclopramide|mesh-list
56873308|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
56873309|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
56873310|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873311|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873312|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56873313|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
56873314|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
56873315|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56873316|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
56873317|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873318|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873319|NCT01165866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56873320|NCT01165866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56873321|NCT01165866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873322|NCT01165866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56873323|NCT01165866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56873324|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56873325|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56873326|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
56873327|NCT01170468|Vitamin D|vitamin d|mesh-list
56873328|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
56873329|NCT01170468|Vitamins|vitamins|mesh-ancestor
56873330|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
56873331|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873332|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56873333|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56873335|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56873336|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873337|NCT01281852|Paclitaxel|paclitaxel|mesh-list
56873338|NCT01281852|Cisplatin|cisplatin|mesh-list
56873339|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56873340|NCT01281852|Veliparib|veliparib|mesh-list
56873341|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56873342|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873343|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
56873344|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
56873345|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
56873346|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873347|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56873348|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873349|NCT01168440|Sunitinib|sunitinib|mesh-list
56873350|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873351|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56873352|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56873353|NCT01168440|Growth Substances|growth substances|mesh-ancestor
56873354|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873355|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
56873356|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56873357|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873358|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873359|NCT01170780|Dexamethasone|dexamethasone|mesh-list
56873360|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56873361|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
56873362|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
56873363|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873364|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873365|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56873366|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
56873367|NCT01170780|Hormones|hormones|mesh-ancestor
56873368|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56873369|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56873370|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873371|NCT01165944|Pramlintide|pramlintide|mesh-list
56873372|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56873373|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904269|NCT02073916|Paclitaxel|paclitaxel|mesh-list
56873374|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56873375|NCT01170858|Icodextrin|icodextrin|mesh-list
56873376|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
56873377|NCT01171092|Bortezomib|bortezomib|mesh-list
56873378|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873379|NCT03753204|Furosemide|furosemide|mesh-list
56873380|NCT03753204|Diuretics|diuretics|mesh-ancestor
56873381|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
56873382|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873383|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56873384|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56873385|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873386|NCT01171170|Paclitaxel|paclitaxel|mesh-list
56873387|NCT01171170|Bevacizumab|bevacizumab|mesh-list
56873388|NCT01171170|Carboplatin|carboplatin|mesh-list
56873389|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56873390|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
56873391|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56873392|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873393|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
56873394|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
56873395|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
56873396|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873397|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56873398|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56873399|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56873400|NCT01171170|Growth Substances|growth substances|mesh-ancestor
56873401|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873402|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
56873403|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
56873404|NCT01166100|Fluoxetine|fluoxetine|mesh-list
56873405|NCT01166100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56873406|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56873407|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56873408|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873409|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873410|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
56873411|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873412|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56873413|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
56873414|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56873415|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56873416|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56873417|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873418|NCT01277016|Melphalan|melphalan|mesh-list
56873419|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56873420|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
56873421|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873422|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873423|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56873424|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873425|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
56873426|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873427|NCT01171326|Minocycline|minocycline|mesh-list
56873428|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56873429|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873430|NCT01171482|Fluorouracil|fluorouracil|mesh-list
56873431|NCT01171482|Sorafenib|sorafenib|mesh-list
56873432|NCT01171482|Mitomycins|mitomycins|mesh-list
56873433|NCT01171482|Mitomycin|mitomycin|mesh-list
56873434|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
56873435|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873436|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56873437|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873438|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873439|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
56873440|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873441|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56873442|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873443|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56873444|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
56873445|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56584249|NCT01067144|Gabapentin|gabapentin|mesh-list
56873447|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56873448|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56873449|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
56873450|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873451|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56873452|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56873453|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873454|NCT01169142|Vitamin D|vitamin d|mesh-list
56873455|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
56873456|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
56873457|NCT01169142|Vitamins|vitamins|mesh-list
56873458|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
56873459|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873460|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56873461|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56873462|NCT01169298|Lenalidomide|lenalidomide|mesh-list
56873463|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
56873464|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873465|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56873466|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56873467|NCT01169298|Growth Substances|growth substances|mesh-ancestor
56873468|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
56873469|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873470|NCT01277484|Decitabine|decitabine|mesh-list
56873471|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56873472|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
56873473|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873474|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873475|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873476|NCT01282632|Olanzapine|olanzapine|mesh-list
56873477|NCT01282632|Risperidone|risperidone|mesh-list
56873478|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56873479|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
56873480|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873481|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873482|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873484|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56873485|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873486|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56873487|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56873488|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
56873489|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
56873490|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
56873491|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873492|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56873493|NCT01282632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56873494|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56873495|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56873497|NCT01172028|Pemetrexed|pemetrexed|mesh-list
56873498|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873499|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56873500|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56873501|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56873502|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873503|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873504|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56873505|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56873506|NCT01278186|Paclitaxel|paclitaxel|mesh-list
56873507|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56873508|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873509|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
56873510|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
56873511|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
56873512|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873513|NCT01169688|Phenylephrine|phenylephrine|mesh-list
56873514|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
56873515|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
56584320|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
56873516|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56873517|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
56873518|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
56873519|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873520|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873521|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
56873522|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56873523|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
56873524|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
56873525|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56873526|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56873527|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56873528|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
56873529|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873530|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873531|NCT01169688|Protective Agents|protective agents|mesh-ancestor
56873532|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
56873533|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56873534|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56873535|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
56873536|NCT01278264|Ropivacaine|ropivacaine|mesh-list
56873537|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
56873538|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
56873539|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873540|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873541|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
56873542|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873543|NCT01172652|Ziprasidone|ziprasidone|mesh-list
56873544|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56873545|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
56873546|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873547|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873548|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873549|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56873550|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56873551|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873552|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56873553|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56873554|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
56873555|NCT02526030|Aripiprazole|aripiprazole|mesh-list
56873556|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56873558|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
56873559|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56873560|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56873561|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56873562|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873563|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873564|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
56873566|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873567|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873568|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56873569|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56873570|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
56873571|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56873572|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56873573|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56873574|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56873575|NCT03867240|Gabapentin|gabapentin|mesh-list
56873576|NCT03867240|Analgesics|analgesics|mesh-ancestor
56873577|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
56873578|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873579|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873580|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
56873581|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56873582|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56873583|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873584|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56873585|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56873586|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56873587|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873588|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873589|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
56873590|NCT01172964|Flucytosine|flucytosine|mesh-list
56873591|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
56873592|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873593|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
56873594|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584397|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
56873595|NCT03866928|Stiripentol|stiripentol|mesh-list
56873596|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
56873597|NCT01172496|Treprostinil|treprostinil|mesh-list
56873598|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56873599|NCT01178034|Warfarin|warfarin|mesh-list
56873600|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
56873601|NCT01288170|Tobramycin|tobramycin|mesh-list
56873602|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56873603|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873604|NCT01178112|Carboplatin|carboplatin|mesh-list
56873605|NCT01178112|Trientine|trientine|mesh-list
56873606|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873607|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
56873608|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
56873609|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873610|NCT01175460|Nedaplatin|nedaplatin|mesh-list
56873611|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873612|NCT01175538|Lactulose|lactulose|mesh-list
56873613|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56873614|NCT01288326|Liraglutide|liraglutide|mesh-list
56873615|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56873616|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873617|NCT01288326|Incretins|incretins|mesh-ancestor
56873618|NCT01288326|Hormones|hormones|mesh-ancestor
56873619|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56873620|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
56873621|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56873622|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56873623|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56873624|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56873625|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
56873626|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873627|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56873628|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56873629|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388195|NCT05142904|Iodine|iodine|mesh-list
56873631|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56873632|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56873633|NCT03435640|Nivolumab|nivolumab|mesh-list
56873634|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56873635|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873636|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56873637|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873638|NCT01175772|Celecoxib|celecoxib|mesh-list
56873639|NCT01175772|Methotrexate|methotrexate|mesh-list
56873640|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
56873641|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56873642|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
56873643|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56873644|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873645|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56873646|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
56873647|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873648|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873649|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
56873650|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873651|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56873652|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873653|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
56873654|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56873655|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56873656|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56873657|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56873658|NCT01175772|Analgesics|analgesics|mesh-ancestor
56873659|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
56873660|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873661|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56873662|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56873663|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56873664|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56873665|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
56873666|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56873667|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56873668|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56873669|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56873670|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873671|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873672|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56873673|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56873674|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56873675|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56873676|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
56873677|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873678|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873679|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56873680|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56873681|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
56873682|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56873683|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56873684|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
56873685|NCT01536964|Morphine|morphine|mesh-list
56873686|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56873687|NCT01536964|Narcotics|narcotics|mesh-ancestor
56873688|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873689|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873690|NCT01536964|Analgesics|analgesics|mesh-ancestor
56873691|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
56873692|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873693|NCT01288404|Fluorometholone|fluorometholone|mesh-list
56873694|NCT01288404|Bevacizumab|bevacizumab|mesh-list
56873695|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56873696|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873697|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56873698|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56873699|NCT01288404|Growth Substances|growth substances|mesh-ancestor
56873700|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873702|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56873703|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
56873704|NCT01288404|Hormones|hormones|mesh-ancestor
56873705|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56873706|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56873707|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56873708|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56873709|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56873710|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
56873711|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873712|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56873713|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56873714|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56873715|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56873716|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56873717|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873718|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56873719|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873720|NCT03859908|Ethanol|ethanol|mesh-list
56873721|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
56873722|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56873723|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56873724|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873725|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873726|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873727|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
56873728|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
56873729|NCT01286688|Terbinafine|terbinafine|mesh-list
56873730|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
56873731|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873732|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873733|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873734|NCT01286766|Cisplatin|cisplatin|mesh-list
56873735|NCT01286766|Docetaxel|docetaxel|mesh-list
56873736|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873737|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
56873738|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
56873739|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
56873740|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478104|NCT02943317|Avelumab|avelumab|mesh-list
56873741|NCT02525484|Pirfenidone|pirfenidone|mesh-list
56873742|NCT02525484|Analgesics|analgesics|mesh-ancestor
56873743|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
56873744|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873745|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873746|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56873747|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56873748|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56873749|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56873750|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873752|NCT01173978|Hormones|hormones|mesh-list
56873753|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56873754|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873755|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56873756|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
56873757|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56873758|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873759|NCT01174056|Pioglitazone|pioglitazone|mesh-list
56873760|NCT01174056|Zileuton|zileuton|mesh-list
56873761|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
56873762|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56873763|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873764|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56873765|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56873766|NCT01174056|Analgesics|analgesics|mesh-ancestor
56873767|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
56873768|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873769|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56873770|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56873771|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56873772|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873773|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873774|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56873775|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
56873776|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56873777|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873778|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
56873779|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56873780|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56873782|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56873783|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873784|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
56873785|NCT01174290|Haloperidol|haloperidol|mesh-list
56873786|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
56873787|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
56873788|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
56873789|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873790|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873791|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56873792|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56873793|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56873794|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873795|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56873796|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56873797|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
56873798|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873799|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873800|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56873801|NCT03862404|Epinephrine|epinephrine|mesh-list
56873802|NCT03862404|Bupivacaine|bupivacaine|mesh-list
56873803|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
56873804|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
56873805|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873806|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873807|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
56873808|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873809|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56873810|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56873811|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
56873812|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873813|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873814|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56873815|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56873816|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
56873817|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56873818|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
56873819|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
56873820|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
56873821|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56873823|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
56873824|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
56873825|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
56873826|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873827|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
56873828|NCT03865680|Protective Agents|protective agents|mesh-ancestor
56873829|NCT01288716|Baclofen|baclofen|mesh-list
56873830|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56873831|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873832|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56873833|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56873834|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56873835|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
56873836|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
56873837|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873838|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873839|NCT01285596|Mirabegron|mirabegron|mesh-list
56873840|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56873841|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56873842|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56873843|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56873844|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56873845|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873846|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873847|NCT01285596|Urological Agents|urological agents|mesh-ancestor
56873848|NCT00655876|Paclitaxel|paclitaxel|mesh-list
56873849|NCT00655876|Cetuximab|cetuximab|mesh-list
56873850|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56873853|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
56873854|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
56873855|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873856|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56873857|NCT01176318|Erdosteine|erdosteine|mesh-list
56873858|NCT01176318|Expectorants|expectorants|mesh-ancestor
56873859|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
56873860|NCT01178658|Cytarabine|cytarabine|mesh-list
56873861|NCT01178658|Etoposide|etoposide|mesh-list
56873862|NCT01178658|Melphalan|melphalan|mesh-list
56873863|NCT01178658|Busulfan|busulfan|mesh-list
56873864|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56873865|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873866|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56873867|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56873868|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873869|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873870|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56873871|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
56873872|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
56873873|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873874|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873875|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
56873876|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873877|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56873878|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
56873879|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56873880|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56873881|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873882|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56873883|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56873884|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56873885|NCT01174524|Gestodene|gestodene|mesh-list
56873886|NCT01174524|Femovan|femovan|mesh-list
56873887|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
56873888|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
56873889|NCT01174524|Estradiol|estradiol|mesh-list
56873890|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56873891|NCT01174524|Estrogens|estrogens|mesh-ancestor
56873892|NCT01174524|Hormones|hormones|mesh-ancestor
56584692|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904281|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56873893|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56873894|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873895|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56873896|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56873897|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56873898|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56873899|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56873900|NCT01174524|Progestins|progestins|mesh-ancestor
56873901|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56873902|NCT02525172|Rituximab|rituximab|mesh-list
56873903|NCT02525172|Methotrexate|methotrexate|mesh-list
56873904|NCT02525172|Bortezomib|bortezomib|mesh-list
56873905|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
56873906|NCT02525172|Antibodies|antibodies|mesh-list
56873907|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
56873908|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56873909|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56873910|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56873911|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873912|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
56873913|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873914|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56873915|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56873916|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
56873917|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56873918|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56873919|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
56873920|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873921|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
56873922|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873923|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56873924|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873925|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56873927|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873928|NCT01285674|Cisplatin|cisplatin|mesh-list
56873929|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873930|NCT03859362|Ertapenem|ertapenem|mesh-list
56873931|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56873932|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873933|NCT05598580|Lenalidomide|lenalidomide|mesh-list
56873934|NCT05598580|Immunologic Factors|immunologic factors|mesh-ancestor
56873935|NCT05598580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873936|NCT05598580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56873937|NCT05598580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56873938|NCT05598580|Growth Substances|growth substances|mesh-ancestor
56873939|NCT05598580|Growth Inhibitors|growth inhibitors|mesh-ancestor
56873940|NCT05598580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873941|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56873942|NCT01287546|Trametinib|trametinib|mesh-list
56873943|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873944|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56873945|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873946|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873947|NCT03182166|Golimumab|golimumab|mesh-list
56873948|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56873949|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56873950|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873951|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
56873952|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873953|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
56873954|NCT03193216|Antacids|antacids|mesh-ancestor
56873955|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873956|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56873957|NCT03864978|Rifaximin|rifaximin|mesh-list
56873958|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56873959|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873960|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56873961|NCT01568788|Vaccines|vaccines|mesh-list
56873962|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
56873963|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873964|NCT01287624|Gemcitabine|gemcitabine|mesh-list
56873965|NCT01287624|Paclitaxel|paclitaxel|mesh-list
56873966|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56873967|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873968|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
56873969|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
56873970|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
56873971|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873972|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56873973|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
56873974|NCT01287624|Antiviral Agents|antiviral agents|mesh-ancestor
56873975|NCT01287624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873976|NCT01287624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56873977|NCT01287624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56873978|NCT01287624|Immunologic Factors|immunologic factors|mesh-ancestor
56873979|NCT01287624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873980|NCT05597800|Nivolumab|nivolumab|mesh-list
56873981|NCT05597800|Ipilimumab|ipilimumab|mesh-list
56873982|NCT05597800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56873983|NCT05597800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873984|NCT05597800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56873985|NCT05597800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56873986|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
56873987|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
56873988|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56873989|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
56873990|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56873991|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
56873992|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873993|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56873994|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
56873995|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56873996|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56873997|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56873998|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56873999|NCT01179438|Analgesics|analgesics|mesh-ancestor
56874001|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874002|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56874003|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56874004|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56874005|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
56874006|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874007|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874008|NCT03864666|Cilostazol|cilostazol|mesh-list
56874009|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56874010|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
56874011|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874012|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874013|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56874014|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
56874015|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56874016|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56874017|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874018|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56874019|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
56874020|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56874021|NCT03864666|Protective Agents|protective agents|mesh-ancestor
56874022|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56874023|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56874024|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874025|NCT03858972|Capecitabine|capecitabine|mesh-list
56874026|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56874027|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
56874028|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874029|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874030|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
56874031|NCT03091348|Testosterone|testosterone|mesh-list
56874032|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
56874033|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
56874034|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56874035|NCT03091348|Androgens|androgens|mesh-ancestor
56874036|NCT03091348|Hormones|hormones|mesh-ancestor
56874037|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56874038|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874039|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56874040|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874041|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
56874042|NCT02525016|Lidocaine|lidocaine|mesh-list
56874043|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
56874044|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
56874045|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56874046|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874047|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
56874048|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874049|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56874050|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56874051|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56874052|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56874053|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874054|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56874055|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
56874056|NCT01179594|Entecavir|entecavir|mesh-list
56874057|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
56874058|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874059|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
56874060|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874061|NCT05597254|Niacin|niacin|mesh-list
56874062|NCT05597254|Niacinamide|niacinamide|mesh-list
56874063|NCT05597254|Nicotinic Acids|nicotinic acids|mesh-list
56874064|NCT05597254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56874065|NCT05597254|Antimetabolites|antimetabolites|mesh-ancestor
56874066|NCT05597254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874067|NCT05597254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56874068|NCT05597254|Vasodilator Agents|vasodilator agents|mesh-ancestor
56874069|NCT05597254|Vitamin B Complex|vitamin b complex|mesh-ancestor
56874070|NCT05597254|Vitamins|vitamins|mesh-ancestor
56874071|NCT05597254|Micronutrients|micronutrients|mesh-ancestor
56874072|NCT05597254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874073|NCT03751098|Phenylephrine|phenylephrine|mesh-list
56874075|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56874077|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56874078|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56874079|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
56874080|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
56874081|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874082|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874083|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
56874084|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56874085|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
56874086|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
56874087|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56874088|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56874089|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56874090|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
56874091|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874092|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874093|NCT03751098|Protective Agents|protective agents|mesh-ancestor
56874094|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56874095|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56874096|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
56874097|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56874098|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
56874099|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874100|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874101|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56874102|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874103|NCT01288794|Furosemide|furosemide|mesh-list
56874104|NCT01288794|Diuretics|diuretics|mesh-list
56874105|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
56874106|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874107|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56874108|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56874109|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874110|NCT01288872|Praziquantel|praziquantel|mesh-list
56874111|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
56874112|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56874113|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874114|NCT03864588|Ropivacaine|ropivacaine|mesh-list
56874115|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
56874116|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
56874117|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56874118|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874119|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
56584919|NCT00920556|Bortezomib|bortezomib|mesh-list
56874120|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874121|NCT01288950|Vitamin D|vitamin d|mesh-list
56874122|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
56874123|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
56874124|NCT01288950|Vitamins|vitamins|mesh-list
56874125|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
56874126|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874127|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56874128|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56874129|NCT01174914|Tenofovir|tenofovir|mesh-list
56874130|NCT01174914|Lamivudine|lamivudine|mesh-list
56874131|NCT01174914|Emtricitabine|emtricitabine|mesh-list
56874132|NCT01174914|Efavirenz|efavirenz|mesh-list
56874133|NCT01174914|Lopinavir|lopinavir|mesh-list
56874134|NCT01174914|Nevirapine|nevirapine|mesh-list
56874135|NCT01174914|Stavudine|stavudine|mesh-list
56874136|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
56874137|NCT01174914|Naltrexone|naltrexone|mesh-list
56874138|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
56874139|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874140|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56874141|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56874142|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874143|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874144|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56874145|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56874146|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56874147|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56874148|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874164|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56874165|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874166|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56874167|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874168|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874169|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
56874170|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56874171|NCT01177176|Bupropion|bupropion|mesh-list
56874172|NCT01177176|Nicotine|nicotine|mesh-list
56874173|NCT01177176|Varenicline|varenicline|mesh-list
56874174|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56874175|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
56874176|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874177|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874178|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56874179|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56874180|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
56874181|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874182|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874183|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56874184|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
56874185|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56874186|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56874187|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56874188|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56874189|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
56874190|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56874191|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56874192|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874193|NCT01287780|Gentamicins|gentamicins|mesh-list
56874194|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56585001|NCT04252248|Decitabine|decitabine|mesh-list
56874195|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874196|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56874197|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874198|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874200|NCT01179828|Clobazam|clobazam|mesh-list
56874201|NCT01179828|Imipramine|imipramine|mesh-list
56874202|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56874203|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56874204|NCT01179828|Narcotics|narcotics|mesh-ancestor
56874205|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56874206|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874207|NCT01179828|Analgesics|analgesics|mesh-ancestor
56874208|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
56874209|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874210|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56874211|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56874212|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
56874213|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874214|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874215|NCT01179828|Urological Agents|urological agents|mesh-ancestor
56874216|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56874217|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
56874218|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56874219|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56874220|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56874221|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56874222|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
56874223|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
56874224|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56874225|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56874226|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56874227|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
56874228|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
56874229|NCT01180062|Latanoprost|latanoprost|mesh-list
56874230|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56874231|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56874232|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
56874233|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56874234|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874235|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
56874236|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56874237|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56874238|NCT01177566|Analgesics|analgesics|mesh-ancestor
56874239|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
56874240|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874241|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874242|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56874243|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56874244|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
56874245|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56874246|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
56874247|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56874248|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874249|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874250|NCT01181154|Rituximab|rituximab|mesh-list
56874251|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56874252|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874253|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
56874254|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874255|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56874256|NCT03101566|Gemcitabine|gemcitabine|mesh-list
56874257|NCT03101566|Nivolumab|nivolumab|mesh-list
56874258|NCT03101566|Ipilimumab|ipilimumab|mesh-list
56874259|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874260|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56874261|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
56874262|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874263|NCT03101566|Antiviral Agents|antiviral agents|mesh-ancestor
56874264|NCT03101566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874265|NCT03101566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874266|NCT03101566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56874267|NCT03101566|Immunologic Factors|immunologic factors|mesh-ancestor
56874268|NCT03101566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874269|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56585072|NCT02829879|Listerine|listerine|mesh-list
56874270|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56874271|NCT01289496|Interferons|interferons|mesh-list
56874272|NCT01289496|Ribavirin|ribavirin|mesh-list
56874273|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
56874274|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
56874275|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56874276|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874277|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
56874278|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874279|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
56874280|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874281|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
56874282|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874285|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56874286|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56874287|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874288|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56874289|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
56874290|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
56874291|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874292|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874293|NCT01181310|Scopolamine|scopolamine|mesh-list
56874294|NCT01181310|Donepezil|donepezil|mesh-list
56874295|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56874296|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56874297|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874298|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874299|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
56874300|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874301|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874302|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
56874303|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56874304|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
56874305|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
56874306|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874307|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56874308|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
56874309|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56874310|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56874311|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
56874312|NCT02525250|Lenalidomide|lenalidomide|mesh-list
56874313|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
56874314|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874315|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56874316|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56874317|NCT02525250|Growth Substances|growth substances|mesh-ancestor
56874318|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
56874319|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874320|NCT01288092|Dactolisib|dactolisib|mesh-list
56874321|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874322|NCT01290744|Clofazimine|clofazimine|mesh-list
56874323|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56874324|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
56874325|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56874326|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874327|NCT01181388|Tirofiban|tirofiban|mesh-list
56874328|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56874329|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56874330|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874331|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56874332|NCT01181544|Heparin|heparin|mesh-list
56874333|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
56874334|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56874335|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56874336|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874337|NCT01184664|Nicotine|nicotine|mesh-list
56874338|NCT01184664|Varenicline|varenicline|mesh-list
56874339|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56874340|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
56874341|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874342|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874343|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56585147|NCT00835120|Pioglitazone|pioglitazone|mesh-list
56874344|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56874345|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
56874346|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874347|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874348|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56874349|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874350|NCT01184820|Factor VIII|factor viii|mesh-list
56874351|NCT01184820|Coagulants|coagulants|mesh-ancestor
56874352|NCT03858270|Memantine|memantine|mesh-list
56874353|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56874354|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56874355|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
56874356|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904729|NCT02087332|Torsemide|torsemide|mesh-list
56874357|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874358|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874359|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56874361|NCT01289730|Etanercept|etanercept|mesh-list
56874362|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56874363|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56874364|NCT01289730|Analgesics|analgesics|mesh-ancestor
56874365|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
56874366|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874367|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874368|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56874369|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56874370|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56874371|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56874372|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
56874373|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
56874374|NCT01290900|Ceftazidime|ceftazidime|mesh-list
56874375|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56874376|NCT01290900|Avibactam|avibactam|mesh-list
56874377|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56874378|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874379|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56874380|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56874381|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874382|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874383|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874384|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56874385|NCT03855306|Glyburide|glyburide|mesh-list
56874386|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56874387|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874388|NCT03855384|Cisplatin|cisplatin|mesh-list
56874389|NCT03855384|Carboplatin|carboplatin|mesh-list
56874390|NCT03855384|Fluorouracil|fluorouracil|mesh-list
56874391|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874392|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
56874393|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874394|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56874395|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56874396|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
56874397|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874398|NCT01181934|Nicotine|nicotine|mesh-list
56874399|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56874400|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
56874401|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874402|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874403|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56874404|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56874405|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
56874406|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874407|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874408|NCT01187862|Efavirenz|efavirenz|mesh-list
56874409|NCT01187862|Losartan|losartan|mesh-list
56874410|NCT01187862|Metoprolol|metoprolol|mesh-list
56874411|NCT01187862|Midazolam|midazolam|mesh-list
56874412|NCT01187862|Caffeine|caffeine|mesh-list
56874413|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
56874414|NCT01187862|Omeprazole|omeprazole|mesh-list
56874415|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56874416|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56874417|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56874418|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874419|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56874420|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56874421|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56874422|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56874423|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
56874424|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
56874425|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
56874426|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
56874427|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874428|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874429|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56874430|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56874431|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56874432|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56874433|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56874434|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56874435|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874436|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56874437|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56874438|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
56874439|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56874440|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56874441|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56874442|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56874443|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56874444|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
56874445|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874446|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56874447|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56874448|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56874449|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56874450|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56874451|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56874452|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
56874453|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
56874454|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874455|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56874456|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56874457|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56874458|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
56874459|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56874460|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56874461|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56874462|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
56874463|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874464|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
56874465|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56874466|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
56874467|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874468|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
56874469|NCT01185444|Protective Agents|protective agents|mesh-ancestor
56874471|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56874472|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
56874473|NCT01185678|Desogestrel|desogestrel|mesh-list
56874474|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
56874475|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56874476|NCT01185678|Progestins|progestins|mesh-list
56874477|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56874478|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874479|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56874480|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56874481|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56874482|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56874483|NCT01185678|Hormones|hormones|mesh-ancestor
56874484|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56874485|NCT01188174|Clofarabine|clofarabine|mesh-list
56874486|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56874487|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
56874488|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874489|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874490|NCT01588002|Ritonavir|ritonavir|mesh-list
56874491|NCT01588002|Efavirenz|efavirenz|mesh-list
56874492|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56874493|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56874494|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
56874495|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874496|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874497|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56874498|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56874499|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
56874500|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874501|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56874502|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56874503|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56874504|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56568561|NCT04401774|Nivolumab|nivolumab|mesh-list
56874506|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56874507|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56874508|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56874509|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56874510|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
56874511|NCT01291212|Testosterone|testosterone|mesh-list
56874512|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
56874513|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
56874514|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56874515|NCT01291212|Androgens|androgens|mesh-ancestor
56874516|NCT01291212|Hormones|hormones|mesh-ancestor
56874517|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56874518|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874519|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56874520|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874521|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
56874522|NCT01182168|Gemcitabine|gemcitabine|mesh-list
56874523|NCT01182168|Everolimus|everolimus|mesh-list
56874524|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874525|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56874526|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
56874527|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874528|NCT01182168|Antiviral Agents|antiviral agents|mesh-ancestor
56874529|NCT01182168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874530|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874531|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56874532|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
56874533|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874534|NCT01182246|Genistein|genistein|mesh-list
56874535|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56874536|NCT01182246|Protective Agents|protective agents|mesh-ancestor
56874537|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874538|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874539|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56874540|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874541|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874542|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
56874543|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56874544|NCT01182246|Estrogens|estrogens|mesh-ancestor
56874545|NCT01182246|Hormones|hormones|mesh-ancestor
56874546|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56874547|NCT01588626|Ticagrelor|ticagrelor|mesh-list
56874548|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56874549|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56874550|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56874551|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56874552|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
56874553|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874554|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874555|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874556|NCT01290120|Rituximab|rituximab|mesh-list
56874557|NCT01290120|Doxorubicin|doxorubicin|mesh-list
56874558|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56874559|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874560|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
56874561|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874562|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56874563|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56874564|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56874565|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56874566|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874567|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874568|NCT01290198|Fluconazole|fluconazole|mesh-list
56874569|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
56874570|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
56874571|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874572|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56874573|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56874574|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874575|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874576|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56874577|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
56874578|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56874579|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874580|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56874581|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56874582|NCT01290276|Ondansetron|ondansetron|mesh-list
56874583|NCT01290276|Methylphenidate|methylphenidate|mesh-list
56874584|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56874585|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874586|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56874587|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56874588|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56874589|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874590|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
56874591|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874592|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
56874593|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
56874594|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874595|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56874596|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
56874597|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
56874598|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56874599|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
56874600|NCT01290276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56874601|NCT01290276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56874602|NCT01290276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56874603|NCT01290276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56874604|NCT01290276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56874605|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
56874606|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
56874607|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56874608|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56874609|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874610|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874611|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874612|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56874613|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56874614|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874615|NCT01182636|Adapalene|adapalene|mesh-list
56874616|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56874617|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56874618|NCT01182636|Analgesics|analgesics|mesh-ancestor
56874619|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
56874620|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874621|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874622|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56874623|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56874624|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56874625|NCT01290354|Lapatinib|lapatinib|mesh-list
56874626|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874627|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56874628|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874629|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874630|NCT01188408|Docetaxel|docetaxel|mesh-list
56874631|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874632|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56874633|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56874634|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56874635|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874636|NCT01186146|Aspirin|aspirin|mesh-list
56874637|NCT01186146|Clopidogrel|clopidogrel|mesh-list
56874638|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56874639|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56874640|NCT01186146|Analgesics|analgesics|mesh-ancestor
56874641|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
56874642|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874643|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874644|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56874645|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56874646|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56874647|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56874648|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874649|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56874650|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56874651|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874653|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56874654|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56874655|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56874656|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
56874657|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874658|NCT01186224|Plerixafor|plerixafor|mesh-list
56874659|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56874660|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56874661|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
56874662|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874663|NCT01183494|Irinotecan|irinotecan|mesh-list
56874664|NCT01183494|Bevacizumab|bevacizumab|mesh-list
56874665|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56874666|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56874667|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874668|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874669|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874670|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56874671|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56874672|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56874673|NCT01183494|Growth Substances|growth substances|mesh-ancestor
56874674|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874675|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
56874676|NCT01183572|Iron|iron|mesh-list
56874677|NCT01183572|Folic Acid|folic acid|mesh-list
56874678|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
56874679|NCT01183572|Trace Elements|trace elements|mesh-ancestor
56874680|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
56874681|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874682|NCT01183572|Hematinics|hematinics|mesh-ancestor
56874683|NCT01183572|Vitamins|vitamins|mesh-ancestor
56874684|NCT03856242|Tamsulosin|tamsulosin|mesh-list
56874685|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56874686|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56874687|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56874688|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
56874689|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874690|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874691|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874692|NCT03856242|Urological Agents|urological agents|mesh-ancestor
56874693|NCT01291524|Pregabalin|pregabalin|mesh-list
56874694|NCT01291524|Analgesics|analgesics|mesh-ancestor
56874695|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
56874696|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874697|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874698|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
56874699|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56874700|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56874701|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874702|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56874703|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56874704|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56874705|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56874706|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56874707|NCT01183806|Rivastigmine|rivastigmine|mesh-list
56874708|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56874709|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874710|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874711|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
56874712|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874713|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874714|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56874715|NCT01183806|Protective Agents|protective agents|mesh-ancestor
56874716|NCT01188954|Doxycycline|doxycycline|mesh-list
56874717|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56874718|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874719|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
56874720|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56874722|NCT01183962|Vitamin D|vitamin d|mesh-list
56874723|NCT01183962|Vitamins|vitamins|mesh-ancestor
56874724|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
56874725|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874726|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56874727|NCT01187238|Cisplatin|cisplatin|mesh-list
56874728|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874729|NCT01588314|Gabapentin|gabapentin|mesh-list
56874730|NCT01588314|Analgesics|analgesics|mesh-ancestor
56874731|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
56874732|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874733|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874734|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
56874735|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56874736|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56874737|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56874738|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56874739|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56874740|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56874741|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874742|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874743|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
56874744|NCT01290432|Folic Acid|folic acid|mesh-list
56874745|NCT01290432|Melatonin|melatonin|mesh-list
56874746|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
56874747|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874748|NCT01290432|Protective Agents|protective agents|mesh-ancestor
56874749|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874750|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56874751|NCT01290432|Hematinics|hematinics|mesh-ancestor
56874752|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
56874753|NCT01290432|Vitamins|vitamins|mesh-ancestor
56874754|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
56874755|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
56874756|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56874757|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
56874758|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874759|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
56874760|NCT01290510|Protective Agents|protective agents|mesh-ancestor
56874761|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
56874762|NCT01184196|Povidone|povidone|mesh-list
56874763|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
56874764|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
56874765|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56874766|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874767|NCT01292460|Timolol|timolol|mesh-list
56874768|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56874769|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56874770|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
56874771|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874772|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874773|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874774|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56874775|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56874776|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
56874777|NCT01292694|Losartan|losartan|mesh-list
56874778|NCT01292694|Captopril|captopril|mesh-list
56874779|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56874780|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56874781|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56874782|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56874783|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874784|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56874785|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
56874786|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874787|NCT03851562|Alprostadil|alprostadil|mesh-list
56874788|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56874789|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
56874790|NCT03851562|Urological Agents|urological agents|mesh-ancestor
56874791|NCT01293630|Paclitaxel|paclitaxel|mesh-list
56874792|NCT01293630|Carboplatin|carboplatin|mesh-list
56874793|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56874794|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874795|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
56874796|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
56874797|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
56874798|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874799|NCT01191060|Lenalidomide|lenalidomide|mesh-list
56874800|NCT01191060|Bortezomib|bortezomib|mesh-list
56874801|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
56874802|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389362|NCT00149292|Olanzapine|olanzapine|mesh-list
56874804|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56874805|NCT01191060|Growth Substances|growth substances|mesh-ancestor
56874806|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
56874807|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874808|NCT01291602|Avibactam|avibactam|mesh-list
56874809|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56874810|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874811|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874812|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56874813|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874814|NCT03851172|Ketorolac|ketorolac|mesh-list
56874815|NCT03851172|Nepafenac|nepafenac|mesh-list
56874816|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
56874817|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56874818|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56874819|NCT03851172|Analgesics|analgesics|mesh-ancestor
56874820|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
56874821|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874822|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874823|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56874824|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56874825|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56874826|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874827|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874828|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
56874829|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
56874830|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
56874831|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56874832|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56874833|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
56874834|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874835|NCT03853512|Petrolatum|petrolatum|mesh-list
56874836|NCT03853512|Emollients|emollients|mesh-ancestor
56874837|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
56874838|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
56874839|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56874840|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874841|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
56874842|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56874843|NCT03853200|Acetic Acid|acetic acid|mesh-list
56874844|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
56874845|NCT03853200|Edetic Acid|edetic acid|mesh-list
56874846|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
56874847|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56874848|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874849|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
56874850|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
56874851|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
56874852|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56874853|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
56874854|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
56874855|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874856|NCT03853200|Antidotes|antidotes|mesh-ancestor
56874857|NCT03853200|Protective Agents|protective agents|mesh-ancestor
56874858|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874859|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56874860|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56874861|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
56874862|NCT01293942|Bevacizumab|bevacizumab|mesh-list
56874863|NCT01293942|Capecitabine|capecitabine|mesh-list
56874864|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
56874865|NCT01293942|Irinotecan|irinotecan|mesh-list
56874866|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56874867|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874868|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56874869|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56874870|NCT01293942|Growth Substances|growth substances|mesh-ancestor
56874871|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874872|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
56874873|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56874874|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
56874875|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874876|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56874877|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56874878|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874879|NCT01189656|Vaccines|vaccines|mesh-list
56874881|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874882|NCT01581138|Ribavirin|ribavirin|mesh-list
56874883|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
56874884|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874885|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
56874886|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56874887|NCT01191216|Docetaxel|docetaxel|mesh-list
56874888|NCT01191216|Tryptophan|tryptophan|mesh-list
56874889|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874890|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
56874891|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
56874892|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
56874893|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874894|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56874895|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
56874896|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56874897|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
56874898|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
56874899|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874900|NCT01294176|Protective Agents|protective agents|mesh-ancestor
56874901|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874902|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
56874903|NCT01294176|Vitamins|vitamins|mesh-ancestor
56874904|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
56874905|NCT03847818|Carboplatin|carboplatin|mesh-list
56874906|NCT03847818|Docetaxel|docetaxel|mesh-list
56874907|NCT03847818|Trastuzumab|trastuzumab|mesh-list
56874908|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874909|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
56874910|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
56874911|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
56874912|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874913|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56874914|NCT01294410|Antibodies|antibodies|mesh-list
56874915|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
56874916|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
56874917|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874918|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
56874919|NCT01191450|Amiloride|amiloride|mesh-list
56874920|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56874921|NCT01191450|Diuretics|diuretics|mesh-ancestor
56874922|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
56874923|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874924|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56874925|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56874926|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874927|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56874928|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56874929|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56874930|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56874931|NCT01194336|Huperzine A|huperzine a|mesh-list
56874932|NCT01194336|Donepezil|donepezil|mesh-list
56874933|NCT01194336|Galantamine|galantamine|mesh-list
56874934|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56874935|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56874936|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874937|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
56874938|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56874939|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874940|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
56874941|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56874942|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
56874943|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56874944|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56874945|NCT01194336|Protective Agents|protective agents|mesh-ancestor
56874946|NCT02660710|Rituximab|rituximab|mesh-list
56874947|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56874948|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874949|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
56874950|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874951|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56874952|NCT01294878|Omalizumab|omalizumab|mesh-list
56874953|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56874954|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56874955|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
56874956|NCT01296438|Insulin|insulin|mesh-list
56874957|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56874958|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
56874959|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
56874960|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56874961|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56874962|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874963|NCT03847272|Prednisone|prednisone|mesh-list
56874964|NCT03847272|Ustekinumab|ustekinumab|mesh-list
56874965|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56874966|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
56874967|NCT03847272|Hormones|hormones|mesh-ancestor
56874968|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56874969|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874970|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56874971|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874972|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
56874973|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56874974|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56874975|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
56874976|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56874977|NCT01294956|Laxatives|laxatives|mesh-ancestor
56874978|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56874979|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
56874980|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56874981|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56874982|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
56874983|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874984|NCT01190358|Protective Agents|protective agents|mesh-ancestor
56874985|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874986|NCT01293162|Folic Acid|folic acid|mesh-list
56874987|NCT01293162|Policosanol|policosanol|mesh-list
56874988|NCT01293162|Hematinics|hematinics|mesh-ancestor
56874989|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
56874990|NCT01293162|Vitamins|vitamins|mesh-ancestor
56874991|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
56874992|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56874993|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56874994|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56874995|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
56874996|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56874997|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56874998|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56874999|NCT01190670|Tacrolimus|tacrolimus|mesh-list
56875000|NCT01190670|Peficitinib|peficitinib|mesh-list
56875001|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56875002|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
56875003|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875004|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56875005|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875006|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875007|NCT01194882|Insulin|insulin|mesh-list
56875008|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56875009|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56875010|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875011|NCT01191684|Vaccines|vaccines|mesh-list
56875012|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
56875013|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875014|NCT02659540|Nivolumab|nivolumab|mesh-list
56875015|NCT02659540|Ipilimumab|ipilimumab|mesh-list
56875016|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875017|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875018|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56875019|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875020|NCT01295268|Emu Oil|emu oil|mesh-list
56875021|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875022|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
56875023|NCT01383694|Piperine|piperine|mesh-list
56875024|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56875025|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875026|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875027|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
56875028|NCT01191918|Donepezil|donepezil|mesh-list
56875029|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56875030|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875031|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875032|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
56875034|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875036|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
56875037|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56875038|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
56875039|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56875040|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875041|NCT03850314|Glycine|glycine|mesh-list
56875042|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
56875043|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875044|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875045|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875046|NCT01097746|Paclitaxel|paclitaxel|mesh-list
56875047|NCT01097746|Bevacizumab|bevacizumab|mesh-list
56875048|NCT01097746|Carboplatin|carboplatin|mesh-list
56875049|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56875050|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56875051|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
56875052|NCT01097746|Antibodies|antibodies|mesh-list
56875053|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
56875054|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56875055|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
56875056|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56875057|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875058|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
56875059|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
56875060|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
56875061|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875062|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56875063|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56875064|NCT01097746|Growth Substances|growth substances|mesh-ancestor
56875065|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875066|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
56875067|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
56875068|NCT01190748|Galantamine|galantamine|mesh-list
56875069|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56875070|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875071|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875072|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
56875073|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875074|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875075|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56875076|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
56875077|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875078|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
56875079|NCT01383538|Leucovorin|leucovorin|mesh-list
56875080|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
56875081|NCT01383538|Irinotecan|irinotecan|mesh-list
56875082|NCT01383538|Folfirinox|folfirinox|mesh-list
56875083|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875084|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56875085|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56875086|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875087|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875088|NCT01383538|Antidotes|antidotes|mesh-ancestor
56875089|NCT01383538|Protective Agents|protective agents|mesh-ancestor
56875090|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875091|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
56875092|NCT01383538|Vitamins|vitamins|mesh-ancestor
56875093|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
56875094|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
56875095|NCT01383460|Lenograstim|lenograstim|mesh-list
56875096|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56875097|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
56875098|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875099|NCT01383460|Hematinics|hematinics|mesh-ancestor
56875100|NCT01192230|Docetaxel|docetaxel|mesh-list
56875101|NCT01192230|Endostatins|endostatins|mesh-list
56875102|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875103|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
56875104|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
56585897|NCT00833638|Tadalafil|tadalafil|mesh-list
56875105|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
56875106|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875107|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56389655|NCT00336310|Repaglinide|repaglinide|mesh-list
56875108|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56875109|NCT01192230|Growth Substances|growth substances|mesh-ancestor
56875110|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875111|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
56875112|NCT05416840|Amlodipine|amlodipine|mesh-list
56875113|NCT05416840|Clonidine|clonidine|mesh-list
56875114|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56875115|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56875116|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56875117|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875118|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56875119|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875120|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
56875121|NCT05416840|Analgesics|analgesics|mesh-ancestor
56875122|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
56875123|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875124|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
56875125|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
56875126|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56875127|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56875128|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56875129|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
56875130|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875131|NCT01192308|Tamoxifen|tamoxifen|mesh-list
56875132|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56875133|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
56875134|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875135|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875136|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56875137|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875138|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56875139|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56875140|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56875141|NCT01190982|Paclitaxel|paclitaxel|mesh-list
56875142|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56875143|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875144|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
56875145|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
56875146|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
56875147|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875148|NCT04170556|Nivolumab|nivolumab|mesh-list
56875149|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875150|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875151|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56875152|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875153|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56875154|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
56875155|NCT01196754|Sevoflurane|sevoflurane|mesh-list
56875156|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56875157|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56875158|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
56875159|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
56875160|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875161|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875162|NCT01295502|Paclitaxel|paclitaxel|mesh-list
56875163|NCT01295502|Cisplatin|cisplatin|mesh-list
56875164|NCT01295502|Carboplatin|carboplatin|mesh-list
56875165|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56875166|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56875167|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875168|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
56875169|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
56875170|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
56875171|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875172|NCT05207644|Letrozole|letrozole|mesh-list
56875173|NCT05207644|Misoprostol|misoprostol|mesh-list
56875174|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875175|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56875176|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56875177|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875178|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875179|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56875180|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
56904730|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56875181|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875183|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56875184|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
56875185|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56875186|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56875187|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56875188|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
56875189|NCT03846102|Acetaminophen|acetaminophen|mesh-list
56875190|NCT03846102|Morphine|morphine|mesh-list
56875191|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
56875192|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56875193|NCT03846102|Narcotics|narcotics|mesh-ancestor
56875194|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875195|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875196|NCT03846102|Analgesics|analgesics|mesh-ancestor
56875197|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
56875198|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875199|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56875200|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
56875201|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
56875202|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
56875203|NCT01383148|Gemcitabine|gemcitabine|mesh-list
56875204|NCT01383148|Paclitaxel|paclitaxel|mesh-list
56875205|NCT01383148|Cisplatin|cisplatin|mesh-list
56875206|NCT01383148|Carboplatin|carboplatin|mesh-list
56875207|NCT01383148|Pemetrexed|pemetrexed|mesh-list
56875208|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56875209|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875210|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
56875211|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
56875212|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
56875213|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875214|NCT01383148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875215|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56875216|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
56875217|NCT01383148|Antiviral Agents|antiviral agents|mesh-ancestor
56875218|NCT01383148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875219|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875220|NCT01383148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56875221|NCT01383148|Immunologic Factors|immunologic factors|mesh-ancestor
56875222|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56875223|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56875224|NCT05131828|Metformin|metformin|mesh-list
56875225|NCT05131828|Clemastine|clemastine|mesh-list
56875226|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56875227|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875228|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
56875229|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
56875230|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56875231|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
56875232|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
56875233|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875234|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875235|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56875236|NCT01192854|Adefovir|adefovir|mesh-list
56875237|NCT01192854|Clevudine|clevudine|mesh-list
56875238|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
56875239|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875240|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56875241|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56875242|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875243|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875244|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
56875245|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56875246|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875247|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
56875248|NCT04905810|Azacitidine|azacitidine|mesh-list
56875249|NCT04905810|Decitabine|decitabine|mesh-list
56875250|NCT04905810|Venetoclax|venetoclax|mesh-list
56875251|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56875252|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
56875253|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875254|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875255|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875256|NCT03912064|Ipilimumab|ipilimumab|mesh-list
56875257|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875258|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875259|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56875260|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875261|NCT05386914|Sirolimus|sirolimus|mesh-list
56875262|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56875263|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875264|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56875265|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875266|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
56875267|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56875268|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
56875269|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875270|NCT01195428|Simvastatin|simvastatin|mesh-list
56875271|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56875272|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56875273|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
56875274|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875275|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56875276|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56875277|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875278|NCT03439462|Sirolimus|sirolimus|mesh-list
56875279|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875280|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875281|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56875282|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875283|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56875284|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
56875285|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56875286|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
56875287|NCT03941860|Lenalidomide|lenalidomide|mesh-list
56875288|NCT03941860|Ixazomib|ixazomib|mesh-list
56875289|NCT03941860|Glycine|glycine|mesh-list
56875290|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
56479623|NCT02925026|Muramidase|muramidase|mesh-list
56875291|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875292|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56875293|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56875294|NCT03941860|Growth Substances|growth substances|mesh-ancestor
56875295|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
56875296|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875297|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875298|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
56875299|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875300|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
56875301|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875302|NCT01193166|Olanzapine|olanzapine|mesh-list
56875303|NCT01193166|Risperidone|risperidone|mesh-list
56875304|NCT01193166|Aripiprazole|aripiprazole|mesh-list
56875305|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56875306|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56875307|NCT01193166|Perphenazine|perphenazine|mesh-list
56875308|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56875309|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
56875310|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875311|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875312|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875313|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56875314|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56875315|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875316|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56875317|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56875318|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
56875319|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
56875320|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
56875321|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875322|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56875323|NCT01193166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56875324|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56875325|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56875326|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
56875327|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
56875328|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56875329|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56875330|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56875331|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56586121|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
56875332|NCT01197144|Adalimumab|adalimumab|mesh-list
56875335|NCT01193400|Cytarabine|cytarabine|mesh-list
56875336|NCT01193400|Clofarabine|clofarabine|mesh-list
56875337|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56875338|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
56875339|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875340|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875341|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
56875342|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875343|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56875344|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
56875345|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875346|NCT03904888|Anesthetics|anesthetics|mesh-list
56875347|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
56875348|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875349|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875350|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
56875351|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875352|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56875353|NCT01193478|Ledipasvir|ledipasvir|mesh-list
56875354|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
56875355|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875356|NCT03726268|Fentanyl|fentanyl|mesh-list
56875357|NCT03726268|Sufentanil|sufentanil|mesh-list
56875358|NCT03726268|Morphine|morphine|mesh-list
56875359|NCT03726268|Methadone|methadone|mesh-list
56875360|NCT03726268|Hydromorphone|hydromorphone|mesh-list
56875361|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56875362|NCT03726268|Narcotics|narcotics|mesh-ancestor
56875363|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875364|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875365|NCT03726268|Analgesics|analgesics|mesh-ancestor
56875366|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
56875367|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875368|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56875369|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56875370|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
56875371|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
56875372|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
56875373|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
56875374|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
56875375|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
56875376|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56875377|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56875378|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875379|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875380|NCT01295736|Urological Agents|urological agents|mesh-ancestor
56875381|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
56875382|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
56875383|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56875384|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56875385|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875386|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875387|NCT03733470|Urological Agents|urological agents|mesh-ancestor
56875388|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56875389|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56875390|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875391|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
56875392|NCT04731376|Testosterone|testosterone|mesh-list
56875393|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
56875394|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
56875395|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56875396|NCT04731376|Androgens|androgens|mesh-ancestor
56875397|NCT04731376|Hormones|hormones|mesh-ancestor
56875398|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875399|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875400|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56875401|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875402|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
56875403|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56875404|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875405|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875406|NCT01295892|Estrogens|estrogens|mesh-list
56875407|NCT01295892|Hormones|hormones|mesh-ancestor
56875408|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875409|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875410|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
56875411|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56875412|NCT05104762|Antibodies|antibodies|mesh-list
56875413|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
56875414|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56875415|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
56875416|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875417|NCT03018418|Mitomycins|mitomycins|mesh-list
56875418|NCT03018418|Mitomycin|mitomycin|mesh-list
56875419|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56875420|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875421|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
56875422|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875423|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56875424|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875425|NCT03255252|Cisplatin|cisplatin|mesh-list
56875426|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875427|NCT01296204|Antibodies|antibodies|mesh-list
56875428|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
56875429|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875430|NCT05505552|Vitamin K|vitamin k|mesh-list
56875431|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
56875432|NCT05505552|Vitamins|vitamins|mesh-ancestor
56875433|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
56875434|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875435|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56875436|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56875437|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875438|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
56875439|NCT05505552|Coagulants|coagulants|mesh-ancestor
56875440|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56875441|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
56875442|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56875443|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56875444|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56875445|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875446|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875447|NCT05670678|Lactoferrin|lactoferrin|mesh-list
56875448|NCT05670678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875449|NCT02914366|Ambroxol|ambroxol|mesh-list
56875450|NCT02914366|Expectorants|expectorants|mesh-ancestor
56875451|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
56875452|NCT03846180|Octreotide|octreotide|mesh-list
56875453|NCT03846180|Terlipressin|terlipressin|mesh-list
56875454|NCT03846180|Somatostatin|somatostatin|mesh-list
56875455|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56875456|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56875457|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875458|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56875459|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56875460|NCT03846180|Hormones|hormones|mesh-ancestor
56875461|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875462|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875463|NCT02773030|Dexamethasone|dexamethasone|mesh-list
56875464|NCT02773030|Bortezomib|bortezomib|mesh-list
56875465|NCT02773030|Daratumumab|daratumumab|mesh-list
56875466|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875467|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
56875468|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
56875469|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875470|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875471|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56875472|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
56875473|NCT02773030|Hormones|hormones|mesh-ancestor
56875474|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875475|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56875476|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875477|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
56875478|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
56875479|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
56875480|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875481|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875482|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
56875483|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875484|NCT02729116|Ertapenem|ertapenem|mesh-list
56875485|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
56875486|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56875487|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875488|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56875489|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56875490|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875491|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875492|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875494|NCT02627092|Trace Elements|trace elements|mesh-ancestor
56875495|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
56875496|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875497|NCT02616640|Dexamethasone|dexamethasone|mesh-list
56875498|NCT02616640|Durvalumab|durvalumab|mesh-list
56875499|NCT02616640|Pomalidomide|pomalidomide|mesh-list
56875500|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875501|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
56875502|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
56875503|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875504|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875505|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56875506|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
56875507|NCT02616640|Hormones|hormones|mesh-ancestor
56875508|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875509|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56875510|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875511|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875512|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
56875513|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56875514|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56875515|NCT02616640|Growth Substances|growth substances|mesh-ancestor
56875516|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
56875517|NCT02567422|Cisplatin|cisplatin|mesh-list
56875518|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875519|NCT05289648|Niraparib|niraparib|mesh-list
56875520|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56875521|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875522|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875523|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875524|NCT01199562|Valganciclovir|valganciclovir|mesh-list
56875525|NCT01199562|Ganciclovir|ganciclovir|mesh-list
56875526|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56875527|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
56875528|NCT01199562|Foscarnet|foscarnet|mesh-list
56875529|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56875530|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875531|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56875532|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875533|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875534|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56875535|NCT03845322|Curcumin|curcumin|mesh-list
56875536|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56875537|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56875538|NCT03845322|Analgesics|analgesics|mesh-ancestor
56875539|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
56875540|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875541|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875542|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875543|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56875544|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875545|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875546|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875547|NCT04831398|Melatonin|melatonin|mesh-list
56875548|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
56875549|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875550|NCT04831398|Protective Agents|protective agents|mesh-ancestor
56875551|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875552|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875553|NCT03844932|Cyclosporine|cyclosporine|mesh-list
56875554|NCT03844932|Cyclosporins|cyclosporins|mesh-list
56875555|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875556|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875557|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56875558|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
56875559|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568566|NCT01004406|Atorvastatin|atorvastatin|mesh-list
56875562|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
56875563|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586358|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
56875564|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56875566|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56875567|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
56875568|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56875569|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875570|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875571|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56875572|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56875573|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56875574|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56875575|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875576|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875577|NCT01202058|Sirolimus|sirolimus|mesh-list
56875578|NCT01202058|Everolimus|everolimus|mesh-list
56875579|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875580|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56875581|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
56875582|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875583|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56875584|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875585|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56875586|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
56875587|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
56875588|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875589|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
56875590|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
56875591|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
56875592|NCT03842046|Phenylephrine|phenylephrine|mesh-list
56875593|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
56875594|NCT03842046|Norepinephrine|norepinephrine|mesh-list
56875595|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56875596|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
56875597|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
56875598|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875599|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875600|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
56875601|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56875602|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
56875603|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
56875604|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56875605|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56875606|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56875607|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
56875608|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875609|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875610|NCT03842046|Protective Agents|protective agents|mesh-ancestor
56875611|NCT01198236|Itraconazole|itraconazole|mesh-list
56875612|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
56875613|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875614|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56875615|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56875616|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875617|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875618|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56875619|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
56875620|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875621|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875622|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56875623|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56875624|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
56875625|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875626|NCT04091490|Nivolumab|nivolumab|mesh-list
56875627|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875628|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875629|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56875630|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875631|NCT05184816|Deferoxamine|deferoxamine|mesh-list
56875632|NCT05184816|Siderophores|siderophores|mesh-ancestor
56875634|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
56875635|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
56875636|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875637|NCT03841890|Tolnaftate|tolnaftate|mesh-list
56875638|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
56875639|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875640|NCT01200108|Budesonide|budesonide|mesh-list
56875641|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875642|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56875643|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
56875644|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875645|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875646|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56875647|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
56875648|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
56875649|NCT01200108|Hormones|hormones|mesh-ancestor
56875650|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875651|NCT01200186|Progestins|progestins|mesh-list
56875652|NCT01200186|Hormones|hormones|mesh-ancestor
56875653|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875654|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875655|NCT03841812|Propofol|propofol|mesh-list
56875656|NCT03841812|Sevoflurane|sevoflurane|mesh-list
56875657|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56875658|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875659|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875660|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56875661|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
56875662|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
56875663|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56875664|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56875665|NCT03882970|Tirzepatide|tirzepatide|mesh-list
56875666|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56875667|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875668|NCT03882970|Incretins|incretins|mesh-ancestor
56875669|NCT03882970|Hormones|hormones|mesh-ancestor
56875670|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875671|NCT05111808|Methylene Blue|methylene blue|mesh-list
56875672|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875673|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875674|NCT01198392|Cisplatin|cisplatin|mesh-list
56875675|NCT01198392|Tegafur|tegafur|mesh-list
56875676|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875677|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56875678|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
56875679|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875680|NCT01200264|Apremilast|apremilast|mesh-list
56875681|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56875682|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56875683|NCT01200264|Analgesics|analgesics|mesh-ancestor
56875684|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
56875685|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875686|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875687|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875688|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56875689|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56875690|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56875691|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875692|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875693|NCT05669820|Antisecretory factor|antisecretory factor|mesh-list
56875694|NCT05669820|Antidiarrheals|antidiarrheals|mesh-ancestor
56875695|NCT05669820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56875696|NCT04799236|Amphotericin B|amphotericin b|mesh-list
56875697|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56875698|NCT04799236|Miltefosine|miltefosine|mesh-list
56875699|NCT04799236|Amebicides|amebicides|mesh-ancestor
56875700|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56875701|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56875702|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875703|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56875704|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
56875705|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875706|NCT03796156|Aspirin|aspirin|mesh-list
56875707|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56875708|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56875709|NCT03796156|Analgesics|analgesics|mesh-ancestor
56875710|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
56875711|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875712|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875713|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875714|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56875715|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56875716|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56875717|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875718|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56875719|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56875720|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875721|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
56875722|NCT05759572|Apatinib|apatinib|mesh-list
56875723|NCT05759572|Fulvestrant|fulvestrant|mesh-list
56875724|NCT05759572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875725|NCT05759572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56875726|NCT05759572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875727|NCT05759572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875728|NCT05759572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56875729|NCT05759572|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56875730|NCT05759572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56875731|NCT05759572|Hormone Antagonists|hormone antagonists|mesh-ancestor
56875732|NCT05759572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875733|NCT05759572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875734|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
56875735|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56875736|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875737|NCT03630952|Aflibercept|aflibercept|mesh-list
56875738|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56875739|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56875740|NCT03630952|Growth Substances|growth substances|mesh-ancestor
56875741|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875742|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
56875743|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875744|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56875745|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
56875746|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56875747|NCT01200654|Linezolid|linezolid|mesh-list
56875748|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56875749|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875750|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56875751|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875752|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875753|NCT01200732|Tadalafil|tadalafil|mesh-list
56875754|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
56875755|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56875756|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56875757|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875758|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875759|NCT01200732|Urological Agents|urological agents|mesh-ancestor
56875760|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
56875761|NCT01198860|Tenofovir|tenofovir|mesh-list
56875762|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
56875763|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875764|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56875765|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56875766|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875767|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875768|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56875769|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56875770|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
56875771|NCT01198860|Protective Agents|protective agents|mesh-ancestor
56875772|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875773|NCT01198860|Vitamins|vitamins|mesh-ancestor
56875774|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
56875775|NCT01198938|Melatonin|melatonin|mesh-list
56875776|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
56875777|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875778|NCT01198938|Protective Agents|protective agents|mesh-ancestor
56875779|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875780|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875781|NCT01201044|Gemcitabine|gemcitabine|mesh-list
56875782|NCT01201044|Nedaplatin|nedaplatin|mesh-list
56875784|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
56875785|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875786|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875787|NCT01201044|Antiviral Agents|antiviral agents|mesh-ancestor
56586569|NCT00766363|Rivastigmine|rivastigmine|mesh-list
56875788|NCT01201044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875789|NCT01201044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875790|NCT01201044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56875791|NCT01201044|Immunologic Factors|immunologic factors|mesh-ancestor
56875792|NCT01201044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875793|NCT03843060|Itraconazole|itraconazole|mesh-list
56875794|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
56875795|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875796|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56875797|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56875798|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875799|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875800|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56875801|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
56875802|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56875803|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875804|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56875805|NCT04497012|Iron|iron|mesh-list
56875806|NCT04497012|Trace Elements|trace elements|mesh-ancestor
56875807|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
56875808|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875809|NCT04427904|Lidocaine|lidocaine|mesh-list
56875810|NCT04427904|Epinephrine|epinephrine|mesh-list
56875811|NCT04427904|Racepinephrine|racepinephrine|mesh-list
56875812|NCT04427904|Bupivacaine|bupivacaine|mesh-list
56875813|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
56875814|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
56875815|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
56875816|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875817|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875818|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
56875819|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875820|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56875821|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56875822|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56875823|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56875824|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875825|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56875826|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56875827|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
56875828|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56875829|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56875830|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56875831|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
56875832|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56875833|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
56875834|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
56875835|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
56875836|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56875837|NCT03792516|Artesunate|artesunate|mesh-list
56875838|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
56875839|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56875840|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56875841|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875842|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875843|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
56875844|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
56875845|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56875846|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
56875847|NCT01201122|Mesalamine|mesalamine|mesh-list
56875848|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56875849|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56875850|NCT01201122|Analgesics|analgesics|mesh-ancestor
56875851|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
56875852|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875853|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875854|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875855|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56875856|NCT03674112|Trastuzumab|trastuzumab|mesh-list
56875858|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875859|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875860|NCT03668808|Insulin|insulin|mesh-list
56875861|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56875862|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
56875863|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
56875864|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56875865|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875867|NCT05281926|Poly ICLC|poly iclc|mesh-list
56875868|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875869|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875870|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56875871|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875872|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
56875873|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
56875874|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875875|NCT03844776|Acetaminophen|acetaminophen|mesh-list
56875876|NCT03844776|Amoxicillin|amoxicillin|mesh-list
56875877|NCT03844776|Metronidazole|metronidazole|mesh-list
56875878|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56875879|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
56875880|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56875881|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56875882|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56875883|NCT03844776|Analgesics|analgesics|mesh-ancestor
56875884|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
56875885|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875886|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875887|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
56875888|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56875889|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
56875890|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56875891|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56875892|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56875893|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875894|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875895|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
56875896|NCT01566942|Irinotecan|irinotecan|mesh-list
56875897|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875898|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56875899|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56875900|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875901|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875902|NCT01201278|Insulin|insulin|mesh-list
56875903|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56875904|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
56875905|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56875906|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875907|NCT01199328|Aspirin|aspirin|mesh-list
56875908|NCT01199328|Esomeprazole|esomeprazole|mesh-list
56875909|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56875910|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56875911|NCT01199328|Analgesics|analgesics|mesh-ancestor
56875912|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
56875913|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875914|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875915|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875916|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56875917|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56875918|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56875919|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875920|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56875921|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56875922|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875923|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
56875924|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56875925|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56875926|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56875927|NCT02982954|Nivolumab|nivolumab|mesh-list
56875928|NCT02982954|Ipilimumab|ipilimumab|mesh-list
56875929|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875930|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875931|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56904731|NCT02087332|Diuretics|diuretics|mesh-ancestor
56875932|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875934|NCT01203228|Busulfan|busulfan|mesh-list
56875935|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
56875936|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56875937|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
56875938|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875939|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56875941|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
56875942|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875943|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875944|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56875945|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56875946|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
56875947|NCT01203696|Amlodipine|amlodipine|mesh-list
56875948|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56875949|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56875950|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56875951|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875952|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56875953|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875954|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
56875955|NCT01203306|Bevacizumab|bevacizumab|mesh-list
56875956|NCT01203306|Capecitabine|capecitabine|mesh-list
56875957|NCT01203306|Octreotide|octreotide|mesh-list
56875958|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875959|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875960|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56875961|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56875962|NCT01203306|Growth Substances|growth substances|mesh-ancestor
56875963|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875964|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
56875965|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56875966|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
56875967|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875968|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56875969|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56875970|NCT01203384|Flurbiprofen|flurbiprofen|mesh-list
56875971|NCT01203384|Analgesics|analgesics|mesh-ancestor
56875972|NCT01203384|Sensory System Agents|sensory system agents|mesh-ancestor
56875973|NCT01203384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56875974|NCT01203384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875975|NCT01203384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56875976|NCT01203384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56875977|NCT01203384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56875978|NCT01203384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56875979|NCT01203384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56875980|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56875981|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875982|NCT03724968|Nivolumab|nivolumab|mesh-list
56875983|NCT03724968|Ipilimumab|ipilimumab|mesh-list
56875984|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56875985|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56875986|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56875987|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56875988|NCT05121324|Midazolam|midazolam|mesh-list
56875989|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56875990|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56875991|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56875992|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56875993|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56875994|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56875995|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56875996|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56875997|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
56875998|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
56875999|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
56876000|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
56876001|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876002|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876003|NCT01204086|Fluoxetine|fluoxetine|mesh-list
56876004|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56876005|NCT01204086|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56876012|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56876013|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
56876014|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56876015|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56876016|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56876017|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876018|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56876019|NCT01201902|Vaccines|vaccines|mesh-list
56876020|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
56876021|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876022|NCT01204164|Dexamethasone|dexamethasone|mesh-list
56876023|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876024|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
56876025|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
56876026|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876027|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876028|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876029|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
56876030|NCT01204164|Hormones|hormones|mesh-ancestor
56876031|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876032|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56876033|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876034|NCT01206036|Sirolimus|sirolimus|mesh-list
56876035|NCT01206036|Docetaxel|docetaxel|mesh-list
56876036|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876037|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
56876038|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
56876039|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
56876040|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876041|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56876042|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876043|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56876044|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
56876045|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876046|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
56876047|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876048|NCT01204320|Paclitaxel|paclitaxel|mesh-list
56876049|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56876050|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56876051|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876052|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
56876053|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
56876054|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
56876055|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876056|NCT03722238|Ibuprofen|ibuprofen|mesh-list
56876057|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56876058|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56876059|NCT03722238|Analgesics|analgesics|mesh-ancestor
56876060|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
56876061|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876062|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876063|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876064|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876065|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56876066|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876067|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876068|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56876069|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56876070|NCT01203618|Farletuzumab|farletuzumab|mesh-list
56876071|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876072|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
56876075|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
56876076|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
56876077|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56876078|NCT01206270|Androgens|androgens|mesh-ancestor
56876079|NCT01206270|Hormones|hormones|mesh-ancestor
56876080|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876081|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876082|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56586868|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
56876083|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876084|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
56876085|NCT01206270|Cathartics|cathartics|mesh-ancestor
56876086|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876087|NCT01298310|Lidocaine|lidocaine|mesh-list
56876088|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
56876089|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
56876090|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876091|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876092|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
56876093|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876094|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56876095|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56876096|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56876097|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56876098|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876099|NCT01298466|Pregabalin|pregabalin|mesh-list
56876100|NCT01298466|Analgesics|analgesics|mesh-ancestor
56876101|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
56876102|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876103|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876104|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
56876105|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56876106|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56876107|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876108|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56876109|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56876110|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56876111|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876112|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56876113|NCT01206348|Minocycline|minocycline|mesh-list
56876114|NCT01206348|Clindamycin|clindamycin|mesh-list
56876115|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
56876116|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
56876117|NCT01206348|Tretinoin|tretinoin|mesh-list
56876118|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56876119|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56876120|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876121|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56876122|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876123|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876124|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
56876125|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876126|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
56876127|NCT05622708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56876128|NCT05622708|Immunologic Factors|immunologic factors|mesh-ancestor
56876129|NCT05622708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876130|NCT05669352|Pembrolizumab|pembrolizumab|mesh-list
56876131|NCT05669352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876132|NCT05669352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876133|NCT01204476|Everolimus|everolimus|mesh-list
56876134|NCT01204476|Octreotide|octreotide|mesh-list
56876135|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56876136|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876137|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876138|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
56876139|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876140|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876141|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56876142|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56876143|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876144|NCT04630210|Atezolizumab|atezolizumab|mesh-list
56876145|NCT04630210|Letrozole|letrozole|mesh-list
56904732|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
56876146|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876147|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56876148|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56876149|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876150|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876151|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56876152|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
56876153|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876154|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876155|NCT02051218|Denosumab|denosumab|mesh-list
56876156|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56876157|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876158|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
56876159|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
56586942|NCT02812719|Analgesics|analgesics|mesh-ancestor
56876160|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56876161|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56876162|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876163|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876164|NCT01382368|Urological Agents|urological agents|mesh-ancestor
56876165|NCT04546828|Gemcitabine|gemcitabine|mesh-list
56876166|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876167|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876168|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
56876169|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876170|NCT04546828|Antiviral Agents|antiviral agents|mesh-ancestor
56876171|NCT04546828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876172|NCT04546828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876173|NCT04546828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876174|NCT04546828|Immunologic Factors|immunologic factors|mesh-ancestor
56876175|NCT04546828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876176|NCT01382134|Aspirin|aspirin|mesh-list
56876177|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56876178|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56876179|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56876180|NCT01382134|Analgesics|analgesics|mesh-ancestor
56876181|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
56876182|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876183|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876184|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876185|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876186|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56876187|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56876188|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876189|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56876190|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56876191|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876192|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
56876193|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
56876194|NCT01382134|Coagulants|coagulants|mesh-ancestor
56876195|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56876196|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
56876197|NCT02563002|Bevacizumab|bevacizumab|mesh-list
56876198|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
56876199|NCT02563002|Cetuximab|cetuximab|mesh-list
56876200|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876201|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876202|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56876203|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56876204|NCT02563002|Growth Substances|growth substances|mesh-ancestor
56876205|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876206|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
56876207|NCT05077488|Lidocaine|lidocaine|mesh-list
56876208|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
56876209|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
56876210|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876211|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876212|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
56876213|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876214|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56876215|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56876216|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56876217|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56876218|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876220|NCT05668572|Immunologic Factors|immunologic factors|mesh-ancestor
56876221|NCT05668572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876222|NCT02410980|Tretinoin|tretinoin|mesh-list
56876223|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876224|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
56876225|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
56876226|NCT01298934|Panobinostat|panobinostat|mesh-list
56876227|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876228|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56876229|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876230|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876231|NCT01300962|Capecitabine|capecitabine|mesh-list
56587017|NCT01038128|Memantine|memantine|mesh-list
56876232|NCT01300962|Trastuzumab|trastuzumab|mesh-list
56876233|NCT01300962|Lapatinib|lapatinib|mesh-list
56876234|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876235|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
56876236|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876237|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876238|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876239|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56876240|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876241|NCT01299012|Liraglutide|liraglutide|mesh-list
56876242|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56876243|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876244|NCT01299012|Incretins|incretins|mesh-ancestor
56876245|NCT01299012|Hormones|hormones|mesh-ancestor
56876246|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876247|NCT02155920|Everolimus|everolimus|mesh-list
56876248|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876249|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876250|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
56876251|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876252|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
56876253|NCT01301040|Docetaxel|docetaxel|mesh-list
56876254|NCT01301040|Epirubicin|epirubicin|mesh-list
56876255|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876256|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
56876257|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876258|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876259|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56876260|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
56876261|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876262|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876263|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56876264|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
56876265|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
56876266|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
56876267|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56876268|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56876269|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56876270|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876271|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
56876272|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
56876273|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876274|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
56876275|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876276|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876277|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56876278|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
56876279|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876280|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876281|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56876282|NCT01206972|Enoxaparin|enoxaparin|mesh-list
56876283|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
56876284|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56876285|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
56876286|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56876287|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
56876288|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876289|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876290|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
56876291|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56876292|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56876293|NCT03817476|BI 425809|bi 425809|mesh-list
56876294|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
56876295|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
56876296|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
56876298|NCT02918292|Tacrolimus|tacrolimus|mesh-list
56876299|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
56876300|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56876301|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876302|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
56876303|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876304|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876305|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56876306|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
56876307|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876308|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876309|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56587086|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56876310|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56876311|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876312|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56876313|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56876314|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
56876315|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56876316|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876317|NCT01207128|Voriconazole|voriconazole|mesh-list
56876318|NCT01207128|Micafungin|micafungin|mesh-list
56876319|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
56876320|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876321|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56876322|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56876323|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876324|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876325|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56876326|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
56876327|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876328|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876329|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56876330|NCT01299558|Fluticasone|fluticasone|mesh-list
56876331|NCT01299558|Xhance|xhance|mesh-list
56876332|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876333|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56876334|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
56876335|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876336|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876337|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56876338|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
56876339|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
56876340|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56876341|NCT01207206|Ketamine|ketamine|mesh-list
56876342|NCT01207206|Analgesics|analgesics|mesh-ancestor
56876343|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
56876344|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876345|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876346|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56876347|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56876348|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
56876349|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
56876350|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876351|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56876352|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56876353|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876354|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876355|NCT03719586|Remdesivir|remdesivir|mesh-list
56876356|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
56876357|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
56876358|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876359|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
56876360|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876361|NCT05602818|Alprazolam|alprazolam|mesh-list
56876362|NCT05602818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56876363|NCT05602818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876364|NCT05602818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876365|NCT05602818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56876366|NCT05602818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56390921|NCT02951260|Metformin|metformin|mesh-list
56876367|NCT05602818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56876368|NCT05602818|GABA Modulators|gaba modulators|mesh-ancestor
56876370|NCT05602818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876371|NCT05602818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876372|NCT00843882|Lenalidomide|lenalidomide|mesh-list
56876373|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
56876374|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
56876375|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876376|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56876377|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56876378|NCT00843882|Growth Substances|growth substances|mesh-ancestor
56876379|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
56876380|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876381|NCT00843882|Hematinics|hematinics|mesh-ancestor
56876382|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
56876383|NCT01205022|Leucovorin|leucovorin|mesh-list
56876384|NCT01205022|Bevacizumab|bevacizumab|mesh-list
56587172|NCT02800785|Cefazolin|cefazolin|mesh-list
56876385|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56876386|NCT01205022|Fluorouracil|fluorouracil|mesh-list
56876387|NCT01205022|Irinotecan|irinotecan|mesh-list
56876388|NCT01205022|Camptothecin|camptothecin|mesh-list
56876389|NCT01205022|Antibodies|antibodies|mesh-list
56876390|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
56876391|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56876392|NCT01205022|Calcium|calcium|mesh-list
56876393|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
56876394|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876395|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56876396|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56876397|NCT01205022|Growth Substances|growth substances|mesh-ancestor
56876398|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876399|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
56876400|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
56876401|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56876402|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56876403|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
56876404|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876405|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876406|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876407|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56876408|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56876409|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876410|NCT01205022|Antidotes|antidotes|mesh-ancestor
56904364|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
56876411|NCT01205022|Protective Agents|protective agents|mesh-ancestor
56876412|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
56876413|NCT01205022|Vitamins|vitamins|mesh-ancestor
56876414|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
56876415|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56876416|NCT01205178|Chloroquine|chloroquine|mesh-list
56876417|NCT01205178|Primaquine|primaquine|mesh-list
56876418|NCT01205178|Tafenoquine|tafenoquine|mesh-list
56876419|NCT01205178|Amebicides|amebicides|mesh-ancestor
56876420|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56876421|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56876422|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876423|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
56876424|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876425|NCT01205256|Methadone|methadone|mesh-list
56876426|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56876427|NCT01205256|Narcotics|narcotics|mesh-ancestor
56876428|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876429|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876430|NCT01205256|Analgesics|analgesics|mesh-ancestor
56876431|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
56876432|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876433|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
56876434|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
56876435|NCT03823482|Lidocaine|lidocaine|mesh-list
56876436|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
56876437|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
56876438|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876439|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876440|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
56876441|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876442|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56876443|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56876444|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56876445|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56876446|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876447|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56876448|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56876449|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876451|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
56876452|NCT03816072|Propofol|propofol|mesh-list
56876453|NCT03816072|Sevoflurane|sevoflurane|mesh-list
56876454|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56876455|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876456|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876457|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56876458|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
56876459|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
56876460|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56876461|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56876463|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
56876464|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
56876465|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876466|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
56876467|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56876468|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
56876469|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
56876470|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56876471|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56876472|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56876473|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
56876474|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876475|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876476|NCT03816072|Protective Agents|protective agents|mesh-ancestor
56876477|NCT01299948|Prednisolone|prednisolone|mesh-list
56876478|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876479|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
56876480|NCT01299948|Hormones|hormones|mesh-ancestor
56876481|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876482|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876483|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56876484|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876485|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
56876486|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876487|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876488|NCT01297452|Paclitaxel|paclitaxel|mesh-list
56876489|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56876490|NCT01297452|Carboplatin|carboplatin|mesh-list
56876491|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56876492|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876493|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
56876494|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
56876495|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
56876496|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876497|NCT01301586|Doxycycline|doxycycline|mesh-list
56876498|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56876499|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876500|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
56876501|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56876502|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56876503|NCT03815838|Fallypride|fallypride|mesh-list
56876504|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56876505|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56876506|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
56876507|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876508|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876509|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876510|NCT01205724|Factor VIII|factor viii|mesh-list
56876511|NCT01205724|Coagulants|coagulants|mesh-ancestor
56876512|NCT01301820|Lenalidomide|lenalidomide|mesh-list
56876513|NCT01301820|Azacitidine|azacitidine|mesh-list
56876514|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
56876515|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876516|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56876517|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56876518|NCT01301820|Growth Substances|growth substances|mesh-ancestor
56876520|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876521|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876522|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
56876523|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876524|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876525|NCT01297686|Dexamethasone|dexamethasone|mesh-list
56876526|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876527|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
56876528|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
56876529|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876530|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876531|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876532|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
56876533|NCT01297686|Hormones|hormones|mesh-ancestor
56876534|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876535|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56876536|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876538|NCT01205880|Clobetasol|clobetasol|mesh-list
56876539|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56876540|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876541|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56876542|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56876543|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876544|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56876545|NCT01205880|Vitamins|vitamins|mesh-ancestor
56876546|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
56876547|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56876548|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876549|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
56876550|NCT01205880|Hormones|hormones|mesh-ancestor
56876551|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876552|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
56876553|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56876554|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56876555|NCT01205958|Analgesics|analgesics|mesh-ancestor
56876556|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
56876557|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876558|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904369|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
56876559|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876560|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876561|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
56876562|NCT01297842|Meropenem|meropenem|mesh-list
56876563|NCT01297842|Imipenem|imipenem|mesh-list
56876564|NCT01297842|Ertapenem|ertapenem|mesh-list
56876565|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56876566|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876567|NCT01297998|Gemcitabine|gemcitabine|mesh-list
56876568|NCT01297998|Cisplatin|cisplatin|mesh-list
56876569|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876570|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876571|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
56876572|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876573|NCT01297998|Antiviral Agents|antiviral agents|mesh-ancestor
56876574|NCT01297998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876575|NCT01297998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876576|NCT01297998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876577|NCT01297998|Immunologic Factors|immunologic factors|mesh-ancestor
56876578|NCT01297998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876579|NCT01298076|Dexamethasone|dexamethasone|mesh-list
56876580|NCT01298076|Bevacizumab|bevacizumab|mesh-list
56876581|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876582|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876583|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56876584|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56876585|NCT01298076|Growth Substances|growth substances|mesh-ancestor
56876586|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876587|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
56876588|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876589|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
56876590|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
56876591|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876592|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876593|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
56876594|NCT01298076|Hormones|hormones|mesh-ancestor
56876595|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876597|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
56876598|NCT03819348|Clotrimazole|clotrimazole|mesh-list
56876599|NCT03819348|Miconazole|miconazole|mesh-list
56876600|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876601|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56876602|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56876603|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56876604|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876605|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876606|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56876607|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
56876608|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876609|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587386|NCT05477589|Melphalan|melphalan|mesh-list
56876610|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56876611|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56876613|NCT01560390|Analgesics|analgesics|mesh-ancestor
56876614|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
56876615|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876616|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876617|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56876618|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56876619|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
56876620|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
56876621|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876622|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56876623|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56876624|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876625|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876626|NCT03807882|Clozapine|clozapine|mesh-list
56876627|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56876628|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
56876629|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876630|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876631|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876632|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56876633|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56876634|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876635|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56876636|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
56876637|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
56876638|NCT03796572|Ropivacaine|ropivacaine|mesh-list
56876639|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
56876640|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
56876641|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876642|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876643|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
56876644|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876645|NCT01304472|Clopidogrel|clopidogrel|mesh-list
56876646|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56876647|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56876648|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56876649|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56876650|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56876651|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
56876652|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876653|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876654|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876655|NCT03795792|Curcumin|curcumin|mesh-list
56876656|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56876657|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56876658|NCT03795792|Analgesics|analgesics|mesh-ancestor
56876659|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
56876660|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876661|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876662|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876663|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876664|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876665|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876666|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876667|NCT01303536|Ondansetron|ondansetron|mesh-list
56876668|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
56876669|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
56876670|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876671|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876672|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876673|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
56876674|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56876675|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56876676|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
56876677|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876678|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876679|NCT01303536|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56876680|NCT01303536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56876681|NCT01303536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876682|NCT01303536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56876684|NCT01303614|Lidocaine|lidocaine|mesh-list
56876685|NCT01303614|Prilocaine|prilocaine|mesh-list
56876686|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56876687|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
56876688|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
56876689|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876690|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876691|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
56876692|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876693|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56876694|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56876695|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56876696|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56876697|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876698|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56876699|NCT03347838|Nivolumab|nivolumab|mesh-list
56876700|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876701|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876702|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56904374|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
56876703|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876704|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
56876705|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56876706|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
56876707|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
56876708|NCT03802422|Vitamins|vitamins|mesh-ancestor
56876709|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
56876710|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876711|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
56876712|NCT03802422|Hematinics|hematinics|mesh-ancestor
56876713|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
56876714|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56876715|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
56876716|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876717|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
56876718|NCT03801564|Protective Agents|protective agents|mesh-ancestor
56876719|NCT03813186|Decitabine|decitabine|mesh-list
56876720|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876721|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
56876722|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876723|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876724|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876725|NCT03293784|Nivolumab|nivolumab|mesh-list
56876726|NCT03293784|Ipilimumab|ipilimumab|mesh-list
56876727|NCT03293784|Infliximab|infliximab|mesh-list
56876728|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
56876729|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876730|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876731|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56876732|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876733|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
56876734|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876735|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876736|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876737|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
56876738|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876739|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
56876740|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56876741|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876742|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
56876743|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56876744|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876745|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56876746|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876748|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56876749|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56876750|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
56876751|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876752|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876753|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876754|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56876755|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
56587540|NCT05511909|Lofexidine|lofexidine|mesh-list
56876756|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
56876757|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876758|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
56876759|NCT03229278|Nivolumab|nivolumab|mesh-list
56876760|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56876761|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876762|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876763|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56876764|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876765|NCT03812796|Avelumab|avelumab|mesh-list
56876766|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876767|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876768|NCT05759104|Adalimumab|adalimumab|mesh-list
56876769|NCT05759104|Infliximab|infliximab|mesh-list
56876770|NCT05759104|Ustekinumab|ustekinumab|mesh-list
56876771|NCT05759104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876772|NCT05759104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876773|NCT05759104|Dermatologic Agents|dermatologic agents|mesh-ancestor
56876774|NCT05759104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876775|NCT03970096|Cyclosporine|cyclosporine|mesh-list
56876776|NCT03970096|Sirolimus|sirolimus|mesh-list
56876777|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
56876778|NCT03970096|Busulfan|busulfan|mesh-list
56876779|NCT03970096|Thiotepa|thiotepa|mesh-list
56876780|NCT03970096|Methotrexate|methotrexate|mesh-list
56876781|NCT03970096|Fludarabine|fludarabine|mesh-list
56876782|NCT03970096|Tacrolimus|tacrolimus|mesh-list
56876783|NCT03970096|Cyclosporins|cyclosporins|mesh-list
56876784|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876785|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
56876786|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876787|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876788|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56876789|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
56876790|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876791|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876792|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56876793|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56876794|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
56876795|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56876796|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876797|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
56876798|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
56876799|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876800|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56876801|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56876802|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56876803|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
56876804|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876805|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56876806|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56876807|NCT01384240|Proflavine|proflavine|mesh-list
56876808|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56876809|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876810|NCT01381510|Finasteride|finasteride|mesh-list
56876811|NCT01381510|Dutasteride|dutasteride|mesh-list
56876812|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
56876813|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56876814|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876815|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876816|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
56876817|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876818|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876819|NCT01381510|Urological Agents|urological agents|mesh-ancestor
56876820|NCT02984800|Anesthetics|anesthetics|mesh-list
56876821|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876822|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876823|NCT04188730|Lofexidine|lofexidine|mesh-list
56876824|NCT04188730|Clonidine|clonidine|mesh-list
56876825|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56876826|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56876827|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876828|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
56876829|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876830|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56876831|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56876832|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56876833|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
56876834|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876835|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876836|NCT04188730|Analgesics|analgesics|mesh-ancestor
56876837|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
56876838|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
56876839|NCT01381432|Azathioprine|azathioprine|mesh-list
56876840|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
56876841|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876842|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876843|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876844|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56876845|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
56876846|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876847|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56876848|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
56876850|NCT01381354|Thiamine|thiamine|mesh-list
56876851|NCT01381354|Niacinamide|niacinamide|mesh-list
56876852|NCT01381354|Niacin|niacin|mesh-list
56876853|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
56876854|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
56876855|NCT01381354|Ubiquinone|ubiquinone|mesh-list
56876856|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
56876857|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
56876858|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56876859|NCT01381354|Vitamins|vitamins|mesh-ancestor
56876860|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
56876861|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876862|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
56876863|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876864|NCT01381354|Expectorants|expectorants|mesh-ancestor
56876865|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
56876866|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56876867|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
56876868|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876869|NCT01381354|Protective Agents|protective agents|mesh-ancestor
56876870|NCT01381354|Antidotes|antidotes|mesh-ancestor
56876871|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
56876872|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56876873|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
56876874|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56876875|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
56876876|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56876877|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
56876878|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56876879|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
56876880|NCT01381276|Beta Carotene|beta carotene|mesh-list
56876881|NCT01381276|Vitamin A|vitamin a|mesh-list
56876882|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
56876883|NCT01381276|Carotenoids|carotenoids|mesh-list
56876884|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
56876885|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876886|NCT01381276|Protective Agents|protective agents|mesh-ancestor
56876887|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876888|NCT01381276|Provitamins|provitamins|mesh-ancestor
56876889|NCT01381276|Vitamins|vitamins|mesh-ancestor
56876890|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
56876891|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56876892|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876893|NCT02661022|Dexamethasone|dexamethasone|mesh-list
56876894|NCT02661022|Pomalidomide|pomalidomide|mesh-list
56876895|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56876896|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
56876897|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
56876898|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876900|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876901|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
56876902|NCT02661022|Hormones|hormones|mesh-ancestor
56876903|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56876904|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56876905|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876906|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
56876907|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56876908|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56876909|NCT02661022|Growth Substances|growth substances|mesh-ancestor
56876910|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
56876911|NCT01569256|Cabergoline|cabergoline|mesh-list
56876912|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56876913|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56876914|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
56876915|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
56876916|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56876917|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876918|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876919|NCT03794544|Durvalumab|durvalumab|mesh-list
56876920|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876921|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876922|NCT01380808|Capecitabine|capecitabine|mesh-list
56876923|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876924|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
56876925|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876926|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876927|NCT03799224|Decitabine|decitabine|mesh-list
56876928|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876929|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
56876930|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876931|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548761|NCT01142388|Paclitaxel|paclitaxel|mesh-list
56876932|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876933|NCT03798912|Octreotide|octreotide|mesh-list
56876934|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56876935|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56876936|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876937|NCT01302210|Mupirocin|mupirocin|mesh-list
56876938|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56876939|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56876940|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56876941|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876942|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876943|NCT03798834|Anesthetics|anesthetics|mesh-list
56876944|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876945|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876946|NCT03812562|Nivolumab|nivolumab|mesh-list
56876947|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876948|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876949|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56876950|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876951|NCT01304784|Paclitaxel|paclitaxel|mesh-list
56876952|NCT01304784|Docetaxel|docetaxel|mesh-list
56876953|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56876954|NCT01304784|Capecitabine|capecitabine|mesh-list
56876955|NCT01304784|Trastuzumab|trastuzumab|mesh-list
56876956|NCT01304784|Lapatinib|lapatinib|mesh-list
56876957|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56876958|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56876959|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876960|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
56876961|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
56876962|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
56876963|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876964|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56876965|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
56876966|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56876967|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56876968|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876969|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
56876970|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876971|NCT03798600|Caspofungin|caspofungin|mesh-list
56876972|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
56876975|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876976|NCT03798522|Nalbuphine|nalbuphine|mesh-list
56876977|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56876978|NCT03798522|Narcotics|narcotics|mesh-ancestor
56876979|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56876980|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876981|NCT03798522|Analgesics|analgesics|mesh-ancestor
56876982|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
56876983|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56876984|NCT01308034|Sunitinib|sunitinib|mesh-list
56876985|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56876986|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56876987|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56876988|NCT01308034|Growth Substances|growth substances|mesh-ancestor
56876989|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876990|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
56876991|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56876992|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56876993|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56876994|NCT04182360|Carbetocin|carbetocin|mesh-list
56876995|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
56876996|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56876997|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56876998|NCT00005044|Bicalutamide|bicalutamide|mesh-list
56876999|NCT00005044|Flutamide|flutamide|mesh-list
56877000|NCT00005044|Hormones|hormones|mesh-list
56877001|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56877002|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56877003|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877004|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
56877005|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
56877006|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877007|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56877008|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56877009|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56877010|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56877011|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56877012|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877013|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877014|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877015|NCT03794154|Analgesics|analgesics|mesh-ancestor
56877016|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
56877017|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877018|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
56877019|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877020|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
56877021|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
56877022|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
56877023|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877024|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877025|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877026|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
56877027|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56877028|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877029|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877030|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
56877031|NCT02722668|Sirolimus|sirolimus|mesh-list
56877032|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
56877033|NCT02722668|Fludarabine|fludarabine|mesh-list
56877034|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56877035|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56877036|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
56877037|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877038|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56877039|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56877040|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
56877041|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877042|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877043|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56877044|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56877049|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877050|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
56877051|NCT01303926|Paclitaxel|paclitaxel|mesh-list
56877052|NCT01303926|Bevacizumab|bevacizumab|mesh-list
56877053|NCT01303926|Carboplatin|carboplatin|mesh-list
56877054|NCT01303926|Pemetrexed|pemetrexed|mesh-list
56877055|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56877056|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877057|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
56877058|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
56877059|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
56877060|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877061|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56587835|NCT02795949|Amoxicillin|amoxicillin|mesh-list
56877062|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56877063|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56877065|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877066|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
56877067|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877068|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56877069|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56877074|NCT03084796|Bromides|bromides|mesh-list
56877075|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
56877076|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56877077|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
56877078|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877079|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877080|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56877081|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
56877082|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
56877083|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56877084|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
56877085|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877086|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877087|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
56877088|NCT03717012|Nintedanib|nintedanib|mesh-list
56877089|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877090|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56877091|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877092|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877093|NCT01302756|Folic Acid|folic acid|mesh-list
56877094|NCT01302756|Hematinics|hematinics|mesh-ancestor
56877095|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
56877096|NCT01302756|Vitamins|vitamins|mesh-ancestor
56877097|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
56877098|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877099|NCT04893252|Durvalumab|durvalumab|mesh-list
56877100|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56877101|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877102|NCT03797508|Progesterone|progesterone|mesh-list
56877103|NCT03797508|Progestins|progestins|mesh-ancestor
56877104|NCT03797508|Hormones|hormones|mesh-ancestor
56877105|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56877106|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877107|NCT01380496|Doxycycline|doxycycline|mesh-list
56877108|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56877109|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877110|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
56877111|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56877112|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56877113|NCT01304316|Phenylephrine|phenylephrine|mesh-list
56877114|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
56877115|NCT01304316|Tetracaine|tetracaine|mesh-list
56877116|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
56877117|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
56877118|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877119|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877120|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
56877121|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877123|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56877124|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
56877125|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877126|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877127|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
56877128|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
56877129|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
56877130|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56877131|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
56877132|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56877133|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
56877134|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56877135|NCT01304316|Protective Agents|protective agents|mesh-ancestor
56877136|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56877137|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56877138|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56877139|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56877140|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877142|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877143|NCT03792828|Analgesics|analgesics|mesh-ancestor
56877144|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
56877145|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877146|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
56877147|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877148|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
56877149|NCT00579826|Letrozole|letrozole|mesh-list
56877150|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877151|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56877152|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56877153|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877154|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877155|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56877156|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
56877157|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56877158|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877159|NCT01379326|Mebendazole|mebendazole|mesh-list
56877160|NCT01379326|Piperazine|piperazine|mesh-list
56877161|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
56877162|NCT01379326|DMP 777|dmp 777|mesh-list
56877163|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
56877164|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
56877165|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56877166|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877167|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56877168|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56877169|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56877170|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877171|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877172|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877173|NCT01560546|Testosterone|testosterone|mesh-list
56877174|NCT01560546|Androgens|androgens|mesh-ancestor
56877175|NCT01560546|Hormones|hormones|mesh-ancestor
56877176|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56877177|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877178|NCT03792984|Vitamin D|vitamin d|mesh-list
56877179|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
56877180|NCT03792984|Metformin|metformin|mesh-list
56877181|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
56877182|NCT03792984|Calcium|calcium|mesh-list
56877183|NCT03792984|Vitamins|vitamins|mesh-ancestor
56877184|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
56877185|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877186|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56877187|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56877188|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56877189|NCT03792984|Antacids|antacids|mesh-ancestor
56877190|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877191|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56877192|NCT03792906|Norepinephrine|norepinephrine|mesh-list
56877193|NCT03792906|Bupivacaine|bupivacaine|mesh-list
56877194|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
56877195|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
56877196|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877197|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877199|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877200|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56877201|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56877202|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
56877203|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877204|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877205|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
56877206|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
56877207|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56877208|NCT05736874|Fluticasone|fluticasone|mesh-list
56877209|NCT05736874|Xhance|xhance|mesh-list
56877210|NCT05736874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56877211|NCT05736874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56877212|NCT05736874|Autonomic Agents|autonomic agents|mesh-ancestor
56877213|NCT05736874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877214|NCT05736874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877215|NCT05736874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56877216|NCT05736874|Respiratory System Agents|respiratory system agents|mesh-ancestor
56877217|NCT05736874|Dermatologic Agents|dermatologic agents|mesh-ancestor
56877218|NCT05736874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56877219|NCT03078556|Lamivudine|lamivudine|mesh-list
56877220|NCT03078556|Dolutegravir|dolutegravir|mesh-list
56877221|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56877222|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56877223|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877224|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877225|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
56877226|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877227|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56877228|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56877229|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56877230|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56877231|NCT03949894|Tolvaptan|tolvaptan|mesh-list
56877232|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56877233|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877234|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
56877235|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877236|NCT03714672|Diclofenac|diclofenac|mesh-list
56877237|NCT03714672|Tramadol|tramadol|mesh-list
56877238|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56877239|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56877240|NCT03714672|Analgesics|analgesics|mesh-ancestor
56877241|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
56877242|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877243|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877244|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56877245|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56877246|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56877247|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877248|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877249|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56877250|NCT03714672|Narcotics|narcotics|mesh-ancestor
56877251|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877252|NCT03083470|Paclitaxel|paclitaxel|mesh-list
56877253|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56877254|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877255|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56877256|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56877257|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56877258|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877259|NCT01377610|Naltrexone|naltrexone|mesh-list
56877260|NCT01377610|Buprenorphine|buprenorphine|mesh-list
56877261|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56877262|NCT01377610|Narcotics|narcotics|mesh-ancestor
56877263|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877264|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877265|NCT01377610|Analgesics|analgesics|mesh-ancestor
56877266|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
56877267|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877268|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56877269|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56877270|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56877271|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877272|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877274|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56877275|NCT03810976|Gemcitabine|gemcitabine|mesh-list
56877276|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56877277|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
56877278|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877279|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877280|NCT03810976|Antiviral Agents|antiviral agents|mesh-ancestor
56877281|NCT03810976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877282|NCT03810976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877283|NCT03810976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56877284|NCT03810976|Immunologic Factors|immunologic factors|mesh-ancestor
56877285|NCT03810976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877286|NCT05405244|Bromocriptine|bromocriptine|mesh-list
56877287|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588065|NCT02791815|Selexipag|selexipag|mesh-list
56877288|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56877289|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56877290|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
56877291|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56877292|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
56877293|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
56877294|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877295|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877296|NCT03788694|Ketamine|ketamine|mesh-list
56877297|NCT03788694|Analgesics|analgesics|mesh-ancestor
56877298|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
56877299|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877300|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877301|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56877302|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56877303|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
56877304|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
56877305|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877306|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56877307|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56877308|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877309|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877310|NCT03789006|Interleukin-2|interleukin-2|mesh-list
56877311|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
56877312|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56877313|NCT03789006|Antibodies|antibodies|mesh-list
56877314|NCT03789006|Basiliximab|basiliximab|mesh-list
56877315|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
56877316|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56877317|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
56877318|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877319|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877320|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56877321|NCT03789006|Analgesics|analgesics|mesh-ancestor
56877322|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
56877323|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877324|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56877325|NCT01306266|Rizatriptan|rizatriptan|mesh-list
56877326|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56877327|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
56877328|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877329|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877330|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877331|NCT03516214|Trametinib|trametinib|mesh-list
56877332|NCT03516214|Nazartinib|nazartinib|mesh-list
56877333|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877334|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56877335|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877336|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877337|NCT03630796|Sevoflurane|sevoflurane|mesh-list
56877338|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56877339|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56877340|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
56877341|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
56877342|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877343|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877344|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56568579|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
56877346|NCT01096966|Bupivacaine|bupivacaine|mesh-list
56877347|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
56877348|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
56877349|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877350|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877351|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
56877352|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877353|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
56877354|NCT01379560|Dinoprost|dinoprost|mesh-list
56877355|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56877356|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56877357|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
56877358|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56877359|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877360|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
56877361|NCT01379482|Paclitaxel|paclitaxel|mesh-list
56877362|NCT01379482|Docetaxel|docetaxel|mesh-list
56877363|NCT01379482|Cisplatin|cisplatin|mesh-list
56877364|NCT01379482|Doxorubicin|doxorubicin|mesh-list
56877365|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
56877366|NCT01379482|Irinotecan|irinotecan|mesh-list
56877367|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56877368|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877369|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
56877370|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
56877371|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
56877372|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877373|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56877374|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56877375|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56877376|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877377|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56877378|NCT05624424|Sufentanil|sufentanil|mesh-list
56877379|NCT05624424|Remifentanil|remifentanil|mesh-list
56877380|NCT05624424|Propofol|propofol|mesh-list
56877381|NCT05624424|Sevoflurane|sevoflurane|mesh-list
56877382|NCT05624424|Cisatracurium|cisatracurium|mesh-list
56877383|NCT05624424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56877384|NCT05624424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877385|NCT05624424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877386|NCT05624424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56877387|NCT05624424|Anesthetics, General|anesthetics, general|mesh-ancestor
56877388|NCT05624424|Anesthetics|anesthetics|mesh-ancestor
56877389|NCT05624424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56877390|NCT05624424|Narcotics|narcotics|mesh-ancestor
56877391|NCT05624424|Analgesics|analgesics|mesh-ancestor
56877392|NCT05624424|Sensory System Agents|sensory system agents|mesh-ancestor
56877393|NCT05624424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904385|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
56877394|NCT05624424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56877395|NCT05624424|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56877396|NCT05624424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56877397|NCT05624424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56877398|NCT05624424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56877399|NCT05461690|Niraparib|niraparib|mesh-list
56877400|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56877401|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877402|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877403|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877404|NCT05456230|Midazolam|midazolam|mesh-list
56877405|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56877406|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56877407|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877408|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877409|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56877410|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56877411|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877412|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56877413|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
56877414|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
56877415|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
56877416|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
56877417|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877418|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877419|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56877420|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
56877421|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877423|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877424|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56877425|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877426|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56877427|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877428|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877429|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
56877430|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56877431|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877432|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877433|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56877434|NCT03788538|Analgesics|analgesics|mesh-ancestor
56877435|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
56877436|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877437|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56877438|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56877439|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56877440|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
56877441|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877442|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877444|NCT05693844|Cyclophosphamide|cyclophosphamide|mesh-list
56877445|NCT05693844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56877446|NCT05693844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56877447|NCT05693844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877448|NCT05693844|Tubulin Modulators|tubulin modulators|mesh-ancestor
56877449|NCT05693844|Antimitotic Agents|antimitotic agents|mesh-ancestor
56877450|NCT05693844|Mitosis Modulators|mitosis modulators|mesh-ancestor
56877451|NCT05693844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877452|NCT05693844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56877453|NCT05693844|Immunologic Factors|immunologic factors|mesh-ancestor
56877454|NCT05693844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877455|NCT05693844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56877456|NCT05693844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56877457|NCT05693844|Alkylating Agents|alkylating agents|mesh-ancestor
56877458|NCT05693844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56877459|NCT05342584|Cytarabine|cytarabine|mesh-list
56877460|NCT05342584|Daunorubicin|daunorubicin|mesh-list
56877461|NCT05342584|Venetoclax|venetoclax|mesh-list
56877462|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56877463|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
56877464|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877465|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877466|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
56877467|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877468|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56877469|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
56877470|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877471|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56877472|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56877473|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56877474|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877475|NCT05320120|Esketamine|esketamine|mesh-list
56877476|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
56877477|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877478|NCT03077698|Megestrol|megestrol|mesh-list
56877479|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
56877480|NCT03077698|Progestins|progestins|mesh-list
56877481|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
56877482|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56877483|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56877484|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56877485|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
56877486|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56877487|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877488|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56877489|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56877490|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56877491|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877492|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
56877493|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56877494|NCT03077698|Hormones|hormones|mesh-ancestor
56877495|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56877496|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
56877497|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
56877498|NCT01377220|Choline|choline|mesh-list
56877499|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
56877500|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56877501|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
56877502|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877503|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56877504|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56877505|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
56877506|NCT05693766|Capecitabine|capecitabine|mesh-list
56877507|NCT05693766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56877508|NCT05693766|Antimetabolites|antimetabolites|mesh-ancestor
56877509|NCT05693766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877510|NCT05693766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877511|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
56877512|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56877513|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
56877514|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877515|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877516|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56877517|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
56877518|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56877519|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
56877520|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877521|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877522|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56877523|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
56877524|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
56877525|NCT03079102|Protective Agents|protective agents|mesh-ancestor
56877526|NCT03791424|Midazolam|midazolam|mesh-list
56877527|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56877528|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56877529|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877530|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877531|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56877532|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56877533|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877534|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56877535|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
56877536|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
56877537|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
56877538|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
56877539|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877540|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877541|NCT03787992|Gefitinib|gefitinib|mesh-list
56877542|NCT03787992|Aflutinib|aflutinib|mesh-list
56877543|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877544|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56877545|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877546|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877547|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
56877548|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56877549|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877550|NCT05693454|Tramadol|tramadol|mesh-list
56877551|NCT05693454|Levobupivacaine|levobupivacaine|mesh-list
56877552|NCT05693454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56877553|NCT05693454|Narcotics|narcotics|mesh-ancestor
56877554|NCT05693454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877555|NCT05693454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877556|NCT05693454|Analgesics|analgesics|mesh-ancestor
56877557|NCT05693454|Sensory System Agents|sensory system agents|mesh-ancestor
56877558|NCT05693454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877559|NCT05693454|Anesthetics, Local|anesthetics, local|mesh-ancestor
56877560|NCT05693454|Anesthetics|anesthetics|mesh-ancestor
56877561|NCT05764018|Caffeine|caffeine|mesh-list
56877562|NCT05764018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56877563|NCT05764018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877564|NCT05764018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56877565|NCT05764018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877566|NCT05764018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877567|NCT05764018|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56877568|NCT05764018|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56877569|NCT05764018|Purinergic Agents|purinergic agents|mesh-ancestor
56877570|NCT05764018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877571|NCT01308528|Enoxaparin|enoxaparin|mesh-list
56877594|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56877595|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877596|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877597|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56877598|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56877599|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877600|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877601|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
56877626|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
56877627|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56877628|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877629|NCT01308606|Simeprevir|simeprevir|mesh-list
56877630|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
56877631|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877632|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
56877633|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877634|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877635|NCT04637386|Anesthetics|anesthetics|mesh-list
56877636|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
56877637|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877638|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877639|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
56877640|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877641|NCT01308684|Bevacizumab|bevacizumab|mesh-list
56877642|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56877643|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877644|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56877645|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56877646|NCT01308684|Growth Substances|growth substances|mesh-ancestor
56877647|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877648|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
56877649|NCT05613114|4-Aminopyridine|4-aminopyridine|mesh-list
56877650|NCT05613114|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56877651|NCT05613114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56877652|NCT05613114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877654|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
56877655|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
56877656|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877657|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877658|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
56877659|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877660|NCT04436224|Fentanyl|fentanyl|mesh-list
56877661|NCT04436224|Hydromorphone|hydromorphone|mesh-list
56877662|NCT04436224|Butorphanol|butorphanol|mesh-list
56877663|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56588441|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877664|NCT04436224|Narcotics|narcotics|mesh-ancestor
56877665|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877666|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877667|NCT04436224|Analgesics|analgesics|mesh-ancestor
56877668|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
56877669|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877670|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56877671|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56877672|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
56877673|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
56877674|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
56877675|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
56877676|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56877677|NCT03785184|Dexamethasone|dexamethasone|mesh-list
56877678|NCT03785184|Lenalidomide|lenalidomide|mesh-list
56877679|NCT03785184|Venetoclax|venetoclax|mesh-list
56877680|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56877681|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
56877682|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
56877683|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877684|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877685|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56877686|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
56877687|NCT03785184|Hormones|hormones|mesh-ancestor
56877688|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56877689|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56877690|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877691|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
56877692|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56877693|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56877694|NCT03785184|Growth Substances|growth substances|mesh-ancestor
56877695|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
56877696|NCT03784794|Thrombin|thrombin|mesh-list
56877697|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
56877698|NCT03784794|Coagulants|coagulants|mesh-ancestor
56877699|NCT01378546|Amifampridine|amifampridine|mesh-list
56877700|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56877701|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877702|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877703|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56877704|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56877705|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877706|NCT05688384|Alfentanil|alfentanil|mesh-list
56877707|NCT05688384|Propofol|propofol|mesh-list
56877708|NCT05688384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56877709|NCT05688384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877710|NCT05688384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877711|NCT05688384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56877712|NCT05688384|Anesthetics, General|anesthetics, general|mesh-ancestor
56877713|NCT05688384|Anesthetics|anesthetics|mesh-ancestor
56877714|NCT05688384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56877715|NCT05688384|Narcotics|narcotics|mesh-ancestor
56877716|NCT05688384|Analgesics|analgesics|mesh-ancestor
56877717|NCT05688384|Sensory System Agents|sensory system agents|mesh-ancestor
56877718|NCT05688384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877719|NCT01307592|Gemcitabine|gemcitabine|mesh-list
56877720|NCT01307592|Rituximab|rituximab|mesh-list
56877721|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
56877722|NCT01307592|Lenalidomide|lenalidomide|mesh-list
56877723|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56877724|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877726|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877727|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56877728|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56877729|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
56877730|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877731|NCT01307592|Antiviral Agents|antiviral agents|mesh-ancestor
56877732|NCT01307592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877733|NCT01307592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877734|NCT01307592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56877735|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56877736|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56877737|NCT01307592|Growth Substances|growth substances|mesh-ancestor
56877738|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
56877739|NCT05687058|Empagliflozin|empagliflozin|mesh-list
56877740|NCT05687058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56547699|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877741|NCT05687058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877742|NCT05687058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56877743|NCT05687058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877745|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
56877746|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
56877747|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877748|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877749|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
56877750|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877751|NCT03075826|Guadecitabine|guadecitabine|mesh-list
56877752|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877753|NCT04749108|Folfirinox|folfirinox|mesh-list
56877754|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877755|NCT01378156|Vaccines|vaccines|mesh-list
56877756|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
56877757|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877758|NCT04108234|Ketamine|ketamine|mesh-list
56877759|NCT04108234|Analgesics|analgesics|mesh-ancestor
56877760|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
56877761|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877762|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877763|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56877764|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56877765|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
56877766|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
56877767|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877768|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56877769|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56877770|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877771|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877772|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56877773|NCT03687814|Laxatives|laxatives|mesh-ancestor
56877774|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56877775|NCT05763550|Pregabalin|pregabalin|mesh-list
56877776|NCT05763550|Analgesics|analgesics|mesh-ancestor
56877777|NCT05763550|Sensory System Agents|sensory system agents|mesh-ancestor
56877778|NCT05763550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877779|NCT05763550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877780|NCT05763550|Anticonvulsants|anticonvulsants|mesh-ancestor
56877781|NCT05763550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56877782|NCT05763550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56877783|NCT05763550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877784|NCT05763550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56877785|NCT05763550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56877786|NCT05763550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56877787|NCT05763550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877788|NCT05763550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877789|NCT03783936|Leucovorin|leucovorin|mesh-list
56877790|NCT03783936|Fluorouracil|fluorouracil|mesh-list
56877791|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
56877792|NCT03783936|Trastuzumab|trastuzumab|mesh-list
56877793|NCT03783936|Avelumab|avelumab|mesh-list
56877794|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
56877795|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392336|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56877797|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877798|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56877799|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
56877800|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877801|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56877802|NCT03783936|Antidotes|antidotes|mesh-ancestor
56877803|NCT03783936|Protective Agents|protective agents|mesh-ancestor
56877804|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
56877805|NCT03783936|Vitamins|vitamins|mesh-ancestor
56877806|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
56877807|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
56877808|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56877809|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877810|NCT03781596|Fluticasone|fluticasone|mesh-list
56877811|NCT03781596|Omeprazole|omeprazole|mesh-list
56877812|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56877813|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56877814|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
56877815|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877816|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877817|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56877818|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
56877819|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
56877820|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56877821|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56877822|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56877823|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56877824|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877825|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877826|NCT03284866|Vaccines|vaccines|mesh-list
56877827|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
56877828|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877829|NCT03781674|Progesterone|progesterone|mesh-list
56877830|NCT03781674|Progestins|progestins|mesh-ancestor
56877831|NCT03781674|Hormones|hormones|mesh-ancestor
56877832|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56877833|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877834|NCT03786120|Zolpidem|zolpidem|mesh-list
56877835|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56877836|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56877837|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877838|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877839|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56877840|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
56877841|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
56877842|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877843|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877844|NCT05517642|Vaccines|vaccines|mesh-list
56877845|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
56877846|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877847|NCT01561014|Fluorouracil|fluorouracil|mesh-list
56877848|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
56877849|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56877850|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56877851|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
56877852|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877853|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56877854|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877855|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56877856|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
56877857|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877858|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56877859|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877860|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56877861|NCT01561092|Citalopram|citalopram|mesh-list
56877862|NCT01561092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56877863|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56877864|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56877865|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877866|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877867|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
56877868|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877869|NCT01561092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56877870|NCT01561092|Antidepressive Agents|antidepressive agents|mesh-ancestor
56877871|NCT01561092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877872|NCT05494866|Cobicistat|cobicistat|mesh-list
56877873|NCT05494866|Gemcitabine|gemcitabine|mesh-list
56877874|NCT05494866|Paclitaxel|paclitaxel|mesh-list
56877875|NCT05494866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56877876|NCT05494866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877877|NCT05494866|Tubulin Modulators|tubulin modulators|mesh-ancestor
56877878|NCT05494866|Antimitotic Agents|antimitotic agents|mesh-ancestor
56877879|NCT05494866|Mitosis Modulators|mitosis modulators|mesh-ancestor
56877880|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877881|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56877882|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56877883|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
56877884|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877885|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56877886|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56877887|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877888|NCT05494866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56877889|NCT05494866|Antimetabolites|antimetabolites|mesh-ancestor
56877890|NCT05494866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547700|NCT04315493|Maleic acid|maleic acid|mesh-list
56877891|NCT05494866|Immunologic Factors|immunologic factors|mesh-ancestor
56877892|NCT05494866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877893|NCT01316874|Valrubicin|valrubicin|mesh-list
56877894|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877895|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56877896|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56877897|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877898|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877899|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56877900|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56877901|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56877902|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56877903|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877904|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877905|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877906|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
56877907|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56877908|NCT01309620|Zinc|zinc|mesh-list
56877909|NCT01309620|Trace Elements|trace elements|mesh-ancestor
56877910|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
56877911|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877912|NCT05585034|Pembrolizumab|pembrolizumab|mesh-list
56877913|NCT05585034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56877914|NCT05585034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877915|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
56877916|NCT05129670|Antacids|antacids|mesh-ancestor
56877917|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877918|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56877919|NCT03783312|Acetaminophen|acetaminophen|mesh-list
56877920|NCT03783312|Ibuprofen|ibuprofen|mesh-list
56877921|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56877922|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56877923|NCT03783312|Analgesics|analgesics|mesh-ancestor
56877924|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
56877925|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877926|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877927|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56877928|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56877929|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56877930|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877931|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877932|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
56877933|NCT03776916|Simethicone|simethicone|mesh-list
56877934|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
56877935|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877936|NCT03776916|Emollients|emollients|mesh-ancestor
56877937|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
56877938|NCT01560702|Epinephrine|epinephrine|mesh-list
56877939|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56877940|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56877941|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
56877942|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56877943|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877944|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877945|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56877946|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56877947|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
56877948|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877949|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56877950|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
56877951|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
56877952|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
56877953|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56877955|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56877956|NCT03776838|Narcotics|narcotics|mesh-ancestor
56877957|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56877958|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877959|NCT03776838|Analgesics|analgesics|mesh-ancestor
56877960|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
56877961|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895241|NCT00734877|BB 1101|bb 1101|mesh-list
56877962|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56877963|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56877964|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
56877965|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
56877966|NCT03781050|Sirolimus|sirolimus|mesh-list
56877967|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56877968|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56877969|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56877970|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56877971|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
56877972|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56877973|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
56877974|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877975|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
56877976|NCT02865850|Hematinics|hematinics|mesh-ancestor
56877977|NCT01309698|Inositol|inositol|mesh-list
56877978|NCT01309698|Vildagliptin|vildagliptin|mesh-list
56877979|NCT01309698|Voglibose|voglibose|mesh-list
56877980|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56877981|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877982|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56877983|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
56877984|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56877985|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56877986|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56877987|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
56877988|NCT01309698|Vitamins|vitamins|mesh-ancestor
56877989|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
56877990|NCT01142284|Cilostazol|cilostazol|mesh-list
56877991|NCT01142284|Probucol|probucol|mesh-list
56877992|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56877993|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
56877994|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56877995|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56877996|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56877997|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
56877998|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56877999|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56878000|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878001|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56878002|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
56878003|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56878004|NCT01142284|Protective Agents|protective agents|mesh-ancestor
56878005|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56878006|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56878007|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878008|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56878009|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56878010|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
56878011|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56878012|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
56878013|NCT01309776|Citalopram|citalopram|mesh-list
56878014|NCT01309776|Tianeptine|tianeptine|mesh-list
56878015|NCT01309776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56878016|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56878017|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56878018|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878019|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568581|NCT01182350|Bevacizumab|bevacizumab|mesh-list
56878021|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878022|NCT01309776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56878023|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
56878024|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56878025|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56878026|NCT03783000|BI 425809|bi 425809|mesh-list
56878027|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
56878028|NCT01309854|Pioglitazone|pioglitazone|mesh-list
56878029|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56878030|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878031|NCT03780192|Sirolimus|sirolimus|mesh-list
56878032|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56878033|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878034|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56878035|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878036|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
56878037|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878038|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
56878039|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878040|NCT05305560|Ivermectin|ivermectin|mesh-list
56878041|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56878042|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878043|NCT05285904|Ofatumumab|ofatumumab|mesh-list
56878044|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878045|NCT03776448|Charcoal|charcoal|mesh-list
56878046|NCT03776448|Antidotes|antidotes|mesh-ancestor
56878047|NCT03776448|Protective Agents|protective agents|mesh-ancestor
56878048|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878049|NCT03780270|Fluorides|fluorides|mesh-list
56878050|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
56878051|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
56878052|NCT03780270|Protective Agents|protective agents|mesh-ancestor
56878053|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878054|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
56878055|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878056|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878057|NCT05517486|Bupivacaine|bupivacaine|mesh-list
56878058|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
56878059|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
56878060|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878061|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878062|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
56878063|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878064|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
56878065|NCT01019356|Acarbose|acarbose|mesh-list
56878066|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56878067|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878068|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56878069|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878070|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878071|NCT01314066|Bevacizumab|bevacizumab|mesh-list
56878072|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878073|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878074|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56878075|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56878076|NCT01314066|Growth Substances|growth substances|mesh-ancestor
56878077|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878078|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
56878079|NCT01314300|Lidocaine|lidocaine|mesh-list
56878080|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
56878081|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
56878082|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878083|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878084|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
56878085|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878086|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56878087|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56878088|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56878089|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56878090|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878091|NCT05762536|Docetaxel|docetaxel|mesh-list
56878092|NCT05762536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878093|NCT05762536|Tubulin Modulators|tubulin modulators|mesh-ancestor
56878094|NCT05762536|Antimitotic Agents|antimitotic agents|mesh-ancestor
56878095|NCT05762536|Mitosis Modulators|mitosis modulators|mesh-ancestor
56878097|NCT03776058|Cinacalcet|cinacalcet|mesh-list
56878098|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56878099|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878100|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56878101|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
56878102|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878103|NCT05202496|Calcitriol|calcitriol|mesh-list
56878104|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56878105|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878106|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56878107|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56878108|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878109|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56878110|NCT05202496|Vitamins|vitamins|mesh-ancestor
56878111|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
56878112|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56878113|NCT03779568|Bupivacaine|bupivacaine|mesh-list
56878114|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
56878115|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
56878116|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547701|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878117|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878118|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
56878119|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878120|NCT05201560|Fentanyl|fentanyl|mesh-list
56878121|NCT05201560|Butorphanol|butorphanol|mesh-list
56878122|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56878123|NCT05201560|Narcotics|narcotics|mesh-ancestor
56878124|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878125|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878126|NCT05201560|Analgesics|analgesics|mesh-ancestor
56878127|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
56878128|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878129|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56878130|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56878131|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
56878132|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
56878133|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
56878134|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
56878135|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56878136|NCT05201326|Bevacizumab|bevacizumab|mesh-list
56878137|NCT05201326|Irinotecan|irinotecan|mesh-list
56878138|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878139|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878140|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56878141|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56878142|NCT05201326|Growth Substances|growth substances|mesh-ancestor
56878143|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878144|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
56878145|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56878146|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56878147|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878148|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878149|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
56878150|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56878151|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878152|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878153|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56878154|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878155|NCT01561404|Everolimus|everolimus|mesh-list
56878156|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878157|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878158|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
56878159|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878160|NCT03775902|Nicorandil|nicorandil|mesh-list
56878161|NCT03775902|Glimepiride|glimepiride|mesh-list
56878162|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56878163|NCT03775902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56878164|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878165|NCT03775902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878166|NCT03775902|Immunologic Factors|immunologic factors|mesh-ancestor
56878167|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56568582|NCT01182350|Temozolomide|temozolomide|mesh-list
56878169|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
56878170|NCT03775902|Vitamins|vitamins|mesh-ancestor
56878171|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
56878172|NCT03775590|Acetic Acid|acetic acid|mesh-list
56878173|NCT03775590|Retinol acetate|retinol acetate|mesh-list
56878174|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56878175|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878176|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56878177|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
56878178|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878179|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56878180|NCT03775590|Protective Agents|protective agents|mesh-ancestor
56878181|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878182|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
56878183|NCT03775746|Clopidogrel|clopidogrel|mesh-list
56878184|NCT03775746|Ticagrelor|ticagrelor|mesh-list
56878185|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56878186|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56878187|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56878188|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56878189|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
56878190|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878191|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878192|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878193|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56878194|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
56878195|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56878196|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
56878197|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878198|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
56878199|NCT03779178|Landiolol|landiolol|mesh-list
56878200|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56878201|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56878202|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
56878203|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878204|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878205|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878206|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56878207|NCT03779100|Lenvatinib|lenvatinib|mesh-list
56878208|NCT03779100|Antibodies|antibodies|mesh-list
56878209|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
56878210|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
56878211|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878212|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878213|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56878214|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878215|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878216|NCT05213884|Cisplatin|cisplatin|mesh-list
56878217|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878218|NCT05711212|Xanthohumol|xanthohumol|mesh-list
56878219|NCT05711212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878220|NCT05711212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56878221|NCT05711212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56878222|NCT05711212|Growth Substances|growth substances|mesh-ancestor
56878223|NCT05711212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878224|NCT05711212|Growth Inhibitors|growth inhibitors|mesh-ancestor
56878225|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
56878226|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56878227|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
56878228|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56878229|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56878230|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878231|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
56878232|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
56878233|NCT03775356|Anesthetics|anesthetics|mesh-list
56878234|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878235|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878236|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
56878237|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
56878238|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56878239|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56878240|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56878241|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878242|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
56878243|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56878244|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
56878245|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878246|NCT05211622|Protective Agents|protective agents|mesh-ancestor
56878247|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878248|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
56878249|NCT05211622|Vitamins|vitamins|mesh-ancestor
56878250|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
56878251|NCT05705518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56878252|NCT05705518|Lubricant Eye Drops|lubricant eye drops|mesh-list
56878253|NCT05705518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56878254|NCT05191264|Analgesics|analgesics|mesh-list
56878255|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
56878256|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878257|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878258|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
56878259|NCT03778008|Gentamicins|gentamicins|mesh-list
56878260|NCT03778008|Dexamethasone|dexamethasone|mesh-list
56878261|NCT03778008|Lidocaine|lidocaine|mesh-list
56878262|NCT03778008|Mitogens|mitogens|mesh-list
56878263|NCT03778008|Vitamins|vitamins|mesh-ancestor
56878264|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
56878265|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878266|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56878267|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
56878268|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
56878269|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589040|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878270|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56878271|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
56878272|NCT03778008|Hormones|hormones|mesh-ancestor
56878273|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878274|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56878275|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878276|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
56878277|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
56878278|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878279|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
56878280|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56878281|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56878282|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56878283|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56878284|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878285|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56878286|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
56878287|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56878288|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878289|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56878290|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878291|NCT03778242|Oxytocin|oxytocin|mesh-list
56878292|NCT03778242|Oxytocics|oxytocics|mesh-ancestor
56878293|NCT03778242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56878294|NCT03778242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878295|NCT05697328|Pseudoephedrine|pseudoephedrine|mesh-list
56878296|NCT05697328|Ephedrine|ephedrine|mesh-list
56878297|NCT05697328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56878298|NCT05697328|Autonomic Agents|autonomic agents|mesh-ancestor
56878299|NCT05697328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878300|NCT05697328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878301|NCT05697328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56878302|NCT05697328|Respiratory System Agents|respiratory system agents|mesh-ancestor
56878303|NCT05697328|Nasal Decongestants|nasal decongestants|mesh-ancestor
56878304|NCT05697328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56878305|NCT05697328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56878306|NCT05697328|Sympathomimetics|sympathomimetics|mesh-ancestor
56878307|NCT05697328|Adrenergic Agents|adrenergic agents|mesh-ancestor
56878308|NCT05697328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878309|NCT05697328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878310|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
56878311|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878312|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878313|NCT03777930|Thalidomide|thalidomide|mesh-list
56878314|NCT03777930|Megestrol|megestrol|mesh-list
56878315|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
56878316|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878317|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
56878318|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878319|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
56878320|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56878322|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56878323|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56878325|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
56878326|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878327|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56878328|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56878329|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56878330|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
56878331|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56878332|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56878333|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56878334|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56878335|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
56878336|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56878337|NCT03777696|Misoprostol|misoprostol|mesh-list
56878338|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56878339|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
56878340|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56878341|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878342|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56878343|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56878344|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
56878345|NCT04581148|Antibodies|antibodies|mesh-list
56878346|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
56878347|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
56878348|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878349|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
56878350|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
56878351|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56878352|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56878353|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
56878354|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878355|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878356|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878357|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878358|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56878359|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878360|NCT03774108|Metformin|metformin|mesh-list
56878361|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56878362|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878363|NCT03438526|Melatonin|melatonin|mesh-list
56878364|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
56878365|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878366|NCT03438526|Protective Agents|protective agents|mesh-ancestor
56878367|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878368|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878369|NCT02575144|Clarithromycin|clarithromycin|mesh-list
56878370|NCT02575144|Dexamethasone|dexamethasone|mesh-list
56878371|NCT02575144|Lenalidomide|lenalidomide|mesh-list
56878372|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56878373|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
56878374|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
56878375|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878376|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878377|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56878378|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
56878379|NCT02575144|Hormones|hormones|mesh-ancestor
56878380|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878381|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56878382|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878383|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
56878384|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56878385|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56878386|NCT02575144|Growth Substances|growth substances|mesh-ancestor
56878387|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
56878388|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56878389|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878390|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56878391|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878392|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878393|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56878395|NCT04140162|Dexamethasone|dexamethasone|mesh-list
56878396|NCT04140162|Lenalidomide|lenalidomide|mesh-list
56878397|NCT04140162|Bortezomib|bortezomib|mesh-list
56878398|NCT04140162|Daratumumab|daratumumab|mesh-list
56878399|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56878400|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
56878401|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
56878402|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878403|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878404|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56878405|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
56878406|NCT04140162|Hormones|hormones|mesh-ancestor
56878407|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878408|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56878409|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878410|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
56904399|NCT02260414|Dalteparin|dalteparin|mesh-list
56878411|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56878412|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56878413|NCT04140162|Growth Substances|growth substances|mesh-ancestor
56878414|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
56878415|NCT03768882|Acetaminophen|acetaminophen|mesh-list
56878416|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56878417|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56878418|NCT03768882|Analgesics|analgesics|mesh-ancestor
56878419|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
56878420|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878421|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589207|NCT02845908|Leucovorin|leucovorin|mesh-list
56878422|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
56878423|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56878424|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56878425|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56878426|NCT02574286|Vitamin D|vitamin d|mesh-list
56878427|NCT02574286|Vitamins|vitamins|mesh-ancestor
56878428|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
56878429|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878430|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56878431|NCT01321944|Nicotine|nicotine|mesh-list
56878432|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56878433|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
56878434|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878435|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878436|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56878437|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56878438|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
56878439|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878440|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878441|NCT03771846|Leucovorin|leucovorin|mesh-list
56878442|NCT03771846|Gemcitabine|gemcitabine|mesh-list
56878443|NCT03771846|Fluorouracil|fluorouracil|mesh-list
56878444|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
56878445|NCT03771846|Irinotecan|irinotecan|mesh-list
56878446|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56878447|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
56878448|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878449|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878450|NCT03771846|Antiviral Agents|antiviral agents|mesh-ancestor
56878451|NCT03771846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878452|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878453|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878454|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
56878455|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878456|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56878457|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56878458|NCT03771846|Antidotes|antidotes|mesh-ancestor
56878459|NCT03771846|Protective Agents|protective agents|mesh-ancestor
56878460|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
56878461|NCT03771846|Vitamins|vitamins|mesh-ancestor
56878462|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
56878463|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56878464|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56878465|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878466|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
56878467|NCT03771768|Triamcinolone|triamcinolone|mesh-list
56878468|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56878469|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56878471|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56878472|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
56878473|NCT03771768|Hormones|hormones|mesh-ancestor
56878474|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878475|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878476|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878477|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
56878478|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878479|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878480|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
56878481|NCT04393350|Lenvatinib|lenvatinib|mesh-list
56878482|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878483|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878484|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56878485|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878486|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878487|NCT03745326|Aldesleukin|aldesleukin|mesh-list
56878488|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
56878489|NCT03745326|Fludarabine|fludarabine|mesh-list
56878490|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878491|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
56878492|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878493|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56878494|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56878495|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
56878496|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589274|NCT01023308|Hormones|hormones|mesh-ancestor
56878497|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878498|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56878499|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56878500|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56878501|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
56878502|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878503|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
56878504|NCT03768258|Anastrozole|anastrozole|mesh-list
56878505|NCT03768258|Testosterone|testosterone|mesh-list
56878506|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
56878507|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
56878508|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56878509|NCT03768258|Androgens|androgens|mesh-ancestor
56878510|NCT03768258|Hormones|hormones|mesh-ancestor
56878511|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878512|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878513|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56878514|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878515|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
56878516|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56878517|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56878518|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878519|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878520|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56878521|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
56878522|NCT03771222|Decitabine|decitabine|mesh-list
56878523|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56878524|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
56878525|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878526|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878527|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878528|NCT02366728|Temozolomide|temozolomide|mesh-list
56878529|NCT02366728|Basiliximab|basiliximab|mesh-list
56878530|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
56878531|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878532|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56878533|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
56878534|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878535|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878536|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878537|NCT03771066|Bisphenol A|bisphenol a|mesh-list
56878538|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56878539|NCT03771066|Estrogens|estrogens|mesh-ancestor
56878540|NCT03771066|Hormones|hormones|mesh-ancestor
56878541|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878542|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878543|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56878545|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878546|NCT03771066|Protective Agents|protective agents|mesh-ancestor
56878547|NCT04478838|Olanzapine|olanzapine|mesh-list
56878548|NCT04478838|Risperidone|risperidone|mesh-list
56878549|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56878550|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
56878551|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878552|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878553|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878554|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56878555|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56878556|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878557|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56878558|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56878559|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
56878560|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
56878561|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
56878562|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878563|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56878564|NCT04478838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56878565|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56878566|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56878567|NCT03768024|Hydromorphone|hydromorphone|mesh-list
56878568|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56878569|NCT03768024|Narcotics|narcotics|mesh-ancestor
56878570|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878571|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878572|NCT03768024|Analgesics|analgesics|mesh-ancestor
56878573|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
56878574|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878575|NCT03999684|Tretinoin|tretinoin|mesh-list
56878576|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878577|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
56878578|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
56878579|NCT02083354|Trametinib|trametinib|mesh-list
56878580|NCT02083354|Dabrafenib|dabrafenib|mesh-list
56878581|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878582|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56878583|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878584|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878585|NCT01399918|Bevacizumab|bevacizumab|mesh-list
56878586|NCT01399918|Everolimus|everolimus|mesh-list
56878587|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878588|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878589|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56878590|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56878591|NCT01399918|Growth Substances|growth substances|mesh-ancestor
56878592|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878593|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
56878594|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878595|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
56878596|NCT03591510|Cytarabine|cytarabine|mesh-list
56878597|NCT03591510|Fludarabine|fludarabine|mesh-list
56878598|NCT03591510|Etoposide|etoposide|mesh-list
56878599|NCT03591510|Daunorubicin|daunorubicin|mesh-list
56878600|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
56878601|NCT03591510|Idarubicin|idarubicin|mesh-list
56878602|NCT03591510|Midostaurin|midostaurin|mesh-list
56878603|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878604|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56878605|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
56878606|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878607|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878608|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
56878609|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878610|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56878611|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56878612|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56878613|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878614|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
56878615|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878616|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56878617|NCT03591510|Analgesics|analgesics|mesh-ancestor
56878618|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
56878619|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878621|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
56878622|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56878623|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
56878624|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878625|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
56878626|NCT03761472|Protective Agents|protective agents|mesh-ancestor
56878628|NCT03767322|Febuxostat|febuxostat|mesh-list
56878629|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
56878630|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878631|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878632|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
56878633|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56878634|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56878635|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
56878636|NCT03767322|Protective Agents|protective agents|mesh-ancestor
56878637|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878638|NCT03761004|Levodopa|levodopa|mesh-list
56878639|NCT03761004|Carbidopa|carbidopa|mesh-list
56878640|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56878641|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56550375|NCT04329442|Tenofovir|tenofovir|mesh-list
56878642|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56878643|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
56878644|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878645|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878646|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878647|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56878648|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589418|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56878649|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56878650|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
56878651|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
56878653|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
56878654|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
56878655|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878656|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878657|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
56878658|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878659|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56878660|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56878661|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56878662|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56878663|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878664|NCT03766854|Insulin|insulin|mesh-list
56878665|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56878666|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
56878667|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56878668|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878669|NCT01322100|Bleomycin|bleomycin|mesh-list
56878670|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56878671|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878672|NCT03493854|Paclitaxel|paclitaxel|mesh-list
56878673|NCT03493854|Docetaxel|docetaxel|mesh-list
56878674|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
56878675|NCT03493854|Doxorubicin|doxorubicin|mesh-list
56878676|NCT03493854|Trastuzumab|trastuzumab|mesh-list
56878677|NCT03493854|Pertuzumab|pertuzumab|mesh-list
56878678|NCT03493854|Hormones|hormones|mesh-list
56878679|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56878680|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878681|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
56878682|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
56878683|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
56878684|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878685|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878686|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
56878687|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878688|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56878689|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56878690|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
56878691|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56878692|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56878693|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56878694|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56878696|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878697|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878698|NCT03760848|Midazolam|midazolam|mesh-list
56878699|NCT03760848|Atorvastatin|atorvastatin|mesh-list
56878700|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56878701|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56878702|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878703|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878704|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56878705|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56878706|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56878707|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56878708|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
56878709|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
56878710|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
56878711|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
56878712|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878713|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878714|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56878715|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56878716|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
56878717|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56878718|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56878719|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878720|NCT01567488|Everolimus|everolimus|mesh-list
56878721|NCT01567488|Octreotide|octreotide|mesh-list
56878722|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878723|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878724|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
56878725|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878726|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56878727|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56878728|NCT03760770|Riboflavin|riboflavin|mesh-list
56878729|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
56878730|NCT03760770|Vitamins|vitamins|mesh-ancestor
56878731|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
56878732|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878733|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56878734|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
56878735|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
56878736|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56878737|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878738|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56878739|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56878740|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878741|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878742|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878743|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56878744|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56878745|NCT01322178|Cetuximab|cetuximab|mesh-list
56878746|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878747|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878748|NCT03760614|Entinostat|entinostat|mesh-list
56878749|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878750|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56878751|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878752|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878753|NCT00112840|Bevacizumab|bevacizumab|mesh-list
56878754|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878755|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878756|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56878757|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56878758|NCT00112840|Growth Substances|growth substances|mesh-ancestor
56878759|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878760|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
56878761|NCT03769818|Dexamethasone|dexamethasone|mesh-list
56878762|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
56878763|NCT03769818|Bupivacaine|bupivacaine|mesh-list
56878764|NCT03769818|BB 1101|bb 1101|mesh-list
56878765|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56878766|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
56878767|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
56878768|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878769|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878773|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878774|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56878775|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878776|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
56878777|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878778|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878779|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
56878780|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
56878781|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878782|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
56878783|NCT05223244|Triamcinolone|triamcinolone|mesh-list
56878784|NCT05223244|Heparin|heparin|mesh-list
56878785|NCT05223244|Bupivacaine|bupivacaine|mesh-list
56878786|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56878787|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
56878788|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
56878789|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878790|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878791|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
56878792|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878793|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
56878794|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56878795|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56878796|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878797|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56878798|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
56878799|NCT05223244|Hormones|hormones|mesh-ancestor
56878800|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878801|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56878802|NCT05223244|Protective Agents|protective agents|mesh-ancestor
56878803|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56878804|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
56878805|NCT04336098|Gemcitabine|gemcitabine|mesh-list
56878806|NCT04336098|Paclitaxel|paclitaxel|mesh-list
56878807|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
56878808|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56878809|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56878810|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878811|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
56878812|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
56878813|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
56878814|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878815|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56878816|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
56878817|NCT04336098|Antiviral Agents|antiviral agents|mesh-ancestor
56878818|NCT04336098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878819|NCT04336098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878820|NCT04336098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878821|NCT04336098|Immunologic Factors|immunologic factors|mesh-ancestor
56878822|NCT04336098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878823|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878824|NCT05223010|Sevoflurane|sevoflurane|mesh-list
56878825|NCT05223010|Melatonin|melatonin|mesh-list
56878826|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56878827|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56878828|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56878829|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
56878830|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
56878831|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878832|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878833|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
56878834|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878835|NCT05223010|Protective Agents|protective agents|mesh-ancestor
56878836|NCT03760302|Analgesics|analgesics|mesh-list
56878837|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56878838|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
56878839|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878840|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878841|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878842|NCT03766074|Vitamin D|vitamin d|mesh-list
56878844|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
56878845|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878846|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56878847|NCT05219656|Cyclosporine|cyclosporine|mesh-list
56878848|NCT05219656|Cyclosporins|cyclosporins|mesh-list
56878849|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878850|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878851|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878852|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
56878853|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878854|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
56878855|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878856|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
56878857|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56878858|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56878859|NCT05168644|Niclosamide|niclosamide|mesh-list
56878860|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
56904409|NCT04169373|Upadacitinib|upadacitinib|mesh-list
56878861|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56878862|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
56878863|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56878864|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878865|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
56878866|NCT05645536|Tamoxifen|tamoxifen|mesh-list
56878867|NCT05645536|Letrozole|letrozole|mesh-list
56878868|NCT05645536|Anastrozole|anastrozole|mesh-list
56878869|NCT05645536|Exemestane|exemestane|mesh-list
56878870|NCT05645536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878871|NCT05645536|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56878872|NCT05645536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56878873|NCT05645536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878874|NCT05645536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878875|NCT05645536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56878876|NCT05645536|Hormone Antagonists|hormone antagonists|mesh-ancestor
56878877|NCT05645536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56878878|NCT05645536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878879|NCT05645536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56878880|NCT05645536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56878881|NCT05645536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56878882|NCT05645536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56878883|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
56878884|NCT03211416|Sorafenib|sorafenib|mesh-list
56878885|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878886|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878887|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56878888|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878889|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878890|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
56878891|NCT05412888|Ubiquinone|ubiquinone|mesh-list
56878892|NCT05412888|Vitamins|vitamins|mesh-ancestor
56878893|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
56878894|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878895|NCT02105766|Sirolimus|sirolimus|mesh-list
56878896|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
56878897|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
56878898|NCT02105766|Pentostatin|pentostatin|mesh-list
56878899|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878900|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
56878901|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878902|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56878903|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56878904|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
56878905|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878906|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878907|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56878908|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56878909|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878910|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56878911|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
56878912|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878913|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56878914|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56878915|NCT05558410|Acetaminophen|acetaminophen|mesh-list
56878916|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56878917|NCT05558410|Analgesics|analgesics|mesh-ancestor
56878918|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
56878920|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878921|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
56878922|NCT03176784|Nicotine|nicotine|mesh-list
56878923|NCT03176784|Varenicline|varenicline|mesh-list
56878924|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56878925|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
56878926|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878927|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878928|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56878929|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56878930|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
56878931|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878932|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878933|NCT05087212|Plerixafor|plerixafor|mesh-list
56878934|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56878935|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56878936|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
56878937|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56878938|NCT01532310|Belimumab|belimumab|mesh-list
56878939|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56878940|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
56878941|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878942|NCT01321788|Tinzaparin|tinzaparin|mesh-list
56878943|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56878944|NCT01321788|Dalteparin|dalteparin|mesh-list
56878945|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
56878946|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56878947|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56878948|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878949|NCT05053828|Clopidogrel|clopidogrel|mesh-list
56878950|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56878951|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56878952|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56878953|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56878954|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
56589722|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
56878955|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878956|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878957|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878958|NCT03120780|Fentanyl|fentanyl|mesh-list
56878959|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56878960|NCT03120780|Narcotics|narcotics|mesh-ancestor
56878961|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878962|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878963|NCT03120780|Analgesics|analgesics|mesh-ancestor
56878964|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
56878965|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878966|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56878967|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56878968|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
56878969|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
56878970|NCT03118986|Olanzapine|olanzapine|mesh-list
56878971|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
56878972|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
56878973|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56878974|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56878975|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56878976|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56878977|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56878978|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56878979|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56878980|NCT03118986|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56878981|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56878982|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56878983|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878984|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56878985|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
56878986|NCT05026606|Nivolumab|nivolumab|mesh-list
56878987|NCT05026606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56878988|NCT05026606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56878989|NCT05026606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56878990|NCT05026606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56878991|NCT04920838|Acetaminophen|acetaminophen|mesh-list
56878992|NCT04920838|Ciclesonide|ciclesonide|mesh-list
56878994|NCT04920838|Budesonide|budesonide|mesh-list
56878995|NCT04920838|Telmisartan|telmisartan|mesh-list
56878996|NCT04920838|Fluoxetine|fluoxetine|mesh-list
56878997|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56878998|NCT04920838|Analgesics|analgesics|mesh-ancestor
56878999|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
56879000|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879001|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879002|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
56879003|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879004|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56879005|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
56879006|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56879007|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
56879008|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
56879009|NCT04920838|Hormones|hormones|mesh-ancestor
56879010|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56879011|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56879012|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56879013|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56879014|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879015|NCT04920838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56879016|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56879017|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879018|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879019|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
56879020|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56879021|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
56879022|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56879023|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56879024|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56879025|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879026|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56879027|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879028|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56879029|NCT03764280|Insulin|insulin|mesh-list
56879030|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
56879031|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56879032|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879033|NCT05133804|Methylphenidate|methylphenidate|mesh-list
56879034|NCT05133804|Reboxetine|reboxetine|mesh-list
56879035|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56879036|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879037|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56879038|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56879039|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879040|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879041|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
56879042|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879043|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
56879044|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56879045|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56879046|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
56879047|NCT03764202|Sufentanil|sufentanil|mesh-list
56879048|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56879049|NCT03764202|Narcotics|narcotics|mesh-ancestor
56879050|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879051|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879052|NCT03764202|Analgesics|analgesics|mesh-ancestor
56879053|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
56879054|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879055|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56879056|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56879057|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
56879058|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
56879059|NCT04680910|Propofol|propofol|mesh-list
56879060|NCT04680910|Anesthetics|anesthetics|mesh-list
56879061|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56879062|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879063|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879064|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56879065|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
56879066|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
56879067|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
56879070|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
56879071|NCT05115630|Tacrolimus|tacrolimus|mesh-list
56879072|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56879073|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
56879074|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879075|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879076|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56879077|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
56879078|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879079|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879080|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56879081|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56879082|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
56879083|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56879084|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904416|NCT04169061|Hormones|hormones|mesh-ancestor
56879085|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56879086|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56879087|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
56879088|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56879089|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879090|NCT04678492|Amoxicillin|amoxicillin|mesh-list
56879091|NCT04678492|Tetracycline|tetracycline|mesh-list
56879092|NCT04678492|Furazolidone|furazolidone|mesh-list
56879093|NCT04678492|Esomeprazole|esomeprazole|mesh-list
56879094|NCT04678492|Bismuth|bismuth|mesh-list
56879095|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56879096|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879097|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56879098|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56879099|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56879100|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879101|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879102|NCT04678492|Antacids|antacids|mesh-ancestor
56879103|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56879104|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56879105|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56879106|NCT04678492|Renal Agents|renal agents|mesh-ancestor
56879107|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56879108|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56879109|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56879110|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56879111|NCT05091528|Capecitabine|capecitabine|mesh-list
56879112|NCT05091528|Trastuzumab|trastuzumab|mesh-list
56879113|NCT05091528|Tucatinib|tucatinib|mesh-list
56879114|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56879115|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
56879116|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879117|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879118|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56879119|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56879120|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879121|NCT04236258|Enalapril|enalapril|mesh-list
56879122|NCT04236258|Nifedipine|nifedipine|mesh-list
56879123|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56879124|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879125|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879126|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56879127|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879128|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
56879129|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
56879130|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56879131|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56879132|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
56879133|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879134|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56879135|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56879136|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
56879137|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56879138|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879139|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56879140|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
56879141|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879155|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879157|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
56879158|NCT04493320|Levodopa|levodopa|mesh-list
56879159|NCT04493320|Carbidopa|carbidopa|mesh-list
56879160|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56879161|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56879162|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56879163|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
56879164|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879165|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879166|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879167|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56879168|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879169|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56879170|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
56879171|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
56879172|NCT04493164|Cytarabine|cytarabine|mesh-list
56879173|NCT04493164|Daunorubicin|daunorubicin|mesh-list
56879174|NCT04493164|Ivosidenib|ivosidenib|mesh-list
56879175|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56879176|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
56879177|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879178|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879179|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
56879180|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879181|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56879182|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
56879183|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879184|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56879185|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56879186|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56879188|NCT05524714|Xanthohumol|xanthohumol|mesh-list
56879189|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879190|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56879191|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56879192|NCT05524714|Growth Substances|growth substances|mesh-ancestor
56879193|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879194|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
56879195|NCT05692804|Protein S|protein s|mesh-list
56879196|NCT05692804|Anticoagulants|anticoagulants|mesh-ancestor
56879197|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
56879198|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56879199|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
56879200|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879201|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879202|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56879203|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
56879204|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
56879205|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56879206|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
56879207|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879208|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879210|NCT05692570|Cobicistat|cobicistat|mesh-list
56879211|NCT05692570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56879212|NCT05692570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56879213|NCT05692570|Protease Inhibitors|protease inhibitors|mesh-ancestor
56879214|NCT05692570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879215|NCT05692570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879216|NCT05692570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56879217|NCT05692570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56879218|NCT05692570|Antiviral Agents|antiviral agents|mesh-ancestor
56879219|NCT05692570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879220|NCT05692570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56879221|NCT05692570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56879222|NCT05692180|Benralizumab|benralizumab|mesh-list
56879223|NCT05692180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56879224|NCT05692180|Respiratory System Agents|respiratory system agents|mesh-ancestor
56879225|NCT05691556|Botulinum Toxins|botulinum toxins|mesh-list
56879226|NCT05691556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56879227|NCT05691556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879228|NCT05691556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879229|NCT05691556|Cholinergic Agents|cholinergic agents|mesh-ancestor
56879230|NCT05691556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879231|NCT05691556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879232|NCT05422612|Fluoxetine|fluoxetine|mesh-list
56879233|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56879234|NCT05422612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56879235|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56879236|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879237|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879238|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879239|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
56879240|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879241|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56879242|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
56879243|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56904419|NCT01562691|Petrolatum|petrolatum|mesh-list
56879244|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56879245|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56879246|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879247|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56879248|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56879249|NCT05691400|Palbociclib|palbociclib|mesh-list
56879250|NCT05691400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879251|NCT05691400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56879252|NCT05691400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879253|NCT05691400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879254|NCT05689450|Amikacin|amikacin|mesh-list
56590024|NCT02776137|Docetaxel|docetaxel|mesh-list
56879255|NCT05689450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56879256|NCT05689450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879257|NCT05417308|Minoxidil|minoxidil|mesh-list
56879258|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56879259|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
56879260|NCT05544136|Carboplatin|carboplatin|mesh-list
56879261|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879262|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
56879263|NCT05501548|Olaparib|olaparib|mesh-list
56879264|NCT05501548|Vitamins|vitamins|mesh-ancestor
56879265|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
56879266|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879267|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
56879268|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879269|NCT05501548|Protective Agents|protective agents|mesh-ancestor
56879270|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56879271|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879272|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879273|NCT05425732|Vaccines|vaccines|mesh-list
56879274|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56879275|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
56879276|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879277|NCT05389462|Gemcitabine|gemcitabine|mesh-list
56879278|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56879281|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879282|NCT05389462|Antiviral Agents|antiviral agents|mesh-ancestor
56879283|NCT05389462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879284|NCT05389462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879285|NCT05389462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56879286|NCT05389462|Immunologic Factors|immunologic factors|mesh-ancestor
56879287|NCT05389462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879288|NCT04650542|Paroxetine|paroxetine|mesh-list
56879289|NCT04650542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56879290|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56879291|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879292|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879293|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879294|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
56879295|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879296|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56879297|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
56879298|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56879299|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56879300|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56879301|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879302|NCT04621058|Vitamin D|vitamin d|mesh-list
56879303|NCT04621058|Vitamins|vitamins|mesh-list
56879304|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
56879305|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879306|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56879307|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
56879308|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
56879309|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56879310|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56879311|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879312|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879313|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879314|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879315|NCT02527434|Durvalumab|durvalumab|mesh-list
56879316|NCT02527434|Tremelimumab|tremelimumab|mesh-list
56879317|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56879318|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56879319|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879320|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
56879321|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879322|NCT04451330|Doxycycline|doxycycline|mesh-list
56879323|NCT04451330|Trifarotene|trifarotene|mesh-list
56879324|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56879325|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879326|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
56879327|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56879328|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56879329|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
56590104|NCT03205956|Levodopa|levodopa|mesh-list
56879330|NCT04609514|Nicotine|nicotine|mesh-list
56879331|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56879332|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
56879333|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879334|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879335|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56879336|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56879337|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
56879338|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879339|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879340|NCT02493426|Oxytocin|oxytocin|mesh-list
56879341|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
56879342|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56879343|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879344|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
56879345|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56879346|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56879347|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56879348|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879349|NCT03763734|Dexamethasone|dexamethasone|mesh-list
56879350|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879351|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
56879353|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879354|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879355|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56879356|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
56879357|NCT03763734|Hormones|hormones|mesh-ancestor
56879358|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56879359|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56879360|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879361|NCT05063136|Capecitabine|capecitabine|mesh-list
56879362|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56879363|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
56879364|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879365|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879366|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56879367|NCT03756324|Cefdinir|cefdinir|mesh-list
56879368|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56879369|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879370|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
56879371|NCT03751202|Fluticasone|fluticasone|mesh-list
56879372|NCT03751202|Xhance|xhance|mesh-list
56879373|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56879374|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56879375|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879376|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56879377|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
56879378|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879379|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879380|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56879381|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
56879382|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
56879383|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56879384|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56879385|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56879386|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56879387|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
56879388|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879389|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879390|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
56879391|NCT03751202|Hormones|hormones|mesh-ancestor
56879392|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56879393|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
56879394|NCT03749408|Mannitol|mannitol|mesh-list
56879395|NCT03749408|Bupivacaine|bupivacaine|mesh-list
56879396|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
56879397|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
56879398|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879399|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879400|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
56879401|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879402|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56879403|NCT03749408|Diuretics|diuretics|mesh-ancestor
56879404|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
56879405|NCT04387136|Sufentanil|sufentanil|mesh-list
56879406|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56879407|NCT04387136|Narcotics|narcotics|mesh-ancestor
56879408|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879409|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879410|NCT04387136|Analgesics|analgesics|mesh-ancestor
56879411|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
56879412|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879413|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56879414|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56879415|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
56879416|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
56879417|NCT04658784|Cyclopropane|cyclopropane|mesh-list
56879418|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
56879419|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879420|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879421|NCT04252586|Cannabidiol|cannabidiol|mesh-list
56879422|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
56879423|NCT04507776|Etanercept|etanercept|mesh-list
56879424|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56879425|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56879426|NCT04507776|Analgesics|analgesics|mesh-ancestor
56879427|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
56879428|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879429|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879430|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879431|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879432|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56879433|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56879434|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
56879436|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56879437|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
56879438|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56879439|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
56879440|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879441|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879442|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
56879443|NCT03756246|Vaccines|vaccines|mesh-list
56879444|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
56879445|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879446|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
56879447|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56879448|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
56879449|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879450|NCT05460858|Expectorants|expectorants|mesh-ancestor
56879451|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
56879452|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56879453|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
56879454|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879455|NCT05460858|Protective Agents|protective agents|mesh-ancestor
56879456|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879457|NCT05460858|Antidotes|antidotes|mesh-ancestor
56879458|NCT05359224|Clopidogrel|clopidogrel|mesh-list
56879459|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56879460|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56879461|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56879462|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56879463|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56879464|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
56879465|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879466|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879467|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879468|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56879469|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
56879470|NCT03756090|Paclitaxel|paclitaxel|mesh-list
56879471|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
56879472|NCT03756090|Epirubicin|epirubicin|mesh-list
56879473|NCT03756090|Palbociclib|palbociclib|mesh-list
56879474|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56879475|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879476|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
56879477|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
56879478|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
56879479|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879480|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56879481|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
56879482|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879483|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879484|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56879485|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
56879486|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56879487|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56879488|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56879489|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56879490|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879491|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56879492|NCT04605588|Ribavirin|ribavirin|mesh-list
56879493|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
56879494|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
56879495|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
56879496|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879497|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
56879498|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879499|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
56879500|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56879501|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56879502|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879503|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879504|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
56879505|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56879506|NCT03752736|Protective Agents|protective agents|mesh-ancestor
56879507|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879508|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
56879509|NCT03752658|Tenofovir|tenofovir|mesh-list
56879510|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
56879511|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879512|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56879513|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56879514|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879515|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879516|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56879517|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56879518|NCT05288062|Dexamethasone|dexamethasone|mesh-list
56879519|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
56879520|NCT05288062|Lenalidomide|lenalidomide|mesh-list
56879521|NCT05288062|Pomalidomide|pomalidomide|mesh-list
56879522|NCT05288062|Ichthammol|ichthammol|mesh-list
56879523|NCT05288062|BB 1101|bb 1101|mesh-list
56879524|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879525|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
56879526|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
56879527|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879528|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879529|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56879530|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
56879531|NCT05288062|Hormones|hormones|mesh-ancestor
56879532|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56879533|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56879534|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879535|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
56879536|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879537|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879538|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
56879539|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56879540|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56879541|NCT05288062|Growth Substances|growth substances|mesh-ancestor
56879542|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
56879543|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
56879544|NCT04582266|Remdesivir|remdesivir|mesh-list
56879545|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
56551255|NCT02857959|Penicillins|penicillins|mesh-list
56879546|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879547|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
56879548|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879549|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
56879550|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56879551|NCT03755778|Itraconazole|itraconazole|mesh-list
56879552|NCT03755778|Rifampin|rifampin|mesh-list
56879553|NCT03755778|Quinidine|quinidine|mesh-list
56879554|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
56879555|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879556|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56879557|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56879558|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879559|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879560|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56879561|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
56879562|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56879563|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879564|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56879565|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56879566|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
56879567|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56879568|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
56879569|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56879570|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56879571|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56879572|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56879573|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56879574|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56879575|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56879576|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56879577|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56879578|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
56879579|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879580|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56879581|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
56879582|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56879583|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56879584|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56879585|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56879586|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
56879587|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56879588|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56879589|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879590|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56879591|NCT03779074|Amoxicillin|amoxicillin|mesh-list
56879592|NCT03779074|Metronidazole|metronidazole|mesh-list
56879593|NCT03779074|Clarithromycin|clarithromycin|mesh-list
56879594|NCT03779074|Tetracycline|tetracycline|mesh-list
56879595|NCT03779074|Rabeprazole|rabeprazole|mesh-list
56879596|NCT03779074|Bismuth|bismuth|mesh-list
56879597|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56879598|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879599|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56879600|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56879601|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56879602|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879603|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879604|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56879605|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56879606|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56879607|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56879608|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56879609|NCT03779074|Antacids|antacids|mesh-ancestor
56879610|NCT03755700|Vitamin E|vitamin e|mesh-list
56879611|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
56879612|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56879613|NCT03755700|Vitamins|vitamins|mesh-ancestor
56879614|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
56879615|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879616|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
56879617|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879618|NCT03755700|Protective Agents|protective agents|mesh-ancestor
56879619|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
56879620|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879621|NCT03755700|Expectorants|expectorants|mesh-ancestor
56879622|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
56879623|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56879624|NCT03755700|Antidotes|antidotes|mesh-ancestor
56879625|NCT03757650|Amoxicillin|amoxicillin|mesh-list
56879626|NCT03757650|Clarithromycin|clarithromycin|mesh-list
56879627|NCT03757650|Omeprazole|omeprazole|mesh-list
56879628|NCT03757650|Bismuth|bismuth|mesh-list
56879629|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56879630|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56879631|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879632|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56879633|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56879634|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56879635|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879636|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879637|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56879638|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56879639|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56879640|NCT03757650|Antacids|antacids|mesh-ancestor
56879641|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
56879642|NCT04432376|Miconazole|miconazole|mesh-list
56879643|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
56879644|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879645|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56879646|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56879647|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879648|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879649|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56879650|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
56879651|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56879652|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879653|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56879654|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56879655|NCT05180968|Dronabinol|dronabinol|mesh-list
56879656|NCT05180968|Nabilone|nabilone|mesh-list
56879657|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
56879658|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
56879659|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879660|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879661|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56879662|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56879663|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56879664|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879665|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56879666|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
56879667|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56879668|NCT05180968|Analgesics|analgesics|mesh-ancestor
56879669|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
56879670|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56879671|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56879672|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879673|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879674|NCT05180968|Hormones|hormones|mesh-ancestor
56879675|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56879676|NCT03693404|Ketorolac|ketorolac|mesh-list
56879677|NCT03693404|Morphine|morphine|mesh-list
56879678|NCT03693404|Bupivacaine|bupivacaine|mesh-list
56879679|NCT03693404|Anesthetics|anesthetics|mesh-list
56879680|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
56879681|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
56879682|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879683|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879684|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
56879685|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879686|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56879687|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56879688|NCT03693404|Analgesics|analgesics|mesh-ancestor
56879689|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879690|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879691|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56879692|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879693|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879694|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56879695|NCT03693404|Narcotics|narcotics|mesh-ancestor
56879696|NCT04219358|Imiquimod|imiquimod|mesh-list
56879697|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
56879698|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56879699|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
56879700|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879701|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879702|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
56879703|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56879704|NCT04219358|Protective Agents|protective agents|mesh-ancestor
56879705|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
56879706|NCT04218110|Ethanol|ethanol|mesh-list
56879707|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
56879708|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56879709|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56879710|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879711|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879712|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879713|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
56879714|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
56879716|NCT05154994|Ipilimumab|ipilimumab|mesh-list
56879717|NCT05154994|Tremelimumab|tremelimumab|mesh-list
56879718|NCT05154994|Belinostat|belinostat|mesh-list
56879719|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
56879720|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56879721|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
56879722|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56879723|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879724|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
56879725|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879726|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56879727|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879728|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56879729|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879730|NCT03752190|Cosyntropin|cosyntropin|mesh-list
56879731|NCT03752190|Hormones|hormones|mesh-ancestor
56879732|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56879733|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879734|NCT04210310|Oxytocin|oxytocin|mesh-list
56879735|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
56879736|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56879737|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879738|NCT03755466|Tofacitinib|tofacitinib|mesh-list
56879739|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56879740|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879741|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879742|NCT03755310|Suvorexant|suvorexant|mesh-list
56879743|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56879744|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56879745|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879746|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879747|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56879748|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879749|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879750|NCT05145010|Infigratinib|infigratinib|mesh-list
56879751|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879752|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
56879753|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
56879754|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56879755|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56879756|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879757|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879758|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879759|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879760|NCT03668392|Asparaginase|asparaginase|mesh-list
56879761|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879762|NCT04176016|Edetic Acid|edetic acid|mesh-list
56879763|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
56879764|NCT04176016|Antidotes|antidotes|mesh-ancestor
56879765|NCT04176016|Protective Agents|protective agents|mesh-ancestor
56879766|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879767|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
56879768|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
56879769|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879770|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56879771|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
56879772|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56879773|NCT03695094|Lamotrigine|lamotrigine|mesh-list
56879774|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
56879775|NCT03695094|Levetiracetam|levetiracetam|mesh-list
56879776|NCT03695094|Brivaracetam|brivaracetam|mesh-list
56879777|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
56879778|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
56879779|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56879780|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879781|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879782|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56879783|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879784|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56879785|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56879786|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879787|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56879788|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56879789|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56879790|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56879791|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56879792|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
56879793|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879794|NCT04495374|Pregabalin|pregabalin|mesh-list
56879795|NCT04495374|Analgesics|analgesics|mesh-ancestor
56879796|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
56879797|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879798|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879799|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
56879800|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56879801|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879802|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879803|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56879804|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56879805|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56879806|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879807|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56879808|NCT03752112|Penicillins|penicillins|mesh-list
56879809|NCT03752112|Cefixime|cefixime|mesh-list
56879810|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56879811|NCT03752112|Penicillin G|penicillin g|mesh-list
56879812|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
56879813|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56879814|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879815|NCT04324606|Acetaminophen|acetaminophen|mesh-list
56879816|NCT04324606|Vaccines|vaccines|mesh-list
56879817|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
56879818|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879819|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56879820|NCT04324606|Analgesics|analgesics|mesh-ancestor
56879821|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
56879822|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879823|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
56879824|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56879825|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56879826|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879827|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56879828|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
56879829|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879830|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
56879831|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56879832|NCT04168190|Vaccines|vaccines|mesh-list
56904438|NCT02792218|Analgesics|analgesics|mesh-ancestor
56879833|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56879834|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
56879835|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879836|NCT03939520|Pirfenidone|pirfenidone|mesh-list
56879837|NCT03939520|Nintedanib|nintedanib|mesh-list
56879838|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879839|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56879840|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879841|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879842|NCT03939520|Analgesics|analgesics|mesh-ancestor
56879843|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
56879844|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879845|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879846|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56879847|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56879848|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879849|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879851|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879852|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
56879853|NCT03529942|Hormones|hormones|mesh-ancestor
56879854|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56879855|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879856|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56879857|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
56879858|NCT03501940|Fluorides|fluorides|mesh-list
56879859|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
56879860|NCT03501940|Protective Agents|protective agents|mesh-ancestor
56879861|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879862|NCT03754842|Niacinamide|niacinamide|mesh-list
56879863|NCT03754842|Niacin|niacin|mesh-list
56879865|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
56879866|NCT03754842|Vitamins|vitamins|mesh-ancestor
56879867|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
56879868|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879869|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56879870|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
56879871|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879872|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56879873|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
56879874|NCT01562210|Olaparib|olaparib|mesh-list
56879875|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879876|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56879877|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879878|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879879|NCT04189952|Rituximab|rituximab|mesh-list
56879880|NCT04189952|Carboplatin|carboplatin|mesh-list
56879881|NCT04189952|Etoposide|etoposide|mesh-list
56879883|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
56879884|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56879885|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56879886|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
56879887|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879888|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879889|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56879890|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56879891|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56879892|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879893|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879894|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56879895|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
56879896|NCT04716426|Tetracycline|tetracycline|mesh-list
56879897|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56879898|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879899|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56879900|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879901|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879902|NCT05761756|Caffeine|caffeine|mesh-list
56879903|NCT05761756|Methylphenidate|methylphenidate|mesh-list
56879904|NCT05761756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56879905|NCT05761756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879906|NCT05761756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56879907|NCT05761756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904440|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879908|NCT05761756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879909|NCT05761756|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56879910|NCT05761756|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56879911|NCT05761756|Purinergic Agents|purinergic agents|mesh-ancestor
56879912|NCT05761756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879913|NCT05761756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56879914|NCT05761756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56879915|NCT05761756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879916|NCT05761756|Dopamine Agents|dopamine agents|mesh-ancestor
56879917|NCT04164758|Pimavanserin|pimavanserin|mesh-list
56879918|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56879919|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
56879920|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56879921|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56879922|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56879923|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879924|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879925|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56879926|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56879927|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56879928|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56879929|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
56879930|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56879931|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879932|NCT03754686|Acetaminophen|acetaminophen|mesh-list
56879933|NCT03754686|Oseltamivir|oseltamivir|mesh-list
56879934|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56879935|NCT03754686|Analgesics|analgesics|mesh-ancestor
56879936|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
56879937|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879938|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879940|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
56879941|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56879942|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56879943|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879944|NCT05200884|Lidocaine|lidocaine|mesh-list
56879945|NCT05200884|Carticaine|carticaine|mesh-list
56879946|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
56879947|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
56879948|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879949|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879950|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
56879951|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879952|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56879953|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56879954|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56394483|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
56879955|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56879956|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56879958|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879959|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879960|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
56879961|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56879962|NCT03749096|Antibodies|antibodies|mesh-list
56879963|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
56879964|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56879965|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
56879966|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879967|NCT03748940|Mirikizumab|mirikizumab|mesh-list
56879968|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56879969|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56879970|NCT03748940|Analgesics|analgesics|mesh-ancestor
56879971|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
56879972|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879973|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879974|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879975|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56879976|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56879977|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56879978|NCT04177862|Fentanyl|fentanyl|mesh-list
56879979|NCT04177862|Sufentanil|sufentanil|mesh-list
56879980|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56879981|NCT04177862|Narcotics|narcotics|mesh-ancestor
56879982|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56879983|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879984|NCT04177862|Analgesics|analgesics|mesh-ancestor
56879985|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
56879986|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56879987|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56879988|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56879989|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
56879990|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
56879991|NCT03746366|Corticosterone|corticosterone|mesh-list
56879992|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56879993|NCT04157738|Insulin|insulin|mesh-list
56879994|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56879995|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
56879996|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
56879997|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56879998|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56879999|NCT04156646|Esomeprazole|esomeprazole|mesh-list
56880000|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56880001|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56880002|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56880003|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880004|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880005|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
56880006|NCT04676412|Lenvatinib|lenvatinib|mesh-list
56880007|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880008|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880009|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56880010|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880011|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880012|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56590773|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
56880013|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56880014|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56880015|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880016|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880017|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56880018|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56880019|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56880020|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
56880021|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880022|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880023|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56880024|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56880025|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
56880026|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56880027|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880028|NCT04537806|Pregnanolone|pregnanolone|mesh-list
56880029|NCT04537806|Brexanolone|brexanolone|mesh-list
56880031|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880032|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880033|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
56880034|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880035|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880036|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
56880037|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
56880038|NCT03744806|Bevacizumab|bevacizumab|mesh-list
56880039|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880040|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880041|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56880042|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56880043|NCT03744806|Growth Substances|growth substances|mesh-ancestor
56880044|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880045|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
56880047|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
56880048|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880049|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
56880050|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
56880051|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880052|NCT04529850|Protective Agents|protective agents|mesh-ancestor
56880053|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880054|NCT00070564|Paclitaxel|paclitaxel|mesh-list
56880055|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
56880056|NCT00070564|Doxorubicin|doxorubicin|mesh-list
56880057|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56880058|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56880059|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880060|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
56880061|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
56880062|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
56880063|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880064|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880065|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
56880066|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880067|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880068|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56880069|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
56880070|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56880071|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56880072|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56880073|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56880074|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880075|NCT01561950|Clopidogrel|clopidogrel|mesh-list
56880076|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56880077|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56880078|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56880079|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56880080|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
56880081|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880082|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880083|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880084|NCT04139018|Timolol|timolol|mesh-list
56880085|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56880086|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56880087|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
56880088|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880089|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880090|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880091|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56880092|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56880093|NCT05206318|Cysteamine|cysteamine|mesh-list
56880094|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56880095|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880096|NCT05027048|Calcium|calcium|mesh-list
56880097|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56880098|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880099|NCT03751332|Tacrolimus|tacrolimus|mesh-list
56880100|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880101|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
56880102|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880103|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56880104|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880105|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880106|NCT04425252|Brequinar|brequinar|mesh-list
56880107|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880108|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880109|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880110|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880111|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
56880112|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880113|NCT04003610|Gemcitabine|gemcitabine|mesh-list
56880114|NCT04003610|Carboplatin|carboplatin|mesh-list
56880115|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
56880116|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880117|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56880118|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
56880119|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880120|NCT04003610|Antiviral Agents|antiviral agents|mesh-ancestor
56880121|NCT04003610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880122|NCT04003610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880123|NCT04003610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880124|NCT04003610|Immunologic Factors|immunologic factors|mesh-ancestor
56880125|NCT04003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880126|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880127|NCT03744104|Vaccines|vaccines|mesh-list
56880128|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
56880129|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880130|NCT03999554|Vaccines|vaccines|mesh-list
56880131|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
56880132|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880133|NCT05280626|Prednisolone|prednisolone|mesh-list
56880134|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56880135|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
56880136|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56880137|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
56880138|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
56880139|NCT05280626|Rituximab|rituximab|mesh-list
56880140|NCT05280626|Doxorubicin|doxorubicin|mesh-list
56880141|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56880142|NCT05280626|Vincristine|vincristine|mesh-list
56880143|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56880144|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
56880145|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880146|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
56880147|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880148|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880149|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56880150|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
56880151|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880152|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880153|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56880154|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880155|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56880156|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56880157|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56880158|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880159|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56880160|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
56880161|NCT05280626|Hormones|hormones|mesh-ancestor
56590929|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
56880162|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56880164|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
56880165|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
56880166|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880167|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56880168|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56880169|NCT05280626|Protective Agents|protective agents|mesh-ancestor
56880170|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56880171|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56880172|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56880173|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56880174|NCT04526574|Vaccines|vaccines|mesh-list
56880175|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56880176|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
56880177|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880178|NCT03993392|Buprenorphine|buprenorphine|mesh-list
56880179|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56880180|NCT03993392|Narcotics|narcotics|mesh-ancestor
56880181|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880182|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880183|NCT03993392|Analgesics|analgesics|mesh-ancestor
56880184|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
56880185|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880186|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56880187|NCT04145258|Aspirin|aspirin|mesh-list
56880188|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56880189|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56880190|NCT04145258|Analgesics|analgesics|mesh-ancestor
56880191|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
56880192|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880193|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880194|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56880195|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880196|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56880197|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56880198|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880199|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56880200|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56880201|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880202|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
56880203|NCT03751176|Leucovorin|leucovorin|mesh-list
56880204|NCT03751176|Folic Acid|folic acid|mesh-list
56880205|NCT03751176|Fluorouracil|fluorouracil|mesh-list
56880206|NCT03751176|Irinotecan|irinotecan|mesh-list
56880207|NCT03751176|Panitumumab|panitumumab|mesh-list
56880208|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
56880209|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
56880210|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880211|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56880212|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880213|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880214|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
56880215|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880216|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56880217|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56880218|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880219|NCT03751176|Antidotes|antidotes|mesh-ancestor
56880220|NCT03751176|Protective Agents|protective agents|mesh-ancestor
56880221|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
56880222|NCT03751176|Vitamins|vitamins|mesh-ancestor
56880223|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
56880224|NCT03751176|Hematinics|hematinics|mesh-ancestor
56880225|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880226|NCT04377308|Fluoxetine|fluoxetine|mesh-list
56880227|NCT04377308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56880228|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56880229|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56880230|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880231|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880232|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
56880233|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880234|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56880235|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
56880236|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56880237|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56880238|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56880239|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880240|NCT03743870|Bupivacaine|bupivacaine|mesh-list
56880241|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
56880242|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
56880243|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
56880244|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880245|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880246|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
56880247|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880248|NCT03988088|Lasmiditan|lasmiditan|mesh-list
56880249|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56880250|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
56880251|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880252|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880253|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880255|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
56880256|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880257|NCT03069352|Cytarabine|cytarabine|mesh-list
56880258|NCT03069352|Venetoclax|venetoclax|mesh-list
56880259|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56880260|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
56880261|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880262|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880263|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
56880264|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880265|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880266|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
56880267|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880268|NCT05204524|Temozolomide|temozolomide|mesh-list
56880269|NCT05204524|Epirubicin|epirubicin|mesh-list
56880270|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56880271|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
56880272|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880273|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880274|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56880275|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56880276|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56880277|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880278|NCT05204056|Epinephrine|epinephrine|mesh-list
56880279|NCT05204056|Morphine|morphine|mesh-list
56880280|NCT05204056|Ropivacaine|ropivacaine|mesh-list
56880281|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
56880282|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56880283|NCT05204056|Narcotics|narcotics|mesh-ancestor
56880284|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880285|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880286|NCT05204056|Analgesics|analgesics|mesh-ancestor
56880287|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
56880288|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880289|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
56880290|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
56880291|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56880292|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56880293|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880294|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
56880295|NCT05204056|Coagulants|coagulants|mesh-ancestor
56880296|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56880297|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56880298|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
56880299|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880300|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56880301|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56880302|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
56880303|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56880304|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
56880305|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
56880306|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
56880307|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56880308|NCT05761444|Atorvastatin|atorvastatin|mesh-list
56880309|NCT05761444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56880310|NCT05761444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56880311|NCT05761444|Antimetabolites|antimetabolites|mesh-ancestor
56880312|NCT05761444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880313|NCT05761444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56880314|NCT05761444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56880315|NCT05761444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880317|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
56880318|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56880319|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56880320|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880321|NCT03987074|Firsocostat|firsocostat|mesh-list
56880322|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880323|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880324|NCT05761366|PSMA-BCH|psma-bch|mesh-list
56880325|NCT05761366|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56880326|NCT05761366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880327|NCT05302466|Silicon|silicon|mesh-list
56880328|NCT05302466|Trace Elements|trace elements|mesh-ancestor
56880329|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
56394860|NCT02927353|Adalimumab|adalimumab|mesh-list
56880330|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880331|NCT05203588|Vitamin D|vitamin d|mesh-list
56880332|NCT05203588|Denosumab|denosumab|mesh-list
56880333|NCT05203588|Calcium|calcium|mesh-list
56880334|NCT05203588|Vitamins|vitamins|mesh-ancestor
56880335|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
56880336|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880337|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56880338|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56880339|NCT05203354|Acitretin|acitretin|mesh-list
56880340|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
56880341|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
56880342|NCT04439214|Nivolumab|nivolumab|mesh-list
56880343|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880344|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880345|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56880346|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880347|NCT03754062|Haloperidol|haloperidol|mesh-list
56880348|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
56880349|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
56880350|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
56880351|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880352|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880353|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56880354|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56880355|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56880356|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880357|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56880358|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56880359|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
56880360|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880361|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880362|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56880363|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
56880364|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
56880365|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56880366|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880367|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56880368|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56880369|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56880370|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56880371|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880372|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880373|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880374|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
56880375|NCT05180032|Denosumab|denosumab|mesh-list
56880376|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56880377|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880378|NCT05761132|Pembrolizumab|pembrolizumab|mesh-list
56880379|NCT05761132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880380|NCT05761132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880381|NCT04411680|Sargramostim|sargramostim|mesh-list
56880382|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
56880383|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880384|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
56880385|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
56880386|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
56880387|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56880388|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56880389|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880390|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880391|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880392|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880393|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56880394|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880395|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56880396|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880397|NCT05760976|Cisatracurium|cisatracurium|mesh-list
56880398|NCT05760976|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56880399|NCT05760976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56880400|NCT05760976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880401|NCT05760976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880402|NCT05324358|Ketorolac|ketorolac|mesh-list
56880403|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56880405|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56880406|NCT05324358|Narcotics|narcotics|mesh-ancestor
56880407|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880408|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880409|NCT05324358|Analgesics|analgesics|mesh-ancestor
56880410|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
56880411|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880412|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56880413|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56880414|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56880415|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880416|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56880417|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880418|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880419|NCT05384496|Nivolumab|nivolumab|mesh-list
56880420|NCT05384496|Ipilimumab|ipilimumab|mesh-list
56880421|NCT05384496|Axitinib|axitinib|mesh-list
56880422|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880423|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880424|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56880425|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880426|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56880427|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880428|NCT03747978|Amlodipine|amlodipine|mesh-list
56880429|NCT03747978|Perindopril|perindopril|mesh-list
56880430|NCT03747978|Indapamide|indapamide|mesh-list
56880431|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
56880432|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56880433|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56880434|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56880435|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880436|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56880437|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880438|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
56880439|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56880440|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
56880441|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880442|NCT03747978|Diuretics|diuretics|mesh-ancestor
56880443|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
56880444|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56880445|NCT04603846|Paclitaxel|paclitaxel|mesh-list
56880446|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56880447|NCT04603846|Antibodies|antibodies|mesh-list
56880448|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56880449|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880450|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
56880451|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56880452|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
56880453|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880454|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
56880455|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880456|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
56880457|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56880458|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56880459|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56880460|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56880461|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880462|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
56880463|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880464|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880465|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56880466|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880468|NCT04578106|Pertuzumab|pertuzumab|mesh-list
56880469|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880470|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880471|NCT04472182|Calcium|calcium|mesh-list
56880472|NCT04472182|Fluorides|fluorides|mesh-list
56880473|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
56880474|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56880475|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880476|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
56880477|NCT04472182|Protective Agents|protective agents|mesh-ancestor
56880478|NCT03772314|Modafinil|modafinil|mesh-list
56880479|NCT03772314|Amphetamine|amphetamine|mesh-list
56880480|NCT03772314|Adderall|adderall|mesh-list
56880481|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
56880482|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56880483|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880484|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56880485|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56880486|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56880487|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880488|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
56880489|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
56880490|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880491|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
56880492|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880493|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
56880494|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56880495|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56880496|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56880497|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56880498|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
56880499|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56880500|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880501|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56880502|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56880503|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880504|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880505|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880506|NCT05759416|Melatonin|melatonin|mesh-list
56880507|NCT05759416|Antioxidants|antioxidants|mesh-ancestor
56880508|NCT05759416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880509|NCT05759416|Protective Agents|protective agents|mesh-ancestor
56880510|NCT05759416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880511|NCT05759416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880512|NCT04165824|Edaravone|edaravone|mesh-list
56880513|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56880514|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
56880515|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880516|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56880517|NCT04165824|Protective Agents|protective agents|mesh-ancestor
56880518|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880519|NCT03746340|Propofol|propofol|mesh-list
56880520|NCT03746340|Sevoflurane|sevoflurane|mesh-list
56880521|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56880522|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880523|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880524|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56880525|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
56880526|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
56880527|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56880528|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56880529|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
56880530|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
56880531|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56880532|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880533|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880534|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
56880535|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56880536|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880537|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880538|NCT04161144|Sirolimus|sirolimus|mesh-list
56880539|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56880540|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880541|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56880542|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880543|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
56880544|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880545|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
56880546|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880547|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56880548|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880549|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880550|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
56904733|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880551|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880552|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880554|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56880555|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880556|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
56880557|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880558|NCT04153188|Phenylephrine|phenylephrine|mesh-list
56880559|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
56880560|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56880561|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56880562|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
56880563|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880564|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880565|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880566|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
56880567|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
56880568|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880569|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
56880570|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56880571|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
56880572|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56880573|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
56880574|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56880575|NCT04153188|Protective Agents|protective agents|mesh-ancestor
56880576|NCT03611010|Atorvastatin|atorvastatin|mesh-list
56880577|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56880578|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56880579|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
56880580|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880581|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56880582|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56880583|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880584|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
56880585|NCT03749850|Doxorubicin|doxorubicin|mesh-list
56880586|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56880587|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880588|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
56880589|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880590|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880591|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56880592|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
56880593|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880594|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880595|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56880596|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56880597|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56880598|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56880599|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880600|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
56880601|NCT04357782|Vitamins|vitamins|mesh-ancestor
56880602|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
56880603|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880604|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
56880605|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880606|NCT04357782|Protective Agents|protective agents|mesh-ancestor
56880607|NCT03980522|Rilonacept|rilonacept|mesh-list
56880608|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56880609|NCT04400682|Favipiravir|favipiravir|mesh-list
56880610|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
56880611|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880612|NCT03066778|Carboplatin|carboplatin|mesh-list
56880613|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
56880614|NCT03066778|Etoposide|etoposide|mesh-list
56880615|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880616|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880617|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56880618|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56880619|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56880620|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880621|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880622|NCT04136548|Fentanyl|fentanyl|mesh-list
56880623|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56880624|NCT04136548|Narcotics|narcotics|mesh-ancestor
56880625|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880626|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880627|NCT04136548|Analgesics|analgesics|mesh-ancestor
56880628|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
56880629|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880630|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56880631|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56880632|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
56880633|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
56880634|NCT04347954|Iodine|iodine|mesh-list
56880635|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
56880636|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
56880637|NCT04347954|Povidone|povidone|mesh-list
56880638|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56880639|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880640|NCT04347954|Trace Elements|trace elements|mesh-ancestor
56880641|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
56880642|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880643|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
56880644|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
56880645|NCT01565200|Trastuzumab|trastuzumab|mesh-list
56880646|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56880647|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880648|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880649|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56880650|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56880651|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56880652|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880653|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
56880654|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56880655|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880656|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880657|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56880658|NCT03065530|Analgesics|analgesics|mesh-ancestor
56880659|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
56880660|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880661|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56880662|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56880663|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56880664|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
56880665|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880666|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880667|NCT05757544|Ganaxolone|ganaxolone|mesh-list
56880668|NCT05757544|Neurosteroids|neurosteroids|mesh-ancestor
56880669|NCT05757544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880670|NCT05757544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880671|NCT05757544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880672|NCT05757544|GABA Modulators|gaba modulators|mesh-ancestor
56880673|NCT05757544|GABA Agents|gaba agents|mesh-ancestor
56880674|NCT03979820|Phenelzine|phenelzine|mesh-list
56880675|NCT03979820|Tyramine|tyramine|mesh-list
56880676|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
56880677|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56880678|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56880679|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880680|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880681|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
56880682|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
56880683|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880684|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880685|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56880686|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56880687|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56880688|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
56880689|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880690|NCT03647488|Docetaxel|docetaxel|mesh-list
56880691|NCT03647488|Spartalizumab|spartalizumab|mesh-list
56880692|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880693|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
56880694|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
56880695|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
56880696|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880697|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56880698|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
56880699|NCT03693950|Hematinics|hematinics|mesh-ancestor
56880700|NCT03579160|Timolol|timolol|mesh-list
56880701|NCT03579160|Petrolatum|petrolatum|mesh-list
56880702|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56880703|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56880704|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
56880705|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880706|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880707|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880708|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56880709|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56880710|NCT03579160|Emollients|emollients|mesh-ancestor
56880711|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
56880712|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
56880713|NCT03531736|Fludarabine|fludarabine|mesh-list
56880714|NCT03531736|Rituximab|rituximab|mesh-list
56880715|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56880716|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
56880717|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880718|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
56880719|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880720|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880721|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56880722|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
56880723|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880724|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880725|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56880726|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880727|NCT04109456|Atezolizumab|atezolizumab|mesh-list
56880728|NCT04109456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880729|NCT04109222|Vaccines|vaccines|mesh-list
56880730|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
56880731|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880732|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
56880733|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880734|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880735|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
56880736|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56880737|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56880738|NCT03745664|Prednisolone|prednisolone|mesh-list
56880739|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
56880740|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56880741|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
56880742|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56880743|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
56880744|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
56880745|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880746|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880747|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56880748|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
56880749|NCT03745664|Hormones|hormones|mesh-ancestor
56880750|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56880751|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56880752|NCT03745664|Protective Agents|protective agents|mesh-ancestor
56880753|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56880754|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880755|NCT03447262|Ivacaftor|ivacaftor|mesh-list
56880756|NCT03447262|VX-659|vx-659|mesh-list
56880757|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56880758|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56880759|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880760|NCT04094870|Sertraline|sertraline|mesh-list
56880761|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
56880762|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56880763|NCT04094870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56880764|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56880765|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56880766|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880767|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880768|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
56880769|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880770|NCT04399356|Niclosamide|niclosamide|mesh-list
56880771|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
56880772|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56880773|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
56880774|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56880775|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880776|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
56880777|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
56880778|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56880779|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
56880780|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880781|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880782|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56880783|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
56880784|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
56880785|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56880786|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
56880787|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880788|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880789|NCT04118166|Nivolumab|nivolumab|mesh-list
56880790|NCT04118166|Ipilimumab|ipilimumab|mesh-list
56880791|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880792|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880793|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56880794|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880795|NCT04346628|Favipiravir|favipiravir|mesh-list
56880796|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
56880797|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880798|NCT03681470|Dapsone|dapsone|mesh-list
56880799|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880800|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
56880801|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56880802|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56880803|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56880804|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880805|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880806|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
56880807|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56880808|NCT02414750|Vemurafenib|vemurafenib|mesh-list
56880809|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880810|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56880811|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880812|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880813|NCT04343976|Interferons|interferons|mesh-list
56880814|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880815|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
56880816|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880817|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
56880818|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880819|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880820|NCT03311308|Metformin|metformin|mesh-list
56880821|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
56880822|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56880823|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880824|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880826|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
56880827|NCT02909452|Entinostat|entinostat|mesh-list
56880828|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880829|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880830|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56880831|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880832|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880833|NCT05753644|Ropivacaine|ropivacaine|mesh-list
56880834|NCT05753644|Anesthetics, Local|anesthetics, local|mesh-ancestor
56880835|NCT05753644|Anesthetics|anesthetics|mesh-ancestor
56880836|NCT05753644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880837|NCT05753644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880838|NCT05753644|Sensory System Agents|sensory system agents|mesh-ancestor
56880839|NCT05753644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880840|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56880841|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
56880842|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880843|NCT01935466|Pioglitazone|pioglitazone|mesh-list
56880844|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56880845|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880846|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
56880847|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
56880848|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56880849|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56880850|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880851|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880852|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880853|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880854|NCT04399122|Acetaminophen|acetaminophen|mesh-list
56880855|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56880856|NCT04399122|Oxycodone|oxycodone|mesh-list
56880857|NCT04399122|Codeine|codeine|mesh-list
56880858|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56880859|NCT04399122|Analgesics|analgesics|mesh-ancestor
56880860|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
56880861|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880862|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880863|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
56880864|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56880865|NCT04399122|Narcotics|narcotics|mesh-ancestor
56880866|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880867|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
56880868|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
56880869|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56880870|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56880871|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880872|NCT00826462|Triamcinolone|triamcinolone|mesh-list
56880873|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56880874|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56880875|NCT00826462|Naproxen|naproxen|mesh-list
56880876|NCT00826462|Lidocaine|lidocaine|mesh-list
56880877|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56880878|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
56880879|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
56880880|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880881|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880882|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
56880883|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880884|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56880885|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56880886|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56880887|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56880888|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880889|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56880890|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
56880891|NCT00826462|Hormones|hormones|mesh-ancestor
56568621|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880892|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56880893|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880894|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
56880895|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880896|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56880897|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56880898|NCT00826462|Analgesics|analgesics|mesh-ancestor
56880899|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880900|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
56880901|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56880902|NCT04398732|Etanercept|etanercept|mesh-list
56880903|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56880904|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56880905|NCT04398732|Analgesics|analgesics|mesh-ancestor
56880906|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
56880907|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880908|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880909|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56880910|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56880911|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56880912|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880913|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
56880914|NCT04322682|Colchicine|colchicine|mesh-list
56880915|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
56880916|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591674|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880917|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
56880918|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
56880919|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
56880920|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880921|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880922|NCT04322526|Naltrexone|naltrexone|mesh-list
56880923|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56880924|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56880925|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880926|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
56880927|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56880928|NCT05743036|Cetuximab|cetuximab|mesh-list
56880929|NCT05743036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880930|NCT05743036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880931|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
56880932|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56880933|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
56880934|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880935|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
56880936|NCT04115358|Protective Agents|protective agents|mesh-ancestor
56880937|NCT05668884|Gemcitabine|gemcitabine|mesh-list
56880938|NCT05668884|Oxaliplatin|oxaliplatin|mesh-list
56880939|NCT05668884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56880940|NCT05668884|Antimetabolites|antimetabolites|mesh-ancestor
56880941|NCT05668884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880942|NCT05668884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880943|NCT05668884|Antiviral Agents|antiviral agents|mesh-ancestor
56880944|NCT05668884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880945|NCT05668884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880946|NCT05668884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880947|NCT05668884|Immunologic Factors|immunologic factors|mesh-ancestor
56880948|NCT05668884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880949|NCT05187208|Niraparib|niraparib|mesh-list
56880950|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56880951|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880952|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880953|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880954|NCT05081206|Propofol|propofol|mesh-list
56880955|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56880956|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56880957|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880964|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880965|NCT05734690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56880966|NCT05734690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56880967|NCT05734690|Adrenergic Agents|adrenergic agents|mesh-ancestor
56880968|NCT05734690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56880969|NCT05734690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880970|NCT05734690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880971|NCT04690192|Gemcitabine|gemcitabine|mesh-list
56880972|NCT04690192|Melphalan|melphalan|mesh-list
56880973|NCT04690192|Busulfan|busulfan|mesh-list
56880974|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56880975|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
56880976|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56880977|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56880978|NCT04690192|Antiviral Agents|antiviral agents|mesh-ancestor
56880979|NCT04690192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880980|NCT04690192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880981|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56880982|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
56880983|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56880984|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56880985|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
56880986|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56880987|NCT05730712|Trastuzumab|trastuzumab|mesh-list
56880988|NCT05730712|Pertuzumab|pertuzumab|mesh-list
56880989|NCT05730712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56880990|NCT05730712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591749|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56880996|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
56880998|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56880999|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
56881000|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881001|NCT04543968|Protective Agents|protective agents|mesh-ancestor
56881002|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881003|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56881004|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56881005|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
56881006|NCT04503148|Propofol|propofol|mesh-list
56881007|NCT04503148|Anesthetics|anesthetics|mesh-list
56881008|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
56881009|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
56881010|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56881011|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881012|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881013|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56881014|NCT04368910|Artesunate|artesunate|mesh-list
56881015|NCT04368910|Chloroquine|chloroquine|mesh-list
56881016|NCT04368910|Pyronaridine|pyronaridine|mesh-list
56881017|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
56881018|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56881019|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56881020|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881021|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881022|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
56881023|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
56881024|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56881025|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
56881026|NCT04368910|Amebicides|amebicides|mesh-ancestor
56881027|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56881028|NCT04249258|Dobutamine|dobutamine|mesh-list
56881029|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56881030|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
56881031|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
56881032|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881033|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881034|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56881035|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56881036|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56881037|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
56881038|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881039|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881040|NCT04249258|Protective Agents|protective agents|mesh-ancestor
56881042|NCT04235608|Sevoflurane|sevoflurane|mesh-list
56881043|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56881044|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881045|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881046|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56881047|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
56881048|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
56881049|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56881050|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56881051|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
56881052|NCT03938584|Vitamins|vitamins|mesh-ancestor
56881053|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
56881054|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881055|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
56881056|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881057|NCT03938584|Protective Agents|protective agents|mesh-ancestor
56881058|NCT03619876|Adalimumab|adalimumab|mesh-list
56881059|NCT03619876|Abatacept|abatacept|mesh-list
56881060|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881061|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56881062|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56881063|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881064|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881065|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56881066|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
56881067|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881068|NCT03269344|Gabapentin|gabapentin|mesh-list
56881069|NCT03269344|Analgesics|analgesics|mesh-ancestor
56881070|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
56881071|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881072|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881073|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
56881074|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56881075|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56881076|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881077|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56881078|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56881079|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56881080|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881081|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881082|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
56881083|NCT04389840|Heparin|heparin|mesh-list
56881084|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
56881085|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56881086|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56881087|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881088|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
56881089|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881090|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
56881091|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56881092|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881093|NCT04307940|Acetaminophen|acetaminophen|mesh-list
56881094|NCT04307940|Naproxen|naproxen|mesh-list
56881095|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56881096|NCT04307940|Hydrocodone|hydrocodone|mesh-list
56881097|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56881098|NCT04307940|Analgesics|analgesics|mesh-ancestor
56881099|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
56881100|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881101|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881102|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
56881103|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56881104|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881105|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56881106|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
56881107|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56881108|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881109|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881110|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56881111|NCT04307940|Narcotics|narcotics|mesh-ancestor
56881112|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881113|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
56881114|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
56881115|NCT02717416|Hemostatics|hemostatics|mesh-list
56881116|NCT02717416|Coagulants|coagulants|mesh-ancestor
56881117|NCT02054104|Celecoxib|celecoxib|mesh-list
56881118|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
56881119|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56881120|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
56881121|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881122|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56881123|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56881124|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
56881125|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881126|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881127|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56881128|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56881129|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56881130|NCT02054104|Analgesics|analgesics|mesh-ancestor
56881131|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
56881132|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881133|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881134|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56881135|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56881136|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881137|NCT04331704|Tenofovir|tenofovir|mesh-list
56881138|NCT04331704|Emtricitabine|emtricitabine|mesh-list
56881139|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
56881140|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881141|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56881142|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56881143|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881144|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881145|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56881146|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56881148|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56881149|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56881150|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881151|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881152|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56881153|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56881154|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
56881155|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881156|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
56881157|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56881158|NCT04181476|Protective Agents|protective agents|mesh-ancestor
56881159|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881160|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
56881161|NCT03900754|Oxytocin|oxytocin|mesh-list
56881162|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
56881163|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56881164|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881165|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56881166|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56881167|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881168|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881169|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56881170|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56881171|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881172|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
56881173|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881174|NCT03854110|Gemcitabine|gemcitabine|mesh-list
56881175|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56881176|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
56881177|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881178|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881179|NCT03854110|Antiviral Agents|antiviral agents|mesh-ancestor
56881180|NCT03854110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881181|NCT03854110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881182|NCT03854110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56881183|NCT03854110|Immunologic Factors|immunologic factors|mesh-ancestor
56881184|NCT03854110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881185|NCT04292730|Remdesivir|remdesivir|mesh-list
56881186|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
56881187|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881188|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
56881189|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881190|NCT04330248|Carbamazepine|carbamazepine|mesh-list
56881191|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
56881192|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
56881193|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56881194|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881195|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881196|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56881197|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56881198|NCT04330248|Analgesics|analgesics|mesh-ancestor
56881199|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
56881200|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881201|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56881202|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56881203|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881204|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56881205|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56881206|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
56881207|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
56881208|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881209|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
56881210|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881211|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56881212|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881213|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881214|NCT02737306|Leronlimab|leronlimab|mesh-list
56881215|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56881216|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56881217|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881218|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56591972|NCT00734929|Dexamethasone|dexamethasone|mesh-list
56881219|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56881220|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
56881221|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881222|NCT02728648|Oxycodone|oxycodone|mesh-list
56881223|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56881225|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881226|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881227|NCT02728648|Analgesics|analgesics|mesh-ancestor
56881228|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
56881229|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881230|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56881231|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
56881232|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
56881233|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881234|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881235|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
56881236|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881237|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56881238|NCT04273776|Zolpidem|zolpidem|mesh-list
56881239|NCT04273776|Suvorexant|suvorexant|mesh-list
56881240|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56881241|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56881242|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881243|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881244|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56881245|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
56881246|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
56881247|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881248|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881249|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56881250|NCT05676112|Pirfenidone|pirfenidone|mesh-list
56881251|NCT05676112|Nintedanib|nintedanib|mesh-list
56881252|NCT05676112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881253|NCT05676112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56881254|NCT05676112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881255|NCT05676112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881256|NCT05676112|Analgesics|analgesics|mesh-ancestor
56881257|NCT05676112|Sensory System Agents|sensory system agents|mesh-ancestor
56881258|NCT05676112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881259|NCT05676112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881260|NCT05676112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56881261|NCT05676112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56881262|NCT05676112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881263|NCT05676112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56881264|NCT01971970|Adalimumab|adalimumab|mesh-list
56881265|NCT01971970|Infliximab|infliximab|mesh-list
56881266|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881267|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56881268|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
56881269|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881270|NCT01161394|Pioglitazone|pioglitazone|mesh-list
56881271|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56881272|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881273|NCT00921856|Acetylcholine|acetylcholine|mesh-list
56881274|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
56881275|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56881276|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
56881277|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881278|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881279|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881280|NCT03749226|Aztreonam|aztreonam|mesh-list
56881281|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56881282|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881283|NCT04259346|Ixekizumab|ixekizumab|mesh-list
56881284|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
56881285|NCT03745404|Lidocaine|lidocaine|mesh-list
56881286|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
56881287|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
56395888|NCT05564039|Dulaglutide|dulaglutide|mesh-list
56395889|NCT05564039|Tirzepatide|tirzepatide|mesh-list
56395890|NCT05564039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56395891|NCT05564039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881288|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881289|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881290|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
56881291|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881292|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56881293|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56881294|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56881295|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56881296|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881297|NCT01348100|Iloperidone|iloperidone|mesh-list
56881298|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56881299|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56881300|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881301|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881302|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56881303|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
56881304|NCT03673670|Olodaterol|olodaterol|mesh-list
56881305|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56881306|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
56881307|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881308|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881309|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56881310|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
56881311|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
56881312|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56881313|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
56881314|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881315|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881316|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
56881317|NCT04369742|Calcium|calcium|mesh-list
56881318|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56881319|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881320|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881321|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
56881322|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56881323|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56881324|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881325|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881326|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56881327|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
56881328|NCT03745586|Hormones|hormones|mesh-ancestor
56881329|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881330|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881331|NCT03055936|Levodopa|levodopa|mesh-list
56881332|NCT03055936|Carbidopa|carbidopa|mesh-list
56881333|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56881334|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56881335|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
56881336|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881337|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881338|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881339|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56881340|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881341|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
56881342|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
56881343|NCT05215366|Coagulants|coagulants|mesh-ancestor
56881344|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56881345|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56881346|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
56881347|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881348|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56881349|NCT03891524|Enoxaparin|enoxaparin|mesh-list
56881350|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
56881351|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56881352|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56881353|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881354|NCT04695652|Somatomedin B|somatomedin b|mesh-list
56881355|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56881356|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56881357|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
56881358|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881359|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881360|NCT04576078|Nefopam|nefopam|mesh-list
56881361|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56881362|NCT04576078|Analgesics|analgesics|mesh-ancestor
56881363|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
56881364|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881365|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881366|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
56881367|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56881368|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56881369|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881370|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
56881371|NCT04489108|Coagulants|coagulants|mesh-ancestor
56881372|NCT03771586|Ketamine|ketamine|mesh-list
56881373|NCT03771586|Analgesics|analgesics|mesh-ancestor
56881374|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
56881375|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881376|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881377|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56881378|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56881379|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
56881380|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
56881381|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881382|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56881383|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56881384|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881385|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881386|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
56881387|NCT02335060|Dronabinol|dronabinol|mesh-list
56881388|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56881389|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
56881390|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881391|NCT02335060|Expectorants|expectorants|mesh-ancestor
56881392|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
56881393|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56881394|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
56881395|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881396|NCT02335060|Protective Agents|protective agents|mesh-ancestor
56881397|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881398|NCT02335060|Antidotes|antidotes|mesh-ancestor
56881399|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
56881400|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56881401|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56881402|NCT02335060|Analgesics|analgesics|mesh-ancestor
56881403|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
56881404|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881405|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56881406|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56881407|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881408|NCT02335060|Hormones|hormones|mesh-ancestor
56881409|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881410|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
56881411|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881412|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
56881413|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881414|NCT04075604|Nivolumab|nivolumab|mesh-list
56881415|NCT04075604|Palbociclib|palbociclib|mesh-list
56881416|NCT04075604|Anastrozole|anastrozole|mesh-list
56881417|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56881418|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881419|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56881420|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881421|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56881422|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881423|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56881424|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56881425|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56881426|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56881427|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
56881428|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881429|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881431|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56881432|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56881433|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56881434|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56881435|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56881436|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
56881437|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881438|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881439|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881440|NCT05217238|Remifentanil|remifentanil|mesh-list
56592194|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56904497|NCT04401579|Remdesivir|remdesivir|mesh-list
56881441|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56881442|NCT05217238|Narcotics|narcotics|mesh-ancestor
56881443|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881444|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881445|NCT05217238|Analgesics|analgesics|mesh-ancestor
56881446|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
56881447|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881448|NCT05217160|Morphine|morphine|mesh-list
56881449|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56881450|NCT05217160|Narcotics|narcotics|mesh-ancestor
56881451|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881452|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881453|NCT05217160|Analgesics|analgesics|mesh-ancestor
56881454|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
56881455|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881456|NCT01495676|Gemcitabine|gemcitabine|mesh-list
56881457|NCT01495676|Cisplatin|cisplatin|mesh-list
56881458|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881459|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56881460|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
56881461|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881462|NCT01495676|Antiviral Agents|antiviral agents|mesh-ancestor
56881463|NCT01495676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881464|NCT01495676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881465|NCT01495676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56881466|NCT01495676|Immunologic Factors|immunologic factors|mesh-ancestor
56881467|NCT01495676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881468|NCT05065294|Psilocybin|psilocybin|mesh-list
56881469|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56881470|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
56881471|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881472|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56881473|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56881474|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
56881475|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881476|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881477|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56881478|NCT05662228|Lorazepam|lorazepam|mesh-list
56881479|NCT05662228|Immunoglobulins|immunoglobulins|mesh-list
56881480|NCT05662228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56881481|NCT05662228|Antibodies|antibodies|mesh-list
56881482|NCT05662228|gamma-Globulins|gamma-globulins|mesh-list
56881483|NCT05662228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56881484|NCT05662228|Tofacitinib|tofacitinib|mesh-list
56881485|NCT05662228|Immunologic Factors|immunologic factors|mesh-ancestor
56881486|NCT05662228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881487|NCT05662228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56881488|NCT05662228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881489|NCT05662228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881490|NCT05662228|Anticonvulsants|anticonvulsants|mesh-ancestor
56881491|NCT05662228|Antiemetics|antiemetics|mesh-ancestor
56881492|NCT05662228|Autonomic Agents|autonomic agents|mesh-ancestor
56881493|NCT05662228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881494|NCT05662228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881495|NCT05662228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56881496|NCT05662228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881497|NCT05662228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56881498|NCT05662228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56881499|NCT05662228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56881500|NCT05662228|GABA Modulators|gaba modulators|mesh-ancestor
56881501|NCT05662228|GABA Agents|gaba agents|mesh-ancestor
56881502|NCT05662228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881503|NCT05052970|Dexamethasone|dexamethasone|mesh-list
56881504|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
56881506|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
56881507|NCT05052970|BB 1101|bb 1101|mesh-list
56881508|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881509|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
56881510|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
56881511|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881512|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881513|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881514|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
56881515|NCT05052970|Hormones|hormones|mesh-ancestor
56881516|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881517|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56881518|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881519|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
56881520|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881521|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881523|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
56881524|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56881525|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56881526|NCT04903210|Niacinamide|niacinamide|mesh-list
56881527|NCT04903210|Niacin|niacin|mesh-list
56881528|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
56881529|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
56881530|NCT04903210|Vitamins|vitamins|mesh-ancestor
56881531|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
56881532|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881533|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56881534|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
56881535|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881536|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56881537|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
56881538|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
56881539|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56881540|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56881541|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
56881542|NCT04719208|Listerine|listerine|mesh-list
56881543|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56881544|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56881545|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881546|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
56881547|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
56881548|NCT04701190|Norepinephrine|norepinephrine|mesh-list
56881549|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881550|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56881551|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56881552|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
56881553|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881554|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881555|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
56881556|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
56881557|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881558|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56881559|NCT04496362|Heparin|heparin|mesh-list
56881560|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
56881562|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56881563|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881564|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
56881565|NCT04423588|Lansoprazole|lansoprazole|mesh-list
56881566|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56881567|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881568|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56881569|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881570|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881571|NCT05659576|Sucralfate|sucralfate|mesh-list
56881572|NCT05659576|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56881573|NCT05659576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881574|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
56881575|NCT04090684|Celecoxib|celecoxib|mesh-list
56881576|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56881577|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56881578|NCT04090684|Analgesics|analgesics|mesh-ancestor
56881579|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
56881580|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881581|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881582|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881583|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56881584|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56881585|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56881586|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881587|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881588|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56881589|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881590|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56881591|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56881592|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881593|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56881594|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56881595|NCT04963816|Dexamethasone|dexamethasone|mesh-list
56881596|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
56881597|NCT04963816|Bupivacaine|bupivacaine|mesh-list
56881598|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56881599|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56881600|NCT04963816|BB 1101|bb 1101|mesh-list
56881601|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881602|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
56881603|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
56881604|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881605|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881606|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881607|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
56881608|NCT04963816|Hormones|hormones|mesh-ancestor
56881609|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881610|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56881611|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881612|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
56881613|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881614|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881615|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
56881616|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
56881617|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881618|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
56881619|NCT05641324|Dexamethasone|dexamethasone|mesh-list
56881620|NCT05641324|Lenalidomide|lenalidomide|mesh-list
56881621|NCT05641324|Daratumumab|daratumumab|mesh-list
56881622|NCT05641324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881623|NCT05641324|Antiemetics|antiemetics|mesh-ancestor
56881624|NCT05641324|Autonomic Agents|autonomic agents|mesh-ancestor
56881625|NCT05641324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881626|NCT05641324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881627|NCT05641324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881628|NCT05641324|Glucocorticoids|glucocorticoids|mesh-ancestor
56881629|NCT05641324|Hormones|hormones|mesh-ancestor
56904626|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881630|NCT05641324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881631|NCT05641324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56881632|NCT05641324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881633|NCT05641324|Immunologic Factors|immunologic factors|mesh-ancestor
56881634|NCT05641324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56881635|NCT05641324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56881636|NCT05641324|Growth Substances|growth substances|mesh-ancestor
56881637|NCT05641324|Growth Inhibitors|growth inhibitors|mesh-ancestor
56881638|NCT04933240|Tamoxifen|tamoxifen|mesh-list
56881639|NCT04933240|Estradiol|estradiol|mesh-list
56881640|NCT04933240|Estrogens|estrogens|mesh-ancestor
56881641|NCT04933240|Hormones|hormones|mesh-ancestor
56881642|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881643|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881644|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56881645|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
56881646|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56881647|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881648|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56881649|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56881650|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56881651|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
56881652|NCT01317940|Vitamin D|vitamin d|mesh-list
56881653|NCT01317940|Calcitriol|calcitriol|mesh-list
56881654|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56881655|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
56881656|NCT01317940|Calcium|calcium|mesh-list
56881657|NCT01317940|Vitamins|vitamins|mesh-ancestor
56881658|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
56881659|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881660|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56881661|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56881662|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881663|NCT01317940|Antacids|antacids|mesh-ancestor
56881664|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881665|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56881666|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56881667|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56881668|NCT05707234|Midazolam|midazolam|mesh-list
56881669|NCT05707234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56881670|NCT05707234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56881671|NCT05707234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881672|NCT05707234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881673|NCT05707234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56881674|NCT05707234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56881676|NCT05707234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56881677|NCT05707234|Anesthetics, General|anesthetics, general|mesh-ancestor
56881678|NCT05707234|Anesthetics|anesthetics|mesh-ancestor
56881679|NCT05707234|GABA Modulators|gaba modulators|mesh-ancestor
56881680|NCT05707234|GABA Agents|gaba agents|mesh-ancestor
56881681|NCT05707234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881682|NCT05707234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881683|NCT05706688|Anesthetics|anesthetics|mesh-list
56881684|NCT05706688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881685|NCT05706688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881686|NCT05706454|Ramatroban|ramatroban|mesh-list
56881687|NCT05706454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56881688|NCT01317550|Minocycline|minocycline|mesh-list
56881689|NCT01317550|Modafinil|modafinil|mesh-list
56881690|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56881691|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881692|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56881693|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881694|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56881695|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56881696|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56881697|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881698|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
56881699|NCT01317472|Lansoprazole|lansoprazole|mesh-list
56881700|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56881701|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881702|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56881703|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881704|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881705|NCT01345630|Ritonavir|ritonavir|mesh-list
56881706|NCT01345630|Darunavir|darunavir|mesh-list
56881707|NCT01345630|Tenofovir|tenofovir|mesh-list
56881708|NCT01345630|Emtricitabine|emtricitabine|mesh-list
56881709|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56881710|NCT01345630|Maraviroc|maraviroc|mesh-list
56881711|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56881712|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56881713|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
56881714|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881715|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881716|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56881717|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56881718|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
56881719|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881720|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56881721|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56881722|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56881723|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56881724|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56881725|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56881726|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56881727|NCT03693612|Paclitaxel|paclitaxel|mesh-list
56881728|NCT03693612|Docetaxel|docetaxel|mesh-list
56881729|NCT03693612|Cetuximab|cetuximab|mesh-list
56881730|NCT03693612|Tremelimumab|tremelimumab|mesh-list
56881731|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56881732|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881733|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
56881734|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56881735|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56881736|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881737|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56881738|NCT03746652|Dexamethasone|dexamethasone|mesh-list
56881739|NCT03746652|Daratumumab|daratumumab|mesh-list
56881740|NCT03746652|Ixazomib|ixazomib|mesh-list
56881741|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881742|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
56881743|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
56881744|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881745|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881746|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881747|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
56881748|NCT03746652|Hormones|hormones|mesh-ancestor
56881749|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881750|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56881751|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881752|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
56881753|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881754|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881755|NCT01562808|Aripiprazole|aripiprazole|mesh-list
56881756|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
56881757|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56881758|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56881759|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56881760|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881761|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881762|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
56881763|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
56881764|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881765|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881766|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56881767|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56881768|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
56881769|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56881770|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56881771|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56881772|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56881773|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
56881774|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56881775|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
56881776|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881777|NCT04067492|Diclofenac|diclofenac|mesh-list
56881778|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56881779|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56881780|NCT04067492|Analgesics|analgesics|mesh-ancestor
56881781|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
56881782|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881783|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881784|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881785|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56881786|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56881787|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881788|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881789|NCT03739112|Vaccines|vaccines|mesh-list
56881790|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
56881791|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881792|NCT04186806|Muramidase|muramidase|mesh-list
56881793|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881794|NCT03748446|Xenon|xenon|mesh-list
56881795|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56881796|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
56881797|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
56881798|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881799|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881800|NCT04036110|Vitamins|vitamins|mesh-list
56881801|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
56881802|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
56881803|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881804|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
56881805|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881806|NCT04036110|Protective Agents|protective agents|mesh-ancestor
56881807|NCT03053050|Selonsertib|selonsertib|mesh-list
56881808|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56881809|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881810|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881811|NCT04369950|Lidocaine|lidocaine|mesh-list
56881812|NCT04369950|Epinephrine|epinephrine|mesh-list
56881813|NCT04369950|Morphine|morphine|mesh-list
56881814|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
56881815|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
56881816|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
56881817|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881818|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881819|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
56881820|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881821|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56881822|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56881823|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56881824|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56881825|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881827|NCT04369950|Narcotics|narcotics|mesh-ancestor
56881828|NCT04369950|Analgesics|analgesics|mesh-ancestor
56881829|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56881830|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56881831|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
56881832|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56881833|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56881834|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56881835|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
56881836|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56881837|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
56881838|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
56881839|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
56881840|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56881841|NCT02955602|Seladelpar|seladelpar|mesh-list
56881842|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56881843|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
56881844|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881845|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56881846|NCT03748290|Pregabalin|pregabalin|mesh-list
56881847|NCT03748290|Analgesics|analgesics|mesh-ancestor
56881848|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
56881849|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881850|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881851|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
56881852|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56881853|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56881854|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881855|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56881856|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56881857|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56881858|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881859|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56881860|NCT03052816|Hydromorphone|hydromorphone|mesh-list
56881861|NCT03052816|Analgesics|analgesics|mesh-ancestor
56881862|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
56881863|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881864|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881865|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56881866|NCT03052816|Narcotics|narcotics|mesh-ancestor
56881867|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881868|NCT05668676|Prednisone|prednisone|mesh-list
56881869|NCT05668676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881870|NCT05668676|Glucocorticoids|glucocorticoids|mesh-ancestor
56881871|NCT05668676|Hormones|hormones|mesh-ancestor
56881872|NCT05668676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881873|NCT05668676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881874|NCT05668676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56881875|NCT05668676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881876|NCT05651074|Omeprazole|omeprazole|mesh-list
56881877|NCT05651074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56881878|NCT05651074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881879|NCT05651074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56881880|NCT05651074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881881|NCT05651074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881882|NCT03738956|Tofacitinib|tofacitinib|mesh-list
56881883|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56881884|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881885|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881886|NCT03738800|Trifarotene|trifarotene|mesh-list
56881887|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
56881888|NCT05609656|Pembrolizumab|pembrolizumab|mesh-list
56881889|NCT05609656|Calcium|calcium|mesh-list
56881890|NCT05609656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56881891|NCT05609656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881892|NCT05609656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56881893|NCT05609656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881894|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
56881895|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56881896|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881897|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56881898|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56881899|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881900|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881901|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881902|NCT05598424|Methylprednisolone|methylprednisolone|mesh-list
56881903|NCT05598424|Glucocorticoids|glucocorticoids|mesh-list
56881904|NCT05598424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881905|NCT05598424|Antiemetics|antiemetics|mesh-ancestor
56881906|NCT05598424|Autonomic Agents|autonomic agents|mesh-ancestor
56881907|NCT05598424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881908|NCT05598424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881909|NCT05598424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56881911|NCT05598424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881912|NCT05598424|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56881913|NCT05598424|Protective Agents|protective agents|mesh-ancestor
56881914|NCT05524168|Gemcitabine|gemcitabine|mesh-list
56881915|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881916|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56881917|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
56881918|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881919|NCT05524168|Antiviral Agents|antiviral agents|mesh-ancestor
56881920|NCT05524168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56881921|NCT05524168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881922|NCT05524168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56881923|NCT05524168|Immunologic Factors|immunologic factors|mesh-ancestor
56881924|NCT05524168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881925|NCT05501860|Carticaine|carticaine|mesh-list
56881926|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
56881927|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
56881928|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56881929|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881930|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
56881931|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56881932|NCT03738176|Triamcinolone|triamcinolone|mesh-list
56881933|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56881934|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
56881935|NCT03738176|Hormones|hormones|mesh-ancestor
56881936|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881937|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881938|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56881939|NCT03051100|Atorvastatin|atorvastatin|mesh-list
56881940|NCT03051100|Ezetimibe|ezetimibe|mesh-list
56881941|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56881942|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56881943|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
56881944|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881945|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56881946|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56881947|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881948|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56881949|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881950|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56881951|NCT05280028|Tibolone|tibolone|mesh-list
56881952|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56881953|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56881954|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
56881955|NCT05280028|Estradiol|estradiol|mesh-list
56881956|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56881957|NCT05280028|Estrogens|estrogens|mesh-ancestor
56881958|NCT05280028|Hormones|hormones|mesh-ancestor
56881959|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56881960|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881961|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56881962|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
56881963|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56881964|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56881965|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56881966|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56881967|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56881968|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56881969|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56881970|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881971|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
56881972|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
56592720|NCT02727309|Apatinib|apatinib|mesh-list
56881973|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56881974|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56881975|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
56881976|NCT05569876|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56881977|NCT05569876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881978|NCT05564650|Azacitidine|azacitidine|mesh-list
56881979|NCT05564650|Decitabine|decitabine|mesh-list
56881980|NCT05564650|Venetoclax|venetoclax|mesh-list
56881981|NCT05564650|Navitoclax|navitoclax|mesh-list
56881982|NCT05564650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56881983|NCT05564650|Antimetabolites|antimetabolites|mesh-ancestor
56881984|NCT05564650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881985|NCT05564650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881986|NCT05564650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881987|NCT01343368|Leuprolide|leuprolide|mesh-list
56881988|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56881989|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
56881990|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56881991|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56881992|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56881993|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56881994|NCT02955212|Upadacitinib|upadacitinib|mesh-list
56881995|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56881996|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56881997|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56881998|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56881999|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56882000|NCT03050398|Letrozole|letrozole|mesh-list
56882001|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882002|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56882003|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56882004|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882005|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882006|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56882007|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882008|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882009|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882010|NCT03626506|Amlodipine|amlodipine|mesh-list
56882011|NCT03626506|Indapamide|indapamide|mesh-list
56882012|NCT03626506|Spironolactone|spironolactone|mesh-list
56882013|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56882014|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56882015|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56882016|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882017|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56882018|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882019|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
56882020|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56882021|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882022|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882023|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56882024|NCT03626506|Diuretics|diuretics|mesh-ancestor
56882025|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
56882026|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56882027|NCT03737708|Adalimumab|adalimumab|mesh-list
56882028|NCT03737708|Methotrexate|methotrexate|mesh-list
56882029|NCT03737708|Abatacept|abatacept|mesh-list
56882030|NCT03737708|Tacrolimus|tacrolimus|mesh-list
56882031|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56882032|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
56882033|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56882034|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882035|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56882036|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
56882037|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882038|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882039|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
56882040|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882041|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56882042|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882043|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
56882044|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56882045|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56882046|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56882047|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56882048|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56882049|NCT05517928|Omeprazole|omeprazole|mesh-list
56882050|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56882051|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56882052|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56882053|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882054|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882055|NCT04052204|Avelumab|avelumab|mesh-list
56882056|NCT04052204|Talazoparib|talazoparib|mesh-list
56882057|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882058|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882059|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56882060|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882061|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882062|NCT04050722|Listerine|listerine|mesh-list
56882063|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
56882064|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
56882065|NCT04050722|Protective Agents|protective agents|mesh-ancestor
56882066|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882067|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56882068|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882069|NCT04049552|Sirolimus|sirolimus|mesh-list
56882070|NCT04049552|Petrolatum|petrolatum|mesh-list
56882072|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882073|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56882074|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882075|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
56882076|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882077|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
56882078|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882079|NCT04049552|Emollients|emollients|mesh-ancestor
56882080|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
56882081|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
56882082|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
56882083|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56882084|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882085|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882086|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
56882087|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
56882088|NCT04093024|Nintedanib|nintedanib|mesh-list
56882089|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882090|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56882091|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882092|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882093|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56882094|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56882095|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56882096|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56882097|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56882098|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
56882099|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56882100|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882101|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882102|NCT03047980|Sirolimus|sirolimus|mesh-list
56882103|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56882104|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553815|NCT04250116|Apixaban|apixaban|mesh-list
56882105|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56882106|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882107|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
56882108|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882109|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
56882110|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882111|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
56882112|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882113|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882114|NCT04022980|Nivolumab|nivolumab|mesh-list
56882115|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882116|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882117|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56882118|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882119|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
56882120|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882121|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882122|NCT03732482|Temozolomide|temozolomide|mesh-list
56882123|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56882124|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
56882125|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882126|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882127|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56882128|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
56882129|NCT03278782|Romidepsin|romidepsin|mesh-list
56882130|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882131|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882132|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882133|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56882134|NCT04047446|Dexamethasone|dexamethasone|mesh-list
56882135|NCT04047446|Bupivacaine|bupivacaine|mesh-list
56882136|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56882137|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
56882138|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
56882139|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882140|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882141|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56882142|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
56882143|NCT04047446|Hormones|hormones|mesh-ancestor
56882144|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882145|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56882146|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882147|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
56882148|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
56882149|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56882150|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
56882151|NCT03271372|Avelumab|avelumab|mesh-list
56882152|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56882153|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882154|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882155|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
56882156|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882157|NCT03049462|Mirabegron|mirabegron|mesh-list
56882158|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882159|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882160|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56882161|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56882162|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56882163|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
56882164|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56882165|NCT03049462|Urological Agents|urological agents|mesh-ancestor
56882166|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
56882167|NCT02782546|Tacrolimus|tacrolimus|mesh-list
56882168|NCT02782546|Lenograstim|lenograstim|mesh-list
56882169|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882170|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
56882171|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882172|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56882173|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882174|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882175|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56904508|NCT03749733|Megestrol|megestrol|mesh-list
56882176|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882177|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56882178|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
56882179|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56882180|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882181|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56882182|NCT03629054|Metformin|metformin|mesh-list
56882183|NCT03629054|Empagliflozin|empagliflozin|mesh-list
56882184|NCT03629054|Linagliptin|linagliptin|mesh-list
56882185|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56882186|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882187|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56882188|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882189|NCT03629054|Incretins|incretins|mesh-ancestor
56882190|NCT03629054|Hormones|hormones|mesh-ancestor
56882191|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882192|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56882193|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
56882194|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882195|NCT02754856|Durvalumab|durvalumab|mesh-list
56882196|NCT02754856|Ipilimumab|ipilimumab|mesh-list
56882197|NCT02754856|Tremelimumab|tremelimumab|mesh-list
56882198|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
56882200|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
56882201|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882202|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882203|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
56882204|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882205|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56882206|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882207|NCT02573896|Lenalidomide|lenalidomide|mesh-list
56882208|NCT02573896|Dinutuximab|dinutuximab|mesh-list
56882209|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
56882210|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882211|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56882212|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56882213|NCT02573896|Growth Substances|growth substances|mesh-ancestor
56882214|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56882215|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882216|NCT03045328|Venetoclax|venetoclax|mesh-list
56882217|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882218|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
56882219|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56882220|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
56882221|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56882222|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882223|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56882224|NCT02278120|Tamoxifen|tamoxifen|mesh-list
56882225|NCT02278120|Letrozole|letrozole|mesh-list
56882226|NCT02278120|Anastrozole|anastrozole|mesh-list
56882227|NCT02278120|Goserelin|goserelin|mesh-list
56882228|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882229|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56882230|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56882231|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882232|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882233|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56882234|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882235|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882236|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882237|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56882238|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56882239|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56882240|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56882241|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56882242|NCT02154490|Nivolumab|nivolumab|mesh-list
56882243|NCT02154490|Ipilimumab|ipilimumab|mesh-list
56882244|NCT02154490|Durvalumab|durvalumab|mesh-list
56882245|NCT02154490|Rilotumumab|rilotumumab|mesh-list
56882246|NCT02154490|Docetaxel|docetaxel|mesh-list
56882247|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56882248|NCT02154490|Palbociclib|palbociclib|mesh-list
56882249|NCT02154490|Tremelimumab|tremelimumab|mesh-list
56882250|NCT02154490|Talazoparib|talazoparib|mesh-list
56882251|NCT02154490|Antibodies|antibodies|mesh-list
56882252|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
56882253|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56882254|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
56882255|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
56882256|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882257|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882258|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
56882259|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
56882260|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
56882261|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882262|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56882263|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56882264|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882265|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56882266|NCT01512316|Cycloserine|cycloserine|mesh-list
56882267|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56882268|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882269|NCT01512316|Renal Agents|renal agents|mesh-ancestor
56882270|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56882271|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
56882272|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56882273|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
56593012|NCT00806260|Ethanol|ethanol|mesh-list
56882274|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882275|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
56882276|NCT01286272|Bortezomib|bortezomib|mesh-list
56882277|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56882278|NCT01286272|Ofatumumab|ofatumumab|mesh-list
56882279|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56882280|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56882281|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882282|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56882283|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
56882284|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882285|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56882286|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
56882287|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
56882288|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882289|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
56882290|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882291|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56882292|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
56882293|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882294|NCT01167712|Paclitaxel|paclitaxel|mesh-list
56882295|NCT01167712|Bevacizumab|bevacizumab|mesh-list
56882296|NCT01167712|Carboplatin|carboplatin|mesh-list
56882297|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56882298|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56882299|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
56882300|NCT01167712|Antibodies|antibodies|mesh-list
56882301|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
56882302|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56882303|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
56882304|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56882305|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882306|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
56882307|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
56882308|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
56882309|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882310|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56882311|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56882312|NCT01167712|Growth Substances|growth substances|mesh-ancestor
56882313|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882314|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
56882315|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
56882316|NCT01048138|Biperiden|biperiden|mesh-list
56882317|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
56882318|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56882319|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56882320|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
56882321|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
56882322|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882323|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882324|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56882325|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56882326|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
56882327|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554031|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
56882328|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882329|NCT00972478|Prednisone|prednisone|mesh-list
56882330|NCT00972478|Cortisone|cortisone|mesh-list
56882331|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
56882332|NCT00972478|Rituximab|rituximab|mesh-list
56882333|NCT00972478|Doxorubicin|doxorubicin|mesh-list
56882334|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56882335|NCT00972478|Vincristine|vincristine|mesh-list
56882336|NCT00972478|Vorinostat|vorinostat|mesh-list
56882337|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56882338|NCT00972478|Antibodies|antibodies|mesh-list
56882339|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
56882340|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56882341|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882342|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
56882343|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882344|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56882345|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56882346|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
56882347|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882348|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593094|NCT04088851|Metformin|metformin|mesh-list
56882349|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56882350|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56882351|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56882352|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56882353|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882354|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56882355|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
56882357|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882358|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56882359|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56882360|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
56882361|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
56882362|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
56882363|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56882364|NCT00823342|Tenofovir|tenofovir|mesh-list
56882365|NCT00823342|Clevudine|clevudine|mesh-list
56882366|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
56882367|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882368|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56882369|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56882370|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882371|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882372|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56882373|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56882374|NCT00310180|Tamoxifen|tamoxifen|mesh-list
56882375|NCT00310180|Letrozole|letrozole|mesh-list
56882376|NCT00310180|Anastrozole|anastrozole|mesh-list
56882377|NCT00310180|Exemestane|exemestane|mesh-list
56882378|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882379|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882380|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56882381|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56882382|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882383|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56882384|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882385|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882386|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882387|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56882388|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56882389|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56882390|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56882391|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
56882392|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56882393|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
56882394|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882395|NCT01082445|Expectorants|expectorants|mesh-ancestor
56882396|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
56882397|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56882398|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
56882399|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882400|NCT01082445|Protective Agents|protective agents|mesh-ancestor
56882401|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882402|NCT01082445|Antidotes|antidotes|mesh-ancestor
56882403|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56882404|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56882405|NCT01085877|Estradiol|estradiol|mesh-list
56882406|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56882407|NCT01085877|Estrogens|estrogens|mesh-ancestor
56882408|NCT01085877|Hormones|hormones|mesh-ancestor
56882409|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882410|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882411|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56882412|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
56882413|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56882414|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56882415|NCT01089855|Carbamazepine|carbamazepine|mesh-list
56882416|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
56882417|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
56882418|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56882419|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56882420|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882421|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56882422|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56882423|NCT01089855|Analgesics|analgesics|mesh-ancestor
56882424|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
56882425|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882426|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56882427|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56882428|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882429|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56882430|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56882431|NCT03980314|Nivolumab|nivolumab|mesh-list
56882432|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882433|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882434|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56882435|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882436|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
56882437|NCT03674320|Testosterone|testosterone|mesh-list
56882438|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
56882439|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
56882440|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56882441|NCT03674320|Androgens|androgens|mesh-ancestor
56882442|NCT03674320|Hormones|hormones|mesh-ancestor
56882443|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882444|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882445|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56882446|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882447|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
56882448|NCT05457946|Vaccines|vaccines|mesh-list
56882449|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
56882450|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882451|NCT03625960|Cantharidin|cantharidin|mesh-list
56882452|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882453|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882454|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
56882455|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
56882456|NCT05457556|Melphalan|melphalan|mesh-list
56882457|NCT05457556|Busulfan|busulfan|mesh-list
56882458|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
56882459|NCT05457556|Thiotepa|thiotepa|mesh-list
56882460|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56882461|NCT05457556|Rituximab|rituximab|mesh-list
56882462|NCT05457556|Methotrexate|methotrexate|mesh-list
56882463|NCT05457556|Fludarabine|fludarabine|mesh-list
56882464|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56882465|NCT05457556|Tacrolimus|tacrolimus|mesh-list
56882466|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
56882467|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56882468|NCT05457556|Antibodies|antibodies|mesh-list
56882469|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
56882470|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56882471|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
56882472|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56882473|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56882474|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882475|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
56904514|NCT03749733|Hormones|hormones|mesh-ancestor
56882476|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882477|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56882478|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56882479|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
56882480|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882481|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882482|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56882483|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56882484|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
56882485|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56882486|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56882487|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
56882488|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56882489|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882490|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56882491|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56882492|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56882493|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56882494|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56882495|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
56882496|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56882497|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882498|NCT03042910|Talazoparib|talazoparib|mesh-list
56882499|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56882500|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882501|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882510|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882512|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56882513|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
56882514|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882515|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
56882516|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882517|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882518|NCT02980666|Teduglutide|teduglutide|mesh-list
56882519|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56882520|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56882521|NCT02980666|Protective Agents|protective agents|mesh-ancestor
56882522|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882523|NCT02962102|Calcitriol|calcitriol|mesh-list
56882524|NCT02962102|Calcifediol|calcifediol|mesh-list
56882525|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56882526|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882527|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56882528|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56882529|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882530|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56882531|NCT02962102|Vitamins|vitamins|mesh-ancestor
56882532|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
56882533|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56882534|NCT02947750|Folic Acid|folic acid|mesh-list
56882535|NCT02947750|Hematinics|hematinics|mesh-ancestor
56882536|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
56882537|NCT02947750|Vitamins|vitamins|mesh-ancestor
56882538|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
56882539|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882540|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
56882541|NCT02630368|Avelumab|avelumab|mesh-list
56882542|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882543|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
56882544|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882545|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56882546|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56882547|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
56882548|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882549|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882550|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56882551|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56317055|NCT00015899|Lonafarnib|lonafarnib|mesh-list
56882568|NCT05244460|Promethazine|promethazine|mesh-list
56882569|NCT05244460|Droperidol|droperidol|mesh-list
56882570|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56882571|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56882572|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56882573|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882574|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
56882575|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
56593314|NCT00248703|Docetaxel|docetaxel|mesh-list
56882576|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
56882577|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882578|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
56882579|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
56882580|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56882581|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56882582|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
56882583|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
56882584|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56882585|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882586|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56882587|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
56882588|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
56882589|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56882590|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56882591|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56882592|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56882593|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56882594|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56882595|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
56882596|NCT00096993|Gemcitabine|gemcitabine|mesh-list
56882597|NCT00096993|Pertuzumab|pertuzumab|mesh-list
56882598|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56882599|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
56882600|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882601|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882602|NCT00096993|Antiviral Agents|antiviral agents|mesh-ancestor
56882603|NCT00096993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882604|NCT00096993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882605|NCT00096993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882606|NCT00096993|Immunologic Factors|immunologic factors|mesh-ancestor
56882607|NCT00096993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882608|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882609|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56882610|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882611|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56882612|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882613|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882614|NCT03040024|Ketamine|ketamine|mesh-list
56882615|NCT03040024|Analgesics|analgesics|mesh-ancestor
56882616|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
56882617|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882618|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882619|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56882620|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56882621|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
56882622|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
56882623|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56882624|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56882625|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56882626|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56882627|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882628|NCT05053126|Pregabalin|pregabalin|mesh-list
56882629|NCT05053126|Oxycodone|oxycodone|mesh-list
56882630|NCT05053126|Analgesics|analgesics|mesh-ancestor
56882631|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
56882632|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882633|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882634|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
56882635|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56882636|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56882637|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882638|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56882639|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56882640|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56882641|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56882642|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56882643|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56882644|NCT05053126|Narcotics|narcotics|mesh-ancestor
56882645|NCT05317000|Nivolumab|nivolumab|mesh-list
56882646|NCT05317000|Azacitidine|azacitidine|mesh-list
56882647|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882648|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593387|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56882649|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56882650|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882651|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56882652|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
56882653|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882654|NCT05292664|Leucovorin|leucovorin|mesh-list
56882655|NCT05292664|Cytarabine|cytarabine|mesh-list
56882656|NCT05292664|Dexamethasone|dexamethasone|mesh-list
56882657|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
56882658|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
56882659|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56882660|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56882661|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56882662|NCT05292664|Cortisone|cortisone|mesh-list
56882663|NCT05292664|Doxorubicin|doxorubicin|mesh-list
56882664|NCT05292664|Methotrexate|methotrexate|mesh-list
56882665|NCT05292664|Vincristine|vincristine|mesh-list
56882666|NCT05292664|Azacitidine|azacitidine|mesh-list
56882667|NCT05292664|Venetoclax|venetoclax|mesh-list
56882668|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
56882669|NCT05292664|Razoxane|razoxane|mesh-list
56882670|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56882671|NCT05292664|BB 1101|bb 1101|mesh-list
56882672|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
56882673|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56882674|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
56882675|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
56882676|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882677|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882678|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56882679|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
56882680|NCT05292664|Hormones|hormones|mesh-ancestor
56882681|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882682|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56882683|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882684|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
56882685|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882686|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882687|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56882688|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56882689|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56882690|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56882691|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
56882692|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56882693|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56882694|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
56882695|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
56882696|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56882697|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882698|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
56882699|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56882700|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56882701|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
56882702|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882703|NCT05292664|Antidotes|antidotes|mesh-ancestor
56882704|NCT05292664|Protective Agents|protective agents|mesh-ancestor
56882705|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
56882706|NCT05292664|Vitamins|vitamins|mesh-ancestor
56882707|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
56882708|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56882709|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
56882710|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
56882711|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
56882712|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56882713|NCT04716946|Durvalumab|durvalumab|mesh-list
56882714|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882715|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882716|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56882717|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56882718|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55895435|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56882719|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882720|NCT03038620|Liraglutide|liraglutide|mesh-list
56882721|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56882722|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882723|NCT03038620|Incretins|incretins|mesh-ancestor
56882724|NCT03038620|Hormones|hormones|mesh-ancestor
56882725|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882726|NCT05203510|Treprostinil|treprostinil|mesh-list
56882727|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56882729|NCT02032810|Panobinostat|panobinostat|mesh-list
56882730|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56882731|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882732|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56882733|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882734|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56882735|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882736|NCT05036278|Factor VIII|factor viii|mesh-list
56882737|NCT05036278|Coagulants|coagulants|mesh-ancestor
56882738|NCT01415674|Afatinib|afatinib|mesh-list
56882739|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882740|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56882741|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882742|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882743|NCT01350934|Vitamin D|vitamin d|mesh-list
56882744|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
56882745|NCT01350934|Alendronate|alendronate|mesh-list
56882746|NCT01350934|Calcitriol|calcitriol|mesh-list
56882747|NCT01350934|Calcium|calcium|mesh-list
56882748|NCT01350934|Vitamins|vitamins|mesh-ancestor
56882749|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
56882750|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882751|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56882752|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56882753|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56882754|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56882755|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882756|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56882757|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56882758|NCT01146418|Hormones|hormones|mesh-ancestor
56882759|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882760|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882761|NCT05654896|Ceftriaxone|ceftriaxone|mesh-list
56882762|NCT05654896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56882763|NCT05654896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882764|NCT00745108|Tibolone|tibolone|mesh-list
56882765|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882766|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56882767|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882768|NCT00745108|Hormones|hormones|mesh-ancestor
56882769|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882770|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
56882771|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882772|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56882773|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56882774|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
56882775|NCT00725374|Tibolone|tibolone|mesh-list
56882776|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
56882777|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882778|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882779|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882780|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56882781|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56882782|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882783|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56882784|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
56882785|NCT00725374|Hormones|hormones|mesh-ancestor
56882786|NCT03622580|Aflibercept|aflibercept|mesh-list
56882787|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56882788|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56882789|NCT03622580|Growth Substances|growth substances|mesh-ancestor
56882790|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882791|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
56882792|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882793|NCT00461032|Montelukast|montelukast|mesh-list
56882794|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56882795|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
56882796|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56882797|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882798|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882799|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882800|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56882801|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56882802|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882803|NCT00446056|Ketotifen|ketotifen|mesh-list
56882804|NCT00446056|Montelukast|montelukast|mesh-list
56882805|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56882806|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882807|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882808|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
56882809|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56882810|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56882811|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882812|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882813|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56882814|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56882815|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
56882816|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
56882817|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56882818|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
56882819|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
56882820|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56882821|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56882822|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882823|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56882824|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882825|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882826|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56882827|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56882828|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56882829|NCT00092092|Budesonide|budesonide|mesh-list
56882831|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56882832|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56882833|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
56882834|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882835|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882836|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56882837|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
56882838|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
56882840|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882841|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56882842|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882843|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56882844|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56882845|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882846|NCT00092014|Vitamin D|vitamin d|mesh-list
56882847|NCT00092014|Alendronate|alendronate|mesh-list
56882848|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
56882849|NCT00092014|Calcium|calcium|mesh-list
56882850|NCT00092014|Vitamins|vitamins|mesh-ancestor
56882851|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
56882852|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882853|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56882854|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56882855|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56882856|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56882857|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882858|NCT00090142|Montelukast|montelukast|mesh-list
56882859|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56882860|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
56882861|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56882862|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882863|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882864|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882865|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56882866|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56882867|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882868|NCT00043108|Paclitaxel|paclitaxel|mesh-list
56882869|NCT00043108|Carboplatin|carboplatin|mesh-list
56882870|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56882871|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882872|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
56882873|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
56882875|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882876|NCT04985266|Tamoxifen|tamoxifen|mesh-list
56882877|NCT04985266|Letrozole|letrozole|mesh-list
56882878|NCT04985266|Fulvestrant|fulvestrant|mesh-list
56882879|NCT04985266|Palbociclib|palbociclib|mesh-list
56882880|NCT04985266|Anastrozole|anastrozole|mesh-list
56882881|NCT04985266|Exemestane|exemestane|mesh-list
56882882|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882883|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56882884|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56882885|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882886|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882887|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56882888|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
56882889|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56882890|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882891|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56882892|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56882893|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56882894|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56882895|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56882896|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56882897|NCT03619408|Antacids|antacids|mesh-list
56882898|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882899|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56882900|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
56882901|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56882902|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
56882903|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882904|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882905|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
56882906|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882907|NCT03620708|Nicotine|nicotine|mesh-list
56882908|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56882909|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
56882910|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882911|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882912|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56882913|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56882914|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
56882915|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56882916|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882917|NCT03654326|Naproxen|naproxen|mesh-list
56882918|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56882919|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56882920|NCT03654326|Analgesics|analgesics|mesh-ancestor
56882921|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
56882922|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882923|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882924|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56882925|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56882926|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
56882927|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56882928|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882929|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882930|NCT03735446|Cytarabine|cytarabine|mesh-list
56882931|NCT03735446|Etoposide|etoposide|mesh-list
56882932|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
56882933|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56882934|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882935|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56882936|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56882937|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882938|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882939|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56882940|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
56882941|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
56882942|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882943|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882944|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
56882945|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882946|NCT03735446|Analgesics|analgesics|mesh-ancestor
56882947|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
56882948|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882950|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
56882951|NCT03735368|Benoxinate|benoxinate|mesh-list
56882952|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
56882953|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56882954|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882955|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56882956|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56882957|NCT03735368|Analgesics|analgesics|mesh-ancestor
56882958|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
56882959|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56882960|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56882961|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56882962|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56882963|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
56882964|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56882965|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882966|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
56882967|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56882968|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56882969|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56882970|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56882971|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56882972|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56882973|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
56882974|NCT00071799|Cytarabine|cytarabine|mesh-list
56882975|NCT00071799|Azacitidine|azacitidine|mesh-list
56882976|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56882977|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
56882978|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56882979|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882980|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
56882981|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56882982|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56882983|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
56882984|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882985|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56882986|NCT03615482|Vaccines|vaccines|mesh-list
56882987|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
56882988|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882989|NCT03652610|Vaccines|vaccines|mesh-list
56882990|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
56882991|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882992|NCT03615404|Molgramostim|molgramostim|mesh-list
56882993|NCT03615404|Sargramostim|sargramostim|mesh-list
56882994|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
56882995|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56882996|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56882997|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
56882998|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56882999|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
56883000|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883001|NCT03730064|Expectorants|expectorants|mesh-ancestor
56883002|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
56883003|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56883004|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
56883005|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883006|NCT03730064|Protective Agents|protective agents|mesh-ancestor
56883007|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883008|NCT03730064|Antidotes|antidotes|mesh-ancestor
56883009|NCT03580382|Trametinib|trametinib|mesh-list
56883010|NCT03580382|Antibodies|antibodies|mesh-list
56883011|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
56883012|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883013|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904526|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
56883014|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56883015|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883016|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883017|NCT03577730|Caffeine|caffeine|mesh-list
56883018|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
56883019|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883020|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56883021|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883022|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56883023|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883024|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56883025|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56883026|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
56883027|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883028|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
56883029|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56883030|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883031|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
56883032|NCT03735134|Colchicine|colchicine|mesh-list
56883033|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
56883034|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56883035|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
56883036|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
56883037|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
56568684|NCT04515394|Cetuximab|cetuximab|mesh-list
56883038|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883039|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883040|NCT03608774|Azithromycin|azithromycin|mesh-list
56883041|NCT03608774|Doxycycline|doxycycline|mesh-list
56883042|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56883043|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883044|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
56883045|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56883046|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56883047|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
56883048|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56883049|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56883050|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56883051|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883052|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
56883053|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
56883054|NCT03729674|Infliximab|infliximab|mesh-list
56883055|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
56883056|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883057|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56883058|NCT03731468|Dexamethasone|dexamethasone|mesh-list
56883059|NCT03731468|Anesthetics|anesthetics|mesh-list
56883060|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
56883061|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883062|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
56883063|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
56883064|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883065|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883066|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883067|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
56883068|NCT03731468|Hormones|hormones|mesh-ancestor
56883069|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56883070|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56883071|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883072|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883073|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
56883074|NCT03600428|Vaccines|vaccines|mesh-list
56883075|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
56883076|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883077|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56883078|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56883079|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56883080|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
56883081|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883082|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883083|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883084|NCT03575702|Urological Agents|urological agents|mesh-ancestor
56883085|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
56883086|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56883087|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895436|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56883088|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883089|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56883090|NCT03639896|Analgesics|analgesics|mesh-ancestor
56883091|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
56883092|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883093|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56883094|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56883095|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56883096|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
56883097|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883098|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593838|NCT02707809|Analgesics|analgesics|mesh-ancestor
56883099|NCT03573908|Linaclotide|linaclotide|mesh-list
56883100|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56883101|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
56883102|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883103|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883104|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56883105|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56883106|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56883107|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56883108|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397878|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
56883109|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883110|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883111|NCT03729284|Analgesics|analgesics|mesh-ancestor
56883112|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
56883113|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883114|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
56883115|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883116|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
56883117|NCT03729128|Memantine|memantine|mesh-list
56883118|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
56883119|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56883120|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56883121|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
56883122|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883123|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883124|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883125|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56883126|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56883127|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
56883128|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
56883129|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
56883130|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
56883131|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883132|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883133|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883134|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
56883135|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
56883136|NCT03728894|Midazolam|midazolam|mesh-list
56883137|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
56883138|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56883139|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56883140|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883141|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883142|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56883143|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56883144|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883145|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56883146|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
56883147|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
56883148|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
56883149|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
56883150|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883151|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883152|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
56883153|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
56883154|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56883155|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
56883156|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
56883157|NCT03730766|Amoxicillin|amoxicillin|mesh-list
56883158|NCT03730766|Metronidazole|metronidazole|mesh-list
56883159|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
56883160|NCT03730766|Esomeprazole|esomeprazole|mesh-list
56883161|NCT03730766|Bismuth|bismuth|mesh-list
56883162|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883163|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56883164|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883165|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56883166|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56883167|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56883168|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883169|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56883170|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883171|NCT03730766|Antacids|antacids|mesh-ancestor
56883172|NCT03730766|Diuretics|diuretics|mesh-ancestor
56883173|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
56883174|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883175|NCT03730766|Expectorants|expectorants|mesh-ancestor
56883176|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
56883178|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56883179|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
56883180|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883181|NCT03962283|Rifaximin|rifaximin|mesh-list
56883182|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56883183|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883184|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883185|NCT03591146|Ropivacaine|ropivacaine|mesh-list
56883186|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
56883187|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
56883188|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883189|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883190|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
56883191|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883192|NCT00096447|Lapatinib|lapatinib|mesh-list
56883193|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883194|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56883195|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883196|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883197|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56883198|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56883199|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56883200|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56883201|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883202|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883203|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883204|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56883205|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
56883206|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883207|NCT00070941|Citalopram|citalopram|mesh-list
56883208|NCT00070941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56883209|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56883210|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56883211|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883212|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883213|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
56883214|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883215|NCT00070941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56883216|NCT00070941|Antidepressive Agents|antidepressive agents|mesh-ancestor
56883217|NCT00070941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883218|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
56883219|NCT00070707|Albuterol|albuterol|mesh-list
56883220|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56883221|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
56883222|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883223|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883224|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56883225|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
56883226|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
56883227|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56883228|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56883229|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56883230|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56883231|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
56883232|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883233|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883234|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883235|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
56883236|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56883237|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
56883238|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56883239|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883240|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56883241|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883242|NCT00070317|Methylene Blue|methylene blue|mesh-list
56883243|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56883244|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883245|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883246|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56883247|NCT01086345|Bevacizumab|bevacizumab|mesh-list
56883248|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56883249|NCT01086345|Irinotecan|irinotecan|mesh-list
56883250|NCT01086345|Camptothecin|camptothecin|mesh-list
56883251|NCT01086345|Antibodies|antibodies|mesh-list
56883252|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
56883253|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56883254|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883255|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56883256|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56883257|NCT01086345|Growth Substances|growth substances|mesh-ancestor
56883258|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883259|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
56883260|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
56883261|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56883262|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56883263|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883264|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883265|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56883266|NCT01089933|Anesthetics|anesthetics|mesh-list
56883267|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
56883268|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883269|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883270|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
56883271|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883272|NCT03960411|Doxycycline|doxycycline|mesh-list
56883273|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56883274|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883275|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
56883276|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56883277|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56883278|NCT01082679|Buprenorphine|buprenorphine|mesh-list
56883279|NCT01082679|Methadone|methadone|mesh-list
56883280|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56883281|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56883282|NCT01082679|Narcotics|narcotics|mesh-ancestor
56883283|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883284|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883285|NCT01082679|Analgesics|analgesics|mesh-ancestor
56883286|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
56883287|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883288|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56883289|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
56883290|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
56883291|NCT01090167|Clofarabine|clofarabine|mesh-list
56883292|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56883293|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
56883294|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883295|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883296|NCT03587636|Bupivacaine|bupivacaine|mesh-list
56883297|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
56883298|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
56883299|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883300|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883301|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
56883302|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883303|NCT03053362|Vortioxetine|vortioxetine|mesh-list
56883304|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
56883305|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883306|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56883307|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56883308|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883309|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883310|NCT03053362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56883311|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56883312|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56883313|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883314|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883315|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
56883316|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56883317|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56883318|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56883319|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56883320|NCT03733652|Interferons|interferons|mesh-list
56883321|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
56883322|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
56883323|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883324|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
56883325|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883326|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
56883327|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883328|NCT03572582|Nivolumab|nivolumab|mesh-list
56883329|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56883330|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398078|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
56883331|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56883332|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883333|NCT03586544|Albuterol|albuterol|mesh-list
56883334|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56883335|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
56883336|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883337|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883338|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56883339|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
56883340|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
56883341|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56883342|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56883343|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56883344|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56883345|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
56883346|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883347|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883348|NCT03737448|Trimetazidine|trimetazidine|mesh-list
56883349|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
56883350|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56883351|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56883352|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56883353|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56883354|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883355|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883356|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883357|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
56883358|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883359|NCT03728192|Camptothecin|camptothecin|mesh-list
56883360|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56883361|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883362|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56883363|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56883364|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883365|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883366|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56883367|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56883368|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
56883369|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883370|NCT03589768|Antacids|antacids|mesh-ancestor
56883371|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883372|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883373|NCT03733340|Imipenem|imipenem|mesh-list
56883374|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56883375|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883376|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
56883377|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56883378|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883379|NCT05137600|Clarithromycin|clarithromycin|mesh-list
56883380|NCT05137600|Midazolam|midazolam|mesh-list
56883381|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56883382|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56883383|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883384|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883385|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56883386|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56883387|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883388|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56883389|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
56883390|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
56883391|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
56883392|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
56883393|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883394|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883395|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56883396|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883397|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56883398|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883399|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56883400|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56883401|NCT02906332|Dexamethasone|dexamethasone|mesh-list
56883402|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
56883403|NCT02906332|Lenalidomide|lenalidomide|mesh-list
56883404|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883405|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
56883406|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
56883407|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883408|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883409|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883410|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
56883412|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56883413|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56883414|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883415|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56883416|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
56883417|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56883418|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56883419|NCT02906332|Growth Substances|growth substances|mesh-ancestor
56883420|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56883421|NCT00089505|Ritonavir|ritonavir|mesh-list
56883422|NCT00089505|Lopinavir|lopinavir|mesh-list
56883423|NCT00089505|Tenofovir|tenofovir|mesh-list
56883424|NCT00089505|Emtricitabine|emtricitabine|mesh-list
56883425|NCT00089505|Nevirapine|nevirapine|mesh-list
56883426|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56883427|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56883428|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56883429|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
56883430|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883431|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883432|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56883433|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56883434|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
56883435|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883436|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56883437|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56883438|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56883439|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56883440|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56883441|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56883442|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56883443|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56883444|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56904540|NCT01582607|Ropivacaine|ropivacaine|mesh-list
56883445|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
56883446|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883447|NCT04009824|Antacids|antacids|mesh-ancestor
56883448|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883449|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883450|NCT05041426|Valganciclovir|valganciclovir|mesh-list
56883451|NCT05041426|Letermovir|letermovir|mesh-list
56883452|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
56883453|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883454|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56883455|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883456|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883457|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883458|NCT04987372|Lidocaine|lidocaine|mesh-list
56883459|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
56883460|NCT04987372|Pregabalin|pregabalin|mesh-list
56883461|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
56883462|NCT04987372|Ketamine|ketamine|mesh-list
56883463|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
56883464|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
56883465|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883466|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883467|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
56883468|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883469|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56883470|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56883471|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56883472|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56883473|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883474|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56883475|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56883476|NCT04987372|Analgesics|analgesics|mesh-ancestor
56883477|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56883479|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56883480|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
56883481|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883482|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56883483|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56883484|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
56883485|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56883486|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56883487|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
56883488|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56883489|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56883490|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56883491|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56883492|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883493|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
56883494|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56883495|NCT03555890|Cetirizine|cetirizine|mesh-list
56883496|NCT03555890|Levocetirizine|levocetirizine|mesh-list
56883497|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56883498|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56883499|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
56883500|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
56883501|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883502|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883503|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883504|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56883505|NCT04905862|Antipyretics|antipyretics|mesh-list
56883506|NCT04905862|Analgesics|analgesics|mesh-list
56883507|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
56883508|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883509|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883510|NCT03630120|Sorafenib|sorafenib|mesh-list
56883511|NCT03630120|Lenvatinib|lenvatinib|mesh-list
56883512|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883513|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56883514|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883515|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883516|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
56883517|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
56883518|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883519|NCT03744702|Protective Agents|protective agents|mesh-ancestor
56883520|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883521|NCT03744702|Vitamins|vitamins|mesh-ancestor
56883522|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
56883523|NCT04004442|Avelumab|avelumab|mesh-list
56883524|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56883525|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883526|NCT03736980|Psilocybin|psilocybin|mesh-list
56883527|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
56883528|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883529|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883530|NCT03727646|Niacinamide|niacinamide|mesh-list
56883531|NCT03727646|Niacin|niacin|mesh-list
56883532|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
56883533|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
56883534|NCT03727646|Vitamins|vitamins|mesh-ancestor
56883535|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
56883536|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883537|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56883538|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
56883539|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883540|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56883541|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
56883542|NCT05666336|Mycophenolic Acid|mycophenolic acid|mesh-list
56883543|NCT05666336|Hydroxychloroquine|hydroxychloroquine|mesh-list
56883544|NCT05666336|Prednisone|prednisone|mesh-list
56883545|NCT05666336|Methylprednisolone|methylprednisolone|mesh-list
56883546|NCT05666336|Cyclophosphamide|cyclophosphamide|mesh-list
56883547|NCT05666336|Tacrolimus|tacrolimus|mesh-list
56883548|NCT05666336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56883549|NCT05666336|Immunologic Factors|immunologic factors|mesh-ancestor
56883550|NCT05666336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883551|NCT05666336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56883552|NCT05666336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56883553|NCT05666336|Alkylating Agents|alkylating agents|mesh-ancestor
56883554|NCT05666336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883555|NCT05666336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883556|NCT05666336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56883557|NCT05666336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883558|NCT05666336|Glucocorticoids|glucocorticoids|mesh-ancestor
56883559|NCT05666336|Hormones|hormones|mesh-ancestor
56883560|NCT05666336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56883561|NCT05666336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56883562|NCT05666336|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56883563|NCT05666336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883564|NCT05666336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56883565|NCT05666336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56883566|NCT05666336|Antitubercular Agents|antitubercular agents|mesh-ancestor
56883567|NCT05666336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56883568|NCT05666336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883569|NCT05666336|Antiemetics|antiemetics|mesh-ancestor
56883570|NCT05666336|Autonomic Agents|autonomic agents|mesh-ancestor
56883571|NCT05666336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883572|NCT05666336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883573|NCT05666336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56883574|NCT05666336|Protective Agents|protective agents|mesh-ancestor
56883575|NCT05666336|Antimalarials|antimalarials|mesh-ancestor
56883576|NCT05666336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56883577|NCT05666336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56883578|NCT03554486|Insulin|insulin|mesh-list
56883579|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56883580|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
56883581|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
56883582|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56883583|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56883584|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883585|NCT03554018|Acetaminophen|acetaminophen|mesh-list
56883586|NCT03554018|Ibuprofen|ibuprofen|mesh-list
56883587|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56883588|NCT03554018|Analgesics|analgesics|mesh-ancestor
56883589|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
56883590|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883591|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883592|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
56883593|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56883594|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883595|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56883596|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56883597|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883598|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883599|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
56883600|NCT05462938|Propofol|propofol|mesh-list
56883601|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56883602|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883603|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883604|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56883605|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
56883606|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
56883607|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56883608|NCT05462938|Analgesics|analgesics|mesh-ancestor
56883609|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
56883610|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883611|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56883612|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56883613|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56883614|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
56883615|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883616|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883617|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
56883618|NCT04787692|Narcotics|narcotics|mesh-ancestor
56883619|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883620|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883621|NCT04787692|Analgesics|analgesics|mesh-ancestor
56883622|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
56883623|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883624|NCT05462548|Luspatercept|luspatercept|mesh-list
56883625|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56883627|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
56883628|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883629|NCT03408340|Fentanyl|fentanyl|mesh-list
56883630|NCT03408340|Ketamine|ketamine|mesh-list
56883632|NCT03408340|Sevoflurane|sevoflurane|mesh-list
56883633|NCT03408340|Rocuronium|rocuronium|mesh-list
56883634|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
56883635|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883636|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883637|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
56883638|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883639|NCT03408340|Analgesics|analgesics|mesh-ancestor
56883640|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56883641|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56883642|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
56883643|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56883644|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56883645|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883646|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883647|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56883648|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56883649|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56883650|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56883651|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56883652|NCT03408340|Narcotics|narcotics|mesh-ancestor
56883653|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56883654|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56883655|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56883656|NCT03570554|Acetaminophen|acetaminophen|mesh-list
56883657|NCT03570554|Celecoxib|celecoxib|mesh-list
56883658|NCT03570554|Naproxen|naproxen|mesh-list
56883659|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56883660|NCT03570554|Analgesics|analgesics|mesh-ancestor
56883661|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
56883662|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883663|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883664|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
56883665|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56883666|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883667|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56883668|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56883669|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56883670|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555351|NCT00677521|Acarbose|acarbose|mesh-list
56883671|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883672|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
56883673|NCT04004208|Aflibercept|aflibercept|mesh-list
56883674|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56883675|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56883676|NCT04004208|Growth Substances|growth substances|mesh-ancestor
56883677|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883678|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
56883679|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883680|NCT03727412|Naproxen|naproxen|mesh-list
56883681|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56883682|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56883683|NCT03727412|Analgesics|analgesics|mesh-ancestor
56883684|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
56883685|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883686|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883687|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883688|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56883689|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
56883690|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56883691|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883692|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883693|NCT03643952|Daptomycin|daptomycin|mesh-list
56883694|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56883695|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883696|NCT03035032|Leuprolide|leuprolide|mesh-list
56883697|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56883698|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
56883699|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594438|NCT03292666|Warfarin|warfarin|mesh-list
56883700|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883701|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56883702|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883703|NCT03629184|Oseltamivir|oseltamivir|mesh-list
56883704|NCT03629184|Baloxavir|baloxavir|mesh-list
56883705|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
56883706|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883707|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883708|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883710|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
56883711|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
56883712|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
56883713|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883714|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883715|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
56883716|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883717|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56883718|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56883719|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56883720|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56883721|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883722|NCT03725228|Analgesics|analgesics|mesh-ancestor
56883723|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
56883724|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56883725|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56883726|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
56883727|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56883728|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
56883729|NCT03724838|Esomeprazole|esomeprazole|mesh-list
56883730|NCT03724838|Citric Acid|citric acid|mesh-list
56883731|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
56883732|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
56883733|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56883734|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
56883735|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
56883736|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883737|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
56883738|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56883739|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56883740|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883741|NCT03724838|Urological Agents|urological agents|mesh-ancestor
56883742|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56883743|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56883744|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56883745|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
56883746|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883747|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
56883748|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56883749|NCT03727100|Clonidine|clonidine|mesh-list
56883750|NCT03727100|Analgesics|analgesics|mesh-ancestor
56883751|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
56883752|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883753|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883754|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56883755|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
56883756|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
56883757|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56883758|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56883759|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56883760|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
56883761|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883762|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883763|NCT03358030|Riboflavin|riboflavin|mesh-list
56883764|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
56883765|NCT03358030|Vitamins|vitamins|mesh-ancestor
56883766|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
56883767|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883768|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56883769|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
56883770|NCT03566810|Metformin|metformin|mesh-list
56883771|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56883772|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883773|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56883774|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56883775|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
56883776|NCT03628716|Atezolizumab|atezolizumab|mesh-list
56883777|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883778|NCT03840616|Fluconazole|fluconazole|mesh-list
56883779|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
56883780|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883781|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56883782|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56883783|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883784|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883785|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56883786|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
56883787|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56883788|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883789|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56883790|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56883791|NCT00088413|Molgramostim|molgramostim|mesh-list
56883792|NCT00088413|Sargramostim|sargramostim|mesh-list
56883793|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
56883794|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883795|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883796|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
56883797|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56883798|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56883799|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
56883800|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883801|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883802|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883803|NCT03787654|Urological Agents|urological agents|mesh-ancestor
56883806|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56883807|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
56883808|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883809|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883810|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56883811|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56883812|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
56883813|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883814|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883815|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56883816|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
56883817|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883818|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56883819|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56883820|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56883821|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
56883822|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56883823|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56883824|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883825|NCT05115838|Islatravir|islatravir|mesh-list
56883826|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
56883827|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883828|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883829|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883830|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56883831|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56883832|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56883833|NCT03993288|Iron|iron|mesh-list
56883834|NCT03993288|Trace Elements|trace elements|mesh-ancestor
56883835|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
56883836|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883837|NCT05093608|Bevacizumab|bevacizumab|mesh-list
56883838|NCT05093608|Atezolizumab|atezolizumab|mesh-list
56883839|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56883840|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883841|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56883842|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56883843|NCT05093608|Growth Substances|growth substances|mesh-ancestor
56883844|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883845|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
56883846|NCT03603964|Guadecitabine|guadecitabine|mesh-list
56883847|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883848|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56883849|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883851|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883852|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883853|NCT04644796|Bupivacaine|bupivacaine|mesh-list
56883854|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
56883855|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
56883856|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56883857|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883858|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
56883859|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883860|NCT00086307|Pramipexole|pramipexole|mesh-list
56883861|NCT00086307|Citalopram|citalopram|mesh-list
56883862|NCT00086307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56883863|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56883864|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56883865|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883866|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883867|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
56883868|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883869|NCT00086307|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56883870|NCT00086307|Antidepressive Agents|antidepressive agents|mesh-ancestor
56883871|NCT00086307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56883872|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56883873|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56883874|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
56883875|NCT00086307|Protective Agents|protective agents|mesh-ancestor
56883876|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
56883877|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
56883878|NCT01086579|Paclitaxel|paclitaxel|mesh-list
56883879|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56883880|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56883881|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883882|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
56883883|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
56883884|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
56883885|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883886|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
56883887|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
56883888|NCT03743922|Vitamin D|vitamin d|mesh-list
56883889|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56883890|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883891|NCT03743922|Vitamins|vitamins|mesh-ancestor
56883892|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
56883893|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56883894|NCT03988842|Heparin|heparin|mesh-list
56883895|NCT03988842|Calcium heparin|calcium heparin|mesh-list
56883896|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56883897|NCT03988842|Plasminogen|plasminogen|mesh-list
56883898|NCT03988842|Apixaban|apixaban|mesh-list
56883899|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
56883900|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56883901|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56883902|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883903|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56883904|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
56883905|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56883906|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
56883907|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883908|NCT02668822|Ibuprofen|ibuprofen|mesh-list
56883909|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56883910|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56883912|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
56883913|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883914|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883915|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56883916|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56883917|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56883918|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883919|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883920|NCT04112589|Cytarabine|cytarabine|mesh-list
56883921|NCT04112589|Fludarabine|fludarabine|mesh-list
56883922|NCT04112589|Idarubicin|idarubicin|mesh-list
56883923|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883924|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56883925|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
56883926|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883927|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56883928|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
56883929|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883930|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
56883931|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883932|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56883933|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56883934|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56883935|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883936|NCT03547154|Interferons|interferons|mesh-list
56883937|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
56883938|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
56883939|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56883940|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883941|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
56883942|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56883943|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
56883944|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883945|NCT02275546|NuvaRing|nuvaring|mesh-list
56883946|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56883947|NCT02275546|Desogestrel|desogestrel|mesh-list
56883948|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56883949|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
56883950|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56883951|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883952|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56883953|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56883954|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56883955|NCT02275546|Estrogens|estrogens|mesh-ancestor
56883956|NCT02275546|Hormones|hormones|mesh-ancestor
56883957|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56883958|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56883959|NCT02275546|Progestins|progestins|mesh-ancestor
56883960|NCT00057837|Cisplatin|cisplatin|mesh-list
56883961|NCT00057837|Irinotecan|irinotecan|mesh-list
56883962|NCT00057837|Etoposide|etoposide|mesh-list
56883963|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
56883964|NCT00057837|Topotecan|topotecan|mesh-list
56883965|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
56883966|NCT00057837|Camptothecin|camptothecin|mesh-list
56883967|NCT00057837|Lenograstim|lenograstim|mesh-list
56883968|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56883969|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56883970|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56883971|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56883972|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883973|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56883974|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56883975|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56883976|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
56883977|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883978|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
56883979|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
56883980|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
56883981|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
56883982|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
56883983|NCT05665088|Dexmedetomidine|dexmedetomidine|mesh-list
56883984|NCT05665088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56072545|NCT02389088|Letrozole|letrozole|mesh-list
56883986|NCT05665088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56883987|NCT05665088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56883988|NCT05665088|Analgesics|analgesics|mesh-ancestor
56883989|NCT05665088|Sensory System Agents|sensory system agents|mesh-ancestor
56883990|NCT05665088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56883991|NCT05665088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56883992|NCT05665088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56883993|NCT05665088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56883994|NCT05665088|Adrenergic Agents|adrenergic agents|mesh-ancestor
56883995|NCT05665088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56883996|NCT05665088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56883997|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56883998|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56883999|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884000|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56884001|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56884002|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56884003|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884004|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
56884005|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884006|NCT01096797|Sevoflurane|sevoflurane|mesh-list
56884007|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56884008|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56884009|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
56884010|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
56884011|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884012|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884013|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
56884014|NCT00068601|Goserelin|goserelin|mesh-list
56884015|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56884016|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
56884017|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884018|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56884019|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56884020|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
56884021|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884022|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884023|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56884024|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56884025|NCT01670656|Ibuprofen|ibuprofen|mesh-list
56884026|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
56884027|NCT01670656|Etonogestrel|etonogestrel|mesh-list
56884028|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56884029|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56884030|NCT01670656|Analgesics|analgesics|mesh-ancestor
56884031|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
56884032|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884033|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884034|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56884035|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56884036|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56884037|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884038|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884039|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56884040|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56884041|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56884042|NCT03621696|Cisplatin|cisplatin|mesh-list
56884043|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884044|NCT00068445|Lamotrigine|lamotrigine|mesh-list
56884045|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
56884046|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56884047|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56884048|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884049|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56884050|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884051|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56884052|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56884053|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884054|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56884055|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56884057|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
56884058|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56884059|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884060|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
56884061|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884062|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56884063|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884064|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884065|NCT02926690|OTS167|ots167|mesh-list
56884066|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56884067|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884068|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884069|NCT03652818|Acetaminophen|acetaminophen|mesh-list
56884070|NCT03652818|Pregabalin|pregabalin|mesh-list
56884071|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56884072|NCT03652818|Analgesics|analgesics|mesh-ancestor
56884073|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
56884074|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594798|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
56884075|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884076|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
56884077|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
56884078|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56884079|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56884080|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884081|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56884082|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56884083|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56884084|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884085|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56884086|NCT03723824|Grazoprevir|grazoprevir|mesh-list
56884087|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56884088|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
56884089|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884090|NCT00620464|Etonogestrel|etonogestrel|mesh-list
56884091|NCT00620464|Desogestrel|desogestrel|mesh-list
56884092|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56884093|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
56884094|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56884095|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884096|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56884097|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56884098|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56884099|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56884100|NCT00620464|Progestins|progestins|mesh-ancestor
56884101|NCT00620464|Hormones|hormones|mesh-ancestor
56884102|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884103|NCT00541684|Atenolol|atenolol|mesh-list
56884104|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
56884105|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884106|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884107|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884108|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
56884109|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884110|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56884111|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56884112|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
56884113|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56884114|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56884115|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56884116|NCT00413764|Tibolone|tibolone|mesh-list
56884117|NCT00413764|Norethindrone|norethindrone|mesh-list
56884118|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
56884119|NCT00413764|Estradiol|estradiol|mesh-list
56884120|NCT00413764|Estrogens|estrogens|mesh-ancestor
56884121|NCT00413764|Hormones|hormones|mesh-ancestor
56884122|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884123|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884124|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56884125|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
56884126|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56884127|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56884128|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56884129|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56884130|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56884131|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
56884132|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
56884133|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56884134|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56884135|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884136|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56884137|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
56884139|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56884140|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56884141|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
56884142|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56884143|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56884144|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56884145|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56884146|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56884147|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884148|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
56884149|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884150|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884151|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56884152|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884153|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56884154|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
56884155|NCT03726788|Hormones|hormones|mesh-ancestor
56884156|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884157|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56884158|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
56884159|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884160|NCT03735264|Docetaxel|docetaxel|mesh-list
56884161|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884162|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
56884163|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
56884164|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
56884165|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884166|NCT03560258|Vaccines|vaccines|mesh-list
56884167|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
56884168|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884169|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
56884170|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56884171|NCT02759380|Estrogens|estrogens|mesh-ancestor
56884172|NCT02759380|Hormones|hormones|mesh-ancestor
56884173|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884174|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884175|NCT02707042|Amoxicillin|amoxicillin|mesh-list
56884176|NCT02707042|Azithromycin|azithromycin|mesh-list
56884177|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56884178|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884179|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
56884180|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56884181|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
56884182|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884183|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56884184|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56884185|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56884186|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884187|NCT03615924|Ticagrelor|ticagrelor|mesh-list
56884188|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56884189|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56884190|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56555859|NCT01102374|Vitamin D|vitamin d|mesh-list
56884191|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56884192|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
56884193|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884194|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884195|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884196|NCT05576038|Tryptophan|tryptophan|mesh-list
56884197|NCT05576038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56884198|NCT05576038|Antidepressive Agents|antidepressive agents|mesh-ancestor
56884199|NCT05576038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56884200|NCT02599714|Fulvestrant|fulvestrant|mesh-list
56884201|NCT02599714|Palbociclib|palbociclib|mesh-list
56884202|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56884203|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884204|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56884205|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56884206|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
56884207|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884208|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884209|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56884210|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884211|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884212|NCT04660240|Sirolimus|sirolimus|mesh-list
56884213|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56884214|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884215|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56884216|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884217|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
56884218|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56884219|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
56884220|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884221|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56884222|NCT03033394|Penicillins|penicillins|mesh-list
56884223|NCT03033394|Lactams|lactams|mesh-list
56884224|NCT03033394|beta-Lactams|beta-lactams|mesh-list
56884225|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884226|NCT03639428|Midazolam|midazolam|mesh-list
56884227|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56884228|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56884229|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884230|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884231|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56884232|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56884233|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56884234|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56884235|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
56884236|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
56884237|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
56884238|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
56884239|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884240|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884241|NCT04575688|Bupivacaine|bupivacaine|mesh-list
56884242|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
56884243|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
56884244|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884245|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884246|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
56884247|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884248|NCT05528848|Fentanyl|fentanyl|mesh-list
56884249|NCT05528848|Carfentanil|carfentanil|mesh-list
56884250|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56884251|NCT05528848|Narcotics|narcotics|mesh-ancestor
56884252|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884253|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884254|NCT05528848|Analgesics|analgesics|mesh-ancestor
56884255|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
56884256|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884257|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56884258|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56884259|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
56884260|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
56884261|NCT04561648|Heparin|heparin|mesh-list
56884262|NCT04561648|Calcium heparin|calcium heparin|mesh-list
56884263|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
56884264|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56884265|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56904556|NCT00149825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56884266|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884267|NCT03981822|Cantharidin|cantharidin|mesh-list
56884268|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884269|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884270|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
56884271|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56884272|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884273|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56884274|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884275|NCT05506930|Morphine|morphine|mesh-list
56884276|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56884278|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884279|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884280|NCT05506930|Analgesics|analgesics|mesh-ancestor
56884281|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
56884282|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884283|NCT05464264|Ketamine|ketamine|mesh-list
56884284|NCT05464264|Analgesics|analgesics|mesh-ancestor
56884285|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
56884286|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884287|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884288|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56884289|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56884290|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
56884291|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
56884292|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884293|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56884294|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56884295|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884296|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595033|NCT00715117|Naltrexone|naltrexone|mesh-list
56884297|NCT01310738|Amphotericin B|amphotericin b|mesh-list
56884298|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56884299|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56884300|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56884301|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
56884302|NCT01310738|Amebicides|amebicides|mesh-ancestor
56884303|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56884304|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56884305|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884306|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56884307|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
56884308|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56884309|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56884310|NCT03704506|Amoxicillin|amoxicillin|mesh-list
56884311|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56884312|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884313|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56884314|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56884315|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884316|NCT03615144|Fludarabine|fludarabine|mesh-list
56884317|NCT03615144|Melphalan|melphalan|mesh-list
56884318|NCT03615144|Thiotepa|thiotepa|mesh-list
56884319|NCT03615144|Clofarabine|clofarabine|mesh-list
56884320|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
56884321|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56884322|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884323|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56884324|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
56884325|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884326|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56884327|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
56884328|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884329|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56884330|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
56884331|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56884332|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
56884333|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56884334|NCT03682302|Bupivacaine|bupivacaine|mesh-list
56884335|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
56884336|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
56884337|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884338|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556012|NCT00684853|Bevacizumab|bevacizumab|mesh-list
56884339|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
56884340|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884341|NCT03522506|Modafinil|modafinil|mesh-list
56884342|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56884343|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884344|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56884345|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56884346|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56884347|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884348|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
56884350|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
56884351|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56884352|NCT03320434|Prednisolone|prednisolone|mesh-list
56884353|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56884354|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
56884355|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56884356|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
56884357|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
56884358|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884359|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884360|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56884361|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
56884362|NCT03320434|Hormones|hormones|mesh-ancestor
56884363|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884364|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56884365|NCT03320434|Protective Agents|protective agents|mesh-ancestor
56884366|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56884367|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884368|NCT02892734|Nivolumab|nivolumab|mesh-list
56884369|NCT02892734|Ipilimumab|ipilimumab|mesh-list
56884370|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56884371|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884372|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56884373|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884374|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
56884376|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
56884377|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884378|NCT00055497|Adalimumab|adalimumab|mesh-list
56884379|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56884380|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56884381|NCT03726398|Macitentan|macitentan|mesh-list
56884382|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56884383|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56884384|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884385|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56884386|NCT04050592|Estradiol|estradiol|mesh-list
56884387|NCT04050592|Estrogens|estrogens|mesh-ancestor
56884388|NCT04050592|Hormones|hormones|mesh-ancestor
56884389|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884390|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884391|NCT03726242|Cromakalim|cromakalim|mesh-list
56884392|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56884393|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56884394|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
56884395|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884396|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884397|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56884398|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
56884399|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
56884400|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
56884401|NCT03731988|Lidocaine|lidocaine|mesh-list
56884402|NCT03731988|Prilocaine|prilocaine|mesh-list
56884403|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56884404|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
56884405|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
56884406|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884407|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884408|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
56884409|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884410|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56884411|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56884412|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56884413|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56884414|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884415|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56884416|NCT01094457|Aspirin|aspirin|mesh-list
56884417|NCT01094457|Cilostazol|cilostazol|mesh-list
56884418|NCT01094457|Clopidogrel|clopidogrel|mesh-list
56884419|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56884420|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56884421|NCT01094457|Analgesics|analgesics|mesh-ancestor
56884422|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
56884423|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884424|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884425|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56884426|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56884427|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56884428|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56884429|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884430|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56884431|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56884432|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884433|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
56884434|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56884435|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56884436|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56884437|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
56884438|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884439|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56884440|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
56884441|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56884442|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
56884443|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
56884444|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56884445|NCT01094457|Protective Agents|protective agents|mesh-ancestor
56884446|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56884447|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56884448|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
56884449|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56884450|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56884451|NCT03701698|Prednisolone|prednisolone|mesh-list
56884452|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
56884453|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56884454|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
56884455|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56884456|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
56884457|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
56884458|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884459|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884460|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56884461|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
56884463|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884464|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56884465|NCT03701698|Protective Agents|protective agents|mesh-ancestor
56884466|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56884467|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884468|NCT03734562|Amiodarone|amiodarone|mesh-list
56884469|NCT03734562|Sotalol|sotalol|mesh-list
56884470|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56884471|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
56884472|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56884473|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56884474|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884475|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56884476|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56884477|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56884478|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884479|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56884480|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56884481|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56884482|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56884483|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56884484|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
56884485|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884486|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884487|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
56884488|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
56884489|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884490|NCT03034096|Propofol|propofol|mesh-list
56884491|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56884492|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884493|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884494|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56884495|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
56884496|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
56884497|NCT03722498|Leucovorin|leucovorin|mesh-list
56884498|NCT03722498|Fluorouracil|fluorouracil|mesh-list
56884499|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
56884500|NCT03722498|Sorafenib|sorafenib|mesh-list
56884501|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
56884502|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884503|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56884504|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884505|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56884506|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
56884507|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884508|NCT03722498|Antidotes|antidotes|mesh-ancestor
56884509|NCT03722498|Protective Agents|protective agents|mesh-ancestor
56884510|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
56884511|NCT03722498|Vitamins|vitamins|mesh-ancestor
56884512|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
56884513|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56884514|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884515|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
56884516|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884517|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56884518|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884519|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884520|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
56595263|NCT04505774|Ticagrelor|ticagrelor|mesh-list
56884521|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56884522|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884524|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884525|NCT03807843|Vaccines|vaccines|mesh-list
56884526|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
56884527|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884528|NCT01094535|Secretin|secretin|mesh-list
56884529|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56884530|NCT01094535|Hormones|hormones|mesh-ancestor
56884531|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884532|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884533|NCT02843074|Dexamethasone|dexamethasone|mesh-list
56884534|NCT02843074|Lenalidomide|lenalidomide|mesh-list
56884535|NCT02843074|Elotuzumab|elotuzumab|mesh-list
56884536|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56884537|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
56884538|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
56884539|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884540|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884541|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56884542|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
56884543|NCT02843074|Hormones|hormones|mesh-ancestor
56884544|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884545|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56884546|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884547|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
56884548|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56884549|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56884550|NCT02843074|Growth Substances|growth substances|mesh-ancestor
56884551|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
56884552|NCT03607422|Upadacitinib|upadacitinib|mesh-list
56884553|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56884554|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56884555|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884556|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884557|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56884558|NCT00038103|Celecoxib|celecoxib|mesh-list
56884559|NCT00038103|Exemestane|exemestane|mesh-list
56884560|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56884561|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56884562|NCT00038103|Analgesics|analgesics|mesh-ancestor
56884563|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
56884564|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884565|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884566|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56884567|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56884568|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56884569|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56884570|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884571|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884572|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884573|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56884574|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56884576|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
56884577|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884578|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
56884579|NCT03678870|Narcotics|narcotics|mesh-ancestor
56884580|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884581|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884582|NCT03678870|Analgesics|analgesics|mesh-ancestor
56884583|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
56884584|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884585|NCT03032380|Meropenem|meropenem|mesh-list
56884586|NCT03032380|Linezolid|linezolid|mesh-list
56884587|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56884588|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884589|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56884590|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884591|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884592|NCT03519854|Bromides|bromides|mesh-list
56884593|NCT03519854|Rocuronium|rocuronium|mesh-list
56884594|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
56884595|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56884596|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56884597|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56884598|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884599|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884600|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56884601|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884602|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884603|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
56884604|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
56884605|NCT03479216|Bupivacaine|bupivacaine|mesh-list
56884606|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
56884607|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
56884608|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884609|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884610|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
56884611|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884612|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56884613|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56884614|NCT03479216|Analgesics|analgesics|mesh-ancestor
56884615|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56884616|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56884617|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56884618|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
56884619|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884620|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884621|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56884622|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
56884623|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56884624|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56884625|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56884626|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
56884627|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56884628|NCT04762888|Edetic Acid|edetic acid|mesh-list
56884629|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56884630|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
56884631|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
56884632|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884633|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
56884634|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56884635|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56884636|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
56884637|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56884638|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884639|NCT03717038|Trifluridine|trifluridine|mesh-list
56884640|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
56884641|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884642|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
56884643|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884644|NCT04745026|Cannabidiol|cannabidiol|mesh-list
56884645|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
56884646|NCT00143182|Olanzapine|olanzapine|mesh-list
56884647|NCT00143182|Asenapine|asenapine|mesh-list
56884648|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
56884649|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
56884650|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884651|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884652|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56884653|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56884654|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56884655|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884656|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56884657|NCT00143182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56884658|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56884659|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56884660|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884661|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884662|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
56884663|NCT03677934|Ranibizumab|ranibizumab|mesh-list
56884664|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56884665|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56884666|NCT03677934|Growth Substances|growth substances|mesh-ancestor
56884667|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884668|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
56884669|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884670|NCT03435692|Acetaminophen|acetaminophen|mesh-list
56884671|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
56884672|NCT03435692|Promethazine|promethazine|mesh-list
56884673|NCT03435692|Fentanyl|fentanyl|mesh-list
56884675|NCT03435692|Oxycodone|oxycodone|mesh-list
56884676|NCT03435692|Lorazepam|lorazepam|mesh-list
56884677|NCT03435692|Ondansetron|ondansetron|mesh-list
56884678|NCT03435692|Ropivacaine|ropivacaine|mesh-list
56884679|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56884680|NCT03435692|Narcotics|narcotics|mesh-ancestor
56884681|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884682|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884683|NCT03435692|Analgesics|analgesics|mesh-ancestor
56884684|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
56884685|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884686|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
56884687|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
56884688|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56884689|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56884690|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
56884691|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56884692|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
56884693|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
56884694|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
56884695|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56884696|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
56884697|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
56884698|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56884699|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
56884700|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884701|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884702|NCT03435692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56884703|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56884704|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56884705|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56884706|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56884707|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56884708|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56884709|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
56884710|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
56884711|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56884712|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
56884713|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
56884714|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
56884715|NCT03705442|Loperamide|loperamide|mesh-list
56884716|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
56884717|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56884718|NCT04817410|Naltrexone|naltrexone|mesh-list
56884719|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56568722|NCT02885558|Nifedipine|nifedipine|mesh-list
56884720|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56884721|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884722|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
56884723|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884724|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
56884725|NCT03673956|Vancomycin|vancomycin|mesh-list
56884726|NCT03673956|Levofloxacin|levofloxacin|mesh-list
56884727|NCT03673956|Ofloxacin|ofloxacin|mesh-list
56884728|NCT03673956|Tobramycin|tobramycin|mesh-list
56884729|NCT03673956|Mupirocin|mupirocin|mesh-list
56884730|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56884731|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884732|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56884733|NCT03673956|Renal Agents|renal agents|mesh-ancestor
56884734|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56884735|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56884736|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884737|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884738|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884739|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56884740|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56884741|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56884742|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
56884743|NCT03716804|Cefuroxime|cefuroxime|mesh-list
56884744|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
56884745|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
56884746|NCT03716804|Cefixime|cefixime|mesh-list
56884747|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56884748|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884749|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56884750|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56884751|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884752|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884753|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884754|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56884755|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56884756|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56884757|NCT03716804|Renal Agents|renal agents|mesh-ancestor
56884758|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56884759|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56884760|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884761|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56884762|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
56884763|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884764|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
56884765|NCT03516812|Olaparib|olaparib|mesh-list
56884766|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56884767|NCT03516812|Testosterone|testosterone|mesh-list
56884768|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
56884769|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
56884770|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56884771|NCT03516812|Androgens|androgens|mesh-ancestor
56884772|NCT03516812|Hormones|hormones|mesh-ancestor
56884773|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884774|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884775|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56884776|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884777|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
56884778|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884779|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884780|NCT04530058|Metformin|metformin|mesh-list
56884781|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56884782|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884783|NCT03733860|Alprostadil|alprostadil|mesh-list
56884784|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56884785|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
56884786|NCT03733860|Urological Agents|urological agents|mesh-ancestor
56884787|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
56884788|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56884789|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884790|NCT01310244|Paclitaxel|paclitaxel|mesh-list
56884791|NCT01310244|Carboplatin|carboplatin|mesh-list
56884792|NCT01310244|Belinostat|belinostat|mesh-list
56884793|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56884794|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884795|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
56884796|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
56884797|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
56884798|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884799|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56884800|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884801|NCT03672006|Heparin|heparin|mesh-list
56884802|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56884803|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
56884804|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56884805|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56884806|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884807|NCT03621072|Fluconazole|fluconazole|mesh-list
56884808|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
56884809|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884810|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56884811|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56884812|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884813|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884814|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56884815|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
56884816|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884817|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884818|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56884819|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56884820|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56884821|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
56884822|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884823|NCT01311050|Bevacizumab|bevacizumab|mesh-list
56884824|NCT01311050|Capecitabine|capecitabine|mesh-list
56884825|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
56884826|NCT01311050|Irinotecan|irinotecan|mesh-list
56884827|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56884828|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884829|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56884830|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56884831|NCT01311050|Growth Substances|growth substances|mesh-ancestor
56884832|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884833|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
56884834|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56884835|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
56884836|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884837|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56884838|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56884839|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884841|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56884842|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
56884843|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
56884844|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884845|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884846|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56884847|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
56884848|NCT04498468|Hormones|hormones|mesh-ancestor
56884849|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56884850|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56884851|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884852|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
56884853|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56884854|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
56884855|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884856|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56884857|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56884858|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
56884859|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884860|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884861|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56884862|NCT03702946|Oxytocin|oxytocin|mesh-list
56884863|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
56884864|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56884865|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884867|NCT03697564|Nivolumab|nivolumab|mesh-list
56884868|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56884869|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
56884870|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884871|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884872|NCT03697564|Antiviral Agents|antiviral agents|mesh-ancestor
56884873|NCT03697564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884874|NCT03697564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884875|NCT03697564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56884876|NCT03697564|Immunologic Factors|immunologic factors|mesh-ancestor
56884877|NCT03697564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884878|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56884879|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56884880|NCT04491526|Tamsulosin|tamsulosin|mesh-list
56884881|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56884882|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56884883|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56884884|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56884885|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884886|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884887|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884888|NCT04491526|Urological Agents|urological agents|mesh-ancestor
56884889|NCT04484350|Enalapril|enalapril|mesh-list
56884890|NCT04484350|Hydralazine|hydralazine|mesh-list
56884891|NCT04484350|Labetalol|labetalol|mesh-list
56884892|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56884893|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
56884894|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884895|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884896|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56884897|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
56884898|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56884899|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56884900|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
56884901|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884902|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884903|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
56884904|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
56884905|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884906|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56884907|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56884908|NCT03699904|Valacyclovir|valacyclovir|mesh-list
56884909|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
56884910|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884911|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
56884912|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
56884913|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56884914|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884915|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884916|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
56884917|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56884918|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56884919|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884920|NCT03696940|Atorvastatin|atorvastatin|mesh-list
56884921|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56884922|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56884923|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
56884924|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884925|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56884926|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56884927|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884929|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56884930|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56884931|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56884932|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884933|NCT03731442|Paclitaxel|paclitaxel|mesh-list
56884934|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56884935|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884936|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56884937|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56884938|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56884939|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884941|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
56884942|NCT03702400|Norepinephrine|norepinephrine|mesh-list
56884943|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56884944|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
56884945|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
56884946|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884947|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884948|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
56884949|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56884950|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
56884951|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
56884952|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56884953|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56884954|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56884955|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
56884956|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884957|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884958|NCT03702400|Protective Agents|protective agents|mesh-ancestor
56884959|NCT04465318|Nicotine|nicotine|mesh-list
56884960|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56884961|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
56884962|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56884963|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56884964|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56884965|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56884966|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
56884967|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56884968|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884969|NCT03699202|Ziresovir|ziresovir|mesh-list
56884970|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
56884971|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56884972|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
56884973|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595717|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884974|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
56884975|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56884976|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56884977|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884978|NCT03598140|Urological Agents|urological agents|mesh-ancestor
56884979|NCT04457596|Trastuzumab|trastuzumab|mesh-list
56884980|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56884981|NCT04457596|Maytansine|maytansine|mesh-list
56884982|NCT04457596|Tucatinib|tucatinib|mesh-list
56884983|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56884984|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884985|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56884986|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
56884987|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
56884988|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
56884989|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56884990|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56884991|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56884992|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
56884993|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56884994|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884995|NCT05668650|Pembrolizumab|pembrolizumab|mesh-list
56884996|NCT05668650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56884997|NCT05668650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56884998|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
56884999|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56885000|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885001|NCT00054717|Ritonavir|ritonavir|mesh-list
56885002|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56885003|NCT00054717|Tipranavir|tipranavir|mesh-list
56885004|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
56885005|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56885006|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885007|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885008|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56885009|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56885010|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
56885011|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885012|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56885013|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56885015|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56885016|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
56885017|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56885018|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885019|NCT01097265|Capecitabine|capecitabine|mesh-list
56885020|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
56885021|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56885022|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
56885023|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885024|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885025|NCT03731286|Caffeine|caffeine|mesh-list
56885026|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56885027|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885028|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56885029|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885030|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885031|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56885032|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56885033|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
56885034|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885035|NCT00066807|Tamoxifen|tamoxifen|mesh-list
56885036|NCT00066807|Epirubicin|epirubicin|mesh-list
56885037|NCT00066807|Exemestane|exemestane|mesh-list
56885038|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56885039|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56885040|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885041|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56885042|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56885043|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885044|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885045|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56885046|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
56885047|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885048|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885049|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56885050|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56885051|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56885052|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56885053|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56885054|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56885055|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
56885056|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56885057|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
56885058|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56885059|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56885060|NCT03619330|Liraglutide|liraglutide|mesh-list
56885061|NCT03619330|Testosterone|testosterone|mesh-list
56885062|NCT03619330|Androgens|androgens|mesh-ancestor
56885063|NCT03619330|Hormones|hormones|mesh-ancestor
56885064|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885065|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885066|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56885067|NCT03619330|Incretins|incretins|mesh-ancestor
56885068|NCT04457284|Nivolumab|nivolumab|mesh-list
56885069|NCT04457284|Temozolomide|temozolomide|mesh-list
56885070|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885071|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56885072|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56885073|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885074|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56885075|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
56885076|NCT00054639|Rituximab|rituximab|mesh-list
56885077|NCT00054639|Oblimersen|oblimersen|mesh-list
56885078|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56885079|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885080|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
56885081|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885082|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885083|NCT02530359|Pirfenidone|pirfenidone|mesh-list
56885084|NCT02530359|Analgesics|analgesics|mesh-ancestor
56885085|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
56885086|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885087|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885088|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56885089|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56885090|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885091|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885092|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885093|NCT03428360|Diazepam|diazepam|mesh-list
56885094|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56885095|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
56885096|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
56885097|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
56885098|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885099|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885100|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56885101|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56885102|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885103|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56885104|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56885105|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56885106|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56885107|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56885108|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56885109|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
56885110|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
56885111|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
56885112|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
56885113|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885114|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885115|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
56885116|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
56885117|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885118|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885119|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885120|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
56885121|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
56885122|NCT04435600|Ustekinumab|ustekinumab|mesh-list
56885123|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
56885124|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
56885126|NCT04867928|Azacitidine|azacitidine|mesh-list
56885127|NCT04867928|Venetoclax|venetoclax|mesh-list
56885128|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56885129|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
56885130|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885131|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885132|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885133|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
56885134|NCT04670068|Fludarabine|fludarabine|mesh-list
56885135|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56885136|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
56885137|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885138|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885139|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56885140|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
56885141|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885142|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885143|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56885144|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
56885145|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56885146|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885147|NCT03425396|Renal Agents|renal agents|mesh-ancestor
56885148|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56885149|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
56885150|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56885151|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56885152|NCT03698734|Analgesics|analgesics|mesh-ancestor
56885153|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
56885154|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885155|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885156|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885157|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885158|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56885159|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
56885160|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885161|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56885162|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
56885163|NCT00033657|Paclitaxel|paclitaxel|mesh-list
56885165|NCT00033657|Cisplatin|cisplatin|mesh-list
56885166|NCT00033657|Irinotecan|irinotecan|mesh-list
56885167|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56885168|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885169|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
56885170|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
56885171|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
56885172|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885173|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56885174|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56885175|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885176|NCT04070157|Lofexidine|lofexidine|mesh-list
56885177|NCT04070157|Clonidine|clonidine|mesh-list
56885178|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56885179|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56885180|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885181|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
56885182|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885183|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56885184|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56885185|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56885186|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
56885187|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885188|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885189|NCT04070157|Analgesics|analgesics|mesh-ancestor
56885190|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
56885191|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
56885192|NCT01091337|Albuterol|albuterol|mesh-list
56885193|NCT01091337|Procaterol|procaterol|mesh-list
56885194|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56885195|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
56885196|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885197|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885198|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56885199|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
56885200|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
56885201|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56885202|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56885203|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56885204|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56885205|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
56885206|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885207|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885208|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
56885209|NCT03955809|Ketamine|ketamine|mesh-list
56885210|NCT03955809|Analgesics|analgesics|mesh-ancestor
56885211|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
56885212|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885213|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885214|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56885215|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56885216|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
56885217|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
56885218|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885219|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56885220|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56885221|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885222|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885223|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
56885224|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
56885225|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885226|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56885227|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885228|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56885229|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
56885230|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885231|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56885232|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885233|NCT03953001|Lidocaine|lidocaine|mesh-list
56885234|NCT03953001|Epinephrine|epinephrine|mesh-list
56885235|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
56885236|NCT03953001|Anesthetics|anesthetics|mesh-list
56885237|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885238|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885239|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
56885240|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885241|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56885242|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56885243|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56885244|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56885245|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885246|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56885247|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56885248|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
56885249|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885250|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56885251|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56885252|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
56885253|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56885254|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
56885255|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
56885256|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
56885257|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56885258|NCT01094769|Moxonidine|moxonidine|mesh-list
56885259|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56885260|NCT01091415|Calcium|calcium|mesh-list
56885261|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56885262|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885263|NCT00032487|Metformin|metformin|mesh-list
56885264|NCT00032487|Glimepiride|glimepiride|mesh-list
56885265|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
56885266|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56885267|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885268|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56885269|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56885270|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
56885271|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
56885272|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56885273|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885274|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56596016|NCT00788710|Etoricoxib|etoricoxib|mesh-list
56885275|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56885276|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885277|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885278|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885279|NCT03692416|Prednisone|prednisone|mesh-list
56885280|NCT03692416|Ibuprofen|ibuprofen|mesh-list
56885281|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56885282|NCT03692416|Methotrexate|methotrexate|mesh-list
56885283|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885284|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
56885285|NCT03692416|Hormones|hormones|mesh-ancestor
56885286|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885287|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885288|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56885289|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885290|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56885291|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
56885292|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56885293|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56885294|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
56885295|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885296|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
56885297|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885298|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56885299|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56885300|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
56885301|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885302|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56568736|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56885303|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56885304|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56885305|NCT03692416|Analgesics|analgesics|mesh-ancestor
56885306|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
56885307|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885308|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56885309|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56885310|NCT03692416|Protective Agents|protective agents|mesh-ancestor
56885311|NCT03594552|Baclofen|baclofen|mesh-list
56885312|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56885313|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885314|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56885315|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885316|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56885317|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
56885318|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
56885319|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885320|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885321|NCT03641508|Dexamethasone|dexamethasone|mesh-list
56885322|NCT03641508|Triamcinolone|triamcinolone|mesh-list
56885323|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885324|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
56885325|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
56885326|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885327|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885328|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56885329|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
56885330|NCT03641508|Hormones|hormones|mesh-ancestor
56885331|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885332|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56885333|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885334|NCT03624244|Letrozole|letrozole|mesh-list
56885335|NCT03624244|Exemestane|exemestane|mesh-list
56885336|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56885337|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885338|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56885339|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885340|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885341|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56885342|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
56885343|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885344|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885345|NCT00066573|Anastrozole|anastrozole|mesh-list
56885346|NCT00066573|Exemestane|exemestane|mesh-list
56596094|NCT00482157|Vitamin D|vitamin d|mesh-list
56885347|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56885348|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885349|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56885350|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56885351|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885352|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885353|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56885354|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
56885355|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885356|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885357|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
56885358|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56885359|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885360|NCT01091571|Dipyridamole|dipyridamole|mesh-list
56885361|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56885362|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885363|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885364|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56885365|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
56885366|NCT01091649|Ritonavir|ritonavir|mesh-list
56885367|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56885368|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56885369|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
56885370|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891122|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56885371|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885372|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56885373|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56885374|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
56885376|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56885377|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56885378|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
56885379|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56885380|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56885381|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56885382|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56885383|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885384|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
56885385|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885386|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885387|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56885388|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885389|NCT03421730|Budesonide|budesonide|mesh-list
56885390|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885391|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56885392|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
56885393|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885394|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885395|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56885396|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
56885397|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
56885398|NCT03421730|Hormones|hormones|mesh-ancestor
56885399|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885400|NCT01094925|Gabapentin|gabapentin|mesh-list
56885401|NCT01094925|Analgesics|analgesics|mesh-ancestor
56885402|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
56885403|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885404|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885405|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
56885406|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56885407|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56885408|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885409|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56885410|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56885411|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56885412|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885413|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885414|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
56885415|NCT03718676|Pemetrexed|pemetrexed|mesh-list
56885416|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885417|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885418|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885419|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56885420|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56885421|NCT00054327|Cytarabine|cytarabine|mesh-list
56885422|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
56885423|NCT00054327|Busulfan|busulfan|mesh-list
56885424|NCT00054327|Etoposide|etoposide|mesh-list
56885425|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
56885426|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56885427|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
56885428|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885429|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885430|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56885431|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
56885432|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885433|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885434|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56885435|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56885436|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56885437|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56885438|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885439|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56885440|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
56885441|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
56885442|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885443|NCT03029650|Scopolamine|scopolamine|mesh-list
56885444|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56885445|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56885446|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
56885447|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
56568747|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
56885448|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885449|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885450|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56885451|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
56885452|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56885453|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
56885454|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885455|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885456|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56885457|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
56885458|NCT03462680|Niacin|niacin|mesh-list
56885459|NCT03462680|Vitamins|vitamins|mesh-ancestor
56885460|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
56885461|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885462|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
56885463|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56885464|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
56885465|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885466|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56885467|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
56885468|NCT03692026|Melatonin|melatonin|mesh-list
56885469|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
56885470|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
56885471|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885472|NCT03692026|Protective Agents|protective agents|mesh-ancestor
56885473|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885474|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885475|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56885476|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
56885477|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
56885478|NCT03624322|Olanzapine|olanzapine|mesh-list
56885479|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
56885480|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
56885481|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885482|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885483|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56885484|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56885485|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56885486|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885487|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56885488|NCT03624322|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56885489|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56885490|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56885491|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885492|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885493|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
56885494|NCT01097811|Erythromycin|erythromycin|mesh-list
56885495|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
56885496|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56885497|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
56885498|NCT01097811|Neomycin|neomycin|mesh-list
56885499|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56885500|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885501|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56885502|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56885503|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885504|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885505|NCT03418922|Nivolumab|nivolumab|mesh-list
56885506|NCT03418922|Lenvatinib|lenvatinib|mesh-list
56885507|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56885508|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885509|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56885510|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885511|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56885512|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885513|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
56885514|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56885515|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
56885516|NCT03957291|Povidone|povidone|mesh-list
56885517|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56557185|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
56885518|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885519|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
56885520|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
56885521|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
56147819|NCT01258374|Darunavir|darunavir|mesh-list
56885522|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
56885523|NCT04044976|Caffeine|caffeine|mesh-list
56885524|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
56885525|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885526|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56885527|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885528|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56885529|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885530|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56885531|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56885532|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
56885533|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885534|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56885535|NCT03691636|Lifitegrast|lifitegrast|mesh-list
56885536|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56885537|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
56885538|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
56885539|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
56885540|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
56885541|NCT03956121|Analgesics|analgesics|mesh-ancestor
56885542|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
56885543|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885544|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885545|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
56885546|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885547|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56885548|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
56885549|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56885550|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56885551|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885552|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56885553|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
56885554|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56885555|NCT03636906|Vaccines|vaccines|mesh-list
56885556|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
56885557|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885558|NCT03028870|Naproxen|naproxen|mesh-list
56885559|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56885560|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56885561|NCT03028870|Analgesics|analgesics|mesh-ancestor
56885562|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
56885563|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885564|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885565|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885566|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885567|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
56885568|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56885569|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885570|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885571|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
56885572|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56596311|NCT02587741|Metformin|metformin|mesh-list
56885573|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
56885574|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885575|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885577|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885578|NCT04294810|Atezolizumab|atezolizumab|mesh-list
56885579|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885580|NCT03663582|Teduglutide|teduglutide|mesh-list
56885581|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56885582|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56885583|NCT03663582|Protective Agents|protective agents|mesh-ancestor
56885584|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885585|NCT01098357|Becaplermin|becaplermin|mesh-list
56885586|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
56885587|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56885588|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56885589|NCT01098357|Growth Substances|growth substances|mesh-ancestor
56885590|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885591|NCT03730740|Lenalidomide|lenalidomide|mesh-list
56885592|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
56885593|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885594|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56885595|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56885596|NCT03730740|Growth Substances|growth substances|mesh-ancestor
56885597|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
56885598|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885599|NCT01098513|Dolutegravir|dolutegravir|mesh-list
56885600|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56885601|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56885602|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885603|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885604|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56885605|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56885606|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
56885607|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885608|NCT03693976|Xylometazoline|xylometazoline|mesh-list
56885609|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
56885610|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56885611|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
56885612|NCT03730584|Ropivacaine|ropivacaine|mesh-list
56885613|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
56885614|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
56885615|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885616|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885617|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
56885618|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885619|NCT03502616|Tofacitinib|tofacitinib|mesh-list
56885620|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56885621|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885622|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885623|NCT04003012|Lidocaine|lidocaine|mesh-list
56885624|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
56885625|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
56885626|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885627|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885628|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
56885629|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885630|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56885631|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56885632|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56885633|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56885634|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885635|NCT04177810|Plerixafor|plerixafor|mesh-list
56885636|NCT04177810|Cemiplimab|cemiplimab|mesh-list
56885637|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56885638|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56885639|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
56885640|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885641|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56885642|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885643|NCT05666076|Bupivacaine|bupivacaine|mesh-list
56885644|NCT05666076|Prilocaine|prilocaine|mesh-list
56885645|NCT05666076|Anesthetics, Local|anesthetics, local|mesh-ancestor
56885646|NCT05666076|Anesthetics|anesthetics|mesh-ancestor
56885647|NCT05666076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885648|NCT05666076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885649|NCT05666076|Sensory System Agents|sensory system agents|mesh-ancestor
56885650|NCT05666076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885651|NCT03028012|Dexamethasone|dexamethasone|mesh-list
56885652|NCT03028012|Ketorolac|ketorolac|mesh-list
56885653|NCT03028012|Lidocaine|lidocaine|mesh-list
56885654|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885655|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
56885656|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
56885657|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885658|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885659|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56885660|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
56885661|NCT03028012|Hormones|hormones|mesh-ancestor
56885662|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885663|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56885664|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885665|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
56885666|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
56885667|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885668|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
56885669|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56885670|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56885671|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56885672|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56885673|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885674|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56885675|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56885676|NCT03028012|Analgesics|analgesics|mesh-ancestor
56885677|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56885678|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56885679|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885680|NCT03634800|Nivolumab|nivolumab|mesh-list
56885681|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56885682|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885683|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56885684|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885685|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
56885686|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56885687|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885688|NCT02955186|Saracatinib|saracatinib|mesh-list
56885689|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885690|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885691|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885692|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56885693|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56885694|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56885695|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
56885696|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885697|NCT03690778|Metformin|metformin|mesh-list
56885698|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56885699|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56885700|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885701|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56885702|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56885703|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
56885704|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885705|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56885706|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56885707|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885708|NCT03715634|Buprenorphine|buprenorphine|mesh-list
56885709|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56885710|NCT03715634|Narcotics|narcotics|mesh-ancestor
56885711|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885712|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885713|NCT03715634|Analgesics|analgesics|mesh-ancestor
56885714|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
56885715|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885716|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56885717|NCT03502070|Tobramycin|tobramycin|mesh-list
56885718|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56885719|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885720|NCT04158934|Factor VIII|factor viii|mesh-list
56885721|NCT04158934|BAX 855|bax 855|mesh-list
56596464|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
56885722|NCT04158934|Coagulants|coagulants|mesh-ancestor
56885723|NCT03715556|Amiodarone|amiodarone|mesh-list
56885724|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56885725|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
56885726|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56885727|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56885728|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885729|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56885730|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56885731|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56885732|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885733|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56885734|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56885735|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56885736|NCT03715478|Dexamethasone|dexamethasone|mesh-list
56885737|NCT03715478|Pomalidomide|pomalidomide|mesh-list
56885738|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56885739|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
56885740|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
56148057|NCT01304238|PENTA|penta|mesh-list
56885741|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885742|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885743|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56885744|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
56885746|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885747|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56885748|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56885749|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
56885750|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56885751|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56885752|NCT03715478|Growth Substances|growth substances|mesh-ancestor
56885753|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
56885754|NCT03730038|Pitavastatin|pitavastatin|mesh-list
56885755|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56885756|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56885757|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56885758|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
56885759|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885760|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885761|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56885762|NCT03725904|Progesterone|progesterone|mesh-list
56885763|NCT03725904|Progestins|progestins|mesh-ancestor
56885764|NCT03725904|Hormones|hormones|mesh-ancestor
56885765|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56885766|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885767|NCT03730272|Analgesics|analgesics|mesh-list
56885768|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
56885769|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885770|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885771|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
56885772|NCT03585504|Etonogestrel|etonogestrel|mesh-list
56885773|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56885774|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885775|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56885776|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56885777|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
56885778|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56885779|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56885780|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885781|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56885782|NCT03690622|Analgesics|analgesics|mesh-ancestor
56885783|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
56885784|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885785|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56885786|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56885787|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56885788|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
56885789|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56885790|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885791|NCT03715322|Tobramycin|tobramycin|mesh-list
56885792|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56885793|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885794|NCT03687268|Naloxone|naloxone|mesh-list
56596543|NCT02603770|Lovastatin|lovastatin|mesh-list
56885795|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56885796|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56885797|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
56885798|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56885799|NCT03576066|Tenofovir|tenofovir|mesh-list
56885800|NCT03576066|Entecavir|entecavir|mesh-list
56885801|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
56885802|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56885803|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56885804|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56885805|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56885806|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56885807|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56904583|NCT05027295|Vitamins|vitamins|mesh-ancestor
56904758|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904759|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904760|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56626911|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56626912|NCT00635310|Liver Extracts|liver extracts|mesh-list
56626913|NCT00635310|Hematinics|hematinics|mesh-ancestor
56626914|NCT02762448|Asunaprevir|asunaprevir|mesh-list
56627126|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56627128|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
56627129|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627130|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56627131|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56627132|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56627133|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
56627157|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56627158|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
56627159|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627160|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627161|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56627162|NCT05661591|Fluconazole|fluconazole|mesh-list
56627163|NCT05661591|Antifungal Agents|antifungal agents|mesh-ancestor
56627164|NCT05661591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627165|NCT05661591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56627166|NCT05661591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56627167|NCT05661591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627168|NCT05661591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627169|NCT05661591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56627170|NCT05661591|Hormone Antagonists|hormone antagonists|mesh-ancestor
56627171|NCT05661591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627172|NCT05661591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627173|NCT05661591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56627174|NCT05661591|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56627175|NCT00951665|Paclitaxel|paclitaxel|mesh-list
56627176|NCT00951665|Maytansine|maytansine|mesh-list
56627177|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56627178|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56627179|NCT00951665|Trastuzumab|trastuzumab|mesh-list
56627180|NCT00951665|Pertuzumab|pertuzumab|mesh-list
56627181|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56627182|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627299|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627300|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627301|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
56627302|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56627303|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
56627304|NCT04114461|Tofacitinib|tofacitinib|mesh-list
56627305|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627306|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56627307|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627308|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56627309|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627310|NCT02768376|Fentanyl|fentanyl|mesh-list
56627311|NCT02768376|Bupivacaine|bupivacaine|mesh-list
56627312|NCT02768376|Anesthetics|anesthetics|mesh-list
56375859|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627313|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
56627314|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627315|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627484|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56627485|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627486|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627487|NCT00887432|Vitamin D|vitamin d|mesh-list
56627488|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
56627489|NCT00887432|Vitamins|vitamins|mesh-ancestor
56627490|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
56627491|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627492|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56627493|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56627494|NCT04222686|Losartan|losartan|mesh-list
56627495|NCT04222686|Perindopril|perindopril|mesh-list
56904761|NCT00187889|Diuretics|diuretics|mesh-ancestor
56904762|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
56904763|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56627496|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56627498|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56627499|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56627500|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627501|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56627502|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
56627503|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627504|NCT04113915|Cyclosporine|cyclosporine|mesh-list
56627505|NCT04113915|Dexamethasone|dexamethasone|mesh-list
56627532|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
56627533|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627534|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627535|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627537|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56627538|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56627539|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627540|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56627541|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56627542|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627543|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
56627544|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56627545|NCT04688658|Nivolumab|nivolumab|mesh-list
56627546|NCT04688658|Axitinib|axitinib|mesh-list
56627547|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627548|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627549|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56627550|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627551|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56627552|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627553|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
56627614|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627615|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56627616|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56627617|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56627618|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56627619|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627620|NCT00951041|Vaccines|vaccines|mesh-list
56627621|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
56627622|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627623|NCT02832596|Norepinephrine|norepinephrine|mesh-list
56627624|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56627625|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56627626|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56627627|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627669|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627670|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
56627671|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627672|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627673|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
56627674|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56627675|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627676|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
56627724|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627725|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627726|NCT00895687|Bortezomib|bortezomib|mesh-list
56627727|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56627728|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627729|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56627730|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627731|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627732|NCT00798135|Itraconazole|itraconazole|mesh-list
56627733|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
56627734|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627735|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56627736|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56627737|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627738|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904764|NCT02087488|Eszopiclone|eszopiclone|mesh-list
56904765|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56904766|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56904767|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904768|NCT02087566|Linezolid|linezolid|mesh-list
56904769|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56648471|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627739|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56627740|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
56627741|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627742|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627779|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
56627780|NCT02753088|Mannitol|mannitol|mesh-list
56628038|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628040|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56628041|NCT02751918|Maytansine|maytansine|mesh-list
56628042|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56628043|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628044|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56628045|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56628046|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628252|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
56628253|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628254|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628255|NCT02751294|Tafenoquine|tafenoquine|mesh-list
56628256|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
56628257|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56628287|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376854|NCT00113802|Antibodies|antibodies|mesh-list
56628288|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56628289|NCT02603757|Vitamin D|vitamin d|mesh-list
56628290|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
56628291|NCT02603757|Vitamins|vitamins|mesh-ancestor
56628292|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
56628293|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628294|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56628295|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56628296|NCT02758782|Celecoxib|celecoxib|mesh-list
56628297|NCT02758782|Golimumab|golimumab|mesh-list
56628298|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56628299|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56628300|NCT02758782|Analgesics|analgesics|mesh-ancestor
56628301|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
56628302|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628339|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56628341|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
56628342|NCT02540785|BB 1101|bb 1101|mesh-list
56628343|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
56628429|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56628430|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
56628431|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56628432|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
56628433|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
56628434|NCT04268927|Letrozole|letrozole|mesh-list
56628435|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
56628436|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56376978|NCT00348400|Dorzolamide|dorzolamide|mesh-list
56628461|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56628462|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628463|NCT00286013|Gemcitabine|gemcitabine|mesh-list
56628464|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
56628465|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628466|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
56628467|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628468|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628469|NCT00286013|Antiviral Agents|antiviral agents|mesh-ancestor
56628470|NCT00286013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628471|NCT00286013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628472|NCT00286013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904770|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904771|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56628473|NCT00286013|Immunologic Factors|immunologic factors|mesh-ancestor
56628474|NCT00286013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628475|NCT02754882|Paclitaxel|paclitaxel|mesh-list
56628476|NCT02754882|Bevacizumab|bevacizumab|mesh-list
56628477|NCT02754882|Carboplatin|carboplatin|mesh-list
56628478|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56628479|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628480|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
56628481|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
56628482|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
56628483|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628484|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56628485|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56628502|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56628503|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
56628504|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628505|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628506|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56628507|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56628508|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
56628509|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628510|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628511|NCT00602615|Torsemide|torsemide|mesh-list
56628512|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56628514|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
56628515|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159927|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56628516|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56628517|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56628518|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628519|NCT00604253|Insulin|insulin|mesh-list
56628520|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56628521|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
56628522|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
56628523|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
56628524|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
56628525|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56628526|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628527|NCT02754960|Thalidomide|thalidomide|mesh-list
56628528|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628529|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
56628530|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628531|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
56628532|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56628533|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628534|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56628535|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56628536|NCT02754960|Growth Substances|growth substances|mesh-ancestor
56628537|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
56628538|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628539|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
56628540|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56628541|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628542|NCT02540239|Simethicone|simethicone|mesh-list
56628543|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
56628544|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628556|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628557|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
56628558|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628559|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56628560|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628561|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628562|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56628563|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628564|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56628565|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
56628566|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56628567|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628568|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56628569|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
56904772|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509821|NCT04550078|Calcium|calcium|mesh-list
56628570|NCT02540395|Hormones|hormones|mesh-ancestor
56628571|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56628572|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56628573|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
56628574|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
56628575|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628576|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56628577|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56628578|NCT02540395|Protective Agents|protective agents|mesh-ancestor
56628579|NCT00254423|Dasatinib|dasatinib|mesh-list
56628580|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628581|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56628582|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628583|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628584|NCT05565729|Levocetirizine|levocetirizine|mesh-list
56628585|NCT05565729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56628586|NCT05565729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56628587|NCT05565729|Histamine Antagonists|histamine antagonists|mesh-ancestor
56628588|NCT05565729|Histamine Agents|histamine agents|mesh-ancestor
56628589|NCT05565729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628590|NCT05565729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628591|NCT05565729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628592|NCT04547166|Bevacizumab|bevacizumab|mesh-list
56628593|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56628594|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628595|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56628596|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56628597|NCT04547166|Growth Substances|growth substances|mesh-ancestor
56628598|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628599|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
56628600|NCT04230252|Acetaminophen|acetaminophen|mesh-list
56628601|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56628602|NCT04230252|Analgesics|analgesics|mesh-ancestor
56628603|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
56628604|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628605|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628606|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
56628607|NCT00602693|Sirolimus|sirolimus|mesh-list
56628608|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
56628609|NCT00602693|Fludarabine|fludarabine|mesh-list
56628610|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
56628624|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628625|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56628626|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
56628627|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628628|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
56628629|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56628631|NCT00602693|Protective Agents|protective agents|mesh-ancestor
56628632|NCT00902395|Midazolam|midazolam|mesh-list
56628633|NCT00902395|Ketamine|ketamine|mesh-list
56628634|NCT00902395|Analgesics|analgesics|mesh-ancestor
56628635|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
56628636|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628637|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628638|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56628639|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56628640|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
56628641|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
56628642|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56628643|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56628644|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56628645|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628646|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628647|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56628648|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56628649|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56628650|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56628651|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56628652|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
56628653|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
56628654|NCT04213404|Spartalizumab|spartalizumab|mesh-list
56628655|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55887682|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56904773|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904774|NCT00148109|Cetuximab|cetuximab|mesh-list
56904775|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56509878|NCT04529187|Midazolam|midazolam|mesh-list
56628656|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628657|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628658|NCT00604409|Capecitabine|capecitabine|mesh-list
56628659|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628660|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
56628661|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628662|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628663|NCT00905905|Simvastatin|simvastatin|mesh-list
56628665|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56628666|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56628667|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56628668|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
56628669|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628670|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56628671|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56628688|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56628689|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56628690|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
56628691|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628692|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628693|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
56628694|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
56628695|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
56628696|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56628697|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
56628698|NCT00938717|Linaclotide|linaclotide|mesh-list
56628699|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56628700|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
56628701|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628702|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56628703|NCT00905983|Gemcitabine|gemcitabine|mesh-list
56628704|NCT00905983|Docetaxel|docetaxel|mesh-list
56628705|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628706|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
56628707|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628708|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628709|NCT00905983|Antiviral Agents|antiviral agents|mesh-ancestor
56628710|NCT00905983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628711|NCT00905983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628712|NCT00905983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628713|NCT00905983|Immunologic Factors|immunologic factors|mesh-ancestor
56628714|NCT00905983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628715|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
56628716|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
56628717|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
56628718|NCT00906061|Gemcitabine|gemcitabine|mesh-list
56628719|NCT00906061|Docetaxel|docetaxel|mesh-list
56628720|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628721|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
56628722|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628723|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628724|NCT00906061|Antiviral Agents|antiviral agents|mesh-ancestor
56628725|NCT00906061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628726|NCT00906061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628727|NCT00906061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628728|NCT00906061|Immunologic Factors|immunologic factors|mesh-ancestor
56628729|NCT00906061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628730|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
56159944|NCT03177798|Icatibant|icatibant|mesh-list
56628731|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
56628732|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
56628733|NCT02754726|Gemcitabine|gemcitabine|mesh-list
56628745|NCT02754726|Antiviral Agents|antiviral agents|mesh-ancestor
56628746|NCT02754726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628747|NCT02754726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628748|NCT02754726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628749|NCT02754726|Immunologic Factors|immunologic factors|mesh-ancestor
56904776|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904777|NCT03746223|Rituximab|rituximab|mesh-list
56509951|NCT01181167|Enoxaparin|enoxaparin|mesh-list
56628750|NCT02754726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628751|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56628752|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56628753|NCT02602509|Rifampin|rifampin|mesh-list
56628754|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
56628755|NCT02602509|Celecoxib|celecoxib|mesh-list
56628756|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56628757|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56628758|NCT02602509|Analgesics|analgesics|mesh-ancestor
56628759|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
56628760|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628761|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628762|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56628763|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628764|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56628765|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56628766|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628767|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628768|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56628769|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
56628770|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56628771|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628772|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
56628773|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56628774|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56628775|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56628776|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56628777|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56628778|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56628779|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56628780|NCT02852837|Daratumumab|daratumumab|mesh-list
56628781|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628782|NCT04342585|Progesterone|progesterone|mesh-list
56628783|NCT04342585|Progestins|progestins|mesh-ancestor
56628784|NCT04342585|Hormones|hormones|mesh-ancestor
56628785|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56628786|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628787|NCT04495452|Fentanyl|fentanyl|mesh-list
56628788|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56628789|NCT04495452|Narcotics|narcotics|mesh-ancestor
56628790|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56628791|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628792|NCT04495452|Analgesics|analgesics|mesh-ancestor
56628793|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
56628794|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628800|NCT00897871|Carboplatin|carboplatin|mesh-list
56628801|NCT00897871|Etoposide|etoposide|mesh-list
56628802|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
56628803|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628804|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
56628805|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628806|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628807|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56628808|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
56628809|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628810|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628811|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56628812|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56628813|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56628814|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56628815|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628816|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
56628817|NCT00902707|Guaifenesin|guaifenesin|mesh-list
56628818|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56628819|NCT00902707|Expectorants|expectorants|mesh-ancestor
56628820|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
56628821|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56628822|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56628823|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
56904778|NCT03746223|Methotrexate|methotrexate|mesh-list
56904779|NCT03746223|Lenalidomide|lenalidomide|mesh-list
56904780|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56628824|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628825|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628826|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628827|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
56628828|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56628829|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
56628830|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
56628831|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628832|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
56628833|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56628834|NCT00906139|Fentanyl|fentanyl|mesh-list
56628835|NCT00906139|Midazolam|midazolam|mesh-list
56628836|NCT00906139|Propofol|propofol|mesh-list
56628837|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56628838|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56628839|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628840|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56628841|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
56628842|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
56628843|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56628844|NCT00906139|Narcotics|narcotics|mesh-ancestor
56628845|NCT00906139|Analgesics|analgesics|mesh-ancestor
56628846|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
56628847|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628848|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56628849|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56628850|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56628851|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56628852|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
56628853|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
56628854|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628855|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628856|NCT00906295|Chrysarobin|chrysarobin|mesh-list
56628857|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56628858|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56628859|NCT00906295|Analgesics|analgesics|mesh-ancestor
56628860|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
56628861|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628862|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628863|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56628864|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628865|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
56628866|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56628900|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628901|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56628903|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
56628920|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56628921|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628922|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628923|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
56628924|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628925|NCT00906451|Simvastatin|simvastatin|mesh-list
56628926|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56628927|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56628928|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
56628929|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628930|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56628931|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56628932|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628933|NCT00898417|Paclitaxel|paclitaxel|mesh-list
56628934|NCT00898417|Bevacizumab|bevacizumab|mesh-list
56628935|NCT00898417|Carboplatin|carboplatin|mesh-list
56628936|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56628937|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628938|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
56628939|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
56628940|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
56628941|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628942|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56628943|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56904781|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904782|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
56904783|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904784|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628944|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56628945|NCT00898417|Growth Substances|growth substances|mesh-ancestor
56628946|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628947|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
56628948|NCT05381363|Interferons|interferons|mesh-list
56628949|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628950|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
56628951|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628952|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
56628953|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
56628954|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56628955|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628956|NCT00783705|Inositol|inositol|mesh-list
56628957|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
56628958|NCT00783705|Vitamins|vitamins|mesh-ancestor
56628959|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
56628960|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628966|NCT04268303|Analgesics|analgesics|mesh-ancestor
56628967|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
56628968|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628969|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56628970|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56628971|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56628972|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
56628973|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628974|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628975|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56628976|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56628977|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56628978|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628979|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628980|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
56628981|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628982|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56628983|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56628984|NCT04103697|Capecitabine|capecitabine|mesh-list
56628985|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
56628986|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628987|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
56628988|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628989|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628990|NCT00898573|Lapatinib|lapatinib|mesh-list
56628991|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628992|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56628993|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628994|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628996|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
56628997|NCT04321668|Protective Agents|protective agents|mesh-ancestor
56628998|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628999|NCT02851745|Linagliptin|linagliptin|mesh-list
56629000|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56629001|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629002|NCT02851745|Incretins|incretins|mesh-ancestor
56629003|NCT02851745|Hormones|hormones|mesh-ancestor
56629004|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629005|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56629006|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
56629007|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629008|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629009|NCT02602197|Acetaminophen|acetaminophen|mesh-list
56629010|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56629011|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56629012|NCT02602197|Analgesics|analgesics|mesh-ancestor
56629013|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
56629014|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629015|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629016|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
56510161|NCT01645449|Atorvastatin|atorvastatin|mesh-list
56629017|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56629018|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629019|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56629020|NCT02753712|Fluticasone|fluticasone|mesh-list
56629021|NCT02753712|Xhance|xhance|mesh-list
56629022|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
56629023|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629024|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56629025|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
56629026|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629027|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629028|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56629029|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
56629034|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56629035|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
56629036|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629037|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629040|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56629041|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629042|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629043|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629044|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56629045|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56629046|NCT02696148|Liraglutide|liraglutide|mesh-list
56629047|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56629048|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629049|NCT02696148|Incretins|incretins|mesh-ancestor
56629050|NCT02696148|Hormones|hormones|mesh-ancestor
56629051|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629052|NCT00887198|Prednisone|prednisone|mesh-list
56629053|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
56629054|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629055|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
56629056|NCT00887198|Hormones|hormones|mesh-ancestor
56629057|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629058|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629059|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56629060|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629061|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56629062|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629063|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629064|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
56629065|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56629066|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56629067|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629068|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629069|NCT00782067|Midostaurin|midostaurin|mesh-list
56629070|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629071|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56629072|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629073|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629074|NCT05520723|Loperamide|loperamide|mesh-list
56629075|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
56629076|NCT05520723|Lenograstim|lenograstim|mesh-list
56629077|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56629078|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
56629079|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629080|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629081|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
56629082|NCT02826746|Analgesics|analgesics|mesh-ancestor
56629083|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
56629084|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629085|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629086|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
56629087|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629088|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56629089|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
56629090|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56629091|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629092|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629093|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56629094|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
56904785|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56904786|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
56904787|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56904788|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56904789|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
56629095|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56629096|NCT02750904|Nicotine|nicotine|mesh-list
56629097|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56629098|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
56629099|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629102|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56629103|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
56629104|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629105|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629106|NCT02831972|Itraconazole|itraconazole|mesh-list
56629107|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
56629108|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629109|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56629110|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56629112|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629113|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56629114|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
56629115|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629116|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629117|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56629118|NCT02695758|Bupivacaine|bupivacaine|mesh-list
56629119|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
56629120|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
56629121|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629122|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629123|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
56629124|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629125|NCT04141644|Ipilimumab|ipilimumab|mesh-list
56629126|NCT04141644|Osimertinib|osimertinib|mesh-list
56629127|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56629128|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629129|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56629130|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629131|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56629132|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629133|NCT00605215|Interferons|interferons|mesh-list
56629134|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
56629135|NCT00605215|Interferon-beta|interferon-beta|mesh-list
56629136|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629137|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
56629138|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629139|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56629140|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
56629141|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629142|NCT02827682|Anesthetics|anesthetics|mesh-list
56629143|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629144|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629145|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
56629146|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
56629147|NCT04244708|Temozolomide|temozolomide|mesh-list
56629148|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56629149|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
56629150|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629151|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629152|NCT02750748|Naltrexone|naltrexone|mesh-list
56629153|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56629154|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56629155|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629156|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
56629157|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629158|NCT00604279|Risperidone|risperidone|mesh-list
56629159|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56629160|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56629162|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904790|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904791|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
56629163|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629164|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629165|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56629166|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56629167|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629168|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56629169|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56629170|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
56629171|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56629172|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56629183|NCT00906685|Growth Substances|growth substances|mesh-ancestor
56629184|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629185|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
56629186|NCT05660720|Moxifloxacin|moxifloxacin|mesh-list
56629187|NCT05660720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56629188|NCT05660720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56629189|NCT05660720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629190|NCT05660720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56629191|NCT05660720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56629192|NCT05660720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629193|NCT05660720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629194|NCT05660720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629195|NCT05660720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56629196|NCT05660720|Contraceptive Agents|contraceptive agents|mesh-ancestor
56629197|NCT05660720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56629198|NCT05660720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629199|NCT05660720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56629200|NCT05660720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56629201|NCT05660720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56629202|NCT02695212|Apremilast|apremilast|mesh-list
56629203|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56629204|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56629205|NCT02695212|Analgesics|analgesics|mesh-ancestor
56629206|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
56629207|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629208|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629209|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629210|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56629211|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56629212|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56629213|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629214|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629215|NCT05381207|Fluticasone|fluticasone|mesh-list
56629216|NCT05381207|Xhance|xhance|mesh-list
56629217|NCT05381207|Montelukast|montelukast|mesh-list
56629218|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629219|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56629220|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
56629221|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629222|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629223|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56629224|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
56629225|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
56629226|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56629227|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56629228|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
56159960|NCT05093790|Ticagrelor|ticagrelor|mesh-list
56629229|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629230|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56629231|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56629248|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
56629249|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629250|NCT02750670|Antiviral Agents|antiviral agents|mesh-ancestor
56629251|NCT02750670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629252|NCT02750670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629253|NCT02750670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56629254|NCT02750670|Immunologic Factors|immunologic factors|mesh-ancestor
56629255|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56904792|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904793|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56510387|NCT01681134|Tacrolimus|tacrolimus|mesh-list
56629256|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56629257|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56629258|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
56629259|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629260|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629261|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56629262|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
56629263|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56629264|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56629265|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56629266|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56629267|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629268|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629269|NCT05122208|Famotidine|famotidine|mesh-list
56629270|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56629271|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629272|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56629273|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
56629274|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
56629275|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629276|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629277|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629278|NCT00781911|Octreotide|octreotide|mesh-list
56629279|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629280|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56629281|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629282|NCT00605917|Sertraline|sertraline|mesh-list
56629283|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
56629284|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56629285|NCT00605917|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56629286|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56629287|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629288|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629297|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
56629299|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56629300|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56629302|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56629303|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56629304|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
56629305|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629306|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629307|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629308|NCT00904111|Lidocaine|lidocaine|mesh-list
56629309|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
56629310|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
56629311|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629312|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629313|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
56629314|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629315|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56629316|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56629317|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56629318|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629319|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629320|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
56629321|NCT03240211|Decitabine|decitabine|mesh-list
56629322|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56629323|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629324|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56629325|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
56629326|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629327|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629329|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56629330|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629331|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56629332|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629333|NCT00899197|Tamoxifen|tamoxifen|mesh-list
56904794|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56510460|NCT04543565|Tenofovir|tenofovir|mesh-list
56629334|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56629335|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
56629336|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629337|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629338|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56629339|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629340|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56629341|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56629342|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56629343|NCT00603083|Ketorolac|ketorolac|mesh-list
56629344|NCT00603083|Ropivacaine|ropivacaine|mesh-list
56629345|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
56629346|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
56629347|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629348|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629349|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
56629350|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629351|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56629352|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56629353|NCT00603083|Analgesics|analgesics|mesh-ancestor
56629354|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629365|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629366|NCT04241744|Vancomycin|vancomycin|mesh-list
56629367|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56629368|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629369|NCT02824094|Crizotinib|crizotinib|mesh-list
56629371|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56629372|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629373|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629374|NCT00899587|Enalapril|enalapril|mesh-list
56629375|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56629376|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
56629377|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629378|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629379|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56629380|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56629381|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56629382|NCT02824406|Acetazolamide|acetazolamide|mesh-list
56629383|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
56629384|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56629385|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629386|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629387|NCT02824406|Diuretics|diuretics|mesh-ancestor
56629388|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
56629389|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629390|NCT04267679|Cannabidiol|cannabidiol|mesh-list
56629391|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
56629392|NCT00915837|Triamcinolone|triamcinolone|mesh-list
56629393|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56629394|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56629395|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56629396|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629397|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
56629398|NCT00915837|Hormones|hormones|mesh-ancestor
56629399|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56377955|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
56629400|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629401|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56629402|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
56629403|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629404|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629405|NCT04951388|Somatomedin B|somatomedin b|mesh-list
56629406|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56629407|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56629408|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
56629409|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629410|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629411|NCT04242914|Midazolam|midazolam|mesh-list
56629412|NCT04242914|Ketamine|ketamine|mesh-list
56629413|NCT04242914|Analgesics|analgesics|mesh-ancestor
56629414|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
56904795|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56904796|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56904797|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56904798|NCT03746223|Growth Substances|growth substances|mesh-ancestor
56904799|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
56904800|NCT03969017|Interferons|interferons|mesh-list
56629415|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629416|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629417|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56629418|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56629428|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56629429|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56629430|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56629431|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
56629432|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
56629433|NCT00780273|Cimetidine|cimetidine|mesh-list
56629434|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56629435|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629436|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56629437|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
56629438|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
56629439|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629440|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629441|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629442|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56629443|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56629444|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629445|NCT02827136|Lidocaine|lidocaine|mesh-list
56629446|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
56629447|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
56629448|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629449|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629450|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
56629451|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629452|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56629453|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56629454|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56629455|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629456|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629457|NCT04102995|Pregnanolone|pregnanolone|mesh-list
56629458|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
56629459|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629460|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629461|NCT00899821|Aldesleukin|aldesleukin|mesh-list
56629462|NCT00899821|Interleukin-12|interleukin-12|mesh-list
56629463|NCT00899821|Sargramostim|sargramostim|mesh-list
56629464|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
56629465|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629466|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629467|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56629468|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56629469|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
56629470|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629471|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56629472|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56629473|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56629474|NCT00899821|Growth Substances|growth substances|mesh-ancestor
56629475|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
56629476|NCT00005112|Hormones|hormones|mesh-list
56629477|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629478|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629479|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
56629480|NCT04163406|Trace Elements|trace elements|mesh-ancestor
56629481|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
56629482|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629483|NCT04218552|Amlodipine|amlodipine|mesh-list
56629508|NCT00904657|Sunitinib|sunitinib|mesh-list
56629509|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629510|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56075358|NCT04926233|Olodaterol|olodaterol|mesh-list
56510595|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629511|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56629512|NCT00904657|Growth Substances|growth substances|mesh-ancestor
56629513|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629514|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
56629515|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56629516|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629517|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629518|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
56629519|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
56629520|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629521|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56629522|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629523|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629524|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
56629525|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56629526|NCT02823626|Spironolactone|spironolactone|mesh-list
56629527|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56629528|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
56629529|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629530|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629531|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56629532|NCT02823626|Diuretics|diuretics|mesh-ancestor
56629533|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
56629534|NCT00779259|Quinine|quinine|mesh-list
56629535|NCT00779259|Theophylline|theophylline|mesh-list
56629536|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56629537|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
56629538|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629539|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629540|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56629541|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
56629542|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56629543|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629544|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629545|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
56629546|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56629547|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56629548|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
56629549|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629550|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
56629551|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56629552|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56629553|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629554|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56629555|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56629556|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56629557|NCT00779259|Analgesics|analgesics|mesh-ancestor
56629558|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
56629559|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
56629574|NCT00915915|Femovan|femovan|mesh-list
56629575|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56629576|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56629577|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56629578|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
56629579|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56629580|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629581|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56629582|NCT00915915|Estrogens|estrogens|mesh-ancestor
56629583|NCT00915915|Hormones|hormones|mesh-ancestor
56629584|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629585|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56629586|NCT00915915|Progestins|progestins|mesh-ancestor
56629587|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56629588|NCT02538367|Prucalopride|prucalopride|mesh-list
56629589|NCT02538367|YH12852|yh12852|mesh-list
56629590|NCT02538367|Laxatives|laxatives|mesh-ancestor
56629591|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629592|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56629593|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56629594|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
56629595|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629596|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904801|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904802|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
56904803|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629597|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629598|NCT00900445|Prednisone|prednisone|mesh-list
56629599|NCT00900445|Prednisolone|prednisolone|mesh-list
56629600|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56629601|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
56629602|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56629603|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
56629604|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
56629605|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56629606|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56629607|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56629608|NCT00900445|Cortisone|cortisone|mesh-list
56629609|NCT00900445|Vincristine|vincristine|mesh-list
56629610|NCT00900445|Daunorubicin|daunorubicin|mesh-list
56629611|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56629612|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
56629613|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629614|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
56629615|NCT00900445|Hormones|hormones|mesh-ancestor
56629616|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629617|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629618|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56629619|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629620|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56629621|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
56629622|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
56629631|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56629632|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56629633|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56629634|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629635|NCT03994419|Anesthetics|anesthetics|mesh-list
56629636|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629637|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629638|NCT00936065|Etanercept|etanercept|mesh-list
56629639|NCT00936065|Acitretin|acitretin|mesh-list
56629640|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56629641|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56629642|NCT00936065|Analgesics|analgesics|mesh-ancestor
56629643|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
56629644|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629645|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629646|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629647|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56629648|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629649|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56629650|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
56629651|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
56629652|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
56629653|NCT04241276|Gemcitabine|gemcitabine|mesh-list
56629654|NCT04241276|Paclitaxel|paclitaxel|mesh-list
56629655|NCT04241276|Tretinoin|tretinoin|mesh-list
56629656|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56629657|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629658|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
56629659|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
56629660|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063477|NCT03962725|Ketamine|ketamine|mesh-list
56629661|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629662|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56629663|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
56629664|NCT04241276|Antiviral Agents|antiviral agents|mesh-ancestor
56629665|NCT04241276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629666|NCT04241276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629667|NCT04241276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56629668|NCT04241276|Immunologic Factors|immunologic factors|mesh-ancestor
56629669|NCT04241276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629670|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
56629671|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
56629672|NCT00905047|Leucovorin|leucovorin|mesh-list
56629673|NCT00905047|Folic Acid|folic acid|mesh-list
56629674|NCT00905047|Tegafur|tegafur|mesh-list
56629675|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
56075493|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56904804|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
56904805|NCT04596033|Fludarabine|fludarabine|mesh-list
56904806|NCT04596033|Interleukin-2|interleukin-2|mesh-list
56904807|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904808|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
56629676|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56629677|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
56629678|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629679|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629680|NCT00905047|Antidotes|antidotes|mesh-ancestor
56629681|NCT00905047|Protective Agents|protective agents|mesh-ancestor
56629682|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629683|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
56629684|NCT00905047|Vitamins|vitamins|mesh-ancestor
56629685|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
56629686|NCT00905047|Hematinics|hematinics|mesh-ancestor
56629687|NCT04102449|Apremilast|apremilast|mesh-list
56629688|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56629689|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56629690|NCT04102449|Analgesics|analgesics|mesh-ancestor
56629700|NCT02823236|Triamcinolone|triamcinolone|mesh-list
56629701|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56629702|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56629704|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56629705|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629706|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
56629707|NCT02823236|Hormones|hormones|mesh-ancestor
56629708|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629709|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629710|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56629711|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
56629712|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629713|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629714|NCT02823236|Analgesics|analgesics|mesh-ancestor
56629715|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
56629716|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629717|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56629718|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56629719|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56629720|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629721|NCT00633698|Niacin|niacin|mesh-list
56629722|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
56629723|NCT00633698|Niacinamide|niacinamide|mesh-list
56629724|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56629725|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
56629726|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629727|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56629728|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
56629729|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
56629730|NCT00633698|Vitamins|vitamins|mesh-ancestor
56629731|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
56629732|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629733|NCT02825342|Citalopram|citalopram|mesh-list
56629734|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56629735|NCT02825342|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56629736|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56629737|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629738|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629739|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629740|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
56629741|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629742|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56629743|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
56629744|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56629745|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629746|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
56629747|NCT02749890|Lixisenatide|lixisenatide|mesh-list
56629748|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56629749|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629750|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
56629751|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56629752|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56904809|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629753|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629754|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56629755|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629763|NCT02745912|Bupropion|bupropion|mesh-list
56629764|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56629765|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629766|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56629767|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56629768|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
56629769|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629770|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56629771|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
56629772|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56629773|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56629774|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56629775|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629776|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629777|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
56629778|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629779|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56629780|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56629781|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629782|NCT02825186|Dexamethasone|dexamethasone|mesh-list
56629783|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629784|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
56629785|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
56629786|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629787|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629788|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629789|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
56629790|NCT02825186|Hormones|hormones|mesh-ancestor
56629791|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629792|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56629793|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629794|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56629795|NCT00604825|Estrogens|estrogens|mesh-ancestor
56629796|NCT00604825|Hormones|hormones|mesh-ancestor
56629797|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629798|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629800|NCT04239560|Trace Elements|trace elements|mesh-ancestor
56629801|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
56629802|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629803|NCT04218162|Lasmiditan|lasmiditan|mesh-list
56629804|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56629805|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
56629806|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629807|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159974|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629808|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629809|NCT00606125|Sorafenib|sorafenib|mesh-list
56629810|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629811|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56629812|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629813|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629814|NCT04242212|Misoprostol|misoprostol|mesh-list
56629815|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56629816|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
56629817|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56629818|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629819|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56629820|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629821|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
56629822|NCT02851433|Anesthetics|anesthetics|mesh-list
56629838|NCT05629806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629839|NCT05629806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629840|NCT02745756|Vaccines|vaccines|mesh-list
56629841|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
56629842|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629843|NCT04242368|Fluticasone|fluticasone|mesh-list
56629844|NCT04242368|Xhance|xhance|mesh-list
56629845|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629846|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56904810|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904811|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56904812|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
56904813|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904814|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615474|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
56904815|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56629847|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
56629848|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629849|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629850|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56629851|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
56629852|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56629853|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56629854|NCT02822144|Lidocaine|lidocaine|mesh-list
56629855|NCT02822144|Remifentanil|remifentanil|mesh-list
56629856|NCT02822144|Propofol|propofol|mesh-list
56629857|NCT02822144|Etomidate|etomidate|mesh-list
56629858|NCT02822144|Succinylcholine|succinylcholine|mesh-list
56629859|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
56629860|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
56629861|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629862|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629863|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
56629864|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629865|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56629866|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56629867|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56629868|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629869|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629870|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56629871|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56629872|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
56629873|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56629874|NCT02822144|Narcotics|narcotics|mesh-ancestor
56629875|NCT02822144|Analgesics|analgesics|mesh-ancestor
56629876|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56629877|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56629878|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56629879|NCT04217148|Dexamethasone|dexamethasone|mesh-list
56629880|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
56629881|NCT04217148|Tretinoin|tretinoin|mesh-list
56629882|NCT04217148|BB 1101|bb 1101|mesh-list
56629883|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629884|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
56629885|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
56629896|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629897|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
56629898|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
56629899|NCT00900913|Ropivacaine|ropivacaine|mesh-list
56629900|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
56629901|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
56629902|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629903|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629904|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
56629905|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629906|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
56629907|NCT04216836|Antacids|antacids|mesh-ancestor
56629908|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629909|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629910|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
56629911|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
56629912|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56629913|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
56629914|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629915|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56629916|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56629917|NCT04034173|Leucovorin|leucovorin|mesh-list
56629918|NCT04034173|Folic Acid|folic acid|mesh-list
56629919|NCT04034173|Irinotecan|irinotecan|mesh-list
56904816|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56904817|NCT04596033|Analgesics|analgesics|mesh-ancestor
56904818|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
56904819|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904820|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
56904821|NCT02092558|Cephalosporins|cephalosporins|mesh-list
56904822|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56904823|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904824|NCT02092558|Renal Agents|renal agents|mesh-ancestor
56904825|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904826|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
56904827|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
56904828|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56904829|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
56904830|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629920|NCT04034173|Panitumumab|panitumumab|mesh-list
56629921|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
56629922|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56629923|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56629924|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629925|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629926|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629927|NCT04034173|Antidotes|antidotes|mesh-ancestor
56378472|NCT05569512|Busulfan|busulfan|mesh-list
56629928|NCT04034173|Protective Agents|protective agents|mesh-ancestor
56629929|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629931|NCT04034173|Vitamins|vitamins|mesh-ancestor
56629932|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
56629933|NCT04034173|Hematinics|hematinics|mesh-ancestor
56629934|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56629935|NCT00606203|Milnacipran|milnacipran|mesh-list
56629936|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
56629937|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56629938|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56629939|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629940|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629941|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629942|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629943|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56629944|NCT00606203|Analgesics|analgesics|mesh-ancestor
56629945|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
56629946|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629947|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
56629948|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56629949|NCT02539849|Adalimumab|adalimumab|mesh-list
56629950|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629954|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56629955|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
56629956|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629957|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56159975|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
56629958|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56629959|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629960|NCT05378867|Bevacizumab|bevacizumab|mesh-list
56629961|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56629962|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629963|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56629964|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56629965|NCT05378867|Growth Substances|growth substances|mesh-ancestor
56629966|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629967|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
56629968|NCT02749656|Desoximetasone|desoximetasone|mesh-list
56629969|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629970|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
56629971|NCT02749656|Hormones|hormones|mesh-ancestor
56629972|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629973|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629974|NCT00603317|Amoxicillin|amoxicillin|mesh-list
56629975|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
56629976|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
56629977|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56629978|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56629979|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629980|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629981|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629982|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56629983|NCT02745522|Oxytocin|oxytocin|mesh-list
56629984|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
56629985|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56629986|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629987|NCT02824718|Teriparatide|teriparatide|mesh-list
56629988|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
56629989|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56629990|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
56629991|NCT02824718|Diuretics|diuretics|mesh-list
56629992|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
56629993|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56629994|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629995|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56629996|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
56629997|NCT02824718|Vitamins|vitamins|mesh-ancestor
56629998|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
56629999|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56630000|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630001|NCT05378711|Fluoxetine|fluoxetine|mesh-list
56630002|NCT05378711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56630003|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56630004|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56630005|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630006|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630007|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
56630008|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630009|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56630010|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
56630011|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56630012|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56630013|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56630014|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630015|NCT00777153|Cediranib|cediranib|mesh-list
56630016|NCT00777153|Lomustine|lomustine|mesh-list
56630017|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630018|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56630019|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630020|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630024|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56630025|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
56630027|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56630028|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063849|NCT04062097|Vitamin K|vitamin k|mesh-list
56630029|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56630030|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56630031|NCT04266509|Rifampin|rifampin|mesh-list
56630032|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56630033|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
56630034|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56630035|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630036|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
56630037|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56630038|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630039|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630040|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56630041|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56630042|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56630043|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56075494|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56904831|NCT01074359|Protective Agents|protective agents|mesh-ancestor
56904832|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904833|NCT02087722|Melatonin|melatonin|mesh-list
56511096|NCT01684449|Sirolimus|sirolimus|mesh-list
56630044|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56630045|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56630046|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56630047|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56630048|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630049|NCT02824874|Incretins|incretins|mesh-ancestor
56630050|NCT02824874|Hormones|hormones|mesh-ancestor
56630051|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630052|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56630053|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
56630054|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630055|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630056|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
56630057|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56630058|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
56630059|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630060|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
56630061|NCT04204265|Protective Agents|protective agents|mesh-ancestor
56630062|NCT04267913|Dexamethasone|dexamethasone|mesh-list
56630063|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
56630064|NCT04267913|Docetaxel|docetaxel|mesh-list
56630065|NCT04267913|Ramucirumab|ramucirumab|mesh-list
56630066|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56630067|NCT04267913|Antibodies|antibodies|mesh-list
56630068|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
56630069|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56630070|NCT04267913|Lexatumumab|lexatumumab|mesh-list
56630071|NCT04267913|BB 1101|bb 1101|mesh-list
56630072|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
56630073|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630074|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630075|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
56630076|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
56630077|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378628|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
56630078|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56630079|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
56630081|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630082|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56630083|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630084|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
56630085|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630086|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630087|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
56630088|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
56630089|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
56630090|NCT04216758|Gemcitabine|gemcitabine|mesh-list
56630091|NCT04216758|Paclitaxel|paclitaxel|mesh-list
56630092|NCT04216758|Tegafur|tegafur|mesh-list
56630098|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630099|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630100|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
56630101|NCT04216758|Antiviral Agents|antiviral agents|mesh-ancestor
56630102|NCT04216758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630103|NCT04216758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630104|NCT04216758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630105|NCT04216758|Immunologic Factors|immunologic factors|mesh-ancestor
56630106|NCT04216758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630107|NCT00606437|Fludarabine|fludarabine|mesh-list
56630108|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630110|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56630111|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
56630112|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630113|NCT02821676|Anesthetics|anesthetics|mesh-list
56630114|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630115|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630116|NCT02745054|Anticoagulants|anticoagulants|mesh-list
56630117|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
56630118|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
56630119|NCT00908089|Prednisolone|prednisolone|mesh-list
56904834|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
56511155|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630120|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56630121|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
56630122|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56630123|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
56630124|NCT00908089|Infliximab|infliximab|mesh-list
56630125|NCT00908089|Naltrexone|naltrexone|mesh-list
56630126|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56630127|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
56630128|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630129|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
56630130|NCT00908089|Hormones|hormones|mesh-ancestor
56630131|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630132|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630133|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56630134|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630135|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
56630136|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
56630137|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630138|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56630139|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56630140|NCT00908089|Protective Agents|protective agents|mesh-ancestor
56630141|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
56630142|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630143|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630144|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56630145|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56630146|NCT00908089|Analgesics|analgesics|mesh-ancestor
56630147|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
56630148|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56630149|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56378704|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56630150|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
56630151|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56630152|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56630153|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630154|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630155|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56630156|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56630157|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630158|NCT05378555|Ketamine|ketamine|mesh-list
56630159|NCT05378555|Analgesics|analgesics|mesh-ancestor
56630160|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
56630161|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630162|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630172|NCT03553446|Sevoflurane|sevoflurane|mesh-list
56630173|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56630174|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56630175|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
56630176|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
56630177|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630178|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630180|NCT00908167|Clofarabine|clofarabine|mesh-list
56630181|NCT00908167|Sorafenib|sorafenib|mesh-list
56630182|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630183|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
56630184|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630185|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630186|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
56630187|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630188|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630189|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
56630190|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630191|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56630192|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630193|NCT02821052|Insulin|insulin|mesh-list
56630194|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
56630195|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56630196|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630197|NCT00606515|Paclitaxel|paclitaxel|mesh-list
56630198|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56630199|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56630200|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630201|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
56904835|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904836|NCT02087722|Protective Agents|protective agents|mesh-ancestor
56630202|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
56630203|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
56630204|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630205|NCT00908323|Vaccines|vaccines|mesh-list
56630206|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
56630207|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630208|NCT02749032|Metformin|metformin|mesh-list
56630209|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56630210|NCT02749032|Vildagliptin|vildagliptin|mesh-list
56630211|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56630212|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630213|NCT02749032|Incretins|incretins|mesh-ancestor
56630214|NCT02749032|Hormones|hormones|mesh-ancestor
56630215|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630216|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56630217|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
56630218|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630219|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630220|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
56630221|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56630222|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56630223|NCT00908713|Prednisolone|prednisolone|mesh-list
56630224|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
56630225|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56630226|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
56630227|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630228|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
56630229|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
56630233|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
56630234|NCT00908713|Hormones|hormones|mesh-ancestor
56630235|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630236|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56630237|NCT00908713|Protective Agents|protective agents|mesh-ancestor
56630238|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56630239|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630240|NCT00908869|Interferons|interferons|mesh-list
56630241|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
56630242|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
56630243|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
56630244|NCT00908869|Vinorelbine|vinorelbine|mesh-list
56630245|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630246|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
56630247|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630248|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630249|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56630250|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
56630251|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630252|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630253|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56630254|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
56630255|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630256|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56630257|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
56630258|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
56630259|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
56630260|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
56630261|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
56630262|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56630263|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630264|NCT03465774|Doxycycline|doxycycline|mesh-list
56630265|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56630266|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630267|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
56630268|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56630269|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56630270|NCT04240496|Clozapine|clozapine|mesh-list
56630271|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56630272|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
56630273|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630274|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630275|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630276|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56904837|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904838|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56904839|NCT01326221|Tenofovir|tenofovir|mesh-list
56904840|NCT01326221|Emtricitabine|emtricitabine|mesh-list
56904841|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
56904842|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904843|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56904844|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56904845|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904846|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904847|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56511302|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
56630277|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56630278|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630279|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56630280|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
56630281|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
56630282|NCT03450018|Gemcitabine|gemcitabine|mesh-list
56630283|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630284|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
56630285|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630286|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630287|NCT03450018|Antiviral Agents|antiviral agents|mesh-ancestor
56630288|NCT03450018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630289|NCT03450018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630290|NCT03450018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630291|NCT03450018|Immunologic Factors|immunologic factors|mesh-ancestor
56630292|NCT03450018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630293|NCT00909337|Bosentan|bosentan|mesh-list
56630294|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56630295|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56630296|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630297|NCT00909571|Tacrolimus|tacrolimus|mesh-list
56630298|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630299|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
56630300|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630301|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56630302|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630307|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56630308|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56630309|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56630310|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630311|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630312|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
56630313|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56630314|NCT04239794|Propofol|propofol|mesh-list
56630315|NCT04239794|Sevoflurane|sevoflurane|mesh-list
56630316|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56630317|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630318|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630319|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56630320|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
56630321|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
56630322|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56630323|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56630324|NCT02850887|Anesthetics|anesthetics|mesh-list
56630325|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630326|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630328|NCT00931645|Dexamethasone|dexamethasone|mesh-list
56630329|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
56630330|NCT00931645|Cisplatin|cisplatin|mesh-list
56630331|NCT00931645|Fludarabine|fludarabine|mesh-list
56630332|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630333|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
56904848|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56904849|NCT04311177|Losartan|losartan|mesh-list
56904850|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56511403|NCT04535960|Hormones|hormones|mesh-ancestor
56630334|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630335|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630336|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56630337|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
56630338|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630339|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630340|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56630341|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630342|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
56630343|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
56630344|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630345|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56630346|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
56630347|NCT00931645|Hormones|hormones|mesh-ancestor
56630348|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630349|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56630350|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630351|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
56630352|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
56630353|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630354|NCT05658692|Anti-Infective Agents|anti-infective agents|mesh-list
56630355|NCT05658692|Dexamethasone|dexamethasone|mesh-list
56630356|NCT05658692|Hydrocortisone|hydrocortisone|mesh-list
56630357|NCT05658692|Simendan|simendan|mesh-list
56630358|NCT05658692|Dopamine|dopamine|mesh-list
56630359|NCT05658692|Isoproterenol|isoproterenol|mesh-list
56630360|NCT05658692|Olprinone|olprinone|mesh-list
56630361|NCT05658692|Epinephrine|epinephrine|mesh-list
56630362|NCT05658692|Norepinephrine|norepinephrine|mesh-list
56630363|NCT05658692|Metaraminol|metaraminol|mesh-list
56630364|NCT05658692|Midazolam|midazolam|mesh-list
56630365|NCT05658692|Dexmedetomidine|dexmedetomidine|mesh-list
56630366|NCT05658692|Bromides|bromides|mesh-list
56630367|NCT05658692|Propofol|propofol|mesh-list
56630368|NCT05658692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56630369|NCT05658692|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56630370|NCT05658692|Simvastatin|simvastatin|mesh-list
56630371|NCT05658692|Glucocorticoids|glucocorticoids|mesh-list
56630372|NCT05658692|Succinylcholine|succinylcholine|mesh-list
56630373|NCT05658692|Vecuronium Bromide|vecuronium bromide|mesh-list
56630374|NCT05658692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630375|NCT05658692|Antiemetics|antiemetics|mesh-ancestor
56630376|NCT05658692|Autonomic Agents|autonomic agents|mesh-ancestor
56630377|NCT05658692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630385|NCT05658692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630386|NCT05658692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630387|NCT05658692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56630389|NCT05658692|Anesthetics|anesthetics|mesh-ancestor
56630390|NCT05658692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56630391|NCT05658692|Analgesics|analgesics|mesh-ancestor
56630392|NCT05658692|Sensory System Agents|sensory system agents|mesh-ancestor
56630393|NCT05658692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56630394|NCT05658692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56630395|NCT05658692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56630396|NCT05658692|Adrenergic Agents|adrenergic agents|mesh-ancestor
56630397|NCT05658692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630398|NCT05658692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56630399|NCT05658692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56630400|NCT05658692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56630401|NCT05658692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56630402|NCT05658692|GABA Modulators|gaba modulators|mesh-ancestor
56630403|NCT05658692|GABA Agents|gaba agents|mesh-ancestor
56630404|NCT05658692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56630405|NCT05658692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56630406|NCT05658692|Antimetabolites|antimetabolites|mesh-ancestor
56630407|NCT05658692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56630408|NCT05658692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56630409|NCT05658692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56630410|NCT05658692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56630411|NCT05658692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56630412|NCT05658692|Respiratory System Agents|respiratory system agents|mesh-ancestor
56630413|NCT05658692|Mydriatics|mydriatics|mesh-ancestor
56904851|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56904852|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56511449|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
56630414|NCT05658692|Sympathomimetics|sympathomimetics|mesh-ancestor
56630415|NCT05658692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56630416|NCT05658692|Anticonvulsants|anticonvulsants|mesh-ancestor
56630417|NCT05658692|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56630418|NCT05658692|Vasodilator Agents|vasodilator agents|mesh-ancestor
56630419|NCT05658692|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56630420|NCT05658692|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56630421|NCT05658692|Protective Agents|protective agents|mesh-ancestor
56630422|NCT05658692|Dopamine Agents|dopamine agents|mesh-ancestor
56630423|NCT05658692|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56630424|NCT05658692|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56630425|NCT05658692|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56630426|NCT05658692|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56630427|NCT05658692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56630428|NCT05658692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56630429|NCT05658692|Cholinergic Agents|cholinergic agents|mesh-ancestor
56630430|NCT05658692|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56630431|NCT02744508|Dexamethasone|dexamethasone|mesh-list
56630432|NCT02744508|Palonosetron|palonosetron|mesh-list
56630433|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630434|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
56630435|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
56630436|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630437|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630438|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56630439|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
56630440|NCT02744508|Hormones|hormones|mesh-ancestor
56630441|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630445|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56630446|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
56630447|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630448|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630450|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56630451|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630452|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56630453|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56630454|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
56630455|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630456|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630457|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
56630458|NCT04637594|Nivolumab|nivolumab|mesh-list
56630460|NCT04637594|Avelumab|avelumab|mesh-list
56630461|NCT04637594|Atezolizumab|atezolizumab|mesh-list
56630462|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56630463|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630464|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56630465|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630466|NCT03211338|Progesterone|progesterone|mesh-list
56630467|NCT03211338|Mitogens|mitogens|mesh-list
56630468|NCT03211338|Progestins|progestins|mesh-ancestor
56630469|NCT03211338|Hormones|hormones|mesh-ancestor
56630470|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630471|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630472|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
56630473|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630474|NCT00936611|Panobinostat|panobinostat|mesh-list
56630475|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159988|NCT04933344|Daptomycin|daptomycin|mesh-list
56630476|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56630477|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630478|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630479|NCT02744196|Methotrexate|methotrexate|mesh-list
56630480|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630481|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
56630482|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630483|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630484|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56630485|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
56904853|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56511526|NCT02218658|Brotizolam|brotizolam|mesh-list
56630486|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56630487|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630488|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
56630489|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630490|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
56630491|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630492|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56630493|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630494|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56630495|NCT02139852|Capsaicin|capsaicin|mesh-list
56630496|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
56630497|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56630498|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
56630499|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630500|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630501|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
56630502|NCT05379647|Rituximab|rituximab|mesh-list
56630503|NCT05379647|Fludarabine|fludarabine|mesh-list
56630504|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630505|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
56630506|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630507|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630508|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56630509|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
56630510|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630511|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630515|NCT02748330|Clopidogrel|clopidogrel|mesh-list
56630517|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56630518|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56630519|NCT02748330|Analgesics|analgesics|mesh-ancestor
56630520|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
56630521|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630522|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630523|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630524|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630525|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56630526|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56630527|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630528|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56630529|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56630530|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630531|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
56630532|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56630533|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56630534|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56630535|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
56630536|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630537|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
56630538|NCT05379569|Fludarabine|fludarabine|mesh-list
56630539|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630540|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
56630541|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630542|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630543|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56630544|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
56630545|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630546|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630547|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56630548|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
56630550|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
56630551|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630552|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
56630553|NCT02818556|Protective Agents|protective agents|mesh-ancestor
56630554|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56630555|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630556|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56630557|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630558|NCT04627142|Irinotecan|irinotecan|mesh-list
56630559|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56630560|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56630561|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904854|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904855|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
56904856|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56904857|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
56904858|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630562|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630563|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630564|NCT00936221|Dacarbazine|dacarbazine|mesh-list
56630565|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56630566|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
56630567|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630568|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630569|NCT00776919|Clindamycin|clindamycin|mesh-list
56630570|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
56630571|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
56630572|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56630573|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56630574|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630575|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56630576|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630577|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630578|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
56630579|NCT05657678|Vitamin D|vitamin d|mesh-list
56630580|NCT05657678|Ergocalciferols|ergocalciferols|mesh-list
56630581|NCT05657678|Cholecalciferol|cholecalciferol|mesh-list
56630582|NCT05657678|Vitamins|vitamins|mesh-list
56630583|NCT05657678|Micronutrients|micronutrients|mesh-ancestor
56630584|NCT05657678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630596|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630597|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56630599|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56630600|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630601|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56630602|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56630603|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
56630604|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
56630605|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630606|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
56630607|NCT04238702|Empagliflozin|empagliflozin|mesh-list
56630609|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56630610|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56630611|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56630612|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56630613|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630614|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56630615|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56630616|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630617|NCT00603785|Omalizumab|omalizumab|mesh-list
56630618|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56630619|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56630620|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
56630621|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
56630622|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56630623|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
56630624|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630625|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630627|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
56630628|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56630629|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56630630|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56630631|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
56630632|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630633|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630634|NCT05382923|Melatonin|melatonin|mesh-list
56630635|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
56630636|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630637|NCT05382923|Protective Agents|protective agents|mesh-ancestor
56630638|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904859|NCT01074593|Interferons|interferons|mesh-list
56904860|NCT01074593|Interferon-beta|interferon-beta|mesh-list
56630639|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630641|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56630642|NCT02743572|Trace Elements|trace elements|mesh-ancestor
56630643|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
56630644|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630645|NCT02743572|Hematinics|hematinics|mesh-ancestor
56630646|NCT00775593|Sirolimus|sirolimus|mesh-list
56630647|NCT00775593|Clofarabine|clofarabine|mesh-list
56630648|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56630649|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630658|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630660|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56630661|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56630662|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56630663|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
56630664|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630665|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630666|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630667|NCT00606983|Urological Agents|urological agents|mesh-ancestor
56630668|NCT02817932|Ranolazine|ranolazine|mesh-list
56630669|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56630670|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56630671|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630672|NCT02743260|Metformin|metformin|mesh-list
56630673|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56630674|NCT02743260|Adefovir|adefovir|mesh-list
56630675|NCT02743260|Digoxin|digoxin|mesh-list
56630676|NCT02743260|Pitavastatin|pitavastatin|mesh-list
56630677|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56630678|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630679|NCT02743260|Incretins|incretins|mesh-ancestor
56630680|NCT02743260|Hormones|hormones|mesh-ancestor
56379227|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630681|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630682|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56630683|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
56630684|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630685|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630686|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56630687|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56630688|NCT02743260|Protective Agents|protective agents|mesh-ancestor
56630689|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
56630690|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630691|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56630692|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56630693|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56630694|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56630695|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56630696|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
56630697|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56630698|NCT05629260|Cyclophosphamide|cyclophosphamide|mesh-list
56630699|NCT05629260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630700|NCT05629260|Immunologic Factors|immunologic factors|mesh-ancestor
56630701|NCT05629260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630702|NCT05629260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630703|NCT05629260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56630704|NCT05629260|Alkylating Agents|alkylating agents|mesh-ancestor
56630705|NCT05629260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630706|NCT05629260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630707|NCT05629260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56630708|NCT02819648|Prednisolone|prednisolone|mesh-list
56630709|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
56630710|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630712|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630713|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630725|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
56630726|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
56630727|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56630728|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630729|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
56630730|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630731|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
56630732|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630734|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630735|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630736|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
56630737|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56630738|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630739|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
56630740|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56630741|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630742|NCT02819414|Acetaminophen|acetaminophen|mesh-list
56630743|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56630744|NCT02819414|Analgesics|analgesics|mesh-ancestor
56630745|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
56630746|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630747|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630748|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
56630749|NCT02743104|Lidocaine|lidocaine|mesh-list
56630750|NCT02743104|Atropine|atropine|mesh-list
56630751|NCT02743104|Midazolam|midazolam|mesh-list
56630752|NCT02743104|Ketamine|ketamine|mesh-list
56630753|NCT02743104|Propofol|propofol|mesh-list
56630754|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
56630755|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
56630756|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630757|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630758|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
56630759|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630760|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56630761|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56630762|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56630763|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56630764|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630765|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56630766|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56630767|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
56630769|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56630770|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56630771|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56630772|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159991|NCT05406180|Vaccines|vaccines|mesh-list
56630773|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56630774|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56630775|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56630776|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56630777|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
56630779|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56630780|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
56630790|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56630791|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630792|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630793|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56630794|NCT00775203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56630795|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56630796|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56630797|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630798|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630799|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
56630800|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56630801|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
56630802|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56630803|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
56630804|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630805|NCT00607217|Vaccines|vaccines|mesh-list
56630806|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
56630807|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630809|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56630810|NCT02747316|Trace Elements|trace elements|mesh-ancestor
56630811|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
56630812|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630813|NCT05648708|Bupivacaine|bupivacaine|mesh-list
56630814|NCT05648708|Prilocaine|prilocaine|mesh-list
56630815|NCT05648708|Anesthetics, Local|anesthetics, local|mesh-ancestor
56630816|NCT05648708|Anesthetics|anesthetics|mesh-ancestor
56630817|NCT05648708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630818|NCT05648708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904861|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
56904862|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904863|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
56511820|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
56630819|NCT05648708|Sensory System Agents|sensory system agents|mesh-ancestor
56630820|NCT05648708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630821|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
56630822|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56630823|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630824|NCT00636246|Sertraline|sertraline|mesh-list
56630825|NCT00636246|Reboxetine|reboxetine|mesh-list
56630826|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
56630827|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56630828|NCT00636246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56630829|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56630830|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56630831|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630832|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630833|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
56630834|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630835|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56630836|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
56630837|NCT02819570|Ampicillin|ampicillin|mesh-list
56630838|NCT02819570|Cefuroxime|cefuroxime|mesh-list
56630839|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
56630840|NCT02819570|Roxithromycin|roxithromycin|mesh-list
56630841|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56630842|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630843|NCT04239170|Gemcitabine|gemcitabine|mesh-list
56630844|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
56630845|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630846|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
56630847|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630848|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630856|NCT04480190|Fluorouracil|fluorouracil|mesh-list
56630857|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630858|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630859|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
56630860|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630861|NCT04480190|Antiviral Agents|antiviral agents|mesh-ancestor
56630862|NCT04480190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630863|NCT04480190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630864|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630865|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
56630866|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630867|NCT02741856|Paclitaxel|paclitaxel|mesh-list
56630868|NCT02741856|Carboplatin|carboplatin|mesh-list
56630869|NCT02741856|Capecitabine|capecitabine|mesh-list
56630870|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56630871|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630872|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
56630873|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
56630874|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
56630875|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630876|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630877|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
56630878|NCT02741232|Lidocaine|lidocaine|mesh-list
56630879|NCT02741232|Epinephrine|epinephrine|mesh-list
56630880|NCT02741232|Racepinephrine|racepinephrine|mesh-list
56630881|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
56630882|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
56630883|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
56630884|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630885|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630886|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
56630887|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630888|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56630889|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56630890|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56630891|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56630892|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630893|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56630894|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56904864|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904865|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
56904866|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630895|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
56630896|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630897|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56630898|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56630899|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
56630900|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56630901|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
56630902|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
56630903|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
56630904|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56630905|NCT04237922|Clopidogrel|clopidogrel|mesh-list
56630906|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56630907|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56630908|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56630909|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56630910|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56630911|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
56630912|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630913|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630914|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630915|NCT04239014|Olaparib|olaparib|mesh-list
56630916|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56630941|NCT02819102|Berotralstat|berotralstat|mesh-list
56630942|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630943|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630944|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
56630945|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630946|NCT02819180|Vaccines|vaccines|mesh-list
56630947|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
56630948|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630949|NCT04661930|Fenofibrate|fenofibrate|mesh-list
56630950|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56630951|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
56630952|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630953|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56630954|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
56630955|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56630956|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56630957|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56630958|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56630959|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630960|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
56630961|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630962|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630963|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56630964|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630965|NCT02601963|Minocycline|minocycline|mesh-list
56630966|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56630967|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630980|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56630981|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630982|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630983|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
56630984|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630985|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630986|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
56630987|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630988|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56630989|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630990|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
56630991|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56630992|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56630993|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56630994|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
56630995|NCT00931957|Hormones|hormones|mesh-ancestor
56630996|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630997|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904867|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56904868|NCT02088970|Riboflavin|riboflavin|mesh-list
56904869|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56904870|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630998|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630999|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56631000|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56631001|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56631002|NCT00931957|Analgesics|analgesics|mesh-ancestor
56631003|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
56631004|NCT05508867|Gemcitabine|gemcitabine|mesh-list
56631005|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
56631006|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56631007|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56631008|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
56631009|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631010|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631011|NCT05508867|Antiviral Agents|antiviral agents|mesh-ancestor
56631012|NCT05508867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631013|NCT05508867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631014|NCT05508867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56631015|NCT05508867|Immunologic Factors|immunologic factors|mesh-ancestor
56631016|NCT05508867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631017|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56631018|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56631019|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
56631020|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
56631021|NCT02731950|Bupivacaine|bupivacaine|mesh-list
56631022|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
56631023|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
56631024|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631025|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631026|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
56631027|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631028|NCT02731950|Analgesics|analgesics|mesh-ancestor
56631029|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56631030|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
56631058|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56631059|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631060|NCT00928213|Progestins|progestins|mesh-ancestor
56631061|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56631062|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631063|NCT02736240|Vaccines|vaccines|mesh-list
56631064|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56631065|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
56631066|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631068|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56631069|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631070|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56631071|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56631072|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631073|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631074|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56631075|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
56631076|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631142|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56631143|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631144|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56631145|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631146|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631147|NCT04306692|Inositol|inositol|mesh-list
56631251|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631252|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56631253|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631254|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56631255|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
56631256|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631257|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56631258|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
56631259|NCT00607685|Protective Agents|protective agents|mesh-ancestor
56631260|NCT05450718|Buprenorphine|buprenorphine|mesh-list
56904871|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
56904872|NCT02088970|Vitamins|vitamins|mesh-ancestor
56904873|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
56631261|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56631262|NCT05450718|Naloxone|naloxone|mesh-list
56631263|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56631264|NCT05450718|Narcotics|narcotics|mesh-ancestor
56631265|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631266|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631267|NCT05450718|Analgesics|analgesics|mesh-ancestor
56631268|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
56631269|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631270|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56631271|NCT04265027|Opicapone|opicapone|mesh-list
56631272|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56631273|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631274|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631275|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56631276|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56631277|NCT00607763|Micafungin|micafungin|mesh-list
56631278|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
56631279|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631280|NCT00928915|Thrombin|thrombin|mesh-list
56379829|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
56631296|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56631298|NCT00939341|Budesonide|budesonide|mesh-list
56631299|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
56631300|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56631301|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56631302|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56631303|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
56631304|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631305|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631306|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56631307|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
56631308|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
56631309|NCT00939341|Hormones|hormones|mesh-ancestor
56631310|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631311|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56631312|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56631313|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56631314|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
56631315|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631316|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631317|NCT00925327|Riboflavin|riboflavin|mesh-list
56631318|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
56631319|NCT00925327|Vitamins|vitamins|mesh-ancestor
56631320|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
56631321|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631322|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56631323|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
56631324|NCT04237376|Tenofovir|tenofovir|mesh-list
56631325|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
56631326|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631327|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56631328|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56631329|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631330|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631331|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56631332|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56631333|NCT04015687|Lamotrigine|lamotrigine|mesh-list
56631334|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
56631335|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56631336|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176768|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56631363|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56631364|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56631366|NCT00932971|Tenofovir|tenofovir|mesh-list
56631367|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56631368|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
56631369|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
56631370|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56631371|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
56075495|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
56512100|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
56631372|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631373|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56631374|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56631375|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631376|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631377|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56631378|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56631379|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
56631380|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631403|NCT05788458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631405|NCT05788393|Dexmedetomidine|dexmedetomidine|mesh-list
56631406|NCT05788393|Anesthetics, Local|anesthetics, local|mesh-ancestor
56631407|NCT05788393|Anesthetics|anesthetics|mesh-ancestor
56631408|NCT05788393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631409|NCT05788393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631410|NCT05788393|Sensory System Agents|sensory system agents|mesh-ancestor
56631411|NCT05788393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631412|NCT05788393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56631413|NCT05788393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56631414|NCT05788393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56631415|NCT05788393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56631416|NCT05788393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631417|NCT05788393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56631418|NCT05788393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56631419|NCT05788393|Analgesics|analgesics|mesh-ancestor
56631420|NCT05788393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56631421|NCT05788393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56631422|NCT05788393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56631423|NCT05788393|Adrenergic Agents|adrenergic agents|mesh-ancestor
56631424|NCT05788393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631425|NCT05788328|Dabigatran|dabigatran|mesh-list
56631426|NCT05788328|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56631427|NCT05788328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56631428|NCT05788328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56631429|NCT05788328|Antimetabolites|antimetabolites|mesh-ancestor
56631430|NCT05788328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631431|NCT05788328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56631470|NCT05788081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631471|NCT05788081|Immunologic Factors|immunologic factors|mesh-ancestor
56631472|NCT05788081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631473|NCT05788081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631474|NCT05788081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56631475|NCT05788081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631476|NCT05788016|Analgesics, Opioid|analgesics, opioid|mesh-list
56631478|NCT05788016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631479|NCT05788016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631480|NCT05788016|Analgesics|analgesics|mesh-ancestor
56631481|NCT05788016|Sensory System Agents|sensory system agents|mesh-ancestor
56631482|NCT05788016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631483|NCT05787925|Vitamin E|vitamin e|mesh-list
56631484|NCT05787925|Vitamins|vitamins|mesh-ancestor
56631485|NCT05787925|Micronutrients|micronutrients|mesh-ancestor
56631486|NCT05787925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631487|NCT05787925|Antioxidants|antioxidants|mesh-ancestor
56631488|NCT05787925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631489|NCT05787925|Protective Agents|protective agents|mesh-ancestor
56631490|NCT05787912|Hyaluronic Acid|hyaluronic acid|mesh-list
56631491|NCT05787912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56631492|NCT05787912|Immunologic Factors|immunologic factors|mesh-ancestor
56631493|NCT05787912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631494|NCT05787912|Viscosupplements|viscosupplements|mesh-ancestor
56631495|NCT05787912|Protective Agents|protective agents|mesh-ancestor
56631588|NCT05786885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631590|NCT05786885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631591|NCT05786885|Protective Agents|protective agents|mesh-ancestor
56631592|NCT05786859|Rifaximin|rifaximin|mesh-list
56631593|NCT05786859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56631594|NCT05786859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631595|NCT05786859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56631596|NCT05786820|Pycnogenols|pycnogenols|mesh-list
56631597|NCT05786820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56631598|NCT05786820|Immunologic Factors|immunologic factors|mesh-ancestor
56904874|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904875|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56904876|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
56631599|NCT05786820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631600|NCT05786820|Antioxidants|antioxidants|mesh-ancestor
56631601|NCT05786820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631602|NCT05786820|Protective Agents|protective agents|mesh-ancestor
56631603|NCT05786820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56631604|NCT05786768|Rituximab|rituximab|mesh-list
56631605|NCT05786768|Obinutuzumab|obinutuzumab|mesh-list
56631606|NCT05786768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56631607|NCT05786768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631608|NCT05786768|Immunologic Factors|immunologic factors|mesh-ancestor
56631609|NCT05786768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631610|NCT05786768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631615|NCT05785897|Sirolimus|sirolimus|mesh-list
56631616|NCT05785897|Ticagrelor|ticagrelor|mesh-list
56631810|NCT05705349|Islatravir|islatravir|mesh-list
56631811|NCT05705349|Antiviral Agents|antiviral agents|mesh-ancestor
56631812|NCT05705349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631813|NCT05705349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631814|NCT05705349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631815|NCT05705349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56631816|NCT05705349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56631817|NCT05705349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56631818|NCT05702827|Meloxicam|meloxicam|mesh-list
56631819|NCT05702827|Bupivacaine|bupivacaine|mesh-list
56631820|NCT05702827|Anesthetics, Local|anesthetics, local|mesh-ancestor
56631821|NCT05702827|Anesthetics|anesthetics|mesh-ancestor
56631822|NCT05702827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631823|NCT05702827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631824|NCT05702827|Sensory System Agents|sensory system agents|mesh-ancestor
56631825|NCT05702827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631826|NCT05702827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56631827|NCT05702827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56631828|NCT05702827|Analgesics|analgesics|mesh-ancestor
56631829|NCT05702827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56631830|NCT05702827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631831|NCT05702827|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56631832|NCT05702827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56631833|NCT05702827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631834|NCT05702827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631835|NCT05696847|Tirzepatide|tirzepatide|mesh-list
56631836|NCT05696847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56631837|NCT05696847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631838|NCT05696847|Incretins|incretins|mesh-ancestor
56631909|NCT05658510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631910|NCT05658510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631911|NCT05658510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56631913|NCT05658510|Sensory System Agents|sensory system agents|mesh-ancestor
56631914|NCT05658510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631915|NCT05658510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56631916|NCT05658510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56631917|NCT05658510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56631918|NCT05658510|Adrenergic Agents|adrenergic agents|mesh-ancestor
56631919|NCT05658510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631920|NCT05658510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631921|NCT05654298|Sumatriptan|sumatriptan|mesh-list
56631922|NCT05654298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56631923|NCT05654298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56631924|NCT05654298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56631925|NCT05654298|Serotonin Agents|serotonin agents|mesh-ancestor
56631926|NCT05654298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631927|NCT05654298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631928|NCT05654298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631941|NCT05649293|Vitamin B 6|vitamin b 6|mesh-list
56631942|NCT05649293|Pyridoxal|pyridoxal|mesh-list
56631943|NCT05649293|Pyridoxine|pyridoxine|mesh-list
56631944|NCT05649293|Vitamins|vitamins|mesh-ancestor
56631945|NCT05649293|Micronutrients|micronutrients|mesh-ancestor
56631946|NCT05649293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631947|NCT05649293|Vitamin B Complex|vitamin b complex|mesh-ancestor
56904877|NCT03968861|Xenon|xenon|mesh-list
56904878|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56904879|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
56904880|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
56512250|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56631948|NCT05647564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56631949|NCT05647564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56631950|NCT05647564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631955|NCT05639972|Aldesleukin|aldesleukin|mesh-list
56631956|NCT05639972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631957|NCT05639972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56631958|NCT05639972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56631959|NCT05639972|Antiviral Agents|antiviral agents|mesh-ancestor
56631960|NCT05639972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631961|NCT05631093|Islatravir|islatravir|mesh-list
56632049|NCT05594563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632051|NCT05587036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56632052|NCT05587036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632053|NCT05587036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56632058|NCT05580562|TIC10 compound|tic10 compound|mesh-list
56632059|NCT05580562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632130|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632141|NCT05535309|Sulbactam|sulbactam|mesh-list
56632142|NCT05535309|Cefoperazone|cefoperazone|mesh-list
56632143|NCT05535309|Sulperazone|sulperazone|mesh-list
56632144|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56632145|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632146|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56632147|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632148|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632149|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56632150|NCT05535309|Renal Agents|renal agents|mesh-ancestor
56632151|NCT05506046|Nicotine|nicotine|mesh-list
56632152|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56632153|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
56632154|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632155|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632156|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56632157|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56632158|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
56632159|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56632160|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632161|NCT05503875|Adalimumab|adalimumab|mesh-list
56632162|NCT05503875|Methotrexate|methotrexate|mesh-list
56632163|NCT05503875|Ixekizumab|ixekizumab|mesh-list
56632164|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56632165|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56632167|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56632168|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632169|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56632170|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
56632171|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632172|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632173|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
56632200|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
56632201|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632202|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56632203|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56632204|NCT05477823|Androgens|androgens|mesh-list
56632205|NCT05477823|Hormones|hormones|mesh-ancestor
56632206|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632207|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632208|NCT05467761|Psilocybin|psilocybin|mesh-list
56632209|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
56632210|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632211|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56632217|NCT05461053|Lidocaine|lidocaine|mesh-list
56632218|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
56632219|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
56632220|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56632221|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176769|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56904881|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56632299|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632326|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56632327|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632328|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632329|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56380883|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
56632364|NCT05388474|Ibalizumab|ibalizumab|mesh-list
56632365|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56632366|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56632367|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56632368|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
56632369|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632370|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
56632371|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632372|NCT05386095|Bupivacaine|bupivacaine|mesh-list
56632373|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
56632374|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
56632375|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56632376|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632377|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
56632378|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160029|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56632409|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
56632410|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
56632411|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
56632412|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632413|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56632414|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632415|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56632416|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632417|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
56632418|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56632419|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632420|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
56632421|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632422|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632423|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56632424|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56632425|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56632426|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
56632546|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632548|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56632549|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56632550|NCT05283720|Growth Substances|growth substances|mesh-ancestor
56632551|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
56632552|NCT05280496|Metformin|metformin|mesh-list
56632553|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56632554|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632555|NCT05280457|Nivolumab|nivolumab|mesh-list
56632556|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632557|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632558|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56632559|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632560|NCT05279937|Lidocaine|lidocaine|mesh-list
56632561|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56632562|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
56632563|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
56632564|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56632565|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632566|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
56632567|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632568|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56632569|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56632570|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56632571|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56632595|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56632596|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
56632597|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632598|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632599|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56632600|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56904882|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904883|NCT04292535|Insulin|insulin|mesh-list
56904884|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56904885|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
56512401|NCT01681550|Incretins|incretins|mesh-list
56632601|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56632602|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
56632603|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56632604|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56632605|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56632606|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56632607|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56632608|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
56632609|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56632610|NCT05211804|Ranibizumab|ranibizumab|mesh-list
56632611|NCT05211804|Aflibercept|aflibercept|mesh-list
56632612|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632613|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56632614|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56632615|NCT05211804|Growth Substances|growth substances|mesh-ancestor
56632616|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632617|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
56632618|NCT05142189|Docetaxel|docetaxel|mesh-list
56632619|NCT05142189|Cemiplimab|cemiplimab|mesh-list
56632620|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632621|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
56632622|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
56632681|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632683|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632684|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632685|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56632686|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56632687|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
56632688|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56632689|NCT05053152|Relugolix|relugolix|mesh-list
56632690|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
56632736|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
56632737|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632738|NCT05009992|TIC10 compound|tic10 compound|mesh-list
56632739|NCT05009992|Dopamine|dopamine|mesh-list
56632740|NCT05009992|GDC-0084|gdc-0084|mesh-list
56632741|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56632742|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
56632743|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
56632744|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632745|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632746|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
56632747|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56632748|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632749|NCT05009992|Protective Agents|protective agents|mesh-ancestor
56632750|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632751|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632752|NCT04975958|Atezolizumab|atezolizumab|mesh-list
56632753|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632754|NCT04974528|Insulin|insulin|mesh-list
56632755|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56632756|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
56632873|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632874|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632875|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56632876|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56632877|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
56632878|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
56632879|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56632880|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56632881|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56632882|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56632883|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632884|NCT04847453|Dexamethasone|dexamethasone|mesh-list
56632885|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
56632886|NCT04847453|Venetoclax|venetoclax|mesh-list
56632887|NCT04847453|Ixazomib|ixazomib|mesh-list
56632888|NCT04847453|Ichthammol|ichthammol|mesh-list
56904886|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
56512464|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
56632889|NCT04847453|BB 1101|bb 1101|mesh-list
56632890|NCT04847453|Glycine|glycine|mesh-list
56632891|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56632892|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
56632893|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
56632894|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632965|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56632967|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632968|NCT04765202|Carisoprodol|carisoprodol|mesh-list
56632969|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56632970|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632971|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56632972|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160037|NCT03872700|Fentanyl|fentanyl|mesh-list
56632980|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
56632981|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632982|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632983|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
56632984|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
56632985|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632986|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632987|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
56632988|NCT04674813|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56632989|NCT04674813|Fludarabine|fludarabine|mesh-list
56632990|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56632991|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
56632992|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632993|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56632994|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56632995|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
56633067|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633068|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56633069|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633071|NCT04594408|Racepinephrine|racepinephrine|mesh-list
56633072|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
56633073|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
56633074|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56633075|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56633076|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633077|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
56633078|NCT04594408|Coagulants|coagulants|mesh-ancestor
56633079|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56633080|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56633081|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
56633082|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56633083|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633084|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56381627|NCT01242046|Caffeine|caffeine|mesh-list
56633085|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56633086|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
56633087|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633088|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56633089|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
56633091|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
56633092|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56633093|NCT04588246|Memantine|memantine|mesh-list
56633094|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56633095|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56633096|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
56633097|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56633098|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633099|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633100|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56633101|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56633102|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
56633103|NCT04557215|Rifaximin|rifaximin|mesh-list
56633104|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56633105|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
56633106|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633107|NCT04557215|Expectorants|expectorants|mesh-ancestor
56633197|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
56633198|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633199|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904887|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56512538|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
56633200|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633201|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633202|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
55930055|NCT05054478|Daratumumab|daratumumab|mesh-list
56633395|NCT04080284|Niraparib|niraparib|mesh-list
56633396|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56633397|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633398|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633399|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633400|NCT04074967|Nivolumab|nivolumab|mesh-list
56633401|NCT04074967|Ipilimumab|ipilimumab|mesh-list
56633402|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633403|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633404|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633405|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633406|NCT04073797|Colchicine|colchicine|mesh-list
56633407|NCT04073797|Gout Suppressants|gout suppressants|mesh-ancestor
56633499|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633500|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
56633501|NCT03958565|Denosumab|denosumab|mesh-list
56633502|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56633503|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56633504|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633505|NCT03947385|Crizotinib|crizotinib|mesh-list
56633506|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633507|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56633508|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633509|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633583|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633584|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633586|NCT03783403|Cetuximab|cetuximab|mesh-list
56633587|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633588|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633589|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
56633590|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633668|NCT03678883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633669|NCT03678883|Immunologic Factors|immunologic factors|mesh-ancestor
56633670|NCT03678883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633671|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56633672|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56633673|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56633674|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56633675|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56633676|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
55930371|NCT05050188|Lansoprazole|lansoprazole|mesh-list
56280659|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56280660|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
56280661|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56280662|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56280663|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56280664|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280665|NCT00006216|Ganciclovir|ganciclovir|mesh-list
56280666|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56280667|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
56280668|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280669|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56280670|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280671|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280672|NCT00006219|Clarithromycin|clarithromycin|mesh-list
56280673|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56280674|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56280675|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280676|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56280677|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280678|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068630|NCT03754049|BB 1101|bb 1101|mesh-list
56280679|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56280680|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56904888|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56904889|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280681|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56280682|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
56280683|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280684|NCT00387582|Ranibizumab|ranibizumab|mesh-list
56280685|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56280686|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56280687|NCT00387582|Growth Substances|growth substances|mesh-ancestor
56280688|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280689|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
56280690|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280691|NCT00006228|Aldesleukin|aldesleukin|mesh-list
56280692|NCT00006228|Trastuzumab|trastuzumab|mesh-list
56280693|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280694|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280695|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56280696|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56280697|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
56280698|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280699|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56280700|NCT03751800|Dienogest|dienogest|mesh-list
56280701|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
56280702|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
56280703|NCT03751800|Estradiol|estradiol|mesh-list
56280704|NCT03751800|Estrogens|estrogens|mesh-ancestor
56280705|NCT03751800|Hormones|hormones|mesh-ancestor
56280706|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280707|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280708|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56280709|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
56280710|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56280711|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56280712|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56280713|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56280714|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56280715|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56280716|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56280717|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280730|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280732|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280733|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
56280734|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
56280735|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56280736|NCT02972463|Antibodies|antibodies|mesh-list
56280737|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
56280738|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280739|NCT00006243|Sargramostim|sargramostim|mesh-list
56280740|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
56280741|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
56280742|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280743|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56280744|NCT00006246|Busulfan|busulfan|mesh-list
56280745|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
56280746|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280747|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280748|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
56280749|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280750|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56280751|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160124|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
56280752|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56280753|NCT00006249|Interferons|interferons|mesh-list
56280754|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
56280755|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280757|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280758|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
56280759|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280760|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
56280761|NCT00006252|Fludarabine|fludarabine|mesh-list
56280762|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
56280763|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280764|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
56280765|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904890|NCT03747081|Warfarin|warfarin|mesh-list
56904891|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
56280766|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280767|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56280768|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
56280769|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280770|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280771|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56280772|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280773|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
56280774|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
56280775|NCT00006258|Methotrexate|methotrexate|mesh-list
56280776|NCT00006258|Etoposide|etoposide|mesh-list
56280777|NCT00006258|Vincristine|vincristine|mesh-list
56280778|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280779|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
56280780|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280781|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280782|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56280808|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280809|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
56280810|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280811|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280812|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56280813|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
56280814|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280815|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280816|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56280817|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
56280818|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
56280819|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
56280820|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56280821|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56280822|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280823|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280824|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280826|NCT00006264|Zidovudine|zidovudine|mesh-list
56280827|NCT00006264|Aldesleukin|aldesleukin|mesh-list
56280828|NCT00006264|Ganciclovir|ganciclovir|mesh-list
56280829|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56280830|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
56280831|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280832|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56280857|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
56280858|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
56280859|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
56280860|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280861|NCT00006279|Nevirapine|nevirapine|mesh-list
56280862|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56280863|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56280864|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280865|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280866|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
56280867|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280868|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56280869|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56280870|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56280871|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56280872|NCT00006291|Aldesleukin|aldesleukin|mesh-list
56280873|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280874|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56280875|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56280876|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
56280877|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280878|NCT00006294|Amlodipine|amlodipine|mesh-list
56280879|NCT00006294|Lisinopril|lisinopril|mesh-list
56280880|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
56280881|NCT00006294|Doxazosin|doxazosin|mesh-list
56280882|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56280883|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56280884|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56280908|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56280910|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56280911|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
56280912|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56904892|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
56280913|NCT00006324|Estradiol|estradiol|mesh-list
56280914|NCT00006324|Estrogens|estrogens|mesh-ancestor
56280915|NCT00006324|Hormones|hormones|mesh-ancestor
56280916|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280917|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280918|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56280919|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
56280920|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56280921|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56280922|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56280923|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56280924|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56280925|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56280926|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56280927|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280928|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56280929|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
56280930|NCT00005824|Busulfan|busulfan|mesh-list
56280931|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280965|NCT00006330|Digoxin|digoxin|mesh-list
56280966|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56280967|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56280968|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280969|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280970|NCT00006330|Protective Agents|protective agents|mesh-ancestor
56280971|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280972|NCT00005839|Capecitabine|capecitabine|mesh-list
56280996|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
56280997|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280998|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280999|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
56281000|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281001|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
56281002|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281003|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56281004|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281005|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56281006|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
56281007|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56281009|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
56281010|NCT00005854|Methotrexate|methotrexate|mesh-list
56281011|NCT00005854|Cyclosporins|cyclosporins|mesh-list
56281012|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281013|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
56281014|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281015|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281016|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281017|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
56281018|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281019|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281020|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281021|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56281022|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
56281023|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55931308|NCT00013611|Aldesleukin|aldesleukin|mesh-list
56281028|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56281029|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281030|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
56281031|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281032|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56281033|NCT00005857|Docetaxel|docetaxel|mesh-list
56281034|NCT00005857|Trastuzumab|trastuzumab|mesh-list
56281035|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281036|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
56281037|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
56281038|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
56281039|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281040|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56281041|NCT00005860|Leucovorin|leucovorin|mesh-list
56281042|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
56281043|NCT00005860|Floxuridine|floxuridine|mesh-list
56281044|NCT00005860|Calcium|calcium|mesh-list
56281045|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
56281046|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56904893|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56512839|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
56281047|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281048|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281049|NCT00005860|Antidotes|antidotes|mesh-ancestor
56281050|NCT00005860|Protective Agents|protective agents|mesh-ancestor
56281051|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
56281052|NCT00005860|Vitamins|vitamins|mesh-ancestor
55903037|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281053|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
56281054|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281055|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
56281056|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281057|NCT00005863|Cytarabine|cytarabine|mesh-list
56281058|NCT00005863|Fludarabine|fludarabine|mesh-list
56281059|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
56281060|NCT00005863|Etoposide|etoposide|mesh-list
56281061|NCT00005863|Daunorubicin|daunorubicin|mesh-list
56281062|NCT00005863|Tretinoin|tretinoin|mesh-list
56281063|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281064|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281065|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
56281066|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281067|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281068|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
56281069|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281070|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281071|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281072|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281073|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281074|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
56281075|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281076|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281077|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
56281078|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
56281079|NCT00005866|Cyclosporine|cyclosporine|mesh-list
56281080|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
56281081|NCT00005866|Busulfan|busulfan|mesh-list
56281082|NCT00005866|Methotrexate|methotrexate|mesh-list
55931324|NCT03094182|Hematinics|hematinics|mesh-ancestor
56281100|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56281101|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281102|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
56281103|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281104|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56281105|NCT00005869|Gemcitabine|gemcitabine|mesh-list
56281106|NCT00005869|Rubitecan|rubitecan|mesh-list
56281107|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281108|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
56281109|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281110|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281111|NCT00005869|Antiviral Agents|antiviral agents|mesh-ancestor
56281112|NCT00005869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281113|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281114|NCT00005869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281115|NCT00005869|Immunologic Factors|immunologic factors|mesh-ancestor
56281116|NCT00005869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281117|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56281118|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281119|NCT00005872|Rubitecan|rubitecan|mesh-list
56281120|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281121|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56281122|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281123|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281124|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281125|NCT00005875|Rubitecan|rubitecan|mesh-list
56281126|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281127|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56281128|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281129|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903113|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281130|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281132|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56281133|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56281134|NCT00005878|Analgesics|analgesics|mesh-ancestor
56904895|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56904896|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
56904897|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904898|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281135|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
56281136|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281137|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281138|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56281139|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281142|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281143|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281145|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281146|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56281147|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56281148|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56281149|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281150|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56281151|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281152|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281153|NCT00005887|Efaproxiral|efaproxiral|mesh-list
56281154|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
56281156|NCT00006339|Indinavir|indinavir|mesh-list
56281157|NCT00006339|Didanosine|didanosine|mesh-list
56281158|NCT00006339|Stavudine|stavudine|mesh-list
56281159|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
56281160|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56281161|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56281162|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
56281163|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281164|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281165|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56281166|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56281167|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
56281168|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281169|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56281170|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56160159|NCT01463670|Lenalidomide|lenalidomide|mesh-list
56281171|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281173|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281174|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
56281175|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56281176|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56281177|NCT00005890|Hormones|hormones|mesh-ancestor
56281178|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56281179|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281180|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
56281181|NCT00005893|Busulfan|busulfan|mesh-list
56281182|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56281183|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281184|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
56281185|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281186|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281187|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281188|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
56281189|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281190|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281191|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281192|NCT00005896|Lenograstim|lenograstim|mesh-list
56281193|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56281194|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
56281195|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281196|NCT00386503|Artesunate|artesunate|mesh-list
56281197|NCT00386503|Amodiaquine|amodiaquine|mesh-list
56281198|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
56281199|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56281200|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56281201|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281202|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281204|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
55903186|NCT00703222|Interleukin-2|interleukin-2|mesh-list
56281205|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56904899|NCT01075841|Cetuximab|cetuximab|mesh-list
56904900|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56281206|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
56281207|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56281208|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56281209|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56281210|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56281211|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281212|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
55931338|NCT03845543|Paclitaxel|paclitaxel|mesh-list
56281219|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
56281220|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281221|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281222|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56281223|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
56281224|NCT00006345|Hormones|hormones|mesh-ancestor
56281225|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56281226|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56281227|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281228|NCT00005920|Caspofungin|caspofungin|mesh-list
56281229|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
56281230|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281231|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281232|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281233|NCT00005926|Gemcitabine|gemcitabine|mesh-list
56281234|NCT00005926|Trastuzumab|trastuzumab|mesh-list
56281235|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281236|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
56281237|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281238|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281239|NCT00005926|Antiviral Agents|antiviral agents|mesh-ancestor
56281240|NCT00005926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281241|NCT00005926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281242|NCT00005926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281243|NCT00005926|Immunologic Factors|immunologic factors|mesh-ancestor
56281244|NCT00005926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281245|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56281246|NCT00005935|Cyclosporine|cyclosporine|mesh-list
56281247|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
56281248|NCT00005935|Cyclosporins|cyclosporins|mesh-list
56281249|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281250|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281251|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281252|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
56281253|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281254|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
56281255|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281256|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
56281257|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281258|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56281259|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281260|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281261|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56281262|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
56281263|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56281264|NCT00006348|Ondansetron|ondansetron|mesh-list
56281265|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
56281266|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
56281267|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281268|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281269|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56281270|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
56281271|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
56281272|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56281273|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
56281274|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56281275|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021573|NCT00521456|Ketorolac|ketorolac|mesh-list
56281276|NCT00006348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56281277|NCT00006348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56281278|NCT00006348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56281279|NCT00006348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56281280|NCT00006348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56904901|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904902|NCT01313390|Docetaxel|docetaxel|mesh-list
56281282|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56281295|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281296|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281297|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
56281298|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281299|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281300|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
56281301|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281302|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
56281303|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281304|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56281305|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281306|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56281307|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
56281308|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56281309|NCT00005944|Leucovorin|leucovorin|mesh-list
56281310|NCT00005944|Fluorouracil|fluorouracil|mesh-list
56281311|NCT00005944|Mitomycins|mitomycins|mesh-list
56281312|NCT00005944|Mitomycin|mitomycin|mesh-list
56281313|NCT00005944|Calcium|calcium|mesh-list
56281314|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
56160166|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281315|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56281316|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281317|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
56281318|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281319|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281320|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281321|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281322|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
56281323|NCT00005944|Antidotes|antidotes|mesh-ancestor
56281324|NCT00005944|Protective Agents|protective agents|mesh-ancestor
56281325|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
56281326|NCT00005944|Vitamins|vitamins|mesh-ancestor
56281327|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
56281328|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281329|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
56281330|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281331|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281332|NCT00387699|Bevacizumab|bevacizumab|mesh-list
56281333|NCT00387699|Etoposide|etoposide|mesh-list
56281334|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56281335|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281336|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56281337|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56281338|NCT00387699|Growth Substances|growth substances|mesh-ancestor
56281339|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281340|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
56281341|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281342|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281343|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281344|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281345|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281346|NCT00005959|Prednisone|prednisone|mesh-list
56281357|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
56281358|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281359|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281360|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281361|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56281362|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281363|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281364|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281365|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281366|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56281367|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
56281368|NCT00005959|Hormones|hormones|mesh-ancestor
56281369|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56281370|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56281371|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281372|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
56281373|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
56281374|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
56904903|NCT01313390|Everolimus|everolimus|mesh-list
56904904|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281375|NCT00387738|Histamine|histamine|mesh-list
56281376|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
56281377|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
56281378|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56281379|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281380|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281381|NCT00005962|Cytarabine|cytarabine|mesh-list
56281382|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
56281383|NCT00005962|Daunorubicin|daunorubicin|mesh-list
56281384|NCT00005962|Topotecan|topotecan|mesh-list
56281385|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
56281386|NCT00005962|Sargramostim|sargramostim|mesh-list
56281387|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281388|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
56281389|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281390|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281391|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281392|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
56281393|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281394|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281395|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281396|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281398|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
56281399|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281400|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281401|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281402|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281403|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281404|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56281405|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56281406|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
56281407|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281408|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56281409|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
56281410|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281411|NCT00005968|Irofulven|irofulven|mesh-list
56281412|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281413|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
56281424|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56281425|NCT00005971|Alvocidib|alvocidib|mesh-list
56281426|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281427|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
56281428|NCT00005971|Growth Substances|growth substances|mesh-ancestor
56281429|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281430|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56281431|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281432|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281433|NCT00005974|Alvocidib|alvocidib|mesh-list
56281434|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281435|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
56281436|NCT00005974|Growth Substances|growth substances|mesh-ancestor
56281437|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281438|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56281439|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281440|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281441|NCT00005977|Leucovorin|leucovorin|mesh-list
56281442|NCT00005977|Cytarabine|cytarabine|mesh-list
56281443|NCT00005977|Dexamethasone|dexamethasone|mesh-list
56281444|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
56281445|NCT00005977|Ifosfamide|ifosfamide|mesh-list
56281446|NCT00005977|Doxorubicin|doxorubicin|mesh-list
56281447|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56281448|NCT00005977|Methotrexate|methotrexate|mesh-list
56281449|NCT00005977|Etoposide|etoposide|mesh-list
56281450|NCT00005977|Vincristine|vincristine|mesh-list
56281451|NCT00005977|Lenograstim|lenograstim|mesh-list
56281452|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
56281453|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281454|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
56281455|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281456|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281457|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281458|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
56281459|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904905|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
56904906|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
56281460|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281461|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281462|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56281463|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
56281464|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
56281465|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281466|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56281467|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
56281468|NCT00005977|Hormones|hormones|mesh-ancestor
56281469|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56281470|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56281471|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281472|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281473|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281474|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281475|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56281476|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
56281477|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56281478|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281479|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
56281491|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56281492|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
56281493|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
56281494|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
56281495|NCT00005980|Doxorubicin|doxorubicin|mesh-list
56281496|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56281497|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281498|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281499|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281500|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281501|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281502|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281503|NCT00005986|Interferons|interferons|mesh-list
56281504|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
56281505|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
56281506|NCT00005986|Busulfan|busulfan|mesh-list
56281507|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281508|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
56281509|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281510|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281511|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281512|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
56281513|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281514|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281515|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281516|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
56281517|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281518|NCT00005989|Tipifarnib|tipifarnib|mesh-list
56281519|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281520|NCT00005998|Cytarabine|cytarabine|mesh-list
56281521|NCT00005998|Dexamethasone|dexamethasone|mesh-list
56281522|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
56281523|NCT00005998|Carmustine|carmustine|mesh-list
56281524|NCT00005998|Etoposide|etoposide|mesh-list
56281525|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
56281526|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281527|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
56281528|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281529|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281530|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281531|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
56281532|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281533|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281534|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281535|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56281536|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
56281537|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
56281538|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281539|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56281540|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
56281542|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56281543|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904907|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
56281544|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281545|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281546|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281561|NCT00006351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281562|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281563|NCT00006351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281564|NCT00006351|Immunologic Factors|immunologic factors|mesh-ancestor
56281565|NCT00006351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281566|NCT00006001|Semaxinib|semaxinib|mesh-list
56281567|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56281568|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56281569|NCT00006001|Growth Substances|growth substances|mesh-ancestor
56281570|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281571|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
56281572|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281573|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56281574|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281575|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281576|NCT00006004|Gemcitabine|gemcitabine|mesh-list
56281577|NCT00006004|Paclitaxel|paclitaxel|mesh-list
56281578|NCT00006004|Carboplatin|carboplatin|mesh-list
56281579|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281580|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281581|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56281582|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56281583|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56281584|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281585|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281586|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
56281587|NCT00006004|Antiviral Agents|antiviral agents|mesh-ancestor
56281588|NCT00006004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281589|NCT00006004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281590|NCT00006004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281591|NCT00006004|Immunologic Factors|immunologic factors|mesh-ancestor
56281592|NCT00006004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281593|NCT00006007|Gemcitabine|gemcitabine|mesh-list
56281594|NCT00006007|Pemetrexed|pemetrexed|mesh-list
56281595|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281596|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
56281597|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281598|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281599|NCT00006007|Antiviral Agents|antiviral agents|mesh-ancestor
56281600|NCT00006007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281601|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281602|NCT00006007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281603|NCT00006007|Immunologic Factors|immunologic factors|mesh-ancestor
56281604|NCT00006007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281605|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56281606|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281607|NCT00006010|Gemcitabine|gemcitabine|mesh-list
56281608|NCT00006010|Docetaxel|docetaxel|mesh-list
55931374|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281620|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
56281621|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
56281622|NCT00006013|Semaxinib|semaxinib|mesh-list
56281623|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56281624|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56281625|NCT00006013|Growth Substances|growth substances|mesh-ancestor
56281626|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281627|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
56281628|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281629|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56281630|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281631|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281632|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
56281633|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281634|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56281635|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281636|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281637|NCT00006016|Thalidomide|thalidomide|mesh-list
56281638|NCT00006016|Doxorubicin|doxorubicin|mesh-list
56281639|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56281640|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281641|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904908|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904909|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904910|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
56904911|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904912|NCT05571332|Cyclosporine|cyclosporine|mesh-list
56904913|NCT05571332|Cyclosporins|cyclosporins|mesh-list
56904914|NCT05571332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281642|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281643|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281644|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281645|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281646|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281647|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
56281648|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281649|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
56281650|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56281651|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281652|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56281653|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56281654|NCT00006016|Growth Substances|growth substances|mesh-ancestor
56281655|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
56281656|NCT00006019|Azacitidine|azacitidine|mesh-list
56281657|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56281658|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281659|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
56281660|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281661|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281662|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281663|NCT00006022|Aldesleukin|aldesleukin|mesh-list
56281664|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
56281665|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281666|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56281667|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56281668|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
56281669|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281670|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56281671|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
56281672|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281692|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281693|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56281694|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56281695|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
56281696|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281697|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56281698|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56281699|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56281700|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281701|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56281702|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56281703|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56281704|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56281705|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56281706|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
56281707|NCT00006028|Gemcitabine|gemcitabine|mesh-list
56281708|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281709|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281710|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
56281711|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281712|NCT00006028|Antiviral Agents|antiviral agents|mesh-ancestor
56281713|NCT00006028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281714|NCT00006028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281715|NCT00006028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281716|NCT00006028|Immunologic Factors|immunologic factors|mesh-ancestor
56281717|NCT00006028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281718|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
56281719|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
56281720|NCT00387933|Vatalanib|vatalanib|mesh-list
56904915|NCT05571332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904916|NCT05571332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904917|NCT05571332|Immunologic Factors|immunologic factors|mesh-ancestor
56513416|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56281721|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281722|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56281723|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281724|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281725|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
56281726|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281727|NCT00006034|Doxorubicin|doxorubicin|mesh-list
56281728|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56281729|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
55931393|NCT02240199|Analgesics|analgesics|mesh-ancestor
56281746|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
56281747|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281748|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56281749|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281750|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281751|NCT00006040|Etoposide|etoposide|mesh-list
56281752|NCT00006040|Antibodies|antibodies|mesh-list
56281753|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56281754|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
56281755|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281756|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281757|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281758|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281759|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281760|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160175|NCT03181308|Nivolumab|nivolumab|mesh-list
56281761|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281762|NCT00006363|Cytarabine|cytarabine|mesh-list
56281763|NCT00006363|Aldesleukin|aldesleukin|mesh-list
56281764|NCT00006363|Etoposide|etoposide|mesh-list
56281765|NCT00006363|Daunorubicin|daunorubicin|mesh-list
56281766|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
56281767|NCT00006363|Busulfan|busulfan|mesh-list
56281768|NCT00006363|Interleukin-2|interleukin-2|mesh-list
56281769|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281770|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281771|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281772|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281773|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281774|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281775|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281776|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
56281777|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
56281778|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281779|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281780|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
56281781|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281782|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
56281783|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281784|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281785|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281786|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56281787|NCT00006363|Analgesics|analgesics|mesh-ancestor
56281788|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
56281789|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281817|NCT05680792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281819|NCT05680792|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56281820|NCT05680792|Antiviral Agents|antiviral agents|mesh-ancestor
56281821|NCT05680792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281822|NCT05680792|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56281823|NCT05680792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56281824|NCT05680792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56281825|NCT05680558|Methoxsalen|methoxsalen|mesh-list
56281826|NCT05680558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56281827|NCT05680558|Dermatologic Agents|dermatologic agents|mesh-ancestor
56281828|NCT00006372|Gemcitabine|gemcitabine|mesh-list
56281829|NCT00006372|Doxorubicin|doxorubicin|mesh-list
56281830|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56513487|NCT01688960|Aflibercept|aflibercept|mesh-list
56281831|NCT00006372|Vinorelbine|vinorelbine|mesh-list
56281832|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281833|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
56281834|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281835|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281869|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56281870|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56281871|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281872|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281873|NCT00006384|Interferons|interferons|mesh-list
56281874|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
56281875|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281876|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
56281893|NCT05679388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281895|NCT05679388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56281896|NCT05679388|Antiviral Agents|antiviral agents|mesh-ancestor
56281897|NCT05679388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281898|NCT05679388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56281899|NCT05679388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56281900|NCT05679388|Antifungal Agents|antifungal agents|mesh-ancestor
56281901|NCT05679388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56281902|NCT05679388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56281903|NCT05679388|Hormone Antagonists|hormone antagonists|mesh-ancestor
56281904|NCT05679388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56281905|NCT05679388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281906|NCT05679388|Androgen Antagonists|androgen antagonists|mesh-ancestor
56281907|NCT05678296|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56281908|NCT05678296|Analgesics|analgesics|mesh-list
56281909|NCT05678296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281910|NCT05678296|Sensory System Agents|sensory system agents|mesh-ancestor
56281911|NCT05678296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281912|NCT05678296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281913|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
56281914|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
56281915|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281916|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
56281917|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281918|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281919|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281920|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
56281921|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281922|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281923|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281924|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56281925|NCT05675293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56281926|NCT05675293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281927|NCT00006396|Zidovudine|zidovudine|mesh-list
56281928|NCT00006396|Nevirapine|nevirapine|mesh-list
56281929|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
56281930|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281931|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56281932|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281933|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281934|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
56281944|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56281945|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56281946|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281947|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56281948|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
56281949|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
56281950|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56281951|NCT03996148|Analgesics|analgesics|mesh-ancestor
56281952|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
56281953|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281954|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56281955|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56281956|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56281957|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
56281958|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56281959|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281960|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56904918|NCT05571332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904919|NCT05571332|Antifungal Agents|antifungal agents|mesh-ancestor
56513566|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
56281961|NCT03996148|Narcotics|narcotics|mesh-ancestor
56281962|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56281963|NCT00006399|Donepezil|donepezil|mesh-list
56281964|NCT00006399|Progesterone|progesterone|mesh-list
56281965|NCT00006399|Estrogens|estrogens|mesh-list
56281966|NCT00006399|Progestins|progestins|mesh-ancestor
56281967|NCT00006399|Hormones|hormones|mesh-ancestor
56281968|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56281969|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281970|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56281971|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281972|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281973|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
56281974|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56281975|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
56281976|NCT05660200|Iron|iron|mesh-list
56281977|NCT05660200|Trace Elements|trace elements|mesh-ancestor
56281978|NCT05660200|Micronutrients|micronutrients|mesh-ancestor
56281979|NCT05660200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281980|NCT05656027|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56281981|NCT05656027|Aceclidine|aceclidine|mesh-list
56281982|NCT05656027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56069922|NCT04188665|Lectins|lectins|mesh-list
56281983|NCT05656027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56281985|NCT05656027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56281986|NCT05656027|Adrenergic Agents|adrenergic agents|mesh-ancestor
56281987|NCT05656027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56281988|NCT05656027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281989|NCT05656027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281990|NCT05656027|Miotics|miotics|mesh-ancestor
56281991|NCT05656027|Autonomic Agents|autonomic agents|mesh-ancestor
56281992|NCT05656027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281993|NCT05656027|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56281994|NCT05552404|Aminophylline|aminophylline|mesh-list
56281995|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56281996|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
56281997|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281998|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281999|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56282000|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
56282001|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56282002|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56282003|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282009|NCT05552404|Protective Agents|protective agents|mesh-ancestor
56282011|NCT05546320|Metoprolol|metoprolol|mesh-list
56282012|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
56282013|NCT05546320|Clopidogrel|clopidogrel|mesh-list
56282014|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56282015|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56282016|NCT05546320|Analgesics|analgesics|mesh-ancestor
56282017|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
56282018|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282019|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282020|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56282021|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282022|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56282023|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56282024|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282025|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56282026|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56282027|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282028|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
56282029|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56282030|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56282031|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56282032|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
56282033|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56282034|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56282035|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
56282036|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56282037|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
56904920|NCT05571332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904921|NCT05571332|Dermatologic Agents|dermatologic agents|mesh-ancestor
55904014|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
56282038|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
56282039|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56282040|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56282041|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
56282042|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
56282043|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56282044|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56282045|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56282046|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
56282047|NCT05535595|Perindopril|perindopril|mesh-list
56282048|NCT05535595|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56282049|NCT05535595|Protease Inhibitors|protease inhibitors|mesh-ancestor
56282050|NCT05535595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282051|NCT05535595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282052|NCT05535595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56282053|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
56282054|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56282055|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56282056|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282057|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
56282058|NCT05470816|Coagulants|coagulants|mesh-ancestor
56282059|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56282060|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56282061|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56282062|NCT05431543|Aceclidine|aceclidine|mesh-list
56282063|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56282064|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56282065|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56282066|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56282067|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
56282068|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56282069|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282070|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282071|NCT05431543|Miotics|miotics|mesh-ancestor
56282085|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282086|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56282087|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282088|NCT05285683|Levodopa|levodopa|mesh-list
56282089|NCT05285683|Carbidopa|carbidopa|mesh-list
56282090|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56282091|NCT05285683|Methylphenidate|methylphenidate|mesh-list
56282092|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56282093|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282094|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56282095|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56282096|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56282097|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282098|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
56282099|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56282100|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56282101|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56282102|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56282103|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282104|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56282105|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
56282106|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
56282107|NCT05247970|Midazolam|midazolam|mesh-list
56282108|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56282109|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56282110|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56282111|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282112|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56282113|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56282114|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56282115|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56282116|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
56282117|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
56282118|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
56282119|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
56282120|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904922|NCT05571332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904923|NCT05571332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56904924|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56904925|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56904926|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56513711|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56282121|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282122|NCT00006441|Lamivudine|lamivudine|mesh-list
56282123|NCT00006441|Zidovudine|zidovudine|mesh-list
56282124|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56282125|NCT00006441|Aldesleukin|aldesleukin|mesh-list
56282126|NCT00006441|Nelfinavir|nelfinavir|mesh-list
56282127|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56282128|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56160183|NCT03202134|Anesthetics|anesthetics|mesh-list
56282129|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282130|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282131|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
56282132|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282133|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56282134|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56282146|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56282147|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
56282148|NCT05147233|Hormones|hormones|mesh-ancestor
56282149|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56282150|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56282151|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282152|NCT03926845|Thiamidol|thiamidol|mesh-list
56282153|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282154|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282155|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56282156|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282157|NCT00006453|Gemcitabine|gemcitabine|mesh-list
56282158|NCT00006453|Carboplatin|carboplatin|mesh-list
56282159|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282160|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282161|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
56282162|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282163|NCT00006453|Antiviral Agents|antiviral agents|mesh-ancestor
56282164|NCT00006453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282165|NCT00006453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282166|NCT00006453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282167|NCT00006453|Immunologic Factors|immunologic factors|mesh-ancestor
56282168|NCT00006453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282169|NCT00387322|Pemetrexed|pemetrexed|mesh-list
56282170|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56282171|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282172|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282173|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282174|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56282175|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56282176|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56282177|NCT00006459|Gemcitabine|gemcitabine|mesh-list
56282178|NCT00006459|Paclitaxel|paclitaxel|mesh-list
56282179|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56282180|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282181|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
56282182|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
56282183|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
56282184|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282185|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282186|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
56282187|NCT00006459|Antiviral Agents|antiviral agents|mesh-ancestor
56282188|NCT00006459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282189|NCT00006459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282190|NCT00006459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282191|NCT00006459|Immunologic Factors|immunologic factors|mesh-ancestor
56282192|NCT00006459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282193|NCT00387400|Everolimus|everolimus|mesh-list
56904927|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904928|NCT02089048|Auranofin|auranofin|mesh-list
56904929|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282194|NCT00387400|Temozolomide|temozolomide|mesh-list
56282195|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282196|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282197|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
56282198|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282199|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56282210|NCT00388089|Bortezomib|bortezomib|mesh-list
56282211|NCT00388089|Topotecan|topotecan|mesh-list
56282212|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282213|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56282214|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282215|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282216|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282217|NCT04742023|Insulin|insulin|mesh-list
56282218|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56282219|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282220|NCT00388128|Caffeine|caffeine|mesh-list
56282221|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56282222|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282223|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56282224|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282225|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282226|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56282227|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56282228|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
56282229|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56282230|NCT00006462|Gemcitabine|gemcitabine|mesh-list
56282231|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282232|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
56282233|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282234|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282235|NCT00006462|Antiviral Agents|antiviral agents|mesh-ancestor
56282236|NCT00006462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282237|NCT00006462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282238|NCT00006462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282239|NCT00006462|Immunologic Factors|immunologic factors|mesh-ancestor
56282240|NCT00006462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282241|NCT04640545|Axitinib|axitinib|mesh-list
56282242|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282243|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56282244|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282245|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282246|NCT00006465|Capecitabine|capecitabine|mesh-list
56282247|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
56282248|NCT00006465|Irinotecan|irinotecan|mesh-list
56282249|NCT00006465|Camptothecin|camptothecin|mesh-list
56282250|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282251|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
56282252|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282253|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282254|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56282255|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282256|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282257|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56282258|NCT04575181|Insulin|insulin|mesh-list
56282259|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56282260|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
56282261|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56282262|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282263|NCT00006468|Leucovorin|leucovorin|mesh-list
56282264|NCT00006468|Fluorouracil|fluorouracil|mesh-list
56282265|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
56282286|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282287|NCT00006471|Fenretinide|fenretinide|mesh-list
56282288|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282289|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56282290|NCT00006471|Protective Agents|protective agents|mesh-ancestor
56282291|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282292|NCT00006474|Temozolomide|temozolomide|mesh-list
56282293|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56904930|NCT02089126|Glimepiride|glimepiride|mesh-list
56904931|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56282294|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56282295|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
56282296|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282297|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282298|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282300|NCT04355572|Vitamins|vitamins|mesh-ancestor
56282301|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
56282302|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282303|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56282304|NCT04201834|Risperidone|risperidone|mesh-list
56282305|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56282306|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
56282307|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56282308|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282309|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282310|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56282311|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56282312|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56282313|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56282314|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56282315|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
56282316|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
56282317|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56282318|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56282319|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282320|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
55931496|NCT03023501|Gabapentin|gabapentin|mesh-list
56282339|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282340|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56282341|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55904326|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
56282342|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56282343|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
56282345|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
56282346|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282347|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
56282348|NCT03765229|Entinostat|entinostat|mesh-list
56282349|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282350|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282351|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56282352|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070296|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
56282353|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282354|NCT03624517|Octreotide|octreotide|mesh-list
56282355|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56282356|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56282357|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282358|NCT03600883|Midazolam|midazolam|mesh-list
56282359|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56282360|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56282361|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56282362|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282363|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56282364|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56282365|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56282366|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56282367|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
56282368|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
56282369|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
56282370|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
56282371|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56282372|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282373|NCT00423397|Interferons|interferons|mesh-list
56282374|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
56282375|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
56282376|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56282377|NCT00423397|Gefitinib|gefitinib|mesh-list
55798261|NCT04938583|Carboplatin|carboplatin|mesh-list
56282396|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282397|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56282398|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282399|NCT03265405|Prednisolone|prednisolone|mesh-list
56282400|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56904932|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56282401|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
56282402|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56282403|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
56282404|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56282405|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
56282406|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56282407|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
56282408|NCT03265405|Hormones|hormones|mesh-ancestor
56282409|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56282410|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282411|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56282412|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282413|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
56282414|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
56282415|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282416|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56282417|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55904392|NCT03164694|Carboplatin|carboplatin|mesh-list
56282418|NCT03265405|Protective Agents|protective agents|mesh-ancestor
56282419|NCT03808480|Nivolumab|nivolumab|mesh-list
56282420|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282421|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282422|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56282423|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282424|NCT03003325|Aspirin|aspirin|mesh-list
56282425|NCT03003325|Interferons|interferons|mesh-list
56282426|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282427|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
56282428|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282429|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56282430|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56282431|NCT03003325|Analgesics|analgesics|mesh-ancestor
56282432|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
55931511|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
56282438|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56282439|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282440|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56282441|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56282442|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282443|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
56282444|NCT02966548|Nivolumab|nivolumab|mesh-list
56282445|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282446|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282447|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56282448|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282449|NCT02890069|Everolimus|everolimus|mesh-list
56282450|NCT02890069|Panobinostat|panobinostat|mesh-list
56282451|NCT02890069|Spartalizumab|spartalizumab|mesh-list
56282452|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282453|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282454|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
56282455|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282456|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56282457|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282458|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282459|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56282460|NCT02712151|Ropivacaine|ropivacaine|mesh-list
56282461|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
56282462|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
56282463|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56282464|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282465|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
56282466|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282467|NCT02425501|Aflibercept|aflibercept|mesh-list
56282468|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56282469|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56282470|NCT02425501|Growth Substances|growth substances|mesh-ancestor
56282471|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282472|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
56282473|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282474|NCT02409238|Metformin|metformin|mesh-list
56282475|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56282476|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282477|NCT00006480|Aldesleukin|aldesleukin|mesh-list
56904933|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904934|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282478|NCT00006480|Ganciclovir|ganciclovir|mesh-list
56282479|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56282480|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282481|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56282482|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56282483|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
56282484|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282485|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56282486|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282487|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282488|NCT00006483|Sargramostim|sargramostim|mesh-list
56282489|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
56282490|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282491|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
56282492|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282494|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56282495|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282496|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56282497|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282498|NCT03606213|Vaccines|vaccines|mesh-list
56282499|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
56282500|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282501|NCT00006519|Capravirine|capravirine|mesh-list
56282502|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56282514|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
56282515|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282516|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282517|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56282518|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56282519|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
56282520|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282521|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56282522|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56282523|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56282524|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
56282525|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56282526|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
56282528|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
56282529|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56282530|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56282531|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
56282532|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282533|NCT00006669|Prednisone|prednisone|mesh-list
56282534|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
56282535|NCT00006669|Rituximab|rituximab|mesh-list
56282536|NCT00006669|Doxorubicin|doxorubicin|mesh-list
56282537|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56282538|NCT00006669|Etoposide|etoposide|mesh-list
56282539|NCT00006669|Vincristine|vincristine|mesh-list
56282540|NCT00006669|Sargramostim|sargramostim|mesh-list
56282541|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282542|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
56282543|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282544|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282545|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56282546|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
56282547|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282548|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282549|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56282550|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282551|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56282552|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56282553|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282554|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282555|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56282556|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
56282557|NCT00006669|Hormones|hormones|mesh-ancestor
56282558|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56282559|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56282560|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56904935|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
56904936|NCT05571176|Ketamine|ketamine|mesh-list
56282561|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56282562|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56282563|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56282564|NCT00006708|Rituximab|rituximab|mesh-list
56282565|NCT00006708|Carboplatin|carboplatin|mesh-list
56282566|NCT00006708|Etoposide|etoposide|mesh-list
56282567|NCT00006708|Ifosfamide|ifosfamide|mesh-list
55904540|NCT01538719|Rilonacept|rilonacept|mesh-list
56282570|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
56282571|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282572|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282573|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56282574|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56282575|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282576|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282577|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282578|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56282579|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
56282581|NCT00006747|Methotrexate|methotrexate|mesh-list
56282582|NCT00006747|Etoposide|etoposide|mesh-list
56282583|NCT00006747|Melphalan|melphalan|mesh-list
56282584|NCT00006747|Carmustine|carmustine|mesh-list
56282585|NCT00006747|Tacrolimus|tacrolimus|mesh-list
56282586|NCT00006747|Sargramostim|sargramostim|mesh-list
56282587|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56282588|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
56282589|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56282590|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282591|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282592|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
56282593|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282594|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282595|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
56282596|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282597|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56282598|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282599|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
56282600|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282601|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56282602|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56282603|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56282604|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282605|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
56282606|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282607|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56282608|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56282609|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
56282610|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56282611|NCT00006786|Leucovorin|leucovorin|mesh-list
56282612|NCT00006786|Bevacizumab|bevacizumab|mesh-list
56282613|NCT00006786|Fluorouracil|fluorouracil|mesh-list
56282614|NCT00006786|Irinotecan|irinotecan|mesh-list
56282615|NCT00006786|Calcium|calcium|mesh-list
56282616|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
56282617|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282618|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282619|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56282620|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56282621|NCT00006786|Growth Substances|growth substances|mesh-ancestor
56282622|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282623|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
56282624|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56282625|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
56282626|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282627|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282628|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282629|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
56282630|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56282631|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282632|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282633|NCT00006786|Antidotes|antidotes|mesh-ancestor
56282634|NCT00006786|Protective Agents|protective agents|mesh-ancestor
56282635|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
56282636|NCT00006786|Vitamins|vitamins|mesh-ancestor
56282637|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
56904937|NCT05571176|Esketamine|esketamine|mesh-list
56904938|NCT05571176|Analgesics|analgesics|mesh-ancestor
56904939|NCT05571176|Sensory System Agents|sensory system agents|mesh-ancestor
56904940|NCT05571176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282638|NCT00006825|Doxorubicin|doxorubicin|mesh-list
56282639|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56282641|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56282642|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282653|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282654|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
56282655|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282656|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56282657|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
56282658|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282659|NCT00006981|Immunotoxins|immunotoxins|mesh-list
56282660|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
56282661|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282662|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
56282663|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56282664|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282665|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56282666|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
56282667|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56282668|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282669|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282670|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282671|NCT00387556|Ondansetron|ondansetron|mesh-list
56282672|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
56282673|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
56282674|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282675|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282676|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56282677|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
56282678|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56282679|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56282680|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
56282681|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56282682|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282683|NCT00387556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56282684|NCT00387556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56282685|NCT00387556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56282686|NCT00387556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56282687|NCT00387556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56282688|NCT03780790|Bupivacaine|bupivacaine|mesh-list
56282689|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
56282690|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
56282691|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56282692|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282693|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
56282694|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282695|NCT00388167|Caspofungin|caspofungin|mesh-list
56282696|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
56282697|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282698|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282699|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282700|NCT00006043|Temozolomide|temozolomide|mesh-list
56282701|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56282702|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
56282703|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282704|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282706|NCT00006049|Carboplatin|carboplatin|mesh-list
56282707|NCT00006049|Gefitinib|gefitinib|mesh-list
56282708|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56282709|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282710|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
56282725|NCT00006055|Cyclosporins|cyclosporins|mesh-list
56282726|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56282727|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282728|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
56282729|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282730|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282731|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56904941|NCT05571176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904942|NCT05571176|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56282732|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
56282733|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282734|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282735|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56282736|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56282737|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
56282738|NCT00006055|Hormones|hormones|mesh-ancestor
56282739|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56282740|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56282741|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282742|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
56282743|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282744|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
56282745|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56282746|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
56282747|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
56282748|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282749|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56282750|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56282751|NCT00006055|Protective Agents|protective agents|mesh-ancestor
56282752|NCT00006070|Etanercept|etanercept|mesh-list
56282753|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56282754|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56282755|NCT00006070|Analgesics|analgesics|mesh-ancestor
56282756|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
56282757|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282758|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282759|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56282760|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282761|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56282762|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282763|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
56282764|NCT00006079|Eflornithine|eflornithine|mesh-list
56282765|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282766|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56282767|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56282768|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56282769|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282770|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56282771|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176773|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56282780|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56282781|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282783|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
56282784|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56282785|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282786|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
56282787|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282788|NCT00006094|Fluorouracil|fluorouracil|mesh-list
56282789|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
56282790|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
56282791|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282792|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282793|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282794|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282796|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282797|NCT00006100|Aldesleukin|aldesleukin|mesh-list
56282798|NCT00006100|Fludarabine|fludarabine|mesh-list
56282799|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
56282800|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282801|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282802|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
56282803|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282804|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282805|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
56282806|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282807|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56282808|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56282809|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
56282810|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282811|NCT00006103|Leucovorin|leucovorin|mesh-list
56514292|NCT02893371|Ziprasidone|ziprasidone|mesh-list
56282812|NCT00006103|Fluorouracil|fluorouracil|mesh-list
56282813|NCT00006103|Irinotecan|irinotecan|mesh-list
56282814|NCT00006103|Calcium|calcium|mesh-list
56282815|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
56282816|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56282817|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282818|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
56282819|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282820|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282821|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282822|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282823|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
56282824|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56282825|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282826|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282827|NCT00006103|Antidotes|antidotes|mesh-ancestor
56282828|NCT00006103|Protective Agents|protective agents|mesh-ancestor
56282829|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
56282830|NCT00006103|Vitamins|vitamins|mesh-ancestor
56282831|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
56282832|NCT00006106|Fluorouracil|fluorouracil|mesh-list
56282834|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282835|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
56282836|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282837|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282838|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282839|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
56282840|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282841|NCT00006112|Leucovorin|leucovorin|mesh-list
56282842|NCT00006112|Fluorouracil|fluorouracil|mesh-list
56282862|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56282863|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282864|NCT00006115|Leucovorin|leucovorin|mesh-list
56282865|NCT00006115|Fluorouracil|fluorouracil|mesh-list
56282866|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
56282867|NCT00006115|Irinotecan|irinotecan|mesh-list
55904843|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282868|NCT00006115|Calcium|calcium|mesh-list
56282870|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56282871|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282872|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
56282873|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282874|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282875|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282876|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282877|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
56282878|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56282879|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282880|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282881|NCT00006115|Antidotes|antidotes|mesh-ancestor
56282882|NCT00006115|Protective Agents|protective agents|mesh-ancestor
56282883|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
56282884|NCT00006115|Vitamins|vitamins|mesh-ancestor
56282885|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
56282886|NCT00006118|Gemcitabine|gemcitabine|mesh-list
56282887|NCT00006118|Paclitaxel|paclitaxel|mesh-list
56282888|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56282889|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282890|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56282891|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56282892|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56282893|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282894|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282895|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
56282896|NCT00006118|Antiviral Agents|antiviral agents|mesh-ancestor
56282897|NCT00006118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282898|NCT00006118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282899|NCT00006118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282900|NCT00006118|Immunologic Factors|immunologic factors|mesh-ancestor
56282901|NCT00006118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282902|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
56282920|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282922|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56282923|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56282924|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56282925|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
56282926|NCT00006133|Norethindrone|norethindrone|mesh-list
56904943|NCT05571176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56904944|NCT05571176|Anesthetics, General|anesthetics, general|mesh-ancestor
56282927|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
56282928|NCT00006133|Estradiol|estradiol|mesh-list
56282929|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56282930|NCT00006133|Estrogens|estrogens|mesh-ancestor
56282931|NCT00006133|Hormones|hormones|mesh-ancestor
56282932|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56282933|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282934|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56282935|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
56282936|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56282937|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56282938|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56282939|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56282940|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56282941|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56282942|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56023225|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
56282943|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282944|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
56282945|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
56282946|NCT00006136|Hematinics|hematinics|mesh-ancestor
56282947|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904918|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
56282948|NCT00006145|Valganciclovir|valganciclovir|mesh-list
56282949|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
56282950|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282951|NCT00006154|Ritonavir|ritonavir|mesh-list
56282952|NCT00006154|Indinavir|indinavir|mesh-list
56282953|NCT00006154|Aldesleukin|aldesleukin|mesh-list
56282954|NCT00006154|Abacavir|abacavir|mesh-list
56282955|NCT00006154|Didanosine|didanosine|mesh-list
56282956|NCT00006154|Stavudine|stavudine|mesh-list
56282957|NCT00006154|Efavirenz|efavirenz|mesh-list
56282958|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56282959|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55798311|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
56282968|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56282969|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282970|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56282971|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56282972|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56282973|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56282974|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56282975|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56282976|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56282977|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
56282978|NCT00006157|Desipramine|desipramine|mesh-list
56282979|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56282980|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
56282981|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56282982|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282983|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282984|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56282985|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56282986|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56282987|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
56282988|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56282989|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282990|NCT00006190|Lamivudine|lamivudine|mesh-list
56282991|NCT00006190|Efavirenz|efavirenz|mesh-list
56282992|NCT00006190|Stavudine|stavudine|mesh-list
56282993|NCT00006190|Nelfinavir|nelfinavir|mesh-list
56282994|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56282995|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56282996|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282997|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282998|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
56282999|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283000|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56283001|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56283002|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56283003|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56904945|NCT05571176|Anesthetics|anesthetics|mesh-ancestor
56514433|NCT02894268|Furazolidone|furazolidone|mesh-list
56283004|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56283005|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56283006|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56283007|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56283008|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56283009|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56283010|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
56283011|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
56283012|NCT00006196|Vitamin D|vitamin d|mesh-list
56283013|NCT00006196|Vitamins|vitamins|mesh-ancestor
56283014|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
56283015|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283016|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56283017|NCT00006199|Topotecan|topotecan|mesh-list
56283018|NCT00006199|Tipifarnib|tipifarnib|mesh-list
56283019|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56283020|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283021|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283022|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283023|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283025|NCT00006205|Ondansetron|ondansetron|mesh-list
56283037|NCT00006205|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56283038|NCT00006205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56283039|NCT00006205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56283040|NCT00006205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56283041|NCT00006205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56283042|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
56283043|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56283044|NCT00006208|Emtricitabine|emtricitabine|mesh-list
56283046|NCT00006208|Didanosine|didanosine|mesh-list
56283047|NCT00006208|Stavudine|stavudine|mesh-list
56283048|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
56283049|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283050|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56283051|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56283052|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283053|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283054|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56283055|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56283056|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56283057|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56283058|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56283059|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56283060|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56283061|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56283062|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
56283063|NCT00006211|Nelfinavir|nelfinavir|mesh-list
56283064|NCT00006211|Capravirine|capravirine|mesh-list
56283065|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56283066|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56283067|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
56283068|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283069|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283070|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56283071|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56283072|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
56283073|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283074|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56283075|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56283076|NCT00006214|Flutamide|flutamide|mesh-list
56283077|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
56283078|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
56283079|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56283080|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283081|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56283082|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283083|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
56283084|NCT00006220|Tretinoin|tretinoin|mesh-list
56283085|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283086|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
56283087|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
56283088|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
56904946|NCT05571176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514509|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56283103|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283104|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56283105|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56283106|NCT00006226|Growth Substances|growth substances|mesh-ancestor
56283107|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
56283108|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283110|NCT00006229|Carboplatin|carboplatin|mesh-list
56283111|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283112|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283113|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
56283114|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
56283115|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
56283116|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283117|NCT00006232|Dexamethasone|dexamethasone|mesh-list
56283118|NCT00006232|Doxorubicin|doxorubicin|mesh-list
56283119|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56283120|NCT00006232|Vincristine|vincristine|mesh-list
56283121|NCT00006232|Idarubicin|idarubicin|mesh-list
56283122|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56283123|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
56283124|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
56283125|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283126|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283127|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283128|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
56283129|NCT00006232|Hormones|hormones|mesh-ancestor
56283130|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56283131|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56283132|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283133|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56283134|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283135|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283136|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283137|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283138|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283139|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
56283140|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
56283141|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
56283142|NCT00006235|Carboplatin|carboplatin|mesh-list
56283143|NCT00006235|Doxorubicin|doxorubicin|mesh-list
56283144|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56283145|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283146|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56283147|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283148|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283149|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283150|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283151|NCT00006241|Lenograstim|lenograstim|mesh-list
56283169|NCT00006250|Chlorambucil|chlorambucil|mesh-list
56283170|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56283171|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
56283173|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283174|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283175|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283176|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
56283178|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56283179|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56283180|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283181|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283182|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
56283183|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283184|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283185|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
56283186|NCT00006250|Analgesics|analgesics|mesh-ancestor
56283187|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
56283188|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283189|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283190|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283191|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283192|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
56904947|NCT05571176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56283194|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
56283195|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283196|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
56283197|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283198|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283199|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
56283200|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283201|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283202|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
56283203|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283204|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56283205|NCT00007527|Buprenorphine|buprenorphine|mesh-list
56283206|NCT00007527|Naloxone|naloxone|mesh-list
56160244|NCT03239106|Apremilast|apremilast|mesh-list
56283207|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56283208|NCT00007527|Narcotics|narcotics|mesh-ancestor
56283209|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56283210|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283211|NCT00007527|Analgesics|analgesics|mesh-ancestor
56283212|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
56283224|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
56283225|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283226|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56283227|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
56283228|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56283229|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56283230|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56283231|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283232|NCT00007605|Amiodarone|amiodarone|mesh-list
56283233|NCT00007605|Sotalol|sotalol|mesh-list
56283234|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56283235|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
56283236|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56283237|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56283238|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283239|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56283240|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56283241|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56283242|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283243|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56283244|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56283245|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56283246|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56283247|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55905218|NCT05071716|Rifaximin|rifaximin|mesh-list
56283248|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
56283249|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283250|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283251|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
56283252|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
56283253|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283254|NCT00006292|Infliximab|infliximab|mesh-list
56283255|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
56283256|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283257|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56283258|NCT03709888|Pregabalin|pregabalin|mesh-list
56283259|NCT03709888|Memantine|memantine|mesh-list
56283260|NCT03709888|Analgesics|analgesics|mesh-ancestor
56283261|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
56283262|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283263|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283264|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
56283265|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56283266|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56283267|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283268|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56283269|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56283270|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56283271|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56283272|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56283277|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56283278|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56904948|NCT05571176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56904949|NCT05571176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283280|NCT00007683|Warfarin|warfarin|mesh-list
56283281|NCT00007683|Clopidogrel|clopidogrel|mesh-list
56283282|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56283283|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56283284|NCT00007683|Analgesics|analgesics|mesh-ancestor
56283285|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
56283286|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283287|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283288|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56283289|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56283290|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56283291|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56283292|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283293|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56283294|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56283295|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283296|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
56283297|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56283298|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56283299|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56283300|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
56283301|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283302|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
56283303|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56283304|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
56283305|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283306|NCT00006337|Levodopa|levodopa|mesh-list
56283307|NCT00006337|Istradefylline|istradefylline|mesh-list
56283308|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56283309|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56283310|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
56283311|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283312|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283313|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283314|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56283315|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56283316|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56283317|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
56283318|NCT00006340|Ganciclovir|ganciclovir|mesh-list
56283319|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56283321|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
56283322|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283323|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56283324|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283325|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283326|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283327|NCT00006343|Interferons|interferons|mesh-list
56283328|NCT00006343|Cytarabine|cytarabine|mesh-list
56283329|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
56283330|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
56283331|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283332|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
56283333|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283334|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283335|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
56283336|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283337|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283338|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
56283339|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283340|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56283341|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283342|NCT00387868|Etoposide|etoposide|mesh-list
56283343|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283344|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283363|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283364|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
56283365|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283366|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
56283367|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
56283368|NCT00006349|Protective Agents|protective agents|mesh-ancestor
56283369|NCT00006352|Antibodies|antibodies|mesh-list
56904950|NCT05571176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283370|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56283371|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
56283372|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
56283373|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283374|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56283375|NCT00007878|Leucovorin|leucovorin|mesh-list
56283376|NCT00007878|Fluorouracil|fluorouracil|mesh-list
56283377|NCT00007878|Bortezomib|bortezomib|mesh-list
56283378|NCT00007878|Calcium|calcium|mesh-list
56283379|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
56283380|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56283381|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283382|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
56283383|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283384|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283385|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283386|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283387|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
56283388|NCT00007878|Antidotes|antidotes|mesh-ancestor
56283389|NCT00007878|Protective Agents|protective agents|mesh-ancestor
56283390|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
56283391|NCT00007878|Vitamins|vitamins|mesh-ancestor
56283392|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
56283393|NCT00006355|NSC 366140|nsc 366140|mesh-list
56283394|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283395|NCT00006358|Thalidomide|thalidomide|mesh-list
56283396|NCT00006358|Temozolomide|temozolomide|mesh-list
56283397|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283398|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
56283399|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283400|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283401|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931603|NCT04193501|Melatonin|melatonin|mesh-list
56283427|NCT00007917|Gemcitabine|gemcitabine|mesh-list
56283428|NCT00007917|Alvocidib|alvocidib|mesh-list
56283429|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283430|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
56283431|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283432|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283433|NCT00007917|Antiviral Agents|antiviral agents|mesh-ancestor
56283434|NCT00007917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283435|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283436|NCT00007917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283437|NCT00007917|Immunologic Factors|immunologic factors|mesh-ancestor
56283438|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283439|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
56283440|NCT00007917|Growth Substances|growth substances|mesh-ancestor
56283441|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56283442|NCT00006367|Cytarabine|cytarabine|mesh-list
56283443|NCT00006367|Busulfan|busulfan|mesh-list
56283444|NCT00006367|Idarubicin|idarubicin|mesh-list
56283445|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283446|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
56283447|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283448|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283449|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
56283450|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283509|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
56283510|NCT00007995|Melphalan|melphalan|mesh-list
56283511|NCT00007995|Busulfan|busulfan|mesh-list
56283512|NCT00007995|Sargramostim|sargramostim|mesh-list
56283513|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283514|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
56283515|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283516|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56283517|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283518|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
56283519|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283520|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283521|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56283522|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
56283523|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283524|NCT00006388|Tamoxifen|tamoxifen|mesh-list
56283525|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56283526|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
56283527|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904951|NCT05571176|Antidepressive Agents|antidepressive agents|mesh-ancestor
56904952|NCT05571176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56904953|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56904954|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56283528|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283529|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56283530|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283531|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56283532|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56283556|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283558|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283559|NCT00006394|Hormones|hormones|mesh-list
56283560|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56283561|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283562|NCT00008073|Doxorubicin|doxorubicin|mesh-list
56283563|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56283564|NCT00008073|Octreotide|octreotide|mesh-list
56283565|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56283566|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283567|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283568|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283569|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283570|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283571|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283572|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56283573|NCT00006397|Ritonavir|ritonavir|mesh-list
56283574|NCT00006397|Indinavir|indinavir|mesh-list
56283575|NCT00006397|Didanosine|didanosine|mesh-list
56283576|NCT00006397|Stavudine|stavudine|mesh-list
56283577|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56283578|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56283579|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
56283580|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283581|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283582|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56283583|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56283584|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
56283585|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931647|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
56283601|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283603|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56283604|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
56283605|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56283606|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56283607|NCT00006427|Analgesics|analgesics|mesh-ancestor
56283608|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
56283609|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283610|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283611|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56283612|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56283613|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56283614|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283615|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
56283616|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283617|NCT00008151|Cyclosporine|cyclosporine|mesh-list
56283618|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
56283619|NCT00008151|Methotrexate|methotrexate|mesh-list
56283620|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
56283621|NCT00008151|Fludarabine|fludarabine|mesh-list
56283622|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
56283623|NCT00008151|Cyclosporins|cyclosporins|mesh-list
56283624|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56283625|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
56283626|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56283627|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283628|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283629|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
56283630|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283631|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283633|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283634|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56904955|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904956|NCT02095834|Dexamethasone|dexamethasone|mesh-list
56283635|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283636|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
56283637|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56283638|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56283639|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
56283640|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283641|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56283642|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56283643|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56283644|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
56283668|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283669|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283670|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56283671|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283672|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283673|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283674|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283676|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56283677|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
56283678|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283679|NCT00006451|Cyclosporine|cyclosporine|mesh-list
56283680|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
56283681|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
56283682|NCT00006451|Methotrexate|methotrexate|mesh-list
56283683|NCT00006451|Cyclosporins|cyclosporins|mesh-list
56283684|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56283685|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283686|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
56283687|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283688|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56283689|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283690|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
56283691|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283692|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283693|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56283694|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56283695|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
56283696|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56283697|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283724|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283726|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283727|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283728|NCT00008229|Melphalan|melphalan|mesh-list
56283729|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
56283730|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283731|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283732|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
56283733|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283734|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283735|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56283736|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283737|NCT00006457|Oltipraz|oltipraz|mesh-list
56283738|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
56283739|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283740|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
56283741|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56283742|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
56283743|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56283744|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56283745|NCT00006457|Protective Agents|protective agents|mesh-ancestor
56283746|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283747|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283758|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283759|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56283760|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283761|NCT00006463|Trabectedin|trabectedin|mesh-list
56283762|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283763|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
56283764|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283765|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904957|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
56904958|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56904959|NCT02095834|Ichthammol|ichthammol|mesh-list
56904960|NCT02095834|BB 1101|bb 1101|mesh-list
56904961|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56283766|NCT00008307|Cyclosporine|cyclosporine|mesh-list
56283767|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
56283768|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
56283769|NCT00008307|Fludarabine|fludarabine|mesh-list
56283770|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
56283771|NCT00008307|Melphalan|melphalan|mesh-list
56283772|NCT00008307|Cyclosporins|cyclosporins|mesh-list
56283773|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56283775|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905751|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
56283776|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
56283777|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283779|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
56283780|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283782|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
56283783|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283784|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
56283785|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56283786|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56283787|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56283788|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56283789|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
56283790|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56283791|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56283792|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
56283793|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
56283794|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283795|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283796|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
56283797|NCT00008307|Hormones|hormones|mesh-ancestor
56283798|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56283799|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56283800|NCT00008307|Protective Agents|protective agents|mesh-ancestor
56283801|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283802|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
56283803|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56283804|NCT00006469|Paclitaxel|paclitaxel|mesh-list
56283805|NCT00006469|Carboplatin|carboplatin|mesh-list
56283806|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283807|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283808|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
56283809|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
56283810|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
56283811|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283812|NCT00006472|Paclitaxel|paclitaxel|mesh-list
56283813|NCT00006472|Carboplatin|carboplatin|mesh-list
56283830|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283832|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56283833|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283834|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283835|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283836|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283837|NCT00006484|Paclitaxel|paclitaxel|mesh-list
56283838|NCT00006484|Carboplatin|carboplatin|mesh-list
56283839|NCT00006484|Tirapazamine|tirapazamine|mesh-list
56283840|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283841|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283842|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
56283843|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
56283844|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
56283845|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283846|NCT00006487|Etoposide|etoposide|mesh-list
56283847|NCT00006487|Tirapazamine|tirapazamine|mesh-list
56283848|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283849|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283850|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283851|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283852|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904962|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
56904963|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
56904964|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904965|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283853|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283855|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56283856|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283857|NCT00008463|Interferons|interferons|mesh-list
56283858|NCT00008463|Ribavirin|ribavirin|mesh-list
56283859|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
56283860|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
56283861|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56283862|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283863|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
56283864|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283865|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
56283866|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283867|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
56283868|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283869|NCT00006508|Insulin|insulin|mesh-list
56283870|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56283871|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283872|NCT00006682|Docetaxel|docetaxel|mesh-list
55931712|NCT05019690|Paclitaxel|paclitaxel|mesh-list
56283889|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283890|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283892|NCT00008736|Metoclopramide|metoclopramide|mesh-list
56283893|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
56283894|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
56283895|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283896|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283897|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283898|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56283899|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56283900|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
56283901|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283902|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283903|NCT00006799|Megestrol|megestrol|mesh-list
56283904|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
56283905|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56160301|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56283906|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56283907|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56283908|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
56283909|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56283910|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283911|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56283912|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56283913|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56283914|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283915|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
56283916|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56283917|NCT00006877|Temozolomide|temozolomide|mesh-list
56283918|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283919|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
56283920|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283921|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283922|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
56283923|NCT00007033|Analgesics|analgesics|mesh-ancestor
56283924|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
56283925|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283926|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283927|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
56283928|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56283929|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56283943|NCT00007189|Analgesics|analgesics|mesh-ancestor
56283944|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
56283945|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283946|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283947|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56283948|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904966|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283949|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56283950|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56283951|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283952|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283953|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
56283954|NCT00388219|Buprenorphine|buprenorphine|mesh-list
56283955|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56283956|NCT00388219|Narcotics|narcotics|mesh-ancestor
56283957|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56283958|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283959|NCT00388219|Analgesics|analgesics|mesh-ancestor
56283960|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
56283961|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283962|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56283963|NCT00388258|Alvimopan|alvimopan|mesh-list
56283964|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283965|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
56283966|NCT00388336|Hematinics|hematinics|mesh-ancestor
56283967|NCT00007306|Hormones|hormones|mesh-list
56283968|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
56283969|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56283970|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283971|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56283972|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
56283973|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56283974|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
56283975|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283976|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56283977|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283978|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
56283980|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
56283981|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56283982|NCT00007423|Protective Agents|protective agents|mesh-ancestor
56283983|NCT00007735|Doxycycline|doxycycline|mesh-list
56283984|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56283985|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283986|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
56283987|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56283988|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56283989|NCT00007774|Haloperidol|haloperidol|mesh-list
56283990|NCT00007774|Olanzapine|olanzapine|mesh-list
56283991|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
56283992|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
56283993|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
56284016|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56284017|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56284018|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
56284019|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284020|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284021|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56284022|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56284023|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56284024|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56284025|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284026|NCT00007852|Cytarabine|cytarabine|mesh-list
56284027|NCT00007852|Rituximab|rituximab|mesh-list
56284028|NCT00007852|Etoposide|etoposide|mesh-list
56284029|NCT00007852|Melphalan|melphalan|mesh-list
56284030|NCT00007852|Carmustine|carmustine|mesh-list
56284031|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56284032|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284033|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
56284034|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284035|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56284036|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56284037|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56284038|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56284039|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284040|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284041|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56284042|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
56284043|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
56284044|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284045|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931738|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
56904967|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
56904968|NCT02095834|Hormones|hormones|mesh-ancestor
56284078|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56284079|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284080|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
56284081|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
56284082|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
56284083|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284085|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56284086|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56284087|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
56284088|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284089|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
56284090|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284091|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284092|NCT00008086|Calcitriol|calcitriol|mesh-list
56284112|NCT00008125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284113|NCT00008125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284114|NCT00008125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56284115|NCT00008125|Immunologic Factors|immunologic factors|mesh-ancestor
56284116|NCT00008125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284117|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
56284118|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
56284119|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
56284121|NCT00008203|Aldesleukin|aldesleukin|mesh-list
56284122|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
56284123|NCT00008203|Cyclosporine|cyclosporine|mesh-list
56284124|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
56284125|NCT00008203|Thiotepa|thiotepa|mesh-list
56284126|NCT00008203|Carboplatin|carboplatin|mesh-list
56284127|NCT00008203|Cyclosporins|cyclosporins|mesh-list
56284128|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56284129|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
56284130|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284131|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56284132|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56284133|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
56284134|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284135|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284136|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56284137|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
56284138|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284139|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284140|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
56284141|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
56284142|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56284143|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56284144|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56284145|NCT00008242|Thalidomide|thalidomide|mesh-list
56284146|NCT00008242|Dexamethasone|dexamethasone|mesh-list
56284147|NCT00008242|Doxorubicin|doxorubicin|mesh-list
56284148|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56284149|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56284150|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
56284175|NCT00008281|Fluorouracil|fluorouracil|mesh-list
56284176|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
56284177|NCT00008281|Calcium|calcium|mesh-list
56284178|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
56284179|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56284180|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284181|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
56284182|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284183|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56284184|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284185|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56284186|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
56284187|NCT00008281|Antidotes|antidotes|mesh-ancestor
56284188|NCT00008281|Protective Agents|protective agents|mesh-ancestor
56284189|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
56284190|NCT00008281|Vitamins|vitamins|mesh-ancestor
56284191|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
56284192|NCT00008359|Amphotericin B|amphotericin b|mesh-list
56284193|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56284194|NCT00008359|Caspofungin|caspofungin|mesh-list
56284195|NCT00008359|Amebicides|amebicides|mesh-ancestor
56284196|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56284197|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56284198|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904969|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515245|NCT01609907|Valsartan|valsartan|mesh-list
56284199|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56284200|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
56284219|NCT00008554|Abacavir|abacavir|mesh-list
56284220|NCT00008554|Nelfinavir|nelfinavir|mesh-list
56284221|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
56284222|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56284223|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284224|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284225|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284226|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
56284227|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284228|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56284229|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56284230|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56284231|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55906211|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
56284232|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
56284233|NCT05636566|Dexmedetomidine|dexmedetomidine|mesh-list
56284234|NCT05636566|Propofol|propofol|mesh-list
56284235|NCT05636566|Sevoflurane|sevoflurane|mesh-list
56284236|NCT05636566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56284237|NCT05636566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56284238|NCT05636566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284239|NCT05636566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56284240|NCT05636566|Anesthetics, General|anesthetics, general|mesh-ancestor
56284241|NCT05636566|Anesthetics|anesthetics|mesh-ancestor
56284242|NCT05636566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56284243|NCT05636566|Analgesics|analgesics|mesh-ancestor
56284244|NCT05636566|Sensory System Agents|sensory system agents|mesh-ancestor
56284245|NCT05636566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284246|NCT05636566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56284247|NCT05636566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56284248|NCT05636566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56284249|NCT05636566|Adrenergic Agents|adrenergic agents|mesh-ancestor
56284250|NCT05636566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284251|NCT05636566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284252|NCT05636566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56284253|NCT05636566|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56284254|NCT05637034|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56284255|NCT05637034|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56284256|NCT05637034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284283|NCT05637216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284285|NCT05638087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56284286|NCT05638087|Antiemetics|antiemetics|mesh-ancestor
56284287|NCT05638087|Autonomic Agents|autonomic agents|mesh-ancestor
56284288|NCT05638087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284289|NCT05638087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284290|NCT05638087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56284291|NCT05638087|Glucocorticoids|glucocorticoids|mesh-ancestor
56284292|NCT05638087|Hormones|hormones|mesh-ancestor
56284293|NCT05638087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284294|NCT05638087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56160361|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
56284296|NCT05638633|Vitamins|vitamins|mesh-list
56284297|NCT05638633|Vitamin B Complex|vitamin b complex|mesh-list
56284298|NCT05638633|Prednisolone|prednisolone|mesh-list
56284299|NCT05638633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56284300|NCT05638633|Methylprednisolone|methylprednisolone|mesh-list
56284301|NCT05638633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56284302|NCT05638633|Prednisolone acetate|prednisolone acetate|mesh-list
56284319|NCT05638633|Protective Agents|protective agents|mesh-ancestor
56284320|NCT05638867|Aspirin|aspirin|mesh-list
56284321|NCT05638867|Rivaroxaban|rivaroxaban|mesh-list
56284322|NCT05638867|Clopidogrel|clopidogrel|mesh-list
56284323|NCT05638867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56284324|NCT05638867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56284325|NCT05638867|Analgesics|analgesics|mesh-ancestor
56284326|NCT05638867|Sensory System Agents|sensory system agents|mesh-ancestor
56284327|NCT05638867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284328|NCT05638867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284329|NCT05638867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56284330|NCT05638867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904970|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56284331|NCT05638867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56284332|NCT05638867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56284333|NCT05638867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284334|NCT05638867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56284335|NCT05638867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56284336|NCT05638867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284337|NCT05638867|Antipyretics|antipyretics|mesh-ancestor
56284338|NCT05638867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56284339|NCT05638867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56284340|NCT05638867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56284341|NCT05638867|Purinergic Agents|purinergic agents|mesh-ancestor
56284342|NCT05638867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284343|NCT05638867|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56284344|NCT05638867|Antithrombins|antithrombins|mesh-ancestor
56284345|NCT05638867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56284346|NCT05638867|Protease Inhibitors|protease inhibitors|mesh-ancestor
56284347|NCT05638867|Anticoagulants|anticoagulants|mesh-ancestor
56284348|NCT05638984|Decitabine|decitabine|mesh-list
56284349|NCT05638984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56284350|NCT05638984|Antimetabolites|antimetabolites|mesh-ancestor
56284351|NCT05638984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284352|NCT05638984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284353|NCT05638984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284354|NCT05639257|Mexiletine|mexiletine|mesh-list
56284355|NCT05639257|Lamotrigine|lamotrigine|mesh-list
56284356|NCT05639257|Anticonvulsants|anticonvulsants|mesh-ancestor
56284357|NCT05639257|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56284358|NCT05639257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56284359|NCT05639257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284360|NCT05639257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56284361|NCT05639257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284369|NCT00000115|Acetazolamide|acetazolamide|mesh-list
56284370|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
56284371|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56284372|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284373|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284374|NCT00000115|Diuretics|diuretics|mesh-ancestor
56284375|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
56284376|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284377|NCT00000136|Ganciclovir|ganciclovir|mesh-list
56284378|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56284380|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
56284381|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284382|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284383|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284384|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284385|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56284386|NCT00000139|Acyclovir|acyclovir|mesh-list
56284387|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
56284388|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284389|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56284390|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56284391|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284392|NCT00000142|Cidofovir|cidofovir|mesh-list
56284393|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
56284394|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284395|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284396|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284398|NCT00000145|Antioxidants|antioxidants|mesh-list
56284399|NCT00000145|Trace Elements|trace elements|mesh-ancestor
56284400|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
56284401|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284402|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284403|NCT00000145|Protective Agents|protective agents|mesh-ancestor
56284404|NCT00000151|Aspirin|aspirin|mesh-list
56284405|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56284406|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56284407|NCT00000151|Analgesics|analgesics|mesh-ancestor
56284408|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
56284409|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284410|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284411|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904971|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904972|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56515397|NCT01605734|Hormones|hormones|mesh-ancestor
56284412|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56284413|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56284414|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56284415|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284416|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56284417|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56284418|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284419|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
56284420|NCT00000157|Aspirin|aspirin|mesh-list
56284421|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56284422|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56284423|NCT00000157|Analgesics|analgesics|mesh-ancestor
56284424|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
56284425|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284426|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284427|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56284428|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56284429|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56284437|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56284438|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284439|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284440|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
56284441|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284442|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284443|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56284444|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
56284445|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284446|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
56284447|NCT00000175|Testosterone|testosterone|mesh-list
56284448|NCT00000175|Estrogens|estrogens|mesh-list
56284449|NCT00000175|Androgens|androgens|mesh-ancestor
56284450|NCT00000175|Hormones|hormones|mesh-ancestor
56284451|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284452|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284453|NCT00000187|Ritanserin|ritanserin|mesh-list
56284454|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56284455|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
56284456|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284457|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906422|NCT02382432|Analgesics|analgesics|mesh-ancestor
56284458|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284460|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56284461|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56284462|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56284463|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56284464|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56284465|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
56284466|NCT00000205|Buprenorphine|buprenorphine|mesh-list
56284467|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56284468|NCT00000205|Narcotics|narcotics|mesh-ancestor
56284469|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56284470|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284471|NCT00000205|Analgesics|analgesics|mesh-ancestor
56284472|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
56284473|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284474|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56284475|NCT00000214|Buprenorphine|buprenorphine|mesh-list
56284476|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56284477|NCT00000214|Narcotics|narcotics|mesh-ancestor
56284478|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56284479|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284480|NCT00000214|Analgesics|analgesics|mesh-ancestor
56284481|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
56284482|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284483|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56284484|NCT00000220|Buprenorphine|buprenorphine|mesh-list
56284485|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56284486|NCT00000220|Narcotics|narcotics|mesh-ancestor
56284487|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56284488|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904973|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
56904974|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904975|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
56284489|NCT00000220|Analgesics|analgesics|mesh-ancestor
56284490|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
56284491|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284492|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56284493|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
56284494|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56284495|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
56284496|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
56284497|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931847|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56284504|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56284505|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
56284506|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284507|NCT00000421|Prednisone|prednisone|mesh-list
56284508|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56284509|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
56284510|NCT00000421|Hormones|hormones|mesh-ancestor
56284511|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284512|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284513|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56284514|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284515|NCT00000427|Alendronate|alendronate|mesh-list
56284516|NCT00000427|Hormones|hormones|mesh-list
56284517|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
56284518|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284519|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284520|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56284521|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56284522|NCT00000457|Bupropion|bupropion|mesh-list
56284523|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56284524|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
56284525|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56284526|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56284527|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56284528|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56160432|NCT03453060|Thrombin|thrombin|mesh-list
56284529|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284531|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284532|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284533|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56284534|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56284535|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284536|NCT00388479|Alvimopan|alvimopan|mesh-list
56284537|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56284538|NCT00000463|Warfarin|warfarin|mesh-list
56284539|NCT00000463|Lovastatin|lovastatin|mesh-list
56284540|NCT00000463|L 647318|l 647318|mesh-list
56284541|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
56284542|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
56284543|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
56284544|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56284545|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56284546|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
56284547|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284548|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56284549|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56284550|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284551|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56284552|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
56284553|NCT00000466|Progesterone|progesterone|mesh-list
56284554|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56284555|NCT00000466|Estrogens|estrogens|mesh-list
56284556|NCT00000466|Progestins|progestins|mesh-ancestor
56284557|NCT00000466|Hormones|hormones|mesh-ancestor
56284558|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284559|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284560|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56284561|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56904976|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515545|NCT02271113|Enoxaparin|enoxaparin|mesh-list
56284562|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56284563|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
56284564|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56284565|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56284570|NCT00000472|Heparin|heparin|mesh-list
56284571|NCT00000472|Plasminogen|plasminogen|mesh-list
56284572|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56284573|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
56284574|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56284575|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56284576|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284577|NCT00000478|Atenolol|atenolol|mesh-list
56284578|NCT00000478|Diltiazem|diltiazem|mesh-list
56284579|NCT00000478|Nifedipine|nifedipine|mesh-list
56284580|NCT00000478|Isosorbide|isosorbide|mesh-list
56284581|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56284582|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56284583|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56284584|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56284585|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284586|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56284587|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284588|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
56284589|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
56284590|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56160437|NCT03459612|Lasmiditan|lasmiditan|mesh-list
56284591|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56284592|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56284593|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
56284594|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
56284595|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284596|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56284597|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56284598|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56284599|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
56284600|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284601|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56284602|NCT00000478|Diuretics|diuretics|mesh-ancestor
56284603|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
56284604|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56284606|NCT00388882|Albuterol|albuterol|mesh-list
56284607|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
56284608|NCT00388882|Ipratropium|ipratropium|mesh-list
56284609|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56284610|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
56284611|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284612|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284613|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56284614|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
56284615|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
56284616|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56284617|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
56284618|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284619|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284620|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
56284621|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
56284622|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56284623|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56284624|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56284625|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56284626|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
56284627|NCT00388999|Lectins|lectins|mesh-list
56284628|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
56284629|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
56284630|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284631|NCT00388999|Coagulants|coagulants|mesh-ancestor
56284632|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
56284633|NCT00000487|Diuretics|diuretics|mesh-list
56284634|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
56284635|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284636|NCT00000493|Propranolol|propranolol|mesh-list
56284637|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55931859|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
56284646|NCT00000499|Metoprolol|metoprolol|mesh-list
56284647|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
56904977|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
56904978|NCT03125642|Cytarabine|cytarabine|mesh-list
56904979|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
56904980|NCT03125642|Melphalan|melphalan|mesh-list
56904981|NCT03125642|Carmustine|carmustine|mesh-list
56904982|NCT03125642|Etoposide|etoposide|mesh-list
56904983|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904984|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
56904985|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904986|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904987|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56284648|NCT00000499|Hydralazine|hydralazine|mesh-list
56284649|NCT00000499|Reserpine|reserpine|mesh-list
56284650|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56284651|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56284652|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
56284653|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
56284654|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284655|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284656|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56284657|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56284658|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56284659|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
56284660|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284661|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284663|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
56284664|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56284665|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56284666|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
56284667|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56284668|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56284669|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56284670|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56284671|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56284672|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56284673|NCT00000514|Atenolol|atenolol|mesh-list
56284674|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
56284675|NCT00000514|Reserpine|reserpine|mesh-list
56284676|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56284677|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56284678|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
56284679|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
56284680|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284681|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284682|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56284683|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56284684|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56284686|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284687|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284688|NCT00000514|Diuretics|diuretics|mesh-ancestor
56284689|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
56284690|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56284691|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56284692|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56284693|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56284694|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56284695|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56284696|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56284697|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56284698|NCT05638425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56284699|NCT05638425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284700|NCT05638425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284701|NCT00000517|Warfarin|warfarin|mesh-list
56284702|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
56284703|NCT00000520|Aspirin|aspirin|mesh-list
56284704|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
56904988|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
56904989|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284705|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56284719|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284720|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56284722|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284724|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
56284725|NCT00000526|Flecainide|flecainide|mesh-list
56284726|NCT00000526|Moricizine|moricizine|mesh-list
56284727|NCT00000526|Encainide|encainide|mesh-list
56284728|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56284729|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56284730|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56284731|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56284732|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284733|NCT00000529|Tamoxifen|tamoxifen|mesh-list
56284734|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56284735|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
56284736|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284737|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284738|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56284739|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284740|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56284741|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56284742|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56284743|NCT00000553|Niacin|niacin|mesh-list
56284744|NCT00000553|Simvastatin|simvastatin|mesh-list
56284745|NCT00000553|Antioxidants|antioxidants|mesh-list
56284746|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56284747|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56284748|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
56284749|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284750|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56284751|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56284752|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284753|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
56284754|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
56284755|NCT00000553|Vitamins|vitamins|mesh-ancestor
56284756|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
56284757|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284758|NCT00000553|Protective Agents|protective agents|mesh-ancestor
56284759|NCT00000556|Quinidine|quinidine|mesh-list
56284760|NCT00000556|Digoxin|digoxin|mesh-list
56284761|NCT00000556|Amiodarone|amiodarone|mesh-list
56284762|NCT00000556|Verapamil|verapamil|mesh-list
56284763|NCT00000556|Sotalol|sotalol|mesh-list
56284764|NCT00000556|Flecainide|flecainide|mesh-list
56284765|NCT00000556|Propafenone|propafenone|mesh-list
56284766|NCT00000556|Procainamide|procainamide|mesh-list
56284767|NCT00000556|Moricizine|moricizine|mesh-list
56284768|NCT00000556|Disopyramide|disopyramide|mesh-list
56284769|NCT00000556|Diltiazem|diltiazem|mesh-list
56284770|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56284815|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56284817|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56284818|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56284819|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56284820|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284821|NCT00000568|Ipratropium|ipratropium|mesh-list
56284822|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56284823|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
56284824|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284825|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284826|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56284827|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
56284828|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56284829|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
56284831|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284832|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
56284833|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284834|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
56284835|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284836|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075689|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
56284837|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284838|NCT00000595|Deferoxamine|deferoxamine|mesh-list
56284839|NCT00000595|Siderophores|siderophores|mesh-ancestor
56284840|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56284841|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
56284842|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
56284843|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284844|NCT00000601|Hormones|hormones|mesh-list
56284845|NCT00000601|Progesterone|progesterone|mesh-list
56284846|NCT00000601|Estrogens|estrogens|mesh-list
56284847|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284848|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284849|NCT00000601|Progestins|progestins|mesh-ancestor
56284850|NCT00000625|Zidovudine|zidovudine|mesh-list
56284851|NCT00000625|Didanosine|didanosine|mesh-list
56284852|NCT00000625|Zalcitabine|zalcitabine|mesh-list
56284853|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
56176774|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56284866|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56284867|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284870|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284871|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56284872|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56284873|NCT00000640|Clindamycin|clindamycin|mesh-list
56284874|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
56284875|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
56284876|NCT00000640|Dapsone|dapsone|mesh-list
56284877|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56284878|NCT00000640|Primaquine|primaquine|mesh-list
56284879|NCT00000640|Trimethoprim|trimethoprim|mesh-list
56284880|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
56284881|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56284882|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284883|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56284884|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284885|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284886|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
56284887|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56284888|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56284889|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56284890|NCT00000640|Renal Agents|renal agents|mesh-ancestor
56284891|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56284892|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56284893|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56284894|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56284895|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
56284896|NCT00000643|Leucovorin|leucovorin|mesh-list
56284897|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
56284898|NCT00000643|Calcium|calcium|mesh-list
56284899|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
56284900|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56284901|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284902|NCT00000643|Antidotes|antidotes|mesh-ancestor
56284903|NCT00000643|Protective Agents|protective agents|mesh-ancestor
56284904|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
56284905|NCT00000643|Vitamins|vitamins|mesh-ancestor
56284906|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
56284907|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
56284908|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56284909|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56284910|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284911|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56284912|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284913|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284914|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
56284915|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56284916|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284917|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176775|NCT01397305|Pemetrexed|pemetrexed|mesh-list
56284922|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
56284923|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56284924|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
56284925|NCT00389038|Amitriptyline|amitriptyline|mesh-list
56284926|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56284927|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
56284928|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56284929|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56284930|NCT00389038|Analgesics|analgesics|mesh-ancestor
56284931|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
56904990|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904991|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56515823|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56284932|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284933|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284934|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56284935|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56284936|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56284937|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284938|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
56284939|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284941|NCT00000652|Didanosine|didanosine|mesh-list
56284942|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
56284943|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284944|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56284945|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284946|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284947|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
56284948|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284949|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56284950|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56284952|NCT00000676|Clotrimazole|clotrimazole|mesh-list
56284953|NCT00000676|Miconazole|miconazole|mesh-list
56284954|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
56284955|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284956|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56284957|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56284958|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284959|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284960|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56284961|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
56284962|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284963|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284964|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56284965|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56284966|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56284967|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56284968|NCT00000679|Zidovudine|zidovudine|mesh-list
56284969|NCT00000679|Zalcitabine|zalcitabine|mesh-list
56284970|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
56284971|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284972|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56284973|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284974|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284975|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
56284976|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284977|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56284978|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56284979|NCT00000682|Zidovudine|zidovudine|mesh-list
56284980|NCT00000682|Zalcitabine|zalcitabine|mesh-list
56284981|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
56284982|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284983|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56284984|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284985|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284986|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
55906991|NCT01498679|Xhance|xhance|mesh-list
56285006|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285007|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285008|NCT00000715|Trimethoprim|trimethoprim|mesh-list
56285009|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56285010|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
56285011|NCT00000715|Pentamidine|pentamidine|mesh-list
56285012|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56285013|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285014|NCT00000715|Renal Agents|renal agents|mesh-ancestor
56285015|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
56285016|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56285017|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56285018|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56285019|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904992|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56904993|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56515928|NCT01335698|Ritonavir|ritonavir|mesh-list
56285020|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285021|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56285022|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56285023|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285024|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
56285025|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56285026|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285028|NCT00000718|Zalcitabine|zalcitabine|mesh-list
56285029|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
56285030|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285031|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285032|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285033|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285034|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
56285035|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285036|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285037|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285038|NCT00000739|Dapsone|dapsone|mesh-list
56285039|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285040|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
56285041|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56285042|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56285043|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55931897|NCT03953261|Curcumin|curcumin|mesh-list
56285055|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285056|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
56285057|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285058|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285059|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285060|NCT00000745|Vaccines|vaccines|mesh-list
56285061|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
56285062|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285063|NCT00000748|Trimethoprim|trimethoprim|mesh-list
56285064|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56285065|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
56285066|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56285067|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285068|NCT00000748|Renal Agents|renal agents|mesh-ancestor
56285069|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
56285070|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56285071|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56285072|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56285073|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285074|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285075|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56285076|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56285077|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285078|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285079|NCT00000751|Zidovudine|zidovudine|mesh-list
56285080|NCT00000751|Immune Sera|immune sera|mesh-list
56285081|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
56285082|NCT00000751|Antibodies|antibodies|mesh-list
56285083|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
56285084|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285085|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285086|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285087|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285089|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285090|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285091|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285092|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
56285093|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285094|NCT00000754|Interferons|interferons|mesh-list
56285095|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
56285096|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
56285097|NCT00000754|Zidovudine|zidovudine|mesh-list
56285098|NCT00000754|Zalcitabine|zalcitabine|mesh-list
56285099|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285100|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
56285101|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285102|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
56904994|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56904995|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904996|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56285103|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285104|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
56285105|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285106|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285107|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285108|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285109|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285117|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285118|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
56285119|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285120|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285121|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285122|NCT00000790|Thalidomide|thalidomide|mesh-list
56285123|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56285124|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
56285125|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285126|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
56285127|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285128|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285129|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56285130|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56285131|NCT00000790|Growth Substances|growth substances|mesh-ancestor
56285132|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
56285133|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285135|NCT00000793|Amitriptyline|amitriptyline|mesh-list
56285136|NCT00000793|Benztropine|benztropine|mesh-list
56285137|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56285138|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
56285139|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56285140|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56285141|NCT00000793|Analgesics|analgesics|mesh-ancestor
56285142|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
56285143|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56285144|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285145|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56285146|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56285147|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56285148|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285149|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
56285150|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56285151|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56285152|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56285153|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56285154|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56285155|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56285156|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
56285157|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
56285158|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56285159|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56285160|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
56285161|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56285162|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
56285163|NCT00000799|Cidofovir|cidofovir|mesh-list
56285164|NCT00000799|Probenecid|probenecid|mesh-list
56285165|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
56285166|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
56285167|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56285169|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
56285170|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285171|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285172|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285173|NCT00000817|Amitriptyline|amitriptyline|mesh-list
56285174|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56285175|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
56285176|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56285177|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56285178|NCT00000817|Analgesics|analgesics|mesh-ancestor
56285179|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
56285180|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075790|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56904997|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
56904998|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
56285191|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285192|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
56285193|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285194|NCT00000826|Clarithromycin|clarithromycin|mesh-list
56285195|NCT00000826|Dapsone|dapsone|mesh-list
56285196|NCT00000826|Rifabutin|rifabutin|mesh-list
56285197|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56285198|NCT00000826|Fluconazole|fluconazole|mesh-list
56285199|NCT00000826|Trimethoprim|trimethoprim|mesh-list
56285200|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
56285201|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285202|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285203|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56285204|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285205|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285206|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56025474|NCT02322242|BB 1101|bb 1101|mesh-list
56285207|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285208|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
56285209|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56285210|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56285211|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
56285212|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56285213|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285214|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56285215|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56285216|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56285217|NCT00000826|Renal Agents|renal agents|mesh-ancestor
56285218|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
56285219|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56285220|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56285221|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56285222|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56285223|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56285224|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
56285225|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56285226|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
56285227|NCT00000859|Ritonavir|ritonavir|mesh-list
56285228|NCT00000859|Nelfinavir|nelfinavir|mesh-list
56285229|NCT00000859|Indinavir|indinavir|mesh-list
56285230|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285231|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285232|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285233|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285234|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285235|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285236|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285237|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
56073141|NCT02366819|Antidotes|antidotes|mesh-ancestor
56285238|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285239|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285240|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285241|NCT00000877|Indinavir|indinavir|mesh-list
56285242|NCT00000877|Rifabutin|rifabutin|mesh-list
56104493|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
56285272|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285273|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285274|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285275|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285276|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285277|NCT00000895|Azithromycin|azithromycin|mesh-list
56285278|NCT00000895|Nevirapine|nevirapine|mesh-list
56285279|NCT00000895|Nelfinavir|nelfinavir|mesh-list
56285280|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285281|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285282|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285283|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285284|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285285|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285286|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
56285287|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285288|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56904999|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905000|NCT03556852|Misoprostol|misoprostol|mesh-list
56905001|NCT03556852|Carbetocin|carbetocin|mesh-list
56285289|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55907240|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56285290|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56285306|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285307|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285308|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
56285309|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56285310|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
56285311|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285312|NCT00389233|Protective Agents|protective agents|mesh-ancestor
56285313|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285314|NCT00389233|Vitamins|vitamins|mesh-ancestor
56285315|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
56285316|NCT00389233|Laxatives|laxatives|mesh-ancestor
56285317|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56285318|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
56285319|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56285320|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
56285321|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285322|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56285323|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285324|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
56285325|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285326|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
56285327|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56285328|NCT00000904|Protective Agents|protective agents|mesh-ancestor
56285329|NCT00000919|Ritonavir|ritonavir|mesh-list
56285330|NCT00000919|Nelfinavir|nelfinavir|mesh-list
56285331|NCT00000919|Indinavir|indinavir|mesh-list
56285332|NCT00000919|Amprenavir|amprenavir|mesh-list
56285333|NCT00000919|Lamivudine|lamivudine|mesh-list
56285334|NCT00000919|Zidovudine|zidovudine|mesh-list
56285335|NCT00000919|Abacavir|abacavir|mesh-list
56285336|NCT00000919|Didanosine|didanosine|mesh-list
56285337|NCT00000919|Stavudine|stavudine|mesh-list
56285338|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56285339|NCT00000919|Efavirenz|efavirenz|mesh-list
56285340|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
56285341|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285342|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285343|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285344|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285345|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285346|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285347|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285348|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
56285349|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285350|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285351|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285352|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285353|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285354|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
56285355|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56285374|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285376|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285377|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
56285378|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285379|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285380|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285381|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56285382|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285383|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56285384|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56285385|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56285386|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56285387|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
56285388|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285389|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285390|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285392|NCT00000940|Amprenavir|amprenavir|mesh-list
56285393|NCT00000940|Lamivudine|lamivudine|mesh-list
56285394|NCT00000940|Abacavir|abacavir|mesh-list
56905002|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56905003|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
56285395|NCT00000940|Stavudine|stavudine|mesh-list
56285396|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285397|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285398|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285399|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285400|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285401|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285402|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285403|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
56285404|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285405|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285406|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285407|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285408|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285409|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
56285410|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56285411|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
56285412|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285413|NCT00000943|Vaccines|vaccines|mesh-list
56285414|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
56285415|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285428|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285429|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285430|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285431|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285432|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
56285433|NCT00000970|Ganciclovir|ganciclovir|mesh-list
56285434|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56285436|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56285437|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
56285438|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285439|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285440|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285441|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285442|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285443|NCT00000973|Leucovorin|leucovorin|mesh-list
56285444|NCT00000973|Zidovudine|zidovudine|mesh-list
56285445|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
55907401|NCT04561206|Nivolumab|nivolumab|mesh-list
56285447|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
56285448|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56285449|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285450|NCT00000973|Antidotes|antidotes|mesh-ancestor
56285451|NCT00000973|Protective Agents|protective agents|mesh-ancestor
56285452|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
56285453|NCT00000973|Vitamins|vitamins|mesh-ancestor
56285454|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
56285455|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
56073356|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285456|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285457|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285458|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285459|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285460|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
56285461|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285462|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285463|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285464|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
56285465|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56285466|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56285467|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56285468|NCT00000985|Acyclovir|acyclovir|mesh-list
56285469|NCT00000985|Foscarnet|foscarnet|mesh-list
56285470|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56285471|NCT00000985|Vidarabine|vidarabine|mesh-list
56285472|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
56285473|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285474|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285475|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285476|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285477|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285478|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
56905004|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56516254|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
56285479|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56285480|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
56285496|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56285498|NCT00001030|Rifabutin|rifabutin|mesh-list
56285499|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285500|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285501|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56285502|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285503|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285504|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285505|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285506|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56285507|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
56285508|NCT05639127|Prednisolone|prednisolone|mesh-list
56285509|NCT05639127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56285510|NCT05639127|Glucocorticoids|glucocorticoids|mesh-ancestor
56285511|NCT05639127|Hormones|hormones|mesh-ancestor
56285512|NCT05639127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56285513|NCT05639127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285514|NCT05639127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56285515|NCT05639127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285516|NCT00001033|Pyridoxine|pyridoxine|mesh-list
56285517|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
56285518|NCT00001033|Levofloxacin|levofloxacin|mesh-list
56285519|NCT00001033|Rifampin|rifampin|mesh-list
56285520|NCT00001033|Isoniazid|isoniazid|mesh-list
56285521|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
56285522|NCT00001033|Ethambutol|ethambutol|mesh-list
56285523|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56285524|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285525|NCT00001033|Renal Agents|renal agents|mesh-ancestor
56285526|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285527|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56285528|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56285529|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285530|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285531|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285532|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56285533|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285534|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56285535|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
56285536|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
56285537|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285538|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56285539|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56285540|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56285548|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
56285550|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
56285551|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285552|NCT00001036|Zidovudine|zidovudine|mesh-list
56285553|NCT00001036|Interleukin-2|interleukin-2|mesh-list
56285554|NCT00001036|Thymalfasin|thymalfasin|mesh-list
56285555|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285556|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56285557|NCT00001036|Analgesics|analgesics|mesh-ancestor
56285558|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
56285559|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56285560|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285561|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
56285562|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285563|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285564|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285565|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285566|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
56285567|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285568|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285569|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285570|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56285571|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
56285572|NCT00001045|Zidovudine|zidovudine|mesh-list
56285573|NCT00001045|Nevirapine|nevirapine|mesh-list
56285574|NCT00001045|Didanosine|didanosine|mesh-list
56905005|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516355|NCT01342094|Timolol|timolol|mesh-list
56285575|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
56285576|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285577|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285578|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285579|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285580|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
56285581|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285582|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285583|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285584|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56285585|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56285586|NCT00001048|Cytarabine|cytarabine|mesh-list
56285587|NCT00001048|Zidovudine|zidovudine|mesh-list
56285588|NCT00001048|Didanosine|didanosine|mesh-list
56285589|NCT00001048|Zalcitabine|zalcitabine|mesh-list
56285590|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56285591|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
56285592|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285593|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285594|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
56285595|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285596|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56285597|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
56285598|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285599|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285600|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285601|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285602|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285603|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285605|NCT00001066|Zidovudine|zidovudine|mesh-list
56285606|NCT00001066|Didanosine|didanosine|mesh-list
56285607|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285608|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285609|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285610|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285611|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
56285612|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285624|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285625|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285626|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
56285627|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285628|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285629|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285630|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285631|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285632|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
56285633|NCT00001084|Lamivudine|lamivudine|mesh-list
56285634|NCT00001084|Zidovudine|zidovudine|mesh-list
56285635|NCT00001084|Stavudine|stavudine|mesh-list
56285636|NCT00001084|Indinavir|indinavir|mesh-list
56285637|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285638|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285639|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285640|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285641|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
56285642|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285643|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285644|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285645|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
56285646|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285647|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285648|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285649|NCT05639322|Ketamine|ketamine|mesh-list
56285650|NCT05639322|Analgesics|analgesics|mesh-ancestor
56285651|NCT05639322|Sensory System Agents|sensory system agents|mesh-ancestor
56285652|NCT05639322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56285653|NCT05639322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285654|NCT05639322|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56285655|NCT05639322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56285656|NCT05639322|Anesthetics, General|anesthetics, general|mesh-ancestor
56285657|NCT05639322|Anesthetics|anesthetics|mesh-ancestor
56285658|NCT05639322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905006|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56905007|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56905008|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
56905009|NCT02808572|Mitogens|mitogens|mesh-list
56905010|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
56905011|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905012|NCT02093728|Itraconazole|itraconazole|mesh-list
56905013|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56905014|NCT02093728|Fluconazole|fluconazole|mesh-list
56905015|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
56905016|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905017|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56905018|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285659|NCT05639322|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56285660|NCT05639322|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56285661|NCT05639322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56285662|NCT05639322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285663|NCT00001087|Ritonavir|ritonavir|mesh-list
56285664|NCT00001087|Nelfinavir|nelfinavir|mesh-list
56285665|NCT00001087|Saquinavir|saquinavir|mesh-list
56285666|NCT00001087|Lamivudine|lamivudine|mesh-list
56285667|NCT00001087|Zidovudine|zidovudine|mesh-list
56285668|NCT00001087|Didanosine|didanosine|mesh-list
56285669|NCT00001087|Stavudine|stavudine|mesh-list
56285670|NCT00001087|Zalcitabine|zalcitabine|mesh-list
56285671|NCT00001087|Efavirenz|efavirenz|mesh-list
56285672|NCT00001087|Adefovir|adefovir|mesh-list
56285673|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56285674|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285675|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285676|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285677|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285678|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285679|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285680|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285681|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
56285682|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285698|NCT00001111|Nevirapine|nevirapine|mesh-list
56285699|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
56285700|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285701|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285702|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285703|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285704|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
56285705|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285706|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285707|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285708|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56285709|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56285710|NCT00001114|Interferons|interferons|mesh-list
56285711|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
56285712|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
56285713|NCT00001114|Didanosine|didanosine|mesh-list
56285714|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285715|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
56285716|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285717|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
56285718|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285719|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
56285720|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285721|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285722|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285723|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285724|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285725|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285726|NCT00001165|Doxorubicin|doxorubicin|mesh-list
56905019|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905020|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285727|NCT00001165|Streptozocin|streptozocin|mesh-list
56285728|NCT00001165|Fluorouracil|fluorouracil|mesh-list
56285729|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56285730|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285731|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56285732|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56285733|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285734|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285735|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
56285736|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56285737|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56285738|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
55931966|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
56285746|NCT00389272|Ibuprofen|ibuprofen|mesh-list
56285747|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56285748|NCT00389272|Analgesics|analgesics|mesh-ancestor
56285749|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
56285750|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907699|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
56285751|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285752|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
56285753|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56285754|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56285755|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56285756|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56285757|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285758|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285760|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56285761|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56285762|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285763|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56285764|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
56285765|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56285766|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56285767|NCT00001213|Cysteamine|cysteamine|mesh-list
56285768|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56285769|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285770|NCT00000114|Vitamins|vitamins|mesh-list
56285771|NCT00000114|Vitamin E|vitamin e|mesh-list
56285772|NCT00000114|Vitamin A|vitamin a|mesh-list
56285773|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
56285774|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285775|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
56285776|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285777|NCT00000114|Protective Agents|protective agents|mesh-ancestor
56285778|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
56285779|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56285780|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56285781|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
56285782|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285783|NCT00001267|Zidovudine|zidovudine|mesh-list
56285784|NCT00001267|Didanosine|didanosine|mesh-list
56285785|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
56285786|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285787|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285788|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285789|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285790|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
56285791|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285792|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285793|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285794|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
56285795|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56285796|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
56285797|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56285798|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285799|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56285800|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
56285801|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56285802|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
56285803|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905021|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56905022|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
56285804|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56285805|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56285818|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285819|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285820|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56285821|NCT00001333|Topotecan|topotecan|mesh-list
56285822|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56285823|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56285824|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285825|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285826|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285828|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285829|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56285830|NCT00001378|Protective Agents|protective agents|mesh-ancestor
56285831|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285832|NCT00001387|Paclitaxel|paclitaxel|mesh-list
56285833|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56285834|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285835|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
56285836|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
56285837|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
56285838|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285839|NCT00388557|Ketoconazole|ketoconazole|mesh-list
56285840|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
56285841|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285842|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56285843|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285844|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285845|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285846|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56285847|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
56285848|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56285849|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285850|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285851|NCT00388635|Prednisone|prednisone|mesh-list
56285852|NCT00388635|Melphalan|melphalan|mesh-list
56285853|NCT00388635|Bortezomib|bortezomib|mesh-list
56285854|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56285855|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
56285856|NCT00388635|Hormones|hormones|mesh-ancestor
56285857|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56285858|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285859|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56285860|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285861|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56285862|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
56285863|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285864|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56285865|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56285866|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
56285867|NCT00001474|Interleukin-2|interleukin-2|mesh-list
56285868|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285869|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56285896|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285897|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285898|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285899|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56285901|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
56285902|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56285903|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
56285904|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285905|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285906|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
56285907|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285908|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
56285909|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285910|NCT00001576|Leucovorin|leucovorin|mesh-list
56285911|NCT00001576|Melphalan|melphalan|mesh-list
56285912|NCT00001576|Floxuridine|floxuridine|mesh-list
56285913|NCT00001576|Antidotes|antidotes|mesh-ancestor
56516604|NCT01113931|Doxycycline|doxycycline|mesh-list
56285914|NCT00001576|Protective Agents|protective agents|mesh-ancestor
56285915|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285916|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
56285917|NCT00001576|Vitamins|vitamins|mesh-ancestor
56285918|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
56285939|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56285940|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285941|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56285942|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285944|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
56285945|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56285946|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56285947|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56285948|NCT00000147|Protective Agents|protective agents|mesh-ancestor
56285949|NCT00001624|Insulin|insulin|mesh-list
56285950|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56285951|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285952|NCT00001666|Methamphetamine|methamphetamine|mesh-list
56285953|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56285954|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285955|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
56285956|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
56285957|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56285958|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
56285959|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56285960|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285961|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
56285962|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56285963|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56285964|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56285965|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56285966|NCT00001669|Mecasermin|mecasermin|mesh-list
56285967|NCT00001669|Growth Substances|growth substances|mesh-ancestor
56285968|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285969|NCT00001693|Celecoxib|celecoxib|mesh-list
56285970|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56285971|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56285972|NCT00001693|Analgesics|analgesics|mesh-ancestor
56285973|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
56285981|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285983|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56285984|NCT00001696|Protective Agents|protective agents|mesh-ancestor
56285985|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285986|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285987|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56285988|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285989|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285990|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
56285991|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56285992|NCT00001696|Estrogens|estrogens|mesh-ancestor
56285993|NCT00001696|Hormones|hormones|mesh-ancestor
56285994|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56285995|NCT00389428|Cytarabine|cytarabine|mesh-list
56285996|NCT00389428|Daunorubicin|daunorubicin|mesh-list
56285997|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56285998|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
56285999|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286000|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286001|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
56286002|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286003|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56286004|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
56286005|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286006|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56286007|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56286008|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56286009|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286010|NCT00001720|Alendronate|alendronate|mesh-list
56286011|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56286012|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286013|NCT00001723|Orlistat|orlistat|mesh-list
56286014|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076623|NCT00361322|Salicylates|salicylates|mesh-list
56648472|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286015|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286016|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56286017|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56286018|NCT00001729|Ribavirin|ribavirin|mesh-list
56286019|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
56286020|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286021|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
56286022|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286023|NCT00001741|Losartan|losartan|mesh-list
56286024|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56286025|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56286026|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56286027|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56286028|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286029|NCT00001777|Sertraline|sertraline|mesh-list
56286030|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286031|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286032|NCT00001777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56286033|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56286034|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286035|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286036|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286037|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
56286049|NCT00000177|Hormones|hormones|mesh-ancestor
56286050|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286051|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286052|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
56286053|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56286054|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286055|NCT00000216|Buprenorphine|buprenorphine|mesh-list
56286056|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56286057|NCT00000216|Narcotics|narcotics|mesh-ancestor
56286058|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286059|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286060|NCT00000216|Analgesics|analgesics|mesh-ancestor
56286061|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
56286062|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286063|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56286064|NCT05641363|Ketorolac|ketorolac|mesh-list
56286065|NCT05641363|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56286066|NCT05641363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56286067|NCT05641363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56286068|NCT05641363|Analgesics|analgesics|mesh-ancestor
56286069|NCT05641363|Sensory System Agents|sensory system agents|mesh-ancestor
56286070|NCT05641363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286071|NCT05641363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286072|NCT05641363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286073|NCT05641363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56286074|NCT05641363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56286075|NCT05641363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286076|NCT05641363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286077|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
56286078|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56286079|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
56286080|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
56286081|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286082|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286083|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56286084|NCT00000252|Analgesics|analgesics|mesh-ancestor
56286085|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
56286086|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286087|NCT05641051|Metoclopramide|metoclopramide|mesh-list
56286088|NCT05641051|Antiemetics|antiemetics|mesh-ancestor
56286089|NCT05641051|Autonomic Agents|autonomic agents|mesh-ancestor
56286090|NCT05641051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286091|NCT05641051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286092|NCT05641051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56286093|NCT05641051|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56286094|NCT05641051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56286095|NCT05641051|Dopamine Agents|dopamine agents|mesh-ancestor
56286096|NCT05641051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648473|NCT00894647|Imiquimod|imiquimod|mesh-list
56286097|NCT05641051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286098|NCT05640817|Pentoxifylline|pentoxifylline|mesh-list
56286099|NCT05640817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56286111|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
56286112|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
56286113|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286114|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286115|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56286116|NCT00000255|Analgesics|analgesics|mesh-ancestor
56286117|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
56286118|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286120|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56286121|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
56286122|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
55908073|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
56286123|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286124|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286125|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56286127|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
56286128|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286129|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
56286130|NCT00389506|Fludarabine|fludarabine|mesh-list
56286131|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
56286132|NCT00389506|Immunotoxins|immunotoxins|mesh-list
56286133|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56286134|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
56286135|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286136|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56286137|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56286138|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
56286139|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286140|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286141|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56286142|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56286143|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
56286144|NCT00389584|Irinotecan|irinotecan|mesh-list
56286145|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56286146|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56286147|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286148|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286149|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286150|NCT00000324|Tryptophan|tryptophan|mesh-list
56286151|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56286152|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286153|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286154|NCT05640427|Dexmedetomidine|dexmedetomidine|mesh-list
56286155|NCT05640427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56286156|NCT05640427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286157|NCT05640427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286158|NCT05640427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56286159|NCT05640427|Analgesics|analgesics|mesh-ancestor
56286160|NCT05640427|Sensory System Agents|sensory system agents|mesh-ancestor
56286161|NCT05640427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286162|NCT05640427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56286163|NCT05640427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56286182|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286183|NCT00000375|Nortriptyline|nortriptyline|mesh-list
56286184|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286185|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286186|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286187|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286188|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56286189|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56286190|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56286191|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286192|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
56286193|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286194|NCT03295747|Peppermint oil|peppermint oil|mesh-list
56286195|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
56286197|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286198|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286200|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
56905023|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286201|NCT05639959|Mometasone Furoate|mometasone furoate|mesh-list
56286202|NCT05639959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286203|NCT05639959|Dermatologic Agents|dermatologic agents|mesh-ancestor
56286204|NCT05639959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56286205|NCT03575208|Interferons|interferons|mesh-list
56286206|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
56286207|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
56286209|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
56286210|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56286211|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56286212|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286213|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
56286214|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286215|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
56286216|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286217|NCT03295552|Carboplatin|carboplatin|mesh-list
56286218|NCT03295552|Decitabine|decitabine|mesh-list
56286219|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286220|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56286221|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
56286230|NCT05631925|Anesthetics|anesthetics|mesh-ancestor
56286231|NCT05629468|Azithromycin|azithromycin|mesh-list
56286232|NCT05629468|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56286233|NCT05629468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56286234|NCT05629468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286235|NCT05629468|Dermatologic Agents|dermatologic agents|mesh-ancestor
56286236|NCT00000378|Sertraline|sertraline|mesh-list
56286237|NCT00000378|Nortriptyline|nortriptyline|mesh-list
56286238|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286239|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286240|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56286241|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56286242|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286243|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286244|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286245|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
56286246|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286247|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56286248|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56286249|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
56286250|NCT05626621|Mometasone Furoate|mometasone furoate|mesh-list
56286251|NCT05626621|Azelastine|azelastine|mesh-list
56286252|NCT05626621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286253|NCT05626621|Dermatologic Agents|dermatologic agents|mesh-ancestor
56286254|NCT05626621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56286255|NCT05626621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56286256|NCT05626621|Autonomic Agents|autonomic agents|mesh-ancestor
56286257|NCT05626621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286258|NCT05626621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286259|NCT05626621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56286260|NCT05626621|Respiratory System Agents|respiratory system agents|mesh-ancestor
56286261|NCT05626621|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56286262|NCT05626621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286263|NCT05626621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286264|NCT05626621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56286265|NCT05626621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56286266|NCT05626621|Histamine Antagonists|histamine antagonists|mesh-ancestor
56286267|NCT05626621|Histamine Agents|histamine agents|mesh-ancestor
56286268|NCT05626621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286269|NCT00000381|Fluoxetine|fluoxetine|mesh-list
56286270|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56286271|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56286272|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286273|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286274|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286275|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
56286276|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286277|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56286278|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286279|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286280|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56286281|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56905024|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905025|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56905026|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56905027|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56905028|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56905029|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
56905030|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286282|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286283|NCT05619172|Cetuximab|cetuximab|mesh-list
56286284|NCT05619172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56286285|NCT05619172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286286|NCT00389701|Dexamethasone|dexamethasone|mesh-list
56286287|NCT00389701|Bortezomib|bortezomib|mesh-list
56286297|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56286298|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286299|NCT00000420|Norinyl|norinyl|mesh-list
56286300|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56286301|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56286302|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56286303|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
56286304|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56286305|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286306|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56286307|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56286308|NCT00000426|Calcium|calcium|mesh-list
56286309|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56286310|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286311|NCT05551858|Proglumide|proglumide|mesh-list
56286312|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56286313|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56286314|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56286315|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286316|NCT00000456|Naltrexone|naltrexone|mesh-list
56286317|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56286318|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56286319|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286320|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
56286321|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286322|NCT05519683|Citalopram|citalopram|mesh-list
56286323|NCT05519683|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56286324|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56286325|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286326|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286327|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286328|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
56286329|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286330|NCT05519683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56286331|NCT05519683|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286332|NCT05519683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286333|NCT05442268|Acetaminophen|acetaminophen|mesh-list
56286334|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56286335|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56286336|NCT05442268|Analgesics|analgesics|mesh-ancestor
56286337|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
56286338|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286339|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286340|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
56286341|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56286342|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56286343|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286344|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286345|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286346|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286347|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286348|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
56516968|NCT04326296|Antibodies|antibodies|mesh-list
56286349|NCT05448820|Doxorubicin|doxorubicin|mesh-list
56286350|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56286351|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286352|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56286377|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
56286378|NCT02972476|Hormones|hormones|mesh-ancestor
56286379|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286380|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56286381|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56286382|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56286383|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
56286384|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286385|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286386|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
56286387|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
56286388|NCT05418868|Cabotegravir|cabotegravir|mesh-list
56286389|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56286390|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56286391|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286392|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286393|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56286394|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56286395|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
56286396|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286397|NCT02972320|Temozolomide|temozolomide|mesh-list
56286398|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56286399|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
56286400|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286401|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286402|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56286403|NCT05349838|Dolutegravir|dolutegravir|mesh-list
56286404|NCT05349838|Rilpivirine|rilpivirine|mesh-list
56286405|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
56286425|NCT05305456|Vitamins|vitamins|mesh-list
56286426|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
56286427|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
56286428|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286429|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
56286430|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286431|NCT05305456|Protective Agents|protective agents|mesh-ancestor
56286432|NCT00388986|Glyburide|glyburide|mesh-list
56286433|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56286434|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286435|NCT05233696|Paclitaxel|paclitaxel|mesh-list
56286436|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56286437|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
56286438|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56286439|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286440|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
56286441|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
56286442|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
56286443|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286444|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56286445|NCT05223673|Trifluridine|trifluridine|mesh-list
56286446|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
56286447|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286448|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
56286449|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286450|NCT00000492|Propranolol|propranolol|mesh-list
56286451|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56286452|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56286453|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
56286454|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286455|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286456|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286457|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56286458|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56286459|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
56286460|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
56286461|NCT00000504|Flecainide|flecainide|mesh-list
56286462|NCT00000504|Moricizine|moricizine|mesh-list
56286463|NCT00000504|Encainide|encainide|mesh-list
56286475|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
56286476|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286477|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905031|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
56905032|NCT02089204|Fluorides|fluorides|mesh-list
56905033|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
56517051|NCT00623168|Ribavirin|ribavirin|mesh-list
56286479|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56286480|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
56286481|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286482|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
56286483|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56286484|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286485|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56286486|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56286487|NCT00389935|Growth Substances|growth substances|mesh-ancestor
56286488|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
56286489|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286490|NCT05116930|Atropine|atropine|mesh-list
56286491|NCT05116930|Neostigmine|neostigmine|mesh-list
56286492|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56286493|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56286494|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56286495|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
56286496|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286497|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286498|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56286499|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
56286500|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
56286501|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
56286502|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56286503|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56286504|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
56286505|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286506|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286507|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56286508|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286509|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56286511|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56286512|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286513|NCT00000516|Enalapril|enalapril|mesh-list
56286514|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56286515|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
56286516|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286517|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286518|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56286519|NCT05049616|Nifedipine|nifedipine|mesh-list
56286520|NCT05049616|Diuretics|diuretics|mesh-list
56286521|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56286522|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56286523|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286524|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286525|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56286554|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
56286555|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286556|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56286557|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
56286559|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286560|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56286561|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56286562|NCT03126799|Bevacizumab|bevacizumab|mesh-list
56286563|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56286564|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56286565|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286566|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56286567|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56286568|NCT03126799|Growth Substances|growth substances|mesh-ancestor
56286569|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286570|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
56286571|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56286572|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286573|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286579|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
56286580|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905034|NCT02089204|Protective Agents|protective agents|mesh-ancestor
56905035|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905036|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
56286581|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56286582|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286583|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286584|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56286585|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56286586|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56286587|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
56286588|NCT05020483|Coagulants|coagulants|mesh-ancestor
56286590|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
56286591|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
56286592|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
56286593|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286594|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286595|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
56286596|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286597|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56286598|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56286599|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56286600|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286601|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286602|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
56286603|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286604|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56286605|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56286606|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
56286607|NCT00000531|Amiodarone|amiodarone|mesh-list
56286608|NCT00000531|Sotalol|sotalol|mesh-list
56286609|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56286610|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
56286611|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56286612|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286613|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286614|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56286615|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56286616|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56286617|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286618|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56286619|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56286620|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56286621|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56286622|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56286623|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
56286624|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286625|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286626|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
56286627|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
56286628|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286629|NCT00000534|Calcium|calcium|mesh-list
56286630|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56286631|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286632|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56286633|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56286634|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286635|NCT04935814|Vasopressins|vasopressins|mesh-list
56286636|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
56286637|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
56286638|NCT04935814|Coagulants|coagulants|mesh-ancestor
56286639|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56286640|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56286641|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
56286642|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286658|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286660|NCT04888858|Fentanyl|fentanyl|mesh-list
56286661|NCT04888858|Bupivacaine|bupivacaine|mesh-list
56286662|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
56286663|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
56286664|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905037|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905038|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
56905039|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286665|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286666|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
56286667|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286668|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56286669|NCT04888858|Narcotics|narcotics|mesh-ancestor
56286670|NCT04888858|Analgesics|analgesics|mesh-ancestor
56286671|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56286672|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56286673|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
56286674|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56286675|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56286676|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56286677|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286678|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286679|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286680|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286681|NCT04870957|Analgesics|analgesics|mesh-ancestor
56286682|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
56286683|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286684|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286685|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286686|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
56286687|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56286688|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56286689|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286690|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
56286691|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
56286692|NCT04862221|Promethazine|promethazine|mesh-list
56286693|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
56286694|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56286695|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56286696|NCT04862221|Prednisolone|prednisolone|mesh-list
56286697|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
56286698|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56286699|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
56286700|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56286701|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286702|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
56286703|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
56286729|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
56286730|NCT04802746|Alprazolam|alprazolam|mesh-list
56286731|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56286732|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286733|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286734|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56286735|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56286736|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286737|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
56286738|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
56286739|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286740|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286741|NCT00000576|Beclomethasone|beclomethasone|mesh-list
56286742|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286743|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
56286744|NCT00000576|Hormones|hormones|mesh-ancestor
56286745|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286746|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286747|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56286748|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
56286749|NCT00000579|Ketoconazole|ketoconazole|mesh-list
56286750|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
56286751|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56286752|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56286753|NCT00000579|Prednisolone|prednisolone|mesh-list
56286754|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
56286755|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55932092|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
56286763|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
56286764|NCT00000579|Hormones|hormones|mesh-ancestor
56076903|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
56905040|NCT02095990|Hydroquinone|hydroquinone|mesh-list
56905041|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
56517257|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56160521|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56286765|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286766|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56286767|NCT00000579|Protective Agents|protective agents|mesh-ancestor
56286768|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56286769|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286770|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
56286771|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286772|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56286773|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56286774|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286775|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286776|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56286777|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
56286778|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56286779|NCT00000588|Pyridoxal|pyridoxal|mesh-list
56286780|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
56286781|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
56286782|NCT00000588|Vitamins|vitamins|mesh-ancestor
56286783|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
56286784|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286785|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
56286786|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
56286787|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286788|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56286789|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
56286790|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56286792|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
56286793|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56286794|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56286795|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
56286796|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286797|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56286798|NCT00390091|Abetimus|abetimus|mesh-list
56286799|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56286800|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
56286801|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286802|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56286803|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
56286804|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286805|NCT04650880|Vitamin D|vitamin d|mesh-list
56286806|NCT04650880|Vitamins|vitamins|mesh-ancestor
56286807|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
56286808|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286809|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56286810|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
56286811|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56286812|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
56286813|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286814|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286815|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56286816|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
56286817|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56286818|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
56286819|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286820|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286821|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56286822|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
56286834|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286835|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56286836|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56286837|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56286839|NCT04547530|Vitamins|vitamins|mesh-ancestor
56286840|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
56286841|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286842|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56286843|NCT04544683|Dexamethasone|dexamethasone|mesh-list
56286844|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
56905042|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905043|NCT02095990|Protective Agents|protective agents|mesh-ancestor
56905044|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286845|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56286846|NCT04544683|BB 1101|bb 1101|mesh-list
56286847|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286848|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
56286849|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
56286850|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286851|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286852|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56286853|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
56286854|NCT04544683|Hormones|hormones|mesh-ancestor
56286855|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286856|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56286857|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286858|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
56286859|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286860|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286861|NCT00000612|Estrogens|estrogens|mesh-list
56286862|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56286863|NCT00000612|Hormones|hormones|mesh-ancestor
56333996|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286864|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286865|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286866|NCT00000639|Itraconazole|itraconazole|mesh-list
56286867|NCT00000639|Fluconazole|fluconazole|mesh-list
56286868|NCT00000639|Amphotericin B|amphotericin b|mesh-list
56286869|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56286870|NCT00000639|Flucytosine|flucytosine|mesh-list
56286871|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
56286872|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286873|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56286874|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56286875|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286876|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286877|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56286878|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
56286879|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286880|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286881|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55932101|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56286899|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286900|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56286901|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
56286902|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286903|NCT04495504|Ropivacaine|ropivacaine|mesh-list
56286904|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
56286905|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
56286906|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286907|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286908|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
56286910|NCT00390208|Dexamethasone|dexamethasone|mesh-list
56286911|NCT00390208|Ranibizumab|ranibizumab|mesh-list
56286912|NCT00390208|Verteporfin|verteporfin|mesh-list
56286913|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286914|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
56286915|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
56286916|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286917|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286918|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56286919|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
56286920|NCT00390208|Hormones|hormones|mesh-ancestor
56286921|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286922|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56286923|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286924|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56286925|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56286926|NCT00390208|Growth Substances|growth substances|mesh-ancestor
56286927|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
56905045|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56905046|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
56905047|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56905048|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905049|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905050|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56905051|NCT02096068|Analgesics|analgesics|mesh-ancestor
56905052|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
56286928|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56286929|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
56286930|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56286931|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56286932|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56286933|NCT00389025|Analgesics|analgesics|mesh-ancestor
56286934|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
56286935|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286936|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286937|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286938|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56286939|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56286940|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56286941|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56286970|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
56286971|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56286972|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56286973|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286974|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56286975|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286976|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286977|NCT00000672|Didanosine|didanosine|mesh-list
56286978|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
56286979|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286980|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56286981|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56286983|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
56286984|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286985|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56286986|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56286987|NCT04321954|Lenvatinib|lenvatinib|mesh-list
56286988|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286997|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
56286998|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286999|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287000|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287001|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287002|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
56287003|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287004|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287005|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287006|NCT00390403|Acetic Acid|acetic acid|mesh-list
56287007|NCT00390403|Temozolomide|temozolomide|mesh-list
56287008|NCT00390403|Retinol acetate|retinol acetate|mesh-list
56287009|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
56287010|NCT00390403|Gossypol|gossypol|mesh-list
56287011|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56287012|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
56287013|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287014|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287015|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56287016|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287017|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56287018|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
56287019|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287020|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56287021|NCT00390403|Protective Agents|protective agents|mesh-ancestor
56287022|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56287023|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
56905053|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905054|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56287024|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56287025|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56287026|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56287027|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56287028|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56287030|NCT00000681|Doxorubicin|doxorubicin|mesh-list
56287031|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56287032|NCT00000681|Bleomycin|bleomycin|mesh-list
56287033|NCT00000681|Vincristine|vincristine|mesh-list
56287034|NCT00000681|Sargramostim|sargramostim|mesh-list
56287035|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56287036|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287037|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56287038|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56287039|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287040|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287041|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56287042|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
56287043|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
56287044|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
56287045|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
56287046|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287047|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287048|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
56287049|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287050|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287051|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287052|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
56287053|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287054|NCT00000684|Dextrans|dextrans|mesh-list
56287055|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
56287056|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
55932124|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
56287070|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287071|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287072|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287073|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287074|NCT00000690|Dextrans|dextrans|mesh-list
56287075|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
56287076|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
56287077|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
56287078|NCT00000696|Interferons|interferons|mesh-list
56287079|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
56287080|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
56287081|NCT00000696|Zidovudine|zidovudine|mesh-list
56287082|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287083|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
56287084|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287085|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
56287086|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287087|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
56287088|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027346|NCT00789776|Tacrolimus|tacrolimus|mesh-list
56287089|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287090|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287091|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287092|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55909066|NCT02332356|Adalimumab|adalimumab|mesh-list
56287093|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287094|NCT00000705|Zidovudine|zidovudine|mesh-list
56287095|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
56287096|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287097|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287098|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287099|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287100|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
56287101|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287102|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287103|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287104|NCT00000708|Fluconazole|fluconazole|mesh-list
56287105|NCT00000708|Amphotericin B|amphotericin b|mesh-list
56287106|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56287107|NCT00000708|Flucytosine|flucytosine|mesh-list
56287108|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
56905055|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56905056|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56905057|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
56905058|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905059|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905060|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56905061|NCT02089438|Vildagliptin|vildagliptin|mesh-list
56287109|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287110|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56287111|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287112|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287113|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287114|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56287115|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
56287116|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56287117|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287118|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56287119|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56287120|NCT00000708|Amebicides|amebicides|mesh-ancestor
56287121|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56287133|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56287134|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287135|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287136|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56287137|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287138|NCT00000711|Zidovudine|zidovudine|mesh-list
56287139|NCT00000711|Sargramostim|sargramostim|mesh-list
56287140|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
56287141|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287142|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287143|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287144|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287145|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
56287146|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287147|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287148|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287149|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
56287150|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287151|NCT00000717|Clindamycin|clindamycin|mesh-list
56287152|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
56287153|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
56287154|NCT00000717|Primaquine|primaquine|mesh-list
56287155|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56287156|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287157|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56287158|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287159|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287160|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
56287161|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56287162|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56287163|NCT04169347|Leucovorin|leucovorin|mesh-list
56287164|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
56287165|NCT04169347|Irinotecan|irinotecan|mesh-list
56287166|NCT04169347|Panitumumab|panitumumab|mesh-list
56287167|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287168|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56287169|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56287170|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287171|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287172|NCT04169347|Antidotes|antidotes|mesh-ancestor
56287173|NCT04169347|Protective Agents|protective agents|mesh-ancestor
56287174|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287175|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
56287177|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
56287178|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56287179|NCT00000720|Zidovudine|zidovudine|mesh-list
56287180|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
56287181|NCT00000720|Antibodies|antibodies|mesh-list
56905062|NCT02089438|Saxagliptin|saxagliptin|mesh-list
56905063|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56905064|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905065|NCT02089438|Incretins|incretins|mesh-ancestor
56905066|NCT02089438|Hormones|hormones|mesh-ancestor
56905067|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56905068|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56517610|NCT01321710|Acetaminophen|acetaminophen|mesh-list
56287182|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
56287183|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287184|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287185|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287186|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287187|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
56287188|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287189|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287203|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287204|NCT04104139|Trifluridine|trifluridine|mesh-list
56287205|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
56287206|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287207|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
56287208|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287209|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
56287210|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56287211|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56287212|NCT00000741|Prednisolone|prednisolone|mesh-list
56287213|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
56287214|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56287215|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
56287216|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56287217|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
56287218|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
56287219|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287220|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287221|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56287222|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
56287223|NCT00000741|Hormones|hormones|mesh-ancestor
56287224|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56287225|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56287226|NCT00000741|Protective Agents|protective agents|mesh-ancestor
56287227|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56287228|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287229|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
56287230|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56287231|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56287232|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56287233|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56287234|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287235|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
56287236|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56287237|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287238|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56287239|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287240|NCT00000744|Fluconazole|fluconazole|mesh-list
56287242|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287243|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56287244|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287245|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287246|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287247|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56287248|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
56287249|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56287250|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932149|NCT03076320|Adapalene|adapalene|mesh-list
56287267|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905069|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
56905070|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287268|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56287269|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
56287270|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56287271|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287272|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287273|NCT04020172|Dobutamine|dobutamine|mesh-list
56287274|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56287275|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
56287276|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
56287277|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287278|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287279|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56287280|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56287281|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56287282|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
56287283|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56287284|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287285|NCT04020172|Protective Agents|protective agents|mesh-ancestor
56287286|NCT00000747|Nevirapine|nevirapine|mesh-list
56287287|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287288|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287289|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287290|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287291|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
56287292|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287293|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287294|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287295|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56287296|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56287297|NCT04009681|Antibodies|antibodies|mesh-list
56287298|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
56287299|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287300|NCT00000753|Zidovudine|zidovudine|mesh-list
56287301|NCT00000753|Didanosine|didanosine|mesh-list
56287302|NCT00000753|Zalcitabine|zalcitabine|mesh-list
56287303|NCT00000753|Atevirdine|atevirdine|mesh-list
56287304|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
56287305|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287306|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287307|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287308|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287309|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
56287310|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287321|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56287322|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56287323|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56287324|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56287325|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
56287326|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
56287327|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56287328|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287329|NCT03991741|Interleukin-2|interleukin-2|mesh-list
56287330|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287331|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56287332|NCT03991741|Analgesics|analgesics|mesh-ancestor
56287333|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
56287334|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287335|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287336|NCT00000768|Ganciclovir|ganciclovir|mesh-list
56287337|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56287338|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
56287339|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287340|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287341|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287342|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287345|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
56287346|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287347|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287348|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287349|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287350|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
56905071|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905072|NCT05471674|Nivolumab|nivolumab|mesh-list
56905073|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56905074|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517751|NCT01313780|Analgesics|analgesics|mesh-ancestor
56287351|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287352|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287353|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287354|NCT00000792|Hypericin|hypericin|mesh-list
56287355|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
56287356|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56287357|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287358|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
56287359|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287360|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287361|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287362|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56287363|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
56287364|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287365|NCT03937609|Infliximab|infliximab|mesh-list
56287366|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
56287367|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56287368|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56287369|NCT00390520|Vildagliptin|vildagliptin|mesh-list
56287370|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56287371|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287372|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56287373|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
56287374|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287375|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287376|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
56287377|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56287383|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287384|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
56287385|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56287386|NCT00000813|Protective Agents|protective agents|mesh-ancestor
56287387|NCT03877549|Dexamethasone|dexamethasone|mesh-list
56287388|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56287390|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
56287391|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287392|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287393|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56287394|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
56287395|NCT03877549|Hormones|hormones|mesh-ancestor
56287396|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56287397|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56287398|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287399|NCT00390598|Sennosides|sennosides|mesh-list
56287400|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56287401|NCT00390598|Laxatives|laxatives|mesh-ancestor
56287402|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56287403|NCT00000816|Trimethoprim|trimethoprim|mesh-list
56287404|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56287405|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
56287406|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56287407|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287408|NCT00000816|Renal Agents|renal agents|mesh-ancestor
56287409|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
56287410|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56287411|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56287412|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56287413|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287414|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287415|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56287416|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56287417|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287418|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56287419|NCT03801031|Lidocaine|lidocaine|mesh-list
56287420|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
56287421|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
56287422|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517818|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56287423|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287424|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
56287425|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287426|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56287427|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56287428|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56287429|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56287430|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287431|NCT00000822|Ritonavir|ritonavir|mesh-list
56287432|NCT00000822|Didanosine|didanosine|mesh-list
56287433|NCT00000822|Stavudine|stavudine|mesh-list
56287434|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56287435|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56287436|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
56287437|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287438|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287439|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287440|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287441|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
56287442|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287443|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56287444|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287445|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
56287446|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287447|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287458|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56287459|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56287460|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56287461|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56287464|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56287465|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287466|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56287467|NCT03646123|Doxorubicin|doxorubicin|mesh-list
56287468|NCT03646123|Nivolumab|nivolumab|mesh-list
56287469|NCT03646123|Dacarbazine|dacarbazine|mesh-list
56287470|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56287471|NCT03646123|Vinblastine|vinblastine|mesh-list
56287472|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56287473|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287474|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56287475|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56287476|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287477|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287478|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56287479|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56287480|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56287481|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
56287482|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56287483|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
56287484|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
56287485|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
56287486|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
56287487|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56287488|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287489|NCT03576547|Dexamethasone|dexamethasone|mesh-list
56287490|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
56287491|NCT03576547|Rituximab|rituximab|mesh-list
56287492|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56287493|NCT03576547|Venetoclax|venetoclax|mesh-list
56287494|NCT03576547|Ponatinib|ponatinib|mesh-list
56287495|NCT03576547|Antibodies|antibodies|mesh-list
56287496|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
56287497|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56287498|NCT03576547|BB 1101|bb 1101|mesh-list
56287499|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
56287500|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287501|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287502|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56287503|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56287504|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
56287505|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
56287506|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287507|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56287509|NCT03576547|Hormones|hormones|mesh-ancestor
56077179|NCT02460133|Ribavirin|ribavirin|mesh-list
56905075|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56905076|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905077|NCT02096224|Sevoflurane|sevoflurane|mesh-list
56905078|NCT02096224|Desflurane|desflurane|mesh-list
56287510|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56287511|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56287512|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
56287513|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287514|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287535|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287537|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56287538|NCT03539302|Flecainide|flecainide|mesh-list
56287539|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56287540|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56287541|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56287542|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56287543|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909520|NCT04477590|Metformin|metformin|mesh-list
56287545|NCT00000831|Zidovudine|zidovudine|mesh-list
56287546|NCT00000831|Didanosine|didanosine|mesh-list
56287547|NCT00000831|Stavudine|stavudine|mesh-list
56287548|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287549|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287550|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287551|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287552|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
56287553|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287554|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287555|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287556|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
56287557|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
56287558|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56287559|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287560|NCT00000849|Aldesleukin|aldesleukin|mesh-list
56287561|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287562|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287563|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287564|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
56287565|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287566|NCT03357952|Daratumumab|daratumumab|mesh-list
56287567|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287568|NCT00000855|Zidovudine|zidovudine|mesh-list
56287569|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
56287570|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287571|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55932191|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
56287588|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56287589|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287590|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287591|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56287592|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56287593|NCT00390676|Carboplatin|carboplatin|mesh-list
56287594|NCT00390676|Docetaxel|docetaxel|mesh-list
56287595|NCT00390676|Capecitabine|capecitabine|mesh-list
56287596|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287597|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
56287598|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
56287599|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
56287600|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287601|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56287602|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
56287603|NCT00000870|Lamivudine|lamivudine|mesh-list
56287604|NCT00000870|Zidovudine|zidovudine|mesh-list
56287605|NCT00000870|Didanosine|didanosine|mesh-list
56287606|NCT00000870|Stavudine|stavudine|mesh-list
56287607|NCT00000870|Aldesleukin|aldesleukin|mesh-list
56287608|NCT00000870|Indinavir|indinavir|mesh-list
56287609|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287610|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287611|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287612|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905079|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56905080|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56905081|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
56905082|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
56905083|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905084|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287613|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
56287614|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287615|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287616|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287617|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
56287618|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287619|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56287620|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56287621|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
56287622|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
56287623|NCT00390832|Hematinics|hematinics|mesh-ancestor
56287624|NCT00390871|Fentanyl|fentanyl|mesh-list
56287625|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
56287626|NCT00390871|Propofol|propofol|mesh-list
56287627|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56287628|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56287629|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287630|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56287631|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
56287664|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287665|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287666|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
56287667|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287668|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287669|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287670|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
56287671|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56287672|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56287673|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
56287674|NCT00000888|Ritonavir|ritonavir|mesh-list
56287675|NCT00000888|Lamivudine|lamivudine|mesh-list
56287676|NCT00000888|Zidovudine|zidovudine|mesh-list
56287677|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56287678|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56287679|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
56287693|NCT00000891|Lamivudine|lamivudine|mesh-list
56287694|NCT00000891|Zidovudine|zidovudine|mesh-list
56287696|NCT00000891|Stavudine|stavudine|mesh-list
56287697|NCT00000891|Delavirdine|delavirdine|mesh-list
56287698|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56287699|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56287700|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
56287701|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287702|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287703|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287704|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287705|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
56287706|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287707|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56287708|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287709|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287710|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287711|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
56287713|NCT00000903|Zidovudine|zidovudine|mesh-list
56287714|NCT00000903|Efavirenz|efavirenz|mesh-list
56287715|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56287716|NCT00000903|Nelfinavir|nelfinavir|mesh-list
56287717|NCT00000903|Indinavir|indinavir|mesh-list
56287718|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287719|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287720|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287721|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287722|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
56287723|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287724|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287725|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56905085|NCT02096380|Cisplatin|cisplatin|mesh-list
56287726|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
56287727|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56287728|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287729|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56287730|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56287731|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56287732|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56287733|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56287734|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56287735|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
56287736|NCT02939365|Abatacept|abatacept|mesh-list
56287737|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56287738|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287739|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287740|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56287741|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
56287742|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287764|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287765|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
56287766|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
56287767|NCT02681302|Nivolumab|nivolumab|mesh-list
56287768|NCT02681302|Ipilimumab|ipilimumab|mesh-list
56287769|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56287770|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287771|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56287772|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287773|NCT00000951|Fluconazole|fluconazole|mesh-list
56287774|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
56287775|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287776|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56287777|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287778|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287779|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287780|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56287781|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
56287782|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56287783|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287784|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56287785|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56287786|NCT02627443|Gemcitabine|gemcitabine|mesh-list
56287787|NCT02627443|Carboplatin|carboplatin|mesh-list
56287788|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287789|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56287790|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
56287791|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287792|NCT02627443|Antiviral Agents|antiviral agents|mesh-ancestor
56287793|NCT02627443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287794|NCT02627443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287795|NCT02627443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56287796|NCT02627443|Immunologic Factors|immunologic factors|mesh-ancestor
56287835|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56287836|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56287837|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
56287838|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56287839|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56287840|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56287841|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56287842|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287843|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56287844|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56287855|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56287856|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287858|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56287859|NCT00000966|Leucovorin|leucovorin|mesh-list
56287860|NCT00000966|Azithromycin|azithromycin|mesh-list
56287861|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
56287862|NCT00000966|Calcium|calcium|mesh-list
56287863|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
56287864|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56287865|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287866|NCT00000966|Antidotes|antidotes|mesh-ancestor
56905086|NCT02096380|Docetaxel|docetaxel|mesh-list
56287867|NCT00000966|Protective Agents|protective agents|mesh-ancestor
56287868|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
56287869|NCT00000966|Vitamins|vitamins|mesh-ancestor
56287870|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
56287871|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56287872|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287873|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
56287874|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56287875|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56287876|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56287877|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287878|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287879|NCT00000969|Didanosine|didanosine|mesh-list
56287880|NCT00000969|Zalcitabine|zalcitabine|mesh-list
56287881|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
56287882|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287883|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287884|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287885|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287886|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
56287887|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287888|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287889|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287890|NCT00000975|Itraconazole|itraconazole|mesh-list
56287891|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
56287892|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287893|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56287894|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287895|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287896|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287897|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56287898|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
56287899|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56287900|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287901|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56287902|NCT00000978|Zidovudine|zidovudine|mesh-list
56287903|NCT00000978|Zalcitabine|zalcitabine|mesh-list
56287904|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
56287905|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287906|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287907|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287908|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287929|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287930|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287931|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
56287932|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287933|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287934|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287935|NCT00005819|Paclitaxel|paclitaxel|mesh-list
56287936|NCT00005819|Fenretinide|fenretinide|mesh-list
56287937|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56287938|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287939|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
56287940|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
56287941|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
56287942|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287943|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56287944|NCT00005819|Protective Agents|protective agents|mesh-ancestor
56287945|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287946|NCT00001005|Zidovudine|zidovudine|mesh-list
56287947|NCT00001005|Aldesleukin|aldesleukin|mesh-list
56287948|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
56287949|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287950|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287951|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287952|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287953|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
56287954|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287955|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287956|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287957|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287958|NCT00391105|Remifentanil|remifentanil|mesh-list
56287959|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56287960|NCT00391105|Narcotics|narcotics|mesh-ancestor
56905087|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905088|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905089|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905090|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56905091|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287961|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56287962|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287963|NCT00391105|Analgesics|analgesics|mesh-ancestor
56287964|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
56287965|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287966|NCT00391144|Triamcinolone|triamcinolone|mesh-list
56288000|NCT00001008|Methadone|methadone|mesh-list
56288001|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
56288002|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288003|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288004|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288005|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932254|NCT05006664|Etoposide|etoposide|mesh-list
56288019|NCT01889992|Sirolimus|sirolimus|mesh-list
56288020|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56288021|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288022|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288023|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288024|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
56288025|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288026|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
56288027|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288028|NCT00005825|Vinorelbine|vinorelbine|mesh-list
56288029|NCT00005825|Mitomycins|mitomycins|mesh-list
56288030|NCT00005825|Mitomycin|mitomycin|mesh-list
56288031|NCT00005825|Tretinoin|tretinoin|mesh-list
56288032|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288033|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288034|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288035|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288036|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288037|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288038|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288039|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
56288040|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288041|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288042|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
56288043|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
56288045|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
56288046|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288047|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288048|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288049|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288050|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
56288051|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288052|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288053|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288054|NCT00001014|Leucovorin|leucovorin|mesh-list
56288055|NCT00001014|Trimethoprim|trimethoprim|mesh-list
56288056|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56288057|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
56288058|NCT00001014|Trimetrexate|trimetrexate|mesh-list
56288059|NCT00001014|Calcium|calcium|mesh-list
56288060|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
56288061|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56288062|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288063|NCT00001014|Antidotes|antidotes|mesh-ancestor
56288064|NCT00001014|Protective Agents|protective agents|mesh-ancestor
56288065|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
56288066|NCT00001014|Vitamins|vitamins|mesh-ancestor
56288067|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
56288068|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56288069|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288070|NCT00001014|Renal Agents|renal agents|mesh-ancestor
56288071|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
56288088|NCT00005831|Trastuzumab|trastuzumab|mesh-list
56288089|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56905092|NCT04384107|Vaccines|vaccines|mesh-list
56905093|NCT04384107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56905094|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
56905095|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288090|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288091|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288092|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288093|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288094|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288095|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56288096|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
56288097|NCT00005831|Antiviral Agents|antiviral agents|mesh-ancestor
56288098|NCT00005831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288099|NCT00005831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288100|NCT00005831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288101|NCT00005831|Immunologic Factors|immunologic factors|mesh-ancestor
56288102|NCT00005831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288103|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56288104|NCT00005834|Thalidomide|thalidomide|mesh-list
56288105|NCT00005834|Dexamethasone|dexamethasone|mesh-list
56288106|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
56288107|NCT00005834|Etoposide|etoposide|mesh-list
56288108|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288109|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
56288110|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160560|NCT03574818|Gemcitabine|gemcitabine|mesh-list
56288111|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288112|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56288113|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
56288114|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288115|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288116|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56288117|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56288118|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
56288119|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
56288120|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288121|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56288122|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
56288123|NCT00005834|Hormones|hormones|mesh-ancestor
56288124|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288125|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56288126|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288127|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56288128|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288129|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288143|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288144|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288145|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
56288146|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288147|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288148|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288149|NCT00001032|Zidovudine|zidovudine|mesh-list
56288150|NCT00001032|Zalcitabine|zalcitabine|mesh-list
56288151|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
56288152|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288153|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288154|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288156|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
56288157|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288158|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288159|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288160|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
56288161|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288162|NCT00001038|Valacyclovir|valacyclovir|mesh-list
56288163|NCT00001038|Acyclovir|acyclovir|mesh-list
56288164|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
56288165|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288166|NCT00005840|Paclitaxel|paclitaxel|mesh-list
56288167|NCT00005840|Cisplatin|cisplatin|mesh-list
56288168|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288169|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288170|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288171|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905096|NCT02250118|Bevacizumab|bevacizumab|mesh-list
56905097|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56905098|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288172|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288173|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288174|NCT00005843|Tipifarnib|tipifarnib|mesh-list
56288175|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288176|NCT00005849|Paclitaxel|paclitaxel|mesh-list
56288177|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
56288178|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288179|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288180|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288181|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288182|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288183|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288184|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56288185|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
56288186|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288188|NCT00001047|Ethambutol|ethambutol|mesh-list
56288189|NCT00001047|Rifabutin|rifabutin|mesh-list
56288190|NCT00001047|Clofazimine|clofazimine|mesh-list
56288191|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56288192|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288193|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56288194|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288195|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932295|NCT04364451|Asparaginase|asparaginase|mesh-list
56288221|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56288222|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56288224|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
56288225|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288226|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56288227|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
56288228|NCT00005852|Hormones|hormones|mesh-ancestor
56288229|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288230|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56288231|NCT00005852|Protective Agents|protective agents|mesh-ancestor
56288232|NCT00001071|Lenograstim|lenograstim|mesh-list
56288233|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56288234|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
56288235|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288236|NCT00005855|Carmustine|carmustine|mesh-list
56288237|NCT00005855|Efaproxiral|efaproxiral|mesh-list
56288238|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56288239|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
56288240|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288241|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288242|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
56288244|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
56288245|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288246|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
55799024|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
56288283|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56288285|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288286|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
56288287|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56288288|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56288289|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
56288290|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288291|NCT00001086|Efavirenz|efavirenz|mesh-list
56288292|NCT00001086|Abacavir|abacavir|mesh-list
56288293|NCT00001086|Indinavir|indinavir|mesh-list
56288294|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288295|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288296|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288297|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288298|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
56288299|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288300|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56288301|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56288302|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56288303|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56905099|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56905100|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56288304|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56288305|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56288306|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288307|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288308|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56288309|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56288310|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
56288311|NCT00700258|Sirolimus|sirolimus|mesh-list
56288312|NCT00700258|Sunitinib|sunitinib|mesh-list
56288313|NCT00700258|Axitinib|axitinib|mesh-list
56288314|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288315|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56288316|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56288317|NCT00700258|Growth Substances|growth substances|mesh-ancestor
56288318|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288319|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
56288320|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56288321|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288322|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288323|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56288324|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288325|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288326|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
56288327|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288328|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
56288329|NCT00001113|Interferons|interferons|mesh-list
56288330|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
56288331|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
56288332|NCT00001113|Zidovudine|zidovudine|mesh-list
56288333|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288334|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
56288335|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288336|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
56288337|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288338|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
56288339|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288340|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288341|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288342|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288343|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288363|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56288364|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288365|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288366|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288367|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288368|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288369|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288370|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56288371|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
56288372|NCT00005867|Hormones|hormones|mesh-ancestor
56288373|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288374|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56288375|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288376|NCT00005867|Analgesics|analgesics|mesh-ancestor
56288377|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
56288378|NCT00005870|Gemcitabine|gemcitabine|mesh-list
56288379|NCT00005870|Fluorouracil|fluorouracil|mesh-list
56288380|NCT00005870|Mitomycins|mitomycins|mesh-list
56288381|NCT00005870|Mitomycin|mitomycin|mesh-list
56288382|NCT00005870|Rubitecan|rubitecan|mesh-list
56288383|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56288384|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
56288385|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288386|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288387|NCT00005870|Antiviral Agents|antiviral agents|mesh-ancestor
56288388|NCT00005870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288389|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288390|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288391|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
56288392|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288393|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288394|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
56905101|NCT02250118|Growth Substances|growth substances|mesh-ancestor
56905102|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905103|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
56905104|NCT03060772|Pioglitazone|pioglitazone|mesh-list
56905105|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56905106|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905107|NCT02096536|Vancomycin|vancomycin|mesh-list
56905108|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56905109|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905110|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
56905111|NCT02096614|Fludarabine|fludarabine|mesh-list
56905112|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56905113|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
56905114|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905115|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56905116|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56905117|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
56905118|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905119|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518467|NCT01080391|Hormones|hormones|mesh-ancestor
56288395|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288396|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56288397|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288399|NCT00017407|Carboplatin|carboplatin|mesh-list
56288400|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288401|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288402|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288403|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288420|NCT00001119|Indinavir|indinavir|mesh-list
56288421|NCT00001119|Amprenavir|amprenavir|mesh-list
56288422|NCT00001119|Lamivudine|lamivudine|mesh-list
56288423|NCT00001119|Zidovudine|zidovudine|mesh-list
56288424|NCT00001119|Abacavir|abacavir|mesh-list
56288425|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56288426|NCT00001119|Efavirenz|efavirenz|mesh-list
56288427|NCT00001119|Vaccines|vaccines|mesh-list
56288428|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
56288429|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288430|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56288431|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56288432|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
56288433|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288434|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288435|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288436|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288437|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
56288438|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288439|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56288440|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56288441|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288442|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288443|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
56288444|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56288445|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56288446|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56288447|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56905120|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56905121|NCT02094196|Ethanol|ethanol|mesh-list
56905122|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56905123|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288448|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56288449|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56288450|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
56288451|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56288452|NCT00009061|Ritonavir|ritonavir|mesh-list
56288453|NCT00009061|Nelfinavir|nelfinavir|mesh-list
56288454|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
56288455|NCT00009061|Lamivudine|lamivudine|mesh-list
56288456|NCT00009061|Abacavir|abacavir|mesh-list
56288457|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56288458|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56288459|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
56288460|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288461|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288462|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288463|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288464|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
56288478|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56288479|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56288480|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288481|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56288482|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
56288483|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288484|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56288485|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
56288486|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56288487|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56288488|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56288489|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288490|NCT00009217|Haloperidol|haloperidol|mesh-list
56288491|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
56288492|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
56288493|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
56288494|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288495|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288496|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56288497|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56288498|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56288499|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56288500|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56288501|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56288502|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
56288503|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56288504|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288505|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56288506|NCT00005876|Rubitecan|rubitecan|mesh-list
56288507|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288508|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56288509|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288510|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288511|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288512|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56288513|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56288514|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56288515|NCT00009646|Indomethacin|indomethacin|mesh-list
56288516|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56288517|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56288518|NCT00009646|Analgesics|analgesics|mesh-ancestor
56288519|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
56288520|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288521|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288522|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55932338|NCT02244255|Tamsulosin|tamsulosin|mesh-list
56288542|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288544|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288545|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288546|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56905124|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905125|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905126|NCT02094274|Fluticasone|fluticasone|mesh-list
56905127|NCT02094274|Xhance|xhance|mesh-list
56288547|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
56288548|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288549|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
56288550|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288551|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56288552|NCT00009802|Calcitriol|calcitriol|mesh-list
56288553|NCT00009802|Paclitaxel|paclitaxel|mesh-list
56288554|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288555|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288556|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288557|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288558|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288559|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288560|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56288561|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288562|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56288563|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56288564|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56288565|NCT00009802|Vitamins|vitamins|mesh-ancestor
56288567|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56288568|NCT00009841|Mitogens|mitogens|mesh-list
56288569|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288570|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288571|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
56288572|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288573|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
56288574|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288575|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288576|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56288577|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
56288578|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288579|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288580|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56288581|NCT00009880|Paclitaxel|paclitaxel|mesh-list
56288603|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288604|NCT00009958|Metronidazole|metronidazole|mesh-list
56288606|NCT00009958|Sargramostim|sargramostim|mesh-list
56288607|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
56288608|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288609|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288610|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56288611|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56288612|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56288613|NCT00009997|Tamoxifen|tamoxifen|mesh-list
56288614|NCT00009997|Paclitaxel|paclitaxel|mesh-list
56288615|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
56288616|NCT00009997|Doxorubicin|doxorubicin|mesh-list
56288617|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56288618|NCT00009997|Trastuzumab|trastuzumab|mesh-list
56288619|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288620|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288621|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288622|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288623|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288624|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288625|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288626|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
56288627|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288628|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288629|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56288630|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
56288631|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56288632|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288633|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56288634|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288635|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288636|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56288655|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
56905128|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56905129|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905130|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56288656|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56288657|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288658|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
56288659|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288660|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56288661|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288662|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288663|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
56288664|NCT00010075|Antidotes|antidotes|mesh-ancestor
56288665|NCT00010075|Protective Agents|protective agents|mesh-ancestor
56288666|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
56288667|NCT00010075|Vitamins|vitamins|mesh-ancestor
56288668|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
56288669|NCT00010075|Analgesics|analgesics|mesh-ancestor
56288670|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
56288671|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288672|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56288673|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288674|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288675|NCT00010153|Fulvestrant|fulvestrant|mesh-list
56288676|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56288677|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288678|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56288679|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56288680|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
56288681|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288682|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288683|NCT00010192|Aldesleukin|aldesleukin|mesh-list
56288684|NCT00010192|Rituximab|rituximab|mesh-list
56288685|NCT00010192|Interleukin-2|interleukin-2|mesh-list
56288686|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56288687|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288688|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
56288689|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288690|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288691|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56288692|NCT00010192|Analgesics|analgesics|mesh-ancestor
56288693|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
56288694|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288695|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288696|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288727|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288729|NCT00010231|Vitamins|vitamins|mesh-ancestor
56288730|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
56288731|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56288732|NCT00010270|Immunotoxins|immunotoxins|mesh-list
56288733|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
56288734|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288735|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
56288736|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288737|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
55932363|NCT04376541|Analgesics|analgesics|mesh-ancestor
56288747|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288748|NCT00386516|Fluorouracil|fluorouracil|mesh-list
56288749|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
56288750|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288751|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56288752|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288753|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288754|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
56288755|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288757|NCT00010699|Vitamins|vitamins|mesh-ancestor
56288758|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
56288759|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288760|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
56288761|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288762|NCT00010699|Protective Agents|protective agents|mesh-ancestor
56288763|NCT00386555|Docetaxel|docetaxel|mesh-list
56288764|NCT00386555|Axitinib|axitinib|mesh-list
56288765|NCT00386555|Crenolanib|crenolanib|mesh-list
56905131|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
56288766|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288767|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288768|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288769|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288770|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288771|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56288772|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288773|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56288774|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56288775|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288777|NCT00001191|Pantoprazole|pantoprazole|mesh-list
56288778|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56288779|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56288780|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56288781|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288782|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288783|NCT00011089|Tenofovir|tenofovir|mesh-list
56288784|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
56288785|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288786|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288787|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288789|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288790|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288791|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288792|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56288793|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
56288794|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288795|NCT00005921|Caspofungin|caspofungin|mesh-list
56288796|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
56288797|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288798|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288799|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288800|NCT00011362|Dexamethasone|dexamethasone|mesh-list
56288801|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
56288802|NCT00011362|BB 1101|bb 1101|mesh-list
56288803|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56288804|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
56288805|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
55932368|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
56029069|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
56288830|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56288831|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
56288832|NCT00001212|Hormones|hormones|mesh-ancestor
56288833|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288834|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56288835|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288836|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
56288837|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288838|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
56288839|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56288840|NCT00011479|Abacavir|abacavir|mesh-list
56288841|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288842|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288843|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288844|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288845|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
56288846|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288847|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288848|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288850|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
56288851|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288852|NCT00011635|Protective Agents|protective agents|mesh-ancestor
56288853|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288854|NCT00001221|Hormones|hormones|mesh-list
55932377|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
56288868|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56288869|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56288870|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
56288871|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288872|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288873|NCT00005942|Daunorubicin|daunorubicin|mesh-list
56288874|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288875|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56518815|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288876|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288877|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56288878|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288879|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288880|NCT00012103|Dimercaprol|dimercaprol|mesh-list
56288881|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
56288882|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
56288883|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288884|NCT00001251|Mafosfamide|mafosfamide|mesh-list
56288885|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56288886|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
56288887|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288888|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288889|NCT00012142|Sirolimus|sirolimus|mesh-list
56288890|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56288891|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288892|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288893|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288894|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
56288895|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288896|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
56288897|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288898|NCT00012181|Alvocidib|alvocidib|mesh-list
56160573|NCT03593538|Metformin|metformin|mesh-list
56288899|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288900|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
56288901|NCT00012181|Growth Substances|growth substances|mesh-ancestor
56288902|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288903|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56288904|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288905|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288907|NCT00005945|Dexamethasone|dexamethasone|mesh-list
56288908|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
56288909|NCT00005945|Doxorubicin|doxorubicin|mesh-list
56288910|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56288911|NCT00005945|Methotrexate|methotrexate|mesh-list
56288912|NCT00005945|Vincristine|vincristine|mesh-list
56288913|NCT00005945|Daunorubicin|daunorubicin|mesh-list
56288914|NCT00005945|Asparaginase|asparaginase|mesh-list
56288915|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
56288916|NCT00005945|Pegaspargase|pegaspargase|mesh-list
56288932|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
56288933|NCT00005945|Hormones|hormones|mesh-ancestor
56288934|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288935|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56288936|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288937|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56288938|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288939|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288940|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56288941|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
56288942|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56288943|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56288944|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
56288945|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
56288946|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56288947|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288948|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
56288949|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288950|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288951|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288952|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288953|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288954|NCT01929811|Metformin|metformin|mesh-list
56288955|NCT01929811|Docetaxel|docetaxel|mesh-list
56288956|NCT01929811|Epirubicin|epirubicin|mesh-list
56288957|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56288958|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288959|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288960|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288961|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288962|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288963|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288964|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288965|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56288966|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56905132|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905133|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905134|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56905135|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
56905136|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
56905137|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56288967|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288968|NCT00012220|Gemcitabine|gemcitabine|mesh-list
56288969|NCT00012220|Docetaxel|docetaxel|mesh-list
56288970|NCT00012220|Irinotecan|irinotecan|mesh-list
56288971|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288972|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56288973|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
56288974|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288975|NCT00012220|Antiviral Agents|antiviral agents|mesh-ancestor
55932391|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
56289001|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289002|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56289004|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
56289005|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
56289006|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56289007|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289008|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289009|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56289010|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56289011|NCT00005948|Interferons|interferons|mesh-list
56289012|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
56289013|NCT00005948|Aldesleukin|aldesleukin|mesh-list
56289014|NCT00005948|Busulfan|busulfan|mesh-list
56289015|NCT00005948|Sargramostim|sargramostim|mesh-list
56289016|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289017|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
56289018|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289019|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
56289020|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289021|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
56289022|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289023|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289024|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289025|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56289026|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56289027|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56289028|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
56289029|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56289030|NCT00012688|Doxycycline|doxycycline|mesh-list
56289044|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289045|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289046|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289047|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
56289048|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
56289049|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56289050|NCT00001287|Antibodies|antibodies|mesh-list
56289051|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
56289052|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56289053|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
56289054|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289055|NCT00005954|Temozolomide|temozolomide|mesh-list
56289056|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289057|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
56289058|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289059|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289060|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
56289061|NCT00005960|Docetaxel|docetaxel|mesh-list
56289062|NCT00005960|Doxorubicin|doxorubicin|mesh-list
56289063|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56289064|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289065|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
56289066|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289067|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289068|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289069|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
56905138|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56518963|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
56289070|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289071|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289072|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56289073|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289074|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289075|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289076|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56289077|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56289078|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289079|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289080|NCT00005963|Carboplatin|carboplatin|mesh-list
56289081|NCT00005963|Docetaxel|docetaxel|mesh-list
56289082|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289083|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289084|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289085|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289086|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289087|NCT00013585|Selegiline|selegiline|mesh-list
56289088|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
56289089|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56289090|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56289091|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56289092|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56289093|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289094|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289161|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289162|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56289163|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56289164|NCT00005972|Gemcitabine|gemcitabine|mesh-list
56289165|NCT00005972|Irinotecan|irinotecan|mesh-list
56289166|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289167|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
56289168|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289169|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289170|NCT00005972|Antiviral Agents|antiviral agents|mesh-ancestor
56289194|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56289196|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289197|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
56289198|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289199|NCT00014209|Antiviral Agents|antiviral agents|mesh-ancestor
56289200|NCT00014209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289201|NCT00014209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289202|NCT00014209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289203|NCT00014209|Immunologic Factors|immunologic factors|mesh-ancestor
56289204|NCT00014248|Adenosine|adenosine|mesh-list
56289205|NCT00014248|Analgesics|analgesics|mesh-ancestor
56289206|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
56289207|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289208|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289209|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56289210|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
56289211|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56289212|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
56289214|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289215|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289216|NCT00005975|Megestrol|megestrol|mesh-list
56289217|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
56289218|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56289219|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56289220|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56289221|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
56289222|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55932460|NCT04025567|Vancomycin|vancomycin|mesh-list
56289224|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56289225|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56289226|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56289228|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
56289229|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56289230|NCT00014287|Gemcitabine|gemcitabine|mesh-list
56289231|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289232|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
56905139|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56289233|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289234|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289235|NCT00014287|Antiviral Agents|antiviral agents|mesh-ancestor
56289236|NCT00014287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289237|NCT00014287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289238|NCT00014287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289239|NCT00014287|Immunologic Factors|immunologic factors|mesh-ancestor
56289240|NCT00014287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289241|NCT02971930|Factor VIII|factor viii|mesh-list
56289242|NCT02971930|Coagulants|coagulants|mesh-ancestor
56289243|NCT00005978|Carboplatin|carboplatin|mesh-list
56289244|NCT00005978|Etoposide|etoposide|mesh-list
56289245|NCT00005978|Melphalan|melphalan|mesh-list
56289246|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56289247|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289248|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289249|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56289250|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289251|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289252|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289253|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
56289254|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289255|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289256|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
56289257|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56289258|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289259|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56289260|NCT00014404|Celecoxib|celecoxib|mesh-list
56289261|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56289262|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56289263|NCT00014404|Analgesics|analgesics|mesh-ancestor
56289264|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
56289265|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289266|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289267|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56289268|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289269|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56289270|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56289271|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289272|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289273|NCT00001332|Cisplatin|cisplatin|mesh-list
56289274|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289275|NCT00014599|Paclitaxel|paclitaxel|mesh-list
56289276|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289277|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289278|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289279|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289280|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289281|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289283|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56289284|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289285|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
56333997|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56289286|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289287|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289288|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289289|NCT00014638|Letrozole|letrozole|mesh-list
56289290|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289291|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56289292|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56289293|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289294|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289309|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289310|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289311|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289312|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
56289313|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
56289314|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56289315|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56289316|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56289317|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077320|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905140|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56905141|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
56519111|NCT04303819|Hormones|hormones|mesh-ancestor
56289318|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56289319|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56289320|NCT00005984|Interferons|interferons|mesh-list
56289321|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
56289322|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
56289323|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289324|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
56289325|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289326|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289327|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289328|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
56289329|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289330|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289331|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56289332|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
56289333|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289334|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
56289335|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56289336|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289337|NCT00391651|Renal Agents|renal agents|mesh-ancestor
56289338|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56289339|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
56289340|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56289341|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289342|NCT00005987|Interferons|interferons|mesh-list
56289343|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
56289344|NCT00005987|Dexamethasone|dexamethasone|mesh-list
56289345|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
56289346|NCT00005987|Carmustine|carmustine|mesh-list
56289347|NCT00005987|Etoposide|etoposide|mesh-list
56289348|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
56289349|NCT00005987|Sargramostim|sargramostim|mesh-list
56289350|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289351|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
56289352|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289353|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289354|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55932484|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
56289377|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
56289378|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56289379|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289380|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
56289381|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289382|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289383|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289384|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
56289385|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289386|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289387|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56289388|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56289389|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
56289390|NCT00014755|Hormones|hormones|mesh-ancestor
56289391|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56289392|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56289393|NCT00005990|Topotecan|topotecan|mesh-list
56289394|NCT00005990|Tipifarnib|tipifarnib|mesh-list
56289395|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56289396|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289397|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289398|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289399|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289400|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
56289401|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
56289402|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
56289403|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56289404|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56289405|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289406|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289407|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289426|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56289427|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
56905142|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648474|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56289428|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289430|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56289431|NCT00015028|Naloxone|naloxone|mesh-list
56289432|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56289433|NCT00015028|Narcotics|narcotics|mesh-ancestor
56289434|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56289435|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289437|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
56289438|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289439|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56289440|NCT00015067|Methylphenidate|methylphenidate|mesh-list
56289441|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56289442|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289443|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56289444|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56289445|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56289446|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289447|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
56289448|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289450|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
56289451|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56289452|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56289453|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289454|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56289455|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289456|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56289457|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56289458|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56289459|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56289460|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56289461|NCT00005996|Gemcitabine|gemcitabine|mesh-list
56289462|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289463|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289464|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
56176776|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289479|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56289480|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56289481|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289482|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
56289483|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289484|NCT00015301|Methylphenidate|methylphenidate|mesh-list
56289485|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56289486|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289487|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56289488|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56289489|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56289490|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289491|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
56289492|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289493|NCT00015340|Buprenorphine|buprenorphine|mesh-list
56289494|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56289495|NCT00015340|Naloxone|naloxone|mesh-list
56289496|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56289498|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56289499|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289500|NCT00015340|Analgesics|analgesics|mesh-ancestor
56289501|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
56289502|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289503|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56289504|NCT00015652|Ribavirin|ribavirin|mesh-list
56289505|NCT00015652|Aldesleukin|aldesleukin|mesh-list
56289506|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56289507|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
56029751|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289508|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289509|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
56289510|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289511|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905143|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905144|NCT02096926|Ibuprofen|ibuprofen|mesh-list
56905145|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56905146|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56289512|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56289513|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56289514|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
56289515|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289516|NCT00015691|Metformin|metformin|mesh-list
56289517|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
56289518|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56289519|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289520|NCT00015769|Levetiracetam|levetiracetam|mesh-list
55911459|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289557|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289558|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289559|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289573|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56289574|NCT00006005|Growth Substances|growth substances|mesh-ancestor
56289575|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
56289576|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289577|NCT00015964|Gefitinib|gefitinib|mesh-list
56289578|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289579|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56289580|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289581|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289582|NCT01630213|Vitamin D|vitamin d|mesh-list
56289583|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
56289584|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
56289585|NCT01630213|Vitamins|vitamins|mesh-list
56289586|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
56289587|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289588|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56289589|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56289590|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
56289591|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289592|NCT00016042|Interferons|interferons|mesh-list
56289593|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
56289594|NCT00016042|Fluorouracil|fluorouracil|mesh-list
56289595|NCT00016042|Sargramostim|sargramostim|mesh-list
56289596|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
56289597|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289598|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289599|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289600|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289601|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
56289602|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289603|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
56289604|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289605|NCT00016081|Ribavirin|ribavirin|mesh-list
56289606|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
56289607|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289608|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
56289609|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289610|NCT00016159|Idarubicin|idarubicin|mesh-list
56289611|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
56289612|NCT00016159|Tretinoin|tretinoin|mesh-list
56289613|NCT00016159|Lintuzumab|lintuzumab|mesh-list
56289614|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56289615|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289616|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56289617|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289618|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289619|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289620|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
56289621|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
56289622|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56289623|NCT00016198|Leucovorin|leucovorin|mesh-list
56289649|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289650|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289651|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289652|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905147|NCT02096926|Analgesics|analgesics|mesh-ancestor
56905148|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
56519330|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
56289653|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289654|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289655|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289656|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
56289657|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289658|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289659|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289660|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
56289661|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56289662|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56289663|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56289664|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289665|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289666|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56289667|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56289668|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
56289669|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56289670|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56289671|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56289672|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56289673|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56289674|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56289675|NCT00016276|Protective Agents|protective agents|mesh-ancestor
56289676|NCT00016315|Gemcitabine|gemcitabine|mesh-list
56289677|NCT00016315|Paclitaxel|paclitaxel|mesh-list
56289700|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56289701|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289702|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289703|NCT00016432|Exemestane|exemestane|mesh-list
56289704|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289705|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56289706|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56289707|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289708|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289709|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56289710|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
56289711|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56289712|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289713|NCT00389376|Silymarin|silymarin|mesh-list
56289714|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
56289715|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289716|NCT00389376|Protective Agents|protective agents|mesh-ancestor
56289717|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289718|NCT00016549|Bevacizumab|bevacizumab|mesh-list
56289719|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56289720|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289721|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56289722|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56289723|NCT00016549|Growth Substances|growth substances|mesh-ancestor
56289724|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289725|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
56289726|NCT00006023|Capecitabine|capecitabine|mesh-list
56289727|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289728|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
56176777|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289741|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289742|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56289743|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289744|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289745|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289746|NCT00016666|Propranolol|propranolol|mesh-list
56289747|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56289748|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56289749|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
56289750|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289751|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289752|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905149|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905150|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905151|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56289753|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56289754|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56289755|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
56289756|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56289757|NCT00016744|Genistein|genistein|mesh-list
56289758|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289759|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56289760|NCT00016744|Protective Agents|protective agents|mesh-ancestor
56289761|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289762|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56289763|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289764|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289765|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
56289766|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56289767|NCT00016744|Estrogens|estrogens|mesh-ancestor
56289768|NCT00016744|Hormones|hormones|mesh-ancestor
56289769|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56289771|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56289772|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289773|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289774|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289775|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289776|NCT00016900|Paclitaxel|paclitaxel|mesh-list
56289777|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289778|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289779|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289780|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289781|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289782|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289783|NCT00016939|Alvocidib|alvocidib|mesh-list
56289784|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289785|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
56289786|NCT00016939|Growth Substances|growth substances|mesh-ancestor
56289787|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289788|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56289789|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289790|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289806|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56289807|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289808|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
56289809|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289810|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289811|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289812|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289813|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
56289815|NCT00016978|Protective Agents|protective agents|mesh-ancestor
56289816|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
56289817|NCT00016978|Vitamins|vitamins|mesh-ancestor
56289818|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
56289819|NCT00017017|Paclitaxel|paclitaxel|mesh-list
56289820|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56289821|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289822|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289823|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289824|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289825|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289826|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289827|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
56289828|NCT00017095|Docetaxel|docetaxel|mesh-list
56289829|NCT00017095|Fluorouracil|fluorouracil|mesh-list
56289830|NCT00017095|Epirubicin|epirubicin|mesh-list
56289831|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289832|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
56289833|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289834|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289835|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289836|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
56289837|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905152|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56905153|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56519487|NCT01314911|Oseltamivir|oseltamivir|mesh-list
56289838|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289839|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56289840|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289841|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289842|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289843|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
56289844|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289845|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56289846|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56289847|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289848|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289849|NCT00006029|Gemcitabine|gemcitabine|mesh-list
56289850|NCT00006029|Doxorubicin|doxorubicin|mesh-list
56289851|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56289852|NCT00006029|Vinorelbine|vinorelbine|mesh-list
56289853|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289854|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
56289889|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56289890|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56289891|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56289892|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932544|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
56289905|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
56289906|NCT04734418|Remifentanil|remifentanil|mesh-list
56289907|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56289908|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56289909|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289910|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56289911|NCT04734418|Analgesics|analgesics|mesh-ancestor
56289912|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
56289913|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289914|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56289915|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56289916|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56289917|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
56289918|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289919|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289920|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56289922|NCT00006032|Etoposide|etoposide|mesh-list
56289923|NCT00006032|Topotecan|topotecan|mesh-list
56289924|NCT00006032|Ifosfamide|ifosfamide|mesh-list
56289925|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289926|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289927|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56289928|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289929|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289930|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289931|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56289932|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289933|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
56289934|NCT00017173|Cisplatin|cisplatin|mesh-list
56289935|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289936|NCT00001509|Tretinoin|tretinoin|mesh-list
56289937|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289938|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
56289939|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
56289941|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56289942|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289943|NCT00017212|Exatecan|exatecan|mesh-list
56289944|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56289945|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289946|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289947|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289948|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289949|NCT00017251|Carboplatin|carboplatin|mesh-list
56289950|NCT00017251|Etoposide|etoposide|mesh-list
56289951|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
56289952|NCT00017251|Oblimersen|oblimersen|mesh-list
56289953|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289954|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289955|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56905154|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905155|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905156|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56905157|NCT02097004|Entecavir|entecavir|mesh-list
56905158|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
56519548|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
56289956|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289994|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289996|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289997|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911979|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56290008|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56290009|NCT00017329|Bortezomib|bortezomib|mesh-list
56290010|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290011|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
56290012|NCT00017368|Melphalan|melphalan|mesh-list
56290013|NCT00017368|Ifosfamide|ifosfamide|mesh-list
56290014|NCT00017368|Thiotepa|thiotepa|mesh-list
56290015|NCT00017368|Carboplatin|carboplatin|mesh-list
56290016|NCT00017368|Doxorubicin|doxorubicin|mesh-list
56290017|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56290018|NCT00017368|Etoposide|etoposide|mesh-list
56290019|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
56290020|NCT00017368|Vincristine|vincristine|mesh-list
56290021|NCT00017368|Isotretinoin|isotretinoin|mesh-list
56290022|NCT00017368|Sargramostim|sargramostim|mesh-list
56290023|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56290024|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
56290025|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290026|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290027|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56290028|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
56290029|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290030|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290031|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56290032|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56290033|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56290034|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56290035|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290036|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56290037|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56290038|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56290039|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56290040|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56290041|NCT00001524|Thalidomide|thalidomide|mesh-list
56290042|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56290043|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
56290044|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290045|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
56290046|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56290047|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290048|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56290049|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56290050|NCT00001524|Growth Substances|growth substances|mesh-ancestor
56290051|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
56290053|NCT00006041|Vaccines|vaccines|mesh-list
56290054|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
56290055|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
56290056|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290057|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56290058|NCT00017602|Dexamethasone|dexamethasone|mesh-list
56290059|NCT00017602|Oblimersen|oblimersen|mesh-list
56290060|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56290061|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
56290062|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
56290063|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290064|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932613|NCT04023149|Aldesleukin|aldesleukin|mesh-list
56290081|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290082|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56290083|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
56290084|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56290085|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56905159|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905160|NCT05453968|Berotralstat|berotralstat|mesh-list
56905161|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905162|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905163|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
56905164|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905165|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
56905166|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290086|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
56290087|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290088|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290089|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56290090|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
56290091|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290092|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290093|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56290094|NCT00017680|Melphalan|melphalan|mesh-list
56290095|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56290096|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
56290097|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290098|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290099|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56290100|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56290101|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
56290102|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290103|NCT00017719|Lamivudine|lamivudine|mesh-list
56290104|NCT00017719|Zidovudine|zidovudine|mesh-list
56290105|NCT00017719|Nevirapine|nevirapine|mesh-list
56290106|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56290107|NCT00017719|Nelfinavir|nelfinavir|mesh-list
56290108|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56290109|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56290110|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290111|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290112|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
56290113|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290114|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56290115|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56290116|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
56290117|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56290118|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56290119|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56290120|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56290121|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
56290122|NCT00001542|Fluconazole|fluconazole|mesh-list
56290123|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
56290158|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56290159|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56290160|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56290184|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160624|NCT03674970|Nicotine|nicotine|mesh-list
56290185|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290186|NCT05680805|Metformin|metformin|mesh-list
56290187|NCT05680805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56290188|NCT05680805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290189|NCT00018148|Nortriptyline|nortriptyline|mesh-list
56290190|NCT00018148|Nicotine|nicotine|mesh-list
56290191|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56290192|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
56290193|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290194|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290195|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56290196|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56290197|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
56290198|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290199|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290200|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56905167|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905168|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56905169|NCT03691779|Ivacaftor|ivacaftor|mesh-list
56290201|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
56290202|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56290203|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56290204|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56290205|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290206|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
56290207|NCT00001563|Rituximab|rituximab|mesh-list
56290208|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290209|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290210|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
56290240|NCT00018343|Hormones|hormones|mesh-ancestor
56290241|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290242|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290243|NCT00001566|Indinavir|indinavir|mesh-list
56290244|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56290245|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56290246|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
56290247|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290248|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290249|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56290250|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56290251|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
56290252|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290253|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
56290254|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55932632|NCT04149275|Nivolumab|nivolumab|mesh-list
56290270|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56290271|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290272|NCT00001575|Antidotes|antidotes|mesh-ancestor
56290273|NCT00001575|Protective Agents|protective agents|mesh-ancestor
56290274|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
56290275|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
56290276|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290277|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56290278|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
56290279|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56290280|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56290281|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56290282|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
56290283|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290284|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290285|NCT00001596|Pirfenidone|pirfenidone|mesh-list
56290286|NCT00001596|Analgesics|analgesics|mesh-ancestor
56290287|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
56290288|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290289|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290290|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56290291|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56290292|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56290293|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290294|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290295|NCT03366103|Navitoclax|navitoclax|mesh-list
56290296|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290298|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
56290299|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56290300|NCT03346135|Daratumumab|daratumumab|mesh-list
56290301|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56290302|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
56290303|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290304|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290305|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56290306|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56290307|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
56290308|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290309|NCT05576194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55912273|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56290310|NCT05576194|Taurolidine|taurolidine|mesh-list
56290311|NCT05576194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56905170|NCT03691779|Elexacaftor|elexacaftor|mesh-list
56905171|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56905172|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290312|NCT05576194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290313|NCT05576194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290314|NCT00391885|Anesthetics|anesthetics|mesh-list
56290315|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290316|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290317|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55932645|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
56290332|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290333|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290334|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56290335|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290336|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
56290337|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56290338|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290339|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290341|NCT05680142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56290343|NCT05680142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290344|NCT05680142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290345|NCT05680142|Analgesics|analgesics|mesh-ancestor
56290346|NCT05680142|Sensory System Agents|sensory system agents|mesh-ancestor
56290347|NCT05680142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290348|NCT00001644|Lamivudine|lamivudine|mesh-list
56290349|NCT00001644|Zidovudine|zidovudine|mesh-list
56290350|NCT00001644|Nevirapine|nevirapine|mesh-list
56290351|NCT00001644|Indinavir|indinavir|mesh-list
56290352|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56290353|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56290354|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290355|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290356|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
56290357|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290358|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56290359|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56290360|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
56290361|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56290362|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56290363|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56290364|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56290365|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
56290366|NCT05573386|Lenograstim|lenograstim|mesh-list
56290367|NCT05573386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56290368|NCT05573386|Immunologic Factors|immunologic factors|mesh-ancestor
56290369|NCT05573386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290370|NCT00001656|Olanzapine|olanzapine|mesh-list
56290371|NCT00001656|Clozapine|clozapine|mesh-list
56290373|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
56290374|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290375|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290376|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56290377|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56290378|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56290379|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290380|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56290393|NCT05573191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290395|NCT05573191|Sensory System Agents|sensory system agents|mesh-ancestor
56290396|NCT05573191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290397|NCT05573191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56290398|NCT05573191|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56290399|NCT05573191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56290400|NCT05573191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290401|NCT05573191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290402|NCT05679830|Cannabidiol|cannabidiol|mesh-list
56290403|NCT05679830|Anticonvulsants|anticonvulsants|mesh-ancestor
56290404|NCT05572996|Treprostinil|treprostinil|mesh-list
56290405|NCT05572996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56290406|NCT05572723|Dexmedetomidine|dexmedetomidine|mesh-list
56290408|NCT05572723|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56290409|NCT05572723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290410|NCT05572723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648475|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
56290411|NCT05572723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56290412|NCT05572723|Analgesics|analgesics|mesh-ancestor
56290413|NCT05572723|Sensory System Agents|sensory system agents|mesh-ancestor
56290414|NCT05572723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290415|NCT05572723|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56290416|NCT05572723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56290417|NCT05572723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56290418|NCT05572723|Adrenergic Agents|adrenergic agents|mesh-ancestor
56290419|NCT05572723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290420|NCT05572723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290421|NCT05572723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56290422|NCT05572723|Narcotics|narcotics|mesh-ancestor
56290423|NCT05563753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56290424|NCT05563753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290425|NCT05558137|Mivacurium|mivacurium|mesh-list
56290426|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56290427|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56290428|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56290429|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290430|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290431|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
56290432|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56290433|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
56290434|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290435|NCT05485558|Expectorants|expectorants|mesh-ancestor
56290436|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
56290437|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56290438|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
56290439|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290440|NCT05485558|Protective Agents|protective agents|mesh-ancestor
56290441|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290442|NCT05485558|Antidotes|antidotes|mesh-ancestor
56290443|NCT00389415|Vildagliptin|vildagliptin|mesh-list
56290444|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55932666|NCT04022525|Leflunomide|leflunomide|mesh-list
56290468|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56290469|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56290470|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56290471|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290472|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290473|NCT00386828|Bevacizumab|bevacizumab|mesh-list
56290474|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290475|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290476|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56290477|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56290478|NCT00386828|Growth Substances|growth substances|mesh-ancestor
56290479|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290480|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
56290481|NCT05367271|Dexamethasone|dexamethasone|mesh-list
56290482|NCT05367271|Cortisone|cortisone|mesh-list
56290483|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56290484|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
56290485|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56290486|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56290487|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
56290488|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
56290489|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290490|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290491|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56290492|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
56290493|NCT05367271|Hormones|hormones|mesh-ancestor
55932672|NCT04022291|Insulin|insulin|mesh-list
56290505|NCT05679401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56290506|NCT05679401|Immunologic Factors|immunologic factors|mesh-ancestor
56290507|NCT05679401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290508|NCT05679401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290509|NCT05679401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56290510|NCT05679401|Alkylating Agents|alkylating agents|mesh-ancestor
56290511|NCT05679401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290512|NCT05679401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290513|NCT05679401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56290515|NCT05679401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290516|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
56290517|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
56905173|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905174|NCT02095054|Cetuximab|cetuximab|mesh-list
56905175|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290518|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
56290519|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56290520|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56290521|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290522|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290523|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290524|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
56290525|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
56290526|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290527|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
56290528|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290529|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
56290530|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290531|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290532|NCT00001728|Alendronate|alendronate|mesh-list
56290533|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56290534|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290535|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56290536|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290537|NCT05673629|Docetaxel|docetaxel|mesh-list
56290538|NCT05673629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290539|NCT05673629|Tubulin Modulators|tubulin modulators|mesh-ancestor
56290540|NCT05673629|Antimitotic Agents|antimitotic agents|mesh-ancestor
56290541|NCT05673629|Mitosis Modulators|mitosis modulators|mesh-ancestor
56290542|NCT05673629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290543|NCT00001731|Cyclosporine|cyclosporine|mesh-list
56290544|NCT00001731|Cyclosporins|cyclosporins|mesh-list
56290545|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290546|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290547|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56290548|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
56290549|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290550|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
56290551|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290552|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
56290553|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290566|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290567|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290568|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290569|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
56290570|NCT00392275|Levofloxacin|levofloxacin|mesh-list
56290571|NCT00392275|Ofloxacin|ofloxacin|mesh-list
56290572|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56290573|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290574|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56290575|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56290576|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290577|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290578|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290579|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56290580|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56290581|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56290582|NCT00392275|Renal Agents|renal agents|mesh-ancestor
56290586|NCT00001749|Cyclosporine|cyclosporine|mesh-list
56290587|NCT00001749|Cyclosporins|cyclosporins|mesh-list
56290588|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56290589|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290590|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290591|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56290592|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
56290594|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
56290595|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290596|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
56290597|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290598|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56290599|NCT00001752|Estrogens|estrogens|mesh-list
56290600|NCT00001752|Hormones|hormones|mesh-ancestor
55887683|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905176|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905177|NCT03555994|Liraglutide|liraglutide|mesh-list
56905178|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56905179|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905180|NCT03555994|Incretins|incretins|mesh-ancestor
56905181|NCT03555994|Hormones|hormones|mesh-ancestor
56290601|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290602|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290603|NCT05171179|Lidocaine|lidocaine|mesh-list
56290604|NCT05171179|Bupivacaine|bupivacaine|mesh-list
56290605|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
56290606|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
56290607|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290608|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290609|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
56290610|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290611|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56290612|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56290613|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56290614|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290615|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290617|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290629|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
56290630|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290631|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56290632|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56290633|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56290634|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56290635|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56290636|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56290637|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56290638|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56290639|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56290640|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
56290641|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56290642|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56290643|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56290644|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
56290645|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
56290646|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56290647|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290648|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56290649|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
56290650|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56290651|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290652|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290653|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290654|NCT04983901|Vancomycin|vancomycin|mesh-list
56290655|NCT04983901|Meropenem|meropenem|mesh-list
56290656|NCT04983901|Tazobactam|tazobactam|mesh-list
56290657|NCT04983901|Linezolid|linezolid|mesh-list
56290658|NCT04983901|Piperacillin|piperacillin|mesh-list
56290659|NCT04983901|Daptomycin|daptomycin|mesh-list
56290660|NCT04983901|Imipenem|imipenem|mesh-list
56290661|NCT04983901|Cefepime|cefepime|mesh-list
56290662|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56290663|NCT04983901|Relebactam|relebactam|mesh-list
56290664|NCT04983901|Cilastatin|cilastatin|mesh-list
56290665|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56290666|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290667|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56290668|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290669|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290670|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56290671|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
56290672|NCT04978675|Fluorides|fluorides|mesh-list
56290673|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
56290674|NCT04978675|Protective Agents|protective agents|mesh-ancestor
56290675|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290676|NCT04971343|Antibodies|antibodies|mesh-list
56290677|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
56905182|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290678|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
56290679|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290680|NCT04951804|Bupivacaine|bupivacaine|mesh-list
56290681|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
56290682|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
56290711|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290712|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290713|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
56290714|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
56290715|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290716|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
56290717|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290718|NCT00000102|Nifedipine|nifedipine|mesh-list
56290719|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56290720|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290721|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290722|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56290723|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290724|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
56290725|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
56290726|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56290727|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
56290728|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56290729|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
56290743|NCT04796779|Trace Elements|trace elements|mesh-ancestor
56290745|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290746|NCT05641506|Niraparib|niraparib|mesh-list
56290747|NCT05641506|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56290748|NCT05641506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290749|NCT05641506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290750|NCT05641506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290751|NCT04752475|Furosemide|furosemide|mesh-list
56290752|NCT04752475|Diuretics|diuretics|mesh-ancestor
56290753|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
56290754|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290755|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56290756|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290757|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290758|NCT05641467|Methamphetamine|methamphetamine|mesh-list
56290759|NCT05641467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56290760|NCT05641467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290761|NCT05641467|Sympathomimetics|sympathomimetics|mesh-ancestor
56290762|NCT05641467|Autonomic Agents|autonomic agents|mesh-ancestor
56290763|NCT05641467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290764|NCT05641467|Dopamine Agents|dopamine agents|mesh-ancestor
56290765|NCT05641467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290766|NCT05641467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290767|NCT05641467|Adrenergic Agents|adrenergic agents|mesh-ancestor
56290768|NCT05641467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56290769|NCT05641467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56290770|NCT05641467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56160642|NCT03704376|Analgesics|analgesics|mesh-ancestor
56290771|NCT05641467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56290772|NCT04734730|Prednisone|prednisone|mesh-list
56290773|NCT04734730|Cortisone|cortisone|mesh-list
56290774|NCT04734730|Leuprolide|leuprolide|mesh-list
56290775|NCT04734730|Goserelin|goserelin|mesh-list
56290776|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
56290777|NCT04734730|Bicalutamide|bicalutamide|mesh-list
56290778|NCT04734730|Talazoparib|talazoparib|mesh-list
56290779|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56290780|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
56290781|NCT04734730|Hormones|hormones|mesh-ancestor
56290782|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290783|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290784|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56290785|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290786|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56290787|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
56290788|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56290789|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56905183|NCT02095366|Sufentanil|sufentanil|mesh-list
56905184|NCT02095366|Morphine|morphine|mesh-list
56520112|NCT02873065|Expectorants|expectorants|mesh-ancestor
56290802|NCT05562713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290803|NCT05555888|Capecitabine|capecitabine|mesh-list
56290804|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
56290805|NCT05555888|Antibodies|antibodies|mesh-list
56290806|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
56290807|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290808|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56290809|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
56290810|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290811|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290812|NCT04619680|Nintedanib|nintedanib|mesh-list
56290813|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290814|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56290815|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290816|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290818|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56290819|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56290820|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
56290821|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
56290822|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290823|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290824|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290825|NCT00386867|Misoprostol|misoprostol|mesh-list
56290826|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56290827|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
56290828|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56290829|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290830|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56290831|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56290832|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
56290833|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
56290834|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56290835|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290836|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290838|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56290839|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290840|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290841|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
56290842|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290843|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290844|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56290845|NCT04495894|Ketorolac|ketorolac|mesh-list
56290846|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56290847|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56290848|NCT04495894|Analgesics|analgesics|mesh-ancestor
56290849|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
56290850|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290869|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290870|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56290871|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56290872|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56290873|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290874|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56290875|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56290876|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56290877|NCT05495204|Ibalizumab|ibalizumab|mesh-list
56290878|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56290879|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56290880|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56290881|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
56290882|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290883|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
56290884|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290885|NCT00392470|Irinotecan|irinotecan|mesh-list
56290886|NCT00392470|Cetuximab|cetuximab|mesh-list
56290887|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56290888|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56290889|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887684|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56905185|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56905186|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56905187|NCT02095366|Narcotics|narcotics|mesh-ancestor
56290890|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290892|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290893|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
56290894|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56290895|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290896|NCT03960151|Dexamethasone|dexamethasone|mesh-list
56290897|NCT03960151|Olanzapine|olanzapine|mesh-list
56290898|NCT03960151|Palonosetron|palonosetron|mesh-list
56290899|NCT03960151|Rolapitant|rolapitant|mesh-list
56290900|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56290901|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
56290902|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
56290903|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290904|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290905|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56290906|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
56290907|NCT03960151|Hormones|hormones|mesh-ancestor
55932714|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56290919|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290921|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56290922|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56290923|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56290925|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56290926|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56290927|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56290928|NCT04733326|Analgesics|analgesics|mesh-ancestor
56290929|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
56290930|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290931|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290932|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56290933|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290934|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56290935|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290936|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290937|NCT00386984|Octreotide|octreotide|mesh-list
56290938|NCT00386984|Somatostatin|somatostatin|mesh-list
56290939|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56290940|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56290941|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290942|NCT00386984|Hormones|hormones|mesh-ancestor
56290943|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290944|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290945|NCT03959761|Nivolumab|nivolumab|mesh-list
56290946|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290947|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290948|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56290949|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290950|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
56290951|NCT03959566|Bedaquiline|bedaquiline|mesh-list
56290952|NCT03959566|Midazolam|midazolam|mesh-list
56290953|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56290954|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56290955|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290956|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290957|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56290958|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56290959|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56290960|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56290961|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
56290962|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
56290963|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
56290964|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
56290965|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290966|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290967|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56290968|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291000|NCT05640726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291001|NCT05640726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291002|NCT05640726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56291003|NCT05640726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56905188|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905189|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905190|NCT02095366|Analgesics|analgesics|mesh-ancestor
56520265|NCT01283139|Sifalimumab|sifalimumab|mesh-list
56291004|NCT05640726|Growth Substances|growth substances|mesh-ancestor
56291005|NCT05640726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291006|NCT05640726|Growth Inhibitors|growth inhibitors|mesh-ancestor
56291007|NCT05640726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56291008|NCT05640726|Antimetabolites|antimetabolites|mesh-ancestor
56291009|NCT05640726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291010|NCT05640726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291011|NCT05640726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291012|NCT05640726|Immunologic Factors|immunologic factors|mesh-ancestor
56291013|NCT05640726|Antidotes|antidotes|mesh-ancestor
56291014|NCT05640726|Protective Agents|protective agents|mesh-ancestor
56291015|NCT05640726|Vitamin B Complex|vitamin b complex|mesh-ancestor
56291016|NCT05640726|Vitamins|vitamins|mesh-ancestor
56291017|NCT05640726|Micronutrients|micronutrients|mesh-ancestor
56291086|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56291087|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56291088|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291089|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55932790|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
56291126|NCT05640453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291146|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56291148|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56291149|NCT05640102|Zanubrutinib|zanubrutinib|mesh-list
56291150|NCT05640102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291151|NCT05640102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56291152|NCT05640102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291153|NCT05640102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291154|NCT03564340|Cemiplimab|cemiplimab|mesh-list
56291155|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291156|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291157|NCT05639907|Ethanol|ethanol|mesh-list
56291158|NCT05639907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56291159|NCT05639907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291160|NCT05639907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291161|NCT05639907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291162|NCT05206175|Methamphetamine|methamphetamine|mesh-list
56291163|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56291164|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291165|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
56291166|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
56291167|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291168|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
56291169|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291170|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291171|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
56291172|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56291173|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56291174|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56291175|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56291176|NCT00392899|Tegafur|tegafur|mesh-list
56291177|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291178|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
56291213|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56291214|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56291215|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56291216|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291217|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56291218|NCT03514108|Diuretics|diuretics|mesh-ancestor
56291252|NCT05634564|Tubulin Modulators|tubulin modulators|mesh-ancestor
56291253|NCT05634564|Antimitotic Agents|antimitotic agents|mesh-ancestor
56291254|NCT05634564|Mitosis Modulators|mitosis modulators|mesh-ancestor
56291255|NCT05634564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291256|NCT05634564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291257|NCT05634564|Antimetabolites|antimetabolites|mesh-ancestor
56291258|NCT05634564|Antiviral Agents|antiviral agents|mesh-ancestor
56291259|NCT05634564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932926|NCT03074136|Eusol|eusol|mesh-list
56905191|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
56905192|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291290|NCT05633472|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56291291|NCT03151876|Gemcitabine|gemcitabine|mesh-list
56291292|NCT03151876|Busulfan|busulfan|mesh-list
56291293|NCT03151876|Cladribine|cladribine|mesh-list
56291294|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291295|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
56291296|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291297|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291298|NCT03151876|Antiviral Agents|antiviral agents|mesh-ancestor
56291299|NCT03151876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291300|NCT03151876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291301|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291302|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
56291303|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291304|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
56291305|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56291339|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56291340|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
56291341|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291342|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291343|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291345|NCT00387374|Bevacizumab|bevacizumab|mesh-list
55932986|NCT02635386|Metformin|metformin|mesh-list
56291379|NCT03912818|Gemcitabine|gemcitabine|mesh-list
56291380|NCT03912818|Carboplatin|carboplatin|mesh-list
56291381|NCT03912818|Doxorubicin|doxorubicin|mesh-list
56291382|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56291383|NCT03912818|Methotrexate|methotrexate|mesh-list
56291384|NCT03912818|Durvalumab|durvalumab|mesh-list
56291385|NCT03912818|Daunorubicin|daunorubicin|mesh-list
56291386|NCT03912818|Vinblastine|vinblastine|mesh-list
56291387|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291388|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291389|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
56291390|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291391|NCT03912818|Antiviral Agents|antiviral agents|mesh-ancestor
56291418|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56291419|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56291420|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291421|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56291422|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56291423|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56291424|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291425|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56291426|NCT03151174|Vitamin D|vitamin d|mesh-list
56291427|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
56291428|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
56291429|NCT03151174|Vitamins|vitamins|mesh-list
56291430|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
56291431|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291432|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56291433|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56291435|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
56291436|NCT03151096|Vitamins|vitamins|mesh-ancestor
56291437|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
56291438|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291439|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56291440|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
56291441|NCT03906539|Atorvastatin|atorvastatin|mesh-list
56291461|NCT05605665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291462|NCT05605665|Antifungal Agents|antifungal agents|mesh-ancestor
56291463|NCT05605665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291464|NCT05605665|Immunologic Factors|immunologic factors|mesh-ancestor
56291465|NCT05605665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291466|NCT05605665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56291467|NCT05605665|Analgesics|analgesics|mesh-ancestor
56291468|NCT05605665|Sensory System Agents|sensory system agents|mesh-ancestor
56291469|NCT05605665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291470|NCT05605665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56291471|NCT05605665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56291472|NCT05605665|Antiviral Agents|antiviral agents|mesh-ancestor
56291474|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291475|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905193|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56905194|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56905195|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
56905196|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
56905197|NCT02097082|Paclitaxel|paclitaxel|mesh-list
56905198|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56905199|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905200|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905201|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905202|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
56520405|NCT01079962|Atenolol|atenolol|mesh-list
56291476|NCT03150667|Clopidogrel|clopidogrel|mesh-list
56291477|NCT03150667|Ticagrelor|ticagrelor|mesh-list
56291478|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56291479|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56291480|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56291481|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56291482|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
56291483|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291484|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291485|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291486|NCT03150316|Dexamethasone|dexamethasone|mesh-list
56291487|NCT03150316|Lenalidomide|lenalidomide|mesh-list
56291488|NCT03150316|CKD-581|ckd-581|mesh-list
56291489|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56291490|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
56291491|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
56291492|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291493|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291494|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291495|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
56291496|NCT03150316|Hormones|hormones|mesh-ancestor
56291564|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56291565|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56291566|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56291567|NCT02250937|Fludarabine|fludarabine|mesh-list
56291568|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
56291570|NCT02250937|Venetoclax|venetoclax|mesh-list
56291571|NCT02250937|Cladribine|cladribine|mesh-list
56291572|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56291573|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291574|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291575|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
56291607|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56291609|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
56291610|NCT02020720|Protective Agents|protective agents|mesh-ancestor
56291611|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291612|NCT04708886|Alendronate|alendronate|mesh-list
56291613|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56291614|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291615|NCT00393328|Ritonavir|ritonavir|mesh-list
56291616|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56291617|NCT00393328|Aripiprazole|aripiprazole|mesh-list
56291651|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
56291652|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291653|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291654|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56291655|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56291656|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
56291658|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291659|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56291692|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
56291693|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56291694|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56291695|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56291696|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
56291697|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905203|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905204|NCT02097160|Vitamin D|vitamin d|mesh-list
56905205|NCT02097160|Vitamins|vitamins|mesh-ancestor
56905206|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
56905207|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905208|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56905209|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
56905210|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905211|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56905212|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
56905213|NCT02097316|Insulin|insulin|mesh-list
56905214|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56905215|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905216|NCT02095522|Colchicine|colchicine|mesh-list
56905217|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
56905218|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56905219|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905220|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905221|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
56648476|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291698|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291699|NCT01807000|Prucalopride|prucalopride|mesh-list
56291700|NCT01807000|Laxatives|laxatives|mesh-ancestor
56291733|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
56291734|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291735|NCT05517291|Paclitaxel|paclitaxel|mesh-list
56291736|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56291737|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291738|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
56291739|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
56291740|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
56291769|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
56291770|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291771|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291772|NCT01806259|Ketorolac|ketorolac|mesh-list
56291773|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56291774|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56291775|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56291776|NCT01806259|Analgesics|analgesics|mesh-ancestor
56291777|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
56291778|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291779|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291780|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56291781|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56291782|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56291783|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291784|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291785|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
56291796|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291798|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56291800|NCT00393445|Hormones|hormones|mesh-ancestor
56291801|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56291802|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291803|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291804|NCT00393562|Methylphenidate|methylphenidate|mesh-list
56291805|NCT00393562|Modafinil|modafinil|mesh-list
56077321|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905222|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905223|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905224|NCT02097394|Pancreatin|pancreatin|mesh-list
56905225|NCT02097394|Pancrelipase|pancrelipase|mesh-list
56905226|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56905227|NCT04123665|Fluorides|fluorides|mesh-list
56905228|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
56905229|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
56905230|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
56905231|NCT04123665|Protective Agents|protective agents|mesh-ancestor
56520539|NCT01016977|Tazarotene|tazarotene|mesh-list
56291806|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56291807|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913774|NCT00604461|Bevacizumab|bevacizumab|mesh-list
56291808|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56291809|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56291810|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56291811|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291812|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
56291813|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291814|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56291815|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56291816|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56291817|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
56291818|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56291819|NCT04551131|Dexamethasone|dexamethasone|mesh-list
56291820|NCT04551131|Etoposide|etoposide|mesh-list
56291821|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
56291822|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56291823|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
56291824|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
56291825|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291826|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291827|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291828|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
56291829|NCT04551131|Hormones|hormones|mesh-ancestor
56291830|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56291831|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56291832|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291833|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56291834|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56291835|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56291836|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291837|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291838|NCT01805908|Pertuzumab|pertuzumab|mesh-list
56291839|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291840|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291841|NCT04527107|Aflibercept|aflibercept|mesh-list
56291842|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56291843|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56291844|NCT04527107|Growth Substances|growth substances|mesh-ancestor
56291845|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291846|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
56291847|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291848|NCT05437887|Fucoidan|fucoidan|mesh-list
56291880|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56291881|NCT05428488|Abatacept|abatacept|mesh-list
56291882|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56291883|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291884|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291885|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291886|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
56291887|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291888|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56291889|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905232|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905233|NCT02250508|Factor VIII|factor viii|mesh-list
56291891|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56291892|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
55933345|NCT05582135|Morphine|morphine|mesh-list
56291925|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56291926|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291927|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
56291928|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
56291929|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
56291930|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291931|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291932|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
56291933|NCT04390763|Antiviral Agents|antiviral agents|mesh-ancestor
56291934|NCT04390763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291935|NCT04390763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933370|NCT04141553|Diltiazem|diltiazem|mesh-list
56291951|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56291952|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291953|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56291954|NCT01465984|Acetaminophen|acetaminophen|mesh-list
56291955|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56291956|NCT01465984|Analgesics|analgesics|mesh-ancestor
56291957|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
56291958|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291959|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291960|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
56291961|NCT01465906|Bromides|bromides|mesh-list
56291962|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
56291963|NCT01465906|Tulobuterol|tulobuterol|mesh-list
56291964|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56291965|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
56291966|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291967|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291968|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56291969|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
56291970|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
56291971|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56291972|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
56291973|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291974|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291975|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
56291976|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56291977|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56291978|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
56291979|NCT01465867|Selenium|selenium|mesh-list
56291980|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
56291981|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291982|NCT01465867|Protective Agents|protective agents|mesh-ancestor
56291983|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291984|NCT01465867|Trace Elements|trace elements|mesh-ancestor
56291985|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
56291986|NCT01465828|Clopidogrel|clopidogrel|mesh-list
56291987|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56291988|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56291989|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56291990|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56291991|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56291992|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
56291993|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292009|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56292010|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292011|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56292012|NCT05393505|Renal Agents|renal agents|mesh-ancestor
56292013|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56292014|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56292015|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292016|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292017|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292018|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56292019|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56292020|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56292021|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
56905234|NCT02250508|Coagulants|coagulants|mesh-ancestor
56905235|NCT03555526|Amoxicillin|amoxicillin|mesh-list
56905236|NCT03555526|Metronidazole|metronidazole|mesh-list
56905237|NCT03555526|Clarithromycin|clarithromycin|mesh-list
56905238|NCT03555526|Levofloxacin|levofloxacin|mesh-list
56905239|NCT03555526|Ofloxacin|ofloxacin|mesh-list
56905240|NCT03555526|Tetracycline|tetracycline|mesh-list
56905241|NCT03555526|Esomeprazole|esomeprazole|mesh-list
56905242|NCT03555526|Bismuth|bismuth|mesh-list
56905243|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56905244|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292022|NCT04201457|Trametinib|trametinib|mesh-list
56292023|NCT04201457|Dabrafenib|dabrafenib|mesh-list
56292024|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56292025|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
56292026|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56292027|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56292028|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292029|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292030|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914023|NCT02740179|Eplerenone|eplerenone|mesh-list
56292031|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292032|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292033|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56292034|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56292036|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292037|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56292038|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
56292039|NCT01465009|Aspirin|aspirin|mesh-list
56292040|NCT01465009|Acetaminophen|acetaminophen|mesh-list
56292041|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56292042|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56292043|NCT01465009|Analgesics|analgesics|mesh-ancestor
56292044|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
56292045|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292046|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292047|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56292048|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292049|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56292050|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56292051|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292052|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56292053|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56292054|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292055|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
56292092|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
56292118|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292120|NCT04078568|Prednisolone|prednisolone|mesh-list
56292121|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
56292122|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56292123|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
56292124|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56292125|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56292126|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56292127|NCT04078568|Analgesics|analgesics|mesh-ancestor
56292128|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
56292129|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292130|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292131|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56292132|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292133|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56292134|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56292135|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292136|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56292137|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56292138|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292139|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
56292140|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
56292141|NCT04078568|Hormones|hormones|mesh-ancestor
55887685|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56905245|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56905246|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56520734|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
56292142|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292143|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56292144|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292180|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56292181|NCT00847678|Amphotericin B|amphotericin b|mesh-list
56292182|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56292183|NCT00847678|Flucytosine|flucytosine|mesh-list
56292184|NCT00847678|Efungumab|efungumab|mesh-list
56292185|NCT00847678|Amebicides|amebicides|mesh-ancestor
56292186|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55933489|NCT05001672|Tenofovir|tenofovir|mesh-list
56292218|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292220|NCT04034927|Immunologic Factors|immunologic factors|mesh-ancestor
56292221|NCT04034927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292222|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292223|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56292224|NCT00847366|Tamoxifen|tamoxifen|mesh-list
56292225|NCT00847366|Trastuzumab|trastuzumab|mesh-list
56292240|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
56292241|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292242|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292243|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56292244|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56292245|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
56292246|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
56292247|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56292248|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56292249|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56292250|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292251|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292252|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56292253|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56292254|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
56292255|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56292256|NCT04009343|Lumefantrine|lumefantrine|mesh-list
56292257|NCT04009343|Artemether|artemether|mesh-list
56292258|NCT04009343|Piperaquine|piperaquine|mesh-list
56292259|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56292260|NCT04009343|Artenimol|artenimol|mesh-list
56292261|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
56292262|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56292263|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56292264|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292265|NCT03969641|Vaccines|vaccines|mesh-list
56292266|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
56292267|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292268|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
56292269|NCT00847210|Lansoprazole|lansoprazole|mesh-list
56292270|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56292271|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56292272|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56292273|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292274|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292275|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
56292276|NCT00847171|Trastuzumab|trastuzumab|mesh-list
56292277|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56292278|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
56292279|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292280|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292281|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56292282|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
56292283|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292284|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292285|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56292325|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292326|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56292327|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292328|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292330|NCT00846703|Methotrexate|methotrexate|mesh-list
56292331|NCT00846703|Vincristine|vincristine|mesh-list
56905247|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56905248|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56905249|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56905250|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905251|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905252|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56905253|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56905254|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56905255|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56905256|NCT03555526|Renal Agents|renal agents|mesh-ancestor
56905257|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56292332|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
56292334|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
56292335|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
56292336|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292337|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292338|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56292339|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
56292340|NCT00846703|Hormones|hormones|mesh-ancestor
56292341|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292342|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56292343|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292344|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56292345|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
56292346|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56292347|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56292348|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
56292349|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292350|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
56292351|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292352|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56292353|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56292354|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
56292355|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292356|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56292357|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292358|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292359|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292360|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292361|NCT03772964|Metformin|metformin|mesh-list
56292362|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56292363|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292364|NCT00846625|Triamcinolone|triamcinolone|mesh-list
56292365|NCT00846625|Ranibizumab|ranibizumab|mesh-list
56292366|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56292367|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56292368|NCT00846625|Growth Substances|growth substances|mesh-ancestor
56292369|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292370|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
56292371|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292372|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56292373|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
56292374|NCT00846625|Hormones|hormones|mesh-ancestor
56292375|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292376|NCT00846508|Cisplatin|cisplatin|mesh-list
56292377|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292378|NCT03721172|Apremilast|apremilast|mesh-list
56292379|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56292380|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56292381|NCT03721172|Analgesics|analgesics|mesh-ancestor
56292382|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
56292383|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887686|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905258|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56905259|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905260|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56905261|NCT03555526|Antacids|antacids|mesh-ancestor
56905262|NCT02102620|Lidocaine|lidocaine|mesh-list
56905263|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
56905264|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
56905265|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905266|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905267|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
56615926|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56905268|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905269|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56905270|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56520873|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
56292384|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292385|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56292386|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292421|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
56292422|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
56292423|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292424|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292425|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292426|NCT00845962|Bupivacaine|bupivacaine|mesh-list
56292430|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56292431|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292432|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
56292433|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292435|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
56292436|NCT03620942|Ephedrine|ephedrine|mesh-list
56292437|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56292438|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56292439|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
56292440|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
56292441|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292442|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292443|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
56292444|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
56292445|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
56292446|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56292447|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56292448|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56292449|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
56292450|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292451|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292452|NCT03620942|Protective Agents|protective agents|mesh-ancestor
56292453|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56292454|NCT00277108|Citalopram|citalopram|mesh-list
56292455|NCT00277108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56292456|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56292457|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56292458|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292459|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292460|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
56292461|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292462|NCT00277108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56292463|NCT00277108|Antidepressive Agents|antidepressive agents|mesh-ancestor
56292464|NCT00277108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56292465|NCT00277069|Carboplatin|carboplatin|mesh-list
56905271|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56905272|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56905273|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905275|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56905276|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56292466|NCT00277069|Capecitabine|capecitabine|mesh-list
56292467|NCT00277069|Vinorelbine|vinorelbine|mesh-list
56292468|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292469|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56292470|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
56292471|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292472|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292473|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292474|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292475|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292476|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56292477|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
56292478|NCT03521570|Nivolumab|nivolumab|mesh-list
56292479|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292480|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292481|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56292482|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292483|NCT00276874|Aripiprazole|aripiprazole|mesh-list
56292484|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
56292485|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56292486|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56292487|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56292488|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56292489|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292490|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
56292491|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
56292492|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292493|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292494|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56292495|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56292496|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
56292497|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56292531|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292532|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56292533|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56292534|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292535|NCT00276757|Leucovorin|leucovorin|mesh-list
56292536|NCT00276757|Prednisolone|prednisolone|mesh-list
56292537|NCT00276757|Methotrexate|methotrexate|mesh-list
56292539|NCT00276757|Calcium|calcium|mesh-list
56292540|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
56292541|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56292542|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933549|NCT03585725|Ribavirin|ribavirin|mesh-list
56292574|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292575|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292576|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56292577|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56292578|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292579|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292580|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56292581|NCT00276679|Temozolomide|temozolomide|mesh-list
56292582|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56292583|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
56292584|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292644|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292645|NCT00389883|Anesthetics|anesthetics|mesh-list
56292646|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56292647|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292648|NCT00389922|Vinorelbine|vinorelbine|mesh-list
56292676|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56292677|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56292678|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
56905277|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905278|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905279|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56905280|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56905281|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
56905282|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292679|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292680|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292681|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292682|NCT00276172|Natalizumab|natalizumab|mesh-list
56292683|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
56292684|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292685|NCT00276133|Atorvastatin|atorvastatin|mesh-list
56292686|NCT00276133|Probucol|probucol|mesh-list
56292687|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56292688|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56292690|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292691|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56292692|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56292693|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292694|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
56292695|NCT00276133|Protective Agents|protective agents|mesh-ancestor
56292707|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56292708|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
56292709|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292710|NCT00276055|Antiviral Agents|antiviral agents|mesh-ancestor
56292711|NCT00276055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292712|NCT00276055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292713|NCT00276055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56292714|NCT00276055|Immunologic Factors|immunologic factors|mesh-ancestor
56292715|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292716|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292717|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292719|NCT00275938|Ribavirin|ribavirin|mesh-list
56292720|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
56292721|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
56292722|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292723|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
56292724|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292725|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
56292726|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292727|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
56292728|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292729|NCT00275665|Valganciclovir|valganciclovir|mesh-list
56292730|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
56292731|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292732|NCT00275548|Ribavirin|ribavirin|mesh-list
56292733|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56292734|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
56292735|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292736|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
56292737|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292738|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
56292739|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292740|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292741|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56292742|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
56292743|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56292744|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292745|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56292746|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56292747|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56292748|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
56292749|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56292750|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
56292751|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292752|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292753|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56292754|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
56905283|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905284|NCT03981614|Trifluridine|trifluridine|mesh-list
56905285|NCT03981614|Palbociclib|palbociclib|mesh-list
56905286|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905287|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56521070|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
56292755|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292756|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292757|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56292759|NCT05566054|Venetoclax|venetoclax|mesh-list
56292760|NCT05566054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56292761|NCT05566054|Antimetabolites|antimetabolites|mesh-ancestor
55933601|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56292780|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56292781|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292782|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292783|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56292784|NCT05424757|Laxatives|laxatives|mesh-ancestor
56292785|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56292786|NCT02921555|Prednisone|prednisone|mesh-list
56292787|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
56292788|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56292789|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56292790|NCT02921555|Prednisolone|prednisolone|mesh-list
56292791|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
56292792|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56292793|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
56292794|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56292795|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
56292796|NCT02921555|Hormones|hormones|mesh-ancestor
56292797|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292798|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292799|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56292800|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292801|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
56292802|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
56292803|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292804|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56292805|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56292806|NCT02921555|Protective Agents|protective agents|mesh-ancestor
56292807|NCT05327530|Avelumab|avelumab|mesh-list
56292808|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292809|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292810|NCT05262556|Nivolumab|nivolumab|mesh-list
56292811|NCT05262556|Ipilimumab|ipilimumab|mesh-list
56292812|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292813|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292814|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56292815|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292816|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
56292817|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914815|NCT01418365|Analgesics|analgesics|mesh-ancestor
56292855|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292856|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292857|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292858|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292891|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56292892|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
56292893|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56292894|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56292895|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56292896|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56292897|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292898|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
56292899|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292900|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56292928|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56292929|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56905288|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905289|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905290|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
56905291|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
56905292|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905293|NCT02102776|Mitomycins|mitomycins|mesh-list
56905294|NCT02102776|Mitomycin|mitomycin|mesh-list
56905295|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56905296|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905297|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
56905298|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905299|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56905300|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905301|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
56905302|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56905303|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
56905304|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905305|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56905306|NCT02670044|Venetoclax|venetoclax|mesh-list
56905307|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905308|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56905309|NCT02307656|Cobicistat|cobicistat|mesh-list
56905310|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56905311|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56905312|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
56905313|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905314|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905315|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56292930|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56292931|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292932|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292933|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
56292934|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56292935|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56292936|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
56292937|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56292938|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56292939|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56292940|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
56292941|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56292942|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
56292943|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292944|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292945|NCT04379713|Vaccines|vaccines|mesh-list
56292946|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56292947|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
56292948|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292949|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
56905316|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56905317|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
56905318|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905319|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56905320|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56905321|NCT04232943|Vaccines|vaccines|mesh-list
56292950|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56292966|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56292967|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
56292968|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292969|NCT04712435|Protective Agents|protective agents|mesh-ancestor
56292970|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292971|NCT04712435|Antidotes|antidotes|mesh-ancestor
56292972|NCT03977194|Paclitaxel|paclitaxel|mesh-list
56292973|NCT03977194|Carboplatin|carboplatin|mesh-list
56292974|NCT03977194|Atezolizumab|atezolizumab|mesh-list
56292975|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292976|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292977|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292978|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292979|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292980|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292981|NCT04729465|Propofol|propofol|mesh-list
56292982|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56292983|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56292984|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292985|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56292986|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
56292987|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
56292988|NCT04712357|Tenofovir|tenofovir|mesh-list
56292989|NCT04712357|Emtricitabine|emtricitabine|mesh-list
56292990|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
56292991|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292992|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56292993|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56292994|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292995|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292996|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56292997|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56292998|NCT00390039|Morphine|morphine|mesh-list
56292999|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56293000|NCT00390039|Narcotics|narcotics|mesh-ancestor
56293001|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293002|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293003|NCT00390039|Analgesics|analgesics|mesh-ancestor
56293004|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
56293005|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293006|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
56293007|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
56293008|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
56293009|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293010|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293012|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293013|NCT02966665|Vitamins|vitamins|mesh-list
56293014|NCT02966665|Vitamin E|vitamin e|mesh-list
56293031|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56293032|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293033|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
56293034|NCT02966665|Protective Agents|protective agents|mesh-ancestor
56293035|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56293036|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56293037|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
56293038|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293039|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
56293040|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
56293041|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293042|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56293043|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
56293044|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56293045|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56905322|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
56905323|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905324|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
56905325|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56521258|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56293046|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56293047|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
56293048|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
56293049|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56293050|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56293051|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56293052|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
56293053|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56293054|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56293055|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
56293056|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293057|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56293058|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
56293059|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56293060|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56293061|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56293062|NCT02832544|Vitamin K|vitamin k|mesh-list
56293063|NCT02832544|Warfarin|warfarin|mesh-list
56293064|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
56293065|NCT02832544|Vitamins|vitamins|mesh-ancestor
56293066|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
56293067|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293068|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
56293069|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56293070|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
56293071|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56293072|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
56293073|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293074|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293075|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56293076|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56293077|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
56293078|NCT02832544|Coagulants|coagulants|mesh-ancestor
56293079|NCT00006044|Testosterone|testosterone|mesh-list
56293080|NCT00006044|Androgens|androgens|mesh-ancestor
56293147|NCT00083902|Growth Substances|growth substances|mesh-ancestor
56293148|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
56293149|NCT00006050|Leucovorin|leucovorin|mesh-list
56293150|NCT00006050|Fluorouracil|fluorouracil|mesh-list
56293151|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
56293152|NCT00006050|Calcium|calcium|mesh-list
56293153|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
56293154|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56293155|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293156|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
56293157|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293158|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293159|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933713|NCT03076203|Niraparib|niraparib|mesh-list
56293182|NCT04893174|Protective Agents|protective agents|mesh-ancestor
56293183|NCT00084019|Ritonavir|ritonavir|mesh-list
56293184|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56293185|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56293186|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56293187|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
56293188|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293189|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293190|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56293191|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56293192|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
56293193|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293194|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56293195|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56293196|NCT00084058|Ritonavir|ritonavir|mesh-list
56293197|NCT00084058|Lopinavir|lopinavir|mesh-list
56293198|NCT00084058|Saquinavir|saquinavir|mesh-list
56293199|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56293200|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56081061|NCT00003867|Capecitabine|capecitabine|mesh-list
56905326|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56905327|NCT02098330|Prednisolone|prednisolone|mesh-list
56905328|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
56905329|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56905330|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
56521327|NCT05507775|Digoxin|digoxin|mesh-list
56293201|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
56293202|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293203|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293204|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56293205|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56293206|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
56293207|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293208|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56293209|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56293210|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
56293211|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293243|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
56293244|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56293245|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293246|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
56293247|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
56293248|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293249|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56293250|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56293251|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293252|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56293253|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293254|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
56293255|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293256|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56293257|NCT00084370|Celecoxib|celecoxib|mesh-list
56293258|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56293263|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293264|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56293265|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293266|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56293267|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56293268|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293269|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293271|NCT00084448|Paclitaxel|paclitaxel|mesh-list
56293272|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293273|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293274|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293275|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293276|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293277|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293278|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56293279|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56293280|NCT00084448|Analgesics|analgesics|mesh-ancestor
56293281|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
56293282|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293283|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293284|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56293285|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293286|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56293287|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56293288|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293289|NCT00084565|Paclitaxel|paclitaxel|mesh-list
56293290|NCT00084565|Topotecan|topotecan|mesh-list
56293291|NCT00084565|Estramustine|estramustine|mesh-list
56293292|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293293|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293294|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293295|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293296|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293297|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293298|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56293299|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56905331|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905332|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
56905333|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
56905334|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521398|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293300|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293301|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56293302|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
56293303|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56293304|NCT00084604|Bevacizumab|bevacizumab|mesh-list
56293305|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56293306|NCT00084604|Irinotecan|irinotecan|mesh-list
56293307|NCT00084604|Antibodies|antibodies|mesh-list
56293308|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
56293309|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56293310|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293311|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55915272|NCT04063267|Nicotine|nicotine|mesh-list
56293312|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56293313|NCT00084604|Growth Substances|growth substances|mesh-ancestor
56293314|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293315|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
56293316|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
56293317|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56293318|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293319|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293320|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293321|NCT00084643|Capecitabine|capecitabine|mesh-list
56293322|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
56293323|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293324|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
56293325|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293326|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293327|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
55933743|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56293336|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56293337|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56293338|NCT00084721|Analgesics|analgesics|mesh-ancestor
56293339|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
56293340|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293341|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293342|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56293343|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293344|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56293345|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56293347|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56293348|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293349|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293350|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293351|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293352|NCT00084916|Sirolimus|sirolimus|mesh-list
56293353|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56293354|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293355|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56293356|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293357|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
56293358|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293359|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
56293360|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293361|NCT00085111|Bevacizumab|bevacizumab|mesh-list
56293362|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56293363|NCT00085111|Antibodies|antibodies|mesh-list
56293364|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
56293365|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56293366|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293367|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56293368|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56293370|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293371|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
56293372|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
56293373|NCT00085150|Immunotoxins|immunotoxins|mesh-list
56905335|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905336|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56905337|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
56905338|NCT02098330|Hormones|hormones|mesh-ancestor
56905339|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56293374|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
56293375|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293376|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
56293377|NCT00400075|Azathioprine|azathioprine|mesh-list
56293378|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293379|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
56293380|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293381|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293382|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56293383|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
56293384|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293385|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293386|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56293387|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
56293388|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293390|NCT00400114|Sunitinib|sunitinib|mesh-list
56293391|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293392|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56293393|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293394|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293395|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293396|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55933747|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
56293413|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293414|NCT00085306|Interferons|interferons|mesh-list
56293415|NCT00085306|Interferon-beta|interferon-beta|mesh-list
56293416|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293417|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
56293418|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293419|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
56293420|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293421|NCT00006077|Levodopa|levodopa|mesh-list
56293422|NCT00006077|Domperidone|domperidone|mesh-list
56293423|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56293424|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56293425|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
56293426|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293427|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293428|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293429|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
56293430|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
56293431|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293432|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56293433|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56293434|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
56293435|NCT04729348|Lenvatinib|lenvatinib|mesh-list
56293436|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56293437|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293438|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56293439|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293440|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293441|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
56293442|NCT00085345|Melphalan|melphalan|mesh-list
56293443|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
56293444|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56293445|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
56293446|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293447|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293448|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56293449|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293451|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293452|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
56293453|NCT00085345|Protective Agents|protective agents|mesh-ancestor
56293454|NCT00085345|Vitamins|vitamins|mesh-ancestor
56293455|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
56293456|NCT00085384|Interferons|interferons|mesh-list
56905340|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56905341|NCT02098330|Protective Agents|protective agents|mesh-ancestor
56521547|NCT01295814|Adalimumab|adalimumab|mesh-list
56293457|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
56293510|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56293511|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
56293512|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293513|NCT00085696|Rituximab|rituximab|mesh-list
56293514|NCT00085696|Bortezomib|bortezomib|mesh-list
56293515|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56293516|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293517|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
56293518|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293519|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293520|NCT00006086|Carboplatin|carboplatin|mesh-list
56293521|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293522|NCT04798638|Osimertinib|osimertinib|mesh-list
56293523|NCT04798638|Complement Factor H|complement factor h|mesh-list
56293524|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293525|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56293526|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293527|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293528|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56293529|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293530|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
56293531|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293532|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56293533|NCT00006089|Trastuzumab|trastuzumab|mesh-list
56293534|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56293535|NCT00006089|Antibodies|antibodies|mesh-list
56293536|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
56293537|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56293538|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
55915492|NCT01435577|Tapentadol|tapentadol|mesh-list
56293539|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293541|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56293542|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
56293543|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56293544|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56293545|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56293546|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293547|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293548|NCT00085969|Exenatide|exenatide|mesh-list
56293549|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56293550|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293551|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56293552|NCT00085969|Incretins|incretins|mesh-ancestor
56293636|NCT04784637|Insulin|insulin|mesh-list
56293637|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56293638|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293639|NCT00086632|Oregovomab|oregovomab|mesh-list
56293640|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56293641|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293642|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
56293643|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56293675|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293676|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293677|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293678|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56293679|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56293680|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
56293682|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293683|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293684|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293685|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293686|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293687|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
56293688|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293689|NCT00087100|Pemetrexed|pemetrexed|mesh-list
56293700|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293702|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293703|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
56293704|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293705|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56293706|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56293707|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56293708|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293710|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293711|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293712|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293713|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293714|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293715|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293716|NCT00087256|Celecoxib|celecoxib|mesh-list
56293717|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56293718|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56293719|NCT00087256|Analgesics|analgesics|mesh-ancestor
56293720|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
56293721|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293722|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293723|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56293724|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293725|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56293726|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56293727|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293728|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293729|NCT00006116|Gemcitabine|gemcitabine|mesh-list
56293730|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293731|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293732|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
56293733|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293734|NCT00006116|Antiviral Agents|antiviral agents|mesh-ancestor
56293735|NCT00006116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293736|NCT00006116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293737|NCT00006116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293738|NCT00006116|Immunologic Factors|immunologic factors|mesh-ancestor
56293739|NCT00006116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293741|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56293742|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293743|NCT04762953|Leucovorin|leucovorin|mesh-list
56293744|NCT04762953|Paclitaxel|paclitaxel|mesh-list
56293745|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56293746|NCT04762953|Fluorouracil|fluorouracil|mesh-list
56293747|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293748|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293749|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293750|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293751|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293752|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293753|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
56293754|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293755|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293756|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
56293817|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293818|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56293819|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56293820|NCT00087802|Gemcitabine|gemcitabine|mesh-list
56293822|NCT00087802|Carboplatin|carboplatin|mesh-list
56293823|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
56293824|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293825|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293826|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293827|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293828|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933821|NCT04405193|Antidotes|antidotes|mesh-ancestor
56293840|NCT00006125|Doxorubicin|doxorubicin|mesh-list
56293841|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56293842|NCT00006125|Topotecan|topotecan|mesh-list
56293843|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56293844|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293845|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56293846|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293847|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293848|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293849|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56293850|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56293851|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293852|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293853|NCT00087880|Bupropion|bupropion|mesh-list
56293854|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56905342|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56905343|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905344|NCT02103166|Scopolamine|scopolamine|mesh-list
56293855|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
56293856|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56293857|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56293858|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56293859|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56293860|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293861|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
56293862|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293863|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293864|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56293865|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56293866|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293867|NCT00088036|Olanzapine|olanzapine|mesh-list
56293868|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
56293869|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
56293870|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293871|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293872|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56293873|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56293874|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56293875|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293876|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56293877|NCT00088036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56293878|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56293879|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56293880|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293881|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293882|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
56293883|NCT00088075|Risperidone|risperidone|mesh-list
56293884|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56293885|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
56293886|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293887|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293888|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293889|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56293914|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293915|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293916|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293917|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293918|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
56293919|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293920|NCT00088270|Antidotes|antidotes|mesh-ancestor
56293921|NCT00088270|Protective Agents|protective agents|mesh-ancestor
56293922|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
56293924|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
56293925|NCT00088387|Valproic Acid|valproic acid|mesh-list
56293926|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56293927|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293928|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293929|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
56293930|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56293931|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293932|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293933|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
56293934|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
56293935|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293936|NCT00088504|Interferons|interferons|mesh-list
56293937|NCT00088504|Ribavirin|ribavirin|mesh-list
56293938|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
56293939|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
56293940|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56293941|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293942|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
56293943|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293944|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
56293945|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293969|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293970|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
56905345|NCT02103166|Bromides|bromides|mesh-list
56293971|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293972|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
56293973|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
56293974|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
56293975|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56293976|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
56293977|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
56293978|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293979|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293980|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293981|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56293982|NCT00088855|Doxorubicin|doxorubicin|mesh-list
56293983|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56293984|NCT00088855|Bortezomib|bortezomib|mesh-list
56293985|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56293986|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293987|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56293988|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293989|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293990|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293991|NCT00088894|Gemcitabine|gemcitabine|mesh-list
56293992|NCT00088894|Bevacizumab|bevacizumab|mesh-list
56293993|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55915934|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
56293995|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
56293996|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56293997|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800375|NCT04873531|Neostigmine|neostigmine|mesh-list
56294004|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294005|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
56294006|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294007|NCT00088894|Antiviral Agents|antiviral agents|mesh-ancestor
56294008|NCT00088894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294009|NCT00088894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294010|NCT00088894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294011|NCT00006152|Ritonavir|ritonavir|mesh-list
56294012|NCT00006152|Amprenavir|amprenavir|mesh-list
56294013|NCT00006152|Abacavir|abacavir|mesh-list
56294014|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56294015|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56294016|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
56294017|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294018|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294019|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56294020|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56294021|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
56294022|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294023|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56294024|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56294025|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56294026|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56160787|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56294028|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
56294029|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294030|NCT00088933|Metronidazole|metronidazole|mesh-list
56294031|NCT00088933|Docetaxel|docetaxel|mesh-list
56294032|NCT00088933|Vaccines|vaccines|mesh-list
56294033|NCT00088933|Sargramostim|sargramostim|mesh-list
56294034|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
56294035|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294036|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294037|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
56294038|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
56294039|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
56294040|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294041|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294042|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294043|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56294044|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56294045|NCT00089050|Cyclosporine|cyclosporine|mesh-list
56294046|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
56294047|NCT00089050|Cyclosporins|cyclosporins|mesh-list
56294048|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294049|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294050|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56905346|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
56905347|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56905349|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
56905350|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905351|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905352|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56905353|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
56294051|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
56294052|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294053|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
56294054|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294055|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
56294056|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294057|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56294058|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56294059|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294060|NCT00006155|Carboplatin|carboplatin|mesh-list
56294061|NCT00006155|Semaxinib|semaxinib|mesh-list
56294062|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294063|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56294064|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294065|NCT00006155|Growth Substances|growth substances|mesh-ancestor
56294066|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294067|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294088|NCT00089167|Hormones|hormones|mesh-ancestor
56294089|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56294090|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56294091|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294092|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
56294093|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56294094|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
56294095|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294096|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56294097|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294098|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
56294099|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294100|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294102|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294103|NCT00089167|Growth Substances|growth substances|mesh-ancestor
56294104|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294105|NCT00089206|Sargramostim|sargramostim|mesh-list
56294106|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
56294107|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
56294108|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294109|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56294110|NCT00400231|Metformin|metformin|mesh-list
56294111|NCT00400231|Fenofibrate|fenofibrate|mesh-list
56294112|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56294113|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294114|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56294115|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
56294116|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294117|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56294118|NCT00006158|Testosterone|testosterone|mesh-list
56294119|NCT00006158|Androgens|androgens|mesh-ancestor
56294120|NCT00006158|Hormones|hormones|mesh-ancestor
56294121|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56294122|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294123|NCT00423826|Cytarabine|cytarabine|mesh-list
56294124|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
56294125|NCT00423826|Fludarabine|fludarabine|mesh-list
56294126|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
56294129|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294130|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294131|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
56294132|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294133|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294134|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
56294135|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905354|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56905355|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
56905356|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294136|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
56294137|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294138|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56294139|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294140|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56294141|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56294142|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
56294143|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294144|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
56294145|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56294146|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56294147|NCT00423865|Everolimus|everolimus|mesh-list
56294148|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294149|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294150|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
56294151|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294159|NCT00423982|Vancomycin|vancomycin|mesh-list
56294160|NCT00423982|Rifampin|rifampin|mesh-list
56294161|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56294162|NCT00423982|Cloxacillin|cloxacillin|mesh-list
56294163|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
56294164|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56294165|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
56294166|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
56294167|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56294168|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294169|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294170|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56294171|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56294172|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56294173|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56294174|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56294176|NCT02965261|Fluoxetine|fluoxetine|mesh-list
56294177|NCT02965261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56294178|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56294179|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56294180|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294181|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294182|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
56294183|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294184|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56294185|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
56294186|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56294187|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56294188|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56294189|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294190|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
56294191|NCT00390156|Bevacizumab|bevacizumab|mesh-list
56294192|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
56294193|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294194|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
56294195|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294196|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294197|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56294198|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
56294199|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294200|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294201|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56294202|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56294203|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56294204|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294205|NCT00390156|Growth Substances|growth substances|mesh-ancestor
56294207|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294238|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56294239|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56294240|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294242|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
56905357|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905358|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56905359|NCT02103244|Carboplatin|carboplatin|mesh-list
56905360|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905361|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
56294243|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
56294244|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
56294245|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294246|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294247|NCT00089830|Squalamine|squalamine|mesh-list
56294248|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294249|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294258|NCT00089869|Olanzapine|olanzapine|mesh-list
56294259|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56294260|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
56294261|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
56294262|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294263|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294264|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56294265|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56294266|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56294267|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56294268|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56294269|NCT00089869|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56294270|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56294271|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56294272|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294273|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294274|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
56294275|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56294276|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
56294277|NCT00006167|Oxandrolone|oxandrolone|mesh-list
56294278|NCT00006167|Androgens|androgens|mesh-ancestor
56294279|NCT00006167|Hormones|hormones|mesh-ancestor
56294280|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56294281|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294282|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
56294283|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
56294284|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56294285|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
56294286|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294287|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294288|NCT00090025|Leucovorin|leucovorin|mesh-list
56294289|NCT00090025|Fluorouracil|fluorouracil|mesh-list
56294290|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
56294291|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916240|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
56294292|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294293|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294294|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294295|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
56294296|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294297|NCT00090025|Antidotes|antidotes|mesh-ancestor
56294298|NCT00090025|Protective Agents|protective agents|mesh-ancestor
56294299|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
56294301|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
56294302|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
56294303|NCT04633902|Olaparib|olaparib|mesh-list
56294304|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56294305|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294306|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56294307|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294308|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294309|NCT00090727|AQ4N|aq4n|mesh-list
56294310|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294311|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
56294312|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56294313|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294314|NCT00091039|Metronidazole|metronidazole|mesh-list
56294315|NCT00091039|Paclitaxel|paclitaxel|mesh-list
56294316|NCT00091039|Carboplatin|carboplatin|mesh-list
56294317|NCT00091039|Vaccines|vaccines|mesh-list
56905362|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
56905363|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56905364|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905365|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56905366|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56905367|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905368|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905369|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905370|NCT02099890|Curcumin|curcumin|mesh-list
56905371|NCT02099890|Antioxidants|antioxidants|mesh-list
56905372|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56522053|NCT01034176|Ofloxacin|ofloxacin|mesh-list
56294318|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
56294321|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294322|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
56294323|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
56294324|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
56294325|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294326|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294327|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294328|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56294329|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56294330|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
56294331|NCT00091078|Oblimersen|oblimersen|mesh-list
56294332|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294333|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294334|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294335|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294336|NCT00091117|Bortezomib|bortezomib|mesh-list
56294337|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294338|NCT00091156|Gefitinib|gefitinib|mesh-list
56294339|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294340|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294341|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294342|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294343|NCT00091195|Romidepsin|romidepsin|mesh-list
56294344|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56294345|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294346|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
56294347|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56294348|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294349|NCT00091312|Leucovorin|leucovorin|mesh-list
56294350|NCT00091312|Fluorouracil|fluorouracil|mesh-list
56294351|NCT00091312|Irinotecan|irinotecan|mesh-list
56294352|NCT00091312|Calcium|calcium|mesh-list
56294353|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
56294354|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56294355|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294356|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
56333998|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56294357|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294358|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294359|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294360|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294361|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
56294362|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56294363|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56294364|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916316|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56294366|NCT00091312|Protective Agents|protective agents|mesh-ancestor
56294367|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
56294368|NCT00091312|Vitamins|vitamins|mesh-ancestor
56294369|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
56294370|NCT04619706|Palmidrol|palmidrol|mesh-list
56294371|NCT04619706|Analgesics|analgesics|mesh-ancestor
56294372|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
56905373|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56905374|NCT02099890|Analgesics|analgesics|mesh-ancestor
56905375|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
56905376|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905377|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905378|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905379|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56905380|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905381|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905382|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905383|NCT02099890|Protective Agents|protective agents|mesh-ancestor
56905384|NCT02250820|Pentobarbital|pentobarbital|mesh-list
56905385|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
56905386|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56905387|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905388|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294373|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294374|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294375|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56294376|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56294377|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56294378|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294379|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
56294380|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294381|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56294382|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56294383|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294384|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294385|NCT04619706|Hormones|hormones|mesh-ancestor
56294386|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56294387|NCT00091429|Ranolazine|ranolazine|mesh-list
56294388|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56294389|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55934175|NCT04404881|Growth Substances|growth substances|mesh-ancestor
56294395|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294396|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56294397|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56294398|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
56294399|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294400|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294401|NCT00006200|Thalidomide|thalidomide|mesh-list
56294402|NCT00006200|Dacarbazine|dacarbazine|mesh-list
56294403|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294404|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
56294405|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294406|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
56294407|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294408|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294409|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56294410|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294411|NCT00006200|Growth Substances|growth substances|mesh-ancestor
56294412|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294413|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294414|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56294415|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
56294416|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294417|NCT00006203|Naltrexone|naltrexone|mesh-list
56905389|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56905390|NCT02250820|Analgesics|analgesics|mesh-ancestor
56905391|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
56905392|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905393|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56905394|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56905395|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56905396|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
56905397|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905398|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905399|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56905400|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
56905401|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
56905402|NCT04292457|Propofol|propofol|mesh-list
56905403|NCT04292457|Sevoflurane|sevoflurane|mesh-list
56905404|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56294418|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56294419|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56294420|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294421|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
56294422|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294423|NCT00091624|Lenalidomide|lenalidomide|mesh-list
56294424|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
56294425|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294426|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56294427|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294428|NCT00091624|Growth Substances|growth substances|mesh-ancestor
56294429|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294430|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294431|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56294432|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294433|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294434|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294435|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294436|NCT00006206|Naltrexone|naltrexone|mesh-list
56294437|NCT00006206|Acamprosate|acamprosate|mesh-list
56294438|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56294439|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56294440|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294441|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
56294442|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294443|NCT00091702|Vaccines|vaccines|mesh-list
56294444|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
56294445|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294446|NCT00091741|Etanercept|etanercept|mesh-list
56294447|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56294448|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56294449|NCT00091741|Analgesics|analgesics|mesh-ancestor
56294450|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
56294451|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294452|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294453|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56294454|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294455|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56294456|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294457|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
56294458|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
56294459|NCT00091858|Hematinics|hematinics|mesh-ancestor
56294466|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56294467|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905405|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905406|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905407|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56905408|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
56905409|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
56905410|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56294468|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
56294469|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294470|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294471|NCT00006212|Vinblastine|vinblastine|mesh-list
56294472|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294473|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56294474|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
56294475|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
56294476|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
56294477|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294478|NCT00091936|Lamivudine|lamivudine|mesh-list
56294479|NCT00091936|Efavirenz|efavirenz|mesh-list
56294480|NCT00091936|Didanosine|didanosine|mesh-list
56294481|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56294482|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56294483|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294484|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294485|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
56294486|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294487|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56294488|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56294489|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56294490|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56294491|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56294492|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56294493|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56294494|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56294495|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
56294496|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56294497|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56294498|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
56294499|NCT02972346|Hormones|hormones|mesh-ancestor
56294500|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56294501|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294502|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294503|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294504|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
56294506|NCT00092170|Ertapenem|ertapenem|mesh-list
56294507|NCT00092170|Ticarcillin|ticarcillin|mesh-list
56294508|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56294509|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294510|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294511|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294512|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294513|NCT00006215|Docetaxel|docetaxel|mesh-list
56294514|NCT00006215|Vinorelbine|vinorelbine|mesh-list
56294515|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294516|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
56294517|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
56294518|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
56294519|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294520|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56294521|NCT00092287|Lanreotide|lanreotide|mesh-list
56294522|NCT00092287|Octreotide|octreotide|mesh-list
56294523|NCT00092287|Somatostatin|somatostatin|mesh-list
56294524|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294525|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56294526|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56294527|NCT00092287|Hormones|hormones|mesh-ancestor
56294528|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56294529|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077322|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
56905411|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56905412|NCT02100046|Ethosuximide|ethosuximide|mesh-list
56905413|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
56294543|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56294544|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294545|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294546|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56294547|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56294548|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294549|NCT00092365|Celecoxib|celecoxib|mesh-list
56294550|NCT00092365|Rofecoxib|rofecoxib|mesh-list
56294551|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56294552|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56294553|NCT00092365|Analgesics|analgesics|mesh-ancestor
56294554|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
56294555|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294556|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294557|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56294558|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294559|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56294560|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56294561|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294562|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294563|NCT00092404|Vaccines|vaccines|mesh-list
56294564|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
56294565|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294566|NCT04728880|Remdesivir|remdesivir|mesh-list
56294567|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
56294568|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294569|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
56294570|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294571|NCT00093028|Bortezomib|bortezomib|mesh-list
56294572|NCT00093028|Lenalidomide|lenalidomide|mesh-list
56294573|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294574|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
56294575|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294576|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56294577|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294578|NCT00093028|Growth Substances|growth substances|mesh-ancestor
56294579|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294580|NCT00093067|Daptomycin|daptomycin|mesh-list
56294581|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294582|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294583|NCT00093184|Anticoagulants|anticoagulants|mesh-list
56294584|NCT00093184|Bivalirudin|bivalirudin|mesh-list
56294585|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
56294586|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56294587|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
56294588|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294589|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294590|NCT00006224|Gemcitabine|gemcitabine|mesh-list
56294591|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294592|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
56294593|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294598|NCT00006224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294599|NCT00006224|Immunologic Factors|immunologic factors|mesh-ancestor
56294600|NCT00006224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294602|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56294603|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56294604|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294605|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
56294606|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
56294607|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
56294608|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294609|NCT00093262|Clevidipine|clevidipine|mesh-list
56294610|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56294611|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56294612|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294613|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56294614|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294615|NCT00093301|Simendan|simendan|mesh-list
56294616|NCT00093301|Dobutamine|dobutamine|mesh-list
56905414|NCT02100202|Turmeric extract|turmeric extract|mesh-list
56905415|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
56905416|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905417|NCT02100202|Protective Agents|protective agents|mesh-ancestor
56294617|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56294618|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
56294619|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56294620|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56294621|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294622|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294623|NCT00093301|Protective Agents|protective agents|mesh-ancestor
56294624|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294625|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
56294626|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
56294627|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294628|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56294629|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56294630|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56294631|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
56294632|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294633|NCT00093418|Tipifarnib|tipifarnib|mesh-list
56294634|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294635|NCT00387608|Veliparib|veliparib|mesh-list
56294636|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56294637|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294638|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294639|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294640|NCT00093457|Sorafenib|sorafenib|mesh-list
56294641|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294642|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294643|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294644|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294645|NCT00093613|Sorafenib|sorafenib|mesh-list
56294646|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294647|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294648|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294649|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294650|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
56294651|NCT00093652|Gefitinib|gefitinib|mesh-list
56294652|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294653|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294654|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294655|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294656|NCT00006230|Rubitecan|rubitecan|mesh-list
56294657|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294658|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56294659|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56294660|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294661|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294668|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294669|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
56294670|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294671|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
56294672|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
56294673|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
56294674|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294675|NCT00006233|Cyclosporine|cyclosporine|mesh-list
56294676|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
56294677|NCT00006233|Fludarabine|fludarabine|mesh-list
56294678|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
56294679|NCT00006233|Cyclosporins|cyclosporins|mesh-list
56294680|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294681|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294682|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
56294683|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294684|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294685|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
56294686|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294687|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294688|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
56294689|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905418|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905419|NCT05423392|Lidocaine|lidocaine|mesh-list
56905420|NCT05423392|Carticaine|carticaine|mesh-list
56905421|NCT05423392|Anesthetics|anesthetics|mesh-list
56905422|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
56905423|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905424|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905425|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
56905426|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905427|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56294690|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
56294691|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294692|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56294693|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56294694|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56294695|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
56294696|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294697|NCT02964715|Empagliflozin|empagliflozin|mesh-list
56294698|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56294699|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294700|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56294701|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294702|NCT00093886|Clevidipine|clevidipine|mesh-list
56294703|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
56294704|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
56294705|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56294706|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56294707|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294708|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56294709|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294710|NCT00093925|Nicardipine|nicardipine|mesh-list
56294711|NCT00093925|Clevidipine|clevidipine|mesh-list
56294712|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56294713|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56294714|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294715|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56294716|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294717|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56294718|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
56294719|NCT00006239|Tretinoin|tretinoin|mesh-list
56294720|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56294721|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294722|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
56294723|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
56294724|NCT00094003|Poly I-C|poly i-c|mesh-list
56294725|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
56294726|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294727|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
56294728|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
56294729|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294754|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294755|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294757|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
56294758|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
56294759|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56294760|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294761|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
56294762|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160802|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
56294763|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56294764|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56294765|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56294766|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56294767|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905428|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56905429|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56905430|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522506|NCT01299896|Bupropion|bupropion|mesh-list
56294768|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
56294769|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294771|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
56294772|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56294773|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56294774|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56294775|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56294776|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294777|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
56294778|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
56294779|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934590|NCT01676597|Rifaximin|rifaximin|mesh-list
56294783|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
56294784|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56294785|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56294786|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56294787|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56294788|NCT00006248|Paclitaxel|paclitaxel|mesh-list
56294789|NCT00006248|Fluorouracil|fluorouracil|mesh-list
56294790|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56294791|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294792|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56294793|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56294794|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56294795|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294796|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
56294797|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294798|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294799|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
56294800|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294801|NCT00094549|Valproic Acid|valproic acid|mesh-list
56294802|NCT00094549|Olanzapine|olanzapine|mesh-list
56294803|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
56294804|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
56294805|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294806|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294807|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56294808|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56294809|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56294810|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56294811|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56294812|NCT00094549|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56294813|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56294814|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56294815|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294816|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294817|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
56294818|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
56294819|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294820|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
56294821|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
56294822|NCT00094627|Gaboxadol|gaboxadol|mesh-list
56294823|NCT00094627|Analgesics|analgesics|mesh-ancestor
56294824|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
56294825|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294826|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294827|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
56294828|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
56294829|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
56294830|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294831|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294832|NCT00094666|Gaboxadol|gaboxadol|mesh-list
56294833|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294834|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294835|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294836|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294837|NCT00094666|Analgesics|analgesics|mesh-ancestor
56294838|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
56905431|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294839|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
56294840|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
56294841|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
56294842|NCT00006251|Cyclosporine|cyclosporine|mesh-list
56294843|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
56294844|NCT00006251|Fludarabine|fludarabine|mesh-list
56294845|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
56294846|NCT00006251|Cyclosporins|cyclosporins|mesh-list
56294847|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294848|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294849|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
56294850|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294851|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294854|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294855|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
56294856|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294857|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
56294858|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56294859|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56294860|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56294861|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56294862|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
56294863|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294864|NCT00094978|Alvocidib|alvocidib|mesh-list
56294865|NCT00094978|Romidepsin|romidepsin|mesh-list
56294866|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294867|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294868|NCT00094978|Growth Substances|growth substances|mesh-ancestor
56294869|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294870|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294871|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294872|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294873|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56294874|NCT00095134|Risperidone|risperidone|mesh-list
56294875|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56294876|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
56294877|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294878|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294879|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294880|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56294881|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56294882|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56294883|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56294884|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56294885|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
56294887|NCT00006257|Semaxinib|semaxinib|mesh-list
56294888|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56294889|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294890|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
56294891|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
56294892|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
56294893|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294894|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56294895|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294896|NCT00006257|Growth Substances|growth substances|mesh-ancestor
56294897|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294898|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294899|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294900|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294901|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
56294902|NCT00095251|Lorazepam|lorazepam|mesh-list
56294903|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56294904|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56294905|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294906|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56294907|NCT00095251|Analgesics|analgesics|mesh-ancestor
56294908|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
56294909|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160807|NCT03933774|Tretinoin|tretinoin|mesh-list
56294910|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56294911|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56294912|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56294913|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
56077323|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
56905432|NCT02103556|Mineral Oil|mineral oil|mesh-list
56905433|NCT02103556|Emollients|emollients|mesh-ancestor
56905434|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56905435|NCT03555136|Vortioxetine|vortioxetine|mesh-list
56294914|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294915|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294916|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
56294917|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
56294918|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
56294919|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56294920|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56294921|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56294922|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56294923|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
56294924|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
56294925|NCT00006260|Etoposide|etoposide|mesh-list
56294937|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294938|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56294939|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294940|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
56294941|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294942|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
56294943|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294944|NCT00095368|Amoxicillin|amoxicillin|mesh-list
56294945|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294946|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294947|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
56294948|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56294949|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294950|NCT00006263|Carboplatin|carboplatin|mesh-list
56294951|NCT00006263|Temozolomide|temozolomide|mesh-list
56294952|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294953|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56294954|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
56294955|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294957|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
56294958|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56294959|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56294960|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56294961|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56294962|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294963|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
56294964|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
56294965|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294966|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916919|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
56294967|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56294968|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56294969|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
56294970|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56294971|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56294972|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56294973|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56294974|NCT04492566|Pancrelipase|pancrelipase|mesh-list
56294975|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56294976|NCT00095641|Capecitabine|capecitabine|mesh-list
56294977|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294978|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
56294979|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294980|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294981|NCT00006269|Irinotecan|irinotecan|mesh-list
56294982|NCT00006269|Octreotide|octreotide|mesh-list
56294983|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56294984|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56294985|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294986|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294987|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934790|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
56294992|NCT04476030|Sertraline|sertraline|mesh-list
56294993|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56294994|NCT04476030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56294995|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56294996|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56905436|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
56905437|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56905438|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56905439|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56905440|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905441|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905442|NCT03555136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56905443|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56522722|NCT01259466|Nicotine|nicotine|mesh-list
56294997|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294998|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294999|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
56295000|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295001|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56295002|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
56295003|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56295004|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295005|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56295006|NCT04476030|Analgesics|analgesics|mesh-ancestor
56295007|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
56295008|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
56295009|NCT00095680|Bortezomib|bortezomib|mesh-list
56295010|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295011|NCT00095719|Aripiprazole|aripiprazole|mesh-list
56295012|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
56295013|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56295014|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56295015|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56295016|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56295017|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295018|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
56295019|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
56295020|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56295021|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295022|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56295023|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56295024|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
56295025|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56295026|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56295027|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56295028|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56295030|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
56295031|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56295032|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56295033|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56295034|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56295035|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295036|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
56295037|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
56295038|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56295039|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295040|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56295041|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56295042|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
55917001|NCT05063370|Simendan|simendan|mesh-list
56295043|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56295044|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56295045|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56295046|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56295047|NCT00095914|Paclitaxel|paclitaxel|mesh-list
56295048|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56295049|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56295050|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295051|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905444|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56905445|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905446|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905447|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
56905448|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56522787|NCT04514484|Nivolumab|nivolumab|mesh-list
56295052|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
56295053|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
56295054|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295055|NCT04432428|Sufentanil|sufentanil|mesh-list
56295056|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56295057|NCT04432428|Narcotics|narcotics|mesh-ancestor
56295078|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
56295079|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295080|NCT00006275|Calcitriol|calcitriol|mesh-list
56295081|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56295082|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295083|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56295084|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56295085|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295086|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56295087|NCT00006275|Vitamins|vitamins|mesh-ancestor
56295088|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
56295089|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56295090|NCT00096148|Cytarabine|cytarabine|mesh-list
56295091|NCT00096148|Bevacizumab|bevacizumab|mesh-list
56295092|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56295093|NCT00096148|Idarubicin|idarubicin|mesh-list
56295094|NCT00096148|Antibodies|antibodies|mesh-list
56295095|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
56295096|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56295097|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295098|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56295099|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56295100|NCT00096148|Growth Substances|growth substances|mesh-ancestor
56295101|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295102|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
56295104|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56295105|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
56295106|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295107|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
56295108|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295109|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295110|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56295111|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56295112|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56295113|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295114|NCT00096187|Pemetrexed|pemetrexed|mesh-list
56295121|NCT00096304|Epirubicin|epirubicin|mesh-list
56295122|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295123|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
56295124|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
56295125|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
56295126|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295127|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56295128|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56295129|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56295130|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295131|NCT00096343|Paclitaxel|paclitaxel|mesh-list
56295132|NCT00096343|Carboplatin|carboplatin|mesh-list
56295133|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56295134|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295135|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
56295136|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
56295137|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
56295138|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295140|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56295141|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
56295142|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522855|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295143|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295144|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56295145|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
56295146|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
56295147|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56295148|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56295149|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56295150|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56295151|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
56295152|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56295153|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295154|NCT00096655|Infliximab|infliximab|mesh-list
56295155|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
56295156|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56295157|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295158|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
56295159|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56295160|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
56295161|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56295162|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295163|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56295164|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56295165|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56295166|NCT00006299|Celecoxib|celecoxib|mesh-list
56295167|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56295168|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56295169|NCT00006299|Analgesics|analgesics|mesh-ancestor
56295170|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
56295171|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295172|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295173|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56295174|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295175|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56295176|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56295177|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295178|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295179|NCT00096811|Entecavir|entecavir|mesh-list
56295180|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
56295181|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295182|NCT00096850|Ritonavir|ritonavir|mesh-list
56295183|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56295184|NCT00096850|Rifampin|rifampin|mesh-list
56295191|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56295192|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
56295193|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295194|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56295195|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56295196|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56295197|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
56295198|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56295199|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
56295200|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56295201|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56295202|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56295203|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56295204|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56295205|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56295206|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56295208|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56295209|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295210|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56295211|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56295212|NCT00096967|Growth Substances|growth substances|mesh-ancestor
56295213|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295214|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
56295216|NCT04340076|Brodalumab|brodalumab|mesh-list
56295217|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
56295218|NCT00097045|Interferons|interferons|mesh-list
56295219|NCT00097045|Ribavirin|ribavirin|mesh-list
56295220|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
56295221|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295222|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
56905449|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56905450|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56905451|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56295223|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295224|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
56295225|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295226|NCT00097084|Insulin|insulin|mesh-list
56295227|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56295228|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
56295229|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
56295230|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
56295231|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56295232|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295233|NCT04310709|Nivolumab|nivolumab|mesh-list
56295234|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56295235|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295236|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56295237|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295238|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
56295239|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56295240|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
56295241|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295242|NCT00097123|Misoprostol|misoprostol|mesh-list
56295243|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56295244|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
56295245|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56295246|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295247|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56295248|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56295249|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
56295250|NCT00097279|Metformin|metformin|mesh-list
56295251|NCT00097279|Pioglitazone|pioglitazone|mesh-list
56295252|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
56295253|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
56295254|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56295255|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295262|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295264|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295265|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
56295266|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295267|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56295268|NCT00097435|Ribavirin|ribavirin|mesh-list
56295269|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
56295270|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295271|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
56295272|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295274|NCT00006326|Indinavir|indinavir|mesh-list
56295275|NCT00006326|Delavirdine|delavirdine|mesh-list
56295276|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56295277|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56295278|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
56295279|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295280|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295281|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56295282|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56295283|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
56295284|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295285|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56295286|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56295287|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56295288|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56295289|NCT00390312|Morphine|morphine|mesh-list
56295290|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56295291|NCT00390312|Narcotics|narcotics|mesh-ancestor
56295292|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56295293|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295294|NCT00390312|Analgesics|analgesics|mesh-ancestor
56295295|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
56295296|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295297|NCT00400387|Riboflavin|riboflavin|mesh-list
56295298|NCT00400387|Thiamine|thiamine|mesh-list
56295299|NCT00400387|Pyridoxine|pyridoxine|mesh-list
56295300|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
56295301|NCT00400387|Folic Acid|folic acid|mesh-list
56905452|NCT03554980|Listerine|listerine|mesh-list
56905453|NCT03554980|Fluorides|fluorides|mesh-list
56905454|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
56905455|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
56905456|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
56905457|NCT03554980|Protective Agents|protective agents|mesh-ancestor
56905458|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905459|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56271144|NCT02001363|Hormones|hormones|mesh-ancestor
56295302|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
56295303|NCT00400387|Tocopherols|tocopherols|mesh-list
56295304|NCT00400387|Vitamin E|vitamin e|mesh-list
56295305|NCT00400387|Tocotrienols|tocotrienols|mesh-list
56295306|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
56295307|NCT00400387|Heparin|heparin|mesh-list
56295308|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56295309|NCT00400387|Tinzaparin|tinzaparin|mesh-list
56295310|NCT00400387|Dalteparin|dalteparin|mesh-list
56295311|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295312|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
56295313|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56295314|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56295315|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295316|NCT00400387|Vitamins|vitamins|mesh-ancestor
56295317|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
56295318|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56295319|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
56295320|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
56295321|NCT00400387|Protective Agents|protective agents|mesh-ancestor
56295322|NCT00400387|Hematinics|hematinics|mesh-ancestor
56295323|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56295324|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
56295325|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
56295326|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295327|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295328|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56295329|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56295330|NCT00006332|Growth Substances|growth substances|mesh-ancestor
56295334|NCT00390390|Lansoprazole|lansoprazole|mesh-list
56295335|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
56295336|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56295337|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56295338|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56295339|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295340|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295341|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
56295342|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56295343|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295344|NCT00097903|Camptothecin|camptothecin|mesh-list
56295345|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56295346|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917297|NCT04341090|Apatinib|apatinib|mesh-list
56295347|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56295348|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56295349|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295350|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295351|NCT00097942|Memantine|memantine|mesh-list
56295352|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56295353|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56295354|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
56295355|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56295356|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295357|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295358|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56295359|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56295360|NCT04294836|Curcumin|curcumin|mesh-list
56295361|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56295362|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56295363|NCT04294836|Analgesics|analgesics|mesh-ancestor
56295364|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
56077324|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
56905460|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905461|NCT04230213|Adalimumab|adalimumab|mesh-list
56905462|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905463|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56905464|NCT03746691|Citalopram|citalopram|mesh-list
56905465|NCT03746691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56523066|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
56295365|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295366|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295367|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56295368|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295369|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295370|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295371|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295372|NCT00098137|Olmesartan|olmesartan|mesh-list
56295373|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56295374|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56295375|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56295376|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295377|NCT00098488|Rituximab|rituximab|mesh-list
56295378|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56295379|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295380|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
56295381|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295382|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295383|NCT00098527|Romidepsin|romidepsin|mesh-list
56295384|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56295385|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295386|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56295387|NCT00006347|Antibodies|antibodies|mesh-list
56295388|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
56295389|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56295390|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
56295391|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295392|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295393|NCT00098605|Lapatinib|lapatinib|mesh-list
56295394|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295395|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56295396|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295397|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295398|NCT04290546|Ipilimumab|ipilimumab|mesh-list
56295399|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55935197|NCT00976521|Abciximab|abciximab|mesh-list
56295401|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295402|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295404|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56295405|NCT00098683|Protective Agents|protective agents|mesh-ancestor
56295406|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295407|NCT00098800|Fenretinide|fenretinide|mesh-list
56295408|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295409|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56295410|NCT00098800|Protective Agents|protective agents|mesh-ancestor
56295411|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295413|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295414|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56295415|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56295416|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295417|NCT00098917|Vaccines|vaccines|mesh-list
56295418|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
56295419|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295420|NCT00098995|Tirapazamine|tirapazamine|mesh-list
56295421|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295422|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
56295423|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295424|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56295425|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56295426|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295427|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295428|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
56905466|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56905467|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56905468|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295429|NCT04231851|Cytarabine|cytarabine|mesh-list
56295430|NCT04231851|Daunorubicin|daunorubicin|mesh-list
56295431|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56295432|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
56295433|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083310|NCT02252406|Ranolazine|ranolazine|mesh-list
56295434|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295435|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
56295436|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295437|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295438|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
56295439|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295440|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56295441|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56295442|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56295443|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295444|NCT00099502|Interferons|interferons|mesh-list
56295445|NCT00099502|Interferon-beta|interferon-beta|mesh-list
56295446|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
56295447|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
56295448|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295449|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
56295450|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295451|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
56295452|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295453|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56295454|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295455|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295456|NCT00387920|Sunitinib|sunitinib|mesh-list
56295457|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295458|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56295459|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56295460|NCT00387920|Growth Substances|growth substances|mesh-ancestor
56295461|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295462|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
56295463|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56295464|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295465|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295466|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
56295467|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56295468|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295469|NCT02888067|Bromides|bromides|mesh-list
56295470|NCT02888067|Rocuronium|rocuronium|mesh-list
56295471|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
56295472|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56295473|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56295476|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295477|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
56295478|NCT00006350|Tacrolimus|tacrolimus|mesh-list
56295479|NCT00006350|Daclizumab|daclizumab|mesh-list
56295480|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295481|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
56295482|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295483|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56295484|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295485|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295486|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56295487|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295488|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56295489|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
56295490|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56295491|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295492|NCT00400582|Candesartan|candesartan|mesh-list
56295493|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56295494|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56295495|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56295496|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295497|NCT00400621|Acetaminophen|acetaminophen|mesh-list
56905469|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905470|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
56905471|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905472|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56905473|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
56905474|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56905475|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56905476|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56905477|NCT03745911|Paclitaxel|paclitaxel|mesh-list
56523208|NCT01296932|BI 836826|bi 836826|mesh-list
56295498|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56295500|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
56295501|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295502|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295503|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
56295504|NCT00006353|Temozolomide|temozolomide|mesh-list
56295505|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56295506|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
56295507|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295508|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295510|NCT00400738|Lopinavir|lopinavir|mesh-list
56295511|NCT00400738|Saquinavir|saquinavir|mesh-list
56295512|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56295513|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56295514|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
56295515|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295516|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295517|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56295518|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56295519|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
56295520|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295521|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56295522|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56295523|NCT00006356|Carboplatin|carboplatin|mesh-list
56295524|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295525|NCT00099619|Insulin|insulin|mesh-list
56295526|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56295527|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
56295528|NCT00099619|Exenatide|exenatide|mesh-list
56295529|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56295530|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295531|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56295532|NCT00099619|Incretins|incretins|mesh-ancestor
56295533|NCT00099619|Hormones|hormones|mesh-ancestor
56295534|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56295535|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
56295536|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
56295537|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56295538|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295539|NCT00099736|Cyclosporine|cyclosporine|mesh-list
56295540|NCT00099736|Cyclosporins|cyclosporins|mesh-list
56295541|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56295542|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
56295543|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295544|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
56295545|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295546|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295547|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295548|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
56295551|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56295552|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56295553|NCT04143711|Paclitaxel|paclitaxel|mesh-list
56295554|NCT04143711|Nivolumab|nivolumab|mesh-list
56295555|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56295556|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295557|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905478|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56905479|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905480|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905481|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905482|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
56905483|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905484|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56905485|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56295558|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
56295559|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333999|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295560|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295561|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56295562|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56295563|NCT00099775|Caspofungin|caspofungin|mesh-list
56295564|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
56295565|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295566|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088481|NCT04737889|Rituximab|rituximab|mesh-list
56295567|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295568|NCT00006362|Bortezomib|bortezomib|mesh-list
56295569|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295570|NCT00099892|Vildagliptin|vildagliptin|mesh-list
56295571|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56295572|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917522|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295573|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56295574|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
56295575|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295576|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295577|NCT00099931|Vildagliptin|vildagliptin|mesh-list
56295578|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56295579|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295580|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56295581|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
56295582|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295583|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295584|NCT00099970|Dacarbazine|dacarbazine|mesh-list
56295585|NCT00099970|Volociximab|volociximab|mesh-list
56295586|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56295587|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
56295588|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295589|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295590|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56295591|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56295592|NCT00099970|Growth Substances|growth substances|mesh-ancestor
56295593|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295594|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
56295595|NCT00100009|Triamcinolone|triamcinolone|mesh-list
56295596|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56295597|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56295598|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56295599|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56295600|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
56295601|NCT00100009|Hormones|hormones|mesh-ancestor
56295602|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56295603|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295604|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295605|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
56295606|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295607|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295608|NCT00100126|Amoxicillin|amoxicillin|mesh-list
56905486|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905487|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56905488|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905489|NCT03554590|Insulin|insulin|mesh-list
56905490|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56905491|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295609|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56295610|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295611|NCT00100243|Abarelix|abarelix|mesh-list
56295612|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
56295613|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56295614|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295615|NCT04071756|Tazarotene|tazarotene|mesh-list
56295616|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
56295617|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
56295621|NCT00100477|Etoposide|etoposide|mesh-list
56295622|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
56295623|NCT00100477|Topotecan|topotecan|mesh-list
56295624|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56295625|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295626|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56295627|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56295628|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295629|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295630|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56295631|NCT00100477|Analgesics|analgesics|mesh-ancestor
56295632|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
56295633|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295634|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295636|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56295637|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295638|NCT00006371|Ketoconazole|ketoconazole|mesh-list
56295639|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
56295640|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56295641|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56295642|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56295643|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
56295644|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56295645|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
56295646|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295647|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56295648|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56295649|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295650|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295651|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56295652|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
56295653|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56295654|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295655|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56295656|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56295657|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295658|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56295659|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56295660|NCT04062708|Durvalumab|durvalumab|mesh-list
56295661|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56295662|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295663|NCT00100594|Lamivudine|lamivudine|mesh-list
56295664|NCT00100594|Zidovudine|zidovudine|mesh-list
56295665|NCT00100594|Efavirenz|efavirenz|mesh-list
56295666|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56295667|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56295668|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56295669|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295670|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295671|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
56295672|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295673|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56905492|NCT02106286|Bisoprolol|bisoprolol|mesh-list
56905493|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56616155|NCT00657709|Vaccines|vaccines|mesh-list
56905494|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
56905495|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
56905496|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905497|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905498|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56905499|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56905500|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56295674|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56295675|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
56295676|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56295677|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56295678|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56295679|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56295680|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56295681|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56295682|NCT00006374|Paclitaxel|paclitaxel|mesh-list
56295683|NCT00006374|Etoposide|etoposide|mesh-list
56295684|NCT00006374|Topotecan|topotecan|mesh-list
56295685|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56295686|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295687|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
56295688|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
56295690|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295691|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56295692|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56295693|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295694|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56295695|NCT00100750|Gemcitabine|gemcitabine|mesh-list
56295696|NCT00100750|Tipifarnib|tipifarnib|mesh-list
56295697|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56295698|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
56295699|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295700|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295701|NCT00100750|Antiviral Agents|antiviral agents|mesh-ancestor
56295702|NCT00100750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295703|NCT00100750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295704|NCT00100750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295705|NCT00100750|Immunologic Factors|immunologic factors|mesh-ancestor
56295706|NCT00100750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295707|NCT00006377|Paclitaxel|paclitaxel|mesh-list
56295708|NCT00006377|Carboplatin|carboplatin|mesh-list
56295709|NCT00006377|Doxorubicin|doxorubicin|mesh-list
56295710|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56295711|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56295712|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295713|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
56295714|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
56295715|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
56295716|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295717|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56295718|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56295719|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55917702|NCT02816424|TEMPO|tempo|mesh-list
56295720|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295721|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
56295722|NCT01350102|Bacitracin|bacitracin|mesh-list
56295723|NCT01350102|Vitamins|vitamins|mesh-ancestor
56295724|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
56295725|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295726|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
56295727|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295728|NCT01350102|Protective Agents|protective agents|mesh-ancestor
56295729|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56905501|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
56905502|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905503|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905504|NCT04109391|Trastuzumab|trastuzumab|mesh-list
56295730|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295731|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56295732|NCT00424060|Sagopilone|sagopilone|mesh-list
56295733|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295734|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56295735|NCT00006380|Antibodies|antibodies|mesh-list
56295736|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
56295737|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56295738|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
56295739|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295740|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295741|NCT00100906|Aldesleukin|aldesleukin|mesh-list
56295742|NCT00100906|Interleukin-2|interleukin-2|mesh-list
56295743|NCT00100906|Tretinoin|tretinoin|mesh-list
56295744|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295745|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56295746|NCT00100906|Analgesics|analgesics|mesh-ancestor
56295747|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
56295748|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295749|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295750|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56295751|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56295752|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
56295753|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295754|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
56295755|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56295756|NCT00100945|Gefitinib|gefitinib|mesh-list
56295757|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295758|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56295759|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295760|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295761|NCT00006383|Vincristine|vincristine|mesh-list
56295762|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56295763|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295764|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
56295776|NCT00101062|Celecoxib|celecoxib|mesh-list
56295777|NCT00101062|Letrozole|letrozole|mesh-list
56295778|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295779|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56295780|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56295781|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295782|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295783|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56295784|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
56295785|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56295786|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083642|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
56295787|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56295788|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56295789|NCT00101062|Analgesics|analgesics|mesh-ancestor
56295790|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
56295791|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295792|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56295793|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295794|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56295795|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56295796|NCT00006386|Carmustine|carmustine|mesh-list
56295797|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56295799|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295800|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295801|NCT00101140|Fludarabine|fludarabine|mesh-list
56295802|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
56295803|NCT00101140|Thiotepa|thiotepa|mesh-list
56295804|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56295805|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295806|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56295807|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
56295808|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905505|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56905506|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905507|NCT02106364|Insulin|insulin|mesh-list
56905508|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56905509|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
56905510|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56905511|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905512|NCT04077866|Temozolomide|temozolomide|mesh-list
56905513|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56905514|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
56905515|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295809|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295810|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
56295811|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295812|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56295813|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
56295814|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56295815|NCT00101179|Azacitidine|azacitidine|mesh-list
56295816|NCT00101179|Entinostat|entinostat|mesh-list
56295817|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56295818|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56295819|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
56295820|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295821|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295822|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295823|NCT00400777|Amlodipine|amlodipine|mesh-list
56295824|NCT00400777|Valsartan|valsartan|mesh-list
56295825|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56295826|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56295827|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56295829|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295830|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56295832|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
56295833|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56295834|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56295835|NCT00400777|Diuretics|diuretics|mesh-ancestor
56295836|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
56295837|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56295838|NCT00400816|Temozolomide|temozolomide|mesh-list
56295839|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56295840|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
56295841|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295842|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295843|NCT00400855|Fluticasone|fluticasone|mesh-list
56295844|NCT00400855|Xhance|xhance|mesh-list
56295845|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56295846|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56295847|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
56295848|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295849|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295850|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56295851|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
56295852|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
56295853|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56295854|NCT00101296|Tipifarnib|tipifarnib|mesh-list
56295855|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295856|NCT00006398|Timolol|timolol|mesh-list
56295857|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295858|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56295859|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56295860|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
56295861|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56295862|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077325|NCT02444936|Vaccines|vaccines|mesh-list
56905516|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295863|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56295864|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56295866|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56295867|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56295868|NCT00101335|Analgesics|analgesics|mesh-ancestor
56295869|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
55917832|NCT02693184|Vitamin D|vitamin d|mesh-list
56295870|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295871|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295872|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56295873|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295874|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56295875|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56295876|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295877|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295878|NCT00101374|Leflunomide|leflunomide|mesh-list
56295879|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295880|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295881|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295882|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
56295883|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295884|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
56295885|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56295886|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
56295887|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295888|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295889|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56295890|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
56295891|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56295892|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
56295893|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295894|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56295895|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56295896|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
56295897|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
56295898|NCT00006401|Protective Agents|protective agents|mesh-ancestor
56295902|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56295903|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56295904|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56295905|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295906|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
56295908|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56295909|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295910|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56295911|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56295912|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
56295913|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56295914|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56295915|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56295916|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56295917|NCT03991884|Prednisone|prednisone|mesh-list
56295918|NCT03991884|Cortisone|cortisone|mesh-list
56295919|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
56295920|NCT03991884|Doxorubicin|doxorubicin|mesh-list
56295921|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56295922|NCT03991884|Etoposide|etoposide|mesh-list
56295923|NCT03991884|Vincristine|vincristine|mesh-list
56295924|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
56295925|NCT03991884|Daunorubicin|daunorubicin|mesh-list
56295926|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
56295927|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56295928|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295929|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
56334000|NCT00064623|Capsaicin|capsaicin|mesh-list
56295930|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295931|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295932|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56295933|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
56295934|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295935|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295936|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56295937|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56295938|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56905517|NCT02101138|Pramipexole|pramipexole|mesh-list
56905518|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
56295939|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56295940|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295941|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56295942|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
56295943|NCT03991884|Hormones|hormones|mesh-ancestor
56295944|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56295945|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56295946|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56295947|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
56295948|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
56295949|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
56295950|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
56295951|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
56295952|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56295954|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56295955|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56295956|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56295957|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56295958|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
56295959|NCT00101764|Hormones|hormones|mesh-ancestor
56295960|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56295961|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295962|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295963|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
56295964|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295965|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295966|NCT00101803|Vildagliptin|vildagliptin|mesh-list
56295967|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56295968|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295969|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56295970|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
56295976|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56295977|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
56295978|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295979|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295980|NCT00101842|Antiviral Agents|antiviral agents|mesh-ancestor
56295981|NCT00101842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295982|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295983|NCT00101842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295984|NCT00101842|Immunologic Factors|immunologic factors|mesh-ancestor
56295985|NCT00101842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295986|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56295987|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56295988|NCT00102115|Talaporfin|talaporfin|mesh-list
56295989|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295990|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56295991|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
56295992|NCT00102154|Gaboxadol|gaboxadol|mesh-list
56295993|NCT00102154|Analgesics|analgesics|mesh-ancestor
56295994|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
56295995|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295996|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295997|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
56295998|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
56295999|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
56296000|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296001|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296002|NCT00102271|Oxypurinol|oxypurinol|mesh-list
56296003|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296004|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296006|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56296007|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296008|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296009|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
56296010|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296011|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296012|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56296013|NCT00102388|Vildagliptin|vildagliptin|mesh-list
56296014|NCT00102388|Gliclazide|gliclazide|mesh-list
56296015|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56296016|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905519|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296017|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56296018|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
56296019|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296020|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296021|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
56296022|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296023|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56296024|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
56296025|NCT00102583|Cyclosporine|cyclosporine|mesh-list
56296026|NCT00102583|Cyclosporins|cyclosporins|mesh-list
56296027|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296028|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296029|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296030|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
56296031|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296032|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
56296033|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296034|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56296035|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56296036|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56296037|NCT00102622|Paclitaxel|paclitaxel|mesh-list
56296038|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56296039|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296040|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
56296041|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
56296042|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
56296054|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56296055|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56296056|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296057|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
56296058|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296059|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
56296060|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56296061|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296062|NCT00102700|Gemcitabine|gemcitabine|mesh-list
56296063|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
56296064|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296065|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
56296066|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296067|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296068|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
56296069|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296070|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296071|NCT00102700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296072|NCT00102700|Immunologic Factors|immunologic factors|mesh-ancestor
56296073|NCT00102700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296074|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56296075|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56296076|NCT00102778|Ritonavir|ritonavir|mesh-list
56296077|NCT00102778|Lopinavir|lopinavir|mesh-list
56296078|NCT00102778|Aplaviroc|aplaviroc|mesh-list
56036283|NCT02179892|Hormones|hormones|mesh-ancestor
56296079|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56296080|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56296082|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296083|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296084|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56296085|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56296086|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
56296087|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296088|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56296089|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56296090|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56296091|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56296092|NCT00101998|Alvimopan|alvimopan|mesh-list
56296093|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56296094|NCT00102856|Pramipexole|pramipexole|mesh-list
56296095|NCT00102856|Rivastigmine|rivastigmine|mesh-list
56296096|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
56296097|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296098|NCT00102856|Protective Agents|protective agents|mesh-ancestor
56296099|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905520|NCT02101138|Protective Agents|protective agents|mesh-ancestor
56905521|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296100|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56296101|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56296102|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
56296103|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
56296104|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935925|NCT02394834|Growth Substances|growth substances|mesh-ancestor
56296124|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296125|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
56296126|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296127|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56296128|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56296129|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56296130|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56296131|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
56296132|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
56296133|NCT00102973|Carboplatin|carboplatin|mesh-list
56296134|NCT00102973|Doxorubicin|doxorubicin|mesh-list
56296135|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56296136|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296137|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56296138|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56296139|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56296140|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296141|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296142|NCT00103051|Gemcitabine|gemcitabine|mesh-list
56296143|NCT00103051|Gefitinib|gefitinib|mesh-list
56296144|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296145|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296146|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
56296147|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296148|NCT00103051|Antiviral Agents|antiviral agents|mesh-ancestor
56296149|NCT00103051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296150|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296151|NCT00103051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296152|NCT00103051|Immunologic Factors|immunologic factors|mesh-ancestor
56296153|NCT00103051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334001|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
56296155|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
56296156|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296157|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56296158|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296159|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296160|NCT02697474|Vaccines|vaccines|mesh-list
56296161|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
56296162|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296164|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
56296165|NCT00103246|Trace Elements|trace elements|mesh-ancestor
56296166|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
56296167|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296168|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
56296169|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56296170|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56296171|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296173|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56296174|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
56296175|NCT00103324|Lapatinib|lapatinib|mesh-list
56296176|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296177|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56296178|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296179|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296180|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
56296181|NCT00103519|Hormones|hormones|mesh-ancestor
56296182|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56296183|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296184|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
56296185|NCT00103597|Domperidone|domperidone|mesh-list
56296186|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
56296187|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
56296188|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296189|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296190|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56296191|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56296192|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
56296193|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296194|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296195|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56296196|NCT00006449|Naltrexone|naltrexone|mesh-list
56296197|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56296198|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56296199|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296200|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
56296201|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296202|NCT00103753|Deferiprone|deferiprone|mesh-list
56296203|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56296204|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
56296205|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
56296206|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296207|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
56296208|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296209|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56296210|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
56296211|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
56296212|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
56296213|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296214|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
56296215|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296216|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56296217|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56296218|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
56296219|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296220|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296221|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56296222|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56296223|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56296224|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
56296225|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56296226|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296227|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296228|NCT00103948|Donepezil|donepezil|mesh-list
56296229|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56296230|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296231|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296232|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
56296233|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296234|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296235|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
56296236|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56296237|NCT00006458|Antibodies|antibodies|mesh-list
56296238|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
56296242|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296243|NCT03879408|Acetaminophen|acetaminophen|mesh-list
56296244|NCT03879408|Naproxen|naproxen|mesh-list
56296245|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56296246|NCT03879408|Hydrocodone|hydrocodone|mesh-list
56296247|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56296248|NCT03879408|Analgesics|analgesics|mesh-ancestor
56296249|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
56296250|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296251|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296252|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
56296253|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56296254|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56296255|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56296256|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
56296257|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56296258|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296259|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296260|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56296261|NCT03879408|Narcotics|narcotics|mesh-ancestor
56296262|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56296263|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
56296264|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
56296265|NCT00104182|Insulin|insulin|mesh-list
56296266|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56296267|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
56296268|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
56296269|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
56296270|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
56905522|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56905523|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56905524|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
56523997|NCT01008904|Antacids|antacids|mesh-ancestor
56296271|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56296272|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296273|NCT00104260|Verapamil|verapamil|mesh-list
56296274|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56296275|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56296276|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56296277|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296278|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56296279|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296280|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
56296281|NCT00388076|Paclitaxel|paclitaxel|mesh-list
56296282|NCT00388076|Carboplatin|carboplatin|mesh-list
56296283|NCT00388076|Lapatinib|lapatinib|mesh-list
56296284|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56296285|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296286|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
56296287|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
56296288|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
56296289|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296290|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56296291|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296292|NCT00104689|Capecitabine|capecitabine|mesh-list
56296293|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
56296294|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296295|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
56296296|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296297|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296298|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
56296300|NCT00006461|Vincristine|vincristine|mesh-list
56296301|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
56296302|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296303|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
56296304|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296305|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56296306|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56296307|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
56296308|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296309|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296310|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56296311|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56296314|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296315|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
56296316|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
56296317|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
56296318|NCT00104767|Celecoxib|celecoxib|mesh-list
56296319|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56296320|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56296321|NCT00104767|Analgesics|analgesics|mesh-ancestor
56296322|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
56296323|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296324|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296325|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56296326|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56296327|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56296328|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56296329|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296330|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296331|NCT02972268|Tamsulosin|tamsulosin|mesh-list
56296332|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
56296333|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56296334|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56296335|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56296336|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
56296337|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296338|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296339|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296340|NCT02972268|Urological Agents|urological agents|mesh-ancestor
56905525|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
56905526|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905527|NCT04064294|Levodopa|levodopa|mesh-list
56296341|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56296342|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56296343|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
56296344|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
56296345|NCT00104806|Vitamin D|vitamin d|mesh-list
56296346|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
56296347|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56296348|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296349|NCT00104806|Vitamins|vitamins|mesh-ancestor
56296350|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
56296351|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56296352|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296353|NCT00401128|Gemcitabine|gemcitabine|mesh-list
56296354|NCT00401128|Irinotecan|irinotecan|mesh-list
56296355|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296356|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
56296357|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296358|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296359|NCT00401128|Antiviral Agents|antiviral agents|mesh-ancestor
56296360|NCT00401128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296361|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296362|NCT00401128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296363|NCT00401128|Immunologic Factors|immunologic factors|mesh-ancestor
56296364|NCT00401128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296365|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56296366|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56296367|NCT00401167|Memantine|memantine|mesh-list
56296368|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56296369|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56296370|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
56296371|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296372|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296373|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296374|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56296375|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56296376|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56296377|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296378|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56296379|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296380|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296382|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
56296383|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296384|NCT03869892|Trifluridine|trifluridine|mesh-list
56296385|NCT03869892|Bevacizumab|bevacizumab|mesh-list
56296388|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296389|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56296390|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56296391|NCT03869892|Growth Substances|growth substances|mesh-ancestor
56296392|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296393|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
56296394|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296396|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296397|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
56296398|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296399|NCT00104923|Fenretinide|fenretinide|mesh-list
56296400|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296401|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56296402|NCT00104923|Protective Agents|protective agents|mesh-ancestor
56296403|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296404|NCT00104962|Lenalidomide|lenalidomide|mesh-list
56296405|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
56296406|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296407|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56296408|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56296409|NCT00104962|Growth Substances|growth substances|mesh-ancestor
56296410|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
56296411|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296412|NCT00006467|Gemcitabine|gemcitabine|mesh-list
56296413|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296414|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
56905528|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56524123|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
56296415|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296416|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296417|NCT00006467|Antiviral Agents|antiviral agents|mesh-ancestor
56296418|NCT00006467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296419|NCT00006467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296420|NCT00006467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296421|NCT00006467|Immunologic Factors|immunologic factors|mesh-ancestor
56296422|NCT00006467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296423|NCT00105040|Levetiracetam|levetiracetam|mesh-list
56296424|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
56296425|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
56296426|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56296427|NCT00006470|Vaccines|vaccines|mesh-list
56296428|NCT00006470|Antibodies|antibodies|mesh-list
56296429|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
56296430|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56296431|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56296432|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
56296433|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296434|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296435|NCT00105352|Glucagon|glucagon|mesh-list
56296436|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56296437|NCT00105352|Hormones|hormones|mesh-ancestor
56296438|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56296439|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296440|NCT03862950|Metformin|metformin|mesh-list
56296441|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56296442|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296443|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
56296444|NCT00105547|Analgesics|analgesics|mesh-ancestor
56296445|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
56296446|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296447|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296448|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56296449|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56296450|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56296451|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56296452|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56296453|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296454|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296455|NCT00390624|Mannitol|mannitol|mesh-list
56296456|NCT00390624|Ularitide|ularitide|mesh-list
56296457|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56296458|NCT00390624|Diuretics|diuretics|mesh-ancestor
56296459|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
56296463|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296465|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
56296466|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
56296467|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296468|NCT00006476|Suramin|suramin|mesh-list
56296469|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
55918428|NCT01408043|Plerixafor|plerixafor|mesh-list
56296470|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
56296471|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56296472|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296473|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296474|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56296475|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56296476|NCT00105937|Fentanyl|fentanyl|mesh-list
56296477|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56296478|NCT00105937|Narcotics|narcotics|mesh-ancestor
56296479|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56296480|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296481|NCT00105937|Analgesics|analgesics|mesh-ancestor
56296482|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
56296483|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296484|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56296485|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56296486|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
56296487|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
56296488|NCT00006479|Leucovorin|leucovorin|mesh-list
56296489|NCT00006479|Fluorouracil|fluorouracil|mesh-list
56296490|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
56296491|NCT00006479|Calcium|calcium|mesh-list
56296492|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
56077326|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
56905529|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56905530|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
56905531|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905532|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296493|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56296494|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296495|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
56296496|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296497|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296498|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296499|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296500|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
56296501|NCT00006479|Antidotes|antidotes|mesh-ancestor
56296502|NCT00006479|Protective Agents|protective agents|mesh-ancestor
56296503|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
56296504|NCT00006479|Vitamins|vitamins|mesh-ancestor
56296505|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
56296506|NCT00106054|Leucovorin|leucovorin|mesh-list
56296507|NCT00106054|Bevacizumab|bevacizumab|mesh-list
56296508|NCT00106054|Irinotecan|irinotecan|mesh-list
56296509|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56296510|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296511|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56296512|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56296513|NCT00106054|Growth Substances|growth substances|mesh-ancestor
56296514|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296515|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
56296516|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56296517|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56296518|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296519|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296520|NCT00106054|Antidotes|antidotes|mesh-ancestor
56296521|NCT00106054|Protective Agents|protective agents|mesh-ancestor
56296522|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
56296523|NCT00106054|Vitamins|vitamins|mesh-ancestor
56296524|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
56296525|NCT00106132|Triamcinolone|triamcinolone|mesh-list
56296526|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56296527|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56296528|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56296529|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56296530|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
56296531|NCT00106132|Hormones|hormones|mesh-ancestor
56296532|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56296533|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296537|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296538|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56296540|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296541|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
56296542|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56296543|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296544|NCT00106288|Amphotericin B|amphotericin b|mesh-list
56296545|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56296547|NCT00106288|Amebicides|amebicides|mesh-ancestor
56296548|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56296549|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56296550|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296551|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56296552|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
56296554|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296555|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296556|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
56296557|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296558|NCT00006482|Antiviral Agents|antiviral agents|mesh-ancestor
56296559|NCT00006482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296560|NCT00006482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296561|NCT00006482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296562|NCT00006482|Immunologic Factors|immunologic factors|mesh-ancestor
56296563|NCT00006482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296565|NCT03809988|Fulvestrant|fulvestrant|mesh-list
56296566|NCT03809988|Palbociclib|palbociclib|mesh-list
56296567|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905533|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905534|NCT02106520|Bevacizumab|bevacizumab|mesh-list
56272407|NCT05778227|Eusol|eusol|mesh-list
56296568|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56296569|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56296570|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296571|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296572|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56296573|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
56296574|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56296575|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296576|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56296577|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56296578|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56296579|NCT00106366|Insulin|insulin|mesh-list
56296580|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56296581|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
56296582|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
56296583|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
56296584|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56296585|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296586|NCT00106405|Memantine|memantine|mesh-list
56296587|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56296588|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56296589|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
56296590|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296591|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296592|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296593|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56296594|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56296595|NCT00006485|Irinotecan|irinotecan|mesh-list
56296596|NCT00006485|Alvocidib|alvocidib|mesh-list
56296597|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56296598|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56296599|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296600|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296601|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296602|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
56296603|NCT00006485|Growth Substances|growth substances|mesh-ancestor
56296604|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296605|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56296606|NCT00106522|Methotrexate|methotrexate|mesh-list
56296607|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55936408|NCT01004991|Hormones|hormones|mesh-ancestor
56296610|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296611|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296612|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
56296613|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296614|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296615|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
56296616|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296617|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56296618|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296619|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
56296620|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56296621|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56296622|NCT00106561|Irbesartan|irbesartan|mesh-list
56296623|NCT00106561|Spironolactone|spironolactone|mesh-list
56296624|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56296625|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
55918575|NCT03027284|Gemcitabine|gemcitabine|mesh-list
56296626|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56296627|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296628|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56296629|NCT00106561|Diuretics|diuretics|mesh-ancestor
56296630|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
56296631|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56296632|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56296633|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56296634|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296635|NCT00106600|Pixantrone|pixantrone|mesh-list
56905535|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56905536|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296636|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56296637|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56296638|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296639|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296640|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296641|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
56296642|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56296643|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56296644|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296645|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56296646|NCT00401206|Analgesics|analgesics|mesh-ancestor
56296647|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
56296648|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296649|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56296650|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56296651|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56296652|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
56296653|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296654|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296655|NCT00401323|Docetaxel|docetaxel|mesh-list
56296656|NCT00401323|Fluorouracil|fluorouracil|mesh-list
56296657|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296658|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
56296659|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
56296660|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
56296661|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296662|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
56296663|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296665|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
56296666|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296667|NCT00401362|Naltrexone|naltrexone|mesh-list
56296668|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
56296669|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56296670|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296671|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
56296672|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296673|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56296674|NCT00106834|Infliximab|infliximab|mesh-list
56296675|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
56296676|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56296677|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56296678|NCT03746106|Thiamine|thiamine|mesh-list
56296679|NCT03746106|Metformin|metformin|mesh-list
56296680|NCT03746106|Trimethoprim|trimethoprim|mesh-list
56296684|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56296685|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
56296686|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56296687|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296688|NCT03746106|Renal Agents|renal agents|mesh-ancestor
56296689|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
56296690|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56296691|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56296692|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56296693|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296694|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296695|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56296696|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56296697|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56296698|NCT00107107|Pramlintide|pramlintide|mesh-list
56296699|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56296700|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296701|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
56296703|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296704|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56296705|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56296706|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296707|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296708|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56296709|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
56296710|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078468|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
56905537|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56905538|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56905539|NCT02106520|Growth Substances|growth substances|mesh-ancestor
56296711|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296712|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56296713|NCT02964949|Edoxaban|edoxaban|mesh-list
56296714|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56296715|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
56296716|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56296717|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
56296718|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296719|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296720|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
56296721|NCT00107341|Paclitaxel|paclitaxel|mesh-list
56296722|NCT00107341|Carboplatin|carboplatin|mesh-list
56296723|NCT00107341|Bortezomib|bortezomib|mesh-list
56296724|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56296725|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296726|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
56296727|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
56296728|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
56296729|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296730|NCT00107419|Pemetrexed|pemetrexed|mesh-list
56296731|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296732|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296733|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296734|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56296735|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56296736|NCT03683667|Azithromycin|azithromycin|mesh-list
56296737|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56296738|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296739|NCT00006578|Ritonavir|ritonavir|mesh-list
56296740|NCT00006578|Amprenavir|amprenavir|mesh-list
56296741|NCT00006578|Lamivudine|lamivudine|mesh-list
56296742|NCT00006578|Abacavir|abacavir|mesh-list
56296743|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56296744|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56296745|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
56296746|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296747|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296748|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56296749|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56296750|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
56296751|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296752|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56296753|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56296754|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56296755|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56296757|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
56296758|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56296759|NCT00107458|Valproic Acid|valproic acid|mesh-list
56296760|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
56296761|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296762|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296763|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
56296764|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296765|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296766|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
56296767|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56296768|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56296769|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56296770|NCT00006617|Lamivudine|lamivudine|mesh-list
56296771|NCT00006617|Zidovudine|zidovudine|mesh-list
56296772|NCT00006617|Abacavir|abacavir|mesh-list
56296773|NCT00006617|Amprenavir|amprenavir|mesh-list
56296774|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56296775|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56296776|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296777|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296779|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296780|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56296781|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56296782|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
56078791|NCT00565851|Antiviral Agents|antiviral agents|mesh-ancestor
56905540|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905541|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
56905542|NCT02101216|Abacavir|abacavir|mesh-list
56905543|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
56296783|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56296784|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
56296785|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56296786|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56296787|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56296788|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
56296789|NCT00107731|Valproic Acid|valproic acid|mesh-list
56296790|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56296791|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
56296792|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56296793|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56296794|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56296795|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56296796|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296797|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296798|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296799|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
56296800|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
56296801|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
56296802|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296803|NCT04712396|Itraconazole|itraconazole|mesh-list
56296804|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
56296805|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296806|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56296807|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56296808|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296809|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296810|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56296811|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
56160861|NCT03806556|Coagulants|coagulants|mesh-ancestor
56296812|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56296813|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296814|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56296815|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56296816|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296817|NCT00107809|Modafinil|modafinil|mesh-list
56296818|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56296819|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296820|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56296821|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56296822|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56296823|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296824|NCT00006656|Ethanol|ethanol|mesh-list
56296825|NCT00006656|Carmustine|carmustine|mesh-list
56296826|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56296827|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936623|NCT04432662|Hematinics|hematinics|mesh-ancestor
56296828|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56296829|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296830|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56296832|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296833|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296834|NCT03667482|Cetuximab|cetuximab|mesh-list
56334002|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
56296835|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56296837|NCT00107848|Modafinil|modafinil|mesh-list
56296838|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56296839|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296840|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56296841|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56296842|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56296843|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296844|NCT00006695|Iodine|iodine|mesh-list
56296845|NCT00006695|Cytarabine|cytarabine|mesh-list
56296846|NCT00006695|Etoposide|etoposide|mesh-list
56296847|NCT00006695|Melphalan|melphalan|mesh-list
56296848|NCT00006695|Carmustine|carmustine|mesh-list
56905544|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56905545|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56905546|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524552|NCT01202877|Azacitidine|azacitidine|mesh-list
56296849|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
56296850|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56296851|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296852|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56296853|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56296854|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296855|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296856|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296857|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
56296858|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
56296859|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296860|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296861|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
56296862|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296863|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56296864|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
56296865|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56296866|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56296867|NCT00006695|Trace Elements|trace elements|mesh-ancestor
56296868|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
56296869|NCT00108004|Pramlintide|pramlintide|mesh-list
56296870|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56296871|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296872|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
56296873|NCT00006734|Ifosfamide|ifosfamide|mesh-list
56296874|NCT00006734|Doxorubicin|doxorubicin|mesh-list
56296875|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56296876|NCT00006734|Etoposide|etoposide|mesh-list
56296877|NCT00006734|Vincristine|vincristine|mesh-list
56296878|NCT00006734|Lenograstim|lenograstim|mesh-list
56296879|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296880|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
56296881|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296882|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56296883|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56296884|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
56296885|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296886|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296887|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56296888|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56296889|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56296890|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56296891|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296892|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56296893|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56296894|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56296895|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56296896|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56296897|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56296899|NCT00108238|Progesterone|progesterone|mesh-list
56296900|NCT00108238|Estrogens|estrogens|mesh-ancestor
56296901|NCT00108238|Hormones|hormones|mesh-ancestor
56296902|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936696|NCT05592951|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56296909|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56296911|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56296912|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296913|NCT00108316|Fluoxetine|fluoxetine|mesh-list
56296914|NCT00108316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56296915|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56296916|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56296917|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296918|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296919|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
56296920|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296921|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56905547|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905548|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
56905549|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905550|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56296922|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
56296923|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56296924|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56296925|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56296926|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296927|NCT00108394|Pamidronate|pamidronate|mesh-list
56296928|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56296929|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296930|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
56296931|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56296932|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
56296933|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296934|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56296935|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56296936|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56296937|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296938|NCT00401440|Misoprostol|misoprostol|mesh-list
56296939|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56296940|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
56296941|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56296942|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296943|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56296944|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56296945|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
56296946|NCT03620019|Denosumab|denosumab|mesh-list
56296947|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
56296948|NCT03620019|Nivolumab|nivolumab|mesh-list
56296949|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56296950|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296951|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56296952|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296953|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56296954|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296955|NCT00108667|Levodopa|levodopa|mesh-list
56296956|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56296957|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56296958|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
56296959|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56296960|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296961|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296962|NCT00006773|Bortezomib|bortezomib|mesh-list
56296963|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296964|NCT00108706|Candesartan|candesartan|mesh-list
56296965|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56296966|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56296967|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56296968|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296970|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
56296971|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296972|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296973|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
56296974|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296975|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56296976|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296977|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56296978|NCT00006812|Capecitabine|capecitabine|mesh-list
56296979|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56296980|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
56296981|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296982|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296983|NCT00006890|Thalidomide|thalidomide|mesh-list
56296984|NCT00006890|Prednisone|prednisone|mesh-list
56296985|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56296986|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
56296987|NCT00006890|Hormones|hormones|mesh-ancestor
56078888|NCT04329585|Flumazenil|flumazenil|mesh-list
56905551|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56905552|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
56905553|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56524701|NCT00977197|Pregabalin|pregabalin|mesh-list
56296988|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56296989|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296990|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56296991|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56296992|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296993|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
56296994|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
56296995|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56296996|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296997|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56296998|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56296999|NCT00006890|Growth Substances|growth substances|mesh-ancestor
56297000|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
56297001|NCT00108979|Citalopram|citalopram|mesh-list
56297002|NCT00108979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56297003|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56297004|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56297005|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297006|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297007|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
56297008|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297009|NCT00108979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56297010|NCT00108979|Antidepressive Agents|antidepressive agents|mesh-ancestor
56297011|NCT00108979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56297012|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56297013|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56297014|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56297015|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297016|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297017|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56297018|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56297019|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297020|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
56297021|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297022|NCT00109057|Bevacizumab|bevacizumab|mesh-list
56297023|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56297024|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297025|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56297026|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56297027|NCT00109057|Growth Substances|growth substances|mesh-ancestor
56297028|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297029|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
56297030|NCT00109096|Pemetrexed|pemetrexed|mesh-list
56297031|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297032|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297033|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297034|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56297035|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56297036|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
56297037|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56297038|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56297040|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297042|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56297043|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297045|NCT00006929|Paclitaxel|paclitaxel|mesh-list
56297046|NCT00006929|Carboplatin|carboplatin|mesh-list
56297047|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297048|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297049|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297050|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297051|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
55887766|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56905554|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
56297052|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297053|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
56297054|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
56297055|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56297056|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297057|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56297058|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56297059|NCT00006968|Cyclosporine|cyclosporine|mesh-list
56297060|NCT00006968|Pentostatin|pentostatin|mesh-list
56297061|NCT00006968|Cyclosporins|cyclosporins|mesh-list
56297062|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
56297063|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297064|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297065|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297066|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297067|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
56297068|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297069|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
56297070|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297071|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56297072|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297073|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56297074|NCT03595917|Prednisone|prednisone|mesh-list
56297075|NCT03595917|Dasatinib|dasatinib|mesh-list
56297076|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56297077|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
56297078|NCT03595917|Hormones|hormones|mesh-ancestor
56297079|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56297080|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297081|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56297082|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297083|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297084|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297085|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297086|NCT00109408|Methotrexate|methotrexate|mesh-list
56297087|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56297088|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
56297089|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56297090|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297091|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56297092|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
56297093|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297094|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297095|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
56297096|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297097|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56297098|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297099|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
56297100|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297101|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56297102|NCT00109564|Acetylcholine|acetylcholine|mesh-list
56297103|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
56297104|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
56297105|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56297106|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
56297107|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297108|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297109|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297110|NCT00109603|Tenofovir|tenofovir|mesh-list
56297111|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
56297122|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
56297123|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297124|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297125|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56297126|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56297127|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297128|NCT00109954|Cisplatin|cisplatin|mesh-list
56297129|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297130|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
56297131|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56297132|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56297133|NCT00109993|Prednisolone|prednisolone|mesh-list
56297134|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
56297135|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
56905555|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297136|NCT00109993|Tacrolimus|tacrolimus|mesh-list
56297137|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56297138|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
56297139|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297140|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
56297141|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297142|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56297143|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297144|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297145|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56297146|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
56297147|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
56297148|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297149|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297150|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
56297151|NCT00109993|Hormones|hormones|mesh-ancestor
56297152|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56297153|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56297154|NCT00109993|Protective Agents|protective agents|mesh-ancestor
56297155|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56297156|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297157|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56297158|NCT00110032|Etanidazole|etanidazole|mesh-list
56297159|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297160|NCT00110071|Iodine|iodine|mesh-list
56297161|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
56297162|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56297163|NCT00110071|Fludarabine|fludarabine|mesh-list
56297164|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
56297165|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
56297166|NCT00110071|Antibodies|antibodies|mesh-list
56297167|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
56297168|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56297169|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
56297170|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297171|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297172|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56297174|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297175|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297176|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56297177|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297181|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56297182|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297183|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56297184|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297186|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297187|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
56297188|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297189|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56297190|NCT00007202|Didanosine|didanosine|mesh-list
56297191|NCT00007202|Stavudine|stavudine|mesh-list
56297192|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56297193|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56297194|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
56297195|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297196|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297197|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56297198|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56297199|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
56297200|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297201|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
56297202|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56297203|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56297204|NCT00110344|Sorafenib|sorafenib|mesh-list
56297205|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297206|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297207|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297208|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297209|NCT00401479|Solabegron|solabegron|mesh-list
56297210|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56297211|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56297212|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56297213|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
56297214|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905556|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56524913|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
56297215|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297216|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297217|NCT03454035|Palbociclib|palbociclib|mesh-list
56297218|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297219|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297220|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297221|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297222|NCT00110578|Aldesleukin|aldesleukin|mesh-list
56297223|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297224|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56297225|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56297226|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
56297227|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297228|NCT03434262|Gemcitabine|gemcitabine|mesh-list
56297229|NCT03434262|Trametinib|trametinib|mesh-list
56297230|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56297231|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
56297232|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297233|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297234|NCT03434262|Antiviral Agents|antiviral agents|mesh-ancestor
56297235|NCT03434262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297236|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297237|NCT03434262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297238|NCT03434262|Immunologic Factors|immunologic factors|mesh-ancestor
56297239|NCT03434262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297240|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297241|NCT00388193|Rituximab|rituximab|mesh-list
56297242|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56297243|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297244|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
56297245|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297246|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297248|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56297249|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297250|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297251|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297254|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297255|NCT00110734|Lidocaine|lidocaine|mesh-list
56297256|NCT00110734|Tetracaine|tetracaine|mesh-list
56297257|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
56297258|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
56297259|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56297260|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297261|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
56297262|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297263|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56297264|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56297265|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56297266|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56297267|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297268|NCT00110773|Lidocaine|lidocaine|mesh-list
56297269|NCT00110773|Tetracaine|tetracaine|mesh-list
56297270|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
56297271|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
56297272|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56297273|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297274|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
56297275|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297276|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56297277|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56297278|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56297279|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56297280|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297281|NCT00110851|Metformin|metformin|mesh-list
56297282|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
56297283|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56297284|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297285|NCT00110929|Cinacalcet|cinacalcet|mesh-list
56297286|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55887767|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
56905557|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56905558|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297287|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297288|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56297289|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
56297290|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56297291|NCT00111046|Ibuprofen|ibuprofen|mesh-list
56297292|NCT00111046|Tramadol|tramadol|mesh-list
56297293|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56297294|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56297295|NCT00111046|Analgesics|analgesics|mesh-ancestor
56297296|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
56297297|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297298|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297299|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56297300|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297301|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56297302|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297303|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297304|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56297306|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56297307|NCT00388271|Alfuzosin|alfuzosin|mesh-list
56297308|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56297309|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56297310|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56297311|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
56297312|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297313|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297314|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297315|NCT00388271|Urological Agents|urological agents|mesh-ancestor
56297316|NCT00111124|Etanercept|etanercept|mesh-list
56160874|NCT03796260|Entrectinib|entrectinib|mesh-list
56297317|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56297318|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56297320|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
56297321|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297322|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297323|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56297325|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297326|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297327|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
56297328|NCT00111163|Artesunate|artesunate|mesh-list
56297329|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
56297330|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
56297331|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56297332|NCT00111163|Amodiaquine|amodiaquine|mesh-list
56297333|NCT00111163|Dapsone|dapsone|mesh-list
56297334|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
56297335|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
56297336|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56297337|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56297338|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297339|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297340|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
56297341|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
56297342|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56297343|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
56297344|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56297345|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297346|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297347|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56297348|NCT00111163|Renal Agents|renal agents|mesh-ancestor
56297349|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
56297350|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56297351|NCT00111280|Etravirine|etravirine|mesh-list
56297352|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56297353|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56297354|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297355|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297356|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
56297357|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297358|NCT00111319|Bortezomib|bortezomib|mesh-list
56297359|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525058|NCT05661227|Dexmedetomidine|dexmedetomidine|mesh-list
56297360|NCT00111397|Interferons|interferons|mesh-list
56297361|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
56297362|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297363|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
56297364|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297365|NCT00111436|Etanercept|etanercept|mesh-list
56297366|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56297367|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56297368|NCT00111436|Analgesics|analgesics|mesh-ancestor
56297369|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
56297370|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297371|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919326|NCT01270347|Levofloxacin|levofloxacin|mesh-list
56297372|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56297373|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297374|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297375|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297376|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
56297377|NCT00111631|Metformin|metformin|mesh-list
56297378|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56297379|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56297380|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297381|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
56297382|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297383|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297384|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56297385|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
56297386|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297387|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297388|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56297389|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297390|NCT00111748|Thalidomide|thalidomide|mesh-list
56297391|NCT00111748|Dexamethasone|dexamethasone|mesh-list
56297392|NCT00111748|Bortezomib|bortezomib|mesh-list
56297393|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56297394|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
56297395|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
56297396|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297397|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297398|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297399|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
56297402|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56297403|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297404|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297405|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
56297406|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
56297407|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56297408|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297409|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56297410|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56297411|NCT00111748|Growth Substances|growth substances|mesh-ancestor
56297412|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
56297413|NCT00111787|Paclitaxel|paclitaxel|mesh-list
56297414|NCT00111787|Lapatinib|lapatinib|mesh-list
56297415|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297416|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297417|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297418|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297419|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297420|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297421|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297422|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297423|NCT00111904|Paclitaxel|paclitaxel|mesh-list
56297424|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297425|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297426|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297427|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297428|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297429|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297430|NCT00111943|Tenofovir|tenofovir|mesh-list
56297431|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
56297432|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297433|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56297434|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56297435|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905559|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905560|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56905561|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56905562|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
56905563|NCT04642430|Apixaban|apixaban|mesh-list
56905564|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56905565|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
56905566|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56905567|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
56905568|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905569|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905570|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
56905571|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
56297436|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297437|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56297438|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56297439|NCT00401596|Omalizumab|omalizumab|mesh-list
56297440|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56297441|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56297442|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
56297443|NCT00401635|Carboplatin|carboplatin|mesh-list
56297444|NCT00401635|Doxorubicin|doxorubicin|mesh-list
56297445|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56297446|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297447|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56297448|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56297449|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56297450|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297451|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297452|NCT00401674|Paclitaxel|paclitaxel|mesh-list
56297453|NCT00401674|Carboplatin|carboplatin|mesh-list
56297454|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297455|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297456|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297457|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297458|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297459|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297460|NCT00112021|Pramlintide|pramlintide|mesh-list
56297461|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
56297462|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56297463|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297464|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
56297465|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56297466|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
56297467|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297468|NCT00007358|Dexamethasone|dexamethasone|mesh-list
56297469|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56297470|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
56297471|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
56297472|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297477|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56297478|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56297479|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297481|NCT00112138|Analgesics|analgesics|mesh-ancestor
56297482|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
56297483|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297484|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297485|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
56297486|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56297487|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56297488|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56297489|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56079167|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
56905572|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56905573|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56297490|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56297491|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56297492|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297493|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297494|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
56297495|NCT03330639|Capsaicin|capsaicin|mesh-list
56297496|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
56297497|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
56297498|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
56297499|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297500|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297501|NCT00007436|Tenofovir|tenofovir|mesh-list
56297503|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297504|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56297505|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56297506|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297507|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297508|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56297509|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56297510|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56297511|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56297512|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
56297513|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297514|NCT00112372|Sirolimus|sirolimus|mesh-list
56297515|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56297516|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297517|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56297518|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297519|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
56297520|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297521|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
56297522|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297523|NCT00112528|Gemcitabine|gemcitabine|mesh-list
56297524|NCT00112528|Bevacizumab|bevacizumab|mesh-list
56297525|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
56297526|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56297527|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297528|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56297529|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56297530|NCT00112528|Growth Substances|growth substances|mesh-ancestor
56297531|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297532|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
56297533|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56297534|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
56297535|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297536|NCT00112528|Antiviral Agents|antiviral agents|mesh-ancestor
56297537|NCT00112528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297538|NCT00112528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297539|NCT00112528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297540|NCT00112528|Immunologic Factors|immunologic factors|mesh-ancestor
56297541|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
56297543|NCT00007592|Diuretics|diuretics|mesh-ancestor
56297544|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
56297545|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297550|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56297551|NCT00007631|Tretinoin|tretinoin|mesh-list
56297552|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297553|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
56297554|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
56297555|NCT00112567|Fludarabine|fludarabine|mesh-list
56297556|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
56297557|NCT00112567|Thiotepa|thiotepa|mesh-list
56297558|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297559|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56297560|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
56297561|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297562|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297563|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
56297564|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297565|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56905574|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905575|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56297566|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
56297567|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56297568|NCT00112645|Cyclosporine|cyclosporine|mesh-list
56297569|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
56297570|NCT00112645|Methotrexate|methotrexate|mesh-list
56297571|NCT00112645|Melphalan|melphalan|mesh-list
56297572|NCT00112645|Busulfan|busulfan|mesh-list
56297573|NCT00112645|Cyclosporins|cyclosporins|mesh-list
56297574|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56297575|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56297576|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
56037783|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
56297577|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56297578|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297579|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56297580|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
56297581|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297582|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297583|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
56297584|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297585|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56297586|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297587|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
56297588|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297589|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56297590|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
56297591|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297592|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56297593|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56297594|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
56297595|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
56297596|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297597|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297598|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
56297599|NCT00112645|Hormones|hormones|mesh-ancestor
56297600|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56297601|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56297602|NCT00112645|Protective Agents|protective agents|mesh-ancestor
56297603|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56297604|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
56297605|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56297607|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297608|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
56297609|NCT00112684|Growth Substances|growth substances|mesh-ancestor
56297610|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297611|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297612|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297613|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297614|NCT00007670|Lamotrigine|lamotrigine|mesh-list
56297615|NCT00007670|Carbamazepine|carbamazepine|mesh-list
56297620|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297622|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56297623|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56297624|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56297625|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56297626|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56297627|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56297628|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297629|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297630|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
56297631|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56297632|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56297633|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56297634|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56297635|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56297636|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56297637|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56297638|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56297639|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
56297640|NCT00112879|Thalidomide|thalidomide|mesh-list
56297641|NCT00112879|Dexamethasone|dexamethasone|mesh-list
56905576|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56905577|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905578|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905579|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905580|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56905581|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
56905582|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56905583|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905584|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56905585|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56905586|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56905587|NCT01562301|Carboplatin|carboplatin|mesh-list
56905589|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905590|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905591|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905592|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
56905593|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905594|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
56525345|NCT01181271|Sirolimus|sirolimus|mesh-list
56297642|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
56297643|NCT00112879|Mitogens|mitogens|mesh-list
56297644|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56297645|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
56297646|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
56297647|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297648|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297649|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297650|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
56297651|NCT00112879|Hormones|hormones|mesh-ancestor
56037860|NCT03713528|Vancomycin|vancomycin|mesh-list
56297652|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56297653|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56297654|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297655|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297656|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297657|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297658|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
56297659|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
56297660|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56297661|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297662|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56297663|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56297664|NCT00112879|Growth Substances|growth substances|mesh-ancestor
56297665|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
56297666|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
56297667|NCT00112879|Protective Agents|protective agents|mesh-ancestor
56297668|NCT00112879|Vitamins|vitamins|mesh-ancestor
56297669|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
56297670|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
56297671|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
56297672|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297673|NCT00112996|Protective Agents|protective agents|mesh-ancestor
56297674|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297676|NCT00112996|Vitamins|vitamins|mesh-ancestor
56297677|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
56297678|NCT00113074|Nicotine|nicotine|mesh-list
56297679|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56905595|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
56297680|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
56297681|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297682|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297683|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56297684|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56297685|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
56297686|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297687|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297691|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56297692|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297693|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297695|NCT00007787|Tacrolimus|tacrolimus|mesh-list
56297696|NCT00007787|Cyclosporins|cyclosporins|mesh-list
56297697|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
56297698|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297699|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
56297700|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297701|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56297702|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297703|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297704|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
56297705|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297706|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
56297707|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297708|NCT00390897|Interferons|interferons|mesh-list
56297709|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297710|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
56297711|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297712|NCT00113347|Docetaxel|docetaxel|mesh-list
56297713|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56297714|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297715|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297716|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297717|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297718|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297719|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297720|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297721|NCT00113503|Azathioprine|azathioprine|mesh-list
56297722|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
56297723|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297724|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56297725|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297726|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297727|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
56297728|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297729|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297730|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56297731|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
56297732|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
56297733|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297734|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297735|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56297736|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56297737|NCT00113542|Growth Substances|growth substances|mesh-ancestor
56297738|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297739|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
56297740|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297741|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56297743|NCT00007826|Antibodies|antibodies|mesh-list
56297744|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56297745|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
56297746|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
56297747|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
56297748|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297749|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56297750|NCT00007826|Antacids|antacids|mesh-ancestor
55919708|NCT04318392|Dimercaprol|dimercaprol|mesh-list
56297751|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297752|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297754|NCT00007865|Carboplatin|carboplatin|mesh-list
56297755|NCT00007865|Etoposide|etoposide|mesh-list
56297756|NCT00007865|Ifosfamide|ifosfamide|mesh-list
56297757|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56297758|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297759|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
56905596|NCT03260894|Sunitinib|sunitinib|mesh-list
56905597|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56905598|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297760|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297761|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297762|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297763|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56297767|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56297768|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
56297770|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56297771|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
56297772|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297773|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297774|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56297775|NCT00113737|Fluoxetine|fluoxetine|mesh-list
56297776|NCT00113737|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56297777|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56297778|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56297779|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297780|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297781|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
56297782|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297783|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56297784|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
56297785|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56297786|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56297787|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56297788|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297789|NCT03272295|Menthol|menthol|mesh-list
56297790|NCT03272295|Sorbitol|sorbitol|mesh-list
56297791|NCT03272295|Glycerol|glycerol|mesh-list
56297792|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
56297793|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
56297794|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56297795|NCT03272295|Protective Agents|protective agents|mesh-ancestor
56297796|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297797|NCT03272295|Cathartics|cathartics|mesh-ancestor
56297798|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297799|NCT00007904|Tamoxifen|tamoxifen|mesh-list
56297800|NCT00007904|Paclitaxel|paclitaxel|mesh-list
56297801|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
56297802|NCT00007904|Doxorubicin|doxorubicin|mesh-list
56297803|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56297804|NCT00007904|Lenograstim|lenograstim|mesh-list
56038010|NCT02434770|Vaccines|vaccines|mesh-list
56297805|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297806|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297807|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297808|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297809|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297810|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297811|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297812|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
56297813|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297814|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297815|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56297816|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
56297817|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56297818|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56297819|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56297820|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56297821|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297822|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56297823|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56297824|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
55919779|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297825|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56297826|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56297827|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56297828|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56297829|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56905599|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56905600|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56905601|NCT03260894|Growth Substances|growth substances|mesh-ancestor
56297832|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56297833|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297834|NCT00113854|Mannitol|mannitol|mesh-list
56297835|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56297837|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
56297838|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297839|NCT00007943|Gemcitabine|gemcitabine|mesh-list
56297840|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56297841|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
56297842|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297843|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297844|NCT00007943|Antiviral Agents|antiviral agents|mesh-ancestor
56297845|NCT00007943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297846|NCT00007943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297847|NCT00007943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297848|NCT00007943|Immunologic Factors|immunologic factors|mesh-ancestor
56297849|NCT00007943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297850|NCT00113971|Epratuzumab|epratuzumab|mesh-list
56297851|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56297852|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297853|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56297854|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56297855|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
56297856|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297857|NCT00114010|Antacids|antacids|mesh-ancestor
56297858|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297859|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297860|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
56297861|NCT00007982|Thiotepa|thiotepa|mesh-list
56297862|NCT00007982|Carmustine|carmustine|mesh-list
56297863|NCT00007982|Etoposide|etoposide|mesh-list
56297864|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297865|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
56297866|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297867|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297868|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56297869|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
56297870|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297871|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297872|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56297873|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297874|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56297875|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56297876|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297877|NCT00114205|Docetaxel|docetaxel|mesh-list
56297878|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297879|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297880|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297881|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
56160882|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297882|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297883|NCT03094884|Paclitaxel|paclitaxel|mesh-list
56297884|NCT03094884|Carboplatin|carboplatin|mesh-list
56297885|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297886|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297887|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297888|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297889|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297890|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297891|NCT00114283|Lapatinib|lapatinib|mesh-list
56297892|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297893|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297894|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297895|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297896|NCT00114361|Ribavirin|ribavirin|mesh-list
56297897|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56297898|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
55919853|NCT04144933|Acetaminophen|acetaminophen|mesh-list
56297899|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297900|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
56905602|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905603|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
56905604|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56297901|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297902|NCT00114400|Vitamins|vitamins|mesh-list
56297903|NCT00114400|Folic Acid|folic acid|mesh-list
56297904|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
56297905|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
56297906|NCT00114400|Pyridoxal|pyridoxal|mesh-list
56297907|NCT00114400|Pyridoxine|pyridoxine|mesh-list
56297908|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
56297909|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
56297910|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297916|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297917|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
56297918|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56297919|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56297920|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297921|NCT00114478|Epinephrine|epinephrine|mesh-list
56297922|NCT00114478|Albuterol|albuterol|mesh-list
56297923|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56297924|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56297925|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
56297926|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297927|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297928|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297929|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56297930|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56297931|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
56297932|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297933|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56297934|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
56297935|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
56297936|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
56297937|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56297938|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
56297939|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56297940|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56297941|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
56297942|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56297943|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297944|NCT00008021|Cyclosporine|cyclosporine|mesh-list
56297945|NCT00008021|Paclitaxel|paclitaxel|mesh-list
56297946|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56297947|NCT00008021|Antibodies|antibodies|mesh-list
56297948|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
56297949|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56297950|NCT00008021|Cyclosporins|cyclosporins|mesh-list
56297951|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56297952|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297953|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
56297954|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297955|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297956|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297957|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
56297958|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297959|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297960|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297961|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
56297962|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297963|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
56297964|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297965|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56297967|NCT03079440|Temozolomide|temozolomide|mesh-list
56297968|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56297969|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
56297970|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297971|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297972|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56297973|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
56297974|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56297975|NCT00008060|Leucovorin|leucovorin|mesh-list
56297976|NCT00008060|Fluorouracil|fluorouracil|mesh-list
56297977|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
56297978|NCT00008060|Irinotecan|irinotecan|mesh-list
56905605|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525695|NCT01000480|Pemetrexed|pemetrexed|mesh-list
56297979|NCT00008060|Calcium|calcium|mesh-list
56297980|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
56297981|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56297982|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297983|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
56297984|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297986|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297987|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56297988|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
56297989|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56297990|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56297991|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297992|NCT00008060|Antidotes|antidotes|mesh-ancestor
56297993|NCT00008060|Protective Agents|protective agents|mesh-ancestor
56297994|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
56297995|NCT00008060|Vitamins|vitamins|mesh-ancestor
56297996|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
56297997|NCT00114868|Vitamins|vitamins|mesh-list
56297998|NCT00114868|Vitamin A|vitamin a|mesh-list
56297999|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
56298000|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
56298001|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298002|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
56298003|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298004|NCT00114868|Protective Agents|protective agents|mesh-ancestor
56298005|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56298006|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298007|NCT03034200|TIC10 compound|tic10 compound|mesh-list
56298008|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298009|NCT00114946|Bevacizumab|bevacizumab|mesh-list
56298010|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298011|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298012|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56298013|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56298014|NCT00114946|Growth Substances|growth substances|mesh-ancestor
56298015|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298016|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
56298017|NCT00115024|Estradiol|estradiol|mesh-list
56298018|NCT00115024|Estrogens|estrogens|mesh-ancestor
56298019|NCT00115024|Hormones|hormones|mesh-ancestor
56298020|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56298021|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298022|NCT00008177|Iodine|iodine|mesh-list
56298023|NCT00008177|Cyclosporine|cyclosporine|mesh-list
56298024|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
56298025|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56298026|NCT00008177|Fludarabine|fludarabine|mesh-list
56298027|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
56298028|NCT00008177|Antibodies|antibodies|mesh-list
56298029|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
56298030|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56298031|NCT00008177|Cyclosporins|cyclosporins|mesh-list
56298032|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
56298033|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298034|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298035|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298036|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
56298037|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298038|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298039|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298040|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
56298041|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298042|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
56298043|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298044|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56298045|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56298046|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56298047|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
56298048|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56298049|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56298050|NCT00008177|Trace Elements|trace elements|mesh-ancestor
56298051|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
56298052|NCT03007407|Durvalumab|durvalumab|mesh-list
56298053|NCT03007407|Tremelimumab|tremelimumab|mesh-list
56298054|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525762|NCT03637543|Nivolumab|nivolumab|mesh-list
56298055|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298056|NCT00115102|Fentanyl|fentanyl|mesh-list
56298057|NCT00115102|Ketamine|ketamine|mesh-list
56298058|NCT00115102|Esketamine|esketamine|mesh-list
56298059|NCT00115102|Analgesics|analgesics|mesh-ancestor
56298060|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
56298061|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298076|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56298078|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56298079|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56298080|NCT00115219|Analgesics|analgesics|mesh-ancestor
56298081|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
56298082|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298083|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298084|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56298085|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298086|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56298087|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298088|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
56298089|NCT00115375|Clopidogrel|clopidogrel|mesh-list
56298090|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56298091|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56298092|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56298093|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56298094|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
56298095|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298096|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298097|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298098|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
56298099|NCT00115414|Docetaxel|docetaxel|mesh-list
56298100|NCT00115414|Doxorubicin|doxorubicin|mesh-list
56298101|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298102|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
56298103|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298104|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298105|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56298106|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
56298107|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298108|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298109|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56298110|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
56298111|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
56298112|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
56298113|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56298114|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56298115|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56298116|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298117|NCT00115492|Fluticasone|fluticasone|mesh-list
56298118|NCT00115492|Xhance|xhance|mesh-list
56298119|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56298120|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56298121|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56298122|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56298124|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298125|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298126|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56298127|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
56298128|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
56298129|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55920082|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56298130|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56298132|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56298133|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
56298134|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298135|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298136|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
56298137|NCT00115492|Hormones|hormones|mesh-ancestor
56298138|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56298139|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
56298140|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56298141|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56298142|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
56298143|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905606|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905607|NCT04094883|Vaccines|vaccines|mesh-list
56905608|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
56298144|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56298145|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298146|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56298147|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298148|NCT00115531|Vaccines|vaccines|mesh-list
56298149|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
56298150|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298151|NCT00115570|Insulin|insulin|mesh-list
56298152|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56298153|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
56298154|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
56298155|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
56298156|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
56298157|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
56298158|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
56298159|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56298160|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298161|NCT00115609|Tenofovir|tenofovir|mesh-list
56298162|NCT00115609|Emtricitabine|emtricitabine|mesh-list
56298163|NCT00115609|Efavirenz|efavirenz|mesh-list
56298164|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
56298165|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298166|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56298167|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56298168|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298169|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298170|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56298171|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56298172|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56298173|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56298174|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56298175|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56298176|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56298177|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56298178|NCT00115648|Zidovudine|zidovudine|mesh-list
56298179|NCT00115648|Nevirapine|nevirapine|mesh-list
56298180|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
56298181|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298182|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56298183|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56298184|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298185|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
56298186|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298187|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56298188|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56298189|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56298190|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56298191|NCT00008294|Leucovorin|leucovorin|mesh-list
56298192|NCT00008294|Dexamethasone|dexamethasone|mesh-list
56298193|NCT00008294|Fluorouracil|fluorouracil|mesh-list
56298196|NCT00008294|Calcium|calcium|mesh-list
56298197|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
56298198|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56298199|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
56298200|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
56298201|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298202|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298203|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56298204|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
56298205|NCT00008294|Hormones|hormones|mesh-ancestor
56298206|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56298207|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56298208|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298209|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56298210|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
56298211|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298212|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298213|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298214|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
56298215|NCT00008294|Antidotes|antidotes|mesh-ancestor
56905609|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905610|NCT02101606|Tenecteplase|tenecteplase|mesh-list
56905611|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56905612|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56905613|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905614|NCT02101840|Oxycodone|oxycodone|mesh-list
56905615|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56905616|NCT02101840|Narcotics|narcotics|mesh-ancestor
56905617|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905618|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905619|NCT02101840|Analgesics|analgesics|mesh-ancestor
56905620|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
56298216|NCT00008294|Protective Agents|protective agents|mesh-ancestor
56298217|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
56298218|NCT00008294|Vitamins|vitamins|mesh-ancestor
56298219|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
56298220|NCT00115687|Nicotine|nicotine|mesh-list
56298221|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56298222|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
56298223|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298224|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298225|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56298226|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56298227|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
56298228|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298229|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298230|NCT00115726|Furosemide|furosemide|mesh-list
56298231|NCT00115726|Diuretics|diuretics|mesh-ancestor
56298232|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
56298233|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298234|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56298235|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56298236|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298237|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
56298238|NCT00401869|Hematinics|hematinics|mesh-ancestor
56298239|NCT00008333|Vinorelbine|vinorelbine|mesh-list
56298240|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56298241|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298242|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
56298243|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
56298244|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
56298245|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298246|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
56298247|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298248|NCT00115921|Antimalarials|antimalarials|mesh-list
56298249|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56298250|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56298251|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298252|NCT00008411|Docetaxel|docetaxel|mesh-list
56298253|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298254|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
56298255|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
56298256|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
56298257|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298258|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56298259|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56298260|NCT04727671|Cetrorelix|cetrorelix|mesh-list
56298261|NCT04727671|Menotropins|menotropins|mesh-list
56298262|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
56298263|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56298264|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
56298265|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56298266|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298267|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56079168|NCT00002835|Idarubicin|idarubicin|mesh-list
56905621|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905622|NCT02107144|Trimetazidine|trimetazidine|mesh-list
56905623|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
56905624|NCT02107378|Paclitaxel|paclitaxel|mesh-list
56905625|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56905626|NCT02107378|Doxorubicin|doxorubicin|mesh-list
56905627|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56905628|NCT02107378|Topotecan|topotecan|mesh-list
56905629|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56905630|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905631|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905632|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905633|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
56905634|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905635|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56905636|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56905637|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56905638|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905639|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56905640|NCT02105350|Gemcitabine|gemcitabine|mesh-list
56905641|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
56525969|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298268|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56298270|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56298272|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
56298273|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56298274|NCT00008450|Cyclosporine|cyclosporine|mesh-list
56298275|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
56298276|NCT00008450|Cyclosporins|cyclosporins|mesh-list
56298277|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298278|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298279|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920231|NCT03476317|Vancomycin|vancomycin|mesh-list
56298280|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
56298281|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298282|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
56298283|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298284|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
56298285|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298286|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56298287|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56298288|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298289|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56298290|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
56298291|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56298292|NCT00008489|Didanosine|didanosine|mesh-list
56298293|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
56298294|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298295|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56298296|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56298297|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298298|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
56298299|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298300|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56298301|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56905642|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56905643|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
56298302|NCT00116350|Misoprostol|misoprostol|mesh-list
56298303|NCT00116350|Oxytocin|oxytocin|mesh-list
56298304|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
56298305|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56298306|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298307|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56298308|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
56298309|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56298310|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56298311|NCT00116389|Gemcitabine|gemcitabine|mesh-list
56298312|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298313|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
56298314|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298315|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298316|NCT00116389|Antiviral Agents|antiviral agents|mesh-ancestor
56298317|NCT00116389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298318|NCT00116389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298319|NCT00116389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298320|NCT00116389|Immunologic Factors|immunologic factors|mesh-ancestor
56298321|NCT00116389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298322|NCT00116467|Vaccines|vaccines|mesh-list
56298323|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
56298324|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298325|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
56298326|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56298327|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56298328|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298329|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56298330|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56298331|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
56298332|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298333|NCT00116506|Bevacizumab|bevacizumab|mesh-list
56298334|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56298335|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298337|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56298338|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56298339|NCT00116506|Growth Substances|growth substances|mesh-ancestor
56298340|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298341|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
56298342|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56298344|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298346|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56298347|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298348|NCT00116623|Indomethacin|indomethacin|mesh-list
56298349|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
56298350|NCT00116623|Analgesics|analgesics|mesh-ancestor
56298351|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
56298352|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298353|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298354|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
56298355|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56298357|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
56298358|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56298359|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56298360|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298361|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56298362|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
56298363|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56298364|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56298365|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56298366|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56298367|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298368|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
56298369|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56298370|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298371|NCT02909322|Hydromorphone|hydromorphone|mesh-list
56298372|NCT02909322|Bupivacaine|bupivacaine|mesh-list
56298373|NCT02909322|Ropivacaine|ropivacaine|mesh-list
56298374|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
56298375|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
56298376|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905644|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905645|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905646|NCT02105350|Antiviral Agents|antiviral agents|mesh-ancestor
56905647|NCT02105350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526095|NCT01286558|Telmisartan|telmisartan|mesh-list
56298377|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298378|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
56298379|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298380|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56298381|NCT02909322|Narcotics|narcotics|mesh-ancestor
56298382|NCT02909322|Analgesics|analgesics|mesh-ancestor
56298383|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
56298384|NCT00116701|Hematinics|hematinics|mesh-ancestor
56298385|NCT00116896|Cisplatin|cisplatin|mesh-list
56298386|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298387|NCT02752815|Prednisone|prednisone|mesh-list
56298388|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
56298389|NCT02752815|Rituximab|rituximab|mesh-list
56298390|NCT02752815|Vincristine|vincristine|mesh-list
56298391|NCT02752815|Epirubicin|epirubicin|mesh-list
56298392|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298393|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
56298394|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298395|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298396|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56298397|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
56298398|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298399|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298400|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56298401|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298402|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56298403|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
56298404|NCT02752815|Hormones|hormones|mesh-ancestor
56298405|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56298406|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56298407|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56298409|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
56298410|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
56298411|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56298412|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56298413|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56298414|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298415|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
56298416|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298417|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56298418|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938215|NCT03450707|Thiamine|thiamine|mesh-list
56298420|NCT00388388|Losartan|losartan|mesh-list
56298421|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56298422|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56298423|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56298424|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56298425|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56298426|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298427|NCT00388388|Diuretics|diuretics|mesh-ancestor
56298428|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
56298429|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920385|NCT04726878|Acetaminophen|acetaminophen|mesh-list
56298430|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56298431|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56298432|NCT00117013|Topotecan|topotecan|mesh-list
56298433|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56298434|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56298435|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298436|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298437|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298438|NCT02743455|Vaccines|vaccines|mesh-list
56298439|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
56298440|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298441|NCT00117052|Cinacalcet|cinacalcet|mesh-list
56298442|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56905648|NCT02105350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905649|NCT02105350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56905650|NCT02105350|Immunologic Factors|immunologic factors|mesh-ancestor
56905651|NCT02105350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905652|NCT02102152|Tobramycin|tobramycin|mesh-list
56905653|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56905654|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905655|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
56905656|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56905657|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905658|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
56905659|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905660|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56905661|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56905662|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905663|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56526166|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298443|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298444|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56298445|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
56298446|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56298447|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56298448|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298449|NCT02972450|Vedolizumab|vedolizumab|mesh-list
56298450|NCT02972450|Vaccines|vaccines|mesh-list
56298451|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
56298452|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298453|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56298454|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
56298455|NCT00117130|Hematinics|hematinics|mesh-ancestor
56298456|NCT00117208|Mannitol|mannitol|mesh-list
56298457|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56298458|NCT00117208|Diuretics|diuretics|mesh-ancestor
56298459|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
56298460|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298461|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
56298462|NCT00117247|Hematinics|hematinics|mesh-ancestor
56298463|NCT00388427|Cetuximab|cetuximab|mesh-list
56298464|NCT00388427|Dasatinib|dasatinib|mesh-list
56298465|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298466|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298467|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56298468|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298469|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298470|NCT05442463|Angiotensin II|angiotensin ii|mesh-list
56298471|NCT05442463|Giapreza|giapreza|mesh-list
56298472|NCT05442463|Angiotensinogen|angiotensinogen|mesh-list
56298473|NCT05442463|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56298474|NCT05442463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56298475|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
56298476|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298477|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298478|NCT00117364|Sacchachitin|sacchachitin|mesh-list
56298479|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
56298480|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298481|NCT00117364|Protective Agents|protective agents|mesh-ancestor
56905664|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905665|NCT02107690|Lidocaine|lidocaine|mesh-list
56905666|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
56905667|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
56905668|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905669|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905670|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
56905671|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905672|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56905673|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56905674|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56905675|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56905676|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905677|NCT05568836|Vitamin D|vitamin d|mesh-list
56905678|NCT05568836|Vitamins|vitamins|mesh-ancestor
56298482|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298483|NCT00117403|Vitamins|vitamins|mesh-list
56298484|NCT00117403|Vitamin E|vitamin e|mesh-list
56298485|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
56298486|NCT00117403|Coenzyme Q10|coenzyme q10|mesh-list
56298487|NCT00117403|Ubiquinone|ubiquinone|mesh-list
56298489|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298490|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
56298491|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298492|NCT00117403|Protective Agents|protective agents|mesh-ancestor
56298493|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
56298495|NCT00117442|Carboplatin|carboplatin|mesh-list
56298496|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56298497|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298498|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56298499|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56298500|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56298501|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298503|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56298504|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298505|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56298506|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298507|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298508|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56298509|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56298510|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
56298511|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298512|NCT04727515|Fentanyl|fentanyl|mesh-list
56298513|NCT04727515|Isoflurane|isoflurane|mesh-list
56298514|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56298515|NCT04727515|Narcotics|narcotics|mesh-ancestor
56298516|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56298517|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298518|NCT04727515|Analgesics|analgesics|mesh-ancestor
56298519|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
56298520|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298521|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56298522|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56298523|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
56298524|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
56298525|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56298526|NCT00117754|Terbinafine|terbinafine|mesh-list
56298527|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
56298528|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298529|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905679|NCT05568836|Micronutrients|micronutrients|mesh-ancestor
56905680|NCT05568836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905681|NCT05568836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56905682|NCT03259490|Metformin|metformin|mesh-list
56905683|NCT03259490|Empagliflozin|empagliflozin|mesh-list
56905684|NCT03259490|Linagliptin|linagliptin|mesh-list
56905685|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56905686|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905687|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56298530|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298531|NCT00117832|Azelastine|azelastine|mesh-list
56298532|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56298533|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
56298534|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298535|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298536|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56298537|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
56298538|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56298539|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298540|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298541|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56298542|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56298543|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56298544|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
56298545|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
56298546|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298547|NCT05636111|Paclitaxel|paclitaxel|mesh-list
56298548|NCT05636111|Bevacizumab|bevacizumab|mesh-list
56160919|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
56298549|NCT05636111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56298550|NCT05636111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298551|NCT05636111|Tubulin Modulators|tubulin modulators|mesh-ancestor
56298552|NCT05636111|Antimitotic Agents|antimitotic agents|mesh-ancestor
56298553|NCT05636111|Mitosis Modulators|mitosis modulators|mesh-ancestor
56298554|NCT05636111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298555|NCT05636111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298556|NCT05636111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56298557|NCT05636111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56298558|NCT05636111|Growth Substances|growth substances|mesh-ancestor
56298559|NCT05636111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298560|NCT05636111|Growth Inhibitors|growth inhibitors|mesh-ancestor
56298561|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
56298563|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56298564|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
56298565|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56298566|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56298567|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298571|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56298573|NCT00118066|Calcitriol|calcitriol|mesh-list
56298574|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56298575|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298576|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56298577|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56298578|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298579|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56298580|NCT00118066|Vitamins|vitamins|mesh-ancestor
56298581|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
56298582|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56298583|NCT00118105|Bevacizumab|bevacizumab|mesh-list
56298584|NCT00118105|Capecitabine|capecitabine|mesh-list
56298585|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
56298586|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298587|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298588|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56298589|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56298590|NCT00118105|Growth Substances|growth substances|mesh-ancestor
56905688|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298591|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298592|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
56298593|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298594|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
56298595|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298596|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56298598|NCT00118183|Docetaxel|docetaxel|mesh-list
56298599|NCT00118183|Bortezomib|bortezomib|mesh-list
56298600|NCT00118183|Antibodies|antibodies|mesh-list
56298601|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
56298602|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56298603|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
56298604|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298605|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298606|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
56298607|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
56298608|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
56298609|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298610|NCT00390975|Tegaserod|tegaserod|mesh-list
56298611|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56298612|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
56298613|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298614|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298615|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298616|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56298617|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
56298618|NCT00118222|Ether|ether|mesh-list
56298619|NCT00118222|Trioxsalen|trioxsalen|mesh-list
56298620|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56298621|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
56298623|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56298624|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298625|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298626|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56298627|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56298628|NCT00118261|Leucovorin|leucovorin|mesh-list
56298629|NCT00118261|Bevacizumab|bevacizumab|mesh-list
56298630|NCT00118261|Fluorouracil|fluorouracil|mesh-list
56298631|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
56298632|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56298633|NCT00118261|Calcium|calcium|mesh-list
56298634|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
56298635|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298636|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298637|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56298638|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56298639|NCT00118261|Growth Substances|growth substances|mesh-ancestor
56298640|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298641|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
56298658|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298659|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298660|NCT02710734|Doxorubicin|doxorubicin|mesh-list
56298661|NCT02710734|Methotrexate|methotrexate|mesh-list
56298663|NCT02710734|Mitomycin|mitomycin|mesh-list
56298664|NCT02710734|Vinblastine|vinblastine|mesh-list
56298665|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298666|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56298667|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56298668|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56298669|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298670|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298671|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56298672|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
56298673|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56298674|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298675|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298676|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
56298677|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
56298678|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56298679|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298680|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
56298681|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298682|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56905689|NCT03259490|Incretins|incretins|mesh-ancestor
56905690|NCT03259490|Hormones|hormones|mesh-ancestor
56526417|NCT00630097|Modafinil|modafinil|mesh-list
56298683|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
56298684|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56298685|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56298686|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56298687|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56298688|NCT00118690|Fluticasone|fluticasone|mesh-list
56298690|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56298691|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56298692|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56298693|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
56298694|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298695|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298696|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56298697|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
56298698|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
56298699|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56298700|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56298701|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56298702|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56298703|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
56298707|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
56298708|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298709|NCT00118768|Interferons|interferons|mesh-list
56298710|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
56298711|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298712|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
56298713|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298714|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
56038900|NCT01721603|Trametinib|trametinib|mesh-list
56298715|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298717|NCT02706873|Upadacitinib|upadacitinib|mesh-list
56298718|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56298719|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
56298720|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56298721|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298722|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298723|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
56298724|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298725|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298726|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
56298727|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298728|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56298729|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298730|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
55920684|NCT03891355|Lenalidomide|lenalidomide|mesh-list
56298731|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298732|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56298733|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56298734|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56298735|NCT00118807|Artesunate|artesunate|mesh-list
56298736|NCT00118807|Chloroquine|chloroquine|mesh-list
56298737|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
56298738|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
56298739|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56298740|NCT00118807|Amodiaquine|amodiaquine|mesh-list
56298741|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
56298742|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56298743|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56298744|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298745|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298746|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
56298747|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
56298748|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56298749|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
56298750|NCT00118807|Amebicides|amebicides|mesh-ancestor
56298751|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56298752|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56298753|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298754|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298755|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56298756|NCT00118807|Renal Agents|renal agents|mesh-ancestor
56298757|NCT00118963|Metformin|metformin|mesh-list
56298758|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
56298759|NCT00118963|Repaglinide|repaglinide|mesh-list
56905691|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526491|NCT00960661|Insulin|insulin|mesh-list
56298760|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56298761|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298762|NCT00119002|Dexamethasone|dexamethasone|mesh-list
56298763|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56298764|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
56298765|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
56298766|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298767|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298768|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56298769|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
56298770|NCT00119002|Hormones|hormones|mesh-ancestor
56298771|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56298772|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56298773|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298774|NCT00119119|Tocopherols|tocopherols|mesh-list
56298775|NCT00119119|Vitamin E|vitamin e|mesh-list
56298776|NCT00119119|Tocotrienols|tocotrienols|mesh-list
56298777|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
56298778|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
55938568|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56298780|NCT00119119|Protective Agents|protective agents|mesh-ancestor
56298781|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298782|NCT00119119|Vitamins|vitamins|mesh-ancestor
56298783|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
56298784|NCT00119236|Irinotecan|irinotecan|mesh-list
56298785|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56298786|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56298787|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298788|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298789|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298790|NCT00119314|Gemcitabine|gemcitabine|mesh-list
56298791|NCT00119314|Capecitabine|capecitabine|mesh-list
56298792|NCT00119314|Docetaxel|docetaxel|mesh-list
56298793|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298794|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
56298795|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298796|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298797|NCT00119314|Antiviral Agents|antiviral agents|mesh-ancestor
56298798|NCT00119314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298799|NCT00119314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298800|NCT00119314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298801|NCT00119314|Immunologic Factors|immunologic factors|mesh-ancestor
56298802|NCT00119314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298803|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
56298804|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
56298805|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
56298806|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56298807|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56298808|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298809|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
56298810|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298811|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
56298812|NCT00119587|Hematinics|hematinics|mesh-ancestor
56298813|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
56298814|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
56298815|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298816|NCT00119626|Protective Agents|protective agents|mesh-ancestor
56298817|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298818|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
56298819|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56298820|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56298821|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56298822|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56298823|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298824|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
56298825|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298826|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298827|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56298828|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298829|NCT02621151|Gemcitabine|gemcitabine|mesh-list
56298830|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
56298831|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56905692|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56905693|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
56298832|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
56298833|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298834|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298835|NCT02621151|Antiviral Agents|antiviral agents|mesh-ancestor
56298836|NCT02621151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298837|NCT02621151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298838|NCT02621151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298839|NCT02621151|Immunologic Factors|immunologic factors|mesh-ancestor
56298840|NCT02621151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298841|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298842|NCT00120055|Atorvastatin|atorvastatin|mesh-list
56298843|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56298844|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56298845|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
56298846|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298847|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56086665|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
56298848|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56298849|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298850|NCT00120133|Atorvastatin|atorvastatin|mesh-list
56298853|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
56298854|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298855|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56298856|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56298857|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298858|NCT00120172|Bevacizumab|bevacizumab|mesh-list
56298859|NCT00120172|Capecitabine|capecitabine|mesh-list
56298860|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
56298861|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298862|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298863|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56298864|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56298865|NCT00120172|Growth Substances|growth substances|mesh-ancestor
56298866|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298867|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
56298868|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298869|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
56298870|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298871|NCT00402181|Dexamethasone|dexamethasone|mesh-list
56298872|NCT00402181|Siltuximab|siltuximab|mesh-list
56298873|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56298874|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
56298875|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
56298876|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298877|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298878|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56298879|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
56298880|NCT00402181|Hormones|hormones|mesh-ancestor
56298881|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56298882|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56298883|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298884|NCT04727437|Heparin|heparin|mesh-list
56298885|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56298886|NCT04727437|Tinzaparin|tinzaparin|mesh-list
56298887|NCT04727437|Dalteparin|dalteparin|mesh-list
56298889|NCT04727437|Anticoagulants|anticoagulants|mesh-list
56298890|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56298891|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56298892|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298893|NCT02454933|Durvalumab|durvalumab|mesh-list
56298894|NCT02454933|Osimertinib|osimertinib|mesh-list
56298895|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56298896|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298897|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56298898|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298899|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298900|NCT00120367|Tenofovir|tenofovir|mesh-list
56298901|NCT00120367|Emtricitabine|emtricitabine|mesh-list
56298902|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
56298903|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
56298904|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905694|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905695|NCT02106130|Rebamipide|rebamipide|mesh-list
56905696|NCT02106130|Mosapride|mosapride|mesh-list
56905697|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298905|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56298906|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56298907|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298908|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298909|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56298910|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56298911|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56298912|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56298913|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56298914|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
56298915|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298916|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56298917|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56298918|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
56298919|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
56298920|NCT00120484|Vitamins|vitamins|mesh-ancestor
56298921|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
56298922|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298923|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
56298924|NCT00120484|Hematinics|hematinics|mesh-ancestor
56298925|NCT00391014|Amphotericin B|amphotericin b|mesh-list
56298926|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56298939|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298940|NCT05637164|Norepinephrine|norepinephrine|mesh-list
56298941|NCT05637164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56298942|NCT05637164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56298943|NCT05637164|Adrenergic Agents|adrenergic agents|mesh-ancestor
56298944|NCT05637164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298945|NCT05637164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298946|NCT05637164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298947|NCT05637164|Sympathomimetics|sympathomimetics|mesh-ancestor
56298948|NCT05637164|Autonomic Agents|autonomic agents|mesh-ancestor
56298949|NCT05637164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56298950|NCT05637164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56298951|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56298952|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56298953|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56298954|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
56298955|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56298956|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298957|NCT00120640|Progestins|progestins|mesh-ancestor
56298959|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
56298960|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
56298961|NCT00120679|Hematinics|hematinics|mesh-ancestor
56298962|NCT00120718|Fasudil|fasudil|mesh-list
56298963|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56298964|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56298965|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298966|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56298967|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298968|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
56298969|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56298970|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298971|NCT00120757|Alendronate|alendronate|mesh-list
56298972|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56298973|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298974|NCT00120796|Lamivudine|lamivudine|mesh-list
56298975|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56298976|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56298977|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298978|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298979|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
56298980|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298981|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56298982|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56298983|NCT00120835|Interferons|interferons|mesh-list
56298984|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905698|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56905699|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56298985|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
56298986|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298987|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
56298988|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56298989|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56298990|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
56298993|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
56298994|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
56298995|NCT00121030|Hematinics|hematinics|mesh-ancestor
56298996|NCT00121069|Citalopram|citalopram|mesh-list
56298997|NCT00121069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56298998|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56298999|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56299000|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299001|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299002|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
56299003|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299004|NCT00121069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56299005|NCT00121069|Antidepressive Agents|antidepressive agents|mesh-ancestor
56299006|NCT00121069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56299008|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56299009|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56299010|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56299011|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56299012|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56299013|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
56299014|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299015|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299016|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299017|NCT00121264|Sorafenib|sorafenib|mesh-list
56299018|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299019|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56299020|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299021|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299023|NCT00121303|Daunorubicin|daunorubicin|mesh-list
56299024|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
56299025|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299026|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
56299027|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299028|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299029|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
56299030|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299031|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299032|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
56299033|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299034|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56299035|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56299036|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56299037|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920987|NCT05701501|Pantothenic Acid|pantothenic acid|mesh-list
56299038|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56299040|NCT00121381|Tacrolimus|tacrolimus|mesh-list
56299041|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56299042|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56299043|NCT00121381|Analgesics|analgesics|mesh-ancestor
56299044|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
56299045|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299046|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299047|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56299048|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56299049|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
56299050|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299051|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
56299052|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56299053|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299054|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299055|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
56299056|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299057|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56299058|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
56299059|NCT00121459|Psyllium|psyllium|mesh-list
56905700|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
56905701|NCT02106130|Protective Agents|protective agents|mesh-ancestor
56905702|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905703|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905704|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56905705|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
56905706|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905707|NCT02251132|Ritonavir|ritonavir|mesh-list
56905708|NCT02251132|Erythromycin|erythromycin|mesh-list
56905709|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
56905710|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56905711|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
56905712|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56905713|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56905714|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
56299060|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
56299061|NCT00121459|Cathartics|cathartics|mesh-ancestor
56299062|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56299063|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
56299064|NCT05637398|Colchicine|colchicine|mesh-list
55938853|NCT04400747|Vitamin D|vitamin d|mesh-list
56299068|NCT05637398|Antimitotic Agents|antimitotic agents|mesh-ancestor
56299069|NCT05637398|Mitosis Modulators|mitosis modulators|mesh-ancestor
56299070|NCT05637398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299071|NCT05637398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299072|NCT00121498|Lidocaine|lidocaine|mesh-list
56299073|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
56299074|NCT00121498|Anesthetics|anesthetics|mesh-list
56299075|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56299076|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299077|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
56299078|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299079|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56299080|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56299081|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56299082|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56299083|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299084|NCT00121615|Etanercept|etanercept|mesh-list
56299085|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56299086|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56299087|NCT00121615|Analgesics|analgesics|mesh-ancestor
56299088|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
56299089|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299090|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299091|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56299092|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039277|NCT00361881|Acyclovir|acyclovir|mesh-list
56299093|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56299094|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299095|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
56299096|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56299097|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299098|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56299099|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299100|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299101|NCT04711096|Bupivacaine|bupivacaine|mesh-list
56299102|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
56299103|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
56299104|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56299105|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299106|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
56299107|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905715|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905716|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905717|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56905718|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56905719|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
56905720|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905721|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56905722|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56905723|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56905724|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56905725|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56905726|NCT01331824|Amrubicin|amrubicin|mesh-list
56905727|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905728|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
56905729|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56905730|NCT05571722|Vancomycin|vancomycin|mesh-list
56905731|NCT05571722|Linezolid|linezolid|mesh-list
56905732|NCT05571722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56905733|NCT05571722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905734|NCT05571722|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56905735|NCT05571722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905736|NCT05571722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905737|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
56905738|NCT02110654|Montelukast|montelukast|mesh-list
56905739|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56526843|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299108|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
56299109|NCT04705948|Ketamine|ketamine|mesh-list
56299110|NCT04705948|Analgesics|analgesics|mesh-ancestor
56299111|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
56299112|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299113|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299114|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56299115|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56299116|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
56299117|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
56299118|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56299119|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56299120|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56299121|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299122|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299123|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56299124|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
56299125|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56299126|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56299127|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56299128|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
56299129|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56299130|NCT00121888|Paroxetine|paroxetine|mesh-list
56079169|NCT00002835|Bleomycin|bleomycin|mesh-list
56905740|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
56905741|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56905742|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
56299131|NCT00121888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56299132|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56299133|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55938926|NCT01150461|Losartan|losartan|mesh-list
56299134|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299135|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299136|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
56299137|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299138|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56299139|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
56299140|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56299141|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56299142|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56299143|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299144|NCT00121966|Insulin|insulin|mesh-list
56299145|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56299146|NCT00121966|Metformin|metformin|mesh-list
56299147|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
56299148|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
56299149|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
56299150|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
56299151|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
56299152|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56299153|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299154|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
56299155|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56299156|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56299157|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56299158|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56299159|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
56299160|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299161|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299162|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299163|NCT02013492|Propranolol|propranolol|mesh-list
56299164|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56299165|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56299166|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
56299167|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299168|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299169|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299170|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56299171|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56299172|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
56299173|NCT00122356|Alendronate|alendronate|mesh-list
56299174|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56299175|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299176|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56299177|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56299178|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299179|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
56299180|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56299181|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
56299182|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299183|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299184|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56299185|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
56299186|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
56299187|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56299188|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
56299189|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299190|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299191|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
56299192|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299193|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56299194|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299195|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299196|NCT00122512|Tenofovir|tenofovir|mesh-list
56299197|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
56905743|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56905744|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526985|NCT01162473|Caseins|caseins|mesh-list
56299198|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299199|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56299200|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56299201|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299202|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299203|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56299204|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56299205|NCT01720407|Imiquimod|imiquimod|mesh-list
56299206|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56299208|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299210|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
56299211|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56299212|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
56299213|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299214|NCT00122590|Ritonavir|ritonavir|mesh-list
56299215|NCT00122590|Lopinavir|lopinavir|mesh-list
56299216|NCT00122590|Nelfinavir|nelfinavir|mesh-list
56299217|NCT00122590|Indinavir|indinavir|mesh-list
56299218|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56299219|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56299220|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
56299221|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299222|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299223|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56299224|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56299225|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
56299226|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299227|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56299228|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56299229|NCT00122629|Interferons|interferons|mesh-list
56299230|NCT00122629|Ribavirin|ribavirin|mesh-list
56299231|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
56299232|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
56299233|NCT00122629|Amantadine|amantadine|mesh-list
56299234|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56299235|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299236|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
56299237|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299238|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
56299239|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299240|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
56299241|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299242|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56299243|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56299244|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
56299245|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299246|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56299247|NCT00122629|Analgesics|analgesics|mesh-ancestor
56299248|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
56299249|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299250|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56299251|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56299252|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
56299253|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56299254|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299255|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299256|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
56299257|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299258|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55921218|NCT03583021|Neostigmine|neostigmine|mesh-list
56299259|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56299260|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56299261|NCT00129337|Bavituximab|bavituximab|mesh-list
56299262|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56299263|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299264|NCT00129298|Tiagabine|tiagabine|mesh-list
56299265|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
56299266|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56299267|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56299268|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527047|NCT01914367|Vaccines|vaccines|mesh-list
56299269|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299270|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
56299271|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299272|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299273|NCT00129181|Levodopa|levodopa|mesh-list
56299274|NCT00129181|Carbidopa|carbidopa|mesh-list
56299275|NCT00129181|Cabergoline|cabergoline|mesh-list
56299276|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56299277|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56299278|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56299279|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
56299280|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939070|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299289|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56299290|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299291|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56299292|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56299293|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
56299294|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56299295|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299296|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56299297|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
56299298|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56299299|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299300|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56299301|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
56299302|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56299303|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299304|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299305|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299306|NCT00819780|Bevacizumab|bevacizumab|mesh-list
56299307|NCT00819780|Panitumumab|panitumumab|mesh-list
56299308|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56299309|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299310|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56299311|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56299312|NCT00819780|Growth Substances|growth substances|mesh-ancestor
56299313|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299314|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
56299315|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56299317|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299318|NCT00128791|Nitroprusside|nitroprusside|mesh-list
56299319|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56299320|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
56299321|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56299322|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299323|NCT00128752|Beta Carotene|beta carotene|mesh-list
56299324|NCT00128752|Carotenoids|carotenoids|mesh-list
56299325|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
56299326|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299327|NCT00128752|Protective Agents|protective agents|mesh-ancestor
56299328|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299329|NCT00128752|Provitamins|provitamins|mesh-ancestor
56299331|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
56299332|NCT05638295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56299333|NCT05638295|Panitumumab|panitumumab|mesh-list
56299334|NCT05638295|Antibodies|antibodies|mesh-list
56299335|NCT05638295|Immunoglobulins|immunoglobulins|mesh-list
56299336|NCT05638295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56299337|NCT05638295|Immunologic Factors|immunologic factors|mesh-ancestor
56299338|NCT05638295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299339|NCT05638295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299340|NCT00063414|Alicaforsen|alicaforsen|mesh-list
56299341|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56299342|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299343|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
56299344|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299345|NCT05638451|Bevacizumab|bevacizumab|mesh-list
56299346|NCT05638451|Temozolomide|temozolomide|mesh-list
55939144|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56299359|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
56299360|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299361|NCT05638763|Ketoconazole|ketoconazole|mesh-list
56299362|NCT05638763|Dasatinib|dasatinib|mesh-list
56299363|NCT05638763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905745|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56905746|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56905747|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905748|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905749|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
56299364|NCT05638763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56299365|NCT05638763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299366|NCT05638763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299367|NCT05638763|Antifungal Agents|antifungal agents|mesh-ancestor
56299368|NCT05638763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299369|NCT05638763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56299370|NCT05638763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56299371|NCT05638763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56299372|NCT05638763|Hormone Antagonists|hormone antagonists|mesh-ancestor
56299373|NCT05638763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56299374|NCT05638763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299375|NCT05638763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56299376|NCT00128635|Antibodies|antibodies|mesh-list
56299377|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56299378|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
56299379|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299380|NCT00009048|Levodopa|levodopa|mesh-list
56299381|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56299382|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56299383|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
56299384|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299385|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299386|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299387|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
56299388|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299389|NCT00128557|Vitamin A|vitamin a|mesh-list
56299390|NCT00128557|Vitamins|vitamins|mesh-ancestor
56299391|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
56299392|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299393|NCT00128518|Perindopril|perindopril|mesh-list
56299394|NCT00128518|Indapamide|indapamide|mesh-list
56299395|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56299396|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
56299397|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299398|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299399|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56299400|NCT00128518|Diuretics|diuretics|mesh-ancestor
56299401|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
56299402|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299403|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56299404|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56299405|NCT00009204|Perphenazine|perphenazine|mesh-list
56299406|NCT00009204|Citalopram|citalopram|mesh-list
56299407|NCT00009204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56299410|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299411|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299412|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
56299413|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299414|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56299415|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
56299416|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56299417|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56299418|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56299419|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56299420|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56299421|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
56299422|NCT00394459|Anesthetics|anesthetics|mesh-list
56299423|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56299424|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299425|NCT05638919|Antiviral Agents|antiviral agents|mesh-list
56299426|NCT05638919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299427|NCT00394498|Lenograstim|lenograstim|mesh-list
56299428|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56905750|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56905751|NCT03258710|Tenofovir|tenofovir|mesh-list
56905752|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
56905753|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905754|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56905755|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56905756|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905757|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905758|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56905759|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56905760|NCT02110810|Indomethacin|indomethacin|mesh-list
56905761|NCT02110810|Glycerol|glycerol|mesh-list
56527183|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56299429|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
56299430|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299431|NCT00394537|Labetalol|labetalol|mesh-list
56299432|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56299433|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56299434|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
56299435|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299436|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299437|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299438|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56299439|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
56299440|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
56299441|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299442|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56299443|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56299444|NCT00009555|Testosterone|testosterone|mesh-list
56299445|NCT00009555|Androgens|androgens|mesh-ancestor
56299446|NCT00009555|Hormones|hormones|mesh-ancestor
56299447|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56299448|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299449|NCT00128479|Mifepristone|mifepristone|mesh-list
56299450|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56299451|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
56299452|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56299453|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299454|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56299455|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56299456|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56299457|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
56299458|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56299459|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56299460|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
56299461|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56299462|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
56299463|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56299464|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56299465|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
56299466|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56299467|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
56299468|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299469|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299470|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56299471|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
56299472|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
56299473|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56299474|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
56299475|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299476|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905762|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56905763|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56905764|NCT02110810|Analgesics|analgesics|mesh-ancestor
56905765|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
56905766|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905767|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905768|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905769|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56905770|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
56905771|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
56905772|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56905773|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56905774|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905775|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905776|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56905777|NCT02110810|Protective Agents|protective agents|mesh-ancestor
56905778|NCT02107924|Vancomycin|vancomycin|mesh-list
56905779|NCT02107924|Tobramycin|tobramycin|mesh-list
56905780|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56905781|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905782|NCT02108002|Vorinostat|vorinostat|mesh-list
56905783|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905784|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56905785|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905786|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905787|NCT02114476|Progestins|progestins|mesh-list
56905788|NCT02114476|Hormones|hormones|mesh-ancestor
56905789|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56905790|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905791|NCT02110966|Tramadol|tramadol|mesh-list
56905792|NCT02110966|Mepivacaine|mepivacaine|mesh-list
56905793|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56905794|NCT02110966|Narcotics|narcotics|mesh-ancestor
56905795|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905796|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905797|NCT02110966|Analgesics|analgesics|mesh-ancestor
56905798|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
56527249|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
56905799|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905800|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
56905801|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
56905802|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
56905803|NCT02937740|Testosterone|testosterone|mesh-list
56905804|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
56905805|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
56905806|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56905807|NCT02937740|Androgens|androgens|mesh-ancestor
56905808|NCT02937740|Hormones|hormones|mesh-ancestor
56905809|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56905810|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905811|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56905812|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905813|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
56905814|NCT02111044|Octreotide|octreotide|mesh-list
56905815|NCT02111044|Somatostatin|somatostatin|mesh-list
56905816|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56905817|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56905818|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905819|NCT02111044|Hormones|hormones|mesh-ancestor
56905820|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56905821|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905822|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
56905823|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905824|NCT02108548|Naproxen|naproxen|mesh-list
56299477|NCT00128401|Cycloserine|cycloserine|mesh-list
56299480|NCT00128401|Renal Agents|renal agents|mesh-ancestor
56299481|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56299482|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
56299483|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56299484|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
56299485|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299486|NCT00128323|Nystatin|nystatin|mesh-list
56299487|NCT00128323|Gentian Violet|gentian violet|mesh-list
56299488|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56299489|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56299490|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299491|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
56299492|NCT00128323|Ionophores|ionophores|mesh-ancestor
56299493|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56299494|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299495|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56299496|NCT00009672|Morphine|morphine|mesh-list
56299497|NCT00009672|Nortriptyline|nortriptyline|mesh-list
56299498|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56299499|NCT00009672|Narcotics|narcotics|mesh-ancestor
56299500|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160949|NCT02985840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56299501|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299502|NCT00009672|Analgesics|analgesics|mesh-ancestor
56299503|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
56905825|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56905826|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56905827|NCT02108548|Analgesics|analgesics|mesh-ancestor
56905828|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
56905829|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905830|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905831|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56299504|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299505|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56299506|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
56299507|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56299508|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56299509|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56299510|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56299511|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299512|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
56299513|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299514|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56299515|NCT00018694|Cathartics|cathartics|mesh-ancestor
56299516|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56299517|NCT00018733|Paroxetine|paroxetine|mesh-list
56299518|NCT00018733|Desipramine|desipramine|mesh-list
56299519|NCT00018733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56299520|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56299521|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56299522|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299523|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299524|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
56299525|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299526|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56299527|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
56299528|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56299529|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56299530|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56299531|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299532|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56299533|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56299534|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
56299535|NCT00018850|Haloperidol|haloperidol|mesh-list
56299536|NCT00018850|Ondansetron|ondansetron|mesh-list
56299537|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
56299539|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56299540|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
56299541|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299542|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299543|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56299544|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56299545|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
56299546|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56299547|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299548|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
56299549|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56299565|NCT00009750|Antibodies|antibodies|mesh-list
56299566|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
56299567|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56299568|NCT00009750|Cyclosporins|cyclosporins|mesh-list
56299569|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56299570|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299571|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
56299572|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
56299573|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
56160952|NCT02985840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56299574|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299575|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
56299576|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299577|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905832|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56905833|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
56905834|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56905835|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905836|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905837|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
56905838|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56905839|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56905840|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
56905841|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
56905842|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905843|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905844|NCT02108626|Nicotine|nicotine|mesh-list
56905845|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56905846|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
56905847|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905848|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905849|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56905850|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56905851|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
56905852|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905853|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299578|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299579|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
56299580|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299581|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
56299582|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56299583|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56299584|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
56299585|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56299586|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
56299587|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299588|NCT00019084|Aldesleukin|aldesleukin|mesh-list
56299589|NCT00019084|Vaccines|vaccines|mesh-list
56299590|NCT00019084|Sargramostim|sargramostim|mesh-list
56299591|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
56299592|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299593|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299594|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56299595|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56299596|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
56299597|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299598|NCT00019123|Thalidomide|thalidomide|mesh-list
56299599|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299600|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
56299601|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299602|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
56299603|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56299604|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299605|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56299606|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56299607|NCT00019123|Growth Substances|growth substances|mesh-ancestor
56299608|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
56299609|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299610|NCT00019240|Cidofovir|cidofovir|mesh-list
56905854|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
56905855|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56905856|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905857|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905858|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56905859|NCT05431322|Analgesics|analgesics|mesh-ancestor
56905860|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
56905861|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905862|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56905863|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56905864|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56905865|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
56905866|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616532|NCT00654355|Tacrolimus|tacrolimus|mesh-list
56905867|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905869|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
56905870|NCT03745599|Benzydamine|benzydamine|mesh-list
56905871|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56905872|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56905873|NCT03745599|Analgesics|analgesics|mesh-ancestor
56905874|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
56905875|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905876|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905877|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56905878|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56905879|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56905880|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905881|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905882|NCT02111434|Testosterone|testosterone|mesh-list
56905883|NCT02111434|Androgens|androgens|mesh-ancestor
56905884|NCT02111434|Hormones|hormones|mesh-ancestor
56905885|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56905886|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905887|NCT03230864|Olanzapine|olanzapine|mesh-list
56905888|NCT03230864|Risperidone|risperidone|mesh-list
56905889|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56905890|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
56299611|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
56905891|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905892|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905893|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905894|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56905895|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56905896|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905897|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56905898|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56905899|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
56905900|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
56905901|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
56905902|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905903|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56905904|NCT03230864|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56905905|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56905906|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56905907|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
56905908|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56905909|NCT02111590|Antibodies|antibodies|mesh-list
56905910|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
56905911|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905912|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56905913|NCT02937350|Calcifediol|calcifediol|mesh-list
56905914|NCT02937350|Vitamins|vitamins|mesh-ancestor
56905915|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
56905916|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905917|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56905918|NCT02109328|Paclitaxel|paclitaxel|mesh-list
56527487|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55939433|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
56299640|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
56299641|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299642|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56299643|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299644|NCT00009828|Antidotes|antidotes|mesh-ancestor
56299645|NCT00009828|Protective Agents|protective agents|mesh-ancestor
56299646|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
56299648|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
56299649|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299650|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
56299651|NCT00019435|Immunotoxins|immunotoxins|mesh-list
56299652|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
56299653|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299654|NCT00019474|Interferons|interferons|mesh-list
56299655|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
56299656|NCT00019474|Fluorouracil|fluorouracil|mesh-list
56299657|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
56299658|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
56905919|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56905920|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905921|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
56905922|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
56905923|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
56905924|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527537|NCT00489307|Hormones|hormones|mesh-ancestor
56299659|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299660|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299661|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299687|NCT00019513|Protective Agents|protective agents|mesh-ancestor
56299688|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
56299689|NCT00019513|Vitamins|vitamins|mesh-ancestor
56299690|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
56299691|NCT00019552|Irofulven|irofulven|mesh-list
56299692|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56299693|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
56299694|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299695|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299696|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
56299697|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299698|NCT00019591|Aldesleukin|aldesleukin|mesh-list
56299699|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299700|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56299701|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56299702|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
56299703|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299704|NCT00019630|Doxorubicin|doxorubicin|mesh-list
56299705|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56299706|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56299707|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299708|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56299709|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56299710|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299711|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299712|NCT00019669|Aldesleukin|aldesleukin|mesh-list
56299713|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299724|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56299725|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
56299726|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299727|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299728|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56299729|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299730|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
56299731|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299732|NCT00019825|Decitabine|decitabine|mesh-list
56299733|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299734|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
56299735|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299736|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299737|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299738|NCT00019864|Leucovorin|leucovorin|mesh-list
56299739|NCT00019864|Doxorubicin|doxorubicin|mesh-list
56299740|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56299741|NCT00019864|Methotrexate|methotrexate|mesh-list
56299742|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
56299743|NCT00019864|Razoxane|razoxane|mesh-list
56299744|NCT00019864|Calcium|calcium|mesh-list
56299745|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
56299746|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299747|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56299748|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56299749|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56299750|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299751|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299752|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56299753|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299754|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56905925|NCT02115490|Diphosphonates|diphosphonates|mesh-list
56905926|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56905927|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905928|NCT02251288|Vaccines|vaccines|mesh-list
56905929|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
56299755|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
56299756|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56299757|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299758|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
56299759|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
56299760|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56299761|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299762|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
56299763|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56299764|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56299765|NCT00019864|Antidotes|antidotes|mesh-ancestor
56299766|NCT00019864|Protective Agents|protective agents|mesh-ancestor
56299767|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
56299768|NCT00019864|Vitamins|vitamins|mesh-ancestor
56299769|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
56299770|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56299771|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
56299773|NCT00020176|Cyclosporine|cyclosporine|mesh-list
56299774|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
56299775|NCT00020176|Fludarabine|fludarabine|mesh-list
56299776|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
56299777|NCT00020176|Cyclosporins|cyclosporins|mesh-list
56299778|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299779|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
56299780|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939585|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
56299800|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299801|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56299802|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56299803|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
56299804|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299805|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
56299806|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
56299807|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56299808|NCT00009984|Thalidomide|thalidomide|mesh-list
56299809|NCT00009984|Fludarabine|fludarabine|mesh-list
56299810|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
56299811|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299812|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299813|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
56299814|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299815|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299816|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
56299817|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299818|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
56299819|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56299820|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299821|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56299822|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56299823|NCT00009984|Growth Substances|growth substances|mesh-ancestor
56299824|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
56299825|NCT00020332|Docetaxel|docetaxel|mesh-list
56299826|NCT00020332|Alvocidib|alvocidib|mesh-list
56299827|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299828|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
56299829|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
56299830|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
56299831|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299832|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56299833|NCT00020332|Growth Substances|growth substances|mesh-ancestor
56299834|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299835|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55939652|NCT01286259|Disulfiram|disulfiram|mesh-list
56299861|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299862|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56299863|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56299864|NCT00020449|Growth Substances|growth substances|mesh-ancestor
56299865|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
56905930|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905931|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
56905932|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56905933|NCT02109718|Petrolatum|petrolatum|mesh-list
56527684|NCT00602407|Cilostazol|cilostazol|mesh-list
56299866|NCT00010023|Capecitabine|capecitabine|mesh-list
56299867|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299868|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299869|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
56299870|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299873|NCT00020488|Irinotecan|irinotecan|mesh-list
56299874|NCT00020488|Calcium|calcium|mesh-list
56299875|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
56299876|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56299877|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299878|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
56299879|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299880|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299881|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299882|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299883|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
56299884|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56299885|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56299886|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299887|NCT00020488|Antidotes|antidotes|mesh-ancestor
56299913|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
56299914|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
56299915|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56299916|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
56299917|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56299918|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299919|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
56299920|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299921|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56299922|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299923|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56299924|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56299926|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
56299927|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299928|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299929|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299930|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299931|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
56299932|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299933|NCT00020605|Naloxone|naloxone|mesh-list
56299934|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56299935|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299936|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
56299937|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56299938|NCT00020644|Gemcitabine|gemcitabine|mesh-list
56299939|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299945|NCT00020644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299948|NCT00020644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299949|NCT00020761|Paclitaxel|paclitaxel|mesh-list
56299950|NCT00020761|Irinotecan|irinotecan|mesh-list
56299951|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56299952|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299953|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
56299954|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
56299955|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
56299956|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299957|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56299958|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56299959|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299960|NCT00020800|Rituximab|rituximab|mesh-list
56299961|NCT00020800|Fludarabine|fludarabine|mesh-list
56299962|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
56299963|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56299964|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299965|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
56299966|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905934|NCT02109718|Emollients|emollients|mesh-ancestor
56905935|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
56905936|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56905937|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56905938|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56905939|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56905940|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
56527742|NCT05199597|Atropine|atropine|mesh-list
56299967|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56299968|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299969|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
56299970|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299971|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299972|NCT00020839|Temozolomide|temozolomide|mesh-list
56299973|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56299974|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
56299975|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299976|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299977|NCT00010140|Tamoxifen|tamoxifen|mesh-list
56299978|NCT00010140|Docetaxel|docetaxel|mesh-list
56299979|NCT00010140|Epirubicin|epirubicin|mesh-list
56299980|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299981|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
56299982|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
56299983|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
56299984|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299985|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56299986|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56299987|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56299988|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299989|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56299990|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
56299991|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56299992|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299993|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56299994|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56299995|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56299996|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56299997|NCT00020878|Celecoxib|celecoxib|mesh-list
56299998|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56299999|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56300000|NCT00020878|Analgesics|analgesics|mesh-ancestor
56300002|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300003|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300004|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300005|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300006|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56300007|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56300008|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939807|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
56300023|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
56300024|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56300025|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300026|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300027|NCT00020917|Antidotes|antidotes|mesh-ancestor
56300028|NCT00020917|Protective Agents|protective agents|mesh-ancestor
56300029|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
56300030|NCT00020917|Vitamins|vitamins|mesh-ancestor
56300031|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
56300032|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56300033|NCT00021034|Taurolidine|taurolidine|mesh-list
56300034|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300035|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56300036|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300037|NCT00010179|Lurtotecan|lurtotecan|mesh-list
56300038|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300039|NCT00021073|Leucovorin|leucovorin|mesh-list
56300040|NCT00021073|Fluorouracil|fluorouracil|mesh-list
56300041|NCT00021073|Irinotecan|irinotecan|mesh-list
56300042|NCT00021073|Alvocidib|alvocidib|mesh-list
56905941|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56905942|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56527809|NCT00602173|Cilostazol|cilostazol|mesh-list
56300043|NCT00021073|Calcium|calcium|mesh-list
56300044|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
56300045|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56300046|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300047|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
56300048|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300049|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300050|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300051|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300052|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
56300053|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56300054|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300055|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300056|NCT00021073|Antidotes|antidotes|mesh-ancestor
56300057|NCT00021073|Protective Agents|protective agents|mesh-ancestor
56300058|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
56300059|NCT00021073|Vitamins|vitamins|mesh-ancestor
56300060|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
56300061|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
56300062|NCT00021073|Growth Substances|growth substances|mesh-ancestor
56300063|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56300064|NCT00021112|Etoposide|etoposide|mesh-list
56300065|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300066|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56300067|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56300068|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300069|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300070|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300071|NCT00000122|Fluorouracil|fluorouracil|mesh-list
56300079|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
56300080|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56300081|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300082|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
56300083|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300084|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
56300085|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300086|NCT00021307|Carboplatin|carboplatin|mesh-list
56300087|NCT00021307|Temozolomide|temozolomide|mesh-list
56300088|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300089|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56300090|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
56300091|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300092|NCT00021346|Gemcitabine|gemcitabine|mesh-list
56300093|NCT00021346|Carboplatin|carboplatin|mesh-list
56300094|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300095|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300097|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300098|NCT00021346|Antiviral Agents|antiviral agents|mesh-ancestor
56300099|NCT00021346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300100|NCT00021346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300101|NCT00021346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300102|NCT00021346|Immunologic Factors|immunologic factors|mesh-ancestor
56300103|NCT00021346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300104|NCT00021385|Squalamine|squalamine|mesh-list
56300105|NCT00021385|Carboplatin|carboplatin|mesh-list
56300106|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300107|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56300108|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300109|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56300110|NCT00021385|Protective Agents|protective agents|mesh-ancestor
56300111|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300112|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56300113|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56300114|NCT00021385|Growth Substances|growth substances|mesh-ancestor
56300115|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
56300116|NCT00021463|Lamivudine|lamivudine|mesh-list
56300117|NCT00021463|Zidovudine|zidovudine|mesh-list
56300118|NCT00021463|Efavirenz|efavirenz|mesh-list
56300119|NCT00021463|Nevirapine|nevirapine|mesh-list
56300120|NCT00021463|Abacavir|abacavir|mesh-list
56300121|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
56079170|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
56905943|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56905944|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905946|NCT02112214|Antacids|antacids|mesh-ancestor
56905947|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905948|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56905949|NCT04014075|Trastuzumab|trastuzumab|mesh-list
56905950|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56905951|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56905952|NCT02112292|Dronabinol|dronabinol|mesh-list
56905953|NCT02112292|Cannabidiol|cannabidiol|mesh-list
56905954|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
56905955|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
56905956|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905957|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56905958|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56905959|NCT02112292|Analgesics|analgesics|mesh-ancestor
56300122|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56300123|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300124|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300125|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300126|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
56300127|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300128|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56300129|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56300130|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
56300131|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56300132|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56300133|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56300134|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56300135|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56300136|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56300137|NCT00021502|Chrysarobin|chrysarobin|mesh-list
56300138|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56300139|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56300153|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300154|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56300156|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300157|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
56300158|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300159|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300160|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56300161|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
56300162|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300163|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300164|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56300165|NCT00010452|Picibanil|picibanil|mesh-list
56300166|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300167|NCT00394693|Interferons|interferons|mesh-list
56300168|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
56300169|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300171|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922123|NCT03661411|Aspirin|aspirin|mesh-list
56300172|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
56300173|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300174|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56300175|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56300176|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56300177|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905960|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
56905961|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905962|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56905963|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56905964|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905965|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905966|NCT02112292|Hormones|hormones|mesh-ancestor
56905967|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56905968|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
56905969|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56905970|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
56905971|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56905972|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
56905973|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56905974|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905975|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
56905976|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
56905977|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56905978|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
56905979|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905980|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300178|NCT00021814|Doxazosin|doxazosin|mesh-list
56300179|NCT00021814|Finasteride|finasteride|mesh-list
56300180|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56300181|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56300182|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300183|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300184|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
56300185|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56300186|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300187|NCT00021814|Urological Agents|urological agents|mesh-ancestor
56300188|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56300189|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56300190|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56300191|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56300192|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
56300193|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56300194|NCT00022009|Gemcitabine|gemcitabine|mesh-list
56300195|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300196|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
56300197|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300198|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300199|NCT00022009|Antiviral Agents|antiviral agents|mesh-ancestor
56300200|NCT00022009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300210|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56300211|NCT00022048|Bevacizumab|bevacizumab|mesh-list
56300212|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56300213|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300214|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56300215|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56300216|NCT00022048|Growth Substances|growth substances|mesh-ancestor
56905981|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56905982|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
56905983|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
56905984|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56905985|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
56905986|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56905987|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905988|NCT02118844|Rocuronium|rocuronium|mesh-list
56905989|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56905990|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56905991|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56300217|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300218|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
56300219|NCT00022087|Vitamin D|vitamin d|mesh-list
56300220|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
56300221|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
56300222|NCT00022087|Calcium|calcium|mesh-list
56300223|NCT00022087|Vitamins|vitamins|mesh-ancestor
56300224|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
56300225|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300226|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56300227|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56300229|NCT00388700|Bevacizumab|bevacizumab|mesh-list
56300230|NCT00388700|Fluorouracil|fluorouracil|mesh-list
56300231|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56300232|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300233|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56300234|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56300235|NCT00388700|Growth Substances|growth substances|mesh-ancestor
56300236|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300237|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
56300238|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
56300239|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300240|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300241|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300242|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
56300243|NCT00388700|Antidotes|antidotes|mesh-ancestor
56300244|NCT00388700|Protective Agents|protective agents|mesh-ancestor
56300245|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
56300247|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
56300248|NCT00022126|Cytarabine|cytarabine|mesh-list
56300249|NCT00022126|Cyclosporine|cyclosporine|mesh-list
56300250|NCT00022126|Dexamethasone|dexamethasone|mesh-list
56300251|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
56300252|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
56300253|NCT00022126|Doxorubicin|doxorubicin|mesh-list
56300254|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56300255|NCT00022126|Methotrexate|methotrexate|mesh-list
56300256|NCT00022126|Vincristine|vincristine|mesh-list
56300257|NCT00022126|Daunorubicin|daunorubicin|mesh-list
56300258|NCT00022126|Asparaginase|asparaginase|mesh-list
56300259|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
56300260|NCT00022126|Pegaspargase|pegaspargase|mesh-list
56300261|NCT00022126|Thioguanine|thioguanine|mesh-list
56300262|NCT00022126|Cyclosporins|cyclosporins|mesh-list
56300263|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300264|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
56300265|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300266|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300267|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56300268|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
56300269|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300270|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300271|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56300283|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300285|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56300286|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
56905992|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56905993|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56905994|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
56905995|NCT02116348|Mitogens|mitogens|mesh-list
56905996|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
56905997|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56905998|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56905999|NCT02116348|Protective Agents|protective agents|mesh-ancestor
56906000|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906001|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
56906002|NCT02119000|Bisacodyl|bisacodyl|mesh-list
56906003|NCT02119000|Cathartics|cathartics|mesh-ancestor
56906004|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56906005|NCT02119000|Laxatives|laxatives|mesh-ancestor
56906006|NCT02119234|Beclomethasone|beclomethasone|mesh-list
56906007|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
56906008|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
56906009|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56300287|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56300288|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300289|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
56300290|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
56300291|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56300292|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300293|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
56300294|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300295|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56300296|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
56300297|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
56300298|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
56300299|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
56300300|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56300301|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56300302|NCT00022126|Protective Agents|protective agents|mesh-ancestor
56300303|NCT00022165|Selenium|selenium|mesh-list
56300304|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
56300305|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300307|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300308|NCT00022165|Trace Elements|trace elements|mesh-ancestor
56300309|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
56300310|NCT00022204|Vitamin E|vitamin e|mesh-list
56300311|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
56300312|NCT00022204|Vitamins|vitamins|mesh-ancestor
56300313|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
56300314|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300315|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
56300316|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300317|NCT00022204|Protective Agents|protective agents|mesh-ancestor
56300318|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56300319|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300320|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56300321|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55922267|NCT03651895|Metformin|metformin|mesh-list
56300323|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56300324|NCT00388739|Prednisolone|prednisolone|mesh-list
56300325|NCT00388739|Budesonide|budesonide|mesh-list
56300326|NCT00388739|Albuterol|albuterol|mesh-list
56300327|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300328|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
56300329|NCT00388739|Hormones|hormones|mesh-ancestor
56300330|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906010|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
56906011|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528134|NCT04267549|Paclitaxel|paclitaxel|mesh-list
56300331|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300332|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56300333|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300334|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
56300335|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300336|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56300346|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300347|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
56300348|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56300349|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300350|NCT00022360|Taurolidine|taurolidine|mesh-list
56300351|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300352|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56300353|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300354|NCT00022399|Celecoxib|celecoxib|mesh-list
56300355|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56300356|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56300357|NCT00022399|Analgesics|analgesics|mesh-ancestor
56300358|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
56300359|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300360|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300361|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300362|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300363|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56300364|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56300365|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300366|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300367|NCT00000143|Ganciclovir|ganciclovir|mesh-list
56300368|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56300369|NCT00000143|Cidofovir|cidofovir|mesh-list
56300370|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
56300371|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300372|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300373|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300374|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300375|NCT00022438|Aldesleukin|aldesleukin|mesh-list
56300376|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
56300377|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300378|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56300379|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56300380|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
56300381|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300382|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56300383|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
56300384|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300385|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
56300386|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56300387|NCT00010686|Estrogens|estrogens|mesh-ancestor
56300388|NCT00010686|Hormones|hormones|mesh-ancestor
56300389|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56300390|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300391|NCT00022555|Vincristine|vincristine|mesh-list
56300392|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
56300393|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56300394|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300395|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
56300396|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
56300397|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
56300398|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300399|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56300400|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
56300401|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300403|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
56300418|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
56300419|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300420|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56300421|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56300422|NCT00000146|Protective Agents|protective agents|mesh-ancestor
56300424|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
56079257|NCT03576001|Androgens|androgens|mesh-ancestor
56906012|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906013|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56906014|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
56906015|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56906016|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56906017|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56300425|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300426|NCT00022594|Lurtotecan|lurtotecan|mesh-list
56300427|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300428|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56300429|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56300430|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
56300431|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56300432|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300433|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300434|NCT00022711|Temozolomide|temozolomide|mesh-list
56300435|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56300436|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
56300437|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300438|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300439|NCT00010842|Vitamin E|vitamin e|mesh-list
56300440|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
56300441|NCT00010842|Selenium|selenium|mesh-list
56300442|NCT00010842|Vitamins|vitamins|mesh-ancestor
56300443|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
56300444|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300445|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
56300446|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300447|NCT00010842|Protective Agents|protective agents|mesh-ancestor
56300448|NCT00010842|Trace Elements|trace elements|mesh-ancestor
56300449|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
56300450|NCT00000152|Aspirin|aspirin|mesh-list
56300451|NCT00000152|Beta Carotene|beta carotene|mesh-list
56300452|NCT00000152|Carotenoids|carotenoids|mesh-list
56300453|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56300454|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56300455|NCT00000152|Analgesics|analgesics|mesh-ancestor
56300456|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
56300457|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300458|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300459|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300461|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56300462|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56300463|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300464|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56300465|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56300477|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
56300479|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
56300480|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300481|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300482|NCT00022945|Prednisone|prednisone|mesh-list
56300483|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
56300484|NCT00022945|Doxorubicin|doxorubicin|mesh-list
56300485|NCT00022945|Vincristine|vincristine|mesh-list
56300486|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
56300487|NCT00022945|Antibodies|antibodies|mesh-list
56300488|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300489|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
56300490|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300491|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300492|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56300493|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
56300494|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300495|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300496|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56300497|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56300498|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56300499|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300500|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906018|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
56906019|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906020|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906021|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56906022|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56906023|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56906024|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
56906025|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56906026|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
56906027|NCT02119234|Hormones|hormones|mesh-ancestor
56906028|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906029|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56906030|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906031|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906032|NCT04068753|Niraparib|niraparib|mesh-list
56906033|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56300501|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300502|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
56300503|NCT00022945|Hormones|hormones|mesh-ancestor
56300504|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56300505|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56300506|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56300507|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
56300508|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
56300509|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
56300510|NCT00023218|Ritonavir|ritonavir|mesh-list
56300511|NCT00023218|Lopinavir|lopinavir|mesh-list
56300512|NCT00023218|Efavirenz|efavirenz|mesh-list
56300513|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56300514|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56300515|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
56300516|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300517|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300518|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56300519|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56300520|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
56300521|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300522|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56300523|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56300524|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56300525|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300526|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56300527|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56300528|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56300529|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56300530|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56300531|NCT00394966|Rolapitant|rolapitant|mesh-list
56300532|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55922503|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
56300551|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300553|NCT02024607|Bevacizumab|bevacizumab|mesh-list
56300554|NCT02024607|Fluorouracil|fluorouracil|mesh-list
56300555|NCT02024607|Capecitabine|capecitabine|mesh-list
56300556|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
56300557|NCT02024607|Irinotecan|irinotecan|mesh-list
56300558|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56300559|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906034|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906035|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906036|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906037|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56906038|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
56906039|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906040|NCT04473716|Paclitaxel|paclitaxel|mesh-list
56906041|NCT04473716|Cisplatin|cisplatin|mesh-list
56906042|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56906043|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906044|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
56906045|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
56906046|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
56528316|NCT04321616|Remdesivir|remdesivir|mesh-list
56300560|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56300561|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56300562|NCT02024607|Growth Substances|growth substances|mesh-ancestor
56300563|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300564|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
56300565|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
56300566|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300567|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300568|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300569|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
56300570|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56300571|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300572|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300573|NCT02024607|Antidotes|antidotes|mesh-ancestor
56300574|NCT02024607|Protective Agents|protective agents|mesh-ancestor
56300575|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
56300576|NCT02024607|Vitamins|vitamins|mesh-ancestor
56300577|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
56300578|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
56300579|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56300580|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
56300581|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300582|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300583|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56300584|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
56300585|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56300586|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
56300587|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300588|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56300589|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56300590|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
56300591|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
56300611|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300612|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300613|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
56300614|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56300615|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
56300616|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
56300617|NCT00000173|Protective Agents|protective agents|mesh-ancestor
56300618|NCT00023374|Rifampin|rifampin|mesh-list
56300619|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
56300620|NCT00023374|Ethambutol|ethambutol|mesh-list
56300621|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56300622|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
56300623|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56300624|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300625|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
56300626|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300627|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906047|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906048|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
56906049|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
56906050|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906051|NCT03919617|Volagidemab|volagidemab|mesh-list
56906052|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56906053|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906054|NCT03748173|Calfactant|calfactant|mesh-list
56906055|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56906056|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
56906057|NCT03848403|Ixekizumab|ixekizumab|mesh-list
56906058|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
56906059|NCT03995355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56906060|NCT03995355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56906061|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
56528376|NCT04262635|Capecitabine|capecitabine|mesh-list
56300628|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300629|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56300630|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56300631|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56300632|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56300633|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56300634|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56300635|NCT00023413|Efavirenz|efavirenz|mesh-list
56300636|NCT00023413|Rifabutin|rifabutin|mesh-list
56300637|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56300638|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300639|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300640|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300641|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
56300642|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300643|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56300644|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56300645|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56300646|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56300647|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56300648|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56300649|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56300657|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
56300658|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
56300659|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300660|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300661|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56300662|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
56300663|NCT00023530|Hormones|hormones|mesh-ancestor
56300664|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56300665|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56300666|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300667|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300668|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
56300669|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
56300670|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56300671|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300672|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56300673|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56300674|NCT00023530|Growth Substances|growth substances|mesh-ancestor
56300675|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
56300676|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
56906062|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56906063|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56300677|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56300678|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56300679|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300680|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300681|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56300682|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
56300683|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56300684|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56300685|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56300686|NCT00000176|Progesterone|progesterone|mesh-list
56300687|NCT00000176|Estrogens|estrogens|mesh-list
56300688|NCT00000176|Progestins|progestins|mesh-ancestor
56300689|NCT00000176|Hormones|hormones|mesh-ancestor
56160984|NCT02774148|Analgesics|analgesics|mesh-ancestor
56300690|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56300692|NCT00000179|Haloperidol|haloperidol|mesh-list
56300693|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
56300694|NCT00000179|Trazodone|trazodone|mesh-list
56300695|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
56300696|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
56300697|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300698|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300699|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56300700|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56300701|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56300702|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56300703|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56300704|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56300705|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
56300706|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56300707|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300708|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56300709|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56300710|NCT00000179|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56300711|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56300712|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56300713|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
56300714|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56300715|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
56300717|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56300718|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56300719|NCT00023725|Growth Substances|growth substances|mesh-ancestor
56300728|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300730|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
56300731|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
56300732|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56300733|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56300734|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300735|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56300736|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56300737|NCT00000191|Analgesics|analgesics|mesh-ancestor
56300738|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
56300739|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300740|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56300741|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56300742|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300743|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56300744|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56300745|NCT00023842|Mitomycins|mitomycins|mesh-list
56300746|NCT00023842|Mitomycin|mitomycin|mesh-list
56300747|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
56300748|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56300749|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300750|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
56300751|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300752|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300753|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300754|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56300755|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
56906064|NCT03743883|Aspirin|aspirin|mesh-list
56906065|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56906066|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56300756|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300757|NCT00000221|Buprenorphine|buprenorphine|mesh-list
56300758|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56300759|NCT00000221|Narcotics|narcotics|mesh-ancestor
56300760|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56300761|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300762|NCT00000221|Analgesics|analgesics|mesh-ancestor
56300763|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
56300764|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300765|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56300767|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300768|NCT00023920|Cytarabine|cytarabine|mesh-list
56300769|NCT00023920|Bevacizumab|bevacizumab|mesh-list
56300770|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56300771|NCT00023920|Idarubicin|idarubicin|mesh-list
56300772|NCT00023920|Antibodies|antibodies|mesh-list
56300773|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
56300774|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56300775|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300776|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56300777|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56300778|NCT00023920|Growth Substances|growth substances|mesh-ancestor
56300779|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300780|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
56300781|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
56300782|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300783|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
56300784|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300785|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
55940572|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
56300786|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300787|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300788|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56300789|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56300790|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300792|NCT00023959|Bevacizumab|bevacizumab|mesh-list
56300793|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56300794|NCT00023959|Fluorouracil|fluorouracil|mesh-list
56300795|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
56300796|NCT00023959|Antibodies|antibodies|mesh-list
56300797|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
56300798|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56300799|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300800|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56300801|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56300802|NCT00023959|Growth Substances|growth substances|mesh-ancestor
56300803|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300804|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
56300805|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
56300806|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
56300807|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300808|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300809|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300810|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
56300811|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300812|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300813|NCT00023998|Leucovorin|leucovorin|mesh-list
56300814|NCT00023998|Doxorubicin|doxorubicin|mesh-list
56300815|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56300816|NCT00023998|Methotrexate|methotrexate|mesh-list
56300817|NCT00023998|Trastuzumab|trastuzumab|mesh-list
56300818|NCT00023998|Etoposide|etoposide|mesh-list
56300819|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
56300820|NCT00023998|Ifosfamide|ifosfamide|mesh-list
56300821|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
56300822|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300823|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56300824|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56300825|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300826|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300827|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300828|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906067|NCT03743883|Analgesics|analgesics|mesh-ancestor
56906068|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
56906069|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906070|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906071|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56906072|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56906073|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56906074|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56906075|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906076|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56906077|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56300829|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56300830|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
56300831|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56300832|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300833|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
56300834|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
56300835|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56300836|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300837|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
56300838|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300839|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300840|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56300841|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56300843|NCT00023998|Protective Agents|protective agents|mesh-ancestor
56300844|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
56300845|NCT00023998|Vitamins|vitamins|mesh-ancestor
56300846|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
56300847|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56300848|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
56300849|NCT00024115|Antibodies|antibodies|mesh-list
56300850|NCT00024115|Immunotoxins|immunotoxins|mesh-list
55922795|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
56300851|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
56300852|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300853|NCT00024154|Trastuzumab|trastuzumab|mesh-list
56300854|NCT00024154|Gefitinib|gefitinib|mesh-list
56300855|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56300856|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300857|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56300858|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300859|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300860|NCT00011076|Pirfenidone|pirfenidone|mesh-list
56300861|NCT00011076|Analgesics|analgesics|mesh-ancestor
55940639|NCT04394377|Calcium heparin|calcium heparin|mesh-list
56300864|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300865|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56300866|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56300867|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300868|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300869|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300870|NCT00000248|Pergolide|pergolide|mesh-list
56300871|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
56300872|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
56300873|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56300874|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300875|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300876|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
56300877|NCT00024193|Melphalan|melphalan|mesh-list
56300878|NCT00024193|Busulfan|busulfan|mesh-list
56300879|NCT00024193|Doxorubicin|doxorubicin|mesh-list
56300880|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56300881|NCT00024193|Etoposide|etoposide|mesh-list
56300882|NCT00024193|Vincristine|vincristine|mesh-list
56300883|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906078|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528649|NCT00922987|Pregabalin|pregabalin|mesh-list
56300884|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
56300885|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300886|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300887|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56300888|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
56300889|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300890|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300891|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56300892|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56300893|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56300894|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300895|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300896|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56300897|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
56300898|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
56300899|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
56300900|NCT00024232|Antibodies|antibodies|mesh-list
56300901|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56300902|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
56300903|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300904|NCT00024271|Gemcitabine|gemcitabine|mesh-list
56300905|NCT00024271|Interferons|interferons|mesh-list
56300906|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
56300907|NCT00024271|Doxorubicin|doxorubicin|mesh-list
56300908|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56300909|NCT00024271|Mitomycins|mitomycins|mesh-list
56300910|NCT00024271|Mitomycin|mitomycin|mesh-list
56300911|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300912|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300914|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300915|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
56300916|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300917|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300918|NCT00024271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300919|NCT00024271|Immunologic Factors|immunologic factors|mesh-ancestor
56300920|NCT00024271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300921|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56300922|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56300923|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56300924|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
56300925|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300926|NCT00024310|Folic Acid|folic acid|mesh-list
56300927|NCT00024310|Paclitaxel|paclitaxel|mesh-list
56300928|NCT00024310|Lometrexol|lometrexol|mesh-list
55922873|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
56300929|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56300930|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300931|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
56300932|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
56300933|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
56300934|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300935|NCT00024310|Hematinics|hematinics|mesh-ancestor
56300936|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
56300959|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56300961|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
56300962|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56300963|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300964|NCT00024388|Paclitaxel|paclitaxel|mesh-list
56300965|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56300966|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300967|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
56300968|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
56300969|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
56300970|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300971|NCT00024427|Gemcitabine|gemcitabine|mesh-list
56300972|NCT00024427|Fluorouracil|fluorouracil|mesh-list
56300973|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300974|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
56300975|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300976|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300977|NCT00024427|Antiviral Agents|antiviral agents|mesh-ancestor
56300978|NCT00024427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300979|NCT00024427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906079|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
56906080|NCT03988803|Memantine|memantine|mesh-list
56906081|NCT03988803|BI 425809|bi 425809|mesh-list
56906082|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56906083|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56906084|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
56906085|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906086|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906087|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906088|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56906089|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56300980|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300981|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
56300982|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300983|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
56300984|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56300985|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
56300986|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
56300987|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56300988|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300990|NCT00000257|Analgesics|analgesics|mesh-ancestor
56300991|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
56300992|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300997|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56300998|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300999|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301000|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301001|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
56301002|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301003|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301005|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56301006|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
56301007|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301008|NCT00395239|Budesonide|budesonide|mesh-list
56301009|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56301010|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56301011|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
56301012|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301013|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301014|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56301015|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
56301016|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
56301017|NCT00395239|Hormones|hormones|mesh-ancestor
56301018|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301019|NCT00025012|Isotretinoin|isotretinoin|mesh-list
56301020|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
56301021|NCT00025051|Celecoxib|celecoxib|mesh-list
56301022|NCT00025051|Mitogens|mitogens|mesh-list
56301023|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56301024|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56301025|NCT00025051|Analgesics|analgesics|mesh-ancestor
56301026|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
56301027|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301028|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301029|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56301030|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301031|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56301032|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56301033|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301034|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301035|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301036|NCT00025090|Fluorouracil|fluorouracil|mesh-list
56301037|NCT00025090|Mitomycins|mitomycins|mesh-list
56301038|NCT00025090|Mitomycin|mitomycin|mesh-list
56301039|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906090|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
56906091|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56906092|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
56906093|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56906094|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56301040|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
56301041|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301042|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301043|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301044|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
56301045|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301046|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56301047|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
56301048|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56301049|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301050|NCT00000368|Paroxetine|paroxetine|mesh-list
56301051|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56301052|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56301053|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56301054|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301055|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56301056|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
56301057|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301058|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56301059|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
56301060|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56301062|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56160991|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
56301063|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301064|NCT00025168|Gemcitabine|gemcitabine|mesh-list
56301065|NCT00025168|Irinotecan|irinotecan|mesh-list
56301076|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56301077|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301078|NCT00025207|Gefitinib|gefitinib|mesh-list
56301079|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301080|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56301081|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301082|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301083|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
56301084|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301085|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56301086|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301087|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301088|NCT00025285|Thalidomide|thalidomide|mesh-list
56301089|NCT00025285|Carboplatin|carboplatin|mesh-list
56301090|NCT00025285|Irinotecan|irinotecan|mesh-list
56301091|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301092|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56301093|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301094|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301095|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301096|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301097|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
56301098|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301099|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
56301100|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56301101|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301102|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301103|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301104|NCT00025285|Growth Substances|growth substances|mesh-ancestor
56301105|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301106|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
56301107|NCT00025324|Thiotepa|thiotepa|mesh-list
56301108|NCT00025324|Carboplatin|carboplatin|mesh-list
56301109|NCT00025324|Etoposide|etoposide|mesh-list
56301110|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301111|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
56301112|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301113|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301114|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301115|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
56906095|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56906096|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906097|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906098|NCT00180713|Simvastatin|simvastatin|mesh-list
56301116|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301117|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301118|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56301119|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301120|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56301121|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301122|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301123|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
56301124|NCT00025363|Ifosfamide|ifosfamide|mesh-list
56301125|NCT00025363|Doxorubicin|doxorubicin|mesh-list
56301126|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56301127|NCT00025363|Irinotecan|irinotecan|mesh-list
56301128|NCT00025363|Etoposide|etoposide|mesh-list
56301129|NCT00025363|Vincristine|vincristine|mesh-list
56301130|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
56301131|NCT00025363|Tirapazamine|tirapazamine|mesh-list
56301142|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56301143|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56301144|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301145|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301146|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56301147|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301148|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
56301149|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
56301150|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301153|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
55923098|NCT00241839|Diuretics|diuretics|mesh-ancestor
56301154|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
56301155|NCT00025402|Busulfan|busulfan|mesh-list
56301156|NCT00025402|Etoposide|etoposide|mesh-list
56301157|NCT00025402|Idarubicin|idarubicin|mesh-list
56301158|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
56301159|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301160|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
56301161|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301162|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301163|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301164|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
56301165|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301166|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301167|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56301168|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301169|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56301170|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301171|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301172|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
56301173|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301174|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301175|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
56301176|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56301177|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
56301178|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56301179|NCT00025441|Dactinomycin|dactinomycin|mesh-list
56301180|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
56301181|NCT00025441|Ifosfamide|ifosfamide|mesh-list
56301182|NCT00025441|Carboplatin|carboplatin|mesh-list
56301183|NCT00025441|Doxorubicin|doxorubicin|mesh-list
56301184|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56301185|NCT00025441|Etoposide|etoposide|mesh-list
56301186|NCT00025441|Vincristine|vincristine|mesh-list
56301187|NCT00025441|Epirubicin|epirubicin|mesh-list
56301188|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301189|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
56301190|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301191|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301192|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301193|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
56301194|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301195|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301196|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56906099|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56906100|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56906101|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
56906102|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906103|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56906104|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56906105|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906106|NCT02531477|Propofol|propofol|mesh-list
56906107|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56906108|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906109|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906110|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56906111|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
56906112|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
56906113|NCT04052139|Naltrexone|naltrexone|mesh-list
56906114|NCT04052139|Gabapentin|gabapentin|mesh-list
56301197|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56301201|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301202|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
56301203|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
56301204|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301205|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56301206|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301207|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56301208|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56301209|NCT00000395|Folic Acid|folic acid|mesh-list
56301210|NCT00000395|Leucovorin|leucovorin|mesh-list
56301211|NCT00000395|Methotrexate|methotrexate|mesh-list
56301212|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
56301213|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56301214|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
56301215|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56301216|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301217|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301218|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
56301219|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301220|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301221|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
56301222|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301223|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56301224|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301225|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
56301226|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301227|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56301228|NCT00000395|Hematinics|hematinics|mesh-ancestor
56301229|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
56301230|NCT00000395|Vitamins|vitamins|mesh-ancestor
56301231|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
56301232|NCT00000395|Antidotes|antidotes|mesh-ancestor
56301233|NCT00000395|Protective Agents|protective agents|mesh-ancestor
56301234|NCT00025480|Paclitaxel|paclitaxel|mesh-list
56301235|NCT00025480|Carboplatin|carboplatin|mesh-list
56301236|NCT00025480|Tipifarnib|tipifarnib|mesh-list
56301237|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301238|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301239|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
56301240|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
56301241|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301242|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301243|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
56301244|NCT00025519|Thalidomide|thalidomide|mesh-list
56301245|NCT00025519|Fludarabine|fludarabine|mesh-list
56906115|NCT04052139|Analgesics|analgesics|mesh-ancestor
56906116|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
56906117|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906118|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906119|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
56906120|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56906121|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56906122|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906123|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56906124|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56906125|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56906126|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906127|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301246|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
56301247|NCT00025519|Tacrolimus|tacrolimus|mesh-list
56301248|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301249|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301250|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
56301251|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301252|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301253|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
56301254|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301255|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56301256|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301257|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56301258|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56301259|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
56301260|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56301261|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301262|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
56301263|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301264|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301265|NCT00025519|Growth Substances|growth substances|mesh-ancestor
56301266|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301267|NCT00025558|Carboplatin|carboplatin|mesh-list
56301268|NCT00025558|Temozolomide|temozolomide|mesh-list
56301269|NCT00025558|Thiotepa|thiotepa|mesh-list
56301270|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301271|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
56301272|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301280|NCT00025597|Doxorubicin|doxorubicin|mesh-list
56301281|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56301282|NCT00025597|Etoposide|etoposide|mesh-list
56301283|NCT00025597|Vincristine|vincristine|mesh-list
56301284|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301285|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
56301286|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301287|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301288|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301289|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
56301290|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301291|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301292|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56301293|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56301294|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56301295|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301296|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301297|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301298|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
56301299|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
56301300|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301301|NCT00025636|Cytarabine|cytarabine|mesh-list
56906128|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
56906129|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56301302|NCT00025636|Dexamethasone|dexamethasone|mesh-list
56301303|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
56301304|NCT00025636|Melphalan|melphalan|mesh-list
56301305|NCT00025636|Carmustine|carmustine|mesh-list
56301306|NCT00025636|Methotrexate|methotrexate|mesh-list
56301307|NCT00025636|Etoposide|etoposide|mesh-list
56301308|NCT00025636|Vincristine|vincristine|mesh-list
56301309|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301310|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
56301311|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301312|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301313|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301314|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
56301315|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301316|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301317|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56301318|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56301319|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
56301320|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
56301321|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301322|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56301323|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
56301324|NCT00025636|Hormones|hormones|mesh-ancestor
56301325|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301326|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56301327|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56301328|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
56301329|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56301330|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301331|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
56301332|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56301333|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301334|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56301335|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56301336|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301337|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56301338|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301339|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
56301340|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941114|NCT00634517|Albuterol|albuterol|mesh-list
56301345|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301346|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56301347|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301348|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301349|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
56301350|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56301351|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301352|NCT00025792|Pramipexole|pramipexole|mesh-list
56301353|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
56301354|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301355|NCT00025792|Protective Agents|protective agents|mesh-ancestor
56301356|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301357|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56301358|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56301359|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
56301360|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
56301361|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56301362|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56301363|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56301364|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56301365|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
56301366|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56301368|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56301369|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56301370|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56301371|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301372|NCT00000419|Estrogens|estrogens|mesh-ancestor
56301373|NCT00000419|Hormones|hormones|mesh-ancestor
56301374|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301375|NCT00026104|Gemcitabine|gemcitabine|mesh-list
56301376|NCT00026104|Paclitaxel|paclitaxel|mesh-list
56301377|NCT00026104|Tipifarnib|tipifarnib|mesh-list
56079264|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
56906130|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56906131|NCT03743805|Naloxone|naloxone|mesh-list
56906132|NCT03743805|Flumazenil|flumazenil|mesh-list
56906133|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56906134|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906135|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
56301378|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301379|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301380|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
56301381|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
56301382|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301383|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301384|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301385|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
55923324|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56301386|NCT00026104|Antiviral Agents|antiviral agents|mesh-ancestor
56301387|NCT00026104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301388|NCT00026104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301389|NCT00026104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301390|NCT00026104|Immunologic Factors|immunologic factors|mesh-ancestor
56301391|NCT00026104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301392|NCT00026143|Interferons|interferons|mesh-list
56301393|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
56301394|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
56301395|NCT00026143|Interleukin-12|interleukin-12|mesh-list
56301396|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301397|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
56301398|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301399|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
56301400|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301401|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56301402|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301403|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301404|NCT00026143|Growth Substances|growth substances|mesh-ancestor
56301405|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301406|NCT00026182|Rituximab|rituximab|mesh-list
56301407|NCT00026182|Interleukin-12|interleukin-12|mesh-list
56301408|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56301409|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301410|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
56301411|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301412|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301413|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56301422|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301423|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301424|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301425|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56301426|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301427|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301428|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
56301429|NCT00026299|Gefitinib|gefitinib|mesh-list
56301430|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301431|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56301432|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301433|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301434|NCT00026338|Gemcitabine|gemcitabine|mesh-list
56301435|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56301436|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301437|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
56301438|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301439|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301440|NCT00026338|Antiviral Agents|antiviral agents|mesh-ancestor
56301441|NCT00026338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301442|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301443|NCT00026338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301444|NCT00026338|Immunologic Factors|immunologic factors|mesh-ancestor
56301445|NCT00026338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301446|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56301447|NCT00026377|Leuprolide|leuprolide|mesh-list
56301448|NCT00026377|Goserelin|goserelin|mesh-list
56301449|NCT00026377|Flutamide|flutamide|mesh-list
56301450|NCT00026377|Bicalutamide|bicalutamide|mesh-list
56906136|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906137|NCT03743805|Antidotes|antidotes|mesh-ancestor
56906138|NCT03743805|Protective Agents|protective agents|mesh-ancestor
56906139|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
56906140|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
56906141|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906142|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906143|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
56906144|NCT03743727|Ledipasvir|ledipasvir|mesh-list
56301451|NCT00026377|Semaxinib|semaxinib|mesh-list
56301452|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56301453|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
56301454|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56301455|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301456|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56301457|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301458|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
56301459|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
55923415|NCT00778869|Infliximab|infliximab|mesh-list
56301460|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301461|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301462|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301463|NCT00026377|Growth Substances|growth substances|mesh-ancestor
56301464|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301465|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56301466|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301467|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301468|NCT00026416|Interferons|interferons|mesh-list
56301469|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
56301470|NCT00026416|Thalidomide|thalidomide|mesh-list
56301471|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301472|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
56301473|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301474|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
56301475|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301476|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301477|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
56301478|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56301479|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55941256|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56301490|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301491|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301492|NCT00026533|Growth Substances|growth substances|mesh-ancestor
56301493|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301494|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301495|NCT00026962|Estradiol|estradiol|mesh-list
56301496|NCT00026962|Progesterone|progesterone|mesh-list
56301497|NCT00026962|Estrogens|estrogens|mesh-ancestor
56301498|NCT00026962|Hormones|hormones|mesh-ancestor
56301499|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301500|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301501|NCT00026962|Progestins|progestins|mesh-ancestor
56301502|NCT00027040|Selegiline|selegiline|mesh-list
56301503|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
56301504|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56301505|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56301506|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56301507|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56301508|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301509|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301510|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56301512|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301513|NCT00027079|Naltrexone|naltrexone|mesh-list
56301514|NCT00027079|Ondansetron|ondansetron|mesh-list
56301515|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56301516|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56301517|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301518|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
56079265|NCT00003519|Docetaxel|docetaxel|mesh-list
56906145|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56906146|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
56906147|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906148|NCT03981861|Metformin|metformin|mesh-list
56906149|NCT03981861|Spironolactone|spironolactone|mesh-list
56906150|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56906151|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906152|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56906153|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
56906154|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906155|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56906156|NCT03981861|Diuretics|diuretics|mesh-ancestor
56906157|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
56906158|NCT03743649|Lorazepam|lorazepam|mesh-list
56906159|NCT03743649|Haloperidol|haloperidol|mesh-list
56906160|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
56906161|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
56906162|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
56906163|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906164|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906165|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56906166|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56906167|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56906168|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906169|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56906170|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56906171|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
56906172|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56301519|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301520|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
56301521|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
56301522|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56301523|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
56301524|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
56301525|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56301526|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
56301527|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56301528|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301529|NCT00027079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56301530|NCT00027079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56301531|NCT00027079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56301532|NCT00027079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56301533|NCT00027079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56301534|NCT00011778|Bortezomib|bortezomib|mesh-list
56301535|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301536|NCT00000425|Acetaminophen|acetaminophen|mesh-list
56301537|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56301538|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56301539|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56906173|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906174|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56906175|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
56301540|NCT00000425|Analgesics|analgesics|mesh-ancestor
56301541|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
56301542|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301543|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301544|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
56301545|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301546|NCT00000428|Amitriptyline|amitriptyline|mesh-list
56301547|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56301557|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56301558|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301560|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56301561|NCT00027391|Albuterol|albuterol|mesh-list
56301562|NCT00027391|Oxandrolone|oxandrolone|mesh-list
56301563|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56301564|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
56301565|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301566|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301567|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56301568|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
56301569|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
56301570|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56301571|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56301572|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56301573|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56301574|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
56301575|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56301576|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301577|NCT00027391|Androgens|androgens|mesh-ancestor
56301578|NCT00027391|Hormones|hormones|mesh-ancestor
56301579|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301580|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
56301581|NCT00000461|Niacin|niacin|mesh-list
56301582|NCT00000461|Pravastatin|pravastatin|mesh-list
56301583|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
56301584|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
56301585|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56301586|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
56301587|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301588|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56301589|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
56301590|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
56301592|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
56301593|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301594|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56301595|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56301596|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301597|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56301598|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56301599|NCT00027508|Trabectedin|trabectedin|mesh-list
56301600|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301601|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
56301602|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301603|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301605|NCT00027547|Cyclosporine|cyclosporine|mesh-list
56301606|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
56301607|NCT00027547|Methotrexate|methotrexate|mesh-list
56301608|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
56301609|NCT00027547|Fludarabine|fludarabine|mesh-list
56301610|NCT00027547|Cyclosporins|cyclosporins|mesh-list
56301611|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56301612|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
55923548|NCT04183062|Docetaxel|docetaxel|mesh-list
56301613|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56301617|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301618|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301619|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
56301620|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301621|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56301622|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906176|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56906177|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56906178|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
56906180|NCT01332266|Cetuximab|cetuximab|mesh-list
56906181|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906182|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906183|NCT03255824|Fentanyl|fentanyl|mesh-list
56906184|NCT03255824|Midazolam|midazolam|mesh-list
56906185|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
56906186|NCT03255824|Propofol|propofol|mesh-list
56906187|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56906188|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906189|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529370|NCT04256473|Saruplase|saruplase|mesh-list
56301623|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
56301624|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301625|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56301626|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
56301627|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301628|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
56301629|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56301630|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56301631|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56301632|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
56301633|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56301634|NCT00011895|Lamivudine|lamivudine|mesh-list
56301635|NCT00011895|Zidovudine|zidovudine|mesh-list
56301636|NCT00011895|Efavirenz|efavirenz|mesh-list
56301637|NCT00011895|Abacavir|abacavir|mesh-list
56301638|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56301639|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56301640|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301641|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301642|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
56301643|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301644|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56301645|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56301646|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
56301647|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56301648|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56301649|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56301650|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56301651|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56301652|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56301653|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
56301654|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301655|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56301656|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301657|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301658|NCT00000464|Quinidine|quinidine|mesh-list
56301659|NCT00000464|Amiodarone|amiodarone|mesh-list
56301660|NCT00000464|Sotalol|sotalol|mesh-list
56089456|NCT02812238|Niacin|niacin|mesh-list
56301661|NCT00000464|Propafenone|propafenone|mesh-list
56301662|NCT00000464|Mexiletine|mexiletine|mesh-list
56301663|NCT00000464|Procainamide|procainamide|mesh-list
56301664|NCT00000464|Imipramine|imipramine|mesh-list
56301665|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56301666|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
56301667|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56301668|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56301669|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301670|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56301671|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56079266|NCT00003519|Doxorubicin|doxorubicin|mesh-list
56906190|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56906191|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
56906192|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
56906193|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56906194|NCT03255824|Analgesics|analgesics|mesh-ancestor
56906195|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
56529430|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
56301672|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56301673|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301674|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56301675|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56301676|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56301677|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56301678|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56301679|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
56301680|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56301681|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301682|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
56301683|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
56301684|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301689|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301690|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56301691|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56301692|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
56301693|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56301694|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56301695|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
56301696|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56301697|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56301698|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56301700|NCT00027625|Gefitinib|gefitinib|mesh-list
56301701|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301702|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
56301703|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301704|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301705|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56301706|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301707|NCT00027664|Interferons|interferons|mesh-list
56301708|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
56301709|NCT00027664|Thalidomide|thalidomide|mesh-list
56301710|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301711|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
56301712|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301713|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
56301714|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301715|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301716|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
56301717|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56301718|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301719|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301720|NCT00027664|Growth Substances|growth substances|mesh-ancestor
56301721|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301722|NCT00027703|Gemcitabine|gemcitabine|mesh-list
56301723|NCT00027703|Bevacizumab|bevacizumab|mesh-list
56301724|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56301725|NCT00027703|Antibodies|antibodies|mesh-list
56301726|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
56301727|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56301728|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301729|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301730|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301731|NCT00027703|Growth Substances|growth substances|mesh-ancestor
56301732|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301733|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301734|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
56301735|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301736|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
56301737|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301738|NCT00027703|Antiviral Agents|antiviral agents|mesh-ancestor
56906196|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906197|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56906198|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56906199|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56906200|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
56906201|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906202|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906203|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56906204|NCT03255824|Narcotics|narcotics|mesh-ancestor
56906205|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56906206|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56906207|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56906208|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56906209|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
56906210|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
56906211|NCT03238352|Listerine|listerine|mesh-list
56906212|NCT03238352|Fluorides|fluorides|mesh-list
56906213|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
56906214|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
56906215|NCT03238352|Protective Agents|protective agents|mesh-ancestor
56906216|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906217|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56906218|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906219|NCT01222754|Lenalidomide|lenalidomide|mesh-list
56301739|NCT00027703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301740|NCT00027703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301741|NCT00027703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301742|NCT00011934|Interferons|interferons|mesh-list
56301743|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
56301744|NCT00011934|Sargramostim|sargramostim|mesh-list
56301745|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301746|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
56301747|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301748|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
56301749|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301750|NCT00027742|Interferons|interferons|mesh-list
56301751|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
56301752|NCT00027742|Temozolomide|temozolomide|mesh-list
56301753|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301754|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
56301755|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301756|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301757|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
56301758|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301774|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
56301775|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301776|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
56301777|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301778|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56301779|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56301780|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56301781|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
56301782|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56301783|NCT00011973|Fenretinide|fenretinide|mesh-list
56906220|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
56906221|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301784|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301785|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56301786|NCT00011973|Protective Agents|protective agents|mesh-ancestor
56301787|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301788|NCT00027859|Ketoconazole|ketoconazole|mesh-list
56301789|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
56301790|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56301791|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56301792|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56301793|NCT00027859|Docetaxel|docetaxel|mesh-list
56301794|NCT00027859|Estramustine|estramustine|mesh-list
56301795|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301796|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
56301797|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
56301798|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301799|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301800|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56301801|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
56301802|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301803|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56301804|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56301805|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301806|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56301807|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
56301808|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301809|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301810|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56301811|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301812|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
56301813|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56301814|NCT00027898|Carboplatin|carboplatin|mesh-list
56301816|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
56301817|NCT00027898|Bortezomib|bortezomib|mesh-list
56301818|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301819|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301839|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923771|NCT03451591|Cilostazol|cilostazol|mesh-list
56301840|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301841|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301842|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
56301843|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56301844|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56301845|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56301846|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
56301847|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301848|NCT00012051|Cytarabine|cytarabine|mesh-list
56301849|NCT00012051|Dexamethasone|dexamethasone|mesh-list
56301850|NCT00012051|Rituximab|rituximab|mesh-list
56301851|NCT00012051|Methotrexate|methotrexate|mesh-list
56301852|NCT00012051|Etoposide|etoposide|mesh-list
56301853|NCT00012051|Melphalan|melphalan|mesh-list
56301854|NCT00012051|Ifosfamide|ifosfamide|mesh-list
56301855|NCT00012051|Carmustine|carmustine|mesh-list
56301856|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56301857|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301858|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
56301859|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301860|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301861|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56301862|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
56301863|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
56301864|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301865|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56301866|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
56301867|NCT00012051|Hormones|hormones|mesh-ancestor
56301868|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301869|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56301870|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56301871|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
56301872|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56301873|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301874|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
56906222|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56906223|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301875|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301876|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
56301877|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301878|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55941661|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
56301881|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301882|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56301883|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301885|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301886|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301887|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
56301888|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56301889|NCT00027976|Celecoxib|celecoxib|mesh-list
56301890|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56301891|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56301892|NCT00027976|Analgesics|analgesics|mesh-ancestor
56301893|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
56301894|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301895|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301896|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56301897|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301898|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56301899|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56301900|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301901|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301902|NCT00000479|Aspirin|aspirin|mesh-list
56301903|NCT00000479|Vitamin E|vitamin e|mesh-list
56301904|NCT00000479|Vitamins|vitamins|mesh-ancestor
56301905|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
56301906|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301907|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56301908|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56301909|NCT00000479|Analgesics|analgesics|mesh-ancestor
56301910|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
56301911|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301912|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56301913|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301914|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56301915|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56301916|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301918|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56301919|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301920|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
56301921|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
56301922|NCT00000479|Protective Agents|protective agents|mesh-ancestor
56301923|NCT00028132|Tenofovir|tenofovir|mesh-list
56301924|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
56301925|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301926|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56301927|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56301928|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301929|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301930|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56301931|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56301932|NCT00028171|Tacrolimus|tacrolimus|mesh-list
56301933|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301934|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
56301935|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301936|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56301937|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301938|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301939|NCT00012090|Goserelin|goserelin|mesh-list
56301940|NCT00012090|Bicalutamide|bicalutamide|mesh-list
56301941|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56301942|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301943|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
56301944|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
56301945|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301946|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301947|NCT00395395|Calcitonin|calcitonin|mesh-list
56301948|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
56906224|NCT01222754|Growth Substances|growth substances|mesh-ancestor
56301949|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56301950|NCT00395395|Katacalcin|katacalcin|mesh-list
56301951|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56301955|NCT00395434|Bevacizumab|bevacizumab|mesh-list
56301956|NCT00395434|Combretastatin|combretastatin|mesh-list
56301957|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
56301958|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56301959|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301960|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301961|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301962|NCT00395434|Growth Substances|growth substances|mesh-ancestor
56301963|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301964|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301965|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301966|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
56301967|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
56301968|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301969|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301970|NCT00395551|Ranibizumab|ranibizumab|mesh-list
56301971|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301972|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301973|NCT00395551|Growth Substances|growth substances|mesh-ancestor
56301974|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301975|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301976|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301977|NCT00012129|Annamycin|annamycin|mesh-list
56301978|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56301979|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301980|NCT00028288|Daclizumab|daclizumab|mesh-list
56301981|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301982|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
56301983|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301984|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56301985|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56301986|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301987|NCT00000482|Niacin|niacin|mesh-list
56301988|NCT00000482|Clofibrate|clofibrate|mesh-list
56301989|NCT00000482|Estrogens|estrogens|mesh-list
55923917|NCT05743725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301990|NCT00000482|Hormones|hormones|mesh-ancestor
56301991|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56301992|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301993|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56301994|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
56301995|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301996|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56301997|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
56301998|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
56301999|NCT00000482|Vitamins|vitamins|mesh-ancestor
56302000|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
56302001|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56302002|NCT00028327|Lamivudine|lamivudine|mesh-list
56302003|NCT00028327|Zidovudine|zidovudine|mesh-list
56302004|NCT00028327|Efavirenz|efavirenz|mesh-list
56302005|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56302006|NCT00028327|Nelfinavir|nelfinavir|mesh-list
56302007|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56302008|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56302009|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302010|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302011|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
56302012|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302013|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56302014|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56302015|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
56302016|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56302017|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56302018|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56302019|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56302020|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56302021|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56302022|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56302031|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
56906225|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
56906226|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906227|NCT05325632|Paclitaxel|paclitaxel|mesh-list
56906228|NCT05325632|Trastuzumab|trastuzumab|mesh-list
56906229|NCT05325632|Pertuzumab|pertuzumab|mesh-list
56906230|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56906231|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906232|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
56906233|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
56529784|NCT01265849|Analgesics|analgesics|mesh-ancestor
56302032|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161009|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302033|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302034|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56302035|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56302036|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
56302037|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302038|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56302039|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56302040|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56302041|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56302042|NCT00028405|Talaporfin|talaporfin|mesh-list
56302043|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302044|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56302045|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
56302046|NCT00012207|Aldesleukin|aldesleukin|mesh-list
56302047|NCT00012207|Prednisone|prednisone|mesh-list
56302048|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
56302050|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302051|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
56302052|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302053|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302054|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56302055|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
56302056|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302057|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302058|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56302059|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302060|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
56302061|NCT00012207|Hormones|hormones|mesh-ancestor
56302062|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302063|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56302064|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55923992|NCT05535231|Curcumin|curcumin|mesh-list
56302065|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302066|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
56302067|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302068|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56302069|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56302070|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
56302071|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302072|NCT00028483|Docetaxel|docetaxel|mesh-list
56302073|NCT00028483|Doxorubicin|doxorubicin|mesh-list
56302074|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
56302075|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302076|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302077|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
56302078|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302079|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302080|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56302081|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56302082|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302083|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302084|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
56302085|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302086|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
56302087|NCT00000485|Diuretics|diuretics|mesh-list
56302088|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
56906234|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
56906235|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906236|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906237|NCT03850418|Azacitidine|azacitidine|mesh-list
56906238|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56906239|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
56906240|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906241|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906242|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906243|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
56906244|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56906245|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529855|NCT01263119|Warfarin|warfarin|mesh-list
56302089|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302090|NCT00028561|Carboplatin|carboplatin|mesh-list
56302091|NCT00028561|Epothilone B|epothilone b|mesh-list
56302092|NCT00028561|Epothilones|epothilones|mesh-list
56302093|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302094|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302095|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
56302096|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302097|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302098|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
56302099|NCT00028600|Melphalan|melphalan|mesh-list
56302100|NCT00028600|Methotrexate|methotrexate|mesh-list
56302101|NCT00028600|Fludarabine|fludarabine|mesh-list
56302102|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
56302103|NCT00028600|Tacrolimus|tacrolimus|mesh-list
56302104|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302105|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
56302106|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302107|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302108|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56302109|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
56302110|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302111|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302112|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56302113|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56302114|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
56302115|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56302116|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302117|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
56302118|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
56302119|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302120|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56302121|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56302122|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56302123|NCT00388778|Doxycycline|doxycycline|mesh-list
56302124|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56302125|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302126|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
56302127|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56302128|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56302130|NCT00028678|Tinzaparin|tinzaparin|mesh-list
56302131|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56302132|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
56302133|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56302134|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56302135|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302136|NCT00012246|Sargramostim|sargramostim|mesh-list
56302137|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
55924066|NCT01479530|Protective Agents|protective agents|mesh-ancestor
56302138|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
56906246|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
56906247|NCT00180479|Paclitaxel|paclitaxel|mesh-list
56906248|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56906249|NCT00180479|Everolimus|everolimus|mesh-list
56906250|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56906251|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906252|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
56906253|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
56906254|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
56906255|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906256|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906257|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
56529908|NCT01259375|Amrubicin|amrubicin|mesh-list
56302139|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302140|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56302141|NCT00028717|Prednisone|prednisone|mesh-list
56302142|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
56302144|NCT00028717|Doxorubicin|doxorubicin|mesh-list
56302145|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56302146|NCT00028717|Vincristine|vincristine|mesh-list
56302147|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302148|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
56302149|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302150|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302151|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56302152|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
56302153|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302154|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302155|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56302156|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56302157|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56302158|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56302159|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302160|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302161|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302162|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
56302163|NCT00028717|Hormones|hormones|mesh-ancestor
56302164|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302165|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56302166|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56302167|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302168|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
56302178|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302179|NCT00028756|Antiviral Agents|antiviral agents|mesh-ancestor
56302180|NCT00028756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302181|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302182|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302183|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
56302184|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302185|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56302186|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56302187|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302188|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56302189|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
56302190|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56302191|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
56302192|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56302193|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302194|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56302195|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56302196|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302197|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
56906258|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906259|NCT03999710|Durvalumab|durvalumab|mesh-list
56906260|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906261|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906262|NCT05169944|Magrolimab|magrolimab|mesh-list
56906263|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906264|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906265|NCT02955069|Spartalizumab|spartalizumab|mesh-list
56906266|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56906267|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302198|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302199|NCT00012324|Doxorubicin|doxorubicin|mesh-list
56302200|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56302202|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56302203|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302204|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56302205|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302206|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302207|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302208|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302209|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
56302210|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56302211|NCT00028795|Temozolomide|temozolomide|mesh-list
56302212|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56302213|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
56302214|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302215|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302216|NCT00012363|Gemcitabine|gemcitabine|mesh-list
56302217|NCT00012363|Irinotecan|irinotecan|mesh-list
56302218|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302219|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
56302220|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302221|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302222|NCT00012363|Antiviral Agents|antiviral agents|mesh-ancestor
56302223|NCT00012363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302224|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302225|NCT00012363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302226|NCT00012363|Immunologic Factors|immunologic factors|mesh-ancestor
56302227|NCT00012363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302228|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56302229|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302230|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
56302231|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302232|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56302233|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302234|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302235|NCT00028834|Gemcitabine|gemcitabine|mesh-list
55942012|NCT05607641|Ketorolac|ketorolac|mesh-list
56302259|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302260|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
56302261|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302262|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302263|NCT00028912|Carboplatin|carboplatin|mesh-list
56302264|NCT00028912|Bortezomib|bortezomib|mesh-list
56302265|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302266|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56302267|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
56302268|NCT00028951|Coagulants|coagulants|mesh-ancestor
56302269|NCT01803555|Budesonide|budesonide|mesh-list
56302270|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
56302271|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56302272|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302273|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56302274|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
56302275|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906268|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906269|NCT03254108|Tolvaptan|tolvaptan|mesh-list
56906270|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56906271|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302277|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56302278|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
56302279|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
56302280|NCT01803555|Hormones|hormones|mesh-ancestor
56302281|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302282|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56302283|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56302284|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56302285|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
56302286|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302287|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302301|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
56302302|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
56302303|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56302304|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56302305|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
56302306|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302307|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56302308|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
56302309|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56302310|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302311|NCT00000491|Aspirin|aspirin|mesh-list
56302312|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56302313|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56302314|NCT00000491|Analgesics|analgesics|mesh-ancestor
56302315|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
56302316|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302317|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302318|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302319|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302320|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56302321|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56302322|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302323|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56302324|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56302325|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302326|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
56302327|NCT00029380|Cyclosporine|cyclosporine|mesh-list
56302328|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
56302329|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
56302330|NCT00029380|Busulfan|busulfan|mesh-list
56302331|NCT00029380|Cyclosporins|cyclosporins|mesh-list
56302332|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302333|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
56302334|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302336|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56302337|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
56302338|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302339|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302340|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56302341|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302342|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
56302343|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302344|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
56302345|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56302346|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56302347|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56302348|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
56302349|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56302371|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56302372|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56302373|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56302374|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302375|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
56906272|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
56906273|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906274|NCT02585895|Evolocumab|evolocumab|mesh-list
56906275|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56302376|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302377|NCT00000494|Indomethacin|indomethacin|mesh-list
56302378|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56302379|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56302380|NCT00000494|Analgesics|analgesics|mesh-ancestor
56302381|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
56302382|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302383|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302384|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302385|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302386|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
56302387|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
56302388|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56302389|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56302390|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302391|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302393|NCT00012519|Indinavir|indinavir|mesh-list
56302394|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56302395|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56302396|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
56302397|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302398|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302399|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56302400|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56302401|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
56302402|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302403|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56302404|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56302406|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56302407|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56302408|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56302409|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302410|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
56302411|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302412|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302413|NCT00029770|Acetaminophen|acetaminophen|mesh-list
56302414|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56302415|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56302416|NCT00029770|Codeine|codeine|mesh-list
56302417|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56302418|NCT00029770|Analgesics|analgesics|mesh-ancestor
56302419|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
56302420|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302421|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302422|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
56302423|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56302424|NCT00029770|Narcotics|narcotics|mesh-ancestor
56302425|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56302426|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
56302427|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
56302428|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302430|NCT00012558|Lamotrigine|lamotrigine|mesh-list
56302431|NCT00012558|Valproic Acid|valproic acid|mesh-list
56302432|NCT00012558|Risperidone|risperidone|mesh-list
56302433|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
56302434|NCT00012558|Bupropion|bupropion|mesh-list
56302435|NCT00012558|Paroxetine|paroxetine|mesh-list
56302436|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56302437|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
56302438|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302439|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302440|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302441|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56302442|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56302443|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56302444|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56302445|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56302446|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
56906276|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56906277|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
56906278|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906279|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56906280|NCT03736161|Methotrexate|methotrexate|mesh-list
56302447|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56302448|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
56302449|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56302450|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56302451|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56302452|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56302453|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56302454|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302455|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
56302456|NCT00012558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56302457|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
56302458|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56302459|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56302460|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56302461|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
56302462|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
56302463|NCT00012558|Vitamins|vitamins|mesh-ancestor
56302464|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
56302465|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56302466|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56302467|NCT00395707|Ranibizumab|ranibizumab|mesh-list
56302468|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56302469|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56302470|NCT00395707|Growth Substances|growth substances|mesh-ancestor
56302471|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302472|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
56302473|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302474|NCT00000500|Aspirin|aspirin|mesh-list
56302475|NCT00000500|Carotenoids|carotenoids|mesh-list
56302476|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56302477|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56302478|NCT00000500|Analgesics|analgesics|mesh-ancestor
56302479|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
56302480|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302494|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56302495|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302496|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56302497|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
56302498|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302499|NCT00029848|Rimonabant|rimonabant|mesh-list
56302500|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56302501|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56302502|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56302503|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302504|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302505|NCT00029848|Hormones|hormones|mesh-ancestor
56302506|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302507|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302508|NCT00000503|Streptokinase|streptokinase|mesh-list
56302509|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
56302510|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
56302511|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56302512|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56302513|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302514|NCT00030004|Midazolam|midazolam|mesh-list
56302515|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56302516|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56302517|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56302518|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302519|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56302520|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56302521|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56302522|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56302523|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
56906281|NCT03736161|Tofacitinib|tofacitinib|mesh-list
56906282|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56906283|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
56906284|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56906285|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906286|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56906287|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
56906288|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302524|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
56302525|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
56302526|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
56302527|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302528|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302529|NCT00030082|Melphalan|melphalan|mesh-list
56302530|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56302531|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
56302532|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302533|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302534|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56302535|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302536|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
56302537|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302538|NCT00000518|Quinidine|quinidine|mesh-list
56302539|NCT00000518|Sotalol|sotalol|mesh-list
56302540|NCT00000518|Mexiletine|mexiletine|mesh-list
56302541|NCT00000518|Procainamide|procainamide|mesh-list
56302542|NCT00000518|Imipramine|imipramine|mesh-list
56302545|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
56302546|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302547|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302548|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302549|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56302550|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
56302551|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
56302552|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302553|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56302554|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
56302555|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56302556|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56302557|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302558|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302559|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56302560|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56302561|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
56302562|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56302563|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56302564|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56302565|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56302566|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56302567|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56302568|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
56302569|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56302570|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56302571|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56302572|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
56302573|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
56302574|NCT00030238|Calcium|calcium|mesh-list
56302575|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56302576|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302577|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
56302578|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56302579|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302580|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56302581|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302582|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302583|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
56906289|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906290|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
56906291|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906292|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56906293|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302584|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302585|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56302586|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302587|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302588|NCT00395941|Pioglitazone|pioglitazone|mesh-list
56302589|NCT00395941|Acitretin|acitretin|mesh-list
56302590|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56302591|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302592|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
56302593|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
56302595|NCT00000524|Prednisone|prednisone|mesh-list
56302596|NCT00000524|Cyclosporins|cyclosporins|mesh-list
56302597|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302598|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
56302599|NCT00000524|Hormones|hormones|mesh-ancestor
56302600|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302601|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302602|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56302603|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302604|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302605|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302606|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302607|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
56302608|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
56302609|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302610|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
56302611|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302612|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56302613|NCT00030433|Gemcitabine|gemcitabine|mesh-list
56302614|NCT00030433|Irinotecan|irinotecan|mesh-list
56302615|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302617|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302618|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302619|NCT00030433|Antiviral Agents|antiviral agents|mesh-ancestor
56302620|NCT00030433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302621|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302622|NCT00030433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302623|NCT00030433|Immunologic Factors|immunologic factors|mesh-ancestor
56302624|NCT00030433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302625|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56302626|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302627|NCT00030472|Doxorubicin|doxorubicin|mesh-list
56302628|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56302629|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56302630|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302631|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56302632|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302633|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302634|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302635|NCT00000527|Aspirin|aspirin|mesh-list
56302636|NCT00000527|Dipyridamole|dipyridamole|mesh-list
56302637|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56302638|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56302639|NCT00000527|Analgesics|analgesics|mesh-ancestor
56302640|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
56302641|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302642|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302643|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302644|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302645|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56302646|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56302647|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302648|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56302649|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56302651|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
56906294|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
56906295|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56906296|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56906297|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56906298|NCT03253796|Golimumab|golimumab|mesh-list
56906299|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56906300|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56906301|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906302|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
56302652|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56302653|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
56302654|NCT00030511|Fluorouracil|fluorouracil|mesh-list
56302655|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
56302656|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302657|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302658|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302659|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302660|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
56302661|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302662|NCT00030550|Thalidomide|thalidomide|mesh-list
56302663|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302664|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
56302665|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924595|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56302666|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
56302667|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56302668|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302669|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56302670|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56302671|NCT00030550|Growth Substances|growth substances|mesh-ancestor
56302672|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
56302673|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302674|NCT00030589|Bexarotene|bexarotene|mesh-list
56302675|NCT00030589|Methoxsalen|methoxsalen|mesh-list
56302676|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302677|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56302678|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
56302679|NCT00000530|Nifedipine|nifedipine|mesh-list
56302680|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56302681|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56302682|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302683|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56302684|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302685|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
56302686|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
56302687|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56302688|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
56302689|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302698|NCT00030745|Antiviral Agents|antiviral agents|mesh-ancestor
56302699|NCT00030745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302700|NCT00030745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302701|NCT00030745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302702|NCT00030745|Immunologic Factors|immunologic factors|mesh-ancestor
56302703|NCT00030745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302704|NCT00030784|Doxorubicin|doxorubicin|mesh-list
56302705|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56302707|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56302708|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302709|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56302710|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302711|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302712|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302713|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56302714|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
56302715|NCT00030862|Irinotecan|irinotecan|mesh-list
56302716|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079267|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56906303|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906304|NCT02956005|Tacrolimus|tacrolimus|mesh-list
56906305|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906306|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
56906307|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906308|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56906309|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906310|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530443|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56302717|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56302718|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302719|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302720|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302721|NCT00000539|Vitamins|vitamins|mesh-list
56302722|NCT00000539|Vitamin E|vitamin e|mesh-list
56302723|NCT00000539|Beta Carotene|beta carotene|mesh-list
56302724|NCT00000539|Warfarin|warfarin|mesh-list
56302725|NCT00000539|Pravastatin|pravastatin|mesh-list
56302726|NCT00000539|Carotenoids|carotenoids|mesh-list
56302727|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
56302728|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302729|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
56302730|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
56302731|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302732|NCT00000539|Protective Agents|protective agents|mesh-ancestor
56302733|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56302734|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
56302735|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56302736|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56302737|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56302738|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302739|NCT00000539|Provitamins|provitamins|mesh-ancestor
55924668|NCT02795520|OTS167|ots167|mesh-list
56302740|NCT00030979|Donepezil|donepezil|mesh-list
56302741|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56302743|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302744|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
56302745|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302746|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302747|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
56302748|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
56302749|NCT00031018|Donepezil|donepezil|mesh-list
56302750|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56302751|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302752|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302753|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
56302754|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302755|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302756|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
56302772|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302773|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302774|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56302775|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56302776|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56302777|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
56302778|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302779|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302780|NCT00000554|Protective Agents|protective agents|mesh-ancestor
56302781|NCT00012909|Hormones|hormones|mesh-list
56302782|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302783|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302784|NCT00031096|Azelaic acid|azelaic acid|mesh-list
56302785|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302786|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
56302787|NCT00031135|Choline|choline|mesh-list
56302788|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
56302789|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56906311|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56906312|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56906313|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56906314|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
56906315|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906316|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906317|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56906318|NCT03253094|Fluconazole|fluconazole|mesh-list
56906319|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
56906320|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
56616977|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56906321|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906322|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56906323|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56906324|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530511|NCT01253135|Petrolatum|petrolatum|mesh-list
56302790|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
56302791|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302792|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56302793|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56302794|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
56302795|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
56302796|NCT00031291|Antibodies|antibodies|mesh-list
56302797|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
56302798|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56302799|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56302800|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
56302801|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302803|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56302804|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302805|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302806|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302807|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56302808|NCT00396058|Methylphenidate|methylphenidate|mesh-list
56302809|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56302810|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302811|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56302812|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56302813|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56302814|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302815|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
55924742|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
56302816|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302817|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56302818|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
56302829|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302831|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
56302832|NCT00000563|Hormones|hormones|mesh-ancestor
56302833|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302834|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56302835|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302836|NCT00031564|Aldesleukin|aldesleukin|mesh-list
56302837|NCT00031564|Interleukin-2|interleukin-2|mesh-list
56302838|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302839|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302840|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56302841|NCT00031564|Analgesics|analgesics|mesh-ancestor
56302842|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
56906325|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906326|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56906327|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
56906328|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906329|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906330|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56906331|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56906332|NCT05179070|Carvedilol|carvedilol|mesh-list
56906333|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56906334|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56906335|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
56906336|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906337|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906338|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906339|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56906340|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
56906341|NCT05179070|Protective Agents|protective agents|mesh-ancestor
56302843|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302844|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56302845|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56302846|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
56302847|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302848|NCT00031642|Rituximab|rituximab|mesh-list
56302849|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56302850|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302851|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
56302852|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302853|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302854|NCT00031681|Irinotecan|irinotecan|mesh-list
56302855|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56302856|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56302857|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56302858|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302859|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302860|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302861|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56302862|NCT00031720|Tamoxifen|tamoxifen|mesh-list
56302863|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56302864|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
56302865|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302866|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302867|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56302868|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302869|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56302870|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56302871|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56302872|NCT00000569|Triamcinolone|triamcinolone|mesh-list
56302873|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302875|NCT00000569|Hormones|hormones|mesh-ancestor
56302876|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302877|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302878|NCT00031759|Imiquimod|imiquimod|mesh-list
56302879|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56302880|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
56906342|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56906343|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56906344|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56906345|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
56906346|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56906347|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56906348|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
56906349|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
56906350|NCT03477500|Cladribine|cladribine|mesh-list
56906351|NCT03477500|Ocrelizumab|ocrelizumab|mesh-list
56906352|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906353|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
56906354|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906355|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56906356|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56906357|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
56906358|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906359|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906360|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56906361|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906362|NCT00179621|Lenalidomide|lenalidomide|mesh-list
56906363|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
56906364|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906365|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56906366|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56906367|NCT00179621|Growth Substances|growth substances|mesh-ancestor
56906368|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
56906369|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906370|NCT04862780|Osimertinib|osimertinib|mesh-list
56906371|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906372|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56906373|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906374|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906375|NCT00179309|Docetaxel|docetaxel|mesh-list
56906376|NCT00179309|Sargramostim|sargramostim|mesh-list
56906377|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906378|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
56906380|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
56906381|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906382|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
56906383|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906384|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
56906385|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
56906386|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56906387|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56906388|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906389|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906390|NCT03142568|Urological Agents|urological agents|mesh-ancestor
56906391|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56906392|NCT00177671|Donepezil|donepezil|mesh-list
56906393|NCT00177671|Citalopram|citalopram|mesh-list
56906394|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56302881|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302882|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302883|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
56302895|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
56302896|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56302897|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56302898|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56302899|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
56302900|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302901|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302902|NCT01791816|Protective Agents|protective agents|mesh-ancestor
56302903|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302904|NCT00031798|Methylphenidate|methylphenidate|mesh-list
56302905|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56302906|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302907|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56302908|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56302909|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56302910|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302911|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
56302912|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302913|NCT00031837|Gemcitabine|gemcitabine|mesh-list
56302914|NCT00031837|Dalteparin|dalteparin|mesh-list
56302915|NCT00031837|Tinzaparin|tinzaparin|mesh-list
56302916|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56302917|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302918|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
56302919|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302920|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302921|NCT00031837|Antiviral Agents|antiviral agents|mesh-ancestor
56302922|NCT00031837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302923|NCT00031837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302924|NCT00031837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302925|NCT00031837|Immunologic Factors|immunologic factors|mesh-ancestor
56302926|NCT00031837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302927|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
56302928|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56302929|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56302930|NCT00031876|Paclitaxel|paclitaxel|mesh-list
56302931|NCT00031876|Capecitabine|capecitabine|mesh-list
56302932|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56302933|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302934|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302935|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
56906395|NCT00177671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56906396|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56906397|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56906398|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906399|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906400|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
56906401|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530727|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56302936|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302937|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302938|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302939|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
56302940|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
56302941|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302942|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56302943|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302944|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302945|NCT00031954|Gemcitabine|gemcitabine|mesh-list
56302946|NCT00031954|Paclitaxel|paclitaxel|mesh-list
56302947|NCT00031954|Carboplatin|carboplatin|mesh-list
56302948|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56302960|NCT00031954|Immunologic Factors|immunologic factors|mesh-ancestor
56302961|NCT00031954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302962|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56302963|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302964|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56302965|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924908|NCT05135286|Carbachol|carbachol|mesh-list
56302966|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302967|NCT00000575|Nedocromil|nedocromil|mesh-list
56302968|NCT00000575|Budesonide|budesonide|mesh-list
56302969|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302970|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56302971|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
56302972|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302973|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302974|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56302975|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
56302976|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
56302977|NCT00000575|Hormones|hormones|mesh-ancestor
56302978|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56302979|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56302980|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
56302981|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56302982|NCT00032032|Paclitaxel|paclitaxel|mesh-list
56302983|NCT00032032|Carboplatin|carboplatin|mesh-list
56302984|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56302985|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302986|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302987|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
56302988|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302989|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302990|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56302991|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302992|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56302993|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302994|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302995|NCT00032149|Prednisolone|prednisolone|mesh-list
56302996|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
56302997|NCT00032149|Etoposide|etoposide|mesh-list
56302998|NCT00032149|Vincristine|vincristine|mesh-list
56302999|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
56303000|NCT00032149|Bleomycin|bleomycin|mesh-list
56303001|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303002|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
56303003|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906402|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56906403|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
56906404|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56906405|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906406|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
56906407|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56906408|NCT00177671|Analgesics|analgesics|mesh-ancestor
56906409|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
56906410|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
56906411|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56906412|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906413|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
56906414|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
56303004|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303005|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56303006|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
56303007|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303008|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303009|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56303010|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55942788|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56303042|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
56303043|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303044|NCT00000596|Dapsone|dapsone|mesh-list
56303045|NCT00000596|Prednisone|prednisone|mesh-list
56303046|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
56303047|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303048|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
56303049|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303050|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303051|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56303052|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
56303053|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303054|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303055|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56303056|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303057|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
56303058|NCT00000596|Hormones|hormones|mesh-ancestor
56303067|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
56303068|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56303069|NCT00000599|Niacin|niacin|mesh-list
56303070|NCT00000599|Colestipol|colestipol|mesh-list
56303071|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56303072|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
56303073|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303074|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56303075|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
56303076|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
56303077|NCT00000599|Vitamins|vitamins|mesh-ancestor
56303078|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
56303079|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303080|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
56303081|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
56303082|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303083|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
56303084|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303085|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303086|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303087|NCT00032734|Satavaptan|satavaptan|mesh-list
56303088|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56303089|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303090|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
56906415|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56906416|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
56906417|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906418|NCT03636932|Expectorants|expectorants|mesh-ancestor
56906419|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
56906420|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56906421|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
56906422|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906423|NCT03636932|Protective Agents|protective agents|mesh-ancestor
56303091|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303092|NCT00032773|Pentostatin|pentostatin|mesh-list
56303093|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303094|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56303095|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303096|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303097|NCT00032812|Raclopride|raclopride|mesh-list
56303098|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56303099|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56303100|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56303101|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303103|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56303104|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
56303105|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56303106|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303107|NCT00032890|Celecoxib|celecoxib|mesh-list
56303108|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56303109|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56303110|NCT00032890|Analgesics|analgesics|mesh-ancestor
56303111|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
56303112|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303113|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303114|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303115|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303116|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56303117|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56303118|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303119|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303120|NCT00032929|Selegiline|selegiline|mesh-list
56303121|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
56303122|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56303123|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56303124|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56303125|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56303139|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56303140|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56303141|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56303142|NCT00032968|Buprenorphine|buprenorphine|mesh-list
56303143|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56303144|NCT00032968|Naloxone|naloxone|mesh-list
56303145|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56303146|NCT00032968|Narcotics|narcotics|mesh-ancestor
56090934|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
56303147|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56303148|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303149|NCT00032968|Analgesics|analgesics|mesh-ancestor
56303150|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
56303151|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303152|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56303153|NCT00033046|Modafinil|modafinil|mesh-list
56303154|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56303155|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303156|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56303157|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56303158|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56079566|NCT00002889|Leuprolide|leuprolide|mesh-list
56906424|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906425|NCT03636932|Antidotes|antidotes|mesh-ancestor
56906426|NCT04781972|Methylphenidate|methylphenidate|mesh-list
56906427|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56906428|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303159|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303160|NCT00033085|Ondansetron|ondansetron|mesh-list
56303161|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
56303162|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
56303163|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303164|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303165|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56303166|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
56303167|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
56303168|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56303169|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
56303170|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56303171|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303172|NCT00033085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56303173|NCT00033085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56303174|NCT00033085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56303175|NCT00033085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56303176|NCT00033085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56303177|NCT00033163|Tenofovir|tenofovir|mesh-list
56303178|NCT00033163|Adefovir|adefovir|mesh-list
56303179|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56303180|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
56303181|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303182|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56303183|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303184|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303185|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303186|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56303187|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56144631|NCT00803010|Tacrolimus|tacrolimus|mesh-list
56303189|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56303190|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303191|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
56303192|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303193|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303194|NCT00033241|Antiviral Agents|antiviral agents|mesh-ancestor
56303195|NCT00033241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303196|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303197|NCT00033241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303198|NCT00033241|Immunologic Factors|immunologic factors|mesh-ancestor
56303199|NCT00033241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303200|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56303201|NCT00000620|Insulin|insulin|mesh-list
56303202|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56303203|NCT00000620|Metformin|metformin|mesh-list
56303204|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
56303205|NCT00000620|Pioglitazone|pioglitazone|mesh-list
56303206|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
56303207|NCT00000620|Glimepiride|glimepiride|mesh-list
56303208|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
56303209|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
56303210|NCT00000620|Acarbose|acarbose|mesh-list
56303211|NCT00000620|Repaglinide|repaglinide|mesh-list
56303212|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56303213|NCT00000620|Metoprolol|metoprolol|mesh-list
56303214|NCT00000620|Felodipine|felodipine|mesh-list
56303215|NCT00000620|Amlodipine|amlodipine|mesh-list
56303216|NCT00000620|Valsartan|valsartan|mesh-list
56303217|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56303218|NCT00000620|Carvedilol|carvedilol|mesh-list
56303219|NCT00000620|Candesartan|candesartan|mesh-list
56303220|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
56303221|NCT00000620|Lisinopril|lisinopril|mesh-list
56303222|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
56303223|NCT00000620|Diltiazem|diltiazem|mesh-list
56303225|NCT00000620|Hydralazine|hydralazine|mesh-list
56303226|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
56303227|NCT00000620|Reserpine|reserpine|mesh-list
56303228|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
56303229|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
56906429|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56906430|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56906431|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56906432|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303230|NCT00000620|Triamterene|triamterene|mesh-list
56303231|NCT00000620|Furosemide|furosemide|mesh-list
56303232|NCT00000620|Simvastatin|simvastatin|mesh-list
56303233|NCT00000620|Fenofibrate|fenofibrate|mesh-list
56303234|NCT00000620|Terazosin|terazosin|mesh-list
56303235|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303236|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56303237|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56303238|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303239|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56303240|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
56303241|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56303242|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56303243|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
56303244|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56303245|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56303246|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303247|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56303248|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56303249|NCT00000620|Diuretics|diuretics|mesh-ancestor
56303250|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
56303251|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56303252|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56303253|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303254|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
56303255|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56303256|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
56303257|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
56303258|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303259|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56303260|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56303261|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56303262|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
56303263|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56303264|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
55925191|NCT01499576|Protective Agents|protective agents|mesh-ancestor
56303265|NCT00000620|Protective Agents|protective agents|mesh-ancestor
56303266|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56303280|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56303281|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56303283|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56303284|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
56303285|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303286|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303287|NCT00033319|Aspirin|aspirin|mesh-list
56303288|NCT00033319|Folic Acid|folic acid|mesh-list
56303289|NCT00033319|Hematinics|hematinics|mesh-ancestor
56303290|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
56303291|NCT00033319|Vitamins|vitamins|mesh-ancestor
56303292|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
56303293|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303294|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56303295|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56303297|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
56303298|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303299|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303300|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303301|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56303302|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56303303|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303304|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56303305|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56303306|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303307|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
56079567|NCT00002889|Goserelin|goserelin|mesh-list
56906433|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
56906434|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906435|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
56303308|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56303309|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56303310|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
56303311|NCT00033358|Norgestrel|norgestrel|mesh-list
56303312|NCT00033358|Estradiol|estradiol|mesh-list
56303313|NCT00033358|Estrogens|estrogens|mesh-ancestor
56303314|NCT00033358|Hormones|hormones|mesh-ancestor
56303315|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56303316|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303317|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56303318|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
56303319|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56303320|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56303321|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56303322|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56303323|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56303324|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56303325|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56303327|NCT02971696|Sorafenib|sorafenib|mesh-list
55943044|NCT01452451|Exenatide|exenatide|mesh-list
56303336|NCT00033436|Vitamins|vitamins|mesh-ancestor
56303337|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
56303338|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303339|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56303340|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
56303341|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303342|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56303343|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
56303344|NCT00000635|Trifluridine|trifluridine|mesh-list
56303345|NCT00000635|Polymyxins|polymyxins|mesh-list
56303346|NCT00000635|Bacitracin|bacitracin|mesh-list
56303347|NCT00000635|Polymyxin B|polymyxin b|mesh-list
56303348|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
56303349|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303350|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
56303351|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303352|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56303353|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56303354|NCT00033553|Gemcitabine|gemcitabine|mesh-list
56303355|NCT00033553|Paclitaxel|paclitaxel|mesh-list
56303356|NCT00033553|Carboplatin|carboplatin|mesh-list
56303357|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56303358|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303359|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303360|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303361|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
56303362|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303363|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303364|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
56303365|NCT00033553|Antiviral Agents|antiviral agents|mesh-ancestor
56303366|NCT00033553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303367|NCT00033553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303368|NCT00033553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303369|NCT00033553|Immunologic Factors|immunologic factors|mesh-ancestor
56303370|NCT00033553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303371|NCT00033592|Bupropion|bupropion|mesh-list
56303372|NCT00033592|Nicotine|nicotine|mesh-list
56303373|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56303374|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
56303375|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303376|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303377|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56303378|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56303379|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
56303380|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56303381|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303382|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56303383|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
56303384|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56303385|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56303386|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56079568|NCT00002889|Flutamide|flutamide|mesh-list
56906436|NCT03235154|Velpatasvir|velpatasvir|mesh-list
56531139|NCT00979576|Pemetrexed|pemetrexed|mesh-list
56303387|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56303388|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
56303389|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56303390|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56303391|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303392|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
56303393|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
56303394|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56303395|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
56303396|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56303408|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303409|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303410|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303411|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
56303412|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303413|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
56303414|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56303415|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303416|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56303417|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56303418|NCT00033709|Growth Substances|growth substances|mesh-ancestor
56303419|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
56303420|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56303423|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56303424|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
56303425|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303426|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303427|NCT00000641|Azithromycin|azithromycin|mesh-list
56303428|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
56303429|NCT00000641|Rifampin|rifampin|mesh-list
56303430|NCT00000641|Amikacin|amikacin|mesh-list
56303431|NCT00000641|Ethambutol|ethambutol|mesh-list
56303432|NCT00000641|Clofazimine|clofazimine|mesh-list
56303433|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56303434|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303435|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56303436|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56303437|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303438|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303439|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303440|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56303441|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56303442|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56303443|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
56303444|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
56303445|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303446|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56303447|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56303448|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56303449|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56303450|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56303451|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56303452|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303453|NCT00000644|Clarithromycin|clarithromycin|mesh-list
56303454|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56303455|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303456|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56303457|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303458|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303459|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56303473|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043638|NCT01551056|Cetirizine|cetirizine|mesh-list
56303475|NCT00389090|Temozolomide|temozolomide|mesh-list
56303476|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56303477|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56303478|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
56303479|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303480|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303481|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303482|NCT00033982|Posaconazole|posaconazole|mesh-list
56906437|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56906438|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
56906439|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906440|NCT04345718|Buprenorphine|buprenorphine|mesh-list
56906441|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
56906442|NCT04345718|Narcotics|narcotics|mesh-ancestor
56906443|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906444|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906445|NCT04345718|Analgesics|analgesics|mesh-ancestor
56906446|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
56303483|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
56303484|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303485|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56303486|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56303487|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56303488|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56303489|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56303490|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303491|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303492|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56303493|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
55925417|NCT05688631|Antioxidants|antioxidants|mesh-list
56303494|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56303495|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303496|NCT00034060|Etanercept|etanercept|mesh-list
56303497|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56303498|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56303499|NCT00034060|Analgesics|analgesics|mesh-ancestor
56303500|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
56303501|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303502|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303503|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303504|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303505|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56303506|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303507|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
56303508|NCT00034138|Oregovomab|oregovomab|mesh-list
56303509|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56303510|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303511|NCT00034177|Paclitaxel|paclitaxel|mesh-list
56303512|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56303513|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56303514|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303515|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303516|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303517|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
56303527|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303528|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56303529|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56303530|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303531|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56303532|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56303533|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303534|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
56303535|NCT00013962|Vitamin D|vitamin d|mesh-list
56303536|NCT00013962|Vitamins|vitamins|mesh-ancestor
56303537|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
56303538|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303539|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56303540|NCT00000665|Ganciclovir|ganciclovir|mesh-list
56303541|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56303542|NCT00000665|Foscarnet|foscarnet|mesh-list
56303543|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56303544|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
56303545|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303546|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56906447|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906448|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56906449|NCT04977908|Insulin|insulin|mesh-list
56906450|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56906451|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906452|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
56906453|NCT02112916|Leucovorin|leucovorin|mesh-list
56906454|NCT02112916|Folic Acid|folic acid|mesh-list
56906455|NCT02112916|Cytarabine|cytarabine|mesh-list
56906456|NCT02112916|Dexamethasone|dexamethasone|mesh-list
56906457|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
56906458|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
56906459|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56906460|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56906461|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56906462|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
56906463|NCT02112916|Ifosfamide|ifosfamide|mesh-list
56906464|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
56906465|NCT02112916|Doxorubicin|doxorubicin|mesh-list
56906466|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56906467|NCT02112916|Methotrexate|methotrexate|mesh-list
56906468|NCT02112916|Etoposide|etoposide|mesh-list
56906469|NCT02112916|Vincristine|vincristine|mesh-list
56906470|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
56906471|NCT02112916|Bortezomib|bortezomib|mesh-list
56906472|NCT02112916|Daunorubicin|daunorubicin|mesh-list
56906473|NCT02112916|Asparaginase|asparaginase|mesh-list
56906474|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
56906475|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
56906476|NCT02112916|Pegaspargase|pegaspargase|mesh-list
56906477|NCT02112916|Thioguanine|thioguanine|mesh-list
56906478|NCT02112916|BB 1101|bb 1101|mesh-list
56906479|NCT02112916|Calcium|calcium|mesh-list
56303547|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303548|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303549|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56303550|NCT00034372|Oregovomab|oregovomab|mesh-list
56303551|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56303552|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303553|NCT00014001|Olanzapine|olanzapine|mesh-list
56303554|NCT00014001|Risperidone|risperidone|mesh-list
56303555|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56303556|NCT00014001|Ziprasidone|ziprasidone|mesh-list
56303557|NCT00014001|Clozapine|clozapine|mesh-list
56303558|NCT00014001|Perphenazine|perphenazine|mesh-list
56303559|NCT00014001|Fluphenazine|fluphenazine|mesh-list
56303560|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
56303561|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
56303562|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56303563|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
56303564|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56303565|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303566|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906480|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
56906481|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
56906482|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906483|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
56906484|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906485|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56906486|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56906487|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
56303567|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56303568|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56303569|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56303570|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56303571|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56303572|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
56303573|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
56303574|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
56303575|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303576|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56303577|NCT00014001|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56303578|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56303579|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56303580|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
56303581|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
56303582|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
56303583|NCT00000671|Zidovudine|zidovudine|mesh-list
56303584|NCT00000671|Didanosine|didanosine|mesh-list
56303585|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
55943302|NCT04937946|Fentanyl|fentanyl|mesh-list
56303601|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303602|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
56303603|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303604|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56303605|NCT02971540|Narcotics|narcotics|mesh-ancestor
56303606|NCT02971540|Analgesics|analgesics|mesh-ancestor
56303607|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56303608|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56303609|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303610|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303611|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
56303612|NCT00034489|Gemcitabine|gemcitabine|mesh-list
56303613|NCT00034489|Pemetrexed|pemetrexed|mesh-list
56303614|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303615|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
56303616|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303617|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303618|NCT00034489|Antiviral Agents|antiviral agents|mesh-ancestor
56303619|NCT00034489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303620|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303621|NCT00034489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303622|NCT00034489|Immunologic Factors|immunologic factors|mesh-ancestor
56303623|NCT00034489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303624|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56303625|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303626|NCT00396487|Fluorouracil|fluorouracil|mesh-list
56303627|NCT00396487|Capecitabine|capecitabine|mesh-list
56303629|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
56303630|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303631|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303632|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303633|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303634|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
56303635|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303636|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56303637|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56303638|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303639|NCT00000674|Leucovorin|leucovorin|mesh-list
56303640|NCT00000674|Clindamycin|clindamycin|mesh-list
56303641|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
56303642|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
56303643|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
56906488|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906489|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906490|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56906491|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56906492|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
56906493|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
56906494|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906495|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56906496|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
56906497|NCT02112916|Hormones|hormones|mesh-ancestor
56906498|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56303644|NCT00000674|Calcium|calcium|mesh-list
56303645|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
56303646|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56303647|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303648|NCT00000674|Antidotes|antidotes|mesh-ancestor
56303649|NCT00000674|Protective Agents|protective agents|mesh-ancestor
56303650|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
56303662|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
56303663|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56303664|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
56303665|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303666|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303667|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56303668|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
56303669|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56303670|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
56303671|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303672|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56303673|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56303674|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
56303675|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
56303676|NCT00014040|Protective Agents|protective agents|mesh-ancestor
56303677|NCT00034528|Prednisone|prednisone|mesh-list
56303678|NCT00034528|Fludarabine|fludarabine|mesh-list
56303679|NCT00034528|Busulfan|busulfan|mesh-list
56303680|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303681|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
56303682|NCT00034528|Hormones|hormones|mesh-ancestor
56303683|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56303684|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303685|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56303686|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303687|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303688|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303689|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
56303690|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
56303691|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56303692|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56303693|NCT00000677|Sch 39304|sch 39304|mesh-list
56303694|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
56303695|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303696|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
56303697|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56303698|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
56303699|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303700|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
56303701|NCT04711642|Protective Agents|protective agents|mesh-ancestor
56303702|NCT00034606|Gemcitabine|gemcitabine|mesh-list
56303703|NCT00034606|Pemetrexed|pemetrexed|mesh-list
56303704|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303705|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
56303706|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303707|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906499|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56906500|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
56906501|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906502|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56906503|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56906504|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56906505|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56906506|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56906507|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56906508|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
56906509|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56906510|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56906511|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
56906512|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
56906513|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56906514|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56906515|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56906516|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
56906517|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906518|NCT02112916|Antidotes|antidotes|mesh-ancestor
56906519|NCT02112916|Protective Agents|protective agents|mesh-ancestor
56906520|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
56906521|NCT02112916|Vitamins|vitamins|mesh-ancestor
56906522|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
56906523|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
56906524|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303708|NCT00034606|Antiviral Agents|antiviral agents|mesh-ancestor
56303709|NCT00034606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303710|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303711|NCT00034606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303712|NCT00034606|Immunologic Factors|immunologic factors|mesh-ancestor
56303713|NCT00034606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303714|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55943420|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
56303715|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303716|NCT00034645|Posaconazole|posaconazole|mesh-list
56303717|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
56303718|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303719|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56303720|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56303721|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56303722|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56303723|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56303725|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303726|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56303727|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
56303728|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56303729|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906525|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
56906526|NCT02112916|Hematinics|hematinics|mesh-ancestor
56906527|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
56906528|NCT03233438|Dalbavancin|dalbavancin|mesh-list
56906529|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56906530|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906531|NCT02251600|Deflazacort|deflazacort|mesh-list
56906532|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56906533|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906534|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
56906535|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906536|NCT02113072|Beclomethasone|beclomethasone|mesh-list
56906537|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56906538|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
56906539|NCT02113072|Hormones|hormones|mesh-ancestor
56906540|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906541|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906542|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56906543|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
56906544|NCT02113150|Ketamine|ketamine|mesh-list
56906545|NCT02113150|Remifentanil|remifentanil|mesh-list
56906546|NCT02113150|Analgesics|analgesics|mesh-ancestor
56906547|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
56906548|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906549|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906550|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56906551|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56906552|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
56906554|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906555|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56906556|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56303731|NCT00014118|Carboplatin|carboplatin|mesh-list
56303732|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56303733|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303734|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303735|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303736|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56303737|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303738|NCT00034762|Risperidone|risperidone|mesh-list
56303739|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56303740|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
56303741|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56303742|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303743|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303744|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56906557|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906558|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906559|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56906560|NCT02113150|Narcotics|narcotics|mesh-ancestor
56906561|NCT04647500|Methylphenidate|methylphenidate|mesh-list
56906562|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56906563|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906564|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56906565|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56906566|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56906567|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906568|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
56906569|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906570|NCT03553108|Olaparib|olaparib|mesh-list
56303745|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56303746|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56303747|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56303748|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56303749|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
56303750|NCT00000686|Stavudine|stavudine|mesh-list
56303751|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
56303752|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303753|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56303754|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303755|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303756|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
56303757|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303758|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56303759|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56303760|NCT00034801|Olanzapine|olanzapine|mesh-list
56303761|NCT00034801|Ziprasidone|ziprasidone|mesh-list
56303762|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
56303763|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
56303764|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303765|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303766|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56303767|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56303768|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56303769|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56303770|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56303771|NCT00034801|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56303772|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56303773|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56303774|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303775|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56303776|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
56303777|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56303778|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56303779|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
56303780|NCT00014196|Docetaxel|docetaxel|mesh-list
56303781|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303782|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303783|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303784|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
56303785|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303786|NCT00034840|Valsartan|valsartan|mesh-list
56303787|NCT00034840|Telmisartan|telmisartan|mesh-list
56303788|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56303789|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56473671|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906571|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56906572|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906573|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906574|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906575|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56906576|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
56906577|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56906578|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56906579|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303819|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56303820|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56303821|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56303822|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56303823|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56303825|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56303826|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
56303827|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56303828|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303829|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
56303830|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
56303831|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56303832|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303833|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
56303834|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303835|NCT00000689|Antidotes|antidotes|mesh-ancestor
56303836|NCT00000689|Protective Agents|protective agents|mesh-ancestor
56303837|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
56303838|NCT00000689|Vitamins|vitamins|mesh-ancestor
56303839|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
56303848|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303849|NCT00000707|Pentamidine|pentamidine|mesh-list
56303850|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
56303851|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303852|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56303853|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56303854|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56303855|NCT00014235|Cyclosporine|cyclosporine|mesh-list
56303856|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
56303857|NCT00014235|Fludarabine|fludarabine|mesh-list
56303858|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
56303859|NCT00014235|Cyclosporins|cyclosporins|mesh-list
56303860|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303861|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303862|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
56303863|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303864|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303865|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
56303866|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303867|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303868|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
56303869|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303870|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
56303871|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303872|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56303873|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56303874|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56303875|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
56303876|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56303879|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303880|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56303881|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303882|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303883|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
56303884|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906580|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
56906581|NCT02117128|Coagulants|coagulants|mesh-ancestor
56906582|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
56906583|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906584|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
56906585|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906586|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56906587|NCT02117362|Ipilimumab|ipilimumab|mesh-list
56906588|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906589|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303885|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56303886|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56303887|NCT00000716|Zidovudine|zidovudine|mesh-list
56303888|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
56303889|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303890|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56303891|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303892|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303893|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
56303894|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303895|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56303896|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56303897|NCT00014274|Gemcitabine|gemcitabine|mesh-list
56303898|NCT00014274|Carboplatin|carboplatin|mesh-list
56303899|NCT00014274|Methotrexate|methotrexate|mesh-list
56303900|NCT00014274|Vinblastine|vinblastine|mesh-list
56303901|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303902|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303903|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
56303904|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303905|NCT00014274|Antiviral Agents|antiviral agents|mesh-ancestor
56303906|NCT00014274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303907|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303908|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303909|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
55943607|NCT04407390|Vitamins|vitamins|mesh-ancestor
56303919|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303920|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303921|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
56303922|NCT00035035|Gemcitabine|gemcitabine|mesh-list
56303923|NCT00035035|Pemetrexed|pemetrexed|mesh-list
56303924|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303925|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
56303926|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303927|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303928|NCT00035035|Antiviral Agents|antiviral agents|mesh-ancestor
56303929|NCT00035035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303930|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303931|NCT00035035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303932|NCT00035035|Immunologic Factors|immunologic factors|mesh-ancestor
56303933|NCT00035035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303934|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56303935|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303936|NCT00000719|Zidovudine|zidovudine|mesh-list
56303937|NCT00000719|Zalcitabine|zalcitabine|mesh-list
56303938|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
56303939|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303940|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56303941|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303942|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303943|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
56303944|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303945|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56303946|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56303947|NCT00014313|Etoposide|etoposide|mesh-list
56303948|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303949|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56303950|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56906590|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56906591|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906592|NCT02113540|Atorvastatin|atorvastatin|mesh-list
56906593|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56906594|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56906595|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
56906596|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303951|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56303952|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303953|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303954|NCT00035074|Methotrexate|methotrexate|mesh-list
56303955|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56303956|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
56303957|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56303958|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303959|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56303960|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
56303961|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303962|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303963|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
56303964|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303965|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56303966|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303967|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
56303968|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303969|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303970|NCT00035113|Epothilones|epothilones|mesh-list
56303971|NCT00035113|Epothilone B|epothilone b|mesh-list
56303972|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303973|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303974|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
56303987|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303988|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303989|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
56303990|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303991|NCT00014352|Ketoconazole|ketoconazole|mesh-list
56303992|NCT00014352|Docetaxel|docetaxel|mesh-list
56303993|NCT00014352|Doxorubicin|doxorubicin|mesh-list
56303994|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56303995|NCT00014352|Estramustine|estramustine|mesh-list
56303996|NCT00014352|Warfarin|warfarin|mesh-list
56303997|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303998|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303999|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
56304000|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
56304001|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304002|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56304003|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56304004|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56304005|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304006|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
56304007|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
56304008|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304009|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56304010|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56304011|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56304012|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
56304013|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56304014|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304015|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56304016|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56304017|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
56091793|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
56304018|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56304020|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56304021|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473672|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
56906597|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56906598|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56906599|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906600|NCT02123056|Metoprolol|metoprolol|mesh-list
56906601|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56906602|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56906603|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
56906604|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
56906605|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531805|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56531806|NCT01101165|Narcotics|narcotics|mesh-ancestor
56531807|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531808|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531809|NCT01101165|Analgesics|analgesics|mesh-ancestor
56531810|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
56531811|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531812|NCT01100853|Naltrexone|naltrexone|mesh-list
56304022|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304023|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
56304024|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56304025|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304026|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56304027|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
56304028|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304029|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
56304030|NCT00035230|Topiramate|topiramate|mesh-list
56304031|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
56304032|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56304033|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304034|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56304035|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304036|NCT00014391|Ribavirin|ribavirin|mesh-list
56304037|NCT00014391|Palivizumab|palivizumab|mesh-list
56304038|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
56304047|NCT00035347|Levofloxacin|levofloxacin|mesh-list
56304049|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
56304050|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304051|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304052|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56304053|NCT00035347|Renal Agents|renal agents|mesh-ancestor
56304054|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56304055|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56304056|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304057|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304058|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304059|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56304060|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56304061|NCT00014430|Trastuzumab|trastuzumab|mesh-list
56304062|NCT00014430|Vinorelbine|vinorelbine|mesh-list
56304063|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56304064|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304065|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56304066|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
56304067|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
56304068|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
56304069|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304070|NCT00035425|Vancomycin|vancomycin|mesh-list
56304071|NCT00035425|Linezolid|linezolid|mesh-list
56304072|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56906606|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906607|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56906608|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56906609|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56906610|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
56906611|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648477|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304073|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304074|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56304075|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304076|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304077|NCT00000752|Cefuroxime|cefuroxime|mesh-list
56304078|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
56304079|NCT00000752|Beclomethasone|beclomethasone|mesh-list
56304080|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
56304081|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
56304082|NCT00000752|Ephedrine|ephedrine|mesh-list
56304083|NCT00000752|Guaifenesin|guaifenesin|mesh-list
56334003|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
56304084|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56304085|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56304086|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
56304088|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56304089|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304090|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56304091|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
56304092|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56304093|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
56304094|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304095|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
56304096|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56304097|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56304098|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
56304099|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
56304100|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56304101|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304102|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304103|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304104|NCT00000752|Expectorants|expectorants|mesh-ancestor
56304106|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56304115|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304116|NCT00014469|Methotrexate|methotrexate|mesh-list
56304118|NCT00014469|Busulfan|busulfan|mesh-list
56304119|NCT00014469|Tacrolimus|tacrolimus|mesh-list
56304120|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56304121|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
56304122|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56304123|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304124|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56304125|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
56304126|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304127|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304128|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
56304129|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304130|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56304131|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304132|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
56304133|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304134|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304135|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56304136|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56304137|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
56304138|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56304139|NCT00000755|Zidovudine|zidovudine|mesh-list
56304140|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
56304141|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304142|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56906612|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906613|NCT02120092|Clopidogrel|clopidogrel|mesh-list
56906614|NCT02120092|Ticagrelor|ticagrelor|mesh-list
56906615|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56906616|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56906617|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56906618|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56906619|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
56906620|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617281|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
56906621|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906622|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906624|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56906625|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906626|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56906627|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906628|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
56304143|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304144|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304145|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
56304146|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304147|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304148|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304149|NCT00014508|Cyclosporine|cyclosporine|mesh-list
56304150|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
56304151|NCT00014508|Melphalan|melphalan|mesh-list
56304152|NCT00014508|Fludarabine|fludarabine|mesh-list
56304153|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
56304154|NCT00014508|Cyclosporins|cyclosporins|mesh-list
56304155|NCT00014508|Sargramostim|sargramostim|mesh-list
56304156|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304157|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
56304158|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304159|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304160|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56304161|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
56304162|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304163|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304164|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56304165|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56304166|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
56304167|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304168|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
56304169|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304170|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
56304171|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56304172|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56304174|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
56304185|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
56304186|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304187|NCT00035620|Lenograstim|lenograstim|mesh-list
56304188|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56304189|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
56304190|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304191|NCT00014547|BBR 3464|bbr 3464|mesh-list
56304192|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304193|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
56304194|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56304195|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
56906629|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906630|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
56906631|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906632|NCT02117752|Dapsone|dapsone|mesh-list
56906633|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906634|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
56906635|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56906636|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56334985|NCT00067899|Vitamins|vitamins|mesh-list
56304196|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304197|NCT02971306|Expectorants|expectorants|mesh-ancestor
56304198|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
56304199|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56304200|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
56304201|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304202|NCT02971306|Protective Agents|protective agents|mesh-ancestor
56304203|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304204|NCT02971306|Antidotes|antidotes|mesh-ancestor
56304205|NCT00000761|Interferons|interferons|mesh-list
56304206|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
56304207|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304208|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
56304209|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304210|NCT00014586|Goserelin|goserelin|mesh-list
56304211|NCT00014586|Bicalutamide|bicalutamide|mesh-list
56304212|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56304213|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304214|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
56304215|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
56304216|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56304217|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304218|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
56304219|NCT04732390|Bupivacaine|bupivacaine|mesh-list
56304220|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
56304221|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
56304222|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56304223|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304224|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
56304225|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304226|NCT04732390|Analgesics|analgesics|mesh-ancestor
56304227|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56304228|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
56304229|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56304230|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56304231|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304232|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56304233|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
56304234|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56304235|NCT00035854|Linezolid|linezolid|mesh-list
56304236|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304237|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304238|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56304239|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943935|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
56304254|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304255|NCT00035971|Alendronate|alendronate|mesh-list
56304256|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56304257|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56304258|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304259|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56304260|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
56304261|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56304262|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56304263|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56304264|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56304265|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079973|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
56906637|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56906638|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906639|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906640|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
56906641|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56906642|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
56906643|NCT02117830|Enclomiphene|enclomiphene|mesh-list
56906644|NCT02117830|Clomiphene|clomiphene|mesh-list
56906645|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
56335046|NCT00144703|Sirolimus|sirolimus|mesh-list
56304266|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56304267|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304268|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304270|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
56304272|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
56304273|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56304274|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304275|NCT02971345|Trace Elements|trace elements|mesh-ancestor
56304276|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
56304277|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304278|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56304279|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304280|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56304281|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56304282|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304283|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304284|NCT00036088|Olanzapine|olanzapine|mesh-list
56304285|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
56304286|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
56304287|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304288|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304289|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56304290|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56304291|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56304292|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56304293|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56304294|NCT00036088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56304295|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56304296|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56304297|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304313|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
56304314|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56304315|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56304316|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56304317|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56304318|NCT00000788|Fluconazole|fluconazole|mesh-list
56304319|NCT00000788|Methadone|methadone|mesh-list
56304320|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56304321|NCT00000788|Narcotics|narcotics|mesh-ancestor
56304322|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56304323|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304324|NCT00000788|Analgesics|analgesics|mesh-ancestor
56304325|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
56304326|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304327|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
56304328|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
56304329|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
56304330|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304331|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56304332|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56304333|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304334|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304335|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56304336|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
56304337|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906646|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56906647|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906648|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56906649|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56906650|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906651|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906652|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906653|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56906654|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304338|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56304339|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56304340|NCT00036166|Micafungin|micafungin|mesh-list
56304341|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
56304342|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304343|NCT00000794|Leucovorin|leucovorin|mesh-list
56304344|NCT00000794|Clarithromycin|clarithromycin|mesh-list
56304345|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
56304346|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
56304347|NCT00000794|Atovaquone|atovaquone|mesh-list
56304348|NCT00000794|Calcium|calcium|mesh-list
56304349|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
56304350|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56304351|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304352|NCT00000794|Antidotes|antidotes|mesh-ancestor
56304353|NCT00000794|Protective Agents|protective agents|mesh-ancestor
56304354|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
56304355|NCT00000794|Vitamins|vitamins|mesh-ancestor
56304356|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
56304357|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304358|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304359|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56304375|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56304376|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56304378|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
56304379|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304380|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304381|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56304382|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304384|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56304385|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304386|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304387|NCT00391638|Interferons|interferons|mesh-list
56304388|NCT00391638|Tenofovir|tenofovir|mesh-list
56304389|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56304390|NCT00391638|Emtricitabine|emtricitabine|mesh-list
56304391|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56304392|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304393|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
56304394|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304395|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304396|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304397|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304398|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304399|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304400|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304401|NCT00036361|Aripiprazole|aripiprazole|mesh-list
56304402|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
56304403|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56304404|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56304405|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56304406|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56304407|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304408|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
56304409|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
56304410|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473673|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906655|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56906656|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
56906657|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906658|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56906659|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
56648478|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
56304411|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304412|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56304413|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56304414|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
56304415|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56304416|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56304417|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56304431|NCT00036556|Atrasentan|atrasentan|mesh-list
56304432|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304433|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56304434|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56304435|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304436|NCT00000827|Immune Sera|immune sera|mesh-list
56304437|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
56304438|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304439|NCT00036634|Tenofovir|tenofovir|mesh-list
56304440|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
56304441|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304442|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304443|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304444|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304445|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304446|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304447|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304448|NCT00000851|Didanosine|didanosine|mesh-list
56304449|NCT00000851|Stavudine|stavudine|mesh-list
56304450|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
56304451|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304452|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304453|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304454|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304455|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
56304456|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304458|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304459|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
56304460|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304461|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56304462|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304463|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304464|NCT00036790|Doxorubicin|doxorubicin|mesh-list
56304465|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56304466|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
56304467|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56304468|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304469|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56304470|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56304471|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304472|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304473|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56304474|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
56304475|NCT00000857|Interleukin-12|interleukin-12|mesh-list
56304476|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56304477|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
56304478|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304479|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56304480|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56304481|NCT00000857|Growth Substances|growth substances|mesh-ancestor
56304482|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
56304497|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
56304498|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56304499|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56906660|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56906661|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56906662|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
56304500|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
56304501|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56304502|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
56304503|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304504|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56304505|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304506|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56304507|NCT00036946|Aflibercept|aflibercept|mesh-list
56304508|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56304509|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56304510|NCT00036946|Growth Substances|growth substances|mesh-ancestor
56304511|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304512|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
56304513|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304514|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
56304515|NCT00036985|Doxorubicin|doxorubicin|mesh-list
56304516|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56304517|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304518|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
56304519|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304520|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304521|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56304522|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
56304523|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304524|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304525|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56304526|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56304527|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56304528|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56304529|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304530|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
56304531|NCT00037063|Vitamin E|vitamin e|mesh-list
56304532|NCT00037063|Riboflavin|riboflavin|mesh-list
56304533|NCT00037063|Thiamine|thiamine|mesh-list
56304534|NCT00037063|Vitamins|vitamins|mesh-ancestor
56304535|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
56304536|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304537|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
56304538|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304539|NCT00037063|Protective Agents|protective agents|mesh-ancestor
56304540|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
56304541|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56304542|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
56304543|NCT00000869|Nevirapine|nevirapine|mesh-list
56304544|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304558|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56304559|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
56304560|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56304561|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304562|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56304563|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
56304564|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304565|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304566|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
56304567|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304568|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56304569|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304570|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
56304571|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304572|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304573|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
56304574|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304575|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56304577|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56304578|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304579|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56304580|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304581|NCT00037180|Leucovorin|leucovorin|mesh-list
56304582|NCT00037180|Celecoxib|celecoxib|mesh-list
56304583|NCT00037180|Fluorouracil|fluorouracil|mesh-list
56906663|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
56906664|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56906665|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906666|NCT03552406|Cetuximab|cetuximab|mesh-list
56906667|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906668|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906669|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
56906670|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56906671|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
56906672|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906673|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
56304584|NCT00037180|Irinotecan|irinotecan|mesh-list
56304585|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
56304586|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304587|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56304588|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304589|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304590|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
56304591|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304592|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56304593|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56304594|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304595|NCT00037180|Antidotes|antidotes|mesh-ancestor
56304596|NCT00037180|Protective Agents|protective agents|mesh-ancestor
56304597|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
56304598|NCT00037180|Vitamins|vitamins|mesh-ancestor
56304599|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
56304600|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56304601|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56304602|NCT00037180|Analgesics|analgesics|mesh-ancestor
56304603|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
56304604|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304605|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56304606|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304607|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56304624|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56304625|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56304626|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56304627|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56304628|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
56304630|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304631|NCT00396526|Amoxicillin|amoxicillin|mesh-list
56304632|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56304633|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304634|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304635|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56304636|NCT00396526|Renal Agents|renal agents|mesh-ancestor
56304637|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
56304638|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56304639|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56304640|NCT00037531|Sirolimus|sirolimus|mesh-list
56304641|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304642|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304643|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56304644|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304645|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
56304646|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304647|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
56304648|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304649|NCT00037570|Pantoprazole|pantoprazole|mesh-list
56304650|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56304651|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56304652|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56304653|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304654|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906674|NCT02123368|Protective Agents|protective agents|mesh-ancestor
56906675|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
56906676|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56906677|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
56906678|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56906679|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
56906680|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906681|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304655|NCT00000899|Lamivudine|lamivudine|mesh-list
56304656|NCT00000899|Stavudine|stavudine|mesh-list
56304657|NCT00000899|Nelfinavir|nelfinavir|mesh-list
56304658|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
56304659|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304660|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
56304661|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304662|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304663|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56304664|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
56304665|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304666|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304667|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55944367|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
56304693|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
56304694|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304695|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56304696|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304697|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56304698|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304699|NCT00037804|Irinotecan|irinotecan|mesh-list
56304700|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56304701|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56304702|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304703|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304704|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304705|NCT00037882|Interferons|interferons|mesh-list
56304706|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
56304707|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
56304708|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56304709|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304710|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
56304711|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304712|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
56304713|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304714|NCT00037999|Testosterone|testosterone|mesh-list
56304724|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304725|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304726|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56304727|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56304728|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56304729|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
56304730|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56304731|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304732|NCT00038116|Dopamine|dopamine|mesh-list
56304733|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56304734|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
56304735|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
56304736|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304737|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304738|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
56304739|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56304740|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304741|NCT00038116|Protective Agents|protective agents|mesh-ancestor
56304742|NCT00038194|Docetaxel|docetaxel|mesh-list
56304743|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
56304744|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304745|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
56304746|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
56304747|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
56906682|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
56906683|NCT02117986|Colistin|colistin|mesh-list
56906684|NCT02117986|Polymyxins|polymyxins|mesh-list
56906685|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56906686|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906687|NCT02118064|Irinotecan|irinotecan|mesh-list
56906688|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56906689|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56906690|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906691|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906692|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906693|NCT02120872|Simvastatin|simvastatin|mesh-list
56906694|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56906695|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56906696|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
56906697|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906698|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56906699|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56906700|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906701|NCT03552016|Riboflavin|riboflavin|mesh-list
56906702|NCT03552016|Vitamins|vitamins|mesh-ancestor
56906703|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
56906704|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906705|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
56906706|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56906707|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
56906708|NCT02788474|Nintedanib|nintedanib|mesh-list
56906709|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906710|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56906711|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906712|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906713|NCT02118142|Betaine|betaine|mesh-list
56906714|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56906715|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
56906716|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56906717|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
56906718|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906720|NCT02118376|Exenatide|exenatide|mesh-list
56906722|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906723|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56906724|NCT02118376|Incretins|incretins|mesh-ancestor
56906725|NCT02118376|Hormones|hormones|mesh-ancestor
56906726|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906727|NCT02124070|Hormones|hormones|mesh-list
56906728|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906729|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906730|NCT02118532|Paclitaxel|paclitaxel|mesh-list
56906731|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56906732|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906733|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
56906734|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
56906735|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
56304748|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304749|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56304750|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304751|NCT00038233|Thalidomide|thalidomide|mesh-list
56304752|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304753|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
56304754|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304755|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
56304756|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304757|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304758|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56304759|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56304760|NCT00038233|Growth Substances|growth substances|mesh-ancestor
56304761|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
56304762|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304763|NCT00000926|Nonoxynol|nonoxynol|mesh-list
56304764|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56304765|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56304766|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304767|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56304768|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
56304769|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56304770|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56304771|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
56304772|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56304773|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304774|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56304775|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
56304776|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304777|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304778|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304779|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304780|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
56304789|NCT00000941|Atorvastatin|atorvastatin|mesh-list
56304790|NCT00000941|Simvastatin|simvastatin|mesh-list
56304791|NCT00000941|Pravastatin|pravastatin|mesh-list
56304792|NCT00000941|Calcium|calcium|mesh-list
56304793|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56304794|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304795|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56304796|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56304797|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
56304798|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304799|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56304800|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56304801|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906736|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906737|NCT02118688|Risperidone|risperidone|mesh-list
56906738|NCT02118688|Trazodone|trazodone|mesh-list
56906739|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56906740|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
56906741|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906742|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906743|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304802|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56304803|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56304804|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
56304805|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304806|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304807|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
56304808|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304809|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56304810|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56304811|NCT00014937|Ritonavir|ritonavir|mesh-list
56304812|NCT00014937|Lopinavir|lopinavir|mesh-list
56304813|NCT00014937|Lamivudine|lamivudine|mesh-list
56304814|NCT00014937|Zidovudine|zidovudine|mesh-list
56304815|NCT00014937|Didanosine|didanosine|mesh-list
56304816|NCT00014937|Stavudine|stavudine|mesh-list
56304817|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56304818|NCT00014937|Efavirenz|efavirenz|mesh-list
56304819|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56304820|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56304821|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
56304822|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304823|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304824|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304825|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304826|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
56304827|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161095|NCT02015910|Hormones|hormones|mesh-ancestor
56304828|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56304829|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56304830|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304831|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304832|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
56304833|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56304834|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56304835|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56304836|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56304837|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56304839|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
56304840|NCT00000959|Isoniazid|isoniazid|mesh-list
56304841|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
56304842|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304843|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304844|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56304845|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56304846|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
56304847|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304848|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56304858|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304860|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304861|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
56304862|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304863|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304864|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304865|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56304866|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56304867|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
56304868|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304869|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
56906744|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56906745|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56906746|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906747|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56906748|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56906749|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
56906750|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56906751|NCT02118688|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56906752|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56906753|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56906754|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56906755|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
56906756|NCT02126956|Ponesimod|ponesimod|mesh-list
56906757|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56906758|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906759|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304870|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304871|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304872|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56304873|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
56304874|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304875|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304876|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56304877|NCT00396721|Sirolimus|sirolimus|mesh-list
56304878|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56304879|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56304880|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304881|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304882|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56304883|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304884|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
56304885|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304886|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
56304887|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304888|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56304889|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56304890|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
56304891|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304892|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304893|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56304894|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
56304895|NCT00000965|Zidovudine|zidovudine|mesh-list
56304896|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
56304897|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304898|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304899|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304900|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304901|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
56304902|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304903|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304904|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304905|NCT00015054|Methylphenidate|methylphenidate|mesh-list
56304906|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56304907|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304908|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56473674|NCT05142098|Dexamethasone|dexamethasone|mesh-list
56906760|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
56906761|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906762|NCT02124148|Leucovorin|leucovorin|mesh-list
56906763|NCT02124148|Fluorouracil|fluorouracil|mesh-list
56906764|NCT02124148|Pemetrexed|pemetrexed|mesh-list
56906765|NCT02124148|Cetuximab|cetuximab|mesh-list
56906766|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906767|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
56906768|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648479|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
56304909|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56304910|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56304911|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304912|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
56304913|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926834|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
56304930|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304931|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304932|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
56304933|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304934|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304935|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304936|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56304937|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56304938|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56304939|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56304940|NCT00015171|Buprenorphine|buprenorphine|mesh-list
56304941|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56304942|NCT00015171|Naloxone|naloxone|mesh-list
56304943|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56304944|NCT00015171|Narcotics|narcotics|mesh-ancestor
56304945|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56304946|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304947|NCT00015171|Analgesics|analgesics|mesh-ancestor
56304948|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
56304949|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304950|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56304951|NCT00015210|Nefazodone|nefazodone|mesh-list
56304952|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56304953|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56304954|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56304955|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304956|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56304957|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304958|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56304959|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
56304960|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56304961|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56304962|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56304963|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
56304964|NCT00000986|Zidovudine|zidovudine|mesh-list
56304965|NCT00000986|Aldesleukin|aldesleukin|mesh-list
56304966|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
56304967|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304968|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304969|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304982|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56304983|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304984|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304985|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56304987|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
56304988|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304989|NCT05195242|Dexamethasone|dexamethasone|mesh-list
56304990|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56906769|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56906770|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56617429|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
56906771|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
56906772|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906773|NCT02124148|Antidotes|antidotes|mesh-ancestor
56906774|NCT02124148|Protective Agents|protective agents|mesh-ancestor
56906775|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
56906776|NCT02124148|Vitamins|vitamins|mesh-ancestor
56906777|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
56906778|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906779|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56906780|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56906781|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906782|NCT02124226|Methotrexate|methotrexate|mesh-list
56906783|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56906784|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
56906785|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56906786|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906787|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56906788|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
56906789|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906790|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906791|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
56906792|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906793|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56906794|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906795|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
56906796|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56906797|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56906798|NCT02127034|Digoxin|digoxin|mesh-list
56906799|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
56906800|NCT02127034|Mirabegron|mirabegron|mesh-list
56906801|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56906802|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56906803|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906804|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304991|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
56304992|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
56906805|NCT02127034|Protective Agents|protective agents|mesh-ancestor
56906806|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906807|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56906808|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56906809|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
56906810|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906811|NCT02127034|Urological Agents|urological agents|mesh-ancestor
56906812|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56906813|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56906814|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56906815|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
56304993|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304994|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304995|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56304996|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
56304997|NCT05195242|Hormones|hormones|mesh-ancestor
56304998|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56304999|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305000|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305001|NCT00015288|Buprenorphine|buprenorphine|mesh-list
56305002|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55926910|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305004|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56305005|NCT00015288|Narcotics|narcotics|mesh-ancestor
56305006|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56305007|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305008|NCT00015288|Analgesics|analgesics|mesh-ancestor
56305009|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
56305010|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305011|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56305012|NCT05083975|Anesthetics|anesthetics|mesh-list
56305013|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
56305014|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56305015|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305016|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
56305017|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305018|NCT00000998|Leucovorin|leucovorin|mesh-list
56305019|NCT00000998|Trimetrexate|trimetrexate|mesh-list
56305020|NCT00000998|Calcium|calcium|mesh-list
56305021|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
56305022|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56305023|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305024|NCT00000998|Antidotes|antidotes|mesh-ancestor
56305025|NCT00000998|Protective Agents|protective agents|mesh-ancestor
56305026|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
56305027|NCT00000998|Vitamins|vitamins|mesh-ancestor
56305028|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
56305029|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
56305030|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305031|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305032|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
56305033|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305034|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305035|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56305036|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305038|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
56305052|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305053|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56305054|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56305055|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56305057|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56305058|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56305059|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56305060|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
56906816|NCT02787304|Volixibat|volixibat|mesh-list
56906817|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56906818|NCT00574496|Gemcitabine|gemcitabine|mesh-list
56906819|NCT00574496|Cyclosporine|cyclosporine|mesh-list
56906820|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
56906821|NCT00574496|Prednisone|prednisone|mesh-list
56305062|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
56305063|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
56305064|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56305065|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305066|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56305067|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56305068|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
56305069|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56305070|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56305071|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305072|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56305073|NCT00001004|Interferons|interferons|mesh-list
56305074|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
56305075|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305076|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
56305077|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305078|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
56305079|NCT00396760|Aprotinin|aprotinin|mesh-list
56305080|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56305081|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56305082|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305083|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
56305084|NCT00396760|Coagulants|coagulants|mesh-ancestor
56305085|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56305086|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56305087|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
56305088|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305089|NCT00001007|Zidovudine|zidovudine|mesh-list
56305090|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
56305091|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305092|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56305093|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305094|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305095|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
56305096|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305097|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56305098|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56305099|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
56305100|NCT00396799|Estrogens|estrogens|mesh-list
56305101|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56305102|NCT00396799|Hormones|hormones|mesh-ancestor
55944798|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56305113|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305115|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
56305116|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305117|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56305118|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56305119|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
56305120|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
56305121|NCT00001010|Zidovudine|zidovudine|mesh-list
56305122|NCT00001010|Acyclovir|acyclovir|mesh-list
56305123|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
56305124|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305125|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56305126|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305127|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305128|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
56305129|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305130|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56305131|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56305132|NCT00001013|Leucovorin|leucovorin|mesh-list
56305133|NCT00001013|Trimethoprim|trimethoprim|mesh-list
56305134|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56305136|NCT00001013|Pentamidine|pentamidine|mesh-list
56305137|NCT00001013|Trimetrexate|trimetrexate|mesh-list
56305138|NCT00001013|Calcium|calcium|mesh-list
56305139|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
56305140|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56906822|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
56906823|NCT00574496|Melphalan|melphalan|mesh-list
56906824|NCT00574496|Ifosfamide|ifosfamide|mesh-list
56906825|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
56906826|NCT00574496|Methotrexate|methotrexate|mesh-list
56335918|NCT00068757|Paclitaxel|paclitaxel|mesh-list
56305141|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305142|NCT00001013|Antidotes|antidotes|mesh-ancestor
56305143|NCT00001013|Protective Agents|protective agents|mesh-ancestor
56305144|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
56305145|NCT00001013|Vitamins|vitamins|mesh-ancestor
56305146|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
56305147|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56305148|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305149|NCT00001013|Renal Agents|renal agents|mesh-ancestor
56305150|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
56305151|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56305152|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56305153|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56305154|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305155|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305156|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56305157|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56305158|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56305159|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
56305160|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56305161|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56305162|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305163|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
56305164|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305165|NCT04680442|Trastuzumab|trastuzumab|mesh-list
56305166|NCT04680442|Pertuzumab|pertuzumab|mesh-list
56305167|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56305168|NCT04680442|Maytansine|maytansine|mesh-list
56305183|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305184|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305185|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
56305186|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305187|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56305188|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305190|NCT00001040|Zalcitabine|zalcitabine|mesh-list
56305191|NCT00001040|Saquinavir|saquinavir|mesh-list
56305192|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
56305193|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305194|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56305195|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305196|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305197|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
56305198|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305199|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56305200|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56305201|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56305202|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56305203|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
56305204|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56305205|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56305206|NCT00015873|Cytarabine|cytarabine|mesh-list
56305207|NCT00015873|Prednisolone|prednisolone|mesh-list
56305208|NCT00015873|Methotrexate|methotrexate|mesh-list
56305209|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
56305210|NCT00015873|Vincristine|vincristine|mesh-list
56305211|NCT00015873|Asparaginase|asparaginase|mesh-list
56305212|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56305213|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
56305214|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56305215|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305216|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305217|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
56305218|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305219|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305220|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
56305221|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305222|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56305223|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906827|NCT00574496|Fludarabine|fludarabine|mesh-list
56906828|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
56906829|NCT00574496|Vincristine|vincristine|mesh-list
56906830|NCT00574496|Vinorelbine|vinorelbine|mesh-list
56906831|NCT00574496|Procarbazine|procarbazine|mesh-list
56906832|NCT00574496|Cyclosporins|cyclosporins|mesh-list
56906833|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906834|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
56906835|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906836|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56906837|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56906838|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
56906839|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906840|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906841|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56335987|NCT00040391|Vitamins|vitamins|mesh-ancestor
56305224|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
56305225|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305226|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305227|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
56305228|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944922|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305242|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305243|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
56305244|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305245|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
56305246|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305247|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305248|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
56305249|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56305250|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56305251|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56305252|NCT00015912|Growth Substances|growth substances|mesh-ancestor
56305253|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
56305254|NCT03668431|Trametinib|trametinib|mesh-list
56305255|NCT03668431|Dabrafenib|dabrafenib|mesh-list
56305256|NCT03668431|Spartalizumab|spartalizumab|mesh-list
56305257|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305258|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56305259|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305260|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305261|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56305262|NCT00001073|Isotretinoin|isotretinoin|mesh-list
56305263|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
56305264|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
56305265|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
56305266|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56305267|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56305268|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56305269|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305270|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
56305272|NCT00015951|Bevacizumab|bevacizumab|mesh-list
56305273|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
56305274|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56305275|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305276|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56305277|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56305278|NCT00015951|Growth Substances|growth substances|mesh-ancestor
56305279|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305280|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
56305281|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305282|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
56336049|NCT00040508|Sirolimus|sirolimus|mesh-list
56305283|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305284|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
56305285|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305286|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305287|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
56305289|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
56305290|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305291|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56305292|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56305293|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305311|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305312|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
56305313|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56305314|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305315|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56305316|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56305317|NCT00015990|Growth Substances|growth substances|mesh-ancestor
56305318|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
56305319|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305320|NCT00001085|Lamivudine|lamivudine|mesh-list
56305321|NCT00001085|Zidovudine|zidovudine|mesh-list
56305322|NCT00001085|Amprenavir|amprenavir|mesh-list
56305323|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56305324|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305325|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305326|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305327|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
56305328|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305329|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56305330|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56305331|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
56305332|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56305333|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
56305334|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093103|NCT04121078|Rifampin|rifampin|mesh-list
56305335|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56305336|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56305337|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
56305338|NCT02970916|Aflibercept|aflibercept|mesh-list
56305339|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56305340|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56305341|NCT02970916|Growth Substances|growth substances|mesh-ancestor
56305342|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305343|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
56305344|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305345|NCT00016068|Valganciclovir|valganciclovir|mesh-list
56305346|NCT00016068|Ganciclovir|ganciclovir|mesh-list
56305347|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56305348|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
56305349|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305350|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305351|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945044|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
56305370|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305372|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
56305373|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305374|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
56305375|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56305376|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56305377|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305378|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56305379|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56305380|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
56305381|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305382|NCT00016185|Docetaxel|docetaxel|mesh-list
56305383|NCT00016185|Alvocidib|alvocidib|mesh-list
56305384|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305385|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
56305386|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
56305387|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
56305388|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305389|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
56305390|NCT00016185|Growth Substances|growth substances|mesh-ancestor
56305391|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473675|NCT05142098|Etoricoxib|etoricoxib|mesh-list
56906842|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56906843|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
56305392|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56305393|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305394|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56305395|NCT00001151|Calcitriol|calcitriol|mesh-list
56305396|NCT00001151|Vitamins|vitamins|mesh-ancestor
56305397|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
56305398|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305399|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56305400|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56305401|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56305402|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56305403|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305404|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56305405|NCT00016224|Thalidomide|thalidomide|mesh-list
56305406|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305407|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
56305408|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305409|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
55945107|NCT01525069|Gemcitabine|gemcitabine|mesh-list
56305432|NCT00016302|Daunorubicin|daunorubicin|mesh-list
56305433|NCT00016302|Asparaginase|asparaginase|mesh-list
56305434|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
56305435|NCT00016302|Pegaspargase|pegaspargase|mesh-list
56305436|NCT00016302|Thioguanine|thioguanine|mesh-list
56305437|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
56305438|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305439|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
56305440|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305441|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305442|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56305443|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
56305444|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305445|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305446|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56305447|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56305448|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
56305449|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
56305450|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305451|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56305452|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
56305453|NCT00016302|Hormones|hormones|mesh-ancestor
56305454|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305455|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305456|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56305457|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56305458|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56305459|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305460|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56305461|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
56305462|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56305463|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305464|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
56305465|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
56305466|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56305478|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
56305479|NCT00389285|Sorafenib|sorafenib|mesh-list
56305480|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305481|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56305482|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305483|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305484|NCT00016341|Tamoxifen|tamoxifen|mesh-list
56305485|NCT00016341|Paclitaxel|paclitaxel|mesh-list
56305486|NCT00016341|Doxorubicin|doxorubicin|mesh-list
56305487|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56305488|NCT00016341|Megestrol|megestrol|mesh-list
56305489|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
56305490|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56305491|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305492|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
56305493|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
56305494|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
56305495|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906844|NCT00574496|Antiviral Agents|antiviral agents|mesh-ancestor
56906845|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305496|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56305497|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56305498|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56305499|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305500|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305501|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56305502|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
56305503|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305504|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305505|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56305506|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56305507|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56305508|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56305509|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56305510|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56305511|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
56305512|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56305513|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56305514|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56305515|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
56305516|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56305518|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305519|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305520|NCT00016380|Dexamethasone|dexamethasone|mesh-list
56305521|NCT00016380|Ondansetron|ondansetron|mesh-list
56305522|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56305523|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
56305524|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
56305525|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305526|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305527|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56305528|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
56305529|NCT00016380|Hormones|hormones|mesh-ancestor
56305530|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305531|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305540|NCT00016380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56305541|NCT00016380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56305542|NCT00016380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56305543|NCT00016380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56305544|NCT00001190|Deslorelin|deslorelin|mesh-list
56305545|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305546|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305547|NCT00001202|Testolactone|testolactone|mesh-list
56305548|NCT00001202|Spironolactone|spironolactone|mesh-list
56305549|NCT00001202|Deslorelin|deslorelin|mesh-list
56305550|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56305551|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
56305552|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305553|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305554|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56305555|NCT00001202|Diuretics|diuretics|mesh-ancestor
56305556|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
56305557|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305558|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305559|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305560|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305561|NCT00016419|Cyclosporine|cyclosporine|mesh-list
56305562|NCT00016419|Cyclosporins|cyclosporins|mesh-list
56305563|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56305564|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305565|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305566|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305567|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
56305568|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305569|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
56305570|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305571|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
56305572|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305573|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56906846|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906847|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56906848|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
56906849|NCT00574496|Hormones|hormones|mesh-ancestor
56906850|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906851|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56906852|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56906854|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56906855|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
56906856|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56906857|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56906858|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56906859|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
56906860|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
56906861|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
56906862|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
56906863|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56906864|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56906865|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56906866|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
56906867|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56906868|NCT02127190|CXA-10|cxa-10|mesh-list
56906869|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56906870|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
56906871|NCT03215810|Nivolumab|nivolumab|mesh-list
56906872|NCT03215810|Fludarabine|fludarabine|mesh-list
56906873|NCT03215810|Interleukin-2|interleukin-2|mesh-list
56906874|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906875|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
56906876|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305574|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
56305575|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56305576|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305577|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
56305578|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305579|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305580|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56305581|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
56305582|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305583|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305584|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56305585|NCT01156545|Afatinib|afatinib|mesh-list
56305586|NCT01156545|Simvastatin|simvastatin|mesh-list
56305587|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56305588|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56305589|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
56906877|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56906878|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56906879|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
56906880|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906881|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906882|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56906883|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906884|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56906885|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56906886|NCT03215810|Analgesics|analgesics|mesh-ancestor
56906887|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
56906888|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906889|NCT02932904|Vortioxetine|vortioxetine|mesh-list
56906890|NCT02932904|Paroxetine|paroxetine|mesh-list
56906891|NCT02932904|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56906892|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56906893|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336314|NCT00209014|Thalidomide|thalidomide|mesh-list
56305590|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305591|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56305592|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56305593|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305594|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305595|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55945283|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305612|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56305613|NCT02734771|Prednisone|prednisone|mesh-list
56305614|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
56305615|NCT02734771|Rituximab|rituximab|mesh-list
56305616|NCT02734771|Doxorubicin|doxorubicin|mesh-list
56305617|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56305618|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305619|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
56305620|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305621|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305622|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56305623|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
56305624|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305625|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305626|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56305627|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56305628|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56305629|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56305630|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56305632|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56305633|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
56305634|NCT02734771|Hormones|hormones|mesh-ancestor
56305635|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305636|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305637|NCT02347111|Sotalol|sotalol|mesh-list
56305638|NCT02347111|Flecainide|flecainide|mesh-list
56305639|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56305640|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56305641|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
56305642|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56080342|NCT00004179|Hormones|hormones|mesh-ancestor
56906894|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906895|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906896|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
56305643|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305644|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305645|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56305646|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
56305647|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
56305648|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305649|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56305650|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56305651|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56305653|NCT00001262|Trace Elements|trace elements|mesh-ancestor
56305654|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
56305655|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305656|NCT00001280|Itraconazole|itraconazole|mesh-list
56305657|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
56305658|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305659|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56305660|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56305678|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305680|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56305681|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
56305682|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305683|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305684|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56305685|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56305686|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
56305687|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
56305688|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305689|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56305690|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
56305691|NCT00016887|Hormones|hormones|mesh-ancestor
56305692|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305693|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305694|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56305695|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56305696|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56305697|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305698|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
56305699|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305700|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305701|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
56305702|NCT00038389|Rofecoxib|rofecoxib|mesh-list
56305703|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56305705|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305706|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305707|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56305708|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56305709|NCT00038389|Analgesics|analgesics|mesh-ancestor
56305710|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
56305711|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305712|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305713|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56305714|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305715|NCT00038506|Tenofovir|tenofovir|mesh-list
56305716|NCT00038506|Lamivudine|lamivudine|mesh-list
56305717|NCT00038506|Zidovudine|zidovudine|mesh-list
56305718|NCT00038506|Abacavir|abacavir|mesh-list
56305719|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56305726|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56305727|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56305728|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
56305729|NCT00016926|Capecitabine|capecitabine|mesh-list
56305730|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305731|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
56305732|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305733|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305734|NCT00038545|Paclitaxel|paclitaxel|mesh-list
56305735|NCT00038545|Topotecan|topotecan|mesh-list
56305736|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56906897|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336442|NCT00209677|Immunologic Factors|immunologic factors|mesh-ancestor
56305737|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305738|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
56305739|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
56305740|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
56305741|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305742|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56305743|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56305744|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305746|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305747|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305748|NCT00038623|Rituximab|rituximab|mesh-list
56305749|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56305750|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305751|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
56305752|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305753|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305754|NCT00038662|Atrasentan|atrasentan|mesh-list
56305755|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305756|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56305757|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56305758|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305759|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
56305760|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56305761|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305762|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56305763|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56305764|NCT00038701|Growth Substances|growth substances|mesh-ancestor
56305765|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305766|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
56305767|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56305768|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56305769|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56305770|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56305771|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305772|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56305773|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305774|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56305775|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
56305776|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56305777|NCT00038935|Factor VIII|factor viii|mesh-list
56305778|NCT00038935|Coagulants|coagulants|mesh-ancestor
56305779|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
56305780|NCT00017004|Hematinics|hematinics|mesh-ancestor
56305781|NCT00038974|Ribavirin|ribavirin|mesh-list
56305782|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56305783|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
56305784|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305785|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
56305786|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305794|NCT00039052|Interleukin-4|interleukin-4|mesh-list
56305795|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56305796|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
56305797|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305798|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305799|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305800|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
56305801|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305802|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56305803|NCT00039091|Ipilimumab|ipilimumab|mesh-list
56305804|NCT00039091|Antibodies|antibodies|mesh-list
56305805|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
56305806|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56305807|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
56305808|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305809|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305810|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56305811|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305812|NCT00039169|IDN 5109|idn 5109|mesh-list
56305813|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305814|NCT00001304|Vitamin D|vitamin d|mesh-list
56906898|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56906899|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
56906900|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56906901|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56906902|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56906903|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906904|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56906905|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56906906|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906907|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56906908|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56906909|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56906910|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56305815|NCT00001304|Calcitriol|calcitriol|mesh-list
56305816|NCT00001304|Calcium|calcium|mesh-list
56305817|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
56305818|NCT00001304|Hormones|hormones|mesh-list
56305819|NCT00001304|Vitamins|vitamins|mesh-ancestor
56305820|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
56305821|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305822|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56305823|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56305824|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305825|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56305826|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56305827|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305828|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56305829|NCT00039208|Leucovorin|leucovorin|mesh-list
56305830|NCT00039208|Fluorouracil|fluorouracil|mesh-list
56305831|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
56305832|NCT00039208|Irinotecan|irinotecan|mesh-list
56305833|NCT00039208|Calcium|calcium|mesh-list
56305834|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
56305835|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56305836|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305837|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
56305838|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305840|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305841|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305842|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
56305843|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56305844|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56305845|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305846|NCT00039208|Antidotes|antidotes|mesh-ancestor
56305847|NCT00039208|Protective Agents|protective agents|mesh-ancestor
56305848|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
56305849|NCT00039208|Vitamins|vitamins|mesh-ancestor
56305850|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
56305851|NCT00017121|Sargramostim|sargramostim|mesh-list
56305852|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
56093622|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
56305853|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305855|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56305856|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305857|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
56305858|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305866|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305868|NCT00039403|Antiviral Agents|antiviral agents|mesh-ancestor
56305869|NCT00039403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305870|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305871|NCT00039403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906911|NCT02127736|Amitriptyline|amitriptyline|mesh-list
56906912|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56906913|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
56906914|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56906915|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56906916|NCT02127736|Analgesics|analgesics|mesh-ancestor
56906917|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
56906918|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906919|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906920|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56906921|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56906922|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56906923|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906924|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
56906925|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906926|NCT02124850|Nivolumab|nivolumab|mesh-list
56305872|NCT00039403|Immunologic Factors|immunologic factors|mesh-ancestor
56305873|NCT00039403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305874|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56305875|NCT00039442|Capecitabine|capecitabine|mesh-list
56305876|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305877|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
56305878|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305879|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305880|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
56305881|NCT00039481|Doxorubicin|doxorubicin|mesh-list
56305882|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56305883|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
56305884|NCT00039481|Razoxane|razoxane|mesh-list
56305885|NCT00039481|Oblimersen|oblimersen|mesh-list
56305886|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305887|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
56305888|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305889|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305890|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56305892|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305893|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305894|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56305895|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56305896|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56305897|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56305898|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305899|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56305900|NCT00039481|Protective Agents|protective agents|mesh-ancestor
56305901|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
56305902|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
56305903|NCT00544830|Leuprolide|leuprolide|mesh-list
56305904|NCT00544830|Goserelin|goserelin|mesh-list
56305905|NCT00544830|Bicalutamide|bicalutamide|mesh-list
56305906|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56305907|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
56305908|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56305909|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305910|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305911|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305912|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
56305913|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
55927807|NCT04440007|Abivertinib|abivertinib|mesh-list
56305914|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906927|NCT02124850|Cetuximab|cetuximab|mesh-list
56906928|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56906929|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906930|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56305915|NCT00001322|Leuprolide|leuprolide|mesh-list
56305916|NCT00001322|Estradiol|estradiol|mesh-list
56305917|NCT00001322|Progesterone|progesterone|mesh-list
56305918|NCT00001322|Estrogens|estrogens|mesh-ancestor
56305919|NCT00001322|Hormones|hormones|mesh-ancestor
56305920|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305921|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305922|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56305923|NCT00001322|Progestins|progestins|mesh-ancestor
56305924|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56305925|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
56093762|NCT03565328|Niacin|niacin|mesh-list
55945606|NCT01428973|Sirolimus|sirolimus|mesh-list
56305929|NCT00039520|Docetaxel|docetaxel|mesh-list
56305930|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305931|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
56305932|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
56305933|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
56305934|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305935|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56305936|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56305937|NCT00039520|Analgesics|analgesics|mesh-ancestor
56305938|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
56305939|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305940|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305941|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56305942|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305943|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56305944|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305945|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56305946|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56305947|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56305948|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305949|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305950|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56305951|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56305952|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305953|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
56305954|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56305955|NCT00001328|Ganciclovir|ganciclovir|mesh-list
56305956|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56305957|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
56305958|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305959|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305960|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305961|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305962|NCT00017160|Doxorubicin|doxorubicin|mesh-list
56305963|NCT00017160|Ifosfamide|ifosfamide|mesh-list
56305964|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
56305965|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56305967|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56305968|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56305969|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305970|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305971|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305972|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56305973|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
56305974|NCT00039832|Reteplase|reteplase|mesh-list
56305975|NCT00039832|Abciximab|abciximab|mesh-list
56305976|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
56305977|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56305978|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56305979|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56305980|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305981|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
56305982|NCT00039988|Albuterol|albuterol|mesh-list
56305983|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
56305984|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56906931|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906932|NCT02125084|Everolimus|everolimus|mesh-list
56906933|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906934|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906935|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
56906936|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906937|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
56906938|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56906939|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906940|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906941|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56906942|NCT02122510|Analgesics|analgesics|mesh-ancestor
56906943|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
56906944|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906945|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56336717|NCT00210457|Lanreotide|lanreotide|mesh-list
56305985|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
56305986|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56305987|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305988|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56305989|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
56305990|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
56305991|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56305992|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56305993|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56305994|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56305995|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
56305996|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56305997|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305998|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56305999|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
56306013|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56306014|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306015|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
56306016|NCT00040066|Cocaine|cocaine|mesh-list
56306017|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
56306018|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
56306019|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56306020|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306021|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
56306022|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306023|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56306024|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56306025|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56306026|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306027|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306028|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
56306029|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306030|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
56306031|NCT00040105|Tipifarnib|tipifarnib|mesh-list
56306032|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306033|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56306034|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306035|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306036|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
56306037|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56080475|NCT00003711|Pemetrexed|pemetrexed|mesh-list
56906946|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56906947|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56906948|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
56906949|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56906950|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906951|NCT02125318|Anagrelide|anagrelide|mesh-list
56906952|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56906953|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56906954|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906955|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56906956|NCT02128126|Vaccines|vaccines|mesh-list
56306038|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56306039|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306040|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306041|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
56306042|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306043|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56306044|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56306045|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56306046|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306047|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56306048|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306049|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306050|NCT00040261|Memantine|memantine|mesh-list
56306051|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56306052|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56306053|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
56306054|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306055|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306056|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306057|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56306058|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56306059|NCT00040300|Racivir|racivir|mesh-list
56306060|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
56306061|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306062|NCT00040378|Vitamins|vitamins|mesh-list
56306063|NCT00040378|Vitamin E|vitamin e|mesh-list
56306064|NCT00040378|Tocopherols|tocopherols|mesh-list
56306076|NCT00040417|Fludarabine|fludarabine|mesh-list
56306077|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
56306078|NCT00040417|Lenograstim|lenograstim|mesh-list
56306079|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306080|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
56306081|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306082|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56306083|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56306084|NCT00040495|Pantoprazole|pantoprazole|mesh-list
56306085|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56306086|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56306087|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56306088|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306089|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306090|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
56306091|NCT00040651|Fludarabine|fludarabine|mesh-list
56306092|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
56306093|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306094|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
56306095|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306096|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306097|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56306098|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
56306099|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306100|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306101|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56906957|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
56906958|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906959|NCT02128204|Lidocaine|lidocaine|mesh-list
56906960|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
56906961|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
56906962|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56906963|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906964|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
56906965|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56906966|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56906967|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56906968|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56906969|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56906970|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906971|NCT02128282|Gemcitabine|gemcitabine|mesh-list
56906972|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906973|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56906974|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
56306103|NCT00040690|Cytarabine|cytarabine|mesh-list
56306104|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
56306105|NCT00040690|Ifosfamide|ifosfamide|mesh-list
56306106|NCT00040690|Doxorubicin|doxorubicin|mesh-list
56306107|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56306108|NCT00040690|Methotrexate|methotrexate|mesh-list
56306109|NCT00040690|Etoposide|etoposide|mesh-list
56306110|NCT00040690|Vincristine|vincristine|mesh-list
56306111|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
56306112|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306113|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
56306114|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306115|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306116|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56306117|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
56306118|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306119|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306120|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56306121|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56306122|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56306123|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56306124|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306125|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56306126|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
56306127|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56306128|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306129|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
56306130|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
56306131|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56306132|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56306145|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306146|NCT00040807|Docetaxel|docetaxel|mesh-list
56306147|NCT00040807|Irinotecan|irinotecan|mesh-list
56306148|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306149|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
56306150|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
56306151|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
56306152|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306153|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56906975|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56906976|NCT02128282|Antiviral Agents|antiviral agents|mesh-ancestor
56906977|NCT02128282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56906978|NCT02128282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56906979|NCT02128282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56906980|NCT02128282|Immunologic Factors|immunologic factors|mesh-ancestor
56906981|NCT02128282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906982|NCT02125630|Hormones|hormones|mesh-list
56906983|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906984|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906985|NCT03551548|Spironolactone|spironolactone|mesh-list
56906986|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56906987|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
56336894|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306154|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56306155|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306156|NCT00017238|KRN 5500|krn 5500|mesh-list
56306157|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306158|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56306159|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306160|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306161|NCT00040885|Docetaxel|docetaxel|mesh-list
56306162|NCT00040885|Infliximab|infliximab|mesh-list
56306163|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306164|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
56306165|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
56306166|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
56306167|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306168|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
56306169|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56306170|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306171|NCT00001421|Methimazole|methimazole|mesh-list
56306172|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
56306173|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
56306174|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56306175|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306176|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
56306177|NCT00017277|Hematinics|hematinics|mesh-ancestor
56306178|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
56306179|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306180|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56306181|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306182|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306183|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
56306184|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306185|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56306186|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306187|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306188|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
56306189|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306190|NCT00041236|Exatecan|exatecan|mesh-list
56306191|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56306192|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56306193|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306194|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306195|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306196|NCT00017316|Thalidomide|thalidomide|mesh-list
56306197|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945871|NCT02124421|Carboplatin|carboplatin|mesh-list
56306207|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56906988|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56906989|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56906990|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56906991|NCT03551548|Diuretics|diuretics|mesh-ancestor
56906992|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
56906993|NCT02542293|Gemcitabine|gemcitabine|mesh-list
56906994|NCT02542293|Paclitaxel|paclitaxel|mesh-list
56906995|NCT02542293|Cisplatin|cisplatin|mesh-list
56906996|NCT02542293|Carboplatin|carboplatin|mesh-list
56906997|NCT02542293|Pemetrexed|pemetrexed|mesh-list
56906998|NCT02542293|Durvalumab|durvalumab|mesh-list
56906999|NCT02542293|Tremelimumab|tremelimumab|mesh-list
56907000|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56907001|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907002|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
56306209|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
56306210|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56306211|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56306212|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56306213|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
56306214|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56306215|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306216|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56306217|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56306218|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56306219|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306220|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
56306221|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56306222|NCT00041314|Gemcitabine|gemcitabine|mesh-list
56306223|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
56306224|NCT00041314|Carboplatin|carboplatin|mesh-list
56306225|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306226|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306227|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
56306228|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306229|NCT00041314|Antiviral Agents|antiviral agents|mesh-ancestor
56306230|NCT00041314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306231|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306232|NCT00041314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306233|NCT00041314|Immunologic Factors|immunologic factors|mesh-ancestor
56306234|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306235|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56306236|NCT00041314|Protective Agents|protective agents|mesh-ancestor
56306237|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56306238|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56306239|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56306240|NCT00041314|Analgesics|analgesics|mesh-ancestor
56306241|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
56306242|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306243|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56306244|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306245|NCT00017355|Lenograstim|lenograstim|mesh-list
56306246|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56306247|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
56306248|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306249|NCT00397072|Sagopilone|sagopilone|mesh-list
56306250|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306251|NCT00017394|Bevacizumab|bevacizumab|mesh-list
56306252|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56306253|NCT00017394|Vinorelbine|vinorelbine|mesh-list
56306254|NCT00017394|Antibodies|antibodies|mesh-list
56306255|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
56306256|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56907003|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
56907004|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
56907005|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907006|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56907007|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
56907008|NCT02542293|Antiviral Agents|antiviral agents|mesh-ancestor
56907009|NCT02542293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306257|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306258|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56306259|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56306260|NCT00017394|Growth Substances|growth substances|mesh-ancestor
56306261|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306262|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
56306263|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
56306264|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56306275|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56306277|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56306278|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306279|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56306280|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56306281|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56306282|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
56306283|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56306284|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
56306285|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306286|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306287|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56306288|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
56306289|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56306291|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306292|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306293|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56306294|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
56306295|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
56306296|NCT00041548|Protective Agents|protective agents|mesh-ancestor
56306297|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
56306298|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306299|NCT00041665|Mitogens|mitogens|mesh-list
56306300|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
56306301|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306302|NCT00041704|Anidulafungin|anidulafungin|mesh-list
56306303|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
56306304|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306305|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56306306|NCT00017472|Antibodies|antibodies|mesh-list
56306307|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
56306308|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56306309|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
56306310|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306311|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306312|NCT00041782|Dalteparin|dalteparin|mesh-list
56306313|NCT00041782|Tinzaparin|tinzaparin|mesh-list
56306314|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56306315|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
56306316|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56306317|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56306318|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306319|NCT00017511|Cevimeline|cevimeline|mesh-list
56306320|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56306321|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
56306322|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306323|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306324|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56306325|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56306326|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
56306327|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946000|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
56907010|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907011|NCT02542293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907012|NCT02542293|Immunologic Factors|immunologic factors|mesh-ancestor
56907013|NCT02542293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907014|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56907015|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56907016|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56907017|NCT02128360|Letrozole|letrozole|mesh-list
56907018|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907019|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56907020|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56907021|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306338|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
56306339|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56306340|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56306342|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306343|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
56306344|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306345|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306346|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306347|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56306348|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
56306349|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306350|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306351|NCT00001457|Lamivudine|lamivudine|mesh-list
56306352|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56306353|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56306354|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306355|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306356|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
56306357|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306358|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56306359|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56306360|NCT00042172|Donepezil|donepezil|mesh-list
56306362|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306363|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306364|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
56306365|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306366|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306367|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
56306368|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
56306369|NCT00017589|Oblimersen|oblimersen|mesh-list
56306370|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56306372|NCT00001475|Thalidomide|thalidomide|mesh-list
56306373|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306374|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
56306375|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306376|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
56306377|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306378|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306379|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56306380|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56306381|NCT00001475|Growth Substances|growth substances|mesh-ancestor
56306382|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
56306383|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306384|NCT00042328|Valacyclovir|valacyclovir|mesh-list
56306385|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
56306386|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306387|NCT00042367|Mafosfamide|mafosfamide|mesh-list
56306388|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
56306389|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56306390|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
56306391|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306392|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907022|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907023|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56907024|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
56907025|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56907026|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907027|NCT02126020|Infliximab|infliximab|mesh-list
56907028|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
56907029|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56337144|NCT00214942|Narcotics|narcotics|mesh-ancestor
56306393|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306394|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306405|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56306406|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56306407|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56306408|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56306409|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56306410|NCT02970643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56306411|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56306412|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306413|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306414|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306415|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
56306416|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56306417|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56306418|NCT00042406|Zanolimumab|zanolimumab|mesh-list
56306419|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56306420|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306421|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
56306422|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56306423|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56306425|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
56306426|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
56306427|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56306428|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
56306429|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306430|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
56306431|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306432|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306433|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56306434|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
56306435|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306437|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56306438|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56306439|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
56306440|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
56306441|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306442|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56306443|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
56306444|NCT00017628|Hormones|hormones|mesh-ancestor
56306445|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56306447|NCT00017628|Protective Agents|protective agents|mesh-ancestor
56306448|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56306449|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56306450|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56306451|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56306452|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306453|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306454|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306455|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306456|NCT00042562|Analgesics|analgesics|mesh-ancestor
56306457|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
56306458|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306459|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
56907030|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907031|NCT00688376|Donepezil|donepezil|mesh-list
56907032|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56907033|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907034|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907035|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
56907036|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56907037|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907038|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
56907039|NCT02126332|Acetaminophen|acetaminophen|mesh-list
56907040|NCT02126332|Sufentanil|sufentanil|mesh-list
56907041|NCT02126332|Nefopam|nefopam|mesh-list
56306474|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306475|NCT00042679|Antiviral Agents|antiviral agents|mesh-ancestor
56306476|NCT00042679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306477|NCT00042679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306478|NCT00042679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306479|NCT00042679|Immunologic Factors|immunologic factors|mesh-ancestor
56306480|NCT00042679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306481|NCT00042718|Amoxicillin|amoxicillin|mesh-list
56306482|NCT00042718|Azithromycin|azithromycin|mesh-list
56306483|NCT00042718|Levofloxacin|levofloxacin|mesh-list
56306484|NCT00042718|Ofloxacin|ofloxacin|mesh-list
56306485|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
56306486|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
56306487|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56306488|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306489|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306490|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56306491|NCT00042718|Renal Agents|renal agents|mesh-ancestor
56306492|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56306493|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56306494|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046646|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
56306495|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306496|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306497|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56306498|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56306499|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56306501|NCT00042796|Azacitidine|azacitidine|mesh-list
56306502|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306503|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
56306504|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306505|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306506|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306507|NCT00042835|Paclitaxel|paclitaxel|mesh-list
56306508|NCT00042835|Etoposide|etoposide|mesh-list
56306509|NCT00042835|Docetaxel|docetaxel|mesh-list
56306510|NCT00042835|Carboplatin|carboplatin|mesh-list
56306511|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
56306512|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56306513|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56306514|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306515|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
56306516|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
56306517|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
56306518|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306519|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56306520|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56306521|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306522|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56306533|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306535|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306536|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080788|NCT00004401|Antibodies|antibodies|mesh-list
56907042|NCT02126332|Tramadol|tramadol|mesh-list
56907043|NCT02126332|Ropivacaine|ropivacaine|mesh-list
56907044|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
56306537|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306538|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306539|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
56306540|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56306541|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56306542|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306543|NCT00042874|Antidotes|antidotes|mesh-ancestor
56306544|NCT00042874|Protective Agents|protective agents|mesh-ancestor
56306545|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
56306546|NCT00042874|Vitamins|vitamins|mesh-ancestor
56306547|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
56306548|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
56306549|NCT00042874|Growth Substances|growth substances|mesh-ancestor
56306550|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56306551|NCT00042913|Epratuzumab|epratuzumab|mesh-list
56306552|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56306553|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306554|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
56306555|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306556|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56306557|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306558|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306559|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
56306560|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
56306561|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
56306562|NCT00043069|Estrogens|estrogens|mesh-list
56306563|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
56306564|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
56306565|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56306566|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306567|NCT00043069|Vitamins|vitamins|mesh-ancestor
56306568|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
56306569|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56306570|NCT00043069|Hormones|hormones|mesh-ancestor
56334005|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306571|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56306572|NCT00043069|Antacids|antacids|mesh-ancestor
56306573|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306574|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56306575|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56306576|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306577|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
56306578|NCT00043147|Prednisone|prednisone|mesh-list
56306579|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
56306580|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56306581|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56306582|NCT00043147|Prednisolone|prednisolone|mesh-list
56306583|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
56306584|NCT00043147|Beclomethasone|beclomethasone|mesh-list
56306585|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56306586|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
56306587|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56306588|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
56306589|NCT00043147|Hormones|hormones|mesh-ancestor
55946256|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306601|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
56306602|NCT00017862|Reslizumab|reslizumab|mesh-list
56306603|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56306604|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
56306605|NCT00043264|Azithromycin|azithromycin|mesh-list
56306606|NCT00043264|Rifampin|rifampin|mesh-list
56306607|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306608|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306609|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56306610|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
56306611|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
56306612|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56306613|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306614|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306615|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56306616|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56306617|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56907045|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
56907046|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907047|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907048|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
56306618|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56306619|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56306620|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56306621|NCT00043303|Interferons|interferons|mesh-list
56306622|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
56306623|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306624|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
56306625|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306626|NCT00017940|Mitogens|mitogens|mesh-list
56306627|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
56306628|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306629|NCT02970604|Aspirin|aspirin|mesh-list
56306630|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56306631|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56306632|NCT02970604|Analgesics|analgesics|mesh-ancestor
56306633|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
56306634|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306635|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306636|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56306637|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306638|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56306639|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56306640|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306641|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56306642|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56306643|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306644|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
56306645|NCT00043342|Interferons|interferons|mesh-list
56306647|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306648|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
56306649|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306650|NCT00043381|Decitabine|decitabine|mesh-list
56306651|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306652|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
55946320|NCT02935361|Atezolizumab|atezolizumab|mesh-list
56306661|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306662|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56306664|NCT00043537|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56306665|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56306666|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306667|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306668|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306669|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
56306670|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928562|NCT01831323|Analgesics|analgesics|mesh-ancestor
56306671|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56306672|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
56306673|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56306674|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56306675|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56306676|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306677|NCT00043576|Calcitriol|calcitriol|mesh-list
56306678|NCT00043576|Docetaxel|docetaxel|mesh-list
56306679|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306680|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
56306681|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
56306682|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56306683|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306684|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56306685|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306686|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56306687|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306688|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56306689|NCT00043576|Vitamins|vitamins|mesh-ancestor
56306690|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
56306691|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56907049|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907050|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56907051|NCT02126332|Analgesics|analgesics|mesh-ancestor
56907052|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
56907053|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56907054|NCT02126332|Narcotics|narcotics|mesh-ancestor
56907055|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56907056|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56907057|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
56907058|NCT01996436|Verapamil|verapamil|mesh-list
56907059|NCT01996436|Nicardipine|nicardipine|mesh-list
56337424|NCT00216619|Topiramate|topiramate|mesh-list
56306692|NCT00043654|Mifepristone|mifepristone|mesh-list
56306693|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56306694|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
56306695|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56306696|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306697|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56306698|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56306699|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56306700|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
56306701|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56306702|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56306703|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
56306704|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56306705|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
56306706|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56306707|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56306708|NCT00043771|Tolvaptan|tolvaptan|mesh-list
56306709|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56306710|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306711|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
56306712|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306713|NCT00043810|Fludarabine|fludarabine|mesh-list
56306714|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
56306715|NCT00043810|Busulfan|busulfan|mesh-list
56306728|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56306729|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306730|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56306731|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
56306732|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56306733|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56306734|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56306735|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56306736|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306737|NCT00001586|Rituximab|rituximab|mesh-list
56306738|NCT00001586|Fludarabine|fludarabine|mesh-list
56306739|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
56306740|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56306741|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306742|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
56306743|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306744|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306745|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306746|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
56306747|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306748|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306749|NCT00043888|Ritonavir|ritonavir|mesh-list
56306750|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
56306751|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56306752|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56306753|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56306754|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
56306755|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306756|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907060|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
56907061|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
56907062|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56907063|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56907064|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306757|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56306758|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56306759|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
56306760|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306761|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56306762|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56306763|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56306764|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56306765|NCT00018018|Zidovudine|zidovudine|mesh-list
56306766|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
56306767|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306768|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56306769|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56306770|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306771|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
56306772|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306773|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56306774|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56306775|NCT00043927|Cisplatin|cisplatin|mesh-list
56306788|NCT00043966|Emtricitabine|emtricitabine|mesh-list
56306789|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56306790|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56306791|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
56306792|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306793|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306794|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56306795|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56306796|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
56306797|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306798|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56306799|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56306800|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56306801|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56306802|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56306803|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56306804|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
56306805|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306806|NCT04731727|Riboflavin|riboflavin|mesh-list
56306807|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
56306808|NCT04731727|Vitamins|vitamins|mesh-ancestor
56306809|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
56306810|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306811|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56306812|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
56306813|NCT00044278|Lamotrigine|lamotrigine|mesh-list
56306814|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
56306815|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56306816|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306817|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306818|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56306819|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306821|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56306822|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56306823|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56306824|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56306825|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
56306826|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306827|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306828|NCT00044434|Bupropion|bupropion|mesh-list
56306829|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56306830|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
56306831|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56306832|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56306833|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56907065|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907066|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56907067|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907068|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56907069|NCT02131246|Insulin|insulin|mesh-list
56907070|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56907071|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
56907072|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
56907073|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56907074|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56907075|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907076|NCT02126644|Glycolic acid|glycolic acid|mesh-list
56907077|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
56306834|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306835|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306836|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
56306837|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306838|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946513|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306857|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306858|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56306860|NCT00018135|Sevelamer|sevelamer|mesh-list
56306861|NCT00018135|Calcium acetate|calcium acetate|mesh-list
56306862|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56306863|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306864|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
56306865|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
56306866|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334006|NCT00037544|Factor VIII|factor viii|mesh-list
56306867|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56306868|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
56306869|NCT00018135|Antacids|antacids|mesh-ancestor
56306870|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56306871|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56306872|NCT00397384|Cetuximab|cetuximab|mesh-list
56306873|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56306874|NCT00397384|Antibodies|antibodies|mesh-list
56306875|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
56306876|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56306877|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
56306878|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306879|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306880|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56306881|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306882|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306883|NCT00397423|Lenograstim|lenograstim|mesh-list
56306884|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56306885|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
56306886|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306887|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
56306888|NCT00397501|Carboplatin|carboplatin|mesh-list
56306889|NCT00397501|Methotrexate|methotrexate|mesh-list
56306890|NCT00397501|Trastuzumab|trastuzumab|mesh-list
56306891|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306892|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56306893|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
56306894|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55946582|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
56306906|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56306908|NCT00397501|Protective Agents|protective agents|mesh-ancestor
56306909|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
56306910|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
56907078|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
56907079|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
56907080|NCT03550534|Calcium|calcium|mesh-list
56907081|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56907082|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907083|NCT03550534|Antacids|antacids|mesh-ancestor
56907084|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907085|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56907086|NCT02131480|Doxorubicin|doxorubicin|mesh-list
56907087|NCT02131480|Trabectedin|trabectedin|mesh-list
56907088|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56337615|NCT00073437|Infliximab|infliximab|mesh-list
56306911|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306912|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306913|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
56306914|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
56306916|NCT00018174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56306917|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56306918|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56306919|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306920|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306921|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
56306922|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306923|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56306924|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
56306925|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56306926|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56306927|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56306928|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306929|NCT00044629|Zolpidem|zolpidem|mesh-list
56306930|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56306931|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56306932|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56306933|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306934|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56306935|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
56306936|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
56306937|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306938|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306939|NCT00044668|Exenatide|exenatide|mesh-list
56306940|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56306941|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306942|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56306944|NCT00044668|Hormones|hormones|mesh-ancestor
56306945|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56306946|NCT00044707|Pramlintide|pramlintide|mesh-list
56306947|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56306948|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306949|NCT00044746|Tazobactam|tazobactam|mesh-list
56306950|NCT00044746|Piperacillin|piperacillin|mesh-list
56306951|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56306952|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306953|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306954|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56306956|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306957|NCT00044785|Leucovorin|leucovorin|mesh-list
56306958|NCT00044785|Fluorouracil|fluorouracil|mesh-list
56306959|NCT00044785|Irinotecan|irinotecan|mesh-list
56306972|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56306973|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56306974|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306975|NCT00044824|Fexofenadine|fexofenadine|mesh-list
56306976|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56473676|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
56907089|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907090|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56907091|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56907092|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648480|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306977|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56306978|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56306979|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
56306980|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
56306981|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306982|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306983|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306984|NCT00018213|Naltrexone|naltrexone|mesh-list
56306985|NCT00018213|Nicotine|nicotine|mesh-list
56306986|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56306987|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
56306988|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306989|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306990|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56306991|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56306992|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
56306993|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56306994|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306995|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56306996|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56306997|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
56306998|NCT00044863|Cetuximab|cetuximab|mesh-list
56306999|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307000|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307001|NCT00044902|Epratuzumab|epratuzumab|mesh-list
56307002|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307003|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307004|NCT00045136|Melphalan|melphalan|mesh-list
56307005|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56307006|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
56307007|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307008|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307009|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56307010|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307011|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
56307012|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307013|NCT00001649|Valacyclovir|valacyclovir|mesh-list
56307014|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
56307015|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307016|NCT00018291|Gabapentin|gabapentin|mesh-list
56307017|NCT00018291|Risperidone|risperidone|mesh-list
56307018|NCT00018291|Analgesics|analgesics|mesh-ancestor
56307019|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
56307020|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307021|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307022|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
56307023|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56307040|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56307041|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307042|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307043|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307044|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56307045|NCT00045292|Valacyclovir|valacyclovir|mesh-list
56307046|NCT00045292|Acyclovir|acyclovir|mesh-list
56307047|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
56307048|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307049|NCT00045370|Interferons|interferons|mesh-list
56307050|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
56307051|NCT00045370|Sirolimus|sirolimus|mesh-list
56307052|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307053|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
56307054|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307055|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
56307056|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307057|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56307058|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56907093|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307059|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
56307060|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307061|NCT02970682|Tamoxifen|tamoxifen|mesh-list
56307062|NCT02970682|Fulvestrant|fulvestrant|mesh-list
56307063|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56307064|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56307065|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
56307066|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56307067|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307068|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56307069|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307070|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56307071|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56307072|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56307073|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56307074|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56307075|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307076|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307077|NCT00045448|Docetaxel|docetaxel|mesh-list
56307078|NCT00045448|Alvocidib|alvocidib|mesh-list
56307079|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307080|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
56307081|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
56307089|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56307090|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307091|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56307092|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307093|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307094|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
56307095|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307096|NCT00045604|Irinotecan|irinotecan|mesh-list
56307097|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
56307098|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307099|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56307100|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56307101|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161163|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307102|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307103|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56307105|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56307106|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56307107|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56307108|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307109|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
56307110|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
56307111|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
56307112|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307113|NCT00045721|Carmustine|carmustine|mesh-list
56307114|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56307115|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56307116|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
56307117|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307118|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307119|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307121|NCT04731766|Fluorides|fluorides|mesh-list
56307122|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
56307123|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
56307124|NCT04731766|Protective Agents|protective agents|mesh-ancestor
56307125|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307126|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56307127|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307128|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56307129|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307130|NCT00018447|Fluorides|fluorides|mesh-list
56307131|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
56307132|NCT00018447|Protective Agents|protective agents|mesh-ancestor
56307133|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307134|NCT00001688|Ritonavir|ritonavir|mesh-list
56307135|NCT00001688|Nevirapine|nevirapine|mesh-list
56307136|NCT00001688|Stavudine|stavudine|mesh-list
56307137|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56307138|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56307139|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
56907094|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56907095|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
56907096|NCT02128906|Docetaxel|docetaxel|mesh-list
56907097|NCT02128906|Cetuximab|cetuximab|mesh-list
56907098|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907099|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
56907100|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
56907101|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
56907102|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907103|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56907104|NCT02128984|Antioxidants|antioxidants|mesh-list
56907105|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307140|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307141|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307142|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56307143|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56307144|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
56307145|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307146|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56307147|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56307148|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56307149|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56307161|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56307162|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56307163|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
56307164|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307165|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56307166|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56307167|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
56307168|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56307169|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
56307170|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307172|NCT00045799|Cimetidine|cimetidine|mesh-list
56307173|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56307174|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56307175|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56307176|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56307177|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307178|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307179|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56307180|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
56307181|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
56307182|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307183|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307184|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56307185|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56307186|NCT04394130|Ropivacaine|ropivacaine|mesh-list
56307187|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
56307188|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
56307189|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307190|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307191|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
56307192|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307193|NCT00045877|Aldesleukin|aldesleukin|mesh-list
56307194|NCT00045877|Rituximab|rituximab|mesh-list
56307195|NCT00045877|Interleukin-2|interleukin-2|mesh-list
56307196|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307197|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307198|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
56307199|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307200|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907106|NCT02128984|Protective Agents|protective agents|mesh-ancestor
56907107|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907108|NCT05243290|Niacinamide|niacinamide|mesh-list
56907110|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
56907111|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
56907112|NCT05243290|Vitamins|vitamins|mesh-ancestor
56907113|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
56907114|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907115|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56907116|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
56907117|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307201|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56307202|NCT00045877|Analgesics|analgesics|mesh-ancestor
56307203|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
56307204|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307205|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56307206|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56307207|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
56307208|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307209|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56307210|NCT00045916|Nortriptyline|nortriptyline|mesh-list
56307211|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
56307212|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307213|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307214|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307230|NCT00045955|Montelukast|montelukast|mesh-list
56307231|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56307232|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
56307233|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56307234|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
56307235|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56307236|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307237|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56307238|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56307239|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307240|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56307241|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56307242|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56307243|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
56307245|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307246|NCT00046033|Ritonavir|ritonavir|mesh-list
56307247|NCT00046033|Lopinavir|lopinavir|mesh-list
56307248|NCT00046033|Saquinavir|saquinavir|mesh-list
56307249|NCT00046033|Amprenavir|amprenavir|mesh-list
56307250|NCT00046033|Tenofovir|tenofovir|mesh-list
56307251|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56307252|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56307253|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
56307254|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307255|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307256|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56307257|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56307258|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
56307259|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307260|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56307261|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56307262|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56307263|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56307264|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56307265|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
56307266|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56307267|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56307268|NCT04369560|Hematinics|hematinics|mesh-ancestor
56307269|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56907118|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56907119|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
56907120|NCT02252302|Albuterol|albuterol|mesh-list
56907121|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56907122|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
56907123|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907124|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907125|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56907126|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
56907127|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
56907128|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56907129|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56907130|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56907131|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56907132|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
56907133|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56907134|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907135|NCT02252614|Acetaminophen|acetaminophen|mesh-list
56907136|NCT02252614|Naproxen|naproxen|mesh-list
56907137|NCT02252614|Codeine|codeine|mesh-list
56907138|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56907139|NCT02252614|Analgesics|analgesics|mesh-ancestor
55959773|NCT00299741|Sunitinib|sunitinib|mesh-list
56307270|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56307271|NCT00046111|Topotecan|topotecan|mesh-list
56307272|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56307280|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307281|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307282|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56307283|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56307284|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56307285|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307286|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56307287|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307288|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307289|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
56307290|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56307291|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307292|NCT00046267|Niacin|niacin|mesh-list
56307293|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56307294|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
56307295|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307296|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56307297|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
56307298|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
56307299|NCT00046267|Vitamins|vitamins|mesh-ancestor
56307300|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
56307301|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307302|NCT00046306|Antioxidants|antioxidants|mesh-list
56307303|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307304|NCT00046306|Protective Agents|protective agents|mesh-ancestor
56307305|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307306|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56307307|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56907140|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
56907141|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907142|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307308|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56307309|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
56307310|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307311|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307312|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56307313|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56307314|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
56307315|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307316|NCT00397657|Niacin|niacin|mesh-list
56307317|NCT00397657|Ezetimibe|ezetimibe|mesh-list
56307318|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56307319|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56307320|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
56307321|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307322|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56307323|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
56307324|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
56307325|NCT00397657|Vitamins|vitamins|mesh-ancestor
56307326|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
56307327|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307328|NCT04305405|Benralizumab|benralizumab|mesh-list
56307329|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56307330|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
56307331|NCT00001763|Interleukin-12|interleukin-12|mesh-list
56307332|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56307333|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
56307334|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307335|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56307336|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56307337|NCT00001763|Growth Substances|growth substances|mesh-ancestor
56307338|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
56307339|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307340|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
56307341|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56307356|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56307357|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307358|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307359|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
56307360|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
56307361|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307362|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307363|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56307364|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56307365|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
56307366|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56307367|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56307368|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56307369|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56307370|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56307371|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307372|NCT04258410|Quercetin|quercetin|mesh-list
56307373|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
56307374|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307375|NCT04258410|Protective Agents|protective agents|mesh-ancestor
56307376|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307377|NCT00046462|Metformin|metformin|mesh-list
56307378|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
56307379|NCT00046462|Glyburide|glyburide|mesh-list
56307380|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56307381|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56307382|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307383|NCT00001766|Ritonavir|ritonavir|mesh-list
56307384|NCT00001766|Nelfinavir|nelfinavir|mesh-list
56307385|NCT00001766|Amprenavir|amprenavir|mesh-list
56307386|NCT00001766|Abacavir|abacavir|mesh-list
56307387|NCT00001766|Efavirenz|efavirenz|mesh-list
56307388|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56307389|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56307390|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
56307391|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307392|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907143|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
56907144|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56907145|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907146|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56617813|NCT00813241|Celecoxib|celecoxib|mesh-list
56907147|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
56907148|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56907149|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907150|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907151|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56907152|NCT02252614|Narcotics|narcotics|mesh-ancestor
56907153|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907154|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
56907155|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
56907156|NCT02260570|Tolcapone|tolcapone|mesh-list
56907157|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56907158|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56307393|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56307394|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56307395|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
56307396|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307397|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56307398|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56307399|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56307400|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56307401|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56307402|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56307403|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56307414|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56307415|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307416|NCT00046735|Lenalidomide|lenalidomide|mesh-list
56307417|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
56307418|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307419|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56307420|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56307421|NCT00046735|Growth Substances|growth substances|mesh-ancestor
56307422|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
56307423|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307424|NCT00001784|Mexiletine|mexiletine|mesh-list
56307425|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56307426|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56307427|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56307428|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307429|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307430|NCT00046813|Nicotine|nicotine|mesh-list
56307431|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56307432|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
56307433|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307434|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307435|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56307436|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56307437|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
56307438|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307439|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307440|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
56307441|NCT00046852|Melphalan|melphalan|mesh-list
56307442|NCT00046852|Carmustine|carmustine|mesh-list
56307443|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56907159|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56907160|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907161|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907162|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
56338128|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307444|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307445|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
56307446|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307447|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307448|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56307449|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
56307450|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307451|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307452|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56307453|NCT00046969|Cisplatin|cisplatin|mesh-list
56307454|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307455|NCT00001805|Rituximab|rituximab|mesh-list
56307456|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307457|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307458|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
56307459|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307460|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307461|NCT00047047|Gemcitabine|gemcitabine|mesh-list
56307462|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307463|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56307464|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
56307465|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307466|NCT00047047|Antiviral Agents|antiviral agents|mesh-ancestor
56307467|NCT00047047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307468|NCT00047047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307471|NCT00047047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307472|NCT04733781|Lidocaine|lidocaine|mesh-list
56307473|NCT04733781|Epinephrine|epinephrine|mesh-list
56307474|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
56307475|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
56307476|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307477|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307478|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
56307479|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307480|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56307481|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56307482|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56307483|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307484|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307485|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56307486|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56307487|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
56307488|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307489|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56307490|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56307491|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
56307492|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56307493|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
56307494|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
56307495|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
55929389|NCT01721655|Diuretics|diuretics|mesh-ancestor
56307496|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56307497|NCT00047164|Ipilimumab|ipilimumab|mesh-list
56307498|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307499|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307500|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56307501|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307502|NCT00047203|Alvocidib|alvocidib|mesh-list
56307503|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307504|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
56307505|NCT00047203|Growth Substances|growth substances|mesh-ancestor
56307506|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307507|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56307508|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907163|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307509|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307510|NCT04163874|Pramlintide|pramlintide|mesh-list
56307511|NCT04163874|Pancrelipase|pancrelipase|mesh-list
56307512|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56307513|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56307514|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307515|NCT00047242|Irinotecan|irinotecan|mesh-list
56307516|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56307517|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56307518|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56307519|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307520|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307521|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307522|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56307523|NCT00047281|Thalidomide|thalidomide|mesh-list
56307524|NCT00047281|Celecoxib|celecoxib|mesh-list
56307525|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
56307526|NCT00047281|Etoposide|etoposide|mesh-list
56307527|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307528|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
56307529|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307530|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307531|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56307532|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
56307533|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307534|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307535|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56307536|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56307537|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56307538|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56307539|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307540|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56307559|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56307560|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307561|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307562|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
56307563|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307564|NCT00047554|Travoprost|travoprost|mesh-list
56307565|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56307566|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56307567|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56307568|NCT00047632|Interferons|interferons|mesh-list
56307569|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
56307570|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307571|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
56307572|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307573|NCT05641376|Dexmedetomidine|dexmedetomidine|mesh-list
56307574|NCT05641376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56307575|NCT05641376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307576|NCT05641376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307577|NCT05641376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56307578|NCT05641376|Analgesics|analgesics|mesh-ancestor
56307579|NCT05641376|Sensory System Agents|sensory system agents|mesh-ancestor
56307580|NCT05641376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307581|NCT05641376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56307582|NCT05641376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56307583|NCT05641376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56307584|NCT05641376|Adrenergic Agents|adrenergic agents|mesh-ancestor
56307585|NCT05641376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307586|NCT05641376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307587|NCT00047671|Citalopram|citalopram|mesh-list
56307588|NCT00047671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56307589|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56307590|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307591|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307592|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307593|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
56307594|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307607|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56307608|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
56307609|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907164|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907165|NCT02131948|Insulin|insulin|mesh-list
56907166|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
56907167|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56907168|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907169|NCT02132026|Denosumab|denosumab|mesh-list
56907170|NCT02132026|Alendronate|alendronate|mesh-list
56907171|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56907172|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907173|NCT03735771|Bupivacaine|bupivacaine|mesh-list
56907174|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
56907175|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
56907176|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907177|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907178|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
56907179|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907180|NCT02132104|Hormones|hormones|mesh-list
56907181|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56907182|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907183|NCT00174785|Dronedarone|dronedarone|mesh-list
56307610|NCT00047749|Ziconotide|ziconotide|mesh-list
56307611|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56307612|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307613|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307614|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56307615|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095385|NCT04204057|Tenalisib|tenalisib|mesh-list
56307616|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56307617|NCT00047749|Protective Agents|protective agents|mesh-ancestor
56307618|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56307620|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
56307621|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307622|NCT00047827|Amphotericin B|amphotericin b|mesh-list
56307623|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56307624|NCT00047827|Micafungin|micafungin|mesh-list
56307625|NCT00047827|Amebicides|amebicides|mesh-ancestor
56307626|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56307627|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56307628|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307629|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56307630|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
56307631|NCT00393783|Trastuzumab|trastuzumab|mesh-list
56307632|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307633|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307634|NCT00048139|Capecitabine|capecitabine|mesh-list
56307635|NCT00048139|Irinotecan|irinotecan|mesh-list
56307636|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56307637|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
56307638|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307639|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307640|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56307641|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56307642|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307643|NCT00048334|Romidepsin|romidepsin|mesh-list
56307644|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56307645|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307646|NCT00048373|Etanercept|etanercept|mesh-list
56907184|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56307647|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56307648|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56307649|NCT00048373|Analgesics|analgesics|mesh-ancestor
56307650|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
56307651|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307652|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307653|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56307654|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307655|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56307656|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307657|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
56307667|NCT05641337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56307668|NCT05641337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56307669|NCT05641337|Protease Inhibitors|protease inhibitors|mesh-ancestor
56307670|NCT05641337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307671|NCT05641337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307673|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
56307674|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307675|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307676|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
56307677|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307678|NCT00048607|Aprepitant|aprepitant|mesh-list
56307679|NCT00048607|Paroxetine|paroxetine|mesh-list
56307680|NCT00048607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56307681|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56307682|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307683|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307684|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307685|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
56307686|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307687|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56307688|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
56307689|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307690|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56307691|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56307692|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307693|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
56307694|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
56307695|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307696|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56307697|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56307698|NCT00048646|Progesterone|progesterone|mesh-list
56307699|NCT00048646|Progestins|progestins|mesh-ancestor
56307701|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56307702|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307703|NCT00048763|Cilostazol|cilostazol|mesh-list
56307704|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56307705|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
56307706|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307707|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307708|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56307709|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
56307710|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56307711|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56307712|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307713|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56307714|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
56307715|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56307716|NCT00048763|Protective Agents|protective agents|mesh-ancestor
56307717|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56307719|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307720|NCT05576298|Insulin|insulin|mesh-list
56307721|NCT05576298|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56307722|NCT05576298|Insulin, Long-Acting|insulin, long-acting|mesh-list
56307723|NCT05576298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56307724|NCT05576298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307725|NCT00048802|Valproic Acid|valproic acid|mesh-list
56307729|NCT00048802|Ziprasidone|ziprasidone|mesh-list
56307730|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56307731|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
56307732|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56907185|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
56907186|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56307733|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307734|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307735|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56307736|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56307737|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307738|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307739|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56307740|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
56307741|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
56307742|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
56307743|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307744|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56307745|NCT00048802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56307746|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56307747|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307748|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
56307749|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307750|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
56307751|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
56307752|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
56307753|NCT00048841|Alendronate|alendronate|mesh-list
56307754|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56307755|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307756|NCT00048880|Antibodies|antibodies|mesh-list
56307757|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56307758|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
56307759|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307760|NCT05641064|Dexmedetomidine|dexmedetomidine|mesh-list
56307761|NCT05641064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56307762|NCT05641064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307763|NCT05641064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307764|NCT05641064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56307765|NCT05641064|Analgesics|analgesics|mesh-ancestor
56307766|NCT05641064|Sensory System Agents|sensory system agents|mesh-ancestor
56307767|NCT05641064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307768|NCT05641064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56307769|NCT05641064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56307770|NCT05641064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56307771|NCT05641064|Adrenergic Agents|adrenergic agents|mesh-ancestor
56307772|NCT05641064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307773|NCT05641064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307774|NCT00049075|Fludarabine|fludarabine|mesh-list
56307775|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
56307776|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307777|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56307778|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
56307779|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307780|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307781|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
56307782|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307783|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
56307784|NCT00049114|Doxorubicin|doxorubicin|mesh-list
56307785|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56307786|NCT00049114|Tipifarnib|tipifarnib|mesh-list
56307787|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307788|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
56307789|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307790|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307791|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56307792|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
55929702|NCT05061732|Antacids|antacids|mesh-ancestor
56307793|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307794|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307795|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56307796|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56307797|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56307809|NCT05576181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307810|NCT05576181|Immunologic Factors|immunologic factors|mesh-ancestor
56307811|NCT05576181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307812|NCT05576181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307813|NCT05576181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56907187|NCT03681093|Growth Substances|growth substances|mesh-ancestor
56907188|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907189|NCT00166439|Cytarabine|cytarabine|mesh-list
56907190|NCT00166439|Dexamethasone|dexamethasone|mesh-list
56907191|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
56907192|NCT00166439|Rituximab|rituximab|mesh-list
56907193|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907194|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
56907195|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
56907196|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907197|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907198|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56907199|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
56907200|NCT00166439|Hormones|hormones|mesh-ancestor
56907201|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56907202|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56907203|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907204|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56907205|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
56907206|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907207|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56907208|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
56307814|NCT05576181|Alkylating Agents|alkylating agents|mesh-ancestor
56307815|NCT05576181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307816|NCT05576181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307817|NCT05576181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56307818|NCT05576181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56307819|NCT05576181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56307820|NCT05576181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56307821|NCT05576181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307822|NCT00049348|Gemcitabine|gemcitabine|mesh-list
56307823|NCT00049348|Fluorouracil|fluorouracil|mesh-list
56307824|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
56307825|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307826|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56307827|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
56307828|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307829|NCT00049348|Antiviral Agents|antiviral agents|mesh-ancestor
56307830|NCT00049348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307831|NCT00049348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307832|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307833|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
56307834|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307835|NCT00049348|Hematinics|hematinics|mesh-ancestor
56307836|NCT00049387|Temozolomide|temozolomide|mesh-list
56307837|NCT00049387|Tipifarnib|tipifarnib|mesh-list
56307838|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56307839|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
56307840|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307841|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307842|NCT05640791|Gemcitabine|gemcitabine|mesh-list
56307843|NCT05640791|Paclitaxel|paclitaxel|mesh-list
56307845|NCT05640791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56307846|NCT05640791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307847|NCT05640791|Tubulin Modulators|tubulin modulators|mesh-ancestor
56907209|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907210|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
56907211|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907212|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907213|NCT01074905|Artesunate|artesunate|mesh-list
56907214|NCT01074905|Chloroquine|chloroquine|mesh-list
56907215|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56907216|NCT01074905|Primaquine|primaquine|mesh-list
56907217|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
56907218|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56907219|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56307848|NCT05640791|Antimitotic Agents|antimitotic agents|mesh-ancestor
56307849|NCT05640791|Mitosis Modulators|mitosis modulators|mesh-ancestor
56307850|NCT05640791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307851|NCT05640791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56307852|NCT05640791|Antimetabolites|antimetabolites|mesh-ancestor
56307853|NCT05640791|Antiviral Agents|antiviral agents|mesh-ancestor
56307854|NCT05640791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307855|NCT05640791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307856|NCT05640791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307857|NCT05640791|Immunologic Factors|immunologic factors|mesh-ancestor
56307858|NCT05640791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307859|NCT05640791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307860|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
56307861|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56307862|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
56307863|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307864|NCT00391911|Expectorants|expectorants|mesh-ancestor
56307867|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
56307868|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307869|NCT00391911|Protective Agents|protective agents|mesh-ancestor
56307870|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307871|NCT00391911|Antidotes|antidotes|mesh-ancestor
56307873|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
56307874|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56307875|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56307876|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307877|NCT00049582|Decitabine|decitabine|mesh-list
56307878|NCT00049582|Azacitidine|azacitidine|mesh-list
56307879|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56307880|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
56307881|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307882|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307883|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307884|NCT00049660|Capecitabine|capecitabine|mesh-list
56307885|NCT00049660|Vinorelbine|vinorelbine|mesh-list
56307886|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56307887|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
56307888|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307889|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307890|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56307891|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
56307892|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
56307893|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
56307894|NCT05640713|Cyclophosphamide|cyclophosphamide|mesh-list
56307895|NCT05640713|Fludarabine|fludarabine|mesh-list
56307896|NCT05640713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307897|NCT05640713|Immunologic Factors|immunologic factors|mesh-ancestor
56307898|NCT05640713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307899|NCT05640713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307900|NCT05640713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56307901|NCT05640713|Alkylating Agents|alkylating agents|mesh-ancestor
56307902|NCT05640713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307903|NCT05640713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307904|NCT05640713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56307905|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
56907220|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907221|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907222|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
56907223|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
56907224|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56907225|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
56907226|NCT01074905|Amebicides|amebicides|mesh-ancestor
56907227|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907228|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56907229|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56907230|NCT01074905|Analgesics|analgesics|mesh-ancestor
56907231|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
56907232|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907233|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907234|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907235|NCT01074905|Filaricides|filaricides|mesh-ancestor
56907236|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
56907237|NCT03968237|Buprenorphine|buprenorphine|mesh-list
56307906|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56307907|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307908|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56307909|NCT00049777|Heparin|heparin|mesh-list
56307910|NCT00049777|Calcium heparin|calcium heparin|mesh-list
56307911|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56307912|NCT00049777|Tinzaparin|tinzaparin|mesh-list
56307913|NCT00049777|Dalteparin|dalteparin|mesh-list
56307914|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
56307915|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56307916|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56307917|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307918|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307919|NCT00392028|Ertapenem|ertapenem|mesh-list
56307921|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307922|NCT00392067|Calcipotriene|calcipotriene|mesh-list
56307923|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
56307924|NCT00389558|Amikacin|amikacin|mesh-list
56307925|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56307926|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307927|NCT00049972|Paroxetine|paroxetine|mesh-list
56307928|NCT00049972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56307929|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56307930|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307931|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307932|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307933|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
56307934|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307935|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56307936|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
56307937|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307938|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56307939|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56307941|NCT00389636|Becaplermin|becaplermin|mesh-list
56307942|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
56307943|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56307944|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56307945|NCT00389636|Growth Substances|growth substances|mesh-ancestor
56307946|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307947|NCT00050206|Olanzapine|olanzapine|mesh-list
56307948|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
56307949|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
56907238|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56907239|NCT03968237|Naloxone|naloxone|mesh-list
56307950|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307951|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307952|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56307953|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56307954|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56307955|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307956|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307957|NCT00050206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56307958|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56307959|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307960|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307961|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307962|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
56307963|NCT00050245|Rituximab|rituximab|mesh-list
56307964|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307965|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307966|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
56307967|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307968|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307969|NCT00050362|Rofecoxib|rofecoxib|mesh-list
56307970|NCT00050362|Bupivacaine|bupivacaine|mesh-list
56307971|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
56307972|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
56307973|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307974|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307975|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
56307976|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307977|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56307978|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56307979|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307980|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307981|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56307982|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56307983|NCT00050362|Analgesics|analgesics|mesh-ancestor
56307984|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56307985|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56307986|NCT00050401|Vancomycin|vancomycin|mesh-list
56307987|NCT00050401|Tobramycin|tobramycin|mesh-list
56307988|NCT00050401|Meropenem|meropenem|mesh-list
56307989|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56307990|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307991|NCT05640362|Benzydamine|benzydamine|mesh-list
56307992|NCT05640362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56307993|NCT00050440|Dexamethasone|dexamethasone|mesh-list
56307994|NCT00050440|Trabectedin|trabectedin|mesh-list
56307995|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56307996|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
56307997|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
56307998|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307999|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308000|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56308001|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
56308002|NCT00050440|Hormones|hormones|mesh-ancestor
56308003|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56308004|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56308005|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308006|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56308007|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
56308008|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308009|NCT00050479|Celecoxib|celecoxib|mesh-list
56308010|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56308011|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56308012|NCT00050479|Analgesics|analgesics|mesh-ancestor
56308013|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
56308024|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308025|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308026|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308027|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308028|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308029|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56473677|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
56338728|NCT00402493|Ibuprofen|ibuprofen|mesh-list
56308030|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56308031|NCT00050635|Octreotide|octreotide|mesh-list
56308032|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56308033|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56308034|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308035|NCT00050674|Lenograstim|lenograstim|mesh-list
56308036|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56308037|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
56308038|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308039|NCT00050713|Sirolimus|sirolimus|mesh-list
56308040|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56308041|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308042|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56308043|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308044|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
56308045|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308046|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
56308047|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308048|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
56308049|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
56308050|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
56308051|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56308052|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308053|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
56308054|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308055|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308056|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56308057|NCT00050830|Protective Agents|protective agents|mesh-ancestor
56308058|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
56308059|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
56308060|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56308061|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56308062|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56161180|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56308063|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308064|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56308065|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56308066|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
56308067|NCT00051142|Travoprost|travoprost|mesh-list
56308068|NCT00051142|Latanoprost|latanoprost|mesh-list
56308069|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56308070|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56308071|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56308072|NCT00051181|Travoprost|travoprost|mesh-list
56308073|NCT00051181|Latanoprost|latanoprost|mesh-list
56308074|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56308075|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56308076|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56308077|NCT00051259|Bupropion|bupropion|mesh-list
56308078|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56308079|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
56308090|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308091|NCT05639777|Dexmedetomidine|dexmedetomidine|mesh-list
56308092|NCT05639777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56308093|NCT05639777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56308094|NCT05639777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308095|NCT05639777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56308096|NCT05639777|Analgesics|analgesics|mesh-ancestor
56308097|NCT05639777|Sensory System Agents|sensory system agents|mesh-ancestor
56308098|NCT05639777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308099|NCT05639777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56308100|NCT05639777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56308101|NCT05639777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56308102|NCT05639777|Adrenergic Agents|adrenergic agents|mesh-ancestor
56308103|NCT05639777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56308104|NCT05639777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308105|NCT00051298|Olanzapine|olanzapine|mesh-list
56308106|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
56308107|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
56308108|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308109|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308110|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56308111|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56308112|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56907240|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56907241|NCT03968237|Narcotics|narcotics|mesh-ancestor
56907242|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907243|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308113|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56308114|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56308115|NCT00051298|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56308116|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56308117|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56308118|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308119|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56308120|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
56308121|NCT00398008|Naltrexone|naltrexone|mesh-list
56308122|NCT00398008|Buprenorphine|buprenorphine|mesh-list
56308123|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56308124|NCT00398008|Narcotics|narcotics|mesh-ancestor
56308125|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56308126|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308127|NCT00398008|Analgesics|analgesics|mesh-ancestor
56308128|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
56308129|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308130|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56308131|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56308132|NCT05636189|Anesthetics|anesthetics|mesh-list
56308133|NCT05636189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56308134|NCT05636189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308135|NCT00051493|Carboplatin|carboplatin|mesh-list
56308136|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308137|NCT00051532|Seocalcitol|seocalcitol|mesh-list
56308138|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308139|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308140|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
56308141|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308150|NCT05573958|Clopidogrel|clopidogrel|mesh-list
56308151|NCT05573958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56308152|NCT05573958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56308153|NCT05573958|Analgesics|analgesics|mesh-ancestor
56308154|NCT05573958|Sensory System Agents|sensory system agents|mesh-ancestor
56308155|NCT05573958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308156|NCT05573958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308157|NCT05573958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56308158|NCT05573958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308159|NCT05573958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56308160|NCT05573958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56308161|NCT05573958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308162|NCT05573958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56308163|NCT05573958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56308164|NCT05573958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308165|NCT05573958|Antipyretics|antipyretics|mesh-ancestor
56308166|NCT05573958|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56308167|NCT05573958|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56308168|NCT05573958|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56308169|NCT05573958|Purinergic Agents|purinergic agents|mesh-ancestor
56308170|NCT05573958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56308171|NCT05573958|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56308172|NCT05573958|Antithrombins|antithrombins|mesh-ancestor
56308173|NCT05573958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56308174|NCT05573958|Protease Inhibitors|protease inhibitors|mesh-ancestor
56308175|NCT05573958|Anticoagulants|anticoagulants|mesh-ancestor
56308176|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
56308177|NCT00051688|Tezacitabine|tezacitabine|mesh-list
56308178|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308179|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308180|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308181|NCT00051844|Capravirine|capravirine|mesh-list
56308182|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56308183|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56308184|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308185|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308186|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
56907244|NCT03968237|Analgesics|analgesics|mesh-ancestor
56338871|NCT00074178|Cytarabine|cytarabine|mesh-list
56308187|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308188|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56308189|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56308191|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56308192|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
56308193|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308194|NCT00052039|Interferons|interferons|mesh-list
56308195|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
56308196|NCT00052039|Azathioprine|azathioprine|mesh-list
56308197|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308198|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
56308199|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308200|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
56308201|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308202|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308203|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308204|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
56308205|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308206|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308207|NCT00052117|Capravirine|capravirine|mesh-list
56308208|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55947890|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308223|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56308224|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56308225|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308226|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308227|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308228|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308229|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308230|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56308231|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56308232|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308233|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308234|NCT00052351|Metronidazole|metronidazole|mesh-list
56308235|NCT00052351|Paclitaxel|paclitaxel|mesh-list
56308236|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
56308237|NCT00052351|Doxorubicin|doxorubicin|mesh-list
56308238|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56308239|NCT00052351|Vaccines|vaccines|mesh-list
56308240|NCT00052351|Sargramostim|sargramostim|mesh-list
56308241|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
56308242|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308243|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56308244|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308245|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308247|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308248|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308249|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308250|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308251|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56308252|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
56308253|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56308254|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56308255|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56308256|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308257|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308258|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308259|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56308260|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56308261|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56308262|NCT00052390|Bevacizumab|bevacizumab|mesh-list
56308263|NCT00052390|Doxorubicin|doxorubicin|mesh-list
56308264|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56308265|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56308266|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308267|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56308268|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56308269|NCT00052390|Growth Substances|growth substances|mesh-ancestor
56308270|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308271|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
56308272|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56308281|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56308282|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907245|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
56907246|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907247|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56907248|NCT00138671|Insulin|insulin|mesh-list
56907249|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56907250|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56907251|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907252|NCT01367158|Vaccines|vaccines|mesh-list
56907253|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
56907254|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907255|NCT00130637|Daclizumab|daclizumab|mesh-list
56907256|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907257|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
56308283|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308284|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308285|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308286|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308287|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308289|NCT00052468|Antiviral Agents|antiviral agents|mesh-ancestor
56308290|NCT00052468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308291|NCT00052468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308292|NCT00052468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308293|NCT00052468|Immunologic Factors|immunologic factors|mesh-ancestor
56308294|NCT00052468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308296|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308297|NCT00052585|Leucovorin|leucovorin|mesh-list
56308298|NCT00052585|Fluorouracil|fluorouracil|mesh-list
56308299|NCT00052585|Irinotecan|irinotecan|mesh-list
56308300|NCT00052585|Gefitinib|gefitinib|mesh-list
56308301|NCT00052585|Calcium|calcium|mesh-list
56308302|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
56308303|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56308304|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308305|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
56308306|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308307|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308308|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308309|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308310|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
56308311|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56308312|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308313|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308314|NCT00052585|Antidotes|antidotes|mesh-ancestor
56308315|NCT00052585|Protective Agents|protective agents|mesh-ancestor
56308316|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
56308317|NCT00052585|Vitamins|vitamins|mesh-ancestor
56308318|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
56308319|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56308320|NCT00052780|Temozolomide|temozolomide|mesh-list
55930217|NCT03836781|Ketorolac|ketorolac|mesh-list
56308321|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56308322|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56308323|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
56308324|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308325|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308326|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308328|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
56308329|NCT00052936|Rituximab|rituximab|mesh-list
56308330|NCT00052936|Doxorubicin|doxorubicin|mesh-list
56308331|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56308332|NCT00052936|Vincristine|vincristine|mesh-list
56308333|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308334|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
56308335|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308336|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308337|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56907258|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907259|NCT01077479|Metformin|metformin|mesh-list
56907260|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56907261|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907262|NCT02136784|Morphine|morphine|mesh-list
56907263|NCT02136784|Oxycodone|oxycodone|mesh-list
56907264|NCT02136784|Buprenorphine|buprenorphine|mesh-list
56907265|NCT02136784|Hydromorphone|hydromorphone|mesh-list
56907266|NCT02136784|Hydrocodone|hydrocodone|mesh-list
56907267|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56907268|NCT02136784|Narcotics|narcotics|mesh-ancestor
56907269|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907270|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907271|NCT02136784|Analgesics|analgesics|mesh-ancestor
56907272|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
56907273|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907274|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56907275|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
56907276|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
56907277|NCT02129764|Prednisone|prednisone|mesh-list
56907278|NCT02129764|Allopurinol|allopurinol|mesh-list
56907279|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56308338|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
56308339|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308340|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308341|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55948022|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
56308355|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308356|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
56308357|NCT00053092|Rituximab|rituximab|mesh-list
56308358|NCT00053092|Fludarabine|fludarabine|mesh-list
56308359|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
56308360|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308361|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
56308362|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308363|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308364|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56308365|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
56308366|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308367|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308368|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56308369|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56308370|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308371|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
56308372|NCT00053131|Cytarabine|cytarabine|mesh-list
56308373|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
56308374|NCT00053131|Sargramostim|sargramostim|mesh-list
56308375|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308376|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
56308377|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308378|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308379|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
56308380|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308381|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308382|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
56308383|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308384|NCT00053131|Analgesics|analgesics|mesh-ancestor
56907280|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
56907281|NCT02129764|Hormones|hormones|mesh-ancestor
56907282|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56907283|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907284|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56907285|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907286|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
56907287|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907288|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907289|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
56907290|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907291|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56907292|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
56907293|NCT02129764|Protective Agents|protective agents|mesh-ancestor
56907294|NCT00130247|Rifampin|rifampin|mesh-list
56907295|NCT00130247|Isoniazid|isoniazid|mesh-list
56907296|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
56907297|NCT00130247|Ethambutol|ethambutol|mesh-list
56308385|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
56308386|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308387|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56308388|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308389|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308390|NCT00053209|Gemcitabine|gemcitabine|mesh-list
56308391|NCT00053209|Pemetrexed|pemetrexed|mesh-list
56308392|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308393|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
56308394|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308395|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308396|NCT00053209|Antiviral Agents|antiviral agents|mesh-ancestor
56308397|NCT00053209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308398|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308399|NCT00053209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308400|NCT00053209|Immunologic Factors|immunologic factors|mesh-ancestor
56308401|NCT00053209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948089|NCT04780945|Olaparib|olaparib|mesh-list
56308419|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308420|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
56308421|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308422|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56308423|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308424|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308425|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
56308426|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56308427|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308428|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56308429|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56308430|NCT00053287|Growth Substances|growth substances|mesh-ancestor
56308431|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
56308432|NCT00053326|Fenretinide|fenretinide|mesh-list
56096193|NCT00000374|Olanzapine|olanzapine|mesh-list
56308433|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308434|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56308435|NCT00053326|Protective Agents|protective agents|mesh-ancestor
56308436|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308437|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56308438|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56308439|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
56308440|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308442|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56907298|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56617953|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
56907299|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
56907300|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56907301|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907302|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
56907303|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56907304|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907305|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308443|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56308444|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
56308445|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308446|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56308447|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56308448|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308449|NCT00053638|Tenofovir|tenofovir|mesh-list
56308450|NCT00053638|Lamivudine|lamivudine|mesh-list
56308451|NCT00053638|Efavirenz|efavirenz|mesh-list
56308452|NCT00053638|Abacavir|abacavir|mesh-list
56308453|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
56308454|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308455|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56308456|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56308457|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308458|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308459|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56308460|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56308461|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56308479|NCT05626478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56308480|NCT05626478|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56308481|NCT05626478|Prednisolone phosphate|prednisolone phosphate|mesh-list
56308482|NCT05626478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56308483|NCT05626478|Antiemetics|antiemetics|mesh-ancestor
56308484|NCT05626478|Autonomic Agents|autonomic agents|mesh-ancestor
56308485|NCT05626478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308486|NCT05626478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308487|NCT05626478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56308488|NCT05626478|Glucocorticoids|glucocorticoids|mesh-ancestor
56308489|NCT05626478|Hormones|hormones|mesh-ancestor
56308490|NCT05626478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56308491|NCT05626478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56308492|NCT05626478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308493|NCT05626478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308494|NCT05626478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308495|NCT05626478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56308496|NCT05626478|Protective Agents|protective agents|mesh-ancestor
56308497|NCT05626478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56308498|NCT05626478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308499|NCT05626478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56308500|NCT05626478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308501|NCT02970175|Terlipressin|terlipressin|mesh-list
56308502|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56308503|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56308504|NCT00053833|Irinotecan|irinotecan|mesh-list
56308505|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56308506|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308507|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308508|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308509|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308510|NCT00053872|Vincristine|vincristine|mesh-list
56308512|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308513|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56308514|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308515|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308516|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
56907306|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56308517|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308518|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56308519|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
56308531|NCT05624918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308532|NCT05624918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308533|NCT05624918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308534|NCT05624918|Immunologic Factors|immunologic factors|mesh-ancestor
56308535|NCT05624918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308536|NCT00053911|Tamoxifen|tamoxifen|mesh-list
56308537|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
56308538|NCT00053911|Docetaxel|docetaxel|mesh-list
56308539|NCT00053911|Fluorouracil|fluorouracil|mesh-list
56308540|NCT00053911|Epirubicin|epirubicin|mesh-list
56308541|NCT00053911|Anastrozole|anastrozole|mesh-list
56308542|NCT00053911|Goserelin|goserelin|mesh-list
56308543|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308544|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
56308545|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308546|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308547|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56308548|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
56308549|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308550|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308551|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56308552|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308553|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308554|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308555|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
56308556|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308557|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56308558|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56308559|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308560|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308561|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56308562|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
56308563|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56308564|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56308565|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56308566|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56308567|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56308568|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56308569|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56308570|NCT00053950|NSC 366140|nsc 366140|mesh-list
56308571|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308572|NCT00054067|Cisplatin|cisplatin|mesh-list
56308573|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308574|NCT00054106|Flutamide|flutamide|mesh-list
56308575|NCT00054106|Buserelin|buserelin|mesh-list
56308576|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
56308577|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
56308578|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56308579|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308580|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56308581|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308582|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56308583|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
56308584|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56308602|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308603|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308604|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56308605|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
56308606|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308607|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308608|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56308609|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56308610|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
56308611|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56308612|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308613|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
56308614|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
56308615|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308616|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56907307|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56907308|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56308617|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56308618|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
56308619|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308620|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56308621|NCT00054418|Vitamin D|vitamin d|mesh-list
56308622|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
56308623|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
56308624|NCT00054418|Calcium|calcium|mesh-list
56308625|NCT00054418|Vitamins|vitamins|mesh-ancestor
56308626|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
56308627|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308628|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56308629|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56308630|NCT00054418|Antacids|antacids|mesh-ancestor
56308631|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308632|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56308633|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56308634|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56308635|NCT05560230|Clonidine|clonidine|mesh-list
56308636|NCT05560230|Analgesics|analgesics|mesh-ancestor
56308637|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
56308638|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308639|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308640|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56308641|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
56308642|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
56308643|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56308645|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55948347|NCT01891019|Thalidomide|thalidomide|mesh-list
56308661|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308662|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308663|NCT00054535|Aldesleukin|aldesleukin|mesh-list
56308664|NCT00054535|Vaccines|vaccines|mesh-list
56308665|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
56308666|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308667|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308668|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56308669|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56308670|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
56308671|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308672|NCT00054574|Panitumumab|panitumumab|mesh-list
56308673|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56308674|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308675|NCT00054613|Methoxsalen|methoxsalen|mesh-list
56308676|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56308677|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
56308678|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
56334007|NCT00037544|Coagulants|coagulants|mesh-ancestor
56308679|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56308680|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308681|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308682|NCT00054886|Sunitinib|sunitinib|mesh-list
56308683|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308684|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56308685|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56308686|NCT00054886|Growth Substances|growth substances|mesh-ancestor
56308687|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308688|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
56308689|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56308690|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308691|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308692|NCT02970097|Fentanyl|fentanyl|mesh-list
56308693|NCT02970097|Midazolam|midazolam|mesh-list
56308694|NCT02970097|Ropivacaine|ropivacaine|mesh-list
56308695|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56308696|NCT02970097|Narcotics|narcotics|mesh-ancestor
56308697|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56308698|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308699|NCT02970097|Analgesics|analgesics|mesh-ancestor
56308700|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
56308701|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308702|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56308703|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56339329|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
56308704|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
56308705|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
56308714|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
56308715|NCT00398281|Dutasteride|dutasteride|mesh-list
56308716|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56308717|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56308718|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308719|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308720|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
56308721|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56308722|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308723|NCT00055042|Vitamin E|vitamin e|mesh-list
56308724|NCT00055042|Vitamins|vitamins|mesh-ancestor
56308725|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
56308726|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308727|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
56308728|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308729|NCT00055042|Protective Agents|protective agents|mesh-ancestor
56308730|NCT00055120|Ritonavir|ritonavir|mesh-list
56308731|NCT00055120|Lopinavir|lopinavir|mesh-list
56308732|NCT00055120|Tenofovir|tenofovir|mesh-list
56308733|NCT00055120|Emtricitabine|emtricitabine|mesh-list
56308734|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56308735|NCT00055120|Stavudine|stavudine|mesh-list
56308736|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56308737|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56308738|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
56308739|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308740|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308741|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56308742|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56308743|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
56308744|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308745|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56308746|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56308747|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56308748|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56308749|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
56308750|NCT05527704|Albuterol|albuterol|mesh-list
56308751|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56308752|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
56308753|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334008|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
56308755|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56308756|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
56308757|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
56308758|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56308759|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56308760|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56308761|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56308762|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
56308763|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56308764|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308765|NCT00055159|Plasminogen|plasminogen|mesh-list
56308766|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56308767|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56308768|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56308769|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308770|NCT00055198|Daptomycin|daptomycin|mesh-list
56308771|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55948464|NCT00716443|Lidocaine|lidocaine|mesh-list
56308785|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56308786|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308787|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56308788|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56308789|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308790|NCT00055432|Gemcitabine|gemcitabine|mesh-list
56308792|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308793|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
56308794|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308795|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308796|NCT00055432|Antiviral Agents|antiviral agents|mesh-ancestor
56308797|NCT00055432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907309|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56907310|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56907311|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56308798|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308799|NCT00055432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308800|NCT00055432|Immunologic Factors|immunologic factors|mesh-ancestor
56308801|NCT00055432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308802|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56308803|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56308804|NCT00055549|Lorazepam|lorazepam|mesh-list
56308805|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
56308806|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
56308807|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
56308808|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56308809|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56308810|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56308811|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308812|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308813|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
56308814|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
56308815|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
56308816|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308817|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56308818|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56308819|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56308820|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56308821|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56308822|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56308823|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
56308824|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
56308877|NCT00055861|Bevacizumab|bevacizumab|mesh-list
56308878|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56308879|NCT00055861|Docetaxel|docetaxel|mesh-list
56308880|NCT00055861|Antibodies|antibodies|mesh-list
56308881|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
56308882|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56308883|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308884|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56308885|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56308886|NCT00055861|Growth Substances|growth substances|mesh-ancestor
56308887|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308888|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
56308889|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
56308890|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308891|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308892|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308893|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308894|NCT00392106|Amiodarone|amiodarone|mesh-list
56308895|NCT00392106|Flecainide|flecainide|mesh-list
56308896|NCT00392106|Propafenone|propafenone|mesh-list
56308897|NCT00392106|Dofetilide|dofetilide|mesh-list
56308898|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56308899|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
56308900|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55948583|NCT00053989|Sargramostim|sargramostim|mesh-list
56308908|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56308909|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56308910|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56308911|NCT00055939|Exatecan|exatecan|mesh-list
56308912|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56308913|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308914|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308915|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308916|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308917|NCT00055978|Celecoxib|celecoxib|mesh-list
56308918|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56308919|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56308920|NCT00055978|Analgesics|analgesics|mesh-ancestor
56308921|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
56308922|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308923|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308924|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907312|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56907313|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56907314|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
56308925|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308926|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56308927|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56308928|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308929|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308930|NCT00056056|Bexarotene|bexarotene|mesh-list
56308931|NCT00056056|Methoxsalen|methoxsalen|mesh-list
56308932|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308933|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56308934|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
56308935|NCT00056095|Cyclosporine|cyclosporine|mesh-list
56308936|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
56308937|NCT00056095|Fludarabine|fludarabine|mesh-list
56308938|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
56308939|NCT00056095|Cyclosporins|cyclosporins|mesh-list
56308940|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308941|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
56308942|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308943|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308944|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56308945|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
56308946|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308947|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308948|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56308949|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308950|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
56308951|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308952|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
56308953|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308954|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
56308955|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56308957|NCT00056329|Tocopherols|tocopherols|mesh-list
56308958|NCT00056329|Vitamins|vitamins|mesh-ancestor
56308959|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
56308960|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308961|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
56308962|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308963|NCT00056329|Protective Agents|protective agents|mesh-ancestor
56308964|NCT00056368|Fluconazole|fluconazole|mesh-list
56308965|NCT00056368|Anidulafungin|anidulafungin|mesh-list
56308966|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
56308967|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308982|NCT00056641|Ritonavir|ritonavir|mesh-list
56308983|NCT00056641|Lopinavir|lopinavir|mesh-list
56308984|NCT00056641|Saquinavir|saquinavir|mesh-list
56308985|NCT00056641|Amprenavir|amprenavir|mesh-list
56308986|NCT00056641|Tipranavir|tipranavir|mesh-list
56308987|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56308988|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56308989|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
56308990|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308991|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308992|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56308993|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56308994|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
56308995|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308996|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56308997|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56308998|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56308999|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
55930896|NCT03830385|Bleomycin|bleomycin|mesh-list
56309000|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56309001|NCT00398437|Trastuzumab|trastuzumab|mesh-list
56309002|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309003|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309004|NCT05433675|Macitentan|macitentan|mesh-list
56309005|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56309006|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56309007|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309008|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56309009|NCT00423709|Fludarabine|fludarabine|mesh-list
56309010|NCT00423709|Melphalan|melphalan|mesh-list
56907315|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56907316|NCT02252926|Acetaminophen|acetaminophen|mesh-list
56907317|NCT02252926|Lidocaine|lidocaine|mesh-list
56907318|NCT02252926|Morphine|morphine|mesh-list
56907319|NCT02252926|Gabapentin|gabapentin|mesh-list
56907320|NCT02252926|Bupivacaine|bupivacaine|mesh-list
56907321|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
56309011|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309012|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309013|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309014|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
56309015|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309016|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56309017|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
56309018|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56309020|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309021|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56309022|NCT00056797|Analgesics|analgesics|mesh-ancestor
56309023|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
56309024|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309025|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309041|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56309042|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56309043|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
56309044|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309045|NCT00056875|Mitogens|mitogens|mesh-list
56309046|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309047|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309048|NCT05410197|Gemcitabine|gemcitabine|mesh-list
56309049|NCT05410197|Lenvatinib|lenvatinib|mesh-list
56309050|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309051|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56309053|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309054|NCT05410197|Antiviral Agents|antiviral agents|mesh-ancestor
56309055|NCT05410197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309056|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309057|NCT05410197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309058|NCT05410197|Immunologic Factors|immunologic factors|mesh-ancestor
56309059|NCT05410197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309060|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56309061|NCT03262454|Atezolizumab|atezolizumab|mesh-list
56309062|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309063|NCT00057031|Calcitriol|calcitriol|mesh-list
56309064|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56309065|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309066|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56309067|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56309068|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309069|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56309070|NCT00057031|Vitamins|vitamins|mesh-ancestor
56309071|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
56309072|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56309073|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
56309074|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309075|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
56309076|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309077|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309078|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56309079|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
56309080|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309081|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309082|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56309083|NCT00057265|Lamivudine|lamivudine|mesh-list
56309084|NCT00057265|Telbivudine|telbivudine|mesh-list
56309085|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56309086|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55948779|NCT02661503|Hormones|hormones|mesh-ancestor
56309095|NCT00057304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309097|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309098|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309099|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
56309100|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309101|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309102|NCT00057382|Doxorubicin|doxorubicin|mesh-list
56309103|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56309104|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309105|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56309106|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309107|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309108|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309109|NCT00057421|Prednisolone|prednisolone|mesh-list
56309110|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309111|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
56309112|NCT00057421|Hormones|hormones|mesh-ancestor
56309113|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56309114|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309115|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56309116|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309117|NCT00057616|Lenalidomide|lenalidomide|mesh-list
56309118|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
56309119|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309120|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56309121|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56309122|NCT00057616|Growth Substances|growth substances|mesh-ancestor
56309123|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
56309124|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309125|NCT02969746|Charcoal|charcoal|mesh-list
56309127|NCT02969746|Protective Agents|protective agents|mesh-ancestor
56309128|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309129|NCT00057850|Cisplatin|cisplatin|mesh-list
56309130|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309131|NCT00057889|Ipilimumab|ipilimumab|mesh-list
56309132|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309133|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309134|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56309135|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309136|NCT00057928|Gemcitabine|gemcitabine|mesh-list
56309137|NCT00057928|Paclitaxel|paclitaxel|mesh-list
56309138|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309139|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309140|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309141|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309142|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309143|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309144|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56309145|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
56309146|NCT00057928|Antiviral Agents|antiviral agents|mesh-ancestor
56309147|NCT00057928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309148|NCT00057928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309149|NCT00057928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309150|NCT00057928|Immunologic Factors|immunologic factors|mesh-ancestor
56309151|NCT00057928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309152|NCT05309304|Cefazolin|cefazolin|mesh-list
56309153|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56309154|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309170|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309172|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309173|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56309174|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56309175|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
56309176|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309178|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
56309179|NCT00058084|Epothilone B|epothilone b|mesh-list
56309180|NCT00058084|Epothilones|epothilones|mesh-list
56309181|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309182|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
56309183|NCT00058084|Hormones|hormones|mesh-ancestor
56309184|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56309185|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309186|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56309187|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309188|NCT00058084|Analgesics|analgesics|mesh-ancestor
56309189|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
56309190|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309191|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081137|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
56907322|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
56907323|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907324|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907325|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
56339691|NCT00045266|Aflibercept|aflibercept|mesh-list
56309192|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309193|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309194|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309195|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309196|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309197|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309198|NCT02969629|Apomorphine|apomorphine|mesh-list
56309199|NCT02969629|Emetics|emetics|mesh-ancestor
56309200|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309201|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
56309202|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309203|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56309204|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
56309205|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
56309206|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56309207|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309208|NCT00058201|Leucovorin|leucovorin|mesh-list
56309209|NCT00058201|Gemcitabine|gemcitabine|mesh-list
56309210|NCT00058201|Fluorouracil|fluorouracil|mesh-list
56309211|NCT00058201|Calcium|calcium|mesh-list
56309212|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
56309213|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56309214|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
56309215|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309241|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56309243|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309244|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309245|NCT00058318|Antiviral Agents|antiviral agents|mesh-ancestor
56309246|NCT00058318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309247|NCT00058318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309248|NCT00058318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309249|NCT00058318|Immunologic Factors|immunologic factors|mesh-ancestor
56309250|NCT00058318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309251|NCT00058357|Lidocaine|lidocaine|mesh-list
56309252|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
56309253|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
56309254|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56309255|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309256|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
56309257|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309258|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56309259|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56309260|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56309261|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56309262|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309263|NCT00058435|Abagovomab|abagovomab|mesh-list
56309264|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309265|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309266|NCT00058474|Fluorouracil|fluorouracil|mesh-list
56309267|NCT00058474|Capecitabine|capecitabine|mesh-list
56309268|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
56309277|NCT00392262|Valsartan|valsartan|mesh-list
56309278|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56309279|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56309280|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56309281|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309282|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56309283|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309284|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
56309285|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56309286|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56309287|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
56309288|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309289|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56309290|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907326|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907327|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56907328|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56907329|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56907330|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56907331|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907332|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56309291|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309292|NCT00058903|Sertraline|sertraline|mesh-list
56309293|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
56309294|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56309295|NCT00058903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56309296|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56309297|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55931191|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56309298|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309299|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56309300|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
56309301|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309302|NCT02969473|Cisplatin|cisplatin|mesh-list
56309303|NCT02969473|Docetaxel|docetaxel|mesh-list
56309304|NCT02969473|Fluorouracil|fluorouracil|mesh-list
56309305|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309306|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309307|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309308|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309309|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309311|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56309312|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309313|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
56309314|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309315|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
56309316|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309317|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309318|NCT01349907|Asenapine|asenapine|mesh-list
56309319|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56309320|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56309321|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56309322|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309323|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56309324|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56309325|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56309326|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309327|NCT05223582|Prednisone|prednisone|mesh-list
56309328|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
56309329|NCT05223582|Androgens|androgens|mesh-list
56309330|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309331|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
56309332|NCT05223582|Hormones|hormones|mesh-ancestor
56309333|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56309343|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309344|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56309345|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309346|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309347|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
56309348|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
56309349|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
56309350|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56309352|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
56309353|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309354|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56309355|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56309356|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309357|NCT02969239|Phenylephrine|phenylephrine|mesh-list
56309358|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
56907333|NCT02252926|Narcotics|narcotics|mesh-ancestor
56907334|NCT02252926|Analgesics|analgesics|mesh-ancestor
56907335|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56309359|NCT02969239|Norepinephrine|norepinephrine|mesh-list
56309360|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56309361|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56309362|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
56309363|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
56309364|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309365|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309366|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
56309367|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
56309368|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
56309369|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56309370|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56309371|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56309372|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
56309373|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56309374|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309375|NCT02969239|Protective Agents|protective agents|mesh-ancestor
56309377|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309378|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56309379|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309380|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309381|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309382|NCT00059800|Boron|boron|mesh-list
56309383|NCT00059800|Trace Elements|trace elements|mesh-ancestor
56309384|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
56309385|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309387|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56309388|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56309389|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309390|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
56309391|NCT03216083|Coagulants|coagulants|mesh-ancestor
56309392|NCT00059878|Interferons|interferons|mesh-list
56309393|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
56309394|NCT00059878|Voriconazole|voriconazole|mesh-list
56309395|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309396|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
56309397|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309398|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
56309399|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56309400|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56309415|NCT00060112|Gemcitabine|gemcitabine|mesh-list
56309416|NCT00060112|Oblimersen|oblimersen|mesh-list
56309417|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56309418|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
56309419|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309420|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309421|NCT00060112|Antiviral Agents|antiviral agents|mesh-ancestor
56309422|NCT00060112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309423|NCT00060112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309424|NCT00060112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309426|NCT00060112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309427|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56309428|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309429|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56309430|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309431|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309432|NCT02968927|Vitamin D|vitamin d|mesh-list
56309433|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
56309434|NCT02968927|Rifabutin|rifabutin|mesh-list
56309435|NCT02968927|Everolimus|everolimus|mesh-list
56309436|NCT02968927|Auranofin|auranofin|mesh-list
56309437|NCT02968927|CC-11050|cc-11050|mesh-list
56309438|NCT02968927|Vitamins|vitamins|mesh-ancestor
56309439|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
56309440|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309441|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56309442|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309443|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309444|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
56309445|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56309446|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56309447|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907336|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
56907337|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
56309448|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56309449|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
56309450|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309451|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56309452|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56309453|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309454|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309456|NCT00398515|Lenalidomide|lenalidomide|mesh-list
56309457|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
56309458|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309459|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55949154|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
56309468|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309469|NCT05105685|Hormones|hormones|mesh-list
56309470|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56309471|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309472|NCT05325164|Morphine|morphine|mesh-list
56309473|NCT05325164|Methadone|methadone|mesh-list
56309474|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56309475|NCT05325164|Narcotics|narcotics|mesh-ancestor
56309476|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56309477|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309478|NCT05325164|Analgesics|analgesics|mesh-ancestor
56309479|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
56309480|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309481|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
56309482|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
56309483|NCT00060385|Prednisone|prednisone|mesh-list
56309484|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
56309485|NCT00060385|Doxorubicin|doxorubicin|mesh-list
56309486|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56309487|NCT00060385|Etoposide|etoposide|mesh-list
56309488|NCT00060385|Vincristine|vincristine|mesh-list
56309489|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309490|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
56309491|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309492|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309493|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56309494|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
56309495|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309496|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309497|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56309498|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56309499|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56309500|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309501|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309502|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309503|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
56309505|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56309506|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56309507|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309508|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309509|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309510|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309511|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
56309512|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
56309513|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56309514|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309515|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56309516|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56309517|NCT02968693|Vancomycin|vancomycin|mesh-list
56309518|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56309519|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56309520|NCT02968693|Calcium|calcium|mesh-list
56309521|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56309522|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309523|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309524|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
56309525|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
56309526|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56309527|NCT02968693|Protective Agents|protective agents|mesh-ancestor
56309536|NCT00060502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907338|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56907339|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56907340|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56907341|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56907342|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56907343|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56907344|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
56309537|NCT00060502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309538|NCT00060502|Immunologic Factors|immunologic factors|mesh-ancestor
56309539|NCT00060502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309540|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
56309541|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56309542|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309544|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309545|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309546|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309547|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309548|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309549|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309550|NCT05038410|Wobenzym|wobenzym|mesh-list
56309551|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56309552|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
56309553|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309554|NCT05030493|Bevacizumab|bevacizumab|mesh-list
56309555|NCT05030493|Panitumumab|panitumumab|mesh-list
56309556|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309557|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309558|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56309559|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56309560|NCT05030493|Growth Substances|growth substances|mesh-ancestor
56309561|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309562|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
56309563|NCT02968498|Methamphetamine|methamphetamine|mesh-list
56309564|NCT02968498|Lactulose|lactulose|mesh-list
56309565|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56309566|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56309567|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309568|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
56309569|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
56309570|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309571|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
56309572|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56309573|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309574|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
56309575|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56309576|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56309577|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56309578|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56309579|NCT00060931|Metoprolol|metoprolol|mesh-list
56309580|NCT00060931|Carvedilol|carvedilol|mesh-list
56309581|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56309582|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56309583|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
56309584|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
56309585|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309586|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309587|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56309588|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56309589|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56309590|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
56309591|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56309592|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309593|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
56309594|NCT00060931|Protective Agents|protective agents|mesh-ancestor
56309608|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309609|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
56309610|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56081247|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907345|NCT02253004|Cilostazol|cilostazol|mesh-list
56907346|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56907347|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
56907348|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309611|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56309612|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
56309613|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56309614|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56309615|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56309616|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309618|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
56309619|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309620|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56309621|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
56309622|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56309623|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56309624|NCT00061321|Nevirapine|nevirapine|mesh-list
56309625|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56309626|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56309627|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309628|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309629|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
56309630|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309631|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56309632|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56309633|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56309634|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56309635|NCT00061360|Cyclosporine|cyclosporine|mesh-list
56309636|NCT00061360|Sirolimus|sirolimus|mesh-list
56309637|NCT00061360|Cyclosporins|cyclosporins|mesh-list
56309638|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309639|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309640|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309641|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
56309642|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309643|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
56309644|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309645|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
56309646|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309647|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56309648|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56309649|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56309650|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309652|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56309653|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309654|NCT00061477|Gemcitabine|gemcitabine|mesh-list
56309662|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309663|NCT00061477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309664|NCT00061477|Immunologic Factors|immunologic factors|mesh-ancestor
56309665|NCT00061477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309666|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56309667|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56309669|NCT02968342|Progestins|progestins|mesh-ancestor
55931574|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309670|NCT02968342|Hormones|hormones|mesh-ancestor
56309671|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56309672|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309673|NCT02968303|Vemurafenib|vemurafenib|mesh-list
56309674|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309675|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56309676|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309677|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309678|NCT04997304|Albuterol|albuterol|mesh-list
56309679|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56309680|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
56309681|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309682|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309683|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56309684|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
56309685|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56907349|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907350|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56340124|NCT00130702|Gefitinib|gefitinib|mesh-list
56309686|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56309687|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56309688|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
56309689|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56309690|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309691|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
56309692|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56309693|NCT00061516|Brinzolamide|brinzolamide|mesh-list
56309694|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56309695|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309696|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309697|NCT00061594|Ranibizumab|ranibizumab|mesh-list
56309698|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56309699|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56309700|NCT00061594|Growth Substances|growth substances|mesh-ancestor
56309701|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309702|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56309703|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309704|NCT04954365|Amisulpride|amisulpride|mesh-list
56309705|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56309706|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56309707|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56309708|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309709|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56309710|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56309711|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
56309712|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56309713|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309714|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56309715|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
56309716|NCT00061711|Hormones|hormones|mesh-list
56309717|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
56309718|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949399|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
56309732|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
56309733|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56309734|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309735|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309736|NCT00061867|Doxorubicin|doxorubicin|mesh-list
56309737|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56309738|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56309739|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309740|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56309741|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309742|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309743|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309744|NCT00061906|Celecoxib|celecoxib|mesh-list
56309745|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56309746|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56309747|NCT00061906|Analgesics|analgesics|mesh-ancestor
56309748|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
56309749|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309750|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309751|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309752|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309753|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56309754|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56309755|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309756|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309757|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
56309759|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
56309760|NCT00398554|Doxorubicin|doxorubicin|mesh-list
56309761|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56309762|NCT00398554|Etoposide|etoposide|mesh-list
56309763|NCT00398554|Vincristine|vincristine|mesh-list
56309764|NCT00398554|Vinblastine|vinblastine|mesh-list
56309765|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309766|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
56309767|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907351|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
56907352|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56907353|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56907354|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309768|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309769|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56309770|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
56309771|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309772|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309773|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56309774|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56309775|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56309776|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309777|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309778|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309779|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
56309780|NCT00398554|Hormones|hormones|mesh-ancestor
56309781|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56309782|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56309795|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309797|NCT05219435|Nivolumab|nivolumab|mesh-list
56309798|NCT05219435|Ipilimumab|ipilimumab|mesh-list
56309799|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309800|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309801|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56309802|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309804|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56309805|NCT00061984|Ifosfamide|ifosfamide|mesh-list
56309806|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56309807|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309808|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56309809|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309810|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309811|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309812|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56309813|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
56309814|NCT00062023|Aspirin|aspirin|mesh-list
56309815|NCT00062023|Sulindac|sulindac|mesh-list
56309816|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56309817|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56309818|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56309819|NCT00062023|Analgesics|analgesics|mesh-ancestor
56309820|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
56309821|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309822|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309823|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309824|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309825|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56309826|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56309827|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309828|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56309829|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56309830|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309832|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56309833|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56309834|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309835|NCT00062062|Paclitaxel|paclitaxel|mesh-list
56309836|NCT00062062|Carboplatin|carboplatin|mesh-list
56309837|NCT00062062|Gefitinib|gefitinib|mesh-list
56309838|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309839|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309840|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309841|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309842|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309843|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309844|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56309845|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309846|NCT00392340|Doxorubicin|doxorubicin|mesh-list
56309863|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907355|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56907356|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
56907357|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56907358|NCT02253004|Protective Agents|protective agents|mesh-ancestor
56907359|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56907360|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56907361|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907362|NCT02252458|Fentanyl|fentanyl|mesh-list
56907363|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56907364|NCT02252458|Narcotics|narcotics|mesh-ancestor
56907365|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907366|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907367|NCT02252458|Analgesics|analgesics|mesh-ancestor
56907368|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
56309864|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56309865|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309866|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309867|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56309868|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56309869|NCT00062101|Analgesics|analgesics|mesh-ancestor
56309870|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
56309871|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309872|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309873|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309874|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309875|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56309876|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56309877|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
56309878|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309879|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
56309880|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309881|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309882|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56309883|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
56309884|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309885|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309886|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56309887|NCT00062179|Celecoxib|celecoxib|mesh-list
56309888|NCT00062179|Paclitaxel|paclitaxel|mesh-list
56309889|NCT00062179|Carboplatin|carboplatin|mesh-list
56309890|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309891|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309892|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309893|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309894|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309895|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309896|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56309897|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56309898|NCT00062179|Analgesics|analgesics|mesh-ancestor
56309899|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
56309900|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309901|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309902|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309903|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309904|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56309906|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309908|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56309909|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
56309910|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309911|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907369|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907370|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56907371|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56340332|NCT00403663|Fentanyl|fentanyl|mesh-list
56309912|NCT00062296|Rituximab|rituximab|mesh-list
56309913|NCT00062296|Epirubicin|epirubicin|mesh-list
56309914|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309915|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309916|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
56309917|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309918|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309919|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56309920|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56309921|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309922|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309923|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309924|NCT05183984|Bevacizumab|bevacizumab|mesh-list
56309925|NCT05183984|Niraparib|niraparib|mesh-list
56309926|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309927|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309928|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56309929|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56309930|NCT05183984|Growth Substances|growth substances|mesh-ancestor
56309931|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309932|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
56309933|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56309934|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309935|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309936|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
56309937|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56309938|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
56309939|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309940|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
56309941|NCT02967874|Protective Agents|protective agents|mesh-ancestor
56309942|NCT04733625|Vitamin D|vitamin d|mesh-list
56309943|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
56309944|NCT04733625|Vitamins|vitamins|mesh-ancestor
56309945|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
56309946|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309947|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56309948|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56309949|NCT00062686|Lapatinib|lapatinib|mesh-list
56309950|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309951|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56309952|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309953|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309954|NCT00062803|Heparin|heparin|mesh-list
56309955|NCT00062803|Warfarin|warfarin|mesh-list
56309956|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
56309957|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
56309958|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56309959|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56309960|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309961|NCT00062842|Irinotecan|irinotecan|mesh-list
56309962|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56309963|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309964|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309965|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309966|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309967|NCT00062881|Mafosfamide|mafosfamide|mesh-list
56309968|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55931889|NCT03401541|Vitamin D|vitamin d|mesh-list
56309969|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
56309970|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309971|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309972|NCT00389909|Doxapram|doxapram|mesh-list
56309973|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56309974|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309975|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
56309977|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309978|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56309991|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
56907372|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
56907373|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
56907374|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
56907375|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56907376|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
56907377|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907378|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618035|NCT02768948|Losartan|losartan|mesh-list
56907379|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
56907380|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309992|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309993|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309994|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56309995|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56309996|NCT00063310|Leuprolide|leuprolide|mesh-list
56309997|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56309998|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
56309999|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56310000|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310001|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56310002|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310003|NCT00063388|Cetuximab|cetuximab|mesh-list
56310004|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310005|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310006|NCT00063583|Pirfenidone|pirfenidone|mesh-list
56310007|NCT00063583|Analgesics|analgesics|mesh-ancestor
56310008|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
56310009|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310010|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310011|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56310012|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56310013|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310014|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310015|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310016|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56310017|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310018|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56310019|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310020|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310021|NCT00064012|Docetaxel|docetaxel|mesh-list
56310022|NCT00064012|Bortezomib|bortezomib|mesh-list
56310023|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310024|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56310025|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56310026|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56310027|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310028|NCT00064051|Gemcitabine|gemcitabine|mesh-list
56310029|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56310030|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
56310031|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310032|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310033|NCT00064051|Antiviral Agents|antiviral agents|mesh-ancestor
56310034|NCT00064051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310035|NCT00064051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310036|NCT00064051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310037|NCT00064051|Immunologic Factors|immunologic factors|mesh-ancestor
56310038|NCT00064051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310039|NCT02967172|Epinephrine|epinephrine|mesh-list
56310040|NCT02967172|Morphine|morphine|mesh-list
56310041|NCT02967172|Ropivacaine|ropivacaine|mesh-list
56310042|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56310043|NCT02967172|Narcotics|narcotics|mesh-ancestor
56310044|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56310063|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56310064|NCT00064090|Cytarabine|cytarabine|mesh-list
56310065|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56310066|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
56907381|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56907382|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56907383|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907384|NCT02132260|Naftifine|naftifine|mesh-list
56907385|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
56907386|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907387|NCT02132416|Acetaminophen|acetaminophen|mesh-list
56907388|NCT02132416|Ibuprofen|ibuprofen|mesh-list
56907389|NCT02132416|Diclofenac|diclofenac|mesh-list
56907390|NCT02132416|Morphine|morphine|mesh-list
56907391|NCT02132416|Oxycodone|oxycodone|mesh-list
56907392|NCT02132416|Tramadol|tramadol|mesh-list
56907393|NCT02132416|Anesthetics|anesthetics|mesh-list
56907394|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907395|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907396|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56907397|NCT02132416|Narcotics|narcotics|mesh-ancestor
56340469|NCT00080418|Paclitaxel|paclitaxel|mesh-list
56310067|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310068|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310069|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
56310070|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310071|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310072|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
56310073|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310074|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
56310075|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310076|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310077|NCT00064129|Ipilimumab|ipilimumab|mesh-list
56310078|NCT00064129|Sargramostim|sargramostim|mesh-list
56310079|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310080|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310081|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56310082|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310083|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
56310084|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310085|NCT00064207|Gemcitabine|gemcitabine|mesh-list
56310086|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56310087|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
56310088|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310089|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310090|NCT00064207|Antiviral Agents|antiviral agents|mesh-ancestor
56310091|NCT00064207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310092|NCT00064207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310093|NCT00064207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310094|NCT00064207|Immunologic Factors|immunologic factors|mesh-ancestor
56310095|NCT00064207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310096|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
56310097|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56310098|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310099|NCT05138822|Renal Agents|renal agents|mesh-ancestor
56310100|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56310101|NCT00064246|Rituximab|rituximab|mesh-list
56310102|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56310103|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310115|NCT00064285|Growth Substances|growth substances|mesh-ancestor
56310116|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310117|NCT00392418|Micronutrients|micronutrients|mesh-list
56310118|NCT00392418|Trace Elements|trace elements|mesh-list
56310119|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310120|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
56310121|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
56907398|NCT02132416|Analgesics|analgesics|mesh-ancestor
56907399|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
56310122|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56310123|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56310124|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310125|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310126|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310127|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310128|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56310129|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
56310130|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56310131|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56310132|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
56310133|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310134|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310135|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56310136|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
56310137|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56310138|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56310139|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56310140|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56310141|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310142|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310143|NCT00423748|Ambrisentan|ambrisentan|mesh-list
56310144|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56310145|NCT02967211|Insulin|insulin|mesh-list
56310146|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56310147|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
56310148|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
56310149|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
56310150|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
56310151|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
56310152|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56310153|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310154|NCT00064636|Bortezomib|bortezomib|mesh-list
56310155|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310156|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
56310157|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310158|NCT00065143|Clofarabine|clofarabine|mesh-list
56310159|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56310160|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
56310161|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310162|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310163|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
56310164|NCT00398749|Hematinics|hematinics|mesh-ancestor
56310165|NCT00398788|Hydromorphone|hydromorphone|mesh-list
56310166|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56310167|NCT00398788|Narcotics|narcotics|mesh-ancestor
56310168|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949863|NCT04304040|Antibodies|antibodies|mesh-list
56310183|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56310184|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
56310185|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310186|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310187|NCT00065455|Vitamin A|vitamin a|mesh-list
56310188|NCT00065455|Vitamins|vitamins|mesh-ancestor
56310189|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
56310190|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310191|NCT00065533|Pemetrexed|pemetrexed|mesh-list
56310192|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310193|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310194|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310195|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56310196|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55932102|NCT02242929|Imiquimod|imiquimod|mesh-list
56310198|NCT04488081|Cyclosporine|cyclosporine|mesh-list
56310199|NCT04488081|Remdesivir|remdesivir|mesh-list
56310200|NCT04488081|Cenicriviroc|cenicriviroc|mesh-list
56310201|NCT04488081|Dexamethasone|dexamethasone|mesh-list
56310202|NCT04488081|Celecoxib|celecoxib|mesh-list
56310203|NCT04488081|Apremilast|apremilast|mesh-list
56310204|NCT04488081|Icatibant|icatibant|mesh-list
56310205|NCT04488081|Imatinib Mesylate|imatinib mesylate|mesh-list
56310206|NCT04488081|Famotidine|famotidine|mesh-list
56310207|NCT04488081|Cyclosporins|cyclosporins|mesh-list
56310208|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310209|NCT04488081|Antiemetics|antiemetics|mesh-ancestor
56310210|NCT04488081|Autonomic Agents|autonomic agents|mesh-ancestor
56907400|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907401|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56310211|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310212|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310213|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56310214|NCT04488081|Glucocorticoids|glucocorticoids|mesh-ancestor
56310215|NCT04488081|Hormones|hormones|mesh-ancestor
56310216|NCT04488081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310217|NCT04488081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56310218|NCT04488081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310219|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310220|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310221|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310222|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
56310223|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
56310224|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310225|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
56310226|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310227|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56310228|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56310229|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56310230|NCT04488081|Analgesics|analgesics|mesh-ancestor
56310242|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
56310243|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
56310244|NCT04488081|Antipruritics|antipruritics|mesh-ancestor
56310245|NCT04488081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56310246|NCT04488081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56310247|NCT04488081|Serotonin Agents|serotonin agents|mesh-ancestor
56310248|NCT04488081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56310249|NCT04488081|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56310250|NCT04488081|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56310251|NCT04488081|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56310252|NCT04488081|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56310253|NCT04488081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56310254|NCT04488081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56310255|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56310256|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56310257|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
56310258|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310259|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310260|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56310261|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56310262|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56310264|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
56310265|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310266|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310267|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
56310268|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310269|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310270|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
56310271|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56310272|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932175|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
56310274|NCT00065923|Topiramate|topiramate|mesh-list
56310275|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
56310276|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56310277|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310278|NCT00065962|Secretin|secretin|mesh-list
56310279|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56310280|NCT00065962|Hormones|hormones|mesh-ancestor
56310281|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310282|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310283|NCT05083754|Temozolomide|temozolomide|mesh-list
56310284|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56310285|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
56310286|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310287|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310288|NCT00066001|Metronidazole|metronidazole|mesh-list
56310289|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310290|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56310291|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56907402|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56310292|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56310293|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56310294|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56310304|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56310305|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
56310306|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56310307|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56310308|NCT00066157|Progestins|progestins|mesh-ancestor
56310309|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56310310|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56310311|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56310312|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56310313|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56310314|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310315|NCT05080322|Fluticasone|fluticasone|mesh-list
56310317|NCT05080322|Azelastine|azelastine|mesh-list
56310318|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310319|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56310320|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
56310321|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310322|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310323|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56310324|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
56310325|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
56310326|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56310327|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56310328|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310329|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310330|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56310331|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56310332|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
56310333|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
56310334|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310335|NCT00066196|Dacarbazine|dacarbazine|mesh-list
56310336|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56310337|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
56310338|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310339|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310340|NCT00066274|Leucovorin|leucovorin|mesh-list
56310341|NCT00066274|Fluorouracil|fluorouracil|mesh-list
56310342|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
56310343|NCT00066274|Irinotecan|irinotecan|mesh-list
56310344|NCT00066274|Calcium|calcium|mesh-list
56310345|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
56310346|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56310347|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310348|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
56310349|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310350|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56310351|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310352|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310353|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
56310354|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56310355|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56310356|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310357|NCT00066274|Antidotes|antidotes|mesh-ancestor
56310358|NCT00066274|Protective Agents|protective agents|mesh-ancestor
56310359|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
56310360|NCT00066274|Vitamins|vitamins|mesh-ancestor
56310361|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
56310362|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
56310376|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310377|NCT04388475|Temozolomide|temozolomide|mesh-list
56310378|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56310379|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
56310380|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310381|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310383|NCT00389987|Piperacillin|piperacillin|mesh-list
56310384|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310385|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56310386|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310387|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56310388|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907403|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907404|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310389|NCT00066508|Bortezomib|bortezomib|mesh-list
56310390|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310391|NCT00066547|Antibodies|antibodies|mesh-list
56310392|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56310393|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
56310394|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310395|NCT00066586|Exemestane|exemestane|mesh-list
56310396|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310397|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56310398|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56310399|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310400|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310401|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56310402|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
56310403|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310404|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310406|NCT04258488|Warfarin|warfarin|mesh-list
56310407|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
56310408|NCT04258488|Vitamins|vitamins|mesh-ancestor
56310409|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
56310410|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310411|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
56310412|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56310413|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
56310414|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56310415|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
56310416|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310417|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310418|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56310419|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56310420|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
56310421|NCT04258488|Coagulants|coagulants|mesh-ancestor
56310422|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
56310423|NCT00066625|Bortezomib|bortezomib|mesh-list
56310424|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310425|NCT05061134|Durvalumab|durvalumab|mesh-list
56310426|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310427|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310435|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310436|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
56310437|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310439|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
56310440|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310441|NCT04235673|Protective Agents|protective agents|mesh-ancestor
56310442|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310443|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56310444|NCT00067015|Goserelin|goserelin|mesh-list
56310445|NCT00067015|Bicalutamide|bicalutamide|mesh-list
56310446|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56310447|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310448|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
56310449|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
56310450|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310451|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310452|NCT00067093|Vitamin K|vitamin k|mesh-list
56310453|NCT00067093|Heparin|heparin|mesh-list
56310454|NCT00067093|Calcium heparin|calcium heparin|mesh-list
56310455|NCT00067093|Idraparinux|idraparinux|mesh-list
56310456|NCT00067093|Vitamins|vitamins|mesh-ancestor
56310457|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
56310458|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310459|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
56310460|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56310461|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56310462|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310463|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56310464|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
56310465|NCT00067093|Coagulants|coagulants|mesh-ancestor
56310466|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56310467|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
56310468|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56310469|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
56310470|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310471|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56907405|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56907406|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340821|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56310472|NCT05041127|Cetuximab|cetuximab|mesh-list
56310473|NCT05041127|Antibodies|antibodies|mesh-list
56310474|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
56310475|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56310476|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
56310477|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310478|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310479|NCT00398905|Enoxaparin|enoxaparin|mesh-list
56310480|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
56310481|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56310482|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
56310483|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56310484|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
56310485|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310486|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310487|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
56310488|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56310489|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56310490|NCT00067405|Micronutrients|micronutrients|mesh-list
56310491|NCT00067405|Trace Elements|trace elements|mesh-list
56310492|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310493|NCT00067444|Paroxetine|paroxetine|mesh-list
56310494|NCT00067444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56310495|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56310496|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56310505|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56310506|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310507|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56310508|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56310509|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56310510|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56310511|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310512|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310513|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310515|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
56310516|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310517|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
56310518|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56310519|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
56310520|NCT05027633|Carboplatin|carboplatin|mesh-list
56310521|NCT05027633|Docetaxel|docetaxel|mesh-list
56310522|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
56310523|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310524|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
56310525|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
56310526|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
56310527|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310528|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310529|NCT02967094|Expectorants|expectorants|mesh-list
56310530|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
56310531|NCT00067561|Alosetron|alosetron|mesh-list
56310532|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56310533|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56310534|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
56310535|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310536|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310537|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310538|NCT00067600|Calcium|calcium|mesh-list
56310539|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56310540|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310541|NCT05010707|Spironolactone|spironolactone|mesh-list
56310542|NCT05010707|Hormones|hormones|mesh-list
56310543|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310544|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310545|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56310546|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
56310547|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56310548|NCT05010707|Diuretics|diuretics|mesh-ancestor
56310549|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
56907407|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907408|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
56907409|NCT00137423|Sunitinib|sunitinib|mesh-list
56310550|NCT00067756|Butyric Acid|butyric acid|mesh-list
56310551|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
56310552|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
56310553|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310554|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310555|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310556|NCT04091880|Vaccines|vaccines|mesh-list
56310557|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
56310558|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310559|NCT04999241|Mesalamine|mesalamine|mesh-list
56310560|NCT04999241|Infliximab|infliximab|mesh-list
56310561|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
56310562|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56310572|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56310573|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56310574|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56310575|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56310576|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310577|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310578|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310579|NCT00067912|Analgesics|analgesics|mesh-ancestor
56310580|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
56310581|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310582|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
56310583|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56310584|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
56310585|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56310586|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
56310587|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310588|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310589|NCT00067951|Metformin|metformin|mesh-list
56310590|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
56310591|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56310592|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310593|NCT00392457|Ketoconazole|ketoconazole|mesh-list
56310594|NCT00392457|Hormones|hormones|mesh-list
56310595|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310596|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310597|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
56310598|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310599|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56310600|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56310601|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310602|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310603|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56310604|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
56310605|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56310606|NCT00068029|Octreotide|octreotide|mesh-list
56310607|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56310608|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56310609|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310610|NCT00068068|Talaporfin|talaporfin|mesh-list
56310611|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310612|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56310613|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
56310614|NCT00068302|Sirolimus|sirolimus|mesh-list
56310615|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56310616|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310617|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56310618|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310619|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
56310620|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310621|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
56310622|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310623|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
56310624|NCT00068458|Calcium|calcium|mesh-list
55950310|NCT02205801|Bupivacaine|bupivacaine|mesh-list
56310642|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310643|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56907410|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340969|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310644|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56310645|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310646|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310647|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310648|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56310649|NCT00068731|Lycopene|lycopene|mesh-list
56310650|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310651|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
56310652|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310653|NCT00068731|Protective Agents|protective agents|mesh-ancestor
56310654|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310655|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56310656|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56310657|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310658|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56310659|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
56310660|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310661|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
56310662|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
56310663|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56310664|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310665|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56310666|NCT00399061|Cyclosporine|cyclosporine|mesh-list
56310667|NCT00399061|Cyclosporins|cyclosporins|mesh-list
56310668|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310669|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310670|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310671|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
56310672|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310673|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
56310674|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310675|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
56310676|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310677|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56310678|NCT00069355|Propranolol|propranolol|mesh-list
56310679|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56310680|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56310681|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
56310696|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310697|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
56310698|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310699|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310700|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
56310701|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
56310702|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
56310703|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56310704|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56310705|NCT03981900|Tofacitinib|tofacitinib|mesh-list
56310706|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56310707|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310708|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310710|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
56310711|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56310712|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
56310713|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310714|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310715|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
56310716|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310717|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56310718|NCT00069706|Latanoprost|latanoprost|mesh-list
56310719|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56310720|NCT00069901|Paclitaxel|paclitaxel|mesh-list
56310721|NCT00069901|Carboplatin|carboplatin|mesh-list
56310722|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56310723|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56310724|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310725|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
55932623|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
56310726|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
56310727|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
56310728|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907411|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56907412|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56907413|NCT00137423|Growth Substances|growth substances|mesh-ancestor
56310729|NCT00069940|Sargramostim|sargramostim|mesh-list
56310730|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
56310731|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310732|NCT00390026|Bevacizumab|bevacizumab|mesh-list
56310733|NCT00390026|Verteporfin|verteporfin|mesh-list
56310734|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310735|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310736|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56310737|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56310738|NCT00390026|Growth Substances|growth substances|mesh-ancestor
56310739|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310740|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
56310741|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56310742|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
56310757|NCT00070174|Cyclosporine|cyclosporine|mesh-list
56310758|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
56310760|NCT00070174|Methotrexate|methotrexate|mesh-list
56310761|NCT00070174|Etoposide|etoposide|mesh-list
56310762|NCT00070174|Daunorubicin|daunorubicin|mesh-list
56310763|NCT00070174|Asparaginase|asparaginase|mesh-list
56310764|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
56310765|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
56310766|NCT00070174|Cyclosporins|cyclosporins|mesh-list
56310767|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310768|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
56310769|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310770|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310771|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56310772|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
56310773|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310774|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310775|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56310776|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56310777|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
56310778|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56310779|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56310780|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
56310781|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098549|NCT00002714|Hormones|hormones|mesh-ancestor
56310782|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310783|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56310784|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56310785|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56310786|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56310787|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56310788|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
56310789|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310790|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
56310791|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56310792|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56310793|NCT00070174|Analgesics|analgesics|mesh-ancestor
56310794|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
56310795|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310796|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310797|NCT00070213|Leucovorin|leucovorin|mesh-list
56310798|NCT00070213|Fluorouracil|fluorouracil|mesh-list
56310799|NCT00070213|Capecitabine|capecitabine|mesh-list
56310800|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
56310801|NCT00070213|Calcium|calcium|mesh-list
56310802|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
56310803|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56310804|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310805|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
56310814|NCT00070213|Vitamins|vitamins|mesh-ancestor
56310815|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
56310816|NCT00070252|Docetaxel|docetaxel|mesh-list
56310817|NCT00070252|Capecitabine|capecitabine|mesh-list
56310818|NCT00070252|Tipifarnib|tipifarnib|mesh-list
56310819|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310820|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
56310821|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
56310822|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
56310823|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907414|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907415|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
56341115|NCT00047450|Citalopram|citalopram|mesh-list
56310824|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56310825|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
56310826|NCT00070447|Prednisone|prednisone|mesh-list
56310827|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
56310828|NCT00070447|Rituximab|rituximab|mesh-list
56310829|NCT00070447|Doxorubicin|doxorubicin|mesh-list
56310830|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56310831|NCT00070447|Vincristine|vincristine|mesh-list
56310832|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310833|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
56310834|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310835|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310836|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56310837|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
56310838|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310839|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310840|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56310841|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310842|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56310843|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56310844|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56310845|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310846|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310847|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
56310848|NCT00070447|Hormones|hormones|mesh-ancestor
56310849|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310850|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56310851|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56310852|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
56310853|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
56310854|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
56310855|NCT03959865|Glucagon|glucagon|mesh-list
56310856|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56310857|NCT03959865|Incretins|incretins|mesh-ancestor
56310858|NCT03959865|Hormones|hormones|mesh-ancestor
56310859|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310860|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310861|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56310862|NCT00070486|Gemcitabine|gemcitabine|mesh-list
56310863|NCT00070486|Celecoxib|celecoxib|mesh-list
56310864|NCT00070486|Zileuton|zileuton|mesh-list
56310865|NCT00070486|Carboplatin|carboplatin|mesh-list
56310866|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310867|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56310868|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
56310869|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310870|NCT00070486|Antiviral Agents|antiviral agents|mesh-ancestor
56310871|NCT00070486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56310872|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310873|NCT00070486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950563|NCT04826016|Paclitaxel|paclitaxel|mesh-list
56310890|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310891|NCT00070642|Dacarbazine|dacarbazine|mesh-list
56310892|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56310893|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
56310894|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310895|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310896|NCT00070759|Daclizumab|daclizumab|mesh-list
56310897|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310898|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
56310899|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310900|NCT00070837|Antibodies|antibodies|mesh-list
56310901|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56310902|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
56310903|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310904|NCT00071071|Zanolimumab|zanolimumab|mesh-list
56310905|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56310906|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310907|NCT00071188|Paclitaxel|paclitaxel|mesh-list
56310908|NCT00071188|Carboplatin|carboplatin|mesh-list
56310909|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56907416|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56907417|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907418|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310910|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310911|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56310912|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56310913|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56310914|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310915|NCT00071227|Triamcinolone|triamcinolone|mesh-list
56310916|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56310917|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56310918|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56310919|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310920|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
56310921|NCT00071227|Hormones|hormones|mesh-ancestor
56310922|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310923|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310924|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310925|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
56310926|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310927|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310929|NCT00071266|Lovastatin|lovastatin|mesh-list
56310930|NCT00071266|L 647318|l 647318|mesh-list
56310931|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
55950640|NCT01470651|Modafinil|modafinil|mesh-list
56310952|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310954|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310955|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56310956|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56310957|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56310958|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56310959|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310960|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56310961|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56310962|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56310963|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310964|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56310965|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56310966|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
56310967|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56310968|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
56310969|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
56310970|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
56310971|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56310972|NCT02966743|Midazolam|midazolam|mesh-list
56310973|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
56310974|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56310975|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56310976|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310977|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56310978|NCT02966743|Analgesics|analgesics|mesh-ancestor
56310979|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
56310980|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310981|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56310982|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56310983|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56310984|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
55950683|NCT04781777|Insulin|insulin|mesh-list
56311006|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311008|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
56311009|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311010|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
56311011|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56311012|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
56311013|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56311014|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
56311015|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311017|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56311018|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311019|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56311020|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907419|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56907420|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
56907421|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311021|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
56311022|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311023|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
56311024|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311025|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
56311026|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56311027|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
56311028|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311029|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311030|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56311031|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
56311032|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56311033|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
56311034|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311035|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311036|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56311054|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311055|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56311056|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311057|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56311058|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56311059|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56311060|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311061|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56311063|NCT00072007|Hormones|hormones|mesh-ancestor
56311064|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56311065|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56311066|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56311067|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
56311068|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
56311069|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311070|NCT00072046|Interferons|interferons|mesh-list
56311071|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
56311072|NCT00072046|Bevacizumab|bevacizumab|mesh-list
56311073|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311074|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311075|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56311076|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56311077|NCT00072046|Growth Substances|growth substances|mesh-ancestor
56311078|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311079|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
56311080|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
56311081|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311082|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
56311083|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
56311084|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56051232|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
56311085|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311086|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
56311087|NCT04730596|Ketamine|ketamine|mesh-list
56311088|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56311089|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56311090|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311091|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56311092|NCT04730596|Analgesics|analgesics|mesh-ancestor
56311093|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
56311094|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950787|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56311102|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56311103|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
56311105|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56311106|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56311107|NCT00072085|Aldesleukin|aldesleukin|mesh-list
56311108|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
56311109|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311110|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56311111|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56311112|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
56311113|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311114|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56907422|NCT02130700|Seviteronel|seviteronel|mesh-list
56907423|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907424|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56907425|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311115|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
56311116|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311117|NCT04730674|Tetracycline|tetracycline|mesh-list
56311118|NCT04730674|Lidocaine|lidocaine|mesh-list
56311119|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
56311120|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
56311121|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56311122|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311123|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
56311124|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311125|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56311126|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56311127|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56311128|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56311129|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311130|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56311131|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311132|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56311133|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311134|NCT03959436|Carbetocin|carbetocin|mesh-list
56311135|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
56311136|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56311137|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311138|NCT00072124|Dacarbazine|dacarbazine|mesh-list
56311139|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311140|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311141|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
56311142|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311143|NCT00072163|Thalidomide|thalidomide|mesh-list
56311144|NCT00072163|Temozolomide|temozolomide|mesh-list
56311145|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311146|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
56311147|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311148|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311149|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311150|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
56311151|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311153|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56311154|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311155|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56311156|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56311157|NCT00072163|Growth Substances|growth substances|mesh-ancestor
56311158|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
56311159|NCT00072319|Paclitaxel|paclitaxel|mesh-list
56311160|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
56311162|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56311190|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
56311191|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311192|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311193|NCT00072436|Antiviral Agents|antiviral agents|mesh-ancestor
56311194|NCT00072436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311195|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311196|NCT00072436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311197|NCT00072436|Immunologic Factors|immunologic factors|mesh-ancestor
56311198|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311199|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
56311200|NCT00072436|Growth Substances|growth substances|mesh-ancestor
56311201|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56311202|NCT04843904|Rituximab|rituximab|mesh-list
56311203|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
56311204|NCT04843904|Venetoclax|venetoclax|mesh-list
56311205|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311206|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311207|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
56311208|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311218|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
56311219|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907426|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907427|NCT02137954|Lidocaine|lidocaine|mesh-list
56907428|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
56907429|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
56907430|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341409|NCT00405730|Ketorolac|ketorolac|mesh-list
56311220|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311221|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311222|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311223|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
56311224|NCT00072553|Antidotes|antidotes|mesh-ancestor
56311225|NCT00072553|Protective Agents|protective agents|mesh-ancestor
56311226|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
56311228|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
56311229|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56311230|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56311231|NCT00072553|Analgesics|analgesics|mesh-ancestor
56311232|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
56311233|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311234|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56311235|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311236|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56311237|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56311238|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311239|NCT00072592|Rituximab|rituximab|mesh-list
56311240|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311241|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311242|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
56311243|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311244|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311245|NCT04840589|Nivolumab|nivolumab|mesh-list
56311246|NCT04840589|Ipilimumab|ipilimumab|mesh-list
56311247|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311248|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311249|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56311250|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311251|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56311252|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311253|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56311254|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311255|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311256|NCT00072670|Trabectedin|trabectedin|mesh-list
56311257|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311258|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
56311259|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311260|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311261|NCT03959358|Lenalidomide|lenalidomide|mesh-list
56311262|NCT03959358|Pomalidomide|pomalidomide|mesh-list
56311263|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
56311264|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311265|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56311266|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56311267|NCT03959358|Growth Substances|growth substances|mesh-ancestor
56311268|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
56311269|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311270|NCT02966704|Caseins|caseins|mesh-list
56311271|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
56311272|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
56311273|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311274|NCT00072748|EKB 569|ekb 569|mesh-list
56311275|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311276|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56311287|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311289|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311290|NCT00072865|Carboplatin|carboplatin|mesh-list
56311291|NCT00072865|Pemetrexed|pemetrexed|mesh-list
56311292|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311293|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311294|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907431|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341477|NCT00146926|Analgesics|analgesics|mesh-ancestor
56311295|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56311296|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56311297|NCT00072904|Repaglinide|repaglinide|mesh-list
56311298|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56311299|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311300|NCT00072943|Interferons|interferons|mesh-list
56161258|NCT01483872|Heparin|heparin|mesh-list
56311301|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
56311303|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56311304|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
56311305|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311306|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311307|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
56311308|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311309|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
56311310|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311311|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311312|NCT00072982|Borage oil|borage oil|mesh-list
56311313|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311314|NCT03959124|Memantine|memantine|mesh-list
56311315|NCT03959124|Rivastigmine|rivastigmine|mesh-list
56311316|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56311317|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56311318|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
56311319|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311320|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311321|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311322|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56311323|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56311324|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56311325|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311326|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
56311327|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56311328|NCT03959124|Protective Agents|protective agents|mesh-ancestor
56311329|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
56311330|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56311331|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56311332|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311333|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
56311334|NCT02966236|Coagulants|coagulants|mesh-ancestor
56311335|NCT04827953|Gemcitabine|gemcitabine|mesh-list
56311337|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56311338|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311339|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56311340|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56311341|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311342|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311343|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311367|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311368|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311369|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311370|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56311371|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311372|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56311373|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
56311374|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
56311375|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56311376|NCT00073411|Citalopram|citalopram|mesh-list
56311377|NCT00073411|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56311378|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56311379|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56311380|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311381|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311382|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
56311383|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311384|NCT00073411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56311385|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
56311386|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56311387|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311388|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56907432|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
56341550|NCT00147355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56311390|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
56311391|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
56311392|NCT02966041|Ondansetron|ondansetron|mesh-list
56311393|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
56311394|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
56311395|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311396|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311413|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
56311414|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311415|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311416|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56311417|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
56311418|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
56311419|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56311420|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56311421|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56311422|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56311423|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
56311424|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311425|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311426|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
56311427|NCT00073879|Fludarabine|fludarabine|mesh-list
56311428|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
56311429|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
56311430|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311431|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
56311432|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311433|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311434|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311435|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
56311436|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311437|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311438|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56311439|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311440|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
56311441|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311442|NCT00074074|Infliximab|infliximab|mesh-list
56311443|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
56311444|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56311445|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311446|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56311447|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56311448|NCT00392652|Protective Agents|protective agents|mesh-ancestor
56161262|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56311449|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311450|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311451|NCT00074191|Cytarabine|cytarabine|mesh-list
56311452|NCT00074191|Dexamethasone|dexamethasone|mesh-list
56311453|NCT00074191|Methotrexate|methotrexate|mesh-list
56311454|NCT00074191|Lomustine|lomustine|mesh-list
56311455|NCT00074191|Procarbazine|procarbazine|mesh-list
56311469|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56311470|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311471|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
56311472|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311473|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
56311474|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311475|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56311476|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311477|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
56311478|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311479|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56311480|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
56311481|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311482|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311483|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
56311484|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
55933378|NCT04141163|Metformin|metformin|mesh-list
56311485|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56311486|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
56311487|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311488|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907433|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907434|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56648481|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311490|NCT00392691|Melphalan|melphalan|mesh-list
56311491|NCT00392691|Vinorelbine|vinorelbine|mesh-list
56311492|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311493|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311494|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
56311495|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311496|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311497|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311498|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
56311499|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311500|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56311501|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311502|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56311503|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
56311504|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
56311505|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311506|NCT02966080|Heparin|heparin|mesh-list
56311507|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
56311508|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56311509|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56311510|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311511|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
56311512|NCT04767776|Charcoal|charcoal|mesh-list
56311513|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56311514|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
55951203|NCT04771559|Antibodies|antibodies|mesh-list
56311539|NCT02972333|Osimertinib|osimertinib|mesh-list
56311540|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311541|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56311542|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311543|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311545|NCT00074737|Idarubicin|idarubicin|mesh-list
56311546|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311547|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
56311548|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311549|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311550|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
56311551|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311552|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311553|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
56311554|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311555|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56311556|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56311557|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56311558|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311559|NCT00074776|Lamotrigine|lamotrigine|mesh-list
56311560|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56311561|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311562|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56311563|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56311564|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311565|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
56311566|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56311567|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56311580|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311581|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311582|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
56311583|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56311584|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56311585|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56311586|NCT04729595|Tempol|tempol|mesh-list
56311587|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
56311588|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311589|NCT04729595|Protective Agents|protective agents|mesh-ancestor
56311590|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311591|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56311592|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311593|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56311594|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56341696|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
56311595|NCT00075205|Rimonabant|rimonabant|mesh-list
56311596|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56311597|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56311598|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56311599|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311600|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311601|NCT00075205|Hormones|hormones|mesh-ancestor
56311602|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56311603|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311604|NCT00075439|Gefitinib|gefitinib|mesh-list
56311605|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311606|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56311607|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311608|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311609|NCT00075517|Gemcitabine|gemcitabine|mesh-list
56311610|NCT00075517|Docetaxel|docetaxel|mesh-list
56311611|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311612|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
56311613|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311614|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311615|NCT00075517|Antiviral Agents|antiviral agents|mesh-ancestor
56311616|NCT00075517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311617|NCT00075517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311618|NCT00075517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311619|NCT00075517|Immunologic Factors|immunologic factors|mesh-ancestor
56311620|NCT00075517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311621|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
56311622|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
56311623|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311624|NCT00075556|Capecitabine|capecitabine|mesh-list
56311625|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311626|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
56311627|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311628|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311629|NCT00075595|Leucovorin|leucovorin|mesh-list
56311630|NCT00075595|Fluorouracil|fluorouracil|mesh-list
56311649|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
56311650|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
56311651|NCT00075634|Doxorubicin|doxorubicin|mesh-list
56311652|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56311653|NCT00075634|Decitabine|decitabine|mesh-list
56311654|NCT00075634|Azacitidine|azacitidine|mesh-list
56311655|NCT00075634|Lenograstim|lenograstim|mesh-list
56311656|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311657|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
56311658|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311659|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311660|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311661|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
56311662|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311663|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311664|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56311665|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56311666|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56311667|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56311668|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311669|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56311670|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311671|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
56311672|NCT00075673|Celecoxib|celecoxib|mesh-list
56311673|NCT00075673|Vinorelbine|vinorelbine|mesh-list
56311674|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56311675|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56311676|NCT00075673|Analgesics|analgesics|mesh-ancestor
56311677|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
56311678|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311679|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311680|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56311681|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311682|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56311683|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56311684|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311685|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081350|NCT00005643|Doxorubicin|doxorubicin|mesh-list
56907435|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56907436|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56907437|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56907438|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341774|NCT00405808|Rimonabant|rimonabant|mesh-list
56311686|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56311687|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311688|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
56311689|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
56311690|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311705|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311706|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311707|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
56311708|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933600|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56311709|NCT00075751|Antiviral Agents|antiviral agents|mesh-ancestor
56311710|NCT00075751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311711|NCT00075751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311712|NCT00075751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311713|NCT00075751|Immunologic Factors|immunologic factors|mesh-ancestor
56311714|NCT00075751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311716|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56311717|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56311718|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311719|NCT00075907|Ritonavir|ritonavir|mesh-list
56311720|NCT00075907|Lopinavir|lopinavir|mesh-list
56311721|NCT00075907|Efavirenz|efavirenz|mesh-list
56311722|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56311723|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56311724|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
56311725|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311726|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311727|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56311728|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56311729|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
56311730|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311731|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56311732|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56311733|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56311734|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56311735|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56311736|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56311737|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56311738|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56311739|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56311740|NCT03958383|Nivolumab|nivolumab|mesh-list
56311741|NCT03958383|Ipilimumab|ipilimumab|mesh-list
56311742|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311744|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56311745|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311746|NCT00076414|Acetylcholine|acetylcholine|mesh-list
56311747|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
56311748|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56311749|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
56311750|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951444|NCT05417087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56311766|NCT00399295|Hydromorphone|hydromorphone|mesh-list
56311767|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
56311768|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56311769|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311770|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
56311771|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311772|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56311773|NCT00399295|Narcotics|narcotics|mesh-ancestor
56311774|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56311775|NCT00399295|Analgesics|analgesics|mesh-ancestor
56311776|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
56311777|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56081351|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56907439|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
56907440|NCT00129935|Docetaxel|docetaxel|mesh-list
56907441|NCT00129935|Capecitabine|capecitabine|mesh-list
56907442|NCT00129935|Epirubicin|epirubicin|mesh-list
56341845|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
56311778|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56311779|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311780|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56311781|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
56311782|NCT00076492|Vitamins|vitamins|mesh-ancestor
56311783|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
56311784|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311785|NCT00076531|Leuprolide|leuprolide|mesh-list
56311786|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56311787|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
56311788|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56311789|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311790|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56311791|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311793|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311794|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
56311795|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311796|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311797|NCT04591808|Perindopril|perindopril|mesh-list
56311798|NCT04591808|Atorvastatin|atorvastatin|mesh-list
56311799|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56311800|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56311801|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
56311802|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311803|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56311804|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56311805|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311806|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56311807|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
56311808|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56311809|NCT00076726|Infliximab|infliximab|mesh-list
56311810|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
56311811|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55951505|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
56311819|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311821|NCT00077116|Cytarabine|cytarabine|mesh-list
56311822|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
56311823|NCT00077116|Busulfan|busulfan|mesh-list
56311824|NCT00077116|Idarubicin|idarubicin|mesh-list
56311825|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
56311826|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311827|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
56311828|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311829|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311830|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311831|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
56311832|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311833|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311834|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56311835|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311836|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
56311837|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
56311838|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311839|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56311840|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56311841|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56311842|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311843|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311844|NCT03951207|Amlodipine|amlodipine|mesh-list
56311845|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56311846|NCT03951207|Atorvastatin|atorvastatin|mesh-list
56311847|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56311848|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56311849|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
56311850|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311851|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56311852|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56907443|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907444|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
56907445|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907446|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907447|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56907448|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
56341909|NCT00148876|Capecitabine|capecitabine|mesh-list
56311853|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311854|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56311855|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56311856|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56311857|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56311858|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311859|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
56311860|NCT00077194|Romidepsin|romidepsin|mesh-list
56311861|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56311862|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311863|NCT00077233|Leucovorin|leucovorin|mesh-list
56311864|NCT00077233|Fluorouracil|fluorouracil|mesh-list
56311865|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
56311866|NCT00077233|Irinotecan|irinotecan|mesh-list
56311867|NCT00077233|Cetuximab|cetuximab|mesh-list
56311868|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311869|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
56311870|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311871|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311872|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311873|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311874|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
56311875|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56311876|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56311877|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311878|NCT00077233|Antidotes|antidotes|mesh-ancestor
56311879|NCT00077233|Protective Agents|protective agents|mesh-ancestor
56311892|NCT03927222|Sargramostim|sargramostim|mesh-list
56311893|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
56311894|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311895|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311896|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
56311897|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311898|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311900|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
56311901|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
56311902|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311903|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
56311904|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
56311905|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311906|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311907|NCT00077311|Hematinics|hematinics|mesh-ancestor
56311908|NCT00077311|Protective Agents|protective agents|mesh-ancestor
56311909|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311910|NCT00077350|Gemcitabine|gemcitabine|mesh-list
56311911|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311912|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
56311913|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311914|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311915|NCT00077350|Antiviral Agents|antiviral agents|mesh-ancestor
56311916|NCT00077350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311917|NCT00077350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311918|NCT00077350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311919|NCT00077350|Immunologic Factors|immunologic factors|mesh-ancestor
56311920|NCT00077350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311921|NCT00077389|Carboplatin|carboplatin|mesh-list
56311922|NCT00077389|Doxorubicin|doxorubicin|mesh-list
56311923|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56311924|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311925|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56311926|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56311927|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56341973|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311928|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311929|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311930|NCT00077428|Doxorubicin|doxorubicin|mesh-list
56311931|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56311932|NCT00077428|Bortezomib|bortezomib|mesh-list
56311933|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56311934|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311935|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55933828|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
56311936|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56311937|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311938|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311939|NCT00077467|Bortezomib|bortezomib|mesh-list
56311940|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311941|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
56311942|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311953|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311954|NCT00077779|Adalimumab|adalimumab|mesh-list
56311955|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56311956|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311957|NCT00077818|Enoxaparin|enoxaparin|mesh-list
56311958|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
56311959|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
56311960|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56311961|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56311962|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311963|NCT03766581|Aspirin|aspirin|mesh-list
56311964|NCT03766581|Clopidogrel|clopidogrel|mesh-list
56311965|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56311966|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56311967|NCT03766581|Analgesics|analgesics|mesh-ancestor
56311968|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
56311969|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311970|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311971|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56311972|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311973|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56311974|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56311975|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311976|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56311977|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56311978|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311980|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56311981|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56311982|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56311983|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
56311984|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311985|NCT00078130|Buprenorphine|buprenorphine|mesh-list
56311986|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56311987|NCT00078130|Naloxone|naloxone|mesh-list
56311988|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56311989|NCT00078130|Narcotics|narcotics|mesh-ancestor
56311990|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56311991|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311992|NCT00078130|Analgesics|analgesics|mesh-ancestor
56311993|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
56311994|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311995|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56311996|NCT00399451|Polidocanol|polidocanol|mesh-list
56311997|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56311998|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56311999|NCT04711213|Dexamethasone|dexamethasone|mesh-list
56312000|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
56312001|NCT04711213|BB 1101|bb 1101|mesh-list
56312002|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312003|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
56312004|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
56312005|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312006|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312007|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56312008|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
56312009|NCT04711213|Hormones|hormones|mesh-ancestor
56312010|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473678|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907449|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907450|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342051|NCT00049088|Docetaxel|docetaxel|mesh-list
56312022|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312024|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312025|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56312026|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56312027|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
56312028|NCT00078442|Interferons|interferons|mesh-list
56312029|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
56312030|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
56312031|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56312032|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312033|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
56312034|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312035|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
56312036|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312037|NCT00078481|Idebenone|idebenone|mesh-list
56312038|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
56312039|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312040|NCT00078481|Protective Agents|protective agents|mesh-ancestor
56312041|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312042|NCT00078598|Rituximab|rituximab|mesh-list
56312043|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
56312044|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56312045|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312046|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
56312047|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312048|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312049|NCT00078793|Etanercept|etanercept|mesh-list
56312050|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56312051|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56312052|NCT00078793|Analgesics|analgesics|mesh-ancestor
56312053|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
56312054|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312055|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312056|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312057|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312058|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56312059|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312060|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
56312061|NCT00078832|Anastrozole|anastrozole|mesh-list
56312062|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56312063|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312064|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56312065|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56312066|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312067|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312068|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56312069|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
56312070|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312071|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312072|NCT01350128|Bromides|bromides|mesh-list
56312073|NCT01350128|Ipratropium|ipratropium|mesh-list
56312074|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
56312084|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312086|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312087|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56312088|NCT00078910|Protective Agents|protective agents|mesh-ancestor
56312089|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312090|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56312091|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312092|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312093|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56312095|NCT00078910|Analgesics|analgesics|mesh-ancestor
56312096|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
56312097|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312098|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312099|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312100|NCT00078988|Carboplatin|carboplatin|mesh-list
56312101|NCT00078988|Etoposide|etoposide|mesh-list
56312102|NCT00078988|Thiotepa|thiotepa|mesh-list
56907451|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56907452|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
56342137|NCT00082251|Niacin|niacin|mesh-list
56312103|NCT00078988|Isotretinoin|isotretinoin|mesh-list
56312104|NCT00078988|Lenograstim|lenograstim|mesh-list
56312105|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312106|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56312107|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312108|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312109|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312110|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312111|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56312112|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
56312113|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312114|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312115|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
56312116|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312117|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312118|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
56312119|NCT00079027|Doxorubicin|doxorubicin|mesh-list
56312120|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56312121|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56312122|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312123|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312124|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312125|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312126|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312127|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
56312128|NCT03655002|Nivolumab|nivolumab|mesh-list
56312129|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312130|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
56312131|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312132|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312133|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312134|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
56312135|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312136|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312137|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312138|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55951826|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
56312164|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312165|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312166|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312167|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312168|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312169|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
56312171|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312172|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56312173|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312174|NCT00079105|Analgesics|analgesics|mesh-ancestor
56312175|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
56312176|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56312177|NCT04472429|Paclitaxel|paclitaxel|mesh-list
56312178|NCT04472429|Carboplatin|carboplatin|mesh-list
56312179|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56312180|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312181|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312182|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312183|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312184|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312185|NCT03647124|Lenalidomide|lenalidomide|mesh-list
56312186|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
56312187|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312188|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56312189|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56312190|NCT03647124|Growth Substances|growth substances|mesh-ancestor
56312191|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
56312192|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312193|NCT00079144|Aldesleukin|aldesleukin|mesh-list
56312194|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
56312208|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
56312209|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56312210|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56907453|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
56907454|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
56907455|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56312211|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56312212|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
56312213|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312215|NCT00079222|Voriconazole|voriconazole|mesh-list
56312216|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
56312217|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052365|NCT03556761|Furosemide|furosemide|mesh-list
56312218|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56312219|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56312220|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312221|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312222|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56312223|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
56312224|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312225|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312226|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56312227|NCT00079261|Gemcitabine|gemcitabine|mesh-list
56312228|NCT00079261|Prednisone|prednisone|mesh-list
56312229|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
56312230|NCT00079261|Doxorubicin|doxorubicin|mesh-list
56312231|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56312232|NCT00079261|Vincristine|vincristine|mesh-list
56312233|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312234|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
56312235|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312236|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312237|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312238|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
56312239|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934124|NCT01673087|Dexamethasone|dexamethasone|mesh-list
56312240|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312241|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312242|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56100029|NCT00000277|Mazindol|mazindol|mesh-list
56312243|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
56312244|NCT00079261|Antiviral Agents|antiviral agents|mesh-ancestor
56312245|NCT00079261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312246|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312247|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56312248|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312249|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312250|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312251|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
56312253|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312263|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312264|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
56312265|NCT00079378|Decitabine|decitabine|mesh-list
56312266|NCT00079378|Azacitidine|azacitidine|mesh-list
56312267|NCT00079378|Valproic Acid|valproic acid|mesh-list
56312268|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56312269|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
56312270|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312271|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312272|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312273|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
56312274|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
56312275|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312276|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312277|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
56312278|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56312279|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312280|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56312281|NCT00079456|Sirolimus|sirolimus|mesh-list
56312282|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56312283|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312284|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56312285|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312286|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
56312287|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312288|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
56907456|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
56907457|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56907458|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312289|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312290|NCT04467086|Propranolol|propranolol|mesh-list
56312291|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56312292|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56312293|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
56312294|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312295|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312296|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312297|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56312298|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56312299|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
56312300|NCT00079612|Sorafenib|sorafenib|mesh-list
56312301|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312302|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56312303|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312304|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312305|NCT03526107|Theobromine|theobromine|mesh-list
56312306|NCT03526107|Caffeine|caffeine|mesh-list
56312307|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56312308|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312309|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56312310|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312311|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312312|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56312313|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56312314|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
56312315|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312316|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56312318|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312319|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56312320|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
56312339|NCT00079924|Teriparatide|teriparatide|mesh-list
56312340|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56312341|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56312342|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312343|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56312344|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56312345|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
56312346|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312347|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56312348|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56312350|NCT00079963|Vitamin E|vitamin e|mesh-list
56312351|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
56312352|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312353|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
56312354|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312355|NCT00079963|Protective Agents|protective agents|mesh-ancestor
56312356|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
56312357|NCT00392886|Temozolomide|temozolomide|mesh-list
56312358|NCT00392886|Thiotepa|thiotepa|mesh-list
56312359|NCT00392886|Carboplatin|carboplatin|mesh-list
56312360|NCT00392886|Methotrexate|methotrexate|mesh-list
56312361|NCT00392886|Etoposide|etoposide|mesh-list
56312362|NCT00392886|Vincristine|vincristine|mesh-list
56312363|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312364|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
56312365|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312366|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312367|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312368|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
56312369|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312370|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312371|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312372|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56312373|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
56312374|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56312375|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56907459|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56907460|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312376|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
56312377|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
56312378|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312379|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56312395|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312396|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312397|NCT00080158|Mirtazapine|mirtazapine|mesh-list
56312398|NCT00080158|Citalopram|citalopram|mesh-list
56312399|NCT00080158|Bupropion|bupropion|mesh-list
56312400|NCT00080158|Fluoxetine|fluoxetine|mesh-list
56312401|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56312402|NCT00080158|Sertraline|sertraline|mesh-list
56312403|NCT00080158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56312404|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56312405|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56312406|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312407|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312408|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
56312409|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312410|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56312411|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
56312412|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56312413|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56312414|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
56312415|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56312416|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56312417|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312418|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56312419|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312420|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56312421|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56312422|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
56312423|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
56312424|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56312425|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56312426|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56312427|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56312428|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56312429|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56312430|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56312431|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56312432|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56312433|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312434|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56312435|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312436|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312437|NCT00080275|Niacin|niacin|mesh-list
56312438|NCT00080275|Simvastatin|simvastatin|mesh-list
56312439|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56312447|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
56312449|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
56312450|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312451|NCT00393003|Anesthetics|anesthetics|mesh-list
56312452|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312453|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312454|NCT00080314|Aripiprazole|aripiprazole|mesh-list
56312455|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
56312456|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56312457|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56312458|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56312459|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312460|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312461|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
56312462|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
56312463|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312464|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312465|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56312466|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56312467|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
56907461|NCT02131012|Celecoxib|celecoxib|mesh-list
56312468|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56312469|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56312470|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56312471|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56312472|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56312473|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56312474|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
56312475|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312476|NCT00080431|Daclizumab|daclizumab|mesh-list
56312477|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312478|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
56312479|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312480|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
56312481|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312482|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312483|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312484|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312485|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312486|NCT03506373|Ixazomib|ixazomib|mesh-list
56312487|NCT03506373|Glycine|glycine|mesh-list
56312488|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312489|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312490|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
56312491|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312492|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
56312493|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312494|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312495|NCT02972411|Acetazolamide|acetazolamide|mesh-list
56312496|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
56312497|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56312498|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312499|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312500|NCT02972411|Diuretics|diuretics|mesh-ancestor
56312501|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
56312502|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312503|NCT00080626|Docetaxel|docetaxel|mesh-list
56312504|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312505|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312506|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312516|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56312518|NCT00080743|Tamoxifen|tamoxifen|mesh-list
56312519|NCT00080743|Gefitinib|gefitinib|mesh-list
56312520|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312521|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56312522|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
56312523|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312524|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312525|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56312526|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312527|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56312528|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56312529|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56312530|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56312531|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312532|NCT04423367|Dexamethasone|dexamethasone|mesh-list
56312533|NCT04423367|Bortezomib|bortezomib|mesh-list
56312534|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312535|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
56312536|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
56312537|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934419|NCT03589547|Durvalumab|durvalumab|mesh-list
56312538|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312539|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56312540|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
56312541|NCT04423367|Hormones|hormones|mesh-ancestor
56312542|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312543|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56312544|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312545|NCT00080782|Celecoxib|celecoxib|mesh-list
56312546|NCT00080782|Doxorubicin|doxorubicin|mesh-list
56312547|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56312548|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56312549|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312550|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56907462|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56907463|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56907464|NCT02131012|Analgesics|analgesics|mesh-ancestor
56907465|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
56312551|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312552|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312553|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312554|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56312555|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56312556|NCT00080782|Analgesics|analgesics|mesh-ancestor
56312557|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
56312558|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312559|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312560|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312561|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312562|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56312563|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56312564|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56312565|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56312566|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312567|NCT00080977|Aldesleukin|aldesleukin|mesh-list
56312568|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312569|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56312570|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56312571|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
56312581|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312582|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312583|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
56312584|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312585|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312586|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312587|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56312588|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
56312589|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56312590|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56312592|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
56312593|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312594|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56312595|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56312596|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
56312597|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312598|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56312599|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56312600|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56312601|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312602|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
56312603|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
56312604|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312605|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56312606|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312607|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312609|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56312610|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
56312611|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312612|NCT03187080|Bupivacaine|bupivacaine|mesh-list
56312613|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
56312614|NCT03187080|Anesthetics|anesthetics|mesh-list
56312615|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312616|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312617|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
56312618|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312619|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
56312620|NCT00081484|Hematinics|hematinics|mesh-ancestor
56312621|NCT00390260|Acetaminophen|acetaminophen|mesh-list
56312623|NCT00390260|Hydrocodone|hydrocodone|mesh-list
56312624|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56312625|NCT00390260|Analgesics|analgesics|mesh-ancestor
56312626|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
56312627|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312628|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907466|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342562|NCT00151567|Tamsulosin|tamsulosin|mesh-list
56312629|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
56312630|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312631|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
56312632|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56312633|NCT00390260|Narcotics|narcotics|mesh-ancestor
56312634|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312635|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
56312636|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56312637|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56312638|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312639|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56312640|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312655|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56312656|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
56312657|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312658|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312659|NCT03152175|Propranolol|propranolol|mesh-list
56312660|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56312661|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56312662|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
56312663|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312664|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312665|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312666|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56312667|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56312668|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
56312669|NCT00399685|Efavirenz|efavirenz|mesh-list
56312670|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
56312671|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56312672|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56312673|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56312674|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312675|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312676|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
56312677|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312678|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56312679|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56312680|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56312681|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56312682|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56312683|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56312684|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56312685|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312686|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312687|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312688|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56312689|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
56312690|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56312691|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312692|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56312693|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56312694|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56312695|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
56312697|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
56312698|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56312699|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56312700|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
56312707|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56312708|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56312709|NCT03152097|Protective Agents|protective agents|mesh-ancestor
56312710|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312711|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312713|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56312714|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56312715|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312716|NCT00082225|Antibodies|antibodies|mesh-list
56312717|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
56312718|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907467|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907468|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907469|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312719|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
56312720|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312721|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
56312722|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312723|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312724|NCT00082537|Caspofungin|caspofungin|mesh-list
56312725|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56312726|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
56312727|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312728|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312729|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312730|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56312731|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56312732|NCT00082576|Azithromycin|azithromycin|mesh-list
56312733|NCT00082576|Chloroquine|chloroquine|mesh-list
56312734|NCT00082576|Mefloquine|mefloquine|mesh-list
56312735|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56312736|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312737|NCT00082576|Amebicides|amebicides|mesh-ancestor
56312738|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56312739|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56312741|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312742|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
56312743|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56312744|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312745|NCT00082966|Bortezomib|bortezomib|mesh-list
56312746|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312747|NCT00083005|Thalidomide|thalidomide|mesh-list
56312748|NCT00083005|Docetaxel|docetaxel|mesh-list
56312749|NCT00083005|Estramustine|estramustine|mesh-list
56312750|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312751|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312752|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312753|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312754|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312755|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312756|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
56312757|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312758|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
56100533|NCT00000865|Lamivudine|lamivudine|mesh-list
56312759|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56312760|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312761|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56312762|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56312763|NCT00083005|Growth Substances|growth substances|mesh-ancestor
56312764|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
56312765|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312767|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56312769|NCT00083083|Etoposide|etoposide|mesh-list
56312770|NCT00083083|Vinorelbine|vinorelbine|mesh-list
56312771|NCT00083083|Vinblastine|vinblastine|mesh-list
56312772|NCT00083083|Docetaxel|docetaxel|mesh-list
56312773|NCT00083083|Carboplatin|carboplatin|mesh-list
56312774|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56312787|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56312788|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312789|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312790|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56312792|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
56312793|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312794|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56312795|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56312796|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56312797|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
56312798|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312799|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312800|NCT03151863|Narcotics|narcotics|mesh-ancestor
56312801|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
56312802|NCT00083161|Etoposide|etoposide|mesh-list
56312803|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312804|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
56312805|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907470|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56907471|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56907472|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342725|NCT00082836|Rituximab|rituximab|mesh-list
56312806|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312807|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312808|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
56312809|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312810|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312811|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312812|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56312813|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312814|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312815|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312816|NCT00083278|Ipilimumab|ipilimumab|mesh-list
56312817|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56312818|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312819|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56312820|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312822|NCT00083434|Hematinics|hematinics|mesh-ancestor
56312823|NCT00083590|Huperzine A|huperzine a|mesh-list
56312824|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56312825|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312826|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312827|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
56312828|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312829|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312830|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56312831|NCT00083590|Protective Agents|protective agents|mesh-ancestor
56312832|NCT03151746|Gabapentin|gabapentin|mesh-list
56312833|NCT03151746|Analgesics|analgesics|mesh-ancestor
56312834|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
56312835|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952523|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312853|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312854|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312855|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56312856|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56312857|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56312858|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
56312859|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312860|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312861|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56312862|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56312863|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
56312865|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312866|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
56312867|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312868|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
56312869|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56312870|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312871|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56312872|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56312873|NCT00083707|Growth Substances|growth substances|mesh-ancestor
56312874|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
56312875|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312877|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312878|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56312879|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56312880|NCT03151707|Niacinamide|niacinamide|mesh-list
56312881|NCT03151707|Niacin|niacin|mesh-list
56312882|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
56312883|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
56312884|NCT03151707|Vitamins|vitamins|mesh-ancestor
56312885|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
56312886|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312887|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56312888|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
56312889|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312890|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56312891|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
56907473|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907474|NCT02138500|PF-06372865|pf-06372865|mesh-list
56907475|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
56312892|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
56312897|NCT03151668|Analgesics|analgesics|mesh-ancestor
56312898|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
56312899|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312908|NCT05568082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312909|NCT05568082|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56312910|NCT05568082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56312911|NCT05568082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312912|NCT05568082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827768|NCT02224274|Clopidogrel|clopidogrel|mesh-list
56312913|NCT05568082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56312914|NCT05568082|Hormone Antagonists|hormone antagonists|mesh-ancestor
56312915|NCT05568082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312916|NCT05568082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312917|NCT05568082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56312922|NCT05567653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312923|NCT05567653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56312924|NCT05567653|Renal Agents|renal agents|mesh-ancestor
56312925|NCT05567653|Antimalarials|antimalarials|mesh-ancestor
56312926|NCT05567653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56312927|NCT05567653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56312928|NCT04733508|Exenatide|exenatide|mesh-list
56312929|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56312930|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312931|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56312932|NCT04733508|Incretins|incretins|mesh-ancestor
56312933|NCT04733508|Hormones|hormones|mesh-ancestor
56312934|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312935|NCT05567536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56312936|NCT00135304|Vitamin D|vitamin d|mesh-list
56312937|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56312938|NCT00135304|Cinacalcet|cinacalcet|mesh-list
56312939|NCT00135304|Vitamins|vitamins|mesh-ancestor
56312940|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
56312941|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312942|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56312943|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56312944|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56312945|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
56312946|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312947|NCT00135499|Prednisone|prednisone|mesh-list
56312948|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
56312949|NCT00135499|Rituximab|rituximab|mesh-list
56312950|NCT00135499|Doxorubicin|doxorubicin|mesh-list
56312951|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56312952|NCT00135499|Vincristine|vincristine|mesh-list
56312953|NCT00135499|Bleomycin|bleomycin|mesh-list
56312954|NCT00135499|Vindesine|vindesine|mesh-list
56312955|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312956|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
56312957|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312958|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312959|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312960|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
56312961|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312962|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312963|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312964|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56312965|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56312966|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312967|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312980|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
56312981|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
56312982|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312983|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312984|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
56312985|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312986|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56312987|NCT03151434|Narcotics|narcotics|mesh-ancestor
56907476|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
56312988|NCT03151434|Analgesics|analgesics|mesh-ancestor
55934875|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312989|NCT00135577|Alvimopan|alvimopan|mesh-list
56312990|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56312991|NCT00135733|Alefacept|alefacept|mesh-list
56312992|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
56312993|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
56312994|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312995|NCT04061798|Heparin|heparin|mesh-list
56312996|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
56312997|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56312998|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56312999|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313000|NCT00135811|Cyclosporine|cyclosporine|mesh-list
56313001|NCT00135811|Dexamethasone|dexamethasone|mesh-list
56313002|NCT00135811|Cyclosporins|cyclosporins|mesh-list
56313003|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313004|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
56313005|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
56313006|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313007|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313008|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56313009|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
56313010|NCT00135811|Hormones|hormones|mesh-ancestor
56313011|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313012|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56313013|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313014|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313015|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313016|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313017|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
56313018|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
56313019|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313020|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
56313021|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313022|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56313023|NCT00135928|Lenograstim|lenograstim|mesh-list
56313024|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56313025|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
56313026|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313027|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
56313028|NCT00135967|Prednisone|prednisone|mesh-list
56313029|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
56313030|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56313031|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56313042|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313043|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56313044|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56313045|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
56313046|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313047|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313048|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313049|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313052|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313053|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56313054|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56313055|NCT00135967|Protective Agents|protective agents|mesh-ancestor
56313056|NCT00136045|Rotigotine|rotigotine|mesh-list
56313057|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
56313058|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
56313059|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313060|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313061|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313062|NCT00136201|Tigecycline|tigecycline|mesh-list
56313063|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313064|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934952|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56313065|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56313066|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313067|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313069|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
56313071|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
56313072|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313073|NCT00136396|Rituximab|rituximab|mesh-list
56313074|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56907477|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342929|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56313075|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313076|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
56313077|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313078|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313079|NCT00136474|Amifostine|amifostine|mesh-list
56313080|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56313081|NCT00136474|Protective Agents|protective agents|mesh-ancestor
56313082|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313083|NCT00136552|Rituximab|rituximab|mesh-list
56313084|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56313085|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313086|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
56313087|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313088|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313089|NCT00136591|Bortezomib|bortezomib|mesh-list
56313090|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313091|NCT03151161|Carboplatin|carboplatin|mesh-list
56313092|NCT03151161|Pemetrexed|pemetrexed|mesh-list
56313093|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313094|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313095|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313096|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56313097|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56313106|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313107|NCT03991130|Nivolumab|nivolumab|mesh-list
56313108|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56313109|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313110|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56313111|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313112|NCT00136747|Memantine|memantine|mesh-list
56313113|NCT00136747|Bupropion|bupropion|mesh-list
56313114|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56313115|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
56313116|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56313117|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56313118|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56313119|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56313120|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313121|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
56313122|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313123|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313124|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56313125|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56313127|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56313128|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56313129|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56313130|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56313131|NCT00136786|Memantine|memantine|mesh-list
56313132|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56313133|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56313134|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
56313135|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313136|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313137|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313138|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56313139|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56313140|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
56313141|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56313142|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
56313143|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313144|NCT00136825|Expectorants|expectorants|mesh-ancestor
56313145|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
56313146|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56313147|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
56313148|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313149|NCT00136825|Protective Agents|protective agents|mesh-ancestor
56313150|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313151|NCT00136825|Antidotes|antidotes|mesh-ancestor
56313152|NCT00393198|Misoprostol|misoprostol|mesh-list
56313153|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
56907478|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907479|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313154|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56313155|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
56313156|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56313157|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313158|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56313159|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56313160|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56313161|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56313162|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
56313175|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56313176|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56313177|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56313178|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56313179|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313180|NCT00136942|Atorvastatin|atorvastatin|mesh-list
56313181|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56313182|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56313183|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
56313184|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313185|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56313186|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56313187|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313188|NCT00136981|Atorvastatin|atorvastatin|mesh-list
56313189|NCT00136981|Torcetrapib|torcetrapib|mesh-list
56313191|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56313192|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
56313193|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313194|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56313195|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56313196|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313197|NCT00137020|Ziprasidone|ziprasidone|mesh-list
56313198|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56313199|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
56313200|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313201|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313202|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313203|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56313204|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56313205|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313206|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56313207|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56313208|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
56313209|NCT00137059|Acetaminophen|acetaminophen|mesh-list
56313210|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56313211|NCT00137059|Analgesics|analgesics|mesh-ancestor
56313212|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
56313213|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313214|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313215|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
56313217|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56313218|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313219|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56313220|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313221|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313222|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56313223|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56313224|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
56313225|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313238|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56313239|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313240|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313241|NCT00137410|Celecoxib|celecoxib|mesh-list
56313242|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56313243|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56313244|NCT00137410|Analgesics|analgesics|mesh-ancestor
56313245|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
56313246|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907480|NCT01561768|Vaccines|vaccines|mesh-list
56313247|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313248|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313249|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313250|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56313251|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56313252|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313253|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313254|NCT03151005|Metformin|metformin|mesh-list
56313255|NCT03151005|Liraglutide|liraglutide|mesh-list
56313256|NCT03151005|Exenatide|exenatide|mesh-list
56313257|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
56313258|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
56313259|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56313260|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313261|NCT03151005|Incretins|incretins|mesh-ancestor
56313262|NCT03151005|Hormones|hormones|mesh-ancestor
56313263|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313264|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56313265|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56313266|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56313267|NCT00137527|Anesthetics|anesthetics|mesh-list
56313268|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313269|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313270|NCT00137566|Acetaminophen|acetaminophen|mesh-list
56313271|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56313272|NCT00137566|Analgesics|analgesics|mesh-ancestor
56313273|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
56313274|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313275|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313276|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
56313277|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56313278|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
56313279|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313281|NCT00137761|Gefitinib|gefitinib|mesh-list
56313282|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313283|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
56313284|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
56313285|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
56313286|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935180|NCT05319756|Gabapentin|gabapentin|mesh-list
56313287|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56313288|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313289|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56313300|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313301|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313302|NCT00137995|Cytarabine|cytarabine|mesh-list
56313303|NCT00137995|Dexamethasone|dexamethasone|mesh-list
56313304|NCT00137995|Rituximab|rituximab|mesh-list
56313305|NCT00137995|Etoposide|etoposide|mesh-list
56313306|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
56313307|NCT00137995|Melphalan|melphalan|mesh-list
56313308|NCT00137995|Ifosfamide|ifosfamide|mesh-list
56313309|NCT00137995|Carboplatin|carboplatin|mesh-list
56313310|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56313311|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313312|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
56313313|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313314|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313315|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313316|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
56313317|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
56313318|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313319|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56313320|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
56313321|NCT00137995|Hormones|hormones|mesh-ancestor
56313322|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313323|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56313324|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56313325|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56313326|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56313327|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313328|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313329|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56313330|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
56313331|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
56907481|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
56313332|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313333|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313334|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56313335|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
56313336|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56313337|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
56313338|NCT00138112|Vancomycin|vancomycin|mesh-list
56313339|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313340|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313342|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
56313343|NCT00138229|Fludarabine|fludarabine|mesh-list
56313344|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
56313345|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313346|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
56313347|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101128|NCT00001057|Zidovudine|zidovudine|mesh-list
56313348|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313349|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56313350|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
56313351|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313352|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313353|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56313354|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56313355|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
56313368|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313370|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56313371|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
56313372|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313373|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313374|NCT00138541|Vildagliptin|vildagliptin|mesh-list
56313375|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56313376|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313377|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56313378|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
56313379|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313380|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313381|NCT00138580|Vildagliptin|vildagliptin|mesh-list
56313382|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56313383|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313384|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56313385|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
56313386|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313387|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313388|NCT03150771|Aripiprazole|aripiprazole|mesh-list
56313389|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
56313390|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56313391|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56313392|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56313393|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313394|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313395|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
56313396|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
56313397|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313398|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313399|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56313400|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56313401|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
56313402|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56313403|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56313404|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56313405|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56313406|NCT00138619|Vildagliptin|vildagliptin|mesh-list
56313407|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56313408|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313409|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56313410|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
56313411|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313412|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313414|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
56313415|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
56313416|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907482|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907483|NCT00137111|Cytarabine|cytarabine|mesh-list
56907484|NCT00137111|Dexamethasone|dexamethasone|mesh-list
56907485|NCT00137111|Prednisone|prednisone|mesh-list
56907486|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
56907487|NCT00137111|Doxorubicin|doxorubicin|mesh-list
56907488|NCT00137111|Methotrexate|methotrexate|mesh-list
56907489|NCT00137111|Etoposide|etoposide|mesh-list
56907490|NCT00137111|Vincristine|vincristine|mesh-list
56907491|NCT00137111|Daunorubicin|daunorubicin|mesh-list
56907492|NCT00137111|Asparaginase|asparaginase|mesh-list
56907493|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
56907494|NCT00137111|Pegaspargase|pegaspargase|mesh-list
56907495|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907496|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
56907497|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907498|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907499|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56907500|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
56907501|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907502|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907503|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56907504|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907505|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
56343228|NCT00154414|Liraglutide|liraglutide|mesh-list
56313417|NCT00138736|Coagulants|coagulants|mesh-ancestor
56313432|NCT03893825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56313433|NCT03893825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56313434|NCT03893825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313435|NCT03893825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56313436|NCT03893825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56313437|NCT03893825|Dopamine Agents|dopamine agents|mesh-ancestor
56313438|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
56313439|NCT00138970|Cyclosporine|cyclosporine|mesh-list
56313440|NCT00138970|Prednisolone|prednisolone|mesh-list
56313441|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56313442|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
56313443|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56313444|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
56313445|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56313446|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
56313447|NCT00138970|Daclizumab|daclizumab|mesh-list
56313448|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313449|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
56313450|NCT00138970|Hormones|hormones|mesh-ancestor
56313451|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313452|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313453|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56313454|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313455|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
56313456|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
56313457|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313458|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56313459|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56313460|NCT00138970|Protective Agents|protective agents|mesh-ancestor
56313461|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56473679|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
56907506|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
56907507|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907508|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56907509|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
56907510|NCT00137111|Hormones|hormones|mesh-ancestor
56907511|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313462|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56313463|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
56313464|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313465|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313466|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313467|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313468|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
56313469|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
56313470|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313471|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
56313472|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313473|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56313474|NCT00139009|Cyclosporine|cyclosporine|mesh-list
56313475|NCT00139009|Cyclosporins|cyclosporins|mesh-list
56313476|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313477|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313478|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313479|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
56313480|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953181|NCT02414724|Gemcitabine|gemcitabine|mesh-list
56313497|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56313498|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
56313499|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313500|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313501|NCT00139165|Budesonide|budesonide|mesh-list
56313502|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313503|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56313504|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
56313505|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313506|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313507|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56313508|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
56313509|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
56313510|NCT00139165|Hormones|hormones|mesh-ancestor
56313511|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313512|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
56313513|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56313514|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313515|NCT00139243|Leucovorin|leucovorin|mesh-list
56313516|NCT00139243|Fluorouracil|fluorouracil|mesh-list
56313517|NCT00139243|Docetaxel|docetaxel|mesh-list
56313518|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313519|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
56313520|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313521|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56313522|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313523|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
56313524|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313525|NCT00139243|Antidotes|antidotes|mesh-ancestor
56313526|NCT00139243|Protective Agents|protective agents|mesh-ancestor
56313527|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
56313528|NCT00139243|Vitamins|vitamins|mesh-ancestor
56313529|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
56313530|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
56313531|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
56313532|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
56313533|NCT00139282|Squalamine|squalamine|mesh-list
56313534|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313535|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313536|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56313537|NCT00139282|Protective Agents|protective agents|mesh-ancestor
56313538|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313539|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313540|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56907512|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56313541|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56313542|NCT00139282|Growth Substances|growth substances|mesh-ancestor
56313552|NCT00139360|Growth Substances|growth substances|mesh-ancestor
56313553|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313554|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
56313555|NCT00139516|Nicotine|nicotine|mesh-list
56313556|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56313557|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
56313558|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313559|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313560|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56313561|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56313562|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
56313563|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313564|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313567|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56313568|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56313569|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56313570|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313571|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56313572|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313573|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
56313574|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56313575|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
56313576|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313577|NCT03844412|Lidocaine|lidocaine|mesh-list
56313578|NCT03844412|Nortriptyline|nortriptyline|mesh-list
56313579|NCT03844412|Estradiol|estradiol|mesh-list
56313580|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
56313581|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
56313582|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313583|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161344|NCT01166724|Sirolimus|sirolimus|mesh-list
56313584|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
56313585|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313586|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56313587|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56313588|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56313589|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56313590|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313591|NCT03844412|Estrogens|estrogens|mesh-ancestor
56313592|NCT03844412|Hormones|hormones|mesh-ancestor
56313593|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313594|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56313595|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
56313596|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56313597|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56313598|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56313599|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
56313600|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313601|NCT00139633|Carboplatin|carboplatin|mesh-list
56313602|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313603|NCT00139711|Docetaxel|docetaxel|mesh-list
56313604|NCT00139711|Irinotecan|irinotecan|mesh-list
56313605|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313606|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
56313607|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
56313608|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953296|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313619|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313621|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
56313622|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
56313623|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313624|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
56313625|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56313626|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313627|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
56313628|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313629|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56313630|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56313631|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313632|NCT03837977|Antidotes|antidotes|mesh-ancestor
56907513|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56907514|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56343430|NCT00051155|Timolol|timolol|mesh-list
56313633|NCT03837977|Protective Agents|protective agents|mesh-ancestor
56313634|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
56313635|NCT03837977|Vitamins|vitamins|mesh-ancestor
56313636|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
56313637|NCT03837977|Hematinics|hematinics|mesh-ancestor
56313638|NCT00404326|Hydralazine|hydralazine|mesh-list
56313639|NCT00404326|Valproic Acid|valproic acid|mesh-list
56313640|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
56313641|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313642|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313644|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313645|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313646|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
56313647|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56313648|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313649|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56313650|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56313651|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
56313652|NCT00139750|Varenicline|varenicline|mesh-list
56313653|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56313654|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56313655|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
56313656|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313657|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313658|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313659|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56313660|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56313661|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
56313662|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313663|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56313664|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56313665|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
56313666|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
56313667|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313668|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313669|NCT03150459|Rifaximin|rifaximin|mesh-list
56313670|NCT03150459|Simvastatin|simvastatin|mesh-list
56313671|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56313672|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56313673|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
56313674|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313675|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56313676|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56313692|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
56313693|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313694|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
56313696|NCT03150420|Protective Agents|protective agents|mesh-ancestor
56313697|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313698|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
56313699|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313700|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
56313701|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313702|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313703|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
56313704|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
56313705|NCT00140218|Pramipexole|pramipexole|mesh-list
56313706|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
56313707|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313708|NCT00140218|Protective Agents|protective agents|mesh-ancestor
56313709|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313710|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56313711|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56313712|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
56313713|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
56313714|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313715|NCT00140257|Citalopram|citalopram|mesh-list
56313716|NCT00140257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56313717|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56313718|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56473680|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
56907515|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56907516|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907517|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56907518|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
56907519|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56907520|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56907521|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
56907522|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
56907523|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56907524|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56907525|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56907526|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
56907527|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907528|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
56907529|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
56313719|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313720|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313722|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313723|NCT00140257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56313724|NCT00140257|Antidepressive Agents|antidepressive agents|mesh-ancestor
56313725|NCT00140257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56313726|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
56313727|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56313728|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313729|NCT00140452|Thalidomide|thalidomide|mesh-list
56313730|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313731|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
56313732|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313733|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
56313734|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313735|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313736|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56313737|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56313748|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313749|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313750|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313751|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56313752|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
56313753|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313754|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
56313755|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313756|NCT00140569|Interferons|interferons|mesh-list
56313757|NCT00140569|Fludarabine|fludarabine|mesh-list
56313758|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313759|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
56313760|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313761|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
56313763|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56313764|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313765|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56313766|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
56313767|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313768|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313769|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56313770|NCT00140725|Interferons|interferons|mesh-list
56313771|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
56313772|NCT00140725|Lamivudine|lamivudine|mesh-list
56313773|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
56313774|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907530|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
56907531|NCT02133118|Pioglitazone|pioglitazone|mesh-list
56907532|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56907533|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343549|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313775|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
56313776|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313777|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
56313778|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313779|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56313780|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56313781|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313782|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313783|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56313784|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56313785|NCT00140764|Metronidazole|metronidazole|mesh-list
56313786|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313787|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313788|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56313789|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56313790|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56313791|NCT00140803|Verteporfin|verteporfin|mesh-list
56313792|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313793|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
56313794|NCT00140803|Hormones|hormones|mesh-ancestor
56313795|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313796|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313797|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313798|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
56313799|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56313800|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
56313801|NCT00140920|Diclofenac|diclofenac|mesh-list
56313802|NCT00140920|Rofecoxib|rofecoxib|mesh-list
56313803|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56313804|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56313805|NCT00140920|Analgesics|analgesics|mesh-ancestor
56313820|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313821|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313822|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56313823|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56313824|NCT00140998|Estradiol|estradiol|mesh-list
56313825|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56313826|NCT00140998|Estrogens|estrogens|mesh-ancestor
56313827|NCT00140998|Hormones|hormones|mesh-ancestor
56313828|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313829|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313830|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56313831|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
56313832|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56313833|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56313834|NCT00141154|Celecoxib|celecoxib|mesh-list
56313835|NCT00141154|Loxoprofen|loxoprofen|mesh-list
56313836|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56313837|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56313838|NCT00141154|Analgesics|analgesics|mesh-ancestor
56313839|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
56313840|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313841|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313842|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313843|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313844|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56313845|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56313846|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313847|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313848|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
56313849|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56313850|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313851|NCT00141193|Celecoxib|celecoxib|mesh-list
56313852|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56313853|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56313854|NCT00141193|Analgesics|analgesics|mesh-ancestor
56343621|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
56313855|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
56313856|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313857|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313858|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313859|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313860|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56313861|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56313862|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313863|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313864|NCT00141232|Atorvastatin|atorvastatin|mesh-list
56313865|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56313877|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
56313878|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313879|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
56313880|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56313881|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56313882|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313883|NCT00141310|Urological Agents|urological agents|mesh-ancestor
56313884|NCT00141388|Pregabalin|pregabalin|mesh-list
56313885|NCT00141388|Analgesics|analgesics|mesh-ancestor
56313886|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
56313887|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313888|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313889|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
56313890|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56313891|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56313892|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313893|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56313894|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56313895|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56313896|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313897|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56313898|NCT00404404|Paclitaxel|paclitaxel|mesh-list
56313899|NCT00404404|Bevacizumab|bevacizumab|mesh-list
56313900|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56313901|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56313902|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313903|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
56313904|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
56313905|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
56313906|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313907|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56313908|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56313909|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56313910|NCT00404404|Growth Substances|growth substances|mesh-ancestor
56313911|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313912|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
56313913|NCT00404482|Cyclosporine|cyclosporine|mesh-list
56313914|NCT00404482|Cyclosporins|cyclosporins|mesh-list
56313915|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313916|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313917|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56313918|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
56313919|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313920|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
56313921|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313922|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
56313923|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313924|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56313925|NCT03073941|Cimetidine|cimetidine|mesh-list
56313926|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56313927|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56313928|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56313936|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313937|NCT00141427|Pregabalin|pregabalin|mesh-list
56313938|NCT00141427|Analgesics|analgesics|mesh-ancestor
56313939|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
56313940|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313941|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313942|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
56313943|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56313944|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56082148|NCT02524561|Estrogens|estrogens|mesh-ancestor
56907535|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56907536|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313945|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313946|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56313947|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56101737|NCT04329650|Hormones|hormones|mesh-ancestor
56313948|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56313949|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313950|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56313968|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
56313970|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
56313971|NCT00141544|Estrone|estrone|mesh-list
56313972|NCT00141544|Testosterone|testosterone|mesh-list
56313973|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
56313974|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
56313975|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56313976|NCT00141544|Hormones|hormones|mesh-ancestor
56313977|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313978|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313979|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56313980|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313981|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
56313982|NCT00141544|Androgens|androgens|mesh-ancestor
56313983|NCT00141583|Candesartan|candesartan|mesh-list
56313984|NCT00141583|Enalapril|enalapril|mesh-list
56313985|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56313986|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56313987|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56313988|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313989|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56313990|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
56313991|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313992|NCT00141700|Rituximab|rituximab|mesh-list
56313993|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56313994|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313995|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
56313996|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313997|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313998|NCT03555149|Bevacizumab|bevacizumab|mesh-list
56313999|NCT03555149|Atezolizumab|atezolizumab|mesh-list
56314000|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56314001|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314002|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56314003|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56314004|NCT03555149|Growth Substances|growth substances|mesh-ancestor
56314005|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314006|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
56314007|NCT00141895|Misoprostol|misoprostol|mesh-list
56314008|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56314009|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
56314010|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55953685|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56314027|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
56314028|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
56314029|NCT00142051|Protective Agents|protective agents|mesh-ancestor
56314031|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314032|NCT02825979|Sotalol|sotalol|mesh-list
56314033|NCT02825979|Flecainide|flecainide|mesh-list
56314034|NCT02825979|Dronedarone|dronedarone|mesh-list
56314035|NCT02825979|Propafenone|propafenone|mesh-list
56314036|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56314037|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56314038|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56314039|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
56314040|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314041|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314042|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314043|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
56314044|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
56314045|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314046|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56314047|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56314048|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56907537|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56907538|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56907539|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56343773|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
56314049|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
56314050|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
56314051|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56314052|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
56314053|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56314054|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56314055|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314056|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56314057|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314058|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314059|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56314060|NCT00142207|Renal Agents|renal agents|mesh-ancestor
56314061|NCT00142246|Amodiaquine|amodiaquine|mesh-list
56314062|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
56314063|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56314064|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56314065|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314066|NCT00142324|Donepezil|donepezil|mesh-list
56314067|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56314068|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314069|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314070|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
56314083|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
56314084|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56314085|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314086|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56314087|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56314088|NCT00142480|Growth Substances|growth substances|mesh-ancestor
56314089|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314090|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
56314091|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56314092|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
56314093|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314094|NCT02806050|Letrozole|letrozole|mesh-list
56314095|NCT02806050|Palbociclib|palbociclib|mesh-list
56314096|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314097|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56314098|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56314099|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314100|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314101|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56314102|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
56314103|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56314104|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314105|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56314106|NCT02781792|Temozolomide|temozolomide|mesh-list
56314107|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56314108|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
56314109|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314110|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314111|NCT00142870|Bupropion|bupropion|mesh-list
56314112|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55936009|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
56314113|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
56314114|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56314115|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56314116|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56314117|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56314118|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314120|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314121|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314122|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56314123|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56314124|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314125|NCT00142948|Naltrexone|naltrexone|mesh-list
56314126|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56907540|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907541|NCT00136955|Irinotecan|irinotecan|mesh-list
56907542|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56907543|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56907544|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907545|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907546|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907547|NCT00135707|Vitamins|vitamins|mesh-list
56907548|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
56907549|NCT00135707|Vitamin E|vitamin e|mesh-list
56907550|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
56907551|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
56907552|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907553|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
56907554|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907555|NCT00135707|Protective Agents|protective agents|mesh-ancestor
56907556|NCT03548818|Interferons|interferons|mesh-list
56907557|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
56907558|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907559|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
56907560|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907561|NCT02252692|Enalapril|enalapril|mesh-list
56907562|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56907563|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
56907564|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907565|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907566|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56314127|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56314128|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314129|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
55953813|NCT01490060|BB 1101|bb 1101|mesh-list
56314134|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314135|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56314136|NCT02780427|Analgesics|analgesics|mesh-ancestor
56314137|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
56314138|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314139|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56314140|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56314141|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56314142|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
56314143|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314144|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314145|NCT00142987|Tegaserod|tegaserod|mesh-list
56314146|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56314147|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
56314148|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314149|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314150|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314151|NCT00143026|Levodopa|levodopa|mesh-list
56907567|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
56907568|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56314152|NCT00143026|Carbidopa|carbidopa|mesh-list
56314153|NCT00143026|Entacapone|entacapone|mesh-list
56314154|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56314155|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56314156|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
56314157|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314158|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314159|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314160|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56314161|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314162|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56314163|NCT00404599|Simvastatin|simvastatin|mesh-list
56314164|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56314165|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56314166|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
56314167|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314168|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56314169|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56314170|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314172|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
56314173|NCT00143065|Fludarabine|fludarabine|mesh-list
56314174|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56314175|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314176|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
56314177|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314178|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56314179|NCT02554383|Amoxicillin|amoxicillin|mesh-list
56314180|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
56314181|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
56314182|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56314183|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56314184|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936085|NCT00929253|Buprenorphine|buprenorphine|mesh-list
56314185|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56314186|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314187|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314188|NCT00143104|Insulin|insulin|mesh-list
56314189|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56314190|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314191|NCT00143143|Pregabalin|pregabalin|mesh-list
56314192|NCT00143143|Analgesics|analgesics|mesh-ancestor
56314193|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
56314194|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314195|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314196|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
56314197|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56314198|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55953875|NCT05557110|Blinatumomab|blinatumomab|mesh-list
56314209|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314210|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314211|NCT00143221|Urological Agents|urological agents|mesh-ancestor
56314212|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
56314213|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314214|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
56314215|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56314216|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56314217|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314218|NCT00143260|Urological Agents|urological agents|mesh-ancestor
56314219|NCT00143299|Varenicline|varenicline|mesh-list
56314220|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56314221|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56314222|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
56314223|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314224|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314225|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314226|NCT00143338|Insulin|insulin|mesh-list
56314227|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56314228|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314229|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56314230|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56314231|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56907569|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
56907570|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907571|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
56314232|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
56314233|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314234|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314235|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314236|NCT00143377|Urological Agents|urological agents|mesh-ancestor
56314238|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314239|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
56314240|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
56314241|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
56314242|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314244|NCT04726345|Terfenadine|terfenadine|mesh-list
56314245|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56314246|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56314247|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56314248|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
56314249|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
56314250|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314251|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314252|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314253|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
56314254|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
56314255|NCT00143533|Irinotecan|irinotecan|mesh-list
56314256|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56314257|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55936169|NCT04981704|Phenytoin|phenytoin|mesh-list
56314258|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314259|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314260|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953947|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
56314280|NCT00143689|Nevirapine|nevirapine|mesh-list
56314281|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56314282|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56314283|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
56314284|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314285|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314286|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56314287|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56314288|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
56314289|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314290|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56314291|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56314292|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56314293|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56314294|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
56314295|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56314296|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56314297|NCT00143728|Lamivudine|lamivudine|mesh-list
56314298|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56314299|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56314300|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314301|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314302|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
56314303|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314304|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56314305|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56314306|NCT00143806|Cyclosporine|cyclosporine|mesh-list
56314307|NCT00143806|Alefacept|alefacept|mesh-list
56314308|NCT00143806|Cyclosporins|cyclosporins|mesh-list
56054497|NCT03964532|Avelumab|avelumab|mesh-list
56314309|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314310|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314311|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56314312|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
56314313|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314314|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
56314316|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
56314317|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56314343|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56314344|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56907572|NCT03548662|Protective Agents|protective agents|mesh-ancestor
56907573|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56907574|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314345|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56314346|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56314347|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
56314348|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56314349|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
56314350|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314351|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314352|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56314353|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
56314354|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
56314355|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56314356|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
56314357|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314358|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314359|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56314360|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56314361|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314362|NCT02231775|Trametinib|trametinib|mesh-list
56314363|NCT02231775|Dabrafenib|dabrafenib|mesh-list
56314364|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314365|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56314366|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314367|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314394|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314395|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314396|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56314397|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
56314398|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56314399|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56314400|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314401|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56314402|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
56314403|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56314404|NCT00404716|Protective Agents|protective agents|mesh-ancestor
56314405|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56314406|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56314407|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314408|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
56314409|NCT00404794|Prednisolone|prednisolone|mesh-list
56314410|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56314411|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
56314412|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56314413|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
56314415|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56314416|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
55954120|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
56314427|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56314428|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314429|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56314430|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
56314431|NCT00404794|Hormones|hormones|mesh-ancestor
56314432|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56314433|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56314434|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
56314435|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
56314436|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314437|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314438|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56314439|NCT00404794|Protective Agents|protective agents|mesh-ancestor
56314440|NCT03191786|Gemcitabine|gemcitabine|mesh-list
56314441|NCT03191786|Atezolizumab|atezolizumab|mesh-list
56314442|NCT03191786|Vinorelbine|vinorelbine|mesh-list
56314443|NCT03191786|Antibodies|antibodies|mesh-list
56314444|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56314445|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
56314446|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314447|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56314448|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
56907575|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907576|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
56907577|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56314449|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314450|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314451|NCT03191786|Antiviral Agents|antiviral agents|mesh-ancestor
56314452|NCT03191786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314453|NCT03191786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314454|NCT03191786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56314455|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56314456|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
56314457|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
56314458|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
56314459|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
56314460|NCT00404833|Prednisolone|prednisolone|mesh-list
56314461|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56314462|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
56314463|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56314465|NCT00404833|Chlorambucil|chlorambucil|mesh-list
56314466|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56314467|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
56314468|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56314469|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314470|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56314471|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
56314472|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56314473|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314474|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314475|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314476|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56314477|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
56314478|NCT00404833|Hormones|hormones|mesh-ancestor
56314479|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56314480|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314481|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56314490|NCT05595109|Silymarin|silymarin|mesh-list
56314491|NCT05595109|Antioxidants|antioxidants|mesh-ancestor
56314492|NCT05595109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314493|NCT05595109|Protective Agents|protective agents|mesh-ancestor
56314494|NCT05595109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314495|NCT01940094|Prednisone|prednisone|mesh-list
56314496|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
56314497|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56314498|NCT01940094|Hormones|hormones|mesh-ancestor
56314499|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56314500|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314501|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56314502|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314503|NCT03128021|Milnacipran|milnacipran|mesh-list
56314504|NCT03128021|Citalopram|citalopram|mesh-list
56314505|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
56314506|NCT03128021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56314507|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56314508|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56314509|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314510|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314511|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
56314512|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314513|NCT03128021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56314514|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
56314515|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56314516|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314517|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56314518|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56314519|NCT03128021|Analgesics|analgesics|mesh-ancestor
56314520|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
56314521|NCT01919619|Lenalidomide|lenalidomide|mesh-list
56314522|NCT01919619|Ipilimumab|ipilimumab|mesh-list
56314523|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
56314524|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314525|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56082149|NCT02524561|Hormones|hormones|mesh-ancestor
56907578|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
56907579|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907580|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907581|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56907582|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
56314526|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56314527|NCT01919619|Growth Substances|growth substances|mesh-ancestor
56314528|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
56314529|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314530|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56314531|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56314532|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314533|NCT05594602|Itraconazole|itraconazole|mesh-list
56314534|NCT05594602|Quinidine|quinidine|mesh-list
56314543|NCT05594602|Hormone Antagonists|hormone antagonists|mesh-ancestor
56161410|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314544|NCT05594602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56314545|NCT05594602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314546|NCT05594602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56314547|NCT05594602|Anticonvulsants|anticonvulsants|mesh-ancestor
56314548|NCT05594602|Antimanic Agents|antimanic agents|mesh-ancestor
56314549|NCT05594602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56314550|NCT05594602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56314551|NCT05594602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56314552|NCT05594602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56314554|NCT05594602|Sensory System Agents|sensory system agents|mesh-ancestor
56314555|NCT05594602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314565|NCT05594602|Antimalarials|antimalarials|mesh-ancestor
56314566|NCT05594602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56314567|NCT05594602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56314568|NCT05594602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56314569|NCT05594602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56314570|NCT05594602|Cholinergic Agents|cholinergic agents|mesh-ancestor
56314571|NCT05594602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56314572|NCT05594602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56314582|NCT01807494|Cimetidine|cimetidine|mesh-list
56314583|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56314584|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314585|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56314586|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
56314587|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
56314588|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314589|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314590|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314591|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56314592|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56314593|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314594|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
56314595|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
56314596|NCT03096782|Melphalan|melphalan|mesh-list
56314597|NCT03096782|Busulfan|busulfan|mesh-list
56314598|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
56314599|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56314600|NCT03096782|Rituximab|rituximab|mesh-list
56314601|NCT03096782|Fludarabine|fludarabine|mesh-list
56314602|NCT03096782|Clofarabine|clofarabine|mesh-list
56314603|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56314604|NCT03096782|Tacrolimus|tacrolimus|mesh-list
56314605|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
56314606|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56314607|NCT03096782|Antibodies|antibodies|mesh-list
56314608|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
56314609|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56314610|NCT03096782|Lenograstim|lenograstim|mesh-list
56314611|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56314612|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
56314613|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314614|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56314615|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56314616|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
56473681|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314617|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314618|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314619|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56314620|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56314621|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
56314622|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56314623|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314624|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56314625|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56314626|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56314627|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
56314628|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56314629|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314631|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
56314632|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
56314640|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56314641|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314643|NCT05594017|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56314644|NCT05594017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56314645|NCT05594017|Antiemetics|antiemetics|mesh-ancestor
56314646|NCT05594017|Autonomic Agents|autonomic agents|mesh-ancestor
56314647|NCT05594017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314648|NCT05594017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314649|NCT05594017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314650|NCT05594017|Mydriatics|mydriatics|mesh-ancestor
56314651|NCT05594017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56314652|NCT05594017|Cholinergic Agents|cholinergic agents|mesh-ancestor
56314653|NCT05594017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314654|NCT05594017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314655|NCT05594017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56314656|NCT05594017|Parasympatholytics|parasympatholytics|mesh-ancestor
56314657|NCT05593939|Niacinamide|niacinamide|mesh-list
56314658|NCT05593939|Niacin|niacin|mesh-list
56314659|NCT05593939|Nicotinic Acids|nicotinic acids|mesh-list
56314660|NCT05593939|Vitamin B Complex|vitamin b complex|mesh-ancestor
56314661|NCT05593939|Vitamins|vitamins|mesh-ancestor
56314662|NCT05593939|Micronutrients|micronutrients|mesh-ancestor
56314663|NCT05593939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314664|NCT05593939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56314665|NCT05593939|Antimetabolites|antimetabolites|mesh-ancestor
56314666|NCT05593939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314667|NCT05593939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56314668|NCT05593939|Vasodilator Agents|vasodilator agents|mesh-ancestor
56314669|NCT05586724|Norethindrone|norethindrone|mesh-list
56314670|NCT05586724|Norethindrone Acetate|norethindrone acetate|mesh-list
56314671|NCT05586724|Progesterone|progesterone|mesh-list
56314672|NCT05586724|Estrogens|estrogens|mesh-list
56314673|NCT05586724|Progestins|progestins|mesh-ancestor
56314674|NCT05586724|Hormones|hormones|mesh-ancestor
56314675|NCT05586724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56314676|NCT05586724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314677|NCT05586724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56314678|NCT05586724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56314679|NCT05586724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56314680|NCT05586724|Contraceptive Agents|contraceptive agents|mesh-ancestor
56314681|NCT05586724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56314682|NCT05586724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56314683|NCT05586724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56314684|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
56314685|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
56314686|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56314687|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
56314688|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314689|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56314690|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56314691|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
56314692|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314693|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314694|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56314695|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56314696|NCT01807377|Midazolam|midazolam|mesh-list
56314697|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56314698|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56314712|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56314713|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314714|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56314715|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314716|NCT02972255|Meropenem|meropenem|mesh-list
56314717|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56314718|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314719|NCT05468671|Remifentanil|remifentanil|mesh-list
56314720|NCT05468671|Oxycodone|oxycodone|mesh-list
56314721|NCT05468671|Propofol|propofol|mesh-list
56314722|NCT05468671|Rocuronium|rocuronium|mesh-list
56314723|NCT05468671|Flumazenil|flumazenil|mesh-list
56314724|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56314725|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56314726|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314727|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56314728|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
56314729|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
56314730|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56314731|NCT05468671|Narcotics|narcotics|mesh-ancestor
56314732|NCT05468671|Analgesics|analgesics|mesh-ancestor
56314733|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
56314734|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314735|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56314736|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56314737|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56314738|NCT05468671|Antidotes|antidotes|mesh-ancestor
56314739|NCT05468671|Protective Agents|protective agents|mesh-ancestor
56314740|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
56314741|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
56314742|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314743|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314744|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
56314745|NCT05462236|Irinotecan|irinotecan|mesh-list
56314746|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56314747|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314748|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56314749|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56314750|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314751|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314752|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56314753|NCT03087071|Panitumumab|panitumumab|mesh-list
56314754|NCT03087071|Trametinib|trametinib|mesh-list
56314755|NCT03087071|Antibodies|antibodies|mesh-list
56314756|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
56314757|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56314758|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
56314759|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314760|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314761|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56314762|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954429|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
56314782|NCT03079427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314783|NCT03079427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56314784|NCT03079427|Immunologic Factors|immunologic factors|mesh-ancestor
56314785|NCT03079427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314786|NCT00390923|Selegiline|selegiline|mesh-list
56314787|NCT00390923|Nicotine|nicotine|mesh-list
56314788|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56314789|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
56314790|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314791|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314792|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56314793|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56314794|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
56314795|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314796|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314797|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
56314798|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56314799|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56314800|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56314801|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56314802|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314803|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56314804|NCT00390923|Protective Agents|protective agents|mesh-ancestor
56314805|NCT00425425|Fluorouracil|fluorouracil|mesh-list
56314806|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
56314808|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
56314809|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314810|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56907583|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56907584|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
56344410|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56314811|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314812|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56314813|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
56314814|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314815|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56314816|NCT01806948|Ramosetron|ramosetron|mesh-list
56314817|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
56314818|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
56314819|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314820|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314821|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314822|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56314833|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
56314834|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314835|NCT02958163|Doxorubicin|doxorubicin|mesh-list
56314836|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56314837|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314838|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56314839|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56314840|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314841|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314842|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56314843|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56314844|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314845|NCT02985866|Pancrelipase|pancrelipase|mesh-list
56314846|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314847|NCT05300152|Antibodies|antibodies|mesh-list
56314848|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
56314849|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
56314850|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314851|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
56314852|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
56314853|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
56314854|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56314855|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314856|NCT01806792|Vitamins|vitamins|mesh-ancestor
56314857|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
56314858|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56314859|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56314860|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56314861|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936760|NCT01075971|Analgesics|analgesics|mesh-ancestor
56314862|NCT05228431|Capecitabine|capecitabine|mesh-list
56314863|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56314864|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
56314865|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314866|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314867|NCT05227456|Etonogestrel|etonogestrel|mesh-list
56314868|NCT05227456|Desogestrel|desogestrel|mesh-list
56314869|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56314870|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
56314871|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56314872|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314873|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56314874|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56314875|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56314876|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56314877|NCT05227456|Progestins|progestins|mesh-ancestor
56314878|NCT05227456|Hormones|hormones|mesh-ancestor
56314879|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56314880|NCT02901041|Zonisamide|zonisamide|mesh-list
56314881|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
56314882|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56314883|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56314884|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954551|NCT01852890|Protective Agents|protective agents|mesh-ancestor
56314896|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56314897|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56314898|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56314899|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
56314900|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
56314901|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314902|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314903|NCT05197075|Darunavir|darunavir|mesh-list
56314904|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56314905|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56314906|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
56314907|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314908|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314909|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56314910|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56314911|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
56314912|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314913|NCT05175430|Paroxetine|paroxetine|mesh-list
56314914|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
56314915|NCT05175430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56314916|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56314917|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56314918|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314919|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314920|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
56314921|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314922|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56314923|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
56314924|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56314925|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56314926|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56314927|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314928|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
56314929|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56314930|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56314931|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56314933|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55936849|NCT03484299|Folfirinox|folfirinox|mesh-list
56314934|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314935|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
56314936|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314937|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314939|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56314940|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56314941|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314942|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
56314943|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
56314944|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
56314945|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314946|NCT05065567|Droperidol|droperidol|mesh-list
56314947|NCT05065567|Haloperidol|haloperidol|mesh-list
56314948|NCT05065567|Ondansetron|ondansetron|mesh-list
56314949|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
56314962|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56314963|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56314964|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56314965|NCT05065567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56314966|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56314967|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
56314968|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56314969|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56314970|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56314971|NCT02739035|Dexamethasone|dexamethasone|mesh-list
56314972|NCT02739035|Celecoxib|celecoxib|mesh-list
56314973|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56314974|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
56314975|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
56314976|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314977|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314978|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314979|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
56314980|NCT02739035|Hormones|hormones|mesh-ancestor
56314981|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56314982|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56314983|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314984|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56314985|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56314986|NCT02739035|Analgesics|analgesics|mesh-ancestor
56314987|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
56907585|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907586|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314988|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56314989|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56314990|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56314991|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314992|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314993|NCT04958044|Calcium|calcium|mesh-list
56314994|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56314995|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314996|NCT04953754|Melatonin|melatonin|mesh-list
56314997|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
56314998|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314999|NCT04953754|Protective Agents|protective agents|mesh-ancestor
56315000|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315001|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315002|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
56315003|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56315004|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315005|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315006|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56315007|NCT04871308|Analgesics|analgesics|mesh-ancestor
56315008|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
56315009|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315010|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55954682|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
56315020|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315021|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56315022|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56315023|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
56315024|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
56315025|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315026|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56315027|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56315028|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315029|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315030|NCT01806363|Telmisartan|telmisartan|mesh-list
56315031|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
56315032|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56315033|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56315034|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56315035|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315036|NCT01806363|Diuretics|diuretics|mesh-ancestor
56315037|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
56315038|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315039|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56315040|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56315041|NCT04846855|Anesthetics|anesthetics|mesh-list
56315042|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
56315043|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315044|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315045|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
56315046|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315047|NCT01806324|Losartan|losartan|mesh-list
56315048|NCT01806324|Atorvastatin|atorvastatin|mesh-list
56315049|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56315050|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56315051|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
56315052|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315053|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56315054|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56315055|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315056|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56315057|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56315058|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56315059|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56315060|NCT02964403|Indomethacin|indomethacin|mesh-list
56315061|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56315062|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56907587|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56907588|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
56907589|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
56907590|NCT02252770|Protective Agents|protective agents|mesh-ancestor
56907591|NCT05578456|Aspirin|aspirin|mesh-list
56315063|NCT02964403|Analgesics|analgesics|mesh-ancestor
56315064|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
56315065|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315066|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315067|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315068|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315069|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
56315070|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
56315071|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56315072|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56315073|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954746|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
56315083|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
56315084|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315085|NCT00393393|Hylan|hylan|mesh-list
56315086|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
56315087|NCT00393393|Protective Agents|protective agents|mesh-ancestor
56315088|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315089|NCT00405262|Ketorolac|ketorolac|mesh-list
56315090|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56315091|NCT00405262|Bupivacaine|bupivacaine|mesh-list
56315092|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
56315093|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
56315094|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315095|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315096|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
56315097|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315098|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56315099|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56315100|NCT00405262|Analgesics|analgesics|mesh-ancestor
56315101|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315102|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315103|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56315104|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315105|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315106|NCT00405301|Rifampin|rifampin|mesh-list
56315107|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
56315108|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56315109|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
56315110|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56315111|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315112|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
56315113|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56315114|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315115|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315116|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56315117|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56315118|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56315119|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56315120|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56315121|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56315122|NCT00405340|Rituximab|rituximab|mesh-list
56315123|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56315124|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315125|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
56315126|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315127|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315128|NCT04713319|Calcium|calcium|mesh-list
56315129|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56315130|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315131|NCT00393471|Etanercept|etanercept|mesh-list
56315132|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56315133|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56315134|NCT00393471|Analgesics|analgesics|mesh-ancestor
56315135|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
56907592|NCT05578456|Prednisone|prednisone|mesh-list
56907593|NCT05578456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907594|NCT05578456|Glucocorticoids|glucocorticoids|mesh-ancestor
56315136|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315137|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315138|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315151|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56315152|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56315153|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56315154|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315155|NCT02646683|Vedolizumab|vedolizumab|mesh-list
56315156|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56315157|NCT02593175|Paclitaxel|paclitaxel|mesh-list
56315158|NCT02593175|Carboplatin|carboplatin|mesh-list
56315159|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56315160|NCT02593175|Panitumumab|panitumumab|mesh-list
56315161|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56315162|NCT02593175|Antibodies|antibodies|mesh-list
56315163|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
56315164|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56315165|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56315166|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315167|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
56315168|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
56315169|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
56315170|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315171|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
56315172|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315173|NCT01806090|Clopidogrel|clopidogrel|mesh-list
56315174|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56315175|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56315176|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56315177|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56315178|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
56315179|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315180|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315181|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315182|NCT02505893|Sirolimus|sirolimus|mesh-list
56315183|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56315184|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315185|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56315186|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315187|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
56315188|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315189|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
56315190|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315191|NCT04427956|Riboflavin|riboflavin|mesh-list
56315192|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
56315193|NCT04427956|Vitamins|vitamins|mesh-ancestor
56315194|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
56315195|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315196|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56315197|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
56315198|NCT04341181|Trastuzumab|trastuzumab|mesh-list
56315199|NCT04341181|Pertuzumab|pertuzumab|mesh-list
56315200|NCT04341181|Avelumab|avelumab|mesh-list
56315201|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56315202|NCT04341181|Atezolizumab|atezolizumab|mesh-list
56315203|NCT04341181|Niraparib|niraparib|mesh-list
56315204|NCT04341181|Axitinib|axitinib|mesh-list
56315205|NCT04341181|Vemurafenib|vemurafenib|mesh-list
56315218|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315219|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315220|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
56315221|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315222|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56315223|NCT02423876|Narcotics|narcotics|mesh-ancestor
56315224|NCT02423876|Analgesics|analgesics|mesh-ancestor
56315225|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
56315226|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56315227|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315228|NCT01805895|Minocycline|minocycline|mesh-list
56315229|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56315230|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315231|NCT01805856|Cefazolin|cefazolin|mesh-list
56907595|NCT05578456|Hormones|hormones|mesh-ancestor
56907596|NCT05578456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344770|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56315232|NCT01805856|Piperacillin|piperacillin|mesh-list
56315233|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56315234|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315235|NCT04234048|Fenretinide|fenretinide|mesh-list
56315236|NCT04234048|Retinamide|retinamide|mesh-list
56315237|NCT04234048|Tretinoin|tretinoin|mesh-list
56315238|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315239|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56315240|NCT04234048|Protective Agents|protective agents|mesh-ancestor
56315241|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315242|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
56315243|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
56315244|NCT01805817|Copper|copper|mesh-list
56315245|NCT01805817|Drospirenone|drospirenone|mesh-list
56315246|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
56315247|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56315248|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56315249|NCT01805817|Estradiol|estradiol|mesh-list
56315250|NCT01805817|Estrogens|estrogens|mesh-ancestor
56315251|NCT01805817|Hormones|hormones|mesh-ancestor
56315252|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56315253|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315254|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56315255|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
56315256|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56315257|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56315258|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56315259|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56315260|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56315261|NCT01805817|Trace Elements|trace elements|mesh-ancestor
56315262|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
56315263|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56315264|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
56315265|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56315266|NCT01805817|Diuretics|diuretics|mesh-ancestor
56315267|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
56315268|NCT04206046|Anesthetics|anesthetics|mesh-list
55954940|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
56315285|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56315286|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315287|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56315288|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315289|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161424|NCT00875394|Metformin|metformin|mesh-list
56315290|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56315291|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56315292|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
56315293|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315295|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
56315296|NCT04033276|Antibodies|antibodies|mesh-list
56315297|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
56315298|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56315299|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56315300|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56315301|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315302|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
56315303|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315304|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315305|NCT04014790|KRN 7000|krn 7000|mesh-list
56315306|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56315307|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
56315308|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315309|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315310|NCT03969823|Osimertinib|osimertinib|mesh-list
55937222|NCT01106859|Zolpidem|zolpidem|mesh-list
56315311|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315312|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56315313|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315314|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315315|NCT00391157|Dexamethasone|dexamethasone|mesh-list
56315316|NCT00391157|Bortezomib|bortezomib|mesh-list
56907597|NCT05578456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907598|NCT05578456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56344848|NCT00053768|Prednisone|prednisone|mesh-list
56315317|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315318|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
56315319|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
56315320|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315321|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315322|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56315323|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
56315324|NCT00391157|Hormones|hormones|mesh-ancestor
56315325|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56315326|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56315327|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315346|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
56315347|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56315348|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315349|NCT01903421|Fentanyl|fentanyl|mesh-list
56315350|NCT01903421|Bupivacaine|bupivacaine|mesh-list
56315351|NCT01903421|Anesthetics|anesthetics|mesh-list
56315352|NCT01903421|Propofol|propofol|mesh-list
56315353|NCT01903421|Sevoflurane|sevoflurane|mesh-list
56315354|NCT01903421|Isoflurane|isoflurane|mesh-list
56315355|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
56315356|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315357|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315358|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
56315359|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315360|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56315361|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56055524|NCT01534143|Tacrolimus|tacrolimus|mesh-list
56315362|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
56315363|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56315365|NCT01903421|Analgesics|analgesics|mesh-ancestor
56315366|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56315367|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56315368|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56315369|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
56315370|NCT03734731|Narcotics|narcotics|mesh-ancestor
56315371|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315372|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315373|NCT03734731|Analgesics|analgesics|mesh-ancestor
56315374|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
56315375|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315413|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56315414|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
56315415|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
56315416|NCT01723839|Rituximab|rituximab|mesh-list
56315417|NCT01723839|Fludarabine|fludarabine|mesh-list
56315418|NCT01723839|Lenalidomide|lenalidomide|mesh-list
56315419|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315420|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
56315421|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315422|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315423|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56315424|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
56315425|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315426|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315427|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56315428|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56315429|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56315430|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56315431|NCT01723839|Growth Substances|growth substances|mesh-ancestor
56315432|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
56315433|NCT03421483|Folic Acid|folic acid|mesh-list
56315434|NCT03421483|Hematinics|hematinics|mesh-ancestor
56315435|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
56315436|NCT03421483|Vitamins|vitamins|mesh-ancestor
56315437|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
56315438|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315439|NCT03363217|Trametinib|trametinib|mesh-list
56315440|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161429|NCT00875394|Hormones|hormones|mesh-ancestor
56315441|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56315442|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082152|NCT02524561|Progestins|progestins|mesh-ancestor
56344923|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
56315443|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315449|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
56315450|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56315451|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315452|NCT01878617|Gemcitabine|gemcitabine|mesh-list
56315453|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
56315454|NCT01878617|Vincristine|vincristine|mesh-list
56315455|NCT01878617|Pemetrexed|pemetrexed|mesh-list
56315456|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315457|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
55955117|NCT05552586|Melatonin|melatonin|mesh-list
56315482|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56315483|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315484|NCT00405535|Glycine|glycine|mesh-list
56315485|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
56315486|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315487|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315488|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315489|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56315490|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
56315491|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
56315492|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315493|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315494|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56315495|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56315496|NCT00405574|Growth Substances|growth substances|mesh-ancestor
56315497|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315498|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
56315499|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315500|NCT02993029|Celecoxib|celecoxib|mesh-list
56315501|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56315502|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56315503|NCT02993029|Analgesics|analgesics|mesh-ancestor
56315504|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
56315505|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315506|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315507|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315508|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315527|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
56315528|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
56315529|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
56315530|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315531|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315532|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
56315533|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315534|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315535|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56315536|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
56315537|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56315538|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56315539|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
56315540|NCT01646034|Antiviral Agents|antiviral agents|mesh-ancestor
56315541|NCT01646034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315542|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315543|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56315544|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56315545|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56315546|NCT01628640|Interferons|interferons|mesh-list
56315547|NCT01628640|Interferon-beta|interferon-beta|mesh-list
56315548|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315549|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
56315550|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315551|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
56315552|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315554|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56315555|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
56315556|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
56315557|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315558|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315559|NCT00391313|Chloroquine|chloroquine|mesh-list
56315560|NCT00391313|Amebicides|amebicides|mesh-ancestor
56315561|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56315562|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56315563|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907599|NCT05578456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907600|NCT05578456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56344999|NCT00053885|Vatalanib|vatalanib|mesh-list
56315564|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
56315565|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315566|NCT01466517|Ibuprofen|ibuprofen|mesh-list
56315567|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56315568|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56315569|NCT01466517|Analgesics|analgesics|mesh-ancestor
55955236|NCT01466348|Caffeine|caffeine|mesh-list
56315580|NCT01466478|Calcipotriene|calcipotriene|mesh-list
56315581|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56315582|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56315583|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315584|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56315585|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56315586|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315587|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56315588|NCT01466478|Vitamins|vitamins|mesh-ancestor
56315589|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
56315590|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56315591|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315592|NCT00063830|Alicaforsen|alicaforsen|mesh-list
56315593|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56315594|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315595|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
56315596|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315597|NCT00062816|Ribavirin|ribavirin|mesh-list
56315598|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
56315599|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315600|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
56315601|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315602|NCT00048113|Alicaforsen|alicaforsen|mesh-list
56315603|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56315604|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315605|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
56315606|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315607|NCT01466361|Nicotine|nicotine|mesh-list
56315608|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56315609|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
56315610|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315611|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315612|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56315613|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56315614|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
56315615|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315616|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315617|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
56315618|NCT00001832|Fludarabine|fludarabine|mesh-list
56315619|NCT00001832|Interleukin-2|interleukin-2|mesh-list
56315620|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56315621|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315622|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
56315623|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315624|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315625|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56315626|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
56315627|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315628|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315629|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56315630|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56315632|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
56315633|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315634|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56315643|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315644|NCT01466127|Oxytocin|oxytocin|mesh-list
56315645|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
56315646|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56315647|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315648|NCT00009191|Sertraline|sertraline|mesh-list
56315649|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
56315650|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56315651|NCT00009191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56907601|NCT05578456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56907602|NCT05578456|Analgesics|analgesics|mesh-ancestor
56907603|NCT05578456|Sensory System Agents|sensory system agents|mesh-ancestor
56907604|NCT05578456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907605|NCT05578456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315652|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56315653|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56315654|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315655|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315656|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
56315657|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315658|NCT01466088|Donepezil|donepezil|mesh-list
56315659|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56315660|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315661|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315662|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
56315663|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315664|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315665|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
56315666|NCT00009230|Celecoxib|celecoxib|mesh-list
56315667|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56315668|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56315669|NCT00009230|Analgesics|analgesics|mesh-ancestor
56315670|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
56315671|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315672|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315673|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315674|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315675|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56315676|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56315677|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315678|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315679|NCT00009581|Acetylcholine|acetylcholine|mesh-list
56315680|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
56315681|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56315682|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
56315683|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315684|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315685|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315686|NCT00009620|Phenobarbital|phenobarbital|mesh-list
56315687|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
56315688|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56315689|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315690|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315691|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56315692|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56315693|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315694|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315696|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
56315697|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56315698|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56315699|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56315700|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
56315712|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315713|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315715|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56315716|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
56315717|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315718|NCT01465893|Vitamin D|vitamin d|mesh-list
56315719|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
56315720|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
56315721|NCT01465893|Vitamins|vitamins|mesh-list
56315722|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
56315723|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315724|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56315725|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56315726|NCT00009776|Cyclosporine|cyclosporine|mesh-list
56315727|NCT00009776|Paclitaxel|paclitaxel|mesh-list
56315728|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56618254|NCT00967499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56345150|NCT00166426|Analgesics|analgesics|mesh-ancestor
56315729|NCT00009776|Antibodies|antibodies|mesh-list
56315730|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
56315731|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56315732|NCT00009776|Cyclosporins|cyclosporins|mesh-list
56315733|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56315734|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315735|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
56315736|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
56315737|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
56315738|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315739|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
56315740|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315741|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315742|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315743|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
56315744|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315745|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
56315746|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315747|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56315748|NCT00009815|Leucovorin|leucovorin|mesh-list
56315749|NCT00009815|Etoposide|etoposide|mesh-list
56315750|NCT00009815|Tegafur|tegafur|mesh-list
56315751|NCT00009815|Calcium|calcium|mesh-list
56315752|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
56315753|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56315754|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315755|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56315756|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315757|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56315758|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56315759|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315760|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315761|NCT00009815|Antidotes|antidotes|mesh-ancestor
56315762|NCT00009815|Protective Agents|protective agents|mesh-ancestor
56315763|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
56315764|NCT00009815|Vitamins|vitamins|mesh-ancestor
56315765|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
56315766|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56315782|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315783|NCT00009893|Leucovorin|leucovorin|mesh-list
56315784|NCT00009893|Gemcitabine|gemcitabine|mesh-list
56315785|NCT00009893|Fluorouracil|fluorouracil|mesh-list
56315786|NCT00009893|Calcium|calcium|mesh-list
56315787|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
56315788|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56315789|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
56315790|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315791|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315792|NCT00009893|Antiviral Agents|antiviral agents|mesh-ancestor
56315793|NCT00009893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315794|NCT00009893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315795|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315796|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
56315797|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315798|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56315799|NCT00009893|Antidotes|antidotes|mesh-ancestor
56315800|NCT00009893|Protective Agents|protective agents|mesh-ancestor
56315801|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
56315802|NCT00009893|Vitamins|vitamins|mesh-ancestor
56315803|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
56315804|NCT00009932|Paclitaxel|paclitaxel|mesh-list
56315805|NCT00009932|Fenretinide|fenretinide|mesh-list
56315806|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56315807|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315808|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
56315809|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
56315810|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
56315811|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315812|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56315813|NCT00009932|Protective Agents|protective agents|mesh-ancestor
56315814|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315815|NCT00009971|Fenretinide|fenretinide|mesh-list
56315816|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315817|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56315818|NCT00009971|Protective Agents|protective agents|mesh-ancestor
56907606|NCT05578456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56907607|NCT05578456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56648482|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56315819|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315820|NCT00010010|Exemestane|exemestane|mesh-list
56315821|NCT00010010|Goserelin|goserelin|mesh-list
56315822|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315823|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56315824|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56315825|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315826|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315836|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315838|NCT00010088|Gemcitabine|gemcitabine|mesh-list
56315839|NCT00010088|Fluorouracil|fluorouracil|mesh-list
56315840|NCT00010088|Calcium|calcium|mesh-list
56315841|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
56315842|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56315843|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
56315844|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315845|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315846|NCT00010088|Antiviral Agents|antiviral agents|mesh-ancestor
56315847|NCT00010088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315848|NCT00010088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315849|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315850|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
56315851|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315852|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56315853|NCT00010088|Antidotes|antidotes|mesh-ancestor
56315854|NCT00010088|Protective Agents|protective agents|mesh-ancestor
56315855|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
56315856|NCT00010088|Vitamins|vitamins|mesh-ancestor
56315857|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
56315858|NCT01465503|Heparin|heparin|mesh-list
56315859|NCT01465503|Calcium heparin|calcium heparin|mesh-list
56315860|NCT01465503|Hirudins|hirudins|mesh-list
56315861|NCT01465503|Bivalirudin|bivalirudin|mesh-list
56315862|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
56315863|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56315864|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56315865|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315866|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
56315867|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56315868|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
56315869|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315870|NCT00010166|Gemcitabine|gemcitabine|mesh-list
56315871|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56315872|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
56315873|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315874|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315875|NCT00010166|Antiviral Agents|antiviral agents|mesh-ancestor
56315876|NCT00010166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315877|NCT00010166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315878|NCT00010166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315879|NCT00010166|Immunologic Factors|immunologic factors|mesh-ancestor
56315880|NCT00010166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315881|NCT01465152|Metformin|metformin|mesh-list
56315882|NCT01465152|Repaglinide|repaglinide|mesh-list
56315883|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56315884|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315885|NCT01465113|Vitamin D|vitamin d|mesh-list
56315886|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
56315887|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
56315888|NCT01465113|Vitamins|vitamins|mesh-list
56315889|NCT01465113|Metformin|metformin|mesh-list
56315890|NCT01465113|Omeprazole|omeprazole|mesh-list
56315891|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
56315892|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315893|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56315894|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56315905|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315906|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56315907|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56315908|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
56315909|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315910|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315911|NCT00010283|Beclomethasone|beclomethasone|mesh-list
56907608|NCT05578456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907609|NCT05578456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56315912|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315913|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
56315914|NCT00010283|Hormones|hormones|mesh-ancestor
56315915|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56315916|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315917|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56315918|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
56315919|NCT00010322|Toremifene|toremifene|mesh-list
56315920|NCT00010322|Atamestane|atamestane|mesh-list
56315921|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56315922|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315923|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56315924|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56315925|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
56315926|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56315927|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315928|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56315929|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315930|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315931|NCT00010361|Cyclosporine|cyclosporine|mesh-list
56315932|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
56315933|NCT00010361|Fludarabine|fludarabine|mesh-list
56315934|NCT00010361|Cyclosporins|cyclosporins|mesh-list
56315935|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315936|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315937|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315938|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
56315939|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315940|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315941|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
56315942|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315943|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
56315944|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315945|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56315946|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56315947|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56315948|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
56315949|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56315950|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
56315951|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315952|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
56315953|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315954|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315955|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56315956|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
55955619|NCT05168475|Rituximab|rituximab|mesh-list
56315981|NCT01464606|Dactinomycin|dactinomycin|mesh-list
56315982|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
56315983|NCT01464606|Ifosfamide|ifosfamide|mesh-list
56315984|NCT01464606|Doxorubicin|doxorubicin|mesh-list
56315985|NCT01464606|Vincristine|vincristine|mesh-list
56315986|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315987|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
56315988|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315989|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315990|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56315991|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
56315992|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315993|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315994|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56315995|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56315996|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56315997|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56315998|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315999|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56316000|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316001|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316002|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316003|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56316004|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907610|NCT05578456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56907611|NCT05578456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907612|NCT05578456|Antipyretics|antipyretics|mesh-ancestor
56907613|NCT02133820|Analgesics|analgesics|mesh-list
56907614|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
56345362|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
56316005|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56316006|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56316007|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
56316022|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316024|NCT00011297|Lorazepam|lorazepam|mesh-list
56316025|NCT00011297|Analgesics|analgesics|mesh-ancestor
56316026|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
56316027|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316028|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316029|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
56316030|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56316031|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56316032|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56316033|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316034|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56316035|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56316036|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316037|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316038|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
56316039|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
56316040|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
56316041|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56316042|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56316043|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
56316044|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
56316045|NCT00011375|Rolipram|rolipram|mesh-list
56316046|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
56316047|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316048|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56316049|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56316050|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316051|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316052|NCT00847938|Neostigmine|neostigmine|mesh-list
56316053|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56316054|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316055|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316056|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
56316057|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316058|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316059|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56316060|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
56316061|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316062|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
56316063|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56316064|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316065|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316066|NCT00847860|Aspirin|aspirin|mesh-list
56316067|NCT00847860|Cilostazol|cilostazol|mesh-list
56316068|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56316069|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56316083|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56316084|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
56316085|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56316086|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
56316087|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
56316088|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56316089|NCT00847860|Protective Agents|protective agents|mesh-ancestor
56316090|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56316091|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56316092|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56316093|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
56316094|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56316095|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
56473682|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907615|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907616|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316096|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56316097|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316098|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56316099|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56316100|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56316101|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
56316102|NCT00847587|Etonogestrel|etonogestrel|mesh-list
56316103|NCT00847587|Desogestrel|desogestrel|mesh-list
56316104|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56316105|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316106|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56316107|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56316108|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56316109|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56316110|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56316111|NCT00847587|Progestins|progestins|mesh-ancestor
56316112|NCT00847587|Hormones|hormones|mesh-ancestor
56316113|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56316114|NCT00011765|Fluoxetine|fluoxetine|mesh-list
56316115|NCT00011765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56316116|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56316117|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316118|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316119|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316120|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
56316121|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316122|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56316123|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
56316125|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56316126|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56316127|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316137|NCT00011921|Ifosfamide|ifosfamide|mesh-list
56316138|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56316139|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316140|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316141|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316142|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316143|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316144|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56316145|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56316146|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316147|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56316148|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316149|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
56316151|NCT00011960|Cisplatin|cisplatin|mesh-list
56316152|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56316153|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316154|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316155|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316156|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316157|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316158|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
56316159|NCT00847314|Testosterone|testosterone|mesh-list
56316160|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
56316161|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
56316162|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56316163|NCT00847314|Androgens|androgens|mesh-ancestor
56316164|NCT00847314|Hormones|hormones|mesh-ancestor
56316165|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56316166|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316167|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56316168|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316169|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
56316170|NCT00011999|Paclitaxel|paclitaxel|mesh-list
56316171|NCT00011999|Cisplatin|cisplatin|mesh-list
56316172|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56316173|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316174|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
56907617|NCT05578378|Cytarabine|cytarabine|mesh-list
56316175|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316176|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316177|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316178|NCT00012038|Irofulven|irofulven|mesh-list
56316179|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316180|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
56316181|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316182|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316183|NCT00012116|Temozolomide|temozolomide|mesh-list
56316184|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316185|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
56316186|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316188|NCT00847119|Bevacizumab|bevacizumab|mesh-list
56316189|NCT00847119|Capecitabine|capecitabine|mesh-list
56316190|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56316191|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316192|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56316193|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56316194|NCT00847119|Growth Substances|growth substances|mesh-ancestor
56316195|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316196|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
56056357|NCT05575505|Antioxidants|antioxidants|mesh-ancestor
55955852|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
56316213|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316214|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316215|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
56316216|NCT00012311|Ifosfamide|ifosfamide|mesh-list
56316217|NCT00012311|Thiotepa|thiotepa|mesh-list
56316218|NCT00012311|Carboplatin|carboplatin|mesh-list
56316219|NCT00012311|Docetaxel|docetaxel|mesh-list
56316220|NCT00012311|Doxorubicin|doxorubicin|mesh-list
56316221|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56316222|NCT00012311|Fluorouracil|fluorouracil|mesh-list
56316223|NCT00012311|Methotrexate|methotrexate|mesh-list
56316225|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316226|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
56316227|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316228|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56316229|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316230|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
56316231|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316232|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316233|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56316234|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316235|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316236|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316237|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56316238|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56316239|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56316240|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316241|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
56316242|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56316243|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56316244|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
56316245|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56316246|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
56316247|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56316248|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56316249|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56316250|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56316251|NCT00847002|Laxatives|laxatives|mesh-ancestor
56316252|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56316253|NCT00012350|Tipifarnib|tipifarnib|mesh-list
56316254|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316255|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56316266|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56316267|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56316268|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56316270|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316271|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316272|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316273|NCT00012467|Interferons|interferons|mesh-list
56316274|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
56316275|NCT00012467|Itraconazole|itraconazole|mesh-list
56907618|NCT05578378|Methotrexate|methotrexate|mesh-list
56316276|NCT00012467|Fluconazole|fluconazole|mesh-list
56316277|NCT00012467|Amphotericin B|amphotericin b|mesh-list
56316278|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56316279|NCT00012467|Flucytosine|flucytosine|mesh-list
56316280|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316281|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
56316282|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316283|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
56316284|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56316285|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56316286|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316287|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316288|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56316289|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
56316290|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56316291|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316292|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56316293|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56316294|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56316295|NCT00012467|Amebicides|amebicides|mesh-ancestor
56316296|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56316297|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56316298|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56316299|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
56316301|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56316302|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56316303|NCT00012506|Analgesics|analgesics|mesh-ancestor
56316304|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
56316305|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316306|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316307|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56316308|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56316309|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56316310|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316311|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
56316312|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
56316313|NCT00012584|Methylphenidate|methylphenidate|mesh-list
56316314|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56316315|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316316|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56316317|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56316318|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316319|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316320|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
56316321|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316323|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56316324|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56316325|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316326|NCT00012584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56316327|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
56316328|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56316329|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
56316330|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56316331|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56316332|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316333|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56316334|NCT00846690|Lidocaine|lidocaine|mesh-list
56316335|NCT00846690|Phenylephrine|phenylephrine|mesh-list
56316336|NCT00846690|Benzocaine|benzocaine|mesh-list
56316337|NCT00846690|Tetracaine|tetracaine|mesh-list
56316338|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
56316339|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
56316340|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56316341|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316342|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
56316343|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316344|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56316345|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56316346|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56316347|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316348|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907619|NCT05578378|Fludarabine|fludarabine|mesh-list
56907620|NCT05578378|Cladribine|cladribine|mesh-list
56907621|NCT05578378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56907622|NCT05578378|Abortifacient Agents|abortifacient agents|mesh-ancestor
56316349|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56316350|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
56316351|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
56316352|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
56316353|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56316354|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
56316355|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
56316356|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56316357|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56316358|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56316359|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
56316360|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316361|NCT00846690|Protective Agents|protective agents|mesh-ancestor
56316362|NCT00846651|Phenylephrine|phenylephrine|mesh-list
56316363|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
56316364|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56316365|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
56316366|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
56316367|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316368|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316369|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
56316370|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56316371|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
56316372|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
56316373|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56316374|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56316375|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56316376|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
56316377|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316378|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316379|NCT00846651|Protective Agents|protective agents|mesh-ancestor
56316380|NCT00846612|Bevacizumab|bevacizumab|mesh-list
56316381|NCT00846612|Doxorubicin|doxorubicin|mesh-list
56316382|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56316383|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316384|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56316385|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56316386|NCT00846612|Growth Substances|growth substances|mesh-ancestor
56316387|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316388|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
56316389|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56316390|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56316391|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56316392|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316393|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316394|NCT00012857|Acetaminophen|acetaminophen|mesh-list
56316395|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56316412|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316413|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56316414|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56316415|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316416|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56316417|NCT00846339|Bupropion|bupropion|mesh-list
56316418|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56316419|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
56316420|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316421|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56316422|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56316423|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316424|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316425|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
56316426|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316427|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316428|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56316429|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56316430|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316431|NCT00846144|Copper|copper|mesh-list
56907623|NCT05578378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56907624|NCT05578378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907625|NCT05578378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56907626|NCT05578378|Antimetabolites|antimetabolites|mesh-ancestor
56907627|NCT05578378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316432|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
56316433|NCT00846144|Trace Elements|trace elements|mesh-ancestor
56316434|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
56316435|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316436|NCT00846144|Antidotes|antidotes|mesh-ancestor
56316437|NCT00846144|Protective Agents|protective agents|mesh-ancestor
56316438|NCT00846144|Emetics|emetics|mesh-ancestor
56316439|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
56316440|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316441|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56316442|NCT00845988|Aripiprazole|aripiprazole|mesh-list
56316443|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
56316444|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316445|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56316446|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56316447|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56316448|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316449|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
56316450|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
56316451|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316452|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316469|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
56316470|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316471|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316472|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316473|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316474|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56316475|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
56316476|NCT00680628|Enoxaparin|enoxaparin|mesh-list
56316477|NCT00680628|Tenecteplase|tenecteplase|mesh-list
56316478|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
56316479|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
56316480|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56316481|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56316482|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316483|NCT00013520|Lamivudine|lamivudine|mesh-list
56316484|NCT00013520|Zidovudine|zidovudine|mesh-list
56316485|NCT00013520|Efavirenz|efavirenz|mesh-list
56316486|NCT00013520|Nevirapine|nevirapine|mesh-list
56316487|NCT00013520|Abacavir|abacavir|mesh-list
56316488|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
56316489|NCT00013520|Didanosine|didanosine|mesh-list
56316490|NCT00013520|Stavudine|stavudine|mesh-list
56316491|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56316492|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56316493|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56316494|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56316495|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316496|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316497|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
56316498|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316499|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56316500|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56316501|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
56316502|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56316503|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56316504|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56316505|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56316506|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56316507|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56316508|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56316509|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56316510|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
56316511|NCT00013598|Pioglitazone|pioglitazone|mesh-list
56316512|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56316513|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907628|NCT05578378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907629|NCT05578378|Dermatologic Agents|dermatologic agents|mesh-ancestor
56907630|NCT05578378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345804|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
56316516|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316517|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
55938398|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
56316518|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316519|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316520|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
56316521|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316522|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
56316523|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56316524|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56316525|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56316526|NCT00277017|Growth Substances|growth substances|mesh-ancestor
56316527|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
56316528|NCT00276978|Aripiprazole|aripiprazole|mesh-list
56316529|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
56316530|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316531|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56316532|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56316533|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56316534|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316535|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
56316536|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
56316537|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316538|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316539|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56316540|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56316541|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
56316542|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56316543|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56316544|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56316545|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56316546|NCT00276900|Sertraline|sertraline|mesh-list
56316547|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
56316548|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316549|NCT00276900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56316550|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56316551|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316552|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316553|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316554|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
56316555|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316556|NCT00276861|Gemcitabine|gemcitabine|mesh-list
56316557|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
56316558|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56316559|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
56316560|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316561|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316562|NCT00276861|Antiviral Agents|antiviral agents|mesh-ancestor
56316563|NCT00276861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316564|NCT00276861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316565|NCT00276861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316566|NCT00276861|Immunologic Factors|immunologic factors|mesh-ancestor
56316567|NCT00276861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316568|NCT00013871|Vaccines|vaccines|mesh-list
56316569|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56316570|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
56316571|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316572|NCT00276783|Pemetrexed|pemetrexed|mesh-list
56316573|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316574|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316575|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316576|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56316577|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56316578|NCT00276705|Thalidomide|thalidomide|mesh-list
56316579|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
56316580|NCT00276705|Doxorubicin|doxorubicin|mesh-list
56316581|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56082268|NCT02464033|Vitamins|vitamins|mesh-ancestor
56907631|NCT05578378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56907632|NCT05578378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907633|NCT05578378|Immunologic Factors|immunologic factors|mesh-ancestor
56316582|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316583|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
56316584|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316585|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956233|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
56316593|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56316594|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316595|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
56316596|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56316597|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316598|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56316599|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56316600|NCT00276705|Growth Substances|growth substances|mesh-ancestor
56316601|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
56316602|NCT00276666|Vincristine|vincristine|mesh-list
56316603|NCT00276666|Lomustine|lomustine|mesh-list
56316604|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316605|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56316606|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316607|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316608|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316609|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316610|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316611|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
56316612|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
56316613|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
56316614|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56316615|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
56316616|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316617|NCT00014105|Carboplatin|carboplatin|mesh-list
56316618|NCT00014105|Temozolomide|temozolomide|mesh-list
56316619|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316620|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316621|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
56316622|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316623|NCT00014144|Gefitinib|gefitinib|mesh-list
56316624|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316625|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56316626|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316627|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316628|NCT00276588|Gemcitabine|gemcitabine|mesh-list
56316629|NCT00276588|Paclitaxel|paclitaxel|mesh-list
56316630|NCT00276588|Carboplatin|carboplatin|mesh-list
56316631|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56316632|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316633|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316634|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316635|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316636|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316637|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56316638|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
56316639|NCT00276588|Antiviral Agents|antiviral agents|mesh-ancestor
56316640|NCT00276588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316641|NCT00276588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316642|NCT00276588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316643|NCT00276588|Immunologic Factors|immunologic factors|mesh-ancestor
56316644|NCT00276588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316645|NCT00276549|Gemcitabine|gemcitabine|mesh-list
56316646|NCT00276549|Docetaxel|docetaxel|mesh-list
56316647|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56316648|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
56316649|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316650|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316651|NCT00276549|Antiviral Agents|antiviral agents|mesh-ancestor
56316652|NCT00276549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316671|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
56316672|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316673|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316674|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
56316675|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345944|NCT00171496|Cyclosporins|cyclosporins|mesh-list
56316676|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
56316677|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316678|NCT00014339|Prednisone|prednisone|mesh-list
56316679|NCT00014339|Melphalan|melphalan|mesh-list
56316680|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56316681|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
56316682|NCT00014339|Hormones|hormones|mesh-ancestor
56316683|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56316684|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316685|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56316686|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316687|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316688|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
56316689|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316690|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56316691|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316692|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
56316693|NCT00014456|Gemcitabine|gemcitabine|mesh-list
56316694|NCT00014456|Docetaxel|docetaxel|mesh-list
56316695|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56316696|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
56316697|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316698|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161445|NCT00749658|Varenicline|varenicline|mesh-list
56316699|NCT00014456|Antiviral Agents|antiviral agents|mesh-ancestor
56316700|NCT00014456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316701|NCT00014456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316702|NCT00014456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316703|NCT00014456|Immunologic Factors|immunologic factors|mesh-ancestor
56316704|NCT00014456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316705|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316706|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316707|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316708|NCT00276393|Insulin|insulin|mesh-list
56316709|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55956376|NCT04617457|Leucovorin|leucovorin|mesh-list
56316725|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56316726|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56316729|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
56316730|NCT00014573|Carmustine|carmustine|mesh-list
56316731|NCT00014573|Sargramostim|sargramostim|mesh-list
56316732|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56316733|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316734|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316735|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316736|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316737|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316738|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316739|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
56316740|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316741|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56316742|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316743|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
56316744|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56316745|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56316746|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56316747|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
56316748|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316749|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
56316750|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56316751|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56316752|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56316753|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316754|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316755|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
56316756|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316757|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316758|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56316759|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316761|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56316762|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56316763|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316764|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316765|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907634|NCT05578378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907635|NCT05578378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56346025|NCT00171691|Diclofenac|diclofenac|mesh-list
56316766|NCT00014651|Vapreotide|vapreotide|mesh-list
56316767|NCT00014651|Analgesics|analgesics|mesh-ancestor
56316768|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
56316769|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956436|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316778|NCT00014729|Isotretinoin|isotretinoin|mesh-list
56316779|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
56316780|NCT00276198|Vitamin D|vitamin d|mesh-list
56316781|NCT00276198|Vitamin A|vitamin a|mesh-list
56316782|NCT00276198|Vitamins|vitamins|mesh-ancestor
56316783|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
56316784|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316785|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56316786|NCT00276081|Gabapentin|gabapentin|mesh-list
56316787|NCT00276081|Estrogens|estrogens|mesh-list
56316788|NCT00276081|Analgesics|analgesics|mesh-ancestor
56316789|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
56316790|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316791|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316792|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
56316793|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56316794|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56316795|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56316796|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316797|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56316798|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56316799|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316800|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316801|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
56316802|NCT00276081|Hormones|hormones|mesh-ancestor
56316803|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56316804|NCT00276003|Gemcitabine|gemcitabine|mesh-list
56316805|NCT00276003|Irinotecan|irinotecan|mesh-list
56316806|NCT00276003|Allopurinol|allopurinol|mesh-list
56316807|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56316808|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
56316809|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316810|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316811|NCT00276003|Antiviral Agents|antiviral agents|mesh-ancestor
56316812|NCT00276003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316813|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316814|NCT00276003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316815|NCT00276003|Immunologic Factors|immunologic factors|mesh-ancestor
56316816|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316817|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56316818|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56316819|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
56316820|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56316821|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56316822|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
55938720|NCT01214109|Pramipexole|pramipexole|mesh-list
56316823|NCT00276003|Protective Agents|protective agents|mesh-ancestor
56316824|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
56316825|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
56316826|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56316827|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56316828|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316829|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316830|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56316831|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56316832|NCT00015041|Buprenorphine|buprenorphine|mesh-list
56316833|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56316834|NCT00015041|Narcotics|narcotics|mesh-ancestor
56316835|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55956499|NCT00029107|Rituximab|rituximab|mesh-list
56316848|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56316849|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56316850|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
56316851|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316852|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
56316853|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473683|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56907636|NCT05578378|Antiviral Agents|antiviral agents|mesh-ancestor
56907637|NCT05578378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907638|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
56346090|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
56316854|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316855|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316856|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56316857|NCT00015236|Analgesics|analgesics|mesh-ancestor
56316858|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
56316859|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316860|NCT00015275|Cocaine|cocaine|mesh-list
56316861|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
56316862|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
56316863|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56316864|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316865|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
56316866|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316867|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56316868|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56316869|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56316870|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316871|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316872|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
56316873|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316875|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56316876|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56316877|NCT00275730|Analgesics|analgesics|mesh-ancestor
56316878|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
56316879|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316880|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316881|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56316882|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56316883|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
56316884|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
56316885|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56316886|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56316887|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316888|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316889|NCT00275652|Lamivudine|lamivudine|mesh-list
56316890|NCT00275652|Telbivudine|telbivudine|mesh-list
56316891|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56316892|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56316893|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316894|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316895|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
56316896|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316898|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56316899|NCT00275613|Rituximab|rituximab|mesh-list
55956564|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
56316937|NCT00275535|Hormones|hormones|mesh-ancestor
56316938|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56316939|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316940|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56316941|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316942|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316943|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
56316944|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56316945|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316946|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316947|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56316948|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56316949|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
56316950|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56316951|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316952|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
56316953|NCT00015626|Metformin|metformin|mesh-list
56316954|NCT00015626|Pioglitazone|pioglitazone|mesh-list
56316955|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
56316956|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56316957|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316958|NCT00015665|Voriconazole|voriconazole|mesh-list
56907639|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56907640|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907641|NCT02139904|Vinorelbine|vinorelbine|mesh-list
56907642|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56907643|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907644|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
56907645|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
56907646|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
56648483|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56316959|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
56316960|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316961|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56316962|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56316963|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316964|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316965|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56316966|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
56316967|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56316968|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316969|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56316970|NCT00275457|Pramipexole|pramipexole|mesh-list
56316971|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
56316972|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316973|NCT00275457|Protective Agents|protective agents|mesh-ancestor
56316974|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316975|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56316976|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56316977|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
56316978|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
56316979|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316980|NCT00015704|Aldesleukin|aldesleukin|mesh-list
56316981|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316982|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56316983|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56316984|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
56316985|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316986|NCT00275418|Beta Carotene|beta carotene|mesh-list
56316987|NCT00275418|Carotenoids|carotenoids|mesh-list
56316988|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
56316989|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316990|NCT00275418|Protective Agents|protective agents|mesh-ancestor
56316991|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316992|NCT00275418|Provitamins|provitamins|mesh-ancestor
56316993|NCT00275418|Vitamins|vitamins|mesh-ancestor
56316994|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
56316995|NCT01784159|Aspirin|aspirin|mesh-list
56316996|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56316997|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56316999|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
56317000|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317001|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317002|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56317003|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317004|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56317005|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56317006|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317007|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56317008|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56317009|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317010|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
56317011|NCT00015821|Thalidomide|thalidomide|mesh-list
56317012|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317013|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
56317014|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317015|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
56473684|NCT05142098|Hormones|hormones|mesh-ancestor
56907647|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907648|NCT05578222|Pembrolizumab|pembrolizumab|mesh-list
56907649|NCT05578222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56346233|NCT00056030|Leucovorin|leucovorin|mesh-list
56317018|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56317019|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56317020|NCT00015821|Growth Substances|growth substances|mesh-ancestor
56317021|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
56317022|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317023|NCT00275184|Metoclopramide|metoclopramide|mesh-list
56317024|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
56317025|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
56317026|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317027|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317028|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56317029|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56317030|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56317031|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
56317032|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317033|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317034|NCT00015860|Prednisone|prednisone|mesh-list
56317035|NCT00015860|Vincristine|vincristine|mesh-list
56317036|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
56317037|NCT00015860|Daunorubicin|daunorubicin|mesh-list
56317038|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56317039|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
56317040|NCT00015860|Hormones|hormones|mesh-ancestor
56317041|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56317042|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317043|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56317044|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317045|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317046|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
56317047|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317048|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317049|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317050|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56317051|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317052|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56317053|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56317054|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317056|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317057|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317058|NCT00275106|Leucovorin|leucovorin|mesh-list
56317059|NCT00275106|Cytarabine|cytarabine|mesh-list
56317060|NCT00275106|Dexamethasone|dexamethasone|mesh-list
56317061|NCT00275106|Prednisolone|prednisolone|mesh-list
56317062|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
56317063|NCT00275106|Doxorubicin|doxorubicin|mesh-list
56317064|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56317065|NCT00275106|Methotrexate|methotrexate|mesh-list
56317066|NCT00275106|Vincristine|vincristine|mesh-list
56317067|NCT00275106|Daunorubicin|daunorubicin|mesh-list
56317068|NCT00275106|Asparaginase|asparaginase|mesh-list
56317069|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
56317070|NCT00275106|Thioguanine|thioguanine|mesh-list
56317071|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
56317072|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317073|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
56317074|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317075|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317076|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317077|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
56317078|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317079|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317080|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56317081|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56317082|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
56317083|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
56317084|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317085|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56317086|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
56317087|NCT00275106|Hormones|hormones|mesh-ancestor
56907650|NCT05578222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907651|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
56907652|NCT05201638|Calcium|calcium|mesh-list
56907653|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56648484|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317088|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56317089|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56317090|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56317091|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56317109|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317110|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
56317111|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317112|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317113|NCT00015938|Docetaxel|docetaxel|mesh-list
56317114|NCT00015938|Vinorelbine|vinorelbine|mesh-list
56317115|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317116|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
56317117|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317118|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317119|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317120|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317121|NCT00275067|Temozolomide|temozolomide|mesh-list
56317122|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
56317123|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317124|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
56317125|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317126|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317127|NCT00274989|Rituximab|rituximab|mesh-list
56317128|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56317129|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56317130|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317131|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
56317132|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317133|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317134|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317135|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
56317136|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317137|NCT00015977|Interleukin-12|interleukin-12|mesh-list
56317138|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56317139|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
56317140|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317141|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56317142|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56317143|NCT00015977|Growth Substances|growth substances|mesh-ancestor
56317144|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
56317145|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317146|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
56317147|NCT01678586|Gabapentin|gabapentin|mesh-list
56317149|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
56317150|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317151|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317169|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56317170|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
56317171|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
56317172|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56317173|NCT00274950|Carboplatin|carboplatin|mesh-list
56317174|NCT00274950|Etoposide|etoposide|mesh-list
56317175|NCT00274950|Ifosfamide|ifosfamide|mesh-list
56317176|NCT00274950|Bleomycin|bleomycin|mesh-list
56317177|NCT00274950|Vinblastine|vinblastine|mesh-list
56317178|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317179|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317180|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56317181|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317182|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317183|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317184|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317185|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
56317186|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56317187|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
56907654|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907655|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56907656|NCT00129545|Warfarin|warfarin|mesh-list
56907657|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
56907658|NCT02134288|Everolimus|everolimus|mesh-list
56907659|NCT02134288|Abatacept|abatacept|mesh-list
56317188|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317189|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317190|NCT00016016|Cytarabine|cytarabine|mesh-list
56317191|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
56317192|NCT00016016|Alvocidib|alvocidib|mesh-list
56317193|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317194|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
56317195|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317196|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317197|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
56317198|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317199|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317200|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
56317201|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317202|NCT00016016|Analgesics|analgesics|mesh-ancestor
56317203|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
56317204|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317205|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56317206|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317207|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317208|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
56317209|NCT00016016|Growth Substances|growth substances|mesh-ancestor
56317210|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56317211|NCT00130455|Citalopram|citalopram|mesh-list
56317223|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317224|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
56317225|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317226|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317227|NCT00016094|Bevacizumab|bevacizumab|mesh-list
56317228|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56317229|NCT00016094|Antibodies|antibodies|mesh-list
56317230|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
56317231|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56317232|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317233|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56317234|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56317235|NCT00016094|Growth Substances|growth substances|mesh-ancestor
56317236|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317237|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
56317238|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
56317239|NCT00130338|Rivastigmine|rivastigmine|mesh-list
56317240|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56317241|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317242|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317243|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
56317244|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317245|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317246|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56317247|NCT00130338|Protective Agents|protective agents|mesh-ancestor
56317248|NCT00016133|Leucovorin|leucovorin|mesh-list
56317249|NCT00016133|Fluorouracil|fluorouracil|mesh-list
56317250|NCT00016133|Vaccines|vaccines|mesh-list
56317251|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
56317252|NCT00016133|Calcium|calcium|mesh-list
56317253|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
56317254|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
56317255|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317256|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56317257|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
56317258|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317259|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317260|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317261|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317262|NCT00016133|Antidotes|antidotes|mesh-ancestor
56317263|NCT00016133|Protective Agents|protective agents|mesh-ancestor
56317264|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
56317266|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
56907660|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907661|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907662|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
56907663|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907664|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56907665|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907666|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907667|NCT00129467|Methylphenidate|methylphenidate|mesh-list
56317267|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56317268|NCT00016172|Doxorubicin|doxorubicin|mesh-list
56317269|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56317270|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56317271|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317272|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56317273|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317274|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317275|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317290|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
56317291|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56317292|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56317293|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56317294|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
56317295|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317296|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317297|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56317298|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
56317300|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56317301|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56317302|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56317303|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56317304|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
56317305|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317306|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317307|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
56317308|NCT00394368|Hormones|hormones|mesh-ancestor
56317309|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56317310|NCT01441349|Simvastatin|simvastatin|mesh-list
56317311|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56317312|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56317313|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
56317314|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317315|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56317316|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56317317|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317318|NCT00394407|Insulin|insulin|mesh-list
56317319|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56317320|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56317321|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317322|NCT00130143|Amifostine|amifostine|mesh-list
56317323|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56317324|NCT00130143|Protective Agents|protective agents|mesh-ancestor
56317325|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317326|NCT00016289|Interleukin-12|interleukin-12|mesh-list
56317327|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56317328|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
56317329|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317330|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56317331|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56317332|NCT00016289|Growth Substances|growth substances|mesh-ancestor
56317333|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
56317334|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317335|NCT00130065|Folic Acid|folic acid|mesh-list
56317336|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
56317337|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
56317338|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56317356|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56907668|NCT00129467|Serotonin|serotonin|mesh-list
56346509|NCT00175396|Androgens|androgens|mesh-list
56317357|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317358|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
56317359|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317360|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
56317361|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317362|NCT00130026|Caffeine|caffeine|mesh-list
56317363|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56317364|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317365|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56317366|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317367|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317368|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56317369|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56317370|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
56317371|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317372|NCT00016367|Gemcitabine|gemcitabine|mesh-list
56317373|NCT00016367|Cisplatin|cisplatin|mesh-list
56317374|NCT00016367|Trastuzumab|trastuzumab|mesh-list
56317375|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317376|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317377|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
56317378|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317379|NCT00016367|Antiviral Agents|antiviral agents|mesh-ancestor
56317380|NCT00016367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317381|NCT00016367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317382|NCT00016367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317383|NCT00016367|Immunologic Factors|immunologic factors|mesh-ancestor
56317384|NCT00016367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317385|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56317386|NCT00129948|Troxacitabine|troxacitabine|mesh-list
56317387|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317388|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56317389|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56317390|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
56317391|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317392|NCT00016406|Paclitaxel|paclitaxel|mesh-list
56317393|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
56317394|NCT00016406|Doxorubicin|doxorubicin|mesh-list
56317395|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317396|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317397|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
55957063|NCT05156268|Olaparib|olaparib|mesh-list
56317406|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
56317407|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56317408|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56317409|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56317410|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317411|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317413|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317414|NCT00016445|Hormones|hormones|mesh-list
56317415|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56317416|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317417|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
56317418|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56317419|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317420|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
56317421|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56317422|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
56317423|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317424|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317425|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56317426|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
56317427|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56317428|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
56317429|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939299|NCT04746365|Ivermectin|ivermectin|mesh-list
56317430|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317431|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56317432|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
56317433|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
56317434|NCT00016523|Protective Agents|protective agents|mesh-ancestor
56317435|NCT00129597|Ketamine|ketamine|mesh-list
56317436|NCT00129597|Analgesics|analgesics|mesh-ancestor
56907669|NCT00129467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56907670|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56317437|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
56317438|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317439|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317440|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56317441|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56317442|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
56317443|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
56317444|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56317445|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56317446|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56317447|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317448|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317449|NCT00016601|Ritonavir|ritonavir|mesh-list
56317450|NCT00016601|Nelfinavir|nelfinavir|mesh-list
56317451|NCT00016601|Indinavir|indinavir|mesh-list
56317452|NCT00016601|Nevirapine|nevirapine|mesh-list
56317453|NCT00016601|Efavirenz|efavirenz|mesh-list
56317454|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56317455|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
56317456|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56317457|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56317458|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
56317459|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317460|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317461|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56317462|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56317494|NCT00016835|Metronidazole|metronidazole|mesh-list
56317495|NCT00016835|Doxycycline|doxycycline|mesh-list
56317496|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317497|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56317498|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56317499|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56317500|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
56317501|NCT00016874|Paclitaxel|paclitaxel|mesh-list
56317502|NCT00016874|Cisplatin|cisplatin|mesh-list
56317513|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
56317514|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56317515|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317516|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
56317517|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317518|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317519|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317520|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317521|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
56317522|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56317523|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317524|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317525|NCT00016952|Antidotes|antidotes|mesh-ancestor
56317526|NCT00016952|Protective Agents|protective agents|mesh-ancestor
56317527|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
56317528|NCT00016952|Vitamins|vitamins|mesh-ancestor
56317529|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
56317530|NCT00129363|Carvedilol|carvedilol|mesh-list
56317531|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56317532|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56317533|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
56317534|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317535|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317536|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317537|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56317538|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
56317539|NCT00129363|Protective Agents|protective agents|mesh-ancestor
56317540|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56317541|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56317542|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56317543|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
56317544|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56317545|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56317546|NCT00016991|Gefitinib|gefitinib|mesh-list
56317547|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317548|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56317549|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907671|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907672|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56907673|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56907674|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346656|NCT00176059|Antibodies|antibodies|mesh-list
56317550|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317551|NCT00017030|Trabectedin|trabectedin|mesh-list
56317552|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317553|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
56317554|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317555|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317556|NCT00017069|Dexamethasone|dexamethasone|mesh-list
56317557|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
56317558|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56317559|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
56317560|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
56317561|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317562|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317563|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56317564|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
56317565|NCT00017069|Hormones|hormones|mesh-ancestor
56317566|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56317567|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55957230|NCT04592952|Calcitonin|calcitonin|mesh-list
56317584|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317585|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
56317586|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317587|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317588|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56317589|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317590|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
56317592|NCT00129246|Bupropion|bupropion|mesh-list
56161462|NCT00738972|Valsartan|valsartan|mesh-list
56317593|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56317594|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56317595|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317596|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
56317597|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317598|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56317599|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
56317600|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56317601|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56317602|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56317603|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56317604|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317605|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
56317606|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317607|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56317608|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56317609|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317610|NCT00017147|Carmustine|carmustine|mesh-list
56317611|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56317612|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317613|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
56317614|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317615|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317616|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317617|NCT00129207|Bortezomib|bortezomib|mesh-list
56317618|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317619|NCT00129168|Cytarabine|cytarabine|mesh-list
56317620|NCT00129168|Daunorubicin|daunorubicin|mesh-list
56317621|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317622|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
55957291|NCT05696574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56317640|NCT00017186|Gemcitabine|gemcitabine|mesh-list
56317641|NCT00017186|Epirubicin|epirubicin|mesh-list
56317642|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317643|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
56082269|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
56907675|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907676|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
56907677|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56907678|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56907679|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
56907680|NCT00129311|Selegiline|selegiline|mesh-list
56907681|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
56907682|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56317644|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317645|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317646|NCT00017186|Antiviral Agents|antiviral agents|mesh-ancestor
56317647|NCT00017186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317648|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317649|NCT00017186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317650|NCT00017186|Immunologic Factors|immunologic factors|mesh-ancestor
56317651|NCT00017186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317652|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56317653|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56317654|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317655|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
56317656|NCT00017225|Melphalan|melphalan|mesh-list
56317657|NCT00017225|Ifosfamide|ifosfamide|mesh-list
56317658|NCT00017225|Dacarbazine|dacarbazine|mesh-list
56317659|NCT00017225|Carboplatin|carboplatin|mesh-list
56317660|NCT00017225|Doxorubicin|doxorubicin|mesh-list
56317661|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56317662|NCT00017225|Etoposide|etoposide|mesh-list
56317663|NCT00017225|Vincristine|vincristine|mesh-list
56317664|NCT00017225|Tretinoin|tretinoin|mesh-list
56317665|NCT00017225|Vindesine|vindesine|mesh-list
56317666|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317667|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
56317668|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317669|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317670|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317671|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
56317672|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317673|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317674|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56317675|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56317676|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56317677|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317678|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317679|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317680|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
56317681|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317699|NCT00017264|Atrasentan|atrasentan|mesh-list
56317700|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317701|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56317702|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56317703|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317704|NCT00128895|Azathioprine|azathioprine|mesh-list
56317705|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
56317706|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317707|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317708|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317709|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317710|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
56317711|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317712|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317713|NCT00017303|Paclitaxel|paclitaxel|mesh-list
56317714|NCT00017303|Carboplatin|carboplatin|mesh-list
56317715|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317716|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317717|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
56317718|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317719|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317720|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907683|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56907684|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56346798|NCT00423527|Levetiracetam|levetiracetam|mesh-list
56317721|NCT00017342|Cytarabine|cytarabine|mesh-list
56317722|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
56317723|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317724|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
56317725|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317726|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317727|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
56317728|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317729|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317730|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
56317731|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317732|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56317733|NCT00128739|Budesonide|budesonide|mesh-list
56317734|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56317735|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56317736|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
56317737|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317738|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317739|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56317753|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317754|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317755|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56317756|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56317757|NCT00128700|Temozolomide|temozolomide|mesh-list
56317758|NCT00128700|Vatalanib|vatalanib|mesh-list
56317759|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317760|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
56317761|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317762|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317763|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56317764|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317765|NCT00017459|Vinorelbine|vinorelbine|mesh-list
56317766|NCT00017459|Tirapazamine|tirapazamine|mesh-list
56317767|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317768|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317769|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
56317770|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317771|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317772|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317773|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
56317774|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317775|NCT00017498|Gemcitabine|gemcitabine|mesh-list
56317776|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317777|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
56317778|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317779|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317780|NCT00017498|Antiviral Agents|antiviral agents|mesh-ancestor
56317781|NCT00017498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317782|NCT00017498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317783|NCT00017498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317784|NCT00017498|Immunologic Factors|immunologic factors|mesh-ancestor
56317785|NCT00017498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317786|NCT00128544|Telbivudine|telbivudine|mesh-list
56317787|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
56317788|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317789|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56317790|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317791|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317792|NCT00128505|Mifepristone|mifepristone|mesh-list
56317793|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56317794|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
56317795|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56317796|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317797|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56317798|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56317799|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56317800|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
56317801|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56317821|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
56907685|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56907686|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907687|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907688|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56907689|NCT00129311|Protective Agents|protective agents|mesh-ancestor
56907690|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907691|NCT01076621|Norethindrone|norethindrone|mesh-list
56907692|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
56907693|NCT01076621|Estradiol|estradiol|mesh-list
56907694|NCT01076621|Estrogens|estrogens|mesh-ancestor
56317822|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
56317823|NCT00017654|Cyclosporins|cyclosporins|mesh-list
56317824|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56317825|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317826|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
56317827|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317828|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317829|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317830|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
56317831|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317832|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317833|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56317834|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317835|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
56317836|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317837|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
56317838|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56317839|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56317840|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
56317841|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
56317842|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317843|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56317844|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
56317845|NCT00017654|Hormones|hormones|mesh-ancestor
56317846|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56317847|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56317848|NCT00017654|Protective Agents|protective agents|mesh-ancestor
56317849|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
56317850|NCT00394485|Procaterol|procaterol|mesh-list
56317851|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56317852|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
56317853|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317854|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317855|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56317856|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
56317857|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
56317858|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56317859|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
56317874|NCT00128466|Streptomycin|streptomycin|mesh-list
56317875|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56317876|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317877|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56317878|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317879|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317880|NCT00128427|Colchicine|colchicine|mesh-list
56317881|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
56317882|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317883|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
56317884|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317885|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317886|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317887|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317888|NCT00128310|Gemcitabine|gemcitabine|mesh-list
56317889|NCT00128310|Vinorelbine|vinorelbine|mesh-list
56317890|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317892|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907695|NCT01076621|Hormones|hormones|mesh-ancestor
56907696|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56907697|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317893|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317894|NCT00128310|Antiviral Agents|antiviral agents|mesh-ancestor
56317895|NCT00128310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317896|NCT00128310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317897|NCT00128310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317898|NCT00128310|Immunologic Factors|immunologic factors|mesh-ancestor
56317899|NCT00128310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317900|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317901|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
56317902|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317903|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317904|NCT00006099|Antibodies|antibodies|mesh-list
56317905|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56317906|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
56317907|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317908|NCT00018603|Guanfacine|guanfacine|mesh-list
56317909|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56317910|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56317911|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56317912|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56317913|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
56317914|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317915|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317916|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317917|NCT00018642|Haloperidol|haloperidol|mesh-list
56317918|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56317919|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
56317920|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
56317921|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56317938|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56317939|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56317940|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317941|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317942|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
56317943|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317944|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56317945|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56317946|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56317947|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56317948|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56317949|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56317950|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
56317951|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56317952|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56317953|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56317954|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
56317955|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56317956|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56317957|NCT00018161|Mecamylamine|mecamylamine|mesh-list
56317958|NCT00018161|Nicotine|nicotine|mesh-list
56317959|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56317960|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
56317961|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317962|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317963|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56317964|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56317965|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
56317966|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317967|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317968|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56317969|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56317970|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56317971|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56317973|NCT00018200|Fluoxetine|fluoxetine|mesh-list
56317974|NCT00018200|Desipramine|desipramine|mesh-list
56317975|NCT00018200|Clomipramine|clomipramine|mesh-list
56317976|NCT00018200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56317977|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56907698|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56907699|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
56907700|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56907701|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56907702|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56907703|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56907704|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56907705|NCT03965819|Acetaminophen|acetaminophen|mesh-list
56907706|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56907707|NCT03965819|Analgesics|analgesics|mesh-ancestor
56907708|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
56907709|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907710|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317978|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56317979|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317980|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317981|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
56317993|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56317994|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
56317995|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
56317996|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317997|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56317998|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56317999|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
56318000|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56318001|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
56318002|NCT00018759|Paroxetine|paroxetine|mesh-list
56318003|NCT00018759|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56318004|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56318005|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56318006|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318007|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56318009|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318010|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56318011|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
56318012|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56318013|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56318014|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56318015|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318016|NCT04734353|Ticagrelor|ticagrelor|mesh-list
56318017|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56318018|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56318019|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56318020|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56318021|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56318022|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
56318023|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56318024|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318025|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318027|NCT00018954|Prednisone|prednisone|mesh-list
56318028|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
56318029|NCT00018954|Ifosfamide|ifosfamide|mesh-list
56318030|NCT00018954|Doxorubicin|doxorubicin|mesh-list
56318031|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56318032|NCT00018954|Methotrexate|methotrexate|mesh-list
56318033|NCT00018954|Etoposide|etoposide|mesh-list
56318034|NCT00018954|Vincristine|vincristine|mesh-list
56318035|NCT00018954|Daunorubicin|daunorubicin|mesh-list
56318036|NCT00018954|Asparaginase|asparaginase|mesh-list
56318037|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
56318038|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318039|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
56907711|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
56907712|NCT02134366|Lorazepam|lorazepam|mesh-list
56907713|NCT02134366|Clonazepam|clonazepam|mesh-list
56907714|NCT02134366|Clobazam|clobazam|mesh-list
56907715|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
56907716|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
56318040|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318041|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56318042|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56318043|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
56318044|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318045|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318049|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56318050|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318051|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56318052|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
56318053|NCT00018954|Hormones|hormones|mesh-ancestor
56318054|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318055|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56318056|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56318057|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
56318058|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56318059|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318060|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
56318061|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
56318062|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56318063|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56318064|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318065|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
56318066|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318067|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318068|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318069|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318070|NCT00018278|Donepezil|donepezil|mesh-list
56318071|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56318072|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318073|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318074|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
56318075|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56318076|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318077|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
56318078|NCT00019032|Antibodies|antibodies|mesh-list
56318079|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56318080|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
56318081|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318082|NCT00019071|Cladribine|cladribine|mesh-list
56318083|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318084|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318085|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
56318086|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318087|NCT04734119|Anesthetics|anesthetics|mesh-list
56318088|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56318089|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318090|NCT00018356|Testosterone|testosterone|mesh-list
56318091|NCT00018356|Androgens|androgens|mesh-ancestor
56318092|NCT00018356|Hormones|hormones|mesh-ancestor
56318093|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318094|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318095|NCT00019188|Interleukin-12|interleukin-12|mesh-list
56318096|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56318097|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
56318098|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318099|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55939982|NCT02736149|Ubenimex|ubenimex|mesh-list
56318100|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56318101|NCT00019188|Growth Substances|growth substances|mesh-ancestor
56318102|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
56318103|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318104|NCT00019227|Calcium|calcium|mesh-list
56318105|NCT00019227|Daclizumab|daclizumab|mesh-list
56318106|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
56318107|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56907717|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
56907718|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318108|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318109|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318110|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
56318112|NCT00019227|Protective Agents|protective agents|mesh-ancestor
56318113|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
56318114|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
56318115|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318116|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56318117|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56318118|NCT00019344|Alvocidib|alvocidib|mesh-list
56318120|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
56318121|NCT00019344|Growth Substances|growth substances|mesh-ancestor
56318122|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318123|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56318124|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318125|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318126|NCT00019383|Aldesleukin|aldesleukin|mesh-list
56318127|NCT00019383|Sargramostim|sargramostim|mesh-list
56318128|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
56318129|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
56318130|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318131|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318132|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56318133|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56318134|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
56318135|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318136|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56318137|NCT00019422|Carboplatin|carboplatin|mesh-list
56318138|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318140|NCT00018551|Hematinics|hematinics|mesh-ancestor
56318141|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
56318142|NCT00018551|Vitamins|vitamins|mesh-ancestor
56318143|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
56318144|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318145|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
56318146|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318147|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56318148|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56318149|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318150|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56318151|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318152|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56318153|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56318154|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
56318155|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318156|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318157|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56318158|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56318159|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56318160|NCT00019539|Thalidomide|thalidomide|mesh-list
56318161|NCT00019539|Bevacizumab|bevacizumab|mesh-list
56318162|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56318163|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318164|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56318165|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56318166|NCT00019539|Growth Substances|growth substances|mesh-ancestor
56318167|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318168|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
56318169|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318170|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
56318171|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
56318172|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56318173|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318174|NCT00019695|Alendronate|alendronate|mesh-list
56318175|NCT00019695|Ketoconazole|ketoconazole|mesh-list
56318176|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
56318177|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318178|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56318179|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56161476|NCT00726180|Trastuzumab|trastuzumab|mesh-list
56318180|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907719|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907720|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56347215|NCT00057356|Conivaptan|conivaptan|mesh-list
56318181|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318182|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56318183|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
56318184|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318185|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318186|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56318187|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56318188|NCT00019734|Aldesleukin|aldesleukin|mesh-list
56318189|NCT00019734|Vaccines|vaccines|mesh-list
56318190|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
56318191|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318193|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56318194|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56318195|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
56318196|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318197|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56318198|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
56318199|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318200|NCT00019773|Capecitabine|capecitabine|mesh-list
56318201|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
56318202|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318203|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
56318204|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318205|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318206|NCT03370406|Fluorouracil|fluorouracil|mesh-list
56318207|NCT03370406|Imiquimod|imiquimod|mesh-list
56318208|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
56318209|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318210|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318211|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318212|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318213|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
56318214|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318215|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56318216|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
56318217|NCT00019812|Paclitaxel|paclitaxel|mesh-list
56318218|NCT00019812|Trastuzumab|trastuzumab|mesh-list
56318219|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318220|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318221|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318222|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318223|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318224|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318225|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56318226|NCT03326063|Ifetroban|ifetroban|mesh-list
56318227|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56318228|NCT00019890|Sargramostim|sargramostim|mesh-list
56318229|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
56318230|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318231|NCT00019968|Melphalan|melphalan|mesh-list
56318232|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56318233|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
56318234|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318235|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318236|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56318237|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318238|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
56318239|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318240|NCT00020007|Paclitaxel|paclitaxel|mesh-list
56318241|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318242|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318243|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318244|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318245|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318246|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318247|NCT00142454|Imiquimod|imiquimod|mesh-list
56318248|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56318249|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
56318250|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907721|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56907722|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907723|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56907724|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56907725|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56907726|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
56318251|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318252|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
56318253|NCT00020046|Thalidomide|thalidomide|mesh-list
56318254|NCT00020046|Docetaxel|docetaxel|mesh-list
56318255|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318256|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318257|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318258|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318259|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318260|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318261|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
56318262|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318263|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
56318264|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56318265|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318278|NCT00020202|Romidepsin|romidepsin|mesh-list
56318279|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318280|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318281|NCT05576675|Sufentanil|sufentanil|mesh-list
56318283|NCT05576675|Hydromorphone|hydromorphone|mesh-list
56318284|NCT05576675|Nalbuphine|nalbuphine|mesh-list
56318285|NCT05576675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56318286|NCT05576675|Narcotics|narcotics|mesh-ancestor
56318287|NCT05576675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56318288|NCT05576675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318289|NCT05576675|Analgesics|analgesics|mesh-ancestor
56318290|NCT05576675|Sensory System Agents|sensory system agents|mesh-ancestor
56318291|NCT05576675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318292|NCT05576675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56318293|NCT05576675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56318294|NCT05576675|Anesthetics, General|anesthetics, general|mesh-ancestor
56318295|NCT05576675|Anesthetics|anesthetics|mesh-ancestor
56318296|NCT00020358|Aldesleukin|aldesleukin|mesh-list
56318297|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
56318298|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318299|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56318300|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56318301|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
56318302|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318303|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56318304|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
56318305|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318306|NCT00020397|Aldesleukin|aldesleukin|mesh-list
56318307|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318308|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56318309|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56318310|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
56318311|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318312|NCT00020475|Interleukin-2|interleukin-2|mesh-list
56318313|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56318314|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318315|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56318316|NCT00020475|Analgesics|analgesics|mesh-ancestor
56318317|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
56318318|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318319|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318320|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56318321|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
56318322|NCT05576480|Capecitabine|capecitabine|mesh-list
56318323|NCT05576480|Oxaliplatin|oxaliplatin|mesh-list
56318324|NCT05576480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318325|NCT05576480|Antimetabolites|antimetabolites|mesh-ancestor
56318326|NCT05576480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318327|NCT05576480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318328|NCT00020631|Pirfenidone|pirfenidone|mesh-list
56318329|NCT00020631|Analgesics|analgesics|mesh-ancestor
56318330|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
56907727|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
56907728|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56907729|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907730|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56106140|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
55957988|NCT01809639|Progesterone|progesterone|mesh-list
56318343|NCT05576324|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56318344|NCT05576324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56318345|NCT05576324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318346|NCT00020709|Docetaxel|docetaxel|mesh-list
56318347|NCT00020709|Etoposide|etoposide|mesh-list
56318348|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
56318349|NCT00020709|Gefitinib|gefitinib|mesh-list
56318350|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318351|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318352|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318353|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318354|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318355|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318356|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56318357|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56318358|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318359|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56318360|NCT00020748|Irinotecan|irinotecan|mesh-list
56318361|NCT00020748|Epirubicin|epirubicin|mesh-list
56318362|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56318363|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56318364|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318365|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318366|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318367|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318368|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56318369|NCT00020787|Cisplatin|cisplatin|mesh-list
56318370|NCT00020787|Fluorouracil|fluorouracil|mesh-list
56318371|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318372|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
56318373|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318374|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318375|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318376|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
56318377|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318378|NCT00020865|Levofloxacin|levofloxacin|mesh-list
56318379|NCT00020865|Ofloxacin|ofloxacin|mesh-list
56318380|NCT00020865|Cefepime|cefepime|mesh-list
56318381|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56318382|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318383|NCT00020865|Renal Agents|renal agents|mesh-ancestor
56318384|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56318385|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56318386|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56318387|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318388|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318389|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318390|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56318391|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56318393|NCT00020943|Cytarabine|cytarabine|mesh-list
56318394|NCT00020943|Prednisone|prednisone|mesh-list
56318395|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
56318399|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56318400|NCT00020943|Methotrexate|methotrexate|mesh-list
56318401|NCT00020943|Etoposide|etoposide|mesh-list
56318402|NCT00020943|Vincristine|vincristine|mesh-list
56318403|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
56318404|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318405|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
56318406|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318407|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56318408|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56318410|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318411|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318412|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56318413|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56907731|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
56907732|NCT01077947|Anesthetics|anesthetics|mesh-list
56318414|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318415|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56318416|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56318417|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318418|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56318419|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
56318420|NCT00020943|Hormones|hormones|mesh-ancestor
56318421|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318422|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56318423|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56318424|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
56318425|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56318426|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318427|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
56318428|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
56318429|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56318430|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56318431|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318432|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
56318433|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318434|NCT00020943|Antidotes|antidotes|mesh-ancestor
56318435|NCT00020943|Protective Agents|protective agents|mesh-ancestor
56318436|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
56318437|NCT00020943|Vitamins|vitamins|mesh-ancestor
56318438|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
56318439|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318440|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318441|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318442|NCT00021060|Paclitaxel|paclitaxel|mesh-list
56318443|NCT00021060|Bevacizumab|bevacizumab|mesh-list
56318444|NCT00021060|Carboplatin|carboplatin|mesh-list
56318445|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56318446|NCT00021060|Antibodies|antibodies|mesh-list
56318447|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
56318448|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56318449|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318450|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318451|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318452|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318453|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318454|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318455|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56318456|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56318457|NCT00021060|Growth Substances|growth substances|mesh-ancestor
56318458|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318459|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
56318460|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
56318462|NCT00021099|Epothilone B|epothilone b|mesh-list
56318463|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318464|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318465|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318466|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318467|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318468|NCT05574257|Propofol|propofol|mesh-list
56318469|NCT05574257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56318470|NCT05574257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56318471|NCT05574257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318472|NCT05574257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56318474|NCT05574257|Anesthetics|anesthetics|mesh-ancestor
56318475|NCT05574218|Glycine|glycine|mesh-list
56318476|NCT05574218|Glycine Agents|glycine agents|mesh-ancestor
56318477|NCT05574218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56318478|NCT05574218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318479|NCT05574218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318480|NCT00021138|Nicotine|nicotine|mesh-list
56318481|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56318482|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
56318483|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940354|NCT02393183|Selenium|selenium|mesh-list
56318484|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318485|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56318486|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56318487|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
56907733|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907734|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907735|NCT00133991|Leucovorin|leucovorin|mesh-list
56907736|NCT00133991|Cytarabine|cytarabine|mesh-list
56907737|NCT00133991|Prednisone|prednisone|mesh-list
56907738|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
56907739|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
56907740|NCT00133991|Rituximab|rituximab|mesh-list
56907741|NCT00133991|Methotrexate|methotrexate|mesh-list
56907742|NCT00133991|Vincristine|vincristine|mesh-list
56907743|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907744|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
56907745|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907746|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907747|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56907748|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
56318488|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56318489|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318491|NCT05574179|Dexmedetomidine|dexmedetomidine|mesh-list
56318492|NCT05574179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56318493|NCT05574179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56318494|NCT05574179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318495|NCT05574179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56318496|NCT05574179|Analgesics|analgesics|mesh-ancestor
56318497|NCT05574179|Sensory System Agents|sensory system agents|mesh-ancestor
56318498|NCT05574179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318499|NCT05574179|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56318500|NCT05574179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56318501|NCT05574179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56318502|NCT05574179|Adrenergic Agents|adrenergic agents|mesh-ancestor
56318503|NCT05574179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56318504|NCT05574179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318505|NCT05574179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56318506|NCT05574179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56318507|NCT05574179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56318508|NCT05574179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56318509|NCT05574179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56318510|NCT05574179|Anesthetics, General|anesthetics, general|mesh-ancestor
56318511|NCT05574179|Anesthetics|anesthetics|mesh-ancestor
56318512|NCT05574179|GABA Modulators|gaba modulators|mesh-ancestor
56318513|NCT05574179|GABA Agents|gaba agents|mesh-ancestor
56318514|NCT00021216|Bortezomib|bortezomib|mesh-list
56318515|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318516|NCT00021294|Eflornithine|eflornithine|mesh-list
56318517|NCT00021294|Triamcinolone|triamcinolone|mesh-list
56318518|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56318519|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
56318520|NCT00021294|Hormones|hormones|mesh-ancestor
56318521|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318522|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318523|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318524|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318525|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318526|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56318527|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56318528|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56318529|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318530|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56318531|NCT00021333|Paclitaxel|paclitaxel|mesh-list
56318532|NCT00021333|Cisplatin|cisplatin|mesh-list
56318533|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318534|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907749|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907750|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907751|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56318535|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318537|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318538|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318539|NCT00021372|Paclitaxel|paclitaxel|mesh-list
56318540|NCT00021372|Estramustine|estramustine|mesh-list
56318541|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318542|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318543|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318544|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318545|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318546|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318547|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56318548|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
56318551|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56318552|NCT00392093|Hormones|hormones|mesh-ancestor
56318553|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318554|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318555|NCT00021450|Goserelin|goserelin|mesh-list
56318556|NCT00021450|Bicalutamide|bicalutamide|mesh-list
56318557|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56318558|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318559|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
56318560|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
56318561|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318562|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318564|NCT00021489|Abacavir|abacavir|mesh-list
56318565|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318566|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318567|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56318568|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
56318569|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56318570|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318571|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318572|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318573|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56318574|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56318575|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
56318576|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56318577|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56318578|NCT00021528|Mirtazapine|mirtazapine|mesh-list
56318579|NCT00021528|Buspirone|buspirone|mesh-list
56318580|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
56318581|NCT00021528|Sertraline|sertraline|mesh-list
56318582|NCT00021528|Citalopram|citalopram|mesh-list
56318583|NCT00021528|Nortriptyline|nortriptyline|mesh-list
56318584|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
56318585|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56318586|NCT00021528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56318587|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56318588|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56318589|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318590|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56318591|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
56318592|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318593|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318594|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56318595|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56318596|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56318597|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56318598|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
56318599|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
56318600|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56318601|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56318602|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56318603|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56318604|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
56318605|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56907752|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56318606|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56318607|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56318608|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56318609|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56318610|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56318611|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56318613|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
56318614|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318615|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
56318616|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318617|NCT00021645|Vitamin E|vitamin e|mesh-list
56318618|NCT00021645|Vitamins|vitamins|mesh-ancestor
56318619|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
56318620|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318621|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
56318622|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958264|NCT04273139|Venetoclax|venetoclax|mesh-list
56318624|NCT05573204|Vitamin E|vitamin e|mesh-list
56318625|NCT05573204|Vitamins|vitamins|mesh-ancestor
56318626|NCT05573204|Micronutrients|micronutrients|mesh-ancestor
56318627|NCT05573204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318628|NCT05573204|Antioxidants|antioxidants|mesh-ancestor
56318629|NCT05573204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318630|NCT05573204|Protective Agents|protective agents|mesh-ancestor
56318631|NCT00021996|Valdecoxib|valdecoxib|mesh-list
56318632|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56318633|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56161482|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
56318634|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318635|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318636|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56318637|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56318638|NCT00021996|Analgesics|analgesics|mesh-ancestor
56318639|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
56318640|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318641|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318642|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56318643|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56318644|NCT00022074|Gabapentin|gabapentin|mesh-list
56318645|NCT00022074|Analgesics|analgesics|mesh-ancestor
56318646|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
56318647|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318648|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318649|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
56318650|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56318651|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56318652|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56318653|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56318654|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56318655|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56318656|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56318657|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318658|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
56318659|NCT00022152|Vinorelbine|vinorelbine|mesh-list
56318660|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318661|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318662|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318663|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318664|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318665|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318666|NCT00022191|Gemcitabine|gemcitabine|mesh-list
56318667|NCT00022191|Paclitaxel|paclitaxel|mesh-list
56318668|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318669|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318670|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318671|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318672|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318673|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318674|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318675|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
56318676|NCT00022191|Antiviral Agents|antiviral agents|mesh-ancestor
56318677|NCT00022191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318678|NCT00022191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907753|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56347707|NCT03816774|Simethicone|simethicone|mesh-list
56318679|NCT00022191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318680|NCT00022191|Immunologic Factors|immunologic factors|mesh-ancestor
56318681|NCT00022191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318682|NCT00022230|Aldesleukin|aldesleukin|mesh-list
56318683|NCT00022230|Paclitaxel|paclitaxel|mesh-list
56318684|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
56318685|NCT00022230|Doxorubicin|doxorubicin|mesh-list
56318687|NCT00022230|Sargramostim|sargramostim|mesh-list
56318688|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318689|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318690|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318691|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318692|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318693|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318694|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318695|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
56318696|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318697|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56318720|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318722|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56318723|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318724|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318725|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318726|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
56318727|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318728|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
56318729|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318730|NCT00022542|Epothilones|epothilones|mesh-list
56318731|NCT00022542|Epothilone B|epothilone b|mesh-list
56318732|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318733|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318734|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318735|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318736|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318737|NCT05557643|Psilocybin|psilocybin|mesh-list
56318738|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
56318739|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318740|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56318741|NCT00022581|Thalidomide|thalidomide|mesh-list
56318742|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318743|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
56318744|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318745|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
56318746|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56318747|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318748|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56318749|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56318750|NCT00022581|Growth Substances|growth substances|mesh-ancestor
56318751|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
56318752|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318753|NCT05551871|Simvastatin|simvastatin|mesh-list
56318754|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56318758|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56318759|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56318760|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318761|NCT00022620|Paclitaxel|paclitaxel|mesh-list
56318763|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318764|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318765|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318766|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318767|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318768|NCT00022737|Leucovorin|leucovorin|mesh-list
56318769|NCT00022737|Cytarabine|cytarabine|mesh-list
56318770|NCT00022737|Cyclosporine|cyclosporine|mesh-list
56318771|NCT00022737|Dexamethasone|dexamethasone|mesh-list
56318772|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
56318773|NCT00022737|Ifosfamide|ifosfamide|mesh-list
56318774|NCT00022737|Methotrexate|methotrexate|mesh-list
56318775|NCT00022737|Etoposide|etoposide|mesh-list
56318776|NCT00022737|Vincristine|vincristine|mesh-list
56318777|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
56318778|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
56318779|NCT00022737|Daunorubicin|daunorubicin|mesh-list
56318780|NCT00022737|Asparaginase|asparaginase|mesh-list
56318781|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
55940656|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56907754|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
56907755|NCT00133991|Hormones|hormones|mesh-ancestor
56907756|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318782|NCT00022737|Pegaspargase|pegaspargase|mesh-list
56318783|NCT00022737|Cyclosporins|cyclosporins|mesh-list
56318784|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
56318785|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56318786|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
56318787|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318788|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56318789|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56318790|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
56318791|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318792|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318793|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56318794|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56318796|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
56318797|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318798|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56318799|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
56318801|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318802|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56318803|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56318804|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
56318805|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56318806|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318807|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
56318808|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
56318809|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318810|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56318811|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56318812|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318813|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56318814|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56318815|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
56318816|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318817|NCT00022737|Antidotes|antidotes|mesh-ancestor
56318818|NCT00022737|Protective Agents|protective agents|mesh-ancestor
56318819|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
56318820|NCT00022737|Vitamins|vitamins|mesh-ancestor
56318821|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
56318822|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318823|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318824|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318825|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
56318826|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56318827|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56318828|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318829|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
56318830|NCT00022893|Antibodies|antibodies|mesh-list
56318831|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
56318834|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56318835|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
56318836|NCT00022932|Antibodies|antibodies|mesh-list
56318837|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
56318838|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318839|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318841|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56318842|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318843|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
56318844|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318845|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56318846|NCT05512754|Ibuprofen|ibuprofen|mesh-list
56318847|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56318848|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56318849|NCT05512754|Analgesics|analgesics|mesh-ancestor
56318850|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
56318851|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318852|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318853|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56318854|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56318855|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56318856|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907757|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56907758|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56318857|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318858|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
56318859|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
56318860|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
56318861|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56318862|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
56318863|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318864|NCT02971878|Protective Agents|protective agents|mesh-ancestor
56318865|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318866|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
56318867|NCT02971878|Vitamins|vitamins|mesh-ancestor
56318868|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
56318869|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
56318870|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
56318871|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318872|NCT02971878|Expectorants|expectorants|mesh-ancestor
56318873|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
56318874|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56318875|NCT02971878|Antidotes|antidotes|mesh-ancestor
56318876|NCT00023166|Paclitaxel|paclitaxel|mesh-list
56318877|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56318878|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318879|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
56318880|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318881|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318882|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318883|NCT00394992|Bevacizumab|bevacizumab|mesh-list
56318884|NCT00394992|Capecitabine|capecitabine|mesh-list
56318885|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
56318886|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56318887|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318888|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56318889|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56318890|NCT00394992|Growth Substances|growth substances|mesh-ancestor
56318891|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318892|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
56318893|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318894|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
56318895|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318896|NCT00395031|Ziprasidone|ziprasidone|mesh-list
56318897|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56318898|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
56318899|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56318900|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318901|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318902|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56318903|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56318904|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56318905|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56318906|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56318908|NCT00395070|Temozolomide|temozolomide|mesh-list
56318909|NCT00395070|Dacarbazine|dacarbazine|mesh-list
56318910|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56318911|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
56318912|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318913|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318914|NCT00023244|Cyclosporine|cyclosporine|mesh-list
56318917|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
56318918|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56318919|NCT00023244|Prednisone|prednisone|mesh-list
56318920|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
56318921|NCT00023244|Tacrolimus|tacrolimus|mesh-list
56318922|NCT00023244|Cyclosporins|cyclosporins|mesh-list
56318923|NCT00023244|Basiliximab|basiliximab|mesh-list
56318924|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56318925|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
56318926|NCT00023244|Hormones|hormones|mesh-ancestor
56318927|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56318928|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318929|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56318930|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318931|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907759|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
56318932|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
56318933|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56318934|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318935|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318936|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
56318937|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318938|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
55940808|NCT03336203|Allopurinol|allopurinol|mesh-list
56318939|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56318940|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56318941|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318943|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
56318944|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318945|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56318946|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56318947|NCT00023244|Protective Agents|protective agents|mesh-ancestor
56318948|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56318949|NCT00023244|Renal Agents|renal agents|mesh-ancestor
56318950|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
56318951|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56318952|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56318953|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56318954|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56318955|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56318956|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56318957|NCT00023283|Buprenorphine|buprenorphine|mesh-list
56318958|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56318959|NCT00023283|Narcotics|narcotics|mesh-ancestor
56318960|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56318961|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318962|NCT00023283|Analgesics|analgesics|mesh-ancestor
56318963|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
56318964|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318965|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56318966|NCT00023361|Rifabutin|rifabutin|mesh-list
56318967|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56318968|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318969|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56318970|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
56318971|NCT00023400|Nelfinavir|nelfinavir|mesh-list
56318972|NCT00023400|Rifabutin|rifabutin|mesh-list
56318973|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56318974|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56318975|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
56318976|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318977|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318978|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56318979|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56318980|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
56318981|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318982|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56318983|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56318988|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318989|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
56318990|NCT05359172|Coagulants|coagulants|mesh-ancestor
56318991|NCT00023634|Sargramostim|sargramostim|mesh-list
56318992|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
56318993|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318994|NCT00023751|Leucovorin|leucovorin|mesh-list
56318995|NCT00023751|Fluorouracil|fluorouracil|mesh-list
56318996|NCT00023751|Calcium|calcium|mesh-list
56318997|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
56318998|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56318999|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319000|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
56319001|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319002|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319003|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319004|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319005|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
56319006|NCT00023751|Antidotes|antidotes|mesh-ancestor
56319007|NCT00023751|Protective Agents|protective agents|mesh-ancestor
56319008|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
56319009|NCT00023751|Vitamins|vitamins|mesh-ancestor
56319010|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
56319011|NCT00023790|Silicon|silicon|mesh-list
56907760|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56347998|NCT00186979|Vincristine|vincristine|mesh-list
56319012|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
56319013|NCT00023790|Trace Elements|trace elements|mesh-ancestor
56319014|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
56319015|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319016|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
56319017|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56319018|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56319019|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319021|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56319022|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
56319023|NCT02971982|Dexamethasone|dexamethasone|mesh-list
56319024|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
56319025|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
56319026|NCT02971982|Rituximab|rituximab|mesh-list
56319027|NCT02971982|Bortezomib|bortezomib|mesh-list
56319028|NCT02971982|BB 1101|bb 1101|mesh-list
56319029|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319030|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
56319031|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319032|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319033|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319034|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
56319035|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319036|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319037|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319038|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56319039|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56319040|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
56319041|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
56319042|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319043|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56319044|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
56319045|NCT02971982|Hormones|hormones|mesh-ancestor
56319046|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56319047|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56319048|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
56319049|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319050|NCT00023829|Bicalutamide|bicalutamide|mesh-list
56319051|NCT00023829|Flutamide|flutamide|mesh-list
56319052|NCT00023829|Hormones|hormones|mesh-list
56319053|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56319054|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319055|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
56319056|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
56319057|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319058|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56319068|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56319069|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319070|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319071|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334009|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56319072|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319073|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319075|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319076|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319077|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
56319078|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56319080|NCT00023868|Protective Agents|protective agents|mesh-ancestor
56319081|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
56319082|NCT00023868|Vitamins|vitamins|mesh-ancestor
56319083|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
56319084|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
56161494|NCT00692094|Melatonin|melatonin|mesh-list
56319085|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56319087|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319088|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319089|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319090|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
56319091|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319092|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319093|NCT00023946|Epothilones|epothilones|mesh-list
56319094|NCT00023946|Epothilone B|epothilone b|mesh-list
56907761|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56907762|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
56907763|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
56319095|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319096|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
56319097|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319098|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319099|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319101|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
56319102|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319103|NCT00024063|Orantinib|orantinib|mesh-list
56319104|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56319105|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319106|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319107|NCT00024141|Fluorouracil|fluorouracil|mesh-list
56319108|NCT00024141|Irinotecan|irinotecan|mesh-list
56319109|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
56319110|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319111|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319112|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319113|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319114|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
56319115|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319116|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56319117|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319118|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319119|NCT05239286|Anesthetics|anesthetics|mesh-list
56319120|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319121|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319122|NCT00024180|Romidepsin|romidepsin|mesh-list
56319123|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56319124|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319125|NCT00024297|Warfarin|warfarin|mesh-list
56319126|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
56319127|NCT00024336|Tamoxifen|tamoxifen|mesh-list
56319128|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55958758|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
56319130|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56319132|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56319133|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319134|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56319135|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56319136|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56319137|NCT00024375|Paclitaxel|paclitaxel|mesh-list
56319138|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319139|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319140|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319141|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
56319142|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319143|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319144|NCT00024414|Paclitaxel|paclitaxel|mesh-list
56319145|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56059253|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319146|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319147|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319148|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
56319149|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319150|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319152|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56319153|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319154|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
56319155|NCT00024492|Analgesics|analgesics|mesh-ancestor
56319156|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
56319157|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319158|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319159|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319160|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319161|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319162|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319163|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319164|NCT00024531|Atorvastatin|atorvastatin|mesh-list
56319165|NCT00024531|Calcium|calcium|mesh-list
56907764|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907765|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56907766|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56907767|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
56319166|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56319167|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319168|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56319169|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56319170|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
56319171|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319172|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56319173|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56319174|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319175|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
56319176|NCT05080049|Hematinics|hematinics|mesh-ancestor
56319177|NCT00024687|Immunotoxins|immunotoxins|mesh-list
56319178|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
56319179|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319180|NCT05072444|QPX7728|qpx7728|mesh-list
56319181|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56319182|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319183|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319184|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56319185|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319186|NCT00025038|Cytarabine|cytarabine|mesh-list
56319187|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
56319188|NCT00025038|Fludarabine|fludarabine|mesh-list
56319189|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
56319190|NCT00025038|Tipifarnib|tipifarnib|mesh-list
56319191|NCT00025038|Isotretinoin|isotretinoin|mesh-list
56319192|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
56319193|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56319194|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
56319195|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319196|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
56319197|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319198|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319199|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319200|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
55958823|NCT05327751|Analgesics|analgesics|mesh-ancestor
56319215|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319216|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319218|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56319219|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56319220|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319221|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319223|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56319224|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
56319225|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319226|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56319227|NCT05055830|Narcotics|narcotics|mesh-ancestor
56319228|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319229|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
56319230|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
56319231|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
56319232|NCT00025077|Thiotepa|thiotepa|mesh-list
56319233|NCT00025077|Carboplatin|carboplatin|mesh-list
56319234|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319235|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
56319236|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319237|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319238|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319239|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
56319240|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319241|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319242|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319243|NCT05051891|Prednisone|prednisone|mesh-list
56319244|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
55941110|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56319245|NCT05051891|Vincristine|vincristine|mesh-list
56319246|NCT05051891|Rituximab|rituximab|mesh-list
56319247|NCT05051891|Doxorubicin|doxorubicin|mesh-list
56319248|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907768|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907769|NCT00133991|Antidotes|antidotes|mesh-ancestor
56319249|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
56319250|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319251|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319252|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319253|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
56319254|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319255|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319256|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319257|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56319258|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
56319259|NCT05051891|Hormones|hormones|mesh-ancestor
56319260|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56319261|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55958891|NCT01899755|Adalimumab|adalimumab|mesh-list
56319266|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56319267|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56319268|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319269|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319270|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319271|NCT00025116|Gefitinib|gefitinib|mesh-list
56319272|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319273|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56319274|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319275|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319276|NCT00025194|Estramustine|estramustine|mesh-list
56319277|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319278|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
56319279|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319280|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319281|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56319282|NCT00025272|Carboplatin|carboplatin|mesh-list
56319283|NCT00025272|Etoposide|etoposide|mesh-list
56319284|NCT00025272|Topotecan|topotecan|mesh-list
56319285|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319286|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319287|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319288|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319289|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319290|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319291|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56319292|NCT05023382|Teduglutide|teduglutide|mesh-list
56319293|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56319294|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56319296|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319297|NCT00025311|Topotecan|topotecan|mesh-list
56319298|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56319299|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319300|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319301|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319302|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319303|NCT00025350|Gefitinib|gefitinib|mesh-list
56319304|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319305|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56319306|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319307|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319308|NCT00025389|Paclitaxel|paclitaxel|mesh-list
56319309|NCT00025389|Bevacizumab|bevacizumab|mesh-list
56319311|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319312|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319313|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319314|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
56319315|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319316|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319317|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56319318|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56319319|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56319320|NCT00025389|Growth Substances|growth substances|mesh-ancestor
56319321|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319322|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
56319323|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
56907770|NCT00133991|Protective Agents|protective agents|mesh-ancestor
56319324|NCT00025428|Carboplatin|carboplatin|mesh-list
56319325|NCT00025428|Doxorubicin|doxorubicin|mesh-list
56319326|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56319327|NCT00025428|Etoposide|etoposide|mesh-list
56319328|NCT00025428|Vincristine|vincristine|mesh-list
56319329|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319330|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
56319331|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319332|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319333|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319334|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
56319337|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319338|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56319339|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319340|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319342|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319343|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319344|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
56319345|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319346|NCT00025467|Thalidomide|thalidomide|mesh-list
56319347|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319348|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
56319349|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319350|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
56319351|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56319352|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319353|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56319354|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56319355|NCT00025467|Growth Substances|growth substances|mesh-ancestor
56319356|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
56319357|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319358|NCT04964414|Budesonide|budesonide|mesh-list
56319359|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
56319360|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56319361|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56319362|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
56319363|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319364|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319365|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56319366|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
56319367|NCT04964414|Hormones|hormones|mesh-ancestor
56319368|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56319369|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
56319370|NCT00025545|Methotrexate|methotrexate|mesh-list
56319371|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319372|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
56319373|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319374|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319375|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319376|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
56319377|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319378|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319379|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319380|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56319381|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
56319382|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56319383|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319384|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
56319385|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
56319386|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319387|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56319388|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56319389|NCT00025584|Bortezomib|bortezomib|mesh-list
56319390|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319391|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
56319392|NCT00025623|Carboplatin|carboplatin|mesh-list
56319393|NCT00025623|Doxorubicin|doxorubicin|mesh-list
56319394|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56319395|NCT00025623|Etoposide|etoposide|mesh-list
56319396|NCT00025623|Vincristine|vincristine|mesh-list
56319397|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319398|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
56319399|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319400|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319401|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56907771|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
56907772|NCT00133991|Vitamins|vitamins|mesh-ancestor
56907773|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
56348370|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56319402|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
56319403|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319404|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319405|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319406|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56319417|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319418|NCT04955678|Cathartics|cathartics|mesh-ancestor
56319419|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56319420|NCT00025740|Clonazepam|clonazepam|mesh-list
56319421|NCT00025740|Paroxetine|paroxetine|mesh-list
56319422|NCT00025740|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56319423|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56319424|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56319425|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319426|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319427|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
56319428|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319429|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56319430|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
56319431|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56319432|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56319433|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56319434|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319435|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
56319436|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
56319437|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
56319438|NCT00025779|Guanfacine|guanfacine|mesh-list
56319439|NCT00025779|Methylphenidate|methylphenidate|mesh-list
56319440|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56319441|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319442|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56319443|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56319444|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56319445|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319446|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
56319447|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319448|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56319449|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56319450|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56319451|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56319452|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56319453|NCT04876079|Insulin|insulin|mesh-list
56319454|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56319455|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319456|NCT04857827|Timolol|timolol|mesh-list
56319458|NCT04857827|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56319459|NCT04857827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319460|NCT04857827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56319461|NCT04857827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56319462|NCT04857827|Adrenergic Agents|adrenergic agents|mesh-ancestor
56319463|NCT04857827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319464|NCT04857827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319465|NCT04857827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56319466|NCT04857827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56319467|NCT00026052|Riluzole|riluzole|mesh-list
56319468|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
55941336|NCT03828019|Tacrolimus|tacrolimus|mesh-list
56319469|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56319470|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56319471|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319482|NCT00026130|Fluorouracil|fluorouracil|mesh-list
56319483|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319484|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
56319485|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319486|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319487|NCT00026130|Antiviral Agents|antiviral agents|mesh-ancestor
56319488|NCT00026130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907774|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56907775|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
56348457|NCT00189553|Paclitaxel|paclitaxel|mesh-list
56319489|NCT00026130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319490|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319491|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
56319492|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319493|NCT04815902|Losartan|losartan|mesh-list
56319494|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56319495|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56319496|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56319497|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56319498|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319499|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
56319500|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319501|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56319502|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319503|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319504|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56319505|NCT04808414|Polymyxins|polymyxins|mesh-list
56319506|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319507|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56319508|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
56319509|NCT00026286|Estrogens|estrogens|mesh-list
56319510|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56319511|NCT00026286|Hormones|hormones|mesh-ancestor
56319512|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56319513|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319514|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56319515|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56319516|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56319517|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
56319518|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56319519|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56319520|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56319521|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56319522|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56319523|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319525|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56319526|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319527|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56161501|NCT00676026|Fluoxetine|fluoxetine|mesh-list
56319528|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319530|NCT00026364|Fluorouracil|fluorouracil|mesh-list
56319531|NCT00026364|Irinotecan|irinotecan|mesh-list
56319532|NCT00026364|Gefitinib|gefitinib|mesh-list
56319533|NCT00026364|Calcium|calcium|mesh-list
56319534|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
56319535|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56319536|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319537|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
56319539|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319540|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319541|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319542|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
56319543|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56319544|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319545|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319546|NCT00026364|Antidotes|antidotes|mesh-ancestor
56319547|NCT00026364|Protective Agents|protective agents|mesh-ancestor
56319548|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
56319549|NCT00026364|Vitamins|vitamins|mesh-ancestor
56319550|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
56319551|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56319552|NCT00026403|Gemcitabine|gemcitabine|mesh-list
56319553|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319554|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319555|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
56319556|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319557|NCT00026403|Antiviral Agents|antiviral agents|mesh-ancestor
56319558|NCT00026403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319559|NCT00026403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907776|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
56907777|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
56907778|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56907779|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
56348514|NCT00047190|Tipifarnib|tipifarnib|mesh-list
56319560|NCT00026403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319561|NCT00026403|Immunologic Factors|immunologic factors|mesh-ancestor
56319562|NCT00026403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319563|NCT00026442|Capecitabine|capecitabine|mesh-list
56319564|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319565|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
56319566|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319567|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319568|NCT04726280|Ropivacaine|ropivacaine|mesh-list
56319569|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56319570|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
56319571|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
56319572|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319573|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319574|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
56319575|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319576|NCT00026520|Interferons|interferons|mesh-list
56319577|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
56319578|NCT00026520|Thalidomide|thalidomide|mesh-list
56319579|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319580|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
56319581|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319582|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
56319583|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319584|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319585|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
56319586|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56319587|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56319588|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56319589|NCT00026520|Growth Substances|growth substances|mesh-ancestor
56319590|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
56319591|NCT00026637|Sertraline|sertraline|mesh-list
56319592|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
56319593|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56319594|NCT00026637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56319595|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56319596|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56319597|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319598|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319600|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319601|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
56319602|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319603|NCT04610684|Carboplatin|carboplatin|mesh-list
56319604|NCT04610684|Etoposide|etoposide|mesh-list
56319605|NCT04610684|Atezolizumab|atezolizumab|mesh-list
56319606|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319607|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319608|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319609|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319610|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319611|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319612|NCT00027066|Aspirin|aspirin|mesh-list
56319613|NCT00027066|Warfarin|warfarin|mesh-list
56319614|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56319615|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56319617|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
55941486|NCT01923077|Simvastatin|simvastatin|mesh-list
56319618|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319619|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319620|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56319621|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319622|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56319623|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56319624|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319625|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56907780|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907781|NCT02140450|Timolol|timolol|mesh-list
56348592|NCT03238365|Nivolumab|nivolumab|mesh-list
56319626|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56319627|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319628|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
56319629|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
56319630|NCT04473950|Naloxone|naloxone|mesh-list
56319631|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56319632|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319633|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
56319634|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319635|NCT04473482|Ethanol|ethanol|mesh-list
56319636|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56319637|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319638|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319639|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319640|NCT00027300|Natalizumab|natalizumab|mesh-list
56319641|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
56319642|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319643|NCT00395382|Alendronate|alendronate|mesh-list
56319644|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56319645|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319646|NCT00027339|Ritonavir|ritonavir|mesh-list
56319647|NCT00027339|Lopinavir|lopinavir|mesh-list
56319648|NCT00027339|Indinavir|indinavir|mesh-list
56319649|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
56319650|NCT00027339|Tenofovir|tenofovir|mesh-list
56319651|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56319652|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56319653|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
56319654|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319655|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319656|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56319657|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56319658|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
56319659|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319660|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56319661|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56319662|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56319663|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56319664|NCT04206488|Digoxin|digoxin|mesh-list
56319665|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56319666|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56319667|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319668|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319669|NCT04206488|Protective Agents|protective agents|mesh-ancestor
56319670|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319671|NCT00027495|Curcumin|curcumin|mesh-list
56319672|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56319673|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56319674|NCT00027495|Analgesics|analgesics|mesh-ancestor
56319675|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
56319676|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319677|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319678|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56319680|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319681|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319682|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319683|NCT00027534|Metronidazole|metronidazole|mesh-list
56319684|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319685|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56319686|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56319687|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56319688|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
56319691|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
56319692|NCT00027573|Tacrolimus|tacrolimus|mesh-list
56319693|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319694|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
56319695|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319696|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319697|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319698|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
56319699|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907782|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56907783|NCT02140450|Mannitol|mannitol|mesh-list
56319700|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319701|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319702|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56319703|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
56319704|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56319705|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319706|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
56319707|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
56319708|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319709|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56319710|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56319711|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56319712|NCT00027612|Irinotecan|irinotecan|mesh-list
56319713|NCT00027612|Carmustine|carmustine|mesh-list
56319714|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56319715|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319716|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319717|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319718|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319719|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319720|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
56319721|NCT04137887|Vaccines|vaccines|mesh-list
56319722|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
56319723|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319724|NCT00027690|Gefitinib|gefitinib|mesh-list
56319725|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319726|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56319727|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319728|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319729|NCT04137536|Antibodies|antibodies|mesh-list
56319730|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56319731|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
56319732|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319733|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
56319734|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319735|NCT00027807|Aldesleukin|aldesleukin|mesh-list
56319736|NCT00027807|Molgramostim|molgramostim|mesh-list
56319737|NCT00027807|Sargramostim|sargramostim|mesh-list
56319738|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
56319739|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319740|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319741|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56319742|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56319743|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
56319744|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319745|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
56319746|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56319747|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
56319749|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319750|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319751|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56319752|NCT00392522|Analgesics|analgesics|mesh-ancestor
56319753|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
56319754|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319755|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
56319756|NCT00027885|Bevacizumab|bevacizumab|mesh-list
56319757|NCT00027885|Docetaxel|docetaxel|mesh-list
56319758|NCT00027885|Doxorubicin|doxorubicin|mesh-list
56319759|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56319760|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319761|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
56319762|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319763|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319764|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319765|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
56319767|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319768|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319769|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56319770|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56319771|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56319772|NCT00027885|Growth Substances|growth substances|mesh-ancestor
56319773|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
56319774|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319775|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
56348730|NCT00190918|Pemetrexed|pemetrexed|mesh-list
56319776|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319777|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56319778|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319779|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319780|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319781|NCT00027924|Cyclosporine|cyclosporine|mesh-list
56319782|NCT00027924|Methotrexate|methotrexate|mesh-list
56319783|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
56319784|NCT00027924|Fludarabine|fludarabine|mesh-list
56319785|NCT00027924|Busulfan|busulfan|mesh-list
56319786|NCT00027924|Cyclosporins|cyclosporins|mesh-list
56319787|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56319788|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
56319789|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56319790|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319791|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319792|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
56319793|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319794|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319795|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
56319796|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319797|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56319798|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319799|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
56319800|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319801|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56319802|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
56319803|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319804|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56319805|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
56319806|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319807|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319808|NCT04022876|Carboplatin|carboplatin|mesh-list
56319809|NCT04022876|Pemetrexed|pemetrexed|mesh-list
56319810|NCT04022876|Topotecan|topotecan|mesh-list
56319811|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319812|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319813|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319814|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56319815|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56319816|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56319817|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319818|NCT00027963|Gabapentin|gabapentin|mesh-list
56319819|NCT00027963|Analgesics|analgesics|mesh-ancestor
56319820|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
56319821|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319822|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319823|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
56319824|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56319825|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56319826|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319827|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56319828|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56319829|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56319830|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319831|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319832|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
56319833|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56319834|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
56319835|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319836|NCT00395499|Risperidone|risperidone|mesh-list
56319837|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56319838|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
56319839|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319847|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
56319848|NCT03960125|Imipramine|imipramine|mesh-list
56319849|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56319850|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
56319851|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56319852|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56319853|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56319854|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56319855|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319856|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
56907784|NCT02140450|Acetazolamide|acetazolamide|mesh-list
56907785|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56348805|NCT00191425|Teriparatide|teriparatide|mesh-list
56319857|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319858|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319859|NCT00395655|Hydralazine|hydralazine|mesh-list
56319860|NCT00395655|Valproic Acid|valproic acid|mesh-list
56319861|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
56319862|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319863|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319864|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
56319865|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319866|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319867|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
56319868|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56319869|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319870|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56319871|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56319872|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
56319873|NCT00392561|Vitamin E|vitamin e|mesh-list
56319874|NCT00392561|Selenium|selenium|mesh-list
56319875|NCT00392561|Vitamins|vitamins|mesh-ancestor
56319876|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
56319877|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319878|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
56319879|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319880|NCT00392561|Protective Agents|protective agents|mesh-ancestor
56319881|NCT00392561|Trace Elements|trace elements|mesh-ancestor
56319882|NCT00028275|Interferons|interferons|mesh-list
56319883|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
56319884|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319885|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
56319886|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319887|NCT03959969|Ibuprofen|ibuprofen|mesh-list
56319888|NCT03959969|Oxycodone|oxycodone|mesh-list
56319889|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56319890|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56319891|NCT03959969|Analgesics|analgesics|mesh-ancestor
56319892|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
56319893|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319894|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319895|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56319896|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319897|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56319898|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319899|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319900|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56319902|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319903|NCT00028314|Ritonavir|ritonavir|mesh-list
56319904|NCT00028314|Lopinavir|lopinavir|mesh-list
56319905|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56319906|NCT00028314|Nevirapine|nevirapine|mesh-list
56319907|NCT00028314|Abacavir|abacavir|mesh-list
56319908|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56319909|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56319913|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56319914|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56319915|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
56319916|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319917|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56319918|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56319919|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56319920|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56319921|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56319922|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56319924|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56319925|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319926|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56319927|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56319928|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
56319929|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56319930|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319931|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56319932|NCT03959852|Fentanyl|fentanyl|mesh-list
56907786|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56907787|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348891|NCT02470299|Ketorolac|ketorolac|mesh-list
56319933|NCT03959852|Ketamine|ketamine|mesh-list
56319934|NCT03959852|Analgesics|analgesics|mesh-ancestor
56319935|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
56319936|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56319937|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319938|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56319939|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56319940|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
56319941|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
56319942|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319943|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56319944|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56319945|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319946|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319947|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56319948|NCT03959852|Narcotics|narcotics|mesh-ancestor
56319949|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56319950|NCT00028431|Ipilimumab|ipilimumab|mesh-list
56319951|NCT00028431|Antibodies|antibodies|mesh-list
56319952|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
56319953|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319954|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56319955|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319956|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56319957|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319958|NCT00028587|Paclitaxel|paclitaxel|mesh-list
56319959|NCT00028587|Carboplatin|carboplatin|mesh-list
56319960|NCT00028587|Bortezomib|bortezomib|mesh-list
56319961|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319962|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319963|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319964|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56319965|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319966|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319967|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
56319968|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56319969|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56319970|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56319971|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319972|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
56319974|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
56319975|NCT00028665|Carmustine|carmustine|mesh-list
56319976|NCT00028665|Rituximab|rituximab|mesh-list
56319977|NCT00028665|Etoposide|etoposide|mesh-list
56319978|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56319979|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
56319980|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319981|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56319982|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56319984|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319986|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319987|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56319988|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319989|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319990|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319991|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319993|NCT03959540|Opicapone|opicapone|mesh-list
56319994|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56319995|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56319996|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
56319997|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56319998|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319999|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320000|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56320001|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320002|NCT00028743|Paclitaxel|paclitaxel|mesh-list
56320003|NCT00028743|Carboplatin|carboplatin|mesh-list
56320004|NCT00028743|Topotecan|topotecan|mesh-list
56320005|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56320006|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320007|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
56907788|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56907789|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320008|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320009|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320010|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320011|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56320012|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56320013|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320014|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56320015|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
56320016|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56320017|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320018|NCT03959501|Incretins|incretins|mesh-ancestor
56320019|NCT03959501|Hormones|hormones|mesh-ancestor
56320020|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320021|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56320022|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
56320023|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320024|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320025|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56320026|NCT00028782|Etanidazole|etanidazole|mesh-list
56320027|NCT00028782|Imidazole|imidazole|mesh-list
56320028|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320029|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320030|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320031|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
56320032|NCT00028821|Estradiol|estradiol|mesh-list
56320033|NCT00028821|Estrogens|estrogens|mesh-ancestor
56320034|NCT00028821|Hormones|hormones|mesh-ancestor
56320035|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320036|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320037|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320038|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320039|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320040|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320041|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320042|NCT03959384|Poractant alfa|poractant alfa|mesh-list
56320043|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56320044|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
56320045|NCT00028860|Gemcitabine|gemcitabine|mesh-list
56320046|NCT00028860|Paclitaxel|paclitaxel|mesh-list
56320047|NCT00028860|Carboplatin|carboplatin|mesh-list
56320048|NCT00028860|Ifosfamide|ifosfamide|mesh-list
56320049|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56320050|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320051|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320052|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320053|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320054|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320055|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320056|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
56320061|NCT00028860|Immunologic Factors|immunologic factors|mesh-ancestor
56320062|NCT00028860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320063|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56320064|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
56320065|NCT00028899|Cytarabine|cytarabine|mesh-list
56320066|NCT00028899|Asparaginase|asparaginase|mesh-list
56320067|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
56320068|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
56320069|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320070|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
56320071|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320072|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320073|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
56320074|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320075|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320076|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
56320077|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320078|NCT00028899|Analgesics|analgesics|mesh-ancestor
56320079|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
56320080|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320081|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56320082|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56907790|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320083|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320084|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56320085|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56320086|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320087|NCT00028938|Paclitaxel|paclitaxel|mesh-list
56320088|NCT00028938|Carboplatin|carboplatin|mesh-list
56320089|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
56320090|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56320091|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320092|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320093|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320094|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320095|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320096|NCT00028938|Hematinics|hematinics|mesh-ancestor
56320097|NCT00029250|Allicin|allicin|mesh-list
56320098|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320099|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56320100|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
56320101|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320102|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56320103|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
56320104|NCT00029250|Protective Agents|protective agents|mesh-ancestor
56320105|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320106|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56320107|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56320108|NCT03959150|Capecitabine|capecitabine|mesh-list
56320109|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320110|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
56320111|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320112|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320113|NCT00029328|Etanercept|etanercept|mesh-list
56320114|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56320115|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56320116|NCT00029328|Analgesics|analgesics|mesh-ancestor
56320117|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
56320118|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320119|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320120|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56320121|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320122|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56320123|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320125|NCT03958877|Interferons|interferons|mesh-list
56320126|NCT03958877|Interferon-beta|interferon-beta|mesh-list
56320127|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320128|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
56320129|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320130|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
56320131|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320132|NCT00029523|Cytarabine|cytarabine|mesh-list
56320133|NCT00029523|Methotrexate|methotrexate|mesh-list
56320134|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56320135|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
56320136|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56320137|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320138|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320139|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
56320140|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320141|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320142|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
56320143|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320144|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56320145|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320146|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
56320147|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320148|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56320149|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
56320150|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320152|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56320153|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56320154|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
56320155|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320156|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56320157|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56907791|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56907792|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56907793|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56349097|NCT00193141|Paclitaxel|paclitaxel|mesh-list
56320158|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320159|NCT00029679|Borage oil|borage oil|mesh-list
56320160|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320161|NCT03958799|Vaccines|vaccines|mesh-list
56320162|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
56320163|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320164|NCT00029757|Estrogens|estrogens|mesh-list
56320165|NCT00029757|Hormones|hormones|mesh-ancestor
56320166|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320167|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320168|NCT03958721|Capecitabine|capecitabine|mesh-list
56320169|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320170|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
56320171|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320172|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320173|NCT00029835|Rimonabant|rimonabant|mesh-list
56320174|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56320175|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56320176|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56320177|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320178|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320179|NCT00029835|Hormones|hormones|mesh-ancestor
56320180|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320181|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320182|NCT00395772|Vitamin K|vitamin k|mesh-list
56320183|NCT00395772|Heparin|heparin|mesh-list
56320184|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
56320185|NCT00395772|Vitamins|vitamins|mesh-ancestor
56320186|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
56320187|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320188|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
56320189|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56320190|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56320191|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320192|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56320193|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
56320194|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56320195|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
56320196|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320197|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56320198|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
56320199|NCT00395772|Coagulants|coagulants|mesh-ancestor
56320209|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
56320210|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320211|NCT00030030|Protective Agents|protective agents|mesh-ancestor
56320212|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320213|NCT00030069|Calcitriol|calcitriol|mesh-list
56320214|NCT00030069|Dexamethasone|dexamethasone|mesh-list
56320215|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56320216|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
56320224|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320225|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320226|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56320227|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56320228|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56320229|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320230|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56320232|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
56320233|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56320234|NCT03958097|Antibodies|antibodies|mesh-list
56320235|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
56320236|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320237|NCT00030342|Interferons|interferons|mesh-list
56320238|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
56320239|NCT00030342|Fluorouracil|fluorouracil|mesh-list
56320240|NCT00030342|Sargramostim|sargramostim|mesh-list
56320241|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
56320242|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083281|NCT04289792|Gemcitabine|gemcitabine|mesh-list
56907794|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56907795|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56907796|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56907797|NCT02140450|Diuretics|diuretics|mesh-ancestor
56907798|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
56907799|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
56907800|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56907801|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907802|NCT05577676|Triamcinolone|triamcinolone|mesh-list
56907803|NCT05577676|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56907804|NCT05577676|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56907805|NCT05577676|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56907806|NCT05577676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907807|NCT05577676|Glucocorticoids|glucocorticoids|mesh-ancestor
56907808|NCT05577676|Hormones|hormones|mesh-ancestor
56907809|NCT05577676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56907810|NCT05577676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907811|NCT05577676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907812|NCT05577676|Immunologic Factors|immunologic factors|mesh-ancestor
56907813|NCT05577676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907814|NCT05577676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907815|NCT03549832|Ritonavir|ritonavir|mesh-list
56907816|NCT03549832|Ribavirin|ribavirin|mesh-list
56320243|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320244|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320245|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320246|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
56320247|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320248|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
56320249|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320250|NCT00030381|Esorubicin|esorubicin|mesh-list
56320251|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56320252|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320253|NCT00030420|Celecoxib|celecoxib|mesh-list
56320254|NCT00030420|Docetaxel|docetaxel|mesh-list
56320255|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320256|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320257|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320258|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320259|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320260|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56320261|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56320262|NCT00030420|Analgesics|analgesics|mesh-ancestor
56320263|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
56320264|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320265|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320266|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56320267|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320268|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56320269|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56320270|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320271|NCT00030459|Vinorelbine|vinorelbine|mesh-list
56320272|NCT00030459|Mitomycins|mitomycins|mesh-list
56320273|NCT00030459|Mitomycin|mitomycin|mesh-list
56320274|NCT00030459|Vinblastine|vinblastine|mesh-list
56907817|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
56907818|NCT03549832|Simeprevir|simeprevir|mesh-list
56907819|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56907820|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56907821|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
56907822|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907823|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907824|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56320275|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320276|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56320277|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320278|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320279|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
56161523|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
56320280|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320281|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56320282|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
56320283|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56320284|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320295|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56320296|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320297|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56320298|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320299|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320300|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56320301|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320302|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56320303|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320304|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320305|NCT00030615|Decitabine|decitabine|mesh-list
56320306|NCT00030615|Azacitidine|azacitidine|mesh-list
56320307|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320308|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
56320309|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320310|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320311|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320312|NCT03857087|Edetic Acid|edetic acid|mesh-list
56320313|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56320314|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
56320315|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
56320316|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320317|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
56320318|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56320319|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56320320|NCT00030654|Ketoconazole|ketoconazole|mesh-list
56320321|NCT00030654|Vinblastine|vinblastine|mesh-list
56320322|NCT00030654|Docetaxel|docetaxel|mesh-list
56320323|NCT00030654|Doxorubicin|doxorubicin|mesh-list
56320324|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56320325|NCT00030654|Bicalutamide|bicalutamide|mesh-list
56320326|NCT00030654|Flutamide|flutamide|mesh-list
56320327|NCT00030654|Estramustine|estramustine|mesh-list
56320328|NCT00030654|Hormones|hormones|mesh-list
56320329|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56320330|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320331|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320332|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320333|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320334|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320335|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56320336|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56320337|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56320338|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320339|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320340|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320341|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
56320342|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320343|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56907825|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56907826|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
56907827|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907828|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56320344|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56320345|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56320346|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
56320347|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56320348|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
55959960|NCT01393964|BB 1101|bb 1101|mesh-list
56320350|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56320351|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
56320352|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
56320355|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
56320356|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320357|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
56320358|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320359|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320360|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56320361|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
56320362|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320363|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320364|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56320365|NCT00030693|Metronidazole|metronidazole|mesh-list
56320366|NCT00030693|Vaccines|vaccines|mesh-list
56320367|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
56320368|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320369|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320370|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56320371|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56320372|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56320373|NCT03823274|Aspirin|aspirin|mesh-list
56320374|NCT03823274|Clopidogrel|clopidogrel|mesh-list
56320375|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56320376|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56320377|NCT03823274|Analgesics|analgesics|mesh-ancestor
56320378|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
56320379|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320380|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320381|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56320382|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320383|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56320384|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56320385|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320386|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56320387|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56320388|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320390|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56320391|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56320392|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56320393|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
56320394|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320395|NCT00030732|Gemcitabine|gemcitabine|mesh-list
56320396|NCT00030732|Capecitabine|capecitabine|mesh-list
56320397|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320398|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
56320399|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320400|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320401|NCT00030732|Antiviral Agents|antiviral agents|mesh-ancestor
56320402|NCT00030732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320403|NCT00030732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320404|NCT00030732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320405|NCT00030732|Immunologic Factors|immunologic factors|mesh-ancestor
56320406|NCT00030732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320407|NCT00030810|Docetaxel|docetaxel|mesh-list
56320408|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320409|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320410|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320411|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320412|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320413|NCT00030849|Interferons|interferons|mesh-list
56907829|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56907830|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
56907831|NCT02134990|Docetaxel|docetaxel|mesh-list
56907832|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907833|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
56907834|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
56907835|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
56907836|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320414|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
56320415|NCT00030849|Bexarotene|bexarotene|mesh-list
56320416|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320417|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
56320418|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320419|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
56320420|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320421|NCT03779789|Vortioxetine|vortioxetine|mesh-list
56320422|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
56320423|NCT03779789|Citalopram|citalopram|mesh-list
56320424|NCT03779789|Fluoxetine|fluoxetine|mesh-list
56320425|NCT03779789|Paroxetine|paroxetine|mesh-list
56320426|NCT03779789|Sertraline|sertraline|mesh-list
56320430|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320431|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320432|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
56320433|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320434|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56320435|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
56320436|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56320437|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56320438|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56320439|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320440|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56320441|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56320442|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56320443|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56320444|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56320445|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56320446|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56320447|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56320448|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56320449|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56320450|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320451|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56320453|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320454|NCT00030966|Natalizumab|natalizumab|mesh-list
56320455|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
56320456|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320457|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
56320458|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56320459|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320460|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
56320461|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56320462|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56320463|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320464|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56320465|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56320466|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
56320467|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320468|NCT03698006|Ropivacaine|ropivacaine|mesh-list
56320469|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56320470|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
56320471|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
56320472|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56320473|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320474|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
56320475|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320476|NCT00031083|Interferons|interferons|mesh-list
56907838|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56907839|NCT02135224|Narcotics|narcotics|mesh-ancestor
56907840|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907841|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907842|NCT02135224|Analgesics|analgesics|mesh-ancestor
56907843|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
56320477|NCT00031083|Interferon-beta|interferon-beta|mesh-list
56320478|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320479|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
56320480|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320481|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
56320482|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320483|NCT03559985|Acetaminophen|acetaminophen|mesh-list
56320484|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56320485|NCT03559985|Analgesics|analgesics|mesh-ancestor
56320486|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
56320487|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320488|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320489|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
56320490|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
56320491|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56320492|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56320493|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56320494|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320495|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56320496|NCT04711863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55960098|NCT04047836|Nicotine|nicotine|mesh-list
56320499|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320500|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320501|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
56320502|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56320503|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
56320504|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56320506|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320507|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56320508|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
56320509|NCT00392912|Testosterone|testosterone|mesh-list
56320510|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
56320511|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
56320512|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56320513|NCT00392912|Androgens|androgens|mesh-ancestor
56320514|NCT00392912|Hormones|hormones|mesh-ancestor
56320515|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320516|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320517|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320518|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320519|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
56320520|NCT04712058|Tenofovir|tenofovir|mesh-list
56320521|NCT04712058|Emtricitabine|emtricitabine|mesh-list
56320522|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56320523|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
56320524|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320525|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56320526|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56320527|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320528|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320529|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56320530|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56320531|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
56320532|NCT00393107|Rituximab|rituximab|mesh-list
56320533|NCT00393107|Fludarabine|fludarabine|mesh-list
56320534|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320535|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
56320536|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320537|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320538|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56320539|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
56320540|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320541|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907844|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907845|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56907846|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56320542|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56320543|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56320544|NCT04711668|Lidocaine|lidocaine|mesh-list
56320545|NCT04711668|Ketamine|ketamine|mesh-list
56320546|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
56320547|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
56320548|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56320549|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320550|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
56320551|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320552|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56320553|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56320554|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56320555|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56320556|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320557|NCT04711668|Analgesics|analgesics|mesh-ancestor
56320558|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56320559|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56320560|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
56320561|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56320562|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56320563|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320564|NCT00031161|Nitisinone|nitisinone|mesh-list
56320565|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320566|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320567|NCT00031278|Trastuzumab|trastuzumab|mesh-list
56320568|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56320569|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320570|NCT00031317|Clozapine|clozapine|mesh-list
56320571|NCT00031317|Paroxetine|paroxetine|mesh-list
56320572|NCT00031317|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56320573|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56320574|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56320575|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320576|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320577|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
56320578|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320579|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56320580|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
56320581|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56320582|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56320583|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56320584|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320585|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56320586|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56320587|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56320588|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56320589|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
56320590|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
56320591|NCT00396045|Lenalidomide|lenalidomide|mesh-list
56320592|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
56320593|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320594|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56320595|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56320596|NCT00396045|Growth Substances|growth substances|mesh-ancestor
56320597|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
56320598|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320599|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56320600|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56320601|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56320602|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
56320603|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320604|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56320605|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56320606|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320607|NCT00031395|Clonidine|clonidine|mesh-list
56320608|NCT00031395|Methylphenidate|methylphenidate|mesh-list
56907847|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
56349581|NCT00084279|Ribavirin|ribavirin|mesh-list
56320609|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56320610|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320611|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56320612|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56320613|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56320614|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320615|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
56320616|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320617|NCT00031395|Analgesics|analgesics|mesh-ancestor
56320618|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
56320619|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320620|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56320621|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
56320622|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
56320623|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56320624|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56320625|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56320626|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
56320627|NCT00031434|Valganciclovir|valganciclovir|mesh-list
56320628|NCT00031434|Ganciclovir|ganciclovir|mesh-list
56320629|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56320630|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
56320631|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320632|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56320633|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320634|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320635|NCT03152123|Phentermine|phentermine|mesh-list
56320636|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56320637|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320638|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
56320639|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56320640|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
56320641|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
56320642|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320662|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
56320663|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320664|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320665|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320666|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320667|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56320668|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
56320669|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56320670|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320671|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56320672|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320673|NCT00031707|Megestrol|megestrol|mesh-list
56320674|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
56320675|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56320676|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56320677|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56320678|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
56320679|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56320680|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320681|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56320682|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56320683|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320684|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320685|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
56320686|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56320688|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
56320689|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
56320690|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320691|NCT00031785|Megestrol|megestrol|mesh-list
56320692|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
56320693|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56320694|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56320695|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56320696|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
56320697|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56320698|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320699|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56320700|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56320703|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
56320704|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56320705|NCT03151772|Metformin|metformin|mesh-list
56320706|NCT03151772|Disulfiram|disulfiram|mesh-list
56320707|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56320708|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320709|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56320710|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56320711|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320712|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320713|NCT02971644|Cobalt|cobalt|mesh-list
56320714|NCT02971644|Trace Elements|trace elements|mesh-ancestor
56320715|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
56320716|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320717|NCT00031824|Cyclosporine|cyclosporine|mesh-list
56320718|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
56320719|NCT00031824|Prednisone|prednisone|mesh-list
56320720|NCT00031824|Tacrolimus|tacrolimus|mesh-list
56320721|NCT00031824|Cyclosporins|cyclosporins|mesh-list
56320722|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56320723|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
56320724|NCT00031824|Hormones|hormones|mesh-ancestor
56108526|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
56320725|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320726|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320727|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320728|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320729|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320730|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
56320731|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56320732|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320733|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320734|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
56320735|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320736|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
56320737|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320739|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56320740|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56320741|NCT00031863|Rofecoxib|rofecoxib|mesh-list
56320742|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56320743|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56320744|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320745|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320746|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56320747|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55942627|NCT04954560|Losartan|losartan|mesh-list
56320748|NCT00031863|Analgesics|analgesics|mesh-ancestor
56320749|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
56320750|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320751|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320752|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56320754|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56320755|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
56320756|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320757|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320758|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320759|NCT00031902|Prednisolone|prednisolone|mesh-list
56320760|NCT00031902|Rituximab|rituximab|mesh-list
56320761|NCT00031902|Vincristine|vincristine|mesh-list
56320762|NCT00031902|Bleomycin|bleomycin|mesh-list
56320763|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56320764|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320765|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
56320766|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320767|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320768|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56320769|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320770|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320771|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320772|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320773|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56320774|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
56320776|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56907848|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
56907849|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
56320777|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320778|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56320779|NCT00031941|Lenalidomide|lenalidomide|mesh-list
56320780|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
56320781|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320782|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56320783|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56320784|NCT00031941|Growth Substances|growth substances|mesh-ancestor
56320785|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
56320786|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320787|NCT00031980|Cyclosporine|cyclosporine|mesh-list
56320788|NCT00031980|Cyclosporins|cyclosporins|mesh-list
56320789|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320790|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320791|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320792|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
56320793|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320794|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
56320795|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320796|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
56320797|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320798|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56320800|NCT03151499|BI 409306|bi 409306|mesh-list
56320801|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56320802|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
56320803|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56320804|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320805|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
56320806|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56320807|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320808|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320809|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56320810|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56320811|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56320812|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56320813|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56320814|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56320815|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56320817|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
56320818|NCT00032019|Rituximab|rituximab|mesh-list
56320819|NCT00032019|Doxorubicin|doxorubicin|mesh-list
56320820|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56320821|NCT00032019|Etoposide|etoposide|mesh-list
56320822|NCT00032019|Vincristine|vincristine|mesh-list
55942698|NCT04954014|Bevacizumab|bevacizumab|mesh-list
56320823|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320824|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
56320825|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320826|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320827|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56320828|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
56320829|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320830|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320831|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56320832|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56320833|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56320834|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56320835|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56320836|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320837|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56320838|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
56320839|NCT00032019|Hormones|hormones|mesh-ancestor
56320840|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320841|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320842|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56320843|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
56320844|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
56320845|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
56320846|NCT03151460|Dopamine|dopamine|mesh-list
56320847|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
56320848|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56320849|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
56907850|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56349782|NCT00084591|Capecitabine|capecitabine|mesh-list
56320862|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320864|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320865|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
56320866|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320867|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320868|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
56320869|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56320870|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56320871|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56320872|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56320873|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56320874|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
56320875|NCT00032136|Tamoxifen|tamoxifen|mesh-list
56320876|NCT00032136|Exemestane|exemestane|mesh-list
56320877|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320878|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56320879|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
56320880|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320881|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320882|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320883|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320884|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56320885|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56320886|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56320887|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56320888|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56320889|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320890|NCT03151343|Empagliflozin|empagliflozin|mesh-list
56320891|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56320892|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320893|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56320894|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320895|NCT00032175|Gemcitabine|gemcitabine|mesh-list
56320897|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320898|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
56320899|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320900|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320901|NCT00032175|Antiviral Agents|antiviral agents|mesh-ancestor
56320902|NCT00032175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320903|NCT00032175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320904|NCT00032175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320905|NCT00032175|Immunologic Factors|immunologic factors|mesh-ancestor
56320906|NCT00032175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320907|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
56320908|NCT04712279|Ivermectin|ivermectin|mesh-list
56320909|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
56320910|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55960535|NCT00353977|Vaccines|vaccines|mesh-list
56320923|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320924|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
56320925|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320926|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
56320927|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320928|NCT00032799|Natalizumab|natalizumab|mesh-list
56320929|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
56320930|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320932|NCT03150836|Tremelimumab|tremelimumab|mesh-list
56320933|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56320934|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320935|NCT00032838|Yohimbine|yohimbine|mesh-list
56320936|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
56320937|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
56320938|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320939|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320940|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56320941|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56320942|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56320943|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
56320944|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320945|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907851|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907852|NCT02785900|Azacitidine|azacitidine|mesh-list
56907853|NCT02785900|Decitabine|decitabine|mesh-list
56907854|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56907855|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
56320946|NCT00032838|Urological Agents|urological agents|mesh-ancestor
56320947|NCT03150797|Melatonin|melatonin|mesh-list
56320948|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
56320949|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320950|NCT03150797|Protective Agents|protective agents|mesh-ancestor
56320951|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320952|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56320953|NCT03150680|Clopidogrel|clopidogrel|mesh-list
56320954|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56320955|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56320956|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56320957|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56320958|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
56320959|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320960|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320961|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320962|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
56320963|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56320964|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
56320965|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320966|NCT00396396|Expectorants|expectorants|mesh-ancestor
56320967|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
56320968|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56320969|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
56320970|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320971|NCT00396396|Protective Agents|protective agents|mesh-ancestor
56320972|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320974|NCT00032955|Buprenorphine|buprenorphine|mesh-list
56320975|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56320976|NCT00032955|Naloxone|naloxone|mesh-list
56320977|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56320978|NCT00032955|Narcotics|narcotics|mesh-ancestor
56320979|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56320980|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320981|NCT00032955|Analgesics|analgesics|mesh-ancestor
56320982|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
56320983|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320984|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56320985|NCT03150524|Verapamil|verapamil|mesh-list
56320986|NCT03150524|Nimodipine|nimodipine|mesh-list
56320987|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56320988|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56320989|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56320990|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320991|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56320992|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320993|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
56320994|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56320995|NCT00033033|Reserpine|reserpine|mesh-list
56320996|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56320997|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56320998|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56320999|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321000|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321001|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321002|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56321003|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56321004|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56321005|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321006|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
56321007|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321008|NCT03150368|Docetaxel|docetaxel|mesh-list
56321009|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321010|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56321011|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56907856|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907857|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907858|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907859|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
56907860|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
56907861|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
56907862|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56907863|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907864|NCT02135770|Heparin|heparin|mesh-list
56907865|NCT02135770|Calcium heparin|calcium heparin|mesh-list
56907866|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
56321012|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56321013|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321014|NCT00033072|Selegiline|selegiline|mesh-list
56321015|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
56321016|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321017|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56321018|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56321019|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56321020|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321021|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321022|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56321023|NCT00033072|Protective Agents|protective agents|mesh-ancestor
56321024|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321025|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56321027|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321028|NCT00033111|Cabergoline|cabergoline|mesh-list
56321029|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56321030|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56321031|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
56321032|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
56321033|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321034|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321035|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321036|NCT00033189|Ubiquinone|ubiquinone|mesh-list
56321037|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
56321038|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
56321039|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321040|NCT00033189|Vitamins|vitamins|mesh-ancestor
56321041|NCT03110978|Nivolumab|nivolumab|mesh-list
56321042|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56321043|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321044|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56321045|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321047|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56321048|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321051|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
56321052|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56321053|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
56321054|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321055|NCT00033306|Irinotecan|irinotecan|mesh-list
56321056|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56321057|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56321058|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321059|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321060|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321061|NCT02984384|Aspirin|aspirin|mesh-list
56321062|NCT02984384|Heparin|heparin|mesh-list
56321063|NCT02984384|Enoxaparin|enoxaparin|mesh-list
56321064|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56321065|NCT02984384|Tinzaparin|tinzaparin|mesh-list
56321066|NCT02984384|Dalteparin|dalteparin|mesh-list
56321067|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56321068|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56321069|NCT02984384|Analgesics|analgesics|mesh-ancestor
56321070|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
56907867|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56907868|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56907869|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907870|NCT05478850|Anesthetics|anesthetics|mesh-list
56321071|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321072|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321073|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56321074|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321075|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56321076|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56321077|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321078|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56321079|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56321080|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321081|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
56321082|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
56321083|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
56321084|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56321085|NCT00033345|Protective Agents|protective agents|mesh-ancestor
56321086|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321087|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321088|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
56321089|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56321090|NCT00033423|Rituximab|rituximab|mesh-list
56321091|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56321092|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321093|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
56321094|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321095|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321096|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56321097|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321098|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56321099|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321100|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321101|NCT00393263|Clobetasol|clobetasol|mesh-list
56321102|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
56321103|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56321104|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
56321105|NCT00393263|Hormones|hormones|mesh-ancestor
56321106|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321107|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321108|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56321109|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56321110|NCT00393263|Analgesics|analgesics|mesh-ancestor
56321111|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
56321112|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321113|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321114|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
56321115|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56321116|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
56321117|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56321118|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321119|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321120|NCT00033618|Epothilones|epothilones|mesh-list
56321121|NCT00033618|Epothilone B|epothilone b|mesh-list
56321122|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
56321124|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
56321125|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321126|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321127|NCT00033696|Paclitaxel|paclitaxel|mesh-list
56321128|NCT00033696|Etoposide|etoposide|mesh-list
56321129|NCT00033696|Carboplatin|carboplatin|mesh-list
56321130|NCT00033696|Topotecan|topotecan|mesh-list
56321131|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56321132|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321133|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
56321134|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
56321135|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
56321136|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321137|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56321138|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56907871|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907872|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907873|NCT05575180|Acetazolamide|acetazolamide|mesh-list
56907874|NCT05575180|Methazolamide|methazolamide|mesh-list
56321139|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321140|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56321141|NCT02548559|Cannabidiol|cannabidiol|mesh-list
56321142|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
56321143|NCT00033735|Fluorouracil|fluorouracil|mesh-list
56321144|NCT00033735|Irofulven|irofulven|mesh-list
56321145|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
56321146|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321147|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56321148|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321149|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56321150|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
56321151|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321152|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56321153|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
56321154|NCT00033813|Oxatomide|oxatomide|mesh-list
56321155|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56321156|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
56321157|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
56321158|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321159|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321160|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321161|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56321162|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56321163|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
56321164|NCT00033891|Infliximab|infliximab|mesh-list
56321165|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
56321166|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321167|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321168|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
56321169|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
56321170|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
56321171|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56321172|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56321173|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321174|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321175|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321176|NCT02149823|Oxytocin|oxytocin|mesh-list
56321177|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
56321179|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321180|NCT02971410|Simvastatin|simvastatin|mesh-list
56321181|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56321182|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56321183|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
56321184|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321185|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56321186|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56321187|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321188|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
56321189|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56321190|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56321191|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56321192|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56321193|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321194|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
56321195|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321196|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321198|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321201|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
56321202|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56321203|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321205|NCT00034086|Lopinavir|lopinavir|mesh-list
56321206|NCT00034086|Tenofovir|tenofovir|mesh-list
56321207|NCT00034086|Lamivudine|lamivudine|mesh-list
56321208|NCT00034086|Zidovudine|zidovudine|mesh-list
56321209|NCT00034086|Didanosine|didanosine|mesh-list
56321210|NCT00034086|Stavudine|stavudine|mesh-list
56321211|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56907875|NCT05575180|Anticonvulsants|anticonvulsants|mesh-ancestor
56907876|NCT05575180|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56907877|NCT05575180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907878|NCT05575180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907879|NCT05575180|Diuretics|diuretics|mesh-ancestor
56321212|NCT00034086|Vaccines|vaccines|mesh-list
56321213|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56321214|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
56321215|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321216|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56321217|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56321218|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
56321219|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321220|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321221|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56321222|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56321223|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
56321224|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321225|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56321226|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56321227|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56321228|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56321229|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
56321230|NCT00034125|Tamoxifen|tamoxifen|mesh-list
56321231|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56321232|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
56321233|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321234|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321235|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56321236|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321237|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56321238|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56321239|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56321240|NCT00034164|Paclitaxel|paclitaxel|mesh-list
56321241|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56321242|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321243|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
56321244|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
56321245|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
56321246|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321248|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56321249|NCT00034242|Antibodies|antibodies|mesh-list
56321250|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
56321251|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56321252|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
56321253|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321254|NCT01807325|Pancrelipase|pancrelipase|mesh-list
56321255|NCT01807325|Pancreatin|pancreatin|mesh-list
56321256|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321257|NCT01807286|Dexamethasone|dexamethasone|mesh-list
56321258|NCT01807286|Melphalan|melphalan|mesh-list
56321259|NCT01807286|Pomalidomide|pomalidomide|mesh-list
56321260|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56321261|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
56321262|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
56321263|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321264|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321265|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321266|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
56321267|NCT01807286|Hormones|hormones|mesh-ancestor
56321268|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321269|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56321270|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321271|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56321272|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
56321273|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321276|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
56321277|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56321278|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56907880|NCT05575180|Natriuretic Agents|natriuretic agents|mesh-ancestor
56907881|NCT05575180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907882|NCT01560754|Nicotine|nicotine|mesh-list
56350216|NCT00085020|Lapatinib|lapatinib|mesh-list
56321279|NCT01807286|Growth Substances|growth substances|mesh-ancestor
56321280|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
56321282|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56321283|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56321284|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321285|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321287|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321288|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56321289|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56321290|NCT00034593|Gemcitabine|gemcitabine|mesh-list
56321291|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56321292|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
56321293|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321294|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321295|NCT00034593|Antiviral Agents|antiviral agents|mesh-ancestor
56321296|NCT00034593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321297|NCT00034593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321298|NCT00034593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56321299|NCT00034593|Immunologic Factors|immunologic factors|mesh-ancestor
56321300|NCT00034593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321301|NCT00034632|Posaconazole|posaconazole|mesh-list
56321302|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
56321303|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321304|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56321305|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56321306|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56321307|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56321308|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56321309|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321310|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321311|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56321312|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
56321313|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321314|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321315|NCT00034671|Posaconazole|posaconazole|mesh-list
56321316|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
56321317|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321318|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56321319|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56321320|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56321321|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56321322|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56321323|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321324|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321325|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56321326|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
56334010|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321327|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321328|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321330|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
56321331|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
56321332|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
56321333|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56321334|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56321335|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321336|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321337|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321338|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56321339|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56321340|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
56321341|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56321342|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
56321343|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55943165|NCT04843423|Cariprazine|cariprazine|mesh-list
56321352|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56907883|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56907884|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
56907885|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907886|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907887|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56907888|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56321353|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56321354|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56321355|NCT00034710|Capsaicin|capsaicin|mesh-list
56321356|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
56321357|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56321358|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
56321359|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321360|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321361|NCT00034749|Risperidone|risperidone|mesh-list
56321362|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56321363|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
56321364|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321365|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321366|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321367|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56321368|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56321369|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321370|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321371|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56321372|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
56321373|NCT00034788|Becaplermin|becaplermin|mesh-list
56321374|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
56321375|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56321376|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56321377|NCT00034788|Growth Substances|growth substances|mesh-ancestor
56321378|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321379|NCT00034866|Tipranavir|tipranavir|mesh-list
56321380|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56321381|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
56321382|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56321383|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56321384|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
56321385|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321386|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321387|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321388|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56321390|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56321391|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56321392|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
56321393|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321394|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321395|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321396|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56321397|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56321398|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321399|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321400|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56321401|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
56321402|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
56321403|NCT01806311|Amlodipine|amlodipine|mesh-list
56321404|NCT01806311|Candesartan|candesartan|mesh-list
56321405|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56321406|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56321407|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56321408|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321409|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56321410|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321426|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
56321427|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321428|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
56321429|NCT01806272|Hematinics|hematinics|mesh-ancestor
56321430|NCT00034983|Aprepitant|aprepitant|mesh-list
56321431|NCT00034983|Paroxetine|paroxetine|mesh-list
56907889|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
56907890|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350347|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56321432|NCT00034983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56321433|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56321434|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56321435|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321436|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321437|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
56321438|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321439|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56321440|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
56321441|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321442|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56321443|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56321444|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321445|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
56321446|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
56321447|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321448|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321449|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56321450|NCT00035061|Pemetrexed|pemetrexed|mesh-list
56321451|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321452|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321453|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321454|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56321455|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56321456|NCT00393497|Bevacizumab|bevacizumab|mesh-list
56321457|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56321458|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321459|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56321460|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56321461|NCT00393497|Growth Substances|growth substances|mesh-ancestor
56321462|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321463|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
56321464|NCT00035100|Epothilones|epothilones|mesh-list
56321465|NCT00035100|Epothilone B|epothilone b|mesh-list
56321466|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
56321467|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
56321468|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
56321469|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321484|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321485|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321486|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
56321487|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56321488|NCT00393614|Levetiracetam|levetiracetam|mesh-list
56321489|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
56321490|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
56321491|NCT00035256|Teriparatide|teriparatide|mesh-list
56321492|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56321493|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56321494|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321495|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56321496|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56321497|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
56321498|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321499|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56321500|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56321502|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
56321503|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
56321504|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321505|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321506|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321507|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56321508|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321509|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321510|NCT01806116|Decitabine|decitabine|mesh-list
56321511|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56321512|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
56350422|NCT00061451|Antiviral Agents|antiviral agents|mesh-ancestor
56321513|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321514|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321515|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321516|NCT00035451|Sotalol|sotalol|mesh-list
56321517|NCT00035451|Azimilide|azimilide|mesh-list
56321518|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56321519|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56321520|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
56321521|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321522|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321523|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321524|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56321525|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
56321526|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
56321527|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321529|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56321530|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56321531|NCT01805999|Psyllium|psyllium|mesh-list
56321532|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
56321533|NCT01805999|Cathartics|cathartics|mesh-ancestor
56321534|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321535|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
56321536|NCT00035490|Azimilide|azimilide|mesh-list
56321537|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56321538|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56321539|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56321540|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321541|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56321542|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321543|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
56321544|NCT00035607|Hematinics|hematinics|mesh-ancestor
56321545|NCT02971254|Sevoflurane|sevoflurane|mesh-list
56321546|NCT02971254|Desflurane|desflurane|mesh-list
56321547|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56321548|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56321549|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
56321550|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
56321551|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321552|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321554|NCT01805882|Ledipasvir|ledipasvir|mesh-list
56321555|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
56321556|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321557|NCT00035802|Topiramate|topiramate|mesh-list
56321558|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
56321559|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56321560|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321561|NCT01805804|Valsartan|valsartan|mesh-list
56321562|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56321563|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56321564|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56321565|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321566|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
56321567|NCT04732377|Bupivacaine|bupivacaine|mesh-list
56321568|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
56321569|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
56321570|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321571|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321572|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
56321573|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321574|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56321575|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56321576|NCT04732377|Analgesics|analgesics|mesh-ancestor
56321577|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56321578|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56321579|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56321580|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
56321581|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321582|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321583|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
56321585|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56321586|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321587|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321588|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56907891|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907892|NCT04768504|Tofacitinib|tofacitinib|mesh-list
56350494|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
56321589|NCT01805726|Analgesics|analgesics|mesh-ancestor
56321590|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
56321591|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321592|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56321593|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56321594|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56321595|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
56321596|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321597|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321598|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56321599|NCT01805726|Narcotics|narcotics|mesh-ancestor
56321600|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56321601|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
56321606|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56321607|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
56321608|NCT00035958|Hormones|hormones|mesh-ancestor
56321609|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321610|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321611|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56321612|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321613|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56321614|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
56321615|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56321616|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56321617|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
56321618|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321619|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
56321620|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321621|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56321622|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061734|NCT04350086|Analgesics|analgesics|mesh-ancestor
56321623|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
56321624|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321625|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56321626|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56321627|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56321629|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
56321630|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321631|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321632|NCT01805687|Zileuton|zileuton|mesh-list
56321633|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56321634|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56321635|NCT01805687|Analgesics|analgesics|mesh-ancestor
56321636|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
56321637|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321638|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321639|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56321640|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321641|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56321643|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321644|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56321645|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
56321646|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321647|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
56321648|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56321649|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321650|NCT01805570|Ticagrelor|ticagrelor|mesh-list
56321651|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56321652|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56321653|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56321654|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56321655|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56321656|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
56321657|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321658|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321659|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907893|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56907894|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350566|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
56321660|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
56321661|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56321662|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
56321663|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56321664|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
56321665|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321666|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321667|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
56321668|NCT00036114|Aripiprazole|aripiprazole|mesh-list
56321669|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
56321670|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321671|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56321672|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55961289|NCT00558519|Cytarabine|cytarabine|mesh-list
56321679|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56321680|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56321681|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
56321682|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56321683|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56321684|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56321685|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56321686|NCT01805453|Losartan|losartan|mesh-list
56321687|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56321688|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56321689|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56321690|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56321691|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321692|NCT00036153|Methotrexate|methotrexate|mesh-list
56321693|NCT00036153|Tacrolimus|tacrolimus|mesh-list
56321694|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56321695|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
56321696|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56321697|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321698|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56321699|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
56321700|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321701|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321702|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
56321703|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321704|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56321705|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56321706|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
56321707|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321708|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56321709|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56321710|NCT00036231|Secretin|secretin|mesh-list
56321711|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321712|NCT00036231|Hormones|hormones|mesh-ancestor
55943538|NCT02792257|Hormones|hormones|mesh-ancestor
56321713|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321714|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321715|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56321716|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56321717|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56321718|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56321719|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321720|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321721|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321722|NCT00036309|Analgesics|analgesics|mesh-ancestor
56321723|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
56321724|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321725|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
56321726|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321727|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
56321728|NCT00036348|Aripiprazole|aripiprazole|mesh-list
56321729|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
56321730|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321731|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56321732|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56907895|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907896|NCT03547804|Apatinib|apatinib|mesh-list
56907897|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907898|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56350642|NCT02968082|Scopolamine|scopolamine|mesh-list
56321733|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321734|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321735|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
56321736|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
55961366|NCT03023631|Vaccines|vaccines|mesh-list
56321739|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56321740|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56321741|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
56321742|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56321743|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56321744|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56321745|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56321746|NCT00036387|Infliximab|infliximab|mesh-list
56321747|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
56321748|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321749|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321750|NCT01466543|Udenafil|udenafil|mesh-list
56321751|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56321752|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56321753|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321754|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321755|NCT01466465|Vitamin D|vitamin d|mesh-list
56321756|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
56321757|NCT01466465|Vitamins|vitamins|mesh-ancestor
56321758|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
56321759|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321760|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56321761|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56321762|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
56321763|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56321764|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321765|NCT00036543|Atrasentan|atrasentan|mesh-list
56321766|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321767|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56321768|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56321769|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321771|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321772|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56321773|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
56321774|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321775|NCT00036582|Clozapine|clozapine|mesh-list
56321776|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56321777|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
56321778|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321779|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321780|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321781|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56321782|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56321783|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321784|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321785|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
56321787|NCT01466114|Norethindrone|norethindrone|mesh-list
56321788|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
56321789|NCT01466114|Progestins|progestins|mesh-list
56321790|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56321791|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56321792|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56321793|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
56321794|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56321795|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321796|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56321797|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56321798|NCT01466114|Hormones|hormones|mesh-ancestor
56321799|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321800|NCT00036777|Carboplatin|carboplatin|mesh-list
56907899|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907900|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907901|NCT02217267|Lidocaine|lidocaine|mesh-list
56321801|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56321802|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321803|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56321804|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321805|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321806|NCT01465919|Mirtazapine|mirtazapine|mesh-list
56321807|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
56321808|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321809|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55961440|NCT03127267|Riluzole|riluzole|mesh-list
56321811|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
56321812|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321813|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321814|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321815|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56321816|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56321817|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321818|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56321819|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56321820|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56321821|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
56321822|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56321824|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
56321825|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56321826|NCT00396513|Metformin|metformin|mesh-list
56321827|NCT00396513|Simvastatin|simvastatin|mesh-list
56321828|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56321829|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321830|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56321831|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56321832|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
56321833|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321834|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56321835|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56321836|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321837|NCT00036855|Rituximab|rituximab|mesh-list
56321838|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56321839|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56321840|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321841|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
56321842|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321843|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321844|NCT00036894|Lenalidomide|lenalidomide|mesh-list
56321845|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
56321846|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321847|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56321848|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56321849|NCT00036894|Growth Substances|growth substances|mesh-ancestor
56321850|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
56321851|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321852|NCT01465685|Methylphenidate|methylphenidate|mesh-list
56321853|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56321854|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56321855|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321856|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56321857|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56321858|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56321859|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321860|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
56321861|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321862|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
56321863|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321864|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
56321865|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56321866|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
56321867|NCT00037011|Antibodies|antibodies|mesh-list
56321868|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56321869|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
56907902|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
56907903|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
56907904|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907905|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321870|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321871|NCT00037050|Vancomycin|vancomycin|mesh-list
56321872|NCT00037050|Linezolid|linezolid|mesh-list
56321873|NCT00037050|Oxacillin|oxacillin|mesh-list
56321874|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
56321875|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56321876|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321877|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56321878|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321879|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321880|NCT00037089|Tegafur|tegafur|mesh-list
56321881|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56321882|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
56321883|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321885|NCT01465568|Denosumab|denosumab|mesh-list
56321886|NCT01465568|Diphosphonates|diphosphonates|mesh-list
56321887|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56321888|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321889|NCT00037206|Anidulafungin|anidulafungin|mesh-list
56321890|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
56321891|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321892|NCT01465412|Adenosine|adenosine|mesh-list
56321893|NCT01465412|Analgesics|analgesics|mesh-ancestor
56321894|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
56321895|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321896|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321897|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56321898|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
56321899|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56321900|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
56321901|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
56321902|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321903|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321904|NCT01465373|Progesterone|progesterone|mesh-list
56321905|NCT01465373|Progestins|progestins|mesh-ancestor
56321906|NCT01465373|Hormones|hormones|mesh-ancestor
56321907|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321908|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321909|NCT01465256|Aspirin|aspirin|mesh-list
56321910|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56321911|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56321912|NCT01465256|Analgesics|analgesics|mesh-ancestor
56321913|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
56321914|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321915|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321916|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56321917|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321918|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56321919|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56321920|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321921|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56321922|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56321923|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321925|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
56321926|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56321927|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321928|NCT01464983|Aspirin|aspirin|mesh-list
56321929|NCT01464983|Ibuprofen|ibuprofen|mesh-list
56321930|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56321931|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56321932|NCT01464983|Analgesics|analgesics|mesh-ancestor
56321933|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
56321934|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321935|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321936|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56321937|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321938|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56321939|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56907906|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
56907907|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907908|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56907909|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56907910|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56321940|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321941|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56321942|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56321943|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321944|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
56321945|NCT00037518|Cinacalcet|cinacalcet|mesh-list
56321946|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56321947|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321948|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56321949|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
56321950|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321951|NCT01464944|Aspirin|aspirin|mesh-list
56321952|NCT01464944|Acetaminophen|acetaminophen|mesh-list
56321953|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56321954|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56321955|NCT01464944|Analgesics|analgesics|mesh-ancestor
56321956|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
56321957|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321958|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321962|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56321963|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321964|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56321965|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56321966|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321967|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
56321968|NCT00037596|Cytarabine|cytarabine|mesh-list
56321969|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
56321970|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56321972|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321973|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321974|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
56321975|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321976|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56321977|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
56321978|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321979|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56321980|NCT00037635|Cinacalcet|cinacalcet|mesh-list
56321981|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56321982|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321983|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56321984|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
56321985|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56321986|NCT00037674|Topiramate|topiramate|mesh-list
56321987|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
56321988|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56321989|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321990|NCT00037752|Sibutramine|sibutramine|mesh-list
56321991|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
56321992|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56321993|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
56321994|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56321995|NCT01464671|Heparin|heparin|mesh-list
56321996|NCT01464671|Bivalirudin|bivalirudin|mesh-list
56321997|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
56321998|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56321999|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56322000|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322001|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
56322002|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56322003|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
56322004|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322005|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56322006|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322007|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907911|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56907912|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907913|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
56907914|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
56907915|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56350924|NCT00062036|Aldesleukin|aldesleukin|mesh-list
56322008|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322009|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56322010|NCT00393731|Misoprostol|misoprostol|mesh-list
56322011|NCT00393731|Oxytocin|oxytocin|mesh-list
56322012|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
56322013|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56322014|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322015|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56322016|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
56322017|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56322018|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56322019|NCT00038025|Pentostatin|pentostatin|mesh-list
56322020|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322021|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56322022|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322023|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322024|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
56322025|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
56322026|NCT00393770|Vitamins|vitamins|mesh-ancestor
56322027|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
56322028|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322029|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
56322030|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
56322031|NCT00038064|Hematinics|hematinics|mesh-ancestor
56322032|NCT00038181|Thalidomide|thalidomide|mesh-list
56322033|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322036|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
56322037|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56322038|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322039|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56322040|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56322041|NCT00038181|Growth Substances|growth substances|mesh-ancestor
56322042|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
56322043|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322044|NCT00038220|Ritonavir|ritonavir|mesh-list
56322045|NCT00038220|Lopinavir|lopinavir|mesh-list
56322047|NCT00038220|Lamivudine|lamivudine|mesh-list
56322048|NCT00038220|Efavirenz|efavirenz|mesh-list
56322049|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56322050|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56322051|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
56322052|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322053|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322054|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56322055|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56322056|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
56322057|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322058|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56322059|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56322060|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56322061|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56322062|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56322063|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56322064|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56322065|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56322066|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56322067|NCT00038259|Aldesleukin|aldesleukin|mesh-list
56322068|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322069|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56322070|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56322071|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
56322072|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322074|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
56322075|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56322076|NCT05433597|Cisplatin|cisplatin|mesh-list
56907916|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907917|NCT03546400|Methylphenidate|methylphenidate|mesh-list
56907918|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56322077|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322078|NCT05433480|Fulvestrant|fulvestrant|mesh-list
56322079|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56322080|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322081|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56322082|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56322083|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
56322084|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56322085|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322086|NCT00847262|Amlodipine|amlodipine|mesh-list
56322087|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56322088|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56322089|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322090|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322091|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56322092|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322094|NCT00847223|Tipifarnib|tipifarnib|mesh-list
56322095|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322096|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
56322097|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56322098|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322099|NCT00847106|Daclizumab|daclizumab|mesh-list
56322100|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322101|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
56322102|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322103|NCT00396669|Bupropion|bupropion|mesh-list
56322104|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56322105|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
56322106|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56322107|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56322108|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56322121|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56322122|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56322124|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
56322125|NCT00396747|Methotrexate|methotrexate|mesh-list
56322127|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56322128|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
56322129|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56322130|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
56322131|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56322132|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322133|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56322134|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
56322135|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322136|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322137|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
56322138|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322139|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56322140|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322141|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
56322142|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322143|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56322144|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322145|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
56322146|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
56322147|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322148|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56322149|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
56322151|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56322152|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56322153|NCT00396747|Protective Agents|protective agents|mesh-ancestor
56322154|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56322155|NCT00846950|Lorazepam|lorazepam|mesh-list
56322156|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56322157|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
56322158|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
56322159|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
56083282|NCT04289792|Paclitaxel|paclitaxel|mesh-list
56907919|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322160|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322161|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322162|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56322163|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56322164|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56322165|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56322166|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56322167|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56322168|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
56322169|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
56322170|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322171|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322173|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
56322175|NCT05432934|Dexamethasone|dexamethasone|mesh-list
56322176|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322177|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
56322178|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
56322179|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322180|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322181|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56322182|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
56322183|NCT05432934|Hormones|hormones|mesh-ancestor
56322184|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56322185|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56322186|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322187|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
56322188|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56322189|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56322190|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322191|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56322192|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56322193|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322194|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110030|NCT00005113|Sirolimus|sirolimus|mesh-list
56322196|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56322197|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
56322198|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56322199|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322200|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56322201|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56322202|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56322203|NCT00846872|Mannitol|mannitol|mesh-list
56322204|NCT00846872|Hormones|hormones|mesh-list
56322205|NCT00846872|Secretagogues|secretagogues|mesh-list
56322206|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56322207|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322208|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56322209|NCT00846872|Diuretics|diuretics|mesh-ancestor
56322210|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
56322211|NCT05432778|Letermovir|letermovir|mesh-list
56322212|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56322213|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322214|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322215|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322216|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
56322217|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322218|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
56322219|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
56322220|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322221|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
56322222|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
56322223|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56322224|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322225|NCT00846716|Pioglitazone|pioglitazone|mesh-list
56322226|NCT00846716|Biguanides|biguanides|mesh-list
56322227|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56322228|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322229|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56322230|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56322231|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322232|NCT00846677|Vitamin D|vitamin d|mesh-list
56322233|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
56351140|NCT00225043|Phenylephrine|phenylephrine|mesh-list
56322234|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
56322235|NCT00846677|Vitamins|vitamins|mesh-list
56322236|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
56322237|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322238|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56322239|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56322240|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
56322241|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322242|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
56322243|NCT05428683|Triamcinolone|triamcinolone|mesh-list
56322244|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55961870|NCT03636503|Rituximab|rituximab|mesh-list
56322247|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56322248|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322249|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322250|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322251|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322252|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322253|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
56322254|NCT05428683|Hormones|hormones|mesh-ancestor
56322255|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56322256|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56322257|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56322258|NCT00846443|Cisplatin|cisplatin|mesh-list
56322259|NCT00846443|Pemetrexed|pemetrexed|mesh-list
56322260|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322261|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322262|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322263|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56322264|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56322265|NCT05417646|Empagliflozin|empagliflozin|mesh-list
56322266|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56322267|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322268|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56322269|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322271|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56322272|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56322273|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56322274|NCT05382546|Analgesics|analgesics|mesh-ancestor
56322275|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
56322276|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322277|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322278|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322279|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322280|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56322281|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322282|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322283|NCT00846326|Fluticasone|fluticasone|mesh-list
56322285|NCT00846326|Phenylephrine|phenylephrine|mesh-list
56322286|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
56322287|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322288|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56322289|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
56322290|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322291|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322292|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56322293|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
56322294|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
56322295|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56322296|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56322297|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56322298|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
56322299|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322300|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322301|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
56322302|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
56322303|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56322304|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56322305|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
56322306|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56322307|NCT00846326|Protective Agents|protective agents|mesh-ancestor
56322308|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
56322309|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56907920|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56907921|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56907922|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351215|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
56322310|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322311|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56322312|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322313|NCT00846248|Chromium|chromium|mesh-list
56322314|NCT00846248|Trace Elements|trace elements|mesh-ancestor
56322315|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
56322316|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322317|NCT00846131|Sorafenib|sorafenib|mesh-list
56322319|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56322320|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322321|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322322|NCT05116059|Amphotericin B|amphotericin b|mesh-list
56322323|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56322324|NCT05116059|Amebicides|amebicides|mesh-ancestor
56322325|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56322326|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56322327|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322328|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56322329|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
56322331|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56322332|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322333|NCT00277082|Camptothecin|camptothecin|mesh-list
56322334|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56322335|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322336|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56322337|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56322338|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161565|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322339|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322340|NCT04888377|Aspirin|aspirin|mesh-list
56322341|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56322342|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56322343|NCT04888377|Analgesics|analgesics|mesh-ancestor
56322344|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
56322345|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322346|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322347|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322348|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322349|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56322350|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56322351|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322352|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56322353|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56322354|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322355|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
56322356|NCT00277043|Paclitaxel|paclitaxel|mesh-list
56322357|NCT00277043|Docetaxel|docetaxel|mesh-list
56322359|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56322360|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322361|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
56322362|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
56322363|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
56322364|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322365|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
56322366|NCT00276965|Sertraline|sertraline|mesh-list
56322367|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
56322368|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56322369|NCT00276965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56322370|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56322371|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322372|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322373|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322374|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
56322375|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322376|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322377|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
56907923|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907924|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
56907925|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56907926|NCT03669861|Abatacept|abatacept|mesh-list
56351294|NCT00225667|Irbesartan|irbesartan|mesh-list
56322378|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56322379|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56322380|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
56322381|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322382|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56322383|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322384|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322386|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
56322387|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56322388|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
56322389|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56322390|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
56322391|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744171|NCT03120403|Morphine|morphine|mesh-list
56322395|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56322397|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
56322398|NCT00276848|Fludarabine|fludarabine|mesh-list
56322399|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
56322400|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322401|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
56322402|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322403|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322404|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56322405|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
56322406|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322407|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322408|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56322409|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56322410|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
56322411|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
56322412|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322413|NCT00276809|Cytarabine|cytarabine|mesh-list
56322414|NCT00276809|Dexamethasone|dexamethasone|mesh-list
56322415|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
56322416|NCT00276809|Melphalan|melphalan|mesh-list
56322417|NCT00276809|Carmustine|carmustine|mesh-list
56322418|NCT00276809|Fludarabine|fludarabine|mesh-list
56322419|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
56322420|NCT00276809|Etoposide|etoposide|mesh-list
56322421|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
56322422|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322423|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
56322424|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322425|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322426|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56322427|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
56322428|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322429|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322430|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56322431|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322432|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
56322433|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
56322434|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322435|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56322436|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
56322437|NCT00276809|Hormones|hormones|mesh-ancestor
56322438|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56322439|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56322440|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56322441|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
56322442|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56322443|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56322444|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56322445|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322446|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
56322447|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322448|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56907927|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56907928|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907929|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907930|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56907931|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
56351357|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
56322450|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
56322451|NCT00276770|Protective Agents|protective agents|mesh-ancestor
56322452|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322453|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
56322454|NCT00276731|Carboplatin|carboplatin|mesh-list
56322455|NCT00276731|Etoposide|etoposide|mesh-list
56322456|NCT00276731|Vincristine|vincristine|mesh-list
56322457|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322458|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
56322459|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322460|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322461|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56322462|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
56322463|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322464|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322465|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56322466|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56322470|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
56322471|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
56322472|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
56322473|NCT00276692|Irinotecan|irinotecan|mesh-list
56322474|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56322475|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56322476|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322477|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322478|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322479|NCT00276575|Bevacizumab|bevacizumab|mesh-list
56322480|NCT00276575|Everolimus|everolimus|mesh-list
56322481|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56322482|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56322483|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322484|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56322485|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56322486|NCT00276575|Growth Substances|growth substances|mesh-ancestor
56322487|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322488|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
56322489|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322490|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
56322491|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56322492|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322493|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322494|NCT00276536|Interferons|interferons|mesh-list
56322495|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
56322496|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56322497|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322498|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
56322499|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322500|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
56322501|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322502|NCT00276497|Pioglitazone|pioglitazone|mesh-list
56322503|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56322504|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322505|NCT04430790|Doxapram|doxapram|mesh-list
56322506|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56322507|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322508|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56322509|NCT04393389|Paclitaxel|paclitaxel|mesh-list
56322510|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56322511|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322512|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
56322513|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
56322514|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
56322515|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907932|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907933|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56907934|NCT00127127|Vorinostat|vorinostat|mesh-list
56907935|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351425|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56322516|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
56322517|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322518|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56322519|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322520|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322521|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
56322522|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56322524|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322525|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
56322526|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322527|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322528|NCT00276146|Dipyridamole|dipyridamole|mesh-list
56322529|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56322530|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322531|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322532|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56322533|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
56322534|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56322535|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
56322536|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322537|NCT04201665|Oxytocin|oxytocin|mesh-list
56322538|NCT04201665|Carbetocin|carbetocin|mesh-list
56322539|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
56322552|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56322553|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322554|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322555|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56322556|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
56322557|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56322558|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322559|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56322560|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56322561|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
56322562|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322563|NCT00276029|Etanercept|etanercept|mesh-list
56322564|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56322565|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56322566|NCT00276029|Analgesics|analgesics|mesh-ancestor
56322567|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
56322568|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322569|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322570|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322571|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322572|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56322573|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322574|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
56322575|NCT00397059|Citalopram|citalopram|mesh-list
56322576|NCT00397059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56322577|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56322578|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322579|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322580|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322581|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
56322582|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322583|NCT00397059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56322584|NCT00397059|Antidepressive Agents|antidepressive agents|mesh-ancestor
56322585|NCT00397059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56322586|NCT04149210|Fluorometholone|fluorometholone|mesh-list
56322587|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
56322588|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56322589|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56322590|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322591|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
56322592|NCT04149210|Hormones|hormones|mesh-ancestor
56907936|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56907937|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907938|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907939|NCT00126659|Sorafenib|sorafenib|mesh-list
56907940|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56907941|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56907942|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907943|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907944|NCT03669081|Ketorolac|ketorolac|mesh-list
56322593|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56322594|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322595|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56322596|NCT00275951|Cetuximab|cetuximab|mesh-list
56322597|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56322598|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322599|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
56322600|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
55962235|NCT00384865|Aspirin|aspirin|mesh-list
56322601|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56322603|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322604|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322605|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56322606|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56322607|NCT00397098|Amibegron|amibegron|mesh-list
56322608|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56322609|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56322610|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
55944444|NCT01378377|Vitamins|vitamins|mesh-ancestor
56322611|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322612|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322613|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322615|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
56322616|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56322617|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322618|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322619|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56322620|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322621|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56322622|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56322623|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56322624|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322625|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322626|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322627|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322628|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
56322629|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56322630|NCT04061421|Decitabine|decitabine|mesh-list
56322631|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56322632|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
56089236|NCT03002012|Sertraline|sertraline|mesh-list
56322633|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322634|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322635|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322636|NCT00275756|Timolol|timolol|mesh-list
56322637|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56322638|NCT00275756|Dorzolamide|dorzolamide|mesh-list
56322639|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56322640|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56322641|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
56322642|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322643|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322644|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907945|NCT03669081|Pregabalin|pregabalin|mesh-list
56907946|NCT03669081|Analgesics|analgesics|mesh-ancestor
56907947|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
56907948|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322645|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56322646|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56322647|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56322648|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56322649|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56322650|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56322651|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322652|NCT00275639|Losartan|losartan|mesh-list
56322653|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56322654|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56322655|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56322656|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56322657|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322658|NCT03957057|Iron|iron|mesh-list
56322659|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56322660|NCT03957057|Trace Elements|trace elements|mesh-ancestor
56322661|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
56322662|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322663|NCT03957057|Hematinics|hematinics|mesh-ancestor
56322664|NCT00275600|Vitamin E|vitamin e|mesh-list
56322665|NCT00275600|Vitamins|vitamins|mesh-ancestor
56322666|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
56322667|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322669|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322670|NCT00275600|Protective Agents|protective agents|mesh-ancestor
56322671|NCT00275522|Sirolimus|sirolimus|mesh-list
56322672|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56322675|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322676|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
56322677|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322678|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
56322679|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322680|NCT03828201|Levofloxacin|levofloxacin|mesh-list
56322681|NCT03828201|Ofloxacin|ofloxacin|mesh-list
56322682|NCT03828201|Linezolid|linezolid|mesh-list
56322683|NCT03828201|Bedaquiline|bedaquiline|mesh-list
56322684|NCT03828201|Clofazimine|clofazimine|mesh-list
56322685|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56322686|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322687|NCT03828201|Renal Agents|renal agents|mesh-ancestor
56322688|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56322689|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56322690|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56322691|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322692|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322693|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322694|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56322695|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56322696|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56322697|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
56322698|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322699|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
56322700|NCT00275444|Tipranavir|tipranavir|mesh-list
56322701|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56322702|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56322703|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
56322704|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322705|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
56322706|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
56322707|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322708|NCT00275405|Protective Agents|protective agents|mesh-ancestor
56322709|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322710|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56322711|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322712|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56322713|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322714|NCT03533946|Rucaparib|rucaparib|mesh-list
56322715|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56322716|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907949|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907950|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
56907951|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56907952|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56907953|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907954|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56907955|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56907956|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56907957|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56907958|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56907959|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56907960|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56351635|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
56322717|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322718|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322719|NCT00275249|Levorphanol|levorphanol|mesh-list
56322720|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56322721|NCT00275249|Narcotics|narcotics|mesh-ancestor
56322722|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56322723|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322724|NCT00275249|Analgesics|analgesics|mesh-ancestor
56322725|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
56322726|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322727|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
56322728|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322729|NCT00041535|Miglustat|miglustat|mesh-list
56322730|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322731|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322732|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56322733|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56322734|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
56322735|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322736|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56322737|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56322738|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322739|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
56322740|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56322741|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
56322742|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334011|NCT00064857|Pycnogenols|pycnogenols|mesh-list
56322743|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322744|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56322745|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
56322748|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322749|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322750|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56322751|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
56322752|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
56322753|NCT00041574|Protective Agents|protective agents|mesh-ancestor
56322754|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56322755|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322756|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56322757|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322758|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322760|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56322761|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322762|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56322763|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322764|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
56351696|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56322765|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322766|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
56322767|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322768|NCT00041652|Labetuzumab|labetuzumab|mesh-list
56322769|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56322770|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322771|NCT03430596|Pramipexole|pramipexole|mesh-list
56322772|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
56322773|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
56322774|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322775|NCT03430596|Protective Agents|protective agents|mesh-ancestor
56322776|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322777|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56322778|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56322779|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
56322780|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
56322781|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322782|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56322783|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56322784|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
56322785|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
56322787|NCT00275054|Fludarabine|fludarabine|mesh-list
56322788|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322789|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
56322790|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322791|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322792|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56322793|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
56322794|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322795|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322796|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56322797|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56322798|NCT03208179|Azithromycin|azithromycin|mesh-list
56322799|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
56322800|NCT03208179|Piperaquine|piperaquine|mesh-list
56322801|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
56322802|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56322803|NCT03208179|Artenimol|artenimol|mesh-list
56322804|NCT03208179|Artemisinins|artemisinins|mesh-list
56322805|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56322806|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322807|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
56322808|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56322809|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56322810|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56322811|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322812|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322813|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56322814|NCT03208179|Renal Agents|renal agents|mesh-ancestor
56322815|NCT00275015|Cytarabine|cytarabine|mesh-list
56322816|NCT00275015|Dexamethasone|dexamethasone|mesh-list
56322817|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
56322818|NCT00275015|Melphalan|melphalan|mesh-list
56322819|NCT00275015|Carmustine|carmustine|mesh-list
56322820|NCT00275015|Fludarabine|fludarabine|mesh-list
56322822|NCT00275015|Etoposide|etoposide|mesh-list
56322823|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322824|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
56322826|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322827|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56322828|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
56322829|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322830|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322831|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56322832|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322833|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
56322834|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
56322835|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322836|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56322837|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
56322838|NCT00275015|Hormones|hormones|mesh-ancestor
56322839|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56322840|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56322841|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56322842|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
56907961|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56907962|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322843|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56322844|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56322845|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56322846|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322847|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
56322848|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322849|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
56322850|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56322851|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322852|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
56322853|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56322854|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322855|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322856|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56322857|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322858|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56322859|NCT03062826|Aspirin|aspirin|mesh-list
56322860|NCT03062826|Clopidogrel|clopidogrel|mesh-list
56322861|NCT03062826|Ticagrelor|ticagrelor|mesh-list
56322862|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56322863|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56322864|NCT03062826|Analgesics|analgesics|mesh-ancestor
56322865|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
56322866|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322867|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322868|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322869|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322870|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56322871|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56322872|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322873|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56322874|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56322875|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322876|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
56322877|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56322878|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56322879|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56322880|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
56322881|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322882|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
56322883|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56322884|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56322885|NCT00130364|Analgesics|analgesics|mesh-ancestor
56322886|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
56322887|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322888|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322889|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56322890|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322891|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
56322892|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322893|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
56322895|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322896|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322897|NCT00130325|Isoniazid|isoniazid|mesh-list
56322901|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56322902|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56322904|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322905|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56322906|NCT00041691|Labetuzumab|labetuzumab|mesh-list
56322907|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56322908|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322909|NCT00394394|Enalapril|enalapril|mesh-list
56322910|NCT00394394|Amiloride|amiloride|mesh-list
56322911|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56322912|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
56322913|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322914|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322915|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56322916|NCT00394394|Diuretics|diuretics|mesh-ancestor
56322917|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
56907963|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56907964|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907965|NCT02253940|Ritonavir|ritonavir|mesh-list
56322918|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322919|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56322920|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56322921|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322922|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56322923|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56322924|NCT00130091|Clonidine|clonidine|mesh-list
56322925|NCT00130091|Analgesics|analgesics|mesh-ancestor
56322926|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
56322927|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322928|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322929|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56322930|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
56322931|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
56161573|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
56322932|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56322934|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56322935|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
56322936|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322937|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322938|NCT00130013|Amoxicillin|amoxicillin|mesh-list
56322939|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56322940|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322942|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56322943|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
56322944|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
56322945|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322946|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322947|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56322948|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56322949|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56322950|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322951|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322952|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56322953|NCT00129857|Protective Agents|protective agents|mesh-ancestor
56322954|NCT00129818|Famciclovir|famciclovir|mesh-list
56322955|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
56322956|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322957|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56322958|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322959|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322960|NCT00129506|Methotrexate|methotrexate|mesh-list
56322961|NCT00129506|Misoprostol|misoprostol|mesh-list
56322962|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56322963|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
56322964|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56322965|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322966|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56322967|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
56322968|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322970|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
56322971|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322972|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56322973|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56322974|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
56322975|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56322976|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56322977|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56322978|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56322980|NCT00129233|Amlodipine|amlodipine|mesh-list
56322981|NCT00129233|Valsartan|valsartan|mesh-list
56322982|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56322983|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56322984|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322985|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322986|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56322987|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322988|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
56907966|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56907967|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56322989|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56322990|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56322991|NCT00129155|Treosulfan|treosulfan|mesh-list
56322992|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56322993|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
56322994|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322995|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322996|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
56322997|NCT00712881|Docetaxel|docetaxel|mesh-list
56322998|NCT00712881|Doxorubicin|doxorubicin|mesh-list
56322999|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56323000|NCT00712881|Trastuzumab|trastuzumab|mesh-list
56323001|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323002|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
56323003|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323004|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323005|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56323007|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323008|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323009|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56323010|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
56323011|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
56323012|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
56323013|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56323014|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56323015|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56323016|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323017|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323018|NCT00042003|Decitabine|decitabine|mesh-list
56323019|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56323020|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
56323021|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323022|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323023|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323024|NCT00129038|Aspirin|aspirin|mesh-list
56323025|NCT00129038|Dipyridamole|dipyridamole|mesh-list
56323026|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56323027|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56323028|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56323029|NCT00129038|Analgesics|analgesics|mesh-ancestor
56323030|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
56323031|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323032|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323033|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56323034|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323035|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56323036|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56323037|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323038|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56323039|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56323040|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323041|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
55962651|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
56323052|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56323054|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323055|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323056|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56323057|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
56323058|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56323059|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323060|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56323061|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
56323062|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
56323063|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56323064|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323065|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
56323066|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323067|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56323068|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56907968|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
56907969|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56907970|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907971|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56907972|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56323069|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56323070|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
56323071|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56323072|NCT00103389|Docetaxel|docetaxel|mesh-list
56323073|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323074|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
56323075|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
56323076|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
56323077|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323078|NCT00128921|Bortezomib|bortezomib|mesh-list
56323079|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323080|NCT00128804|Beta Carotene|beta carotene|mesh-list
56323081|NCT00128804|Carotenoids|carotenoids|mesh-list
56323082|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
56323083|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323084|NCT00128804|Protective Agents|protective agents|mesh-ancestor
56323085|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323086|NCT00128804|Provitamins|provitamins|mesh-ancestor
56323087|NCT00128804|Vitamins|vitamins|mesh-ancestor
56323088|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
56323089|NCT00097851|Docetaxel|docetaxel|mesh-list
56323090|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323091|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
56323092|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
56323093|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
56323094|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323095|NCT00038376|Interferons|interferons|mesh-list
56323096|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
56323097|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
56323098|NCT00038376|Isotretinoin|isotretinoin|mesh-list
56323099|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323100|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
56323101|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323102|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
56323103|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323104|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
56323105|NCT00128531|Leuprolide|leuprolide|mesh-list
56323106|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56323107|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
56323108|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55962726|NCT00448357|Methotrexate|methotrexate|mesh-list
56323111|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323112|NCT00038454|Chrysarobin|chrysarobin|mesh-list
56323113|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56323114|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56323115|NCT00038454|Analgesics|analgesics|mesh-ancestor
56323116|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
56323117|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323118|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323122|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
56323123|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323124|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
56323125|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
56323126|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
56323127|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323128|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323129|NCT00128414|Colchicine|colchicine|mesh-list
56323130|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
56323131|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323132|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
56323133|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
56323134|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
56323135|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323136|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323137|NCT00038493|Temozolomide|temozolomide|mesh-list
56323138|NCT00038493|Lonafarnib|lonafarnib|mesh-list
56323139|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56323140|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
56907973|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
56907974|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907975|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56907976|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56907977|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
56323141|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323142|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323143|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323144|NCT00038532|Ritonavir|ritonavir|mesh-list
56323145|NCT00038532|Saquinavir|saquinavir|mesh-list
56323146|NCT00038532|Amprenavir|amprenavir|mesh-list
56323147|NCT00038532|Efavirenz|efavirenz|mesh-list
56323148|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56323149|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56323150|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
56323151|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323152|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323153|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56323154|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56323155|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
56323156|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323157|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56323158|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56323159|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56323160|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56323161|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56323162|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56323163|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56323164|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56323165|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56323166|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56323167|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
56323168|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56323169|NCT00038571|Bortezomib|bortezomib|mesh-list
56323170|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323174|NCT05770687|Dapagliflozin|dapagliflozin|mesh-list
56323175|NCT05770687|Empagliflozin|empagliflozin|mesh-list
56323176|NCT05770687|Ertugliflozin|ertugliflozin|mesh-list
56323177|NCT05770687|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56323178|NCT05770687|Ipragliflozin|ipragliflozin|mesh-list
56323179|NCT05770687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323180|NCT05770687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56323181|NCT05770687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323186|NCT05770375|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56323187|NCT05770375|Hallucinogens|hallucinogens|mesh-ancestor
56323188|NCT05770375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323189|NCT05770375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56323190|NCT05770375|Serotonin Agents|serotonin agents|mesh-ancestor
56323197|NCT05770323|Uric Acid|uric acid|mesh-list
56323198|NCT05770323|Antioxidants|antioxidants|mesh-ancestor
56323199|NCT05770323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323200|NCT05770323|Protective Agents|protective agents|mesh-ancestor
56323201|NCT05770323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323207|NCT05770102|Atezolizumab|atezolizumab|mesh-list
56323208|NCT05770102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323209|NCT05769920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55945047|NCT01335789|Oxytocin|oxytocin|mesh-list
56323210|NCT05769920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56323211|NCT05769881|Anesthetics|anesthetics|mesh-list
56323212|NCT05769881|Anesthetics, Local|anesthetics, local|mesh-list
56323213|NCT05769881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323214|NCT05769881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323215|NCT05769881|Sensory System Agents|sensory system agents|mesh-ancestor
56323216|NCT05769881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323217|NCT05769855|Ropivacaine|ropivacaine|mesh-list
56323218|NCT05769855|Anesthetics, Local|anesthetics, local|mesh-ancestor
56323219|NCT05769855|Anesthetics|anesthetics|mesh-ancestor
56323220|NCT05769855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323221|NCT05769855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323222|NCT05769855|Sensory System Agents|sensory system agents|mesh-ancestor
56907978|NCT02253550|Simeprevir|simeprevir|mesh-list
56907979|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
56907980|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56907981|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
56323223|NCT05769855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323224|NCT05769816|Antibodies|antibodies|mesh-list
56323225|NCT05769816|Immunologic Factors|immunologic factors|mesh-ancestor
56323226|NCT05769816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323227|NCT05769738|Furosemide|furosemide|mesh-list
56323228|NCT05769738|Diuretics|diuretics|mesh-list
56323229|NCT05769738|Natriuretic Agents|natriuretic agents|mesh-ancestor
56323230|NCT05769738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323231|NCT05769738|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56323232|NCT05769738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56323233|NCT05769738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323234|NCT05769725|Docetaxel|docetaxel|mesh-list
56323235|NCT05769725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323236|NCT05769725|Tubulin Modulators|tubulin modulators|mesh-ancestor
56323237|NCT05769725|Antimitotic Agents|antimitotic agents|mesh-ancestor
56323238|NCT05769725|Mitosis Modulators|mitosis modulators|mesh-ancestor
56323239|NCT05769725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323240|NCT05769660|Temozolomide|temozolomide|mesh-list
56323241|NCT05769660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56323242|NCT05769660|Alkylating Agents|alkylating agents|mesh-ancestor
56323243|NCT05769660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323244|NCT05769660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323245|NCT05769569|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56323246|NCT05769569|Antiviral Agents|antiviral agents|mesh-ancestor
56323247|NCT05769569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323248|NCT05769530|Dexmedetomidine|dexmedetomidine|mesh-list
56323249|NCT05769530|Nalbuphine|nalbuphine|mesh-list
56323250|NCT05769530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56323251|NCT05769530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323252|NCT05769530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323253|NCT05769530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56323254|NCT05769530|Analgesics|analgesics|mesh-ancestor
56323255|NCT05769530|Sensory System Agents|sensory system agents|mesh-ancestor
56323256|NCT05769530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323257|NCT05769530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56323258|NCT05769530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56323259|NCT05769530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56323260|NCT05769530|Adrenergic Agents|adrenergic agents|mesh-ancestor
56323261|NCT05769530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56323262|NCT05769530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323263|NCT05769530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56323264|NCT05769530|Narcotics|narcotics|mesh-ancestor
56323265|NCT05769478|Amifampridine|amifampridine|mesh-list
56323266|NCT05769478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55962865|NCT00450463|Metronidazole|metronidazole|mesh-list
56323268|NCT05769478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323270|NCT05769478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56323271|NCT05769478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323273|NCT05769309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56323274|NCT05769309|Narcotics|narcotics|mesh-ancestor
56323275|NCT05769309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323276|NCT05769309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323277|NCT05769309|Analgesics|analgesics|mesh-ancestor
56323278|NCT05769309|Sensory System Agents|sensory system agents|mesh-ancestor
56323279|NCT05769309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323280|NCT05769309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56323281|NCT05769309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56323282|NCT05769309|Anesthetics, General|anesthetics, general|mesh-ancestor
56323283|NCT05769309|Anesthetics|anesthetics|mesh-ancestor
56323284|NCT05769153|Aflibercept|aflibercept|mesh-list
56323285|NCT05769153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56323286|NCT05769153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56323287|NCT05769153|Growth Substances|growth substances|mesh-ancestor
56323288|NCT05769153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323289|NCT05769153|Growth Inhibitors|growth inhibitors|mesh-ancestor
56323290|NCT05769153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323291|NCT05769049|Vaccines|vaccines|mesh-list
56323292|NCT05769049|Immunologic Factors|immunologic factors|mesh-ancestor
56907982|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618638|NCT00623779|Aspirin|aspirin|mesh-list
56907983|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56907984|NCT05203432|Atropine|atropine|mesh-list
56323293|NCT05769049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323294|NCT05769010|Bevacizumab|bevacizumab|mesh-list
56323295|NCT05769010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323296|NCT05769010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323297|NCT05769010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56323298|NCT05769010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56323299|NCT05769010|Growth Substances|growth substances|mesh-ancestor
56323300|NCT05769010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323301|NCT05769010|Growth Inhibitors|growth inhibitors|mesh-ancestor
56323302|NCT05768997|Darbepoetin alfa|darbepoetin alfa|mesh-list
56323303|NCT05768997|Hematinics|hematinics|mesh-ancestor
56323304|NCT05768945|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56323305|NCT05768945|Protease Inhibitors|protease inhibitors|mesh-ancestor
56323306|NCT05768945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323307|NCT05768945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323308|NCT05768945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56323309|NCT05768945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323310|NCT05765305|Chromium|chromium|mesh-list
56323311|NCT05765305|Letrozole|letrozole|mesh-list
56323312|NCT05765305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323314|NCT05765305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56323315|NCT05765305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323316|NCT05765305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323317|NCT05765305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56323318|NCT05765305|Hormone Antagonists|hormone antagonists|mesh-ancestor
56323319|NCT05765305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56323320|NCT05765305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323321|NCT05765305|Trace Elements|trace elements|mesh-ancestor
56323322|NCT05765305|Micronutrients|micronutrients|mesh-ancestor
56323323|NCT05765227|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56323324|NCT05765227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56323325|NCT05765227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323326|NCT05762146|Perphenazine|perphenazine|mesh-list
56323327|NCT05762146|Riociguat|riociguat|mesh-list
56323328|NCT05762146|Propylthiouracil|propylthiouracil|mesh-list
56323329|NCT05762146|Enzyme Activators|enzyme activators|mesh-ancestor
56323330|NCT05762146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323331|NCT05762146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56323332|NCT05762146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56323333|NCT05762146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323334|NCT05762146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323335|NCT05762146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56323336|NCT05762146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56323337|NCT05762146|Dopamine Agents|dopamine agents|mesh-ancestor
56323338|NCT05762146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56323339|NCT05762146|Antimetabolites|antimetabolites|mesh-ancestor
56323340|NCT05762146|Antithyroid Agents|antithyroid agents|mesh-ancestor
56323341|NCT05762146|Hormone Antagonists|hormone antagonists|mesh-ancestor
56334012|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56323349|NCT05760144|Contraceptive Agents|contraceptive agents|mesh-ancestor
56323350|NCT05760144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56323351|NCT05760144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323352|NCT05760144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56323353|NCT05760144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56323354|NCT05760144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56323355|NCT05760144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323357|NCT05744674|Anesthetics, Local|anesthetics, local|mesh-ancestor
56323358|NCT05744674|Anesthetics|anesthetics|mesh-ancestor
56323359|NCT05744674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323360|NCT05744674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323361|NCT05744674|Sensory System Agents|sensory system agents|mesh-ancestor
56323362|NCT05744674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323363|NCT05742594|Lazertinib|lazertinib|mesh-list
56323364|NCT05742594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56323365|NCT05742594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323366|NCT05742594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323367|NCT05736978|Azacitidine|azacitidine|mesh-list
56907985|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56907986|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56907987|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56907988|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
56907989|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56907990|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56907991|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56907992|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
56907993|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
56907994|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
56907995|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56907996|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56907997|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
56907998|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56907999|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908000|NCT03667053|Glucagon|glucagon|mesh-list
56908001|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908002|NCT03667053|Hormones|hormones|mesh-ancestor
56908003|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908004|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908005|NCT04589728|Venetoclax|venetoclax|mesh-list
56908006|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908007|NCT05557240|Poly I-C|poly i-c|mesh-list
56908008|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56908009|NCT05557240|Vaccines|vaccines|mesh-list
56908010|NCT05557240|Poly ICLC|poly iclc|mesh-list
56908011|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
56908012|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908013|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
56908014|NCT05557240|Laxatives|laxatives|mesh-ancestor
56908015|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908016|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
56908017|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908018|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
56323368|NCT05736978|Venetoclax|venetoclax|mesh-list
56323369|NCT05736978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56323370|NCT05736978|Antimetabolites|antimetabolites|mesh-ancestor
56323371|NCT05736978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323372|NCT05736978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323373|NCT05736978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323374|NCT05736965|Azacitidine|azacitidine|mesh-list
56323375|NCT05736965|Venetoclax|venetoclax|mesh-list
56323376|NCT05736965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56323377|NCT05736965|Antimetabolites|antimetabolites|mesh-ancestor
56908019|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56908020|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908021|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
56908022|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56908023|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908024|NCT03547024|Midazolam|midazolam|mesh-list
56908025|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
56323378|NCT05736965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323379|NCT05736965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323380|NCT05736965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323381|NCT05706727|Phenylephrine|phenylephrine|mesh-list
56323382|NCT05706727|Oxymetazoline|oxymetazoline|mesh-list
56323383|NCT05706727|Mephentermine|mephentermine|mesh-list
56323384|NCT05706727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56323385|NCT05706727|Mydriatics|mydriatics|mesh-ancestor
56323386|NCT05706727|Autonomic Agents|autonomic agents|mesh-ancestor
56165398|NCT00002880|Etoposide|etoposide|mesh-list
56323387|NCT05706727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323388|NCT05706727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323389|NCT05706727|Sympathomimetics|sympathomimetics|mesh-ancestor
56323390|NCT05706727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56323391|NCT05706727|Nasal Decongestants|nasal decongestants|mesh-ancestor
56323392|NCT05706727|Respiratory System Agents|respiratory system agents|mesh-ancestor
56323393|NCT05706727|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56323394|NCT05706727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56323395|NCT05706727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56323396|NCT05706727|Adrenergic Agents|adrenergic agents|mesh-ancestor
56323397|NCT05706727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56323398|NCT05706727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323399|NCT05706727|Protective Agents|protective agents|mesh-ancestor
56323407|NCT05697783|Fentanyl|fentanyl|mesh-list
56323408|NCT05697783|Methadone|methadone|mesh-list
56323409|NCT05697783|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56323410|NCT05697783|Narcotics|narcotics|mesh-ancestor
56323411|NCT05697783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323412|NCT05697783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323413|NCT05697783|Analgesics|analgesics|mesh-ancestor
56323414|NCT05697783|Sensory System Agents|sensory system agents|mesh-ancestor
56323415|NCT05697783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323416|NCT05697783|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56323429|NCT05672225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323430|NCT05672225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56323432|NCT05672225|Sensory System Agents|sensory system agents|mesh-ancestor
56323433|NCT05672225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323434|NCT05672225|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56323435|NCT05672225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56323436|NCT05672225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56323437|NCT05672225|Adrenergic Agents|adrenergic agents|mesh-ancestor
56323438|NCT05672225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56323439|NCT05672225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323440|NCT05664789|Acetylcysteine|acetylcysteine|mesh-list
56323441|NCT05664789|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56323442|NCT05664789|Antiviral Agents|antiviral agents|mesh-ancestor
56323443|NCT05664789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323444|NCT05664789|Expectorants|expectorants|mesh-ancestor
56323445|NCT05664789|Respiratory System Agents|respiratory system agents|mesh-ancestor
56323446|NCT05664789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56323447|NCT05664789|Antioxidants|antioxidants|mesh-ancestor
56323448|NCT05664789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323449|NCT05664789|Protective Agents|protective agents|mesh-ancestor
56323450|NCT05664789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323451|NCT05664789|Antidotes|antidotes|mesh-ancestor
56323452|NCT05663580|Rilpivirine|rilpivirine|mesh-list
56323453|NCT05663580|Cabotegravir|cabotegravir|mesh-list
56323454|NCT05663580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56323455|NCT05663580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56323456|NCT05663580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323457|NCT05663580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323458|NCT05663580|Antiviral Agents|antiviral agents|mesh-ancestor
56908026|NCT03547024|Omeprazole|omeprazole|mesh-list
56908027|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
56908028|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56908029|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56352450|NCT00232531|Niacin|niacin|mesh-list
56323459|NCT05663580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323460|NCT05663580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56323461|NCT05663580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56323462|NCT05663580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56323463|NCT05663580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56323464|NCT05663411|Cinacalcet|cinacalcet|mesh-list
56323465|NCT05663411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56323466|NCT05663411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323467|NCT05663411|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56323468|NCT05663411|Hormone Antagonists|hormone antagonists|mesh-ancestor
56323469|NCT05663411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56323470|NCT05657860|Guanfacine|guanfacine|mesh-list
56323471|NCT05657860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56323472|NCT05657860|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56323473|NCT05657860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56323474|NCT05657860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56323475|NCT05657860|Adrenergic Agents|adrenergic agents|mesh-ancestor
56323476|NCT05657860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56323477|NCT05657860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323478|NCT05657860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323482|NCT05654623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56323483|NCT05654623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56323484|NCT05654623|Hormone Antagonists|hormone antagonists|mesh-ancestor
56323485|NCT05654623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56323486|NCT05654623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323487|NCT05653427|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56323488|NCT05653427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323489|NCT05653427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323490|NCT05642962|Pancrelipase|pancrelipase|mesh-list
56323492|NCT05633615|Cyclophosphamide|cyclophosphamide|mesh-list
56323493|NCT05633615|Fludarabine|fludarabine|mesh-list
56323495|NCT05633615|Immunoglobulins|immunoglobulins|mesh-list
56323496|NCT05633615|Immunoconjugates|immunoconjugates|mesh-list
56323497|NCT05633615|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56323498|NCT05633615|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56323499|NCT05633615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323500|NCT05633615|Immunologic Factors|immunologic factors|mesh-ancestor
56323501|NCT05633615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323502|NCT05633615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323503|NCT05633615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56323504|NCT05633615|Alkylating Agents|alkylating agents|mesh-ancestor
56323505|NCT05633615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323506|NCT05633615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323507|NCT05633615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56323513|NCT05619627|Dexmedetomidine|dexmedetomidine|mesh-list
56323514|NCT05619627|Anesthetics|anesthetics|mesh-list
56323515|NCT05619627|Anesthetics, General|anesthetics, general|mesh-list
56323516|NCT05619627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56323517|NCT05619627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323518|NCT05619627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323519|NCT05619627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56323520|NCT05619627|Analgesics|analgesics|mesh-ancestor
56323521|NCT05619627|Sensory System Agents|sensory system agents|mesh-ancestor
56323522|NCT05619627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323523|NCT05619627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56323524|NCT05619627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56323525|NCT05619627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56323526|NCT05619627|Adrenergic Agents|adrenergic agents|mesh-ancestor
56323527|NCT05619627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56323528|NCT05619627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323529|NCT05615818|Gemcitabine|gemcitabine|mesh-list
56323530|NCT05615818|Trastuzumab|trastuzumab|mesh-list
56323531|NCT05615818|Niraparib|niraparib|mesh-list
56323532|NCT05615818|Ivosidenib|ivosidenib|mesh-list
56323533|NCT05615818|Futibatinib|futibatinib|mesh-list
56323534|NCT05615818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908030|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
56908031|NCT03547024|Estradiol|estradiol|mesh-list
56908032|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56323535|NCT05615818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56323536|NCT05615818|Antimetabolites|antimetabolites|mesh-ancestor
56323537|NCT05615818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323538|NCT05615818|Antiviral Agents|antiviral agents|mesh-ancestor
56323539|NCT05615818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323540|NCT05615818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323541|NCT05615818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323542|NCT05615818|Immunologic Factors|immunologic factors|mesh-ancestor
56323543|NCT05615818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323544|NCT05615818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323545|NCT05615818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56323546|NCT05608291|Pembrolizumab|pembrolizumab|mesh-list
56323547|NCT05608291|Cemiplimab|cemiplimab|mesh-list
56323548|NCT05608291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323549|NCT05608291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323552|NCT05595603|Gentamicins|gentamicins|mesh-list
56323553|NCT05595603|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56323554|NCT05595603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56323555|NCT05595603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323556|NCT05595603|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56323557|NCT05595603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323558|NCT05595603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323561|NCT05595603|Protective Agents|protective agents|mesh-ancestor
56323562|NCT05595603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323563|NCT05579626|Ezetimibe|ezetimibe|mesh-list
56323564|NCT05579626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56323565|NCT05579626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56323566|NCT05579626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56323568|NCT05579626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323569|NCT05579626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56323570|NCT05579626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323571|NCT05577715|Farletuzumab|farletuzumab|mesh-list
56323572|NCT05577715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323573|NCT05568940|Tibolone|tibolone|mesh-list
56323574|NCT05568940|Androgen Antagonists|androgen antagonists|mesh-ancestor
56323575|NCT05568940|Hormone Antagonists|hormone antagonists|mesh-ancestor
56323576|NCT05568940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56323577|NCT05568940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323578|NCT05568940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56323579|NCT05568940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56323580|NCT05568940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323581|NCT05568940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56323582|NCT05568940|Anabolic Agents|anabolic agents|mesh-ancestor
56323583|NCT05568940|Hormones|hormones|mesh-ancestor
56323584|NCT05562973|Psilocybin|psilocybin|mesh-list
56323585|NCT05562973|Hallucinogens|hallucinogens|mesh-ancestor
56323586|NCT05562973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323587|NCT05562973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56323588|NCT05557838|Durvalumab|durvalumab|mesh-list
56323589|NCT05557838|Tremelimumab|tremelimumab|mesh-list
56323590|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323591|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323592|NCT05556616|Lenalidomide|lenalidomide|mesh-list
56323593|NCT05556616|Pomalidomide|pomalidomide|mesh-list
56323594|NCT05556616|Bortezomib|bortezomib|mesh-list
56323595|NCT05556616|Daratumumab|daratumumab|mesh-list
56323596|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
56323597|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323598|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56323599|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56323600|NCT05556616|Growth Substances|growth substances|mesh-ancestor
56323601|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
56323602|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323603|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
56323604|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
56323605|NCT05543785|Ketorolac|ketorolac|mesh-list
56323606|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56323607|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56323608|NCT05543785|Analgesics|analgesics|mesh-ancestor
56323609|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
56323610|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352532|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56323611|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323612|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56323613|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323614|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56323615|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323616|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323617|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56323618|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
56323619|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323621|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56323622|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56323623|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
56323624|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323625|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56323626|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56323627|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323628|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323643|NCT05478499|BMS-986165|bms-986165|mesh-list
56323644|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
56323645|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56323646|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323647|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323648|NCT05457465|Cannabidiol|cannabidiol|mesh-list
56323662|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56323663|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
56323664|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
56323665|NCT05452772|Vitamins|vitamins|mesh-ancestor
56323666|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
56323667|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323668|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
56323669|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56323670|NCT05450692|Docetaxel|docetaxel|mesh-list
56323671|NCT05450692|Durvalumab|durvalumab|mesh-list
56323672|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323673|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
56323674|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
56323675|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
56323676|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323677|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323678|NCT05447559|Cefazolin|cefazolin|mesh-list
56323679|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56323680|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323681|NCT05438043|Dexamethasone|dexamethasone|mesh-list
56323682|NCT05438043|Lenalidomide|lenalidomide|mesh-list
56323683|NCT05438043|Daratumumab|daratumumab|mesh-list
56323684|NCT05438043|Pomalidomide|pomalidomide|mesh-list
56323685|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56323686|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
56323687|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
56323688|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323689|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323690|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56323691|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
56323693|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56323694|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56323695|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323696|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
56323697|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56323698|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56323699|NCT05438043|Growth Substances|growth substances|mesh-ancestor
56323700|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
56323701|NCT05427786|Nicorandil|nicorandil|mesh-list
56323702|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56323703|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56323704|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
56323705|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
56323706|NCT05427786|Vitamins|vitamins|mesh-ancestor
56323707|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
56323708|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323709|NCT05426525|Empagliflozin|empagliflozin|mesh-list
56323710|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56323711|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323712|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56323713|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908033|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56908034|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908035|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908036|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56908037|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56908038|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56908039|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56908040|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
56908041|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
56908042|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
56908043|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
56908044|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56908045|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908046|NCT03547024|Estrogens|estrogens|mesh-ancestor
56908047|NCT03547024|Hormones|hormones|mesh-ancestor
56908048|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908049|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56908050|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
56908051|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56908052|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56908053|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56908054|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908055|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56908056|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908057|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56908058|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56352611|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
56323714|NCT05423106|Tenofovir|tenofovir|mesh-list
56323715|NCT05423106|Entecavir|entecavir|mesh-list
56323717|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323718|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56323719|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56323720|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323721|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323722|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56323723|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56323724|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56323725|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
56323726|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
56323727|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323728|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
56323729|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56323730|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323731|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56323732|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323733|NCT05402553|Ondansetron|ondansetron|mesh-list
56908059|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56908060|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
56908061|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
56352657|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
56323734|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
56323735|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
56323736|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323737|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323738|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56323739|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
56323740|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
56323741|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56323742|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
56323743|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56323744|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323745|NCT05402553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56323746|NCT05402553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56323747|NCT05402553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323748|NCT05402553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56323749|NCT05402553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56323750|NCT05379595|Leucovorin|leucovorin|mesh-list
56323751|NCT05379595|Fluorouracil|fluorouracil|mesh-list
56323752|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
56323753|NCT05379595|Irinotecan|irinotecan|mesh-list
56323754|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56323755|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
56323756|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323757|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56323758|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323759|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323760|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
56323761|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323762|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56323763|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56323764|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323765|NCT05379595|Antidotes|antidotes|mesh-ancestor
56323766|NCT05379595|Protective Agents|protective agents|mesh-ancestor
56323767|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
56323768|NCT05379595|Vitamins|vitamins|mesh-ancestor
56323769|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
56323770|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323771|NCT05379322|Adalimumab|adalimumab|mesh-list
56323772|NCT05379322|Etanercept|etanercept|mesh-list
56323773|NCT05379322|Golimumab|golimumab|mesh-list
56323774|NCT05379322|Upadacitinib|upadacitinib|mesh-list
56323775|NCT05379322|Tofacitinib|tofacitinib|mesh-list
56323776|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56323777|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56323778|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323779|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56323780|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56323781|NCT05379322|Analgesics|analgesics|mesh-ancestor
56323782|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
56323783|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323784|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323785|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56323786|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323787|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
56323788|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56323789|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963361|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
56323807|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56323808|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323809|NCT05351801|Hormones|hormones|mesh-ancestor
56323810|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56323811|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
55945642|NCT01475643|Hormones|hormones|mesh-ancestor
56323812|NCT05347485|Fludarabine|fludarabine|mesh-list
56323813|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323814|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
56323815|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323816|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323817|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56908062|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56908063|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56908064|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56323818|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
56323819|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323820|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323821|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56323822|NCT05341115|Leuprolide|leuprolide|mesh-list
56323823|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56323824|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
56323825|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56323826|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323827|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56323828|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323829|NCT05329766|Leucovorin|leucovorin|mesh-list
56323830|NCT05329766|Fluorouracil|fluorouracil|mesh-list
56323831|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
56323832|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
56323833|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323834|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56323835|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323836|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323837|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
56323838|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323839|NCT05329766|Antidotes|antidotes|mesh-ancestor
56323840|NCT05329766|Protective Agents|protective agents|mesh-ancestor
56323841|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
56323842|NCT05329766|Vitamins|vitamins|mesh-ancestor
56323843|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
56323844|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
56323845|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56323846|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323847|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323848|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56323849|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56323850|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323851|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
56323852|NCT05299073|Denosumab|denosumab|mesh-list
56323854|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323856|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56323857|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
56323858|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323859|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323860|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56323861|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
56323862|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56323863|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56323864|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323865|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56323866|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
56323867|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56323868|NCT05298696|Protective Agents|protective agents|mesh-ancestor
56323869|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56323870|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56323871|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323873|NCT05287425|Gentamicins|gentamicins|mesh-list
56323874|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
56323875|NCT05287425|Povidone|povidone|mesh-list
56323876|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56323877|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323878|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56323879|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56323880|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323881|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323882|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323883|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56323884|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56323885|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56323886|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
56323887|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
56323888|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56908065|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
56908066|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56908067|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56908068|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
56323889|NCT05276492|Prednisone|prednisone|mesh-list
56323890|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945738|NCT05257902|Choline|choline|mesh-list
56323891|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
56323892|NCT05276492|Hormones|hormones|mesh-ancestor
56323893|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56323894|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323895|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56323896|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323897|NCT05275023|Tenofovir|tenofovir|mesh-list
56323898|NCT05275023|Entecavir|entecavir|mesh-list
56323899|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56323900|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
56323901|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323902|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56323903|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56323904|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323905|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323906|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56323907|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56323908|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323909|NCT05261399|Carboplatin|carboplatin|mesh-list
56323910|NCT05261399|Pemetrexed|pemetrexed|mesh-list
56323911|NCT05261399|Osimertinib|osimertinib|mesh-list
56323912|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323913|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323914|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323915|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56323916|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56323917|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56323918|NCT05259722|Alitretinoin|alitretinoin|mesh-list
56323919|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323920|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
56323921|NCT05258721|Fluorides|fluorides|mesh-list
56323922|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
56323923|NCT05258721|Protective Agents|protective agents|mesh-ancestor
56323924|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323925|NCT05255003|Enoxaparin|enoxaparin|mesh-list
56323926|NCT05255003|Dalteparin|dalteparin|mesh-list
56323929|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
56323930|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56323931|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56323932|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323933|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56323934|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323935|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323936|NCT05242484|Golimumab|golimumab|mesh-list
56323937|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56323938|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56323939|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323940|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
56323941|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323942|NCT05242471|Golimumab|golimumab|mesh-list
56323943|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56323944|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56323945|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56323946|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
56323947|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323948|NCT05232032|Nociceptin|nociceptin|mesh-list
56323949|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
56323950|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
56323951|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56323952|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
56323953|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323954|NCT05215730|Copper|copper|mesh-list
56323955|NCT05215730|Trace Elements|trace elements|mesh-ancestor
56323956|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
56323957|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323958|NCT05209074|Ivosidenib|ivosidenib|mesh-list
56908069|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
56908070|NCT04012996|Meloxicam|meloxicam|mesh-list
56908071|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56908072|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56908073|NCT04012996|Analgesics|analgesics|mesh-ancestor
56908074|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
56908075|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908076|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908077|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56908078|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908079|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56323959|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323960|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323961|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323962|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56323963|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56323964|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
56323965|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323966|NCT05192850|Metformin|metformin|mesh-list
56323967|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56323968|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323969|NCT05174065|Apremilast|apremilast|mesh-list
56323970|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56323971|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56323972|NCT05174065|Analgesics|analgesics|mesh-ancestor
56323973|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
56323974|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323975|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323976|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56323977|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323978|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56323979|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56323980|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323981|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323982|NCT05151640|Nintedanib|nintedanib|mesh-list
56323983|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161585|NCT00569868|Bortezomib|bortezomib|mesh-list
56323984|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56323985|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323986|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323987|NCT05123599|Tenofovir|tenofovir|mesh-list
56323988|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
56323989|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56323990|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56323991|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56323992|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56323993|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323994|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56323995|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56323996|NCT05112939|Cabotegravir|cabotegravir|mesh-list
56323997|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56323998|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56323999|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324001|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56324002|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56324003|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
56324004|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324005|NCT05111717|Desflurane|desflurane|mesh-list
56324006|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56324007|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
56324008|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
56324009|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56324010|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324011|NCT05105919|Aspirin|aspirin|mesh-list
56083498|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
56908080|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56908081|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908082|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908083|NCT02253784|Dexamethasone|dexamethasone|mesh-list
56908084|NCT02253784|Bupivacaine|bupivacaine|mesh-list
56908085|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324012|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56324013|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56324014|NCT05105919|Analgesics|analgesics|mesh-ancestor
56324015|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
56324016|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324017|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324018|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324019|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324020|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56324021|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56324022|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324023|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56324024|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56324025|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324027|NCT05098938|Acyclovir|acyclovir|mesh-list
56324028|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
56324029|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324030|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
56324031|NCT05096195|Vitamin D|vitamin d|mesh-list
56324032|NCT05096195|Denosumab|denosumab|mesh-list
56324033|NCT05096195|Calcium|calcium|mesh-list
56324034|NCT05096195|Vitamins|vitamins|mesh-ancestor
56324035|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
56324036|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324037|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56324038|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56324039|NCT05083247|Gemcitabine|gemcitabine|mesh-list
56324040|NCT05083247|Paclitaxel|paclitaxel|mesh-list
56324041|NCT05083247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56324042|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945865|NCT02127073|Oxytocin|oxytocin|mesh-list
56324043|NCT05083247|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324044|NCT05083247|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324045|NCT05083247|Mitosis Modulators|mitosis modulators|mesh-ancestor
56324046|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324047|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56324048|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
56324049|NCT05083247|Antiviral Agents|antiviral agents|mesh-ancestor
56324050|NCT05083247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324051|NCT05083247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324052|NCT05083247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324053|NCT05083247|Immunologic Factors|immunologic factors|mesh-ancestor
56324054|NCT05083247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324055|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
56324056|NCT05077527|Fludarabine|fludarabine|mesh-list
56324057|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324058|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
56324059|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324060|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324061|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56324062|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
56324063|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324064|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324065|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56324067|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56324068|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324069|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324070|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
56324071|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324072|NCT05070364|Interferons|interferons|mesh-list
56324073|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324074|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
56324075|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324077|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908086|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
56908087|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
56324078|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324079|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324080|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324081|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
56324082|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324083|NCT05050097|Lenalidomide|lenalidomide|mesh-list
56324084|NCT05050097|Pomalidomide|pomalidomide|mesh-list
56324085|NCT05050097|Daratumumab|daratumumab|mesh-list
56324086|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
56324087|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324088|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56324089|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56324090|NCT05050097|Growth Substances|growth substances|mesh-ancestor
56324091|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
56324092|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324093|NCT05049603|Atorvastatin|atorvastatin|mesh-list
56324094|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56324095|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56324096|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
56324097|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324098|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56324099|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56324100|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324101|NCT05048797|Carboplatin|carboplatin|mesh-list
56324102|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
56324103|NCT05048797|Trastuzumab|trastuzumab|mesh-list
56324105|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324106|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324107|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324108|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324109|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56324110|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56324111|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
56324112|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56324113|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56324114|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324115|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
56324116|NCT05037162|Coagulants|coagulants|mesh-ancestor
56324117|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
56324118|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324119|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324120|NCT05022654|Irinotecan|irinotecan|mesh-list
56324121|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56324122|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56324123|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324124|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324125|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324126|NCT05020457|Paclitaxel|paclitaxel|mesh-list
56324127|NCT05020457|Docetaxel|docetaxel|mesh-list
56324128|NCT05020457|Cisplatin|cisplatin|mesh-list
56324129|NCT05020457|Pemetrexed|pemetrexed|mesh-list
56324130|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56324131|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324132|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324133|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324134|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
56324135|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324136|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324137|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56324138|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56324139|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
56324140|NCT05020444|Fludarabine|fludarabine|mesh-list
56324141|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324142|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
56324143|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324144|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324145|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56324146|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
56324147|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324148|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324149|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56324150|NCT05012189|Oseltamivir|oseltamivir|mesh-list
56324161|NCT04954599|Nivolumab|nivolumab|mesh-list
56908088|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908089|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324162|NCT04954599|Ipilimumab|ipilimumab|mesh-list
56324163|NCT04954599|Atezolizumab|atezolizumab|mesh-list
56324164|NCT04954599|Durvalumab|durvalumab|mesh-list
56324165|NCT04954599|Avelumab|avelumab|mesh-list
56324166|NCT04954599|Cemiplimab|cemiplimab|mesh-list
56324167|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56324168|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324169|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324170|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324171|NCT04952610|Etripamil|etripamil|mesh-list
56324172|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56324173|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56324174|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324187|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324189|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324190|NCT04921189|Vitamins|vitamins|mesh-ancestor
56324191|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
56324192|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
56324193|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324209|NCT04908189|Apremilast|apremilast|mesh-list
56324210|NCT04908189|BMS-986165|bms-986165|mesh-list
56324211|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56324212|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56324213|NCT04908189|Analgesics|analgesics|mesh-ancestor
56324214|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
56324215|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324216|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324217|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324218|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324219|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56324220|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56324221|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112012|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56324222|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324223|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
56324224|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56324225|NCT04902911|Antibodies|antibodies|mesh-list
56324226|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
56324227|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
56324228|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324229|NCT04864366|Tenofovir|tenofovir|mesh-list
55963804|NCT00462605|Entinostat|entinostat|mesh-list
56324237|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56324239|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
56324240|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324241|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56324242|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56324243|NCT04859296|Analgesics|analgesics|mesh-ancestor
56324244|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
56324245|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324246|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56324247|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56324248|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56324249|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324250|NCT04859296|Hormones|hormones|mesh-ancestor
56324251|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324252|NCT04857684|Bevacizumab|bevacizumab|mesh-list
56324253|NCT04857684|Atezolizumab|atezolizumab|mesh-list
56324254|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324255|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324256|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56324257|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56324258|NCT04857684|Growth Substances|growth substances|mesh-ancestor
56324259|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324260|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
56324261|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
56324262|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56324263|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324264|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324265|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
56908090|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908091|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
56908092|NCT02253784|Hormones|hormones|mesh-ancestor
56353165|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
56324266|NCT04846348|Promethazine|promethazine|mesh-list
56324267|NCT04846348|Salicylates|salicylates|mesh-list
56324268|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
56324269|NCT04846348|Emollients|emollients|mesh-list
56324270|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56324271|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55946091|NCT03046758|Fosfomycin|fosfomycin|mesh-list
56324272|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56324273|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324274|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
56324275|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
56324276|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
56324277|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324278|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
56324279|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
56324280|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56324281|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56324282|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
56324283|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
56324284|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56324285|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324286|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56324287|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
56324288|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
56324289|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56324290|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56324291|NCT04846348|Analgesics|analgesics|mesh-ancestor
56324292|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324293|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324294|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56324295|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324297|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
56324298|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56324299|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
56324300|NCT04844918|Tirzepatide|tirzepatide|mesh-list
56324301|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56324302|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324303|NCT04844918|Incretins|incretins|mesh-ancestor
56324304|NCT04844918|Hormones|hormones|mesh-ancestor
56324305|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324306|NCT04790903|Prednisone|prednisone|mesh-list
56324307|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
56324308|NCT04790903|Rituximab|rituximab|mesh-list
56324309|NCT04790903|Doxorubicin|doxorubicin|mesh-list
56324310|NCT04790903|Venetoclax|venetoclax|mesh-list
56324311|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324312|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
56324313|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324314|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324315|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56324316|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
56324317|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324318|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324319|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56324320|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324321|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56324322|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56324323|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56324324|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324325|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324327|NCT04790903|Hormones|hormones|mesh-ancestor
56324328|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324329|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56324330|NCT04771520|Piperazine|piperazine|mesh-list
56324331|NCT04771520|Mebendazole|mebendazole|mesh-list
56324332|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
56324333|NCT04771520|DMP 777|dmp 777|mesh-list
56324334|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
56324335|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
56324336|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56324337|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908093|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908094|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56908095|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908096|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
56324338|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324339|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324340|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
56324341|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324342|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324343|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324344|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
56324345|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56324346|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
56324347|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324348|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
56324349|NCT04769453|Protective Agents|protective agents|mesh-ancestor
56324350|NCT04765709|Carboplatin|carboplatin|mesh-list
56324351|NCT04765709|Pemetrexed|pemetrexed|mesh-list
56324352|NCT04765709|Durvalumab|durvalumab|mesh-list
56324353|NCT04765709|Vinorelbine|vinorelbine|mesh-list
56324354|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56324355|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324356|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324357|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324358|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56324359|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56324360|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324361|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
56324362|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324363|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56324364|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324365|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324366|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
56324367|NCT04762069|Lomustine|lomustine|mesh-list
56324368|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56324369|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
56324370|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324371|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324372|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56324374|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56324375|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324376|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
56324377|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56324378|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324379|NCT04752059|Trastuzumab|trastuzumab|mesh-list
56324380|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324381|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324382|NCT04742699|Lemborexant|lemborexant|mesh-list
56324383|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56324384|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56324385|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324386|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56324387|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56324388|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56324389|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324390|NCT04722146|Lenalidomide|lenalidomide|mesh-list
56324391|NCT04722146|Pomalidomide|pomalidomide|mesh-list
56324392|NCT04722146|Bortezomib|bortezomib|mesh-list
56324393|NCT04722146|Daratumumab|daratumumab|mesh-list
56324394|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
56324395|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324396|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56324397|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56324398|NCT04722146|Growth Substances|growth substances|mesh-ancestor
56324399|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
56324400|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324401|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56324402|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
56324403|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908097|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
56908098|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908099|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
56324404|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56324405|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
56324406|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56324407|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324408|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56324409|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56324410|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56324411|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
56324412|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56324413|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
56324414|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324415|NCT04667104|Tenofovir|tenofovir|mesh-list
56324416|NCT04667104|Entecavir|entecavir|mesh-list
56324417|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56324418|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
56324419|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324420|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56324421|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56324422|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946247|NCT02064673|Curcumin|curcumin|mesh-list
56324423|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324424|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56324425|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56324426|NCT04657016|Tirzepatide|tirzepatide|mesh-list
56324427|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56324428|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324429|NCT04657016|Incretins|incretins|mesh-ancestor
56324430|NCT04657016|Hormones|hormones|mesh-ancestor
56324431|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324432|NCT04654689|Curcumin|curcumin|mesh-list
56324433|NCT04654689|Resveratrol|resveratrol|mesh-list
56324434|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56324435|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56324436|NCT04654689|Analgesics|analgesics|mesh-ancestor
56324437|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
56324438|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324439|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324440|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324442|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324443|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324444|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324445|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
56324447|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56324449|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56324450|NCT04634838|Trace Elements|trace elements|mesh-ancestor
56324451|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
56324452|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324453|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324454|NCT04630145|Clarithromycin|clarithromycin|mesh-list
56324455|NCT04630145|Rifampin|rifampin|mesh-list
56324456|NCT04630145|Ethambutol|ethambutol|mesh-list
56324457|NCT04630145|Rifabutin|rifabutin|mesh-list
56324458|NCT04630145|Bedaquiline|bedaquiline|mesh-list
56324459|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56324460|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324461|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56324462|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324463|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324464|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56324465|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56324466|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56324467|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
56324468|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
56324469|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56324470|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56324471|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56324472|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56324473|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56324474|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56908100|NCT03734445|Vitamins|vitamins|mesh-list
56908101|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
56908102|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908103|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56908104|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334013|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
56324475|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56324476|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
56324477|NCT04629534|Vitamin D|vitamin d|mesh-list
56324478|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56324479|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324480|NCT04629534|Vitamins|vitamins|mesh-ancestor
56324481|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
56324482|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56324483|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56324484|NCT04616183|Cetuximab|cetuximab|mesh-list
56324485|NCT04616183|Antibodies|antibodies|mesh-list
56324486|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
56324487|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56324488|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
56324489|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324490|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324491|NCT04612751|Carboplatin|carboplatin|mesh-list
56324492|NCT04612751|Durvalumab|durvalumab|mesh-list
56324493|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324494|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324495|NCT04602065|Antibodies|antibodies|mesh-list
56324496|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56324497|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
56324498|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324500|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56324501|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324502|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56324503|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324504|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
56324505|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324506|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
56324507|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324508|NCT04584112|Paclitaxel|paclitaxel|mesh-list
56324509|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56324510|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
56324511|NCT04584112|Carboplatin|carboplatin|mesh-list
56324512|NCT04584112|Doxorubicin|doxorubicin|mesh-list
56324513|NCT04584112|Atezolizumab|atezolizumab|mesh-list
56324514|NCT04584112|Molgramostim|molgramostim|mesh-list
56324515|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56324516|NCT04584112|Lenograstim|lenograstim|mesh-list
56324517|NCT04584112|Sargramostim|sargramostim|mesh-list
56324518|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56324519|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324520|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324521|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324522|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
55964073|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
56324523|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324524|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324525|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
56324526|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324527|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324528|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56324529|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
56324530|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56324531|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56324532|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56324533|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56324534|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324535|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56324537|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
56324538|NCT04577833|Niraparib|niraparib|mesh-list
56324539|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324540|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
56324541|NCT04577833|Hormones|hormones|mesh-ancestor
56324542|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083607|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56908105|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56908106|NCT04538092|Analgesics|analgesics|mesh-list
56908107|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908108|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
56324543|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324544|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56324545|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324546|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56324547|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324548|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324549|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
56324550|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56324551|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56324552|NCT04576156|Imetelstat|imetelstat|mesh-list
56324554|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324555|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324556|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56324557|NCT04573777|Evolocumab|evolocumab|mesh-list
56324558|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56324559|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56324560|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
56324561|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324562|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56324563|NCT04536532|Entecavir|entecavir|mesh-list
56324564|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
56324565|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324566|NCT04535544|Tenofovir|tenofovir|mesh-list
56324567|NCT04535544|Entecavir|entecavir|mesh-list
56324568|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
56324569|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324570|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56324571|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56324572|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324573|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324574|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56324575|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56324576|NCT04523207|Relugolix|relugolix|mesh-list
56324577|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
56324578|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
56324579|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324580|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324581|NCT04507711|Palonosetron|palonosetron|mesh-list
56324582|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
56324583|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
56324584|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324585|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324586|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56324587|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56324588|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56324589|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
56324590|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56324591|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324592|NCT04499274|Ondansetron|ondansetron|mesh-list
56324593|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
56324594|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
56324595|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324596|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964154|NCT00492973|Cefuroxime|cefuroxime|mesh-list
56324609|NCT04497961|Lenalidomide|lenalidomide|mesh-list
56324610|NCT04497961|Daratumumab|daratumumab|mesh-list
56324611|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
56324612|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324613|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56324614|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56324615|NCT04497961|Growth Substances|growth substances|mesh-ancestor
56324616|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
56324617|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324618|NCT04497844|Prednisone|prednisone|mesh-list
56324619|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
56324620|NCT04497844|Niraparib|niraparib|mesh-list
56324621|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324622|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
56324623|NCT04497844|Hormones|hormones|mesh-ancestor
56908109|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908110|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908111|NCT03546088|Anesthetics|anesthetics|mesh-list
56908112|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908113|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908114|NCT04522336|Docetaxel|docetaxel|mesh-list
56908115|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
56908116|NCT04522336|Fluorouracil|fluorouracil|mesh-list
56908117|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
56908118|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908119|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908120|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
56908121|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
56908122|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908123|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56908124|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
56353521|NCT00238225|Calcitriol|calcitriol|mesh-list
56324624|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324625|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324626|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56324627|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324628|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56324629|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324630|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324631|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
56324632|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56324633|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56324635|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56324636|NCT04494425|Capecitabine|capecitabine|mesh-list
56324637|NCT04494425|Trastuzumab|trastuzumab|mesh-list
56324638|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56324639|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324640|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324641|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324642|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
56324643|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324644|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56324645|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
56324646|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324647|NCT04488159|Leucovorin|leucovorin|mesh-list
56324648|NCT04488159|Fluorouracil|fluorouracil|mesh-list
56324649|NCT04488159|Capecitabine|capecitabine|mesh-list
56324650|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
56324651|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
56324652|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324653|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56324654|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324655|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324656|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
56324657|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324658|NCT04488159|Antidotes|antidotes|mesh-ancestor
56324659|NCT04488159|Protective Agents|protective agents|mesh-ancestor
56324660|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
56324671|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56324672|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56324673|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324674|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908125|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56908126|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56908127|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
56908128|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324675|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56324676|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56324677|NCT04435691|Azacitidine|azacitidine|mesh-list
56324678|NCT04435691|Venetoclax|venetoclax|mesh-list
56324679|NCT04435691|Magrolimab|magrolimab|mesh-list
56324680|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56324681|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
56324682|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324683|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324684|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324685|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324686|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56324687|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
56324688|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324689|NCT04357951|Cycloserine|cycloserine|mesh-list
56324690|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56324691|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324692|NCT04357951|Renal Agents|renal agents|mesh-ancestor
56324693|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56324694|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
56324695|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56324696|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
56324697|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324698|NCT04351555|Carboplatin|carboplatin|mesh-list
56324699|NCT04351555|Pemetrexed|pemetrexed|mesh-list
56324700|NCT04351555|Osimertinib|osimertinib|mesh-list
56324701|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324702|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324703|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324704|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56324705|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56324706|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56324708|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324709|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324710|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
56324711|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324712|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324713|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
56324714|NCT04321993|Remdesivir|remdesivir|mesh-list
56324715|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56324716|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324717|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
56324718|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324719|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56324720|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324721|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56324722|NCT04319627|Calcium|calcium|mesh-list
56324723|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56324724|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324725|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56324726|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56324727|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
56324728|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324736|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56324737|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324739|NCT04315948|Ritonavir|ritonavir|mesh-list
56324740|NCT04315948|Lopinavir|lopinavir|mesh-list
56324741|NCT04315948|Interferon-beta|interferon-beta|mesh-list
56324742|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
56324743|NCT04315948|Remdesivir|remdesivir|mesh-list
56324744|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
56324745|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324746|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
56324747|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324748|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56324749|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56324750|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
56324751|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908129|NCT03875872|Propofol|propofol|mesh-list
56908130|NCT03875872|Anesthetics|anesthetics|mesh-list
56324752|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324753|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56324754|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56324755|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56324756|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56324757|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
56324758|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56324759|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56324760|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324761|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
56324762|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324763|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56324764|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
56324770|NCT04300127|Pioglitazone|pioglitazone|mesh-list
56324771|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56324772|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324773|NCT04296305|Hydromorphone|hydromorphone|mesh-list
56324774|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56324775|NCT04296305|Narcotics|narcotics|mesh-ancestor
56324776|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56324777|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324778|NCT04296305|Analgesics|analgesics|mesh-ancestor
56064898|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
56324779|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
56324780|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324782|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324783|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324784|NCT04266236|Ropivacaine|ropivacaine|mesh-list
56324785|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
56324786|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56324787|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324788|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
56324789|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
56324790|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324791|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
56324792|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324793|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56324794|NCT04256343|Protective Agents|protective agents|mesh-ancestor
56324795|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324796|NCT04243629|Pramlintide|pramlintide|mesh-list
56324797|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
56324798|NCT04243629|Pancrelipase|pancrelipase|mesh-list
56324799|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56324800|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324801|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56324802|NCT04238819|Irinotecan|irinotecan|mesh-list
55946618|NCT01728805|Vorinostat|vorinostat|mesh-list
56324803|NCT04238819|Temozolomide|temozolomide|mesh-list
56324806|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56324807|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324808|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324809|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324810|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56324811|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
56324812|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56324813|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
56324814|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324815|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
56324816|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
56324817|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56324818|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324819|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
56324820|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324821|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324822|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56324823|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
56324824|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324825|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324826|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56324827|NCT04199026|Sirolimus|sirolimus|mesh-list
56324828|NCT04199026|Doxorubicin|doxorubicin|mesh-list
56324829|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56324830|NCT04199026|Daunorubicin|daunorubicin|mesh-list
56324831|NCT04199026|Irinotecan|irinotecan|mesh-list
56908131|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
56908132|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56908133|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908134|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353728|NCT00239278|Hormones|hormones|mesh-ancestor
56324832|NCT04199026|Vincristine|vincristine|mesh-list
56324833|NCT04199026|Everolimus|everolimus|mesh-list
56324834|NCT04199026|Temozolomide|temozolomide|mesh-list
56324835|NCT04199026|Ifosfamide|ifosfamide|mesh-list
56324836|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
56324837|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56324838|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56324839|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324840|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56324841|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56324842|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324843|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324844|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56324845|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56324846|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324847|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324848|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
56324849|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324850|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
56324851|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324852|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56324853|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
56324854|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064972|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
56324855|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324856|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
56324857|NCT04182997|Dexamethasone|dexamethasone|mesh-list
56324858|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324859|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
56324860|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
56324861|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324862|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324863|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56324864|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
56324865|NCT04182997|Hormones|hormones|mesh-ancestor
56324866|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324867|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56324868|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324869|NCT04181827|Dexamethasone|dexamethasone|mesh-list
56324870|NCT04181827|Bortezomib|bortezomib|mesh-list
56324871|NCT04181827|Daratumumab|daratumumab|mesh-list
56324872|NCT04181827|Pomalidomide|pomalidomide|mesh-list
56324873|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324874|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
56324875|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
56324876|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324877|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324878|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56324895|NCT04134936|Lenalidomide|lenalidomide|mesh-list
56324896|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
56324897|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324898|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56324899|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56324900|NCT04134936|Growth Substances|growth substances|mesh-ancestor
56324901|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
56324902|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324903|NCT04121260|Daratumumab|daratumumab|mesh-list
56324904|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324905|NCT04115111|Durvalumab|durvalumab|mesh-list
56324906|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324907|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324908|NCT04113109|Icatibant|icatibant|mesh-list
56324909|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56324910|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56324911|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324912|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56324913|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56324914|NCT04113109|Analgesics|analgesics|mesh-ancestor
56324915|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
56324916|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56324917|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324918|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324919|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56324920|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56324921|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56324922|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56324923|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56324924|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
56324925|NCT04108208|Androgens|androgens|mesh-list
56324926|NCT04108208|Hormones|hormones|mesh-ancestor
56324927|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324928|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324929|NCT04108195|Daratumumab|daratumumab|mesh-list
56324930|NCT04108195|Pomalidomide|pomalidomide|mesh-list
56324931|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324932|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
56324933|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324934|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56324935|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56324936|NCT04108195|Growth Substances|growth substances|mesh-ancestor
56324937|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
56324938|NCT04107038|Anesthetics|anesthetics|mesh-list
56324939|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964501|NCT00503113|Alendronate|alendronate|mesh-list
56324943|NCT04101357|Atezolizumab|atezolizumab|mesh-list
56324944|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324945|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56324946|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56324947|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56324948|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324949|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324950|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56324951|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56324952|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56324953|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
56324954|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324955|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56324956|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56324957|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324959|NCT04091386|Coagulants|coagulants|mesh-ancestor
56324960|NCT04042233|Vancomycin|vancomycin|mesh-list
56324961|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56324962|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324963|NCT04034095|Prednisolone|prednisolone|mesh-list
56324964|NCT04034095|Docetaxel|docetaxel|mesh-list
56324965|NCT04034095|Bicalutamide|bicalutamide|mesh-list
56324966|NCT04034095|Androgens|androgens|mesh-list
56324967|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324968|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
56324969|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
56324970|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
56324971|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324972|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56324973|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
56324974|NCT04034095|Hormones|hormones|mesh-ancestor
56324975|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324976|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324977|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56324978|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
56324979|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
56324980|NCT04023331|Copper|copper|mesh-list
56324981|NCT04023331|Trace Elements|trace elements|mesh-ancestor
56324982|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
56324983|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324984|NCT03984565|Cannabidiol|cannabidiol|mesh-list
56324985|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
56324986|NCT03982693|Edetic Acid|edetic acid|mesh-list
56324987|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
56324988|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
56324989|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56324990|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
56324991|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
55887845|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908135|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56908136|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
56908137|NCT03866980|Carboplatin|carboplatin|mesh-list
56908138|NCT03866980|Pemetrexed|pemetrexed|mesh-list
56324992|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324993|NCT03982693|Antidotes|antidotes|mesh-ancestor
56324994|NCT03982693|Protective Agents|protective agents|mesh-ancestor
56324995|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324996|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56324997|NCT03965195|Vaccines|vaccines|mesh-list
56324998|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
56324999|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325000|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
56325001|NCT03942653|Goserelin|goserelin|mesh-list
56325002|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325003|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325004|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325005|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
56325006|NCT03941262|Avelumab|avelumab|mesh-list
56325007|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325008|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325009|NCT03928314|Paclitaxel|paclitaxel|mesh-list
56325010|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56325011|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325012|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
56325013|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
56325014|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
56325015|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325024|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325025|NCT03901963|Growth Substances|growth substances|mesh-ancestor
56325026|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325027|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325029|NCT03878082|Propacetamol|propacetamol|mesh-list
56325030|NCT03878082|Analgesics|analgesics|mesh-ancestor
56325031|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
56325032|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325033|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325034|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56325035|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56325036|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325037|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325041|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
56325042|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56325043|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325044|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56325045|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325046|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325047|NCT03846310|Carboplatin|carboplatin|mesh-list
56325048|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
56325049|NCT03846310|Pemetrexed|pemetrexed|mesh-list
56325050|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325051|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325052|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325053|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325054|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56325055|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56325056|NCT03833154|Durvalumab|durvalumab|mesh-list
56325057|NCT03833154|Osimertinib|osimertinib|mesh-list
56325058|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325059|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325060|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56325061|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325062|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325063|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56325064|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
56325065|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325066|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
56325067|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56325068|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325069|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
56325070|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
56325071|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908139|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908140|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353941|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325072|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325073|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325074|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
56325075|NCT03818737|Hormones|hormones|mesh-ancestor
56325076|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325077|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56325078|NCT03818737|Protective Agents|protective agents|mesh-ancestor
56325079|NCT03814941|Anesthetics|anesthetics|mesh-list
56325080|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56325081|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325082|NCT03784326|Fluorouracil|fluorouracil|mesh-list
56325083|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
56325084|NCT03784326|Atezolizumab|atezolizumab|mesh-list
56065205|NCT02506673|Midazolam|midazolam|mesh-list
56325088|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56325089|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325090|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325091|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
56325092|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325094|NCT03767244|Hormones|hormones|mesh-ancestor
56325095|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325096|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325097|NCT03761095|Dacarbazine|dacarbazine|mesh-list
56325098|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56325099|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
56325100|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325101|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325102|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
56325103|NCT03759938|Apixaban|apixaban|mesh-list
56325104|NCT03759938|Edoxaban|edoxaban|mesh-list
56325105|NCT03759938|Dabigatran|dabigatran|mesh-list
56325106|NCT03759938|Anticoagulants|anticoagulants|mesh-list
56325108|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
56325109|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56325110|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
56325111|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325112|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325113|NCT03748641|Prednisone|prednisone|mesh-list
56325114|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
56325115|NCT03748641|Niraparib|niraparib|mesh-list
56325116|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325117|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
56325118|NCT03748641|Hormones|hormones|mesh-ancestor
56325119|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325120|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325121|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325122|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325123|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56325124|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325125|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325126|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
56325127|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56325128|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56325129|NCT03737240|Insulin|insulin|mesh-list
56325130|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56325131|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
56325132|NCT03737240|Liraglutide|liraglutide|mesh-list
56325133|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
56325134|NCT03737240|Xultophy|xultophy|mesh-list
56325135|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56325136|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325137|NCT03737240|Incretins|incretins|mesh-ancestor
56325138|NCT03737240|Hormones|hormones|mesh-ancestor
56325139|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325140|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
56325141|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325142|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325143|NCT03729349|Golimumab|golimumab|mesh-list
56325144|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56325145|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56908141|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908142|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56908143|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56325146|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325147|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
56325148|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325149|NCT03686488|Ramucirumab|ramucirumab|mesh-list
56325150|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325151|NCT03672539|Cytarabine|cytarabine|mesh-list
56325152|NCT03672539|Daunorubicin|daunorubicin|mesh-list
56325153|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
56325154|NCT03672539|Calicheamicins|calicheamicins|mesh-list
56325155|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56325156|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
56325157|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325158|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325159|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
55964702|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
56325161|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325163|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325164|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56325165|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56325166|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56325167|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325168|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325169|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
56325170|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325171|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325172|NCT03652064|Dexamethasone|dexamethasone|mesh-list
56325173|NCT03652064|Lenalidomide|lenalidomide|mesh-list
56325174|NCT03652064|Bortezomib|bortezomib|mesh-list
56325175|NCT03652064|Daratumumab|daratumumab|mesh-list
56325176|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325177|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
56325178|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
56325179|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325180|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325181|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325182|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
56325183|NCT03652064|Hormones|hormones|mesh-ancestor
56325184|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325185|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325186|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325188|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56325189|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325190|NCT03652064|Growth Substances|growth substances|mesh-ancestor
56325191|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325193|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325194|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325195|NCT03635983|Nivolumab|nivolumab|mesh-list
56325196|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325197|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325198|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56325199|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325200|NCT03599622|BMS-986165|bms-986165|mesh-list
56325201|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56325202|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56325203|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325204|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325205|NCT03596164|Teduglutide|teduglutide|mesh-list
56325206|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325207|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56325208|NCT03596164|Protective Agents|protective agents|mesh-ancestor
56325209|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325210|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
56325211|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325212|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325213|NCT03556332|Dexamethasone|dexamethasone|mesh-list
56325214|NCT03556332|Lenalidomide|lenalidomide|mesh-list
56325215|NCT03556332|Daratumumab|daratumumab|mesh-list
56325216|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325217|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
56908144|NCT02253862|Ritonavir|ritonavir|mesh-list
56908145|NCT02253862|Tipranavir|tipranavir|mesh-list
56908146|NCT02253862|Tadalafil|tadalafil|mesh-list
56908147|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56908148|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56908149|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
56354084|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
56325218|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
56325219|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325220|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325221|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325222|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
56325223|NCT03556332|Hormones|hormones|mesh-ancestor
56325224|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325225|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325226|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325227|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
56325228|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56325229|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325230|NCT03556332|Growth Substances|growth substances|mesh-ancestor
56325231|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325232|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56325233|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56325234|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55964771|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
56325240|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56325241|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
56325243|NCT03539900|Bupropion|bupropion|mesh-list
56325244|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56325245|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56325246|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325247|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
56325248|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325249|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56325250|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
56325251|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56325252|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56325253|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56325254|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55947071|NCT01659307|Analgesics|analgesics|mesh-ancestor
56325255|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325256|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
56325257|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113043|NCT01938833|Romidepsin|romidepsin|mesh-list
56325258|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56325259|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56325260|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325261|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56325262|NCT03530683|Dexamethasone|dexamethasone|mesh-list
56325263|NCT03530683|Azacitidine|azacitidine|mesh-list
56325264|NCT03530683|Venetoclax|venetoclax|mesh-list
56325265|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325266|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
56325267|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
56325268|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325269|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325270|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325271|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
56325272|NCT03530683|Hormones|hormones|mesh-ancestor
56325273|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325274|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325275|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325276|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56325277|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
56325278|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325279|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325280|NCT03525873|Methylphenidate|methylphenidate|mesh-list
56325281|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56908150|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354151|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56325282|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325283|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56325284|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56325285|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56325286|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325287|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
56325288|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56325289|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
56325290|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56325291|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56325292|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325293|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
56325294|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
56325295|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325296|NCT03492125|Rituximab|rituximab|mesh-list
56325297|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
56325298|NCT03492125|Venetoclax|venetoclax|mesh-list
56325299|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
56325323|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
56325324|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325325|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
56325326|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
56325327|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
56325328|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325329|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325330|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325331|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
56325332|NCT03456843|Protective Agents|protective agents|mesh-ancestor
56325334|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
56325335|NCT03456843|Estrogens|estrogens|mesh-ancestor
56325336|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325337|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
56325338|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
56325339|NCT03451851|Etanercept|etanercept|mesh-list
56325340|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56325341|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56325342|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56325343|NCT03451851|Analgesics|analgesics|mesh-ancestor
56325344|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
56325345|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325346|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325347|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325348|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325349|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325350|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325351|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
56325352|NCT03432741|Gemcitabine|gemcitabine|mesh-list
56325353|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
56325361|NCT03432741|Romidepsin|romidepsin|mesh-list
56325362|NCT03432741|Belinostat|belinostat|mesh-list
56325363|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56325364|NCT03432741|Antibodies|antibodies|mesh-list
56325365|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
56325366|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56325367|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56325368|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
56325369|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325370|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325371|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325372|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56325373|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
56325374|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325375|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
56325376|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325377|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325378|NCT03432741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325379|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56325380|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56325381|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56325382|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56325383|NCT03431350|Prednisone|prednisone|mesh-list
56325384|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
56325385|NCT03431350|Niraparib|niraparib|mesh-list
56908151|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908152|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56908153|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56908154|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
56354230|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
56325386|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325387|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
56325389|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325390|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325391|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325392|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325393|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56325394|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325395|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325396|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
56325397|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56325398|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56325400|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56325401|NCT03427463|Narcotics|narcotics|mesh-ancestor
56325402|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56325403|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947220|NCT01546987|Buserelin|buserelin|mesh-list
56325404|NCT03427463|Analgesics|analgesics|mesh-ancestor
56325405|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
56325406|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325407|NCT03412565|Dexamethasone|dexamethasone|mesh-list
56325409|NCT03412565|Lenalidomide|lenalidomide|mesh-list
56325410|NCT03412565|Bortezomib|bortezomib|mesh-list
56325411|NCT03412565|Melphalan|melphalan|mesh-list
56325412|NCT03412565|Daratumumab|daratumumab|mesh-list
56325413|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325414|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
56325415|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
56325416|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325417|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325418|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325419|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
56325420|NCT03412565|Hormones|hormones|mesh-ancestor
56325421|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325422|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325423|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325424|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
56325425|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56325426|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325427|NCT03412565|Growth Substances|growth substances|mesh-ancestor
56325430|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
56325431|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325432|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56325433|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325434|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
56325435|NCT03399773|Thiotepa|thiotepa|mesh-list
56325436|NCT03399773|Fludarabine|fludarabine|mesh-list
56325437|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325438|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
56325439|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325440|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325441|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56325442|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
56325443|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325444|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325445|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56325446|NCT03384641|Bedaquiline|bedaquiline|mesh-list
56325447|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
56325448|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56325449|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325450|NCT03363867|Bevacizumab|bevacizumab|mesh-list
56325451|NCT03363867|Atezolizumab|atezolizumab|mesh-list
56325452|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325453|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325454|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56908155|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908156|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56908157|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56908158|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
56354303|NCT00077103|Doxorubicin|doxorubicin|mesh-list
56325455|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325456|NCT03363867|Growth Substances|growth substances|mesh-ancestor
56325457|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325458|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325459|NCT03356873|Vitamin D|vitamin d|mesh-list
56325460|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
56325461|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
56325462|NCT03356873|Vitamins|vitamins|mesh-list
56325463|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
56325464|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325465|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56325466|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56325467|NCT03308578|Atorvastatin|atorvastatin|mesh-list
56325468|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56325469|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56325470|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
56325471|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325472|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56325473|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56325474|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325475|NCT03305341|Molgramostim|molgramostim|mesh-list
56325476|NCT03305341|Sargramostim|sargramostim|mesh-list
56325477|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
56325478|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325479|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325480|NCT03301220|Daratumumab|daratumumab|mesh-list
56325481|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325482|NCT03297606|Nivolumab|nivolumab|mesh-list
56325483|NCT03297606|Trastuzumab|trastuzumab|mesh-list
56325484|NCT03297606|Ipilimumab|ipilimumab|mesh-list
56325485|NCT03297606|Pertuzumab|pertuzumab|mesh-list
56325486|NCT03297606|Sunitinib|sunitinib|mesh-list
56325487|NCT03297606|Dasatinib|dasatinib|mesh-list
56325488|NCT03297606|Olaparib|olaparib|mesh-list
56325489|NCT03297606|Palbociclib|palbociclib|mesh-list
56325490|NCT03297606|Axitinib|axitinib|mesh-list
56325491|NCT03297606|Vemurafenib|vemurafenib|mesh-list
56325492|NCT03297606|Crizotinib|crizotinib|mesh-list
56325493|NCT03297606|Tucatinib|tucatinib|mesh-list
56325494|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325495|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325496|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56325497|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325498|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56325499|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325500|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56325501|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325502|NCT03297606|Growth Substances|growth substances|mesh-ancestor
56325503|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325513|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
56325514|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325515|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325516|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325517|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
56325518|NCT03255473|Hormones|hormones|mesh-ancestor
56325519|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325520|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325521|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325522|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
56325523|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325524|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325525|NCT03234972|Dexamethasone|dexamethasone|mesh-list
56325526|NCT03234972|Bortezomib|bortezomib|mesh-list
56325527|NCT03234972|Daratumumab|daratumumab|mesh-list
56325528|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325529|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
56325530|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
56325531|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908159|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56908160|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56908161|NCT02253862|Urological Agents|urological agents|mesh-ancestor
56325532|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325533|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325534|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
56325535|NCT03234972|Hormones|hormones|mesh-ancestor
56325536|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325537|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325538|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325539|NCT03217812|Prednisone|prednisone|mesh-list
56325540|NCT03217812|Bortezomib|bortezomib|mesh-list
56325542|NCT03217812|Daratumumab|daratumumab|mesh-list
56325543|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325544|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
56325545|NCT03217812|Hormones|hormones|mesh-ancestor
56325546|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325547|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325548|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325549|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325550|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56325551|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
56325552|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325553|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56325554|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325555|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
56325556|NCT03217747|Avelumab|avelumab|mesh-list
56325557|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56325558|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
56325559|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325560|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325562|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325563|NCT03176277|Venetoclax|venetoclax|mesh-list
56325564|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325565|NCT03173560|Everolimus|everolimus|mesh-list
56325566|NCT03173560|Lenvatinib|lenvatinib|mesh-list
56325567|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325568|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325569|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
56325570|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325571|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56325572|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325573|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325583|NCT03098225|Prednisolone|prednisolone|mesh-list
56325584|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
56325585|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56325586|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
56325587|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325588|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
56325589|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
56325590|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325591|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325592|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325593|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
56325595|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325596|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56325597|NCT03098225|Protective Agents|protective agents|mesh-ancestor
56325598|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325599|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325600|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
56325601|NCT03030378|Interleukin-12|interleukin-12|mesh-list
56325602|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325603|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325604|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56325605|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
56325606|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325607|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56325608|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325609|NCT03030378|Growth Substances|growth substances|mesh-ancestor
56325610|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325611|NCT03017131|Aldesleukin|aldesleukin|mesh-list
56325612|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
56325613|NCT03017131|Decitabine|decitabine|mesh-list
56908162|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56908163|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56908164|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56908165|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908166|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325614|NCT03017131|Interleukin-2|interleukin-2|mesh-list
56325615|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325616|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
56325617|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325618|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325619|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56325620|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
56325621|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325622|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325623|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56325624|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56325625|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
56325626|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325627|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56325628|NCT03017131|Analgesics|analgesics|mesh-ancestor
56325629|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
56325630|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325631|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56325632|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56325633|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
56325634|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325635|NCT02990468|Cisplatin|cisplatin|mesh-list
56325636|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325637|NCT02972840|Rituximab|rituximab|mesh-list
56325638|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56325639|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
56325640|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325641|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325642|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
56325643|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325644|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325645|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56325646|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
56325647|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325648|NCT02940301|Nivolumab|nivolumab|mesh-list
56325649|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325650|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325651|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56325652|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325653|NCT02927769|Nivolumab|nivolumab|mesh-list
56325654|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56325655|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56325656|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325657|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325658|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56325659|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325660|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56325661|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
56325662|NCT02899299|Carboplatin|carboplatin|mesh-list
56325663|NCT02899299|Nivolumab|nivolumab|mesh-list
56325664|NCT02899299|Pemetrexed|pemetrexed|mesh-list
56325665|NCT02899299|Ipilimumab|ipilimumab|mesh-list
56325666|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325667|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325668|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56325669|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325670|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325671|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56325672|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56325673|NCT02882100|Vaccines|vaccines|mesh-list
56325674|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
56325675|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325676|NCT02855944|Gemcitabine|gemcitabine|mesh-list
56325677|NCT02855944|Paclitaxel|paclitaxel|mesh-list
56325678|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56908167|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56908168|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56908169|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56908170|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56908171|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
56908172|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354512|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325679|NCT02855944|Cisplatin|cisplatin|mesh-list
56325680|NCT02855944|Carboplatin|carboplatin|mesh-list
56325681|NCT02855944|Rucaparib|rucaparib|mesh-list
56325682|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56325683|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325684|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
56325685|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
56325686|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
56325687|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325688|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56325689|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
56325690|NCT02855944|Antiviral Agents|antiviral agents|mesh-ancestor
56325691|NCT02855944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325692|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325693|NCT02855944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325694|NCT02855944|Immunologic Factors|immunologic factors|mesh-ancestor
56325695|NCT02855944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325696|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56325697|NCT02854436|Niraparib|niraparib|mesh-list
56325698|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56325699|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325700|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325701|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325702|NCT02733185|Vitamins|vitamins|mesh-list
56325703|NCT02733185|Edetic Acid|edetic acid|mesh-list
56325704|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
56325705|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
56325706|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325707|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
56325708|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56325709|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
56325710|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
56325711|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325712|NCT02733185|Antidotes|antidotes|mesh-ancestor
56325713|NCT02733185|Protective Agents|protective agents|mesh-ancestor
56325714|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55947525|NCT01542255|Dacarbazine|dacarbazine|mesh-list
56325717|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56325728|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325729|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325730|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
56325731|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325732|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325733|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56325734|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325736|NCT02603848|Morphine|morphine|mesh-list
56325737|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56325738|NCT02603848|Narcotics|narcotics|mesh-ancestor
56325739|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56325740|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325741|NCT02603848|Analgesics|analgesics|mesh-ancestor
56325742|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
56325743|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325744|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56325745|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56325746|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325747|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325748|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56325749|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325750|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325751|NCT02531516|Bicalutamide|bicalutamide|mesh-list
56908173|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908174|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56325752|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
56325753|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
56325754|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325755|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325756|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325757|NCT02519452|Daratumumab|daratumumab|mesh-list
56325758|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325759|NCT02512887|Anesthetics|anesthetics|mesh-list
56325760|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56325761|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325762|NCT02505984|Oxytocin|oxytocin|mesh-list
56325763|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
56325764|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56325765|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325766|NCT02489318|Androgens|androgens|mesh-list
56325767|NCT02489318|Hormones|hormones|mesh-ancestor
56325768|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325769|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325770|NCT02484261|Bortezomib|bortezomib|mesh-list
56325771|NCT02484261|Pravastatin|pravastatin|mesh-list
56325772|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325773|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56325774|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56325775|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
56325776|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325777|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56325778|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56325779|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325780|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
56325781|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325782|NCT02471430|Interferons|interferons|mesh-list
56325785|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56325786|NCT02471430|Panobinostat|panobinostat|mesh-list
56325787|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325788|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
56325789|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325790|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
56325791|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325792|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56325793|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325794|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325795|NCT02451943|Doxorubicin|doxorubicin|mesh-list
56325797|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56325798|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325799|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56325800|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56325801|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325802|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325803|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
56325804|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325805|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325806|NCT02421939|Cytarabine|cytarabine|mesh-list
56325807|NCT02421939|Fludarabine|fludarabine|mesh-list
56325808|NCT02421939|Etoposide|etoposide|mesh-list
56325809|NCT02421939|Azacitidine|azacitidine|mesh-list
56325810|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
56325811|NCT02421939|Idarubicin|idarubicin|mesh-list
56325812|NCT02421939|Lenograstim|lenograstim|mesh-list
56325813|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325814|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56325815|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
56325816|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325817|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325818|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
56325819|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325820|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56325821|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56325822|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56325823|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325824|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
56908175|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56908176|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
56354656|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
56325825|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325826|NCT02421939|Analgesics|analgesics|mesh-ancestor
56325827|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
56325828|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325829|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56325830|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56325831|NCT02409342|Gemcitabine|gemcitabine|mesh-list
56325832|NCT02409342|Carboplatin|carboplatin|mesh-list
56325833|NCT02409342|Pemetrexed|pemetrexed|mesh-list
56325834|NCT02409342|Atezolizumab|atezolizumab|mesh-list
56325835|NCT02409342|Antibodies|antibodies|mesh-list
56325836|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56325837|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
56325838|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325839|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325840|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56325841|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
56325842|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325843|NCT02409342|Antiviral Agents|antiviral agents|mesh-ancestor
56325844|NCT02409342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325845|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325846|NCT02409342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325847|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56325848|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56325849|NCT02399085|Lenalidomide|lenalidomide|mesh-list
56325850|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
56325851|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325852|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56325853|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325854|NCT02399085|Growth Substances|growth substances|mesh-ancestor
56325855|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325856|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325857|NCT02354014|Bedaquiline|bedaquiline|mesh-list
56325858|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
56325872|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
56325873|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325874|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325875|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
56325876|NCT02288247|Hormones|hormones|mesh-ancestor
56325877|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325878|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325879|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325880|NCT02277444|Golimumab|golimumab|mesh-list
56325881|NCT02277444|Methotrexate|methotrexate|mesh-list
56325882|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56325883|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
56325884|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56325885|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325886|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56325887|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
56325888|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325889|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325890|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
56325891|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325892|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56325893|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325894|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
56325895|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325896|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56325897|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56325898|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325899|NCT02257736|Prednisone|prednisone|mesh-list
56325900|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
56325901|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325902|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
56325903|NCT02257736|Hormones|hormones|mesh-ancestor
56325904|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325905|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325906|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325907|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908177|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56908178|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56908179|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
56908180|NCT03776656|Allopurinol|allopurinol|mesh-list
56908181|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
56354728|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56325908|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56325909|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325910|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325911|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
56325912|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56325913|NCT02255409|Vaccines|vaccines|mesh-list
56325914|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
56325915|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325916|NCT02252172|Dexamethasone|dexamethasone|mesh-list
56325917|NCT02252172|Lenalidomide|lenalidomide|mesh-list
56325918|NCT02252172|Daratumumab|daratumumab|mesh-list
56325919|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56325920|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55965460|NCT05533567|Atracurium|atracurium|mesh-list
56325931|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
56325932|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56325933|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325934|NCT02252172|Growth Substances|growth substances|mesh-ancestor
56325935|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325936|NCT02213757|Estrogens|estrogens|mesh-list
56325937|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56325939|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325940|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325941|NCT02195479|Dexamethasone|dexamethasone|mesh-list
56325942|NCT02195479|Prednisone|prednisone|mesh-list
56325943|NCT02195479|Melphalan|melphalan|mesh-list
56325944|NCT02195479|Bortezomib|bortezomib|mesh-list
56325945|NCT02195479|Daratumumab|daratumumab|mesh-list
56325946|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56325947|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325948|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
56325949|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
56325950|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325951|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325952|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325953|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
56325954|NCT02195479|Hormones|hormones|mesh-ancestor
56325955|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325956|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325957|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325958|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56325959|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
56325960|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325961|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56325962|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325963|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
56325964|NCT02136134|Dexamethasone|dexamethasone|mesh-list
56325965|NCT02136134|Bortezomib|bortezomib|mesh-list
56325966|NCT02136134|Daratumumab|daratumumab|mesh-list
56325967|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325968|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
56325969|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
56325970|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325971|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325972|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325973|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
56325974|NCT02136134|Hormones|hormones|mesh-ancestor
56325975|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325976|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325977|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325978|NCT02123758|Prednisone|prednisone|mesh-list
56325979|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
56325980|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325981|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
56325982|NCT02123758|Hormones|hormones|mesh-ancestor
56325983|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908182|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908183|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908184|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
56908185|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908186|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56908187|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
56908188|NCT03776656|Protective Agents|protective agents|mesh-ancestor
56325984|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325985|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325986|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325989|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325991|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56325992|NCT02120404|Esmolol|esmolol|mesh-list
56325993|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56325994|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56325995|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56325996|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
56325997|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56325998|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325999|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326000|NCT02117791|Riociguat|riociguat|mesh-list
56326001|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
56326002|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326003|NCT02102243|Insulin|insulin|mesh-list
56326004|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56326005|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56326006|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326007|NCT02079740|Trametinib|trametinib|mesh-list
56326008|NCT02079740|Navitoclax|navitoclax|mesh-list
56326009|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326010|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56326011|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326012|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326014|NCT02076009|Lenalidomide|lenalidomide|mesh-list
55947825|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56326015|NCT02076009|Daratumumab|daratumumab|mesh-list
56326016|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326017|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
56326018|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
56326019|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326020|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326021|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56326022|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
56326023|NCT02076009|Hormones|hormones|mesh-ancestor
56326024|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326025|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56326026|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326027|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
56326028|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56326029|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56326030|NCT02076009|Growth Substances|growth substances|mesh-ancestor
56326031|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
56326032|NCT01998971|Acetaminophen|acetaminophen|mesh-list
56326033|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
56326034|NCT01998971|Promethazine|promethazine|mesh-list
56326035|NCT01998971|Thalidomide|thalidomide|mesh-list
56326036|NCT01998971|Dexamethasone|dexamethasone|mesh-list
56326037|NCT01998971|Prednisone|prednisone|mesh-list
56326038|NCT01998971|Lenalidomide|lenalidomide|mesh-list
56326039|NCT01998971|Melphalan|melphalan|mesh-list
56326040|NCT01998971|Bortezomib|bortezomib|mesh-list
56326041|NCT01998971|Daratumumab|daratumumab|mesh-list
56326042|NCT01998971|Pomalidomide|pomalidomide|mesh-list
56326043|NCT01998971|Montelukast|montelukast|mesh-list
56326044|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326045|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
56326046|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
56326047|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326048|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326049|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908189|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326050|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
56326051|NCT01998971|Hormones|hormones|mesh-ancestor
56326052|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326053|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56326054|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326055|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
56326056|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56326057|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56326058|NCT01998971|Growth Substances|growth substances|mesh-ancestor
56326059|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
56326060|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56326061|NCT01998971|Analgesics|analgesics|mesh-ancestor
56326063|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
56326064|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56326065|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
56326066|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326067|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56326068|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326069|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
56326070|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56326071|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326072|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56326073|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
56326074|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56326076|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56326077|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56326078|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56326079|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56326080|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326081|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
56326082|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
56326083|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56326084|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
56326086|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326087|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56326088|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
56326089|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
56326090|NCT01969227|Ketamine|ketamine|mesh-list
56326091|NCT01969227|Analgesics|analgesics|mesh-ancestor
56326092|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
56326093|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326094|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326096|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56326097|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
56326098|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
56326099|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326100|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56326101|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56326102|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326103|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326104|NCT01900574|Golimumab|golimumab|mesh-list
56326105|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56326106|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326107|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326108|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
56326109|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326110|NCT01792687|Prednisone|prednisone|mesh-list
56326111|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
56326112|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326113|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
56326114|NCT01792687|Hormones|hormones|mesh-ancestor
56326115|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326116|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326117|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56326118|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326119|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56326120|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326121|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326122|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
56326123|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56326124|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
56908190|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
56908191|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56908192|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
56326125|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326126|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326127|NCT01615029|Dexamethasone|dexamethasone|mesh-list
56326128|NCT01615029|Lenalidomide|lenalidomide|mesh-list
56326129|NCT01615029|Daratumumab|daratumumab|mesh-list
56326130|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56326131|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326132|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
56326133|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
56326134|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326135|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326136|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56326137|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
56326154|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
56326155|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
56326156|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
56326157|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
56326158|NCT01314118|Prednisone|prednisone|mesh-list
56326159|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
56326160|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326161|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
56326163|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326164|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326165|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56326166|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326167|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56326168|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326169|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326170|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
56326171|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56326172|NCT00981058|Gemcitabine|gemcitabine|mesh-list
56326173|NCT00981058|Necitumumab|necitumumab|mesh-list
56326174|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326175|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326176|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
56326177|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326178|NCT00981058|Antiviral Agents|antiviral agents|mesh-ancestor
56326179|NCT00981058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326180|NCT00981058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326181|NCT00981058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326182|NCT00981058|Immunologic Factors|immunologic factors|mesh-ancestor
56326183|NCT00981058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326184|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326185|NCT00980538|Etravirine|etravirine|mesh-list
56326186|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56326187|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56326188|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326189|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326190|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
56326191|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326192|NCT00644189|Clofarabine|clofarabine|mesh-list
56326193|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326194|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
56326195|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326196|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326197|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
56326198|NCT00630032|Docetaxel|docetaxel|mesh-list
56326199|NCT00630032|Fluorouracil|fluorouracil|mesh-list
56326207|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326209|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56326210|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
56326211|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
56326212|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
56326213|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
56326214|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326215|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56326216|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56326217|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56326218|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326219|NCT00465517|Ganaxolone|ganaxolone|mesh-list
56908193|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355021|NCT00247702|Warfarin|warfarin|mesh-list
56326220|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
56326221|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326222|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066326|NCT04484623|Dexamethasone|dexamethasone|mesh-list
56326223|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326224|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
56326226|NCT00289952|Valproic Acid|valproic acid|mesh-list
56326227|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
56326228|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326229|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326230|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
56326231|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326232|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326233|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
56326234|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56114002|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
56326235|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326236|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56326238|NCT05772871|Prednisone|prednisone|mesh-list
56326239|NCT05772871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326240|NCT05772871|Glucocorticoids|glucocorticoids|mesh-ancestor
56326241|NCT05772871|Hormones|hormones|mesh-ancestor
56326242|NCT05772871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326243|NCT05772871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326244|NCT05772871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56326245|NCT05772871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326246|NCT05772871|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56326247|NCT05772871|Immunologic Factors|immunologic factors|mesh-ancestor
56326248|NCT05772871|Antinematodal Agents|antinematodal agents|mesh-ancestor
56326249|NCT05772871|Anthelmintics|anthelmintics|mesh-ancestor
56326250|NCT05772871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56326251|NCT05772871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326252|NCT05772871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326253|NCT05772832|Dexmedetomidine|dexmedetomidine|mesh-list
56326254|NCT05772832|Remifentanil|remifentanil|mesh-list
56326255|NCT05772832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56326256|NCT05772832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326257|NCT05772832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326258|NCT05772832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56326259|NCT05772832|Analgesics|analgesics|mesh-ancestor
56326260|NCT05772832|Sensory System Agents|sensory system agents|mesh-ancestor
56326261|NCT05772832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326262|NCT05772832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56326263|NCT05772832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56326264|NCT05772832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56326265|NCT05772832|Adrenergic Agents|adrenergic agents|mesh-ancestor
56326266|NCT05772832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965794|NCT00450983|Methotrexate|methotrexate|mesh-list
56326268|NCT05772832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56326269|NCT05772832|Narcotics|narcotics|mesh-ancestor
56326270|NCT05772728|Azacitidine|azacitidine|mesh-list
56326271|NCT05772728|Mitoxantrone|mitoxantrone|mesh-list
56326272|NCT05772728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326273|NCT05772728|Antimetabolites|antimetabolites|mesh-ancestor
56326274|NCT05772728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326275|NCT05772728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326276|NCT05772728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326277|NCT05772728|Analgesics|analgesics|mesh-ancestor
56326278|NCT05772728|Sensory System Agents|sensory system agents|mesh-ancestor
56326279|NCT05772728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326280|NCT05772728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326281|NCT05772728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56326282|NCT05772728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56326284|NCT05772676|Antiemetics|antiemetics|mesh-ancestor
56326285|NCT05772676|Autonomic Agents|autonomic agents|mesh-ancestor
56326286|NCT05772676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326287|NCT05772676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326288|NCT05772676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56326289|NCT05772676|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56326290|NCT05772676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326291|NCT05772676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326292|NCT05772624|Nivolumab|nivolumab|mesh-list
56908194|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908195|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56908196|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
56326293|NCT05772624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326294|NCT05772624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326295|NCT05772624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56326296|NCT05772624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326297|NCT05772546|Maleic acid|maleic acid|mesh-list
56326299|NCT05772546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326300|NCT05772429|Cannabidiol|cannabidiol|mesh-list
56326301|NCT05772429|Anticonvulsants|anticonvulsants|mesh-ancestor
56326302|NCT05772377|Carboplatin|carboplatin|mesh-list
56326303|NCT05772377|Cisplatin|cisplatin|mesh-list
56326304|NCT05772377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326305|NCT05772364|Calcium, Dietary|calcium, dietary|mesh-list
56326306|NCT05772364|Calcium|calcium|mesh-list
56326307|NCT05772364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56326308|NCT05772364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326309|NCT05772364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56326310|NCT05772273|Azacitidine|azacitidine|mesh-list
56326311|NCT05772273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326312|NCT05772273|Antimetabolites|antimetabolites|mesh-ancestor
56326313|NCT05772273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326314|NCT05772273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326315|NCT05772273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326316|NCT05772208|Nimotuzumab|nimotuzumab|mesh-list
56326317|NCT05772208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326318|NCT05772208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326319|NCT05772169|Mifepristone|mifepristone|mesh-list
56326320|NCT05772169|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56326321|NCT05772169|Abortifacient Agents|abortifacient agents|mesh-ancestor
56326322|NCT05772169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56326323|NCT05772169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326324|NCT05772169|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56326325|NCT05772169|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56326326|NCT05772169|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56326327|NCT05772169|Contraceptive Agents|contraceptive agents|mesh-ancestor
56326328|NCT05772169|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56326329|NCT05772169|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56326330|NCT05772169|Hormone Antagonists|hormone antagonists|mesh-ancestor
56326331|NCT05772169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326332|NCT05772169|Luteolytic Agents|luteolytic agents|mesh-ancestor
56326333|NCT05772169|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56326334|NCT05772169|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56326335|NCT05772156|Methylergonovine|methylergonovine|mesh-list
56326336|NCT05772156|Oxytocics|oxytocics|mesh-ancestor
56326337|NCT05772156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56326338|NCT05772156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326339|NCT05772039|Listerine|listerine|mesh-list
56326343|NCT05772039|Protective Agents|protective agents|mesh-ancestor
56326344|NCT05772039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326345|NCT05772039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56326346|NCT05772039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326347|NCT05772013|Azithromycin|azithromycin|mesh-list
56326348|NCT05772013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56326349|NCT05772013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326350|NCT05771883|Lenalidomide|lenalidomide|mesh-list
56326351|NCT05771883|Immunologic Factors|immunologic factors|mesh-ancestor
56326352|NCT05771883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326353|NCT05771883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56326354|NCT05771883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56326355|NCT05771883|Growth Substances|growth substances|mesh-ancestor
56326356|NCT05771883|Growth Inhibitors|growth inhibitors|mesh-ancestor
56326357|NCT05771883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326358|NCT05771779|Vaccines|vaccines|mesh-list
56326359|NCT05771779|Immunologic Factors|immunologic factors|mesh-ancestor
56326360|NCT05771779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326361|NCT05771675|Simvastatin|simvastatin|mesh-list
56326362|NCT05771675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56326363|NCT05771675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56326364|NCT05771675|Antimetabolites|antimetabolites|mesh-ancestor
55887846|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56908197|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908198|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326365|NCT05771675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326366|NCT05771675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56326367|NCT05771675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56326368|NCT05771675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326369|NCT05771584|Sargramostim|sargramostim|mesh-list
56326370|NCT05771584|Immunologic Factors|immunologic factors|mesh-ancestor
56326371|NCT05771584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326372|NCT05771480|Gemcitabine|gemcitabine|mesh-list
56326374|NCT05771480|Cisplatin|cisplatin|mesh-list
56326375|NCT05771480|Carboplatin|carboplatin|mesh-list
56326376|NCT05771480|Oxaliplatin|oxaliplatin|mesh-list
56326377|NCT05771480|Durvalumab|durvalumab|mesh-list
56326378|NCT05771480|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56326379|NCT05771480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56326380|NCT05771480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326381|NCT05771480|Tubulin Modulators|tubulin modulators|mesh-ancestor
56326382|NCT05771480|Antimitotic Agents|antimitotic agents|mesh-ancestor
56326383|NCT05771480|Mitosis Modulators|mitosis modulators|mesh-ancestor
56326384|NCT05771480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326385|NCT05771480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326386|NCT05771480|Antimetabolites|antimetabolites|mesh-ancestor
56326387|NCT05771480|Antiviral Agents|antiviral agents|mesh-ancestor
56326388|NCT05771480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326389|NCT05771480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326390|NCT05771480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326391|NCT05771480|Immunologic Factors|immunologic factors|mesh-ancestor
56326392|NCT05771480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326393|NCT05771480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326394|NCT05771402|Antibodies|antibodies|mesh-list
56326395|NCT05771402|Immunologic Factors|immunologic factors|mesh-ancestor
56326396|NCT05771402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326397|NCT05771194|Lubricant Eye Drops|lubricant eye drops|mesh-list
56326398|NCT05771194|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56326399|NCT05771194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56326400|NCT05771181|Vitamin E|vitamin e|mesh-list
56326401|NCT05771181|Vitamins|vitamins|mesh-ancestor
56326402|NCT05771181|Micronutrients|micronutrients|mesh-ancestor
56326403|NCT05771181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326404|NCT05771181|Antioxidants|antioxidants|mesh-ancestor
56326405|NCT05771181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326406|NCT05771181|Protective Agents|protective agents|mesh-ancestor
56326407|NCT05771038|Alendronate|alendronate|mesh-list
56326408|NCT05771038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56326409|NCT05771038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326410|NCT05771012|Cyclosporine|cyclosporine|mesh-list
56326411|NCT05771012|Cyclosporins|cyclosporins|mesh-list
56326412|NCT05771012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326413|NCT05771012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326414|NCT05771012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326415|NCT05771012|Immunologic Factors|immunologic factors|mesh-ancestor
56326427|NCT05770960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326428|NCT05770960|Analgesics|analgesics|mesh-ancestor
56326429|NCT05770960|Sensory System Agents|sensory system agents|mesh-ancestor
56326430|NCT05770960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326431|NCT05770960|Antitussive Agents|antitussive agents|mesh-ancestor
56326432|NCT05770960|Respiratory System Agents|respiratory system agents|mesh-ancestor
56326433|NCT05770960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56326434|NCT05769946|Hemay005|hemay005|mesh-list
56326435|NCT05769946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56326436|NCT05769946|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56326437|NCT05769946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56326438|NCT05769946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326439|NCT05769946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326440|NCT05768282|Prednisolone|prednisolone|mesh-list
56326441|NCT05768282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326442|NCT05768282|Glucocorticoids|glucocorticoids|mesh-ancestor
56326443|NCT05768282|Hormones|hormones|mesh-ancestor
56326444|NCT05768282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326445|NCT05768282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326446|NCT05768282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56326447|NCT05768282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908199|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56908200|NCT00126581|Paclitaxel|paclitaxel|mesh-list
56908201|NCT00126581|Carboplatin|carboplatin|mesh-list
56908202|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56908203|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56908204|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908205|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908206|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908207|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
56618851|NCT00825019|Paroxetine|paroxetine|mesh-list
56908208|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
56355231|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
56326448|NCT05766800|Paclitaxel|paclitaxel|mesh-list
56326449|NCT05766800|Carboplatin|carboplatin|mesh-list
56326451|NCT05766800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56326452|NCT05766800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326453|NCT05766800|Tubulin Modulators|tubulin modulators|mesh-ancestor
56326454|NCT05766800|Antimitotic Agents|antimitotic agents|mesh-ancestor
56326455|NCT05766800|Mitosis Modulators|mitosis modulators|mesh-ancestor
56326456|NCT05766800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326457|NCT05766800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326458|NCT05766800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56326459|NCT05766800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56326460|NCT05766410|Letrozole|letrozole|mesh-list
56326461|NCT05766410|Palbociclib|palbociclib|mesh-list
56326462|NCT05766410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326463|NCT05766410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56326464|NCT05766410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56326465|NCT05766410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326466|NCT05766410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326467|NCT05766410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56326468|NCT05766410|Hormone Antagonists|hormone antagonists|mesh-ancestor
56326469|NCT05766410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326470|NCT05766410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326471|NCT05766410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56326472|NCT05757011|Bupivacaine|bupivacaine|mesh-list
56326473|NCT05757011|Anesthetics, Local|anesthetics, local|mesh-ancestor
56326474|NCT05757011|Anesthetics|anesthetics|mesh-ancestor
56326475|NCT05757011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326476|NCT05757011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326477|NCT05757011|Sensory System Agents|sensory system agents|mesh-ancestor
56326478|NCT05757011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326479|NCT05756166|Interferons|interferons|mesh-list
56326480|NCT05756166|Interferon-alpha|interferon-alpha|mesh-list
56326481|NCT05756166|Interferon alpha-2|interferon alpha-2|mesh-list
56326484|NCT05756166|Pembrolizumab|pembrolizumab|mesh-list
56326485|NCT05756166|Benzenesulfonamide|benzenesulfonamide|mesh-list
56326486|NCT05756166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326487|NCT05756166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326488|NCT05756166|Antiviral Agents|antiviral agents|mesh-ancestor
56326489|NCT05756166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326490|NCT05756166|Immunologic Factors|immunologic factors|mesh-ancestor
56326491|NCT05756166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326492|NCT05756166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56326493|NCT05756166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56326494|NCT05756166|Analgesics|analgesics|mesh-ancestor
56326495|NCT05756166|Sensory System Agents|sensory system agents|mesh-ancestor
56326496|NCT05756166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326497|NCT05756166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326498|NCT05756166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326499|NCT05756166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56326500|NCT05756166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56326501|NCT05756166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326502|NCT05756166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887847|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908209|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908210|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56326503|NCT05756166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56326504|NCT05754996|Nifuroxazide|nifuroxazide|mesh-list
56326505|NCT05754996|Lactulose|lactulose|mesh-list
56326506|NCT05754996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56326507|NCT05754996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326508|NCT05750875|Loratadine|loratadine|mesh-list
56326509|NCT05750875|Gabapentin|gabapentin|mesh-list
56326510|NCT05750875|Analgesics|analgesics|mesh-ancestor
56326511|NCT05750875|Sensory System Agents|sensory system agents|mesh-ancestor
56326512|NCT05750875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326513|NCT05750875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326514|NCT05750875|Anticonvulsants|anticonvulsants|mesh-ancestor
56326515|NCT05750875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56326516|NCT05750875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56326517|NCT05750875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326518|NCT05750875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56326519|NCT05750875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56326520|NCT05750875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56326521|NCT05750875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326522|NCT05750875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326523|NCT05750875|Antimanic Agents|antimanic agents|mesh-ancestor
56326524|NCT05750875|Antipruritics|antipruritics|mesh-ancestor
56326526|NCT05750875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56326527|NCT05750875|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56326528|NCT05750875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56326529|NCT05750875|Histamine Antagonists|histamine antagonists|mesh-ancestor
56326530|NCT05750875|Histamine Agents|histamine agents|mesh-ancestor
56326531|NCT05736562|Vitamins|vitamins|mesh-list
56326532|NCT05736562|Micronutrients|micronutrients|mesh-ancestor
56326533|NCT05736562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326534|NCT05734794|Rituximab|rituximab|mesh-list
56326535|NCT05734794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326536|NCT05734794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326537|NCT05734794|Immunologic Factors|immunologic factors|mesh-ancestor
56326538|NCT05734794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326539|NCT05734794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326540|NCT05724134|Insulin|insulin|mesh-list
56326541|NCT05724134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56326542|NCT05724134|Octreotide|octreotide|mesh-list
56326543|NCT05724134|Glucagon|glucagon|mesh-list
56326544|NCT05724134|Hormones|hormones|mesh-list
56326545|NCT05724134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56326546|NCT05724134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326547|NCT05724134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326548|NCT05724134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56326549|NCT05724134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56326550|NCT05724134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326551|NCT05715073|Caffeine|caffeine|mesh-list
56326552|NCT05715073|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56326553|NCT05715073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326554|NCT05715073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56326555|NCT05715073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326556|NCT05715073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326558|NCT05715073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56326559|NCT05715073|Purinergic Agents|purinergic agents|mesh-ancestor
56326560|NCT05715073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326561|NCT05702671|Immunoglobulins|immunoglobulins|mesh-list
56326562|NCT05702671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56326563|NCT05702671|Antibodies|antibodies|mesh-list
56326564|NCT05702671|Immunologic Factors|immunologic factors|mesh-ancestor
56326565|NCT05702671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326566|NCT05702463|Aspirin|aspirin|mesh-list
56326567|NCT05702463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56326568|NCT05702463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56326569|NCT05702463|Analgesics|analgesics|mesh-ancestor
56326570|NCT05702463|Sensory System Agents|sensory system agents|mesh-ancestor
56326571|NCT05702463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326572|NCT05702463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326573|NCT05702463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326574|NCT05702463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326575|NCT05702463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56908211|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908212|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
56326576|NCT05702463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56326577|NCT05702463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326578|NCT05702463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56326579|NCT05702463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56326580|NCT05702463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326581|NCT05702463|Antipyretics|antipyretics|mesh-ancestor
56326582|NCT05696795|Abrocitinib|abrocitinib|mesh-list
56326583|NCT05696795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56326584|NCT05696795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326585|NCT05696795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326586|NCT05694637|Varenicline|varenicline|mesh-list
56326587|NCT05694637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56326588|NCT05694637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56326589|NCT05694637|Cholinergic Agents|cholinergic agents|mesh-ancestor
56326590|NCT05694637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326591|NCT05694637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326592|NCT05694637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326593|NCT05689359|Hydroxychloroquine|hydroxychloroquine|mesh-list
56326594|NCT05689359|Antimalarials|antimalarials|mesh-ancestor
56326595|NCT05689359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56326596|NCT05689359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56326597|NCT05689359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326598|NCT05689359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066693|NCT01930747|Analgesics|analgesics|mesh-ancestor
56326599|NCT05689359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326600|NCT05689359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326602|NCT05680584|Hydroxyzine|hydroxyzine|mesh-list
56326603|NCT05680584|Antioxidants|antioxidants|mesh-ancestor
56326604|NCT05680584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326605|NCT05680584|Protective Agents|protective agents|mesh-ancestor
56326606|NCT05680584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326607|NCT05680584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326608|NCT05680584|Antipruritics|antipruritics|mesh-ancestor
56326609|NCT05680584|Dermatologic Agents|dermatologic agents|mesh-ancestor
56326610|NCT05680584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56326612|NCT05680584|Histamine Agents|histamine agents|mesh-ancestor
56326613|NCT05680584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326614|NCT05676034|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56326615|NCT05676034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326616|NCT05673200|Paclitaxel|paclitaxel|mesh-list
56326617|NCT05673200|Pembrolizumab|pembrolizumab|mesh-list
56326618|NCT05673200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56326619|NCT05673200|Decitabine|decitabine|mesh-list
56326620|NCT05673200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56326621|NCT05673200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326622|NCT05673200|Tubulin Modulators|tubulin modulators|mesh-ancestor
55948442|NCT01892813|Bupropion|bupropion|mesh-list
56326623|NCT05673200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56326624|NCT05673200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56326625|NCT05673200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326626|NCT05673200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326627|NCT05673200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326628|NCT05673200|Antimetabolites|antimetabolites|mesh-ancestor
56326629|NCT05673200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326630|NCT05672173|Cyclophosphamide|cyclophosphamide|mesh-list
56326632|NCT05672173|Fludarabine|fludarabine|mesh-list
56326636|NCT05672173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326637|NCT05672173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56326638|NCT05672173|Alkylating Agents|alkylating agents|mesh-ancestor
56326639|NCT05672173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326640|NCT05672173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326641|NCT05672173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56326642|NCT05672173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326643|NCT05672173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56326644|NCT05668091|Ritonavir|ritonavir|mesh-list
56326645|NCT05668091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56326646|NCT05668091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56326647|NCT05668091|Protease Inhibitors|protease inhibitors|mesh-ancestor
56326648|NCT05668091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326649|NCT05668091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326650|NCT05668091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56326651|NCT05668091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56355442|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56326652|NCT05668091|Antiviral Agents|antiviral agents|mesh-ancestor
56326653|NCT05668091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326654|NCT05668091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56326655|NCT05668091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56326656|NCT05664737|Luspatercept|luspatercept|mesh-list
56326657|NCT05664737|Hematinics|hematinics|mesh-ancestor
56326658|NCT05660967|Lenalidomide|lenalidomide|mesh-list
56326659|NCT05660967|Immunologic Factors|immunologic factors|mesh-ancestor
56326660|NCT05660967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326661|NCT05660967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56326662|NCT05660967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56326663|NCT05660967|Growth Substances|growth substances|mesh-ancestor
56326664|NCT05660967|Growth Inhibitors|growth inhibitors|mesh-ancestor
56326665|NCT05660967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326666|NCT05655949|Gemcitabine|gemcitabine|mesh-list
56326667|NCT05655949|Cisplatin|cisplatin|mesh-list
56326668|NCT05655949|Durvalumab|durvalumab|mesh-list
56326669|NCT05655949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326670|NCT05655949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326671|NCT05655949|Antimetabolites|antimetabolites|mesh-ancestor
56326672|NCT05655949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326673|NCT05655949|Antiviral Agents|antiviral agents|mesh-ancestor
56066773|NCT02641691|Leucovorin|leucovorin|mesh-list
56326676|NCT05655949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326677|NCT05655949|Immunologic Factors|immunologic factors|mesh-ancestor
56326678|NCT05655949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326679|NCT05655949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326680|NCT05650736|Abrocitinib|abrocitinib|mesh-list
56326681|NCT05650736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56326682|NCT05650736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326683|NCT05650736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326684|NCT05646992|Azathioprine|azathioprine|mesh-list
56326685|NCT05646992|Tacrolimus|tacrolimus|mesh-list
56326686|NCT05646992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326687|NCT05646992|Immunologic Factors|immunologic factors|mesh-ancestor
56326688|NCT05646992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326689|NCT05646992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56326690|NCT05646992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326691|NCT05646992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326692|NCT05646992|Antimetabolites|antimetabolites|mesh-ancestor
56326693|NCT05646992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326694|NCT05646992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326695|NCT05646992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326696|NCT05646693|Amitriptyline|amitriptyline|mesh-list
56326697|NCT05646693|Magnesium Oxide|magnesium oxide|mesh-list
56326698|NCT05646693|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56326699|NCT05646693|Antidepressive Agents|antidepressive agents|mesh-ancestor
56326700|NCT05646693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56326701|NCT05646693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56326702|NCT05646693|Analgesics|analgesics|mesh-ancestor
56326703|NCT05646693|Sensory System Agents|sensory system agents|mesh-ancestor
56326704|NCT05646693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326705|NCT05646693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326706|NCT05646693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56326707|NCT05646693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56326708|NCT05646693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56326709|NCT05646693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326710|NCT05646693|Adrenergic Agents|adrenergic agents|mesh-ancestor
56326711|NCT05646693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326713|NCT05646693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56326714|NCT05646303|Psilocybin|psilocybin|mesh-list
56326715|NCT05646303|Hallucinogens|hallucinogens|mesh-ancestor
56326716|NCT05646303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326717|NCT05646303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56326718|NCT05644665|Ozanimod|ozanimod|mesh-list
56326719|NCT05644665|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56326720|NCT05644665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326721|NCT05644665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326722|NCT05644665|Immunologic Factors|immunologic factors|mesh-ancestor
56326723|NCT05644665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326724|NCT05637606|Etilefrine|etilefrine|mesh-list
56326725|NCT05637606|Norepinephrine|norepinephrine|mesh-list
56326726|NCT05637606|Ephedrine|ephedrine|mesh-list
56326727|NCT05637606|Pseudoephedrine|pseudoephedrine|mesh-list
56908213|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56908214|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56326728|NCT05637606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56326729|NCT05637606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56326730|NCT05637606|Adrenergic Agents|adrenergic agents|mesh-ancestor
56326731|NCT05637606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326732|NCT05637606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326733|NCT05637606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326734|NCT05637606|Sympathomimetics|sympathomimetics|mesh-ancestor
56326735|NCT05637606|Autonomic Agents|autonomic agents|mesh-ancestor
56326736|NCT05637606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326737|NCT05637606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56326738|NCT05637606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56326739|NCT05637606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56326740|NCT05637606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56326741|NCT05637606|Respiratory System Agents|respiratory system agents|mesh-ancestor
56326742|NCT05637606|Nasal Decongestants|nasal decongestants|mesh-ancestor
56326743|NCT05637606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56326744|NCT05637606|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56326745|NCT05637606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56326746|NCT05637606|Protective Agents|protective agents|mesh-ancestor
56326761|NCT05630755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56326762|NCT05630755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56326771|NCT05625412|Docetaxel|docetaxel|mesh-list
56326772|NCT05625412|Capecitabine|capecitabine|mesh-list
55948587|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326774|NCT05625412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326775|NCT05625412|Tubulin Modulators|tubulin modulators|mesh-ancestor
56326776|NCT05625412|Antimitotic Agents|antimitotic agents|mesh-ancestor
56326777|NCT05625412|Mitosis Modulators|mitosis modulators|mesh-ancestor
56326778|NCT05625412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326779|NCT05625412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56326781|NCT05625412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326782|NCT05625412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56326783|NCT05604222|Mirabegron|mirabegron|mesh-list
56326784|NCT05604222|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56326785|NCT05604222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56326786|NCT05604222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56326787|NCT05604222|Adrenergic Agents|adrenergic agents|mesh-ancestor
56326788|NCT05604222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326789|NCT05604222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326790|NCT05604222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326791|NCT05604222|Urological Agents|urological agents|mesh-ancestor
56326792|NCT05597878|Acetaminophen|acetaminophen|mesh-list
56326793|NCT05597878|Ketorolac|ketorolac|mesh-list
56326794|NCT05597878|Ketamine|ketamine|mesh-list
56326795|NCT05597878|Oxycodone|oxycodone|mesh-list
56326796|NCT05597878|Analgesics|analgesics|mesh-ancestor
56326797|NCT05597878|Sensory System Agents|sensory system agents|mesh-ancestor
56326798|NCT05597878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326799|NCT05597878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326800|NCT05597878|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56326801|NCT05597878|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56326802|NCT05597878|Anesthetics, General|anesthetics, general|mesh-ancestor
56326803|NCT05597878|Anesthetics|anesthetics|mesh-ancestor
56326806|NCT05597878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56326807|NCT05597878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326808|NCT05597878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326809|NCT05597878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56326810|NCT05597878|Antipyretics|antipyretics|mesh-ancestor
56326811|NCT05597878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56326812|NCT05597878|Narcotics|narcotics|mesh-ancestor
56326813|NCT05597878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56326814|NCT05597878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326815|NCT05597878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326816|NCT05597878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56326817|NCT05597878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326819|NCT05592223|BCG Vaccine|bcg vaccine|mesh-list
56326820|NCT05592223|Antitubercular Agents|antitubercular agents|mesh-ancestor
56326821|NCT05592223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56326822|NCT05592223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326823|NCT05592223|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56326824|NCT05592223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56908215|NCT03704584|Prednisolone|prednisolone|mesh-list
56908216|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
56908217|NCT03704584|Lidocaine|lidocaine|mesh-list
56908218|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56908219|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
56908220|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
56326825|NCT05592223|Antimetabolites|antimetabolites|mesh-ancestor
56326826|NCT05592223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326827|NCT05592223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56326828|NCT05592223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56326829|NCT05592223|Immunologic Factors|immunologic factors|mesh-ancestor
56326830|NCT05592223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326831|NCT05581589|Camptothecin|camptothecin|mesh-list
56326832|NCT05581589|Irinotecan|irinotecan|mesh-list
56326833|NCT05581589|Immunoconjugates|immunoconjugates|mesh-list
56326834|NCT05581589|Immunologic Factors|immunologic factors|mesh-ancestor
56326835|NCT05581589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326836|NCT05581589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56326837|NCT05581589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326838|NCT05581589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56326839|NCT05581589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56326840|NCT05581589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326841|NCT05581589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326842|NCT05576077|Pembrolizumab|pembrolizumab|mesh-list
56326843|NCT05576077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326844|NCT05576077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326845|NCT05570825|Pembrolizumab|pembrolizumab|mesh-list
56326846|NCT05570825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326847|NCT05570825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326849|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56326850|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
56326851|NCT05549206|Vaccines|vaccines|mesh-list
56326852|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
56326853|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326854|NCT05533684|Gabapentin|gabapentin|mesh-list
56326855|NCT05533684|Analgesics|analgesics|mesh-ancestor
56326856|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
56326857|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326858|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326859|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
56326860|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56326861|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56326862|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326863|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56326864|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56326865|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56326866|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326867|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326868|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
56326869|NCT05533164|Rituximab|rituximab|mesh-list
56326870|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326871|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326872|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
56326873|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326874|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326875|NCT05514132|Durvalumab|durvalumab|mesh-list
56326876|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56326898|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326899|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326905|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326912|NCT05458479|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56326913|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56326914|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56326915|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326916|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326917|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
56326918|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326919|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56326920|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
56908221|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
56908222|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908223|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908224|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
56355668|NCT00251914|Esomeprazole|esomeprazole|mesh-list
56326921|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56326922|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56326923|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56326924|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326925|NCT05444530|Ipilimumab|ipilimumab|mesh-list
56326926|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326927|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326928|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56326929|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326930|NCT05433961|Xenon|xenon|mesh-list
56326931|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56326932|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
56326933|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
56326934|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326935|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326936|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56326937|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56326938|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326939|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326943|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56326944|NCT05420337|Narcotics|narcotics|mesh-ancestor
56326945|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326946|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326947|NCT05420337|Analgesics|analgesics|mesh-ancestor
56326948|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
56326949|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326950|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
56326951|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56326952|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
56326953|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326954|NCT05408247|Expectorants|expectorants|mesh-ancestor
56326955|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
56326956|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56326957|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
56326958|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326959|NCT05408247|Protective Agents|protective agents|mesh-ancestor
56326960|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326961|NCT05408247|Antidotes|antidotes|mesh-ancestor
56326962|NCT05406401|Prednisone|prednisone|mesh-list
56326963|NCT05406401|Prednisolone|prednisolone|mesh-list
56326964|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
56326965|NCT05406401|Rituximab|rituximab|mesh-list
56326966|NCT05406401|Doxorubicin|doxorubicin|mesh-list
56326967|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326968|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
56326969|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326970|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326971|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56326972|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
56067077|NCT02654483|Serlopitant|serlopitant|mesh-list
56326977|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56326978|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56326979|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56326981|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56326982|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
56326983|NCT05406401|Hormones|hormones|mesh-ancestor
56326984|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326985|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56326986|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
56326987|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56326988|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
56326989|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326990|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083608|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
56908225|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908226|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56908227|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56326991|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326992|NCT05383352|Leucovorin|leucovorin|mesh-list
56326993|NCT05383352|Folic Acid|folic acid|mesh-list
56326994|NCT05383352|Fluorouracil|fluorouracil|mesh-list
56326995|NCT05383352|Irinotecan|irinotecan|mesh-list
56326996|NCT05383352|Camptothecin|camptothecin|mesh-list
56326997|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
56326998|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
56326999|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327000|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56327001|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327002|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327003|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
56327004|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327005|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56327006|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56327007|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327008|NCT05383352|Antidotes|antidotes|mesh-ancestor
56327009|NCT05383352|Protective Agents|protective agents|mesh-ancestor
56327010|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
56327011|NCT05383352|Vitamins|vitamins|mesh-ancestor
56327012|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
56327013|NCT05383352|Hematinics|hematinics|mesh-ancestor
56327014|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56327015|NCT05375942|Infliximab|infliximab|mesh-list
56327016|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
56327017|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56327023|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
56327024|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327025|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327026|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56327027|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
56327028|NCT05372354|Hormones|hormones|mesh-ancestor
56327029|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56327030|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56327031|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327032|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327033|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327034|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327035|NCT05345782|Bupivacaine|bupivacaine|mesh-list
56327036|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
56327037|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
56327038|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56327039|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327040|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
56327041|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327051|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56327052|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327053|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327054|NCT05287906|Protective Agents|protective agents|mesh-ancestor
56327055|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327057|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
56327058|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327059|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56327060|NCT05209308|Rituximab|rituximab|mesh-list
56327061|NCT05209308|Venetoclax|venetoclax|mesh-list
56327062|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327063|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327064|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
56327065|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327066|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56327070|NCT05201066|Azacitidine|azacitidine|mesh-list
56327071|NCT05201066|Decitabine|decitabine|mesh-list
56327072|NCT05201066|Venetoclax|venetoclax|mesh-list
55948889|NCT02588105|Leucovorin|leucovorin|mesh-list
56327073|NCT05201066|Spartalizumab|spartalizumab|mesh-list
56327074|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56327075|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
56327076|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327077|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908228|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56908229|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56908230|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908231|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56908232|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
56908233|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
56908234|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908235|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
56327078|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327079|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56327080|NCT05180357|Benralizumab|benralizumab|mesh-list
56327081|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56327082|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
56327083|NCT05157581|Methoxsalen|methoxsalen|mesh-list
56327084|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56327085|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
56327086|NCT05153317|Ivacaftor|ivacaftor|mesh-list
56327087|NCT05153317|Elexacaftor|elexacaftor|mesh-list
56327088|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56327089|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56327090|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327091|NCT05150938|Vitamin K|vitamin k|mesh-list
56327092|NCT05150938|Heparin|heparin|mesh-list
56327093|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56327094|NCT05150938|Tinzaparin|tinzaparin|mesh-list
56327095|NCT05150938|Dalteparin|dalteparin|mesh-list
56327096|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
56327097|NCT05150938|Vitamins|vitamins|mesh-ancestor
56327098|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
56327099|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327100|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
56327101|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56327102|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55966583|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
56327142|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56327143|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56327144|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327145|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
56327146|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327147|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56327148|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56327149|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56327150|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56327151|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
56327152|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327153|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327154|NCT05050253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56327155|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56327156|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
56327157|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56327158|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
56327159|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56327160|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327161|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56327162|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56327163|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327164|NCT05010122|Decitabine|decitabine|mesh-list
56327165|NCT05010122|Venetoclax|venetoclax|mesh-list
56327166|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56327167|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
56327168|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327169|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327170|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327172|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
56327173|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327174|NCT05006794|Gemcitabine|gemcitabine|mesh-list
56327175|NCT05006794|Docetaxel|docetaxel|mesh-list
56327176|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56327177|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
56908236|NCT03704584|Hormones|hormones|mesh-ancestor
56908237|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908238|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56908239|NCT03704584|Protective Agents|protective agents|mesh-ancestor
56908240|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56908241|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908242|NCT03643510|Fulvestrant|fulvestrant|mesh-list
56908243|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55744289|NCT02496715|Fluticasone|fluticasone|mesh-list
56327184|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
56327185|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327186|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
56327187|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
56327188|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
56327189|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
56327191|NCT04949256|Paclitaxel|paclitaxel|mesh-list
56327192|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
56327193|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
56327194|NCT04949256|Lenvatinib|lenvatinib|mesh-list
56327195|NCT04949256|Calcium|calcium|mesh-list
56327196|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
56327197|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56327198|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327199|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56327200|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56327201|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56327202|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327203|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327204|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56327205|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327206|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56327207|NCT04949256|Antidotes|antidotes|mesh-ancestor
56327208|NCT04949256|Protective Agents|protective agents|mesh-ancestor
56327209|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
56327210|NCT04949256|Vitamins|vitamins|mesh-ancestor
56327211|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
56327212|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327213|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327214|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56327215|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56327216|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56327217|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327218|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
56327219|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327220|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327221|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
56327222|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
56327223|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
56327224|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
56327225|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327226|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327227|NCT04916418|Ropivacaine|ropivacaine|mesh-list
56327228|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
56327229|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
56327230|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56327231|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327232|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
56327233|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327239|NCT04905693|Treprostinil|treprostinil|mesh-list
56327240|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56327241|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56161658|NCT03582930|Calfactant|calfactant|mesh-list
56327242|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56327243|NCT04893096|Felzartamab|felzartamab|mesh-list
56327244|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327245|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
56327246|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327247|NCT04892511|Nitroprusside|nitroprusside|mesh-list
56327248|NCT04892511|Labetalol|labetalol|mesh-list
56327249|NCT04892511|Urapidil|urapidil|mesh-list
56908244|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908245|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56908246|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56908247|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
56908248|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908249|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908250|NCT03737721|Avelumab|avelumab|mesh-list
56355936|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
56327250|NCT04892511|Phenylephrine|phenylephrine|mesh-list
56327251|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56327252|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
56327253|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
56327255|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327256|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
56327257|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56327258|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
56327259|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
56327260|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56327261|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56327262|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56327263|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
56327264|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327265|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327266|NCT04892511|Protective Agents|protective agents|mesh-ancestor
56327267|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56327268|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
56327269|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56327270|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56327271|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56327272|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56327273|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56327274|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56327275|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
56327276|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56327277|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56327287|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
56327288|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327289|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327290|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56327291|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56327292|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327293|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
56327294|NCT04785118|Scopolamine|scopolamine|mesh-list
56327295|NCT04785118|Ondansetron|ondansetron|mesh-list
56327296|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56327297|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
56327298|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
56327299|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327300|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327301|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56327302|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
56327303|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
56327304|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56327305|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
56327306|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327307|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327308|NCT04785118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56327309|NCT04785118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56327310|NCT04785118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56327311|NCT04785118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56327312|NCT04785118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56327313|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56327314|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
56327315|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56327316|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
56327317|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56327318|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
56908251|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56908252|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908253|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
56908254|NCT03647709|Narcotics|narcotics|mesh-ancestor
56908255|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908256|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908257|NCT03647709|Analgesics|analgesics|mesh-ancestor
56908258|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
56908259|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908260|NCT03546634|Vaccines|vaccines|mesh-list
56908261|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
56908262|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908263|NCT03621748|Anesthetics|anesthetics|mesh-list
56327327|NCT04752163|Leucovorin|leucovorin|mesh-list
56327328|NCT04752163|Cytarabine|cytarabine|mesh-list
56327329|NCT04752163|Voriconazole|voriconazole|mesh-list
56327330|NCT04752163|Posaconazole|posaconazole|mesh-list
56327331|NCT04752163|Dexamethasone|dexamethasone|mesh-list
56327332|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
56327333|NCT04752163|Prednisone|prednisone|mesh-list
56327334|NCT04752163|Cortisone|cortisone|mesh-list
56327335|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
56327337|NCT04752163|Methotrexate|methotrexate|mesh-list
56327338|NCT04752163|Vincristine|vincristine|mesh-list
56327339|NCT04752163|Azacitidine|azacitidine|mesh-list
56327340|NCT04752163|Venetoclax|venetoclax|mesh-list
56327341|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56327342|NCT04752163|Antibodies|antibodies|mesh-list
56327343|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
56327344|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56327345|NCT04752163|Lenograstim|lenograstim|mesh-list
56327346|NCT04752163|BB 1101|bb 1101|mesh-list
56327347|NCT04752163|Mesna|mesna|mesh-list
56327348|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327350|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327352|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56327353|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
56327354|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327355|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327356|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56327357|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56327358|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
56327359|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
56327360|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327361|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56327363|NCT04752163|Hormones|hormones|mesh-ancestor
56327364|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56327365|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56327366|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
56327367|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327368|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56327369|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
56327370|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56327371|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56327372|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
56327373|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
56327374|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56327375|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56327376|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
56327377|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56327378|NCT04752163|Antidotes|antidotes|mesh-ancestor
56327379|NCT04752163|Protective Agents|protective agents|mesh-ancestor
56327380|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
56327381|NCT04752163|Vitamins|vitamins|mesh-ancestor
56327382|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
56327383|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56327384|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908264|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908265|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908266|NCT03661983|Aripiprazole|aripiprazole|mesh-list
56908267|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
56908268|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56356066|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
56327385|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
56327386|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
56327387|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
56327388|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
56327389|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56327390|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56327391|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56327392|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
56327393|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56327394|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56327395|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56327396|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56327397|NCT04735926|Calcifediol|calcifediol|mesh-list
56327399|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
56327400|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327401|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56327402|NCT04720768|Palbociclib|palbociclib|mesh-list
56327403|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327404|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327405|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327406|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327407|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
56327408|NCT04702256|Prednisone|prednisone|mesh-list
56327409|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
56327410|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56327411|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56327412|NCT04702256|Prednisolone|prednisolone|mesh-list
56327413|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
56327414|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
56115106|NCT00002369|Zidovudine|zidovudine|mesh-list
56327415|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56327416|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
56327417|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56327418|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56327419|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
56327420|NCT04702256|Hormones|hormones|mesh-ancestor
56327421|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56327422|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327423|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56327438|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327439|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56327440|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
56327441|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
56327442|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327444|NCT04700072|Lenvatinib|lenvatinib|mesh-list
56327445|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327446|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327447|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327448|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327449|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327450|NCT04671966|Cetrorelix|cetrorelix|mesh-list
56327451|NCT04671966|Estradiol|estradiol|mesh-list
56327452|NCT04671966|Estrogens|estrogens|mesh-ancestor
56327453|NCT04671966|Hormones|hormones|mesh-ancestor
56327454|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56327455|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327456|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56327457|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56327458|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
56327459|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
56327460|NCT04641702|Atropine|atropine|mesh-list
56327461|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56327462|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56327463|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56327464|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
56908269|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56908270|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56908271|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908272|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327465|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327466|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327467|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56327468|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
56327469|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
56327470|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
56327471|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56327472|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56327473|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
56327474|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327475|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327476|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
56327477|NCT04629729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56327478|NCT04629729|Fludarabine|fludarabine|mesh-list
56327479|NCT04629729|Interleukin-2|interleukin-2|mesh-list
56327480|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327481|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
56327482|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327483|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56327484|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56327485|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
56327487|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327488|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56327489|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56327490|NCT04629729|Analgesics|analgesics|mesh-ancestor
56327491|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
56327492|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327493|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
56327494|NCT04626518|Lenvatinib|lenvatinib|mesh-list
56327495|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327496|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327497|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327498|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327499|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327500|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
56327501|NCT04626479|Lenvatinib|lenvatinib|mesh-list
56327502|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327503|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327504|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327505|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327506|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327507|NCT04624750|Mexiletine|mexiletine|mesh-list
56327508|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56327509|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56327510|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56327511|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56327512|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327513|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
56327514|NCT04624204|Etoposide|etoposide|mesh-list
56327515|NCT04624204|Olaparib|olaparib|mesh-list
56327516|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327517|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327518|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56327519|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56327520|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56327521|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327522|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327523|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56327524|NCT04622553|Mexiletine|mexiletine|mesh-list
56327525|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56327526|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56327527|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56327528|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56327529|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327530|NCT04616807|Mexiletine|mexiletine|mesh-list
56908273|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
56356219|NCT00070187|Interferons|interferons|mesh-list
56327531|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56327532|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56327533|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56327534|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56327535|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327536|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
56327537|NCT04608630|Denosumab|denosumab|mesh-list
56327538|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56327539|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327540|NCT04603183|Paclitaxel|paclitaxel|mesh-list
56327541|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56327542|NCT04603183|Letrozole|letrozole|mesh-list
56327543|NCT04603183|Fulvestrant|fulvestrant|mesh-list
56327544|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56327545|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327546|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
56327547|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
56327548|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
56327549|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327550|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56327551|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56327552|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327553|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56327554|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
56327555|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56327556|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327557|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56327558|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56327560|NCT04580134|Clozapine|clozapine|mesh-list
56327562|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
56327563|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327564|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327565|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327566|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56327567|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56327568|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56327569|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56327570|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56327571|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
56327572|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
56327573|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
56327574|NCT04556773|Paclitaxel|paclitaxel|mesh-list
56327575|NCT04556773|Capecitabine|capecitabine|mesh-list
56327576|NCT04556773|Trastuzumab|trastuzumab|mesh-list
56327577|NCT04556773|Durvalumab|durvalumab|mesh-list
56327578|NCT04556773|Fulvestrant|fulvestrant|mesh-list
56327579|NCT04556773|Anastrozole|anastrozole|mesh-list
56327580|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56327581|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327582|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
56327583|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
56327584|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334014|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327588|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327590|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56327591|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56327592|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
56327593|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56327594|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327595|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56327596|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56327597|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327598|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
56327599|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327600|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327601|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
56327602|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327603|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327604|NCT04533750|Peposertib|peposertib|mesh-list
56327605|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327606|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083609|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
56908274|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
56908275|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327607|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949424|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
56327608|NCT04529954|Valproic Acid|valproic acid|mesh-list
56327609|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
56327610|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327611|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327612|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
56327613|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327614|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327615|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
56327616|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56327617|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56327618|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56327619|NCT04525755|Nicotine|nicotine|mesh-list
56327620|NCT04525755|Varenicline|varenicline|mesh-list
56327621|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56327622|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
56327623|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327624|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327625|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56327626|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56327627|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
56327628|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327629|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327630|NCT04512079|Enoxaparin|enoxaparin|mesh-list
56327631|NCT04512079|Apixaban|apixaban|mesh-list
56327632|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
56327633|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56327634|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56327635|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327637|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
56327638|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56327639|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
56327640|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327642|NCT04508725|Endothelial Growth Factors|endothelial growth factors|mesh-list
56327643|NCT04508725|Mitosis Modulators|mitosis modulators|mesh-ancestor
56327644|NCT04508725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327645|NCT04508725|Growth Substances|growth substances|mesh-ancestor
56327646|NCT04508725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327651|NCT04490057|Bupropion|bupropion|mesh-list
56327652|NCT04490057|Nicotine|nicotine|mesh-list
56327653|NCT04490057|Varenicline|varenicline|mesh-list
56327654|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56327655|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
56327656|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327657|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327658|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56327674|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
56327675|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327676|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
56327677|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327678|NCT04437485|Norepinephrine|norepinephrine|mesh-list
56327679|NCT04437485|Bupropion|bupropion|mesh-list
56327680|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
56327681|NCT04437485|Serotonin|serotonin|mesh-list
56327682|NCT04437485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56327683|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56327684|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56327685|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56327686|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56327687|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56327688|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327689|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
56327690|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327691|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327692|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56327693|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56327694|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327695|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56327696|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56327697|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
56327698|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
56908276|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356359|NCT00104715|Docetaxel|docetaxel|mesh-list
56327699|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
56327700|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327701|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56327702|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56327703|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
56327721|NCT04421560|Rituximab|rituximab|mesh-list
56327722|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
56327723|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327724|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327725|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
56327726|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327727|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56327728|NCT04410796|Carboplatin|carboplatin|mesh-list
56327729|NCT04410796|Pemetrexed|pemetrexed|mesh-list
56327730|NCT04410796|Osimertinib|osimertinib|mesh-list
56327731|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327732|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327733|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327735|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56327736|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327737|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
56327738|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56327739|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
56327740|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
56327741|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327742|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327743|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327744|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56327745|NCT04406649|Analgesics|analgesics|mesh-ancestor
56327746|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
55967152|NCT00499655|Celecoxib|celecoxib|mesh-list
56327749|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327750|NCT04380636|Paclitaxel|paclitaxel|mesh-list
56327751|NCT04380636|Etoposide|etoposide|mesh-list
56327752|NCT04380636|Carboplatin|carboplatin|mesh-list
56327753|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
56327754|NCT04380636|Pemetrexed|pemetrexed|mesh-list
56327755|NCT04380636|Durvalumab|durvalumab|mesh-list
56327756|NCT04380636|Olaparib|olaparib|mesh-list
56327757|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56327758|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327759|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
56327760|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
56327761|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
56327762|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327763|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327764|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56327765|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56327766|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327767|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56327768|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56327769|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56327770|NCT04372108|Ustekinumab|ustekinumab|mesh-list
56327771|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
56327772|NCT04332341|Niacinamide|niacinamide|mesh-list
56327773|NCT04332341|Niacin|niacin|mesh-list
56327774|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
56327775|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
56327776|NCT04332341|Vitamins|vitamins|mesh-ancestor
56327777|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
56327778|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327779|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56327780|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
56327781|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327782|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56327783|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
56327784|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
56327785|NCT04323657|Fludarabine|fludarabine|mesh-list
56327786|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327787|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
56327788|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327789|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56327790|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56327791|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
56908277|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56908278|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56327792|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327793|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327794|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56327795|NCT04318691|Dimercaprol|dimercaprol|mesh-list
56327796|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
56327797|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
56327798|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327799|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
56327800|NCT04305054|Lenvatinib|lenvatinib|mesh-list
56327801|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327802|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327803|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327804|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327805|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327806|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
56327807|NCT04305041|Lenvatinib|lenvatinib|mesh-list
56327808|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327809|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327810|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327811|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327812|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327813|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
56327814|NCT04303169|Tretinoin|tretinoin|mesh-list
56327815|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327816|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327817|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
56327818|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
56327819|NCT04278092|Paclitaxel|paclitaxel|mesh-list
56327820|NCT04278092|Cetuximab|cetuximab|mesh-list
56327821|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56327822|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327825|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
56327826|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327827|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327829|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56327830|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56327831|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327832|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327833|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327834|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56327835|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56327836|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
56327837|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56327838|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327840|NCT04220489|Analgesics|analgesics|mesh-ancestor
56327841|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
56327842|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327843|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327844|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56327845|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56327846|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
56327847|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
56327848|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56327849|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56327850|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56327851|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327852|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327853|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
56327854|NCT04210505|Povidone|povidone|mesh-list
56327855|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
56327856|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
56327857|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56327858|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56327859|NCT04201262|Ravulizumab|ravulizumab|mesh-list
56327860|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56327861|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327862|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
56327863|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327864|NCT04189107|Dexamethasone|dexamethasone|mesh-list
56908279|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
56908280|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56908281|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56618929|NCT05337332|Hormones|hormones|mesh-ancestor
56327865|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
56327866|NCT04189107|BB 1101|bb 1101|mesh-list
56327867|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56327868|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
56327869|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
56327870|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327871|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327872|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56327873|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
56327874|NCT04189107|Hormones|hormones|mesh-ancestor
56327875|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56327876|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56327877|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327878|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
56327879|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327880|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327881|NCT04172675|Gemcitabine|gemcitabine|mesh-list
56327882|NCT04172675|Mitomycins|mitomycins|mesh-list
56327883|NCT04172675|Mitomycin|mitomycin|mesh-list
56327884|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56327892|NCT04172675|Immunologic Factors|immunologic factors|mesh-ancestor
56327893|NCT04172675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327894|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56327895|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
56327896|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56327897|NCT04166331|Dobutamine|dobutamine|mesh-list
56327898|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56327899|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
56327900|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
56327901|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327902|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327914|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
56327915|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
56327916|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327917|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
56327918|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56327919|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56327920|NCT04124991|Durvalumab|durvalumab|mesh-list
56327921|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327922|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327930|NCT04123314|Psilocybin|psilocybin|mesh-list
56327931|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
56327932|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327933|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56327934|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
56327935|NCT04081389|Interferons|interferons|mesh-list
56327936|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
56327937|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
56327938|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56327939|NCT04081389|Celecoxib|celecoxib|mesh-list
56327940|NCT04081389|Paclitaxel|paclitaxel|mesh-list
56327941|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
56327942|NCT04081389|Doxorubicin|doxorubicin|mesh-list
56327943|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56327944|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56327945|NCT04081389|Daunorubicin|daunorubicin|mesh-list
56327946|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
56327947|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56327948|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327949|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
56327950|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
56327951|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
56327952|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327953|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327954|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
56327955|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327956|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56327957|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56327958|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
56327959|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56908282|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56908283|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56908284|NCT02783170|Vaccines|vaccines|mesh-list
56908285|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
56356572|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
56327960|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56327961|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56327962|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56327963|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327964|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
56327965|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56327966|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56327967|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56327969|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
56327970|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327971|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56327972|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56327973|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56327974|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56327975|NCT04064060|Luspatercept|luspatercept|mesh-list
56327976|NCT04064060|Hematinics|hematinics|mesh-ancestor
56327977|NCT04053634|Benralizumab|benralizumab|mesh-list
56327982|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327983|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56327984|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327985|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327986|NCT03934567|Abexinostat|abexinostat|mesh-list
56327987|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56327988|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327989|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327990|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
56327991|NCT03907852|Nivolumab|nivolumab|mesh-list
56327992|NCT03907852|Fludarabine|fludarabine|mesh-list
56327993|NCT03907852|Ipilimumab|ipilimumab|mesh-list
56327994|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327995|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
56327996|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327997|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56327998|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56327999|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
56328000|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328001|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328002|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56328003|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328004|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56328005|NCT03900884|Letrozole|letrozole|mesh-list
56328006|NCT03900884|Venetoclax|venetoclax|mesh-list
56328007|NCT03900884|Palbociclib|palbociclib|mesh-list
56328008|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328009|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56328010|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56328011|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328012|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328013|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56328014|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
56328015|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56328016|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328017|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56328018|NCT03872388|Capecitabine|capecitabine|mesh-list
56328019|NCT03872388|Atorvastatin|atorvastatin|mesh-list
56328020|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328021|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
56328022|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328023|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328024|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56328025|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56328026|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56328027|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56328028|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328029|NCT03865940|Lidocaine|lidocaine|mesh-list
56328030|NCT03865940|Guanfacine|guanfacine|mesh-list
56908286|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908287|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56356643|NCT00100971|Vaccines|vaccines|mesh-list
56328031|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
56328032|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
56328033|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328034|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328035|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
56328041|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328042|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56328043|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56328044|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56328045|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56328046|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
56328047|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56328048|NCT03844997|Palbociclib|palbociclib|mesh-list
56328049|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328050|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56328051|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328052|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328053|NCT03840967|Niraparib|niraparib|mesh-list
56328062|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328064|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328065|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56328066|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56328067|NCT03776071|Temozolomide|temozolomide|mesh-list
56328068|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56328069|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
56328070|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328071|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328072|NCT03761173|Anticoagulants|anticoagulants|mesh-list
56328082|NCT03671811|Megestrol|megestrol|mesh-list
56328083|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
56328084|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56328085|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56328086|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56328087|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
56328088|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56328089|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328090|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56328091|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56328092|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56328093|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328094|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
56328095|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56328096|NCT03668119|Nivolumab|nivolumab|mesh-list
56328097|NCT03668119|Ipilimumab|ipilimumab|mesh-list
56328098|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328099|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328100|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56328101|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328102|NCT03625388|Dasatinib|dasatinib|mesh-list
56328103|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328104|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56328105|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334015|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
56328106|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328140|NCT03595059|Paclitaxel|paclitaxel|mesh-list
56328141|NCT03595059|Docetaxel|docetaxel|mesh-list
56328142|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56328143|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328144|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328145|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328146|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328147|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328148|NCT03589729|Cytarabine|cytarabine|mesh-list
56328149|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56328150|NCT03589729|Idarubicin|idarubicin|mesh-list
56328151|NCT03589729|Cladribine|cladribine|mesh-list
56328152|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
56328153|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
56328154|NCT03589729|Razoxane|razoxane|mesh-list
56328155|NCT03589729|Calicheamicins|calicheamicins|mesh-list
56908288|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56908289|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908290|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56908291|NCT02254018|Maytansine|maytansine|mesh-list
56356718|NCT00423761|Midazolam|midazolam|mesh-list
56328156|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328157|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
56328158|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328159|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328161|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328162|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328163|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
56328164|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328165|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56328166|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56328167|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56328168|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328169|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328170|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56328171|NCT03589729|Protective Agents|protective agents|mesh-ancestor
56328172|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328173|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328174|NCT03585686|Cytarabine|cytarabine|mesh-list
56328175|NCT03585686|Vemurafenib|vemurafenib|mesh-list
56328176|NCT03585686|Cladribine|cladribine|mesh-list
56328177|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328178|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
56328179|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328180|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328181|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
56328182|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328183|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328184|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
56398584|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
56328185|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328186|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56328187|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328189|NCT03543969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328190|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328191|NCT03543969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56328192|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328193|NCT03479307|Ketotifen|ketotifen|mesh-list
56328194|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56328195|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56328196|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
56328197|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
56328198|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56328199|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
56328200|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
56328201|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56328202|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328203|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328204|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56328205|NCT03473743|Carboplatin|carboplatin|mesh-list
56328206|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328207|NCT03467867|Rituximab|rituximab|mesh-list
56328208|NCT03467867|Venetoclax|venetoclax|mesh-list
56328209|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328210|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328211|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
56328212|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328213|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56328214|NCT03452111|ST 1435|st 1435|mesh-list
56328215|NCT03452111|Testosterone|testosterone|mesh-list
56328216|NCT03452111|Androgens|androgens|mesh-ancestor
56328217|NCT03452111|Hormones|hormones|mesh-ancestor
56328218|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56328219|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328220|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56328221|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
56328222|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56908292|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
56908293|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908294|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908295|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328223|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56328224|NCT03393884|Paclitaxel|paclitaxel|mesh-list
56328225|NCT03393884|Carboplatin|carboplatin|mesh-list
56328226|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56328227|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328228|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328229|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328230|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328231|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328232|NCT03390933|Fluoxetine|fluoxetine|mesh-list
56328233|NCT03390933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55967580|NCT00556049|Sunitinib|sunitinib|mesh-list
56328237|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56328238|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
56328239|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328240|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56328241|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
56328242|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56328243|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56328244|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56328245|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328246|NCT03390504|Docetaxel|docetaxel|mesh-list
56328247|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
56328248|NCT03390504|Mitogens|mitogens|mesh-list
56328249|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328250|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328251|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328252|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328253|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328254|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328255|NCT03387787|Insulin|insulin|mesh-list
56328256|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56328257|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328258|NCT03364036|Cladribine|cladribine|mesh-list
56328259|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328260|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328261|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
56328262|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328263|NCT03338790|Prednisone|prednisone|mesh-list
56328264|NCT03338790|Docetaxel|docetaxel|mesh-list
56328265|NCT03338790|Nivolumab|nivolumab|mesh-list
56328266|NCT03338790|Rucaparib|rucaparib|mesh-list
56328267|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328268|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328269|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328270|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328271|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328272|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56328273|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
56328274|NCT03338790|Hormones|hormones|mesh-ancestor
56328275|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56328276|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328277|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56328278|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328279|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56328280|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56328281|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328282|NCT03323463|Carboplatin|carboplatin|mesh-list
56328283|NCT03323463|Fluorouracil|fluorouracil|mesh-list
56328284|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328285|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
56328286|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328287|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950107|NCT01061411|Sunitinib|sunitinib|mesh-list
56328288|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328289|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
56328290|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328291|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
56908296|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56908297|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56908298|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908299|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56908300|NCT04249882|Naltrexone|naltrexone|mesh-list
56908301|NCT04249882|Varenicline|varenicline|mesh-list
56908302|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56908303|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56908304|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908305|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
56908306|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908307|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56908308|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56908309|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
56908310|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56908311|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908312|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
56908313|NCT05138614|Narcotics|narcotics|mesh-ancestor
56908314|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908315|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356876|NCT00071240|Hormones|hormones|mesh-list
56328292|NCT03315897|Hematinics|hematinics|mesh-ancestor
56328293|NCT03299660|Fluorouracil|fluorouracil|mesh-list
56328294|NCT03299660|Capecitabine|capecitabine|mesh-list
56328295|NCT03299660|Avelumab|avelumab|mesh-list
56328296|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
56328297|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328298|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328299|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328300|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328301|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
56328302|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328303|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328305|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56328306|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56328307|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
56328308|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
56328309|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328310|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328311|NCT03243058|Aldesleukin|aldesleukin|mesh-list
56328312|NCT03243058|Interleukin-2|interleukin-2|mesh-list
56328313|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328314|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56328315|NCT03243058|Analgesics|analgesics|mesh-ancestor
56328316|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
56328317|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328318|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328319|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56328320|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56328321|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
56328322|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328323|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
56328325|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328326|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328327|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56356927|NCT00259987|Lapatinib|lapatinib|mesh-list
56328328|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328329|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328330|NCT03140358|Atropine|atropine|mesh-list
56328331|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56328332|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56328333|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56328334|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
56328335|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328337|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56328338|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
56328339|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
56328340|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
56328341|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56328342|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56328343|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
56328344|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56328345|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328346|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
56328347|NCT03007147|Leucovorin|leucovorin|mesh-list
56328348|NCT03007147|Folic Acid|folic acid|mesh-list
56328349|NCT03007147|Cytarabine|cytarabine|mesh-list
56328350|NCT03007147|Dexamethasone|dexamethasone|mesh-list
56328351|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
56328352|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
56328353|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56328354|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56328355|NCT03007147|Prednisolone|prednisolone|mesh-list
56328356|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
56328357|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
56328358|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56328359|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56328360|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56328361|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
56328362|NCT03007147|Ifosfamide|ifosfamide|mesh-list
56328363|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
56328364|NCT03007147|Doxorubicin|doxorubicin|mesh-list
56328365|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56328366|NCT03007147|Methotrexate|methotrexate|mesh-list
56328369|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
56328370|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
56328371|NCT03007147|Daunorubicin|daunorubicin|mesh-list
56328372|NCT03007147|Asparaginase|asparaginase|mesh-list
56328373|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
56328374|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
56328375|NCT03007147|Pegaspargase|pegaspargase|mesh-list
56328376|NCT03007147|Thioguanine|thioguanine|mesh-list
56328377|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
56328378|NCT03007147|Razoxane|razoxane|mesh-list
56328379|NCT03007147|Azathioprine|azathioprine|mesh-list
56328380|NCT03007147|Lenograstim|lenograstim|mesh-list
56328381|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56328382|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
56328383|NCT03007147|BB 1101|bb 1101|mesh-list
56328384|NCT03007147|Calcium|calcium|mesh-list
56328385|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
56328386|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
56328387|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328389|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328390|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56328391|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56328392|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
56328393|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328394|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328395|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56328396|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56328397|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
56328398|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
56328399|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328400|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56328401|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
56328402|NCT03007147|Hormones|hormones|mesh-ancestor
56328403|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56328404|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56328405|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
56328406|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328407|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56328408|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56328409|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56328410|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56908316|NCT05138614|Analgesics|analgesics|mesh-ancestor
56908317|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
56908318|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908319|NCT03396952|Aspirin|aspirin|mesh-list
56356992|NCT00261118|Rituximab|rituximab|mesh-list
56328411|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56328412|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56328413|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
56328414|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56328415|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328457|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
56328458|NCT02954536|Fluorouracil|fluorouracil|mesh-list
56328459|NCT02954536|Capecitabine|capecitabine|mesh-list
56328460|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
56328461|NCT02954536|Trastuzumab|trastuzumab|mesh-list
56328462|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328463|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328464|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
56328465|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328466|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328467|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328468|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
56328469|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328470|NCT02899611|Valproic Acid|valproic acid|mesh-list
56328471|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
56328472|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328473|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328474|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
56328475|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56328476|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328477|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
56328478|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56328479|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328480|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56328481|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
56328482|NCT02778685|Letrozole|letrozole|mesh-list
56328483|NCT02778685|Fulvestrant|fulvestrant|mesh-list
56328484|NCT02778685|Palbociclib|palbociclib|mesh-list
56328485|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328486|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328487|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56328488|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56328489|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328490|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328491|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56328492|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
56328493|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56328494|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328495|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56328496|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56328497|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56328499|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328500|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
56328501|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328509|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56328510|NCT02645266|Growth Substances|growth substances|mesh-ancestor
56328511|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328512|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
56328513|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328514|NCT02634294|Interferons|interferons|mesh-list
56328515|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
56328516|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
56328517|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56328518|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328519|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
56328520|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950332|NCT00068575|Cisplatin|cisplatin|mesh-list
56328521|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
56328522|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328524|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328525|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908320|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
56908321|NCT03396952|Ipilimumab|ipilimumab|mesh-list
56908322|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328526|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56328527|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328528|NCT02598661|Imetelstat|imetelstat|mesh-list
56328529|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
56328530|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328531|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328532|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56328533|NCT02586831|Exenatide|exenatide|mesh-list
56328534|NCT02586831|Aldesleukin|aldesleukin|mesh-list
56328535|NCT02586831|Adalimumab|adalimumab|mesh-list
56328536|NCT02586831|Interleukin-2|interleukin-2|mesh-list
56328537|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
56328538|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56328539|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56328540|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56328541|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328542|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56328543|NCT02586831|Analgesics|analgesics|mesh-ancestor
56328544|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
56328545|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328546|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328547|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56328548|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56328549|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
56328550|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328551|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56328552|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56328553|NCT02586831|Incretins|incretins|mesh-ancestor
56328554|NCT02586831|Hormones|hormones|mesh-ancestor
56328555|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56328556|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
56328557|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328558|NCT02575677|Oxycodone|oxycodone|mesh-list
56328559|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56328560|NCT02575677|Narcotics|narcotics|mesh-ancestor
56328561|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328562|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328563|NCT02575677|Analgesics|analgesics|mesh-ancestor
56328564|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
56328565|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328566|NCT02573909|Oxycodone|oxycodone|mesh-list
56328567|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56328568|NCT02573909|Narcotics|narcotics|mesh-ancestor
56328569|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328570|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328571|NCT02573909|Analgesics|analgesics|mesh-ancestor
56328572|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
55967875|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
56328573|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328575|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56328576|NCT02573831|Narcotics|narcotics|mesh-ancestor
56328577|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328578|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328579|NCT02573831|Analgesics|analgesics|mesh-ancestor
56328580|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
56328581|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328582|NCT02571881|Oxycodone|oxycodone|mesh-list
56328583|NCT02571881|Naloxone|naloxone|mesh-list
56328584|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56328585|NCT02571881|Narcotics|narcotics|mesh-ancestor
56328586|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328587|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328588|NCT02571881|Analgesics|analgesics|mesh-ancestor
56328589|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
56328590|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328591|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56328592|NCT02571179|Fentanyl|fentanyl|mesh-list
56328593|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56328594|NCT02571179|Narcotics|narcotics|mesh-ancestor
56328595|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328596|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328597|NCT02571179|Analgesics|analgesics|mesh-ancestor
56328598|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
56328599|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328600|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56328601|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56328602|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
56328603|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
56328604|NCT02531126|Ozanimod|ozanimod|mesh-list
56328605|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56328606|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328607|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328608|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
56328609|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328610|NCT02511418|Simvastatin|simvastatin|mesh-list
56328611|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56328612|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56328613|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
56328614|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328615|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56328616|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56328617|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328618|NCT02365597|Metformin|metformin|mesh-list
56328619|NCT02365597|Midazolam|midazolam|mesh-list
56328620|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56328621|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328622|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56328623|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56328624|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328625|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56328626|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56328627|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56328628|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56328629|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
56328631|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
56328632|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
56328633|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56328634|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328635|NCT02278250|Carboplatin|carboplatin|mesh-list
56328636|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328637|NCT02250326|Paclitaxel|paclitaxel|mesh-list
56328638|NCT02250326|Azacitidine|azacitidine|mesh-list
56328639|NCT02250326|Cc-486|cc-486|mesh-list
56328640|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56328641|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328642|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328643|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328644|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328645|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328646|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328647|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
56328648|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328649|NCT02225600|Oxytocin|oxytocin|mesh-list
56328650|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
56328662|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328663|NCT02081404|Esomeprazole|esomeprazole|mesh-list
56328664|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56328665|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56328666|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56328667|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328668|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328669|NCT01526603|Carboplatin|carboplatin|mesh-list
56328670|NCT01526603|Etoposide|etoposide|mesh-list
56328671|NCT01526603|Melphalan|melphalan|mesh-list
56328672|NCT01526603|Tretinoin|tretinoin|mesh-list
56328673|NCT01526603|Isotretinoin|isotretinoin|mesh-list
56328674|NCT01526603|Lenograstim|lenograstim|mesh-list
56328675|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328676|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56328677|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56328678|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56328679|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328680|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328681|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56328682|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
56328683|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56328684|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328685|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
56328686|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357215|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328687|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56328688|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
56328689|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
56328690|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56328691|NCT01407263|Hemostatics|hemostatics|mesh-list
56328692|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328693|NCT01407263|Coagulants|coagulants|mesh-ancestor
56161693|NCT02411526|Risperidone|risperidone|mesh-list
56328705|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
56328706|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
56328707|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328708|NCT01124695|Tamoxifen|tamoxifen|mesh-list
56328709|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56328710|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
56328711|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56328712|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328713|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56328714|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328715|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56328716|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56328717|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56328718|NCT01013649|Gemcitabine|gemcitabine|mesh-list
56328719|NCT01013649|Fluorouracil|fluorouracil|mesh-list
56328720|NCT01013649|Capecitabine|capecitabine|mesh-list
56328721|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56328722|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328723|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
55968024|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
56328752|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328753|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328755|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56328756|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328757|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
56328758|NCT00070070|Sargramostim|sargramostim|mesh-list
56328759|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
56328760|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
56328761|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328762|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56328763|NCT00042315|Vinorelbine|vinorelbine|mesh-list
56328764|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56328765|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328766|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328767|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328768|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328769|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328770|NCT00018668|Olanzapine|olanzapine|mesh-list
56328771|NCT00018668|Risperidone|risperidone|mesh-list
56328772|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56116361|NCT05749445|Ritonavir|ritonavir|mesh-list
56328773|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56328774|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
56328775|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56328776|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328777|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328778|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56328779|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56328780|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56328781|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56328782|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56328783|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
56328784|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
56328785|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
56328786|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328787|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56328788|NCT00018668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56328789|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56328790|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56328791|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
56328792|NCT00042354|Clofarabine|clofarabine|mesh-list
56328793|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328794|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
56328795|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328796|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328809|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
56908323|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328810|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56328811|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
56328812|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328813|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56328814|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56328815|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56328817|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56328818|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
56328819|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328820|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
56328821|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328822|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328823|NCT00018824|Naltrexone|naltrexone|mesh-list
56328824|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56328825|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56328826|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328827|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
56328828|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328829|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
56328830|NCT00038844|Rituximab|rituximab|mesh-list
56328831|NCT00038844|Fludarabine|fludarabine|mesh-list
56328832|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
56328833|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
56328834|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328835|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
56328836|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328837|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56328838|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56328839|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
56328840|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328841|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328842|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56328843|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328844|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328845|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
56328846|NCT00018863|Methylphenidate|methylphenidate|mesh-list
56328847|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56328848|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328849|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56328850|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56328851|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56328852|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328853|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
56328854|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56328855|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
55968168|NCT04459117|Analgesics|analgesics|mesh-ancestor
56328866|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
56328867|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328868|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56328869|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
56328870|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56398586|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328871|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56328872|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56328873|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328874|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56328876|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328877|NCT00018941|Aldesleukin|aldesleukin|mesh-list
56328878|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328879|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56328880|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56328881|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
56328882|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328883|NCT00038961|PENTA|penta|mesh-list
56328884|NCT00038961|Fondaparinux|fondaparinux|mesh-list
56328885|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56328886|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
56328887|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56328888|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
56328889|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328890|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328891|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
56328892|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56908324|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56328893|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56328894|NCT00019019|Paclitaxel|paclitaxel|mesh-list
56328895|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
56328896|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56328897|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328898|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328899|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328900|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328901|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328902|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56328903|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56328904|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56328905|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328906|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
56328907|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
56328908|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328909|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
56328910|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161703|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56328911|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328912|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56328913|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56328914|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56328915|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56328916|NCT00019058|Protective Agents|protective agents|mesh-ancestor
56328917|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328921|NCT00039039|Paclitaxel|paclitaxel|mesh-list
56328922|NCT00039039|Carboplatin|carboplatin|mesh-list
56328923|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56328924|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328925|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328926|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328927|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328928|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328929|NCT00019097|Melphalan|melphalan|mesh-list
56328930|NCT00019097|Sargramostim|sargramostim|mesh-list
56328931|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56328932|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56328933|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
56328934|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328935|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328936|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56328937|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328938|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
56328939|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328940|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56328941|NCT00019136|Aldesleukin|aldesleukin|mesh-list
56328942|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328943|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56328944|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56328945|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
56328946|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328948|NCT00039117|Daunorubicin|daunorubicin|mesh-list
56328949|NCT00039117|Oblimersen|oblimersen|mesh-list
56328950|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328951|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
56328952|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328953|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328954|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
56328955|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328956|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328957|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
56328958|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328959|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56328960|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56328961|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56328962|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328963|NCT00019175|Aldesleukin|aldesleukin|mesh-list
56328964|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328965|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56328966|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56328967|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
56083731|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
56908325|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56908326|NCT03396952|Analgesics|analgesics|mesh-ancestor
56908327|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
56908328|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357437|NCT04709029|Hormones|hormones|mesh-ancestor
56328968|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328969|NCT00039156|IDN 5109|idn 5109|mesh-list
56328970|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328971|NCT00019214|Aldesleukin|aldesleukin|mesh-list
56328972|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328973|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56328974|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55950781|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
56328976|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328977|NCT00039234|Aldesleukin|aldesleukin|mesh-list
56328978|NCT00039234|Histamine|histamine|mesh-list
56328979|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
56328980|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328981|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56328982|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56328983|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
56328984|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328985|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
56328986|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
56328987|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161705|NCT00564876|Dasatinib|dasatinib|mesh-list
56328988|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328989|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328990|NCT00019331|Aldesleukin|aldesleukin|mesh-list
56328991|NCT00019331|Sargramostim|sargramostim|mesh-list
56328992|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
56328993|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329002|NCT00019409|Cytarabine|cytarabine|mesh-list
56329003|NCT00019409|Prednisone|prednisone|mesh-list
56329004|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
56329005|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56329006|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56329007|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56329008|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
56329009|NCT00019409|Methotrexate|methotrexate|mesh-list
56329010|NCT00019409|Vincristine|vincristine|mesh-list
56329011|NCT00019409|Daunorubicin|daunorubicin|mesh-list
56329012|NCT00019409|Asparaginase|asparaginase|mesh-list
56329013|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
56329014|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329015|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
56329016|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329017|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329018|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329019|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
56329020|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329021|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329022|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329023|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56329025|NCT00019409|Hormones|hormones|mesh-ancestor
56329026|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56329027|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56329028|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56329029|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
56329030|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56329031|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329032|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
56329033|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56329034|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329035|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56329036|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56329037|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
56329038|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329039|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329040|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329041|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329042|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329043|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56908329|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329044|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56329045|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329046|NCT00019448|Interleukin-2|interleukin-2|mesh-list
56329047|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329048|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56329049|NCT00019448|Analgesics|analgesics|mesh-ancestor
56329050|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
56329051|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56329052|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329054|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
56329055|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329056|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56329057|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56329058|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
56329059|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329060|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56329061|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
56329062|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329063|NCT00039351|Prednisone|prednisone|mesh-list
56329064|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
56329081|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329082|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329083|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329084|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56329085|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56329086|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329087|NCT00039390|Capecitabine|capecitabine|mesh-list
56329088|NCT00039390|Gefitinib|gefitinib|mesh-list
56329089|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329090|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
56329091|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329092|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329093|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56329094|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329095|NCT00039429|Atrasentan|atrasentan|mesh-list
56329096|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329097|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56329098|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56329099|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329101|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
56329102|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329103|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56329104|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56329105|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
56329106|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329107|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56329108|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
56329109|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329110|NCT00019760|Leucovorin|leucovorin|mesh-list
56329111|NCT00019760|Melphalan|melphalan|mesh-list
56329112|NCT00019760|Floxuridine|floxuridine|mesh-list
56329113|NCT00019760|Calcium|calcium|mesh-list
56329114|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
56329115|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56329116|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329117|NCT00019760|Antidotes|antidotes|mesh-ancestor
56329118|NCT00019760|Protective Agents|protective agents|mesh-ancestor
56329119|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
56329120|NCT00019760|Vitamins|vitamins|mesh-ancestor
56329121|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
56329122|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329123|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
56329124|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329137|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329138|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329139|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
56329140|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329141|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
56329142|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56329143|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329144|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56329145|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56329146|NCT00039468|Growth Substances|growth substances|mesh-ancestor
56329147|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
56329148|NCT00019838|Fludarabine|fludarabine|mesh-list
56357575|NCT00265876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329149|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
56329150|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56329151|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329152|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329153|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
56329154|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329155|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329156|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
56329157|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329158|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56329159|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329160|NCT00019916|Aldesleukin|aldesleukin|mesh-list
56329161|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329162|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56329163|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56329164|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
56329165|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329166|NCT00039546|Gemcitabine|gemcitabine|mesh-list
56329167|NCT00039546|Paclitaxel|paclitaxel|mesh-list
56329168|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
56329169|NCT00039546|Epirubicin|epirubicin|mesh-list
56329170|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329171|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329172|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329173|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329174|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329175|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329176|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329177|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
56329178|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329179|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329180|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329181|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
56329182|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329183|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329184|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
56329185|NCT00039546|Antiviral Agents|antiviral agents|mesh-ancestor
56329186|NCT00039546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329187|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329188|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56329191|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
56329192|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329193|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56329194|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329195|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329196|NCT00019994|Aldesleukin|aldesleukin|mesh-list
56329197|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
56329198|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329199|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56329200|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56329201|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
56329202|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329203|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55951010|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
56329204|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
56329205|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329207|NCT00039663|Pravastatin|pravastatin|mesh-list
56329208|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
56329209|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56329210|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329211|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56329212|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56329213|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
56329214|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329215|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56116807|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
56329216|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56329217|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329218|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56329219|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56329220|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
56329221|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329222|NCT00020150|Temozolomide|temozolomide|mesh-list
56329223|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56329224|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329225|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
56329226|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329227|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329228|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329230|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
56329231|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56329232|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
56329233|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329234|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329235|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
56329236|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56329237|NCT00020189|Aspirin|aspirin|mesh-list
56329238|NCT00020189|Alvocidib|alvocidib|mesh-list
56329239|NCT00020189|Clopidogrel|clopidogrel|mesh-list
56329240|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56329241|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56329242|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56329243|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56329244|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
56329245|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56329246|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329247|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329248|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56329249|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56329250|NCT00020189|Analgesics|analgesics|mesh-ancestor
56329251|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
56329252|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56329253|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56329254|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329255|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56329256|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56329257|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56329258|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329259|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
56329260|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329261|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
56329265|NCT00039975|Indinavir|indinavir|mesh-list
56329266|NCT00039975|Amlodipine|amlodipine|mesh-list
56329267|NCT00039975|Diltiazem|diltiazem|mesh-list
56329268|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56329269|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56329270|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
56329271|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329272|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329273|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56329274|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56329275|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
56329276|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329277|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56329278|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56329279|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56329280|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56329281|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56329282|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56329283|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329284|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
56329285|NCT00020267|Interleukin-2|interleukin-2|mesh-list
56329286|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56329287|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329288|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56329289|NCT00020267|Analgesics|analgesics|mesh-ancestor
56116887|NCT04882241|Docetaxel|docetaxel|mesh-list
56329290|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
56329291|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56329292|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329293|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56329294|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
56329296|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329297|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56329298|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56329299|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329300|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329301|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56329302|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
56908330|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56908331|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908332|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56908333|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56329303|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56329304|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329305|NCT00020345|Gemcitabine|gemcitabine|mesh-list
56329306|NCT00020345|Fluorouracil|fluorouracil|mesh-list
56329307|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329308|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
56329309|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329310|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329311|NCT00020345|Antiviral Agents|antiviral agents|mesh-ancestor
56329312|NCT00020345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329313|NCT00020345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329314|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329315|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
56329316|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329317|NCT00040053|Ondansetron|ondansetron|mesh-list
56329318|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
56329319|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
56329320|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56329321|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329322|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56329323|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
56329324|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
56329325|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56329326|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
56329327|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56329328|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329330|NCT00040053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56329331|NCT00040053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56329332|NCT00040053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56329333|NCT00040053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56329334|NCT00020462|Aldesleukin|aldesleukin|mesh-list
56329335|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329338|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
56329339|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329340|NCT00020501|Leucovorin|leucovorin|mesh-list
56329341|NCT00020501|Fluorouracil|fluorouracil|mesh-list
56329342|NCT00020501|Floxuridine|floxuridine|mesh-list
56329343|NCT00020501|Irinotecan|irinotecan|mesh-list
56329344|NCT00020501|Melphalan|melphalan|mesh-list
56329345|NCT00020501|Calcium|calcium|mesh-list
56329346|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
56329347|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56329348|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329349|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
56329350|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329351|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329352|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329353|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951166|NCT00075829|Hormones|hormones|mesh-ancestor
56329354|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
56329355|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56329356|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329357|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329358|NCT00020501|Antidotes|antidotes|mesh-ancestor
56329359|NCT00020501|Protective Agents|protective agents|mesh-ancestor
56329360|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
56329361|NCT00020501|Vitamins|vitamins|mesh-ancestor
56329362|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
56329363|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329364|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
56329365|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56116960|NCT00002897|Fluorouracil|fluorouracil|mesh-list
56329366|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
56329367|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56329368|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
56329369|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329370|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56329371|NCT00020540|Protective Agents|protective agents|mesh-ancestor
56329372|NCT00020579|Entinostat|entinostat|mesh-list
56329373|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908334|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357797|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
56329374|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56329375|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329376|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329377|NCT00040209|Levodopa|levodopa|mesh-list
56329378|NCT00040209|Apomorphine|apomorphine|mesh-list
56329379|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56329380|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56329381|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
56329382|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56329383|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329384|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329385|NCT00040209|Emetics|emetics|mesh-ancestor
56329386|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
56329387|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56329388|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56329389|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
56329390|NCT00040248|Daclizumab|daclizumab|mesh-list
56329391|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329392|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
56329393|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329394|NCT00020618|Morphine|morphine|mesh-list
56329395|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56329396|NCT00020618|Narcotics|narcotics|mesh-ancestor
56329397|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56329398|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329399|NCT00020618|Analgesics|analgesics|mesh-ancestor
56329400|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
56329401|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56329402|NCT00020657|Ondansetron|ondansetron|mesh-list
56329403|NCT00020657|Granisetron|granisetron|mesh-list
56329404|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
56329405|NCT00020657|Dolasetron|dolasetron|mesh-list
56329406|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
56329407|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
56329408|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56329409|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329410|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56329411|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
56329414|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
56329415|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56329416|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329417|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56329418|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56329419|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56329420|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56329421|NCT00020657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56329422|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56329423|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
56329424|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
56329425|NCT00020696|Tirapazamine|tirapazamine|mesh-list
56329426|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329427|NCT02970630|Everolimus|everolimus|mesh-list
56329428|NCT02970630|Tacrolimus|tacrolimus|mesh-list
56329429|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329430|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
56329431|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329432|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55951241|NCT02763137|Carbidopa|carbidopa|mesh-list
56329433|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329434|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329435|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329436|NCT00020735|Toremifene|toremifene|mesh-list
56329437|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56329438|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329439|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56329440|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56329441|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
56329442|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56329443|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329444|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56329445|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
56329446|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56908335|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56908336|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56908337|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908338|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
56357873|NCT00268255|Gefitinib|gefitinib|mesh-list
56329447|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
56329448|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329449|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329450|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329451|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
56329452|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329453|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329454|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329455|NCT00020774|Gemcitabine|gemcitabine|mesh-list
56329456|NCT00020774|Lonafarnib|lonafarnib|mesh-list
56329457|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329458|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
56329459|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329460|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329461|NCT00020774|Antiviral Agents|antiviral agents|mesh-ancestor
56329462|NCT00020774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329463|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329464|NCT00020774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329465|NCT00020774|Immunologic Factors|immunologic factors|mesh-ancestor
56329466|NCT00020774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329467|NCT00040521|Oprelvekin|oprelvekin|mesh-list
56329468|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329469|NCT00040599|Labetuzumab|labetuzumab|mesh-list
56329470|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56329471|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329472|NCT00020930|Cetuximab|cetuximab|mesh-list
56329473|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56329474|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329475|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
56329476|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329477|NCT00040794|Paclitaxel|paclitaxel|mesh-list
56329478|NCT00040794|Carboplatin|carboplatin|mesh-list
56329479|NCT00040794|Gefitinib|gefitinib|mesh-list
56329480|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329481|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329482|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329483|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329484|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329501|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329502|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56329503|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56329504|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
56329505|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329506|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56329507|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
55951325|NCT05606315|Midazolam|midazolam|mesh-list
56329508|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329510|NCT00040872|Thiotepa|thiotepa|mesh-list
56329511|NCT00040872|Carboplatin|carboplatin|mesh-list
56329512|NCT00040872|Doxorubicin|doxorubicin|mesh-list
56329513|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56329514|NCT00040872|Etoposide|etoposide|mesh-list
56329515|NCT00040872|Vincristine|vincristine|mesh-list
56329516|NCT00040872|Topotecan|topotecan|mesh-list
56329517|NCT00040872|Isotretinoin|isotretinoin|mesh-list
56329518|NCT00040872|Antibodies|antibodies|mesh-list
56329519|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56329520|NCT00040872|Sargramostim|sargramostim|mesh-list
56329521|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329522|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
56329523|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329524|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329525|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329526|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
56329527|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329528|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329529|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329530|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56329531|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56908339|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56908340|NCT03378934|Aspirin|aspirin|mesh-list
56329532|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329533|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329534|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329535|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329536|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329537|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329538|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56329539|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
56329540|NCT00021242|Docetaxel|docetaxel|mesh-list
56329541|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329542|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329543|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329544|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329545|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329546|NCT00040950|Rituximab|rituximab|mesh-list
56329560|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329562|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329563|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329564|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329565|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329566|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
56329567|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56329568|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329569|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329571|NCT00021281|Protective Agents|protective agents|mesh-ancestor
56329572|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
56329573|NCT00021281|Vitamins|vitamins|mesh-ancestor
56329574|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
56329575|NCT00041106|Gemcitabine|gemcitabine|mesh-list
56329576|NCT00041106|Gefitinib|gefitinib|mesh-list
56329577|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329578|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329579|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
56329580|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329581|NCT00041106|Antiviral Agents|antiviral agents|mesh-ancestor
56329582|NCT00041106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329583|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329584|NCT00041106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329585|NCT00041106|Immunologic Factors|immunologic factors|mesh-ancestor
56329586|NCT00041106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329587|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56329589|NCT00021320|Fluorouracil|fluorouracil|mesh-list
56329590|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329591|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329592|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329593|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329594|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329595|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329596|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
56329597|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329598|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329599|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
56329600|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329601|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
56329602|NCT00041223|Procyanidin|procyanidin|mesh-list
56329603|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
56329604|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329605|NCT00041223|Protective Agents|protective agents|mesh-ancestor
56329606|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329607|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56329608|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56329609|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329610|NCT00021359|Dexamethasone|dexamethasone|mesh-list
56329611|NCT00021359|Isotretinoin|isotretinoin|mesh-list
56329617|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56329618|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
56329619|NCT00021359|Hormones|hormones|mesh-ancestor
56329620|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56329621|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56329622|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329623|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
56329624|NCT00041262|Fluorouracil|fluorouracil|mesh-list
56329625|NCT00041262|Epirubicin|epirubicin|mesh-list
56908341|NCT03378934|Clopidogrel|clopidogrel|mesh-list
56908342|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56908343|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56908344|NCT03378934|Analgesics|analgesics|mesh-ancestor
56908345|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
56329626|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329627|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
56329628|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329629|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329630|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329631|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
56329632|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329633|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56329634|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56329635|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329637|NCT00021398|Leucovorin|leucovorin|mesh-list
56329638|NCT00021398|Fluorouracil|fluorouracil|mesh-list
56329639|NCT00021398|Calcium|calcium|mesh-list
56329640|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
56329641|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56329642|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329643|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
56329644|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329645|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329646|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329647|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329648|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
56329649|NCT00021398|Antidotes|antidotes|mesh-ancestor
56329650|NCT00021398|Protective Agents|protective agents|mesh-ancestor
56329651|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
56329652|NCT00021398|Vitamins|vitamins|mesh-ancestor
56329653|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
56329654|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56329655|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
56329656|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329657|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
56329658|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56329659|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56329660|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329661|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56329663|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
56329664|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329665|NCT00049023|Octreotide|octreotide|mesh-list
56329666|NCT00049023|Edotreotide|edotreotide|mesh-list
56329667|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56329668|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56329669|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329670|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56329671|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329673|NCT00021671|Nevirapine|nevirapine|mesh-list
56329674|NCT00021671|Erythromycin|erythromycin|mesh-list
56329675|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
56329676|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56329677|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
56329678|NCT00021671|Ampicillin|ampicillin|mesh-list
56329679|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329680|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56329681|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56329682|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56329683|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56329684|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56329685|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968974|NCT02510300|Ledipasvir|ledipasvir|mesh-list
56329687|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
56329688|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56329689|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56329690|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56329691|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56329692|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56329693|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56329694|NCT00049062|Gefitinib|gefitinib|mesh-list
56329695|NCT00049062|Anastrozole|anastrozole|mesh-list
56084075|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
56908346|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908347|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908348|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56329696|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329697|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56329698|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329699|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329700|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56329701|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56329702|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56329703|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56329704|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
56329705|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56329706|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329707|NCT00049101|Leucovorin|leucovorin|mesh-list
56329708|NCT00049101|Fluorouracil|fluorouracil|mesh-list
56329709|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
56329710|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56329711|NCT00049101|Calcium|calcium|mesh-list
56329712|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
56329713|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56329714|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329716|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329717|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329718|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329719|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329720|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
56329721|NCT00049101|Antidotes|antidotes|mesh-ancestor
56329722|NCT00049101|Protective Agents|protective agents|mesh-ancestor
56329723|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
56329724|NCT00049101|Vitamins|vitamins|mesh-ancestor
56329725|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
56329726|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56329727|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329728|NCT00394628|Temozolomide|temozolomide|mesh-list
56329729|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329730|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
56329731|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329732|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329733|NCT00049179|Cytarabine|cytarabine|mesh-list
56329734|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
56329735|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329736|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
55951536|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
56329737|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329738|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329739|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
56329740|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329741|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329742|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
56329743|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329744|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56329745|NCT00394745|Valsartan|valsartan|mesh-list
56329746|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56329747|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56329748|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56329749|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329750|NCT00049218|Carboplatin|carboplatin|mesh-list
56329751|NCT00049218|Etoposide|etoposide|mesh-list
56329752|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329753|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329754|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56329755|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329756|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329757|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329758|NCT00049296|Thalidomide|thalidomide|mesh-list
56329771|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56329772|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56329773|NCT00049296|Growth Substances|growth substances|mesh-ancestor
56329774|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
56329775|NCT00021827|Hormones|hormones|mesh-list
56908349|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908350|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56908351|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56908352|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329776|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
56329777|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
56329778|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56329779|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329780|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56329781|NCT00049335|Capecitabine|capecitabine|mesh-list
56329782|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329783|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
56329784|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329785|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329786|NCT00049374|Thalidomide|thalidomide|mesh-list
56329787|NCT00049374|Dexamethasone|dexamethasone|mesh-list
56329788|NCT00049374|Oblimersen|oblimersen|mesh-list
56329789|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56329790|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
56329791|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
56329792|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56329793|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329794|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56329795|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
56329796|NCT00049374|Hormones|hormones|mesh-ancestor
56329797|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56329798|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56329799|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329800|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329801|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
56329802|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
56329803|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56329804|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329805|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56329806|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56329807|NCT00049374|Growth Substances|growth substances|mesh-ancestor
56329808|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
56329809|NCT00021983|Immunotoxins|immunotoxins|mesh-list
56329810|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
56329811|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329812|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
56329813|NCT00049413|Rituximab|rituximab|mesh-list
56329814|NCT00049413|Pentostatin|pentostatin|mesh-list
56329815|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329816|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
56329817|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329818|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329819|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329820|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
56329821|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329836|NCT00022139|Paclitaxel|paclitaxel|mesh-list
56329837|NCT00022139|Carboplatin|carboplatin|mesh-list
56329838|NCT00022139|Fluorouracil|fluorouracil|mesh-list
56329839|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329840|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329841|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329842|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329843|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329844|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329845|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
56329846|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329847|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329848|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
56329849|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329850|NCT00049569|Leucovorin|leucovorin|mesh-list
56329851|NCT00049569|Cytarabine|cytarabine|mesh-list
56329852|NCT00049569|Prednisone|prednisone|mesh-list
56329853|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
56329854|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56329855|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56329856|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56908353|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56908354|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56619007|NCT04201808|Tenofovir|tenofovir|mesh-list
56908355|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908357|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56908358|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56908359|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56908360|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
56908361|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56908362|NCT00126503|Bevacizumab|bevacizumab|mesh-list
56908363|NCT00126503|Sorafenib|sorafenib|mesh-list
56908364|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56908365|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908366|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56908367|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56908368|NCT00126503|Growth Substances|growth substances|mesh-ancestor
56908369|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908370|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
56908371|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56908372|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908373|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908374|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56908375|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908376|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908377|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908378|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56908379|NCT00126191|Leucovorin|leucovorin|mesh-list
56908380|NCT00126191|Cytarabine|cytarabine|mesh-list
56329857|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
56329858|NCT00049569|Doxorubicin|doxorubicin|mesh-list
56329859|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56329860|NCT00049569|Methotrexate|methotrexate|mesh-list
56329861|NCT00049569|Etoposide|etoposide|mesh-list
56329862|NCT00049569|Vincristine|vincristine|mesh-list
56329863|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
56329864|NCT00049569|Asparaginase|asparaginase|mesh-list
56329865|NCT00049569|Pegaspargase|pegaspargase|mesh-list
56329866|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
56329867|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329868|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
56329869|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329870|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329871|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329872|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
56329873|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329874|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329875|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329876|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56908381|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
56908382|NCT00126191|Ifosfamide|ifosfamide|mesh-list
56908383|NCT00126191|Rituximab|rituximab|mesh-list
56908384|NCT00126191|Doxorubicin|doxorubicin|mesh-list
56329877|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56329878|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329879|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329880|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56329881|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
56329882|NCT00049569|Hormones|hormones|mesh-ancestor
56329883|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56329884|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55969201|NCT03749018|Nivolumab|nivolumab|mesh-list
56329901|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329902|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329903|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329904|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56329905|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
56329906|NCT00022178|Doxorubicin|doxorubicin|mesh-list
56329907|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56329908|NCT00022178|Fluorouracil|fluorouracil|mesh-list
56329909|NCT00022178|Vincristine|vincristine|mesh-list
56329910|NCT00022178|Epirubicin|epirubicin|mesh-list
56329911|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329912|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
56329913|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329914|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329915|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329916|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
56329917|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329918|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329919|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329920|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56329921|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56329922|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329923|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329924|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
56329925|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329926|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329927|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329928|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329929|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329930|NCT00049608|Gemcitabine|gemcitabine|mesh-list
56329931|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329932|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
56329933|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329934|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329935|NCT00049608|Antiviral Agents|antiviral agents|mesh-ancestor
56329936|NCT00049608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329937|NCT00049608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398587|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56329938|NCT00049608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329939|NCT00049608|Immunologic Factors|immunologic factors|mesh-ancestor
55969263|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
56329949|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
56329950|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329951|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56329952|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
56329953|NCT00049725|Daclizumab|daclizumab|mesh-list
56329954|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329955|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
56329956|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329957|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56329958|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329959|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
56329960|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55951762|NCT01533207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329961|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56329962|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
56329963|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
56329964|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56329965|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329966|NCT00397761|Paclitaxel|paclitaxel|mesh-list
56329967|NCT00397761|Capecitabine|capecitabine|mesh-list
56329968|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56908385|NCT00126191|Methotrexate|methotrexate|mesh-list
56908386|NCT00126191|Etoposide|etoposide|mesh-list
56908387|NCT00126191|Vincristine|vincristine|mesh-list
56908388|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56908389|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
56908390|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908391|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908392|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56908393|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
56908394|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908395|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908396|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56908397|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56908398|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56908399|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56908400|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329969|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329970|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329971|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329972|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329973|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329974|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329975|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329976|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
56329977|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56329978|NCT00022412|Vitamins|vitamins|mesh-ancestor
56329979|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
56329980|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329981|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56329982|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
56329983|NCT00397800|Rituximab|rituximab|mesh-list
56329984|NCT00397800|Fludarabine|fludarabine|mesh-list
56329985|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
56329986|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329987|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
56329988|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329989|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329990|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329991|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
56329992|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329993|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329994|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329995|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56329996|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329997|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
56329998|NCT00022451|Tipifarnib|tipifarnib|mesh-list
56329999|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330000|NCT00022529|Trastuzumab|trastuzumab|mesh-list
56330001|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56330002|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330003|NCT00022607|Thalidomide|thalidomide|mesh-list
56330004|NCT00022607|Bevacizumab|bevacizumab|mesh-list
56330005|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56330007|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56330008|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56330009|NCT00022607|Growth Substances|growth substances|mesh-ancestor
56330010|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330011|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
56330012|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56908401|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908402|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56908403|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
56908404|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56908405|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56908406|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
56908407|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
56908408|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56358412|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
56330013|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
56330014|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
56330015|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330016|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330017|NCT00049998|Topotecan|topotecan|mesh-list
56330018|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56330019|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330020|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330021|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330022|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330023|NCT00022646|Gemcitabine|gemcitabine|mesh-list
56330024|NCT00022646|Pemetrexed|pemetrexed|mesh-list
56330025|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330026|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
56330027|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161716|NCT00558870|Analgesics|analgesics|mesh-ancestor
56330029|NCT00022646|Antiviral Agents|antiviral agents|mesh-ancestor
56330030|NCT00022646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330031|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330032|NCT00022646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330033|NCT00022646|Immunologic Factors|immunologic factors|mesh-ancestor
56330034|NCT00022646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330035|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56330036|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330037|NCT00022685|Epratuzumab|epratuzumab|mesh-list
55951838|NCT03006003|Alendronate|alendronate|mesh-list
56330038|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56330039|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330041|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330042|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330043|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56330044|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330045|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
56330046|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330047|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
56330048|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330049|NCT00050154|Tipifarnib|tipifarnib|mesh-list
56330050|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330051|NCT00022841|Pamidronate|pamidronate|mesh-list
56330052|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56330053|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330054|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
56330055|NCT00022880|Antibodies|antibodies|mesh-list
56330056|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
56330057|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330058|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330059|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
56330060|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
56330061|NCT00050271|Vitamins|vitamins|mesh-ancestor
56330062|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
56330063|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330064|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
56330065|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
56330066|NCT00022958|Antibodies|antibodies|mesh-list
56330067|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
56330068|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330069|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330070|NCT00050349|Epothilones|epothilones|mesh-list
56330071|NCT00050349|Epothilone B|epothilone b|mesh-list
56330072|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908409|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56358474|NCT00416377|Prednisolone|prednisolone|mesh-list
56330073|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
56330074|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
56330075|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330076|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330077|NCT00050427|Trabectedin|trabectedin|mesh-list
56330078|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330079|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
56330080|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330081|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330083|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56330084|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
56330085|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330086|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56330087|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330088|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330089|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330090|NCT00050505|Vaccines|vaccines|mesh-list
56330091|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
56330092|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330093|NCT00050661|Daclizumab|daclizumab|mesh-list
56330094|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330095|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
56330096|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330097|NCT00050817|Clopidogrel|clopidogrel|mesh-list
56330098|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56330099|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56330100|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56330101|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56330102|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
56330103|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56330104|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330105|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330106|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
56330107|NCT00023231|Sirolimus|sirolimus|mesh-list
56330108|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56330109|NCT00023231|Ganciclovir|ganciclovir|mesh-list
56330110|NCT00023231|Prednisone|prednisone|mesh-list
56330111|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
56330112|NCT00023231|Atorvastatin|atorvastatin|mesh-list
56330113|NCT00023231|Daclizumab|daclizumab|mesh-list
56330114|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56330115|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
56330116|NCT00023231|Hormones|hormones|mesh-ancestor
56330117|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56330118|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330119|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56330120|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330121|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56330122|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56330123|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
56330124|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330125|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330126|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330127|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330128|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
56330129|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330130|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
56330131|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
56330132|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
56330133|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330134|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56330135|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56330136|NCT00023231|Protective Agents|protective agents|mesh-ancestor
56330137|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56330138|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56330139|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
56330140|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56330141|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56330142|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
56330143|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56908410|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908411|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
56908412|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908413|NCT00126191|Antidotes|antidotes|mesh-ancestor
56908414|NCT00126191|Protective Agents|protective agents|mesh-ancestor
56908415|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
56908416|NCT00126191|Vitamins|vitamins|mesh-ancestor
56908417|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
56330144|NCT00023231|Renal Agents|renal agents|mesh-ancestor
56330145|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
56330146|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56330147|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56330148|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
56330149|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56330150|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56330151|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330152|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56330153|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56330154|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
56330155|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330156|NCT00023348|Isoniazid|isoniazid|mesh-list
56330158|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
56330159|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330160|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161728|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56330161|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56330162|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56330163|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
56398588|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
56330164|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330165|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56330166|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56330167|NCT00050895|Ritonavir|ritonavir|mesh-list
56330168|NCT00050895|Lopinavir|lopinavir|mesh-list
56330169|NCT00050895|Tenofovir|tenofovir|mesh-list
56330170|NCT00050895|Lamivudine|lamivudine|mesh-list
56330171|NCT00050895|Zidovudine|zidovudine|mesh-list
56330172|NCT00050895|Stavudine|stavudine|mesh-list
56330173|NCT00050895|Efavirenz|efavirenz|mesh-list
56330174|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56330175|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56330176|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
56330177|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330178|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330179|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56330180|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56330181|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
56330182|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330183|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56330184|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56330185|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56330186|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330187|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
56330188|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56330189|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56330190|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56330192|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56330193|NCT00023387|Isoniazid|isoniazid|mesh-list
56330194|NCT00023387|Rifapentine|rifapentine|mesh-list
56330195|NCT00023387|Rifampin|rifampin|mesh-list
56330196|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
56330197|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330198|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330199|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56330200|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56330201|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
56330202|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330203|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56330204|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56330205|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
56908418|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908419|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
56908420|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
56908421|NCT03207958|Belimumab|belimumab|mesh-list
56908422|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56908423|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
56908424|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908425|NCT00124943|Paclitaxel|paclitaxel|mesh-list
56330206|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330207|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330208|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56330209|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56330210|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56330211|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56330212|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56330213|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56330214|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
56330215|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
56330216|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56330217|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56330218|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56330219|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330220|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56330221|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56330222|NCT00023426|Rifapentine|rifapentine|mesh-list
56330223|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56330224|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
56330225|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330226|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330227|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
56330228|NCT00050973|Bexarotene|bexarotene|mesh-list
56330229|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330231|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
56330232|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330233|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
56330234|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
56330236|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56330237|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330238|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
56330239|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330240|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330241|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56330242|NCT00051051|Protective Agents|protective agents|mesh-ancestor
56330244|NCT00051090|Efavirenz|efavirenz|mesh-list
56330245|NCT00051090|Abacavir|abacavir|mesh-list
56330246|NCT00051090|Didanosine|didanosine|mesh-list
56330247|NCT00051090|Telbivudine|telbivudine|mesh-list
56330248|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56330249|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330250|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330251|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330252|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
56330253|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330254|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56330255|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56330256|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56330257|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56330258|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56330259|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56330260|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56330261|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56330262|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
56330263|NCT00023621|Celecoxib|celecoxib|mesh-list
56330264|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56330265|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56330266|NCT00023621|Analgesics|analgesics|mesh-ancestor
56330267|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
56908426|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56908427|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908428|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908429|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
56619074|NCT00623623|Enoxaparin|enoxaparin|mesh-list
56330268|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330269|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330270|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56330271|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330272|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56330273|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56330274|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330275|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330276|NCT00023660|Celecoxib|celecoxib|mesh-list
56330277|NCT00023660|Fluorouracil|fluorouracil|mesh-list
56330278|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330279|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
56330280|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330281|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330282|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330283|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
56330284|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330285|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56330286|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56330287|NCT00023660|Analgesics|analgesics|mesh-ancestor
56330288|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
56330289|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330290|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56330291|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330292|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56330293|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56330294|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330295|NCT00051285|Enoximone|enoximone|mesh-list
56330296|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56330297|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
56330298|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56330299|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56330300|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330301|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330302|NCT00051285|Protective Agents|protective agents|mesh-ancestor
56330317|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56330318|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330319|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330320|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330321|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330322|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
56330323|NCT00397917|Folic Acid|folic acid|mesh-list
56330324|NCT00397917|Hematinics|hematinics|mesh-ancestor
56330325|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
56330326|NCT00397917|Vitamins|vitamins|mesh-ancestor
56330327|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
56330328|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330329|NCT00397956|Ertapenem|ertapenem|mesh-list
56330330|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330331|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330332|NCT00023777|Cytarabine|cytarabine|mesh-list
56330333|NCT00023777|Daunorubicin|daunorubicin|mesh-list
56330334|NCT00023777|Sargramostim|sargramostim|mesh-list
56330335|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330336|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
56330337|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330338|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330339|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
56330340|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330341|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330342|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
56330343|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330344|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56330345|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56330346|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56908430|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
56908431|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
56908432|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908433|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
56908434|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56358752|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56330347|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330349|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
56330350|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
56330351|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56330352|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330353|NCT00398034|Testosterone|testosterone|mesh-list
56330354|NCT00398034|Androgens|androgens|mesh-ancestor
56330355|NCT00398034|Hormones|hormones|mesh-ancestor
56330356|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56330357|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330358|NCT00023855|Doxorubicin|doxorubicin|mesh-list
56330359|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56330360|NCT00023855|Bortezomib|bortezomib|mesh-list
56330361|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56330362|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330363|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56330364|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330365|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330366|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330367|NCT00023894|Alvocidib|alvocidib|mesh-list
56330368|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330369|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
56330370|NCT00023894|Growth Substances|growth substances|mesh-ancestor
56330386|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
56330387|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330388|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330389|NCT00023972|Antiviral Agents|antiviral agents|mesh-ancestor
56330390|NCT00023972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330391|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330392|NCT00023972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330393|NCT00023972|Immunologic Factors|immunologic factors|mesh-ancestor
56330394|NCT00023972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330395|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56330396|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330397|NCT00024011|Bortezomib|bortezomib|mesh-list
56330398|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330399|NCT00051753|Amoxicillin|amoxicillin|mesh-list
56330400|NCT00051753|Levofloxacin|levofloxacin|mesh-list
56330401|NCT00051753|Ofloxacin|ofloxacin|mesh-list
56330402|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
56330403|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
56330404|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56330405|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330406|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330407|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56330408|NCT00051753|Renal Agents|renal agents|mesh-ancestor
56330409|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56330410|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330411|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330412|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330413|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330414|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56330415|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56330416|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56330417|NCT00024050|Cyclosporine|cyclosporine|mesh-list
56330418|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
56330419|NCT00024050|Busulfan|busulfan|mesh-list
56330420|NCT00024050|Methotrexate|methotrexate|mesh-list
56330421|NCT00024050|Cyclosporins|cyclosporins|mesh-list
56330422|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330423|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
56330424|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330425|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330426|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56908435|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56908436|NCT00124709|Analgesics|analgesics|mesh-ancestor
56330427|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
56330428|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330429|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330430|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55969759|NCT00667615|Prednisone|prednisone|mesh-list
56330432|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
56330433|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56330434|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330435|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
56330436|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
56330437|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330438|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56330439|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330440|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
56330441|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330442|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56330443|NCT00024089|Gefitinib|gefitinib|mesh-list
56330444|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330445|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56330446|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330447|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330448|NCT00051831|Ritonavir|ritonavir|mesh-list
56330449|NCT00051831|Saquinavir|saquinavir|mesh-list
56330450|NCT00051831|Tenofovir|tenofovir|mesh-list
56330451|NCT00051831|Emtricitabine|emtricitabine|mesh-list
56330452|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
56330453|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56330454|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56330455|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
56330456|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330457|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330458|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56330459|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56330460|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
56330461|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330462|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56330463|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56330464|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56330465|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330466|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56330467|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56398589|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330469|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
56330470|NCT00024128|Cyclosporins|cyclosporins|mesh-list
56330471|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56330472|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330473|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
56330474|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330475|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330476|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330477|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
56330478|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330479|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330480|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56330481|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330482|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
56330483|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330484|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
56330485|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56330487|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56330488|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330489|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330490|NCT00024245|Probenecid|probenecid|mesh-list
56330491|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
56330492|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
56330493|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330494|NCT00024245|Renal Agents|renal agents|mesh-ancestor
56330495|NCT00051987|Bortezomib|bortezomib|mesh-list
56330496|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330497|NCT00024284|Carboplatin|carboplatin|mesh-list
56330498|NCT00024284|Irinotecan|irinotecan|mesh-list
56330499|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330500|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56908437|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
56330501|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330502|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330503|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330504|NCT00052026|Carvedilol|carvedilol|mesh-list
56330505|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56330506|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56330508|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56330509|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330510|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330511|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56330512|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
56330513|NCT00052026|Protective Agents|protective agents|mesh-ancestor
56330514|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56330515|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56330516|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56330517|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
56330518|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56330519|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56330520|NCT00024323|Cisplatin|cisplatin|mesh-list
56330521|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330522|NCT00024362|BBR 3464|bbr 3464|mesh-list
56330523|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330524|NCT00024401|Paclitaxel|paclitaxel|mesh-list
56330525|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56330526|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330527|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
56330528|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
56330529|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
56330530|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330531|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
56330532|NCT00024440|Fludarabine|fludarabine|mesh-list
56330533|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
56330534|NCT00024440|Oblimersen|oblimersen|mesh-list
56330535|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330536|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
56330537|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330538|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330539|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330540|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
56330541|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330542|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330543|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56330544|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330545|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
56330547|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
56330548|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330549|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
56330550|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330551|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
56330552|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330553|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
56330554|NCT00052221|Hematinics|hematinics|mesh-ancestor
56330555|NCT00052299|Cytarabine|cytarabine|mesh-list
56330556|NCT00052299|Etoposide|etoposide|mesh-list
56330557|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
56330558|NCT00052299|Idarubicin|idarubicin|mesh-list
56330559|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
56330560|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56330561|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330562|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56330563|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330564|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330565|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330566|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330567|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
56330568|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
56330569|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330570|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330571|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
56330572|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330573|NCT00052299|Analgesics|analgesics|mesh-ancestor
56330574|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
56330575|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330576|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56358962|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
56330577|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56330578|NCT00052338|Gemcitabine|gemcitabine|mesh-list
56330579|NCT00052338|Carboplatin|carboplatin|mesh-list
56330580|NCT00052338|Bortezomib|bortezomib|mesh-list
56330581|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330582|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330583|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
56330586|NCT00052338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330587|NCT00052338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330588|NCT00052338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330589|NCT00052338|Immunologic Factors|immunologic factors|mesh-ancestor
56330590|NCT00052338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330591|NCT04733066|Teduglutide|teduglutide|mesh-list
56330592|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56330593|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56330594|NCT04733066|Protective Agents|protective agents|mesh-ancestor
56330595|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330596|NCT00052377|Aldesleukin|aldesleukin|mesh-list
56330597|NCT00052377|Interleukin-2|interleukin-2|mesh-list
56330598|NCT00052377|Interleukin-12|interleukin-12|mesh-list
56330599|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330600|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56330601|NCT00052377|Analgesics|analgesics|mesh-ancestor
56330602|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
56330603|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330604|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330605|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56330606|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56330607|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
56330608|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330609|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56330610|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
56330611|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56330612|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56330613|NCT00052377|Growth Substances|growth substances|mesh-ancestor
56330614|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
56330615|NCT00052416|Thalidomide|thalidomide|mesh-list
56330616|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330617|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
56330618|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330619|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
56330620|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330621|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330622|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56330623|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56330624|NCT00052416|Growth Substances|growth substances|mesh-ancestor
56330625|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
56330626|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330627|NCT00052455|Vincristine|vincristine|mesh-list
56330628|NCT00052455|Temozolomide|temozolomide|mesh-list
56330630|NCT00052455|Procarbazine|procarbazine|mesh-list
56330631|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56330632|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330633|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
56330634|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
56330635|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
56330636|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330637|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330638|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
56330639|NCT00052494|Irinotecan|irinotecan|mesh-list
56330640|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
56330641|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330642|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56330643|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330644|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330645|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330646|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56330648|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
56330649|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
56330650|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330651|NCT00395213|Norepinephrine|norepinephrine|mesh-list
56330652|NCT00395213|Serotonin|serotonin|mesh-list
56330653|NCT00395213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56330654|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56330655|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56330656|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
56908438|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908439|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330657|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56330658|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330659|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330673|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330674|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330675|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56330676|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330677|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56330678|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56330679|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330680|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330681|NCT00395252|Gemcitabine|gemcitabine|mesh-list
56330682|NCT00395252|Cetuximab|cetuximab|mesh-list
56330683|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330684|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
56330685|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330686|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330687|NCT00395252|Antiviral Agents|antiviral agents|mesh-ancestor
56330688|NCT00395252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330689|NCT00395252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330690|NCT00395252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330691|NCT00395252|Immunologic Factors|immunologic factors|mesh-ancestor
56330692|NCT00395252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330693|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56330694|NCT00052689|Gemcitabine|gemcitabine|mesh-list
56330695|NCT00052689|Bortezomib|bortezomib|mesh-list
56330696|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330697|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
56330698|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330699|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330700|NCT00052689|Antiviral Agents|antiviral agents|mesh-ancestor
56330701|NCT00052689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330702|NCT00052689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330703|NCT00052689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330704|NCT00052689|Immunologic Factors|immunologic factors|mesh-ancestor
56330705|NCT00052689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330706|NCT00052728|Tamoxifen|tamoxifen|mesh-list
56330707|NCT00052728|Tipifarnib|tipifarnib|mesh-list
56330708|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56330709|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
56330710|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56330711|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330712|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56330713|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330714|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56330715|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56330716|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56330717|NCT00395369|Aprotinin|aprotinin|mesh-list
56330718|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
56330719|NCT00395369|Coagulants|coagulants|mesh-ancestor
56330720|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55952526|NCT04788654|Celecoxib|celecoxib|mesh-list
56330722|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
56330723|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330724|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330725|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
56330726|NCT00052845|Docetaxel|docetaxel|mesh-list
56330727|NCT00052845|Estramustine|estramustine|mesh-list
56330728|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330729|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
56330730|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
56330731|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
56330732|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330733|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330734|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
56330735|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56330736|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56330737|NCT00052845|Protective Agents|protective agents|mesh-ancestor
56330738|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330739|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56908440|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56908441|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908442|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
56908443|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359113|NCT00278122|Paclitaxel|paclitaxel|mesh-list
56330740|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330741|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56330742|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56330743|NCT00052845|Analgesics|analgesics|mesh-ancestor
56330744|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
56330745|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330746|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56330747|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330748|NCT00024986|Tenofovir|tenofovir|mesh-list
56330749|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
56330750|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330751|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56330752|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330753|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330754|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330755|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56330756|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56330757|NCT00052884|Melphalan|melphalan|mesh-list
56330758|NCT00052884|Amifostine|amifostine|mesh-list
56330759|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
56330760|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330761|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330762|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
56330763|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330764|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330765|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56330766|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330767|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56330768|NCT00052884|Protective Agents|protective agents|mesh-ancestor
56330769|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
56330770|NCT00052923|Carmustine|carmustine|mesh-list
56330771|NCT00052923|Rituximab|rituximab|mesh-list
56330772|NCT00052923|Etoposide|etoposide|mesh-list
56330773|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330774|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
56330775|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330776|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330777|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330778|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
56330779|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330780|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330781|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56330782|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56330783|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56330784|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56330785|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330786|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330787|NCT00025064|Prednisolone|prednisolone|mesh-list
56330788|NCT00025064|Doxorubicin|doxorubicin|mesh-list
56330789|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56330790|NCT00025064|Etoposide|etoposide|mesh-list
56330791|NCT00025064|Vincristine|vincristine|mesh-list
56330792|NCT00025064|Melphalan|melphalan|mesh-list
56330793|NCT00025064|Ifosfamide|ifosfamide|mesh-list
56330794|NCT00025064|Dacarbazine|dacarbazine|mesh-list
56330795|NCT00025064|Bleomycin|bleomycin|mesh-list
56330796|NCT00025064|Vinblastine|vinblastine|mesh-list
56330797|NCT00025064|Procarbazine|procarbazine|mesh-list
56330799|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330800|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56330801|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56330802|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330803|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330804|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330805|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56330806|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
56330807|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
56330808|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
56908444|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
56908445|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56908446|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359178|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
56330809|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330810|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
56330811|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56330812|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330813|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
56330814|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330815|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56330816|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
56330817|NCT00025064|Hormones|hormones|mesh-ancestor
56330818|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56330819|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56330820|NCT00053001|Thalidomide|thalidomide|mesh-list
56330821|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
56330822|NCT00053001|Hematinics|hematinics|mesh-ancestor
56330823|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330824|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
56330825|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330826|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
56330827|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330828|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330829|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56330830|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56330831|NCT00053001|Growth Substances|growth substances|mesh-ancestor
56330832|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
56330833|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330834|NCT00025103|Dactinomycin|dactinomycin|mesh-list
56330835|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
56330836|NCT00025103|Melphalan|melphalan|mesh-list
56330837|NCT00025103|Carboplatin|carboplatin|mesh-list
56330838|NCT00025103|Doxorubicin|doxorubicin|mesh-list
56330839|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56330840|NCT00025103|Etoposide|etoposide|mesh-list
56330841|NCT00025103|Vincristine|vincristine|mesh-list
56330842|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330843|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
56330844|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330845|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330846|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330847|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
56330848|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330849|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330850|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56330851|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56330852|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56330853|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330854|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330855|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56330856|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
56330857|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
56330858|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
56330859|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330860|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330861|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56330862|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330864|NCT00025142|Fluorouracil|fluorouracil|mesh-list
56330865|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
56330866|NCT00025142|Gefitinib|gefitinib|mesh-list
56330867|NCT00025142|Calcium|calcium|mesh-list
56330868|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
56330869|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56330870|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330871|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
56330872|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330873|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330874|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330882|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56330883|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330885|NCT00053118|Etoposide|etoposide|mesh-list
56330886|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908447|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908448|NCT04139434|Azacitidine|azacitidine|mesh-list
56908449|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330887|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56330888|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56330889|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56330890|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330891|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330892|NCT00025181|Ipilimumab|ipilimumab|mesh-list
56330893|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
56330894|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56330895|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330896|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56330897|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330898|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56330899|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
56330900|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330901|NCT00025220|Thalidomide|thalidomide|mesh-list
56330902|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330903|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
56330904|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330905|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
56330906|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330907|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56330908|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56330909|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56330910|NCT00025220|Growth Substances|growth substances|mesh-ancestor
56330911|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
56330912|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330914|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
56330915|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330916|NCT00025298|Paclitaxel|paclitaxel|mesh-list
56330917|NCT00025298|Carboplatin|carboplatin|mesh-list
56330918|NCT00025298|Amifostine|amifostine|mesh-list
56330919|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56330920|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330921|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
56330922|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
56330923|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
56330924|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330925|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56330926|NCT00025298|Protective Agents|protective agents|mesh-ancestor
56330927|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330928|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
56330929|NCT00053196|Methotrexate|methotrexate|mesh-list
56330930|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
56330931|NCT00053196|Fludarabine|fludarabine|mesh-list
56330932|NCT00053196|Busulfan|busulfan|mesh-list
56330933|NCT00053196|Allopurinol|allopurinol|mesh-list
56330934|NCT00053196|Tacrolimus|tacrolimus|mesh-list
56330935|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56330936|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56330937|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
56330938|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56330939|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330940|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330941|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
56330942|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330943|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330944|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
56330945|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330946|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56330947|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55952745|NCT01490918|Metformin|metformin|mesh-list
56330949|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330950|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56330951|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56330952|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56330953|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56330954|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
56330955|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56330956|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908450|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
56330957|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
56330958|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56330959|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56330960|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
56330961|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56330962|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
56330963|NCT00053196|Protective Agents|protective agents|mesh-ancestor
56330964|NCT00025337|Leucovorin|leucovorin|mesh-list
56330965|NCT00025337|Bevacizumab|bevacizumab|mesh-list
56330966|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56330967|NCT00025337|Fluorouracil|fluorouracil|mesh-list
56330968|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
56330969|NCT00025337|Antibodies|antibodies|mesh-list
56330970|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
56330971|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56330972|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
56330973|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330974|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56330975|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56330976|NCT00025337|Growth Substances|growth substances|mesh-ancestor
56330977|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330978|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
56330979|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
56330980|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
56330981|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330982|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330983|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330984|NCT00025337|Antidotes|antidotes|mesh-ancestor
56330985|NCT00025337|Protective Agents|protective agents|mesh-ancestor
56330986|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
56330987|NCT00025337|Vitamins|vitamins|mesh-ancestor
56330988|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
56330989|NCT00025376|Bortezomib|bortezomib|mesh-list
56330990|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330991|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
56330992|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330993|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56330994|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330995|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330996|NCT00025454|Tipifarnib|tipifarnib|mesh-list
56330997|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330998|NCT00025493|Docetaxel|docetaxel|mesh-list
56330999|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331000|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331001|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
56398590|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331002|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331003|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331004|NCT00025532|Antibodies|antibodies|mesh-list
56331005|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56331006|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
56331007|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331008|NCT00053430|Thalidomide|thalidomide|mesh-list
56331009|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331010|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
56331011|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331012|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
56331013|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56331014|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331015|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331016|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331017|NCT00053430|Growth Substances|growth substances|mesh-ancestor
56331018|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331019|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331020|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
56331021|NCT00025610|Carboplatin|carboplatin|mesh-list
56331022|NCT00025610|Doxorubicin|doxorubicin|mesh-list
56331023|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56331026|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331027|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
56331028|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331029|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331030|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56331031|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
56331032|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331033|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908451|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908452|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908453|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908454|NCT04130464|Ketorolac|ketorolac|mesh-list
56908455|NCT04130464|Ropivacaine|ropivacaine|mesh-list
56908456|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
56908457|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
56359399|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331034|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56331035|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56331036|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56331037|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331038|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331039|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56331040|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331041|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331042|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331043|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
56331045|NCT00025649|Busulfan|busulfan|mesh-list
56331046|NCT00025649|Carboplatin|carboplatin|mesh-list
56331047|NCT00025649|Doxorubicin|doxorubicin|mesh-list
56331048|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56331049|NCT00025649|Etoposide|etoposide|mesh-list
56331050|NCT00025649|Vincristine|vincristine|mesh-list
56331051|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331052|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
56331053|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331054|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331055|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56331056|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
56331057|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331058|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331059|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56331060|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56331061|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56331062|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331063|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331064|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56331065|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331066|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331067|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331068|NCT00025688|Paclitaxel|paclitaxel|mesh-list
56331069|NCT00025688|Carboplatin|carboplatin|mesh-list
56331070|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56331071|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331072|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331073|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331074|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331075|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331076|NCT00025727|Ritonavir|ritonavir|mesh-list
56331077|NCT00025727|Lopinavir|lopinavir|mesh-list
56331078|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
56331079|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56331080|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56331081|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
56331082|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331083|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331084|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56331085|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56331086|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
56331087|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331088|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56331089|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56331090|NCT00053820|Interferons|interferons|mesh-list
56331091|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
56331092|NCT00053820|Aldesleukin|aldesleukin|mesh-list
56331093|NCT00053820|Fluorouracil|fluorouracil|mesh-list
56331094|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
56331095|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084226|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
56331096|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331097|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331098|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331107|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56331108|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331109|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
56331110|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56331111|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331112|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331113|NCT00053937|Pirfenidone|pirfenidone|mesh-list
56331114|NCT00053937|Analgesics|analgesics|mesh-ancestor
56331115|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
56331116|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331117|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331118|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56331119|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56331120|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331121|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331122|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331123|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
56331124|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56331125|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56331126|NCT00053976|Prednisolone|prednisolone|mesh-list
56331127|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
56331128|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56331129|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
56331131|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331132|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
56331133|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
56331134|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331135|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331136|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56331137|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
56331138|NCT00053976|Hormones|hormones|mesh-ancestor
56161761|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331139|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331141|NCT00053976|Protective Agents|protective agents|mesh-ancestor
56331142|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56331143|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331144|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331145|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
56331146|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
56331147|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331148|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
56331149|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
56331150|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
56331151|NCT00026039|Estrogens|estrogens|mesh-list
56331152|NCT00026039|Hormones|hormones|mesh-ancestor
56331153|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331154|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331155|NCT00054054|Docetaxel|docetaxel|mesh-list
56331156|NCT00054054|Fluorouracil|fluorouracil|mesh-list
56331157|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331158|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
56398591|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331159|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331160|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331161|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331162|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
56331163|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331164|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331165|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
56331166|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331169|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331170|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331171|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331172|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331173|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331174|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56331175|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
56331176|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56331177|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56331178|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331179|NCT00026156|Docetaxel|docetaxel|mesh-list
56331180|NCT00026156|Vinorelbine|vinorelbine|mesh-list
56908458|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908459|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908460|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
56331181|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331182|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331183|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331184|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331185|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331186|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56331187|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56331188|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56331189|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
56331190|NCT00026195|Irinotecan|irinotecan|mesh-list
56331191|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56331192|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331193|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331194|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331195|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331196|NCT00054210|Paclitaxel|paclitaxel|mesh-list
56331197|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56331198|NCT00054210|Carboplatin|carboplatin|mesh-list
56331199|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56331200|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56331201|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331202|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331203|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331204|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331205|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331206|NCT00026234|Dexamethasone|dexamethasone|mesh-list
56331207|NCT00026234|Capecitabine|capecitabine|mesh-list
56331208|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
56331209|NCT00026234|Floxuridine|floxuridine|mesh-list
56331210|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331211|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
56331212|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
56331213|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331214|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331215|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56331216|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
56331217|NCT00026234|Hormones|hormones|mesh-ancestor
56331218|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331219|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56331220|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331221|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331222|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
56331223|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331224|NCT00054288|Gemcitabine|gemcitabine|mesh-list
56331225|NCT00054288|Irinotecan|irinotecan|mesh-list
56331226|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331227|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
56331228|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331229|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331230|NCT00054288|Antiviral Agents|antiviral agents|mesh-ancestor
56331231|NCT00054288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331232|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331233|NCT00054288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331234|NCT00054288|Immunologic Factors|immunologic factors|mesh-ancestor
56331235|NCT00054288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331236|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56331237|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331238|NCT00026273|Leucovorin|leucovorin|mesh-list
56331239|NCT00026273|Fluorouracil|fluorouracil|mesh-list
56331240|NCT00026273|Irinotecan|irinotecan|mesh-list
56331241|NCT00026273|Calcium|calcium|mesh-list
56331242|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
56331249|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331250|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
56331251|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56331252|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331253|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331255|NCT00026273|Protective Agents|protective agents|mesh-ancestor
56331256|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
55953045|NCT03172897|Analgesics|analgesics|mesh-ancestor
56331257|NCT00026273|Vitamins|vitamins|mesh-ancestor
56908461|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908462|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56908463|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56331259|NCT00054405|Aldesleukin|aldesleukin|mesh-list
56331260|NCT00054405|Interleukin-2|interleukin-2|mesh-list
56331261|NCT00054405|Interleukin-12|interleukin-12|mesh-list
56331262|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331263|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56331264|NCT00054405|Analgesics|analgesics|mesh-ancestor
56331265|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
56331266|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331267|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331268|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56331269|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56331270|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
56331271|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331272|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56331273|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
56331274|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331275|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331276|NCT00054405|Growth Substances|growth substances|mesh-ancestor
56331277|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331278|NCT00026351|Rituximab|rituximab|mesh-list
56331279|NCT00026351|Pentostatin|pentostatin|mesh-list
56331280|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56331281|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331282|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
56331283|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331284|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331285|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56331286|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331287|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331288|NCT00054444|Topotecan|topotecan|mesh-list
56331289|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331290|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56331291|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331293|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331294|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
56331295|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331296|NCT00054483|Bortezomib|bortezomib|mesh-list
56331297|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331298|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
56331299|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331300|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56331301|NCT00026468|Protective Agents|protective agents|mesh-ancestor
56331302|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331303|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56331304|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331305|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331306|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56331307|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56331308|NCT00026468|Analgesics|analgesics|mesh-ancestor
56331309|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
56331310|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331311|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331322|NCT00054522|Hormones|hormones|mesh-ancestor
56331323|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331324|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56331325|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331326|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56331327|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56331328|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56331329|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331330|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56331331|NCT00054522|Vitamins|vitamins|mesh-ancestor
56331332|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
56331333|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56331334|NCT00054561|Vitamin E|vitamin e|mesh-list
56331335|NCT00054561|Interferons|interferons|mesh-list
56331336|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
56331337|NCT00054561|Isotretinoin|isotretinoin|mesh-list
56331338|NCT00054561|Vitamins|vitamins|mesh-ancestor
56908464|NCT04130464|Analgesics|analgesics|mesh-ancestor
56908465|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56908466|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908467|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56331339|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
56331340|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331341|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331342|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
56331343|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331344|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
56331345|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
56331346|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331347|NCT00054561|Protective Agents|protective agents|mesh-ancestor
56331348|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
56331349|NCT00026585|Tamoxifen|tamoxifen|mesh-list
56331350|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56331351|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
56331352|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331353|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331354|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56331355|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331356|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56331357|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56331358|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56331359|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56331360|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56331361|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
56331362|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331364|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56331365|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
56331366|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
56331367|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331368|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56331369|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
56331370|NCT00026819|Rofecoxib|rofecoxib|mesh-list
56331371|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56331372|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56331373|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331374|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331375|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56331376|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56331377|NCT00026819|Analgesics|analgesics|mesh-ancestor
56331378|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
55970670|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331381|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331382|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331383|NCT00054834|Epratuzumab|epratuzumab|mesh-list
56331384|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56331385|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331386|NCT00054873|Fluorouracil|fluorouracil|mesh-list
56331387|NCT00054873|Tezacitabine|tezacitabine|mesh-list
56331388|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
56331389|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331390|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331391|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331392|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331393|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
56331394|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331395|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331396|NCT00398385|Gemcitabine|gemcitabine|mesh-list
56331397|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331398|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331399|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
56331400|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331401|NCT00398385|Antiviral Agents|antiviral agents|mesh-ancestor
56331402|NCT00398385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331403|NCT00398385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331404|NCT00398385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331405|NCT00398385|Immunologic Factors|immunologic factors|mesh-ancestor
56331406|NCT00398385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331407|NCT00027014|Fentanyl|fentanyl|mesh-list
56908468|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908469|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331408|NCT00027014|Oxycodone|oxycodone|mesh-list
56331409|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56331410|NCT00027014|Narcotics|narcotics|mesh-ancestor
56331411|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56331412|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331413|NCT00027014|Analgesics|analgesics|mesh-ancestor
56331414|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
56331415|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331416|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56331417|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56331418|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
56331419|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
56331420|NCT00398424|Cisplatin|cisplatin|mesh-list
56331421|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331422|NCT00027053|Trazodone|trazodone|mesh-list
56331423|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56331424|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56331425|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56331426|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331427|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56331428|NCT00027053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56331429|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56331430|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56331431|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331432|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56331433|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
56331435|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
56331436|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
56331437|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56331438|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331439|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
56331440|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
56331441|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331442|NCT00055302|Anastrozole|anastrozole|mesh-list
56331443|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56331444|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331445|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56331446|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56331447|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331448|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331449|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56331450|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
56331451|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331452|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331454|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331455|NCT00055341|Ribavirin|ribavirin|mesh-list
56331456|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56331457|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
56331458|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331459|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
56331460|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331461|NCT00027287|Vitamin E|vitamin e|mesh-list
56331462|NCT00027287|Vitamins|vitamins|mesh-ancestor
56331463|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
56331464|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331465|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
56331466|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331467|NCT00027287|Protective Agents|protective agents|mesh-ancestor
56331468|NCT00055419|Cetuximab|cetuximab|mesh-list
56331469|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56331470|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331471|NCT00027404|Fluoxetine|fluoxetine|mesh-list
56331472|NCT00027404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56331473|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56331474|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56331475|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331476|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56331477|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
56331478|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331479|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56908470|NCT03058354|Propofol|propofol|mesh-list
56331480|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
56331481|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56331482|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56331483|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56331484|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331485|NCT00055536|Natalizumab|natalizumab|mesh-list
56331486|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
56331487|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331488|NCT00027443|Cyclosporine|cyclosporine|mesh-list
56331489|NCT00027443|Cyclosporins|cyclosporins|mesh-list
56331490|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
56331491|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331492|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331493|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331494|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
56331495|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331496|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
56331497|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331498|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
56331499|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331500|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56331501|NCT00055614|Topotecan|topotecan|mesh-list
56331502|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56331503|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331504|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331505|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331506|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331509|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331510|NCT00027599|Bevacizumab|bevacizumab|mesh-list
56331511|NCT00027599|Sargramostim|sargramostim|mesh-list
56331512|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56331513|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331514|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331515|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331516|NCT00027599|Growth Substances|growth substances|mesh-ancestor
56331517|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331518|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331519|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
56331520|NCT00055653|Cyclosporine|cyclosporine|mesh-list
56331521|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
56331522|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
56331523|NCT00055653|Melphalan|melphalan|mesh-list
56331524|NCT00055653|Busulfan|busulfan|mesh-list
56331525|NCT00055653|Fludarabine|fludarabine|mesh-list
56331526|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
56331527|NCT00055653|Cyclosporins|cyclosporins|mesh-list
56331528|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56331529|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331530|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
56331532|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331533|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56331534|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
56331535|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331536|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331537|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56331538|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331539|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
56331540|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331541|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
56331542|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331543|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
56331544|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56331545|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331546|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
56331547|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
56331548|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331549|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56331550|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
56331551|NCT00055653|Hormones|hormones|mesh-ancestor
56331552|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331553|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56331554|NCT00055653|Protective Agents|protective agents|mesh-ancestor
56331555|NCT00055770|Docetaxel|docetaxel|mesh-list
56331556|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56331557|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331558|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908471|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
56359896|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56331559|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331560|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331561|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331562|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56331563|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331564|NCT00027638|Thalidomide|thalidomide|mesh-list
56331565|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331566|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
56331567|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331568|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
56331569|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56331570|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331571|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331572|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331573|NCT00027638|Growth Substances|growth substances|mesh-ancestor
56331574|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331575|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331576|NCT00055809|Interferons|interferons|mesh-list
56331577|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
56331578|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
56331579|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56331580|NCT00055809|Bevacizumab|bevacizumab|mesh-list
56331581|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56331582|NCT00055809|Antibodies|antibodies|mesh-list
56331583|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
56331585|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331586|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331587|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331588|NCT00055809|Growth Substances|growth substances|mesh-ancestor
56331589|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331590|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331591|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
56331592|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
56331593|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331594|NCT00027677|Halofuginone|halofuginone|mesh-list
56331595|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331596|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
56331597|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56331598|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56331599|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331600|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56331601|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331602|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331603|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331604|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331605|NCT00027677|Growth Substances|growth substances|mesh-ancestor
56331606|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331612|NCT00055887|Vinorelbine|vinorelbine|mesh-list
56331613|NCT00055887|Carboplatin|carboplatin|mesh-list
56331614|NCT00055887|Efaproxiral|efaproxiral|mesh-list
56331615|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56331616|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331617|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331618|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331619|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331620|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331621|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331622|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
56331623|NCT00055887|Antiviral Agents|antiviral agents|mesh-ancestor
56331624|NCT00055887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331625|NCT00055887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331626|NCT00055887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331627|NCT00055887|Immunologic Factors|immunologic factors|mesh-ancestor
56331628|NCT00055887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331629|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
56331630|NCT00055965|Gemcitabine|gemcitabine|mesh-list
56331631|NCT00055965|Carboplatin|carboplatin|mesh-list
56331632|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331633|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331634|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
56331635|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331636|NCT00055965|Antiviral Agents|antiviral agents|mesh-ancestor
56331637|NCT00055965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359973|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331638|NCT00055965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331639|NCT00055965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331640|NCT00055965|Immunologic Factors|immunologic factors|mesh-ancestor
56331641|NCT00055965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331643|NCT00027833|Fluorouracil|fluorouracil|mesh-list
56331644|NCT00027833|Irinotecan|irinotecan|mesh-list
56331645|NCT00027833|Calcium|calcium|mesh-list
56331646|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
56331647|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56331648|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331649|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
56331650|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331651|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331652|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331653|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331654|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
56331655|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56331656|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331657|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331658|NCT00027833|Antidotes|antidotes|mesh-ancestor
56331659|NCT00027833|Protective Agents|protective agents|mesh-ancestor
56331660|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
56331661|NCT00027833|Vitamins|vitamins|mesh-ancestor
56331662|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
56331663|NCT00027872|Tipifarnib|tipifarnib|mesh-list
56331664|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331665|NCT00027911|Sargramostim|sargramostim|mesh-list
56331666|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
56331667|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331668|NCT00027989|Gemcitabine|gemcitabine|mesh-list
56331669|NCT00027989|Doxorubicin|doxorubicin|mesh-list
56331670|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56331671|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331672|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
56331673|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331674|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331675|NCT00027989|Antiviral Agents|antiviral agents|mesh-ancestor
56331676|NCT00027989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331677|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331678|NCT00027989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331679|NCT00027989|Immunologic Factors|immunologic factors|mesh-ancestor
56331680|NCT00027989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331681|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56331684|NCT00056004|Zileuton|zileuton|mesh-list
56331685|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56331686|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56331687|NCT00056004|Analgesics|analgesics|mesh-ancestor
56331688|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
56331689|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331690|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331691|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331692|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331693|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56331694|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331695|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331696|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56331697|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
56331698|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331700|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56331701|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331702|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56331703|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331704|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
56331705|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331706|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
56331707|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331708|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56331709|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331710|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331711|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331712|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56331713|NCT00056082|Celecoxib|celecoxib|mesh-list
55953493|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56331714|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56908472|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908473|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908474|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56331715|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56331716|NCT00056082|Analgesics|analgesics|mesh-ancestor
56331717|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
56331718|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331719|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331720|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331721|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331722|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56331723|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56331724|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331725|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331726|NCT04730973|Evolocumab|evolocumab|mesh-list
56331727|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56331728|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56331729|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
56331730|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331731|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56331732|NCT00028418|Clofarabine|clofarabine|mesh-list
56331733|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331734|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
56331735|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331736|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331737|NCT00028496|Metronidazole|metronidazole|mesh-list
56331738|NCT00028496|Molgramostim|molgramostim|mesh-list
56331740|NCT00028496|Sargramostim|sargramostim|mesh-list
56331741|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
56331742|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331743|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331744|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331745|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56331746|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56331747|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56331748|NCT00028535|Paclitaxel|paclitaxel|mesh-list
56331749|NCT00028535|Trastuzumab|trastuzumab|mesh-list
56331750|NCT00028535|Interleukin-12|interleukin-12|mesh-list
56331751|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56331752|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331753|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331754|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331755|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331768|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56331769|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331770|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56331771|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331772|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56331773|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56331774|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56331775|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56331776|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56331777|NCT00028574|Gabapentin|gabapentin|mesh-list
56331778|NCT00028574|Analgesics|analgesics|mesh-ancestor
56331779|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
56331780|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331781|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331782|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
56331783|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56331784|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56331785|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56331786|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56331787|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55953576|NCT03086993|Gemcitabine|gemcitabine|mesh-list
56331788|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56331789|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56331790|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331791|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
56331792|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
56331793|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
56331794|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
55811405|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908475|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56908476|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
56908477|NCT02911792|Metformin|metformin|mesh-list
56908478|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
56908479|NCT02911792|Glipizide|glipizide|mesh-list
56331795|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56331796|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56331797|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331798|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331799|NCT00056433|Urological Agents|urological agents|mesh-ancestor
56331800|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331801|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
56331802|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56331803|NCT00028613|Antibodies|antibodies|mesh-list
56331804|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56331805|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
56331806|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331807|NCT00028652|Interleukin-12|interleukin-12|mesh-list
56331808|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56331809|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
56331810|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331811|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331812|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331813|NCT00028652|Growth Substances|growth substances|mesh-ancestor
56331814|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331818|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
56331819|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331820|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331821|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
56331822|NCT00028730|Thiotepa|thiotepa|mesh-list
56331823|NCT00028730|Fludarabine|fludarabine|mesh-list
56331824|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
56331825|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56331826|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331827|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
56331828|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331829|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331830|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56331831|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
56331832|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331833|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331834|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56331835|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331836|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
56331837|NCT00028847|Cytarabine|cytarabine|mesh-list
56331838|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
56331839|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331840|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
56331841|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331842|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331843|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
56331844|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331845|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331846|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
56331847|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331848|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56331849|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331850|NCT00028886|Interferons|interferons|mesh-list
56331851|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
56331852|NCT00028886|Thalidomide|thalidomide|mesh-list
56331853|NCT00028886|Dexamethasone|dexamethasone|mesh-list
56331854|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
56331856|NCT00028886|Doxorubicin|doxorubicin|mesh-list
56331857|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56331858|NCT00028886|Vincristine|vincristine|mesh-list
56331859|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331860|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
56331861|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331862|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331863|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56331864|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
56331865|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331866|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908480|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56331867|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56331868|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331869|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
56331870|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
56331871|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331872|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56331873|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
56331874|NCT00028886|Hormones|hormones|mesh-ancestor
56331875|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331876|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56331877|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56331878|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56331879|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331880|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331881|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
56331882|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331883|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56331884|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
56331885|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
56331886|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
56331887|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
55971171|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
56331897|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331898|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331899|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331900|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
56331901|NCT00398463|Tirofiban|tirofiban|mesh-list
56331902|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56331903|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56331904|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331905|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56331906|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56331907|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
56331908|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331909|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56331910|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331911|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
56331912|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331913|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
56331914|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56331915|NCT00398463|Protective Agents|protective agents|mesh-ancestor
56331916|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
56331917|NCT00028964|Doxorubicin|doxorubicin|mesh-list
56331918|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56331919|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331920|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
56331921|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331922|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331923|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56331924|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
56331925|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331926|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331927|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56331928|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56331929|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56331930|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331931|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331932|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56331933|NCT00423501|Incretins|incretins|mesh-ancestor
56331934|NCT00423501|Hormones|hormones|mesh-ancestor
56331935|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331936|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331937|NCT00029003|Gefitinib|gefitinib|mesh-list
56331938|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953723|NCT04745988|Leucovorin|leucovorin|mesh-list
56331939|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56331940|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331941|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331942|NCT00029042|Infliximab|infliximab|mesh-list
56331943|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
56331944|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56331945|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331946|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
56331947|NCT00423540|Analgesics|analgesics|mesh-ancestor
56908481|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908482|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56360260|NCT00077441|Bortezomib|bortezomib|mesh-list
56331948|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
56331949|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331950|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331951|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
56331952|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56331954|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
56331970|NCT00423696|Irinotecan|irinotecan|mesh-list
56331971|NCT00423696|Calcium|calcium|mesh-list
56331972|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
56331973|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56331974|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331975|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331976|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331977|NCT00423696|Growth Substances|growth substances|mesh-ancestor
56331978|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331979|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331980|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56331981|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
56331982|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331983|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331984|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56331985|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
56331986|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56331987|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331988|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331989|NCT00423696|Antidotes|antidotes|mesh-ancestor
56331990|NCT00423696|Protective Agents|protective agents|mesh-ancestor
56331991|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
56331993|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
56331994|NCT00029315|Plasminogen|plasminogen|mesh-list
56331995|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56331996|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56331997|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56331998|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331999|NCT00056823|Ranibizumab|ranibizumab|mesh-list
56332000|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56332001|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56332002|NCT00056823|Growth Substances|growth substances|mesh-ancestor
56332003|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332004|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
56332005|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332006|NCT00029627|Yohimbine|yohimbine|mesh-list
56332007|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
56332008|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
56332009|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332010|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332011|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56332012|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56332013|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56332014|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
56332015|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971309|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
56332016|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332017|NCT00029627|Urological Agents|urological agents|mesh-ancestor
56332019|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
56332020|NCT02970084|Vitamins|vitamins|mesh-ancestor
56332021|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
56332022|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332023|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56332024|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56332025|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332026|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
56332027|NCT02970084|Coagulants|coagulants|mesh-ancestor
56332028|NCT00056979|Fludarabine|fludarabine|mesh-list
56332029|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
56332031|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56332032|NCT00029822|Alfuzosin|alfuzosin|mesh-list
56332033|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56332034|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56908483|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908484|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56332035|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56332036|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
56332037|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332038|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332039|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332040|NCT00029822|Urological Agents|urological agents|mesh-ancestor
56332041|NCT00395681|Propofol|propofol|mesh-list
56332042|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56332043|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56332044|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332045|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56332046|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
56332047|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
56332048|NCT00395720|Vaccines|vaccines|mesh-list
56332049|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
56332050|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332051|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
56332052|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56332053|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56332054|NCT00395915|Aripiprazole|aripiprazole|mesh-list
56332055|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
56332056|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56332057|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56332058|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56332059|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56332060|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332061|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
56332062|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
56332063|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332064|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332065|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56332066|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56332067|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
56332068|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56332069|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56332070|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56332071|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56332072|NCT00029861|Rimonabant|rimonabant|mesh-list
56332073|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56332074|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56332075|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56332076|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332077|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332078|NCT00029861|Hormones|hormones|mesh-ancestor
56332079|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56332080|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332081|NCT00057369|Dalbavancin|dalbavancin|mesh-list
56332082|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56332083|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332084|NCT00057408|Olanzapine|olanzapine|mesh-list
56332085|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
56332086|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
56332087|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
56332088|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332089|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332090|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56332091|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56332092|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56332094|NCT00057408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56332095|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56332096|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56332097|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332098|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332099|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
56332100|NCT00030056|Molgramostim|molgramostim|mesh-list
56332101|NCT00030056|Sargramostim|sargramostim|mesh-list
56332102|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
56332103|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332104|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908485|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
56908486|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332105|NCT00057447|Interferons|interferons|mesh-list
56332106|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
56332107|NCT00057447|Rituximab|rituximab|mesh-list
56332108|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56332109|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332110|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
56332111|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332112|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332113|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
56332114|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332115|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
56332116|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332117|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332118|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332119|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332120|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332121|NCT00030173|Epothilones|epothilones|mesh-list
56332122|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
56332123|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332124|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332125|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332126|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332127|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332128|NCT00057564|Thalidomide|thalidomide|mesh-list
56332129|NCT00057564|Dexamethasone|dexamethasone|mesh-list
56332130|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
56332131|NCT00057564|BB 1101|bb 1101|mesh-list
56332132|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56332133|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
56332134|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
56332135|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332136|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332137|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56332138|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
56332139|NCT00057564|Hormones|hormones|mesh-ancestor
56332140|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56332141|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56332142|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332143|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
56332144|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332145|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332146|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332147|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
56332148|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
56332149|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56332150|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332151|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56332152|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56332153|NCT00057564|Growth Substances|growth substances|mesh-ancestor
56332154|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
56332155|NCT00030368|Paclitaxel|paclitaxel|mesh-list
56332156|NCT00030368|Bortezomib|bortezomib|mesh-list
56332157|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56332158|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332159|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332160|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332161|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332162|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332163|NCT00030407|Celecoxib|celecoxib|mesh-list
56332164|NCT00030407|Docetaxel|docetaxel|mesh-list
56332165|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332166|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332167|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332169|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332170|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56332171|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56332173|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
56332174|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332175|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161787|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
56332176|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56332177|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908487|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56908488|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
56332178|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56332179|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56332180|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332181|NCT00057642|Sertraline|sertraline|mesh-list
56332182|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56332183|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
56332184|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56332185|NCT00057642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56332186|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56332187|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56332188|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332189|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332190|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
56332191|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332192|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56332193|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56332194|NCT00030446|Carboplatin|carboplatin|mesh-list
56332195|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56332196|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332197|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56332198|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332199|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332200|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56332201|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332202|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56332203|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332204|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332205|NCT00057720|Doxorubicin|doxorubicin|mesh-list
56332206|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56332207|NCT00057720|Topotecan|topotecan|mesh-list
56332208|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56332209|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332210|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56332211|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332212|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332213|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332214|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56332215|NCT00030524|Gefitinib|gefitinib|mesh-list
56332216|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332217|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56332218|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332219|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332221|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56332222|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332223|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332224|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332225|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332226|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
56332227|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56332228|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
56332229|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332230|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
56332231|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332232|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
56332233|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56332234|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56332235|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332236|NCT00057759|Urological Agents|urological agents|mesh-ancestor
56332237|NCT00030641|Docetaxel|docetaxel|mesh-list
56332238|NCT00030641|Oblimersen|oblimersen|mesh-list
56332248|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332250|NCT00057798|Antiviral Agents|antiviral agents|mesh-ancestor
56332251|NCT00057798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332252|NCT00057798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332253|NCT00057798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332254|NCT00057798|Immunologic Factors|immunologic factors|mesh-ancestor
56332255|NCT00057798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332256|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56332257|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908489|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56908490|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332258|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332259|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332260|NCT02969733|Lidocaine|lidocaine|mesh-list
56332261|NCT02969733|Ketamine|ketamine|mesh-list
56332262|NCT02969733|Analgesics|analgesics|mesh-ancestor
56332263|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
56332264|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332265|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332266|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56332267|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56332268|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
56332269|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
56332270|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56332271|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56332272|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56332273|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332274|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332275|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
56332276|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56332277|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56332278|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56332279|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56332280|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
56332281|NCT00030719|Melphalan|melphalan|mesh-list
56332282|NCT00030719|Busulfan|busulfan|mesh-list
56332283|NCT00030719|Carboplatin|carboplatin|mesh-list
56332284|NCT00030719|Etoposide|etoposide|mesh-list
56332285|NCT00030719|Vincristine|vincristine|mesh-list
56332286|NCT00030719|Dinutuximab|dinutuximab|mesh-list
56332287|NCT00030719|Isotretinoin|isotretinoin|mesh-list
56332288|NCT00030719|Antibodies|antibodies|mesh-list
56332289|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56332290|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332291|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
56332292|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332293|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332294|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56332295|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
56332296|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332297|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332298|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56332299|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56332300|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56332301|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332302|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332303|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332304|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332305|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332306|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
56332319|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
56332320|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
56332321|NCT00030797|Irinotecan|irinotecan|mesh-list
56332322|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56332323|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332324|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161788|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332325|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332326|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332327|NCT00030875|Bortezomib|bortezomib|mesh-list
56332328|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332329|NCT00058071|Amifostine|amifostine|mesh-list
56332330|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56332331|NCT00058071|Protective Agents|protective agents|mesh-ancestor
56332332|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332333|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56332334|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56332335|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
56332336|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56332337|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56332338|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56332339|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908491|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56908492|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56332340|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332341|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332342|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56332343|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
56332344|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56332345|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56332346|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56332347|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56332348|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
56332349|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56332350|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56332351|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56332352|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56332353|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56332354|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332355|NCT00058149|Gemcitabine|gemcitabine|mesh-list
56332356|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
56332357|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56332358|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
56332359|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332360|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332361|NCT00058149|Antiviral Agents|antiviral agents|mesh-ancestor
56332362|NCT00058149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332363|NCT00058149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332364|NCT00058149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332365|NCT00058149|Immunologic Factors|immunologic factors|mesh-ancestor
56332366|NCT00058149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332383|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332384|NCT00031070|Cyclosporine|cyclosporine|mesh-list
56332385|NCT00031070|Lamivudine|lamivudine|mesh-list
56332386|NCT00031070|Zidovudine|zidovudine|mesh-list
56332387|NCT00031070|Efavirenz|efavirenz|mesh-list
56332388|NCT00031070|Abacavir|abacavir|mesh-list
56332389|NCT00031070|Vaccines|vaccines|mesh-list
55954175|NCT01664559|Ketorolac|ketorolac|mesh-list
56332390|NCT00031070|Cyclosporins|cyclosporins|mesh-list
56332391|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56332392|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
56332393|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332394|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332395|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332396|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332397|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
56332398|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332399|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
56332400|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332401|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56332402|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56332403|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56332404|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
56332405|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56332406|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56332407|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
56332408|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56332409|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56332410|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56332411|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56332412|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56332413|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56332414|NCT00058305|Vincristine|vincristine|mesh-list
56332415|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
56332416|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56332417|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332418|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332419|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332420|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332421|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332422|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56332423|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
56332424|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332425|NCT00058461|Cytarabine|cytarabine|mesh-list
56908493|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56908494|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
56908495|NCT02143570|Darifenacin|darifenacin|mesh-list
56332426|NCT00058461|Rituximab|rituximab|mesh-list
56332427|NCT00058461|Carboplatin|carboplatin|mesh-list
56332430|NCT00058461|Ifosfamide|ifosfamide|mesh-list
56332431|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56332432|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332433|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
56332434|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332435|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332436|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56332437|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
56332438|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56332439|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56332440|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
56332441|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332442|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
56332443|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332444|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56332445|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332446|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56332447|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56332448|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56332449|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332450|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
56332451|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332452|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56332453|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
56332454|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
56332455|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332456|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
56332457|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332458|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332459|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56332460|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
56332461|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332462|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332463|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56332466|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56332467|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
56332468|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332469|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332470|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56332471|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56332472|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
56332473|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332474|NCT00031109|Antacids|antacids|mesh-ancestor
56332475|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332476|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56332477|NCT00031148|Mitogens|mitogens|mesh-list
56332478|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332479|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332480|NCT00031187|Docetaxel|docetaxel|mesh-list
56332481|NCT00031187|Doxorubicin|doxorubicin|mesh-list
56332482|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
56332483|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332484|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332485|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332486|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332487|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332488|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56332489|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56332490|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332491|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332492|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
56332493|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332494|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56332495|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
56332496|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332497|NCT00058890|Gabapentin|gabapentin|mesh-list
56332498|NCT00058890|Analgesics|analgesics|mesh-ancestor
56908496|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56908497|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56908498|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
56908499|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332499|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
56332500|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332501|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332502|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
56332515|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56332517|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332518|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332519|NCT00058929|Treprostinil|treprostinil|mesh-list
56332520|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56332521|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56332522|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56332523|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56332524|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56332525|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332526|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332527|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332528|NCT00058968|Analgesics|analgesics|mesh-ancestor
56332529|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
56332530|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332531|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
56332532|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56332533|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
56332534|NCT00396227|Pioglitazone|pioglitazone|mesh-list
56332535|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
56332536|NCT00396227|Vildagliptin|vildagliptin|mesh-list
56332537|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56332538|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56332539|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332540|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56332542|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332543|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332544|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
56332545|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56332546|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56332547|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56332548|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56332549|NCT00031499|Azithromycin|azithromycin|mesh-list
56332550|NCT00031499|Doxycycline|doxycycline|mesh-list
56332551|NCT00031499|Penicillins|penicillins|mesh-list
56332552|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56332553|NCT00031499|Penicillin G|penicillin g|mesh-list
56332554|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
56332555|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56332556|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332557|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
56332558|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56332559|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56332560|NCT00059358|Interferons|interferons|mesh-list
56332561|NCT00059358|Ribavirin|ribavirin|mesh-list
56332562|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
56332563|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
56332564|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55971868|NCT01905423|Piperazine|piperazine|mesh-list
56332577|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332578|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332579|NCT00031616|Brivudine|brivudine|mesh-list
56332580|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
56332581|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
56332582|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332583|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332584|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332585|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56332586|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
56332587|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332588|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
56332589|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332590|NCT00031655|Cyclosporine|cyclosporine|mesh-list
56332591|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
56332592|NCT00031655|Fludarabine|fludarabine|mesh-list
56908500|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908501|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908502|NCT02143570|Urological Agents|urological agents|mesh-ancestor
56908503|NCT02143804|Molgramostim|molgramostim|mesh-list
56332593|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
56332595|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332596|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56332597|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
56332598|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332599|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332600|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
56332601|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332602|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332603|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
56332604|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332605|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
56332606|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332607|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56332608|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56332609|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56332610|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
56332611|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56332612|NCT00059592|Valacyclovir|valacyclovir|mesh-list
56332613|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
56332614|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332615|NCT00031733|Interleukin-12|interleukin-12|mesh-list
56332616|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56332618|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
56332619|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
56332620|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
56332621|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332622|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332623|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56332624|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56332625|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56332626|NCT00031733|Growth Substances|growth substances|mesh-ancestor
56332627|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
56332628|NCT00031733|Antacids|antacids|mesh-ancestor
56332629|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971920|NCT00753337|Cobalt|cobalt|mesh-list
56332639|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332640|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
56332641|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56332642|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56332643|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56332644|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56332645|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
56332646|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56332647|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332648|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56332649|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56332650|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56332651|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56332653|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56332654|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332655|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56332656|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
56332657|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56332658|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332659|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56332660|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56332661|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56332662|NCT00059631|Bortezomib|bortezomib|mesh-list
56332663|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
56332664|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332665|NCT00059631|Analgesics|analgesics|mesh-ancestor
56332666|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
56072694|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
56332667|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332668|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332670|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332671|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332672|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332673|NCT00031889|Exemestane|exemestane|mesh-list
56332674|NCT00031889|Bicalutamide|bicalutamide|mesh-list
56332675|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332676|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56332677|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56332678|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332679|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332680|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56332681|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
56332682|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56332683|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332684|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
56332685|NCT00031928|Mafosfamide|mafosfamide|mesh-list
56332686|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56332687|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
56332688|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332689|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332690|NCT00031967|Melatonin|melatonin|mesh-list
56332691|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
55971982|NCT01913535|Aticaprant|aticaprant|mesh-list
56332700|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332701|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
56332702|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332703|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56332704|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332705|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
56332706|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332707|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
56332708|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332709|NCT00032045|Ipilimumab|ipilimumab|mesh-list
56332710|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
56332711|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56332712|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332713|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56332714|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332715|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56332716|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
56332717|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332718|NCT00059865|Gemcitabine|gemcitabine|mesh-list
56332719|NCT00059865|Pemetrexed|pemetrexed|mesh-list
56332720|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56332721|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
56332722|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332723|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332724|NCT00059865|Antiviral Agents|antiviral agents|mesh-ancestor
56332725|NCT00059865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332726|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332727|NCT00059865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332728|NCT00059865|Immunologic Factors|immunologic factors|mesh-ancestor
56332729|NCT00059865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332730|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56332731|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56332732|NCT00032084|Bupropion|bupropion|mesh-list
56332733|NCT00032084|Nicotine|nicotine|mesh-list
56332734|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56332735|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
56332736|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332737|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332738|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56332739|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56332740|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
56332742|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332743|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56332744|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
56332745|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56332746|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56332747|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56332748|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56332749|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
56332750|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56908504|NCT02143804|Sargramostim|sargramostim|mesh-list
56332751|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56332752|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332753|NCT00059904|Aldesleukin|aldesleukin|mesh-list
56332754|NCT00059904|Rituximab|rituximab|mesh-list
56332755|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56332756|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332757|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
55972047|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332783|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332785|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
56332786|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332787|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
56332788|NCT00060138|Antibodies|antibodies|mesh-list
56332789|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56332790|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
56332791|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332792|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56332793|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56332794|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56332795|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
56332796|NCT00032396|Hormones|hormones|mesh-ancestor
56332797|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56332798|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332799|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
56332800|NCT00060255|Melphalan|melphalan|mesh-list
56332801|NCT00060255|Busulfan|busulfan|mesh-list
56332802|NCT00060255|Thiotepa|thiotepa|mesh-list
56332803|NCT00060255|Carmustine|carmustine|mesh-list
56332804|NCT00060255|Carboplatin|carboplatin|mesh-list
56332805|NCT00060255|Etoposide|etoposide|mesh-list
56332806|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332807|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
56332808|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332820|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56332821|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332822|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
56332823|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332824|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332825|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56332826|NCT00060372|Ipilimumab|ipilimumab|mesh-list
56332827|NCT00060372|Antibodies|antibodies|mesh-list
56332828|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
56332829|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56332830|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
56332831|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332832|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332833|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56332834|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332835|NCT00060411|Leucovorin|leucovorin|mesh-list
56332836|NCT00060411|Bevacizumab|bevacizumab|mesh-list
56332837|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56332838|NCT00060411|Fluorouracil|fluorouracil|mesh-list
56332839|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
56332840|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56332841|NCT00060411|Antibodies|antibodies|mesh-list
56332842|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
56332843|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56332844|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
56332845|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332846|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56332847|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56332848|NCT00060411|Growth Substances|growth substances|mesh-ancestor
56332849|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332850|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
56332851|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
56332852|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
56332853|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332854|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56332855|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332856|NCT00060411|Antidotes|antidotes|mesh-ancestor
56332857|NCT00060411|Protective Agents|protective agents|mesh-ancestor
56332858|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
56332859|NCT00060411|Vitamins|vitamins|mesh-ancestor
56332860|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
56332861|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56332862|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332863|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
56908505|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
56908506|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908507|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361070|NCT00112515|Modafinil|modafinil|mesh-list
56332864|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56332865|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
56332866|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332867|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332868|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56332869|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
56332870|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56332871|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
56332872|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332873|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332889|NCT02968719|Donepezil|donepezil|mesh-list
56332890|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56332891|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161825|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
56332892|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332893|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
56332894|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332895|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332896|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
56332897|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56332898|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
56332899|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56332900|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56332901|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56332902|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56332903|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332905|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56332906|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56332907|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332908|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332909|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332910|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332911|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56332912|NCT00032825|Ketoconazole|ketoconazole|mesh-list
56332913|NCT00032825|Docetaxel|docetaxel|mesh-list
56332914|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332915|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332916|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332917|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332918|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332920|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332921|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56332922|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56332923|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332924|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56332925|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
56332926|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56332927|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332928|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56332929|NCT00060645|Sirolimus|sirolimus|mesh-list
56332930|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56332931|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332932|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56332933|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332934|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
56332944|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
56332945|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332946|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332947|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56332949|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
56332950|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332951|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56332952|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
56332953|NCT00060684|Hormones|hormones|mesh-ancestor
56332954|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908509|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56361140|NCT00112710|Gemcitabine|gemcitabine|mesh-list
56332955|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56332956|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332957|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56332958|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332959|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332960|NCT02971475|Analgesics|analgesics|mesh-list
56332961|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
56332962|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332963|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332964|NCT00032942|Lofexidine|lofexidine|mesh-list
56332965|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56332966|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56332967|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332968|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
56332969|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332970|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56332971|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56332972|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56332973|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
56332974|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332975|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332977|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56332978|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56332979|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56332980|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332981|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332982|NCT00060918|Metoprolol|metoprolol|mesh-list
56332983|NCT00060918|Carvedilol|carvedilol|mesh-list
56332984|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56332985|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56332986|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
56332987|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
56332988|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332989|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332990|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56332991|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56332992|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56332993|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
56332994|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332995|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332996|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
56332997|NCT00060918|Protective Agents|protective agents|mesh-ancestor
56332998|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56332999|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333000|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56333008|NCT02968641|Ritonavir|ritonavir|mesh-list
56333009|NCT02968641|Lonafarnib|lonafarnib|mesh-list
56333010|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56333011|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56333012|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
56333013|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333014|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333015|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56333016|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56333017|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
56333018|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333019|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56333020|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56333021|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
56333022|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
56333023|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333024|NCT00033176|Protective Agents|protective agents|mesh-ancestor
56333025|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333026|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
56333027|NCT00033176|Vitamins|vitamins|mesh-ancestor
56333028|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
56333029|NCT00033215|S 3304|s 3304|mesh-list
56333030|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
56333031|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
56333032|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084331|NCT00366067|Phenytoin|phenytoin|mesh-list
56908510|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908511|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56361215|NCT00274963|Analgesics|analgesics|mesh-ancestor
56333033|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333034|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
56333035|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56333036|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56333037|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56333038|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333039|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333041|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333042|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333043|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56333044|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333045|NCT00060996|Treprostinil|treprostinil|mesh-list
56333046|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56333047|NCT00033254|Thalidomide|thalidomide|mesh-list
56333048|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333049|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
56333050|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333051|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
56333052|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56333053|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333054|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56333055|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56333056|NCT00033254|Growth Substances|growth substances|mesh-ancestor
56333057|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
56333058|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333059|NCT00061074|Nicotine|nicotine|mesh-list
56333060|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55954849|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333061|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
56333062|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333063|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333064|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56333065|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56333066|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
56333067|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333068|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333079|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
56333080|NCT00033332|Hormones|hormones|mesh-ancestor
56333081|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56333082|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56333083|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333084|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333085|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
56333086|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
56333087|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56333088|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333089|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56333090|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56333091|NCT00033332|Growth Substances|growth substances|mesh-ancestor
56333092|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56333093|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56333094|NCT00033410|Paclitaxel|paclitaxel|mesh-list
56333095|NCT00033410|Carboplatin|carboplatin|mesh-list
56333096|NCT00033410|Tirapazamine|tirapazamine|mesh-list
56333097|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56333098|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333099|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333100|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333101|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333102|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333103|NCT00061113|Fluoxetine|fluoxetine|mesh-list
56333104|NCT00061113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56333105|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56333106|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333107|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333108|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333109|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
56161831|NCT00058188|Vitamins|vitamins|mesh-ancestor
56084332|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
56908512|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
56908513|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56333110|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333111|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56333112|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
56333114|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56333115|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56333116|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333117|NCT00033449|Gefitinib|gefitinib|mesh-list
56333118|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333119|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56333120|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333121|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333122|NCT00061152|Capsaicin|capsaicin|mesh-list
56333123|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
56333124|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
56333125|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
56333126|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333127|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333128|NCT00033566|S 3304|s 3304|mesh-list
56333129|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
56333130|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
56333131|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333132|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333133|NCT00033605|Octreotide|octreotide|mesh-list
56333134|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333151|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
56333152|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56333153|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56333155|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
56333156|NCT00033683|Docetaxel|docetaxel|mesh-list
56333157|NCT00033683|Fluorouracil|fluorouracil|mesh-list
56333158|NCT00033683|Methotrexate|methotrexate|mesh-list
56333159|NCT00033683|Epirubicin|epirubicin|mesh-list
56333160|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333161|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
56333162|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333163|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56333164|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56333165|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
56333166|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333167|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333168|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56333169|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333170|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333171|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333172|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
56333173|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56333174|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56333175|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
56333176|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56333177|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
56333178|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333179|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56333180|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56333181|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56333182|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56333183|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333184|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56333185|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
56333186|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56333187|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56333188|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56333189|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56333190|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56333191|NCT00061308|Gemcitabine|gemcitabine|mesh-list
56333192|NCT00061308|Topotecan|topotecan|mesh-list
56333193|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56333203|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56333204|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333205|NCT00033722|Folic Acid|folic acid|mesh-list
56333206|NCT00033722|Lometrexol|lometrexol|mesh-list
56908514|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
56908515|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56908516|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361360|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
56333207|NCT00033722|Hematinics|hematinics|mesh-ancestor
56333208|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
56333209|NCT00033722|Vitamins|vitamins|mesh-ancestor
56333210|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
56333211|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333212|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56333213|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
56333214|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333215|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333216|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56333217|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333218|NCT00061425|Epratuzumab|epratuzumab|mesh-list
56333219|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56333220|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333221|NCT00061464|Gemcitabine|gemcitabine|mesh-list
56333222|NCT00061464|Pemetrexed|pemetrexed|mesh-list
56333223|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56333224|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
56333225|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333226|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333227|NCT00061464|Antiviral Agents|antiviral agents|mesh-ancestor
56333228|NCT00061464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333229|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333230|NCT00061464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333231|NCT00061464|Immunologic Factors|immunologic factors|mesh-ancestor
56333232|NCT00061464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333233|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56333234|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56333235|NCT00061503|Travoprost|travoprost|mesh-list
56333236|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56333237|NCT00061542|Timolol|timolol|mesh-list
56333238|NCT00061542|Betaxolol|betaxolol|mesh-list
56333239|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56333240|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56333241|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
56333242|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333243|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333244|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333245|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56333246|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56333247|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
56333248|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
56333249|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333250|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56333251|NCT00061620|Tezacitabine|tezacitabine|mesh-list
56333252|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333253|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333254|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333255|NCT00034151|Paclitaxel|paclitaxel|mesh-list
56333256|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56333257|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333258|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333259|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333260|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333274|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333275|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333277|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56333278|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333279|NCT00061776|Capsaicin|capsaicin|mesh-list
56333280|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
56333281|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
56333282|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
56333283|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333284|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333285|NCT00034346|Paclitaxel|paclitaxel|mesh-list
56333286|NCT00034346|Carboplatin|carboplatin|mesh-list
56333287|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908517|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56908518|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56908519|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908520|NCT00006256|Paclitaxel|paclitaxel|mesh-list
56908521|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56333288|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333289|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
55955071|NCT01676415|Hormones|hormones|mesh-ancestor
56333291|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333292|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333293|NCT00034385|Valganciclovir|valganciclovir|mesh-list
56333294|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
56333295|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333296|NCT00034463|Folic Acid|folic acid|mesh-list
56333297|NCT00034463|Vitamins|vitamins|mesh-ancestor
56333298|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
56333299|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333300|NCT00034463|Hematinics|hematinics|mesh-ancestor
56333301|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
56333302|NCT02971397|Cytarabine|cytarabine|mesh-list
56333303|NCT02971397|Daunorubicin|daunorubicin|mesh-list
56333304|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56333305|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
56333306|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333307|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333308|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
56333309|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333310|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333311|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
56333312|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333313|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56333314|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56333315|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333316|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333317|NCT00396500|Vitamin A|vitamin a|mesh-list
56333318|NCT00396500|Albendazole|albendazole|mesh-list
56333319|NCT00396500|Vitamins|vitamins|mesh-ancestor
56333320|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
56333321|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333322|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333323|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333324|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
56333325|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56333341|NCT00034541|Cetuximab|cetuximab|mesh-list
56333342|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56333343|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333344|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333345|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333346|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333347|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333348|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56333349|NCT00034580|Olanzapine|olanzapine|mesh-list
56333350|NCT00034580|Risperidone|risperidone|mesh-list
56333351|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56333352|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
56333353|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333354|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333355|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333356|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56333357|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56333358|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56333359|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56333360|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56333361|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
56333362|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
56333363|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
56333364|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333365|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333366|NCT00034580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56333367|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56333368|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333369|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
56908522|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908523|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908524|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56908525|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333370|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333371|NCT00061815|Leucovorin|leucovorin|mesh-list
56333372|NCT00061815|Fluorouracil|fluorouracil|mesh-list
56333373|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
56333374|NCT00061815|Cetuximab|cetuximab|mesh-list
56333375|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
56333376|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333377|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56333378|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333379|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333380|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
56333381|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333382|NCT00061815|Antidotes|antidotes|mesh-ancestor
56333383|NCT00061815|Protective Agents|protective agents|mesh-ancestor
56333384|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
56333385|NCT00061815|Vitamins|vitamins|mesh-ancestor
56333386|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
56333387|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56333393|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56333394|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56333395|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56333396|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56333397|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56333398|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333399|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333400|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56333401|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
56333402|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56333403|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333404|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
56333405|NCT00398580|Testosterone|testosterone|mesh-list
56333406|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
56333408|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56333409|NCT00398580|Dutasteride|dutasteride|mesh-list
56333410|NCT00398580|Androgens|androgens|mesh-ancestor
56333411|NCT00398580|Hormones|hormones|mesh-ancestor
56333412|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56333413|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333414|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56333415|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333416|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
56333417|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56333418|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56333419|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333420|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333421|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
56333422|NCT00034697|Temozolomide|temozolomide|mesh-list
56333423|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56333424|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
56333425|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333426|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333427|NCT00034736|Levofloxacin|levofloxacin|mesh-list
56333428|NCT00034736|Ofloxacin|ofloxacin|mesh-list
56333429|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56333430|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333431|NCT00034736|Renal Agents|renal agents|mesh-ancestor
56333432|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56333433|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56333434|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333435|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333436|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333437|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333438|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56333439|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56333440|NCT02967939|Tenofovir|tenofovir|mesh-list
56333441|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
56333442|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908526|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908527|NCT02144194|Docetaxel|docetaxel|mesh-list
56908528|NCT02144194|Vinorelbine|vinorelbine|mesh-list
56333443|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56333444|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56333445|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333446|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333447|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56333448|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56333449|NCT00034775|Risperidone|risperidone|mesh-list
56333450|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56333451|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
56333452|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333453|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333454|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333455|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56333456|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56333457|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56333459|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56333461|NCT00062127|Thalidomide|thalidomide|mesh-list
56333462|NCT00062127|Irinotecan|irinotecan|mesh-list
56333463|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56333464|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333465|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333466|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333467|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333468|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333469|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
56333470|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333471|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
56333472|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56333473|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333474|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56333475|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56333476|NCT00062127|Growth Substances|growth substances|mesh-ancestor
56333477|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
56333478|NCT00034853|Naproxen|naproxen|mesh-list
56333479|NCT00034853|Meloxicam|meloxicam|mesh-list
56161841|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56333480|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56333481|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56333482|NCT00034853|Analgesics|analgesics|mesh-ancestor
56333483|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
56333484|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333485|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333486|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56333487|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56333488|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
56333489|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56333490|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333491|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333492|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56333494|NCT00034892|Risperidone|risperidone|mesh-list
56333495|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56333496|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
56333497|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333498|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333499|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333500|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56333501|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56333502|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56333503|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56333504|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56333505|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
56333506|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
56333507|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
56333508|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333509|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333510|NCT00034892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56333511|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56333512|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56908529|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361655|NCT00299065|Zileuton|zileuton|mesh-list
56333513|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
56333514|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333515|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56333516|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333517|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333519|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333520|NCT00035009|Aprepitant|aprepitant|mesh-list
56333521|NCT00035009|Paroxetine|paroxetine|mesh-list
56333522|NCT00035009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56333523|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56333524|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333525|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333526|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333527|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
56333528|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333529|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56333530|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
56333531|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56333543|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
56333544|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
56333545|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333546|NCT00035048|Aprepitant|aprepitant|mesh-list
56333547|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
56333548|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
56333549|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333550|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333551|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333552|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56333553|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333554|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333555|NCT00035087|Epothilones|epothilones|mesh-list
56333556|NCT00035087|Epothilone B|epothilone b|mesh-list
56333557|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333558|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333559|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333560|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333561|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333562|NCT00062322|Irinotecan|irinotecan|mesh-list
56333563|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333564|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56333565|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56073620|NCT02360215|Memantine|memantine|mesh-list
56333566|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333567|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333568|NCT00035126|Epothilones|epothilones|mesh-list
56333569|NCT00035126|Epothilone B|epothilone b|mesh-list
56333570|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333571|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333572|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333573|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333574|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333575|NCT00035165|Epothilones|epothilones|mesh-list
56333576|NCT00035165|Epothilone B|epothilone b|mesh-list
56333577|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333578|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333579|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333580|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333581|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333582|NCT00035204|Galantamine|galantamine|mesh-list
56333583|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56333584|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333585|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333586|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
56333587|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333588|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333589|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56333590|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
56333591|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333592|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
56333593|NCT00062478|Camptothecin|camptothecin|mesh-list
56333594|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908530|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908531|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
56908532|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333604|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333605|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333606|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333608|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
56333609|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
56333610|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333611|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333612|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333613|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56333614|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333615|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333617|NCT00062556|Lovastatin|lovastatin|mesh-list
56333618|NCT00062556|L 647318|l 647318|mesh-list
56333619|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
56333620|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56333621|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
56333622|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333623|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56333624|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
56333625|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
56333626|NCT00062556|Vitamins|vitamins|mesh-ancestor
56333627|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
56333628|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333629|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56333630|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56333631|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333632|NCT00035321|Olanzapine|olanzapine|mesh-list
56333633|NCT00035321|Fluoxetine|fluoxetine|mesh-list
56333634|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
56333635|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
56333636|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333637|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333638|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333639|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56333640|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56333641|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56333643|NCT00035321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56333644|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56333645|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333646|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333647|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333648|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
56333649|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56333650|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
56333651|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56333652|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56333653|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333654|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
56333655|NCT00062595|Vitamin K|vitamin k|mesh-list
56333656|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56333657|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56333658|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333659|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
56333660|NCT00062595|Coagulants|coagulants|mesh-ancestor
56333661|NCT00062595|Vitamins|vitamins|mesh-ancestor
56333662|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
56333663|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333664|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55955455|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333666|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333667|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56333668|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56333669|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56333670|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333671|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333672|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333673|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333674|NCT00062673|Analgesics|analgesics|mesh-ancestor
56333675|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
56333676|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333677|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
56333678|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56333679|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
56333680|NCT00035477|Azimilide|azimilide|mesh-list
56333681|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56333682|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56333683|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333684|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333685|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56333686|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333687|NCT00062712|Sirolimus|sirolimus|mesh-list
56333688|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56333689|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56333690|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333691|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56333692|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333693|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
56333694|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333695|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
56333696|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333697|NCT00062790|Dutasteride|dutasteride|mesh-list
56333698|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56333699|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56333700|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161845|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56333701|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333702|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
56333703|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56333704|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333705|NCT00035516|Epothilones|epothilones|mesh-list
56333706|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333707|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333708|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333709|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333710|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333711|NCT00062946|Fallypride|fallypride|mesh-list
56333712|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56333713|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56333714|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
56333715|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333716|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333717|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333718|NCT00063024|Calcium|calcium|mesh-list
56333719|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56333720|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333721|NCT00035984|Exenatide|exenatide|mesh-list
56333722|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56333723|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333724|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56333725|NCT00035984|Incretins|incretins|mesh-ancestor
56333726|NCT00035984|Hormones|hormones|mesh-ancestor
56333727|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56333728|NCT00063141|Irinotecan|irinotecan|mesh-list
56333729|NCT00063141|Cetuximab|cetuximab|mesh-list
56333730|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56333731|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333732|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973009|NCT05688020|Epinephrine|epinephrine|mesh-list
56333733|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333735|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56333736|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
56333737|NCT00036023|Hematinics|hematinics|mesh-ancestor
56333738|NCT00036062|Sivelestat|sivelestat|mesh-list
56333740|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
56333741|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333742|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333743|NCT00036101|Aripiprazole|aripiprazole|mesh-list
56333744|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
56333745|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56333746|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56333747|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56333748|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908533|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908534|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56333749|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333750|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
56333751|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
56333752|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333753|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333754|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56333755|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56333756|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
56333757|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56333758|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56333759|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56333760|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56333761|NCT00036179|Micafungin|micafungin|mesh-list
56333762|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
56333763|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333764|NCT00036218|Ropinirole|ropinirole|mesh-list
56333765|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56333766|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56333767|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
56333768|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
56333769|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333770|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333771|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333772|NCT00063453|Vitamins|vitamins|mesh-list
56333773|NCT00063453|Vitamin E|vitamin e|mesh-list
56333774|NCT00063453|Tocopherols|tocopherols|mesh-list
56333775|NCT00063453|Tocotrienols|tocotrienols|mesh-list
56333776|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
56333778|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
56333779|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333780|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
56333781|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333782|NCT00063453|Protective Agents|protective agents|mesh-ancestor
56333783|NCT00063453|Trace Elements|trace elements|mesh-ancestor
56333784|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56333785|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56333786|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56333787|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333788|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398592|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333789|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333790|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333791|NCT00036335|Analgesics|analgesics|mesh-ancestor
56333792|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
56333793|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333794|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
56333795|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56333796|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
56333797|NCT00036374|Infliximab|infliximab|mesh-list
56333798|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
56333799|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333800|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56333801|NCT00036452|Ritonavir|ritonavir|mesh-list
56333802|NCT00036452|Lopinavir|lopinavir|mesh-list
56333803|NCT00036452|Tenofovir|tenofovir|mesh-list
56333804|NCT00036452|Emtricitabine|emtricitabine|mesh-list
56333805|NCT00036452|Stavudine|stavudine|mesh-list
56333806|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55973087|NCT00670241|Calcipotriene|calcipotriene|mesh-list
56333816|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56333817|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56333818|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56333820|NCT02967276|Metformin|metformin|mesh-list
56333821|NCT02967276|Dexamethasone|dexamethasone|mesh-list
56333822|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56333823|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
56333824|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
56333825|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333826|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333827|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333828|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
56333829|NCT02967276|Hormones|hormones|mesh-ancestor
56908535|NCT02140840|Trametinib|trametinib|mesh-list
56333830|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56333831|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56333832|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333833|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56333834|NCT00036491|Rituximab|rituximab|mesh-list
56333835|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56333836|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333837|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
56333838|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333839|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56333840|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
56333841|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56333842|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333843|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
56333844|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56333845|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333846|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56333847|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333848|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56333849|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333850|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333851|NCT00063687|Oxypurinol|oxypurinol|mesh-list
56333852|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333853|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333854|NCT00036764|Epothilones|epothilones|mesh-list
56333855|NCT00036764|Epothilone B|epothilone b|mesh-list
56333856|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333857|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333858|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333859|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333860|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333861|NCT00063726|Bortezomib|bortezomib|mesh-list
56333862|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333863|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
56398594|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398595|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56398596|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
56398597|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398598|NCT02915731|Vitamin A|vitamin a|mesh-list
56398599|NCT02915731|Vitamins|vitamins|mesh-ancestor
56398600|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
55973186|NCT05039619|Acetaminophen|acetaminophen|mesh-list
56398601|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398603|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
56398604|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398605|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
56398606|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56398607|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398608|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56398609|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
56398610|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56398611|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398612|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398613|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398614|NCT04724148|Fentanyl|fentanyl|mesh-list
56398615|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56398616|NCT04724148|Narcotics|narcotics|mesh-ancestor
56398617|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398618|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398619|NCT04724148|Analgesics|analgesics|mesh-ancestor
56398620|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
56398621|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398622|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56398623|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56398624|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
56398625|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
56398626|NCT02914678|Fentanyl|fentanyl|mesh-list
56398627|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56398628|NCT02914678|Narcotics|narcotics|mesh-ancestor
56398629|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398630|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398631|NCT02914678|Analgesics|analgesics|mesh-ancestor
56398632|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
56398633|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908536|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908537|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56398634|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56398635|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56398636|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
56398637|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
56398638|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56398639|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56398640|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
56398641|NCT00405977|Analgesics|analgesics|mesh-ancestor
56398642|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
56398643|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398644|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398645|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
56398646|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398647|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56398648|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
56398649|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56398650|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56398651|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398652|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56398653|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
56398654|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56398655|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
56398656|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56398657|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398658|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56398659|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
56398660|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56398661|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398662|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398663|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398664|NCT02914015|Morphine|morphine|mesh-list
56398665|NCT02914015|Ropivacaine|ropivacaine|mesh-list
56398666|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
56398667|NCT02914015|Anesthetics|anesthetics|mesh-list
56398668|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56398669|NCT02914015|Narcotics|narcotics|mesh-ancestor
56398670|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398671|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398673|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
56398674|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398675|NCT00171093|Valsartan|valsartan|mesh-list
56398676|NCT00171093|Simvastatin|simvastatin|mesh-list
56398677|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56398681|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56398682|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56398683|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398684|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56398685|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56398686|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56398687|NCT02914054|Dexamethasone|dexamethasone|mesh-list
56398688|NCT02914054|Prednisone|prednisone|mesh-list
56398689|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398690|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
56398691|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
56398692|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398693|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398694|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398695|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
56398696|NCT02914054|Hormones|hormones|mesh-ancestor
56398697|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398698|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56398699|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398700|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
56398701|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56398702|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56398703|NCT00150059|Analgesics|analgesics|mesh-ancestor
56398704|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
56398705|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398706|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398707|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398708|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908538|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908539|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908540|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
56908541|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398709|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
56398710|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56398711|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
56398712|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56398713|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398714|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398715|NCT00171132|Atenolol|atenolol|mesh-list
56398716|NCT00171132|Valsartan|valsartan|mesh-list
56398717|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56398718|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56398719|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56398720|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56398721|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398722|NCT00171132|Diuretics|diuretics|mesh-ancestor
56398723|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
56398724|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398725|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56398726|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56398727|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56398728|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
56398729|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
56398730|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398731|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56398732|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56398733|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56398734|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
56398735|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398736|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
56398737|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
56398738|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398739|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398741|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
56398742|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
56398743|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398744|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398745|NCT00150215|Olanzapine|olanzapine|mesh-list
56398746|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
56398747|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
56398748|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398755|NCT00150215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56398756|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56398757|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56398758|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398759|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398761|NCT00171171|Deferasirox|deferasirox|mesh-list
56398762|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56398763|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
56398764|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
56398765|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398766|NCT02913430|Tamoxifen|tamoxifen|mesh-list
56398767|NCT02913430|Fulvestrant|fulvestrant|mesh-list
56398768|NCT02913430|Palbociclib|palbociclib|mesh-list
56398769|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56398770|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
56398771|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398772|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398773|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56398774|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398775|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56398776|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56398777|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56398778|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56398779|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56908542|NCT00108160|Mupirocin|mupirocin|mesh-list
56908543|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56908544|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398780|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398781|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398782|NCT02913469|Morphine|morphine|mesh-list
56398783|NCT02913469|Metoclopramide|metoclopramide|mesh-list
56398784|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56398785|NCT02913469|Narcotics|narcotics|mesh-ancestor
56398786|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398787|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398788|NCT02913469|Analgesics|analgesics|mesh-ancestor
56398789|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
56398790|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398791|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
56398792|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
56398793|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398794|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56398795|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56398796|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
56398797|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398798|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398799|NCT00150254|Varenicline|varenicline|mesh-list
56398800|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56398801|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56398802|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
56398803|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398804|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398805|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398806|NCT02913508|Vedolizumab|vedolizumab|mesh-list
56398807|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398808|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
56398809|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
56398810|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56398811|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56398812|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398813|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398814|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398815|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56398821|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
56398822|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56398823|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56398824|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398825|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56398826|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56398827|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56398828|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398829|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56398830|NCT02913118|Amoxicillin|amoxicillin|mesh-list
56398831|NCT02913118|Azithromycin|azithromycin|mesh-list
56398832|NCT02913118|Doxycycline|doxycycline|mesh-list
56398833|NCT02913118|Minocycline|minocycline|mesh-list
56398834|NCT02913118|Cephalosporins|cephalosporins|mesh-list
56398835|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
56398836|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56398837|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398838|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
56398839|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56398840|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56398841|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56398842|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398843|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398844|NCT00150332|Linezolid|linezolid|mesh-list
56398845|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56398846|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398847|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56398848|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398849|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398850|NCT00150371|Atorvastatin|atorvastatin|mesh-list
56398851|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56398852|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56398853|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
56398854|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362239|NCT00201799|Infliximab|infliximab|mesh-list
56398855|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56398856|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56398857|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398858|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
56398859|NCT02912494|Hematinics|hematinics|mesh-ancestor
56398860|NCT00150410|Insulin|insulin|mesh-list
56398861|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56398862|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398863|NCT00171288|Ezetimibe|ezetimibe|mesh-list
56398864|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56398865|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56398866|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
56398867|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161854|NCT04422210|Etoposide|etoposide|mesh-list
56398869|NCT00150449|Pregabalin|pregabalin|mesh-list
56398870|NCT00150449|Analgesics|analgesics|mesh-ancestor
56398871|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
56398872|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398873|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398874|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
56398875|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56398876|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56398877|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398878|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56398879|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56398880|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56398881|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398882|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56398883|NCT02912182|Prednisolone|prednisolone|mesh-list
56398884|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56398885|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
55973462|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56398897|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398898|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
56398899|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
56398900|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398901|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398902|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56398903|NCT02912182|Protective Agents|protective agents|mesh-ancestor
56398904|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56398905|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
56398906|NCT02912026|Olorofim|olorofim|mesh-list
56398907|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
56398908|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398909|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
56398910|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56398911|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398912|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56398913|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56398914|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398915|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398916|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398917|NCT02843230|Bevacizumab|bevacizumab|mesh-list
56398918|NCT02843230|Temozolomide|temozolomide|mesh-list
56398919|NCT02843230|Lomustine|lomustine|mesh-list
56398920|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56398921|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398922|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56398923|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56398924|NCT02843230|Growth Substances|growth substances|mesh-ancestor
56398925|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398926|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
56398927|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56398928|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
56398929|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398930|NCT02712814|Estrogens|estrogens|mesh-list
56398931|NCT02712814|Hormones|hormones|mesh-ancestor
56398932|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398933|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398934|NCT00150527|Dexamethasone|dexamethasone|mesh-list
56398935|NCT00150527|Citalopram|citalopram|mesh-list
56398936|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398937|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
56398938|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
56398939|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908545|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56908546|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398940|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398941|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398942|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
56398943|NCT00150527|Hormones|hormones|mesh-ancestor
56398944|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398945|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56398946|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398947|NCT00150527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56398948|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56398949|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55973533|NCT05567601|Doxorubicin|doxorubicin|mesh-list
56398960|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398962|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56398963|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56398964|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398965|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
56398967|NCT02911480|Oxytocin|oxytocin|mesh-list
56398968|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
56398969|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56398970|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398971|NCT00171366|Amlodipine|amlodipine|mesh-list
56398972|NCT00171366|Benazepril|benazepril|mesh-list
56398973|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56398974|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56398975|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56398976|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398977|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56398978|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398979|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
56398980|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56398981|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
56398982|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398983|NCT00150605|Carbamazepine|carbamazepine|mesh-list
56398984|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
56398985|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
56398986|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56398987|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398988|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398989|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56398990|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56398991|NCT00150605|Analgesics|analgesics|mesh-ancestor
56398992|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
56398993|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398994|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56398995|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56398996|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398997|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56398998|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56398999|NCT02910778|Ticagrelor|ticagrelor|mesh-list
56399000|NCT02910778|Atorvastatin|atorvastatin|mesh-list
56399001|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56399002|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56399003|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
56399004|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399005|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56399006|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56399007|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399008|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56399009|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56399010|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56399011|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56399015|NCT00164112|Azithromycin|azithromycin|mesh-list
56399016|NCT00164112|Levofloxacin|levofloxacin|mesh-list
56399017|NCT00164112|Ofloxacin|ofloxacin|mesh-list
56399018|NCT00164112|Telithromycin|telithromycin|mesh-list
56399019|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56399020|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399021|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56399022|NCT00164112|Renal Agents|renal agents|mesh-ancestor
56084424|NCT00365287|Cyclosporins|cyclosporins|mesh-list
56362386|NCT00080951|Protective Agents|protective agents|mesh-ancestor
56399023|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56399024|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56399025|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399026|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399027|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399028|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56399029|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56399030|NCT02910817|Metformin|metformin|mesh-list
56399031|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56399032|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399033|NCT00150722|Atorvastatin|atorvastatin|mesh-list
56399034|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56399035|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56399036|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
56399037|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399038|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56399039|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56399040|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399041|NCT00150761|Levocetirizine|levocetirizine|mesh-list
56399042|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56399043|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56399044|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
56399045|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
56399046|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399047|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399048|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399049|NCT03782740|Melatonin|melatonin|mesh-list
56399050|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
56399051|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399052|NCT03782740|Protective Agents|protective agents|mesh-ancestor
56399053|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399054|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56399055|NCT00171483|Tegaserod|tegaserod|mesh-list
56399056|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56399057|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
56399058|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399059|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399060|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399062|NCT03777904|Trace Elements|trace elements|mesh-ancestor
56399063|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
56399064|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399065|NCT00150839|Mirtazapine|mirtazapine|mesh-list
56399066|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56399067|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56399068|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56399069|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399070|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399071|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399072|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399073|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56399074|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
56399075|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56399076|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56399077|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
56399078|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
56399079|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56399080|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56399081|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973662|NCT00680225|Growth Substances|growth substances|mesh-ancestor
56399083|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56399084|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56399085|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
56399086|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56399087|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56399088|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
56399089|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56399090|NCT03732820|Olaparib|olaparib|mesh-list
56399091|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
56399092|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56399093|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908547|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908548|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
56908549|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56399094|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399095|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399096|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56399097|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
56399098|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399099|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399100|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56399101|NCT03719092|Vitamins|vitamins|mesh-list
56399102|NCT03719092|Vitamin A|vitamin a|mesh-list
56399103|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
56399104|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
56399105|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399106|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
56399107|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399108|NCT03719092|Protective Agents|protective agents|mesh-ancestor
56399109|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56399110|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399111|NCT03669367|Abatacept|abatacept|mesh-list
56399112|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56399113|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399114|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399115|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56399116|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
56399117|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399118|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399119|NCT00532168|Ritonavir|ritonavir|mesh-list
56399120|NCT00532168|Lopinavir|lopinavir|mesh-list
56399121|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56399122|NCT00532168|Tenofovir|tenofovir|mesh-list
56399123|NCT00532168|Emtricitabine|emtricitabine|mesh-list
56399124|NCT00532168|Efavirenz|efavirenz|mesh-list
56399125|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56399126|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56399127|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
56399128|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399129|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399130|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56399131|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56399132|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
56399133|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399134|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56399135|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56399136|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56399137|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56399138|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56399139|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56399140|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56399141|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56399142|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56399143|NCT00532207|Teriparatide|teriparatide|mesh-list
56399144|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56399145|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399146|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56399147|NCT04723836|Riboflavin|riboflavin|mesh-list
56399148|NCT04723836|Vitamins|vitamins|mesh-ancestor
56399149|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
56399150|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399151|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
56399152|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56399153|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
56399154|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56399157|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399159|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56399160|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56399161|NCT00150995|Growth Substances|growth substances|mesh-ancestor
56399162|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399163|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
56908550|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56908551|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
56908552|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908553|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399164|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399165|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56399166|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56399167|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
56399168|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399169|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399170|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56399171|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56399172|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56399173|NCT00532285|Gemcitabine|gemcitabine|mesh-list
56399174|NCT00532285|Paclitaxel|paclitaxel|mesh-list
56399175|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56399176|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56399177|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399178|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
56399179|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
56399180|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
56399181|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399182|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56399183|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
56146792|NCT01100112|Budesonide|budesonide|mesh-list
56399184|NCT00532285|Antiviral Agents|antiviral agents|mesh-ancestor
56399185|NCT00532285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399186|NCT00532285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399187|NCT00532285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56399188|NCT00532285|Immunologic Factors|immunologic factors|mesh-ancestor
56399189|NCT00532285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399190|NCT03138733|Daptomycin|daptomycin|mesh-list
56399191|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
56399192|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56399193|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56399194|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399195|NCT00151034|Gemcitabine|gemcitabine|mesh-list
56399196|NCT00151034|Paclitaxel|paclitaxel|mesh-list
56399197|NCT00151034|Carboplatin|carboplatin|mesh-list
56399198|NCT00151034|Trastuzumab|trastuzumab|mesh-list
56399199|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56399200|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399201|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
56399202|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
56399203|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
56399204|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399205|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56399206|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
56399207|NCT00151034|Antiviral Agents|antiviral agents|mesh-ancestor
56399208|NCT00151034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399209|NCT00151034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399210|NCT00151034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56399211|NCT00151034|Immunologic Factors|immunologic factors|mesh-ancestor
56399212|NCT00151034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161863|NCT00000132|Betaxolol|betaxolol|mesh-list
56399213|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56399214|NCT02817451|Vaccines|vaccines|mesh-list
56399215|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
56399216|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399217|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56399218|NCT00171522|Tegaserod|tegaserod|mesh-list
56399219|NCT00171522|Laxatives|laxatives|mesh-ancestor
56399220|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56399221|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56399222|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
56399223|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399224|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399225|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399227|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399228|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56399229|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888001|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56908554|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56908555|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
56908556|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
56399230|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399231|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
56399233|NCT00151073|Estramustine|estramustine|mesh-list
56399234|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399235|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
56399236|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
56399237|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
56399238|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399239|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56399240|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399241|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56399242|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
56399243|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56399244|NCT00171561|Valsartan|valsartan|mesh-list
56399245|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56399246|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56399247|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56399248|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56399249|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399250|NCT00171561|Diuretics|diuretics|mesh-ancestor
56399251|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
56399252|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399253|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56399254|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399255|NCT00151112|Anesthetics|anesthetics|mesh-list
56399256|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56399257|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399258|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
56146872|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
56399259|NCT00532324|Mupirocin|mupirocin|mesh-list
56399260|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56399261|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399262|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
56399263|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56399264|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56399265|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399266|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399267|NCT00171600|Valsartan|valsartan|mesh-list
56399268|NCT00171600|Lisinopril|lisinopril|mesh-list
56399269|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56399270|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56399271|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56399272|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399273|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56399274|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
56399275|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399276|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56399277|NCT00171600|Protective Agents|protective agents|mesh-ancestor
56399278|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399279|NCT05467384|Amlodipine|amlodipine|mesh-list
56399280|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56399281|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56399282|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399283|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399284|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56399285|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399286|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
56399287|NCT05467189|Paclitaxel|paclitaxel|mesh-list
56399288|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56399289|NCT05467189|Busulfan|busulfan|mesh-list
56399290|NCT05467189|Lapatinib|lapatinib|mesh-list
56399291|NCT05467189|Afatinib|afatinib|mesh-list
56399292|NCT05467189|Crizotinib|crizotinib|mesh-list
56399293|NCT05467189|Ceritinib|ceritinib|mesh-list
56399294|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
56399295|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56399296|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
56399297|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
56908557|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56908558|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
56908559|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362679|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
56399298|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
56399299|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399301|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56399302|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
56399303|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399304|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56399305|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56399306|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56399307|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399308|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
56399309|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56399310|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399311|NCT05466604|Dexamethasone|dexamethasone|mesh-list
56399312|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56399313|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
56399314|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
56399315|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399316|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399317|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56399318|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
56399319|NCT05466604|Hormones|hormones|mesh-ancestor
56399320|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399321|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56399322|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399323|NCT04723875|Paclitaxel|paclitaxel|mesh-list
56399324|NCT04723875|Docetaxel|docetaxel|mesh-list
56399325|NCT04723875|Carboplatin|carboplatin|mesh-list
56399326|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56399327|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399328|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
56399329|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
56399330|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
56399331|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399332|NCT05466019|Leucovorin|leucovorin|mesh-list
56399333|NCT05466019|Docetaxel|docetaxel|mesh-list
56399334|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
56399335|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399336|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
56399337|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
56399338|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
56399339|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399340|NCT05466019|Antidotes|antidotes|mesh-ancestor
56399341|NCT05466019|Protective Agents|protective agents|mesh-ancestor
56399342|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399343|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
56399344|NCT05466019|Vitamins|vitamins|mesh-ancestor
56399345|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
56399346|NCT05465902|Vaccines|vaccines|mesh-list
56399347|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
56399348|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399349|NCT00151346|Fentanyl|fentanyl|mesh-list
56399350|NCT00151346|Bupivacaine|bupivacaine|mesh-list
56399351|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
56399352|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
56399353|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56399354|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399355|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
56399356|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399357|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56399358|NCT00151346|Narcotics|narcotics|mesh-ancestor
56399359|NCT00151346|Analgesics|analgesics|mesh-ancestor
56399360|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56399361|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56399362|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
56399363|NCT00164424|Acyclovir|acyclovir|mesh-list
56399364|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
56399365|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399366|NCT00532519|Citalopram|citalopram|mesh-list
56399367|NCT00532519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56399368|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56908560|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908561|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56908562|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56908563|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56362753|NCT00303277|Simvastatin|simvastatin|mesh-list
56399369|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399370|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399371|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399372|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
56399373|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973968|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56399399|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399400|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399402|NCT00171717|Cyclosporins|cyclosporins|mesh-list
56399403|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399404|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399405|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56399406|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
56399407|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399408|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
56399409|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399410|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
56399411|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399412|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56399413|NCT00151502|Atorvastatin|atorvastatin|mesh-list
56399414|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56399415|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56399416|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
56399417|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399418|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56399419|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56399420|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399428|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399429|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399430|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
56161885|NCT00000138|Hormones|hormones|mesh-ancestor
56399431|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56399432|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56399433|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
56399434|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56399435|NCT00171756|Atenolol|atenolol|mesh-list
56399436|NCT00171756|Valsartan|valsartan|mesh-list
56399437|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56399438|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56399439|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56399440|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399441|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56399442|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
56399443|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
56399444|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399445|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399446|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56399447|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56399448|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56399449|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
56399450|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399451|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56399452|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
56399453|NCT05399173|Coagulants|coagulants|mesh-ancestor
56399454|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56399455|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
56399456|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399457|NCT00171795|Rivastigmine|rivastigmine|mesh-list
56399458|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56399459|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399460|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399461|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
56908564|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
56908565|NCT03545308|Rocuronium|rocuronium|mesh-list
56908566|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56399462|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399463|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399464|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56399465|NCT00171795|Protective Agents|protective agents|mesh-ancestor
56399466|NCT00151541|Dapsone|dapsone|mesh-list
56399467|NCT00151541|Adapalene|adapalene|mesh-list
56399468|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56399469|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
56399470|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56399471|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56399472|NCT00151541|Analgesics|analgesics|mesh-ancestor
56399473|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
56399474|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399475|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399476|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56399477|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399478|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399479|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
56399480|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56399481|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56399482|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56399483|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399484|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399485|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
56399486|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56399487|NCT00151580|Ribavirin|ribavirin|mesh-list
56399488|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
55974087|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
56399489|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399490|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
56399491|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399492|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
56399493|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399494|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56399495|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399496|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399498|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56399499|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56399500|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399501|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399502|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56399503|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399504|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
56399505|NCT05324761|Pregabalin|pregabalin|mesh-list
56399506|NCT05324761|Gabapentin|gabapentin|mesh-list
56399507|NCT05324761|Analgesics|analgesics|mesh-ancestor
56399508|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
56399509|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399510|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399511|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
56399512|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56399513|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399514|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399515|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56399516|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56399517|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56399518|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56399519|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56399520|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56399521|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56399522|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399523|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
56399524|NCT00532675|Lenalidomide|lenalidomide|mesh-list
56399525|NCT00532675|Panobinostat|panobinostat|mesh-list
56399526|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
56399527|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399528|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56399529|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56399530|NCT00532675|Growth Substances|growth substances|mesh-ancestor
56908567|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56908568|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56908569|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908570|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908571|NCT00108082|Atenolol|atenolol|mesh-list
56908572|NCT00108082|Carvedilol|carvedilol|mesh-list
56399531|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
56399532|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399533|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56399534|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399535|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399536|NCT05308030|Aspirin|aspirin|mesh-list
56399537|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
56399538|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56399539|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56399540|NCT05308030|Analgesics|analgesics|mesh-ancestor
56399541|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
56399542|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399543|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399544|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56399545|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399546|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56399547|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56399548|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399549|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56399550|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56399551|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399552|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
56399553|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56399554|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
56399555|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56399556|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
56399557|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
56399558|NCT05293600|Acetazolamide|acetazolamide|mesh-list
56399559|NCT05293600|Eszopiclone|eszopiclone|mesh-list
56399560|NCT05293600|Trazodone|trazodone|mesh-list
56399561|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56399562|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56399564|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399565|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399566|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
56399567|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399568|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399569|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
56399570|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56399571|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399572|NCT05293600|Diuretics|diuretics|mesh-ancestor
56399573|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
56399574|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56399575|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56399576|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56399577|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56399578|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56399579|NCT05293600|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56399581|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56399582|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
56399583|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
56399584|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56399585|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56399586|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399587|NCT00532714|Capecitabine|capecitabine|mesh-list
56399588|NCT00532714|Irinotecan|irinotecan|mesh-list
56399589|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56399590|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
56399591|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399592|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399593|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56399594|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56399595|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908573|NCT00108082|Lisinopril|lisinopril|mesh-list
56399596|NCT00151736|Etodolac|etodolac|mesh-list
56399597|NCT00151736|Chlorambucil|chlorambucil|mesh-list
56399598|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56399599|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
56399600|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399601|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399602|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56399603|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56399604|NCT00151736|Analgesics|analgesics|mesh-ancestor
56399605|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
56399606|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399607|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399608|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56399609|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399610|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56399611|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56399612|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399613|NCT00171990|Famciclovir|famciclovir|mesh-list
56399614|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
56399615|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399616|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56399617|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399618|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399619|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
56399620|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56399621|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399622|NCT00406094|Montelukast|montelukast|mesh-list
56399623|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56399624|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
56399625|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56399626|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
56399627|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399628|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399629|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56399630|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56399631|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147252|NCT01147302|Complement C1s|complement c1s|mesh-list
56399633|NCT00164736|Lopinavir|lopinavir|mesh-list
56399634|NCT00164736|Lamivudine|lamivudine|mesh-list
56399636|NCT00164736|Nevirapine|nevirapine|mesh-list
56399637|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56399638|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56399639|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
56399640|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399641|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399642|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56399643|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56399644|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
56399645|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399646|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56399647|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56399648|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56161890|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
56399649|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56399650|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
56399651|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56399652|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56399653|NCT04725383|Amitriptyline|amitriptyline|mesh-list
56399654|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56399655|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
56399656|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56399657|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56399658|NCT04725383|Analgesics|analgesics|mesh-ancestor
56399659|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
56399660|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399661|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399662|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56399663|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56399664|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399665|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399666|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
56908574|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56908575|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56908576|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
56908577|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399667|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399668|NCT05177146|Ketamine|ketamine|mesh-list
56399669|NCT05177146|Analgesics|analgesics|mesh-ancestor
56399670|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
56399671|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399672|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399673|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56399674|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56399675|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
56399676|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
56399677|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56399678|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56399679|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56399680|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399681|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399682|NCT00532909|Bevacizumab|bevacizumab|mesh-list
56399683|NCT00532909|Capecitabine|capecitabine|mesh-list
56399684|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
56399685|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56399686|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399687|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56399688|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56399689|NCT00532909|Growth Substances|growth substances|mesh-ancestor
56399690|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399691|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
56399692|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56399693|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
56399694|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399695|NCT00172068|Vitamin D|vitamin d|mesh-list
56399696|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
56399697|NCT00172068|Calcium|calcium|mesh-list
56399698|NCT00172068|Vitamins|vitamins|mesh-ancestor
56399699|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
56399700|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399701|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56399702|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56399703|NCT00151970|Methylphenidate|methylphenidate|mesh-list
56399704|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56399705|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399706|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56399709|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399711|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399712|NCT00152048|Eflornithine|eflornithine|mesh-list
56399713|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399714|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56399715|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56399716|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56399717|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399718|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56399719|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399720|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399722|NCT05060068|Esketamine|esketamine|mesh-list
56399723|NCT05060068|Analgesics|analgesics|mesh-ancestor
56399724|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
56399725|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399726|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399727|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56399728|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56399729|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
56399730|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
56399731|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56399732|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56399733|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56399734|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399735|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399736|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
56908578|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908579|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908581|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
56399737|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56399738|NCT04687111|Valsartan|valsartan|mesh-list
56399739|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56399740|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56399741|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56399742|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56399743|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399744|NCT00164775|Imipramine|imipramine|mesh-list
56399745|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56399746|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
56399747|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56399748|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56399749|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56399750|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399751|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399752|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
56399753|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399754|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399755|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56399756|NCT00533026|Warfarin|warfarin|mesh-list
56399757|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
56399758|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56399759|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56399760|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399761|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399762|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399763|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399764|NCT00533026|Analgesics|analgesics|mesh-ancestor
56399765|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
56399766|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399767|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
56399768|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56399769|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
56399770|NCT00152126|Melphalan|melphalan|mesh-list
56399771|NCT00152126|Busulfan|busulfan|mesh-list
56399772|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56399773|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
56399774|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399775|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399777|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56399779|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399780|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
56399781|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56399782|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399783|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
56399784|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
56399785|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56399786|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
56399787|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56399788|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399789|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
56399790|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
56399791|NCT00425451|Analgesics|analgesics|mesh-ancestor
56399792|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
56399793|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399794|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399795|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56399796|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56399797|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56399798|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399799|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56399800|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399801|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399802|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
56399803|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
56399804|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56908582|NCT00108082|Protective Agents|protective agents|mesh-ancestor
56908583|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56399805|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
56399806|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56399807|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56399808|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399809|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56399810|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399811|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399812|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56399813|NCT00152204|Renal Agents|renal agents|mesh-ancestor
56399814|NCT00533065|Donepezil|donepezil|mesh-list
56399815|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56399816|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399817|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399818|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
56399819|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399820|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399821|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
56399822|NCT00152243|Tegafur|tegafur|mesh-list
56399823|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56399824|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
56399825|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399826|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399827|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
56399828|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56399829|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399830|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56399831|NCT00152282|Estrogens|estrogens|mesh-ancestor
56399832|NCT00152282|Hormones|hormones|mesh-ancestor
56399833|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399834|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399835|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
56399836|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56399837|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56399838|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56399839|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399840|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399841|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
56399842|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399843|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399844|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56399845|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399846|NCT04914247|Selexipag|selexipag|mesh-list
56399847|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56399848|NCT00152360|Orlistat|orlistat|mesh-list
56399859|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56399860|NCT00164892|Analgesics|analgesics|mesh-ancestor
56399861|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
56399862|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399863|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399864|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56399865|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399866|NCT00152399|Somatostatin|somatostatin|mesh-list
56399867|NCT00152399|Hormones|hormones|mesh-ancestor
56399868|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399869|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399870|NCT00164931|Omeprazole|omeprazole|mesh-list
56399871|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56399872|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56399873|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56399874|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399875|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399876|NCT00152438|Progesterone|progesterone|mesh-list
56399877|NCT00152438|Progestins|progestins|mesh-ancestor
56399878|NCT00152438|Hormones|hormones|mesh-ancestor
56399879|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399880|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399881|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
56399882|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
56399883|NCT00164970|Vitamins|vitamins|mesh-ancestor
56399884|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
56399885|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908584|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399886|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
56399887|NCT00164970|Hematinics|hematinics|mesh-ancestor
56399888|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
56399889|NCT02937844|Fludarabine|fludarabine|mesh-list
56399890|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56399891|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
56399892|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399893|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399894|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56399895|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
56399896|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399897|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399898|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56399899|NCT02937415|Antioxidants|antioxidants|mesh-list
56399900|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
56399901|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399902|NCT02937415|Protective Agents|protective agents|mesh-ancestor
56399903|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399904|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
56399905|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
56399906|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399907|NCT00152594|Voriconazole|voriconazole|mesh-list
56399908|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
56399909|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399910|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56399911|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56399912|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399924|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147544|NCT01215318|Silicon|silicon|mesh-list
56399925|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399926|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
56399927|NCT04725422|Pamidronate|pamidronate|mesh-list
56399928|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
56399929|NCT04725422|Adalimumab|adalimumab|mesh-list
56399930|NCT04725422|Etanercept|etanercept|mesh-list
56399931|NCT04725422|Golimumab|golimumab|mesh-list
56399932|NCT04725422|Methotrexate|methotrexate|mesh-list
56399933|NCT04725422|Infliximab|infliximab|mesh-list
56399935|NCT04725422|Leflunomide|leflunomide|mesh-list
56399936|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56399937|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
56399938|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56399939|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399940|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56399941|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
56399942|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399943|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399944|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
56399945|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399946|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56399947|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56399948|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
56399949|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399950|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56399951|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56399952|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56399953|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56399954|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56399955|NCT04725422|Analgesics|analgesics|mesh-ancestor
56399956|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
56399957|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399958|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56399959|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56399960|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399961|NCT00152633|Losartan|losartan|mesh-list
56399962|NCT00152633|Metoprolol|metoprolol|mesh-list
56399963|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56399964|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56399965|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56399966|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56399967|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399968|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
56399969|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
56399970|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908585|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56399971|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399972|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56399973|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55974595|NCT01781637|Omalizumab|omalizumab|mesh-list
56399985|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399986|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56399987|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
56399988|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399989|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399991|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
56399992|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56399993|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56399994|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399995|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399996|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333864|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399997|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56399998|NCT03457753|Protective Agents|protective agents|mesh-ancestor
56399999|NCT02936830|Listerine|listerine|mesh-list
56400000|NCT02936830|Fluorides|fluorides|mesh-list
56400001|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
56400002|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
56400003|NCT02936830|Glycerol|glycerol|mesh-list
56400004|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
56400005|NCT02936830|Protective Agents|protective agents|mesh-ancestor
56400006|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400007|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56400008|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400009|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56400011|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56400012|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56400013|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400014|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400015|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56400016|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400017|NCT00165048|Analgesics|analgesics|mesh-ancestor
56400018|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
56400019|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400020|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400021|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400022|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400023|NCT04690270|Sumatriptan|sumatriptan|mesh-list
56400024|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56400025|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56400026|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56400027|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
56400028|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400029|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400030|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400031|NCT00165087|Doxorubicin|doxorubicin|mesh-list
56400032|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
56400033|NCT00165087|Asparaginase|asparaginase|mesh-list
56400034|NCT00165087|Razoxane|razoxane|mesh-list
56400035|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56400036|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400037|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56400046|NCT00152750|Clonidine|clonidine|mesh-list
56400047|NCT00152750|Analgesics|analgesics|mesh-ancestor
56400048|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
56400049|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400050|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400051|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56400052|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
56400053|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
56400054|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56400055|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56400056|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56400057|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
56400058|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400059|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400060|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
56908586|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
56400061|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56400062|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56400063|NCT00152828|Celecoxib|celecoxib|mesh-list
56400064|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56400065|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400066|NCT00152828|Analgesics|analgesics|mesh-ancestor
56400067|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
56400068|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400069|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400070|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400071|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400072|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56400073|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56400074|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400075|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400076|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
56400079|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
56400080|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
56400081|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56400082|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400083|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
56400084|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400085|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56400086|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400087|NCT02935933|Analgesics|analgesics|mesh-ancestor
56400088|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56400089|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56400090|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56400091|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
56400092|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400093|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400094|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56400095|NCT02935933|Narcotics|narcotics|mesh-ancestor
56400096|NCT00152867|Dexamethasone|dexamethasone|mesh-list
56400097|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400098|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
56400099|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
56400100|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400101|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400102|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56400103|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
56400104|NCT00152867|Hormones|hormones|mesh-ancestor
55974713|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400115|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400116|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56400117|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56400118|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56400119|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56400120|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400121|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56400122|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
56400123|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
56400124|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
56400125|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56400126|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56400127|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56400128|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56400129|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56400130|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56400131|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56400132|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56400133|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
56400134|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
56400135|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
56400136|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400137|NCT02935855|Warfarin|warfarin|mesh-list
56400138|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
56400139|NCT02935855|Dabigatran|dabigatran|mesh-list
56400140|NCT02935855|Apixaban|apixaban|mesh-list
56400141|NCT02935855|Edoxaban|edoxaban|mesh-list
56400142|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
56400143|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56400144|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
56400145|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56400146|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
56908587|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56363475|NCT00307996|Ubiquinone|ubiquinone|mesh-list
56400147|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400148|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400149|NCT02935582|Betamethasone|betamethasone|mesh-list
56400150|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
56400151|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56400152|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
56400153|NCT02935582|Calcipotriene|calcipotriene|mesh-list
56400154|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56400155|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400158|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56400159|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400160|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56400161|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
56400162|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
56400163|NCT00406172|Bevacizumab|bevacizumab|mesh-list
56400164|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56400165|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400166|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56400167|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56400168|NCT00406172|Growth Substances|growth substances|mesh-ancestor
56400169|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400170|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
56400171|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56400172|NCT00152945|Glycerol|glycerol|mesh-list
56400182|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400184|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56400185|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
56400186|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400187|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400188|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56400189|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56400190|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
56400191|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400192|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400193|NCT00172380|Docetaxel|docetaxel|mesh-list
56400194|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400195|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56400196|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56400197|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56400198|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400199|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
56400200|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56400201|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
56400202|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400203|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400204|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56400205|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
56400206|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
56400207|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56400208|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
56400209|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400210|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400211|NCT02935075|Tenofovir|tenofovir|mesh-list
56400212|NCT02935075|Lamivudine|lamivudine|mesh-list
56400213|NCT02935075|Efavirenz|efavirenz|mesh-list
56400214|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
56400215|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400216|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56400217|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56400218|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400219|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400220|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56400221|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56400222|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56400223|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56400224|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56400225|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56400226|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56400227|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56908588|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56908589|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56400229|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56400230|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400231|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
56400232|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400233|NCT00172419|Atorvastatin|atorvastatin|mesh-list
56400234|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56400235|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56400236|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
56400237|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400245|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56400246|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400248|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
56400249|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
56400250|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56400251|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400252|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56400253|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56400254|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400255|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56400256|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
56400257|NCT00165204|Hormones|hormones|mesh-ancestor
56400258|NCT02934763|Propranolol|propranolol|mesh-list
56400259|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56400260|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56400261|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
56400262|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400263|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400264|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400265|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56400266|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56400267|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
56400268|NCT04689958|Vitamin D|vitamin d|mesh-list
56400269|NCT04689958|Vitamins|vitamins|mesh-ancestor
56400270|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
56400271|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400272|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56400273|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56400274|NCT00153140|Laxatives|laxatives|mesh-ancestor
56400275|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56400276|NCT04684420|Metformin|metformin|mesh-list
56400277|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56400278|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400279|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56400280|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56400281|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
56400282|NCT00153296|Carbamazepine|carbamazepine|mesh-list
56400283|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
56400284|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
56400285|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56400286|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56400287|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400288|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56400289|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400290|NCT00153296|Analgesics|analgesics|mesh-ancestor
56400291|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
56400292|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400293|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56400294|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56400295|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400296|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56400297|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56400298|NCT02934295|Antibodies|antibodies|mesh-list
56400299|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
56400300|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400302|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56400303|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55974905|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400312|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
55888002|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56908590|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
56908591|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908592|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56908593|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56400313|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400314|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400315|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
56400316|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56400317|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56400318|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
56400319|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
56400320|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56400321|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56400322|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56400323|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
56400324|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400325|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400326|NCT02934217|Cyclosporine|cyclosporine|mesh-list
56400327|NCT02934217|Cyclosporins|cyclosporins|mesh-list
56400328|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400329|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400330|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56400331|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
56400332|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400333|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
56400334|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400335|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
56400336|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400337|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56400338|NCT00165360|Temozolomide|temozolomide|mesh-list
56400339|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56400340|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
56400341|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400342|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400343|NCT02933905|Ranibizumab|ranibizumab|mesh-list
56400344|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56400345|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56400346|NCT02933905|Growth Substances|growth substances|mesh-ancestor
56400347|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400348|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
56400349|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400350|NCT02933788|Aspirin|aspirin|mesh-list
56400351|NCT02933788|Cilostazol|cilostazol|mesh-list
56400352|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56400353|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400354|NCT02933788|Analgesics|analgesics|mesh-ancestor
56400355|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
56400356|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400357|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400358|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400359|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400360|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56400361|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56400362|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400363|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56400364|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56400365|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400366|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
56400367|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56400368|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
56400369|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56400370|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
56400383|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
56400384|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400385|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56400386|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
56400387|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
56400388|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56400389|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400390|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56908594|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
56908595|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
56908596|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908597|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56908598|NCT02144662|Ranibizumab|ranibizumab|mesh-list
56908599|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56908600|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56908601|NCT02144662|Growth Substances|growth substances|mesh-ancestor
56908602|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908603|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
56908604|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908605|NCT02141698|Esomeprazole|esomeprazole|mesh-list
56908606|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56908607|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908608|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56908609|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908610|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908611|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56908612|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
56908613|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56908614|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
56908615|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56908616|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908617|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56908618|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56363720|NCT00309517|Leucovorin|leucovorin|mesh-list
56400391|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
56400393|NCT02933593|Labetalol|labetalol|mesh-list
56400394|NCT02933593|Nifedipine|nifedipine|mesh-list
56400395|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56400396|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56400397|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400398|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56400399|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400400|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
56400401|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
56400402|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56400403|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56400404|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56400405|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56400406|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
56400407|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400408|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
56400409|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
56400410|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400411|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56400412|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56400413|NCT00153491|Lumefantrine|lumefantrine|mesh-list
56400414|NCT00153491|Artemether|artemether|mesh-list
56908619|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908620|NCT02147938|Tacrolimus|tacrolimus|mesh-list
56908621|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56908622|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
56908623|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908624|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56908625|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908626|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908627|NCT02148016|Levofloxacin|levofloxacin|mesh-list
56908628|NCT02148016|Ofloxacin|ofloxacin|mesh-list
56908629|NCT02148016|Betamethasone|betamethasone|mesh-list
56908630|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56908631|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908632|NCT02148016|Renal Agents|renal agents|mesh-ancestor
56908633|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56908634|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56908635|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56908636|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363754|NCT00309556|Docetaxel|docetaxel|mesh-list
56400415|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56400416|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
56400417|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56400418|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56400419|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400420|NCT02933437|Ajmaline|ajmaline|mesh-list
56400421|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56400422|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56400423|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56400424|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56400425|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400426|NCT00153530|Methotrexate|methotrexate|mesh-list
56400427|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56400428|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
56400429|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56400430|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400431|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56400432|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
55975035|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56400444|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400445|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56123316|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
56400446|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56400447|NCT00165477|Growth Substances|growth substances|mesh-ancestor
56400448|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
56400449|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400450|NCT02932930|Ropivacaine|ropivacaine|mesh-list
56400451|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
56400452|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
56400453|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56400454|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400455|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
56400456|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400457|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
56400458|NCT00165516|Antidotes|antidotes|mesh-ancestor
56400459|NCT00165516|Protective Agents|protective agents|mesh-ancestor
56400460|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400461|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
56400462|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908637|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908638|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400463|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
56400464|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56400465|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400466|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
56400467|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
56400468|NCT04642378|Insulin|insulin|mesh-list
56400469|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56400470|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56400471|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400472|NCT00407784|Eplerenone|eplerenone|mesh-list
56400473|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56400474|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
56400475|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56400476|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400477|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56400478|NCT00407784|Diuretics|diuretics|mesh-ancestor
56400479|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
56400480|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56400481|NCT02932774|Cetirizine|cetirizine|mesh-list
56400482|NCT02932774|Loratadine|loratadine|mesh-list
56400483|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56400484|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56400485|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56400486|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
56400487|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
56400488|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400489|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400490|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400491|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
56400492|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
56400493|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56400494|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400495|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400507|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400508|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56400509|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56400510|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400511|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
56400513|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
56400514|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400515|NCT00180102|Cytarabine|cytarabine|mesh-list
56400516|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
56400517|NCT00180102|Amsacrine|amsacrine|mesh-list
56400518|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56400519|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
56400520|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400521|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400522|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
56400523|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400524|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56400525|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
56400526|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400527|NCT00180102|Analgesics|analgesics|mesh-ancestor
56400528|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
56400529|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400530|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56400531|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56400532|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400534|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56400535|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56400536|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400537|NCT00153881|Carboplatin|carboplatin|mesh-list
56400539|NCT00153881|Capecitabine|capecitabine|mesh-list
56400540|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400541|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
56400542|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
56400543|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
56400544|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400545|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56400546|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
56400547|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
56908639|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56908640|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56908641|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400548|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56400549|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400550|NCT00180141|Analgesics|analgesics|mesh-ancestor
56400551|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
56400552|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400553|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400554|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400555|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400556|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
56400557|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56400558|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
56400559|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56400560|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400561|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400564|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56400565|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56400566|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400567|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56400568|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
56400569|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
56400570|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56400571|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56400572|NCT00153998|Leucovorin|leucovorin|mesh-list
56400573|NCT00153998|Folic Acid|folic acid|mesh-list
56400574|NCT00153998|Fluorouracil|fluorouracil|mesh-list
56400575|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
56400576|NCT00153998|Irinotecan|irinotecan|mesh-list
56400577|NCT00153998|Cetuximab|cetuximab|mesh-list
56400578|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
56400579|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
56400580|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400581|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56400582|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400583|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56400584|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
56400585|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400586|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56400587|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56400588|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400589|NCT00153998|Antidotes|antidotes|mesh-ancestor
56400590|NCT00153998|Protective Agents|protective agents|mesh-ancestor
56400591|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
56400592|NCT00153998|Vitamins|vitamins|mesh-ancestor
56400593|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
56400594|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56400595|NCT00153998|Hematinics|hematinics|mesh-ancestor
56400596|NCT02925130|Albuterol|albuterol|mesh-list
56400597|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56400598|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
56400599|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400600|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400601|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56400602|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
56400603|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
56400604|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56400605|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56400606|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56400607|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56400608|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
56400609|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400610|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400612|NCT02924974|Morphine|morphine|mesh-list
56400613|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
56400614|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
56400615|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56400616|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400617|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
56400618|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400619|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56908642|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
56908643|NCT02148016|Hormones|hormones|mesh-ancestor
56908644|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908645|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908646|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56908647|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
56908648|NCT02148094|Tenofovir|tenofovir|mesh-list
56908649|NCT02148094|Emtricitabine|emtricitabine|mesh-list
56908650|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56908651|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
56908652|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908653|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56400620|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56400621|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56400622|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56400623|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400624|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56400625|NCT02924974|Narcotics|narcotics|mesh-ancestor
56400626|NCT02924974|Analgesics|analgesics|mesh-ancestor
56400627|NCT00154037|Pioglitazone|pioglitazone|mesh-list
56400628|NCT00154037|Candesartan|candesartan|mesh-list
56400629|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56400630|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400631|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56400632|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56400633|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56400634|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400635|NCT02924857|Paclitaxel|paclitaxel|mesh-list
56400636|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56400637|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400653|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
56400654|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56400655|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56400656|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400657|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400658|NCT00154115|Protective Agents|protective agents|mesh-ancestor
56400659|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400661|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56400662|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400663|NCT02924506|Analgesics|analgesics|mesh-ancestor
56400664|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
56400665|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400666|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400667|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400668|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400669|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56400670|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56400671|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400672|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400673|NCT02924311|Aflibercept|aflibercept|mesh-list
56400674|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56400675|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56400676|NCT02924311|Growth Substances|growth substances|mesh-ancestor
56400677|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400678|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
56400679|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400681|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56400682|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400683|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55888003|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
56908654|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56908655|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908656|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908657|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56908658|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56908659|NCT00104884|Romidepsin|romidepsin|mesh-list
56908660|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56908661|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400684|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400685|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56400686|NCT02923999|Antibodies|antibodies|mesh-list
56400687|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
56400688|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56400689|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
56400690|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400691|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400692|NCT00154193|Cyclosporine|cyclosporine|mesh-list
56400693|NCT00154193|Cyclosporins|cyclosporins|mesh-list
56400694|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400695|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975300|NCT03246074|Paclitaxel|paclitaxel|mesh-list
56400705|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56400706|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400707|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56400708|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
56400709|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56400710|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400711|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400712|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400714|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56400715|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56400716|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56400717|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400718|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
56400719|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400720|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56400721|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400722|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400723|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
56400724|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56400725|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400726|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56400727|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
56400728|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56400729|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400730|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400731|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400732|NCT02923687|Ketorolac|ketorolac|mesh-list
56400733|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56400734|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56400735|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400736|NCT02923687|Analgesics|analgesics|mesh-ancestor
56400737|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
56400738|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400739|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400740|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400741|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400742|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56400743|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400744|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400745|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
56400746|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400747|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56400748|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084425|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56908662|NCT02148328|Vaccines|vaccines|mesh-list
56908663|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
56908664|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908665|NCT02142010|Paclitaxel|paclitaxel|mesh-list
56908666|NCT02142010|Cisplatin|cisplatin|mesh-list
56908667|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908668|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908669|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908670|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
56400749|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400751|NCT02923258|Cisplatin|cisplatin|mesh-list
56400752|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400753|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
56400754|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
56400755|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
56400756|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400757|NCT02923336|Propranolol|propranolol|mesh-list
56400758|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56400759|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56400760|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
56400770|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400771|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400773|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56400774|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400775|NCT02922712|Analgesics|analgesics|mesh-ancestor
56400776|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
56400777|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400778|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400779|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400780|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400781|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56400782|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400783|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400784|NCT02922673|Aspirin|aspirin|mesh-list
56400785|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56400786|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400787|NCT02922673|Analgesics|analgesics|mesh-ancestor
56400788|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
56400789|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400790|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400791|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400792|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400793|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56400794|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56400795|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400796|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56400797|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56400798|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400799|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
56400800|NCT02922283|Interleukin-2|interleukin-2|mesh-list
56400801|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400802|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400803|NCT02922283|Analgesics|analgesics|mesh-ancestor
56400804|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
56400805|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400806|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400807|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56400808|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56400809|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400810|NCT02922166|SRX246|srx246|mesh-list
56400811|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56400812|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400813|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
56400814|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400815|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
56400816|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
56908671|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
56908672|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908673|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
56908674|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56908675|NCT05054140|Calcium|calcium|mesh-list
56908676|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56908677|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908678|NCT03543826|Rocuronium|rocuronium|mesh-list
56908679|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56908680|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56400817|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
56400818|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56400819|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56400820|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400821|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56400822|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56400823|NCT02921659|Niacinamide|niacinamide|mesh-list
56400845|NCT04689100|Antidotes|antidotes|mesh-ancestor
56400846|NCT04689100|Protective Agents|protective agents|mesh-ancestor
56400847|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
56400848|NCT04689100|Vitamins|vitamins|mesh-ancestor
56400849|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
56400850|NCT00188136|Fludarabine|fludarabine|mesh-list
56400851|NCT00188136|Melphalan|melphalan|mesh-list
56400852|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400853|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400854|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56400855|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
56400856|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400857|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56400858|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
56400859|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56400860|NCT00406250|Bevacizumab|bevacizumab|mesh-list
56400861|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56400862|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400863|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56400864|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56400865|NCT00406250|Growth Substances|growth substances|mesh-ancestor
56400866|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400867|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
56400868|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56400869|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56400870|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400871|NCT02921269|Bevacizumab|bevacizumab|mesh-list
56400872|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56400873|NCT02921269|Atezolizumab|atezolizumab|mesh-list
56400874|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
56400875|NCT02921269|Antibodies|antibodies|mesh-list
56400876|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
56400877|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56400878|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
56400879|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975496|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
56400888|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
56400889|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400890|NCT02920801|Metformin|metformin|mesh-list
56400891|NCT02920801|Saxagliptin|saxagliptin|mesh-list
56400892|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56400893|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400894|NCT02920801|Incretins|incretins|mesh-ancestor
56400895|NCT02920801|Hormones|hormones|mesh-ancestor
56400896|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56400897|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56400898|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
56400899|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085590|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
56908681|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56908682|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908683|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908684|NCT02148640|Infliximab|infliximab|mesh-list
56908685|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
56908686|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908687|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56908688|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56908689|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
56908690|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56908691|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56908692|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56908693|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908694|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908695|NCT02142634|Budesonide|budesonide|mesh-list
56908696|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56908697|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56908698|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
56908699|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400900|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400902|NCT00180843|Albuterol|albuterol|mesh-list
56400903|NCT00180843|Ipratropium|ipratropium|mesh-list
56400904|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
56400905|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56400906|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
56400907|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400908|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400909|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56400910|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
56400911|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
56400912|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56400913|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56400914|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56400915|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56400916|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
56400917|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400918|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400919|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56400920|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
56400921|NCT02920567|Octreotide|octreotide|mesh-list
56400922|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56400923|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56400924|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400925|NCT00180882|Rituximab|rituximab|mesh-list
56400926|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56400927|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400928|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
56400929|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400930|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400931|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
56400932|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400933|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56400934|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400935|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400936|NCT02920489|Sufentanil|sufentanil|mesh-list
56400938|NCT02920489|Ropivacaine|ropivacaine|mesh-list
56400939|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
56908700|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908701|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56908702|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
56908703|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
56908704|NCT02142634|Hormones|hormones|mesh-ancestor
56908705|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908706|NCT02142790|Paclitaxel|paclitaxel|mesh-list
56908707|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56908708|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400940|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
56400941|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56400942|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400943|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
56400944|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400945|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56400946|NCT02920489|Narcotics|narcotics|mesh-ancestor
56400947|NCT02920489|Analgesics|analgesics|mesh-ancestor
56400948|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56400957|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56400958|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56400959|NCT00154661|Protective Agents|protective agents|mesh-ancestor
56400960|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400961|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
56400962|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56400963|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
56400964|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
56400965|NCT00180960|Irinotecan|irinotecan|mesh-list
56400966|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400967|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56400968|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56400969|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400970|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400971|NCT00154700|Folic Acid|folic acid|mesh-list
56400972|NCT00154700|Paclitaxel|paclitaxel|mesh-list
56400973|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56400974|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333865|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
56400975|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56400976|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56400977|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56400978|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400979|NCT00154700|Hematinics|hematinics|mesh-ancestor
56400980|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
56400981|NCT00154700|Vitamins|vitamins|mesh-ancestor
56400982|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
56400983|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400984|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
56400985|NCT04688983|Blinatumomab|blinatumomab|mesh-list
56400986|NCT04688983|Ponatinib|ponatinib|mesh-list
56400987|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400988|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56400989|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400990|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400991|NCT02920060|Levetiracetam|levetiracetam|mesh-list
56400992|NCT02920060|Valproic Acid|valproic acid|mesh-list
56400993|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
56400994|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
56400995|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400996|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400997|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
56400998|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400999|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401000|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
56401001|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56401002|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401003|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401004|NCT00154739|Gemcitabine|gemcitabine|mesh-list
56401005|NCT00154739|Epirubicin|epirubicin|mesh-list
56908709|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908710|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
56908711|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56908712|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908713|NCT02142868|Letrozole|letrozole|mesh-list
56908714|NCT02142868|Palbociclib|palbociclib|mesh-list
56908715|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908716|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56908717|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56908718|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908719|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908720|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56908721|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
56908722|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401006|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401007|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56401008|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
56401009|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401010|NCT00154739|Antiviral Agents|antiviral agents|mesh-ancestor
56401011|NCT00154739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401012|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401013|NCT00154739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56401014|NCT00154739|Immunologic Factors|immunologic factors|mesh-ancestor
56401015|NCT00154739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401038|NCT00181116|Levetiracetam|levetiracetam|mesh-list
56401039|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
56401040|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
56401041|NCT02918812|Diclofenac|diclofenac|mesh-list
56401042|NCT02918812|Lidocaine|lidocaine|mesh-list
56401043|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
56401044|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
56401045|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401046|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401047|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
56401048|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401049|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56401050|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56401051|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56401052|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333866|NCT00036881|Astringents|astringents|mesh-ancestor
56401053|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401054|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56401055|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56401057|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56401058|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56401059|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56401060|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401061|NCT02918110|Misoprostol|misoprostol|mesh-list
56401062|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56401063|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
56401064|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56401065|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401066|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56401067|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56401068|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
56401069|NCT00181272|Azithromycin|azithromycin|mesh-list
56401070|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56401071|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401072|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
56401077|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908723|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908724|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56908725|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
56908726|NCT02145520|Analgesics|analgesics|mesh-ancestor
56908727|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
56908728|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364399|NCT00293800|Latanoprost|latanoprost|mesh-list
56401078|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401079|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56401080|NCT02910115|Oxytocin|oxytocin|mesh-list
56401081|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
56401082|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56401083|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401084|NCT00188565|Celecoxib|celecoxib|mesh-list
56401085|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56401086|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56401087|NCT00188565|Analgesics|analgesics|mesh-ancestor
56401088|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
56401089|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401090|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401091|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56401092|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56401093|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56401094|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56401095|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401096|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401097|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
56401098|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56401099|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401100|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401101|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56401102|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56401103|NCT00155246|Protective Agents|protective agents|mesh-ancestor
56401104|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401105|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
56401106|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56401107|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
56401108|NCT02909413|Sevoflurane|sevoflurane|mesh-list
56401110|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56401111|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56401112|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
56401113|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
56401114|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401115|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401116|NCT02909257|Bupivacaine|bupivacaine|mesh-list
56401117|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
56401118|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
56401119|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401120|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401121|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
56401122|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401123|NCT02908945|Ketamine|ketamine|mesh-list
56401124|NCT02908945|Analgesics|analgesics|mesh-ancestor
56401125|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
56401126|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401127|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401128|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56401129|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56401130|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
56401131|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
56401132|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401133|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56401134|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56401135|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401136|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401137|NCT02939833|Ropivacaine|ropivacaine|mesh-list
56401138|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
56401139|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
56908729|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908731|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908732|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56401140|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401141|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401142|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
56401143|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401144|NCT00188604|Selenious Acid|selenious acid|mesh-list
56401147|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
56401148|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401149|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56401150|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56401152|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56401153|NCT04865029|Progesterone|progesterone|mesh-list
56401154|NCT04865029|Estrogens|estrogens|mesh-ancestor
56401155|NCT04865029|Hormones|hormones|mesh-ancestor
56401156|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401157|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401158|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56401159|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
56401160|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56401161|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56401162|NCT04865029|Progestins|progestins|mesh-ancestor
56401163|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56401164|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
56401165|NCT00155402|Coagulants|coagulants|mesh-ancestor
56401166|NCT04808323|Capecitabine|capecitabine|mesh-list
56401167|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
56401168|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56401169|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
56401170|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401171|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401172|NCT00188643|Lamotrigine|lamotrigine|mesh-list
56401173|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56401174|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56401175|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56401176|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401177|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401178|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401179|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401180|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56401181|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
56401182|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401183|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
56401184|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56401185|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56401186|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56401187|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56401188|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401189|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56401191|NCT00533299|Valproic Acid|valproic acid|mesh-list
56401192|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
56401193|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401194|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401195|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
56401196|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401197|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401198|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
56401199|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56401200|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148816|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56401201|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401202|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56401203|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
56401204|NCT04788823|Prednisone|prednisone|mesh-list
56401205|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56401206|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
56401207|NCT04788823|Hormones|hormones|mesh-ancestor
56401208|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401209|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908733|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
56908734|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56908735|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56908736|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908737|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56908738|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
56908739|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56908740|NCT02145598|Lenalidomide|lenalidomide|mesh-list
56908741|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
56908742|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908743|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56908744|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56908745|NCT02145598|Growth Substances|growth substances|mesh-ancestor
56908746|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
56401210|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56401211|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401212|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
56401213|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56401214|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401215|NCT04696042|Lanreotide|lanreotide|mesh-list
56401216|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401217|NCT00181662|Curcumin|curcumin|mesh-list
56401218|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56401220|NCT00181662|Analgesics|analgesics|mesh-ancestor
56401221|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
56401222|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401223|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401224|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56401225|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56401226|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401227|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401228|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401229|NCT00533416|ON 01910|on 01910|mesh-list
56401230|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401231|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56401232|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401233|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401234|NCT00155558|Leucovorin|leucovorin|mesh-list
56401235|NCT00155558|Fluorouracil|fluorouracil|mesh-list
56401236|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
56401237|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401238|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56401239|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401240|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56401241|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
56401242|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401243|NCT00155558|Antidotes|antidotes|mesh-ancestor
56124108|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
56401244|NCT00155558|Protective Agents|protective agents|mesh-ancestor
56401245|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
56401246|NCT00155558|Vitamins|vitamins|mesh-ancestor
56401247|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
56401248|NCT00533455|Gabapentin|gabapentin|mesh-list
56401249|NCT00533455|Analgesics|analgesics|mesh-ancestor
56401250|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
56401251|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401252|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401253|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
56401254|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56401255|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56401256|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364599|NCT00294892|Carbamazepine|carbamazepine|mesh-list
56364600|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56364601|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56364602|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364603|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364604|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
56364605|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364606|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56364607|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56401257|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401258|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56401259|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56401260|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401261|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401262|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
56401263|NCT00533533|Docetaxel|docetaxel|mesh-list
56401264|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
56401265|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401266|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
56401267|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
56401268|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
56401269|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401270|NCT00533611|Niacin|niacin|mesh-list
56401271|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401272|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401273|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56401274|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
56401275|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56401276|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
56401277|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
56401278|NCT00533611|Vitamins|vitamins|mesh-ancestor
56401279|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
56401280|NCT04575844|Liraglutide|liraglutide|mesh-list
56401281|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56401282|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401283|NCT04575844|Incretins|incretins|mesh-ancestor
56401284|NCT04575844|Hormones|hormones|mesh-ancestor
56401285|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401286|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
56401287|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
56401288|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
56401289|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56401290|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401291|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401292|NCT00155714|Urological Agents|urological agents|mesh-ancestor
56401294|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56401295|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56401296|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401297|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401298|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56401299|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401300|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401301|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
56401302|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56401303|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
56401304|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56401305|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
56401306|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401307|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401308|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
56401309|NCT00181779|Aripiprazole|aripiprazole|mesh-list
56401310|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
56401311|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401312|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56401313|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56908747|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908748|NCT02145832|Fluconazole|fluconazole|mesh-list
56908749|NCT02145832|Micafungin|micafungin|mesh-list
56908750|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
56908751|NCT02145832|Clotrimazole|clotrimazole|mesh-list
56908752|NCT02145832|Miconazole|miconazole|mesh-list
56908753|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908754|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56908755|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56908756|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908757|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908758|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56908759|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
56908760|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908761|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401314|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401315|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401316|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
56401317|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
56401318|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401319|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401320|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56401321|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56401322|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
56401323|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56401324|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56401325|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56401326|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56401327|NCT00533923|Cyclosporine|cyclosporine|mesh-list
56401328|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
56401329|NCT00533923|Fludarabine|fludarabine|mesh-list
56401330|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
56401331|NCT00533923|Cyclosporins|cyclosporins|mesh-list
56401332|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56401333|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
56401334|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401335|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56401336|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56401337|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
56401338|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401339|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401340|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56401341|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401342|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
56401343|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401344|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
56401345|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56401346|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56401347|NCT00409227|Alfuzosin|alfuzosin|mesh-list
56401348|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56401349|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56401350|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56148968|NCT01472874|Trientine|trientine|mesh-list
56401351|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
56401352|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401353|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401354|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401355|NCT00409227|Urological Agents|urological agents|mesh-ancestor
56401356|NCT00533962|Anecortave|anecortave|mesh-list
56908762|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56908763|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56908764|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56908765|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56908766|NCT00104728|Gefitinib|gefitinib|mesh-list
56908767|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908768|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56908769|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908770|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908771|NCT02145910|Vemurafenib|vemurafenib|mesh-list
56401357|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56401358|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56401359|NCT00533962|Growth Substances|growth substances|mesh-ancestor
56401360|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401361|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
56401362|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401363|NCT00181818|Bupropion|bupropion|mesh-list
56401364|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56401368|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56401369|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401370|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401372|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401373|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401374|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56401375|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56401376|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401377|NCT04462627|Antibodies|antibodies|mesh-list
56401378|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
56401379|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401380|NCT00406601|Sorafenib|sorafenib|mesh-list
56401381|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401382|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56401383|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401384|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401385|NCT00409305|Betahistine|betahistine|mesh-list
56401386|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
56401387|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
56401388|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
56401389|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401390|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401391|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401392|NCT00406679|Acetaminophen|acetaminophen|mesh-list
56401393|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56401394|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56401395|NCT00406679|Analgesics|analgesics|mesh-ancestor
56401396|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
56401397|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401398|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401399|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
56401400|NCT00181896|Bupropion|bupropion|mesh-list
56401401|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56401402|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
56401403|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401404|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56401405|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56401406|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401407|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401408|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
56401409|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401410|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401411|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56085694|NCT02666846|Salicylates|salicylates|mesh-list
56364801|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56401412|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56401413|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401414|NCT04686448|Fentanyl|fentanyl|mesh-list
56401415|NCT04686448|Ketamine|ketamine|mesh-list
56401416|NCT04686448|Propofol|propofol|mesh-list
56401417|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56401418|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401419|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401420|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56401421|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
56401422|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
56401423|NCT04686448|Analgesics|analgesics|mesh-ancestor
56401424|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
56401425|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401426|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56401427|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56401428|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56401429|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401430|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401431|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56401432|NCT04686448|Narcotics|narcotics|mesh-ancestor
56401433|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56401434|NCT00181935|Olanzapine|olanzapine|mesh-list
56401438|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401439|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401440|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401441|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56401442|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56401443|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401444|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401445|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56401447|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
56401448|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
56401449|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401450|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56401451|NCT00181935|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56401452|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56401453|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401454|NCT00409383|Paclitaxel|paclitaxel|mesh-list
56401455|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56401456|NCT00409383|Temozolomide|temozolomide|mesh-list
56401457|NCT00409383|Oblimersen|oblimersen|mesh-list
56401458|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56401459|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401460|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
56401461|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
56401462|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
56401463|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401464|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56401465|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
56401466|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
56401467|NCT04893148|Dulaglutide|dulaglutide|mesh-list
56401468|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56401469|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401470|NCT04883632|Lidocaine|lidocaine|mesh-list
56401471|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
56401472|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
56401473|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401474|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401475|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
56401476|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401477|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56401478|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56401479|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56401480|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401481|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401482|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56401483|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
56401484|NCT00181974|Coagulants|coagulants|mesh-ancestor
56401485|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56401486|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56401487|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56401488|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
56908772|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908773|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56908774|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401489|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401490|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56401491|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56401492|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401493|NCT02500147|Metformin|metformin|mesh-list
56401494|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56401495|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401496|NCT00182013|Olanzapine|olanzapine|mesh-list
56401497|NCT00182013|Risperidone|risperidone|mesh-list
56401498|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56401499|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56401500|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
56401501|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401502|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401503|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401504|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56401505|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55976097|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56401514|NCT00182013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56401515|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56401516|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401517|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
56401519|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56401520|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401521|NCT02115724|Vitamins|vitamins|mesh-list
56401522|NCT02115724|Vitamin E|vitamin e|mesh-list
56401523|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
56401524|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
56401525|NCT02115724|Antioxidants|antioxidants|mesh-list
56161956|NCT00000228|Analgesics|analgesics|mesh-ancestor
56401526|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
56401527|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401528|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401529|NCT02115724|Protective Agents|protective agents|mesh-ancestor
56401530|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
56401531|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
56401532|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
56401534|NCT02081755|Azathioprine|azathioprine|mesh-list
56401535|NCT02081755|Tacrolimus|tacrolimus|mesh-list
56401536|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56401537|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
56401538|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401539|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56401540|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401541|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401542|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401543|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56401544|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56401545|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
56401546|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56401547|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401548|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
56401549|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56401550|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56401551|NCT01715974|Molgramostim|molgramostim|mesh-list
56401552|NCT01715974|Sargramostim|sargramostim|mesh-list
56401553|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
56401554|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401555|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401556|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
56401557|NCT01413100|Plerixafor|plerixafor|mesh-list
56401558|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
56401559|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
56401560|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56401561|NCT01413100|Lenograstim|lenograstim|mesh-list
56401562|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56401563|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
56401564|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401565|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56401566|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56401567|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
56908775|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908776|NCT02146222|Docetaxel|docetaxel|mesh-list
56908777|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908778|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
56908779|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
56908780|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
56908781|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908782|NCT02146300|Xylometazoline|xylometazoline|mesh-list
56401568|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401569|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401570|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56401571|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56401572|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56401573|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56401574|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
56401589|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401590|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56401592|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401593|NCT00182169|Hormones|hormones|mesh-list
56401594|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401595|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401596|NCT05471050|Danazol|danazol|mesh-list
56401597|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56401598|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
56401599|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401600|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401602|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56401603|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401604|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401605|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401606|NCT04686058|Midazolam|midazolam|mesh-list
56401607|NCT04686058|Meperidine|meperidine|mesh-list
56401608|NCT04686058|Propofol|propofol|mesh-list
56401609|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56401610|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401611|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401612|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56401613|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
56401614|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
56401615|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56401616|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56401617|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56401618|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401619|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
56401620|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
56401621|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401622|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401623|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56401624|NCT04686058|Narcotics|narcotics|mesh-ancestor
56401625|NCT04686058|Analgesics|analgesics|mesh-ancestor
56401626|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
56401627|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401628|NCT00156299|Dexamethasone|dexamethasone|mesh-list
56401629|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
56401630|NCT00156299|Choline|choline|mesh-list
56401631|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56401632|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
56401633|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
56401634|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401635|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401636|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56401637|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
56401638|NCT00156299|Hormones|hormones|mesh-ancestor
56401641|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401642|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
56401643|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56401644|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
56085695|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
56908783|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
56908784|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56365013|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
56401645|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401646|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56401647|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
56401648|NCT00156299|Analgesics|analgesics|mesh-ancestor
56401649|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
56401650|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56401651|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56401652|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56401654|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401655|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56401656|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401657|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401658|NCT00188955|Sirolimus|sirolimus|mesh-list
56401659|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56401660|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401661|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56401662|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401663|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
56401664|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56401665|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
56401666|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401667|NCT00536068|Acetaminophen|acetaminophen|mesh-list
56401668|NCT00536068|Aspirin|aspirin|mesh-list
56401669|NCT00536068|Diclofenac|diclofenac|mesh-list
56401670|NCT00536068|Naproxen|naproxen|mesh-list
56401671|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56401672|NCT00536068|Analgesics|analgesics|mesh-ancestor
56401673|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
56401674|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401675|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401676|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
56162038|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
56162109|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
56162344|NCT00000810|Zidovudine|zidovudine|mesh-list
56162489|NCT00000936|Cyclosporins|cyclosporins|mesh-list
56162566|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162794|NCT00001860|Octreotide|octreotide|mesh-list
56162939|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163011|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163165|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401677|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56401678|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56401679|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56401680|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56401681|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401682|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401683|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
56401684|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56401685|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56401686|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56401687|NCT05470582|Vaccines|vaccines|mesh-list
56401688|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
56401689|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401690|NCT00156377|Mupirocin|mupirocin|mesh-list
56401691|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56401692|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401693|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56401694|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401695|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401696|NCT00188994|Insulin|insulin|mesh-list
56401697|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56401698|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401699|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56401700|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
56401701|NCT00408525|Donepezil|donepezil|mesh-list
56401702|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56401703|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976297|NCT01276613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401722|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401724|NCT00189033|Cathartics|cathartics|mesh-ancestor
56401725|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908785|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
56908786|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
56908787|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56908788|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56908789|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908790|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
56401726|NCT05469061|Cisplatin|cisplatin|mesh-list
56401727|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401728|NCT05469022|Lazertinib|lazertinib|mesh-list
56401729|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56401730|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401731|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401732|NCT00189072|Gabapentin|gabapentin|mesh-list
56401733|NCT00189072|Analgesics|analgesics|mesh-ancestor
56401734|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
56401735|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401736|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401737|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
56401738|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56401739|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56401740|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401741|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401742|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56401743|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56401744|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401745|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401746|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
56401747|NCT00156611|Abciximab|abciximab|mesh-list
56401748|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
56401749|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56401750|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56401751|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
56401752|NCT00156650|Testosterone|testosterone|mesh-list
56401753|NCT00156650|Acyline|acyline|mesh-list
56401754|NCT00156650|Androgens|androgens|mesh-ancestor
56401755|NCT00156650|Hormones|hormones|mesh-ancestor
56401756|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401757|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401758|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56401765|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56401766|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56401767|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56401768|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
56401769|NCT00536419|Methylphenidate|methylphenidate|mesh-list
56401770|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56401771|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401772|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56401773|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56401774|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401775|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401776|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
56401777|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401778|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
56401779|NCT00189150|Valganciclovir|valganciclovir|mesh-list
56401780|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56401781|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401782|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56401783|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
56401784|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56401785|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401786|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401787|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401788|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
56401789|NCT00156689|Levetiracetam|levetiracetam|mesh-list
56401790|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
56401791|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
56401792|NCT00536614|Cetuximab|cetuximab|mesh-list
56401793|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56401794|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908791|NCT02146456|Coagulants|coagulants|mesh-ancestor
56401795|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56401796|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401797|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56401798|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149408|NCT01565538|Pemetrexed|pemetrexed|mesh-list
56401799|NCT05468164|Omeprazole|omeprazole|mesh-list
56401800|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56401801|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56401803|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401804|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401805|NCT05468047|Ketamine|ketamine|mesh-list
56401806|NCT05468047|Analgesics|analgesics|mesh-ancestor
56401807|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
56401808|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401809|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401810|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56401811|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56401812|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
56401813|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
56401814|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401815|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56401816|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56401817|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401818|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401819|NCT00182364|Heparin|heparin|mesh-list
56401820|NCT00182364|Calcium heparin|calcium heparin|mesh-list
56401821|NCT00182364|Dalteparin|dalteparin|mesh-list
56401822|NCT00182364|Tinzaparin|tinzaparin|mesh-list
56401823|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56401824|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
56401825|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56401826|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56401827|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401829|NCT00536653|Vitamin D|vitamin d|mesh-list
56401830|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
56401831|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
56401832|NCT00536653|Vitamins|vitamins|mesh-list
56401833|NCT00536653|Goserelin|goserelin|mesh-list
56401834|NCT00536653|Bicalutamide|bicalutamide|mesh-list
56401835|NCT00536653|Calcium|calcium|mesh-list
56401836|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56401837|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
56401838|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401839|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56401840|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56401841|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56401842|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401843|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
56401844|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
56401845|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401846|NCT00536653|Hormones|hormones|mesh-ancestor
56401847|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
56401848|NCT05467852|Progestins|progestins|mesh-ancestor
56401849|NCT05467852|Hormones|hormones|mesh-ancestor
56401850|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401851|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401852|NCT00536692|Mecamylamine|mecamylamine|mesh-list
56401853|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56401854|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56401855|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
56401856|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401857|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401858|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56401859|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56401860|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
56401861|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401862|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401863|NCT00189345|Catumaxomab|catumaxomab|mesh-list
56401864|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
56401865|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
56401866|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401867|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56401868|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56401869|NCT00156884|Cisplatin|cisplatin|mesh-list
56085696|NCT02666846|Menthol|menthol|mesh-list
56908792|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
56908793|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56908794|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401870|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401871|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56401872|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401873|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
56401874|NCT00156962|Hematinics|hematinics|mesh-ancestor
56401875|NCT00182442|Olanzapine|olanzapine|mesh-list
56401876|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56401877|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
56401878|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
56401879|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401880|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401881|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56401882|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56401883|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56401884|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401885|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401886|NCT00182442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56401887|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56401888|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401889|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401890|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401891|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
56401892|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
56401893|NCT00536770|Calcitriol|calcitriol|mesh-list
56401894|NCT00536770|Gemcitabine|gemcitabine|mesh-list
56401895|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56401896|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56401897|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
56401898|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401899|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401900|NCT00536770|Antiviral Agents|antiviral agents|mesh-ancestor
56401901|NCT00536770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401902|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401904|NCT00536770|Immunologic Factors|immunologic factors|mesh-ancestor
56401905|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401906|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56401907|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56401908|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56401909|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56401910|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56401911|NCT00536770|Vitamins|vitamins|mesh-ancestor
56401912|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
56401913|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56401914|NCT04685512|Tenofovir|tenofovir|mesh-list
56401915|NCT04685512|Emtricitabine|emtricitabine|mesh-list
56401916|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
56401917|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401918|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56401919|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56401920|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401921|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401922|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56401923|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56401924|NCT00157040|Factor VIII|factor viii|mesh-list
56401925|NCT00157040|Coagulants|coagulants|mesh-ancestor
56401926|NCT00189384|Gentamicins|gentamicins|mesh-list
56401927|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
56401928|NCT00189384|Penicillins|penicillins|mesh-list
56401929|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56401930|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
56401931|NCT00189384|Penicillin G|penicillin g|mesh-list
56401932|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56401933|NCT00189384|Procaine|procaine|mesh-list
56401934|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56401935|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401936|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56401937|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401938|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401939|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56401940|NCT00189384|Renal Agents|renal agents|mesh-ancestor
56908795|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908796|NCT02151916|Fluorides|fluorides|mesh-list
56908797|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
56908798|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
56908799|NCT02151916|Protective Agents|protective agents|mesh-ancestor
56908800|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908802|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908803|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56401941|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
56401942|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56401943|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56401944|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
56401945|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
56401946|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401947|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401948|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
56401949|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401950|NCT00536848|Metronidazole|metronidazole|mesh-list
56401951|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401952|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56401953|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56401954|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56401955|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
56401956|NCT00157079|Antibodies|antibodies|mesh-list
56401957|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
56401958|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56401959|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56401960|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
56401961|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401962|NCT00189501|Cinacalcet|cinacalcet|mesh-list
56401963|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56401964|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401965|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56401966|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
56401967|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401968|NCT00157118|Protein C|protein c|mesh-list
56401969|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
56401970|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56401971|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56401972|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401973|NCT00189579|Trastuzumab|trastuzumab|mesh-list
56401974|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56401975|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401976|NCT00157235|Bromides|bromides|mesh-list
56401977|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
56401978|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56401981|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401982|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56401983|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
56401984|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
56401985|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56401986|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
56401987|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401988|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401989|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
56401990|NCT00182520|Topiramate|topiramate|mesh-list
56401991|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
56401992|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56401993|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401994|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
56401995|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56401996|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401997|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56401998|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
56401999|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56402000|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
56402001|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402002|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56908804|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908805|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908806|NCT02152228|Teriparatide|teriparatide|mesh-list
56908807|NCT02152228|Hormones|hormones|mesh-list
56402003|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56402004|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56402005|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56402006|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402007|NCT00182559|Cyclosporine|cyclosporine|mesh-list
56402008|NCT00182559|Tacrolimus|tacrolimus|mesh-list
56402009|NCT00182559|Cyclosporins|cyclosporins|mesh-list
56402010|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402011|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
56402012|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402013|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56402014|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402015|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402016|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
56402017|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402018|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
56402019|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402020|NCT00425568|Testosterone|testosterone|mesh-list
56402021|NCT00425568|Androgens|androgens|mesh-ancestor
56402022|NCT00425568|Hormones|hormones|mesh-ancestor
56402023|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56402024|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402025|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
56402026|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56402027|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56402028|NCT00157508|Analgesics|analgesics|mesh-ancestor
56402029|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
56149631|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402030|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402031|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402032|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56402033|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402034|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56402035|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56402036|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402037|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56402038|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56402039|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
56402040|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402042|NCT00189618|Clopidogrel|clopidogrel|mesh-list
56402043|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56402044|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56402045|NCT00189618|Analgesics|analgesics|mesh-ancestor
56402046|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
56402047|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402048|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402049|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56402050|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402051|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56402061|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
56402062|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402064|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56402065|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56402066|NCT00406796|Growth Substances|growth substances|mesh-ancestor
56402067|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402068|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
56402069|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402070|NCT00534391|Polymyxins|polymyxins|mesh-list
56402071|NCT00534391|Neomycin|neomycin|mesh-list
56402072|NCT00534391|Polymyxin B|polymyxin b|mesh-list
56402073|NCT00534391|Gramicidin|gramicidin|mesh-list
56402074|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
56402075|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56402076|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56402077|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402078|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402079|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56402080|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085966|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
56908808|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
56908809|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908810|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908811|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56365454|NCT00425152|Leucovorin|leucovorin|mesh-list
56402081|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402082|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56402083|NCT00534508|Tacrolimus|tacrolimus|mesh-list
56402084|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402085|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
56402086|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402087|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56402088|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402089|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402090|NCT00182715|Leucovorin|leucovorin|mesh-list
56402091|NCT00182715|Fluorouracil|fluorouracil|mesh-list
56402092|NCT00182715|Capecitabine|capecitabine|mesh-list
56402093|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
56402094|NCT00182715|Cetuximab|cetuximab|mesh-list
56402095|NCT00182715|Calcium|calcium|mesh-list
56402096|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
56402097|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56402098|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402099|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
56402100|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402101|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56402102|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402103|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402104|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
56402105|NCT00182715|Antidotes|antidotes|mesh-ancestor
56402106|NCT00182715|Protective Agents|protective agents|mesh-ancestor
56402107|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
56402108|NCT00182715|Vitamins|vitamins|mesh-ancestor
56402109|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
56402110|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56402111|NCT00534586|Ketamine|ketamine|mesh-list
56402112|NCT00534586|Remifentanil|remifentanil|mesh-list
56402113|NCT00534586|Propofol|propofol|mesh-list
56402114|NCT00534586|Sevoflurane|sevoflurane|mesh-list
56402115|NCT00534586|Esketamine|esketamine|mesh-list
56402116|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56402117|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56402118|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402120|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
56402121|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
56402122|NCT00534586|Analgesics|analgesics|mesh-ancestor
56402123|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
56402124|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402125|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56402126|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56402127|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56402128|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402129|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402130|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56402131|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56402132|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56402133|NCT00534586|Narcotics|narcotics|mesh-ancestor
56402134|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
56402135|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56402136|NCT00534625|Zileuton|zileuton|mesh-list
56402137|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
56402138|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56402139|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56402140|NCT00534625|Analgesics|analgesics|mesh-ancestor
56402141|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
56402142|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402143|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402144|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56402145|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402146|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56402147|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908812|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56908813|NCT02152306|Amlodipine|amlodipine|mesh-list
56908814|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56402148|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402149|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56402150|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
56402151|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56402152|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402153|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
56402154|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56402155|NCT00406874|Folic Acid|folic acid|mesh-list
56402156|NCT00406874|Hematinics|hematinics|mesh-ancestor
56402157|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
56402158|NCT00406874|Vitamins|vitamins|mesh-ancestor
56402159|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
56402160|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402161|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
56402162|NCT04106830|Azathioprine|azathioprine|mesh-list
56402163|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402164|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
56402165|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402166|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402167|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56402168|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56402169|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
56402170|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402171|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402172|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402173|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402174|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
56402175|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56402176|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402177|NCT00189657|Irinotecan|irinotecan|mesh-list
56333867|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402178|NCT00189657|Fluorouracil|fluorouracil|mesh-list
56402179|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56402181|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402182|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402183|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402184|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
56402185|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56402186|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402187|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
56402188|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402189|NCT00406913|Mupirocin|mupirocin|mesh-list
56402190|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402191|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402192|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56402195|NCT00406952|Sertraline|sertraline|mesh-list
56402196|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
56402197|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56402198|NCT00406952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56402199|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56402200|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56402201|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402202|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402203|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
56402204|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402205|NCT04090879|Nicotine|nicotine|mesh-list
56402206|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56402207|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
56402208|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402209|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402210|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56402211|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56402212|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
56402213|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402214|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402215|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
56402216|NCT00157547|Citalopram|citalopram|mesh-list
56402217|NCT00157547|Fluoxetine|fluoxetine|mesh-list
56402218|NCT00157547|Paroxetine|paroxetine|mesh-list
56402219|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56365590|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402220|NCT00157547|Sertraline|sertraline|mesh-list
56402221|NCT00157547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56402222|NCT00157547|Serotonin|serotonin|mesh-list
56402223|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56402224|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56402225|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402226|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402227|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
56402228|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402229|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56402230|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
56402231|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56402232|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56402233|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56402234|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402235|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56402236|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56402237|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56402238|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56402239|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56402240|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56402241|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56402242|NCT04061161|Bromides|bromides|mesh-list
56402243|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
56402244|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56402245|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
56402246|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402247|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402248|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56163493|NCT00002430|Lamivudine|lamivudine|mesh-list
56402249|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
56402251|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56402252|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
56402253|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402254|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402255|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
56402256|NCT00157586|Manidipine|manidipine|mesh-list
56402257|NCT00157586|Delapril|delapril|mesh-list
56402258|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56402259|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56402260|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56402261|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402262|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56402263|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402265|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
56402266|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402268|NCT00182871|Androgens|androgens|mesh-ancestor
56402269|NCT00182871|Hormones|hormones|mesh-ancestor
56402270|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56402271|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402272|NCT00189774|Nateglinide|nateglinide|mesh-list
56402273|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56402274|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402275|NCT04686643|Niacin|niacin|mesh-list
56402276|NCT04686643|Amlodipine|amlodipine|mesh-list
56402277|NCT04686643|Valsartan|valsartan|mesh-list
56402278|NCT04686643|Indapamide|indapamide|mesh-list
56402279|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56402280|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56402281|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56402282|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402283|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56402284|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402285|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
56402286|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56402287|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56402288|NCT04686643|Diuretics|diuretics|mesh-ancestor
56402289|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
56402290|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56402291|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56402292|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
56908815|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56908816|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56908817|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402293|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56402294|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
56402295|NCT04686643|Vitamins|vitamins|mesh-ancestor
56402296|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
56402297|NCT00534898|Fenretinide|fenretinide|mesh-list
56402298|NCT00534898|Bexarotene|bexarotene|mesh-list
56402299|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402300|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56402301|NCT00534898|Protective Agents|protective agents|mesh-ancestor
56402302|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402303|NCT03748810|Metformin|metformin|mesh-list
56402304|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
56402305|NCT03748810|Empagliflozin|empagliflozin|mesh-list
56402306|NCT03748810|Glimepiride|glimepiride|mesh-list
56402307|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56402308|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56402309|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402310|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56402311|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402312|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56402313|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402314|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
56402315|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
56402316|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402317|NCT00157859|Chloroquine|chloroquine|mesh-list
56402318|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
56402319|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
56402320|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56402321|NCT00157859|Amebicides|amebicides|mesh-ancestor
56402322|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56402323|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56402324|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402325|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
56402326|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402327|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56402328|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402329|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402330|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56149941|NCT01619982|Vancomycin|vancomycin|mesh-list
56402332|NCT00157898|Metronidazole|metronidazole|mesh-list
56402333|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
56402334|NCT00157898|Ertapenem|ertapenem|mesh-list
56402335|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402336|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402337|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56402338|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56402339|NCT03669523|Denosumab|denosumab|mesh-list
56402340|NCT03669523|Nivolumab|nivolumab|mesh-list
56402342|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402343|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56402344|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402345|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56402346|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402347|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
56402348|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56402349|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
56402350|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
56402351|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56402352|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402353|NCT03522961|Renal Agents|renal agents|mesh-ancestor
56402354|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402355|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
56402356|NCT00158093|Atenolol|atenolol|mesh-list
56402357|NCT00158093|Nebivolol|nebivolol|mesh-list
56402358|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402359|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402360|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56402361|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56402362|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402363|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402364|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086059|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
56908818|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56908819|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908820|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
56908821|NCT02261116|Telmisartan|telmisartan|mesh-list
56402365|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402366|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56402367|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56402368|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
56402369|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
56402370|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402371|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56402372|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56402373|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56402374|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
56402375|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402376|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
56402377|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56402378|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56402379|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56402380|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56402381|NCT03429946|Spironolactone|spironolactone|mesh-list
56402382|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56402383|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
56402384|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56402385|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402386|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56402387|NCT03429946|Diuretics|diuretics|mesh-ancestor
56402388|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
56402389|NCT00158132|Amantadine|amantadine|mesh-list
56402390|NCT00158132|Propranolol|propranolol|mesh-list
56402391|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56402392|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56402393|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
56402394|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402395|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402396|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402397|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56402398|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56402399|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
56402400|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56402401|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56402402|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
56402403|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402404|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
56402405|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56402406|NCT00158132|Analgesics|analgesics|mesh-ancestor
56402408|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402409|NCT00158171|Folic Acid|folic acid|mesh-list
56402410|NCT00158171|Nicotine|nicotine|mesh-list
56402411|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56402412|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
56402413|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402414|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977000|NCT00638456|Lansoprazole|lansoprazole|mesh-list
56402428|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402429|NCT00158210|Rivastigmine|rivastigmine|mesh-list
56402430|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56402431|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402432|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402433|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
56402434|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402435|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402436|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56402437|NCT00158210|Protective Agents|protective agents|mesh-ancestor
56402438|NCT03358693|Infliximab|infliximab|mesh-list
56402439|NCT03358693|Upadacitinib|upadacitinib|mesh-list
56402440|NCT03358693|Ustekinumab|ustekinumab|mesh-list
56402441|NCT03358693|Ixekizumab|ixekizumab|mesh-list
56402442|NCT03358693|Brodalumab|brodalumab|mesh-list
56402443|NCT03358693|Abrocitinib|abrocitinib|mesh-list
56402444|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
56402445|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908822|NCT02261116|Candesartan|candesartan|mesh-list
56908823|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56908824|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56908825|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56908826|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908827|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56908828|NCT02147548|Lorazepam|lorazepam|mesh-list
56908829|NCT02147548|Etifoxine|etifoxine|mesh-list
56908830|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
56908831|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
56402446|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402447|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56402448|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56402449|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402450|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402451|NCT00190008|Piracetam|piracetam|mesh-list
56402452|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56402453|NCT00190008|Protective Agents|protective agents|mesh-ancestor
56402454|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402455|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
56402456|NCT00183222|Naltrexone|naltrexone|mesh-list
56402457|NCT00183222|Ondansetron|ondansetron|mesh-list
56402458|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56402459|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56402460|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402461|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
56402462|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402463|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
56402464|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
56402465|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56402466|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
56402467|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56402468|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56402469|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
56402470|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402471|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402472|NCT00183222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56402473|NCT00183222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56163502|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402474|NCT00183222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56402475|NCT00183222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56402476|NCT00183222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56402477|NCT00158405|Ritonavir|ritonavir|mesh-list
56402478|NCT00158405|Indinavir|indinavir|mesh-list
56402479|NCT00158405|Lamivudine|lamivudine|mesh-list
56402482|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56402483|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56402484|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
56402485|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402486|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402487|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56402488|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56402489|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
56402490|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402491|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56402492|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56402493|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56402494|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56402495|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
56402496|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56402497|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56402498|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56402499|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56402500|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56402501|NCT05275738|Niacinamide|niacinamide|mesh-list
56402502|NCT05275738|Niacin|niacin|mesh-list
56908832|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
56908833|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908834|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908835|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56908836|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56365879|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
56402503|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
56402504|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
56402505|NCT05275738|Vitamins|vitamins|mesh-ancestor
56402506|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
56402507|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402508|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56402509|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
56402510|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402511|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56402512|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
56402513|NCT00158483|Acyclovir|acyclovir|mesh-list
56402514|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
56402515|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402516|NCT00158522|Interferons|interferons|mesh-list
56402517|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
56402518|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
56402519|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56402520|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402521|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
56402522|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402523|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
56402524|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402525|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
56402526|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
56402527|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56402528|NCT00158561|Dapsone|dapsone|mesh-list
56402529|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
56402530|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
56402531|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56402532|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56402533|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402534|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56402535|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402536|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402537|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56402538|NCT00158561|Renal Agents|renal agents|mesh-ancestor
56402539|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
56402540|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402541|NCT05169229|Vancomycin|vancomycin|mesh-list
56402542|NCT05169229|Tobramycin|tobramycin|mesh-list
56402543|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402544|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402545|NCT00538018|Telithromycin|telithromycin|mesh-list
56402546|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402547|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402548|NCT00538096|Blinatumomab|blinatumomab|mesh-list
56402549|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402550|NCT00158678|Cisplatin|cisplatin|mesh-list
56402551|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402553|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56402554|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402555|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56402556|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402561|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
56402562|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56402563|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
56402564|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56402565|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402566|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56402567|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56402568|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402569|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56402570|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
56402571|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
56402572|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908837|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908838|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56402573|NCT00538330|Tamoxifen|tamoxifen|mesh-list
56402574|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56402575|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
56402576|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56402577|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402578|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56402579|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402580|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56402581|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56402582|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56402583|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56402584|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
56402585|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402586|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56402587|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56402588|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402589|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402590|NCT00538486|Metformin|metformin|mesh-list
56402591|NCT00538486|Amlodipine|amlodipine|mesh-list
56402592|NCT00538486|Telmisartan|telmisartan|mesh-list
56402593|NCT00538486|Candesartan|candesartan|mesh-list
56402594|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
56402595|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56402596|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402597|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56402598|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56402599|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56402600|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402601|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56402602|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
56402603|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56402604|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56402605|NCT00538525|Docetaxel|docetaxel|mesh-list
56402606|NCT00538525|Doxorubicin|doxorubicin|mesh-list
56402607|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402608|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
56402609|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
56402610|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
56402611|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402612|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56402613|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56402614|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56402615|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402616|NCT00538564|Tadalafil|tadalafil|mesh-list
56402617|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
56402618|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56402619|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56402620|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402621|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402622|NCT00538564|Urological Agents|urological agents|mesh-ancestor
56402623|NCT00538603|Paclitaxel|paclitaxel|mesh-list
56402624|NCT00538603|Carboplatin|carboplatin|mesh-list
56402625|NCT00538603|Doxorubicin|doxorubicin|mesh-list
56402626|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55977208|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56402628|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402629|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
56402630|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
56402631|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
56402632|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402633|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56402634|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56402635|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333868|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
56402636|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402637|NCT00158834|Fluticasone|fluticasone|mesh-list
56402638|NCT00158834|Xhance|xhance|mesh-list
56402639|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56402640|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56402641|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56402642|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
56908839|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56908840|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56908841|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
56908842|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
56402643|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402644|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402645|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56402646|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
56402647|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
56402648|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56402649|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56402650|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56402651|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56402652|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
56402653|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402654|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402655|NCT00538720|Vitamin D|vitamin d|mesh-list
56402656|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
56402657|NCT00538720|Vitamins|vitamins|mesh-ancestor
56402658|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
56402659|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402660|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56402661|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56402662|NCT00536887|Atorvastatin|atorvastatin|mesh-list
56402663|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56402664|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56402665|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
56402666|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402667|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56402668|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56402669|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402670|NCT00158873|Fentanyl|fentanyl|mesh-list
56402671|NCT00158873|Midazolam|midazolam|mesh-list
56402672|NCT00158873|Morphine|morphine|mesh-list
56402673|NCT00158873|Remifentanil|remifentanil|mesh-list
56402674|NCT00158873|Lorazepam|lorazepam|mesh-list
56402675|NCT00158873|Propofol|propofol|mesh-list
56402676|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56402677|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56402678|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402679|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56402680|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
56402681|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
56402682|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56402683|NCT00158873|Narcotics|narcotics|mesh-ancestor
56402684|NCT00158873|Analgesics|analgesics|mesh-ancestor
56402685|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
56402686|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402687|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56402688|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56402689|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56402690|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56402691|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
56402693|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402694|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402695|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
56402696|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
56402697|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
56402698|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56402699|NCT00537121|Leucovorin|leucovorin|mesh-list
56402700|NCT00537121|Fluorouracil|fluorouracil|mesh-list
56402701|NCT00537121|Irinotecan|irinotecan|mesh-list
56402702|NCT00537121|Vorinostat|vorinostat|mesh-list
56402703|NCT00537121|Calcium|calcium|mesh-list
56402704|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
56402705|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56402706|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402708|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402709|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56402710|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402711|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402712|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
56333869|NCT00063804|Ritonavir|ritonavir|mesh-list
56402713|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56402714|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56908843|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56908844|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908845|NCT03622593|Aflibercept|aflibercept|mesh-list
56908846|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56402715|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402716|NCT00537121|Antidotes|antidotes|mesh-ancestor
56402717|NCT00537121|Protective Agents|protective agents|mesh-ancestor
56402718|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
56402719|NCT00537121|Vitamins|vitamins|mesh-ancestor
56402720|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
56402721|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56402722|NCT00406991|Aspirin|aspirin|mesh-list
56402723|NCT00406991|Clopidogrel|clopidogrel|mesh-list
56402724|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56402725|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56402726|NCT00406991|Analgesics|analgesics|mesh-ancestor
56402727|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
56402728|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402729|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402730|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56402731|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402732|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56402733|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56402734|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402735|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56402736|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56402737|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402738|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
56402739|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56402740|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56402741|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56402742|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
56402743|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402744|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56402745|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56402746|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402747|NCT00158990|Sertraline|sertraline|mesh-list
56402748|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
56402749|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56402750|NCT00158990|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56402751|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56402752|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56402753|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402754|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402755|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
56402756|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402757|NCT00537355|Histamine|histamine|mesh-list
56402758|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
56402759|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
56402760|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402761|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402762|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402763|NCT00183612|Olanzapine|olanzapine|mesh-list
56402764|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
56402765|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
56402766|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402767|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402768|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56402769|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56402770|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56402771|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56402772|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56402773|NCT00183612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56402774|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56402775|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56402776|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402781|NCT00537472|Bupivacaine|bupivacaine|mesh-list
56402782|NCT00537472|Anesthetics|anesthetics|mesh-list
56402783|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
56402784|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908847|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56908848|NCT03622593|Growth Substances|growth substances|mesh-ancestor
56908849|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908850|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
56402785|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402786|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
56402787|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402788|NCT00159107|Acamprosate|acamprosate|mesh-list
56402789|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56402790|NCT00537550|Methotrexate|methotrexate|mesh-list
56402791|NCT00537550|Vincristine|vincristine|mesh-list
56402792|NCT00537550|Asparaginase|asparaginase|mesh-list
56402793|NCT00537550|Daunorubicin|daunorubicin|mesh-list
56402794|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56402795|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
56402796|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56402797|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402798|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56402799|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
56402800|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402801|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402802|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56402803|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402804|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56402805|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402806|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
56402807|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402808|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56402809|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56402810|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
56402811|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
56402812|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
56402813|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56402814|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56402815|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56402816|NCT00159146|Pindolol|pindolol|mesh-list
56402817|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56402818|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56402819|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
56402820|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402821|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402822|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402823|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56402824|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56402825|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
56402826|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
56402827|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56402828|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402829|NCT00538876|Decitabine|decitabine|mesh-list
56402830|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56402831|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
56402832|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402833|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402834|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402835|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
56402836|NCT00538954|Antacids|antacids|mesh-ancestor
56402837|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402838|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56402839|NCT00539071|Risperidone|risperidone|mesh-list
56402840|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56402841|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
56402842|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402843|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402844|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402845|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56402846|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56402847|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56402848|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56402852|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402853|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402854|NCT00183807|Celecoxib|celecoxib|mesh-list
56908851|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908852|NCT00122681|Vaccines|vaccines|mesh-list
56908853|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
56402855|NCT00183807|Irinotecan|irinotecan|mesh-list
56402856|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402857|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56402858|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56402859|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402860|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402861|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56402862|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56402863|NCT00183807|Analgesics|analgesics|mesh-ancestor
56402864|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
56402865|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402866|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402867|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56402868|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56402869|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56402870|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56402871|NCT00539773|Interferons|interferons|mesh-list
56402872|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402873|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
56402874|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402875|NCT00409461|Sirolimus|sirolimus|mesh-list
56402876|NCT00409461|Tacrolimus|tacrolimus|mesh-list
56402877|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402878|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
56402879|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402880|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56402881|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402882|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402883|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56402884|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402885|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56402886|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402887|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
56402888|NCT00539890|Insulin|insulin|mesh-list
56402889|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56402890|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402891|NCT00539968|Docetaxel|docetaxel|mesh-list
56402892|NCT00539968|Lonafarnib|lonafarnib|mesh-list
56402893|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402894|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
56402895|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
56402896|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
56402897|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402898|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402899|NCT00183846|Irinotecan|irinotecan|mesh-list
56402900|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56402901|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56402902|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402903|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402904|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402905|NCT00540085|Rocuronium|rocuronium|mesh-list
56402906|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56402907|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56402909|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402910|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402911|NCT00540202|Lumefantrine|lumefantrine|mesh-list
56402912|NCT00540202|Artemether|artemether|mesh-list
56402913|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56402914|NCT00540202|Quinine|quinine|mesh-list
56402915|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
56402916|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56402917|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56402918|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402919|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56402920|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402921|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56402922|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402923|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56402945|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402946|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908854|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402947|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56402948|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56402949|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
56402950|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402951|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56402952|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56402953|NCT00540280|Gemcitabine|gemcitabine|mesh-list
56402954|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402955|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56402956|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
56402957|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402958|NCT00540280|Antiviral Agents|antiviral agents|mesh-ancestor
56402959|NCT00540280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402960|NCT00540280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402961|NCT00540280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56402962|NCT00540280|Immunologic Factors|immunologic factors|mesh-ancestor
56402963|NCT00540280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402964|NCT00183924|Carboplatin|carboplatin|mesh-list
56402965|NCT00183924|Docetaxel|docetaxel|mesh-list
56402966|NCT00183924|Estramustine|estramustine|mesh-list
56402967|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402968|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
56402969|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
56402970|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
56402971|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402972|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56402973|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
56402974|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56402975|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
56402976|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56402977|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
55977576|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56402992|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402994|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
56402995|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56402996|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402997|NCT00540787|Quinidine|quinidine|mesh-list
56402998|NCT00540787|Amiodarone|amiodarone|mesh-list
56402999|NCT00540787|Sotalol|sotalol|mesh-list
56403000|NCT00540787|Flecainide|flecainide|mesh-list
56403001|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56403002|NCT00540787|Propafenone|propafenone|mesh-list
56403003|NCT00540787|Dofetilide|dofetilide|mesh-list
56403004|NCT00540787|Cifenline|cifenline|mesh-list
56403005|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
56403006|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56403007|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403008|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
56403009|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56403010|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403011|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403012|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56403013|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56403014|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56403015|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403016|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56403017|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56403018|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56403019|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56403020|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56403021|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
56403022|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403023|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
56403024|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
56403025|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403026|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56403027|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56403028|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
56403029|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56403030|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56403031|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403032|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56403033|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56908855|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56908856|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403034|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
56403035|NCT00159380|Pimagedine|pimagedine|mesh-list
56403036|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977630|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56403043|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
56403044|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403045|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403047|NCT00540943|Cetuximab|cetuximab|mesh-list
56403048|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56403049|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56403050|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403051|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403052|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403053|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56403054|NCT00159458|Gemcitabine|gemcitabine|mesh-list
56403055|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
56403056|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56403057|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
56403058|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403059|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403060|NCT00159458|Antiviral Agents|antiviral agents|mesh-ancestor
56403061|NCT00159458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403062|NCT00159458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403063|NCT00159458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403064|NCT00159458|Immunologic Factors|immunologic factors|mesh-ancestor
56403065|NCT00159458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403066|NCT00541021|Gemcitabine|gemcitabine|mesh-list
56403067|NCT00541021|Sorafenib|sorafenib|mesh-list
56403068|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56403069|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
56403070|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403071|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403072|NCT00541021|Antiviral Agents|antiviral agents|mesh-ancestor
56403073|NCT00541021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403074|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403075|NCT00541021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403076|NCT00541021|Immunologic Factors|immunologic factors|mesh-ancestor
56403077|NCT00541021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403078|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56403079|NCT00541138|Tamoxifen|tamoxifen|mesh-list
56403080|NCT00541138|Carboplatin|carboplatin|mesh-list
56403081|NCT00541138|Topotecan|topotecan|mesh-list
56403082|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403083|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403084|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56403085|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56403086|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403087|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56403088|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
56403089|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56403091|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56403092|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56403093|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56403094|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56403095|NCT00541177|Atropine|atropine|mesh-list
56403096|NCT00541177|Tropicamide|tropicamide|mesh-list
56403097|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56403098|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56403099|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56403100|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
56403101|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403102|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403103|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55977689|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
56403139|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
56403140|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
56403141|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
56403142|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403143|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56403145|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56403146|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56908857|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56908858|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908859|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908860|NCT05666349|Niraparib|niraparib|mesh-list
56366464|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56403147|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56403148|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56403149|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403150|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56403152|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56403153|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56403154|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56403155|NCT00541489|Analgesics|analgesics|mesh-ancestor
56403156|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
56403157|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403158|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403159|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56403160|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403161|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
56403162|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56403163|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403164|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403165|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56403166|NCT00190437|Amoxicillin|amoxicillin|mesh-list
56403167|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56403168|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403169|NCT00159575|Metformin|metformin|mesh-list
56403170|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56403171|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403172|NCT00541567|Ibipinabant|ibipinabant|mesh-list
56403173|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56403174|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56403175|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403176|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403177|NCT00541567|Hormones|hormones|mesh-ancestor
56403178|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56403179|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403180|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
56403181|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56403182|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56403183|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56403184|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403185|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403186|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
56403187|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403188|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403190|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403191|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56403192|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56403193|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403194|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403195|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56403196|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403197|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403198|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
56403199|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403200|NCT00159614|Rolofylline|rolofylline|mesh-list
56403201|NCT00159614|Diuretics|diuretics|mesh-ancestor
56403202|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
56403203|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403204|NCT00541840|Sorafenib|sorafenib|mesh-list
56403205|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403206|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56403207|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403208|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403209|NCT00190476|Docetaxel|docetaxel|mesh-list
56403210|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908861|NCT05666349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56908862|NCT05666349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908863|NCT05666349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908864|NCT05666349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403211|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
56403212|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
56403213|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
56403214|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403215|NCT00159653|Timolol|timolol|mesh-list
56403216|NCT00159653|Latanoprost|latanoprost|mesh-list
56403218|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56403219|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
56403220|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403221|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403222|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403223|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56403224|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56403225|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56403226|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56403227|NCT00541918|Propofol|propofol|mesh-list
56403228|NCT00541918|Sevoflurane|sevoflurane|mesh-list
56403229|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56403230|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56403231|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403232|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56403233|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
56403234|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
56403235|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56403236|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56403237|NCT00190515|Leucovorin|leucovorin|mesh-list
56403239|NCT00190515|Antidotes|antidotes|mesh-ancestor
56403240|NCT00190515|Protective Agents|protective agents|mesh-ancestor
56403241|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403242|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
56403243|NCT00190515|Vitamins|vitamins|mesh-ancestor
56403244|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
56403245|NCT00159692|Amlodipine|amlodipine|mesh-list
56403246|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56403247|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56403248|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403249|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403250|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56403251|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403252|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
56403253|NCT00542074|Ethanol|ethanol|mesh-list
56403254|NCT00542074|Emollients|emollients|mesh-list
56403255|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
56403256|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56403257|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403258|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56403259|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403260|NCT00542152|Cyclosporine|cyclosporine|mesh-list
56403261|NCT00542152|Infliximab|infliximab|mesh-list
56403262|NCT00542152|Cyclosporins|cyclosporins|mesh-list
56403263|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403264|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403265|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403266|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
56403267|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403268|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
56403269|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403270|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
56403271|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403272|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56403273|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56403274|NCT00159731|Pregabalin|pregabalin|mesh-list
56403275|NCT00159731|Analgesics|analgesics|mesh-ancestor
56403276|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
56403277|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403278|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403279|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
56908865|NCT03733275|Lidocaine|lidocaine|mesh-list
56908866|NCT03733275|Bupivacaine|bupivacaine|mesh-list
56908867|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
56908868|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
56908869|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56908870|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908871|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
56908872|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56908873|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56908874|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56908875|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56908876|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56908877|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908878|NCT03542422|Apatinib|apatinib|mesh-list
56908879|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403280|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56403281|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403282|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403283|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56403284|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56403285|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56403286|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56403287|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403288|NCT00408915|Lisuride|lisuride|mesh-list
56403289|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56403290|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56403291|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56403292|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
56403294|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403295|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403296|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
56403297|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
56403298|NCT00542347|Esomeprazole|esomeprazole|mesh-list
56403300|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56403301|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56403302|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56403303|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403304|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403305|NCT00190554|Cisplatin|cisplatin|mesh-list
56403306|NCT00190554|Fluorouracil|fluorouracil|mesh-list
56403307|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403308|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
56403309|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403310|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56403311|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403312|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
56150915|NCT01749930|Timolol|timolol|mesh-list
56403313|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403314|NCT00159770|Olanzapine|olanzapine|mesh-list
56403315|NCT00159770|Risperidone|risperidone|mesh-list
56403316|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56403317|NCT00159770|Ziprasidone|ziprasidone|mesh-list
56403318|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56403319|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
56403320|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403321|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403322|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403323|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56403324|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56086172|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
56908880|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56908881|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366670|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
56403325|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56403326|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403327|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56403328|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
56403329|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
56403330|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
56403331|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403332|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56403333|NCT00159770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56403334|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56403335|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403336|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
56403337|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56403338|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56403339|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
56403340|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56403341|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403342|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56403343|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56403344|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56403345|NCT00542893|Dacarbazine|dacarbazine|mesh-list
56403346|NCT00542893|Oblimersen|oblimersen|mesh-list
56403347|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56403348|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
56403349|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403350|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403351|NCT00184041|Cytarabine|cytarabine|mesh-list
56403352|NCT00184041|Prednisone|prednisone|mesh-list
56403353|NCT00184041|Methotrexate|methotrexate|mesh-list
56403354|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
56403355|NCT00184041|Vincristine|vincristine|mesh-list
56403356|NCT00184041|Daunorubicin|daunorubicin|mesh-list
56403357|NCT00184041|Asparaginase|asparaginase|mesh-list
56403358|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
56403359|NCT00184041|Thioguanine|thioguanine|mesh-list
56403360|NCT00184041|Pegaspargase|pegaspargase|mesh-list
56403361|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56403362|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
56403363|NCT00184041|Hormones|hormones|mesh-ancestor
56403364|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56403365|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403366|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56403371|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56403372|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
56403373|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403374|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
56403375|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403376|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56403377|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403378|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
56403379|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403380|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56403381|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56403382|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
56403383|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56403384|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56403385|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
56403386|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
56403387|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
56150991|NCT01760304|Hormones|hormones|mesh-ancestor
56403388|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
56403389|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403390|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56403391|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56403392|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56403393|NCT00543049|Sunitinib|sunitinib|mesh-list
56403394|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403395|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56403396|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56403397|NCT00543049|Growth Substances|growth substances|mesh-ancestor
56908882|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908883|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56908884|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
56908885|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56908886|NCT02153866|Vaccines|vaccines|mesh-list
56908887|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
56908888|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403398|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403399|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
56403400|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56403401|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403402|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403403|NCT04685005|Caffeine|caffeine|mesh-list
56403404|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56403405|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403406|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56403407|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403408|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403409|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56403410|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56403411|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
56403412|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403413|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56403414|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56403415|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56403416|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403417|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403418|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403419|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403420|NCT00190632|Analgesics|analgesics|mesh-ancestor
56403421|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
56403422|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403423|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
56403424|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403425|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
56403426|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56403427|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56403428|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
56403429|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403430|NCT00543205|Oblimersen|oblimersen|mesh-list
56403431|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403432|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
56403433|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403435|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56403436|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56403437|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403438|NCT00159809|Urological Agents|urological agents|mesh-ancestor
56403439|NCT00543244|Interferons|interferons|mesh-list
56403441|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
56403442|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56403443|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403444|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
56403445|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403446|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
56403447|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403448|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
56403449|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403450|NCT00190710|Gemcitabine|gemcitabine|mesh-list
56403451|NCT00190710|Carboplatin|carboplatin|mesh-list
56403452|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403453|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56403454|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
56403455|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403456|NCT00190710|Antiviral Agents|antiviral agents|mesh-ancestor
56403457|NCT00190710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403458|NCT00190710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908889|NCT03645057|Tacrolimus|tacrolimus|mesh-list
56908890|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56908891|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
56908892|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403459|NCT00190710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403460|NCT00190710|Immunologic Factors|immunologic factors|mesh-ancestor
56151068|NCT01778634|Azithromycin|azithromycin|mesh-list
56403461|NCT00190710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403462|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
56403463|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
56403464|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56403465|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56403466|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403467|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56403468|NCT03456661|Analgesics|analgesics|mesh-ancestor
56403469|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
56403470|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403471|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56403472|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56403473|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56403474|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
56403475|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403476|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403477|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
56403478|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
56403479|NCT03456544|Vancomycin|vancomycin|mesh-list
56403480|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56403481|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403482|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
56403483|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403484|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
56403485|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56403486|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56403487|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403488|NCT00159887|Urological Agents|urological agents|mesh-ancestor
56403489|NCT00543361|Metformin|metformin|mesh-list
56403490|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56403491|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403492|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56403493|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403494|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56403495|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56403496|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56403497|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
56403498|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56403499|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403500|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56403501|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56403502|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56403503|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403504|NCT00543634|Estrogens|estrogens|mesh-ancestor
56403505|NCT00543634|Hormones|hormones|mesh-ancestor
56403506|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56403508|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56403509|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403510|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403511|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
56403512|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403513|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403514|NCT00543829|Tamoxifen|tamoxifen|mesh-list
56403515|NCT00543829|Docetaxel|docetaxel|mesh-list
56403516|NCT00543829|Doxorubicin|doxorubicin|mesh-list
56403517|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56403518|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403519|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
56403520|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
56403521|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
56403522|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403523|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56403524|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56908893|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56908894|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908895|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403525|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56403526|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403527|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56403528|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
56403529|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56403530|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403531|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56403532|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56403533|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56403534|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56403535|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56403536|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56403537|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56403538|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403539|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403540|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403541|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403542|NCT00190827|Analgesics|analgesics|mesh-ancestor
56403543|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
56403544|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403545|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
56403546|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403547|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
56403548|NCT00160043|Vatalanib|vatalanib|mesh-list
56403549|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56403550|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403551|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403552|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
56403554|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403555|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56403556|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56403557|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403558|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403559|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
56403560|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56403561|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403562|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403563|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56403564|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403565|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56403566|NCT00544219|Prednisone|prednisone|mesh-list
56403567|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
56403568|NCT00544219|Rituximab|rituximab|mesh-list
56403569|NCT00544219|Doxorubicin|doxorubicin|mesh-list
56403570|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56403571|NCT00544219|Vincristine|vincristine|mesh-list
56403572|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403573|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
56403574|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403575|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403576|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56403577|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
56403578|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403579|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403580|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56403581|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56403582|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56403583|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56403584|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56403585|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403586|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56403587|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
56403588|NCT00544219|Hormones|hormones|mesh-ancestor
56403589|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56403590|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56908896|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
56908897|NCT04863430|Apatinib|apatinib|mesh-list
56908898|NCT04863430|Tegafur|tegafur|mesh-list
56403591|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56403592|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
56403593|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
56403594|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
56403595|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56403596|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56403597|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56403598|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403599|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403600|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403601|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403602|NCT00190866|Analgesics|analgesics|mesh-ancestor
56403603|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
56403604|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403605|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
56403606|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403607|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
56403608|NCT00160160|Eprosartan|eprosartan|mesh-list
56403609|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56403610|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
56403611|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56403612|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403613|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
56403614|NCT00544570|Melphalan|melphalan|mesh-list
56403615|NCT00544570|Carmustine|carmustine|mesh-list
56403616|NCT00544570|Etoposide|etoposide|mesh-list
56403617|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403618|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
56403619|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403620|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403621|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56403622|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
56403623|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403624|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403625|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56403626|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56403627|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56403628|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56403629|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403630|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56403631|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56403632|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56403633|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403634|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403635|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403636|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403637|NCT00190905|Analgesics|analgesics|mesh-ancestor
56403638|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
56403639|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403640|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
56403641|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403642|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
56403643|NCT00544609|Sorafenib|sorafenib|mesh-list
56403644|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403645|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56403646|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403647|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403648|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
56403649|NCT00544687|Nortriptyline|nortriptyline|mesh-list
56403650|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56403653|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56403654|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
56403655|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403656|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56403657|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56403658|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403659|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908899|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908900|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56403660|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
56403661|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403662|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403664|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
56403665|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
56403666|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
56403667|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403668|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403669|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403670|NCT00544804|Lapatinib|lapatinib|mesh-list
56403671|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403672|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56403673|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403674|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403675|NCT00160277|Moxonidine|moxonidine|mesh-list
56403676|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56403677|NCT02963181|Melatonin|melatonin|mesh-list
56403678|NCT02963181|Yohimbine|yohimbine|mesh-list
56403679|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
56403680|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403682|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403683|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56403684|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
56403685|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
56403686|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403687|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56403688|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56403689|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56403690|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
56403691|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403692|NCT02963181|Urological Agents|urological agents|mesh-ancestor
56403693|NCT00544999|Cytarabine|cytarabine|mesh-list
56403694|NCT00544999|Everolimus|everolimus|mesh-list
56403695|NCT00544999|Daunorubicin|daunorubicin|mesh-list
56403696|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56403697|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
56403698|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403699|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403700|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
56403701|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403702|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403703|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
56403704|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403705|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56403706|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56403707|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56403708|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403709|NCT00160316|Estradiol|estradiol|mesh-list
56403710|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
56403711|NCT00160316|Estrogens|estrogens|mesh-ancestor
56403712|NCT00160316|Hormones|hormones|mesh-ancestor
56403713|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56403714|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403715|NCT00160316|Progestins|progestins|mesh-ancestor
56403716|NCT00545194|Dinoprostone|dinoprostone|mesh-list
56403717|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
56403718|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56403719|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403720|NCT00190944|Teriparatide|teriparatide|mesh-list
56403721|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56403722|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403723|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56403724|NCT03456466|Rituximab|rituximab|mesh-list
56403733|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403734|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403735|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403736|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
56403737|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403738|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56403739|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
56403740|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56908901|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403741|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
56403742|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56403743|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56403744|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56403745|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
56403746|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403747|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403748|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403749|NCT00160394|Adapalene|adapalene|mesh-list
56403750|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56403751|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56403752|NCT00160394|Analgesics|analgesics|mesh-ancestor
56403753|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
56151368|NCT01834404|Topiramate|topiramate|mesh-list
56403754|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403755|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403756|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56403757|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403758|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
56403759|NCT00191022|Paroxetine|paroxetine|mesh-list
56403760|NCT00191022|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56403761|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56403762|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403763|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403764|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403765|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
56403766|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403767|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56403768|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
56403769|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403770|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56403771|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56403772|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403773|NCT00545389|Mesalamine|mesalamine|mesh-list
56403774|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56403775|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56403776|NCT00545389|Analgesics|analgesics|mesh-ancestor
56403777|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
56403778|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403779|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403780|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56403781|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403782|NCT00545467|Aripiprazole|aripiprazole|mesh-list
56403783|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
56403784|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403785|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56403786|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56403787|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56403788|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403789|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
56403790|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
56403803|NCT00545935|Artesunate|artesunate|mesh-list
56403804|NCT00545935|Amodiaquine|amodiaquine|mesh-list
56403805|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
56403806|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56403807|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56403808|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403809|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403810|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
56403811|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
56403812|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56403813|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
56403815|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
56403816|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
56403817|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56403818|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56403819|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56403820|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403821|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403822|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403823|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403824|NCT00191061|Analgesics|analgesics|mesh-ancestor
56403825|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
56908902|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908903|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56908904|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
56908905|NCT02153944|Propranolol|propranolol|mesh-list
56403826|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403827|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
56403828|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56403829|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
56403830|NCT00160550|Levetiracetam|levetiracetam|mesh-list
56403831|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
56403832|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
56403833|NCT00160589|Levocetirizine|levocetirizine|mesh-list
56403834|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56403835|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56403836|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
56403837|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
56403838|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403839|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403840|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403841|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
56403842|NCT00546130|Cisplatin|cisplatin|mesh-list
56403843|NCT00546130|Irinotecan|irinotecan|mesh-list
56403844|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403845|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56403846|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56403847|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403848|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403849|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56403850|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
56403851|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403852|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56403853|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
56403854|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403855|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
56403856|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56403857|NCT00546130|Protective Agents|protective agents|mesh-ancestor
56403858|NCT00191178|Insulin|insulin|mesh-list
56403859|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56403860|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
56403861|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
56403862|NCT00191178|Protamines|protamines|mesh-list
56403863|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56403864|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403865|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
56403866|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403867|NCT00191178|Coagulants|coagulants|mesh-ancestor
56403868|NCT00546169|Thrombin|thrombin|mesh-list
56403869|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
56403870|NCT00546169|Coagulants|coagulants|mesh-ancestor
56403871|NCT00160628|Levetiracetam|levetiracetam|mesh-list
56403872|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
56403873|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
56403874|NCT00546286|Timolol|timolol|mesh-list
56403875|NCT00546286|Dorzolamide|dorzolamide|mesh-list
56403876|NCT00546286|Maleic acid|maleic acid|mesh-list
56403877|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403878|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403879|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56403880|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56403881|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
56403882|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403883|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403884|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56403885|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56403886|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56403887|NCT00546325|Rimonabant|rimonabant|mesh-list
56403888|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56403889|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56403890|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56403891|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403892|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403893|NCT00546325|Hormones|hormones|mesh-ancestor
56403894|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56908906|NCT02153944|Methylphenidate|methylphenidate|mesh-list
56908907|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56367252|NCT00084461|Romidepsin|romidepsin|mesh-list
56403895|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403896|NCT00546403|Modafinil|modafinil|mesh-list
56403897|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56403898|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403899|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56403900|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56403901|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56403902|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403903|NCT00546442|Metformin|metformin|mesh-list
56403904|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56403905|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403907|NCT00191256|Paclitaxel|paclitaxel|mesh-list
56403908|NCT00191256|Carboplatin|carboplatin|mesh-list
56403909|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56403910|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403911|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56403912|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56403913|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56403914|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403915|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56403916|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
56403917|NCT00191256|Antiviral Agents|antiviral agents|mesh-ancestor
56403918|NCT00191256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403919|NCT00191256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403920|NCT00191256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403921|NCT00191256|Immunologic Factors|immunologic factors|mesh-ancestor
56403922|NCT00191256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403923|NCT00546520|Ciclesonide|ciclesonide|mesh-list
56403924|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
56403925|NCT00546520|Hormones|hormones|mesh-ancestor
56403926|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56403927|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403928|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56403929|NCT00546559|Simvastatin|simvastatin|mesh-list
56403930|NCT00546559|Pravastatin|pravastatin|mesh-list
56403931|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56403935|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56403936|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56403937|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403938|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56403939|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56403940|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56403942|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403943|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56403944|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56403945|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403946|NCT00546676|Telithromycin|telithromycin|mesh-list
56403947|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56403948|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403949|NCT00546832|Celecoxib|celecoxib|mesh-list
56403950|NCT00546832|Diclofenac|diclofenac|mesh-list
56403951|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56403952|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56403953|NCT00546832|Analgesics|analgesics|mesh-ancestor
56403954|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
56403955|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56403956|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403957|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56403958|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403959|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56403960|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56403961|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403962|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403963|NCT00184587|Candesartan|candesartan|mesh-list
56403964|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
56403965|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
56403966|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56403967|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55888004|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56908908|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403968|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56403969|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403970|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56403971|NCT00547144|Gemcitabine|gemcitabine|mesh-list
56403972|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56403973|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
56403974|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403975|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403976|NCT00547144|Antiviral Agents|antiviral agents|mesh-ancestor
56403977|NCT00547144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56403978|NCT00547144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403979|NCT00547144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403980|NCT00547144|Immunologic Factors|immunologic factors|mesh-ancestor
56403981|NCT00547144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403982|NCT00547183|Tadalafil|tadalafil|mesh-list
56403983|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
56403984|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56403985|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56403986|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56403987|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403988|NCT00547183|Urological Agents|urological agents|mesh-ancestor
56403989|NCT00184626|Insulin|insulin|mesh-list
56403990|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56403991|NCT00184626|Metformin|metformin|mesh-list
56403992|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
56403993|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
56403994|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
56403995|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56403996|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403997|NCT00547417|Tadalafil|tadalafil|mesh-list
56403998|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
56403999|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56404000|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56404001|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978605|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404008|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404009|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
56404010|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404011|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404012|NCT00547495|Tadalafil|tadalafil|mesh-list
56404013|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
56404014|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56404015|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56404016|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404017|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404018|NCT00547495|Urological Agents|urological agents|mesh-ancestor
56404019|NCT02277223|Curcumin|curcumin|mesh-list
56404020|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56404021|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56404022|NCT02277223|Analgesics|analgesics|mesh-ancestor
56404023|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
56404024|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404025|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404026|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56404027|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404028|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404029|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404030|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404031|NCT00547573|Tadalafil|tadalafil|mesh-list
56404032|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
56404033|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56404034|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56404035|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404036|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404037|NCT00547573|Urological Agents|urological agents|mesh-ancestor
56404038|NCT00191373|Gemcitabine|gemcitabine|mesh-list
56404039|NCT00191373|Trastuzumab|trastuzumab|mesh-list
56404040|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56404041|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
56404042|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404043|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404044|NCT00191373|Antiviral Agents|antiviral agents|mesh-ancestor
56908909|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56908910|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56908911|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56908912|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908913|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
56908914|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56908915|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56404045|NCT00191373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404046|NCT00191373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404047|NCT00191373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404048|NCT00191373|Immunologic Factors|immunologic factors|mesh-ancestor
56404049|NCT00191373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404050|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404051|NCT00547612|Substance P|substance p|mesh-list
56404052|NCT00547612|Neurokinin A|neurokinin a|mesh-list
56151668|NCT04774068|Romidepsin|romidepsin|mesh-list
56404053|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404054|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404055|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404057|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56404058|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56404059|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56404060|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
56404061|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
56404062|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404063|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404064|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404065|NCT00184665|Insulin|insulin|mesh-list
56404066|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56404067|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
56404069|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
56404070|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
56404071|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
56404072|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56404073|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404074|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
56404075|NCT04983238|Trastuzumab|trastuzumab|mesh-list
56404076|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404077|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404078|NCT04983238|Antidotes|antidotes|mesh-ancestor
56404079|NCT04983238|Protective Agents|protective agents|mesh-ancestor
56404080|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404081|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
56404082|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404083|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
56404084|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56404085|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404086|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
56404087|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
56404088|NCT04974385|Bupivacaine|bupivacaine|mesh-list
56404089|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
56404090|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
56404091|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56404092|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404093|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
56404094|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404095|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
56404096|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56404097|NCT00547885|Narcotics|narcotics|mesh-ancestor
56404098|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56404099|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404100|NCT00547885|Analgesics|analgesics|mesh-ancestor
56404101|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
56404102|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404103|NCT00161018|Risperidone|risperidone|mesh-list
56404104|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56404105|NCT00161018|Fluphenazine|fluphenazine|mesh-list
56404106|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
56908916|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56908917|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
56908918|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56908919|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56908920|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
56908921|NCT05665881|Phenylephrine|phenylephrine|mesh-list
56908922|NCT05665881|Oxymetazoline|oxymetazoline|mesh-list
56908923|NCT05665881|Norepinephrine|norepinephrine|mesh-list
56908924|NCT05665881|Ephedrine|ephedrine|mesh-list
56908925|NCT05665881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56908926|NCT05665881|Mydriatics|mydriatics|mesh-ancestor
56908927|NCT05665881|Autonomic Agents|autonomic agents|mesh-ancestor
56908928|NCT05665881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404107|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
56404108|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56404109|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
56404110|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404111|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404112|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404113|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56404114|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56404115|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56404116|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56404117|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56404118|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
56404119|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
56404120|NCT00191412|Pemetrexed|pemetrexed|mesh-list
56404121|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404122|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404123|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404124|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56404125|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56404126|NCT00548002|Levofloxacin|levofloxacin|mesh-list
56404127|NCT00548002|Ofloxacin|ofloxacin|mesh-list
56404128|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
56404129|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56404130|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404131|NCT00548002|Renal Agents|renal agents|mesh-ancestor
56404132|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56404133|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56404134|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56404135|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404136|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404137|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404138|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56404139|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56404140|NCT00191490|Gemcitabine|gemcitabine|mesh-list
56404141|NCT00191490|Docetaxel|docetaxel|mesh-list
56404142|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404143|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56404163|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56404164|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404165|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404166|NCT00184821|Glyburide|glyburide|mesh-list
56404167|NCT00184821|Adenosine|adenosine|mesh-list
56404168|NCT00184821|Diazoxide|diazoxide|mesh-list
56404169|NCT00184821|Annexin A5|annexin a5|mesh-list
56404170|NCT00184821|Analgesics|analgesics|mesh-ancestor
56404171|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
56404172|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404173|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404174|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56404175|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
56404176|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56404177|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
56404178|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
56908929|NCT05665881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908930|NCT05665881|Sympathomimetics|sympathomimetics|mesh-ancestor
56404179|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404180|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404181|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56404182|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56404183|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404185|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
56404186|NCT00548509|Menatetrenone|menatetrenone|mesh-list
56404187|NCT00548509|Vitamins|vitamins|mesh-ancestor
56404188|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
56404189|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404190|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56404191|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56404192|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404193|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
56404194|NCT00548509|Coagulants|coagulants|mesh-ancestor
56404195|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
56404196|NCT00548704|Razoxane|razoxane|mesh-list
56404197|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404198|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56404199|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56404200|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56404201|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404202|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404205|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
56404206|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
56404208|NCT00184899|Calcium heparin|calcium heparin|mesh-list
56404209|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56404210|NCT00184899|Glycerol|glycerol|mesh-list
56404211|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
56404212|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56404213|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56404214|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404215|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56404216|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56404217|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56404218|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56404219|NCT00184899|Protective Agents|protective agents|mesh-ancestor
56404220|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404221|NCT00548821|Cisplatin|cisplatin|mesh-list
56404222|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404223|NCT00161291|Bevacizumab|bevacizumab|mesh-list
56404224|NCT00161291|Letrozole|letrozole|mesh-list
56404225|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404226|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404227|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56404228|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56404229|NCT00161291|Growth Substances|growth substances|mesh-ancestor
56404230|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404231|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
56404232|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56404233|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56404234|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404235|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404236|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56404237|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
56404238|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56404239|NCT00548899|Sorafenib|sorafenib|mesh-list
56404240|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404241|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56404242|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404243|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404244|NCT00191568|Gemcitabine|gemcitabine|mesh-list
56404245|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
56404246|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56404247|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
56404248|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404249|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404250|NCT00191568|Antiviral Agents|antiviral agents|mesh-ancestor
56404251|NCT00191568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404252|NCT00191568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404253|NCT00191568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56908931|NCT05665881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56908932|NCT05665881|Nasal Decongestants|nasal decongestants|mesh-ancestor
56908933|NCT05665881|Respiratory System Agents|respiratory system agents|mesh-ancestor
56908934|NCT05665881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56908935|NCT05665881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56908936|NCT05665881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56367593|NCT00085163|Leucovorin|leucovorin|mesh-list
56404254|NCT00191568|Immunologic Factors|immunologic factors|mesh-ancestor
56404255|NCT00191568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404257|NCT00548938|Carmustine|carmustine|mesh-list
56404258|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56404259|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
56404260|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404261|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404262|NCT00161330|Amoxicillin|amoxicillin|mesh-list
56404263|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
56404264|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
56404265|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
56404266|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56404267|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404268|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404269|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404270|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56404271|NCT04939480|Atezolizumab|atezolizumab|mesh-list
56404272|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404273|NCT00184938|Morphine|morphine|mesh-list
56404274|NCT00184938|Naloxone|naloxone|mesh-list
56404275|NCT00184938|Annexin A5|annexin a5|mesh-list
56404276|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56404277|NCT00184938|Narcotics|narcotics|mesh-ancestor
55978874|NCT00800839|Busulfan|busulfan|mesh-list
56404285|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404286|NCT00549133|Irbesartan|irbesartan|mesh-list
56404287|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56404288|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56404289|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56404290|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404291|NCT00191607|Gemcitabine|gemcitabine|mesh-list
56404292|NCT00191607|Doxorubicin|doxorubicin|mesh-list
56404293|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56404294|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56404295|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
56404296|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404297|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404298|NCT00191607|Antiviral Agents|antiviral agents|mesh-ancestor
56404299|NCT00191607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404300|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404301|NCT00191607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404302|NCT00191607|Immunologic Factors|immunologic factors|mesh-ancestor
56404303|NCT00191607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404304|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56404305|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56404306|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56404307|NCT00549289|Cyclosporine|cyclosporine|mesh-list
56404308|NCT00549289|Cyclosporins|cyclosporins|mesh-list
56404309|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404310|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404311|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404312|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
56404313|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163599|NCT00002478|Etoposide|etoposide|mesh-list
56404314|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
56404315|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404316|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
56404317|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404318|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56404319|NCT00184977|Fluticasone|fluticasone|mesh-list
56404320|NCT00184977|Xhance|xhance|mesh-list
56404321|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
56404322|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56908937|NCT05665881|Adrenergic Agents|adrenergic agents|mesh-ancestor
56908938|NCT05665881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56908939|NCT05665881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908940|NCT05665881|Protective Agents|protective agents|mesh-ancestor
56908941|NCT05665881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56908942|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
56908943|NCT03643575|Guaifenesin|guaifenesin|mesh-list
56908944|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56908945|NCT03643575|Expectorants|expectorants|mesh-ancestor
56908946|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
56404323|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56404324|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56404325|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
56404326|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404327|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404328|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56404329|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
56404330|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
56404331|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56404332|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
56404333|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404334|NCT00184977|Expectorants|expectorants|mesh-ancestor
56404335|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56404336|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
56404337|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404338|NCT00184977|Protective Agents|protective agents|mesh-ancestor
56404339|NCT00184977|Antidotes|antidotes|mesh-ancestor
56404340|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
56404341|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404342|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
56404343|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
56404344|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
56404345|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56404346|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
56404347|NCT00161447|Testosterone|testosterone|mesh-list
56404361|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56404362|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56404363|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
56404364|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56404365|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56404366|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56404367|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56404368|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404369|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404370|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404371|NCT00191685|Analgesics|analgesics|mesh-ancestor
56404372|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
56404373|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404374|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
56404375|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56404376|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
56404377|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
56404378|NCT00161486|Testosterone|testosterone|mesh-list
56404379|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
56404380|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
56404381|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56404383|NCT00161486|Androgens|androgens|mesh-ancestor
56404384|NCT00161486|Hormones|hormones|mesh-ancestor
56404385|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56404386|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404387|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56404388|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404389|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
56404390|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
56908947|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56367725|NCT00085358|Paclitaxel|paclitaxel|mesh-list
56404391|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
56404392|NCT00549874|Glyburide|glyburide|mesh-list
56404393|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56404394|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404395|NCT00191763|Gemcitabine|gemcitabine|mesh-list
56404396|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404397|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56404398|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
56404399|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404400|NCT00191763|Antiviral Agents|antiviral agents|mesh-ancestor
56404401|NCT00191763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404402|NCT00191763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404403|NCT00191763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404404|NCT00191763|Immunologic Factors|immunologic factors|mesh-ancestor
56404405|NCT00191763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404406|NCT00161564|Rituximab|rituximab|mesh-list
56404407|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404418|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56404419|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404420|NCT00550108|Ethanol|ethanol|mesh-list
56404421|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56404422|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404423|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56404424|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404425|NCT00185094|Losartan|losartan|mesh-list
56404426|NCT00185094|Atenolol|atenolol|mesh-list
56404427|NCT00185094|Olmesartan|olmesartan|mesh-list
56404428|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56404429|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56404430|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56404431|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56404432|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56404433|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404434|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
56404435|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
56404436|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404437|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404438|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56404439|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56404440|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56404441|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
56404442|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404443|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
56404445|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56404446|NCT00550303|Hormones|hormones|mesh-ancestor
56404447|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56404448|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404449|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56404450|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56404451|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
56404452|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56404453|NCT00550342|Rituximab|rituximab|mesh-list
56404454|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404455|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404456|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
56404457|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404458|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404459|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
56404460|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56404461|NCT00161681|Estradiol|estradiol|mesh-list
56404462|NCT00161681|Estrogens|estrogens|mesh-ancestor
56404463|NCT00161681|Hormones|hormones|mesh-ancestor
56404464|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56404465|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404466|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56404467|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
56404468|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56404469|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56404470|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56404471|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56086968|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
56619609|NCT02838264|Itraconazole|itraconazole|mesh-list
56908948|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56908949|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
56404472|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56404473|NCT02963454|Simendan|simendan|mesh-list
56404482|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404483|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
56404484|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
56404485|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404486|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56404487|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56404488|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56404489|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56404490|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404491|NCT00191802|Teriparatide|teriparatide|mesh-list
56404492|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56404493|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404494|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56404495|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
56404496|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56404497|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404498|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
56404499|NCT00550810|Sunitinib|sunitinib|mesh-list
56404500|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404501|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56404502|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56404503|NCT00550810|Growth Substances|growth substances|mesh-ancestor
56404504|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152119|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
56404505|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
56404506|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56404507|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404508|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404509|NCT00191841|Gemcitabine|gemcitabine|mesh-list
56404510|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404511|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56404512|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
56404513|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404514|NCT00191841|Antiviral Agents|antiviral agents|mesh-ancestor
56404515|NCT00191841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404516|NCT00191841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404517|NCT00191841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404518|NCT00191841|Immunologic Factors|immunologic factors|mesh-ancestor
56404519|NCT00191841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404520|NCT00550927|Bevacizumab|bevacizumab|mesh-list
56404521|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404522|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404523|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56404524|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56404525|NCT00550927|Growth Substances|growth substances|mesh-ancestor
56404526|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404527|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
56404528|NCT00161720|Protein C|protein c|mesh-list
56404529|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
56404530|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56404531|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56404532|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404533|NCT00185133|Amlodipine|amlodipine|mesh-list
56404534|NCT00185133|Olmesartan|olmesartan|mesh-list
56404535|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56404536|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56404537|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56404538|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55979141|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56404540|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56404541|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404542|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
56404543|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56404544|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56404545|NCT00551005|Celecoxib|celecoxib|mesh-list
56404546|NCT00551005|Etoposide|etoposide|mesh-list
56404547|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56404548|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908950|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56908951|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367873|NCT04717102|Desflurane|desflurane|mesh-list
56404549|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56404550|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56404551|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404552|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404553|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56404554|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56404555|NCT00551005|Analgesics|analgesics|mesh-ancestor
56404556|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
56404557|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404558|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404559|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56404560|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404561|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56404562|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56404563|NCT00551044|Bicalutamide|bicalutamide|mesh-list
56404564|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
56404565|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
56404566|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56404567|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404568|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404569|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56404570|NCT00161759|Thrombin|thrombin|mesh-list
56404571|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
56404572|NCT00161759|Coagulants|coagulants|mesh-ancestor
56404573|NCT00551122|Gemcitabine|gemcitabine|mesh-list
56404574|NCT00551122|Paclitaxel|paclitaxel|mesh-list
56404575|NCT00551122|Ifosfamide|ifosfamide|mesh-list
56404576|NCT00551122|Lenograstim|lenograstim|mesh-list
56404577|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56404578|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404579|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
56404580|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
56404581|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
56404582|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404583|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56404584|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
56404585|NCT00551122|Antiviral Agents|antiviral agents|mesh-ancestor
56404586|NCT00551122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404587|NCT00551122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404588|NCT00551122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404589|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
56404590|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404591|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56404592|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56404593|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
56404595|NCT00551239|Fludarabine|fludarabine|mesh-list
56404596|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
56404597|NCT00551239|Pixantrone|pixantrone|mesh-list
56404598|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404599|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404600|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
56404601|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404602|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404603|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56404604|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
56404605|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404606|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404607|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56404608|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56404609|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404610|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56404611|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56404612|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56404627|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
56404629|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56404630|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404631|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
56404632|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367943|NCT00327145|Amlodipine|amlodipine|mesh-list
56404633|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56404634|NCT02963337|Narcotics|narcotics|mesh-ancestor
56404635|NCT02963337|Analgesics|analgesics|mesh-ancestor
56404636|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56404637|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56404638|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56404639|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56404640|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404641|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404642|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404643|NCT00191919|Analgesics|analgesics|mesh-ancestor
56404644|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
56404645|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404646|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
56404647|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56404648|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
56404649|NCT00161837|Vaccines|vaccines|mesh-list
56404650|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
56404651|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404652|NCT00551512|Cisplatin|cisplatin|mesh-list
56152266|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
56404653|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404654|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56404655|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56404656|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404657|NCT00551590|Incretins|incretins|mesh-ancestor
56404658|NCT00551590|Hormones|hormones|mesh-ancestor
56404659|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56404660|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56404661|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
56404662|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404663|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404665|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
56404666|NCT00161915|Coagulants|coagulants|mesh-ancestor
56404667|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56404668|NCT00185172|Olmesartan|olmesartan|mesh-list
56404669|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56404670|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56404671|NCT00185172|Diuretics|diuretics|mesh-ancestor
56404672|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
56404694|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
56404695|NCT00551824|Mitomycins|mitomycins|mesh-list
56404696|NCT00551824|Mitomycin|mitomycin|mesh-list
56404697|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56404698|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404699|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
56404700|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404701|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56404702|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404703|NCT00185250|Interferons|interferons|mesh-list
56404704|NCT00185250|Interferon-beta|interferon-beta|mesh-list
56404705|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
56404706|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404707|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
56404708|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404709|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
56404710|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404711|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56404712|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
56404713|NCT00161993|Antibodies|antibodies|mesh-list
56404714|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
56404715|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56404716|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56404717|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
56404718|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404719|NCT00185328|Estradiol|estradiol|mesh-list
56404720|NCT00185328|Estrogens|estrogens|mesh-ancestor
56404721|NCT00185328|Hormones|hormones|mesh-ancestor
56404722|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979345|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
56404727|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
56152352|NCT01953432|Doxazosin|doxazosin|mesh-list
56404728|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56404729|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404730|NCT00162149|Ritonavir|ritonavir|mesh-list
56404731|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56404732|NCT00162149|Nevirapine|nevirapine|mesh-list
56908952|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908953|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
56908954|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56404733|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56404734|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56404735|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
56404736|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404737|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404738|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56404739|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56404740|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
56404741|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404742|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56404743|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56404744|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56404745|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56404746|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56404747|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56404748|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
56404749|NCT00162188|Efavirenz|efavirenz|mesh-list
56404750|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56404751|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56404752|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404753|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404754|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
56404755|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404756|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56404757|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56404758|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56404759|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56404760|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56404761|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56404762|NCT00162227|Efavirenz|efavirenz|mesh-list
56404763|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56404764|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56404765|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404766|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404767|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
56404768|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404769|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56404770|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56404771|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56404772|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56404773|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56404774|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56404775|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56404776|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56404777|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404778|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56404779|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56404780|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56404781|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56404782|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404783|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404784|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404785|NCT00552682|Analgesics|analgesics|mesh-ancestor
56404786|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
56404787|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404788|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
56404809|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56404810|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56404811|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
56404812|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404813|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56404814|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56404815|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56908955|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
56908956|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
56404816|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56404817|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56404818|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404819|NCT04684498|Oseltamivir|oseltamivir|mesh-list
56404820|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
56404821|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404822|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404823|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404824|NCT00552799|Penicillins|penicillins|mesh-list
56404825|NCT00552799|Penicillin V|penicillin v|mesh-list
56404826|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56404827|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404828|NCT00409071|Sinomenine|sinomenine|mesh-list
56404829|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404830|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
56404831|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56404832|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404833|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56404834|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404835|NCT04513015|Antioxidants|antioxidants|mesh-list
56404836|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404837|NCT04513015|Protective Agents|protective agents|mesh-ancestor
56404838|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404839|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56404840|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56404856|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56404857|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
56404858|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404859|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404860|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
56404861|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56404862|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56404863|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56404864|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
56404865|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56404866|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56404867|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
56404868|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
56404869|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404870|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
56404871|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
56404872|NCT00162422|Albuterol|albuterol|mesh-list
56404873|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56404874|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
56404875|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404876|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404877|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56404878|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56404879|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
56404880|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56404881|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56404882|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56404883|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56404884|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
56404885|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404886|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404888|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
56404889|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404890|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
56404891|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
56404892|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
56404893|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404894|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404895|NCT00185445|Fludarabine|fludarabine|mesh-list
56404896|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
56404897|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404898|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56404899|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
56404909|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56163667|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
56404910|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404911|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56908957|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368163|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
56404912|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404914|NCT04202809|Durvalumab|durvalumab|mesh-list
56404915|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404916|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404917|NCT04187053|Methylene Blue|methylene blue|mesh-list
56404918|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404919|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404920|NCT00162461|Phenytoin|phenytoin|mesh-list
56404921|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
56404922|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56404923|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56404924|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56404925|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404926|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56404927|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56404928|NCT04165096|Acetaminophen|acetaminophen|mesh-list
56404929|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
56404930|NCT04165096|Promethazine|promethazine|mesh-list
56404931|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
56404932|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404933|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404934|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56404935|NCT04165096|Analgesics|analgesics|mesh-ancestor
56404936|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
56404937|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404938|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404939|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
56404940|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56404941|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56404942|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56404943|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
56404944|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
56404945|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
56152565|NCT05665140|Bortezomib|bortezomib|mesh-list
56404946|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
56404947|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56404948|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56404949|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
56404950|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
56404951|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404952|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404953|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56404954|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
56404955|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
56404956|NCT00185562|Adalimumab|adalimumab|mesh-list
56404957|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56404958|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404959|NCT04095364|Paclitaxel|paclitaxel|mesh-list
56404960|NCT04095364|Carboplatin|carboplatin|mesh-list
56404961|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56404962|NCT04095364|Letrozole|letrozole|mesh-list
56404963|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56404964|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404965|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
56404971|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404972|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56404973|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
56404974|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56404975|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404976|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
56404977|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404978|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
56404979|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404980|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404981|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56404982|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
56404983|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404984|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404985|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56404987|NCT00162695|Vincristine|vincristine|mesh-list
56404988|NCT00162695|Epirubicin|epirubicin|mesh-list
56404989|NCT00162695|Ifosfamide|ifosfamide|mesh-list
56404990|NCT00162695|Carboplatin|carboplatin|mesh-list
56908958|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
56908959|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56908960|NCT02768194|Fluorides|fluorides|mesh-list
56368234|NCT05457829|Irinotecan|irinotecan|mesh-list
56404991|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56404992|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404993|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56404994|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56404995|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404996|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404997|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56404998|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
56404999|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405000|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405001|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405002|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56405003|NCT00162734|Interferons|interferons|mesh-list
56405004|NCT00162734|Ribavirin|ribavirin|mesh-list
56405005|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
56405006|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405007|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
56405008|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405009|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
56405010|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405011|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56405012|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
56405013|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405014|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405015|NCT00162812|Epirubicin|epirubicin|mesh-list
56405016|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56405017|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405018|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56405019|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405020|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405021|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405022|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
56405023|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56405024|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405025|NCT04015414|Varenicline|varenicline|mesh-list
56405026|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56405027|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56405028|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
56405029|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405030|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405031|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405032|NCT00185835|Gefitinib|gefitinib|mesh-list
56405033|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405034|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56405039|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56405040|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405041|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405043|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
56405044|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405045|NCT00162968|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56405046|NCT00162968|Antidepressive Agents|antidepressive agents|mesh-ancestor
56405048|NCT03970330|Naltrexone|naltrexone|mesh-list
56405049|NCT03970330|Norethindrone|norethindrone|mesh-list
56405050|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
56405051|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56405052|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56405053|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405054|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
56405055|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405056|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56405057|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56405058|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56405059|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
56405060|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56405061|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56405062|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56405063|NCT03757585|Inositol|inositol|mesh-list
56405064|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
56405065|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56405066|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
56405067|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405068|NCT03757585|Expectorants|expectorants|mesh-ancestor
56405069|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
56405070|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56405071|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
56405072|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405073|NCT03757585|Protective Agents|protective agents|mesh-ancestor
56405074|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405075|NCT03757585|Antidotes|antidotes|mesh-ancestor
56405076|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
56405077|NCT03757585|Vitamins|vitamins|mesh-ancestor
56405078|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
56405079|NCT03657160|Vedolizumab|vedolizumab|mesh-list
56405080|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405081|NCT00163046|Gabapentin|gabapentin|mesh-list
56405082|NCT00163046|Analgesics|analgesics|mesh-ancestor
56405083|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
56405084|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405085|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405086|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
56405087|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56405088|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56405089|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56405090|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56405091|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56405092|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56405093|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405094|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405095|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
56405096|NCT00185952|Nifedipine|nifedipine|mesh-list
56405097|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56405098|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405099|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405100|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56405101|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405102|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
56405103|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
56405104|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56405106|NCT03541447|Tolvaptan|tolvaptan|mesh-list
56405108|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56405110|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56405111|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405112|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
56405113|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405114|NCT00192621|Lamivudine|lamivudine|mesh-list
56405115|NCT00192621|Zidovudine|zidovudine|mesh-list
56405116|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56405117|NCT00192621|Lopinavir|lopinavir|mesh-list
56405118|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56405119|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56405120|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405121|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405122|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
56405123|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405124|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56405125|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56405126|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
56405127|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56405128|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56405129|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
56405130|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56405131|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56405132|NCT03516604|Citalopram|citalopram|mesh-list
56405133|NCT03516604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56405134|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56405135|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405136|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405137|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405138|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
56405139|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405140|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56908961|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
56908962|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
56368384|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
56405141|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
56405142|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56405143|NCT00185991|Gentamicins|gentamicins|mesh-list
56405144|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56405145|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405146|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56405147|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405148|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405149|NCT03434158|Olaparib|olaparib|mesh-list
56405150|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56405151|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405152|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405153|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405154|NCT00163202|Atorvastatin|atorvastatin|mesh-list
56405155|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56405156|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56405157|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
56405158|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405159|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56405160|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56405161|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405162|NCT03318952|Lidocaine|lidocaine|mesh-list
56405163|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-list
56405164|NCT03318952|Carticaine|carticaine|mesh-list
56405165|NCT03318952|Anesthetics|anesthetics|mesh-list
56405166|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56405167|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405168|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
56405169|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405170|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56405171|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56405172|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56405173|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405174|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405176|NCT00192660|Nelfinavir|nelfinavir|mesh-list
56405177|NCT00192660|Indinavir|indinavir|mesh-list
56405178|NCT00192660|Saquinavir|saquinavir|mesh-list
56405181|NCT00192660|Lamivudine|lamivudine|mesh-list
56405182|NCT00192660|Zidovudine|zidovudine|mesh-list
56405183|NCT00192660|Nevirapine|nevirapine|mesh-list
56405184|NCT00192660|Abacavir|abacavir|mesh-list
56405185|NCT00192660|Didanosine|didanosine|mesh-list
56405186|NCT00192660|Stavudine|stavudine|mesh-list
56405187|NCT00192660|Tipranavir|tipranavir|mesh-list
56405188|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
56405189|NCT00192660|Efavirenz|efavirenz|mesh-list
56405190|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56405191|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56405192|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
56405193|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163697|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405194|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405195|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56405196|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56405197|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
56405198|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405199|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56405200|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56405201|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56405202|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56405203|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
56405204|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56405205|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56405206|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56405207|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56405208|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56405209|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56405210|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56405211|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56405212|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
56088609|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
56908963|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
56908964|NCT02768194|Protective Agents|protective agents|mesh-ancestor
56368459|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
56405213|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56405214|NCT00163241|Celecoxib|celecoxib|mesh-list
56405215|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56405216|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56405217|NCT00163241|Analgesics|analgesics|mesh-ancestor
56405218|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
56405219|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405220|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405221|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56405222|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56405223|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56405224|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56405225|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405226|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405227|NCT03016819|Dacarbazine|dacarbazine|mesh-list
56405228|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56405229|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
56405230|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405231|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405232|NCT02916316|Doxorubicin|doxorubicin|mesh-list
56405233|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56405234|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56405235|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405236|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56405237|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405238|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405239|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405240|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
56405241|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56405242|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56405243|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56405244|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56405246|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405247|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405248|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405249|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56405250|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
56405251|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56405254|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405255|NCT00163319|Ciclesonide|ciclesonide|mesh-list
56405256|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
56405257|NCT00163319|Hormones|hormones|mesh-ancestor
56405258|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405259|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405260|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56405261|NCT02812420|Durvalumab|durvalumab|mesh-list
56405262|NCT02812420|Ipilimumab|ipilimumab|mesh-list
56405263|NCT02812420|Tremelimumab|tremelimumab|mesh-list
56405264|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
56405265|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56405266|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
56405267|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56405268|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405269|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
56405270|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405271|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56405272|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405273|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
56405274|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
56405275|NCT02556931|Fludarabine|fludarabine|mesh-list
56405276|NCT02556931|Tacrolimus|tacrolimus|mesh-list
56405277|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405278|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
56405279|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405280|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56405281|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56405282|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
56405283|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908965|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908966|NCT02254954|Temozolomide|temozolomide|mesh-list
56908967|NCT02254954|Macitentan|macitentan|mesh-list
56908968|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56908969|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
56908970|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908971|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405284|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405285|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56405286|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56405287|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405288|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56405289|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56405290|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
56405291|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56405292|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405293|NCT00163358|Ciclesonide|ciclesonide|mesh-list
56405294|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
56405295|NCT00163358|Hormones|hormones|mesh-ancestor
56405296|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405297|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405298|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56405299|NCT00163397|Ciclesonide|ciclesonide|mesh-list
56405300|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
56405301|NCT00163397|Hormones|hormones|mesh-ancestor
56405302|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405303|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405304|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56405305|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56405306|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56405307|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405308|NCT00163436|Ciclesonide|ciclesonide|mesh-list
56405309|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
56405310|NCT00163436|Hormones|hormones|mesh-ancestor
56405311|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405312|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405313|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56405314|NCT00186420|Docetaxel|docetaxel|mesh-list
56405315|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405316|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405317|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405318|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405319|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405321|NCT01628029|Methylphenidate|methylphenidate|mesh-list
56405322|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
56405323|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405324|NCT01628029|Protective Agents|protective agents|mesh-ancestor
56405325|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979945|NCT02370693|Bortezomib|bortezomib|mesh-list
56405327|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56405328|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56405329|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56405330|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405331|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
56405332|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405333|NCT01269190|Proflavine|proflavine|mesh-list
56405334|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56405335|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405336|NCT00163514|Ciclesonide|ciclesonide|mesh-list
56405337|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
56405339|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405340|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405341|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56405342|NCT00717652|Triamcinolone|triamcinolone|mesh-list
56405343|NCT00717652|Tretinoin|tretinoin|mesh-list
56405344|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56405345|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
56405346|NCT00717652|Hormones|hormones|mesh-ancestor
56908972|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56405347|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405348|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405349|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405350|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
56405351|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
56405352|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
56405353|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
56405354|NCT00066040|Fluorides|fluorides|mesh-list
56405355|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
56405356|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
56405357|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
56405358|NCT00066040|Protective Agents|protective agents|mesh-ancestor
56405359|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405360|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56405361|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405362|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
56405363|NCT00163553|Meperidine|meperidine|mesh-list
56405364|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56405365|NCT00163553|Narcotics|narcotics|mesh-ancestor
56405366|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56405367|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405368|NCT00163553|Analgesics|analgesics|mesh-ancestor
56405369|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
56405370|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405371|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56405372|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56405373|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
56405374|NCT00163592|Coagulants|coagulants|mesh-ancestor
56405375|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
56405376|NCT04683445|Trastuzumab|trastuzumab|mesh-list
56405377|NCT04683445|Pertuzumab|pertuzumab|mesh-list
56405378|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56405379|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405380|NCT00192777|Capecitabine|capecitabine|mesh-list
56405381|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405382|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
56405383|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405384|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405385|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
56405386|NCT00553072|Analgesics|analgesics|mesh-ancestor
56405387|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
56405388|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405389|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405390|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
56405391|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56405392|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56153021|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56405393|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
56405394|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56405395|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405396|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405397|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56405398|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
56405399|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56405400|NCT00192855|Entacapone|entacapone|mesh-list
56405401|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56405402|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56405403|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56405404|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405405|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405406|NCT00407186|Cisplatin|cisplatin|mesh-list
56405407|NCT00407186|Capecitabine|capecitabine|mesh-list
56405408|NCT00407186|Epirubicin|epirubicin|mesh-list
56405409|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405410|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405411|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
56405412|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405413|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56405414|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56405415|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405416|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405417|NCT00163748|Gemcitabine|gemcitabine|mesh-list
56405418|NCT00163748|Vinorelbine|vinorelbine|mesh-list
56908973|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56368669|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56405419|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405420|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
56405421|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405422|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405423|NCT00163748|Antiviral Agents|antiviral agents|mesh-ancestor
56405424|NCT00163748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405425|NCT00163748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405426|NCT00163748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405427|NCT00163748|Immunologic Factors|immunologic factors|mesh-ancestor
56405428|NCT00163748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405429|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56405430|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405431|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405432|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405433|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
56405434|NCT00193011|Docetaxel|docetaxel|mesh-list
56405435|NCT00193011|Fluorouracil|fluorouracil|mesh-list
56405436|NCT00193011|Methotrexate|methotrexate|mesh-list
56405437|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405438|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
56405439|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405440|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56405441|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56405442|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
56405443|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405444|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405445|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56405446|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405447|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405448|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405449|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
56405450|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405451|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56405452|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
56405453|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56405454|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
56405455|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405456|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56405457|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56405458|NCT00193089|Docetaxel|docetaxel|mesh-list
56405459|NCT00193089|Trastuzumab|trastuzumab|mesh-list
56405460|NCT00193089|Vinorelbine|vinorelbine|mesh-list
56405461|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405462|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405463|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405464|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405465|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405466|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56405467|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56405468|NCT00193167|Topotecan|topotecan|mesh-list
56405469|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56405470|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405471|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405472|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405473|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405475|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
56405476|NCT05208307|Pomalidomide|pomalidomide|mesh-list
56405477|NCT05208307|Ichthammol|ichthammol|mesh-list
56405481|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
56405482|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405483|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405484|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405485|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
56405486|NCT05208307|Hormones|hormones|mesh-ancestor
56163705|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405487|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405488|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56405489|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405490|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
56405491|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405492|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908974|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56908975|NCT00130793|Vaccines|vaccines|mesh-list
56908976|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
56405493|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
56405494|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56405495|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56405496|NCT05208307|Growth Substances|growth substances|mesh-ancestor
56405497|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
56405498|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
56405499|NCT00193245|Docetaxel|docetaxel|mesh-list
56405500|NCT00193245|Topotecan|topotecan|mesh-list
56405501|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405502|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405503|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405504|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405505|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405506|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56405507|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405508|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405509|NCT00193284|Carboplatin|carboplatin|mesh-list
56405510|NCT00193284|Docetaxel|docetaxel|mesh-list
56405511|NCT00193284|Fluorouracil|fluorouracil|mesh-list
56405512|NCT00193284|Gefitinib|gefitinib|mesh-list
56405513|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405514|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405515|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405516|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405517|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405518|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
56405519|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405520|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405521|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
56405522|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405523|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56405524|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405525|NCT00163982|Norfloxacin|norfloxacin|mesh-list
56405526|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56405527|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405528|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56405529|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405530|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405531|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405532|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405533|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56405534|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56405535|NCT00193323|Gemcitabine|gemcitabine|mesh-list
56405536|NCT00193323|Docetaxel|docetaxel|mesh-list
56405537|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405538|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
56405539|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405540|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405541|NCT00193323|Antiviral Agents|antiviral agents|mesh-ancestor
56405542|NCT00193323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405543|NCT00193323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153184|NCT01965366|Hormones|hormones|mesh-ancestor
56405544|NCT00193323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405545|NCT00193323|Immunologic Factors|immunologic factors|mesh-ancestor
56405546|NCT00193323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405547|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405548|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405549|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405552|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405554|NCT00193362|Paclitaxel|paclitaxel|mesh-list
56405555|NCT00193362|Vinorelbine|vinorelbine|mesh-list
56405556|NCT00193362|Carboplatin|carboplatin|mesh-list
56405557|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56405558|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405559|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405560|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405561|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405562|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405563|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405564|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
56405565|NCT00193362|Antiviral Agents|antiviral agents|mesh-ancestor
56908977|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56908978|NCT03732105|Apatinib|apatinib|mesh-list
56908979|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56908980|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56908981|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56908982|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405566|NCT00193362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405567|NCT00193362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405568|NCT00193362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405569|NCT00193362|Immunologic Factors|immunologic factors|mesh-ancestor
56405570|NCT00193362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405572|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56405573|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405574|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405575|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405576|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405577|NCT00553189|Topotecan|topotecan|mesh-list
56405578|NCT00553189|Veliparib|veliparib|mesh-list
56405579|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56405580|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405581|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405582|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405583|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405584|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56405585|NCT00193440|Rituximab|rituximab|mesh-list
56405586|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56405587|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405588|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
56405589|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405590|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56405591|NCT05077969|Celecoxib|celecoxib|mesh-list
56405592|NCT05077969|Famotidine|famotidine|mesh-list
56405593|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56405594|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56405595|NCT05077969|Analgesics|analgesics|mesh-ancestor
56405596|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
56405597|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405598|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405599|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56405600|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56405601|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56405602|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56405603|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405604|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405605|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56405606|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405607|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56405608|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
56405609|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
56405610|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405611|NCT05063734|Aflibercept|aflibercept|mesh-list
56405612|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56405613|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56405614|NCT05063734|Growth Substances|growth substances|mesh-ancestor
56153246|NCT01988922|Analgesics|analgesics|mesh-ancestor
56405615|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405616|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
56405617|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405618|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
56405619|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405621|NCT00164216|Mefloquine|mefloquine|mesh-list
56405622|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
56405623|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56405624|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56405625|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405626|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405629|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56405630|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
56405632|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405633|NCT00164255|Artesunate|artesunate|mesh-list
56405634|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
56908983|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908984|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56908985|NCT03732105|Growth Substances|growth substances|mesh-ancestor
56908986|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405635|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
56405636|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
56405637|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56405638|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56405639|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405640|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405641|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
56405642|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
56405643|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56405644|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
56405645|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56405646|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405647|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405648|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56405649|NCT00164255|Renal Agents|renal agents|mesh-ancestor
56405650|NCT04683406|Oseltamivir|oseltamivir|mesh-list
56405651|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
56405652|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405653|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405654|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405655|NCT00409656|Basiliximab|basiliximab|mesh-list
56405656|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405657|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
56405658|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405659|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
56405660|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56405661|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
56405662|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405663|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405664|NCT04977232|Citalopram|citalopram|mesh-list
56405665|NCT04977232|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56405666|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56405667|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405668|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405669|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405670|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
56405671|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405672|NCT04977232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56405673|NCT04977232|Antidepressive Agents|antidepressive agents|mesh-ancestor
56405674|NCT04977232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56405675|NCT04974814|Atorvastatin|atorvastatin|mesh-list
56405676|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56405677|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56405678|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56405679|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
56405680|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405681|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56405682|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56405683|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405684|NCT00164411|Vaccines|vaccines|mesh-list
56405685|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56405686|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
56405687|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405688|NCT04910815|Rifaximin|rifaximin|mesh-list
56405689|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56405690|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405691|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405692|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
56405693|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56405694|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405695|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56405696|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
56405697|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56405698|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405699|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405700|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56908987|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
56908988|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
56908989|NCT02154334|Phenylephrine|phenylephrine|mesh-list
56908990|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
56908991|NCT02154334|Esketamine|esketamine|mesh-list
56405701|NCT04902703|Molgramostim|molgramostim|mesh-list
56405702|NCT04902703|Sargramostim|sargramostim|mesh-list
56163710|NCT00002520|Nicotine|nicotine|mesh-list
56405703|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
56405704|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405705|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405706|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
56405707|NCT00193674|Progestins|progestins|mesh-ancestor
56405708|NCT00193674|Hormones|hormones|mesh-ancestor
56405709|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405710|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405711|NCT04899778|Iron|iron|mesh-list
56405712|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56405713|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56405714|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
56405715|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
56405716|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56405717|NCT04899778|Estradiol|estradiol|mesh-list
56405718|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56405719|NCT04899778|Trace Elements|trace elements|mesh-ancestor
56405720|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
56405721|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405722|NCT04899778|Estrogens|estrogens|mesh-ancestor
56405723|NCT04899778|Hormones|hormones|mesh-ancestor
56405724|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405725|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56405726|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56405727|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56405728|NCT00164450|Isoniazid|isoniazid|mesh-list
56405729|NCT00164450|Rifapentine|rifapentine|mesh-list
56405730|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
56405731|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56405732|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405733|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56405734|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56405735|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
56405736|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405737|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56405738|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56405739|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
56405740|NCT04878211|Interferons|interferons|mesh-list
56405741|NCT04878211|Ofatumumab|ofatumumab|mesh-list
56405742|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
56405743|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
56405744|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405745|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
56405746|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405747|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56405748|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
56405749|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405750|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405751|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56405752|NCT00193869|Dexamethasone|dexamethasone|mesh-list
56405753|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56405754|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
56405755|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
56405756|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405757|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405758|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405759|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
56405760|NCT00193869|Hormones|hormones|mesh-ancestor
56405761|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405762|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56405763|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405764|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56405765|NCT04743934|Androgens|androgens|mesh-list
56405766|NCT04743934|Hormones|hormones|mesh-ancestor
56405767|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405768|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405769|NCT00176241|Gemcitabine|gemcitabine|mesh-list
56908992|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56908993|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
56908994|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56405770|NCT00176241|Paclitaxel|paclitaxel|mesh-list
56405771|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56405772|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405773|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405774|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405775|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405776|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906356|NCT04123561|BB 1101|bb 1101|mesh-list
56405780|NCT00176241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405781|NCT00176241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405782|NCT00176241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405783|NCT00176241|Immunologic Factors|immunologic factors|mesh-ancestor
56405784|NCT00176241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405785|NCT04742959|Paclitaxel|paclitaxel|mesh-list
56405786|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56405787|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405788|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405789|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405790|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
56405791|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405792|NCT00164801|Diltiazem|diltiazem|mesh-list
56405793|NCT00164801|Baclofen|baclofen|mesh-list
56405794|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56405795|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405796|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56405797|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405798|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56405799|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
56405800|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
56405801|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405802|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405803|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56405804|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56405805|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405806|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56405807|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
56405808|NCT00176280|Dexamethasone|dexamethasone|mesh-list
56405809|NCT00176280|Sargramostim|sargramostim|mesh-list
56405810|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56405811|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
56405812|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
56405813|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405814|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405815|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405816|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
56405817|NCT00176280|Hormones|hormones|mesh-ancestor
56405818|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405819|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56405820|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405821|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
56405822|NCT04704271|Dronabinol|dronabinol|mesh-list
56405823|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
56405824|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405825|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56405826|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56405827|NCT04704271|Analgesics|analgesics|mesh-ancestor
56405828|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
56405829|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405830|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56405831|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56405832|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405833|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405834|NCT04704271|Hormones|hormones|mesh-ancestor
56405835|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405836|NCT04723940|Doxycycline|doxycycline|mesh-list
56405837|NCT04723940|Clindamycin|clindamycin|mesh-list
56405838|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
56405839|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
56405840|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56908995|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
56908996|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56908997|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56908998|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56405841|NCT04723940|Cefadroxil|cefadroxil|mesh-list
56405842|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56405843|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405844|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
56405845|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56405846|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56405847|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56405849|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405850|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56405851|NCT04723940|Renal Agents|renal agents|mesh-ancestor
56405852|NCT00164840|Esomeprazole|esomeprazole|mesh-list
56405853|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56405854|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405855|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56405856|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405857|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405858|NCT04641247|Niraparib|niraparib|mesh-list
56405859|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56405860|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405861|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405862|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405863|NCT04635007|Misoprostol|misoprostol|mesh-list
56405864|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
56405865|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56405866|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56405867|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405868|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
56405869|NCT04635007|Coagulants|coagulants|mesh-ancestor
56405870|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56405871|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
56405872|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56405873|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405874|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56405875|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405876|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
56405877|NCT00194064|Olanzapine|olanzapine|mesh-list
56405878|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
56405879|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
56405880|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405881|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405882|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405883|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56405884|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56405885|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56405886|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56405887|NCT00194064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56405888|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56405889|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405890|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405891|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405892|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
56405893|NCT04426825|Bevacizumab|bevacizumab|mesh-list
56405894|NCT04426825|Atezolizumab|atezolizumab|mesh-list
56405895|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56405896|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405897|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56405898|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56405899|NCT04426825|Growth Substances|growth substances|mesh-ancestor
56405900|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405901|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
56405902|NCT00164996|Anesthetics|anesthetics|mesh-list
56405903|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56405904|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405905|NCT04418557|Antibodies|antibodies|mesh-list
56405906|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
56405907|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405908|NCT04682782|Esketamine|esketamine|mesh-list
56908999|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
56909000|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56909001|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909002|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909003|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
56909004|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
56909005|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909006|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
56909007|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56405909|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
56405910|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56405911|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56405912|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56405913|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56405914|NCT00165035|Paclitaxel|paclitaxel|mesh-list
56405915|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56405916|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56405917|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405918|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
56405919|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
56405920|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
56153544|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56405921|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405925|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
56405926|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
56405927|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405928|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
56405929|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405930|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405931|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
56405932|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56405933|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56405934|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56405935|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56405936|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
56405937|NCT04326673|Testosterone|testosterone|mesh-list
56405938|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
56405939|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
56405940|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56405941|NCT04326673|Androgens|androgens|mesh-ancestor
56405942|NCT04326673|Hormones|hormones|mesh-ancestor
56405943|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56405944|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405945|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56405946|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405947|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
56405948|NCT00165074|Calfactant|calfactant|mesh-list
56405949|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56405950|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
56405951|NCT04307953|Saracatinib|saracatinib|mesh-list
56405952|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405953|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405954|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405955|NCT04297267|Gemcitabine|gemcitabine|mesh-list
56405956|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405957|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405958|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
56405959|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405960|NCT04297267|Antiviral Agents|antiviral agents|mesh-ancestor
56405961|NCT04297267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56405962|NCT04297267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405963|NCT04297267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405964|NCT04297267|Immunologic Factors|immunologic factors|mesh-ancestor
56405965|NCT04297267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405966|NCT00176475|Rituximab|rituximab|mesh-list
56909008|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
56909009|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56909010|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
56909011|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56909012|NCT02154334|Protective Agents|protective agents|mesh-ancestor
56909013|NCT01078961|Bortezomib|bortezomib|mesh-list
56405967|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56405968|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405969|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
56405970|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405971|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56405972|NCT00165191|Doxorubicin|doxorubicin|mesh-list
56405973|NCT00165191|Fluorouracil|fluorouracil|mesh-list
56405974|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405975|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56405976|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56405977|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56405978|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405979|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405980|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
56405981|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405982|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56405983|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
56405984|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405985|NCT04224571|Rituximab|rituximab|mesh-list
56405986|NCT04224571|Bortezomib|bortezomib|mesh-list
56405987|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56405988|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405989|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
56405990|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405991|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56405992|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
56153621|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
56405993|NCT00165230|Thalidomide|thalidomide|mesh-list
56405996|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
56405997|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405998|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
56405999|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406000|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406001|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56406002|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56406003|NCT00165230|Growth Substances|growth substances|mesh-ancestor
56406004|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
56406005|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406006|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56406007|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
56406008|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406009|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
56406010|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
56406011|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
56406012|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56406013|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56406014|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406015|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406016|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406017|NCT00165308|Tamoxifen|tamoxifen|mesh-list
56406018|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56406019|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
56406020|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406021|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406022|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56406023|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406024|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56406025|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56406026|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56406027|NCT00165347|Vatalanib|vatalanib|mesh-list
56406028|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56406029|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909014|NCT01078961|Sorafenib|sorafenib|mesh-list
56909015|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909016|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909017|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909018|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909019|NCT03818399|Buprenorphine|buprenorphine|mesh-list
56909020|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56909021|NCT03818399|Narcotics|narcotics|mesh-ancestor
56909022|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406030|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406031|NCT00176670|Midazolam|midazolam|mesh-list
56406032|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56406033|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56406034|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406035|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406036|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56406037|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56406038|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56406039|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56406040|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
56406041|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
56406042|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
56406043|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
56406044|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406045|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406046|NCT00165464|Irinotecan|irinotecan|mesh-list
56406047|NCT00165464|Docetaxel|docetaxel|mesh-list
56406048|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406049|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56406050|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56406051|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406052|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406053|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
56406054|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
56406055|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
56406056|NCT04082650|Vitamin D|vitamin d|mesh-list
56406057|NCT04082650|Vitamins|vitamins|mesh-ancestor
56406058|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
56406059|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406060|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56406061|NCT00176787|Capecitabine|capecitabine|mesh-list
56406062|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56406063|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
56406064|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406065|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406066|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56406067|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56406071|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56406072|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56406073|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56406074|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
56406076|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406077|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406078|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406079|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
56406080|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406081|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406082|NCT00176943|Imiquimod|imiquimod|mesh-list
56406083|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56406084|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
56406085|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406086|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406087|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
56406088|NCT03978208|Naproxen|naproxen|mesh-list
56406089|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56406090|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56406091|NCT03978208|Analgesics|analgesics|mesh-ancestor
56909023|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909025|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
56909026|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369375|NCT00089258|Isotretinoin|isotretinoin|mesh-list
56406092|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
56406093|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406094|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406095|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56406096|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406097|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
56406098|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56406099|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406100|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406101|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
56406102|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406103|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
56406104|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406105|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406106|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56406107|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
56406108|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406109|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406110|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56406111|NCT00165659|Donepezil|donepezil|mesh-list
56406112|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56406113|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406114|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406115|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
56406116|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406117|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406118|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
56406119|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
56406120|NCT03935893|Fludarabine|fludarabine|mesh-list
56406121|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406122|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
56406123|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406124|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406125|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56406126|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
56406127|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406128|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406129|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56406130|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
56406131|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
56406132|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56406133|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56406134|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406135|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406136|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406137|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406140|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56406141|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56406142|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406143|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
56406144|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406145|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406147|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56406148|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406149|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406150|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
56406151|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406152|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406153|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
56406154|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56406155|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56406156|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406157|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
56406158|NCT03789916|Aspirin|aspirin|mesh-list
56406159|NCT03789916|Ticagrelor|ticagrelor|mesh-list
56909027|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56369446|NCT00089453|Melphalan|melphalan|mesh-list
56406160|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56406161|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56406162|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56406163|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56406164|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
56406165|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406166|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406167|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406168|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56406169|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56406170|NCT03789916|Analgesics|analgesics|mesh-ancestor
56406171|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
56406172|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406173|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56406174|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406175|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56406176|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56406177|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56406178|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406179|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
56406180|NCT00165815|Donepezil|donepezil|mesh-list
56406181|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56406182|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406183|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406184|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
56406185|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406186|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406187|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
56406188|NCT00177021|Imiquimod|imiquimod|mesh-list
56406189|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56406190|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
56406191|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406192|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406193|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
56406194|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
56406195|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
56406196|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406197|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406198|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406199|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
56406200|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
56406201|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56406202|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406203|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56406204|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406205|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406206|NCT00177060|Hydromorphone|hydromorphone|mesh-list
56406207|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56406208|NCT00177060|Narcotics|narcotics|mesh-ancestor
56406209|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980827|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
56406212|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
56406213|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406214|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
56153840|NCT02206776|Midazolam|midazolam|mesh-list
56406215|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56406216|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406217|NCT03421639|Leuprolide|leuprolide|mesh-list
56406218|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56406219|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56406220|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56406221|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
56406222|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56406223|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406224|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56406225|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406226|NCT03421639|Hormones|hormones|mesh-ancestor
56406227|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406228|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56406229|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088610|NCT04767074|Guaifenesin|guaifenesin|mesh-list
56909028|NCT02154646|Gemcitabine|gemcitabine|mesh-list
56369527|NCT04715152|BB 1101|bb 1101|mesh-list
56406230|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406231|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56406232|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
56406233|NCT00177099|Tacrolimus|tacrolimus|mesh-list
56406234|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406235|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
56406236|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406237|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56406238|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406239|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406240|NCT03413800|Dexamethasone|dexamethasone|mesh-list
56406241|NCT03413800|Lenalidomide|lenalidomide|mesh-list
56406242|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56406243|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
56406244|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
56406245|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406246|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406247|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56406248|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
56406249|NCT03413800|Hormones|hormones|mesh-ancestor
56406250|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406251|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56406252|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406253|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
56406254|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56406255|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56406256|NCT03413800|Growth Substances|growth substances|mesh-ancestor
56406257|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
56406258|NCT03354013|Calcium|calcium|mesh-list
56406259|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56406260|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406261|NCT03335839|Plasminogen|plasminogen|mesh-list
56406262|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56406263|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56406264|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56406265|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406266|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56406267|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
56406268|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406269|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56406270|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56406271|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406272|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56406273|NCT05336812|Venetoclax|venetoclax|mesh-list
56406274|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
56406275|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
56406276|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406277|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56406278|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
56406279|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56406280|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406281|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56406283|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406284|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406285|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406286|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406287|NCT00537901|Bevacizumab|bevacizumab|mesh-list
56406288|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56406289|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406290|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56406291|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56406292|NCT00537901|Growth Substances|growth substances|mesh-ancestor
56406293|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406294|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
56406295|NCT00166127|Simendan|simendan|mesh-list
56406296|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56406297|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
56406298|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56406299|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56406300|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406301|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909029|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56909030|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
56909031|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909032|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909033|NCT02154646|Antiviral Agents|antiviral agents|mesh-ancestor
56406302|NCT00166127|Protective Agents|protective agents|mesh-ancestor
56406303|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406304|NCT00194649|Miglustat|miglustat|mesh-list
56406305|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406306|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406307|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56406308|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56406309|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
56406310|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406311|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56406312|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56406313|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406314|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
56406315|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56406316|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406317|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56406318|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
56406319|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406320|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406321|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406322|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406323|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
56406324|NCT00177138|Tacrolimus|tacrolimus|mesh-list
56406325|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406326|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
56406327|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406328|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56406329|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406330|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406331|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56406332|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406333|NCT05311774|Tramadol|tramadol|mesh-list
56406334|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56406335|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56406336|NCT05311774|Narcotics|narcotics|mesh-ancestor
56406337|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406338|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406339|NCT05311774|Analgesics|analgesics|mesh-ancestor
56406340|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
56406341|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406342|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56406343|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56406344|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56406345|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406346|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406347|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
56406348|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56406349|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
56406350|NCT00194727|Capecitabine|capecitabine|mesh-list
56406351|NCT00194727|Vinorelbine|vinorelbine|mesh-list
56406352|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56406353|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
55980974|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56406355|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406356|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56406357|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
56406358|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
56406359|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
56406361|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56406362|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56406363|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
56406364|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
56406365|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406366|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909034|NCT02154646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909035|NCT02154646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909036|NCT02154646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909037|NCT02154646|Immunologic Factors|immunologic factors|mesh-ancestor
56406367|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56406368|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56406369|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56406370|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
56406371|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406372|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406373|NCT02042287|Metronidazole|metronidazole|mesh-list
56406374|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406375|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406376|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56406377|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56406378|NCT05296213|Calcium|calcium|mesh-list
56406379|NCT05296213|Fluorides|fluorides|mesh-list
56406380|NCT05296213|Caseins|caseins|mesh-list
56406381|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56406382|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406383|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
56406384|NCT05296213|Protective Agents|protective agents|mesh-ancestor
56406385|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
56406386|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
56406387|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406388|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
56406389|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406390|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56406391|NCT00166478|Protective Agents|protective agents|mesh-ancestor
56406392|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406393|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56406394|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406395|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406396|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56406397|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56406398|NCT00166478|Analgesics|analgesics|mesh-ancestor
56406399|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
56406400|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406401|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56406402|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406403|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56406404|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
56406405|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406406|NCT00194766|Temozolomide|temozolomide|mesh-list
56406407|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56406408|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
56406409|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406410|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406411|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
56406412|NCT00166556|Tacrolimus|tacrolimus|mesh-list
56406413|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406414|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
56406415|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406416|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56406417|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406418|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406419|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56406420|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406421|NCT05276206|Anesthetics|anesthetics|mesh-list
56406422|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
56406423|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406424|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406425|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
56406429|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
56406430|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406431|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406432|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406433|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56406434|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56406435|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909038|NCT02154646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909039|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
56909040|NCT03642873|Hydrocodone|hydrocodone|mesh-list
56909041|NCT03642873|Guaifenesin|guaifenesin|mesh-list
56909042|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56154064|NCT02267772|Narcotics|narcotics|mesh-ancestor
56406488|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
56406489|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
56406490|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406491|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406492|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56406493|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
56406494|NCT05124067|Hormones|hormones|mesh-ancestor
56406495|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406496|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56406497|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406498|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
56406499|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406500|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406501|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56406502|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406503|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56406504|NCT05124067|Analgesics|analgesics|mesh-ancestor
56406505|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
56406506|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56406507|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56406508|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56406509|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
56406510|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406511|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
56406512|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
56406513|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56406514|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
56406515|NCT05124067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56406516|NCT05124067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56406517|NCT05124067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56406518|NCT05124067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56406519|NCT00194883|Hormones|hormones|mesh-list
56406520|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406521|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406522|NCT02277184|Cisplatin|cisplatin|mesh-list
56406523|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406524|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
56406525|NCT00166829|Sirolimus|sirolimus|mesh-list
56406526|NCT00166829|Tacrolimus|tacrolimus|mesh-list
56406527|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406528|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
56406529|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406530|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56406531|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406532|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406533|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56406534|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406535|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56406536|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
56406537|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406538|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406539|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
56406540|NCT00177333|Doxycycline|doxycycline|mesh-list
56406541|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406542|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406543|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
56406544|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56406545|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56406546|NCT05046535|Nicotine|nicotine|mesh-list
56406547|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56406548|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
56406549|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406552|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56406553|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
56406554|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56909043|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56909044|NCT03642873|Narcotics|narcotics|mesh-ancestor
56909045|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909046|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909047|NCT03642873|Analgesics|analgesics|mesh-ancestor
56909048|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
56406555|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406556|NCT00166868|Neomycin|neomycin|mesh-list
56406557|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406558|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406559|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56406560|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406561|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406562|NCT00194961|Hormones|hormones|mesh-list
56406563|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406564|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406565|NCT00177372|Misoprostol|misoprostol|mesh-list
56406566|NCT00177372|Mifepristone|mifepristone|mesh-list
56406567|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56406568|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
56406569|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56406570|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406571|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56406572|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56406573|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
56406574|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56406575|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56406576|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56406577|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56406578|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
56406579|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56406580|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56406581|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
56406582|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406583|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
56333870|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56406584|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56406585|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56406587|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
56406588|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56406589|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
56406590|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406591|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406592|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
56406593|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406594|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406595|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
56406596|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406597|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56406598|NCT04819399|Catumaxomab|catumaxomab|mesh-list
56406599|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56406601|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
56406602|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
56406603|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406604|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406605|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56406606|NCT00195078|Gefitinib|gefitinib|mesh-list
56406607|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406608|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56406609|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406610|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406611|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
56406612|NCT04669210|Tacrolimus|tacrolimus|mesh-list
56406613|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406614|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
56406615|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909049|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909050|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
56909051|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
56909052|NCT03642873|Expectorants|expectorants|mesh-ancestor
56909053|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56909054|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56909055|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
56369877|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
56406616|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56406617|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406618|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406619|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56406620|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406623|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406624|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406625|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
56406626|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
56406627|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56406628|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406629|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
56406630|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406631|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56406632|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56406633|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56406634|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56406635|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406636|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406637|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406638|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56406639|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
56406640|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56406641|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56406642|NCT04566250|Analgesics|analgesics|mesh-ancestor
56406643|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
56406644|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406645|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406646|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
56406647|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56406648|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
56406649|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406650|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56406651|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56406652|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56406653|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56406654|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406655|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
56154300|NCT02299050|Bromocriptine|bromocriptine|mesh-list
56406656|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406657|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406659|NCT00177567|Valproic Acid|valproic acid|mesh-list
56406660|NCT00177567|Olanzapine|olanzapine|mesh-list
56406661|NCT00177567|Risperidone|risperidone|mesh-list
56406662|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
56406663|NCT00177567|Mirtazapine|mirtazapine|mesh-list
56406664|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
56406665|NCT00177567|Bupropion|bupropion|mesh-list
56406666|NCT00177567|Paroxetine|paroxetine|mesh-list
56406667|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56406668|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56406669|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
56406670|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406671|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406672|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406673|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56406674|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56406675|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369944|NCT00127998|Mefloquine|mefloquine|mesh-list
56406676|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56406677|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56406678|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
56406679|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
56406680|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
56406681|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406682|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56406683|NCT00177567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56406684|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56406685|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56406686|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56406687|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
56406688|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56406689|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56406690|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56406691|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406692|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
56406693|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56406694|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
56406695|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56406696|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56406697|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56406698|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56406699|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
56406700|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
56406701|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56406702|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56406703|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56406704|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56406705|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
56406706|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56406707|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56406708|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
56406709|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56406710|NCT00195156|Valproic Acid|valproic acid|mesh-list
56406711|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
56406712|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406713|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406714|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
56406715|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406716|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406717|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
56406718|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56406719|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406720|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56406721|NCT00167375|Eszopiclone|eszopiclone|mesh-list
56406722|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56406723|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406724|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406725|NCT00195195|Sirolimus|sirolimus|mesh-list
56406726|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406727|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406728|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56406729|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406730|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
56406731|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406732|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
56406733|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406734|NCT04299880|Leucovorin|leucovorin|mesh-list
56406735|NCT04299880|Gemcitabine|gemcitabine|mesh-list
56406736|NCT04299880|Paclitaxel|paclitaxel|mesh-list
56406737|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56406738|NCT04299880|Bevacizumab|bevacizumab|mesh-list
56406739|NCT04299880|Fluorouracil|fluorouracil|mesh-list
56406740|NCT04299880|Nivolumab|nivolumab|mesh-list
56406741|NCT04299880|Irinotecan|irinotecan|mesh-list
56406742|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56406743|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406744|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
56406745|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
56406746|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
56406747|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406748|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56406749|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56909056|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56909057|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406750|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56406751|NCT04299880|Growth Substances|growth substances|mesh-ancestor
56406752|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406753|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
56406754|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56406755|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
56406756|NCT04299880|Antiviral Agents|antiviral agents|mesh-ancestor
56406757|NCT04299880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406758|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406759|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406760|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
56406761|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56406762|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56406763|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56406764|NCT04299880|Antidotes|antidotes|mesh-ancestor
56406765|NCT04299880|Protective Agents|protective agents|mesh-ancestor
56406766|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
56406767|NCT04299880|Vitamins|vitamins|mesh-ancestor
56406768|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
56406769|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
56406771|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406772|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56406773|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
56406774|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406775|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406776|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406777|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406778|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
56406779|NCT04087096|Denosumab|denosumab|mesh-list
56406780|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56406781|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406782|NCT00177684|Amphotericin B|amphotericin b|mesh-list
56406783|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56406784|NCT00177684|Amebicides|amebicides|mesh-ancestor
56406785|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56406786|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56406787|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406788|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406789|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
56406790|NCT00532090|R04929097|r04929097|mesh-list
56406791|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406792|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406793|NCT00195312|Bupivacaine|bupivacaine|mesh-list
56406794|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
56406795|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
56406796|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406797|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406798|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
56406799|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406800|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56406801|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56406802|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
56406803|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406804|NCT03888079|Anesthetics|anesthetics|mesh-list
56406805|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
56406806|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
56406807|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406808|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406809|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
56406810|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406812|NCT00167648|Goserelin|goserelin|mesh-list
56406813|NCT00167648|Estradiol|estradiol|mesh-list
56406814|NCT00167648|Estrogens|estrogens|mesh-ancestor
56406815|NCT00167648|Hormones|hormones|mesh-ancestor
56406816|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406817|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406818|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56406819|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56406820|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
56406821|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56406822|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406823|NCT02906722|Colistin|colistin|mesh-list
56909058|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
56909059|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56909060|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
56909061|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
56909062|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
56909063|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56909064|NCT02156596|Ketoprofen|ketoprofen|mesh-list
56909065|NCT02156596|Morphine|morphine|mesh-list
56909066|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56406824|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406825|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406826|NCT00167687|Prazosin|prazosin|mesh-list
56406827|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56406828|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56406829|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56406830|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56406831|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
56406832|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406833|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406834|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406835|NCT02906995|Nicotine|nicotine|mesh-list
56406836|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56406837|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
56406838|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406839|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406840|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56406841|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56406842|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
56406843|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406844|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406845|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56406847|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406848|NCT02906800|Digoxin|digoxin|mesh-list
56406849|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56406850|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56406851|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406852|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406853|NCT02906800|Protective Agents|protective agents|mesh-ancestor
56406854|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406855|NCT00195468|Cyclosporine|cyclosporine|mesh-list
56406856|NCT00195468|Cyclosporins|cyclosporins|mesh-list
56406857|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406858|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406859|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406860|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
56406861|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406862|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
56406863|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406864|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
56406865|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406866|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56406867|NCT00167765|Abciximab|abciximab|mesh-list
56406868|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
56406869|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56406870|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56406871|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406872|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
56406873|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
56406874|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56406875|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
56406876|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56406877|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56406878|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406879|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56406880|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406881|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406882|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56154539|NCT02391714|Povidone|povidone|mesh-list
56909067|NCT02156596|Narcotics|narcotics|mesh-ancestor
56909068|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406885|NCT02906059|Adavosertib|adavosertib|mesh-list
56406886|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56406887|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56406888|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406889|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406890|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56406891|NCT02906176|Voriconazole|voriconazole|mesh-list
56406892|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
56406893|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406894|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56406895|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56406896|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406897|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406898|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56406899|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
56406900|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406901|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406902|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56406903|NCT02905864|Liraglutide|liraglutide|mesh-list
56406904|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56406905|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406906|NCT02905864|Incretins|incretins|mesh-ancestor
56406907|NCT02905864|Hormones|hormones|mesh-ancestor
56406908|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406909|NCT00167882|Mesalamine|mesalamine|mesh-list
56406910|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56406911|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56406912|NCT00167882|Analgesics|analgesics|mesh-ancestor
56406913|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
56406914|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406915|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406916|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56406917|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406918|NCT02905708|Charcoal|charcoal|mesh-list
56406919|NCT02905708|Antidotes|antidotes|mesh-ancestor
56406922|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56406923|NCT00167921|Estrogens|estrogens|mesh-ancestor
56406924|NCT00167921|Hormones|hormones|mesh-ancestor
56406925|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406926|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406927|NCT00167960|Tazobactam|tazobactam|mesh-list
56406928|NCT00167960|Piperacillin|piperacillin|mesh-list
56406929|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56406930|NCT00167960|Lactams|lactams|mesh-list
56406931|NCT00167960|beta-Lactams|beta-lactams|mesh-list
56406932|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406933|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406934|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56406935|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406936|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406937|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
56406938|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56406939|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406940|NCT00167999|Tazobactam|tazobactam|mesh-list
56406941|NCT00167999|Piperacillin|piperacillin|mesh-list
56406942|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56406943|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406944|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406945|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56406946|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406947|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406948|NCT00177996|Sertraline|sertraline|mesh-list
56406949|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
56406950|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56406951|NCT00177996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56406952|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56406953|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56163783|NCT00002544|Docetaxel|docetaxel|mesh-list
56406954|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088946|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909069|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909070|NCT02156596|Analgesics|analgesics|mesh-ancestor
56909071|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
56406955|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56406956|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
56406957|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406958|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
56406959|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56406960|NCT04682041|Antibodies|antibodies|mesh-list
56406961|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
56406962|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406963|NCT00168077|Thrombin|thrombin|mesh-list
56406964|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
56406965|NCT00168077|Coagulants|coagulants|mesh-ancestor
56406966|NCT00195585|Leucovorin|leucovorin|mesh-list
56406967|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
56406968|NCT00195585|Antidotes|antidotes|mesh-ancestor
56406969|NCT00195585|Protective Agents|protective agents|mesh-ancestor
56406970|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406971|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
56406972|NCT00195585|Vitamins|vitamins|mesh-ancestor
56406973|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
56406974|NCT02905045|Ketoprofen|ketoprofen|mesh-list
56406975|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56406976|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56406977|NCT02905045|Analgesics|analgesics|mesh-ancestor
56406978|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
56406979|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406980|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406981|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56406982|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406983|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56406984|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406985|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406986|NCT02904772|Cyclosporine|cyclosporine|mesh-list
56406987|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
56406988|NCT02904772|Prednisolone|prednisolone|mesh-list
56406989|NCT02904772|Cyclosporins|cyclosporins|mesh-list
56406990|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406991|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406992|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56406993|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
56406994|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406995|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
56406996|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406997|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
56406998|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56406999|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56407000|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56407001|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407002|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56407003|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
56407004|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56407005|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56407006|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
56407007|NCT02904772|Hormones|hormones|mesh-ancestor
56407008|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56407009|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56407010|NCT00195741|Valproic Acid|valproic acid|mesh-list
56407011|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
56407012|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407013|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407014|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
56407015|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407016|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407017|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
56407018|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56407019|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407020|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407021|NCT00178035|Paroxetine|paroxetine|mesh-list
56407022|NCT00178035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56407023|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56407024|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407025|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370306|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56407026|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407028|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407029|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56407030|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
56407031|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407032|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56407033|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56407034|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407035|NCT02904538|Dexamethasone|dexamethasone|mesh-list
56407036|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56407037|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
56407038|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
56407039|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407040|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407041|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407042|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
56407044|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56407045|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56407046|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407047|NCT02963103|Tacrolimus|tacrolimus|mesh-list
56407048|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407049|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
56407050|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407051|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56407052|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407053|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407054|NCT00407264|Fluticasone|fluticasone|mesh-list
56407056|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56407057|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56407058|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
56407059|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407060|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407061|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56407062|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
56407063|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
56407064|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56407065|NCT02904499|Dabigatran|dabigatran|mesh-list
56407066|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
56407067|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56407068|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
56407069|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407072|NCT00195780|Valproic Acid|valproic acid|mesh-list
56407073|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
56407074|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407075|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407076|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
56407077|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407078|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407079|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
56407080|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56407081|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407082|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407083|NCT00407342|Alefacept|alefacept|mesh-list
56407084|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
56407085|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
56407086|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407087|NCT00553423|Lactulose|lactulose|mesh-list
56407088|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407089|NCT02904304|Ibuprofen|ibuprofen|mesh-list
56407090|NCT02904304|Phenylephrine|phenylephrine|mesh-list
56407091|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
56407092|NCT02904304|Desloratadine|desloratadine|mesh-list
56407093|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56407094|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56407095|NCT02904304|Analgesics|analgesics|mesh-ancestor
56407096|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
56407097|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407098|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407099|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56407100|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407101|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55907628|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
56407103|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407104|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56909072|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909073|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56909074|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56909075|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909076|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909077|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56909078|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909079|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909080|NCT01079117|Morphine|morphine|mesh-list
56909081|NCT01079117|Methadone|methadone|mesh-list
56407105|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
56407106|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
56407107|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
56407108|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56407109|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
56407110|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
56407111|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56407112|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56407114|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
56407115|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407116|NCT02904304|Protective Agents|protective agents|mesh-ancestor
56407117|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56407118|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
56407119|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56407120|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56407121|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
56407122|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
56407123|NCT00407459|Bevacizumab|bevacizumab|mesh-list
56407124|NCT00407459|Carboplatin|carboplatin|mesh-list
56407125|NCT00407459|Pemetrexed|pemetrexed|mesh-list
56407126|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407127|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407128|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56407129|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56407130|NCT00407459|Growth Substances|growth substances|mesh-ancestor
56407131|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407132|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
56407133|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407134|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407135|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56407136|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56407137|NCT02904031|Leucovorin|leucovorin|mesh-list
56407138|NCT02904031|Fluorouracil|fluorouracil|mesh-list
56407139|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
56407140|NCT02904031|Panitumumab|panitumumab|mesh-list
56407141|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
56407142|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
56407143|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407144|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55981719|NCT04952194|Levodopa|levodopa|mesh-list
56407147|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
56407148|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407149|NCT02904031|Antidotes|antidotes|mesh-ancestor
56407150|NCT02904031|Protective Agents|protective agents|mesh-ancestor
56407151|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
56407152|NCT02904031|Vitamins|vitamins|mesh-ancestor
56407153|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
56407154|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407155|NCT02904109|Mannitol|mannitol|mesh-list
56407156|NCT02904109|Triflusal|triflusal|mesh-list
56407157|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56407158|NCT02904109|Diuretics|diuretics|mesh-ancestor
56407159|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
56407160|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407161|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56407162|NCT00178113|Lycopene|lycopene|mesh-list
56407163|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56407164|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
56909082|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56909083|NCT01079117|Narcotics|narcotics|mesh-ancestor
56909084|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407165|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407166|NCT00178113|Protective Agents|protective agents|mesh-ancestor
56407167|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407168|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56407169|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56407170|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407171|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
56407172|NCT02903524|Doxorubicin|doxorubicin|mesh-list
56407173|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56407174|NCT02903524|Pirarubicin|pirarubicin|mesh-list
56407175|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407176|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
56407177|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407178|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407179|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56407180|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
56407181|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407182|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407183|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56407184|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56407185|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56407186|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56407187|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407189|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56407190|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56407191|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
56407192|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407193|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407194|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407195|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56407196|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56407197|NCT02903485|Anesthetics|anesthetics|mesh-list
56407198|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407199|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407200|NCT02903719|Ropivacaine|ropivacaine|mesh-list
56407201|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
56407202|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
56407203|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407204|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407205|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
56407206|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407207|NCT00178269|Docetaxel|docetaxel|mesh-list
56407208|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407209|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
56407210|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
56407211|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
56407212|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407213|NCT02903251|Oxytocin|oxytocin|mesh-list
56407214|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
56407215|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56407216|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407217|NCT00168467|Ramipril|ramipril|mesh-list
56407218|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56407219|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
56407220|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407221|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407222|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56407223|NCT00195936|Cinacalcet|cinacalcet|mesh-list
56407224|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56407225|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407226|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56407227|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
56407228|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56407229|NCT02902861|Methotrexate|methotrexate|mesh-list
56407230|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56407231|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
56407232|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56909085|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909086|NCT01079117|Analgesics|analgesics|mesh-ancestor
56909087|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
56407233|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407234|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56407235|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
56407236|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407237|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407238|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
56407239|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407240|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56407241|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407242|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
56407243|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407244|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56407245|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
56407246|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56407247|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56407248|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407249|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
56407250|NCT02903017|Coagulants|coagulants|mesh-ancestor
56407251|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56407252|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56407253|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
56407254|NCT02902744|Hormones|hormones|mesh-ancestor
56407255|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56407256|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407257|NCT00168584|Vitamin A|vitamin a|mesh-list
56407258|NCT00168584|Vitamins|vitamins|mesh-ancestor
56407259|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
56407260|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407262|NCT02902666|Codeine|codeine|mesh-list
56407263|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56407264|NCT02902666|Analgesics|analgesics|mesh-ancestor
56407265|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
56407266|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407267|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407268|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
56407269|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56407270|NCT02902666|Narcotics|narcotics|mesh-ancestor
56407271|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407272|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
56407273|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
56407274|NCT02902354|Nifedipine|nifedipine|mesh-list
56407275|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56407276|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407277|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407278|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56407279|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407280|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
56407281|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
56407282|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56407283|NCT00168623|Vitamin A|vitamin a|mesh-list
56407284|NCT00168623|Vitamins|vitamins|mesh-ancestor
56407285|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
56407286|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407287|NCT02902315|Vitamins|vitamins|mesh-list
56407288|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
56407289|NCT02902315|Tocopherols|tocopherols|mesh-list
56407290|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
56407291|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
56407292|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407293|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
56407294|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407295|NCT02902315|Protective Agents|protective agents|mesh-ancestor
56407296|NCT02902432|Endostar protein|endostar protein|mesh-list
56407299|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56407300|NCT02902432|Growth Substances|growth substances|mesh-ancestor
56407301|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407302|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
56407303|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407304|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56407305|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56407306|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909088|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909089|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
56370593|NCT04705519|Growth Substances|growth substances|mesh-ancestor
56407307|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
56407308|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407309|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
56407310|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407311|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407313|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407314|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407315|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
56407316|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407317|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407318|NCT00168779|Valsartan|valsartan|mesh-list
56407319|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56407320|NCT00168779|Telmisartan|telmisartan|mesh-list
56407321|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56407322|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56407323|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56407324|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407325|NCT00168779|Diuretics|diuretics|mesh-ancestor
56407326|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
56407327|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407328|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56407329|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407330|NCT00168857|Losartan|losartan|mesh-list
56407331|NCT00168857|Telmisartan|telmisartan|mesh-list
56407332|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56407333|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56407334|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56407335|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56407336|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407337|NCT00196131|Morphine|morphine|mesh-list
56407338|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56407339|NCT00196131|Narcotics|narcotics|mesh-ancestor
56407340|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407341|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407342|NCT00196131|Analgesics|analgesics|mesh-ancestor
56407343|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
56407344|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407345|NCT00168896|Carboplatin|carboplatin|mesh-list
56407346|NCT00168896|Irinotecan|irinotecan|mesh-list
56407347|NCT00168896|Etoposide|etoposide|mesh-list
56407348|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407349|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56407350|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56407351|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407352|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407353|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56407354|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56407355|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
56407356|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
56407357|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407358|NCT02901379|Atorvastatin|atorvastatin|mesh-list
56407359|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56407360|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56407361|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
56407362|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407363|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56407364|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56407365|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407366|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56407367|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56407368|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407369|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
56407370|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407373|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407374|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
56407375|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407376|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407377|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56370696|NCT04050462|Nivolumab|nivolumab|mesh-list
56407378|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
56407379|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407380|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407381|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56407382|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407383|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56407384|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
56407385|NCT02901301|Capecitabine|capecitabine|mesh-list
56407386|NCT02901301|Trastuzumab|trastuzumab|mesh-list
56407387|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407388|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407389|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56407390|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
56407391|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407392|NCT00169013|Gabapentin|gabapentin|mesh-list
56407393|NCT00169013|Analgesics|analgesics|mesh-ancestor
56407394|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
56407395|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407396|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407397|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
56407398|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56407399|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56407400|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407401|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407402|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56407403|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56407404|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407405|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407406|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
56407407|NCT00169091|Haloperidol|haloperidol|mesh-list
56407408|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
56407409|NCT00169091|Clozapine|clozapine|mesh-list
56407410|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
56407411|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
56407412|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407413|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407414|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407415|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56407416|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56407417|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407418|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407419|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56407420|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
56407421|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407422|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407423|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56407424|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56407425|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
56407426|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
56407427|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
56407428|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
56407429|NCT00169130|Doxorubicin|doxorubicin|mesh-list
56407430|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407431|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
56407432|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407433|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407434|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56407435|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
56407436|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407437|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407438|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56407439|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56407440|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56407441|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56407442|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407444|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56407445|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56407447|NCT00169169|Rituximab|rituximab|mesh-list
56407448|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407449|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407450|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
56407451|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407452|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407453|NCT00169208|Rituximab|rituximab|mesh-list
56909090|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
56909091|NCT03732963|Melatonin|melatonin|mesh-list
56909092|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
56407454|NCT00169208|Fludarabine|fludarabine|mesh-list
56407455|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
56163814|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407456|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407457|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407458|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
56407459|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407460|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407461|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407463|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
56407464|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407465|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56407466|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56407467|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407468|NCT00178698|Gemcitabine|gemcitabine|mesh-list
56407469|NCT00178698|Interferons|interferons|mesh-list
56407470|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407471|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56407472|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
56407473|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407474|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
56407475|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407476|NCT00178698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407477|NCT00178698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407478|NCT00178698|Immunologic Factors|immunologic factors|mesh-ancestor
56407479|NCT00178698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407480|NCT00169247|Cetuximab|cetuximab|mesh-list
56407481|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407482|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407483|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56407484|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
56407485|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407486|NCT02899507|Amoxicillin|amoxicillin|mesh-list
56407487|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56407488|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
56407489|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
56407490|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56407491|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407492|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56407493|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407494|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407495|NCT00178854|Risperidone|risperidone|mesh-list
56407496|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56407497|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
56407498|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407499|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407500|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407501|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56407502|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56407503|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407504|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407505|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56407506|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
56407507|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
56407508|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56407509|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
56407510|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56407511|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407512|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56407513|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56407514|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56407515|NCT02898961|Gentamicins|gentamicins|mesh-list
56407516|NCT02898961|Amikacin|amikacin|mesh-list
56407517|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56407518|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407521|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407522|NCT00553618|Aldesleukin|aldesleukin|mesh-list
56407523|NCT00553618|Dacarbazine|dacarbazine|mesh-list
56407524|NCT00553618|Interleukin-2|interleukin-2|mesh-list
56407525|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56909093|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909094|NCT03732963|Protective Agents|protective agents|mesh-ancestor
56909095|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407526|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
56407527|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407528|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407529|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56407530|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56407531|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
56407532|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407533|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56407535|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
56407536|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407537|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407538|NCT02898376|Tocopherols|tocopherols|mesh-list
56407539|NCT02898376|Vitamin E|vitamin e|mesh-list
56407540|NCT02898376|Tocotrienols|tocotrienols|mesh-list
56407541|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
56407542|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
56407543|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56407544|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407545|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407546|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56407547|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56407548|NCT02898376|Protective Agents|protective agents|mesh-ancestor
56407549|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407550|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
56407551|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56407552|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
56407553|NCT02898376|Vitamins|vitamins|mesh-ancestor
56407554|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
56407555|NCT00408174|Balsalazide|balsalazide|mesh-list
56407556|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56407557|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56407558|NCT00408174|Analgesics|analgesics|mesh-ancestor
56407559|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
56407560|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407561|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407563|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407564|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407565|NCT00169520|Docetaxel|docetaxel|mesh-list
56407566|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407567|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
56407568|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
56407569|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
56407570|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407571|NCT02897986|Vinorelbine|vinorelbine|mesh-list
56407572|NCT02897986|Propranolol|propranolol|mesh-list
56407573|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56407574|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407575|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
56407576|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
56407577|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
56407578|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407579|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56407580|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56407581|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
56407582|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407583|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407584|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56407585|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56407586|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
56407587|NCT00169559|Fenofibrate|fenofibrate|mesh-list
56407588|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56407589|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
56407590|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407591|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56407592|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
56407593|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56407594|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407596|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
56407597|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909096|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909097|NCT03729687|Capecitabine|capecitabine|mesh-list
56909098|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
56619774|NCT00704145|Paclitaxel|paclitaxel|mesh-list
56909099|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56909101|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909102|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909103|NCT03818321|Methenamine|methenamine|mesh-list
56909104|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
56909105|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
56909106|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56909107|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909108|NCT03818321|Renal Agents|renal agents|mesh-ancestor
56909109|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909110|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
56909111|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56909112|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909113|NCT04996719|Sirolimus|sirolimus|mesh-list
56909114|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909115|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909116|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56909117|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909118|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
56909119|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909120|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
56909121|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909122|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
56909123|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56909124|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909125|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
56909126|NCT02770612|Narcotics|narcotics|mesh-ancestor
56909127|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407598|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407599|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163822|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
56407600|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407602|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407603|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56407604|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56407605|NCT00408252|Growth Substances|growth substances|mesh-ancestor
56407606|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407607|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
56407608|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56407609|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888086|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56909128|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909129|NCT02770612|Analgesics|analgesics|mesh-ancestor
56909130|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
56909131|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909132|NCT03575871|Abrocitinib|abrocitinib|mesh-list
56909133|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909134|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407610|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407611|NCT02897869|Amikacin|amikacin|mesh-list
56407612|NCT02897869|Murepavadin|murepavadin|mesh-list
56407613|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56407614|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407615|NCT02897830|Dexamethasone|dexamethasone|mesh-list
56407616|NCT02897830|Lenalidomide|lenalidomide|mesh-list
56407617|NCT02897830|Ixazomib|ixazomib|mesh-list
56407618|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56407619|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
56407620|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
56407621|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407622|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407623|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407624|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
56407625|NCT02897830|Hormones|hormones|mesh-ancestor
56407626|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56407627|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56407628|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407629|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
56407630|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56407631|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56407632|NCT02897830|Growth Substances|growth substances|mesh-ancestor
56407633|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
56407634|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
56407635|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155269|NCT05579730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56407636|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407637|NCT02897557|Pancrelipase|pancrelipase|mesh-list
56407638|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407639|NCT02897596|Grazoprevir|grazoprevir|mesh-list
56407640|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
56407641|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407642|NCT04681027|Oxymorphone|oxymorphone|mesh-list
56407643|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56407644|NCT04681027|Narcotics|narcotics|mesh-ancestor
56407645|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407646|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407647|NCT04681027|Analgesics|analgesics|mesh-ancestor
56407648|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
56407649|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407650|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56407651|NCT00408330|Azelaic acid|azelaic acid|mesh-list
56407652|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407653|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
56407654|NCT00408369|Pafuramidine|pafuramidine|mesh-list
56407655|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56407656|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56407657|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56407658|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407659|NCT02897206|Imipenem|imipenem|mesh-list
56407660|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
56407661|NCT02897206|Cilastatin|cilastatin|mesh-list
56407662|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56407663|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407664|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
56407665|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407666|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407667|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
56407668|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
56407670|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
56407671|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407672|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407673|NCT02897011|Methotrexate|methotrexate|mesh-list
56909135|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909136|NCT02155504|Itraconazole|itraconazole|mesh-list
56909137|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
56909138|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407674|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56407675|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
56407676|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56407677|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407678|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56407679|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
56407680|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407681|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407682|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
56407683|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407684|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56407685|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407686|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
56407687|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407688|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56407689|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
56407690|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56407691|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407692|NCT00196599|Emtricitabine|emtricitabine|mesh-list
56407693|NCT00196599|Efavirenz|efavirenz|mesh-list
56407694|NCT00196599|Didanosine|didanosine|mesh-list
56407695|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
56407696|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407697|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56407698|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56407699|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407700|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407701|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56407702|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56407703|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56407704|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56407705|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56407706|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56407707|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56407708|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56407709|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
56407710|NCT00178971|Buspirone|buspirone|mesh-list
56407711|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56407713|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407714|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407715|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407716|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56407717|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
56407718|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407719|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407720|NCT02896621|Amlodipine|amlodipine|mesh-list
56407721|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
56407722|NCT02896621|Amiloride|amiloride|mesh-list
56407723|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56407724|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56407725|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407726|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407727|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56407728|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407729|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
56407730|NCT02896621|Diuretics|diuretics|mesh-ancestor
56407731|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
56407732|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56407733|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56407734|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56407735|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56407736|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56407737|NCT02896582|Cytarabine|cytarabine|mesh-list
56407739|NCT02896582|Etoposide|etoposide|mesh-list
56407740|NCT02896582|Melphalan|melphalan|mesh-list
56407741|NCT02896582|Cisplatin|cisplatin|mesh-list
56909139|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56909140|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56407742|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
56407743|NCT02896582|Carmustine|carmustine|mesh-list
56407746|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
56407747|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407748|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407749|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407750|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
56407751|NCT02896582|Hormones|hormones|mesh-ancestor
56407752|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56407753|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56407754|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407755|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56407756|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56407757|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56407758|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407759|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407760|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56407761|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
56407762|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
56407763|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407764|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407765|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
56407766|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56407767|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
56407768|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56407769|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407770|NCT00196638|Interferons|interferons|mesh-list
56407771|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
56407772|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56407773|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407774|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
56407775|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407776|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
56407777|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407778|NCT02896270|Valproic Acid|valproic acid|mesh-list
56407779|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
56407780|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407781|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407782|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
56407783|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407784|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407785|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
56407786|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56407787|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407788|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407789|NCT00196677|Vitamins|vitamins|mesh-list
56407790|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
56407791|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407792|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56407793|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
56407794|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407795|NCT00169949|Aripiprazole|aripiprazole|mesh-list
56407796|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
56407797|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407798|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56407799|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56407800|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407801|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407802|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
56407803|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
56407804|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407805|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407806|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56407807|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56407808|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
56407809|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56407810|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56407811|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56407812|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56407813|NCT00196755|Calcium|calcium|mesh-list
56909141|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909142|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407814|NCT00196755|Sevelamer|sevelamer|mesh-list
56407815|NCT00196755|Calcium acetate|calcium acetate|mesh-list
56407816|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56407819|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
56407820|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407821|NCT00169988|Risperidone|risperidone|mesh-list
56407822|NCT00169988|Sertraline|sertraline|mesh-list
56407823|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56407824|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
56407825|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407826|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407827|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407828|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56407829|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56407830|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407831|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407832|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56407833|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
56407834|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
56407835|NCT00169988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56407836|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56407837|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407838|NCT02895529|Itraconazole|itraconazole|mesh-list
56407839|NCT02895529|Caspofungin|caspofungin|mesh-list
56407840|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
56407841|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407842|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56407843|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56407844|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407845|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407846|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56407847|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
56407848|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56407849|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407850|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56407851|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
56407852|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56407853|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56407854|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407855|NCT02895061|Vitamins|vitamins|mesh-ancestor
56407856|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
56407857|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56407858|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
56407859|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407860|NCT00170222|Doxycycline|doxycycline|mesh-list
56407862|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56407863|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
56407864|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56407865|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56407866|NCT02894983|Calpastatin|calpastatin|mesh-list
56407867|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56407868|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
56407869|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407870|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407872|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
56407873|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
56407874|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407875|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407876|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
56407877|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407878|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56407879|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56407880|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56407881|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407882|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407883|NCT00409851|Amlodipine|amlodipine|mesh-list
56407884|NCT00409851|Valsartan|valsartan|mesh-list
56407885|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56407886|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56909143|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56909144|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
56909145|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371222|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
56407887|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407888|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407889|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56407892|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56407893|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56407895|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56407896|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
56407897|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56407898|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407899|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56407900|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407901|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
56407902|NCT00409890|Scopolamine|scopolamine|mesh-list
56407903|NCT00409890|Bromides|bromides|mesh-list
56407904|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56407905|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
56407906|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56407907|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
56407908|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
56407909|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407910|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407911|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407912|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
56407913|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56407914|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
56407915|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407916|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407917|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56407918|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
56407919|NCT05423821|Anesthetics|anesthetics|mesh-list
56407920|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407921|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407922|NCT00170378|Enoxaparin|enoxaparin|mesh-list
56407923|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
56407924|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56407925|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56407926|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407927|NCT00179244|Bupropion|bupropion|mesh-list
56407928|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56163863|NCT00002580|Leuprolide|leuprolide|mesh-list
56407929|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
56407930|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407931|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56407932|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56407933|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407934|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407936|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407937|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407938|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56407939|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56407940|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407941|NCT05423197|Panitumumab|panitumumab|mesh-list
56407942|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56407943|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407944|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
56407945|NCT00196872|Epirubicin|epirubicin|mesh-list
56407946|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407947|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
56407948|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407949|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56407950|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56407951|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
56407952|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407953|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909146|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909147|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56909148|NCT03642717|Empagliflozin|empagliflozin|mesh-list
56909149|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56909150|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909151|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56909152|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909153|NCT02766478|Genistein|genistein|mesh-list
56909154|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56909155|NCT02766478|Protective Agents|protective agents|mesh-ancestor
56909156|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909157|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909158|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56407954|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56407955|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56407956|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56407957|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56407958|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407959|NCT05422885|Dasatinib|dasatinib|mesh-list
56407960|NCT05422885|Quercetin|quercetin|mesh-list
56407961|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407964|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407965|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
56407966|NCT05422885|Protective Agents|protective agents|mesh-ancestor
56407967|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407968|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56407969|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56407970|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
56407971|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407972|NCT00170456|Antacids|antacids|mesh-ancestor
56407973|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407974|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56407975|NCT00179283|Sertraline|sertraline|mesh-list
56407976|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56407977|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
56407978|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56407979|NCT00179283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56407980|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56407981|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407982|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407983|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407984|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
56407985|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407986|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56407987|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56407988|NCT04680286|Methadone|methadone|mesh-list
56407989|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56407990|NCT04680286|Narcotics|narcotics|mesh-ancestor
56407991|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56407992|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407993|NCT04680286|Analgesics|analgesics|mesh-ancestor
56407994|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
56407995|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56407996|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
56407997|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
56407998|NCT05420350|Lamotrigine|lamotrigine|mesh-list
56407999|NCT05420350|Bupropion|bupropion|mesh-list
56408000|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56408001|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
56408002|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56909159|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909160|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909161|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
56909162|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56909163|NCT02766478|Estrogens|estrogens|mesh-ancestor
56909164|NCT02766478|Hormones|hormones|mesh-ancestor
56909165|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909166|NCT03729375|Bupivacaine|bupivacaine|mesh-list
56909167|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
56909168|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
56909169|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909170|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408003|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56408004|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56408005|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56155652|NCT04509414|Midazolam|midazolam|mesh-list
56408006|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408007|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
56408008|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408009|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408010|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56408011|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56408012|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408013|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
56408014|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56408015|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56408016|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56408017|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56408018|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408019|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56408020|NCT03097939|Nivolumab|nivolumab|mesh-list
56408021|NCT03097939|Ipilimumab|ipilimumab|mesh-list
56408022|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56408023|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408024|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56408025|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408026|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
56408027|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56408028|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56408029|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56408030|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55982603|NCT00885079|Protective Agents|protective agents|mesh-ancestor
56408031|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408032|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
56408033|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408034|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408035|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56408036|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408037|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56408038|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56408039|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408040|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
56408041|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56408042|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56408043|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408044|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
56408045|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
56408046|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408047|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56408048|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56408049|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
56909171|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
56909172|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371419|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
56408050|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408051|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408052|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56408053|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
56408054|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408056|NCT00170690|Busulfan|busulfan|mesh-list
56408057|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56408058|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
56408059|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408060|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408061|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408062|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
56408063|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408064|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56408065|NCT00196989|Pioglitazone|pioglitazone|mesh-list
56408066|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56408067|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408068|NCT00170729|Prednisolone|prednisolone|mesh-list
56408069|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56408070|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
56163870|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
56408071|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56408072|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
56408073|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56408074|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
56408075|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56408076|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
56408077|NCT00170729|Hormones|hormones|mesh-ancestor
56408078|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56408079|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408080|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56408081|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408082|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
56408083|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
56408084|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408085|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56408086|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56408087|NCT00170729|Protective Agents|protective agents|mesh-ancestor
56408089|NCT00170768|Darifenacin|darifenacin|mesh-list
56408090|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
56408091|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
56408092|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408093|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408094|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56408095|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56408096|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
56408097|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408098|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408099|NCT00170768|Urological Agents|urological agents|mesh-ancestor
56408100|NCT02655562|Montelukast|montelukast|mesh-list
56408101|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56408102|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
56408103|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56408104|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
56408107|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56408108|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56408109|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408110|NCT00170885|Everolimus|everolimus|mesh-list
56408111|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408112|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408113|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
56408114|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408115|NCT02607748|Listerine|listerine|mesh-list
56408116|NCT02607748|Fluorides|fluorides|mesh-list
56408117|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
56408118|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
56408119|NCT02607748|Protective Agents|protective agents|mesh-ancestor
56408120|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088985|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909173|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56909174|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56909175|NCT02159326|Riociguat|riociguat|mesh-list
56909176|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
56371491|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408121|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56408122|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408123|NCT02502253|Resveratrol|resveratrol|mesh-list
56408124|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
56408125|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408126|NCT02502253|Protective Agents|protective agents|mesh-ancestor
56408127|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408128|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408129|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56408130|NCT00170924|Valsartan|valsartan|mesh-list
56408131|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56408132|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56408133|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56408134|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408135|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
56408136|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56408137|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56408138|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408139|NCT00170963|Amlodipine|amlodipine|mesh-list
56408140|NCT00170963|Valsartan|valsartan|mesh-list
56408141|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56408142|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56408143|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56408144|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408145|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56408146|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408147|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
56408148|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56408149|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56408150|NCT02492776|Omeprazole|omeprazole|mesh-list
56408151|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56408152|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56408153|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56408154|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408155|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408156|NCT00171002|Amlodipine|amlodipine|mesh-list
56408157|NCT00171002|Valsartan|valsartan|mesh-list
56408158|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56408159|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56408160|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56408161|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408162|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56408163|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408164|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
56408165|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56408166|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56408167|NCT05400031|Propolis|propolis|mesh-list
56408168|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408169|NCT00171041|Valsartan|valsartan|mesh-list
56408170|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56408171|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56408172|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55982763|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56408177|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56408178|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408179|NCT05392699|Interleukin-12|interleukin-12|mesh-list
56408180|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56408181|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
56408182|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408183|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56408184|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56909177|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909178|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56909179|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
56408185|NCT05392699|Growth Substances|growth substances|mesh-ancestor
56408186|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
56408187|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408188|NCT00171080|Valsartan|valsartan|mesh-list
56408189|NCT00171080|Irbesartan|irbesartan|mesh-list
56408190|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56408191|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56408192|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56408193|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408194|NCT02229877|Omeprazole|omeprazole|mesh-list
56408195|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56408196|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56408197|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56408198|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408199|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408200|NCT00171119|Valsartan|valsartan|mesh-list
56163874|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
56408201|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56408202|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56408203|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56408204|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408205|NCT02102113|Dronabinol|dronabinol|mesh-list
56408206|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
56408207|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408208|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56408209|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56408210|NCT02102113|Analgesics|analgesics|mesh-ancestor
56408211|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
56408212|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408213|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56408214|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56408215|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408216|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408217|NCT02102113|Hormones|hormones|mesh-ancestor
56408218|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56408219|NCT05379790|Irinotecan|irinotecan|mesh-list
56408220|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56408221|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56408222|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155869|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56408223|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408224|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408226|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56408227|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56408228|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
56408229|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56408230|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56408231|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408232|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408233|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56408234|NCT05349448|Analgesics|analgesics|mesh-ancestor
56408235|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
56408236|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408237|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56408238|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56408239|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56408242|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408243|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56408244|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
56408245|NCT05349448|Hormones|hormones|mesh-ancestor
56408246|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56408247|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408248|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
56408249|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408250|NCT00171353|Valsartan|valsartan|mesh-list
56408251|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56909180|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56909181|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909182|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56408252|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56408253|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56408254|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408255|NCT01656343|Abatacept|abatacept|mesh-list
56408256|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56408257|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56408258|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408259|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408260|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408261|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
56408262|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408263|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408264|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408265|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56408266|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56408267|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408268|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
56408269|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
56408270|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56408271|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408272|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56408273|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
56408274|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56408275|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408276|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408277|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408279|NCT01367002|Carboplatin|carboplatin|mesh-list
56408280|NCT01367002|Trastuzumab|trastuzumab|mesh-list
56408281|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56408282|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408283|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
56408284|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
56408285|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
56408286|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408287|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56408288|NCT00171431|Tegaserod|tegaserod|mesh-list
56408289|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56408290|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
56408291|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408292|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408293|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408294|NCT04679740|Sirolimus|sirolimus|mesh-list
56408295|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56408296|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408297|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56408298|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408299|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
56408300|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408301|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
56408302|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408303|NCT01330030|Selegiline|selegiline|mesh-list
56408304|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
56408305|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56408306|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56408307|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56408308|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56408309|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408310|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408311|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56408312|NCT01330030|Protective Agents|protective agents|mesh-ancestor
56408315|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56408317|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408318|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408319|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408320|NCT00171509|Cyclosporine|cyclosporine|mesh-list
56408321|NCT00171509|Cyclosporins|cyclosporins|mesh-list
56408322|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909183|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56909184|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56909185|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56909186|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56909187|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56909188|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56909189|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56909190|NCT02255266|Liraglutide|liraglutide|mesh-list
56909191|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56408323|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408324|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408325|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
56408326|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408327|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
56408328|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408329|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
56408330|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408331|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56408332|NCT00179712|Topotecan|topotecan|mesh-list
56408333|NCT00179712|Lenalidomide|lenalidomide|mesh-list
56408334|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56408335|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56408336|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408337|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408338|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408339|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
56408340|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408341|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56408342|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56408343|NCT00179712|Growth Substances|growth substances|mesh-ancestor
56408344|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
56408345|NCT00611572|Flumazenil|flumazenil|mesh-list
56408346|NCT00611572|Antidotes|antidotes|mesh-ancestor
56408347|NCT00611572|Protective Agents|protective agents|mesh-ancestor
56408348|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408349|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
56408350|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
56408351|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408352|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408353|NCT00197340|Ropivacaine|ropivacaine|mesh-list
56408354|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
56408355|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
56408356|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408357|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408358|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
56408359|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408360|NCT02474368|Cisplatin|cisplatin|mesh-list
56408361|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408362|NCT00171587|Vatalanib|vatalanib|mesh-list
56408363|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56408364|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408365|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408366|NCT05265052|Oxycodone|oxycodone|mesh-list
56408367|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56408368|NCT05265052|Narcotics|narcotics|mesh-ancestor
56408369|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408370|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408371|NCT05265052|Analgesics|analgesics|mesh-ancestor
56408372|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
56408373|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408374|NCT00171626|Diclofenac|diclofenac|mesh-list
56408375|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56408376|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56408377|NCT00171626|Analgesics|analgesics|mesh-ancestor
56408378|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
56408379|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909192|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909193|NCT02255266|Incretins|incretins|mesh-ancestor
56909194|NCT02255266|Hormones|hormones|mesh-ancestor
56909195|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909196|NCT00104650|Diphosphonates|diphosphonates|mesh-list
56909197|NCT00104650|Denosumab|denosumab|mesh-list
56909198|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56909199|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909200|NCT02158078|Insulin|insulin|mesh-list
56909201|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56909202|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909203|NCT00104416|Lamotrigine|lamotrigine|mesh-list
56909204|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
56909205|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56909206|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56909207|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909208|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56371770|NCT00096512|Sorafenib|sorafenib|mesh-list
56408380|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408381|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56408382|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408383|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56408384|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408385|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408388|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408389|NCT00171665|Diclofenac|diclofenac|mesh-list
56408390|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56408391|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56408392|NCT00171665|Analgesics|analgesics|mesh-ancestor
56408393|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
56408394|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408395|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408396|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56408397|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408398|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56408399|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408400|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408401|NCT00179751|Gemcitabine|gemcitabine|mesh-list
56408402|NCT00179751|Lenalidomide|lenalidomide|mesh-list
56408403|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56408404|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
56408405|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408406|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408407|NCT00179751|Antiviral Agents|antiviral agents|mesh-ancestor
56408408|NCT00179751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408409|NCT00179751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408410|NCT00179751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408411|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
56408412|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408413|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56408414|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56408415|NCT00179751|Growth Substances|growth substances|mesh-ancestor
56408416|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
56408417|NCT05233228|Nicotine|nicotine|mesh-list
56408418|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56408419|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
56909209|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909210|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56909211|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56909212|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909213|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56909214|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56909215|NCT04817254|Nivolumab|nivolumab|mesh-list
56909216|NCT04817254|Ipilimumab|ipilimumab|mesh-list
56909217|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56909218|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909219|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56408420|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408421|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408422|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56408423|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56408424|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
56408425|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408426|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408427|NCT05223478|Phentolamine|phentolamine|mesh-list
56408428|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56408429|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56408430|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56408431|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56408432|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
56408433|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408434|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408435|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408436|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56408437|NCT00171743|Cyclosporine|cyclosporine|mesh-list
56408438|NCT00171743|Cyclosporins|cyclosporins|mesh-list
56408439|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408440|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408441|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408442|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
56408443|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408444|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
56156094|NCT02486718|Immunologic Factors|immunologic factors|mesh-ancestor
56408445|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408446|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
56408447|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408448|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56408449|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
56408450|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56408451|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408452|NCT00171782|Valsartan|valsartan|mesh-list
56408453|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56408454|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56408455|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56408456|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55983051|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
56408458|NCT00171782|Diuretics|diuretics|mesh-ancestor
56408459|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
56408460|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408461|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56408462|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56408463|NCT00197379|Roxithromycin|roxithromycin|mesh-list
56408464|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56408465|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408466|NCT05159050|Paclitaxel|paclitaxel|mesh-list
56408467|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56408468|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408469|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
56408470|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
56408471|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
56909220|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909221|NCT02149888|Tenofovir|tenofovir|mesh-list
56909222|NCT02149888|Emtricitabine|emtricitabine|mesh-list
56909223|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
56909224|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909225|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56909226|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56909227|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909228|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408472|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408474|NCT00197418|Metronidazole|metronidazole|mesh-list
56408475|NCT00197418|Clarithromycin|clarithromycin|mesh-list
56408476|NCT00197418|Rabeprazole|rabeprazole|mesh-list
56408477|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56408478|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408479|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56408480|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56408481|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56408482|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408483|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408484|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56408485|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56408486|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56408487|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56408488|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56408489|NCT05103904|Lenvatinib|lenvatinib|mesh-list
56408490|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408491|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56408492|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408493|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408494|NCT00171821|Deferasirox|deferasirox|mesh-list
56408495|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56408496|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
56408497|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
56408498|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408499|NCT05054023|Piroxicam|piroxicam|mesh-list
56408500|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56408501|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56408502|NCT05054023|Analgesics|analgesics|mesh-ancestor
56408503|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
56408504|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408505|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408506|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56408507|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408508|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56408509|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408510|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408511|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
56408512|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408513|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56408514|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408515|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408516|NCT00553930|Interferons|interferons|mesh-list
56408517|NCT00553930|Ribavirin|ribavirin|mesh-list
56408518|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
56408519|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
56408520|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56408521|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408522|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
56408523|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408524|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
56408525|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408526|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
56408527|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408528|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
56909229|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56909230|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56909231|NCT03639675|Aflibercept|aflibercept|mesh-list
56909232|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56909233|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56408529|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408530|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56408532|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408533|NCT05004259|Daratumumab|daratumumab|mesh-list
56408534|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408536|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408537|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56408538|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408539|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408540|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
56408541|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408542|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56408543|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408544|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408545|NCT00197613|Lamivudine|lamivudine|mesh-list
56408546|NCT00197613|Zidovudine|zidovudine|mesh-list
56408547|NCT00197613|Efavirenz|efavirenz|mesh-list
56408548|NCT00197613|Nevirapine|nevirapine|mesh-list
56408549|NCT00197613|Didanosine|didanosine|mesh-list
56408550|NCT00197613|Stavudine|stavudine|mesh-list
56408551|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56408552|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56408553|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408554|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408555|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
56408556|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408557|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56408558|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56408559|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
56408560|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56408561|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56408562|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56408563|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56408564|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56408565|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56408566|NCT02240407|Acetaminophen|acetaminophen|mesh-list
56408567|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
56408568|NCT02240407|Promethazine|promethazine|mesh-list
56408569|NCT02240407|Sirolimus|sirolimus|mesh-list
56408570|NCT02240407|Rituximab|rituximab|mesh-list
56408571|NCT02240407|Lidocaine|lidocaine|mesh-list
56408572|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56408573|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408574|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
56408575|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408576|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408577|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
56408578|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
56408579|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408580|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
56408581|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408582|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56408583|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56408584|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56408585|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56408586|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408587|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56408588|NCT02240407|Analgesics|analgesics|mesh-ancestor
56408589|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
56408590|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56408591|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408592|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56408593|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
56408594|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408595|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56408596|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56909234|NCT03639675|Growth Substances|growth substances|mesh-ancestor
56909235|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909236|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
56909237|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909238|NCT03543436|Meropenem|meropenem|mesh-list
56909239|NCT03543436|Imipenem|imipenem|mesh-list
56909240|NCT03543436|Temocillin|temocillin|mesh-list
56909241|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909242|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909243|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
56909244|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
56619907|NCT00833469|Citalopram|citalopram|mesh-list
56909245|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909247|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408597|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
56408598|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
56408599|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56408600|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56408601|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
56408602|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
56408603|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408604|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56408605|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
56408606|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
56408609|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408611|NCT04958122|Cefixime|cefixime|mesh-list
56408612|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56408613|NCT04958122|Penicillin G|penicillin g|mesh-list
56408614|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
56408615|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56408616|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408617|NCT00180024|Irbesartan|irbesartan|mesh-list
56408618|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56408619|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56408620|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56408621|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408622|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
56408623|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56408624|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408625|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
56408626|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408627|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
56408628|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
56408629|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
56408630|NCT03455179|Methamphetamine|methamphetamine|mesh-list
56408631|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56408632|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408633|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
56408634|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
56408635|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408636|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
56408637|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408638|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408639|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
56408640|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56408641|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56408642|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56408643|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56408644|NCT00202293|Olanzapine|olanzapine|mesh-list
56408645|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
56408646|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
56408647|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
56408648|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408649|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909248|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909249|NCT01310361|Amoxicillin|amoxicillin|mesh-list
56909250|NCT01310361|Penicillins|penicillins|mesh-list
56909251|NCT01310361|Penicillin G|penicillin g|mesh-list
56408650|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56408651|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56408652|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56408653|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408654|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56408655|NCT00202293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56408656|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56408657|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56408658|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408659|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408660|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
56408661|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56408662|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
56408663|NCT00197730|Folic Acid|folic acid|mesh-list
56408664|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
56408665|NCT00197730|Vitamins|vitamins|mesh-ancestor
56408666|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
56408667|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408668|NCT00197730|Hematinics|hematinics|mesh-ancestor
56408669|NCT00172172|Calcium|calcium|mesh-list
56408670|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
56333871|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56408671|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56408672|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408674|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
56408675|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
56408676|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408677|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408678|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
55983272|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56408682|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56408683|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56408684|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408685|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408686|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56408687|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408688|NCT02908438|Hormones|hormones|mesh-list
56408689|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56408690|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408691|NCT04731844|Curcumin|curcumin|mesh-list
56408692|NCT04731844|Piperine|piperine|mesh-list
56408693|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56408694|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56408695|NCT04731844|Analgesics|analgesics|mesh-ancestor
56408696|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
56408697|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408698|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408699|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56408700|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408701|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408702|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408703|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408704|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56408705|NCT00172367|Lycopene|lycopene|mesh-list
56408706|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56408707|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
56408708|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408709|NCT00172367|Protective Agents|protective agents|mesh-ancestor
56408710|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408711|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56408712|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56408713|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408714|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
56408715|NCT04632316|Fludarabine|fludarabine|mesh-list
56408716|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408717|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
56408718|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408719|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909252|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56909253|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
56909254|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909255|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909256|NCT03541798|Anesthetics|anesthetics|mesh-list
56408720|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56408721|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
56408722|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408723|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408724|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56408725|NCT00197886|Norepinephrine|norepinephrine|mesh-list
56408726|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56408727|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56408728|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56408729|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408730|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408731|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408732|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
56408733|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
56408734|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408735|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56408736|NCT04569877|Molgramostim|molgramostim|mesh-list
56408737|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56408738|NCT04569877|Sargramostim|sargramostim|mesh-list
56408739|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408740|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
56408741|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408743|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
56408744|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408745|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56408746|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408747|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408748|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56408749|NCT02908165|Estrogens|estrogens|mesh-ancestor
56408750|NCT02908165|Hormones|hormones|mesh-ancestor
56408751|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55983344|NCT00905515|Tacrolimus|tacrolimus|mesh-list
56408753|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56408754|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
56408755|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56408756|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408757|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56408758|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408759|NCT02908282|Povidone|povidone|mesh-list
56408760|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
56408761|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
56408762|NCT02908126|Oxytocin|oxytocin|mesh-list
56408763|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
56408764|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56408765|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408766|NCT00202605|Amphetamine|amphetamine|mesh-list
56408767|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
56408768|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56408769|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408770|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
56408771|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
56408772|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408773|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
56408774|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408775|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408776|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
56408777|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56408778|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56408779|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56408780|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56408781|NCT00198120|Cycloserine|cycloserine|mesh-list
56408782|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56408783|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408784|NCT00198120|Renal Agents|renal agents|mesh-ancestor
56408785|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56909257|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909258|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909259|NCT02150122|Vitamin D|vitamin d|mesh-list
56909260|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
56909261|NCT02150122|Vitamins|vitamins|mesh-ancestor
56408786|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
56408787|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56408788|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
56408789|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408790|NCT00198159|Gefitinib|gefitinib|mesh-list
56408791|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408792|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56408793|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408794|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408795|NCT02907307|Clotrimazole|clotrimazole|mesh-list
56408796|NCT02907307|Miconazole|miconazole|mesh-list
56408797|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56408798|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408799|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
56408800|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56408801|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56408802|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408803|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408804|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56408805|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
56408806|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56408807|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408808|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56408809|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56408810|NCT00553345|Vitamin E|vitamin e|mesh-list
56408811|NCT00553345|Selenium|selenium|mesh-list
56408812|NCT00553345|Vitamins|vitamins|mesh-ancestor
56408813|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
56408814|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408816|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156471|NCT02472522|Analgesics|analgesics|mesh-ancestor
56408817|NCT00553345|Protective Agents|protective agents|mesh-ancestor
56408818|NCT00553345|Trace Elements|trace elements|mesh-ancestor
56408819|NCT00202800|Gemcitabine|gemcitabine|mesh-list
56408820|NCT00202800|Etoposide|etoposide|mesh-list
56408821|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56408822|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
56408823|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408824|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408827|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408828|NCT00202800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408829|NCT00202800|Immunologic Factors|immunologic factors|mesh-ancestor
56408830|NCT00202800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408831|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56408832|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56408833|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56408834|NCT00407771|Tirofiban|tirofiban|mesh-list
56408835|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56408836|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56408837|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408838|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56408839|NCT00198198|Aripiprazole|aripiprazole|mesh-list
56408840|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
56408841|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56408842|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56408843|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56408844|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408845|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408846|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
56408847|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
56408848|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408849|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408850|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56408851|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56909262|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
56909263|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909264|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56909265|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56909266|NCT03728829|Carboplatin|carboplatin|mesh-list
56909267|NCT03728829|Docetaxel|docetaxel|mesh-list
56909268|NCT03728829|Trastuzumab|trastuzumab|mesh-list
56909269|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909270|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
56408852|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
56408853|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56408854|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56408855|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56408856|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56408857|NCT02206087|Heparin|heparin|mesh-list
56408858|NCT02206087|Calcium heparin|calcium heparin|mesh-list
56408859|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
56408860|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56408861|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56408862|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408863|NCT00198237|Docetaxel|docetaxel|mesh-list
56408864|NCT00198237|Capecitabine|capecitabine|mesh-list
56408865|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408866|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56408867|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56408868|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56408869|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408870|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56408871|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
56408872|NCT00198354|Gemcitabine|gemcitabine|mesh-list
56408873|NCT00198354|Paclitaxel|paclitaxel|mesh-list
56408874|NCT00198354|Carboplatin|carboplatin|mesh-list
56408875|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56408876|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408877|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
56408878|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
56408879|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
56408880|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408881|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56408882|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
56408883|NCT00198354|Antiviral Agents|antiviral agents|mesh-ancestor
56408884|NCT00198354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408885|NCT00198354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408886|NCT00198354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408887|NCT00198354|Immunologic Factors|immunologic factors|mesh-ancestor
56408888|NCT00198354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408889|NCT02158585|Lamotrigine|lamotrigine|mesh-list
56408890|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
56408891|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56408892|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56408893|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408894|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56408895|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408896|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56408897|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56408899|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56408900|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56408902|NCT00202917|Melphalan|melphalan|mesh-list
56408903|NCT00202917|Thiotepa|thiotepa|mesh-list
56408904|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408905|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408906|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408907|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
56408908|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408909|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56408910|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
56408911|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56909271|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
56909272|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
56909273|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909274|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56909275|NCT00121667|Metformin|metformin|mesh-list
56909276|NCT00121667|Pioglitazone|pioglitazone|mesh-list
56909277|NCT00121667|Saxagliptin|saxagliptin|mesh-list
56909278|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56909279|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909280|NCT00121667|Incretins|incretins|mesh-ancestor
56909281|NCT00121667|Hormones|hormones|mesh-ancestor
56909282|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909283|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56909284|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
56909285|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372371|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408912|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
56408913|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
56408914|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
56408915|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56408916|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
56408917|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408918|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408919|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408920|NCT04677868|Methotrexate|methotrexate|mesh-list
56408921|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56408922|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
56408923|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56408924|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408925|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56408926|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
56408927|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408928|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408929|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
56408930|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408931|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56408932|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408933|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
56408934|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408935|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56408936|NCT00198393|Gemcitabine|gemcitabine|mesh-list
56408937|NCT00198393|Docetaxel|docetaxel|mesh-list
56408938|NCT00198393|Gefitinib|gefitinib|mesh-list
56408939|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56408940|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
56408941|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408942|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408943|NCT00198393|Antiviral Agents|antiviral agents|mesh-ancestor
56408944|NCT00198393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408945|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408946|NCT00198393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408947|NCT00198393|Immunologic Factors|immunologic factors|mesh-ancestor
56408948|NCT00198393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408949|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
56408950|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
56408951|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
56408952|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56408953|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
56408954|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408955|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909286|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909287|NCT02954601|Insulin|insulin|mesh-list
56909288|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56909289|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56909290|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909291|NCT00121199|Prednisone|prednisone|mesh-list
56909292|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
56909293|NCT00121199|Bevacizumab|bevacizumab|mesh-list
56909294|NCT00121199|Rituximab|rituximab|mesh-list
56909354|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56909355|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909356|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909357|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56909358|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56909359|NCT01079351|Analgesics|analgesics|mesh-ancestor
56909360|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
56909361|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408956|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408957|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408958|NCT00554827|Vitamins|vitamins|mesh-list
56408959|NCT00554827|Folic Acid|folic acid|mesh-list
56408960|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
56408961|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
56408962|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
56408963|NCT00554827|Aminopterin|aminopterin|mesh-list
56408964|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
56408965|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408966|NCT00554827|Hematinics|hematinics|mesh-ancestor
56408967|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56408968|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408969|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408970|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408972|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56408973|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408974|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408977|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408978|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
56408979|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
56408980|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
56408981|NCT00203073|Analgesics|analgesics|mesh-ancestor
56408982|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
56408983|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408984|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408985|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408986|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56408987|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56408988|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408989|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408990|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56408991|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
56408992|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56408993|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56408994|NCT00198432|Paclitaxel|paclitaxel|mesh-list
56408995|NCT00198432|Vinorelbine|vinorelbine|mesh-list
56408996|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56408997|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408998|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
56408999|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409000|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409001|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409002|NCT02072863|Prednisone|prednisone|mesh-list
56409003|NCT02072863|Melphalan|melphalan|mesh-list
56409004|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409005|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
56409006|NCT02072863|Hormones|hormones|mesh-ancestor
56409007|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409008|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409009|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56409010|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409011|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56409012|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
56409013|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409014|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56409015|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409016|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
55888087|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56909362|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56909363|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56909364|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909365|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56909366|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56909367|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
56909368|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56909369|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909370|NCT02158624|Ranibizumab|ranibizumab|mesh-list
56909371|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56909372|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56909373|NCT02158624|Growth Substances|growth substances|mesh-ancestor
56909374|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909375|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
56909376|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909377|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
56909378|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909379|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909380|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409017|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56409018|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56409019|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
56409020|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409021|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56409022|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409023|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56409024|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409025|NCT00203112|Minocycline|minocycline|mesh-list
56409026|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
56409027|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
56409028|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56409029|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409030|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56409031|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
56409032|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409033|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409034|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409035|NCT02057380|Dexamethasone|dexamethasone|mesh-list
56409036|NCT02057380|Paclitaxel|paclitaxel|mesh-list
56409037|NCT02057380|Bortezomib|bortezomib|mesh-list
56409038|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56409039|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56409040|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409041|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56409042|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409043|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409044|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409045|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409046|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
56409047|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
56409048|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409051|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
56409052|NCT02057380|Hormones|hormones|mesh-ancestor
56409053|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409054|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56909381|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909382|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
56409055|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56409056|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409057|NCT02052778|Futibatinib|futibatinib|mesh-list
56409058|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409059|NCT02050828|Ranibizumab|ranibizumab|mesh-list
56409060|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56409061|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56409062|NCT02050828|Growth Substances|growth substances|mesh-ancestor
56409063|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409064|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
56409065|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409066|NCT02046694|Allopurinol|allopurinol|mesh-list
56409067|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
56409068|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409069|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409070|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
56409071|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409072|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56409073|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
56409074|NCT02046694|Protective Agents|protective agents|mesh-ancestor
56409075|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409076|NCT00203190|Topiramate|topiramate|mesh-list
56409077|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
56409078|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56409079|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409080|NCT02019589|Progesterone|progesterone|mesh-list
56409081|NCT02019589|Progestins|progestins|mesh-ancestor
56409082|NCT02019589|Hormones|hormones|mesh-ancestor
56409083|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409084|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409085|NCT02018926|Azacitidine|azacitidine|mesh-list
56409086|NCT02018926|Mocetinostat|mocetinostat|mesh-list
56409087|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56409088|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
56409089|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409090|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409091|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409092|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56409093|NCT01989325|Dexamethasone|dexamethasone|mesh-list
56409094|NCT01989325|Filanesib|filanesib|mesh-list
56409095|NCT01989325|Lenograstim|lenograstim|mesh-list
56409096|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56409097|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409098|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
56409099|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
56409100|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409101|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409102|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56409103|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
56409104|NCT01989325|Hormones|hormones|mesh-ancestor
56409105|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409106|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56409107|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409108|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56409109|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
56409110|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
56409111|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409112|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409113|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409114|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409115|NCT01978366|Halofuginone|halofuginone|mesh-list
56409116|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409117|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
56409118|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56156772|NCT02547012|Amoxicillin|amoxicillin|mesh-list
56409119|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56409120|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409121|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56409122|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409125|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56409126|NCT01978366|Growth Substances|growth substances|mesh-ancestor
56409127|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409128|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
56909383|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
56909384|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909385|NCT03639519|Protective Agents|protective agents|mesh-ancestor
56909386|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909387|NCT03639519|Vitamins|vitamins|mesh-ancestor
56409130|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
56409131|NCT02962986|Norepinephrine|norepinephrine|mesh-list
56409132|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56409133|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
56409134|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
56409135|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409136|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409137|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
56409138|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56409139|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
56409140|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
56409141|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56409142|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56409143|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56409144|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
56409145|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409146|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409147|NCT02962986|Protective Agents|protective agents|mesh-ancestor
56409148|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
56409149|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56409150|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409151|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
56409152|NCT01968733|Solithromycin|solithromycin|mesh-list
56409153|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56409154|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409155|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56409156|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56409157|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409158|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409159|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409160|NCT00410553|Gemcitabine|gemcitabine|mesh-list
56409161|NCT00410553|Halichondrin B|halichondrin b|mesh-list
56409162|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56409163|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
56409164|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409165|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409166|NCT00410553|Antiviral Agents|antiviral agents|mesh-ancestor
56409167|NCT00410553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409168|NCT00410553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409169|NCT00410553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409170|NCT00410553|Immunologic Factors|immunologic factors|mesh-ancestor
56409171|NCT00410553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409172|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
56409173|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409174|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409175|NCT00410592|Esomeprazole|esomeprazole|mesh-list
56409176|NCT00410592|Pantoprazole|pantoprazole|mesh-list
56409177|NCT00410592|Lansoprazole|lansoprazole|mesh-list
56409178|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
56409179|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56409180|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56409181|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56409182|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409183|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409184|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
56409185|NCT00410631|Melphalan|melphalan|mesh-list
56409186|NCT00410631|Ifosfamide|ifosfamide|mesh-list
56409187|NCT00410631|Dacarbazine|dacarbazine|mesh-list
56409188|NCT00410631|Carboplatin|carboplatin|mesh-list
56409189|NCT00410631|Doxorubicin|doxorubicin|mesh-list
56409190|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56409191|NCT00410631|Etoposide|etoposide|mesh-list
56409192|NCT00410631|Vincristine|vincristine|mesh-list
56409193|NCT00410631|Topotecan|topotecan|mesh-list
56409194|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
56333872|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
56409195|NCT00410631|Vindesine|vindesine|mesh-list
56409196|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56409197|NCT00410631|Isotretinoin|isotretinoin|mesh-list
56909388|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
56909389|NCT02158702|Dexamethasone|dexamethasone|mesh-list
56909390|NCT02158702|Pomalidomide|pomalidomide|mesh-list
56909391|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909392|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
56909393|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
56909394|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909395|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909396|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56909397|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
56909398|NCT02158702|Hormones|hormones|mesh-ancestor
56909399|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909400|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56909401|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909402|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
56372706|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409200|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409202|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56409203|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
56409204|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409205|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409206|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56409207|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56409208|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56409209|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56409210|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409211|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56409212|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
56409213|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409214|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409215|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56409216|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
56409217|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56409219|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
56409220|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409221|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
56409222|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56409223|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409224|NCT01903954|Ribavirin|ribavirin|mesh-list
56409225|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56409226|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
56409227|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409228|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
56409229|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409230|NCT01893190|Nimodipine|nimodipine|mesh-list
56409231|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56409232|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56409233|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56409234|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409235|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56409236|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409237|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
56409238|NCT00198588|Argatroban|argatroban|mesh-list
56409239|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
56409240|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56409241|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
56409242|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409243|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409244|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
56909403|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56909404|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56909405|NCT02158702|Growth Substances|growth substances|mesh-ancestor
56909406|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
56909407|NCT03725709|Anesthetics|anesthetics|mesh-list
56909408|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909409|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909410|NCT01761890|Dasatinib|dasatinib|mesh-list
56909411|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909412|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909413|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909414|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909415|NCT02160028|Anesthetics|anesthetics|mesh-list
56909416|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909417|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909418|NCT03246152|Bevacizumab|bevacizumab|mesh-list
56909419|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56909420|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909421|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56909422|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56909423|NCT03246152|Growth Substances|growth substances|mesh-ancestor
56409245|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56409246|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56409247|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409248|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56409249|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409250|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409252|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
56409253|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409254|NCT01874626|Ibuprofen|ibuprofen|mesh-list
56409255|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56409256|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56409257|NCT01874626|Analgesics|analgesics|mesh-ancestor
56409258|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
56409259|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409260|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409261|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409262|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409263|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56409264|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409265|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409266|NCT00410748|Hydromorphone|hydromorphone|mesh-list
56409267|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56409268|NCT00410748|Narcotics|narcotics|mesh-ancestor
56409269|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56409270|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409273|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409274|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56409275|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56409276|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409277|NCT00198627|Renal Agents|renal agents|mesh-ancestor
56088986|NCT02885636|Albuterol|albuterol|mesh-list
56909424|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909425|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
56909426|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
56909427|NCT03541564|BMS-986165|bms-986165|mesh-list
56909428|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909429|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909430|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56909431|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56909432|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909433|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909434|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909435|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
56909436|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909437|NCT00115349|Deferiprone|deferiprone|mesh-list
56909438|NCT00115349|Deferoxamine|deferoxamine|mesh-list
56909439|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56909440|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
56909441|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
56909442|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909443|NCT00115349|Siderophores|siderophores|mesh-ancestor
56909444|NCT04804696|Paclitaxel|paclitaxel|mesh-list
56909445|NCT04804696|Cisplatin|cisplatin|mesh-list
56909446|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56909447|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909448|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
56909449|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
56909450|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
56909451|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909473|NCT03604341|Dronabinol|dronabinol|mesh-list
56909474|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
56909547|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56909548|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56909549|NCT02778100|Phenylephrine|phenylephrine|mesh-list
56909550|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
56909551|NCT02778100|Glucagon|glucagon|mesh-list
56909552|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56909553|NCT02778100|Hormones|hormones|mesh-ancestor
56909554|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909555|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909556|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56909557|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56909558|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
56909559|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56909560|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909561|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
56909562|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
56909563|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909564|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
56909565|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56909566|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
56909567|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56909568|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
56909569|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56909570|NCT02778100|Protective Agents|protective agents|mesh-ancestor
56409278|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56409279|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
56409280|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56409281|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56409282|NCT01862224|Methotrexate|methotrexate|mesh-list
56409283|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56409284|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
56409285|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56409286|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409287|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56409288|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
56409289|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409290|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409291|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
56409292|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409293|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56409294|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409295|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
56409296|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409297|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56409298|NCT01859962|Ribavirin|ribavirin|mesh-list
56409299|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
56409300|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409301|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
56409302|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409303|NCT00173888|Gemcitabine|gemcitabine|mesh-list
56409304|NCT00173888|Cisplatin|cisplatin|mesh-list
56409305|NCT00173888|Docetaxel|docetaxel|mesh-list
56909571|NCT02159248|Gemcitabine|gemcitabine|mesh-list
56909572|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
56909573|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56909574|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
56909575|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909576|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909577|NCT02159248|Antiviral Agents|antiviral agents|mesh-ancestor
56909578|NCT02159248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909579|NCT02159248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909580|NCT02159248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909581|NCT02159248|Immunologic Factors|immunologic factors|mesh-ancestor
56909582|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909583|NCT02159248|Analgesics|analgesics|mesh-ancestor
56909584|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
56909585|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909586|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56909587|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56909588|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909589|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909590|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56409306|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409307|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56409308|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
56409309|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409310|NCT00173888|Antiviral Agents|antiviral agents|mesh-ancestor
56409311|NCT00173888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409312|NCT00173888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409313|NCT00173888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409314|NCT00173888|Immunologic Factors|immunologic factors|mesh-ancestor
56409315|NCT00173888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409316|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56409317|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409318|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409320|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
56409321|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56409322|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
56409323|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409324|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409325|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56409326|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
56409327|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
56409328|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56409329|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
56409330|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409331|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409332|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
56409333|NCT00203385|Valproic Acid|valproic acid|mesh-list
56409334|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
56409335|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409336|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409337|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
56409338|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409339|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409340|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
56909591|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56909592|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56909593|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
56409341|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56409342|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56409343|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56409344|NCT00555100|Dexamethasone|dexamethasone|mesh-list
56409345|NCT00555100|Lenalidomide|lenalidomide|mesh-list
56409346|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409347|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
56409349|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409350|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409351|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56409352|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
56409354|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409355|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56409356|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409357|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
56409358|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56409359|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56409360|NCT00555100|Growth Substances|growth substances|mesh-ancestor
56409361|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
56409362|NCT00555139|Alprazolam|alprazolam|mesh-list
56409363|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56409364|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56409365|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409366|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56409367|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56409368|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56409369|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
56409370|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
56409371|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409372|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409373|NCT00203463|Topiramate|topiramate|mesh-list
56409374|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
56409375|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56409376|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409377|NCT00407849|Triamcinolone|triamcinolone|mesh-list
56409378|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56409379|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56409380|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56409381|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409382|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
56409383|NCT00407849|Hormones|hormones|mesh-ancestor
56409384|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409385|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409386|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409387|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
56409388|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409389|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409391|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56409392|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
56409393|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
56409394|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409395|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409396|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409397|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
56409398|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56409399|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56409400|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56409401|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56409402|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409403|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
56409404|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409405|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409406|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56409407|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409408|NCT01807546|ON 01910|on 01910|mesh-list
56409409|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409410|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909594|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
56909595|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909596|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56909597|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
56909598|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56909599|NCT00118157|Tamoxifen|tamoxifen|mesh-list
56909600|NCT00118157|Lapatinib|lapatinib|mesh-list
56909601|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909602|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56909603|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
56909604|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56373025|NCT04728659|Progestins|progestins|mesh-ancestor
56409411|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409412|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409413|NCT03454984|Guadecitabine|guadecitabine|mesh-list
56409414|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409415|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
56409416|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56409417|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
56409418|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409419|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409420|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56157093|NCT03560466|Prednisone|prednisone|mesh-list
56409422|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
56409423|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56409424|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
56409425|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409426|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409427|NCT00203580|Tinzaparin|tinzaparin|mesh-list
56409428|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56409429|NCT00203580|Dalteparin|dalteparin|mesh-list
56409430|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
56409431|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56409432|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56409433|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409434|NCT01777555|Levodopa|levodopa|mesh-list
56409435|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56409436|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56409437|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
56409438|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409439|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409440|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409441|NCT01773928|Vaccines|vaccines|mesh-list
56409442|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
56409443|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409444|NCT01768975|Dapansutrile|dapansutrile|mesh-list
56409445|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409446|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56409447|NCT01756924|Vancomycin|vancomycin|mesh-list
56409448|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
56409449|NCT01756924|Levofloxacin|levofloxacin|mesh-list
56409450|NCT01756924|Rifampin|rifampin|mesh-list
56409451|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
56409452|NCT01756924|Cefazolin|cefazolin|mesh-list
56409453|NCT01756924|Linezolid|linezolid|mesh-list
56409454|NCT01756924|Daptomycin|daptomycin|mesh-list
56409455|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56409456|NCT01756924|Oxacillin|oxacillin|mesh-list
56409457|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
56409458|NCT01756924|Nafcillin|nafcillin|mesh-list
56409459|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409460|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56409461|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
56409462|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56409463|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56909605|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909606|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56909607|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373089|NCT00100880|Lenalidomide|lenalidomide|mesh-list
56409464|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409465|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409466|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409467|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56409468|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56409469|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56409470|NCT01756924|Renal Agents|renal agents|mesh-ancestor
56409471|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
56409472|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56409473|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56409474|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56409475|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56409476|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56409477|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56409478|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56409479|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56409480|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
56409481|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56409482|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56409483|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
56409484|NCT01756339|Solithromycin|solithromycin|mesh-list
56409485|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56409486|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409487|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56409488|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56409489|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409490|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409491|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409492|NCT00174200|Risperidone|risperidone|mesh-list
56409493|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56409494|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
56409495|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984083|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409498|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56409499|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56409500|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56409501|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56409502|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56409503|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
56409504|NCT00203658|Tinzaparin|tinzaparin|mesh-list
56409505|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56409506|NCT00203658|Dalteparin|dalteparin|mesh-list
56409507|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
56409508|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56409509|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56409510|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409511|NCT00174239|Levodopa|levodopa|mesh-list
56409512|NCT00174239|Carbidopa|carbidopa|mesh-list
56409513|NCT00174239|Cabergoline|cabergoline|mesh-list
56409514|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56409515|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56409516|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
56409517|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409518|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409519|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409520|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56409521|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409522|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
56409523|NCT00203697|Minocycline|minocycline|mesh-list
56409524|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56409525|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409526|NCT00174317|Celecoxib|celecoxib|mesh-list
56409527|NCT00174317|Diclofenac|diclofenac|mesh-list
56409528|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56409529|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56409530|NCT00174317|Analgesics|analgesics|mesh-ancestor
56409531|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
56909608|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56909609|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56909610|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56909611|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909612|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909613|NCT03543202|Anesthetics|anesthetics|mesh-list
56909614|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909615|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909616|NCT03552549|Interferons|interferons|mesh-list
56909617|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
56909618|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
56373163|NCT00135408|Budesonide|budesonide|mesh-list
56409532|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409533|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409534|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409535|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409536|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56409537|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56409538|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409539|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409540|NCT01737892|Epinephrine|epinephrine|mesh-list
56409541|NCT01737892|Racepinephrine|racepinephrine|mesh-list
56409542|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
56409543|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56409544|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56409545|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
56409546|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409547|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409548|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409549|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56409550|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56409551|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
56409552|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409553|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56409554|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
56409555|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
56409556|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
56409557|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56409558|NCT00203736|Artesunate|artesunate|mesh-list
56409559|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
56409560|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
56409561|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56409562|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
56409563|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56409564|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56409565|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409566|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409567|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
56409568|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
56409569|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56409572|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409573|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409574|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56409575|NCT00203736|Renal Agents|renal agents|mesh-ancestor
56409576|NCT01719016|Adenosine|adenosine|mesh-list
56409577|NCT01719016|Analgesics|analgesics|mesh-ancestor
56409578|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
56409579|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409580|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409581|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56409582|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
56409583|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56409584|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
56409585|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
56909619|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56909620|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909621|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
56909622|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909623|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
56909624|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909625|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
56909626|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909627|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
56909628|NCT02761642|Hematinics|hematinics|mesh-ancestor
56909629|NCT03731403|Fluorides|fluorides|mesh-list
56909630|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
56909631|NCT03731403|Protective Agents|protective agents|mesh-ancestor
56909632|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909633|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
56909634|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409586|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409587|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409588|NCT00174356|Paclitaxel|paclitaxel|mesh-list
56409589|NCT00174356|Carboplatin|carboplatin|mesh-list
56409590|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56409591|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409592|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
56409593|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409594|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409595|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409596|NCT01718158|Ribavirin|ribavirin|mesh-list
56409597|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56409598|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
56409599|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409600|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
56409601|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409602|NCT00174395|Eletriptan|eletriptan|mesh-list
56409603|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56409604|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
56409605|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409606|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409607|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409608|NCT00203775|Risperidone|risperidone|mesh-list
56409609|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56409610|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
56409611|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409612|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409613|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409614|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56409615|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56409616|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56409617|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56409618|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56409619|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
56409620|NCT00555256|Sirolimus|sirolimus|mesh-list
56409621|NCT00555256|Sunitinib|sunitinib|mesh-list
56409622|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409623|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56409624|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56409625|NCT00555256|Growth Substances|growth substances|mesh-ancestor
56409626|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409627|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
56409628|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56409629|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409630|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909635|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909636|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909637|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373288|NCT00135681|Hormones|hormones|mesh-ancestor
56409631|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56409632|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409633|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56409634|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
56409635|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409636|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
56409637|NCT00174434|Paclitaxel|paclitaxel|mesh-list
56409638|NCT00174434|Sunitinib|sunitinib|mesh-list
56409639|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56409640|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409641|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
56409642|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409643|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409645|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56409646|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56409647|NCT00174434|Growth Substances|growth substances|mesh-ancestor
56409648|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409649|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
56409650|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56409651|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409652|NCT00203814|Artesunate|artesunate|mesh-list
56409653|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
56409654|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
56409655|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56409656|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
56409657|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56409658|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56409659|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409660|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409661|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
56409662|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
56409663|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56409664|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
56409665|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56409666|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409667|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409668|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56409669|NCT00203814|Renal Agents|renal agents|mesh-ancestor
56409670|NCT00174473|Voriconazole|voriconazole|mesh-list
56409671|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
56409672|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409673|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56409674|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56409675|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409676|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409677|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56409678|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
56409679|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409680|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409681|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56409683|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56409684|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409685|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56409686|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56409687|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409688|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409689|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409690|NCT00199017|Cytarabine|cytarabine|mesh-list
56409691|NCT00199017|Dexamethasone|dexamethasone|mesh-list
56409692|NCT00199017|Prednisolone|prednisolone|mesh-list
56409693|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
56409694|NCT00199017|Methotrexate|methotrexate|mesh-list
56409695|NCT00199017|Vincristine|vincristine|mesh-list
56409696|NCT00199017|Doxorubicin|doxorubicin|mesh-list
56409697|NCT00199017|Daunorubicin|daunorubicin|mesh-list
56409698|NCT00199017|Asparaginase|asparaginase|mesh-list
56409699|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
56409700|NCT00199017|Thioguanine|thioguanine|mesh-list
56409701|NCT00199017|Cladribine|cladribine|mesh-list
56909638|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
56909639|NCT03600909|Busulfan|busulfan|mesh-list
56909640|NCT03600909|Fludarabine|fludarabine|mesh-list
56909641|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56909642|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
56909643|NCT03600909|Lenograstim|lenograstim|mesh-list
56909644|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409702|NCT00199017|Vindesine|vindesine|mesh-list
56409703|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409704|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
56409705|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409706|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409707|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56409708|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
56409709|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409710|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409711|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56409712|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409713|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
56409714|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
56409715|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409716|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56409717|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
56409718|NCT00199017|Hormones|hormones|mesh-ancestor
56409719|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409721|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56409723|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56409724|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56409725|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
56409727|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409728|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56409729|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56409730|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
56409731|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409732|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56409733|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
56409734|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409735|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409736|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56409737|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56409738|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56409739|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56409740|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
56409741|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409742|NCT01660633|Melphalan|melphalan|mesh-list
56409743|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56409744|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
56409745|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409746|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409748|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409749|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
56409750|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409751|NCT00174551|Prazosin|prazosin|mesh-list
56409752|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56409753|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56409754|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56409755|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56409756|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
56409757|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409758|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409759|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409760|NCT04676659|Tenecteplase|tenecteplase|mesh-list
56409761|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56409762|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56409763|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409764|NCT00174590|Risperidone|risperidone|mesh-list
56409765|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56409766|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
56409767|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409768|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409769|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409770|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56409771|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56409772|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56409773|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56409774|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56409775|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
56409776|NCT01652482|Leucovorin|leucovorin|mesh-list
56409777|NCT01652482|Fluorouracil|fluorouracil|mesh-list
56409778|NCT01652482|Irinotecan|irinotecan|mesh-list
56409779|NCT01652482|Cetuximab|cetuximab|mesh-list
56409780|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
56909709|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56909710|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56909711|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909712|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909713|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909714|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
56373445|NCT00135954|Hormones|hormones|mesh-ancestor
56409781|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409782|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56409783|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409784|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409785|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
56409786|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409787|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56409788|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56409789|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409790|NCT01652482|Antidotes|antidotes|mesh-ancestor
56409791|NCT01652482|Protective Agents|protective agents|mesh-ancestor
56409792|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
56409793|NCT01652482|Vitamins|vitamins|mesh-ancestor
56409794|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
56409797|NCT00174629|Docetaxel|docetaxel|mesh-list
56409798|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56333873|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409799|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
56409800|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409801|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409802|NCT00174629|Antiviral Agents|antiviral agents|mesh-ancestor
56409803|NCT00174629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409804|NCT00174629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409805|NCT00174629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409806|NCT00174629|Immunologic Factors|immunologic factors|mesh-ancestor
56409807|NCT00174629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409808|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
56409809|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409810|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409811|NCT02962947|Propranolol|propranolol|mesh-list
56409812|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56409813|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56409814|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
56409815|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409816|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409817|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409818|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56409819|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56409820|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
56409821|NCT00555334|Lamivudine|lamivudine|mesh-list
56409822|NCT00555334|Entecavir|entecavir|mesh-list
56409823|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56409824|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56409825|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409826|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409827|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
56409828|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409829|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56409830|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56409831|NCT01640080|Esketamine|esketamine|mesh-list
56409832|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
56409833|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56409834|NCT00174668|Insulin|insulin|mesh-list
56409835|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56409836|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
56409837|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
56409838|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56409839|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409840|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
56409841|NCT00174707|Docetaxel|docetaxel|mesh-list
56409842|NCT00174707|Methotrexate|methotrexate|mesh-list
56409843|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409844|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
56909715|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
56909716|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909717|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909718|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56909719|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56909720|NCT02777554|Growth Substances|growth substances|mesh-ancestor
56909721|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
56909722|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909723|NCT03220178|Letrozole|letrozole|mesh-list
56909724|NCT03220178|Fulvestrant|fulvestrant|mesh-list
56409845|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409846|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409847|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56409848|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
56409849|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409850|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409851|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56409852|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
56409853|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
56409854|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
56409855|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56409856|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
56409857|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56409858|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56409859|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
56409860|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
56409861|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409862|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56409863|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56409864|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
56409865|NCT01235923|Hematinics|hematinics|mesh-ancestor
56409866|NCT00199134|Letrozole|letrozole|mesh-list
56409867|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409868|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56409870|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409871|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409872|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56409873|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
56409874|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409875|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409876|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
56409877|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56409878|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409879|NCT00174863|SR 31747|sr 31747|mesh-list
56409880|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409881|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409882|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409883|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
56409884|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409885|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
56409886|NCT00712582|Ifosfamide|ifosfamide|mesh-list
56409887|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
56409888|NCT00712582|Carmustine|carmustine|mesh-list
56409889|NCT00712582|Rituximab|rituximab|mesh-list
56409890|NCT00712582|Carboplatin|carboplatin|mesh-list
56409891|NCT00712582|Etoposide|etoposide|mesh-list
56409892|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
56409893|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
56409894|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409895|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
56409896|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409897|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409898|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56409899|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
56409900|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409901|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409902|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56909725|NCT03220178|Palbociclib|palbociclib|mesh-list
56909726|NCT03220178|Anastrozole|anastrozole|mesh-list
56909727|NCT03220178|Exemestane|exemestane|mesh-list
56909728|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909729|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56909730|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56909731|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909732|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909733|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56909734|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
56909735|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909736|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909737|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56909738|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56909739|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909740|NCT02764762|Adalimumab|adalimumab|mesh-list
56909741|NCT02764762|Methotrexate|methotrexate|mesh-list
56909742|NCT02764762|Vedolizumab|vedolizumab|mesh-list
56909743|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56909744|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
56909745|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56909746|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909747|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56909748|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
56373573|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56409903|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56409904|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56409905|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56409906|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56409907|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409908|NCT00712582|Analgesics|analgesics|mesh-ancestor
56409909|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
56409910|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409911|NCT00174902|Aspirin|aspirin|mesh-list
56409912|NCT00174902|Propranolol|propranolol|mesh-list
56409913|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56409914|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56409915|NCT00174902|Analgesics|analgesics|mesh-ancestor
56409916|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
56409917|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409918|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409919|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56409920|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409921|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56409922|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56409923|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409924|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56409925|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56409926|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909749|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909750|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909751|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
56909752|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56409927|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
56409928|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56409929|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56409930|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
56409931|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409932|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56409933|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56409934|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
56409935|NCT00373711|Iodine|iodine|mesh-list
56409936|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
56409937|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56409938|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56409939|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409940|NCT00373711|Trace Elements|trace elements|mesh-ancestor
56409941|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
56409942|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409943|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56409945|NCT00199212|Trastuzumab|trastuzumab|mesh-list
56409946|NCT00199212|Bortezomib|bortezomib|mesh-list
56409947|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56409948|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409949|NCT00555373|Sirolimus|sirolimus|mesh-list
56409950|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56409951|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56409952|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56409953|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409954|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
56409955|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409956|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
56409957|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409958|NCT00555412|Loxapine|loxapine|mesh-list
56409959|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56409960|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56409961|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56409962|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409963|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56409964|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56409965|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
56409966|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409967|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409968|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
56409969|NCT04676776|Mifepristone|mifepristone|mesh-list
56409970|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56409971|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
56409972|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56409973|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409974|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56409975|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56409977|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56409978|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
56409979|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56409980|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56409981|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
56409982|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56409983|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
56409984|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56409985|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
56409986|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56409987|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56409988|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56409989|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56409990|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409991|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409992|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
56409993|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409994|NCT00199329|Ondansetron|ondansetron|mesh-list
56909753|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56909754|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909755|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
56373697|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
56409995|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
56409996|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
56409997|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56409998|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409999|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56410000|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
56410001|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
56410002|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56410003|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
56410004|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410005|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410006|NCT00199329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56410007|NCT00199329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56410008|NCT00199329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410009|NCT00199329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56410010|NCT00199329|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56410011|NCT00555607|Prednisolone|prednisolone|mesh-list
56410012|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410013|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
56410014|NCT00555607|Hormones|hormones|mesh-ancestor
56410015|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56410016|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410018|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410019|NCT00199368|Istradefylline|istradefylline|mesh-list
56410020|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56410021|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56410022|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56410023|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
56410024|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410025|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410026|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410027|NCT04675528|Paclitaxel|paclitaxel|mesh-list
56410028|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56410029|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410030|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
56410031|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
56410032|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
56410033|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410034|NCT04675177|Polidocanol|polidocanol|mesh-list
56410035|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56410036|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56410037|NCT00175370|Vancomycin|vancomycin|mesh-list
56410038|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56410039|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410040|NCT00204243|Naltrexone|naltrexone|mesh-list
56410041|NCT00204243|Methadone|methadone|mesh-list
56410042|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56410044|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410045|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
56410046|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410047|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56410048|NCT00204243|Narcotics|narcotics|mesh-ancestor
56410049|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410050|NCT00204243|Analgesics|analgesics|mesh-ancestor
56410051|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
56410052|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
56410053|NCT04675372|Midazolam|midazolam|mesh-list
56410054|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
56410055|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56410056|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410057|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410058|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56410059|NCT04675372|Analgesics|analgesics|mesh-ancestor
56410060|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
56410061|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410062|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56410063|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56410064|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56909756|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909757|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56909758|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909759|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56410065|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
56410066|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410067|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410068|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56410069|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56410070|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56410071|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56410072|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56410073|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
56410074|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
56410075|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
56410076|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
56410077|NCT04447768|Venetoclax|venetoclax|mesh-list
56410078|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
56410079|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410080|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56410081|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
56410082|NCT04424602|Dimethoate|dimethoate|mesh-list
56410083|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410084|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410085|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410086|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56410087|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
56410088|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410089|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410090|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410091|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
56410092|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410095|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56410096|NCT04395079|Durvalumab|durvalumab|mesh-list
56410097|NCT04395079|Ipilimumab|ipilimumab|mesh-list
56410098|NCT04395079|Tremelimumab|tremelimumab|mesh-list
56410099|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
56410100|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56410101|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
56410102|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56410103|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410104|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
56410105|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410106|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56164001|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56410107|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410108|NCT00199407|Istradefylline|istradefylline|mesh-list
56410109|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56410110|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56410111|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56410112|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
56410113|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410114|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410115|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410116|NCT00199446|Istradefylline|istradefylline|mesh-list
56410117|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56410118|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56410119|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56410120|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
56410121|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410122|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410123|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410124|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
56410125|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56410126|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
56410127|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410128|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410129|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56410130|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
56410131|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56410132|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
56909760|NCT03032510|Levofloxacin|levofloxacin|mesh-list
56909761|NCT03032510|Ofloxacin|ofloxacin|mesh-list
56410133|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410134|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410135|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56410136|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
56410137|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
56410138|NCT04306393|Protective Agents|protective agents|mesh-ancestor
56410140|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56410141|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410142|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56410143|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410144|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
56410145|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410146|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
56410147|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410148|NCT00175565|Fluticasone|fluticasone|mesh-list
56410149|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410150|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56410151|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
56410152|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410153|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410154|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56410155|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
56410156|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
56410157|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56410158|NCT04230187|Leucovorin|leucovorin|mesh-list
56410159|NCT04230187|Bevacizumab|bevacizumab|mesh-list
56410160|NCT04230187|Fluorouracil|fluorouracil|mesh-list
56410161|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
56410162|NCT04230187|Irinotecan|irinotecan|mesh-list
56410163|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
56410164|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56410165|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410167|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56410168|NCT04230187|Growth Substances|growth substances|mesh-ancestor
56410169|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410170|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
56410171|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
56410172|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410173|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410174|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410175|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
56410176|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56157821|NCT02695290|Afatinib|afatinib|mesh-list
56410177|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56410178|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410180|NCT04230187|Protective Agents|protective agents|mesh-ancestor
56410181|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
56410182|NCT04230187|Vitamins|vitamins|mesh-ancestor
56410183|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
56410184|NCT00175643|Imiquimod|imiquimod|mesh-list
56410185|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56410186|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
56410187|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410188|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410189|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
56410190|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56410191|NCT00204438|Desogestrel|desogestrel|mesh-list
56410192|NCT00204438|Estradiol|estradiol|mesh-list
56410193|NCT00204438|Estrogens|estrogens|mesh-ancestor
56410194|NCT00204438|Hormones|hormones|mesh-ancestor
56410195|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56410196|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410197|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56410198|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
56410199|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56410200|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56410201|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56410202|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56410203|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56410204|NCT00204438|Progestins|progestins|mesh-ancestor
56410205|NCT00175682|Prazosin|prazosin|mesh-list
56410206|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56410207|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56410208|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56909762|NCT03032510|Ertapenem|ertapenem|mesh-list
56909763|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56909764|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410209|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56410210|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
56410211|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410212|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410213|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410214|NCT00554086|Bicalutamide|bicalutamide|mesh-list
56410215|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
56410216|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
56410217|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56410218|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410219|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410220|NCT04173364|Ropivacaine|ropivacaine|mesh-list
56410221|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56410222|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
56410223|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
56410224|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410225|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410226|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
56410227|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410228|NCT04171453|Pregabalin|pregabalin|mesh-list
56410229|NCT04171453|Analgesics|analgesics|mesh-ancestor
56410230|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
56410231|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410232|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410233|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
56410234|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56410235|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56410236|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410237|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56410238|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56410239|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56410240|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410241|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56410243|NCT04111315|Ibuprofen|ibuprofen|mesh-list
56410244|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56410245|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56410246|NCT04111315|Analgesics|analgesics|mesh-ancestor
56410247|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
56410248|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410249|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410250|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410251|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410252|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56410253|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410254|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410255|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
56410256|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
56410257|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
56410258|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56410259|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56410260|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410261|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410262|NCT00199563|Urological Agents|urological agents|mesh-ancestor
56410263|NCT04679506|Cytarabine|cytarabine|mesh-list
56410264|NCT04679506|Etoposide|etoposide|mesh-list
56410265|NCT04679506|Cladribine|cladribine|mesh-list
56410266|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56410267|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410268|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56410269|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56410270|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410271|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410272|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410273|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
56410274|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
56410275|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410276|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410277|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
56909765|NCT03032510|Renal Agents|renal agents|mesh-ancestor
56909766|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909767|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56909768|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56620432|NCT02827890|Incretins|incretins|mesh-ancestor
56909769|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909770|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909772|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56909773|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56909774|NCT03022292|Aflibercept|aflibercept|mesh-list
56909775|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56373987|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410278|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410279|NCT02962830|Sufentanil|sufentanil|mesh-list
56410280|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56410281|NCT02962830|Narcotics|narcotics|mesh-ancestor
56410282|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410283|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410284|NCT02962830|Analgesics|analgesics|mesh-ancestor
56410285|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
56410286|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410287|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56410288|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56410289|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
56410290|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
56410291|NCT00199602|Heparin|heparin|mesh-list
56410292|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
56410293|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56410294|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56410295|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410296|NCT00554125|Sirolimus|sirolimus|mesh-list
56410297|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56410298|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410299|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56410300|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410301|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
56410302|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410303|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
56410304|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410305|NCT00175838|Aspirin|aspirin|mesh-list
56410306|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
56410307|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56410308|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56410309|NCT00175838|Analgesics|analgesics|mesh-ancestor
56410310|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
56410311|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410312|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410313|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410314|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410315|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56410317|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410318|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56410319|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56410320|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410321|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
56410322|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410323|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
56410324|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56157966|NCT05444088|Growth Substances|growth substances|mesh-ancestor
56410325|NCT00204555|Imiquimod|imiquimod|mesh-list
56410326|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56410327|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
56410328|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410329|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909776|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56909777|NCT03022292|Growth Substances|growth substances|mesh-ancestor
56909778|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410330|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
56410331|NCT00175955|Levetiracetam|levetiracetam|mesh-list
56410332|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
56410333|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
56410334|NCT03758287|Gefitinib|gefitinib|mesh-list
56410335|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410336|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56410337|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410338|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410339|NCT03733210|Panitumumab|panitumumab|mesh-list
56410340|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56410341|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410342|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
56410343|NCT00204633|Hematinics|hematinics|mesh-ancestor
56410344|NCT00199719|Ribavirin|ribavirin|mesh-list
56410345|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
56410346|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410347|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
56410348|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410349|NCT03430882|Paclitaxel|paclitaxel|mesh-list
56410350|NCT03430882|Carboplatin|carboplatin|mesh-list
56410351|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56410352|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56410353|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410354|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
56410355|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
56410356|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
56410357|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410358|NCT03374254|Leucovorin|leucovorin|mesh-list
56410359|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
56410360|NCT03374254|Fluorouracil|fluorouracil|mesh-list
56410361|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
56410362|NCT03374254|Irinotecan|irinotecan|mesh-list
56410363|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56410364|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410365|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410366|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
56410367|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410368|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410369|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410370|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
56410371|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56410372|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56410373|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410374|NCT03374254|Antidotes|antidotes|mesh-ancestor
56410375|NCT03374254|Protective Agents|protective agents|mesh-ancestor
56410376|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
56410377|NCT03374254|Vitamins|vitamins|mesh-ancestor
56410378|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
56410379|NCT00199758|Gemcitabine|gemcitabine|mesh-list
56410380|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410381|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410382|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
56410383|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410384|NCT00199758|Antiviral Agents|antiviral agents|mesh-ancestor
56410385|NCT00199758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410386|NCT00199758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410387|NCT00199758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410388|NCT00199758|Immunologic Factors|immunologic factors|mesh-ancestor
56410389|NCT00199758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410390|NCT03291886|Exemestane|exemestane|mesh-list
56410391|NCT03291886|Entinostat|entinostat|mesh-list
56410392|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410393|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56410394|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56410395|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410396|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410397|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56410398|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
56410399|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56410400|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909779|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
56909780|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909781|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
56909782|NCT03599193|Tazarotene|tazarotene|mesh-list
56909783|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
56909784|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
56909785|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
56909786|NCT03599193|Vitamins|vitamins|mesh-ancestor
56909787|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
56909788|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909789|NCT02161354|Buprenorphine|buprenorphine|mesh-list
56909790|NCT02161354|Naloxone|naloxone|mesh-list
56909791|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56909792|NCT02161354|Narcotics|narcotics|mesh-ancestor
56909793|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56909794|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909795|NCT02161354|Analgesics|analgesics|mesh-ancestor
56909796|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
56909797|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909798|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56909799|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
56909800|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56909801|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909802|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
56909803|NCT02777242|Testosterone|testosterone|mesh-list
56909804|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
56410401|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56410402|NCT00176267|Paclitaxel|paclitaxel|mesh-list
56410403|NCT00176267|Carboplatin|carboplatin|mesh-list
56410404|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56410405|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410406|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
56410407|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
56410408|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
56410409|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410410|NCT03252808|Gemcitabine|gemcitabine|mesh-list
56410411|NCT03252808|Paclitaxel|paclitaxel|mesh-list
56410412|NCT03252808|Tegafur|tegafur|mesh-list
56410413|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56410414|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410415|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
56410416|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
56410417|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
56410418|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410419|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410420|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
56410421|NCT03252808|Antiviral Agents|antiviral agents|mesh-ancestor
56410422|NCT03252808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410423|NCT03252808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410424|NCT03252808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410425|NCT03252808|Immunologic Factors|immunologic factors|mesh-ancestor
56410426|NCT03252808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410427|NCT03191461|Adenosine|adenosine|mesh-list
56410428|NCT03191461|Analgesics|analgesics|mesh-ancestor
56909805|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
56909806|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56909807|NCT02777242|Androgens|androgens|mesh-ancestor
56909808|NCT02777242|Hormones|hormones|mesh-ancestor
56909809|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909810|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909811|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56909812|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909813|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
56909814|NCT02163070|Vitamins|vitamins|mesh-list
56909815|NCT02163070|Vitamin E|vitamin e|mesh-list
56909816|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
56909817|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909818|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
56909819|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909820|NCT02163070|Protective Agents|protective agents|mesh-ancestor
56909821|NCT03484520|Venetoclax|venetoclax|mesh-list
56909822|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909823|NCT03566979|Naproxen|naproxen|mesh-list
56374178|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
56410429|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
56410430|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410431|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410432|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56410433|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
56410434|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56410435|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
56410436|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
56410437|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410438|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410439|NCT00199953|Rabeprazole|rabeprazole|mesh-list
56410440|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56410441|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56410442|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56410443|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410444|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410445|NCT03184090|Palbociclib|palbociclib|mesh-list
56410446|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410447|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56410448|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410449|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410450|NCT03160846|Milrinone|milrinone|mesh-list
56410451|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56410452|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56410453|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
56410454|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56410455|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56410456|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410457|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410458|NCT03160846|Protective Agents|protective agents|mesh-ancestor
56410459|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410460|NCT00204789|Eflornithine|eflornithine|mesh-list
56410461|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410462|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56410463|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56410464|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56909824|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56909825|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56909826|NCT03566979|Analgesics|analgesics|mesh-ancestor
56909827|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
56909828|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909829|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909830|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909831|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909832|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
56909833|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56909834|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909835|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909836|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
56909837|NCT00116831|Glipizide|glipizide|mesh-list
56909838|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56410466|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56410467|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410468|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410469|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
56410470|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
56410471|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
56410472|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56410473|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56410474|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410475|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410476|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410479|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56410480|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
56410481|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56410482|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56410483|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410484|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56410485|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56410486|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56410487|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410488|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56410489|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56410490|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56410491|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56410492|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56410493|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
56410494|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410495|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410496|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
56410497|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
56410498|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410499|NCT02827435|Bromides|bromides|mesh-list
56410500|NCT02827435|Rocuronium|rocuronium|mesh-list
56410501|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
56410502|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56410503|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56410504|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56410505|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410506|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410507|NCT00176618|Curcumin|curcumin|mesh-list
56410508|NCT00176618|Sulindac|sulindac|mesh-list
56410509|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56909839|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909840|NCT02784704|Meropenem|meropenem|mesh-list
56909841|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56410510|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56410511|NCT00176618|Analgesics|analgesics|mesh-ancestor
56410512|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
56410513|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410514|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410515|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410516|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410517|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410518|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410519|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410520|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56410521|NCT02675959|Defibrotide|defibrotide|mesh-list
56410522|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56410523|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56410524|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410525|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56410526|NCT00410787|Hydromorphone|hydromorphone|mesh-list
56410527|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56410528|NCT00410787|Narcotics|narcotics|mesh-ancestor
56410529|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410530|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410531|NCT00410787|Analgesics|analgesics|mesh-ancestor
56410532|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
56410533|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410534|NCT00554164|Prednisone|prednisone|mesh-list
56410535|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
56410536|NCT00554164|Doxorubicin|doxorubicin|mesh-list
56410537|NCT00554164|Vincristine|vincristine|mesh-list
56410539|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
56410540|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410541|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410542|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56410544|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410545|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410546|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56410547|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56410548|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56410549|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56410550|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410551|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410552|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
56410553|NCT00554164|Hormones|hormones|mesh-ancestor
56410554|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56410555|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56410556|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56410557|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
56410558|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
56410559|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
56410560|NCT02572141|Leucovorin|leucovorin|mesh-list
56410561|NCT02572141|Fluorouracil|fluorouracil|mesh-list
56410562|NCT02572141|Capecitabine|capecitabine|mesh-list
56410563|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
56410564|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
56410565|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
56410566|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410567|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410568|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410569|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410570|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
56410571|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410572|NCT02572141|Antidotes|antidotes|mesh-ancestor
56410573|NCT02572141|Protective Agents|protective agents|mesh-ancestor
56410574|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
56410575|NCT02572141|Vitamins|vitamins|mesh-ancestor
56410576|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
56410577|NCT02521363|Taxane|taxane|mesh-list
56410578|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410579|NCT02470039|Insulin|insulin|mesh-list
56410580|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56410581|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
56410582|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56374377|NCT00435175|Estradiol|estradiol|mesh-list
56410583|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410584|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
56410585|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410586|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56410587|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56410588|NCT00554203|Analgesics|analgesics|mesh-ancestor
56410589|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
56410590|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410591|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410592|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410593|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410594|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56410595|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
56410596|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
56410597|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
56410598|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410599|NCT00554242|Protective Agents|protective agents|mesh-ancestor
56410600|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410601|NCT00554242|Vitamins|vitamins|mesh-ancestor
56410602|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
56410603|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56410604|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410605|NCT00176735|Capecitabine|capecitabine|mesh-list
56410606|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410607|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
56410608|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410609|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410610|NCT00410943|Hydromorphone|hydromorphone|mesh-list
56410611|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56410612|NCT00410943|Narcotics|narcotics|mesh-ancestor
55985167|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
56410614|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410616|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
56410617|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410619|NCT00176774|Fluorouracil|fluorouracil|mesh-list
56410620|NCT00176774|Irinotecan|irinotecan|mesh-list
56410621|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56410622|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
56410623|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410624|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410625|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410626|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410627|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
56410628|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410629|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56410630|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56410631|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410632|NCT00176774|Antidotes|antidotes|mesh-ancestor
56410633|NCT00176774|Protective Agents|protective agents|mesh-ancestor
56410634|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
56410635|NCT00176774|Vitamins|vitamins|mesh-ancestor
56410636|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
56410637|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
56410638|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
56410639|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56410640|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56410641|NCT00176774|Growth Substances|growth substances|mesh-ancestor
56410642|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
56410643|NCT02434744|Metformin|metformin|mesh-list
56410644|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56410645|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410646|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
56410647|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56410648|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
56410649|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56410650|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56410651|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410652|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56410653|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410654|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56410655|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410656|NCT00410982|Gemcitabine|gemcitabine|mesh-list
56410657|NCT00410982|Rituximab|rituximab|mesh-list
56410658|NCT00410982|Melphalan|melphalan|mesh-list
56410659|NCT00410982|Busulfan|busulfan|mesh-list
56410660|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56909842|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909843|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
56909844|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909845|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
56909846|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909847|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410661|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410662|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
56410663|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410664|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410665|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410666|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
56410667|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410668|NCT00410982|Antiviral Agents|antiviral agents|mesh-ancestor
56410669|NCT00410982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410670|NCT00410982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410671|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410672|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56410673|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
56410674|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56410675|NCT02372578|Pregabalin|pregabalin|mesh-list
56410676|NCT02372578|Analgesics|analgesics|mesh-ancestor
56410677|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
56410678|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410679|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410680|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
56410681|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56410682|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56410683|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410684|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56410685|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56410686|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56410687|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410690|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56410691|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56410692|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
56410693|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410694|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56410695|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56410696|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410697|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410698|NCT00554476|Triamcinolone|triamcinolone|mesh-list
56410699|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56410700|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56410701|NCT00554476|Indomethacin|indomethacin|mesh-list
56410702|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56410703|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410704|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
56410705|NCT00554476|Hormones|hormones|mesh-ancestor
56410706|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56410707|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410708|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410709|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
56410710|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410711|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410712|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56410713|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56410714|NCT00554476|Analgesics|analgesics|mesh-ancestor
56410715|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
56410716|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410717|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410718|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
56410719|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
56410720|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56410721|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56410722|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56410723|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
56410724|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909848|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56909850|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410725|NCT00204906|Vitamin D|vitamin d|mesh-list
56410726|NCT00204906|Vitamins|vitamins|mesh-ancestor
56410727|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
56410728|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410729|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56410730|NCT02335918|Nivolumab|nivolumab|mesh-list
56410731|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56410732|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410733|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56410734|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410735|NCT00176813|Gemcitabine|gemcitabine|mesh-list
56410736|NCT00176813|Celecoxib|celecoxib|mesh-list
56410737|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410738|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410739|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
56410740|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410741|NCT00176813|Antiviral Agents|antiviral agents|mesh-ancestor
56410742|NCT00176813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410743|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410744|NCT00176813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410745|NCT00176813|Immunologic Factors|immunologic factors|mesh-ancestor
56410746|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410747|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56410748|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56410749|NCT00176813|Analgesics|analgesics|mesh-ancestor
56410750|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
56410751|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410752|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410753|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410754|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56410755|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56410756|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
56410757|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56410758|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410759|NCT02320708|Acetaminophen|acetaminophen|mesh-list
56410760|NCT02320708|Ibuprofen|ibuprofen|mesh-list
56410761|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56410763|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
56410764|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410765|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410767|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56410768|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410769|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410770|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56410771|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410772|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410773|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56410774|NCT02309671|Hormones|hormones|mesh-ancestor
56410775|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56410776|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410777|NCT02296645|Ethanol|ethanol|mesh-list
56410778|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
56158411|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410779|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56410780|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56410781|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410782|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410783|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410784|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
56410785|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
56410786|NCT02295865|Toreforant|toreforant|mesh-list
56410787|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
56410788|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
56410789|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410790|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410791|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410792|NCT02282215|Lenograstim|lenograstim|mesh-list
56410793|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56410794|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
56410795|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909851|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
56909852|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909853|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56909854|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909855|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909856|NCT03152786|Propranolol|propranolol|mesh-list
56909857|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56909858|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56909859|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
56909860|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56909861|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909862|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909863|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56909864|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56909865|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
56909866|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56410796|NCT00176969|Capsaicin|capsaicin|mesh-list
56410797|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
56410798|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
56410799|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
56410800|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410801|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410802|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56410803|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
56410804|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410805|NCT00177008|Aripiprazole|aripiprazole|mesh-list
56410806|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
56410807|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56410808|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56410809|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56410810|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410811|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410812|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
56410813|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
56410814|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410815|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410816|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56410817|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56410818|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
56410819|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56410820|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56410821|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56410822|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56410823|NCT04677985|Analgesics|analgesics|mesh-list
56410824|NCT04677985|Menthol|menthol|mesh-list
56410825|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
56410826|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410827|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410828|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
56410829|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
56410830|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56410831|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56410832|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56410833|NCT00554632|Norgestimate|norgestimate|mesh-list
56410834|NCT00554632|Norelgestromin|norelgestromin|mesh-list
56410837|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56410839|NCT00554632|Hormones|hormones|mesh-ancestor
56410840|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909867|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56909868|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56909869|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
56909870|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410841|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410842|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56410843|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
56410844|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56410845|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56410846|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56410847|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56410848|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56410849|NCT00204984|Hydralazine|hydralazine|mesh-list
56410850|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56410851|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
56410852|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410853|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56410854|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
56410855|NCT02236195|Mocetinostat|mocetinostat|mesh-list
56410856|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56410857|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410858|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410859|NCT02236156|Metronidazole|metronidazole|mesh-list
56410860|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410861|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56410862|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56410863|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56410864|NCT00177086|Alfuzosin|alfuzosin|mesh-list
56410865|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56410866|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56410867|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56410868|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
56410869|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410870|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410871|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410872|NCT00177086|Urological Agents|urological agents|mesh-ancestor
56410873|NCT02207257|Edoxaban|edoxaban|mesh-list
56410874|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56410875|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
56410876|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56410877|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
56410878|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410879|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410880|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
56410881|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
56410882|NCT00554710|Budesonide|budesonide|mesh-list
56410883|NCT00554710|Azathioprine|azathioprine|mesh-list
56410884|NCT00554710|Infliximab|infliximab|mesh-list
56410885|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56410886|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
56410887|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
56410888|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410889|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410890|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56410891|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
56410892|NCT00554710|Hormones|hormones|mesh-ancestor
56410893|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56410894|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56410895|NCT00554710|Protective Agents|protective agents|mesh-ancestor
56410896|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410897|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56410898|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56410899|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
56410900|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56410901|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56410902|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
56410903|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410904|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56410905|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410906|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
56410907|NCT00200187|Anesthetics|anesthetics|mesh-list
56909871|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56909872|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56909873|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909874|NCT01310283|Fluorides|fluorides|mesh-list
56909875|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
56909876|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
56909877|NCT01310283|Protective Agents|protective agents|mesh-ancestor
56909878|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909879|NCT02161822|Simvastatin|simvastatin|mesh-list
56410908|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410909|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410911|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
56410912|NCT00177242|Gefitinib|gefitinib|mesh-list
56410913|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410914|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56410915|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410916|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410917|NCT04659070|Telmisartan|telmisartan|mesh-list
56410918|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56410919|NCT04659070|Ezetimibe|ezetimibe|mesh-list
56410920|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56410921|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56410922|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
56410923|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410924|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56410925|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56410926|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410927|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56410928|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56410929|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56410930|NCT00177281|Belotecan|belotecan|mesh-list
56410931|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56410932|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56410933|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56410934|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410935|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410937|NCT00200226|Pyridoxal|pyridoxal|mesh-list
56410938|NCT00200226|Pyridoxine|pyridoxine|mesh-list
56410939|NCT00200226|Misoprostol|misoprostol|mesh-list
56410940|NCT00200226|Vitamins|vitamins|mesh-ancestor
56410941|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
56410942|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410943|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56410944|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
56410945|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56410946|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56410947|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56410948|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
56410949|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
56410950|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56410951|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
56410952|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410953|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
56410954|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410955|NCT04658134|Glycine|glycine|mesh-list
56410956|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
56410957|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410958|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410959|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410960|NCT00200382|Bortezomib|bortezomib|mesh-list
56410961|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56410962|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56410963|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56410964|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410965|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410966|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
56410967|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909880|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56909881|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56909882|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
56909883|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909884|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56909885|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56909886|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909887|NCT03183908|Vaccines|vaccines|mesh-list
56410968|NCT00177398|Insulin|insulin|mesh-list
56410969|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56410970|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
56410971|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56410972|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410973|NCT00200421|Atenolol|atenolol|mesh-list
56410974|NCT00200421|Nebivolol|nebivolol|mesh-list
56410975|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56410976|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56410977|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
56410978|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
56410979|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56410980|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410981|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56410982|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56410983|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56410984|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
56410985|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56410987|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
56410988|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56410989|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56410990|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56410991|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56410992|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56410993|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410994|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
56410995|NCT04656262|Doxorubicin|doxorubicin|mesh-list
56410996|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56410997|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
56410998|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410999|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411000|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411001|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
56411002|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411003|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411004|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411005|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56411006|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411007|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411008|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411010|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56411011|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
56411012|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56411013|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56411014|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56411015|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
56411016|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411017|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411018|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411019|NCT00200499|Nebivolol|nebivolol|mesh-list
56411020|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56411021|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
56411022|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56411023|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56411024|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56411025|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
56411026|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411027|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909888|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
56909889|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909890|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56909891|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56909892|NCT02737046|Interferons|interferons|mesh-list
56909893|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
56909894|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
56411028|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411029|NCT00200538|Memantine|memantine|mesh-list
56411030|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56411031|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56411032|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
56411033|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411034|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411035|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411036|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56411037|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56411038|NCT00177710|Amphotericin B|amphotericin b|mesh-list
56411039|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56411040|NCT00177710|Amebicides|amebicides|mesh-ancestor
56411041|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56411042|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56411043|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411044|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56411045|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
56411046|NCT00177749|Posaconazole|posaconazole|mesh-list
56411047|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
56411048|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411049|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56411050|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56411051|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56411052|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56411053|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56411054|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911582|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
56411055|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411056|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55985617|NCT01044745|Busulfan|busulfan|mesh-list
56411058|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411059|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411060|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56411061|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56411062|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56411063|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56411064|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411065|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411066|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411067|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56411068|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
56411069|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56411071|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411072|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411073|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56411074|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
56411075|NCT04654741|Ganirelix|ganirelix|mesh-list
56411076|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56411077|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56411078|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56411079|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
56411080|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56411081|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411082|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56411083|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56411084|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56411085|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56411086|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909895|NCT02737046|Zidovudine|zidovudine|mesh-list
56909896|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56909897|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56909898|NCT02737046|Belinostat|belinostat|mesh-list
56909899|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909900|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
56909901|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909902|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
56909903|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909904|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
56909905|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909906|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56909907|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56909908|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909909|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56909910|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56909911|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56909912|NCT00113399|Paclitaxel|paclitaxel|mesh-list
56909913|NCT00113399|Docetaxel|docetaxel|mesh-list
56909914|NCT00113399|Fluorouracil|fluorouracil|mesh-list
56909915|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56909916|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909917|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
56909918|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
56909919|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
56374920|NCT00439543|Iloprost|iloprost|mesh-list
56411087|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
56411088|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411089|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
56411090|NCT04654195|Doxorubicin|doxorubicin|mesh-list
56411091|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411092|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
56411093|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411094|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411095|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411096|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
56411097|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411098|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411099|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411100|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56411101|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411102|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411103|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411104|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
56411105|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56411106|NCT03454789|Lidocaine|lidocaine|mesh-list
56411107|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
56411108|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
56411109|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411110|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411111|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
56089780|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
56909920|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909921|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
56909922|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56909923|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909924|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
56909925|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909926|NCT01326611|Clarithromycin|clarithromycin|mesh-list
56909927|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909928|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909929|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56909930|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909931|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909932|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56909933|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56411112|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411113|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56411114|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56411115|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56411116|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56411117|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411118|NCT00200655|Pravastatin|pravastatin|mesh-list
56411119|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56411120|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56411121|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
56411122|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411123|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56411124|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56411125|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411128|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411129|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
56411130|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411131|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411132|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411133|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
56411134|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411135|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411136|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411138|NCT00200694|Ramipril|ramipril|mesh-list
56411139|NCT00200694|Furosemide|furosemide|mesh-list
56411140|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56411141|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56411142|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56411143|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411144|NCT00200694|Diuretics|diuretics|mesh-ancestor
56411145|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
56411146|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411147|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56411148|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56158798|NCT01682616|Rituximab|rituximab|mesh-list
56411149|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56411150|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
56411151|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411153|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56411154|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411155|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56411156|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56909935|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56909936|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
56909937|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411157|NCT00557713|Growth Substances|growth substances|mesh-ancestor
56411158|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411159|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
56411160|NCT00178100|Paroxetine|paroxetine|mesh-list
56411161|NCT00178100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56411162|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56411163|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56411164|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411165|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411166|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
56411167|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411168|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56411169|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
56411170|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56411171|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56411172|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56411173|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411174|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
56411175|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56411176|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56411177|NCT04653415|Prednisolone|prednisolone|mesh-list
56411178|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
56411179|NCT04653415|Gabapentin|gabapentin|mesh-list
56411180|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56411181|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
56411182|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56411183|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
56411184|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
56411185|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411186|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411187|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56411188|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
56411189|NCT04653415|Hormones|hormones|mesh-ancestor
56411190|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411191|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56411192|NCT04653415|Protective Agents|protective agents|mesh-ancestor
56411193|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56411194|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411195|NCT04653415|Analgesics|analgesics|mesh-ancestor
56411196|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
56411197|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
56411199|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56411200|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411201|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56411202|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56411203|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56411204|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411205|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411206|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
56411207|NCT00557791|Ranibizumab|ranibizumab|mesh-list
56411208|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56411209|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56411210|NCT00557791|Growth Substances|growth substances|mesh-ancestor
56411211|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411212|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
56411213|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411214|NCT04652284|Amoxicillin|amoxicillin|mesh-list
56411215|NCT04652284|Clarithromycin|clarithromycin|mesh-list
56411217|NCT04652284|Tinidazole|tinidazole|mesh-list
56411218|NCT04652284|Esomeprazole|esomeprazole|mesh-list
56411219|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56411220|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411221|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56411222|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56411223|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56411224|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411225|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411226|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56089813|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
56375105|NCT03279562|Nalmefene|nalmefene|mesh-list
56411227|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56411228|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56411229|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56411230|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
56411231|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
56411232|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56411233|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56411234|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56411236|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56411237|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411238|NCT04652011|Analgesics|analgesics|mesh-list
56411239|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
56411240|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411241|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411242|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
56411243|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56411244|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411245|NCT00205725|Olanzapine|olanzapine|mesh-list
56411246|NCT00205725|Ziprasidone|ziprasidone|mesh-list
56411247|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
56411248|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
56411249|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411250|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411251|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56411252|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56411253|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56411254|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411255|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56411256|NCT00205725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56411257|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56411258|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56411259|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411260|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411261|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
56411262|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56411263|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56411264|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
56411265|NCT00178373|Modafinil|modafinil|mesh-list
56411266|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56411267|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411268|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56411269|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56411270|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55985834|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56411273|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411274|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
56411275|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411276|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411277|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411278|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411279|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
56411280|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411281|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
56411282|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56411283|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
56411284|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411285|NCT00558142|Expectorants|expectorants|mesh-ancestor
56411286|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
56411287|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56411288|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
56411289|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411290|NCT00558142|Protective Agents|protective agents|mesh-ancestor
56411291|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411292|NCT00558142|Antidotes|antidotes|mesh-ancestor
56411293|NCT00205842|Alvimopan|alvimopan|mesh-list
56411294|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56411295|NCT00178451|Abciximab|abciximab|mesh-list
56411296|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
56158944|NCT05349474|Metformin|metformin|mesh-list
56411297|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56411298|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56411299|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
56411300|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56909938|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909939|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56909940|NCT00112463|Romidepsin|romidepsin|mesh-list
56909941|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56909942|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909943|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
56909944|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
56411301|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56411302|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56411303|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411304|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411306|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
56411307|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56411308|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56411309|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
56411310|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411311|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411312|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56411313|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
56411314|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
56411315|NCT00206154|Hormones|hormones|mesh-ancestor
56411316|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411317|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56411318|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56411319|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56411320|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
56411321|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411322|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411323|NCT00559702|Natalizumab|natalizumab|mesh-list
56411324|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
56411325|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411326|NCT00559741|Leucovorin|leucovorin|mesh-list
56411327|NCT00559741|Fluorouracil|fluorouracil|mesh-list
56411328|NCT00559741|Irinotecan|irinotecan|mesh-list
56411329|NCT00559741|Cetuximab|cetuximab|mesh-list
56411330|NCT00559741|Calcium|calcium|mesh-list
56411331|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
56411332|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56411333|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411334|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
56411335|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411336|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56411337|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411338|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411339|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
56411340|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56411341|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411342|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411343|NCT00559741|Antidotes|antidotes|mesh-ancestor
56411344|NCT00559741|Protective Agents|protective agents|mesh-ancestor
56411349|NCT00178763|Gemcitabine|gemcitabine|mesh-list
56411350|NCT00178763|Interferons|interferons|mesh-list
56411351|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
56411352|NCT00178763|Cisplatin|cisplatin|mesh-list
56411353|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411354|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56411355|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
56411356|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411357|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
56411358|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411359|NCT00178763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411360|NCT00178763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411361|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
56411362|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411363|NCT00559858|Pyridoxine|pyridoxine|mesh-list
56411364|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
56411365|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
56411366|NCT00559858|Vitamins|vitamins|mesh-ancestor
56411367|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
56411368|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909945|NCT01083017|Diuretics|diuretics|mesh-ancestor
56909946|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
56909947|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909948|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56909949|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56909950|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909951|NCT00112385|Etanercept|etanercept|mesh-list
56909952|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56909953|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56909954|NCT00112385|Analgesics|analgesics|mesh-ancestor
56909955|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
56909956|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909957|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909958|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909959|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909960|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56909961|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909962|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
56909963|NCT03731169|Voriconazole|voriconazole|mesh-list
56909964|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
56909965|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909966|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56375253|NCT00441532|Lidocaine|lidocaine|mesh-list
56411369|NCT00559975|Vaccines|vaccines|mesh-list
56411370|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
56411371|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411372|NCT00206193|Misoprostol|misoprostol|mesh-list
56411373|NCT00206193|Sulprostone|sulprostone|mesh-list
56411374|NCT00206193|Mifepristone|mifepristone|mesh-list
56411375|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56411377|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56411378|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411379|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56411380|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56411381|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
56411382|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56411383|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56411384|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56411385|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56411386|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
56411387|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56411388|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56411389|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
56411390|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411391|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
56411392|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56411393|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56411394|NCT04638439|Entecavir|entecavir|mesh-list
56411395|NCT04638439|Nivolumab|nivolumab|mesh-list
56411396|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56411397|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411398|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56909967|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56909968|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375298|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56411399|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411400|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
56411401|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411402|NCT00178802|Interferons|interferons|mesh-list
56411403|NCT00178802|Doxorubicin|doxorubicin|mesh-list
56411404|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56411405|NCT00178802|Fluorouracil|fluorouracil|mesh-list
56411406|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56411407|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411408|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411409|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411410|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411411|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411412|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
56411413|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56411414|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411415|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
56411416|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411417|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
56411418|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411419|NCT00408239|Enoxaparin|enoxaparin|mesh-list
56411420|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
56411422|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56411423|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411425|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411427|NCT00408278|Analgesics|analgesics|mesh-ancestor
56411428|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
56411429|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411430|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411431|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411432|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411433|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411434|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411435|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411436|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
56411437|NCT00560092|Analgesics|analgesics|mesh-ancestor
56411438|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
56411439|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411440|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411441|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
56411442|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411443|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56411444|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
56411445|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56411446|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56411447|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411448|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56411449|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
56411450|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56411451|NCT00560170|Simvastatin|simvastatin|mesh-list
56411452|NCT00560170|Ezetimibe|ezetimibe|mesh-list
56411453|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56411454|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56411455|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56411456|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
56411457|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411458|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56411459|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56411460|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411461|NCT04637152|Valsartan|valsartan|mesh-list
56411462|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56411463|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56411464|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56411465|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56411466|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411467|NCT04636918|Cyclosporine|cyclosporine|mesh-list
56411468|NCT04636918|Cyclosporins|cyclosporins|mesh-list
56909969|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909970|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56909971|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
56375370|NCT00108095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56411469|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411470|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411471|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411472|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
56411473|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411474|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
56411475|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411476|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
56411477|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411478|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56411479|NCT00560209|Landiolol|landiolol|mesh-list
56411480|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56411481|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56411482|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
56411483|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411484|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411485|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411486|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56411487|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
56411488|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56164045|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
56411489|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56411490|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56411491|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411492|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411493|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411494|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411495|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411496|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411497|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56411498|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56411499|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56411500|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
56411501|NCT04636957|Hormones|hormones|mesh-ancestor
56411502|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411503|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411504|NCT00560326|Tacrolimus|tacrolimus|mesh-list
56411505|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411506|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
56411507|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411508|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56411509|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411510|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411511|NCT00560443|Ketorolac|ketorolac|mesh-list
56411512|NCT00560443|Tramadol|tramadol|mesh-list
56411513|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56411514|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56411515|NCT00560443|Analgesics|analgesics|mesh-ancestor
56411516|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
56411517|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411518|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411519|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159173|NCT03797196|Everolimus|everolimus|mesh-list
56411520|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411521|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56411522|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411523|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411524|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56411526|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411527|NCT00179114|Baclofen|baclofen|mesh-list
56411528|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
56411529|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56411530|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56411531|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56411532|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56909972|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909973|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909974|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56909975|NCT03731091|Calcitriol|calcitriol|mesh-list
56909976|NCT03731091|Betamethasone|betamethasone|mesh-list
56909977|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
56909978|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56909979|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
56909980|NCT03731091|Calcipotriene|calcipotriene|mesh-list
56909981|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56909982|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909983|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
56909984|NCT03731091|Hormones|hormones|mesh-ancestor
56909985|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909986|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909987|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56411533|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411534|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
56411535|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411536|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411537|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56411538|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411539|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56411540|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56411541|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
56411542|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
56411543|NCT00201318|Lamivudine|lamivudine|mesh-list
56411544|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
56411545|NCT00201318|Doxorubicin|doxorubicin|mesh-list
56411546|NCT00201318|Vincristine|vincristine|mesh-list
56411547|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411548|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
56411549|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411550|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411551|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411552|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
56411553|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411554|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411555|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411556|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56411557|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411558|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411559|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411560|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56411561|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
56411562|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
56411563|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
56411564|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56411565|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56411566|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
56411567|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411568|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56411569|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56411570|NCT00201357|Thalidomide|thalidomide|mesh-list
56411571|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411572|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
56411573|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411574|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
56909988|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
56909989|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
56909990|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56909991|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56909992|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56620650|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
56909993|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909995|NCT03731091|Vitamins|vitamins|mesh-ancestor
56910053|NCT00101452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56910054|NCT02162134|Cefuroxime|cefuroxime|mesh-list
56910055|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
56910056|NCT02162134|Ketorolac|ketorolac|mesh-list
56910057|NCT02162134|Midazolam|midazolam|mesh-list
56910058|NCT02162134|Propofol|propofol|mesh-list
56910059|NCT02162134|Sevoflurane|sevoflurane|mesh-list
56910060|NCT02162134|Atracurium|atracurium|mesh-list
56910061|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56411575|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56411576|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411577|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56411578|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56411579|NCT00201357|Growth Substances|growth substances|mesh-ancestor
56411580|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
56411581|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411582|NCT00201396|Leucovorin|leucovorin|mesh-list
56411583|NCT00201396|Fluorouracil|fluorouracil|mesh-list
56411584|NCT00201396|Epirubicin|epirubicin|mesh-list
56411585|NCT00201396|Mitomycins|mitomycins|mesh-list
56411586|NCT00201396|Mitomycin|mitomycin|mesh-list
56411587|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411588|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
56411589|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411590|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56411591|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411592|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
56411593|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411594|NCT00201396|Antidotes|antidotes|mesh-ancestor
56411595|NCT00201396|Protective Agents|protective agents|mesh-ancestor
56411596|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
56411597|NCT00201396|Vitamins|vitamins|mesh-ancestor
56411598|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
56411599|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56411600|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411601|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411602|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411603|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
56411604|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56411605|NCT00201435|Paclitaxel|paclitaxel|mesh-list
56411606|NCT00201435|Docetaxel|docetaxel|mesh-list
56411607|NCT00201435|Capecitabine|capecitabine|mesh-list
56411608|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56411609|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411610|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
56411611|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
56411612|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
56411613|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411614|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56411615|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
56411616|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
56411617|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56411618|NCT00560599|Mupirocin|mupirocin|mesh-list
56411619|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56411620|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411621|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
56411622|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
56411623|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56411624|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56411625|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411626|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411627|NCT04635553|Praziquantel|praziquantel|mesh-list
56411628|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
56411629|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56411630|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411631|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56411632|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56411633|NCT04634656|Lidocaine|lidocaine|mesh-list
56411634|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
56411635|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
56411636|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411637|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411638|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
56910062|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910063|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910064|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56910065|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
56910066|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
56910067|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56910068|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56910069|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56910071|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
56910072|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
56910073|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411639|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411640|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56411641|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56411642|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56411643|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56411644|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411645|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
56411646|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56411647|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411648|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56411649|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411650|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56411651|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56411652|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56411653|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56411654|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56411655|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
56411656|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411657|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411658|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411660|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56411661|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56411662|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56411663|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
56411664|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411665|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411666|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411667|NCT00201630|Urological Agents|urological agents|mesh-ancestor
56411668|NCT00179231|Olanzapine|olanzapine|mesh-list
56411669|NCT00179231|Clozapine|clozapine|mesh-list
56411670|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
56411672|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411673|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411674|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56411675|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56411676|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56411677|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411678|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56411679|NCT00179231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56411680|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56411681|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56411682|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411683|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411684|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
56411685|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56411686|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
56411687|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
56411688|NCT00201669|Clofarabine|clofarabine|mesh-list
56411689|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56411690|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
56411691|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910074|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910075|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56375643|NCT00443716|Estrogens|estrogens|mesh-list
56411692|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411693|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
56411694|NCT00201708|Docetaxel|docetaxel|mesh-list
56411695|NCT00201708|Doxorubicin|doxorubicin|mesh-list
56411696|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411697|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
56411698|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411699|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411700|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411701|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
56411702|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411703|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411704|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411705|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56411706|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56411707|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56411708|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56411709|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411710|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411711|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411712|NCT00179465|Tiagabine|tiagabine|mesh-list
56411713|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
56411714|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56411715|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411716|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986302|NCT00892697|Ribavirin|ribavirin|mesh-list
56411723|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
56411724|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411730|NCT04632121|Nicorandil|nicorandil|mesh-list
56411731|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56411732|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56411733|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
56411734|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
56411735|NCT04632121|Vitamins|vitamins|mesh-ancestor
56411736|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
56411737|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411738|NCT00179699|Pemetrexed|pemetrexed|mesh-list
56411739|NCT00179699|Lenalidomide|lenalidomide|mesh-list
56411740|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411741|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411742|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411743|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56411744|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56411745|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
56411746|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411747|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56411748|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56411749|NCT00179699|Growth Substances|growth substances|mesh-ancestor
56411750|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
56411751|NCT00201747|Mitomycins|mitomycins|mesh-list
56411752|NCT00201747|Mitomycin|mitomycin|mesh-list
56411753|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56411754|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411755|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
56411756|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411757|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56411758|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411759|NCT00179738|Lenalidomide|lenalidomide|mesh-list
56411760|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
56411761|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411762|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56411763|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56411764|NCT00179738|Growth Substances|growth substances|mesh-ancestor
56411765|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
56411766|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411767|NCT04631341|Melatonin|melatonin|mesh-list
56411768|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
56411769|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411770|NCT04631341|Protective Agents|protective agents|mesh-ancestor
56411771|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910076|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56910077|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56910078|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56910079|NCT02162134|Analgesics|analgesics|mesh-ancestor
56910080|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
56411772|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56411773|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56411774|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56411775|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56411776|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56411777|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411778|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411779|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411780|NCT04723238|Analgesics|analgesics|mesh-ancestor
56411781|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
56411782|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411783|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
56411784|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56411785|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
56411786|NCT00201786|Pentostatin|pentostatin|mesh-list
56411787|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411788|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56411789|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411791|NCT04630522|Vitamin D|vitamin d|mesh-list
56411792|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
56411793|NCT04630522|Calcium|calcium|mesh-list
56411794|NCT04630522|Vitamins|vitamins|mesh-ancestor
56411795|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
56411796|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411797|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56411798|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56411799|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
56411800|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411801|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
56411802|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411803|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411804|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411805|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
56411806|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411807|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411808|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411809|NCT04630444|Riluzole|riluzole|mesh-list
56411810|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
56411811|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56411812|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56411813|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411814|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411815|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411816|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56411817|NCT04630444|Protective Agents|protective agents|mesh-ancestor
56411818|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
56159477|NCT02911818|Hormones|hormones|mesh-ancestor
56411820|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411821|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
56411822|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411823|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411824|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411825|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
56411826|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411827|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411828|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411829|NCT04630288|Clopidogrel|clopidogrel|mesh-list
56411830|NCT04630288|Ticagrelor|ticagrelor|mesh-list
56411831|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56411832|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56411833|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56411834|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56411835|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
56910081|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910082|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56910083|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910084|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56910085|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910086|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56910087|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910088|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56910089|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56910090|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56910091|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56910092|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56910093|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
56910094|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56910095|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56910096|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56910097|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910098|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
56910099|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910100|NCT04735978|Nivolumab|nivolumab|mesh-list
56910101|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56910102|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910103|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56910104|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910105|NCT03546621|Tenofovir|tenofovir|mesh-list
56910106|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
56910107|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910108|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56910109|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56910110|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910111|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910112|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56411836|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56411837|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411838|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411839|NCT00561028|Antibodies|antibodies|mesh-list
56411840|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
56411841|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411842|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
56411843|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56411844|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56910113|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56910114|NCT02761330|Ketamine|ketamine|mesh-list
56910115|NCT02761330|Analgesics|analgesics|mesh-ancestor
56910116|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
56910117|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910118|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910119|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56375827|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
56411845|NCT00561067|Prednisolone|prednisolone|mesh-list
56411846|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
56411847|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
56411848|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56411849|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
56411850|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56411851|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
56411852|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
56411853|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411854|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411855|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56411856|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
56411857|NCT00561067|Hormones|hormones|mesh-ancestor
56411858|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411859|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56411860|NCT00561067|Protective Agents|protective agents|mesh-ancestor
56411861|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55986455|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
56411866|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56411867|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
56411868|NCT00561106|Hormones|hormones|mesh-ancestor
56411869|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411870|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411871|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56411872|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411873|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
56411874|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411875|NCT00561184|Vaccines|vaccines|mesh-list
56411876|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
56411877|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411878|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
56411879|NCT00186849|Ifosfamide|ifosfamide|mesh-list
56411880|NCT00186849|Carboplatin|carboplatin|mesh-list
56411881|NCT00186849|Doxorubicin|doxorubicin|mesh-list
56411882|NCT00186849|Etoposide|etoposide|mesh-list
56411883|NCT00186849|Topotecan|topotecan|mesh-list
56411884|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411885|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
56411886|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411887|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411888|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411889|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
56411890|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411891|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411892|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411893|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56411894|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411895|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411896|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411897|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56411898|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56411900|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56411901|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56411902|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
56411903|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411904|NCT00201981|Protective Agents|protective agents|mesh-ancestor
56411905|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411906|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411907|NCT00561223|Iloprost|iloprost|mesh-list
56411908|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56411909|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
56910120|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56910121|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
56910122|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
56910123|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910124|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56910125|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56910126|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910127|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910128|NCT03724071|Flucytosine|flucytosine|mesh-list
56910129|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
56411910|NCT00180011|Omalizumab|omalizumab|mesh-list
56411911|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56411912|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56411913|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
56411914|NCT00186966|Cytarabine|cytarabine|mesh-list
56411915|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
56411916|NCT00186966|Melphalan|melphalan|mesh-list
56411917|NCT00186966|Busulfan|busulfan|mesh-list
56411918|NCT00186966|Fludarabine|fludarabine|mesh-list
56411919|NCT00186966|Etoposide|etoposide|mesh-list
56411920|NCT00186966|Daunorubicin|daunorubicin|mesh-list
56411921|NCT00186966|Thioguanine|thioguanine|mesh-list
56411922|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411924|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411925|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56411926|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56411927|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
56411928|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411929|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411930|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56411931|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56411932|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
56411933|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56411934|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411935|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411936|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411937|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
56411938|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411940|NCT00180050|Budesonide|budesonide|mesh-list
56411941|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56411942|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56411943|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
56411944|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411945|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411946|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56411947|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56411948|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
56411949|NCT00180050|Hormones|hormones|mesh-ancestor
56411950|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411951|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56411952|NCT00575302|Hormones|hormones|mesh-ancestor
56411953|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411954|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411955|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56411956|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56411957|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
56411958|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411959|NCT00180089|Budesonide|budesonide|mesh-list
56411960|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56411961|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56411962|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
56411963|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56411964|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411965|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56411966|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
56411967|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
56910130|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910131|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
56910132|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910133|NCT03730857|Olanzapine|olanzapine|mesh-list
56910134|NCT03730857|Risperidone|risperidone|mesh-list
56910135|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56910136|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
56910137|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56910138|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
56910139|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910140|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910141|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910142|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56910143|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910144|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56910145|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56411968|NCT00180089|Hormones|hormones|mesh-ancestor
56411969|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56411970|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
56411971|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56411972|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
56411973|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411974|NCT00575419|Expectorants|expectorants|mesh-ancestor
56411975|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
56411976|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56411977|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
56411978|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411979|NCT00575419|Protective Agents|protective agents|mesh-ancestor
56411980|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411981|NCT00575419|Antidotes|antidotes|mesh-ancestor
56411982|NCT00180128|Cytarabine|cytarabine|mesh-list
56411983|NCT00180128|Daunorubicin|daunorubicin|mesh-list
56411984|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
56411985|NCT00180128|Idarubicin|idarubicin|mesh-list
56411986|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56411987|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
56411988|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411989|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411990|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
56411991|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56411992|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56411993|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
56411994|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411995|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56411996|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56411997|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56411998|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411999|NCT00180128|Analgesics|analgesics|mesh-ancestor
56412000|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
56412001|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412002|NCT00575614|Prucalopride|prucalopride|mesh-list
56412003|NCT00575614|Laxatives|laxatives|mesh-ancestor
56412004|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412005|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56412006|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56412007|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
56412008|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412009|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412010|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412011|NCT00575848|Glycine|glycine|mesh-list
56910146|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
56910147|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
56910148|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
56910149|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910150|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56910151|NCT03730857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56376021|NCT00143364|Varenicline|varenicline|mesh-list
56412012|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
56412013|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412014|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412016|NCT00576238|Betamethasone|betamethasone|mesh-list
56412017|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
56412018|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56412019|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
56412020|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56412021|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56412022|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
56412023|NCT00576238|Hormones|hormones|mesh-ancestor
56412024|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412025|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412026|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56412027|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
56412028|NCT00576394|Insulin|insulin|mesh-list
56412029|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56412030|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56412031|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412032|NCT00576433|Rituximab|rituximab|mesh-list
56412033|NCT00576433|Methotrexate|methotrexate|mesh-list
56412034|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56412035|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412036|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
56412037|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412038|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412039|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56412040|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
56412041|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56412042|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56412043|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
56412044|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412045|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
56159699|NCT03012594|Lanreotide|lanreotide|mesh-list
56412046|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412047|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56412048|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412049|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56412050|NCT00576511|Prucalopride|prucalopride|mesh-list
56412051|NCT00576511|Laxatives|laxatives|mesh-ancestor
56412052|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412053|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56412054|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56412055|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
56412056|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412057|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412058|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412059|NCT00576550|Betamethasone|betamethasone|mesh-list
56412060|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
56412061|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56412062|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
56412063|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56412064|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56412065|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
56412066|NCT00576550|Hormones|hormones|mesh-ancestor
56412067|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412068|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412069|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56412070|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
56412071|NCT00576706|Misoprostol|misoprostol|mesh-list
56412072|NCT00576706|Rebamipide|rebamipide|mesh-list
56412073|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56910152|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56910153|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56376084|NCT00453076|Paclitaxel|paclitaxel|mesh-list
56412074|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
56412075|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56412076|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412077|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56412078|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412079|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
56412080|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
56412081|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412082|NCT00576706|Protective Agents|protective agents|mesh-ancestor
56412083|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412084|NCT00576784|Pioglitazone|pioglitazone|mesh-list
56412085|NCT00576784|Glimepiride|glimepiride|mesh-list
56412086|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56412089|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412090|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
56412091|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
56412092|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56412093|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412094|NCT00202020|Aspirin|aspirin|mesh-list
56412095|NCT00202020|Cilostazol|cilostazol|mesh-list
56412096|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56412097|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56412098|NCT00202020|Analgesics|analgesics|mesh-ancestor
56412099|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
56412100|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412101|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412102|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56412103|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412104|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56412105|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56412106|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412107|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56412108|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56412109|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412110|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
56412111|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56412112|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
56412113|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56412114|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
56412115|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
56412116|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56412117|NCT00202020|Protective Agents|protective agents|mesh-ancestor
56412118|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56412119|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56412120|NCT00577018|Prucalopride|prucalopride|mesh-list
56159770|NCT03040362|Lasmiditan|lasmiditan|mesh-list
56412121|NCT00577018|Laxatives|laxatives|mesh-ancestor
56412122|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412123|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56412124|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56412125|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
56412126|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412127|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412128|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412129|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
56412130|NCT04578847|Dasatinib|dasatinib|mesh-list
56412131|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412132|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56412133|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412134|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412135|NCT00577057|Fluorouracil|fluorouracil|mesh-list
56412136|NCT00577057|Capecitabine|capecitabine|mesh-list
56412137|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412138|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
56412139|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412140|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56412141|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412142|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
56412143|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412144|NCT00187005|Cytarabine|cytarabine|mesh-list
56910154|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56910155|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56910157|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56910158|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56910159|NCT03726177|Analgesics|analgesics|mesh-ancestor
56910160|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
56910161|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910162|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910163|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56910164|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910165|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56910166|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56910167|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910168|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56910169|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56376160|NCT00453856|Renal Agents|renal agents|mesh-ancestor
56412145|NCT00187005|Dexamethasone|dexamethasone|mesh-list
56412146|NCT00187005|Prednisone|prednisone|mesh-list
56412147|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
56412148|NCT00187005|Methotrexate|methotrexate|mesh-list
56412149|NCT00187005|Etoposide|etoposide|mesh-list
56412150|NCT00187005|Vincristine|vincristine|mesh-list
56412151|NCT00187005|Daunorubicin|daunorubicin|mesh-list
56412152|NCT00187005|Asparaginase|asparaginase|mesh-list
56412153|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
56412154|NCT00187005|Idarubicin|idarubicin|mesh-list
56412155|NCT00187005|Pegaspargase|pegaspargase|mesh-list
56412156|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412157|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
56412158|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412159|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412160|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56412161|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
56412163|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412164|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56412165|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56412166|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
56412167|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
56412168|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412169|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412170|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
56412171|NCT00187005|Hormones|hormones|mesh-ancestor
56412172|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412173|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56412174|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56412175|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
56412176|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56412177|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56412178|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
56412179|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
56412180|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412181|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56412182|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56412183|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56412184|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56412185|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56412186|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
56412187|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412188|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56910170|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910171|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
56910172|NCT03726099|Amoxicillin|amoxicillin|mesh-list
56910173|NCT03726099|Tetracycline|tetracycline|mesh-list
56910174|NCT03726099|Furazolidone|furazolidone|mesh-list
56910175|NCT03726099|Esomeprazole|esomeprazole|mesh-list
56910176|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56910177|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910178|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56910179|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56910180|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56910181|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910182|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910183|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56910184|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56412189|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56412190|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
56412191|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412192|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
56412193|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56412194|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412195|NCT00577369|Desflurane|desflurane|mesh-list
56412196|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56412197|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
56412198|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
56412199|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412200|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412201|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56412202|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
56412203|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412204|NCT00577798|Doxorubicin|doxorubicin|mesh-list
56412205|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56412206|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412207|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412208|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56412209|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56412210|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412211|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412212|NCT00187083|Dexamethasone|dexamethasone|mesh-list
56412213|NCT00187083|Methotrexate|methotrexate|mesh-list
56412214|NCT00187083|Fludarabine|fludarabine|mesh-list
56412215|NCT00187083|Etoposide|etoposide|mesh-list
56412216|NCT00187083|Vincristine|vincristine|mesh-list
56412217|NCT00187083|Topotecan|topotecan|mesh-list
56412218|NCT00187083|Asparaginase|asparaginase|mesh-list
56412219|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
56412220|NCT00187083|Idarubicin|idarubicin|mesh-list
56412221|NCT00187083|Pegaspargase|pegaspargase|mesh-list
56412222|NCT00187083|Teniposide|teniposide|mesh-list
56412223|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56412224|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
56412225|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
56412226|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412227|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412228|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412229|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
56412230|NCT00187083|Hormones|hormones|mesh-ancestor
56412231|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412232|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56412233|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412234|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56412235|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
56412236|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56412239|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910185|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56910186|NCT03726099|Renal Agents|renal agents|mesh-ancestor
56910187|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56910188|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56412240|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
56412241|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412242|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56412243|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412244|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
56412245|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412246|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56412247|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56412248|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56412249|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56412250|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
56412251|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
56412252|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
56412253|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56412254|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412255|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
56412256|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
56412257|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56412258|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56412259|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412260|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56412261|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412262|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56412263|NCT00578149|Paclitaxel|paclitaxel|mesh-list
56412264|NCT00578149|Bevacizumab|bevacizumab|mesh-list
56412265|NCT00578149|Carboplatin|carboplatin|mesh-list
56412266|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56412267|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412268|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
56412269|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
56412270|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
56412271|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412272|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56412273|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56412274|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56412275|NCT00578149|Growth Substances|growth substances|mesh-ancestor
56412276|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412277|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
56412278|NCT00187122|Cytarabine|cytarabine|mesh-list
56412279|NCT00187122|Dexamethasone|dexamethasone|mesh-list
56412280|NCT00187122|Prednisone|prednisone|mesh-list
56412281|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
56412282|NCT00187122|Methotrexate|methotrexate|mesh-list
56412283|NCT00187122|Etoposide|etoposide|mesh-list
56412284|NCT00187122|Vincristine|vincristine|mesh-list
56412285|NCT00187122|Asparaginase|asparaginase|mesh-list
56412286|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
56412287|NCT00187122|Daunorubicin|daunorubicin|mesh-list
56412288|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412289|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
56412290|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412291|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412292|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56412293|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
56412294|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412295|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412296|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56412297|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56412298|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
56412299|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
56412300|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412301|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412302|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
56412303|NCT00187122|Hormones|hormones|mesh-ancestor
56412304|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412305|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56412306|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56412307|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
56910189|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56376355|NCT00455416|Selenium|selenium|mesh-list
56412308|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56412309|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56412311|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
56412312|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412313|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56412314|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56412315|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56412316|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56412317|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56412318|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
56412319|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412320|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
56412321|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
56412322|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
56412323|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412324|NCT00180635|Pimagedine|pimagedine|mesh-list
56412325|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412326|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412327|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
56412328|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
56412329|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412330|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
56412331|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412332|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412333|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56412334|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
56412335|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412336|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412337|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56412338|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56412339|NCT04578496|Afamelanotide|afamelanotide|mesh-list
56412340|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
56412341|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
56412342|NCT00579046|Hematinics|hematinics|mesh-ancestor
56412343|NCT00579085|Ketamine|ketamine|mesh-list
56412344|NCT00579085|Analgesics|analgesics|mesh-ancestor
56412345|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
56412346|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412347|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412348|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56412349|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56412350|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
56412351|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
56412352|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412353|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56412354|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56412355|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412356|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412357|NCT00187161|Cytarabine|cytarabine|mesh-list
56412358|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
56412359|NCT00187161|Doxorubicin|doxorubicin|mesh-list
56412360|NCT00187161|Methotrexate|methotrexate|mesh-list
56412361|NCT00187161|Etoposide|etoposide|mesh-list
56412362|NCT00187161|Vincristine|vincristine|mesh-list
56412363|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412364|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
56412365|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412366|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412367|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56412368|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
56412369|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412370|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412371|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56412372|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412373|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56412374|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56412375|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412376|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56412377|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
56412378|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56412379|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56412380|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
56910190|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56910191|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
56412381|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
56412382|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56412383|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55986968|NCT01835639|Vitamin D|vitamin d|mesh-list
56412385|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
56412386|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412387|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
56412388|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
56412389|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
56412390|NCT00579475|Mifepristone|mifepristone|mesh-list
56412391|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56412392|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
56412393|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56412394|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412395|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56412396|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56412397|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56412398|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
56412399|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56412400|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56412401|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
56412402|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412403|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
56412404|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56412405|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56412406|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
56412407|NCT00579592|Rituximab|rituximab|mesh-list
56412408|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
56412409|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56412410|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412411|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
56412412|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412413|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412414|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412415|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56412416|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
56412417|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56412418|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412419|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412420|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412421|NCT00180791|Carboplatin|carboplatin|mesh-list
56412422|NCT00180791|Etoposide|etoposide|mesh-list
56412423|NCT00180791|Melphalan|melphalan|mesh-list
56412424|NCT00180791|Thiotepa|thiotepa|mesh-list
56160076|NCT04426500|Bupivacaine|bupivacaine|mesh-list
56412425|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412426|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56412427|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56412428|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56412429|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412430|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412431|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56412432|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
56412433|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56412434|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412435|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
56412436|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412438|NCT01054248|Piperaquine|piperaquine|mesh-list
56412439|NCT01054248|Artenimol|artenimol|mesh-list
56412440|NCT01054248|Mefloquine|mefloquine|mesh-list
56412441|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
56412442|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56412443|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56412444|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412445|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412446|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
56412447|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
56412448|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56412449|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
56412450|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
56412451|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412452|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56412453|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910192|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
56910193|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56910194|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56910195|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910196|NCT03558555|Acetaminophen|acetaminophen|mesh-list
56910197|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56910198|NCT03558555|Analgesics|analgesics|mesh-ancestor
56910199|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
56910200|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910201|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910202|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
56910203|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
56910204|NCT03726021|Irinotecan|irinotecan|mesh-list
56910205|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910206|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56910207|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56910208|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910209|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910210|NCT05665023|Bevacizumab|bevacizumab|mesh-list
56910211|NCT05665023|Folfirinox|folfirinox|mesh-list
56910212|NCT05665023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56910213|NCT05665023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910214|NCT05665023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56910215|NCT05665023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56910216|NCT05665023|Growth Substances|growth substances|mesh-ancestor
56910217|NCT05665023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910218|NCT05665023|Growth Inhibitors|growth inhibitors|mesh-ancestor
56910219|NCT03557931|Olanzapine|olanzapine|mesh-list
56910220|NCT03557931|Risperidone|risperidone|mesh-list
56910221|NCT03557931|Aripiprazole|aripiprazole|mesh-list
56910222|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56910223|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56412454|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412455|NCT00202176|Bromides|bromides|mesh-list
56412456|NCT00202176|Ipratropium|ipratropium|mesh-list
56412457|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
56412458|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56412461|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412462|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56412463|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
56412464|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56412465|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
56412466|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412467|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412468|NCT00580060|Molgramostim|molgramostim|mesh-list
56910224|NCT03557931|Ziprasidone|ziprasidone|mesh-list
56910225|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56910226|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
56910227|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56910228|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
56910229|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910230|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910231|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910232|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56910233|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56910234|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910235|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56910236|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56910237|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
56910238|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
56910239|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
56910240|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412469|NCT00580060|Sargramostim|sargramostim|mesh-list
56412470|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
56412471|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412472|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412473|NCT00180908|Doxorubicin|doxorubicin|mesh-list
56412474|NCT00180908|Etoposide|etoposide|mesh-list
56412475|NCT00180908|Methotrexate|methotrexate|mesh-list
56412476|NCT00180908|Ifosfamide|ifosfamide|mesh-list
56412477|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412478|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412479|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56412480|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56412481|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412482|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412483|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56412484|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
56412485|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56412486|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412487|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56412488|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
56412489|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
56412490|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56412491|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412492|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
56412493|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412494|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56412495|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56412496|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56412497|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
56412498|NCT00580450|Thymalfasin|thymalfasin|mesh-list
56412499|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56412500|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
56412501|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412502|NCT00180947|Vinorelbine|vinorelbine|mesh-list
56412503|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56412504|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412505|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
56412506|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
56412507|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
56412508|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412509|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56412510|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
56910241|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376598|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412511|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412512|NCT00581425|Interferons|interferons|mesh-list
56412513|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
56412514|NCT00581425|Imiquimod|imiquimod|mesh-list
56412515|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412516|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
56412517|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412518|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
56412519|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412520|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56412521|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
56412522|NCT00209079|Docetaxel|docetaxel|mesh-list
56412523|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
56412524|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412525|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
56412526|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
56412527|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
56412528|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412529|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56412530|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412531|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
56412532|NCT04576975|Ketamine|ketamine|mesh-list
56412533|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56412534|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412535|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412536|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56412538|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
56412539|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412540|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56412541|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56412542|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56412543|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
56412544|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412545|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412546|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56412547|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56412548|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
56412549|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
56412550|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56412551|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56412552|NCT00209118|Paroxetine|paroxetine|mesh-list
56412553|NCT00209118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56412554|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56412555|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56412556|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412557|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412558|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
56412559|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412560|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56412561|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
56412562|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56412563|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56412564|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56412565|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412566|NCT00181025|Melphalan|melphalan|mesh-list
56412567|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56412568|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
56412569|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412570|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412571|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56412572|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412573|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
56160231|NCT03223272|Reserpine|reserpine|mesh-list
56412574|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412576|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
56412577|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412578|NCT00582634|Docetaxel|docetaxel|mesh-list
56412579|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412580|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
56412581|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
56412582|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
56910242|NCT03557931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56910243|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56910244|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56910245|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
56910246|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
56910247|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56910248|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56910249|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56910250|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56910251|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56910252|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56910253|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56910254|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
56910255|NCT03977675|Ketamine|ketamine|mesh-list
56910256|NCT03977675|Analgesics|analgesics|mesh-ancestor
56910257|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
56412583|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412584|NCT00209352|Acyclovir|acyclovir|mesh-list
56412585|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
56412586|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412587|NCT00181142|Daclizumab|daclizumab|mesh-list
56412588|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412589|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
56412590|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412591|NCT00582985|Antibodies|antibodies|mesh-list
56412592|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
56412593|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412594|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
56412595|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56412596|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56412597|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412598|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56412599|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56412600|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
56412601|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412602|NCT00181181|Atorvastatin|atorvastatin|mesh-list
56412603|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56412604|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56412605|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
55987185|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412609|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412610|NCT00181220|Valproic Acid|valproic acid|mesh-list
56412611|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
56412612|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412613|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412614|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
56412615|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412616|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412617|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
56412618|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56412619|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412620|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56412621|NCT00583063|Sirolimus|sirolimus|mesh-list
56412622|NCT00583063|Sunitinib|sunitinib|mesh-list
56412623|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412624|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56412625|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56412626|NCT00583063|Growth Substances|growth substances|mesh-ancestor
56412627|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910258|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910259|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910260|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56910261|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56910262|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
56910263|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
56412628|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
56412629|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56412630|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412631|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412632|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56412633|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412634|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412635|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
56412636|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412637|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
56412638|NCT00181298|Memantine|memantine|mesh-list
56412639|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56412640|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56412641|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
56412642|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412643|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412644|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412645|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56412646|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56412647|NCT00583180|Capsaicin|capsaicin|mesh-list
56412648|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
56412649|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
56412650|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
56412651|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412652|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412654|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56412655|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56412657|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
56412658|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412659|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412660|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412661|NCT00583258|Urological Agents|urological agents|mesh-ancestor
56412662|NCT00181532|Celecoxib|celecoxib|mesh-list
56412663|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56412664|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56412665|NCT00181532|Analgesics|analgesics|mesh-ancestor
56412666|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
56412667|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412668|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412669|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56412670|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56412671|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56412672|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56412673|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412674|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412675|NCT04576390|Ondansetron|ondansetron|mesh-list
56412676|NCT04576390|Palonosetron|palonosetron|mesh-list
56412677|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
56412679|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412680|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412681|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412682|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
56412683|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
56412684|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56412685|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
56412686|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412687|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412688|NCT04576390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56412689|NCT04576390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56412690|NCT04576390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412691|NCT04576390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56412692|NCT04576390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56910264|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910265|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56910266|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56910267|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910268|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910269|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56910270|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
56910271|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56910272|NCT01066559|Protective Agents|protective agents|mesh-ancestor
56910273|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910274|NCT00293813|Denosumab|denosumab|mesh-list
56910275|NCT00293813|Alendronate|alendronate|mesh-list
56910276|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56910277|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910278|NCT00293579|Pemetrexed|pemetrexed|mesh-list
56910279|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910280|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376794|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56412693|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56412694|NCT00181571|Methylphenidate|methylphenidate|mesh-list
56412695|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56412696|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412697|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56412698|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56412699|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56412700|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412701|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
56412702|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412703|NCT00187707|Gabapentin|gabapentin|mesh-list
56412704|NCT00187707|Analgesics|analgesics|mesh-ancestor
56412705|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
56412706|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412707|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412708|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
56412709|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56412710|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56412711|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412712|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56412713|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56412714|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56412715|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412716|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412717|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
56412718|NCT00187746|Adefovir|adefovir|mesh-list
56412719|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56412720|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
56412721|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412722|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56412723|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56412724|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412725|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412727|NCT00181688|Gefitinib|gefitinib|mesh-list
55913259|NCT00525135|Valproic Acid|valproic acid|mesh-list
56412728|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56412730|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56412731|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56910281|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910282|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56910283|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56910284|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
56910285|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56910286|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
56910287|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910288|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412732|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412733|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412734|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56412735|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
56412736|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412737|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412738|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56412739|NCT00209469|Alendronate|alendronate|mesh-list
56412740|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56412741|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412742|NCT00181727|Valproic Acid|valproic acid|mesh-list
56412743|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
56412744|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412745|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412746|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
56412747|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412748|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412749|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
56412750|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56412751|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412753|NCT00584155|Ofloxacin|ofloxacin|mesh-list
56412754|NCT00584155|Levofloxacin|levofloxacin|mesh-list
56412755|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56412756|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56412757|NCT00584155|Renal Agents|renal agents|mesh-ancestor
56412758|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56412759|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56412760|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56412761|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412762|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412763|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412764|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56412765|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56412766|NCT00411372|Fluticasone|fluticasone|mesh-list
56412767|NCT00411372|Xhance|xhance|mesh-list
56412768|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56412769|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56412770|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56412771|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56412772|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
56412773|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412774|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412775|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56412776|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
56412777|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
56412778|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56412779|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56412780|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56412781|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56412782|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
56412783|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412784|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412785|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
56412786|NCT00411372|Hormones|hormones|mesh-ancestor
56412787|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412788|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
56910289|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412789|NCT00181922|Ziprasidone|ziprasidone|mesh-list
56412790|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56412791|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
56412792|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412793|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412794|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160467|NCT03485976|Ixekizumab|ixekizumab|mesh-list
56412795|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56412796|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56412797|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412798|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56412799|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56412801|NCT00182039|Metoprolol|metoprolol|mesh-list
56412802|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56412803|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56412804|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
56412805|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
56412806|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412807|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412808|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56412809|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56412810|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56412811|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
56412812|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412813|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412814|NCT00584389|Rimonabant|rimonabant|mesh-list
56412815|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56412816|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56412817|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56412818|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412819|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412820|NCT00584389|Hormones|hormones|mesh-ancestor
56412821|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412822|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412823|NCT00216372|Lanreotide|lanreotide|mesh-list
56412825|NCT00584662|Phenylephrine|phenylephrine|mesh-list
56412826|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
56412827|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56412828|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56412829|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
56412830|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412831|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412832|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412833|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
56412834|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
56412835|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412836|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
56412837|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56412838|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
56412839|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56412840|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
56412841|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56412842|NCT00584662|Protective Agents|protective agents|mesh-ancestor
56412844|NCT00584779|Analgesics|analgesics|mesh-ancestor
56412845|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
56412846|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412847|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412848|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
56412849|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56412850|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56412851|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412852|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56412853|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56412854|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56412855|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412856|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412857|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
56412858|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
56412859|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56412860|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56412861|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56412862|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56910290|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
56910291|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910292|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
56910293|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56910294|NCT00293423|Protective Agents|protective agents|mesh-ancestor
56910295|NCT03521817|Ethanol|ethanol|mesh-list
56910296|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56910297|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910298|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910299|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910300|NCT03538431|Buspirone|buspirone|mesh-list
56910301|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56910302|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56910303|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910304|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910305|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56910306|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56910307|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
56910308|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910309|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910310|NCT03521193|Aspirin|aspirin|mesh-list
56910311|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56910312|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56376997|NCT00144456|Vitamins|vitamins|mesh-ancestor
56412863|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412864|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
56412865|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412866|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412867|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56412868|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412869|NCT00585091|Phenylephrine|phenylephrine|mesh-list
56412870|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
56412871|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56412872|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
56412874|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412875|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412876|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
56412877|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56412878|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
56412879|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
56412880|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56412881|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56412882|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56412883|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
56412884|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412885|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412886|NCT00585091|Protective Agents|protective agents|mesh-ancestor
56412887|NCT00216450|Rabeprazole|rabeprazole|mesh-list
56412888|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56412889|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412890|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56910313|NCT03521193|Analgesics|analgesics|mesh-ancestor
56910314|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
56910315|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377049|NCT00111371|Levodopa|levodopa|mesh-list
56412891|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412892|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412893|NCT00585442|Vitamin D|vitamin d|mesh-list
56412894|NCT00585442|Calcitriol|calcitriol|mesh-list
56412895|NCT00585442|Vitamins|vitamins|mesh-ancestor
56412896|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
56412897|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412898|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56412899|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56412900|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56412901|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56412902|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412903|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56412905|NCT00585520|Progestins|progestins|mesh-ancestor
56412906|NCT00585520|Hormones|hormones|mesh-ancestor
56412907|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56412908|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412909|NCT00216489|Rabeprazole|rabeprazole|mesh-list
56412910|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56412911|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56412912|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56412913|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412914|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412915|NCT00585754|Guanfacine|guanfacine|mesh-list
56412916|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56412917|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56412918|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56412919|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56412920|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
56412921|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412922|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412923|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412924|NCT00209547|Fospropofol|fospropofol|mesh-list
56412925|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56412926|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412927|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412928|NCT00585871|Metoprolol|metoprolol|mesh-list
56412929|NCT00585871|Clonidine|clonidine|mesh-list
56412930|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56412931|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56412932|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
56412933|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
56412934|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412935|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412936|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56412937|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56412938|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56412939|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
56412940|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56412941|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412942|NCT00585871|Analgesics|analgesics|mesh-ancestor
56412943|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
56412944|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56412945|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56412946|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56412947|NCT03452722|Plasminogen|plasminogen|mesh-list
56412948|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56412949|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56412950|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56412951|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412952|NCT00408551|Leucovorin|leucovorin|mesh-list
56412953|NCT00408551|Fluorouracil|fluorouracil|mesh-list
56412954|NCT00408551|Floxuridine|floxuridine|mesh-list
56412955|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
56412956|NCT00408551|Irinotecan|irinotecan|mesh-list
56412957|NCT00408551|Calcium|calcium|mesh-list
56412958|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
56412959|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56910316|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910317|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56910318|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910319|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56412960|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412961|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
56412962|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412963|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56412964|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412965|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56412966|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
56412967|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56412968|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56412969|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412970|NCT00408551|Antidotes|antidotes|mesh-ancestor
56412971|NCT00408551|Protective Agents|protective agents|mesh-ancestor
56412972|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
56412975|NCT04575415|Bevacizumab|bevacizumab|mesh-list
56412976|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56412977|NCT04575415|Gefitinib|gefitinib|mesh-list
56412978|NCT04575415|Osimertinib|osimertinib|mesh-list
56412979|NCT04575415|Afatinib|afatinib|mesh-list
56412980|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56412981|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412982|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56412983|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56412984|NCT04575415|Growth Substances|growth substances|mesh-ancestor
56412985|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412986|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
56412987|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56412988|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412989|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412990|NCT00209586|Fospropofol|fospropofol|mesh-list
56412991|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56412992|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56412993|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412994|NCT00209625|Leucovorin|leucovorin|mesh-list
56412995|NCT00209625|Fluorouracil|fluorouracil|mesh-list
56412996|NCT00209625|Irinotecan|irinotecan|mesh-list
56412997|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
56412998|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412999|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413000|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413001|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413002|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
56413003|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413004|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56413005|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56413006|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413007|NCT00209625|Antidotes|antidotes|mesh-ancestor
56413008|NCT00209625|Protective Agents|protective agents|mesh-ancestor
56413009|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
56413010|NCT00209625|Vitamins|vitamins|mesh-ancestor
56413011|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
56413012|NCT00216528|Risperidone|risperidone|mesh-list
56413013|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56413014|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
56413015|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413016|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413017|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413018|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56413019|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56160683|NCT04323852|Vitamin D|vitamin d|mesh-list
56413020|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55913557|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
56413021|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413022|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56413024|NCT00182312|Caffeine|caffeine|mesh-list
56413025|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
56413026|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413027|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56413028|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910320|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56910321|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413029|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56413030|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413031|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56413032|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56413033|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
56413034|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413035|NCT00209664|Irinotecan|irinotecan|mesh-list
56413036|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56413037|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56413038|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413039|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413040|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413041|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
56413042|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56413043|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413044|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56413045|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56413046|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413048|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413049|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56413050|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56413052|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413053|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56413054|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
56413055|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413056|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413057|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56413058|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
56413059|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
56413060|NCT00587119|Hormones|hormones|mesh-ancestor
56413061|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413062|NCT00216567|Topiramate|topiramate|mesh-list
56413063|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
56413064|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56413065|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413066|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
56413067|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56413068|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56413069|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413070|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
56413071|NCT00182351|Coagulants|coagulants|mesh-ancestor
56413072|NCT00587470|Candesartan|candesartan|mesh-list
56413073|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
56413074|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56413075|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56413076|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56413077|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413078|NCT00209703|Leucovorin|leucovorin|mesh-list
56413079|NCT00209703|Fluorouracil|fluorouracil|mesh-list
56413080|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
56413081|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
56413082|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
56413083|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413084|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413085|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413086|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413087|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
56413088|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413089|NCT00209703|Antidotes|antidotes|mesh-ancestor
56413090|NCT00209703|Protective Agents|protective agents|mesh-ancestor
56413091|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
56413092|NCT00209703|Vitamins|vitamins|mesh-ancestor
56413093|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
56413094|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
56413095|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56413096|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413097|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413098|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413100|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56413101|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910322|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56910323|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56910324|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413103|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
56413104|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56413105|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413106|NCT00587665|Ketamine|ketamine|mesh-list
56413107|NCT00587665|Analgesics|analgesics|mesh-ancestor
56413108|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
56413109|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413110|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413111|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56413112|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56413113|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
56413114|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
56413115|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413116|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56413117|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56413118|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413119|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413120|NCT00182429|Metronidazole|metronidazole|mesh-list
55987711|NCT03406793|Iron|iron|mesh-list
56413124|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56413125|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56413126|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56413127|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
56413128|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
56413129|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56413130|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413131|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413132|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56413133|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56413134|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56413135|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56413136|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56413137|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56413138|NCT00216645|Doxorubicin|doxorubicin|mesh-list
56413139|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56413140|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56413141|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413142|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56413143|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56413144|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413145|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413146|NCT00588016|Itraconazole|itraconazole|mesh-list
56413147|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
56413148|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413149|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56413150|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56413151|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413152|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413153|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56413154|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
56413155|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413156|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413157|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56413158|NCT00216684|Fentanyl|fentanyl|mesh-list
56413159|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56413160|NCT00216684|Narcotics|narcotics|mesh-ancestor
56413161|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413162|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413163|NCT00216684|Analgesics|analgesics|mesh-ancestor
56413164|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
56413165|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413166|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56160830|NCT03930264|Azathioprine|azathioprine|mesh-list
56413168|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
56413169|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
56413170|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
56413171|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56910325|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
56910326|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
56377346|NCT00114270|Letrozole|letrozole|mesh-list
56413172|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56413173|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413174|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
56413175|NCT00588133|Coagulants|coagulants|mesh-ancestor
56413176|NCT00588172|Metformin|metformin|mesh-list
56413177|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56413178|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413179|NCT00182507|Olanzapine|olanzapine|mesh-list
56413180|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
56413181|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
56413182|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413183|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413184|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56413185|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56413186|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56413187|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413188|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413189|NCT00182507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56413190|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56413191|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413193|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413194|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
56413195|NCT00209742|Leucovorin|leucovorin|mesh-list
56413196|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
56413197|NCT00209742|Tegafur|tegafur|mesh-list
56413198|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
56413199|NCT00209742|Antidotes|antidotes|mesh-ancestor
56413200|NCT00209742|Protective Agents|protective agents|mesh-ancestor
56413201|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413202|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
56413203|NCT00209742|Vitamins|vitamins|mesh-ancestor
56413204|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
56413205|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413206|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
56413207|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413208|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413209|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56413210|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
56413211|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56413212|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
56413213|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413214|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
56413215|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56413216|NCT00216723|Aripiprazole|aripiprazole|mesh-list
56413217|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
56413218|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413219|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56413220|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56413221|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413222|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413223|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
56413224|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
56413225|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413226|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413227|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56413228|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56413229|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
56413230|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56413231|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56413232|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56413233|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56413234|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
56413235|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
56413236|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56413237|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
56413238|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56413239|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56413240|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413241|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56413242|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164096|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55888088|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56910327|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56910328|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56910329|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
56910330|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910331|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56910332|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56910333|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910334|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413243|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413244|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56413245|NCT00209781|Renal Agents|renal agents|mesh-ancestor
56413246|NCT00182663|Clarithromycin|clarithromycin|mesh-list
56413247|NCT00182663|Thalidomide|thalidomide|mesh-list
56413248|NCT00182663|Dexamethasone|dexamethasone|mesh-list
56413249|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413250|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
56413251|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
56413252|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413253|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413254|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56413255|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
56413256|NCT00182663|Hormones|hormones|mesh-ancestor
56413257|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413258|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56413259|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413260|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56413261|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413262|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56413263|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413264|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413266|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56413267|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413268|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
56413269|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
56413270|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56413271|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56413272|NCT00182663|Growth Substances|growth substances|mesh-ancestor
56413273|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
56413275|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56413276|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413277|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
56413278|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413279|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413280|NCT00182702|Epothilones|epothilones|mesh-list
56413281|NCT00182702|Epothilone B|epothilone b|mesh-list
56413282|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
56413283|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
56413284|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
56413285|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413286|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413287|NCT00588835|Dexamethasone|dexamethasone|mesh-list
56413288|NCT00588835|Ondansetron|ondansetron|mesh-list
56413289|NCT00588835|Aprepitant|aprepitant|mesh-list
56413290|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413291|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
56413292|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
56413293|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413294|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413295|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56413296|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
56413297|NCT00588835|Hormones|hormones|mesh-ancestor
56413298|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413299|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56413300|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413301|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
56413302|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
56413303|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56413304|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
56910335|NCT03977441|Pramipexole|pramipexole|mesh-list
56910336|NCT03977441|S 20098|s 20098|mesh-list
56910337|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
56910338|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910339|NCT03977441|Protective Agents|protective agents|mesh-ancestor
56910340|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910341|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56910342|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56910343|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
56910344|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
56910345|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910346|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56910347|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910348|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56910349|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56910350|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
56910351|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56910352|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910353|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56910354|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
56413305|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413306|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413307|NCT00588835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56413308|NCT00588835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56413309|NCT00588835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413310|NCT00588835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413311|NCT00588835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56413312|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56413313|NCT00209859|Cyclosporine|cyclosporine|mesh-list
56413314|NCT00209859|Betamethasone|betamethasone|mesh-list
56413315|NCT00209859|Methotrexate|methotrexate|mesh-list
56413316|NCT00209859|Cyclosporins|cyclosporins|mesh-list
56413317|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56413318|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
56413319|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56413320|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413321|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413322|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
56413323|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413324|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413325|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
56413326|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413327|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56413328|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413329|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
56413330|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413331|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56413332|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
56413333|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413334|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56413335|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413336|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
56413337|NCT00209859|Hormones|hormones|mesh-ancestor
56413338|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413342|NCT00588913|Aldesleukin|aldesleukin|mesh-list
56413343|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910355|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56910356|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910357|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910358|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910359|NCT00111917|Infliximab|infliximab|mesh-list
56910360|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
56910361|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56413344|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56413345|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56413346|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
56413347|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413348|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56413349|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413350|NCT00182741|Calcitriol|calcitriol|mesh-list
56413351|NCT00182741|Prednisone|prednisone|mesh-list
56413352|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
56413353|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413354|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
56413355|NCT00182741|Hormones|hormones|mesh-ancestor
56413356|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413357|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413358|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56413359|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413360|NCT00182741|Analgesics|analgesics|mesh-ancestor
56413361|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
56413362|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413363|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56413364|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56413365|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413366|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413367|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56413368|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56413369|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413370|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56413371|NCT00182741|Vitamins|vitamins|mesh-ancestor
56413372|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
56413373|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56413374|NCT00589186|Celecoxib|celecoxib|mesh-list
56413375|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56413376|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56413377|NCT00589186|Analgesics|analgesics|mesh-ancestor
56413378|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
56413379|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413380|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413381|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413382|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413383|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56413384|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56413385|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413386|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413387|NCT00589264|Copper|copper|mesh-list
56413388|NCT00589264|Trace Elements|trace elements|mesh-ancestor
56413389|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
56413390|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413391|NCT00589381|Fenretinide|fenretinide|mesh-list
56413392|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161052|NCT02345460|Antidotes|antidotes|mesh-ancestor
56413393|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56413394|NCT00589381|Protective Agents|protective agents|mesh-ancestor
56413395|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413396|NCT00182819|Temozolomide|temozolomide|mesh-list
56413397|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56413398|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
56413399|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413400|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413401|NCT00216840|Betamethasone|betamethasone|mesh-list
56413402|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
56413403|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56910362|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910363|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
56910364|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
56910365|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56910366|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56910367|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910368|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910369|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910370|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910371|NCT03520569|Octreotide|octreotide|mesh-list
56413404|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
56413405|NCT00216840|Calcipotriene|calcipotriene|mesh-list
56413406|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56413407|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413408|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
56413409|NCT00216840|Hormones|hormones|mesh-ancestor
56413410|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413412|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56413413|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
56413414|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
56413415|NCT00589732|Valsartan|valsartan|mesh-list
56413416|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56413417|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56413418|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56413419|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413420|NCT00216879|Betamethasone|betamethasone|mesh-list
56413421|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
56413422|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56413423|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
56413424|NCT00216879|Calcipotriene|calcipotriene|mesh-list
56413425|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56413426|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413427|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
56413428|NCT00216879|Hormones|hormones|mesh-ancestor
56413429|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413430|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413431|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56413432|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
56413433|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
56413434|NCT00589927|Cilostazol|cilostazol|mesh-list
56413435|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56413436|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
56413437|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413438|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413439|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56413440|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
56413441|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56413442|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56413443|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413444|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56413445|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
56413446|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56413447|NCT00589927|Protective Agents|protective agents|mesh-ancestor
56413448|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56413449|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56413450|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413451|NCT00209937|Gaboxadol|gaboxadol|mesh-list
56413452|NCT00209937|Analgesics|analgesics|mesh-ancestor
56413453|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
56413454|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164102|NCT00002664|Sargramostim|sargramostim|mesh-list
56413455|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413456|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
56413457|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
56413458|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
56413459|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910372|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56910373|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56910374|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413460|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413461|NCT00590278|Raltitrexed|raltitrexed|mesh-list
56413462|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413463|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
56413464|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413465|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413466|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56413468|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56413469|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56413470|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56413471|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413472|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413473|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
56413474|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413475|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413476|NCT04574791|Tizanidine|tizanidine|mesh-list
56413477|NCT04574791|Analgesics|analgesics|mesh-ancestor
56413478|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
56413479|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413480|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413481|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
56413482|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56413483|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56413486|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56413487|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56413488|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56413489|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
56413490|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413491|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413492|NCT03452332|Durvalumab|durvalumab|mesh-list
56413493|NCT03452332|Ipilimumab|ipilimumab|mesh-list
56413494|NCT03452332|Tremelimumab|tremelimumab|mesh-list
56413495|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
56413496|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56413497|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
56413498|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56413499|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413500|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
56413501|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413502|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56413503|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413504|NCT00590629|Niacin|niacin|mesh-list
56413505|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
56413506|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56413507|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
56413508|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413509|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56413510|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
56413511|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
56413512|NCT00590629|Vitamins|vitamins|mesh-ancestor
56413513|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
56413514|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413515|NCT00590785|Tamoxifen|tamoxifen|mesh-list
56413516|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
56413517|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
56413518|NCT00590785|Doxorubicin|doxorubicin|mesh-list
56413519|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413520|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
56413521|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413522|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413523|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56413524|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
56413525|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413526|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413527|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56413528|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56413529|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56413530|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56910375|NCT00111839|Pemetrexed|pemetrexed|mesh-list
56910376|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910377|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910378|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910379|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56910380|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56910381|NCT03723291|Tocopherols|tocopherols|mesh-list
56910382|NCT03723291|Vitamin E|vitamin e|mesh-list
56910383|NCT03723291|Tocotrienols|tocotrienols|mesh-list
56910384|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
56910385|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
56910386|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56910387|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910388|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910389|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56910390|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56910391|NCT03723291|Protective Agents|protective agents|mesh-ancestor
56910392|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910393|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
56377736|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
56413531|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413532|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56413533|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
56413534|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413535|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56413536|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56413537|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56413538|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56413539|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56413540|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413541|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56413542|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56413544|NCT00477295|Zonisamide|zonisamide|mesh-list
56413545|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
56413546|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
56413547|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56413548|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413549|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413550|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413551|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56413552|NCT00477295|Analgesics|analgesics|mesh-ancestor
56413553|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
56413554|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413555|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56413556|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413557|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413574|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56413576|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413577|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56413578|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56413579|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56413580|NCT00476593|Analgesics|analgesics|mesh-ancestor
56413581|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
56413582|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910394|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56910395|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
56910396|NCT03723291|Vitamins|vitamins|mesh-ancestor
56910397|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
56910398|NCT00111761|Leucovorin|leucovorin|mesh-list
56910399|NCT00111761|Fluorouracil|fluorouracil|mesh-list
56910400|NCT00111761|Irinotecan|irinotecan|mesh-list
56910401|NCT00111761|Panitumumab|panitumumab|mesh-list
56910402|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
56910403|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910404|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56910405|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910406|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56910407|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
56910408|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910409|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56910410|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56910411|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910412|NCT00111761|Antidotes|antidotes|mesh-ancestor
56910413|NCT00111761|Protective Agents|protective agents|mesh-ancestor
56910414|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
56910415|NCT00111761|Vitamins|vitamins|mesh-ancestor
56910416|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
56910417|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56910418|NCT03519867|Bromides|bromides|mesh-list
56910419|NCT03519867|Rocuronium|rocuronium|mesh-list
56910420|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
56910421|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56910422|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56910423|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56910424|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910425|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910426|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
56910427|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56910428|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910429|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
56910430|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
56910431|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56910437|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910438|NCT02164552|Vitamin D|vitamin d|mesh-list
56910439|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
56910440|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
56910441|NCT02164552|Vitamins|vitamins|mesh-list
56910442|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
56910443|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910444|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56910445|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56910446|NCT03723135|Azacitidine|azacitidine|mesh-list
56910447|NCT03723135|Cc-486|cc-486|mesh-list
56910448|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56910450|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910451|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910452|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910453|NCT02762578|Insulin|insulin|mesh-list
56910454|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56910455|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
56910456|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
56413583|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56413584|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413585|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413586|NCT00476593|Cathartics|cathartics|mesh-ancestor
56413587|NCT00210132|Ropivacaine|ropivacaine|mesh-list
56413588|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
56413589|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
56413590|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413591|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413592|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
56413593|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413594|NCT00183404|Olanzapine|olanzapine|mesh-list
56413595|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
56413596|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
56413597|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413598|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413599|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56413600|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56413601|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56413602|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413603|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413604|NCT00183404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56413605|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56413606|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413607|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413608|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413609|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
56413610|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56413611|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413612|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56413613|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161273|NCT01385280|Estrogens|estrogens|mesh-ancestor
55988220|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413615|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
56413616|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413617|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
56413618|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56413619|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413620|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56910457|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56910458|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
56910459|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56910460|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910461|NCT03540628|Thiamine|thiamine|mesh-list
56910462|NCT03540628|Vitamins|vitamins|mesh-ancestor
56910463|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
56910464|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910465|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
56910466|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
56910467|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56910468|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910469|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910470|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56910471|NCT02170948|Analgesics|analgesics|mesh-ancestor
56910472|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
56910473|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910474|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56910475|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56910476|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56910477|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
56910478|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910479|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910480|NCT02171026|Amiodarone|amiodarone|mesh-list
56910481|NCT02171026|Dabigatran|dabigatran|mesh-list
56910482|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
56910483|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56910484|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
56413621|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
56413622|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56413623|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413624|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413625|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413626|NCT00210210|Ketamine|ketamine|mesh-list
56413627|NCT00210210|Analgesics|analgesics|mesh-ancestor
56413628|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
56413629|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413630|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413631|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56413632|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56413633|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
56413634|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
56413635|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413636|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56413637|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56413638|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413639|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910485|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910486|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910487|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
56910488|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56910489|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
56910490|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56910491|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56910492|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56910493|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56910494|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56910495|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56910496|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56910497|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56910498|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
56910499|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56910500|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
56910501|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910502|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
56910503|NCT02165020|Protective Agents|protective agents|mesh-ancestor
56910504|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
56910505|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56910506|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910507|NCT03539224|Lamivudine|lamivudine|mesh-list
56910508|NCT03539224|Dolutegravir|dolutegravir|mesh-list
56910509|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56910510|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56910511|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910512|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910513|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
56910514|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910529|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910530|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910531|NCT02165098|Cariprazine|cariprazine|mesh-list
56910532|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56910533|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56910534|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910535|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910536|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56910537|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56910538|NCT02171338|Azithromycin|azithromycin|mesh-list
56910539|NCT02171338|Clarithromycin|clarithromycin|mesh-list
56910540|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
56910541|NCT02171338|Tazobactam|tazobactam|mesh-list
56910542|NCT02171338|Piperacillin|piperacillin|mesh-list
56910543|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56910544|NCT02171338|Penicillin G|penicillin g|mesh-list
56910545|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910546|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56910547|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910548|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910549|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56910550|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56910551|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56910552|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56910553|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910554|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56413640|NCT00476086|Gemcitabine|gemcitabine|mesh-list
56413641|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
56413642|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413643|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
56413644|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413645|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413646|NCT00476086|Antiviral Agents|antiviral agents|mesh-ancestor
56413647|NCT00476086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413648|NCT00476086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413649|NCT00476086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413650|NCT00476086|Immunologic Factors|immunologic factors|mesh-ancestor
56413651|NCT00476086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413652|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
56413653|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413654|NCT00217191|Ibuprofen|ibuprofen|mesh-list
56413655|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56413656|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56413657|NCT00217191|Analgesics|analgesics|mesh-ancestor
56413658|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
56413659|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413660|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413661|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413662|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910555|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56910556|NCT02171416|Rilonacept|rilonacept|mesh-list
56910557|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56910558|NCT02171494|Warfarin|warfarin|mesh-list
56910559|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
56910560|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
56910561|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56910562|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56910563|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910564|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56910565|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56910566|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910567|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910568|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910569|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56910570|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
56910571|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56910572|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910573|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56910574|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56910575|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56910576|NCT02171572|Dabigatran|dabigatran|mesh-list
56910577|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
56910578|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56910579|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
56910580|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378002|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
56413663|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56413664|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413665|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413666|NCT00476008|Memantine|memantine|mesh-list
56413667|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56413668|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56413669|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
56413670|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413671|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164115|NCT00002676|Carmustine|carmustine|mesh-list
56413672|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413673|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56413674|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56413675|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
56413676|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56413677|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56413678|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56413679|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413680|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413681|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
56910581|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910582|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
56910583|NCT02255578|Clomiphene|clomiphene|mesh-list
56910584|NCT02255578|Enclomiphene|enclomiphene|mesh-list
56910585|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
56910586|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56910587|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
56910588|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56910589|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910590|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56910591|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
56910592|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56910593|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56910594|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56910595|NCT02169154|Diclofenac|diclofenac|mesh-list
56910596|NCT02169154|Menthol|menthol|mesh-list
56910597|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56910598|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56910600|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
56910601|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910602|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910603|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56910604|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910605|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56910606|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910607|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910608|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
56910609|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
56910610|NCT00100048|Tenofovir|tenofovir|mesh-list
56910611|NCT00100048|Lamivudine|lamivudine|mesh-list
56910612|NCT00100048|Efavirenz|efavirenz|mesh-list
56910613|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
56910614|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
56910615|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910616|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56910617|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56910618|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378040|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56910619|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910620|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56910621|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56910622|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56910623|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56910624|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56910625|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56413682|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413683|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413684|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56413687|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
56413688|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413689|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
56413690|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413691|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413692|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56413693|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413695|NCT00183911|Fluorouracil|fluorouracil|mesh-list
56413696|NCT00183911|Floxuridine|floxuridine|mesh-list
56413697|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
56413698|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413699|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413700|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413701|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413702|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
56413703|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413704|NCT00183911|Antidotes|antidotes|mesh-ancestor
56413705|NCT00183911|Protective Agents|protective agents|mesh-ancestor
56413706|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
56413707|NCT00183911|Vitamins|vitamins|mesh-ancestor
56413708|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
56413709|NCT00412152|Oxycodone|oxycodone|mesh-list
56413710|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56413711|NCT00412152|Narcotics|narcotics|mesh-ancestor
56413712|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413713|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413714|NCT00412152|Analgesics|analgesics|mesh-ancestor
56413715|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
56413716|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413717|NCT02963402|Adalimumab|adalimumab|mesh-list
56413718|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413719|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413720|NCT00210327|Bortezomib|bortezomib|mesh-list
56413721|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413722|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
56413723|NCT00425516|Docetaxel|docetaxel|mesh-list
56413724|NCT00425516|Fluorouracil|fluorouracil|mesh-list
56413725|NCT00425516|Epirubicin|epirubicin|mesh-list
56413726|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413727|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
56413728|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413729|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413730|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56413731|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
56413732|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413733|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413734|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56413735|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
56413736|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
56413737|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
56413738|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
56413739|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413740|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56413741|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56413742|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56413743|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413744|NCT00412191|Lamotrigine|lamotrigine|mesh-list
56413745|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
56910626|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56910627|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56164116|NCT00002676|Doxorubicin|doxorubicin|mesh-list
56413746|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56413747|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413748|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413749|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56413750|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413751|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56413752|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56413753|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413754|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413755|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56413756|NCT00183950|Noscapine|noscapine|mesh-list
56413757|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
56413758|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
56413759|NCT00210366|Idarubicin|idarubicin|mesh-list
55988368|NCT03402815|Maraviroc|maraviroc|mesh-list
56413762|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56413763|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56413764|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413765|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413766|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
56413767|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56413768|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56413769|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56413770|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413771|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413772|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
56413773|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413774|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413775|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56413776|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413777|NCT00475735|Methylphenidate|methylphenidate|mesh-list
56413778|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56413779|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413780|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56413781|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56413782|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413783|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413784|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
56413785|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413786|NCT00475657|Pemetrexed|pemetrexed|mesh-list
56413787|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413788|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413789|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413790|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56413791|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56413792|NCT00210405|Micronutrients|micronutrients|mesh-list
56413793|NCT00210405|Trace Elements|trace elements|mesh-list
56413794|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413795|NCT00408941|Propofol|propofol|mesh-list
56413796|NCT00408941|Prilocaine|prilocaine|mesh-list
56413797|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56413798|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413799|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413800|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56413801|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
56413802|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
56413803|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
56413804|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
56413805|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413806|NCT00475423|Rituximab|rituximab|mesh-list
56413807|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56413808|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413809|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
56413810|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413811|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413812|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
56413813|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56413814|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56090414|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
56910628|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56910629|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56910630|NCT02171650|Afatinib|afatinib|mesh-list
56910631|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910632|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56910633|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910634|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910635|NCT02165566|Insulin|insulin|mesh-list
56910636|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56910637|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
56910638|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56910639|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910640|NCT02171728|Afatinib|afatinib|mesh-list
56910641|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910642|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56910643|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378214|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413815|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56413816|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56164119|NCT00002676|Vincristine|vincristine|mesh-list
56413817|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413818|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
56413819|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413820|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413821|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56413822|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413823|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
56413824|NCT00475306|Promethazine|promethazine|mesh-list
56413825|NCT00475306|Metoclopramide|metoclopramide|mesh-list
56413826|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56413827|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56413828|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413829|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413831|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
56413832|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
56413833|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413834|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
56413835|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
56413836|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56161500|NCT00676026|Zolpidem|zolpidem|mesh-list
56413837|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56413838|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
56413839|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
56413840|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413841|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413842|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56413843|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
56413844|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
56413845|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56413846|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56413847|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
56413848|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
56413849|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56413850|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
56413851|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56413852|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413853|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56413854|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56413855|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56413856|NCT00183989|Rituximab|rituximab|mesh-list
56910644|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910645|NCT02165644|Nimodipine|nimodipine|mesh-list
56910646|NCT02165644|Acetazolamide|acetazolamide|mesh-list
56910647|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
56910648|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56910649|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413857|NCT00183989|Fludarabine|fludarabine|mesh-list
56413858|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
56413859|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56413860|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413861|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
56413862|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413863|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413864|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413865|NCT00183989|Analgesics|analgesics|mesh-ancestor
56413866|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
56413867|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413868|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56413869|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56413870|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413871|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56413872|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56413873|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
56413874|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413875|NCT00184106|Paroxetine|paroxetine|mesh-list
56413876|NCT00184106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56413877|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56413878|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56413879|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413880|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413881|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
56413882|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413883|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56413884|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
56413885|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413886|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56413887|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56413888|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413889|NCT00210483|Almotriptan|almotriptan|mesh-list
56413890|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56413891|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
56413892|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413893|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413894|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413895|NCT00210561|Acetaminophen|acetaminophen|mesh-list
56413896|NCT00210561|Tramadol|tramadol|mesh-list
56413897|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56413898|NCT00210561|Analgesics|analgesics|mesh-ancestor
56413899|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
56413900|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413901|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413902|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
56413907|NCT00210600|Hematinics|hematinics|mesh-ancestor
56413908|NCT00217386|Etanercept|etanercept|mesh-list
56413909|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56413910|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56413911|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56413912|NCT00217386|Analgesics|analgesics|mesh-ancestor
56413913|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
56413914|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413915|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413916|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413917|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413918|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56413919|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413920|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
56413921|NCT00217503|Zidovudine|zidovudine|mesh-list
56413922|NCT00217503|Valganciclovir|valganciclovir|mesh-list
56413923|NCT00217503|Ganciclovir|ganciclovir|mesh-list
56413924|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
56910650|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910651|NCT02165644|Diuretics|diuretics|mesh-ancestor
56910652|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
56910653|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910654|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56910655|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56910656|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56910657|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56910658|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
56910659|NCT02171806|Olodaterol|olodaterol|mesh-list
56910660|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56910661|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
56910662|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910663|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910664|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56910665|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
56910666|NCT02169544|Abatacept|abatacept|mesh-list
56910667|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56910668|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413925|NCT00217503|Bevacizumab|bevacizumab|mesh-list
56413926|NCT00217503|Doxorubicin|doxorubicin|mesh-list
56413927|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56413928|NCT00217503|Etoposide|etoposide|mesh-list
56413929|NCT00217503|Bortezomib|bortezomib|mesh-list
56413930|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56413931|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
56413932|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413933|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413934|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56413935|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
56413936|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413937|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413938|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56413939|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56413940|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56413941|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56413942|NCT00217503|Growth Substances|growth substances|mesh-ancestor
56413943|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
56413944|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56413945|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56413946|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56413947|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413948|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56413949|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
56413950|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56413951|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56413952|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
56413953|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413954|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56413955|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56413956|NCT00217542|Interferons|interferons|mesh-list
56413957|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
56413958|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
56413959|NCT00217542|Azacitidine|azacitidine|mesh-list
56413960|NCT00217542|Amifostine|amifostine|mesh-list
56413961|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910669|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910670|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56910671|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
56910672|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910673|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56413962|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
56413963|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413964|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56413965|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
56413966|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413967|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56413968|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
56413969|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413970|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56413971|NCT00217542|Protective Agents|protective agents|mesh-ancestor
56413972|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56413973|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56413974|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56413975|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988589|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56413977|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56413978|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56413979|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56413980|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
56413981|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56413982|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413983|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56413984|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56413985|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
56413986|NCT00184496|Methadone|methadone|mesh-list
56413987|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56413988|NCT00184496|Narcotics|narcotics|mesh-ancestor
56413989|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413990|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413991|NCT00184496|Analgesics|analgesics|mesh-ancestor
56413992|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
56413993|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413994|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
56413995|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
56413996|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
56413997|NCT00210756|Hematinics|hematinics|mesh-ancestor
56413998|NCT00217659|Anastrozole|anastrozole|mesh-list
56413999|NCT00217659|Goserelin|goserelin|mesh-list
56414000|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56414001|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414002|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56414003|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56414004|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414005|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414006|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56414007|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
56414008|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414009|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414010|NCT00184574|Metformin|metformin|mesh-list
56414011|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
56414012|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
56414013|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414014|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414015|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
56414016|NCT00210795|Hematinics|hematinics|mesh-ancestor
56414017|NCT00217698|Gemcitabine|gemcitabine|mesh-list
56414018|NCT00217698|Gefitinib|gefitinib|mesh-list
56414019|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414020|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414021|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
56414022|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414023|NCT00217698|Antiviral Agents|antiviral agents|mesh-ancestor
56414024|NCT00217698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414025|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414026|NCT00217698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414027|NCT00217698|Immunologic Factors|immunologic factors|mesh-ancestor
56910674|NCT02169856|Cefuroxime|cefuroxime|mesh-list
56910675|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
56910676|NCT02169856|Ketorolac|ketorolac|mesh-list
56910677|NCT02169856|Midazolam|midazolam|mesh-list
56910678|NCT02169856|Propofol|propofol|mesh-list
56910679|NCT02169856|Sevoflurane|sevoflurane|mesh-list
56414028|NCT00217698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414029|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56414030|NCT00184613|Insulin|insulin|mesh-list
56414031|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56414032|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
56414033|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
56414034|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414035|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414036|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
56414037|NCT00210834|Hematinics|hematinics|mesh-ancestor
56414038|NCT00217815|Efungumab|efungumab|mesh-list
56414039|NCT00217815|Docetaxel|docetaxel|mesh-list
56414040|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414041|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
56414042|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
56414043|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
56414044|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414045|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
56414046|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414047|NCT04722471|Progesterone|progesterone|mesh-list
56414048|NCT04722471|Progestins|progestins|mesh-ancestor
56414049|NCT04722471|Hormones|hormones|mesh-ancestor
56414050|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414051|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414052|NCT00210873|Topiramate|topiramate|mesh-list
56414054|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414055|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414057|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
56414058|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414059|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414060|NCT00184847|Adenosine|adenosine|mesh-list
56414061|NCT00184847|Acetylcholine|acetylcholine|mesh-list
56414062|NCT00184847|Caffeine|caffeine|mesh-list
56161737|NCT00538980|Dasatinib|dasatinib|mesh-list
56414063|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56414064|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414065|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56414066|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414067|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414068|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56414069|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56414070|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
56414071|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414072|NCT00184847|Analgesics|analgesics|mesh-ancestor
56414073|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
56414074|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414075|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56414076|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
56414077|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56414078|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
56414079|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56414080|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
56414081|NCT00184886|Methotrexate|methotrexate|mesh-list
56414082|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56414083|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
56414084|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56414085|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414086|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414087|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
56414088|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414089|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414090|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
56414091|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414092|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56414093|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414094|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
56414095|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56414096|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56910680|NCT02169856|Atracurium|atracurium|mesh-list
56910681|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56910682|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910683|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910684|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56910685|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
56910686|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
56910687|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56910688|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56910689|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56910690|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56910691|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
56910692|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
56910693|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910694|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910695|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56910696|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56378540|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
56414097|NCT00217932|Valproic Acid|valproic acid|mesh-list
56414098|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
56414099|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414100|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414101|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
56414102|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414103|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414104|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
56414105|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56414106|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56414107|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56414109|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56414110|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414111|NCT00185003|Tolbutamide|tolbutamide|mesh-list
56414112|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
56414113|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414114|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414115|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414116|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414117|NCT00185120|Amlodipine|amlodipine|mesh-list
56414118|NCT00185120|Olmesartan|olmesartan|mesh-list
56414119|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56414120|NCT00185120|Benazepril|benazepril|mesh-list
56414121|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56414122|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56414123|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414124|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414125|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55988737|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
56414128|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56414129|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56414130|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56414131|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
56414132|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414133|NCT00218049|Vanoxerine|vanoxerine|mesh-list
56414134|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56414135|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56414136|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888089|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910697|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56910698|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56414137|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414138|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
56414139|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414140|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414141|NCT00185159|Olmesartan|olmesartan|mesh-list
56414142|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56414143|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56414144|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56414145|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56414146|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414147|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
56414148|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56414149|NCT00218127|Narcotics|narcotics|mesh-ancestor
56414150|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56414151|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414152|NCT00218127|Analgesics|analgesics|mesh-ancestor
56414153|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
56414154|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414155|NCT00185198|Testosterone|testosterone|mesh-list
56414156|NCT00185198|Androgens|androgens|mesh-ancestor
56414157|NCT00185198|Hormones|hormones|mesh-ancestor
56414158|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414159|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414160|NCT00185237|Estradiol|estradiol|mesh-list
56414161|NCT00185237|Estrogens|estrogens|mesh-ancestor
56414162|NCT00185237|Hormones|hormones|mesh-ancestor
56414163|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414164|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414165|NCT00218166|Triazolam|triazolam|mesh-list
56414166|NCT00218166|Tiagabine|tiagabine|mesh-list
56414167|NCT00218166|Baclofen|baclofen|mesh-list
56414168|NCT00218166|GABA Agonists|gaba agonists|mesh-list
56414169|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56414170|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414171|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56414172|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414173|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56414174|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
56414175|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414176|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414177|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56414178|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56414179|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56414180|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56414181|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56414182|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
56414183|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
56414184|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56414185|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56414186|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414187|NCT00185315|Iloprost|iloprost|mesh-list
56414188|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56414189|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
56414190|NCT00409019|Tenofovir|tenofovir|mesh-list
56414191|NCT00409019|Adefovir|adefovir|mesh-list
56414192|NCT00409019|Telbivudine|telbivudine|mesh-list
56414193|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
56414194|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414195|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56414196|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56414197|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988808|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
56414198|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414200|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56414201|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
56414202|NCT00211146|Hematinics|hematinics|mesh-ancestor
56414203|NCT00211224|Riluzole|riluzole|mesh-list
56414204|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
56414205|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56414206|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56414207|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910699|NCT02169856|Analgesics|analgesics|mesh-ancestor
56910700|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
56910701|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910702|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56910703|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910704|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56910705|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910706|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56910707|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910708|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56414208|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414209|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414210|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56414211|NCT00211224|Protective Agents|protective agents|mesh-ancestor
56414212|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
56414213|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414214|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414215|NCT00218205|Celecoxib|celecoxib|mesh-list
56414216|NCT00218205|Epirubicin|epirubicin|mesh-list
56414217|NCT00218205|Estramustine|estramustine|mesh-list
56414218|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56414219|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56414220|NCT00218205|Analgesics|analgesics|mesh-ancestor
56414221|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
56414222|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414223|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414224|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56414225|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56414226|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56414227|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56414228|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414229|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414230|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56414231|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414232|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56414233|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56414234|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56414235|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
56414236|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56414237|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
56414238|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56414239|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56414240|NCT00185510|Prednisolone|prednisolone|mesh-list
56414241|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
56414242|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
56414243|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56414244|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
56414245|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56414246|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
56414247|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
56414248|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414249|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414250|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56414251|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
56414253|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414254|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56414255|NCT00185510|Protective Agents|protective agents|mesh-ancestor
56414256|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56414257|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414258|NCT00218244|Lobeline|lobeline|mesh-list
56414259|NCT00218244|Nicotine|nicotine|mesh-list
56414260|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56414261|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
56414262|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888090|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
56910709|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56910710|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56910711|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56414263|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414264|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56414265|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56414266|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
56414267|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414268|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414269|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
56414270|NCT00211302|Aripiprazole|aripiprazole|mesh-list
56414271|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
56414272|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56414275|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56414276|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414277|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
56414278|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
56414279|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414280|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414281|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56414282|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56414283|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
56414284|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56414285|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56414286|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56414287|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56414288|NCT00218283|Nicotine|nicotine|mesh-list
56414289|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56414290|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
56414291|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414292|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414293|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56414294|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56414295|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
56414296|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414297|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414298|NCT00185705|Telmisartan|telmisartan|mesh-list
56414299|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56414300|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56414301|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56414302|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414304|NCT00211341|Vitamins|vitamins|mesh-ancestor
56414305|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
56414306|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414307|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
56414308|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56414309|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
56414310|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414311|NCT00211380|Aripiprazole|aripiprazole|mesh-list
56414312|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
56414313|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56414314|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56414315|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56414316|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56414317|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414318|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
56414319|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
56414320|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414321|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414322|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56414323|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56414324|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
56414325|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56414326|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56414327|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56414328|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56414329|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56414330|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56414331|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414332|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56910712|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56910713|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
56910714|NCT02170246|Telmisartan|telmisartan|mesh-list
56910715|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56910716|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56910717|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56378816|NCT00450736|Celecoxib|celecoxib|mesh-list
56414333|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414334|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414335|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56414336|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56414337|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56414338|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414339|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414340|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
56414341|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414342|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414343|NCT00218361|Hydromorphone|hydromorphone|mesh-list
56414345|NCT00218361|Narcotics|narcotics|mesh-ancestor
56414346|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56414347|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414348|NCT00218361|Analgesics|analgesics|mesh-ancestor
56414349|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
56414350|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414351|NCT00218517|Selegiline|selegiline|mesh-list
56414352|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
56414353|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56414354|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56414355|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56414356|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56414357|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414358|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414359|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56414360|NCT00218517|Protective Agents|protective agents|mesh-ancestor
56414361|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414362|NCT00211419|Triamcinolone|triamcinolone|mesh-list
56414363|NCT00211419|Anecortave|anecortave|mesh-list
56414364|NCT00211419|Verteporfin|verteporfin|mesh-list
56414365|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56414366|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
56414367|NCT00211419|Hormones|hormones|mesh-ancestor
56414368|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414369|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414370|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56414371|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
56414372|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56414373|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56414374|NCT00211419|Growth Substances|growth substances|mesh-ancestor
56414375|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
56414376|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414377|NCT00211458|Anecortave|anecortave|mesh-list
56414378|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56414379|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56414380|NCT00211458|Growth Substances|growth substances|mesh-ancestor
56414381|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414382|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
56414383|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414384|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
56414385|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414386|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56414387|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
56414388|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414389|NCT00211614|Lansoprazole|lansoprazole|mesh-list
56414390|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
56414391|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56414392|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56414393|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56414394|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910718|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910719|NCT02170324|Exenatide|exenatide|mesh-list
56910720|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414395|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414396|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
56414397|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56414398|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
56414399|NCT00186797|Fludarabine|fludarabine|mesh-list
56414400|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414401|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
56414402|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414403|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56414404|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56414405|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
56414406|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414407|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414408|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56414409|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
56414410|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56414411|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
56414412|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414413|NCT00211653|Expectorants|expectorants|mesh-ancestor
56414414|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
56414415|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56414416|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
56414417|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414418|NCT00211653|Protective Agents|protective agents|mesh-ancestor
56414421|NCT00187031|Topotecan|topotecan|mesh-list
56414422|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56414423|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56414424|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414425|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414426|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414427|NCT00187070|Cytarabine|cytarabine|mesh-list
56414428|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56414429|NCT00187070|Dexamethasone|dexamethasone|mesh-list
56414430|NCT00187070|Prednisone|prednisone|mesh-list
56414431|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
56414432|NCT00187070|Ifosfamide|ifosfamide|mesh-list
56414433|NCT00187070|Carboplatin|carboplatin|mesh-list
56414434|NCT00187070|Doxorubicin|doxorubicin|mesh-list
56414435|NCT00187070|Methotrexate|methotrexate|mesh-list
56414436|NCT00187070|Etoposide|etoposide|mesh-list
56162094|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
56414437|NCT00187070|Vincristine|vincristine|mesh-list
56414438|NCT00187070|Vinblastine|vinblastine|mesh-list
56414439|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414440|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
56414441|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414442|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56414443|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56414444|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
56414445|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414446|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414447|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56414448|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56414449|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
56414450|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
56414451|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414452|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56414453|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
56414454|NCT00187070|Hormones|hormones|mesh-ancestor
56414455|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414456|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56414457|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56414458|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56414459|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56414460|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414461|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56414462|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
56414463|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56414464|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414465|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
56910721|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910722|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56910723|NCT02170324|Incretins|incretins|mesh-ancestor
56910724|NCT02170324|Hormones|hormones|mesh-ancestor
56910725|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56910726|NCT02170402|Factor VIII|factor viii|mesh-list
56910727|NCT02170402|Coagulants|coagulants|mesh-ancestor
56910728|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56910729|NCT02172196|Empagliflozin|empagliflozin|mesh-list
56910730|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56910731|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910732|NCT02172196|Incretins|incretins|mesh-ancestor
56910733|NCT02172196|Hormones|hormones|mesh-ancestor
56910734|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56910735|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56910736|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
56910737|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910738|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910739|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56910740|NCT02172274|Empagliflozin|empagliflozin|mesh-list
56910741|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56910742|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910743|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56910744|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910745|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
56910747|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
56910769|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910783|NCT02172586|Losartan|losartan|mesh-list
56910843|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414466|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
56414467|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56414468|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56414469|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56414470|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
56414471|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414472|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
56414473|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
56414474|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
56414475|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56414476|NCT00187070|Renal Agents|renal agents|mesh-ancestor
56414477|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56414478|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
56414479|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56414480|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56414481|NCT00211848|Interferons|interferons|mesh-list
56414482|NCT00211848|Ribavirin|ribavirin|mesh-list
56164135|NCT00002676|Hormones|hormones|mesh-ancestor
56414483|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414484|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
56414485|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414486|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
56414487|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414488|NCT00412347|Insulin|insulin|mesh-list
56414489|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414490|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414491|NCT00187499|Fluticasone|fluticasone|mesh-list
56414492|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56414495|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414496|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414497|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56414498|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
56414499|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
56414500|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56414501|NCT00212004|Pioglitazone|pioglitazone|mesh-list
56414502|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414503|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414504|NCT00187577|Bimatoprost|bimatoprost|mesh-list
56414505|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56414506|NCT00187577|Latanoprost|latanoprost|mesh-list
56414507|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56414508|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56414509|NCT00212043|Gemcitabine|gemcitabine|mesh-list
56414510|NCT00212043|Carboplatin|carboplatin|mesh-list
56414511|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414512|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414513|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
56414514|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414515|NCT00212043|Antiviral Agents|antiviral agents|mesh-ancestor
56414516|NCT00212043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414517|NCT00212043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414518|NCT00212043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414519|NCT00212043|Immunologic Factors|immunologic factors|mesh-ancestor
56414520|NCT00212043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414522|NCT00212082|Doxorubicin|doxorubicin|mesh-list
56414523|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414524|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
56414525|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
56414526|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
56414527|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414528|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56414529|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56414530|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56414531|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414532|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
56414533|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56414534|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414535|NCT00187928|Topiramate|topiramate|mesh-list
56414536|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
56414537|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56414538|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414539|NCT00212199|Orlistat|orlistat|mesh-list
56414540|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414541|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414542|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56414543|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56910844|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
56910845|NCT02172976|Gemcitabine|gemcitabine|mesh-list
56414544|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
56414545|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56414546|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414547|NCT00188006|Heparin|heparin|mesh-list
56414548|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
56414549|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56414550|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56414551|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414552|NCT00188045|Propranolol|propranolol|mesh-list
56414553|NCT00188045|Spironolactone|spironolactone|mesh-list
56414554|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56414555|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56414556|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
56414557|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414558|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414559|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414560|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56414561|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56414562|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
56414563|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56414564|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
56414565|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414566|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56414570|NCT00212277|Norethindrone|norethindrone|mesh-list
56414571|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
56414572|NCT00212277|Estradiol|estradiol|mesh-list
56414573|NCT00212277|Estrogens|estrogens|mesh-ancestor
56414574|NCT00212277|Hormones|hormones|mesh-ancestor
56414575|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414576|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414577|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56414578|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
56414579|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56414580|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56414581|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56414582|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56414583|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56414584|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56414585|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414586|NCT00219375|Sivelestat|sivelestat|mesh-list
56414587|NCT00219375|Glycine|glycine|mesh-list
56414588|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56414589|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
56414590|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414591|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414592|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
56414593|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414594|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414595|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56414596|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
56414597|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414598|NCT00188396|Citalopram|citalopram|mesh-list
56414599|NCT00188396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56414600|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56414601|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414602|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414603|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414604|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
56414605|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414606|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56414607|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
56414608|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56414609|NCT00219570|Clindamycin|clindamycin|mesh-list
56414610|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
56414611|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
56414612|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
56414613|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56414614|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414615|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56414616|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414617|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910846|NCT02172976|Fluorouracil|fluorouracil|mesh-list
56910847|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
56910848|NCT02172976|Irinotecan|irinotecan|mesh-list
56910849|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56910850|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
56414618|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56414619|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56414620|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414621|NCT00212472|Factor VIII|factor viii|mesh-list
56414622|NCT00212472|Coagulants|coagulants|mesh-ancestor
56414623|NCT00188552|Tocopherols|tocopherols|mesh-list
56414624|NCT00188552|Vitamin E|vitamin e|mesh-list
56414625|NCT00188552|Tocotrienols|tocotrienols|mesh-list
56414626|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
56414627|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
56414628|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56414629|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414630|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414631|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56414633|NCT00188552|Protective Agents|protective agents|mesh-ancestor
56414634|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414635|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
56414636|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56414637|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
56414638|NCT00188552|Vitamins|vitamins|mesh-ancestor
56414639|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
56414640|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
56414641|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56414642|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
56414645|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
56414646|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56414647|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
56414648|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414649|NCT00188630|Protective Agents|protective agents|mesh-ancestor
56414650|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414651|NCT00188630|Antidotes|antidotes|mesh-ancestor
56414652|NCT00188669|Tocopherols|tocopherols|mesh-list
56414654|NCT00188669|Tocotrienols|tocotrienols|mesh-list
56414655|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
56414656|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
56414657|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56414658|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414659|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414660|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56414661|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56414662|NCT00188669|Protective Agents|protective agents|mesh-ancestor
56414663|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414664|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
56414665|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56414666|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
56414667|NCT00188669|Vitamins|vitamins|mesh-ancestor
56414668|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
56414669|NCT00409214|Talaporfin|talaporfin|mesh-list
56414670|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414671|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56414672|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
56414674|NCT02963051|Disulfiram|disulfiram|mesh-list
56414675|NCT02963051|Trace Elements|trace elements|mesh-ancestor
56414676|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
56414677|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414678|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56414679|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56414680|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414681|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414682|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
56414683|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414684|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56414685|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414686|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414687|NCT00409253|Nicardipine|nicardipine|mesh-list
56414688|NCT00409253|Urapidil|urapidil|mesh-list
56414689|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56414690|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56414691|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888091|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
56910851|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379205|NCT03273556|Lidocaine|lidocaine|mesh-list
56414692|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414693|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56414694|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414695|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
56414696|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56414697|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
56414698|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414699|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56414700|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56414701|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56414702|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
56414703|NCT00219765|Cytarabine|cytarabine|mesh-list
56414704|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
56414705|NCT00219765|Daunorubicin|daunorubicin|mesh-list
56414706|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414707|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
55915241|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
56414708|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414709|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414710|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
56414711|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414712|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414713|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
56414714|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414715|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56414716|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414719|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56414720|NCT00212589|Leucovorin|leucovorin|mesh-list
56414721|NCT00212589|Folic Acid|folic acid|mesh-list
56414722|NCT00212589|Fluorouracil|fluorouracil|mesh-list
56414723|NCT00212589|Capecitabine|capecitabine|mesh-list
56414724|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
56414725|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
56414726|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414727|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414728|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414729|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414730|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
56414731|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414732|NCT00212589|Antidotes|antidotes|mesh-ancestor
56414733|NCT00212589|Protective Agents|protective agents|mesh-ancestor
56414734|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
56414735|NCT00212589|Vitamins|vitamins|mesh-ancestor
56414736|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
56414737|NCT00212589|Hematinics|hematinics|mesh-ancestor
56414738|NCT00188825|Basiliximab|basiliximab|mesh-list
56414739|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414740|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
56414741|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414742|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
56414743|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56414744|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56414745|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414746|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414747|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
56414748|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414749|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414750|NCT00188864|Dexamethasone|dexamethasone|mesh-list
56414751|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56414752|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
56414753|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
56414754|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414755|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414756|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56414757|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
56414758|NCT00188864|Hormones|hormones|mesh-ancestor
56414759|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414760|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56414761|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414762|NCT00188942|Olanzapine|olanzapine|mesh-list
56414763|NCT00188942|Fluoxetine|fluoxetine|mesh-list
56414764|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
56910852|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910853|NCT02172976|Antiviral Agents|antiviral agents|mesh-ancestor
56414765|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
56414766|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414767|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414768|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56414769|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56414770|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56414771|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56414772|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56414773|NCT00188942|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56414774|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56414775|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414776|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414777|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414778|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
56414779|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56414780|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
56414781|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56414782|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56414783|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414784|NCT00219882|Turmeric extract|turmeric extract|mesh-list
56414786|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414787|NCT00219882|Protective Agents|protective agents|mesh-ancestor
56414788|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414789|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56414790|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
56414792|NCT00219921|Morphine|morphine|mesh-list
56414793|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56414794|NCT00219921|Narcotics|narcotics|mesh-ancestor
56414795|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56414796|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414797|NCT00219921|Analgesics|analgesics|mesh-ancestor
56414798|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
56414799|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414800|NCT00212823|Almotriptan|almotriptan|mesh-list
56414801|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56414802|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
56414803|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414804|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414805|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414806|NCT00189059|Amitriptyline|amitriptyline|mesh-list
56414807|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56414808|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
56414809|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56414810|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56414811|NCT00189059|Analgesics|analgesics|mesh-ancestor
56414812|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
56414813|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56414814|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414815|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56414816|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56414817|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414818|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414819|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
56414820|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414821|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56414822|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
56414823|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
56414824|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414825|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414826|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56414827|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56414828|NCT00189176|Growth Substances|growth substances|mesh-ancestor
56414829|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414830|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
56414831|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414833|NCT00189371|Carboplatin|carboplatin|mesh-list
56414834|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
56414835|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55888092|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
56910854|NCT02172976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910855|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910856|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56910857|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
56910858|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910859|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56910860|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56910861|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
56910862|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
56910863|NCT02173132|Vitamins|vitamins|mesh-ancestor
56910864|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
56910865|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910866|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
56910867|NCT02173288|Furosemide|furosemide|mesh-list
56910868|NCT02173288|Spironolactone|spironolactone|mesh-list
56910869|NCT02173288|Tolvaptan|tolvaptan|mesh-list
56910870|NCT02173288|Midodrine|midodrine|mesh-list
56910871|NCT02173288|Diuretics|diuretics|mesh-ancestor
56910872|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
56910873|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910874|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56414836|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414837|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
56414838|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
56414839|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
56414840|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414841|NCT00189371|Hematinics|hematinics|mesh-ancestor
56414842|NCT00189410|Carboplatin|carboplatin|mesh-list
56414843|NCT00189410|Doxorubicin|doxorubicin|mesh-list
56414844|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56414845|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414846|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56414847|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56414848|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56414849|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414850|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414851|NCT00189566|Paclitaxel|paclitaxel|mesh-list
56414852|NCT00189566|Carboplatin|carboplatin|mesh-list
56414853|NCT00189566|Topotecan|topotecan|mesh-list
56414854|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56414855|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414856|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
56414857|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
56414858|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
56414859|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414860|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56414861|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56414862|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414863|NCT00220116|Capecitabine|capecitabine|mesh-list
56414864|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
56414865|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414874|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414875|NCT00220155|Gemcitabine|gemcitabine|mesh-list
56414876|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414877|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
56414878|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414879|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910875|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56910876|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910877|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56910878|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
56910879|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56910880|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56910881|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56910882|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
56910883|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
56910884|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910885|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56910886|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56910887|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56910888|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56910889|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
56910890|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910891|NCT02175394|Linagliptin|linagliptin|mesh-list
56910892|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56414880|NCT00220155|Antiviral Agents|antiviral agents|mesh-ancestor
56414881|NCT00220155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414882|NCT00220155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414883|NCT00220155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414884|NCT00220155|Immunologic Factors|immunologic factors|mesh-ancestor
56414885|NCT00220155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414886|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
56414887|NCT00189644|Fluorouracil|fluorouracil|mesh-list
56414888|NCT00189644|Epirubicin|epirubicin|mesh-list
56414889|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414890|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
56414891|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414892|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56414893|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56414894|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
56414895|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414896|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414897|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56414898|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
56414899|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414900|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56414901|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56414902|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56414903|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414904|NCT00189683|Capecitabine|capecitabine|mesh-list
56414905|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414906|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
56414907|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414908|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414909|NCT00189722|Tacrolimus|tacrolimus|mesh-list
56414910|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414911|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
56414912|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414913|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56414914|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910893|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56910894|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56621555|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56910895|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910896|NCT02175394|Incretins|incretins|mesh-ancestor
56910897|NCT02175394|Hormones|hormones|mesh-ancestor
56910898|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56910899|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56910900|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
56910901|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910902|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910903|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56910904|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
56910905|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56910906|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56910907|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56379463|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56414915|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414916|NCT00220194|Leuprolide|leuprolide|mesh-list
56414917|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56414918|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
56414919|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56414920|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414921|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56414923|NCT00189761|Tacrolimus|tacrolimus|mesh-list
56414924|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414925|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
56414926|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414927|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56414928|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414929|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414930|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56414931|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56414932|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
56414934|NCT00213096|ST 1435|st 1435|mesh-list
56414935|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
56414936|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
56414937|NCT00213096|Estradiol|estradiol|mesh-list
56414938|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56414939|NCT00213096|Estrogens|estrogens|mesh-ancestor
56414940|NCT00213096|Hormones|hormones|mesh-ancestor
56414941|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56414942|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414943|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56414944|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56414945|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56414946|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56414947|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56414948|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
56414949|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56414950|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56414951|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
56414952|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56414953|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414954|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910908|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56910909|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56910910|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56910911|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56910912|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56910913|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56910914|NCT02256124|Lamotrigine|lamotrigine|mesh-list
56910915|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
56910916|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56910917|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56910918|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910919|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56910920|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910921|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56910922|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56910923|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910924|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56910925|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56910926|NCT02173756|Morphine|morphine|mesh-list
56910927|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56910928|NCT02173756|Narcotics|narcotics|mesh-ancestor
56910929|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910930|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910931|NCT02173756|Analgesics|analgesics|mesh-ancestor
56910932|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
56910933|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910934|NCT00102466|Metformin|metformin|mesh-list
56910935|NCT00102466|Vildagliptin|vildagliptin|mesh-list
56910936|NCT00102466|Gliclazide|gliclazide|mesh-list
56910937|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379519|NCT00464035|Calcium|calcium|mesh-list
56414955|NCT00189800|Urological Agents|urological agents|mesh-ancestor
56414956|NCT00220233|Amlodipine|amlodipine|mesh-list
56414957|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56414958|NCT00220233|Olmesartan|olmesartan|mesh-list
56414959|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56414960|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56414961|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56414962|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414963|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414964|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56414965|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414966|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
56414967|NCT00220233|Diuretics|diuretics|mesh-ancestor
56910938|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910939|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56910940|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
56910941|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910942|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910943|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56910944|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56910945|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56910946|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910947|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910948|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910949|NCT02173912|Amlodipine|amlodipine|mesh-list
56910950|NCT02173912|Candesartan|candesartan|mesh-list
56910951|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
56910952|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56910953|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56910954|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56379576|NCT00464503|Pravastatin|pravastatin|mesh-list
56162626|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
56414968|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
56414969|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56414970|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56414971|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56414972|NCT00189839|Tacrolimus|tacrolimus|mesh-list
56414973|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414974|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
56414975|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414976|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56414977|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414978|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414979|NCT00189878|Methotrexate|methotrexate|mesh-list
56414980|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56414981|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
56414982|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56414983|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414984|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414985|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
56414986|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414987|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414988|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
56414989|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414990|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56414991|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56414993|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56414994|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56414995|NCT00220311|Fludarabine|fludarabine|mesh-list
56414996|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
56414997|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414998|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56414999|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
56415000|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415001|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415002|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
56415003|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415004|NCT00213252|Prednisolone|prednisolone|mesh-list
55989621|NCT04347005|Febuxostat|febuxostat|mesh-list
56910955|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379621|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56415005|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56415006|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
56415007|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56415008|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
56415010|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56415011|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
56415012|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56415013|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
56415014|NCT00213252|Hormones|hormones|mesh-ancestor
56415015|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56415016|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415017|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56415018|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415019|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
56415020|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
56415021|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415022|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415023|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56415024|NCT00213252|Protective Agents|protective agents|mesh-ancestor
56415025|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56415026|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
56415027|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56415028|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
56415029|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56415030|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56415031|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415032|NCT00189995|Haloperidol|haloperidol|mesh-list
56415033|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
56415034|NCT00189995|Clozapine|clozapine|mesh-list
56415035|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
56415036|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
56415037|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415038|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415039|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415040|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56415041|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415042|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415043|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415044|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56415046|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415047|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415048|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56415049|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56415050|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
56415051|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
56415052|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
56415053|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
56415054|NCT00213291|Hematinics|hematinics|mesh-ancestor
56415055|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
56415056|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56415057|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
56415058|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415059|NCT00190034|Expectorants|expectorants|mesh-ancestor
56415060|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
56415061|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56415062|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
56415063|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415064|NCT00190034|Protective Agents|protective agents|mesh-ancestor
56415065|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415067|NCT00412503|Temozolomide|temozolomide|mesh-list
56415068|NCT00412503|Topotecan|topotecan|mesh-list
56415069|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56415070|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
56415071|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415072|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415073|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56415074|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56415075|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415076|NCT00412581|Lenalidomide|lenalidomide|mesh-list
56415077|NCT00412581|Dacarbazine|dacarbazine|mesh-list
56415078|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
56910956|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56910957|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910958|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
56910959|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56910960|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56910961|NCT02173990|Aflibercept|aflibercept|mesh-list
56910962|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56910963|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56910964|NCT02173990|Growth Substances|growth substances|mesh-ancestor
56910965|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910966|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
56910967|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910968|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
56910969|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56379693|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
56415079|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415080|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56415081|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56415082|NCT00412581|Growth Substances|growth substances|mesh-ancestor
56415083|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
56415084|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415085|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56415086|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
56415087|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415088|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
56415089|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56415090|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415091|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56415092|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56415093|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415094|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415095|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415096|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56415097|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56415098|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
56415099|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415100|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
56415101|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415102|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56415103|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56415104|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
56415105|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415106|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415107|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56415108|NCT00190268|Amifampridine|amifampridine|mesh-list
56415109|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56415110|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415111|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415112|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56415113|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415114|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415115|NCT00220350|Leuprolide|leuprolide|mesh-list
56415116|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56415117|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
56415118|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56415119|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910970|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910971|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56910972|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910973|NCT02256280|Neostigmine|neostigmine|mesh-list
56415120|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56415121|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415123|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56415124|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56415125|NCT00190307|Analgesics|analgesics|mesh-ancestor
56415126|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
56415127|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415128|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415129|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56415130|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56415131|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56415132|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56415133|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415134|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56415135|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56415136|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415137|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
56415139|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415140|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
56415141|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
56415142|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
56415143|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415144|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
56415145|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56415146|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
56415147|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415148|NCT00190463|Amphotericin B|amphotericin b|mesh-list
56415149|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56415150|NCT00190463|Amebicides|amebicides|mesh-ancestor
56415151|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56415152|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56415153|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415154|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56415155|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
56415156|NCT00213486|Irinotecan|irinotecan|mesh-list
56415157|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56415160|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415161|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415162|NCT00190502|Antibodies|antibodies|mesh-list
56415163|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
56415164|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415165|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56415166|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56415167|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56415168|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415169|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415170|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415171|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415172|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415173|NCT00122837|Analgesics|analgesics|mesh-ancestor
56415174|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
56415175|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415176|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415177|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415178|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
56415179|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56415180|NCT00190580|Valsartan|valsartan|mesh-list
56415181|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
56415182|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56415183|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56415184|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415185|NCT00220506|Modafinil|modafinil|mesh-list
56415186|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56415187|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910974|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56910975|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415188|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56415189|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56415190|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56415191|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415192|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56415193|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56415194|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415195|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415196|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415197|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415198|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415199|NCT00190619|Analgesics|analgesics|mesh-ancestor
56415200|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
56415201|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415202|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415203|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415204|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
56415205|NCT00213564|Methotrexate|methotrexate|mesh-list
56415206|NCT00213564|Infliximab|infliximab|mesh-list
56415207|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56415208|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
56415209|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56415210|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415211|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415212|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
56415213|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415214|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415215|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
56415216|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415217|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56415218|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415219|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
56415220|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56415221|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56415222|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415223|NCT00122876|Talaporfin|talaporfin|mesh-list
56415224|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415225|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56415226|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
56415229|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415230|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415231|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415232|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
56415233|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415234|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415235|NCT00220584|Donepezil|donepezil|mesh-list
56415236|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56415237|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415238|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415239|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
56415240|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415241|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415242|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
56415243|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56415244|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56415245|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415246|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415247|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415248|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415249|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415250|NCT00190814|Analgesics|analgesics|mesh-ancestor
56415251|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
56415252|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415253|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415254|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415255|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
56415256|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
56910976|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910977|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
56910978|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415257|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415258|NCT00220818|Lansoprazole|lansoprazole|mesh-list
56415259|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
56415260|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56415261|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415262|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56415263|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415264|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415265|NCT00213759|Lenograstim|lenograstim|mesh-list
56415266|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56415267|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
56415268|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415269|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56415270|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56415271|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415272|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415273|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415274|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415275|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415276|NCT00190853|Analgesics|analgesics|mesh-ancestor
56415277|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
56415278|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415279|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415280|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415281|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
56415282|NCT00190892|Carbamazepine|carbamazepine|mesh-list
56415283|NCT00190892|Olanzapine|olanzapine|mesh-list
56415284|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
56415285|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
56415286|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415287|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415288|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415289|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56415290|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415291|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415292|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415293|NCT00190892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56415294|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415295|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415296|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415298|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
56415299|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
56415300|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
56415301|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56415302|NCT00190892|Analgesics|analgesics|mesh-ancestor
56415303|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
56415304|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56415305|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56415306|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56415307|NCT00220857|Rabeprazole|rabeprazole|mesh-list
56415308|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56415309|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415310|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56415311|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415312|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415313|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56415314|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56415315|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415316|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415317|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415318|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
56415319|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415320|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415321|NCT00220896|Donepezil|donepezil|mesh-list
56415322|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56415323|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888155|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56910979|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910980|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56910981|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
56910982|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910983|NCT02174068|Acetaminophen|acetaminophen|mesh-list
56910984|NCT02174068|Nefopam|nefopam|mesh-list
56910985|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56910986|NCT02174068|Analgesics|analgesics|mesh-ancestor
56910987|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
56910988|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910989|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910990|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
56415324|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415325|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
56415326|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415327|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415328|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
56415329|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
56415330|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415331|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415332|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56415333|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56415334|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415335|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415336|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415337|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
56415338|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415339|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415340|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56415341|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56415342|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415343|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415344|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415345|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56415346|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415347|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415348|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
56415349|NCT00123149|Hematinics|hematinics|mesh-ancestor
56415350|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56164158|NCT00002682|Amoxicillin|amoxicillin|mesh-list
56415351|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56415352|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415353|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415354|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415355|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415356|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415357|NCT00191087|Analgesics|analgesics|mesh-ancestor
56415358|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
56415359|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415360|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415361|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415362|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
56415363|NCT00191126|Gemcitabine|gemcitabine|mesh-list
56415364|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415365|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415366|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
56415368|NCT00191126|Antiviral Agents|antiviral agents|mesh-ancestor
56415369|NCT00191126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415370|NCT00191126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415371|NCT00191126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415372|NCT00191126|Immunologic Factors|immunologic factors|mesh-ancestor
56415373|NCT00191126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910991|NCT02179294|Meperidine|meperidine|mesh-list
56910992|NCT02179294|Remifentanil|remifentanil|mesh-list
56910993|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56910994|NCT02179294|Narcotics|narcotics|mesh-ancestor
56910995|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56910996|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910997|NCT02179294|Analgesics|analgesics|mesh-ancestor
56910998|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
56415375|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56415376|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56415377|NCT00221052|Analgesics|analgesics|mesh-ancestor
56415378|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
56415379|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415380|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415381|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56415382|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56415383|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56415384|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415385|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415386|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56415387|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56415388|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415389|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415390|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415391|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415392|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415393|NCT00191204|Analgesics|analgesics|mesh-ancestor
56415394|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
56415395|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415396|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415397|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415398|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
56415399|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
56415400|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56415401|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415402|NCT00191243|Gemcitabine|gemcitabine|mesh-list
56415403|NCT00191243|Docetaxel|docetaxel|mesh-list
56163073|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56415404|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415405|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
56415406|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415407|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415408|NCT00191243|Antiviral Agents|antiviral agents|mesh-ancestor
56415409|NCT00191243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415410|NCT00191243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415411|NCT00191243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415412|NCT00191243|Immunologic Factors|immunologic factors|mesh-ancestor
56415413|NCT00191243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415414|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
56415415|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
56415416|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
56415417|NCT00214032|Pycnogenols|pycnogenols|mesh-list
56415418|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56415419|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
56415420|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415421|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
56415422|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415423|NCT00214032|Protective Agents|protective agents|mesh-ancestor
56415424|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56415425|NCT00123266|Plasminogen|plasminogen|mesh-list
56415426|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56415427|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56415428|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415429|NCT00191321|Teriparatide|teriparatide|mesh-list
56415430|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56415431|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090658|NCT02867605|Protective Agents|protective agents|mesh-ancestor
56910999|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911000|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56911001|NCT02179528|Etoposide|etoposide|mesh-list
56911002|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56911003|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911004|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56911005|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56911006|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911007|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911008|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
56911009|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
56380107|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
56415432|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56415433|NCT00123305|Plasminogen|plasminogen|mesh-list
56415434|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
56415435|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56415436|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56415437|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415438|NCT00214110|Tamoxifen|tamoxifen|mesh-list
56415441|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56415442|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415443|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56415444|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415445|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56415446|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56415447|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56415448|NCT00191399|Olanzapine|olanzapine|mesh-list
56415449|NCT00191399|Fluoxetine|fluoxetine|mesh-list
56415450|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
56415451|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
56415452|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415453|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415454|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415455|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56415456|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415457|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415458|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415459|NCT00191399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56415460|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415461|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415462|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415463|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415464|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
56415465|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56415466|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415467|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56415468|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56415469|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415470|NCT00191438|Gemcitabine|gemcitabine|mesh-list
56415471|NCT00191438|Capecitabine|capecitabine|mesh-list
56415472|NCT00191438|Docetaxel|docetaxel|mesh-list
56415473|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415474|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
56415475|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415476|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415477|NCT00191438|Antiviral Agents|antiviral agents|mesh-ancestor
56415478|NCT00191438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415479|NCT00191438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415480|NCT00191438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415481|NCT00191438|Immunologic Factors|immunologic factors|mesh-ancestor
56415482|NCT00191438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911010|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911011|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911012|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56911013|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
56911014|NCT02182102|Pemetrexed|pemetrexed|mesh-list
56415483|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
56415484|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
56415485|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
56415486|NCT00221286|Interferons|interferons|mesh-list
56415487|NCT00221286|Tenofovir|tenofovir|mesh-list
56415488|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
56415489|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
56415490|NCT00221286|Emtricitabine|emtricitabine|mesh-list
56415491|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56415492|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415493|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
56415494|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415495|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56415496|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56415497|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415498|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415499|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56415500|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56415501|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
56415502|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415503|NCT00123383|Modafinil|modafinil|mesh-list
56415504|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56415505|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415506|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56415507|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56415508|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56415509|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415510|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
56415512|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
56415513|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56415514|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415515|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
56415516|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415517|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56415518|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56415519|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56415520|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
56415521|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56415522|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415523|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415524|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415525|NCT00221325|Rituximab|rituximab|mesh-list
56415526|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56415527|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415528|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
56415529|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415530|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56415531|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56415532|NCT00123461|Vitamins|vitamins|mesh-ancestor
56415533|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
56415534|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415535|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56415536|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56415537|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56415538|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415539|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415540|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415541|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
56415542|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415543|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415544|NCT00191555|Haloperidol|haloperidol|mesh-list
56415545|NCT00191555|Olanzapine|olanzapine|mesh-list
56415546|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
56415547|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
56415548|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
56911015|NCT02182102|Nintedanib|nintedanib|mesh-list
56911016|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911017|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911018|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415549|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415550|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415551|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415552|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56415553|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415554|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415555|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415556|NCT00191555|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56415557|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415558|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415559|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415560|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415561|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
56415562|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56415563|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
56415564|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56415565|NCT00221364|Azithromycin|azithromycin|mesh-list
56415566|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56415567|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415569|NCT00123539|Hormones|hormones|mesh-ancestor
56415570|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56415571|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415572|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56415573|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56415574|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415575|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415576|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415577|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415578|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415579|NCT00191594|Analgesics|analgesics|mesh-ancestor
56415580|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
56415581|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415582|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415583|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415586|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
56415587|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56415588|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415589|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415590|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56415591|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415592|NCT00123578|Pentobarbital|pentobarbital|mesh-list
56415593|NCT00123578|Lorazepam|lorazepam|mesh-list
56415594|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
56415595|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
56415596|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
56415597|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415598|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415599|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415600|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56415601|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415602|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56415603|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415604|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415605|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
56415606|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
56415607|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415608|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415609|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56415610|NCT00221481|Valproic Acid|valproic acid|mesh-list
56415611|NCT00221481|Olanzapine|olanzapine|mesh-list
56415612|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
56415613|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
56415614|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415615|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415616|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56911019|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56911020|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56415617|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56415618|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415619|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415620|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415621|NCT00221481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56415622|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415623|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333874|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415624|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415626|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
56415627|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
56415628|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415629|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
56415630|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
56415631|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56415632|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56415633|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415634|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415635|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415636|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
56415637|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415638|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415639|NCT00221520|Midazolam|midazolam|mesh-list
56415640|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56415641|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56415642|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415643|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415644|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56415645|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415646|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415647|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56415648|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
56415649|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
56415650|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
56415651|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
56415652|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415653|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415654|NCT00191672|Gemcitabine|gemcitabine|mesh-list
56415655|NCT00191672|Paclitaxel|paclitaxel|mesh-list
56415656|NCT00191672|Docetaxel|docetaxel|mesh-list
56415657|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56415660|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
56415661|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
56415662|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415663|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415664|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
56415665|NCT00191672|Antiviral Agents|antiviral agents|mesh-ancestor
56415666|NCT00191672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415667|NCT00191672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415668|NCT00191672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415669|NCT00191672|Immunologic Factors|immunologic factors|mesh-ancestor
56415670|NCT00191672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415671|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56415672|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415673|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415674|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56415675|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415676|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415677|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415678|NCT00191711|Gemcitabine|gemcitabine|mesh-list
56415679|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415680|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
56415681|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415682|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415683|NCT00191711|Antiviral Agents|antiviral agents|mesh-ancestor
56415684|NCT00191711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415685|NCT00191711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415686|NCT00191711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415687|NCT00191711|Immunologic Factors|immunologic factors|mesh-ancestor
56415688|NCT00191711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911021|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56911022|NCT02176720|Fluorides|fluorides|mesh-list
56911023|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56911024|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
56911025|NCT02176720|Protective Agents|protective agents|mesh-ancestor
56911026|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911027|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
56911028|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911029|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911030|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56911031|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
56911032|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415689|NCT00221637|Valproic Acid|valproic acid|mesh-list
56415690|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
56415691|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415692|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415693|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
56415694|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415695|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415696|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
56415697|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56163376|NCT00002376|Lamivudine|lamivudine|mesh-list
56415698|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415700|NCT00123656|Fluticasone|fluticasone|mesh-list
56415701|NCT00123656|Esomeprazole|esomeprazole|mesh-list
56415702|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56415703|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56415704|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
56415705|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415706|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415707|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56415708|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
56415709|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
56415710|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56415711|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56415712|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415713|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56415714|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415715|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415716|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56415717|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56415718|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56415719|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
56415720|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415721|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56415722|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56415723|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415724|NCT00191750|Pemetrexed|pemetrexed|mesh-list
56415725|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415726|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415727|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415728|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56415729|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56415730|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
56415734|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56415735|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
56415736|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415737|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56415738|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56415739|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415740|NCT00191828|Olanzapine|olanzapine|mesh-list
56415741|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
56415742|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
56911033|NCT03537196|Ribavirin|ribavirin|mesh-list
56911034|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
56911035|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
56911036|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911037|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
56415743|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415744|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415745|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56415746|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56415747|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415748|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415749|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415750|NCT00191828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56415751|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415752|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415753|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415754|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415755|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
56415756|NCT00191867|Teriparatide|teriparatide|mesh-list
56415757|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56415758|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415759|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56415760|NCT00123851|Capecitabine|capecitabine|mesh-list
56415761|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
56415762|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56415763|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415764|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
56415765|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415766|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415767|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56415768|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415769|NCT00123890|Aplaviroc|aplaviroc|mesh-list
56415770|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56415771|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56415772|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415773|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56415774|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56415775|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
56415776|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415777|NCT00412698|Rimonabant|rimonabant|mesh-list
56415778|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56415779|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56415780|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56415781|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415782|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415783|NCT00412698|Hormones|hormones|mesh-ancestor
56415784|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56415785|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415786|NCT00123929|Docetaxel|docetaxel|mesh-list
56415787|NCT00123929|Doxorubicin|doxorubicin|mesh-list
56415788|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415789|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
56415790|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
56415791|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
56415792|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415793|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56415794|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56415795|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56415796|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415797|NCT00475033|Vaccines|vaccines|mesh-list
56415798|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56415799|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
56415800|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415801|NCT00192062|Gemcitabine|gemcitabine|mesh-list
56415805|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415806|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415807|NCT00192062|Antiviral Agents|antiviral agents|mesh-ancestor
56415808|NCT00192062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415809|NCT00192062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911038|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911039|NCT02182258|Nintedanib|nintedanib|mesh-list
56911040|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911041|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56911042|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415810|NCT00192062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415811|NCT00192062|Immunologic Factors|immunologic factors|mesh-ancestor
56415812|NCT00192062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415813|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56415814|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
56415815|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
56415816|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
56415817|NCT00192101|Gemcitabine|gemcitabine|mesh-list
56415818|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415819|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415820|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
56415821|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415822|NCT00192101|Antiviral Agents|antiviral agents|mesh-ancestor
56415823|NCT00192101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415824|NCT00192101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415825|NCT00192101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415826|NCT00192101|Immunologic Factors|immunologic factors|mesh-ancestor
56415827|NCT00192101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415828|NCT00215007|Levofloxacin|levofloxacin|mesh-list
56415830|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56415831|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415832|NCT00215007|Renal Agents|renal agents|mesh-ancestor
56415833|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56415834|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56415835|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56415836|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415837|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415838|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415839|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56415840|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56415841|NCT00474994|Sunitinib|sunitinib|mesh-list
56415842|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415843|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56415844|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56415845|NCT00474994|Growth Substances|growth substances|mesh-ancestor
56415846|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415847|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
56415848|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56415849|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415850|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415851|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56415853|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415854|NCT00215046|Methotrexate|methotrexate|mesh-list
56415855|NCT00215046|Vinblastine|vinblastine|mesh-list
56415856|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56415857|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
56415858|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56415859|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415860|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415861|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
56415862|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415863|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415864|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
56415865|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415866|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56415867|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56415868|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
56415869|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56415870|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56415871|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56415872|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
56415873|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
56415874|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
56415876|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
56090659|NCT00375596|Ketotifen|ketotifen|mesh-list
56911043|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911044|NCT02182336|Vitamin K|vitamin k|mesh-list
56911045|NCT02182336|Digoxin|digoxin|mesh-list
56911046|NCT02182336|Midazolam|midazolam|mesh-list
56380590|NCT00480064|Cytarabine|cytarabine|mesh-list
56415877|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415878|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56415879|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56415880|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
56415881|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415882|NCT00474253|Rocuronium|rocuronium|mesh-list
56415883|NCT00474253|Succinylcholine|succinylcholine|mesh-list
56415884|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56415885|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56415886|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56415887|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415888|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415889|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56415890|NCT00221871|Ketamine|ketamine|mesh-list
56415891|NCT00221871|Analgesics|analgesics|mesh-ancestor
56415892|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
56415893|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415894|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415895|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56415896|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56415897|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
56415898|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
56415899|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415900|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56415901|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56415902|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415903|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415904|NCT00474058|Rotigotine|rotigotine|mesh-list
56415905|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
56415906|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
56415907|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415908|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415909|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415910|NCT02277730|Phenylephrine|phenylephrine|mesh-list
56415911|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
56415912|NCT02277730|Ephedrine|ephedrine|mesh-list
56415913|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56415914|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56415915|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
56415916|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
56415917|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415918|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415919|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
56415921|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
56415922|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56415923|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56415924|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56415925|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
56415926|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916481|NCT00691197|Glycerol|glycerol|mesh-list
56415927|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415928|NCT02277730|Protective Agents|protective agents|mesh-ancestor
56415929|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56415931|NCT04571437|Letrozole|letrozole|mesh-list
56415932|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415933|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
56415934|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415935|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415936|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56415937|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56415938|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415939|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56415940|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
56415941|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56415942|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415943|NCT00215124|Lenograstim|lenograstim|mesh-list
56911047|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
56911048|NCT02182336|Caffeine|caffeine|mesh-list
56911049|NCT02182336|Omeprazole|omeprazole|mesh-list
56911050|NCT02182336|Warfarin|warfarin|mesh-list
56911051|NCT02182336|Vitamins|vitamins|mesh-ancestor
56911052|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
56911053|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911054|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56911055|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56911056|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911057|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56911058|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56911059|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415944|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56415945|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
56415946|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415947|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
56415948|NCT00473824|Antibodies|antibodies|mesh-list
55990597|NCT02976987|Cidofovir|cidofovir|mesh-list
56415949|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
56415950|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56415951|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56415952|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
56415953|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415954|NCT00215163|Paroxetine|paroxetine|mesh-list
56415955|NCT00215163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56415956|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415957|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415958|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415959|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415960|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
56415961|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415962|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56415963|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415964|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415965|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56415966|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56415967|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415968|NCT00215202|Gefitinib|gefitinib|mesh-list
56415969|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415970|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56415971|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415972|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415973|NCT00215241|Risperidone|risperidone|mesh-list
56415974|NCT00215241|Sertraline|sertraline|mesh-list
56415975|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56415976|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
56415977|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415978|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415979|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56415980|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56415981|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56415982|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56415983|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56415984|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56415985|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
56415986|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
56415987|NCT00215241|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56415988|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56415989|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56415990|NCT00124241|Lamivudine|lamivudine|mesh-list
56415991|NCT00124241|Telbivudine|telbivudine|mesh-list
56415992|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56415993|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56911060|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56911061|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
56911062|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
56911063|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
56911064|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
56911065|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911066|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911067|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
56911068|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56911069|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56911070|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911071|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56911072|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56911073|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
56911074|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56911075|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56911076|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56911077|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56415995|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415996|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
56415997|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56415998|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56415999|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56416000|NCT00124280|Everolimus|everolimus|mesh-list
56416001|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416002|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416003|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
56416004|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416005|NCT00215280|Ivermectin|ivermectin|mesh-list
56416006|NCT00215280|Albendazole|albendazole|mesh-list
56416007|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56416008|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416009|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
56416010|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
56416011|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56416012|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56416013|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416014|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416015|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416016|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416017|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416018|NCT00192413|Vaccines|vaccines|mesh-list
56416019|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
56416020|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416021|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
56416022|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56416023|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
56416024|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416025|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416026|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56416027|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
56416028|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56416029|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56416030|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56416031|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
56416032|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416033|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416035|NCT00192569|Ribavirin|ribavirin|mesh-list
56911078|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56911079|NCT02182336|Protective Agents|protective agents|mesh-ancestor
56911080|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56911081|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56911082|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
56416036|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
56416037|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
56416038|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56416039|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416040|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
56416041|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416042|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
56416043|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416044|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
56416045|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416046|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
56416047|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56416048|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
56416049|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416050|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416051|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56416052|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
56416053|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56416054|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56416055|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56416056|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
56416057|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416058|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416059|NCT00192608|Saquinavir|saquinavir|mesh-list
56416060|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56416061|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56416062|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
56416063|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416064|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416065|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56416066|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56416067|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
56416068|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416069|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56416070|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56416071|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
56416072|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56416073|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
56416074|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416075|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416076|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56416077|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
56416078|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56416079|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56416081|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
56416082|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416083|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416084|NCT00215514|Fluorouracil|fluorouracil|mesh-list
56416085|NCT00215514|Epirubicin|epirubicin|mesh-list
56416086|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416087|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
56416088|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416089|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56416090|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416091|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
56416092|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416093|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56416094|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56416095|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56416096|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416097|NCT00192725|Tryptophan|tryptophan|mesh-list
56416098|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56416099|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
56416100|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56416101|NCT00215592|Zonisamide|zonisamide|mesh-list
56911083|NCT02182336|Coagulants|coagulants|mesh-ancestor
56911084|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
56911085|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
56911086|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56380854|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
56416102|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
56416103|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56416104|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56416105|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416106|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56416107|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416108|NCT00222144|Docetaxel|docetaxel|mesh-list
56416109|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
56416110|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416111|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416112|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416113|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416114|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416115|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56416116|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416117|NCT00411879|Vasopressins|vasopressins|mesh-list
56416118|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
56416119|NCT00411879|Epinephrine|epinephrine|mesh-list
56416120|NCT00411879|Racepinephrine|racepinephrine|mesh-list
56416121|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
56416122|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56416123|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56416124|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
56416125|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416126|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416127|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416128|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56416129|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56416130|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
56416131|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416132|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56416133|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
56416134|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
56416135|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
56416136|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56416137|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
56416138|NCT00411879|Coagulants|coagulants|mesh-ancestor
56416139|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56416140|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
56416141|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
56416142|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56416143|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56416144|NCT00222183|Analgesics|analgesics|mesh-ancestor
56416145|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
56416146|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164177|NCT00002682|Antacids|antacids|mesh-ancestor
56416147|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416148|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56416149|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416150|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
56416151|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416152|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
56416153|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56416154|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416155|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416156|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
56416157|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416158|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
56416159|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416160|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416161|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56416162|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
56416163|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416164|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416165|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56911087|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56911088|NCT02182570|Epinastine|epinastine|mesh-list
56911089|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56911090|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
56911091|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
56911092|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911093|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911094|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911095|NCT02182648|Propofol|propofol|mesh-list
56911096|NCT02182648|Etomidate|etomidate|mesh-list
56911097|NCT02182648|Sevoflurane|sevoflurane|mesh-list
56380931|NCT00481975|Hormones|hormones|mesh-ancestor
56416166|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56416167|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56416168|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56416169|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
56416170|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416171|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416172|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56416173|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56416177|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56416178|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56416179|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56416180|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416181|NCT00192842|Gemcitabine|gemcitabine|mesh-list
56416183|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56416184|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
56416185|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416186|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416187|NCT00192842|Antiviral Agents|antiviral agents|mesh-ancestor
56416188|NCT00192842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416189|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416190|NCT00192842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416191|NCT00192842|Immunologic Factors|immunologic factors|mesh-ancestor
56416192|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416193|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56416194|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56416195|NCT00192842|Analgesics|analgesics|mesh-ancestor
56416196|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
56416197|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416198|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56416199|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416200|NCT00411996|Ritonavir|ritonavir|mesh-list
56416201|NCT00411996|Indinavir|indinavir|mesh-list
56416202|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56416203|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56416204|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
56416205|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416206|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416207|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56416208|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56416209|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
56416210|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416211|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56416212|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56416213|NCT00222261|Aspirin|aspirin|mesh-list
56416214|NCT00222261|Clopidogrel|clopidogrel|mesh-list
56416215|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56416216|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56416217|NCT00222261|Analgesics|analgesics|mesh-ancestor
56416218|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
56416219|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416220|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416221|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911098|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56911099|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911100|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911101|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56911102|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
56911103|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
56911104|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56911105|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56911106|NCT02179996|Vaccines|vaccines|mesh-list
56911107|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
56381002|NCT00482716|Iron|iron|mesh-list
56416222|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416223|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56416224|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56416225|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416226|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56416227|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56416228|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416229|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
56416230|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56416231|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56416232|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56416233|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
56416234|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416235|NCT00192959|Propofol|propofol|mesh-list
56416236|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56416237|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56416238|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416239|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56416240|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
56416241|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
56416242|NCT00215631|Tadalafil|tadalafil|mesh-list
56416243|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
56416244|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56416245|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56416246|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416248|NCT00215631|Urological Agents|urological agents|mesh-ancestor
56416250|NCT00193076|Carboplatin|carboplatin|mesh-list
56416251|NCT00193076|Trastuzumab|trastuzumab|mesh-list
56416252|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416253|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56416254|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
56416255|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416256|NCT00193076|Antiviral Agents|antiviral agents|mesh-ancestor
56416257|NCT00193076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416258|NCT00193076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416259|NCT00193076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416260|NCT00193076|Immunologic Factors|immunologic factors|mesh-ancestor
56416261|NCT00193076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416262|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56416263|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
56416264|NCT00193115|Docetaxel|docetaxel|mesh-list
56416265|NCT00193115|Doxorubicin|doxorubicin|mesh-list
56416266|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416267|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
56416268|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416269|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416270|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56416271|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
56416272|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416273|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416274|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56416275|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416276|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416277|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
56911108|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911109|NCT02177344|Bromides|bromides|mesh-list
56911110|NCT02177344|Ipratropium|ipratropium|mesh-list
56911111|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
56416278|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56416279|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56416280|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56416281|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416282|NCT00193154|Bevacizumab|bevacizumab|mesh-list
56416283|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56416284|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56416285|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416286|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56416287|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56416288|NCT00193154|Growth Substances|growth substances|mesh-ancestor
56416289|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416290|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
56416291|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56416292|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416293|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416295|NCT00193193|Carboplatin|carboplatin|mesh-list
56416296|NCT00193193|Estramustine|estramustine|mesh-list
56416297|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56416298|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416299|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416300|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416301|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416302|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416303|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56416304|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
56416305|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56416306|NCT00193232|Docetaxel|docetaxel|mesh-list
56416307|NCT00193232|Bortezomib|bortezomib|mesh-list
56416308|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416309|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416310|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416311|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416312|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416313|NCT00222495|Olanzapine|olanzapine|mesh-list
56416314|NCT00222495|Risperidone|risperidone|mesh-list
56416315|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56416316|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56416317|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
56416318|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416319|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416320|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416323|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56416324|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56416325|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56416326|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
56416327|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
56416328|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
56416329|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416330|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56416331|NCT00222495|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56416332|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56416333|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56416334|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
56416335|NCT00193271|Docetaxel|docetaxel|mesh-list
56416336|NCT00193271|Estramustine|estramustine|mesh-list
56416337|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416338|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416339|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416340|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416341|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416342|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56416343|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
56416344|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56416345|NCT00222534|Acetazolamide|acetazolamide|mesh-list
56416346|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
56416347|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56416348|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911112|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56911113|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
56911114|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911115|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911116|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56911117|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
56911118|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56911119|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
56911120|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911121|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911122|NCT03536494|Mirabegron|mirabegron|mesh-list
56911123|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56911124|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56911125|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56416349|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416350|NCT00222534|Diuretics|diuretics|mesh-ancestor
56416351|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
56416352|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416353|NCT00193310|Paclitaxel|paclitaxel|mesh-list
56416354|NCT00193310|Carboplatin|carboplatin|mesh-list
56416355|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56416356|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416357|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416358|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416359|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416360|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416361|NCT00193349|Carboplatin|carboplatin|mesh-list
56416362|NCT00193349|Irinotecan|irinotecan|mesh-list
56416363|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
56416364|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416365|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56416366|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56416367|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416368|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416369|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56416371|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56416372|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56416373|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416374|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416375|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416376|NCT00215709|Docetaxel|docetaxel|mesh-list
56416377|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416378|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416379|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416380|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416381|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416382|NCT00193466|Rituximab|rituximab|mesh-list
56416383|NCT00193466|Fludarabine|fludarabine|mesh-list
56416384|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56416385|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416386|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
56416387|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416388|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416389|NCT00215748|Dexamethasone|dexamethasone|mesh-list
56416390|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56416391|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
56416392|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
56416393|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416394|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991040|NCT03128008|Paclitaxel|paclitaxel|mesh-list
56416396|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
56911126|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
56416397|NCT00215748|Hormones|hormones|mesh-ancestor
56416398|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416399|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56416400|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416401|NCT00193505|Rituximab|rituximab|mesh-list
56416402|NCT00193505|Carboplatin|carboplatin|mesh-list
56416403|NCT00193505|Etoposide|etoposide|mesh-list
56416404|NCT00193505|Ifosfamide|ifosfamide|mesh-list
56416405|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56416406|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416407|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
56416408|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416409|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416410|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56416411|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56416412|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56416413|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416414|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416415|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56416416|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
56416417|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
56416418|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
56416419|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416420|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
56416421|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416422|NCT00193544|Thalidomide|thalidomide|mesh-list
56416423|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
56416424|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416425|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
56416426|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416427|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
56416428|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56416429|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416430|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56416431|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56416432|NCT00193544|Growth Substances|growth substances|mesh-ancestor
56416433|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
56416434|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416435|NCT00215865|Ribavirin|ribavirin|mesh-list
56416436|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56416437|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
56416438|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416439|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
56416440|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416441|NCT00124358|Buprenorphine|buprenorphine|mesh-list
56416442|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56416443|NCT00124358|Narcotics|narcotics|mesh-ancestor
56416444|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56416445|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416446|NCT00124358|Analgesics|analgesics|mesh-ancestor
56416447|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
56416448|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416449|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56416450|NCT00193583|Carboplatin|carboplatin|mesh-list
56416451|NCT00193583|Topotecan|topotecan|mesh-list
56416452|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416453|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56416454|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56416455|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416456|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416457|NCT00215982|Capecitabine|capecitabine|mesh-list
56416458|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
56416459|NCT00215982|Irinotecan|irinotecan|mesh-list
56416460|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56416461|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
56416462|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416463|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416464|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56416465|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56416466|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416467|NCT00124397|Atorvastatin|atorvastatin|mesh-list
56416468|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56416469|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56416470|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
55888156|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911127|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911128|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911129|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911130|NCT03536494|Urological Agents|urological agents|mesh-ancestor
56911131|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56911132|NCT02177422|Telmisartan|telmisartan|mesh-list
56911133|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56911134|NCT02177422|Diuretics|diuretics|mesh-ancestor
56911135|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
56911136|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911137|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56381259|NCT00120731|Acetazolamide|acetazolamide|mesh-list
56416473|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56416474|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416475|NCT00216021|Capecitabine|capecitabine|mesh-list
56416476|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
56416477|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56416478|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
56416479|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416480|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416482|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56416483|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
56416484|NCT00216138|Docetaxel|docetaxel|mesh-list
56416485|NCT00216138|Capecitabine|capecitabine|mesh-list
56416486|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416487|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416488|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416489|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416490|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416491|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56416492|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
56416493|NCT00216177|Adalimumab|adalimumab|mesh-list
56416494|NCT00216177|Infliximab|infliximab|mesh-list
56416495|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56416496|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416497|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
56416498|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56416499|NCT00124436|Alitretinoin|alitretinoin|mesh-list
56416500|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416501|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
56416502|NCT00216216|Pemetrexed|pemetrexed|mesh-list
56416503|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416504|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416505|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416506|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56416507|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56416508|NCT00473746|Dexamethasone|dexamethasone|mesh-list
56416509|NCT00473746|Prednisone|prednisone|mesh-list
56416510|NCT00473746|Prednisolone|prednisolone|mesh-list
56416511|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
56416512|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56416513|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
56416514|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
56416515|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416516|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416517|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56416518|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
56416519|NCT00473746|Hormones|hormones|mesh-ancestor
56416520|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416521|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56416522|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416523|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56416524|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416525|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911138|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56911139|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911140|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56911141|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56911142|NCT02182960|Ibuprofen|ibuprofen|mesh-list
56911143|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911144|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911145|NCT02182960|Analgesics|analgesics|mesh-ancestor
56911146|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
56911147|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911148|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416526|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
56416527|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56416528|NCT00409643|Amlodipine|amlodipine|mesh-list
56416529|NCT00409643|Valsartan|valsartan|mesh-list
56416530|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56416531|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56416532|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56416533|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416534|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56416535|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416536|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
56416537|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56416538|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56416539|NCT00216294|Secretin|secretin|mesh-list
56416540|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56416541|NCT00216294|Hormones|hormones|mesh-ancestor
56416542|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416543|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416545|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416546|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
56416547|NCT00409721|Memantine|memantine|mesh-list
56416548|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56416549|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56416550|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
56416551|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416552|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416553|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416554|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56416555|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56416556|NCT00193622|Bevacizumab|bevacizumab|mesh-list
56416557|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56416558|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56416559|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416560|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56416561|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56416562|NCT00193622|Growth Substances|growth substances|mesh-ancestor
56416563|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416564|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
56416565|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56416566|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416567|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416568|NCT00473590|Bevacizumab|bevacizumab|mesh-list
56416569|NCT00473590|Bortezomib|bortezomib|mesh-list
56416570|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56416571|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416572|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56416573|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56416574|NCT00473590|Growth Substances|growth substances|mesh-ancestor
56416575|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911149|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911150|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911151|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56911152|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911153|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911154|NCT05141968|Vitamin D|vitamin d|mesh-list
56911155|NCT05141968|Vitamins|vitamins|mesh-ancestor
56911156|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
56911157|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911158|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56911159|NCT00110357|Irinotecan|irinotecan|mesh-list
56911160|NCT00110357|Cetuximab|cetuximab|mesh-list
56911161|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56911162|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56911163|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911164|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911165|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911166|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56911167|NCT02183038|Naproxen|naproxen|mesh-list
56911168|NCT02183038|Meloxicam|meloxicam|mesh-list
56911169|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911170|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911171|NCT02183038|Analgesics|analgesics|mesh-ancestor
56911172|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
56911173|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911174|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911175|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911176|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911177|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
56911178|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56911179|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911180|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911181|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56911182|NCT02752906|Vaccines|vaccines|mesh-list
56911183|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
56381389|NCT01241500|ON 01910|on 01910|mesh-list
56416576|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
56416577|NCT00223275|Naltrexone|naltrexone|mesh-list
56416578|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56416579|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56416580|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911184|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911185|NCT00293033|Fentanyl|fentanyl|mesh-list
56911186|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56911187|NCT00293033|Narcotics|narcotics|mesh-ancestor
56911188|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911189|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911190|NCT00293033|Analgesics|analgesics|mesh-ancestor
56911191|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
56911192|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416581|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
56416582|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416583|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
56416584|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
56416585|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
56416586|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416587|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416588|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56416589|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56416590|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
56416592|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416593|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416594|NCT00193661|Testosterone|testosterone|mesh-list
56416595|NCT00193661|Androgens|androgens|mesh-ancestor
56416596|NCT00193661|Hormones|hormones|mesh-ancestor
56416597|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416598|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416599|NCT00206232|Spironolactone|spironolactone|mesh-list
56416600|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56416601|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
56416602|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416603|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416604|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56416605|NCT00206232|Diuretics|diuretics|mesh-ancestor
56416606|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
56416607|NCT00193700|Testosterone|testosterone|mesh-list
56416608|NCT00193700|Androgens|androgens|mesh-ancestor
56416609|NCT00193700|Hormones|hormones|mesh-ancestor
56416610|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416611|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416612|NCT00124826|Insulin|insulin|mesh-list
56416613|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56416614|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416615|NCT00193739|Paclitaxel|paclitaxel|mesh-list
56416616|NCT00193739|Carboplatin|carboplatin|mesh-list
56416617|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56416618|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416619|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416620|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416621|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416622|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416623|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56416624|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56416625|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56416627|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416628|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56416629|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56416630|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416631|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
56416632|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416633|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
56416634|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416635|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416636|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56416637|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
56416638|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911193|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56911194|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56911195|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
56911196|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
56911197|NCT02183116|Meloxicam|meloxicam|mesh-list
56911198|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911199|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911200|NCT02183116|Analgesics|analgesics|mesh-ancestor
56911201|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
56911202|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911203|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911204|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911205|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911206|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56911207|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56911208|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911209|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911210|NCT02183194|Paclitaxel|paclitaxel|mesh-list
56911211|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56416639|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416640|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56416641|NCT00125021|Capecitabine|capecitabine|mesh-list
56416642|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56416643|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56416644|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
56416645|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416646|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416647|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56416648|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416649|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
56416650|NCT00193856|Leuprolide|leuprolide|mesh-list
56416651|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56416652|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416653|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56416654|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
56416655|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56416656|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56416657|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416658|NCT00223509|Lamotrigine|lamotrigine|mesh-list
56416659|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
56416660|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56416661|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56416662|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416663|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56416664|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416665|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56416666|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56164387|NCT00002784|Tamoxifen|tamoxifen|mesh-list
56416667|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56416668|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56416669|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56416670|NCT00193895|Carboplatin|carboplatin|mesh-list
56416671|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416672|NCT00223548|Mesna|mesna|mesh-list
56416673|NCT00223548|Protective Agents|protective agents|mesh-ancestor
56416674|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911212|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911213|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
56911214|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416675|NCT00125060|Simvastatin|simvastatin|mesh-list
56416676|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56416677|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56416678|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
56416679|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416680|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56416681|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56416682|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416683|NCT00223626|Topiramate|topiramate|mesh-list
56416684|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
56416685|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56416686|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416687|NCT00223743|Zonisamide|zonisamide|mesh-list
56416688|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
56416689|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55765905|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416691|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416692|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56416693|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416695|NCT00193973|Idarubicin|idarubicin|mesh-list
56416696|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56416697|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
56416698|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56416699|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416700|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56416701|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
56416702|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416703|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416704|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
56416705|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416706|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56416707|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416708|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
56416709|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416710|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56416711|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56416712|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56416713|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56416714|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56416715|NCT00223860|Hormones|hormones|mesh-list
56416716|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56416717|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416718|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416719|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56416720|NCT00125255|Lidocaine|lidocaine|mesh-list
56416721|NCT00125255|Tetracaine|tetracaine|mesh-list
56416722|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
56416723|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
56416724|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56416725|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416726|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
56416727|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416728|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56416729|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56416730|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56416731|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56416732|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416733|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
56416734|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
56416735|NCT00223938|Hematinics|hematinics|mesh-ancestor
56416736|NCT00125294|Methadone|methadone|mesh-list
56416737|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56416738|NCT00125294|Narcotics|narcotics|mesh-ancestor
56416739|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56416740|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416741|NCT00125294|Analgesics|analgesics|mesh-ancestor
56416742|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
56416743|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911215|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416744|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
56416745|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
56416746|NCT00206466|Docetaxel|docetaxel|mesh-list
56416747|NCT00206466|Doxorubicin|doxorubicin|mesh-list
56416748|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
56416749|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56416750|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416751|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416752|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416753|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416754|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416755|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56416756|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56416757|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56416758|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416759|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416760|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
55765973|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416764|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
56416765|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56416766|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56416767|NCT00224094|Estrogens|estrogens|mesh-ancestor
56416768|NCT00224094|Hormones|hormones|mesh-ancestor
56416769|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416770|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416771|NCT00125411|Docetaxel|docetaxel|mesh-list
56416772|NCT00125411|Satraplatin|satraplatin|mesh-list
56416773|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416774|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416775|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416776|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416777|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416778|NCT00206505|Docetaxel|docetaxel|mesh-list
56416779|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416780|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416781|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
56416782|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416783|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416784|NCT00206544|Tamoxifen|tamoxifen|mesh-list
56416785|NCT00206544|Progesterone|progesterone|mesh-list
56416786|NCT00206544|Progestins|progestins|mesh-ancestor
56416787|NCT00206544|Hormones|hormones|mesh-ancestor
56416788|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416789|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416790|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56416791|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
56416792|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56416793|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416794|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56416795|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56416796|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56416797|NCT00194324|Miconazole|miconazole|mesh-list
56416798|NCT00194324|Clotrimazole|clotrimazole|mesh-list
56416799|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
56416800|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416801|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56416802|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56416803|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416804|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416805|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56416806|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
56416807|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416808|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416809|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56416810|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56416811|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56416812|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56416813|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56416814|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
56416815|NCT00206622|Estradiol|estradiol|mesh-list
56416816|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56416817|NCT00206622|Estrogens|estrogens|mesh-ancestor
56416818|NCT00206622|Hormones|hormones|mesh-ancestor
56911216|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416819|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416820|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416821|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56416822|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
56416823|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56416824|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56416825|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56416826|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56416827|NCT00194402|Niacin|niacin|mesh-list
56416828|NCT00194402|Niacinamide|niacinamide|mesh-list
56416829|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
56416830|NCT00194402|Atorvastatin|atorvastatin|mesh-list
56416831|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56416833|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
56416834|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416835|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56416836|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56416837|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416838|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
56416839|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
56416840|NCT00194402|Vitamins|vitamins|mesh-ancestor
56416841|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
56416842|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416843|NCT00473512|Dexamethasone|dexamethasone|mesh-list
56416844|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
56416845|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56416846|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
56416847|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
56416848|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416849|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416850|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56416851|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
56416852|NCT00473512|Hormones|hormones|mesh-ancestor
56416853|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416854|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56416855|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416856|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56416857|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416858|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416859|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
56416860|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56416861|NCT00125489|Chloroquine|chloroquine|mesh-list
56416862|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56416863|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
56416864|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
56416865|NCT00125489|Amebicides|amebicides|mesh-ancestor
56416866|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56416867|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56416868|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416869|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
56416870|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416871|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56416872|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56416873|NCT00125489|Analgesics|analgesics|mesh-ancestor
56416874|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
56416875|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416876|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416877|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56416878|NCT00125489|Filaricides|filaricides|mesh-ancestor
56416879|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
56416880|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
56416881|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56416882|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416883|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416884|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56416885|NCT00125489|Renal Agents|renal agents|mesh-ancestor
56416886|NCT00206661|Molgramostim|molgramostim|mesh-list
56416887|NCT00206661|Sargramostim|sargramostim|mesh-list
56416888|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
56416889|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416890|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416891|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56416892|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56911217|NCT02183272|Ketamine|ketamine|mesh-list
56911218|NCT02183272|Analgesics|analgesics|mesh-ancestor
56911219|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
56911220|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911221|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911222|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56911223|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56911224|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
56911225|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
56381760|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56416893|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56416894|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56416895|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416896|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56416897|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56416898|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56416899|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
56416900|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416901|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416902|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56416903|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56416904|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
56416905|NCT00125567|Levodopa|levodopa|mesh-list
56416906|NCT00125567|Carbidopa|carbidopa|mesh-list
56416909|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56416910|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
56416911|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56416912|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416913|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416914|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56416915|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416916|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56416917|NCT00473083|Minocycline|minocycline|mesh-list
56416918|NCT00473083|Clindamycin|clindamycin|mesh-list
56416919|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
56416920|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
56416921|NCT00473083|Triamcinolone|triamcinolone|mesh-list
56416922|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56416923|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56416924|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
56416925|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56416926|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416927|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416928|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56416929|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
56416931|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56416932|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416933|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56416934|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
56416935|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56416936|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416937|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56416938|NCT00194480|Interferons|interferons|mesh-list
56416939|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416940|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
56416941|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416942|NCT00472420|Rituximab|rituximab|mesh-list
56416943|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56416944|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416945|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
56416946|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416947|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416948|NCT00194519|Acyclovir|acyclovir|mesh-list
56416949|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
56416950|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416951|NCT00206700|Sargramostim|sargramostim|mesh-list
56911226|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911227|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56416952|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
56416953|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416954|NCT00125645|Irbesartan|irbesartan|mesh-list
56416955|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56416956|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56416957|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56416958|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416959|NCT00125684|Morphine|morphine|mesh-list
56416960|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56416961|NCT00125684|Narcotics|narcotics|mesh-ancestor
56416962|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56416963|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416964|NCT00125684|Analgesics|analgesics|mesh-ancestor
56416965|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
56416966|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56416967|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
56416968|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416969|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
56416970|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56416971|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56416972|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416973|NCT00194597|Urological Agents|urological agents|mesh-ancestor
56416975|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
56416976|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
56416977|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56416978|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56416979|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416980|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56416981|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416983|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56416984|NCT00206739|Renal Agents|renal agents|mesh-ancestor
56416985|NCT00206778|Lamotrigine|lamotrigine|mesh-list
56416986|NCT00206778|Valproic Acid|valproic acid|mesh-list
56416987|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
56416988|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56416989|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56416990|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416991|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56416992|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416993|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56416994|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56416995|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56416996|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56416997|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56416998|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56416999|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
56417000|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417001|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
56417002|NCT00125801|Hydromorphone|hydromorphone|mesh-list
56417003|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56417004|NCT00125801|Narcotics|narcotics|mesh-ancestor
56417005|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417006|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417007|NCT00125801|Analgesics|analgesics|mesh-ancestor
56417008|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
56417009|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417010|NCT00125840|Clofarabine|clofarabine|mesh-list
56417011|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56417012|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
56417013|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417014|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417015|NCT00224445|Ritonavir|ritonavir|mesh-list
56417016|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56417017|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56417018|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56417019|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56417020|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
56417021|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417022|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417023|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56911228|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56911229|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911230|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911231|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56417024|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56417025|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
56417026|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417027|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55917597|NCT02993835|Iron|iron|mesh-list
56417028|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56417029|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56417030|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56417031|NCT00194753|Paclitaxel|paclitaxel|mesh-list
56417032|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
56417033|NCT00194753|Doxorubicin|doxorubicin|mesh-list
56417034|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56417035|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417036|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
56417037|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
56417038|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
56417039|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417040|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164752|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
56417042|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417043|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417044|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56417045|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
56417046|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56417047|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56417048|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56417049|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56417050|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417051|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56417052|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
55766257|NCT02415569|Cathartics|cathartics|mesh-ancestor
56417055|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
56417056|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56417057|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56417058|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417059|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417060|NCT00125918|Urological Agents|urological agents|mesh-ancestor
56417061|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
56417062|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56417063|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
56417064|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56417065|NCT00472303|Morphine|morphine|mesh-list
56417066|NCT00472303|Tapentadol|tapentadol|mesh-list
56417067|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56417068|NCT00472303|Narcotics|narcotics|mesh-ancestor
56417069|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417070|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417071|NCT00472303|Analgesics|analgesics|mesh-ancestor
56417072|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
56417073|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417074|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56417075|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56417076|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56417077|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417078|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
56417079|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417080|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56417081|NCT00125996|Hematinics|hematinics|mesh-ancestor
56417082|NCT00206934|Dexetimide|dexetimide|mesh-list
56417083|NCT00206934|Citalopram|citalopram|mesh-list
56417084|NCT00206934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56417085|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56417086|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56417087|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417088|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417089|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
56381970|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
56417090|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417091|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56417092|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
56417093|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417094|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56417095|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56417096|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
56417097|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
56417098|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417099|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56417100|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56417101|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
56417102|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
56417103|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
56417104|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56417105|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56417106|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417107|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417108|NCT00194909|Urological Agents|urological agents|mesh-ancestor
56417109|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
56417110|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
56417111|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
56417112|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417113|NCT00194948|Citalopram|citalopram|mesh-list
56417114|NCT00194948|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56417115|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56417116|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56417117|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417118|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417120|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417121|NCT00194948|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56417122|NCT00194948|Antidepressive Agents|antidepressive agents|mesh-ancestor
56417123|NCT00194948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417124|NCT00206973|Mannitol|mannitol|mesh-list
56417125|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56417126|NCT00206973|Diuretics|diuretics|mesh-ancestor
56417127|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
56417128|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417129|NCT00471445|Ketamine|ketamine|mesh-list
56417130|NCT00471445|Amitriptyline|amitriptyline|mesh-list
56417131|NCT00471445|Analgesics|analgesics|mesh-ancestor
56417132|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
56417133|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417134|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417135|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56417136|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56417137|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
56417138|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
56417139|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417140|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56417141|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56417142|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417143|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417144|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56417145|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
56417146|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417147|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56417148|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56417149|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56417150|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56417151|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
56417152|NCT00207051|Cetuximab|cetuximab|mesh-list
56417153|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56417154|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417155|NCT00402467|Enoxaparin|enoxaparin|mesh-list
56417156|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
56417157|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
56417158|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56164200|NCT00002700|Leucovorin|leucovorin|mesh-list
56417159|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
56417160|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56417161|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
56417162|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911232|NCT02177500|Telmisartan|telmisartan|mesh-list
56911233|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
56382041|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56417163|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417164|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
56417165|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56417166|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56417168|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56417169|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56417170|NCT00224679|Analgesics|analgesics|mesh-ancestor
56417171|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
56417172|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417173|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417174|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56417175|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417176|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56417177|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56417178|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417179|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56417180|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56417181|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417182|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
56417183|NCT00402506|Pyridoxal|pyridoxal|mesh-list
56417184|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
56417185|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
56417186|NCT00402506|Vitamins|vitamins|mesh-ancestor
56417187|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
56417188|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417189|NCT00207129|Capecitabine|capecitabine|mesh-list
56417190|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56417191|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
56417192|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417193|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417194|NCT00402545|Docetaxel|docetaxel|mesh-list
56417195|NCT00402545|Fluorouracil|fluorouracil|mesh-list
56417196|NCT00402545|Cetuximab|cetuximab|mesh-list
56417197|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417198|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
56417199|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
56417200|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
56417201|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417206|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417207|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56417208|NCT00126074|Tedisamil|tedisamil|mesh-list
56417209|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56417210|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56417211|NCT00126074|Protective Agents|protective agents|mesh-ancestor
56417212|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417213|NCT00195104|Cytarabine|cytarabine|mesh-list
56417214|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
56417215|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56417216|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
56417217|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417218|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417219|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
56417220|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417221|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417222|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
56417223|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417224|NCT00413088|Bemiparin|bemiparin|mesh-list
56417225|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
56417226|NCT00409760|Amlodipine|amlodipine|mesh-list
56417227|NCT00409760|Valsartan|valsartan|mesh-list
56417228|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56417229|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56417230|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56417231|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417232|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56417233|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417234|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
56417235|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56417236|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56911234|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56911235|NCT02177500|Diuretics|diuretics|mesh-ancestor
56911236|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
56911237|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911238|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56911239|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56911240|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911241|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56911242|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56911243|NCT02183350|Linagliptin|linagliptin|mesh-list
56911244|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911245|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911246|NCT02183350|Incretins|incretins|mesh-ancestor
56417237|NCT00413127|Lidocaine|lidocaine|mesh-list
56417238|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
56417239|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
56417240|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417241|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417242|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
56417243|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417244|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56417245|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56417246|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56417247|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56417248|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417249|NCT00126230|Docetaxel|docetaxel|mesh-list
56417250|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417251|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
56417252|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
56417253|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
56417254|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417255|NCT00207363|Interferons|interferons|mesh-list
56417256|NCT00207363|Ribavirin|ribavirin|mesh-list
56417257|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
56417258|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
56417259|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56417260|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417261|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
56417262|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417263|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
56417264|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417266|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417267|NCT00126269|Gemcitabine|gemcitabine|mesh-list
56417268|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417269|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56417270|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
56417271|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417272|NCT00126269|Antiviral Agents|antiviral agents|mesh-ancestor
56417273|NCT00126269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417277|NCT00126269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417279|NCT00207402|Interferons|interferons|mesh-list
56417280|NCT00207402|Ribavirin|ribavirin|mesh-list
56417281|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
56417282|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417283|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
56417284|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417285|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
56417286|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417287|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56417288|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417289|NCT00195299|Sirolimus|sirolimus|mesh-list
56911247|NCT02183350|Hormones|hormones|mesh-ancestor
56911248|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911249|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56911250|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
56911251|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911252|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911253|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56911254|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
56911255|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56911256|NCT02183428|Glyburide|glyburide|mesh-list
56911257|NCT02183428|Linagliptin|linagliptin|mesh-list
56911258|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911259|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911260|NCT02183428|Incretins|incretins|mesh-ancestor
56911261|NCT02183428|Hormones|hormones|mesh-ancestor
56911262|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911263|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56911264|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
56911265|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911266|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911267|NCT01080911|Morphine|morphine|mesh-list
56911268|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
56911269|NCT01080911|Narcotics|narcotics|mesh-ancestor
56911270|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911271|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911272|NCT01080911|Analgesics|analgesics|mesh-ancestor
56911273|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
56382183|NCT00122603|Saquinavir|saquinavir|mesh-list
56417290|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56417291|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417292|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56417293|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417294|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
56417295|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417296|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
56417297|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417298|NCT00471328|Sunitinib|sunitinib|mesh-list
56417299|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
56417300|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417301|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56417302|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56417303|NCT00471328|Growth Substances|growth substances|mesh-ancestor
56417304|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417305|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
56417306|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56417307|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164217|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
55888157|NCT04630834|Acetaminophen|acetaminophen|mesh-list
56911274|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911275|NCT02183506|Metformin|metformin|mesh-list
56911276|NCT02183506|Linagliptin|linagliptin|mesh-list
56911277|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911278|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911279|NCT02183506|Incretins|incretins|mesh-ancestor
56911280|NCT02183506|Hormones|hormones|mesh-ancestor
56911281|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911282|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56911283|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
56911284|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911285|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911286|NCT02177734|Vaccines|vaccines|mesh-list
56911287|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
56911288|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911289|NCT02183584|Linagliptin|linagliptin|mesh-list
56911290|NCT02183584|Rifampin|rifampin|mesh-list
56911291|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56382225|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56417308|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417309|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
56417310|NCT00126308|Mannitol|mannitol|mesh-list
56417311|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56417312|NCT00126308|Diuretics|diuretics|mesh-ancestor
56417313|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
56417314|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417315|NCT00195377|Etanercept|etanercept|mesh-list
56417316|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56417317|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56417318|NCT00195377|Analgesics|analgesics|mesh-ancestor
56417319|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
56417320|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417321|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417322|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56417323|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417324|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56417325|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417326|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
56417327|NCT00225108|Tinzaparin|tinzaparin|mesh-list
56417328|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56417329|NCT00225108|Dalteparin|dalteparin|mesh-list
56417330|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
56417331|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56417332|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56417333|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417334|NCT00195416|Etanercept|etanercept|mesh-list
56417335|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56417336|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56417337|NCT00195416|Analgesics|analgesics|mesh-ancestor
56417338|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
56417339|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417340|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417341|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56417342|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417343|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56417344|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417345|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
56417346|NCT00195455|Estradiol|estradiol|mesh-list
56911292|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911293|NCT02183584|Incretins|incretins|mesh-ancestor
56911294|NCT02183584|Hormones|hormones|mesh-ancestor
56911295|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56417349|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56417350|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417351|NCT00126347|Folic Acid|folic acid|mesh-list
56417352|NCT00126347|Betaine|betaine|mesh-list
56417353|NCT00126347|Hematinics|hematinics|mesh-ancestor
56417354|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
56417355|NCT00126347|Vitamins|vitamins|mesh-ancestor
56417356|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
56417357|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417358|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56417359|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
56417360|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56417361|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
56417362|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417363|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56417364|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
56417365|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56417366|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417367|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
56417368|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56417369|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417370|NCT00225264|Pioglitazone|pioglitazone|mesh-list
56417371|NCT00225264|Glimepiride|glimepiride|mesh-list
56417372|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56417373|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417374|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56417375|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417376|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
56417377|NCT00126464|Tamoxifen|tamoxifen|mesh-list
56417378|NCT00126464|Fulvestrant|fulvestrant|mesh-list
56417379|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56417380|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
56417381|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56417382|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417383|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56417384|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417385|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56417386|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56417387|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56417388|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56417389|NCT00195533|Tazobactam|tazobactam|mesh-list
56417390|NCT00195533|Piperacillin|piperacillin|mesh-list
56417391|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56417392|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56417393|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417394|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56417395|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417396|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417397|NCT00207558|Folic Acid|folic acid|mesh-list
56417398|NCT00207558|Hematinics|hematinics|mesh-ancestor
56417399|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
56417400|NCT00207558|Vitamins|vitamins|mesh-ancestor
56417401|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
56417402|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417403|NCT00195572|Leucovorin|leucovorin|mesh-list
56417404|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
56417405|NCT00195572|Antidotes|antidotes|mesh-ancestor
56417406|NCT00195572|Protective Agents|protective agents|mesh-ancestor
56417407|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417408|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
56417409|NCT00195572|Vitamins|vitamins|mesh-ancestor
56417410|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
56417411|NCT00470704|Trastuzumab|trastuzumab|mesh-list
56417412|NCT00470704|Lapatinib|lapatinib|mesh-list
56417413|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56417414|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417415|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56417416|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888158|NCT04630834|Ibuprofen|ibuprofen|mesh-list
56911296|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56911297|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
56417417|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417418|NCT00202280|Folic Acid|folic acid|mesh-list
56417419|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
56417420|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
56417421|NCT00202280|Vitamins|vitamins|mesh-ancestor
56417422|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
56417423|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417426|NCT00225303|Etravirine|etravirine|mesh-list
56417427|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56417428|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56417429|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417430|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417431|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
56417432|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417433|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
56417434|NCT00225342|Gliclazide|gliclazide|mesh-list
56417435|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56417436|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417437|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56417438|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
56417439|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417440|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
56417441|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417442|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56417443|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417444|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417445|NCT00195689|Adalimumab|adalimumab|mesh-list
56417446|NCT00195689|Antibodies|antibodies|mesh-list
56417447|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56417448|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
56417449|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417450|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56417451|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417452|NCT00470275|Cytarabine|cytarabine|mesh-list
56417453|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56417454|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
56417455|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417456|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417457|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
56417458|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417459|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417460|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
56417461|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417463|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417464|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417465|NCT00195728|Acetaminophen|acetaminophen|mesh-list
56417466|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56417467|NCT00195728|Hydrocodone|hydrocodone|mesh-list
56417468|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56417469|NCT00195728|Analgesics|analgesics|mesh-ancestor
56417470|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
56417471|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417472|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417473|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
56417474|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56417475|NCT00195728|Narcotics|narcotics|mesh-ancestor
56417476|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417477|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
56417478|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
56417479|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56417480|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56417481|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417482|NCT00470158|Iron|iron|mesh-list
56417483|NCT00470158|Zinc|zinc|mesh-list
56417484|NCT00470158|Trace Elements|trace elements|mesh-ancestor
56417485|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
56417486|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417487|NCT00472186|Lansoprazole|lansoprazole|mesh-list
56417488|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
56417489|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56417490|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56417491|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56417492|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911298|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911299|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911300|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56911301|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
56911302|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56911303|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911304|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
56911305|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56382428|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
56417493|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417494|NCT00195767|Valproic Acid|valproic acid|mesh-list
56417495|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
56417496|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417497|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417498|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
56417499|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417500|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417502|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56417503|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417504|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417506|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
56417507|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56417508|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417509|NCT00202358|Atenolol|atenolol|mesh-list
56417510|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56417511|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56417512|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
56417513|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
56417514|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417515|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417516|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56417517|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56417518|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56417519|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
56417520|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417521|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417522|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56417523|NCT00479713|Simvastatin|simvastatin|mesh-list
56417524|NCT00479713|Ezetimibe|ezetimibe|mesh-list
56417525|NCT00479713|Calcium|calcium|mesh-list
56417526|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56417527|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417528|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56417529|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56417530|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
56417531|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417532|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55918123|NCT04018105|Metformin|metformin|mesh-list
56417533|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56417535|NCT00207753|Ivermectin|ivermectin|mesh-list
56417536|NCT00207753|Albendazole|albendazole|mesh-list
56417537|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56417538|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417539|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
56417540|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
56417541|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56417542|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56417543|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
56417544|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
56417545|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
56417546|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417547|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417548|NCT00202397|Riluzole|riluzole|mesh-list
56417549|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
56417550|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56911306|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56911307|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56911308|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56417551|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56417552|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417553|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417554|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417555|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56417556|NCT00202397|Protective Agents|protective agents|mesh-ancestor
56417557|NCT00478972|Rimonabant|rimonabant|mesh-list
56417558|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56417559|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56417560|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56417561|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417562|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417563|NCT00478972|Hormones|hormones|mesh-ancestor
56417564|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56417565|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417566|NCT00207792|Lenograstim|lenograstim|mesh-list
56417567|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56417568|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
56417569|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333875|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56417570|NCT00195806|Valproic Acid|valproic acid|mesh-list
56417571|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
56417572|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417573|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417577|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
56417578|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56417579|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417580|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417581|NCT00477529|Docetaxel|docetaxel|mesh-list
56417582|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417583|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
56417584|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
56417585|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
56417586|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417587|NCT00472693|Bevacizumab|bevacizumab|mesh-list
56417588|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56417589|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56417590|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417591|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56417592|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56417593|NCT00472693|Growth Substances|growth substances|mesh-ancestor
56417594|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417595|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
56417596|NCT00195845|Galantamine|galantamine|mesh-list
56417597|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56417598|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417599|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417600|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
56417601|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417602|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417603|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56417604|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
55918194|NCT05631847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56417606|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
56417607|NCT00202514|Valproic Acid|valproic acid|mesh-list
56417608|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
56417609|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417610|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417611|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
56417612|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417613|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417614|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
56417615|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56417616|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417617|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417618|NCT00207831|Tegafur|tegafur|mesh-list
56417619|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56417620|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
56911309|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56911310|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56911311|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56911312|NCT03964493|Vancomycin|vancomycin|mesh-list
56911313|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56911314|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911315|NCT01068353|Etanercept|etanercept|mesh-list
56911316|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56417621|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417622|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417623|NCT00195923|Clindamycin|clindamycin|mesh-list
56417624|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
56417625|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
56417626|NCT00195923|Gentamicins|gentamicins|mesh-list
56417627|NCT00195923|Ceftazidime|ceftazidime|mesh-list
56417628|NCT00195923|Ampicillin|ampicillin|mesh-list
56417629|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56417630|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417631|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56417632|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417633|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417634|NCT00225615|Verapamil|verapamil|mesh-list
56417635|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56417636|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56417637|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56417638|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417639|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56417640|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417641|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
56417642|NCT00202553|Perindopril|perindopril|mesh-list
56417643|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56165350|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417644|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
56417645|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417646|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417647|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56417649|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56417650|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
56417651|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417652|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417653|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56417654|NCT00411333|Triamcinolone|triamcinolone|mesh-list
56417655|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56417656|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56417657|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56417658|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56417659|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
56417661|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56417662|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417663|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417664|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
56417665|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417666|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417667|NCT00225849|Aspirin|aspirin|mesh-list
56417668|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56417669|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56417670|NCT00225849|Analgesics|analgesics|mesh-ancestor
56417671|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
56417672|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417673|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417674|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56417675|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417676|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56417677|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55888159|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911317|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911318|NCT01068353|Analgesics|analgesics|mesh-ancestor
56911319|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
56911320|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911321|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911322|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911323|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911324|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56417678|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417679|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56417680|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56417681|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417682|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
56417683|NCT00202787|Leucovorin|leucovorin|mesh-list
56417684|NCT00202787|Cetuximab|cetuximab|mesh-list
56417685|NCT00202787|Fluorouracil|fluorouracil|mesh-list
56417686|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
56417687|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56417688|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417689|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
56417690|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417691|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56417692|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417693|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
56417694|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417695|NCT00202787|Antidotes|antidotes|mesh-ancestor
56417696|NCT00202787|Protective Agents|protective agents|mesh-ancestor
56417697|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
56417698|NCT00202787|Vitamins|vitamins|mesh-ancestor
56417699|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
56417700|NCT00424437|Insulin|insulin|mesh-list
56417701|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56417702|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56417703|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417704|NCT00202865|Infliximab|infliximab|mesh-list
56417705|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
56417706|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56417707|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417708|NCT00226005|Vatalanib|vatalanib|mesh-list
56417709|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56417710|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417711|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417712|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
56417713|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56417714|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
56417715|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56417716|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417717|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56417718|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56417719|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56417720|NCT00226044|Omeprazole|omeprazole|mesh-list
55766912|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
56417722|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56417723|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56417724|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417725|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417726|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
56417728|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56417729|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
56417730|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417731|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417732|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417733|NCT00207948|Ritonavir|ritonavir|mesh-list
56417734|NCT00207948|Lopinavir|lopinavir|mesh-list
56417735|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56417736|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56417737|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
56417738|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417739|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911325|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56911326|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
56911327|NCT01083251|Vitamin D|vitamin d|mesh-list
56911328|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
56911329|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
56911330|NCT01083251|Vitamins|vitamins|mesh-list
56911331|NCT01083251|Entecavir|entecavir|mesh-list
56911394|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56911395|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56911396|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
56911397|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56911398|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56911399|NCT02178124|Donepezil|donepezil|mesh-list
56911400|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56911401|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911402|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911403|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
56911404|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911405|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911406|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
56911407|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
56911408|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56911409|NCT02030314|Diuretics|diuretics|mesh-ancestor
56417740|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56417741|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56417742|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
56417743|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417744|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56417745|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56417746|NCT00196391|Progesterone|progesterone|mesh-list
56417747|NCT00196391|Progestins|progestins|mesh-ancestor
56417748|NCT00196391|Hormones|hormones|mesh-ancestor
56417749|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56417750|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417751|NCT00203060|Rasagiline|rasagiline|mesh-list
56417752|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56417753|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417754|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417755|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56417756|NCT00203060|Protective Agents|protective agents|mesh-ancestor
56417757|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417758|NCT00226122|Indomethacin|indomethacin|mesh-list
56417759|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56417760|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56417761|NCT00226122|Analgesics|analgesics|mesh-ancestor
56417762|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
56417763|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417764|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417765|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56417766|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417767|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
56417768|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
56417769|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56417770|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56417771|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417772|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417773|NCT00196469|Heparin|heparin|mesh-list
56417774|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
56417775|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56417776|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56417777|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417778|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
56417779|NCT00208065|Ephedrine|ephedrine|mesh-list
56417780|NCT00208065|Almotriptan|almotriptan|mesh-list
56417781|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56417782|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
56911410|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
56382776|NCT04665765|Rituximab|rituximab|mesh-list
56417783|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417784|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417785|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56417786|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
56417787|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
56417788|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56417789|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56417790|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
56417791|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
56417792|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165506|NCT00002976|Estrogens|estrogens|mesh-list
56417793|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417797|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
56417798|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56417800|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
56417801|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417802|NCT00203099|Expectorants|expectorants|mesh-ancestor
56417803|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
56417804|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56417805|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
56417806|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417807|NCT00203099|Protective Agents|protective agents|mesh-ancestor
56417808|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417809|NCT00203099|Antidotes|antidotes|mesh-ancestor
56417810|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56417811|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
56417812|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417813|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56417814|NCT00226200|Omalizumab|omalizumab|mesh-list
56417815|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56417816|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56417817|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
56417818|NCT00203138|Rasagiline|rasagiline|mesh-list
56417819|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56417820|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417821|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417822|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56417823|NCT00203138|Protective Agents|protective agents|mesh-ancestor
56417824|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417825|NCT00196547|Montelukast|montelukast|mesh-list
56417826|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56417827|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
56417828|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56417829|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
56417830|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56417831|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417832|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56417833|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56417834|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417835|NCT00203177|Rasagiline|rasagiline|mesh-list
56417836|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56417837|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417838|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417839|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56417840|NCT00203177|Protective Agents|protective agents|mesh-ancestor
56417841|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417842|NCT00208143|Risperidone|risperidone|mesh-list
56417843|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56417844|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56417845|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
56417846|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417847|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417848|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417849|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56417850|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56417851|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417852|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417853|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56417854|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
56417855|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
56417856|NCT00196586|Interferons|interferons|mesh-list
56911411|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382837|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56417857|NCT00196586|Ribavirin|ribavirin|mesh-list
56417858|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
56417859|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
56417860|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56417861|NCT00196586|Interleukin-2|interleukin-2|mesh-list
56417862|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417863|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
56417864|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417865|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
56417866|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417867|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
56417868|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417872|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417874|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
56417875|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417876|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56417877|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56417878|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417879|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417880|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
56417881|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
56417882|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417883|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417884|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56417885|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56417886|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
56417887|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56417888|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56417889|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56417890|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56417891|NCT00226356|Betaine|betaine|mesh-list
56417892|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56417893|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
56417894|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56417895|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
56417896|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417897|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56417898|NCT00208182|Risperidone|risperidone|mesh-list
56417899|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56417900|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
56417901|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918487|NCT01406873|Mexiletine|mexiletine|mesh-list
56417902|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417903|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417904|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56417905|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56417906|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417907|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417908|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56417910|NCT00226395|Oxymorphone|oxymorphone|mesh-list
56417911|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56417912|NCT00226395|Narcotics|narcotics|mesh-ancestor
56417913|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417914|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417915|NCT00226395|Analgesics|analgesics|mesh-ancestor
56417916|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
56417917|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56417918|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56417919|NCT00208221|Telmisartan|telmisartan|mesh-list
56417920|NCT00208221|Ramipril|ramipril|mesh-list
56417921|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56417922|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56417923|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56417924|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417925|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56417926|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
56417927|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417928|NCT00196625|Ritonavir|ritonavir|mesh-list
56417929|NCT00196625|Amprenavir|amprenavir|mesh-list
56417930|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56417931|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56911412|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56911413|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56911414|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911415|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56911416|NCT02184364|Estrogens|estrogens|mesh-ancestor
56911417|NCT02184364|Hormones|hormones|mesh-ancestor
56911418|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911419|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622074|NCT00962585|Equol|equol|mesh-list
56911420|NCT02181478|Cyclosporine|cyclosporine|mesh-list
56911421|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
56911422|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
56911423|NCT02181478|Fludarabine|fludarabine|mesh-list
56911424|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
56911425|NCT02181478|Cyclosporins|cyclosporins|mesh-list
56911426|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56911427|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
56911428|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911429|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911430|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56911431|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
56911432|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911433|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382910|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
56417932|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
56417933|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417934|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417935|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56417936|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56417937|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
56417938|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417939|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56417940|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56417941|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56417944|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56417945|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
56417946|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56417948|NCT00208260|Fluorouracil|fluorouracil|mesh-list
56417949|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
56417950|NCT00208260|Folfirinox|folfirinox|mesh-list
56417951|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
56417952|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417953|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56417954|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417955|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417956|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
56417957|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417958|NCT00208260|Antidotes|antidotes|mesh-ancestor
56417959|NCT00208260|Protective Agents|protective agents|mesh-ancestor
56417960|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
56417961|NCT00208260|Vitamins|vitamins|mesh-ancestor
56417962|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
56911434|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56911435|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56911436|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
56417963|NCT00226473|Dacarbazine|dacarbazine|mesh-list
56417964|NCT00226473|Vindesine|vindesine|mesh-list
56417965|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56417966|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56417967|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
56417968|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417969|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56417970|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
56417971|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
56417972|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
56417973|NCT00208299|Adenosine|adenosine|mesh-list
56417974|NCT00208299|Regadenoson|regadenoson|mesh-list
56417975|NCT00208299|Analgesics|analgesics|mesh-ancestor
56417976|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
56417978|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417979|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56417980|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
56417981|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56417982|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
56417983|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
56417984|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417985|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417986|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56417987|NCT00196664|Paroxetine|paroxetine|mesh-list
56417988|NCT00196664|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56417989|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56417990|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56417991|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417992|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417993|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
56417994|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417995|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56417996|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
56417997|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56417998|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56417999|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56418000|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418001|NCT00196703|Memantine|memantine|mesh-list
56418002|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56418003|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56418004|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
56418005|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418006|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418007|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418008|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56418009|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56418010|NCT00413322|Fluorouracil|fluorouracil|mesh-list
56418011|NCT00413322|Belinostat|belinostat|mesh-list
56418012|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
56418013|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418014|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56418015|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165738|NCT00003120|Paclitaxel|paclitaxel|mesh-list
56418017|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
56418018|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418019|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56418020|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418021|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
56418022|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
56418023|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56418024|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56418025|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418026|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418027|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418028|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418030|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
56418031|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56418032|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56911437|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911438|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
56911439|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911440|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56911441|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56911442|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56911443|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56911444|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
56911445|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56911446|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
56911447|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56911448|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
56911449|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
56911450|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911451|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911452|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911453|NCT02755090|Analgesics|analgesics|mesh-ancestor
56911454|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
56911455|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418033|NCT00410657|Prednisolone|prednisolone|mesh-list
56418034|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
56418035|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
56418036|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56418037|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
56418038|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418039|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
56418040|NCT00410657|Hormones|hormones|mesh-ancestor
56418041|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56418042|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418043|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56418044|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418045|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
56418046|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
56418047|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418048|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56418049|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56418050|NCT00410657|Protective Agents|protective agents|mesh-ancestor
56418051|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56418052|NCT00413439|Isavuconazole|isavuconazole|mesh-list
56418053|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
56418054|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418055|NCT00196820|Capecitabine|capecitabine|mesh-list
56418056|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56418057|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
56418058|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418059|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418060|NCT00410696|Lenograstim|lenograstim|mesh-list
56418061|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56418062|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
56418063|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418064|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
56418065|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56418066|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418067|NCT00410735|Pranlukast|pranlukast|mesh-list
56418068|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56418069|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
56418070|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56911456|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56911457|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
56911458|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911459|NCT02185690|Carboplatin|carboplatin|mesh-list
56911460|NCT02185690|Pemetrexed|pemetrexed|mesh-list
56911461|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911462|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911463|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911464|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56418071|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
56418072|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56418073|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418074|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
56418075|NCT00203372|Bevacizumab|bevacizumab|mesh-list
56418076|NCT00203372|Docetaxel|docetaxel|mesh-list
56418077|NCT00203372|Doxorubicin|doxorubicin|mesh-list
56418078|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418079|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
56418080|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418081|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418082|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56418083|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
56418084|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418085|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418086|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56418087|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56418088|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56418089|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56418091|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
56418093|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
56418094|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
56418095|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56418096|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56418097|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56418098|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418100|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56418101|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56418102|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
56418103|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418104|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418105|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418106|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56418107|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
56418108|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418109|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56418110|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
56418111|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56418112|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
56418113|NCT00226551|Protective Agents|protective agents|mesh-ancestor
56418114|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
56418115|NCT00196859|Capecitabine|capecitabine|mesh-list
56418116|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56418117|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
56418118|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418119|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418120|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56418121|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418122|NCT00208533|Aripiprazole|aripiprazole|mesh-list
56418123|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
56418124|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418125|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56418126|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56418127|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418128|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418129|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
56911465|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56911466|NCT03536806|Canrenone|canrenone|mesh-list
56383163|NCT00499018|Cytarabine|cytarabine|mesh-list
56418130|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
56418131|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418132|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418133|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56418134|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56418135|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
56418136|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56418137|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56418138|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56418139|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56418140|NCT00203450|Zonisamide|zonisamide|mesh-list
56418141|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
56418142|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56418143|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56418144|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418145|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56418146|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418147|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
56418148|NCT00226668|Hormones|hormones|mesh-ancestor
56418149|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56418150|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418151|NCT00208572|Citalopram|citalopram|mesh-list
56418152|NCT00208572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56418153|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56418154|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56418155|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418156|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418157|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
56418158|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418159|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56418160|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
56418161|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418182|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418184|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56418185|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56418186|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418187|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418188|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56418189|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
56418190|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
56418191|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418193|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
56418195|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
56418196|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
56418197|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
56418198|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
56418199|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418200|NCT00208611|Hematinics|hematinics|mesh-ancestor
56418201|NCT00203567|Carbamazepine|carbamazepine|mesh-list
56418202|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
56418203|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
56418204|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56418205|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418206|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418207|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418208|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56418209|NCT00203567|Analgesics|analgesics|mesh-ancestor
56418210|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
56418211|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418212|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56418213|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56418214|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418215|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56418216|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56418218|NCT00226746|Paclitaxel|paclitaxel|mesh-list
56418219|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56418220|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418221|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
56911467|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56911468|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
56911469|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911470|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911471|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56911472|NCT03536806|Diuretics|diuretics|mesh-ancestor
56911473|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
56911474|NCT00108485|Niacin|niacin|mesh-list
56911475|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56911476|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
56911477|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911478|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56911479|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
56911480|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
56911481|NCT00108485|Vitamins|vitamins|mesh-ancestor
56418222|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
56418223|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
56418224|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418225|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56418226|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
56418227|NCT00226746|Antiviral Agents|antiviral agents|mesh-ancestor
56418228|NCT00226746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418229|NCT00226746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418230|NCT00226746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418231|NCT00226746|Immunologic Factors|immunologic factors|mesh-ancestor
56418232|NCT00226746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418233|NCT00203606|Interferons|interferons|mesh-list
56418234|NCT00203606|Ribavirin|ribavirin|mesh-list
56418235|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
56418236|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
56418237|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56418238|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418239|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
56418240|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418241|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
56418242|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418243|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
56418244|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418245|NCT00203684|Flunisolide|flunisolide|mesh-list
56418246|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418247|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56418248|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
56418249|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
56418250|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56418251|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418252|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418253|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56418254|NCT00226785|Analgesics|analgesics|mesh-ancestor
56418255|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
56418256|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418257|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56418258|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56418259|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56418260|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
56418261|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418262|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418263|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
56418264|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56418265|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418266|NCT00226824|Galantamine|galantamine|mesh-list
56911482|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
56911483|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383293|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
56418267|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56418268|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418269|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418270|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
56418271|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418272|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418273|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56418274|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
56418275|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418276|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
56418277|NCT00197249|Vaccines|vaccines|mesh-list
56418278|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
56418279|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418280|NCT00203723|Risperidone|risperidone|mesh-list
56418281|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56418282|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
56418283|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418284|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418285|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418286|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56418287|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56418288|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418289|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418290|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56418291|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
56418293|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56418295|NCT00226902|Analgesics|analgesics|mesh-ancestor
56418296|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
56418297|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418298|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418299|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418300|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418301|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56418302|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
56418303|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418304|NCT00226980|Thalidomide|thalidomide|mesh-list
56418305|NCT00226980|Capecitabine|capecitabine|mesh-list
56418306|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56418307|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
56418308|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418309|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418310|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418311|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
56418312|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418313|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
56418314|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56418315|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418316|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56418317|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56418318|NCT00226980|Growth Substances|growth substances|mesh-ancestor
56418319|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
56418320|NCT00203801|Artesunate|artesunate|mesh-list
56418321|NCT00203801|Lumefantrine|lumefantrine|mesh-list
56418322|NCT00203801|Artemether|artemether|mesh-list
56418323|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
56418324|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
56418325|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56418326|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56418327|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
56418328|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56418329|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56418330|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418331|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418332|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
56418333|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
56418334|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56418335|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
56418336|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56418337|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418338|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911484|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56911485|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911486|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56911487|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911488|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911489|NCT02181946|Fluconazole|fluconazole|mesh-list
56911490|NCT02181946|Nevirapine|nevirapine|mesh-list
56911491|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
56911492|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911493|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56911494|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56622146|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911495|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911496|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911497|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56911498|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
56418339|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56418340|NCT00203801|Renal Agents|renal agents|mesh-ancestor
56418341|NCT00197327|Bupivacaine|bupivacaine|mesh-list
56418342|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
56418343|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
56418344|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418345|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418346|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
56418347|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418348|NCT00227097|Anticoagulants|anticoagulants|mesh-list
56418349|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
56418350|NCT00208923|Busulfan|busulfan|mesh-list
56418351|NCT00208923|Fludarabine|fludarabine|mesh-list
56418352|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418353|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
56418354|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418355|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418356|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56418357|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
56418358|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418359|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418360|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56418361|NCT00227136|Serotonin|serotonin|mesh-list
56418362|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56418363|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
56418364|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418365|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418366|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418369|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56418370|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56418371|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
56418372|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418373|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418374|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418375|NCT00197444|Nedaplatin|nedaplatin|mesh-list
56418376|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418377|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56418378|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56418379|NCT00204074|Estradiol|estradiol|mesh-list
56418380|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56418381|NCT00204074|Estrogens|estrogens|mesh-ancestor
56418382|NCT00204074|Hormones|hormones|mesh-ancestor
56911499|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911500|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911501|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56911502|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56911503|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56911504|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56911505|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
56911506|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56911507|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56911508|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56911509|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56911510|NCT00107783|Nitisinone|nitisinone|mesh-list
56911511|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418383|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56418384|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418385|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56418386|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
56418387|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56418388|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56418389|NCT00227292|Citalopram|citalopram|mesh-list
56418390|NCT00227292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56418391|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56418392|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56418393|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418394|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418395|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
56418396|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418397|NCT00227292|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56418398|NCT00227292|Antidepressive Agents|antidepressive agents|mesh-ancestor
56418399|NCT00227292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418400|NCT00197483|Pergolide|pergolide|mesh-list
56418401|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
56418402|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
56418403|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418404|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418405|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418406|NCT00230529|Infliximab|infliximab|mesh-list
56418407|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
56418408|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56418409|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418410|NCT00230568|Donepezil|donepezil|mesh-list
56418411|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56418412|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418413|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418414|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
56418415|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418416|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418417|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
56418418|NCT00227331|Amoxicillin|amoxicillin|mesh-list
56418419|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56418420|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418421|NCT00197561|Selenium|selenium|mesh-list
56418422|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
56418423|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418424|NCT00197561|Protective Agents|protective agents|mesh-ancestor
56418425|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418426|NCT00197561|Trace Elements|trace elements|mesh-ancestor
56418427|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
56418428|NCT00227409|Edetic Acid|edetic acid|mesh-list
56911512|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911513|NCT02185768|Idarubicin|idarubicin|mesh-list
56911514|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56911515|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911516|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56911517|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56911518|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911519|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911520|NCT02182024|Dabigatran|dabigatran|mesh-list
56911521|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
56911522|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56911523|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
56911524|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911525|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911526|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
56911527|NCT02185846|Dirithromycin|dirithromycin|mesh-list
56911528|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56911529|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911530|NCT02184832|Metformin|metformin|mesh-list
56911531|NCT02184832|Tryptophan|tryptophan|mesh-list
56911532|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911533|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418429|NCT00227409|Calcium|calcium|mesh-list
56418430|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
56418431|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56418432|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418433|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
56418434|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56418435|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
56418436|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
56418437|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418438|NCT00227409|Antidotes|antidotes|mesh-ancestor
56418439|NCT00227409|Protective Agents|protective agents|mesh-ancestor
56418443|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56418444|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56418445|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
56418446|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418447|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418448|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56418449|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56418450|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
56418451|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418452|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56418453|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56418454|NCT00227448|Phenylephrine|phenylephrine|mesh-list
56418455|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
56418456|NCT00227448|Midodrine|midodrine|mesh-list
56418457|NCT00227448|Norepinephrine|norepinephrine|mesh-list
56418458|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56418459|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
56418460|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
56418461|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418462|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418463|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
56418464|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56911534|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56911535|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
56911536|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56911537|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
56911538|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
56911539|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56911540|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911541|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911542|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56418465|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
56418466|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
56418467|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56418468|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56418469|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56418470|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
56418471|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418472|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418473|NCT00227448|Protective Agents|protective agents|mesh-ancestor
56418474|NCT00204191|Tacrolimus|tacrolimus|mesh-list
56418475|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418476|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
56418477|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418478|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56418479|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418480|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418481|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
56418482|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56418483|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418484|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56418485|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
56418486|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56418487|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418489|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418490|NCT00204269|Testosterone|testosterone|mesh-list
56418491|NCT00204269|Androgens|androgens|mesh-ancestor
56418492|NCT00204269|Hormones|hormones|mesh-ancestor
56418493|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56418494|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418495|NCT00197756|Vitamins|vitamins|mesh-list
56418496|NCT00197756|Vitamin A|vitamin a|mesh-list
56418497|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
56418498|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
56418499|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418500|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
56418501|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418502|NCT00197756|Protective Agents|protective agents|mesh-ancestor
56418503|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56418504|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418505|NCT00227565|Carboplatin|carboplatin|mesh-list
56418506|NCT00227565|Pemetrexed|pemetrexed|mesh-list
56418507|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418508|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418509|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418510|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56418511|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56418512|NCT00204308|Tenofovir|tenofovir|mesh-list
56418513|NCT00204308|Emtricitabine|emtricitabine|mesh-list
56418514|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
56418517|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56418518|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418519|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418520|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56418521|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56418522|NCT00204347|Risperidone|risperidone|mesh-list
56418523|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56911543|NCT01083797|Analgesics|analgesics|mesh-ancestor
56911544|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
56383618|NCT00502684|Analgesics|analgesics|mesh-ancestor
56418524|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
56418525|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418526|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418527|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418528|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56418529|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56418530|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418531|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418532|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56418533|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
56418534|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
56418535|NCT00227682|Thalidomide|thalidomide|mesh-list
56418536|NCT00227682|Dexamethasone|dexamethasone|mesh-list
56418537|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
56418538|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418539|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
56166263|NCT00003606|Etoposide|etoposide|mesh-list
56418540|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
56418541|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418542|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418543|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56418544|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
56418545|NCT00227682|Hormones|hormones|mesh-ancestor
56418546|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56418547|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56418548|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418549|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418550|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
56418551|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
56418552|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56418553|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418554|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56418555|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56418556|NCT00227682|Growth Substances|growth substances|mesh-ancestor
56418557|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
56418558|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
56418559|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919151|NCT04195633|Cyclosporine|cyclosporine|mesh-list
56418560|NCT00227682|Protective Agents|protective agents|mesh-ancestor
56418561|NCT00227682|Vitamins|vitamins|mesh-ancestor
56418562|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
56418563|NCT00230763|Timolol|timolol|mesh-list
56418564|NCT00230763|Latanoprost|latanoprost|mesh-list
56418565|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56418566|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56418567|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
56418568|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418569|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418570|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418571|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56418572|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56418573|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56418574|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56418575|NCT00204386|Topiramate|topiramate|mesh-list
56418576|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
56418577|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56418578|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418579|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
56418580|NCT04721964|Trace Elements|trace elements|mesh-ancestor
56418581|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
56418582|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418583|NCT00197834|Valproic Acid|valproic acid|mesh-list
56418584|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
56418585|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418586|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418587|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
56418589|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418590|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
56418591|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56418592|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418593|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418594|NCT00197912|Celecoxib|celecoxib|mesh-list
56418595|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
56911545|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911546|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56911547|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56911548|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56911549|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
56911550|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418596|NCT00197912|Interleukin-2|interleukin-2|mesh-list
56418597|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
56418598|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418599|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418600|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418601|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56418602|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
56418603|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418604|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418605|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56418606|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56418607|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56418608|NCT00197912|Analgesics|analgesics|mesh-ancestor
56418609|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
56418610|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418611|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418612|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56418613|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56418614|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418615|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56418616|NCT02962323|Calcium|calcium|mesh-list
56418617|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56418618|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418619|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56418620|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56418621|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
56418622|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418623|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56418624|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56418625|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418626|NCT00204503|Valproic Acid|valproic acid|mesh-list
56418627|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
56418628|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418629|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418630|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
56418631|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418632|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418633|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
56418634|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56418635|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418636|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418637|NCT00204542|Diclofenac|diclofenac|mesh-list
56418638|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56418639|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56418640|NCT00204542|Analgesics|analgesics|mesh-ancestor
56418641|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
56418642|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418643|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418644|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418645|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418646|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56418647|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418648|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418649|NCT00230958|Interferons|interferons|mesh-list
56418650|NCT00230958|Ribavirin|ribavirin|mesh-list
56418651|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
56418652|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
56418653|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56418654|NCT00230958|Taribavirin|taribavirin|mesh-list
56418655|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418656|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
56418657|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911551|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911552|NCT01083875|Amlexanox|amlexanox|mesh-list
56418658|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
56418659|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418660|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
56418661|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418662|NCT00227955|Imipramine|imipramine|mesh-list
56418663|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56418664|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
56418665|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418666|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56418667|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56418668|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56418669|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418670|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
56418671|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418672|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418673|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
56418674|NCT00228033|Calcium|calcium|mesh-list
56418675|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56418676|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418677|NCT00228033|Antacids|antacids|mesh-ancestor
56418678|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418679|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56418680|NCT00230997|Galantamine|galantamine|mesh-list
56418681|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56418682|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418683|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418684|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
56418685|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418686|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418687|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56418688|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
56418689|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418690|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
56418691|NCT00204581|Aldesleukin|aldesleukin|mesh-list
56418692|NCT00204581|Interleukin-2|interleukin-2|mesh-list
56418693|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418694|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56418695|NCT00204581|Analgesics|analgesics|mesh-ancestor
56418696|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
56418697|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418698|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418699|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56418700|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56418701|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
56418702|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418703|NCT00231075|Paclitaxel|paclitaxel|mesh-list
56418704|NCT00231075|Carboplatin|carboplatin|mesh-list
56418705|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56418706|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418707|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
56418708|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
56418709|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
56418710|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418711|NCT00198146|Daclizumab|daclizumab|mesh-list
56418712|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418713|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
56418714|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418715|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56418716|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56418717|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
56418718|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418719|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418720|NCT02962518|Triamcinolone|triamcinolone|mesh-list
56418721|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418722|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
56418723|NCT02962518|Hormones|hormones|mesh-ancestor
56418724|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56418725|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418726|NCT00204659|Rituximab|rituximab|mesh-list
56418727|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56911553|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56911554|NCT01068977|Bevacizumab|bevacizumab|mesh-list
56911555|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56911556|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56911557|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911558|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56911559|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56911560|NCT01068977|Growth Substances|growth substances|mesh-ancestor
56911561|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911562|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
56911563|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
56911564|NCT02184910|Gastrins|gastrins|mesh-list
56418728|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418729|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
56418730|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418731|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418732|NCT00231192|Repaglinide|repaglinide|mesh-list
56418733|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56418734|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418735|NCT00204698|Rabeprazole|rabeprazole|mesh-list
56418736|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56418738|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56418740|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418741|NCT00204737|Prednisone|prednisone|mesh-list
56418742|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418743|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
56418744|NCT00204737|Hormones|hormones|mesh-ancestor
56418745|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56418746|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418747|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56418748|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418749|NCT00198380|Gefitinib|gefitinib|mesh-list
56418750|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418751|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56418752|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418753|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418754|NCT00228267|Propofol|propofol|mesh-list
56418755|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56418756|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418757|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418758|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56418759|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
56418760|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
56418761|NCT00231348|Nefazodone|nefazodone|mesh-list
56418762|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56418763|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56418764|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56418765|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418766|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418767|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418768|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56418769|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
56418770|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418771|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56418772|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56418773|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
56418774|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
56418775|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56418776|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418777|NCT00198536|Ecabet|ecabet|mesh-list
56418778|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418779|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56418780|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56911565|NCT02184910|Hormones|hormones|mesh-ancestor
56911566|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911567|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911568|NCT02185924|Parecoxib|parecoxib|mesh-list
56911570|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
56911571|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
56911572|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911573|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911574|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
56911575|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911576|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56911577|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56911578|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911579|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383890|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418781|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
56418783|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418784|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56418785|NCT00198536|Protective Agents|protective agents|mesh-ancestor
56418786|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418787|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418788|NCT00409994|Sirolimus|sirolimus|mesh-list
56418789|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56418790|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418791|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56418792|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418793|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
56418794|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418795|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
56418796|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418797|NCT00410033|Insulin|insulin|mesh-list
56418798|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56418799|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
56418800|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
56418801|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
56418802|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
56418803|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56418804|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418805|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56418806|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
56418807|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56418808|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56418809|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56418810|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56418813|NCT00198614|Carvedilol|carvedilol|mesh-list
56418814|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56418815|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56418816|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
56418817|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
56418818|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418819|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418820|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56418821|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56418822|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56418823|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
56418824|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418825|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418826|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
56418827|NCT00198614|Protective Agents|protective agents|mesh-ancestor
56911580|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911581|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911582|NCT02185924|Analgesics|analgesics|mesh-ancestor
56911583|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911584|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911585|NCT02185066|Metformin|metformin|mesh-list
56911586|NCT02185066|Atorvastatin|atorvastatin|mesh-list
56911587|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911588|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911589|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56911590|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56911591|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
56911592|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911593|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56911594|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56911595|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911596|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
56911597|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
56911598|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911599|NCT01069055|Acetaminophen|acetaminophen|mesh-list
56911600|NCT01069055|Lornoxicam|lornoxicam|mesh-list
56418828|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56418829|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56418830|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56418831|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
56418832|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56418833|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56418834|NCT00231582|Paclitaxel|paclitaxel|mesh-list
56418835|NCT00231582|Etoposide|etoposide|mesh-list
56418836|NCT00231582|Carboplatin|carboplatin|mesh-list
56418837|NCT00231582|Epirubicin|epirubicin|mesh-list
56418838|NCT00231582|Ifosfamide|ifosfamide|mesh-list
56418839|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56418840|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418841|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56418842|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56418843|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56418844|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418845|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56418846|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56418847|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418848|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56418849|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56418850|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
56418852|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56418853|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418854|NCT00228540|Modafinil|modafinil|mesh-list
56418855|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56418856|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418857|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56418858|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56418859|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56418860|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418861|NCT00231621|Topiramate|topiramate|mesh-list
56911601|NCT01069055|Piroxicam|piroxicam|mesh-list
56911602|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56418862|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
56418863|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56418864|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418865|NCT00474526|Vaccines|vaccines|mesh-list
56418866|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56418867|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
56418868|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418869|NCT00231660|Topiramate|topiramate|mesh-list
56418870|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
56418871|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56418872|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418873|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56418874|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56418875|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56418876|NCT00198848|Folic Acid|folic acid|mesh-list
56418877|NCT00198848|Hematinics|hematinics|mesh-ancestor
56418878|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
56418879|NCT00198848|Vitamins|vitamins|mesh-ancestor
56418880|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
56418881|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418882|NCT00478426|Sunitinib|sunitinib|mesh-list
56418883|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418884|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55768055|NCT05498025|Charcoal|charcoal|mesh-list
56418887|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418888|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
56418889|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56418890|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418891|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418892|NCT00231855|Docetaxel|docetaxel|mesh-list
56418893|NCT00231855|Topotecan|topotecan|mesh-list
56418894|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418895|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
56418896|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
56418897|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
56418898|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418899|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56418900|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56418901|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418902|NCT00199004|Cytarabine|cytarabine|mesh-list
56418903|NCT00199004|Dexamethasone|dexamethasone|mesh-list
56418904|NCT00199004|Prednisolone|prednisolone|mesh-list
56418905|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
56418906|NCT00199004|Rituximab|rituximab|mesh-list
56418907|NCT00199004|Methotrexate|methotrexate|mesh-list
56418908|NCT00199004|Vincristine|vincristine|mesh-list
56418909|NCT00199004|Doxorubicin|doxorubicin|mesh-list
56418910|NCT00199004|Daunorubicin|daunorubicin|mesh-list
56418911|NCT00199004|Asparaginase|asparaginase|mesh-list
56418912|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
56418913|NCT00199004|Thioguanine|thioguanine|mesh-list
56418914|NCT00199004|Vindesine|vindesine|mesh-list
56418915|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418916|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
56418917|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418918|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418919|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166643|NCT00003912|Carboplatin|carboplatin|mesh-list
56418920|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
56418921|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418922|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418923|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56418924|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56418925|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418926|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
56418927|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
56418928|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418929|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56418930|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
56418931|NCT00199004|Hormones|hormones|mesh-ancestor
56418932|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56418933|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56418934|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56418935|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
56418936|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56911603|NCT01069055|Analgesics|analgesics|mesh-ancestor
56384077|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56418937|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56418938|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
56418939|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
56418940|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418941|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56418942|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56418943|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
56418944|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418945|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56418946|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56418947|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56418948|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56418949|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56418950|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56418951|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56418952|NCT00228852|Fludarabine|fludarabine|mesh-list
56418953|NCT00228852|Busulfan|busulfan|mesh-list
56418954|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418955|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418956|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418957|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
56418958|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418960|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56418962|NCT00204776|Capecitabine|capecitabine|mesh-list
56418963|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
56418964|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56418965|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
56418966|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418967|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418968|NCT00228891|Insulin|insulin|mesh-list
56418969|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56418970|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56418971|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418972|NCT00477412|Cytarabine|cytarabine|mesh-list
56418973|NCT00477412|Dexamethasone|dexamethasone|mesh-list
56418974|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
56418975|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
56418976|NCT00477412|Rituximab|rituximab|mesh-list
56418977|NCT00477412|Doxorubicin|doxorubicin|mesh-list
56418978|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56418979|NCT00477412|Methotrexate|methotrexate|mesh-list
56418980|NCT00477412|Vincristine|vincristine|mesh-list
56418981|NCT00477412|Bortezomib|bortezomib|mesh-list
56418982|NCT00477412|Daunorubicin|daunorubicin|mesh-list
56418983|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56418984|NCT00477412|Antibodies|antibodies|mesh-list
56418985|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
56418986|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56418987|NCT00477412|BB 1101|bb 1101|mesh-list
56418988|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418989|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
56418990|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418991|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418992|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56418993|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
56418994|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418995|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56418996|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56418997|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418998|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
56418999|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
56419000|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419001|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419002|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
56419003|NCT00477412|Hormones|hormones|mesh-ancestor
56419004|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419005|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419006|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56164249|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
56419007|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56419008|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56419009|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419010|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56419011|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
56911604|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
56911605|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911606|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911607|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
56911608|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911609|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911610|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911611|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56384149|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
56419012|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56419013|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56419014|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
56419015|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
56419016|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56419017|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56419018|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
56419019|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419020|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56419021|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
56419022|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
56419023|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
56419024|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
56419025|NCT00410774|Gemcitabine|gemcitabine|mesh-list
56419026|NCT00410774|Bevacizumab|bevacizumab|mesh-list
56419027|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56419028|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419029|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56419030|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56419031|NCT00410774|Growth Substances|growth substances|mesh-ancestor
56419032|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419033|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
56419035|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
56419036|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419037|NCT00410774|Antiviral Agents|antiviral agents|mesh-ancestor
56419038|NCT00410774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419039|NCT00410774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419040|NCT00410774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419041|NCT00410774|Immunologic Factors|immunologic factors|mesh-ancestor
56419042|NCT00228930|Tamoxifen|tamoxifen|mesh-list
56419043|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56419044|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
56419045|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419046|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419047|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419048|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419049|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56419050|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56419051|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56419052|NCT00410852|Insulin|insulin|mesh-list
56419053|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56419054|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56419055|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419056|NCT01086982|Octreotide|octreotide|mesh-list
56419057|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419058|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419059|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419060|NCT00204893|Calcium|calcium|mesh-list
56419061|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56419062|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419063|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
56419064|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56419065|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56419066|NCT00232011|Analgesics|analgesics|mesh-ancestor
56419067|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
56419068|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911612|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911613|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911614|NCT01083953|Sevoflurane|sevoflurane|mesh-list
56911615|NCT01083953|Desflurane|desflurane|mesh-list
56911616|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56911617|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56911618|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
56911619|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
56911620|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911621|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911622|NCT02190526|Mesalamine|mesalamine|mesh-list
56911623|NCT02190526|Amitriptyline|amitriptyline|mesh-list
56911624|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911625|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911626|NCT02190526|Analgesics|analgesics|mesh-ancestor
56911627|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
56911628|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911629|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911630|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911631|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911632|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56911633|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419069|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419070|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56419071|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56419072|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
56419073|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419074|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
56419075|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56419076|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419077|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419078|NCT00232050|Omalizumab|omalizumab|mesh-list
56419079|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56419080|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56419081|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56419082|NCT00232089|Tegaserod|tegaserod|mesh-list
56419083|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56419084|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
56419085|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419086|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419087|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419088|NCT00205166|Caffeine|caffeine|mesh-list
56419089|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56419090|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419091|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56419092|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419093|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419094|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56419095|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56419096|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
56419097|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419098|NCT00229125|Gabapentin|gabapentin|mesh-list
56419099|NCT00229125|Lorazepam|lorazepam|mesh-list
56911634|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56911635|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56911636|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56911637|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56911638|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911639|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56384272|NCT00139269|Docetaxel|docetaxel|mesh-list
56419100|NCT00229125|Analgesics|analgesics|mesh-ancestor
56419101|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
56419102|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419103|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419104|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
56419105|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56419106|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419108|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419109|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56419110|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56419111|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419112|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419113|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
56419114|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
56419115|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
56419116|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419117|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56419118|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
56419119|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
56419120|NCT00205283|Nelfinavir|nelfinavir|mesh-list
56419121|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56419122|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56419123|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
56419124|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419125|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419126|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56419127|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56419128|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
56419129|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419130|NCT00232167|Indiplon|indiplon|mesh-list
56419131|NCT00232167|Sertraline|sertraline|mesh-list
56419132|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419133|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419134|NCT00232167|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56419135|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56419136|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419137|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419138|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419139|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
56419140|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419141|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56419142|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419143|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
56419144|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
56419145|NCT00205322|Leucovorin|leucovorin|mesh-list
56419146|NCT00205322|Capecitabine|capecitabine|mesh-list
56419147|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
56419148|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56419149|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
56419150|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419151|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419152|NCT00205322|Antidotes|antidotes|mesh-ancestor
56419153|NCT00205322|Protective Agents|protective agents|mesh-ancestor
56419154|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419155|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
56419156|NCT00205322|Vitamins|vitamins|mesh-ancestor
56419157|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
56419158|NCT00232206|Docetaxel|docetaxel|mesh-list
56419159|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419160|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56419161|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56419162|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56911640|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911641|NCT01084031|Propofol|propofol|mesh-list
56419163|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419164|NCT00229242|Diuretics|diuretics|mesh-list
56419165|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
56419166|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419167|NCT00232284|Sertraline|sertraline|mesh-list
56419168|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419169|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419170|NCT00232284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56419171|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56419172|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419173|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419174|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419175|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
56419176|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419177|NCT00205634|Clarithromycin|clarithromycin|mesh-list
56419178|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56419179|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419180|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56419181|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419182|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419183|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56419184|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56419186|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
56419187|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56419188|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419189|NCT00205751|Thalidomide|thalidomide|mesh-list
56419190|NCT00205751|Dexamethasone|dexamethasone|mesh-list
56419191|NCT00205751|Prednisone|prednisone|mesh-list
56419192|NCT00205751|Melphalan|melphalan|mesh-list
56419193|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56419194|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
56419195|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
56419196|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419197|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419198|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419199|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
56419200|NCT00205751|Hormones|hormones|mesh-ancestor
56419201|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419202|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419203|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419204|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56419205|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
56419206|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419207|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56419208|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419209|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
56419210|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
56419211|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56419212|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419213|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56419214|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56419215|NCT00205751|Growth Substances|growth substances|mesh-ancestor
56419216|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
56419217|NCT00229476|Sertraline|sertraline|mesh-list
56419218|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419219|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419220|NCT00229476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56419221|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56419222|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419223|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419224|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419225|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
56419226|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419227|NCT00205946|Bupropion|bupropion|mesh-list
56419228|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56419229|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419230|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419231|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56419232|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56419233|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56911642|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56911643|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419234|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419235|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
56419236|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419237|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419238|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56419239|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56419240|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419241|NCT00229515|Sirolimus|sirolimus|mesh-list
56419242|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
56419243|NCT00229515|Tirofiban|tirofiban|mesh-list
56419244|NCT00229515|Abciximab|abciximab|mesh-list
56419245|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56419246|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419247|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56419248|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419249|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
56419250|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419251|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
56419252|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419253|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
56419254|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56419255|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56419264|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56419265|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419266|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56419267|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419268|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419269|NCT00206063|Ximelagatran|ximelagatran|mesh-list
56419270|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
56419271|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56419272|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
56419273|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419274|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419275|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
56419276|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56419277|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419278|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419279|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56419280|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56164275|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56419281|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419282|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419283|NCT00229593|ST 1435|st 1435|mesh-list
56419284|NCT00229593|Testosterone|testosterone|mesh-list
56419285|NCT00229593|Androgens|androgens|mesh-ancestor
56419286|NCT00229593|Hormones|hormones|mesh-ancestor
56419287|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419288|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419289|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56419290|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
56419291|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56419292|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56419293|NCT00229632|Idebenone|idebenone|mesh-list
56419294|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
56419295|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419296|NCT00229632|Protective Agents|protective agents|mesh-ancestor
56167029|NCT00004206|Leucovorin|leucovorin|mesh-list
56419297|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419298|NCT00206180|Esomeprazole|esomeprazole|mesh-list
56419299|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56419300|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419301|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56419302|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419303|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419304|NCT00206219|Methotrexate|methotrexate|mesh-list
56419305|NCT00206219|Gefitinib|gefitinib|mesh-list
56419306|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56419307|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
56419308|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56419309|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419310|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56911644|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911645|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56911646|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
56911647|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
56911648|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
56419311|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
56419312|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419313|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419314|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
56419315|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419316|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56419317|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419318|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
56419319|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56419320|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56419323|NCT00206258|Glucagon|glucagon|mesh-list
56419324|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419325|NCT00206258|Hormones|hormones|mesh-ancestor
56419326|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419327|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419328|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56419329|NCT00206297|Pramlintide|pramlintide|mesh-list
56419330|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56419331|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419332|NCT00411047|Gefitinib|gefitinib|mesh-list
56419333|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419334|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56419335|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419336|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419337|NCT00411125|Calcitonin|calcitonin|mesh-list
56419338|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
56419339|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56419340|NCT00411125|Katacalcin|katacalcin|mesh-list
56419341|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56419342|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419343|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56419344|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
56419345|NCT00411164|Hydromorphone|hydromorphone|mesh-list
56419346|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56419347|NCT00411164|Narcotics|narcotics|mesh-ancestor
56419348|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419349|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419350|NCT00411164|Analgesics|analgesics|mesh-ancestor
56419351|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
56419352|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419353|NCT00411203|Tamoxifen|tamoxifen|mesh-list
56419354|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56419355|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
56419356|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419357|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419358|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419359|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419360|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56419361|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56419362|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56419363|NCT00411281|Cytarabine|cytarabine|mesh-list
56419364|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56419365|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
56419366|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419367|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419368|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
56419369|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419370|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419371|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
56419372|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419373|NCT00206414|Gefitinib|gefitinib|mesh-list
56419374|NCT00206414|Fulvestrant|fulvestrant|mesh-list
56419375|NCT00206414|Anastrozole|anastrozole|mesh-list
56419376|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419377|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56911649|NCT02185222|Vitamin D|vitamin d|mesh-list
56911650|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56911651|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911652|NCT02185222|Vitamins|vitamins|mesh-ancestor
56911653|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
56911654|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56911655|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56911656|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
56911657|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56911658|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56911659|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384562|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419378|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419379|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419380|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419381|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56419382|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56419383|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
56419384|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419385|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419386|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56419387|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56419388|NCT00232674|Budesonide|budesonide|mesh-list
56419389|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56419390|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56419391|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
56419392|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768551|NCT04016805|Venetoclax|venetoclax|mesh-list
56419395|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
56419396|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
56419397|NCT00232674|Hormones|hormones|mesh-ancestor
56419398|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419399|NCT00206453|Docetaxel|docetaxel|mesh-list
56419400|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419401|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
56419402|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
56419403|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
56419404|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419405|NCT00206492|Tamoxifen|tamoxifen|mesh-list
56419406|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56419407|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
56419408|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419409|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419410|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419411|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419412|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56419413|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56419414|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56419415|NCT00206570|Estradiol|estradiol|mesh-list
56419416|NCT00206570|Estrogens|estrogens|mesh-ancestor
56419417|NCT00206570|Hormones|hormones|mesh-ancestor
56419418|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419419|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419420|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
56419421|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56419422|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
56419423|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419424|NCT01056159|Albuterol|albuterol|mesh-list
56419425|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56419426|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
56419427|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419428|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911660|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911661|NCT01084187|Urological Agents|urological agents|mesh-ancestor
56911662|NCT02185300|Dolutegravir|dolutegravir|mesh-list
56911663|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56911664|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56911665|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911666|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911667|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56911668|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56911669|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
56911670|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911671|NCT02190760|Dexamethasone|dexamethasone|mesh-list
56911672|NCT02190760|Bupivacaine|bupivacaine|mesh-list
56911673|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911674|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
56911675|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
56419429|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56419430|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
56419431|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
56419432|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56419433|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56419434|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56419435|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56419436|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
56419437|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419438|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419439|NCT00206765|Risperidone|risperidone|mesh-list
56419440|NCT00206765|Paroxetine|paroxetine|mesh-list
56419441|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56419442|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
56419443|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419444|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419445|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419446|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56419447|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419448|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419449|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419450|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56419451|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
56419452|NCT00206765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56419453|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56419454|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419455|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56419456|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419457|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56419458|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56419459|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419460|NCT00424710|Ranibizumab|ranibizumab|mesh-list
56419461|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56419462|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56419463|NCT00424710|Growth Substances|growth substances|mesh-ancestor
56419465|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
56419466|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419467|NCT00206960|Risperidone|risperidone|mesh-list
56419468|NCT00206960|Clopenthixol|clopenthixol|mesh-list
56419469|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56419470|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
56419471|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419472|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911676|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911677|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911678|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56911679|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
56911680|NCT02190760|Hormones|hormones|mesh-ancestor
56911681|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911682|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56911683|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911684|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
56911685|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
56384686|NCT03095274|Tremelimumab|tremelimumab|mesh-list
56419473|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419474|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56419475|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419476|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419477|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419478|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56419479|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
56419480|NCT00206999|Imipramine|imipramine|mesh-list
56419481|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56419482|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419483|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419484|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56419485|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56419486|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419487|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419488|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
56419489|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419490|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419491|NCT00229944|Azithromycin|azithromycin|mesh-list
56419492|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56419493|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419494|NCT00207077|Cetuximab|cetuximab|mesh-list
56419495|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56419496|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56419497|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419498|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56419499|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419500|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419501|NCT00207116|Cetuximab|cetuximab|mesh-list
56419502|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56419503|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419504|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
56419505|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56419506|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56419507|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419508|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56419509|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56419510|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
56419511|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419512|NCT00207155|Cetuximab|cetuximab|mesh-list
56419513|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56419514|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419515|NCT00232947|Vaccines|vaccines|mesh-list
56419516|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
56419517|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419518|NCT00413712|Adenosine|adenosine|mesh-list
56419519|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
56419520|NCT00413712|Calcium|calcium|mesh-list
56419521|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56419522|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419523|NCT00413712|Analgesics|analgesics|mesh-ancestor
56419524|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
56419525|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911686|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911687|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
56911688|NCT02190838|Metformin|metformin|mesh-list
56419526|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56419527|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
56419528|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56419529|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
56419530|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
56419531|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419532|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419533|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419534|NCT00230217|Rasburicase|rasburicase|mesh-list
56419535|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
56419536|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56419537|NCT00207311|Interferons|interferons|mesh-list
56419540|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56419541|NCT00207311|Orlistat|orlistat|mesh-list
56419542|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419543|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
56419544|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419545|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
56419546|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419547|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419548|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419549|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56419550|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56419551|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56419552|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56419553|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56419554|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419555|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419556|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419557|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419558|NCT00233025|Analgesics|analgesics|mesh-ancestor
56419559|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
56419560|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419561|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419562|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419563|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
56419564|NCT00207428|Carbamazepine|carbamazepine|mesh-list
56419565|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
56419566|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
56419567|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419568|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419569|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419570|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419571|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56419572|NCT00207428|Analgesics|analgesics|mesh-ancestor
56419573|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
56419574|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419575|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56419576|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419577|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419578|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56419579|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56419580|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
56419581|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419582|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56419583|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419584|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419585|NCT00207584|Doxycycline|doxycycline|mesh-list
56419586|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56419587|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419588|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
56419589|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56419590|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56419591|NCT00207662|Infliximab|infliximab|mesh-list
56419592|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56419593|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419594|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56419596|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56419597|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56911689|NCT02190838|Dacarbazine|dacarbazine|mesh-list
56911690|NCT02190838|Melatonin|melatonin|mesh-list
56911691|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911692|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911693|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
56911694|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911695|NCT02190838|Protective Agents|protective agents|mesh-ancestor
56911696|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911697|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56911698|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
56911699|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911700|NCT02185456|Metronidazole|metronidazole|mesh-list
56911701|NCT02185456|Miconazole|miconazole|mesh-list
56911702|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384825|NCT00140517|Renal Agents|renal agents|mesh-ancestor
56419598|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56419599|NCT00207779|Heparin|heparin|mesh-list
56419600|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
56419601|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56419602|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56419603|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419604|NCT00230373|Imiquimod|imiquimod|mesh-list
56419605|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56419606|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
56419607|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419608|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419609|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
56419610|NCT00230451|Paclitaxel|paclitaxel|mesh-list
56419611|NCT00230451|Fluorouracil|fluorouracil|mesh-list
55768773|NCT03426891|Temozolomide|temozolomide|mesh-list
56419615|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
56419616|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
56419617|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419618|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
56419619|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56419620|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419621|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
56419622|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419623|NCT00411320|Dexamethasone|dexamethasone|mesh-list
56419624|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56419625|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
56419626|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
56419627|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419628|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419629|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419630|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
56419631|NCT00411320|Hormones|hormones|mesh-ancestor
56419632|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419633|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419634|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419635|NCT00233337|Artemether|artemether|mesh-list
56419636|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56419637|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
56419638|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56419639|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56419640|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419641|NCT00230490|Adefovir|adefovir|mesh-list
56419642|NCT00230490|Pradefovir|pradefovir|mesh-list
56419643|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
56419644|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419645|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56419646|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56419647|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911703|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56911704|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56384903|NCT02333370|Tamoxifen|tamoxifen|mesh-list
56419648|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419649|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56419650|NCT01089556|Pregabalin|pregabalin|mesh-list
56419651|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56419652|NCT01089556|Analgesics|analgesics|mesh-ancestor
56419653|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
56419654|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419655|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419656|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
56419657|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56419658|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419659|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419660|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56419661|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56419662|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419663|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419664|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419665|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56419666|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56419667|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167397|NCT00004686|Prednisone|prednisone|mesh-list
56419668|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419670|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56419671|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56419672|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419673|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
56419674|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
56419675|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56419676|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419677|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56419678|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56419679|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
56419680|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419681|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419682|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56419690|NCT00424580|Montelukast|montelukast|mesh-list
56419691|NCT00424580|Desloratadine|desloratadine|mesh-list
56419692|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56419693|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
56419694|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56419695|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
56419696|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419697|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419698|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56419699|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56419700|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419701|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56419702|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
56419703|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419704|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56419705|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56419706|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
56419707|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
56419709|NCT00233532|Trandolapril|trandolapril|mesh-list
56419710|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56419711|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56419712|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419713|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419714|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56419715|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419716|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
56419717|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56419718|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
56419719|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419720|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56419721|NCT00233571|Adalimumab|adalimumab|mesh-list
56419722|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911705|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56911706|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
56911707|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56384958|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56419723|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56419724|NCT00237198|Letrozole|letrozole|mesh-list
56419725|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419726|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56419727|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56419728|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419729|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419730|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56419731|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
56419732|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419733|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419734|NCT00233610|Tamoxifen|tamoxifen|mesh-list
56419735|NCT00233610|Bicalutamide|bicalutamide|mesh-list
56419736|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56419737|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
56419738|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419739|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419740|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419741|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419742|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56419743|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56419744|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56419745|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
56419746|NCT00208130|Topiramate|topiramate|mesh-list
56419748|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56419749|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419750|NCT00237237|Vildagliptin|vildagliptin|mesh-list
56419751|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56419752|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419753|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56419754|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
56419755|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419756|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419757|NCT00208169|Aripiprazole|aripiprazole|mesh-list
56419758|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419759|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419760|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56419761|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419762|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419763|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419764|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
56419765|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
56419766|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419767|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419768|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56419769|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56419770|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
56419771|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56419772|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56419773|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56419774|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56419775|NCT01087723|Heparin|heparin|mesh-list
56419776|NCT01087723|Bivalirudin|bivalirudin|mesh-list
56419777|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
56419778|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56419779|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56419780|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419781|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
56419782|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56419783|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
56419784|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419785|NCT00208208|Ziprasidone|ziprasidone|mesh-list
56419786|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56419788|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419789|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911708|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56911709|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911710|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419790|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419791|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56419792|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419793|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419794|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419795|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56419796|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
56419797|NCT01085812|Milnacipran|milnacipran|mesh-list
56419798|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
56419799|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56419800|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56419801|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419802|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419803|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419804|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419805|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419806|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419807|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56419808|NCT01085812|Analgesics|analgesics|mesh-ancestor
56419809|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
56419810|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419811|NCT01085734|Bevacizumab|bevacizumab|mesh-list
56419812|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56419813|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419814|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56419815|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56419816|NCT01085734|Growth Substances|growth substances|mesh-ancestor
56419817|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419818|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
56419819|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56419820|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
56419822|NCT00208403|Protective Agents|protective agents|mesh-ancestor
56419823|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419824|NCT01084603|Nicotine|nicotine|mesh-list
56419825|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56419826|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
56419827|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419828|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419829|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56419830|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56419831|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
56419832|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419833|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419834|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
56419835|NCT00208442|Diuretics|diuretics|mesh-ancestor
56419836|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
56419837|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419838|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56419839|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419840|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419841|NCT00233766|Sirolimus|sirolimus|mesh-list
56419842|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56419843|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419844|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56419845|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419846|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
56419847|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419848|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
56419849|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419850|NCT00208520|Lamotrigine|lamotrigine|mesh-list
56419851|NCT00208520|Carbamazepine|carbamazepine|mesh-list
56419852|NCT00208520|Levetiracetam|levetiracetam|mesh-list
56419853|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
56419854|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
56419855|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56419856|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56419857|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911711|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56911712|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
56911713|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385101|NCT00133172|Prednisone|prednisone|mesh-list
56419858|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55920481|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56419859|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419860|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56419861|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419862|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419863|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419864|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56419865|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
56419866|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56419867|NCT00208520|Analgesics|analgesics|mesh-ancestor
56419868|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
56419869|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419870|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56419871|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56419872|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56419873|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
56419874|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419875|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56419876|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419877|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419878|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419879|NCT00208559|Ziprasidone|ziprasidone|mesh-list
56419880|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56419881|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
56419882|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419883|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419884|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419885|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56419886|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56419887|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419888|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56419889|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56419890|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
56419891|NCT00233805|Sirolimus|sirolimus|mesh-list
56419892|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56419893|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419896|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
56419897|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419898|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
56419899|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419900|NCT01084135|Rivastigmine|rivastigmine|mesh-list
56419901|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56419902|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419903|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419904|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
56419905|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419906|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419907|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56419908|NCT01084135|Protective Agents|protective agents|mesh-ancestor
56419909|NCT01083316|Dexamethasone|dexamethasone|mesh-list
56419910|NCT01083316|Bortezomib|bortezomib|mesh-list
56419911|NCT01083316|Melphalan|melphalan|mesh-list
56419912|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56419913|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
56419914|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
56419915|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56419916|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419917|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419918|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
56419919|NCT01083316|Hormones|hormones|mesh-ancestor
56419920|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56419921|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419922|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419923|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56419924|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
55888160|NCT04630834|Analgesics|analgesics|mesh-ancestor
56911714|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911715|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56911716|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56911717|NCT02190994|Prednisone|prednisone|mesh-list
56911719|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911720|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
56911721|NCT02190994|Hormones|hormones|mesh-ancestor
56911722|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911723|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911724|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56911725|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911726|NCT02193568|Anesthetics|anesthetics|mesh-list
56385178|NCT00403910|Canrenone|canrenone|mesh-list
56419925|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419926|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56419927|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56419928|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
56419929|NCT00208715|Modafinil|modafinil|mesh-list
56419930|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56419931|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419932|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56419933|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56419934|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56419935|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419936|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
56419937|NCT00208793|Vitamin D|vitamin d|mesh-list
56419938|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
56419939|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
56419940|NCT00208793|Vitamins|vitamins|mesh-list
56419941|NCT00208793|Calcium|calcium|mesh-list
56419942|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
56419943|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419944|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56419945|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56419946|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
56419947|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56419948|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56419949|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419950|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56419951|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56419952|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
56419953|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56419954|NCT01081873|Leuprolide|leuprolide|mesh-list
56419955|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56419956|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
56419957|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56419958|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419959|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56419960|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419961|NCT00237471|Insulin|insulin|mesh-list
56419962|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56419963|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419964|NCT00237510|Terazosin|terazosin|mesh-list
56419965|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56419966|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56419968|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
56419969|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419970|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419971|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419972|NCT00237510|Urological Agents|urological agents|mesh-ancestor
56419973|NCT01081795|Topiramate|topiramate|mesh-list
56911727|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911728|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911729|NCT02191072|Omalizumab|omalizumab|mesh-list
56911730|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56911731|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56911732|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
56911733|NCT02191228|Linagliptin|linagliptin|mesh-list
56911734|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911735|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911736|NCT02191228|Incretins|incretins|mesh-ancestor
56911737|NCT02191228|Hormones|hormones|mesh-ancestor
56911738|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911739|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56911740|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
56911741|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419974|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
56419975|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56419976|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419977|NCT00233961|Lenograstim|lenograstim|mesh-list
56419978|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56419979|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
56419980|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419981|NCT00234000|Azacitidine|azacitidine|mesh-list
56419982|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
56419983|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56419984|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
56419985|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419986|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419987|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419988|NCT00234117|Rabeprazole|rabeprazole|mesh-list
56419989|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56419990|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56419991|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56419992|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56419993|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419994|NCT00209144|Insulin|insulin|mesh-list
56419995|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56419996|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419997|NCT00209222|Cytarabine|cytarabine|mesh-list
56419998|NCT00209222|Dexamethasone|dexamethasone|mesh-list
56419999|NCT00209222|Prednisone|prednisone|mesh-list
56420000|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
56420001|NCT00209222|Melphalan|melphalan|mesh-list
56420002|NCT00209222|Rituximab|rituximab|mesh-list
56420003|NCT00209222|Doxorubicin|doxorubicin|mesh-list
56420004|NCT00209222|Etoposide|etoposide|mesh-list
56420005|NCT00209222|Vincristine|vincristine|mesh-list
56420006|NCT00209222|Cisplatin|cisplatin|mesh-list
56420007|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420008|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
56420009|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420010|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56420011|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56420012|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
56420013|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420014|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420015|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56420016|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56420017|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56420018|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
56420019|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
56420020|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385308|NCT00144846|Albuterol|albuterol|mesh-list
56420021|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56420022|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
56420023|NCT00209222|Hormones|hormones|mesh-ancestor
56420024|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56420025|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56420026|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56420027|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56420028|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56420029|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420030|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56420031|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
56420032|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
56420033|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
56420034|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56420035|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
56420036|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
56420037|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420038|NCT00234195|Bupropion|bupropion|mesh-list
56420039|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56420040|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
56420041|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420042|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56420044|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420045|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420047|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420048|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420049|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56420050|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56420051|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420052|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56420053|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
56420054|NCT00209261|Coagulants|coagulants|mesh-ancestor
56420055|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56420056|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
56420057|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420058|NCT00209300|Mesalamine|mesalamine|mesh-list
56420059|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56420060|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56420061|NCT00209300|Analgesics|analgesics|mesh-ancestor
56420062|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
56420063|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420064|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420065|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56420066|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56420067|NCT00234234|Adalimumab|adalimumab|mesh-list
56420068|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56420069|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56420070|NCT00237588|Losartan|losartan|mesh-list
56420071|NCT00237588|Amlodipine|amlodipine|mesh-list
56420072|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56420073|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56420074|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420075|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420076|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56420077|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420078|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
56420079|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56420080|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56420081|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56164285|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
56420082|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56420083|NCT00411437|Oxybutynin|oxybutynin|mesh-list
56420084|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56420085|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56420086|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
56420087|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420088|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420089|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420090|NCT00411437|Urological Agents|urological agents|mesh-ancestor
56420091|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
56420092|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
56420093|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420094|NCT00234312|Citalopram|citalopram|mesh-list
56911742|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420095|NCT00234312|Sertraline|sertraline|mesh-list
56420096|NCT00234312|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56420097|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56420098|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420099|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420100|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420101|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
56420102|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420103|NCT00234312|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56420104|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
56420105|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420106|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
56420107|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56420108|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420109|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56420110|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
56420111|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56420112|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420113|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420114|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420116|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56420117|NCT00237627|Bortezomib|bortezomib|mesh-list
56420118|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56420119|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420120|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56420121|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56420122|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420123|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420124|NCT00209495|Dexamethasone|dexamethasone|mesh-list
56420125|NCT00209495|Pregabalin|pregabalin|mesh-list
56420126|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56420127|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
56420128|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
56420129|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420130|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420131|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56420132|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
56420133|NCT00209495|Hormones|hormones|mesh-ancestor
56420134|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56420135|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56420136|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420137|NCT00209495|Analgesics|analgesics|mesh-ancestor
56420138|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
56420139|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
56420140|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56420141|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420142|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420143|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56420144|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56420145|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56420146|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420147|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420148|NCT00234390|Budesonide|budesonide|mesh-list
56420149|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56420150|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56420151|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
56420152|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420153|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420154|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56420155|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
56420157|NCT00234390|Hormones|hormones|mesh-ancestor
56420158|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56420159|NCT00209534|Fospropofol|fospropofol|mesh-list
56420160|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56420161|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420162|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420163|NCT00209573|Fospropofol|fospropofol|mesh-list
56420164|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56420165|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420166|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911743|NCT02186782|Citric Acid|citric acid|mesh-list
56911744|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
56911745|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56911746|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56911747|NCT02186782|Clomiphene|clomiphene|mesh-list
56911748|NCT02186782|Enclomiphene|enclomiphene|mesh-list
56911749|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
56911750|NCT02186782|Estradiol|estradiol|mesh-list
56911751|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56911752|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
56911753|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56911754|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
56911755|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
56911756|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911757|NCT02186782|Estrogens|estrogens|mesh-ancestor
56911758|NCT02186782|Hormones|hormones|mesh-ancestor
56911759|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911760|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911761|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56911762|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
56911763|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56911764|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56911765|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56911766|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
56420167|NCT00209612|Paclitaxel|paclitaxel|mesh-list
56420168|NCT00209612|Irinotecan|irinotecan|mesh-list
56420169|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56420170|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420171|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
56420172|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56420173|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56420174|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420175|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56420176|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56420177|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420178|NCT01081249|Oxytocin|oxytocin|mesh-list
56420179|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
56420180|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56420181|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420182|NCT00234429|Gefitinib|gefitinib|mesh-list
56420183|NCT00234429|Raltitrexed|raltitrexed|mesh-list
56420184|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420185|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56420186|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420187|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167939|NCT00005814|Cetuximab|cetuximab|mesh-list
56420192|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56420193|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56420194|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420195|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420196|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420197|NCT02961855|Diclofenac|diclofenac|mesh-list
56420198|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56420199|NCT02961855|Lidocaine|lidocaine|mesh-list
56911767|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56911768|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
56911769|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56911770|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56911771|NCT02187250|Metformin|metformin|mesh-list
56911772|NCT02187250|Liraglutide|liraglutide|mesh-list
56911773|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911774|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911775|NCT02187250|Incretins|incretins|mesh-ancestor
56911776|NCT02187250|Hormones|hormones|mesh-ancestor
56911777|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56420200|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
56420201|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
56420202|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420203|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420204|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
56420205|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420206|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56420207|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56420208|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56420209|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420210|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420211|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56420212|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56420213|NCT02961855|Analgesics|analgesics|mesh-ancestor
56420214|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56420215|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56420216|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420217|NCT00209690|Cisplatin|cisplatin|mesh-list
56420218|NCT00209690|Docetaxel|docetaxel|mesh-list
56420219|NCT00209690|Fluorouracil|fluorouracil|mesh-list
56420220|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420221|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56420222|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56420223|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56420224|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420225|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
56420226|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56420227|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420228|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
56420229|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420231|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56420232|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56420233|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56420234|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56420235|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
56420236|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420237|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420238|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420239|NCT00234468|Gefitinib|gefitinib|mesh-list
56420240|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420241|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56420242|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420243|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420244|NCT01080625|Phenylephrine|phenylephrine|mesh-list
56420245|NCT01080625|Epinephrine|epinephrine|mesh-list
56420246|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
56420247|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56420248|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56420249|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
56420250|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420251|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420252|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911778|NCT03535480|Lenograstim|lenograstim|mesh-list
56911779|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56911780|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
56911781|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911782|NCT02187484|Telmisartan|telmisartan|mesh-list
56911783|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56911784|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56911785|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56911786|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911787|NCT02256748|Midazolam|midazolam|mesh-list
56911788|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56911789|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56911790|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911791|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911792|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56911793|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56911794|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56911795|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56911796|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
56911797|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
56911798|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
56911799|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
56911800|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911801|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911802|NCT02187562|Aspirin|aspirin|mesh-list
56420253|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56420254|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56420255|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
56420256|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420257|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56420258|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
56420259|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
56420261|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56420262|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56420263|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
56420264|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56420265|NCT01080625|Protective Agents|protective agents|mesh-ancestor
56420267|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420268|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
56420269|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
56420270|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
56420271|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420272|NCT00414180|Bupropion|bupropion|mesh-list
56420273|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56420274|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
56420275|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420276|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56420277|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56420278|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888161|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
56911803|NCT02187562|Meloxicam|meloxicam|mesh-list
56911804|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911805|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911806|NCT02187562|Analgesics|analgesics|mesh-ancestor
56911807|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
56911808|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911809|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911810|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911811|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911812|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56911813|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56911814|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911815|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56911816|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56911817|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420279|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420280|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
56420281|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420282|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420283|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56420284|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56420285|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420286|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56420287|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56420288|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420289|NCT01089790|Incretins|incretins|mesh-ancestor
56420290|NCT01089790|Hormones|hormones|mesh-ancestor
56420291|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56420292|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56420293|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
56420294|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420295|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420296|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
56420297|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56420298|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56420299|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56420300|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420301|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420302|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
56420303|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420304|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420305|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56420306|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420307|NCT01084330|Docetaxel|docetaxel|mesh-list
56420308|NCT01084330|Irinotecan|irinotecan|mesh-list
56420309|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420310|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
56420311|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
56420312|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
56420313|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420314|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56420315|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56420316|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420317|NCT00209807|Citalopram|citalopram|mesh-list
56420318|NCT00209807|Reboxetine|reboxetine|mesh-list
56420319|NCT00209807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56420320|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56420321|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56911818|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
56911819|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56911820|NCT02187718|Anesthetics|anesthetics|mesh-list
56911821|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911822|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911823|NCT03535168|Midazolam|midazolam|mesh-list
56420322|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420323|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420324|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
56420325|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420326|NCT00209807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56420327|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
56420328|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420329|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56420330|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
56420331|NCT00209846|Gaboxadol|gaboxadol|mesh-list
56420333|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
56420334|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420335|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420336|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
56420337|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
56420338|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
56420339|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420340|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420341|NCT01082068|Letrozole|letrozole|mesh-list
56420342|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420343|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56420344|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56420345|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420346|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420347|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56420348|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
56420349|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56420350|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420351|NCT01086748|Risperidone|risperidone|mesh-list
56420352|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56420353|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
56420354|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420355|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420356|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420357|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56420358|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56420359|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420360|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420361|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56420362|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
56420363|NCT00237705|Metoclopramide|metoclopramide|mesh-list
56420364|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
56420365|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
56420366|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420367|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420368|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56420369|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56420370|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56420371|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
56420372|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420373|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420374|NCT00209885|Lidocaine|lidocaine|mesh-list
56420375|NCT00209885|Droperidol|droperidol|mesh-list
56420376|NCT00209885|Ketamine|ketamine|mesh-list
56420377|NCT00209885|Gabapentin|gabapentin|mesh-list
56420378|NCT00209885|Esketamine|esketamine|mesh-list
56420379|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
56420380|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
56420381|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420382|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420383|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
56420384|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420385|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56090660|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56911824|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56911825|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56911826|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56911827|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911828|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56911829|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56911830|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56911831|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56911832|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
56911833|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
56911834|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
56911835|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
56911836|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911837|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911838|NCT02192320|Dexamethasone|dexamethasone|mesh-list
56911839|NCT02192320|Atorvastatin|atorvastatin|mesh-list
56911840|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911841|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
56911842|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
56911843|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911844|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420386|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56420387|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56420388|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420389|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420390|NCT00209885|Analgesics|analgesics|mesh-ancestor
56420391|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56420392|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56420393|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
56420394|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56420395|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56420396|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420397|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
56420398|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56420399|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56420400|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420401|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
56420402|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
56420403|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56420404|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
56420405|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
56420406|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56420411|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
56420412|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56420413|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56420414|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56420415|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420416|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420417|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
56420418|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420419|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420420|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56420421|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420423|NCT00209924|Analgesics|analgesics|mesh-ancestor
56420424|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
56911845|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56911846|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
56911847|NCT02192320|Hormones|hormones|mesh-ancestor
56911848|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911849|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56911850|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911851|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56911852|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56911853|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
56911854|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911855|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56385796|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
56420425|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420426|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420427|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
56420428|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
56420429|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
56420430|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420431|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420432|NCT00209963|Gaboxadol|gaboxadol|mesh-list
56420433|NCT00209963|Analgesics|analgesics|mesh-ancestor
56420434|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
56420435|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420436|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420437|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
56420438|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
56420439|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
56420440|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420441|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420442|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
56420443|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56420444|NCT00210002|Hematinics|hematinics|mesh-ancestor
56420445|NCT02277886|Esomeprazole|esomeprazole|mesh-list
56420446|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56420447|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56420448|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56420449|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420450|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420451|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56420452|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56420453|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56420454|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56420455|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56420456|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56420457|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56420458|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
56420459|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420460|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420461|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420462|NCT00210041|Gemcitabine|gemcitabine|mesh-list
56420463|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420464|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56420465|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
56420466|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420467|NCT00210041|Antiviral Agents|antiviral agents|mesh-ancestor
56420468|NCT00210041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420469|NCT00210041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420470|NCT00210041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420471|NCT00210041|Immunologic Factors|immunologic factors|mesh-ancestor
56420472|NCT00210041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420473|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
56420474|NCT04990804|Analgesics|analgesics|mesh-list
56420475|NCT04990804|Narcotics|narcotics|mesh-ancestor
56911856|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56911857|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911858|NCT02187874|Oxytocin|oxytocin|mesh-list
56911859|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
56911860|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56911861|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911862|NCT04870138|Azithromycin|azithromycin|mesh-list
56911863|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
56911864|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
56911865|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56911866|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911867|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56911868|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56911869|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911870|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911871|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420476|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420477|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420481|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56420482|NCT04991662|Phenylephrine|phenylephrine|mesh-list
56420483|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
56420484|NCT04991662|Norepinephrine|norepinephrine|mesh-list
56420485|NCT04991662|Metaraminol|metaraminol|mesh-list
56420486|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56420487|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
56420488|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
56420489|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420490|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420491|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
56420492|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56420493|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
56420494|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
56420495|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56420496|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56420497|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56420498|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
56420499|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420500|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420501|NCT04991662|Protective Agents|protective agents|mesh-ancestor
56420503|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56420504|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
56420505|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56420506|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420507|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56420508|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420509|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56420510|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56420511|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56420512|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
56420513|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56420514|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
56420515|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
56420516|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420517|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420518|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56420519|NCT00210158|Analgesics|analgesics|mesh-ancestor
56420520|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
56420521|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420522|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56911872|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56911873|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56911874|NCT02188186|Metformin|metformin|mesh-list
56911875|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56911876|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911877|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911878|NCT02188186|Incretins|incretins|mesh-ancestor
56911879|NCT02188186|Hormones|hormones|mesh-ancestor
56911880|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911881|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56911882|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
56911883|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911884|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911885|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56420523|NCT00413790|Darifenacin|darifenacin|mesh-list
56420524|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56420525|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56420526|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
56420527|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420528|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420529|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420530|NCT00413790|Urological Agents|urological agents|mesh-ancestor
56420531|NCT04571164|Rotigotine|rotigotine|mesh-list
56420532|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
56420533|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
56420534|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420535|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420536|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420537|NCT01059903|Rotigotine|rotigotine|mesh-list
56420538|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
56420539|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
56420540|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420541|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420542|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420543|NCT04996771|Cisplatin|cisplatin|mesh-list
56420544|NCT04996771|Etoposide|etoposide|mesh-list
56420545|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
56420546|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420547|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56420548|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56420549|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56420550|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420552|NCT00210314|Cytarabine|cytarabine|mesh-list
56420553|NCT00210314|Methotrexate|methotrexate|mesh-list
56420554|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56420555|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
56420556|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56420557|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420558|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56420559|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
56420560|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420561|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420562|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
56420563|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420564|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56420565|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420566|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
56420567|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56420568|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56911886|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911887|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911888|NCT02192632|Analgesics|analgesics|mesh-ancestor
56911889|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
56420569|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
56420570|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420571|NCT00237861|Olanzapine|olanzapine|mesh-list
56420572|NCT00237861|Risperidone|risperidone|mesh-list
56420573|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56420574|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56420575|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
56420576|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420577|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420578|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420579|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56420580|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56420581|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420582|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420583|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56420584|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
56420585|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
56420586|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
56420587|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420588|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56420589|NCT00237861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56420590|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56420591|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420592|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
56420593|NCT00210392|Bortezomib|bortezomib|mesh-list
56420594|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420595|NCT00413829|Ranibizumab|ranibizumab|mesh-list
56420596|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56420597|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56420598|NCT00413829|Growth Substances|growth substances|mesh-ancestor
56420599|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420600|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
56420601|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420602|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
56420603|NCT02210104|Ipilimumab|ipilimumab|mesh-list
56420604|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420605|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
56420606|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420607|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56420608|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56420609|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
56420610|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420611|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420612|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56420613|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56420614|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56420615|NCT02210182|Pentamidine|pentamidine|mesh-list
56420616|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
56420617|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420618|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56420619|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56420620|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56420621|NCT00210509|Almotriptan|almotriptan|mesh-list
56420622|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56420623|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
56420624|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420625|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420626|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420627|NCT02210260|Heroin|heroin|mesh-list
56420628|NCT02210260|Bupivacaine|bupivacaine|mesh-list
56420629|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
56420630|NCT02210260|Anesthetics|anesthetics|mesh-list
56420631|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420632|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420633|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
56420634|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168387|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
56420635|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56911890|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911891|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386060|NCT00153192|Hormones|hormones|mesh-ancestor
56420636|NCT02210260|Narcotics|narcotics|mesh-ancestor
56420637|NCT02210260|Analgesics|analgesics|mesh-ancestor
56420638|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56420639|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56420640|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56420641|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420642|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420643|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420644|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56420645|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56420646|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
56420647|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420648|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420649|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56420650|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56420651|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
56420652|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
56420653|NCT00210587|Hematinics|hematinics|mesh-ancestor
56420654|NCT00210665|Trabectedin|trabectedin|mesh-list
56420655|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56420656|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
56420657|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420658|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420659|NCT04570345|Aspirin|aspirin|mesh-list
56420660|NCT04570345|Ticagrelor|ticagrelor|mesh-list
56420661|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56420662|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56420663|NCT04570345|Analgesics|analgesics|mesh-ancestor
56420664|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
56420665|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420666|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420667|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56420668|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56420669|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56420670|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56420671|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420672|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56420673|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56420674|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420675|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
56420676|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56420677|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56420678|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56420679|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
56420680|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420681|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
56420683|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56420684|NCT00234819|Hormones|hormones|mesh-ancestor
56420685|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56420686|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420687|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56420688|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56420689|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
56420690|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56420691|NCT04570150|Neostigmine|neostigmine|mesh-list
56420692|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56420693|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420694|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420695|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
56420696|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420697|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420698|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56420703|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
56420704|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420705|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
56420706|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56420707|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420708|NCT00234858|Losartan|losartan|mesh-list
56911892|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911893|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911894|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
56911895|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
56911896|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56911897|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56911898|NCT03535090|Prednisolone|prednisolone|mesh-list
56911899|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
56911900|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56911901|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
56911902|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911903|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
56911904|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
56911905|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911906|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911907|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56911908|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
56420709|NCT00234858|Verapamil|verapamil|mesh-list
56420710|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56420711|NCT00234858|Trandolapril|trandolapril|mesh-list
56420712|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56420713|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56420714|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56420715|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56420716|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420717|NCT00234858|Diuretics|diuretics|mesh-ancestor
56420718|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
56420719|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420720|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56420721|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420722|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56420723|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56420724|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
56420725|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56420726|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
56420727|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420728|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56420729|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56420730|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
56420731|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420732|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420733|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
56420734|NCT00210743|Hematinics|hematinics|mesh-ancestor
56420735|NCT04569916|Irinotecan|irinotecan|mesh-list
56420736|NCT04569916|Apatinib|apatinib|mesh-list
56420737|NCT04569916|Antibodies|antibodies|mesh-list
56420738|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
56420739|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420740|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56420741|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56420742|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420743|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420744|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420745|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56420746|NCT00210782|Topiramate|topiramate|mesh-list
56420747|NCT00210782|Phenytoin|phenytoin|mesh-list
56420748|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
56420749|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56420750|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090661|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
56911909|NCT03535090|Hormones|hormones|mesh-ancestor
56911910|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911911|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56911912|NCT03535090|Protective Agents|protective agents|mesh-ancestor
56911913|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56911914|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911915|NCT03535870|Fluticasone|fluticasone|mesh-list
56911916|NCT03535870|Xhance|xhance|mesh-list
56420751|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56420752|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56420753|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56420754|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420755|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56420756|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56420757|NCT00237900|Leucovorin|leucovorin|mesh-list
56420758|NCT00237900|Fluorouracil|fluorouracil|mesh-list
56420759|NCT00237900|Gefitinib|gefitinib|mesh-list
56420760|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
56420761|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420762|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56420763|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420764|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420765|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
56420766|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420767|NCT00237900|Antidotes|antidotes|mesh-ancestor
56420768|NCT00237900|Protective Agents|protective agents|mesh-ancestor
56420769|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
56420773|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420774|NCT00210821|Topiramate|topiramate|mesh-list
56420775|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
56420776|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56420777|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420778|NCT00237939|Aripiprazole|aripiprazole|mesh-list
56420779|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
56420780|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420781|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56420782|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56420783|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420784|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420785|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
56420786|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
56420787|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420788|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420789|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56420790|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56420791|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
56420792|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56420793|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56420794|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56420795|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56420797|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56420798|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420799|NCT00210860|Topiramate|topiramate|mesh-list
56420800|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
56420801|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56420802|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420803|NCT00210899|Vancomycin|vancomycin|mesh-list
56420804|NCT00210899|Ceftazidime|ceftazidime|mesh-list
56420805|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
56420806|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56164305|NCT00002742|Amphotericin B|amphotericin b|mesh-list
56420807|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56420808|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420809|NCT04568863|Melatonin|melatonin|mesh-list
56420810|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
56420811|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420812|NCT04568863|Protective Agents|protective agents|mesh-ancestor
56420813|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911917|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56911918|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56911919|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911920|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56420814|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420815|NCT00210938|Doripenem|doripenem|mesh-list
56420816|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56420817|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420818|NCT02278081|Lansoprazole|lansoprazole|mesh-list
56420819|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
56420820|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56420821|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56420822|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56420823|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420824|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420825|NCT00211016|Doripenem|doripenem|mesh-list
56420826|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56420827|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420828|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
56420829|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420830|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
56420831|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420832|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56420833|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56420834|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
56420835|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420836|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420837|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56420838|NCT00238017|Artesunate|artesunate|mesh-list
56420839|NCT00238017|Amodiaquine|amodiaquine|mesh-list
56420840|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
56420841|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56420842|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56420843|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420844|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420847|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56420848|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
56420849|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
56420850|NCT00238056|Domperidone|domperidone|mesh-list
56420851|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
56420852|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
56420853|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420854|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420855|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56420856|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56420857|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
56420858|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420859|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420860|NCT04566952|Olaparib|olaparib|mesh-list
56420861|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56420862|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420863|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420864|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420865|NCT04567069|Vaccines|vaccines|mesh-list
56420866|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
56420867|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420868|NCT04566796|Neostigmine|neostigmine|mesh-list
56420869|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56420870|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420871|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420872|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
56420873|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420874|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420875|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56420876|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
56420877|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420878|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
56420879|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
56420880|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
56420881|NCT00238173|Carboplatin|carboplatin|mesh-list
56420883|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
56420884|NCT00238173|Mannitol|mannitol|mesh-list
56420885|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56911921|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
56911922|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911923|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911924|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56911925|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
56911926|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
56911927|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56911928|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56911929|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56911930|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56911931|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
56911932|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911933|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911934|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
56911935|NCT03535870|Hormones|hormones|mesh-ancestor
56420886|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420887|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
56420888|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420889|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56420890|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56420891|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
56420892|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420893|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420894|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56420895|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56420896|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56420897|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56420898|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420899|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
56420900|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420901|NCT00238173|Expectorants|expectorants|mesh-ancestor
56420902|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
56420903|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56420904|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
56420905|NCT00238173|Protective Agents|protective agents|mesh-ancestor
56420906|NCT00238173|Antidotes|antidotes|mesh-ancestor
56420907|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56420908|NCT00238173|Diuretics|diuretics|mesh-ancestor
56420909|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
56420910|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
56420911|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56420912|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
56420913|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
56420914|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
56420915|NCT00211133|Hematinics|hematinics|mesh-ancestor
56420916|NCT00238212|Sorafenib|sorafenib|mesh-list
56420917|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420918|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56420919|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420920|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420921|NCT00211250|Valproic Acid|valproic acid|mesh-list
56420930|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56420931|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420932|NCT00238251|Temozolomide|temozolomide|mesh-list
56420934|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56420935|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
56420936|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420937|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420938|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56420939|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420940|NCT04566718|Metformin|metformin|mesh-list
56911936|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56911937|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
56911938|NCT02192710|Midazolam|midazolam|mesh-list
56911939|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56911940|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56911941|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622606|NCT00617929|Rituximab|rituximab|mesh-list
56911942|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911943|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56386382|NCT00404222|Oxycodone|oxycodone|mesh-list
56420941|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56420942|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420943|NCT02210884|Vitamin D|vitamin d|mesh-list
56420944|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
56420945|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
56420946|NCT02210884|Vitamins|vitamins|mesh-list
56420947|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
56420948|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420949|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56420950|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56420951|NCT00238290|Trastuzumab|trastuzumab|mesh-list
56420952|NCT00238290|Letrozole|letrozole|mesh-list
56420953|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56420954|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420955|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56420956|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56420957|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420958|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420959|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56420960|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
56420961|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56420962|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420963|NCT00211328|Anecortave|anecortave|mesh-list
56420964|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56420965|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56420966|NCT00211328|Growth Substances|growth substances|mesh-ancestor
56420967|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420968|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
56420969|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420970|NCT00238329|Interferons|interferons|mesh-list
56420971|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
56420972|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
56420973|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56420974|NCT00238329|Thalidomide|thalidomide|mesh-list
56420975|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420976|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
56420977|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420978|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
56420979|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420980|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420981|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
56420982|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56420983|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56420984|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56420985|NCT00238329|Growth Substances|growth substances|mesh-ancestor
56420986|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
56420987|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
56420988|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
56420989|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56420991|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56420992|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56420993|NCT00211367|Growth Substances|growth substances|mesh-ancestor
56420994|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420995|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
56420996|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420997|NCT00238368|Cytarabine|cytarabine|mesh-list
56420998|NCT00238368|Prednisone|prednisone|mesh-list
56911944|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56911945|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56420999|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
56421000|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
56421001|NCT00238368|Busulfan|busulfan|mesh-list
56421002|NCT00238368|Rituximab|rituximab|mesh-list
56421003|NCT00238368|Doxorubicin|doxorubicin|mesh-list
56421004|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56421005|NCT00238368|Etoposide|etoposide|mesh-list
56421006|NCT00238368|Vincristine|vincristine|mesh-list
56421007|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56421008|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56421009|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
56421010|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421011|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421012|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56421013|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
56421014|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421015|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421016|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56421017|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56421018|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56421019|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56421020|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56421021|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421022|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56421024|NCT00238368|Hormones|hormones|mesh-ancestor
56421025|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56421026|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56421027|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56421028|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56421029|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
56421030|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
56421031|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421033|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56421034|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56421035|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
56421036|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
56421037|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421038|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56421039|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56421040|NCT00238368|Protective Agents|protective agents|mesh-ancestor
56421041|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56421042|NCT02894593|Ethanol|ethanol|mesh-list
56421043|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
56421044|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56421045|NCT02894593|Listerine|listerine|mesh-list
56421046|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
56421047|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56421048|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421049|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421050|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421051|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
56421052|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
56421053|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
56421054|NCT02894593|Protective Agents|protective agents|mesh-ancestor
56421055|NCT00211406|Anecortave|anecortave|mesh-list
56421056|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56421057|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56421058|NCT00211406|Growth Substances|growth substances|mesh-ancestor
56421059|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421060|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
56421061|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421062|NCT02894554|Lamivudine|lamivudine|mesh-list
56421063|NCT02894554|Telbivudine|telbivudine|mesh-list
56421064|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56421065|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56421066|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421067|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421068|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
56421070|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56421071|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56421072|NCT00238407|Docetaxel|docetaxel|mesh-list
56421073|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421074|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
56421075|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
56911946|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56911947|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
56911948|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
56911949|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
56911950|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
56421076|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
56421077|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421078|NCT00211445|Verteporfin|verteporfin|mesh-list
56421079|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56421080|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
56421081|NCT02894710|Lidocaine|lidocaine|mesh-list
56421082|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
56421083|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
56421084|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421085|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421086|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
56421087|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421088|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56421089|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56421090|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56421091|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56421092|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421093|NCT00211484|Anecortave|anecortave|mesh-list
56333876|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56421094|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56421095|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56421096|NCT00211484|Growth Substances|growth substances|mesh-ancestor
56421097|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421098|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
56421099|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421100|NCT05428072|Aspirin|aspirin|mesh-list
56421101|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56421102|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56421103|NCT05428072|Analgesics|analgesics|mesh-ancestor
56421104|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
56421105|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421106|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421107|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56421108|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421109|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56421110|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56421111|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421112|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56421113|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56421114|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421115|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
56421116|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
56421117|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421118|NCT00211562|Vitamin E|vitamin e|mesh-list
56421119|NCT00211562|Olanzapine|olanzapine|mesh-list
56421120|NCT00211562|Vitamins|vitamins|mesh-ancestor
56421121|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
56421122|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421123|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
56421124|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
56421125|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421126|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56421127|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56421128|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56421129|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421130|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56421131|NCT00211562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56421132|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56421133|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56421134|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421135|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421136|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
56421137|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
56421138|NCT00211562|Protective Agents|protective agents|mesh-ancestor
56421139|NCT00238563|Triamcinolone|triamcinolone|mesh-list
56421140|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56421141|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
56421142|NCT00238563|Hormones|hormones|mesh-ancestor
56421143|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56421146|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421147|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56421148|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
56421149|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
56421150|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
56421151|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56421152|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56421153|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56421154|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56421155|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421156|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
56421157|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421158|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421159|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56421160|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421161|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56421162|NCT05427175|Methotrexate|methotrexate|mesh-list
56421163|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56421164|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
56421165|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56421166|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421167|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56421168|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
56168911|NCT00377052|Gemcitabine|gemcitabine|mesh-list
56421169|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421170|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421171|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
56421172|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421173|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56421174|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56421175|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
56421176|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421177|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56421178|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
56421179|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56421180|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56421181|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56421182|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56421183|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421184|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
56421185|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421186|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421187|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56421188|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421189|NCT04680091|Efavirenz|efavirenz|mesh-list
56421190|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421191|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421192|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56421193|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56421194|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
56421195|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421196|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56421197|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56421198|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56421199|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56421200|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56421201|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56421202|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
56421203|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56421204|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56421205|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56421206|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56421207|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421208|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
56421209|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421210|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421211|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56421212|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090662|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
56911951|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911952|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911953|NCT02188654|Metformin|metformin|mesh-list
56911954|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56911955|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911956|NCT02192944|Chloroquine|chloroquine|mesh-list
56911957|NCT02192944|Piperaquine|piperaquine|mesh-list
56911958|NCT02192944|Artenimol|artenimol|mesh-list
56911959|NCT02192944|Amebicides|amebicides|mesh-ancestor
56911960|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56911961|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56421215|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56421216|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56421217|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421218|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421219|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421220|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56421221|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
56421222|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56421223|NCT04680208|Anesthetics|anesthetics|mesh-list
56421224|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421225|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421226|NCT00211796|Valproic Acid|valproic acid|mesh-list
56421227|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
56421228|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421229|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421230|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
56421231|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421232|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421233|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
56421234|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56421235|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421236|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56421237|NCT05426824|Pegaspargase|pegaspargase|mesh-list
56421238|NCT05426824|Asparaginase|asparaginase|mesh-list
56333877|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
56421239|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421241|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421242|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56421243|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421244|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421245|NCT05426044|Metformin|metformin|mesh-list
56421246|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56421247|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164316|NCT00002742|Ionophores|ionophores|mesh-ancestor
56421248|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
56421249|NCT05425654|Busulfan|busulfan|mesh-list
56421250|NCT05425654|Carmustine|carmustine|mesh-list
56421251|NCT05425654|Rituximab|rituximab|mesh-list
56421252|NCT05425654|Methotrexate|methotrexate|mesh-list
56421253|NCT05425654|Vincristine|vincristine|mesh-list
56421254|NCT05425654|Lenalidomide|lenalidomide|mesh-list
56421255|NCT05425654|Procarbazine|procarbazine|mesh-list
56421256|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56421257|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
56421258|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421259|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421260|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56421261|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
56421262|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421263|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421264|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56421265|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56421266|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56421267|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
56421268|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56911962|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911963|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
56386726|NCT00139646|Parecoxib|parecoxib|mesh-list
56421269|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56421270|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
56421271|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
56421272|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421273|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56421274|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56421275|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56421276|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
56421277|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
56421278|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
56421279|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56421280|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56421281|NCT05425654|Growth Substances|growth substances|mesh-ancestor
56421282|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
56421283|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
55770463|NCT02385071|Simeprevir|simeprevir|mesh-list
56421285|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421286|NCT00238914|Naltrexone|naltrexone|mesh-list
56421287|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56421288|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56421289|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421290|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
56421291|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421292|NCT04668976|Gemcitabine|gemcitabine|mesh-list
56421293|NCT04668976|Fluorouracil|fluorouracil|mesh-list
56421294|NCT04668976|Floxuridine|floxuridine|mesh-list
56421295|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
56421296|NCT04668976|Irinotecan|irinotecan|mesh-list
56421297|NCT04668976|Cetuximab|cetuximab|mesh-list
56421298|NCT04668976|Panitumumab|panitumumab|mesh-list
56421299|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56421300|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
56421301|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421302|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421303|NCT04668976|Antiviral Agents|antiviral agents|mesh-ancestor
56421304|NCT04668976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421305|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421306|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56421307|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
56421308|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421309|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56421310|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56421311|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56421312|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
56421313|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56421314|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421315|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56421316|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
56421317|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56421318|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421319|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421320|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421322|NCT04669366|Axitinib|axitinib|mesh-list
56421323|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421324|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56421325|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56421326|NCT04669366|Growth Substances|growth substances|mesh-ancestor
56421327|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421328|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
56421329|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56421330|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421331|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421332|NCT04721301|Maraviroc|maraviroc|mesh-list
56421333|NCT04721301|Nivolumab|nivolumab|mesh-list
56421334|NCT04721301|Ipilimumab|ipilimumab|mesh-list
56421335|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56421336|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421337|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56421338|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421339|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56421340|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56911964|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911965|NCT02193022|Miltefosine|miltefosine|mesh-list
56421341|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56421342|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56421343|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
56421344|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421345|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56421346|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
56421347|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56421348|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421349|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56421350|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
56421351|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56421352|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421353|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421354|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421355|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
56421356|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56421357|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
56421358|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421359|NCT00556465|Expectorants|expectorants|mesh-ancestor
56421362|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
56421363|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421364|NCT00556465|Protective Agents|protective agents|mesh-ancestor
56421365|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421366|NCT00556465|Antidotes|antidotes|mesh-ancestor
56421367|NCT04668469|Acetaminophen|acetaminophen|mesh-list
56421368|NCT04668469|Vitamins|vitamins|mesh-list
56421369|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
56421371|NCT04668469|Azithromycin|azithromycin|mesh-list
56421372|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
56421373|NCT04668469|Ivermectin|ivermectin|mesh-list
56421374|NCT04668469|Lactoferrin|lactoferrin|mesh-list
56421375|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
56421376|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
56421377|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421378|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56421379|NCT04668469|Analgesics|analgesics|mesh-ancestor
56421380|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
56421381|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421382|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
56421383|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56421384|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421385|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
56421386|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56421387|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56421388|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421389|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169133|NCT00382980|Antacids|antacids|mesh-ancestor
56421390|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421391|NCT04668469|Trace Elements|trace elements|mesh-ancestor
56421392|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
56421393|NCT04668469|Protective Agents|protective agents|mesh-ancestor
56421394|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56421395|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56421396|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
56421397|NCT04668469|Coagulants|coagulants|mesh-ancestor
56421398|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
56421399|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56421400|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421401|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56421402|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
56421403|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56421404|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421405|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421406|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421407|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
56421408|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56421409|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421410|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56421411|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
56421412|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56421413|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421414|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421415|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421417|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911966|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
56911967|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911968|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56911969|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56911970|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56911971|NCT02188810|Vaccines|vaccines|mesh-list
56911972|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
56911973|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911974|NCT02188888|Esmolol|esmolol|mesh-list
56911975|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56386903|NCT00140075|Taxane|taxane|mesh-list
56421418|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56421419|NCT00211952|Analgesics|analgesics|mesh-ancestor
56421420|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
56421421|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421422|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421423|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56421424|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421425|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56421426|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56421427|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421428|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421429|NCT00239109|Olanzapine|olanzapine|mesh-list
56421430|NCT00239109|Ziprasidone|ziprasidone|mesh-list
56421431|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
56421432|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
56421433|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421434|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421435|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56421438|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421439|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56421440|NCT00239109|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56421441|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56421442|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56421443|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421444|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421446|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56421447|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56421448|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
56421449|NCT00212030|Nicorandil|nicorandil|mesh-list
56421450|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56421451|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56421452|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
56421453|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
56421454|NCT00212030|Vitamins|vitamins|mesh-ancestor
56421455|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
56421456|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421457|NCT00212069|Gemcitabine|gemcitabine|mesh-list
56421458|NCT00212069|Carboplatin|carboplatin|mesh-list
56421459|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421460|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56421461|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
56421462|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421463|NCT00212069|Antiviral Agents|antiviral agents|mesh-ancestor
56421464|NCT00212069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421465|NCT00212069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421466|NCT00212069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56421467|NCT00212069|Immunologic Factors|immunologic factors|mesh-ancestor
56421468|NCT00212069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421470|NCT00212108|Gefitinib|gefitinib|mesh-list
56421471|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56421472|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56421473|NCT00212108|Analgesics|analgesics|mesh-ancestor
56164321|NCT00002748|Interleukin-2|interleukin-2|mesh-list
56421474|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
56421475|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911976|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56911977|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56911978|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
56911979|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911980|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911981|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911982|NCT02256826|Ritonavir|ritonavir|mesh-list
56911983|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56911984|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56911985|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
56911986|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911987|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911988|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56911989|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56911990|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
56911991|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911992|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56911993|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56421476|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421477|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56421478|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421479|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56421480|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56421481|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421482|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421483|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421484|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56421485|NCT00212186|Selenium|selenium|mesh-list
56421486|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
56421487|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421488|NCT00212186|Protective Agents|protective agents|mesh-ancestor
56421489|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421490|NCT00212186|Trace Elements|trace elements|mesh-ancestor
56421491|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
56421492|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56421493|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56421494|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
56421495|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421496|NCT00414336|Antacids|antacids|mesh-ancestor
56421497|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421498|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56421499|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56421500|NCT00212342|Norethindrone|norethindrone|mesh-list
56421501|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
56421502|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56421503|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56421504|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56421505|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
56421506|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56421507|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421508|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56421511|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56421512|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56421514|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911994|NCT03535792|Fentanyl|fentanyl|mesh-list
56911995|NCT03535792|Nalbuphine|nalbuphine|mesh-list
56911996|NCT03535792|Bupivacaine|bupivacaine|mesh-list
56911997|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
56421515|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
56421516|NCT00414414|Hormones|hormones|mesh-ancestor
56421517|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56421518|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421519|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56421520|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421521|NCT00239304|Gefitinib|gefitinib|mesh-list
56421522|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421523|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56421524|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421525|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421526|NCT00239343|Gefitinib|gefitinib|mesh-list
56421527|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421528|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56421529|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421530|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421531|NCT00411593|Bevacizumab|bevacizumab|mesh-list
56421532|NCT00411593|Bortezomib|bortezomib|mesh-list
56421533|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56421534|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421535|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56421536|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56421537|NCT00411593|Growth Substances|growth substances|mesh-ancestor
56421538|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421539|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
56421540|NCT00239382|Meloxicam|meloxicam|mesh-list
56421541|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56421542|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56421543|NCT00239382|Analgesics|analgesics|mesh-ancestor
56421544|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
56421545|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421546|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421547|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56421548|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421549|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56421550|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56421551|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421552|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421555|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
56421556|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
56421557|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56421558|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56421559|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56421560|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
56421561|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421562|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421563|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56421564|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
56421565|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
56421566|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56421567|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56421568|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56421569|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56421570|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
56421571|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421572|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421573|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
56421574|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56421575|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
56421576|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
56421577|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56421578|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
56421579|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421580|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421581|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56421582|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
56421585|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
56421586|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56911998|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
56421587|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421589|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
56421590|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56421591|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56421592|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56421593|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
56421594|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421595|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421596|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56421597|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
56421598|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
56421599|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56421600|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
56421601|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56421602|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
56421603|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421604|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421605|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56421606|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56421607|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56421608|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
56421609|NCT00212615|Capecitabine|capecitabine|mesh-list
56421610|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
56421611|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56421612|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
56421613|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421614|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421615|NCT00222573|Metoprolol|metoprolol|mesh-list
56421616|NCT00222573|Clopidogrel|clopidogrel|mesh-list
56421617|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56421618|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56421619|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56421620|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56421622|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421623|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421624|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421625|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56421626|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56421627|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
56421628|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
56421629|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421630|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56421631|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56421632|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56421633|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
56421635|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56421636|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56421637|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
56421638|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421639|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421640|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421641|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56421642|NCT00239538|Valsartan|valsartan|mesh-list
56421643|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56421644|NCT00239538|Telmisartan|telmisartan|mesh-list
56421645|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56421646|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56421647|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56421648|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421649|NCT00239538|Diuretics|diuretics|mesh-ancestor
56421650|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
56421651|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421652|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56421653|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56421654|NCT00212810|Topiramate|topiramate|mesh-list
56421655|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
56421659|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56421660|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56421661|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421662|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56421663|NCT00239616|Hematinics|hematinics|mesh-ancestor
56421664|NCT00213122|Miglitol|miglitol|mesh-list
56911999|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912000|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912001|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
56912002|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912003|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56912004|NCT03535792|Narcotics|narcotics|mesh-ancestor
56912005|NCT03535792|Analgesics|analgesics|mesh-ancestor
56912006|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56912007|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56912008|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
56912009|NCT02193256|Prazosin|prazosin|mesh-list
56912010|NCT02193256|Varenicline|varenicline|mesh-list
56912011|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56912012|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56912013|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
56912014|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912015|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912016|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912017|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56912018|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56421665|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421666|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421667|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56421668|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421669|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56421670|NCT00213200|Morphine|morphine|mesh-list
56421671|NCT00213200|Tetracaine|tetracaine|mesh-list
56421672|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56421673|NCT00213200|Narcotics|narcotics|mesh-ancestor
56421674|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421675|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421676|NCT00213200|Analgesics|analgesics|mesh-ancestor
56421677|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
56421678|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421679|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
56421680|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
56421681|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56421682|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56421683|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421684|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56421685|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
56421686|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421687|NCT00213278|Vinblastine|vinblastine|mesh-list
56421688|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56421689|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421690|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
56421691|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
56421692|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
56421693|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421695|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
56421696|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56421697|NCT00239889|Katacalcin|katacalcin|mesh-list
56421698|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56421699|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387193|NCT00141089|Tegaserod|tegaserod|mesh-list
56421700|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56421701|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
56421702|NCT00239967|Rimonabant|rimonabant|mesh-list
56421703|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56421704|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56421705|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56421706|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421707|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421708|NCT00239967|Hormones|hormones|mesh-ancestor
56421709|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56421710|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421711|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
56421712|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56421713|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421714|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
56421715|NCT00213512|Rituximab|rituximab|mesh-list
56421716|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56421717|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421718|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
56421719|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421720|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421721|NCT00213551|Antioxidants|antioxidants|mesh-list
56421722|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421723|NCT00213551|Protective Agents|protective agents|mesh-ancestor
56421724|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421725|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56421726|NCT00213590|Cyclosporine|cyclosporine|mesh-list
56421727|NCT00213590|Cyclosporins|cyclosporins|mesh-list
56421731|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
56421732|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421733|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
56421734|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421735|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
56421736|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421737|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56421738|NCT00240045|Octreotide|octreotide|mesh-list
56421739|NCT00240045|Midodrine|midodrine|mesh-list
56421740|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56421741|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56421742|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421743|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
56421744|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
56421745|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421746|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421747|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56421748|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56421749|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56421750|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56421751|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
56421752|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421753|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421754|NCT00243672|Atorvastatin|atorvastatin|mesh-list
56421755|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
56421756|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56421757|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56421758|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
56421759|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421760|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56421761|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56421762|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169510|NCT02993640|Vasopressins|vasopressins|mesh-list
56421763|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56421764|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56421765|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56421766|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
56421767|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421768|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56421770|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56421771|NCT00243711|Protective Agents|protective agents|mesh-ancestor
56421772|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421773|NCT00243711|Laxatives|laxatives|mesh-ancestor
56421774|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56421775|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
56912019|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56912020|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56912021|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
56421776|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56421777|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56421778|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421779|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421780|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
56421781|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
56421782|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
56421783|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421784|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
56421785|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
56421786|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56421787|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56421788|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
56421789|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
56421790|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421791|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421792|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56421793|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56421794|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56421795|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56421796|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
56421797|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421798|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56421800|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421802|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56421803|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
56421804|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56421805|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421806|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56421807|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
56421808|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421809|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421810|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
56421811|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421812|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56421813|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56421814|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
56421815|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56421816|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56421817|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
56421818|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56421819|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421820|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421821|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56421822|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56421823|NCT00243789|Protective Agents|protective agents|mesh-ancestor
56421824|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421825|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
56421826|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56421828|NCT00214058|Carboplatin|carboplatin|mesh-list
56421829|NCT00214058|Docetaxel|docetaxel|mesh-list
56421830|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421831|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
56421832|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
56421833|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
56421834|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421835|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56421836|NCT00240318|Calcium|calcium|mesh-list
56421837|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56421838|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421839|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56421840|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56421841|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
56421842|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421843|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56421844|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56421845|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912023|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
56912024|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56421847|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
56421848|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
56421849|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421850|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421851|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421852|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
56421853|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56421854|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421855|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56421856|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56421857|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421858|NCT00240396|Narcotics|narcotics|mesh-list
56421859|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421860|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421861|NCT00240396|Analgesics|analgesics|mesh-ancestor
56421862|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
56421863|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421864|NCT00214331|Azithromycin|azithromycin|mesh-list
56421865|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
56421866|NCT00214331|Gentamicins|gentamicins|mesh-list
56421867|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56421868|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421869|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56421870|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56421871|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771036|NCT02365493|beta-Lactams|beta-lactams|mesh-list
56421874|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56421875|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56421876|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56421877|NCT00243984|Topiramate|topiramate|mesh-list
56421878|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
56421879|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56421880|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421881|NCT00214370|Fentanyl|fentanyl|mesh-list
56421882|NCT00214370|Propofol|propofol|mesh-list
56421883|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56421884|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421885|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421886|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56421887|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
56421888|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
56421889|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56421890|NCT00214370|Narcotics|narcotics|mesh-ancestor
56421891|NCT00214370|Analgesics|analgesics|mesh-ancestor
56421892|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
56421893|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421894|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56421895|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56421896|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
56421897|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56421898|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
56421899|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421900|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421901|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56421902|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
56421903|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
56421904|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56421905|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
56421906|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56421907|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421908|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
56421909|NCT00244023|Testosterone|testosterone|mesh-list
56421910|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
56169673|NCT01271166|Leucovorin|leucovorin|mesh-list
56421911|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
56421912|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56421913|NCT00244023|Androgens|androgens|mesh-ancestor
56421914|NCT00244023|Hormones|hormones|mesh-ancestor
56421915|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56421916|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421917|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56421918|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912025|NCT03535558|Trimethoprim|trimethoprim|mesh-list
56912026|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
56912027|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56912028|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912029|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56912030|NCT03535558|Renal Agents|renal agents|mesh-ancestor
56912031|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
56912032|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56912033|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56912034|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56912035|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912036|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912037|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56912038|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56912039|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56912040|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56912041|NCT02193334|Mitogens|mitogens|mesh-list
56912042|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
56421919|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
56421920|NCT00240474|Amlodipine|amlodipine|mesh-list
56421921|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56421922|NCT00240474|Telmisartan|telmisartan|mesh-list
56421923|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56421924|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56421925|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56421926|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421927|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56421928|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421929|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
56421930|NCT00240474|Diuretics|diuretics|mesh-ancestor
56421931|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
56421932|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56421933|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56421934|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56421935|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56421936|NCT00214604|Pravastatin|pravastatin|mesh-list
56421937|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56421938|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56421939|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
56421940|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421941|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56421942|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56421943|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421944|NCT00214643|Clindamycin|clindamycin|mesh-list
56421945|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
56421946|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
56421947|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
56421948|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56421949|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421950|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56421951|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421952|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421953|NCT00414531|Atorvastatin|atorvastatin|mesh-list
56421954|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56421955|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56421956|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
56421957|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912043|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912044|NCT04247542|Vancomycin|vancomycin|mesh-list
56912045|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56912046|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912047|NCT02194192|Ephedrine|ephedrine|mesh-list
56421958|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56421959|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56421960|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421961|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
56421962|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
56421964|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
56421965|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421966|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
56421967|NCT00214682|Hematinics|hematinics|mesh-ancestor
56421968|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
56421969|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56421970|NCT00240513|Minocycline|minocycline|mesh-list
56421971|NCT00240513|Tretinoin|tretinoin|mesh-list
56421972|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56421973|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421974|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421975|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
56421976|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
56421977|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
56421978|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56421979|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56421980|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
56421981|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421982|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421983|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56421984|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56421985|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
56421986|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421987|NCT00214877|Methylene Blue|methylene blue|mesh-list
56421988|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421989|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421991|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56421992|NCT00214955|Narcotics|narcotics|mesh-ancestor
56421993|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56421994|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421995|NCT00214955|Analgesics|analgesics|mesh-ancestor
56421996|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
56421997|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56421998|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56421999|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56422000|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
56422001|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
56422002|NCT00244179|Interferons|interferons|mesh-list
56422003|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
56422004|NCT00244179|Infliximab|infliximab|mesh-list
56422005|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422006|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
56422007|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422008|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
56422009|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56422010|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422011|NCT00214994|Tiagabine|tiagabine|mesh-list
56422012|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
56422013|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56422014|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56422015|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422016|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422017|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
56422018|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422019|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422020|NCT00240630|Naproxen|naproxen|mesh-list
56422021|NCT00240630|Sumatriptan|sumatriptan|mesh-list
56422023|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56422024|NCT00240630|Analgesics|analgesics|mesh-ancestor
56422025|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
56422026|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422027|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422028|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912048|NCT02194192|Ondansetron|ondansetron|mesh-list
56912049|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
56912050|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
56422029|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422030|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
56422031|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56422032|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422033|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422034|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56422035|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56422036|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56422037|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
56422038|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422039|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56422040|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56422041|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56422042|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422043|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422044|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422045|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422047|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
56422048|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422049|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
56422050|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422051|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
56422052|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56422053|NCT00215228|Citalopram|citalopram|mesh-list
56422054|NCT00215228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56422055|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56422056|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422057|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422058|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422059|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
56422060|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422061|NCT00215228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56422062|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
56422063|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422064|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422065|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56422066|NCT00215228|Analgesics|analgesics|mesh-ancestor
56422067|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
56422068|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
56422069|NCT00215267|Praziquantel|praziquantel|mesh-list
56422070|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
56422071|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56422072|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422073|NCT00240708|Risperidone|risperidone|mesh-list
56422074|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56422075|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
56422076|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422077|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422078|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422079|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56422080|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56422081|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422082|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422083|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56422084|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
56422085|NCT00215345|Celecoxib|celecoxib|mesh-list
56422086|NCT00215345|Docetaxel|docetaxel|mesh-list
56422087|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422088|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
56422089|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
56422090|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
56422091|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422092|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55771252|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
56422096|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422097|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422098|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422099|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912051|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912052|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912053|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56912054|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
56912055|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
56912056|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56912057|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
56422100|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56422101|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56422102|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422103|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
56422104|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56422105|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422106|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56422107|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422108|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422109|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
56422110|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56422111|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
56422112|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422113|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422114|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56422115|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
56422116|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56422117|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56422118|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56422119|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
56422120|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422121|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422122|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
56422123|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56422124|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
56422125|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422126|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422127|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56422128|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
56422129|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56422130|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56422131|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56422132|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
56422133|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422134|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422135|NCT04668352|Dactolisib|dactolisib|mesh-list
56422136|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422137|NCT00215462|Vinorelbine|vinorelbine|mesh-list
56422138|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56422139|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422140|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
56422141|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
56422142|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
56422143|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422144|NCT00215501|Fluorouracil|fluorouracil|mesh-list
56422145|NCT00215501|Capecitabine|capecitabine|mesh-list
56422146|NCT00215501|Irinotecan|irinotecan|mesh-list
56422147|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422148|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
56422149|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422150|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56422151|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422152|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
56422153|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422154|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56422155|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56422156|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422157|NCT00240786|Acetaminophen|acetaminophen|mesh-list
56422158|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56422159|NCT00240786|Analgesics|analgesics|mesh-ancestor
56912058|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912059|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009676|NCT00003694|Cytarabine|cytarabine|mesh-list
56422160|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
56422161|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422162|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422163|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
56422166|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
56422167|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422168|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422169|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422170|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56422171|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56422172|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422173|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422174|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56422175|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
56422176|NCT00556621|Gemcitabine|gemcitabine|mesh-list
56422177|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422178|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56422179|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
56422180|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422181|NCT00556621|Antiviral Agents|antiviral agents|mesh-ancestor
56422182|NCT00556621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422183|NCT00556621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422184|NCT00556621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422185|NCT00556621|Immunologic Factors|immunologic factors|mesh-ancestor
56422186|NCT00556621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422187|NCT00244452|Cetrorelix|cetrorelix|mesh-list
56422188|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56422189|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
56422190|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56422191|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422193|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422194|NCT00556699|Rituximab|rituximab|mesh-list
56422195|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56422196|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422197|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
56422198|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422199|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422200|NCT00411866|Ketoconazole|ketoconazole|mesh-list
56422201|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
56422202|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422203|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56422204|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56422205|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422206|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422207|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56422208|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
56422209|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422210|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422211|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56422212|NCT04667299|Amoxicillin|amoxicillin|mesh-list
56422213|NCT04667299|Metronidazole|metronidazole|mesh-list
56422214|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
56422215|NCT04667299|Rabeprazole|rabeprazole|mesh-list
56422216|NCT04667299|Bismuth|bismuth|mesh-list
56422217|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422218|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56422219|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422220|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56422221|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56422222|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56422223|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56422224|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56422225|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422226|NCT04667299|Antacids|antacids|mesh-ancestor
56422227|NCT04667299|Diuretics|diuretics|mesh-ancestor
56422228|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
56422229|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422230|NCT04667299|Expectorants|expectorants|mesh-ancestor
56912060|NCT02194192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56912061|NCT02194192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56912062|NCT02194192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422231|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
56422232|NCT04667143|Metformin|metformin|mesh-list
56422233|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56422234|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422235|NCT00240825|Acetaminophen|acetaminophen|mesh-list
56422236|NCT00240825|Ibuprofen|ibuprofen|mesh-list
56422237|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56422238|NCT00240825|Analgesics|analgesics|mesh-ancestor
56422241|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422242|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
56422243|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56422244|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422245|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422246|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56422247|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422248|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422249|NCT04666675|Upadacitinib|upadacitinib|mesh-list
56422250|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56422251|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56422252|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422253|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422254|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422256|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56422257|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422258|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422259|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56422260|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422261|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
56422262|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
56422263|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56422264|NCT00411905|Bortezomib|bortezomib|mesh-list
56422265|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422266|NCT00240864|Acetaminophen|acetaminophen|mesh-list
56422267|NCT00240864|Ibuprofen|ibuprofen|mesh-list
56422268|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56422269|NCT00240864|Analgesics|analgesics|mesh-ancestor
56422270|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
56422271|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422272|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422273|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
56422274|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56422275|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422276|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422277|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56422278|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422279|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422280|NCT00557011|Amphetamine|amphetamine|mesh-list
56422281|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56422282|NCT00557011|Adderall|adderall|mesh-list
56422283|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56422284|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422286|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
56422287|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422288|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
56422289|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422290|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422291|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
56422292|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56422293|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56422294|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422295|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56422296|NCT04666324|Simethicone|simethicone|mesh-list
56422297|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
56422298|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422299|NCT04666324|Emollients|emollients|mesh-ancestor
56422300|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
56422301|NCT04720833|Vitamin D|vitamin d|mesh-list
56422302|NCT04720833|Calcium|calcium|mesh-list
56422303|NCT04720833|Vitamins|vitamins|mesh-ancestor
56912063|NCT02194192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56912064|NCT02194192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56912065|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56912066|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
56912067|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56912068|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
56912069|NCT02194270|Ambroxol|ambroxol|mesh-list
56912070|NCT02194270|Expectorants|expectorants|mesh-ancestor
56912071|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
56912072|NCT02190058|DS-1971a|ds-1971a|mesh-list
56912073|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56912074|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56912075|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422304|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
56422305|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422306|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56422307|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56422308|NCT00244608|Budesonide|budesonide|mesh-list
56422309|NCT00244608|Terbutaline|terbutaline|mesh-list
56422310|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
56422311|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422314|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422315|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422316|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56422317|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
56422318|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
56422319|NCT00244608|Hormones|hormones|mesh-ancestor
56422320|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422321|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56422322|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56422323|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56422324|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
56422325|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422326|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422327|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
56422328|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
56422329|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56422330|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
56422331|NCT04666168|Fludarabine|fludarabine|mesh-list
56422332|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422333|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
56422334|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422335|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422336|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56422337|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
56422338|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422339|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422340|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56422341|NCT04665895|Fluticasone|fluticasone|mesh-list
56422342|NCT04665895|Xhance|xhance|mesh-list
56422343|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422344|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56422345|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
56422346|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422347|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422348|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56422349|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
56422350|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
56422351|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56422352|NCT00215774|Flecainide|flecainide|mesh-list
56422353|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56422354|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56422355|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56912076|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912077|NCT02195908|Antiemetics|antiemetics|mesh-list
56912078|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
56912079|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912080|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912081|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56912082|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56912083|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56912084|NCT02197000|Protective Agents|protective agents|mesh-ancestor
56912085|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912086|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912087|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
56422356|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422357|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170119|NCT03801252|Cefazolin|cefazolin|mesh-list
56422358|NCT00240942|Letrozole|letrozole|mesh-list
56422359|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422361|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56422362|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422363|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422364|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56422365|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
56422366|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422367|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422368|NCT00215891|Interferons|interferons|mesh-list
56422369|NCT00215891|Ribavirin|ribavirin|mesh-list
56422370|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422371|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
56422372|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422373|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
56422374|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422375|NCT02961816|Pyridoxine|pyridoxine|mesh-list
56422376|NCT02961816|Gemcitabine|gemcitabine|mesh-list
56422377|NCT02961816|Dexamethasone|dexamethasone|mesh-list
56422378|NCT02961816|Rituximab|rituximab|mesh-list
56422379|NCT02961816|Melphalan|melphalan|mesh-list
56422380|NCT02961816|Busulfan|busulfan|mesh-list
56422381|NCT02961816|Panobinostat|panobinostat|mesh-list
56422382|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56422383|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422384|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
56422385|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422388|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
56422389|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
56422390|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422391|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56422392|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
56422393|NCT02961816|Hormones|hormones|mesh-ancestor
56422394|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422395|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56422396|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56422397|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
56422398|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422399|NCT02961816|Antiviral Agents|antiviral agents|mesh-ancestor
56422400|NCT02961816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422401|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422402|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422403|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56422404|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
56422405|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56422406|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56422407|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
56422408|NCT02961816|Vitamins|vitamins|mesh-ancestor
56422409|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
56912088|NCT02196142|Mannitol|mannitol|mesh-list
56912089|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56912090|NCT02196142|Diuretics|diuretics|mesh-ancestor
56912091|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
56912092|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912093|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912094|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56912095|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56912096|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56912097|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912098|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56912099|NCT03534388|Eusol|eusol|mesh-list
56912100|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
56912101|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912102|NCT04308694|Methadone|methadone|mesh-list
56912103|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56912104|NCT04308694|Narcotics|narcotics|mesh-ancestor
56422410|NCT04665232|Progesterone|progesterone|mesh-list
56422411|NCT04665232|Progestins|progestins|mesh-ancestor
56422412|NCT04665232|Hormones|hormones|mesh-ancestor
56422413|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422414|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422415|NCT00216008|Docetaxel|docetaxel|mesh-list
56422416|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422417|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56422418|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56422419|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56422420|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422421|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
56422422|NCT04665076|Fludarabine|fludarabine|mesh-list
56422423|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422424|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
56422425|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422426|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422427|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56422428|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
56422429|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422430|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422431|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56422432|NCT00241020|Octreotide|octreotide|mesh-list
56170185|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
56422433|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56422434|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56422435|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422436|NCT00216047|Trastuzumab|trastuzumab|mesh-list
56422437|NCT00216047|Vatalanib|vatalanib|mesh-list
56422438|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56422439|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422440|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56422441|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422442|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422443|NCT04665310|Tacrolimus|tacrolimus|mesh-list
56422444|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422445|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
56422446|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422447|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56422448|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422449|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422450|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
56422451|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56422452|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912105|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912106|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912107|NCT04308694|Analgesics|analgesics|mesh-ancestor
56912108|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
56912109|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912110|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
56912111|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
56912112|NCT03534310|Liraglutide|liraglutide|mesh-list
56912113|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56912114|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912115|NCT03534310|Incretins|incretins|mesh-ancestor
56912116|NCT03534310|Hormones|hormones|mesh-ancestor
56912117|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56912118|NCT02194894|Acetaminophen|acetaminophen|mesh-list
56912119|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912120|NCT02194894|Analgesics|analgesics|mesh-ancestor
56912121|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
56912122|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912123|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912124|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
56912125|NCT02197702|Vitamin D|vitamin d|mesh-list
56912126|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
56422453|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56422454|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
56422455|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56422456|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422457|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422460|NCT00216164|Rituximab|rituximab|mesh-list
56422461|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56422462|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422463|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
56422464|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422465|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422466|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56422467|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
56422468|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422469|NCT00216164|Antiviral Agents|antiviral agents|mesh-ancestor
56422470|NCT00216164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422471|NCT00216164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422472|NCT00216164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422473|NCT04664803|Cefdinir|cefdinir|mesh-list
56422474|NCT04664803|Cefetamet|cefetamet|mesh-list
56422475|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56422476|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422478|NCT04664725|Bupropion|bupropion|mesh-list
56422479|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56422480|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
56422481|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422482|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56422483|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56422484|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422485|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422486|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
56422487|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912127|NCT02197702|Vitamins|vitamins|mesh-ancestor
56912128|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
56912129|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912130|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56912131|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56912132|NCT02031016|Fentanyl|fentanyl|mesh-list
56912133|NCT02031016|Remifentanil|remifentanil|mesh-list
56912134|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56912135|NCT02031016|Narcotics|narcotics|mesh-ancestor
56422488|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422489|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56422490|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56422491|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422492|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56422493|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
56422494|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
56422495|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
56422496|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56422497|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422498|NCT00241098|Valsartan|valsartan|mesh-list
56422499|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56422500|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56422501|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56422502|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422503|NCT00216281|Clozapine|clozapine|mesh-list
56422504|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56422505|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56170258|NCT03265080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56422506|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56422507|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422508|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422509|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
56422510|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422511|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422512|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56422513|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
56422514|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56422515|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56422516|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422517|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422518|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
56422519|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
56422520|NCT00241137|Valsartan|valsartan|mesh-list
56422521|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56422522|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56422523|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56422524|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422525|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56422526|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
56422527|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
55771689|NCT02356445|Infliximab|infliximab|mesh-list
56422530|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56422531|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422532|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56422533|NCT04664530|Esketamine|esketamine|mesh-list
56422534|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
56422535|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422536|NCT00216398|Lanreotide|lanreotide|mesh-list
56422537|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422538|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
56422539|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56422540|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422541|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422542|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
56422543|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422544|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912136|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912137|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912138|NCT02031016|Analgesics|analgesics|mesh-ancestor
56912139|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
56912140|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912141|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56912142|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56912143|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
56912144|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
56912145|NCT00095147|Methotrexate|methotrexate|mesh-list
56912146|NCT00095147|Abatacept|abatacept|mesh-list
56912147|NCT00095147|Infliximab|infliximab|mesh-list
56912148|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56912149|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
56912150|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56912151|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912152|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56912153|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
56912154|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912155|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912156|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
56422545|NCT00216437|Capecitabine|capecitabine|mesh-list
56422546|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56422547|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
56422548|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422549|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422550|NCT00244920|Squalamine|squalamine|mesh-list
56422551|NCT00244920|Leuprolide|leuprolide|mesh-list
56422552|NCT00244920|Bicalutamide|bicalutamide|mesh-list
56422553|NCT00244920|Hormones|hormones|mesh-list
56422554|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
56422555|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422556|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422557|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56422558|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
56422559|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56422560|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56422561|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422562|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
56422563|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56422564|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422565|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56422566|NCT00244920|Protective Agents|protective agents|mesh-ancestor
56422567|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56422568|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56422569|NCT00244920|Growth Substances|growth substances|mesh-ancestor
56422570|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
56422571|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
56170344|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
56170345|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56170346|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
56170347|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
56170348|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170349|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170350|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912157|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912158|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56912159|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56912160|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
56912161|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912162|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56912163|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56912164|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56912165|NCT02198170|Ketoconazole|ketoconazole|mesh-list
56912166|NCT02198170|Lenvatinib|lenvatinib|mesh-list
56170351|NCT01622322|Analgesics|analgesics|mesh-ancestor
56170352|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
56422572|NCT00216515|Galantamine|galantamine|mesh-list
56422573|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56422574|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422575|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422576|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
56422577|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422578|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422579|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56422580|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
56422581|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422582|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
56422583|NCT00244959|Anastrozole|anastrozole|mesh-list
56422584|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56422585|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422586|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56422587|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56422588|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422589|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422590|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56422591|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
56422592|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422593|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422595|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56422596|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422597|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56422598|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56422599|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
56422600|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422601|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422602|NCT00216554|Risperidone|risperidone|mesh-list
56422603|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56422604|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
56422605|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422606|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422607|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422608|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56422609|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56422610|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422611|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422612|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56422613|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
56422614|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
56422615|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56422616|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56422618|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
56422619|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
56422620|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56422621|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
56422622|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422623|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
56422624|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422625|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56091177|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56912167|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
56912168|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912169|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56912170|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56912171|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912172|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912173|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56912174|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
56912175|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56912176|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912177|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56912178|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912179|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56912180|NCT02198248|Prednisolone|prednisolone|mesh-list
56912181|NCT02198248|Rituximab|rituximab|mesh-list
56422626|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56422627|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
56422628|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422629|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422630|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56422631|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422632|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
56422633|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
56422634|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422635|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56422636|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
56422637|NCT00241254|Hormones|hormones|mesh-ancestor
56422638|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422639|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56422640|NCT00241254|Protective Agents|protective agents|mesh-ancestor
56422641|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56422642|NCT00216632|Risperidone|risperidone|mesh-list
56422643|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56422644|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
56422645|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422646|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422647|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422648|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56422649|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56422650|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422651|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422652|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56422653|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
56422654|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56422655|NCT04662736|Tedizolid|tedizolid|mesh-list
56422656|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422657|NCT04662658|Xenon|xenon|mesh-list
56422658|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56422659|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
56422660|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
56422661|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422662|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422663|NCT00216788|Esomeprazole|esomeprazole|mesh-list
56422664|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56422665|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56422666|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56422668|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422670|NCT00245115|Busulfan|busulfan|mesh-list
56912182|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
56912183|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56912184|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912185|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
56912254|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56912255|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56912256|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56912257|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56912258|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912259|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912260|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56912261|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56912262|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912263|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
56422671|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422672|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
56422673|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422674|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422675|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56422676|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
56422677|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422678|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422679|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56422680|NCT04662385|Listerine|listerine|mesh-list
56422681|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
56422682|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
56422684|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422685|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56422686|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422687|NCT00216827|Betamethasone|betamethasone|mesh-list
56422688|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
56422689|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56422690|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
56422691|NCT00216827|Calcipotriene|calcipotriene|mesh-list
56422692|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56422693|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422694|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
56422695|NCT00216827|Hormones|hormones|mesh-ancestor
56422696|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422697|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422698|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56422699|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
56422700|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
56422701|NCT00241332|Fentanyl|fentanyl|mesh-list
56422702|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56422703|NCT00241332|Narcotics|narcotics|mesh-ancestor
56422704|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422705|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422706|NCT00241332|Analgesics|analgesics|mesh-ancestor
56422707|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
56422708|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422709|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56422710|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56422711|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
56422712|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
56422713|NCT00216866|Dalteparin|dalteparin|mesh-list
56422714|NCT00216866|Tinzaparin|tinzaparin|mesh-list
56422715|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56422716|NCT00216866|Warfarin|warfarin|mesh-list
56422717|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
56170490|NCT03214536|Ropivacaine|ropivacaine|mesh-list
56422718|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56422719|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56422720|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422721|NCT00557206|Docetaxel|docetaxel|mesh-list
56422722|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
56422723|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422724|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56422725|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56912264|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912265|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
56912266|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56912267|NCT02202304|Thymol|thymol|mesh-list
56912268|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56912269|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912270|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
56912271|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
56912272|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
56912273|NCT02207452|Albuterol|albuterol|mesh-list
56912274|NCT02207452|Ipratropium|ipratropium|mesh-list
56912275|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56912276|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
56422726|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56422727|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422728|NCT00245154|Paclitaxel|paclitaxel|mesh-list
56422729|NCT00245154|Carboplatin|carboplatin|mesh-list
56422730|NCT00245154|Cediranib|cediranib|mesh-list
56422731|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56422732|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422733|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
56422734|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
56422735|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
56422736|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422737|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422738|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56422739|NCT00241371|Clofarabine|clofarabine|mesh-list
56422740|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56422741|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
55771900|NCT02353949|Flutemetamol|flutemetamol|mesh-list
56422744|NCT04660786|Vitamin D|vitamin d|mesh-list
56422745|NCT04660786|Triamcinolone|triamcinolone|mesh-list
56422746|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56422747|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56422748|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56422749|NCT04660786|Vitamins|vitamins|mesh-ancestor
56422750|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
56422751|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422752|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56422753|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422754|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
56422755|NCT04660786|Hormones|hormones|mesh-ancestor
56422756|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422757|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56422758|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
56422759|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422760|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422761|NCT00217178|Folic Acid|folic acid|mesh-list
56422762|NCT00217178|Vitamins|vitamins|mesh-ancestor
56422763|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
56422764|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422765|NCT00217178|Hematinics|hematinics|mesh-ancestor
56422766|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
56422767|NCT00241449|Tamoxifen|tamoxifen|mesh-list
56422768|NCT00241449|Fulvestrant|fulvestrant|mesh-list
56422769|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56422770|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
56422771|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422772|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422773|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56422774|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422775|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56422776|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56422777|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56422778|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56422779|NCT00412100|Oxycodone|oxycodone|mesh-list
56912277|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912278|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912279|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56912280|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
56912281|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
56912282|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56912283|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56912284|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56912285|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56912286|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
56912287|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912288|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912289|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56912290|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
56912291|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
56912292|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56912293|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56912294|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56912295|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56912296|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56388445|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56422780|NCT00412100|Naloxone|naloxone|mesh-list
56422781|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56422782|NCT00412100|Narcotics|narcotics|mesh-ancestor
56422783|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422784|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422785|NCT00412100|Analgesics|analgesics|mesh-ancestor
56422786|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
56422787|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422788|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56422789|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56422790|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56422791|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56422792|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
56422793|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422794|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56422795|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56422796|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422797|NCT04659499|Paclitaxel|paclitaxel|mesh-list
56422798|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56422799|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422800|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
56422801|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
56422802|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
56422803|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422804|NCT00241527|Esomeprazole|esomeprazole|mesh-list
56422805|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56422806|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56422807|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56422808|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422809|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422810|NCT04648813|Bromides|bromides|mesh-list
56912297|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912298|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
56912299|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912300|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912301|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56912302|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912303|NCT02207920|Vaccines|vaccines|mesh-list
56912304|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
56912305|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912306|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
56912307|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56912308|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56912309|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912310|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
56912311|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
56422811|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
56422812|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56422813|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
56422814|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422817|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
56422818|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
56422819|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56422820|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
56422821|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422822|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422823|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
56422824|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
56422825|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56422826|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56422827|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
56422828|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
56422829|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422830|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422831|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
56422832|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56422833|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56422834|NCT00558181|Prednisolone|prednisolone|mesh-list
56422835|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
56422837|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56422838|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
56422839|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56422840|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422841|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
56422842|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422843|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422844|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422845|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
56422846|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
56422847|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422848|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56422849|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
56422851|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56422852|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56422853|NCT00558181|Protective Agents|protective agents|mesh-ancestor
56422854|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56422855|NCT00217295|Topiramate|topiramate|mesh-list
56422856|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
56422857|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56422858|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422859|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56422860|NCT00245427|Lactams|lactams|mesh-list
56912312|NCT03532906|Bupivacaine|bupivacaine|mesh-list
56912313|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
56912314|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
56912315|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912316|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422861|NCT00245427|beta-Lactams|beta-lactams|mesh-list
56422862|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56422863|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422864|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
56422865|NCT00558298|Risperidone|risperidone|mesh-list
56422866|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56422867|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
56422868|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422869|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422870|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422871|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56422872|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56422873|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422874|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422875|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56422876|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
56422877|NCT04647877|Phenytoin|phenytoin|mesh-list
56422878|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
56422879|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56422880|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56422881|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422882|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422883|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56422884|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56422885|NCT00245505|Mesalamine|mesalamine|mesh-list
56422886|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56422887|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56422888|NCT00245505|Analgesics|analgesics|mesh-ancestor
56422891|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422892|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422893|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422895|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422896|NCT00217373|Interferons|interferons|mesh-list
56422897|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
56422898|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
56422899|NCT00217373|Metronidazole|metronidazole|mesh-list
56422900|NCT00217373|Vaccines|vaccines|mesh-list
56422901|NCT00217373|Sargramostim|sargramostim|mesh-list
56422902|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
56422903|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422904|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422905|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
56422906|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422907|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56422908|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56422909|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56422910|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
56422911|NCT00241605|Metformin|metformin|mesh-list
56422912|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
56422913|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56422914|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422915|NCT00217412|Vorinostat|vorinostat|mesh-list
56422916|NCT00217412|Isotretinoin|isotretinoin|mesh-list
56422917|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422918|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56422919|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422920|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422921|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
56422922|NCT04646824|Pemetrexed|pemetrexed|mesh-list
56422923|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422924|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422925|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422926|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56422927|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56422928|NCT00217451|Clindamycin|clindamycin|mesh-list
56422929|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
56422930|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
56912317|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
56912318|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912319|NCT02199418|Paclitaxel|paclitaxel|mesh-list
56912320|NCT02199418|Cisplatin|cisplatin|mesh-list
56912321|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56912322|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622982|NCT00855205|Rituximab|rituximab|mesh-list
56912323|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
56912324|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
56912325|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
56912326|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912328|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56912329|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56912330|NCT02208778|Narcotics|narcotics|mesh-ancestor
56912331|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912332|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912333|NCT02208778|Analgesics|analgesics|mesh-ancestor
56912334|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
56912335|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912336|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56912337|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56912338|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56912339|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912340|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912341|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
56912342|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422931|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
56422932|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56422933|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422934|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56422935|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422936|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422937|NCT04646707|Lidocaine|lidocaine|mesh-list
56422938|NCT04646707|Bupivacaine|bupivacaine|mesh-list
56422939|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
56422940|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
56422941|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422942|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422943|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
56422944|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422945|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56422946|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56422947|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56422948|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56422949|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422950|NCT00217529|Carboplatin|carboplatin|mesh-list
56422951|NCT00217529|Docetaxel|docetaxel|mesh-list
56912343|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
56912344|NCT02203396|Cyclosporine|cyclosporine|mesh-list
56912345|NCT02203396|Levamisole|levamisole|mesh-list
56912346|NCT02203396|Cyclosporins|cyclosporins|mesh-list
56912347|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
56912348|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912349|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912350|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56912351|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
56912352|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912353|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
56912354|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422952|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56422953|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422954|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
56422955|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
56422956|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
56422957|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422958|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56422959|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422961|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56422962|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422963|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422967|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
56422969|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422970|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422971|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
56422972|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56422973|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56422974|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422975|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56422976|NCT04646317|Analgesics|analgesics|mesh-ancestor
56422977|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
56422978|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422979|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56422980|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56422981|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56422982|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
56422983|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56422984|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422985|NCT00217568|Carboplatin|carboplatin|mesh-list
56422986|NCT00217568|Docetaxel|docetaxel|mesh-list
56422987|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422988|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
56422989|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
56422990|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
56422991|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422992|NCT04646161|Misoprostol|misoprostol|mesh-list
56422993|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56422994|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
56422995|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56422996|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422997|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56422998|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56422999|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
56423000|NCT00241722|Alvimopan|alvimopan|mesh-list
56423001|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56423002|NCT00217607|Paclitaxel|paclitaxel|mesh-list
56423003|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56423004|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423005|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
56423006|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
56423007|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
56423008|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912355|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
56912356|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912357|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56912358|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56912359|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
56912360|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
56912361|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56912362|NCT02203552|Minocycline|minocycline|mesh-list
56912363|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56912364|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912365|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56912366|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56912367|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
56912368|NCT02200354|Bevacizumab|bevacizumab|mesh-list
56912369|NCT02200354|Pemetrexed|pemetrexed|mesh-list
56912370|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56912371|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912372|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56912373|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56912374|NCT02200354|Growth Substances|growth substances|mesh-ancestor
56912375|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912376|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
56912377|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912378|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912379|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56912380|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56912381|NCT02204020|Azacitidine|azacitidine|mesh-list
56912382|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56912383|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
56912384|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912385|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912386|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912387|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56912388|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56423009|NCT00558337|Levodopa|levodopa|mesh-list
56423010|NCT00558337|Carbidopa|carbidopa|mesh-list
56423011|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56423012|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56423013|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56423014|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
56423015|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423016|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912389|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
56912390|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912391|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912392|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912393|NCT02220634|Regadenoson|regadenoson|mesh-list
56912394|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56912395|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56912396|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
56912397|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
56912398|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912399|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912400|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912401|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
56912402|NCT02204644|HH-GV-678|hh-gv-678|mesh-list
56912403|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912404|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56912405|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388806|NCT00507832|Tacrolimus|tacrolimus|mesh-list
56423017|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423018|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56423019|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423020|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56423021|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
56423022|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
56423023|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56423024|NCT00558376|Laxatives|laxatives|mesh-ancestor
56423025|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56423026|NCT00217646|Sorafenib|sorafenib|mesh-list
56423027|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423028|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56423029|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423030|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423031|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
56423032|NCT00558454|Hematinics|hematinics|mesh-ancestor
56423033|NCT00558493|Clevudine|clevudine|mesh-list
56423034|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
56423035|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423036|NCT04645303|Triamcinolone|triamcinolone|mesh-list
56423046|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423047|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
56423048|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423049|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423050|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56423051|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
56423052|NCT04645303|Protective Agents|protective agents|mesh-ancestor
56423053|NCT04644484|Vaccines|vaccines|mesh-list
56423054|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
56423055|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
56423056|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423057|NCT04644250|Paclitaxel|paclitaxel|mesh-list
56423058|NCT04644250|Carboplatin|carboplatin|mesh-list
56423059|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56423060|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423061|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
56423062|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
56423063|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
56423064|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423065|NCT00245739|Darunavir|darunavir|mesh-list
56912406|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912407|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
56912408|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912409|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56912410|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912411|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912412|NCT02204878|Parecoxib|parecoxib|mesh-list
56912413|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56912414|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56912415|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912416|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912417|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56423066|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56423067|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56423068|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
56423069|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423070|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423071|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56423072|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56423073|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
56423074|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423075|NCT00558883|Acarbose|acarbose|mesh-list
56423076|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56423077|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423078|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423079|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56423080|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423081|NCT04644094|Dexamethasone|dexamethasone|mesh-list
56423082|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423083|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
56423084|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
56423085|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423086|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423087|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56423088|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
56423089|NCT04644094|Hormones|hormones|mesh-ancestor
56423090|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423091|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56423092|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423093|NCT04644406|Trastuzumab|trastuzumab|mesh-list
56423094|NCT04644406|Pertuzumab|pertuzumab|mesh-list
56423095|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56423096|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423097|NCT04643821|Calcitriol|calcitriol|mesh-list
56423098|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
56423099|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56423100|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
56423101|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423102|NCT04643821|Expectorants|expectorants|mesh-ancestor
56423103|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423112|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56423113|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56423114|NCT04643821|Vitamins|vitamins|mesh-ancestor
56423115|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
56423116|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56423117|NCT00218075|Levodopa|levodopa|mesh-list
56423118|NCT00218075|Carbidopa|carbidopa|mesh-list
56423119|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56423120|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56423121|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
56423122|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423123|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912418|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912419|NCT02204878|Analgesics|analgesics|mesh-ancestor
56388906|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56423124|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423125|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56423126|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423127|NCT00218114|Valproic Acid|valproic acid|mesh-list
56423128|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
56423129|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423130|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423131|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
56423132|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423133|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423134|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
56423135|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56423136|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56423137|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56423138|NCT00424788|Natalizumab|natalizumab|mesh-list
56423139|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
56423140|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423141|NCT00218153|Naltrexone|naltrexone|mesh-list
56423142|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56423143|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56423144|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423145|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
56423146|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423147|NCT04642846|Fluorides|fluorides|mesh-list
56423148|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
56423149|NCT04642846|Protective Agents|protective agents|mesh-ancestor
56423150|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423151|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
56423152|NCT00245895|Hematinics|hematinics|mesh-ancestor
56423153|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
56423154|NCT00559195|Hematinics|hematinics|mesh-ancestor
56423155|NCT00245934|Etanercept|etanercept|mesh-list
56423156|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56423157|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423158|NCT00245934|Analgesics|analgesics|mesh-ancestor
56423159|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
56423160|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423161|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423162|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423163|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56423164|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56423165|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423166|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
56423167|NCT00218231|Bupropion|bupropion|mesh-list
56423168|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56423169|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
56423170|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56423171|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56423172|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56423175|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
56423176|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423177|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423178|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56423179|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56423180|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423181|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
56423182|NCT00218309|Hydromorphone|hydromorphone|mesh-list
56423183|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56423184|NCT00218309|Narcotics|narcotics|mesh-ancestor
56423185|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56423186|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423187|NCT00218309|Analgesics|analgesics|mesh-ancestor
56423188|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
56423189|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423190|NCT00218348|Amphetamine|amphetamine|mesh-list
56423191|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
56423192|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56423193|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423194|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
56423195|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
56423196|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912420|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
56912421|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912422|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912423|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56388984|NCT00466609|Fluoxetine|fluoxetine|mesh-list
56423197|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
56423198|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423199|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423200|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
56423201|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56423202|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56423203|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56423204|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56423205|NCT00559312|Fluticasone|fluticasone|mesh-list
56423206|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56423207|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56423208|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423209|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56423210|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
56423211|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423212|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423213|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56423214|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423215|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56423216|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56423217|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56423218|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56423219|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56423220|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
56423221|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423222|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423223|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
56423224|NCT00559312|Hormones|hormones|mesh-ancestor
56423225|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423226|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
56423227|NCT00559351|Fluorouracil|fluorouracil|mesh-list
56423228|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423229|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
56423230|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423231|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56423232|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423233|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
56423234|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423235|NCT00218504|Dronabinol|dronabinol|mesh-list
56423236|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
56423237|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423238|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56423239|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423240|NCT00218504|Analgesics|analgesics|mesh-ancestor
56423241|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
56423242|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423243|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56423245|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423246|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423248|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423249|NCT00559429|Docetaxel|docetaxel|mesh-list
56423250|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
56423251|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423252|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
56423253|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
56423254|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
56423255|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423256|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423258|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
56423259|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423260|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423261|NCT00218621|Buprenorphine|buprenorphine|mesh-list
56423262|NCT00218621|Methadone|methadone|mesh-list
56912424|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912425|NCT02205034|Oxytocin|oxytocin|mesh-list
56912426|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
56423263|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56423264|NCT00218621|Narcotics|narcotics|mesh-ancestor
56423265|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56423266|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423267|NCT00218621|Analgesics|analgesics|mesh-ancestor
56423268|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
56423269|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423270|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56423271|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
56423272|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423273|NCT00246168|Acetaminophen|acetaminophen|mesh-list
56423274|NCT00246168|Tramadol|tramadol|mesh-list
56423275|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423277|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
56423278|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423279|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423280|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
56423281|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56423282|NCT00246168|Narcotics|narcotics|mesh-ancestor
56423283|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56423284|NCT00218660|Naltrexone|naltrexone|mesh-list
56423285|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56423286|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56423287|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423288|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
56423289|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423290|NCT00559546|Montelukast|montelukast|mesh-list
56423291|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56423292|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423293|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56423294|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
56423295|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423296|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423297|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56423298|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56423299|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423300|NCT00246207|Methylphenidate|methylphenidate|mesh-list
56423301|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56423302|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423303|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56423304|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56423305|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56423306|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423307|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
56423308|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423309|NCT04639804|Celecoxib|celecoxib|mesh-list
56423310|NCT04639804|Naproxen|naproxen|mesh-list
56423311|NCT04639804|Aceclofenac|aceclofenac|mesh-list
56423312|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56423313|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423314|NCT04639804|Analgesics|analgesics|mesh-ancestor
56423315|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
56423316|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423317|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423318|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423319|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56423320|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56423321|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56423322|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423323|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423324|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
56423325|NCT00218855|Thalidomide|thalidomide|mesh-list
56423326|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423327|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
56423328|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423329|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
56423330|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56423331|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423332|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56912427|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56912428|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912429|NCT02210728|Methylphenidate|methylphenidate|mesh-list
56912430|NCT02210728|Amphetamine|amphetamine|mesh-list
56912431|NCT02210728|Adderall|adderall|mesh-list
56912432|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
56912433|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56912434|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912435|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56389123|NCT00467506|Antibodies|antibodies|mesh-list
56423333|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56423334|NCT00218855|Growth Substances|growth substances|mesh-ancestor
56423335|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
56423336|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423337|NCT00246246|Risperidone|risperidone|mesh-list
56423338|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56423339|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
56423340|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423341|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423342|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423343|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56423344|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56423345|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56423346|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56423347|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56423348|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
56423349|NCT00242190|Gemcitabine|gemcitabine|mesh-list
56423350|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
56423351|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56423352|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
56423353|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423354|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423355|NCT00242190|Antiviral Agents|antiviral agents|mesh-ancestor
56423356|NCT00242190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423357|NCT00242190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423358|NCT00242190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423359|NCT00242190|Immunologic Factors|immunologic factors|mesh-ancestor
56423360|NCT00242190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423361|NCT04639180|Apatinib|apatinib|mesh-list
56423362|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423363|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56423364|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423365|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423366|NCT04628884|Heparin|heparin|mesh-list
56423367|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
56423368|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56423369|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56423370|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423371|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56423372|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
56423373|NCT00412334|Ribavirin|ribavirin|mesh-list
56423374|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
56423375|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423376|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
56423377|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423378|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
56423379|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423380|NCT00561379|Rituximab|rituximab|mesh-list
56423381|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56423382|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423383|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
56423384|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423385|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56423386|NCT04629118|Sirolimus|sirolimus|mesh-list
56423387|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56423388|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423389|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56912436|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56912437|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56912438|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912439|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
56912440|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912441|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
56912442|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
56912443|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912444|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
56912445|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56912446|NCT02220868|Ribavirin|ribavirin|mesh-list
56912447|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
56389193|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423390|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423391|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
56423392|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423393|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
56423396|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
56423397|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423398|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56423399|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56423400|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423401|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423402|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56423404|NCT00246285|Risperidone|risperidone|mesh-list
56423405|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56423406|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
56423407|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423408|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423409|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423410|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56423411|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56423412|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56423413|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56423414|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56423415|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
56423416|NCT00242268|Simvastatin|simvastatin|mesh-list
56423417|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56423418|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56423419|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
56423420|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423421|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56423422|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56423423|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423424|NCT00246363|Silymarin|silymarin|mesh-list
56423425|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
56423426|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423427|NCT00246363|Protective Agents|protective agents|mesh-ancestor
56423428|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423429|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
56423430|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56423431|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56423432|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
56423433|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423434|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423435|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423436|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
56423437|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
56423438|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423439|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
56423440|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56423441|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
56912448|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56912449|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
56912450|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912451|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
56912452|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912453|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56912454|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56912455|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56912456|NCT02221102|Aspirin|aspirin|mesh-list
56912457|NCT02221102|Edoxaban|edoxaban|mesh-list
56423442|NCT00246402|Acipimox|acipimox|mesh-list
56423443|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56423444|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
56423445|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423446|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56423447|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
56423448|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56423449|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423450|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56423451|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
56423452|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56423453|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
56423454|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56423455|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423456|NCT04628143|Nafamostat|nafamostat|mesh-list
56423457|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56423458|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423459|NCT04628143|Analgesics|analgesics|mesh-ancestor
56423460|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
56423461|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423462|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423463|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423464|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56423465|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
56423466|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
56423467|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423470|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56423471|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56423472|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423473|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
56423474|NCT00242346|Candesartan|candesartan|mesh-list
56423475|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
56423476|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56423477|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56423478|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56423479|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423480|NCT00219245|Rivastigmine|rivastigmine|mesh-list
56423481|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56423482|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423483|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423484|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
56423485|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423486|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423487|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56423488|NCT00219245|Protective Agents|protective agents|mesh-ancestor
56423489|NCT04627363|Bevacizumab|bevacizumab|mesh-list
56423490|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56423491|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423492|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56423493|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56423494|NCT04627363|Growth Substances|growth substances|mesh-ancestor
56423495|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423496|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
56912458|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56912459|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912460|NCT02221102|Analgesics|analgesics|mesh-ancestor
56912461|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
56912462|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912463|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912464|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912465|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912466|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56912467|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56912468|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912469|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56912470|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56912471|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423497|NCT00219323|Omalizumab|omalizumab|mesh-list
56423498|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56423499|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56423500|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423501|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
56423502|NCT00246597|Hematinics|hematinics|mesh-ancestor
56423503|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
56423504|NCT04626739|Fludarabine|fludarabine|mesh-list
56423505|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423506|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
56423507|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423508|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56423509|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56423510|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
56423511|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423512|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423513|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56423514|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56423515|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
56423516|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423517|NCT04627129|Itraconazole|itraconazole|mesh-list
56423518|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
56423519|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423520|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56423521|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56423522|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423523|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423524|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56423525|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
56423526|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423527|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423528|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56423529|NCT00246636|Fenofibrate|fenofibrate|mesh-list
56423530|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56423531|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
56423532|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423533|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56423534|NCT00219440|Metformin|metformin|mesh-list
56423535|NCT00219440|Pioglitazone|pioglitazone|mesh-list
56423536|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56423537|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423538|NCT00246675|Furosemide|furosemide|mesh-list
56423541|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423542|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56912472|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
56423543|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56423544|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423546|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
56423547|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56423548|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56171312|NCT03402204|Ubenimex|ubenimex|mesh-list
56423549|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56423550|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423551|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56423552|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56423553|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56423554|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56423555|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423557|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56423558|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56423559|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56423560|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
56423561|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423562|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56423563|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423564|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
56423566|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
56423567|NCT00242463|Testosterone Congeners|testosterone congeners|mesh-list
56423568|NCT00242463|Androgens|androgens|mesh-ancestor
56423569|NCT00242463|Hormones|hormones|mesh-ancestor
56423570|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423571|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423572|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
56423573|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56423574|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
56423575|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56423576|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
56423577|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423578|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423579|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56423580|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423581|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56423582|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56423583|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56423584|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56423585|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423586|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423587|NCT00561964|Irbesartan|irbesartan|mesh-list
56423588|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56423589|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56423590|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56423591|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423592|NCT00219596|Timolol|timolol|mesh-list
56423593|NCT00219596|Latanoprost|latanoprost|mesh-list
56423594|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56423595|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56423596|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56423597|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423598|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423599|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423600|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56423601|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56423602|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56423603|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56423604|NCT04626193|Amoxicillin|amoxicillin|mesh-list
56423605|NCT04626193|Doxycycline|doxycycline|mesh-list
56423606|NCT04626193|Levofloxacin|levofloxacin|mesh-list
56423607|NCT04626193|Ofloxacin|ofloxacin|mesh-list
56423608|NCT04626193|Esomeprazole|esomeprazole|mesh-list
56423609|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56423610|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423613|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56423614|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423615|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423616|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
56423617|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56423618|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56912473|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56912474|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
56912475|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56912476|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
56912477|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
56912478|NCT02213302|Midazolam|midazolam|mesh-list
56912479|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56912480|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56912481|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912482|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912483|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56912484|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56912485|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56912486|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56912487|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
56912488|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
56912489|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
56912490|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
56912491|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912492|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912493|NCT02221180|Metformin|metformin|mesh-list
56912494|NCT02221180|Canagliflozin|canagliflozin|mesh-list
56912495|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56912496|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389463|NCT05350592|Dobutamine|dobutamine|mesh-list
56423619|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56423620|NCT04626193|Renal Agents|renal agents|mesh-ancestor
56423621|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56423622|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56423623|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423624|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56423625|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56423626|NCT00242541|Octreotide|octreotide|mesh-list
56423627|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56423628|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56423629|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423630|NCT04625608|Acetaminophen|acetaminophen|mesh-list
56423631|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423632|NCT04625608|Analgesics|analgesics|mesh-ancestor
56423633|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
56423634|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423635|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423636|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
56423637|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
56423638|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56423639|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
56423640|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
56423641|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56423642|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423643|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423644|NCT00219713|Analgesics|analgesics|mesh-ancestor
56423645|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
56423646|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423647|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
56912497|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56912498|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389516|NCT00471289|Paclitaxel|paclitaxel|mesh-list
56423648|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423649|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56423650|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423651|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423652|NCT00242697|Anesthetics|anesthetics|mesh-list
56423653|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56423654|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423655|NCT04625179|Melatonin|melatonin|mesh-list
56423656|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
56423657|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
56423658|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423659|NCT04625179|Protective Agents|protective agents|mesh-ancestor
56423660|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423661|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56423662|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56423663|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
56423664|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
56423665|NCT02962232|Paclitaxel|paclitaxel|mesh-list
56423666|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56423667|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423668|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
56423669|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
56423670|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
56423671|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423672|NCT00246909|Pantoprazole|pantoprazole|mesh-list
56423673|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56423674|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56423675|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56423676|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423677|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423678|NCT00219869|Galantamine|galantamine|mesh-list
56423679|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56423680|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423681|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423682|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
56423683|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423686|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
56423687|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423688|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
56423689|NCT04624360|Dexamethasone|dexamethasone|mesh-list
56423690|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423691|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
56423692|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
56423693|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423694|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423695|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56423696|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
56171456|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
56423697|NCT04624360|Hormones|hormones|mesh-ancestor
56423698|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423699|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56423700|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423702|NCT00219908|Analgesics|analgesics|mesh-ancestor
56423703|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
56423704|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423705|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423706|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423707|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56423708|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56423709|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423710|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423711|NCT00242736|Esomeprazole|esomeprazole|mesh-list
56423712|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56423713|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56423714|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56423715|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423716|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912499|NCT02205112|Levofloxacin|levofloxacin|mesh-list
56912500|NCT02205112|Ofloxacin|ofloxacin|mesh-list
56912501|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56912502|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912503|NCT02205112|Renal Agents|renal agents|mesh-ancestor
56912504|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56912505|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56912506|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56912507|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912508|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912509|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912510|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56389585|NCT00471640|Dexamethasone|dexamethasone|mesh-list
56423717|NCT00242775|Fluticasone|fluticasone|mesh-list
56423719|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
56423720|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56423721|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423722|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56423723|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
56423724|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423725|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423726|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56423727|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423728|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
56423729|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56423730|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
56423731|NCT00242775|Hormones|hormones|mesh-ancestor
56423732|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423733|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56423734|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56423735|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56423736|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
56423737|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423738|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423739|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
56423740|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
56423741|NCT04623619|Vitamins|vitamins|mesh-ancestor
56423742|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
56423743|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423744|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
56423745|NCT00562198|Carbidopa|carbidopa|mesh-list
56423746|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56423747|NCT00562198|Entacapone|entacapone|mesh-list
56423748|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56423749|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56423750|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
56423751|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423752|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423753|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423754|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56423755|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423756|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56423757|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
56423759|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56423760|NCT00220064|Leucovorin|leucovorin|mesh-list
56423761|NCT00220064|Fluorouracil|fluorouracil|mesh-list
56423762|NCT00220064|Irinotecan|irinotecan|mesh-list
56423763|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
56423764|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423765|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56423766|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423767|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423768|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
56912511|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56912512|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56912513|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56912514|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56912515|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
56912516|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912517|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56912518|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56912519|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912520|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
56912521|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56912522|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912523|NCT02221414|Metformin|metformin|mesh-list
56912524|NCT02221414|Linagliptin|linagliptin|mesh-list
56912525|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56912526|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912527|NCT02221414|Incretins|incretins|mesh-ancestor
56912528|NCT02221414|Hormones|hormones|mesh-ancestor
56912529|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56912530|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56912531|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
56912532|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912533|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912534|NCT02221492|Plerixafor|plerixafor|mesh-list
56912535|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56912536|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56912537|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
56389647|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56423769|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423770|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56423771|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56423772|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423773|NCT00220064|Antidotes|antidotes|mesh-ancestor
56423774|NCT00220064|Protective Agents|protective agents|mesh-ancestor
56423775|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
56423777|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
56423778|NCT00220103|Capecitabine|capecitabine|mesh-list
56423779|NCT00220103|Epirubicin|epirubicin|mesh-list
56423780|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423781|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56423782|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
56164399|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
56423783|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423784|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56423785|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56423786|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56423787|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423789|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
56912538|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912539|NCT05164978|Antibodies|antibodies|mesh-list
56912540|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
56912541|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623199|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
56912542|NCT02221570|Baclofen|baclofen|mesh-list
56912543|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56912544|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912545|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56912546|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912547|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56912548|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
56912549|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
56912550|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912551|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912552|NCT05151484|Alendronate|alendronate|mesh-list
56912553|NCT05151484|Teriparatide|teriparatide|mesh-list
56912554|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56912555|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912556|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56912557|NCT02205502|Lidocaine|lidocaine|mesh-list
56912558|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
56912559|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
56912560|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912561|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912562|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
56912563|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912564|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56912565|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56912566|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56912567|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56912568|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423790|NCT00247026|Curcumin|curcumin|mesh-list
56423791|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56423792|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423793|NCT00247026|Analgesics|analgesics|mesh-ancestor
56423794|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
56423795|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423796|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423797|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423798|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56423799|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912569|NCT02219698|Acetaminophen|acetaminophen|mesh-list
56912570|NCT02219698|Ibuprofen|ibuprofen|mesh-list
56912571|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56912572|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912573|NCT02219698|Analgesics|analgesics|mesh-ancestor
56912574|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
56912575|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912576|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912577|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912578|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912579|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56389752|NCT00158301|Fluoxetine|fluoxetine|mesh-list
56423800|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423801|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423802|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
56423803|NCT00247026|Vitamins|vitamins|mesh-ancestor
56423804|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
56423805|NCT01580683|Vitamins|vitamins|mesh-ancestor
56423806|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
56423807|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423808|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
56423809|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423810|NCT01580683|Protective Agents|protective agents|mesh-ancestor
56423811|NCT00242814|Amlodipine|amlodipine|mesh-list
56423812|NCT00242814|Telmisartan|telmisartan|mesh-list
56423813|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56423814|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56423815|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56423816|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423817|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56423818|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423819|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
56423820|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56423821|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56423822|NCT04623385|Tretinoin|tretinoin|mesh-list
56423823|NCT04623385|Isotretinoin|isotretinoin|mesh-list
56423824|NCT04623385|Testosterone|testosterone|mesh-list
56423825|NCT04623385|Androgens|androgens|mesh-ancestor
56423826|NCT04623385|Hormones|hormones|mesh-ancestor
56423827|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423828|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423829|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423830|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
56423831|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
56423832|NCT00220220|Amlodipine|amlodipine|mesh-list
56423833|NCT00220220|Olmesartan|olmesartan|mesh-list
56423834|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56423835|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56423836|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56423837|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56423838|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423839|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56423840|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423841|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
56423842|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56423843|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56423845|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56423846|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
56423847|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423848|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423849|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56423850|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423851|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56423852|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
56912580|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912581|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912582|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
56912583|NCT02205580|Sufentanil|sufentanil|mesh-list
56912584|NCT02205580|Dsuvia|dsuvia|mesh-list
56912585|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56912586|NCT02205580|Narcotics|narcotics|mesh-ancestor
56912587|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912588|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912589|NCT02205580|Analgesics|analgesics|mesh-ancestor
56912590|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
56912591|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912592|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56912593|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56912594|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
56912595|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
56912596|NCT02221960|Durvalumab|durvalumab|mesh-list
56912597|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56912598|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912599|NCT02220088|Leucovorin|leucovorin|mesh-list
56912600|NCT02220088|Fluorouracil|fluorouracil|mesh-list
56912601|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
56423853|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423854|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56423855|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55924531|NCT01425203|Ribavirin|ribavirin|mesh-list
56423856|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
56423857|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
56423858|NCT00242853|Protective Agents|protective agents|mesh-ancestor
56423859|NCT00220259|Fluticasone|fluticasone|mesh-list
56423860|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423861|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56423862|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
56423863|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423864|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423865|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56423866|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423867|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
56423868|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56423869|NCT04622956|Methotrexate|methotrexate|mesh-list
56423870|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56423871|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
56423872|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56423873|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423874|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56423875|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
56423876|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423877|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423878|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
56423879|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423880|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56423881|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423882|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
56423883|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56423884|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56423885|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
56912602|NCT02220088|Sorafenib|sorafenib|mesh-list
56912603|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
56912604|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912605|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56912606|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912607|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56912608|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
56912609|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912610|NCT02220088|Antidotes|antidotes|mesh-ancestor
56912611|NCT02220088|Protective Agents|protective agents|mesh-ancestor
56912612|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
56912613|NCT02220088|Vitamins|vitamins|mesh-ancestor
56912614|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
56912615|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56912616|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912617|NCT02220400|Ketamine|ketamine|mesh-list
56912618|NCT02220400|Analgesics|analgesics|mesh-ancestor
56912619|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
56912620|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912621|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912622|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56912623|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56912624|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
56912625|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
56389865|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
56423886|NCT04622566|Lenvatinib|lenvatinib|mesh-list
56423887|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56423888|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423889|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56423890|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423891|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423892|NCT04622488|Diclofenac|diclofenac|mesh-list
56423893|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56423894|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56423895|NCT04622488|Analgesics|analgesics|mesh-ancestor
56423896|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
56423897|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423898|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423899|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423900|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56423901|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56423902|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423903|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423904|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
56423905|NCT00220298|Testosterone|testosterone|mesh-list
55773041|NCT02333123|Aspirin|aspirin|mesh-list
56423908|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56423910|NCT00220298|Hormones|hormones|mesh-ancestor
56423911|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423912|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423913|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56423914|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912626|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912627|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56912628|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56912629|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912630|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912632|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912633|NCT02224768|Ipilimumab|ipilimumab|mesh-list
56912634|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56912635|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912636|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56389907|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
56423915|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
56423916|NCT00220337|Lacosamide|lacosamide|mesh-list
56423917|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
56423918|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56423919|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56423920|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56423921|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423922|NCT00412412|Trastuzumab|trastuzumab|mesh-list
56423923|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56423924|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423925|NCT04621669|Metformin|metformin|mesh-list
56423926|NCT04621669|Digoxin|digoxin|mesh-list
56423927|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56423928|NCT04621669|Calcium|calcium|mesh-list
56423929|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56423930|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423931|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56423932|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56423933|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56423934|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
56423935|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423936|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56423937|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56423938|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423939|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56423940|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56423941|NCT04621669|Protective Agents|protective agents|mesh-ancestor
56423942|NCT00412646|Etravirine|etravirine|mesh-list
56423943|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56423944|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56423945|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423946|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423947|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
56423948|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423949|NCT00243009|Cyclosporine|cyclosporine|mesh-list
56423950|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
56423951|NCT00243009|Fludarabine|fludarabine|mesh-list
56423952|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
56423953|NCT00243009|Cyclosporins|cyclosporins|mesh-list
56423954|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423955|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56423956|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
56423957|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423958|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56423959|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
56423960|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423961|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423962|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
56423963|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423964|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
56423965|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56423966|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56912637|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912638|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
56912639|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56912640|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912641|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912642|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912643|NCT05262166|Analgesics|analgesics|mesh-ancestor
56912644|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
56912645|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912646|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56912647|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56912648|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56423967|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56423968|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56423969|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
56423970|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56423971|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
56423972|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56423973|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56423974|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
56423975|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423976|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56423977|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56423978|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56423981|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56423982|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
56423983|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56423985|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423986|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423987|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56423988|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56423989|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423990|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
56423991|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56423992|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56423993|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56171754|NCT02244762|Hydrocodone|hydrocodone|mesh-list
56423994|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423995|NCT00562705|Hormones|hormones|mesh-list
56423996|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423997|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423998|NCT04620967|Insulin|insulin|mesh-list
56423999|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56424000|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
56424001|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
56424002|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56424003|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56424004|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424005|NCT00220493|Methylphenidate|methylphenidate|mesh-list
56424006|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56424007|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424008|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56424009|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56424010|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56424011|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424012|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
56424013|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424014|NCT04620616|Menthol|menthol|mesh-list
56424015|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
56424016|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
56912649|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
56912650|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912651|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912652|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
56912653|NCT02206204|Selexipag|selexipag|mesh-list
56912654|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56912655|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56912656|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912657|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56912658|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56912659|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912660|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912661|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912662|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56424017|NCT00220532|Folic Acid|folic acid|mesh-list
56424018|NCT00220532|Riboflavin|riboflavin|mesh-list
56424019|NCT00220532|Hematinics|hematinics|mesh-ancestor
56424020|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
56424021|NCT00220532|Vitamins|vitamins|mesh-ancestor
56424022|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
56424023|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424024|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56424025|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424026|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
56424027|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424028|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
56424029|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424030|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424031|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56424032|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
56424033|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424034|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424035|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56424036|NCT00243204|Docetaxel|docetaxel|mesh-list
56424037|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424038|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
56424039|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
56424040|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
56424041|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424042|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56424043|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424044|NCT04620031|Propofol|propofol|mesh-list
56424045|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56424046|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424047|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424048|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56424051|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56424052|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56424053|NCT00220649|Leucovorin|leucovorin|mesh-list
56424054|NCT00220649|Gemcitabine|gemcitabine|mesh-list
56424055|NCT00220649|Fluorouracil|fluorouracil|mesh-list
56424056|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
56424057|NCT00220649|Irinotecan|irinotecan|mesh-list
56424058|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56424059|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
56424060|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424061|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424062|NCT00220649|Antiviral Agents|antiviral agents|mesh-ancestor
56424063|NCT00220649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424064|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424065|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56912663|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
56912664|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56912665|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912666|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56912667|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56912668|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56912669|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56912670|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
56912671|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56912672|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56912673|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56912674|NCT02230930|Apomorphine|apomorphine|mesh-list
56912675|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912676|NCT02230930|Emetics|emetics|mesh-ancestor
56424066|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
56424067|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424068|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56424069|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56424070|NCT00220649|Antidotes|antidotes|mesh-ancestor
56424071|NCT00220649|Protective Agents|protective agents|mesh-ancestor
56424072|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
56424073|NCT00220649|Vitamins|vitamins|mesh-ancestor
56424074|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
56424075|NCT04619758|Emollients|emollients|mesh-list
56424076|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424077|NCT04619914|Letrozole|letrozole|mesh-list
56424078|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424079|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56424080|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56424081|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424082|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424083|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56424084|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
56424085|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424086|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424088|NCT00220766|Antibodies|antibodies|mesh-list
56424089|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
56424090|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56424091|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56424092|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
56424093|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
56424094|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424095|NCT04619875|Lactulose|lactulose|mesh-list
56424096|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56424097|NCT04619290|Methylene Blue|methylene blue|mesh-list
56424098|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424099|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424100|NCT04619563|Docetaxel|docetaxel|mesh-list
56424101|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424102|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
56424103|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
56424104|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
56424105|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424106|NCT00220844|Amitriptyline|amitriptyline|mesh-list
56424107|NCT00220844|Desipramine|desipramine|mesh-list
56424108|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56424109|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
56424110|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424111|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56424112|NCT00220844|Analgesics|analgesics|mesh-ancestor
56424113|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
56424114|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424115|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912677|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912678|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
56912679|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912680|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56912681|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
56912682|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
56912683|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912684|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912685|NCT02222350|Firuglipel|firuglipel|mesh-list
56424116|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56424117|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56424118|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56424119|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424120|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
56424121|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424122|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424123|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
56424124|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56424125|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424150|NCT00220922|Ethanol|ethanol|mesh-list
56424151|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56424152|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424153|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424154|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424155|NCT00221000|Methoxsalen|methoxsalen|mesh-list
56424156|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56424157|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424158|NCT00243477|Citalopram|citalopram|mesh-list
56424159|NCT00243477|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56424160|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56424161|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56424162|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424163|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424164|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
56424165|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424166|NCT00243477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56424167|NCT00243477|Antidepressive Agents|antidepressive agents|mesh-ancestor
56424168|NCT00243477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424169|NCT00221039|Methoxsalen|methoxsalen|mesh-list
56424170|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56424171|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424172|NCT00562939|Vaccines|vaccines|mesh-list
56424173|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56424175|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424176|NCT00221156|Acarbose|acarbose|mesh-list
56424177|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56424178|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424179|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424180|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56424181|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424182|NCT04617613|Amoxicillin|amoxicillin|mesh-list
56424183|NCT04617613|Metronidazole|metronidazole|mesh-list
56424184|NCT04617613|Clarithromycin|clarithromycin|mesh-list
56424185|NCT04617613|Omeprazole|omeprazole|mesh-list
56424186|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56424187|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424188|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56424189|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56424190|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56424191|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56424192|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56424193|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424194|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424195|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56424196|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56912686|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56912687|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912688|NCT02222428|Olodaterol|olodaterol|mesh-list
56912689|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56912690|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
56912691|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912692|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912693|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56912694|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
56912695|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
56912696|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56912697|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
56912698|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912699|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912700|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56912701|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
56912702|NCT02225470|Vinorelbine|vinorelbine|mesh-list
56912703|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56912704|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912705|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56424197|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56424198|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
56424199|NCT04617652|Analgesics|analgesics|mesh-ancestor
56424200|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
56424201|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424202|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424203|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
56424204|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424205|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56424206|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
56424207|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56424208|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56424209|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424210|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56424211|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
56424212|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56424213|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56424214|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56424215|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424216|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56171974|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
56424217|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56424218|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56424219|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424220|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
56424221|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424223|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56424224|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424225|NCT04616872|Methotrexate|methotrexate|mesh-list
56424226|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56424227|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
56424228|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56912706|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56912707|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56912708|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912709|NCT02225548|Tadalafil|tadalafil|mesh-list
56912710|NCT02225548|Selegiline|selegiline|mesh-list
56912711|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
56912712|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56912713|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56912714|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912715|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912716|NCT02225548|Urological Agents|urological agents|mesh-ancestor
56912717|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
56912718|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56912719|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56390297|NCT00339196|Azacitidine|azacitidine|mesh-list
56424229|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424230|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56424231|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
56424232|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424233|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424234|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424235|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424236|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56424237|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424238|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
56424239|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424240|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56424241|NCT00221390|Ropinirole|ropinirole|mesh-list
56424242|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56424243|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56424244|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
56424246|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424247|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424248|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424249|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
56424251|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424252|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56424253|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56424254|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424255|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424256|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56424257|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
56424258|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424259|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424260|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56424261|NCT00221429|Valproic Acid|valproic acid|mesh-list
56424262|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424263|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424264|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424265|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
56424266|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56424267|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424268|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424269|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
56424270|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
56424271|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424272|NCT00563017|Risperidone|risperidone|mesh-list
56424273|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56424274|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
56912720|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56912721|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56912722|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56912723|NCT02225548|Protective Agents|protective agents|mesh-ancestor
56912724|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912725|NCT02223052|Azacitidine|azacitidine|mesh-list
56912726|NCT02223052|Cc-486|cc-486|mesh-list
56912727|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56912728|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
56912729|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912730|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912731|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912732|NCT02231632|Vaccines|vaccines|mesh-list
56912733|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
56912734|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912735|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56912736|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56912737|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56912738|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912739|NCT02231788|Amlodipine|amlodipine|mesh-list
56912740|NCT02231788|Telmisartan|telmisartan|mesh-list
56912741|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56912742|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56912743|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56912744|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912745|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56912746|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912747|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
56912748|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56424275|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424276|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424277|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424278|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56424279|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56424280|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424281|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424282|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56424283|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
56424284|NCT00563056|Fluticasone|fluticasone|mesh-list
56424285|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
56424286|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56424287|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
56424288|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424289|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912749|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56912750|NCT02258620|Isosorbide|isosorbide|mesh-list
56172048|NCT04278846|Bupivacaine|bupivacaine|mesh-list
56424290|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56424291|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
56424292|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56424293|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56424294|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56424295|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
56424296|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424297|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424298|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56424299|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424300|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56424301|NCT00563095|Interferons|interferons|mesh-list
56424302|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424303|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
56424304|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424305|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56424306|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
56424307|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424308|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56424309|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56424310|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424311|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424312|NCT00563212|Interferons|interferons|mesh-list
56424313|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
56424314|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424315|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
56424316|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424317|NCT00563251|Azithromycin|azithromycin|mesh-list
56424319|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424320|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56424321|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56424322|NCT00251082|Estradiol|estradiol|mesh-list
56424323|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56424324|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
56424325|NCT00251082|Estrogens|estrogens|mesh-ancestor
56424326|NCT00251082|Hormones|hormones|mesh-ancestor
56424327|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424328|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424329|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56424330|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
56424331|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56424332|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56424333|NCT00251082|Progestins|progestins|mesh-ancestor
56424334|NCT00221624|Ribavirin|ribavirin|mesh-list
56424335|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56424336|NCT00221624|Amantadine|amantadine|mesh-list
56424337|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
56424338|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424339|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
56424340|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424341|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56424342|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56424343|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
56424344|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424345|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424346|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56424347|NCT00221624|Analgesics|analgesics|mesh-ancestor
56424348|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
56424349|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424350|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
56424351|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56424352|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
56424353|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56424354|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
56424355|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424356|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424357|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
56424358|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56424359|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
56424360|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424361|NCT04615702|Acetaminophen|acetaminophen|mesh-list
56424362|NCT04615702|Metronidazole|metronidazole|mesh-list
56424363|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
56424364|NCT04615702|Imipenem|imipenem|mesh-list
56912751|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56912752|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56912753|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
56912754|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
56912755|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56912756|NCT02258620|Diuretics|diuretics|mesh-ancestor
56912757|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
56912758|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912759|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56912760|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912761|NCT02223598|Dexamethasone|dexamethasone|mesh-list
56912762|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912763|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
56912764|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
56912765|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912766|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912767|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56912768|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
56912769|NCT02223598|Hormones|hormones|mesh-ancestor
56912770|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424365|NCT04615702|Diclofenac|diclofenac|mesh-list
56424366|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56424367|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
56424368|NCT04615702|Secretin|secretin|mesh-list
56424370|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424371|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56424373|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
56424374|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424375|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
56424376|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424377|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56424378|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56424379|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56424380|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56424381|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424382|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56424383|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424384|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424385|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56424386|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56424387|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424388|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56424389|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56424390|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56424391|NCT04615702|Narcotics|narcotics|mesh-ancestor
56424392|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424393|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56424394|NCT04615702|Hormones|hormones|mesh-ancestor
56424395|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424399|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56424400|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424401|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
56424402|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56424403|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
56424404|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390518|NCT00511849|Growth Substances|growth substances|mesh-ancestor
56424405|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
56424406|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424407|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56424408|NCT04614727|Calcium|calcium|mesh-list
56424409|NCT04614727|Fluorides|fluorides|mesh-list
56424410|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56424411|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424412|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
56424413|NCT04614727|Protective Agents|protective agents|mesh-ancestor
56424414|NCT04614298|Brodalumab|brodalumab|mesh-list
56424415|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424416|NCT04614259|Bupivacaine|bupivacaine|mesh-list
56424417|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
56424418|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
56424419|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424420|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424421|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
56424422|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424423|NCT00412763|Silymarin|silymarin|mesh-list
56424424|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
56424425|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424426|NCT00412763|Protective Agents|protective agents|mesh-ancestor
56424427|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424428|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
56424429|NCT00563446|Hematinics|hematinics|mesh-ancestor
56424430|NCT00563485|Doxazosin|doxazosin|mesh-list
56424431|NCT00563485|Terazosin|terazosin|mesh-list
56424432|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56424433|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56424434|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56424435|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56424436|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
56424437|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424438|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424439|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424440|NCT00563485|Urological Agents|urological agents|mesh-ancestor
56424441|NCT00251277|Rituximab|rituximab|mesh-list
56172194|NCT05768542|Sympatholytics|sympatholytics|mesh-ancestor
56424442|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56424443|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424444|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
56424445|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424446|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424449|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
56424450|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56424451|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56424452|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424453|NCT00563524|Fezakinumab|fezakinumab|mesh-list
56424454|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424455|NCT04613869|Hydromorphone|hydromorphone|mesh-list
56424456|NCT04613869|Esketamine|esketamine|mesh-list
56424457|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56424458|NCT04613869|Narcotics|narcotics|mesh-ancestor
56424459|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424460|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424461|NCT04613869|Analgesics|analgesics|mesh-ancestor
56424462|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
56424463|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424464|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
56424465|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424466|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
56424467|NCT04613557|Fludarabine|fludarabine|mesh-list
56424468|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
56424469|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424470|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
56424471|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424472|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424473|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56424474|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
56424475|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424476|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424477|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56424478|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56424479|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
56424480|NCT00251355|Gemcitabine|gemcitabine|mesh-list
56424481|NCT00251355|Fluorouracil|fluorouracil|mesh-list
56912771|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56390593|NCT04864067|Capecitabine|capecitabine|mesh-list
56424482|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56424483|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
56424484|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424485|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424486|NCT00251355|Antiviral Agents|antiviral agents|mesh-ancestor
56424487|NCT00251355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424488|NCT00251355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424489|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424490|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
56424491|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424492|NCT02962388|Anagrelide|anagrelide|mesh-list
56424493|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56424494|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56424495|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424496|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56424497|NCT04613167|Evolocumab|evolocumab|mesh-list
56424498|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56424499|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56424500|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
56424501|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424502|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56424503|NCT04613284|Durvalumab|durvalumab|mesh-list
56424504|NCT04613284|Endostar protein|endostar protein|mesh-list
56424505|NCT04613284|Endostatins|endostatins|mesh-list
56424506|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56424507|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424508|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56424509|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56424510|NCT04613284|Growth Substances|growth substances|mesh-ancestor
56424511|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424512|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
56424513|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56424514|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
56424515|NCT00248118|Bupropion|bupropion|mesh-list
56424516|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56424517|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
56424518|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424519|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55925211|NCT03084601|Calcium|calcium|mesh-list
56424520|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56424521|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56424522|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424524|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424525|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424526|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56424527|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56424528|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424529|NCT04612894|Apatinib|apatinib|mesh-list
56424530|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424531|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56424532|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424533|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424534|NCT00251394|Rituximab|rituximab|mesh-list
56424535|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56424536|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424537|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
56424538|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424539|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424540|NCT00221975|Lamotrigine|lamotrigine|mesh-list
56424541|NCT00221975|Valproic Acid|valproic acid|mesh-list
56424542|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424543|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424544|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424545|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
56424546|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56424549|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
56424550|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56424551|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56424552|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56424553|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56912772|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912774|NCT00094835|Carboplatin|carboplatin|mesh-list
56912775|NCT00094835|Panitumumab|panitumumab|mesh-list
56912776|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
56424554|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56424555|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
56424556|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424557|NCT04612582|Thalidomide|thalidomide|mesh-list
56424558|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
56424559|NCT04612582|Bortezomib|bortezomib|mesh-list
56424560|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424561|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
56424562|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424563|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424564|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56424565|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
56424566|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424567|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424568|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56424569|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
56424570|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56424571|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424572|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56424573|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56424574|NCT04612582|Growth Substances|growth substances|mesh-ancestor
56424575|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
56424576|NCT00248157|Octreotide|octreotide|mesh-list
56424577|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56424578|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56424579|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424580|NCT00251472|Paclitaxel|paclitaxel|mesh-list
56424581|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56424582|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424583|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56424584|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56424585|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56424586|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424587|NCT00222053|Diphosphonates|diphosphonates|mesh-list
56424588|NCT00222053|Thalidomide|thalidomide|mesh-list
56424589|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424590|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
56424591|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424592|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
56424593|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56424594|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424595|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56424596|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56424597|NCT00222053|Growth Substances|growth substances|mesh-ancestor
56424598|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
56424599|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424600|NCT00222053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56424601|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
56424602|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424604|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
56424605|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
56424606|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424607|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424608|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
56424609|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424610|NCT00412919|Azacitidine|azacitidine|mesh-list
56424611|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56424612|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
56424613|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424614|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424615|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424616|NCT00222170|Rabeprazole|rabeprazole|mesh-list
56424617|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56424618|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56424619|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56424620|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424633|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56424634|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56424635|NCT00563875|Analgesics|analgesics|mesh-ancestor
56912777|NCT00094835|Imetelstat|imetelstat|mesh-list
56912778|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56912779|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424636|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
56424637|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424638|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424639|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56424640|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424641|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56424642|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56424643|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424644|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56424645|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56424646|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424647|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
56424649|NCT04611685|Loxoprofen|loxoprofen|mesh-list
56424650|NCT04611685|Tramadol|tramadol|mesh-list
56424651|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56424652|NCT04611685|Narcotics|narcotics|mesh-ancestor
56424653|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424654|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424655|NCT04611685|Analgesics|analgesics|mesh-ancestor
56424656|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
56424657|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424658|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56424659|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56424660|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424661|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424662|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56424663|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56424664|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56424665|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424667|NCT00563914|Ferroquine|ferroquine|mesh-list
56424668|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
56424669|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56424670|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56424671|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424672|NCT00563953|Doxorubicin|doxorubicin|mesh-list
56424673|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56424674|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424675|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56424676|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56424677|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424678|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424679|NCT00563992|Valproic Acid|valproic acid|mesh-list
56424680|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424681|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424682|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424683|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
55773744|NCT03182257|ONO-7579|ono-7579|mesh-list
56424685|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424686|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424687|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
56424688|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
56424689|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424690|NCT00251550|Pemetrexed|pemetrexed|mesh-list
56424691|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424692|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424693|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424694|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56424695|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56424696|NCT04611373|Levamisole|levamisole|mesh-list
56424697|NCT04611373|Acetazolamide|acetazolamide|mesh-list
56424698|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
56424699|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56424700|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424701|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424702|NCT04611373|Diuretics|diuretics|mesh-ancestor
56424703|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
56424704|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424705|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56424706|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
56912780|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
56912781|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
56912782|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
56424707|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
56424708|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
56424709|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56424710|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424711|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424712|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56424713|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
56424714|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56424715|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
56424716|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56424717|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424718|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56424719|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56424720|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56424721|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424722|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56424723|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56424724|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56424725|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
56424726|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
56424727|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424728|NCT04610320|Daratumumab|daratumumab|mesh-list
56424729|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424730|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
56424731|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56424732|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56424733|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424734|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
56424735|NCT04610164|Coagulants|coagulants|mesh-ancestor
56424736|NCT00222443|Irinotecan|irinotecan|mesh-list
56424737|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56424738|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56424739|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164410|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
56424740|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424742|NCT04610398|Dexamethasone|dexamethasone|mesh-list
56424743|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
56424744|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56424745|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
56424747|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424748|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424749|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56424750|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
56424751|NCT04610398|Hormones|hormones|mesh-ancestor
56424752|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424753|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56424754|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424755|NCT00222482|Valproic Acid|valproic acid|mesh-list
56424756|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
56424757|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424758|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424759|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
56424763|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56424764|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424765|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424766|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
56424767|NCT04610125|Fludarabine|fludarabine|mesh-list
56424768|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424769|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
56424770|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424771|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424772|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56424773|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
56424774|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424775|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424776|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56424777|NCT00564148|Bevacizumab|bevacizumab|mesh-list
56424778|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56424779|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424780|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56912783|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424781|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56424782|NCT00564148|Growth Substances|growth substances|mesh-ancestor
56424783|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424784|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
56424785|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
56424786|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56424787|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424788|NCT04609540|Trastuzumab|trastuzumab|mesh-list
56424789|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56424790|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424792|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56424793|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56424794|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56424795|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424796|NCT04609189|Vitamin D|vitamin d|mesh-list
56424797|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
56424798|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
56424799|NCT04609189|Calcium|calcium|mesh-list
56424800|NCT04609189|Vitamins|vitamins|mesh-ancestor
56424801|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
56424802|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424803|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56424804|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56424805|NCT04609189|Antacids|antacids|mesh-ancestor
56424806|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424807|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56424808|NCT00222677|Aspirin|aspirin|mesh-list
56424809|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56424810|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56424811|NCT00222677|Analgesics|analgesics|mesh-ancestor
56424812|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
56424813|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164412|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424814|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424815|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56424816|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56424817|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56424818|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56172569|NCT05754073|Oxytocics|oxytocics|mesh-ancestor
56424819|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424820|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56424821|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56424822|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424824|NCT00564460|Finasteride|finasteride|mesh-list
56424825|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56424826|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56424827|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424828|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424829|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
56424830|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424831|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424832|NCT00564460|Urological Agents|urological agents|mesh-ancestor
56424833|NCT04609033|Ketamine|ketamine|mesh-list
56424834|NCT04609033|Morphine|morphine|mesh-list
56424835|NCT04609033|Bupivacaine|bupivacaine|mesh-list
56424836|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
56424837|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
56424838|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424839|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424840|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
56424841|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424842|NCT04609033|Analgesics|analgesics|mesh-ancestor
56424843|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56424844|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56424845|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
56424846|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56424847|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56424848|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424849|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424850|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56424851|NCT04609033|Narcotics|narcotics|mesh-ancestor
56912784|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56912785|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56424852|NCT00248313|Sirolimus|sirolimus|mesh-list
56424853|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56424854|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424855|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56424856|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424857|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
56424858|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424859|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
56424860|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424861|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56424862|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56424863|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56424864|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56424865|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424866|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
56424867|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424868|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424869|NCT04608253|Choline|choline|mesh-list
56424870|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
56424871|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56424872|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
56424873|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424874|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56424875|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56424876|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
56424877|NCT00222833|Aripiprazole|aripiprazole|mesh-list
56424878|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
56424879|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56424880|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56424881|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56424882|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424883|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424884|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
56424885|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
56424886|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424887|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424888|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56424889|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56424890|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
56424891|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56424892|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56424893|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56424894|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56424896|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
56424897|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56424898|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424899|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
56424900|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424901|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56424902|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424903|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424904|NCT00251706|Amiodarone|amiodarone|mesh-list
56424908|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56424909|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424910|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56424911|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56424912|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56424913|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424914|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56424915|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56424916|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56424917|NCT00199121|Zidovudine|zidovudine|mesh-list
56424918|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
56424919|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424920|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56424921|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56424922|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424923|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
56912786|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912787|NCT02226328|Fentanyl|fentanyl|mesh-list
56424924|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424925|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56424926|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56424927|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
56424928|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56424929|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56424930|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424931|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
56424932|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56424933|NCT00199160|Sorafenib|sorafenib|mesh-list
56424934|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424935|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56424936|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424937|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424938|NCT04607629|Omalizumab|omalizumab|mesh-list
56424939|NCT04607629|Budesonide|budesonide|mesh-list
56424940|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
56424941|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56424942|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56424943|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56424944|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56424945|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
56424946|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424947|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424948|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56424949|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
56424950|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
56424951|NCT04607629|Hormones|hormones|mesh-ancestor
56424952|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424953|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56424954|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56424955|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56424956|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
56424957|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424958|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424959|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56424960|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
56424961|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
56424962|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
56424963|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56424964|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56424965|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424966|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424967|NCT00251784|Urological Agents|urological agents|mesh-ancestor
56424968|NCT00248430|Aldesleukin|aldesleukin|mesh-list
56424969|NCT00248430|Melphalan|melphalan|mesh-list
56424970|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56424971|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
56424972|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424973|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424974|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56424979|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56424980|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
56424981|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424982|NCT05556356|Acetaminophen|acetaminophen|mesh-list
56424983|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56424984|NCT05556356|Analgesics|analgesics|mesh-ancestor
56424985|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
56424986|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424987|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424988|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
56424989|NCT00564655|Epinephrine|epinephrine|mesh-list
56424990|NCT00564655|Racepinephrine|racepinephrine|mesh-list
56424991|NCT00564655|Bupivacaine|bupivacaine|mesh-list
56424992|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
56424993|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
56424994|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
56424995|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424996|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424997|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
56424998|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56424999|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56425000|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56912788|NCT02226328|Midazolam|midazolam|mesh-list
56912789|NCT02226328|Propofol|propofol|mesh-list
56912790|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56425001|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
56425002|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425003|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425004|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56425005|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56425006|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
56425007|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56425008|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
56425009|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
56425010|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
56425011|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56425015|NCT04606537|Itraconazole|itraconazole|mesh-list
56425016|NCT04606537|Rifampin|rifampin|mesh-list
56425017|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
56425018|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425019|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56425020|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56425021|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425022|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425023|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56425024|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
56425025|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56425026|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425027|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56425028|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56425029|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
56425030|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56425031|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
56425032|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56425033|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56425034|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56425035|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56425036|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56425037|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56425038|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56425039|NCT00251823|Eptifibatide|eptifibatide|mesh-list
56172835|NCT05483465|Niacin|niacin|mesh-list
56425040|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56425042|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56425043|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56425044|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56425045|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56425046|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774033|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56425047|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56425048|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425049|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425051|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56425052|NCT04719507|Narcotics|narcotics|mesh-ancestor
56425053|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425054|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425055|NCT04719507|Analgesics|analgesics|mesh-ancestor
56425056|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
56425057|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425058|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56425059|NCT04605952|Antibodies|antibodies|mesh-list
56425060|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
56425061|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
56425062|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425063|NCT04605562|Palbociclib|palbociclib|mesh-list
56425064|NCT04605562|Antibodies|antibodies|mesh-list
56425065|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
56425066|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
56425067|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425068|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425069|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56425070|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425071|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912791|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912792|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912793|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56425072|NCT00251901|Esomeprazole|esomeprazole|mesh-list
56425073|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56425074|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425075|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56425076|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425077|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425078|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
56425079|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56425080|NCT00564772|Ritonavir|ritonavir|mesh-list
56425081|NCT00564772|Lopinavir|lopinavir|mesh-list
56425082|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
56425083|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56425084|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56425085|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
56425086|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425087|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425088|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56425089|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56425090|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
56425091|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425092|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56425093|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56425094|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56425095|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56425096|NCT00251940|Glyburide|glyburide|mesh-list
56425097|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56425098|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425099|NCT04604938|Losartan|losartan|mesh-list
56425100|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56425101|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56425102|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56425103|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56425104|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425105|NCT05473520|Doxycycline|doxycycline|mesh-list
56425106|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56425107|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425108|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
56425109|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56425110|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56425111|NCT00565006|Anacetrapib|anacetrapib|mesh-list
56425112|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56425113|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56425114|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
56425115|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425116|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56425117|NCT00565123|Levofloxacin|levofloxacin|mesh-list
56425118|NCT00565123|Ofloxacin|ofloxacin|mesh-list
56425119|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56425120|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56425121|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56425122|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425124|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56425125|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56425126|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56425127|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425128|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425129|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425130|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56425131|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56425132|NCT04604509|Bupropion|bupropion|mesh-list
56425133|NCT04604509|Nicotine|nicotine|mesh-list
56425134|NCT04604509|Varenicline|varenicline|mesh-list
56425135|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56425136|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
56425137|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425138|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425139|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56425140|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56425141|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
56912794|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
56912795|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
56425142|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425143|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425144|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56425145|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
56425146|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425147|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56425148|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56425149|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56425150|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
56425151|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56425152|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56425153|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425154|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
56425155|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56425156|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425157|NCT04603729|Dexamethasone|dexamethasone|mesh-list
56425158|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
56425159|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56425160|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56425161|NCT04603729|Prednisolone|prednisolone|mesh-list
56425162|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
56425163|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56425164|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
56425165|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425166|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
56425167|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
56425168|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425169|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425170|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425171|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
56425172|NCT04603729|Hormones|hormones|mesh-ancestor
56425173|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56425174|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56425175|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425176|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56425177|NCT04603729|Protective Agents|protective agents|mesh-ancestor
56425178|NCT04603924|Niclosamide|niclosamide|mesh-list
56425179|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
56425180|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56425181|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
56425182|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56425183|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425184|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
56425185|NCT04603573|Listerine|listerine|mesh-list
56425186|NCT04603573|Fluorides|fluorides|mesh-list
56425187|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
56425188|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
56425189|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
56425190|NCT04603573|Protective Agents|protective agents|mesh-ancestor
56425191|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425192|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56425193|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425194|NCT05361824|Acetaminophen|acetaminophen|mesh-list
56425195|NCT05361824|Ketorolac|ketorolac|mesh-list
56425196|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56425197|NCT05361824|Analgesics|analgesics|mesh-ancestor
56425198|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
56425200|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425201|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
56425202|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56425203|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425204|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56425205|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56425206|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425207|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425208|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
56425210|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425211|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425212|NCT04603066|Ondansetron|ondansetron|mesh-list
56425213|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
56425214|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
56425215|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091178|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912796|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56912797|NCT02226328|Narcotics|narcotics|mesh-ancestor
56425216|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425217|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425218|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
56425219|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
56425220|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56425221|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
56425222|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425223|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425224|NCT04603066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56425225|NCT04603066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56425226|NCT04603066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425227|NCT04603066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425228|NCT04603066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56425229|NCT05285813|Acetaminophen|acetaminophen|mesh-list
56425230|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
56425231|NCT05285813|Promethazine|promethazine|mesh-list
56425232|NCT05285813|Dexamethasone|dexamethasone|mesh-list
56425233|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425234|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
56425235|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
56425236|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425237|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425238|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425239|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
56425240|NCT05285813|Hormones|hormones|mesh-ancestor
56425241|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56425242|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56425243|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425244|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56425245|NCT05285813|Analgesics|analgesics|mesh-ancestor
56425246|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
56425247|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
56425248|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56425249|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56425250|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425251|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
56425252|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
56425253|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56425254|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
56425255|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
56425256|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425257|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425258|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56425259|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
56425260|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
56425261|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
56425262|NCT00252291|Miotics|miotics|mesh-ancestor
56425263|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
56425264|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425265|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425266|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56173020|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
56425267|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56425268|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
56425269|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56425270|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56425271|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
55774237|NCT02018458|Vaccines|vaccines|mesh-list
56425274|NCT00565240|Letrozole|letrozole|mesh-list
56425275|NCT00565240|NuvaRing|nuvaring|mesh-list
56425276|NCT00565240|Desogestrel|desogestrel|mesh-list
56425277|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425278|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56425279|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56425280|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425281|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425282|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56425283|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
56425284|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56425285|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425286|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56425287|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
56425288|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56912798|NCT02226328|Analgesics|analgesics|mesh-ancestor
56912799|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
56425289|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56425290|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56425291|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56425292|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56425293|NCT00565240|Progestins|progestins|mesh-ancestor
56425294|NCT00565240|Hormones|hormones|mesh-ancestor
56425295|NCT04602247|Fesoterodine|fesoterodine|mesh-list
56425296|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56425297|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56425298|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
56425299|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425300|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425301|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425302|NCT04602247|Urological Agents|urological agents|mesh-ancestor
56425303|NCT00252330|Amibegron|amibegron|mesh-list
56425304|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56425305|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56425306|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
56425307|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425308|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425309|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425310|NCT04602013|Paclitaxel|paclitaxel|mesh-list
56425311|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56425312|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56425313|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425314|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
56425315|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56425316|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
56425317|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425318|NCT04601701|Dexamethasone|dexamethasone|mesh-list
56425319|NCT04601701|Bevacizumab|bevacizumab|mesh-list
56425320|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56425321|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425322|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56425323|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56425324|NCT04601701|Growth Substances|growth substances|mesh-ancestor
56425325|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425326|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
56425327|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425328|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
56425329|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
56425330|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425331|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425332|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
56425333|NCT04601701|Hormones|hormones|mesh-ancestor
56425334|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56425335|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56425336|NCT00252369|Infliximab|infliximab|mesh-list
56425337|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56425338|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
56425339|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425340|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56425341|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
56425343|NCT00565318|Benphothiamine|benphothiamine|mesh-list
56425344|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56425345|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
56425349|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425351|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
56425352|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56425353|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56425354|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425355|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425356|NCT05201144|Urological Agents|urological agents|mesh-ancestor
56425357|NCT00252408|Hormones|hormones|mesh-list
56425358|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56425359|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425360|NCT04601389|Omalizumab|omalizumab|mesh-list
56425361|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56425362|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56425363|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56425364|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
56912800|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912801|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56912802|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56912803|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56425365|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
56425366|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425367|NCT00565396|Losartan|losartan|mesh-list
56425368|NCT00565396|Fosinopril|fosinopril|mesh-list
56425369|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56425370|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56425371|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56425372|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56425373|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425374|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56425375|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
56425376|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425377|NCT04601116|Atorvastatin|atorvastatin|mesh-list
56425378|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56425379|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56425380|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
56425381|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425382|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56425383|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56425384|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425385|NCT04600648|Insulin|insulin|mesh-list
56425386|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56425387|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425388|NCT00249132|Risperidone|risperidone|mesh-list
56425389|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56425390|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
56425391|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425392|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425393|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425394|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56425395|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56425396|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425397|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425398|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56425399|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
56425400|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
56425401|NCT04600414|Narcotics|narcotics|mesh-ancestor
56425402|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425403|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425404|NCT04600414|Analgesics|analgesics|mesh-ancestor
56425405|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
56425406|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425407|NCT04600492|Riociguat|riociguat|mesh-list
56425408|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
56425409|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425410|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56425411|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56425412|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425413|NCT00414648|Sirolimus|sirolimus|mesh-list
56425414|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56425415|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425417|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425418|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
56425419|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56425420|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
56425421|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425422|NCT00414687|Iloprost|iloprost|mesh-list
56425423|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56425424|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
56425425|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
56425426|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56425427|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56425428|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425429|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
56425430|NCT04599205|Coagulants|coagulants|mesh-ancestor
56425431|NCT05070260|Glenzocimab|glenzocimab|mesh-list
56425432|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
56425433|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
56912804|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56912805|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
56912806|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
56912807|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912808|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912809|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
56912810|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56912811|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912812|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
56912813|NCT02226484|Quercetin|quercetin|mesh-list
56425434|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
56425435|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425436|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425437|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425438|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
56425439|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56425440|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425441|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425442|NCT05055128|Lansoprazole|lansoprazole|mesh-list
56425443|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
56425444|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56425445|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425446|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56425447|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425448|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425449|NCT00565591|Albuterol|albuterol|mesh-list
56425450|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56425451|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
56425452|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425453|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425454|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56425455|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
56425456|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
56425457|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56425458|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56425459|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56425460|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56425461|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
56425462|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425463|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425464|NCT00252603|Galantamine|galantamine|mesh-list
56425465|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56425466|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425467|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425468|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
56425469|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425470|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425471|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56425472|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
56425473|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425474|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
56425475|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
56425476|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56425478|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425479|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56425480|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56425481|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425482|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425483|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425484|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56425485|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
56425486|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56425487|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425488|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55774461|NCT05385263|Nivolumab|nivolumab|mesh-list
56912814|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
56912815|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425492|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56425493|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56425494|NCT00565708|Analgesics|analgesics|mesh-ancestor
56425495|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
56425496|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425497|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425498|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425499|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56425500|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56425501|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56425502|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425503|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56425504|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56425505|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425506|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
56425507|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56425508|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
56425509|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425510|NCT04598542|Triamcinolone|triamcinolone|mesh-list
56425511|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56425512|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56425513|NCT04598542|Lorecivivint|lorecivivint|mesh-list
56425514|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56425515|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425516|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
56425517|NCT04598542|Hormones|hormones|mesh-ancestor
56425518|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56425519|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425520|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56425521|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
56425522|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425523|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425524|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56425525|NCT04995263|Caffeine|caffeine|mesh-list
56425526|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56425527|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425528|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56425529|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425530|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425531|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56425532|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56425533|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
56425534|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425535|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425536|NCT04598191|Iloprost|iloprost|mesh-list
56425537|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56425538|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
56425539|NCT04955366|Abatacept|abatacept|mesh-list
56425540|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56425541|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425542|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425543|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56425544|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
56425545|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425546|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56425547|NCT00249171|Risperidone|risperidone|mesh-list
56425548|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56425549|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
56425550|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425551|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425552|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425553|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56425554|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56425555|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425556|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425557|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56425558|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
56425560|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
56425561|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
56425562|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912816|NCT02226484|Protective Agents|protective agents|mesh-ancestor
56425564|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
56425565|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425566|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56425567|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
56425568|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425569|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56425570|NCT04952519|Amantadine|amantadine|mesh-list
56425571|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56425572|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56425573|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
56425574|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425575|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
56425576|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425577|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425578|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425579|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56425580|NCT04952519|Analgesics|analgesics|mesh-ancestor
56425581|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
56425582|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425583|NCT00414921|Clonidine|clonidine|mesh-list
56425584|NCT00414921|Methylphenidate|methylphenidate|mesh-list
56425585|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56425586|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425587|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56425588|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56425589|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56425590|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425591|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
56425592|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425593|NCT00414921|Analgesics|analgesics|mesh-ancestor
56425594|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
56425595|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425596|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56425597|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
56425598|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
56425599|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56425600|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56425601|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56425602|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
56425603|NCT04597762|Cyclosporine|cyclosporine|mesh-list
56425604|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
56425605|NCT04597762|Cyclosporins|cyclosporins|mesh-list
56425606|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425607|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425608|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56425609|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
56425610|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425611|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
56425612|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425613|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
56425614|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56425615|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56425616|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425617|NCT00249210|Levofloxacin|levofloxacin|mesh-list
56425618|NCT00249210|Ofloxacin|ofloxacin|mesh-list
56425619|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56425620|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425621|NCT00249210|Renal Agents|renal agents|mesh-ancestor
56425622|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56425623|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56425624|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56425625|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425626|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425627|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425628|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56425629|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56425631|NCT00252798|Carboplatin|carboplatin|mesh-list
56425632|NCT00252798|Gefitinib|gefitinib|mesh-list
56425633|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56425634|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425635|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
56425636|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
56425637|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
56912817|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912818|NCT04453852|Vaccines|vaccines|mesh-list
56912819|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
56912820|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912821|NCT00094757|Pioglitazone|pioglitazone|mesh-list
56912822|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56912823|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56912824|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912825|NCT00094757|Incretins|incretins|mesh-ancestor
56912826|NCT00094757|Hormones|hormones|mesh-ancestor
56912827|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56912828|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56912829|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
56425638|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425639|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56425640|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425642|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
56425643|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425644|NCT00403013|Anesthetics|anesthetics|mesh-list
56425645|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425646|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425647|NCT00566332|Fludarabine|fludarabine|mesh-list
56425648|NCT00566332|Chlorambucil|chlorambucil|mesh-list
56425649|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425650|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425651|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56425652|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
56425653|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
56425654|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56425655|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
56425656|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425657|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56425658|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56425659|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56425660|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56425661|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425662|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56425663|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425664|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425665|NCT04595929|Leucovorin|leucovorin|mesh-list
56425666|NCT04595929|Docetaxel|docetaxel|mesh-list
56425667|NCT04595929|Fluorouracil|fluorouracil|mesh-list
56425668|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
56425669|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425670|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
56425671|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
56425672|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
56425673|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425674|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
56425675|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56425676|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56425677|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
56425678|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425679|NCT04595929|Antidotes|antidotes|mesh-ancestor
56425680|NCT04595929|Protective Agents|protective agents|mesh-ancestor
56425681|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
56425682|NCT04595929|Vitamins|vitamins|mesh-ancestor
56425683|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
56425684|NCT00252954|Levetiracetam|levetiracetam|mesh-list
56425685|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
56425686|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
56425687|NCT04595812|Misoprostol|misoprostol|mesh-list
56425688|NCT04595812|Hemostatics|hemostatics|mesh-list
56425689|NCT04595812|Oxytocin|oxytocin|mesh-list
56912830|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912831|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425690|NCT04595812|Carbetocin|carbetocin|mesh-list
56425691|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
56425692|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56425693|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425694|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56425695|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
56425696|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56425697|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425698|NCT04595812|Coagulants|coagulants|mesh-ancestor
56425699|NCT00249366|Lorazepam|lorazepam|mesh-list
56164422|NCT00002790|Cyclosporine|cyclosporine|mesh-list
56425700|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
56425701|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
56425702|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
56425703|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425704|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425705|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425706|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56425707|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425708|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56425709|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56425710|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425711|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
56425712|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
56425713|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425714|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425715|NCT04635683|Lenalidomide|lenalidomide|mesh-list
56425717|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425718|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56425719|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56425720|NCT04635683|Growth Substances|growth substances|mesh-ancestor
56425721|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
56425722|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425724|NCT00249405|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56425725|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56425726|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56425727|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425728|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425729|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
56425730|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425731|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56425732|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
56425733|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425734|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
56425735|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56425736|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
56425737|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56425738|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425739|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56425740|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56425741|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56425742|NCT00253110|Haloperidol|haloperidol|mesh-list
56425743|NCT00253110|Risperidone|risperidone|mesh-list
56425744|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
56425745|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56425746|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
56425747|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425748|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425749|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425750|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56425751|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56425752|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425753|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425754|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56425755|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
56425756|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
56425757|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
56425758|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425759|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425760|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56425761|NCT00566683|Meperidine|meperidine|mesh-list
56912832|NCT02223832|Ponesimod|ponesimod|mesh-list
56912833|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56425762|NCT00566683|Diazepam|diazepam|mesh-list
56425763|NCT00566683|Alfentanil|alfentanil|mesh-list
56425764|NCT00566683|Propofol|propofol|mesh-list
56425765|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56425766|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425767|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425768|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56425769|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
56425770|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
56425771|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56425772|NCT00566683|Narcotics|narcotics|mesh-ancestor
56425773|NCT00566683|Analgesics|analgesics|mesh-ancestor
56164423|NCT00002790|Sirolimus|sirolimus|mesh-list
56425774|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
56425775|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425776|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56425777|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
56425778|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
56425779|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
56425780|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425781|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56425782|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56425783|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56425784|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56425785|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425786|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
56425787|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
56425788|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425789|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774731|NCT03116971|Peposertib|peposertib|mesh-list
56425790|NCT00566761|Triamcinolone|triamcinolone|mesh-list
56425791|NCT00566761|Bevacizumab|bevacizumab|mesh-list
56425792|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56425793|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425794|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56425795|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56425796|NCT00566761|Growth Substances|growth substances|mesh-ancestor
56425797|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425798|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
56425799|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425800|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
56425802|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56425803|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56425804|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425805|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56425806|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425807|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425808|NCT04593706|Dexamethasone|dexamethasone|mesh-list
56425809|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
56425810|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56425811|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56425812|NCT04593706|Prednisolone|prednisolone|mesh-list
56425813|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
56425814|NCT04593706|Triamcinolone|triamcinolone|mesh-list
56425815|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56425816|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56425817|NCT04593706|Betamethasone|betamethasone|mesh-list
56425818|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
56425819|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56425820|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
56425821|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
56425822|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
56425823|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56425824|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
56425825|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56425826|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56425827|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56425829|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425830|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
56425831|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
56425832|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425833|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425834|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56425835|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
56912834|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912835|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56912836|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
56912837|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425836|NCT04593706|Hormones|hormones|mesh-ancestor
56425837|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56425838|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56425839|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425840|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56425841|NCT04593706|Protective Agents|protective agents|mesh-ancestor
56425842|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56425843|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
56425844|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425845|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425846|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56425847|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
56425848|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
56425849|NCT04587830|Temozolomide|temozolomide|mesh-list
56425850|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56425851|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
56425852|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425853|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425854|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56425856|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56425857|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425858|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56425859|NCT04593160|Acetaminophen|acetaminophen|mesh-list
56425860|NCT04593160|Diclofenac|diclofenac|mesh-list
56425861|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56425862|NCT04593160|Analgesics|analgesics|mesh-ancestor
56425863|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
56425864|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425865|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425866|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
56425867|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56425868|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425870|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56425871|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425872|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425873|NCT00253149|Risperidone|risperidone|mesh-list
56425874|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56425875|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
56425876|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425877|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425878|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425879|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56425880|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56425881|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425882|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425883|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56425884|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
56425885|NCT04539236|Lenalidomide|lenalidomide|mesh-list
56425886|NCT04539236|Luspatercept|luspatercept|mesh-list
56425887|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
56425888|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425889|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56425890|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56425891|NCT04539236|Growth Substances|growth substances|mesh-ancestor
56425892|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
56425893|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425894|NCT04539236|Hematinics|hematinics|mesh-ancestor
56425895|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56425896|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56425897|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56425898|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56425899|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425900|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425901|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912838|NCT02224066|Aspirin|aspirin|mesh-list
56912839|NCT02224066|Clopidogrel|clopidogrel|mesh-list
56912840|NCT02224066|Ticagrelor|ticagrelor|mesh-list
56425902|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56425903|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
56425904|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425905|NCT00567034|Naltrexone|naltrexone|mesh-list
56425906|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56425907|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56425908|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425909|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
56425910|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425911|NCT04593043|Warfarin|warfarin|mesh-list
56425912|NCT04593043|Dabigatran|dabigatran|mesh-list
56425913|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
56425914|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
56425915|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56425916|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
56425917|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425918|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425919|NCT04484363|Azacitidine|azacitidine|mesh-list
56425920|NCT04484363|Pevonedistat|pevonedistat|mesh-list
56425921|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56425922|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
56425923|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425924|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425925|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425926|NCT04592380|Clevidipine|clevidipine|mesh-list
56425927|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56425928|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56425929|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56425930|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56425931|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56425932|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56425933|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425934|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56425935|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425936|NCT00253188|Galantamine|galantamine|mesh-list
56425937|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56425938|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774864|NCT05737511|Paroxetine|paroxetine|mesh-list
56425941|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425942|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425943|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56425944|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
56425945|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425946|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
56425947|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
56425948|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56425949|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56425950|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56425951|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425952|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
56425953|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
56425954|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
56425955|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56425956|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425957|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
56425958|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425959|NCT04591795|Diclofenac|diclofenac|mesh-list
56425960|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56425961|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56425962|NCT04591795|Analgesics|analgesics|mesh-ancestor
56425963|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
56425964|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425965|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425966|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56425967|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56425968|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56425969|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56425970|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425971|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
56425972|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56912841|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56912842|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56425973|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425974|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56425975|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425976|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56425977|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425978|NCT04719585|Analgesics|analgesics|mesh-ancestor
56425979|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
56425980|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425981|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56425982|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56425983|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56425984|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425985|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425986|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
56425987|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56425988|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
56425989|NCT04592029|Bevacizumab|bevacizumab|mesh-list
56425990|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56425991|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425992|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56425993|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56425994|NCT04592029|Growth Substances|growth substances|mesh-ancestor
56425995|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425996|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
56425997|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56425998|NCT04409873|Listerine|listerine|mesh-list
56425999|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
56426000|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
56426001|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56426002|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426003|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
56426004|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
56426005|NCT00253227|Galantamine|galantamine|mesh-list
56426006|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56426007|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426008|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774938|NCT03179839|Sertraline|sertraline|mesh-list
56426011|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426012|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56426013|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
56426014|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426015|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
56426016|NCT04591444|Fluorides|fluorides|mesh-list
56426017|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
56426018|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
56426019|NCT04591444|Protective Agents|protective agents|mesh-ancestor
56426020|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426021|NCT04591327|Anesthetics|anesthetics|mesh-list
56426022|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426023|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426024|NCT04396730|Cannabidiol|cannabidiol|mesh-list
56426025|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
56426026|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
56426027|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56426028|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56426029|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426030|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
56426031|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56426032|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56426033|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56426034|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
56426035|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426036|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56426037|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56426038|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426039|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426040|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56426041|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56426042|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56912843|NCT02224066|Analgesics|analgesics|mesh-ancestor
56392189|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
56426043|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426044|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426045|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56426046|NCT00253305|Terbinafine|terbinafine|mesh-list
56426047|NCT00253305|Naftifine|naftifine|mesh-list
56426048|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
56426049|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426050|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426051|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426052|NCT04591600|Ivermectin|ivermectin|mesh-list
56426053|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56426054|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426055|NCT04591405|Vaccines|vaccines|mesh-list
56426056|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
56426057|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426058|NCT04590742|Melatonin|melatonin|mesh-list
56426059|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
56426060|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426061|NCT04590742|Protective Agents|protective agents|mesh-ancestor
56426062|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426063|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426064|NCT00253344|Docetaxel|docetaxel|mesh-list
56426065|NCT00253344|Lenalidomide|lenalidomide|mesh-list
56426066|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426067|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
56426068|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
56426069|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
56426070|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426071|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
56426072|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426073|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56426074|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56426075|NCT00253344|Growth Substances|growth substances|mesh-ancestor
56426076|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
56426077|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
56426078|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56426079|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56426080|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426081|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
56426082|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
56426083|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426084|NCT00567463|Fluticasone|fluticasone|mesh-list
56426085|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426086|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56426087|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
56426088|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426089|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426090|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56426091|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
56426092|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
56426093|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56426094|NCT00253422|Fulvestrant|fulvestrant|mesh-list
56426095|NCT00253422|Anastrozole|anastrozole|mesh-list
56426096|NCT00253422|Exemestane|exemestane|mesh-list
56426097|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56426098|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426099|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56426100|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56426101|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
56426102|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56426103|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426104|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56426105|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56426106|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426107|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426108|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56426109|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56426110|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56426111|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
56426112|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426113|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56091319|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56912844|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
56426114|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56426115|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426116|NCT04590625|Carboplatin|carboplatin|mesh-list
56426117|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56426118|NCT04590625|Apatinib|apatinib|mesh-list
56426119|NCT04590625|Cisplatin|cisplatin|mesh-list
56426120|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426121|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426122|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56426123|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426124|NCT00253461|Topotecan|topotecan|mesh-list
56426125|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56426126|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56426127|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56426128|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426129|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426130|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426131|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56426132|NCT04272242|Pyridoxine|pyridoxine|mesh-list
56426133|NCT04272242|Pyridoxal|pyridoxal|mesh-list
56426134|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
56426135|NCT04272242|Isoniazid|isoniazid|mesh-list
56426136|NCT04272242|Rifapentine|rifapentine|mesh-list
56426137|NCT04272242|Dolutegravir|dolutegravir|mesh-list
56426138|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56426139|NCT04272242|Vitamins|vitamins|mesh-ancestor
56426140|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
56426141|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426142|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
56426143|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
56426144|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56426145|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426146|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56426147|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56426148|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
56426149|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426150|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56426151|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56426152|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56426153|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426154|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56426155|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
56426156|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56426157|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
56426158|NCT04244552|Doxorubicin|doxorubicin|mesh-list
56426162|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426163|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56426164|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56426166|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173936|NCT03623854|Nivolumab|nivolumab|mesh-list
56426167|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56426168|NCT04590196|Curcumin|curcumin|mesh-list
56426169|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56426170|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56426171|NCT04590196|Analgesics|analgesics|mesh-ancestor
56426172|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
56426173|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426174|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426175|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426176|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56426177|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426178|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426179|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426180|NCT00567658|Esomeprazole|esomeprazole|mesh-list
56426181|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56426182|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56426183|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56426184|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426185|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426186|NCT00567697|Ranibizumab|ranibizumab|mesh-list
56426187|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56426188|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56426189|NCT00567697|Growth Substances|growth substances|mesh-ancestor
56426190|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426191|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
56912845|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392338|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
56426192|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426193|NCT04589494|Morphine|morphine|mesh-list
56426194|NCT04589494|Tramadol|tramadol|mesh-list
56426195|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56426196|NCT04589494|Narcotics|narcotics|mesh-ancestor
56426197|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426198|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426199|NCT04589494|Analgesics|analgesics|mesh-ancestor
56426200|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
56426201|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426202|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
56426203|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56426204|NCT04589299|Antibodies|antibodies|mesh-list
56426205|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
56426206|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426207|NCT00253500|Epirubicin|epirubicin|mesh-list
56426208|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56426209|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426210|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56426211|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56426212|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426213|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426214|NCT04589143|S 20098|s 20098|mesh-list
56426215|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56426216|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426217|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426219|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426220|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56426221|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426222|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426223|NCT00253539|Tamoxifen|tamoxifen|mesh-list
56426224|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56426225|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
56426226|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56426227|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426228|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56426229|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426230|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56426232|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56426233|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
56426234|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426235|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
56426236|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
56426237|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56426238|NCT00567775|Insulin|insulin|mesh-list
56426239|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56426240|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56426241|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426242|NCT00567814|Oxazepam|oxazepam|mesh-list
56426243|NCT00567814|Metyrapone|metyrapone|mesh-list
56426244|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
56426245|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426246|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426247|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56426248|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426249|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426250|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56426251|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56426252|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426253|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
56426254|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
56426255|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426256|NCT04588441|Adenosine|adenosine|mesh-list
56426257|NCT04588441|Analgesics|analgesics|mesh-ancestor
56426258|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
56426259|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426260|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426261|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56426262|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
56426263|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56426264|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
56426265|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
56426266|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426267|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426268|NCT04588090|Cisplatin|cisplatin|mesh-list
56426269|NCT04588090|Paclitaxel|paclitaxel|mesh-list
56426270|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426271|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56426272|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
56426273|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
56426274|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
56426275|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426276|NCT00253578|Sorafenib|sorafenib|mesh-list
56426277|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426278|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56426279|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426280|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426281|NCT04588285|Ambroxol|ambroxol|mesh-list
56426282|NCT04588285|Expectorants|expectorants|mesh-ancestor
56426283|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
56426284|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
56426285|NCT04153565|Pemetrexed|pemetrexed|mesh-list
56426286|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426287|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56426288|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426289|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426290|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56426291|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56426292|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
56426293|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56426294|NCT00253617|Trioxsalen|trioxsalen|mesh-list
56426295|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426296|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
56426297|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56426298|NCT04587778|Ketamine|ketamine|mesh-list
56426299|NCT04587778|Esketamine|esketamine|mesh-list
56426300|NCT04587778|Analgesics|analgesics|mesh-ancestor
56426301|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
56426302|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426303|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426304|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56426305|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56426308|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426309|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56426310|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56426311|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426312|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426313|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
56426314|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426315|NCT04587505|Morphine|morphine|mesh-list
56426316|NCT04587505|Tramadol|tramadol|mesh-list
56426317|NCT04587505|Anesthetics|anesthetics|mesh-list
56174082|NCT02834637|Vaccines|vaccines|mesh-list
56426318|NCT04587505|Ropivacaine|ropivacaine|mesh-list
56426319|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426320|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426321|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56426322|NCT04587505|Narcotics|narcotics|mesh-ancestor
56426323|NCT04587505|Analgesics|analgesics|mesh-ancestor
56426324|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
56426325|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426326|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
56426327|NCT04128683|Bromocriptine|bromocriptine|mesh-list
56426328|NCT04128683|Amisulpride|amisulpride|mesh-list
56426329|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56426330|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56426331|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426332|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426333|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426334|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56426335|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
56426336|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426337|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426338|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56426339|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
56426340|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56426341|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56426342|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
56912846|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912847|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426343|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56426344|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
56426345|NCT04587115|Oxycodone|oxycodone|mesh-list
56426346|NCT04587115|Risperidone|risperidone|mesh-list
56426347|NCT04587115|Ziprasidone|ziprasidone|mesh-list
56426348|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56426349|NCT04587115|Narcotics|narcotics|mesh-ancestor
56426350|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426351|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426352|NCT04587115|Analgesics|analgesics|mesh-ancestor
56426353|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
56426354|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426355|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56426356|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
56426357|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426358|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426359|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56426360|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56426361|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426362|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56426364|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
56426365|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
56426366|NCT00403247|Pyridoxine|pyridoxine|mesh-list
56426367|NCT00403247|Vitamins|vitamins|mesh-ancestor
56426368|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
56426369|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426370|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
56426371|NCT00403247|Hematinics|hematinics|mesh-ancestor
56426372|NCT00253773|Acetaminophen|acetaminophen|mesh-list
56426373|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56426374|NCT00253773|Analgesics|analgesics|mesh-ancestor
56426375|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
56426376|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426377|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426378|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
56426379|NCT00403286|Fluticasone|fluticasone|mesh-list
56426380|NCT00403286|Xhance|xhance|mesh-list
56426381|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
56426382|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56426384|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56426385|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
56426386|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426387|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426388|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56426389|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
56426390|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
56426391|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56426392|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56426393|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56426394|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56426395|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
56426396|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426397|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426398|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56426399|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56426400|NCT04585867|Bupivacaine|bupivacaine|mesh-list
56426401|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
56426402|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
56426403|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426404|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426405|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
56426406|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426407|NCT00253851|Heparin|heparin|mesh-list
56426408|NCT00253851|Calcium heparin|calcium heparin|mesh-list
56426409|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
56426410|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56426411|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56426412|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426413|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56426414|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56426415|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56426416|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
56426417|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912848|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912849|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56426418|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56426419|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56426420|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426421|NCT04585438|Diclofenac|diclofenac|mesh-list
56426422|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56426423|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56426424|NCT04585438|Analgesics|analgesics|mesh-ancestor
56426425|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
56426426|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426427|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426428|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426429|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56426430|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56426431|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426432|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426433|NCT00223223|Levetiracetam|levetiracetam|mesh-list
56426434|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
56426435|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
56426436|NCT00567931|Tryptophan|tryptophan|mesh-list
56426438|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
56426439|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426440|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
56426441|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56426442|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426443|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56426444|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
56426445|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56426446|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426447|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426448|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426449|NCT04585321|Diclofenac|diclofenac|mesh-list
56426450|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
56426451|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56426452|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56426453|NCT04585321|Analgesics|analgesics|mesh-ancestor
56426454|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
56426455|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426456|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426458|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56426459|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56426460|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426461|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426462|NCT00412997|Panobinostat|panobinostat|mesh-list
56426463|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426464|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56426465|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426466|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426467|NCT00253929|Adenosine|adenosine|mesh-list
56333878|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426468|NCT00253929|Nitroprusside|nitroprusside|mesh-list
56426469|NCT00253929|Acetylcholine|acetylcholine|mesh-list
56426470|NCT00253929|Caffeine|caffeine|mesh-list
56426471|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56426472|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426473|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56426474|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426475|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426476|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56426477|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56426478|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
56426479|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426480|NCT00253929|Analgesics|analgesics|mesh-ancestor
56426481|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
56426482|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426483|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56426484|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
56426485|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56426486|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
56426487|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56426488|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56426489|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56912850|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56912851|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912852|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56912853|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56426490|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
56426491|NCT00568048|Bevacizumab|bevacizumab|mesh-list
56426492|NCT00568048|Temozolomide|temozolomide|mesh-list
56426493|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56426494|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426495|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56426496|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56426497|NCT00568048|Growth Substances|growth substances|mesh-ancestor
56426498|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426499|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
56426500|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56426501|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
56426502|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426503|NCT04584580|Heparin|heparin|mesh-list
56426504|NCT04584580|Enoxaparin|enoxaparin|mesh-list
56426505|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56426506|NCT04584580|Tinzaparin|tinzaparin|mesh-list
56426507|NCT04584580|Dalteparin|dalteparin|mesh-list
56426508|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
56426509|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56426510|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56426511|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426512|NCT00250029|Capecitabine|capecitabine|mesh-list
56426513|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
56426514|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56426515|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
56426516|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426517|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426518|NCT00223418|Aripiprazole|aripiprazole|mesh-list
56426519|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
56426520|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426521|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56426522|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56426523|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426524|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426525|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
56426526|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
56426527|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426528|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426529|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56426531|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
56426532|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56426533|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56426534|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56426535|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56426536|NCT04584736|Ezetimibe|ezetimibe|mesh-list
56426537|NCT04584736|Pitavastatin|pitavastatin|mesh-list
56426538|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56426539|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56426540|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
56426541|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426542|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56426543|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56426544|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426546|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426547|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56426548|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56426549|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426550|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426551|NCT04584307|Pomalidomide|pomalidomide|mesh-list
56426552|NCT04584307|Elotuzumab|elotuzumab|mesh-list
56426553|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
56426554|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426555|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56426556|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56426557|NCT04584307|Growth Substances|growth substances|mesh-ancestor
56912854|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912855|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
56426558|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
56426559|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426560|NCT04584034|Albuterol|albuterol|mesh-list
56426561|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
56426562|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
56426563|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426564|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426565|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56426566|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
56426567|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
56426568|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56426569|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56426570|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56426571|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56426572|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
56426573|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426574|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426575|NCT04583410|Nicotine|nicotine|mesh-list
56426576|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56426577|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
56426578|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426579|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426580|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56426581|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56426582|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
56426583|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426584|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426585|NCT00254007|Citalopram|citalopram|mesh-list
56426586|NCT00254007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56426587|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56426588|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56426589|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426590|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426591|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
56426592|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426593|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56426594|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
56426595|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426596|NCT00223613|Insulin|insulin|mesh-list
56426597|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56426598|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426599|NCT04583137|Lidocaine|lidocaine|mesh-list
56426600|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
56426601|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
56426602|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426603|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426605|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426606|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56426607|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56426608|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56426609|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56426610|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426611|NCT00223691|Acarbose|acarbose|mesh-list
56426612|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
56426613|NCT00223691|Promethazine|promethazine|mesh-list
56426614|NCT00223691|Ibuprofen|ibuprofen|mesh-list
56426615|NCT00223691|Celecoxib|celecoxib|mesh-list
56426616|NCT00223691|Indomethacin|indomethacin|mesh-list
56426617|NCT00223691|Octreotide|octreotide|mesh-list
56333879|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56426618|NCT00223691|Phenylephrine|phenylephrine|mesh-list
56426619|NCT00223691|Acetazolamide|acetazolamide|mesh-list
56426620|NCT00223691|Midodrine|midodrine|mesh-list
56426621|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
56426622|NCT00223691|Ephedrine|ephedrine|mesh-list
56426623|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
56426624|NCT00223691|Ergotamine|ergotamine|mesh-list
56426625|NCT00223691|Bromides|bromides|mesh-list
56426626|NCT00223691|Levodopa|levodopa|mesh-list
56426627|NCT00223691|Carbidopa|carbidopa|mesh-list
56426628|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56426629|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
56426630|NCT00223691|Caffeine|caffeine|mesh-list
56426631|NCT00223691|Methylphenidate|methylphenidate|mesh-list
56426632|NCT00223691|Modafinil|modafinil|mesh-list
56912856|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56912857|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56912858|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56392775|NCT02460887|Gemcitabine|gemcitabine|mesh-list
56426633|NCT00223691|Rivastigmine|rivastigmine|mesh-list
56426634|NCT00223691|Ranitidine|ranitidine|mesh-list
56426635|NCT00223691|Yohimbine|yohimbine|mesh-list
56426636|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56426637|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56426638|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56426639|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56426640|NCT00223691|Analgesics|analgesics|mesh-ancestor
56426641|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
56426642|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426643|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426644|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426645|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56426646|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56426647|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426648|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426649|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56426650|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56426651|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56426652|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56426653|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56426654|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
56426655|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426656|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56426657|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56426658|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56426659|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
56426660|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
56426661|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56426662|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56426663|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56426664|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56426665|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426666|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56426667|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56426668|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
56426669|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56426670|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56426671|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426672|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
56426674|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
56426675|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
56426676|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56426677|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
56426678|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
56426679|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56426680|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
56426681|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
56426686|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
56426687|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56426688|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56426689|NCT00223691|Diuretics|diuretics|mesh-ancestor
56426690|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
56426691|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56426692|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56426693|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56426694|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
56426695|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56426696|NCT00223691|Protective Agents|protective agents|mesh-ancestor
56426697|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
56426698|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56426699|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56426700|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56426701|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56426702|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56426703|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
56426704|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
56912859|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
56912860|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392858|NCT00529750|Atenolol|atenolol|mesh-list
56426705|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56426706|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56426707|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
56426708|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
56426709|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56426710|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
56426711|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56426712|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56426713|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56426714|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56426715|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56426716|NCT00223691|Urological Agents|urological agents|mesh-ancestor
56426717|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
56426718|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426719|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56426720|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56426721|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56426722|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
56426723|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56426724|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
56426725|NCT04583020|Temozolomide|temozolomide|mesh-list
56426726|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56426727|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
56426728|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426729|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426730|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56426731|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426732|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426733|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426734|NCT04582786|Morphine|morphine|mesh-list
56426735|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56426736|NCT04582786|Narcotics|narcotics|mesh-ancestor
56426737|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426738|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426739|NCT04582786|Analgesics|analgesics|mesh-ancestor
56426740|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
56426741|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426742|NCT00223769|Oxandrolone|oxandrolone|mesh-list
56426743|NCT00223769|Androgens|androgens|mesh-ancestor
56426744|NCT00223769|Hormones|hormones|mesh-ancestor
56426745|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56426746|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426747|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
56426748|NCT04582084|Etanercept|etanercept|mesh-list
56426749|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56426750|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56426751|NCT04582084|Analgesics|analgesics|mesh-ancestor
56426752|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
56426757|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56426758|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56426759|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
56426760|NCT00254046|Etravirine|etravirine|mesh-list
56426761|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56426762|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56426763|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426764|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426765|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
56426766|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426767|NCT00223925|Maribavir|maribavir|mesh-list
56426768|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
56426769|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426770|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
56426771|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56426772|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426773|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
56426775|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56426776|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
56426777|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426778|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56426779|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56912861|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56912862|NCT04378114|Acetaminophen|acetaminophen|mesh-list
56426780|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
56426781|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426782|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426783|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56426784|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56426785|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56426786|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56426787|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426788|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
56426789|NCT00223964|Hematinics|hematinics|mesh-ancestor
56426790|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
56426791|NCT00224081|Hematinics|hematinics|mesh-ancestor
56426792|NCT04581265|Paclitaxel|paclitaxel|mesh-list
56426793|NCT04581265|Ifosfamide|ifosfamide|mesh-list
56426794|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56426795|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56426796|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426797|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
56426798|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
56426799|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
56426800|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426801|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56426802|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
56426803|NCT04580797|PF-06700841|pf-06700841|mesh-list
56426804|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56426805|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426806|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426807|NCT00568477|Rituximab|rituximab|mesh-list
56426808|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56426809|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426810|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
56426811|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426812|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56426814|NCT00568711|Rifampin|rifampin|mesh-list
56426815|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56426816|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426817|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
56426818|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56426819|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56426820|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56426821|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
56426822|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
56426823|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56426824|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426825|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426828|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56426829|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56426830|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56426831|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56426833|NCT00415116|Docetaxel|docetaxel|mesh-list
56426834|NCT00415116|Lenalidomide|lenalidomide|mesh-list
56426835|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426836|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
56426837|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
56426838|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
56426839|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426840|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
56426841|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426842|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56426843|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56426844|NCT00415116|Growth Substances|growth substances|mesh-ancestor
56426845|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
56426846|NCT00568750|Dasatinib|dasatinib|mesh-list
56426847|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426848|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56426849|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426850|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426852|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56426853|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56426854|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426855|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912863|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912864|NCT04378114|Analgesics|analgesics|mesh-ancestor
56912865|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
56426856|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56426857|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
56426858|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
56426859|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426860|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426861|NCT00254202|Iloperidone|iloperidone|mesh-list
56426862|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56426863|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56426864|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426865|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426866|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426867|NCT00568984|Metformin|metformin|mesh-list
56426868|NCT00568984|Repaglinide|repaglinide|mesh-list
56426869|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56426870|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426871|NCT00254241|Risperidone|risperidone|mesh-list
56426872|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56426873|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56426874|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
56426875|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426876|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426877|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426878|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56426879|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56426880|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426881|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426882|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56426884|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
56426885|NCT00224315|Risperidone|risperidone|mesh-list
56426886|NCT00224315|Ziprasidone|ziprasidone|mesh-list
56426887|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56426888|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
56426889|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426890|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426891|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426892|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56426893|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56426894|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56426895|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56426896|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56426897|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
56426898|NCT00569101|Tacrolimus|tacrolimus|mesh-list
56426899|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56426902|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56426903|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426904|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426905|NCT00224354|Interleukin-2|interleukin-2|mesh-list
56426906|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
56426907|NCT00224354|Immunotoxins|immunotoxins|mesh-list
56426908|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426909|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56426910|NCT00224354|Analgesics|analgesics|mesh-ancestor
56426911|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
56426912|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426913|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426914|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
56426915|NCT00569296|Aldesleukin|aldesleukin|mesh-list
56426916|NCT00569296|Sargramostim|sargramostim|mesh-list
56426917|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
56426918|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426919|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426920|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56426921|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56426922|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
56426923|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426925|NCT00569335|Irinotecan|irinotecan|mesh-list
56426926|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56426927|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426928|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56426929|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56426930|NCT00569335|Growth Substances|growth substances|mesh-ancestor
56426931|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426932|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
56426933|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56426934|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56426935|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426936|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426937|NCT00224393|Etanercept|etanercept|mesh-list
56426938|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56426939|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56426940|NCT00224393|Analgesics|analgesics|mesh-ancestor
56426941|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
56426942|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426943|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426944|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426945|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56426946|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56426947|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56426948|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
56426949|NCT00254319|Bevacizumab|bevacizumab|mesh-list
56426950|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56426951|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426952|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56426953|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56426954|NCT00254319|Growth Substances|growth substances|mesh-ancestor
56426955|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426956|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
56426957|NCT00569452|Insulin|insulin|mesh-list
56426958|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56426959|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56426960|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426961|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
56426962|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
56426963|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56426964|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56426965|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56426966|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56426967|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426968|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426969|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426970|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56426971|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56426972|NCT00224471|Vaccines|vaccines|mesh-list
56426973|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
56426974|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426976|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
56426977|NCT00569920|BB 1101|bb 1101|mesh-list
56426978|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426979|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
56426980|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
56426981|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426982|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426983|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56426984|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
56426985|NCT00569920|Hormones|hormones|mesh-ancestor
56426986|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56426987|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56426988|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56426989|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
56426990|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426991|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56426992|NCT00224510|Lamotrigine|lamotrigine|mesh-list
56426993|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
56426994|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56426995|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56426996|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174765|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
56426997|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56426998|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426999|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56427000|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56427001|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427002|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427003|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56427004|NCT00570193|Ranibizumab|ranibizumab|mesh-list
56427005|NCT00570193|Verteporfin|verteporfin|mesh-list
56393145|NCT00528385|Diuretics|diuretics|mesh-ancestor
56427006|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56427007|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56427008|NCT00570193|Growth Substances|growth substances|mesh-ancestor
56427009|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427010|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
56427011|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427012|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56427013|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
56427014|NCT00224549|Amlodipine|amlodipine|mesh-list
56427015|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56427016|NCT00224549|Irbesartan|irbesartan|mesh-list
56427017|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56427018|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56427019|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427020|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427021|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56427022|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427023|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
56427024|NCT00224549|Diuretics|diuretics|mesh-ancestor
56427025|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
56427026|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56427027|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56427028|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56427029|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
56427030|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56427031|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
56427032|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427033|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427034|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56427035|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
56427036|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
56427037|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56427038|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
56427039|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427040|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427041|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
56427042|NCT00254436|Hematinics|hematinics|mesh-ancestor
56427043|NCT00224588|Ketamine|ketamine|mesh-list
56427044|NCT00224588|Analgesics|analgesics|mesh-ancestor
56427045|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
56427046|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427047|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427050|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
56427051|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
56427052|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427053|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56427054|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56427055|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427056|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427057|NCT00570622|Pioglitazone|pioglitazone|mesh-list
56427058|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56427059|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427060|NCT00254475|Valsartan|valsartan|mesh-list
56427061|NCT00254475|Simvastatin|simvastatin|mesh-list
56427062|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56427063|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56427064|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
56427065|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427066|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56427067|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56427068|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427069|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56427070|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56427071|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56427072|NCT00570856|Folic Acid|folic acid|mesh-list
56427073|NCT00570856|Hematinics|hematinics|mesh-ancestor
56427074|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
56427075|NCT00570856|Vitamins|vitamins|mesh-ancestor
56427076|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
56427077|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427078|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
56427079|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
56427080|NCT00570934|Vitamin D|vitamin d|mesh-list
56427081|NCT00570934|Calcium|calcium|mesh-list
56912866|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912867|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912868|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
56427082|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56427083|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427084|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56427085|NCT00570934|Vitamins|vitamins|mesh-ancestor
56427086|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
56427087|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
56427088|NCT00254553|Testosterone|testosterone|mesh-list
56427089|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
56427090|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
56427091|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56427092|NCT00254553|Androgens|androgens|mesh-ancestor
56427093|NCT00254553|Hormones|hormones|mesh-ancestor
56427094|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427095|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427096|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56427097|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427098|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
56427099|NCT00571129|Mitomycins|mitomycins|mesh-list
56427100|NCT00571129|Mitomycin|mitomycin|mesh-list
56427101|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56427102|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427103|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
56427104|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427105|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56427106|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427107|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56427108|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427109|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
56427110|NCT03453931|Hormones|hormones|mesh-ancestor
56427111|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427112|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427113|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56427114|NCT03453931|Protective Agents|protective agents|mesh-ancestor
56427115|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56427116|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427117|NCT00571246|Topiramate|topiramate|mesh-list
56427118|NCT00571246|Lamotrigine|lamotrigine|mesh-list
56427119|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
56427120|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56427121|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427123|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427124|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427125|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56427126|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56427127|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56427128|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427129|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427130|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56427131|NCT00254631|Oxycodone|oxycodone|mesh-list
56427132|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56427133|NCT00254631|Narcotics|narcotics|mesh-ancestor
56427134|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427135|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427136|NCT00254631|Analgesics|analgesics|mesh-ancestor
56427137|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
56427138|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427139|NCT00571285|Vitamin D|vitamin d|mesh-list
56427140|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
56427141|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
56427142|NCT00571285|Vitamins|vitamins|mesh-list
56427143|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
56427144|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427145|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56427146|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56427147|NCT00254670|Naltrexone|naltrexone|mesh-list
56427148|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56427149|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56427150|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427151|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
56912869|NCT00082433|Capecitabine|capecitabine|mesh-list
56912870|NCT00082433|Epothilones|epothilones|mesh-list
56912871|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56427152|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427153|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56427154|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56427155|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
56427156|NCT00571636|Fentanyl|fentanyl|mesh-list
56427157|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56427158|NCT00571636|Narcotics|narcotics|mesh-ancestor
56427159|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427160|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427161|NCT00571636|Analgesics|analgesics|mesh-ancestor
56427162|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
56427163|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427164|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56427165|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56427166|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
56427167|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
56427168|NCT00571675|Prednisone|prednisone|mesh-list
56427169|NCT00571675|Docetaxel|docetaxel|mesh-list
56427170|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427171|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
56427172|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
56427173|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
56427174|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427175|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427176|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
56427177|NCT00571675|Hormones|hormones|mesh-ancestor
56427178|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427179|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427180|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56427181|NCT00571714|Ribavirin|ribavirin|mesh-list
56427182|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56427183|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
56427184|NCT00571714|Betaine|betaine|mesh-list
56427185|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
56427186|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427187|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
56427188|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427189|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
56427190|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427191|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56427192|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
56427193|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56427194|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56427195|NCT00571753|Isoniazid|isoniazid|mesh-list
56427196|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
56427197|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56427200|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56427201|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
56427202|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427203|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56427204|NCT00254709|Sirolimus|sirolimus|mesh-list
56427205|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56427206|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427207|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56427208|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427209|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
56427210|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56427211|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
56427212|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427213|NCT00224822|Aripiprazole|aripiprazole|mesh-list
56427214|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
56427215|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427216|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56427217|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56427218|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427219|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427220|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
56427221|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
56174983|NCT01386879|Methylene Blue|methylene blue|mesh-list
56427222|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427223|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912872|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
56912873|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912874|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912875|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
56427224|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56427225|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56427226|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
56427227|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56427228|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56427229|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56427230|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56427231|NCT00571870|Cetrorelix|cetrorelix|mesh-list
56427232|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56427233|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
56427234|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56427235|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427236|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
56427237|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427238|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56427239|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
56427240|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427241|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56427242|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56427243|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427244|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427245|NCT00572026|Methylphenidate|methylphenidate|mesh-list
56427246|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56427247|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427248|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56427249|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56427250|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427251|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427252|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
56427253|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427255|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
56427256|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56427257|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
56427258|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427259|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427260|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
56427261|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427262|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56427263|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
56427264|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427265|NCT00234897|Adalimumab|adalimumab|mesh-list
56427266|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427267|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56427268|NCT00572299|Alendronate|alendronate|mesh-list
56427269|NCT00572299|Prednisone|prednisone|mesh-list
56427271|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
56427272|NCT00572299|Hormones|hormones|mesh-ancestor
56427273|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427274|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427275|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56427276|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427277|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56427278|NCT00234936|Adalimumab|adalimumab|mesh-list
56427279|NCT00234936|Methotrexate|methotrexate|mesh-list
56427280|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56427281|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
56427282|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56427283|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427284|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56427285|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
56427286|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427287|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427288|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
56427289|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427290|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56912876|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
56912877|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
56912878|NCT00094445|Curcumin|curcumin|mesh-list
56427291|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56427292|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
56427293|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56427294|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56427295|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427296|NCT00413075|Belinostat|belinostat|mesh-list
56427297|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427298|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56427299|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427300|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427301|NCT00572650|Vildagliptin|vildagliptin|mesh-list
56427302|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56427303|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427304|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56427305|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
56427306|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427307|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427308|NCT00572689|Exenatide|exenatide|mesh-list
56427309|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56427310|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427311|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56427312|NCT00572689|Incretins|incretins|mesh-ancestor
56427313|NCT00572689|Hormones|hormones|mesh-ancestor
56427314|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427315|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
56427316|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56427317|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427318|NCT00224978|Chloroquine|chloroquine|mesh-list
56427319|NCT00224978|Amebicides|amebicides|mesh-ancestor
56427320|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56427321|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56427322|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427323|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
56427324|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56427325|NCT00572884|Permethrin|permethrin|mesh-list
56427326|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427327|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427328|NCT00573001|Ritonavir|ritonavir|mesh-list
56427329|NCT00573001|Lopinavir|lopinavir|mesh-list
56427330|NCT00573001|Tenofovir|tenofovir|mesh-list
56427331|NCT00573001|Zidovudine|zidovudine|mesh-list
56427332|NCT00573001|Emtricitabine|emtricitabine|mesh-list
56427333|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56427334|NCT00573001|Nevirapine|nevirapine|mesh-list
56427335|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56427336|NCT00573001|Efavirenz|efavirenz|mesh-list
56427337|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56427338|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56427339|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
56427340|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427341|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427342|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56427343|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56427346|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56427347|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56427348|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56427349|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56427350|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
56427351|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56427352|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56427353|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56427354|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56427355|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56427356|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56427357|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
56427358|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427359|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56427360|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56427361|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393507|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427362|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427363|NCT00225056|Docetaxel|docetaxel|mesh-list
56427364|NCT00225056|Capecitabine|capecitabine|mesh-list
56427365|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427366|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
56427367|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
56427368|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
56427369|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427370|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56427371|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
56427372|NCT00225173|Gemcitabine|gemcitabine|mesh-list
56427373|NCT00225173|Prednisone|prednisone|mesh-list
56427374|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
56427375|NCT00225173|Doxorubicin|doxorubicin|mesh-list
56427376|NCT00225173|Etoposide|etoposide|mesh-list
56427377|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
56427378|NCT00225173|Vincristine|vincristine|mesh-list
56427379|NCT00225173|Vinorelbine|vinorelbine|mesh-list
56427380|NCT00225173|Bleomycin|bleomycin|mesh-list
56427381|NCT00225173|Vinblastine|vinblastine|mesh-list
56427382|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56427383|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
56427384|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427385|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56427386|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56427387|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
56427388|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427389|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427390|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56427391|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56427392|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
56427393|NCT00225173|Antiviral Agents|antiviral agents|mesh-ancestor
56427394|NCT00225173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427395|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427396|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56427397|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56427398|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56427399|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427400|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
56427401|NCT00225173|Hormones|hormones|mesh-ancestor
56427402|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427403|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56427404|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56427405|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
56427406|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
56427407|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
56427408|NCT00234975|Ritonavir|ritonavir|mesh-list
56427409|NCT00234975|Lopinavir|lopinavir|mesh-list
56427410|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56427411|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56427412|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
56427413|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427414|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427415|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56427416|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56427417|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
56427423|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56427424|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56427425|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427426|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427427|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56427428|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427429|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
56427430|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56427431|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
56427432|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427433|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56427435|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56427436|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
56427437|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427438|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
56427439|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56427440|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427441|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56912879|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56912880|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912881|NCT00094445|Analgesics|analgesics|mesh-ancestor
56393580|NCT00169182|Vitamins|vitamins|mesh-ancestor
56427442|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56427443|NCT00225290|Growth Substances|growth substances|mesh-ancestor
56427444|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
56427445|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427446|NCT00573547|Fluoxetine|fluoxetine|mesh-list
56427447|NCT00573547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56427448|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56427449|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427450|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427451|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427452|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
56427453|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427454|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56427455|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
56427456|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427457|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56427458|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56427459|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427460|NCT00573664|Gabapentin|gabapentin|mesh-list
56427461|NCT00573664|Analgesics|analgesics|mesh-ancestor
56427462|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
56427463|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427464|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427465|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
56427466|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56427467|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56427468|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427469|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427470|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56427471|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56427472|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427473|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427474|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
56427475|NCT00573742|Candesartan|candesartan|mesh-list
56427476|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56427477|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56427478|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56427479|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427480|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56427481|NCT00254865|Norelgestromin|norelgestromin|mesh-list
56427482|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
56427483|NCT00254865|Estradiol|estradiol|mesh-list
56427484|NCT00254865|Estrogens|estrogens|mesh-ancestor
56427485|NCT00254865|Hormones|hormones|mesh-ancestor
56427486|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427488|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56427489|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56427490|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56427491|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56427492|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56427493|NCT00235053|Fluticasone|fluticasone|mesh-list
56427494|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56427495|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56427496|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427497|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56427498|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
56427499|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427500|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427501|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56427502|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
56427503|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
56427504|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56427505|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56427506|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56427507|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56912882|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
56427508|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
56427509|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427510|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427511|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
56427512|NCT00235053|Hormones|hormones|mesh-ancestor
56427513|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427514|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
56427515|NCT00574015|Acetaminophen|acetaminophen|mesh-list
56427516|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56427517|NCT00574015|Hydrocodone|hydrocodone|mesh-list
56427518|NCT00574015|Bupivacaine|bupivacaine|mesh-list
56427519|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
56427520|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
56427521|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427522|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427523|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
56427524|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427525|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56427526|NCT00574015|Analgesics|analgesics|mesh-ancestor
56427527|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
56427528|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56427529|NCT00574015|Narcotics|narcotics|mesh-ancestor
56427530|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
56427531|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
56427532|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56427533|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427534|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56427535|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56427536|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56427537|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56427538|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427539|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427540|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427541|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427542|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56427543|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
56427544|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427545|NCT00574093|Ranibizumab|ranibizumab|mesh-list
56427546|NCT00574093|Verteporfin|verteporfin|mesh-list
56427547|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56427548|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56427549|NCT00574093|Growth Substances|growth substances|mesh-ancestor
56427550|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427551|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
56427552|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427553|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56427554|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
56427555|NCT00574366|Everolimus|everolimus|mesh-list
56427556|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56427557|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427559|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
56427560|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427561|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56427562|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427563|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427564|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56427565|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56427566|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56427567|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427568|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427569|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427570|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427571|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56427572|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
56427573|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427574|NCT00574483|Quinacrine|quinacrine|mesh-list
56427575|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
56427576|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56427577|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
56427578|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56427579|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912883|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393726|NCT02942602|Ezetimibe|ezetimibe|mesh-list
56427580|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
56427581|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56427582|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
56427583|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427584|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427585|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427586|NCT00235092|Sirolimus|sirolimus|mesh-list
56427587|NCT00235092|Paclitaxel|paclitaxel|mesh-list
56427588|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56427589|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427590|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
56427591|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
56427592|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
56427593|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427594|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56427595|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427596|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56427597|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
56427598|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56427599|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
56427600|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427601|NCT00574600|Vaccines|vaccines|mesh-list
56427602|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
56427603|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427604|NCT00574639|Alprazolam|alprazolam|mesh-list
56427605|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56427606|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427607|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164460|NCT05751876|Dienogest|dienogest|mesh-list
56427608|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56427609|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56427610|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427611|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
56427612|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
56427613|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427614|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427615|NCT00255255|Budesonide|budesonide|mesh-list
56427616|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
56427617|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427618|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56427619|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
56427620|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427621|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427622|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56427623|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
56427624|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
56427625|NCT00255255|Hormones|hormones|mesh-ancestor
56427626|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427627|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56427628|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56427629|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56427631|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427632|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427633|NCT00574756|Ranolazine|ranolazine|mesh-list
56427634|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56427635|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427636|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427637|NCT03453346|Ribavirin|ribavirin|mesh-list
56427638|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
56427639|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
56427640|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427641|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
56427642|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427643|NCT00575068|Galiximab|galiximab|mesh-list
56427644|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427645|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427646|NCT00575224|Interferons|interferons|mesh-list
56427647|NCT00575224|Ribavirin|ribavirin|mesh-list
56427648|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427649|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
56427650|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427651|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
56092046|NCT03459794|Ivermectin|ivermectin|mesh-list
56912884|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912885|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912886|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912887|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912888|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912889|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912890|NCT01081535|Ketorolac|ketorolac|mesh-list
56912891|NCT01081535|Fentanyl|fentanyl|mesh-list
56912892|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56912893|NCT01081535|Narcotics|narcotics|mesh-ancestor
56912894|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912895|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912896|NCT01081535|Analgesics|analgesics|mesh-ancestor
56912897|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
56912898|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427652|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427653|NCT00225797|Oxymorphone|oxymorphone|mesh-list
56427654|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56427655|NCT00225797|Narcotics|narcotics|mesh-ancestor
56427656|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427657|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427658|NCT00225797|Analgesics|analgesics|mesh-ancestor
56427659|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
56427660|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427661|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56427662|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
56427663|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56427664|NCT00591487|Lidocaine|lidocaine|mesh-list
56427665|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
56427666|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
56427667|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427668|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427669|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
56427670|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427671|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56427672|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56427673|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56427674|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427675|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427677|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56427678|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427679|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
56427680|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427681|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56427682|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
56427683|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56427684|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427685|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
56427687|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56427688|NCT00225914|Paroxetine|paroxetine|mesh-list
56427689|NCT00225914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56427690|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56427691|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56427692|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427693|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427694|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
56427695|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427696|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56427697|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
56912899|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56912900|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56912901|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
56427698|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427699|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56427700|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56427701|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427702|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56427703|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56427704|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56427705|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427707|NCT00235248|Warfarin|warfarin|mesh-list
56427708|NCT00235248|Clopidogrel|clopidogrel|mesh-list
56427709|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56427710|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56427711|NCT00235248|Analgesics|analgesics|mesh-ancestor
56427712|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
56427713|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427714|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427715|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427716|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56427717|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56427718|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56427719|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427720|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56427721|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56427722|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427723|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
56427724|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56427725|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56427726|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56427727|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
56427728|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427729|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
56427730|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
56427731|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427732|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
56427733|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56427734|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
56427735|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427736|NCT03451435|Expectorants|expectorants|mesh-ancestor
56427737|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
56427738|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56427739|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
56427740|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427741|NCT03451435|Protective Agents|protective agents|mesh-ancestor
56427742|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427743|NCT03451435|Antidotes|antidotes|mesh-ancestor
56427744|NCT04575064|Remdesivir|remdesivir|mesh-list
56427745|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
56427746|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427747|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
56427748|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427749|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
56427750|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427751|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
56427752|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56427753|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56427754|NCT00255450|Hematinics|hematinics|mesh-ancestor
56427755|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56427756|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56427757|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
56427758|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56427760|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
56427761|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427762|NCT00226109|Spironolactone|spironolactone|mesh-list
56427763|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56427764|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
56427765|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427766|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427767|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56427768|NCT00226109|Diuretics|diuretics|mesh-ancestor
56912902|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
56912903|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56912904|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912905|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912906|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912907|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56912908|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393931|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56427769|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
56427770|NCT04573426|Acetaminophen|acetaminophen|mesh-list
56427771|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56427772|NCT04573426|Analgesics|analgesics|mesh-ancestor
56427773|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
56427774|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427775|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427776|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
56427777|NCT00235287|Candesartan|candesartan|mesh-list
56427778|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
56427779|NCT00235287|Enalapril|enalapril|mesh-list
56427780|NCT00235287|Enalaprilat|enalaprilat|mesh-list
56427781|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56427783|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56427784|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427785|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56427786|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
56427787|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427788|NCT00255489|Gefitinib|gefitinib|mesh-list
56427789|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427790|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56427791|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427792|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427793|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
56427794|NCT04573153|Sorbitol|sorbitol|mesh-list
56427795|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
56427796|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56427797|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56427798|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427799|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427800|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427801|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56427802|NCT04573153|Cathartics|cathartics|mesh-ancestor
56427803|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56427804|NCT04573192|Lomustine|lomustine|mesh-list
56427805|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56427806|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
56427807|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427808|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427809|NCT00255528|Metoprolol|metoprolol|mesh-list
56427810|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56427811|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56427812|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
56427813|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
56427814|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427815|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427816|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56427817|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56427818|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56427819|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
56175584|NCT01390519|Everolimus|everolimus|mesh-list
56427821|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427822|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56427823|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56427824|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56427825|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427826|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427827|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427828|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56912909|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912910|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
56427829|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56427831|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427832|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427833|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56427834|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56427835|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
56427836|NCT04572724|Valsartan|valsartan|mesh-list
56427837|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56427838|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56427839|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56427840|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56427841|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427842|NCT00255567|Paromomycin|paromomycin|mesh-list
56427843|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56427844|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56427845|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427846|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56427847|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56427848|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
56427849|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56427850|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
56427851|NCT03450967|Durvalumab|durvalumab|mesh-list
56427852|NCT03450967|Tremelimumab|tremelimumab|mesh-list
56427853|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56427854|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427859|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
56427860|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
56427861|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427862|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427863|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
56427864|NCT00255606|Hormones|hormones|mesh-ancestor
56427865|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427866|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427867|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56427868|NCT00226343|Valproic Acid|valproic acid|mesh-list
56427869|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
56427870|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427871|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427872|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
56427873|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427874|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427875|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
56427876|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56427877|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427878|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56427879|NCT03450499|Ketamine|ketamine|mesh-list
56427880|NCT03450499|Analgesics|analgesics|mesh-ancestor
56427881|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
56427882|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427883|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427884|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56427885|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56427886|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
56427887|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
56427888|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427889|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56427890|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56427891|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333880|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56427892|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427893|NCT00226382|Interferons|interferons|mesh-list
56427894|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
56427895|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
56427896|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56427897|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427898|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
56427899|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427900|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
56427901|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912911|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56912912|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
56912913|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
56912914|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912915|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427902|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56427903|NCT01580839|Plasminogen|plasminogen|mesh-list
56427904|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56427905|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56427906|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427907|NCT03450226|Bupivacaine|bupivacaine|mesh-list
56427908|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
56427909|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
56427910|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427911|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427912|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
56427913|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427914|NCT00226421|Oxymorphone|oxymorphone|mesh-list
56427915|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56427916|NCT00226421|Narcotics|narcotics|mesh-ancestor
56427917|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56427918|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427919|NCT00226421|Analgesics|analgesics|mesh-ancestor
56427920|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
56427921|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427922|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56427923|NCT04572373|SMOFlipid|smoflipid|mesh-list
56427924|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56427925|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56427926|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56427928|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56427929|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427930|NCT03456700|Sirolimus|sirolimus|mesh-list
56427931|NCT03456700|Auranofin|auranofin|mesh-list
56427932|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56427933|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427934|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56427935|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427936|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
56427937|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56427938|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
56427939|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427940|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56427941|NCT00413387|Budesonide|budesonide|mesh-list
56427942|NCT00413387|Beclomethasone|beclomethasone|mesh-list
56427943|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
56427944|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427945|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56427946|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
56427947|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427948|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427949|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56427950|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
56427951|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
56427952|NCT00413387|Hormones|hormones|mesh-ancestor
56427953|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56427954|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56427955|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56427956|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56427957|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
56427958|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427959|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427960|NCT00413426|Darifenacin|darifenacin|mesh-list
56427961|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56427962|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56427963|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
56427964|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427965|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427966|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175728|NCT01391377|Niacin|niacin|mesh-list
56912916|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912917|NCT01087229|Analgesics|analgesics|mesh-ancestor
56912918|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
56912919|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912920|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56912921|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56427967|NCT00413426|Urological Agents|urological agents|mesh-ancestor
56427968|NCT00255762|Paclitaxel|paclitaxel|mesh-list
56427969|NCT00255762|Bevacizumab|bevacizumab|mesh-list
56427970|NCT00255762|Carboplatin|carboplatin|mesh-list
56427971|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56427972|NCT00255762|Antibodies|antibodies|mesh-list
56427973|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
56427974|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56427975|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56427976|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427977|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
56427978|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
56427979|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
56427980|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427981|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56427982|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56427983|NCT00255762|Growth Substances|growth substances|mesh-ancestor
56427984|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427985|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
56427986|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
56427987|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56427988|NCT02277457|Crizotinib|crizotinib|mesh-list
56427989|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427990|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56427991|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427992|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56427993|NCT00255879|Olanzapine|olanzapine|mesh-list
56427994|NCT00255879|Risperidone|risperidone|mesh-list
56427995|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56427996|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56427997|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
56427998|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56427999|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776716|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56428001|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56428002|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56428003|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428004|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56428005|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56428006|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
56428007|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
56428008|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
56428009|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428010|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428011|NCT00255879|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56428012|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56428013|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56428014|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
56428015|NCT00413504|PENTA|penta|mesh-list
56428016|NCT00413504|Fondaparinux|fondaparinux|mesh-list
56428017|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56428018|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
56428019|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56428020|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
56428021|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428022|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428023|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
56428024|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56428025|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56428026|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56428027|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428028|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428029|NCT04710498|Atezolizumab|atezolizumab|mesh-list
56428030|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428031|NCT00226538|Fluconazole|fluconazole|mesh-list
56912922|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56912923|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912924|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56912925|NCT01084577|Laxatives|laxatives|mesh-ancestor
56912926|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56912927|NCT00094055|Axitinib|axitinib|mesh-list
56394212|NCT02939248|Analgesics|analgesics|mesh-ancestor
56428032|NCT00226538|Rifampin|rifampin|mesh-list
56428033|NCT00226538|Diclofenac|diclofenac|mesh-list
56428034|NCT00226538|Phenytoin|phenytoin|mesh-list
56428035|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56428036|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56428037|NCT00226538|Analgesics|analgesics|mesh-ancestor
56428038|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
56428039|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428040|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428041|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56428042|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56428043|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56428044|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428045|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428046|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
56428047|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428049|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56428050|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56428051|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
56428052|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56428053|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56428054|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56428055|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56428056|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
56428057|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428058|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
56428059|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56428060|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56428061|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56428062|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56428063|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56428064|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56428065|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56428066|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
56428067|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56428068|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56428069|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56428070|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56428071|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
56428072|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56428079|NCT00226694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56428080|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56428081|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56428082|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428083|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428084|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
56428085|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428086|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56428087|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
56428088|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56428090|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428091|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428092|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56428093|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428094|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428095|NCT00226889|Bosentan|bosentan|mesh-list
56428096|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56394284|NCT00169728|Vaccines|vaccines|mesh-list
56428097|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56428098|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428099|NCT00226967|Octreotide|octreotide|mesh-list
56428100|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428101|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56428102|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428103|NCT00199381|Istradefylline|istradefylline|mesh-list
56428104|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56428105|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56428106|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56428107|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
56428108|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428109|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428110|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428111|NCT00227084|Hemostatics|hemostatics|mesh-list
56428112|NCT00227084|Coagulants|coagulants|mesh-ancestor
56428113|NCT00227123|Risperidone|risperidone|mesh-list
56428114|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56428115|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56428117|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428118|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428119|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428120|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56428121|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56428122|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428123|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56428124|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56428125|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
56428126|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
56428127|NCT00235521|Iloprost|iloprost|mesh-list
56428128|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56428129|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
56428130|NCT00235560|Sirolimus|sirolimus|mesh-list
56428131|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428132|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428133|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56428134|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428135|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
56428136|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428137|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
56428138|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428139|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
56428140|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56428142|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56428143|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428144|NCT00227357|Buprenorphine|buprenorphine|mesh-list
56428145|NCT00227357|Methadone|methadone|mesh-list
56428146|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56428147|NCT00227357|Naloxone|naloxone|mesh-list
56428148|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56428149|NCT00227357|Narcotics|narcotics|mesh-ancestor
56428150|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428151|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428152|NCT00227357|Analgesics|analgesics|mesh-ancestor
56428153|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
56428154|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428155|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56428156|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
56428157|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
56428158|NCT00198133|Pemetrexed|pemetrexed|mesh-list
56428159|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428160|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428161|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428162|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56428163|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56428164|NCT00227474|Vaccines|vaccines|mesh-list
56428165|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
56428166|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428167|NCT00227513|Bortezomib|bortezomib|mesh-list
56428168|NCT00227513|Vorinostat|vorinostat|mesh-list
56428169|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428170|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56428171|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888162|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912928|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912929|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56428172|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428173|NCT00227630|Pemetrexed|pemetrexed|mesh-list
56428174|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428175|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428176|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428177|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56428178|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56428179|NCT00256230|Disulfiram|disulfiram|mesh-list
56428180|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56428181|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56428182|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428183|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428184|NCT00227669|Gemcitabine|gemcitabine|mesh-list
56428185|NCT00227669|Docetaxel|docetaxel|mesh-list
56428186|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56428187|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
56428188|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428189|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428190|NCT00227669|Antiviral Agents|antiviral agents|mesh-ancestor
56428191|NCT00227669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428192|NCT00227669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428193|NCT00227669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428194|NCT00227669|Immunologic Factors|immunologic factors|mesh-ancestor
56428195|NCT00227669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428196|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56428197|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56428198|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56428199|NCT00235794|Sirolimus|sirolimus|mesh-list
56428200|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428201|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428202|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56428203|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428204|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
56428205|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428206|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
56428207|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428208|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
56428209|NCT00256269|Irinotecan|irinotecan|mesh-list
56428210|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428211|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56428212|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56428213|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776879|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
56428216|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
56428217|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428218|NCT00227708|Docetaxel|docetaxel|mesh-list
56428219|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428220|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56428221|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56428222|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56428223|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428224|NCT00235911|Budesonide|budesonide|mesh-list
56428225|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
56428226|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56428227|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56428228|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
56428229|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428230|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428231|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56428232|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
56428233|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
56428234|NCT00235911|Hormones|hormones|mesh-ancestor
56428235|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56428236|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56428237|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56428238|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56428239|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
56428240|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428241|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428242|NCT00256347|Morphine|morphine|mesh-list
56428243|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56912930|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912931|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912932|NCT02531165|Aspirin|aspirin|mesh-list
56428244|NCT00256347|Narcotics|narcotics|mesh-ancestor
56428245|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428246|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428247|NCT00256347|Analgesics|analgesics|mesh-ancestor
56428248|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
56428249|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428250|NCT00227747|Capecitabine|capecitabine|mesh-list
56428251|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
56428252|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56428253|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
56428254|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428255|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428256|NCT00235950|Clopidogrel|clopidogrel|mesh-list
56428257|NCT00235950|Atorvastatin|atorvastatin|mesh-list
56428258|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56428259|NCT00235950|Simvastatin|simvastatin|mesh-list
56428260|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56428261|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56428262|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
56428263|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428264|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56428265|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56428266|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428267|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56428268|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56428269|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56428270|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56428271|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
56428272|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428273|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428275|NCT00227942|Estrogens|estrogens|mesh-list
56428276|NCT00227942|Hormones|hormones|mesh-ancestor
56428277|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56428278|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428279|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56428280|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56428281|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428282|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56428283|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
56428284|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
56428285|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428289|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56428290|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56428291|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428292|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428293|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
56428294|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428295|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56428296|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
56428297|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56428298|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56428299|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56428300|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428301|NCT00236028|Infliximab|infliximab|mesh-list
56428302|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
56428303|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428304|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56428305|NCT00256542|Lidocaine|lidocaine|mesh-list
56428306|NCT00256542|Heparin|heparin|mesh-list
56428307|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
56428308|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
56428309|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428310|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428311|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
56428312|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428313|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56428314|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56912933|NCT02531165|Heparin|heparin|mesh-list
56912934|NCT02531165|Fentanyl|fentanyl|mesh-list
56912935|NCT02531165|Morphine|morphine|mesh-list
56912936|NCT02531165|Ticagrelor|ticagrelor|mesh-list
56912937|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56912938|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56912939|NCT02531165|Analgesics|analgesics|mesh-ancestor
56912940|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
56912941|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912942|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912943|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56428315|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56428316|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56428317|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428318|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
56428319|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56428320|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56428321|NCT00228020|Cyclosporine|cyclosporine|mesh-list
56428322|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
56428323|NCT00228020|Prednisone|prednisone|mesh-list
56428324|NCT00228020|Cyclosporins|cyclosporins|mesh-list
56428325|NCT00228020|Basiliximab|basiliximab|mesh-list
56428326|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56428327|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
56428328|NCT00228020|Hormones|hormones|mesh-ancestor
56428329|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56428330|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428331|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56428332|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428333|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428334|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428335|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428336|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
56428337|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
56428338|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428339|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
56428340|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56428341|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56428342|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56428343|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56428344|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
56428345|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428346|NCT00236067|Tiagabine|tiagabine|mesh-list
56428347|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
56428348|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56428349|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56428350|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56428351|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428352|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
56428353|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428354|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428355|NCT00195715|Adalimumab|adalimumab|mesh-list
56428356|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56428360|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428361|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
56428362|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428363|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56428364|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428365|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428366|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56428367|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56428368|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56428369|NCT00236145|Fentanyl|fentanyl|mesh-list
56428370|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56428371|NCT00236145|Narcotics|narcotics|mesh-ancestor
56428372|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912944|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912945|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56912946|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56428373|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428374|NCT00236145|Analgesics|analgesics|mesh-ancestor
56428375|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
56428376|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428377|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56428378|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56428379|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
56428380|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
56428381|NCT00228254|Vitamin A|vitamin a|mesh-list
56428382|NCT00228254|Vitamins|vitamins|mesh-ancestor
56428383|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
56428384|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428385|NCT00195676|Adalimumab|adalimumab|mesh-list
56428386|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56428387|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56428388|NCT00194077|Aripiprazole|aripiprazole|mesh-list
56428389|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
56428390|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56428391|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56428392|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56428393|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428394|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428395|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
56428396|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
56428397|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428398|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428399|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56428400|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56428401|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
56428402|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56428403|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56428404|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56428405|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56428406|NCT00193609|Capecitabine|capecitabine|mesh-list
56428407|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
56428408|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56428409|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
56428410|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428411|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428412|NCT00228410|Vancomycin|vancomycin|mesh-list
56428413|NCT00228410|Tigecycline|tigecycline|mesh-list
56428414|NCT00228410|Aztreonam|aztreonam|mesh-list
56428415|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428416|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428417|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56428418|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428419|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428420|NCT00193180|Docetaxel|docetaxel|mesh-list
56428421|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
56428422|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428423|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
56428424|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
56428425|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
56428426|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428427|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56428428|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428429|NCT00193063|Gemcitabine|gemcitabine|mesh-list
56428430|NCT00193063|Trastuzumab|trastuzumab|mesh-list
55777105|NCT02944799|Vitamin D|vitamin d|mesh-list
56428446|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428447|NCT00228527|Esomeprazole|esomeprazole|mesh-list
56428448|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56428449|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428450|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56428451|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428452|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428453|NCT00191854|Gemcitabine|gemcitabine|mesh-list
56428454|NCT00191854|Paclitaxel|paclitaxel|mesh-list
56428455|NCT00191854|Carboplatin|carboplatin|mesh-list
56428456|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56428457|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912947|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912948|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56912949|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56912950|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912951|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
56912952|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56912953|NCT02531165|Narcotics|narcotics|mesh-ancestor
56912954|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912955|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56394642|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56428458|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
56428459|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
56428460|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
56428461|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428462|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56428463|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
56428464|NCT00191854|Antiviral Agents|antiviral agents|mesh-ancestor
56428465|NCT00191854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428466|NCT00191854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428467|NCT00191854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428468|NCT00191854|Immunologic Factors|immunologic factors|mesh-ancestor
56428469|NCT00191854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428470|NCT00228605|Fentanyl|fentanyl|mesh-list
56428471|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56428472|NCT00228605|Narcotics|narcotics|mesh-ancestor
56428473|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428474|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428475|NCT00228605|Analgesics|analgesics|mesh-ancestor
56428476|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
56428477|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428478|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56428479|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56428480|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
56428481|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
56428482|NCT00191815|Gemcitabine|gemcitabine|mesh-list
56428483|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428484|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56428485|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
56428486|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428487|NCT00191815|Antiviral Agents|antiviral agents|mesh-ancestor
56428488|NCT00191815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428489|NCT00191815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428490|NCT00191815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428491|NCT00191815|Immunologic Factors|immunologic factors|mesh-ancestor
56428492|NCT00191815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428493|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56428494|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56428495|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56428496|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56428497|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428498|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
56428499|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428500|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428502|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428503|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428504|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428505|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56428506|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56428508|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
56428509|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428510|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56428511|NCT00191269|Gemcitabine|gemcitabine|mesh-list
56428512|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56428513|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
56912956|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56912957|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
56428514|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428515|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428516|NCT00191269|Antiviral Agents|antiviral agents|mesh-ancestor
56428517|NCT00191269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428518|NCT00191269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428519|NCT00191269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428520|NCT00191269|Immunologic Factors|immunologic factors|mesh-ancestor
56428521|NCT00191269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428522|NCT00228878|Insulin|insulin|mesh-list
56428523|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
56428524|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56428525|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428526|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
56428527|NCT00228995|Hematinics|hematinics|mesh-ancestor
56428528|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
56428529|NCT00413946|Hematinics|hematinics|mesh-ancestor
56428530|NCT00229112|Tazobactam|tazobactam|mesh-list
56428531|NCT00229112|Piperacillin|piperacillin|mesh-list
56428532|NCT00229112|Ertapenem|ertapenem|mesh-list
56428533|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56428534|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428535|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428536|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428537|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56428538|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428539|NCT00256737|Omeprazole|omeprazole|mesh-list
56428540|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56428541|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428542|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56428543|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428544|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428545|NCT00191191|Pemetrexed|pemetrexed|mesh-list
56428546|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428547|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428548|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428549|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56428550|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56428551|NCT00414024|Tegaserod|tegaserod|mesh-list
56428552|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56428553|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
56428554|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428555|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428556|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428557|NCT00256893|Ropinirole|ropinirole|mesh-list
56428558|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56428559|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56428560|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
56428561|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
56428562|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428563|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428564|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428565|NCT00229385|Ziprasidone|ziprasidone|mesh-list
55777216|NCT01986010|Antacids|antacids|mesh-ancestor
56428567|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
56428568|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428569|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428570|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428571|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56428572|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56428573|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428574|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56428575|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56428576|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
56428577|NCT00236223|Dexamethasone|dexamethasone|mesh-list
56428579|NCT00236223|Gabapentin|gabapentin|mesh-list
56428580|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56428581|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
56428582|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
56428583|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428584|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428585|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428586|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
56428587|NCT00236223|Hormones|hormones|mesh-ancestor
56912958|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
56912959|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
56912960|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56394781|NCT00175929|Brivaracetam|brivaracetam|mesh-list
56428588|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56428589|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56428590|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428591|NCT00236223|Analgesics|analgesics|mesh-ancestor
56428592|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
56428593|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56428594|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56428595|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
56428596|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
56428597|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428598|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56428599|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56428600|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428601|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428602|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
56428603|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56428604|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56428605|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56428606|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
56428607|NCT00229424|Famotidine|famotidine|mesh-list
56428608|NCT00229424|Lafutidine|lafutidine|mesh-list
56428609|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56428610|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428611|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56428612|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
56428613|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
56428614|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428615|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428616|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428617|NCT00256932|Alvimopan|alvimopan|mesh-list
56428618|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428619|NCT00191152|Gemcitabine|gemcitabine|mesh-list
56428620|NCT00191152|Capecitabine|capecitabine|mesh-list
56428621|NCT00191152|Docetaxel|docetaxel|mesh-list
56428622|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56428623|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
56428624|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428625|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428626|NCT00191152|Antiviral Agents|antiviral agents|mesh-ancestor
56428627|NCT00191152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428628|NCT00191152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428629|NCT00191152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428630|NCT00191152|Immunologic Factors|immunologic factors|mesh-ancestor
56428631|NCT00191152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428632|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
56428633|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
56428634|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
56428635|NCT00257049|Levofloxacin|levofloxacin|mesh-list
56428636|NCT00257049|Ofloxacin|ofloxacin|mesh-list
56428637|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56428639|NCT00257049|Renal Agents|renal agents|mesh-ancestor
56428640|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428641|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56428642|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55777285|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428644|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428646|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56428647|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56428648|NCT01059188|Docetaxel|docetaxel|mesh-list
56428649|NCT01059188|Cetuximab|cetuximab|mesh-list
56428650|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428651|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56428652|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56428653|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56428654|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428655|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56428656|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56428657|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56912961|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56912962|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56912963|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
56912964|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912965|NCT00099983|Risperidone|risperidone|mesh-list
56912966|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56912967|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
56912968|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56912969|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394855|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
56428658|NCT00236301|Estradiol|estradiol|mesh-list
56428659|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56428660|NCT00236301|Estrogens|estrogens|mesh-ancestor
56428661|NCT00236301|Hormones|hormones|mesh-ancestor
56428662|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56428663|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428664|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56428665|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
56428666|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56428667|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56428668|NCT00229697|Tamoxifen|tamoxifen|mesh-list
56428669|NCT00229697|Gefitinib|gefitinib|mesh-list
56428670|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56428671|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
56428672|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56428673|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428674|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56428675|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428676|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56428677|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56428678|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56428679|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56428680|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428681|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428682|NCT00236379|Olanzapine|olanzapine|mesh-list
56428683|NCT00236379|Risperidone|risperidone|mesh-list
56428684|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56428685|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
56428686|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428687|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428688|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428689|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56428690|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56428691|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428692|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56428693|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56428694|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
56428695|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
56428696|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
56428697|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428698|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428699|NCT00236379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56428700|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56428701|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56428702|NCT00229775|Chloroquine|chloroquine|mesh-list
56428703|NCT00229775|Artemether|artemether|mesh-list
56428704|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
56428705|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
56428706|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56428707|NCT00229775|Amebicides|amebicides|mesh-ancestor
56428708|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56428709|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56428710|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428711|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
56428712|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912970|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912971|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56912972|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56912973|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912974|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56912975|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56912976|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
56912977|NCT00099359|Lamivudine|lamivudine|mesh-list
56912978|NCT00099359|Zidovudine|zidovudine|mesh-list
56912979|NCT00099359|Nevirapine|nevirapine|mesh-list
56912980|NCT00099359|Nelfinavir|nelfinavir|mesh-list
56912981|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56912982|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56912983|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912984|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912985|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
56912986|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912987|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56912988|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56912989|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
56428713|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56428714|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428715|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176481|NCT01395654|Rifampin|rifampin|mesh-list
55777359|NCT04416334|Acetaminophen|acetaminophen|mesh-list
56428720|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
56428721|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428722|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56428723|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56428724|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56428725|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56428726|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428727|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
56428728|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428729|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428730|NCT00236418|Topiramate|topiramate|mesh-list
56428731|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
56428732|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56428733|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428734|NCT00236457|Risperidone|risperidone|mesh-list
56428735|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56428736|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
56428737|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428738|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428739|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428740|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56428741|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56428742|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428743|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56428744|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56428745|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
56428746|NCT00236496|Topiramate|topiramate|mesh-list
56428747|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
56428748|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56428749|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428750|NCT00199277|Iron|iron|mesh-list
56428751|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56912990|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56912991|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56428752|NCT00199277|Trace Elements|trace elements|mesh-ancestor
56428753|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
56428754|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428755|NCT00199277|Hematinics|hematinics|mesh-ancestor
56428756|NCT00236535|Acetaminophen|acetaminophen|mesh-list
56428757|NCT00236535|Tramadol|tramadol|mesh-list
56428758|NCT00236535|Hydrocodone|hydrocodone|mesh-list
56428759|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56428760|NCT00236535|Analgesics|analgesics|mesh-ancestor
56428761|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
56428762|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428763|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428764|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
56428765|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56428766|NCT00236535|Narcotics|narcotics|mesh-ancestor
56428767|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428768|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
56428769|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
56428770|NCT00193219|Leucovorin|leucovorin|mesh-list
56428771|NCT00193219|Bevacizumab|bevacizumab|mesh-list
56428772|NCT00193219|Cetuximab|cetuximab|mesh-list
56428773|NCT00193219|Fluorouracil|fluorouracil|mesh-list
56428774|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
56428775|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56428776|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428777|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56428778|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56428779|NCT00193219|Growth Substances|growth substances|mesh-ancestor
56428780|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428781|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
56428782|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
56428783|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428784|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56428786|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
56428787|NCT00193219|Antidotes|antidotes|mesh-ancestor
56428788|NCT00193219|Protective Agents|protective agents|mesh-ancestor
56176561|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
56428789|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
56428790|NCT00193219|Vitamins|vitamins|mesh-ancestor
56428791|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
56428804|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56428805|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428806|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428807|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56428808|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
56428809|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56428810|NCT00257361|Cycloserine|cycloserine|mesh-list
56428811|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56428812|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428813|NCT00257361|Renal Agents|renal agents|mesh-ancestor
56428814|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56428815|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
56428816|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428817|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
56428818|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428819|NCT00199355|Istradefylline|istradefylline|mesh-list
56428820|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56428821|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56428822|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56428823|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
56428824|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428825|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428826|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428827|NCT00179959|Mupirocin|mupirocin|mesh-list
56428828|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56428829|NCT00179959|Eusol|eusol|mesh-list
56428830|NCT00179959|Petrolatum|petrolatum|mesh-list
56428831|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428832|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428833|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56428834|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428835|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912992|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56912993|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56912994|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
56428836|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
56428837|NCT00179959|Emollients|emollients|mesh-ancestor
56428838|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
56428839|NCT00199394|Istradefylline|istradefylline|mesh-list
56428840|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56428841|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56428842|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56428843|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
56428844|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428845|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428846|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428847|NCT00236574|Galantamine|galantamine|mesh-list
56428848|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56428849|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428850|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428851|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
56428852|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428853|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428854|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56428881|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428882|NCT00236652|Renal Agents|renal agents|mesh-ancestor
56428883|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428884|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56428885|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56428886|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428887|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428888|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428889|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56428890|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56428891|NCT00257595|Cetirizine|cetirizine|mesh-list
56428892|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56428893|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56428894|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56428895|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
56428896|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
56428897|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428898|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428899|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428900|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
56428901|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56428902|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428903|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56428904|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
56428905|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428918|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56428919|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56428920|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
56428921|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428922|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56428923|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56428924|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428925|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
56428926|NCT04709172|Cefditoren|cefditoren|mesh-list
56428927|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428928|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428929|NCT00199784|Phenylephrine|phenylephrine|mesh-list
56428930|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
56428931|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56428932|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
56428933|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
56428934|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428935|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428936|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
56428937|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56428938|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
56428939|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
56333881|NCT02967432|Mupirocin|mupirocin|mesh-list
56428940|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56912995|NCT00092417|Vaccines|vaccines|mesh-list
56912996|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
56428941|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56428942|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56428943|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
56428944|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428945|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428946|NCT00199784|Protective Agents|protective agents|mesh-ancestor
56428947|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56428948|NCT00236769|Norelgestromin|norelgestromin|mesh-list
56428949|NCT00236769|Estradiol|estradiol|mesh-list
56428950|NCT00236769|Estrogens|estrogens|mesh-ancestor
56428951|NCT00236769|Hormones|hormones|mesh-ancestor
56428952|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56428953|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428954|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56428955|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
56428956|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56428957|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56428958|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56428959|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56428960|NCT00415311|Lectins|lectins|mesh-list
56428961|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
56428962|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
56428963|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428964|NCT00415311|Coagulants|coagulants|mesh-ancestor
56428965|NCT00199940|Ziprasidone|ziprasidone|mesh-list
56428966|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56428967|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
56428968|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428969|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428975|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56428976|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
56428977|NCT00236808|Levofloxacin|levofloxacin|mesh-list
56428978|NCT00236808|Ofloxacin|ofloxacin|mesh-list
56428979|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56428980|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428981|NCT00236808|Renal Agents|renal agents|mesh-ancestor
56428982|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56428983|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56428984|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56428985|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428986|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428987|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428988|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56428989|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56428990|NCT00199979|Nevirapine|nevirapine|mesh-list
56428991|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56428992|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56428993|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428994|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428995|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
56428996|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428997|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56428998|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56428999|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56429000|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56429001|NCT00257634|Dexamethasone|dexamethasone|mesh-list
56429002|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429003|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
56429004|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
56429005|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429006|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429007|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429008|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
56429009|NCT00257634|Hormones|hormones|mesh-ancestor
56429010|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429011|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56429012|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429013|NCT00236847|Topiramate|topiramate|mesh-list
56429014|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
56429015|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429016|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429017|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
56429018|NCT00410306|Testosterone|testosterone|mesh-list
56912997|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912998|NCT00091949|Pioglitazone|pioglitazone|mesh-list
56912999|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429019|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
56429020|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
56429021|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56429022|NCT00410306|Androgens|androgens|mesh-ancestor
56429023|NCT00410306|Hormones|hormones|mesh-ancestor
56429024|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429025|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429026|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56429027|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429028|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
56429029|NCT00257712|Hormones|hormones|mesh-list
56429030|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56429031|NCT00257712|Tesamorelin|tesamorelin|mesh-list
56429032|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429033|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429034|NCT00257712|Growth Substances|growth substances|mesh-ancestor
56429035|NCT00179647|Dexamethasone|dexamethasone|mesh-list
56429036|NCT00179647|Lenalidomide|lenalidomide|mesh-list
56429037|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429038|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
56429039|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
56429048|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
56429049|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56429050|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56429051|NCT00179647|Growth Substances|growth substances|mesh-ancestor
56429052|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
56429054|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
56429055|NCT00257751|Coagulants|coagulants|mesh-ancestor
56429056|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56429057|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56429058|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
56429059|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429060|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429061|NCT00179413|Interferons|interferons|mesh-list
56429062|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
56429063|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
56429064|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56429065|NCT00179413|Colchicine|colchicine|mesh-list
56429066|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429067|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
56429068|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429069|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
56429070|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429071|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
56429072|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56429073|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
56429074|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
56429075|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
56429076|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429077|NCT00236886|Topiramate|topiramate|mesh-list
56429078|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
56429079|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429080|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429081|NCT00257790|Tobramycin|tobramycin|mesh-list
56429082|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56429083|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429084|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56429085|NCT00200174|Exemestane|exemestane|mesh-list
56429086|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429087|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56429088|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56429089|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429090|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429091|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56429092|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
56333882|NCT02967432|Petrolatum|petrolatum|mesh-list
56429093|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429094|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429095|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56429096|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56429097|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56913000|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913001|NCT02258542|Benralizumab|benralizumab|mesh-list
56395267|NCT05786365|Ketamine|ketamine|mesh-list
56429098|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
56429099|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429100|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
56429101|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56429102|NCT00236964|Hematinics|hematinics|mesh-ancestor
56429104|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
56429105|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56429106|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429108|NCT00177307|Capecitabine|capecitabine|mesh-list
56429109|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
56429110|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56429111|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429112|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56429113|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56429114|NCT00177307|Growth Substances|growth substances|mesh-ancestor
56429115|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429116|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
56429117|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56429118|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
56429119|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429120|NCT00257829|Methazolamide|methazolamide|mesh-list
56429121|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56429122|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429123|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429124|NCT00257829|Diuretics|diuretics|mesh-ancestor
56429125|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
56429126|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429127|NCT00176644|Estradiol|estradiol|mesh-list
56429128|NCT00176644|Estrogens|estrogens|mesh-ancestor
56429129|NCT00176644|Hormones|hormones|mesh-ancestor
56429130|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429131|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429132|NCT02484664|Celecoxib|celecoxib|mesh-list
56429133|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56429134|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56429135|NCT02484664|Analgesics|analgesics|mesh-ancestor
56429136|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
56429137|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429138|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429139|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429140|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56429141|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56429142|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56429143|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429144|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429145|NCT00257868|Rivastigmine|rivastigmine|mesh-list
56429146|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56429147|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429148|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429149|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
56429150|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429151|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429152|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56429153|NCT00257868|Protective Agents|protective agents|mesh-ancestor
56429154|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
56429155|NCT00176605|Etoposide|etoposide|mesh-list
56429156|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56429157|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
56429158|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429159|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56429160|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56429161|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
56429162|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429163|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429164|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56429165|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56429166|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56429167|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56429168|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913002|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56395375|NCT05785377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429169|NCT00176488|Vinorelbine|vinorelbine|mesh-list
56429170|NCT00176488|Epirubicin|epirubicin|mesh-list
56429171|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56429172|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429173|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
56429174|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
56429175|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
56429176|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429177|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56429178|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56429179|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56429187|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
56429188|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429189|NCT00200447|Carbidopa|carbidopa|mesh-list
56429190|NCT00200447|Levodopa|levodopa|mesh-list
56429191|NCT00200447|Entacapone|entacapone|mesh-list
56429192|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56429193|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56429194|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56429195|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
56429196|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429197|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429198|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429199|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56429200|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429201|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56429202|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
56429203|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429204|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56429205|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429206|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429207|NCT00175825|Brivaracetam|brivaracetam|mesh-list
56429208|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
56429209|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
56429210|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
56429211|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429212|NCT04710329|Protective Agents|protective agents|mesh-ancestor
56429213|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429214|NCT04710329|Vitamins|vitamins|mesh-ancestor
56429215|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
56429216|NCT00200525|Apomorphine|apomorphine|mesh-list
56429217|NCT00200525|Emetics|emetics|mesh-ancestor
56429218|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429219|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
56429220|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429221|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429222|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
56429223|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
56429224|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429225|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429226|NCT00174967|Febuxostat|febuxostat|mesh-list
56429228|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56429229|NCT00200564|Ketamine|ketamine|mesh-list
56429230|NCT00200564|Analgesics|analgesics|mesh-ancestor
56429231|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
56429232|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429233|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429234|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56429235|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56429236|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
56429237|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
56429238|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56429239|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56429240|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56429241|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429242|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429243|NCT00174265|Olanzapine|olanzapine|mesh-list
56429244|NCT00174265|Asenapine|asenapine|mesh-list
56429245|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
56429246|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
56429247|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429248|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913003|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
56913004|NCT00091793|Denosumab|denosumab|mesh-list
56429249|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429250|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56429262|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429263|NCT00200681|Bortezomib|bortezomib|mesh-list
56429264|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429265|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56429266|NCT00258063|Norelgestromin|norelgestromin|mesh-list
56429267|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
56429268|NCT00258063|Estradiol|estradiol|mesh-list
56429269|NCT00258063|Estrogens|estrogens|mesh-ancestor
56429270|NCT00258063|Hormones|hormones|mesh-ancestor
56429271|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429272|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429273|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56429274|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56429275|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56429276|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56429277|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56429278|NCT00258102|Levofloxacin|levofloxacin|mesh-list
56429279|NCT00258102|Ofloxacin|ofloxacin|mesh-list
56429280|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56429281|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429282|NCT00258102|Renal Agents|renal agents|mesh-ancestor
56429283|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56429284|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56429285|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56429286|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429287|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429288|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429289|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56429290|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56429291|NCT00265278|Modafinil|modafinil|mesh-list
56429292|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56429293|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429294|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56429295|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56429296|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56429297|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429298|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
56429299|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56429300|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429302|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56429303|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429304|NCT00258297|Gefitinib|gefitinib|mesh-list
56429305|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56429306|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429307|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56429308|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429309|NCT00258336|Rituximab|rituximab|mesh-list
56429310|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
56429311|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56429312|NCT00258336|Antibodies|antibodies|mesh-list
56429313|NCT00258336|Sargramostim|sargramostim|mesh-list
56429335|NCT00201305|Gemcitabine|gemcitabine|mesh-list
56429336|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56429337|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
56429338|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429339|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429340|NCT00201305|Antiviral Agents|antiviral agents|mesh-ancestor
56429341|NCT00201305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429342|NCT00201305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429343|NCT00201305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56429344|NCT00201305|Immunologic Factors|immunologic factors|mesh-ancestor
56429345|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429346|NCT00201305|Antidotes|antidotes|mesh-ancestor
56429347|NCT00201305|Protective Agents|protective agents|mesh-ancestor
56429348|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
56429349|NCT00201305|Vitamins|vitamins|mesh-ancestor
56429350|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
56429351|NCT00265551|Olanzapine|olanzapine|mesh-list
56429352|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
56429353|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
56092047|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56913005|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56913006|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913007|NCT00098813|Romidepsin|romidepsin|mesh-list
56913008|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56913009|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913010|NCT01081613|Bevacizumab|bevacizumab|mesh-list
56913011|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
56913012|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56913013|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913014|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56913015|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56913016|NCT01081613|Growth Substances|growth substances|mesh-ancestor
56913017|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913018|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
56913019|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56429354|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429355|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429356|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429357|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56429358|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56429359|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56429360|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56429361|NCT00265551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56429362|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56429363|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56429364|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429365|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429366|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
56429367|NCT00201344|Leucovorin|leucovorin|mesh-list
56429368|NCT00201344|Antidotes|antidotes|mesh-ancestor
56429369|NCT00201344|Protective Agents|protective agents|mesh-ancestor
56429370|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429381|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56429382|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429383|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56429384|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429385|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429386|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56429387|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56429388|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56429389|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
56429390|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56429391|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56429392|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56429393|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56429394|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429395|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
56429396|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429397|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429398|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56429399|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429400|NCT00265746|Metformin|metformin|mesh-list
56429401|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429402|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429403|NCT00201539|Morphine|morphine|mesh-list
56429404|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56429405|NCT00201539|Narcotics|narcotics|mesh-ancestor
56429406|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092413|NCT03397394|Rucaparib|rucaparib|mesh-list
56913020|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429407|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429408|NCT00201539|Analgesics|analgesics|mesh-ancestor
56429409|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
56429410|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429411|NCT00265824|Bevacizumab|bevacizumab|mesh-list
56429412|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56429413|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56429414|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429415|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56429416|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56429417|NCT00265824|Growth Substances|growth substances|mesh-ancestor
56429418|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429419|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
56429420|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56429421|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429422|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429423|NCT00201695|Dexamethasone|dexamethasone|mesh-list
56429424|NCT00201695|Doxorubicin|doxorubicin|mesh-list
56429425|NCT00201695|Vincristine|vincristine|mesh-list
56429426|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
56429427|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429428|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
56429429|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
56429430|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429431|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429432|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429433|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
56429434|NCT00201695|Hormones|hormones|mesh-ancestor
56429435|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429436|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56429437|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429438|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56429439|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56429448|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56429449|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
56429450|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56429451|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429452|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56429453|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56429454|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56429455|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
56429456|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56429457|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56429458|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
56429459|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429460|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
56429461|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56429462|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56429463|NCT00265863|Mitomycins|mitomycins|mesh-list
56429464|NCT00265863|Mitomycin|mitomycin|mesh-list
56429465|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56429466|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429467|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
56429468|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429469|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56429470|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429471|NCT00410462|Doxorubicin|doxorubicin|mesh-list
56429472|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56429473|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56429474|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429475|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56429476|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56429477|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429478|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429479|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
56429480|NCT00258765|Docetaxel|docetaxel|mesh-list
56429481|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429482|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
56429483|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
56429484|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
56429485|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913021|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
56913022|NCT02227264|Cinacalcet|cinacalcet|mesh-list
56913023|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56429486|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56429487|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429488|NCT00410540|Morphine|morphine|mesh-list
56429489|NCT00410540|Hydromorphone|hydromorphone|mesh-list
56429490|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56429491|NCT00410540|Narcotics|narcotics|mesh-ancestor
56429492|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56429493|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429494|NCT00410540|Analgesics|analgesics|mesh-ancestor
56429495|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
56429496|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429497|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
56429498|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429499|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429500|NCT00201812|Dexamethasone|dexamethasone|mesh-list
56429501|NCT00201812|Etanercept|etanercept|mesh-list
56429502|NCT00201812|Docetaxel|docetaxel|mesh-list
56429503|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
56429504|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429505|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
56429506|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
56429521|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
56429522|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56429523|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56429524|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
56429525|NCT00258843|Vaccines|vaccines|mesh-list
56429526|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
56429527|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429528|NCT04709094|Bupropion|bupropion|mesh-list
56429529|NCT04709094|Warfarin|warfarin|mesh-list
56429530|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56429531|NCT04709094|Norethindrone|norethindrone|mesh-list
56429532|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
56429533|NCT04709094|Norinyl|norinyl|mesh-list
56429534|NCT04709094|Estradiol|estradiol|mesh-list
56429535|NCT04709094|Estrogens|estrogens|mesh-ancestor
56429536|NCT04709094|Hormones|hormones|mesh-ancestor
56429537|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429538|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429539|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56429540|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
56429541|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56429542|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56429543|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
56429544|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56429545|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
56429546|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56429547|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56429548|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56429549|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56429550|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429552|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429553|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56429554|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56429555|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429556|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56429557|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56429558|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56429559|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56429560|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
56429561|NCT00171340|Letrozole|letrozole|mesh-list
56429562|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429563|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56429564|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56429565|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778139|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
56429582|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56429583|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56429584|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
56429585|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
56429586|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
56429587|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56913024|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913025|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56913026|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
56913027|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56913028|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56913029|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56913030|NCT04772248|Adalimumab|adalimumab|mesh-list
56395817|NCT05616260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395818|NCT05616260|Diuretics|diuretics|mesh-ancestor
56395819|NCT05616260|Natriuretic Agents|natriuretic agents|mesh-ancestor
56395820|NCT05616260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395821|NCT05611034|Oxaliplatin|oxaliplatin|mesh-list
56395822|NCT05611034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395829|NCT05592509|Vitamins|vitamins|mesh-list
56395830|NCT05592509|Micronutrients|micronutrients|mesh-ancestor
56395831|NCT05592509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395832|NCT05591092|Iodine|iodine|mesh-list
56395833|NCT05591092|Cadexomer iodine|cadexomer iodine|mesh-list
56395834|NCT05591092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56395835|NCT05591092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395836|NCT05591092|Trace Elements|trace elements|mesh-ancestor
56395837|NCT05591092|Micronutrients|micronutrients|mesh-ancestor
56395838|NCT05591092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395839|NCT05583227|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56395840|NCT05583227|Immunologic Factors|immunologic factors|mesh-ancestor
56395841|NCT05583227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395846|NCT05582213|Anesthetics|anesthetics|mesh-list
56395847|NCT05582213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395848|NCT05582213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395909|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
56395910|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
56395911|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395912|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395913|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
56395914|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395921|NCT05541276|Melatonin|melatonin|mesh-list
56913031|NCT04772248|Etanercept|etanercept|mesh-list
56913032|NCT04772248|Golimumab|golimumab|mesh-list
56913033|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56913034|NCT04772248|Infliximab|infliximab|mesh-list
56429588|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56429589|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56429590|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56429592|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56429593|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
56429594|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
56429595|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429596|NCT00266058|Ritonavir|ritonavir|mesh-list
56429597|NCT00266058|Lopinavir|lopinavir|mesh-list
56429598|NCT00266058|Efavirenz|efavirenz|mesh-list
56429599|NCT00266058|Lumefantrine|lumefantrine|mesh-list
56429600|NCT00266058|Artemether|artemether|mesh-list
56429601|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56429602|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56429603|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56429604|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
56429605|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429606|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429607|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56429608|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56429609|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
56429610|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429611|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56429612|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56429613|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56429614|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56429615|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56429616|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56429617|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56429618|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56177381|NCT05209841|Heparin|heparin|mesh-list
56429619|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56429624|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429625|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56429626|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429627|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429628|NCT00202124|Tryptophan|tryptophan|mesh-list
56429629|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56429630|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
56429631|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56429632|NCT00266097|Gemcitabine|gemcitabine|mesh-list
56429633|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
56429634|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56429635|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56429636|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
56429637|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429638|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429639|NCT00266097|Antiviral Agents|antiviral agents|mesh-ancestor
56429640|NCT00266097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429641|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429642|NCT00266097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56429643|NCT00266097|Immunologic Factors|immunologic factors|mesh-ancestor
56429644|NCT00266097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429645|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56429646|NCT00202163|Testosterone|testosterone|mesh-list
56429647|NCT00202163|Androgens|androgens|mesh-ancestor
56429648|NCT00202163|Hormones|hormones|mesh-ancestor
56429649|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429650|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429651|NCT00476554|Sapacitabine|sapacitabine|mesh-list
56429652|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429653|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56429654|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56429655|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
56429656|NCT00202241|Testosterone|testosterone|mesh-list
56429657|NCT00202241|Androgens|androgens|mesh-ancestor
56429658|NCT00202241|Hormones|hormones|mesh-ancestor
56429659|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56913035|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
56913036|NCT04772248|Tofacitinib|tofacitinib|mesh-list
56913037|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429660|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429661|NCT00266136|Cytarabine|cytarabine|mesh-list
56429662|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
56429663|NCT00266136|Daunorubicin|daunorubicin|mesh-list
56429664|NCT00266136|Thioguanine|thioguanine|mesh-list
56429665|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56429666|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
56429667|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429668|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56429669|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56429670|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
56429671|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429672|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429673|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56429674|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56429676|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
56429677|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429678|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56429679|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56429680|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56429681|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429682|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56429683|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
56429684|NCT00230594|Coagulants|coagulants|mesh-ancestor
56429685|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56429686|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
56429687|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429688|NCT00259077|Omeprazole|omeprazole|mesh-list
56177452|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177453|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56177454|NCT05138029|Dexamethasone|dexamethasone|mesh-list
56177455|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
56177456|NCT05138029|Ranibizumab|ranibizumab|mesh-list
56177457|NCT05138029|BB 1101|bb 1101|mesh-list
56429692|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429693|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429694|NCT00479674|Paclitaxel|paclitaxel|mesh-list
56429695|NCT00479674|Bevacizumab|bevacizumab|mesh-list
56429696|NCT00479674|Carboplatin|carboplatin|mesh-list
56429697|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56429698|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56429699|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429700|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
56429701|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
56429702|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
56429703|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429704|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56429705|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56429706|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56429707|NCT00479674|Growth Substances|growth substances|mesh-ancestor
56429708|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429709|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
56429710|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56429711|NCT02962310|Calcium|calcium|mesh-list
56429712|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56429713|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429714|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56429715|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56429716|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
56429717|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429718|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56429719|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56429720|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429721|NCT00259116|Methocarbamol|methocarbamol|mesh-list
56429722|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56429723|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429724|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56429725|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429726|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
56429727|NCT00415779|Docetaxel|docetaxel|mesh-list
56429728|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913038|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56913039|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
56913040|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429729|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
56429730|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
56429731|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
56429732|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429733|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56429734|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429735|NCT00259155|Rifaximin|rifaximin|mesh-list
56429737|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429738|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429739|NCT00479401|Pramipexole|pramipexole|mesh-list
56429740|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
56429741|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429742|NCT00479401|Protective Agents|protective agents|mesh-ancestor
56429743|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429744|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56429745|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56429746|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
56429747|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
56429748|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429749|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56429750|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56429751|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56429752|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
56429753|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429754|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429755|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429756|NCT00230789|Urological Agents|urological agents|mesh-ancestor
56429757|NCT00478777|Dexamethasone|dexamethasone|mesh-list
56429758|NCT00478777|Lenalidomide|lenalidomide|mesh-list
55778314|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
56429762|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429763|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429765|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
56429766|NCT00478777|Hormones|hormones|mesh-ancestor
56429767|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429768|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56429769|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429770|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
56429771|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56429772|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56429773|NCT00478777|Growth Substances|growth substances|mesh-ancestor
56429774|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
56429775|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
56429776|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
56429777|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429778|NCT00477607|Protective Agents|protective agents|mesh-ancestor
56429779|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429780|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
56429781|NCT00477607|Vitamins|vitamins|mesh-ancestor
56429782|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
56429783|NCT00230867|Acyclovir|acyclovir|mesh-list
56429784|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
56429785|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429786|NCT00266214|Lidocaine|lidocaine|mesh-list
56429787|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
56429788|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
56429789|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56429790|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429791|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
56429792|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429793|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56429794|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56429795|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56429796|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56429797|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429798|NCT00266253|Metformin|metformin|mesh-list
56429799|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429800|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429801|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
56429802|NCT00230984|Testosterone|testosterone|mesh-list
56913041|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56913042|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56429803|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
56429804|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
56429805|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56429806|NCT00230984|Androgens|androgens|mesh-ancestor
56429807|NCT00230984|Hormones|hormones|mesh-ancestor
56429808|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429809|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429810|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56429811|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429812|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
56429814|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56429815|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429816|NCT00231023|Triamcinolone|triamcinolone|mesh-list
56429817|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56429818|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56429819|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56429820|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429821|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
56429822|NCT00231023|Hormones|hormones|mesh-ancestor
56429823|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429824|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429825|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56429826|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
56429827|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429828|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429829|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56429830|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
56429831|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56429834|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56429836|NCT00231140|Thalidomide|thalidomide|mesh-list
56429837|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56429838|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
56177608|NCT05045313|Probenecid|probenecid|mesh-list
56429839|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429840|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
56429841|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56429842|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429843|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56429844|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56429845|NCT00231140|Growth Substances|growth substances|mesh-ancestor
56429846|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
56429847|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429848|NCT00231218|Propolis|propolis|mesh-list
56429849|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429850|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
56429851|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56429852|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429853|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
56429854|NCT00231335|Citalopram|citalopram|mesh-list
56429855|NCT00231335|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56429856|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56429857|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56429858|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429859|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429860|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
56429861|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429862|NCT00231335|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56429863|NCT00231335|Antidepressive Agents|antidepressive agents|mesh-ancestor
56429864|NCT00231335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56429865|NCT00266487|Vitamins|vitamins|mesh-list
56429866|NCT00266487|Folic Acid|folic acid|mesh-list
56429867|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
56429868|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
56429869|NCT00266487|Pyridoxal|pyridoxal|mesh-list
56429870|NCT00266487|Pyridoxine|pyridoxine|mesh-list
56429871|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
56429872|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
56429873|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429874|NCT00266487|Hematinics|hematinics|mesh-ancestor
56429875|NCT00231452|Artesunate|artesunate|mesh-list
56429876|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
56429877|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
56429878|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56913043|NCT04772248|Analgesics|analgesics|mesh-ancestor
56396336|NCT05169567|Fulvestrant|fulvestrant|mesh-list
56429879|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
56429880|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56429881|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56429882|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429883|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429884|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
56429885|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
56429886|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56429887|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
56429888|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56429889|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429890|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429891|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56429892|NCT00231452|Renal Agents|renal agents|mesh-ancestor
56429893|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
56429894|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56429895|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56429896|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56429897|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56429898|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429899|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
56429900|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429901|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429902|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56429903|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429904|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56429905|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
56429912|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429913|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177681|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429914|NCT00231569|Mipomersen|mipomersen|mesh-list
56429915|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56429916|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56429917|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
56429918|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429919|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56429920|NCT00477334|Famciclovir|famciclovir|mesh-list
56429921|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
56429922|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429923|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56429924|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429925|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429926|NCT00231608|Topiramate|topiramate|mesh-list
56429927|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
56429928|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429929|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429930|NCT00266604|Topiramate|topiramate|mesh-list
56429931|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
56429932|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429933|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429934|NCT04561336|Cetuximab|cetuximab|mesh-list
56429935|NCT04561336|Avelumab|avelumab|mesh-list
56429936|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56429937|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429938|NCT00259428|Dronedarone|dronedarone|mesh-list
56429939|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56429940|NCT00231647|Topiramate|topiramate|mesh-list
56429941|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
56429942|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429943|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429944|NCT04560322|Venetoclax|venetoclax|mesh-list
56429945|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
56429946|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
56429947|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429948|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56429949|NCT04560751|Lenvatinib|lenvatinib|mesh-list
56429950|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429951|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56429952|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429953|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429954|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56429955|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56429956|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56913044|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
56913045|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913046|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429957|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56429958|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429960|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429961|NCT00266643|Analgesics|analgesics|mesh-ancestor
56429962|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
56429963|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429964|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
56429965|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56429966|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
56429967|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
56429968|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56429969|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429971|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
56429972|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56429973|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429974|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
56429975|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56429976|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56429977|NCT04559425|Dexamethasone|dexamethasone|mesh-list
56429982|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
56429983|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429984|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429985|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429986|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
56429988|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429989|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56429990|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429991|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
56429992|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429993|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429994|NCT00231764|Daclizumab|daclizumab|mesh-list
56429995|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56429996|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
56429997|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429998|NCT04559308|Metformin|metformin|mesh-list
56429999|NCT04559308|Paclitaxel|paclitaxel|mesh-list
56430000|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
56430001|NCT04559308|Doxorubicin|doxorubicin|mesh-list
56430002|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56430003|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430004|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
56430005|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
56430006|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
56430007|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430008|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430009|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
56430010|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430011|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430012|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56430013|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
56430014|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56430015|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56430016|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56430017|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56430018|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56430019|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430020|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
56430021|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56430022|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56430023|NCT04559113|Prednisolone|prednisolone|mesh-list
56430024|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
56430025|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56430026|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
56430027|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430028|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
56430029|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
56430030|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430031|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430032|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56913047|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430033|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
56430034|NCT04559113|Hormones|hormones|mesh-ancestor
56164503|NCT05748990|Insulin Lispro|insulin lispro|mesh-list
56430035|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56430037|NCT04559113|Protective Agents|protective agents|mesh-ancestor
56430038|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56430039|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430040|NCT00266721|Pancrelipase|pancrelipase|mesh-list
56430041|NCT00266721|Pancreatin|pancreatin|mesh-list
56430042|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56430043|NCT04559074|Amlodipine|amlodipine|mesh-list
56430044|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56430045|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56430046|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56430047|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430048|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56430049|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430050|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
56430052|NCT02211976|Cathartics|cathartics|mesh-ancestor
56430053|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56430054|NCT02211976|Laxatives|laxatives|mesh-ancestor
56430055|NCT00231959|Pramipexole|pramipexole|mesh-list
56430056|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
56430057|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430058|NCT00231959|Protective Agents|protective agents|mesh-ancestor
56430059|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430060|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56430061|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56430062|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
56430063|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
56430064|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430065|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
56430066|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56430067|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56430068|NCT00231998|Analgesics|analgesics|mesh-ancestor
56177840|NCT04530006|Analgesics|analgesics|mesh-ancestor
56430069|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
56430070|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430071|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430072|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430073|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430074|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
56430075|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430076|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
56430077|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56430078|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430079|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430080|NCT00266838|Dexamethasone|dexamethasone|mesh-list
56430081|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430082|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
56430083|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
56430084|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430085|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430086|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56430087|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
56430088|NCT00266838|Hormones|hormones|mesh-ancestor
56430089|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56430090|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56430091|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430092|NCT00232037|Tegaserod|tegaserod|mesh-list
56430093|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56430094|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
56430095|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430096|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430097|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430098|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
56430099|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56430100|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56430101|NCT02212210|Prednisolone|prednisolone|mesh-list
56430102|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
56430103|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56430104|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
56430105|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430106|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
56913048|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
56913049|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56913050|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430107|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
56430108|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430109|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430110|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56430111|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
56430112|NCT02212210|Hormones|hormones|mesh-ancestor
56430113|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56430114|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56430115|NCT02212210|Protective Agents|protective agents|mesh-ancestor
56430116|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56430117|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430118|NCT00232076|Cyclosporine|cyclosporine|mesh-list
56430119|NCT00232076|Cyclosporins|cyclosporins|mesh-list
56430120|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430121|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430122|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430123|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
55778654|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
56430127|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
56430128|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430129|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56430130|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
56430131|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56430132|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56430133|NCT00232115|Analgesics|analgesics|mesh-ancestor
56430134|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
56430135|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430136|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430137|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430138|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430139|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
56430140|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430141|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
56430142|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56177912|NCT04245644|Aspirin|aspirin|mesh-list
56430143|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430144|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430145|NCT04558021|Niclosamide|niclosamide|mesh-list
56430146|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
56430147|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56430148|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
56430149|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56430150|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430151|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
56430152|NCT00232154|Azithromycin|azithromycin|mesh-list
56430153|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430154|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430155|NCT00259662|Atorvastatin|atorvastatin|mesh-list
56430156|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56430157|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56430158|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
56430159|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430160|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56430161|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56430162|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430163|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
56430164|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56430165|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
56430166|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430167|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
56430168|NCT04557943|Protective Agents|protective agents|mesh-ancestor
56430169|NCT04557475|Aspirin|aspirin|mesh-list
56430170|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56430171|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56430172|NCT04557475|Analgesics|analgesics|mesh-ancestor
56430173|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
56430174|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430175|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430176|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430177|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56396652|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56430178|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56430179|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56430180|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430181|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56430182|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56430183|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430184|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
56430185|NCT00232271|Enoxaparin|enoxaparin|mesh-list
56430186|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
56430187|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56430188|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56430189|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430190|NCT04557397|Itraconazole|itraconazole|mesh-list
56430191|NCT04557397|Rifampin|rifampin|mesh-list
56430192|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
56430193|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430194|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56430195|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56430204|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
56430205|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430206|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
56430207|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56430208|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56430209|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56430210|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56430211|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56430212|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56430213|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56430215|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56430216|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56430217|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56430218|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
56430219|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430220|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430221|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430222|NCT04557202|Urological Agents|urological agents|mesh-ancestor
56430223|NCT00232349|Galantamine|galantamine|mesh-list
56430224|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56430225|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430226|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430227|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
56430228|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430229|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430230|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56430231|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
56430232|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430233|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
56430234|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
56430235|NCT00259701|Acetylcholine|acetylcholine|mesh-list
56430236|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
56430237|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56430238|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
56430239|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430240|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430241|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430242|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56430243|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56430244|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
56430245|NCT04566211|Amoxicillin|amoxicillin|mesh-list
56430246|NCT04566211|Metronidazole|metronidazole|mesh-list
56430247|NCT04566211|Clarithromycin|clarithromycin|mesh-list
56430248|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56430249|NCT04566211|Pantoprazole|pantoprazole|mesh-list
56430250|NCT04566211|Bismuth|bismuth|mesh-list
56430251|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430252|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430253|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56430254|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56430255|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56430256|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430257|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778786|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
56913051|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913052|NCT00090857|Letrozole|letrozole|mesh-list
56913053|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430261|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56430262|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56430264|NCT00259779|Prednisolone|prednisolone|mesh-list
56430265|NCT00259779|Budesonide|budesonide|mesh-list
56430266|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
56430267|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430268|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
56430269|NCT00259779|Hormones|hormones|mesh-ancestor
56430270|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56430271|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430272|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56430273|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430274|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
56430275|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430276|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56430277|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56430278|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
56430279|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56430280|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56430281|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56430282|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56430283|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430284|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430285|NCT02211079|Tolbutamide|tolbutamide|mesh-list
56430286|NCT02211079|Midazolam|midazolam|mesh-list
56430287|NCT02211079|Caffeine|caffeine|mesh-list
56430288|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56430289|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56430290|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430291|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430292|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56430293|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56430294|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56430295|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56430296|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
56430297|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
56430298|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
56430299|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
56430300|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430301|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430302|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56430303|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56430304|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430305|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56430306|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56430307|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
56430308|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56430309|NCT00232622|Streptokinase|streptokinase|mesh-list
56430310|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56430311|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56430312|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430313|NCT00232661|Tamoxifen|tamoxifen|mesh-list
56430314|NCT00232661|Anastrozole|anastrozole|mesh-list
56430315|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56430316|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
56430317|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56430318|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430319|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56430320|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430321|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56430322|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56430323|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56430324|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56430325|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56430326|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430327|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430331|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56430332|NCT00267267|Torcetrapib|torcetrapib|mesh-list
56913054|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56913055|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56913056|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913057|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913058|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56913059|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
56913060|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56913061|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430333|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56430334|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56430335|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
56430336|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430337|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56430338|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56430339|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430341|NCT04564690|Selenium|selenium|mesh-list
56430342|NCT04564690|Vitamins|vitamins|mesh-ancestor
56430343|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
56430344|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430345|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
56430346|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430347|NCT04564690|Protective Agents|protective agents|mesh-ancestor
56430348|NCT04564690|Trace Elements|trace elements|mesh-ancestor
56430349|NCT00232700|Citalopram|citalopram|mesh-list
56430350|NCT00232700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56430351|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56430352|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56430353|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430354|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430355|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
56430356|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430357|NCT00232700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56430358|NCT00232700|Antidepressive Agents|antidepressive agents|mesh-ancestor
56430359|NCT00232700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56430360|NCT04564456|Fluticasone|fluticasone|mesh-list
56430361|NCT04564456|Xhance|xhance|mesh-list
56430362|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56430363|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56430364|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430365|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56430366|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
56430367|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430368|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430369|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56430370|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
56430371|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
56430372|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56430373|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56430374|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56430375|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56430376|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
56430377|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430378|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430379|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
56430380|NCT04564456|Hormones|hormones|mesh-ancestor
56430381|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56430382|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
56430383|NCT04564144|Meclizine|meclizine|mesh-list
56430384|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
56430385|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
56430386|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430387|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430388|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56430389|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56913062|NCT01775644|Bevacizumab|bevacizumab|mesh-list
56396878|NCT04595994|Antiviral Agents|antiviral agents|mesh-ancestor
56430390|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
56430391|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
56430392|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430393|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430394|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56430395|NCT00267306|Visilizumab|visilizumab|mesh-list
56430396|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
56430397|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430398|NCT00259896|Exenatide|exenatide|mesh-list
56430399|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56430400|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430404|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56430406|NCT04721795|Atorvastatin|atorvastatin|mesh-list
56430407|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56430408|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56430409|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
56430410|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430411|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56430412|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56430413|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430414|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430415|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430416|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56430417|NCT04564222|Micronutrients|micronutrients|mesh-list
56430418|NCT04564222|Trace Elements|trace elements|mesh-list
56430419|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430420|NCT00232817|Nicotine|nicotine|mesh-list
56430421|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56430422|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
56430423|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430424|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430425|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56430426|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56430427|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
56430428|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430429|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430430|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
56430431|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56430432|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
56430433|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430434|NCT00267384|Expectorants|expectorants|mesh-ancestor
56430435|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
56430436|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56430437|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
56430438|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430439|NCT00267384|Protective Agents|protective agents|mesh-ancestor
56430440|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430441|NCT00267384|Antidotes|antidotes|mesh-ancestor
56430442|NCT00259935|Topotecan|topotecan|mesh-list
56430443|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56430444|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56430445|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430446|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430447|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430448|NCT00232856|Sirolimus|sirolimus|mesh-list
56430449|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430450|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430451|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56430452|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430453|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
56430454|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430455|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
56430456|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430457|NCT00259974|Rituximab|rituximab|mesh-list
56430458|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56430459|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430460|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
56430461|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430462|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430463|NCT00232895|Propofol|propofol|mesh-list
56430464|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56430465|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913063|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56913064|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913065|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56396957|NCT04513925|Durvalumab|durvalumab|mesh-list
56430466|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430467|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56430468|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
56430469|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
56430470|NCT00232934|Thalidomide|thalidomide|mesh-list
56430471|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430472|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
56430473|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430477|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56430478|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56430479|NCT00232934|Growth Substances|growth substances|mesh-ancestor
56430480|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
56430481|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430482|NCT04673812|Fentanyl|fentanyl|mesh-list
56430483|NCT04673812|Bupivacaine|bupivacaine|mesh-list
56430484|NCT04673812|Naloxone|naloxone|mesh-list
56430485|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
56430486|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
56430487|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430488|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430489|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
56430490|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430491|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56430492|NCT04673812|Narcotics|narcotics|mesh-ancestor
56430493|NCT04673812|Analgesics|analgesics|mesh-ancestor
56430494|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56430495|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56430496|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
56430497|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56430498|NCT04673461|Xylometazoline|xylometazoline|mesh-list
56430499|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
56430500|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56430501|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
56430502|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
56430503|NCT00260052|Hematinics|hematinics|mesh-ancestor
56430504|NCT04673500|Lidocaine|lidocaine|mesh-list
56430505|NCT04673500|Propofol|propofol|mesh-list
56430506|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
56430507|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
56430508|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430509|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430510|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
56430511|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430512|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56430513|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56430514|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56430515|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56430516|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430517|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56430518|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56430519|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
56430520|NCT00233012|Topiramate|topiramate|mesh-list
56430521|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
56430522|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56430523|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430524|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
56430525|NCT00267540|Vitamin D|vitamin d|mesh-list
56430526|NCT00267540|Vitamins|vitamins|mesh-ancestor
56430527|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
56430528|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430529|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56430530|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56430531|NCT00233051|Fluticasone|fluticasone|mesh-list
56430532|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56430533|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430534|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56430535|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
56430536|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430537|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430538|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56913066|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56913067|NCT01775644|Growth Substances|growth substances|mesh-ancestor
56430539|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
56430540|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
56430541|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56430542|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56430543|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56430544|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56430545|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
56430546|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430547|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430550|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56430551|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430552|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
56430553|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430554|NCT00260247|Carbamazepine|carbamazepine|mesh-list
56430555|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
56430556|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
56430557|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
56430558|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56430559|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430560|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430561|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56430562|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56430563|NCT00260247|Analgesics|analgesics|mesh-ancestor
56430564|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
56430565|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430566|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56430567|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56430568|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430569|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56430570|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56430571|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56430572|NCT04671589|Meropenem|meropenem|mesh-list
56430573|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430574|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430575|NCT00260325|Valdecoxib|valdecoxib|mesh-list
56430576|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56430577|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56430578|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430579|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430580|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56430581|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56430582|NCT00260325|Analgesics|analgesics|mesh-ancestor
56430583|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
56430584|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430585|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430586|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430587|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430588|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56430589|NCT04671160|Dalteparin|dalteparin|mesh-list
56430590|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
56430591|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56430592|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56430593|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178365|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
56430594|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
56430595|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
56430596|NCT00233558|Adalimumab|adalimumab|mesh-list
56430597|NCT00233558|Methotrexate|methotrexate|mesh-list
56430598|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56430599|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
56430600|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56430601|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430602|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56430603|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
56430604|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430605|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430606|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
56430607|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430608|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56092651|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56913068|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913069|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
56913070|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56913071|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56913072|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56913073|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913074|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913075|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56913076|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913077|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913078|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
56913079|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913080|NCT04229368|Vitamin D|vitamin d|mesh-list
56913081|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
56913082|NCT04229368|Vitamins|vitamins|mesh-ancestor
56913083|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
56913084|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913085|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56913086|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56913087|NCT00090779|Ritonavir|ritonavir|mesh-list
56913088|NCT00090779|Lopinavir|lopinavir|mesh-list
56913089|NCT00090779|Tenofovir|tenofovir|mesh-list
56913090|NCT00090779|Emtricitabine|emtricitabine|mesh-list
56397127|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430609|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430610|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
56430611|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430612|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56430613|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430614|NCT00233636|Gefitinib|gefitinib|mesh-list
56430615|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430616|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56430617|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430618|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430619|NCT00233675|Tiagabine|tiagabine|mesh-list
56430620|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
55779109|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430622|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56430623|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56430624|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430625|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
56430626|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430627|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430628|NCT00267657|Reserpine|reserpine|mesh-list
56430629|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56430630|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56430631|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56430632|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430633|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430634|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56430635|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56648485|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648486|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648487|NCT02841839|Fluorides|fluorides|mesh-list
56648488|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
56648489|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
56294505|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
56648490|NCT02841839|Protective Agents|protective agents|mesh-ancestor
56648491|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648493|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56648494|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
56648495|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648496|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648497|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56648498|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
56648499|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56648500|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
56430636|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56430637|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56430638|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430639|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
56430640|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430641|NCT04670809|Clevidipine|clevidipine|mesh-list
56430642|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56430643|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56430644|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430645|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56430646|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430647|NCT00233714|Sirolimus|sirolimus|mesh-list
56430648|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430649|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430650|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56430651|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430652|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
56430653|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430654|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
56430655|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430656|NCT04670497|Epinephrine|epinephrine|mesh-list
56430657|NCT04670497|Racepinephrine|racepinephrine|mesh-list
56430658|NCT04670497|Bupivacaine|bupivacaine|mesh-list
56430659|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
56430660|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
56430661|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
56430662|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430663|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430664|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
56430665|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430666|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56430667|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56430668|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
56430669|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430670|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430671|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56430672|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56430673|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
56430674|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56430675|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
56430676|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
56430677|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
56397280|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
56430678|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56430679|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56430680|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430681|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430682|NCT00260364|Gemcitabine|gemcitabine|mesh-list
56430683|NCT00260364|Bevacizumab|bevacizumab|mesh-list
56430684|NCT00260364|Capecitabine|capecitabine|mesh-list
56430685|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56430686|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56430687|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430688|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56430689|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56430690|NCT00260364|Growth Substances|growth substances|mesh-ancestor
56430691|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430692|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
55779184|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430693|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56430695|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430696|NCT00260364|Antiviral Agents|antiviral agents|mesh-ancestor
56430697|NCT00260364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430698|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430699|NCT00260364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430700|NCT00260364|Immunologic Factors|immunologic factors|mesh-ancestor
56430701|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56430702|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
56430703|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56430704|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430705|NCT00233792|Sirolimus|sirolimus|mesh-list
56430706|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430707|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430708|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56430709|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430710|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
56430711|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430712|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
56430713|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430714|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56430715|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430716|NCT00556192|Rituximab|rituximab|mesh-list
56430717|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56430718|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430719|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
56430720|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430721|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430722|NCT00556270|Fentanyl|fentanyl|mesh-list
56430723|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56430724|NCT00556270|Narcotics|narcotics|mesh-ancestor
56430725|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430726|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430727|NCT00556270|Analgesics|analgesics|mesh-ancestor
56430728|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
56430729|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430730|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56430731|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56430732|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
56430733|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
56430734|NCT00260520|Dalteparin|dalteparin|mesh-list
56430735|NCT00260520|Tinzaparin|tinzaparin|mesh-list
56430736|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56430737|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
56430738|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56430739|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56430740|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430741|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
56430742|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56430743|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430744|NCT00267813|Bupropion|bupropion|mesh-list
56430745|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56430746|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
56430747|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56430748|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56430749|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56430750|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913091|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56913092|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56430751|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430752|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
56430753|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430754|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430755|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56430756|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56430757|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430758|NCT00234026|Gemcitabine|gemcitabine|mesh-list
56430759|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56430760|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
56164525|NCT05709990|Solifenacin Succinate|solifenacin succinate|mesh-list
56430761|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430762|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430764|NCT00234026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430765|NCT00234026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430766|NCT00234026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430768|NCT00234026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430770|NCT00234143|Hematinics|hematinics|mesh-ancestor
56430771|NCT00234182|Interferons|interferons|mesh-list
56430772|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
56430773|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
56430774|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430775|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
56430776|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430777|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
56430778|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430779|NCT04669990|Remdesivir|remdesivir|mesh-list
56430780|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
56430781|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430782|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
56430783|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430784|NCT00556348|Bevacizumab|bevacizumab|mesh-list
56430785|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56430786|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430787|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56430788|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56430789|NCT00556348|Growth Substances|growth substances|mesh-ancestor
56430790|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430791|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
56430792|NCT00556387|Ketamine|ketamine|mesh-list
56430793|NCT00556387|Analgesics|analgesics|mesh-ancestor
56430794|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
56430795|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430796|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430797|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56430798|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56430799|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
56430800|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
56430801|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430802|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56430803|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56430804|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430805|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430806|NCT04552093|Floxuridine|floxuridine|mesh-list
56430807|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56430808|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
56430809|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430810|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430811|NCT04556110|Perindopril|perindopril|mesh-list
56430812|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56430813|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
56430814|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430815|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430816|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56430817|NCT00234299|Aspirin|aspirin|mesh-list
56430818|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56430819|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56430821|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
56913093|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56913094|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
56913095|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913096|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913097|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56913098|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56913099|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
56913100|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397456|NCT03914625|Doxorubicin|doxorubicin|mesh-list
56430822|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430823|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430824|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430825|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430826|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56430827|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56430828|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430829|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56430830|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56430831|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430832|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
56430833|NCT04556032|Ergothioneine|ergothioneine|mesh-list
56430835|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430836|NCT04556032|Protective Agents|protective agents|mesh-ancestor
56430837|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430838|NCT04556071|Bevacizumab|bevacizumab|mesh-list
56430839|NCT04556071|Niraparib|niraparib|mesh-list
56430840|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56430841|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430855|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56430856|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
56430857|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56430858|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56430859|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56430860|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430861|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430862|NCT04563754|Proflavine|proflavine|mesh-list
56430863|NCT04563754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56430864|NCT04563754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430865|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
56430866|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56430867|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430868|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430869|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56430870|NCT02211118|Analgesics|analgesics|mesh-ancestor
56430871|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
56430872|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430873|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56430874|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56430875|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56430876|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
56430877|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430878|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430879|NCT00234416|Gemcitabine|gemcitabine|mesh-list
56430880|NCT00234416|Gefitinib|gefitinib|mesh-list
56430881|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56430882|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
56430883|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430884|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430885|NCT00234416|Antiviral Agents|antiviral agents|mesh-ancestor
56430886|NCT00234416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430887|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430888|NCT00234416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430889|NCT00234416|Immunologic Factors|immunologic factors|mesh-ancestor
56430890|NCT00234416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430891|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56430893|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430894|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430895|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56430896|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430897|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
56430898|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430899|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
56430900|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430901|NCT00234572|Lanreotide|lanreotide|mesh-list
56430911|NCT00415935|Methotrexate|methotrexate|mesh-list
56430912|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56430913|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
56430914|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56430915|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430916|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56430917|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
56430918|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430919|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430920|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
56430921|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430922|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56430923|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56430924|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
56430925|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56430926|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56430927|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56430928|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430930|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
56430931|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
56430932|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430933|NCT00234689|Naltrexone|naltrexone|mesh-list
56430934|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56430935|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56430936|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430937|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
56430938|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430939|NCT04561960|Fluorides|fluorides|mesh-list
56430940|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
56430941|NCT04561960|Protective Agents|protective agents|mesh-ancestor
56430942|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430943|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
56430944|NCT04561921|Nordefrin|nordefrin|mesh-list
56430945|NCT04561921|Mepivacaine|mepivacaine|mesh-list
56430946|NCT04561921|Analgesics|analgesics|mesh-ancestor
56430947|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
56430948|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56430949|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430950|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
56430951|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56430952|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56430953|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
56430954|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56164529|NCT05709990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56164530|NCT05709990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56164531|NCT05709990|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56164532|NCT05709990|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56164533|NCT05709990|Cholinergic Agents|cholinergic agents|mesh-ancestor
56164534|NCT05709990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56164535|NCT05709990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164544|NCT05660850|Mannitol|mannitol|mesh-list
56430955|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56430956|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430957|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56430958|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
56430969|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430970|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56430971|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
56430972|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
56913101|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56913102|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56913103|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56430973|NCT04561687|Hormones|hormones|mesh-ancestor
56430974|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56430975|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56430976|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
56430977|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56430978|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56430979|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430980|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56430981|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430982|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56430983|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56430984|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56430985|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
56430986|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
56430987|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430988|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
56430989|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56430990|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430991|NCT00234845|Adalimumab|adalimumab|mesh-list
56430992|NCT00234845|Methotrexate|methotrexate|mesh-list
56430993|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56430994|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
56430995|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56430996|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430997|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56430998|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
56430999|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431000|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431001|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
56431002|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431003|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56431004|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431005|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
56431006|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431007|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56431008|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431009|NCT02211625|Oxycodone|oxycodone|mesh-list
56431010|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56431011|NCT02211625|Narcotics|narcotics|mesh-ancestor
56431012|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431013|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431014|NCT02211625|Analgesics|analgesics|mesh-ancestor
56431015|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
56431016|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431017|NCT00234923|Ritonavir|ritonavir|mesh-list
56431018|NCT00234923|Lopinavir|lopinavir|mesh-list
56431019|NCT00234923|Lamivudine|lamivudine|mesh-list
56431020|NCT00234923|Zidovudine|zidovudine|mesh-list
56431021|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56431022|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56431023|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56431024|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
56431025|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431039|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56431040|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431041|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431042|NCT00234962|Ritonavir|ritonavir|mesh-list
56431043|NCT00234962|Lopinavir|lopinavir|mesh-list
56431044|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56431045|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56431046|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
56431047|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431048|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431049|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56431050|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56431051|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
56431052|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901649|NCT02410590|Cisatracurium|cisatracurium|mesh-list
56397743|NCT03460314|Analgesics|analgesics|mesh-ancestor
56431053|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56431054|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56431055|NCT04551703|Epinephrine|epinephrine|mesh-list
56431056|NCT04551703|Racepinephrine|racepinephrine|mesh-list
56431057|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
56431058|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56431059|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56431060|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
56431061|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431062|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431063|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431064|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56431065|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56431066|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
56431067|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431068|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56431069|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
56431070|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
56431071|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
56431072|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56431073|NCT00235001|Verapamil|verapamil|mesh-list
56431074|NCT00235001|Trandolapril|trandolapril|mesh-list
56431075|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56431076|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56431077|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431078|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431079|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56431080|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431081|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
56431082|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56431083|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
56431085|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56431087|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431088|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
56431089|NCT04551781|Hormones|hormones|mesh-ancestor
56431090|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431091|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431092|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56431093|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431094|NCT00424944|Vaccines|vaccines|mesh-list
56431095|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
56431096|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431097|NCT02214004|Trastuzumab|trastuzumab|mesh-list
56431098|NCT02214004|Letrozole|letrozole|mesh-list
56431099|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56431100|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431101|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56431102|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56431103|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431104|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431105|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56431106|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
56431107|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431108|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431109|NCT00235079|Colchicine|colchicine|mesh-list
56431110|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
56431111|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431112|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
56431113|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
56431114|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
56431115|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178902|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
56431116|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431118|NCT00260988|Tinzaparin|tinzaparin|mesh-list
56431119|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56431120|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
56431121|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56431122|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56431123|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431124|NCT00235157|Sirolimus|sirolimus|mesh-list
56431125|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56431126|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431127|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56913104|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56913105|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56913106|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
56913107|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431128|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431129|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
56431130|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431131|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
56431132|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431133|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
56431134|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56431135|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56431136|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431137|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
56431138|NCT04550338|Coagulants|coagulants|mesh-ancestor
56431139|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
56431140|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56431141|NCT04550611|Antibodies|antibodies|mesh-list
56431142|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
56431143|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56431144|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
56431145|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431146|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
56431147|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56431148|NCT00261027|Exemestane|exemestane|mesh-list
56431149|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431150|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56431151|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56431152|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431153|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431154|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56431155|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
56431156|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431157|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431167|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56431168|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
56431169|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431170|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431171|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56431172|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56431173|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
56431174|NCT00235235|Antiviral Agents|antiviral agents|mesh-ancestor
56431175|NCT00235235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431176|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431177|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56431178|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56431179|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56431180|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56431181|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
56431182|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
56431183|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
56431184|NCT00268359|Bevacizumab|bevacizumab|mesh-list
56431185|NCT00268359|Irinotecan|irinotecan|mesh-list
56431186|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56431187|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431188|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56431189|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56431190|NCT00268359|Growth Substances|growth substances|mesh-ancestor
56431191|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431192|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
56431193|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56431194|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56431195|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431196|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431197|NCT00235274|Secretin|secretin|mesh-list
56431198|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56431199|NCT00235274|Hormones|hormones|mesh-ancestor
56431200|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431201|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431202|NCT00268398|Leucovorin|leucovorin|mesh-list
56913108|NCT01081847|Mannitol|mannitol|mesh-list
56913109|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56397896|NCT03201965|Daratumumab|daratumumab|mesh-list
56431203|NCT00268398|Folic Acid|folic acid|mesh-list
56431204|NCT00268398|Fluorouracil|fluorouracil|mesh-list
56431205|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
56431206|NCT00268398|Irinotecan|irinotecan|mesh-list
56431207|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
56431208|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
56431209|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431210|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56431211|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431212|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431213|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
56431214|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431215|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56431216|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56431217|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431218|NCT00268398|Antidotes|antidotes|mesh-ancestor
56431219|NCT00268398|Protective Agents|protective agents|mesh-ancestor
56431220|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
56431221|NCT00268398|Vitamins|vitamins|mesh-ancestor
56431222|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
56431223|NCT00268398|Hematinics|hematinics|mesh-ancestor
56431224|NCT00235313|Nicotine|nicotine|mesh-list
56431225|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56431226|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
55779722|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56431230|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56431231|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
56431232|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431233|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431234|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
56431235|NCT04549012|Oxytocin|oxytocin|mesh-list
56431236|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
56431237|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56431238|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431239|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56431240|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56431241|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431242|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
56431243|NCT04549012|Coagulants|coagulants|mesh-ancestor
56431244|NCT00261105|Telithromycin|telithromycin|mesh-list
56431245|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56431246|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431247|NCT00235508|Eszopiclone|eszopiclone|mesh-list
56431248|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56431249|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431250|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431251|NCT00268515|Cyclosporine|cyclosporine|mesh-list
56431252|NCT00268515|Prednisone|prednisone|mesh-list
56431254|NCT00268515|Tacrolimus|tacrolimus|mesh-list
56431255|NCT00268515|Cyclosporins|cyclosporins|mesh-list
56431256|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431257|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
56431258|NCT00268515|Hormones|hormones|mesh-ancestor
56431259|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431260|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431261|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56431262|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431263|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431264|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
56431265|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56431266|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431267|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431268|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
56431269|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431270|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
56431271|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431272|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
56431273|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56431275|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
56431276|NCT04548700|Vincristine|vincristine|mesh-list
56431277|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
56431278|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431279|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
56431280|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913110|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
56913111|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56913112|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
56397971|NCT02927249|Analgesics|analgesics|mesh-ancestor
56431281|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431282|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56431283|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
56431284|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431285|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431286|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56431287|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431288|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
56431289|NCT04548700|Hormones|hormones|mesh-ancestor
56431290|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431291|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56431292|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56431293|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56431294|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56431295|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56431296|NCT04548700|Analgesics|analgesics|mesh-ancestor
56431297|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
56431298|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431299|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56431300|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56431311|NCT02212561|Methotrexate|methotrexate|mesh-list
56431312|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
56431313|NCT02212561|Fludarabine|fludarabine|mesh-list
56431314|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56431315|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
56431316|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56431317|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431318|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56431319|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
56431320|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431321|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431322|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
56431323|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431324|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56431325|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431326|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
56431327|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932025|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56431328|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56431329|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
56431330|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431331|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431332|NCT00268554|Dipyridamole|dipyridamole|mesh-list
56431334|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56431335|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431336|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56431337|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431338|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431339|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56431340|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56431341|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
56179126|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
56431342|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431343|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56431344|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
56431345|NCT00268593|Prednisone|prednisone|mesh-list
56431346|NCT00268593|Docetaxel|docetaxel|mesh-list
56431347|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431348|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
56431349|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
56431350|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
56431351|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431352|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431353|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
56431354|NCT00268593|Hormones|hormones|mesh-ancestor
56431355|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431356|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913113|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913114|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56431357|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56431358|NCT04555525|Sarecycline|sarecycline|mesh-list
56431359|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56431360|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431361|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
56431362|NCT00261183|Melatonin|melatonin|mesh-list
56431363|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
56431364|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779857|NCT03748433|Insulin|insulin|mesh-list
56431374|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56431375|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56431376|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
56431377|NCT04554979|Anticoagulants|anticoagulants|mesh-list
56431378|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431379|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
56431380|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56431381|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56431382|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431383|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431384|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431385|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
56431386|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56431387|NCT00261222|Amodiaquine|amodiaquine|mesh-list
56431388|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
56431389|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56431390|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56431391|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431392|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
56431393|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
56431394|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431395|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431396|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
56431397|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56431398|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56431399|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56431400|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
56431401|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431402|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431403|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431404|NCT00268671|Docetaxel|docetaxel|mesh-list
56431405|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431406|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
56431407|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
56431408|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
56431409|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431410|NCT04554433|Ethanol|ethanol|mesh-list
56431411|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56431412|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431413|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431414|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431415|NCT04721054|Lidocaine|lidocaine|mesh-list
56431416|NCT04721054|Bupivacaine|bupivacaine|mesh-list
56431417|NCT04721054|Anesthetics|anesthetics|mesh-list
56431418|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
56431419|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431420|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431421|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
56431422|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431423|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56431424|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56431425|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56431426|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431427|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431428|NCT02212639|Digoxin|digoxin|mesh-list
56431437|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431438|NCT02212795|Levofloxacin|levofloxacin|mesh-list
56431439|NCT02212795|Ofloxacin|ofloxacin|mesh-list
56431440|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
56431441|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56431442|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431443|NCT02212795|Renal Agents|renal agents|mesh-ancestor
56431444|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55901650|NCT02410590|Succinylcholine|succinylcholine|mesh-list
56913115|NCT01081847|Diuretics|diuretics|mesh-ancestor
56398120|NCT02406209|Hormones|hormones|mesh-ancestor
56431445|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56431446|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56431447|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431448|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431449|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431450|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56431451|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56431452|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56431453|NCT00261261|Midazolam|midazolam|mesh-list
56431454|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56431455|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56431456|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431457|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431458|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56431459|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56431460|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56431461|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56431462|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
56431463|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
56431464|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
56431465|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
56431466|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431467|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431468|NCT00235820|Adalimumab|adalimumab|mesh-list
56164563|NCT05588388|Bevacizumab|bevacizumab|mesh-list
56164568|NCT05588388|Growth Substances|growth substances|mesh-ancestor
56431469|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431470|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431471|NCT00268710|Docetaxel|docetaxel|mesh-list
56431472|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431473|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
56431474|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
56431475|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
56431476|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431477|NCT00261300|Pantoprazole|pantoprazole|mesh-list
56431478|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56431479|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56431480|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56431481|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431482|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431483|NCT02212990|Acetaminophen|acetaminophen|mesh-list
56431484|NCT02212990|Ibuprofen|ibuprofen|mesh-list
56431485|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56431486|NCT02212990|Analgesics|analgesics|mesh-ancestor
56431487|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
56431488|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431489|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431490|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
56431491|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56431492|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431493|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431494|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56431502|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431503|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56431504|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
56431505|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431506|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431507|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
56431508|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431509|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56431510|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431511|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
56431512|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431513|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56431514|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431516|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
56431517|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56431518|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431519|NCT02213146|Insulin|insulin|mesh-list
56431520|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
56431521|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56431522|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55901744|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
56913116|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
56913117|NCT02224456|Tenofovir|tenofovir|mesh-list
56913118|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
56913119|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913120|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56913121|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56913122|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913123|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913124|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56913125|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56913126|NCT02224534|Clopidogrel|clopidogrel|mesh-list
56913127|NCT02224534|Ticagrelor|ticagrelor|mesh-list
56913128|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56913129|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56913130|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56913131|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56913132|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
56913133|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398191|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398192|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398193|NCT02233829|Protective Agents|protective agents|mesh-ancestor
56020145|NCT00538616|Analgesics|analgesics|mesh-ancestor
56431523|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431524|NCT00268749|Glycine|glycine|mesh-list
56431525|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
56431526|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431527|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431528|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431529|NCT00235898|Leucovorin|leucovorin|mesh-list
56913134|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913135|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913136|NCT02393794|Nivolumab|nivolumab|mesh-list
56913137|NCT02393794|Romidepsin|romidepsin|mesh-list
56398248|NCT02169310|Raclopride|raclopride|mesh-list
56431530|NCT00235898|Fluorouracil|fluorouracil|mesh-list
56431531|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
56431532|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431533|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56431534|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431535|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431536|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
56431537|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431538|NCT00235898|Antidotes|antidotes|mesh-ancestor
56431539|NCT00235898|Protective Agents|protective agents|mesh-ancestor
56431540|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
56431541|NCT00235898|Vitamins|vitamins|mesh-ancestor
56431542|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
56431543|NCT02213224|Amlodipine|amlodipine|mesh-list
56431544|NCT02213224|Telmisartan|telmisartan|mesh-list
56431546|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56431547|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56431548|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431549|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431550|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56431551|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431552|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
56431553|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56431554|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56431555|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56431556|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
56431557|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431558|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
56431559|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56431560|NCT00268788|Antibodies|antibodies|mesh-list
56431561|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
56431562|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56431563|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
56431598|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56431599|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431600|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56431601|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56431602|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431604|NCT04553458|Ethanol|ethanol|mesh-list
56431605|NCT04553458|Sorafenib|sorafenib|mesh-list
56431606|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431607|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56431608|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431609|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431610|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56431611|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431612|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431613|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431614|NCT00236054|Tiagabine|tiagabine|mesh-list
56431615|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
56431616|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56431617|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56431618|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431619|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431620|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
56431621|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431622|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431623|NCT04552951|Vitamin D|vitamin d|mesh-list
56431624|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
56431625|NCT04552951|Vitamins|vitamins|mesh-ancestor
56431626|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
56431627|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431628|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56431629|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56431630|NCT02213419|Ethanol|ethanol|mesh-list
56431631|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56913138|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56913139|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398329|NCT01631617|Doxycycline|doxycycline|mesh-list
56431632|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431633|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431634|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431635|NCT00236093|Fentanyl|fentanyl|mesh-list
56431636|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56431637|NCT00236093|Narcotics|narcotics|mesh-ancestor
56431638|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431639|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431640|NCT00236093|Analgesics|analgesics|mesh-ancestor
56431641|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
56431642|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431643|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56431644|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56431645|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
56431646|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
56431647|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
56431648|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56431649|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431650|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
56431651|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
56431652|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56431653|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431654|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431655|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
56431656|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56431657|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431658|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431659|NCT02213653|Iron|iron|mesh-list
56431660|NCT02213653|Trace Elements|trace elements|mesh-ancestor
56431661|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
56431662|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431663|NCT04552444|Biapenem|biapenem|mesh-list
56431664|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431665|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
56431666|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431667|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56431668|NCT02213848|Calcium|calcium|mesh-list
56431669|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56431670|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431671|NCT00261573|Galantamine|galantamine|mesh-list
56431672|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56431673|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431674|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431675|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
56431676|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431684|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56431685|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431686|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431688|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56431689|NCT04541719|Narcotics|narcotics|mesh-ancestor
56431690|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431691|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431692|NCT04541719|Analgesics|analgesics|mesh-ancestor
56431693|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
56431694|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431695|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56431696|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
56431697|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431698|NCT00261612|Dexamethasone|dexamethasone|mesh-list
56431699|NCT00261612|Rituximab|rituximab|mesh-list
56431700|NCT00261612|Bortezomib|bortezomib|mesh-list
56431701|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56431702|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431703|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
56431704|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431705|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431706|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56431707|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
56431708|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
56431709|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093379|NCT00377546|Ketorolac|ketorolac|mesh-list
56913140|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56913141|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56913142|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431710|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56431711|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
56431712|NCT00261612|Hormones|hormones|mesh-ancestor
56431713|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431714|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56431715|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56431716|NCT04547764|Calcium|calcium|mesh-list
56431717|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56431718|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431719|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179500|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
56431720|NCT04547608|Propofol|propofol|mesh-list
56431721|NCT04547608|Rocuronium|rocuronium|mesh-list
56431722|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56431723|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431724|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431725|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56431726|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
56431727|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
56431728|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56431729|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56431730|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56431731|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431732|NCT00236249|Lidocaine|lidocaine|mesh-list
56431733|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
56431734|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
56431735|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431736|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431737|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
56431738|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431739|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56431740|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56431741|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56431742|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431743|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431747|NCT04547452|Antibodies|antibodies|mesh-list
56431748|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
56431749|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431750|NCT04547335|Voriconazole|voriconazole|mesh-list
56431751|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
56431752|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431753|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56431754|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56431755|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431756|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431757|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56431758|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
56431759|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431760|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431761|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56431762|NCT00236288|Bupropion|bupropion|mesh-list
56431763|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56431764|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
56431765|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56431766|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56431767|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56431768|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431769|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431770|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
56431771|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431772|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431773|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56431774|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56431775|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913143|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56913144|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431776|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56431777|NCT00236327|Fentanyl|fentanyl|mesh-list
56431778|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56431779|NCT00236327|Narcotics|narcotics|mesh-ancestor
56431780|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431781|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431782|NCT00236327|Analgesics|analgesics|mesh-ancestor
56431783|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
56431784|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431785|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56431786|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56431787|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
56431788|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
56431789|NCT00236366|Fentanyl|fentanyl|mesh-list
56431790|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56431791|NCT00236366|Narcotics|narcotics|mesh-ancestor
56431792|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179584|NCT01400191|Metformin|metformin|mesh-list
56431793|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431795|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
56431796|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431797|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56431798|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56431799|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
56431800|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
56431801|NCT04547179|Erenumab|erenumab|mesh-list
56431802|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56431803|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431804|NCT04547179|Analgesics|analgesics|mesh-ancestor
56431805|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
56431806|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431807|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431808|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
56431809|NCT00236405|Hematinics|hematinics|mesh-ancestor
56431810|NCT00236444|Risperidone|risperidone|mesh-list
56431811|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56431812|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
56431813|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431814|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431818|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431819|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56431820|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56431822|NCT00269217|Niacin|niacin|mesh-list
56431823|NCT00269217|Niacinamide|niacinamide|mesh-list
56431824|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
56431825|NCT00269217|Simvastatin|simvastatin|mesh-list
56431826|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56431827|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56431828|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
56431829|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431830|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56431831|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56431832|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431833|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
56431834|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
56431835|NCT00269217|Vitamins|vitamins|mesh-ancestor
56431836|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
56431837|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431838|NCT04546282|Osimertinib|osimertinib|mesh-list
56431839|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431840|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56431841|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431842|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431843|NCT00236483|Acetaminophen|acetaminophen|mesh-list
56431844|NCT00236483|Tramadol|tramadol|mesh-list
56431845|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56431846|NCT00236483|Analgesics|analgesics|mesh-ancestor
56431847|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
56431848|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431849|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431850|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
56431851|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56431852|NCT00236483|Narcotics|narcotics|mesh-ancestor
56093380|NCT00377546|Nepafenac|nepafenac|mesh-list
56913145|NCT04174612|Cytarabine|cytarabine|mesh-list
56913146|NCT04174612|Daunorubicin|daunorubicin|mesh-list
56431853|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431854|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
56431855|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56431856|NCT04545970|Protective Agents|protective agents|mesh-ancestor
56431857|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431858|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
56431859|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56431860|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
56431861|NCT04545931|Coagulants|coagulants|mesh-ancestor
56431862|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56431863|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
56431864|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431865|NCT00236522|Levofloxacin|levofloxacin|mesh-list
56431866|NCT00236522|Ofloxacin|ofloxacin|mesh-list
56431867|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56431868|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431869|NCT00236522|Renal Agents|renal agents|mesh-ancestor
56431870|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56431871|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56431872|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56431873|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431874|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431875|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431876|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56431877|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56431878|NCT00261729|Prazosin|prazosin|mesh-list
56431879|NCT00261729|Paroxetine|paroxetine|mesh-list
56431880|NCT00261729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56431881|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56431882|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431883|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431884|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431885|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
56431886|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780363|NCT02389231|Analgesics|analgesics|mesh-ancestor
56431889|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56431890|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56431891|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56431892|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431893|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56431894|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56431895|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56431896|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56431897|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
56431899|NCT00236561|Propranolol|propranolol|mesh-list
56431900|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56431901|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56431902|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
56431903|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431904|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431905|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431906|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56431907|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56431908|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
56431909|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
56431910|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56431911|NCT02215330|Eplerenone|eplerenone|mesh-list
56431912|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56431913|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
55932617|NCT04023149|Analgesics|analgesics|mesh-ancestor
56431914|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431915|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431916|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56431917|NCT02215330|Diuretics|diuretics|mesh-ancestor
56431918|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
56431919|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56431921|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56431922|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56431923|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431924|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623815|NCT00867295|Cefazolin|cefazolin|mesh-list
56913147|NCT04174612|Midostaurin|midostaurin|mesh-list
56913148|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56431925|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431926|NCT04545892|Capsaicin|capsaicin|mesh-list
56431927|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
56431928|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
56431929|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
56431930|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431931|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431932|NCT02214706|Sirolimus|sirolimus|mesh-list
56431933|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56431934|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431935|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56431936|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431937|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
56431938|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431939|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
56431940|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431941|NCT00236600|Topiramate|topiramate|mesh-list
56431942|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
56431943|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56431944|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431945|NCT00236639|Topiramate|topiramate|mesh-list
56431946|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
56431947|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56431948|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431949|NCT04545463|Psyllium|psyllium|mesh-list
56431950|NCT04545463|Cathartics|cathartics|mesh-ancestor
56431951|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56431952|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
56431953|NCT00236678|Hematinics|hematinics|mesh-ancestor
56431954|NCT00269334|Paroxetine|paroxetine|mesh-list
56431955|NCT00269334|Citalopram|citalopram|mesh-list
56431956|NCT00269334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56431957|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56431958|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431959|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431965|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56431966|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56431967|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56431968|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431969|NCT04541251|Paclitaxel|paclitaxel|mesh-list
56431970|NCT04541251|Carboplatin|carboplatin|mesh-list
56431971|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56431972|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431973|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
56431974|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
56431975|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
56431976|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431977|NCT00236717|Topiramate|topiramate|mesh-list
56431978|NCT00236717|Carbamazepine|carbamazepine|mesh-list
56431979|NCT00236717|Valproic Acid|valproic acid|mesh-list
56431980|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
56431981|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56431982|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431983|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431984|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431985|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
56431986|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431987|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
56431988|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56431989|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431990|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56431991|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56431992|NCT00236717|Analgesics|analgesics|mesh-ancestor
56431993|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
56431994|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431995|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56431996|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431997|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56431998|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56431999|NCT04540666|Propofol|propofol|mesh-list
56432000|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56432001|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913149|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
56056904|NCT00001911|Growth Substances|growth substances|mesh-ancestor
56432002|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432003|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56432004|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
56432005|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
56432006|NCT00236756|Topiramate|topiramate|mesh-list
56432007|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
56432008|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56432009|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432010|NCT00269412|Rifaximin|rifaximin|mesh-list
56432011|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432012|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432013|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56432014|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56432015|NCT00236795|Norelgestromin|norelgestromin|mesh-list
56432016|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56432017|NCT00236795|Estradiol|estradiol|mesh-list
56432018|NCT00236795|Estrogens|estrogens|mesh-ancestor
56432019|NCT00236795|Hormones|hormones|mesh-ancestor
56432020|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432021|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432022|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56432023|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
56432024|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56432025|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56432026|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56432027|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56432028|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55780506|NCT02376049|Betamethasone|betamethasone|mesh-list
56432030|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56432032|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56432033|NCT04540627|Palivizumab|palivizumab|mesh-list
56432034|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
56432035|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432036|NCT00236834|Levofloxacin|levofloxacin|mesh-list
56432038|NCT00236834|Imipenem|imipenem|mesh-list
56432039|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56432040|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432041|NCT00236834|Renal Agents|renal agents|mesh-ancestor
56432042|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432043|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56432044|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56432045|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432046|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432047|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432048|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56432049|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56432050|NCT00236873|Topiramate|topiramate|mesh-list
56432051|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
56432052|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56432053|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432054|NCT00236912|Metronidazole|metronidazole|mesh-list
56432055|NCT00236912|Levofloxacin|levofloxacin|mesh-list
56432056|NCT00236912|Ofloxacin|ofloxacin|mesh-list
56432057|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432058|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432059|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56432060|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56432061|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56432062|NCT00236912|Renal Agents|renal agents|mesh-ancestor
56432063|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56432064|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56432065|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432066|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432067|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432068|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56432069|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56432071|NCT02215447|Carboplatin|carboplatin|mesh-list
56432072|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56432073|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432074|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
56432075|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
56432076|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
56913150|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432077|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432078|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
56432079|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
56432080|NCT00237068|Lansoprazole|lansoprazole|mesh-list
56432081|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
56432082|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56432083|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56432084|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56432085|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432086|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432087|NCT00269568|Misoprostol|misoprostol|mesh-list
56432088|NCT00269568|Mifepristone|mifepristone|mesh-list
56432089|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56432090|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
56432091|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56432092|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432093|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56179884|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
56432094|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56432095|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
56432096|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56432097|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56432098|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56432099|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56432100|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
56432101|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56432102|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56432105|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
56432106|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56432107|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56432108|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
56432109|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56432110|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432111|NCT04544059|Lenalidomide|lenalidomide|mesh-list
56432112|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
56432113|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432114|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56432115|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56432116|NCT04544059|Growth Substances|growth substances|mesh-ancestor
56432117|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
56432118|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432119|NCT00269607|Naltrexone|naltrexone|mesh-list
56432120|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56432121|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56432122|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432123|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
56432124|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432125|NCT00237224|Letrozole|letrozole|mesh-list
56432126|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432127|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56432128|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56432129|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432130|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432131|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56432132|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
56164575|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56432133|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432134|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432135|NCT00237263|Entacapone|entacapone|mesh-list
56432136|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56432137|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56432138|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56432139|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432140|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432141|NCT00237302|Topiramate|topiramate|mesh-list
56432142|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
56432143|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56432144|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432145|NCT00262275|Aspirin|aspirin|mesh-list
56432146|NCT00262275|Clopidogrel|clopidogrel|mesh-list
56432147|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56432148|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56913151|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913152|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
56146373|NCT05593458|Oxaliplatin|oxaliplatin|mesh-list
56432149|NCT00262275|Analgesics|analgesics|mesh-ancestor
56432150|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
56432151|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432152|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432153|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432154|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432155|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56432156|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56432157|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432158|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56432159|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56432160|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432161|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
56432162|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56432163|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56432164|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56432165|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
56432166|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432167|NCT02214979|Telmisartan|telmisartan|mesh-list
56432168|NCT02214979|Ramipril|ramipril|mesh-list
56432169|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56432170|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56432171|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56432172|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432202|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56432203|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432204|NCT00416130|Vorinostat|vorinostat|mesh-list
56432205|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432206|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56432207|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432208|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432209|NCT00416169|Galantamine|galantamine|mesh-list
56432210|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56432211|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432212|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432213|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
56432214|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432215|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432216|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56432217|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
56432218|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432219|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
56432220|NCT00237536|Lonidamine|lonidamine|mesh-list
56432224|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56432225|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
56432226|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56432227|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56432228|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56432229|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56432230|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432231|NCT02215720|Sirolimus|sirolimus|mesh-list
56432232|NCT02215720|Cetuximab|cetuximab|mesh-list
56432233|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56432234|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432235|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432236|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432237|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56432238|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
56432239|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56432240|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
56432241|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432242|NCT00416208|Bortezomib|bortezomib|mesh-list
56432243|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432244|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56432245|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56432246|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56432247|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56432248|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913153|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913154|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913155|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
56432249|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432250|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432251|NCT02215798|Analgesics|analgesics|mesh-ancestor
56432252|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
56432253|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432254|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
56432255|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56432256|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
56432257|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56432258|NCT02215057|Lidocaine|lidocaine|mesh-list
56432259|NCT02215057|Anesthetics|anesthetics|mesh-list
56432260|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
56432261|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56432262|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432263|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
56432264|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432265|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56432266|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56432267|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56432268|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56432269|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432270|NCT00269685|Vasopressins|vasopressins|mesh-list
56432271|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
56432272|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
56432273|NCT00269685|Coagulants|coagulants|mesh-ancestor
56432274|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56432275|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56432276|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
56432277|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432279|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
56432280|NCT04543123|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56432281|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56432282|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56432283|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432284|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432285|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
56432286|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432287|NCT04543123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56432288|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56432289|NCT04539418|Vitamin K|vitamin k|mesh-list
56432290|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
56432291|NCT04539418|Vitamins|vitamins|mesh-ancestor
56432292|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
56432295|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56432296|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432297|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
56432298|NCT04539418|Coagulants|coagulants|mesh-ancestor
56432299|NCT00269724|Oxybutynin|oxybutynin|mesh-list
56432300|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
56432301|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
56432302|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432303|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432304|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56432305|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56432306|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
56432307|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432308|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432309|NCT00269724|Urological Agents|urological agents|mesh-ancestor
56432310|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56432311|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
56432312|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
56432313|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56432314|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56432315|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432316|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
56432317|NCT04710017|Coagulants|coagulants|mesh-ancestor
56432318|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56432319|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56432320|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56913156|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913157|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56146511|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432321|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
56432322|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56432323|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432324|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56432325|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56432326|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56432327|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56432328|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432329|NCT04538521|Niacin|niacin|mesh-list
56432330|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
56432331|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56432332|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
56432333|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432334|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56432335|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
56432336|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
56432337|NCT04538521|Vitamins|vitamins|mesh-ancestor
56432338|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
56432339|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432340|NCT00269763|Fentanyl|fentanyl|mesh-list
56432341|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56432342|NCT00269763|Narcotics|narcotics|mesh-ancestor
55933060|NCT04355949|Hematinics|hematinics|mesh-ancestor
56432343|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56432344|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432345|NCT00269763|Analgesics|analgesics|mesh-ancestor
56432346|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
56432347|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432348|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56432349|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56432350|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
56432351|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
56432352|NCT00237575|Gemcitabine|gemcitabine|mesh-list
56432353|NCT00237575|Sargramostim|sargramostim|mesh-list
56432354|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432355|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56432356|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
56432357|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432358|NCT00237575|Antiviral Agents|antiviral agents|mesh-ancestor
56432359|NCT00237575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432360|NCT00237575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432361|NCT00237575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56432362|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
56432363|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432364|NCT00269802|Methylphenidate|methylphenidate|mesh-list
56432365|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56432374|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56432376|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
56432377|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432378|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56432379|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56432380|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432381|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
56432382|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56432383|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
56432384|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432385|NCT00237614|Expectorants|expectorants|mesh-ancestor
56432386|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
56432387|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56432388|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
56432389|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432390|NCT00237614|Protective Agents|protective agents|mesh-ancestor
56432391|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432392|NCT00237614|Antidotes|antidotes|mesh-ancestor
56432393|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56432394|NCT00269841|Infliximab|infliximab|mesh-list
56432395|NCT00269841|Antibodies|antibodies|mesh-list
56432396|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
56432397|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56432398|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
56913158|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56913159|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56913160|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432399|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432400|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432401|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
56432402|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56432403|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432404|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
56432405|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
56432406|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56432407|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
56432408|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432409|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432410|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56432411|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
56432412|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432413|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432414|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56432416|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56432417|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
56432418|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432419|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432420|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432421|NCT04538365|Triclosan|triclosan|mesh-list
56432422|NCT04538365|Propranolol|propranolol|mesh-list
56432423|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56432424|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56432425|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432426|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56432427|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56432428|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
56432429|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432430|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56432431|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56432441|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432442|NCT00269880|Heparin|heparin|mesh-list
56432443|NCT00269880|Abciximab|abciximab|mesh-list
56432444|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
56432445|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56432446|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56432447|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432448|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56432449|NCT00237653|Valganciclovir|valganciclovir|mesh-list
56432450|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
56432451|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432452|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
56432453|NCT00269958|Hematinics|hematinics|mesh-ancestor
56432454|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
56432455|NCT02215876|Doxorubicin|doxorubicin|mesh-list
56432456|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56432457|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
56432458|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432459|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432460|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56432461|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
56432462|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432463|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432464|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56432465|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56432466|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56432467|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56432468|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180257|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
56432469|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
56432470|NCT00269997|Hematinics|hematinics|mesh-ancestor
56432471|NCT00237731|Morphine|morphine|mesh-list
56432472|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56432473|NCT00237731|Narcotics|narcotics|mesh-ancestor
56432474|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56432475|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432476|NCT00237731|Analgesics|analgesics|mesh-ancestor
56432477|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
56913161|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56913162|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
56913163|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56913164|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432478|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432479|NCT04542226|Bromides|bromides|mesh-list
56432480|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
56432481|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
56432482|NCT00270036|Hematinics|hematinics|mesh-ancestor
56432483|NCT00262392|Pamidronate|pamidronate|mesh-list
56432484|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56432485|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432486|NCT04537780|Montelukast|montelukast|mesh-list
56432487|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56432488|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
56432489|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56432490|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
56432491|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432492|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432493|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56432494|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56432495|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432496|NCT00237887|Adalimumab|adalimumab|mesh-list
56432497|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432498|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432501|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56432502|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56432503|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56432504|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56432505|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
56432506|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432507|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432508|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432509|NCT02216149|Capecitabine|capecitabine|mesh-list
56432510|NCT02216149|Tegafur|tegafur|mesh-list
56432511|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
56432512|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56432513|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
56432514|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432515|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432516|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
56432517|NCT00238004|Niacin|niacin|mesh-list
56432518|NCT00238004|Niacinamide|niacinamide|mesh-list
56432519|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
56432520|NCT00238004|Vitamins|vitamins|mesh-ancestor
56432521|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
56432522|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432523|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56432524|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
56432525|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432526|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56432527|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
56432528|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56432529|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56432530|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56432531|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
56432532|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432533|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56432534|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56432535|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432536|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
56432537|NCT00238043|Hematinics|hematinics|mesh-ancestor
56432538|NCT00415584|Cinacalcet|cinacalcet|mesh-list
56432539|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56432540|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432541|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56432542|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
56432543|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432544|NCT04536922|Aldesleukin|aldesleukin|mesh-list
56432545|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
56432546|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
56913165|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913166|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56913167|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56432547|NCT04536922|Fludarabine|fludarabine|mesh-list
56432548|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56432549|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
56432550|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432551|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432552|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56432553|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
56432554|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432555|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432556|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56432557|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56432558|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56432559|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56432560|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
56432561|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432562|NCT00238082|Beclomethasone|beclomethasone|mesh-list
56432564|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432565|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
56432566|NCT00238082|Hormones|hormones|mesh-ancestor
56432567|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432568|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432569|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56432570|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
56432571|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
56432572|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56432573|NCT04536961|BMS-986165|bms-986165|mesh-list
56432588|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
56432589|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432590|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56432591|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56432592|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
56432593|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432594|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
56432595|NCT00415701|Propofol|propofol|mesh-list
56432596|NCT00415701|Etomidate|etomidate|mesh-list
56432597|NCT00415701|Cosyntropin|cosyntropin|mesh-list
56432598|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56432599|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56432600|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432601|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56432602|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
56432603|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
56432604|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432605|NCT00415701|Hormones|hormones|mesh-ancestor
56432606|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432607|NCT02961998|Celecoxib|celecoxib|mesh-list
56432608|NCT02961998|Sorafenib|sorafenib|mesh-list
56432609|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432610|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56432611|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432612|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432613|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56432614|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56432615|NCT02961998|Analgesics|analgesics|mesh-ancestor
56432616|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
56432617|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432618|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432619|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432620|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432621|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56432622|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56432623|NCT04536415|Oseltamivir|oseltamivir|mesh-list
56432624|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
56432625|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432626|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432627|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432628|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56146801|NCT01100112|Hormones|hormones|mesh-ancestor
56432629|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56432630|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
56432631|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432632|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432633|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55781112|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56432653|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56432655|NCT04536493|Epinephrine|epinephrine|mesh-list
56432656|NCT04536493|Racepinephrine|racepinephrine|mesh-list
56432657|NCT04536493|Tetracaine|tetracaine|mesh-list
56432658|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
56432659|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
56432660|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
56432661|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56432662|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432663|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
56432664|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432665|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56432666|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56432667|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56432668|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56432669|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432670|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56432671|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56432672|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
56432673|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432674|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56432675|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56432676|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
56432677|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56432678|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
56432679|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
56432680|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
56432681|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56432682|NCT04536181|Prednisone|prednisone|mesh-list
56432683|NCT04536181|Prednisolone|prednisolone|mesh-list
56432684|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432685|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
56432686|NCT04536181|Hormones|hormones|mesh-ancestor
56432687|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432688|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781167|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
56432693|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432695|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
56432696|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56180481|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
56432697|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
56432699|NCT02216227|Cefazolin|cefazolin|mesh-list
56432700|NCT02216227|Mupirocin|mupirocin|mesh-list
56432701|NCT02216227|Povidone|povidone|mesh-list
56432702|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56432703|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432704|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
56432705|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
56432706|NCT02216227|Trace Elements|trace elements|mesh-ancestor
56432707|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
56432708|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432709|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432710|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
56432711|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
56432712|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56432713|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432714|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432715|NCT00238277|Temozolomide|temozolomide|mesh-list
56432716|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56432717|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
56432718|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432719|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432720|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56432721|NCT02216266|Physostigmine|physostigmine|mesh-list
56432722|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56432723|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432724|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432725|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
56432726|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913168|NCT01082003|Protective Agents|protective agents|mesh-ancestor
56432727|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432728|NCT02216266|Miotics|miotics|mesh-ancestor
56432729|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
56432730|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432731|NCT00238316|Letrozole|letrozole|mesh-list
56432732|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432733|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56432734|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56432735|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432736|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432737|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56432738|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
56432739|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432740|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432741|NCT04535518|Aspirin|aspirin|mesh-list
56432742|NCT04535518|Infliximab|infliximab|mesh-list
56432743|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
56432744|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56432745|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
56432746|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56432747|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56432748|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56432749|NCT04535518|Analgesics|analgesics|mesh-ancestor
56432750|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
56432751|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432752|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432753|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432754|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432755|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56432756|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56432757|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432758|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56432759|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56432760|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432763|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
56432764|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56432766|NCT02216383|Carbetocin|carbetocin|mesh-list
56432767|NCT02216383|Syntometrine|syntometrine|mesh-list
56432768|NCT02216383|Ergonovine|ergonovine|mesh-list
56432769|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
56432770|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56432771|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432772|NCT00262782|Fludarabine|fludarabine|mesh-list
56432773|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432774|NCT00238394|Cediranib|cediranib|mesh-list
56432775|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432776|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432777|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432778|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56432779|NCT00238472|Nateglinide|nateglinide|mesh-list
56432780|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56432781|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432782|NCT00238628|Bexarotene|bexarotene|mesh-list
56432783|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432784|NCT02216617|Docetaxel|docetaxel|mesh-list
56432785|NCT02216617|Afatinib|afatinib|mesh-list
56432786|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432787|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
56432788|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
56432789|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
56432790|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432791|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56432792|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432793|NCT00262977|Aspirin|aspirin|mesh-list
56432794|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56432795|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56432796|NCT00262977|Analgesics|analgesics|mesh-ancestor
56432797|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
56432798|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432799|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432800|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432801|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432802|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56432803|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56093381|NCT00377546|Bromfenac|bromfenac|mesh-list
56913169|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432804|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432805|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56432806|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56432807|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432808|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
56432809|NCT00238667|Aspirin|aspirin|mesh-list
56432810|NCT00238667|Heparin|heparin|mesh-list
56432811|NCT00238667|Calcium heparin|calcium heparin|mesh-list
56432812|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56432813|NCT00238667|Dalteparin|dalteparin|mesh-list
56432814|NCT00238667|Dipyridamole|dipyridamole|mesh-list
56432815|NCT00238667|Warfarin|warfarin|mesh-list
56432816|NCT00238667|Anticoagulants|anticoagulants|mesh-list
56432817|NCT00238667|Clopidogrel|clopidogrel|mesh-list
56432818|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56432819|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56432820|NCT00238667|Analgesics|analgesics|mesh-ancestor
56432821|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
56432822|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432823|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432824|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432825|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432826|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56432827|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56432828|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432829|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56432830|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56432831|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432832|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
56432833|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56432834|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56432835|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56432836|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
56432838|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56432839|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
56432840|NCT00263016|Docetaxel|docetaxel|mesh-list
56432841|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432842|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
56432843|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
56432844|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
56432845|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432846|NCT04534465|Mannitol|mannitol|mesh-list
56432847|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56432848|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56432849|NCT04534465|Diuretics|diuretics|mesh-ancestor
56432850|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
56432851|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432852|NCT04534465|Laxatives|laxatives|mesh-ancestor
56432853|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56432854|NCT02216656|Cinacalcet|cinacalcet|mesh-list
56432855|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56432856|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432857|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56432858|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
56432859|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432860|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
56432861|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432863|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56432864|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56432865|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
56432866|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432867|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432868|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56432869|NCT04534231|Nicotine|nicotine|mesh-list
56432870|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56432871|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
56432872|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432873|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432874|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56432875|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56432876|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
56432877|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432878|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432879|NCT00263094|Rofecoxib|rofecoxib|mesh-list
56432880|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56432881|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56432882|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432883|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432884|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56432885|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56432886|NCT00263094|Analgesics|analgesics|mesh-ancestor
56432887|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
56432888|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432889|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432890|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432891|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432892|NCT00238784|Budesonide|budesonide|mesh-list
56432893|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
56432894|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56432895|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56432896|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
56432897|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432898|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432899|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56432900|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
56432901|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
56432902|NCT00238784|Hormones|hormones|mesh-ancestor
56432903|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432904|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56432905|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56432906|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56432907|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
56432908|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432909|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432910|NCT00263133|Sertraline|sertraline|mesh-list
56432914|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56432915|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56432916|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432917|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432918|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
56432919|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432920|NCT04533724|Amisulpride|amisulpride|mesh-list
56432921|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56432922|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56432923|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180735|NCT01406301|PENTA|penta|mesh-list
56432924|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432925|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56432926|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56432927|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
56432928|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432929|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432930|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55933649|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432931|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
56432932|NCT00238901|Basiliximab|basiliximab|mesh-list
56432933|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56432934|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
56432935|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432936|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
56432937|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56432938|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432939|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56432940|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
56432941|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432942|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432943|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432944|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432945|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
56432946|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56432947|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432948|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56432949|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
56432950|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432951|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432952|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093642|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
56913170|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
56913171|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56913172|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
56913173|NCT01082237|Citalopram|citalopram|mesh-list
56432953|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432954|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
56432955|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56432956|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432957|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56432958|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
56432959|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432960|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432961|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432962|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432963|NCT04532671|Ether|ether|mesh-list
56432964|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56432965|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
56432966|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
56432967|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56432968|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432969|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
56432970|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56432971|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432972|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56432973|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
56432974|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56432975|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432976|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432977|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432978|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
56432979|NCT02217007|Acamprosate|acamprosate|mesh-list
56432992|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432993|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432995|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56180801|NCT01406639|Ranibizumab|ranibizumab|mesh-list
56432996|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56432997|NCT02217163|Dexamethasone|dexamethasone|mesh-list
56432998|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
56432999|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56433000|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
56433001|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433002|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433004|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
56433005|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433006|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433007|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56433008|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433009|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
56433010|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
56433011|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433012|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433013|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
56433014|NCT02217163|Hormones|hormones|mesh-ancestor
56433015|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433016|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56433017|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56433018|NCT02217202|Laxatives|laxatives|mesh-ancestor
56433019|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433020|NCT00239174|Surinabant|surinabant|mesh-list
56433021|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56433022|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56433023|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433024|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433025|NCT00239174|Hormones|hormones|mesh-ancestor
56433026|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433027|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433028|NCT04531423|Golimumab|golimumab|mesh-list
56433029|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56433030|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433031|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56433032|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
56913174|NCT01082237|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56433033|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433034|NCT00239252|Interferons|interferons|mesh-list
56433035|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
56433036|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433037|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
56433038|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433039|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56433042|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433043|NCT04531267|Calcium|calcium|mesh-list
56433044|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56433045|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433046|NCT04531228|Lenvatinib|lenvatinib|mesh-list
56433047|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433048|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56433049|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433050|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433051|NCT04531072|Ritonavir|ritonavir|mesh-list
56433052|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56433053|NCT04531072|Lumefantrine|lumefantrine|mesh-list
56433054|NCT04531072|Artemether|artemether|mesh-list
56433055|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56433056|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56433057|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56433058|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
56433059|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433060|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433061|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56433062|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56433063|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
56433064|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433065|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56433066|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56433067|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
56433068|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56433069|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56433070|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56433072|NCT00414323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56433073|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56433074|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433075|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433076|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433077|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
56433078|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433079|NCT00414323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56433080|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
56433081|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56433082|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433083|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56433084|NCT00414323|Analgesics|analgesics|mesh-ancestor
56433085|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
56433086|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
56433087|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
56433088|NCT00263484|Thalidomide|thalidomide|mesh-list
56433089|NCT00263484|Dexamethasone|dexamethasone|mesh-list
56433090|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
56433091|NCT00263484|BB 1101|bb 1101|mesh-list
56433092|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433093|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
56433094|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
56433095|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433096|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433097|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433098|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
56433099|NCT00263484|Hormones|hormones|mesh-ancestor
56433100|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433101|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56433102|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433103|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
56433104|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433105|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433106|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56433107|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
56913175|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56913176|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913177|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913178|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913179|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
56433108|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
56433109|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56433110|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433111|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56433112|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56433125|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56433126|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433127|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433128|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56433129|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56433130|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56433131|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56433132|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
56433133|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
56433134|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
56433135|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
56433136|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433137|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433138|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
56433139|NCT02217553|Vitamin D|vitamin d|mesh-list
56433140|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56433141|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433142|NCT02217553|Vitamins|vitamins|mesh-ancestor
56433143|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
56180944|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433144|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56433145|NCT02217631|Prednisolone|prednisolone|mesh-list
56433146|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56433147|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
56433148|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55933904|NCT03034707|Biotin|biotin|mesh-list
56433149|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
56433150|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56433151|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
56433152|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433153|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
56433154|NCT02217631|Hormones|hormones|mesh-ancestor
56433155|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433156|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433157|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56433158|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433159|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
56433160|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
56433161|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433162|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433163|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56433164|NCT02217631|Protective Agents|protective agents|mesh-ancestor
56433165|NCT02217670|Metformin|metformin|mesh-list
56433166|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56433167|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433168|NCT00239291|Gefitinib|gefitinib|mesh-list
56433169|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433170|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56433171|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433172|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433173|NCT02217826|Octreotide|octreotide|mesh-list
56433174|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433175|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56433185|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433187|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56433188|NCT02218021|Narcotics|narcotics|mesh-ancestor
56433189|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433190|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433191|NCT02218021|Analgesics|analgesics|mesh-ancestor
56433192|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
56913180|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913181|NCT01082237|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56913182|NCT01082237|Antidepressive Agents|antidepressive agents|mesh-ancestor
56913183|NCT01082237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56433193|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433194|NCT00239369|Telmisartan|telmisartan|mesh-list
56433195|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56433196|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56433197|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56433198|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56433199|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433200|NCT00239369|Diuretics|diuretics|mesh-ancestor
56433201|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
56433202|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433203|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56433204|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433205|NCT04529668|Vitamin D|vitamin d|mesh-list
56433206|NCT04529668|Vitamins|vitamins|mesh-ancestor
56433207|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
56433208|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433209|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56433210|NCT00239408|Bromides|bromides|mesh-list
56433211|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
56433212|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56433213|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
56433214|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433215|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433216|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56433217|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
56433218|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
56181013|NCT01408446|Menthol|menthol|mesh-list
56433219|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56433221|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933955|NCT03027843|Hormones|hormones|mesh-list
56433222|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433223|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
56433225|NCT02218177|Aflibercept|aflibercept|mesh-list
56433226|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56433227|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56433228|NCT02218177|Growth Substances|growth substances|mesh-ancestor
56433229|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433230|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
56433231|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433232|NCT00263718|Betamethasone|betamethasone|mesh-list
56433233|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
56433234|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56433235|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
56433236|NCT00263718|Calcipotriene|calcipotriene|mesh-list
56433237|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56433238|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433239|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
56433240|NCT00263718|Hormones|hormones|mesh-ancestor
55783648|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433244|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
56433245|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
56433246|NCT02218645|Brotizolam|brotizolam|mesh-list
56433247|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56433248|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433249|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433250|NCT02218684|Telmisartan|telmisartan|mesh-list
56433251|NCT02218684|Lacidipine|lacidipine|mesh-list
56433252|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56433253|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56433254|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56433255|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433256|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56433257|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433258|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56433259|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433260|NCT02278861|Tretinoin|tretinoin|mesh-list
56433261|NCT02278861|Isotretinoin|isotretinoin|mesh-list
56913184|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56913185|NCT02228122|Laxatives|laxatives|mesh-ancestor
56913186|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56913187|NCT01082315|Cetuximab|cetuximab|mesh-list
56147383|NCT01177098|Timolol|timolol|mesh-list
56433262|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
56433263|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
56433264|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433265|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
56433266|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56433267|NCT02278861|Protective Agents|protective agents|mesh-ancestor
56433268|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433269|NCT01642030|Buprenorphine|buprenorphine|mesh-list
56433270|NCT01642030|Hydromorphone|hydromorphone|mesh-list
56433271|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56433272|NCT01642030|Narcotics|narcotics|mesh-ancestor
56433273|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433274|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433275|NCT01642030|Analgesics|analgesics|mesh-ancestor
56433276|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
56433277|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433278|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56433279|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
56433280|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56433281|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
56433282|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433283|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433284|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56433285|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
56433286|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
56433287|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56433288|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
56433289|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433290|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433291|NCT00263796|Oxytocin|oxytocin|mesh-list
56433292|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
56433293|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56433294|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433295|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56433296|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56433297|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433298|NCT01642108|Incretins|incretins|mesh-ancestor
56433299|NCT01642108|Hormones|hormones|mesh-ancestor
56433300|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433301|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56433302|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
56433303|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433304|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433305|NCT00250185|Acetylcholine|acetylcholine|mesh-list
56433306|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
56433307|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56433308|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
56433309|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781705|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433313|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
56433314|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433315|NCT00239486|Protective Agents|protective agents|mesh-ancestor
56433316|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433317|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56433318|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56433319|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
56433320|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
56433321|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433322|NCT01642966|Ticagrelor|ticagrelor|mesh-list
56433323|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56433324|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56433325|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56433326|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56433327|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56433328|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
56433329|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093643|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
56913188|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56433330|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433331|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433332|NCT01643083|Rifaximin|rifaximin|mesh-list
56433333|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56433334|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433335|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433336|NCT01643278|Ipilimumab|ipilimumab|mesh-list
56433337|NCT01643278|Dasatinib|dasatinib|mesh-list
56433338|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56433339|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433340|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56433341|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433342|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56433343|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433344|NCT01643629|Minoxidil|minoxidil|mesh-list
56433345|NCT01643629|Finasteride|finasteride|mesh-list
56433346|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56433347|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
56433348|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56433349|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56433350|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433351|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433352|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
56433353|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433354|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433355|NCT01643629|Urological Agents|urological agents|mesh-ancestor
56433356|NCT01644253|Rituximab|rituximab|mesh-list
56433357|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
56433358|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56433359|NCT01644253|Idelalisib|idelalisib|mesh-list
56433360|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
56433361|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56433362|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433363|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
56433364|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433365|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433366|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56433367|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
56433368|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433370|NCT01644799|Lenalidomide|lenalidomide|mesh-list
56433371|NCT01644799|Idelalisib|idelalisib|mesh-list
56433372|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
56433373|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433374|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56433375|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56433376|NCT01644799|Growth Substances|growth substances|mesh-ancestor
56433377|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
56433378|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433379|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433380|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433381|NCT01644838|Promethazine|promethazine|mesh-list
56433385|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
56433386|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
56433387|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433388|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433389|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433390|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
56433391|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56433392|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
56433393|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433394|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433395|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56433396|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
56433397|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
56433398|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56433399|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
56433400|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
56433401|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56433402|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56433403|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56433404|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433405|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
56433406|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
56147533|NCT01211730|Insulin|insulin|mesh-list
56433407|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
56433408|NCT01644955|Carboplatin|carboplatin|mesh-list
56433409|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433410|NCT01644994|Cisplatin|cisplatin|mesh-list
56433411|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433412|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
56433413|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56433414|NCT04528888|Heparin|heparin|mesh-list
56433415|NCT04528888|Enoxaparin|enoxaparin|mesh-list
56433416|NCT04528888|Calcium heparin|calcium heparin|mesh-list
56433417|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433418|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
56433419|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
56433420|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433421|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433422|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433423|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
56433424|NCT04528888|Hormones|hormones|mesh-ancestor
56433425|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433426|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56433427|NCT04528888|Protective Agents|protective agents|mesh-ancestor
56433428|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56433429|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433430|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
56433431|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56433432|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56433433|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433434|NCT01645384|Atorvastatin|atorvastatin|mesh-list
56433435|NCT01645384|Calcium|calcium|mesh-list
56433436|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56433437|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433438|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56433439|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56433440|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
56433441|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433442|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56433443|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56433444|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433445|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56433446|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56433447|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433448|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56433449|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
56433450|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433451|NCT01645423|Atorvastatin|atorvastatin|mesh-list
56433452|NCT01645423|Calcium|calcium|mesh-list
56433453|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56433454|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433463|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56433464|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56433465|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
56433466|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433467|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433468|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433469|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
56433470|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
56433471|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433472|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
56433473|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56433474|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
56433475|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56433476|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56433477|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433478|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56433479|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
56433480|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433481|NCT02961075|Anesthetics|anesthetics|mesh-list
56433482|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433483|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433484|NCT01646281|Flecainide|flecainide|mesh-list
56433485|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56433486|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56913189|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433487|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56433488|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433489|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433490|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
56433491|NCT01646554|Aflibercept|aflibercept|mesh-list
56433492|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433493|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56433494|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56433495|NCT01646554|Growth Substances|growth substances|mesh-ancestor
56433496|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433497|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
56433498|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
56433499|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
56433500|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56433501|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56433502|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433503|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433504|NCT01646788|Paclitaxel|paclitaxel|mesh-list
56433505|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56433506|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433507|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
56433508|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
56433509|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
56433510|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433511|NCT01647256|Nikkomycin|nikkomycin|mesh-list
56433512|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
56433513|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433514|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433515|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433517|NCT00239954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56433518|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55781922|NCT05049473|Hormones|hormones|mesh-ancestor
56433519|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433520|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433521|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433523|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433524|NCT00239954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56433525|NCT00239954|Antidepressive Agents|antidepressive agents|mesh-ancestor
56433526|NCT00239954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56433527|NCT04528927|Azithromycin|azithromycin|mesh-list
56433528|NCT04528927|Doxycycline|doxycycline|mesh-list
56433529|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56433530|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433531|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
56433532|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56433533|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56433534|NCT04720287|Bupivacaine|bupivacaine|mesh-list
56433535|NCT04720287|Neostigmine|neostigmine|mesh-list
56433536|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
56433537|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
56433538|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433539|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433540|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
56433541|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433542|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56433543|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433544|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433545|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
56433546|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433547|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56433548|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
56433549|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
56433550|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
56433551|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56433552|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
56433553|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433554|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56433555|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433556|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
56433557|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
56433558|NCT00264108|Hematinics|hematinics|mesh-ancestor
56433559|NCT01647412|Curcumin|curcumin|mesh-list
56433560|NCT01647412|Hormones|hormones|mesh-list
56433561|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56913190|NCT01082471|Morphine|morphine|mesh-list
56913191|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56913192|NCT01082471|Narcotics|narcotics|mesh-ancestor
56433562|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433563|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56433564|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56433565|NCT01647412|Analgesics|analgesics|mesh-ancestor
56433566|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
56433567|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433568|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433569|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433570|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433571|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433572|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433573|NCT01647529|Ganciclovir|ganciclovir|mesh-list
56433574|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56433575|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
56433576|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433577|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56433578|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433579|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433580|NCT00240032|Cetirizine|cetirizine|mesh-list
56433581|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
56433582|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
56433583|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56433584|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56433585|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56433586|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
56433587|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
56433588|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433589|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433590|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433592|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
56433593|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56433594|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433598|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433599|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56433600|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56433601|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
56433602|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56433603|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
56433604|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433605|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433606|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
56433607|NCT01647646|Hormones|hormones|mesh-ancestor
56433608|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433609|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
56433610|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
56433611|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56433612|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56433613|NCT01647685|Prednisolone|prednisolone|mesh-list
56433614|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
56433615|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56433616|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
56433617|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433618|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
56433619|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
56433620|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433621|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433622|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433623|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
56433624|NCT01647685|Hormones|hormones|mesh-ancestor
56433625|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433626|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56433627|NCT01647685|Protective Agents|protective agents|mesh-ancestor
56433628|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56433629|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433630|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56433631|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56433632|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56433633|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
56433634|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913193|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147746|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
56433635|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56433636|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56433637|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433638|NCT01648036|Heparin|heparin|mesh-list
56433639|NCT01648036|Calcium heparin|calcium heparin|mesh-list
56433640|NCT01648036|Dalteparin|dalteparin|mesh-list
56433641|NCT01648036|Tinzaparin|tinzaparin|mesh-list
56433642|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56433643|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
56433644|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56433645|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56433646|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433647|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56433648|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56433649|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56433650|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
56433651|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433652|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56433653|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56433654|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433655|NCT01648231|Losartan|losartan|mesh-list
56433656|NCT01648231|Amlodipine|amlodipine|mesh-list
56433657|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56433658|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56433659|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433660|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433661|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56433662|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433663|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
56433664|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56433665|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55782059|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
56433669|NCT00264186|Acetylcholine|acetylcholine|mesh-list
56433670|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56433671|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56433672|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
56433673|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433674|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433675|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433676|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
56433677|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
56433678|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433679|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56433680|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
56433681|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56433682|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
56433683|NCT00240422|Telmisartan|telmisartan|mesh-list
56433684|NCT00240422|Ramipril|ramipril|mesh-list
56433685|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56433686|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56433687|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56433688|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433689|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56433690|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
56433691|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433692|NCT00264225|Codeine|codeine|mesh-list
56433693|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56433694|NCT00264225|Narcotics|narcotics|mesh-ancestor
56433695|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433696|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433697|NCT00264225|Analgesics|analgesics|mesh-ancestor
56433698|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
56433699|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433700|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
56433701|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
56433702|NCT02279563|Fluticasone|fluticasone|mesh-list
56433704|NCT02279563|Azelastine|azelastine|mesh-list
56433705|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433706|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56433707|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
56433708|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913194|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913195|NCT01082471|Analgesics|analgesics|mesh-ancestor
56913196|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
56147818|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
56433709|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433710|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56433711|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
56433712|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
56433713|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56433714|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56433715|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433716|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433717|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56433718|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56433719|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
56433720|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
56433721|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433722|NCT02279758|Metformin|metformin|mesh-list
56433723|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56433724|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433725|NCT01649245|Interferons|interferons|mesh-list
56433726|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433727|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
56433728|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433729|NCT01649284|Afatinib|afatinib|mesh-list
56433730|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433731|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56433732|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433733|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433734|NCT00415740|Levodopa|levodopa|mesh-list
56433735|NCT00415740|Carbidopa|carbidopa|mesh-list
56433736|NCT00415740|Entacapone|entacapone|mesh-list
56433737|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56433738|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56181568|NCT01412073|Oxytocin|oxytocin|mesh-list
56433739|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56433755|NCT01649635|Prednisone|prednisone|mesh-list
56433756|NCT01649635|Lenograstim|lenograstim|mesh-list
56433757|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433758|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
56433759|NCT01649635|Hormones|hormones|mesh-ancestor
56433760|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433761|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433762|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56433763|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433764|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56433765|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433766|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56433767|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56433768|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433769|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433770|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56433771|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56433772|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56433773|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
56433774|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
56433775|NCT00250536|Nandrolone|nandrolone|mesh-list
56433776|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
56433777|NCT00250536|Androgens|androgens|mesh-ancestor
56433778|NCT00250536|Hormones|hormones|mesh-ancestor
56433779|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433780|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433781|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
56433782|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56433783|NCT00240617|Naproxen|naproxen|mesh-list
56433784|NCT00240617|Sumatriptan|sumatriptan|mesh-list
56433785|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56433786|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56433787|NCT00240617|Analgesics|analgesics|mesh-ancestor
56433788|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
56433789|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433790|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913197|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913198|NCT03553498|Acetaminophen|acetaminophen|mesh-list
56913199|NCT03553498|Hydromorphone|hydromorphone|mesh-list
56913200|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56913201|NCT03553498|Analgesics|analgesics|mesh-ancestor
56913202|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
56913203|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913204|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913205|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
56913206|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56913207|NCT03553498|Narcotics|narcotics|mesh-ancestor
56913208|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913209|NCT01589393|Enoxaparin|enoxaparin|mesh-list
56913210|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
56913211|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56913212|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56147890|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56433791|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433792|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433793|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
56433794|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56433795|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433796|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433797|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56433798|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56433810|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56433812|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181612|NCT01412515|Everolimus|everolimus|mesh-list
56433813|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433814|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56433816|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
56433817|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56433818|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56433819|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
56433820|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433821|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433822|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56433823|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
56433824|NCT00240656|Protective Agents|protective agents|mesh-ancestor
56433825|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56433826|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433827|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56433828|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
56433829|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56433830|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56433831|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56433832|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
56433833|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433834|NCT00250575|Clozapine|clozapine|mesh-list
56433835|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56433836|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
56433837|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433838|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433839|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433840|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56433841|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56433842|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433843|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56913213|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913214|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
56433844|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
56433845|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
56433846|NCT00240695|Galantamine|galantamine|mesh-list
56433847|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56433848|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433849|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433850|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
56433851|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433852|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433853|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56433854|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
56433855|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433856|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
56433857|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
56433858|NCT00240734|Hematinics|hematinics|mesh-ancestor
56433859|NCT04720248|Dipyrone|dipyrone|mesh-list
56433860|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56433861|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56433863|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
56433864|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433865|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433866|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433867|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433869|NCT01646515|Udenafil|udenafil|mesh-list
56433870|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56433871|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56433872|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433873|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433874|NCT00240773|Acetaminophen|acetaminophen|mesh-list
56433875|NCT00240773|Naproxen|naproxen|mesh-list
56433876|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56433877|NCT00240773|Analgesics|analgesics|mesh-ancestor
56433878|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
56433879|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433880|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433881|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
56433882|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56433883|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433884|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433885|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
56433886|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56181689|NCT01413022|Vitamins|vitamins|mesh-ancestor
56433887|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433888|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433889|NCT01688401|Melphalan|melphalan|mesh-list
56433890|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56433891|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
56433892|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433893|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433894|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56433895|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56433896|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
56433897|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433898|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56433899|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56433900|NCT04708821|Dexamethasone|dexamethasone|mesh-list
56433901|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56433902|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433903|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
56433904|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
56433905|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433906|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433907|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56433908|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
56433909|NCT04708821|Hormones|hormones|mesh-ancestor
56433910|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433911|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56433912|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433913|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56433914|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56433915|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56913215|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56913216|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56148022|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
56433916|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56433917|NCT04708821|Analgesics|analgesics|mesh-ancestor
56433918|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
56433919|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433920|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56433921|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56433922|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
56433923|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
56433924|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433925|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433926|NCT00240812|Ibuprofen|ibuprofen|mesh-list
56433927|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
56433928|NCT00240812|Ephedrine|ephedrine|mesh-list
56433929|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56433930|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56433931|NCT00240812|Analgesics|analgesics|mesh-ancestor
56433932|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
56433933|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433934|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433939|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433940|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56433941|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
56433942|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56433943|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
56433944|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
56433945|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56433946|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56433947|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
56433948|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
56433949|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433950|NCT01688518|Lidocaine|lidocaine|mesh-list
56433951|NCT01688518|Tetracaine|tetracaine|mesh-list
56433952|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
56433953|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
56433954|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433955|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433956|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
56433957|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433958|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56433959|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56433960|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56181768|NCT01413854|Diclofenac|diclofenac|mesh-list
56433961|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433962|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433963|NCT00240851|Acetaminophen|acetaminophen|mesh-list
56433964|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56433965|NCT00240851|Analgesics|analgesics|mesh-ancestor
56433966|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
56433967|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433968|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433969|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
56433970|NCT00240929|Palivizumab|palivizumab|mesh-list
56433971|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
56433972|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56433973|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
56433974|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56433975|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
56433976|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
56433977|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433978|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433979|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56433980|NCT00250692|Analgesics|analgesics|mesh-ancestor
56433981|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
56433982|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433983|NCT01688791|Paclitaxel|paclitaxel|mesh-list
56433984|NCT01688791|Carboplatin|carboplatin|mesh-list
56433985|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56433986|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433987|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
56433988|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
56433989|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
56433990|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433991|NCT01688947|Pregabalin|pregabalin|mesh-list
56433992|NCT01688947|Analgesics|analgesics|mesh-ancestor
56433993|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
56433994|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56433995|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433996|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
56433997|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56433998|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433999|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434000|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56434001|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56434002|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56434003|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434004|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56434008|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56434010|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434011|NCT00241007|Diuretics|diuretics|mesh-ancestor
56434012|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
56434013|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434014|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56434015|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56434016|NCT01689142|Insulin|insulin|mesh-list
56434017|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56434018|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
56434019|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56434020|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434021|NCT00241046|Letrozole|letrozole|mesh-list
56434022|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434023|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56434024|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56434025|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434026|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434027|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56434028|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
56434029|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434030|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434031|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
56434032|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56434033|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
56434034|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56434036|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434037|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56434038|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434039|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56434040|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434041|NCT01689298|Oxytocin|oxytocin|mesh-list
56434042|NCT01689298|Carbetocin|carbetocin|mesh-list
56434043|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
56434044|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56434045|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434046|NCT00241085|Valsartan|valsartan|mesh-list
56434047|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56434048|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56434049|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56434050|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434051|NCT02271919|Nicotine|nicotine|mesh-list
56434052|NCT02271919|Varenicline|varenicline|mesh-list
56434053|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56434054|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
56434055|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434056|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434057|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56434058|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56434059|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
56434060|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434061|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434062|NCT00241124|Valsartan|valsartan|mesh-list
56434063|NCT00241124|Lisinopril|lisinopril|mesh-list
56434064|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56434065|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56434066|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56434067|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913217|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56913218|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56434068|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56434069|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
56434070|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434071|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56434072|NCT00241124|Protective Agents|protective agents|mesh-ancestor
56434073|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434074|NCT00241163|Thrombin|thrombin|mesh-list
56434075|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
56434076|NCT00241163|Coagulants|coagulants|mesh-ancestor
56434080|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434081|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434082|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
56434083|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
56434084|NCT00241241|Interferons|interferons|mesh-list
56434085|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
56434086|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
56434087|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56434088|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434089|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
56434090|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56434091|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
56434092|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434093|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
56434094|NCT02279602|Combretastatin|combretastatin|mesh-list
56434095|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434096|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434097|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434098|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434099|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434100|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434101|NCT00241436|Anastrozole|anastrozole|mesh-list
56434102|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56434103|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434104|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56434105|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56434106|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434107|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434108|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56434109|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
56434110|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434111|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434113|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56434114|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434115|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
56434116|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56434117|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434118|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
56434119|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56434120|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434122|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434123|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56434124|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434125|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434126|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
56434127|NCT01685359|Hematinics|hematinics|mesh-ancestor
56434128|NCT02278978|Nintedanib|nintedanib|mesh-list
56434129|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434130|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56434131|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434132|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434133|NCT02218762|Fluticasone|fluticasone|mesh-list
56434134|NCT02218762|Xhance|xhance|mesh-list
56434135|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56434136|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56434137|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434138|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56434139|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
56434140|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434141|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913219|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913220|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
56913221|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148256|NCT01328184|Hormones|hormones|mesh-ancestor
56434142|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56434143|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
56434144|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
56434145|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56434146|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56434147|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56434148|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56434151|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434153|NCT02218762|Hormones|hormones|mesh-ancestor
56164606|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56434154|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434156|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
56434157|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434158|NCT00241514|Esomeprazole|esomeprazole|mesh-list
56434159|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56434160|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56434161|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56434162|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434163|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434164|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56434165|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
56434166|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56434167|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
56434168|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434169|NCT00241553|Esomeprazole|esomeprazole|mesh-list
56434170|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56434171|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56434172|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56434173|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434174|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434175|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
56434176|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56434177|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56434178|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434179|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
56434180|NCT02219152|Coagulants|coagulants|mesh-ancestor
56434181|NCT00264615|Lamotrigine|lamotrigine|mesh-list
56434182|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
56434183|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56434184|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56434185|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434186|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56434187|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434188|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56434189|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56434190|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434191|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56434192|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56434194|NCT02219191|Atorvastatin|atorvastatin|mesh-list
56434195|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56434196|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56434197|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
56434198|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434199|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56434200|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56434201|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434202|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
56434203|NCT04529512|Dexamethasone|dexamethasone|mesh-list
56434204|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434205|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
56434206|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
56434207|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434208|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434209|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56434210|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
56434211|NCT04529512|Hormones|hormones|mesh-ancestor
56913222|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913223|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56913224|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434212|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434213|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56434214|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434215|NCT04720131|Capecitabine|capecitabine|mesh-list
56434216|NCT04720131|Apatinib|apatinib|mesh-list
56434217|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56434218|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
56434219|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434220|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434223|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56434224|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56434225|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56434226|NCT02219737|Rituximab|rituximab|mesh-list
55934989|NCT00967551|Zinc|zinc|mesh-list
56434227|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56434228|NCT02219737|Carboplatin|carboplatin|mesh-list
56434229|NCT02219737|Etoposide|etoposide|mesh-list
56434230|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
56434231|NCT02219737|Ifosfamide|ifosfamide|mesh-list
56434232|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
56434233|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
56434234|NCT02219737|Antibodies|antibodies|mesh-list
56434235|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
56434236|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56434237|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
56434238|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434239|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434240|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56434241|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434242|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56434243|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56434244|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434245|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434246|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56434247|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
56434248|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
56434249|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
56434250|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434251|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434252|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434253|NCT02219893|Immunotoxins|immunotoxins|mesh-list
56434254|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
56434255|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434256|NCT02218606|Prednisone|prednisone|mesh-list
56182062|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
56434257|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
56434258|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434259|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
56434260|NCT02218606|Hormones|hormones|mesh-ancestor
56434261|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434262|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434263|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56434264|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434265|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56434266|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434267|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434268|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
56434269|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56434270|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
56434271|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56434272|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434273|NCT02210806|Albuterol|albuterol|mesh-list
56434274|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56434275|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
56434276|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434277|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434278|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56434279|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
56434280|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
56434281|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56913225|NCT00096941|Pertuzumab|pertuzumab|mesh-list
56913226|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56913227|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913228|NCT00096785|Entecavir|entecavir|mesh-list
56913229|NCT00096785|Adefovir|adefovir|mesh-list
56913230|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
56913231|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913232|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56913233|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56913234|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148385|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
56434282|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56434283|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56434284|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56434285|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
56434286|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434287|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434288|NCT00264654|Paroxetine|paroxetine|mesh-list
56434289|NCT00264654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56434290|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56434291|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56434292|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434296|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56434297|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
56434298|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56434299|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56434300|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56434301|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434302|NCT02219659|Fentanyl|fentanyl|mesh-list
56434303|NCT02219659|Midazolam|midazolam|mesh-list
56434304|NCT02219659|Propofol|propofol|mesh-list
56434305|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56434306|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434307|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434308|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56434309|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
56434310|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
56434311|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56434312|NCT02219659|Narcotics|narcotics|mesh-ancestor
56434313|NCT02219659|Analgesics|analgesics|mesh-ancestor
56434314|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
56434315|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434316|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56434317|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56434318|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56434319|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56434320|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
56434321|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
56434322|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434323|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434324|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
56434325|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56434326|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56434327|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56434328|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
56434329|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56434330|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434331|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56434332|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56434333|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
56434334|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56434336|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434337|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
56434338|NCT00241982|Hormones|hormones|mesh-ancestor
56913235|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913236|NCT01326767|Paclitaxel|paclitaxel|mesh-list
56434339|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434340|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434341|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56434342|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434343|NCT02212015|Paclitaxel|paclitaxel|mesh-list
56434344|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434345|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434346|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434347|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434348|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434349|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434350|NCT04720859|Canagliflozin|canagliflozin|mesh-list
56434351|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56434352|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434353|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56434354|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434355|NCT02279134|Paclitaxel|paclitaxel|mesh-list
56434356|NCT02279134|Nedaplatin|nedaplatin|mesh-list
56434357|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434358|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434359|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434360|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434361|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434362|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434363|NCT02961842|Ephedrine|ephedrine|mesh-list
56434364|NCT02961842|Fentanyl|fentanyl|mesh-list
56434366|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
56434367|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
56434368|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434369|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434370|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
56434371|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434372|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56434373|NCT02961842|Narcotics|narcotics|mesh-ancestor
56434374|NCT02961842|Analgesics|analgesics|mesh-ancestor
56434375|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56434376|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56434377|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
56434378|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56434379|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
56434380|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
56434381|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56434382|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
56434383|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434384|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434385|NCT00272805|Carvedilol|carvedilol|mesh-list
56434386|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56434387|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56434388|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
56434389|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434390|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434391|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434392|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56434393|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
56434394|NCT00272805|Protective Agents|protective agents|mesh-ancestor
56434395|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56434396|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56434397|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56434398|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
56434399|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56434400|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56434401|NCT00242177|Pioglitazone|pioglitazone|mesh-list
56434402|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56434403|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434404|NCT00264927|Satavaptan|satavaptan|mesh-list
56434405|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56434406|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434407|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
56434408|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434409|NCT00242372|Insulin|insulin|mesh-list
56434410|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56434411|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434412|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56434413|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56434414|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56434415|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434416|NCT00242411|Budesonide|budesonide|mesh-list
56434417|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
56434418|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434419|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56434420|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
56434421|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434422|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434423|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56434424|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
56434425|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
56434426|NCT00242411|Hormones|hormones|mesh-ancestor
56434427|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434428|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56434429|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56434430|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56434431|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
56434432|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434433|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434434|NCT02962037|Melatonin|melatonin|mesh-list
56434435|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
56434436|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434437|NCT02962037|Protective Agents|protective agents|mesh-ancestor
56434444|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434445|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434446|NCT00242450|Metoclopramide|metoclopramide|mesh-list
56434447|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
56434448|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
56434449|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434450|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434451|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56434452|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56434453|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56434454|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
56434455|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434456|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434457|NCT00273039|Paroxetine|paroxetine|mesh-list
56434458|NCT00273039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56434459|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56434460|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56434461|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434462|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434463|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
56434464|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434465|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56434466|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
56434467|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56434468|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56434469|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56434470|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434471|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
56434472|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56434473|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434474|NCT00242606|Lamotrigine|lamotrigine|mesh-list
56434475|NCT00242606|Levetiracetam|levetiracetam|mesh-list
56434476|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
56434477|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
56434478|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56434479|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56434480|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434481|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56434482|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434483|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56434484|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56434485|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434486|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56434487|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56913237|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56148603|NCT01378416|Decitabine|decitabine|mesh-list
56434489|NCT00242762|Gefitinib|gefitinib|mesh-list
56434490|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434491|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434492|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434493|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434494|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434495|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56434496|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434497|NCT00242801|Gefitinib|gefitinib|mesh-list
56434498|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434499|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56434500|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434501|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434502|NCT00242879|Ritonavir|ritonavir|mesh-list
56434503|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56434504|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56434505|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
56434513|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56434514|NCT00282594|Insulin|insulin|mesh-list
56434515|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56434516|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434517|NCT00242918|Docetaxel|docetaxel|mesh-list
56434519|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434520|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434521|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434522|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434523|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434524|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56434525|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434526|NCT00273312|Epothilone B|epothilone b|mesh-list
56434527|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434528|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434529|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434530|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434531|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434532|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
56434533|NCT00242996|Carmustine|carmustine|mesh-list
56434534|NCT00242996|Rituximab|rituximab|mesh-list
56434535|NCT00242996|Etoposide|etoposide|mesh-list
56434536|NCT00242996|Sargramostim|sargramostim|mesh-list
56434537|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56434538|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
56434539|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434540|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56434541|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56434542|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
56434543|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434544|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434545|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56434546|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56434547|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434548|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56434549|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56434550|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434551|NCT00273390|Infliximab|infliximab|mesh-list
56182365|NCT01417897|Insulin|insulin|mesh-list
56434552|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
56434553|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56434554|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56434555|NCT00243035|Bortezomib|bortezomib|mesh-list
56434556|NCT00243035|Tipifarnib|tipifarnib|mesh-list
56434557|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434558|NCT00243113|Docetaxel|docetaxel|mesh-list
56434559|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434560|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434561|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434562|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434563|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434564|NCT00273429|Timolol|timolol|mesh-list
56434565|NCT00273429|Dorzolamide|dorzolamide|mesh-list
56434566|NCT00273429|Latanoprost|latanoprost|mesh-list
56434567|NCT00273429|Maleic acid|maleic acid|mesh-list
56434568|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434569|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913238|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434570|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56434571|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56434572|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
56434573|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434574|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434575|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56434578|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56434579|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56434581|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
56434582|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
56434583|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434584|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434585|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56434586|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56434587|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
56434588|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434589|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434590|NCT00243464|Betamethasone|betamethasone|mesh-list
56434591|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
56434592|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56434593|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
56434594|NCT00243464|Calcipotriene|calcipotriene|mesh-list
56434595|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56434596|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434597|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
56434598|NCT00243464|Hormones|hormones|mesh-ancestor
56434599|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434600|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434601|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56434602|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
56434603|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
56434604|NCT00273507|Paclitaxel|paclitaxel|mesh-list
56434605|NCT00273507|Carboplatin|carboplatin|mesh-list
56434606|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434607|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434608|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434609|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434610|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434611|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434612|NCT00282945|Metformin|metformin|mesh-list
56434613|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
56434614|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56434615|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434616|NCT00273546|Docetaxel|docetaxel|mesh-list
56434617|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434618|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434619|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434620|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434621|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434622|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
56434623|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56434624|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434625|NCT00243737|Artesunate|artesunate|mesh-list
56434626|NCT00243737|Mefloquine|mefloquine|mesh-list
56434627|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
56434628|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56434629|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56434630|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56434631|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434632|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
56434633|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
56434634|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56434635|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
56434636|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
56434637|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56434638|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
56434639|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56434640|NCT00273702|Expectorants|expectorants|mesh-ancestor
56434641|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
56434642|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56434643|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
56434644|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434645|NCT00273702|Protective Agents|protective agents|mesh-ancestor
56434646|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434647|NCT00273702|Antidotes|antidotes|mesh-ancestor
56913239|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913240|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
56148753|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
56434648|NCT00243815|Ibuprofen|ibuprofen|mesh-list
56434649|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56434650|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56434655|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434656|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56434657|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56434658|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434659|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434660|NCT00283179|Risperidone|risperidone|mesh-list
56434661|NCT00283179|Aripiprazole|aripiprazole|mesh-list
56434662|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56434663|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
56434664|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434665|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434666|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434667|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56434668|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56434669|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434670|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56434671|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56434672|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
56434673|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
56434674|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
56434675|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56434676|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56434677|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56434678|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56434679|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56434680|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434681|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56434682|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434683|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434684|NCT00273741|Methylphenidate|methylphenidate|mesh-list
56434685|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56434686|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434687|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56434688|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56434689|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56434690|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434691|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
56434692|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434693|NCT00243893|Doxycycline|doxycycline|mesh-list
56434694|NCT00243893|Minocycline|minocycline|mesh-list
56434695|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56434696|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56434697|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
56434698|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56182515|NCT01418599|Urological Agents|urological agents|mesh-ancestor
56434699|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56434700|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
56434701|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56434702|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56434703|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434704|NCT00244127|Prednisone|prednisone|mesh-list
56434705|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
56434706|NCT00244127|Rituximab|rituximab|mesh-list
56434707|NCT00244127|Vincristine|vincristine|mesh-list
56434708|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56434709|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
56434710|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434711|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56434712|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56434713|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
56434714|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434715|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434716|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56434717|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56434718|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56913241|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
56913242|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
56913243|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434721|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434722|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56434723|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434724|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434725|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434726|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434727|NCT00244166|Prednisolone|prednisolone|mesh-list
56434728|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434729|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
56434730|NCT00244166|Hormones|hormones|mesh-ancestor
56434731|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434732|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434733|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56434734|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434735|NCT00273975|Lamivudine|lamivudine|mesh-list
56434736|NCT00273975|Zidovudine|zidovudine|mesh-list
56434737|NCT00273975|Nevirapine|nevirapine|mesh-list
56434738|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56434739|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56434740|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434741|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434742|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
56434743|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56434744|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56434745|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56434746|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
56434747|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56434748|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56434749|NCT00244283|Sevoflurane|sevoflurane|mesh-list
56434750|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56434751|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56434752|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
56434753|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
56434754|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434755|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434756|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
56434757|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56434758|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
56434759|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434760|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56434761|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56434762|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56434763|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434764|NCT00244361|Rituximab|rituximab|mesh-list
56434765|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56434766|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434767|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
56434768|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434769|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56434770|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
56434771|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56434772|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
56434773|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434774|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434775|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56434776|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
56434777|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
56434778|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56434779|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
56434780|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434781|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434782|NCT00244439|Permethrin|permethrin|mesh-list
56434783|NCT00244439|Malathion|malathion|mesh-list
56434784|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434785|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434786|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56434787|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
56913244|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
56913245|NCT03963479|Pyridoxal|pyridoxal|mesh-list
56913246|NCT03963479|Pyridoxine|pyridoxine|mesh-list
56913247|NCT03963479|Vitamins|vitamins|mesh-ancestor
56434788|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434789|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434790|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56434791|NCT00417144|Ganirelix|ganirelix|mesh-list
56434794|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
56434795|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56434796|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434797|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56434798|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56434799|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434800|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
56434801|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434802|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
56434803|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56434804|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
56434805|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434806|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434807|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56434808|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
56434809|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
56434810|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56434811|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
56434812|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434813|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434814|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56434815|NCT00417183|Ganirelix|ganirelix|mesh-list
56434816|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
56434817|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56434818|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
56434819|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56434820|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434821|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56434822|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56434823|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434824|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
56434825|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434826|NCT00244517|Remifentanil|remifentanil|mesh-list
56434827|NCT00244517|Sevoflurane|sevoflurane|mesh-list
56434828|NCT00244517|Desflurane|desflurane|mesh-list
56434829|NCT00244517|Isoflurane|isoflurane|mesh-list
56434830|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
56434831|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434832|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434833|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56434834|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56434835|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
56434836|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56434837|NCT00244517|Narcotics|narcotics|mesh-ancestor
56434838|NCT00244517|Analgesics|analgesics|mesh-ancestor
56434839|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
56434840|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434841|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
56434842|NCT00274092|Ipratropium|ipratropium|mesh-list
56434843|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56434844|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
56434845|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434846|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434847|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56434848|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
56434849|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
56434850|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56434851|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
56182658|NCT01419548|Veliparib|veliparib|mesh-list
56434852|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434853|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434854|NCT00244556|Etanercept|etanercept|mesh-list
56434855|NCT00244556|Methotrexate|methotrexate|mesh-list
56434856|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56434857|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
56913248|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
56913249|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913250|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
56913251|NCT02228512|Prednisone|prednisone|mesh-list
56434858|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56434859|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434860|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56434861|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
56434862|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434864|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56434865|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434866|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56434867|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56434868|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
56434869|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56434870|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56434871|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56434872|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56434873|NCT00244556|Analgesics|analgesics|mesh-ancestor
56434874|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
56434875|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434876|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434877|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56434878|NCT00274131|Pramipexole|pramipexole|mesh-list
56434879|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
56434880|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434881|NCT00274131|Protective Agents|protective agents|mesh-ancestor
56434882|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434883|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56434884|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56434885|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
56434886|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
56434887|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434889|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56434890|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56434891|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434892|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
56434893|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434894|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56434895|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434896|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434897|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
56434899|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56434900|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56434901|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434902|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56434903|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434904|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56434905|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56434906|NCT00244907|Protective Agents|protective agents|mesh-ancestor
56434907|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434908|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56434909|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434910|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
56434911|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56434912|NCT00244907|Estrogens|estrogens|mesh-ancestor
56434913|NCT00244907|Hormones|hormones|mesh-ancestor
56434914|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56434915|NCT00244946|Cytarabine|cytarabine|mesh-list
56434916|NCT00244946|Etoposide|etoposide|mesh-list
56434917|NCT00244946|Melphalan|melphalan|mesh-list
56434918|NCT00244946|Carmustine|carmustine|mesh-list
56434919|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434920|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434921|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56434922|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56434923|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434924|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434925|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56434926|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
56434927|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
56434928|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56434929|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56434930|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
56434931|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434932|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56434933|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
56434934|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56434936|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56434937|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56434940|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434941|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434942|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56434943|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56434944|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434945|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56434946|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434947|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434949|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56434950|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434951|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
56434952|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434953|NCT00245141|Dactinomycin|dactinomycin|mesh-list
56434954|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
56434955|NCT00245141|Vincristine|vincristine|mesh-list
56434956|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56434957|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
56434958|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434959|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56434960|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56434961|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
56434962|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434963|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434964|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56434965|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56434966|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
56434967|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
56434968|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
56434969|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56434970|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56434971|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56434972|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56434973|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434974|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56434975|NCT00416637|Bevacizumab|bevacizumab|mesh-list
56434976|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56434977|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434978|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56434979|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56434980|NCT00416637|Growth Substances|growth substances|mesh-ancestor
56434981|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434982|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
56434983|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
56434984|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434985|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
56434986|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56434987|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56434988|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434989|NCT00245258|Urological Agents|urological agents|mesh-ancestor
56434990|NCT02961803|Biotin|biotin|mesh-list
56434991|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
56434992|NCT02961803|Vitamins|vitamins|mesh-ancestor
56434993|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
56434994|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434995|NCT00245297|Factor VIII|factor viii|mesh-list
56434996|NCT00245297|Coagulants|coagulants|mesh-ancestor
56434997|NCT00274404|Valacyclovir|valacyclovir|mesh-list
56434998|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
56434999|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435000|NCT00283764|Latanoprost|latanoprost|mesh-list
56435001|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56435002|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56435004|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
56435005|NCT00245336|Coagulants|coagulants|mesh-ancestor
56435006|NCT00274443|Carboplatin|carboplatin|mesh-list
56435007|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56913252|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
56913253|NCT02228512|Rituximab|rituximab|mesh-list
56913254|NCT02228512|Doxorubicin|doxorubicin|mesh-list
56913255|NCT02228512|Etoposide|etoposide|mesh-list
56913256|NCT02228512|Vincristine|vincristine|mesh-list
56913257|NCT02228512|Pomalidomide|pomalidomide|mesh-list
56913258|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913259|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
56435008|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435009|NCT00245375|Acetaminophen|acetaminophen|mesh-list
56435010|NCT00245375|Ibuprofen|ibuprofen|mesh-list
56435011|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55783962|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
56435016|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435017|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56435018|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56435019|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56435020|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435021|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435022|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
56435023|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56435024|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
56435025|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
56435026|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435027|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
56435028|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435029|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
56435030|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56435031|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
56435032|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435033|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435034|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56435035|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
56435037|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56435038|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
56435039|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435040|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435041|NCT00245453|Azithromycin|azithromycin|mesh-list
56435042|NCT00245453|Clarithromycin|clarithromycin|mesh-list
56435043|NCT00245453|Telithromycin|telithromycin|mesh-list
56435044|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56435045|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435046|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56435047|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435048|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435049|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56435050|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56435051|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
56435052|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56435053|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56435054|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
56435055|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435056|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435057|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56435058|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
56435059|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
56435060|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56435061|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
56435062|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435063|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435064|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56435065|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56435066|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56435067|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
56435068|NCT00245609|Pregabalin|pregabalin|mesh-list
56435069|NCT00245609|Alprazolam|alprazolam|mesh-list
56435070|NCT00245609|Analgesics|analgesics|mesh-ancestor
56435071|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
56435072|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182886|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
56913260|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913261|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56913262|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56913263|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
56913264|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913265|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913266|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56913267|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56435073|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435074|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
56435075|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56435076|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435077|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435078|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56435079|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56435080|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435081|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435083|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56435084|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
56435085|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
56435086|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435087|NCT00274599|Telmisartan|telmisartan|mesh-list
56435088|NCT00274599|Ramipril|ramipril|mesh-list
56435089|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56435090|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56435091|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56435092|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435093|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56435094|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
56435095|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435096|NCT00274638|Losartan|losartan|mesh-list
56435097|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56435098|NCT00274638|Telmisartan|telmisartan|mesh-list
56435099|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56435100|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56435101|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56435102|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56435103|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435104|NCT00274638|Diuretics|diuretics|mesh-ancestor
56435105|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
56435106|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435107|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56435108|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435109|NCT00274677|Lamotrigine|lamotrigine|mesh-list
56435110|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
56435111|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56435112|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435113|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435114|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56435115|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435116|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56435117|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435118|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435119|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435120|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56435121|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
56435122|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56435123|NCT00245921|Estradiol|estradiol|mesh-list
56435124|NCT00245921|Estrogens|estrogens|mesh-ancestor
56435125|NCT00245921|Hormones|hormones|mesh-ancestor
56435126|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56435127|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435128|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56913268|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56913269|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56149247|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
56435129|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
56435130|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56435131|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56435132|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56435133|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56435134|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56435135|NCT00274794|Rituximab|rituximab|mesh-list
56435136|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56435137|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435138|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
56435139|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435140|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56435141|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
56435142|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56435143|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56435144|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56435145|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435146|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435147|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
56435148|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435149|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435150|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56435151|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435152|NCT00284193|Thrombin|thrombin|mesh-list
56435153|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
56435154|NCT00284193|Factor VIII|factor viii|mesh-list
56435160|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435161|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435162|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435163|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56435164|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435165|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435166|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435167|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56435168|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
56435169|NCT00284232|Insulin|insulin|mesh-list
56435170|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56435171|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435172|NCT00246233|Methylphenidate|methylphenidate|mesh-list
56435173|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56435174|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435175|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56435176|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56435177|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435178|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435179|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
56435180|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435181|NCT00274833|Temozolomide|temozolomide|mesh-list
56435182|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56435183|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56435184|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
56435185|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435186|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435187|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56435188|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435189|NCT00274872|Leucovorin|leucovorin|mesh-list
56435190|NCT00274872|Fluorouracil|fluorouracil|mesh-list
56435191|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
56435192|NCT00274872|Calcium|calcium|mesh-list
56435193|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
56435194|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56435195|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435196|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
56435197|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435198|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56435199|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435200|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435201|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
56913270|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56913271|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913272|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56435202|NCT00274872|Antidotes|antidotes|mesh-ancestor
56435203|NCT00274872|Protective Agents|protective agents|mesh-ancestor
56435204|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
56435205|NCT00274872|Vitamins|vitamins|mesh-ancestor
56435206|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
56435207|NCT00246272|Risperidone|risperidone|mesh-list
56435208|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56435209|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
56435210|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435211|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435212|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435213|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56435214|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435215|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435216|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435217|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56435218|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
56435219|NCT00284271|Prednisone|prednisone|mesh-list
56435220|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
56435221|NCT00284271|Vincristine|vincristine|mesh-list
56435222|NCT00284271|Bleomycin|bleomycin|mesh-list
56435223|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
56435224|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435225|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
56435226|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435227|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56435234|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
56435236|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56435237|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56435238|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56435239|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435240|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435241|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435242|NCT00284271|Hematinics|hematinics|mesh-ancestor
56435243|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56435244|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
56435245|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56435246|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
56435247|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435248|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56435249|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435250|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56435251|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435252|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435253|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435254|NCT00274911|Vincristine|vincristine|mesh-list
56435255|NCT00274911|Lomustine|lomustine|mesh-list
56435256|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435257|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56435258|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435259|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435260|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435261|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435262|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56435263|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
56435264|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56435265|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56435266|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
56435267|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435268|NCT00246467|Antacids|antacids|mesh-ancestor
56435269|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435270|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56435271|NCT00277251|Alendronate|alendronate|mesh-list
56435272|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56435273|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435274|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
56435275|NCT00416676|Carboplatin|carboplatin|mesh-list
56435276|NCT00416676|Etoposide|etoposide|mesh-list
56435277|NCT00416676|Vincristine|vincristine|mesh-list
56435278|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435279|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
56913273|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
56913274|NCT02228512|Hormones|hormones|mesh-ancestor
56435280|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435281|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56435282|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56435283|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
56435284|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435285|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435286|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56435287|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56435288|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56435289|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56435290|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435291|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435292|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435293|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435294|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56435301|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435304|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56435305|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56435306|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
56435307|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435308|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56435309|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56435310|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435311|NCT00284505|Thalidomide|thalidomide|mesh-list
56435312|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435313|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
56435314|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435315|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
56435316|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56435317|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435318|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56435319|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56435320|NCT00284505|Growth Substances|growth substances|mesh-ancestor
56435321|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
56435322|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435323|NCT00246974|Gemcitabine|gemcitabine|mesh-list
56435324|NCT00246974|Gefitinib|gefitinib|mesh-list
56435325|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435326|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56435327|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
56435328|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435329|NCT00246974|Antiviral Agents|antiviral agents|mesh-ancestor
56435330|NCT00246974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435331|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435332|NCT00246974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435333|NCT00246974|Immunologic Factors|immunologic factors|mesh-ancestor
56435334|NCT00246974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435335|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56435337|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
56435338|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
56435339|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435340|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435341|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
56435342|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435343|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56435344|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56435345|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56435346|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435347|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435348|NCT00247052|Diclofenac|diclofenac|mesh-list
56435349|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56435350|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56435351|NCT00247052|Analgesics|analgesics|mesh-ancestor
56435352|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
56435353|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435354|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435355|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56435356|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56435357|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56435358|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913275|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56913276|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56149463|NCT01577706|Alprazolam|alprazolam|mesh-list
56435359|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435360|NCT00277602|Riluzole|riluzole|mesh-list
56435361|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
56435362|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56435363|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56435364|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435370|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
56435371|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56435372|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56183195|NCT01423019|Synephrine|synephrine|mesh-list
56435373|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435374|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56435375|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435376|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56435377|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435378|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435379|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435380|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56435381|NCT00247130|Omeprazole|omeprazole|mesh-list
56435382|NCT00247130|Ranitidine|ranitidine|mesh-list
56435383|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56435384|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56435385|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56435386|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56435387|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435388|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435389|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56435390|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
56435391|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
56435392|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435393|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435394|NCT00247169|Progesterone|progesterone|mesh-list
56435395|NCT00247169|Progestins|progestins|mesh-ancestor
56435396|NCT00247169|Hormones|hormones|mesh-ancestor
56435397|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56435398|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435399|NCT00247208|Paclitaxel|paclitaxel|mesh-list
56435400|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56435401|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435402|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435403|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435404|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435405|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435406|NCT00284778|Docetaxel|docetaxel|mesh-list
56435407|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435408|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435409|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435410|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435411|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435412|NCT00247247|Entacapone|entacapone|mesh-list
56435413|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56435414|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56435415|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56435416|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435417|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435418|NCT00277758|Interferons|interferons|mesh-list
56435419|NCT00277758|Ribavirin|ribavirin|mesh-list
56435420|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
56435421|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56435422|NCT00277758|Interleukin-2|interleukin-2|mesh-list
56435423|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435424|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
56435425|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435426|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
56435427|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435428|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
56435429|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435430|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56913277|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56913278|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435431|NCT00277758|Analgesics|analgesics|mesh-ancestor
56435432|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
56435433|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435441|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435442|NCT00424814|Ritonavir|ritonavir|mesh-list
56435443|NCT00424814|Lopinavir|lopinavir|mesh-list
56435444|NCT00424814|Lamivudine|lamivudine|mesh-list
56435445|NCT00424814|Zidovudine|zidovudine|mesh-list
56435446|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56435447|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56435448|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56183263|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
56435449|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
56435450|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435451|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435452|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56435453|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56435454|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
56435455|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435456|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56435457|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56435458|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56435459|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56435460|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
56435461|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56435462|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56435463|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
56435464|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435465|NCT00247481|Docetaxel|docetaxel|mesh-list
56435466|NCT00247481|Gefitinib|gefitinib|mesh-list
56435467|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435468|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435469|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435470|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435471|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435472|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56435473|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435474|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
56435475|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56435476|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56435477|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56435478|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435479|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435480|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
56435481|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435482|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435483|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56435484|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435485|NCT00285051|Ondansetron|ondansetron|mesh-list
56435486|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
56435487|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
56435488|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435489|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435490|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56435491|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
56435492|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
56435493|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56435494|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
56435495|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435496|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435497|NCT00285051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56435498|NCT00285051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435499|NCT00285051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435500|NCT00285051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435501|NCT00285051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56435502|NCT00247715|Pantoprazole|pantoprazole|mesh-list
56435508|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56435509|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56435510|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435511|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435512|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56913279|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
56913280|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435513|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
56435514|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
56435515|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435516|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435517|NCT00247715|Antacids|antacids|mesh-ancestor
56435518|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56435519|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
56435520|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
56435521|NCT00285090|Vitamin D|vitamin d|mesh-list
56435522|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
56435523|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
56435524|NCT00285090|Vitamins|vitamins|mesh-list
56435525|NCT00285090|Calcium|calcium|mesh-list
56435526|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
56435527|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435528|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56435529|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56435530|NCT00417222|Olmesartan|olmesartan|mesh-list
56435531|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56435532|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56435533|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56435534|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56435535|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435536|NCT00278070|Vinorelbine|vinorelbine|mesh-list
56435537|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56435538|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435539|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435540|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435541|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435542|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435543|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
56435544|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56435545|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435546|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56435547|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56435548|NCT00247910|Diuretics|diuretics|mesh-ancestor
56435549|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
56435550|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435551|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56435552|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435553|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435554|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56435555|NCT00278187|Volociximab|volociximab|mesh-list
56435556|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435557|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56435558|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435559|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435560|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56435561|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56435562|NCT00278187|Growth Substances|growth substances|mesh-ancestor
56435563|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435564|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
56435565|NCT00247988|Carboplatin|carboplatin|mesh-list
56435566|NCT00247988|Docetaxel|docetaxel|mesh-list
56435567|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435568|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435569|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435570|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435571|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435572|NCT00248144|Famciclovir|famciclovir|mesh-list
56435573|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
56435577|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435578|NCT00278265|Methotrexate|methotrexate|mesh-list
56435579|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
56435580|NCT00278265|Fludarabine|fludarabine|mesh-list
56435581|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56435582|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
56435583|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56435584|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435585|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56435586|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
56913281|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56435587|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435588|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435589|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
56435590|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435591|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56435592|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435593|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
56435594|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56435595|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56435596|NCT00248183|Naluzotan|naluzotan|mesh-list
56435597|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56435598|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56435599|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
56435600|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435601|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435602|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435603|NCT00278343|Cediranib|cediranib|mesh-list
56435604|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435605|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435606|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435607|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56435608|NCT00248261|Ziprasidone|ziprasidone|mesh-list
56435609|NCT00248261|Sertraline|sertraline|mesh-list
56435610|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
56435611|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435612|NCT00248261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56435613|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56435614|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435615|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435616|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435617|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
56435618|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435619|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56435620|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56435621|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435622|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435623|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56435624|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
56435625|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
56435626|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56435627|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435628|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
56435629|NCT00278382|Sorafenib|sorafenib|mesh-list
56435630|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435631|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56435632|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435633|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435634|NCT00248339|Ribavirin|ribavirin|mesh-list
56435635|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56435636|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
56435637|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
56435638|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435639|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
56435640|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435641|NCT00248339|Hematinics|hematinics|mesh-ancestor
56435642|NCT00278421|Prednisone|prednisone|mesh-list
56435643|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
56435644|NCT00278421|Rituximab|rituximab|mesh-list
56435645|NCT00278421|Doxorubicin|doxorubicin|mesh-list
56435647|NCT00278421|Vincristine|vincristine|mesh-list
56435648|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435649|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
56435650|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435651|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56435652|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56435653|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
56435654|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435655|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435656|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56435657|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56435658|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56435659|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56435660|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56913282|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56913283|NCT02228512|Growth Substances|growth substances|mesh-ancestor
56913284|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
56913285|NCT01082627|Somatostatin|somatostatin|mesh-list
56435661|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435662|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56435663|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
56435664|NCT00278421|Hormones|hormones|mesh-ancestor
56435665|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56435666|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56435667|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56435668|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435669|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435670|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435671|NCT00248456|Betamethasone|betamethasone|mesh-list
56435672|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
56435673|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56435674|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
56435676|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56435677|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56435678|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
56435679|NCT00248456|Hormones|hormones|mesh-ancestor
56435680|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56435681|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435682|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56435683|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
56435684|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
56435685|NCT00278460|Gemcitabine|gemcitabine|mesh-list
56435686|NCT00278460|Docetaxel|docetaxel|mesh-list
56435687|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56435688|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
56435689|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435690|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435691|NCT00278460|Antiviral Agents|antiviral agents|mesh-ancestor
56435692|NCT00278460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435693|NCT00278460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435694|NCT00278460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435695|NCT00278460|Immunologic Factors|immunologic factors|mesh-ancestor
56435696|NCT00278460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435697|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
56435698|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
56435699|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
56435700|NCT00248729|Midazolam|midazolam|mesh-list
56435701|NCT00248729|Etomidate|etomidate|mesh-list
56435702|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56435703|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56435704|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435705|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435706|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56435707|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435708|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435709|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56435710|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
56435711|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
56435712|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
56435713|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
56435714|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435715|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435716|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
56435717|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435718|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
56435719|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56435720|NCT00248963|Estradiol|estradiol|mesh-list
56435721|NCT00248963|Estrogens|estrogens|mesh-ancestor
56435722|NCT00248963|Hormones|hormones|mesh-ancestor
56435723|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56435724|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435725|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56435726|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
56435727|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56435728|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56435729|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56435730|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56913286|NCT01082627|Hormones|hormones|mesh-ancestor
56913287|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56913288|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435731|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56435732|NCT00249041|Etanercept|etanercept|mesh-list
56435733|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56435734|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56435735|NCT00249041|Analgesics|analgesics|mesh-ancestor
56435736|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
56435737|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435738|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435739|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56435740|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56435741|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56435742|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435743|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
56435744|NCT00285519|Doxazosin|doxazosin|mesh-list
56435745|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56435746|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56435747|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56435748|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56435749|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
56435750|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435751|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435752|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435753|NCT00278772|Valproic Acid|valproic acid|mesh-list
56435754|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
56435755|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435756|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435757|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
56435758|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435759|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435760|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
56435761|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435762|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435763|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435764|NCT00249119|Risperidone|risperidone|mesh-list
56435765|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56435766|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
56435767|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435768|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435769|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435770|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56435772|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435773|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435774|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56435775|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
56435776|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56435777|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56435778|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56435779|NCT00249158|Risperidone|risperidone|mesh-list
56435780|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56435781|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
56435782|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435783|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435784|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435785|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56435786|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435787|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435788|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435789|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56435790|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
56435791|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56435792|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56435793|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56435794|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56435795|NCT00249197|Levofloxacin|levofloxacin|mesh-list
56435796|NCT00249197|Ofloxacin|ofloxacin|mesh-list
56435797|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56435800|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56435801|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56913289|NCT03515044|Rifaximin|rifaximin|mesh-list
56913290|NCT03515044|Lactulose|lactulose|mesh-list
56435802|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56435803|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435804|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435805|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435806|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56435807|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56435809|NCT00278967|Cathartics|cathartics|mesh-ancestor
56435810|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56435811|NCT00278967|Laxatives|laxatives|mesh-ancestor
56435812|NCT00249236|Risperidone|risperidone|mesh-list
56435813|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56435814|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
56435815|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435816|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435817|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435818|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56435819|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56435820|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435821|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435822|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56435823|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
56435824|NCT00285675|Calcitriol|calcitriol|mesh-list
56435825|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56435826|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435827|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56435828|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435829|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435830|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56435832|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
56435833|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56435834|NCT02215096|GSK2636771|gsk2636771|mesh-list
56435835|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435836|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56435837|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435838|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435839|NCT00279045|Metformin|metformin|mesh-list
56435840|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
56435841|NCT00279045|Glyburide|glyburide|mesh-list
56435842|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56435843|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435844|NCT00249353|Methylphenidate|methylphenidate|mesh-list
56435845|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56435846|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435847|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56435848|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56435849|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435850|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435851|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
56435852|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435854|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
56435855|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435856|NCT00249431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56435857|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56435858|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435859|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435860|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435861|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
56435862|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435863|NCT00249509|Bupropion|bupropion|mesh-list
56435864|NCT00249509|Nefazodone|nefazodone|mesh-list
56435865|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56435866|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
56435867|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435868|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56435869|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56435870|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56435873|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56435874|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435875|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56093795|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56913291|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56913292|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435876|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56435877|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435878|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56435879|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56435880|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56435881|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
56435882|NCT00279084|Chrysarobin|chrysarobin|mesh-list
56435883|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
56435884|NCT00279084|Hematinics|hematinics|mesh-ancestor
56435885|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56435886|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56435887|NCT00279084|Analgesics|analgesics|mesh-ancestor
56435888|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
56435889|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435890|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435891|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56435892|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56435893|NCT00249587|Methadone|methadone|mesh-list
56435894|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56435895|NCT00249587|Narcotics|narcotics|mesh-ancestor
56435896|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56435897|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435898|NCT00249587|Analgesics|analgesics|mesh-ancestor
56435899|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
56435900|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435901|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
56435902|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
56435903|NCT00279123|Pantoprazole|pantoprazole|mesh-list
56435904|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56435905|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56435906|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56435907|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435908|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435909|NCT00279162|Betamethasone|betamethasone|mesh-list
56435910|NCT00279162|Calcipotriene|calcipotriene|mesh-list
56435911|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56435912|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
56435913|NCT00279162|Hormones|hormones|mesh-ancestor
56435914|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56435915|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435916|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56435917|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
56435918|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
56435919|NCT00249704|Vitamin D|vitamin d|mesh-list
56435920|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
56435921|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
56435922|NCT00249704|Vitamins|vitamins|mesh-list
56435923|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
56435924|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435925|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56435926|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56435927|NCT00249782|Metronidazole|metronidazole|mesh-list
56435928|NCT00249782|Dapsone|dapsone|mesh-list
56435929|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435930|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56435931|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56435932|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56435933|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
56435934|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56435935|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435936|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435937|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
56435938|NCT00279240|Metformin|metformin|mesh-list
56435939|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56435940|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435941|NCT00249860|Interferons|interferons|mesh-list
56435942|NCT00249860|Ribavirin|ribavirin|mesh-list
56435943|NCT00249860|Interferon-beta|interferon-beta|mesh-list
56435944|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
56435945|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435946|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
56435947|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435948|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
56094055|NCT04327843|Haloperidol|haloperidol|mesh-list
56913293|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56913294|NCT01082705|Lumefantrine|lumefantrine|mesh-list
56913295|NCT01082705|Artemether|artemether|mesh-list
56913296|NCT01082705|Piperaquine|piperaquine|mesh-list
56913297|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56623951|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
56913298|NCT01082705|Artenimol|artenimol|mesh-list
56913299|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
56913300|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56913301|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56913302|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913303|NCT01582997|Dabrafenib|dabrafenib|mesh-list
56913304|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913305|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56913306|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913307|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913308|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
56913309|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913310|NCT01085981|Niacin|niacin|mesh-list
56913311|NCT01085981|Niacinamide|niacinamide|mesh-list
56913312|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
56913313|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56913314|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
56913315|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913316|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56913317|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
56913318|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
56435949|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435950|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
56435951|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435952|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56435953|NCT00249899|Atorvastatin|atorvastatin|mesh-list
56435954|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56435955|NCT00249899|Simvastatin|simvastatin|mesh-list
56435956|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56435957|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56435958|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56435959|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
56435960|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435961|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56435962|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435963|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56435964|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56435965|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56435966|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
56435967|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435968|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56435969|NCT00249977|Capecitabine|capecitabine|mesh-list
56435970|NCT00249977|Irinotecan|irinotecan|mesh-list
56435971|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435972|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56435973|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
56913319|NCT01085981|Vitamins|vitamins|mesh-ancestor
56150095|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
56435974|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435975|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56435976|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56435977|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435978|NCT00250094|Topotecan|topotecan|mesh-list
56435979|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56435980|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56435981|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435982|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435983|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435984|NCT00279435|Visilizumab|visilizumab|mesh-list
56435985|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
56435986|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164659|NCT05427162|Epoprostenol|epoprostenol|mesh-list
56435987|NCT00286026|Azithromycin|azithromycin|mesh-list
56435988|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56435989|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435990|NCT00250172|Rolipram|rolipram|mesh-list
56435991|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
56435992|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435993|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56435994|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56435995|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435996|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435997|NCT02961608|Tacrolimus|tacrolimus|mesh-list
56435998|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56435999|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
56436000|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436001|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56436002|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436003|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436004|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56436005|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436006|NCT00286143|Fentanyl|fentanyl|mesh-list
56436007|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56436008|NCT00286143|Narcotics|narcotics|mesh-ancestor
56436009|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56436010|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436011|NCT00286143|Analgesics|analgesics|mesh-ancestor
56436012|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
56436013|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436014|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56436015|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56436016|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
56436017|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
56436018|NCT00286260|Levetiracetam|levetiracetam|mesh-list
56436019|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
56436021|NCT00250367|Risperidone|risperidone|mesh-list
56436022|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56436023|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
56436024|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436025|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436026|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436027|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56436028|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56436029|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56436030|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56436031|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56436032|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
56436033|NCT00250562|Valsartan|valsartan|mesh-list
56436034|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56436035|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56436036|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56436037|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56436038|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436039|NCT00250562|Diuretics|diuretics|mesh-ancestor
56436040|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
56436041|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436042|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56436043|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56436044|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
56436045|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
56436046|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56150169|NCT01661088|Folfirinox|folfirinox|mesh-list
56436047|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
56436048|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56436049|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
56436050|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436051|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436052|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
56436053|NCT00279747|Naproxen|naproxen|mesh-list
56436054|NCT00279747|Meloxicam|meloxicam|mesh-list
56436055|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56436056|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56436057|NCT00279747|Analgesics|analgesics|mesh-ancestor
56436058|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
56436059|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436060|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436061|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56436062|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56436063|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
56436064|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56436065|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436066|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436067|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56436068|NCT00250640|Iloprost|iloprost|mesh-list
56436069|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56436070|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
56436071|NCT00250796|Interferons|interferons|mesh-list
56436072|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
56436073|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56436074|NCT00250796|Thalidomide|thalidomide|mesh-list
56436075|NCT00250796|Octreotide|octreotide|mesh-list
56436076|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436077|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
56436078|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436079|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436080|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
56436081|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436082|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
56436083|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56436084|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56436085|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56436086|NCT00250796|Growth Substances|growth substances|mesh-ancestor
56436087|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
56436088|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436089|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56436090|NCT00286416|Omalizumab|omalizumab|mesh-list
56436091|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56436092|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56436093|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
56436094|NCT00250874|Docetaxel|docetaxel|mesh-list
56436095|NCT00250874|Doxorubicin|doxorubicin|mesh-list
56436098|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436099|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
56436100|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
56436101|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
56436102|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436103|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56436104|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56436105|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56436106|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436107|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56436108|NCT00279825|Levodopa|levodopa|mesh-list
56436109|NCT00279825|Carbidopa|carbidopa|mesh-list
56436110|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56436111|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56436112|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56436113|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
56436114|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436115|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436116|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436117|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56436118|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436119|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56436120|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
56183933|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56183934|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
55888163|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913320|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
56913321|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913322|NCT03345082|Ranibizumab|ranibizumab|mesh-list
56913323|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56183935|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183936|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183937|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56183938|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56183939|NCT05113615|Bromides|bromides|mesh-list
56436121|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
56436122|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56436123|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56436124|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56436125|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436126|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436127|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55936888|NCT01822314|Paclitaxel|paclitaxel|mesh-list
56436128|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56436129|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436130|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
56436131|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436132|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56436133|NCT00250991|Eptifibatide|eptifibatide|mesh-list
56436134|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56436135|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56436136|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436137|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56436138|NCT00286611|Amifostine|amifostine|mesh-list
56436139|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56436140|NCT00286611|Protective Agents|protective agents|mesh-ancestor
56436141|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436142|NCT00416832|Prednisone|prednisone|mesh-list
56436143|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
56436144|NCT00416832|Dacarbazine|dacarbazine|mesh-list
56436145|NCT00416832|Doxorubicin|doxorubicin|mesh-list
56436146|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56436147|NCT00416832|Etoposide|etoposide|mesh-list
56436148|NCT00416832|Vincristine|vincristine|mesh-list
56436149|NCT00416832|Procarbazine|procarbazine|mesh-list
56436150|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436151|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
56436152|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436153|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56436154|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56436155|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
56436156|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436157|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436158|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56436159|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55814873|NCT02106975|Vitamins|vitamins|mesh-ancestor
56436160|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56436161|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56436162|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436163|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56436164|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
56436166|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56436167|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56436168|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56436169|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
56436170|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
56436171|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
56436172|NCT00251030|Nelfinavir|nelfinavir|mesh-list
56436173|NCT00251030|Omeprazole|omeprazole|mesh-list
56436174|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56436175|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436176|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56436177|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436178|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436179|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56436180|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56436181|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
56913324|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56913325|NCT03345082|Growth Substances|growth substances|mesh-ancestor
56913326|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436182|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56436183|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56436184|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
56436185|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436186|NCT00286689|Hormones|hormones|mesh-list
56436187|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56436188|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436189|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56436190|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436191|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436192|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436193|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56436194|NCT01640002|Bromides|bromides|mesh-list
56436195|NCT01640002|Propantheline|propantheline|mesh-list
56436196|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
56436197|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56436198|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436199|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56436200|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56436201|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
56164664|NCT05408910|Rifaximin|rifaximin|mesh-list
56436203|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436204|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436206|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
56436207|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56436208|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56436209|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56436210|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56436211|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436212|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
56436213|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436214|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436215|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56436216|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436217|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56436218|NCT01640275|Propofol|propofol|mesh-list
56436219|NCT01640275|Isoflurane|isoflurane|mesh-list
56436220|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56436221|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56436222|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436223|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56436224|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
56436225|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
56436226|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56436227|NCT04529356|Acetaminophen|acetaminophen|mesh-list
56436228|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56436229|NCT04529356|Analgesics|analgesics|mesh-ancestor
56436230|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
56436231|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436232|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436233|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
56436234|NCT01640665|Capecitabine|capecitabine|mesh-list
56436235|NCT01640665|Sorafenib|sorafenib|mesh-list
55814963|NCT05063201|Cariprazine|cariprazine|mesh-list
56436237|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
56436238|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436239|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436240|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56436241|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436243|NCT01640782|Docetaxel|docetaxel|mesh-list
56436244|NCT01640782|Fluorouracil|fluorouracil|mesh-list
56436245|NCT01640782|Irinotecan|irinotecan|mesh-list
56436246|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
56436247|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436248|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
56436249|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
56436250|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
56436251|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436252|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
56436253|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56913327|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
56913328|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913329|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
56913330|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
56913331|NCT02228902|Trace Elements|trace elements|mesh-ancestor
56913332|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
56913333|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913334|NCT02228902|Hematinics|hematinics|mesh-ancestor
56913335|NCT03288454|Apixaban|apixaban|mesh-list
56913336|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56436254|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436255|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
56436256|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436257|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56436258|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56436259|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436260|NCT01640782|Antidotes|antidotes|mesh-ancestor
56436261|NCT01640782|Protective Agents|protective agents|mesh-ancestor
56436262|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
56436263|NCT01640782|Vitamins|vitamins|mesh-ancestor
56436264|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
56436265|NCT00251186|Capecitabine|capecitabine|mesh-list
56436266|NCT00251186|Cetuximab|cetuximab|mesh-list
56436267|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56436268|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
56436269|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436270|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436271|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56436272|NCT01641250|Cytarabine|cytarabine|mesh-list
56436273|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56436274|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
56436275|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436276|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436277|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
56436278|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436279|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436280|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
56436281|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436282|NCT01641289|Acetaminophen|acetaminophen|mesh-list
56436283|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56436284|NCT01641289|Analgesics|analgesics|mesh-ancestor
56436285|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
56436286|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436287|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436288|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
56436289|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
56436290|NCT01641406|Bevacizumab|bevacizumab|mesh-list
56436292|NCT01641406|Capecitabine|capecitabine|mesh-list
56436293|NCT01641406|Trastuzumab|trastuzumab|mesh-list
56436294|NCT01641406|Epirubicin|epirubicin|mesh-list
56436295|NCT01641406|Vinorelbine|vinorelbine|mesh-list
56436296|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436297|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
56436298|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436299|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56436300|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56436301|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
56436302|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436303|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436304|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56436305|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56436306|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56436307|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56436308|NCT01641406|Growth Substances|growth substances|mesh-ancestor
56436309|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
56436310|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
56436311|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
56436312|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
56436316|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56913337|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
56913338|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56436317|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56436318|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436319|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56436320|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56436321|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
56436322|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56436323|NCT01641523|Protective Agents|protective agents|mesh-ancestor
56436324|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436325|NCT01641796|Paromomycin|paromomycin|mesh-list
56436326|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56436327|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436328|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56436329|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56436330|NCT04823845|Adapalene|adapalene|mesh-list
56436331|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56436332|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56436333|NCT04823845|Analgesics|analgesics|mesh-ancestor
56436334|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
56436335|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436336|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436337|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56436338|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56436339|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
56436340|NCT00280098|Docetaxel|docetaxel|mesh-list
56436341|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436342|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
56436343|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
56436344|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
56436345|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436346|NCT00251381|Cetuximab|cetuximab|mesh-list
56436347|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56436348|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436349|NCT01685827|Eflornithine|eflornithine|mesh-list
56436350|NCT01685827|Nifurtimox|nifurtimox|mesh-list
56436352|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56436353|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56436354|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56436355|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436356|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56436358|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436359|NCT05140096|Fluconazole|fluconazole|mesh-list
56436360|NCT05140096|Isavuconazole|isavuconazole|mesh-list
56436361|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
56436362|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
56436363|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436364|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56436365|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56436366|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436367|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436368|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56436369|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
56436370|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56436371|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436372|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56436373|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56436374|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436375|NCT00251459|Ranibizumab|ranibizumab|mesh-list
56436376|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56436377|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56436378|NCT00251459|Growth Substances|growth substances|mesh-ancestor
56436379|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436380|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
56436381|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436382|NCT04823065|Scopolamine|scopolamine|mesh-list
56436383|NCT04823065|Loperamide|loperamide|mesh-list
56436384|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
56436385|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56436386|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436389|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
56436390|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436391|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436392|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
56913339|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
56913340|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913341|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913342|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
56913343|NCT00090545|Sorafenib|sorafenib|mesh-list
56913344|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913345|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56913346|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913347|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913348|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
56913349|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56913350|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
56913351|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56913352|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56913353|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913354|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56150550|NCT03768570|Durvalumab|durvalumab|mesh-list
56436393|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56436394|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
56436395|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436396|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436397|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56436398|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
56436399|NCT00280176|Fluorouracil|fluorouracil|mesh-list
56436400|NCT00280176|Bortezomib|bortezomib|mesh-list
56436401|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
56436402|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436403|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56436404|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436405|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436406|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
56436407|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436408|NCT00280215|Losartan|losartan|mesh-list
56436409|NCT00280215|Lisinopril|lisinopril|mesh-list
56436410|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56436411|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56436412|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56436413|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56436414|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56436415|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56436416|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436417|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
56436418|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56436419|NCT00280215|Protective Agents|protective agents|mesh-ancestor
56436420|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436421|NCT04828135|Xenon|xenon|mesh-list
56436422|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56436423|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
56436424|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
56436425|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56436426|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436427|NCT00251498|Cetuximab|cetuximab|mesh-list
56436428|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56436429|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436431|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56436432|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
56436433|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436434|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913355|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913356|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56913357|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913358|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56150596|NCT00577278|Sirolimus|sirolimus|mesh-list
56436435|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56436436|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
56436437|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
56436438|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56436439|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56436440|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56436441|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56436442|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436443|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436444|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436445|NCT02276755|Vitamin D|vitamin d|mesh-list
56436446|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
56436447|NCT02276755|Vitamins|vitamins|mesh-ancestor
56436448|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
56436449|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436450|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56436451|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56436452|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
56436453|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56436454|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
56436455|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436456|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436457|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56436458|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
56436459|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56436460|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56436462|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436463|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436464|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436465|NCT04455139|Melphalan|melphalan|mesh-list
56436466|NCT04455139|Topotecan|topotecan|mesh-list
56436467|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56436468|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
56436469|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436470|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436471|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56436472|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436473|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
56436474|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436475|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56436476|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56436477|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436478|NCT00251654|Anesthetics|anesthetics|mesh-list
56436479|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56436480|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436481|NCT00286923|Topiramate|topiramate|mesh-list
56436482|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
56436483|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56436484|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436485|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
56436486|NCT00251732|Nortriptyline|nortriptyline|mesh-list
56436487|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
56436488|NCT00251732|Rabeprazole|rabeprazole|mesh-list
56436489|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56436490|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436491|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56436492|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436493|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436494|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56436495|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56436496|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56436497|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56436498|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436499|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913359|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56913360|NCT02229058|Paclitaxel|paclitaxel|mesh-list
56913361|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56913362|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164669|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56436500|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436501|NCT00286962|Insulin|insulin|mesh-list
56436502|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56436503|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56436504|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436505|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
56436506|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56436507|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436508|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
56436509|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56436510|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436511|NCT00251849|KRM 1648|krm 1648|mesh-list
56436512|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56436513|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
56436514|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56436515|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436516|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
56436517|NCT04822597|Lidocaine|lidocaine|mesh-list
56436518|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
56436519|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
56436520|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56436521|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436522|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
56436523|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436524|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56436525|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56436526|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56436527|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56436528|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436529|NCT00251888|Irinotecan|irinotecan|mesh-list
56436530|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436531|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56436532|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56436533|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436534|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436536|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56436537|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436538|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56436539|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436540|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436541|NCT00252044|Pergolide|pergolide|mesh-list
56436542|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
56436543|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
56436544|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436545|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436546|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436547|NCT01805284|Linezolid|linezolid|mesh-list
56436548|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56436549|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436550|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56436551|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436552|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436553|NCT00280605|Alfuzosin|alfuzosin|mesh-list
56436554|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56436555|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56164673|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
56436556|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56436558|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436559|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436560|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436561|NCT00280605|Urological Agents|urological agents|mesh-ancestor
56436562|NCT01134601|Capecitabine|capecitabine|mesh-list
56436563|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56436564|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
56436565|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913363|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913364|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
56913365|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
56913366|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
56913367|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150738|NCT04894188|Goserelin|goserelin|mesh-list
56436566|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436567|NCT00252122|Ketamine|ketamine|mesh-list
56436568|NCT00252122|Analgesics|analgesics|mesh-ancestor
56436569|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
56436570|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436571|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436572|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56436573|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56436574|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
56436575|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
56436576|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56436577|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56436578|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56436579|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436580|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436581|NCT00287157|Tizanidine|tizanidine|mesh-list
56436582|NCT00287157|Analgesics|analgesics|mesh-ancestor
56436583|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
56436584|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436585|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436586|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
56436587|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56436588|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56436589|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
56436590|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
56436591|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56436592|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56436593|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56436594|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436595|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436596|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436597|NCT00280644|Leflunomide|leflunomide|mesh-list
56436598|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436599|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436600|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436601|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
56436602|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436603|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56436604|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
56436605|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436608|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56436609|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56436610|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436611|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436612|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436613|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436614|NCT00252317|Captopril|captopril|mesh-list
56436615|NCT00252317|Trandolapril|trandolapril|mesh-list
56436616|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56436617|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
56436618|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436619|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436620|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56436621|NCT00252356|Amibegron|amibegron|mesh-list
56436622|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56436623|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56436624|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436625|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436626|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436627|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436628|NCT02753998|Paclitaxel|paclitaxel|mesh-list
55888164|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
56913368|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
56913369|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56913370|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56150806|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436629|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56436630|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436631|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
56436632|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
56436633|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
56436634|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436635|NCT02754154|Warfarin|warfarin|mesh-list
56436636|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
56436637|NCT02754154|Dabigatran|dabigatran|mesh-list
56436638|NCT02754154|Apixaban|apixaban|mesh-list
56436639|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
56436640|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56436641|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
56436642|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56436643|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
56436644|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436645|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333883|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56436646|NCT00252434|Methamphetamine|methamphetamine|mesh-list
56436647|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56436648|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436649|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
56436650|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
56436651|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436652|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
56436653|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436654|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436655|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436656|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56436657|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56436658|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56436659|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56436661|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
56436662|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56436663|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436664|NCT02757898|Biotin|biotin|mesh-list
56436665|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
56436666|NCT02757898|Vitamins|vitamins|mesh-ancestor
56436667|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
56436668|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436669|NCT00280878|Gemcitabine|gemcitabine|mesh-list
56436670|NCT00280878|Rituximab|rituximab|mesh-list
56436671|NCT00280878|Vinorelbine|vinorelbine|mesh-list
56436672|NCT00280878|Ifosfamide|ifosfamide|mesh-list
56436673|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56436674|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436675|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
56436676|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436677|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56436678|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56436679|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
56436681|NCT00280878|Antiviral Agents|antiviral agents|mesh-ancestor
56436682|NCT00280878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436683|NCT00280878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436684|NCT00280878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436685|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56436686|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
56436687|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
56436688|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
56436689|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56436690|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
56436691|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56436693|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56436694|NCT02758717|Antibodies|antibodies|mesh-list
56436695|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
56436696|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56436697|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
56436698|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
56436699|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913371|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913372|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
56913373|NCT02229292|Coagulants|coagulants|mesh-ancestor
56913374|NCT00070109|Trabectedin|trabectedin|mesh-list
56150880|NCT01740726|Fluoxetine|fluoxetine|mesh-list
56436700|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436701|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56436702|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436703|NCT00287313|Vitamin K|vitamin k|mesh-list
56436704|NCT00287313|Vitamins|vitamins|mesh-ancestor
56436705|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
56436706|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436707|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56436708|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56436709|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436710|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
56436711|NCT00287313|Coagulants|coagulants|mesh-ancestor
56436712|NCT01680250|Sirolimus|sirolimus|mesh-list
56436713|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56436714|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436715|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56436716|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436717|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
56436718|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436719|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
56436720|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436721|NCT00280956|Natalizumab|natalizumab|mesh-list
56436722|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
56436723|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436725|NCT02279875|Isoniazid|isoniazid|mesh-list
56436726|NCT02279875|Linezolid|linezolid|mesh-list
56436727|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
56436728|NCT02279875|Ethambutol|ethambutol|mesh-list
56436729|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56436730|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
56436731|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56436732|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436733|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
56436734|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56436735|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436736|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436737|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56436738|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56436739|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56436740|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56436741|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56436742|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56436743|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56436744|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56436745|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
56436746|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56436747|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56436748|NCT00280995|Mipomersen|mipomersen|mesh-list
56436749|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56436750|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56436751|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
56436752|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436753|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56436754|NCT05139667|Tacrolimus|tacrolimus|mesh-list
56436755|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436757|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436758|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56436759|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436760|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436761|NCT00287352|Amantadine|amantadine|mesh-list
56436762|NCT00287352|Olanzapine|olanzapine|mesh-list
56436763|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
56436764|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
56436765|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436766|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436767|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436768|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56913375|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56913376|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
56913377|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913378|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913379|NCT00069953|Paclitaxel|paclitaxel|mesh-list
56913380|NCT00069953|Fluorouracil|fluorouracil|mesh-list
56913381|NCT00069953|Lenograstim|lenograstim|mesh-list
56913382|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56913383|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150945|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
56436769|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56436770|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56436771|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56436772|NCT00287352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56436773|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56436774|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56436775|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436776|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436777|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
56436778|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56436779|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56436780|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
56436781|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436782|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
56436783|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56436784|NCT00287352|Analgesics|analgesics|mesh-ancestor
56436785|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
56436786|NCT04823962|Molgramostim|molgramostim|mesh-list
56436787|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436788|NCT00252668|Etanercept|etanercept|mesh-list
56436789|NCT00252668|Methotrexate|methotrexate|mesh-list
56436790|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56436791|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
56436792|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56436793|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436794|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56436795|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
56436796|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436797|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436798|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
56436799|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436800|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56436801|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436802|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
56436803|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56436804|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56436805|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56436806|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56436807|NCT00252668|Analgesics|analgesics|mesh-ancestor
56436808|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
56436809|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436810|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56436811|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436812|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
56436813|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
56436814|NCT02271997|Trace Elements|trace elements|mesh-ancestor
56436815|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
56436816|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436817|NCT02271997|Hematinics|hematinics|mesh-ancestor
56436818|NCT00287391|Rabeprazole|rabeprazole|mesh-list
56436819|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56436820|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436821|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56436822|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436823|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436824|NCT00252707|Docetaxel|docetaxel|mesh-list
56913384|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56436825|NCT00252707|Gefitinib|gefitinib|mesh-list
56436826|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436827|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
56436828|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
56436829|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
55817723|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
56436830|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436831|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56436833|NCT01680406|Chloroquine|chloroquine|mesh-list
56436834|NCT01680406|Lumefantrine|lumefantrine|mesh-list
56436835|NCT01680406|Artemether|artemether|mesh-list
56436836|NCT01680406|Primaquine|primaquine|mesh-list
56436837|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56436838|NCT01680406|Amebicides|amebicides|mesh-ancestor
56436839|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56436840|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56436841|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436842|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
56436843|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56436844|NCT00287430|Hormones|hormones|mesh-list
56436845|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56436846|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436847|NCT01680679|Vaccines|vaccines|mesh-list
56436848|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
56436849|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436850|NCT01680718|Vasopressins|vasopressins|mesh-list
56436851|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
56436852|NCT01680718|Oxytocin|oxytocin|mesh-list
56436853|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
56436854|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56436855|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436856|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
56436857|NCT01680718|Coagulants|coagulants|mesh-ancestor
56436858|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56436859|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56436860|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
56436861|NCT01680796|Dexamethasone|dexamethasone|mesh-list
56436862|NCT01680796|Bortezomib|bortezomib|mesh-list
56436863|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56436864|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
56436865|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
56436866|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436867|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436868|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56436869|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
56436870|NCT01680796|Hormones|hormones|mesh-ancestor
56436871|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56436872|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56436873|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436874|NCT00252785|Budesonide|budesonide|mesh-list
56436875|NCT00252785|Theophylline|theophylline|mesh-list
56436876|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
56436877|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56436878|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56436879|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
56436880|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436881|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436882|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56436883|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
56436884|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
56436885|NCT00252785|Hormones|hormones|mesh-ancestor
56436886|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56436887|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56436888|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56436889|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56436890|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436891|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436892|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436893|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56436894|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436895|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
56436896|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56436897|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56436898|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
56436899|NCT01680913|Anesthetics|anesthetics|mesh-list
56436900|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913385|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56913386|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56913387|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913388|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
56913389|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56913390|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913391|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
56436901|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436902|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
56436903|NCT01680952|Sirolimus|sirolimus|mesh-list
56436904|NCT01680952|Tacrolimus|tacrolimus|mesh-list
56436905|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436906|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
56436908|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56436909|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436910|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436911|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56436912|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436913|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56436914|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
56436915|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56436916|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436917|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
56436918|NCT00252824|Budesonide|budesonide|mesh-list
56436919|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
56436920|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56436921|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56436922|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
56436923|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436924|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436925|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56436926|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
56436927|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
56436928|NCT00252824|Hormones|hormones|mesh-ancestor
56436929|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56436930|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56436931|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56436932|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56436933|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436934|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436935|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436936|NCT00281190|Dimercaprol|dimercaprol|mesh-list
56436937|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
56436938|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
56436939|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436940|NCT00252863|Fluticasone|fluticasone|mesh-list
56436941|NCT00252863|Xhance|xhance|mesh-list
56436942|NCT00252863|Budesonide|budesonide|mesh-list
56436943|NCT00252863|Theophylline|theophylline|mesh-list
56436944|NCT00252863|Albuterol|albuterol|mesh-list
56436945|NCT00252863|Terbutaline|terbutaline|mesh-list
56436946|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
56436947|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56436948|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56436949|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56436950|NCT00252863|Montelukast|montelukast|mesh-list
56436951|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56436952|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56436953|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
56436954|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56436955|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436956|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56436957|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
56436958|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
56436959|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56436960|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
56436961|NCT00252863|Hormones|hormones|mesh-ancestor
56436962|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094056|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
56913392|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913393|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56913394|NCT03118570|Vitamin D|vitamin d|mesh-list
56436963|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56436964|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56436965|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56436966|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
56436967|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56436968|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436969|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
56436970|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56436971|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56436972|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
56436973|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56436974|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56436975|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56436976|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436977|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
56436978|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56436979|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56436980|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
56436982|NCT01681537|Cytarabine|cytarabine|mesh-list
56436983|NCT01681537|Etoposide|etoposide|mesh-list
56436984|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
56436985|NCT01681537|Lenalidomide|lenalidomide|mesh-list
56436986|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56436987|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56436988|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56436989|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56436990|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436991|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436992|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56436993|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
56436994|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
56436995|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56436996|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56436997|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
56436998|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436999|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56437000|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56437001|NCT01681537|Growth Substances|growth substances|mesh-ancestor
56437002|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
56437003|NCT01681537|Analgesics|analgesics|mesh-ancestor
56437004|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
56437005|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437006|NCT01681693|Metformin|metformin|mesh-list
56437007|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56437008|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437009|NCT01681966|Ropivacaine|ropivacaine|mesh-list
56437010|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56437011|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
56437012|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
56437013|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437014|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437015|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
56437016|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437017|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56437018|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437019|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437020|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437021|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437022|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437023|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56437024|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56437025|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
56437026|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437027|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437028|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56437029|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56437030|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
56437031|NCT02279914|Misoprostol|misoprostol|mesh-list
56437032|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56913395|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
56913396|NCT03118570|Calcium|calcium|mesh-list
56913397|NCT03118570|Vitamins|vitamins|mesh-ancestor
56913398|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
56913399|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437033|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
56437034|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56437035|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437036|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56437037|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56437038|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
56437039|NCT00281307|Tocopherols|tocopherols|mesh-list
56437040|NCT00281307|Vitamin E|vitamin e|mesh-list
56437041|NCT00281307|Tocotrienols|tocotrienols|mesh-list
56437042|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
56437043|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
56437044|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437045|NCT00281307|Protective Agents|protective agents|mesh-ancestor
56437046|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437047|NCT00281307|Vitamins|vitamins|mesh-ancestor
56437048|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
56437049|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56437050|NCT01682746|Trioxsalen|trioxsalen|mesh-list
56437051|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437052|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
56437053|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56437054|NCT00287664|Terlipressin|terlipressin|mesh-list
56437055|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55818847|NCT02435069|Protective Agents|protective agents|mesh-ancestor
56437058|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56437059|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
56437060|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
56437061|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56437062|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56437063|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437064|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56437065|NCT01683175|Cisplatin|cisplatin|mesh-list
56437066|NCT01683175|Vinorelbine|vinorelbine|mesh-list
56437067|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437068|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437069|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437070|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437071|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56437072|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
56437073|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
56437074|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
56437076|NCT01683253|Levodopa|levodopa|mesh-list
56437077|NCT01683253|Carbidopa|carbidopa|mesh-list
56437078|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
56437079|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56437080|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56437081|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
56437082|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437083|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437084|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437085|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56437086|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437087|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56437088|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
56437089|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
56437090|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437091|NCT01683253|Protective Agents|protective agents|mesh-ancestor
56437092|NCT01683292|Apomorphine|apomorphine|mesh-list
56437093|NCT01683292|Emetics|emetics|mesh-ancestor
56437094|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437095|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
56437096|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437097|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56437098|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
56437099|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
56437100|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437101|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437102|NCT00253058|Cetirizine|cetirizine|mesh-list
56437103|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56913400|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56437104|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56437105|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56437106|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
56437107|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
56437108|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437109|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437110|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437111|NCT01683682|Carboplatin|carboplatin|mesh-list
56437112|NCT01683682|Vinorelbine|vinorelbine|mesh-list
56437113|NCT01683682|Nintedanib|nintedanib|mesh-list
56437114|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437115|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56437116|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
56437117|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
56437118|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
56437119|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437120|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437121|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437122|NCT00287742|Risperidone|risperidone|mesh-list
56437123|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56437124|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
56437125|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437126|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437127|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437128|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437129|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437130|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437132|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56437133|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
56437135|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
56437136|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56437137|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
56437138|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
56437139|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
56437140|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437141|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437142|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
56437143|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56437144|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56437145|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437146|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
56437147|NCT01683955|Coagulants|coagulants|mesh-ancestor
56437148|NCT01684072|Vaccines|vaccines|mesh-list
56437149|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
56437150|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437151|NCT01684111|Vinorelbine|vinorelbine|mesh-list
56437152|NCT01684111|Nintedanib|nintedanib|mesh-list
56437153|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56437154|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437155|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
56437156|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
56437157|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
56437158|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437159|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437160|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437161|NCT00253136|Risperidone|risperidone|mesh-list
56437162|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56437163|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
56437164|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437165|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437166|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437167|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437168|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437169|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437170|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437171|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56437172|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
56437173|NCT01684306|Modafinil|modafinil|mesh-list
56437174|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56437175|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437176|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56437177|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56913401|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56913402|NCT02750800|Adalimumab|adalimumab|mesh-list
56437178|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56437179|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437180|NCT00287781|Lidocaine|lidocaine|mesh-list
56437181|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
56437182|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
56437183|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437184|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437185|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
56437186|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437187|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56437188|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56437189|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56437190|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56437191|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437192|NCT00416871|Interferons|interferons|mesh-list
56437193|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
56437194|NCT00416871|Aldesleukin|aldesleukin|mesh-list
56437195|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437196|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
56437197|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437198|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
56437199|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437200|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56437201|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56437202|NCT01684657|Asenapine|asenapine|mesh-list
56437203|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437204|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437205|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437208|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
56437209|NCT00416910|Fludarabine|fludarabine|mesh-list
56437210|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
56437211|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56437212|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
56437213|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437214|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56437215|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56437216|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
56437217|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437218|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437219|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56437220|NCT00416910|Analgesics|analgesics|mesh-ancestor
56437221|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
56437222|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437223|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56437224|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56437225|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437226|NCT01684774|Bupivacaine|bupivacaine|mesh-list
56437227|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
56437228|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
56437229|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437230|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437231|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
56437232|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437233|NCT02279992|Carboplatin|carboplatin|mesh-list
56437234|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56437235|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437236|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
56437237|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56437238|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56437239|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437240|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437241|NCT02279992|Urological Agents|urological agents|mesh-ancestor
56437242|NCT00253175|Topiramate|topiramate|mesh-list
56437243|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
56437244|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56437245|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437246|NCT00287820|Olanzapine|olanzapine|mesh-list
56437247|NCT00287820|Risperidone|risperidone|mesh-list
56437248|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56437249|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
56437250|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437251|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913403|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56913404|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56913405|NCT02229760|Ritonavir|ritonavir|mesh-list
56913406|NCT02229760|Tipranavir|tipranavir|mesh-list
56913407|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56437252|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164743|NCT05218668|Fasudil|fasudil|mesh-list
56437253|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437254|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437255|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437257|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56437258|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
56437259|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
56437260|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
56437261|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437262|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56437263|NCT00287820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56437264|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56437265|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56437266|NCT02272348|Insulin|insulin|mesh-list
56437267|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56437268|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437269|NCT00253214|Galantamine|galantamine|mesh-list
56437270|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56437271|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437272|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437273|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
56437274|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437275|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437276|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56437277|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
56437278|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437279|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
56437281|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56437282|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56437283|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437284|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437285|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437287|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
56437288|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
56437289|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
56437290|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437291|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437292|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56437293|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437294|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437295|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437296|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437297|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56437298|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
56437299|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437300|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437301|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56437302|NCT01685125|Prednisone|prednisone|mesh-list
56437303|NCT01685125|Dasatinib|dasatinib|mesh-list
56437304|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
56437305|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56437306|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
56437307|NCT01685125|Hormones|hormones|mesh-ancestor
56437308|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56437309|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437310|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56437311|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437312|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437313|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437314|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437315|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56437316|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
56437317|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56437318|NCT04527679|Lenvatinib|lenvatinib|mesh-list
56437319|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913408|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56913409|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
56151527|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
56437320|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437321|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437322|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437323|NCT01685281|Metadoxine|metadoxine|mesh-list
56437324|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56437325|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56437326|NCT00417066|Ganirelix|ganirelix|mesh-list
56437327|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
56437328|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56437329|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
56437330|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56437331|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437332|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56437333|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56437334|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437335|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
56437336|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56437337|NCT01685398|Timolol|timolol|mesh-list
56437338|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56437339|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56437340|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437341|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56437342|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56437343|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
56437344|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437345|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437346|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56437347|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56437348|NCT01685515|Decitabine|decitabine|mesh-list
56437349|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
56437350|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56437351|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
56437352|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437355|NCT00281502|Rifaximin|rifaximin|mesh-list
56437356|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56437357|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437358|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56437359|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
56437360|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
56437361|NCT00253487|Temozolomide|temozolomide|mesh-list
56437362|NCT00253487|Busulfan|busulfan|mesh-list
56437363|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56437364|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56437365|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
56437366|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437367|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437368|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56437369|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
56437370|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437371|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56437372|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437373|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
56437374|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56437375|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437376|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56437377|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
56437378|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56437379|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437380|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437381|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437382|NCT04527211|Ivermectin|ivermectin|mesh-list
56437383|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56437384|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437385|NCT00253526|Gemcitabine|gemcitabine|mesh-list
56437386|NCT00253526|Bevacizumab|bevacizumab|mesh-list
56437387|NCT00253526|Antibodies|antibodies|mesh-list
56437388|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
56437389|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56437390|NCT00253526|Mitogens|mitogens|mesh-list
56437391|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56913410|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913411|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913412|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56913413|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56913414|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
56913415|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913416|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56913417|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56913418|NCT03662542|Golimumab|golimumab|mesh-list
56913419|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56151592|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437392|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437393|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56437394|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56437395|NCT00253526|Growth Substances|growth substances|mesh-ancestor
56437396|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437397|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
56437398|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
56437399|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56437400|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
56437401|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437402|NCT00253526|Antiviral Agents|antiviral agents|mesh-ancestor
56437403|NCT00253526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437404|NCT00253526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437405|NCT00253526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56437406|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
56437408|NCT01686217|Peficitinib|peficitinib|mesh-list
56437409|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437410|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437411|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56437412|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
56437413|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437414|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
56437415|NCT01686217|Vitamins|vitamins|mesh-ancestor
56437416|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
56437417|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
56437418|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56437419|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437420|NCT00253565|Capecitabine|capecitabine|mesh-list
56437421|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
56437422|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56437423|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
56437424|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437425|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437426|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437427|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437428|NCT01686529|Bevacizumab|bevacizumab|mesh-list
56437430|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437431|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56437432|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56437433|NCT01686529|Growth Substances|growth substances|mesh-ancestor
56437434|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437435|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
56437437|NCT01686607|Fluconazole|fluconazole|mesh-list
56437438|NCT01686607|Voriconazole|voriconazole|mesh-list
56437439|NCT01686607|Amphotericin B|amphotericin b|mesh-list
56437440|NCT01686607|Caspofungin|caspofungin|mesh-list
56437441|NCT01686607|Micafungin|micafungin|mesh-list
56437442|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
56437443|NCT01686607|Clotrimazole|clotrimazole|mesh-list
56437444|NCT01686607|Miconazole|miconazole|mesh-list
56437445|NCT01686607|Anidulafungin|anidulafungin|mesh-list
56437446|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437447|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56437448|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56913420|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56437449|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437450|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437451|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56437452|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
56437453|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56437454|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437455|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56437456|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56437457|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56437458|NCT01686607|Amebicides|amebicides|mesh-ancestor
56437459|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56437460|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56437461|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56437462|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56437463|NCT01686802|Ibuprofen|ibuprofen|mesh-list
56437464|NCT01686802|Morphine|morphine|mesh-list
56437465|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56437466|NCT01686802|Narcotics|narcotics|mesh-ancestor
56437467|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437468|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437469|NCT01686802|Analgesics|analgesics|mesh-ancestor
56437470|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
56437471|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437472|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56437473|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56437474|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56437475|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56437476|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56437477|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437478|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437479|NCT00253721|Melphalan|melphalan|mesh-list
56437480|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56437481|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
56437482|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437483|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437484|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56437485|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56437486|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
56437487|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437488|NCT00281892|Vidarabine|vidarabine|mesh-list
56437489|NCT00281892|Fludarabine|fludarabine|mesh-list
56437490|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
56437491|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437492|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56437493|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
56437494|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437495|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56437496|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
56437497|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437498|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
56437499|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437500|NCT02274571|Estrogens|estrogens|mesh-list
56437501|NCT02274571|Hormones|hormones|mesh-ancestor
55819757|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
56437507|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437509|NCT00281931|Rituximab|rituximab|mesh-list
56437510|NCT00281931|Fludarabine|fludarabine|mesh-list
56437511|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
56437512|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56437513|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
56437514|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437515|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56437516|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56437517|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
56437518|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437519|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437520|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56437521|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56437522|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56437523|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
56437524|NCT01687348|Lidocaine|lidocaine|mesh-list
56437525|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
56913421|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56913422|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913423|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
56913424|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913425|NCT01329562|Naproxen|naproxen|mesh-list
56913426|NCT01329562|Sumatriptan|sumatriptan|mesh-list
56437526|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
56437527|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437528|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437529|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
56437530|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437531|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56437532|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56437533|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56437534|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56437535|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437536|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56437537|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56437538|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56437539|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56437540|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56437541|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
56437542|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437543|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437544|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437545|NCT01687582|Liraglutide|liraglutide|mesh-list
56437546|NCT01687582|Exenatide|exenatide|mesh-list
56437547|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56437548|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437549|NCT01687582|Incretins|incretins|mesh-ancestor
56437550|NCT01687582|Hormones|hormones|mesh-ancestor
56437551|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56437552|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56437553|NCT01687699|Spironolactone|spironolactone|mesh-list
56437554|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56437555|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
56437556|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56437557|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437558|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56437559|NCT01687699|Diuretics|diuretics|mesh-ancestor
56437560|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
56437561|NCT00287937|Paclitaxel|paclitaxel|mesh-list
56437562|NCT00287937|Carboplatin|carboplatin|mesh-list
56437563|NCT00287937|Vorinostat|vorinostat|mesh-list
56437564|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56437565|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437566|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
56437567|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
56437568|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
56437569|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437570|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56437573|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
56437574|NCT01687894|Propofol|propofol|mesh-list
56437575|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56437576|NCT01687894|Anesthetics|anesthetics|mesh-list
56437577|NCT01687894|Sevoflurane|sevoflurane|mesh-list
56437578|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
56437579|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56437580|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437581|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437582|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56437583|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56437584|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
56437585|NCT01687894|Coagulants|coagulants|mesh-ancestor
56437586|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56437587|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56437588|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
56437589|NCT00287976|Irinotecan|irinotecan|mesh-list
56437590|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56094057|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
56913427|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56913428|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56913429|NCT01329562|Analgesics|analgesics|mesh-ancestor
56913430|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
56913431|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913432|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437591|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56437592|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437593|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437594|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437595|NCT01688089|Levodopa|levodopa|mesh-list
56437596|NCT01688089|Carbidopa|carbidopa|mesh-list
56437597|NCT01688089|Entacapone|entacapone|mesh-list
56437598|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56437599|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56437600|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
56437601|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437602|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437603|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437604|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56437605|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437606|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56437607|NCT01688206|Atezolizumab|atezolizumab|mesh-list
56437608|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437609|NCT00288171|Allopurinol|allopurinol|mesh-list
56437610|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
56437611|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437612|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437613|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
56437614|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56437615|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56437616|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
56437617|NCT00288171|Protective Agents|protective agents|mesh-ancestor
56437618|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437619|NCT00253955|Levofloxacin|levofloxacin|mesh-list
56437620|NCT00253955|Ofloxacin|ofloxacin|mesh-list
56437621|NCT00253955|Tazobactam|tazobactam|mesh-list
56437622|NCT00253955|Piperacillin|piperacillin|mesh-list
56437623|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56437624|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56437626|NCT00253955|Renal Agents|renal agents|mesh-ancestor
56437627|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56437628|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56437629|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56437630|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437631|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437632|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437633|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56437634|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56437635|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56437637|NCT00288249|Epothilones|epothilones|mesh-list
56437638|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437639|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
56437640|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
56437641|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
56437642|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437643|NCT00254033|Methylphenidate|methylphenidate|mesh-list
56437644|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
56437645|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56437646|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437647|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56437648|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56437649|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56437650|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437652|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437653|NCT01600573|Topotecan|topotecan|mesh-list
56437654|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56094058|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
56913433|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56913434|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56913435|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
56913436|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56437655|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56437656|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437657|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437658|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437659|NCT01600612|Oxytocin|oxytocin|mesh-list
56437660|NCT01600612|Carbetocin|carbetocin|mesh-list
56437661|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
56437662|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56437663|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437664|NCT01600768|Lactams|lactams|mesh-list
56437665|NCT01600768|beta-Lactams|beta-lactams|mesh-list
56437666|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56437667|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437668|NCT00414947|Vildagliptin|vildagliptin|mesh-list
56437669|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56437670|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437671|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56437672|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
56437673|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437674|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437675|NCT00288444|Docetaxel|docetaxel|mesh-list
56437676|NCT00288444|Lonafarnib|lonafarnib|mesh-list
56437677|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437678|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
56437679|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
56437680|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
56437681|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437682|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437683|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56437684|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
56437685|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437686|NCT00415064|Dexamethasone|dexamethasone|mesh-list
56437687|NCT00415064|Lenalidomide|lenalidomide|mesh-list
56437688|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56437689|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
56437690|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
56437691|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437692|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437693|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56437694|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
56437695|NCT00415064|Hormones|hormones|mesh-ancestor
56437696|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56437697|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56437698|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437699|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
56437700|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56437701|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56437702|NCT00415064|Growth Substances|growth substances|mesh-ancestor
56437703|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
56437704|NCT00415103|Aprepitant|aprepitant|mesh-list
56437705|NCT00415103|Palonosetron|palonosetron|mesh-list
56437706|NCT00415103|Granisetron|granisetron|mesh-list
56437707|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
56437708|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
56437709|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437710|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437711|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56437712|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56437713|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437714|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437715|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56437716|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56437717|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
56437718|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56437719|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
56437720|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56437721|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437722|NCT00417729|Acarbose|acarbose|mesh-list
56437723|NCT00417729|Glyburide|glyburide|mesh-list
56913437|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913438|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913439|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56913440|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56437726|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437727|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56437728|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437729|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
56437730|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56437731|NCT00254189|Estradiol|estradiol|mesh-list
56437732|NCT00254189|Estrogens|estrogens|mesh-ancestor
56437733|NCT00254189|Hormones|hormones|mesh-ancestor
56437734|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56437735|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437736|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56437737|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
56437738|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56437739|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56437740|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56437741|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56437742|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56437743|NCT01600807|Gemcitabine|gemcitabine|mesh-list
56437744|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56437745|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56437746|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
56437747|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437748|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437749|NCT01600807|Antiviral Agents|antiviral agents|mesh-ancestor
56437750|NCT01600807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437751|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437752|NCT01600807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56437753|NCT01600807|Immunologic Factors|immunologic factors|mesh-ancestor
56437754|NCT01600807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437755|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437756|NCT00288483|Policosanol|policosanol|mesh-list
56437757|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56437758|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56437759|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
56437760|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437761|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56437762|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56437763|NCT01600963|Bedaquiline|bedaquiline|mesh-list
56437764|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
56437765|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
56437766|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56437767|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56437768|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56437769|NCT00288522|Lanreotide|lanreotide|mesh-list
56437770|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437771|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
56437772|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437773|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437774|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437775|NCT01601002|Mirtazapine|mirtazapine|mesh-list
56437776|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
56437777|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437778|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56437779|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
56437780|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
56437781|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437782|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437783|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437784|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56437785|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437786|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437787|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56437788|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56437789|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56437790|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
56913441|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56913442|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
56913443|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913444|NCT02230228|Vitamin A|vitamin a|mesh-list
55807034|NCT02301975|Xhance|xhance|mesh-list
56437791|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56437792|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56437794|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56437795|NCT00288561|Ranibizumab|ranibizumab|mesh-list
56437796|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56437802|NCT01607086|Lamotrigine|lamotrigine|mesh-list
56437803|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
56437804|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56437805|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56437806|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437807|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56437808|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437809|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437810|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437811|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437812|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437813|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56437814|NCT01607125|Vortioxetine|vortioxetine|mesh-list
56437815|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
56437816|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437817|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56437818|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437819|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437820|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437821|NCT01607125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56437822|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56437823|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56437824|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437825|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437826|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
56437827|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56437828|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56437829|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56437830|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56437831|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56437832|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
56437833|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56437834|NCT00254345|Protective Agents|protective agents|mesh-ancestor
56437835|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437836|NCT00254618|Mesalamine|mesalamine|mesh-list
56164755|NCT05162976|Nivolumab|nivolumab|mesh-list
56437837|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56437839|NCT00254618|Analgesics|analgesics|mesh-ancestor
56437840|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
56437841|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437842|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437843|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56437844|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56437845|NCT00288717|Telmisartan|telmisartan|mesh-list
56437846|NCT00288717|Candesartan|candesartan|mesh-list
56437847|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56437848|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56437849|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56437850|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437851|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
56437852|NCT01601314|Analgesics|analgesics|mesh-ancestor
56437853|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
56437854|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437855|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437856|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
56437857|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437858|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56437859|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
56437860|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56094204|NCT00376987|Protective Agents|protective agents|mesh-ancestor
56913445|NCT02230228|Retinol acetate|retinol acetate|mesh-list
56913446|NCT02230228|Vitamins|vitamins|mesh-ancestor
56913447|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
56913448|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913449|NCT02230228|Protective Agents|protective agents|mesh-ancestor
56913450|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56437861|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56437862|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437863|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56437866|NCT00254657|Levetiracetam|levetiracetam|mesh-list
56437867|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
56437868|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
56437869|NCT02482753|Exemestane|exemestane|mesh-list
56437870|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437871|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56437872|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56437873|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437874|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437875|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56437876|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
56437877|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56437878|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437879|NCT01607671|Timolol|timolol|mesh-list
56437880|NCT01607671|Maleic acid|maleic acid|mesh-list
56437881|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437882|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437883|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56437884|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56437885|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
56437886|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437887|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437888|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56437889|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56437890|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56437891|NCT00254735|Clomipramine|clomipramine|mesh-list
56437892|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
56437893|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437894|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437895|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437896|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437897|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437898|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56437899|NCT00254735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56437900|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56437901|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56437902|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437903|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437904|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
56437905|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
56437906|NCT00288873|Vitamin D|vitamin d|mesh-list
56437907|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
55938668|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
56437908|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56437909|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437910|NCT00288873|Vitamins|vitamins|mesh-ancestor
56437911|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
56437912|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56437913|NCT01608139|Curcumin|curcumin|mesh-list
56437914|NCT01608139|Sorafenib|sorafenib|mesh-list
56437915|NCT01608139|Vorinostat|vorinostat|mesh-list
56437916|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437917|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437918|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437919|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437920|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56437921|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56437922|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56437923|NCT01608139|Analgesics|analgesics|mesh-ancestor
56437924|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
56913451|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913452|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56913453|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
56437925|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437926|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437927|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56437928|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56437929|NCT00288951|Travoprost|travoprost|mesh-list
56437930|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56437931|NCT00254774|Valproic Acid|valproic acid|mesh-list
56437932|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56437933|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
56437934|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437935|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437936|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437939|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
56437940|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437941|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437942|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
56437943|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437944|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
56437945|NCT01608334|Fentanyl|fentanyl|mesh-list
56437946|NCT01608334|Sufentanil|sufentanil|mesh-list
56437947|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56437948|NCT01608334|Narcotics|narcotics|mesh-ancestor
56437949|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437950|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437951|NCT01608334|Analgesics|analgesics|mesh-ancestor
56437952|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
56437953|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437954|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56437955|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56437956|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
56437957|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
56437958|NCT01608373|Lidocaine|lidocaine|mesh-list
56437959|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
56437960|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
56437961|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437962|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437963|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
56437964|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437965|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56437966|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56437967|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56437968|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56437969|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437970|NCT01608412|Everolimus|everolimus|mesh-list
56437971|NCT01608412|Tacrolimus|tacrolimus|mesh-list
56437972|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56437973|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
56437974|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437975|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56437976|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437977|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437978|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164762|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
56437979|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56437980|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
56437981|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437982|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56437983|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56437984|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437985|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437986|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
56437987|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437988|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56437989|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437990|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56437991|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437992|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437993|NCT00254930|Risperidone|risperidone|mesh-list
56437994|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56437995|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
56094896|NCT00521924|Analgesics|analgesics|mesh-ancestor
56913454|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
56913456|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56437996|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56437997|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56437998|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437999|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56438000|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56438001|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438002|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438003|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56438004|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
56438005|NCT02273440|Theophylline|theophylline|mesh-list
56438006|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56438007|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
56438008|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438010|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56438011|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
56438012|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56438013|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438014|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438015|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
56438016|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56438017|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56438018|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
56438019|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438020|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
56438021|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56438022|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56438023|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56438024|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
56438025|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438026|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438027|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438028|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
56438029|NCT00270075|Hematinics|hematinics|mesh-ancestor
56438030|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
56438032|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
56438033|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438034|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56438035|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164764|NCT05161338|Estradiol|estradiol|mesh-list
56438037|NCT01588756|Growth Substances|growth substances|mesh-ancestor
56438038|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438039|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56438040|NCT01588756|Protective Agents|protective agents|mesh-ancestor
56438041|NCT04719104|Bilirubin|bilirubin|mesh-list
56438042|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
56438043|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438044|NCT04719104|Protective Agents|protective agents|mesh-ancestor
56438045|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438046|NCT01588795|Vitamin D|vitamin d|mesh-list
56438047|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
56438048|NCT01588795|Diuretics|diuretics|mesh-list
56438049|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56438050|NCT01588795|Vitamins|vitamins|mesh-ancestor
56438051|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
56438052|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438053|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56438054|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56438055|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
56438056|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438057|NCT00107614|Rituximab|rituximab|mesh-list
56438058|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56438059|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438060|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
56438061|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438062|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438063|NCT00255242|Simvastatin|simvastatin|mesh-list
56438064|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56438065|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56438066|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
56438067|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913457|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56913458|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438068|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56438069|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56438070|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438071|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
56438072|NCT00270114|Hematinics|hematinics|mesh-ancestor
56438073|NCT00107380|Prednisone|prednisone|mesh-list
56438074|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
56438075|NCT00107380|Rituximab|rituximab|mesh-list
56438076|NCT00107380|Doxorubicin|doxorubicin|mesh-list
56438077|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56438078|NCT00107380|Vincristine|vincristine|mesh-list
56438079|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
56438080|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438081|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
56438082|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438083|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438084|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56438086|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438088|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56438089|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56438090|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56438091|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56438092|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56438093|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438094|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438095|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
56438096|NCT00107380|Hormones|hormones|mesh-ancestor
56438097|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56438098|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56438099|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56438100|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56438101|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56438102|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56438103|NCT00270153|Enalapril|enalapril|mesh-list
56438104|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56438105|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
56438106|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438107|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438108|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56438109|NCT04050085|Nivolumab|nivolumab|mesh-list
56438110|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56438112|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56438113|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438114|NCT04054531|Paclitaxel|paclitaxel|mesh-list
56438115|NCT04054531|Carboplatin|carboplatin|mesh-list
56438116|NCT04054531|Pemetrexed|pemetrexed|mesh-list
56438117|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56438118|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438119|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
56438120|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
56438121|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
56438122|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438123|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438124|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56438125|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56438126|NCT00289263|Paclitaxel|paclitaxel|mesh-list
56438127|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56438128|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438129|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
56438130|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
56438131|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
56438132|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438133|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56438134|NCT00255437|Hematinics|hematinics|mesh-ancestor
56438135|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56438136|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56438137|NCT00255476|Gefitinib|gefitinib|mesh-list
56438138|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438139|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56438140|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438141|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913459|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56913460|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56152376|NCT01957410|Ketamine|ketamine|mesh-list
56438142|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
56438143|NCT00270270|Hematinics|hematinics|mesh-ancestor
56438144|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56438145|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56438146|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438147|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56438148|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
56438149|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438150|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56438151|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56438152|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438153|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438154|NCT00289419|Ketorolac|ketorolac|mesh-list
56438155|NCT00289419|Epinephrine|epinephrine|mesh-list
56438156|NCT00289419|Racepinephrine|racepinephrine|mesh-list
56438157|NCT00289419|Morphine|morphine|mesh-list
56438158|NCT00289419|Ropivacaine|ropivacaine|mesh-list
56438166|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438167|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
56438168|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
56438169|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56438170|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56438171|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438172|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438173|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56438174|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438175|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438176|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56438177|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56438178|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
56438179|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438180|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56438181|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56438182|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
56438183|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56438184|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
56438185|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
56438186|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
56438187|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56438188|NCT00255554|Citalopram|citalopram|mesh-list
56438189|NCT00255554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56438190|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56438191|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56438192|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438193|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438194|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
56438195|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438196|NCT00255554|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56438197|NCT00255554|Antidepressive Agents|antidepressive agents|mesh-ancestor
56438198|NCT00255554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438199|NCT00270348|Ciclesonide|ciclesonide|mesh-list
56438200|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
56438201|NCT00270348|Hormones|hormones|mesh-ancestor
56438202|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56438203|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438204|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56438205|NCT00255593|Rituximab|rituximab|mesh-list
56438206|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56438207|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438208|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
56438209|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438210|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438211|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56438212|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
56438213|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438214|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
56438215|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
56438216|NCT00255710|Fludarabine|fludarabine|mesh-list
56438217|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
56438218|NCT00255710|Tacrolimus|tacrolimus|mesh-list
56438219|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913461|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913462|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152444|NCT05738616|Lenvatinib|lenvatinib|mesh-list
56438220|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
56438221|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438222|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438223|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56438224|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
56438225|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784396|NCT03072173|Xylometazoline|xylometazoline|mesh-list
56438227|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56438228|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56438229|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
56438230|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56438231|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438232|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56438233|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56438234|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
56438235|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56438236|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438237|NCT00270426|Benazepril|benazepril|mesh-list
56438238|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56438239|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
56438240|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438241|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438242|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56438243|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
56438244|NCT00255749|Hematinics|hematinics|mesh-ancestor
56438245|NCT00255788|Everolimus|everolimus|mesh-list
56438246|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438247|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438248|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
56438249|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438250|NCT04482361|Antibodies|antibodies|mesh-list
56438251|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
56438252|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438253|NCT00270543|Leucovorin|leucovorin|mesh-list
56438254|NCT00270543|Fluorouracil|fluorouracil|mesh-list
56438256|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
56438257|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438258|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56438259|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438260|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438261|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
56438262|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438263|NCT00270543|Antidotes|antidotes|mesh-ancestor
56438264|NCT00270543|Protective Agents|protective agents|mesh-ancestor
56438265|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
56438266|NCT00270543|Vitamins|vitamins|mesh-ancestor
56438267|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
56438268|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
56438269|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
56438270|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
56438271|NCT02960919|Amoxicillin|amoxicillin|mesh-list
56438272|NCT02960919|Gentamicins|gentamicins|mesh-list
56438273|NCT02960919|Penicillins|penicillins|mesh-list
56438274|NCT02960919|Ampicillin|ampicillin|mesh-list
56438275|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56438276|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438277|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56438278|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438279|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438280|NCT00270582|Gemcitabine|gemcitabine|mesh-list
56438281|NCT00270582|Docetaxel|docetaxel|mesh-list
56438282|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438283|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56438284|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
56438285|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438286|NCT00270582|Antiviral Agents|antiviral agents|mesh-ancestor
56438287|NCT00270582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438288|NCT00270582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438289|NCT00270582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438290|NCT00270582|Immunologic Factors|immunologic factors|mesh-ancestor
56438291|NCT00270582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913463|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913464|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56913465|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
56152516|NCT05725200|Talazoparib|talazoparib|mesh-list
56438292|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56438293|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56438294|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56438295|NCT01600456|Sertraline|sertraline|mesh-list
56438296|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
56438297|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438298|NCT01600456|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56438299|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56438300|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56438301|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438302|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438304|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186120|NCT01435213|Ketamine|ketamine|mesh-list
56438305|NCT00289809|Ifosfamide|ifosfamide|mesh-list
56438306|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56438307|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
56438308|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438309|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438310|NCT00256100|PENTA|penta|mesh-list
56438311|NCT00256100|Fondaparinux|fondaparinux|mesh-list
56438312|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56438313|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
56438314|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56438315|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
56438316|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438317|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438318|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
56438319|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56438320|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56438321|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56438322|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56438323|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
56438324|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438325|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
56438326|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438327|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
56438328|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438329|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438330|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56438331|NCT01609387|Tocopherols|tocopherols|mesh-list
56438332|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
56438333|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438334|NCT01609387|Protective Agents|protective agents|mesh-ancestor
56438335|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438336|NCT01609387|Vitamins|vitamins|mesh-ancestor
56438337|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
56438338|NCT00256178|Simvastatin|simvastatin|mesh-list
56438339|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56438340|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56438341|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
56438342|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438343|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56438344|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56438345|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438346|NCT02488408|Cytarabine|cytarabine|mesh-list
56438347|NCT02488408|Decitabine|decitabine|mesh-list
56438348|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56438349|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
56438350|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438351|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438352|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
56438353|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438354|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438355|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
56438356|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438357|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438358|NCT00270777|Promethazine|promethazine|mesh-list
56438359|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
56913466|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56152587|NCT05650008|Anesthetics|anesthetics|mesh-list
56438360|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
56438361|NCT00270777|Epinephrine|epinephrine|mesh-list
56438362|NCT00270777|Racepinephrine|racepinephrine|mesh-list
56438363|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
56438364|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438365|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56438366|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56438367|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
56438368|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438369|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438370|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438371|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56438372|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56438373|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
56438374|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438375|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56438376|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
56438377|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
56438378|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
56438379|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56438380|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
56438381|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
56438382|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56186197|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
56438383|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
56438384|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
56438385|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56438386|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56438387|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56438388|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438389|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
56438390|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
56438391|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
56438392|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
56438393|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56438394|NCT00256256|Glucagon|glucagon|mesh-list
56438395|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56438396|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56438397|NCT00256256|Hormones|hormones|mesh-ancestor
56438398|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56438399|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438400|NCT00256256|Incretins|incretins|mesh-ancestor
56438401|NCT00256334|Resveratrol|resveratrol|mesh-list
56438402|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
56438403|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438404|NCT00256334|Protective Agents|protective agents|mesh-ancestor
56438405|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438406|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438407|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56438408|NCT01609855|Scopolamine|scopolamine|mesh-list
56438410|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56438411|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
56438412|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56438413|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
56438414|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
56438415|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438416|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438417|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56438418|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
56438419|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56438420|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
56438421|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438422|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438423|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56438424|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
56438425|NCT00270816|Interferons|interferons|mesh-list
56438426|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438427|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
56438428|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438429|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
56438430|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438431|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56438432|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
56438433|NCT01609816|Dasatinib|dasatinib|mesh-list
56913467|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438434|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438435|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56438436|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438437|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438438|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
56438439|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56438440|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438441|NCT00290082|Midazolam|midazolam|mesh-list
56438442|NCT00290082|Loxapine|loxapine|mesh-list
56438443|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56438444|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56438445|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438446|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438447|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56438448|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56438449|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438450|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56438451|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
56438452|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
56438453|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
56438454|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
56438455|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438456|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438457|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56438458|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56438459|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
56438460|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
56438461|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56438462|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438463|NCT02270437|Epinephrine|epinephrine|mesh-list
56438464|NCT02270437|Racepinephrine|racepinephrine|mesh-list
56438465|NCT02270437|Fentanyl|fentanyl|mesh-list
56164807|NCT04836780|Hormones|hormones|mesh-ancestor
56438467|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
56438468|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
56438469|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
56438470|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438471|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438472|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
56438473|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438474|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56438475|NCT02270437|Narcotics|narcotics|mesh-ancestor
56438476|NCT02270437|Analgesics|analgesics|mesh-ancestor
56438477|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56438478|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56438479|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
56438480|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56438481|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56438482|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
56438483|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438484|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438485|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56438486|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56438487|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
56438488|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56438489|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
56438490|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
56438491|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
56438492|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56438493|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
56438494|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
56438495|NCT02270749|Vitamins|vitamins|mesh-ancestor
56438496|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
56438497|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438498|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
56438499|NCT02270749|Hematinics|hematinics|mesh-ancestor
56438500|NCT02270788|Leucovorin|leucovorin|mesh-list
56438501|NCT02270788|Cytarabine|cytarabine|mesh-list
56438502|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
56438503|NCT02270788|Methotrexate|methotrexate|mesh-list
56438504|NCT02270788|Sorafenib|sorafenib|mesh-list
56438505|NCT02270788|Crenolanib|crenolanib|mesh-list
56438506|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56438507|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
56438508|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56438509|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438510|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56913468|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56913469|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56152735|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
56438511|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
56438512|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438513|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438514|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
56438515|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438516|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56438517|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438518|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
56438519|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438520|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56438521|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
56438522|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438523|NCT02270788|Antidotes|antidotes|mesh-ancestor
56438524|NCT02270788|Protective Agents|protective agents|mesh-ancestor
56438525|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
56438526|NCT02270788|Vitamins|vitamins|mesh-ancestor
56438527|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
56438528|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56438529|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438530|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
56438531|NCT02270827|Aminophylline|aminophylline|mesh-list
56438532|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438533|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56438534|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
56438535|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438536|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438537|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56438538|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
56438539|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56438540|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56438541|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438542|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438543|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56438545|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
56438546|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438547|NCT02270827|Protective Agents|protective agents|mesh-ancestor
56438548|NCT00290121|Olanzapine|olanzapine|mesh-list
56438549|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
56438550|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
56438551|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438552|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438553|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56438554|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56438555|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56438556|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438557|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438558|NCT00290121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56438559|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56438560|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56438561|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438562|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438563|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
56438564|NCT04709744|Vitamin D|vitamin d|mesh-list
56438565|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
56438566|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
56438567|NCT04709744|Vitamins|vitamins|mesh-list
56438568|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
56438569|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438570|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56438571|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56438572|NCT02271295|Enoxaparin|enoxaparin|mesh-list
56438573|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
56438574|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56438575|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56438576|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438577|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56438578|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56438579|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56438580|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913470|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56913471|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56438581|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438582|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438583|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438584|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
56438585|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438586|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56438587|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
56438588|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438589|NCT02271646|Bupivacaine|bupivacaine|mesh-list
56438590|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
56438591|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
56438592|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438593|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438594|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
56438595|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438596|NCT02271802|Butyric Acid|butyric acid|mesh-list
56438597|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
56438598|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
56438599|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438600|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438601|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438602|NCT02271958|Mifepristone|mifepristone|mesh-list
56438603|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56438604|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
56438605|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56438606|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438607|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56438609|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56438610|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
56438611|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56438612|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56333884|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438614|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56438615|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
56438616|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56438617|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56438618|NCT00257036|Levofloxacin|levofloxacin|mesh-list
56438619|NCT00257036|Ofloxacin|ofloxacin|mesh-list
56438620|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56438621|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438622|NCT00257036|Renal Agents|renal agents|mesh-ancestor
56438623|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56438624|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56438625|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56438626|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438627|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438628|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438629|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56438630|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56438631|NCT00257075|Risperidone|risperidone|mesh-list
56438632|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56438633|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
56438634|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438635|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438636|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438637|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56438638|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56438639|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438640|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438641|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56438642|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
56438643|NCT02272270|Minocycline|minocycline|mesh-list
56438644|NCT02272270|Temozolomide|temozolomide|mesh-list
56438645|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56438646|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
56438647|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438648|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438649|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56913472|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56913473|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
56438650|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438651|NCT02272387|Vitamin D|vitamin d|mesh-list
56438652|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
56438653|NCT02272387|Vitamins|vitamins|mesh-ancestor
56438654|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
56438655|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438656|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56438657|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56438658|NCT00257114|Bortezomib|bortezomib|mesh-list
56438659|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438660|NCT00271206|Progesterone|progesterone|mesh-list
56438661|NCT00271206|Progestins|progestins|mesh-ancestor
56438662|NCT00271206|Hormones|hormones|mesh-ancestor
56438663|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56438664|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438665|NCT02272582|Heparin|heparin|mesh-list
56438666|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
56438667|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56438668|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56438669|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438670|NCT02272660|Parecoxib|parecoxib|mesh-list
56438671|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56438672|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56438673|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438674|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438675|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56438676|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56438677|NCT02272660|Analgesics|analgesics|mesh-ancestor
56438678|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
56438679|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438680|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438683|NCT02272699|Paclitaxel|paclitaxel|mesh-list
56438684|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
56438685|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56438686|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186491|NCT01437696|Vitamin D|vitamin d|mesh-list
56438687|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
56438688|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
56438689|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
56438690|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438691|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56438692|NCT02272738|Gemcitabine|gemcitabine|mesh-list
56438693|NCT02272738|Paclitaxel|paclitaxel|mesh-list
56438694|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56438695|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56438696|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438697|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
56438698|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
56438699|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
56438700|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438701|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56438702|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
56438703|NCT02272738|Antiviral Agents|antiviral agents|mesh-ancestor
56438704|NCT02272738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438705|NCT02272738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438706|NCT02272738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438707|NCT02272738|Immunologic Factors|immunologic factors|mesh-ancestor
56438708|NCT02272738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438709|NCT00271245|Selenium|selenium|mesh-list
56438710|NCT00271245|Selenic Acid|selenic acid|mesh-list
56438711|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
56438712|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438713|NCT00271245|Protective Agents|protective agents|mesh-ancestor
56438714|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438715|NCT00271245|Trace Elements|trace elements|mesh-ancestor
56438716|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
56438717|NCT02272855|Ipilimumab|ipilimumab|mesh-list
56438718|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56438719|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438720|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56438721|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438722|NCT00257270|Gabapentin|gabapentin|mesh-list
56438723|NCT00257270|Analgesics|analgesics|mesh-ancestor
56913474|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56913475|NCT05563480|Gemcitabine|gemcitabine|mesh-list
56913476|NCT05563480|Cisplatin|cisplatin|mesh-list
56438724|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
56438725|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438726|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438727|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
56438728|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56438729|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56438730|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438731|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438732|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56438733|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56438734|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438735|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438736|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
56438737|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
56438738|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56438739|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438740|NCT00257348|Docetaxel|docetaxel|mesh-list
56438741|NCT00257348|Capecitabine|capecitabine|mesh-list
56438742|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438743|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
56438744|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
56438745|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
56438746|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438747|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56438748|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
56438749|NCT02273128|Calcitonin|calcitonin|mesh-list
56438750|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56438751|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438752|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56438753|NCT00257387|Cyclosporine|cyclosporine|mesh-list
56438756|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438757|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438758|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
56438759|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438760|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
56438761|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438762|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
56438763|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438764|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56438766|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56438767|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56438768|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438769|NCT01601509|Tramazoline|tramazoline|mesh-list
56438770|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
56438771|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
56438772|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438773|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438774|NCT00416325|Lycopene|lycopene|mesh-list
56438775|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438776|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
56438777|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438778|NCT00416325|Protective Agents|protective agents|mesh-ancestor
56438779|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438780|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56438781|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56438782|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438783|NCT00257465|Vaccines|vaccines|mesh-list
56438784|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
56438785|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438786|NCT01601899|Tenofovir|tenofovir|mesh-list
56438787|NCT01601899|Lamivudine|lamivudine|mesh-list
56438788|NCT01601899|Efavirenz|efavirenz|mesh-list
56438789|NCT01601899|Stavudine|stavudine|mesh-list
56438790|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
56438791|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438792|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56438793|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56438794|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438795|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438796|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56913477|NCT05563480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913478|NCT05563480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56913479|NCT05563480|Antimetabolites|antimetabolites|mesh-ancestor
56438797|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56438798|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56438799|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56438800|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56438801|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56438802|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56438803|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56438804|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
56438805|NCT01601938|Selenium|selenium|mesh-list
56438806|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
56438807|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438808|NCT01601938|Protective Agents|protective agents|mesh-ancestor
56438809|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438810|NCT01601938|Trace Elements|trace elements|mesh-ancestor
56438811|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
56438812|NCT01602055|Azithromycin|azithromycin|mesh-list
56438813|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56438814|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438815|NCT01602250|Ropivacaine|ropivacaine|mesh-list
56438816|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
56438817|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56438818|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
56438819|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
56438820|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438821|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438822|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
56438823|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438824|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56438825|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56438826|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56438827|NCT00257582|Cetirizine|cetirizine|mesh-list
56438829|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56438830|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56438831|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
56438833|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438834|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438835|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438836|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56438837|NCT01602289|Gefitinib|gefitinib|mesh-list
56438838|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438839|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56438840|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438841|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438842|NCT00257621|Ritonavir|ritonavir|mesh-list
56438843|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56438844|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56438845|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
56438846|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438847|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438848|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56438849|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56438850|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
56438851|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438852|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56438853|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56438854|NCT01602406|Trastuzumab|trastuzumab|mesh-list
56438855|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56438856|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438857|NCT00290628|Cyclosporine|cyclosporine|mesh-list
56438858|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
56438859|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
56438860|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
56438861|NCT00290628|Melphalan|melphalan|mesh-list
56438862|NCT00290628|Busulfan|busulfan|mesh-list
56438863|NCT00290628|Cyclosporins|cyclosporins|mesh-list
56438864|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56438865|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438866|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
56438867|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913480|NCT05563480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913481|NCT05563480|Antiviral Agents|antiviral agents|mesh-ancestor
56913482|NCT05563480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438868|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438869|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56438870|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
56438871|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438872|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438873|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56438874|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438875|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
56438876|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56438877|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
56438878|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56438879|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56438880|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56438881|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
56438882|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56438883|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438884|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
56438885|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
56438886|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438887|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56438888|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
56438889|NCT00290628|Hormones|hormones|mesh-ancestor
56438890|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56438891|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56438892|NCT00290628|Protective Agents|protective agents|mesh-ancestor
56438893|NCT01602523|Budesonide|budesonide|mesh-list
56438894|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
56438895|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438896|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56438897|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
56438898|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438899|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438900|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56438901|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
56438903|NCT01602523|Hormones|hormones|mesh-ancestor
56438904|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56438905|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56438906|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56438907|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56438908|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
56438909|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438910|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438911|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
56438912|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438913|NCT01602640|Fentanyl|fentanyl|mesh-list
56438914|NCT01602640|Midazolam|midazolam|mesh-list
56438915|NCT01602640|Morphine|morphine|mesh-list
56438916|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56438917|NCT01602640|Narcotics|narcotics|mesh-ancestor
56438918|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438919|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438920|NCT01602640|Analgesics|analgesics|mesh-ancestor
56438921|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
56438922|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438923|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56438924|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56438925|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
56438926|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
56438927|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56438928|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56438929|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56438930|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438931|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
56438932|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
56438933|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438934|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438935|NCT00290667|Prednisone|prednisone|mesh-list
56438936|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
56438937|NCT00290667|Rituximab|rituximab|mesh-list
56438938|NCT00290667|Doxorubicin|doxorubicin|mesh-list
56913483|NCT05563480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913484|NCT05563480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913485|NCT05563480|Immunologic Factors|immunologic factors|mesh-ancestor
56438939|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56438940|NCT00290667|Vincristine|vincristine|mesh-list
56438941|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56438942|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
56438943|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438944|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438945|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56438946|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
56438947|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438948|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438949|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56438950|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56438951|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56438952|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56438953|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56438954|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438955|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438956|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
56438957|NCT00290667|Hormones|hormones|mesh-ancestor
56438958|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56438959|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56438960|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56438961|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
56438962|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
56438963|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
56438964|NCT01602757|Lidocaine|lidocaine|mesh-list
56438965|NCT01602757|Tetracaine|tetracaine|mesh-list
56438966|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
56438967|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
56438968|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438969|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438970|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
56438971|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438972|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56438973|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56438974|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56438975|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56438976|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438979|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
56438980|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438981|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55939745|NCT03879629|Carvedilol|carvedilol|mesh-list
56438983|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438984|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438985|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438986|NCT01602913|Paroxetine|paroxetine|mesh-list
56438987|NCT01602913|Pravastatin|pravastatin|mesh-list
56438988|NCT01602913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56438989|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56438990|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56438991|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56438992|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438993|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
56438994|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438995|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56438996|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
56438997|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56438998|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56438999|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56439000|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439001|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56439002|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56439003|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
56439004|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56439005|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56439006|NCT00257699|Metronidazole|metronidazole|mesh-list
56439007|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
56913486|NCT05563480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153252|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
56439008|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439009|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56439010|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56439011|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56439012|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56439013|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56439014|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439015|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439016|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439017|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56439018|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56439019|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
56439020|NCT01603030|Prednisolone|prednisolone|mesh-list
56439021|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56439022|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
56439023|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56439024|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
56439025|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56439026|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56439027|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
56439028|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439029|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
56439030|NCT01603030|Hormones|hormones|mesh-ancestor
56439031|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439032|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439033|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56439034|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439035|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
56439036|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
56439037|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439038|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439039|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56439040|NCT01603030|Protective Agents|protective agents|mesh-ancestor
56439041|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56439042|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439043|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56439044|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56439045|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439046|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822631|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
56439049|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56439050|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56439051|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56439052|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56439053|NCT01603108|Rifaximin|rifaximin|mesh-list
56439054|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56439055|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439056|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439057|NCT00290823|Albendazole|albendazole|mesh-list
56439058|NCT00290823|Dexamethasone|dexamethasone|mesh-list
56439059|NCT00290823|Omeprazole|omeprazole|mesh-list
56439060|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439061|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
56439062|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
56439063|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439064|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439065|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439067|NCT00290823|Hormones|hormones|mesh-ancestor
56439068|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439069|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56439070|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439071|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56439072|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56439073|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439074|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439075|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
56439076|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56439077|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439078|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
56439079|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56913487|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56913488|NCT05546398|Ezetimibe|ezetimibe|mesh-list
56913489|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56439080|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56439081|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
56439082|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
56439083|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
56439084|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56439085|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
56439086|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439087|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56439088|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56439089|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439090|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439091|NCT00271284|Insulin|insulin|mesh-list
56439092|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56439093|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
56439094|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
56439095|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
56439096|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56439097|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439098|NCT00257816|Topotecan|topotecan|mesh-list
56439099|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439100|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56439101|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56439102|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439103|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439104|NCT00271323|Docetaxel|docetaxel|mesh-list
56439105|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439106|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
56439107|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
56439108|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
56439109|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439110|NCT01603342|Clopidogrel|clopidogrel|mesh-list
56439111|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56439112|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56439113|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56439114|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56439115|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
56439116|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439117|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439118|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439119|NCT00257855|Lamotrigine|lamotrigine|mesh-list
56439120|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
56439121|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56439123|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439124|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56439125|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439126|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56439127|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55939889|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
56439128|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439129|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439130|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56439132|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
56439133|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56439134|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56439135|NCT01603498|Prednisolone|prednisolone|mesh-list
56439136|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
56186941|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439137|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56439138|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
56439139|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439140|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
56439141|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
56439142|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439143|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439144|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439145|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
56439146|NCT01603498|Hormones|hormones|mesh-ancestor
56439147|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439148|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56913490|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56913491|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
56913492|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439149|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439150|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56439151|NCT01603498|Protective Agents|protective agents|mesh-ancestor
56439152|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
56439153|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
56439154|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
56439155|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439156|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
56439157|NCT01603654|Protective Agents|protective agents|mesh-ancestor
56439158|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439159|NCT01603654|Vitamins|vitamins|mesh-ancestor
56439160|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
56439161|NCT01603654|Cathartics|cathartics|mesh-ancestor
56439162|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439163|NCT00257972|Aripiprazole|aripiprazole|mesh-list
56439164|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
56439165|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439166|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56439167|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56439168|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439169|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439170|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
56439171|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
56439172|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439173|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439174|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56439175|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56439176|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
56439177|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56439178|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56439179|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56439180|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56439181|NCT01603693|Calcium|calcium|mesh-list
56439182|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56439183|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439184|NCT00258050|Lapatinib|lapatinib|mesh-list
56439185|NCT00258050|Midazolam|midazolam|mesh-list
56439186|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56439187|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56439188|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439189|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439190|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56439191|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56439192|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439193|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56439194|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
56439196|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
56439197|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
56439198|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439199|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439200|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439201|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56439202|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439203|NCT00271401|Heparin|heparin|mesh-list
56439204|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
56439205|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56439206|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56439207|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439208|NCT00258089|Levofloxacin|levofloxacin|mesh-list
56439209|NCT00258089|Ofloxacin|ofloxacin|mesh-list
56439210|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56439211|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439212|NCT00258089|Renal Agents|renal agents|mesh-ancestor
56439213|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56439214|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56439215|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56439216|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439217|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439218|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095387|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913493|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56913494|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913495|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56153478|NCT02047500|Gemcitabine|gemcitabine|mesh-list
56439219|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56439220|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56439221|NCT00290901|Celecoxib|celecoxib|mesh-list
56439222|NCT00290901|Tramadol|tramadol|mesh-list
56439223|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56439224|NCT00290901|Narcotics|narcotics|mesh-ancestor
56439225|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439226|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439227|NCT00290901|Analgesics|analgesics|mesh-ancestor
56439228|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
56439229|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439230|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56439231|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56439232|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439233|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439234|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56439235|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56439236|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439237|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439238|NCT00258245|Aspirin|aspirin|mesh-list
56439239|NCT00258245|Vitamins|vitamins|mesh-list
56439240|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
56439241|NCT00258245|Thalidomide|thalidomide|mesh-list
56439242|NCT00258245|Dexamethasone|dexamethasone|mesh-list
56439243|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
56439244|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
56439245|NCT00258245|Bortezomib|bortezomib|mesh-list
56439246|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
56439247|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56439248|NCT00258245|BB 1101|bb 1101|mesh-list
56439249|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
56439250|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439251|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439252|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
56439253|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
56439254|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439255|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439256|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
56439257|NCT00258245|Hormones|hormones|mesh-ancestor
56439258|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439259|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56439260|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439261|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
56439262|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439263|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439264|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56439265|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56439266|NCT00258245|Analgesics|analgesics|mesh-ancestor
56439267|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
56439268|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439269|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56439272|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56439273|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
56439274|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
56439276|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56439277|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
56439278|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
56439279|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56439280|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439281|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56439282|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56439283|NCT00258245|Growth Substances|growth substances|mesh-ancestor
56439284|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
56439285|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
56439286|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56439287|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439288|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
56439289|NCT01604629|Adalimumab|adalimumab|mesh-list
56439290|NCT01604629|Etanercept|etanercept|mesh-list
56439291|NCT01604629|Golimumab|golimumab|mesh-list
56913496|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913497|NCT05472766|Anticoagulants|anticoagulants|mesh-list
56081231|NCT00005583|Epirubicin|epirubicin|mesh-list
56439292|NCT01604629|Infliximab|infliximab|mesh-list
56439293|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56439294|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439295|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439296|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
56439297|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439298|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56439299|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56439300|NCT01604629|Analgesics|analgesics|mesh-ancestor
56439301|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
56439302|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439303|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439304|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56439305|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
56439306|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56439307|NCT00258284|Docetaxel|docetaxel|mesh-list
56439308|NCT00258284|Capecitabine|capecitabine|mesh-list
56439309|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439310|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
56439311|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
56439312|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
56439313|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439314|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56439315|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
56439316|NCT00290940|Metformin|metformin|mesh-list
56439317|NCT00290940|Pioglitazone|pioglitazone|mesh-list
56439318|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56439319|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439320|NCT00258323|Fluorouracil|fluorouracil|mesh-list
56439321|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439322|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
56439323|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439324|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56439325|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56439326|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
56439327|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439328|NCT01604863|Paclitaxel|paclitaxel|mesh-list
56439329|NCT01604863|Etoposide|etoposide|mesh-list
56439330|NCT01604863|Docetaxel|docetaxel|mesh-list
56439331|NCT01604863|Carboplatin|carboplatin|mesh-list
56439332|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56439333|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439334|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
56439335|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
56439336|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
56439337|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439338|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56439339|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56439340|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439341|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
56439342|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56439343|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439344|NCT00258479|Modafinil|modafinil|mesh-list
56439345|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56439346|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439347|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56439348|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56439349|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56439350|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439352|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439353|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439355|NCT01340014|Dorzolamide|dorzolamide|mesh-list
56439356|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56439357|NCT01340014|Brinzolamide|brinzolamide|mesh-list
56439358|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56439359|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56439360|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56439361|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
56439362|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051591|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56913498|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
56913499|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
56439363|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439364|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439365|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56439366|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56439367|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56439368|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439369|NCT00258557|Darunavir|darunavir|mesh-list
56439370|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56439371|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56439372|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
56439373|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439374|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439375|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56439376|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56439377|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
56439378|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439379|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56439380|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
56439381|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439382|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
56439383|NCT00271635|Vitamins|vitamins|mesh-ancestor
56439384|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
56439385|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439386|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
56439387|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439388|NCT00271635|Protective Agents|protective agents|mesh-ancestor
56439389|NCT00258596|Sirolimus|sirolimus|mesh-list
56439390|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56439391|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439392|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56439393|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439394|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
56439395|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56439396|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
56439397|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439398|NCT01339273|Anesthetics|anesthetics|mesh-list
56439399|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
56439400|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439401|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439402|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
56439403|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439404|NCT04709315|Choline|choline|mesh-list
56439405|NCT04709315|Rocuronium|rocuronium|mesh-list
56439406|NCT04709315|Succinylcholine|succinylcholine|mesh-list
56439407|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56439408|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56439409|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56439410|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439411|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439412|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
56439413|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56439414|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
56439415|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439416|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439417|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56439418|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
56439419|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56439420|NCT01334710|Sorafenib|sorafenib|mesh-list
56439421|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439424|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439425|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
56439426|NCT00271713|Vitamin D|vitamin d|mesh-list
56439427|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
56439428|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
56439429|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
56439430|NCT00271713|Vitamins|vitamins|mesh-list
56439431|NCT00271713|Calcium|calcium|mesh-list
56439432|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
56439433|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439434|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56439435|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56439436|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
56439437|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
56913500|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56913501|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
56913502|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439438|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56439439|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56439440|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439441|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439442|NCT01334554|Urological Agents|urological agents|mesh-ancestor
56439443|NCT00291213|Levetiracetam|levetiracetam|mesh-list
56439444|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
56439445|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
56439446|NCT01332799|Allopurinol|allopurinol|mesh-list
56439447|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
56439448|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439449|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439450|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
56439451|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439452|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56439453|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
56439454|NCT01332799|Protective Agents|protective agents|mesh-ancestor
56439455|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439456|NCT00258791|Ibuprofen|ibuprofen|mesh-list
56439457|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56439458|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56439459|NCT00258791|Analgesics|analgesics|mesh-ancestor
56439460|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
56439461|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439462|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439463|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439464|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439465|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56439466|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439467|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439468|NCT00291369|Interferons|interferons|mesh-list
56439469|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
56439470|NCT00291369|Interleukin-2|interleukin-2|mesh-list
56439471|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56439472|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
56439473|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439474|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
56439475|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439476|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
56439477|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439478|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56439479|NCT00291369|Analgesics|analgesics|mesh-ancestor
56439480|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
56439481|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439482|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56439483|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56439484|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56439485|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
56439486|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56439487|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56439488|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56439489|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56439490|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56439491|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
56439492|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56439493|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
56439494|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439495|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439498|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56439499|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
56439500|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439501|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439502|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56439503|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
56439505|NCT00291408|Protective Agents|protective agents|mesh-ancestor
56439507|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439508|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
56439509|NCT00271791|Hormones|hormones|mesh-ancestor
56439510|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153758|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439511|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439512|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56439513|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439514|NCT01332331|Ambrisentan|ambrisentan|mesh-list
56439515|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56439516|NCT00259064|Gefitinib|gefitinib|mesh-list
56187321|NCT02986334|Naproxen|naproxen|mesh-list
56439517|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439518|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56439519|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439520|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439521|NCT01332292|Fluticasone|fluticasone|mesh-list
56439522|NCT01332292|Xhance|xhance|mesh-list
56439523|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439524|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56439525|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
56439526|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439527|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439528|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56439529|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
56439530|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
56439531|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56439532|NCT00259142|Chloroquine|chloroquine|mesh-list
56439533|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
56439534|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
56439535|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56439536|NCT00259142|Amebicides|amebicides|mesh-ancestor
56439537|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56439538|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56439539|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439540|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
56439541|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439542|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56439543|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439544|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439545|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56439546|NCT00259142|Renal Agents|renal agents|mesh-ancestor
56439547|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
56439548|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56439549|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56439550|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56439551|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439552|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
56439553|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
56439554|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
56439555|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56439556|NCT00259181|Protective Agents|protective agents|mesh-ancestor
56439557|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439558|NCT00291720|Spironolactone|spironolactone|mesh-list
56439559|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56439560|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
56439561|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439562|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439563|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56439564|NCT00291720|Diuretics|diuretics|mesh-ancestor
56439565|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
56439566|NCT00259220|Erythromycin|erythromycin|mesh-list
56439567|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
56439568|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56439569|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
56439572|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439573|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55940332|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
56439574|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439575|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439576|NCT00291759|Tamoxifen|tamoxifen|mesh-list
56439577|NCT00291759|Anastrozole|anastrozole|mesh-list
56439578|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56439579|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
56439580|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439581|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439582|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56439583|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439584|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56913503|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913504|NCT03653026|Upadacitinib|upadacitinib|mesh-list
56913505|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56439585|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56439586|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56439587|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56439588|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56439589|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439590|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439591|NCT00272025|Citalopram|citalopram|mesh-list
56439592|NCT00272025|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56439593|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56439594|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56439595|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439596|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439598|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439599|NCT00272025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56439600|NCT00272025|Antidepressive Agents|antidepressive agents|mesh-ancestor
56439601|NCT00272025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439602|NCT04709081|Itraconazole|itraconazole|mesh-list
56439603|NCT04709081|Digoxin|digoxin|mesh-list
56439604|NCT04709081|Midazolam|midazolam|mesh-list
56439605|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56439606|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56439607|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439608|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439609|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56439610|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56439611|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439612|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56439613|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
56439614|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
56439615|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
56439616|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
56439617|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439618|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439619|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
56439620|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439621|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56439622|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56439623|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439624|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56439625|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
56439626|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439627|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56439628|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56439629|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56439630|NCT04709081|Protective Agents|protective agents|mesh-ancestor
56439631|NCT00272064|Insulin|insulin|mesh-list
56439632|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56439633|NCT00272064|Metformin|metformin|mesh-list
56439634|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
56439635|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
56439636|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56439637|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439638|NCT00259376|Dronedarone|dronedarone|mesh-list
56439639|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56439640|NCT01332019|Interferons|interferons|mesh-list
56439641|NCT01332019|Interferon-beta|interferon-beta|mesh-list
56439642|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
56439643|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439644|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
56439645|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439646|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
55940410|NCT05600881|Dopamine Agents|dopamine agents|mesh-ancestor
56439647|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439648|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56439649|NCT00415376|Levetiracetam|levetiracetam|mesh-list
56439650|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
56439651|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
56439652|NCT00291915|Adalimumab|adalimumab|mesh-list
56439653|NCT00291915|Methotrexate|methotrexate|mesh-list
56439654|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56913506|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56439655|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
56439656|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56439657|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439658|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56439659|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
56439660|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439661|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439662|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
56439663|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439664|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56439665|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56439666|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
56187465|NCT00113763|Panitumumab|panitumumab|mesh-list
56439668|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56439669|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439670|NCT00259766|Budesonide|budesonide|mesh-list
56439671|NCT00259766|Terbutaline|terbutaline|mesh-list
56439672|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
56439673|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439674|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56439675|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
56439676|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439677|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439678|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56439679|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
56439680|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
56439681|NCT00259766|Hormones|hormones|mesh-ancestor
56439682|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439683|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56439684|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56439685|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56439686|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
56439687|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439688|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439689|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
56439690|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
56439691|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56439692|NCT00292071|Caspofungin|caspofungin|mesh-list
56439693|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
56439694|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439695|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439696|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439697|NCT00292110|Methadone|methadone|mesh-list
56439698|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56439699|NCT00292110|Narcotics|narcotics|mesh-ancestor
56439700|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439701|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439702|NCT00292110|Analgesics|analgesics|mesh-ancestor
56439703|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
56439704|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439705|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
56439706|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56439707|NCT00259805|Rituximab|rituximab|mesh-list
56439708|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56439709|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439710|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
56439711|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439712|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439713|NCT00259883|Paroxetine|paroxetine|mesh-list
56439714|NCT00259883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56439715|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56439716|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56439717|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439718|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439720|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439721|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56439722|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
56439723|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439724|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56439725|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56439726|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439727|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
56913507|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913508|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439728|NCT04718376|Analgesics|analgesics|mesh-ancestor
56439729|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
56439730|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439731|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439732|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439733|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56439734|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56439735|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439736|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439737|NCT00272415|Temozolomide|temozolomide|mesh-list
56439738|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56439739|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
56439740|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439741|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439742|NCT00259922|Alvimopan|alvimopan|mesh-list
56439743|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439744|NCT00272454|Aspirin|aspirin|mesh-list
56439745|NCT00272454|Cilostazol|cilostazol|mesh-list
56439746|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56439747|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56439748|NCT00272454|Analgesics|analgesics|mesh-ancestor
56439749|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
56439750|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439751|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439752|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439753|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439754|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56439755|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56439756|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439757|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56439758|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56439759|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439760|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
56439761|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56439762|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
56439763|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56439764|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
56439765|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
56439766|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56439767|NCT00272454|Protective Agents|protective agents|mesh-ancestor
56439768|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56439769|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56439770|NCT00272493|Vaccines|vaccines|mesh-list
56439771|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
56439772|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439773|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
56439774|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56439775|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
56439776|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439777|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439778|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
56439779|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439780|NCT00260039|Vaccines|vaccines|mesh-list
56439781|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
56439782|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439783|NCT00292344|Rifaximin|rifaximin|mesh-list
56439784|NCT00292344|Loperamide|loperamide|mesh-list
56439785|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
56439786|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56439787|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439788|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439789|NCT00417768|Plasminogen|plasminogen|mesh-list
56439790|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56439791|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56439793|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439795|NCT00272610|Vitamins|vitamins|mesh-ancestor
56439796|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
56439797|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439798|NCT00260351|Vaccines|vaccines|mesh-list
56439799|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
56439800|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439801|NCT00272688|Levodopa|levodopa|mesh-list
56913509|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439802|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56439803|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56439804|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
56439805|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439806|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439807|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439808|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
56439809|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56439810|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439811|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
56439812|NCT00260390|Hormones|hormones|mesh-ancestor
56439813|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56439814|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439815|NCT00260624|Citalopram|citalopram|mesh-list
56439816|NCT00260624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56439817|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56439818|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56439819|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439820|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439821|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
56439822|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439823|NCT00260624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56439824|NCT00260624|Antidepressive Agents|antidepressive agents|mesh-ancestor
56439825|NCT00260624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439826|NCT00292695|Ifosfamide|ifosfamide|mesh-list
56439827|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439828|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56439829|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
56439830|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439831|NCT00292734|Zolpidem|zolpidem|mesh-list
56439832|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56439833|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56439834|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439835|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439836|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56439837|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
56439838|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
56439839|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439840|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439841|NCT00260702|Omalizumab|omalizumab|mesh-list
56439842|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56439843|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56439844|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
56439845|NCT00260819|Bosentan|bosentan|mesh-list
56439846|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56439847|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56439848|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439849|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
56439850|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
56439851|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439852|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439853|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56439854|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56439855|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
56439856|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439857|NCT00292890|Insulin|insulin|mesh-list
56439858|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56439859|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439860|NCT00292929|Artesunate|artesunate|mesh-list
56439861|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
56439862|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56439863|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56439864|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439867|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
56439868|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56439869|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
56439870|NCT00424853|Gemcitabine|gemcitabine|mesh-list
56439871|NCT00424853|Cisplatin|cisplatin|mesh-list
56439872|NCT00424853|Docetaxel|docetaxel|mesh-list
56439873|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439874|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56439875|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
56439876|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913510|NCT02232724|Choline|choline|mesh-list
56913511|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
56913512|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56913513|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
56154126|NCT02282904|Sirolimus|sirolimus|mesh-list
56439877|NCT00424853|Antiviral Agents|antiviral agents|mesh-ancestor
56439878|NCT00424853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439879|NCT00424853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439880|NCT00424853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56439881|NCT00424853|Immunologic Factors|immunologic factors|mesh-ancestor
56439882|NCT00424853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439883|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
56439884|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
56439885|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
56439886|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
56439887|NCT00298506|Tacrolimus|tacrolimus|mesh-list
56439888|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56439889|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
56439890|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439891|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56439892|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439893|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439894|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56439895|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439896|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56439897|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
56439898|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56439899|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439900|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56439901|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56439902|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56439903|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56439904|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439905|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439906|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439907|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
56439908|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439910|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56439911|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439912|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56439913|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56439914|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56439915|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439916|NCT00298545|Calcitriol|calcitriol|mesh-list
56439917|NCT00298545|Calcium|calcium|mesh-list
56439918|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56439919|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439920|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56439921|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56439922|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439923|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56439924|NCT00298545|Vitamins|vitamins|mesh-ancestor
56439925|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
56439926|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56439927|NCT01331161|Vaccines|vaccines|mesh-list
56439928|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
56439929|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439930|NCT00424970|Acetazolamide|acetazolamide|mesh-list
56439931|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
56439932|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56439933|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439934|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439935|NCT00424970|Diuretics|diuretics|mesh-ancestor
56439936|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
56439937|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439939|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56439941|NCT01331005|Analgesics|analgesics|mesh-ancestor
56439942|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
55940713|NCT03015259|Hormones|hormones|mesh-ancestor
56439943|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913514|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913515|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439944|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439945|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439946|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439947|NCT01330459|Acetaminophen|acetaminophen|mesh-list
56439948|NCT01330459|Ibuprofen|ibuprofen|mesh-list
56439949|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56439950|NCT01330459|Lidocaine|lidocaine|mesh-list
56439951|NCT01330459|Hydrocodone|hydrocodone|mesh-list
56439952|NCT01330459|Lorazepam|lorazepam|mesh-list
56439953|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
56439954|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
56439955|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56439956|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439957|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
56439958|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439959|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56439960|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56439961|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56439962|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56439963|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439964|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56439965|NCT01330459|Analgesics|analgesics|mesh-ancestor
56439966|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
56439967|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56439968|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56439969|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56439970|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56439971|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439972|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56439973|NCT01330459|Narcotics|narcotics|mesh-ancestor
56439974|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
56439975|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
56439976|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
56439977|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
56439978|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
56439979|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56439980|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56439981|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56439982|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56439983|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56439984|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
56439985|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
56439986|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439987|NCT00293085|Docetaxel|docetaxel|mesh-list
56439988|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439989|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
56439990|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
56439991|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
56439992|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56439993|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56439994|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56439995|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56439996|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
56439997|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439998|NCT00298662|Interferons|interferons|mesh-list
56439999|NCT00298662|Interferon-beta|interferon-beta|mesh-list
56440000|NCT00298662|Tacrolimus|tacrolimus|mesh-list
56440001|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
56440002|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440003|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
56440004|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440005|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56440006|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
56440007|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440008|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56440009|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440010|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440011|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55824425|NCT01717456|Loperamide|loperamide|mesh-list
56440013|NCT01330381|Laxatives|laxatives|mesh-ancestor
56440014|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56440015|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56154310|NCT02302092|Cefepime|cefepime|mesh-list
56440016|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56440017|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
56440018|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440019|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440020|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440021|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
56440022|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440023|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
56440024|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440025|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56440026|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440027|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440028|NCT01330108|Ambrisentan|ambrisentan|mesh-list
56440029|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56440030|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
56440031|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56440032|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56440033|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56440034|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440035|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440036|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
56187843|NCT01440842|Insulin|insulin|mesh-list
56440037|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440038|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440039|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56440040|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440042|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56440043|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
56440044|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56440045|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56440046|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56440047|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440048|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440049|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
56440050|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440051|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440052|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56440053|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56440054|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440055|NCT00261287|Ciclesonide|ciclesonide|mesh-list
56440056|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
56440057|NCT00261287|Hormones|hormones|mesh-ancestor
56440058|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440059|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440060|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56440061|NCT00261326|Simvastatin|simvastatin|mesh-list
56440062|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56440063|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56440064|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
56440065|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440066|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56440067|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56440068|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440069|NCT00293163|Hylan|hylan|mesh-list
56440070|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
56440071|NCT00293163|Protective Agents|protective agents|mesh-ancestor
56440072|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440073|NCT00261365|Ipilimumab|ipilimumab|mesh-list
56440074|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56440075|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440076|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56440077|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440078|NCT00293280|Lomustine|lomustine|mesh-list
56440079|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56440080|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
56440081|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440082|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440083|NCT00298779|Bortezomib|bortezomib|mesh-list
56440086|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56440087|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56440088|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56913516|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56913517|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
56913518|NCT02234440|Metformin|metformin|mesh-list
56440089|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440090|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440092|NCT00261482|Norelgestromin|norelgestromin|mesh-list
56440093|NCT00261482|Estradiol|estradiol|mesh-list
56440094|NCT00261482|Estrogens|estrogens|mesh-ancestor
56440095|NCT00261482|Hormones|hormones|mesh-ancestor
56440096|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440097|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440098|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56440099|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
56440100|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56440101|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56440102|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56440103|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56440104|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
56440105|NCT00261521|Hematinics|hematinics|mesh-ancestor
56440106|NCT00298857|Valproic Acid|valproic acid|mesh-list
56440107|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
56440108|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440109|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440110|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
56440111|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440112|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440113|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
56440114|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56440115|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56440116|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56440117|NCT00261560|Acetaminophen|acetaminophen|mesh-list
56440118|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440119|NCT00261560|Analgesics|analgesics|mesh-ancestor
56440120|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
56440121|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440122|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440123|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
56440124|NCT00261599|Midazolam|midazolam|mesh-list
56440125|NCT00261599|Fospropofol|fospropofol|mesh-list
56440126|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56440127|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56440128|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56440129|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440130|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56440131|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56440132|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56440133|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56440134|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
56440135|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
56440136|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
56440137|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
56440138|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440139|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440140|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56440141|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440142|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440143|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440144|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56440145|NCT00293358|Carboplatin|carboplatin|mesh-list
56440146|NCT00293358|Etoposide|etoposide|mesh-list
56440147|NCT00293358|Ifosfamide|ifosfamide|mesh-list
56440148|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
56440149|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440150|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56440151|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56440152|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56440153|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440154|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440155|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56440156|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
56440157|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
56440158|NCT00261677|Hematinics|hematinics|mesh-ancestor
56440159|NCT00261755|Analgesics|analgesics|mesh-list
56440160|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
56440161|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913519|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56913520|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913521|NCT04981678|Buprenorphine|buprenorphine|mesh-list
56440162|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440163|NCT00298974|Acetaminophen|acetaminophen|mesh-list
56440164|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56440165|NCT00298974|Hydrocodone|hydrocodone|mesh-list
56440166|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440167|NCT00298974|Analgesics|analgesics|mesh-ancestor
56440168|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
56440169|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440170|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440171|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
56440172|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56440173|NCT00298974|Narcotics|narcotics|mesh-ancestor
56440174|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56440175|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
56440176|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
56440177|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56440178|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440179|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440180|NCT00293436|Celecoxib|celecoxib|mesh-list
56440181|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56440182|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440183|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56440184|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440185|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440186|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56440187|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440188|NCT00293436|Analgesics|analgesics|mesh-ancestor
56440189|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
56440190|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440191|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440192|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440193|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440194|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56440195|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56440196|NCT00261872|Methylphenidate|methylphenidate|mesh-list
56440197|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56440198|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440199|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56440200|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56440201|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440202|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440203|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
56440204|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440205|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
56440206|NCT00293475|Rituximab|rituximab|mesh-list
56440207|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56440208|NCT00293475|Carboplatin|carboplatin|mesh-list
56440209|NCT00293475|Methotrexate|methotrexate|mesh-list
56440210|NCT00293475|Mannitol|mannitol|mesh-list
56440211|NCT00293475|Antibodies|antibodies|mesh-list
56440212|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
56440213|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56440214|NCT00293475|Antidotes|antidotes|mesh-list
56440215|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
56440216|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440217|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440218|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440219|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56440220|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
56440221|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56440222|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56440223|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
56440224|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440225|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
56440226|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440227|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56440228|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56440229|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56440230|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56913522|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56913523|NCT04981678|Narcotics|narcotics|mesh-ancestor
56913524|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913525|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913526|NCT04981678|Analgesics|analgesics|mesh-ancestor
56913527|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
56913528|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913529|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56913530|NCT04966546|Memantine|memantine|mesh-list
56913531|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56913532|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56913533|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
56440231|NCT00293475|Diuretics|diuretics|mesh-ancestor
56440232|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
56440233|NCT00293475|Protective Agents|protective agents|mesh-ancestor
56440236|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56440237|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440238|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
56440239|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
56440240|NCT00261911|Sibutramine|sibutramine|mesh-list
56440241|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
56440242|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56440243|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
56440244|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56440245|NCT00299013|Prednisolone|prednisolone|mesh-list
56440246|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56440247|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
56440248|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56440249|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
56440250|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56440251|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
56440252|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440253|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
56440254|NCT00299013|Hormones|hormones|mesh-ancestor
56440255|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440256|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440257|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56440258|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440259|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
56440260|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
56440261|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440262|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56440263|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56440264|NCT00299013|Protective Agents|protective agents|mesh-ancestor
56440265|NCT00293514|Thrombin|thrombin|mesh-list
56440266|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
56188064|NCT01442272|Calcifediol|calcifediol|mesh-list
56440267|NCT00293514|Coagulants|coagulants|mesh-ancestor
56440269|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56440270|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56440271|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440272|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440273|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
56440274|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440275|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56440276|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56440277|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56440278|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56440279|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56440280|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56440281|NCT00299208|Azithromycin|azithromycin|mesh-list
56440282|NCT00299208|Artesunate|artesunate|mesh-list
56440283|NCT00299208|Quinine|quinine|mesh-list
56440284|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56440285|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440286|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
56913534|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913535|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440287|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56440288|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56440289|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440290|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
56440291|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
56440292|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56440293|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
56440294|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56440295|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440296|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56440297|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440298|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440299|NCT00299208|Analgesics|analgesics|mesh-ancestor
56440300|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
56440301|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
56440302|NCT00418119|Hematinics|hematinics|mesh-ancestor
56440303|NCT00293592|Dexamethasone|dexamethasone|mesh-list
56440304|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440305|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
56440306|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
56440307|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440308|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440309|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56440311|NCT00293592|Hormones|hormones|mesh-ancestor
56440312|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440313|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56440314|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440315|NCT00293631|Ketorolac|ketorolac|mesh-list
56440316|NCT00293631|Lornoxicam|lornoxicam|mesh-list
56440317|NCT00293631|Piroxicam|piroxicam|mesh-list
56440318|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56440319|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440320|NCT00293631|Analgesics|analgesics|mesh-ancestor
56440321|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
56440322|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440323|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440324|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440325|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440326|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56440327|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440328|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440329|NCT00262262|Levetiracetam|levetiracetam|mesh-list
56440330|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
56440331|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
56440332|NCT00293670|Goserelin|goserelin|mesh-list
56440333|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56440334|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440335|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
56440336|NCT00262379|Hematinics|hematinics|mesh-ancestor
56440337|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
56440338|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
56440339|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
56440340|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56440341|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56440342|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440343|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56440344|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440345|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440346|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56440347|NCT00299247|Renal Agents|renal agents|mesh-ancestor
56440348|NCT00262418|Ivermectin|ivermectin|mesh-list
56440349|NCT00262418|Permethrin|permethrin|mesh-list
56440350|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56440351|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440352|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440353|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440354|NCT00299286|Lapatinib|lapatinib|mesh-list
56440355|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440356|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56440357|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440358|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440359|NCT00293787|Timolol|timolol|mesh-list
56440360|NCT00293787|Travoprost|travoprost|mesh-list
56096327|NCT00000452|Naltrexone|naltrexone|mesh-list
56913536|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913537|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56913538|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56440361|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56440362|NCT00293787|Latanoprost|latanoprost|mesh-list
56440363|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56440364|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440365|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56440366|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56440367|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
56440368|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440369|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440370|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56440371|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56440373|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
56440374|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
56440375|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440376|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440377|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56440378|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56440379|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440380|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56440381|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
56440382|NCT00299364|Hormones|hormones|mesh-ancestor
56440383|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56440384|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
56440385|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440386|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56440388|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440389|NCT00262769|Gemcitabine|gemcitabine|mesh-list
56440390|NCT00262769|Cisplatin|cisplatin|mesh-list
56440391|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440392|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56440393|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
56440394|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440395|NCT00262769|Antiviral Agents|antiviral agents|mesh-ancestor
56440396|NCT00262769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440397|NCT00262769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440398|NCT00262769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56440399|NCT00262769|Immunologic Factors|immunologic factors|mesh-ancestor
56440400|NCT00262769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440401|NCT00299520|Linezolid|linezolid|mesh-list
56440402|NCT00299520|Iclaprim|iclaprim|mesh-list
56440403|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56440404|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440405|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56440406|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440407|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440408|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56440409|NCT00262808|Leucovorin|leucovorin|mesh-list
56440410|NCT00262808|Fluorouracil|fluorouracil|mesh-list
56440411|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
56440412|NCT00262808|Calcium|calcium|mesh-list
56440413|NCT00262808|Sargramostim|sargramostim|mesh-list
56440414|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
56440415|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56440416|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440417|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
56440418|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440419|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56440420|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440421|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56440422|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
56440423|NCT00262808|Antidotes|antidotes|mesh-ancestor
56440424|NCT00262808|Protective Agents|protective agents|mesh-ancestor
56440425|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
56440426|NCT00262808|Vitamins|vitamins|mesh-ancestor
56440427|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
56440428|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
56440429|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
56440430|NCT00262886|Fludarabine|fludarabine|mesh-list
56440431|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
56440432|NCT00262886|Tacrolimus|tacrolimus|mesh-list
56913539|NCT02230618|Insulin|insulin|mesh-list
56913540|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
56913541|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56440433|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56440434|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56440435|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
56440436|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440437|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440438|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56440439|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
56440440|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440441|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440442|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56440443|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56440444|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
56440445|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56440446|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941207|NCT01920503|Doxorubicin|doxorubicin|mesh-list
56440448|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56440449|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
56440450|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56440451|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440452|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56440453|NCT00263003|Irbesartan|irbesartan|mesh-list
56440454|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56440455|NCT00263003|Diuretics|diuretics|mesh-ancestor
56440456|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
56440457|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440458|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56440459|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440460|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440461|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56440462|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56440466|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
56440467|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56440468|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440469|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56440470|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440471|NCT00263198|Letrozole|letrozole|mesh-list
56440472|NCT00263198|Vatalanib|vatalanib|mesh-list
56440473|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440474|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56440475|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56440476|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440477|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440478|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56440479|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
56440480|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440481|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440482|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56440483|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56440484|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56440485|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
56440486|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440487|NCT00294099|Antacids|antacids|mesh-ancestor
56440488|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440489|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56440490|NCT00299676|Galantamine|galantamine|mesh-list
56440491|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56440492|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440493|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440494|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
56440495|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440496|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440497|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56440498|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
56440499|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440500|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
56440502|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
56440503|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56440504|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440505|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56913542|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913543|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
56913544|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56913545|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913546|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440506|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440507|NCT00299754|Misoprostol|misoprostol|mesh-list
56440508|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56440509|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
56440510|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56440511|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440512|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56440513|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56440514|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
56440515|NCT00263315|Amphotericin B|amphotericin b|mesh-list
56440516|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56440517|NCT00263315|Amebicides|amebicides|mesh-ancestor
56440518|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56440519|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56440520|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440521|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56440522|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
56440523|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
56440524|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440525|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56440526|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440527|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440528|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
56440529|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440531|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56440532|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56440533|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56440534|NCT00263393|Diuretics|diuretics|mesh-ancestor
56440535|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
56440536|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440537|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56440539|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440540|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56440541|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
56440542|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
56440543|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440544|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56440545|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56440546|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56440547|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
56440548|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440549|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
56440550|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440551|NCT00299871|Lixisenatide|lixisenatide|mesh-list
56440552|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56440553|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440554|NCT00299910|Montelukast|montelukast|mesh-list
56440555|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56440556|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
56440557|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56440558|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
56440559|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440560|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440561|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56440562|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56440563|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440564|NCT00425594|Bisacodyl|bisacodyl|mesh-list
56440565|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56440566|NCT00425594|Cathartics|cathartics|mesh-ancestor
56440567|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56440568|NCT00425594|Laxatives|laxatives|mesh-ancestor
56440569|NCT00294255|Risperidone|risperidone|mesh-list
56440570|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56913547|NCT04669288|Azithromycin|azithromycin|mesh-list
56913548|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56913549|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913550|NCT02262520|Digoxin|digoxin|mesh-list
56913551|NCT02262520|Apixaban|apixaban|mesh-list
56913552|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56913553|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
56913554|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56913555|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
56913556|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188382|NCT01443572|Desflurane|desflurane|mesh-list
56440571|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
56440572|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440573|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440574|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440575|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56440576|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56440577|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56440578|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56440579|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56440580|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
56440581|NCT00263705|Capecitabine|capecitabine|mesh-list
56440582|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56440583|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
56440584|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440585|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440586|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56440587|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56440588|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
56440589|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440590|NCT00263744|Antacids|antacids|mesh-ancestor
56440591|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440592|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56440593|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56440594|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
56440595|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440596|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56440597|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440598|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56440599|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440600|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440601|NCT00300222|Capsaicin|capsaicin|mesh-list
56440602|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
56440603|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56440604|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
56440605|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440606|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440607|NCT00263978|Defibrotide|defibrotide|mesh-list
56440608|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56440609|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56440611|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56440612|NCT00264134|Carboplatin|carboplatin|mesh-list
56440613|NCT00264134|Docetaxel|docetaxel|mesh-list
56440614|NCT00264134|Irinotecan|irinotecan|mesh-list
56440615|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440616|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
56440617|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
56440618|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
56440619|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440620|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56440621|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56440622|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440623|NCT00300339|Clopidogrel|clopidogrel|mesh-list
56440624|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56440625|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56440626|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56096346|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
56913557|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913558|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
56913559|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56913560|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56913561|NCT02262520|Protective Agents|protective agents|mesh-ancestor
56913562|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913563|NCT02233504|Deferasirox|deferasirox|mesh-list
56913564|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56913565|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
56913566|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
56913567|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913568|NCT02262598|Telmisartan|telmisartan|mesh-list
56913569|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56913570|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56913571|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56913572|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56154911|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
56440627|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56440628|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
56440629|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440630|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440631|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440632|NCT00264173|Valproic Acid|valproic acid|mesh-list
56440633|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
56440634|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440635|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440636|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
56440637|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440638|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440639|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
56440640|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56440641|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56440642|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56440643|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56440644|NCT00264212|Irbesartan|irbesartan|mesh-list
56440645|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56440646|NCT00264212|Diuretics|diuretics|mesh-ancestor
56440647|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
56440648|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440649|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56440650|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440651|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440652|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56440653|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56440654|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56440655|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56440656|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56440657|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440658|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440659|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440660|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440661|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
56440662|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56440663|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
56440664|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56096504|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913573|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913574|NCT02262598|Diuretics|diuretics|mesh-ancestor
56913575|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
56154969|NCT02519322|Nivolumab|nivolumab|mesh-list
56440665|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440666|NCT00294567|Amlodipine|amlodipine|mesh-list
56440667|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
56440668|NCT00294567|Calcium|calcium|mesh-list
56440669|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56440670|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440671|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56440672|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440673|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440674|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
56440675|NCT00294606|Phenylephrine|phenylephrine|mesh-list
56440676|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
56440677|NCT00294606|Norepinephrine|norepinephrine|mesh-list
56440678|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56440679|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
56440680|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
56440681|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440682|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440683|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
56440684|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56440685|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
56440686|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
56440687|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56440688|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56440689|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56440690|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
56440691|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440692|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440693|NCT00294606|Protective Agents|protective agents|mesh-ancestor
56440694|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
56440695|NCT04708964|Analgesics|analgesics|mesh-ancestor
56440696|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
56440697|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440698|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440699|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56440700|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440701|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440702|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440703|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56440704|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440705|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440706|NCT00264368|Ganciclovir|ganciclovir|mesh-list
56440707|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56440708|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
56440709|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440710|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56440711|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440712|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440713|NCT00264407|Hormones|hormones|mesh-list
56440714|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440715|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440716|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
56440717|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56440718|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56440719|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440720|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440721|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
56440722|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440723|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56440724|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56440725|NCT00264446|Eniluracil|eniluracil|mesh-list
56440726|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440727|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440728|NCT00264485|Fentanyl|fentanyl|mesh-list
56440729|NCT00264485|Morphine|morphine|mesh-list
56440730|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56440731|NCT00264485|Narcotics|narcotics|mesh-ancestor
56913576|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913577|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56913578|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913579|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56440732|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56440733|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440734|NCT00264485|Analgesics|analgesics|mesh-ancestor
56440735|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
56440736|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440737|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56440738|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56440739|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
56440740|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
56440741|NCT00294918|Hormones|hormones|mesh-list
56440742|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440743|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440744|NCT00264680|Lamotrigine|lamotrigine|mesh-list
56440745|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
56440746|NCT00264680|Valproic Acid|valproic acid|mesh-list
56440747|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56440748|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440749|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440750|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56440751|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440752|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56440753|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56440754|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56440758|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
56440759|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440760|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
56440761|NCT00300729|Celecoxib|celecoxib|mesh-list
56440762|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56440763|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440764|NCT00300729|Analgesics|analgesics|mesh-ancestor
56440765|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
56440766|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440767|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440768|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440769|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440770|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56440771|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56440772|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440773|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440774|NCT00264719|Metoclopramide|metoclopramide|mesh-list
56440775|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
56440776|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
56440777|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440778|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440779|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56440780|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56440781|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56440782|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
56440783|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440784|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440785|NCT00264914|Satavaptan|satavaptan|mesh-list
56440786|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56440787|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440788|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
56440789|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188597|NCT01445223|Ritonavir|ritonavir|mesh-list
56440790|NCT00264953|Prednisone|prednisone|mesh-list
56440791|NCT00264953|Etoposide|etoposide|mesh-list
56440792|NCT00264953|Vincristine|vincristine|mesh-list
56164872|NCT04609020|Lidocaine|lidocaine|mesh-list
56440793|NCT00264953|Doxorubicin|doxorubicin|mesh-list
56440794|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56440795|NCT00264953|Bleomycin|bleomycin|mesh-list
56440796|NCT00264953|Vinblastine|vinblastine|mesh-list
56440797|NCT00264953|Procarbazine|procarbazine|mesh-list
56440798|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440799|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
56913580|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56913581|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56913582|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
56155115|NCT05720442|Serotonin Agents|serotonin agents|mesh-ancestor
56440800|NCT00264953|Hormones|hormones|mesh-ancestor
56440801|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440802|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440803|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56440804|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440805|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56440806|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56440807|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56440808|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440809|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440810|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56440811|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56440812|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56440813|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56440814|NCT00300846|Aripiprazole|aripiprazole|mesh-list
56440815|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
56440816|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56440817|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56440818|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56440819|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56440820|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440821|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
56440822|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
56440823|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440824|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440825|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56440827|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
56440828|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56440829|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56440830|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56440831|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56440832|NCT00294996|Doxorubicin|doxorubicin|mesh-list
56440833|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56440834|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440835|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56440836|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56440837|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440838|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440839|NCT00265031|Prednisone|prednisone|mesh-list
56440840|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
56440841|NCT00265031|Etoposide|etoposide|mesh-list
56440842|NCT00265031|Vincristine|vincristine|mesh-list
56440843|NCT00265031|Doxorubicin|doxorubicin|mesh-list
56440844|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56440845|NCT00265031|Bleomycin|bleomycin|mesh-list
56440846|NCT00265031|Procarbazine|procarbazine|mesh-list
56440847|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56440848|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
56440849|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440850|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440851|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56440852|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
56440853|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440854|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440855|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56440856|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440857|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
56440858|NCT00265031|Hormones|hormones|mesh-ancestor
56164876|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440859|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440860|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56440861|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56440862|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56440863|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56188686|NCT01445587|Bortezomib|bortezomib|mesh-list
56440864|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440865|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
56155183|NCT05716854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440866|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
56440867|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
56440868|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56440869|NCT00300924|Acetaminophen|acetaminophen|mesh-list
56440870|NCT00300924|Rizatriptan|rizatriptan|mesh-list
56440871|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440872|NCT00300924|Analgesics|analgesics|mesh-ancestor
56440873|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
56440874|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440875|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440876|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
56440877|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56440878|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
56440879|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440880|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440881|NCT00265070|Gefitinib|gefitinib|mesh-list
56440882|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440883|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56440884|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440885|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440886|NCT00295035|Celecoxib|celecoxib|mesh-list
56440887|NCT00295035|Curcumin|curcumin|mesh-list
56440888|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56440889|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440890|NCT00295035|Analgesics|analgesics|mesh-ancestor
56440891|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
56440892|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440893|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440894|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440895|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440896|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56440897|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56440898|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440900|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440901|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56440902|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56440903|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56440904|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440905|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440906|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
56440907|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440908|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440909|NCT00418275|Plasminogen|plasminogen|mesh-list
56440910|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56440911|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56440912|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440913|NCT00265304|Ketoprofen|ketoprofen|mesh-list
56440914|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56440915|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440916|NCT00265304|Analgesics|analgesics|mesh-ancestor
56440917|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
56440918|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440919|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440920|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56440921|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56440922|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56440923|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440924|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440925|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
56440926|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56440927|NCT00265460|Lobeline|lobeline|mesh-list
56440928|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56440929|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
55941704|NCT01926197|Antidotes|antidotes|mesh-ancestor
56440930|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440931|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440932|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56440933|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56440934|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
56440935|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440936|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440937|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
56913583|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913584|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56913585|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56440938|NCT00301002|Alefacept|alefacept|mesh-list
56440939|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
56440940|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
56440941|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440942|NCT00265694|Gemcitabine|gemcitabine|mesh-list
56440943|NCT00265694|Carboplatin|carboplatin|mesh-list
56440944|NCT00265694|Vinorelbine|vinorelbine|mesh-list
56440945|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440946|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56440947|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
56440948|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440949|NCT00265694|Antiviral Agents|antiviral agents|mesh-ancestor
56440950|NCT00265694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56440951|NCT00265694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440952|NCT00265694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56440953|NCT00265694|Immunologic Factors|immunologic factors|mesh-ancestor
56440954|NCT00265694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440955|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56440956|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
56440957|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
56440958|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
56440959|NCT00265733|Paclitaxel|paclitaxel|mesh-list
56440960|NCT00265733|Capecitabine|capecitabine|mesh-list
56440961|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56440962|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56440963|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440964|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
56440965|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
56440966|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
56440967|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440968|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56440969|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
56440970|NCT00265772|Prednisolone|prednisolone|mesh-list
56440972|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
56440973|NCT00265772|Hormones|hormones|mesh-ancestor
56440974|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56440975|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440976|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56440977|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440978|NCT00265811|Cetuximab|cetuximab|mesh-list
56440979|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56440980|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440981|NCT00295308|Clonidine|clonidine|mesh-list
56440982|NCT00295308|Analgesics|analgesics|mesh-ancestor
56440983|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
56440984|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56440985|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440986|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56440987|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
56440988|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
56440989|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56440990|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56440991|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56440992|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
56440993|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56440994|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440995|NCT00265928|Rituximab|rituximab|mesh-list
56440996|NCT00265928|Bortezomib|bortezomib|mesh-list
56440997|NCT00265928|Antibodies|antibodies|mesh-list
56440998|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
56440999|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56441000|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56441001|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
56441002|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441003|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56441004|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441005|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441006|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441007|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
56155347|NCT05425056|Sirolimus|sirolimus|mesh-list
56441008|NCT00295347|Spironolactone|spironolactone|mesh-list
56441009|NCT00295347|Citalopram|citalopram|mesh-list
56441010|NCT00295347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56441011|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56441012|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441013|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441014|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441015|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
56441016|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441017|NCT00295347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56441018|NCT00295347|Antidepressive Agents|antidepressive agents|mesh-ancestor
56441019|NCT00295347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56441020|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56441021|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
56441022|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56441023|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56441024|NCT00295347|Diuretics|diuretics|mesh-ancestor
56441025|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
56441026|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441028|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56441029|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56441030|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56441031|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441032|NCT00295386|Zopiclone|zopiclone|mesh-list
56441033|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56441034|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441035|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441036|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56441037|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56441038|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441039|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56441040|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56441041|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441042|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441046|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
56441047|NCT00295425|Cyclosporins|cyclosporins|mesh-list
56441048|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441049|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441050|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441051|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
56441052|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441053|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
56441054|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441055|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
56441056|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441057|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56441058|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56441059|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441060|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56441061|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
56441062|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56441063|NCT00266123|Sirolimus|sirolimus|mesh-list
56441064|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56441065|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441066|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56441067|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441068|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
56441069|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441070|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
56441071|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441072|NCT00266162|Bosentan|bosentan|mesh-list
56441073|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56441074|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56441075|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441077|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441078|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
56441079|NCT00295464|Hormones|hormones|mesh-ancestor
56441080|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56441081|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441082|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56913586|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913587|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
56155411|NCT05281614|Etanercept|etanercept|mesh-list
56441083|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
56441084|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56441085|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56441086|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441087|NCT00301392|Pitavastatin|pitavastatin|mesh-list
56441088|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56441089|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56441090|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56441091|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
56441092|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441093|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441094|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56441095|NCT00415844|Levodopa|levodopa|mesh-list
56441096|NCT00415844|Carbidopa|carbidopa|mesh-list
56441097|NCT00415844|Entacapone|entacapone|mesh-list
56441098|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56441099|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56441100|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56441101|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
56441102|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441103|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441104|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441105|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56441106|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441107|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56441108|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56441109|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
56441110|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
56441111|NCT00415883|Valsartan|valsartan|mesh-list
56441112|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56441113|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56441114|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55827131|NCT05619653|Prednisolone|prednisolone|mesh-list
56441120|NCT00295542|Olmesartan|olmesartan|mesh-list
56441121|NCT00295542|Enalapril|enalapril|mesh-list
56441122|NCT00295542|Lisinopril|lisinopril|mesh-list
56441123|NCT00295542|Nebivolol|nebivolol|mesh-list
56441124|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
56441125|NCT00295542|Doxazosin|doxazosin|mesh-list
56441126|NCT00295542|Indapamide|indapamide|mesh-list
56441127|NCT00295542|Quinapril|quinapril|mesh-list
56441128|NCT00295542|Torsemide|torsemide|mesh-list
56441129|NCT00295542|Spirapril|spirapril|mesh-list
56441130|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56441131|NCT00295542|Diuretics|diuretics|mesh-list
56441132|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56441133|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56441134|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441135|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56441136|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
56441137|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441138|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441139|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
56441140|NCT00295542|Protective Agents|protective agents|mesh-ancestor
56441141|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56441142|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441143|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56441144|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
56441145|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56441146|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56441147|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56441148|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
56441149|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441150|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
56441151|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56441152|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56441153|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
56441154|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
56441155|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441156|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56441157|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56913588|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56155481|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56441158|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56188975|NCT01447368|Cinacalcet|cinacalcet|mesh-list
56441159|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56441160|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56441161|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56441162|NCT00266318|Interferons|interferons|mesh-list
56441163|NCT00266318|Ribavirin|ribavirin|mesh-list
56441164|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
56441165|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441166|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
56441167|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441168|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
56441169|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441170|NCT00266357|Gaboxadol|gaboxadol|mesh-list
56441171|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441172|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441173|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441174|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441175|NCT00266357|Analgesics|analgesics|mesh-ancestor
56441176|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
56441177|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
56441178|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
56441179|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
56441180|NCT00301509|Ribavirin|ribavirin|mesh-list
56441181|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
56441182|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441183|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
56441184|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441185|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
56441186|NCT00295698|Filaricides|filaricides|mesh-ancestor
56441187|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
56441192|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441193|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441194|NCT00266552|Risperidone|risperidone|mesh-list
56441195|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56441196|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
56441197|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441198|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441199|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441200|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56441201|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56441202|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441203|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56441204|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56441205|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
56441206|NCT00301587|Folic Acid|folic acid|mesh-list
56441207|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
56441208|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56441209|NCT00301587|Norgestimate|norgestimate|mesh-list
56441210|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56441211|NCT00301587|Estradiol|estradiol|mesh-list
56441212|NCT00301587|Estrogens|estrogens|mesh-ancestor
56441213|NCT00301587|Hormones|hormones|mesh-ancestor
56441214|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56441215|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441216|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56441217|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
56441218|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56441219|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56441220|NCT00301587|Hematinics|hematinics|mesh-ancestor
56441221|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
56441222|NCT00301587|Vitamins|vitamins|mesh-ancestor
56441223|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
56441224|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56441225|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56441226|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56441227|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56441228|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441229|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56441230|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56441231|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441232|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913589|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913590|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913591|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56913592|NCT03723538|Analgesics|analgesics|mesh-ancestor
56913593|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
56441233|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441234|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56441235|NCT00266591|Topiramate|topiramate|mesh-list
56441236|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
56441237|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56441238|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441239|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
56441240|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56441241|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56441242|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56441243|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441244|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441245|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
56441246|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441247|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441248|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56441249|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441250|NCT00295776|Lamotrigine|lamotrigine|mesh-list
56441251|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
56441252|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56441253|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441254|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441255|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56441256|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441257|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56441258|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56441277|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441278|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441279|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441281|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56441282|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441283|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441284|NCT00295815|Lomustine|lomustine|mesh-list
56441285|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56441286|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
56441287|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441288|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441289|NCT00295971|Fludarabine|fludarabine|mesh-list
56441290|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
56441291|NCT00295971|Thiotepa|thiotepa|mesh-list
56441292|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56441293|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441294|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56441295|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
55942080|NCT05608499|Hormones|hormones|mesh-ancestor
56441296|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441297|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441298|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
56441299|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441300|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56441301|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
56441302|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56441303|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
56441304|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56441305|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56441306|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441307|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441308|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56441309|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56441310|NCT00267176|Analgesics|analgesics|mesh-ancestor
56189123|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
56441311|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
55827760|NCT02166476|Renal Agents|renal agents|mesh-ancestor
56441317|NCT00296010|Doxorubicin|doxorubicin|mesh-list
56913594|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913595|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56155628|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
56441318|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56441319|NCT00296010|Methotrexate|methotrexate|mesh-list
56441320|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441321|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
56441322|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441323|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441324|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56441325|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
56441326|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441327|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441328|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56441329|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56441330|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56441331|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56441332|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441333|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56441334|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
56441335|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56441336|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56441337|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
56441338|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
56441339|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56441340|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56441341|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
56441342|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56441343|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56441344|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441345|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441346|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56441347|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56441348|NCT00267215|Analgesics|analgesics|mesh-ancestor
56441349|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
56441350|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441351|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441352|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441353|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441354|NCT00296049|Vancomycin|vancomycin|mesh-list
56441355|NCT00296049|Daptomycin|daptomycin|mesh-list
56441356|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56441357|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441358|NCT00267254|Atorvastatin|atorvastatin|mesh-list
56441359|NCT00267254|Simvastatin|simvastatin|mesh-list
56441360|NCT00267254|Torcetrapib|torcetrapib|mesh-list
56441361|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56441362|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56441363|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
56441364|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441365|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56441366|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56441367|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441368|NCT00301782|Carboplatin|carboplatin|mesh-list
56441370|NCT00301782|Vincristine|vincristine|mesh-list
56441371|NCT00301782|Bleomycin|bleomycin|mesh-list
56441372|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
56441373|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441374|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56441375|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56441376|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56441377|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441378|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441379|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
56441380|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
56441381|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
55827848|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56441384|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56441385|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441386|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56441387|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56913596|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56913597|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56441388|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56441389|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441390|NCT04718649|Celecoxib|celecoxib|mesh-list
56441391|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56441392|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56441393|NCT04718649|Analgesics|analgesics|mesh-ancestor
56441394|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
56441395|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441396|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441397|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441398|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441399|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56441400|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56441401|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441402|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441403|NCT00301860|Cyclosporine|cyclosporine|mesh-list
56441404|NCT00301860|Methotrexate|methotrexate|mesh-list
56441405|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
56441406|NCT00301860|Fludarabine|fludarabine|mesh-list
56441407|NCT00301860|Melphalan|melphalan|mesh-list
56441408|NCT00301860|Cyclosporins|cyclosporins|mesh-list
56441409|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56441410|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56441411|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
56441412|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56441413|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441414|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56441415|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
56441416|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441417|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441418|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
56441419|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441420|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56441421|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441422|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
56441423|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441424|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56441425|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
56441426|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441427|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56441428|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56441429|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
56441430|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56441431|NCT00301899|Trastuzumab|trastuzumab|mesh-list
56441432|NCT00301899|Pertuzumab|pertuzumab|mesh-list
56441433|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56441434|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441435|NCT00296127|Celecoxib|celecoxib|mesh-list
56441436|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56441437|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56441438|NCT00296127|Analgesics|analgesics|mesh-ancestor
56441439|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
56441440|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441441|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441442|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441443|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441444|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56441445|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56441446|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441447|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441448|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
56441449|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441450|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
56441451|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441452|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441453|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56441456|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441457|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56441458|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
56441459|NCT00267683|Glyburide|glyburide|mesh-list
56441460|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56913598|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
56913599|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913600|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441461|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441462|NCT00267722|Visilizumab|visilizumab|mesh-list
56441463|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
56441464|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441465|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56441466|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441467|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56441468|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441469|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441470|NCT00267917|Fenoterol|fenoterol|mesh-list
56441471|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
56441472|NCT00267917|Ipratropium|ipratropium|mesh-list
56441473|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56441474|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
56441475|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441476|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441477|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56441478|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
56441479|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
56441480|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
56441481|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56441482|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56441483|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56441484|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56441485|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
56441486|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441487|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441488|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56441489|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
56441490|NCT00296361|Tacrolimus|tacrolimus|mesh-list
56441491|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441492|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
56441493|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441494|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56441495|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441496|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441497|NCT00415922|Levodopa|levodopa|mesh-list
56441498|NCT00415922|Carbidopa|carbidopa|mesh-list
56441499|NCT00415922|Entacapone|entacapone|mesh-list
56441500|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56441501|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56441502|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56441503|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
56441504|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441505|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441506|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441507|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56441508|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441509|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56441510|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56441511|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
56441512|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
56441513|NCT00415961|Paclitaxel|paclitaxel|mesh-list
56441514|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56441515|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441516|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
56441517|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
56441518|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
56441519|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441520|NCT00416039|Midazolam|midazolam|mesh-list
56441521|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56441522|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56441523|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441524|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441525|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56441529|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
56441530|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
56441531|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
56913601|NCT01337674|Metoprolol|metoprolol|mesh-list
56913602|NCT01337674|Amlodipine|amlodipine|mesh-list
56441532|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
56441533|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441534|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441535|NCT00296478|Progesterone|progesterone|mesh-list
56441536|NCT00296478|Progestins|progestins|mesh-ancestor
56441537|NCT00296478|Hormones|hormones|mesh-ancestor
56441538|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56441539|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441540|NCT00268151|Capecitabine|capecitabine|mesh-list
56441541|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
56441542|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56441543|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
56441544|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441545|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441546|NCT00418080|Bicalutamide|bicalutamide|mesh-list
56441547|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
56441548|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56441549|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56441550|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441551|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441552|NCT00268229|Cytarabine|cytarabine|mesh-list
56441553|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
56441554|NCT00268229|Daunorubicin|daunorubicin|mesh-list
56441555|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56441556|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
56441557|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441558|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441559|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
56441560|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441561|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441562|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
56441563|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441564|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56441565|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441566|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56441567|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56441568|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56441569|NCT00302289|Caffeine|caffeine|mesh-list
56441570|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56441571|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441572|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56441573|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441574|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441575|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56441576|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56441577|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
56441578|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441579|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56441580|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56441581|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
56441582|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441583|NCT00296634|Antacids|antacids|mesh-ancestor
56441584|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164892|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56441585|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56441586|NCT00268619|Ramipril|ramipril|mesh-list
56441587|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56441588|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
56441589|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441590|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441591|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56441592|NCT00296712|Dexetimide|dexetimide|mesh-list
56441593|NCT00296712|Citalopram|citalopram|mesh-list
56441594|NCT00296712|Bupropion|bupropion|mesh-list
56441595|NCT00296712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56441596|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56441598|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441599|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441601|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441602|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56441603|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
56913603|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56913604|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56913605|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56155920|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441604|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56441605|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56441606|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56441607|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
56441608|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
56441609|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441610|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56441611|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56441612|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
56441613|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56441614|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
56441615|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56441616|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56441617|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441618|NCT00268697|Ezetimibe|ezetimibe|mesh-list
56441619|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56441620|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56441621|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
56441622|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441623|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56441624|NCT00296751|Fentanyl|fentanyl|mesh-list
56441625|NCT00296751|Meperidine|meperidine|mesh-list
56441626|NCT00296751|Bupivacaine|bupivacaine|mesh-list
56441627|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
56441628|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
56441629|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441630|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441631|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
56441632|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441633|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56441634|NCT00296751|Narcotics|narcotics|mesh-ancestor
56441635|NCT00296751|Analgesics|analgesics|mesh-ancestor
56441636|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56441637|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56441638|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
56441639|NCT00302367|Methylphenidate|methylphenidate|mesh-list
56441640|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56441641|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441642|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56441643|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56441644|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441645|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441646|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
56441647|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441648|NCT00296790|Zolpidem|zolpidem|mesh-list
56441649|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56441650|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56441651|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441652|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441653|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56441654|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
56441655|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
56441656|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441657|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441658|NCT00302406|Methylphenidate|methylphenidate|mesh-list
56441659|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56441660|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441661|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56441662|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56441663|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441664|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441665|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
56441666|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441667|NCT00268814|Methadone|methadone|mesh-list
56441669|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56441672|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913606|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913607|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56913608|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913609|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
56441673|NCT00268814|Analgesics|analgesics|mesh-ancestor
56441674|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
56441675|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441676|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
56441677|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
56441678|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
56441679|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56441680|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441681|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
56441682|NCT00296868|Vitamins|vitamins|mesh-ancestor
56189497|NCT01452243|Vitamin D|vitamin d|mesh-list
56441684|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441685|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
56441686|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441687|NCT00296868|Protective Agents|protective agents|mesh-ancestor
56441688|NCT00268970|Paclitaxel|paclitaxel|mesh-list
56441689|NCT00268970|Satraplatin|satraplatin|mesh-list
56441690|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56441691|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441692|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
56441693|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
56441694|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
56441695|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441696|NCT00296946|Bromides|bromides|mesh-list
56441697|NCT00296946|Ipratropium|ipratropium|mesh-list
56441698|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
56441699|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56441700|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
56441701|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441702|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441703|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56441704|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
56441705|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56441706|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
56441707|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441708|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441709|NCT00302523|Tacrolimus|tacrolimus|mesh-list
56441710|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441711|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
56441712|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441713|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56441714|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441715|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441716|NCT02960412|Furosemide|furosemide|mesh-list
56441717|NCT02960412|Diuretics|diuretics|mesh-ancestor
56441718|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
56441719|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441720|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56441721|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441722|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441723|NCT00269126|Fluticasone|fluticasone|mesh-list
56441725|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56441726|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56441727|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441728|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56441729|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
56441730|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441731|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441732|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56441733|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
56441734|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
56441735|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56441736|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56441737|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56441738|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56913610|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56913611|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
56441739|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
56441740|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441741|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441742|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
55831107|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
56441745|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
56441746|NCT00269204|Niacin|niacin|mesh-list
56441747|NCT00269204|Niacinamide|niacinamide|mesh-list
56441748|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
56441749|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56441750|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
56441751|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441752|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56441753|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
56441754|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
56441755|NCT00269204|Vitamins|vitamins|mesh-ancestor
56441756|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
56189572|NCT01456507|Naltrexone|naltrexone|mesh-list
56441757|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441758|NCT00297141|Capecitabine|capecitabine|mesh-list
56441759|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
56441760|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56441761|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
56441762|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441763|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441764|NCT00269243|Quinapril|quinapril|mesh-list
56441765|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56441766|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
56441767|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441768|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441769|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56441770|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56441771|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56441772|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441773|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441774|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
56441775|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441776|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
56441777|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
56441778|NCT00297219|Calcium|calcium|mesh-list
56441779|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56441780|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441781|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56441782|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56441783|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
56441784|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56441785|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441786|NCT00418353|Dexamethasone|dexamethasone|mesh-list
56441787|NCT00418353|Betamethasone|betamethasone|mesh-list
56441788|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
56441789|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56441790|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
56441791|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
56441792|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56441793|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441794|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
56441795|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
56441796|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441797|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441798|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56441799|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
56441800|NCT00418353|Hormones|hormones|mesh-ancestor
56441801|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56441802|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56441803|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441804|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56441805|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
56441806|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56441807|NCT00418392|Minocycline|minocycline|mesh-list
56441808|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56441809|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441810|NCT00269555|Genistein|genistein|mesh-list
56156132|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156133|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56156134|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
56156135|NCT02037048|Leucovorin|leucovorin|mesh-list
56156136|NCT02037048|Paclitaxel|paclitaxel|mesh-list
56156137|NCT02037048|Carboplatin|carboplatin|mesh-list
56156138|NCT02037048|Fluorouracil|fluorouracil|mesh-list
56156139|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
56156140|NCT02037048|Calcium|calcium|mesh-list
56156141|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
56156142|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56156143|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156144|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
56156145|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
56156146|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
56441811|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56441812|NCT00269555|Protective Agents|protective agents|mesh-ancestor
56441813|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441814|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441815|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56441816|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441818|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
56441819|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56441820|NCT00269555|Estrogens|estrogens|mesh-ancestor
56441821|NCT00269555|Hormones|hormones|mesh-ancestor
56441822|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56441823|NCT00418431|Bevacizumab|bevacizumab|mesh-list
56441824|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56441825|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441826|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56441827|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56441828|NCT00418431|Growth Substances|growth substances|mesh-ancestor
56441829|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441830|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
56441831|NCT00269594|Lamotrigine|lamotrigine|mesh-list
56441832|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
56441833|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56441834|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441835|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441836|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56441837|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441838|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56441839|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56441840|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441841|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56441842|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56441843|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56441844|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56441845|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441846|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
56441847|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56441848|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
56441849|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441850|NCT00302835|Analgesics|analgesics|mesh-list
56441851|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
56441852|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441853|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441854|NCT00269750|Oxybutynin|oxybutynin|mesh-list
56441855|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
56441856|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
56441857|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913612|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
56913613|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441858|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441859|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56441860|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56441861|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
56441862|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441863|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441864|NCT00269750|Urological Agents|urological agents|mesh-ancestor
56441865|NCT00269789|Methylphenidate|methylphenidate|mesh-list
56441866|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56441867|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441868|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56441869|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56441870|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441871|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441872|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
56441873|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441874|NCT00302913|Clopidogrel|clopidogrel|mesh-list
56164899|NCT04529538|Vaccines|vaccines|mesh-list
56441875|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56441876|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56441877|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56441878|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56441879|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
56441880|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441881|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441882|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441883|NCT00269828|Paclitaxel|paclitaxel|mesh-list
56441884|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56441885|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56441886|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56441889|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
56441890|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
56441891|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441892|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56441893|NCT00269867|Infliximab|infliximab|mesh-list
56441894|NCT00269867|Antibodies|antibodies|mesh-list
56441895|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
56441896|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56441897|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
56441898|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441899|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441900|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
56441901|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56441902|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441903|NCT00269906|Abciximab|abciximab|mesh-list
56441904|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
56441905|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56441906|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
56441907|NCT00269945|Hematinics|hematinics|mesh-ancestor
56441908|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
56441909|NCT00269984|Hematinics|hematinics|mesh-ancestor
56441910|NCT00297336|Topiramate|topiramate|mesh-list
56441911|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
56441912|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56441913|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441914|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
56441915|NCT00270023|Hematinics|hematinics|mesh-ancestor
56441916|NCT00297375|Acetaminophen|acetaminophen|mesh-list
56441917|NCT00297375|Tramadol|tramadol|mesh-list
56441918|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56441919|NCT00297375|Analgesics|analgesics|mesh-ancestor
56441920|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
56441921|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441922|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441923|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
56441924|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56441925|NCT00297375|Narcotics|narcotics|mesh-ancestor
56441926|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441927|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
56441928|NCT00270062|Hematinics|hematinics|mesh-ancestor
56441929|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
56441930|NCT00270101|Hematinics|hematinics|mesh-ancestor
56441931|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
56441932|NCT00270140|Hematinics|hematinics|mesh-ancestor
56913614|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56913615|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56156282|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
56441933|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
56441934|NCT00270179|Hematinics|hematinics|mesh-ancestor
56441935|NCT00297570|Interferons|interferons|mesh-list
56441936|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
56441937|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441938|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
56441939|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441940|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56441941|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441942|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441943|NCT00270335|Propofol|propofol|mesh-list
56441944|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56441945|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441946|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441947|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56441948|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
56441949|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
56441950|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56441951|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
56441952|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441953|NCT00270491|Paclitaxel|paclitaxel|mesh-list
56441954|NCT00270491|Capecitabine|capecitabine|mesh-list
56441956|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441957|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
56441958|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
56441959|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
56441960|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441961|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56441962|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
56441963|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
56441964|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
56441965|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56441966|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
56441971|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441972|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441973|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56441974|NCT00270530|Renal Agents|renal agents|mesh-ancestor
56441975|NCT00297765|Tacrolimus|tacrolimus|mesh-list
56441976|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56441977|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
56441978|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441979|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56441980|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441981|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441982|NCT00270569|Cisplatin|cisplatin|mesh-list
56441983|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441984|NCT00297804|Paclitaxel|paclitaxel|mesh-list
56441985|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56441986|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441987|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
56441988|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
56441989|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56441990|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441991|NCT00270647|Vitamins|vitamins|mesh-list
56441992|NCT00270647|Vitamin E|vitamin e|mesh-list
56441993|NCT00270647|Beta Carotene|beta carotene|mesh-list
56441994|NCT00270647|Carotenoids|carotenoids|mesh-list
56441995|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
56441996|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441997|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
56441998|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441999|NCT00270647|Protective Agents|protective agents|mesh-ancestor
56442000|NCT00270647|Provitamins|provitamins|mesh-ancestor
56442001|NCT00297960|Olanzapine|olanzapine|mesh-list
56442002|NCT00297960|Ziprasidone|ziprasidone|mesh-list
56442003|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
56442004|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
56442005|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442006|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442007|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442008|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56913616|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56913617|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
56156361|NCT02448654|Tolcapone|tolcapone|mesh-list
56442009|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56442010|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442011|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56442012|NCT00297960|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56442013|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56442014|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56442015|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442016|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442017|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
56442018|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56442019|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56442020|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
56442021|NCT00270881|Cytarabine|cytarabine|mesh-list
56442022|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
56442023|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56442024|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
56442025|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442026|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56442027|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56442028|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
56442029|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442030|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442031|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56442032|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56442033|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
56442034|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
56442035|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442037|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56442038|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442039|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442042|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442043|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442044|NCT00418548|Etanercept|etanercept|mesh-list
56442045|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56442046|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56442047|NCT00418548|Analgesics|analgesics|mesh-ancestor
56442048|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
56442049|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442050|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442051|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442052|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56442053|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442054|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56442055|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
56442056|NCT00418587|Vitamin D|vitamin d|mesh-list
56442057|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
56442058|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
56442059|NCT00418587|Vitamins|vitamins|mesh-list
56442060|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
56442061|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442062|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56442063|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56442064|NCT00416273|Bortezomib|bortezomib|mesh-list
56442065|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442066|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
56442067|NCT00306462|Nifedipine|nifedipine|mesh-list
56442068|NCT00306462|Analgesics|analgesics|mesh-ancestor
56442069|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
56442070|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442071|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442072|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
56442073|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442074|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56442075|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
56442076|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56442077|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56442078|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442079|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56442080|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
56913618|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913619|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
56913620|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56913621|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
56913622|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56913623|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
56442081|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56442082|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
56442083|NCT00416390|Lycopene|lycopene|mesh-list
56442084|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442085|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
56442086|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442087|NCT00416390|Protective Agents|protective agents|mesh-ancestor
56442088|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442089|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56442090|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56442091|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442092|NCT00416429|Interferons|interferons|mesh-list
56442093|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
56442094|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
56442095|NCT00416429|Aldesleukin|aldesleukin|mesh-list
56442096|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56442097|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
56442098|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442099|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
56442100|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442101|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
56442102|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442103|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56442104|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56442105|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56442106|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56442107|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56442108|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
56442109|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56442110|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56442111|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56442112|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56442113|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56442119|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442120|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442121|NCT00271271|Gemcitabine|gemcitabine|mesh-list
56442122|NCT00271271|Vinorelbine|vinorelbine|mesh-list
56442123|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
56442124|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56442125|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
56442126|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442127|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442128|NCT00271271|Antiviral Agents|antiviral agents|mesh-ancestor
56442129|NCT00271271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442130|NCT00271271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442131|NCT00271271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56442132|NCT00271271|Immunologic Factors|immunologic factors|mesh-ancestor
56442133|NCT00271271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442134|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56442135|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
56442136|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
56442137|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
56442138|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
56442139|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442140|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
56442141|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
56442142|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
56442143|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442144|NCT00271349|Budesonide|budesonide|mesh-list
56442145|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442146|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442147|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
56442148|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442149|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156498|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
56442150|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442151|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442152|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
56442153|NCT00271349|Hormones|hormones|mesh-ancestor
56442154|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442155|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
56442156|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56442157|NCT00306696|Spironolactone|spironolactone|mesh-list
56442158|NCT00306696|Furosemide|furosemide|mesh-list
56442159|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56442160|NCT00306696|Diuretics|diuretics|mesh-ancestor
56442161|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
56442162|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442163|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56442164|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56442165|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442166|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56442167|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
56442168|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442169|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56442170|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56442171|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56442172|NCT00271427|Selenium|selenium|mesh-list
56442173|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
56442174|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442175|NCT00271427|Protective Agents|protective agents|mesh-ancestor
56442176|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442177|NCT00271427|Trace Elements|trace elements|mesh-ancestor
56442178|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
56442179|NCT00271466|Fentanyl|fentanyl|mesh-list
56442180|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56442181|NCT00271466|Narcotics|narcotics|mesh-ancestor
56442182|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442183|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442185|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
56442186|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442187|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56442188|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56442189|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
56442190|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
56442191|NCT00306735|Palonosetron|palonosetron|mesh-list
56442192|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
56442193|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
56442194|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442195|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442196|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442197|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56442198|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56442199|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
56442200|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442201|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442202|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
56442203|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56442204|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
56442205|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56442206|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442207|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56442208|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56442209|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56442212|NCT00306774|Vitamins|vitamins|mesh-ancestor
56442213|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
56442214|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442215|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56442216|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56442217|NCT00306813|Lenalidomide|lenalidomide|mesh-list
56442218|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
56442219|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442220|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56442221|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56442222|NCT00306813|Growth Substances|growth substances|mesh-ancestor
56442223|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
56442224|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442225|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
56913624|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913625|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442226|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56442227|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442228|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56442229|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442230|NCT00271973|Oxycodone|oxycodone|mesh-list
56442231|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56442232|NCT00271973|Narcotics|narcotics|mesh-ancestor
56442233|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442234|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442235|NCT00271973|Analgesics|analgesics|mesh-ancestor
56442236|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
56442237|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442238|NCT00306969|Bexarotene|bexarotene|mesh-list
56442239|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442240|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
56442241|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56442242|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442243|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56442244|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
56442245|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442246|NCT00272051|Xaliproden|xaliproden|mesh-list
56442247|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56442248|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56442249|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
56442250|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442251|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442252|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442253|NCT00307203|Bupropion|bupropion|mesh-list
56442254|NCT00307203|Nicotine|nicotine|mesh-list
56442255|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56442256|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
56442257|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442258|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442262|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442263|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442264|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56442265|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
56442267|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56442268|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56442269|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56442270|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
56442271|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56442272|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56442273|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442274|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
56442275|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56442276|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442277|NCT00272207|Nabilone|nabilone|mesh-list
56442278|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
56442279|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
56442280|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442281|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442282|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442283|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56442284|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56442285|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442286|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56442287|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56442288|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
56442289|NCT00307515|Coagulants|coagulants|mesh-ancestor
56442290|NCT00272285|Granisetron|granisetron|mesh-list
56442291|NCT00272285|Ramosetron|ramosetron|mesh-list
56442292|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
56442293|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
56442294|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442295|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442296|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442297|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56442298|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
56442299|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913626|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
56442300|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442301|NCT00272324|Aspirin|aspirin|mesh-list
56442302|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56442303|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56442304|NCT00272324|Analgesics|analgesics|mesh-ancestor
56442305|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
56442306|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442307|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442308|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442309|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56442310|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56442311|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56442312|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442313|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56442314|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56442315|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442316|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
56442317|NCT00307593|Rituximab|rituximab|mesh-list
56442318|NCT00307593|Infliximab|infliximab|mesh-list
56442319|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56442320|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442321|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
56442322|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442323|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56442324|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
56442325|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442326|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56442328|NCT00307632|Estrogens|estrogens|mesh-ancestor
56442329|NCT00307632|Hormones|hormones|mesh-ancestor
56442330|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442331|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442333|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
56442334|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56442335|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56442336|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56442337|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56442338|NCT00272480|Lamivudine|lamivudine|mesh-list
56442339|NCT00272480|Zidovudine|zidovudine|mesh-list
56442340|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56442341|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56442342|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442343|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442344|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
56442345|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442346|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56442347|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56442348|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
56442349|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
56442350|NCT00307671|Prednisone|prednisone|mesh-list
56442351|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
56442352|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56442353|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56442354|NCT00307671|Prednisolone|prednisolone|mesh-list
56442355|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
56442356|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
56442357|NCT00307671|Methotrexate|methotrexate|mesh-list
56442358|NCT00307671|Azathioprine|azathioprine|mesh-list
56442359|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56442360|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
56442361|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56442362|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
56442363|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442364|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56442365|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56442366|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
56442367|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442368|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442369|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56442370|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442371|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
56442372|NCT00307671|Hormones|hormones|mesh-ancestor
56442373|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442374|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56096792|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
56913627|NCT02233582|Ibuprofen|ibuprofen|mesh-list
56913628|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56156720|NCT02538354|Vitamins|vitamins|mesh-ancestor
56442375|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56442376|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
56442377|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56442378|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56442379|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
56442380|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
56442381|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442382|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56442383|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56442384|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56442385|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56442386|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
56442387|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56442388|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442389|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
56442390|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
56442391|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442392|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442393|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56442394|NCT00307671|Protective Agents|protective agents|mesh-ancestor
56442395|NCT00272558|Carboplatin|carboplatin|mesh-list
56442396|NCT00272558|Vinorelbine|vinorelbine|mesh-list
56442397|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442398|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56442399|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
56442400|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
56442402|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442403|NCT00272597|Risperidone|risperidone|mesh-list
56442404|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56442405|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
56442406|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833765|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
56442410|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56442411|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442412|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56442413|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56442414|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
56442415|NCT00272636|Amiodarone|amiodarone|mesh-list
56442416|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56442417|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
56442418|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56442419|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56442420|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442421|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56442422|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56442423|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56442424|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442425|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56442426|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56442427|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56442428|NCT00281970|Docetaxel|docetaxel|mesh-list
56442429|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442430|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
56442431|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
56442432|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
56442433|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442434|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
56442435|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56442436|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56442437|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442438|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
56442439|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
56442440|NCT00307827|Visilizumab|visilizumab|mesh-list
56442441|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
56442442|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442443|NCT00272714|Afimoxifene|afimoxifene|mesh-list
56442444|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442445|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56442446|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
56096905|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
56913629|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56913630|NCT02233582|Analgesics|analgesics|mesh-ancestor
56156805|NCT02560038|Paclitaxel|paclitaxel|mesh-list
56442447|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442448|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442449|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56442450|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56442451|NCT00272753|Budesonide|budesonide|mesh-list
56442452|NCT00272753|Albuterol|albuterol|mesh-list
56442453|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
56442454|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442455|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442456|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
56442457|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442458|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442459|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442460|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442461|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
56442462|NCT00272753|Hormones|hormones|mesh-ancestor
56442463|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442464|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56442465|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56442466|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56442467|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
56442468|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442469|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442470|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
56442471|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56442472|NCT00272831|Cilostazol|cilostazol|mesh-list
56442473|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442474|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
56442475|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442476|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442479|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56442480|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56442481|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442482|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56442483|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
56442484|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56442485|NCT00272831|Protective Agents|protective agents|mesh-ancestor
56442486|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56442487|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56442488|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442489|NCT00416468|Valsartan|valsartan|mesh-list
56442490|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56442491|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56442492|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56442493|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442494|NCT00307944|Pantoprazole|pantoprazole|mesh-list
56442495|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56442496|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442497|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56442498|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442499|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442500|NCT00416507|Gemcitabine|gemcitabine|mesh-list
56442501|NCT00416507|Fluorouracil|fluorouracil|mesh-list
56442502|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442503|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56442504|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
56442505|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442506|NCT00416507|Antiviral Agents|antiviral agents|mesh-ancestor
56442507|NCT00416507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442508|NCT00416507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442509|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56442510|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
56442511|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442512|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
56442513|NCT00282126|Diuretics|diuretics|mesh-ancestor
56442514|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
56442515|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442516|NCT00282126|Expectorants|expectorants|mesh-ancestor
56097046|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
56913631|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
56913632|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913633|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442517|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442518|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56442519|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442520|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442521|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442522|NCT00272909|Piclozotan|piclozotan|mesh-list
56442523|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56442524|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56442525|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
56442526|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442527|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442528|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442529|NCT00282165|Naratriptan|naratriptan|mesh-list
56442530|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56442531|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56442532|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56442533|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
56442534|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442535|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442536|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442537|NCT00272948|Defibrotide|defibrotide|mesh-list
56442538|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56442539|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56442540|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442541|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56442542|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56442543|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
56442544|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
56442545|NCT00273026|Fluticasone|fluticasone|mesh-list
56442547|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56442548|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442550|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
56442551|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442552|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442553|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442554|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442555|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
56442556|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56442557|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56442558|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56442559|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56442560|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
56442561|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442562|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442563|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56442564|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442565|NCT00282360|Trimetazidine|trimetazidine|mesh-list
56442566|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
56442567|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
56442568|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56442569|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56442570|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442571|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442572|NCT00418704|Docetaxel|docetaxel|mesh-list
56442573|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56442574|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442575|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
56442576|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
56442577|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
56442578|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442579|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56442580|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442581|NCT00313950|Vaccines|vaccines|mesh-list
56442582|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
56442583|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190412|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
56442584|NCT00273299|Valsartan|valsartan|mesh-list
56442585|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56913634|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56913635|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56913636|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56442586|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56442587|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56442588|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56442589|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442590|NCT00273299|Diuretics|diuretics|mesh-ancestor
56442591|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
56442592|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442593|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56442594|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56442595|NCT00418782|Naproxen|naproxen|mesh-list
56442596|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56442597|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56442598|NCT00418782|Analgesics|analgesics|mesh-ancestor
56442599|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
56442600|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442601|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442602|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442603|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56442604|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
56442605|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56442606|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442607|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442608|NCT00273338|Calcitriol|calcitriol|mesh-list
56442609|NCT00273338|Docetaxel|docetaxel|mesh-list
56442610|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442611|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
56442612|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
56442613|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
56442614|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442615|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56442616|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164911|NCT04521114|Immunologic Factors|immunologic factors|mesh-ancestor
56442617|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56442618|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56442619|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56442622|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56442624|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442625|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
56442626|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
56442627|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442628|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442629|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442630|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
56442631|NCT00273377|Hormones|hormones|mesh-ancestor
56442632|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442633|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56442634|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442635|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
56442636|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
56442637|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56442638|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56442639|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442640|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442641|NCT00273416|Urological Agents|urological agents|mesh-ancestor
56442642|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56442643|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
56442644|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56442645|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56442646|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56442647|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442648|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442649|NCT00273455|Timolol|timolol|mesh-list
56442650|NCT00273455|Bimatoprost|bimatoprost|mesh-list
56442651|NCT00273455|Dorzolamide|dorzolamide|mesh-list
56442652|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442653|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442654|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56157018|NCT02056236|Midazolam|midazolam|mesh-list
56442655|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56442656|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
56442657|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442658|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442659|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56442660|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56442661|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56442662|NCT00273533|Ramipril|ramipril|mesh-list
56442663|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56442664|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
56442665|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442666|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442667|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56442668|NCT00273611|Vitamin D|vitamin d|mesh-list
56442669|NCT00273611|Vitamins|vitamins|mesh-ancestor
56442670|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
56442671|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442672|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56442673|NCT00273689|Albuterol|albuterol|mesh-list
56442674|NCT00273689|Montelukast|montelukast|mesh-list
56442675|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442676|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442677|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56442678|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
56442679|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442680|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442681|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56442682|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56442683|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442684|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442685|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
56442686|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442687|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
56442688|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56442689|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56442690|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56442691|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56442695|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
56442696|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
56442697|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442698|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442699|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442700|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56442701|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
56442702|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442703|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442704|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
56442705|NCT00273767|Hematinics|hematinics|mesh-ancestor
56442706|NCT00314379|Vitamin E|vitamin e|mesh-list
56442707|NCT00314379|Vitamins|vitamins|mesh-ancestor
56442708|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
56442709|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442710|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
56442711|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442712|NCT00314379|Protective Agents|protective agents|mesh-ancestor
56442713|NCT00273884|Cytarabine|cytarabine|mesh-list
56442714|NCT00273884|Amonafide|amonafide|mesh-list
56442715|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56442716|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
56442717|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442718|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442719|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
56442720|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442721|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56442722|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
56442723|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442724|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442725|NCT00308373|Metformin|metformin|mesh-list
56442726|NCT00308373|Pioglitazone|pioglitazone|mesh-list
56442727|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56442728|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190552|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
56442729|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442730|NCT00273962|Albuterol|albuterol|mesh-list
56442731|NCT00273962|Ipratropium|ipratropium|mesh-list
56913637|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157094|NCT03560466|Prednisolone|prednisolone|mesh-list
56442732|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442733|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
56442735|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442736|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442737|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442738|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
56442739|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56442740|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56442741|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56442742|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56442743|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
56442744|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442745|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442746|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56442747|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
56442748|NCT00274001|Nevirapine|nevirapine|mesh-list
56442749|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56442750|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56442751|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442752|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442753|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
56442754|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442755|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56442756|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56442757|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56442758|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56442759|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
56442760|NCT00274040|Ipratropium|ipratropium|mesh-list
56442761|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442762|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
56442763|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442764|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442765|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442768|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56442769|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
56442770|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442771|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442773|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
56442774|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
56442775|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442776|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442777|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
56442778|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442779|NCT00308451|Chromium|chromium|mesh-list
56442780|NCT00308451|Biotin|biotin|mesh-list
56442781|NCT00308451|Picolinic acid|picolinic acid|mesh-list
56442782|NCT00308451|Trace Elements|trace elements|mesh-ancestor
56442783|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
56442784|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442785|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
56442786|NCT00308451|Vitamins|vitamins|mesh-ancestor
56442787|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56442788|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
56442789|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
56442790|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442791|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
56442792|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442793|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
56442794|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442795|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442796|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442797|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442798|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
56442799|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56442800|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
56442801|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442802|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442803|NCT00274118|Telmisartan|telmisartan|mesh-list
56442804|NCT00274118|Enalapril|enalapril|mesh-list
56442805|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56442806|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56097047|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
56157163|NCT05731986|Immunologic Factors|immunologic factors|mesh-ancestor
56442807|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56442808|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442809|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56442810|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
56442811|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442812|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56442813|NCT00308490|Hematinics|hematinics|mesh-ancestor
56442814|NCT00416585|Isotretinoin|isotretinoin|mesh-list
56442815|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
56442816|NCT00308529|Bevacizumab|bevacizumab|mesh-list
56442817|NCT00308529|Carboplatin|carboplatin|mesh-list
56442818|NCT00308529|Irinotecan|irinotecan|mesh-list
56442819|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56442820|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442821|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56442822|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56442823|NCT00308529|Growth Substances|growth substances|mesh-ancestor
56442824|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442825|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
56442826|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56442827|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56442828|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442829|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442830|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
56442831|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
56442832|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56442833|NCT00274235|Mefloquine|mefloquine|mesh-list
56442834|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
56442835|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56442836|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56442837|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442838|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56442839|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442840|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442845|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
56442846|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
56442847|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56442848|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442849|NCT00308607|Interferons|interferons|mesh-list
56442850|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
56442851|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
56442852|NCT00308607|Bevacizumab|bevacizumab|mesh-list
56442853|NCT00308607|Dacarbazine|dacarbazine|mesh-list
56442854|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56442855|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442856|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56442857|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56442858|NCT00308607|Growth Substances|growth substances|mesh-ancestor
56442859|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442860|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
56442861|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
56442862|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442863|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
56442864|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56442865|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
56442866|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442867|NCT00314613|Risperidone|risperidone|mesh-list
56442868|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
56442869|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56442870|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
56442871|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442872|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442873|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442874|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56442875|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442876|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56442877|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56442878|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
56442879|NCT00274352|Adalimumab|adalimumab|mesh-list
56442880|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442881|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56190709|NCT01469988|Hormones|hormones|mesh-ancestor
56442882|NCT00314652|Buprenorphine|buprenorphine|mesh-list
56442883|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56442884|NCT00314652|Narcotics|narcotics|mesh-ancestor
56157235|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157236|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56442885|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442886|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442887|NCT00314652|Analgesics|analgesics|mesh-ancestor
56442888|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
56442889|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442890|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56442891|NCT00274391|Amiloride|amiloride|mesh-list
56442892|NCT00274391|Diuretics|diuretics|mesh-ancestor
56442893|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
56442894|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442895|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56442896|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56442897|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56442898|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442899|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56442900|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56442901|NCT00274430|Dexamethasone|dexamethasone|mesh-list
56442902|NCT00274430|Tadalafil|tadalafil|mesh-list
56442903|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442904|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
56442905|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
56442906|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442907|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442908|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442909|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
56442910|NCT00274430|Hormones|hormones|mesh-ancestor
56442911|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442912|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56442913|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442914|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
56442916|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56442917|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442918|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442919|NCT00274430|Urological Agents|urological agents|mesh-ancestor
56442920|NCT00274508|Bromides|bromides|mesh-list
56442921|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
56442922|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442923|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
56442924|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442925|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442926|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442927|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442928|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
56442929|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56442930|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
56442931|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442932|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442933|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
56442934|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
56442935|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442936|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
56442937|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442938|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442939|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442940|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442941|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
56442942|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56442943|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
56442944|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442945|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442946|NCT00308763|Bupropion|bupropion|mesh-list
56442947|NCT00308763|Nicotine|nicotine|mesh-list
56442948|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56442949|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
56442950|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442951|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442952|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56442953|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56442954|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
56157311|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442955|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442956|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442957|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56442958|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
56442959|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56442960|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56442961|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56442962|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56442963|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
56442964|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56442965|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56442966|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56442967|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56442968|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56442969|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
56442970|NCT00274820|Thalidomide|thalidomide|mesh-list
56442971|NCT00274820|Dexamethasone|dexamethasone|mesh-list
56442972|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
56442973|NCT00274820|Vitamins|vitamins|mesh-ancestor
56442974|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
56442975|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442976|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56442977|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
56442978|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
56442979|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56442980|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56442981|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
56442982|NCT00274820|Hormones|hormones|mesh-ancestor
56442983|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56442984|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56442985|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56442986|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
56442987|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442991|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
56442992|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56442993|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56442994|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56442995|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56442996|NCT00274820|Growth Substances|growth substances|mesh-ancestor
56442997|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
56442998|NCT00308841|Lidocaine|lidocaine|mesh-list
56442999|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
56443000|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
56443001|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56443002|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443003|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
56443004|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443005|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56443006|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56443007|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56443008|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56443009|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443010|NCT00274859|Gemcitabine|gemcitabine|mesh-list
56443011|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
56443012|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56443013|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
56443014|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443015|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443016|NCT00274859|Antiviral Agents|antiviral agents|mesh-ancestor
56443017|NCT00274859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443018|NCT00274859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443019|NCT00274859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443020|NCT00274859|Immunologic Factors|immunologic factors|mesh-ancestor
56443021|NCT00274859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443022|NCT00274898|Celecoxib|celecoxib|mesh-list
56443023|NCT00274898|Docetaxel|docetaxel|mesh-list
56443024|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443025|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
56443026|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
56443027|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
56443028|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097147|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157388|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56443029|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56443030|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56443031|NCT00274898|Analgesics|analgesics|mesh-ancestor
56443032|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
56443033|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443034|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443035|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443036|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443037|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56443038|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56443039|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443040|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
56443041|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56443042|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56443043|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443045|NCT00308880|Coagulants|coagulants|mesh-ancestor
56443046|NCT00277199|Abatacept|abatacept|mesh-list
56443047|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56443048|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443049|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443050|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443051|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
56443052|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443053|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443054|NCT00277472|Valsartan|valsartan|mesh-list
56443055|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56443056|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56443057|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56443058|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56443059|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443061|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
56443062|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443063|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56443064|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56443066|NCT00277511|Ofloxacin|ofloxacin|mesh-list
56443067|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56443068|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443069|NCT00277511|Renal Agents|renal agents|mesh-ancestor
56443070|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56443071|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443072|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443073|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443074|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443075|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443076|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56443077|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56443078|NCT00315003|Azithromycin|azithromycin|mesh-list
56443079|NCT00315003|Telithromycin|telithromycin|mesh-list
56443080|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56443081|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443082|NCT00277550|Tegaserod|tegaserod|mesh-list
56443083|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56443084|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
56443085|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443086|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443087|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443088|NCT00277589|Iodine|iodine|mesh-list
56443089|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56443090|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443091|NCT00277589|Trace Elements|trace elements|mesh-ancestor
56443092|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
56443093|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443094|NCT00315042|Penicillins|penicillins|mesh-list
56443095|NCT00315042|Telithromycin|telithromycin|mesh-list
56443096|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56443097|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443098|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56443099|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
56443100|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56443101|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56443102|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56443103|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56097213|NCT00002354|Indinavir|indinavir|mesh-list
56913638|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913639|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
56913640|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56913641|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56443104|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443105|NCT00315081|Bromocriptine|bromocriptine|mesh-list
56443106|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56443107|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56443108|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
56443109|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56443110|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443111|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
56443112|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
56443113|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443114|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443116|NCT00277706|Calcium|calcium|mesh-list
56443117|NCT00277706|Vitamins|vitamins|mesh-ancestor
56443118|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
56443119|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443120|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56443121|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56443122|NCT00277862|Ribavirin|ribavirin|mesh-list
56443123|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
56443124|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
56443125|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56443126|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56443127|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
56443128|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443129|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
56443130|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443131|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
56443132|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443133|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443134|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
55835408|NCT01807221|Diuretics|diuretics|mesh-ancestor
56443136|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443137|NCT00315276|Modafinil|modafinil|mesh-list
56443138|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56443139|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443140|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56443141|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56443142|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56443143|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443144|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
56443145|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56443146|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443147|NCT00278174|Interferons|interferons|mesh-list
56443148|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
56443149|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56443150|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443151|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
56443152|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443153|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
56443154|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443155|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
56443156|NCT00278213|Fludarabine|fludarabine|mesh-list
56443157|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
56443158|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
56443159|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
56443160|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443161|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
56443162|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443163|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443164|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56443165|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
56443166|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443167|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443168|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56443169|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56443170|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
56443171|NCT00278213|Analgesics|analgesics|mesh-ancestor
56443172|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
56157530|NCT05150652|Tamoxifen|tamoxifen|mesh-list
56443173|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443174|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443175|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443176|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443177|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56443178|NCT00278252|Etoposide|etoposide|mesh-list
56443179|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56443180|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443181|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443182|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443183|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443184|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443185|NCT00315432|Interferons|interferons|mesh-list
56443186|NCT00315432|Ribavirin|ribavirin|mesh-list
56443187|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443188|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
56443189|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443190|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
56443191|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443192|NCT00278330|Vorinostat|vorinostat|mesh-list
56443193|NCT00278330|Alvocidib|alvocidib|mesh-list
56443194|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443195|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56443196|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443197|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443198|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
56443199|NCT00278330|Growth Substances|growth substances|mesh-ancestor
56443200|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443201|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56443202|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56443203|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56443204|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56443205|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
56443206|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443207|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55943927|NCT04037241|Leucovorin|leucovorin|mesh-list
56443210|NCT00278369|Aldesleukin|aldesleukin|mesh-list
56443211|NCT00278369|Interleukin-2|interleukin-2|mesh-list
56443212|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
56443213|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443214|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56443215|NCT00278369|Analgesics|analgesics|mesh-ancestor
56443216|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
56443217|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443218|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443219|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56443220|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56443221|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
56443222|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443223|NCT00315549|Penicillins|penicillins|mesh-list
56443224|NCT00315549|Telithromycin|telithromycin|mesh-list
56443225|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56443226|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443227|NCT00278408|Prednisone|prednisone|mesh-list
56443228|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
56443229|NCT00278408|Rituximab|rituximab|mesh-list
56443230|NCT00278408|Doxorubicin|doxorubicin|mesh-list
56443231|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56443232|NCT00278408|Vincristine|vincristine|mesh-list
56443233|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443234|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
56443235|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443236|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443237|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56443238|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
56443239|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443240|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443241|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56443242|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56443243|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56443244|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443245|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443246|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443247|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443248|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
56443249|NCT00278408|Hormones|hormones|mesh-ancestor
56913642|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56913643|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56443250|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56443251|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56443252|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56443253|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56443254|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56443255|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56443256|NCT00315666|Memantine|memantine|mesh-list
56443257|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56443258|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56191076|NCT01472029|Vitamins|vitamins|mesh-ancestor
56443259|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
56443260|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443261|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443262|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443263|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56443264|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56443265|NCT00315744|Fluticasone|fluticasone|mesh-list
56443267|NCT00315744|Albuterol|albuterol|mesh-list
56443268|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56443269|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443270|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56443271|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
56443272|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443273|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443274|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56443275|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
56443276|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56443277|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56443278|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56443279|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56443280|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56443281|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
56443282|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443285|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56443287|NCT00309543|Fluorouracil|fluorouracil|mesh-list
56443288|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
56443289|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443290|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56443291|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443292|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443293|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
56443294|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443295|NCT00309543|Antidotes|antidotes|mesh-ancestor
56443296|NCT00309543|Protective Agents|protective agents|mesh-ancestor
56443297|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
56443298|NCT00309543|Vitamins|vitamins|mesh-ancestor
56443299|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
56443300|NCT00309621|Alitretinoin|alitretinoin|mesh-list
56443301|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443302|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
56443303|NCT00315861|Pemetrexed|pemetrexed|mesh-list
56443304|NCT00315861|Topotecan|topotecan|mesh-list
56443305|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443306|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443307|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443308|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56443309|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56443310|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56443311|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443312|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
56443313|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56443314|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443315|NCT00315900|Valproic Acid|valproic acid|mesh-list
56443316|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56443317|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
56443318|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56443319|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56443320|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56443321|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56443322|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443323|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
56443324|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443325|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443326|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
56443327|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443328|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
56443329|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56443330|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
56443331|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443332|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56443333|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56443334|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
56443335|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56443336|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56443338|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56443339|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443340|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56443341|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56443342|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
56443343|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443344|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443345|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56443346|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56443347|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
56443348|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
56443349|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
56443350|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56443351|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56443352|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443353|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443354|NCT00309816|Urological Agents|urological agents|mesh-ancestor
56443355|NCT00279266|Thiamine|thiamine|mesh-list
56443356|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
56443358|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
56443359|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443360|NCT00316095|Telmisartan|telmisartan|mesh-list
56443361|NCT00316095|Simvastatin|simvastatin|mesh-list
56443362|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56443363|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56443364|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
56443365|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443366|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56443367|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56443368|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443369|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56443370|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56443371|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56443372|NCT00279344|Fentanyl|fentanyl|mesh-list
56443373|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56443374|NCT00279344|Narcotics|narcotics|mesh-ancestor
56443375|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56443376|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443377|NCT00279344|Analgesics|analgesics|mesh-ancestor
56443378|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
56443379|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443380|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56443381|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56443382|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
56443383|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
56443384|NCT00418860|Aspirin|aspirin|mesh-list
56443385|NCT00418860|Clopidogrel|clopidogrel|mesh-list
56443386|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56443387|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56443388|NCT00418860|Analgesics|analgesics|mesh-ancestor
56443389|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
56443390|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443391|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443392|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443393|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443394|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56443395|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56443396|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443397|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56443398|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56443399|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443400|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
56913644|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913645|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
56913646|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443401|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56443402|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56443403|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56443404|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
56443405|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443406|NCT00316212|INS 50589|ins 50589|mesh-list
56443407|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56443408|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56443409|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
56443410|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443411|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443412|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443414|NCT00309855|Testosterone|testosterone|mesh-list
56443415|NCT00309855|Dutasteride|dutasteride|mesh-list
56443416|NCT00309855|Androgens|androgens|mesh-ancestor
56443417|NCT00309855|Hormones|hormones|mesh-ancestor
56443418|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56443419|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443420|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56443421|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443422|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56443423|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56443424|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443425|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443426|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
56443427|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56443428|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56443429|NCT00279383|Thrombin|thrombin|mesh-list
56443430|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
56443431|NCT00279383|Coagulants|coagulants|mesh-ancestor
56443432|NCT00279422|Visilizumab|visilizumab|mesh-list
56443435|NCT00309894|Ketoconazole|ketoconazole|mesh-list
56443436|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
56443437|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56443438|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56443439|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56443440|NCT00309894|Sargramostim|sargramostim|mesh-list
56443441|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443442|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
56443443|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443444|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
56443445|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443446|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56443447|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56443448|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443449|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443450|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56443451|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
56443452|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56443453|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56443454|NCT00279461|Vitamin D|vitamin d|mesh-list
56443455|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
56443456|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
56443457|NCT00279461|Vitamins|vitamins|mesh-list
56443458|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
56443459|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443460|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56443461|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56443462|NCT00316329|Artesunate|artesunate|mesh-list
56443463|NCT00316329|Amodiaquine|amodiaquine|mesh-list
56443464|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
56443465|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56443466|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56443467|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443468|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443469|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
56443470|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
56443471|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56443472|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
56913647|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443473|NCT00279539|Mitogens|mitogens|mesh-list
56443474|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
56443475|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
56443476|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443477|NCT00279539|Growth Substances|growth substances|mesh-ancestor
56443478|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443479|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
56443480|NCT00279578|Factor VIII|factor viii|mesh-list
56443481|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56443482|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56443483|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443484|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
56443485|NCT00279578|Coagulants|coagulants|mesh-ancestor
56443486|NCT00279617|Levetiracetam|levetiracetam|mesh-list
56443487|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
56443488|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
56443489|NCT00310011|Gemcitabine|gemcitabine|mesh-list
56443490|NCT00310011|Paclitaxel|paclitaxel|mesh-list
56443491|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56443492|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443493|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
56443494|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
56443495|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
56443496|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443497|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56443498|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
56443499|NCT00310011|Antiviral Agents|antiviral agents|mesh-ancestor
56443500|NCT00310011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443501|NCT00310011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443502|NCT00310011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443503|NCT00310011|Immunologic Factors|immunologic factors|mesh-ancestor
56443504|NCT00310011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443505|NCT00316407|Paclitaxel|paclitaxel|mesh-list
56443506|NCT00316407|Carboplatin|carboplatin|mesh-list
56443507|NCT00316407|Lapatinib|lapatinib|mesh-list
56443510|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
56443511|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
56443512|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
56443513|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443514|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56443515|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443516|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
56443517|NCT00310089|Docetaxel|docetaxel|mesh-list
56443518|NCT00310089|Doxorubicin|doxorubicin|mesh-list
56443519|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56443520|NCT00310089|Cediranib|cediranib|mesh-list
56443521|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443522|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
56443523|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443524|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443525|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56443526|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
56443527|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443528|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443529|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56443530|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
56443531|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
56443532|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
56443533|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56443534|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443535|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443536|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443537|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56443538|NCT00279734|Abatacept|abatacept|mesh-list
56443539|NCT00279734|Vaccines|vaccines|mesh-list
56443540|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
56443541|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443542|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56443543|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443544|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443545|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443546|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443547|NCT00310128|Cytarabine|cytarabine|mesh-list
56443548|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
56443549|NCT00310128|Rituximab|rituximab|mesh-list
56443550|NCT00310128|Etoposide|etoposide|mesh-list
56913648|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56157897|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56443551|NCT00310128|Antibodies|antibodies|mesh-list
56443552|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
56443553|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56443554|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
56443555|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443556|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56443557|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443558|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443559|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56443560|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443561|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443562|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191382|NCT01474902|Enoxaparin|enoxaparin|mesh-list
56443563|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443564|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56443565|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
56443566|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
56443567|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443568|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443569|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443570|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
56443571|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
56443572|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443573|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56443574|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
56443575|NCT00310128|Hormones|hormones|mesh-ancestor
56443576|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56443577|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56443578|NCT00310128|Protective Agents|protective agents|mesh-ancestor
56443579|NCT00316563|Dronabinol|dronabinol|mesh-list
56443580|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
56443581|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443583|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56443585|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
56443586|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443587|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56443588|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56443589|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443590|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443592|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56443593|NCT00416819|Leucovorin|leucovorin|mesh-list
56443594|NCT00416819|Cytarabine|cytarabine|mesh-list
56443595|NCT00416819|Rituximab|rituximab|mesh-list
56443596|NCT00416819|Methotrexate|methotrexate|mesh-list
56443597|NCT00416819|Etoposide|etoposide|mesh-list
56443598|NCT00416819|Temozolomide|temozolomide|mesh-list
56443599|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
56443600|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
56443601|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56443602|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443603|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
56443604|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443605|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443606|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56443607|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
56443608|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56443609|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56443610|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
56443611|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443612|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
56443613|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443614|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56443615|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443616|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56443617|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56443618|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443619|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443620|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
56443621|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443622|NCT00416819|Antidotes|antidotes|mesh-ancestor
56443623|NCT00416819|Protective Agents|protective agents|mesh-ancestor
56443624|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
56913649|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913650|NCT05209984|Topiramate|topiramate|mesh-list
56913651|NCT05209984|Sibutramine|sibutramine|mesh-list
56913652|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
56913653|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56443625|NCT00416819|Vitamins|vitamins|mesh-ancestor
56443626|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
56443627|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56443628|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
56443629|NCT00310206|Vaccines|vaccines|mesh-list
56443630|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
56443631|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443632|NCT00280007|Bevacizumab|bevacizumab|mesh-list
56443633|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56443634|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443635|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56443636|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56443637|NCT00280007|Growth Substances|growth substances|mesh-ancestor
56443638|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191452|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56443639|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
56443640|NCT00316680|Vaccines|vaccines|mesh-list
56443641|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
56443642|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443643|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
56443644|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
56443645|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56443646|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443647|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
56443648|NCT00310323|Caffeine|caffeine|mesh-list
56443649|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56443650|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443651|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56443652|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443653|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443654|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56443655|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56443658|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
56443659|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
56443660|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56443661|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56443662|NCT00280280|Baclofen|baclofen|mesh-list
56443663|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56443664|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443665|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56443666|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443667|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56443668|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
56443669|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
56443670|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443671|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443672|NCT00316758|Metformin|metformin|mesh-list
56443673|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56443674|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443675|NCT00280358|Fluticasone|fluticasone|mesh-list
56443676|NCT00280358|Xhance|xhance|mesh-list
56443677|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
56443678|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443679|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56443680|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
56443681|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443682|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443683|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56443684|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
56443685|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
56443686|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56443687|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56443688|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56443689|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56443690|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
56443691|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051593|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913654|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913655|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
56913656|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56913657|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
56913658|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56443692|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443693|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
56443694|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443695|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56443696|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56443697|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443698|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443699|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
56443700|NCT00280436|Casopitant|casopitant|mesh-list
56443701|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
56443702|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
56443703|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443704|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443705|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56443706|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56443707|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443708|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443709|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
56443710|NCT00280514|Cefpirome|cefpirome|mesh-list
56443711|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56443712|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443713|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443714|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443715|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443716|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443717|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443718|NCT00280553|Bupivacaine|bupivacaine|mesh-list
56443719|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
56443720|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
56443721|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56443722|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443723|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
56443724|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443725|NCT00316875|Doxorubicin|doxorubicin|mesh-list
56443727|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56443728|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443729|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443732|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443733|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56443735|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443736|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56443737|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443738|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443739|NCT00419172|Rifampin|rifampin|mesh-list
56443740|NCT00419172|Deferasirox|deferasirox|mesh-list
56443741|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56443742|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
56443743|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56443744|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443745|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
56443746|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56443747|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443748|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443749|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56443750|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56443751|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56443752|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56443753|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56443754|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56443755|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56443756|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
56443757|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
56443758|NCT00280787|Paclitaxel|paclitaxel|mesh-list
56005951|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
56443759|NCT00280787|Carboplatin|carboplatin|mesh-list
56443760|NCT00280787|Irinotecan|irinotecan|mesh-list
56443761|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56443762|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443763|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
56443764|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
56443765|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
56443766|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443767|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56443768|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443769|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443770|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
56443771|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56443772|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56443773|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443774|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443775|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443776|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443777|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443778|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443779|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56443780|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
56443781|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56443782|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443783|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56443784|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56443785|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56443786|NCT00280865|Pioglitazone|pioglitazone|mesh-list
56443788|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443789|NCT00317031|Naltrexone|naltrexone|mesh-list
56443790|NCT00317031|Acamprosate|acamprosate|mesh-list
56443791|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56443792|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56443793|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443794|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
56443795|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443796|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56443797|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56443798|NCT00317070|Protective Agents|protective agents|mesh-ancestor
56443799|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443800|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56443801|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
56443802|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443805|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
56443806|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443807|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443808|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
56443809|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443810|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56443811|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
56443812|NCT00281255|Protective Agents|protective agents|mesh-ancestor
56443813|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443814|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56443815|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
56443816|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
56443817|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443818|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56443819|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56443820|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56443821|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
56443822|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443823|NCT00317187|Vaccines|vaccines|mesh-list
56443824|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
56443825|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443826|NCT00310908|Tramadol|tramadol|mesh-list
56443827|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56443828|NCT00310908|Narcotics|narcotics|mesh-ancestor
56443829|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56443830|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443831|NCT00310908|Analgesics|analgesics|mesh-ancestor
56443832|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
56443833|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443834|NCT00281489|Anesthetics|anesthetics|mesh-list
56051594|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
56913659|NCT02233816|Vaccines|vaccines|mesh-list
56913660|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
56443835|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56443836|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443837|NCT00317343|Anticoagulants|anticoagulants|mesh-list
56443838|NCT00317343|Bivalirudin|bivalirudin|mesh-list
56443839|NCT00317343|Thrombin|thrombin|mesh-list
56443840|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
56443841|NCT00317343|Coagulants|coagulants|mesh-ancestor
56443842|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
56443843|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56443844|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
56443845|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443846|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443847|NCT00416858|Fluorouracil|fluorouracil|mesh-list
56443848|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443849|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
56443850|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443851|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56443852|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443853|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
56443854|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443855|NCT00416897|Dexamethasone|dexamethasone|mesh-list
56443856|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443857|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
56443858|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
56443859|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443860|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443861|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56443862|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
56443863|NCT00416897|Hormones|hormones|mesh-ancestor
56443864|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56443865|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56443866|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443867|NCT00417014|Prednisolone|prednisolone|mesh-list
56443868|NCT00417014|Vinblastine|vinblastine|mesh-list
56443869|NCT00417014|Procarbazine|procarbazine|mesh-list
56443870|NCT00417014|Chlorambucil|chlorambucil|mesh-list
56443871|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443872|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
56443873|NCT00417014|Hormones|hormones|mesh-ancestor
56443874|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56443875|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443876|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56443877|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443878|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56443885|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
56443886|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443887|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
56443888|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56443889|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56443890|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443891|NCT00317421|Urological Agents|urological agents|mesh-ancestor
56443892|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
56443894|NCT00417053|Busulfan|busulfan|mesh-list
56443895|NCT00417053|Carboplatin|carboplatin|mesh-list
56443896|NCT00417053|Doxorubicin|doxorubicin|mesh-list
56443897|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56443898|NCT00417053|Etoposide|etoposide|mesh-list
56443899|NCT00417053|Vincristine|vincristine|mesh-list
56443900|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
56443901|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443902|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
56443903|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443904|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443905|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56443906|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
56443907|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443908|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443909|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56443910|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56443911|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56443912|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443913|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443914|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56913661|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913662|NCT02750410|Dulaglutide|dulaglutide|mesh-list
56913663|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56158251|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56443915|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
56443916|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
56443917|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
56443918|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
56443919|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56443920|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
56443921|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443922|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443923|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56443924|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
56443925|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
56443926|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56443927|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
56443928|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443929|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443930|NCT00317499|Etanercept|etanercept|mesh-list
56443931|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56443932|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56443933|NCT00317499|Analgesics|analgesics|mesh-ancestor
56443934|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
56443935|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443936|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443937|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443938|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443940|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443941|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
56443942|NCT00281606|Ritonavir|ritonavir|mesh-list
56443943|NCT00281606|Lopinavir|lopinavir|mesh-list
56443944|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56443945|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56443946|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
56443947|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443948|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443949|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55839386|NCT01386970|Zidovudine|zidovudine|mesh-list
56443954|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56443956|NCT00317538|Infliximab|infliximab|mesh-list
56443957|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
56443958|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56443959|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443960|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56443961|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56443962|NCT00317538|Analgesics|analgesics|mesh-ancestor
56443963|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
56443964|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443965|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443966|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443967|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56443968|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
56443969|NCT00281645|Analgesics|analgesics|mesh-list
56443970|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
56443971|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443972|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443973|NCT00317577|Timolol|timolol|mesh-list
56443974|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56443975|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56443976|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56443977|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
56443978|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443979|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443980|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443981|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56443982|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56443983|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56443984|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56443985|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56443986|NCT00317655|Ibuprofen|ibuprofen|mesh-list
56051595|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913664|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913665|NCT02750332|Nitisinone|nitisinone|mesh-list
56913666|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913667|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913668|NCT02233894|Ipratropium|ipratropium|mesh-list
56443987|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56443988|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56443989|NCT00317655|Analgesics|analgesics|mesh-ancestor
56443990|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
56443991|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56443992|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443993|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56443994|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56443995|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56443996|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443997|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443998|NCT00281996|Gemcitabine|gemcitabine|mesh-list
56443999|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
56444000|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56444001|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
56444002|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444003|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444004|NCT00281996|Antiviral Agents|antiviral agents|mesh-ancestor
56444005|NCT00281996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444006|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444007|NCT00281996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56444008|NCT00281996|Immunologic Factors|immunologic factors|mesh-ancestor
56444009|NCT00281996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444010|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56444011|NCT00311259|Melatonin|melatonin|mesh-list
56191831|NCT01477632|Norethindrone|norethindrone|mesh-list
56444012|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
56444013|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444014|NCT00311259|Protective Agents|protective agents|mesh-ancestor
56444015|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444016|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444017|NCT00317733|Ketoprofen|ketoprofen|mesh-list
55839496|NCT01778049|Empagliflozin|empagliflozin|mesh-list
56444020|NCT00317733|Analgesics|analgesics|mesh-ancestor
56444021|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
56444022|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444023|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444024|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56444025|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56444026|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56444027|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444028|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444029|NCT00311337|Bortezomib|bortezomib|mesh-list
56444030|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444031|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
56444032|NCT00317811|Bortezomib|bortezomib|mesh-list
56444033|NCT00317811|Melphalan|melphalan|mesh-list
56444034|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444035|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56444036|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
56444037|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444038|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56444039|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56444040|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
56444041|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444042|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
56444043|NCT00317811|Protective Agents|protective agents|mesh-ancestor
56444044|NCT00317811|Vitamins|vitamins|mesh-ancestor
56444045|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
56444046|NCT00282386|Rofecoxib|rofecoxib|mesh-list
56444047|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444048|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444049|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444050|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56444051|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56913669|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56913670|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
56913671|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012368|NCT03907423|Metformin|metformin|mesh-list
56444052|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444053|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56444054|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56444055|NCT00282386|Analgesics|analgesics|mesh-ancestor
56444056|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
56444057|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56444058|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56444059|NCT00317850|Gabapentin|gabapentin|mesh-list
56444060|NCT00317850|Analgesics|analgesics|mesh-ancestor
56444061|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
56444062|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444063|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444064|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
56444065|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56444066|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56444067|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444068|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56444069|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56444070|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56444071|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444072|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444073|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
56444074|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
56444075|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56444076|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56444077|NCT00282503|Prednisolone|prednisolone|mesh-list
56444078|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
56444079|NCT00282503|Methoxsalen|methoxsalen|mesh-list
56444080|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56444081|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
56444082|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56444083|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
56444084|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
56444085|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444086|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444087|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444088|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
56444089|NCT00282503|Hormones|hormones|mesh-ancestor
56444090|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444092|NCT00282503|Protective Agents|protective agents|mesh-ancestor
56444093|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56444094|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444095|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56444096|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
56444097|NCT00317928|Metformin|metformin|mesh-list
56444098|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444099|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444100|NCT00282698|Insulin|insulin|mesh-list
56444101|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444102|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444103|NCT00317967|Atorvastatin|atorvastatin|mesh-list
56444104|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56444105|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56444106|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
56444107|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444108|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56444109|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56444110|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444111|NCT00318084|Esomeprazole|esomeprazole|mesh-list
56444112|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56444113|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444114|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56444115|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444116|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444117|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56444118|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56444119|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56444120|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
56913672|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913673|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56913674|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
56913675|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56913676|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
56913677|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913678|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913679|NCT02233972|Midazolam|midazolam|mesh-list
56913680|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56913681|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56913682|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913683|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913684|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56913685|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56913686|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56913687|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56913688|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
56913689|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
56913690|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
56913691|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
56444121|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444122|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444123|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444124|NCT00282932|Urological Agents|urological agents|mesh-ancestor
56444125|NCT00318162|Naltrexone|naltrexone|mesh-list
56444126|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56444127|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56444128|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444129|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
56444130|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444131|NCT00283088|Plasminogen|plasminogen|mesh-list
56444132|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56444133|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56444134|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56444135|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444136|NCT00318201|Erythromycin|erythromycin|mesh-list
56444137|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
56444138|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56444139|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
56444140|NCT00318201|Diltiazem|diltiazem|mesh-list
56444141|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56444142|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56444143|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56444144|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444145|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56444146|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444147|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
56444148|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56444149|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444150|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444151|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56444152|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444153|NCT00311688|Interleukin-2|interleukin-2|mesh-list
56444154|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444155|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56913692|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913693|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913694|NCT02234050|Trabectedin|trabectedin|mesh-list
56444156|NCT00311688|Analgesics|analgesics|mesh-ancestor
56444157|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
56444158|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444159|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444160|NCT00283478|Gemcitabine|gemcitabine|mesh-list
56444161|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56444162|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
56444163|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444165|NCT00283478|Antiviral Agents|antiviral agents|mesh-ancestor
56444166|NCT00283478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444167|NCT00283478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444168|NCT00283478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56444169|NCT00283478|Immunologic Factors|immunologic factors|mesh-ancestor
56444170|NCT00283478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444171|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56444173|NCT00318318|Hormones|hormones|mesh-ancestor
56444174|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444175|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444176|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
56444177|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56444178|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444179|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444180|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56444181|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
56444182|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
56444183|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56444184|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56444185|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444186|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444187|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444188|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56444189|NCT00283556|Irinotecan|irinotecan|mesh-list
56444190|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56444191|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444192|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444193|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444194|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444195|NCT00283634|Bortezomib|bortezomib|mesh-list
56444196|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56444197|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444198|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56444199|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444200|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444201|NCT00318513|Bevacizumab|bevacizumab|mesh-list
56444202|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56444203|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444204|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56444205|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56444206|NCT00318513|Growth Substances|growth substances|mesh-ancestor
56444207|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444208|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
56444209|NCT00318552|Meropenem|meropenem|mesh-list
56444210|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56444211|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444212|NCT00283751|Insulin|insulin|mesh-list
56444213|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56444214|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
56444215|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
56444216|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444217|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444218|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
56444219|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444220|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444221|NCT00283790|Zolpidem|zolpidem|mesh-list
56444222|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56444223|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56444224|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444225|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051596|NCT01420874|Antidotes|antidotes|mesh-ancestor
56444226|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56444227|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
56444228|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
56444229|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444230|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444231|NCT00318669|Paroxetine|paroxetine|mesh-list
56444232|NCT00318669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56444233|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56444234|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56444235|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444236|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444237|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
55840094|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444240|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
56444241|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56444242|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56444243|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56444244|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444245|NCT00283829|Docetaxel|docetaxel|mesh-list
56444246|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444247|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
56444248|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
56444249|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
56444250|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444251|NCT00311961|Prednisolone|prednisolone|mesh-list
56444252|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56444253|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
56444254|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56444255|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
56444256|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56444257|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
56444258|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56444259|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
56444260|NCT00311961|Hormones|hormones|mesh-ancestor
56444261|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444262|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444263|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56444264|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444265|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
56444266|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
56444267|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444268|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444269|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56444270|NCT00311961|Protective Agents|protective agents|mesh-ancestor
56444271|NCT00283946|Zolpidem|zolpidem|mesh-list
56444272|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56444273|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56444274|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444275|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444276|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56444277|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
56444278|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
56444279|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444280|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444281|NCT00312000|Capecitabine|capecitabine|mesh-list
56444282|NCT00312000|Irinotecan|irinotecan|mesh-list
56444283|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56444284|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
56444285|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444286|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444287|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56444288|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444289|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444290|NCT00283985|Dexamethasone|dexamethasone|mesh-list
56444291|NCT00283985|Methotrexate|methotrexate|mesh-list
56444292|NCT00283985|Asparaginase|asparaginase|mesh-list
56444293|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56444294|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
56444295|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
56444296|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444297|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444298|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444299|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
56444300|NCT00283985|Hormones|hormones|mesh-ancestor
56444301|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56913695|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56158640|NCT05453448|Tenofovir|tenofovir|mesh-list
56444302|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56444303|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444304|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56444305|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
56444306|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56444307|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56444308|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
56444309|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444310|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
56444311|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444312|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56444313|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56444314|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
56444315|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56444316|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56444317|NCT00419250|Lenalidomide|lenalidomide|mesh-list
56444318|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
56444319|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444320|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56444321|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56444322|NCT00419250|Growth Substances|growth substances|mesh-ancestor
56444323|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
56444324|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444325|NCT00284024|Domperidone|domperidone|mesh-list
56444326|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
56444327|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
56444328|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444329|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444330|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444331|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56444332|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
56444333|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444334|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444335|NCT00312039|Lamivudine|lamivudine|mesh-list
56444336|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
56444337|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56444338|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56444339|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444340|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444341|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
56444342|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444343|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56444344|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56444345|NCT00284258|Irinotecan|irinotecan|mesh-list
56444346|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56444347|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444348|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444349|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444350|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444351|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
56444352|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
56444353|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444354|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444355|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
56444356|NCT00284336|Doxorubicin|doxorubicin|mesh-list
56444357|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56444358|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56444359|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
56444360|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444361|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56444362|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56444363|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
56444364|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444365|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444366|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56444367|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56444368|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56444369|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444370|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444371|NCT00312156|Insulin|insulin|mesh-list
56444372|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56913696|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
56158701|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
56444373|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
56444374|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
56444375|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
56444376|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
56444377|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
56444378|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444379|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444380|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
56444381|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56444382|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
56444383|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
56444384|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56192225|NCT01479881|Simeprevir|simeprevir|mesh-list
56444385|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444386|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56444388|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
56444389|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444392|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
56444393|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444394|NCT00312273|Aminophylline|aminophylline|mesh-list
56444395|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56444396|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
56444397|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444398|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444399|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56444400|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
56444401|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56444402|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56444403|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444404|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444405|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56444406|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56444407|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
56444408|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444409|NCT00312273|Protective Agents|protective agents|mesh-ancestor
56444410|NCT00318903|Docetaxel|docetaxel|mesh-list
56444411|NCT00318903|Irinotecan|irinotecan|mesh-list
56444412|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444413|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
56444414|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
56444415|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
56444416|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444417|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56444418|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444419|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444420|NCT00284687|Artesunate|artesunate|mesh-list
56444421|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
56444422|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56444423|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56444424|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444425|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444426|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
56444427|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
56444428|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56444429|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
56444430|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
56444431|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56444432|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56444433|NCT00284765|Analgesics|analgesics|mesh-ancestor
56444434|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
56444435|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444436|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444437|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56444438|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56444439|NCT00318981|Methylphenidate|methylphenidate|mesh-list
56444440|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56444441|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444442|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56444443|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56444444|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56444445|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444446|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
56444447|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444448|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
56444449|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56444450|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444451|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56444452|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
56444453|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56444454|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444455|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444456|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444457|NCT00319059|Annexin A5|annexin a5|mesh-list
56444458|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444459|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444460|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55840473|NCT01876082|Vinblastine|vinblastine|mesh-list
56444463|NCT00312546|Valproic Acid|valproic acid|mesh-list
56444464|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
56444465|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444466|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444467|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
56444468|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444469|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444470|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
56444471|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56444472|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444473|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56444474|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56444475|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56444476|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56444477|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56444478|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
56444479|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444480|NCT00425009|Metformin|metformin|mesh-list
56444481|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444482|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444483|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
56444484|NCT04718402|Analgesics|analgesics|mesh-ancestor
56444485|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
56444486|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444487|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444488|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444489|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56444490|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444491|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444492|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444493|NCT00319215|Zopiclone|zopiclone|mesh-list
56444494|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56444495|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444496|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444497|NCT00285155|Bupropion|bupropion|mesh-list
56444498|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56444499|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
56444500|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56444501|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56444502|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56444503|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56444504|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444505|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
56444506|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444507|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444508|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56444509|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56444510|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444511|NCT00319293|Metformin|metformin|mesh-list
56444512|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444513|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444514|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
56444515|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444516|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
56444517|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56444518|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444519|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56444520|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
56444521|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56158842|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444522|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444523|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444524|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444525|NCT00285389|Dexamethasone|dexamethasone|mesh-list
56444526|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
56444527|NCT00285389|Melphalan|melphalan|mesh-list
56444528|NCT00285389|Chlorambucil|chlorambucil|mesh-list
56444529|NCT00285389|Rituximab|rituximab|mesh-list
56444530|NCT00285389|Vincristine|vincristine|mesh-list
56444531|NCT00285389|Doxorubicin|doxorubicin|mesh-list
56444532|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56444533|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
56444534|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444536|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56444538|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444539|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444540|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56444541|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56444542|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56444543|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
56444544|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
56444545|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444546|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444547|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
56444548|NCT00285389|Hormones|hormones|mesh-ancestor
56444549|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444550|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56444551|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56444552|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
56444553|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
56444554|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
56444555|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56444556|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56444557|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444558|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444559|NCT00285428|Veltuzumab|veltuzumab|mesh-list
56444560|NCT00285428|Antibodies|antibodies|mesh-list
56444561|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
56444562|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444563|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444564|NCT00312819|Disulfiram|disulfiram|mesh-list
56444565|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56444566|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56444567|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444568|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444569|NCT00319488|Budesonide|budesonide|mesh-list
56444570|NCT00319488|Albuterol|albuterol|mesh-list
56444571|NCT00319488|Montelukast|montelukast|mesh-list
56444572|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
56444573|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56444574|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56444575|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
56444576|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444577|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444578|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56444579|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
56444580|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
56444581|NCT00319488|Hormones|hormones|mesh-ancestor
56444582|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444583|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
56444584|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56444585|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56444586|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444587|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
56444588|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56444589|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56444590|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56444591|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56444592|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
56444593|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444594|NCT00285623|Thrombin|thrombin|mesh-list
56444595|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
56444596|NCT00285623|Coagulants|coagulants|mesh-ancestor
56444597|NCT00285662|Artesunate|artesunate|mesh-list
56444598|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
56913697|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158921|NCT02775240|Maribavir|maribavir|mesh-list
56444599|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
56444600|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56444601|NCT00285662|Amodiaquine|amodiaquine|mesh-list
56444602|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
56444603|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56444604|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56444605|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444606|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444607|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
56444608|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
56444609|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56444617|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
56444618|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56444619|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56444620|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56444621|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56444622|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
56444623|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56444624|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444625|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56444626|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56444627|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56444628|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56444629|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444630|NCT00319566|Estrogens|estrogens|mesh-ancestor
56444631|NCT00319566|Hormones|hormones|mesh-ancestor
56444632|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444633|NCT00319605|Levetiracetam|levetiracetam|mesh-list
56444634|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
56444635|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
56444636|NCT00313053|Vincristine|vincristine|mesh-list
56444637|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56444638|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444639|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
56444640|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
56444641|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
56444642|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444643|NCT00285896|Glucagon|glucagon|mesh-list
56444644|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56444645|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444646|NCT00285896|Hormones|hormones|mesh-ancestor
56444647|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444648|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444649|NCT00285896|Incretins|incretins|mesh-ancestor
56444650|NCT00319683|Eniluracil|eniluracil|mesh-list
56444651|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444652|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444653|NCT00286052|Naloxone|naloxone|mesh-list
56444654|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56444655|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444656|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
56444657|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444658|NCT00319761|Calcitriol|calcitriol|mesh-list
56444659|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56444660|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444661|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56444662|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56444663|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444664|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56444665|NCT00319761|Vitamins|vitamins|mesh-ancestor
56444666|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
56444667|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56444668|NCT00286130|Leucovorin|leucovorin|mesh-list
56444669|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
56444670|NCT00286130|Irinotecan|irinotecan|mesh-list
56444671|NCT00286130|Cetuximab|cetuximab|mesh-list
56444672|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444673|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56444674|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444675|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444676|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913698|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913699|NCT04385290|Cytarabine|cytarabine|mesh-list
56913700|NCT04385290|Daunorubicin|daunorubicin|mesh-list
56913701|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
56444678|NCT00286130|Protective Agents|protective agents|mesh-ancestor
56444679|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444680|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
56444681|NCT00286130|Vitamins|vitamins|mesh-ancestor
56444682|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
56444683|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56444684|NCT00286208|Misoprostol|misoprostol|mesh-list
56444685|NCT00286208|Mifepristone|mifepristone|mesh-list
56444686|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56192513|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
56444687|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
56444688|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56444689|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444690|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56444691|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56444692|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
56444693|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56444694|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56444695|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56444696|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56444697|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
56444698|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56444699|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56444700|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
56444701|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444702|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
56444703|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56444704|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56444705|NCT00319800|Irinotecan|irinotecan|mesh-list
56444706|NCT00319800|Gefitinib|gefitinib|mesh-list
56444707|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56444708|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444709|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444710|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444711|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444712|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56444713|NCT00313131|Metronidazole|metronidazole|mesh-list
56444714|NCT00313131|Fluconazole|fluconazole|mesh-list
56444715|NCT00313131|Clotrimazole|clotrimazole|mesh-list
56444716|NCT00313131|Miconazole|miconazole|mesh-list
56444717|NCT00313131|Tinidazole|tinidazole|mesh-list
56444718|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444719|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56444720|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56444721|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56444722|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
56444723|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56444724|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56444725|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444726|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444727|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56444728|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
56444729|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444730|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444731|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56444732|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56444733|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56444734|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56444735|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
56444736|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56444737|NCT00319878|Cyclosporine|cyclosporine|mesh-list
56444738|NCT00319878|Sirolimus|sirolimus|mesh-list
56444739|NCT00319878|Cyclosporins|cyclosporins|mesh-list
56444740|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444741|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444742|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56444743|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
56444744|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913702|NCT04385290|Midostaurin|midostaurin|mesh-list
56913703|NCT04385290|Staurosporine|staurosporine|mesh-list
56159066|NCT03568890|Aspirin|aspirin|mesh-list
56444745|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
56444746|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444747|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
56444748|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56444749|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56444751|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56444752|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444753|NCT00286364|Androgens|androgens|mesh-list
56444754|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56444755|NCT00286364|Hormones|hormones|mesh-ancestor
56164948|NCT04360824|Enoxaparin|enoxaparin|mesh-list
56444756|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444757|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444758|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56444759|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192580|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
56444760|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444761|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56444762|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
56444763|NCT00319917|Tacrolimus|tacrolimus|mesh-list
56444764|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56444765|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
56444766|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444767|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56444768|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444769|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444770|NCT00286403|Fenoldopam|fenoldopam|mesh-list
56444771|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444772|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56444773|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
56444774|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
56444775|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
56444776|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444777|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444778|NCT00313287|Clevudine|clevudine|mesh-list
56444779|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
56444780|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444781|NCT00286481|Simvastatin|simvastatin|mesh-list
56444782|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56444783|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56444784|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
56444785|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444786|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56444787|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56444788|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444789|NCT00320034|Albuterol|albuterol|mesh-list
56444790|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56444791|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
56444792|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444793|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444794|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56444795|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
56444796|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
56444797|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56444798|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56444799|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56444800|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56444801|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
56444802|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444803|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444804|NCT00320073|Pemetrexed|pemetrexed|mesh-list
56444805|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56444806|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444807|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444808|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444809|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56444810|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56444811|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56444812|NCT00286871|Tacrolimus|tacrolimus|mesh-list
56444813|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913704|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56444814|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
56444815|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444816|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56444817|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444818|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444819|NCT00417326|Sivelestat|sivelestat|mesh-list
56444820|NCT00417326|Glycine|glycine|mesh-list
56444821|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56444824|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444825|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
56444826|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444827|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444829|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
56444830|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56444831|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56444832|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
56444833|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56444834|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56444835|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56444836|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444837|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444839|NCT00417404|Vitamin A|vitamin a|mesh-list
56444840|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
56444841|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
56444842|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444843|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
56444844|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444845|NCT00417404|Protective Agents|protective agents|mesh-ancestor
56444846|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56444847|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444848|NCT00417443|Clonidine|clonidine|mesh-list
56444849|NCT00417443|Analgesics|analgesics|mesh-ancestor
56444850|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
56444851|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444852|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444853|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56444854|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
56444855|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
56444856|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56444857|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56444858|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56444859|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
56444860|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56444861|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444862|NCT00313482|Prednisone|prednisone|mesh-list
56444863|NCT00313482|Docetaxel|docetaxel|mesh-list
56444864|NCT00313482|Sargramostim|sargramostim|mesh-list
56444865|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444866|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
56444867|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
56444868|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
56444869|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444870|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56444871|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
56444872|NCT00313482|Hormones|hormones|mesh-ancestor
56444873|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444874|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444875|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56444876|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
56444877|NCT00286988|Topiramate|topiramate|mesh-list
56444878|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
56444879|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444880|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444881|NCT00320307|Abacavir|abacavir|mesh-list
56444882|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56444883|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56444884|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444885|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444886|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
56444887|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444888|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56444889|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56444890|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
56913705|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
56159196|NCT03556800|Estrogens|estrogens|mesh-ancestor
56444891|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444892|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56444893|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444894|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56444895|NCT02960906|Nivolumab|nivolumab|mesh-list
56444896|NCT02960906|Ipilimumab|ipilimumab|mesh-list
56444899|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444900|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56444901|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444903|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56444904|NCT02960906|Growth Substances|growth substances|mesh-ancestor
56444905|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444906|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
56444907|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56444908|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444909|NCT00287066|Insulin|insulin|mesh-list
56444910|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56444912|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444913|NCT00313521|Thiotepa|thiotepa|mesh-list
56444914|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56444915|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
56444916|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444917|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444918|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56444919|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56444920|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
56444921|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444922|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
56444923|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444924|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56444925|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444926|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444927|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
56444928|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56444929|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444930|NCT00313599|Paclitaxel|paclitaxel|mesh-list
56444931|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56444932|NCT00313599|Lapatinib|lapatinib|mesh-list
56444933|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56444934|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444935|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
56444936|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
56444937|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
56444938|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444939|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56444940|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444941|NCT00287300|Azithromycin|azithromycin|mesh-list
56444942|NCT00287300|Artesunate|artesunate|mesh-list
56444943|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
56444944|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
56444945|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56444946|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56444947|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56444948|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
56444949|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56444950|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56444951|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444952|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
56444953|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
56444954|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56444955|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
56444956|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56444957|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444958|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444959|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56444960|NCT00287300|Renal Agents|renal agents|mesh-ancestor
56444961|NCT00287378|Omalizumab|omalizumab|mesh-list
56444962|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56444963|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56444964|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
56444965|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56444966|NCT00320580|Norelgestromin|norelgestromin|mesh-list
56444967|NCT00320580|Estradiol|estradiol|mesh-list
56913706|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913707|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444968|NCT00320580|Estrogens|estrogens|mesh-ancestor
56444969|NCT00320580|Hormones|hormones|mesh-ancestor
56444970|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56444971|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444972|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56444975|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56444976|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56444977|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56444978|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
56444979|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56444980|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56444981|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444982|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
56444983|NCT00320619|Coagulants|coagulants|mesh-ancestor
56444984|NCT00287456|Insulin|insulin|mesh-list
56444985|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56444986|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56444987|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444988|NCT00313833|Buprenorphine|buprenorphine|mesh-list
56444989|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56444990|NCT00313833|Narcotics|narcotics|mesh-ancestor
56444991|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56444992|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444993|NCT00313833|Analgesics|analgesics|mesh-ancestor
56444994|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
56444995|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56444996|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56444997|NCT00287495|Sorafenib|sorafenib|mesh-list
56444998|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444999|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56445000|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445001|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445002|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56445003|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56445004|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
56445005|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445006|NCT00320658|Antacids|antacids|mesh-ancestor
56445007|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445008|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56445009|NCT00287534|Tamoxifen|tamoxifen|mesh-list
56445010|NCT00287534|Anastrozole|anastrozole|mesh-list
56445011|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56445012|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
56445013|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56445014|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445015|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56445016|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445017|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56445018|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56445019|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56445020|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56445021|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56445022|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445023|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445024|NCT00320697|Bupropion|bupropion|mesh-list
56445025|NCT00320697|Nicotine|nicotine|mesh-list
56445026|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56445027|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
56445028|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445029|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445030|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56445031|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56445032|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
56445033|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445034|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445035|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56445036|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
56445037|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56445038|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56913708|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
56038599|NCT02192684|Pioglitazone|pioglitazone|mesh-list
56445039|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56445040|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56445041|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
56445042|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56445043|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56445044|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445052|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56445053|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445054|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445055|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
56445056|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445057|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445058|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56445059|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
56445060|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445061|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
56445063|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445064|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445065|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445066|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445067|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445068|NCT00320775|Aflibercept|aflibercept|mesh-list
56445069|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56445070|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56445071|NCT00320775|Growth Substances|growth substances|mesh-ancestor
56445072|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445073|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
56445074|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445075|NCT00320814|Aflibercept|aflibercept|mesh-list
56445076|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56445077|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56445078|NCT00320814|Growth Substances|growth substances|mesh-ancestor
56445079|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445080|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
56445081|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445082|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
56445083|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445084|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56445085|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445086|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445087|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
56445088|NCT00322413|Hematinics|hematinics|mesh-ancestor
56445089|NCT00320853|Vitamin D|vitamin d|mesh-list
56445090|NCT00320853|Vitamins|vitamins|mesh-ancestor
56445091|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
56445092|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445093|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56445094|NCT00287885|Docetaxel|docetaxel|mesh-list
56445095|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445096|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445097|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445098|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445099|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445100|NCT00287924|Methotrexate|methotrexate|mesh-list
56445101|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56445102|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
56445103|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56445104|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445105|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56445106|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
56445107|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445108|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445109|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
56445110|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445111|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56445113|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
56445114|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56445115|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56445116|NCT00287963|Topotecan|topotecan|mesh-list
56445117|NCT00287963|Vinorelbine|vinorelbine|mesh-list
56445118|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56051597|NCT01420874|Protective Agents|protective agents|mesh-ancestor
56913709|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913710|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913711|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
56445119|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56445120|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445121|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445123|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56445124|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445125|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445126|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445127|NCT00320892|Atropine|atropine|mesh-list
56445128|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56445129|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56445130|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56445131|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56445132|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
56445133|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445134|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445135|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56445136|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
56445137|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
56445138|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
56445139|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56445140|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56445141|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
56445142|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445143|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445144|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56445145|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
56445146|NCT00288002|Docetaxel|docetaxel|mesh-list
56445147|NCT00288002|Capecitabine|capecitabine|mesh-list
56445148|NCT00288002|Trastuzumab|trastuzumab|mesh-list
56445149|NCT00288002|Epirubicin|epirubicin|mesh-list
56445150|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445151|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
56445152|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445153|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56445154|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56445155|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
56445156|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445157|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445158|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56445159|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445160|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445161|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445162|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56445163|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
56445164|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56445165|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56445166|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56445167|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56445168|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445169|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
56445170|NCT00322569|Paclitaxel|paclitaxel|mesh-list
56445171|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56445172|NCT00322569|Tacrolimus|tacrolimus|mesh-list
56445173|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56445174|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445175|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445176|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445177|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445178|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445179|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56445180|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56445181|NCT00322569|Analgesics|analgesics|mesh-ancestor
56445182|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
56445183|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445184|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445185|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56445186|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56445187|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
56445189|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
56445190|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56913712|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913713|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56913714|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56159451|NCT02907918|Goserelin|goserelin|mesh-list
56445191|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445192|NCT00288041|Paclitaxel|paclitaxel|mesh-list
56445193|NCT00288041|Carboplatin|carboplatin|mesh-list
56445194|NCT00288041|Bortezomib|bortezomib|mesh-list
56445195|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56445196|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445197|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445198|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445199|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445200|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445201|NCT00320970|Candesartan|candesartan|mesh-list
56445202|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56445203|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56445204|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56445205|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445206|NCT00288158|Allopurinol|allopurinol|mesh-list
56445207|NCT00288158|Probenecid|probenecid|mesh-list
56445208|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
56445209|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445210|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445211|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
56445212|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56445213|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56445214|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
56445215|NCT00288158|Protective Agents|protective agents|mesh-ancestor
56445216|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445217|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
56445218|NCT00288158|Renal Agents|renal agents|mesh-ancestor
56445219|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56445220|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56445221|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445222|NCT00288197|Voriconazole|voriconazole|mesh-list
56445223|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
56445224|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445225|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56445226|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56445227|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445228|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445229|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56445230|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
56445231|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56445232|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445233|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56445234|NCT00288236|Rimonabant|rimonabant|mesh-list
56445235|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56445236|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56445237|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56445238|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445239|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445240|NCT00288236|Hormones|hormones|mesh-ancestor
56445241|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56445242|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445243|NCT00321126|Zinc|zinc|mesh-list
56445244|NCT00321126|Trace Elements|trace elements|mesh-ancestor
56445245|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
56445246|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445247|NCT00288353|Aripiprazole|aripiprazole|mesh-list
56445248|NCT00288353|Ziprasidone|ziprasidone|mesh-list
56445249|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
56445250|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56445251|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56445252|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56445253|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56445254|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445255|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
56445256|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
56051598|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
56913715|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56913716|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445257|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445258|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445259|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56445260|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56445262|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56445263|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56445264|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56445265|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56445266|NCT00288431|Sirolimus|sirolimus|mesh-list
56445267|NCT00288431|Doxorubicin|doxorubicin|mesh-list
56445268|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56445269|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445270|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56445271|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56445272|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445273|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445274|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56445275|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445276|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
56445277|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445278|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
56445279|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445280|NCT00321165|Taurolidine|taurolidine|mesh-list
56445281|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445282|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56445283|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445284|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
56445285|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
56445286|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56445287|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56445288|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56445289|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445290|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56445291|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56445292|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
56445293|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
56445294|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445295|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445296|NCT00322920|Topotecan|topotecan|mesh-list
56445297|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445298|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56445299|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56445300|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445301|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445302|NCT00321009|Enoxaparin|enoxaparin|mesh-list
56445303|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
56445304|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56445305|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56445306|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445307|NCT00417677|Sirolimus|sirolimus|mesh-list
56445308|NCT00417677|Sunitinib|sunitinib|mesh-list
56445309|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445310|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56445311|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56445312|NCT00417677|Growth Substances|growth substances|mesh-ancestor
56445313|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445314|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
56445315|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56445316|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445317|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445318|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56445319|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445320|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56445321|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
56445322|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445323|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
56445324|NCT00417716|Bevacizumab|bevacizumab|mesh-list
56445325|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56445326|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445327|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56445328|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56445329|NCT00417716|Growth Substances|growth substances|mesh-ancestor
56445330|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445331|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
56445332|NCT00288470|Hylan|hylan|mesh-list
56445333|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
56445334|NCT00288470|Protective Agents|protective agents|mesh-ancestor
56445336|NCT00321360|Propofol|propofol|mesh-list
56445337|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56445338|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56445339|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445340|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56445341|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
56445342|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
56445343|NCT00288548|Metoprolol|metoprolol|mesh-list
56445344|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56445345|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56445346|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
56445347|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
56445348|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445349|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445350|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56445351|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56445352|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56445353|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
56445354|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445355|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445356|NCT00321477|Casopitant|casopitant|mesh-list
56445357|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
56445358|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
56193188|NCT01486082|Amoxicillin|amoxicillin|mesh-list
56445359|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445360|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445361|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56445362|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56445363|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445364|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445365|NCT00321516|Aripiprazole|aripiprazole|mesh-list
56445366|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
56445367|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56445368|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56445369|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56445370|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56445371|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445372|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
56445373|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
56445374|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445375|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445376|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56445377|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56445378|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
56445379|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56445380|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56445381|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56445382|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56445383|NCT00288743|Insulin|insulin|mesh-list
56445384|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56445385|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445386|NCT00321633|Carboplatin|carboplatin|mesh-list
56445387|NCT00321633|Docetaxel|docetaxel|mesh-list
56445388|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445389|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445390|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445391|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445392|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445393|NCT00288782|Mirtazapine|mirtazapine|mesh-list
56445394|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
56445395|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56445396|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56445397|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
56445398|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
56445399|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445400|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445401|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445402|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56913717|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56913718|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56913719|NCT02263066|Factor VIII|factor viii|mesh-list
56913720|NCT02263066|Coagulants|coagulants|mesh-ancestor
56445403|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56445404|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56445405|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56445406|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56445409|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56445410|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56445411|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
56445412|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56445413|NCT01059825|Metformin|metformin|mesh-list
56445414|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56445415|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
56445417|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445418|NCT01059825|Incretins|incretins|mesh-ancestor
56445419|NCT01059825|Hormones|hormones|mesh-ancestor
56445420|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56445421|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56445422|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
56445423|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445424|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445425|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56445426|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
56445427|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56445428|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56445429|NCT00321750|Analgesics|analgesics|mesh-ancestor
56445430|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
56445431|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445432|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193260|NCT01486511|Liver Extracts|liver extracts|mesh-list
56445433|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56445434|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56445435|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
56445436|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445437|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
56445438|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56445439|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445440|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445441|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56445442|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56445443|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
56445444|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445445|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445446|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56445447|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56445448|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445449|NCT00323154|Nalbuphine|nalbuphine|mesh-list
56445450|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56445451|NCT00323154|Narcotics|narcotics|mesh-ancestor
56445452|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56445453|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445454|NCT00323154|Analgesics|analgesics|mesh-ancestor
56445455|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
56445456|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445457|NCT00289250|Artesunate|artesunate|mesh-list
56445458|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
56445459|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
56445460|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56445461|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
56445462|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56445463|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56445464|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445465|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445466|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
56445467|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
56445468|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56445469|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
56445470|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56913721|NCT02235532|Fluorides|fluorides|mesh-list
56913722|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
56913723|NCT02235532|Protective Agents|protective agents|mesh-ancestor
56913724|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445471|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445472|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445473|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56445474|NCT00289250|Renal Agents|renal agents|mesh-ancestor
56445475|NCT00323505|Interferons|interferons|mesh-list
56445476|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
56445477|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
56445478|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445479|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
56445481|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
56445482|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445484|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56445485|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56445486|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56445487|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946232|NCT01895257|Leucovorin|leucovorin|mesh-list
56445488|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56445489|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445490|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
56445491|NCT00323544|Tenofovir|tenofovir|mesh-list
56445492|NCT00323544|Lamivudine|lamivudine|mesh-list
56445493|NCT00323544|Zidovudine|zidovudine|mesh-list
56445494|NCT00323544|Emtricitabine|emtricitabine|mesh-list
56445495|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56445496|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
56445497|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445498|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56445499|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56445500|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445501|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445502|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56445503|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56445504|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
56445505|NCT00289445|Leucovorin|leucovorin|mesh-list
56445506|NCT00289445|Folic Acid|folic acid|mesh-list
56445507|NCT00289445|Mitomycins|mitomycins|mesh-list
56445508|NCT00289445|Mitomycin|mitomycin|mesh-list
56445509|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
56445511|NCT00289445|Protective Agents|protective agents|mesh-ancestor
56445512|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445513|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
56445514|NCT00289445|Vitamins|vitamins|mesh-ancestor
56445515|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
56445516|NCT00289445|Hematinics|hematinics|mesh-ancestor
56445517|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56445518|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445519|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
56445520|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445521|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56445522|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445523|NCT00323583|Leucovorin|leucovorin|mesh-list
56445524|NCT00323583|Paclitaxel|paclitaxel|mesh-list
56445525|NCT00323583|Fluorouracil|fluorouracil|mesh-list
56445526|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
56445527|NCT00323583|Calcium|calcium|mesh-list
56445528|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56445529|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445530|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445531|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445532|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445533|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445534|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56445535|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445536|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
56445537|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56445538|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445539|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
56445540|NCT00323583|Antidotes|antidotes|mesh-ancestor
56445541|NCT00323583|Protective Agents|protective agents|mesh-ancestor
56445542|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
56445543|NCT00323583|Vitamins|vitamins|mesh-ancestor
56913725|NCT00069095|Leucovorin|leucovorin|mesh-list
56913726|NCT00069095|Bevacizumab|bevacizumab|mesh-list
56445544|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
56445545|NCT00289601|Eptifibatide|eptifibatide|mesh-list
56445546|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56445547|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
56445548|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56445549|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
56445550|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445551|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
56445552|NCT00323778|Protective Agents|protective agents|mesh-ancestor
56445553|NCT00323817|Z 338|z 338|mesh-list
56445554|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56445555|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445556|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445560|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56445562|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56445563|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56445564|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445565|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445566|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445567|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445568|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445569|NCT00323934|Mocetinostat|mocetinostat|mesh-list
56445570|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56445571|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445572|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445573|NCT00290030|Alfuzosin|alfuzosin|mesh-list
56445574|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56445575|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56445576|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56445577|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
56445578|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445579|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445580|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445581|NCT00290030|Urological Agents|urological agents|mesh-ancestor
56445582|NCT00303264|Esomeprazole|esomeprazole|mesh-list
56445583|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56445584|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193408|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
56445585|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56445586|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445587|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445588|NCT00290069|Sirolimus|sirolimus|mesh-list
56445589|NCT00290069|Tacrolimus|tacrolimus|mesh-list
56445590|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445591|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
56445592|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445593|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56445594|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445595|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445596|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56445597|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445598|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56445599|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445600|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
56445601|NCT04718259|Midazolam|midazolam|mesh-list
56445602|NCT04718259|Bupivacaine|bupivacaine|mesh-list
56445603|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
56445604|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
56445605|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56445606|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445607|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
56445608|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445609|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56445610|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56445611|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56445612|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56445613|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56445614|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56445615|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
56445616|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
56445617|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
56445618|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051599|NCT01420874|Vitamins|vitamins|mesh-ancestor
56913727|NCT00069095|Fluorouracil|fluorouracil|mesh-list
56913728|NCT00069095|Capecitabine|capecitabine|mesh-list
56913729|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
56445619|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445620|NCT00290108|Propofol|propofol|mesh-list
56445621|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56445622|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56445623|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445624|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56445625|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
56445626|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
56445627|NCT00323973|Bisoprolol|bisoprolol|mesh-list
56445629|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
56445630|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
56445631|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445632|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445633|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56445634|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56445635|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56445636|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
56445637|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445638|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445639|NCT00324012|Docetaxel|docetaxel|mesh-list
56445640|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445641|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445642|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445643|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445644|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445645|NCT00290264|Budesonide|budesonide|mesh-list
56445646|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
56445647|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56445648|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56445649|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
56445650|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445651|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445652|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56445653|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
56445654|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
56445655|NCT00290264|Hormones|hormones|mesh-ancestor
56445656|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56445657|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56445658|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56193487|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
56445659|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56445660|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
56445661|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445662|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445663|NCT00324051|Olanzapine|olanzapine|mesh-list
56445664|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
56445665|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
56445666|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445667|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445668|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56445669|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56445670|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56445671|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56445672|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56445673|NCT00324051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56445674|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56445675|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56445676|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445677|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445678|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
56445679|NCT00303381|Interferons|interferons|mesh-list
56445680|NCT00303381|Interferon-beta|interferon-beta|mesh-list
56445681|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
56445682|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445683|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
56445684|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445685|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
56445686|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445687|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56445688|NCT00290420|Chloroquine|chloroquine|mesh-list
56913730|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56913731|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445689|NCT00290420|Amebicides|amebicides|mesh-ancestor
56445690|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56445691|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56445692|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445693|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
56445694|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56445695|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56445696|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56445697|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56445698|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445699|NCT00324129|Mocetinostat|mocetinostat|mesh-list
56445700|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56445702|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445704|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56445705|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445706|NCT00290849|Bivalirudin|bivalirudin|mesh-list
56445707|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
55946476|NCT00984659|Xhance|xhance|mesh-list
56445708|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56445709|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
56445710|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445711|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445712|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
56445713|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
56445714|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56445715|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445716|NCT00303576|Dapivirine|dapivirine|mesh-list
56445717|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56445718|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56445719|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
56445720|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445721|NCT00291005|Docetaxel|docetaxel|mesh-list
56445722|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445723|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445724|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445725|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445726|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445727|NCT00303615|Anastrozole|anastrozole|mesh-list
56445728|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
56445729|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56445730|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445731|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56445732|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56445733|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445734|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445735|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56445736|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
56445737|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56445738|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445739|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
56445740|NCT00303615|Hormones|hormones|mesh-ancestor
56445741|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
56445742|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56445743|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56445744|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445745|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56445746|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56445747|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445748|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445749|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445750|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56445751|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
56445752|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56445753|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445754|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56445755|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56445756|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56445757|NCT00291122|Celecoxib|celecoxib|mesh-list
56445758|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56445759|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56445760|NCT00291122|Analgesics|analgesics|mesh-ancestor
56445761|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
56445762|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445763|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445764|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56445765|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56445766|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56445767|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56445768|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445769|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445770|NCT00324363|Exenatide|exenatide|mesh-list
56445771|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56445772|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445775|NCT00324363|Hormones|hormones|mesh-ancestor
56445776|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56445777|NCT00303732|Everolimus|everolimus|mesh-list
56445778|NCT00303732|Vatalanib|vatalanib|mesh-list
56445779|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445780|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445781|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
56445782|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445783|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56445784|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445785|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445787|NCT00303771|Fluorouracil|fluorouracil|mesh-list
56445788|NCT00303771|Irinotecan|irinotecan|mesh-list
56445789|NCT00303771|Calcium|calcium|mesh-list
56445790|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
56445791|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56445792|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445793|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
56445794|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445795|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56445796|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445797|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445798|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
56445799|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56445800|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56445801|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445802|NCT00303771|Antidotes|antidotes|mesh-ancestor
56445803|NCT00303771|Protective Agents|protective agents|mesh-ancestor
56445804|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
56445805|NCT00303771|Vitamins|vitamins|mesh-ancestor
56445806|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
56445807|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
56445808|NCT00303810|Thiotepa|thiotepa|mesh-list
56445809|NCT00303810|Lomustine|lomustine|mesh-list
56445810|NCT00303810|Carboplatin|carboplatin|mesh-list
56445811|NCT00303810|Methotrexate|methotrexate|mesh-list
56445812|NCT00303810|Etoposide|etoposide|mesh-list
56445813|NCT00303810|Vincristine|vincristine|mesh-list
56445814|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
56445815|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445816|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
56445817|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445818|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56445819|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56445820|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
56445821|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445822|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445823|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56445824|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56445825|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
56445826|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56445827|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56445828|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
56445829|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
56445830|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445831|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56445832|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56445833|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56445834|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56445835|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56445836|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445837|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445838|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445839|NCT00324480|Vorinostat|vorinostat|mesh-list
56913732|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56913733|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56445840|NCT00324480|Alvocidib|alvocidib|mesh-list
56445841|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445842|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56445843|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445844|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445845|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
56445846|NCT00324480|Growth Substances|growth substances|mesh-ancestor
56445847|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445848|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56445849|NCT00303888|Docetaxel|docetaxel|mesh-list
56445857|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445858|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445859|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445860|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56445861|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56445862|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56445864|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56445865|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
56445866|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56445867|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445868|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56445869|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56445870|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
56445871|NCT00291746|Esomeprazole|esomeprazole|mesh-list
56445872|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56445873|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56445874|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56445875|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445876|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445877|NCT00303927|Capecitabine|capecitabine|mesh-list
56445878|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56445879|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
56445880|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445881|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445882|NCT00419484|Pioglitazone|pioglitazone|mesh-list
56445883|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56445884|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445885|NCT00291785|Leucovorin|leucovorin|mesh-list
56445886|NCT00291785|Folic Acid|folic acid|mesh-list
56445887|NCT00291785|Fluorouracil|fluorouracil|mesh-list
56445888|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
56445889|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
56445890|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445891|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56445892|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445893|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445894|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
56445895|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445896|NCT00291785|Antidotes|antidotes|mesh-ancestor
56445897|NCT00291785|Protective Agents|protective agents|mesh-ancestor
56445898|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
56445899|NCT00291785|Vitamins|vitamins|mesh-ancestor
56445900|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
56445901|NCT00291785|Hematinics|hematinics|mesh-ancestor
56445902|NCT00324558|Bemiparin|bemiparin|mesh-list
56445903|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
56445904|NCT00291863|Simvastatin|simvastatin|mesh-list
56445905|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56445906|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56445907|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
56445908|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445909|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56445910|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56445911|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445912|NCT00304200|Temozolomide|temozolomide|mesh-list
56445913|NCT00304200|Sunitinib|sunitinib|mesh-list
56445914|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56445915|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
56445916|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445917|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445918|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56913734|NCT00069095|Growth Substances|growth substances|mesh-ancestor
56913735|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445923|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56445924|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445925|NCT00304239|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56445926|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56445927|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56445928|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
56445929|NCT00291980|Vaccines|vaccines|mesh-list
56445930|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
56445931|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445932|NCT00324597|Gemcitabine|gemcitabine|mesh-list
56445933|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
56445934|NCT00324597|Imetelstat|imetelstat|mesh-list
56445935|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56445936|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
56445937|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445938|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445939|NCT00324597|Antiviral Agents|antiviral agents|mesh-ancestor
56445940|NCT00324597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445941|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445942|NCT00324597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445943|NCT00324597|Immunologic Factors|immunologic factors|mesh-ancestor
56445944|NCT00324597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445945|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56445946|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
56445947|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56445948|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56445949|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445950|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56445951|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445952|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56445953|NCT00304317|Celecoxib|celecoxib|mesh-list
56445954|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56445955|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56445956|NCT00304317|Analgesics|analgesics|mesh-ancestor
56445957|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
56445958|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445959|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445960|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193786|NCT01489592|Turmeric extract|turmeric extract|mesh-list
56445961|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56445962|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56445963|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56445964|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445965|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445966|NCT00324792|Insulin|insulin|mesh-list
56445967|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56445968|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445969|NCT04717908|Linezolid|linezolid|mesh-list
56445970|NCT04717908|Cycloserine|cycloserine|mesh-list
56445971|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
56445972|NCT04717908|Bedaquiline|bedaquiline|mesh-list
56445973|NCT04717908|Clofazimine|clofazimine|mesh-list
56445974|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56445975|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445976|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56445977|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445978|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445979|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56445980|NCT04717908|Renal Agents|renal agents|mesh-ancestor
56445981|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56445982|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
56445983|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
56445984|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56445985|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
56445986|NCT00292214|Acetaminophen|acetaminophen|mesh-list
56445987|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56445988|NCT00292214|Analgesics|analgesics|mesh-ancestor
56445989|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
56445990|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445991|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445992|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
56445993|NCT00324831|Prednisone|prednisone|mesh-list
56913736|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
56913737|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
56445994|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
56445995|NCT00324831|Rituximab|rituximab|mesh-list
56445996|NCT00324831|Doxorubicin|doxorubicin|mesh-list
56445997|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56445998|NCT00324831|Vincristine|vincristine|mesh-list
56445999|NCT00324831|Vaccines|vaccines|mesh-list
56446000|NCT00324831|Antibodies|antibodies|mesh-list
56446001|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
56446002|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56446003|NCT00324831|Sargramostim|sargramostim|mesh-list
56446004|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56446005|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
56446006|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446007|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446008|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56446009|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56446010|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
56446011|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446012|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446013|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56446014|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56446015|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56446016|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56446017|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56446018|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446019|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56446020|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
56446021|NCT00324831|Hormones|hormones|mesh-ancestor
56446022|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446023|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56446024|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56446025|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
56446026|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
56446027|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
56446028|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
56446029|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56446030|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
56446031|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446032|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446033|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
56446034|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446035|NCT00304434|Oseltamivir|oseltamivir|mesh-list
56193866|NCT01489865|Veliparib|veliparib|mesh-list
56446036|NCT00304434|Probenecid|probenecid|mesh-list
56446037|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
56446038|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446039|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446040|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446041|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
56446042|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
56446043|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56446044|NCT00304434|Renal Agents|renal agents|mesh-ancestor
56446045|NCT00292409|Aripiprazole|aripiprazole|mesh-list
56446046|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
56446047|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56446048|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56446049|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56446050|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446051|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446052|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
56446053|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
56446054|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446055|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446056|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56446057|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56446058|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
56446059|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56446060|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56446061|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56446062|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56446063|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56446064|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
56446065|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56913738|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913739|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56913740|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56071565|NCT02354534|Artesunate|artesunate|mesh-list
56446068|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446069|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446070|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
56446071|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56446072|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
56446073|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446074|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446075|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56446076|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
56446077|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
56446078|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56446079|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
56446080|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446081|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164971|NCT04168710|Bupivacaine|bupivacaine|mesh-list
56446082|NCT00324948|Alprostadil|alprostadil|mesh-list
56446083|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56446084|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
56446085|NCT00324948|Urological Agents|urological agents|mesh-ancestor
56446086|NCT00304551|Ribavirin|ribavirin|mesh-list
56446087|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56446088|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
56446089|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
56446090|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446091|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
56446092|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446093|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
56446094|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446095|NCT00325026|Misoprostol|misoprostol|mesh-list
56446096|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56446097|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
56446098|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56446099|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446100|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56446101|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56446102|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
56446103|NCT00325104|Calcium|calcium|mesh-list
56446104|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
56446105|NCT00325104|Hormones|hormones|mesh-list
56446106|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56446107|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446108|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446109|NCT00292526|Enalapril|enalapril|mesh-list
56446110|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56446111|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
56446112|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194003|NCT01490268|Dsuvia|dsuvia|mesh-list
56446113|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446114|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56446115|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
56446116|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
56446117|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56446118|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
56446119|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446120|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446121|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56446122|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
56446123|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56446124|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56446125|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56446126|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
56446127|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446128|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446129|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56446130|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
56446131|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56913741|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
56913742|NCT00069095|Antidotes|antidotes|mesh-ancestor
56913743|NCT00069095|Protective Agents|protective agents|mesh-ancestor
56913744|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
56913745|NCT00069095|Vitamins|vitamins|mesh-ancestor
56913746|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
56913747|NCT00086411|Bupropion|bupropion|mesh-list
56913748|NCT00086411|Nicotine|nicotine|mesh-list
56160343|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56446132|NCT00292721|Celecoxib|celecoxib|mesh-list
56446133|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56446134|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56446135|NCT00292721|Analgesics|analgesics|mesh-ancestor
56446136|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
56446139|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56446140|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56446141|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56446142|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56446143|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446144|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446145|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
56446146|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56446147|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446148|NCT00325182|Levetiracetam|levetiracetam|mesh-list
56446149|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
56446150|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
56446151|NCT00292799|Metformin|metformin|mesh-list
56446152|NCT00292799|Orlistat|orlistat|mesh-list
56446153|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56446154|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446155|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446156|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446157|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56446158|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56446159|NCT00304629|Galantamine|galantamine|mesh-list
56446160|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56446161|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446162|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446163|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
56446164|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446165|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446166|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56446167|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
56446168|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446169|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
56446170|NCT00292838|Fluticasone|fluticasone|mesh-list
56446171|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56446172|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56446173|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
56446174|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446175|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446176|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56446177|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
56446178|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
56446179|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56446180|NCT00304668|Dapivirine|dapivirine|mesh-list
56446181|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56446182|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56446183|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
56446184|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446185|NCT00292955|Cetuximab|cetuximab|mesh-list
56446186|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56446187|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446188|NCT00293072|Rituximab|rituximab|mesh-list
56446189|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56446190|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446191|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
56446192|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446193|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56446194|NCT00293111|Etodolac|etodolac|mesh-list
56446195|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56913749|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56913750|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
56160418|NCT03448068|Ketamine|ketamine|mesh-list
56446196|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56446197|NCT00293111|Analgesics|analgesics|mesh-ancestor
56446198|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
56446199|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446200|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446201|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56446202|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56446203|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56446204|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56446205|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446206|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446207|NCT00304785|Latanoprost|latanoprost|mesh-list
56446208|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56446209|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56446210|NCT00293150|Eplerenone|eplerenone|mesh-list
56446214|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446215|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56446216|NCT00293150|Diuretics|diuretics|mesh-ancestor
56446217|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
56446218|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56446219|NCT00293228|Isoniazid|isoniazid|mesh-list
56446220|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
56446221|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56446222|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446223|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56446224|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56446225|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
56446226|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446227|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56446228|NCT00293345|Gemcitabine|gemcitabine|mesh-list
56446229|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56446230|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
56446231|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446232|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446233|NCT00293345|Antiviral Agents|antiviral agents|mesh-ancestor
56446234|NCT00293345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446235|NCT00293345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446236|NCT00293345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446237|NCT00293345|Immunologic Factors|immunologic factors|mesh-ancestor
56446238|NCT00293345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446239|NCT00293501|Tinzaparin|tinzaparin|mesh-list
56446240|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56446241|NCT00293501|Dalteparin|dalteparin|mesh-list
56446242|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
56446243|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56446244|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56446245|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446246|NCT00325455|Anacetrapib|anacetrapib|mesh-list
56446247|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56446248|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56446249|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
56446250|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446251|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56446252|NCT00293657|Lornoxicam|lornoxicam|mesh-list
56446253|NCT00293657|Piroxicam|piroxicam|mesh-list
56446254|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56446255|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56446256|NCT00293657|Analgesics|analgesics|mesh-ancestor
56446257|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
56446258|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446259|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446260|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56446261|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56446262|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56194085|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
56446263|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446264|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446265|NCT00293696|Goserelin|goserelin|mesh-list
56446266|NCT00293696|Bicalutamide|bicalutamide|mesh-list
56446267|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56446268|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913751|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913752|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913753|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56446269|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
56446270|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
56446271|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446272|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446273|NCT00293735|Labetalol|labetalol|mesh-list
56446274|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56446275|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56446276|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
56446277|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446278|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446279|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446281|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
56446282|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
56446283|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446284|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56446285|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56446286|NCT00304980|Lumefantrine|lumefantrine|mesh-list
56446287|NCT00304980|Artemether|artemether|mesh-list
56446288|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
56446289|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
56446290|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56446291|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56446292|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
56446293|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56446294|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56446295|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446296|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56446297|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446298|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446299|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56446300|NCT00304980|Renal Agents|renal agents|mesh-ancestor
56446301|NCT00293891|Tacrolimus|tacrolimus|mesh-list
56446302|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446303|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
56446304|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446305|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56446306|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446307|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446308|NCT00293930|Tacrolimus|tacrolimus|mesh-list
56446309|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446310|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
56446311|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446312|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56446313|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446314|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446315|NCT00305019|Clevudine|clevudine|mesh-list
56446316|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
56446317|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446318|NCT00293969|Morphine|morphine|mesh-list
56446319|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56446320|NCT00293969|Narcotics|narcotics|mesh-ancestor
56446321|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446322|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446323|NCT00293969|Analgesics|analgesics|mesh-ancestor
56446324|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
56446325|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446326|NCT00294008|Risperidone|risperidone|mesh-list
56446327|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56446328|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
56446329|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446330|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446331|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446332|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56446333|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56446334|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446335|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56446336|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56446337|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
56913754|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56913755|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
56913756|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913757|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913758|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56913759|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
56913760|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56913761|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56913762|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56913763|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913764|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
56913765|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56913766|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56913767|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913768|NCT00068393|Gemcitabine|gemcitabine|mesh-list
56913769|NCT00068393|Doxorubicin|doxorubicin|mesh-list
56913770|NCT00068393|Lenograstim|lenograstim|mesh-list
56160590|NCT03615534|Niacin|niacin|mesh-list
56446339|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56446340|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56446341|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56446342|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446343|NCT00325689|Risperidone|risperidone|mesh-list
56446344|NCT00325689|Aripiprazole|aripiprazole|mesh-list
56446345|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56446346|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56446347|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
56446348|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446349|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446350|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446351|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56446352|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56446353|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446354|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56446358|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
56446359|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56446360|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56446361|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56446362|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56446363|NCT00294164|Hormones|hormones|mesh-list
56446364|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446365|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446366|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56446367|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56446368|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56446369|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56446370|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446371|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
56446372|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446373|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446375|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56446376|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446377|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56051600|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
56913771|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56913772|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
56160601|NCT03630198|Lidocaine|lidocaine|mesh-list
56446378|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56446379|NCT00417833|Growth Substances|growth substances|mesh-ancestor
56446380|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446381|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
56446382|NCT00417872|Metronidazole|metronidazole|mesh-list
56446383|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
56446384|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446385|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56446386|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56446387|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56446388|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
56446389|NCT00294203|Hematinics|hematinics|mesh-ancestor
56446390|NCT00305292|Modafinil|modafinil|mesh-list
56446391|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56446392|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446393|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56446394|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56446395|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56446396|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446397|NCT00305331|Domperidone|domperidone|mesh-list
56446398|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
56446399|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
56446400|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446401|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446402|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56446403|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56446404|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
56446405|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446406|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446407|NCT00325767|Albuterol|albuterol|mesh-list
56446408|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56446409|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
56446410|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446411|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446412|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56446413|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
56446415|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56446416|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56446417|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56446418|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56446419|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
56446420|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446421|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446422|NCT00294359|Bevacizumab|bevacizumab|mesh-list
56446423|NCT00294359|Capecitabine|capecitabine|mesh-list
56446424|NCT00294359|Mitomycins|mitomycins|mesh-list
56446425|NCT00294359|Mitomycin|mitomycin|mesh-list
56446426|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56446427|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446429|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56446430|NCT00294359|Growth Substances|growth substances|mesh-ancestor
56446431|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446432|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
56446433|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56446434|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
56446435|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446436|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56446437|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
56446438|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56446439|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446440|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
56446441|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56446442|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446443|NCT00305370|Aripiprazole|aripiprazole|mesh-list
56164980|NCT04029480|Metformin|metformin|mesh-list
56446444|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
56446445|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56446446|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56446447|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56446448|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913773|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913774|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446449|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446450|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
56446451|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
56446452|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446453|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446454|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56446455|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56446456|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
56446457|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56446458|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56446459|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56446460|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56446461|NCT00325806|Ramipril|ramipril|mesh-list
56446462|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56446463|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
56446464|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446465|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446466|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56446467|NCT00305409|Sulfalene|sulfalene|mesh-list
56446468|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446469|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56446470|NCT00305409|Renal Agents|renal agents|mesh-ancestor
56446471|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
56446472|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56446473|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56446474|NCT00294593|Leucovorin|leucovorin|mesh-list
56446475|NCT00294593|Folic Acid|folic acid|mesh-list
56446476|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
56446477|NCT00294593|Antidotes|antidotes|mesh-ancestor
56446478|NCT00294593|Protective Agents|protective agents|mesh-ancestor
56446479|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446480|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
56446481|NCT00294593|Vitamins|vitamins|mesh-ancestor
56446482|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
56446483|NCT00294593|Hematinics|hematinics|mesh-ancestor
56446484|NCT00325845|Hylan|hylan|mesh-list
56446485|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
56446486|NCT00325845|Protective Agents|protective agents|mesh-ancestor
56446487|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446488|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
56446489|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56446490|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446491|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56446492|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56446493|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446494|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446495|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446496|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56446497|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56446498|NCT00325962|Verapamil|verapamil|mesh-list
56446499|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56446500|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56446501|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56446505|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
56446506|NCT00305487|Ciclesonide|ciclesonide|mesh-list
56446507|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
56446508|NCT00305487|Hormones|hormones|mesh-ancestor
56446509|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446510|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446511|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56446512|NCT00294944|Idazoxan|idazoxan|mesh-list
56446513|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56446514|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56446515|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56446516|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
56446517|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446518|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446519|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446520|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56446521|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
56446522|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913775|NCT00068393|Antiviral Agents|antiviral agents|mesh-ancestor
56913776|NCT00068393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913777|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446523|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56446524|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56446525|NCT00295100|Tamoxifen|tamoxifen|mesh-list
56446526|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56446527|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
56446528|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446529|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446530|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56446531|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446532|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56446533|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56446534|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56446535|NCT00326235|Buspirone|buspirone|mesh-list
56446536|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56446537|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56446538|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446539|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446540|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56446541|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56446542|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
56446543|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446544|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446545|NCT00295178|Vancomycin|vancomycin|mesh-list
56446546|NCT00295178|Daptomycin|daptomycin|mesh-list
56446547|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56446548|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446549|NCT00305838|Tamoxifen|tamoxifen|mesh-list
56446550|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56446551|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
56446552|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446553|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446554|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56446555|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446556|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56446557|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56194385|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
56446558|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56446559|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56446560|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56446561|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56446562|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
56446563|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446564|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56446565|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56446566|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446567|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56446568|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
56446571|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56446572|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446573|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446574|NCT00326352|Remifentanil|remifentanil|mesh-list
56446575|NCT00326352|Propofol|propofol|mesh-list
56446576|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56446577|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446578|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446579|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56446580|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
56446581|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
56446582|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56446583|NCT00326352|Narcotics|narcotics|mesh-ancestor
56446584|NCT00326352|Analgesics|analgesics|mesh-ancestor
56446585|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
56446586|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446587|NCT00419601|Fentanyl|fentanyl|mesh-list
56446588|NCT00419601|Remifentanil|remifentanil|mesh-list
56446589|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56446590|NCT00419601|Narcotics|narcotics|mesh-ancestor
56446591|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446592|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913778|NCT00068393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913779|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
56913780|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913781|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56913782|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56913783|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56913784|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56913785|NCT01086527|Montelukast|montelukast|mesh-list
56913786|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56913787|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
56913788|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56913789|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
56913790|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446593|NCT00419601|Analgesics|analgesics|mesh-ancestor
56446594|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
56446595|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446596|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56446597|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56446598|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
56446599|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
56446600|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56446601|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
56446602|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56446603|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
56446604|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
56446605|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446606|NCT00295607|Antibodies|antibodies|mesh-list
56446607|NCT00295607|Tacrolimus|tacrolimus|mesh-list
56446608|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
56446609|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446610|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446611|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56446612|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446613|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446614|NCT00326391|Methylphenidate|methylphenidate|mesh-list
56446615|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56446616|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446617|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56446618|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56446619|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56446620|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446621|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
56446622|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446623|NCT00295685|Antacids|antacids|mesh-list
56446624|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446625|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56446626|NCT00306150|Aprotinin|aprotinin|mesh-list
56446627|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
56446628|NCT00306150|Coagulants|coagulants|mesh-ancestor
56446629|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56446630|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56446631|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
56446632|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446633|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446634|NCT00417911|Bortezomib|bortezomib|mesh-list
56446635|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446636|NCT00326469|Lanreotide|lanreotide|mesh-list
56446637|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446638|NCT00417950|Acarbose|acarbose|mesh-list
56446639|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56446640|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051601|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
56913791|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913792|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56913793|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56446641|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446642|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56446643|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446645|NCT00306267|Hematinics|hematinics|mesh-ancestor
56446646|NCT00326508|Daclizumab|daclizumab|mesh-list
56446647|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446648|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
56446649|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446650|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
56446651|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
56446652|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
56446653|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446654|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446655|NCT00295841|Cytarabine|cytarabine|mesh-list
56446656|NCT00295841|Clofarabine|clofarabine|mesh-list
56446657|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56446658|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
56446659|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446660|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446661|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
56446662|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446663|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446664|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
56446665|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446666|NCT00326664|Cediranib|cediranib|mesh-list
56446667|NCT00326664|Maleic acid|maleic acid|mesh-list
56446668|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446669|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446670|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446671|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56446672|NCT00295919|Ketoconazole|ketoconazole|mesh-list
56446673|NCT00295919|Fenretinide|fenretinide|mesh-list
56446674|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
56446675|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446676|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56446677|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56446678|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446679|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446680|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56446681|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
56446682|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446683|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446684|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56446685|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446686|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56446687|NCT00295919|Protective Agents|protective agents|mesh-ancestor
56446688|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
56446689|NCT00295958|Immunotoxins|immunotoxins|mesh-list
56446690|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56446691|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
56446692|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446693|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
56446694|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
56446695|NCT00295997|Busulfan|busulfan|mesh-list
56446696|NCT00295997|Methotrexate|methotrexate|mesh-list
56446697|NCT00295997|Fludarabine|fludarabine|mesh-list
56446698|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
56446699|NCT00295997|Tacrolimus|tacrolimus|mesh-list
56446700|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56446701|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446702|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
56446703|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446704|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56446705|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56446706|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
56446707|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446708|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446709|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56913794|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913795|NCT01093937|Varenicline|varenicline|mesh-list
56913796|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56160930|NCT02985840|Dexamethasone|dexamethasone|mesh-list
56446710|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56446711|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
56446712|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56446713|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56446714|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
56446715|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
56446716|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446717|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55785326|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
56446719|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56446720|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56446721|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56446722|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
56446723|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56446724|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446725|NCT00418067|Sirolimus|sirolimus|mesh-list
56446726|NCT00418067|Paclitaxel|paclitaxel|mesh-list
56446727|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56446728|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446729|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
56446730|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
56446731|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
56446732|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446733|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56446734|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446735|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56446736|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
56446737|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446738|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
56446739|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446740|NCT00296309|Tacrolimus|tacrolimus|mesh-list
56446741|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446742|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
56446743|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446744|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56446745|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446746|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446747|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
56446748|NCT00296348|Tacrolimus|tacrolimus|mesh-list
56446749|NCT00296348|Daclizumab|daclizumab|mesh-list
56446750|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446751|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
56446752|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446753|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56446754|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446755|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446756|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56446757|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446758|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56446759|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
56446760|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56446761|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446762|NCT00296387|Atorvastatin|atorvastatin|mesh-list
56446763|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56446764|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56446765|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56446766|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
56446767|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446768|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56446769|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56446770|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446771|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
56446772|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
56446773|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56446774|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446775|NCT00296465|Citric Acid|citric acid|mesh-list
56446776|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
56446777|NCT00296465|Clomiphene|clomiphene|mesh-list
56913797|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56913798|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
56446778|NCT00296465|Enclomiphene|enclomiphene|mesh-list
56446779|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
56446780|NCT00296465|Hormones|hormones|mesh-list
56446781|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56446782|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
56446783|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56446784|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
56446785|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
56446786|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446787|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446788|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446789|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56446790|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
56446791|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56446793|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56446794|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56446795|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56446796|NCT00326859|Remifentanil|remifentanil|mesh-list
56446797|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56446798|NCT00326859|Narcotics|narcotics|mesh-ancestor
56446799|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446800|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446801|NCT00326859|Analgesics|analgesics|mesh-ancestor
56446802|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
56446803|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446804|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56446805|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56446806|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56446807|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56446808|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446809|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446810|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446811|NCT00296699|Analgesics|analgesics|mesh-ancestor
56446812|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
56446813|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446814|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
56446815|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56446816|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
56446817|NCT04717089|Anesthetics|anesthetics|mesh-list
56446818|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56446819|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446820|NCT00296777|Citalopram|citalopram|mesh-list
56446821|NCT00296777|Bupropion|bupropion|mesh-list
56446822|NCT00296777|Imipramine|imipramine|mesh-list
56446823|NCT00296777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56446824|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56446825|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56446826|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446827|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446828|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
56446829|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446830|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56446831|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
56446832|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56446833|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56446834|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
56446835|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56446836|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56446837|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446838|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56446839|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56446840|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
56446841|NCT00296894|Adalimumab|adalimumab|mesh-list
56446842|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56446843|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56446844|NCT00296933|Citalopram|citalopram|mesh-list
56446845|NCT00296933|Bupropion|bupropion|mesh-list
56446846|NCT00296933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56446847|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56446848|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913799|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913800|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913801|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913802|NCT01094015|Lidocaine|lidocaine|mesh-list
56913803|NCT01094015|Prilocaine|prilocaine|mesh-list
56913804|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56913805|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
56913806|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
56091514|NCT01801189|Pregabalin|pregabalin|mesh-list
56446849|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446850|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446851|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
56446852|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446853|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56446854|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
56446855|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56446856|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56333885|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56446858|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56446859|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56446860|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446861|NCT00296972|Interferons|interferons|mesh-list
56446862|NCT00296972|Ribavirin|ribavirin|mesh-list
56446863|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446866|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
56446867|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446868|NCT00297011|Valacyclovir|valacyclovir|mesh-list
56446869|NCT00297011|Clobetasol|clobetasol|mesh-list
56446870|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
56446871|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446872|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56446873|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
56446874|NCT00297011|Hormones|hormones|mesh-ancestor
56446875|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446876|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446877|NCT00327093|Bevacizumab|bevacizumab|mesh-list
56446878|NCT00327093|Cetuximab|cetuximab|mesh-list
56446879|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56446880|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446881|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56446882|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56446883|NCT00327093|Growth Substances|growth substances|mesh-ancestor
56446884|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446885|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
56446886|NCT00297050|Peramivir|peramivir|mesh-list
56446887|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
56446888|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446889|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446890|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446891|NCT00297128|Capecitabine|capecitabine|mesh-list
56446892|NCT00297128|Cetuximab|cetuximab|mesh-list
56446893|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56446894|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
56446895|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446896|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446897|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56446898|NCT00327132|Amoxicillin|amoxicillin|mesh-list
56446899|NCT00327132|Clarithromycin|clarithromycin|mesh-list
56446900|NCT00327132|Omeprazole|omeprazole|mesh-list
56446901|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56446902|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446903|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56446904|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56446905|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56446906|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446907|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446908|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56913807|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913808|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913809|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
56913810|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913811|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56913812|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56446909|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56446910|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56446911|NCT00297206|Valacyclovir|valacyclovir|mesh-list
56446912|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
56446913|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446914|NCT04485195|Procainamide|procainamide|mesh-list
56446915|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56446916|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56446917|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56446918|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56446919|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446920|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
56446921|NCT04478019|Povidone|povidone|mesh-list
56446922|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
56446923|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
56446924|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56446925|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446926|NCT00297284|Modafinil|modafinil|mesh-list
56446927|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56446928|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446929|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56446930|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56446931|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56446932|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446933|NCT04392531|Cyclosporine|cyclosporine|mesh-list
56446934|NCT04392531|Cyclosporins|cyclosporins|mesh-list
56446935|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446936|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446939|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446940|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
56446941|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446942|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
56446943|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56446944|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56446945|NCT00297323|Topiramate|topiramate|mesh-list
56446946|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
56446947|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56446948|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446950|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446951|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
56446952|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
56446953|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
56446954|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446955|NCT00327327|Gemcitabine|gemcitabine|mesh-list
56446956|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56446957|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
56446958|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446959|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56446960|NCT00327327|Antiviral Agents|antiviral agents|mesh-ancestor
56446961|NCT00327327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446962|NCT00327327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446963|NCT00327327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446964|NCT00327327|Immunologic Factors|immunologic factors|mesh-ancestor
56446965|NCT00327327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446966|NCT00297362|Galantamine|galantamine|mesh-list
56446967|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56446968|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446969|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446970|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
56446971|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051602|NCT04847063|Doxorubicin|doxorubicin|mesh-list
56913813|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56913814|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913815|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913816|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56913817|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
56913818|NCT01090895|Vitamins|vitamins|mesh-ancestor
56913819|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
56913820|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913821|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
56913822|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913823|NCT01090895|Protective Agents|protective agents|mesh-ancestor
56913824|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
56913825|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
56913826|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
56161189|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446972|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446973|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56446974|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
56446975|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446976|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
56446977|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
56446978|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56446979|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
56446980|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446981|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446982|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56446983|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
56446984|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56446985|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
56446986|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446987|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56446988|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56446989|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
56446990|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
56446991|NCT04231773|Protective Agents|protective agents|mesh-ancestor
56446992|NCT00297674|Clarithromycin|clarithromycin|mesh-list
56446993|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56446994|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446995|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56446996|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56446997|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446998|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56446999|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56447000|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56447001|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56447002|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447003|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56447004|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
56447005|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56194839|NCT01495260|Vitamin E|vitamin e|mesh-list
56447006|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56447007|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56447008|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846040|NCT03141424|Hormones|hormones|mesh-ancestor
56447010|NCT04718714|Midazolam|midazolam|mesh-list
56447011|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
56447012|NCT04718714|Propofol|propofol|mesh-list
56447013|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56164998|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447014|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051603|NCT04847063|Fluorouracil|fluorouracil|mesh-list
56913827|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913828|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913829|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
56913830|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913831|NCT01094249|Valproic Acid|valproic acid|mesh-list
56913832|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56913833|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56913834|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56913835|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913836|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913837|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56913838|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56913839|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56913840|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
56913841|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56913842|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913843|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56913844|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56913845|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
56913846|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
56913847|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913848|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
56913849|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
56913850|NCT00055601|Gemcitabine|gemcitabine|mesh-list
56913851|NCT00055601|Paclitaxel|paclitaxel|mesh-list
56913852|NCT00055601|Fluorouracil|fluorouracil|mesh-list
56447015|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447016|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56447017|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
56447018|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
56447019|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56447020|NCT04718714|Analgesics|analgesics|mesh-ancestor
56447021|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
56447022|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447023|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56447024|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56447025|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56447026|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
56447027|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447028|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447029|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56447030|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56447031|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56447032|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56447033|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
56447034|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
56447036|NCT00298025|Menotropins|menotropins|mesh-list
56447037|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56447038|NCT00298025|Hormones|hormones|mesh-list
56447039|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56447040|NCT00298025|Ganirelix|ganirelix|mesh-list
56913853|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56913854|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913855|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
56913856|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
56913857|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
56161292|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447041|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56447042|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447043|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
56447044|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56447045|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
56447046|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56447047|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
56447048|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56447049|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
56447050|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447051|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56447052|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447053|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
56447054|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447055|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
56447056|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56447057|NCT00298181|Protective Agents|protective agents|mesh-ancestor
56447058|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56447059|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56447060|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447061|NCT03754140|Polidocanol|polidocanol|mesh-list
56447062|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56447063|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56447064|NCT00298415|Gemcitabine|gemcitabine|mesh-list
56447065|NCT00298415|Paclitaxel|paclitaxel|mesh-list
56447066|NCT00298415|Vinorelbine|vinorelbine|mesh-list
56447067|NCT00298415|Carboplatin|carboplatin|mesh-list
56447068|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56447069|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56447070|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447071|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
56447072|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
56447073|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
56447074|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447075|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56447076|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
56447077|NCT00298415|Antiviral Agents|antiviral agents|mesh-ancestor
56447078|NCT00298415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447079|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447080|NCT00298415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447081|NCT00298415|Immunologic Factors|immunologic factors|mesh-ancestor
56447082|NCT00298415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447084|NCT00298454|Furosemide|furosemide|mesh-list
56447085|NCT00298454|Diuretics|diuretics|mesh-ancestor
56447089|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56447090|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447091|NCT00298571|Epinephrine|epinephrine|mesh-list
56447092|NCT00298571|Bupivacaine|bupivacaine|mesh-list
56447093|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
56447094|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
56447095|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56447096|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447097|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
56447098|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447099|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56447100|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56447101|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
56447102|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447103|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447104|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56447105|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56447106|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
56447107|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56913858|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913859|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56913860|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
56913861|NCT00055601|Antiviral Agents|antiviral agents|mesh-ancestor
56913862|NCT00055601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913863|NCT00055601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913864|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913865|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
56913866|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447108|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
56447109|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
56447110|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
56447111|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56447112|NCT00298688|Gefitinib|gefitinib|mesh-list
56447113|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447114|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56447115|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447116|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447117|NCT05457894|Vaccines|vaccines|mesh-list
56447118|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
56447119|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447120|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
56447121|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56447122|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447123|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56447124|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
56447125|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56447126|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447127|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447128|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447129|NCT00298922|Azithromycin|azithromycin|mesh-list
56447130|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56447131|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447132|NCT00299039|Acetaminophen|acetaminophen|mesh-list
56447133|NCT00299039|Ibuprofen|ibuprofen|mesh-list
56447134|NCT00299039|Codeine|codeine|mesh-list
56447135|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56447136|NCT00299039|Analgesics|analgesics|mesh-ancestor
56447137|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
56447138|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447139|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447140|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
56447141|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56447142|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56447143|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447144|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56447145|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447146|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447147|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56447148|NCT00299039|Narcotics|narcotics|mesh-ancestor
56447149|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56447150|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
56447151|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
56447152|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56447153|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56447154|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56447155|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56194995|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
56447162|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447163|NCT00299390|Sagopilone|sagopilone|mesh-list
56447164|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447165|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
56447166|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
56447167|NCT00299819|Sifalimumab|sifalimumab|mesh-list
56447168|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56447169|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
56051604|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
56913867|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
56913868|NCT01583621|Vitamin D|vitamin d|mesh-list
56913869|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56913870|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913871|NCT01583621|Vitamins|vitamins|mesh-ancestor
56913872|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
56913873|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56913874|NCT03806231|Dinoprostone|dinoprostone|mesh-list
56913875|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
56913876|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56913877|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913878|NCT01091051|Ustekinumab|ustekinumab|mesh-list
56913879|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
56913880|NCT01327079|Methadone|methadone|mesh-list
56447170|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447171|NCT00299858|Theophylline|theophylline|mesh-list
56447172|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56447173|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
56447174|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447175|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447176|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56447177|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
56447178|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56447179|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447180|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447181|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
56447182|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56447183|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56447184|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
56447185|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447186|NCT05455944|Pregabalin|pregabalin|mesh-list
56447187|NCT05455944|Analgesics|analgesics|mesh-ancestor
56447188|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
56447189|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447190|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447191|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
56447192|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56447193|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56447194|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447195|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56447196|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56447197|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56447198|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56447199|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56447200|NCT00299936|Ribavirin|ribavirin|mesh-list
56447201|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56447202|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
56447203|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447204|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
56447205|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447206|NCT00300014|Triamcinolone|triamcinolone|mesh-list
56447207|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56447208|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
56447209|NCT00300014|Hormones|hormones|mesh-ancestor
56447210|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56447211|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447212|NCT02329080|Cytarabine|cytarabine|mesh-list
56447213|NCT02329080|Rituximab|rituximab|mesh-list
56447214|NCT02329080|Methotrexate|methotrexate|mesh-list
56447215|NCT02329080|Etoposide|etoposide|mesh-list
56447216|NCT02329080|Ifosfamide|ifosfamide|mesh-list
56447217|NCT02329080|Thiotepa|thiotepa|mesh-list
56447218|NCT02329080|Carmustine|carmustine|mesh-list
56447219|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56913881|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56913882|NCT01327079|Narcotics|narcotics|mesh-ancestor
56913883|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56913884|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913885|NCT01327079|Analgesics|analgesics|mesh-ancestor
56913886|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
56913887|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56913888|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
56913889|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
56913890|NCT01091207|Sorafenib|sorafenib|mesh-list
56913891|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913892|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56447220|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447221|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
56447222|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447223|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447224|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56447225|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
56447226|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56447227|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56447229|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447230|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
56447231|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447232|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56447233|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447234|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56447235|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56447236|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56447237|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56447239|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447240|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56447241|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
56447242|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56447243|NCT00300131|Everolimus|everolimus|mesh-list
56447244|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447245|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447246|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
56447247|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447248|NCT01820910|Doxycycline|doxycycline|mesh-list
56447249|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56447250|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447251|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
56447252|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56447253|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56447254|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
56447255|NCT01785459|Bupivacaine|bupivacaine|mesh-list
56447256|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
56447257|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
56447258|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56447259|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447260|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
56447261|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447262|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
56447263|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
56447264|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56447265|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56447266|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56447267|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56447268|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56447269|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
56447270|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447271|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447272|NCT04716894|Itraconazole|itraconazole|mesh-list
56447273|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
56913893|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913894|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913895|NCT00054275|Docetaxel|docetaxel|mesh-list
56913896|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56913897|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913898|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
56913899|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
56913900|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
56913901|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913902|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56913903|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913904|NCT01095185|Simvastatin|simvastatin|mesh-list
56913905|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56913906|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56913907|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
56913908|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913909|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56913910|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56913911|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913912|NCT01583777|Belinostat|belinostat|mesh-list
56913913|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913914|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56913915|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913916|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913917|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
56913918|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56913919|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913920|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913921|NCT00052715|Poly ICLC|poly iclc|mesh-list
56913922|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
56913923|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
56913925|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
56913934|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56913935|NCT00051311|Cyclosporine|cyclosporine|mesh-list
56913936|NCT00051311|Prednisone|prednisone|mesh-list
56913937|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
56913938|NCT00051311|Doxorubicin|doxorubicin|mesh-list
56913939|NCT00051311|Methotrexate|methotrexate|mesh-list
56913940|NCT00051311|Fludarabine|fludarabine|mesh-list
56913941|NCT00051311|Etoposide|etoposide|mesh-list
56913942|NCT00051311|Vincristine|vincristine|mesh-list
56913943|NCT00051311|Cyclosporins|cyclosporins|mesh-list
56913944|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913945|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
56913946|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913947|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56913948|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56913949|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
56913950|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913951|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913952|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56913953|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56913954|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56913955|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56913956|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56913957|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56913958|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
56913959|NCT00051311|Hormones|hormones|mesh-ancestor
56913960|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56913961|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56447274|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447275|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56447276|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56447277|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447278|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447279|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56447280|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
56447281|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56447282|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447283|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56447284|NCT00300287|Vildagliptin|vildagliptin|mesh-list
56447285|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56447286|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447287|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56447288|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
56447289|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447290|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447291|NCT00300404|Leucovorin|leucovorin|mesh-list
56447292|NCT00300404|Folic Acid|folic acid|mesh-list
56447293|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
56913962|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56913963|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
56913964|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56913965|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56913966|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
56913967|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
56913968|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56913969|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56447294|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
56447295|NCT00300404|Antidotes|antidotes|mesh-ancestor
56447296|NCT00300404|Protective Agents|protective agents|mesh-ancestor
56447297|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447298|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
56447299|NCT00300404|Vitamins|vitamins|mesh-ancestor
56447300|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
56447301|NCT00300404|Hematinics|hematinics|mesh-ancestor
56447304|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56447305|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447306|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56447307|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447308|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447310|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56447311|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56447312|NCT01539447|Analgesics|analgesics|mesh-ancestor
56447313|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
56447314|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447315|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447317|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447318|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
56447319|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56447320|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447321|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447322|NCT00300443|Bimatoprost|bimatoprost|mesh-list
56447323|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56447324|NCT00300560|Colistin|colistin|mesh-list
56447325|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56447326|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447327|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56447328|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
56447329|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447330|NCT00300716|Memantine|memantine|mesh-list
56447331|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56447332|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56447333|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
56447334|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447335|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447336|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447337|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56447338|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56447339|NCT00300794|Ketamine|ketamine|mesh-list
56447340|NCT00300794|Analgesics|analgesics|mesh-ancestor
56447341|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
56447342|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447343|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447344|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56447345|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56447346|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
56447347|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
56447348|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56447349|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56447350|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56447351|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447352|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447353|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
56447354|NCT05373303|Hematinics|hematinics|mesh-ancestor
56447355|NCT00300833|Tirofiban|tirofiban|mesh-list
56447356|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56913970|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56913971|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
56447357|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56447358|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447359|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56447360|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
56447361|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56447362|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447363|NCT00327678|Rituximab|rituximab|mesh-list
56447364|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
56447365|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56447366|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447367|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
56447368|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447369|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447370|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56447371|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447372|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447373|NCT00300950|Gemcitabine|gemcitabine|mesh-list
56447374|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56447377|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447378|NCT00300950|Antiviral Agents|antiviral agents|mesh-ancestor
56447379|NCT00300950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447380|NCT00300950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333886|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447381|NCT00300950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447382|NCT00300950|Immunologic Factors|immunologic factors|mesh-ancestor
56447383|NCT00300950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447384|NCT00327756|Ubiquinone|ubiquinone|mesh-list
56447385|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
56447386|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
56447387|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447388|NCT00327756|Vitamins|vitamins|mesh-ancestor
56447389|NCT00301106|Interleukin-12|interleukin-12|mesh-list
56447390|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56447391|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
56447392|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447393|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56447394|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56447395|NCT00301106|Growth Substances|growth substances|mesh-ancestor
56447396|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
56447397|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447398|NCT00301145|Varenicline|varenicline|mesh-list
56447399|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56447400|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56447401|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
56447402|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447403|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447404|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447405|NCT00301223|Pregabalin|pregabalin|mesh-list
56447406|NCT00301223|Analgesics|analgesics|mesh-ancestor
56447407|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
56447408|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447409|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447410|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
56447411|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56447412|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56447413|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447414|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56447415|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56447416|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56447417|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56447418|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56447419|NCT00301301|Gemcitabine|gemcitabine|mesh-list
56447420|NCT00301301|Rituximab|rituximab|mesh-list
56447421|NCT00301301|Cisplatin|cisplatin|mesh-list
56447422|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56447423|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447424|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
56447425|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447426|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447427|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56447428|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
56913972|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
56913973|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
56447429|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447430|NCT00301301|Antiviral Agents|antiviral agents|mesh-ancestor
56447431|NCT00301301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447432|NCT00301301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447433|NCT00301301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447434|NCT00301535|Chrysarobin|chrysarobin|mesh-list
56447435|NCT00301535|HBOC 201|hboc 201|mesh-list
56447436|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56447437|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56447438|NCT00301535|Analgesics|analgesics|mesh-ancestor
56447439|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
56447440|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447441|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447442|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56447443|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447444|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
56447445|NCT00301574|Galantamine|galantamine|mesh-list
56447446|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56447447|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447448|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447450|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447451|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447452|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56447453|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
56447454|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447455|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
56447456|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56447457|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56447458|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56447459|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56447460|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447462|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447463|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447464|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
56447465|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56447466|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447467|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56447468|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
56447469|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56447470|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447471|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447472|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447473|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
56447474|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56447475|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447476|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56447477|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
56447478|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56447479|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447480|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447481|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447482|NCT00301730|Aldesleukin|aldesleukin|mesh-list
56447483|NCT00301730|Paclitaxel|paclitaxel|mesh-list
56447484|NCT00301730|Trastuzumab|trastuzumab|mesh-list
56447485|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56447486|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447487|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
56447488|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
56447489|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
56447490|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447491|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56447492|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56447493|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56447494|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
56447495|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447496|NCT00301847|Sorafenib|sorafenib|mesh-list
56447497|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447498|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56447499|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447500|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913974|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
56913975|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161812|NCT00074724|Dobutamine|dobutamine|mesh-list
56447501|NCT00327990|Alendronate|alendronate|mesh-list
56447502|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
56447503|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56447504|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447505|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
56447506|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
56447507|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56447508|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447509|NCT05238831|Paclitaxel|paclitaxel|mesh-list
56447510|NCT05238831|Vinorelbine|vinorelbine|mesh-list
56447511|NCT05238831|Maytansine|maytansine|mesh-list
56447512|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56447513|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56447514|NCT05238831|Bevacizumab|bevacizumab|mesh-list
56447515|NCT05238831|Carboplatin|carboplatin|mesh-list
56447516|NCT05238831|Capecitabine|capecitabine|mesh-list
56447517|NCT05238831|Trastuzumab|trastuzumab|mesh-list
56447518|NCT05238831|Irinotecan|irinotecan|mesh-list
56447519|NCT05238831|Atezolizumab|atezolizumab|mesh-list
56447520|NCT05238831|Letrozole|letrozole|mesh-list
56447521|NCT05238831|Olaparib|olaparib|mesh-list
56447522|NCT05238831|Fulvestrant|fulvestrant|mesh-list
56447523|NCT05238831|Palbociclib|palbociclib|mesh-list
56447524|NCT05238831|Anastrozole|anastrozole|mesh-list
56447526|NCT05238831|Niraparib|niraparib|mesh-list
56447527|NCT05238831|Vemurafenib|vemurafenib|mesh-list
56447528|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56447529|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
56195361|NCT01498562|Gefitinib|gefitinib|mesh-list
56447530|NCT05238831|Antibodies|antibodies|mesh-list
56447531|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
56447532|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56447533|NCT05238831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56447536|NCT05238831|Entrectinib|entrectinib|mesh-list
56447537|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
56447538|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56447539|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447540|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
56447541|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
56447542|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
56447543|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447544|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56447545|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56447546|NCT05238831|Growth Substances|growth substances|mesh-ancestor
56447547|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447548|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
56447549|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
56447550|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56447551|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
56447552|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56447553|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56447554|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447555|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56447556|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56447557|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56447558|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
56447559|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56447560|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56447561|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56447562|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56447563|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56447564|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
56447565|NCT00301925|Fluorouracil|fluorouracil|mesh-list
56447566|NCT00301925|Capecitabine|capecitabine|mesh-list
56447567|NCT00301925|Methotrexate|methotrexate|mesh-list
56447568|NCT00301925|Epirubicin|epirubicin|mesh-list
56447569|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447570|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
56447571|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447572|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447573|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56447574|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
56447575|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913976|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56913977|NCT01091753|Amlodipine|amlodipine|mesh-list
56913978|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56624621|NCT02784054|Bleomycin|bleomycin|mesh-list
56913979|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56913980|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56913981|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913982|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56913983|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913984|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
56913985|NCT00049673|Thalidomide|thalidomide|mesh-list
56913986|NCT00049673|Prednisone|prednisone|mesh-list
56913987|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56913988|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
56913989|NCT00049673|Hormones|hormones|mesh-ancestor
56913990|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56447576|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447577|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56447578|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
56447579|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56447580|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56447581|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
56447582|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56447583|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
56447584|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447585|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56447586|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56447587|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56447588|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56447589|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56447590|NCT00328029|Busulfan|busulfan|mesh-list
56447591|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
56447592|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447593|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447594|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
56447595|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447596|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56447597|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447598|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56447599|NCT00302354|Methylphenidate|methylphenidate|mesh-list
56447600|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56447601|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447602|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56447603|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56447604|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56447605|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447606|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
56447608|NCT00302393|Methylphenidate|methylphenidate|mesh-list
56447609|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56447610|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447611|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56447612|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56447613|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56447614|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447615|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
56447616|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447617|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
56913991|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913992|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56161932|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56447618|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
56447619|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
56447620|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447621|NCT00302432|Menthol|menthol|mesh-list
56447622|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
56447623|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
56447624|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56447625|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56447626|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
56447627|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447628|NCT00302549|Tacrolimus|tacrolimus|mesh-list
56447629|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447630|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
56447631|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447632|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56447633|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447634|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447635|NCT00419991|Tigecycline|tigecycline|mesh-list
56447636|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56447637|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447638|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56447639|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447640|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447641|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
56447642|NCT00302627|Vitamin D|vitamin d|mesh-list
56447643|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
56447644|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
56447645|NCT00302627|Pamidronate|pamidronate|mesh-list
56447646|NCT00302627|Vitamins|vitamins|mesh-list
56447647|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
56447648|NCT00302627|Calcium|calcium|mesh-list
56447649|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
56447650|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447651|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56447652|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56447653|NCT00302627|Antacids|antacids|mesh-ancestor
56447654|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447655|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56447656|NCT00302666|Dienogest|dienogest|mesh-list
56447657|NCT00302666|Nandrolone|nandrolone|mesh-list
56447658|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56447659|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
56447660|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56447661|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447662|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56447663|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56447664|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56447665|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56447666|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
56447667|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56447668|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56447669|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447670|NCT00302666|Androgens|androgens|mesh-ancestor
56447671|NCT00302666|Hormones|hormones|mesh-ancestor
56447672|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
56447673|NCT00328302|Candesartan|candesartan|mesh-list
56447674|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56447675|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56447691|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447692|NCT00302705|Valsartan|valsartan|mesh-list
56447693|NCT00302705|Enalapril|enalapril|mesh-list
56447694|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56447695|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56447696|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56447697|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447698|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56447699|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
56447700|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447701|NCT00302822|Tenofovir|tenofovir|mesh-list
56447702|NCT00302822|Emtricitabine|emtricitabine|mesh-list
56913993|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56913994|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913995|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
56913996|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
56913997|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56913998|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56913999|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56914000|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56914001|NCT00049673|Growth Substances|growth substances|mesh-ancestor
56914002|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56914003|NCT00049517|Cytarabine|cytarabine|mesh-list
56914004|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
56914005|NCT00049517|Busulfan|busulfan|mesh-list
56914006|NCT00049517|Daunorubicin|daunorubicin|mesh-list
56447703|NCT00302822|Efavirenz|efavirenz|mesh-list
56447704|NCT00302822|Lopinavir|lopinavir|mesh-list
56447705|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
56447706|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
56447707|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447708|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56447709|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56447710|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447711|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447712|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56447713|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56447714|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56447715|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56447716|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56447717|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56447718|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56447719|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56447720|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56447721|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56447722|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
56447723|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56447724|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56447725|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56447726|NCT00328458|Epothilones|epothilones|mesh-list
56447727|NCT00328458|Epothilone B|epothilone b|mesh-list
56447728|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
56447729|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
56447730|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
56447731|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447732|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447733|NCT05008224|Prednisone|prednisone|mesh-list
56447734|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
56447735|NCT05008224|Dacarbazine|dacarbazine|mesh-list
56447736|NCT05008224|Doxorubicin|doxorubicin|mesh-list
56447737|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
56447748|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56447749|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
56447750|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447751|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447752|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56447753|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56447754|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56447755|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56447756|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165013|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56447757|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56447758|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56447760|NCT05008224|Hormones|hormones|mesh-ancestor
55886641|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914007|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
56914008|NCT00049517|Sargramostim|sargramostim|mesh-list
56914009|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914010|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
56447761|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56447762|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56447763|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56447764|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
56447765|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
56447766|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
56447767|NCT00303017|Naproxen|naproxen|mesh-list
56447768|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56447769|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56447770|NCT00303017|Analgesics|analgesics|mesh-ancestor
56447771|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
56447772|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447773|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447774|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56447775|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447776|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
56447777|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56447778|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447779|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447780|NCT00303056|Icatibant|icatibant|mesh-list
56447781|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56447782|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56447783|NCT00303056|Analgesics|analgesics|mesh-ancestor
56447784|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
56447785|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447786|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447787|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56447788|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447789|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56447790|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56447791|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447792|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56447793|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447794|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
56447795|NCT00328497|Bevacizumab|bevacizumab|mesh-list
56447796|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
56447797|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56447798|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447799|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56447800|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56447801|NCT00328497|Growth Substances|growth substances|mesh-ancestor
56447802|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447803|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
56447804|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
56447805|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
56447806|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
56447807|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447809|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56447810|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56447811|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447812|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
56447813|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447814|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447815|NCT00303290|Interferons|interferons|mesh-list
56447816|NCT00303290|Cytarabine|cytarabine|mesh-list
56447817|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
56447818|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
56447819|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56447820|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447821|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
56447822|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447823|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56447824|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
56447825|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447826|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447827|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
55888209|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
56914011|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914012|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56162142|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
56447828|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447829|NCT00328692|Rolofylline|rolofylline|mesh-list
56447830|NCT00328692|Diuretics|diuretics|mesh-ancestor
56195659|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56447832|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447833|NCT04982796|Psilocybin|psilocybin|mesh-list
56447834|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
56447835|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447836|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56447837|NCT00419718|Insulin|insulin|mesh-list
56447838|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56447839|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56447840|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447841|NCT00303407|Nadroparin|nadroparin|mesh-list
56447842|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
56447843|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56447844|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56447845|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447846|NCT00303524|Goserelin|goserelin|mesh-list
56447847|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56447848|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447849|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
56447850|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56447851|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56447852|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447853|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447854|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56447855|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56447856|NCT00419796|Analgesics|analgesics|mesh-ancestor
56447857|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
56447858|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447859|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447860|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56447861|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447862|NCT00419835|Losartan|losartan|mesh-list
56447863|NCT00419835|Enalapril|enalapril|mesh-list
56447864|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56447865|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56447866|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56447867|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56447868|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447869|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56447870|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
56447871|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447872|NCT00328809|Spironolactone|spironolactone|mesh-list
56447873|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56447874|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
56447875|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56447876|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847883|NCT02720068|Leucovorin|leucovorin|mesh-list
56447878|NCT00328809|Diuretics|diuretics|mesh-ancestor
56447879|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
56447880|NCT00420030|Abciximab|abciximab|mesh-list
56447881|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
56447882|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56447883|NCT00303758|Leucovorin|leucovorin|mesh-list
56447884|NCT00303758|Gemcitabine|gemcitabine|mesh-list
56447885|NCT00303758|Fluorouracil|fluorouracil|mesh-list
56447886|NCT00303758|Calcium|calcium|mesh-list
56447887|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
56447888|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447889|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56447890|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
56447891|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447892|NCT00303758|Antiviral Agents|antiviral agents|mesh-ancestor
56447893|NCT00303758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447894|NCT00303758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447895|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447896|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
56447897|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097214|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
56914013|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56914014|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
56914015|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914016|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914017|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56914018|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914019|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
56914020|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
56914021|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914022|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56914023|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56914024|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56914025|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914026|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56914027|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
56914028|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914029|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56914030|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914031|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914032|NCT00066365|Molgramostim|molgramostim|mesh-list
56914033|NCT00066365|Sargramostim|sargramostim|mesh-list
56914034|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
56914035|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914036|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914037|NCT00048581|Abatacept|abatacept|mesh-list
56914038|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56914039|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914040|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914041|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914042|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
56914043|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914044|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56914045|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
56914046|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56914047|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
56914048|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447898|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56914049|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914050|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
56914051|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914052|NCT03957629|Interferons|interferons|mesh-list
56914053|NCT03957629|Tenofovir|tenofovir|mesh-list
56624703|NCT00590967|Cisplatin|cisplatin|mesh-list
56914054|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
56914055|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
56914056|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56914057|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914058|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
56914059|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914060|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56914061|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56914062|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914063|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914064|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56914065|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56914066|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
56914067|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914068|NCT00065507|Entecavir|entecavir|mesh-list
56914069|NCT00065507|Adefovir|adefovir|mesh-list
56914070|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
56914071|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914072|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56914073|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56914074|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914075|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914076|NCT01095575|Morphine|morphine|mesh-list
56914077|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56914078|NCT01095575|Narcotics|narcotics|mesh-ancestor
56914079|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56914080|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914081|NCT01095575|Analgesics|analgesics|mesh-ancestor
56914082|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
56914083|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914084|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
56447899|NCT00303758|Antidotes|antidotes|mesh-ancestor
56447900|NCT00303758|Protective Agents|protective agents|mesh-ancestor
56447901|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
56447902|NCT00303758|Vitamins|vitamins|mesh-ancestor
56914085|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56914086|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914087|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56914088|NCT01095731|Acetic Acid|acetic acid|mesh-list
56914089|NCT01095731|Retinol acetate|retinol acetate|mesh-list
56914090|NCT01095731|Glycine|glycine|mesh-list
56914091|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
56914092|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914093|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914094|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914095|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914096|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914097|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56914098|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
56914099|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56914100|NCT01095731|Protective Agents|protective agents|mesh-ancestor
56914101|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914102|NCT01095809|Triamcinolone|triamcinolone|mesh-list
56914103|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56447903|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
56447904|NCT00303797|Bortezomib|bortezomib|mesh-list
56447905|NCT00303797|Sorafenib|sorafenib|mesh-list
56447906|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447907|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56447908|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447909|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447910|NCT00303836|Aldesleukin|aldesleukin|mesh-list
56447911|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
56447912|NCT00303836|Fludarabine|fludarabine|mesh-list
56447913|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
56447914|NCT00303836|Interleukin-2|interleukin-2|mesh-list
56447915|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
56447916|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447917|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
56447918|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447919|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447920|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56447921|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
56447922|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447923|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447924|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56447925|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56447926|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
56447927|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56447928|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56447929|NCT00303836|Analgesics|analgesics|mesh-ancestor
56447930|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
56447931|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447932|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56447933|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56447934|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
56447935|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447936|NCT00303992|Trastuzumab|trastuzumab|mesh-list
56447937|NCT00303992|Irinotecan|irinotecan|mesh-list
56447938|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56447939|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447940|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56447941|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56914104|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56914105|NCT01095809|Bevacizumab|bevacizumab|mesh-list
56914106|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56162345|NCT00000810|Didanosine|didanosine|mesh-list
56447942|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447943|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447944|NCT00304226|Amlodipine|amlodipine|mesh-list
56447945|NCT00304226|Valsartan|valsartan|mesh-list
56447946|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56447947|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56447948|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56447949|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447950|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56447951|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447952|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
55848161|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447954|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56447955|NCT00332319|Casopitant|casopitant|mesh-list
56447956|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
56447957|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
56447958|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447959|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447960|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56447961|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56447962|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447963|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447964|NCT00304382|Vaccines|vaccines|mesh-list
56447965|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56447966|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
56165017|NCT03915366|Valganciclovir|valganciclovir|mesh-list
56447967|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447968|NCT00304421|Rabeprazole|rabeprazole|mesh-list
56447969|NCT00304421|Pantoprazole|pantoprazole|mesh-list
56447970|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56447971|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56447972|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56447973|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447974|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447975|NCT00332397|Sirolimus|sirolimus|mesh-list
56447976|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56447977|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447978|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56447979|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447980|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
56447981|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447982|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
56447983|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447985|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447986|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56447987|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56447988|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
56447989|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447990|NCT00304499|Oxybutynin|oxybutynin|mesh-list
56447991|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
56447992|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
56447993|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56447994|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447995|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56447996|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56447997|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
56447998|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447999|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448000|NCT00304499|Urological Agents|urological agents|mesh-ancestor
56448001|NCT00304538|Glucagon|glucagon|mesh-list
56448002|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56448003|NCT00304538|Hormones|hormones|mesh-ancestor
56448004|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448005|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448006|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56448007|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56448008|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56914107|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56448009|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56448010|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448011|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
56448012|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448013|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448014|NCT00328965|Lacidipine|lacidipine|mesh-list
56448015|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56448016|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56448017|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56448018|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448019|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56448020|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448021|NCT00304616|Olanzapine|olanzapine|mesh-list
56448022|NCT00304616|Risperidone|risperidone|mesh-list
56448023|NCT00304616|Aripiprazole|aripiprazole|mesh-list
56448024|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56448027|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448028|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448029|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448030|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56448031|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56448032|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448033|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56448034|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56448035|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
56448036|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
56448037|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
56448038|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448039|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56448040|NCT00304616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56448041|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56448042|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56448043|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
56448044|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
56448045|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56448046|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56448047|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56448048|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56448050|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56448051|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56448052|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56448053|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
56448054|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448055|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448057|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56448058|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56448059|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56448060|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56448061|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56448062|NCT00304655|Aripiprazole|aripiprazole|mesh-list
56448063|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
56448064|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56448065|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56448066|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56448067|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448068|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448069|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
56448070|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
56448071|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448072|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448073|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56448074|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56448075|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
56448076|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56448077|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56448078|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56448079|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56448080|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56448081|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56097306|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914108|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914109|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56914110|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56914111|NCT01095809|Growth Substances|growth substances|mesh-ancestor
56914112|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448082|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56448083|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56448084|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
56448085|NCT00332553|Estradiol|estradiol|mesh-list
56448086|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56448087|NCT00332553|Estrogens|estrogens|mesh-list
56448088|NCT00332553|Hormones|hormones|mesh-ancestor
56448089|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448090|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448091|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56448092|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
56448093|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56448094|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56448095|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55848506|NCT03829696|Misoprostol|misoprostol|mesh-list
56448097|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56448098|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56448099|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56448100|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448101|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56448102|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
56448103|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56448104|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56448105|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56448106|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
56448107|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56448108|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
56448109|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448110|NCT00332631|Expectorants|expectorants|mesh-ancestor
56448111|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
56448112|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56448113|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
56448114|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448115|NCT00332631|Protective Agents|protective agents|mesh-ancestor
56448116|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448117|NCT00332631|Antidotes|antidotes|mesh-ancestor
56448118|NCT00304772|Fluconazole|fluconazole|mesh-list
56448120|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
56448121|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448122|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56448123|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56448124|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448125|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448126|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56448127|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
56195976|NCT01501422|Estrogens|estrogens|mesh-list
56448128|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448129|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448130|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56448131|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56448133|NCT00304811|Rifampin|rifampin|mesh-list
56448134|NCT00304811|Gentamicins|gentamicins|mesh-list
56448135|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448136|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448137|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56448138|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
56448139|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
56448140|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56448141|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448142|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448143|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56448144|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56448145|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56914113|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
56914114|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914115|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
56914116|NCT01095809|Hormones|hormones|mesh-ancestor
56914117|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914118|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914119|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
56914120|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914121|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914122|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
56914123|NCT00048035|Hematinics|hematinics|mesh-ancestor
56914124|NCT01092221|Allopurinol|allopurinol|mesh-list
56914125|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
56448146|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56448147|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56448148|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56448149|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56448150|NCT00332787|Fluoxetine|fluoxetine|mesh-list
56448151|NCT00332787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56448152|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56448153|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56448154|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448155|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448156|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
56448157|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448158|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56448159|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
56448160|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56448161|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56448162|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56448163|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448164|NCT00304850|Ketamine|ketamine|mesh-list
56448165|NCT00304850|Analgesics|analgesics|mesh-ancestor
56448166|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
56448168|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448169|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56448170|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56448171|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
56448172|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
56448173|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448174|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56448175|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56448176|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448177|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448178|NCT00329316|Progesterone|progesterone|mesh-list
56448179|NCT00329316|Progestins|progestins|mesh-ancestor
56448180|NCT00329316|Hormones|hormones|mesh-ancestor
56448181|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448182|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448183|NCT00332826|Insulin|insulin|mesh-list
56448184|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56448185|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448186|NCT00305201|Pravastatin|pravastatin|mesh-list
56448187|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56448188|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56448189|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
56448190|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448191|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56448192|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56448193|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448194|NCT00329355|Naproxen|naproxen|mesh-list
56914126|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914127|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624783|NCT00875875|Rifaximin|rifaximin|mesh-list
56448195|NCT00329355|Sumatriptan|sumatriptan|mesh-list
56448196|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56448197|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56196034|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448198|NCT00329355|Analgesics|analgesics|mesh-ancestor
56448199|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
56448200|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448201|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448202|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56448203|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56448204|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
56448205|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56448206|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448207|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448208|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56448209|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56448210|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56448211|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
56448212|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448213|NCT00332904|Propranolol|propranolol|mesh-list
56448214|NCT00332904|Spironolactone|spironolactone|mesh-list
56448215|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56448216|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56448217|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
56448218|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448219|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448220|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448221|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56448222|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56448223|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
56448224|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56448225|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
56448226|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448227|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56448228|NCT00332904|Diuretics|diuretics|mesh-ancestor
56448229|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
56448230|NCT00329394|Ketamine|ketamine|mesh-list
56448231|NCT00329394|Analgesics|analgesics|mesh-ancestor
56448232|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
56448233|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448234|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448235|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56448236|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56448237|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
56448239|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448240|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56448241|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56448242|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448243|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448244|NCT00305396|Sirolimus|sirolimus|mesh-list
56448245|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448246|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448247|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56448248|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448249|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
56448250|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448251|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
56448252|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448253|NCT00329472|Gemcitabine|gemcitabine|mesh-list
56448254|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448255|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56448256|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
56448257|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448258|NCT00329472|Antiviral Agents|antiviral agents|mesh-ancestor
56448259|NCT00329472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448260|NCT00329472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448261|NCT00329472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56162702|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
56448262|NCT00329472|Immunologic Factors|immunologic factors|mesh-ancestor
56448263|NCT00329472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448264|NCT00305474|Risperidone|risperidone|mesh-list
56448265|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56448266|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
56448267|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448268|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448269|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448270|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56196120|NCT01501799|Adapalene|adapalene|mesh-list
56448272|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448273|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56448274|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56448275|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
56448276|NCT00329511|Clonidine|clonidine|mesh-list
56448277|NCT00329511|Methyldopa|methyldopa|mesh-list
56448278|NCT00329511|Analgesics|analgesics|mesh-ancestor
56448279|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
56448280|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448281|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448282|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56448283|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
56448284|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
56448285|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56448286|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56448287|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56448288|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
56448289|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448290|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448291|NCT00305513|Caffeine|caffeine|mesh-list
56448292|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56448293|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448294|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56448295|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448296|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448297|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56448298|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56448299|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
56448300|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448302|NCT00333021|Fondaparinux|fondaparinux|mesh-list
56448303|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56448304|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
56448305|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56448306|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
56448307|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448308|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448309|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
56448310|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56448311|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56448313|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448314|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
56448315|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448316|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
56448317|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448318|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448319|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56448320|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56448321|NCT00305552|Growth Substances|growth substances|mesh-ancestor
56448323|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448324|NCT00329589|Bortezomib|bortezomib|mesh-list
56448325|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448326|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
56448327|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56448328|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56448329|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448330|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448331|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448332|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56448333|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56448334|NCT00305630|Triamcinolone|triamcinolone|mesh-list
56448335|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56448336|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56448337|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56914128|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
56914129|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56914130|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56914131|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
56448338|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56448339|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
56448340|NCT00305630|Hormones|hormones|mesh-ancestor
56448341|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448342|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448343|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448344|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
56448345|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448346|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448348|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
56448349|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56448350|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
56448351|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56448352|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
56448353|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448354|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448355|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
56448356|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56448357|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56448358|NCT00305669|Sargramostim|sargramostim|mesh-list
56448359|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
56448360|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448361|NCT00305708|Fludarabine|fludarabine|mesh-list
56448362|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
56448363|NCT00305708|Busulfan|busulfan|mesh-list
56448364|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56448365|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448366|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56448367|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
56448368|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448369|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448370|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
56448371|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448372|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
56448373|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56448374|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56448375|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56448376|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56448377|NCT00305747|Protective Agents|protective agents|mesh-ancestor
56448378|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448379|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448380|NCT00333255|Nepafenac|nepafenac|mesh-list
56448381|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56448382|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56448383|NCT00333255|Analgesics|analgesics|mesh-ancestor
56448384|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
56448385|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448386|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448387|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56448391|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56448393|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448394|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448395|NCT00305786|Antiviral Agents|antiviral agents|mesh-ancestor
56448396|NCT00305786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448397|NCT00305786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448398|NCT00305786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448399|NCT00305786|Immunologic Factors|immunologic factors|mesh-ancestor
56448400|NCT00305786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448401|NCT00305825|Bevacizumab|bevacizumab|mesh-list
56448402|NCT00305825|Letrozole|letrozole|mesh-list
56448403|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56448404|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448405|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56448406|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56448407|NCT00305825|Growth Substances|growth substances|mesh-ancestor
56448408|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448409|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
56914132|NCT01092221|Protective Agents|protective agents|mesh-ancestor
56448410|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56448411|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56448412|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448413|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448414|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56448415|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
56448416|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448417|NCT00333294|Vinorelbine|vinorelbine|mesh-list
56448418|NCT00333294|Gefitinib|gefitinib|mesh-list
56448419|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448420|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56448422|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
56448423|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
56448424|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448425|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56448426|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448427|NCT00305903|Memantine|memantine|mesh-list
56448428|NCT00305903|Rivastigmine|rivastigmine|mesh-list
56448429|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56448430|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56448431|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
56448432|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448433|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448434|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448435|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56448436|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56448437|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56448438|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448439|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
56448440|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56448441|NCT00305903|Protective Agents|protective agents|mesh-ancestor
56448442|NCT00329823|Etanercept|etanercept|mesh-list
56448443|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56448444|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56448445|NCT00329823|Analgesics|analgesics|mesh-ancestor
56448446|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
56448447|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448448|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448449|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56448450|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56448451|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56448452|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448453|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
56448454|NCT00306020|Morphine|morphine|mesh-list
56448455|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56448456|NCT00306020|Narcotics|narcotics|mesh-ancestor
56448457|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448458|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448459|NCT00306020|Analgesics|analgesics|mesh-ancestor
56448460|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
56448462|NCT00306137|Aprotinin|aprotinin|mesh-list
56448463|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
56448464|NCT00306137|Coagulants|coagulants|mesh-ancestor
56448465|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56448466|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56448467|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
56448468|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448469|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448470|NCT00329940|Letrozole|letrozole|mesh-list
56448471|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448472|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56448473|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56448474|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448475|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448476|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56448477|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
56448478|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448479|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448480|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
56448481|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56448482|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448483|NCT00333372|Z 338|z 338|mesh-list
56448484|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56914133|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914134|NCT00047879|Interferons|interferons|mesh-list
56914135|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
56914136|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
56914137|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56914138|NCT00047879|Thalidomide|thalidomide|mesh-list
56914139|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914140|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
56914141|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914142|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
56914143|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914144|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914145|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
56914146|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914147|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56914148|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56914149|NCT00047879|Growth Substances|growth substances|mesh-ancestor
56914150|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
56914151|NCT00064337|Thalidomide|thalidomide|mesh-list
56914152|NCT00064337|Dexamethasone|dexamethasone|mesh-list
56914153|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
56914154|NCT00064337|Melphalan|melphalan|mesh-list
56914155|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914156|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
56914157|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914158|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56914159|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56914160|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
56914161|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914162|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448485|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448486|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448487|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
56448488|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448489|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448490|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56448491|NCT00330018|Acyclovir|acyclovir|mesh-list
56448492|NCT00330018|Valganciclovir|valganciclovir|mesh-list
56448493|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
56448494|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196332|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
56448495|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56448496|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
56448497|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448498|NCT00306254|Enoxaparin|enoxaparin|mesh-list
56448499|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
56914163|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56914164|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914165|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
56914166|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
56914167|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914168|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56914169|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
56914170|NCT00064337|Hormones|hormones|mesh-ancestor
56914171|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914172|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56448500|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
56448501|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56448502|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56448503|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448504|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56448505|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
56448506|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56448507|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
56448508|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448509|NCT00333489|Valsartan|valsartan|mesh-list
56448510|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56448511|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56448512|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56448513|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448514|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
56448515|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56448516|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
56448517|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448518|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
56448519|NCT00330135|Protective Agents|protective agents|mesh-ancestor
56448520|NCT03275558|Sunitinib|sunitinib|mesh-list
56448521|NCT03275558|Axitinib|axitinib|mesh-list
56448522|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448523|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56448524|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56448525|NCT03275558|Growth Substances|growth substances|mesh-ancestor
56448526|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448527|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
56448528|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56448529|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448530|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448531|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56448532|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56448534|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
56448535|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
56448536|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56448537|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56448538|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949306|NCT01495923|Gabapentin|gabapentin|mesh-list
56448539|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448540|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56448541|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56448542|NCT00333567|Analgesics|analgesics|mesh-ancestor
56448543|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
56448544|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448545|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448546|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56448547|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56448549|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
56448550|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56448551|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448552|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
56448553|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448554|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56448555|NCT00333645|Caspofungin|caspofungin|mesh-list
56914173|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
56914174|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448556|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
56448557|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448558|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448559|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448560|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
56448561|NCT00451100|Neostigmine|neostigmine|mesh-list
56448562|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56448563|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448564|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448565|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
56448566|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448567|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448568|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56448569|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
56448570|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448571|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56448572|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56448573|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56448574|NCT00420537|Cyclosporine|cyclosporine|mesh-list
56448575|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
56448576|NCT00420537|Everolimus|everolimus|mesh-list
56448577|NCT00420537|Cyclosporins|cyclosporins|mesh-list
56448578|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448579|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448580|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448581|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
56448582|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448583|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
56448584|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448585|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
56448586|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56448587|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56448588|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448589|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56448590|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56448591|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
56448592|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448593|NCT00451139|Lumefantrine|lumefantrine|mesh-list
56448594|NCT00451139|Artemether|artemether|mesh-list
56448595|NCT00451139|Quinine|quinine|mesh-list
56448596|NCT00451139|Atovaquone|atovaquone|mesh-list
56448597|NCT00451139|Proguanil|proguanil|mesh-list
56448598|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56448599|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56448600|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
56448601|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56448602|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56448603|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448604|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56448605|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448606|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56448607|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448609|NCT00451139|Analgesics|analgesics|mesh-ancestor
56448610|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
56448611|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448612|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448613|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
56448614|NCT00330486|Acamprosate|acamprosate|mesh-list
56448615|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56448616|NCT00451373|Vancomycin|vancomycin|mesh-list
56448617|NCT00451373|Daptomycin|daptomycin|mesh-list
56448618|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448619|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448620|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
56448621|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56448622|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448623|NCT00451412|Heparin|heparin|mesh-list
56448624|NCT00451412|Calcium heparin|calcium heparin|mesh-list
56448625|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56448626|NCT00451412|Tinzaparin|tinzaparin|mesh-list
56448627|NCT00451412|Dalteparin|dalteparin|mesh-list
56448628|NCT00451412|Certoparin|certoparin|mesh-list
56448629|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
56448630|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56448631|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56163112|NCT00002190|Lamivudine|lamivudine|mesh-list
56448632|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448633|NCT00451490|S 20098|s 20098|mesh-list
56448634|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56448635|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448636|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448637|NCT00330525|Sibutramine|sibutramine|mesh-list
56448638|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
56448639|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56448640|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
56448641|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56448642|NCT00333918|Bromfenac|bromfenac|mesh-list
56448643|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56448644|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56448645|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56448646|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56448648|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
56448649|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448650|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448651|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56448652|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56448653|NCT00451568|Metformin|metformin|mesh-list
56448654|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56448655|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448656|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56448657|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56448658|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56448659|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56448660|NCT00451724|Ketamine|ketamine|mesh-list
56448661|NCT00451724|Analgesics|analgesics|mesh-ancestor
56448662|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
56448663|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448664|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448665|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56448666|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56448667|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
56448668|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
56448669|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448670|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56448671|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56448672|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448673|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448674|NCT00451763|Bevacizumab|bevacizumab|mesh-list
56448675|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56448676|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448677|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56448678|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56448679|NCT00451763|Growth Substances|growth substances|mesh-ancestor
56448680|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448681|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
56448682|NCT00330798|Ketorolac|ketorolac|mesh-list
56448683|NCT00330798|Nepafenac|nepafenac|mesh-list
56448684|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56448687|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
56448688|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448689|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448690|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56448692|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56448693|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448694|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448695|NCT00451880|Famotidine|famotidine|mesh-list
56448696|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56448697|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56448698|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56448699|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
56448700|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
56448701|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448702|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448703|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448704|NCT00451997|Cytarabine|cytarabine|mesh-list
56448705|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
56448706|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56448707|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
56097801|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914175|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914176|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56448708|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448709|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448710|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
56448711|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448712|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448713|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
56448714|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448715|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56448716|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448717|NCT00330993|Misoprostol|misoprostol|mesh-list
56448718|NCT00330993|Mifepristone|mifepristone|mesh-list
56448719|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56448720|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
56448721|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56448722|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448723|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56448724|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56448725|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
56448726|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56448727|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56448728|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56448729|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56448730|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
56448731|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56448732|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56448733|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
56448734|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448735|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
56448736|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56448737|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56448738|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56448739|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448740|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56448741|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448742|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448743|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
56448744|NCT00331071|Ortho Evra|ortho evra|mesh-list
56448745|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
56448746|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56448747|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448748|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56448749|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56448750|NCT00333996|Dexamethasone|dexamethasone|mesh-list
56448751|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56448752|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
56448753|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
56448754|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448755|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448756|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56448757|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
56448759|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56448761|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448762|NCT00452192|Telmisartan|telmisartan|mesh-list
56448763|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56448764|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56448765|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56448766|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448767|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56448768|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
56448769|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56448770|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56448771|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56448772|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448773|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448774|NCT00334152|Casopitant|casopitant|mesh-list
56448775|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
56448776|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
56448777|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448778|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914177|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56914178|NCT00064337|Growth Substances|growth substances|mesh-ancestor
56914179|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
56914180|NCT00045305|Cyclosporine|cyclosporine|mesh-list
56448779|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56448780|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56448781|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448782|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448783|NCT04698512|Sirolimus|sirolimus|mesh-list
56448784|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448785|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448786|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56448787|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448788|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
56448789|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448790|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
56448791|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448792|NCT00334308|Caseins|caseins|mesh-list
56196631|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56448793|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
56448794|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
56448795|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448796|NCT00334347|Valproic Acid|valproic acid|mesh-list
56448797|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
56448798|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448799|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448800|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
56448801|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448802|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448803|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
56448804|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56448805|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448806|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56448807|NCT00334386|Torsemide|torsemide|mesh-list
56448808|NCT00334386|Diuretics|diuretics|mesh-list
56448809|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56448810|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
56448811|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448812|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56448813|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448814|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56448815|NCT00452231|Cycloserine|cycloserine|mesh-list
56448816|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56448817|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448818|NCT00452231|Renal Agents|renal agents|mesh-ancestor
56448819|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56448820|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
56448821|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448822|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
56448823|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448824|NCT00334425|Menotropins|menotropins|mesh-list
56448825|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56448826|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
56448827|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56448828|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448831|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448832|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448833|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56448834|NCT03275207|Analgesics|analgesics|mesh-ancestor
56448835|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
56448836|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448837|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56448838|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56448839|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56448840|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
56448841|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448842|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448844|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
56448846|NCT03275012|Gabapentin|gabapentin|mesh-list
56448847|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56448848|NCT03275012|Narcotics|narcotics|mesh-ancestor
56914181|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
56448849|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448850|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448851|NCT03275012|Analgesics|analgesics|mesh-ancestor
56448852|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
56448853|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448854|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
56448855|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56448856|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56448857|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56448858|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56448859|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56448860|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448861|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448862|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
56448863|NCT00334503|Miglitol|miglitol|mesh-list
56448864|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448865|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196710|NCT01504659|Ketamine|ketamine|mesh-list
56448866|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56448867|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448868|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56448869|NCT00334581|Irbesartan|irbesartan|mesh-list
56448870|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56448871|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56448872|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56448873|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448874|NCT00452270|Xylometazoline|xylometazoline|mesh-list
56448875|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
56448876|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56448877|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
56448878|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
56448879|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
56448880|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56448881|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56448882|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448883|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448884|NCT00452582|Urological Agents|urological agents|mesh-ancestor
56448885|NCT00334698|Cetirizine|cetirizine|mesh-list
56448886|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
56448887|NCT00334698|Ephedrine|ephedrine|mesh-list
56448888|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56448889|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56448890|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56448891|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
56448892|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
56448893|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448894|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448895|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448896|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56448897|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
56448898|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448899|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56448900|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
56448902|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56448903|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56448904|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
56448905|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
56448906|NCT00452660|Deferasirox|deferasirox|mesh-list
56448907|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56448908|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
55949672|NCT01895621|Vitamins|vitamins|mesh-ancestor
56448909|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
56448910|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448912|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56448913|NCT00334854|Ifosfamide|ifosfamide|mesh-list
56448914|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56448915|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448916|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56448917|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56448918|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448919|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448920|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56914182|NCT00045305|Methotrexate|methotrexate|mesh-list
56914183|NCT00045305|Pentostatin|pentostatin|mesh-list
56914184|NCT00045305|Methoxsalen|methoxsalen|mesh-list
56914185|NCT00045305|Cyclosporins|cyclosporins|mesh-list
56914186|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56914187|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
56914188|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56914189|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914190|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914191|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
56914192|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914193|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914194|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
56914195|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914196|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56914197|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914198|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
56914199|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56448921|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
56448922|NCT00334932|Doxorubicin|doxorubicin|mesh-list
56448923|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56448924|NCT00334932|Bortezomib|bortezomib|mesh-list
56448925|NCT00334932|Melphalan|melphalan|mesh-list
56448926|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56448927|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448928|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56448929|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56448930|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448931|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448932|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56448933|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
56448934|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56448935|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56448936|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
56448937|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448938|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
56448939|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
56448940|NCT00452855|Remifentanil|remifentanil|mesh-list
56448941|NCT00452855|Sevoflurane|sevoflurane|mesh-list
56448942|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
56448943|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448944|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448945|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56448946|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56448947|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
56448948|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56448949|NCT00452855|Narcotics|narcotics|mesh-ancestor
56448950|NCT00452855|Analgesics|analgesics|mesh-ancestor
56448951|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
56448952|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448953|NCT00335088|Iodine|iodine|mesh-list
56448954|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
56448955|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
56448956|NCT00335088|Povidone|povidone|mesh-list
56448957|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448958|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448959|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56448960|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56448961|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448962|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914200|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56914201|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
56914202|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914203|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56914204|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56914205|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56914206|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
56914207|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914208|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56914209|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56914210|NCT01096121|Enalapril|enalapril|mesh-list
56163467|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56448963|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56448964|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448965|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56448966|NCT00335088|Trace Elements|trace elements|mesh-ancestor
56448967|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
56448968|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
56448969|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
56448970|NCT00452894|Varenicline|varenicline|mesh-list
56448971|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56448972|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56448973|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
56448974|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448975|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448976|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448979|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448980|NCT00335166|Protective Agents|protective agents|mesh-ancestor
56448981|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448982|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56448983|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56448984|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
56448985|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
56448986|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448987|NCT00452972|Anesthetics|anesthetics|mesh-list
56448988|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56448989|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448990|NCT00335205|Ropinirole|ropinirole|mesh-list
56448991|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56448992|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56448993|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
56448994|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
56448995|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56448996|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448997|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448998|NCT00453050|Imiquimod|imiquimod|mesh-list
56448999|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56449000|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
56449001|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449002|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449003|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
56449004|NCT00335400|Anesthetics|anesthetics|mesh-list
56449005|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56449006|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449007|NCT00420615|Epothilone B|epothilone b|mesh-list
56449008|NCT00420615|Epothilones|epothilones|mesh-list
56449009|NCT00420615|Omeprazole|omeprazole|mesh-list
56449010|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56449011|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449012|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56449013|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449014|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449015|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914211|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56914212|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
56914213|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914214|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914215|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56914216|NCT00064259|Fluorouracil|fluorouracil|mesh-list
56914217|NCT00064259|Oblimersen|oblimersen|mesh-list
56914218|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914219|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
56449016|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
56449017|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
56449018|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
56449019|NCT00453167|Gemcitabine|gemcitabine|mesh-list
56449020|NCT00453167|Paclitaxel|paclitaxel|mesh-list
56449021|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56449022|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449023|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
56449024|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
56449025|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
56449026|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449027|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449028|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
56449029|NCT00453167|Antiviral Agents|antiviral agents|mesh-ancestor
56449030|NCT00453167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449031|NCT00453167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449032|NCT00453167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449033|NCT00453167|Immunologic Factors|immunologic factors|mesh-ancestor
56449034|NCT00453167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449035|NCT00420654|Hormones|hormones|mesh-list
56449036|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449037|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449038|NCT00420693|Sevoflurane|sevoflurane|mesh-list
56449039|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56449040|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56449041|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
56449042|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
56449043|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56449044|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449045|NCT03274895|Biguanides|biguanides|mesh-list
56449046|NCT03274895|Polihexanide|polihexanide|mesh-list
56449047|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
56449048|NCT03274895|Propamidine|propamidine|mesh-list
56449049|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56449050|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449051|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
56449053|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56449054|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56449055|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56449056|NCT00453323|Paclitaxel|paclitaxel|mesh-list
56449057|NCT00453323|Capecitabine|capecitabine|mesh-list
56449058|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56449059|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449060|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
56449061|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
56449062|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
56449063|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449064|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449065|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
56449066|NCT00335439|Ketorolac|ketorolac|mesh-list
56449067|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56449068|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56449069|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56449070|NCT00335439|Analgesics|analgesics|mesh-ancestor
56449071|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
56449072|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449073|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449074|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914220|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914221|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914222|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914223|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
56914224|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914225|NCT03954197|Hormones|hormones|mesh-list
56914226|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914227|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914228|NCT00044213|Vitamins|vitamins|mesh-list
56914229|NCT00044213|Edetic Acid|edetic acid|mesh-list
56449075|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449076|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56449077|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449078|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449079|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
56449080|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
56449081|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449082|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449083|NCT00335673|Irbesartan|irbesartan|mesh-list
56449084|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56449085|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56449086|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56449087|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449088|NCT00453635|Carboplatin|carboplatin|mesh-list
56449089|NCT00453635|Docetaxel|docetaxel|mesh-list
56449090|NCT00453635|Trastuzumab|trastuzumab|mesh-list
56449091|NCT00453635|Vinorelbine|vinorelbine|mesh-list
56449092|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449093|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
56449094|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
56449095|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
56449096|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449097|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56449098|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56449099|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56449100|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
56449101|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56449102|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
56449103|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56449104|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
56449105|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449106|NCT00336141|Vorinostat|vorinostat|mesh-list
56449107|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449108|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56449109|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449110|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449111|NCT00336219|Pantoprazole|pantoprazole|mesh-list
56449112|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56449113|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449114|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56449115|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449116|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449117|NCT00453908|Alfuzosin|alfuzosin|mesh-list
56449118|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56449119|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56449120|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56449121|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
56449122|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56449123|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449126|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56449127|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56449128|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56914230|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
56914231|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
56449129|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
56449130|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449131|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56449132|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56449133|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449134|NCT00336375|Lumefantrine|lumefantrine|mesh-list
56449135|NCT00336375|Artemether|artemether|mesh-list
56449136|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56449137|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
56449138|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56449139|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56449140|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449141|NCT00336414|Prednisone|prednisone|mesh-list
56449142|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
56449143|NCT00336414|Azathioprine|azathioprine|mesh-list
56449144|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449145|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
56449146|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449147|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449148|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56449149|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
56449150|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449151|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449152|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56449153|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449154|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
56449155|NCT00336414|Hormones|hormones|mesh-ancestor
56449156|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449157|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449158|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
56449159|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449160|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
56449161|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
56449162|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
56449163|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449164|NCT00336531|Itraconazole|itraconazole|mesh-list
56449165|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
56449166|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449167|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56449168|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56449169|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449170|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449171|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56449172|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
56449173|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449174|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449175|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56449176|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
56449177|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56449178|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
56449179|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449180|NCT00322062|Protective Agents|protective agents|mesh-ancestor
56449181|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449182|NCT00322062|Vitamins|vitamins|mesh-ancestor
56449183|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
56449184|NCT00322062|Laxatives|laxatives|mesh-ancestor
56449185|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449186|NCT00336648|Gemcitabine|gemcitabine|mesh-list
56449187|NCT00336648|Bevacizumab|bevacizumab|mesh-list
56449188|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56449189|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449190|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56449191|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56449192|NCT00336648|Growth Substances|growth substances|mesh-ancestor
56449193|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449194|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
56449195|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449197|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449198|NCT00336648|Antiviral Agents|antiviral agents|mesh-ancestor
56449199|NCT00336648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449200|NCT00336648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914232|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914233|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
56914234|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56914235|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
56914236|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
56914237|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914238|NCT00044213|Antidotes|antidotes|mesh-ancestor
56914239|NCT00044213|Protective Agents|protective agents|mesh-ancestor
56914240|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56914241|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56914242|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
56163733|NCT00002532|Dexamethasone|dexamethasone|mesh-list
56449201|NCT00336648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449202|NCT00336648|Immunologic Factors|immunologic factors|mesh-ancestor
56449203|NCT03274817|Citalopram|citalopram|mesh-list
56449204|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56449205|NCT03274817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56449206|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56449207|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56449208|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449209|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56449210|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
56449211|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449212|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56449213|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
56449214|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56449215|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56449216|NCT00230204|Antibodies|antibodies|mesh-list
56449217|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
56449218|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449219|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
56449220|NCT00230321|Hematinics|hematinics|mesh-ancestor
56449221|NCT00230399|Celecoxib|celecoxib|mesh-list
56449222|NCT00230399|Capecitabine|capecitabine|mesh-list
56449223|NCT00230399|Irinotecan|irinotecan|mesh-list
56449224|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449225|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
56449226|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449227|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449228|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56449229|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56449230|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449231|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56449232|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56449233|NCT00230399|Analgesics|analgesics|mesh-ancestor
56449234|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
56449235|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449236|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449237|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449238|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449239|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56449240|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56449243|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56449244|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449245|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449246|NCT00230477|Lamivudine|lamivudine|mesh-list
56449247|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56449248|NCT00230477|Adefovir|adefovir|mesh-list
56449249|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56449250|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56449251|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449252|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449253|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
56914243|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56449254|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449255|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56449256|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56449257|NCT00230516|Lansoprazole|lansoprazole|mesh-list
56449258|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56449259|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449260|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56449261|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449262|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449263|NCT00336882|Midazolam|midazolam|mesh-list
56449264|NCT00336882|Propofol|propofol|mesh-list
56449265|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56449266|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56449267|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449268|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56449269|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
56449270|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
56449273|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56449274|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56449275|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
56449276|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
56449277|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56449278|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449279|NCT00336921|Alfuzosin|alfuzosin|mesh-list
56449280|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56449281|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56449282|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56449283|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
56449284|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56449285|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449286|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449287|NCT00336921|Urological Agents|urological agents|mesh-ancestor
56449288|NCT00336960|Celecoxib|celecoxib|mesh-list
56449289|NCT00336960|Fluorouracil|fluorouracil|mesh-list
56449290|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
56449291|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449292|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449293|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449294|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449295|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
56449296|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449297|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56449298|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56449299|NCT00336960|Analgesics|analgesics|mesh-ancestor
56449300|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
56449301|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449302|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449303|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449304|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56449305|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56449306|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449307|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
56449308|NCT00306410|Vitamin D|vitamin d|mesh-list
56449309|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56449310|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449311|NCT00306410|Vitamins|vitamins|mesh-ancestor
56449312|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
56449313|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56449314|NCT00340080|Abacavir|abacavir|mesh-list
56449315|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56197161|NCT01506739|Donepezil|donepezil|mesh-list
56449316|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56449317|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449318|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449319|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
56449320|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449321|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56449322|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56449323|NCT00418535|Cisplatin|cisplatin|mesh-list
56449324|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449325|NCT02960711|Metformin|metformin|mesh-list
56449326|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56449327|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449328|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56914244|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56914245|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56914246|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
56449329|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449330|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56449331|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
56449332|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56449333|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449334|NCT00306683|Diazoxide|diazoxide|mesh-list
56449335|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56449336|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
56449337|NCT00306722|Fospropofol|fospropofol|mesh-list
56449338|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56449339|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56449340|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449341|NCT00337389|Leucovorin|leucovorin|mesh-list
56449342|NCT00337389|Bevacizumab|bevacizumab|mesh-list
56449343|NCT00337389|Fluorouracil|fluorouracil|mesh-list
56449344|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56449346|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56449347|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56449348|NCT00337389|Growth Substances|growth substances|mesh-ancestor
56449349|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449350|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
56449351|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
56449352|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449353|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449354|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449355|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
56449356|NCT00337389|Antidotes|antidotes|mesh-ancestor
56449357|NCT00337389|Protective Agents|protective agents|mesh-ancestor
56449358|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
56449359|NCT00337389|Vitamins|vitamins|mesh-ancestor
56449360|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
56449361|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56449362|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56449363|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56449364|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
56449365|NCT00306878|Abatacept|abatacept|mesh-list
56449366|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56449367|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449368|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449369|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449370|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
56449371|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449372|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449373|NCT00337506|Dexamethasone|dexamethasone|mesh-list
56449374|NCT00337506|Bortezomib|bortezomib|mesh-list
56449375|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449376|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
56449377|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
56449378|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449379|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449380|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449381|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
56449382|NCT00337506|Hormones|hormones|mesh-ancestor
56449383|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449384|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449385|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449386|NCT00337545|Everolimus|everolimus|mesh-list
56449387|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449388|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449389|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
56449390|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449391|NCT00307307|Niacin|niacin|mesh-list
56449392|NCT00307307|Simvastatin|simvastatin|mesh-list
56449393|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56449394|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56449395|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
56449396|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449397|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56449398|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56449399|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449400|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
56914247|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55909355|NCT02330640|Ticagrelor|ticagrelor|mesh-list
56449401|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
56449402|NCT00307307|Vitamins|vitamins|mesh-ancestor
56449403|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
56449404|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449405|NCT00337623|Prednisolone|prednisolone|mesh-list
56449406|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449407|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
56449408|NCT00337623|Hormones|hormones|mesh-ancestor
56449409|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449410|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449411|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449412|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449413|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
56449414|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56449415|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56449416|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449417|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56449418|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56449419|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
56449420|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449421|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
56449423|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56449424|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56449425|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56449426|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56449427|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449428|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449429|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56449430|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56449431|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
56449432|NCT00307502|Ritonavir|ritonavir|mesh-list
56449433|NCT00307502|Lopinavir|lopinavir|mesh-list
56449434|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56449435|NCT00307502|Darunavir|darunavir|mesh-list
56449436|NCT00307502|Nelfinavir|nelfinavir|mesh-list
56449437|NCT00307502|Indinavir|indinavir|mesh-list
56449438|NCT00307502|Saquinavir|saquinavir|mesh-list
56449439|NCT00307502|Amprenavir|amprenavir|mesh-list
56449440|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
56449441|NCT00307502|Nevirapine|nevirapine|mesh-list
56449442|NCT00307502|Tipranavir|tipranavir|mesh-list
56449443|NCT00307502|Efavirenz|efavirenz|mesh-list
56449444|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56449445|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56449446|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
56449447|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449448|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449449|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56449450|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56449451|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
56449452|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449453|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56449454|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56449455|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56449456|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56449457|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56449458|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56449459|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56449460|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56449461|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56449462|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56449463|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
56449464|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56449465|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56449466|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56449467|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56449468|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197305|NCT01507337|Hormones|hormones|mesh-ancestor
56449470|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
56449471|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56449472|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449473|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
56449474|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56914248|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914249|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55910776|NCT01470599|Tofacitinib|tofacitinib|mesh-list
56449475|NCT00307658|Antibodies|antibodies|mesh-list
56449476|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
56449477|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
56449478|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56449479|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
56449480|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449481|NCT00307775|Estradiol|estradiol|mesh-list
56449482|NCT00307775|Estrogens|estrogens|mesh-ancestor
56449483|NCT00307775|Hormones|hormones|mesh-ancestor
56449484|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449485|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449486|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
56449487|NCT00307814|Hematinics|hematinics|mesh-ancestor
56449488|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
56449489|NCT00341055|Hematinics|hematinics|mesh-ancestor
56449490|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56449492|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
56449493|NCT00338052|Estradiol|estradiol|mesh-list
56449494|NCT00338052|Estrogens|estrogens|mesh-ancestor
56449495|NCT00338052|Hormones|hormones|mesh-ancestor
56449496|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449497|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851690|NCT00006178|Sirolimus|sirolimus|mesh-list
56449501|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56449502|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56449503|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56449504|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56449505|NCT00338091|Losartan|losartan|mesh-list
56449506|NCT00338091|Benazepril|benazepril|mesh-list
56449507|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56449508|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56449509|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56449510|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56449511|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449512|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56449513|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
56449514|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449515|NCT00308048|Interferons|interferons|mesh-list
56449516|NCT00308048|Ribavirin|ribavirin|mesh-list
56449517|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
56449518|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
56449519|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56449520|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449521|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
56449522|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449523|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
56449524|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449525|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
56449526|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449527|NCT00338130|Temozolomide|temozolomide|mesh-list
56449528|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56449529|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
56449530|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449531|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449532|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56449533|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
56449534|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
56449535|NCT00308165|Topotecan|topotecan|mesh-list
56449536|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56449537|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56449538|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449539|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449540|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449541|NCT04715568|Losartan|losartan|mesh-list
56449542|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
56449543|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
56449544|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56449545|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56449546|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56449547|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914250|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56914251|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56449548|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56449550|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
56449551|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449552|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449553|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56449554|NCT00338247|Capecitabine|capecitabine|mesh-list
56449555|NCT00338247|Lapatinib|lapatinib|mesh-list
56449556|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449557|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
56449558|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449559|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449560|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56449561|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449562|NCT00308321|Prednisolone|prednisolone|mesh-list
56449563|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56449564|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
56449565|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56449566|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
56449567|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56449568|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
56449569|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449572|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449573|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449574|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449575|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449577|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
56449578|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449579|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449580|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56449581|NCT00308321|Protective Agents|protective agents|mesh-ancestor
56449582|NCT00308360|Valproic Acid|valproic acid|mesh-list
56449583|NCT00308360|Risperidone|risperidone|mesh-list
56449584|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56449585|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
56449586|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56449587|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449588|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449589|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56449590|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56449591|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56449592|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56449593|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56449594|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
56449595|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
56449596|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449597|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
56449598|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
56449599|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56449600|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56449601|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
56449602|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449603|NCT00341250|Antacids|antacids|mesh-ancestor
56449604|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449605|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449606|NCT00308438|Teduglutide|teduglutide|mesh-list
56449607|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449608|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56449609|NCT00308438|Protective Agents|protective agents|mesh-ancestor
56449610|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449611|NCT00308477|Dexamethasone|dexamethasone|mesh-list
56449612|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449613|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
56449614|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
56449615|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449616|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449617|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449618|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
56449619|NCT00308477|Hormones|hormones|mesh-ancestor
56449620|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449621|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449622|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914252|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449623|NCT00308594|Dexamethasone|dexamethasone|mesh-list
56449624|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449625|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
56449626|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
56449627|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449628|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449629|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449630|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
56449631|NCT00308594|Hormones|hormones|mesh-ancestor
56449632|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449633|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449634|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449635|NCT00308945|Travoprost|travoprost|mesh-list
56449636|NCT00308945|Latanoprost|latanoprost|mesh-list
56449637|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56449638|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56449639|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56449640|NCT00338481|Morphine|morphine|mesh-list
56449641|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55950427|NCT04826406|Apatinib|apatinib|mesh-list
56449642|NCT00338481|Narcotics|narcotics|mesh-ancestor
56449643|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56449644|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449646|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
56449647|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449648|NCT00309101|Tacrolimus|tacrolimus|mesh-list
56449649|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449650|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
56449651|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449652|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56449653|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449654|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449655|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
56449656|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56449657|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56449658|NCT00309218|Prednisolone|prednisolone|mesh-list
56449659|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
56449660|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56449661|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
56449662|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449663|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
56449664|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
56449665|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449666|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449667|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449668|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
56449669|NCT00309218|Hormones|hormones|mesh-ancestor
56449670|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449671|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56449672|NCT00309218|Protective Agents|protective agents|mesh-ancestor
56449673|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449674|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449675|NCT00309257|Valsartan|valsartan|mesh-list
56449676|NCT00309257|Benazepril|benazepril|mesh-list
56449677|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56449678|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56449679|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56449680|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449681|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56449682|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
56449683|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449684|NCT00309335|Phentolamine|phentolamine|mesh-list
56449685|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56449686|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56449687|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
56449688|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56449689|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449690|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449691|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56449692|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56449693|NCT00309374|Simvastatin|simvastatin|mesh-list
56449694|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56197539|NCT01508260|Furosemide|furosemide|mesh-list
56449695|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56449696|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
56449697|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449698|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56449699|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56449700|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449701|NCT00309413|Cannabidiol|cannabidiol|mesh-list
56449702|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
56449703|NCT00309491|Tamoxifen|tamoxifen|mesh-list
56449704|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
56449705|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56449706|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
56449707|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449708|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449709|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449710|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449711|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56165070|NCT03737370|Docetaxel|docetaxel|mesh-list
56449712|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56449713|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56449714|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55852099|NCT00041938|Warfarin|warfarin|mesh-list
56449722|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
56449723|NCT00309530|Interferons|interferons|mesh-list
56449724|NCT00309530|Fluorouracil|fluorouracil|mesh-list
56449725|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
56449726|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449727|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449728|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449729|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449730|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
56449731|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449732|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
56449733|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449734|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
56449735|NCT00309569|Fluorouracil|fluorouracil|mesh-list
56449736|NCT00309569|Methotrexate|methotrexate|mesh-list
56449737|NCT00309569|Epirubicin|epirubicin|mesh-list
56449738|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449739|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
56449740|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449741|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449742|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56449743|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
56449744|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449745|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449746|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56449747|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
56449748|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449749|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56449750|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
56449751|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56449752|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
56449753|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449754|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56449755|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56449756|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56449757|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56449758|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56449759|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56449760|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56449761|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56449762|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56449763|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449764|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56449765|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56449766|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56449767|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
56449768|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197606|NCT01508572|Growth Substances|growth substances|mesh-ancestor
56449769|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449770|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56449771|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56449772|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
56449773|NCT00309725|Galantamine|galantamine|mesh-list
56098672|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914253|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914254|NCT01096199|Cisplatin|cisplatin|mesh-list
56914255|NCT01096199|Everolimus|everolimus|mesh-list
56914256|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914257|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914258|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
56914259|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914260|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56914261|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56914262|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914263|NCT01096277|Incretins|incretins|mesh-ancestor
56914264|NCT01096277|Hormones|hormones|mesh-ancestor
56914265|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914266|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56914267|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
56914268|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914269|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914270|NCT01096355|R04929097|r04929097|mesh-list
56914271|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914272|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914273|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
55921084|NCT04818372|Hormones|hormones|mesh-ancestor
56449774|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56449775|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449776|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449777|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
56449778|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56449779|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449780|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56449782|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449783|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
56449784|NCT00338754|Adalimumab|adalimumab|mesh-list
56449785|NCT00338754|Antibodies|antibodies|mesh-list
56449786|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56449787|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
56449788|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449789|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449790|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449791|NCT00338793|Prednisolone|prednisolone|mesh-list
56449792|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449793|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
56449794|NCT00338793|Hormones|hormones|mesh-ancestor
56449795|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449796|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449797|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449798|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449799|NCT00418847|Miglustat|miglustat|mesh-list
56449800|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449801|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449802|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56449803|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56449804|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
56449805|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449806|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56914274|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56914275|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914276|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914277|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56914278|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56914279|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914280|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449807|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56449808|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449809|NCT00309881|Prednisone|prednisone|mesh-list
56449810|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
56449811|NCT00309881|Rituximab|rituximab|mesh-list
56449812|NCT00309881|Doxorubicin|doxorubicin|mesh-list
56449813|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56449814|NCT00309881|Vincristine|vincristine|mesh-list
56449815|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449816|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
56449817|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449818|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449819|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56449820|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
56449821|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449822|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449823|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56449824|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56449825|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56449826|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56449827|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56449828|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449829|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449830|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
56449831|NCT00309881|Hormones|hormones|mesh-ancestor
56449832|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449833|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56449834|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56449835|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
56449836|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
56449837|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
56449838|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
56449839|NCT00309920|Docetaxel|docetaxel|mesh-list
56449840|NCT00309920|Doxorubicin|doxorubicin|mesh-list
56449841|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56449842|NCT00309920|Fluorouracil|fluorouracil|mesh-list
56449843|NCT00309920|Epirubicin|epirubicin|mesh-list
56449844|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
56449845|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449846|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
56449847|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449848|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449849|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56449850|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
56449851|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449852|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449853|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56449854|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
56449855|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
56449856|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
56449858|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56449859|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56449860|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449861|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
56449862|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56449865|NCT00309998|Vinorelbine|vinorelbine|mesh-list
56449866|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56449867|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449868|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56449869|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56914281|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925162|NCT03088891|Antioxidants|antioxidants|mesh-list
56449870|NCT00309998|Growth Substances|growth substances|mesh-ancestor
56449871|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449872|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
56449873|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56449874|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
56449875|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
56449876|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
56449877|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449878|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
56449879|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56449880|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
56449881|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449882|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449883|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56449884|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
56449885|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449886|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449887|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56449888|NCT00310154|Docetaxel|docetaxel|mesh-list
56449889|NCT00310154|Gefitinib|gefitinib|mesh-list
56449890|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449891|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
56449892|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
56449893|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
56449894|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449895|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56449896|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449897|NCT00338910|Metronidazole|metronidazole|mesh-list
56449898|NCT00338910|Budesonide|budesonide|mesh-list
56449899|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56449900|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56449901|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
56449902|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449903|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449904|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56449905|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
56449906|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
56449907|NCT00338910|Hormones|hormones|mesh-ancestor
56449908|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56449909|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449910|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56449911|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56449912|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56449913|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
56449914|NCT00310232|Hematinics|hematinics|mesh-ancestor
56449915|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56449916|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
56449917|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449918|NCT00310505|Amphotericin B|amphotericin b|mesh-list
56449919|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56197766|NCT01509469|Caseins|caseins|mesh-list
56449920|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56449921|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
56449922|NCT00310505|Amebicides|amebicides|mesh-ancestor
56449923|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56449924|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56449925|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449926|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56449927|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
56449928|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56449929|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56449930|NCT00339066|Sertraline|sertraline|mesh-list
56449931|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
56449932|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56449935|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56449936|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449938|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
56449939|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449940|NCT00310583|Pregabalin|pregabalin|mesh-list
56449941|NCT00310583|Analgesics|analgesics|mesh-ancestor
56449942|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
56449943|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914282|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56914283|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
56914284|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56914285|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914286|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56914287|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56914288|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56914289|NCT01092455|Heparin|heparin|mesh-list
56914290|NCT01092455|Calcium heparin|calcium heparin|mesh-list
56914291|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
56914292|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56449944|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449945|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
56449946|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56449947|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56449948|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449949|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56449950|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56449951|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56449952|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56449953|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56449954|NCT00421044|Epothilone B|epothilone b|mesh-list
56449955|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449956|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
56449957|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
56449958|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
56449959|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449960|NCT00425217|Rituximab|rituximab|mesh-list
56449961|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56449962|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449963|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
56449964|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449965|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56449966|NCT00310778|Atenolol|atenolol|mesh-list
56449967|NCT00310778|Valsartan|valsartan|mesh-list
56449968|NCT00310778|Candesartan|candesartan|mesh-list
56449969|NCT00310778|Ramipril|ramipril|mesh-list
56449970|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56449971|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56449972|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56449973|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449974|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56449975|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
56449976|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449977|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56449978|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
56449979|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
56449980|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56449981|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449982|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56449983|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56449984|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56449985|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
56449986|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56449987|NCT00421083|Tadalafil|tadalafil|mesh-list
56449988|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
56449989|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56449990|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56449991|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449992|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449993|NCT00421083|Urological Agents|urological agents|mesh-ancestor
56449994|NCT00310895|Imetelstat|imetelstat|mesh-list
56449995|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
56449996|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914293|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56914294|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914295|NCT02095132|Irinotecan|irinotecan|mesh-list
56914296|NCT02095132|Camptothecin|camptothecin|mesh-list
56914297|NCT02095132|Adavosertib|adavosertib|mesh-list
56914298|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56914299|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56914300|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914301|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914302|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914303|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56914304|NCT02264938|Antioxidants|antioxidants|mesh-list
56914305|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914306|NCT02264938|Protective Agents|protective agents|mesh-ancestor
56914307|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914308|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
56914309|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56914310|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914311|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56914312|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914313|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56914314|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
56914315|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
56914316|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914317|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914318|NCT04235140|Ivacaftor|ivacaftor|mesh-list
56914319|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56914320|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56914322|NCT00043979|Cyclosporine|cyclosporine|mesh-list
56914340|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56914341|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
56914342|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914343|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914344|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56914345|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56914346|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56914347|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56914348|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449997|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449998|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56449999|NCT00310934|Buprenorphine|buprenorphine|mesh-list
56450000|NCT00310934|Methadone|methadone|mesh-list
56450001|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56450002|NCT00310934|Narcotics|narcotics|mesh-ancestor
56450003|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450004|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450006|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
56450007|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450009|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
56450010|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
56450011|NCT00421122|Budesonide|budesonide|mesh-list
56450012|NCT00421122|Terbutaline|terbutaline|mesh-list
56450013|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
56450014|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56450015|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56450016|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56450017|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
56450018|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450019|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450020|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56450021|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
56450022|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
56450023|NCT00421122|Hormones|hormones|mesh-ancestor
56450024|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450025|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56450026|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56450027|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56450028|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
56450029|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450030|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450031|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
56450032|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
56450033|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56450034|NCT00311051|Ramatroban|ramatroban|mesh-list
56450035|NCT00311051|Montelukast|montelukast|mesh-list
56450036|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56450037|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
56450038|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56450039|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
56450040|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450041|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450042|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56450043|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56450044|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450045|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56450046|NCT00311129|Rituximab|rituximab|mesh-list
56450047|NCT00311129|Fludarabine|fludarabine|mesh-list
56450048|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
56450049|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56450050|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450051|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
56450052|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914349|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914350|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
56450053|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450054|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56450055|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
56450056|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450057|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450058|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
56450059|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56450060|NCT00342381|Amifampridine|amifampridine|mesh-list
56450061|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56450062|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450063|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450064|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56450065|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450066|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450067|NCT00311558|Interferons|interferons|mesh-list
56450069|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
56450070|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56450071|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450072|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
56450073|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450074|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
56450075|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450076|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56450078|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
55852735|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56450080|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
56450081|NCT00418925|Dronabinol|dronabinol|mesh-list
56450082|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
56450083|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450084|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56450085|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56450086|NCT00418925|Analgesics|analgesics|mesh-ancestor
56450087|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
56450088|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450089|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56450090|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56450091|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450092|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450093|NCT00418925|Hormones|hormones|mesh-ancestor
56450094|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450095|NCT00339417|Ivermectin|ivermectin|mesh-list
56450096|NCT00339417|Albendazole|albendazole|mesh-list
56450097|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56450098|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450099|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
56450100|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
56450101|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56450102|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56450103|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
56450104|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
56450105|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
56450106|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450107|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450108|NCT00311636|Paclitaxel|paclitaxel|mesh-list
56450109|NCT00311636|Docetaxel|docetaxel|mesh-list
56450110|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
56450111|NCT00311636|Doxorubicin|doxorubicin|mesh-list
56450112|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56450113|NCT00311636|Fluorouracil|fluorouracil|mesh-list
56450114|NCT00311636|Methotrexate|methotrexate|mesh-list
56450115|NCT00311636|Epirubicin|epirubicin|mesh-list
56450116|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56450117|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56450118|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450119|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
56450120|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
56450121|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
56450122|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450123|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450124|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
56450125|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450126|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450127|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56914351|NCT00043979|Hormones|hormones|mesh-ancestor
56914352|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450128|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
56450129|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56450130|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56450131|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56450132|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56450133|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450134|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
56450135|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56450136|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56450137|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
56450138|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56450139|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56450140|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56450141|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56450142|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
56197983|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450143|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56450144|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
56450145|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56450146|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56450147|NCT00311753|Heparin|heparin|mesh-list
56450148|NCT00311753|Certoparin|certoparin|mesh-list
56450149|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
56450150|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56450151|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56450152|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450155|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56450156|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
56450157|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450158|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450159|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56450160|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56450161|NCT00311870|Protective Agents|protective agents|mesh-ancestor
56450162|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450163|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56450164|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450165|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56450166|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
56450167|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
56450169|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450170|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450171|NCT00342849|Succimer|succimer|mesh-list
56450172|NCT00342849|Antidotes|antidotes|mesh-ancestor
56450173|NCT00342849|Protective Agents|protective agents|mesh-ancestor
56450174|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450175|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
56450176|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
56450177|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450178|NCT00312104|Insulin|insulin|mesh-list
56450179|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56450180|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
56450181|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
56450182|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
56450183|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450184|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450185|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
56450186|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56450187|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450188|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56450189|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
56450190|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56450191|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450192|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450193|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450194|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56450195|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56450196|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
56450197|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450198|NCT00343005|Antacids|antacids|mesh-ancestor
56625002|NCT01503606|Clarithromycin|clarithromycin|mesh-list
56914353|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56914354|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914356|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56914357|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56914358|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56914359|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56914360|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56914361|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
56914362|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914363|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
56914364|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914365|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56914366|NCT01436032|Ketorolac|ketorolac|mesh-list
56914367|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56914368|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56914369|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56914370|NCT01436032|Analgesics|analgesics|mesh-ancestor
56914371|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
56914372|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914373|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914374|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914375|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56914376|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56164772|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
56164773|NCT05048940|Vaccines|vaccines|mesh-list
56164774|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
56164775|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164776|NCT05043090|Durvalumab|durvalumab|mesh-list
56164777|NCT05043090|Sunitinib|sunitinib|mesh-list
56164778|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164779|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164780|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56164781|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56450199|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450200|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56450201|NCT00312182|Nelfinavir|nelfinavir|mesh-list
56450202|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56450203|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56450204|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
56450205|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450206|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914377|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914378|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914379|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
56914380|NCT01092533|Prednisolone|prednisolone|mesh-list
56450207|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56450208|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56450209|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
56450210|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450211|NCT00312260|Gabapentin|gabapentin|mesh-list
56450212|NCT00312260|Amitriptyline|amitriptyline|mesh-list
56450213|NCT00312260|Analgesics|analgesics|mesh-ancestor
56450214|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
56450215|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450216|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450217|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
56450218|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56450219|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56450220|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450221|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56450222|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56450223|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56450224|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450225|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450228|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
56450229|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56450230|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56450231|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56450232|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450233|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
56450234|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56450235|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
56450236|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56450237|NCT00312299|Protective Agents|protective agents|mesh-ancestor
56450238|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450239|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56450240|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56450241|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56450242|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56450243|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56450244|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
56450245|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450246|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450247|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450248|NCT00339768|Amoxicillin|amoxicillin|mesh-list
56450249|NCT00339768|Omeprazole|omeprazole|mesh-list
56450250|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56450251|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450252|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56450253|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56450254|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56450255|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450256|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450257|NCT00343161|Esomeprazole|esomeprazole|mesh-list
56450258|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56450259|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
56450260|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56450261|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56450262|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56450263|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450264|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450265|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56450266|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
56450267|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450268|NCT00343161|Antacids|antacids|mesh-ancestor
56450269|NCT00312533|Hylan|hylan|mesh-list
56450270|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
56450271|NCT00312533|Protective Agents|protective agents|mesh-ancestor
56450272|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450273|NCT00312650|Gemcitabine|gemcitabine|mesh-list
56450274|NCT00312650|Doxorubicin|doxorubicin|mesh-list
56450275|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56450276|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914381|NCT01092533|Prednisone|prednisone|mesh-list
56914382|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56914383|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914384|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56450277|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
56450278|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450279|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450280|NCT00312650|Antiviral Agents|antiviral agents|mesh-ancestor
56450281|NCT00312650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450282|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450283|NCT00312650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450284|NCT00312650|Immunologic Factors|immunologic factors|mesh-ancestor
56450285|NCT00312650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450286|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56450287|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56450288|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56450289|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
56450290|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450291|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
56450292|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56450293|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56450294|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450295|NCT00343200|Urological Agents|urological agents|mesh-ancestor
56450297|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56450298|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56450299|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56450307|NCT00347685|Analgesics|analgesics|mesh-ancestor
56450308|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
56450309|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450310|NCT00343239|Docetaxel|docetaxel|mesh-list
56450311|NCT00343239|Fluorouracil|fluorouracil|mesh-list
56450312|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450313|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
56450314|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
56450315|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
56450316|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450317|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
56450318|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56450319|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450320|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
56450321|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450322|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
56450323|NCT00313001|Exenatide|exenatide|mesh-list
56450324|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
56450325|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450326|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450327|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56450328|NCT00313001|Incretins|incretins|mesh-ancestor
56450329|NCT00313001|Hormones|hormones|mesh-ancestor
56450330|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450331|NCT00343278|Valacyclovir|valacyclovir|mesh-list
56450332|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
56450333|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450334|NCT00343317|Cefoxitin|cefoxitin|mesh-list
56450335|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56450336|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450337|NCT00313079|Vincristine|vincristine|mesh-list
56450338|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56450339|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450340|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
56450341|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
56450342|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
56450343|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450344|NCT00347724|Tramadol|tramadol|mesh-list
56450345|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56450346|NCT00347724|Narcotics|narcotics|mesh-ancestor
56450347|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450348|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450349|NCT00347724|Analgesics|analgesics|mesh-ancestor
56450350|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
56450351|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450352|NCT00313157|Metoprolol|metoprolol|mesh-list
56450353|NCT00313157|Verapamil|verapamil|mesh-list
56914385|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
56914386|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914387|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914388|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450354|NCT00313157|Carvedilol|carvedilol|mesh-list
56450355|NCT00313157|Diltiazem|diltiazem|mesh-list
56450356|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56450357|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56450358|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
56450359|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
56450360|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450361|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450362|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56450363|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56450364|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56450365|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
56450366|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450367|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450368|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
56450369|NCT00313157|Protective Agents|protective agents|mesh-ancestor
56450370|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56450371|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450372|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56450373|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
56450374|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56450375|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56450376|NCT00347763|Permethrin|permethrin|mesh-list
56450377|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450378|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450379|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
56450380|NCT00313235|Vaccines|vaccines|mesh-list
56450381|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
56450382|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450383|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450384|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450385|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56450386|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
56450387|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450388|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450389|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56450390|NCT00347802|Bimatoprost|bimatoprost|mesh-list
56450391|NCT00347802|Travoprost|travoprost|mesh-list
56450392|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56450393|NCT00313274|Clevudine|clevudine|mesh-list
56450394|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
56450395|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450396|NCT00419042|Gemcitabine|gemcitabine|mesh-list
56450397|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56450398|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56450399|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
56450400|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450401|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450402|NCT00419042|Antiviral Agents|antiviral agents|mesh-ancestor
56450403|NCT00419042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450404|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450405|NCT00419042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450406|NCT00419042|Immunologic Factors|immunologic factors|mesh-ancestor
56450407|NCT00419042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450408|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56450409|NCT00347841|Bimatoprost|bimatoprost|mesh-list
56450410|NCT00347841|Latanoprost|latanoprost|mesh-list
56450411|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56450412|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56450413|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56450414|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
56450415|NCT00425126|Hematinics|hematinics|mesh-ancestor
56450416|NCT00343629|Sulindac|sulindac|mesh-list
56450417|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56450418|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56450419|NCT00343629|Analgesics|analgesics|mesh-ancestor
56450420|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
56450421|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914389|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450422|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450423|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56450424|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450425|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450426|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56450427|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450428|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450429|NCT00343668|Irinotecan|irinotecan|mesh-list
56450430|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56450431|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56450432|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450433|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450434|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450435|NCT00343707|Paroxetine|paroxetine|mesh-list
56450436|NCT00343707|Vestipitant|vestipitant|mesh-list
56450437|NCT00343707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56450438|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56450439|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450440|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450441|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450442|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
56450443|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450444|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56450448|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56450449|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450450|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56450451|NCT00313391|Risperidone|risperidone|mesh-list
56450452|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56450453|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
56450454|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450455|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450456|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450457|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56450458|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56450459|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450460|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56450461|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56450462|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
56450464|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56450465|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450466|NCT00313508|Vidarabine|vidarabine|mesh-list
56450467|NCT00313508|Fludarabine|fludarabine|mesh-list
56450468|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
56450469|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450470|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56450471|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
56450472|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450473|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450474|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
56450475|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450476|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
56450477|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450478|NCT00313547|Amlodipine|amlodipine|mesh-list
56450479|NCT00313547|Quinapril|quinapril|mesh-list
56450480|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56450481|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56450482|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450483|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450484|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56450485|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450486|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
56450487|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56450488|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
56450489|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450490|NCT00348192|Donepezil|donepezil|mesh-list
56450491|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56450492|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450493|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450494|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
56450495|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914390|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914391|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
56914392|NCT01092533|Hormones|hormones|mesh-ancestor
56450496|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450497|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
56450498|NCT00313625|Methotrexate|methotrexate|mesh-list
56450499|NCT00313625|Melphalan|melphalan|mesh-list
56450500|NCT00313625|Busulfan|busulfan|mesh-list
56450501|NCT00313625|Tacrolimus|tacrolimus|mesh-list
56450502|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56450503|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
56450504|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56450505|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450506|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56450507|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
56450508|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450509|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450510|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
56450511|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450512|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56450513|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450514|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
56450515|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853654|NCT01755416|Hormones|hormones|mesh-ancestor
56450517|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56165087|NCT03662022|Rifampin|rifampin|mesh-list
56450518|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56450519|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
56450520|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56450521|NCT00343980|Insulin|insulin|mesh-list
56450522|NCT00343980|Glimepiride|glimepiride|mesh-list
56450523|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
56450524|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56450525|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450526|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450527|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56450528|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450529|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
56450530|NCT00313742|Insulin|insulin|mesh-list
56450531|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56450532|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
56450533|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
56450534|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
56450535|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
56450536|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
56450537|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450538|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450539|NCT00313859|Simvastatin|simvastatin|mesh-list
56450540|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56450541|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56450542|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
56450543|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450544|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56450545|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56450546|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450547|NCT00348231|Insulin|insulin|mesh-list
56450548|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450549|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450550|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
56450551|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
56450552|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56450553|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56450554|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450555|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450556|NCT00313898|Urological Agents|urological agents|mesh-ancestor
56450557|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
56450558|NCT00344058|Analgesics|analgesics|mesh-ancestor
56450559|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
56450560|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450561|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450562|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
56450563|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450564|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56450565|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
56450566|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56099460|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
56914393|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450567|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450568|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450569|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56450570|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
56450571|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56450572|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
56450573|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450574|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450575|NCT00313976|Interferons|interferons|mesh-list
56450576|NCT00313976|Interferon-beta|interferon-beta|mesh-list
56450577|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
56450578|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450579|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
56450580|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450581|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
56450582|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450583|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56450584|NCT00348387|Vaccines|vaccines|mesh-list
56450585|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
56450586|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450587|NCT00314171|Timolol|timolol|mesh-list
56450588|NCT00314171|Dorzolamide|dorzolamide|mesh-list
56450589|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56450590|NCT00314171|Brinzolamide|brinzolamide|mesh-list
56450594|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
56450595|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450596|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450597|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450598|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56450599|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56450600|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56450601|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450602|NCT00348426|Antitoxins|antitoxins|mesh-list
56450603|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
56450604|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
56450605|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450606|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56450607|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
56450608|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56450609|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56450610|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56450611|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450612|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450613|NCT00344253|Interferons|interferons|mesh-list
56450614|NCT00344253|Interferon-beta|interferon-beta|mesh-list
56450615|NCT00344253|Methotrexate|methotrexate|mesh-list
56450616|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56450617|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
56450618|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56450619|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450620|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56450621|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
56450622|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450623|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450624|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
56450625|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450626|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56450627|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450628|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
56450629|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450630|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56450631|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
56450632|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450633|NCT00314405|Methylene Blue|methylene blue|mesh-list
56450634|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450635|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450636|NCT04715295|Azithromycin|azithromycin|mesh-list
56450637|NCT04715295|Doxycycline|doxycycline|mesh-list
56450638|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
56450639|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
56450640|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56450641|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450642|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56914394|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914395|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56450643|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
56450644|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56450645|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
56450646|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450647|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450648|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
56450649|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
56450650|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56450651|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56450652|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450653|NCT00348504|Simendan|simendan|mesh-list
56450654|NCT00348504|Dobutamine|dobutamine|mesh-list
55854096|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450656|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
56450657|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56450658|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56450659|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450660|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450661|NCT00348504|Protective Agents|protective agents|mesh-ancestor
56450662|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450663|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
56450664|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
56450665|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450666|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56450667|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56450668|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56450669|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
56450670|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450671|NCT00314561|Pioglitazone|pioglitazone|mesh-list
56450672|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
56450673|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450674|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450675|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
56450677|NCT00348582|Ketorolac|ketorolac|mesh-list
56450678|NCT00348582|Nepafenac|nepafenac|mesh-list
56450679|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56450680|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56450681|NCT00348582|Analgesics|analgesics|mesh-ancestor
56450682|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
56450683|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450684|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450685|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56450686|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450687|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56450688|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450689|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450690|NCT00314639|Modafinil|modafinil|mesh-list
56450691|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56450692|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450693|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56450694|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56450695|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56450696|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450697|NCT00314678|Paclitaxel|paclitaxel|mesh-list
56450698|NCT00314678|Topotecan|topotecan|mesh-list
56450699|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56450700|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450701|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
56450702|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
56450703|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
56450704|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450705|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56450706|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56450707|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450708|NCT00344526|Dexamethasone|dexamethasone|mesh-list
56450709|NCT00344526|Melphalan|melphalan|mesh-list
56450710|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56450711|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
56450712|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
56450713|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450714|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914396|NCT01431820|Luliconazole|luliconazole|mesh-list
56914397|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56914398|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
56914399|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450715|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56450716|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
56450717|NCT00344526|Hormones|hormones|mesh-ancestor
56450718|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450719|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56450720|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450721|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56450722|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
56450723|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450724|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56450725|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450726|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
56450727|NCT00314756|Imiquimod|imiquimod|mesh-list
56450728|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56450729|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
56450731|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450733|NCT00344565|Modafinil|modafinil|mesh-list
56450734|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56450735|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450736|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56450737|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56450738|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56450739|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450740|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
56450741|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450742|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56450743|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450744|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450745|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
56450746|NCT00348738|Hematinics|hematinics|mesh-ancestor
56450747|NCT00314912|Tramiprosate|tramiprosate|mesh-list
56198582|NCT01513720|Lamotrigine|lamotrigine|mesh-list
56450749|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
56450750|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
56450751|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450752|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450753|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450754|NCT00314990|Folic Acid|folic acid|mesh-list
56450755|NCT00314990|Pyridoxine|pyridoxine|mesh-list
56450756|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
56450757|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
56450758|NCT00314990|Hematinics|hematinics|mesh-ancestor
56450759|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
56450760|NCT00314990|Vitamins|vitamins|mesh-ancestor
56450761|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
56450762|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450763|NCT02960126|Aspirin|aspirin|mesh-list
56450764|NCT02960126|Clopidogrel|clopidogrel|mesh-list
56450765|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56450766|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56450767|NCT02960126|Analgesics|analgesics|mesh-ancestor
56450768|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
56450769|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450770|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450771|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56450772|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450773|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56450774|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56450775|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450776|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56450777|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56450778|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450779|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
56450780|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56450781|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56450782|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56450783|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
56450784|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914400|NCT01425970|Interferons|interferons|mesh-list
56914401|NCT01425970|Ribavirin|ribavirin|mesh-list
56334070|NCT00065169|Celecoxib|celecoxib|mesh-list
56450785|NCT00315185|Cetuximab|cetuximab|mesh-list
56450786|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56450787|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450788|NCT00344760|Tenofovir|tenofovir|mesh-list
56450789|NCT00344760|Lamivudine|lamivudine|mesh-list
56450790|NCT00344760|Efavirenz|efavirenz|mesh-list
56450791|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
56450792|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
56450793|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450794|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56450795|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56450796|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450797|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450798|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56450799|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56450800|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56450801|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56450802|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56450803|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56450805|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56450807|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56450808|NCT00348894|Reboxetine|reboxetine|mesh-list
56450809|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
56450810|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56450811|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56450812|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56450813|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450814|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450815|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
56450816|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450817|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450818|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
56450819|NCT00315536|Remifentanil|remifentanil|mesh-list
56450820|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56450821|NCT00315536|Narcotics|narcotics|mesh-ancestor
56450822|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450823|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450824|NCT00315536|Analgesics|analgesics|mesh-ancestor
56450825|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
56450826|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450827|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56450828|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56450829|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56450830|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
56450831|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450832|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450833|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
56450834|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450835|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450836|NCT00349089|Pemetrexed|pemetrexed|mesh-list
56450837|NCT00349089|Vinorelbine|vinorelbine|mesh-list
56450838|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450839|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450840|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450841|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56450842|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56450843|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56450844|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
56450845|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
56450846|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
56450847|NCT00349128|Metformin|metformin|mesh-list
56450848|NCT00349128|Fenofibrate|fenofibrate|mesh-list
56450849|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450850|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450851|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56450852|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
56450853|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450854|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56450855|NCT00315848|Buprenorphine|buprenorphine|mesh-list
56450856|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56450857|NCT00315848|Narcotics|narcotics|mesh-ancestor
56914402|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
56914403|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
56450858|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450859|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450860|NCT00315848|Analgesics|analgesics|mesh-ancestor
56450861|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
56450862|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450863|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56450864|NCT00349206|Sirolimus|sirolimus|mesh-list
56450865|NCT00349206|Sorafenib|sorafenib|mesh-list
56450866|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450867|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56450868|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450869|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450870|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56450871|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450872|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56450873|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
56450874|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56450875|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
56450876|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450878|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56450879|NCT00315887|Narcotics|narcotics|mesh-ancestor
56450880|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450881|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450882|NCT00315887|Analgesics|analgesics|mesh-ancestor
56450883|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
56450884|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450885|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56450886|NCT00421395|Epratuzumab|epratuzumab|mesh-list
56450887|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56450888|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56450890|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
56450891|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450892|NCT00315926|Protective Agents|protective agents|mesh-ancestor
56450893|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450894|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450895|NCT00421434|Ribavirin|ribavirin|mesh-list
56450896|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56450897|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
56450898|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
56450899|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
56450900|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450901|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
56450902|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56450903|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
56450904|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450905|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56450906|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
56450907|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
56450908|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56450909|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
56450910|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450911|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450912|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56450913|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
56450914|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56450915|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
56450916|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450917|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450918|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56450919|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
56450920|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
56450921|NCT00315965|Protective Agents|protective agents|mesh-ancestor
56450922|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
56450923|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
56450924|NCT00349245|Remifentanil|remifentanil|mesh-list
56450925|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56450926|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450927|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450928|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56450929|NCT00349245|Analgesics|analgesics|mesh-ancestor
56450930|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
56450931|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914404|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56914405|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914406|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
56914407|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914408|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
56914409|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914410|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
56914411|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450932|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56450933|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56450934|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56450935|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
56450936|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450937|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450938|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56450939|NCT00349245|Narcotics|narcotics|mesh-ancestor
56450940|NCT00349284|Ezetimibe|ezetimibe|mesh-list
56450941|NCT00349284|Fenofibrate|fenofibrate|mesh-list
56450942|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56450943|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56450944|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
56450945|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450946|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56450947|NCT00316160|Bupropion|bupropion|mesh-list
56450948|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56450949|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56450950|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
56450951|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56450954|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450955|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450956|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
56450957|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450958|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450959|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56450960|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56450961|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450962|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56450963|NCT00349362|Testosterone|testosterone|mesh-list
56450964|NCT00349362|Androgens|androgens|mesh-ancestor
56450965|NCT00349362|Hormones|hormones|mesh-ancestor
56450966|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56450967|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450968|NCT00316238|Olanzapine|olanzapine|mesh-list
56450969|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
56450970|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
56450971|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450972|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450973|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56450974|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56450975|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56450976|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450977|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56450978|NCT00316238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56450979|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56450980|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56450981|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450982|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450983|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
56450984|NCT00349401|Ketorolac|ketorolac|mesh-list
56450985|NCT00349401|Morphine|morphine|mesh-list
56450986|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56450987|NCT00349401|Narcotics|narcotics|mesh-ancestor
56450988|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450989|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450990|NCT00349401|Analgesics|analgesics|mesh-ancestor
56450991|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
56914412|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56914413|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56914414|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914415|NCT01619332|Incretins|incretins|mesh-ancestor
56914416|NCT01619332|Hormones|hormones|mesh-ancestor
56914417|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914418|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56914419|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
56914420|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914421|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914422|NCT01616524|Interferons|interferons|mesh-list
56914423|NCT01616524|Ribavirin|ribavirin|mesh-list
56914424|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
56914425|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
56450992|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56450993|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56450994|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56450995|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56450996|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56450997|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56450998|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450999|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451000|NCT00349440|Cyclosporine|cyclosporine|mesh-list
56451001|NCT00349440|Cyclosporins|cyclosporins|mesh-list
56451002|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451003|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451004|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451005|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
56451006|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451007|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
56451008|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451009|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
56451010|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451011|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56451012|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
56451013|NCT00316433|Irinotecan|irinotecan|mesh-list
56451014|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451015|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56451016|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56451017|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451018|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451019|NCT00349518|Dasatinib|dasatinib|mesh-list
56451020|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451021|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56451022|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451023|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451025|NCT00316472|Niacin|niacin|mesh-list
56451026|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
56451027|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
56451028|NCT00316472|Vitamins|vitamins|mesh-ancestor
56451029|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
56451030|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451031|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56451032|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
56451033|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451034|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56451035|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
56451036|NCT00349557|Bevacizumab|bevacizumab|mesh-list
56451037|NCT00349557|Goserelin|goserelin|mesh-list
56451038|NCT00349557|Bicalutamide|bicalutamide|mesh-list
56451039|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56451040|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914426|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56451041|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56451042|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56451043|NCT00349557|Growth Substances|growth substances|mesh-ancestor
56451044|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451045|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
56451046|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56451047|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
56451048|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
56451049|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451051|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451052|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
56451053|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451054|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451055|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451056|NCT00349635|Metformin|metformin|mesh-list
56451057|NCT00349635|Fenofibrate|fenofibrate|mesh-list
56451058|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56451059|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451060|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56451061|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
56451062|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451063|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56451064|NCT00316745|Leucovorin|leucovorin|mesh-list
56451065|NCT00316745|Fluorouracil|fluorouracil|mesh-list
56451066|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
56451067|NCT00316745|Irinotecan|irinotecan|mesh-list
56451068|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
56451069|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451070|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451071|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451072|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451073|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
56451074|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451075|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56451076|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56451077|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451078|NCT00316745|Antidotes|antidotes|mesh-ancestor
56451079|NCT00316745|Protective Agents|protective agents|mesh-ancestor
56451080|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
56451081|NCT00316745|Vitamins|vitamins|mesh-ancestor
56451082|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
56451083|NCT00349674|Methotrexate|methotrexate|mesh-list
56451084|NCT00349674|Azathioprine|azathioprine|mesh-list
56451085|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56451086|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
56451087|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56451088|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451089|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451090|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
56451091|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451092|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451093|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
56451094|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451095|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56451096|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451097|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
56451098|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451099|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56451102|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451104|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56451105|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56451106|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
56451107|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451108|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56451109|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56451110|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451111|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56451112|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56451113|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451114|NCT00316940|Bortezomib|bortezomib|mesh-list
56451115|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
56451116|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914427|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914428|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
56914429|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914430|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
56451117|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56451118|NCT00316940|Analgesics|analgesics|mesh-ancestor
56451119|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
56451120|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451121|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451122|NCT00344994|Pramipexole|pramipexole|mesh-list
56451123|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
56451124|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451125|NCT00344994|Protective Agents|protective agents|mesh-ancestor
56451126|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451127|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56451128|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56451129|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
56451130|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
56451131|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451132|NCT00349791|Testosterone|testosterone|mesh-list
56451133|NCT00349791|Androgens|androgens|mesh-ancestor
56451134|NCT00349791|Hormones|hormones|mesh-ancestor
56451135|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451136|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451137|NCT00317096|Rituximab|rituximab|mesh-list
56451138|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56451139|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451140|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
56451141|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451142|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451143|NCT00317135|Vaccines|vaccines|mesh-list
56451144|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
56451145|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451146|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
56451147|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56451148|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451149|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56451150|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451151|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451152|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56451153|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
56451154|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451155|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451156|NCT00317330|Rifampin|rifampin|mesh-list
56451157|NCT00317330|Isoniazid|isoniazid|mesh-list
56451158|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
56451159|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56451160|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
56451161|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56451162|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451163|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
56451164|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56451165|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451166|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451167|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56451168|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56451169|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56451170|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56451172|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56451173|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56451174|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56451175|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
56451176|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56451178|NCT00317408|Cytarabine|cytarabine|mesh-list
56451179|NCT00317408|Cyclosporine|cyclosporine|mesh-list
56451180|NCT00317408|Dexamethasone|dexamethasone|mesh-list
56451181|NCT00317408|Prednisolone|prednisolone|mesh-list
56451182|NCT00317408|Carboplatin|carboplatin|mesh-list
56451183|NCT00317408|Methotrexate|methotrexate|mesh-list
56451184|NCT00317408|Etoposide|etoposide|mesh-list
56451185|NCT00317408|Melphalan|melphalan|mesh-list
56451186|NCT00317408|Busulfan|busulfan|mesh-list
56451187|NCT00317408|Ifosfamide|ifosfamide|mesh-list
56451188|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
56914431|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914432|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
56451189|NCT00317408|Idarubicin|idarubicin|mesh-list
56451190|NCT00317408|Thiotepa|thiotepa|mesh-list
56451191|NCT00317408|Carmustine|carmustine|mesh-list
56451192|NCT00317408|Vinblastine|vinblastine|mesh-list
56451193|NCT00317408|Lomustine|lomustine|mesh-list
56451194|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
56451195|NCT00317408|Vindesine|vindesine|mesh-list
56451196|NCT00317408|Cyclosporins|cyclosporins|mesh-list
56451197|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56199035|NCT01516138|Insulin|insulin|mesh-list
56451198|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
56451199|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56451200|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
56451201|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
56451202|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451204|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56451205|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
56451206|NCT00317408|Hormones|hormones|mesh-ancestor
56451207|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451208|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56451209|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451210|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56451211|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
56451212|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56451213|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451214|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
56451215|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451216|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
56451217|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451218|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56451219|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451220|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
56451221|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451222|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56451223|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56451224|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56451225|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56451226|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
56451227|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451228|NCT00317408|Antidotes|antidotes|mesh-ancestor
56451229|NCT00317408|Protective Agents|protective agents|mesh-ancestor
56451230|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
56451231|NCT00317408|Vitamins|vitamins|mesh-ancestor
56451232|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
56451233|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
56451234|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56451235|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56451236|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
56451237|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56451238|NCT00317408|Analgesics|analgesics|mesh-ancestor
56451239|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
56451240|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56451241|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56451242|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56451243|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56451245|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56451246|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
56451247|NCT00317447|Hormones|hormones|mesh-ancestor
56451248|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451249|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451250|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56451252|NCT02959554|Nivolumab|nivolumab|mesh-list
56451253|NCT02959554|Sunitinib|sunitinib|mesh-list
56451254|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56451255|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451256|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56451257|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451258|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56451259|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56451260|NCT02959554|Growth Substances|growth substances|mesh-ancestor
56451261|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451262|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
56100048|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
56914433|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451263|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56451264|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451265|NCT00345306|Progesterone|progesterone|mesh-list
56451266|NCT00345306|Progestins|progestins|mesh-ancestor
56451267|NCT00345306|Hormones|hormones|mesh-ancestor
56451268|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451269|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451270|NCT00317681|Tacrolimus|tacrolimus|mesh-list
56451271|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451272|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
56451273|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451274|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56451275|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199105|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56451276|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451277|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
56451278|NCT00350181|Sirolimus|sirolimus|mesh-list
56451279|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
56451280|NCT00350181|Busulfan|busulfan|mesh-list
56451281|NCT00350181|Carmustine|carmustine|mesh-list
56451282|NCT00350181|Etoposide|etoposide|mesh-list
56451283|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451284|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
56451285|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451286|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451287|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56451288|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
56451289|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451290|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451291|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56451292|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56451293|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56451294|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56451295|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451296|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56451297|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56451298|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
56451299|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56451300|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451301|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
56451302|NCT00317759|Fludarabine|fludarabine|mesh-list
56451303|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
56451304|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451305|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451306|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
56451307|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451308|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451309|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
56451310|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451311|NCT00317798|Sirolimus|sirolimus|mesh-list
56451312|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56451313|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56451314|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451315|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56451316|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451317|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
56451318|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451319|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
56451320|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451321|NCT00345501|Iloprost|iloprost|mesh-list
56451322|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56451323|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
56451324|NCT00345657|Niacin|niacin|mesh-list
56451327|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
56451328|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56451329|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
56451330|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451331|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56451332|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
56451333|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
56451334|NCT00345657|Vitamins|vitamins|mesh-ancestor
56451335|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
56451336|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451337|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56914434|NCT02265328|Prednisolone|prednisolone|mesh-list
56914435|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914436|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
56914437|NCT02265328|Hormones|hormones|mesh-ancestor
56914438|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914439|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914440|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56914441|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914442|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
56914443|NCT01422148|Minocycline|minocycline|mesh-list
56914444|NCT01422148|Amiodarone|amiodarone|mesh-list
56914445|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914446|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914447|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56914448|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
56914449|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56914450|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56914451|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914452|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56914453|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56914454|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56914455|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914456|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56451338|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56451339|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451340|NCT00317876|Cyclosporine|cyclosporine|mesh-list
56451341|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
56451342|NCT00317876|Methotrexate|methotrexate|mesh-list
56451343|NCT00317876|Cyclosporins|cyclosporins|mesh-list
56451344|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451345|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
56451346|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451347|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451348|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56451349|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
56451350|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451351|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199186|NCT01516866|Listerine|listerine|mesh-list
56451352|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56451353|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56451355|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56451356|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451357|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
56451358|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
56451359|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451360|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56451361|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56451362|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
56451363|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451364|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56914457|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56914458|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56914459|NCT01421056|Flurbiprofen|flurbiprofen|mesh-list
56914460|NCT01421056|Analgesics|analgesics|mesh-ancestor
56914461|NCT01421056|Sensory System Agents|sensory system agents|mesh-ancestor
56914462|NCT01421056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914463|NCT01421056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914464|NCT01421056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56914465|NCT01421056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56334646|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
56451365|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
56451366|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451367|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
56451368|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451369|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451370|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56451371|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
56165123|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451372|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451373|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451374|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56451376|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56451377|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56451378|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56451379|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451380|NCT00317954|Spironolactone|spironolactone|mesh-list
56451381|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56451382|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
56451383|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451384|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451385|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56451386|NCT00317954|Diuretics|diuretics|mesh-ancestor
56451387|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
56451388|NCT00317993|Simvastatin|simvastatin|mesh-list
56451389|NCT00317993|Ezetimibe|ezetimibe|mesh-list
56451390|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56451391|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56451392|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
56451393|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451394|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56451395|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56451396|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451397|NCT00350415|Mesalamine|mesalamine|mesh-list
56451398|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56451400|NCT00350415|Analgesics|analgesics|mesh-ancestor
56451401|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
56451402|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451403|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451404|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56451405|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451406|NCT00345696|Bevacizumab|bevacizumab|mesh-list
56451407|NCT00345696|Capecitabine|capecitabine|mesh-list
56451408|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
56451409|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56451410|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451411|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56451412|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56451413|NCT00345696|Growth Substances|growth substances|mesh-ancestor
56451414|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451415|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
56451416|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451417|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
56914466|NCT01421056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914467|NCT01421056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56914468|NCT01421056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56451418|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451419|NCT00350454|Sirolimus|sirolimus|mesh-list
56451420|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56451421|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451422|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56451423|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451424|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
56451425|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451426|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
56451427|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451428|NCT00345735|Fentanyl|fentanyl|mesh-list
56451429|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56451430|NCT00345735|Narcotics|narcotics|mesh-ancestor
56451431|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56451432|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451433|NCT00345735|Analgesics|analgesics|mesh-ancestor
56451434|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
56451435|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451436|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56451437|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56451438|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
56451439|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
56451440|NCT02959749|Bevacizumab|bevacizumab|mesh-list
56451441|NCT02959749|Docetaxel|docetaxel|mesh-list
56451442|NCT02959749|Osimertinib|osimertinib|mesh-list
56451443|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56451444|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451445|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56451446|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56451447|NCT02959749|Growth Substances|growth substances|mesh-ancestor
56451448|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451449|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
56451450|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
56451451|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
56451452|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
56451453|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451454|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56451455|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451456|NCT00318383|Vaccines|vaccines|mesh-list
56451457|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
56451458|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451459|NCT00318422|Liraglutide|liraglutide|mesh-list
56451460|NCT00318422|Glimepiride|glimepiride|mesh-list
56451461|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
56451462|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56451463|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451464|NCT00318422|Incretins|incretins|mesh-ancestor
56451465|NCT00318422|Hormones|hormones|mesh-ancestor
56451466|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451467|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56451468|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451469|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
56451470|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56451471|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
56451472|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56451473|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56451475|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56451476|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451477|NCT00346047|Buprenorphine|buprenorphine|mesh-list
56451478|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56451479|NCT00346047|Narcotics|narcotics|mesh-ancestor
56451480|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56451481|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451482|NCT00346047|Analgesics|analgesics|mesh-ancestor
56451483|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
56451484|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451485|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56451486|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56451487|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56451488|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
56451489|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
56914469|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914470|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914471|NCT03971734|Regadenoson|regadenoson|mesh-list
56914472|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56914473|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56914474|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
56914475|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
56914476|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914477|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451490|NCT00318773|Sertraline|sertraline|mesh-list
56451491|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
56451492|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56451493|NCT00318773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56451494|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56451495|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56451496|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451497|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451498|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
56451499|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451500|NCT00318890|Docetaxel|docetaxel|mesh-list
56451501|NCT00318890|Amifostine|amifostine|mesh-list
56451502|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451503|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56451504|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56451505|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56451506|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451507|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56451508|NCT00318890|Protective Agents|protective agents|mesh-ancestor
56451509|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451510|NCT00318968|Esomeprazole|esomeprazole|mesh-list
56451511|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56451512|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56451513|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56451514|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451515|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451516|NCT00319007|Sulindac|sulindac|mesh-list
56451517|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56451518|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56451519|NCT00319007|Analgesics|analgesics|mesh-ancestor
56451520|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
56451521|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451522|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451523|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56451524|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451525|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451526|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56451527|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451528|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451529|NCT00350961|Gemcitabine|gemcitabine|mesh-list
56451530|NCT00350961|Capecitabine|capecitabine|mesh-list
56451531|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
56451532|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451533|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
56451534|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451535|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451536|NCT00350961|Antiviral Agents|antiviral agents|mesh-ancestor
56451537|NCT00350961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451538|NCT00350961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451539|NCT00350961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451540|NCT00350961|Immunologic Factors|immunologic factors|mesh-ancestor
56451541|NCT00350961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451542|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
56451543|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56451544|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914478|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914479|NCT01416064|Molindone|molindone|mesh-list
56914480|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56914481|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56914482|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56914483|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914484|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56914547|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914548|NCT02265718|Methylphenidate|methylphenidate|mesh-list
56914549|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56914550|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914551|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56914552|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56914553|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56914554|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914555|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
56914556|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914557|NCT02265874|Nicotine|nicotine|mesh-list
56914558|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56914559|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
56914560|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914561|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451545|NCT00421473|Atovaquone|atovaquone|mesh-list
56451546|NCT00421473|Proguanil|proguanil|mesh-list
56451547|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56451549|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
56451550|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56451551|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56451552|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451553|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451554|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
56451555|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
56451556|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56451557|NCT00319163|Estradiol|estradiol|mesh-list
56451558|NCT00319163|Estrogens|estrogens|mesh-ancestor
56451559|NCT00319163|Hormones|hormones|mesh-ancestor
56451560|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451561|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451562|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56451563|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
56451564|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56451565|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56451566|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56451567|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56451568|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56451569|NCT00319202|Candesartan|candesartan|mesh-list
56451570|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56451571|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56451572|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56451573|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451574|NCT00421512|Bevacizumab|bevacizumab|mesh-list
56451575|NCT00421512|Sunitinib|sunitinib|mesh-list
56451576|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56451577|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451578|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56451579|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56451580|NCT00421512|Growth Substances|growth substances|mesh-ancestor
56451581|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451582|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
56451583|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56451584|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451585|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451586|NCT00319319|Mecamylamine|mecamylamine|mesh-list
56451587|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56451588|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56914562|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56914563|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56914564|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
56914565|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914566|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914567|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56914568|NCT02266030|Aspirin|aspirin|mesh-list
56914569|NCT02266030|Cilostazol|cilostazol|mesh-list
56914570|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56914571|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56914572|NCT02266030|Analgesics|analgesics|mesh-ancestor
56914573|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
56914574|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914575|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914576|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914577|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625227|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56914578|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56914579|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56914580|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914581|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56914582|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56914583|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914584|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
56914585|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56914586|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
56914587|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56914588|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
56914589|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
56914590|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56914591|NCT02266030|Protective Agents|protective agents|mesh-ancestor
56914592|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56914593|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56914594|NCT01527916|Donepezil|donepezil|mesh-list
56914595|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55988995|NCT01725113|Calcitriol|calcitriol|mesh-list
56451589|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
56451590|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451591|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451592|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56914596|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914597|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914598|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
56914599|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914600|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914601|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
56914602|NCT01373086|Eplerenone|eplerenone|mesh-list
56914603|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56914604|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
56914605|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914606|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334915|NCT00067626|Trace Elements|trace elements|mesh-ancestor
56334918|NCT00067743|Lenalidomide|lenalidomide|mesh-list
56451593|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56451594|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
56451595|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451596|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451597|NCT00346359|Methotrexate|methotrexate|mesh-list
56451598|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
56451599|NCT00346359|Fludarabine|fludarabine|mesh-list
56451601|NCT00346359|Tacrolimus|tacrolimus|mesh-list
56451602|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56451603|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56451604|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
56451605|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56451606|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451607|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451608|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
56451609|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451610|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451611|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
56451612|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451613|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56451614|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451615|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
56451616|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56451617|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56451618|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56451619|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
56451620|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56451621|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56451623|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451624|NCT00319358|Protective Agents|protective agents|mesh-ancestor
56451625|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451626|NCT00319514|Docetaxel|docetaxel|mesh-list
56451627|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451628|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
56451629|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
56451630|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
56451631|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451632|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56451633|NCT00319670|Laxatives|laxatives|mesh-ancestor
56451634|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56451635|NCT00351195|Capecitabine|capecitabine|mesh-list
56451636|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
56451637|NCT00351195|Etoposide|etoposide|mesh-list
56451638|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451639|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
56451640|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451641|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100198|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
56914607|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56914608|NCT01373086|Diuretics|diuretics|mesh-ancestor
56914609|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
56914610|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56914611|NCT01519804|Paclitaxel|paclitaxel|mesh-list
56914612|NCT01519804|Carboplatin|carboplatin|mesh-list
56914613|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56914614|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914615|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
56914616|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
56914617|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56914618|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914619|NCT02263924|Tocotrienols|tocotrienols|mesh-list
56914620|NCT02263924|Vitamin E|vitamin e|mesh-list
56914621|NCT02263924|Tocopherols|tocopherols|mesh-list
56914622|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
56914623|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914624|NCT02263924|Protective Agents|protective agents|mesh-ancestor
56914625|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914626|NCT02263924|Vitamins|vitamins|mesh-ancestor
56914627|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
56914628|NCT02264002|Metoprolol|metoprolol|mesh-list
56914629|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56914630|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56914631|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
56914632|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
56914633|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914634|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167873|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
56451642|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56451643|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56451644|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56451645|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451646|NCT00319709|Amibegron|amibegron|mesh-list
56451647|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56451648|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56451649|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
56451650|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451651|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451652|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451653|NCT00319787|Gefitinib|gefitinib|mesh-list
56451654|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451655|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56451656|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451657|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451658|NCT00319865|Thalidomide|thalidomide|mesh-list
56451659|NCT00319865|Dexamethasone|dexamethasone|mesh-list
56451660|NCT00319865|Doxorubicin|doxorubicin|mesh-list
56451661|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56451662|NCT00319865|Bortezomib|bortezomib|mesh-list
56914635|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56914636|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56914637|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56914638|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
56914639|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914640|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914641|NCT01517776|Temozolomide|temozolomide|mesh-list
56914642|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56914643|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
56914644|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914645|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914646|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
56914647|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56914648|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914649|NCT01516918|Ribavirin|ribavirin|mesh-list
56914650|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56914651|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
56914652|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914653|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
56914654|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914655|NCT01508026|Valsartan|valsartan|mesh-list
56914656|NCT01508026|Nebivolol|nebivolol|mesh-list
56914657|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56914658|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56914659|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56914660|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914661|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
56914662|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56914663|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56914664|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56914665|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
56914666|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451663|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56451664|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
56451665|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
56451666|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451667|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451668|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56451669|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
56451670|NCT00319865|Hormones|hormones|mesh-ancestor
56451671|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914667|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914668|NCT01357642|Epinephrine|epinephrine|mesh-list
56914669|NCT01357642|Racepinephrine|racepinephrine|mesh-list
56914670|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
56914671|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56914672|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56914673|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
56914674|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914675|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914676|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914677|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56914678|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56914679|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
56914680|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914681|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56914682|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
56914683|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
56914684|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
56167961|NCT00355524|Ritonavir|ritonavir|mesh-list
56451672|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56451673|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451674|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56451675|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56451676|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56451677|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451678|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451679|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451680|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
56451681|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
56451682|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56451683|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451684|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56451685|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56451686|NCT00319865|Growth Substances|growth substances|mesh-ancestor
56451687|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
56451688|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
56451689|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
56451690|NCT00320021|Vitamins|vitamins|mesh-ancestor
56451691|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
56451692|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451693|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
56451694|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
56451695|NCT00320060|Vitamins|vitamins|mesh-ancestor
56451696|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
56451697|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451699|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56451700|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
56451701|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56451702|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56451703|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56451704|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
56451705|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56451706|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451707|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56451708|NCT00320294|Irinotecan|irinotecan|mesh-list
56451709|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451710|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56451711|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56914685|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56914686|NCT03135340|Anesthetics|anesthetics|mesh-list
56914687|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56914688|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914689|NCT01356160|Ribavirin|ribavirin|mesh-list
56914690|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56914691|NCT01356160|Ledipasvir|ledipasvir|mesh-list
56914692|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
56914693|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914694|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
56914695|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914696|NCT02264158|Telmisartan|telmisartan|mesh-list
56914697|NCT02264158|Lacidipine|lacidipine|mesh-list
56914698|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56914699|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56914700|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56914701|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914702|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56914703|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56914704|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56914705|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914706|NCT02264236|Vaccines|vaccines|mesh-list
56914707|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
56914708|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914709|NCT01476904|Epinephrine|epinephrine|mesh-list
56914710|NCT01476904|Racepinephrine|racepinephrine|mesh-list
56914711|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
56914712|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56914713|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56914714|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
56914715|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914716|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914728|NCT01337752|Bortezomib|bortezomib|mesh-list
56914729|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56914730|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914731|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
56914732|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
56914733|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914734|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914735|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56914736|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
56914737|NCT01337752|Hormones|hormones|mesh-ancestor
56914738|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914739|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56914740|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914741|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
56914742|NCT01318642|Gemcitabine|gemcitabine|mesh-list
56914743|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914744|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
56914745|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914746|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914747|NCT01318642|Antiviral Agents|antiviral agents|mesh-ancestor
56914748|NCT01318642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914749|NCT01318642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914750|NCT01318642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914751|NCT01318642|Immunologic Factors|immunologic factors|mesh-ancestor
56914752|NCT01318642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914753|NCT01318252|Latanoprost|latanoprost|mesh-list
56914754|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56914755|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56914756|NCT01313572|Adenosine|adenosine|mesh-list
56914757|NCT01313572|Analgesics|analgesics|mesh-ancestor
56451712|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451713|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451714|NCT00346749|Fluticasone|fluticasone|mesh-list
56451716|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56451717|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56451718|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56451719|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
56451720|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451721|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451722|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56451723|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
56451724|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
56451725|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56451726|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56451727|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56451728|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56451729|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
56914758|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
56914759|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914760|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914761|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56168089|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
56451730|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451731|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451732|NCT00351507|Vildagliptin|vildagliptin|mesh-list
56451733|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56451734|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451735|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56451736|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
56451737|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451738|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451739|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56451740|NCT00320567|Norgestimate|norgestimate|mesh-list
56451741|NCT00320567|Estradiol|estradiol|mesh-list
56451742|NCT00320567|Estrogens|estrogens|mesh-ancestor
56451743|NCT00320567|Hormones|hormones|mesh-ancestor
56451744|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451745|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451746|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56451747|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
56451748|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56451749|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56451750|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56451751|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56451752|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56451753|NCT00346827|Apomorphine|apomorphine|mesh-list
56451754|NCT00346827|Emetics|emetics|mesh-ancestor
56451755|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451756|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
56451757|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451758|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56451759|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
56451760|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
56451761|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451762|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451763|NCT00346866|Anecortave|anecortave|mesh-list
56451764|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56451765|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56451766|NCT00346866|Growth Substances|growth substances|mesh-ancestor
56451767|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451768|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
56451769|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451770|NCT00320723|Bupropion|bupropion|mesh-list
56451771|NCT00320723|Nicotine|nicotine|mesh-list
56451772|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56451773|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
56451778|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
56451779|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451780|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451781|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56451782|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
56451783|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56451784|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56451785|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56451786|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56451787|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
56451788|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56451789|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56451790|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451791|NCT00351546|Vildagliptin|vildagliptin|mesh-list
56451792|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56451793|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451794|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56451795|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
56451796|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888210|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56914762|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
56914763|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56914764|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
56914765|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
56914766|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914767|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914768|NCT02265484|Rifaximin|rifaximin|mesh-list
56914769|NCT02265484|Bromocriptine|bromocriptine|mesh-list
56914770|NCT02265484|Lactulose|lactulose|mesh-list
56914771|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56451797|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451798|NCT00351585|Vildagliptin|vildagliptin|mesh-list
56451799|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56451800|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451801|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56199654|NCT01519336|Ritonavir|ritonavir|mesh-list
56451802|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
56451803|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451804|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451805|NCT00320879|Irbesartan|irbesartan|mesh-list
56451806|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56451807|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56451808|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56451809|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451811|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
56451812|NCT00347100|Glyburide|glyburide|mesh-list
56451813|NCT00347100|Glipizide|glipizide|mesh-list
56451814|NCT00347100|Gliclazide|gliclazide|mesh-list
56451815|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56451816|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451817|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56451818|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56451819|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
56451820|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451821|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451822|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56451823|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
56451824|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56451825|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56451826|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56451827|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
56451828|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451829|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451830|NCT00321074|Tacrolimus|tacrolimus|mesh-list
56451831|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451832|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
56451833|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451834|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56451835|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451836|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451837|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
56451838|NCT00321113|Tacrolimus|tacrolimus|mesh-list
56451839|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451840|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
56451841|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451842|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56451844|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451845|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56451846|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451847|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56451848|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
56451849|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56451850|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451852|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451853|NCT00347295|Estazolam|estazolam|mesh-list
56914772|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914773|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56914774|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56914775|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56914776|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
56914777|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914778|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914779|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
56914780|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
56914781|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914782|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914783|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
56914784|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56914785|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
56914786|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914787|NCT02264626|Remifentanil|remifentanil|mesh-list
56451854|NCT00347295|Brotizolam|brotizolam|mesh-list
56451855|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
56451856|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56451857|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56451858|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56451859|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451860|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56451861|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
56451862|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
56451863|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451864|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451865|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56451866|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
56451867|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56451868|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
56451869|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
56451870|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56451871|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451872|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56451873|NCT00321191|Analgesics|analgesics|mesh-ancestor
56451874|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
56451875|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451876|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
56451877|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56451879|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451880|NCT00321230|Protective Agents|protective agents|mesh-ancestor
56451881|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451883|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
56451884|NCT00321230|Laxatives|laxatives|mesh-ancestor
56451885|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56451886|NCT00351663|Enoxaparin|enoxaparin|mesh-list
56451887|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
56451888|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56451889|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56451890|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451891|NCT00321347|Lidocaine|lidocaine|mesh-list
56451892|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
56451893|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
56451894|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56451895|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451896|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
56451897|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451898|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56914788|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56914789|NCT02264626|Narcotics|narcotics|mesh-ancestor
56914790|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56914791|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914792|NCT02264626|Analgesics|analgesics|mesh-ancestor
56914793|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
56914794|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914795|NCT03993262|Bortezomib|bortezomib|mesh-list
56914796|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914797|NCT02267044|Ropivacaine|ropivacaine|mesh-list
56914798|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
56914799|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
56914800|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56914801|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914802|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
56914803|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914804|NCT02267122|Mupirocin|mupirocin|mesh-list
56914805|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914806|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914807|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56914808|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914809|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914810|NCT01261312|Guadecitabine|guadecitabine|mesh-list
56914811|NCT01261312|Azacitidine|azacitidine|mesh-list
56914812|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914813|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914814|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
56914815|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914816|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914817|NCT01254370|Travoprost|travoprost|mesh-list
56914818|NCT01254370|Latanoprost|latanoprost|mesh-list
56914819|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56451899|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56451900|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56451901|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56451902|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451903|NCT00351702|Isoniazid|isoniazid|mesh-list
56451904|NCT00351702|Ethambutol|ethambutol|mesh-list
56451905|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
56451906|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56451907|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451908|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56451909|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56451910|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
55888211|NCT03300960|Ganirelix|ganirelix|mesh-list
56914820|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56914821|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56914822|NCT01254136|Trastuzumab|trastuzumab|mesh-list
56914823|NCT01254136|Vinorelbine|vinorelbine|mesh-list
56914824|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56914825|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914826|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56914827|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
56914828|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
56914829|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
56451911|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451912|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56451913|NCT00351975|Azacitidine|azacitidine|mesh-list
56451914|NCT00351975|Belinostat|belinostat|mesh-list
56451915|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56451916|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
56451917|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451918|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451922|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451923|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56451924|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451925|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451926|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
56451927|NCT00352092|Sirolimus|sirolimus|mesh-list
56451928|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56451929|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56451930|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451931|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56451932|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
56451933|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56451934|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451935|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451936|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451937|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
56451938|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56451939|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
56451940|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451941|NCT00322127|Plerixafor|plerixafor|mesh-list
56451942|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56451943|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56451944|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
56451945|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451946|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
56451947|NCT00352170|Vitamin D|vitamin d|mesh-list
56451948|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
56451949|NCT00352170|Calcium|calcium|mesh-list
56451950|NCT00352170|Vitamins|vitamins|mesh-ancestor
56451951|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
56451952|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451953|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56451954|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56451956|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56451957|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451958|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
56451959|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
56451960|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56451961|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
56451962|NCT00352287|Pioglitazone|pioglitazone|mesh-list
56451963|NCT00352287|Hormones|hormones|mesh-list
56451964|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56451965|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451966|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56451967|NCT00352443|Everolimus|everolimus|mesh-list
56451968|NCT00352443|Lapatinib|lapatinib|mesh-list
56451969|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451970|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914830|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914831|NCT02268370|Dasatinib|dasatinib|mesh-list
56914832|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914833|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56914834|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914835|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914836|NCT00039377|Leucovorin|leucovorin|mesh-list
56914837|NCT00039377|Cytarabine|cytarabine|mesh-list
56914838|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
56914839|NCT00039377|Methotrexate|methotrexate|mesh-list
56914840|NCT00039377|Etoposide|etoposide|mesh-list
56914841|NCT00039377|Vincristine|vincristine|mesh-list
56914842|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
56914843|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
56914844|NCT00039377|Tacrolimus|tacrolimus|mesh-list
56914845|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
56914846|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914847|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
56914848|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914849|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56914850|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56914851|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
56914852|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914853|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914854|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56914855|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56914856|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
56914857|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56914858|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914859|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
56914860|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
56914861|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914862|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56914863|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56914864|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56914872|NCT00039377|Vitamins|vitamins|mesh-ancestor
56914873|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
56914874|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56914875|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
56914876|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
56914877|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
56914878|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56914879|NCT01096745|Gemcitabine|gemcitabine|mesh-list
56914880|NCT01096745|Cisplatin|cisplatin|mesh-list
56914881|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168415|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
56451971|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
56451972|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451973|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56451974|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451975|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451976|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
56451977|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
56451978|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56451979|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56451980|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451981|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451982|NCT00352482|Urological Agents|urological agents|mesh-ancestor
56451983|NCT00322400|Paclitaxel|paclitaxel|mesh-list
56451984|NCT00322400|Docetaxel|docetaxel|mesh-list
56451985|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
56451986|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56451987|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451988|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
56451989|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
56451990|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
56451991|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56451992|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56451994|NCT00352521|Bevacizumab|bevacizumab|mesh-list
56451995|NCT00352521|Irinotecan|irinotecan|mesh-list
56451996|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56451997|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451998|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56451999|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56452000|NCT00352521|Growth Substances|growth substances|mesh-ancestor
56452001|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452002|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
56452003|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56452004|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56452005|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452006|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452007|NCT00352599|Lovastatin|lovastatin|mesh-list
56452008|NCT00352599|L 647318|l 647318|mesh-list
56452009|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
56452010|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56452011|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56452012|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
56452013|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452014|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56452015|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56452016|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452017|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56452018|NCT00322595|Paroxetine|paroxetine|mesh-list
56452019|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
56452020|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452021|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56452022|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56452023|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56452024|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452026|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56452027|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56914882|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914883|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
56914884|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914885|NCT01096745|Antiviral Agents|antiviral agents|mesh-ancestor
56914886|NCT01096745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914887|NCT01096745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914888|NCT01096745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914889|NCT01096745|Immunologic Factors|immunologic factors|mesh-ancestor
56914890|NCT01096745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914891|NCT03953729|Ibuprofen|ibuprofen|mesh-list
56452028|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452029|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452030|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
56452031|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56452032|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56452033|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56452034|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452035|NCT00352677|Bafetinib|bafetinib|mesh-list
56452036|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56452037|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452038|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452039|NCT00331149|Ropinirole|ropinirole|mesh-list
56452040|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56452041|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56452042|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
56452043|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
56452044|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452045|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452046|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452047|NCT00331188|Vapreotide|vapreotide|mesh-list
56452048|NCT00331188|Analgesics|analgesics|mesh-ancestor
56452049|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
56452050|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452051|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452052|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452053|NCT00352833|Catumaxomab|catumaxomab|mesh-list
56452054|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452055|NCT00331305|Sertraline|sertraline|mesh-list
56452056|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
56452057|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452058|NCT00331305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56452059|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56452060|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452061|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452062|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452063|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
56452064|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452065|NCT00322751|Topotecan|topotecan|mesh-list
56452066|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56452068|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452069|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452070|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452072|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56452073|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452074|NCT00322907|Mefloquine|mefloquine|mesh-list
56452075|NCT00322907|Quinine|quinine|mesh-list
56452076|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
56452077|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56452078|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56452079|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452080|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56452081|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452082|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56452083|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914892|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56914893|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56914894|NCT03953729|Analgesics|analgesics|mesh-ancestor
56914895|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
56914896|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914897|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914898|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914899|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56914900|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56914901|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914902|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914903|NCT01097213|Ethanol|ethanol|mesh-list
56914956|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
56914957|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625602|NCT02838758|Lidocaine|lidocaine|mesh-list
56914958|NCT01222702|Vancomycin|vancomycin|mesh-list
56914959|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
56914960|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914961|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914962|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56914963|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914964|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914965|NCT01204762|Entecavir|entecavir|mesh-list
56914966|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
56914967|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914968|NCT02236078|Isoniazid|isoniazid|mesh-list
56914969|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
56914970|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914971|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914972|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56914973|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56914974|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
56914975|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914976|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56914977|NCT01198834|Etodolac|etodolac|mesh-list
56914978|NCT01198834|Lidocaine|lidocaine|mesh-list
56914979|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
56914980|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
56914981|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56914982|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914983|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
56914984|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914985|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56914986|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56914987|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56914988|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56914991|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56914996|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56914997|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914998|NCT01193140|Temozolomide|temozolomide|mesh-list
56914999|NCT01193140|Veliparib|veliparib|mesh-list
56915000|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56915001|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
56915002|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915003|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915004|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56915005|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915006|NCT03956680|Nivolumab|nivolumab|mesh-list
56915007|NCT03956680|Ipilimumab|ipilimumab|mesh-list
56915008|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56915009|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915010|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56915011|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915012|NCT01189396|Albuterol|albuterol|mesh-list
56915013|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56915014|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
56452084|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56452085|NCT00322907|Analgesics|analgesics|mesh-ancestor
56452086|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
56452087|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56452088|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56452089|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56452090|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56452091|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56452092|NCT00331500|Analgesics|analgesics|mesh-ancestor
56452093|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
56452094|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452095|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452096|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56452097|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452098|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56452099|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56452100|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56452101|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
56452102|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
56452103|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452104|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452105|NCT00322985|Lenalidomide|lenalidomide|mesh-list
56452106|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
56452107|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452108|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56452109|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56452110|NCT00322985|Growth Substances|growth substances|mesh-ancestor
56452111|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
56452112|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452113|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
56452114|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452115|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452116|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56452117|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56452118|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56452119|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915015|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915016|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915017|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56915018|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
56915019|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
56915020|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915021|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56915022|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56915023|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56915024|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
56915025|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915026|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915027|NCT05626972|Tenecteplase|tenecteplase|mesh-list
56452120|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452121|NCT00353028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56452122|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56452123|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452124|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452125|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
56452126|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56452127|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
56452128|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56452129|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56452130|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56452131|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
56452132|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56452133|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56452134|NCT00353067|Analgesics|analgesics|mesh-ancestor
56452135|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
56452136|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452137|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452141|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452142|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452143|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
56452145|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56452146|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452147|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56452148|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56452149|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452150|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452151|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452152|NCT00323375|Chloroquine|chloroquine|mesh-list
56452153|NCT00323375|Amebicides|amebicides|mesh-ancestor
56452154|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56452155|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56452156|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452157|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
56452158|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452159|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56452160|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56452161|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56452162|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165164|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452163|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452164|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452165|NCT00331695|Progestins|progestins|mesh-ancestor
56452166|NCT00331695|Hormones|hormones|mesh-ancestor
56452167|NCT00353145|Gemcitabine|gemcitabine|mesh-list
56452168|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
56915028|NCT05626972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56915029|NCT05626972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56915030|NCT05626972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915031|NCT01174732|Albuterol|albuterol|mesh-list
56915032|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56915033|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
56915034|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915035|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915036|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56915037|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
56915038|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
56915039|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915040|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56452169|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56452170|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
56452171|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452172|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452173|NCT00353145|Antiviral Agents|antiviral agents|mesh-ancestor
56452174|NCT00353145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452175|NCT00353145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452176|NCT00353145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452177|NCT00353145|Immunologic Factors|immunologic factors|mesh-ancestor
56452178|NCT00353145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452179|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56452180|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452181|NCT00353184|Montelukast|montelukast|mesh-list
56452182|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56452183|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
56452184|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56452185|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
56452186|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452187|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452188|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56452189|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56452190|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452191|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56452192|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56452193|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56452194|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452195|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452196|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
56452197|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452198|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56452199|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56452200|NCT00323804|Ribavirin|ribavirin|mesh-list
56452201|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56452202|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
56452203|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452204|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
56452205|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452206|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
56452207|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56452208|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
56452216|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452217|NCT00353340|Antidotes|antidotes|mesh-ancestor
56452218|NCT00323843|Isoproterenol|isoproterenol|mesh-list
56452219|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56452220|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56452221|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
56452222|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915041|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56915042|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56915043|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
56915044|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915045|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915046|NCT01076764|Heparin|heparin|mesh-list
56915047|NCT01076764|Calcium heparin|calcium heparin|mesh-list
56915048|NCT01076764|Otamixaban|otamixaban|mesh-list
56915049|NCT01076764|Eptifibatide|eptifibatide|mesh-list
56915050|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
56915051|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56915052|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56915053|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915054|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56915055|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56915056|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
56915057|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56915058|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
56915059|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915060|NCT02269072|Anastrozole|anastrozole|mesh-list
56915061|NCT02269072|Leuprolide|leuprolide|mesh-list
56915062|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56915063|NCT02269072|Testosterone|testosterone|mesh-list
56915064|NCT02269072|Androgens|androgens|mesh-ancestor
56915065|NCT02269072|Hormones|hormones|mesh-ancestor
56915093|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56915094|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915095|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915096|NCT01035502|Idarubicin|idarubicin|mesh-list
56915097|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56915098|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915099|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56915100|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56915101|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915102|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915103|NCT01030432|Ribavirin|ribavirin|mesh-list
56915104|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56915105|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
56915106|NCT01030432|Asunaprevir|asunaprevir|mesh-list
56915107|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
56915108|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915109|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
56915110|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915111|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
56915112|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915113|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
56915114|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915115|NCT02269462|Efavirenz|efavirenz|mesh-list
56915116|NCT02269462|Nevirapine|nevirapine|mesh-list
56915117|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56915118|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56452223|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452224|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452225|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56452226|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
56452227|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452228|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56452229|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
56452230|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56452231|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
56452232|NCT00323843|Protective Agents|protective agents|mesh-ancestor
56452233|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
56452234|NCT00331851|Metformin|metformin|mesh-list
56452235|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
56452236|NCT00331851|Liraglutide|liraglutide|mesh-list
56452237|NCT00331851|Glimepiride|glimepiride|mesh-list
56452238|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56452239|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452240|NCT00331851|Incretins|incretins|mesh-ancestor
56452242|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452243|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56452244|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452245|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
56452246|NCT00331890|Choline|choline|mesh-list
56452247|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56915119|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915120|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915121|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
56915122|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915123|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56915124|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56915125|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56915126|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56915127|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56452248|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
56452249|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56452250|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
56452251|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452252|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452253|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56452254|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
56452255|NCT01059773|Methotrexate|methotrexate|mesh-list
56452256|NCT01059773|Ustekinumab|ustekinumab|mesh-list
56452257|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56452258|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
56452259|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56452260|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452261|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56452262|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
56452263|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452264|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452265|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
56452266|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452267|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56452268|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452269|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
56452270|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452271|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56452272|NCT00353379|Guanfacine|guanfacine|mesh-list
56452273|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56452274|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56452275|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56452276|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56452277|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
56452278|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452280|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452281|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
56452282|NCT00324077|Dasatinib|dasatinib|mesh-list
56452283|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452284|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56452285|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452286|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452287|NCT00324194|Mocetinostat|mocetinostat|mesh-list
56452288|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56452289|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452290|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452291|NCT00324389|Interferons|interferons|mesh-list
56452292|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
56452293|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452294|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
56452295|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452296|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
56452297|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452298|NCT00353691|Metformin|metformin|mesh-list
56452299|NCT00353691|Glimepiride|glimepiride|mesh-list
56452300|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56452301|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452302|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56452303|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915128|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56915129|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56915130|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56915131|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56915132|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56915133|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915134|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
56915135|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
56915136|NCT02269540|Sertraline|sertraline|mesh-list
56915137|NCT02269540|Citalopram|citalopram|mesh-list
56915138|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56915139|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
56915140|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915141|NCT02269540|Expectorants|expectorants|mesh-ancestor
56915142|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
56915143|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56915144|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
56915145|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915146|NCT02269540|Protective Agents|protective agents|mesh-ancestor
56915147|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915148|NCT02269540|Antidotes|antidotes|mesh-ancestor
56915149|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
56915150|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56915151|NCT02269540|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56915152|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56915153|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56915154|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915155|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
56915156|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56915157|NCT01023880|Delanzomib|delanzomib|mesh-list
56168898|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
56452304|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
56452305|NCT00332046|Casopitant|casopitant|mesh-list
56452306|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
56452307|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
56452308|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452309|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452310|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452311|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56452312|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452313|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452314|NCT00324467|Acetaminophen|acetaminophen|mesh-list
56452315|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
56452316|NCT00324467|Promethazine|promethazine|mesh-list
56452317|NCT00324467|Dexamethasone|dexamethasone|mesh-list
56452318|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
56452319|NCT00324467|Prednisone|prednisone|mesh-list
56915158|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
56915159|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
56915160|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915161|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915162|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
56915163|NCT02650804|Gemcitabine|gemcitabine|mesh-list
56915164|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56915165|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
56168944|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56452320|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
56452321|NCT00324467|Ifosfamide|ifosfamide|mesh-list
56452322|NCT00324467|Rituximab|rituximab|mesh-list
56452323|NCT00324467|Carboplatin|carboplatin|mesh-list
56452324|NCT00324467|Doxorubicin|doxorubicin|mesh-list
56452325|NCT00324467|Etoposide|etoposide|mesh-list
56452326|NCT00324467|Vincristine|vincristine|mesh-list
56452327|NCT00324467|Ondansetron|ondansetron|mesh-list
56452328|NCT00324467|BB 1101|bb 1101|mesh-list
56452329|NCT00324467|Mesna|mesna|mesh-list
56452330|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452331|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
56452332|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452333|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452334|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56452335|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
56452336|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452337|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452338|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56452339|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56452340|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56452341|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
56452342|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
56452343|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452344|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452345|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
56452346|NCT00324467|Hormones|hormones|mesh-ancestor
56452347|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452348|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56452349|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
56452350|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452351|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56452352|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56452353|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56452354|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56452355|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
56452356|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
56452357|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
56452358|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56452360|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
56452361|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
56452362|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
56452363|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
56452364|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56452365|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
56452366|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452367|NCT00324467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56452368|NCT00324467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56452369|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56452370|NCT00324467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452371|NCT00324467|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56452372|NCT00324467|Protective Agents|protective agents|mesh-ancestor
56452373|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56452374|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56452375|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
56452376|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
56452377|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56452378|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
56452379|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
56452380|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56452381|NCT00332085|Chromium|chromium|mesh-list
56915166|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915167|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915168|NCT02650804|Antiviral Agents|antiviral agents|mesh-ancestor
56915169|NCT02650804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915170|NCT02650804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915171|NCT02650804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915172|NCT02650804|Immunologic Factors|immunologic factors|mesh-ancestor
56915173|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915174|NCT02650804|Vitamins|vitamins|mesh-ancestor
56915175|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
56915176|NCT02269696|Metoprolol|metoprolol|mesh-list
56915177|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56915178|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56915179|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
56915180|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
56915181|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915182|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452382|NCT00332085|Picolinic acid|picolinic acid|mesh-list
56452383|NCT00332085|Trace Elements|trace elements|mesh-ancestor
56452384|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
56452385|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452386|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56452387|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
56452388|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
56452389|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452390|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
56452391|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56452392|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452393|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56452394|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
56452395|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56452396|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452397|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452398|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452399|NCT00332124|Choline|choline|mesh-list
56452400|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
56452401|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56452402|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
56452403|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200240|NCT01523015|Docetaxel|docetaxel|mesh-list
56452404|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452405|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56452406|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
56452407|NCT04714554|Erythromycin|erythromycin|mesh-list
56452408|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
56452409|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56452410|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
56452411|NCT04714554|Relugolix|relugolix|mesh-list
56452412|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56452413|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452414|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452415|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56452416|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452417|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452418|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
56452419|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
56452420|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452421|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452422|NCT00419471|Citalopram|citalopram|mesh-list
56915183|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56625826|NCT04249154|Leuprolide|leuprolide|mesh-list
56915184|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56915185|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56915186|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
56915187|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915188|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915189|NCT03135184|Coal Tar|coal tar|mesh-list
56915190|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
56915191|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
56915192|NCT05613400|Simvastatin|simvastatin|mesh-list
56915193|NCT05613400|Ezetimibe|ezetimibe|mesh-list
56915194|NCT05613400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56915195|NCT05613400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56915196|NCT05613400|Antimetabolites|antimetabolites|mesh-ancestor
56915197|NCT05613400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452423|NCT00419471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56452424|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56452425|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452426|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452427|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452428|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
56452429|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452431|NCT00419471|Antidepressive Agents|antidepressive agents|mesh-ancestor
56452432|NCT00419471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452434|NCT00426348|Probucol|probucol|mesh-list
56452435|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56452436|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56452437|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56452438|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452439|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56452440|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56452441|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
56452442|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56452443|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
56452444|NCT00426348|Protective Agents|protective agents|mesh-ancestor
56452445|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452446|NCT00353808|Reboxetine|reboxetine|mesh-list
56452447|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
56452448|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452449|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56452450|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56452451|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452452|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452453|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
56452454|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452455|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452456|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
56452457|NCT00324623|Fludarabine|fludarabine|mesh-list
56452458|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
56452459|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452460|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
56452461|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452462|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452463|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56452464|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
56452465|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452466|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915198|NCT05613400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56915199|NCT05613400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56915200|NCT05613400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915201|NCT02261662|Ribavirin|ribavirin|mesh-list
56915202|NCT02261662|Betamethasone|betamethasone|mesh-list
56915203|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
56915204|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915205|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
56915206|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915207|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915208|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
56915209|NCT02261662|Hormones|hormones|mesh-ancestor
56915210|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915211|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915212|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56915213|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
56915214|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
56915215|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56915216|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915217|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56915218|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56915219|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915220|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915221|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915222|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56169126|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56452467|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56452468|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56452469|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
56452470|NCT00324779|Rituximab|rituximab|mesh-list
56452471|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56452472|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452473|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
56452474|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452475|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452476|NCT00324818|Azithromycin|azithromycin|mesh-list
56200331|NCT01523314|Hormones|hormones|mesh-ancestor
56452477|NCT00324818|Metronidazole|metronidazole|mesh-list
56452478|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56452479|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452480|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56452481|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56452482|NCT00324974|Lansoprazole|lansoprazole|mesh-list
56452483|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
56452484|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56452485|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452486|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56452487|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888212|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56169176|NCT00383994|Rituximab|rituximab|mesh-list
56452488|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452489|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
56452490|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56452491|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56452492|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
56452493|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452494|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452495|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56452496|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
56452497|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
56452498|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56452499|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
56452500|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452501|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452502|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
56452503|NCT00325169|Hormones|hormones|mesh-ancestor
56452504|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452505|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
56452506|NCT00426543|Rituximab|rituximab|mesh-list
56452507|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56452508|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452509|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
56452510|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452511|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452512|NCT00325286|Carbamazepine|carbamazepine|mesh-list
56452513|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452514|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452515|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
56452516|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56452517|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56452518|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452519|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
56452520|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56452521|NCT00325286|Analgesics|analgesics|mesh-ancestor
56452522|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
56452523|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452524|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56452525|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452526|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56452527|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56452528|NCT00325325|Everolimus|everolimus|mesh-list
56452529|NCT00325325|Tacrolimus|tacrolimus|mesh-list
56452530|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452531|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
56452532|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452533|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56452534|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452535|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452536|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452538|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
56452539|NCT04705428|Protective Agents|protective agents|mesh-ancestor
56452540|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452541|NCT00354081|Vitamins|vitamins|mesh-list
56452542|NCT00354081|Folic Acid|folic acid|mesh-list
56452543|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
56452544|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
56452545|NCT00354081|Pyridoxine|pyridoxine|mesh-list
56452546|NCT00354081|Pyridoxal|pyridoxal|mesh-list
56452547|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
56452548|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
56452549|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
56452550|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452551|NCT00354081|Hematinics|hematinics|mesh-ancestor
56452552|NCT00325637|Losartan|losartan|mesh-list
56452553|NCT00325637|Cilnidipine|cilnidipine|mesh-list
56452554|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56452555|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56452556|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56452557|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56452558|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452559|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56452560|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452561|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56452562|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915223|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56915224|NCT00035555|Cyclosporine|cyclosporine|mesh-list
56915225|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
56915226|NCT00035555|Abatacept|abatacept|mesh-list
56169247|NCT00385554|UC-781|uc-781|mesh-list
56452563|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
56452564|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452565|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
56452566|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452567|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452568|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56452569|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
56452570|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452571|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452572|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56452573|NCT00426582|Epothilone B|epothilone b|mesh-list
56452574|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452575|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56452576|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56452577|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56452578|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452581|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56452582|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452583|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452584|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56452585|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56452586|NCT00354198|Protective Agents|protective agents|mesh-ancestor
56452587|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452588|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
56452589|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56452591|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56452592|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
56452593|NCT00354198|Hormones|hormones|mesh-ancestor
56452594|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452595|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56452596|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56452597|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452598|NCT00325676|Pantoprazole|pantoprazole|mesh-list
56452599|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56452600|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452601|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56452602|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452603|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452604|NCT00325715|Esomeprazole|esomeprazole|mesh-list
56452605|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56452606|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452607|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56452608|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452609|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452610|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56452611|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452612|NCT00325793|Nicardipine|nicardipine|mesh-list
56452613|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56452614|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56452615|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452616|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452617|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56452618|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452619|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
56452620|NCT00426621|Diclofenac|diclofenac|mesh-list
56452621|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56452622|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56452623|NCT00426621|Analgesics|analgesics|mesh-ancestor
56452624|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
56452625|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452626|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452627|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56452628|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452629|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56915227|NCT00035555|Cyclosporins|cyclosporins|mesh-list
56915228|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915229|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915230|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915231|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
56915232|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169323|NCT00422682|Gemcitabine|gemcitabine|mesh-list
56452630|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452631|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452633|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56452634|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56452635|NCT04714242|Growth Substances|growth substances|mesh-ancestor
56452636|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452637|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56452638|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452639|NCT00354276|Cytarabine|cytarabine|mesh-list
56452640|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56452641|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
56452642|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452643|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452644|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
56452645|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452646|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452647|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
56452648|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452649|NCT00325910|Metformin|metformin|mesh-list
55859797|NCT00670774|Eculizumab|eculizumab|mesh-list
56452652|NCT00325949|Acetaminophen|acetaminophen|mesh-list
56452653|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56452654|NCT00325949|Hydrocodone|hydrocodone|mesh-list
56452655|NCT00325949|Oxycodone|oxycodone|mesh-list
56452656|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56452657|NCT00325949|Analgesics|analgesics|mesh-ancestor
56452658|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
56452659|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452660|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452661|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
56452662|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56452663|NCT00325949|Narcotics|narcotics|mesh-ancestor
56452664|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56452665|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
56452666|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
56452667|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56452668|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56452669|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452670|NCT00326027|Pantoprazole|pantoprazole|mesh-list
56452671|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56452672|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452673|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56452674|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452675|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452676|NCT01059318|Everolimus|everolimus|mesh-list
56452677|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452678|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452679|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
56452680|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452681|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
56452682|NCT04714515|Ivermectin|ivermectin|mesh-list
56452683|NCT04714515|Montelukast|montelukast|mesh-list
56452684|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
56452685|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56452686|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56452687|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452688|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452689|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452690|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452691|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56452692|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
56452693|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56915233|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
56915234|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915235|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
56915236|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915237|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56915238|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56915239|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452694|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
56452695|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452696|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452697|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56452698|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56452699|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56452700|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
56452701|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452702|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56452703|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56452704|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56452705|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452706|NCT00354354|Ipratropium|ipratropium|mesh-list
56452707|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56452708|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
56452709|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452710|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452711|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56452712|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
56452713|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452714|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452715|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56452716|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
56452717|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56452718|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
56452719|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452720|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56452721|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56452722|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56452726|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452727|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
56452728|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452729|NCT00326300|Methylphenidate|methylphenidate|mesh-list
56452730|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56452731|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452732|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56452733|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56452734|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452735|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452736|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
56452737|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452738|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
56452739|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
56452740|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56165179|NCT01821690|Buspirone|buspirone|mesh-list
56452741|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452742|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452743|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56452744|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452745|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56452746|NCT00419549|Valdecoxib|valdecoxib|mesh-list
56452747|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56452748|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56452749|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452750|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452751|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56452752|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56452753|NCT00419549|Analgesics|analgesics|mesh-ancestor
56915240|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56915241|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
56915242|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56915243|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56915244|NCT01093157|Hormones|hormones|mesh-list
56915245|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56915246|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915247|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915248|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
56915249|NCT01093235|Bevacizumab|bevacizumab|mesh-list
56915250|NCT01093235|Docetaxel|docetaxel|mesh-list
56915251|NCT01093235|Fluorouracil|fluorouracil|mesh-list
56915252|NCT01093235|Epirubicin|epirubicin|mesh-list
56452754|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
56452755|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452756|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452757|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56452758|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452759|NCT00354393|Methotrexate|methotrexate|mesh-list
56452760|NCT00354393|Vinorelbine|vinorelbine|mesh-list
56452761|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452762|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56452763|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
56452764|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56452765|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452766|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56452767|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
56452768|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452769|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
56452770|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452771|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56452772|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452773|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
56452774|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452775|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56452776|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56452777|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
56452778|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
56452779|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
56452780|NCT00326378|Docetaxel|docetaxel|mesh-list
56452781|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452782|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
56452783|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
56452784|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
56452785|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452786|NCT00326768|Telmisartan|telmisartan|mesh-list
56452787|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56452788|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56452789|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56452790|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56452791|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452792|NCT00326768|Diuretics|diuretics|mesh-ancestor
56452794|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452795|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56452796|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452797|NCT00326807|Naltrexone|naltrexone|mesh-list
56452798|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56452799|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56452800|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452801|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
56452802|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452803|NCT00354549|Gemcitabine|gemcitabine|mesh-list
56915253|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915254|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
56915255|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169519|NCT02993094|Ixazomib|ixazomib|mesh-list
56452804|NCT00354549|Bevacizumab|bevacizumab|mesh-list
56452805|NCT00354549|Carboplatin|carboplatin|mesh-list
56452806|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56452807|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56452808|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452809|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56452810|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56452811|NCT00354549|Growth Substances|growth substances|mesh-ancestor
56452812|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452814|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56452815|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
56452816|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452817|NCT00354549|Antiviral Agents|antiviral agents|mesh-ancestor
56452818|NCT00354549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452819|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452820|NCT00354549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452821|NCT00354549|Immunologic Factors|immunologic factors|mesh-ancestor
56452822|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56452823|NCT01057251|Nebivolol|nebivolol|mesh-list
56452824|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56452825|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
56452826|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56452827|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56452828|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56452829|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
56452830|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452831|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452832|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452833|NCT04708353|Pregabalin|pregabalin|mesh-list
56452834|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452835|NCT04708353|Analgesics|analgesics|mesh-ancestor
56452836|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
56452837|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452838|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
56452839|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56452840|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452841|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452842|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56452843|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56452844|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56452845|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56452846|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452847|NCT00425646|Bevacizumab|bevacizumab|mesh-list
56452848|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
56452849|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56452850|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452851|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56452852|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56452853|NCT00425646|Growth Substances|growth substances|mesh-ancestor
56452854|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452855|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
56452856|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56452857|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452858|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452859|NCT00327080|Acetylcholine|acetylcholine|mesh-list
56452860|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
56452861|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56452862|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
56452863|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452864|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452865|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452866|NCT00327119|Panitumumab|panitumumab|mesh-list
56452868|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452870|NCT00426933|Daptomycin|daptomycin|mesh-list
56452871|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56452872|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452873|NCT00327197|Prednisolone|prednisolone|mesh-list
56915256|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915257|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56915258|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
56915259|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915260|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915261|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56915262|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56915263|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56915264|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56915265|NCT01093235|Growth Substances|growth substances|mesh-ancestor
56915266|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
56915267|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
56915268|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
56915269|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
56915270|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
56915271|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56915272|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56915273|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56915274|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56915275|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915276|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
56452874|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56452875|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
56452876|NCT00327197|Hormones|hormones|mesh-ancestor
56452877|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452878|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452879|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56452880|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452881|NCT00425724|Cyclosporine|cyclosporine|mesh-list
56452882|NCT00425724|Prednisone|prednisone|mesh-list
56452883|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
56452884|NCT00425724|Cyclosporins|cyclosporins|mesh-list
56452885|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56452886|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
56452887|NCT00425724|Hormones|hormones|mesh-ancestor
56452888|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452889|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452890|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56452891|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452892|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452893|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452894|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452895|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
56452896|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
56452897|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452898|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
56452899|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452900|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56452901|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
56452902|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
56452903|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452904|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452905|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56452906|NCT00425724|Protective Agents|protective agents|mesh-ancestor
56915277|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56915278|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452907|NCT00426972|Estradiol|estradiol|mesh-list
56452908|NCT00426972|Estrogens|estrogens|mesh-ancestor
56452909|NCT00426972|Hormones|hormones|mesh-ancestor
56452910|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56452911|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452912|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
56452913|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56452914|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56452915|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
56452916|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452917|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452918|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56452919|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
56452920|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56452921|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56200764|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
56452922|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56452923|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
56452924|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452925|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452927|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
56452928|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56452929|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
56452930|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452931|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452932|NCT00425841|Antiviral Agents|antiviral agents|mesh-ancestor
56452933|NCT00425841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452934|NCT00425841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452935|NCT00425841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452936|NCT00425841|Immunologic Factors|immunologic factors|mesh-ancestor
56452937|NCT00425841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452938|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
56452939|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56452940|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
56452941|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452944|NCT00427089|Vitamins|vitamins|mesh-ancestor
56452945|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
56452946|NCT00427089|Laxatives|laxatives|mesh-ancestor
56452947|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452948|NCT00427128|Fluoxetine|fluoxetine|mesh-list
56452949|NCT00427128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56452950|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56452951|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452952|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452953|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452954|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
56452955|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452956|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56452957|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
56452958|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56452959|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56452960|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56452961|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452962|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56452963|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56452964|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
56452965|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452966|NCT00427167|Antacids|antacids|mesh-ancestor
56452967|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452968|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56452969|NCT00427206|Acetaminophen|acetaminophen|mesh-list
56452970|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56452971|NCT00427206|Analgesics|analgesics|mesh-ancestor
56452972|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
56452973|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56452974|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452975|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
56452976|NCT00425997|Amlodipine|amlodipine|mesh-list
56452977|NCT00425997|Valsartan|valsartan|mesh-list
56452978|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56915279|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56915280|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452979|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56452980|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56452981|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56452982|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452983|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56452984|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452985|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
56452986|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56452987|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56452988|NCT00425997|Diuretics|diuretics|mesh-ancestor
56452989|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
56452990|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56452991|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
56452992|NCT00427245|Goserelin|goserelin|mesh-list
56452993|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56452994|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
56452995|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452996|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452997|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56452998|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
56452999|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453000|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453001|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56453002|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56453003|NCT05458076|Ritonavir|ritonavir|mesh-list
56453004|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56453005|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56453006|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
56453007|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453008|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453009|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56453010|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56453011|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
56453012|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453013|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56453014|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56453016|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453017|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453018|NCT00426192|Mannitol|mannitol|mesh-list
56453019|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56453020|NCT00426192|Diuretics|diuretics|mesh-ancestor
56453021|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
56453022|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453023|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56453024|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
56453025|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453026|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56453027|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56453028|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453029|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453030|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56453031|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56453032|NCT00432393|Levodopa|levodopa|mesh-list
56453033|NCT00432393|Carbidopa|carbidopa|mesh-list
56453034|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56453035|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56453036|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56453037|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
56453038|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453039|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453040|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453041|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56453042|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453043|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56453044|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
56453045|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
56453046|NCT05453045|Albendazole|albendazole|mesh-list
56453047|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
56453048|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56915281|NCT01088009|Lamivudine|lamivudine|mesh-list
56915282|NCT01088009|Adefovir|adefovir|mesh-list
56915283|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56915284|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56915285|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915286|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915287|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
56915288|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915289|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56915290|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56915291|NCT03894046|Imipenem|imipenem|mesh-list
56915292|NCT03894046|Colistin|colistin|mesh-list
56915293|NCT03894046|Sulbactam|sulbactam|mesh-list
56915294|NCT03894046|Cilastatin|cilastatin|mesh-list
56915295|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56915296|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915297|NCT03894046|Protease Inhibitors|protease inhibitors|mesh-ancestor
56915298|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915299|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453049|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453050|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
56453051|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56453052|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56453053|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
56453054|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
56453055|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
56453056|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453057|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453058|NCT00432432|Infliximab|infliximab|mesh-list
56453059|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
56453060|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56453061|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453062|NCT05420402|Propofol|propofol|mesh-list
56453063|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56453064|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453065|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453066|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56453067|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
56453068|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
56453069|NCT02957448|Rifampin|rifampin|mesh-list
56453070|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56453071|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
56453078|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56453079|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56453080|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56453081|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56453082|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56453083|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56453084|NCT05371964|Imetelstat|imetelstat|mesh-list
56453085|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
56453086|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453087|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453088|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56453089|NCT00427596|Solabegron|solabegron|mesh-list
56453090|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56453091|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56453092|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56453093|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56915300|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56915301|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
56915302|NCT04475614|Vitamins|vitamins|mesh-ancestor
56915303|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
56915304|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915305|NCT01143064|Progesterone|progesterone|mesh-list
56915306|NCT01143064|Progestins|progestins|mesh-ancestor
56915307|NCT01143064|Hormones|hormones|mesh-ancestor
56915308|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915309|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915310|NCT00033371|Eflornithine|eflornithine|mesh-list
56915311|NCT00033371|Celecoxib|celecoxib|mesh-list
56915312|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56915313|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56915314|NCT00033371|Analgesics|analgesics|mesh-ancestor
56915315|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
56915316|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915317|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915318|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453094|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453096|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453103|NCT00432510|Complement C1s|complement c1s|mesh-list
56453104|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56453105|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56453106|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
56453107|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453108|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56453109|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56453110|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
56453111|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
56453112|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56453113|NCT05354258|Amodiaquine|amodiaquine|mesh-list
56453114|NCT05354258|Albendazole|albendazole|mesh-list
56453115|NCT05354258|Praziquantel|praziquantel|mesh-list
56453116|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
56453117|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56453118|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56453119|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453120|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56453121|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453122|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453123|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56453124|NCT05354258|Renal Agents|renal agents|mesh-ancestor
56453125|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
56453126|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
56453127|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56453128|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
56453129|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
56453130|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
56453131|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453132|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
56453133|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453134|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453135|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56453136|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453137|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453138|NCT02273466|Desipramine|desipramine|mesh-list
56453139|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56915319|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915320|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56915321|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56453140|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
56453141|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56453142|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453143|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453144|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56453145|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56453146|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56453147|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
56453148|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453149|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453150|NCT00427713|Capecitabine|capecitabine|mesh-list
56453151|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
56453152|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56453153|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
56453154|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453155|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453156|NCT02273505|Aspirin|aspirin|mesh-list
56453157|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
56453158|NCT02273505|Salicylates|salicylates|mesh-list
56453159|NCT02273505|Dipyridamole|dipyridamole|mesh-list
56453160|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56453161|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453162|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
56453163|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
56453164|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
56453165|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56453166|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56453167|NCT02273505|Analgesics|analgesics|mesh-ancestor
56453168|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
56453169|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453170|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453171|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453172|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453173|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56453174|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453175|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453176|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56453177|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56453178|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56453179|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
56453180|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56453181|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
56453182|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
56453183|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
56453184|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453185|NCT05198960|Aspirin|aspirin|mesh-list
56453186|NCT05198960|Anticoagulants|anticoagulants|mesh-list
56453187|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56453188|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56453189|NCT05198960|Analgesics|analgesics|mesh-ancestor
56453190|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
56453191|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453192|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453193|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453194|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453195|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56453196|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56453197|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453198|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56453199|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56453200|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453201|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
56453202|NCT00432549|Topiramate|topiramate|mesh-list
56453203|NCT00432549|Almotriptan|almotriptan|mesh-list
56453204|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
56453205|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56453206|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453207|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56453208|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
56915322|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915323|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915324|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915325|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56915326|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56915327|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56915328|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915329|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56915330|NCT01001338|Allopurinol|allopurinol|mesh-list
56915331|NCT01001338|Lesinurad|lesinurad|mesh-list
56915332|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
56915333|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915334|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915335|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
56453209|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453210|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453211|NCT00427947|Ropivacaine|ropivacaine|mesh-list
56453212|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
56453213|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
56453214|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453215|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453216|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
56453217|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453218|NCT00432588|Misoprostol|misoprostol|mesh-list
56453219|NCT00432588|Dinoprostone|dinoprostone|mesh-list
56453220|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56453221|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
56453222|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56453223|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453224|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56453225|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56453226|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
56453227|NCT00428025|Diclofenac|diclofenac|mesh-list
56453228|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56453229|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56453230|NCT00428025|Analgesics|analgesics|mesh-ancestor
56453231|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
56453232|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453233|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453234|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453235|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453236|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56453237|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453238|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453239|NCT00428064|Cyclosporine|cyclosporine|mesh-list
56453240|NCT00428064|Sirolimus|sirolimus|mesh-list
56453241|NCT00428064|Cyclosporins|cyclosporins|mesh-list
56453242|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453243|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453244|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56453245|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
56453246|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453247|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
56453248|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453249|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
56453250|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453251|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56453252|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56453253|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56453254|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453256|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56915336|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915337|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56915338|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
56915339|NCT01001338|Protective Agents|protective agents|mesh-ancestor
56915340|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915341|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
56915342|NCT01001338|Renal Agents|renal agents|mesh-ancestor
56915343|NCT03952715|Ibuprofen|ibuprofen|mesh-list
56915344|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56915345|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56915346|NCT03952715|Analgesics|analgesics|mesh-ancestor
56915347|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
56915348|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915349|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915350|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915351|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915352|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56915353|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915354|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915355|NCT01137526|Donepezil|donepezil|mesh-list
56915356|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56915357|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915358|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915359|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
56915360|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170035|NCT00245856|Dalteparin|dalteparin|mesh-list
56453257|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
56453258|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
56453259|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453260|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
56453261|NCT00419783|Ketoconazole|ketoconazole|mesh-list
56453262|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56453263|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453264|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56453265|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56453266|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453267|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453268|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453269|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453270|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
56453271|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56453272|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56453273|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56453274|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
56453275|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453276|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56453277|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
56453278|NCT04942340|Caffeine|caffeine|mesh-list
56453279|NCT04942340|Atipamezole|atipamezole|mesh-list
56915361|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915362|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
56915363|NCT00993382|Amiodarone|amiodarone|mesh-list
56915364|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56915365|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
56915366|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56170084|NCT03804840|Hormones|hormones|mesh-ancestor
56453280|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56453281|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453282|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453283|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56453284|NCT04942340|Analgesics|analgesics|mesh-ancestor
56453285|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
56453286|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453287|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56453288|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56453289|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56453290|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
56453291|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453292|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453293|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56201132|NCT01527422|Vincristine|vincristine|mesh-list
56453294|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56453295|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453296|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56453297|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56453298|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
56453299|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56453300|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56453301|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56453302|NCT00428142|Prednisone|prednisone|mesh-list
56453303|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
56453304|NCT00428142|Rituximab|rituximab|mesh-list
56453305|NCT00428142|Vincristine|vincristine|mesh-list
56453306|NCT00428142|Bortezomib|bortezomib|mesh-list
56453307|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56453308|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
56453309|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453310|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453311|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56453312|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
56453313|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453314|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453315|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56453316|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453317|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453318|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
56453319|NCT00428142|Hormones|hormones|mesh-ancestor
56453320|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453321|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55861569|NCT03945513|Hormones|hormones|mesh-ancestor
56453322|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56453324|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
56453325|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
56453326|NCT00428181|Ethanol|ethanol|mesh-list
56453327|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56453328|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453329|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453330|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453331|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56453332|NCT04803422|Amoxicillin|amoxicillin|mesh-list
56453333|NCT04803422|Metronidazole|metronidazole|mesh-list
56453334|NCT04803422|Tazobactam|tazobactam|mesh-list
56453335|NCT04803422|Piperacillin|piperacillin|mesh-list
56453336|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
56453337|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
56453338|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56453339|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453340|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56915367|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56915368|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915369|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56915370|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56915371|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56915372|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915373|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56915374|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56915375|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56915376|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
56915377|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56915378|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56170148|NCT05742750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170149|NCT05742750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56170150|NCT05742750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170152|NCT05740332|Hand Sanitizers|hand sanitizers|mesh-list
56453341|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56453342|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56453343|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453344|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453351|NCT00432861|Pancrelipase|pancrelipase|mesh-list
56453352|NCT00432861|Pancreatin|pancreatin|mesh-list
56453353|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56453354|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
56453355|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453356|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453357|NCT04575233|Ropivacaine|ropivacaine|mesh-list
56453358|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
56453359|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
56453360|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453361|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453362|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
56453363|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453364|NCT04507412|Dexamethasone|dexamethasone|mesh-list
56453365|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453366|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
56201221|NCT01527747|Hormones|hormones|mesh-ancestor
56453367|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
56453368|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453369|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453370|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56453371|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
56453373|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453374|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56453375|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453376|NCT00428454|Sirolimus|sirolimus|mesh-list
56453377|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56453378|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453379|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56453380|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453381|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
56453382|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56453383|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
56453384|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453385|NCT00432978|Bosentan|bosentan|mesh-list
56453386|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56915379|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56915380|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915381|NCT05628610|Paclitaxel|paclitaxel|mesh-list
56915382|NCT05628610|Carboplatin|carboplatin|mesh-list
56915383|NCT05628610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56915384|NCT05628610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915385|NCT05628610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56915386|NCT05628610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56915387|NCT05628610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56915388|NCT05628610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915389|NCT00079937|Fluticasone|fluticasone|mesh-list
56915390|NCT00079937|Omalizumab|omalizumab|mesh-list
56915391|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453387|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56453388|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453389|NCT01051791|Everolimus|everolimus|mesh-list
56453390|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453391|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56453392|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
56453393|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453394|NCT01056510|Rituximab|rituximab|mesh-list
56453395|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56453396|NCT01056510|Chlorambucil|chlorambucil|mesh-list
56453397|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453398|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453399|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
56453400|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453401|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453402|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56453403|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
56453405|NCT04326257|Nivolumab|nivolumab|mesh-list
56453406|NCT04326257|Ipilimumab|ipilimumab|mesh-list
56453407|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453408|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453409|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56453410|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453411|NCT01056276|Dexamethasone|dexamethasone|mesh-list
56453412|NCT01056276|Bortezomib|bortezomib|mesh-list
56453413|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56453414|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453415|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
56453416|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
56453417|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453418|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453419|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56453420|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
56453421|NCT01056276|Hormones|hormones|mesh-ancestor
56453422|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453423|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56453424|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453425|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56453426|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
56453427|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453428|NCT01055886|Nicotine|nicotine|mesh-list
56453429|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56453430|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
56453431|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453432|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453433|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56453434|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56453435|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
55888213|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
56915392|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56915393|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
56915394|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915395|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915396|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56915397|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
56915398|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
56915399|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56915400|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56915401|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56915402|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56915403|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56453436|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453437|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453438|NCT00433095|Trastuzumab|trastuzumab|mesh-list
56453439|NCT00433095|Vinorelbine|vinorelbine|mesh-list
56453440|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453441|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453442|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56453443|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
56453444|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
56453445|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
56453446|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453447|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56453448|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56453449|NCT00428649|Selenium|selenium|mesh-list
56453450|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
56453451|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453452|NCT00428649|Protective Agents|protective agents|mesh-ancestor
56453453|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453454|NCT00428649|Trace Elements|trace elements|mesh-ancestor
56453455|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
56453456|NCT03852992|Minoxidil|minoxidil|mesh-list
56453457|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56453458|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
56453459|NCT00433173|Anastrozole|anastrozole|mesh-list
56453460|NCT00433173|Goserelin|goserelin|mesh-list
56453461|NCT00433173|Testosterone|testosterone|mesh-list
56453462|NCT00433173|Androgens|androgens|mesh-ancestor
56453463|NCT00433173|Hormones|hormones|mesh-ancestor
56453464|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453465|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453466|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56453467|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453468|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56453469|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56453470|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453471|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453472|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56453473|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
56453474|NCT01055028|Paclitaxel|paclitaxel|mesh-list
56453475|NCT01055028|Bevacizumab|bevacizumab|mesh-list
56453476|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56453477|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453480|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165202|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
56453481|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453482|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453484|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56453485|NCT01055028|Growth Substances|growth substances|mesh-ancestor
56453486|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453487|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
56453488|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
56915404|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56915405|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
56915406|NCT03126110|Nivolumab|nivolumab|mesh-list
56915407|NCT03126110|Ipilimumab|ipilimumab|mesh-list
56915408|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56915409|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915410|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56915411|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915412|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
56915413|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56453489|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56453490|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
56453491|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453492|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453493|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56453494|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
56453495|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56453496|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
56453497|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453498|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453499|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56453500|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
56453501|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
56453502|NCT00428727|Protective Agents|protective agents|mesh-ancestor
56453503|NCT03474029|Rifampin|rifampin|mesh-list
56453504|NCT03474029|Rifapentine|rifapentine|mesh-list
56453505|NCT03474029|Isoniazid|isoniazid|mesh-list
56453506|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56453507|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
56453508|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56453509|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453510|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
56453511|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56453512|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453513|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453514|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56453515|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56453516|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56453517|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56201356|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
56453518|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56453519|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56453520|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56453521|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56453522|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
56453523|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56453524|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
56453525|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56453526|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56453527|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453528|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453529|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453530|NCT00428766|Farletuzumab|farletuzumab|mesh-list
56453531|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453533|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56453534|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453535|NCT04703127|Lidocaine|lidocaine|mesh-list
56453536|NCT04703127|Tadalafil|tadalafil|mesh-list
56453537|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
56453538|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
56453539|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453540|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453541|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
56453542|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915414|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915415|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56915416|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
56915417|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56915418|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915419|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915420|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915421|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
56915422|NCT05480878|Citalopram|citalopram|mesh-list
56915423|NCT05480878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56915424|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56453543|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56453544|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56453545|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56453546|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56453547|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453548|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
56453552|NCT04703127|Urological Agents|urological agents|mesh-ancestor
56453553|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
56453554|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56453555|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
56453556|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453557|NCT00428883|Expectorants|expectorants|mesh-ancestor
56453558|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
56453559|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56453560|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
56453561|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453562|NCT00428883|Protective Agents|protective agents|mesh-ancestor
56453563|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453564|NCT00428883|Antidotes|antidotes|mesh-ancestor
56453565|NCT04702971|Flunarizine|flunarizine|mesh-list
56453566|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
56453567|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56453568|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56453569|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453570|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56453571|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453572|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56453573|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
56453574|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
56453575|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453576|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
56453577|NCT00433407|Trastuzumab|trastuzumab|mesh-list
56453578|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453579|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453580|NCT00433485|Sirolimus|sirolimus|mesh-list
56453581|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56453582|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453583|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56453584|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453585|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
56453586|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56453587|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
56453588|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453589|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
56453590|NCT02676791|Povidone|povidone|mesh-list
56453591|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
56453592|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
56453593|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56453594|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453595|NCT02244125|Dexamethasone|dexamethasone|mesh-list
56453596|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
56453597|NCT02244125|Pomalidomide|pomalidomide|mesh-list
56453598|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915425|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56915426|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915427|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915428|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
56915429|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915430|NCT05480878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56915431|NCT05480878|Antidepressive Agents|antidepressive agents|mesh-ancestor
56915432|NCT05480878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56915433|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56915434|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915435|NCT00906334|ON 01910|on 01910|mesh-list
56915436|NCT00906334|Glycine|glycine|mesh-list
56915437|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915438|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56915439|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915440|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915441|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
56915442|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915443|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915444|NCT00905164|Topiramate|topiramate|mesh-list
56915445|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
56915446|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56915447|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915448|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
56915449|NCT00978016|Baclofen|baclofen|mesh-list
55852330|NCT00119158|Xhance|xhance|mesh-list
56453599|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
56453600|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453601|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453602|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56453603|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
56453604|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453605|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453606|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56453607|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453608|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
56453609|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
56453610|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453611|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56453612|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
56453613|NCT02244125|Hormones|hormones|mesh-ancestor
56453614|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453615|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56453616|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56453617|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56453618|NCT02244125|Growth Substances|growth substances|mesh-ancestor
56453619|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
56453620|NCT01600079|Vaccines|vaccines|mesh-list
56453621|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
56453623|NCT01370486|Melatonin|melatonin|mesh-list
56915450|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56915451|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915452|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915453|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56453624|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
56453625|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453626|NCT01370486|Protective Agents|protective agents|mesh-ancestor
56453627|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453628|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453629|NCT00327587|Amlodipine|amlodipine|mesh-list
56453630|NCT00327587|Valsartan|valsartan|mesh-list
56453631|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56453632|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56453633|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56453634|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56453635|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453636|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56453637|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453638|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
56453639|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56453640|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56453641|NCT00327587|Diuretics|diuretics|mesh-ancestor
56453642|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
56453643|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56453644|NCT00327665|Vaccines|vaccines|mesh-list
56453645|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56453646|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
56453647|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453648|NCT00433641|Sibutramine|sibutramine|mesh-list
56453649|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
56453650|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56453651|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
56453652|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56453653|NCT00429234|Gemcitabine|gemcitabine|mesh-list
56453654|NCT00429234|Dasatinib|dasatinib|mesh-list
56453655|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56453656|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
56453657|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453658|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453659|NCT00429234|Antiviral Agents|antiviral agents|mesh-ancestor
56453660|NCT00429234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453661|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453662|NCT00429234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56453663|NCT00429234|Immunologic Factors|immunologic factors|mesh-ancestor
56453664|NCT00429234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453665|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56453666|NCT00433719|Efavirenz|efavirenz|mesh-list
56453667|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56453668|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56453669|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56453670|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453671|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453672|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
56453673|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453674|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56453675|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56453676|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56453677|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56453678|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56453679|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56453680|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56453681|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56453682|NCT04704297|Acetaminophen|acetaminophen|mesh-list
56453683|NCT04704297|Ibuprofen|ibuprofen|mesh-list
56453684|NCT04704297|Ketorolac|ketorolac|mesh-list
56453685|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56453686|NCT04704297|Amitriptyline|amitriptyline|mesh-list
56453687|NCT04704297|Bupivacaine|bupivacaine|mesh-list
56453688|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
56453689|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
56915454|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915455|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56915456|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915457|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56915458|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
56915459|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
56915460|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915461|NCT01129648|Allopurinol|allopurinol|mesh-list
56915462|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
56915463|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915464|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915465|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
56915466|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915467|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56915468|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
56915469|NCT01129648|Protective Agents|protective agents|mesh-ancestor
56915470|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915471|NCT04438720|Nifedipine|nifedipine|mesh-list
56453690|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
56453691|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453692|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453693|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
56453694|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453697|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
56453698|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56453699|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453700|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453701|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56453702|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453703|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453704|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56453705|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
56453706|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56453707|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56453708|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56453709|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56453710|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56453711|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56453712|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56453713|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
56453714|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453715|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
56453716|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56453717|NCT00328367|Aripiprazole|aripiprazole|mesh-list
56453718|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
56453719|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56453720|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56453721|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56453722|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453723|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453724|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
56453725|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
56453726|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453727|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453728|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56453729|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56453730|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
56915472|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56915473|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56915474|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915475|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56915476|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915477|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
56915478|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
56915479|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915480|NCT05464810|Letrozole|letrozole|mesh-list
56915481|NCT05464810|Simvastatin|simvastatin|mesh-list
56915482|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56915483|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56626123|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56915484|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
56915485|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915486|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56915487|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56453731|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56453732|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56453733|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56453734|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56453735|NCT04703088|Ondansetron|ondansetron|mesh-list
56453736|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
56453737|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
56453738|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453739|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453740|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56453741|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
56453742|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
56453743|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56453744|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
56453745|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453746|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453747|NCT04703088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56453748|NCT04703088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56453749|NCT04703088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453750|NCT04703088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56453751|NCT04703088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56453752|NCT00328718|Fluticasone|fluticasone|mesh-list
56453754|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56453755|NCT00328718|Montelukast|montelukast|mesh-list
56453756|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453757|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56453758|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
56453759|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453760|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453761|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56453762|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
56453763|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
56453764|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56453765|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56453766|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56453767|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56453768|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
56453771|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56453772|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
56100200|NCT03521102|Acetaminophen|acetaminophen|mesh-list
56915488|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915489|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915490|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56915491|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56915492|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56915493|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
56915494|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915495|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915496|NCT03176966|Vitamin E|vitamin e|mesh-list
56915497|NCT03176966|Ropinirole|ropinirole|mesh-list
56915498|NCT03176966|Vitamins|vitamins|mesh-ancestor
56915499|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
56915500|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915501|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
56915502|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915503|NCT03176966|Protective Agents|protective agents|mesh-ancestor
56915504|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56915505|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56915506|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
56170714|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
55785664|NCT05728775|Propofol|propofol|mesh-list
56453773|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453774|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56453775|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56453777|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
56453779|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453780|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453781|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
56453782|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453783|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56453784|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56453785|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56453786|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56453787|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453788|NCT00429468|Acetaminophen|acetaminophen|mesh-list
56453789|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56453790|NCT00429468|Hydrocodone|hydrocodone|mesh-list
56453791|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56453792|NCT00429468|Analgesics|analgesics|mesh-ancestor
56453793|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
56453794|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453795|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453796|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
56453797|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56453798|NCT00429468|Narcotics|narcotics|mesh-ancestor
56453799|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453800|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
56453801|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
56453802|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56453803|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453804|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453805|NCT04702698|Peposertib|peposertib|mesh-list
56453806|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56453807|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915507|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
56915508|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915509|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
56915510|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
56915511|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
56915512|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56915513|NCT03209570|Protective Agents|protective agents|mesh-ancestor
56915514|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915576|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915577|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915578|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915579|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
56915580|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915581|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915582|NCT01098383|Acetylcholine|acetylcholine|mesh-list
56915583|NCT01098383|Donepezil|donepezil|mesh-list
56915584|NCT01098383|Choline|choline|mesh-list
56915585|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56915586|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915587|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915588|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
56915589|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915590|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915591|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
56453808|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453809|NCT00328874|Ubiquinone|ubiquinone|mesh-list
56453810|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
56453811|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
56453812|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453813|NCT00328874|Vitamins|vitamins|mesh-ancestor
56453814|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
56453815|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56453816|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
56453817|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56453819|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56453820|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453821|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56453822|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
56453823|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56453824|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453825|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453826|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453827|NCT02957643|Iron|iron|mesh-list
56453828|NCT02957643|Trace Elements|trace elements|mesh-ancestor
56453829|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
56453830|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453831|NCT02957604|Evolocumab|evolocumab|mesh-list
56453832|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56453833|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56453834|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
56453835|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453836|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56453837|NCT00329069|Atorvastatin|atorvastatin|mesh-list
56453838|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56453839|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56453840|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
55862633|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
56453841|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453842|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56453843|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56453844|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453845|NCT00429624|Acetaminophen|acetaminophen|mesh-list
56453846|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56453847|NCT00429624|Analgesics|analgesics|mesh-ancestor
56453848|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
56453849|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915592|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
56915593|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56915594|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
56915595|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56915596|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56915597|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
56915598|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56915599|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
56915600|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56915601|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915602|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56915603|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56915604|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
56915605|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56915606|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56915607|NCT01088477|Estradiol|estradiol|mesh-list
56915608|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56915609|NCT01088477|Estrogens|estrogens|mesh-ancestor
56915610|NCT01088477|Hormones|hormones|mesh-ancestor
56915611|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453850|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453851|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
56453852|NCT00329147|Paroxetine|paroxetine|mesh-list
56453853|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56453854|NCT00329147|Desipramine|desipramine|mesh-list
56453855|NCT00329147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56453856|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56453857|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56453858|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453859|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453860|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
56453861|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453862|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56453863|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
56453864|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56453865|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56453866|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56453867|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453868|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56453869|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56453870|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56453871|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
56453872|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56453873|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56453874|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56453875|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56453876|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56453877|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453878|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453879|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453880|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56453881|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
56453882|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56453883|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
56915612|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453884|NCT00434031|Docetaxel|docetaxel|mesh-list
56453885|NCT00434031|Doxorubicin|doxorubicin|mesh-list
56453886|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56453887|NCT00434031|Trastuzumab|trastuzumab|mesh-list
56201732|NCT01530295|Docetaxel|docetaxel|mesh-list
56453888|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56453889|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
56453890|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453891|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453892|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56453893|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
56453894|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453895|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453896|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56453897|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
56453898|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
56453899|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
56453900|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56453901|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56453902|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56453903|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453904|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56453905|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
56453906|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56453907|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453908|NCT01050543|Neostigmine|neostigmine|mesh-list
56453909|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56453910|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453911|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453914|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453915|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56453916|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
56453917|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453918|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56453919|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
56453920|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56453921|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56453922|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56453923|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56453924|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453925|NCT04704141|Hormones|hormones|mesh-list
56453926|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453927|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453928|NCT00329381|Omalizumab|omalizumab|mesh-list
56453929|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56453930|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56453931|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56453932|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
56453933|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
56453934|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453935|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
56453936|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56453937|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
56453938|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453939|NCT00329459|Naproxen|naproxen|mesh-list
56453940|NCT00329459|Sumatriptan|sumatriptan|mesh-list
56453941|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56453942|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56453943|NCT00329459|Analgesics|analgesics|mesh-ancestor
56453944|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
56453945|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56453946|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453947|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56453948|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56453949|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
56453950|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56453951|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453952|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453953|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56453954|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56453955|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56453956|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
56453957|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915613|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56915614|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
56915615|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915616|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56915617|NCT05627752|Docetaxel|docetaxel|mesh-list
56915618|NCT05627752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915619|NCT05627752|Tubulin Modulators|tubulin modulators|mesh-ancestor
56915620|NCT05627752|Antimitotic Agents|antimitotic agents|mesh-ancestor
56915621|NCT05627752|Mitosis Modulators|mitosis modulators|mesh-ancestor
56170970|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
56453958|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
56453959|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
56453960|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453961|NCT00329498|Protective Agents|protective agents|mesh-ancestor
56453962|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453963|NCT00329498|Vitamins|vitamins|mesh-ancestor
56453964|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
56453965|NCT00329537|Sargramostim|sargramostim|mesh-list
56453966|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
56453967|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453968|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
56453969|NCT00429897|Amiloride|amiloride|mesh-list
56453970|NCT00429897|Spironolactone|spironolactone|mesh-list
56453971|NCT00429897|Furosemide|furosemide|mesh-list
56453972|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56453973|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
56453974|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56453975|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453976|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56453977|NCT00429897|Diuretics|diuretics|mesh-ancestor
56453978|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
56453979|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56453980|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56453981|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56453982|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453983|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55863218|NCT03808168|Nivolumab|nivolumab|mesh-list
56453984|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56453986|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56453988|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56453989|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56453990|NCT00429936|Protective Agents|protective agents|mesh-ancestor
56453991|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453992|NCT00429975|Levofloxacin|levofloxacin|mesh-list
56453993|NCT00429975|Ofloxacin|ofloxacin|mesh-list
56453994|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
56453995|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56453996|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453997|NCT00429975|Renal Agents|renal agents|mesh-ancestor
56453998|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56453999|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56454000|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56454001|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454002|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454003|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454004|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56454005|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56454006|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
56454007|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
56454008|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
56454009|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56454010|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454011|NCT04716686|Niraparib|niraparib|mesh-list
56454012|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56454013|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100257|NCT00000781|Zalcitabine|zalcitabine|mesh-list
56915622|NCT05627752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915623|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
56915624|NCT01088555|Antidotes|antidotes|mesh-ancestor
56915625|NCT01088555|Protective Agents|protective agents|mesh-ancestor
56915626|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454014|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454015|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454016|NCT01056393|Ibalizumab|ibalizumab|mesh-list
56454017|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56454018|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56454019|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56454020|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
56454021|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454022|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
56454023|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454024|NCT01055106|Metronidazole|metronidazole|mesh-list
56454025|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454026|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56454027|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56454028|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56454029|NCT00329693|Quinagolide|quinagolide|mesh-list
56454030|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
56454031|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
56454032|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454033|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454034|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454035|NCT00329810|Aripiprazole|aripiprazole|mesh-list
56201881|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
56454036|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
56454037|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56454038|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56454039|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56454040|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454041|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454042|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
56454043|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
56454044|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454045|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454046|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56454047|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56454048|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
56454049|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56454050|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56454051|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56454052|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56454053|NCT00430170|Dipyridamole|dipyridamole|mesh-list
56454054|NCT00430170|Caffeine|caffeine|mesh-list
56454055|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56454056|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454057|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56454058|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454059|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454060|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56454061|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56454062|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
56454063|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454064|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56454065|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
56454067|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454068|NCT00430365|Lenalidomide|lenalidomide|mesh-list
56454069|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
56454070|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454071|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56454072|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56454073|NCT00430365|Growth Substances|growth substances|mesh-ancestor
56454074|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
56454075|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454077|NCT00330239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56454078|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56915627|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
56915628|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915629|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
56915630|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56454079|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56454080|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454081|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454082|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
56454083|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454084|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56454085|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
56454086|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56454087|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56454088|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56454089|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454090|NCT01051557|Sirolimus|sirolimus|mesh-list
56454091|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56454092|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454093|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56454094|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454095|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
56454096|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56454097|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
56454098|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454099|NCT00330278|Cefazolin|cefazolin|mesh-list
56454100|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56454101|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454102|NCT00330317|Letrozole|letrozole|mesh-list
56454103|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454104|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56454105|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56454106|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454107|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454108|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56454109|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
56454110|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454111|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454113|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56454114|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454115|NCT00330395|Caspofungin|caspofungin|mesh-list
56454116|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
56454117|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454118|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454119|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454120|NCT00434382|Fentanyl|fentanyl|mesh-list
56454121|NCT00434382|Sufentanil|sufentanil|mesh-list
56454122|NCT00434382|Remifentanil|remifentanil|mesh-list
56454123|NCT00434382|Alfentanil|alfentanil|mesh-list
56454124|NCT00434382|Propofol|propofol|mesh-list
56454125|NCT00434382|Sevoflurane|sevoflurane|mesh-list
56454126|NCT00434382|Desflurane|desflurane|mesh-list
56454127|NCT00434382|Isoflurane|isoflurane|mesh-list
56454128|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56454129|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454130|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454131|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56454132|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
56454133|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
56454134|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56454136|NCT00434382|Analgesics|analgesics|mesh-ancestor
56454137|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
56454138|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454139|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56454140|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56454141|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56454142|NCT00330707|Interferons|interferons|mesh-list
56454143|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
56454144|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
56454145|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454146|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
56454147|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454148|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
56915631|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915632|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
56915633|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
56915634|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
56915635|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
56915636|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915637|NCT00078767|Sertraline|sertraline|mesh-list
56915638|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
56915639|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56915640|NCT00078767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56915641|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56915642|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56454149|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454150|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56454151|NCT00330746|Gemcitabine|gemcitabine|mesh-list
56454152|NCT00330746|Cetuximab|cetuximab|mesh-list
56454153|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56454154|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
56454155|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454156|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454157|NCT00330746|Antiviral Agents|antiviral agents|mesh-ancestor
56454158|NCT00330746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454159|NCT00330746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454160|NCT00330746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56454161|NCT00330746|Immunologic Factors|immunologic factors|mesh-ancestor
56454162|NCT00330746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454163|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56454164|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
56454165|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56454166|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56454167|NCT00330785|Amlodipine|amlodipine|mesh-list
56454168|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56454169|NCT00330785|Atorvastatin|atorvastatin|mesh-list
56454170|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56454171|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56454172|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
56454173|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454174|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56454175|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56454176|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454177|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56454178|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56454179|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56454180|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56454181|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454182|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
56454183|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56454184|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
56454185|NCT00330824|Dexamethasone|dexamethasone|mesh-list
56454186|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
56454187|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56454189|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56454190|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
56454191|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
56454192|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454193|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454194|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56454195|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
56454196|NCT00330824|Hormones|hormones|mesh-ancestor
56454197|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454198|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56454199|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454200|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
56915643|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915644|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915645|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
56915646|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915647|NCT04474288|Antibodies|antibodies|mesh-list
56454201|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454202|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454203|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454204|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56454205|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56454206|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56454207|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
56454208|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56454209|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56454211|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56454212|NCT00330902|Artesunate|artesunate|mesh-list
56454213|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
56454214|NCT00330902|Primaquine|primaquine|mesh-list
56454215|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
56454216|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56454217|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
56454218|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56454219|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56454220|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454221|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454222|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
56454223|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
56454224|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56454225|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
56454226|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56454227|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454228|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454229|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56454230|NCT00330902|Renal Agents|renal agents|mesh-ancestor
56454231|NCT00330941|Lidocaine|lidocaine|mesh-list
56454232|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
56454233|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
56454234|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454235|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454236|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
56454237|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454238|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56454239|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56454240|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56454241|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56454242|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454243|NCT04703868|Rabeprazole|rabeprazole|mesh-list
56454244|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56454245|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56454246|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56454247|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454248|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454249|NCT04716296|Ketamine|ketamine|mesh-list
56454250|NCT04716296|Analgesics|analgesics|mesh-ancestor
56454251|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
56454252|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454253|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454254|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56454255|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56454256|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
56454257|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
56454258|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454259|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56202109|NCT01532466|Rocuronium|rocuronium|mesh-list
56454260|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56454261|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454262|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454263|NCT00430794|Spironolactone|spironolactone|mesh-list
56454264|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56915648|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
56915649|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915650|NCT00078377|Modafinil|modafinil|mesh-list
56915651|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56915652|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915653|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56915654|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56915655|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56915656|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915657|NCT01107496|Viloxazine|viloxazine|mesh-list
56915658|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56915659|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
56915660|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56915661|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56915662|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56915663|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56454265|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
56454266|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454267|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454268|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56454269|NCT00430794|Diuretics|diuretics|mesh-ancestor
56454270|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
56454271|NCT00330980|Simvastatin|simvastatin|mesh-list
56454272|NCT00330980|Pravastatin|pravastatin|mesh-list
56454273|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56454274|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56454275|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
56454276|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454277|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56454278|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56454279|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454280|NCT00430833|Candesartan|candesartan|mesh-list
56454281|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56454284|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454286|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56454287|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
56454288|NCT00331058|Hormones|hormones|mesh-ancestor
56454289|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454290|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454291|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56454292|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454293|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
56454294|NCT00331097|Docetaxel|docetaxel|mesh-list
56454295|NCT00331097|Fluorouracil|fluorouracil|mesh-list
56454296|NCT00331097|Methotrexate|methotrexate|mesh-list
56454297|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56454298|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
56454299|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454300|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56454301|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56454302|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
56454303|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454304|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454305|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56454306|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
56454307|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
56915664|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915665|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
56915666|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915667|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454308|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
56454309|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
56454310|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56454311|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56454312|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
56454313|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56454314|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
56454315|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454316|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56454317|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56454318|NCT00331214|Testosterone|testosterone|mesh-list
56454319|NCT00331214|Androgens|androgens|mesh-ancestor
56454320|NCT00331214|Hormones|hormones|mesh-ancestor
56454321|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454322|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454323|NCT00434772|Glucagon|glucagon|mesh-list
56454324|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56454325|NCT00434772|Hormones|hormones|mesh-ancestor
56454326|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454327|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454328|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
56454329|NCT00431028|Triamcinolone|triamcinolone|mesh-list
56454330|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56454331|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
56454332|NCT00431028|Hormones|hormones|mesh-ancestor
56454333|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454334|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454335|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454336|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165218|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454337|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56454338|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454339|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56454340|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56454341|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454342|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56454343|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56454344|NCT00431106|Gemcitabine|gemcitabine|mesh-list
56454345|NCT00431106|Capecitabine|capecitabine|mesh-list
56454346|NCT00431106|Vinorelbine|vinorelbine|mesh-list
56454347|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56454348|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
56454349|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454350|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454351|NCT00431106|Antiviral Agents|antiviral agents|mesh-ancestor
56454353|NCT00431106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454354|NCT00431106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56454355|NCT00431106|Immunologic Factors|immunologic factors|mesh-ancestor
56454356|NCT00431106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454357|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56454358|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
56454359|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
56454360|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
56454361|NCT00431145|Niacin|niacin|mesh-list
56454362|NCT00431145|Niacinamide|niacinamide|mesh-list
56454363|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
56454364|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56454365|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
56454366|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454367|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56454368|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
56454369|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
56454370|NCT00431145|Vitamins|vitamins|mesh-ancestor
56454371|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
56454372|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454373|NCT00331487|Pioglitazone|pioglitazone|mesh-list
56454374|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
56915668|NCT00886600|Losartan|losartan|mesh-list
56915669|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56454375|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56454376|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454377|NCT00331526|Aldesleukin|aldesleukin|mesh-list
56454378|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454379|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56454380|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56454381|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
56454382|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454383|NCT00431262|Disulfiram|disulfiram|mesh-list
56454384|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56454385|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56454386|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454387|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454388|NCT00331604|Insulin|insulin|mesh-list
56454389|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56454390|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
56454391|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
56454392|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56454393|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
56454394|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56454395|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454396|NCT00331643|Epothilones|epothilones|mesh-list
56454397|NCT00331643|Epothilone B|epothilone b|mesh-list
56454398|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
56454399|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
56454400|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
56454401|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454402|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454403|NCT00431340|Belinostat|belinostat|mesh-list
56454404|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454405|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56454406|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454407|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454408|NCT00431379|Tenecteplase|tenecteplase|mesh-list
56454409|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56454410|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56454411|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454413|NCT00331838|Semuloparin|semuloparin|mesh-list
56454414|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56454415|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
56454416|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
56454417|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56454418|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56454419|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454420|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
56454421|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
56454422|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56454423|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56454424|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454425|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454426|NCT00431418|Urological Agents|urological agents|mesh-ancestor
56454427|NCT00331955|Doxorubicin|doxorubicin|mesh-list
56454428|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56454430|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56454431|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454432|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56454433|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56454434|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454435|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454436|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56454437|NCT03277482|Durvalumab|durvalumab|mesh-list
56454438|NCT03277482|Tremelimumab|tremelimumab|mesh-list
56454439|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56454440|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454441|NCT00331994|Metronidazole|metronidazole|mesh-list
56454442|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454443|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56454444|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56454445|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56454446|NCT00332033|Pirfenidone|pirfenidone|mesh-list
56454447|NCT00332033|Analgesics|analgesics|mesh-ancestor
56454448|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
56454449|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915670|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56454450|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454451|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56454452|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56454453|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56454454|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56454455|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454456|NCT00435279|Eszopiclone|eszopiclone|mesh-list
56454457|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56454458|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56454459|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56454460|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56454461|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454462|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454463|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454464|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56454465|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
56454466|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56454467|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56454468|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454469|NCT00332072|Timolol|timolol|mesh-list
56454470|NCT00332072|Bimatoprost|bimatoprost|mesh-list
56454471|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56454472|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56454473|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
56454474|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454475|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454476|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454477|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56165240|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
56454478|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56454479|NCT00431613|Gemcitabine|gemcitabine|mesh-list
56454480|NCT00431613|Carboplatin|carboplatin|mesh-list
56454481|NCT00431613|Docetaxel|docetaxel|mesh-list
56454482|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454483|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56454484|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
56454485|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454486|NCT00431613|Antiviral Agents|antiviral agents|mesh-ancestor
56454487|NCT00431613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454488|NCT00431613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454489|NCT00431613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56454490|NCT00431613|Immunologic Factors|immunologic factors|mesh-ancestor
56454491|NCT00431613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454492|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
56454493|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
56454494|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
56454495|NCT00332228|Naltrexone|naltrexone|mesh-list
56454496|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56454497|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56454498|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454499|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
56454500|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454501|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
56454502|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
56454503|NCT00332306|Lamivudine|lamivudine|mesh-list
56454504|NCT00332306|Efavirenz|efavirenz|mesh-list
56454505|NCT00332306|Nevirapine|nevirapine|mesh-list
56454506|NCT00332306|Didanosine|didanosine|mesh-list
56454507|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56454508|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56454509|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454510|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454511|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
56454512|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454513|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56454514|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56454515|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56454516|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56454517|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56454518|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56454519|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56454520|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56915671|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56915672|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56915673|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56915674|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915675|NCT00886600|Diuretics|diuretics|mesh-ancestor
56915676|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
56454521|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
56454522|NCT00332345|Timolol|timolol|mesh-list
56454523|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56454524|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56454525|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56454526|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
56454527|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454528|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454529|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454530|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56454531|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56454532|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56454533|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56454534|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56454535|NCT00332384|Timolol|timolol|mesh-list
56454536|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56454537|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56454538|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56454539|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
56454540|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454541|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454542|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454543|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56454544|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56454545|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56454546|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56454547|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56454548|NCT00435435|Disulfiram|disulfiram|mesh-list
56454549|NCT00435435|Acamprosate|acamprosate|mesh-list
56454550|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56454551|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56454552|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454553|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454555|NCT00332540|Bimatoprost|bimatoprost|mesh-list
56454556|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56454557|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56454558|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
56454559|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454560|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454561|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454562|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56454563|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56454564|NCT00332618|Glycerol|glycerol|mesh-list
56454565|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56454566|NCT00332618|Protective Agents|protective agents|mesh-ancestor
56454567|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454568|NCT00332735|Bupivacaine|bupivacaine|mesh-list
56454569|NCT00332735|Carticaine|carticaine|mesh-list
56454570|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
56454571|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
56454572|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454573|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454574|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
56454575|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454576|NCT00332774|Ketorolac|ketorolac|mesh-list
56454577|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56454581|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56454582|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56454583|NCT00332774|Analgesics|analgesics|mesh-ancestor
56454584|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
56454585|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915677|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915678|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56915679|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56915680|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
56915681|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56171626|NCT02247414|Heparin|heparin|mesh-list
56454586|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454587|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56454588|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56454589|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56454590|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454591|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454592|NCT00431769|Bortezomib|bortezomib|mesh-list
56454593|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454594|NCT00332852|Letrozole|letrozole|mesh-list
56454595|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454596|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56454597|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56454598|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454599|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454600|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56454601|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
56454602|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454603|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454604|NCT00332891|Amibegron|amibegron|mesh-list
56454605|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56454606|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56454607|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56454608|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454609|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454610|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454611|NCT00332930|Interferons|interferons|mesh-list
56454612|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
56454613|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454614|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
56454615|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454616|NCT00332969|Octreotide|octreotide|mesh-list
56454617|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56454618|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56454619|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454620|NCT00333008|Prednisone|prednisone|mesh-list
56454621|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
56454622|NCT00333008|Rituximab|rituximab|mesh-list
56454623|NCT00333008|Vincristine|vincristine|mesh-list
56454624|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56454625|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
56454626|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454627|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56454628|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56454629|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
56454630|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454631|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454632|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56454633|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56454634|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56454635|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
56454636|NCT00333008|Hormones|hormones|mesh-ancestor
56454637|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454638|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56454639|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56454640|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56454641|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56454642|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56454643|NCT00435747|Parecoxib|parecoxib|mesh-list
56454644|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56454645|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56454646|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454647|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915682|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915683|NCT03134872|Carboplatin|carboplatin|mesh-list
56915684|NCT03134872|Pemetrexed|pemetrexed|mesh-list
56454648|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56454649|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56454653|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454654|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56454655|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56454657|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454658|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56454659|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56454660|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454661|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454662|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56454663|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
56454664|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454665|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454666|NCT00333086|Letrozole|letrozole|mesh-list
56454667|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454668|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56454669|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56454670|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454671|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454672|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56454673|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
56454674|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454675|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454676|NCT00333125|Timolol|timolol|mesh-list
56454677|NCT00333125|Travoprost|travoprost|mesh-list
56454678|NCT00333125|Dorzolamide|dorzolamide|mesh-list
56454679|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56454680|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56454681|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56454682|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56454683|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
56454684|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454685|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454686|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454687|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56454688|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56454689|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56454690|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454691|NCT00333164|Cilostazol|cilostazol|mesh-list
56454692|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56454693|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
56454694|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165250|NCT00577200|Narcotics|narcotics|mesh-ancestor
56454695|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454696|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56454697|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
56454699|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56454700|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454701|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56454702|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
56454703|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56202563|NCT01535027|Alendronate|alendronate|mesh-list
56454704|NCT00333164|Protective Agents|protective agents|mesh-ancestor
56454705|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56454706|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56454707|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454708|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
56454709|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56454710|NCT01052493|Hormones|hormones|mesh-ancestor
56454711|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454712|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454713|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
56454714|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
56454715|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
56454716|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56454717|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56454718|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915685|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915686|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915687|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454722|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
56454723|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56454724|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56454725|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454726|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454727|NCT00333281|Urological Agents|urological agents|mesh-ancestor
56454728|NCT00333398|Vaccines|vaccines|mesh-list
56454729|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
56454730|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454731|NCT00333476|Squalamine|squalamine|mesh-list
56454732|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56454733|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454734|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56454735|NCT00333476|Protective Agents|protective agents|mesh-ancestor
56454736|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454737|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454738|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56454739|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56454740|NCT00333476|Growth Substances|growth substances|mesh-ancestor
56454741|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
56454742|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56454743|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56454744|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
56454745|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454746|NCT00435981|Antacids|antacids|mesh-ancestor
56454747|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454748|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56454749|NCT00432081|Indomethacin|indomethacin|mesh-list
56454750|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56454751|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56454752|NCT00432081|Analgesics|analgesics|mesh-ancestor
56454753|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
56454754|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454755|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454756|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56454757|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56454758|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
56454759|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
56454760|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56454761|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56454762|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454763|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454764|NCT00333632|Fentanyl|fentanyl|mesh-list
56454765|NCT00333632|Midazolam|midazolam|mesh-list
55955608|NCT01895075|Budesonide|budesonide|mesh-list
56454766|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
56454767|NCT00333632|Propofol|propofol|mesh-list
56454768|NCT00333632|Isoflurane|isoflurane|mesh-list
56454769|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56454770|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454771|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454772|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56454773|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
56454774|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
56454775|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56454776|NCT00333632|Analgesics|analgesics|mesh-ancestor
56454777|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
56454778|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454779|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56454780|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56454781|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56454782|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
56454783|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454784|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454785|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56454786|NCT00333632|Narcotics|narcotics|mesh-ancestor
56454787|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56454788|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56454789|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56454790|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56915688|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56915689|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56915690|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56454792|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
56454793|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56454794|NCT00436059|Bortezomib|bortezomib|mesh-list
56454795|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454796|NCT00420524|Epothilone B|epothilone b|mesh-list
56454797|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454798|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
56454799|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
56454800|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
56454801|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454802|NCT00432120|Clopidogrel|clopidogrel|mesh-list
56454803|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56454804|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56454805|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56454806|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56454807|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
56454808|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454809|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454810|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454811|NCT00432198|Zolpidem|zolpidem|mesh-list
56454812|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56454813|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56454814|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454815|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454816|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56454817|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
56454818|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
56454819|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454820|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454821|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
56454822|NCT00420563|Megestrol|megestrol|mesh-list
56454823|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56454824|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
56454825|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454826|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56454827|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56454828|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
56454829|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454830|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454831|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56454832|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56454833|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56454834|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56454835|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
56454836|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56454837|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56454838|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56454839|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56454840|NCT00432315|Docetaxel|docetaxel|mesh-list
56454841|NCT00432315|Cisplatin|cisplatin|mesh-list
56454842|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454843|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
56454844|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
56454845|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56454846|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454847|NCT00333671|Glycerol|glycerol|mesh-list
56454848|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56454849|NCT00333671|Protective Agents|protective agents|mesh-ancestor
56454850|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454851|NCT00432354|Atorvastatin|atorvastatin|mesh-list
56454852|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56454853|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56454854|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
56454855|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454856|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56454857|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56454858|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454859|NCT00333944|Pralidoxime|pralidoxime|mesh-list
56915691|NCT03952481|Lifitegrast|lifitegrast|mesh-list
56915692|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56915693|NCT05135312|Etanercept|etanercept|mesh-list
56915694|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56915695|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56454860|NCT00333944|Antidotes|antidotes|mesh-ancestor
56454861|NCT00333944|Protective Agents|protective agents|mesh-ancestor
56454862|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454863|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
56454864|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
56454866|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
56454867|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454868|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
56454869|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56454870|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56454871|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454872|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56454873|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56454874|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
56454875|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454876|NCT04701528|Tacrolimus|tacrolimus|mesh-list
56454877|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56454878|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
56454879|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454880|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56454881|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454882|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454883|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
56454884|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56454885|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454886|NCT03279978|Midazolam|midazolam|mesh-list
56454887|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56454888|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56454889|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454890|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454891|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56454892|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56454893|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56454894|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56454895|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
56454896|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
56454897|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
56454898|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
56454899|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454900|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454901|NCT00438048|Pilocarpine|pilocarpine|mesh-list
56454902|NCT00438048|Miotics|miotics|mesh-ancestor
56454903|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
56454904|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454905|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454906|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56454907|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56454908|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
56454909|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454910|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454911|NCT00334256|Tenofovir|tenofovir|mesh-list
56454912|NCT00334256|Emtricitabine|emtricitabine|mesh-list
56454913|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
56454914|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454915|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56454916|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56454917|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454918|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454919|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56454920|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56454921|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
56454922|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56454923|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56454924|NCT00438087|Prednisolone|prednisolone|mesh-list
56454925|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
56454926|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56915696|NCT05135312|Analgesics|analgesics|mesh-ancestor
56915697|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
56915698|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915699|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915700|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915701|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915702|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56454927|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
56454928|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56454929|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
56454930|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
56454931|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454932|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454933|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56454934|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
56454935|NCT00438087|Hormones|hormones|mesh-ancestor
56454936|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56454937|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56454938|NCT00438087|Protective Agents|protective agents|mesh-ancestor
56454939|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56454940|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454942|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56454943|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
56454944|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454945|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454946|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454947|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56454948|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56454949|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
56454950|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
56454951|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56454952|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56454953|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454954|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454955|NCT00334490|Urological Agents|urological agents|mesh-ancestor
56454956|NCT00334529|Oseltamivir|oseltamivir|mesh-list
56454957|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
56454958|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454959|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56454960|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454961|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
56454962|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56454963|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454964|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56454965|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56454966|NCT00436293|Docetaxel|docetaxel|mesh-list
56454967|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454968|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
56454969|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
56454970|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
56454971|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454972|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
56454973|NCT00334646|Casopitant|casopitant|mesh-list
56454974|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56454975|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
56454976|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454977|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56454978|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56454979|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
56454980|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454981|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454982|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56454983|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
56454984|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
56454985|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454986|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56454987|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56915703|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915704|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
56915705|NCT00881452|Citric Acid|citric acid|mesh-list
56915706|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
56915707|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56915708|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
56915709|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
56915710|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172038|NCT04271202|Erenumab|erenumab|mesh-list
56454988|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56454989|NCT04701606|Artesunate|artesunate|mesh-list
56454990|NCT04701606|Pyronaridine|pyronaridine|mesh-list
56454991|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
56454992|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56454993|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56454994|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454995|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454996|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
56454997|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
56454998|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56454999|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
56455000|NCT00334685|Pregabalin|pregabalin|mesh-list
56455001|NCT00334685|Reboxetine|reboxetine|mesh-list
56455002|NCT00334685|Analgesics|analgesics|mesh-ancestor
56455003|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
56455004|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455005|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455006|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
56455007|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56455008|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455009|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455010|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56455011|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56455012|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56455013|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455016|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56455017|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56455018|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
56455019|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455020|NCT00436371|Amisulpride|amisulpride|mesh-list
56455021|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56455022|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56455023|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455024|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455025|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56455026|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56455027|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
56455028|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455029|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455030|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56455031|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
56455032|NCT00334763|Paclitaxel|paclitaxel|mesh-list
56455033|NCT00334763|Bevacizumab|bevacizumab|mesh-list
56455034|NCT00334763|Carboplatin|carboplatin|mesh-list
56455035|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56455036|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455037|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
56455038|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
56455039|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
56455040|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455041|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56455042|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56455043|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56455044|NCT00334763|Growth Substances|growth substances|mesh-ancestor
56455045|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455046|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
56455047|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
56455048|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56915711|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
56915712|NCT03952325|Nivolumab|nivolumab|mesh-list
56915713|NCT03952325|Atezolizumab|atezolizumab|mesh-list
56915714|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56915715|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915716|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56915717|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915718|NCT04958486|Trastuzumab|trastuzumab|mesh-list
56915719|NCT04958486|Azacitidine|azacitidine|mesh-list
56915720|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56915721|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915722|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56915723|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
56915724|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915725|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915726|NCT05436418|Sirolimus|sirolimus|mesh-list
56915727|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
56915728|NCT05436418|Melphalan|melphalan|mesh-list
56915729|NCT05436418|Fludarabine|fludarabine|mesh-list
56915730|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915731|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
56915732|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915733|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915734|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56915735|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
56915736|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455049|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
56455050|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455051|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56455052|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56455053|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56455054|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455055|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56455056|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56455057|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455058|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455060|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455061|NCT00436761|Cyclosporine|cyclosporine|mesh-list
56455062|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
56455063|NCT00436761|Melphalan|melphalan|mesh-list
56455064|NCT00436761|Busulfan|busulfan|mesh-list
56455065|NCT00436761|Cyclosporins|cyclosporins|mesh-list
56455066|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56455067|NCT00436761|Sargramostim|sargramostim|mesh-list
56455068|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455069|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455070|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56455071|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
56455072|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915737|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915738|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56915739|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56915740|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56915741|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915742|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
56915743|NCT00948142|Linezolid|linezolid|mesh-list
56915744|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
56915745|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56915746|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915747|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56915748|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915749|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915750|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
56915751|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56915752|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915753|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
56915754|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
56915755|NCT00945802|Dexamethasone|dexamethasone|mesh-list
56915756|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
56915757|NCT00945802|BB 1101|bb 1101|mesh-list
56915758|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915759|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
56915760|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
56915761|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455073|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
56455074|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455075|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
56455076|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56455077|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56455078|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56455079|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
56455080|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
56455081|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455082|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56455083|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
56455084|NCT00436761|Hormones|hormones|mesh-ancestor
56455085|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455086|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56455087|NCT00436761|Protective Agents|protective agents|mesh-ancestor
56455089|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56455091|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56455092|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56455093|NCT00436800|Gemcitabine|gemcitabine|mesh-list
56455094|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
56455095|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56455096|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
56455097|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455098|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455099|NCT00436800|Antiviral Agents|antiviral agents|mesh-ancestor
56455100|NCT00436800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455101|NCT00436800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455102|NCT00436800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915762|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915763|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56915764|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
56915765|NCT00945802|Hormones|hormones|mesh-ancestor
56915766|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915767|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56915768|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915769|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
56915770|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172191|NCT05768542|Metoprolol|metoprolol|mesh-list
56455103|NCT00436800|Immunologic Factors|immunologic factors|mesh-ancestor
56455104|NCT00436800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455105|NCT00436839|Prednisone|prednisone|mesh-list
56455106|NCT00436839|Docetaxel|docetaxel|mesh-list
56455107|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
56455108|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455109|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
56455110|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
56455111|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
56455112|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455113|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56455114|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
56455115|NCT00436839|Hormones|hormones|mesh-ancestor
56455116|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455117|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455118|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56455119|NCT00436839|Analgesics|analgesics|mesh-ancestor
56455120|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
56455121|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455122|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56455123|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56455124|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455125|NCT00335075|Temozolomide|temozolomide|mesh-list
56455126|NCT00335075|Semustine|semustine|mesh-list
56455127|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56455128|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
56455129|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455130|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455131|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
56455132|NCT00436995|Hematinics|hematinics|mesh-ancestor
56455133|NCT00335114|Cyclosporine|cyclosporine|mesh-list
56455134|NCT00335114|Cyclosporins|cyclosporins|mesh-list
56455135|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455136|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455137|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56455138|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
56455139|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455140|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
56455141|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455142|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
56455143|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56455144|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56455145|NCT04716179|Hormones|hormones|mesh-list
56455146|NCT04716179|Testosterone|testosterone|mesh-list
56455147|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455148|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455149|NCT04716179|Androgens|androgens|mesh-ancestor
56455150|NCT00437229|Dexamethasone|dexamethasone|mesh-list
56455151|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
56455152|NCT00437229|Ondansetron|ondansetron|mesh-list
56455153|NCT00437229|Casopitant|casopitant|mesh-list
56455154|NCT00437229|BB 1101|bb 1101|mesh-list
56455155|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56455156|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
56455157|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
56455158|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455159|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915771|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915772|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56915773|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915774|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56915775|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56915776|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56915777|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56915778|NCT01105624|Azithromycin|azithromycin|mesh-list
56915779|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56915780|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56915781|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56172261|NCT05768204|Hormones|hormones|mesh-ancestor
56455160|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56455161|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
56455163|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455164|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56455165|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455166|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
56455167|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455168|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455169|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
56455170|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
56455171|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56455172|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
56455173|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455174|NCT00437229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56455175|NCT00437229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56455176|NCT00437229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455177|NCT00437229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56455178|NCT00437229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56455179|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56455181|NCT00335192|Lamivudine|lamivudine|mesh-list
56455182|NCT00335192|Abacavir|abacavir|mesh-list
56455183|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
56455184|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455185|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56455186|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56455187|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455188|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455189|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56455190|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56455191|NCT00437307|Topotecan|topotecan|mesh-list
56455192|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56455193|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56455194|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455195|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455196|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455197|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
56455198|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56455199|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455200|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56455201|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56455202|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56455203|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56455204|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455205|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455206|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455207|NCT00335270|Ritonavir|ritonavir|mesh-list
56455208|NCT00335270|Amprenavir|amprenavir|mesh-list
56455209|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
56455210|NCT00335270|Lamivudine|lamivudine|mesh-list
56455211|NCT00335270|Abacavir|abacavir|mesh-list
56455212|NCT00335270|Calcium|calcium|mesh-list
56626425|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915782|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915783|NCT01102660|Naproxen|naproxen|mesh-list
56915784|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56915785|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56915786|NCT01102660|Analgesics|analgesics|mesh-ancestor
56915787|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
56915788|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915789|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915790|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915791|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915792|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
56915793|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56915794|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915795|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915796|NCT03135106|Itraconazole|itraconazole|mesh-list
56915797|NCT03135106|Fluconazole|fluconazole|mesh-list
56455213|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56455214|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455215|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56455216|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56455217|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
56455218|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455219|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455220|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56455221|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56455222|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
56455223|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455224|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56455225|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56455226|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56455227|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56455228|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56455229|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
56455230|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56455231|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
56455232|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
56455233|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56455234|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455235|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455236|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
56455237|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56455238|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455239|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455240|NCT00335309|Amoxicillin|amoxicillin|mesh-list
56455241|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
56455242|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
56455243|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56455244|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455245|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56455246|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455247|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455248|NCT00335348|Dexamethasone|dexamethasone|mesh-list
56455249|NCT00335348|Bortezomib|bortezomib|mesh-list
56455250|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56455251|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
56455252|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
56100258|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
56915798|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
56915799|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915800|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56915801|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56455253|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455254|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455255|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56455256|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
56455257|NCT00335348|Hormones|hormones|mesh-ancestor
56455258|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455259|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56455260|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455261|NCT00437463|Ramipril|ramipril|mesh-list
56455262|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56455263|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
56455264|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455265|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455266|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56455267|NCT00437502|Vaccines|vaccines|mesh-list
56455268|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
56455269|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455270|NCT00420797|Phenylephrine|phenylephrine|mesh-list
56455271|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
56455272|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56455273|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
56455274|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
56455275|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455276|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455277|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
56455278|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56455279|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
56455280|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
56455281|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56455282|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56455283|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56455284|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
56455285|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455286|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455287|NCT00420797|Protective Agents|protective agents|mesh-ancestor
56455288|NCT00437619|Calcipotriene|calcipotriene|mesh-list
56455289|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
56455290|NCT00420836|Tobramycin|tobramycin|mesh-list
56455291|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56455292|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455293|NCT00437697|Dalteparin|dalteparin|mesh-list
56455294|NCT00437697|Tinzaparin|tinzaparin|mesh-list
56455295|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56455296|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
56455297|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56455298|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56455299|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455300|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
56455301|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56455302|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455303|NCT00335543|Gemcitabine|gemcitabine|mesh-list
56455304|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455305|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56455306|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
56455307|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455308|NCT00335543|Antiviral Agents|antiviral agents|mesh-ancestor
56455309|NCT00335543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455310|NCT00335543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455311|NCT00335543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56455312|NCT00335543|Immunologic Factors|immunologic factors|mesh-ancestor
56455313|NCT00335543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455314|NCT00437814|Ketamine|ketamine|mesh-list
56455315|NCT00437814|Analgesics|analgesics|mesh-ancestor
56455318|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455319|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56455320|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56455321|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
56915802|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915803|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915804|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56915805|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
56915806|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915807|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915808|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56915809|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56915810|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56915811|NCT00872014|Sorafenib|sorafenib|mesh-list
56915812|NCT00872014|Trebananib|trebananib|mesh-list
56915813|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915814|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56915815|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915816|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915817|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56915818|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56915819|NCT00872014|Growth Substances|growth substances|mesh-ancestor
56915820|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915821|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
56915822|NCT00871936|Metformin|metformin|mesh-list
56915823|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56915824|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915825|NCT05122546|Nivolumab|nivolumab|mesh-list
56455323|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455324|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56455325|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56455326|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455327|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455328|NCT00335582|Clonidine|clonidine|mesh-list
56455329|NCT00335582|Analgesics|analgesics|mesh-ancestor
56455330|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
56455331|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455332|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455333|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56455334|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
56455335|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
56455336|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56455337|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56455338|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56165283|NCT00002802|Ifosfamide|ifosfamide|mesh-list
56455339|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
56455340|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455341|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455342|NCT00437853|Anastrozole|anastrozole|mesh-list
56455343|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56455344|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915826|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56915827|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915828|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56915829|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915830|NCT00870688|Valproic Acid|valproic acid|mesh-list
56915831|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
56915832|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915833|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915834|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
56915835|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915836|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915837|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
56915838|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56915839|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56915840|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56915841|NCT00870454|Pregabalin|pregabalin|mesh-list
56915842|NCT00870454|Analgesics|analgesics|mesh-ancestor
56915843|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
56915844|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915845|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915846|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
56915847|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56455345|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56455346|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56455347|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455348|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455349|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56455350|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
56455351|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455352|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455353|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
56455354|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56455355|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
56455356|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455357|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455358|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56455359|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
56455360|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
56455361|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56455362|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
56455363|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455364|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455365|NCT00437892|Atorvastatin|atorvastatin|mesh-list
56455366|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56455367|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56455368|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
56455369|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455370|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56455371|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56455372|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455373|NCT00437970|Metformin|metformin|mesh-list
56915848|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56915849|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915850|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56915851|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56915852|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56915853|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56915854|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56915855|NCT05096962|Antibodies|antibodies|mesh-list
56915856|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
56915857|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915859|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
56915860|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915861|NCT00869128|Protective Agents|protective agents|mesh-ancestor
56915862|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915863|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56915864|NCT00945646|Dexamethasone|dexamethasone|mesh-list
56915865|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915866|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
56915867|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
56915868|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915869|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915870|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56915871|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
56915872|NCT00945646|Hormones|hormones|mesh-ancestor
56915873|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915874|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56915875|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455374|NCT00437970|Pioglitazone|pioglitazone|mesh-list
56455375|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56455376|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455377|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56455378|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56455379|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56455380|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
56455381|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455382|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56455383|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56455384|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455386|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56455387|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
56455388|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56455389|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
56455390|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455391|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100521|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56915876|NCT00077675|Vancomycin|vancomycin|mesh-list
56915877|NCT00077675|Penicillins|penicillins|mesh-list
56915878|NCT00077675|Telavancin|telavancin|mesh-list
56915879|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56915880|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915881|NCT00934180|Ondansetron|ondansetron|mesh-list
56915882|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
56915883|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
56915884|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915885|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915886|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56915887|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
56915888|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
56915889|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56915940|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915941|NCT04473820|Lidocaine|lidocaine|mesh-list
56915942|NCT04473820|Prilocaine|prilocaine|mesh-list
56915943|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56915944|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
56915945|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
56915946|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56915947|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915948|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
56915949|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915950|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56915951|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56915952|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56915953|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56915954|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915955|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56915956|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56915957|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
56915958|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
56915959|NCT05064332|Estradiol|estradiol|mesh-list
56915960|NCT05064332|Estrogens|estrogens|mesh-ancestor
56915961|NCT05064332|Hormones|hormones|mesh-ancestor
56915962|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455392|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56455393|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56455394|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455396|NCT00335933|Analgesics|analgesics|mesh-ancestor
56455397|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
56455398|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455399|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455400|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
56455401|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56455402|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56455403|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455404|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56455405|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56455406|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56455407|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455408|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455409|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
56455410|NCT00336167|Bezafibrate|bezafibrate|mesh-list
56455411|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56455412|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
56455413|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455414|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56455415|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
56455416|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56455417|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455418|NCT00336245|Copper|copper|mesh-list
56455419|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
56455420|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915963|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915964|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56915965|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915966|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56915967|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56915968|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
56915969|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56915970|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
56915971|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
56915972|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56915973|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56172682|NCT05612074|Antioxidants|antioxidants|mesh-ancestor
56455421|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455422|NCT00336245|Trace Elements|trace elements|mesh-ancestor
56455423|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
56455424|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
56455425|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455426|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
56455427|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455428|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455429|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56455430|NCT00336401|Propofol|propofol|mesh-list
56455431|NCT00336401|Sevoflurane|sevoflurane|mesh-list
56455432|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56455433|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455434|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455435|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56455436|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
56455437|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
56455438|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56455439|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56455440|NCT00336518|Ribavirin|ribavirin|mesh-list
56455441|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56455442|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
56455443|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455444|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
56455445|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455446|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
56455447|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
56455448|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
56455449|NCT00347490|Enoxaparin|enoxaparin|mesh-list
56455450|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
56455451|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56455452|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56455453|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455454|NCT00336674|Insulin|insulin|mesh-list
56455455|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56455456|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455457|NCT00444522|Alprazolam|alprazolam|mesh-list
56455458|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56455459|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455460|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455461|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56455462|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56455463|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56455464|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
56455465|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
56455466|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455467|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455468|NCT00336791|Paclitaxel|paclitaxel|mesh-list
56455469|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
56455470|NCT00336791|Doxorubicin|doxorubicin|mesh-list
56455471|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56455472|NCT00336791|Fluorouracil|fluorouracil|mesh-list
56455473|NCT00336791|Epirubicin|epirubicin|mesh-list
56915974|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56915975|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915976|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56915977|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56915978|NCT00849862|Levetiracetam|levetiracetam|mesh-list
56915979|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
56915980|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
56915981|NCT00077207|Carboplatin|carboplatin|mesh-list
56915982|NCT00077207|Vincristine|vincristine|mesh-list
56915983|NCT00077207|Temozolomide|temozolomide|mesh-list
56915984|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915985|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56915986|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
56915987|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
56915988|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
56915989|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915990|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56915991|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
56915992|NCT01099085|Simvastatin|simvastatin|mesh-list
56915993|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56915994|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56915995|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
56172741|NCT05602519|Propofol|propofol|mesh-list
56455474|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56455475|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455476|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
56455477|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
56455478|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
56455479|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455480|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56455481|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
56455482|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455483|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56455484|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56455485|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
56455486|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56455487|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56455488|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56455489|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56455490|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455491|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
56455492|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56455493|NCT00444561|Pramlintide|pramlintide|mesh-list
56455494|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56455495|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455496|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56455497|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
56455498|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56455499|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
56455500|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56455501|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455502|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56915996|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915997|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56915998|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56915999|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916000|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
56916001|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916002|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56916003|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626649|NCT05683821|Nicotine|nicotine|mesh-list
56455503|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56455504|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455505|NCT00336947|Tegafur|tegafur|mesh-list
56455506|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56455507|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
56455508|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455509|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455510|NCT00444717|Pitavastatin|pitavastatin|mesh-list
56455511|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56455512|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56455513|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56455514|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
56455515|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455516|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455517|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56455518|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
56455519|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56455520|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56455521|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455522|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
56455523|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455524|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56455525|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455526|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455527|NCT00337259|Gemcitabine|gemcitabine|mesh-list
56455528|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56203386|NCT01539473|Tyramine|tyramine|mesh-list
56455529|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
56455530|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455531|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455532|NCT00337259|Antiviral Agents|antiviral agents|mesh-ancestor
56455533|NCT00337259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455537|NCT00337259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455539|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
56455540|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
56455541|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455542|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455543|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
56455544|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455545|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56455546|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56455547|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56455548|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455549|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455550|NCT00337298|Amlodipine|amlodipine|mesh-list
56455551|NCT00337298|Lisinopril|lisinopril|mesh-list
56455552|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56455553|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56455554|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455555|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455556|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56455557|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455558|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
55888214|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56916004|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916005|NCT05283226|Paclitaxel|paclitaxel|mesh-list
56916006|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56916007|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916008|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
56916009|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
56916010|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
56916011|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916012|NCT05095064|Irinotecan|irinotecan|mesh-list
56916013|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56455559|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56455560|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
56455561|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455562|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56455563|NCT00337298|Protective Agents|protective agents|mesh-ancestor
56455565|NCT00337376|Paclitaxel|paclitaxel|mesh-list
56455566|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56455567|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56455568|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455569|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
56455570|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
56455571|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
56455572|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455573|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56455574|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455575|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56455576|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
56455577|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56455578|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
56455579|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455580|NCT00337493|Cyclosporine|cyclosporine|mesh-list
56455581|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
56455582|NCT00337493|Tacrolimus|tacrolimus|mesh-list
56455583|NCT00337493|Cyclosporins|cyclosporins|mesh-list
56455584|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56455585|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
56455586|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455587|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56455588|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455589|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455590|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
56455591|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455592|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
56455593|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56455594|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56455595|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455596|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56455597|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
56455598|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56455599|NCT00444756|Lidocaine|lidocaine|mesh-list
56455600|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
56455601|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
56455602|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203460|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56455603|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455604|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
56455607|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56455609|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455610|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455611|NCT00337649|Trastuzumab|trastuzumab|mesh-list
56455612|NCT00337649|Epothilones|epothilones|mesh-list
56455613|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
56455614|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56455615|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916014|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56916015|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916016|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916017|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916018|NCT03169244|Bupropion|bupropion|mesh-list
56916019|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56916020|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
56916021|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56916022|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56916023|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56916024|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56916025|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916026|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
56916027|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916028|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916029|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56916030|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56916031|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916032|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56916033|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56916034|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56916035|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56916036|NCT00920764|Atrasentan|atrasentan|mesh-list
56916037|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916038|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56916039|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56916040|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916041|NCT05376046|Thrombin|thrombin|mesh-list
56916042|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
56916043|NCT05376046|Coagulants|coagulants|mesh-ancestor
56916057|NCT03034304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916058|NCT03034304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172965|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56455616|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
56455617|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
56455618|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
56455619|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455620|NCT00444834|Carvedilol|carvedilol|mesh-list
56455621|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56455622|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56455623|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
56455624|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455625|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455626|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455627|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56455628|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
56455629|NCT00444834|Protective Agents|protective agents|mesh-ancestor
56455630|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56455631|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455632|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56455633|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
56455634|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56455635|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56455636|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56455637|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
56455638|NCT00337766|Coagulants|coagulants|mesh-ancestor
56455639|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56455640|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
56455641|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455642|NCT00444873|Lanreotide|lanreotide|mesh-list
56455643|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455644|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56455645|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
56455646|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
56455647|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56455648|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455649|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56455650|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455651|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455652|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56455653|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56455654|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56455655|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455656|NCT00451113|Incretins|incretins|mesh-ancestor
56455657|NCT00451113|Hormones|hormones|mesh-ancestor
56455658|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455659|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
56455660|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455661|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455662|NCT00337922|Lamivudine|lamivudine|mesh-list
56455663|NCT00337922|Abacavir|abacavir|mesh-list
56455664|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56455665|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56455666|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455667|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455668|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
56455669|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455670|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56455671|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56455672|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
56455673|NCT00451230|Cocaine|cocaine|mesh-list
56455674|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56455675|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
56455677|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455678|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455679|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
56455680|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455681|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56455682|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56455683|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56455684|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56173041|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56173042|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56173049|NCT05180240|Cannabidiol|cannabidiol|mesh-list
56455685|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455686|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
56455687|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455689|NCT00338000|Hematinics|hematinics|mesh-ancestor
56455690|NCT00338117|Galantamine|galantamine|mesh-list
56455691|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56455692|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455693|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455694|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
56455695|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455696|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455697|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56455698|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
56455699|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455700|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
56455702|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56455703|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455704|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56455705|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455706|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455707|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56455708|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56455709|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
56455710|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455711|NCT00338273|Aripiprazole|aripiprazole|mesh-list
56455712|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
56455713|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56455714|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56455715|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56455716|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455717|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455718|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
56455719|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
56455720|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455721|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455722|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56455723|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56455724|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
56455725|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56455726|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56455727|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56455728|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56455729|NCT00338312|Testosterone|testosterone|mesh-list
56455730|NCT00338312|Androgens|androgens|mesh-ancestor
56455731|NCT00338312|Hormones|hormones|mesh-ancestor
56455732|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455733|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455734|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
56455735|NCT00451386|Ertapenem|ertapenem|mesh-list
56455736|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56455737|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455738|NCT00338390|Lamivudine|lamivudine|mesh-list
56455739|NCT00338390|Abacavir|abacavir|mesh-list
56455740|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
56455741|NCT00338390|Didanosine|didanosine|mesh-list
56455742|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56455743|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56455744|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455745|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455746|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
56455747|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455748|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56455749|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56455752|NCT00338468|Hematinics|hematinics|mesh-ancestor
56455753|NCT00338507|Erdosteine|erdosteine|mesh-list
56455754|NCT00338507|Expectorants|expectorants|mesh-ancestor
56455755|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
56455756|NCT00445185|Vaccines|vaccines|mesh-list
56455757|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
56455758|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916059|NCT03034304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56916060|NCT03034304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56916061|NCT03034304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56455759|NCT00338546|Cocaine|cocaine|mesh-list
56455760|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
56455761|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56455762|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455763|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455764|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56455765|NCT00338546|Analgesics|analgesics|mesh-ancestor
56455766|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
56455767|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455768|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56455769|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56455770|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56455771|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56455772|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455773|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455774|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
56455775|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
56455776|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56455777|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56455778|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56455779|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455780|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
56455781|NCT00338624|Oxybutynin|oxybutynin|mesh-list
56455782|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
56455783|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
56455784|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455785|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455786|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56455787|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56455788|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
56455789|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455790|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455791|NCT00338624|Urological Agents|urological agents|mesh-ancestor
56455792|NCT00338780|Lamivudine|lamivudine|mesh-list
56455793|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56455794|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56455795|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455796|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455797|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
56455798|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455799|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56455800|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56455801|NCT00451620|Glyburide|glyburide|mesh-list
56455802|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56455803|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455804|NCT00445497|Amoxicillin|amoxicillin|mesh-list
56455805|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
56455806|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
56455807|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
56455808|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56455809|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56455810|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455811|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56455812|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56455813|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455814|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455815|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455816|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56455817|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56455818|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56455819|NCT00451776|Propofol|propofol|mesh-list
56455820|NCT00451776|Etomidate|etomidate|mesh-list
56455821|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56455822|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455823|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455824|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56455827|NCT00338936|Valsartan|valsartan|mesh-list
56455828|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56916062|NCT03034304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56916063|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56916064|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
56916065|NCT00914602|Levodopa|levodopa|mesh-list
56916066|NCT00914602|Carbidopa|carbidopa|mesh-list
56916067|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56916068|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56916069|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56916070|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
56916071|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916072|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916073|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916074|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56916075|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916076|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56626723|NCT02770794|Infliximab|infliximab|mesh-list
56916077|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
56916078|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
56916079|NCT00914290|Baclofen|baclofen|mesh-list
56916080|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56916081|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916082|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56916083|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916084|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56916085|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
56916086|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
56916087|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916088|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916089|NCT00057941|Fulvestrant|fulvestrant|mesh-list
56916090|NCT00057941|Anastrozole|anastrozole|mesh-list
56916091|NCT00057941|Gefitinib|gefitinib|mesh-list
56916092|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56916093|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173192|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
56173193|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56916094|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56916095|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56916096|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
56455829|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56455830|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56455831|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56455832|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455833|NCT00338936|Diuretics|diuretics|mesh-ancestor
56455834|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
56455835|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455836|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56455837|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455838|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
56455839|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
56455840|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56455841|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455842|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455843|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56455844|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455845|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56455846|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
56455847|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56455848|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56455849|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56455850|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
56455851|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455852|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455853|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455854|NCT00339014|Zonisamide|zonisamide|mesh-list
56455855|NCT00339014|Bupropion|bupropion|mesh-list
56455856|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56455857|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
56455858|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56455859|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56455860|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56455861|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455862|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455863|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
56455864|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455865|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455866|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56455867|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56455868|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455869|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
56455870|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56455871|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56455872|NCT00420953|Amiodarone|amiodarone|mesh-list
56455873|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56455874|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
56455875|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56455876|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56455877|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455878|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56455879|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56455880|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56455881|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455882|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56455883|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56455884|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56455885|NCT03275415|Budesonide|budesonide|mesh-list
56455886|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56455887|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56455888|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
56455889|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455890|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455891|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56916097|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916098|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916099|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56455892|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
56455893|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
56455895|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455897|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56455898|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455899|NCT00425243|Zolpidem|zolpidem|mesh-list
56455900|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56455901|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56455902|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56455903|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455904|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56455905|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
56455906|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
56455907|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56455908|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455909|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56455910|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455911|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455912|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455913|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56455914|NCT00451971|Leflunomide|leflunomide|mesh-list
56455915|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455916|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455917|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56455918|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
56455919|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455920|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
56455921|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56455922|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455923|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
56455924|NCT00446004|Omeprazole|omeprazole|mesh-list
56455925|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56455926|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455927|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56455928|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455929|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455930|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56455931|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56455932|NCT00446043|Adapalene|adapalene|mesh-list
56455933|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56455934|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56455935|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
56455936|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56455937|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56455938|NCT00446043|Analgesics|analgesics|mesh-ancestor
56455939|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
56455940|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455941|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455942|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56455943|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56455944|NCT00446082|Pasireotide|pasireotide|mesh-list
56455945|NCT00446082|Hormones|hormones|mesh-ancestor
56455946|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56455947|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455948|NCT03275376|Atorvastatin|atorvastatin|mesh-list
56455949|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56455950|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56455951|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
56455952|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455953|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56455954|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56455955|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455956|NCT00340184|Paclitaxel|paclitaxel|mesh-list
56455957|NCT00340184|Carboplatin|carboplatin|mesh-list
56455958|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56455959|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916100|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916101|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916102|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56916103|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56916104|NCT03005522|Dexamethasone|dexamethasone|mesh-list
56916105|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916106|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
56916107|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
56916108|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916109|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916110|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56455960|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
56455961|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
56455962|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
56455963|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455964|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
56455965|NCT00446316|Antacids|antacids|mesh-list
56455966|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455969|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455970|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56455971|NCT00446433|Lenalidomide|lenalidomide|mesh-list
56455972|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
56455973|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455974|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56455975|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56455976|NCT00446433|Growth Substances|growth substances|mesh-ancestor
56455977|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
56455978|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455979|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56455980|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56455981|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
56455982|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455983|NCT00340574|Antacids|antacids|mesh-ancestor
56455984|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455985|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56455986|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
56455987|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56455988|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56455989|NCT00340691|Doxycycline|doxycycline|mesh-list
56455990|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56455991|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56455992|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
56455993|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56455994|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56455995|NCT00452244|Gefitinib|gefitinib|mesh-list
56455996|NCT00452244|Simvastatin|simvastatin|mesh-list
56455997|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56455998|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56455999|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
56456000|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456001|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56456002|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56456003|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456004|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456005|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56456006|NCT00446472|Becaplermin|becaplermin|mesh-list
56456007|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
56456008|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56456009|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56456010|NCT00446472|Growth Substances|growth substances|mesh-ancestor
56456011|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456012|NCT00446589|Teriparatide|teriparatide|mesh-list
56456013|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
56456014|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56054997|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
56916111|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
56916112|NCT03005522|Hormones|hormones|mesh-ancestor
56173447|NCT04520139|Protective Agents|protective agents|mesh-ancestor
56456015|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456016|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56456017|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
56456018|NCT00452322|Testosterone|testosterone|mesh-list
56456019|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
56456020|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
56456021|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56456022|NCT00452322|Androgens|androgens|mesh-ancestor
56456023|NCT00452322|Hormones|hormones|mesh-ancestor
56456024|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456025|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456026|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56456027|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456028|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
56456029|NCT00452556|Docetaxel|docetaxel|mesh-list
56456030|NCT00452556|Leuprolide|leuprolide|mesh-list
56456031|NCT00452556|Androgens|androgens|mesh-list
56456032|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456033|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56456034|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56456035|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56456036|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456037|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56456038|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
56456039|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56456040|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456044|NCT00446667|Mannitol|mannitol|mesh-list
56456045|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56456046|NCT00446667|Diuretics|diuretics|mesh-ancestor
56456047|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
56456048|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456049|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
56456050|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
56456051|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456052|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56456053|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56456054|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56456055|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56456056|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456058|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456059|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
56456060|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56456061|NCT00341432|Nicotine|nicotine|mesh-list
56456062|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56456063|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
56456064|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456065|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456066|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56456067|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56456068|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
56456069|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456070|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456071|NCT00452634|Irinotecan|irinotecan|mesh-list
56456072|NCT00452634|Simvastatin|simvastatin|mesh-list
56456073|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456074|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56456075|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56456076|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456077|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456078|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56456079|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56456080|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
56456081|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56456082|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56456083|NCT03277599|Tramadol|tramadol|mesh-list
56456084|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56456085|NCT03277599|Narcotics|narcotics|mesh-ancestor
56456086|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56456087|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456088|NCT03277599|Analgesics|analgesics|mesh-ancestor
56648501|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456089|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
56456090|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456091|NCT00452829|Folic Acid|folic acid|mesh-list
56456092|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
56456093|NCT00452829|Inositol|inositol|mesh-list
56456094|NCT00452829|Hematinics|hematinics|mesh-ancestor
56456095|NCT00452829|Vitamins|vitamins|mesh-ancestor
56456096|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
56456097|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456098|NCT00452907|Artesunate|artesunate|mesh-list
56456099|NCT00452907|Lumefantrine|lumefantrine|mesh-list
56456100|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
56456101|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
56456102|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56456103|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
56456104|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56456105|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56456106|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456107|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456108|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
56456109|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
56456110|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56456111|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
56456112|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56456113|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456114|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456117|NCT00446784|Methotrexate|methotrexate|mesh-list
56456118|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56456119|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
56456120|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56456121|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456122|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56456123|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
56456124|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456125|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456126|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
56456127|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456128|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56456129|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456130|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
56456131|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456132|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56456133|NCT00452985|Carboplatin|carboplatin|mesh-list
56456134|NCT00452985|Docetaxel|docetaxel|mesh-list
56456135|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456136|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
56456137|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
56456138|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
56456139|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456140|NCT03277209|Plerixafor|plerixafor|mesh-list
56456141|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56456142|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56456143|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
56456144|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456145|NCT00453141|Betamethasone|betamethasone|mesh-list
56456146|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56456147|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
56456148|NCT00453141|Hormones|hormones|mesh-ancestor
56456149|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456150|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456151|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56456152|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
56456153|NCT00421109|Levocetirizine|levocetirizine|mesh-list
56456154|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56456155|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56456156|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
56456157|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
56456158|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456159|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456160|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456161|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
56456162|NCT02273583|Methotrexate|methotrexate|mesh-list
56456163|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456164|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
55897470|NCT01706939|Carboplatin|carboplatin|mesh-list
56916113|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916114|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56916115|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916116|NCT02998736|Tadalafil|tadalafil|mesh-list
56916117|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
56916118|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56916119|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56916120|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456165|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456166|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456167|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56456168|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
56456169|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456170|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456171|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56456172|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56456173|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
56456174|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56456175|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56456176|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
56456177|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56456178|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456179|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56456180|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56456181|NCT00446862|Losartan|losartan|mesh-list
56456182|NCT00446862|Enalapril|enalapril|mesh-list
56456183|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56456184|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56456185|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56456186|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56456187|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56456189|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456191|NCT00446901|Selenium|selenium|mesh-list
56456192|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
56456193|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456194|NCT00446901|Protective Agents|protective agents|mesh-ancestor
56456195|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456196|NCT00446901|Trace Elements|trace elements|mesh-ancestor
56456197|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
56456198|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
56456199|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
56456200|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456201|NCT00453375|Protective Agents|protective agents|mesh-ancestor
56456202|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456203|NCT00446940|Atorvastatin|atorvastatin|mesh-list
56456204|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56456205|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56456206|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56456207|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
56456208|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456209|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56456210|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56456211|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456212|NCT00453414|Iloprost|iloprost|mesh-list
56456213|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56456214|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
56456215|NCT00446979|UC-781|uc-781|mesh-list
56456216|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56456217|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
56456218|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456219|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56456220|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
56456221|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456222|NCT00447018|Mannitol|mannitol|mesh-list
56456223|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56456224|NCT00447018|Diuretics|diuretics|mesh-ancestor
56916121|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916122|NCT02998736|Urological Agents|urological agents|mesh-ancestor
56916123|NCT00075881|Bortezomib|bortezomib|mesh-list
56916124|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916125|NCT00838630|Cilostazol|cilostazol|mesh-list
56916126|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56916127|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
56916128|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916129|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916130|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56173737|NCT04040959|Niacin|niacin|mesh-list
56456225|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
56456226|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456227|NCT00343070|Citalopram|citalopram|mesh-list
56456228|NCT00343070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56456229|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56456230|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56456231|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456232|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456233|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
56456234|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456235|NCT00343070|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56456236|NCT00343070|Antidepressive Agents|antidepressive agents|mesh-ancestor
56456237|NCT00343070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56456238|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
56456239|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56456240|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56456241|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456242|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56456243|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456244|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56456245|NCT00343187|Dapsone|dapsone|mesh-list
56456246|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456247|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
56456248|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56456249|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56456250|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56456251|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456252|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456253|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
56456254|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56456255|NCT00343226|Basiliximab|basiliximab|mesh-list
56456256|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456257|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
56456258|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456259|NCT00343265|Progesterone|progesterone|mesh-list
56456262|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456263|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456265|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56456266|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56456267|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456268|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
56456269|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456270|NCT00447213|Insulin|insulin|mesh-list
56456271|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56456272|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
56456273|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56456274|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456275|NCT00453648|Vitamin A|vitamin a|mesh-list
56456276|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
56456277|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
56456278|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456279|NCT00453648|Protective Agents|protective agents|mesh-ancestor
56165308|NCT00002802|Trace Elements|trace elements|mesh-ancestor
56173756|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56173757|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56125164|NCT01380990|Busulfan|busulfan|mesh-list
56173768|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
56173769|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56173770|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173771|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173772|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173773|NCT03980561|Varenicline|varenicline|mesh-list
56173774|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56173775|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56173780|NCT03965689|Paclitaxel|paclitaxel|mesh-list
56456280|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456281|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56456282|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456283|NCT00453648|Vitamins|vitamins|mesh-ancestor
56456284|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
56456285|NCT00343421|Vaccines|vaccines|mesh-list
56456286|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56456287|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
56456288|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456289|NCT00343499|Valsartan|valsartan|mesh-list
56456290|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56456291|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56456292|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56456293|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456294|NCT04715360|Favipiravir|favipiravir|mesh-list
56456295|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
56456296|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456297|NCT00447369|Pregabalin|pregabalin|mesh-list
56456298|NCT00447369|Valproic Acid|valproic acid|mesh-list
56456299|NCT00447369|Analgesics|analgesics|mesh-ancestor
56456300|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
56456301|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456302|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456303|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
56456304|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56456305|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56456306|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456307|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56456308|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56456309|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56456310|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56456311|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56456312|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456313|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
56456314|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456315|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
56456316|NCT00343655|Atorvastatin|atorvastatin|mesh-list
56456317|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56456318|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56456319|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
56456320|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456321|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56456322|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56456323|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456324|NCT00453765|Montelukast|montelukast|mesh-list
56456325|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56456326|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
56456327|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56456328|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
56456329|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897591|NCT05718466|Alkylating Agents|alkylating agents|mesh-ancestor
56916131|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
56916132|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56456330|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456331|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56456333|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456335|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56456336|NCT00343733|Narcotics|narcotics|mesh-ancestor
56456337|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56456338|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456339|NCT00343733|Analgesics|analgesics|mesh-ancestor
56456340|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
56456341|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456342|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56456343|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56456344|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
56456345|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
56456346|NCT00343811|Modafinil|modafinil|mesh-list
56456347|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56456348|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456349|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56456350|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56456351|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56165310|NCT00002814|Paclitaxel|paclitaxel|mesh-list
56456352|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456353|NCT00453804|Naltrexone|naltrexone|mesh-list
56456354|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56456355|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56456356|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456357|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
56456358|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456359|NCT00343850|Mesalamine|mesalamine|mesh-list
56456360|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56456361|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56456362|NCT00343850|Analgesics|analgesics|mesh-ancestor
56456363|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
56456364|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456365|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456366|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56456367|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456368|NCT00344006|Artesunate|artesunate|mesh-list
56456369|NCT00344006|Lumefantrine|lumefantrine|mesh-list
56456370|NCT00344006|Artemether|artemether|mesh-list
56456371|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56456372|NCT00344006|Dapsone|dapsone|mesh-list
56456373|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
56456374|NCT00344006|Proguanil|proguanil|mesh-list
56456375|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
56456376|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56456377|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56456378|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456379|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456380|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
56456381|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
56456382|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56456383|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
56456384|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56456385|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456386|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456387|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
56456388|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56456389|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
56456390|NCT02273661|Amphotericin B|amphotericin b|mesh-list
56456391|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56456392|NCT02273661|Amebicides|amebicides|mesh-ancestor
56456393|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56456394|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56456395|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456396|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56456397|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
56456398|NCT00344123|Ritonavir|ritonavir|mesh-list
56456399|NCT00344123|Tipranavir|tipranavir|mesh-list
56456400|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56456401|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56456402|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56456403|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
56456404|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456405|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456406|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56456409|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456410|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56456411|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56456412|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56456413|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56456414|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
56456415|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56456416|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56456417|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56456418|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
56204286|NCT01544725|Ketamine|ketamine|mesh-list
56456419|NCT00344201|Coagulants|coagulants|mesh-ancestor
56456420|NCT00453960|Norethindrone|norethindrone|mesh-list
56456421|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
56456422|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56456423|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56456424|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56456425|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
56456426|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56165311|NCT00002814|Topotecan|topotecan|mesh-list
56456427|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456428|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56456429|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56456430|NCT00447681|Fezakinumab|fezakinumab|mesh-list
56456431|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
56456432|NCT00447759|Ibuprofen|ibuprofen|mesh-list
56456433|NCT00447759|Celecoxib|celecoxib|mesh-list
56456434|NCT00447759|Diclofenac|diclofenac|mesh-list
56456435|NCT00447759|Naproxen|naproxen|mesh-list
56456436|NCT00447759|Meloxicam|meloxicam|mesh-list
56456437|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56456438|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56456439|NCT00447759|Analgesics|analgesics|mesh-ancestor
56456440|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
56456441|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456442|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456443|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56456444|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456445|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56456446|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456447|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456448|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56456449|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
56456450|NCT00344513|Carvedilol|carvedilol|mesh-list
56456451|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56456452|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56456453|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56456454|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
56456455|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456456|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456457|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456458|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56456459|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
56456460|NCT00344513|Protective Agents|protective agents|mesh-ancestor
56456461|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56456462|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56456463|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56456464|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
56456465|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56456466|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56456467|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
56456468|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456469|NCT00344552|Paclitaxel|paclitaxel|mesh-list
56456470|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56456471|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456472|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
56456473|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
56456474|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
56456475|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456476|NCT00447915|Vitamin D|vitamin d|mesh-list
56456477|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
56456478|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
56456482|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897592|NCT04835506|Infliximab|infliximab|mesh-list
56916133|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56916134|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916135|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56916136|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
56916137|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56916138|NCT00838630|Protective Agents|protective agents|mesh-ancestor
56916139|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56456483|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56456484|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56456485|NCT00344669|Albendazole|albendazole|mesh-list
56456486|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
56456487|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56456488|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456489|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
56456490|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56456491|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56456492|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56456493|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56456494|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56456495|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456496|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204362|NCT01544959|Analgesics|analgesics|mesh-ancestor
56456497|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
56456498|NCT04715165|Bupivacaine|bupivacaine|mesh-list
56456499|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
56456500|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
55957350|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
56456501|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56456502|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456503|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
56456504|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456505|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56456506|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56456507|NCT04715165|Analgesics|analgesics|mesh-ancestor
56456508|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56456509|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56456510|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56456511|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
56456512|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456513|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456515|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56456516|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456517|NCT00454272|Vancomycin|vancomycin|mesh-list
56456518|NCT00454272|Teicoplanin|teicoplanin|mesh-list
56456519|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56456520|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456521|NCT00344825|Fludarabine|fludarabine|mesh-list
56456522|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
56456523|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
56456524|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456525|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56456526|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
56456527|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456528|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456529|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
56456530|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456531|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56456532|NCT00448110|Ketorolac|ketorolac|mesh-list
56456533|NCT00448110|Diclofenac|diclofenac|mesh-list
56456534|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56456535|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56456536|NCT00448110|Analgesics|analgesics|mesh-ancestor
56456537|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
56456538|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456539|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456540|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56456541|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56916140|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56916141|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916142|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
56916143|NCT02996474|Decitabine|decitabine|mesh-list
56916144|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56916145|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174053|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
56456542|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56456543|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456544|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456545|NCT00448149|Everolimus|everolimus|mesh-list
56456546|NCT00448149|Sorafenib|sorafenib|mesh-list
56456547|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456548|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456549|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
56456550|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456551|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56456553|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456555|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56456556|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56456557|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56456558|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56456559|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
56456560|NCT00344942|Hormones|hormones|mesh-ancestor
56456561|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456562|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456563|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456564|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
56456565|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456566|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456567|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56456568|NCT00454350|Vitamins|vitamins|mesh-ancestor
56456569|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
56456570|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456571|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56456572|NCT00454389|Ranibizumab|ranibizumab|mesh-list
56456573|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56456574|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56456575|NCT00454389|Growth Substances|growth substances|mesh-ancestor
56456576|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456577|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
56456578|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456580|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
56456581|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
56456582|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456583|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56456584|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56456585|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456586|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456587|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56456588|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56456589|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456590|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
56456591|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
56456592|NCT00448266|Thiotepa|thiotepa|mesh-list
56456593|NCT00448266|Carboplatin|carboplatin|mesh-list
56456594|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456595|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
56456596|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456597|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456598|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56456599|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
56456600|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456601|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456602|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56456603|NCT00454545|Atorvastatin|atorvastatin|mesh-list
56456604|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56456605|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56916146|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56916147|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
56916148|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916149|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916150|NCT00821002|Latanoprost|latanoprost|mesh-list
56916151|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56916152|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56916153|NCT00820924|Lapatinib|lapatinib|mesh-list
56916154|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174127|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56456606|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
56456607|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456608|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56456609|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56456610|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456611|NCT00345059|Gemcitabine|gemcitabine|mesh-list
56456612|NCT00345059|Capecitabine|capecitabine|mesh-list
56456613|NCT00345059|Docetaxel|docetaxel|mesh-list
56456614|NCT00345059|Vinorelbine|vinorelbine|mesh-list
56456615|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56456616|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
56456617|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456618|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456619|NCT00345059|Antiviral Agents|antiviral agents|mesh-ancestor
56456620|NCT00345059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456621|NCT00345059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456622|NCT00345059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456623|NCT00345059|Immunologic Factors|immunologic factors|mesh-ancestor
56456624|NCT00345059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456625|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
56456628|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56456629|NCT00345098|Amibegron|amibegron|mesh-list
56456630|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56456631|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56456632|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
56456633|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456634|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456635|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456636|NCT00448305|Paclitaxel|paclitaxel|mesh-list
56456637|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56456638|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56456639|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456640|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
56456641|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
56456642|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
56456643|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456644|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56456645|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456646|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456647|NCT00448383|Adalimumab|adalimumab|mesh-list
56456648|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56456649|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456651|NCT00448461|Bivalirudin|bivalirudin|mesh-list
56456652|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
56456653|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56456654|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56456655|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456656|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
56456657|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56456658|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
56456659|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456660|NCT00454662|Amlodipine|amlodipine|mesh-list
56456661|NCT00454662|Olmesartan|olmesartan|mesh-list
56456662|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56456663|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56456664|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56916155|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56916156|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916157|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916158|NCT00820300|Latanoprost|latanoprost|mesh-list
56916159|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56916160|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56916161|NCT00814372|Metformin|metformin|mesh-list
56916162|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916163|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456665|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56456666|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456667|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56456668|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456669|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
56456670|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56456671|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56456672|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
56456673|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
56456674|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56456675|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56456676|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456677|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56456678|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456679|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56456680|NCT00454701|Alefacept|alefacept|mesh-list
56456681|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56456682|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
56456683|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456684|NCT00345761|Bevacizumab|bevacizumab|mesh-list
56456685|NCT00345761|Capecitabine|capecitabine|mesh-list
56456686|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
56456687|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56456688|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456689|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56456690|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56456691|NCT00345761|Growth Substances|growth substances|mesh-ancestor
56456692|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456693|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
56456694|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56456695|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
56456696|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456697|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
56456698|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56456702|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56456703|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456705|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56456706|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56456707|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
56456708|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456709|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456710|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456711|NCT00454740|Urological Agents|urological agents|mesh-ancestor
56456712|NCT03276858|Midazolam|midazolam|mesh-list
56456713|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56456714|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56456715|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56456716|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56456717|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456718|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56456719|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56456720|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56456721|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56456722|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
56456724|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
56916164|NCT03134638|Carboplatin|carboplatin|mesh-list
56916165|NCT03134638|Fulvestrant|fulvestrant|mesh-list
56916166|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916167|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56916168|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56916169|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56916170|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
56916171|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916172|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916173|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
56916174|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916175|NCT04855526|Dronabinol|dronabinol|mesh-list
56916176|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
56456725|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
56456726|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456727|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456728|NCT00421187|Amphotericin B|amphotericin b|mesh-list
56456729|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56456730|NCT00421187|Amebicides|amebicides|mesh-ancestor
56456731|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56456732|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56456733|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456734|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56456735|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
56456736|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
56456737|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56456738|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56456739|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
56456740|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56456741|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456742|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456743|NCT00454896|Urological Agents|urological agents|mesh-ancestor
56456744|NCT00346190|Alendronate|alendronate|mesh-list
56456745|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56456746|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456747|NCT00346229|Doxorubicin|doxorubicin|mesh-list
56456748|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56456749|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56456750|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456751|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56456752|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56456753|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456754|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456755|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
56456756|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56456757|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456758|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56456759|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56456760|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
56456761|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56456762|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56456763|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56456764|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56456765|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456766|NCT00346463|Allopurinol|allopurinol|mesh-list
56456767|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
56456768|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456769|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456770|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
56456773|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
56456774|NCT00346463|Protective Agents|protective agents|mesh-ancestor
56456775|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916177|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916178|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56916179|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56916180|NCT04855526|Analgesics|analgesics|mesh-ancestor
56916181|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
56916182|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916183|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56916184|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56916185|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916186|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916187|NCT04855526|Hormones|hormones|mesh-ancestor
56916188|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916189|NCT03204812|Durvalumab|durvalumab|mesh-list
56916190|NCT03204812|Ipilimumab|ipilimumab|mesh-list
56916191|NCT03204812|Tremelimumab|tremelimumab|mesh-list
56916192|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
56174331|NCT01992653|Hormones|hormones|mesh-ancestor
56456776|NCT00455091|Lamivudine|lamivudine|mesh-list
56456777|NCT00455091|Adefovir|adefovir|mesh-list
56456778|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56456779|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56456780|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56456781|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456782|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456783|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
56456784|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456785|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56456786|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56456787|NCT00346502|Betulinic acid|betulinic acid|mesh-list
56456788|NCT00346502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56456789|NCT00346502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56456790|NCT00346502|Analgesics|analgesics|mesh-ancestor
56456791|NCT00346502|Sensory System Agents|sensory system agents|mesh-ancestor
56456792|NCT00346502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456793|NCT00346502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456794|NCT00346502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56456795|NCT00346502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456796|NCT00346502|Antimalarials|antimalarials|mesh-ancestor
56456797|NCT00346502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56456798|NCT00346502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56456799|NCT00346502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456800|NCT00346502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56456801|NCT00346502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456802|NCT00346502|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
56456803|NCT00346502|Hormone Antagonists|hormone antagonists|mesh-ancestor
56456804|NCT00346502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456805|NCT00346502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56456806|NCT00346502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56456807|NCT00346502|Antiviral Agents|antiviral agents|mesh-ancestor
56456808|NCT00346580|Nelfinavir|nelfinavir|mesh-list
56456809|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56456810|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56456811|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
56456812|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456813|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456814|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56456815|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56456816|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
56456817|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916193|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56174377|NCT01861106|Tacrolimus|tacrolimus|mesh-list
56456818|NCT00346619|Nelfinavir|nelfinavir|mesh-list
56456819|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56456820|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56456821|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
56456822|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456823|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456824|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56456825|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56456826|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
56456827|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456828|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
56456829|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56456830|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
56456831|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56456832|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
56456833|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456834|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456835|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
56456836|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56456837|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
56456838|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456839|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
56456840|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456841|NCT04698213|Avelumab|avelumab|mesh-list
56456842|NCT04698213|Axitinib|axitinib|mesh-list
56456843|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56456844|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456845|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56456849|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
56456850|NCT02273817|Hormones|hormones|mesh-ancestor
56456851|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456852|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456853|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56456854|NCT00346853|Fomepizole|fomepizole|mesh-list
56456855|NCT00346853|Antidotes|antidotes|mesh-ancestor
56456856|NCT00346853|Protective Agents|protective agents|mesh-ancestor
56456857|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456858|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456859|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456860|NCT00448734|Docetaxel|docetaxel|mesh-list
56456861|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456862|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56456863|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56456864|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56456865|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456867|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56456868|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
56456869|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456870|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56456871|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
56456872|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
56456873|NCT00346970|Vitamins|vitamins|mesh-ancestor
56456874|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
56456875|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456876|NCT00455130|Mannitol|mannitol|mesh-list
56456877|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56456878|NCT00455130|Diuretics|diuretics|mesh-ancestor
56456879|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
56456880|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456881|NCT00347048|Tacrolimus|tacrolimus|mesh-list
56456882|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456883|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
56456884|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456885|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56456886|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456887|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456888|NCT00347087|Irbesartan|irbesartan|mesh-list
56456889|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56456890|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56456891|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56456892|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456893|NCT00347165|Bevacizumab|bevacizumab|mesh-list
56456894|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56916194|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
56456895|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456896|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56456897|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56456898|NCT00347165|Growth Substances|growth substances|mesh-ancestor
56456899|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456900|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
56456901|NCT00347204|Ketorolac|ketorolac|mesh-list
56456902|NCT00347204|Nepafenac|nepafenac|mesh-list
56456903|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56456904|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56456905|NCT00347204|Analgesics|analgesics|mesh-ancestor
56456906|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
56456907|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456908|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456909|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56456910|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456911|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56456912|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456913|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456914|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
56456915|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56456916|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56456917|NCT00455286|Prednisolone|prednisolone|mesh-list
56456918|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
56456932|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456933|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56456934|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56456935|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
56456936|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456937|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56456938|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56456939|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
56456940|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56456941|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
56456942|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
56456943|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56456944|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56456945|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
56456946|NCT00455286|Hormones|hormones|mesh-ancestor
56456947|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456948|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56456949|NCT00455286|Protective Agents|protective agents|mesh-ancestor
56456950|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56456951|NCT00455364|Voriconazole|voriconazole|mesh-list
56456952|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
56456953|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56456954|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56456955|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56456956|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456957|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456958|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56456959|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
56456960|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456961|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456962|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56456963|NCT00347399|Bevacizumab|bevacizumab|mesh-list
56456964|NCT00347399|Verteporfin|verteporfin|mesh-list
56456965|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56456966|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456967|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56456968|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56456969|NCT00347399|Growth Substances|growth substances|mesh-ancestor
56456970|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456971|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
56456972|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56456973|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
56456974|NCT00455442|Mifepristone|mifepristone|mesh-list
56456975|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56456976|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
56456977|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56456978|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456980|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56916195|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56916196|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916197|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
56916198|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916199|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56916200|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916201|NCT02339090|Hormones|hormones|mesh-list
56916202|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916203|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916204|NCT05442008|Erenumab|erenumab|mesh-list
56916205|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56916206|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916207|NCT05442008|Analgesics|analgesics|mesh-ancestor
56456981|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56456982|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
56456983|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56456984|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56456985|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
56456986|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456987|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
56456988|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56456989|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56456990|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
56456991|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56456992|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
56456993|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456994|NCT00347555|Antacids|antacids|mesh-ancestor
56456995|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456996|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56456997|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
56456998|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56456999|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56457000|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56457001|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56457002|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457003|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
56457004|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457005|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457006|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56457007|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457008|NCT00347750|Lopinavir|lopinavir|mesh-list
56457009|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56457010|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56457011|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
56457012|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334018|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56457013|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457014|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56457015|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56457016|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
56457017|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457018|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56457019|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56457020|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
56457021|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
56457022|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56457023|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56457024|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457025|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457026|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56457027|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56457028|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457029|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457030|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457031|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
56457032|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457033|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56457034|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56457035|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457036|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457037|NCT00347867|Urological Agents|urological agents|mesh-ancestor
56457038|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
56457039|NCT00449202|Estrone|estrone|mesh-list
56457040|NCT00449202|Estrogens|estrogens|mesh-ancestor
56457041|NCT00449202|Hormones|hormones|mesh-ancestor
56457042|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457043|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457044|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56457045|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
56457046|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457047|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56457048|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56457049|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457050|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457051|NCT00455715|Urological Agents|urological agents|mesh-ancestor
56457052|NCT00455754|Esomeprazole|esomeprazole|mesh-list
56457053|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56457054|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56457055|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56457056|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457057|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457058|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56457059|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
56457060|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56457061|NCT00348023|Timolol|timolol|mesh-list
56457062|NCT00348023|Bimatoprost|bimatoprost|mesh-list
56457063|NCT00348023|Travoprost|travoprost|mesh-list
56457064|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56457065|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56457066|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
56457067|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457068|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457069|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457070|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56457071|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56457072|NCT00348062|Bimatoprost|bimatoprost|mesh-list
56457073|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56457074|NCT00348101|Enoximone|enoximone|mesh-list
56457075|NCT00348101|Esmolol|esmolol|mesh-list
56457076|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56457077|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56457078|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56457079|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
56457080|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457081|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457082|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457083|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56457084|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457085|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56457086|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56457087|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457088|NCT00348101|Protective Agents|protective agents|mesh-ancestor
56457090|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
56457091|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457092|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
56457093|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457094|NCT00455871|Ranibizumab|ranibizumab|mesh-list
56457095|NCT00455871|Verteporfin|verteporfin|mesh-list
56457096|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56457097|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56457098|NCT00455871|Growth Substances|growth substances|mesh-ancestor
56457099|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916208|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
56457100|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
56457101|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457102|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56457103|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
56457104|NCT00449280|Sirolimus|sirolimus|mesh-list
56457105|NCT00449280|Sorafenib|sorafenib|mesh-list
56457106|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457107|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56457108|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457109|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457110|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457111|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457112|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56457113|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
56457114|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457115|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
56457116|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457117|NCT00455910|Thalidomide|thalidomide|mesh-list
56457118|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457119|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
56457120|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457121|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
56457122|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457123|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457124|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56457125|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56457126|NCT00455910|Growth Substances|growth substances|mesh-ancestor
56457128|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457129|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
56457130|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56457131|NCT00348296|Antibodies|antibodies|mesh-list
56457132|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
56457133|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56457134|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
56457135|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457136|NCT00449319|Daunorubicin|daunorubicin|mesh-list
56457137|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56457138|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457139|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56457140|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56457141|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457142|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457143|NCT00348335|Cyclosporine|cyclosporine|mesh-list
56457144|NCT00348335|Cyclosporins|cyclosporins|mesh-list
56457145|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457146|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457147|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457148|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
56457149|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457150|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
56457151|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457152|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
56457153|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56457154|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56457155|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
56457156|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56457157|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56457158|NCT00348413|Prednisolone|prednisolone|mesh-list
56457159|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
56457160|NCT00348413|Methotrexate|methotrexate|mesh-list
56457161|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56457162|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
56457163|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56457164|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
56457165|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56457166|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457167|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56457168|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
56457169|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457170|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457171|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
56457172|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457173|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56457174|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56916209|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916210|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916211|NCT03524092|Mirikizumab|mirikizumab|mesh-list
56916212|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56916213|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56457175|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
56457176|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56457177|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56457178|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457179|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
56457180|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
56457181|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457182|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56457183|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
56457184|NCT00348413|Hormones|hormones|mesh-ancestor
56457185|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457186|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56457187|NCT00348413|Protective Agents|protective agents|mesh-ancestor
56457188|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56457189|NCT00348452|Celecoxib|celecoxib|mesh-list
56457190|NCT00348452|Tramadol|tramadol|mesh-list
56457191|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56457192|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56457193|NCT00348452|Analgesics|analgesics|mesh-ancestor
56457194|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
56457195|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457196|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457197|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457198|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56457199|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56457200|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56457201|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457203|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56457204|NCT00348452|Narcotics|narcotics|mesh-ancestor
56457205|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56457206|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56457207|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
56457208|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56457209|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56457210|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56457211|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56457212|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457213|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
56457214|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56457215|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56457216|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457217|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457218|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56457219|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56457220|NCT00348491|Analgesics|analgesics|mesh-ancestor
56457221|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
56457222|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457223|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457224|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457225|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56457226|NCT03274323|Travoprost|travoprost|mesh-list
56457227|NCT03274323|Latanoprost|latanoprost|mesh-list
56457228|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56457229|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56457230|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56457231|NCT00348530|Verapamil|verapamil|mesh-list
56457232|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56457233|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56457234|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56457235|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457236|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56457237|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457238|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457239|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56916214|NCT03524092|Analgesics|analgesics|mesh-ancestor
56916215|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
56457240|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56457241|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
56457242|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56457243|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457244|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457245|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
56205115|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56457246|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457247|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56457248|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56457249|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56457250|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56457251|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56457252|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
56457253|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457254|NCT00456027|Antacids|antacids|mesh-ancestor
56457255|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457256|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56457257|NCT00348725|Metformin|metformin|mesh-list
56457258|NCT00348725|Fenofibrate|fenofibrate|mesh-list
56457259|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56457260|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457261|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56457262|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
56457263|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457264|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56457265|NCT00348764|Polidocanol|polidocanol|mesh-list
56457266|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56457267|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56457268|NCT03276156|Apatinib|apatinib|mesh-list
56457269|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457270|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56457271|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457272|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457273|NCT00456144|Hormones|hormones|mesh-list
56457276|NCT00348920|Bupivacaine|bupivacaine|mesh-list
56457277|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
56457278|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
56457279|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56457280|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457281|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
56457282|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457283|NCT00449514|Tamoxifen|tamoxifen|mesh-list
56457284|NCT00449514|Clomiphene|clomiphene|mesh-list
56457285|NCT00449514|Enclomiphene|enclomiphene|mesh-list
56457286|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
56457287|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56457288|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
56457289|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457290|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457291|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56457292|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457293|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56457294|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56457295|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56457296|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56457297|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
56457298|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56457299|NCT00348998|Bevacizumab|bevacizumab|mesh-list
56457300|NCT00348998|Goserelin|goserelin|mesh-list
56457301|NCT00348998|Bicalutamide|bicalutamide|mesh-list
56457302|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56457303|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457304|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56457305|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56457306|NCT00348998|Growth Substances|growth substances|mesh-ancestor
56457307|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457308|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
56457309|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56457310|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
56457311|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
55886643|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916216|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916217|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916218|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916219|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56916220|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56916221|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56916222|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
56916223|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
56916224|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56916225|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916226|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56916227|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916228|NCT03331562|Vitamins|vitamins|mesh-ancestor
56916229|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
56916230|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56916231|NCT00814294|Insulin|insulin|mesh-list
56916232|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56916233|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916234|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916235|NCT02038634|Betamethasone|betamethasone|mesh-list
56916236|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916237|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
56916238|NCT02038634|Hormones|hormones|mesh-ancestor
56174865|NCT01386502|Pidilizumab|pidilizumab|mesh-list
56457312|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457314|NCT00449553|Pioglitazone|pioglitazone|mesh-list
56457315|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56457316|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457317|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
56457318|NCT00349076|Fluorouracil|fluorouracil|mesh-list
56205189|NCT01550770|Propofol|propofol|mesh-list
56457319|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457320|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
56457321|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457322|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56457323|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457324|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
56457325|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457326|NCT00349115|Thalidomide|thalidomide|mesh-list
56457327|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457328|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
56457329|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457330|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
56457331|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457332|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457333|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56457334|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56457335|NCT00349115|Growth Substances|growth substances|mesh-ancestor
56457336|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
56457337|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457338|NCT00456339|Amoxicillin|amoxicillin|mesh-list
56457339|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
56457340|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
55886644|NCT01772758|Protective Agents|protective agents|mesh-ancestor
56916239|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916240|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916241|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56916242|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
56916243|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56916244|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56916245|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
56916246|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916247|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916248|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56916249|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56457341|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56457342|NCT00456339|Prednisolone|prednisolone|mesh-list
56457343|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457344|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457345|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457348|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457349|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457350|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56457351|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457352|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56457353|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457354|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457355|NCT00421421|Dutasteride|dutasteride|mesh-list
56457356|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56457357|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56457358|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457359|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457360|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
56457361|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457362|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457363|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
56457364|NCT00421460|Testosterone|testosterone|mesh-list
56457365|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
56457366|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
56457367|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56457368|NCT00421460|Androgens|androgens|mesh-ancestor
56457369|NCT00421460|Hormones|hormones|mesh-ancestor
56457370|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457371|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457372|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56457373|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457374|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
56457375|NCT00349310|Pramipexole|pramipexole|mesh-list
56457376|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
56457377|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457378|NCT00349310|Protective Agents|protective agents|mesh-ancestor
56457379|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457380|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56457381|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56457382|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
56457383|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
56457384|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457385|NCT03274167|Gabapentin|gabapentin|mesh-list
56457386|NCT03274167|Analgesics|analgesics|mesh-ancestor
56457387|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
56457388|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457389|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457390|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
56457391|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56457392|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56916250|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56916251|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56916252|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56916253|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
56916254|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916255|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916256|NCT03636308|Gemcitabine|gemcitabine|mesh-list
56916257|NCT03636308|Paclitaxel|paclitaxel|mesh-list
56916258|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56916259|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56916260|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916261|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
56916262|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
56916263|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
56916264|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916265|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56916266|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
56916267|NCT03636308|Antiviral Agents|antiviral agents|mesh-ancestor
56916268|NCT03636308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174997|NCT01386996|Hormones|hormones|mesh-ancestor
56457393|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56457394|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56457395|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56457396|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56457397|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457398|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457399|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
56457401|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56457402|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457403|NCT00349583|Cyclosporine|cyclosporine|mesh-list
56457404|NCT00349583|Cyclosporins|cyclosporins|mesh-list
56457405|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457406|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457407|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457408|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
56457409|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457410|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
56457411|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457412|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56457413|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56457414|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56457415|NCT00349739|Anecortave|anecortave|mesh-list
56457416|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56457417|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56457418|NCT00349739|Growth Substances|growth substances|mesh-ancestor
55785897|NCT05092945|Niacin|niacin|mesh-list
56457421|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457422|NCT00456729|Metronidazole|metronidazole|mesh-list
56457423|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457424|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457425|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56457426|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56457427|NCT00450099|Bupivacaine|bupivacaine|mesh-list
56457428|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
56457429|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
56457430|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56916269|NCT03636308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916270|NCT03636308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56916271|NCT03636308|Immunologic Factors|immunologic factors|mesh-ancestor
56916272|NCT03636308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916273|NCT00836056|Clindamycin|clindamycin|mesh-list
56916274|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
56916275|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
56916276|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56916277|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916278|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56916279|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916280|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916281|NCT04639466|Vaccines|vaccines|mesh-list
56916282|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
56457431|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457432|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
56457433|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457435|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457436|NCT00350051|Prednisone|prednisone|mesh-list
56457437|NCT00350051|Sagopilone|sagopilone|mesh-list
56457438|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457439|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
56457440|NCT00350051|Hormones|hormones|mesh-ancestor
56457441|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457442|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457443|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56457444|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457445|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
56457446|NCT00350090|Hematinics|hematinics|mesh-ancestor
56457447|NCT04699110|Adenosine|adenosine|mesh-list
56457448|NCT04699110|Epinephrine|epinephrine|mesh-list
56457449|NCT04699110|Racepinephrine|racepinephrine|mesh-list
56457450|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
56457451|NCT04699110|Analgesics|analgesics|mesh-ancestor
56457452|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
56457453|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457454|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457455|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56457456|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457457|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56457458|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
56457459|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
56457460|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457461|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457462|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56457463|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56457464|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
56457465|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56457466|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56457467|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
56457468|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56457469|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56457470|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
56457471|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
56457472|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56457473|NCT00350168|Amlodipine|amlodipine|mesh-list
56457474|NCT00350168|Valsartan|valsartan|mesh-list
56457475|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56457476|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56457477|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56457478|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457479|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56457480|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916283|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916284|NCT00835666|Finasteride|finasteride|mesh-list
56916285|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56457481|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457482|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56457483|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56457484|NCT00105534|Azithromycin|azithromycin|mesh-list
56457485|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457486|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457487|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
56334066|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
56457488|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457489|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457490|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56457491|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56457496|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56457497|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56457498|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
56457499|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56457500|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457501|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56457502|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56457503|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56457504|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457505|NCT00456963|Losartan|losartan|mesh-list
56457506|NCT00456963|Enalapril|enalapril|mesh-list
56457507|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56457508|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56457509|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56457510|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56457511|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457512|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56457513|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
56457514|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457515|NCT00350597|Molgramostim|molgramostim|mesh-list
56457516|NCT00350597|Sargramostim|sargramostim|mesh-list
56457517|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
56457518|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457519|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457520|NCT00350753|Bevacizumab|bevacizumab|mesh-list
56457521|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56457522|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56457523|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457524|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56457525|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56457526|NCT00350753|Growth Substances|growth substances|mesh-ancestor
56457527|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457528|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
56457529|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56457530|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457531|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457532|NCT00457119|Everolimus|everolimus|mesh-list
56457533|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457534|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457535|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
56457536|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457537|NCT00350948|Doxorubicin|doxorubicin|mesh-list
56457538|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56457539|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56457540|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457541|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56457542|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56457543|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457544|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457545|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56457546|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56457547|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457549|NCT00421538|Calcium|calcium|mesh-list
56457550|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56457551|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175151|NCT01388270|Heparin|heparin|mesh-list
56457553|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56457554|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56457555|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457556|NCT00351026|Methadone|methadone|mesh-list
56457557|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56457558|NCT00351026|Narcotics|narcotics|mesh-ancestor
56457559|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56457560|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457561|NCT00351026|Analgesics|analgesics|mesh-ancestor
56457562|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
56457563|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457565|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
56457566|NCT00351104|Ketoprofen|ketoprofen|mesh-list
56457567|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56457568|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56457569|NCT00351104|Analgesics|analgesics|mesh-ancestor
56457570|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
56457571|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457572|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457573|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457574|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56457575|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56457576|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457577|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457578|NCT00351143|Fluticasone|fluticasone|mesh-list
56457579|NCT00351143|Xhance|xhance|mesh-list
56457580|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56457581|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457582|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56457583|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
56457584|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457585|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457586|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56457587|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
56457588|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
56457589|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56457590|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56457591|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56457592|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56457593|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
56457594|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457595|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457596|NCT00351182|Doxycycline|doxycycline|mesh-list
56457597|NCT00351182|Telithromycin|telithromycin|mesh-list
56457598|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457599|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457600|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
56457601|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56457602|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56457603|NCT00457470|Rucaparib|rucaparib|mesh-list
56457604|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56457605|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457606|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457607|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457608|NCT00457509|Vaccines|vaccines|mesh-list
56457609|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
56457610|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457611|NCT00450645|Heparin|heparin|mesh-list
56457612|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56457613|NCT00450645|Tinzaparin|tinzaparin|mesh-list
56457614|NCT00450645|Dalteparin|dalteparin|mesh-list
56457615|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
56457616|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56457617|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56457618|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457619|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
56457620|NCT00457860|Immunotoxins|immunotoxins|mesh-list
56457621|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
56457622|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457623|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457624|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56457625|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
56457626|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56457627|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56457628|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56916286|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56916287|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175229|NCT01388621|Gemcitabine|gemcitabine|mesh-list
56457629|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56457630|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457632|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56457633|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457634|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56457635|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
56457636|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457637|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457639|NCT00458055|Atorvastatin|atorvastatin|mesh-list
56457640|NCT00458055|Fenofibrate|fenofibrate|mesh-list
56457643|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
56457644|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457645|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56457646|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56457647|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457648|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457649|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
56457650|NCT00458055|Vitamins|vitamins|mesh-ancestor
56457651|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
56457652|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457653|NCT00450762|Gemcitabine|gemcitabine|mesh-list
56457654|NCT00450762|Carboplatin|carboplatin|mesh-list
56457655|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457656|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56457657|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
56457658|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457659|NCT00450762|Antiviral Agents|antiviral agents|mesh-ancestor
56457660|NCT00450762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457661|NCT00450762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457662|NCT00450762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457663|NCT00450762|Immunologic Factors|immunologic factors|mesh-ancestor
56457664|NCT00450762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457665|NCT00352079|Gefitinib|gefitinib|mesh-list
56457666|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
56457667|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457668|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56457669|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457670|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457671|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56457672|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
56457673|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457674|NCT00450840|Simvastatin|simvastatin|mesh-list
56457675|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56457676|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56457677|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
56457678|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457679|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56457680|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56457681|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457682|NCT00352196|Risperidone|risperidone|mesh-list
56457683|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56457684|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
56457685|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457686|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457687|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457688|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56457689|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56457690|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56457691|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56457692|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56457693|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
56457694|NCT00352235|KRN 7000|krn 7000|mesh-list
56457695|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56457697|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457698|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457699|NCT00352313|Carboplatin|carboplatin|mesh-list
56457700|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457701|NCT00450957|Lycopene|lycopene|mesh-list
56457702|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457703|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
56916288|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457704|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457705|NCT00450957|Protective Agents|protective agents|mesh-ancestor
56457706|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457707|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56457708|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56457709|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457710|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
56457711|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56457712|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
56457713|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457714|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457716|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
56457717|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56457718|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
56457719|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457720|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457721|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56457722|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457723|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
56457724|NCT00352430|Protective Agents|protective agents|mesh-ancestor
56457725|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56457726|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
56457727|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56457728|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56457729|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56457730|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56457731|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457732|NCT00451074|Gentamicins|gentamicins|mesh-list
56457733|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457734|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457735|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56457736|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457737|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457738|NCT00465621|Latanoprost|latanoprost|mesh-list
56457739|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56457740|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56457741|NCT00352625|Ketoprofen|ketoprofen|mesh-list
56457742|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56457743|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56457744|NCT00352625|Analgesics|analgesics|mesh-ancestor
56457745|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
56457746|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457747|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457748|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457749|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56457750|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56457751|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457752|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457753|NCT00352742|Bortezomib|bortezomib|mesh-list
56457754|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56457755|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457756|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
56457757|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
56457758|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457759|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457760|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56457761|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56457762|NCT00352742|Growth Substances|growth substances|mesh-ancestor
56457763|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457764|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
56457765|NCT00352859|Gemcitabine|gemcitabine|mesh-list
56457766|NCT00352859|Interferons|interferons|mesh-list
56457767|NCT00352859|Sorafenib|sorafenib|mesh-list
56457768|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56457769|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
56205641|NCT01554345|Selenium|selenium|mesh-list
56457770|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457772|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
56334083|NCT00038012|Carboplatin|carboplatin|mesh-list
56457773|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457774|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457775|NCT00352859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56916289|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
56648502|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457776|NCT00352859|Immunologic Factors|immunologic factors|mesh-ancestor
56457777|NCT00352859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457778|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56457779|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
56457780|NCT00105183|Antibodies|antibodies|mesh-list
56457781|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
56457782|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56457783|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56457784|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
56457785|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56457786|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
56457787|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457788|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457792|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457793|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457794|NCT00466128|Indomethacin|indomethacin|mesh-list
56457795|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56457796|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56457797|NCT00466128|Analgesics|analgesics|mesh-ancestor
56457798|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
56457799|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457800|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457801|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56457802|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56457803|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
56457804|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
56457805|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56457806|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56457807|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457808|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457809|NCT00353015|Cisplatin|cisplatin|mesh-list
56457810|NCT00353015|Irinotecan|irinotecan|mesh-list
56457811|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457812|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56457813|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56457814|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457815|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457816|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56457817|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457818|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56457819|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457820|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457821|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
56457822|NCT00353054|Antacids|antacids|mesh-ancestor
56457823|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457824|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56457825|NCT00466401|Simvastatin|simvastatin|mesh-list
56457826|NCT00466401|Ezetimibe|ezetimibe|mesh-list
56457827|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56457828|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56457829|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
56457830|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457831|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56457832|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56457833|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457834|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56457835|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56457836|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56457837|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56457838|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56457839|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
56457840|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457841|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205719|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457842|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457843|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56457844|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56457845|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457847|NCT00466518|Hormones|hormones|mesh-ancestor
56457848|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916290|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916291|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916292|NCT00835666|Urological Agents|urological agents|mesh-ancestor
56916293|NCT00835588|Pantoprazole|pantoprazole|mesh-list
56457849|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56457850|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
56457851|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457852|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457853|NCT00353561|Fluconazole|fluconazole|mesh-list
56457854|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
56457855|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457856|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56457857|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56457859|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457860|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56457862|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457863|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457864|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56457865|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56457866|NCT00466596|Vitamins|vitamins|mesh-list
56457867|NCT00466596|Vitamin E|vitamin e|mesh-list
56457868|NCT00466596|Tocopherols|tocopherols|mesh-list
56457869|NCT00466596|Tocotrienols|tocotrienols|mesh-list
56457870|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
56457871|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
56457872|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
56457873|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457874|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
56457875|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457876|NCT00466596|Protective Agents|protective agents|mesh-ancestor
56457877|NCT00353678|Darexaban|darexaban|mesh-list
56457878|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56457879|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
56457880|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56457881|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
56457882|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457883|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457884|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
56457885|NCT00458250|Cyclosporine|cyclosporine|mesh-list
56457886|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
56457887|NCT00458250|Busulfan|busulfan|mesh-list
56457888|NCT00458250|Methotrexate|methotrexate|mesh-list
56457889|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
56457890|NCT00458250|Cyclosporins|cyclosporins|mesh-list
56457891|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56457892|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
56457893|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457894|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56457895|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56457896|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
56457897|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457898|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457899|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56457900|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56457901|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
56457902|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56457903|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56457904|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
56457905|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56457906|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457907|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56457908|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56457909|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
56457910|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56457911|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56457912|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56457913|NCT00353717|Paclitaxel|paclitaxel|mesh-list
56457914|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56457915|NCT00353717|Cetuximab|cetuximab|mesh-list
56457916|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56916294|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56916295|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56457917|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457918|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
56457919|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
56457920|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
56457921|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457922|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56457924|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56457925|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457926|NCT00466791|Methylphenidate|methylphenidate|mesh-list
56457927|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56457928|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457929|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56457930|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56457931|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56457936|NCT00353912|Valsartan|valsartan|mesh-list
56457937|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56457938|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56457939|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56457940|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457941|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56457942|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457943|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457944|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56457945|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56457946|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
56457947|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56457948|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457949|NCT00458328|Z 338|z 338|mesh-list
56457950|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56457951|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457952|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457953|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
56457954|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457955|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457956|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56457957|NCT00354068|Temozolomide|temozolomide|mesh-list
56457958|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
56457959|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56457960|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
56457961|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457962|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457963|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56457964|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457965|NCT00466869|Betahistine|betahistine|mesh-list
56457966|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
56457967|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
56457968|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
56457969|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457970|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457971|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457972|NCT00354146|Tipifarnib|tipifarnib|mesh-list
56457973|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457974|NCT00458367|Risperidone|risperidone|mesh-list
56457975|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56457976|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
56457977|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457978|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457979|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457980|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56457981|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56457982|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56457983|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56457984|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56457985|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
56457986|NCT00354185|Belinostat|belinostat|mesh-list
56457987|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457988|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56457989|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457990|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916296|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56916297|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916298|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916299|NCT00713518|Ranibizumab|ranibizumab|mesh-list
56916300|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56916301|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56916302|NCT00713518|Growth Substances|growth substances|mesh-ancestor
56916303|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916304|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
56916305|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916306|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
56916307|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56916308|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
56916309|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916310|NCT00708292|Dexamethasone|dexamethasone|mesh-list
56916311|NCT00708292|Bortezomib|bortezomib|mesh-list
56916312|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916313|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
56457992|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457993|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
56457994|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
56457995|NCT00354302|Alendronate|alendronate|mesh-list
56457996|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
56457997|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
56457998|NCT00354302|Calcium|calcium|mesh-list
56457999|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56458000|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458001|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56458002|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458004|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
56458005|NCT00354302|Antacids|antacids|mesh-ancestor
56458006|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56458007|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56458008|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56458009|NCT04714229|Vaccines|vaccines|mesh-list
56458010|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
56458011|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458012|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
56458013|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56458014|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458015|NCT00354380|Artesunate|artesunate|mesh-list
56458016|NCT00354380|Amodiaquine|amodiaquine|mesh-list
56458017|NCT00354380|Methylene Blue|methylene blue|mesh-list
56458018|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
56458019|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56458020|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56458021|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458022|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458023|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
56458024|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
56458025|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56458026|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
56458027|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458028|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458029|NCT00354419|Cyclosporine|cyclosporine|mesh-list
56458030|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
56458031|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
56458032|NCT00354419|Cyclosporins|cyclosporins|mesh-list
56458033|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
56458034|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56458035|NCT00354419|Lenograstim|lenograstim|mesh-list
56916314|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
56916315|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916316|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916317|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56916318|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
56916319|NCT00708292|Hormones|hormones|mesh-ancestor
56916320|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916321|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56916322|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916323|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
56916324|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56916325|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916326|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916327|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916328|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
56916329|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
56916330|NCT00835354|Cefprozil|cefprozil|mesh-list
56916331|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56916332|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916333|NCT04874480|Decitabine|decitabine|mesh-list
56458036|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
56458037|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458038|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
56458039|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458040|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56458041|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56458042|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
56458043|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458044|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458045|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56458046|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56458047|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458048|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
56458049|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458050|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
56458051|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56458052|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56458053|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56458054|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
56458055|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56458056|NCT00354458|Rolofylline|rolofylline|mesh-list
56458057|NCT00354458|Diuretics|diuretics|mesh-ancestor
56458058|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
56458059|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458060|NCT00458718|Rimonabant|rimonabant|mesh-list
56458061|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56458062|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56458063|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56458064|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958920|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458065|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458066|NCT00458718|Hormones|hormones|mesh-ancestor
56458067|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458068|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916334|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56916335|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
56916336|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916337|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916338|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916339|NCT00698230|Metformin|metformin|mesh-list
56916340|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916341|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916342|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
56916343|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56916344|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916345|NCT01330472|Alprazolam|alprazolam|mesh-list
56175693|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56458069|NCT00467181|Fenoldopam|fenoldopam|mesh-list
56458070|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56458071|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
56458072|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
56458073|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
56458074|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458075|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458076|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458077|NCT00425711|Acamprosate|acamprosate|mesh-list
56458078|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56458081|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56458082|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458083|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458085|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56458086|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
56458087|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458088|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458089|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56458090|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56458091|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
56458092|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458093|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458094|NCT00467376|Insulin|insulin|mesh-list
56458095|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56458096|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
56458097|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
56458098|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56458099|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458100|NCT00426023|Ketotifen|ketotifen|mesh-list
56458101|NCT00426023|Cyclosporine|cyclosporine|mesh-list
56458102|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56458103|NCT00426023|Cyclosporins|cyclosporins|mesh-list
56458104|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458105|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458106|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458107|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
56458108|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458109|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
56458110|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458111|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
56458112|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56458113|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56458114|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56458115|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
56458116|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56458117|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
56458118|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
56458119|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458120|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56458121|NCT00467454|Naltrexone|naltrexone|mesh-list
56916346|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56916347|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56916348|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916349|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56916350|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56916351|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56916352|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
56916353|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
56916354|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916355|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916356|NCT00835276|Fexofenadine|fexofenadine|mesh-list
56916357|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56916358|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56916359|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56916360|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
56916361|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
56916362|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916363|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916364|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916365|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
56916366|NCT01860170|Bortezomib|bortezomib|mesh-list
56916367|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458122|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56458123|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56458124|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458125|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
56458126|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458127|NCT00426101|Cyclosporine|cyclosporine|mesh-list
56458128|NCT00426101|Dexamethasone|dexamethasone|mesh-list
56458129|NCT00426101|Etoposide|etoposide|mesh-list
56458130|NCT00426101|Cyclosporins|cyclosporins|mesh-list
56458131|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56458132|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
56458133|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
56458134|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458135|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458136|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56458137|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
56458138|NCT00426101|Hormones|hormones|mesh-ancestor
56206016|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458139|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458140|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56458141|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458142|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56458143|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56458144|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56458145|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458146|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458147|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458148|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
56458149|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
56458150|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458151|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
56916368|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
56916369|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916370|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56916371|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56916372|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
56916373|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916374|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916375|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56916377|NCT04718740|Repaglinide|repaglinide|mesh-list
56916378|NCT04718740|Midazolam|midazolam|mesh-list
56916379|NCT04718740|Caffeine|caffeine|mesh-list
56916380|NCT04718740|Bupropion|bupropion|mesh-list
56916381|NCT04718740|Omeprazole|omeprazole|mesh-list
56916382|NCT04718740|Warfarin|warfarin|mesh-list
56916383|NCT04718740|Vitamins|vitamins|mesh-ancestor
56916384|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
56916385|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916386|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56916387|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56916388|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56916389|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56458152|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56458153|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56458155|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458156|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
56458157|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
56458158|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
56458159|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458160|NCT00467493|Anastrozole|anastrozole|mesh-list
56458161|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56458162|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458163|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56458164|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56458165|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458166|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458167|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56458168|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
56458169|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458170|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458171|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
56458172|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458173|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56458174|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458175|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458177|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458178|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
56458179|NCT00458991|Caffeine|caffeine|mesh-list
56458180|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56458181|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458182|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56458183|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458184|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458185|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56458186|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56458187|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
56916390|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56916391|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56916392|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56916393|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
56916394|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
56916395|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
56916396|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
56916397|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458188|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458189|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
56458190|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
56458191|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56458192|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56458193|NCT01059617|Vaccines|vaccines|mesh-list
56458194|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
56458195|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458196|NCT04705337|Simendan|simendan|mesh-list
56458197|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56458198|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
56458199|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56458200|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56458201|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458202|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458203|NCT04705337|Protective Agents|protective agents|mesh-ancestor
56458204|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458205|NCT00467571|Amoxicillin|amoxicillin|mesh-list
56458206|NCT00467571|Clarithromycin|clarithromycin|mesh-list
56458207|NCT00467571|Lansoprazole|lansoprazole|mesh-list
56458208|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
56458209|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56458210|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458211|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56458212|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458213|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458214|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56458215|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56458216|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56458217|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56458218|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56458219|NCT00426296|Ritonavir|ritonavir|mesh-list
56458220|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56458221|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56458222|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56458223|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
56458224|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458225|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458226|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56458228|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
56458229|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458230|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56458231|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56458232|NCT03271905|Bromides|bromides|mesh-list
56458233|NCT03271905|Albuterol|albuterol|mesh-list
56458234|NCT03271905|Ipratropium|ipratropium|mesh-list
56458235|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
56458236|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56458237|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
56458238|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458239|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458240|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56458241|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
56458242|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
56458243|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56458244|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56458245|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56458246|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56458247|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
56458248|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458249|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916398|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916399|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
56916400|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56916401|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56916402|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916403|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56916404|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56916405|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
56916406|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56916407|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56916408|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56916409|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56916410|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
56175943|NCT01392833|Prednisone|prednisone|mesh-list
56458250|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56458251|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
56458252|NCT00426413|Pioglitazone|pioglitazone|mesh-list
56458253|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56458254|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458255|NCT00459264|Folic Acid|folic acid|mesh-list
56458256|NCT00459264|Hematinics|hematinics|mesh-ancestor
56458257|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
56458258|NCT00459264|Vitamins|vitamins|mesh-ancestor
56458259|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
56458260|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458261|NCT00426452|Vatalanib|vatalanib|mesh-list
56458262|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56458263|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458264|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458265|NCT00426491|Misoprostol|misoprostol|mesh-list
56458266|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56458267|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
56458268|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56458269|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458270|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56458271|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56458272|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
56458273|NCT00426530|Everolimus|everolimus|mesh-list
56458274|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458275|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458276|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
56458277|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458278|NCT00459420|Caffeine|caffeine|mesh-list
56458279|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56458280|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458281|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56458282|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458283|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458284|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56458285|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56458286|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
56458287|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458288|NCT00467766|Donepezil|donepezil|mesh-list
56458289|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56458290|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458291|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458292|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
56458293|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458294|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458295|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
56458296|NCT04705415|Niclosamide|niclosamide|mesh-list
56916411|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56458297|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
56458298|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56458299|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
56458300|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56458301|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458303|NCT00467883|Amphotericin B|amphotericin b|mesh-list
56458304|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56458305|NCT00467883|Amebicides|amebicides|mesh-ancestor
56458306|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56458307|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56458308|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458309|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56458310|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
56458312|NCT00426608|Metyrapone|metyrapone|mesh-list
56458313|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56458314|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56458315|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458316|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56458317|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56458318|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56458319|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
56458320|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
56458321|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458322|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458323|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
56458324|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458325|NCT00426647|Buprenorphine|buprenorphine|mesh-list
56458326|NCT00426647|Tramadol|tramadol|mesh-list
56458327|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56458328|NCT00426647|Narcotics|narcotics|mesh-ancestor
56458329|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56458330|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458331|NCT00426647|Analgesics|analgesics|mesh-ancestor
56458332|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
56458333|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458334|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56458335|NCT01059071|Eflornithine|eflornithine|mesh-list
56458336|NCT01059071|Etoposide|etoposide|mesh-list
56458337|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56458338|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458339|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56458340|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56458341|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458342|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458343|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56458344|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56458345|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56458346|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458347|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56458348|NCT00468234|Nicotine|nicotine|mesh-list
56458349|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56458350|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
56458351|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458352|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458353|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56458354|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56458355|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
56458356|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458357|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458358|NCT00459615|Artesunate|artesunate|mesh-list
56458360|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56458361|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56458362|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458363|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458364|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
56458365|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
56458366|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56458367|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
56458368|NCT01058642|Pregabalin|pregabalin|mesh-list
56458369|NCT01058642|Analgesics|analgesics|mesh-ancestor
56458370|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
56458371|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458372|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458373|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
56458374|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56458375|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56916412|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56916413|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56916414|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
56916415|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56916416|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56916417|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56458376|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458377|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56458378|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56458380|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56458381|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56458382|NCT00468351|Triamcinolone|triamcinolone|mesh-list
56458383|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56458384|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56458385|NCT00468351|Bevacizumab|bevacizumab|mesh-list
56458386|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56458387|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56458388|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458389|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56458390|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56458391|NCT00468351|Growth Substances|growth substances|mesh-ancestor
56458392|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458393|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
56458394|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56458395|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
56458397|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458398|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458399|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
56458400|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458401|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458402|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56458403|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458404|NCT00468429|Bevacizumab|bevacizumab|mesh-list
56458405|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56458406|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458407|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56458408|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56458409|NCT00468429|Growth Substances|growth substances|mesh-ancestor
56458410|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458411|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
56458412|NCT00459771|Candesartan|candesartan|mesh-list
56458413|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56458414|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56458415|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56458416|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458417|NCT01058369|Deferasirox|deferasirox|mesh-list
56458418|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56458419|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
56458420|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
56458421|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458422|NCT01057433|Ritonavir|ritonavir|mesh-list
56458423|NCT01057433|Lopinavir|lopinavir|mesh-list
56458424|NCT01057433|Pitavastatin|pitavastatin|mesh-list
56458425|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56458426|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56458427|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
56458428|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458429|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458430|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56458431|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56458432|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
56458433|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458434|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56458435|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56458436|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56916418|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56916419|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
56916420|NCT04718740|Coagulants|coagulants|mesh-ancestor
56916421|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916422|NCT03344536|Fulvestrant|fulvestrant|mesh-list
56916423|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56916424|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916425|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56916426|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56916427|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
56916428|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916429|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916430|NCT01759238|Bevacizumab|bevacizumab|mesh-list
56916431|NCT01759238|Capecitabine|capecitabine|mesh-list
56176158|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
56458437|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56458438|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56458440|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56458441|NCT00426920|Insulin|insulin|mesh-list
56458442|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56458443|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458445|NCT00426998|Verteporfin|verteporfin|mesh-list
56458446|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56458447|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458448|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56458449|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56458450|NCT00426998|Growth Substances|growth substances|mesh-ancestor
56458451|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458452|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
56458453|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56458454|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
56458457|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56458458|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458459|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56458461|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
56458462|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56458463|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56458464|NCT00427232|BQ 788|bq 788|mesh-list
56458465|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56458466|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56458467|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458468|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56458469|NCT00427271|Aspirin|aspirin|mesh-list
56458470|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56458471|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56458472|NCT00427271|Analgesics|analgesics|mesh-ancestor
56458473|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
56458474|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458475|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458476|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56458477|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56458478|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56458479|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56458480|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458481|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56458482|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56458483|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458484|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
56458485|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
56458486|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55897593|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
56916432|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56916433|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916434|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56916435|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56916436|NCT01759238|Growth Substances|growth substances|mesh-ancestor
56916437|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916438|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
56916439|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56916440|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
56916441|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916442|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56916443|NCT00835042|Moexipril|moexipril|mesh-list
56916444|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56916445|NCT00835042|Diuretics|diuretics|mesh-ancestor
56916446|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
56916447|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916448|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56627100|NCT02542111|Gemcitabine|gemcitabine|mesh-list
56916449|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56458487|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56458488|NCT00460083|Analgesics|analgesics|mesh-ancestor
56458489|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
56458490|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458491|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458492|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56458493|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56458494|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
56458495|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458496|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
56458497|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56458498|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458499|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458500|NCT00427310|Fluorouracil|fluorouracil|mesh-list
56458501|NCT00427310|Heparin|heparin|mesh-list
56458502|NCT00427310|Calcium heparin|calcium heparin|mesh-list
56458503|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
56458504|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458505|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56458506|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458507|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458508|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
56458509|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458510|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
56458511|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56458512|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56458513|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
56458514|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56458515|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56458516|NCT00427388|Prednisolone|prednisolone|mesh-list
56458517|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
56206407|NCT01559480|Hormones|hormones|mesh-ancestor
56458518|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56458519|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
56458520|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56458521|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
56458522|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
55897738|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916450|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916451|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56916452|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
56916453|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916454|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
56916455|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
56916456|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
56916457|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56916458|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916459|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
56916460|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916461|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56458523|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458524|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458525|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56458526|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
56458530|NCT00427388|Protective Agents|protective agents|mesh-ancestor
56458531|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56458532|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458533|NCT00427427|Trastuzumab|trastuzumab|mesh-list
56458534|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56458535|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458536|NCT04704947|Alendronate|alendronate|mesh-list
56458537|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56458538|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
56458539|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56458540|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458541|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56458542|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
56458543|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458544|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458545|NCT00427466|Pemetrexed|pemetrexed|mesh-list
56458546|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458547|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458548|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458549|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56458550|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56458551|NCT00427505|Deferasirox|deferasirox|mesh-list
56458552|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56458553|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
56458554|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
56458555|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458556|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
56458557|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458558|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56458559|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458560|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458561|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
56458562|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56458563|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458564|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56458565|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
56458566|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56458567|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458568|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458569|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458570|NCT00469053|Buprenorphine|buprenorphine|mesh-list
56458571|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56458572|NCT00469053|Narcotics|narcotics|mesh-ancestor
56458573|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56916462|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56916463|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56916464|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56916465|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916466|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916467|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916468|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56916469|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
56916470|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56916471|NCT03180502|Temozolomide|temozolomide|mesh-list
56916472|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56458574|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458575|NCT00469053|Analgesics|analgesics|mesh-ancestor
56458576|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
56458577|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458578|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56458579|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
56458580|NCT00469131|Tacrolimus|tacrolimus|mesh-list
56458581|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458582|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
56458583|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458584|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56458585|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458586|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458587|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56458588|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458589|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56458590|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
56458591|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56458592|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458593|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
56458594|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
56458595|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56458596|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56458599|NCT04704440|Urological Agents|urological agents|mesh-ancestor
56458600|NCT00428129|Plasminogen|plasminogen|mesh-list
56458601|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56458602|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56458603|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458604|NCT00428168|Betahistine|betahistine|mesh-list
56458605|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
56458606|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
56458607|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
56458608|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458609|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458610|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458611|NCT00428480|Methamphetamine|methamphetamine|mesh-list
56458612|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56458613|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458614|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
56458615|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
56458616|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458617|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
56458618|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458619|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458620|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
56458621|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56458622|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56458623|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56458624|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56916473|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
56916474|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916475|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916476|NCT03072238|Prednisone|prednisone|mesh-list
56458625|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
56458626|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56458627|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56458628|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458629|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56458630|NCT00460473|Analgesics|analgesics|mesh-ancestor
56458631|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
56458632|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458633|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56458634|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56458635|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56458636|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
56458637|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458638|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458639|NCT00428519|Aprepitant|aprepitant|mesh-list
56458640|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
56458641|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
56458642|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
56458643|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458644|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458645|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56458646|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56458647|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458648|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458649|NCT00428558|Cytarabine|cytarabine|mesh-list
56458650|NCT00428558|Daunorubicin|daunorubicin|mesh-list
56458651|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56458652|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
56458653|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458654|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458655|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
56458656|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458657|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458658|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
56458659|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458660|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56458661|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56458662|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56458663|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458664|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56458665|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56458666|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56458667|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56458668|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458669|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56458670|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56458671|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56458672|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
56458673|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458674|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458675|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56458676|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56458677|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
56458678|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
56458679|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56458680|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458681|NCT01055834|Eszopiclone|eszopiclone|mesh-list
56458682|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56458683|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56458684|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458685|NCT00469326|Atorvastatin|atorvastatin|mesh-list
56458686|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56458687|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56458688|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
56458689|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458690|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56916477|NCT03072238|Prednisolone|prednisolone|mesh-list
56916478|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916479|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
56916480|NCT03072238|Hormones|hormones|mesh-ancestor
56916481|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916482|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916483|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56916484|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916485|NCT03070522|Prednisone|prednisone|mesh-list
56916486|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916487|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
56916488|NCT03070522|Hormones|hormones|mesh-ancestor
56916489|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458691|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56458692|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458693|NCT04704713|Afamelanotide|afamelanotide|mesh-list
56458694|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
56458695|NCT00460707|Ketoconazole|ketoconazole|mesh-list
56458696|NCT00460707|Casopitant|casopitant|mesh-list
56458697|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
56458698|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458699|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56458700|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56458701|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458702|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458703|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56458704|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
56458705|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458706|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458707|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56458708|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
56458709|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
56458710|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458711|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56458712|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56458713|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458714|NCT00469404|Buprenorphine|buprenorphine|mesh-list
56458715|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56458716|NCT00469404|Narcotics|narcotics|mesh-ancestor
56458717|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56458718|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458719|NCT00469404|Analgesics|analgesics|mesh-ancestor
56458720|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
56458721|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458722|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56458723|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
56458724|NCT00460785|Narcotics|narcotics|mesh-ancestor
56458725|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56458726|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458727|NCT00460785|Analgesics|analgesics|mesh-ancestor
56458728|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
56458729|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458730|NCT01054976|Galantamine|galantamine|mesh-list
56458731|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56458732|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458733|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458734|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
56458735|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458736|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458737|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56458738|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
56916490|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916491|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56458739|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458740|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
56458741|NCT00469443|Leucovorin|leucovorin|mesh-list
56458746|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56458747|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458748|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56458749|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56458750|NCT00469443|Growth Substances|growth substances|mesh-ancestor
56458751|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458752|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
56458753|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
56458754|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458755|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56458756|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458757|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
56458758|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56458759|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56458760|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458761|NCT00469443|Antidotes|antidotes|mesh-ancestor
56458762|NCT00469443|Protective Agents|protective agents|mesh-ancestor
56458763|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
56458764|NCT00469443|Vitamins|vitamins|mesh-ancestor
56458765|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
56458766|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
56458767|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56458768|NCT00428909|Acetaminophen|acetaminophen|mesh-list
56458769|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
56458770|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56458771|NCT00428909|Analgesics|analgesics|mesh-ancestor
56458772|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
56458773|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458774|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458775|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
56458776|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458777|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56458778|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458779|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458780|NCT00429065|Rituximab|rituximab|mesh-list
56458781|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56458782|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458783|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
56458784|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458785|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56458786|NCT00469560|Deferasirox|deferasirox|mesh-list
56458787|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56458788|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
56458789|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
56458790|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458791|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
56458792|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56458793|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56458794|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458796|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
56458797|NCT00429377|Tacrolimus|tacrolimus|mesh-list
56458798|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458799|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
56458800|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458801|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56458802|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458803|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458804|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56458805|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
56458806|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
56458807|NCT00429533|Dapsone|dapsone|mesh-list
56458808|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458809|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
56458810|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56458811|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56206685|NCT05229965|Codeine|codeine|mesh-list
56458812|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56458813|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458814|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916492|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916493|NCT00834574|Cefdinir|cefdinir|mesh-list
56916494|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56916495|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916496|NCT04879966|Infliximab|infliximab|mesh-list
56916497|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
56916498|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56916499|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56916500|NCT00834418|Leflunomide|leflunomide|mesh-list
56916501|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916502|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916503|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56916504|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
56916505|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916506|NCT04621318|Denosumab|denosumab|mesh-list
56458815|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
56458818|NCT04704245|Mitogens|mitogens|mesh-list
56458819|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
56458820|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458821|NCT04704245|Emollients|emollients|mesh-ancestor
56458822|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
56458823|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56458824|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56458825|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
56458826|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458827|NCT00429962|Ranibizumab|ranibizumab|mesh-list
56458828|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56458829|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56458830|NCT00429962|Growth Substances|growth substances|mesh-ancestor
56458831|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458832|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
56458833|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458834|NCT00430001|Docetaxel|docetaxel|mesh-list
56458835|NCT00430001|Trastuzumab|trastuzumab|mesh-list
56458836|NCT00430001|Vinorelbine|vinorelbine|mesh-list
56458837|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458838|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
56458839|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
56458840|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
56458841|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458842|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56458843|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56458844|NCT00430079|Etanidazole|etanidazole|mesh-list
56458845|NCT00430079|Imidazole|imidazole|mesh-list
56458846|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458847|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458848|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458849|NCT00430118|Cytarabine|cytarabine|mesh-list
56458850|NCT00430118|Dexamethasone|dexamethasone|mesh-list
56458851|NCT00430118|Prednisone|prednisone|mesh-list
56458852|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
56458853|NCT00430118|Ifosfamide|ifosfamide|mesh-list
56458854|NCT00430118|Doxorubicin|doxorubicin|mesh-list
56458855|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56458856|NCT00430118|Methotrexate|methotrexate|mesh-list
56458857|NCT00430118|Etoposide|etoposide|mesh-list
56458858|NCT00430118|Vincristine|vincristine|mesh-list
56458859|NCT00430118|Daunorubicin|daunorubicin|mesh-list
56458860|NCT00430118|Asparaginase|asparaginase|mesh-list
56458861|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
56458862|NCT00430118|Thioguanine|thioguanine|mesh-list
56458863|NCT00430118|Vindesine|vindesine|mesh-list
56458864|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458865|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
56458866|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458867|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56916507|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56916508|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916509|NCT00834340|Glimepiride|glimepiride|mesh-list
56916510|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56458868|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56458869|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
56458870|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458871|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458872|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56458873|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56458874|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
56458875|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
56458876|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458877|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56458878|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
56458879|NCT00430118|Hormones|hormones|mesh-ancestor
56458880|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458881|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56458882|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56458883|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56458884|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56458885|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458886|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56458887|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
56458888|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56458889|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56458890|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
56458891|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
56458892|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56458893|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56458900|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
56458901|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56458902|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56458903|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458904|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458905|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
56458906|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56458907|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
56458908|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56458909|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56458910|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458911|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458912|NCT00461565|Urological Agents|urological agents|mesh-ancestor
56458914|NCT00430196|Analgesics|analgesics|mesh-ancestor
56458915|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
56458916|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458917|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458918|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
56458919|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56458920|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56458921|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
56458922|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
56458923|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56458924|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56458925|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56458926|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
56458927|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458928|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458929|NCT00430235|Sorafenib|sorafenib|mesh-list
56458930|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458931|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56458932|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458933|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458934|NCT00470340|Gemcitabine|gemcitabine|mesh-list
56458935|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
56458936|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
56458937|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055325|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
56916511|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916512|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916513|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56916514|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
56916515|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
56916516|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916517|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
56916518|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916519|NCT04473274|Pioglitazone|pioglitazone|mesh-list
56916520|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916521|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916522|NCT00679588|Enoxaparin|enoxaparin|mesh-list
56916523|NCT00679588|Semuloparin|semuloparin|mesh-list
56458938|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56458939|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
56458940|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458941|NCT00470340|Antiviral Agents|antiviral agents|mesh-ancestor
56458942|NCT00470340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458943|NCT00470340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959806|NCT01860807|Ibudilast|ibudilast|mesh-list
56458944|NCT00470340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56458945|NCT00470340|Immunologic Factors|immunologic factors|mesh-ancestor
56458946|NCT00470340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458948|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458949|NCT00461643|Metformin|metformin|mesh-list
56458950|NCT00461643|Citric Acid|citric acid|mesh-list
56458951|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
56458952|NCT00461643|Clomiphene|clomiphene|mesh-list
56458953|NCT00461643|Enclomiphene|enclomiphene|mesh-list
56458954|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
56458955|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56458956|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458957|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
56458958|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56458959|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
56458960|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
56458961|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458962|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56458963|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
56458966|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
56458967|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56458968|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56458969|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56458971|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
56458972|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
56458973|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458974|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458975|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56458976|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56458977|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
56458978|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56458979|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56458980|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56458981|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458982|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56458983|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56458984|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458985|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
56458986|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56458987|NCT01053962|Plecanatide|plecanatide|mesh-list
56458988|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56458989|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
56458990|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458991|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56916524|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
56916525|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
56916526|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56916527|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56916528|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916529|NCT00151996|Guanfacine|guanfacine|mesh-list
56916530|NCT00151996|Methylphenidate|methylphenidate|mesh-list
56916531|NCT00151996|Amphetamine|amphetamine|mesh-list
56916532|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56916533|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916534|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56176788|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
56458992|NCT00461799|Orlistat|orlistat|mesh-list
56458993|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458994|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458995|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56458996|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56458997|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
56458998|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56458999|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459000|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
56459001|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56459002|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56459003|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459004|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459005|NCT00430742|Hormones|hormones|mesh-ancestor
56459006|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459007|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459008|NCT03271164|Vitamin E|vitamin e|mesh-list
56459009|NCT03271164|Vitamins|vitamins|mesh-ancestor
56459010|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
56459011|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459012|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
56459013|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459014|NCT03271164|Protective Agents|protective agents|mesh-ancestor
56459015|NCT00430898|Basiliximab|basiliximab|mesh-list
56459016|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459017|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
56459018|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459019|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56459020|NCT00461916|Buserelin|buserelin|mesh-list
56459021|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
56459022|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56459023|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
56459024|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56459025|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459026|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56459027|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56459028|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459029|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56459030|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
56459031|NCT02957409|Valsartan|valsartan|mesh-list
56459032|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56459034|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56459035|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56459036|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459038|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56459039|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459040|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56459041|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
56916535|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56916536|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176849|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
56459042|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56459043|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459044|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459045|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459046|NCT00431054|Docetaxel|docetaxel|mesh-list
56459047|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459048|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
56459049|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
56459050|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
56459051|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459052|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
56459053|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
56459054|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56459055|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459056|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459057|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
56459058|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56459059|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459060|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459061|NCT00431249|Cilostazol|cilostazol|mesh-list
56459062|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56459063|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
56459064|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459065|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459066|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56459067|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
56459068|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56459069|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56459070|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459071|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56459072|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
56459073|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56459074|NCT00431249|Protective Agents|protective agents|mesh-ancestor
56459075|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56459076|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56459077|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459078|NCT00470886|Telmisartan|telmisartan|mesh-list
56459079|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56459080|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56459081|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56459082|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459083|NCT00431522|Valproic Acid|valproic acid|mesh-list
56459084|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
56459085|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334115|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56459086|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459087|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
56459088|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459089|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459090|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
56459091|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56459092|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459093|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56459094|NCT00462111|Indomethacin|indomethacin|mesh-list
56459095|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56459096|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56459097|NCT00462111|Analgesics|analgesics|mesh-ancestor
56459098|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
56459099|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459100|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459101|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56459102|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56459104|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
56459105|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56459106|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56459107|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459108|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176921|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
56459109|NCT00431561|Temozolomide|temozolomide|mesh-list
56206985|NCT03710590|Nicotine|nicotine|mesh-list
56459110|NCT00431561|Lomustine|lomustine|mesh-list
56459112|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56459113|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
56459114|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459115|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459116|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
56459117|NCT00462189|Immunotoxins|immunotoxins|mesh-list
56459118|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
56459119|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459120|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459121|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
56459122|NCT00431678|Levofloxacin|levofloxacin|mesh-list
56459123|NCT00431678|Ofloxacin|ofloxacin|mesh-list
56459124|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
56459125|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56459126|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56459127|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459128|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56459129|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56459130|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459131|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459132|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459133|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56459134|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
56459135|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56459136|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459137|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56459138|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56459139|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56459140|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56459141|NCT00431678|Renal Agents|renal agents|mesh-ancestor
56459142|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56459143|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56459144|NCT00471003|Telmisartan|telmisartan|mesh-list
56459145|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56459146|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56459147|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56459148|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459149|NCT00471042|Buprenorphine|buprenorphine|mesh-list
56459150|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56459151|NCT00471042|Narcotics|narcotics|mesh-ancestor
56459152|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459153|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459154|NCT00471042|Analgesics|analgesics|mesh-ancestor
56459155|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
56459156|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459157|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56459158|NCT00462540|Bromides|bromides|mesh-list
56459159|NCT00462540|Albuterol|albuterol|mesh-list
56459160|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
56459161|NCT00462540|Ipratropium|ipratropium|mesh-list
56459162|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56459163|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
56459164|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459165|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459166|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56459167|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
56459168|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56459169|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56459170|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56459171|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
56459172|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459173|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459174|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
56459175|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
56459176|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56459179|NCT04703465|Tenofovir|tenofovir|mesh-list
56459180|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
56459181|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459182|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56459183|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56916537|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916538|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
56916539|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459184|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459185|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459186|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56459187|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56459188|NCT00471159|Docetaxel|docetaxel|mesh-list
56459189|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459190|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
56459191|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
56459192|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
56459193|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459194|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56459195|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
56459196|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56459197|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56459198|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56459199|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459200|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459201|NCT00431795|Doxorubicin|doxorubicin|mesh-list
56459202|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56459203|NCT00431795|Epirubicin|epirubicin|mesh-list
56459204|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56459205|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459206|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56459207|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56459208|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459209|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459210|NCT00462657|Dimercaprol|dimercaprol|mesh-list
56459211|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
56459212|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
56459213|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459214|NCT00431990|Dexamethasone|dexamethasone|mesh-list
56459215|NCT00431990|Bortezomib|bortezomib|mesh-list
56459216|NCT00431990|Romidepsin|romidepsin|mesh-list
56459217|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56459218|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
56459219|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
56459220|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459221|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459222|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56459223|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
56459224|NCT00431990|Hormones|hormones|mesh-ancestor
56459225|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459226|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56459227|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459228|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56459229|NCT00462696|Docetaxel|docetaxel|mesh-list
56459230|NCT00462696|Epirubicin|epirubicin|mesh-list
56459231|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459232|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
56459233|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
56459234|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
56459235|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459236|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56459237|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56459238|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56459239|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459240|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56459241|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56459242|NCT00462813|Protective Agents|protective agents|mesh-ancestor
56459243|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459244|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459245|NCT01052012|Bupivacaine|bupivacaine|mesh-list
56459246|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
56459247|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
56459248|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459249|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459250|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
56459253|NCT00462852|Dalteparin|dalteparin|mesh-list
56459254|NCT00462852|Tinzaparin|tinzaparin|mesh-list
56459255|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56916540|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
56916541|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
56916542|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916543|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56916544|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56916545|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56916546|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56916547|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56916548|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56916549|NCT00830206|Azithromycin|azithromycin|mesh-list
56916550|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56916551|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916552|NCT04464070|Aspirin|aspirin|mesh-list
56916553|NCT04464070|Niacin|niacin|mesh-list
56459256|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56459257|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
56459258|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459259|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459260|NCT00462852|Antiviral Agents|antiviral agents|mesh-ancestor
56459261|NCT00462852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459262|NCT00462852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459263|NCT00462852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459264|NCT00462852|Immunologic Factors|immunologic factors|mesh-ancestor
56459265|NCT00462852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459266|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
56459267|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56459268|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56459269|NCT00471393|Diclofenac|diclofenac|mesh-list
56459270|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56459271|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56459272|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56459273|NCT00471393|Analgesics|analgesics|mesh-ancestor
56459274|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
56459275|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459276|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459277|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56459278|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56459279|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56459280|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459281|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459282|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56459283|NCT00471393|Protective Agents|protective agents|mesh-ancestor
56459284|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56459285|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
56459286|NCT00432068|Octreotide|octreotide|mesh-list
56459287|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56459288|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56459289|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459290|NCT03273231|Ketamine|ketamine|mesh-list
56459291|NCT03273231|Analgesics|analgesics|mesh-ancestor
56459292|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
56459293|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459294|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459295|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56459296|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56459297|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
56459298|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
56459299|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459300|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56459301|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56459302|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459303|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916554|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56916555|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56916556|NCT04464070|Analgesics|analgesics|mesh-ancestor
56916557|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
56916558|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177118|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
56459304|NCT00432146|Lugol's solution|lugol's solution|mesh-list
56459305|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
56459306|NCT00432146|Coagulants|coagulants|mesh-ancestor
56459307|NCT00432302|Sagopilone|sagopilone|mesh-list
56459308|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459310|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56459311|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
56459312|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56459313|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459314|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56459315|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
56459316|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459317|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459318|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
56459319|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459320|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56459321|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459322|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
56459323|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56459324|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56459325|NCT00471432|Docetaxel|docetaxel|mesh-list
56459330|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459332|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
56459333|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56459334|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459335|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56459336|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56459337|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
56459338|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459339|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56459340|NCT02957435|Eplerenone|eplerenone|mesh-list
56459341|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56459342|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
56459343|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459344|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459345|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56459346|NCT02957435|Diuretics|diuretics|mesh-ancestor
56459347|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
56459348|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56459349|NCT00471471|Sargramostim|sargramostim|mesh-list
56459350|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
56459351|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459352|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56459353|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56459354|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56459355|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
56459356|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459357|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459358|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56459359|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56459360|NCT00463203|Bevacizumab|bevacizumab|mesh-list
56459361|NCT00463203|Irinotecan|irinotecan|mesh-list
56459362|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56459363|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459364|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56459365|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56459366|NCT00463203|Growth Substances|growth substances|mesh-ancestor
56459367|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459368|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
56459369|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56459370|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56916559|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916560|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916561|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56459371|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459372|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459373|NCT00471549|Simvastatin|simvastatin|mesh-list
56459374|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56459375|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56459376|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
56459377|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459378|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56459379|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56459380|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459381|NCT00432575|Surinabant|surinabant|mesh-list
56459382|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56459383|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56459384|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459385|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459386|NCT00432575|Hormones|hormones|mesh-ancestor
56459387|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459388|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459389|NCT00432614|Citalopram|citalopram|mesh-list
56459390|NCT00432614|Amibegron|amibegron|mesh-list
56459391|NCT00432614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56459392|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55785994|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
56459394|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459395|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459396|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
56459397|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459398|NCT00432614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56459399|NCT00432614|Antidepressive Agents|antidepressive agents|mesh-ancestor
56459400|NCT00432614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56459401|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56459402|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56459403|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
56459404|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56459405|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56459406|NCT00432653|Rituximab|rituximab|mesh-list
56459407|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56207288|NCT01564095|Tryptophan|tryptophan|mesh-list
56459408|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459409|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
56459410|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459411|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56459412|NCT00471588|Pramipexole|pramipexole|mesh-list
56459413|NCT00471588|Amisulpride|amisulpride|mesh-list
56459414|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
56459415|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459416|NCT00471588|Protective Agents|protective agents|mesh-ancestor
56459417|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459418|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56459419|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56459420|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
56459421|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
56459422|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459423|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56459424|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56459425|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459426|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56459427|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56459428|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56459429|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
56459430|NCT00463359|Imiquimod|imiquimod|mesh-list
56459431|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56459432|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
56459433|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459434|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459435|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
56459436|NCT00471627|Pancrelipase|pancrelipase|mesh-list
56459437|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56459438|NCT00432887|Caffeine|caffeine|mesh-list
56916562|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56459439|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56459440|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459441|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56459442|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459443|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459444|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56459445|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56459446|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
56459447|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459448|NCT00471744|Levetiracetam|levetiracetam|mesh-list
56459449|NCT00471744|Sulthiame|sulthiame|mesh-list
56459450|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
56459451|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
56459452|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
56459453|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56459454|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459455|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
56459456|NCT00463515|Gemcitabine|gemcitabine|mesh-list
56459457|NCT00463515|Carboplatin|carboplatin|mesh-list
56459458|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459459|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56459460|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
56459461|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459462|NCT00463515|Antiviral Agents|antiviral agents|mesh-ancestor
56459463|NCT00463515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459464|NCT00463515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459465|NCT00463515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459466|NCT00463515|Immunologic Factors|immunologic factors|mesh-ancestor
56459468|NCT00433043|Metoprolol|metoprolol|mesh-list
56459469|NCT00433043|Carvedilol|carvedilol|mesh-list
56459470|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56459471|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56459472|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56459473|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
56459474|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
56459475|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459476|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459477|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56459478|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56207364|NCT01566890|Regadenoson|regadenoson|mesh-list
56459479|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
56459480|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459481|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459482|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
56459483|NCT00433043|Protective Agents|protective agents|mesh-ancestor
56459484|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56459485|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56459486|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56459487|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
56459488|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56459489|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56459490|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
56459491|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
56459492|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56459493|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56459494|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459495|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459496|NCT04697862|Urological Agents|urological agents|mesh-ancestor
56459497|NCT03273075|Ticagrelor|ticagrelor|mesh-list
56459498|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56459499|NCT03273075|Cangrelor|cangrelor|mesh-list
56459500|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56459501|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56459502|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56459503|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56459504|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
56459505|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459506|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459507|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459508|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56459509|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56459510|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
56055326|NCT02101853|Asparaginase|asparaginase|mesh-list
56916563|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56916564|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459511|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459512|NCT01051661|Vaccines|vaccines|mesh-list
56459513|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
56459514|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459515|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56459516|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56459517|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56459518|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56459519|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459520|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459521|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459522|NCT01051466|Analgesics|analgesics|mesh-ancestor
56459523|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
56459524|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459525|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
56459526|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56459527|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
56459528|NCT04446793|Bevacizumab|bevacizumab|mesh-list
56459529|NCT04446793|Onvansertib|onvansertib|mesh-list
56459530|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56459531|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459532|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56459533|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56459534|NCT04446793|Growth Substances|growth substances|mesh-ancestor
56459535|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459536|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
56459537|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56459539|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459540|NCT01051349|Daclizumab|daclizumab|mesh-list
56459541|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459542|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
56459543|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459544|NCT00433121|Olanzapine|olanzapine|mesh-list
56459545|NCT00433121|Risperidone|risperidone|mesh-list
56459546|NCT00433121|Citalopram|citalopram|mesh-list
56459547|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56459548|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
56459549|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459550|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459551|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459552|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56459553|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56459554|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459555|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207443|NCT01570088|Folic Acid|folic acid|mesh-list
56459556|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56459557|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
56459558|NCT00433121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56459559|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56459560|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56459561|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56459562|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
56459563|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
56459564|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459565|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
56459566|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56459567|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
56459568|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56459569|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
56459570|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459571|NCT00463671|Expectorants|expectorants|mesh-ancestor
56459572|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
56459573|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56459574|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
56459575|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459576|NCT00463671|Protective Agents|protective agents|mesh-ancestor
56459577|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459578|NCT00463671|Antidotes|antidotes|mesh-ancestor
56459579|NCT00591526|Cytarabine|cytarabine|mesh-list
56459580|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56916565|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56916566|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56916567|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916568|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
56916569|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56916570|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
56916571|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56916572|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
56916573|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
56916574|NCT04464070|Vitamins|vitamins|mesh-ancestor
56916575|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
56916576|NCT00829504|Ropinirole|ropinirole|mesh-list
56916577|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56916578|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56916579|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
56916580|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
56916581|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916582|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916583|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459581|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
56459582|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459583|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459584|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
56459585|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459586|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459587|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
56459588|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459589|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
56459590|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56459591|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
56459592|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459593|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459595|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459596|NCT00433277|Cyclosporine|cyclosporine|mesh-list
56459597|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56459598|NCT00433277|Cyclosporins|cyclosporins|mesh-list
56459599|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459600|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459601|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459602|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
56459603|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459604|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
56459605|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459606|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
56459607|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56459608|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56459609|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56459610|NCT00463827|Atorvastatin|atorvastatin|mesh-list
56459611|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56459612|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56459613|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
56459616|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56459618|NCT00433316|Ropivacaine|ropivacaine|mesh-list
56459619|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
56459620|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
56459621|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459622|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459623|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
56916584|NCT00829426|Alprazolam|alprazolam|mesh-list
56916585|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56459624|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459625|NCT00472134|Bupivacaine|bupivacaine|mesh-list
56459626|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
56459627|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
56459628|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459629|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459630|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
56207506|NCT01570582|Gemcitabine|gemcitabine|mesh-list
56459631|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459632|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56459633|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56459634|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459636|NCT03270969|Emtricitabine|emtricitabine|mesh-list
56459637|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
56459638|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459639|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56459640|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56459641|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459642|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459643|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56459644|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56459645|NCT00463983|Octreotide|octreotide|mesh-list
56459646|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56459647|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56459648|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459649|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
56459650|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56459651|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56459652|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
56459653|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459654|NCT00472173|Calcium|calcium|mesh-list
56459655|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56459656|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459657|NCT00472329|Fludarabine|fludarabine|mesh-list
56459658|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459659|NCT00464217|Idarubicin|idarubicin|mesh-list
56459660|NCT00464217|Molgramostim|molgramostim|mesh-list
56459661|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56459662|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459663|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56459664|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56459665|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459666|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459667|NCT00433784|Clopidogrel|clopidogrel|mesh-list
56459668|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56459669|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56459670|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56459671|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56459672|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
56459673|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459674|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459675|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459676|NCT00464256|Rimonabant|rimonabant|mesh-list
56459677|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56459678|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56459679|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56459680|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459681|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459682|NCT00464256|Hormones|hormones|mesh-ancestor
56459683|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459685|NCT00433823|Atorvastatin|atorvastatin|mesh-list
56459686|NCT00433823|Ezetimibe|ezetimibe|mesh-list
56459687|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56459688|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56459689|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
56459690|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459691|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56459692|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56459693|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459694|NCT00464295|Capecitabine|capecitabine|mesh-list
56916586|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459695|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56459696|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
56459697|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459698|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459699|NCT03273036|Triamcinolone|triamcinolone|mesh-list
56459700|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56459701|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
56459702|NCT03273036|Hormones|hormones|mesh-ancestor
56459703|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459704|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459705|NCT03270735|Thrombin|thrombin|mesh-list
56459706|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
56459707|NCT03270735|Coagulants|coagulants|mesh-ancestor
56459708|NCT04702685|Ropivacaine|ropivacaine|mesh-list
56459709|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
56459710|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
56459711|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459712|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459713|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
56459714|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459715|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
56459716|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56459717|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56459718|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56459719|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56459720|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459721|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
56459722|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459723|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459724|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56459725|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459726|NCT00472368|Panobinostat|panobinostat|mesh-list
56459727|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459728|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56459729|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459730|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459731|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
56459732|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56459733|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56459734|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459735|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56459736|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459737|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56459738|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
56459739|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
56459740|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56459741|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459742|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459743|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56459744|NCT00464451|Analgesics|analgesics|mesh-ancestor
56459745|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
56459746|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459747|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56459748|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56459749|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56459750|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
56459751|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459752|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459753|NCT00433940|Prednisolone|prednisolone|mesh-list
56459754|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56459755|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
56459756|NCT00433940|Hormones|hormones|mesh-ancestor
56459757|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459758|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459759|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56459760|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459761|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56459762|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
56459763|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459764|NCT01050764|Vidarabine|vidarabine|mesh-list
56459765|NCT01050764|Fludarabine|fludarabine|mesh-list
56916587|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916588|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56916589|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56916590|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56916591|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
56916592|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
56916593|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916594|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916595|NCT00152464|Levocetirizine|levocetirizine|mesh-list
56177623|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56459766|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
56459767|NCT01050764|Melphalan|melphalan|mesh-list
56459768|NCT01050764|Thiotepa|thiotepa|mesh-list
56459769|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
56459770|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56459771|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459772|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56459773|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
56459774|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459775|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459776|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
56459777|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459778|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
56459779|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459780|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56459781|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
56459782|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56459783|NCT00434096|Rimonabant|rimonabant|mesh-list
56459784|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56459785|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56459786|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56459787|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459788|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459789|NCT00434096|Hormones|hormones|mesh-ancestor
56459790|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459791|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459792|NCT01050569|Nicotine|nicotine|mesh-list
56459793|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56459794|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
56459795|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459796|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459797|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56459798|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56459799|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
56459800|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459801|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459802|NCT04702490|Empagliflozin|empagliflozin|mesh-list
56459803|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56459804|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459805|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56459806|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459807|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
56459808|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56459809|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459810|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459811|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56459812|NCT00464763|Analgesics|analgesics|mesh-ancestor
56459813|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
56459814|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459815|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56459816|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56459817|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56459818|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
56459819|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916596|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56916597|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56916598|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
56916599|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
56916600|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916601|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916602|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916603|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
56916604|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56916605|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56916606|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177690|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56177691|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56459820|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459821|NCT00434135|Gemcitabine|gemcitabine|mesh-list
56459822|NCT00434135|Paclitaxel|paclitaxel|mesh-list
56459823|NCT00434135|Pemetrexed|pemetrexed|mesh-list
56459824|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56459825|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459826|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
56459827|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
56459828|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
56459829|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459832|NCT00434135|Antiviral Agents|antiviral agents|mesh-ancestor
56459833|NCT00434135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459834|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459835|NCT00434135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459836|NCT00434135|Immunologic Factors|immunologic factors|mesh-ancestor
56459837|NCT00434135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459838|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56459839|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56459840|NCT01050530|Tolvaptan|tolvaptan|mesh-list
56459841|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56459842|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459843|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
56459844|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459845|NCT01050257|Oseltamivir|oseltamivir|mesh-list
56459846|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
56459847|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56459848|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459849|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459850|NCT03272802|Riluzole|riluzole|mesh-list
56459851|NCT03272802|Edaravone|edaravone|mesh-list
56459852|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
56459853|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56459854|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56459855|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459856|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459857|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459858|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56459859|NCT03272802|Protective Agents|protective agents|mesh-ancestor
56459860|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56459861|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
56459862|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56459863|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56459864|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56459865|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56459866|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916607|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916608|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
56916609|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916610|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56916611|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56916612|NCT04472806|Endostar protein|endostar protein|mesh-list
56916613|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56916614|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56916615|NCT04472806|Growth Substances|growth substances|mesh-ancestor
56916616|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916617|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
56916618|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177755|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56177756|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56177757|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56213187|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56177758|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177759|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56177760|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56177762|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56177763|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56177764|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56177765|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
56177766|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177767|NCT04690686|Paclitaxel|paclitaxel|mesh-list
56177768|NCT04690686|Atezolizumab|atezolizumab|mesh-list
56177769|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56177770|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177771|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
56177772|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
56177773|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
56177776|NCT04682626|Vitamin D|vitamin d|mesh-list
56459867|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459868|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459869|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
56459870|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56459871|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56459872|NCT01050062|Telmisartan|telmisartan|mesh-list
56459873|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56459874|NCT01050062|Diuretics|diuretics|mesh-ancestor
56459875|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
56459876|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916619|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56916620|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
56916621|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459877|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56459878|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56459879|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459880|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56459881|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56459882|NCT00464919|Sorafenib|sorafenib|mesh-list
56459884|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459885|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56459886|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459887|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459888|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56459889|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
56459890|NCT00434174|Pemetrexed|pemetrexed|mesh-list
56459891|NCT00434174|Everolimus|everolimus|mesh-list
56459892|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459893|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459894|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459895|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56459896|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56459897|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56459898|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
56459899|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459900|NCT00464958|Tizanidine|tizanidine|mesh-list
56459901|NCT00464958|Analgesics|analgesics|mesh-ancestor
56459906|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56459907|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56459908|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
56459909|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
56459910|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56459911|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56459912|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56459913|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
56459914|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56459915|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459916|NCT00472758|Sifalimumab|sifalimumab|mesh-list
56459917|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
56459918|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459919|NCT01055444|Lidocaine|lidocaine|mesh-list
56459920|NCT01055444|Tetracaine|tetracaine|mesh-list
56459921|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
56459922|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
56459923|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207819|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
56459924|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459925|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
56459926|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459927|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56459928|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56459929|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56459930|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56459931|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459932|NCT01055015|Morphine|morphine|mesh-list
56459933|NCT01055015|Oxycodone|oxycodone|mesh-list
56459934|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56459935|NCT01055015|Narcotics|narcotics|mesh-ancestor
56459936|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459937|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459938|NCT01055015|Analgesics|analgesics|mesh-ancestor
56459939|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
56459940|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459941|NCT00472875|Glyburide|glyburide|mesh-list
56459942|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56459943|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459944|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
56459945|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56459946|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459947|NCT00472953|Insulin|insulin|mesh-list
56459948|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56459949|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
56916622|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916623|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916624|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56916625|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
56916626|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56916627|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56916628|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56916629|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56916630|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916631|NCT00770848|Prednisone|prednisone|mesh-list
56916632|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
56916633|NCT00770848|Rilotumumab|rilotumumab|mesh-list
56916634|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56916635|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916636|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
56916637|NCT00770848|Hormones|hormones|mesh-ancestor
56916638|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916639|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916640|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56916641|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916642|NCT00770848|Analgesics|analgesics|mesh-ancestor
56916643|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
56916644|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916645|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56916646|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56916647|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177895|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56459950|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56459951|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459952|NCT02957630|Drospirenone|drospirenone|mesh-list
56459953|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
56459954|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56459955|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56459956|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
56459957|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56459958|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459959|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56459960|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56459961|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56459962|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56459963|NCT02957630|Estrogens|estrogens|mesh-ancestor
56459964|NCT02957630|Hormones|hormones|mesh-ancestor
56459965|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459966|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56459967|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
56459968|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56459969|NCT02957630|Diuretics|diuretics|mesh-ancestor
56459970|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
56916648|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916649|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56916650|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
56916651|NCT00672412|Lamivudine|lamivudine|mesh-list
56916652|NCT00672412|Zidovudine|zidovudine|mesh-list
56916653|NCT00672412|Nevirapine|nevirapine|mesh-list
56916654|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56916655|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56916656|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916657|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916658|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
56916659|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916660|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56459971|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56459974|NCT04702061|Anesthetics|anesthetics|mesh-list
56459975|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56459976|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459977|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
56459978|NCT00465075|Estrogens|estrogens|mesh-list
56459979|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56459980|NCT00465075|Hormones|hormones|mesh-ancestor
56459981|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459982|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459983|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56459984|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56459985|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
56459986|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56459987|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56459988|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56459989|NCT00465192|Estradiol|estradiol|mesh-list
56459990|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56459991|NCT00465192|Estrogens|estrogens|mesh-ancestor
56459992|NCT00465192|Hormones|hormones|mesh-ancestor
56459993|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56459994|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459995|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56459996|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
56459997|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56459998|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56459999|NCT00434681|Acetaminophen|acetaminophen|mesh-list
56460000|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56460001|NCT00434681|Analgesics|analgesics|mesh-ancestor
56460002|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
56460003|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460004|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460005|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
56460006|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56460007|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460008|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56460009|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460010|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
56460011|NCT00473070|Hormones|hormones|mesh-ancestor
56460012|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460013|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460014|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56460015|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56460016|NCT00465231|Fentanyl|fentanyl|mesh-list
56460017|NCT00465231|Bupivacaine|bupivacaine|mesh-list
56460018|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
56460019|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
56460020|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055327|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
56916661|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56916662|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
56916663|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56916664|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56916665|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
56460021|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460022|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
56460023|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460024|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56460025|NCT00465231|Narcotics|narcotics|mesh-ancestor
56460026|NCT00465231|Analgesics|analgesics|mesh-ancestor
56460027|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56460028|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56460029|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
56460030|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56460031|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
56460032|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460033|NCT04702334|Lidocaine|lidocaine|mesh-list
56460034|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
56460035|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
56460036|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
56460037|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460038|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460039|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
56460040|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460041|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56460042|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56460043|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56460044|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460049|NCT04702334|Protective Agents|protective agents|mesh-ancestor
56460050|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
56460051|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56460052|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56460053|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460054|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56460055|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56460056|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460057|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460058|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460059|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56460060|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
56460061|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56460062|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460063|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56460064|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56460065|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56460066|NCT00435305|Vancomycin|vancomycin|mesh-list
56460067|NCT00435305|Meropenem|meropenem|mesh-list
56460068|NCT00435305|Tazobactam|tazobactam|mesh-list
56460069|NCT00435305|Linezolid|linezolid|mesh-list
56460070|NCT00435305|Piperacillin|piperacillin|mesh-list
56460071|NCT00435305|Ceftazidime|ceftazidime|mesh-list
56460072|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56460073|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56460074|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460075|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56460076|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460077|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460078|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56460080|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56460081|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56460082|NCT00465543|Analgesics|analgesics|mesh-ancestor
56460083|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
56460084|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460085|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460086|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460087|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56460088|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
56460089|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916666|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
56916667|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56916668|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56460090|NCT00465543|Protective Agents|protective agents|mesh-ancestor
56460091|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56460092|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56460093|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
56460094|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460095|NCT00435500|Fluorides|fluorides|mesh-list
56460096|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
56460097|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
56460098|NCT00435500|Protective Agents|protective agents|mesh-ancestor
56460099|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460100|NCT03272412|Progesterone|progesterone|mesh-list
56460101|NCT03272412|Progestins|progestins|mesh-ancestor
56460102|NCT03272412|Hormones|hormones|mesh-ancestor
56460103|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460104|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460105|NCT00473616|Irinotecan|irinotecan|mesh-list
56460106|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56460107|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56460108|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460109|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460110|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460111|NCT00435851|Hormones|hormones|mesh-list
56460112|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460113|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460114|NCT00436124|Oseltamivir|oseltamivir|mesh-list
56460115|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
56460118|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460119|NCT02957474|Omeprazole|omeprazole|mesh-list
56460120|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56460121|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56460122|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56460123|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460124|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460125|NCT00436241|Capecitabine|capecitabine|mesh-list
56460126|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
56460127|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56460128|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
56460129|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460130|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460131|NCT00481455|Temozolomide|temozolomide|mesh-list
56460132|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
56460133|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56460134|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
56460135|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460136|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460137|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
56460138|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
56460139|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
56460140|NCT00481533|Oxytocin|oxytocin|mesh-list
56460141|NCT00481533|Ergonovine|ergonovine|mesh-list
56460142|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
56460143|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56460144|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460145|NCT00481572|Terlipressin|terlipressin|mesh-list
56460146|NCT00481572|Vasopressins|vasopressins|mesh-list
56460147|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
56460148|NCT00481572|Norepinephrine|norepinephrine|mesh-list
56460149|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56460150|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56460151|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
56460152|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460153|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460154|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460156|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
56460157|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460158|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56460159|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
56460160|NCT00481572|Coagulants|coagulants|mesh-ancestor
56460161|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56460162|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
56916669|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916670|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460163|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56460164|NCT00474006|Daunorubicin|daunorubicin|mesh-list
56460165|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56460166|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460167|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56460168|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56460169|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460170|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460171|NCT04697745|Dexamethasone|dexamethasone|mesh-list
56460172|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
56460173|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460174|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
56460175|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
56460176|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460177|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460178|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56460179|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
56460180|NCT04697745|Hormones|hormones|mesh-ancestor
56460181|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460182|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56460183|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460184|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56460185|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460186|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56460187|NCT04697745|Analgesics|analgesics|mesh-ancestor
56460188|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
56460189|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56460190|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56460194|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460195|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
56460196|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56460197|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460198|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56460199|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56460200|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460201|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460202|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460203|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56460204|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56460205|NCT00436709|Paclitaxel|paclitaxel|mesh-list
56460206|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
56460207|NCT00436709|Bevacizumab|bevacizumab|mesh-list
56460208|NCT00436709|Doxorubicin|doxorubicin|mesh-list
56460209|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56460210|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56460211|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56460212|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460213|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
56460214|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
56460215|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
56460216|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460217|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56460218|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
56460219|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460220|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56460221|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56460222|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
56460223|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56460224|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56460226|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56460227|NCT00436709|Growth Substances|growth substances|mesh-ancestor
56460228|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
56460229|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56460230|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56460231|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56460232|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460234|NCT00436787|Fondaparinux|fondaparinux|mesh-list
56460235|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56460236|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
56916671|NCT01315262|Urological Agents|urological agents|mesh-ancestor
56916672|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
56916673|NCT03197324|Digoxin|digoxin|mesh-list
56916674|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56916675|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56460237|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56460238|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
56460239|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460240|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460241|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
56460242|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56460243|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56460244|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56460245|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56460246|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56460247|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
56460248|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460249|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460250|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460251|NCT00481728|Urological Agents|urological agents|mesh-ancestor
56460252|NCT00436943|Bupropion|bupropion|mesh-list
56460253|NCT00436943|Nicotine|nicotine|mesh-list
56460254|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56460255|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
56460256|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460257|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460258|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56460259|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56460260|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
56460261|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460262|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460263|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56460267|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56460268|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460270|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56460271|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56460272|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460273|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56460274|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
56460275|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
56460276|NCT00481884|Petrolatum|petrolatum|mesh-list
56460277|NCT00481884|Emollients|emollients|mesh-ancestor
56460278|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
56460279|NCT00481923|Rimonabant|rimonabant|mesh-list
56460280|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56460281|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56460282|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56460283|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460284|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460285|NCT00481923|Hormones|hormones|mesh-ancestor
56460286|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460287|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460288|NCT00481962|Tigecycline|tigecycline|mesh-list
56460289|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56460290|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460291|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56460292|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460293|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460294|NCT00437177|Apomorphine|apomorphine|mesh-list
56460295|NCT00437177|Emetics|emetics|mesh-ancestor
56460296|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460297|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
56460298|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460299|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56460300|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
56460301|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
56460302|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460303|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460304|NCT00437333|Metformin|metformin|mesh-list
56460305|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916676|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916677|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460306|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460307|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56460308|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56460309|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460310|NCT00482079|Incretins|incretins|mesh-ancestor
56460311|NCT00482079|Hormones|hormones|mesh-ancestor
56460312|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460313|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56460314|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
56460315|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460316|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460317|NCT00437372|Sunitinib|sunitinib|mesh-list
56460318|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460319|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56460320|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56460321|NCT00437372|Growth Substances|growth substances|mesh-ancestor
56460322|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460323|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
56460324|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56460325|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460326|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460327|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
56460328|NCT00437450|Hematinics|hematinics|mesh-ancestor
56460329|NCT04701710|Ivermectin|ivermectin|mesh-list
56460330|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56460331|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460332|NCT00437606|Ethanol|ethanol|mesh-list
56460333|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56460334|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460340|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56460341|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56460342|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460343|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460344|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
56460345|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460346|NCT00437684|Ribavirin|ribavirin|mesh-list
56460347|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56460348|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
56460349|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460350|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
56460351|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460352|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
56460353|NCT00437723|Hematinics|hematinics|mesh-ancestor
56460354|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
56460355|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56460356|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56460357|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56460358|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460359|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460360|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
56460361|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460362|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460363|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56460364|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460365|NCT00482508|Omalizumab|omalizumab|mesh-list
56460366|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56460367|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56460368|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
56460369|NCT00437918|Acarbose|acarbose|mesh-list
56460370|NCT00437918|Nateglinide|nateglinide|mesh-list
56460371|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56208262|NCT01575483|Saxagliptin|saxagliptin|mesh-list
56460372|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460373|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460374|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56460375|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460376|NCT00437957|Temozolomide|temozolomide|mesh-list
56460377|NCT00437957|Valproic Acid|valproic acid|mesh-list
56460378|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56460379|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
56055328|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
56916678|NCT03197324|Protective Agents|protective agents|mesh-ancestor
56916679|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178356|NCT03141671|Hormones|hormones|mesh-ancestor
56460380|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460381|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460382|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
56460383|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460384|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
56460385|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460386|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460387|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
56460388|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56460389|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460390|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56460391|NCT03270176|Avelumab|avelumab|mesh-list
56460392|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56460393|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460394|NCT00474279|Hormones|hormones|mesh-list
56460395|NCT00474279|Secretagogues|secretagogues|mesh-list
56460396|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460397|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460398|NCT03270696|Propofol|propofol|mesh-list
56460399|NCT03270696|Rocuronium|rocuronium|mesh-list
56460400|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56460401|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460402|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460407|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56460408|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56460409|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460410|NCT00437996|Clonidine|clonidine|mesh-list
56460411|NCT00437996|Sufentanil|sufentanil|mesh-list
56460412|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
56460413|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56460414|NCT00437996|Narcotics|narcotics|mesh-ancestor
56460415|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460416|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460417|NCT00437996|Analgesics|analgesics|mesh-ancestor
56460418|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
56460419|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460420|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56460421|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56460422|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
56460423|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
56460424|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56460425|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
56460426|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
56460427|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56460428|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56460429|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56460430|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56460431|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460432|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460433|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
56460434|NCT04701242|Ezetimibe|ezetimibe|mesh-list
56460435|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56460436|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56460437|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
56460438|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460439|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56460440|NCT00474435|Tenofovir|tenofovir|mesh-list
56460441|NCT00474435|Emtricitabine|emtricitabine|mesh-list
56460442|NCT00474435|Efavirenz|efavirenz|mesh-list
56460443|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
56460444|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208397|NCT01576627|Zinc|zinc|mesh-list
56460445|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56460446|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56460447|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460448|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460449|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56460450|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56460451|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56460452|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56055329|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
56916680|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56460453|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56460454|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56460455|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56460456|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56460457|NCT04701320|Methamphetamine|methamphetamine|mesh-list
56460458|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56460459|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460460|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
56460461|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
56460462|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460463|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
56460464|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460465|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460466|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
56460467|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56460468|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56460469|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460470|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56460471|NCT00438113|Atenolol|atenolol|mesh-list
56460472|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56460481|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56460482|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
56460483|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
56460484|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460485|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56460486|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56460487|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56460488|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
56460489|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460490|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56460491|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56460492|NCT00438113|Urological Agents|urological agents|mesh-ancestor
56460493|NCT00438152|Ritonavir|ritonavir|mesh-list
56460494|NCT00438152|Lopinavir|lopinavir|mesh-list
56460495|NCT00438152|Saquinavir|saquinavir|mesh-list
56460496|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56460497|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56460498|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
56460499|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460500|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460501|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56460502|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56460503|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
56460504|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460505|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56460506|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56460507|NCT00438230|Warfarin|warfarin|mesh-list
56460508|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
56460509|NCT00438269|Metronidazole|metronidazole|mesh-list
56460510|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
56460511|NCT00438269|Meropenem|meropenem|mesh-list
56460512|NCT00438269|Cefazolin|cefazolin|mesh-list
56460513|NCT00438269|Tazobactam|tazobactam|mesh-list
56460514|NCT00438269|Piperacillin|piperacillin|mesh-list
56460515|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56460516|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460517|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56460518|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56460519|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56460520|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56208403|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
56460521|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56460522|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460523|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460524|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460525|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56460526|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56460527|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56460529|NCT00474591|Fondaparinux|fondaparinux|mesh-list
56460530|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56460531|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
56460532|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56460533|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
56916681|NCT01330706|Polihexanide|polihexanide|mesh-list
56916682|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
56916683|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916684|NCT01156220|Furosemide|furosemide|mesh-list
56460534|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460535|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460536|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
56460537|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56460538|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56460539|NCT00474669|Docetaxel|docetaxel|mesh-list
56460540|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460541|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56460547|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56460549|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
56460550|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460551|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460552|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460553|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56460554|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56460555|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56460556|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460557|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56460558|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56460559|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460560|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
56460561|NCT00438386|Aripiprazole|aripiprazole|mesh-list
56460562|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
56460563|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56460564|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56460565|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56460566|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460567|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460568|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
56460569|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
56460570|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460571|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460572|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56460573|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56460574|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
56460575|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56460576|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56460577|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56460578|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56460580|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56460581|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56460582|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56460583|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
56460584|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
56460585|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460586|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460587|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460588|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56460589|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56460590|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460591|NCT00475098|Tinzaparin|tinzaparin|mesh-list
56460592|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56460593|NCT00475098|Dalteparin|dalteparin|mesh-list
56460594|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
56460595|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56460596|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56460597|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460598|NCT00475137|Lamotrigine|lamotrigine|mesh-list
56460599|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
56460600|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56460601|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460602|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460603|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56460604|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460605|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56460606|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56055330|NCT02101853|Pegaspargase|pegaspargase|mesh-list
56916685|NCT01156220|Diuretics|diuretics|mesh-ancestor
56916686|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
56460607|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460608|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56460609|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56460616|NCT00438737|Leucovorin|leucovorin|mesh-list
56460617|NCT00438737|Bevacizumab|bevacizumab|mesh-list
56460618|NCT00438737|Cetuximab|cetuximab|mesh-list
56460619|NCT00438737|Fluorouracil|fluorouracil|mesh-list
56460620|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
56460621|NCT00438737|Calcium|calcium|mesh-list
56460622|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
56460623|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56460624|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460625|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56460626|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56460627|NCT00438737|Growth Substances|growth substances|mesh-ancestor
56460628|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460629|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
56460630|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56460631|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
56460632|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460633|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56460634|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56460635|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
56460636|NCT00438737|Antidotes|antidotes|mesh-ancestor
56460637|NCT00438737|Protective Agents|protective agents|mesh-ancestor
56460638|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
56460639|NCT00438737|Vitamins|vitamins|mesh-ancestor
56460640|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
56460641|NCT00438776|Olanzapine|olanzapine|mesh-list
56460642|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
56460643|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
56460644|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460645|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460646|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56460647|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56460648|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56460649|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460650|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56460651|NCT00438776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56460652|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56460653|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460654|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460655|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460656|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
56460657|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56460658|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
56460659|NCT00475410|Coagulants|coagulants|mesh-ancestor
56460660|NCT00475527|Amoxicillin|amoxicillin|mesh-list
56460661|NCT00475527|Metronidazole|metronidazole|mesh-list
56460662|NCT00475527|Clarithromycin|clarithromycin|mesh-list
56460663|NCT00475527|Omeprazole|omeprazole|mesh-list
56460664|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56460665|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460666|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56208552|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460667|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56460668|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56460669|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56460670|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56460671|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460672|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460673|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56460674|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56460675|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56460677|NCT00439049|Modafinil|modafinil|mesh-list
56460678|NCT00439049|Amphetamine|amphetamine|mesh-list
56460679|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
56460680|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56460681|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56460683|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
56460684|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460685|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56460686|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56460687|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56916687|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916688|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56916689|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56916690|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916691|NCT03192488|Cetirizine|cetirizine|mesh-list
56916692|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56916693|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56916694|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56916695|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
56916696|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
56916697|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916698|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916699|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916700|NCT01642004|Docetaxel|docetaxel|mesh-list
56916701|NCT01642004|Nivolumab|nivolumab|mesh-list
56916702|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916703|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56916704|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56916705|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56916706|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916707|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56916708|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56916709|NCT03907826|Antibodies|antibodies|mesh-list
56916710|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
56916711|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
56916712|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916713|NCT00042289|Ritonavir|ritonavir|mesh-list
56916714|NCT00042289|Lopinavir|lopinavir|mesh-list
56916715|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56916716|NCT00042289|Darunavir|darunavir|mesh-list
56916717|NCT00042289|Nelfinavir|nelfinavir|mesh-list
56916718|NCT00042289|Indinavir|indinavir|mesh-list
56916719|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
56916720|NCT00042289|Amprenavir|amprenavir|mesh-list
56916721|NCT00042289|Tenofovir|tenofovir|mesh-list
56916722|NCT00042289|Emtricitabine|emtricitabine|mesh-list
56916723|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
56916724|NCT00042289|Nevirapine|nevirapine|mesh-list
56916725|NCT00042289|Maraviroc|maraviroc|mesh-list
56916727|NCT00042289|Abacavir|abacavir|mesh-list
56916728|NCT00042289|Didanosine|didanosine|mesh-list
56916729|NCT00042289|Cobicistat|cobicistat|mesh-list
56916730|NCT00042289|Rilpivirine|rilpivirine|mesh-list
56916731|NCT00042289|Tipranavir|tipranavir|mesh-list
56916732|NCT00042289|Elvitegravir|elvitegravir|mesh-list
56916733|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56916734|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
56916735|NCT00042289|Efavirenz|efavirenz|mesh-list
56916736|NCT00042289|Rifampin|rifampin|mesh-list
56916737|NCT00042289|Isoniazid|isoniazid|mesh-list
56916738|NCT00042289|Linezolid|linezolid|mesh-list
56916739|NCT00042289|Cycloserine|cycloserine|mesh-list
56916740|NCT00042289|Amikacin|amikacin|mesh-list
56916741|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
56460688|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56460689|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460690|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
56460691|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
56460692|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
56460693|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460694|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
56460695|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56460696|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56460697|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460698|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56460699|NCT00475566|Everolimus|everolimus|mesh-list
56460700|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460701|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56460702|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
56460703|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460704|NCT00439166|Doxycycline|doxycycline|mesh-list
56460705|NCT00439166|Rifampin|rifampin|mesh-list
56460706|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56460707|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460708|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
56460709|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56460710|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56460711|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56460712|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
56460713|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
56460714|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56460715|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460716|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460717|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56460718|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56460719|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56460720|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56460721|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56460722|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56460723|NCT00439283|Methotrexate|methotrexate|mesh-list
56460724|NCT00439283|Infliximab|infliximab|mesh-list
56460725|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56460726|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
56460727|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56460728|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460729|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56460730|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
56460731|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460732|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460733|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
56460734|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460735|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56460736|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56460737|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
56460738|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56916742|NCT00042289|Ethambutol|ethambutol|mesh-list
56916743|NCT00042289|Bedaquiline|bedaquiline|mesh-list
56916744|NCT00042289|Etravirine|etravirine|mesh-list
56460739|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56460740|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56460741|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
56460742|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56460743|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56460744|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460745|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460746|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56460747|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56460748|NCT00475800|Analgesics|analgesics|mesh-ancestor
56460749|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
56460750|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460751|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460752|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460755|NCT00439361|Etoposide|etoposide|mesh-list
56460756|NCT00439361|Bortezomib|bortezomib|mesh-list
56460757|NCT00439361|Ifosfamide|ifosfamide|mesh-list
56460758|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460759|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56460760|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56460761|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56460762|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460763|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460764|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56460765|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
56460766|NCT00475917|Gemcitabine|gemcitabine|mesh-list
56460767|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56460768|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
56460769|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460770|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460771|NCT00475917|Antiviral Agents|antiviral agents|mesh-ancestor
56460772|NCT00475917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460773|NCT00475917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460774|NCT00475917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56460775|NCT00475917|Immunologic Factors|immunologic factors|mesh-ancestor
56460776|NCT00475917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460777|NCT00439400|Doxycycline|doxycycline|mesh-list
56460778|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56460779|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460780|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
56460781|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56460782|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56460783|NCT00475956|Cediranib|cediranib|mesh-list
56460784|NCT00475956|Saracatinib|saracatinib|mesh-list
56460785|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460786|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56460787|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460788|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460789|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
56460790|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56460791|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56460792|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460793|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460794|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56460795|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56460796|NCT00476034|Analgesics|analgesics|mesh-ancestor
56460797|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
56460798|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460799|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460800|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460801|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56460802|NCT00476073|Fluticasone|fluticasone|mesh-list
56460804|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
56460805|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460806|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56460807|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
56460808|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460809|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460810|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56460811|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
56916745|NCT00042289|Clofazimine|clofazimine|mesh-list
56916746|NCT00042289|Ofloxacin|ofloxacin|mesh-list
56916747|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56916748|NCT00042289|Ethionamide|ethionamide|mesh-list
56916749|NCT00042289|Kanamycin|kanamycin|mesh-list
56916750|NCT00042289|Capreomycin|capreomycin|mesh-list
56916751|NCT00042289|Prothionamide|prothionamide|mesh-list
56916752|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56916753|NCT00042289|Etonogestrel|etonogestrel|mesh-list
56916754|NCT00042289|Estradiol|estradiol|mesh-list
56916755|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56916756|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56916757|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
56916758|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916759|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916760|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56916761|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56916762|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
56916763|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916764|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56916765|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56916766|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56916767|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56916768|NCT00042289|Estrogens|estrogens|mesh-ancestor
56916769|NCT00042289|Hormones|hormones|mesh-ancestor
56916770|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916771|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916772|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56916773|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
56916774|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56916775|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56916776|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56916777|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56916778|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56916779|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916780|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56916781|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56178848|NCT02427581|Poly I-C|poly i-c|mesh-list
56460812|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
56916782|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56916783|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56106609|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
56460813|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56460814|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56460815|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56460816|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56460817|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
56460818|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460819|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460820|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
56460821|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56460822|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460823|NCT00476268|Beclomethasone|beclomethasone|mesh-list
56460824|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
56460825|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56460826|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
56460834|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
56460835|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460836|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460837|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460838|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
56460839|NCT00476268|Hormones|hormones|mesh-ancestor
56460840|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460841|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55961737|NCT00315341|Naloxone|naloxone|mesh-list
56460842|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56460843|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56460844|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460845|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460846|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460847|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460848|NCT00105989|Analgesics|analgesics|mesh-ancestor
56460849|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
56460850|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460851|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
56460852|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56460853|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
56460854|NCT00476346|Vitamin D|vitamin d|mesh-list
56460855|NCT00476346|Calcium|calcium|mesh-list
56460856|NCT00476346|Vitamins|vitamins|mesh-ancestor
56460857|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
56460858|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460859|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56460860|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56460861|NCT00476424|Efavirenz|efavirenz|mesh-list
56460862|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56460863|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56460864|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460865|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460866|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
56460867|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460868|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56460869|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56460870|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56460871|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56460872|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56460873|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56460874|NCT00439712|Levocetirizine|levocetirizine|mesh-list
56460875|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56460876|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56460877|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
56460878|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
56460879|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460880|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460881|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460882|NCT00476463|Emtricitabine|emtricitabine|mesh-list
56460883|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
56460884|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916784|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56916785|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56460885|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56460886|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56460887|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460888|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460889|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56460892|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56460893|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460894|NCT00438243|Bromfenac|bromfenac|mesh-list
56460895|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56460896|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56460897|NCT00438243|Analgesics|analgesics|mesh-ancestor
56460898|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
56460899|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460900|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460901|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460902|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56460903|NCT00439829|Cetrorelix|cetrorelix|mesh-list
56460904|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56460905|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
56460906|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56460907|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460908|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
56460909|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460910|NCT03279861|Valsartan|valsartan|mesh-list
56460911|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56460912|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56460913|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56460914|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56460915|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460916|NCT03277248|Teriflunomide|teriflunomide|mesh-list
56460917|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56460918|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56460919|NCT03277248|Analgesics|analgesics|mesh-ancestor
56460920|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
56460921|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460922|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460923|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460924|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56460925|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56460926|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
56460927|NCT00440024|Tazarotene|tazarotene|mesh-list
56460928|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
56460929|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
56460930|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
56460931|NCT00440063|Hematinics|hematinics|mesh-ancestor
56460932|NCT00440102|Ketamine|ketamine|mesh-list
56460933|NCT00440102|Etomidate|etomidate|mesh-list
56460934|NCT00440102|Analgesics|analgesics|mesh-ancestor
56460935|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
56460936|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460937|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460938|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56460939|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56460940|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
56460941|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
56460942|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460943|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56460944|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56460945|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460946|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460947|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56460948|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
56460949|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56460950|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460951|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56460952|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56460953|NCT00440141|Latanoprost|latanoprost|mesh-list
56460954|NCT00440141|Brinzolamide|brinzolamide|mesh-list
56460955|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56460956|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56916786|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56916787|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56460957|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56460958|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56460959|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56460960|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
56460961|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460962|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208850|NCT01578824|Miotics|miotics|mesh-ancestor
56460966|NCT00438321|Anastrozole|anastrozole|mesh-list
56460967|NCT00438321|Goserelin|goserelin|mesh-list
56460968|NCT00438321|Testosterone|testosterone|mesh-list
56460969|NCT00438321|Androgens|androgens|mesh-ancestor
56460970|NCT00438321|Hormones|hormones|mesh-ancestor
56460971|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460972|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460973|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56460974|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460975|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56460976|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56460977|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460978|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460979|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56460980|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
56460981|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
56460982|NCT00476619|Hematinics|hematinics|mesh-ancestor
56460983|NCT03279536|Lactoferrin|lactoferrin|mesh-list
56460984|NCT03279536|Dextrans|dextrans|mesh-list
56460985|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
56460986|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460987|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
56460988|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
56460989|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
56460990|NCT03279536|Hematinics|hematinics|mesh-ancestor
56460991|NCT00440219|Prednisone|prednisone|mesh-list
56460992|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56460993|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
56460994|NCT00440219|Hormones|hormones|mesh-ancestor
56460995|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56460996|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460997|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56460998|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460999|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56461000|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56461001|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461002|NCT00440258|Cabergoline|cabergoline|mesh-list
56461003|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56461004|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56461005|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
56461006|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
56461007|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461008|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461009|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461010|NCT00440336|Latanoprost|latanoprost|mesh-list
56461011|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56461012|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56461013|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
56461014|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56461015|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461016|NCT00440414|Pemetrexed|pemetrexed|mesh-list
56461017|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56461018|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461019|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461020|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461021|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56461022|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56461023|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56461024|NCT03270462|Tacrolimus|tacrolimus|mesh-list
56461025|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56461026|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
56461027|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461028|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56461029|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461030|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916788|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56916789|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56916790|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
56916791|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
56916792|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56916793|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56916794|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56916795|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56916796|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56916797|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
56916798|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56916799|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56916800|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56916801|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56916802|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56916803|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56916804|NCT00042289|Renal Agents|renal agents|mesh-ancestor
56916805|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916806|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56916807|NCT00039871|Ribavirin|ribavirin|mesh-list
56916808|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56916809|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
56916810|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
56916811|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916812|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
56916813|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916814|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
56916815|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916816|NCT01096693|Substance P|substance p|mesh-list
56916817|NCT01096693|Neurokinin A|neurokinin a|mesh-list
56916818|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916821|NCT00015457|Amlodipine|amlodipine|mesh-list
56916830|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56916832|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
56916833|NCT03564470|Dasatinib|dasatinib|mesh-list
56916834|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916835|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56916836|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916837|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916838|NCT03191396|Liraglutide|liraglutide|mesh-list
56916839|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916840|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916841|NCT03191396|Incretins|incretins|mesh-ancestor
56916842|NCT03191396|Hormones|hormones|mesh-ancestor
56179141|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56461031|NCT00440609|Ranibizumab|ranibizumab|mesh-list
56461032|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56461033|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56461034|NCT00440609|Growth Substances|growth substances|mesh-ancestor
56461035|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461036|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
56461047|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461048|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56461049|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
56461050|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
56461051|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56461054|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56461055|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461056|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56461057|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461058|NCT00440765|Bortezomib|bortezomib|mesh-list
56461059|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461060|NCT00440804|Ibuprofen|ibuprofen|mesh-list
56461061|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56461062|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461063|NCT00440804|Analgesics|analgesics|mesh-ancestor
56461064|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
56461065|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461066|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461067|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461068|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461069|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56461070|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461071|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461072|NCT00440843|Olanzapine|olanzapine|mesh-list
56461073|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
56461074|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
56461075|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461076|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461077|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461078|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56461079|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56461080|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461081|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56461082|NCT00440843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56461083|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56461084|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56461085|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461086|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461087|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
56461088|NCT00438789|Eculizumab|eculizumab|mesh-list
56461089|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56461090|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56461091|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
56055331|NCT02101853|Thioguanine|thioguanine|mesh-list
56916843|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916844|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56916845|NCT00007345|Romidepsin|romidepsin|mesh-list
56916846|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56916847|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916848|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56916849|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
56916850|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916851|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56916852|NCT00031447|Acyclovir|acyclovir|mesh-list
56916853|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
56916854|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916855|NCT00006721|Prednisone|prednisone|mesh-list
56916856|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
56916857|NCT00006721|Rituximab|rituximab|mesh-list
56916858|NCT00006721|Doxorubicin|doxorubicin|mesh-list
56461092|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461093|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56461094|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
56461095|NCT00440921|Coagulants|coagulants|mesh-ancestor
56461096|NCT00440960|Lidocaine|lidocaine|mesh-list
56461097|NCT00440960|Midazolam|midazolam|mesh-list
56461098|NCT00440960|Alfentanil|alfentanil|mesh-list
56461099|NCT00440960|Propofol|propofol|mesh-list
56461100|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
56461101|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
56461102|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461108|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56461109|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56461110|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461111|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56461112|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56461113|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
56461114|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56461115|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56461116|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56461117|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56461118|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
56461119|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
56461120|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461121|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56461122|NCT00440960|Narcotics|narcotics|mesh-ancestor
56461123|NCT00440960|Analgesics|analgesics|mesh-ancestor
56461124|NCT00438828|Dexamethasone|dexamethasone|mesh-list
56461125|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461126|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
56461127|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
56461128|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461129|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461130|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461131|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
56461133|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56461134|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56461135|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461136|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
56461137|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461138|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56461139|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461140|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461142|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461143|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461144|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461145|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56916859|NCT00006721|Vincristine|vincristine|mesh-list
56916860|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56916861|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
56916862|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916863|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56916864|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56916865|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
56916866|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916867|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916868|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56916869|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56916870|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56916871|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56916872|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56179272|NCT01397994|Vitamins|vitamins|mesh-ancestor
56461146|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56461147|NCT00476853|Nevirapine|nevirapine|mesh-list
56461148|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56461149|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56461150|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461151|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461152|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
56461153|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461154|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56461155|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56461156|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56461157|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56461158|NCT00438906|Secretin|secretin|mesh-list
56461159|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461160|NCT00438906|Hormones|hormones|mesh-ancestor
56461161|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56461162|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461163|NCT00438945|Eprosartan|eprosartan|mesh-list
56461164|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56461165|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
56461166|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56461167|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461168|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
56461169|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56461170|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56461171|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
56461177|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
56461178|NCT00438984|Interleukin-2|interleukin-2|mesh-list
56461179|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56461180|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
56461181|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461182|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461183|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56461184|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
56461185|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461186|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461187|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56461188|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461189|NCT00438984|Analgesics|analgesics|mesh-ancestor
56461190|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
56461191|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461192|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56461193|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56916873|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916874|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916875|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
56916876|NCT00006721|Hormones|hormones|mesh-ancestor
56916877|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916878|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56916879|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56916880|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
56916881|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
56916882|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
56916883|NCT00006289|Neurotropin|neurotropin|mesh-list
56916884|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56916885|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
56916886|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916887|NCT00006289|Analgesics|analgesics|mesh-ancestor
56916888|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
56916889|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916890|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
56916891|NCT05625841|Propolis|propolis|mesh-list
56916931|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56916932|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916933|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916934|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56916935|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
56461194|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
56334155|NCT00398697|Antiviral Agents|antiviral agents|mesh-ancestor
56461195|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461196|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56461197|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461198|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461200|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461201|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
56461202|NCT00441662|Hormones|hormones|mesh-ancestor
56461203|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56461204|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461205|NCT00439062|Roxithromycin|roxithromycin|mesh-list
56461206|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56461207|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461208|NCT02957162|Atorvastatin|atorvastatin|mesh-list
56461209|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56461210|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56461211|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
56461212|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461213|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56461214|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56461215|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461216|NCT00441740|Gemcitabine|gemcitabine|mesh-list
56461217|NCT00441740|Docetaxel|docetaxel|mesh-list
56461218|NCT00441740|Vinorelbine|vinorelbine|mesh-list
56461219|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56461220|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
56461221|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461222|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461223|NCT00441740|Antiviral Agents|antiviral agents|mesh-ancestor
56461224|NCT00441740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461225|NCT00441740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461226|NCT00441740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56461227|NCT00441740|Immunologic Factors|immunologic factors|mesh-ancestor
56461228|NCT00441740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461229|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
56461230|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
56461231|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
56461232|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56461233|NCT02274012|Paclitaxel|paclitaxel|mesh-list
56461234|NCT02274012|Afatinib|afatinib|mesh-list
56461235|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56461236|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461237|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56461238|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56461239|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56461240|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461241|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56461248|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461250|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56461251|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
56461252|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461253|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56461254|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56461255|NCT00477126|Ritonavir|ritonavir|mesh-list
56461256|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56461257|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56461258|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
56461259|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461260|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461261|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56461262|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56461263|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
56461264|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916936|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56179402|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
56461265|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56461266|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56461267|NCT03279341|Prucalopride|prucalopride|mesh-list
56461268|NCT03279341|Bisacodyl|bisacodyl|mesh-list
56461269|NCT03279341|Laxatives|laxatives|mesh-ancestor
56461270|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461271|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56461272|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56461273|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
56461274|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461275|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461276|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461277|NCT03279341|Cathartics|cathartics|mesh-ancestor
56461278|NCT03279146|Tenofovir|tenofovir|mesh-list
56461279|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
56461280|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461281|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56461282|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56461283|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461284|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461285|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56461286|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56461287|NCT00442052|Aspirin|aspirin|mesh-list
56461288|NCT00442052|Omeprazole|omeprazole|mesh-list
56461289|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56461290|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461291|NCT00442052|Analgesics|analgesics|mesh-ancestor
56461292|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
56461293|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461294|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461295|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461296|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461297|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56461298|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56461299|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461300|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56461301|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56461302|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461303|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
56461304|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56461305|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461306|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56461307|NCT00477282|Topotecan|topotecan|mesh-list
56461308|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56461309|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56461310|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461314|NCT00439530|Probenecid|probenecid|mesh-list
56461315|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
56461316|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461317|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461318|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461319|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
56461320|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
56461321|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461322|NCT00439530|Renal Agents|renal agents|mesh-ancestor
56461323|NCT00442325|Atorvastatin|atorvastatin|mesh-list
56461324|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56461325|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56461326|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
56461327|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461328|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56461329|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56461330|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461331|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
56461332|NCT00477516|Calcium|calcium|mesh-list
56461333|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56461334|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461335|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56461336|NCT00477711|Capecitabine|capecitabine|mesh-list
56461337|NCT00477711|Cetuximab|cetuximab|mesh-list
56461338|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461339|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56916937|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916938|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56916939|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
56916940|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
56916941|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56916942|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56916943|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
56916944|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56916945|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56916946|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56916947|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
56916948|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
56916949|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
56916950|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56916951|NCT01103635|Ipilimumab|ipilimumab|mesh-list
56916952|NCT01103635|Tremelimumab|tremelimumab|mesh-list
56916953|NCT01103635|Antibodies|antibodies|mesh-list
56916954|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
56916955|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56916956|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
56916957|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916958|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916959|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56916960|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916961|NCT03949075|Enalapril|enalapril|mesh-list
56461340|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
56461341|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461342|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56461344|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56461345|NCT00442403|Amebicides|amebicides|mesh-ancestor
56461346|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56461347|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56461348|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461349|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
56461350|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461351|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461352|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56461353|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
56461354|NCT00477789|Allopurinol|allopurinol|mesh-list
56461355|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
56461356|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461357|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461358|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
56461359|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461360|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56461361|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
56461362|NCT00477789|Protective Agents|protective agents|mesh-ancestor
56461363|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461364|NCT00442481|Citalopram|citalopram|mesh-list
56461365|NCT00442481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56055332|NCT02101853|Blinatumomab|blinatumomab|mesh-list
56916962|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56916963|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
56916964|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916965|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916966|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56916967|NCT01101529|Aprepitant|aprepitant|mesh-list
56916968|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
56916969|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
56916970|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916971|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461366|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56461367|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56461368|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461369|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461370|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
56461371|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461372|NCT00442481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56461373|NCT00442481|Antidepressive Agents|antidepressive agents|mesh-ancestor
56461374|NCT00442481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56461375|NCT00442637|Bevacizumab|bevacizumab|mesh-list
56461376|NCT00442637|Capecitabine|capecitabine|mesh-list
56461377|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56461378|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461379|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56461380|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56461381|NCT00442637|Growth Substances|growth substances|mesh-ancestor
56461382|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461383|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
56461388|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56461389|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461390|NCT00442676|Analgesics|analgesics|mesh-ancestor
56461391|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
56461392|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461393|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461394|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461395|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461396|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56461397|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56461398|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461399|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461400|NCT00477945|Clofarabine|clofarabine|mesh-list
56461401|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56461402|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
56461403|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461404|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461405|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
56461406|NCT00442793|Hematinics|hematinics|mesh-ancestor
56461407|NCT00442832|Vancomycin|vancomycin|mesh-list
56461408|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56461409|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461410|NCT00477984|Ethanol|ethanol|mesh-list
56461411|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56461412|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461413|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461414|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461415|NCT00478101|Fentanyl|fentanyl|mesh-list
56461417|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56461418|NCT00478101|Narcotics|narcotics|mesh-ancestor
56461419|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461420|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461421|NCT00478101|Analgesics|analgesics|mesh-ancestor
56461422|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
56461423|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916972|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56916973|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56916974|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916975|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916976|NCT00003907|Cisplatin|cisplatin|mesh-list
56916977|NCT00003907|Doxorubicin|doxorubicin|mesh-list
56916978|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56916979|NCT00003907|Mitomycins|mitomycins|mesh-list
56916980|NCT00003907|Mitomycin|mitomycin|mesh-list
56547711|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56461424|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56461425|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56461426|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
56461427|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
56461428|NCT00440076|Bortezomib|bortezomib|mesh-list
56461429|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461430|NCT00443105|Tacrolimus|tacrolimus|mesh-list
56461431|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56461432|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
56461433|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461434|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56461435|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461436|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461437|NCT00443144|Hormones|hormones|mesh-list
56461438|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56461439|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461440|NCT00440154|Ezetimibe|ezetimibe|mesh-list
56461441|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56461442|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56461443|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
56461444|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461445|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56461446|NCT00478374|Doxorubicin|doxorubicin|mesh-list
56461447|NCT00478374|Sorafenib|sorafenib|mesh-list
56461448|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56461449|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461450|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56461451|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56461452|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461453|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461454|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56461455|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
56461458|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461460|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56461461|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
56461462|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461463|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461464|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56461465|NCT03279549|Mitogens|mitogens|mesh-list
56461466|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56461467|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461468|NCT03271983|Metronidazole|metronidazole|mesh-list
56461469|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461470|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56461471|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56461472|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56461473|NCT00443222|Infliximab|infliximab|mesh-list
56461474|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56461475|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461476|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461477|NCT00440349|Tamoxifen|tamoxifen|mesh-list
56461478|NCT00440349|Prednisone|prednisone|mesh-list
56461479|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461480|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
56461481|NCT00440349|Hormones|hormones|mesh-ancestor
56461482|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916981|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916982|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56916983|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56916984|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56916985|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916986|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916987|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
56916988|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56916990|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56916991|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56916992|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
56916993|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56916994|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916995|NCT01100125|Incretins|incretins|mesh-ancestor
56916996|NCT01100125|Hormones|hormones|mesh-ancestor
56916997|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916998|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56916999|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
56461483|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461484|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56461485|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461486|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56461487|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
56461488|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56461489|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56461490|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56461492|NCT00443339|Hematinics|hematinics|mesh-ancestor
56461493|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
56461494|NCT04700228|Bupivacaine|bupivacaine|mesh-list
56461495|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
56461496|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
56461497|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461498|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461499|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
56461500|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461501|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56461502|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461503|NCT04700228|Analgesics|analgesics|mesh-ancestor
56461504|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56461505|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56461506|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56461507|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
56461508|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461509|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461510|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56461511|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56461512|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56461513|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56461514|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461515|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461516|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461517|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
56461518|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56917000|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917001|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917002|NCT01100203|Eplerenone|eplerenone|mesh-list
56180996|NCT01408342|Rituximab|rituximab|mesh-list
56461520|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
56461521|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
56461522|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461523|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461524|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461525|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56461526|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
56461527|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461528|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461531|NCT00440622|Trastuzumab|trastuzumab|mesh-list
56461532|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56461533|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
56461534|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461535|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461536|NCT00440622|Antiviral Agents|antiviral agents|mesh-ancestor
56461537|NCT00440622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461538|NCT00440622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461539|NCT00440622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56461540|NCT00440622|Immunologic Factors|immunologic factors|mesh-ancestor
56461541|NCT00440622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461542|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56461543|NCT00440661|Diacetylrhein|diacetylrhein|mesh-list
56461544|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461545|NCT03278444|Trimetazidine|trimetazidine|mesh-list
56461546|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
56461547|NCT00440739|Etoricoxib|etoricoxib|mesh-list
56461548|NCT00440739|Flavoxate|flavoxate|mesh-list
56461549|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56461550|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461551|NCT00440739|Analgesics|analgesics|mesh-ancestor
56461552|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
56461553|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461554|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461555|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461556|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461557|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56461558|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56461559|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461560|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461561|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
56461562|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
56461563|NCT00440739|Urological Agents|urological agents|mesh-ancestor
56461564|NCT00443573|Protein C|protein c|mesh-list
56461565|NCT00443573|Anticoagulants|anticoagulants|mesh-list
56461566|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56461567|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56461568|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461569|NCT00478764|Triamcinolone|triamcinolone|mesh-list
56461570|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461571|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
56461572|NCT00478764|Hormones|hormones|mesh-ancestor
56461573|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56461574|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461575|NCT00440778|Abciximab|abciximab|mesh-list
56461576|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
56461577|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56461578|NCT03278405|Avelumab|avelumab|mesh-list
56461579|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56461580|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461581|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56461582|NCT00443612|Irbesartan|irbesartan|mesh-list
56461583|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56461584|NCT00443612|Diuretics|diuretics|mesh-ancestor
56461585|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
56461586|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461587|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56461588|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56461589|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917003|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56917004|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
56917005|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56917006|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917007|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56917008|NCT01100203|Diuretics|diuretics|mesh-ancestor
56917009|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
56917010|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56917011|NCT03948685|Carvedilol|carvedilol|mesh-list
56461590|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56461591|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56461592|NCT00443690|Rolofylline|rolofylline|mesh-list
56461593|NCT00443690|Diuretics|diuretics|mesh-ancestor
56461594|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
56461595|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461596|NCT00440895|Abciximab|abciximab|mesh-list
56461597|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
56461598|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56461599|NCT00440973|Bevacizumab|bevacizumab|mesh-list
56461600|NCT00440973|Interleukin-2|interleukin-2|mesh-list
56461601|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56461602|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461603|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56461607|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
56461608|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461610|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
56461611|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461612|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56461613|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56461614|NCT00441051|Diclofenac|diclofenac|mesh-list
56461615|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56461616|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461617|NCT00441051|Analgesics|analgesics|mesh-ancestor
56461618|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
56461619|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461620|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461621|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461622|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461623|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56461624|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461625|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461626|NCT00443963|Esomeprazole|esomeprazole|mesh-list
56461627|NCT00443963|Ranitidine|ranitidine|mesh-list
56461628|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56461629|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461630|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56461631|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461632|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461633|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56461634|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
56461635|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
56461636|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334165|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461637|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461639|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
56461640|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461641|NCT00441207|Protective Agents|protective agents|mesh-ancestor
56461642|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461644|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
56461645|NCT00444041|Bevacizumab|bevacizumab|mesh-list
56461646|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56461647|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461648|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56461649|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56461650|NCT00444041|Growth Substances|growth substances|mesh-ancestor
56917012|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56917013|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56917014|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
56917015|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917016|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917017|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917018|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56917019|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
56917020|NCT03948685|Protective Agents|protective agents|mesh-ancestor
56461651|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461652|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
56461653|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
56461654|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
56461655|NCT00441246|Ephedrine|ephedrine|mesh-list
56461656|NCT00441246|Guaifenesin|guaifenesin|mesh-list
56461657|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56461658|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56461659|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
56461660|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461661|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461662|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56461663|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
56461664|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
56461665|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56461666|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56461667|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
56461668|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
56461669|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461670|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461671|NCT00441246|Expectorants|expectorants|mesh-ancestor
56461672|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56461673|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56461674|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
56461675|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56461680|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56461681|NCT00478959|Growth Substances|growth substances|mesh-ancestor
56461682|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
56461683|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461684|NCT00444236|Esomeprazole|esomeprazole|mesh-list
56461685|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56461686|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461687|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56461688|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461689|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461690|NCT00478998|Tamsulosin|tamsulosin|mesh-list
56461691|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56461692|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56461693|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56461694|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
56461695|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461696|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461697|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461698|NCT00478998|Urological Agents|urological agents|mesh-ancestor
56461699|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56461700|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461701|NCT00479076|Aflibercept|aflibercept|mesh-list
56461702|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56461703|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56461704|NCT00479076|Growth Substances|growth substances|mesh-ancestor
56461705|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461706|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
56461707|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461708|NCT00441519|Aspirin|aspirin|mesh-list
56461709|NCT00441519|Omeprazole|omeprazole|mesh-list
56461710|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56917021|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56917022|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56917023|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56917024|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
56917025|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56917026|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56917027|NCT01585051|Vitamin D|vitamin d|mesh-list
56917028|NCT01585051|Vitamins|vitamins|mesh-ancestor
56917029|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
56917030|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917031|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56461711|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461712|NCT00441519|Analgesics|analgesics|mesh-ancestor
56461713|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
56461714|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461715|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209607|NCT01592136|Ponatinib|ponatinib|mesh-list
56461717|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461718|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56461719|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56461720|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461721|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56461722|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56461723|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461724|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
56461725|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56461726|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461727|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56461728|NCT00441597|Atorvastatin|atorvastatin|mesh-list
56461729|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56461730|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56461731|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
56461732|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461733|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56461734|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56461735|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461736|NCT00479193|Bacitracin|bacitracin|mesh-list
56461737|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56461738|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461739|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56461740|NCT03278015|Gemcitabine|gemcitabine|mesh-list
56461741|NCT03278015|Paclitaxel|paclitaxel|mesh-list
56461742|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56461743|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56461744|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461745|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
56461746|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
56461747|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
56461749|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56461751|NCT03278015|Antiviral Agents|antiviral agents|mesh-ancestor
56461752|NCT03278015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461753|NCT03278015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461754|NCT03278015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56461755|NCT03278015|Immunologic Factors|immunologic factors|mesh-ancestor
56461756|NCT03278015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461757|NCT00444314|Sunitinib|sunitinib|mesh-list
56461758|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461759|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56461760|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56461761|NCT00444314|Growth Substances|growth substances|mesh-ancestor
56461762|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461763|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
56461764|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56461765|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917032|NCT01103791|Docetaxel|docetaxel|mesh-list
56917033|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917034|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
56917035|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
56917036|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
56917037|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917038|NCT03800173|Galidesivir|galidesivir|mesh-list
56917039|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
56917040|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917041|NCT00003631|Cytarabine|cytarabine|mesh-list
56917042|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
56917043|NCT00003631|Melphalan|melphalan|mesh-list
56917044|NCT00003631|Ifosfamide|ifosfamide|mesh-list
56917045|NCT00003631|Carmustine|carmustine|mesh-list
56917046|NCT00003631|Carboplatin|carboplatin|mesh-list
56917047|NCT00003631|Etoposide|etoposide|mesh-list
56917048|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917049|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
56917050|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917051|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56917052|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56917053|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
56917054|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917055|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917056|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56461766|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461767|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
56461768|NCT04700826|Apixaban|apixaban|mesh-list
56461769|NCT04700826|Edoxaban|edoxaban|mesh-list
56461770|NCT04700826|Dabigatran|dabigatran|mesh-list
56461771|NCT04700826|Anticoagulants|anticoagulants|mesh-list
56461772|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56461773|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
56461774|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56461775|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
56461776|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461777|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461778|NCT02274051|Kinetin|kinetin|mesh-list
56461779|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56461780|NCT02274051|Growth Substances|growth substances|mesh-ancestor
56461781|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461783|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56461784|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56461785|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461786|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
56461787|NCT00444470|Coagulants|coagulants|mesh-ancestor
56461788|NCT00444548|Reboxetine|reboxetine|mesh-list
56461789|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
56461790|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56461791|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56461792|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56461793|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56461794|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917057|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56917058|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56917059|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56917061|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56917062|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
56917063|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
56917064|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917065|NCT01101685|Citalopram|citalopram|mesh-list
56917066|NCT01101685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56917067|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56917068|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56917069|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917070|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917071|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
56917072|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917073|NCT01101685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56917074|NCT01101685|Antidepressive Agents|antidepressive agents|mesh-ancestor
56917075|NCT01101685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56917076|NCT00030901|Selenium|selenium|mesh-list
56461795|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
56461796|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461797|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461798|NCT00444665|Travoprost|travoprost|mesh-list
56461799|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56461800|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
56461801|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56461802|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461803|NCT02274090|Metformin|metformin|mesh-list
56461804|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56461805|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461806|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
56461807|NCT00479661|Propofol|propofol|mesh-list
56461808|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56461809|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461810|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461811|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56461812|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
56461813|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
56461814|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461815|NCT00479661|Analgesics|analgesics|mesh-ancestor
56461816|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
56461817|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461818|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56461819|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56461820|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56461821|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
56461822|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461825|NCT04700670|Coagulants|coagulants|mesh-ancestor
56461826|NCT00441870|Folic Acid|folic acid|mesh-list
56461827|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
56461828|NCT00441870|Hematinics|hematinics|mesh-ancestor
56461829|NCT00441870|Vitamins|vitamins|mesh-ancestor
56461830|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
56461831|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461832|NCT04700592|Ketamine|ketamine|mesh-list
56461833|NCT04700592|Gabapentin|gabapentin|mesh-list
56461834|NCT04700592|Analgesics|analgesics|mesh-ancestor
56917077|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
56917078|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917079|NCT00030901|Protective Agents|protective agents|mesh-ancestor
56917080|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917081|NCT00030901|Trace Elements|trace elements|mesh-ancestor
56917082|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
56917083|NCT01104259|Vinorelbine|vinorelbine|mesh-list
56917084|NCT01104259|Veliparib|veliparib|mesh-list
56917085|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917086|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56917087|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
56917088|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
56917089|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
56917090|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917091|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56917092|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917093|NCT01104337|Acetaminophen|acetaminophen|mesh-list
56917094|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56917095|NCT01104337|Analgesics|analgesics|mesh-ancestor
56917096|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
56917097|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917098|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917099|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
56917100|NCT01100359|Carboplatin|carboplatin|mesh-list
56917101|NCT01100359|Doxorubicin|doxorubicin|mesh-list
56917102|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56917103|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179561|NCT01400165|Pindolol|pindolol|mesh-list
56461835|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
56461836|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461837|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461838|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56461839|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56461840|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
56461841|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
56461842|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461843|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56461844|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56461845|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461846|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461847|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
56461848|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56461849|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56461850|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56461851|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
56461852|NCT00441909|UC-781|uc-781|mesh-list
56461853|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56461855|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917104|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56917105|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56917106|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56461856|NCT00445016|Anesthetics|anesthetics|mesh-list
56461857|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461858|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461859|NCT00445055|Droperidol|droperidol|mesh-list
56461860|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56461861|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
56461862|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
56461863|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461864|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461865|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56461866|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56461867|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56461868|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56461869|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56461870|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56461871|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56461872|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
56461873|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461874|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461875|NCT00479739|Fluticasone|fluticasone|mesh-list
56461876|NCT00479739|Xhance|xhance|mesh-list
56461877|NCT00479739|Budesonide|budesonide|mesh-list
56461878|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
56461879|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56461880|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461881|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56461882|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
56461883|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461884|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461885|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56461886|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
56461887|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
56461888|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56461889|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
56461890|NCT00479739|Hormones|hormones|mesh-ancestor
56461891|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56461892|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56461893|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56461894|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56461895|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
56461896|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461897|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461898|NCT00445094|Vancomycin|vancomycin|mesh-list
56461903|NCT00445094|Cilastatin|cilastatin|mesh-list
56461904|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56461905|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461906|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461907|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
56461908|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461909|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56461910|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
56461911|NCT00479778|Estrogens|estrogens|mesh-list
56461912|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56461913|NCT00479778|Hormones|hormones|mesh-ancestor
56461914|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56461915|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461916|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56461917|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56461918|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
56461919|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56461920|NCT00442026|Gemcitabine|gemcitabine|mesh-list
56461921|NCT00442026|Docetaxel|docetaxel|mesh-list
56461922|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56461923|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
56461924|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461925|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461926|NCT00442026|Antiviral Agents|antiviral agents|mesh-ancestor
56461927|NCT00442026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461928|NCT00442026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917107|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917108|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917109|NCT00003199|Tamoxifen|tamoxifen|mesh-list
56917110|NCT00003199|Aldesleukin|aldesleukin|mesh-list
56917111|NCT00003199|Melphalan|melphalan|mesh-list
56461929|NCT00442026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56461930|NCT00442026|Immunologic Factors|immunologic factors|mesh-ancestor
56461931|NCT00442026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461932|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
56461933|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
56461934|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
56461935|NCT00479895|Chrysarobin|chrysarobin|mesh-list
56461936|NCT00479895|HBOC 201|hboc 201|mesh-list
56461937|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56461938|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461939|NCT00479895|Analgesics|analgesics|mesh-ancestor
56461940|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
56461941|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461942|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461943|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461944|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461945|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
56461946|NCT00445250|Calcipotriene|calcipotriene|mesh-list
56461947|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56461948|NCT03279120|Tenofovir|tenofovir|mesh-list
56461949|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
56461950|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
56461951|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56461952|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56461953|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56461954|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461955|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461956|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56461957|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56461958|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56461959|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
56461960|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56461961|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461962|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56461963|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56461964|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56461965|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
56461966|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461967|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56461968|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461969|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461977|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56461978|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
56461979|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461980|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461981|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461982|NCT03274700|Urological Agents|urological agents|mesh-ancestor
56461984|NCT00442221|Sumatriptan|sumatriptan|mesh-list
56461985|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56461986|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56461987|NCT00442221|Analgesics|analgesics|mesh-ancestor
56461988|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
56461989|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461990|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461991|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461992|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461993|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
56461994|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56461995|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461996|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461997|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56461998|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56461999|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56462000|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
56462001|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917112|NCT00003199|Busulfan|busulfan|mesh-list
56917113|NCT00003199|Thiotepa|thiotepa|mesh-list
56462002|NCT00454259|Fentanyl|fentanyl|mesh-list
56462003|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56462004|NCT00454259|Narcotics|narcotics|mesh-ancestor
56462005|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462006|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462007|NCT00454259|Analgesics|analgesics|mesh-ancestor
56462008|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
56462009|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462010|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56462011|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56462012|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
56462013|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
56462014|NCT03278808|Azithromycin|azithromycin|mesh-list
56462015|NCT03278808|Chloroquine|chloroquine|mesh-list
56462016|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56462017|NCT03278808|Atovaquone|atovaquone|mesh-list
56462018|NCT03278808|Proguanil|proguanil|mesh-list
56462019|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56462020|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462021|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462022|NCT03278808|Amebicides|amebicides|mesh-ancestor
56462023|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56462024|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56462025|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
56462026|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56462027|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56462028|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56462029|NCT03278808|Analgesics|analgesics|mesh-ancestor
56462030|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
56462031|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462032|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462033|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56462034|NCT03278808|Filaricides|filaricides|mesh-ancestor
56462035|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
56462036|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
56462041|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56462042|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
56462043|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462044|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462045|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
56462046|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462047|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462048|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
56462049|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462050|NCT00454883|Ziprasidone|ziprasidone|mesh-list
56462051|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56462052|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
56462053|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462054|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462055|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462056|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56462057|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56462058|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462059|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56462060|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56462061|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
56462062|NCT03278652|Analgesics|analgesics|mesh-list
56462063|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
56462064|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462065|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462066|NCT00454961|Lumefantrine|lumefantrine|mesh-list
56462067|NCT00454961|Artemether|artemether|mesh-list
56462068|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56462069|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
56462070|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56462071|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56462072|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462073|NCT00455039|Lapatinib|lapatinib|mesh-list
56462074|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462075|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56462076|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462077|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462078|NCT00480207|Folic Acid|folic acid|mesh-list
56462079|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
56462080|NCT00480207|Hematinics|hematinics|mesh-ancestor
56917114|NCT00003199|Interleukin-2|interleukin-2|mesh-list
56917115|NCT00003199|Sargramostim|sargramostim|mesh-list
56917116|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917117|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56917118|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
56917119|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917120|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56917121|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917122|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
56917123|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917124|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56917125|NCT00003199|Analgesics|analgesics|mesh-ancestor
56917126|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
56917127|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917128|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56917129|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
56917130|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56917131|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56917132|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56917133|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56917134|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56917135|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56917136|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56917137|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
56917138|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917139|NCT01327261|Levodopa|levodopa|mesh-list
56917140|NCT01327261|Benserazide|benserazide|mesh-list
56462081|NCT00480207|Vitamins|vitamins|mesh-ancestor
56462082|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
56462083|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462084|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56462085|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462086|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56462087|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462088|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462089|NCT02956655|Insulin|insulin|mesh-list
56462090|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56462091|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56462092|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462093|NCT00480246|Perphenazine|perphenazine|mesh-list
56462094|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56462095|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56209979|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
56462096|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462097|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462098|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56462099|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56917141|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56917142|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56917143|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
56917144|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917145|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917146|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917147|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917148|NCT01101919|Tofacitinib|tofacitinib|mesh-list
56917149|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56917150|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917151|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917152|NCT03951415|Durvalumab|durvalumab|mesh-list
56917153|NCT03951415|Olaparib|olaparib|mesh-list
56917154|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56917155|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56917156|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917157|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917158|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917159|NCT00001849|Edetic Acid|edetic acid|mesh-list
56917160|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
56917161|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917162|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917163|NCT00001849|Antidotes|antidotes|mesh-ancestor
56917164|NCT00001849|Protective Agents|protective agents|mesh-ancestor
56462100|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
56462101|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462102|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462103|NCT00455117|Parecoxib|parecoxib|mesh-list
56462104|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56462105|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56462106|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462107|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462109|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56462111|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
56462112|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462113|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462114|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56462115|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56462116|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
56462117|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56462118|NCT03274427|Trimetazidine|trimetazidine|mesh-list
56462119|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
56462120|NCT00455234|Promethazine|promethazine|mesh-list
56462121|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
56462122|NCT00455234|Haloperidol|haloperidol|mesh-list
56462123|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
56462124|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
56462125|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
56462126|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898122|NCT03194724|Vitamin A|vitamin a|mesh-list
56917165|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
56917166|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
56462127|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462128|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56462129|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56462130|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56462131|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462132|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56462133|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56462134|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
56462135|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462136|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462137|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56462138|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
56462139|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
56462140|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56462141|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
56462142|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
56462143|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56462144|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56462145|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56462146|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
56462147|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
56462148|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
56462149|NCT00480363|Dexamethasone|dexamethasone|mesh-list
56462151|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56462152|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
56462153|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
56462154|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462155|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462156|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56462157|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
56462158|NCT00480363|Hormones|hormones|mesh-ancestor
56462159|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462160|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56462161|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462162|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
56462163|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56462164|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56462165|NCT00480363|Growth Substances|growth substances|mesh-ancestor
56462166|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
56462167|NCT00455351|Vorinostat|vorinostat|mesh-list
56462168|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462169|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56462170|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462171|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462173|NCT00442845|Atorvastatin|atorvastatin|mesh-list
56462174|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56462175|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56462176|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
56462177|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462178|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56462179|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56462180|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462181|NCT00455507|Istradefylline|istradefylline|mesh-list
56462182|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56462183|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56462185|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
56462186|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462187|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462188|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462189|NCT00480402|Progesterone|progesterone|mesh-list
56462190|NCT00480402|Progestins|progestins|mesh-ancestor
56462191|NCT00480402|Hormones|hormones|mesh-ancestor
56462192|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462193|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462194|NCT00455585|Lamivudine|lamivudine|mesh-list
56462195|NCT00455585|Nevirapine|nevirapine|mesh-list
56462196|NCT00455585|Stavudine|stavudine|mesh-list
56462197|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56462198|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56462199|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917167|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56917168|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
56917169|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56917170|NCT05627635|Calcium, Dietary|calcium, dietary|mesh-list
56917171|NCT05627635|Leucovorin|leucovorin|mesh-list
56917172|NCT05627635|Folic Acid|folic acid|mesh-list
56917173|NCT05627635|Bevacizumab|bevacizumab|mesh-list
56917174|NCT05627635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56917175|NCT05627635|Fluorouracil|fluorouracil|mesh-list
56917176|NCT05627635|Oxaliplatin|oxaliplatin|mesh-list
56917177|NCT05627635|Endothelial Growth Factors|endothelial growth factors|mesh-list
56917178|NCT05627635|Antibodies|antibodies|mesh-list
56917179|NCT05627635|Immunoglobulins|immunoglobulins|mesh-list
56917180|NCT05627635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56917181|NCT05627635|Immunoglobulin G|immunoglobulin g|mesh-list
56462200|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462201|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
56462202|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462203|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56462204|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56462205|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56462206|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56462207|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
56462208|NCT00455624|Androgens|androgens|mesh-list
56462209|NCT00455624|Hormones|hormones|mesh-ancestor
56462210|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462211|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462212|NCT00455897|Rituximab|rituximab|mesh-list
56462213|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56462214|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462215|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
56462216|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462217|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56462218|NCT00455936|Gefitinib|gefitinib|mesh-list
56462219|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462220|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56462221|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462222|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462224|NCT00443235|Prednisone|prednisone|mesh-list
56462225|NCT00443235|Melphalan|melphalan|mesh-list
56462226|NCT00443235|Bortezomib|bortezomib|mesh-list
56462227|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56462228|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
56462229|NCT00443235|Hormones|hormones|mesh-ancestor
56462230|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462231|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462232|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56462233|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462234|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56462235|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
56462236|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462237|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56462238|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462239|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
56462240|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
56462241|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462242|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462243|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56462244|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56462245|NCT00443235|Growth Substances|growth substances|mesh-ancestor
56462246|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
56462247|NCT04700943|Anesthetics|anesthetics|mesh-list
56462248|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56917182|NCT05627635|Calcium|calcium|mesh-list
56917183|NCT05627635|Levoleucovorin|levoleucovorin|mesh-list
56917184|NCT05627635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917185|NCT05627635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56917186|NCT05627635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56917187|NCT05627635|Growth Substances|growth substances|mesh-ancestor
56917188|NCT05627635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917189|NCT05627635|Growth Inhibitors|growth inhibitors|mesh-ancestor
56917190|NCT05627635|Immunologic Factors|immunologic factors|mesh-ancestor
56917191|NCT05627635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56917192|NCT05627635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56917193|NCT05627635|Antimetabolites|antimetabolites|mesh-ancestor
56917194|NCT05627635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917195|NCT05627635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56917196|NCT05627635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917197|NCT05627635|Antidotes|antidotes|mesh-ancestor
56917198|NCT05627635|Protective Agents|protective agents|mesh-ancestor
56462249|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462250|NCT00456248|Ribavirin|ribavirin|mesh-list
56462251|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
56462252|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
56462253|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462254|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
56462255|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462256|NCT00480558|Vaccines|vaccines|mesh-list
56462257|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
56462258|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462263|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56462264|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
56462265|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462266|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462267|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462268|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462269|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
56462270|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462271|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
56462272|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462273|NCT04698317|Mitogens|mitogens|mesh-list
56462274|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
56462275|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462276|NCT04700475|Citric Acid|citric acid|mesh-list
56462277|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
56462278|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
56462279|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56462280|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
56462281|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
56462282|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462283|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56462284|NCT04700436|Ezetimibe|ezetimibe|mesh-list
56462285|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56462286|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56462287|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
56462288|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462289|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56462290|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56462291|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462292|NCT00480597|Gemcitabine|gemcitabine|mesh-list
56462293|NCT00480597|Capecitabine|capecitabine|mesh-list
56917199|NCT05627635|Vitamin B Complex|vitamin b complex|mesh-ancestor
56917200|NCT05627635|Vitamins|vitamins|mesh-ancestor
56917201|NCT05627635|Micronutrients|micronutrients|mesh-ancestor
56917202|NCT05627635|Hematinics|hematinics|mesh-ancestor
56917203|NCT01104571|Trastuzumab|trastuzumab|mesh-list
56917204|NCT01104571|Lapatinib|lapatinib|mesh-list
56917205|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56547712|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917206|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917207|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56917208|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917209|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917210|NCT01104649|Riluzole|riluzole|mesh-list
56917211|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
56917212|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56917213|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56917214|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917215|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917216|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917217|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56917218|NCT01104649|Protective Agents|protective agents|mesh-ancestor
56917219|NCT01327729|Interferons|interferons|mesh-list
56917220|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
56917221|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
56462294|NCT00480597|Vinorelbine|vinorelbine|mesh-list
56462295|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462296|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56462297|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
56462298|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462299|NCT00480597|Antiviral Agents|antiviral agents|mesh-ancestor
56462300|NCT00480597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462301|NCT00480597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462302|NCT00480597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462303|NCT00480597|Immunologic Factors|immunologic factors|mesh-ancestor
56462304|NCT00480597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462305|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56462306|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
56462307|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
56462308|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
56462309|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56462310|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56462311|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
56462312|NCT00456482|Hormones|hormones|mesh-ancestor
56462313|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462314|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462315|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56462316|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
56462317|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56462318|NCT00480675|Prednisolone|prednisolone|mesh-list
56462319|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
56462320|NCT00480675|Bupivacaine|bupivacaine|mesh-list
56462321|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56917222|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56917223|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917224|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
56917225|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917226|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
56917227|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917228|NCT01342952|Ambrisentan|ambrisentan|mesh-list
56917229|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56917231|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56917232|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917233|NCT01104883|Trace Elements|trace elements|mesh-ancestor
56917234|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
56917235|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917236|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56917237|NCT04371380|Rilpivirine|rilpivirine|mesh-list
56917238|NCT04371380|Cabotegravir|cabotegravir|mesh-list
56917239|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56917240|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56917241|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917242|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917243|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
56917244|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917245|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56917246|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56917247|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56917248|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56917249|NCT01341080|Varenicline|varenicline|mesh-list
56917250|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56179711|NCT01400867|Vancomycin|vancomycin|mesh-list
56462322|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
56462323|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
56462324|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
56462325|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462326|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462327|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
56462328|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462329|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56462330|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
56462335|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462336|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56462337|NCT00480675|Protective Agents|protective agents|mesh-ancestor
56462338|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56462339|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462340|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
56462341|NCT00456560|Paroxetine|paroxetine|mesh-list
56462342|NCT00456560|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56462343|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56917251|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56917252|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
56917253|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917254|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917255|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917256|NCT01333982|Amoxicillin|amoxicillin|mesh-list
56917257|NCT01333982|Gentamicins|gentamicins|mesh-list
56917258|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56917259|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917260|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56917261|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917262|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462344|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56462345|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462346|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462347|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
56462348|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462349|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56462350|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
56462351|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56462352|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56462353|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56462354|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462355|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56462356|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56462357|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462358|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56462359|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56462360|NCT00456677|Minocycline|minocycline|mesh-list
56462361|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462362|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462363|NCT00456716|Sorafenib|sorafenib|mesh-list
56462364|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462365|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56462366|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462367|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462368|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
56462369|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
56462370|NCT00456794|Istradefylline|istradefylline|mesh-list
56462371|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56462372|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56462373|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56462374|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
56462375|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462376|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462377|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462378|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56462379|NCT00456833|Everolimus|everolimus|mesh-list
56462380|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462381|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56462382|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462383|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462384|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462385|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
56462386|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462387|NCT00456872|Lidocaine|lidocaine|mesh-list
56462388|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
56462389|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
56462390|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462391|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917263|NCT01334060|Vaccines|vaccines|mesh-list
56917264|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
56917265|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179739|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56462392|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
56462393|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210278|NCT01595867|Morphine|morphine|mesh-list
56462394|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56462395|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56462396|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56462397|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56462398|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462399|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
56462400|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
56462405|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56462406|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462407|NCT00457067|Ranibizumab|ranibizumab|mesh-list
56462408|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56462409|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56462410|NCT00457067|Growth Substances|growth substances|mesh-ancestor
56462411|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462412|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
56462413|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462414|NCT00480870|Donepezil|donepezil|mesh-list
56462415|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56462416|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462417|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462418|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
56462419|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462420|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462421|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
56462422|NCT00457106|Risperidone|risperidone|mesh-list
56462423|NCT00457106|Paroxetine|paroxetine|mesh-list
56462424|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56462425|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
56462426|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462427|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462428|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462429|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56462430|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56462431|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462432|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56462433|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56462434|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
56462435|NCT00457106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56462436|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56462437|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56462438|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56462439|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
56462440|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56462441|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56462443|NCT00457145|Ranibizumab|ranibizumab|mesh-list
56462444|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56462445|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56462446|NCT00457145|Growth Substances|growth substances|mesh-ancestor
56462447|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462448|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
56462449|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462450|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56462451|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
56462452|NCT00457223|Coagulants|coagulants|mesh-ancestor
56462453|NCT00443508|Everolimus|everolimus|mesh-list
56462454|NCT00443508|Tacrolimus|tacrolimus|mesh-list
56462455|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462456|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
56462457|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462458|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56462459|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462460|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462461|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462462|NCT00457340|Atorvastatin|atorvastatin|mesh-list
56917266|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56917267|NCT04250636|Antibodies|antibodies|mesh-list
56917268|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
56917269|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56917270|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
56917271|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195180|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
56462463|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56462464|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56462465|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
56462466|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462467|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56462468|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56462469|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462470|NCT03278379|Avelumab|avelumab|mesh-list
56462471|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56462476|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462477|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
56462478|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462479|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462480|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56462481|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56462482|NCT02956538|Growth Substances|growth substances|mesh-ancestor
56462483|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
56462484|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462485|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56462486|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56462487|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56462488|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
56462489|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462490|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56462491|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56462492|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462493|NCT00457769|Donepezil|donepezil|mesh-list
56462494|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56462495|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462496|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462497|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
56462498|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462499|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462500|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
56462501|NCT00457808|Sirolimus|sirolimus|mesh-list
56462502|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462503|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462504|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56462505|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462506|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
56462507|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462508|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
56462509|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462510|NCT00481143|Deferasirox|deferasirox|mesh-list
56462511|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56462512|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
56462513|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
56462514|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462515|NCT00457964|Everolimus|everolimus|mesh-list
56462516|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462517|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462518|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
56462519|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462520|NCT00458042|Treprostinil|treprostinil|mesh-list
56462521|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56462522|NCT00458081|Rimonabant|rimonabant|mesh-list
56462523|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56462524|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56462525|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56462526|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462527|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917272|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917273|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
56917274|NCT04130828|Trace Elements|trace elements|mesh-ancestor
56917275|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
56917276|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917277|NCT01241708|Bortezomib|bortezomib|mesh-list
56917278|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917279|NCT01332344|Fluticasone|fluticasone|mesh-list
56917280|NCT01332344|Xhance|xhance|mesh-list
56917281|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56917282|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56917283|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56627913|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56917284|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
56917285|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917286|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462528|NCT00458081|Hormones|hormones|mesh-ancestor
56462529|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462530|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462531|NCT00481182|Ritonavir|ritonavir|mesh-list
56462532|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
56462533|NCT00481182|Methadone|methadone|mesh-list
56462534|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56462535|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56462536|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
56462537|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462538|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462539|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56462540|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56462541|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
56210431|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
56462542|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462550|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
56462551|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462552|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
56462553|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
56462554|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
56462555|NCT00443937|Everolimus|everolimus|mesh-list
56462556|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462557|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462558|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
56462559|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462560|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56462561|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56462562|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
56462563|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462564|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462565|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462566|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462567|NCT00458315|Gemcitabine|gemcitabine|mesh-list
56462568|NCT00458315|Paclitaxel|paclitaxel|mesh-list
56462569|NCT00458315|Bevacizumab|bevacizumab|mesh-list
56462570|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56462571|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462572|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
56462573|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
56462574|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56462575|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462576|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56462577|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56462578|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56917287|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56917288|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
56917289|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
56917290|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56917291|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56917292|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56917293|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56917294|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
56917295|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917296|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917297|NCT01112306|Selexipag|selexipag|mesh-list
56917298|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56462579|NCT00458315|Growth Substances|growth substances|mesh-ancestor
56462580|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462581|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
56462582|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56462583|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
56462584|NCT00458315|Antiviral Agents|antiviral agents|mesh-ancestor
56462585|NCT00458315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462586|NCT00458315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462587|NCT00458315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462588|NCT00458315|Immunologic Factors|immunologic factors|mesh-ancestor
56462589|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56462591|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462592|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56462593|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462594|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462595|NCT00458510|Fentanyl|fentanyl|mesh-list
56462596|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56462597|NCT00458510|Narcotics|narcotics|mesh-ancestor
56462598|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462599|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462600|NCT00458510|Analgesics|analgesics|mesh-ancestor
56462601|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
56462602|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462603|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56462604|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56462605|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
56462606|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
56462607|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
56462608|NCT00444093|Loperamide|loperamide|mesh-list
56462609|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56462610|NCT00444132|Clopidogrel|clopidogrel|mesh-list
56462611|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56462612|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56462613|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56462618|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462619|NCT00444171|Insulin|insulin|mesh-list
56462620|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56462621|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56462622|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462623|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
56462624|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462625|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462626|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56462627|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56462628|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462629|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462630|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462631|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56462632|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56462633|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55898123|NCT03194724|Vitamins|vitamins|mesh-ancestor
56917299|NCT01332422|Fluticasone|fluticasone|mesh-list
56917300|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56462634|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56462635|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462636|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
56462637|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462638|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462639|NCT00459173|Rimonabant|rimonabant|mesh-list
56462640|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56462641|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56462642|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56462643|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462644|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462645|NCT00459173|Hormones|hormones|mesh-ancestor
56462646|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462647|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462648|NCT00444249|Dipivefrin|dipivefrin|mesh-list
56462649|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56462650|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
56462651|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462652|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462653|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462654|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56462655|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
56462656|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462657|NCT00459407|Protective Agents|protective agents|mesh-ancestor
56462658|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462659|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56462660|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56462661|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963565|NCT00486031|Balsalazide|balsalazide|mesh-list
56462662|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56462663|NCT03278262|Aflibercept|aflibercept|mesh-list
56462664|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56462665|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56462666|NCT03278262|Growth Substances|growth substances|mesh-ancestor
56462667|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462668|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56462669|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462670|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
56462671|NCT00459485|Astringents|astringents|mesh-ancestor
56462672|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462673|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
56462674|NCT00459563|Vitamin D|vitamin d|mesh-list
56462675|NCT00459563|Calcitriol|calcitriol|mesh-list
56462676|NCT00459563|Vitamins|vitamins|mesh-ancestor
56462677|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
56462678|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462679|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56462680|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56462681|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56462693|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462694|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462696|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462697|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
56462698|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462699|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
56462700|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56462701|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56462702|NCT00459719|Tacrolimus|tacrolimus|mesh-list
56462703|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462704|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
56462705|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462706|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56462707|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462708|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462709|NCT00495183|Biperiden|biperiden|mesh-list
56462710|NCT00495183|Caffeine|caffeine|mesh-list
56462711|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56462712|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462713|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56462714|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898124|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
56917301|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56917302|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56917303|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56917304|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
56917305|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917306|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917307|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56917308|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56917309|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
56917310|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56917311|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56917312|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56917313|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56917314|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
56917315|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917316|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917317|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
56917318|NCT01332422|Hormones|hormones|mesh-ancestor
56917319|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56917320|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
56917321|NCT03162224|Durvalumab|durvalumab|mesh-list
56917322|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56917323|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917324|NCT00904046|Pioglitazone|pioglitazone|mesh-list
56917325|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56179780|NCT01401387|Pancreatin|pancreatin|mesh-list
56462715|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462716|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56462717|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56462718|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
56462719|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462720|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56462721|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56462722|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
56462723|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
56462724|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462725|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56462726|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56462727|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
56462728|NCT00488670|Citalopram|citalopram|mesh-list
56462729|NCT00488670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56462730|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56462731|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56462732|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462733|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462734|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
56462735|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917326|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56917327|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917328|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
56917329|NCT01332734|Analgesics|analgesics|mesh-ancestor
56917330|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
56917331|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917332|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917333|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
56917334|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56917335|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56917336|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
56917337|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56917338|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56917339|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917340|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56917341|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
56917342|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56917343|NCT00719888|Cyclosporine|cyclosporine|mesh-list
56462736|NCT00488670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56462737|NCT00488670|Antidepressive Agents|antidepressive agents|mesh-ancestor
56462738|NCT00488670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56462739|NCT00459836|Gemcitabine|gemcitabine|mesh-list
56462740|NCT00459836|Docetaxel|docetaxel|mesh-list
56462741|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56462742|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
56462743|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462746|NCT00459836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462747|NCT00459836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462748|NCT00459836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462749|NCT00459836|Immunologic Factors|immunologic factors|mesh-ancestor
56462750|NCT00459836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462751|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
56462752|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
56462753|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
56462754|NCT00488709|Cytarabine|cytarabine|mesh-list
56462755|NCT00488709|Fludarabine|fludarabine|mesh-list
56462756|NCT00488709|Topotecan|topotecan|mesh-list
56462757|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462758|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56462759|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
56462760|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462761|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462762|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
56462763|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462764|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
56462765|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462766|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56462767|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56462768|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462770|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
56462771|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
56462772|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
56462773|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462774|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462775|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462776|NCT00495339|Levofloxacin|levofloxacin|mesh-list
56917344|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
56917345|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
56917346|NCT00719888|Thiotepa|thiotepa|mesh-list
56917347|NCT00719888|Fludarabine|fludarabine|mesh-list
56917348|NCT00719888|Cyclosporins|cyclosporins|mesh-list
56917349|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917350|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
56917351|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917352|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56917353|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56917354|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
56917355|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917356|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917357|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56917358|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628027|NCT00944645|Niacin|niacin|mesh-list
56462777|NCT00495339|Ofloxacin|ofloxacin|mesh-list
56462778|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56462779|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462780|NCT00495339|Renal Agents|renal agents|mesh-ancestor
56462781|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462782|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56462783|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56462784|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462785|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462786|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462787|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56462788|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56462789|NCT00460148|Ropinirole|ropinirole|mesh-list
56462790|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56462791|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56462792|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
56462793|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
56462794|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462795|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462796|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462797|NCT00460226|Lamotrigine|lamotrigine|mesh-list
56462798|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
56462799|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56462800|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56462801|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462802|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56462803|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462804|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56462805|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56462806|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462807|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56462808|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56462809|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
56462810|NCT00495378|Hematinics|hematinics|mesh-ancestor
56462811|NCT00460304|Pramlintide|pramlintide|mesh-list
56462812|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56462813|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462814|NCT00460382|Ritonavir|ritonavir|mesh-list
56462815|NCT00460382|Darunavir|darunavir|mesh-list
56462816|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
56462817|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
56462818|NCT00460382|Etravirine|etravirine|mesh-list
56462819|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56462821|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
56462822|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917359|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
56917360|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917361|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
56917362|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56917363|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56917364|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56917365|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
56917366|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56917367|NCT03326492|Antivenins|antivenins|mesh-list
56917368|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
56917369|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917370|NCT01524536|Prednisone|prednisone|mesh-list
56917371|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56917372|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
56917373|NCT01524536|Hormones|hormones|mesh-ancestor
56917374|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462823|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462824|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56462825|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56462826|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
56462827|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462828|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56462829|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56462830|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56462831|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56462832|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56462833|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56462834|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56462835|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56462836|NCT01242579|Maraviroc|maraviroc|mesh-list
56462837|NCT01242579|Dapivirine|dapivirine|mesh-list
56462838|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56462839|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56462840|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462841|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56462842|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56462843|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
56462844|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462845|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56462846|NCT00460499|Insulin|insulin|mesh-list
56462847|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56462848|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462849|NCT00495573|Acyclovir|acyclovir|mesh-list
56462850|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
56462851|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462852|NCT00488787|Ketamine|ketamine|mesh-list
56462853|NCT00488787|Analgesics|analgesics|mesh-ancestor
56462854|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
56462855|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56462856|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462857|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56462858|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56462859|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
56462860|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
56462861|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462862|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56462863|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56462864|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462865|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917375|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917376|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56917377|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917378|NCT00533468|Lidocaine|lidocaine|mesh-list
56917379|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
56917380|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
56917381|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462866|NCT00460616|Cabergoline|cabergoline|mesh-list
56462867|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56462868|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56462869|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
56462870|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
56462871|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462872|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462873|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462874|NCT00495651|Isoniazid|isoniazid|mesh-list
56462875|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56462876|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
56462877|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462878|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462879|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56462880|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56462881|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
56462882|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462883|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56462884|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
56462885|NCT00460733|Vitamin D|vitamin d|mesh-list
56462886|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
56462887|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
56462888|NCT00460733|Calcium|calcium|mesh-list
56462889|NCT00460733|Vitamins|vitamins|mesh-ancestor
56462890|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
56462891|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462892|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56462893|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56462898|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
56462899|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462900|NCT00495729|Simvastatin|simvastatin|mesh-list
56462901|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56462902|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56462903|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
56462904|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462905|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56462906|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56462907|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462908|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
56462910|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
56462911|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56462912|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56462913|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
56462914|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462915|NCT00461084|Clarithromycin|clarithromycin|mesh-list
56462916|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462917|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462918|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56462919|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462920|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462921|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56462922|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56462923|NCT00495846|Octreotide|octreotide|mesh-list
56462924|NCT00495846|Lanreotide|lanreotide|mesh-list
56462925|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56462926|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56462927|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462928|NCT00105482|Naltrexone|naltrexone|mesh-list
56462929|NCT00105482|Nicotine|nicotine|mesh-list
56462930|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56462931|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
56462932|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917382|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917383|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
56917384|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917385|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56917386|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56201768|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
56462933|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462934|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56462935|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56462936|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
56462937|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462938|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462939|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56462940|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56462941|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
56462942|NCT00496002|Adefovir|adefovir|mesh-list
56462943|NCT00496002|Clevudine|clevudine|mesh-list
56462944|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
56462945|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462946|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56462947|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56462948|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462949|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462950|NCT00489099|Vaccines|vaccines|mesh-list
56462951|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
56462952|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462953|NCT00496158|Adefovir|adefovir|mesh-list
56462954|NCT00496158|Clevudine|clevudine|mesh-list
56462955|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
56462956|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462957|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56462958|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56462959|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462960|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462961|NCT00489138|Ertapenem|ertapenem|mesh-list
56462962|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56462963|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462964|NCT00461396|Interferons|interferons|mesh-list
56462969|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56462970|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
56462971|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462972|NCT01327651|Tenofovir|tenofovir|mesh-list
56462973|NCT01327651|Emtricitabine|emtricitabine|mesh-list
56462974|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
56462975|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462976|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56462977|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56462978|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462979|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462980|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56462981|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56462982|NCT00496275|Gemcitabine|gemcitabine|mesh-list
56462983|NCT00496275|Cisplatin|cisplatin|mesh-list
56462984|NCT00496275|Vinorelbine|vinorelbine|mesh-list
56462985|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462986|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56462987|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
56462988|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462989|NCT00496275|Antiviral Agents|antiviral agents|mesh-ancestor
56462990|NCT00496275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56462991|NCT00496275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210910|NCT01598441|Iloprost|iloprost|mesh-list
56462992|NCT00496275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462993|NCT00496275|Immunologic Factors|immunologic factors|mesh-ancestor
56462994|NCT00496275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462995|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56462996|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
56462997|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
56462998|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
56462999|NCT00591604|Vitamin D|vitamin d|mesh-list
56917387|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56917388|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56917389|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917390|NCT01333124|Gemcitabine|gemcitabine|mesh-list
56917391|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56917392|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
56917393|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917394|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917395|NCT01333124|Antiviral Agents|antiviral agents|mesh-ancestor
56917396|NCT01333124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917397|NCT01333124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917398|NCT01333124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917399|NCT01333124|Immunologic Factors|immunologic factors|mesh-ancestor
56917400|NCT01333124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917401|NCT03035630|Sunitinib|sunitinib|mesh-list
56463000|NCT00591604|Vitamins|vitamins|mesh-ancestor
56463001|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
56463002|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463003|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56463004|NCT00591643|Epinephrine|epinephrine|mesh-list
56463005|NCT00591643|Racepinephrine|racepinephrine|mesh-list
56463006|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
56463007|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56463008|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56463009|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
56463010|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463011|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463012|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463013|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56463014|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56463015|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
56463016|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463017|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56463018|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
56463019|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
56463020|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
56463021|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56463022|NCT00461747|Thalidomide|thalidomide|mesh-list
56463023|NCT00461747|Dexamethasone|dexamethasone|mesh-list
56463024|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
56463025|NCT00461747|Bortezomib|bortezomib|mesh-list
56463026|NCT00461747|BB 1101|bb 1101|mesh-list
56463027|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463028|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
56463029|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
56463030|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463031|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463032|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56463034|NCT00461747|Hormones|hormones|mesh-ancestor
56463035|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463036|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56463037|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463038|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
56463042|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
56463043|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
56463044|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463045|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463046|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56463047|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56463048|NCT00461747|Growth Substances|growth substances|mesh-ancestor
56917402|NCT03035630|Avelumab|avelumab|mesh-list
56917403|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917404|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56917405|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56917406|NCT03035630|Growth Substances|growth substances|mesh-ancestor
56917407|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917408|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
56917409|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56917410|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917411|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917412|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56917413|NCT00004124|Prednisone|prednisone|mesh-list
56917414|NCT00004124|Goserelin|goserelin|mesh-list
56917415|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
56917416|NCT00004124|Bicalutamide|bicalutamide|mesh-list
56463049|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
56463050|NCT00461825|Cyclosporine|cyclosporine|mesh-list
56463051|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
56463052|NCT00461825|Azathioprine|azathioprine|mesh-list
56463053|NCT00461825|Cyclosporins|cyclosporins|mesh-list
56463054|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463055|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463056|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463057|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
56463058|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463059|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
56463060|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463061|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
56463062|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56463063|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56463064|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56463065|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463066|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56463067|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
56210969|NCT01598675|Methamphetamine|methamphetamine|mesh-list
56463068|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463069|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
56463070|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56463071|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56463072|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
56463073|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463074|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
56463075|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56463076|NCT00489372|Protective Agents|protective agents|mesh-ancestor
56463077|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463078|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463079|NCT00461903|Perindopril|perindopril|mesh-list
56463080|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56463081|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
56463082|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463083|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463084|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56463085|NCT00496392|Fentanyl|fentanyl|mesh-list
56463086|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56463087|NCT00496392|Narcotics|narcotics|mesh-ancestor
56463088|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56463089|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463090|NCT00496392|Analgesics|analgesics|mesh-ancestor
56463091|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
56463092|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463093|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56917417|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56917418|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
56917419|NCT00004124|Hormones|hormones|mesh-ancestor
56917420|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56917421|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463094|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56463095|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
56463096|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
56463097|NCT02893618|Diazoxide|diazoxide|mesh-list
56463098|NCT02893618|Choline|choline|mesh-list
56463099|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
56463100|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56463101|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
56463102|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463103|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56463104|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56463105|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
56463106|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56463107|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
56463108|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
56463109|NCT00496665|Methotrexate|methotrexate|mesh-list
56463110|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463114|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56463116|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463117|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463118|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56463119|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56463120|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
56463121|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56463122|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56463123|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
56463124|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
56463125|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463126|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56463127|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56463128|NCT00496704|Gemcitabine|gemcitabine|mesh-list
56463129|NCT00496704|Capecitabine|capecitabine|mesh-list
56463130|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
56463131|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56463132|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
56463133|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463134|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463135|NCT00496704|Antiviral Agents|antiviral agents|mesh-ancestor
56463136|NCT00496704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463137|NCT00496704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463138|NCT00496704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463139|NCT00496704|Immunologic Factors|immunologic factors|mesh-ancestor
56463140|NCT00496704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463141|NCT00591916|Thrombin|thrombin|mesh-list
56463142|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
56211045|NCT01599312|Cobalt|cobalt|mesh-list
56463143|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
56463144|NCT00591916|Coagulants|coagulants|mesh-ancestor
56463145|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56463146|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
56463147|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463148|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
56463149|NCT00591916|Protective Agents|protective agents|mesh-ancestor
56463150|NCT00462215|Vaccines|vaccines|mesh-list
56463151|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
56463152|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463153|NCT00462371|Insulin|insulin|mesh-list
56463154|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56463155|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463156|NCT00497016|Atorvastatin|atorvastatin|mesh-list
56463157|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56463158|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56463159|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
56463160|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463161|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56463162|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56463163|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917422|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56917423|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463164|NCT00222872|Hormones|hormones|mesh-list
56463165|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
56463166|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
56463167|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463168|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463169|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56463170|NCT00497172|Sirolimus|sirolimus|mesh-list
56463171|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463172|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463173|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56463174|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463175|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
56463176|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463177|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
56463178|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463179|NCT03273296|Amoxicillin|amoxicillin|mesh-list
56463180|NCT03273296|Azithromycin|azithromycin|mesh-list
56463182|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463186|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56463187|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463188|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463189|NCT00462878|Vancomycin|vancomycin|mesh-list
56463190|NCT00462878|Meropenem|meropenem|mesh-list
56463191|NCT00462878|Teicoplanin|teicoplanin|mesh-list
56463192|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463193|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463194|NCT00462956|Lapatinib|lapatinib|mesh-list
56463195|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463196|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56463197|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463198|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463199|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56463200|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463201|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56463202|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463203|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463204|NCT00489528|Hormones|hormones|mesh-list
56463205|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463206|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463207|NCT00463073|Bevacizumab|bevacizumab|mesh-list
56463208|NCT00463073|Cetuximab|cetuximab|mesh-list
56463209|NCT00463073|Irinotecan|irinotecan|mesh-list
56463210|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56463211|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463212|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56463213|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56463214|NCT00463073|Growth Substances|growth substances|mesh-ancestor
56463215|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463216|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
56463217|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56463218|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56463219|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463220|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463222|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
56463223|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56463224|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
56463225|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56463226|NCT00223028|Sirolimus|sirolimus|mesh-list
56463227|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463228|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463229|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56463230|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463231|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
56463232|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463233|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
56463234|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463235|NCT00489645|Pramlintide|pramlintide|mesh-list
56463236|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
56463237|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56463238|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917424|NCT00004124|Analgesics|analgesics|mesh-ancestor
56917425|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
56917426|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463239|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
56463240|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56463241|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
56463242|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463243|NCT00463268|Vitamin D|vitamin d|mesh-list
56463244|NCT00463268|Alendronate|alendronate|mesh-list
56463245|NCT00463268|Calcium|calcium|mesh-list
56463246|NCT00463268|Vitamins|vitamins|mesh-ancestor
56463247|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
56463248|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463249|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56463250|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56463251|NCT00489723|Tamsulosin|tamsulosin|mesh-list
56463252|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56463253|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56463254|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56463255|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
56463256|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463259|NCT00489723|Urological Agents|urological agents|mesh-ancestor
56463261|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463262|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56463263|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463264|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463265|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
56463266|NCT00489840|Anecortave|anecortave|mesh-list
56463267|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56463268|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56463269|NCT00489840|Growth Substances|growth substances|mesh-ancestor
56463270|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463271|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
56463272|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463273|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463274|NCT00463502|Metformin|metformin|mesh-list
56463275|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56463276|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463277|NCT00489996|Gemcitabine|gemcitabine|mesh-list
56463278|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463279|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56463280|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
56463281|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463282|NCT00489996|Antiviral Agents|antiviral agents|mesh-ancestor
56463283|NCT00489996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463284|NCT00489996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463285|NCT00489996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463286|NCT00489996|Immunologic Factors|immunologic factors|mesh-ancestor
56463287|NCT00489996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463288|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
56463289|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56463290|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56463291|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
56463292|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463293|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463294|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463295|NCT00463541|Urological Agents|urological agents|mesh-ancestor
56463296|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
56463297|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
56463298|NCT00490113|Vitamins|vitamins|mesh-ancestor
56463299|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
56463300|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463301|NCT01243203|Varenicline|varenicline|mesh-list
56463302|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56463303|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56463304|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
56463305|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463306|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463307|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463308|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
56463309|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56463310|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
56463311|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463312|NCT00497328|Expectorants|expectorants|mesh-ancestor
56917427|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56917428|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56917429|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917430|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917431|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
56917432|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
56917433|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
56917434|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56917435|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917436|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
56917437|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
56917438|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56917439|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56917440|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917441|NCT01334684|Metformin|metformin|mesh-list
56917442|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56917443|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917444|NCT01334762|Letrozole|letrozole|mesh-list
56917445|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917446|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56917447|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56917448|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463313|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
56463314|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56463315|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
56463316|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463317|NCT00497328|Protective Agents|protective agents|mesh-ancestor
56463318|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463319|NCT00497328|Antidotes|antidotes|mesh-ancestor
56463320|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
56463321|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
56463322|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56463323|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
56463324|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463325|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463326|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56463327|NCT00466154|Aspirin|aspirin|mesh-list
56463328|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56463329|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56463333|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463334|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463335|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56463336|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56463337|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56463338|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463339|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56463340|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56463341|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463342|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
56463343|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56463344|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56463345|NCT00490308|Estradiol|estradiol|mesh-list
56463346|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56917449|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917450|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56917451|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
56917452|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56917453|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917454|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
56917455|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
56917456|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56917457|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
56917458|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917459|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917460|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56917461|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
56917462|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56917463|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56917464|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56917465|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
56917466|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917467|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917468|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56917469|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
56917470|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56917471|NCT01335074|Sirolimus|sirolimus|mesh-list
56917472|NCT01335074|Sorafenib|sorafenib|mesh-list
56917473|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917474|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56917475|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917476|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917477|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56179931|NCT01402479|Ramipril|ramipril|mesh-list
56463347|NCT00490308|Estrogens|estrogens|mesh-ancestor
56463348|NCT00490308|Hormones|hormones|mesh-ancestor
56463349|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463350|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463351|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56463352|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
56463353|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56463354|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56463355|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
56463356|NCT00463736|Analgesics|analgesics|mesh-ancestor
56463357|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
56463358|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917478|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917479|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56463359|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463360|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
56463361|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56463362|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56463363|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
56463364|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56463365|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56463366|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463367|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56463368|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
56211273|NCT05689242|Analgesics|analgesics|mesh-ancestor
56463369|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56463371|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56463372|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56463373|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56463374|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463375|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56463376|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463377|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
56463378|NCT00497523|Beclomethasone|beclomethasone|mesh-list
56463379|NCT00497523|Albuterol|albuterol|mesh-list
56463380|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56463381|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
56463382|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463383|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463384|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56463385|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
56463386|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
56463387|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56463388|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56463389|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56463390|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56463391|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
56463392|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463393|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463394|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463395|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
56463396|NCT00497523|Hormones|hormones|mesh-ancestor
56463397|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463398|NCT00463775|Topiramate|topiramate|mesh-list
56463399|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
56463400|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56463403|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463404|NCT00466232|Sorafenib|sorafenib|mesh-list
56463405|NCT00466232|Topotecan|topotecan|mesh-list
56463406|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463407|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56463408|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463409|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463410|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56463411|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56463412|NCT00490659|Gemcitabine|gemcitabine|mesh-list
56463413|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463414|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56463415|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
56463416|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463417|NCT00490659|Antiviral Agents|antiviral agents|mesh-ancestor
56463418|NCT00490659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463419|NCT00490659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463420|NCT00490659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463421|NCT00490659|Immunologic Factors|immunologic factors|mesh-ancestor
56463422|NCT00490659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463423|NCT00490737|Daptomycin|daptomycin|mesh-list
56463424|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463425|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463426|NCT00497562|Tramadol|tramadol|mesh-list
56463427|NCT00497562|Amitriptyline|amitriptyline|mesh-list
56463428|NCT00497562|Fluoxetine|fluoxetine|mesh-list
56463429|NCT00497562|Hormones|hormones|mesh-list
56463430|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56917480|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
56917481|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463431|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463432|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56463433|NCT00497562|Narcotics|narcotics|mesh-ancestor
56463434|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56463435|NCT00497562|Analgesics|analgesics|mesh-ancestor
56463436|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
56463437|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463438|NCT00497562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56463439|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56463440|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56463441|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463442|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463443|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
56463444|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56463445|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
56463446|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56463447|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56463448|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56463449|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463450|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56463451|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56463452|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56463453|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
56463454|NCT00497601|Amphotericin B|amphotericin b|mesh-list
56463455|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56463456|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56463457|NCT00497601|Amebicides|amebicides|mesh-ancestor
56463458|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56463459|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56463460|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463461|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463462|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
56463463|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56463464|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56463465|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56463466|NCT00466388|Cevimeline|cevimeline|mesh-list
56463467|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56463468|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
56463469|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463470|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463471|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56463472|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56463473|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
56463475|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463476|NCT00466466|Everolimus|everolimus|mesh-list
56463477|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463478|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463479|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
56463480|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463481|NCT00490854|Insulin|insulin|mesh-list
56463482|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56463483|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
56463484|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
56463485|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
56463486|NCT00490854|Protamines|protamines|mesh-list
56463487|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56463488|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463489|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
56463490|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463491|NCT00490854|Coagulants|coagulants|mesh-ancestor
56463492|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
56463493|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56463494|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463495|NCT03272126|Vitamin D|vitamin d|mesh-list
56463496|NCT03272126|Vitamins|vitamins|mesh-ancestor
56463497|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
56463498|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463499|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56463500|NCT00491049|Levofloxacin|levofloxacin|mesh-list
56463501|NCT00491049|Ofloxacin|ofloxacin|mesh-list
56463502|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56463503|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56917482|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
56917483|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917484|NCT01337492|Sorafenib|sorafenib|mesh-list
56917485|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917486|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56917487|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917488|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917489|NCT01337570|Dapivirine|dapivirine|mesh-list
56917490|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56917491|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56917492|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
56917493|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917494|NCT01337804|Omeprazole|omeprazole|mesh-list
56917495|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56917496|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56463504|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56463505|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463506|NCT00491049|Renal Agents|renal agents|mesh-ancestor
56463507|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463508|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56463509|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56463510|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463511|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463512|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463513|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56463514|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56463515|NCT00464165|Rimonabant|rimonabant|mesh-list
56463516|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56463517|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56463518|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56463519|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463520|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463521|NCT00464165|Hormones|hormones|mesh-ancestor
56463522|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463523|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463524|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
56463525|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56463526|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56463527|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56463528|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56463529|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463530|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
56463531|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463532|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463533|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56463534|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463535|NCT03272321|Oxytocin|oxytocin|mesh-list
56463536|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
56463537|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56463538|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463539|NCT00491127|Gemcitabine|gemcitabine|mesh-list
56463540|NCT00491127|Dexamethasone|dexamethasone|mesh-list
56463541|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463543|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
56463544|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463545|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463546|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56463547|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
56463548|NCT00491127|Hormones|hormones|mesh-ancestor
56917497|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56917498|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56917499|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917500|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917501|NCT01776424|Aspirin|aspirin|mesh-list
56917502|NCT01776424|Pantoprazole|pantoprazole|mesh-list
55786225|NCT01117441|Vindesine|vindesine|mesh-list
56463550|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56463552|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56463553|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
56463554|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463555|NCT00491127|Antiviral Agents|antiviral agents|mesh-ancestor
56463556|NCT00491127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463557|NCT00491127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463558|NCT00491127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463559|NCT00491127|Immunologic Factors|immunologic factors|mesh-ancestor
56463560|NCT00491166|Bromfenac|bromfenac|mesh-list
56463561|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56463562|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56463563|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56463564|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56463565|NCT00491166|Analgesics|analgesics|mesh-ancestor
56463566|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
56463567|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463568|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463569|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463570|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56463571|NCT03273062|Tolcapone|tolcapone|mesh-list
56463572|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56463573|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56463574|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56463575|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463576|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463577|NCT00498108|Rotigotine|rotigotine|mesh-list
56463578|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
56463579|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
56463580|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463581|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463582|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463583|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56463584|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
56463585|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463586|NCT00498225|Gemcitabine|gemcitabine|mesh-list
56463587|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56463588|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
56463589|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463590|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463591|NCT00498225|Antiviral Agents|antiviral agents|mesh-ancestor
56463592|NCT00498225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211497|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
56463593|NCT00498225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463594|NCT00498225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463595|NCT00498225|Immunologic Factors|immunologic factors|mesh-ancestor
56463596|NCT00498225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463597|NCT00466622|Metformin|metformin|mesh-list
56463598|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56463599|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463600|NCT01327612|Leucovorin|leucovorin|mesh-list
56463601|NCT01327612|Bevacizumab|bevacizumab|mesh-list
56463602|NCT01327612|Conatumumab|conatumumab|mesh-list
56463603|NCT01327612|Fluorouracil|fluorouracil|mesh-list
56463604|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
56463605|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56463606|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463607|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56463608|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56463609|NCT01327612|Growth Substances|growth substances|mesh-ancestor
56463610|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463611|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
56463612|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
56917503|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
56917504|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56917505|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56917506|NCT01776424|Analgesics|analgesics|mesh-ancestor
56917507|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
56628142|NCT04268537|Antibodies|antibodies|mesh-list
56463613|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334216|NCT00398853|Trace Elements|trace elements|mesh-ancestor
56463614|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56463615|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463616|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
56463617|NCT01327612|Antidotes|antidotes|mesh-ancestor
56463618|NCT01327612|Protective Agents|protective agents|mesh-ancestor
56463619|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
56463624|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463626|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463627|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463628|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
56463629|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463630|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
56463631|NCT04132882|Antidotes|antidotes|mesh-ancestor
56463632|NCT04132882|Protective Agents|protective agents|mesh-ancestor
56463633|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463634|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
56463635|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463636|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
56463637|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463638|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463639|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
56463640|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
56463641|NCT01243359|Bevacizumab|bevacizumab|mesh-list
56463642|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56463643|NCT01243359|Sunitinib|sunitinib|mesh-list
56463644|NCT01243359|Antibodies|antibodies|mesh-list
56463645|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
56463646|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56463647|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463648|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56463649|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56463650|NCT01243359|Growth Substances|growth substances|mesh-ancestor
56463651|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463652|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
56463653|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
56463654|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56463655|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463656|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463657|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
56463658|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56463659|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
56463660|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463661|NCT00498342|Expectorants|expectorants|mesh-ancestor
56463662|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
56463663|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56463664|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
56463665|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463666|NCT00498342|Protective Agents|protective agents|mesh-ancestor
56463667|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463668|NCT00498342|Antidotes|antidotes|mesh-ancestor
56463669|NCT00466856|Octreotide|octreotide|mesh-list
56463670|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56463671|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56463672|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463673|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
56463674|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463675|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463676|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56463677|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56463678|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463679|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463680|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463681|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56917508|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917509|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917510|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463682|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56463683|NCT00591994|Piribedil|piribedil|mesh-list
56463684|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56463685|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56463686|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
56463687|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
56463688|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463689|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463690|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463691|NCT00464594|Metformin|metformin|mesh-list
56463692|NCT00464594|Acarbose|acarbose|mesh-list
56463693|NCT00464594|Gliclazide|gliclazide|mesh-list
56463696|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56463698|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463699|NCT04397302|Valsartan|valsartan|mesh-list
56463700|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56463701|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56463702|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56463703|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56463704|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463705|NCT00466895|Lenalidomide|lenalidomide|mesh-list
56463706|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
56463707|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463708|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56463709|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56463710|NCT00466895|Growth Substances|growth substances|mesh-ancestor
56463711|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
56463712|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463713|NCT02893540|Capecitabine|capecitabine|mesh-list
56463714|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56463715|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
56463716|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463717|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463718|NCT01327573|Eculizumab|eculizumab|mesh-list
56463719|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56463720|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463721|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
56463722|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463723|NCT02893384|Anesthetics|anesthetics|mesh-list
56463724|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
56463725|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56463726|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463727|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
56463728|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463729|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
56463730|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
56463731|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
56463732|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56463733|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463734|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
56463735|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463736|NCT00498537|Spironolactone|spironolactone|mesh-list
56463737|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56463738|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
56463739|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463740|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463741|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56463742|NCT00498537|Diuretics|diuretics|mesh-ancestor
56463743|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
56463744|NCT00491478|Sertraline|sertraline|mesh-list
56463745|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
56463746|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56463747|NCT00491478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56463748|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56463749|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56463750|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917511|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56917512|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56917513|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56917514|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917515|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56917516|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56917517|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917519|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56917520|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
56917521|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56917522|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
56917523|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
56917524|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56917525|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203286|NCT01538953|Eusol|eusol|mesh-list
56463751|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463752|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
56463753|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463755|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463756|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463757|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56463758|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463759|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
56463760|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463761|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
56463762|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463763|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
56463764|NCT00464789|Estrogens|estrogens|mesh-list
56463768|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463769|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56463770|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56463771|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
56463772|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56463774|NCT00467012|Bevacizumab|bevacizumab|mesh-list
56463775|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56463776|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463777|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56463778|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56463779|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56463780|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463781|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56463782|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56463783|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56463784|NCT00467012|Growth Substances|growth substances|mesh-ancestor
56463785|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463786|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
56463787|NCT03272867|Mannitol|mannitol|mesh-list
56463788|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56463789|NCT03272867|Diuretics|diuretics|mesh-ancestor
56463790|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
56463791|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463792|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
56463793|NCT01327495|Testosterone|testosterone|mesh-list
56463794|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
56463795|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
56463796|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56463797|NCT01327495|Acyline|acyline|mesh-list
56463798|NCT01327495|Androgens|androgens|mesh-ancestor
56463799|NCT01327495|Hormones|hormones|mesh-ancestor
56463800|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898853|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56917526|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56917527|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56917528|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56917529|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
56917530|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917531|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917532|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56917533|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
56180011|NCT01403181|Ribavirin|ribavirin|mesh-list
56463801|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463802|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56463803|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463804|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
56463805|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
56463806|NCT00491634|Treosulfan|treosulfan|mesh-list
56463807|NCT00491634|Busulfan|busulfan|mesh-list
56463808|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56463809|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
56463810|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463811|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463812|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463813|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
56463814|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463815|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56463816|NCT01327339|Ropinirole|ropinirole|mesh-list
56463817|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56463818|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56463819|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
56463821|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463822|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463823|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463824|NCT01327300|Mesalamine|mesalamine|mesh-list
56463825|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56463826|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56463827|NCT01327300|Analgesics|analgesics|mesh-ancestor
56463828|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
56463829|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463830|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463831|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463832|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56463833|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
56463834|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56463835|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56463836|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56463839|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
56463840|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463841|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463842|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56463843|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463844|NCT00592111|Prednisone|prednisone|mesh-list
56463845|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
56463846|NCT00592111|Etoposide|etoposide|mesh-list
56463847|NCT00592111|Vincristine|vincristine|mesh-list
56463848|NCT00592111|Doxorubicin|doxorubicin|mesh-list
56463849|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56463850|NCT00592111|Bleomycin|bleomycin|mesh-list
56463851|NCT00592111|Vinblastine|vinblastine|mesh-list
56463852|NCT00592111|Procarbazine|procarbazine|mesh-list
56463853|NCT00592111|Mitogens|mitogens|mesh-list
56463854|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463855|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
56463856|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463857|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56463858|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56463859|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
56463860|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463861|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917534|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
56917535|NCT00642148|Hormones|hormones|mesh-ancestor
56463862|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56463863|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463864|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
56463865|NCT00592111|Hormones|hormones|mesh-ancestor
56463866|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463867|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56463868|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56463869|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56463870|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56463871|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463872|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
56463873|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
56463874|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
56463875|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56463876|NCT00592150|Fenoldopam|fenoldopam|mesh-list
56463877|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56463878|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
56463879|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
56463880|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
56463881|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211809|NCT04583501|Omalizumab|omalizumab|mesh-list
56211810|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56211811|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56211812|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
56211813|NCT04563494|Dexamethasone|dexamethasone|mesh-list
56211814|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56211815|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
56211816|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
56211817|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211818|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211819|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56211820|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
56211821|NCT04563494|Hormones|hormones|mesh-ancestor
56211825|NCT04552288|Benralizumab|benralizumab|mesh-list
56463882|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463883|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463884|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
56463885|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56463886|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
56463887|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463888|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463889|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
56463890|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56463891|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463892|NCT04377295|Ranibizumab|ranibizumab|mesh-list
56463893|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56463894|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56463895|NCT04377295|Growth Substances|growth substances|mesh-ancestor
56463896|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463897|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
56463900|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56463901|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
56463902|NCT00491712|Hormones|hormones|mesh-ancestor
56463903|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463904|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463905|NCT02893111|Bortezomib|bortezomib|mesh-list
56463906|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463907|NCT04328272|Azithromycin|azithromycin|mesh-list
56463908|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
56463909|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463910|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463911|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
56463912|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56463913|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56463914|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463915|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463916|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56463917|NCT04328194|Thrombin|thrombin|mesh-list
56463918|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
56463919|NCT04328194|Coagulants|coagulants|mesh-ancestor
56463920|NCT00491790|Montelukast|montelukast|mesh-list
56463921|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56463922|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56463923|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56463924|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
56917536|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56917537|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
56917538|NCT00629980|Azithromycin|azithromycin|mesh-list
56463925|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463926|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463927|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56463928|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56463929|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463930|NCT03272009|Interferons|interferons|mesh-list
56463931|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
56463932|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
56463933|NCT03272009|Entecavir|entecavir|mesh-list
56463934|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56463935|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463936|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
56463937|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463938|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
56463939|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463940|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56463941|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56463942|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56463943|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
56463944|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463945|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463946|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463947|NCT00498888|Urological Agents|urological agents|mesh-ancestor
56463948|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
56463949|NCT00491868|Hematinics|hematinics|mesh-ancestor
56463950|NCT00491907|Folic Acid|folic acid|mesh-list
56463951|NCT00491907|Hematinics|hematinics|mesh-ancestor
56463952|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
56463953|NCT00491907|Vitamins|vitamins|mesh-ancestor
56463954|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
56463955|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463956|NCT00499005|Carbetocin|carbetocin|mesh-list
56463957|NCT00499005|Oxytocin|oxytocin|mesh-list
56463958|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
56463959|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56463960|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463961|NCT00491946|Dactinomycin|dactinomycin|mesh-list
56463962|NCT00491946|Vincristine|vincristine|mesh-list
56463963|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56463964|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463965|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
56463966|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
56463967|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
56463968|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463969|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463970|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463971|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56463972|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56463973|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463978|NCT02892916|Ketamine|ketamine|mesh-list
56463979|NCT02892916|Analgesics|analgesics|mesh-ancestor
56463980|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
56463981|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463982|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463983|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56463984|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56463985|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
56463986|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
56463987|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56463988|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56463989|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56463990|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463991|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463992|NCT00492102|Montelukast|montelukast|mesh-list
56463993|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56463994|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
56463995|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56463996|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
56463997|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56917539|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56917540|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917541|NCT00629590|Azithromycin|azithromycin|mesh-list
56917542|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56463998|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463999|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56464000|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56464001|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464002|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
56464003|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56464004|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464005|NCT00492141|Temozolomide|temozolomide|mesh-list
56464006|NCT00492141|Camptothecin|camptothecin|mesh-list
56464007|NCT00492141|Rubitecan|rubitecan|mesh-list
56464008|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56464009|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
56464010|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464011|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464012|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56464013|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56464014|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56464015|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464016|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
56464017|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56464018|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464019|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464020|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56464021|NCT04327726|Analgesics|analgesics|mesh-ancestor
56464022|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
56464023|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464024|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56464025|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56464026|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56464027|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
56464028|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464029|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464030|NCT00492219|Cimetidine|cimetidine|mesh-list
56464031|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56211949|NCT04098250|Analgesics|analgesics|mesh-ancestor
56464032|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56464033|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56464034|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
56464036|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464037|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464038|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464039|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56464040|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56464041|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464047|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464048|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464049|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
56464050|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
56464051|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56464052|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
56464053|NCT04130776|Kallikreins|kallikreins|mesh-list
56464054|NCT04130776|Coagulants|coagulants|mesh-ancestor
56464055|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56464056|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
56464057|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56464058|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464059|NCT00492258|Sorafenib|sorafenib|mesh-list
56464060|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464061|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56464062|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464063|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464064|NCT02955810|Dexamethasone|dexamethasone|mesh-list
56464065|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
56464066|NCT02955810|Bortezomib|bortezomib|mesh-list
56464067|NCT02955810|Daratumumab|daratumumab|mesh-list
56464068|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56464069|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
56917543|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203586|NCT01540708|Hormones|hormones|mesh-ancestor
56464070|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464071|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56464072|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56464073|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
56464074|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464075|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464076|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56464077|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56464078|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
56464079|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
56464080|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464081|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56464082|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
56464083|NCT02955810|Hormones|hormones|mesh-ancestor
56464084|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56464085|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56464086|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
56464087|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56464088|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464089|NCT00492414|Paroxetine|paroxetine|mesh-list
56464090|NCT00492414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56464091|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56464092|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56464093|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464094|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464095|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
56464096|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464097|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56464098|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
56464099|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56464100|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56464101|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56464102|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464103|NCT01243632|Gemcitabine|gemcitabine|mesh-list
56464104|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56464105|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
56212022|NCT03926026|Fluticasone|fluticasone|mesh-list
56464106|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464107|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464108|NCT01243632|Antiviral Agents|antiviral agents|mesh-ancestor
56464109|NCT01243632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464110|NCT01243632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464111|NCT01243632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56464112|NCT01243632|Immunologic Factors|immunologic factors|mesh-ancestor
56464114|NCT00467909|Micronutrients|micronutrients|mesh-list
56464115|NCT00467909|Trace Elements|trace elements|mesh-list
56464116|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464117|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56464118|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56464119|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464120|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
56464121|NCT00467948|Cefazolin|cefazolin|mesh-list
56464122|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56464123|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464124|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
56464125|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464126|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
56464127|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
56464128|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
56464129|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464130|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
56464131|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56464132|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
56464133|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464134|NCT00592618|Expectorants|expectorants|mesh-ancestor
56464135|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
56464136|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56464137|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
56464138|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464139|NCT00592618|Protective Agents|protective agents|mesh-ancestor
56464140|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917544|NCT00626704|Doxorubicin|doxorubicin|mesh-list
56917545|NCT00626704|Conatumumab|conatumumab|mesh-list
56917546|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56917547|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917548|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56917549|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56917550|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917551|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917552|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56917553|NCT00765700|Ketoprofen|ketoprofen|mesh-list
56917554|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56917555|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56917556|NCT00765700|Analgesics|analgesics|mesh-ancestor
56917557|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
56917558|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917559|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464141|NCT00592618|Antidotes|antidotes|mesh-ancestor
56464142|NCT01243710|Taurolidine|taurolidine|mesh-list
56464143|NCT01243710|Heparin|heparin|mesh-list
56464144|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
56464145|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56464146|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56464147|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464148|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464149|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56464150|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464151|NCT00622843|Vaccines|vaccines|mesh-list
56464152|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56464153|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
56464154|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464155|NCT01245543|Docetaxel|docetaxel|mesh-list
56464156|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464157|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
56464158|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
56464159|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
56464160|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464161|NCT00592930|Olanzapine|olanzapine|mesh-list
56464162|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
56464163|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
56464164|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464165|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464166|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56464167|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56464168|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56464169|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464170|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56464171|NCT00592930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56464172|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56464173|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56464174|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464175|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464176|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
56464177|NCT00592969|Metformin|metformin|mesh-list
56464178|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
56464179|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
56464180|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56464181|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464182|NCT01245582|Capecitabine|capecitabine|mesh-list
56464183|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
56917560|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56917561|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56464184|NCT01245582|Sorafenib|sorafenib|mesh-list
56464185|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56464186|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
56464187|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464188|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464194|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
56464195|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464196|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464197|NCT00593008|Antiviral Agents|antiviral agents|mesh-ancestor
56464198|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464199|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464200|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56464201|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
56464202|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464203|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56464204|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56464205|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
56464206|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56464207|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56464208|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464209|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56464210|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
56464211|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464212|NCT00593125|Levetiracetam|levetiracetam|mesh-list
56464213|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
56464214|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
56464215|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
56464216|NCT00593164|Analgesics|analgesics|mesh-ancestor
56464217|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
56464218|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464219|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464220|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
56464221|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464222|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56464223|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
56464224|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56464225|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56464226|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464227|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56464228|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
56464229|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56464230|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
56464231|NCT01316107|Nateglinide|nateglinide|mesh-list
56464232|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56464233|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464234|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56464235|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464236|NCT05654194|Azacitidine|azacitidine|mesh-list
56464237|NCT05654194|Venetoclax|venetoclax|mesh-list
56464238|NCT05654194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56464239|NCT05654194|Antimetabolites|antimetabolites|mesh-ancestor
56464240|NCT05654194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464241|NCT05654194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464242|NCT05654194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464243|NCT05653453|Gemcitabine|gemcitabine|mesh-list
56464244|NCT05653453|Paclitaxel|paclitaxel|mesh-list
56464245|NCT05653453|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56464246|NCT05653453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56464247|NCT05653453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464248|NCT05653453|Tubulin Modulators|tubulin modulators|mesh-ancestor
56464249|NCT05653453|Antimitotic Agents|antimitotic agents|mesh-ancestor
56464250|NCT05653453|Mitosis Modulators|mitosis modulators|mesh-ancestor
56464251|NCT05653453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464252|NCT05653453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56464253|NCT05653453|Antimetabolites|antimetabolites|mesh-ancestor
56464254|NCT05653453|Antiviral Agents|antiviral agents|mesh-ancestor
56464255|NCT05653453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212173|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
56464256|NCT05653453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464257|NCT05653453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917562|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56917563|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917564|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917565|NCT02280694|Celecoxib|celecoxib|mesh-list
56917566|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
56917567|NCT02280694|Capecitabine|capecitabine|mesh-list
56917568|NCT02280694|Methotrexate|methotrexate|mesh-list
56917569|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917570|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
56917571|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917572|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56917573|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56917574|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
56917575|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917576|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464263|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464264|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
56464265|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464266|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
56464267|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464268|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56464269|NCT00465452|Dopamine|dopamine|mesh-list
56464270|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
56464271|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56464272|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
56464273|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
56464274|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464275|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464276|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
56464277|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464278|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464279|NCT00465452|Protective Agents|protective agents|mesh-ancestor
56464280|NCT01379521|Everolimus|everolimus|mesh-list
56464281|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464282|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56464283|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
56464284|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464285|NCT00468260|Epothilone B|epothilone b|mesh-list
56464286|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464287|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
56464288|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
56464289|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
56464290|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464291|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
56464292|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56464293|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56464294|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
56464295|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464296|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464297|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464298|NCT01371994|Urological Agents|urological agents|mesh-ancestor
56464299|NCT00465608|Propranolol|propranolol|mesh-list
56464300|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56464301|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56464302|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
56464303|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464304|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464305|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464306|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56917577|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56917578|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56464307|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56464308|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
56464309|NCT01371877|Vitamin D|vitamin d|mesh-list
56464310|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
56464311|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
56464312|NCT01371877|Vitamins|vitamins|mesh-list
56464313|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
56464314|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464315|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56464316|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56464317|NCT01245816|Eflornithine|eflornithine|mesh-list
56464318|NCT01245816|Sulindac|sulindac|mesh-list
56464319|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464320|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56464321|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56464322|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56464323|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464324|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56464325|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464326|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464327|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56464328|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56464330|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
56464331|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464332|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464334|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56464335|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56464338|NCT00492687|Temozolomide|temozolomide|mesh-list
56464339|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464340|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464341|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56464342|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
56464343|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56464344|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
56464345|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56464346|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464347|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56464348|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56464349|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56464350|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56464351|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
56464352|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56464353|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56464354|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464355|NCT01245855|Alprostadil|alprostadil|mesh-list
56464356|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56464357|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
56464358|NCT01245855|Urological Agents|urological agents|mesh-ancestor
56464359|NCT00473603|Heparin|heparin|mesh-list
56464360|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
56464361|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56464362|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56464363|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464364|NCT00492765|Interferons|interferons|mesh-list
56464365|NCT00492765|Interferon-beta|interferon-beta|mesh-list
56464366|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
56464367|NCT00492765|Simvastatin|simvastatin|mesh-list
56464368|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464369|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
56464370|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464371|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56464372|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56464373|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
56464374|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464375|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56464376|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56464377|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464378|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
56464379|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464380|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56917579|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
56180067|NCT01403415|Hormones|hormones|mesh-ancestor
56464381|NCT00468533|Aripiprazole|aripiprazole|mesh-list
56464382|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
56464383|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56464384|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56464385|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56464386|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464387|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464388|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
56464389|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
56464390|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464391|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464392|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56464393|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56464394|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
56464395|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56464396|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56464397|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56464398|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56464399|NCT00473720|Paclitaxel|paclitaxel|mesh-list
56464400|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56464401|NCT00473720|Satraplatin|satraplatin|mesh-list
56464402|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56464403|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464409|NCT00499668|Aprepitant|aprepitant|mesh-list
56464410|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
56464411|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
56464412|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464413|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464414|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56464415|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
56464416|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
56464417|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56464418|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
56464419|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464420|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464421|NCT00499668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56464422|NCT00499668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56464423|NCT00499668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464424|NCT00499668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56464425|NCT00499668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56464426|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56464427|NCT00499707|Metformin|metformin|mesh-list
56464428|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
56464429|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56464430|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464431|NCT01366534|Vaccines|vaccines|mesh-list
56464432|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
56464433|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464434|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
56464435|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56464436|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464437|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
56464438|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
56464439|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
56464440|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56464441|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56464442|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
56464443|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
56464444|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464445|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464446|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464447|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56464448|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
56464449|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56464450|NCT01605526|Doxorubicin|doxorubicin|mesh-list
56464451|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56464452|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464453|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56464454|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56464455|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464456|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464457|NCT00468689|Ketoconazole|ketoconazole|mesh-list
56464458|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
56917580|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56917581|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
56917582|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56917584|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917585|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56917586|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56917587|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56917588|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56917589|NCT02280694|Analgesics|analgesics|mesh-ancestor
56917590|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
56917591|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464459|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464460|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56464461|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56464462|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464463|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464464|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56464465|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
56464466|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56464467|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464468|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56464469|NCT00473915|Fluticasone|fluticasone|mesh-list
56464470|NCT00473915|Xhance|xhance|mesh-list
56464471|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56464472|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56464473|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
56212399|NCT05703555|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212400|NCT05703555|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212403|NCT05703425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212404|NCT05703425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56464474|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464475|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464476|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56464477|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
56464478|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
56464479|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56464481|NCT00493077|Interferon-beta|interferon-beta|mesh-list
56464482|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
56464483|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464484|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
56464485|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464486|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
56464487|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464488|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56464489|NCT00474071|Remifentanil|remifentanil|mesh-list
56464490|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56464491|NCT00474071|Narcotics|narcotics|mesh-ancestor
56464492|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464493|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464494|NCT00474071|Analgesics|analgesics|mesh-ancestor
56464495|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
56464496|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464497|NCT00474110|Ketamine|ketamine|mesh-list
56464498|NCT00474110|Hydromorphone|hydromorphone|mesh-list
56464499|NCT00474110|Analgesics|analgesics|mesh-ancestor
56464500|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
56464501|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464502|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464503|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56464504|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56464505|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
56464506|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
55899182|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
56917592|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56917593|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56464507|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464508|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56464509|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56464510|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464511|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464512|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56464513|NCT00474110|Narcotics|narcotics|mesh-ancestor
56464514|NCT00500058|Rituximab|rituximab|mesh-list
56464515|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56464516|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464517|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
56464518|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464519|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56464520|NCT00468923|Candesartan|candesartan|mesh-list
56464521|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56464522|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56464523|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56464524|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
56464525|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464526|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56464527|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56464528|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464529|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56464530|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56464531|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56464532|NCT01365481|Amlodipine|amlodipine|mesh-list
56464533|NCT01365481|Valsartan|valsartan|mesh-list
56464534|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56464535|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56464536|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56464537|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56464538|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464539|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56464540|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464541|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
56464543|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56464544|NCT01365481|Diuretics|diuretics|mesh-ancestor
56464545|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
56464546|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56464547|NCT00493116|Interferons|interferons|mesh-list
56464548|NCT00493116|Interferon-beta|interferon-beta|mesh-list
56464549|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
56464550|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
56464551|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464552|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
56464553|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464554|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56464555|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
56464556|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
56464557|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464558|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464559|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56464560|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
56464562|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56464563|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56464564|NCT00493116|Protective Agents|protective agents|mesh-ancestor
56464565|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
56464566|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56464567|NCT00493194|Cyclosporine|cyclosporine|mesh-list
56464568|NCT00493194|Sirolimus|sirolimus|mesh-list
56464569|NCT00493194|Cyclosporins|cyclosporins|mesh-list
56464570|NCT00493194|Daclizumab|daclizumab|mesh-list
56464571|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464572|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464573|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56464574|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
56464575|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464576|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
56464577|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464578|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
56464579|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56917594|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56917595|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56917596|NCT02280772|Cathartics|cathartics|mesh-ancestor
56917597|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56917598|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
56917599|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
56917600|NCT00799864|Tenofovir|tenofovir|mesh-list
56917601|NCT00799864|Lamivudine|lamivudine|mesh-list
56917602|NCT00799864|Zidovudine|zidovudine|mesh-list
56917603|NCT00799864|Emtricitabine|emtricitabine|mesh-list
56917604|NCT00799864|Abacavir|abacavir|mesh-list
56917605|NCT00799864|Rilpivirine|rilpivirine|mesh-list
56917606|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
56917607|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917608|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56204085|NCT01543399|Hormones|hormones|mesh-ancestor
56464580|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56464581|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56464582|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56464583|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464584|NCT01605721|Everolimus|everolimus|mesh-list
56464585|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464586|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56464587|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
56464588|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464589|NCT01350271|Mebendazole|mebendazole|mesh-list
56464590|NCT01350271|Piperazine|piperazine|mesh-list
56464591|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
56464592|NCT01350271|DMP 777|dmp 777|mesh-list
56464593|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
56464594|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
56464595|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56464596|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464597|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
56464598|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
56464599|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
56464600|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464601|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464602|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464603|NCT00493233|Olanzapine|olanzapine|mesh-list
56464604|NCT00493233|Risperidone|risperidone|mesh-list
56464605|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56464606|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
56464607|NCT00493233|Clozapine|clozapine|mesh-list
56464608|NCT00493233|Perphenazine|perphenazine|mesh-list
56464609|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56464610|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
56464611|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464612|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464613|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464614|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56464615|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464616|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56464617|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56464618|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
56464619|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
56464621|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464622|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56464623|NCT00493233|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56464624|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56464625|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56464626|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
56464627|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
56464630|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
56464631|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56464632|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
56917609|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56917610|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917611|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917612|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56464633|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464634|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464635|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56464636|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
56464637|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56464638|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
56464639|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464640|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464641|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56464642|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
56464643|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
56464644|NCT00500253|Protective Agents|protective agents|mesh-ancestor
56464645|NCT00500253|Miotics|miotics|mesh-ancestor
56464646|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56464647|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56464648|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56464649|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56464650|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
56464651|NCT01243788|Fluticasone|fluticasone|mesh-list
56464652|NCT01243788|Xhance|xhance|mesh-list
56464653|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56464654|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56464655|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56464656|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
56464657|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464658|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464659|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56464660|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
56464661|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
56464662|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56464663|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56464664|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56464665|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56464666|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
56464667|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464668|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464669|NCT01243827|Carvedilol|carvedilol|mesh-list
56464670|NCT01243827|Bisoprolol|bisoprolol|mesh-list
56464671|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56464672|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56464673|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
56464674|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464675|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464676|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464677|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56464678|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
56464679|NCT01243827|Protective Agents|protective agents|mesh-ancestor
56464680|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56464681|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56464682|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56464683|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
56464684|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56464685|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56464686|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
56464687|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
56464688|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464689|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56464690|NCT00500409|Vitamin D|vitamin d|mesh-list
56464691|NCT00500409|Vitamins|vitamins|mesh-ancestor
56464692|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
56464693|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464694|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56464697|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56212625|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56212626|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899236|NCT00044655|Aripiprazole|aripiprazole|mesh-list
56917613|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56917614|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
56917615|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
56917616|NCT02281006|Antidotes|antidotes|mesh-ancestor
56212627|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212628|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
56464699|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464700|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
56464701|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464703|NCT00469430|Cefotaxime|cefotaxime|mesh-list
56464704|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464705|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56464706|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56464707|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56464708|NCT00469469|Bevacizumab|bevacizumab|mesh-list
56464709|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56464710|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464711|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56464712|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56464713|NCT00469469|Growth Substances|growth substances|mesh-ancestor
56464714|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464715|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
56464716|NCT00500565|Bupivacaine|bupivacaine|mesh-list
56464717|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
56464718|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
56464719|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464720|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464721|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
56464722|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464723|NCT00469547|Ethanol|ethanol|mesh-list
56464724|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
56464725|NCT00469547|Emollients|emollients|mesh-list
56464726|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56464727|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464728|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464729|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
56464730|NCT00500604|Valsartan|valsartan|mesh-list
56464731|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56464732|NCT00500604|Irbesartan|irbesartan|mesh-list
56464733|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56464734|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56464735|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56464736|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464737|NCT00500604|Diuretics|diuretics|mesh-ancestor
56464738|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
56464739|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464740|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56464741|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56464742|NCT00493389|Hormones|hormones|mesh-list
56464743|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56464744|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56464745|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464746|NCT01605994|Antacids|antacids|mesh-list
56464747|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464748|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56464749|NCT00500721|Desipramine|desipramine|mesh-list
56464750|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56464751|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
56464752|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56464753|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464754|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464755|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56464756|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56464757|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56464758|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
56464759|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464760|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464761|NCT00469586|Insulin|insulin|mesh-list
56464762|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56464763|NCT00469586|Metformin|metformin|mesh-list
56464764|NCT00469586|Glimepiride|glimepiride|mesh-list
56917617|NCT02281006|Protective Agents|protective agents|mesh-ancestor
56464765|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56464767|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56464768|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56464769|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
56464770|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
56464771|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56464772|NCT01606111|Protective Agents|protective agents|mesh-ancestor
56464773|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464774|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
56464775|NCT00493428|Baclofen|baclofen|mesh-list
56464776|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56464777|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464778|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56464779|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464780|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56464781|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
56464782|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
56464783|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464784|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464785|NCT01342510|Lidocaine|lidocaine|mesh-list
56464786|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
56464787|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
56464788|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
56464789|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464790|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464791|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
56464792|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464793|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56464794|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56464795|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56464796|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56464797|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464798|NCT01342510|Analgesics|analgesics|mesh-ancestor
56464799|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
56464800|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56464801|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56464802|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
56464803|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56464804|NCT01606345|Valrubicin|valrubicin|mesh-list
56464805|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464806|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56464807|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56464808|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464809|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464810|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56464811|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56464812|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56464813|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
56464814|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464815|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56464816|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56464817|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464818|NCT00469664|Guanfacine|guanfacine|mesh-list
56464819|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56464820|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56464821|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56464822|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56464823|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
56464824|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464825|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464826|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464827|NCT00469703|Thalidomide|thalidomide|mesh-list
56464828|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56464829|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
56464830|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464831|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
56464832|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56464833|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464834|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56464835|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56464836|NCT00469703|Growth Substances|growth substances|mesh-ancestor
56464837|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
56917618|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464838|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464842|NCT01244100|Analgesics|analgesics|mesh-ancestor
56464843|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
56464844|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464845|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464846|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56464847|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56464848|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56464849|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56464850|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464851|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56464852|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56464853|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464854|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
56464855|NCT01340872|Ferric maltol|ferric maltol|mesh-list
56464856|NCT01340872|Hematinics|hematinics|mesh-ancestor
56464857|NCT00469781|Bromfenac|bromfenac|mesh-list
56464858|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
56464859|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56464860|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
56464861|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56464862|NCT00469781|Prednisolone|prednisolone|mesh-list
56464863|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56464864|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
56464865|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56464866|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56464867|NCT00469781|Analgesics|analgesics|mesh-ancestor
56464868|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
56464869|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464870|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464871|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56464872|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56464873|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
56464874|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
56464875|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56464876|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
56464877|NCT00469781|Hormones|hormones|mesh-ancestor
56464878|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56464879|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56464880|NCT00469781|Protective Agents|protective agents|mesh-ancestor
56464881|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56464882|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464883|NCT00474695|Ranibizumab|ranibizumab|mesh-list
56464884|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56464885|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56464886|NCT00474695|Growth Substances|growth substances|mesh-ancestor
56464887|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464888|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
56464889|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464890|NCT03271502|Anesthetics|anesthetics|mesh-list
56464891|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464892|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464893|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
56464894|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56464895|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464896|NCT00474773|Celecoxib|celecoxib|mesh-list
56464897|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56464898|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56464899|NCT00474773|Analgesics|analgesics|mesh-ancestor
56464900|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
56464901|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464902|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464903|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56464904|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56464905|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56464906|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56464907|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464908|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464909|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
56464910|NCT00474890|Ephedrine|ephedrine|mesh-list
56464911|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56464917|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
56464918|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55899237|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56917619|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
56917620|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464919|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56464920|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
56464921|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
56212853|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
56464922|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464923|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464925|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56464926|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464927|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464928|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
56464929|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464930|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464931|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
56464932|NCT00501150|Linezolid|linezolid|mesh-list
56464933|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56464934|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464935|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56464936|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464937|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464938|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
56464939|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56464940|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
56464941|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464942|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464943|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56464944|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
56464945|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
56464946|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56464947|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
56464948|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464949|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464950|NCT01246089|Ranibizumab|ranibizumab|mesh-list
56464951|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56464952|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56464953|NCT01246089|Growth Substances|growth substances|mesh-ancestor
56464954|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464955|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
56464956|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56464957|NCT00598897|Clarithromycin|clarithromycin|mesh-list
56464958|NCT00598897|Rifabutin|rifabutin|mesh-list
56464959|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56464960|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464961|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56464962|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464963|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464964|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56464965|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56464966|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56464967|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
56464968|NCT04697732|Anesthetics|anesthetics|mesh-list
56464969|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56464970|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464971|NCT00501267|Oxybutynin|oxybutynin|mesh-list
56464972|NCT00501267|Solabegron|solabegron|mesh-list
56464973|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
56464974|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
56464975|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464976|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464977|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56464978|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56464979|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
56464980|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464984|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56464985|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56464986|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
56464987|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
56464988|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
56464989|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56464990|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886645|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917621|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
56917622|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56917623|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56464991|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464992|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
56464993|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56464994|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212932|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56464995|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464996|NCT00599287|Haloperidol|haloperidol|mesh-list
56464997|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
56464998|NCT00599287|Methylphenidate|methylphenidate|mesh-list
56464999|NCT00599287|Rivastigmine|rivastigmine|mesh-list
56465000|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56465001|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465002|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56465003|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56465004|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56465005|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465006|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
56465007|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465008|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
56465009|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
56465010|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465011|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56465012|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56465013|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56465014|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56465015|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56465016|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56465017|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56465018|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56465019|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465020|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
56465021|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56465022|NCT00599287|Protective Agents|protective agents|mesh-ancestor
56465023|NCT04326166|Metformin|metformin|mesh-list
56465024|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56465025|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465026|NCT00501384|Satavaptan|satavaptan|mesh-list
56465027|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56465028|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465029|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
56465030|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465031|NCT00599560|Vasopressins|vasopressins|mesh-list
56465032|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
56465033|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
56465034|NCT00599560|Coagulants|coagulants|mesh-ancestor
56465035|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56465036|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56465037|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
56465038|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465039|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
56465040|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56465041|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
56465042|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465043|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
56465044|NCT00599716|Protective Agents|protective agents|mesh-ancestor
56465045|NCT01246284|Triamcinolone|triamcinolone|mesh-list
56465046|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56465047|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56465048|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56465049|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465050|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
56465051|NCT01246284|Hormones|hormones|mesh-ancestor
56465053|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465054|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465056|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465057|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465058|NCT00599833|Cetuximab|cetuximab|mesh-list
56465059|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56465060|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465061|NCT00469976|Gemcitabine|gemcitabine|mesh-list
56917624|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
56917625|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
56917626|NCT00758290|Triclosan|triclosan|mesh-list
56917627|NCT00758290|Fluorides|fluorides|mesh-list
56465062|NCT00469976|Bevacizumab|bevacizumab|mesh-list
56465063|NCT00469976|Carboplatin|carboplatin|mesh-list
56465064|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56465065|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465066|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56465067|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56465068|NCT00469976|Growth Substances|growth substances|mesh-ancestor
56213004|NCT03624127|Apremilast|apremilast|mesh-list
56465069|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465070|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
56465071|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56465072|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
56465073|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465074|NCT00469976|Antiviral Agents|antiviral agents|mesh-ancestor
56465075|NCT00469976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465076|NCT00469976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465077|NCT00469976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465078|NCT00469976|Immunologic Factors|immunologic factors|mesh-ancestor
56465079|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56465080|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56465081|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56465082|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56465083|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465084|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465085|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465086|NCT00599911|Analgesics|analgesics|mesh-ancestor
56465087|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
56465088|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465089|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
56465090|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56465091|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
56465092|NCT00599950|Mitomycins|mitomycins|mesh-list
56465093|NCT00599950|Mitomycin|mitomycin|mesh-list
56465094|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56465095|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465096|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
56465097|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465098|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56465099|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465100|NCT00600145|Mirtazapine|mirtazapine|mesh-list
56465101|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
56465102|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56465103|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56465104|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
56465105|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
56465106|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465107|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465108|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465109|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56465110|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56465111|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56465112|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56465113|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56465114|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56465115|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
56465116|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56465117|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56465118|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
56465119|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56465120|NCT00470015|Aldesleukin|aldesleukin|mesh-list
56465121|NCT00470015|Interleukin-2|interleukin-2|mesh-list
56465125|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
56465126|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465127|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465128|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56465129|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56465130|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
56917628|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
56917629|NCT00758290|Protective Agents|protective agents|mesh-ancestor
56917630|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917631|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56465131|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465132|NCT00600262|Bevacizumab|bevacizumab|mesh-list
56465133|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56465134|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465135|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56465136|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56465137|NCT00600262|Growth Substances|growth substances|mesh-ancestor
56465138|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465139|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56465140|NCT00600301|Triamcinolone|triamcinolone|mesh-list
56465141|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56465142|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56465143|NCT00600301|Bevacizumab|bevacizumab|mesh-list
56465144|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56465145|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56465146|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465147|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56465148|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56465149|NCT00600301|Growth Substances|growth substances|mesh-ancestor
56465150|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465151|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
56465152|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465153|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
56465154|NCT00600301|Hormones|hormones|mesh-ancestor
56465155|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465156|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465157|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
56465158|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465159|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465160|NCT00501579|Prednisolone|prednisolone|mesh-list
56465161|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56465162|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
56465163|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56465164|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
56465165|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56465166|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
56465167|NCT00501579|Difluprednate|difluprednate|mesh-list
56465168|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465169|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
56465170|NCT00501579|Hormones|hormones|mesh-ancestor
56465171|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465172|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465173|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56465174|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465175|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
56465176|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
56465177|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465178|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56465179|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56465180|NCT00501579|Protective Agents|protective agents|mesh-ancestor
56465181|NCT00501618|Clozapine|clozapine|mesh-list
56465182|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56465183|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
56465184|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465185|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465186|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465187|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56465188|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56465189|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56465190|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56465191|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
56465192|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
56465193|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
56465194|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
56465198|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465199|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
55886646|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
56917632|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917633|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56917634|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56465200|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465201|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465202|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56465204|NCT00600691|Finasteride|finasteride|mesh-list
56465205|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56465206|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56465207|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465208|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465209|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
56465210|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465211|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465212|NCT00600691|Urological Agents|urological agents|mesh-ancestor
56465214|NCT00623077|Melphalan|melphalan|mesh-list
56465215|NCT00623077|Busulfan|busulfan|mesh-list
56465216|NCT00623077|Ifosfamide|ifosfamide|mesh-list
56465217|NCT00623077|Thiotepa|thiotepa|mesh-list
56465218|NCT00623077|Sargramostim|sargramostim|mesh-list
56465219|NCT00623077|Mesna|mesna|mesh-list
56465220|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56465221|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465222|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56465223|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56465224|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465225|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465226|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
56465227|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465228|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56465229|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
56465230|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56465231|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465232|NCT00623077|Protective Agents|protective agents|mesh-ancestor
56465233|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56465234|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56465235|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56465236|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56465237|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465238|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465239|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465240|NCT00475358|Analgesics|analgesics|mesh-ancestor
56465241|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
56465242|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465243|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
56465244|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56465245|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
56465246|NCT00623116|Testosterone|testosterone|mesh-list
56465247|NCT00623116|Estrogens|estrogens|mesh-list
56465248|NCT00623116|Androgens|androgens|mesh-ancestor
56465249|NCT00623116|Hormones|hormones|mesh-ancestor
56465250|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465251|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465252|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
56465253|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
56465254|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56465255|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
56465256|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56465257|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56465258|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465259|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56465260|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465261|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465262|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56465263|NCT00623155|Renal Agents|renal agents|mesh-ancestor
56465264|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56465265|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465269|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56465270|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465271|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465272|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56465273|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56465275|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56465276|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
56465277|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465278|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
56465279|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465280|NCT00600847|Loratadine|loratadine|mesh-list
56465281|NCT00600847|Desloratadine|desloratadine|mesh-list
56465282|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56465283|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
56465284|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465285|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465286|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465287|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56465288|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56465289|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
56465290|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
56465291|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
56465292|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
56465293|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56465295|NCT04325932|Coagulants|coagulants|mesh-ancestor
56465296|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56465297|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
56465298|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56465299|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465300|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56465301|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56465302|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465303|NCT00501657|Incretins|incretins|mesh-ancestor
56465304|NCT00501657|Hormones|hormones|mesh-ancestor
56465305|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465306|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56465307|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
56465308|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465309|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465310|NCT00600964|Obatoclax|obatoclax|mesh-list
56465311|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465312|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465313|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56465314|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56465315|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56465316|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56465317|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465318|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465319|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465320|NCT00475397|Analgesics|analgesics|mesh-ancestor
56465321|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
56465322|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465323|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
56465324|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56465325|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
56465326|NCT00601042|Lobeline|lobeline|mesh-list
56465327|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56465328|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
56465329|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465330|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465331|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56465332|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56465333|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
56465334|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465335|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465336|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
56465341|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
56465342|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465343|NCT00601198|Leucovorin|leucovorin|mesh-list
56465344|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
56465345|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
56465346|NCT00601198|Amifostine|amifostine|mesh-list
56465347|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465348|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465349|NCT00601198|Antidotes|antidotes|mesh-ancestor
56465350|NCT00601198|Protective Agents|protective agents|mesh-ancestor
56465351|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
56917635|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
56917636|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917637|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56917638|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
56917639|NCT03799627|Glycine|glycine|mesh-list
56465353|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
56465354|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56465355|NCT00601276|Leuprolide|leuprolide|mesh-list
56465356|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
56465357|NCT00601276|Cyproterone|cyproterone|mesh-list
56465358|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56465359|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
56465360|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56465361|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465362|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56465363|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465364|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
56465365|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
56465366|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465367|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56465368|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
56465369|NCT00601315|Clarithromycin|clarithromycin|mesh-list
56465370|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56465371|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465372|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56465373|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465374|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465375|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56465376|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56465377|NCT00470249|Gemcitabine|gemcitabine|mesh-list
56465378|NCT00470249|Carboplatin|carboplatin|mesh-list
56465379|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465380|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56465381|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
56465382|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465383|NCT00470249|Antiviral Agents|antiviral agents|mesh-ancestor
56465384|NCT00470249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465385|NCT00470249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465386|NCT00470249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465387|NCT00470249|Immunologic Factors|immunologic factors|mesh-ancestor
56465388|NCT00470249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465389|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
56465390|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
56465391|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56465392|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56465393|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465394|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465395|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465396|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56465397|NCT00601432|Levofloxacin|levofloxacin|mesh-list
56465398|NCT00601432|Ofloxacin|ofloxacin|mesh-list
56465399|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56465400|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465401|NCT00601432|Renal Agents|renal agents|mesh-ancestor
56465402|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56465403|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56465404|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56465405|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465406|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465407|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465408|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56465409|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56465414|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465415|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465416|NCT00601510|Capecitabine|capecitabine|mesh-list
56465417|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
56465418|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465419|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56465420|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
55886647|NCT02485080|Simeprevir|simeprevir|mesh-list
56917640|NCT03799627|Hematinics|hematinics|mesh-ancestor
56917641|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
56917642|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917643|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917644|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917645|NCT02274142|Methamphetamine|methamphetamine|mesh-list
56917646|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56917647|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917648|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
56917649|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
56465421|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465422|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56465423|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465425|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
56465426|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56465427|NCT00601588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56465428|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56465429|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56465430|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465431|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465432|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
56465433|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465434|NCT00601666|Zolpidem|zolpidem|mesh-list
56465435|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56465436|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56465437|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56465438|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465439|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56465440|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
56465441|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
56465442|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465443|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465445|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56465446|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56465447|NCT01246362|Analgesics|analgesics|mesh-ancestor
56465448|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
56465449|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465450|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465451|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465452|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56465453|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56465454|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56465455|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465456|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465457|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
56465458|NCT00470405|Pemetrexed|pemetrexed|mesh-list
56465459|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465460|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465461|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465462|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56465463|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56465464|NCT00601978|Levodopa|levodopa|mesh-list
56465465|NCT00601978|Carbidopa|carbidopa|mesh-list
56465466|NCT00601978|Entacapone|entacapone|mesh-list
56465467|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56465468|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56465469|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56465470|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
56465471|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465472|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465473|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465474|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56917650|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917651|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
56917652|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917653|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465475|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465476|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56465477|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56465478|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
56465479|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
56465482|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56465483|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
56465484|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465485|NCT00601159|Antiviral Agents|antiviral agents|mesh-ancestor
56465486|NCT00601159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465487|NCT00601159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465488|NCT00601159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465489|NCT00601159|Immunologic Factors|immunologic factors|mesh-ancestor
56465490|NCT00601159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465492|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56465493|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56465494|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56465495|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465496|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56465497|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465499|NCT00470483|Paroxetine|paroxetine|mesh-list
56465500|NCT00470483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56465501|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56465502|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56465503|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465504|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465505|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
56465506|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465507|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56465508|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
56465509|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56465510|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56465511|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56465512|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465513|NCT00602095|Misoprostol|misoprostol|mesh-list
56465514|NCT00602095|Dinoprostone|dinoprostone|mesh-list
56465515|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56465516|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
56465517|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56465518|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465519|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56465520|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56465521|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
56465522|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56465523|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56465524|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56465525|NCT00475553|Etonogestrel|etonogestrel|mesh-list
56465526|NCT00475553|Desogestrel|desogestrel|mesh-list
56465528|NCT00475553|Estradiol|estradiol|mesh-list
56465529|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56465530|NCT00475553|Estrogens|estrogens|mesh-ancestor
56465531|NCT00475553|Hormones|hormones|mesh-ancestor
56465532|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465533|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465534|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56465535|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
56465536|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56465537|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56465538|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56465539|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56465540|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56465541|NCT00475553|Progestins|progestins|mesh-ancestor
56465542|NCT01326481|Capecitabine|capecitabine|mesh-list
56465543|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56465544|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
56917654|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
56917655|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56917656|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56465545|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465546|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465547|NCT00502164|Cediranib|cediranib|mesh-list
56465548|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465549|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56465550|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465551|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465552|NCT00470522|Folic Acid|folic acid|mesh-list
56465553|NCT00470522|Methotrexate|methotrexate|mesh-list
56465555|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
56465556|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56465557|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465558|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56465559|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
56465560|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465561|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465562|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
56465563|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465564|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56465565|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465566|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
56465567|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56465568|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56465570|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
56465571|NCT00470522|Vitamins|vitamins|mesh-ancestor
56465572|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
56465573|NCT01244178|Insulin|insulin|mesh-list
56465574|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56465575|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56465576|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465577|NCT00470561|Aspirin|aspirin|mesh-list
56465578|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56465579|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56465580|NCT00470561|Analgesics|analgesics|mesh-ancestor
56465581|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
56465582|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465583|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465584|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465585|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56465586|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56465587|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56465588|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213541|NCT02855229|Methylphenidate|methylphenidate|mesh-list
56465589|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56465590|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56465591|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465593|NCT00475826|Ezetimibe|ezetimibe|mesh-list
56465594|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56465595|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56465596|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
56465597|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465598|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56465599|NCT00502437|Granisetron|granisetron|mesh-list
56465600|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
56465601|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
56465602|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465603|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465604|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56465605|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56465606|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
56465607|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465608|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465609|NCT00470678|Ranibizumab|ranibizumab|mesh-list
56465610|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56465611|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56465612|NCT00470678|Growth Substances|growth substances|mesh-ancestor
56465613|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465614|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
55886648|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
56917657|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56917658|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56180142|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
56465615|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465616|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
56465617|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56465618|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465619|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
56465620|NCT00493545|Poly ICLC|poly iclc|mesh-list
56465621|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
56465622|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
56465623|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465624|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56465625|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
56465626|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56465627|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56465631|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
56465632|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56465633|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465634|NCT00476099|Budesonide|budesonide|mesh-list
56465635|NCT00476099|Beclomethasone|beclomethasone|mesh-list
56465636|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
56465637|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465638|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56465639|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
56465640|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465641|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465642|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56465643|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
56465644|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
56465645|NCT00476099|Hormones|hormones|mesh-ancestor
56465646|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465647|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56465648|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56465649|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56465650|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
56465651|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465652|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465653|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
56465654|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56465655|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
56465656|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465657|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
56465658|NCT00493662|Protective Agents|protective agents|mesh-ancestor
56465659|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
56465660|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56465661|NCT00470912|Protective Agents|protective agents|mesh-ancestor
56465662|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465663|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
56465664|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56465665|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
56465666|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465667|NCT00476138|Protective Agents|protective agents|mesh-ancestor
56465668|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465669|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56465670|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56465671|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465672|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56465673|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56465674|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56465675|NCT00470990|Acyline|acyline|mesh-list
56465676|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
56465677|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465678|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465679|NCT01246440|Catumaxomab|catumaxomab|mesh-list
56465680|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56465681|NCT00471029|Esomeprazole|esomeprazole|mesh-list
56465682|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56465683|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56465684|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56465685|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465686|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917659|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
56917660|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56917661|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56917662|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56917663|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56917664|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917665|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
56917666|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917667|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917668|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56917669|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917670|NCT02276014|Beta Carotene|beta carotene|mesh-list
56917671|NCT02276014|Carotenoids|carotenoids|mesh-list
56917672|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
56917673|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917674|NCT02276014|Protective Agents|protective agents|mesh-ancestor
56917675|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917676|NCT02276014|Provitamins|provitamins|mesh-ancestor
56917677|NCT02276014|Vitamins|vitamins|mesh-ancestor
56917678|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
56465687|NCT00476216|Fondaparinux|fondaparinux|mesh-list
56465688|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56465689|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
56465690|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56465691|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
56465692|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465693|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465694|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
56465695|NCT00471185|Acyline|acyline|mesh-list
56465696|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
56465697|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465698|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465701|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56465702|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
56465703|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465704|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56465705|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465706|NCT00502788|Ribavirin|ribavirin|mesh-list
56465707|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56465708|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
56465709|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465710|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
56465711|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465712|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
56465713|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
56465714|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465715|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56465716|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465717|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465718|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
56465719|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465720|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56465721|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465722|NCT00494208|Testosterone|testosterone|mesh-list
56465723|NCT00494208|Androgens|androgens|mesh-ancestor
56917679|NCT01102387|Octenidine|octenidine|mesh-list
56465724|NCT00494208|Hormones|hormones|mesh-ancestor
56465725|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465726|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465727|NCT00471341|Celecoxib|celecoxib|mesh-list
56465728|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56465729|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56465730|NCT00471341|Analgesics|analgesics|mesh-ancestor
56465731|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
56465732|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465733|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465734|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465735|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56465736|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56465737|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56465738|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465739|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465741|NCT01325428|Afatinib|afatinib|mesh-list
56465742|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56465743|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465744|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
56465745|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
56465746|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
56465747|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465748|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56465749|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465750|NCT00494247|Antibodies|antibodies|mesh-list
56465751|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
56465752|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465753|NCT00471419|Rimexolone|rimexolone|mesh-list
56465754|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
56465755|NCT00471419|Hormones|hormones|mesh-ancestor
56465756|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465757|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465758|NCT01325350|Bimatoprost|bimatoprost|mesh-list
56465759|NCT01325350|Minoxidil|minoxidil|mesh-list
56465760|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56465761|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56465762|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
56465763|NCT01324999|Tadalafil|tadalafil|mesh-list
56465764|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
56465765|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56465766|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56465767|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465768|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465769|NCT01324999|Urological Agents|urological agents|mesh-ancestor
56465770|NCT01324570|Buprenorphine|buprenorphine|mesh-list
56465771|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56465772|NCT01324570|Narcotics|narcotics|mesh-ancestor
56465773|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56465775|NCT01324570|Analgesics|analgesics|mesh-ancestor
56465776|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
56465777|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465778|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56465779|NCT04325698|Paclitaxel|paclitaxel|mesh-list
56465780|NCT04325698|Bevacizumab|bevacizumab|mesh-list
56465781|NCT04325698|Carboplatin|carboplatin|mesh-list
56465782|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56465783|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465784|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
56465785|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
56465786|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
56465787|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465788|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56465789|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56465790|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56465791|NCT04325698|Growth Substances|growth substances|mesh-ancestor
56465792|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465793|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
56465794|NCT01324141|Fluorouracil|fluorouracil|mesh-list
56465795|NCT01324141|Mitomycins|mitomycins|mesh-list
56465796|NCT01324141|Mitomycin|mitomycin|mesh-list
56465798|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
56465799|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465800|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56917680|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917681|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56917682|NCT02277808|Amikacin|amikacin|mesh-list
56917683|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56917684|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917685|NCT02281240|Oprelvekin|oprelvekin|mesh-list
56917686|NCT02281240|Heparin|heparin|mesh-list
56917687|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
56917688|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56917689|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56917690|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917691|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917692|NCT01102465|Losartan|losartan|mesh-list
56917693|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56917694|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56917695|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56917696|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56917697|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56180163|NCT01404000|Charcoal|charcoal|mesh-list
56465801|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465802|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465803|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
56465804|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465805|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56465806|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
56465807|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56465808|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465809|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
56465810|NCT01324141|Protective Agents|protective agents|mesh-ancestor
56465811|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56465812|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56465813|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56213763|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
56465814|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56465815|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56465816|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465817|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56465818|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56465819|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56465820|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465821|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
56465822|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465824|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56465825|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56465826|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56465827|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
56465828|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
56465829|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465830|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465831|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465832|NCT00471653|Temozolomide|temozolomide|mesh-list
56465833|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56465834|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
56465835|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465836|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917698|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917699|NCT01102465|Diuretics|diuretics|mesh-ancestor
56917700|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
56917701|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917702|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56917703|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56917704|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
56917705|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56917706|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917707|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
56917708|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
56917709|NCT00749632|Oxybutynin|oxybutynin|mesh-list
56917710|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
56917711|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
56917712|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465837|NCT00494559|Pioglitazone|pioglitazone|mesh-list
56465838|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56465839|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465840|NCT00494598|Sufentanil|sufentanil|mesh-list
56465841|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56465842|NCT00494598|Narcotics|narcotics|mesh-ancestor
56465843|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56465844|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465845|NCT00494598|Analgesics|analgesics|mesh-ancestor
56465846|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
56465847|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465851|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
56465852|NCT00503412|Cediranib|cediranib|mesh-list
56465853|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465854|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56465855|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465856|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465857|NCT00503451|Panobinostat|panobinostat|mesh-list
56465858|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465859|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56465860|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465861|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465862|NCT00471809|Azithromycin|azithromycin|mesh-list
56465863|NCT00471809|Budesonide|budesonide|mesh-list
56465864|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56465865|NCT00471809|Montelukast|montelukast|mesh-list
56465866|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465867|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56465868|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
56465869|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465870|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465871|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56465872|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
56465873|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
56465874|NCT00471809|Hormones|hormones|mesh-ancestor
56465875|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465876|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56465877|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465878|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56465879|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56465880|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56465881|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
56465882|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465883|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465884|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56917713|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917714|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56205344|NCT01551680|Iniparib|iniparib|mesh-list
56465885|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
56465886|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56465887|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56465888|NCT00503490|Levofloxacin|levofloxacin|mesh-list
56465889|NCT00503490|Ofloxacin|ofloxacin|mesh-list
56465890|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56465891|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465892|NCT00503490|Renal Agents|renal agents|mesh-ancestor
56465893|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56465894|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56465895|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56465896|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465897|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465898|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465899|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56465900|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56465901|NCT00471965|Leucovorin|leucovorin|mesh-list
56465902|NCT00471965|Doxorubicin|doxorubicin|mesh-list
56465903|NCT00471965|Fluorouracil|fluorouracil|mesh-list
56465904|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
56465905|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56465906|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465907|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56465908|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56465909|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465910|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465911|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
56465912|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56465913|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465914|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
56465915|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465916|NCT00471965|Antidotes|antidotes|mesh-ancestor
56465917|NCT00471965|Protective Agents|protective agents|mesh-ancestor
56465918|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
56465919|NCT00471965|Vitamins|vitamins|mesh-ancestor
56465920|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
56465926|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465927|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
56465928|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
56465929|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56465930|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56465931|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465932|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56465934|NCT00494715|Valsartan|valsartan|mesh-list
56465935|NCT00494715|Benazepril|benazepril|mesh-list
56465936|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56465937|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56465938|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56465939|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465940|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56465941|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
56465942|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465943|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56465944|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56465945|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
56465946|NCT03271073|Apatinib|apatinib|mesh-list
56465947|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465948|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56465949|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465950|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465951|NCT01246557|Dexamethasone|dexamethasone|mesh-list
56465952|NCT01246557|Lenalidomide|lenalidomide|mesh-list
56465953|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465954|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
56465955|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
56465956|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465957|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465958|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56465959|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
56465960|NCT01246557|Hormones|hormones|mesh-ancestor
56917715|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56917716|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
56917717|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917718|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917719|NCT00749632|Urological Agents|urological agents|mesh-ancestor
56917720|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56917721|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917722|NCT00749632|Renal Agents|renal agents|mesh-ancestor
56917723|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
56917724|NCT01105273|Fludarabine|fludarabine|mesh-list
56465961|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465962|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56465963|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465964|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
56465965|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56465966|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56465967|NCT01246557|Growth Substances|growth substances|mesh-ancestor
56465968|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
56465969|NCT00476918|Triamcinolone|triamcinolone|mesh-list
56465970|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56465971|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56465972|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56465973|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56465974|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
56465975|NCT00476918|Hormones|hormones|mesh-ancestor
56465976|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465977|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465978|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465979|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
56465980|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465981|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465982|NCT01323790|Naloxegol|naloxegol|mesh-list
56465983|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56465984|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465985|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
56465986|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56465987|NCT00477035|Gemcitabine|gemcitabine|mesh-list
56465988|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
56465989|NCT00477035|Melphalan|melphalan|mesh-list
56465990|NCT00477035|Carmustine|carmustine|mesh-list
56465991|NCT00477035|Etoposide|etoposide|mesh-list
56465992|NCT00477035|Vinorelbine|vinorelbine|mesh-list
56465993|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56465994|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
56465995|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465996|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56465997|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56465998|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
56465999|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466000|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466001|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56466002|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56466004|NCT00477035|Antiviral Agents|antiviral agents|mesh-ancestor
56466005|NCT00477035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466006|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466007|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56466008|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56466009|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56466010|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
56466011|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
56466012|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
56466014|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56466015|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466016|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917725|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56917726|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917727|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
56917728|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917729|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56917730|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56466017|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56466018|NCT00494832|Analgesics|analgesics|mesh-ancestor
56466019|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
56466020|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466021|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56466022|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56466023|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56466024|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
56466025|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466026|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466027|NCT00477074|Dimercaprol|dimercaprol|mesh-list
56466028|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
56466029|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
56466030|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466031|NCT01323673|Clobetasol|clobetasol|mesh-list
56466032|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56466033|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
56466034|NCT01323673|Hormones|hormones|mesh-ancestor
56466035|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56466036|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466037|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56466038|NCT01246752|Cytarabine|cytarabine|mesh-list
56466039|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56466040|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
56466041|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466042|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466043|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
56466044|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466045|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466046|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
56466047|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466048|NCT01323634|Fluticasone|fluticasone|mesh-list
56466049|NCT01323634|Xhance|xhance|mesh-list
56466050|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56466051|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56466052|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56466053|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
56466054|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466055|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466056|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56466057|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
56466058|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
56466059|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56466060|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56466061|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56466062|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56466063|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56466064|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466065|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466066|NCT05645302|Lidocaine|lidocaine|mesh-list
56466067|NCT05645302|Anesthetics, Local|anesthetics, local|mesh-ancestor
56466068|NCT05645302|Anesthetics|anesthetics|mesh-ancestor
56466071|NCT05645302|Sensory System Agents|sensory system agents|mesh-ancestor
56466072|NCT05645302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466073|NCT05645302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56466074|NCT05645302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56466075|NCT05645302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56466076|NCT05645302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56466077|NCT05645302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967029|NCT03021590|Ofloxacin|ofloxacin|mesh-list
56466079|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56466080|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
56917731|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
56917732|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917733|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917734|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56917735|NCT05215327|Vaccines|vaccines|mesh-list
56917736|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
56917737|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917738|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56917739|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917740|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56917741|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917742|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466081|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
56466082|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
56466083|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
56466084|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56466085|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466086|NCT01323478|Vortioxetine|vortioxetine|mesh-list
56466087|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
56466088|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56466089|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56466090|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56466091|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466092|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466093|NCT01323478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56466094|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56466095|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56466096|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466097|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466098|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
56466099|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56466100|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56466101|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56466102|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56466103|NCT00472355|Apomorphine|apomorphine|mesh-list
56466104|NCT00472355|Emetics|emetics|mesh-ancestor
56466105|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466106|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
56466107|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466108|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56466109|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
56466110|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
56466111|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466112|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466113|NCT04325581|Liraglutide|liraglutide|mesh-list
56466114|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56466115|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466116|NCT04325581|Incretins|incretins|mesh-ancestor
56466117|NCT04325581|Hormones|hormones|mesh-ancestor
56466118|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56466119|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
56466120|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56466121|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466122|NCT01322386|Vancomycin|vancomycin|mesh-list
56466123|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56466124|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466125|NCT00495066|Ipilimumab|ipilimumab|mesh-list
56466126|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466127|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466128|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55899238|NCT00044655|Ziprasidone|ziprasidone|mesh-list
56917743|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
56466129|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466130|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
56466131|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466132|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466133|NCT00472472|Paclitaxel|paclitaxel|mesh-list
56466134|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56466135|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466136|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56466137|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56466138|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56466143|NCT00472550|Esomeprazole|esomeprazole|mesh-list
56466144|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56466145|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56466146|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56466147|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466148|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466149|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56466150|NCT00503607|Laxatives|laxatives|mesh-ancestor
56466151|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56466152|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
56466154|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
56466155|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
56466156|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466157|NCT00477503|Antidotes|antidotes|mesh-ancestor
56466158|NCT00477503|Protective Agents|protective agents|mesh-ancestor
56466159|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466160|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56466161|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56466162|NCT01244334|Prednisolone|prednisolone|mesh-list
56466163|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56466164|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
56466165|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56466166|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
56466167|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56466168|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
56466169|NCT01244334|Difluprednate|difluprednate|mesh-list
56466170|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56466171|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
56466172|NCT01244334|Hormones|hormones|mesh-ancestor
56466173|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56466174|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466175|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56466176|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466177|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
56466178|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
56466179|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466180|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56466181|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56466182|NCT01244334|Protective Agents|protective agents|mesh-ancestor
56466183|NCT00477542|Clofarabine|clofarabine|mesh-list
56466184|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56466185|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
56466186|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466187|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466188|NCT00503763|Simvastatin|simvastatin|mesh-list
56466189|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56466190|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56466191|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
56466192|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466193|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56466194|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56466195|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466196|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56466197|NCT00477581|Exenatide|exenatide|mesh-list
56466198|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56466199|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466200|NCT00477581|Incretins|incretins|mesh-ancestor
56466201|NCT00477581|Hormones|hormones|mesh-ancestor
56466202|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56466203|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56466204|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
56466205|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466206|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917744|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56917745|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56917746|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
56917747|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917748|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917749|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56466207|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56466208|NCT00477737|Propofol|propofol|mesh-list
56466209|NCT00477737|Sevoflurane|sevoflurane|mesh-list
56466210|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56466214|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
56466215|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
56466216|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56466217|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56466218|NCT00477776|Metoclopramide|metoclopramide|mesh-list
56466219|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
56466220|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
56466221|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466222|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466223|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56466224|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56466225|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56466226|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
56466227|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466228|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466230|NCT00477815|Melphalan|melphalan|mesh-list
56466231|NCT00477815|Sargramostim|sargramostim|mesh-list
56466232|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56466233|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466234|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466235|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
56466236|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466237|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56466238|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56466239|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
56466240|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466241|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56466242|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466243|NCT00477854|Chromium|chromium|mesh-list
56466244|NCT00477854|Picolinic acid|picolinic acid|mesh-list
56466245|NCT00477854|Trace Elements|trace elements|mesh-ancestor
56466246|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
56466247|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466248|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56466249|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
56466250|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
56466251|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466252|NCT00477893|Adalimumab|adalimumab|mesh-list
56466253|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56466254|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56466255|NCT01247337|Gemcitabine|gemcitabine|mesh-list
56466256|NCT01247337|Capecitabine|capecitabine|mesh-list
56466257|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
56466258|NCT01247337|Cetuximab|cetuximab|mesh-list
56466259|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56466260|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
56466261|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466262|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466263|NCT01247337|Antiviral Agents|antiviral agents|mesh-ancestor
56466264|NCT01247337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466265|NCT01247337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466266|NCT01247337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466267|NCT01247337|Immunologic Factors|immunologic factors|mesh-ancestor
56466268|NCT01247337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466269|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466270|NCT00478049|Docetaxel|docetaxel|mesh-list
56466271|NCT00478049|Gefitinib|gefitinib|mesh-list
56466272|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466273|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
56466274|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
56466275|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
56466276|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466277|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56466278|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466279|NCT01248975|Montelukast|montelukast|mesh-list
56466280|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56466281|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
56466282|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56466283|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
56466289|NCT02955927|Atropine|atropine|mesh-list
56466290|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56466291|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56466292|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56466293|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56466294|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56466295|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
56466296|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466297|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466298|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56466299|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
56466301|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
56466302|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56466303|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56466304|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
56466305|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466306|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466307|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
56466308|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56466309|NCT01247493|Cytarabine|cytarabine|mesh-list
56466310|NCT01247493|Fludarabine|fludarabine|mesh-list
56466311|NCT01247493|Idarubicin|idarubicin|mesh-list
56466312|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466313|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56466314|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
56466315|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466316|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466317|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
56466318|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466319|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
56466320|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466321|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56466322|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56466323|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56466324|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466325|NCT04325425|Carboplatin|carboplatin|mesh-list
56466326|NCT04325425|Etoposide|etoposide|mesh-list
56466327|NCT04325425|Folfirinox|folfirinox|mesh-list
56466328|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466329|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56466330|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56466331|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56466332|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466333|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466334|NCT04512066|Risperidone|risperidone|mesh-list
56466335|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56466336|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
56466337|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466338|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466339|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466341|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56466342|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466343|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56466344|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56466345|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
56466346|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
56466347|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466348|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56466349|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466350|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466351|NCT05645146|Nicotine|nicotine|mesh-list
56466352|NCT05645146|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56466353|NCT05645146|Autonomic Agents|autonomic agents|mesh-ancestor
56466357|NCT05645146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56466358|NCT05645146|Cholinergic Agents|cholinergic agents|mesh-ancestor
56466359|NCT05645146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466360|NCT05645146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917750|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
56917751|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
56205806|NCT01555580|Molgramostim|molgramostim|mesh-list
56466361|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
56466362|NCT00478517|Hematinics|hematinics|mesh-ancestor
56466363|NCT01321879|Telavancin|telavancin|mesh-list
56466364|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56466365|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466366|NCT01321723|Teriparatide|teriparatide|mesh-list
56466367|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56466368|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466369|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56466370|NCT00478634|Irinotecan|irinotecan|mesh-list
56466371|NCT00478634|Cetuximab|cetuximab|mesh-list
56466372|NCT00478634|Everolimus|everolimus|mesh-list
56466373|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56466374|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56466375|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334281|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56466376|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466377|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466378|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466379|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466380|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
56466381|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466383|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
56466384|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466385|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466386|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466387|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
56466388|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466389|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56466390|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56466391|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
56466392|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56466393|NCT00478907|Ketamine|ketamine|mesh-list
56466394|NCT00478907|Thiopental|thiopental|mesh-list
56466395|NCT00478907|Propofol|propofol|mesh-list
56466396|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56466397|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466398|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466399|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56466400|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
56466401|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
56466402|NCT00478907|Analgesics|analgesics|mesh-ancestor
56466403|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
56466404|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466405|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56466406|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56466407|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56466408|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466409|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466410|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
56466411|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
56466412|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
56466413|NCT00478946|Leucovorin|leucovorin|mesh-list
56466414|NCT00478946|Antidotes|antidotes|mesh-ancestor
56466415|NCT00478946|Protective Agents|protective agents|mesh-ancestor
56466416|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466417|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
56466418|NCT00478946|Vitamins|vitamins|mesh-ancestor
56466419|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
56466420|NCT01247961|Dexamethasone|dexamethasone|mesh-list
56466421|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
56466422|NCT01247961|BB 1101|bb 1101|mesh-list
56466423|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56466424|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
56466425|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
56466426|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466427|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466432|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56466433|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466434|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
56466435|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886649|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917752|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56917753|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
56917754|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917755|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917756|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56917757|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56917758|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56917759|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56917760|NCT01105351|Folic Acid|folic acid|mesh-list
56917761|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
56917762|NCT01105351|Hematinics|hematinics|mesh-ancestor
56466436|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466437|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
56466438|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466439|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56466440|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466441|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466442|NCT01248078|Cephalexin|cephalexin|mesh-list
56466443|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56466444|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466445|NCT00472823|Vitamin D|vitamin d|mesh-list
56466446|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
56466447|NCT00472823|Calcium|calcium|mesh-list
56466448|NCT00472823|Vitamins|vitamins|mesh-ancestor
56466449|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
56466450|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466451|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56466452|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56466453|NCT02275416|Ipilimumab|ipilimumab|mesh-list
56466454|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466455|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466456|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56466457|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466458|NCT00472901|Afamelanotide|afamelanotide|mesh-list
56466459|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56466460|NCT02483247|Paclitaxel|paclitaxel|mesh-list
56466461|NCT02483247|Doxorubicin|doxorubicin|mesh-list
56466462|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
56466463|NCT02483247|Capecitabine|capecitabine|mesh-list
56466464|NCT02483247|Nivolumab|nivolumab|mesh-list
56466465|NCT02483247|Sunitinib|sunitinib|mesh-list
56466466|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56466467|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466468|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
56466469|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
56466470|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
56466471|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466472|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56466473|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56466474|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56466475|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466476|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466477|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56466478|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
56466479|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56466480|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56466481|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56466482|NCT02483247|Growth Substances|growth substances|mesh-ancestor
56466483|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466484|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
56466485|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56466486|NCT02482233|Nicotine|nicotine|mesh-list
56466487|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56466488|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
56466489|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917763|NCT01105351|Vitamins|vitamins|mesh-ancestor
56917764|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
56917765|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917766|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
56917767|NCT00662506|Temozolomide|temozolomide|mesh-list
56917768|NCT00662506|Cediranib|cediranib|mesh-list
56917769|NCT00662506|Maleic acid|maleic acid|mesh-list
56917770|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56917771|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56917772|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
56917773|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917774|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917775|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917776|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56466490|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466491|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56466492|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56466493|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
56466494|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466495|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466497|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56466498|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56466499|NCT01248117|Growth Substances|growth substances|mesh-ancestor
56466501|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
56466502|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466504|NCT01248234|Etomidate|etomidate|mesh-list
56466505|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56466506|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466507|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466508|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56466509|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
56466510|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
56466511|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
56466512|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
56466513|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466514|NCT00473174|Ramipril|ramipril|mesh-list
56466515|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56466516|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
56466517|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334283|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56466518|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466519|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56466520|NCT00473213|Interferons|interferons|mesh-list
56466521|NCT00473213|Interferon-beta|interferon-beta|mesh-list
56466522|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466523|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
56466524|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466525|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
56466526|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466527|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
56466528|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56466529|NCT01319383|Vorinostat|vorinostat|mesh-list
56466530|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466531|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56466532|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466533|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466534|NCT05645029|Chlorhexidine|chlorhexidine|mesh-list
56466535|NCT05645029|Methamphetamine|methamphetamine|mesh-list
56466536|NCT05645029|Titanium dioxide|titanium dioxide|mesh-list
56466537|NCT05645029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56466538|NCT05645029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466539|NCT05645029|Disinfectants|disinfectants|mesh-ancestor
56466540|NCT05645029|Dermatologic Agents|dermatologic agents|mesh-ancestor
56917777|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56917778|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
56917779|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
56917780|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466541|NCT05645029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56466542|NCT05645029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466543|NCT05645029|Sympathomimetics|sympathomimetics|mesh-ancestor
56466544|NCT05645029|Autonomic Agents|autonomic agents|mesh-ancestor
56466545|NCT05645029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466546|NCT05645029|Dopamine Agents|dopamine agents|mesh-ancestor
56466547|NCT05645029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466548|NCT05645029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466549|NCT05645029|Adrenergic Agents|adrenergic agents|mesh-ancestor
56466550|NCT05645029|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56466551|NCT05645029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56466552|NCT05645029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56466553|NCT05645029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56466554|NCT05645029|Sunscreening Agents|sunscreening agents|mesh-ancestor
56466555|NCT05645029|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56466556|NCT05645029|Protective Agents|protective agents|mesh-ancestor
56466557|NCT05645029|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56466558|NCT00479609|Testosterone|testosterone|mesh-list
56466559|NCT00479609|Androgens|androgens|mesh-ancestor
56466560|NCT00479609|Hormones|hormones|mesh-ancestor
56466561|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56466562|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466563|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
56466564|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
56466565|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
56466566|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466567|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466568|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
56466569|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466571|NCT05644717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56466572|NCT05644717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466585|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466586|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466587|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56466588|NCT02955732|Analgesics|analgesics|mesh-ancestor
56466589|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
56466590|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466591|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56466592|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56466593|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56466594|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
56466595|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466596|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466597|NCT01315678|Tobramycin|tobramycin|mesh-list
56466598|NCT01315678|Amikacin|amikacin|mesh-list
56466599|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56466600|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466601|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56466602|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
56466603|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466604|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
56466605|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466606|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56466607|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56466608|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56466609|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56466610|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466611|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466612|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466613|NCT00479726|Analgesics|analgesics|mesh-ancestor
56466614|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
56466615|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466616|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
56466617|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56466618|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
56917781|NCT03947125|Buprenorphine|buprenorphine|mesh-list
56917782|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56917783|NCT03947125|Narcotics|narcotics|mesh-ancestor
56180268|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
56466619|NCT01315249|Fluticasone|fluticasone|mesh-list
56466620|NCT01315249|Xhance|xhance|mesh-list
56466621|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
56466622|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56466623|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56466624|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56466625|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56466626|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
56466627|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466628|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466629|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56466630|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
56466631|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
56466632|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56466633|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56466634|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56466635|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56466636|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
56466637|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466638|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466639|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56466640|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56466641|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56466642|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
56466643|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
56466645|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56466648|NCT04207411|Bupivacaine|bupivacaine|mesh-list
56466649|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
56466650|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
56466651|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466652|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466653|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
56466654|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466655|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56466656|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56466657|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56466658|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56466659|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466660|NCT00473486|Carboplatin|carboplatin|mesh-list
56466661|NCT00473486|Pemetrexed|pemetrexed|mesh-list
56466662|NCT00473486|Sorafenib|sorafenib|mesh-list
56334294|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
56466663|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466664|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466665|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466666|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56466667|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56466668|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56466669|NCT05644483|Propofol|propofol|mesh-list
56466670|NCT05644483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56466671|NCT05644483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466672|NCT05644483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466673|NCT05644483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56466674|NCT05644483|Anesthetics, General|anesthetics, general|mesh-ancestor
56466675|NCT05644483|Anesthetics|anesthetics|mesh-ancestor
56466676|NCT02891278|Cytarabine|cytarabine|mesh-list
56466677|NCT02891278|Sertraline|sertraline|mesh-list
56466678|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56466679|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
56466680|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466681|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466682|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
56466683|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466684|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466685|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
56466686|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466687|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
56466688|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56917784|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56917785|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917786|NCT03947125|Analgesics|analgesics|mesh-ancestor
56917787|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
56917788|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466689|NCT02891278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56466690|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56466691|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56466692|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466693|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
56466694|NCT01248819|Ropivacaine|ropivacaine|mesh-list
56466695|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
56466696|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
56466697|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466698|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466699|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
56466700|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466701|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
56466702|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56466703|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56466704|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56466705|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56466706|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466707|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
56466708|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466709|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466710|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56466711|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466712|NCT01248858|Trametinib|trametinib|mesh-list
56466713|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333887|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466714|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56466715|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466716|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466719|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466720|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
56466721|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
56466722|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466723|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
56466724|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56466725|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56466726|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56466727|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466728|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466729|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
56466730|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56466731|NCT00481364|Atorvastatin|atorvastatin|mesh-list
56466732|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56466733|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56466735|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466736|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56466737|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56466738|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466739|NCT00481442|Phenylephrine|phenylephrine|mesh-list
56466740|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
56466741|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56466742|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
56466743|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
56466744|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466745|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466746|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
56466747|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56466748|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
56466749|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56466750|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56466751|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56466752|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56466753|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56917789|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56917790|NCT00658762|Paroxetine|paroxetine|mesh-list
56917791|NCT00658762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56917859|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56917860|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56917861|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56917862|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917863|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917864|NCT00612742|Testosterone|testosterone|mesh-list
56917865|NCT00612742|Androgens|androgens|mesh-ancestor
56917866|NCT00612742|Hormones|hormones|mesh-ancestor
56917867|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56917868|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466754|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466755|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466756|NCT00481442|Protective Agents|protective agents|mesh-ancestor
56466757|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
56466758|NCT04697537|Ropivacaine|ropivacaine|mesh-list
56466759|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
56466760|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466761|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466762|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56466763|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56466764|NCT04697537|Analgesics|analgesics|mesh-ancestor
56466765|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
56466766|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466767|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56466768|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56466769|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56466770|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
56466771|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466772|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466773|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
56466774|NCT00481481|Tacrolimus|tacrolimus|mesh-list
56466775|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466776|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
56466777|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466778|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56466779|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466780|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466781|NCT04516317|Artesunate|artesunate|mesh-list
56466782|NCT04516317|Quinine|quinine|mesh-list
56466783|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
56466784|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56466785|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56466786|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466787|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466788|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
56466789|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
56466790|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56466792|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56466793|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466796|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56466797|NCT04516317|Analgesics|analgesics|mesh-ancestor
56466798|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
56466799|NCT02891083|Paclitaxel|paclitaxel|mesh-list
56466800|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56466801|NCT02891083|Cisplatin|cisplatin|mesh-list
56466802|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56466803|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466804|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
56466805|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
56466806|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
56466807|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466808|NCT04515147|Vaccines|vaccines|mesh-list
56466809|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56466811|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917869|NCT05016895|Azithromycin|azithromycin|mesh-list
56917870|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56917871|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917872|NCT01106131|Pioglitazone|pioglitazone|mesh-list
56917873|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56917874|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917875|NCT00612118|Azelastine|azelastine|mesh-list
56917876|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
56917877|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56917878|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
56180358|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
56466812|NCT05661253|Bupivacaine|bupivacaine|mesh-list
56466813|NCT05661253|Anesthetics, Local|anesthetics, local|mesh-ancestor
56466814|NCT05661253|Anesthetics|anesthetics|mesh-ancestor
56466815|NCT05661253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466816|NCT05661253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466817|NCT05661253|Sensory System Agents|sensory system agents|mesh-ancestor
56466818|NCT05661253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466819|NCT02891005|Paclitaxel|paclitaxel|mesh-list
56466820|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56466821|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466822|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56466823|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56466824|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
56466825|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466826|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
56466827|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56466828|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56466829|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56466830|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
56466831|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56466832|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466833|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56466834|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56466835|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
56466836|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56466837|NCT00480116|Vaccines|vaccines|mesh-list
56466838|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
56466839|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466840|NCT00504855|Calpastatin|calpastatin|mesh-list
56466841|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56466842|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
56466843|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466844|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466845|NCT00504933|Cetirizine|cetirizine|mesh-list
56466846|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56466847|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56466848|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56466849|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
56466850|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
56466851|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466852|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466853|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466854|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
56466855|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56466856|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56466857|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56466858|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56466859|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466860|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
56917879|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628513|NCT00602615|Diuretics|diuretics|mesh-ancestor
56917880|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206274|NCT01558648|Analgesics|analgesics|mesh-list
56466861|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466862|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466863|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56466864|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466865|NCT01313221|Etanercept|etanercept|mesh-list
56466866|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56466867|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56466868|NCT01313221|Analgesics|analgesics|mesh-ancestor
56466869|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
56466870|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466871|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466872|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56466873|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56466874|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56466875|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466876|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
56466877|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
56466878|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56466879|NCT01313182|Mupirocin|mupirocin|mesh-list
56466880|NCT01313182|Povidone|povidone|mesh-list
56466881|NCT01313182|Calcium|calcium|mesh-list
56466882|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56466883|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466884|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
56466885|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
56466886|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466887|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56466888|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56466889|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466890|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466891|NCT04512534|Antibodies|antibodies|mesh-list
56466892|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56466893|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
56466894|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466895|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466896|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466897|NCT00480194|Xylometazoline|xylometazoline|mesh-list
56466898|NCT00480194|Bromides|bromides|mesh-list
56466899|NCT00480194|Ipratropium|ipratropium|mesh-list
56466900|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
56466901|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56466902|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
56466903|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466904|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466905|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56466906|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
56466907|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56466908|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
56466909|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466910|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466911|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
56466912|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56466913|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56466914|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
56466915|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466916|NCT00505167|Memantine|memantine|mesh-list
56466917|NCT00505167|Donepezil|donepezil|mesh-list
56466918|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56466919|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466920|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466921|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
56466922|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466923|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466924|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
56466925|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56466926|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56466927|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
56466928|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56917881|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56917882|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
56917883|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56917884|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917885|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917886|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56917887|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56917888|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56917889|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
56917890|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
56466929|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56466930|NCT00480272|Prednisone|prednisone|mesh-list
56466931|NCT00480272|Adalimumab|adalimumab|mesh-list
56466932|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56466933|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
56466934|NCT00480272|Hormones|hormones|mesh-ancestor
56466935|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56333888|NCT02967432|Emollients|emollients|mesh-ancestor
56466936|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466937|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56466938|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466939|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56466944|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56466945|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56466946|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466948|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
56466949|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466950|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466951|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
56466952|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466953|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56466954|NCT00482027|Vaccines|vaccines|mesh-list
56466955|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
56466956|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466957|NCT00482066|Abatacept|abatacept|mesh-list
56466958|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56466959|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466960|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466961|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466962|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
56466963|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466964|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56466965|NCT00482183|Pioglitazone|pioglitazone|mesh-list
56466966|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56466967|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466968|NCT01312909|Varenicline|varenicline|mesh-list
56466969|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56466970|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56466971|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
56466972|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466973|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466974|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466975|NCT00482222|Leucovorin|leucovorin|mesh-list
56466976|NCT00482222|Fluorouracil|fluorouracil|mesh-list
56466977|NCT00482222|Capecitabine|capecitabine|mesh-list
56466978|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
56466979|NCT00482222|Cetuximab|cetuximab|mesh-list
56466980|NCT00482222|Calcium|calcium|mesh-list
56466981|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
56466982|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56466983|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466984|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
56466985|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466986|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56466987|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917891|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917892|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56917893|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56917894|NCT00743002|Metformin|metformin|mesh-list
56917895|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56917896|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917897|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56917898|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917899|NCT01102699|Lenograstim|lenograstim|mesh-list
56917900|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56917901|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
56917902|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917903|NCT00603616|Rifaximin|rifaximin|mesh-list
56917904|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56917905|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917906|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56917907|NCT02280070|Leucovorin|leucovorin|mesh-list
56917908|NCT02280070|Fluorouracil|fluorouracil|mesh-list
56917909|NCT02280070|Tegafur|tegafur|mesh-list
56917910|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
56466988|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56466989|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
56466990|NCT00482222|Antidotes|antidotes|mesh-ancestor
56466991|NCT00482222|Protective Agents|protective agents|mesh-ancestor
56466992|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
56466993|NCT00482222|Vitamins|vitamins|mesh-ancestor
56466994|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
56466995|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466996|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
56466997|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56466998|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56466999|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56467000|NCT01312129|Analgesics|analgesics|mesh-ancestor
56467001|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
56467002|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467003|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467004|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56467005|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56467006|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56467007|NCT04518852|Sorafenib|sorafenib|mesh-list
56467008|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467009|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56467010|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467011|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467012|NCT01311661|Olodaterol|olodaterol|mesh-list
56467014|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
56467015|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467016|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467017|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56467018|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
56467020|NCT00482261|Aspirin|aspirin|mesh-list
56467021|NCT00482261|Dexamethasone|dexamethasone|mesh-list
56467022|NCT00482261|Lenalidomide|lenalidomide|mesh-list
56467023|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56467024|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
56467025|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
56467026|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467027|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467028|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56917911|NCT02280070|Antibodies|antibodies|mesh-list
56917912|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
56917913|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
56917914|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
56180401|NCT01404767|Esmolol|esmolol|mesh-list
56467029|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
56467030|NCT00482261|Hormones|hormones|mesh-ancestor
56467031|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467032|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56467033|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467034|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56467035|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56467036|NCT00482261|Analgesics|analgesics|mesh-ancestor
56467037|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
56467038|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56467039|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56467040|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56467041|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467042|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56467043|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56467044|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467045|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
56467046|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
56467047|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56467048|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56467049|NCT00482261|Growth Substances|growth substances|mesh-ancestor
56467050|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
56467051|NCT04518618|Fentanyl|fentanyl|mesh-list
56467052|NCT04518618|Naloxone|naloxone|mesh-list
56467053|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56467054|NCT04518618|Narcotics|narcotics|mesh-ancestor
56467055|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467056|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467057|NCT04518618|Analgesics|analgesics|mesh-ancestor
56467058|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
56467059|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467060|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56467061|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56467062|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
56467063|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
56467064|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56467065|NCT00480584|Gemcitabine|gemcitabine|mesh-list
56467066|NCT00480584|Capecitabine|capecitabine|mesh-list
56467067|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56467068|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56467069|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
56467070|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467071|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467072|NCT00480584|Antiviral Agents|antiviral agents|mesh-ancestor
56467073|NCT00480584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467074|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467075|NCT00480584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56467076|NCT00480584|Immunologic Factors|immunologic factors|mesh-ancestor
56467077|NCT00480584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467078|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56467079|NCT01311505|Rifampin|rifampin|mesh-list
56467080|NCT01311505|Isoniazid|isoniazid|mesh-list
56467081|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56467082|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
56467083|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56467084|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467085|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
56467086|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56467087|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467088|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467095|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56467096|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56467097|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
56467098|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56467099|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
56467100|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56467101|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
55886650|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
56917915|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917916|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
56917990|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
56917991|NCT01111513|Analgesics|analgesics|mesh-list
56917992|NCT01111513|Ropivacaine|ropivacaine|mesh-list
56467102|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467103|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56467104|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56467105|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
56467106|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467107|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467108|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56467109|NCT01310803|Valrubicin|valrubicin|mesh-list
56467110|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467111|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56467112|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56467113|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467114|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467115|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
56467116|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
56467117|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467118|NCT04518540|Protective Agents|protective agents|mesh-ancestor
56467119|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467120|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
56467121|NCT04518540|Vitamins|vitamins|mesh-ancestor
56467122|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
56467123|NCT00480623|Satraplatin|satraplatin|mesh-list
56467124|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467125|NCT01240655|Paclitaxel|paclitaxel|mesh-list
56467126|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56467127|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467128|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
56467129|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
56467130|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
56467131|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467132|NCT04518189|Lidocaine|lidocaine|mesh-list
56467133|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
56467134|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
56467135|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467136|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467137|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
56467138|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467139|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56467140|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56467141|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56467142|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56467143|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467144|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
56467145|NCT00482378|Pamidronate|pamidronate|mesh-list
56467146|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56467147|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467148|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
56467149|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56467150|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
56467151|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
56467152|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467153|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467154|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56467155|NCT00482456|Analgesics|analgesics|mesh-ancestor
56467158|NCT00480896|Tacrolimus|tacrolimus|mesh-list
56467159|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56467160|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
56467161|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467162|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56467163|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467164|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467165|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56467166|NCT01309828|Olmesartan|olmesartan|mesh-list
56467167|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56467168|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
56467169|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56467170|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56467171|NCT01309828|Diuretics|diuretics|mesh-ancestor
56467172|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
56467173|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886651|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917993|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
56917994|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
56917995|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56917996|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917997|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
56917998|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917999|NCT01111591|Celecoxib|celecoxib|mesh-list
56918000|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
56918001|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56918002|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56467174|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56467175|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56467176|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467177|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56467178|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56467179|NCT00482495|Bevacizumab|bevacizumab|mesh-list
56467180|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56467181|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467182|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56467183|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56467184|NCT00482495|Growth Substances|growth substances|mesh-ancestor
56467185|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467186|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
56467187|NCT00480935|Sunitinib|sunitinib|mesh-list
56467188|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467189|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56467190|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56467191|NCT00480935|Growth Substances|growth substances|mesh-ancestor
56467192|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467193|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
56467194|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56467195|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467196|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467197|NCT00482573|Epinephrine|epinephrine|mesh-list
56467198|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56467199|NCT00482573|Anesthetics|anesthetics|mesh-list
56467200|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467201|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467202|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56467203|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56467204|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
56467205|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467206|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467207|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56467208|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56467209|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
56467210|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467211|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56467212|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
56467213|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
56467214|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
56467215|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
56467216|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467217|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467218|NCT00481013|Valproic Acid|valproic acid|mesh-list
56467219|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
56467220|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467221|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467222|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
56467223|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467224|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467225|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
56467226|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56918003|NCT01111591|Analgesics|analgesics|mesh-ancestor
56918004|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
56918005|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918006|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918007|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918008|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918009|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56918010|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918011|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918012|NCT04161898|Prednisolone|prednisolone|mesh-list
56918013|NCT04161898|Upadacitinib|upadacitinib|mesh-list
56918014|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918015|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
56918016|NCT04161898|Hormones|hormones|mesh-ancestor
56467227|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467232|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56467233|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467234|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467235|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
56467236|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467238|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56467239|NCT01240109|Remifentanil|remifentanil|mesh-list
56467240|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56467241|NCT01240109|Narcotics|narcotics|mesh-ancestor
56467242|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467243|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467244|NCT01240109|Analgesics|analgesics|mesh-ancestor
56467245|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
56467246|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467247|NCT04517526|Bevacizumab|bevacizumab|mesh-list
56467249|NCT04517526|Carboplatin|carboplatin|mesh-list
56467250|NCT04517526|Pemetrexed|pemetrexed|mesh-list
56467251|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56467252|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467253|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56467254|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56467255|NCT04517526|Growth Substances|growth substances|mesh-ancestor
56467256|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467257|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
56467258|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467259|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467260|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56467261|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56467262|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56467263|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56467264|NCT01309204|Brinzolamide|brinzolamide|mesh-list
56467265|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56467266|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56467267|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56467268|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56467269|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56467270|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
56467271|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467272|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467273|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467274|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56467275|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467276|NCT00482807|Docetaxel|docetaxel|mesh-list
56467277|NCT00482807|Goserelin|goserelin|mesh-list
56467278|NCT00482807|Bicalutamide|bicalutamide|mesh-list
56467279|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180494|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
56467280|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
56467281|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
56467282|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
56467283|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467284|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56467285|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
56467286|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
56467287|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467288|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467289|NCT01240148|Lidocaine|lidocaine|mesh-list
56467290|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
56467291|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
56467292|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467293|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467294|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
56467295|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467298|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56467299|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56467300|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467301|NCT04325191|Melatonin|melatonin|mesh-list
56467302|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
56467303|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467304|NCT04325191|Protective Agents|protective agents|mesh-ancestor
56467305|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467306|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467307|NCT04517292|Gemcitabine|gemcitabine|mesh-list
56467308|NCT04517292|Cisplatin|cisplatin|mesh-list
56467309|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467310|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56467311|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
56467312|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467313|NCT04517292|Antiviral Agents|antiviral agents|mesh-ancestor
56467314|NCT04517292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467315|NCT04517292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467316|NCT04517292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56467317|NCT04517292|Immunologic Factors|immunologic factors|mesh-ancestor
56467318|NCT04517292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467319|NCT00482846|Melphalan|melphalan|mesh-list
56467320|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56467321|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
56467322|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467323|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467324|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56467325|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56467326|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
56467327|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467328|NCT01308736|Varenicline|varenicline|mesh-list
56467329|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56467330|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56467331|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
56467332|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467333|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467334|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467335|NCT04517214|Gemcitabine|gemcitabine|mesh-list
56467336|NCT04517214|Capecitabine|capecitabine|mesh-list
56467337|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467338|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56467339|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
56467340|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467341|NCT04517214|Antiviral Agents|antiviral agents|mesh-ancestor
56467342|NCT04517214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467343|NCT04517214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467344|NCT04517214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56467345|NCT04517214|Immunologic Factors|immunologic factors|mesh-ancestor
56467346|NCT04517214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467347|NCT00483054|Efavirenz|efavirenz|mesh-list
56467348|NCT00483054|Nevirapine|nevirapine|mesh-list
56467349|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56467350|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56467351|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467352|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180495|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467353|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
56467354|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467355|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56467356|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56467357|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56467358|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56467359|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56467360|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56467361|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56467362|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56467363|NCT01240226|Ketoconazole|ketoconazole|mesh-list
56467364|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
56467365|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467366|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56467369|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467370|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56467371|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
56467372|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467373|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467374|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56467375|NCT01240824|Aminophylline|aminophylline|mesh-list
56467376|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56467377|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
56467378|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467379|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467380|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56467381|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
56467382|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56467383|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56467384|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467385|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467386|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56467387|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56467388|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
56467389|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467390|NCT01240824|Protective Agents|protective agents|mesh-ancestor
56467393|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467394|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56467395|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56467396|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467397|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467398|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56467399|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
56467400|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467401|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467402|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56467403|NCT00482963|Efavirenz|efavirenz|mesh-list
56467404|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
56467405|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56467406|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56467407|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467408|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467409|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
56467410|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467411|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56467412|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56467413|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56467414|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56467415|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56467416|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56467417|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56467418|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
56467419|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56467420|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467421|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56467422|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56467423|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56467424|NCT01241019|Topiramate|topiramate|mesh-list
56918017|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918018|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467425|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
56467426|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56467427|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467428|NCT01240928|Exemestane|exemestane|mesh-list
56467429|NCT01240928|Goserelin|goserelin|mesh-list
56467430|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467431|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56467432|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56467433|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467434|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467435|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56467436|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
56467440|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
56467441|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56467442|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56467443|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
56467444|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467445|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467446|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56467447|NCT00483093|Cisplatin|cisplatin|mesh-list
56467448|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467449|NCT00483132|Interferons|interferons|mesh-list
56467450|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
56467451|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
56467452|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467453|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
56467454|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467455|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
56467456|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467457|NCT00483210|Fenofibrate|fenofibrate|mesh-list
56467458|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56467459|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
56467460|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467461|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56467462|NCT00487994|Atorvastatin|atorvastatin|mesh-list
56467463|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56467464|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56467465|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
56467466|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467467|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56467468|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56467469|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467470|NCT00483158|Finafloxacin|finafloxacin|mesh-list
56467471|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56467472|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467473|NCT00483158|Renal Agents|renal agents|mesh-ancestor
56467474|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56467475|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56467476|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56467477|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467478|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467479|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467480|NCT00483366|Gemcitabine|gemcitabine|mesh-list
56467481|NCT00483366|Capecitabine|capecitabine|mesh-list
56467482|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
56467483|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56467484|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
56467485|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467486|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467487|NCT00483366|Antiviral Agents|antiviral agents|mesh-ancestor
56467488|NCT00483366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467489|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467490|NCT00483366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56467491|NCT00483366|Immunologic Factors|immunologic factors|mesh-ancestor
56467492|NCT00483366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467493|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56467494|NCT01308580|Prednisone|prednisone|mesh-list
56467495|NCT01308580|Prednisolone|prednisolone|mesh-list
56467496|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56467497|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
56918019|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56206912|NCT04182672|Hormones|hormones|mesh-ancestor
56467498|NCT01308580|Hormones|hormones|mesh-ancestor
56467499|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467500|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467501|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56467502|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467503|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
56467504|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56467505|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56467506|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467513|NCT00483314|Expectorants|expectorants|mesh-ancestor
56467514|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
56467515|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56467516|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
56467517|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467518|NCT00483314|Protective Agents|protective agents|mesh-ancestor
56467519|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467520|NCT00483314|Antidotes|antidotes|mesh-ancestor
56467521|NCT00483392|Metformin|metformin|mesh-list
56467522|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
56467523|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56467524|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467525|NCT00483431|Vitamin MK 7|vitamin mk 7|mesh-list
56467526|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
56467527|NCT00483431|Coagulants|coagulants|mesh-ancestor
56467528|NCT00483600|PENTA|penta|mesh-list
56467529|NCT00483600|Fondaparinux|fondaparinux|mesh-list
56467530|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56467531|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
56467532|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56467533|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
56467534|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467535|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467536|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
56467537|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56467538|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56467539|NCT00488189|Tazobactam|tazobactam|mesh-list
56467540|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56467541|NCT00488189|Piperacillin|piperacillin|mesh-list
56467542|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56467543|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467544|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56467545|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467546|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467547|NCT02956421|Vaccines|vaccines|mesh-list
56467548|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
56467549|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467550|NCT00483470|Vaccines|vaccines|mesh-list
56467551|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
56467552|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467553|NCT00488306|Tigecycline|tigecycline|mesh-list
56467554|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56467555|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467556|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56467557|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467558|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467559|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
56467560|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
56467561|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56467562|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56467563|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467564|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467565|NCT00483626|Urological Agents|urological agents|mesh-ancestor
56467566|NCT00483795|Citric Acid|citric acid|mesh-list
56467567|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
56467568|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
56467569|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56467570|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
56467571|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
56467572|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467573|NCT05644210|Aspirin|aspirin|mesh-list
56467574|NCT05644210|Hydroxychloroquine|hydroxychloroquine|mesh-list
56467575|NCT05644210|Prednisone|prednisone|mesh-list
56467576|NCT05644210|Rituximab|rituximab|mesh-list
56467577|NCT05644210|Warfarin|warfarin|mesh-list
56918020|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918021|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56918022|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56918023|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180499|NCT01405157|Prednisolone|prednisolone|mesh-list
56467578|NCT05644210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56467579|NCT05644210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467580|NCT05644210|Immunologic Factors|immunologic factors|mesh-ancestor
56467582|NCT05644210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56467583|NCT05644210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56467584|NCT05644210|Glucocorticoids|glucocorticoids|mesh-ancestor
56467585|NCT05644210|Hormones|hormones|mesh-ancestor
56467586|NCT05644210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467587|NCT05644210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56467588|NCT05644210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56467589|NCT05644210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56467590|NCT05644210|Analgesics|analgesics|mesh-ancestor
56467591|NCT05644210|Sensory System Agents|sensory system agents|mesh-ancestor
56467592|NCT05644210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467593|NCT05644210|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56467594|NCT05644210|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56467595|NCT05644210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467596|NCT05644210|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56467597|NCT05644210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56467598|NCT05644210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467599|NCT05644210|Antipyretics|antipyretics|mesh-ancestor
56467600|NCT05644210|Anticoagulants|anticoagulants|mesh-ancestor
56467601|NCT05644210|Antimalarials|antimalarials|mesh-ancestor
56467602|NCT05644210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56467603|NCT05644210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56467604|NCT05644210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467605|NCT00488384|Acitretin|acitretin|mesh-list
56215555|NCT01619436|Clonidine|clonidine|mesh-list
56467606|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
56467607|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
56467608|NCT00483834|Bevacizumab|bevacizumab|mesh-list
56467609|NCT00483834|Capecitabine|capecitabine|mesh-list
56467610|NCT00483834|Irinotecan|irinotecan|mesh-list
56467611|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56467612|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467613|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56467614|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56467615|NCT00483834|Growth Substances|growth substances|mesh-ancestor
56467616|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467617|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
56467618|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56467619|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
56467620|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467621|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56467622|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56467623|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467624|NCT01307449|Vaccines|vaccines|mesh-list
56467625|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56467626|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
56467627|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467628|NCT01307020|Ibuprofen|ibuprofen|mesh-list
56467629|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56467630|NCT01307020|Ketoprofen|ketoprofen|mesh-list
56467631|NCT01307020|Tramadol|tramadol|mesh-list
56467632|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56467633|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56467634|NCT01307020|Analgesics|analgesics|mesh-ancestor
56467635|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
56467636|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467637|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467638|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56467639|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56467640|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56467641|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467642|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467643|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56918024|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918025|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918026|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
56918027|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56918028|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56918029|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918030|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
56918031|NCT01111669|Coagulants|coagulants|mesh-ancestor
56918032|NCT01108939|Antimalarials|antimalarials|mesh-list
56918033|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56918034|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56918035|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918036|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56918037|NCT00654706|Sertindole|sertindole|mesh-list
56918038|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
56918039|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56467644|NCT01307020|Narcotics|narcotics|mesh-ancestor
56467645|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467646|NCT00483743|Budesonide|budesonide|mesh-list
56467647|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56467648|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56467649|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
56467650|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467651|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467652|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56467653|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
56467654|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
56467668|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56467670|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467671|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
56467684|NCT02890771|Turmeric extract|turmeric extract|mesh-list
56467685|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
56467686|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467687|NCT02890771|Protective Agents|protective agents|mesh-ancestor
56467688|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467689|NCT01306162|Dronedarone|dronedarone|mesh-list
56467690|NCT01306162|Dabigatran|dabigatran|mesh-list
56467691|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
56467692|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56467693|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
56467694|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467695|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467696|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
56467697|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56467698|NCT04515732|Apremilast|apremilast|mesh-list
56467699|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56467700|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56467701|NCT04515732|Analgesics|analgesics|mesh-ancestor
56467702|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
56467703|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467704|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467705|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56467706|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56467707|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56467708|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56467709|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467710|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467711|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
56467712|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56467713|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56918040|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56918041|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56918042|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918043|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918044|NCT03944473|Neostigmine|neostigmine|mesh-list
56467714|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56467715|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
56467716|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
56467717|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467718|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467719|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
56467720|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467721|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56467722|NCT01304329|Empagliflozin|empagliflozin|mesh-list
56467723|NCT01304329|Simvastatin|simvastatin|mesh-list
56467724|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56467725|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56467726|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
56467727|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467728|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56467732|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56467733|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467734|NCT04515420|Norepinephrine|norepinephrine|mesh-list
56467735|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56467736|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56467737|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
56467738|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467739|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467740|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467741|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
56467742|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
56467743|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467744|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56467745|NCT00488540|Acetaminophen|acetaminophen|mesh-list
56467746|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56467747|NCT00488540|Analgesics|analgesics|mesh-ancestor
56467748|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
56467749|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467750|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467751|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
56467753|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56467754|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
56467755|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467756|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467757|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56467758|NCT00483860|Topotecan|topotecan|mesh-list
56467759|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56467760|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56467761|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467762|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467763|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467764|NCT01241097|Simvastatin|simvastatin|mesh-list
56467765|NCT01241097|Ezetimibe|ezetimibe|mesh-list
56467766|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56467767|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56467768|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
56467769|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467770|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56467771|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56467772|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467773|NCT01303861|Bupropion|bupropion|mesh-list
56467774|NCT01303861|Nicotine|nicotine|mesh-list
56467775|NCT01303861|Varenicline|varenicline|mesh-list
56467776|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56467777|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
56467778|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467779|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467780|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56467781|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56467782|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
56918045|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56918046|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918047|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918048|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
56918049|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918050|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918051|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56918052|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
56918053|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918054|NCT03944317|Azithromycin|azithromycin|mesh-list
56918055|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
56918056|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
56467783|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467784|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467785|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56467786|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
56467787|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56467788|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56467789|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56467790|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56467791|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
56467792|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56467793|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56467794|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467795|NCT01303627|Remifentanil|remifentanil|mesh-list
56467796|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56467797|NCT01303627|Narcotics|narcotics|mesh-ancestor
56467798|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467799|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467803|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
56467804|NCT01241175|Analgesics|analgesics|mesh-ancestor
56467805|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
56467806|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467807|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467808|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
56467809|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467810|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56467811|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
56467812|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56467813|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56467814|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467815|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56467816|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
56467817|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56467819|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56467820|NCT00484107|Hormones|hormones|mesh-ancestor
56467821|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467822|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467823|NCT01302964|Mirtazapine|mirtazapine|mesh-list
56467824|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
56467825|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56467826|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56467827|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
56467828|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
56467829|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467830|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467831|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467832|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56467833|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56467834|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899240|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
56918057|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56918058|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56207201|NCT02546492|beta-Endorphin|beta-endorphin|mesh-list
56467835|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56467836|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56467837|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56467838|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
56467839|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56467840|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56467841|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
56467842|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56467843|NCT00484055|Gentamicins|gentamicins|mesh-list
56467844|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56467845|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467846|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56467847|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467848|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467849|NCT01302691|Losartan|losartan|mesh-list
56467850|NCT01302691|Amlodipine|amlodipine|mesh-list
56467851|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56467852|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56467853|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56467854|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56467855|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467856|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56467857|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467858|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
56467859|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56467860|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56467861|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56467862|NCT01302691|Diuretics|diuretics|mesh-ancestor
56467863|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
56467864|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56467865|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
56467866|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
56467867|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467868|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467869|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56467874|NCT05643820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467875|NCT05643820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467876|NCT05643820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467877|NCT01242449|Trastuzumab|trastuzumab|mesh-list
56467878|NCT01242449|Vinorelbine|vinorelbine|mesh-list
56467879|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56467880|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467881|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56467882|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
56467883|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
56467884|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
56467885|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467886|NCT01241162|Decitabine|decitabine|mesh-list
56467887|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56467888|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
56467889|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467890|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467891|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467892|NCT00484133|Dobutamine|dobutamine|mesh-list
56467893|NCT00484133|Dopamine|dopamine|mesh-list
56467894|NCT00484133|Enoximone|enoximone|mesh-list
56467895|NCT00484133|Norepinephrine|norepinephrine|mesh-list
56467896|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
56467897|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
56467898|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56467899|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
56467900|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
56467901|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467902|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467903|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56467904|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56467905|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56467906|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
56918059|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918060|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
56918061|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56918062|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56918063|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56467907|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467908|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467909|NCT00484133|Protective Agents|protective agents|mesh-ancestor
56467910|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
56467911|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56467912|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56467913|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56467914|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56467915|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467916|NCT00484341|Doxorubicin|doxorubicin|mesh-list
56467917|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56467918|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467919|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56467920|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56467921|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467922|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467923|NCT01242566|Temozolomide|temozolomide|mesh-list
56467924|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56467925|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
56467926|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467927|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467928|NCT04514835|Capecitabine|capecitabine|mesh-list
56467929|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467930|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56467931|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
56467932|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467933|NCT00488813|Cephalosporins|cephalosporins|mesh-list
56467934|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56467935|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467936|NCT00484250|Metronidazole|metronidazole|mesh-list
56467937|NCT00484250|Doxycycline|doxycycline|mesh-list
56467938|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467939|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56467940|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56467941|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56467942|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
56467945|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56467946|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467947|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467948|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56467949|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56467950|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56467951|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
56467952|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467953|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467954|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56467955|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56467956|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
56467958|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
56467959|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467960|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
56467961|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467962|NCT00484575|Propofol|propofol|mesh-list
56467963|NCT00484575|Sevoflurane|sevoflurane|mesh-list
56467964|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56467965|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56467966|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467967|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56467968|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
56467969|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
56467970|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56467971|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56467972|NCT04514796|Adalimumab|adalimumab|mesh-list
56467973|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56467974|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918064|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918065|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918066|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56918067|NCT03944317|Renal Agents|renal agents|mesh-ancestor
56918068|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
56918069|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56918070|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
56918071|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918072|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
56918073|NCT02280538|Protective Agents|protective agents|mesh-ancestor
56918074|NCT01111747|Mitogens|mitogens|mesh-list
56918075|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
56918076|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918077|NCT02281708|Cisplatin|cisplatin|mesh-list
56918078|NCT02281708|Vinorelbine|vinorelbine|mesh-list
56918079|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918080|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56918081|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56918082|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56467975|NCT00488969|Morphine|morphine|mesh-list
56467976|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56467977|NCT00488969|Narcotics|narcotics|mesh-ancestor
56467978|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215936|NCT01621451|Aspirin|aspirin|mesh-list
56467979|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467980|NCT00488969|Analgesics|analgesics|mesh-ancestor
56467981|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
56467982|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467983|NCT00484692|Bupropion|bupropion|mesh-list
56467984|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56467985|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
56467986|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56467987|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56467988|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56467989|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56467990|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467991|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
56467992|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56467993|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467994|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56467995|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56467996|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467997|NCT00484731|Bupivacaine|bupivacaine|mesh-list
56467998|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
56467999|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
56468000|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468001|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468002|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
56468003|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468004|NCT00484484|Ketamine|ketamine|mesh-list
56468005|NCT00484484|Analgesics|analgesics|mesh-ancestor
56468006|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
56468007|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468008|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468009|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56468010|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56918083|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56918084|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918085|NCT01111903|Lenalidomide|lenalidomide|mesh-list
56468011|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
56468012|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
56468013|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468014|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56468015|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56468017|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468018|NCT00484601|Doxorubicin|doxorubicin|mesh-list
56468019|NCT00484601|Ifosfamide|ifosfamide|mesh-list
56468020|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56468021|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468022|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56468023|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56468024|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468025|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468026|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56468027|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
56468028|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56468029|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
56468030|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468031|NCT00484640|Warfarin|warfarin|mesh-list
56468032|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
56468033|NCT00489164|Sirolimus|sirolimus|mesh-list
56468034|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56468035|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468036|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56468037|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468038|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
56468039|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468040|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
56468041|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468042|NCT00484809|Etanercept|etanercept|mesh-list
56468043|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56468044|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56468045|NCT00484809|Analgesics|analgesics|mesh-ancestor
56468046|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
56468047|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468048|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468049|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56468050|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468051|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468052|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468053|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
56468055|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
56468056|NCT04514094|Protective Agents|protective agents|mesh-ancestor
56468057|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468058|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56468059|NCT00484926|Aspirin|aspirin|mesh-list
56468060|NCT00484926|Clopidogrel|clopidogrel|mesh-list
56468061|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56468062|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56468063|NCT00484926|Analgesics|analgesics|mesh-ancestor
56468064|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
56468065|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468066|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468067|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56468068|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468069|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56468070|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56468071|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468072|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56468073|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56468074|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468075|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
56468076|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56468077|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56468078|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56468079|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
56468080|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468081|NCT02275806|Irinotecan|irinotecan|mesh-list
56918086|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
56918087|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918088|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56918089|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56918090|NCT01111903|Growth Substances|growth substances|mesh-ancestor
56918091|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
56918092|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918093|NCT02280616|Budesonide|budesonide|mesh-list
56207446|NCT01570088|Vitamins|vitamins|mesh-ancestor
56468082|NCT02275806|Camptothecin|camptothecin|mesh-list
56468083|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468084|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56468085|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56468086|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468087|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468088|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56468089|NCT01241409|Rabeprazole|rabeprazole|mesh-list
56468090|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56468094|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468095|NCT02275845|Metformin|metformin|mesh-list
56468096|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55969057|NCT00557193|Methotrexate|methotrexate|mesh-list
56468097|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468098|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56468099|NCT00489398|Epinastine|epinastine|mesh-list
56468100|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56468101|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56468102|NCT00489398|Analgesics|analgesics|mesh-ancestor
56468103|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
56468104|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468105|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468106|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56468107|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468108|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56468109|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56468110|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56468111|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
56468112|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
56468113|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468114|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468115|NCT00485004|Sirolimus|sirolimus|mesh-list
56468116|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56468117|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468118|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56468119|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468120|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
56468121|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468122|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
56468123|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468124|NCT00484991|Verapamil|verapamil|mesh-list
56468125|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56468126|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56468127|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468128|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468129|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56468130|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468131|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
56468132|NCT00485121|Ezetimibe|ezetimibe|mesh-list
56468133|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56468134|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56468135|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
56468136|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468137|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56468138|NCT00489437|Heparin|heparin|mesh-list
56468139|NCT00489437|Antibodies|antibodies|mesh-list
56468140|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
56055856|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
56918094|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918095|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56918096|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
56918097|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918098|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918099|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56918100|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
56918101|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
56918102|NCT02280616|Hormones|hormones|mesh-ancestor
56918103|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918104|NCT01111981|Clobetasol|clobetasol|mesh-list
56918105|NCT01111981|Emollients|emollients|mesh-list
56918106|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918107|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
56918108|NCT01111981|Hormones|hormones|mesh-ancestor
56923704|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207507|NCT01570582|Paclitaxel|paclitaxel|mesh-list
56468141|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468142|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
56468143|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56468144|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56468145|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468146|NCT00485160|Ibuprofen|ibuprofen|mesh-list
56468147|NCT00485160|Indomethacin|indomethacin|mesh-list
56468148|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56468149|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56468150|NCT00485160|Analgesics|analgesics|mesh-ancestor
56468151|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
56468152|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468153|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468154|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56468155|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468156|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56468157|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468158|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468159|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
56468160|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
56468161|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56468165|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468166|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
56468167|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468168|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56468169|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468170|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56468171|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
56468173|NCT04513821|Minocycline|minocycline|mesh-list
56468174|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56468175|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468176|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468177|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468178|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56468179|NCT00485108|Prednisolone|prednisolone|mesh-list
56468180|NCT00485108|Ketorolac|ketorolac|mesh-list
56468181|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
56468182|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56468183|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
56468184|NCT00485108|Hormones|hormones|mesh-ancestor
56468185|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918109|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207547|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
56468186|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468187|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56468188|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468189|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468190|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56468191|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56468192|NCT00485108|Analgesics|analgesics|mesh-ancestor
56468193|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
56468194|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468195|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56468196|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468197|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468198|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56468199|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56468200|NCT00485238|Acetazolamide|acetazolamide|mesh-list
56468201|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
56468202|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56468203|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468204|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468206|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
56468207|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468208|NCT04513509|Propranolol|propranolol|mesh-list
56468209|NCT04513509|Metoprolol|metoprolol|mesh-list
56468210|NCT04513509|Digoxin|digoxin|mesh-list
56468211|NCT04513509|Atenolol|atenolol|mesh-list
56468212|NCT04513509|Verapamil|verapamil|mesh-list
56468213|NCT04513509|Nebivolol|nebivolol|mesh-list
56468214|NCT04513509|Bisoprolol|bisoprolol|mesh-list
56468215|NCT04513509|Diltiazem|diltiazem|mesh-list
56468216|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56468217|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56468218|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468219|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468220|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468221|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468222|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56468223|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56468224|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
56468225|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
56468226|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
56468227|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468228|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56468229|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56468230|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468231|NCT04513509|Protective Agents|protective agents|mesh-ancestor
56468232|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56468233|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56468234|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56468235|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56468236|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468237|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56468238|NCT00485342|Interferons|interferons|mesh-list
56468239|NCT00485342|Ribavirin|ribavirin|mesh-list
56468240|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
56468241|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
56468242|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56468243|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468244|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
56468245|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468246|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
56468247|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468248|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
56468249|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468251|NCT00489593|Fluoxetine|fluoxetine|mesh-list
56468252|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
56468253|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
56468254|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468255|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468256|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468257|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56468258|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56468259|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918110|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918111|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
56918113|NCT02283424|Docetaxel|docetaxel|mesh-list
56918114|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918115|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
56918116|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
56918117|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
56918118|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918119|NCT03942601|Sirolimus|sirolimus|mesh-list
56918120|NCT03942601|Dexamethasone|dexamethasone|mesh-list
56468260|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468261|NCT00489593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56468262|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468263|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468264|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468265|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468266|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
56468267|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56468268|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
56468269|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56468270|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56468271|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468272|NCT01241487|Amlodipine|amlodipine|mesh-list
56468273|NCT01241487|Valsartan|valsartan|mesh-list
56468274|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56468275|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56468276|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468277|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216231|NCT01623440|Naltrexone|naltrexone|mesh-list
56468278|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56468279|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468280|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
56468281|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56468282|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56468283|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56468284|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
56468285|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468286|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
56468287|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56468288|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56468289|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
56468290|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468291|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56468292|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56468293|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468294|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468295|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56468296|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56468297|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468298|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468299|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468300|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468301|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468302|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468303|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56468304|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468305|NCT04697511|Midazolam|midazolam|mesh-list
56468306|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56468307|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56468308|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468309|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468312|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468313|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56918121|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
56918122|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56918123|NCT03942601|BB 1101|bb 1101|mesh-list
56918124|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918125|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
56918126|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
56918127|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918128|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918129|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56918130|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
56918131|NCT03942601|Hormones|hormones|mesh-ancestor
56918132|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180599|NCT01405612|Midazolam|midazolam|mesh-list
56468314|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
56468315|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
56468316|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
56468317|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
56468318|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468319|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468320|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
56468321|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468322|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
56468323|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468324|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468325|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56468326|NCT00485498|Olanzapine|olanzapine|mesh-list
56468327|NCT00485498|Risperidone|risperidone|mesh-list
56468328|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56468329|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
56468330|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468331|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468332|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468333|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56468334|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56468335|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468336|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468337|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56468338|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
56468339|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
56468340|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
56468341|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468342|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468343|NCT00485498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56468344|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468345|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468346|NCT01302067|Fesoterodine|fesoterodine|mesh-list
56468347|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56468348|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56468349|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
56468350|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216311|NCT01624025|Docetaxel|docetaxel|mesh-list
56468351|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468352|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468353|NCT01302067|Urological Agents|urological agents|mesh-ancestor
56468354|NCT00485550|Methylphenidate|methylphenidate|mesh-list
56468355|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56468356|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56468357|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468358|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56468359|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468360|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468361|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918133|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56918134|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918135|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56918136|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918137|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56918138|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
56918139|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918140|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
56918141|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
56468362|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
56468363|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468364|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56468365|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468366|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56468367|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56468368|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468369|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468370|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468371|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468372|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468373|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468374|NCT00485576|Eculizumab|eculizumab|mesh-list
56468375|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56468376|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468377|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
56468378|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468379|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
56334355|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
56468381|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468382|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56468383|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56468384|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468385|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468386|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468387|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
56468388|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56468389|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468390|NCT00489944|Tamoxifen|tamoxifen|mesh-list
56468391|NCT00489944|Sunitinib|sunitinib|mesh-list
56468392|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468393|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468394|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56468395|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56468396|NCT00489944|Growth Substances|growth substances|mesh-ancestor
56468397|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468398|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
56468399|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56468400|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468401|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56468402|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
56468403|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56468404|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56468405|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56468406|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56468407|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56468408|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
56468409|NCT00485706|Calcium|calcium|mesh-list
56468410|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56468411|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468412|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56468413|NCT00505947|Infliximab|infliximab|mesh-list
56468414|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
56468415|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468416|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918142|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918143|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918144|NCT00598312|Leuprolide|leuprolide|mesh-list
56918145|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56918146|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
56918147|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56918148|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918149|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56918150|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918151|NCT00595426|Warfarin|warfarin|mesh-list
56918152|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
56918153|NCT01112137|Clopidogrel|clopidogrel|mesh-list
56918154|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56468417|NCT00489983|Gemcitabine|gemcitabine|mesh-list
56468418|NCT00489983|Pemetrexed|pemetrexed|mesh-list
56468419|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56468420|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
56468421|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333889|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
56468422|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468424|NCT00489983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468425|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468426|NCT00489983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468427|NCT00489983|Immunologic Factors|immunologic factors|mesh-ancestor
56468428|NCT00489983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468429|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56468430|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56468431|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
56468432|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468433|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
56468434|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468435|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468436|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56468437|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
56468438|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468439|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468440|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56468441|NCT00490178|Metformin|metformin|mesh-list
56468442|NCT00490178|Fenofibrate|fenofibrate|mesh-list
56468443|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56468444|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468445|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56468446|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
56468447|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468448|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56468449|NCT00485771|Lamotrigine|lamotrigine|mesh-list
56468450|NCT00485771|Olanzapine|olanzapine|mesh-list
56468451|NCT00485771|Fluoxetine|fluoxetine|mesh-list
56468452|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
56468455|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468456|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468457|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56468458|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56468459|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468460|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468461|NCT00485771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56468462|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468463|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468464|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468465|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468466|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
56468467|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56918155|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56918156|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56918157|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56918158|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
56918159|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918160|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918161|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918162|NCT02282098|Colchicine|colchicine|mesh-list
56918163|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
56918164|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918165|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
56918166|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
56918167|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
56918168|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918169|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918170|NCT01208935|Nicotine|nicotine|mesh-list
56468468|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
56468469|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56468470|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56468471|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468472|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
56468473|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56468474|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56468475|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56468476|NCT00485810|Olanzapine|olanzapine|mesh-list
56468477|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
56468478|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
56468479|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468480|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468481|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468482|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56468483|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56468484|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468485|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468486|NCT00485810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56468487|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468488|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468489|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468490|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468491|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
56468492|NCT00490373|Pemetrexed|pemetrexed|mesh-list
56468493|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468494|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333890|NCT00063960|Irinotecan|irinotecan|mesh-list
56468495|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468496|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56468497|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56468498|NCT00485823|Olanzapine|olanzapine|mesh-list
56468499|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
56468500|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
56468501|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468502|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468503|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468504|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56468505|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56468506|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468507|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56918171|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56918172|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
56918173|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918174|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918175|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56918176|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56918177|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
56918178|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918179|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918180|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56918181|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56918182|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56918183|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918184|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918185|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918186|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918187|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56918188|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
56918189|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56918190|NCT01107067|Testosterone|testosterone|mesh-list
56918191|NCT01107067|Androgens|androgens|mesh-ancestor
56468508|NCT00485823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56468509|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468510|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468511|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468512|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468513|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
56468514|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56468515|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56468516|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468517|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468518|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468519|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468520|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468521|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468524|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468525|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468526|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468527|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468528|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
56468529|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468530|NCT00485888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56468531|NCT00485888|Antidepressive Agents|antidepressive agents|mesh-ancestor
56468532|NCT00485888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468533|NCT00485862|Sertraline|sertraline|mesh-list
56468534|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56468535|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
56468536|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56918192|NCT01107067|Hormones|hormones|mesh-ancestor
56918193|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918194|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918195|NCT02282176|Azithromycin|azithromycin|mesh-list
56180673|NCT01406080|Analgesics|analgesics|mesh-ancestor
56468537|NCT00485862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56468538|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468539|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468540|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468541|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468542|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
56468543|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468544|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56468545|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468546|NCT00485901|Haloperidol|haloperidol|mesh-list
56468547|NCT00485901|Olanzapine|olanzapine|mesh-list
56468548|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
56468549|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
56468550|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
56468551|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468552|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468553|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468554|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56468555|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56468556|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468557|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468558|NCT00485901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56468559|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468560|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468561|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468562|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468563|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
56468564|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56468565|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
56216527|NCT01625520|Everolimus|everolimus|mesh-list
56468566|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56468568|NCT00490412|Vitamins|vitamins|mesh-ancestor
56468569|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
56468570|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468571|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56468572|NCT00485940|Prucalopride|prucalopride|mesh-list
56468573|NCT00485940|Laxatives|laxatives|mesh-ancestor
56468574|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468575|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56468576|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56468577|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
56468578|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468579|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468580|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468581|NCT00486005|Olanzapine|olanzapine|mesh-list
56468582|NCT00486005|Nizatidine|nizatidine|mesh-list
56468583|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
56468584|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
56468585|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468586|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468587|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468588|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56468589|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56468590|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468591|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468592|NCT00486005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56468593|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468594|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468596|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468597|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
56468598|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56468599|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56468600|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
56468601|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
56468602|NCT00485979|Docetaxel|docetaxel|mesh-list
56918196|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56918197|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918198|NCT00580216|Biotin|biotin|mesh-list
56918199|NCT00580216|Warfarin|warfarin|mesh-list
56918200|NCT00580216|Idraparinux|idraparinux|mesh-list
56918201|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
56918202|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
56918203|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56918204|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
56918205|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56918206|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
56918207|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918208|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918209|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
56918210|NCT00580216|Vitamins|vitamins|mesh-ancestor
56918211|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
56918212|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918213|NCT01107145|Artesunate|artesunate|mesh-list
56918214|NCT01107145|Chloroquine|chloroquine|mesh-list
56918215|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56918216|NCT01107145|Lumefantrine|lumefantrine|mesh-list
56918217|NCT01107145|Artemether|artemether|mesh-list
56918218|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56918219|NCT01107145|Mefloquine|mefloquine|mesh-list
56918220|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
56180697|NCT01406171|Midazolam|midazolam|mesh-list
56468603|NCT00485979|Trastuzumab|trastuzumab|mesh-list
56468604|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468605|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56468606|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56468607|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56468608|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468609|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56468610|NCT00486083|Methylphenidate|methylphenidate|mesh-list
56468611|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56468612|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56468613|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468614|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56468615|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468616|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468617|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468618|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
56468619|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468620|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56468621|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468622|NCT00490685|Sorafenib|sorafenib|mesh-list
56468623|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468624|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56468625|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468626|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468627|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56468628|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56055857|NCT00357851|Coagulants|coagulants|mesh-ancestor
56918221|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56918222|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56918223|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918224|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918225|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
56918226|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
56918227|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56918228|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
56918229|NCT01107145|Amebicides|amebicides|mesh-ancestor
56918230|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918231|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56918232|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56918233|NCT01107145|Analgesics|analgesics|mesh-ancestor
56918234|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
56918235|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180699|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56468629|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468630|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468631|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468632|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468633|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468634|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468635|NCT04511715|Bevacizumab|bevacizumab|mesh-list
56468636|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56468637|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468638|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56468639|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56468640|NCT04511715|Growth Substances|growth substances|mesh-ancestor
56468641|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468642|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
56468643|NCT00486317|Calcitonin|calcitonin|mesh-list
56468644|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
56468645|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56468646|NCT00486317|Katacalcin|katacalcin|mesh-list
56468647|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56468648|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468649|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56468650|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
56468651|NCT00490880|Gemcitabine|gemcitabine|mesh-list
56468652|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468653|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56468654|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
56468655|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468656|NCT00490880|Antiviral Agents|antiviral agents|mesh-ancestor
56468657|NCT00490880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468658|NCT00490880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468659|NCT00490880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468660|NCT00490880|Immunologic Factors|immunologic factors|mesh-ancestor
56468661|NCT00490880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468662|NCT00486174|Methylene Blue|methylene blue|mesh-list
56468663|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468664|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468665|NCT00486356|Carboplatin|carboplatin|mesh-list
56468666|NCT00486356|Capecitabine|capecitabine|mesh-list
56468675|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468676|NCT00490958|Telmisartan|telmisartan|mesh-list
56468677|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56468678|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56468679|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56918236|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918237|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918238|NCT01107145|Filaricides|filaricides|mesh-ancestor
56468680|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468681|NCT00486213|Pyridoxine|pyridoxine|mesh-list
56468682|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
56468683|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
56468684|NCT00486213|Vitamins|vitamins|mesh-ancestor
56468685|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
56468686|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468687|NCT00486369|Calcitonin|calcitonin|mesh-list
56468688|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
56468689|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56468690|NCT00486369|Katacalcin|katacalcin|mesh-list
56468691|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56468692|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468693|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56468694|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
56468695|NCT00490997|Ketamine|ketamine|mesh-list
56468696|NCT00490997|Propofol|propofol|mesh-list
56468697|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56468698|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468699|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468700|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56468701|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
56468702|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
56468703|NCT00490997|Analgesics|analgesics|mesh-ancestor
56468704|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
56468705|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468706|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56468707|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56468708|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56468709|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468710|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468711|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
56468712|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56468713|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
56468714|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56468716|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468717|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468718|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
56468719|NCT00486486|Timolol|timolol|mesh-list
56468720|NCT00486486|Bimatoprost|bimatoprost|mesh-list
56468721|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56468722|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56468723|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468724|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468725|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468726|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468727|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56468728|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56468729|NCT00491114|Gemcitabine|gemcitabine|mesh-list
56468730|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56468731|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
56468732|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468733|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468734|NCT00491114|Antiviral Agents|antiviral agents|mesh-ancestor
56468740|NCT00486564|Nifurtimox|nifurtimox|mesh-list
56468741|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56468742|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56468743|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56468744|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468745|NCT00486668|Paclitaxel|paclitaxel|mesh-list
56468746|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
56468747|NCT00486668|Doxorubicin|doxorubicin|mesh-list
56468748|NCT00486668|Trastuzumab|trastuzumab|mesh-list
56468749|NCT00486668|Lapatinib|lapatinib|mesh-list
56468750|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56468751|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468752|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
56468753|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
56468754|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
56468755|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468756|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918239|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
56918240|NCT03944005|Anesthetics|anesthetics|mesh-list
56918241|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918242|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468757|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
56468758|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468759|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468760|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56468761|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
56468762|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56468763|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56468764|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56468765|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56468766|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468767|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56468768|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56468769|NCT04510935|Anesthetics|anesthetics|mesh-list
56468770|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468771|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468772|NCT00491192|Diclofenac|diclofenac|mesh-list
56468773|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56468774|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56468775|NCT00491192|Analgesics|analgesics|mesh-ancestor
56468776|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
56468777|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468778|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468779|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56468780|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468781|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56468782|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468783|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468784|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56468785|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
56468786|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468787|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56468788|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56216750|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
56468789|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56468790|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468791|NCT01301833|Biguanides|biguanides|mesh-list
56468792|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
56468793|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56468794|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468795|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468796|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468797|NCT00486785|Alfuzosin|alfuzosin|mesh-list
56468798|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56468799|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56468800|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56468801|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468802|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468803|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468805|NCT00486785|Urological Agents|urological agents|mesh-ancestor
56468806|NCT04324411|Sirolimus|sirolimus|mesh-list
56468807|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56468808|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468809|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56468810|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468811|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
56468812|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468813|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
56468814|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468815|NCT00486876|Tofisopam|tofisopam|mesh-list
56468816|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
56468817|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468818|NCT05643586|Ticagrelor|ticagrelor|mesh-list
56468819|NCT05643586|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56468820|NCT05643586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56468821|NCT05643586|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56468822|NCT05643586|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56918243|NCT01209403|Insulin|insulin|mesh-list
56918244|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
56918245|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918246|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468823|NCT05643586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56468824|NCT05643586|Purinergic Agents|purinergic agents|mesh-ancestor
56468825|NCT05643586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468826|NCT05643586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468827|NCT05643586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468828|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
56468829|NCT01242072|Ifosfamide|ifosfamide|mesh-list
56468830|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56468831|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
56468832|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468833|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468834|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56468835|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56468836|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56468837|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56468838|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468839|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468840|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468841|NCT00491348|Analgesics|analgesics|mesh-ancestor
56468842|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
56468843|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468844|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
56468845|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56468846|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
56468847|NCT01242098|Fluticasone|fluticasone|mesh-list
56468848|NCT01242098|Beclomethasone|beclomethasone|mesh-list
56468849|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
56468850|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56468851|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56468852|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56468853|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
56468854|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468855|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468856|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56468857|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
56468858|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
56468859|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56468860|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56468861|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56468862|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56468863|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468864|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468865|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468866|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
56468867|NCT01242098|Hormones|hormones|mesh-ancestor
56468868|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56468869|NCT01301092|Dulaglutide|dulaglutide|mesh-list
56468870|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56468871|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468872|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56468873|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
56468874|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468875|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468879|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468880|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468882|NCT05642845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56468883|NCT05642845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56468884|NCT05642845|Antimetabolites|antimetabolites|mesh-ancestor
56468885|NCT05642845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468886|NCT05642845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56468887|NCT05642845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56468888|NCT05642845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468889|NCT04510662|Telmisartan|telmisartan|mesh-list
56468890|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56918247|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
56918248|NCT01112215|Azathioprine|azathioprine|mesh-list
56918249|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56918250|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918251|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56468891|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56468892|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56468893|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468894|NCT05642767|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56468895|NCT05642767|Cetrimonium|cetrimonium|mesh-list
56468896|NCT05642767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468897|NCT05642767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56468898|NCT05642689|Iron|iron|mesh-list
56468899|NCT05642689|Trace Elements|trace elements|mesh-ancestor
56468900|NCT05642689|Micronutrients|micronutrients|mesh-ancestor
56468901|NCT05642689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468902|NCT01300819|Rotigotine|rotigotine|mesh-list
56468903|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
56468904|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
56468905|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468906|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468907|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468908|NCT00486980|Peramivir|peramivir|mesh-list
56468909|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
56468910|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468911|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468912|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468913|NCT05642572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56468914|NCT05642572|Osimertinib|osimertinib|mesh-list
56468915|NCT05642572|Ramucirumab|ramucirumab|mesh-list
56468916|NCT05642572|Antibodies|antibodies|mesh-list
56468917|NCT05642572|Immunoglobulins|immunoglobulins|mesh-list
56468918|NCT05642572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56468919|NCT05642572|Lexatumumab|lexatumumab|mesh-list
56468920|NCT05642572|Immunologic Factors|immunologic factors|mesh-ancestor
56468921|NCT05642572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468922|NCT05642572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468923|NCT05642572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56468924|NCT05642572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468925|NCT05642572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468926|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
56468927|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
56468928|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468929|NCT02275962|Rifampin|rifampin|mesh-list
56468930|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56468931|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
56468932|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56468933|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468934|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
56468935|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56468936|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468937|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468938|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56468939|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56468940|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56468941|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56468942|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56468943|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56468945|NCT00487032|Xhance|xhance|mesh-list
56468946|NCT00487032|Prazosin|prazosin|mesh-list
56468947|NCT00487032|Phenylephrine|phenylephrine|mesh-list
56468948|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
56468952|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334374|NCT00070122|Vitamins|vitamins|mesh-ancestor
56468953|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468954|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56468955|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
56468956|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
56468957|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56468958|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56468959|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56918252|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
56918253|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56918254|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918255|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468960|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
56468961|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468962|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468963|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
56468964|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
56468965|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56468966|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56468967|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
56468968|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56468969|NCT00487032|Protective Agents|protective agents|mesh-ancestor
56468970|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56468971|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56468972|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56468973|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56468974|NCT00491426|Metronidazole|metronidazole|mesh-list
56468975|NCT00491426|Tazobactam|tazobactam|mesh-list
56468976|NCT00491426|Piperacillin|piperacillin|mesh-list
56468977|NCT00491426|Amphotericin B|amphotericin b|mesh-list
56468978|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56468979|NCT00491426|Acyclovir|acyclovir|mesh-list
56468980|NCT00491426|Ampicillin|ampicillin|mesh-list
56468981|NCT00491426|Caspofungin|caspofungin|mesh-list
56468982|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56468983|NCT00491426|Anidulafungin|anidulafungin|mesh-list
56468984|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468985|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56468986|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56468987|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56468988|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56468989|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468990|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468991|NCT00491426|Amebicides|amebicides|mesh-ancestor
56468992|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
56468993|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
56468994|NCT01300546|Naproxen|naproxen|mesh-list
56468995|NCT01300546|Sumatriptan|sumatriptan|mesh-list
56468996|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56468997|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56468998|NCT01300546|Analgesics|analgesics|mesh-ancestor
56468999|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
56469000|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469001|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469002|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56469003|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56469004|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
56469005|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56469006|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469007|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469008|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56469009|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56469010|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56333891|NCT00063960|Floxuridine|floxuridine|mesh-list
56469011|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
56469012|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469013|NCT00487110|Acetaminophen|acetaminophen|mesh-list
56469014|NCT00487110|Tropisetron|tropisetron|mesh-list
56469015|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56469016|NCT00487110|Analgesics|analgesics|mesh-ancestor
56469017|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
56469018|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469019|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469020|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
56469021|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
56469024|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56469025|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56469026|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
56469027|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469028|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469029|NCT00487136|Warfarin|warfarin|mesh-list
56918256|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469030|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56469031|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
56469032|NCT00487136|Fenofibrate|fenofibrate|mesh-list
56469033|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56469034|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56469035|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
56469036|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469037|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56469038|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56469039|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469040|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
56469041|NCT02276001|Cyclosporine|cyclosporine|mesh-list
56469042|NCT02276001|Cyclosporins|cyclosporins|mesh-list
56469043|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469044|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469045|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469046|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
56469047|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469048|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
56469049|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469050|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
56469051|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56469052|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56469053|NCT00491582|Hormones|hormones|mesh-list
56469054|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469055|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469056|NCT00487175|Tramadol|tramadol|mesh-list
56469057|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56469058|NCT00487175|Narcotics|narcotics|mesh-ancestor
56469059|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469060|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469061|NCT00487175|Analgesics|analgesics|mesh-ancestor
56469062|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
56469063|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469064|NCT00487227|Caffeine|caffeine|mesh-list
56469065|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56469066|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469067|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56469068|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469069|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469070|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56469071|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56469072|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
56469073|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469074|NCT01300351|Fulvestrant|fulvestrant|mesh-list
56469075|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56469076|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469077|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56469078|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56469079|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
56469080|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469081|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469082|NCT00487253|Miltefosine|miltefosine|mesh-list
56469083|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56469084|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
56469085|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469086|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469087|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56469088|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56469089|NCT04510233|Ivermectin|ivermectin|mesh-list
56469090|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56469091|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469092|NCT05641909|Fentanyl|fentanyl|mesh-list
56469093|NCT05641909|Remifentanil|remifentanil|mesh-list
56469094|NCT05641909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56469095|NCT05641909|Narcotics|narcotics|mesh-ancestor
56334383|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
56469096|NCT05641909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469100|NCT05641909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469101|NCT05641909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56469102|NCT05641909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56469103|NCT05641909|Anesthetics, General|anesthetics, general|mesh-ancestor
56469104|NCT05641909|Anesthetics|anesthetics|mesh-ancestor
56918257|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
56469105|NCT05641753|Atorvastatin|atorvastatin|mesh-list
56469106|NCT05641753|Ezetimibe|ezetimibe|mesh-list
56469107|NCT05641753|Evolocumab|evolocumab|mesh-list
56469108|NCT05641753|Calcium|calcium|mesh-list
56469109|NCT05641753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56469110|NCT05641753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469111|NCT05641753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56469112|NCT05641753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56469113|NCT05641753|Antimetabolites|antimetabolites|mesh-ancestor
56469114|NCT05641753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469115|NCT05641753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56469116|NCT05641753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56469117|NCT05641753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469118|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
56469119|NCT02276196|Lixisenatide|lixisenatide|mesh-list
56469120|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56469121|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469122|NCT00487422|Prucalopride|prucalopride|mesh-list
56469123|NCT00487422|Laxatives|laxatives|mesh-ancestor
56469124|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56469125|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56469126|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56469127|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
56469128|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469129|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469130|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469131|NCT04697355|Beta Carotene|beta carotene|mesh-list
56469132|NCT04697355|Naringenin|naringenin|mesh-list
56469133|NCT04697355|Carotenoids|carotenoids|mesh-list
56469134|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
56469135|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469136|NCT04697355|Protective Agents|protective agents|mesh-ancestor
56469137|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469138|NCT04697355|Provitamins|provitamins|mesh-ancestor
56469139|NCT04697355|Vitamins|vitamins|mesh-ancestor
56469140|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
56469141|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56469142|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56469143|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56469144|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
56469145|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469146|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56469147|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469148|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56469149|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469150|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469151|NCT00491855|Paclitaxel|paclitaxel|mesh-list
56469152|NCT00491855|Bevacizumab|bevacizumab|mesh-list
56469153|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
56469154|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56469155|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469156|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
56469157|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
56469158|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
56469159|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469160|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56469161|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56469162|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56469163|NCT00491855|Growth Substances|growth substances|mesh-ancestor
56469164|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469165|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
56469166|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56469167|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469168|NCT00487448|Cytarabine|cytarabine|mesh-list
56469169|NCT00487448|Fludarabine|fludarabine|mesh-list
56469170|NCT00487448|Idarubicin|idarubicin|mesh-list
56469173|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
56469174|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469175|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469176|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
56469177|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469178|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
56469179|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469180|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56918258|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56918259|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918260|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
56918261|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918262|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918263|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56918264|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56918265|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918266|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
56918267|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56180736|NCT01406301|Fondaparinux|fondaparinux|mesh-list
56469181|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56469182|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56469183|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469185|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
56469186|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469187|NCT00506259|Protective Agents|protective agents|mesh-ancestor
56469188|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469189|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469190|NCT00506298|Diflunisal|diflunisal|mesh-list
56469191|NCT00506298|Bezafibrate|bezafibrate|mesh-list
56469192|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56469193|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
56469194|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469195|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56469196|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56469197|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56469198|NCT00506298|Analgesics|analgesics|mesh-ancestor
56469199|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
56469200|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469201|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469202|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56469203|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56469204|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56469205|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469206|NCT01242215|Glimepiride|glimepiride|mesh-list
56469207|NCT01242215|Gliclazide|gliclazide|mesh-list
56469208|NCT01242215|Glyburide|glyburide|mesh-list
56469209|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
56469210|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56469211|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56469212|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469213|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469214|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
56469215|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56469216|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469217|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56469218|NCT01242228|Vildagliptin|vildagliptin|mesh-list
56469219|NCT01242228|Saxagliptin|saxagliptin|mesh-list
56469220|NCT01242228|Alogliptin|alogliptin|mesh-list
56469221|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
56469222|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56469223|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56469224|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469225|NCT01242228|Incretins|incretins|mesh-ancestor
56469226|NCT01242228|Hormones|hormones|mesh-ancestor
56469227|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469228|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
56469229|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469230|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469231|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56469232|NCT01242306|Acetylcholine|acetylcholine|mesh-list
56469233|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
56469234|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56918268|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918269|NCT02286544|Atorvastatin|atorvastatin|mesh-list
56918270|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56918271|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56918272|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
56918273|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918274|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56918275|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56918276|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918277|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56918278|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918279|NCT00384904|Ritonavir|ritonavir|mesh-list
56918280|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56469235|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
56469236|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469237|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469238|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469239|NCT00492128|Losartan|losartan|mesh-list
56469240|NCT00492128|Amlodipine|amlodipine|mesh-list
56469241|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56469242|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56469243|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56469244|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56469245|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469247|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469248|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
56469249|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56469250|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56469251|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56469252|NCT00492128|Diuretics|diuretics|mesh-ancestor
56469253|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
56469254|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56469255|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
56469256|NCT00487734|Testosterone|testosterone|mesh-list
56469257|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
56469258|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
56469259|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56469260|NCT00487734|Androgens|androgens|mesh-ancestor
56469262|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469263|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469264|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56469265|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469266|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
56469267|NCT01300234|Tenofovir|tenofovir|mesh-list
56469268|NCT01300234|Adefovir|adefovir|mesh-list
56469269|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56469270|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
56469271|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469272|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56469273|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56469274|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469275|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469276|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56469277|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56469278|NCT01242332|Pregabalin|pregabalin|mesh-list
56469279|NCT01242332|Analgesics|analgesics|mesh-ancestor
56469280|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
56469281|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469282|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469283|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
56469284|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56055858|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56918281|NCT00384904|Tenofovir|tenofovir|mesh-list
56918282|NCT00384904|Famotidine|famotidine|mesh-list
56918283|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56918284|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56918285|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
56918286|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918287|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918288|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56918289|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56918290|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
56918291|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918292|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56918293|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56918294|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56918295|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56918296|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56918297|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56918298|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56180769|NCT01406470|Antibodies|antibodies|mesh-list
56469285|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56469286|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469287|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56469288|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56469289|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56469290|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469291|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56469292|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
56469293|NCT00487773|Budesonide|budesonide|mesh-list
56469294|NCT00487773|Albuterol|albuterol|mesh-list
56469295|NCT00487773|Montelukast|montelukast|mesh-list
56469296|NCT00487773|Vitamins|vitamins|mesh-ancestor
56469297|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
56469298|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469299|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56469300|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56469301|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
56469302|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469303|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56469304|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
56469305|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
56469306|NCT00487773|Hormones|hormones|mesh-ancestor
56469307|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469308|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56469309|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
56469310|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56469311|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56469312|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469313|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
56469314|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56469315|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56469316|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56469317|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56469318|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
56469321|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56469323|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56918299|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
56918300|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
56918301|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918302|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918303|NCT01335386|Glycerol|glycerol|mesh-list
56918304|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56469324|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469325|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469326|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469327|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
56469328|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469329|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56469331|NCT00492245|Mitomycin|mitomycin|mesh-list
56469332|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56469333|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469334|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
56469335|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469336|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56469337|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469338|NCT00487812|Dobutamine|dobutamine|mesh-list
56469339|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56469340|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
56469341|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
56469342|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469343|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469344|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56469345|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56469346|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56469347|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
56469348|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469349|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469350|NCT00487812|Protective Agents|protective agents|mesh-ancestor
56469351|NCT01299805|Vortioxetine|vortioxetine|mesh-list
56469352|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
56469353|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56469354|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56469355|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56469356|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469357|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469358|NCT01299805|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56469359|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56469360|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56469361|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469362|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469363|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
56469364|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56469365|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56469366|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56469367|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56469368|NCT00487682|Valacyclovir|valacyclovir|mesh-list
56469369|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
56469370|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469371|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
56469372|NCT04512261|Trastuzumab|trastuzumab|mesh-list
56469373|NCT04512261|Tucatinib|tucatinib|mesh-list
56469374|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56469375|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469376|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56469377|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469378|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469379|NCT00487799|Ularitide|ularitide|mesh-list
56469380|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56469381|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
56469382|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469383|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469384|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56469385|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
56469386|NCT00487799|Diuretics|diuretics|mesh-ancestor
56918305|NCT01335386|Protective Agents|protective agents|mesh-ancestor
56918306|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918307|NCT00383578|Metformin|metformin|mesh-list
56918308|NCT00383578|Vildagliptin|vildagliptin|mesh-list
56918309|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918310|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918311|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56918312|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
56918313|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918314|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918316|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56918368|NCT00382096|Vildagliptin|vildagliptin|mesh-list
56918369|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918370|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918371|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56918372|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
56918373|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918374|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918375|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
56918376|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56469387|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
56469388|NCT05149170|Antibodies|antibodies|mesh-list
56469389|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56469390|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
56469391|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469393|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
56469407|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469409|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56469410|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469411|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56469412|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469413|NCT00495326|Efavirenz|efavirenz|mesh-list
56469414|NCT00495326|Nevirapine|nevirapine|mesh-list
56469415|NCT00495326|Rifampin|rifampin|mesh-list
56469416|NCT00495326|Isoniazid|isoniazid|mesh-list
56469417|NCT00495326|Ethambutol|ethambutol|mesh-list
56469418|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56469419|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56469420|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469421|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469422|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
56469423|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469424|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56469425|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56469426|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56469427|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56469428|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56469429|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56469430|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56469431|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
56469432|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56469433|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
56469434|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56469435|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56469436|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56469437|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56469438|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56469439|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56469440|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56469441|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
56469442|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56469443|NCT00492479|Kinetin|kinetin|mesh-list
56469444|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56469445|NCT00492479|Growth Substances|growth substances|mesh-ancestor
56469446|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469447|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
56469448|NCT00495365|Hematinics|hematinics|mesh-ancestor
56469449|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
56469450|NCT00492518|Theophylline|theophylline|mesh-list
56469451|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56469452|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
56469453|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469454|NCT00492518|Expectorants|expectorants|mesh-ancestor
56469457|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
56469458|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469459|NCT00492518|Protective Agents|protective agents|mesh-ancestor
56469460|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918377|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
56918378|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918379|NCT00379990|Prednisolone|prednisolone|mesh-list
56918380|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918381|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
56918382|NCT00379990|Hormones|hormones|mesh-ancestor
56918383|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918384|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918385|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56918386|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918387|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56918388|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
56918389|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918390|NCT01341938|Nicotine|nicotine|mesh-list
56918391|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56469461|NCT00492518|Antidotes|antidotes|mesh-ancestor
56469462|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56469463|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
56334392|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469464|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469465|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56469466|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56469467|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469468|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
56469469|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56469470|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56469471|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
56469472|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469473|NCT04513860|Cenobamate|cenobamate|mesh-list
56469474|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
56469475|NCT00495560|Misoprostol|misoprostol|mesh-list
56469476|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56469477|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
56469478|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56469479|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469480|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56469481|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56469482|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
56469483|NCT04510506|Pancrelipase|pancrelipase|mesh-list
56469484|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56469485|NCT00506844|Capecitabine|capecitabine|mesh-list
56469486|NCT00506844|Irinotecan|irinotecan|mesh-list
56469487|NCT00506844|Cetuximab|cetuximab|mesh-list
56469488|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56469489|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
56469490|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469491|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469492|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56469493|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56469494|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469495|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56469496|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56469497|NCT00506961|Simvastatin|simvastatin|mesh-list
56469498|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56469499|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56469500|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
56469501|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469502|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56469503|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56469504|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469505|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56918392|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
56918393|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918394|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918395|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56918396|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56918397|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
56918398|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918399|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918400|NCT02284048|Ticagrelor|ticagrelor|mesh-list
56918401|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56918402|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56918403|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56469506|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
56469507|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56469508|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56469509|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469510|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469511|NCT00492635|Urological Agents|urological agents|mesh-ancestor
56469512|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56469513|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469514|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469515|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469516|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56469517|NCT00507000|Vitamin D|vitamin d|mesh-list
56469518|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
56469519|NCT00507000|Vitamins|vitamins|mesh-ancestor
56469520|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
56469521|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469522|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56469523|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56469524|NCT00495872|Lenalidomide|lenalidomide|mesh-list
56469525|NCT00495872|Sunitinib|sunitinib|mesh-list
56469526|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56469527|NCT00495872|Sorafenib|sorafenib|mesh-list
56469531|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
56469532|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469533|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56469534|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56469535|NCT00495872|Growth Substances|growth substances|mesh-ancestor
56469536|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
56469537|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469538|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56469539|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469540|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469541|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
56469542|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
56469543|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469544|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
56469545|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56469546|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469547|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56469548|NCT00507117|Eszopiclone|eszopiclone|mesh-list
56469549|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56469550|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469551|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469552|NCT00492830|Antibodies|antibodies|mesh-list
56469553|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56469554|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
56469555|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469556|NCT01299571|Dutasteride|dutasteride|mesh-list
56469557|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56469558|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56918404|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56918405|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
56918406|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629038|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
56180890|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
56469559|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469560|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469561|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
56469562|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469563|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469564|NCT01243736|Metoclopramide|metoclopramide|mesh-list
56469565|NCT01243736|Simethicone|simethicone|mesh-list
56469566|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
56469567|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
56469568|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469569|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469570|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56469571|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56469572|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56469573|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
56469574|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469575|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469576|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
56469577|NCT01243736|Emollients|emollients|mesh-ancestor
56469578|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
56469579|NCT00492986|Sorafenib|sorafenib|mesh-list
56469580|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469581|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56469582|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469583|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469584|NCT01243970|Phenylephrine|phenylephrine|mesh-list
56469585|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
56469586|NCT01243970|Ephedrine|ephedrine|mesh-list
56469587|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56469588|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
56469589|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
56469590|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469591|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469592|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
56469593|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56469594|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
56469595|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
56469596|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56469597|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56469598|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56469599|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
56469600|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469601|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469604|NCT04515576|Dulaglutide|dulaglutide|mesh-list
56469605|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56469606|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469607|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56469608|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56469609|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469610|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469611|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56469612|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
56469613|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469614|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469615|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
56217575|NCT01632605|Sirolimus|sirolimus|mesh-list
56469617|NCT01244009|Niraparib|niraparib|mesh-list
56469618|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56469619|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469620|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469621|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469622|NCT04511832|Diclofenac|diclofenac|mesh-list
56469623|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56469624|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56469625|NCT04511832|Analgesics|analgesics|mesh-ancestor
56918407|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918408|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918409|NCT00374296|Mocetinostat|mocetinostat|mesh-list
56918410|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56918411|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918412|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918413|NCT00547066|Veltuzumab|veltuzumab|mesh-list
56918414|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918415|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
56918416|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56918417|NCT01315496|Antibodies|antibodies|mesh-list
56918418|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
56918419|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
56918420|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918421|NCT00544960|Docetaxel|docetaxel|mesh-list
56918422|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918423|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
56918424|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
56180905|NCT01407848|Furosemide|furosemide|mesh-list
56469626|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
56469627|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469628|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469629|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56469630|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56469631|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56469632|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469633|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469634|NCT01244204|Vitamin D|vitamin d|mesh-list
56469635|NCT01244204|Vitamins|vitamins|mesh-ancestor
56469636|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
56469637|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469638|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56469639|NCT00496028|Paclitaxel|paclitaxel|mesh-list
56469640|NCT00496028|Carboplatin|carboplatin|mesh-list
56469641|NCT00496028|Saracatinib|saracatinib|mesh-list
56469642|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56469643|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469644|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56469645|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56469646|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56469647|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469648|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469649|NCT04516278|Bevacizumab|bevacizumab|mesh-list
56469650|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56469651|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469652|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56469653|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56469654|NCT04516278|Growth Substances|growth substances|mesh-ancestor
56469655|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469656|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
56469657|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
56469658|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56469659|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469660|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56469661|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56469662|NCT01297465|Hormones|hormones|mesh-ancestor
55887135|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56918425|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
56918426|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918427|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56918428|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56918429|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56918430|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918431|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918432|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
56918433|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918434|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918435|NCT00468442|Sirolimus|sirolimus|mesh-list
56918436|NCT00468442|Rituximab|rituximab|mesh-list
56918437|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56918438|NCT00468442|Daclizumab|daclizumab|mesh-list
56918439|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56918440|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918441|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
56918442|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469663|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469664|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469665|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56469666|NCT04518462|Bupivacaine|bupivacaine|mesh-list
56469667|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
56469668|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
56469669|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469670|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469671|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
56469672|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469673|NCT00496184|Nifedipine|nifedipine|mesh-list
56469675|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56469676|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469677|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56469678|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469679|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
56469680|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
56469681|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56469682|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
56469683|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56469684|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
56469685|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469686|NCT00493610|Expectorants|expectorants|mesh-ancestor
56469687|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
56469688|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56469689|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
56469690|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469691|NCT00493610|Protective Agents|protective agents|mesh-ancestor
56469692|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469693|NCT00493610|Antidotes|antidotes|mesh-ancestor
56469694|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
56469695|NCT02274506|Fludarabine|fludarabine|mesh-list
56469696|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
56469697|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469698|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
56469699|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918443|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918444|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56918445|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469700|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56469701|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56469702|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
56469703|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469704|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469705|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56469706|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56469707|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
56469708|NCT00496223|Sunitinib|sunitinib|mesh-list
56469709|NCT00496223|Dacarbazine|dacarbazine|mesh-list
56469710|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469711|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56469712|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56469713|NCT00496223|Growth Substances|growth substances|mesh-ancestor
56469714|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469715|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
56469716|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56469717|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469718|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469719|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56469720|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
56469721|NCT00496301|Gemcitabine|gemcitabine|mesh-list
56469722|NCT00496301|Capecitabine|capecitabine|mesh-list
56469723|NCT00496301|Sorafenib|sorafenib|mesh-list
56469724|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56469725|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
56469726|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469727|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469728|NCT00496301|Antiviral Agents|antiviral agents|mesh-ancestor
56469729|NCT00496301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469730|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469731|NCT00496301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469732|NCT00496301|Immunologic Factors|immunologic factors|mesh-ancestor
56469733|NCT00496301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469734|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56469735|NCT05141838|Vitamin D|vitamin d|mesh-list
56469736|NCT05141838|Vitamins|vitamins|mesh-ancestor
56469737|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
56469738|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469739|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56469740|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
56469741|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56469742|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
56469743|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469744|NCT00493727|Expectorants|expectorants|mesh-ancestor
56469745|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
56469746|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56469749|NCT00493727|Protective Agents|protective agents|mesh-ancestor
56469750|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469751|NCT00493727|Antidotes|antidotes|mesh-ancestor
56469752|NCT00493766|Panobinostat|panobinostat|mesh-list
56469753|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469754|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56469755|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469756|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469757|NCT05146479|Fluorides|fluorides|mesh-list
56469758|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
56469759|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
56469760|NCT05146479|Protective Agents|protective agents|mesh-ancestor
56469761|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469762|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56469763|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56469764|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469765|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469766|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
56469767|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469768|NCT01296568|Gemcitabine|gemcitabine|mesh-list
56469769|NCT01296568|Pemetrexed|pemetrexed|mesh-list
56469770|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56469771|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
56918446|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56918447|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
56918448|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918449|NCT01339442|Fulvestrant|fulvestrant|mesh-list
56918450|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56918451|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918452|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56918453|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56918454|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
56180936|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469772|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469773|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469774|NCT01296568|Antiviral Agents|antiviral agents|mesh-ancestor
56469775|NCT01296568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469776|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469777|NCT01296568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469778|NCT01296568|Immunologic Factors|immunologic factors|mesh-ancestor
56469779|NCT01296568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469780|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56469781|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56469782|NCT02598999|Lactoferrin|lactoferrin|mesh-list
56469783|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
56469784|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469785|NCT01296412|Metformin|metformin|mesh-list
56469786|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56469787|NCT01296412|Liraglutide|liraglutide|mesh-list
56469788|NCT01296412|Glimepiride|glimepiride|mesh-list
56469789|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56469790|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469791|NCT01296412|Incretins|incretins|mesh-ancestor
56469792|NCT01296412|Hormones|hormones|mesh-ancestor
56469793|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469794|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56469795|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
56469796|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469797|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469798|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56333892|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56333893|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333894|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333895|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333896|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333897|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56333898|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
56333899|NCT00064116|Rituximab|rituximab|mesh-list
56333900|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56333901|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333902|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
56333903|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333904|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56333905|NCT00037037|Sargramostim|sargramostim|mesh-list
56333906|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
56333907|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333908|NCT00064194|Vitamin E|vitamin e|mesh-list
56333909|NCT00064194|Selenium|selenium|mesh-list
56333910|NCT00064194|Vitamins|vitamins|mesh-ancestor
56333911|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
56333912|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333919|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56333921|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333922|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
56333923|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56333924|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333925|NCT00037115|Interferons|interferons|mesh-list
56333926|NCT00037115|Interferon-beta|interferon-beta|mesh-list
56333927|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
56918455|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918456|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918457|NCT02286934|Carvedilol|carvedilol|mesh-list
56918458|NCT02286934|Isoproterenol|isoproterenol|mesh-list
56918459|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56918466|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
56918523|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
56918524|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918525|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918526|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56918527|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56918528|NCT00535366|Fluticasone|fluticasone|mesh-list
56918529|NCT00535366|Ciclesonide|ciclesonide|mesh-list
56918530|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
56918531|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56918532|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918533|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56918534|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
56918535|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918536|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918537|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56918538|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
56918539|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
56918540|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56918541|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
56918542|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56918543|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
56918544|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918545|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918546|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56918547|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56918548|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56918549|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
56333928|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
56333929|NCT00037115|Methotrexate|methotrexate|mesh-list
56333930|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56333931|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
56333932|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56333933|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469799|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469800|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
56469801|NCT00496652|Zalutumumab|zalutumumab|mesh-list
56469802|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56469803|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469804|NCT02597634|Ibuprofen|ibuprofen|mesh-list
56469805|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56469806|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56469807|NCT02597634|Analgesics|analgesics|mesh-ancestor
56469808|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
56469809|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469810|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469811|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56469812|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918550|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
56918551|NCT00535366|Hormones|hormones|mesh-ancestor
56918552|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918553|NCT00369070|Paclitaxel|paclitaxel|mesh-list
56918554|NCT00369070|Bevacizumab|bevacizumab|mesh-list
56918555|NCT00369070|Carboplatin|carboplatin|mesh-list
56918556|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
56918557|NCT00369070|Imetelstat|imetelstat|mesh-list
56918558|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56918559|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918560|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
56918561|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
56918562|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
56918563|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918564|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56918565|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56918566|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56469813|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56469814|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469815|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469816|NCT02591199|Lidocaine|lidocaine|mesh-list
56469817|NCT02591199|Heparin|heparin|mesh-list
56469818|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
56469819|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
56469820|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469821|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469822|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
56469823|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469824|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56469825|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56469826|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56469827|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56469828|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469829|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
56469830|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56469831|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56469832|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
56469833|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
56469834|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56469835|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56469836|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469837|NCT02596035|Nivolumab|nivolumab|mesh-list
56469838|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56469839|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469840|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56469841|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469842|NCT00494156|Aspirin|aspirin|mesh-list
56469843|NCT00494156|Heparin|heparin|mesh-list
56469844|NCT00494156|Clopidogrel|clopidogrel|mesh-list
56469845|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56469846|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56469847|NCT00494156|Analgesics|analgesics|mesh-ancestor
56469850|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469851|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56334411|NCT00066339|Gefitinib|gefitinib|mesh-list
56469852|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56469853|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56918567|NCT00369070|Growth Substances|growth substances|mesh-ancestor
56918568|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918569|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
56918570|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56918571|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918572|NCT02284204|Midazolam|midazolam|mesh-list
56918573|NCT02284204|Ketamine|ketamine|mesh-list
56918574|NCT02284204|Sevoflurane|sevoflurane|mesh-list
56918575|NCT02284204|Analgesics|analgesics|mesh-ancestor
56918576|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
56918577|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918578|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918579|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56918580|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56918581|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
56918582|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
56918583|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918584|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56918585|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56918586|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918587|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918588|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56918589|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56918590|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56469854|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56469855|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469856|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56469857|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56469858|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469859|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
56469860|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56469861|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56469862|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56469863|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
56469864|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469865|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
56469867|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
56469868|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
56469869|NCT02595489|Vitamins|vitamins|mesh-list
56469870|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
56469871|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469872|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56469873|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56469874|NCT00497003|Metoprolol|metoprolol|mesh-list
56469875|NCT00497003|Carvedilol|carvedilol|mesh-list
56469876|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56469877|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56469878|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
56469879|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
56469880|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469881|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918591|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56918592|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56918593|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
56918594|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
56918595|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56918596|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56918597|NCT01352416|Ranolazine|ranolazine|mesh-list
56918598|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56918599|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918600|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918601|NCT00531622|Citalopram|citalopram|mesh-list
56918602|NCT00531622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56918603|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56918604|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918605|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918606|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469882|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56469883|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56469884|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56469885|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
56469886|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469887|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469888|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
56469889|NCT00497003|Protective Agents|protective agents|mesh-ancestor
56469890|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56469891|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56469892|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56469893|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
56469894|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56469895|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56469896|NCT00494312|Pioglitazone|pioglitazone|mesh-list
56469897|NCT00494312|Glyburide|glyburide|mesh-list
56469898|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56469899|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469900|NCT02595372|Omeprazole|omeprazole|mesh-list
56469901|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56469902|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56469903|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56469904|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469905|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469906|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
56469907|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56469908|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469909|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
56469910|NCT02596503|Cefixime|cefixime|mesh-list
56469911|NCT02596503|Irinotecan|irinotecan|mesh-list
56469912|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56469913|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56469914|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469915|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469916|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469917|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56469918|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469919|NCT00494429|Morphine|morphine|mesh-list
56469920|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56469921|NCT00494429|Narcotics|narcotics|mesh-ancestor
56469923|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469924|NCT00494429|Analgesics|analgesics|mesh-ancestor
56918607|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
56918608|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181103|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56469925|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
56469926|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469927|NCT00497120|Acetazolamide|acetazolamide|mesh-list
56469928|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
56469929|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56469930|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469931|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469932|NCT00497120|Diuretics|diuretics|mesh-ancestor
56469933|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
56469934|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469935|NCT00494468|Zolpidem|zolpidem|mesh-list
56469936|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56469937|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56469938|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469939|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469940|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56469941|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
56469942|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
56469943|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469944|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469945|NCT00497237|Fluticasone|fluticasone|mesh-list
56469946|NCT00497237|Beclomethasone|beclomethasone|mesh-list
56469947|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
56469948|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56469949|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56469950|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56469951|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
56469952|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469953|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469954|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56469955|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
56469956|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
56469957|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56469958|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56469959|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56469960|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56469961|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
56469962|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469963|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469964|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
56469965|NCT00497237|Hormones|hormones|mesh-ancestor
56469966|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469967|NCT00497315|Pemetrexed|pemetrexed|mesh-list
56469968|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469969|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469970|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469971|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56469972|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56469973|NCT05142072|Vitamin D|vitamin d|mesh-list
56469974|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
56469975|NCT05142072|Vitamins|vitamins|mesh-ancestor
56469976|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
56469977|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469978|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56469979|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56469980|NCT00497354|Anesthetics|anesthetics|mesh-list
56469981|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
56469982|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469983|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469984|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
56469985|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469986|NCT00494624|Prednisolone|prednisolone|mesh-list
56469987|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56469988|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
56469989|NCT00494624|Hormones|hormones|mesh-ancestor
56469990|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56469991|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469992|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56918609|NCT00531622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56918610|NCT00531622|Antidepressive Agents|antidepressive agents|mesh-ancestor
56918611|NCT00531622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56918612|NCT00364546|Tapentadol|tapentadol|mesh-list
56918613|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56918614|NCT00364546|Narcotics|narcotics|mesh-ancestor
56918615|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918616|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918617|NCT00364546|Analgesics|analgesics|mesh-ancestor
56918618|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
56918619|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918620|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56918621|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56918622|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918623|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918624|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56918625|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918626|NCT00361582|Tapentadol|tapentadol|mesh-list
56918627|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56918628|NCT00361582|Narcotics|narcotics|mesh-ancestor
56918629|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918630|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918631|NCT00361582|Analgesics|analgesics|mesh-ancestor
56918632|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
56918633|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918634|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56918635|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56918636|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918637|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918638|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
56918639|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918640|NCT00450970|Satraplatin|satraplatin|mesh-list
56918641|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918642|NCT02282800|Vitamin D|vitamin d|mesh-list
56469993|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469994|NCT00494663|Ketoconazole|ketoconazole|mesh-list
56469996|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469997|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56918643|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56918644|NCT02282800|Vitamins|vitamins|mesh-ancestor
56918645|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
56918646|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918647|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56918648|NCT05208034|Methotrexate|methotrexate|mesh-list
56918649|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56918650|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
56918651|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56918652|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469998|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56469999|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470000|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470001|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56470002|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
56470003|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56470004|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470005|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56470006|NCT05146674|Tadalafil|tadalafil|mesh-list
56470007|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
56470008|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56470009|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56470010|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470011|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470012|NCT05146674|Urological Agents|urological agents|mesh-ancestor
56470013|NCT00507195|Midazolam|midazolam|mesh-list
56470014|NCT00507195|Propofol|propofol|mesh-list
56470015|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56470016|NCT00507195|Sevoflurane|sevoflurane|mesh-list
56470017|NCT00507195|Desflurane|desflurane|mesh-list
56470018|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56470019|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470020|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56470021|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
56470022|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
56470023|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56470024|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56470025|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56470026|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56470027|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
56470028|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
56470029|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470030|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470031|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56470032|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56470033|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
56470034|NCT00497471|Dapsone|dapsone|mesh-list
56470035|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
56470036|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56470037|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56470038|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470039|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56470040|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470041|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470042|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
56470043|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56470044|NCT05146635|Epirubicin|epirubicin|mesh-list
56470045|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56470046|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470047|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56470048|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56470049|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470050|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470051|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
56470052|NCT00494741|Azathioprine|azathioprine|mesh-list
56918653|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56918654|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
56470053|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56470054|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470055|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56470056|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
56470057|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56470058|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470059|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470060|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470061|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
56470063|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470064|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
56470065|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470066|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470067|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
56470068|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56470069|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
56470072|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56470073|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
56470074|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56470075|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56470076|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56470077|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
56218068|NCT01635829|Carbamazepine|carbamazepine|mesh-list
56470078|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470079|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470080|NCT05148546|Nivolumab|nivolumab|mesh-list
56470081|NCT05148546|Ipilimumab|ipilimumab|mesh-list
56470082|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56470083|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470084|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56470085|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470086|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56470087|NCT00506532|Calfactant|calfactant|mesh-list
56470088|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
56470089|NCT05149560|Ticagrelor|ticagrelor|mesh-list
56470090|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56470091|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56470092|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56470093|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56470094|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
56470095|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470096|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470097|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470098|NCT00494897|Cytarabine|cytarabine|mesh-list
56470099|NCT00494897|Prednisone|prednisone|mesh-list
56470100|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
56470101|NCT00494897|Methotrexate|methotrexate|mesh-list
56470102|NCT00494897|Vincristine|vincristine|mesh-list
56470103|NCT00494897|Daunorubicin|daunorubicin|mesh-list
56470104|NCT00494897|Asparaginase|asparaginase|mesh-list
56470105|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
56470106|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470107|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
56470108|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470109|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470110|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56470111|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
56470112|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470113|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470114|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56470115|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470116|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
56470117|NCT00494897|Hormones|hormones|mesh-ancestor
56470118|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56470119|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56470120|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56470121|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
56470122|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56470123|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56470124|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
56470125|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
56918655|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918656|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918657|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56918658|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918659|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56918660|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918661|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
56918662|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918663|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56918664|NCT02284282|Lidocaine|lidocaine|mesh-list
56918665|NCT02284282|Morphine|morphine|mesh-list
56918666|NCT02284282|Bupivacaine|bupivacaine|mesh-list
56918667|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
56918668|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
56918669|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918670|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918671|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
56918672|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918673|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56470126|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470127|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56470128|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56470129|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
56470130|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470131|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56470132|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
56470133|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
56470134|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
56470135|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56470136|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56470137|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56470138|NCT00497744|Cefepime|cefepime|mesh-list
56470139|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56470140|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470141|NCT00495092|Biperiden|biperiden|mesh-list
56470150|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
56470151|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470152|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56470153|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56470154|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
56470155|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
56470156|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470157|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56470158|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56470159|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
56470160|NCT05143281|Dexamethasone|dexamethasone|mesh-list
56470161|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
56470162|NCT05143281|BB 1101|bb 1101|mesh-list
56470163|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470164|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
56470165|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
56470166|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470167|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470168|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56470169|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
56470170|NCT05143281|Hormones|hormones|mesh-ancestor
56470171|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918674|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56918675|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56918676|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918677|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918678|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56918679|NCT02284282|Narcotics|narcotics|mesh-ancestor
56918680|NCT02284282|Analgesics|analgesics|mesh-ancestor
56918681|NCT00359086|Mocetinostat|mocetinostat|mesh-list
56918682|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56918683|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918684|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918685|NCT03133780|Midazolam|midazolam|mesh-list
56918686|NCT03133780|Ketamine|ketamine|mesh-list
56918687|NCT03133780|Analgesics|analgesics|mesh-ancestor
56918688|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
56918689|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918690|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918691|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56918692|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56918693|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
56918694|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
56470172|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56470173|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470174|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
56470175|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470176|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470177|NCT01244360|Resveratrol|resveratrol|mesh-list
56470178|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
56470179|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470180|NCT01244360|Protective Agents|protective agents|mesh-ancestor
56470181|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470182|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470183|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56470184|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
56470185|NCT00506571|Irinotecan|irinotecan|mesh-list
56470186|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470187|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56470188|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56470189|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470190|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470191|NCT00497900|Vitamin D|vitamin d|mesh-list
56470192|NCT00497900|Vitamins|vitamins|mesh-ancestor
56470193|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
56470194|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470195|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56470196|NCT05143125|Decitabine|decitabine|mesh-list
56470197|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56470198|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
56470199|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470200|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470201|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470202|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
56470203|NCT00497939|Urological Agents|urological agents|mesh-ancestor
56918695|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918696|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56918697|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56918698|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918699|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918700|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56918701|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56918702|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56629328|NCT04278144|Nivolumab|nivolumab|mesh-list
56918703|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56918704|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56918705|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
56918706|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
56918707|NCT02282956|Droperidol|droperidol|mesh-list
56918708|NCT02282956|Morphine|morphine|mesh-list
56918709|NCT02282956|Ropivacaine|ropivacaine|mesh-list
56918710|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56918711|NCT02282956|Narcotics|narcotics|mesh-ancestor
56918712|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918713|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918714|NCT02282956|Analgesics|analgesics|mesh-ancestor
56918715|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
56918716|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918717|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
56918718|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
56918719|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56918720|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
56918721|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
56918722|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56918723|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56918724|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56918725|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56918726|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56918727|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56918728|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
56181233|NCT01409603|Naproxen|naproxen|mesh-list
56470204|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
56470205|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56470206|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470207|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470209|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56470211|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
56470212|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470213|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470214|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470215|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470216|NCT00498251|Albuterol|albuterol|mesh-list
56470217|NCT00498251|Ipratropium|ipratropium|mesh-list
56470218|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56470219|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
56470220|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470221|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470222|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56470223|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
56470224|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
56470225|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56470226|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56470227|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56470228|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56470229|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
56218214|NCT01636557|Vitamin K|vitamin k|mesh-list
56470230|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470231|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470232|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56470233|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
56470234|NCT00502658|Vitamins|vitamins|mesh-list
56470235|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
56470236|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470237|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
56470238|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56470239|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470240|NCT05146245|Risperidone|risperidone|mesh-list
56470241|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56470242|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
56470243|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470244|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470245|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470246|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56470247|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56470248|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56470249|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56470250|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56470251|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
56470252|NCT05146089|Bosentan|bosentan|mesh-list
56470253|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56470254|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56470255|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470256|NCT02954913|Liver Extracts|liver extracts|mesh-list
56470257|NCT02954913|Hematinics|hematinics|mesh-ancestor
56470258|NCT00502892|Carboplatin|carboplatin|mesh-list
56470259|NCT00502892|Topotecan|topotecan|mesh-list
56470260|NCT00502892|Ifosfamide|ifosfamide|mesh-list
56470261|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470262|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56470263|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56470264|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470265|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470266|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56470267|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
56470268|NCT00502970|Interferons|interferons|mesh-list
56470269|NCT00502970|Ribavirin|ribavirin|mesh-list
56470270|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
56470271|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470272|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
56470273|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470274|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
56470275|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470276|NCT00502970|Hematinics|hematinics|mesh-ancestor
56470277|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
56470278|NCT05149287|Lidocaine|lidocaine|mesh-list
56470279|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
56918735|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56918736|NCT02287558|Growth Substances|growth substances|mesh-ancestor
56918737|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
56918738|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918739|NCT04470076|Gemcitabine|gemcitabine|mesh-list
56918740|NCT04470076|Carboplatin|carboplatin|mesh-list
56918741|NCT04470076|Pemetrexed|pemetrexed|mesh-list
56918742|NCT04470076|Afatinib|afatinib|mesh-list
56918743|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918744|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56918745|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
56918746|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918747|NCT04470076|Antiviral Agents|antiviral agents|mesh-ancestor
56918748|NCT04470076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918749|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918750|NCT04470076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918751|NCT04470076|Immunologic Factors|immunologic factors|mesh-ancestor
56918752|NCT04470076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918753|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56470280|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
56470281|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56470282|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470285|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56470286|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56470287|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56470288|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56470289|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470290|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56470291|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470293|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56470294|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
56470295|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56470296|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56470297|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470298|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470299|NCT00498680|Urological Agents|urological agents|mesh-ancestor
56470300|NCT00498953|Carboplatin|carboplatin|mesh-list
56470301|NCT00498953|Docetaxel|docetaxel|mesh-list
56470302|NCT00498953|Fluorouracil|fluorouracil|mesh-list
56470303|NCT00498953|Lapatinib|lapatinib|mesh-list
56470304|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56470305|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470306|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56470307|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56470308|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56470309|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470310|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
56470311|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56470312|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470313|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
56470314|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470315|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56470316|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470317|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56470319|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
56470320|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56918754|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56918755|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56918756|NCT00445198|Navitoclax|navitoclax|mesh-list
56918757|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918758|NCT00345748|Abatacept|abatacept|mesh-list
56918759|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56918760|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918761|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918762|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181253|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
56470321|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
56470322|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470323|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470324|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
56470325|NCT05145543|Dexamethasone|dexamethasone|mesh-list
56470326|NCT05145543|Fentanyl|fentanyl|mesh-list
56470327|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
56470328|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470329|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
56470330|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
56470331|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470332|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470333|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56470334|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
56470335|NCT05145543|Hormones|hormones|mesh-ancestor
56470336|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56470337|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56470338|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470339|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56470340|NCT05145543|Narcotics|narcotics|mesh-ancestor
56470341|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56470342|NCT05145543|Analgesics|analgesics|mesh-ancestor
56470343|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
56470344|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56470345|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56470346|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
56470347|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
56470348|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
56470349|NCT00503204|Cediranib|cediranib|mesh-list
56470350|NCT00503204|Lomustine|lomustine|mesh-list
56470351|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470352|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56470353|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470354|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470355|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56470356|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
56470380|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470382|NCT00498992|Protective Agents|protective agents|mesh-ancestor
56470383|NCT02276391|Telmisartan|telmisartan|mesh-list
56470384|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56470385|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56470386|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56470387|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470388|NCT05145270|Sulforaphane|sulforaphane|mesh-list
56470389|NCT05145270|Dexetimide|dexetimide|mesh-list
56470390|NCT05145270|Citalopram|citalopram|mesh-list
56470391|NCT05145270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56470392|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56470393|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56470394|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470395|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470396|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
56470397|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470398|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56918763|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
56918764|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918765|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918766|NCT00439738|Amlodipine|amlodipine|mesh-list
56918767|NCT00439738|Valsartan|valsartan|mesh-list
56918768|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56918769|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56918770|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56918771|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918772|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918773|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56918774|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918775|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
56918776|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56918777|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56918778|NCT00439738|Diuretics|diuretics|mesh-ancestor
56918779|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
56918780|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56918819|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918820|NCT00333502|Camptothecin|camptothecin|mesh-list
56918821|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56918822|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918823|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56918824|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56918825|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918826|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918827|NCT00332956|Vaccines|vaccines|mesh-list
56918828|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
56918829|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918830|NCT00324220|Mocetinostat|mocetinostat|mesh-list
56918831|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56918832|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918833|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918834|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56918835|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56918836|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918837|NCT00417118|Citalopram|citalopram|mesh-list
56918838|NCT00417118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56918839|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56918840|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918841|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918842|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918843|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
56918844|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918845|NCT00417118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56918846|NCT00417118|Antidepressive Agents|antidepressive agents|mesh-ancestor
56918847|NCT00417118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56918848|NCT02883452|Infliximab|infliximab|mesh-list
56918849|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
56918850|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56918851|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918852|NCT00508066|Bupivacaine|bupivacaine|mesh-list
56918856|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918857|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
56918858|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918859|NCT01336010|Ribavirin|ribavirin|mesh-list
56918860|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56918861|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
56918862|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918863|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
56918864|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918865|NCT02207504|Crizotinib|crizotinib|mesh-list
56918866|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918867|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56470399|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
56470400|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56470401|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56470402|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56470403|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
56470404|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
56470405|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470406|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56470410|NCT05145270|Protective Agents|protective agents|mesh-ancestor
56470411|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470412|NCT01245179|Panobinostat|panobinostat|mesh-list
56470413|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470414|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56470415|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470416|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470417|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
56470418|NCT00503321|Tegafur|tegafur|mesh-list
56470419|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56470420|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
56470421|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470422|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470423|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56470424|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
56470425|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470426|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56470427|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
56470428|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470429|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
56470430|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56470431|NCT00503321|Protective Agents|protective agents|mesh-ancestor
56470432|NCT00503477|Cediranib|cediranib|mesh-list
56470433|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470434|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56470435|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470436|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470437|NCT05144295|Lactulose|lactulose|mesh-list
56470438|NCT05144295|Bisacodyl|bisacodyl|mesh-list
56470439|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
56470440|NCT05144295|Lubiprostone|lubiprostone|mesh-list
56470441|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56470442|NCT05144295|Cathartics|cathartics|mesh-ancestor
56470443|NCT05144295|Laxatives|laxatives|mesh-ancestor
56470444|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56470445|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56470446|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470447|NCT01245452|Methotrexate|methotrexate|mesh-list
56470448|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56470449|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
56470450|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56470451|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470452|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56918868|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918869|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918870|NCT01342016|Prednisone|prednisone|mesh-list
56918871|NCT01342016|Tacrolimus|tacrolimus|mesh-list
56918872|NCT01342016|Leflunomide|leflunomide|mesh-list
56918873|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918874|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
56918875|NCT01342016|Hormones|hormones|mesh-ancestor
56918876|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918877|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918878|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56470453|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
56470454|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218451|NCT01637545|Ramosetron|ramosetron|mesh-list
56470455|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470456|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
56470457|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470458|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56470459|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470460|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
56470461|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470462|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56470463|NCT00503516|Megestrol|megestrol|mesh-list
56470464|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
56470465|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56470466|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56470467|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56470468|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
56470469|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56470470|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470471|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56470472|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56470473|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56470474|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470475|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
56470476|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56470477|NCT05148195|Leucovorin|leucovorin|mesh-list
56470481|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
56470482|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470483|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
56470484|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
56470485|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
56470486|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470487|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56470488|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470489|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56470490|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56470491|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470492|NCT05148195|Antidotes|antidotes|mesh-ancestor
56470493|NCT05148195|Protective Agents|protective agents|mesh-ancestor
56470494|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
56470495|NCT05148195|Vitamins|vitamins|mesh-ancestor
56470496|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
56470497|NCT00499265|Gemcitabine|gemcitabine|mesh-list
56470498|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
56470499|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
56470500|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56470501|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
56470502|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470503|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470504|NCT00499265|Antiviral Agents|antiviral agents|mesh-ancestor
56470505|NCT00499265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470506|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470507|NCT00499265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918879|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918880|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918881|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
56918882|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56918883|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918884|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918885|NCT01336166|Vaccines|vaccines|mesh-list
56918886|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
56470508|NCT00499265|Immunologic Factors|immunologic factors|mesh-ancestor
56470509|NCT00499265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470510|NCT01246622|Cytarabine|cytarabine|mesh-list
56470511|NCT01246622|Lenalidomide|lenalidomide|mesh-list
56470512|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56470513|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
56470514|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470515|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470516|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
56470517|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470518|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470519|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
56470520|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470521|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56470522|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56470523|NCT01246622|Growth Substances|growth substances|mesh-ancestor
56470524|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
56470525|NCT01245530|Donepezil|donepezil|mesh-list
56470526|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56470527|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470528|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470529|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
56470530|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470531|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470532|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
56470533|NCT05148312|Budesonide|budesonide|mesh-list
56470534|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470535|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56470536|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
56470537|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470538|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470539|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56470540|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
56470541|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
56470542|NCT05148312|Hormones|hormones|mesh-ancestor
56470543|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56470544|NCT01246817|Sirolimus|sirolimus|mesh-list
56470545|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56470546|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470547|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56470548|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470549|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
56470550|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470551|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
55786566|NCT04982549|Carboplatin|carboplatin|mesh-list
56470552|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470553|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56470554|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56470555|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56470556|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
56470557|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470558|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56470559|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56470560|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470561|NCT05148975|Dimercaprol|dimercaprol|mesh-list
56470562|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
56470563|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
56470564|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470565|NCT00499577|Vaccines|vaccines|mesh-list
56918887|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918888|NCT04470310|Pioglitazone|pioglitazone|mesh-list
56918889|NCT04470310|Glimepiride|glimepiride|mesh-list
56918890|NCT04470310|Alogliptin|alogliptin|mesh-list
56918891|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918892|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181393|NCT01411072|Antiviral Agents|antiviral agents|mesh-ancestor
56470566|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56470567|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
56470568|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470569|NCT02274740|Metformin|metformin|mesh-list
56470570|NCT02274740|Lixisenatide|lixisenatide|mesh-list
56470571|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56470572|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470573|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
56470574|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470575|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
56470576|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470577|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470578|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56470579|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
56470580|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470581|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470582|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56470583|NCT00503594|Cytarabine|cytarabine|mesh-list
56470584|NCT00503594|Methotrexate|methotrexate|mesh-list
56470585|NCT00503594|Vincristine|vincristine|mesh-list
56470586|NCT00503594|Temozolomide|temozolomide|mesh-list
56470587|NCT00503594|Procarbazine|procarbazine|mesh-list
56470588|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56470589|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
56470590|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56470591|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470592|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56470593|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
56470594|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470595|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470596|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
56470597|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470598|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56470599|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470600|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
56470601|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470602|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56470603|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
56470604|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218602|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
56470605|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56470606|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
56470607|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
56470608|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
56470609|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56470610|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
56470611|NCT00499811|Vorinostat|vorinostat|mesh-list
56470612|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470613|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56470614|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470615|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470616|NCT00499850|Leucovorin|leucovorin|mesh-list
56470617|NCT00499850|Fluorouracil|fluorouracil|mesh-list
56470618|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
56470619|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
56470620|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470621|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56470622|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470623|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470624|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
56470625|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470631|NCT05146713|Propolis|propolis|mesh-list
56470632|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56918893|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56918894|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918895|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
56918896|NCT04470310|Incretins|incretins|mesh-ancestor
56918897|NCT04470310|Hormones|hormones|mesh-ancestor
56918898|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918899|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56918900|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
56918901|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918902|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918903|NCT02083250|Fludarabine|fludarabine|mesh-list
56918904|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
56470633|NCT05146713|Eusol|eusol|mesh-list
56470634|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470635|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
56470636|NCT00503828|Naproxen|naproxen|mesh-list
56470637|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56470638|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56470639|NCT00503828|Analgesics|analgesics|mesh-ancestor
56470640|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
56470641|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470642|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470643|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470644|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470645|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
56470646|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56470647|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470648|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470650|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470651|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56470652|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470653|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470654|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56470655|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
56470656|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56470657|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56470658|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
56470659|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470660|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470661|NCT00506727|Amphetamine|amphetamine|mesh-list
56470662|NCT00506727|Adderall|adderall|mesh-list
56470663|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56470664|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56470665|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56470666|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56470667|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470668|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
56470669|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470670|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470671|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56470672|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
56470673|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
56470674|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470675|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
56470676|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56470677|NCT03455517|Rituximab|rituximab|mesh-list
56470678|NCT03455517|Venetoclax|venetoclax|mesh-list
56470679|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56470680|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470681|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
56470682|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470683|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918905|NCT02083250|Busulfan|busulfan|mesh-list
56918906|NCT02083250|Vorinostat|vorinostat|mesh-list
56918907|NCT02083250|Clofarabine|clofarabine|mesh-list
56918908|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
56918909|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56918910|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918911|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56918912|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
56918913|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918914|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918915|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
56181417|NCT01411124|Gabapentin|gabapentin|mesh-list
56470684|NCT04696536|Listerine|listerine|mesh-list
56470685|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56470686|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470687|NCT00500279|Celecoxib|celecoxib|mesh-list
56470688|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56470689|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56470690|NCT00500279|Analgesics|analgesics|mesh-ancestor
56470691|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
56470692|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470693|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470694|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470695|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470696|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56470697|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56470698|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470701|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56470702|NCT01245881|Protective Agents|protective agents|mesh-ancestor
56470703|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470704|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
56470705|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
56470706|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470707|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56470708|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470709|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470710|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
56470711|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56470712|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470713|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56470714|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
56470715|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
56470716|NCT01247558|Vitamins|vitamins|mesh-ancestor
56470717|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
56470718|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470719|NCT00500552|Perhexiline|perhexiline|mesh-list
56470720|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56470721|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56470722|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470723|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56470724|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470725|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
56470726|NCT00508209|Bortezomib|bortezomib|mesh-list
56470727|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470728|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
56470729|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56470730|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470731|NCT00507585|Leucovorin|leucovorin|mesh-list
56470732|NCT00507585|Bevacizumab|bevacizumab|mesh-list
56470733|NCT00507585|Fluorouracil|fluorouracil|mesh-list
56470734|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
56470735|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56470736|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470737|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55887136|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
56918916|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918917|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
56918918|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56918919|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56470738|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56470739|NCT00507585|Growth Substances|growth substances|mesh-ancestor
56470740|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470741|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
56470742|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
56470743|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470744|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56470745|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56470746|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
56470747|NCT00507585|Antidotes|antidotes|mesh-ancestor
56470748|NCT00507585|Protective Agents|protective agents|mesh-ancestor
56470749|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
56470750|NCT00507585|Vitamins|vitamins|mesh-ancestor
56470751|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
56470752|NCT01247714|Phentermine|phentermine|mesh-list
56470753|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56470754|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470755|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
56470756|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56470757|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
56470758|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
56470759|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470760|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
56470761|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470762|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470763|NCT00507663|Atenolol|atenolol|mesh-list
56470764|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56470765|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56470766|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
56470767|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
56470768|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470769|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470770|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56470776|NCT00508287|Exenatide|exenatide|mesh-list
56470777|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56470778|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470779|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56470780|NCT00508287|Incretins|incretins|mesh-ancestor
56470781|NCT00508287|Hormones|hormones|mesh-ancestor
56470782|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56470783|NCT00508326|Paclitaxel|paclitaxel|mesh-list
56470784|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56470785|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470786|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56470787|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56470788|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56470789|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470790|NCT00507858|Dexamethasone|dexamethasone|mesh-list
56470792|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470793|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
56470794|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
56470795|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470796|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470797|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56470798|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
56470799|NCT00507858|Hormones|hormones|mesh-ancestor
56470800|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56470801|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56470802|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470803|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470804|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470805|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56470806|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56470807|NCT00508365|Carvedilol|carvedilol|mesh-list
56470808|NCT00508365|Lisinopril|lisinopril|mesh-list
56470809|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56056137|NCT00000213|Fluoxetine|fluoxetine|mesh-list
56918920|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56918921|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918922|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
56918923|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56918924|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918925|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
56918926|NCT00315640|Anecortave|anecortave|mesh-list
56918927|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56918928|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56918929|NCT00315640|Growth Substances|growth substances|mesh-ancestor
56918930|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470810|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56470811|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
56470812|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470813|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470814|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470815|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56470816|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
56470817|NCT00508365|Protective Agents|protective agents|mesh-ancestor
56470818|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56470819|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56470820|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56470821|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
56470822|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56470823|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56470824|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56470825|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
56470826|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470827|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56470828|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
56470829|NCT00500864|Analgesics|analgesics|mesh-ancestor
56470830|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
56470831|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470832|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470833|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
56470834|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56470835|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56470836|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
56470837|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56470838|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56470839|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470842|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56470843|NCT00507975|Nicotine|nicotine|mesh-list
56470844|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56470845|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
56470846|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470847|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470848|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56470849|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56470850|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
56470851|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470852|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470853|NCT01247909|Gentamicins|gentamicins|mesh-list
56470854|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
56470855|NCT01247909|Penicillins|penicillins|mesh-list
56470856|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56470857|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470858|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56470859|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470860|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470861|NCT01245998|Dalteparin|dalteparin|mesh-list
56470862|NCT01245998|Tinzaparin|tinzaparin|mesh-list
56470863|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56918931|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
56918932|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918933|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918934|NCT00411892|Insulin|insulin|mesh-list
56918935|NCT00411892|Pioglitazone|pioglitazone|mesh-list
56918936|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56918937|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918938|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918939|NCT01336322|Metformin|metformin|mesh-list
56918940|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56918941|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918942|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918943|NCT01336322|Incretins|incretins|mesh-ancestor
56918944|NCT01336322|Hormones|hormones|mesh-ancestor
56918945|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918946|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56918947|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
56918948|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918949|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918950|NCT01339676|Vitamin D|vitamin d|mesh-list
56918951|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
56470864|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
56470865|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56470866|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56470867|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470868|NCT02954484|Acetaminophen|acetaminophen|mesh-list
56470869|NCT02954484|Etoricoxib|etoricoxib|mesh-list
56470870|NCT02954484|Pregabalin|pregabalin|mesh-list
56470871|NCT02954484|Morphine|morphine|mesh-list
56470872|NCT02954484|Ropivacaine|ropivacaine|mesh-list
56470873|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56470874|NCT02954484|Narcotics|narcotics|mesh-ancestor
56470875|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56470876|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470877|NCT02954484|Analgesics|analgesics|mesh-ancestor
56470878|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
56470879|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470880|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
56470881|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
56470882|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56470883|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
56470884|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
56470885|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56470886|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56470887|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470888|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56470889|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56470890|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56470891|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56470892|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56470893|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470894|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470895|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56470896|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56470897|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470898|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
56918952|NCT01339676|Vitamins|vitamins|mesh-ancestor
56918953|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
56918954|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470899|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56470900|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470901|NCT00501098|Caspofungin|caspofungin|mesh-list
56470902|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
56470903|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470904|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470905|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470906|NCT00508092|Anesthetics|anesthetics|mesh-list
56218901|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56470907|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
56470908|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56470909|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470910|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
56470911|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470912|NCT00501137|Vaccines|vaccines|mesh-list
56470913|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
56470916|NCT01248260|Hematinics|hematinics|mesh-ancestor
56470917|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
56470918|NCT01248260|Vitamins|vitamins|mesh-ancestor
56470919|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
56470920|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470921|NCT01246037|Bisoprolol|bisoprolol|mesh-list
56470922|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56470923|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
56470924|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
56470925|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470926|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470927|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56470928|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56470929|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56470930|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
56470931|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470932|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470933|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
56470934|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56470935|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470937|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56470938|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470939|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
56470940|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470941|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470942|NCT00501254|Aspirin|aspirin|mesh-list
56470943|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
56470944|NCT00501254|Salicylates|salicylates|mesh-list
56470945|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56470946|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
56470947|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
56470948|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
56470949|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56470950|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56470951|NCT00501254|Analgesics|analgesics|mesh-ancestor
56470952|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
56470953|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470954|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470955|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470956|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470957|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56470958|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470959|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470960|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56470961|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56470962|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56470963|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
56470964|NCT01248338|Metoprolol|metoprolol|mesh-list
56470965|NCT01248338|Nebivolol|nebivolol|mesh-list
56470966|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56470967|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56470968|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
56470969|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
56470970|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900077|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
56918955|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56918956|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56918957|NCT01339754|Trabectedin|trabectedin|mesh-list
56918958|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56918959|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
56918960|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918961|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918962|NCT00313768|Paclitaxel|paclitaxel|mesh-list
56918963|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56918964|NCT00313768|Bevacizumab|bevacizumab|mesh-list
56918965|NCT00313768|Carboplatin|carboplatin|mesh-list
56918966|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56918967|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470971|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470972|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56470973|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56470974|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56470975|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
56470976|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470977|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470978|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
56470979|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56470980|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56470981|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56218978|NCT01641016|Efavirenz|efavirenz|mesh-list
56470982|NCT02953743|Lenvatinib|lenvatinib|mesh-list
56470983|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56470984|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56470985|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470986|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470989|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56470991|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
56470992|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470993|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470994|NCT02274974|Lidocaine|lidocaine|mesh-list
56470995|NCT02274974|Epinephrine|epinephrine|mesh-list
56470996|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
56470997|NCT02274974|Anesthetics|anesthetics|mesh-list
56470998|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56470999|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471000|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
56471001|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471002|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56471003|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56471004|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56471005|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56471006|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471007|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56471008|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56471009|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
56471010|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471011|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56471012|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56471013|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
56471014|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56471015|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
56471016|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
56471017|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
56471018|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56471019|NCT02274545|Vaccines|vaccines|mesh-list
56918968|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
56918969|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
56918970|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
56918971|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918972|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56918973|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56918974|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56918975|NCT00313768|Growth Substances|growth substances|mesh-ancestor
56918976|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918977|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
56471020|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
56471021|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471022|NCT02275013|Simendan|simendan|mesh-list
56471023|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56471024|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
56471025|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56471026|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56471027|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471028|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471029|NCT02275013|Protective Agents|protective agents|mesh-ancestor
56471030|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471031|NCT02274623|Calcifediol|calcifediol|mesh-list
56471032|NCT02274623|Vitamins|vitamins|mesh-ancestor
56471033|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
56471034|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471035|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56471036|NCT00509613|Sirolimus|sirolimus|mesh-list
56471037|NCT00509613|Sorafenib|sorafenib|mesh-list
56471038|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471039|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56471040|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471041|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471042|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56471043|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471044|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56471045|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
56471046|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471047|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
56471048|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471049|NCT00501410|Leucovorin|leucovorin|mesh-list
56471050|NCT00501410|Fluorouracil|fluorouracil|mesh-list
56471051|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
56471052|NCT00501410|Cetuximab|cetuximab|mesh-list
56471053|NCT00501410|Dasatinib|dasatinib|mesh-list
56471054|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
56471055|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471056|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56471057|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471058|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471059|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
56471060|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471061|NCT00501410|Antidotes|antidotes|mesh-ancestor
56471066|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56471067|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56471068|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471069|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
56471070|NCT02953275|Vedolizumab|vedolizumab|mesh-list
56471071|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56471072|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471073|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471074|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56471075|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56471076|NCT02953275|Protective Agents|protective agents|mesh-ancestor
56471077|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918978|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
56918979|NCT01339988|Busulfan|busulfan|mesh-list
56918980|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471078|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
56471079|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56471080|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
56471081|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56471082|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
56471083|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56471084|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471085|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
56471086|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
56471087|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56471088|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471089|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56471090|NCT02955719|Sertraline|sertraline|mesh-list
56471091|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56471092|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
56471093|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56471094|NCT02955719|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56471095|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56471096|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56471097|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471098|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471099|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
56471100|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471101|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56471102|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56471103|NCT02955524|Lidocaine|lidocaine|mesh-list
56471104|NCT02955524|Tetracaine|tetracaine|mesh-list
56471105|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
56471106|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
56471107|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471108|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471109|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
56471110|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471111|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56471112|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56471113|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56471114|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56471115|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471116|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
56471117|NCT02953041|Bromides|bromides|mesh-list
56471118|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
56471119|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56471120|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56471121|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56471122|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
56471123|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471124|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471125|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471126|NCT00501566|Satavaptan|satavaptan|mesh-list
56471127|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56471128|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471129|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
56471130|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471131|NCT00501605|Cediranib|cediranib|mesh-list
56471134|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471135|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471136|NCT00509847|Lactoferrin|lactoferrin|mesh-list
56471137|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471138|NCT01248494|Letrozole|letrozole|mesh-list
56471139|NCT01248494|Dactolisib|dactolisib|mesh-list
56471140|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471141|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56471142|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56471143|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471144|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471145|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56471146|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
56471147|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918981|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
56918982|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918983|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56918984|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56918985|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
56918986|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918987|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918988|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56918989|NCT00406588|Levodopa|levodopa|mesh-list
56918990|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56918991|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56918992|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
56471148|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471149|NCT02952573|Dexamethasone|dexamethasone|mesh-list
56471150|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
56471151|NCT02952573|BB 1101|bb 1101|mesh-list
56471152|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56471153|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
56471154|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
56471155|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471156|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471157|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56471158|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
56471159|NCT02952573|Hormones|hormones|mesh-ancestor
56471160|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471161|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56471162|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471163|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
56471164|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471165|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471166|NCT00501722|Satavaptan|satavaptan|mesh-list
56471167|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56471168|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471169|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
56471170|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471171|NCT01248611|Fentanyl|fentanyl|mesh-list
56471172|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56471173|NCT01248611|Narcotics|narcotics|mesh-ancestor
56471174|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471175|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471176|NCT01248611|Analgesics|analgesics|mesh-ancestor
56471177|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
56471178|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471179|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56471180|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56471181|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
56471182|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
56471183|NCT00509964|Irinotecan|irinotecan|mesh-list
56471184|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56471185|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56471186|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471187|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471188|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471189|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
56471190|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56471191|NCT00510471|Antibodies|antibodies|mesh-list
56471192|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56471193|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
56471194|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471195|NCT00501839|Clomiphene|clomiphene|mesh-list
56471196|NCT00501839|Enclomiphene|enclomiphene|mesh-list
56471197|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
56471198|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56918993|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918994|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918995|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918996|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
56918997|NCT01342328|Propofol|propofol|mesh-list
56918998|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56918999|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919000|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919001|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56919002|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
56919003|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
56471199|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
56471200|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471201|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471202|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56471203|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
56471204|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56471209|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56471210|NCT00510003|Analgesics|analgesics|mesh-ancestor
56471211|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
56471212|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471213|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471214|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56471215|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56471216|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
56471217|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471218|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
56471219|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56471220|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471221|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471222|NCT00501878|Phenylephrine|phenylephrine|mesh-list
56471223|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
56471224|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56471225|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
56471226|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
56471227|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471228|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471229|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
56471230|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56471231|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
56471232|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
56471233|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56471234|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56471235|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56471236|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
56471237|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471238|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471239|NCT00501878|Protective Agents|protective agents|mesh-ancestor
56471240|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
56471241|NCT00501917|Hematinics|hematinics|mesh-ancestor
56471243|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56471244|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471245|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
56471246|NCT00510627|Irinotecan|irinotecan|mesh-list
56471247|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471248|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56471249|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56471250|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471251|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471252|NCT00502034|Interferons|interferons|mesh-list
56471253|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
56471254|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
56471255|NCT00502034|Interleukin-2|interleukin-2|mesh-list
56471256|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919004|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56919005|NCT01342328|Analgesics|analgesics|mesh-ancestor
56919006|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
56919007|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919008|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56919009|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56919010|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56471257|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
56471258|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471259|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
56471260|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471261|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56471262|NCT00502034|Analgesics|analgesics|mesh-ancestor
56471263|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
56471264|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471265|NCT00510666|Tramadol|tramadol|mesh-list
56471266|NCT00510666|Butorphanol|butorphanol|mesh-list
56471267|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56471268|NCT00510666|Narcotics|narcotics|mesh-ancestor
56471269|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471270|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471271|NCT00510666|Analgesics|analgesics|mesh-ancestor
56471272|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
56471273|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471274|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
56471275|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
56471276|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56471277|NCT00510705|Metformin|metformin|mesh-list
56471280|NCT00502073|Cyclosporine|cyclosporine|mesh-list
56219278|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56471281|NCT00502073|Cyclosporins|cyclosporins|mesh-list
56471282|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471283|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471284|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471285|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
56471286|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471287|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
56471288|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471289|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
56471290|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56471291|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56471292|NCT01248923|Dexamethasone|dexamethasone|mesh-list
56471293|NCT01248923|Bortezomib|bortezomib|mesh-list
56471294|NCT01248923|Filanesib|filanesib|mesh-list
56471295|NCT01248923|Lenograstim|lenograstim|mesh-list
56471296|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56471297|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56471298|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
56471299|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
56471300|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471301|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471302|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56471303|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
56471304|NCT01248923|Hormones|hormones|mesh-ancestor
56471305|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471306|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56471307|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471308|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56471309|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
56471310|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
56471311|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471312|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471313|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
56471314|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
56471315|NCT01249001|Aprepitant|aprepitant|mesh-list
56471316|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
56471317|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
56471318|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
56471319|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471320|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919011|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
56919012|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919013|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745507|NCT05072691|Antibodies|antibodies|mesh-list
56471321|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56471322|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56471323|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471324|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471325|NCT00502112|Lenalidomide|lenalidomide|mesh-list
56471326|NCT00502112|Lintuzumab|lintuzumab|mesh-list
56471327|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
56471328|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471329|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56471330|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56471331|NCT00502112|Growth Substances|growth substances|mesh-ancestor
56471332|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
56471333|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471334|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56471335|NCT00502190|Silicon|silicon|mesh-list
56471336|NCT00502190|Trace Elements|trace elements|mesh-ancestor
56471337|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
56471338|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471339|NCT00502229|Metformin|metformin|mesh-list
56471340|NCT00502229|Clomiphene|clomiphene|mesh-list
56471341|NCT00502229|Enclomiphene|enclomiphene|mesh-list
56471342|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
56471343|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56471344|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471345|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56471346|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
56471347|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471348|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56471349|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
56471350|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56471351|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56471354|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
56471355|NCT00502268|Vitamins|vitamins|mesh-ancestor
56471356|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
56471357|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219354|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
56471358|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56471359|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56471360|NCT00510081|Calcium|calcium|mesh-list
56471361|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56471362|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471363|NCT00502385|Cediranib|cediranib|mesh-list
56471364|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471365|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56471366|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471367|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471368|NCT00510159|Artesunate|artesunate|mesh-list
56471370|NCT00510159|Praziquantel|praziquantel|mesh-list
56471371|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
56471372|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56471373|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56471374|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471375|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471376|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
56471377|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
56471378|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56471379|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
56471380|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56471381|NCT00510159|Renal Agents|renal agents|mesh-ancestor
56471382|NCT02952807|Misoprostol|misoprostol|mesh-list
56471383|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56471384|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
56471385|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56471386|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471387|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56471388|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56471389|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
56471390|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
56471391|NCT02275130|Calcium|calcium|mesh-list
56919015|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56919016|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56919017|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919018|NCT05726032|Empagliflozin|empagliflozin|mesh-list
56919019|NCT05726032|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56919020|NCT05726032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919021|NCT05726032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56919022|NCT05726032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919023|NCT05184530|Evolocumab|evolocumab|mesh-list
56919024|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56919025|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56919026|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
56919027|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919028|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56919029|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56919030|NCT05184374|Hormones|hormones|mesh-ancestor
56181516|NCT01411930|Olanzapine|olanzapine|mesh-list
56471392|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56471393|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471394|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56471395|NCT05653973|Acetylcholine|acetylcholine|mesh-list
56471396|NCT05653973|Vasodilator Agents|vasodilator agents|mesh-ancestor
56471397|NCT05653973|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56471398|NCT05653973|Cholinergic Agents|cholinergic agents|mesh-ancestor
56471399|NCT05653973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471400|NCT05653973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471401|NCT05653973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471402|NCT03459417|Morphine|morphine|mesh-list
56471403|NCT03459417|Sulpiride|sulpiride|mesh-list
56471404|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56471405|NCT03459417|Narcotics|narcotics|mesh-ancestor
56471406|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471407|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471408|NCT03459417|Analgesics|analgesics|mesh-ancestor
56471409|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
56471410|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471411|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56471412|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56471413|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56471414|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56471415|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
56471416|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471417|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471418|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56471419|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
56471420|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56471421|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56471422|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
56471423|NCT00502541|Hormones|hormones|mesh-ancestor
56471424|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471425|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471429|NCT01249430|Azacitidine|azacitidine|mesh-list
56471430|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
56471431|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56471432|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919031|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919032|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919033|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56919034|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
56471433|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56471434|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56471435|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471436|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471437|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56471438|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
56471439|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
56471440|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471441|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471442|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
56471443|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471444|NCT01249430|Analgesics|analgesics|mesh-ancestor
56471445|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
56471446|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471447|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56471448|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56471449|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56471450|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56471451|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
56471452|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471453|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56471454|NCT02952963|Cathartics|cathartics|mesh-ancestor
56471455|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56471456|NCT00510939|Bortezomib|bortezomib|mesh-list
56471457|NCT00510939|Tipifarnib|tipifarnib|mesh-list
56471458|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471459|NCT00504062|Fluticasone|fluticasone|mesh-list
56471460|NCT00504062|Budesonide|budesonide|mesh-list
56471461|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56471462|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56471463|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
56471464|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471465|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471466|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56471467|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
56471468|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
56471469|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56471470|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
56471471|NCT00504062|Hormones|hormones|mesh-ancestor
56471472|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471473|NCT00504101|Bortezomib|bortezomib|mesh-list
56471474|NCT00504101|Melphalan|melphalan|mesh-list
56471475|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
56471476|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471477|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56471478|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
56471479|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471480|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56471481|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471482|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
56471483|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471484|NCT00504140|Interferons|interferons|mesh-list
56471485|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
56471486|NCT00504140|Etoposide|etoposide|mesh-list
56471487|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56471488|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471489|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56471490|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56471491|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471492|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471493|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
56471494|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471495|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
56471496|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471497|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56471498|NCT00511017|Vitamins|vitamins|mesh-ancestor
56919035|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
56919036|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919037|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919038|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
56919039|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919040|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56919041|NCT01342562|Anesthetics|anesthetics|mesh-list
56919042|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919043|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919044|NCT00116116|Lamivudine|lamivudine|mesh-list
56919045|NCT00116116|Efavirenz|efavirenz|mesh-list
56471499|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
56471502|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
56471503|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56471504|NCT00511212|Antibodies|antibodies|mesh-list
56471505|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
56471506|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56471507|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
56471508|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471509|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
56471510|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471511|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56471512|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471513|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471514|NCT01241006|Dexamethasone|dexamethasone|mesh-list
56471515|NCT01241006|Prednisone|prednisone|mesh-list
56471516|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
56471517|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56471518|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
56471519|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
56471520|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471521|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471522|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56471523|NCT01241006|Hormones|hormones|mesh-ancestor
56471524|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471525|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56471526|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471527|NCT00510393|Everolimus|everolimus|mesh-list
56471528|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471529|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471530|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
56471531|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471532|NCT01249547|Axitinib|axitinib|mesh-list
56471533|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471534|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56471535|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471536|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471537|NCT00511719|Insulin|insulin|mesh-list
56471538|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56471539|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56471540|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471541|NCT01246232|Amisulpride|amisulpride|mesh-list
56471542|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56471543|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56471544|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471545|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471546|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56471547|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56471548|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
56471549|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471550|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471551|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56471552|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
56471553|NCT01248962|Carboplatin|carboplatin|mesh-list
56471554|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919046|NCT00116116|Stavudine|stavudine|mesh-list
56919047|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56919048|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56919049|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181547|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471555|NCT00511446|Docetaxel|docetaxel|mesh-list
56471556|NCT00511446|Capecitabine|capecitabine|mesh-list
56471557|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
56471558|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471559|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
56471560|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
56471561|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
56471562|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471563|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56471564|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
56471565|NCT00511602|Insulin|insulin|mesh-list
56471566|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56471567|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471568|NCT00511953|Gabapentin|gabapentin|mesh-list
56471569|NCT00511953|Analgesics|analgesics|mesh-ancestor
56471570|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
56471571|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471572|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471573|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
56471576|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471577|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56471578|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56471579|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56471580|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471581|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471582|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
56471583|NCT01249820|Anidulafungin|anidulafungin|mesh-list
56471584|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
56471585|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471586|NCT01247090|Vasopressins|vasopressins|mesh-list
56471587|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
56471588|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
56471589|NCT01247090|Coagulants|coagulants|mesh-ancestor
56471590|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56471591|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56471592|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
56471593|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471594|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
56471595|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471596|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56471597|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471598|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471599|NCT02951754|Methylphenidate|methylphenidate|mesh-list
56471600|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56471601|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471602|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56471603|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56471604|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56471605|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471606|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
56471607|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471608|NCT00504413|Digoxin|digoxin|mesh-list
56471609|NCT00504413|Midazolam|midazolam|mesh-list
56471610|NCT00504413|Methadone|methadone|mesh-list
56471611|NCT00504413|Bupropion|bupropion|mesh-list
56471612|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56471613|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56471614|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471615|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471616|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56471617|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56471618|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56471619|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56471620|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
56471621|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
56471622|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
56471623|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
56919050|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919051|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
56919052|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919053|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56919054|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56471624|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471625|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471626|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56471627|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
56471628|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56471629|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56471630|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56471631|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
56471632|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56471633|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56471634|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471635|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56471636|NCT00504413|Narcotics|narcotics|mesh-ancestor
56471637|NCT00504413|Analgesics|analgesics|mesh-ancestor
56471638|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
56471639|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471640|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
56471641|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
56471642|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56471643|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56471644|NCT00504413|Protective Agents|protective agents|mesh-ancestor
56471645|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
56471646|NCT01243658|Oxytocin|oxytocin|mesh-list
56471647|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
56471658|NCT00513162|Valproic Acid|valproic acid|mesh-list
56471659|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56471660|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471661|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56471662|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56471663|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471664|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219652|NCT01652417|Prednisolone|prednisolone|mesh-list
56471666|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
56471667|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972695|NCT03389750|Oxymorphone|oxymorphone|mesh-list
56471668|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471669|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
56471670|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56471671|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471672|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56471673|NCT00513201|Insulin|insulin|mesh-list
56471674|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56471675|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56471676|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471677|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
56471678|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56471679|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
56471680|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471681|NCT00512265|Expectorants|expectorants|mesh-ancestor
56471682|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
56471683|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56471684|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
56471685|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471686|NCT00512265|Protective Agents|protective agents|mesh-ancestor
56471687|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471688|NCT00512265|Antidotes|antidotes|mesh-ancestor
56471689|NCT00513396|Isoniazid|isoniazid|mesh-list
56471690|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
56471691|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56471692|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471693|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56471694|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56471695|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
56471696|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471697|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56471698|NCT01249274|Progesterone|progesterone|mesh-list
56919055|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56919056|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56919057|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56919058|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56919059|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56919060|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56919061|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
56919062|NCT02287870|Lidocaine|lidocaine|mesh-list
56919063|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
56919064|NCT02287870|Procaine|procaine|mesh-list
56919065|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
56919066|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
56919067|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919068|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919069|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
56471699|NCT01249274|Progestins|progestins|mesh-ancestor
56471700|NCT01249274|Hormones|hormones|mesh-ancestor
56471701|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471702|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471703|NCT00513513|Ritonavir|ritonavir|mesh-list
56471704|NCT00513513|Darunavir|darunavir|mesh-list
56471705|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56471706|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56471707|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
56471708|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471709|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471710|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56471711|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56471712|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
56471713|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471725|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471726|NCT00505037|Sevelamer|sevelamer|mesh-list
56471727|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
56471728|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
56471729|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471730|NCT00513552|Clarithromycin|clarithromycin|mesh-list
56471731|NCT00513552|Rifabutin|rifabutin|mesh-list
56471732|NCT00513552|Clofazimine|clofazimine|mesh-list
56471733|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56471734|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471735|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56471736|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471737|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471738|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56471739|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56471740|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56471741|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
56471742|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56471743|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
56471745|NCT00513630|Glipizide|glipizide|mesh-list
56471746|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56471747|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471748|NCT02275247|Ropivacaine|ropivacaine|mesh-list
56471749|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
56471750|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
56471751|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471752|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471753|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
56471754|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471755|NCT04515719|Belimumab|belimumab|mesh-list
56919070|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919071|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56919072|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56919073|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56919074|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56919075|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919076|NCT01340456|Rifampin|rifampin|mesh-list
56919077|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56919078|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
56919079|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56919080|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56629703|NCT02823236|Pirfenidone|pirfenidone|mesh-list
56919081|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
56919082|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56919083|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919084|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919085|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56919086|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56919087|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56919088|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56919089|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56919090|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56919091|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56919092|NCT00110422|Irbesartan|irbesartan|mesh-list
56919093|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56919094|NCT00110422|Diuretics|diuretics|mesh-ancestor
56919095|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
56919096|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181576|NCT01412294|Capecitabine|capecitabine|mesh-list
56471756|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471757|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
56471758|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471759|NCT00513786|Paclitaxel|paclitaxel|mesh-list
56471760|NCT00513786|Bevacizumab|bevacizumab|mesh-list
56471761|NCT00513786|Carboplatin|carboplatin|mesh-list
56471762|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56471763|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471764|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
56471765|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
56471766|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
56471767|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471768|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56919097|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56919098|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56919099|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919100|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56919101|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56919102|NCT00305656|Cediranib|cediranib|mesh-list
56919103|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919104|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919105|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919106|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56919107|NCT02284984|Rituximab|rituximab|mesh-list
56919108|NCT02284984|Belimumab|belimumab|mesh-list
56919109|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56919110|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919111|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
56919112|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919113|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56919114|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56919115|NCT00305188|Leucovorin|leucovorin|mesh-list
56919116|NCT00305188|Fluorouracil|fluorouracil|mesh-list
56919117|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
56919118|NCT00305188|Xaliproden|xaliproden|mesh-list
56919119|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
56919120|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919121|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56919122|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919123|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56919124|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
56919125|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919126|NCT00305188|Antidotes|antidotes|mesh-ancestor
56471769|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56471770|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56471771|NCT00513786|Growth Substances|growth substances|mesh-ancestor
56471772|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471773|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
56471774|NCT00504491|Rituximab|rituximab|mesh-list
56471775|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
56471776|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56471777|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471778|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
56471779|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471780|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56471782|NCT00512811|Diuretics|diuretics|mesh-ancestor
56471783|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
56919127|NCT00305188|Protective Agents|protective agents|mesh-ancestor
56919128|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
56919129|NCT00305188|Vitamins|vitamins|mesh-ancestor
56919130|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
56919131|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56919132|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56919133|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
56919134|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919135|NCT05725876|Ustekinumab|ustekinumab|mesh-list
56919136|NCT05725876|Dermatologic Agents|dermatologic agents|mesh-ancestor
56919137|NCT00297310|Tacrolimus|tacrolimus|mesh-list
56919138|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56919139|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
56919140|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919141|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56919142|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181638|NCT01412645|Protective Agents|protective agents|mesh-ancestor
56471784|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471785|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56471786|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56471787|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471788|NCT00513864|Morphine|morphine|mesh-list
56471789|NCT00513864|Codeine|codeine|mesh-list
56471790|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
56471791|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56471792|NCT00513864|Narcotics|narcotics|mesh-ancestor
56471793|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471794|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471795|NCT00513864|Analgesics|analgesics|mesh-ancestor
56471796|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
56471797|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471798|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
56471799|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
56471800|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56471801|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56471802|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471803|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471804|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56471805|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
56471806|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471807|NCT00512850|Folic Acid|folic acid|mesh-list
56471808|NCT00512850|Hematinics|hematinics|mesh-ancestor
56471809|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
56471810|NCT00512850|Vitamins|vitamins|mesh-ancestor
56471811|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
56471812|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471813|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
56471814|NCT00512928|Vitamin K|vitamin k|mesh-list
56471815|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
56219803|NCT01653067|Dexamethasone|dexamethasone|mesh-list
56471816|NCT00512928|Vitamin MK 7|vitamin mk 7|mesh-list
56471817|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56471818|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56471819|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471821|NCT00512928|Coagulants|coagulants|mesh-ancestor
56471822|NCT00512928|Vitamins|vitamins|mesh-ancestor
56471823|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
56471824|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471825|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
56471826|NCT04696523|Xenon|xenon|mesh-list
56471827|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56919143|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919144|NCT00095290|Ramipril|ramipril|mesh-list
56919145|NCT00095290|Irbesartan|irbesartan|mesh-list
56471828|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
56471829|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
56471830|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471831|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471832|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56471833|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56471834|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56471835|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
56471836|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471837|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56471838|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56471839|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471840|NCT01246973|Curcumin|curcumin|mesh-list
56471841|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56471842|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56471843|NCT01246973|Analgesics|analgesics|mesh-ancestor
56471844|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
56471845|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471846|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471847|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56471848|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56471849|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471850|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471851|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471852|NCT00514605|Antibodies|antibodies|mesh-list
56471853|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
56471857|NCT00513981|Methotrexate|methotrexate|mesh-list
56471858|NCT00513981|Calcium|calcium|mesh-list
56471859|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
56471860|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56471861|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471862|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56471863|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
56471864|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56471865|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56471866|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
56471867|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471868|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471869|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
56471870|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471871|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56471872|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56471873|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
56471874|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56471875|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56471876|NCT00513981|Antidotes|antidotes|mesh-ancestor
56471877|NCT00513981|Protective Agents|protective agents|mesh-ancestor
56471878|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
56471879|NCT00513981|Vitamins|vitamins|mesh-ancestor
56471880|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
56471881|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56471882|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
56471883|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471884|NCT00514761|Capecitabine|capecitabine|mesh-list
56471885|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56471886|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
56471887|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471888|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471889|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
56471890|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56471891|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56219881|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56471892|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56471893|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56471894|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471895|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
56471896|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471897|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471898|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56919146|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56919147|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
56919148|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919149|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919150|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56919151|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56919152|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56919153|NCT01340846|Ketoconazole|ketoconazole|mesh-list
56919154|NCT01340846|Dabrafenib|dabrafenib|mesh-list
56919155|NCT01340846|Warfarin|warfarin|mesh-list
56471899|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471900|NCT01245140|Alitretinoin|alitretinoin|mesh-list
56471901|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471902|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
56471903|NCT02951637|Carboplatin|carboplatin|mesh-list
56471904|NCT02951637|Pemetrexed|pemetrexed|mesh-list
56471905|NCT02951637|Gefitinib|gefitinib|mesh-list
56471906|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471907|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471908|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471909|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56471910|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56471911|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56471912|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
56471913|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56471914|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56471915|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
56471916|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471917|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56471918|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56471919|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471920|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471921|NCT01245062|Trametinib|trametinib|mesh-list
56471922|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471923|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56471924|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56471925|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471929|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56471930|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
56471931|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471932|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471933|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56471934|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
56471935|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
56471936|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56471937|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56471938|NCT04695483|Hormones|hormones|mesh-ancestor
56471939|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471940|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471941|NCT01244126|Fentanyl|fentanyl|mesh-list
56471942|NCT01244126|Morphine|morphine|mesh-list
56471943|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56471944|NCT01244126|Narcotics|narcotics|mesh-ancestor
56471945|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56471946|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471947|NCT01244126|Analgesics|analgesics|mesh-ancestor
56471948|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
56471949|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471950|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56471951|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56471952|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
56471953|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
56471954|NCT01243775|Docetaxel|docetaxel|mesh-list
56471955|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
56471956|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919157|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
56919158|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
56919159|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56471957|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
56471958|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
56471959|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
56471960|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471961|NCT00514293|Carboplatin|carboplatin|mesh-list
56471962|NCT00514293|Docetaxel|docetaxel|mesh-list
56471963|NCT00514293|Capecitabine|capecitabine|mesh-list
56219955|NCT01654120|Incretins|incretins|mesh-ancestor
56471964|NCT00514293|Tretinoin|tretinoin|mesh-list
56471965|NCT00514293|Bexarotene|bexarotene|mesh-list
56471966|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471967|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
56471968|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
56471969|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
56471970|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56471971|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56471973|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
56471974|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
56471975|NCT02955641|Dexamethasone|dexamethasone|mesh-list
56471976|NCT02955641|Nepafenac|nepafenac|mesh-list
56471977|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56471978|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56471979|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
56471980|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
56471981|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56471982|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471983|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56471984|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
56471985|NCT02955641|Hormones|hormones|mesh-ancestor
56471986|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56471987|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56471988|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471989|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56471990|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56471991|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56471992|NCT02955641|Analgesics|analgesics|mesh-ancestor
56471993|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
56471994|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56471995|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56471996|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56471997|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56471998|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56471999|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472000|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
56472007|NCT01242176|Empagliflozin|empagliflozin|mesh-list
56472008|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56472009|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472010|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56472011|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472012|NCT00515151|Ethanol|ethanol|mesh-list
56472013|NCT00515151|Octenidine|octenidine|mesh-list
56472014|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56472015|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472016|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472017|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472018|NCT01241786|Lenalidomide|lenalidomide|mesh-list
56472019|NCT01241786|Azacitidine|azacitidine|mesh-list
56472020|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
56472021|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472022|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56472023|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56472024|NCT01241786|Growth Substances|growth substances|mesh-ancestor
56472025|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
56472026|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472027|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472028|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
56472029|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472030|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472031|NCT00514410|Folic Acid|folic acid|mesh-list
56472032|NCT00514410|Hematinics|hematinics|mesh-ancestor
56919160|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56919161|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56919162|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919163|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919164|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56919165|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
56919166|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919167|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919168|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56919169|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919170|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56919171|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56919172|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
56919173|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56919174|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56919175|NCT01342874|Inositol|inositol|mesh-list
56919176|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
56181667|NCT01412892|Everolimus|everolimus|mesh-list
56181668|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181669|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181670|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
56181671|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181672|NCT01413022|Leucovorin|leucovorin|mesh-list
56181673|NCT01413022|Fluorouracil|fluorouracil|mesh-list
56181674|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
56181675|NCT01413022|Irinotecan|irinotecan|mesh-list
56181676|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
56181677|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181678|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56181679|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181680|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181681|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
56472033|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
56472034|NCT00514410|Vitamins|vitamins|mesh-ancestor
56472035|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
56472036|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472037|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
56472038|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56472039|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55973090|NCT00670241|Hormones|hormones|mesh-ancestor
56472040|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472041|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
56919177|NCT01342874|Vitamins|vitamins|mesh-ancestor
56919178|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
56919179|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919180|NCT01337258|Dutasteride|dutasteride|mesh-list
56919181|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56919182|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56919183|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181691|NCT01413048|Carvedilol|carvedilol|mesh-list
56472042|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
56472043|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
56472044|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472045|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56472046|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472047|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472049|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56472050|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472051|NCT01241240|Timolol|timolol|mesh-list
56472052|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56472053|NCT01241240|Bimatoprost|bimatoprost|mesh-list
56472054|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56472055|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56472056|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56472057|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56472058|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
56472059|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472060|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472061|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472062|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56472063|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56472064|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56472065|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56472066|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56472067|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
56472068|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
56472069|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56472070|NCT02950623|Protective Agents|protective agents|mesh-ancestor
56472071|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472073|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56472074|NCT00516009|Dexamethasone|dexamethasone|mesh-list
56472075|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56472076|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
56472077|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
56472078|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472079|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472080|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56472081|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
56472082|NCT00516009|Hormones|hormones|mesh-ancestor
56472083|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56472084|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56472085|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472086|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
56472087|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
56472088|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56334488|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
56472089|NCT02950584|Protective Agents|protective agents|mesh-ancestor
56472090|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472091|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
56472092|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56472094|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
56472095|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56472096|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
56472097|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56472098|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472099|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56472100|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56472101|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56472102|NCT01240811|Trace Elements|trace elements|mesh-ancestor
56472103|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
56472104|NCT03459144|Ranibizumab|ranibizumab|mesh-list
56919184|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919185|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
56919186|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919187|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919188|NCT02603809|Lisinopril|lisinopril|mesh-list
56919189|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56919190|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
56919191|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919192|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919193|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56919194|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56472105|NCT03459144|Verteporfin|verteporfin|mesh-list
56472106|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56472107|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56472108|NCT03459144|Growth Substances|growth substances|mesh-ancestor
56472109|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472110|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
56472111|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472112|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56472113|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
56472114|NCT03459105|Bupivacaine|bupivacaine|mesh-list
56472115|NCT03459105|Anesthetics|anesthetics|mesh-list
56472116|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
56472117|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472118|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472119|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
56472120|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472121|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56472122|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56472123|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
56472124|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56472125|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
56472126|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472127|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
56472128|NCT01240382|Protective Agents|protective agents|mesh-ancestor
56472129|NCT01244828|Asenapine|asenapine|mesh-list
56472130|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56472131|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56472132|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472133|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472134|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56472135|NCT00504192|Gemcitabine|gemcitabine|mesh-list
56472136|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
56472137|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472138|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
56472139|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472140|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472141|NCT00504192|Antiviral Agents|antiviral agents|mesh-ancestor
56472142|NCT00504192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472143|NCT00504192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472144|NCT00504192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472145|NCT00504192|Immunologic Factors|immunologic factors|mesh-ancestor
56472146|NCT00504192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472151|NCT01249443|Vorinostat|vorinostat|mesh-list
56472152|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56472153|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472154|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
56472155|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
56472156|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
56472157|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472158|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56472159|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919195|NCT02603809|Protective Agents|protective agents|mesh-ancestor
56919196|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919197|NCT01341158|Interferons|interferons|mesh-list
56919198|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919199|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
56919200|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919201|NCT00393952|Fluticasone|fluticasone|mesh-list
56919202|NCT00393952|Xhance|xhance|mesh-list
56919203|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
56919204|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56919205|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56919206|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
56919207|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919208|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919209|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56919210|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
56919211|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
56919212|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56919213|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56919214|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56919215|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56919216|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
56919217|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919218|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919219|NCT02285374|Tenofovir|tenofovir|mesh-list
56919220|NCT02285374|Emtricitabine|emtricitabine|mesh-list
56919221|NCT02285374|Efavirenz|efavirenz|mesh-list
56919222|NCT02285374|Dolutegravir|dolutegravir|mesh-list
56919223|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56919224|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
56919225|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919226|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56919227|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56919228|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919229|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919230|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56472160|NCT01243073|Imetelstat|imetelstat|mesh-list
56472161|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
56919231|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56919232|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56919233|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56919234|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56919235|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56919236|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56919237|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56919238|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56919239|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56919240|NCT01112449|Selenium|selenium|mesh-list
56919241|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
56919242|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919243|NCT01112449|Protective Agents|protective agents|mesh-ancestor
56919244|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919245|NCT01112449|Trace Elements|trace elements|mesh-ancestor
56919246|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
56919247|NCT01341392|Amlodipine|amlodipine|mesh-list
56919248|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56919249|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56919250|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56919251|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919252|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56919253|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919254|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
56919255|NCT04390958|Paclitaxel|paclitaxel|mesh-list
56919256|NCT04390958|Capecitabine|capecitabine|mesh-list
56919257|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56472162|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472163|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472164|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56334508|NCT00070434|Irinotecan|irinotecan|mesh-list
56472165|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56472166|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
56472167|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472168|NCT00516243|Protective Agents|protective agents|mesh-ancestor
56472169|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472170|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56472171|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56472172|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472173|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56472174|NCT01240889|Fluticasone|fluticasone|mesh-list
56472175|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56472176|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56472177|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
56472178|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919258|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919259|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
56919260|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
56919261|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
56919262|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919263|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56919264|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
56919266|NCT03943459|Quercetin|quercetin|mesh-list
56919326|NCT01109485|Analgesics|analgesics|mesh-ancestor
56919327|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
56919328|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919329|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919330|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56919331|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56919332|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56919333|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56919334|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56919335|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
56919336|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
56919337|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919338|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919339|NCT00292396|Antibodies|antibodies|mesh-list
56211461|NCT05344911|Propofol|propofol|mesh-list
56472179|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472180|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56472181|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
56472182|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
56472183|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56472184|NCT00516282|Temozolomide|temozolomide|mesh-list
56472185|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56472186|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
56472187|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472188|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472189|NCT01249521|Bevacizumab|bevacizumab|mesh-list
56472190|NCT01249521|Trebananib|trebananib|mesh-list
56472191|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56472192|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472193|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56472194|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56472195|NCT01249521|Growth Substances|growth substances|mesh-ancestor
56472196|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472197|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
56472198|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
56472199|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56472200|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472201|NCT04511975|Azacitidine|azacitidine|mesh-list
56472202|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472203|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
56472204|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472205|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472206|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472207|NCT04511897|Expectorants|expectorants|mesh-list
56472208|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
56472210|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
56472211|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
56472212|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472213|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472214|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
56472215|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472216|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56472217|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56472218|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56472220|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472222|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56472223|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472224|NCT01244256|Gentamicins|gentamicins|mesh-list
56472225|NCT01244256|Clotrimazole|clotrimazole|mesh-list
56919340|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56919341|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
56919342|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919343|NCT03942289|Norepinephrine|norepinephrine|mesh-list
56919344|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56919345|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56919346|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
56919347|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919348|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919349|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919350|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
56919351|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
56919352|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472226|NCT01244256|Miconazole|miconazole|mesh-list
56472227|NCT01244256|Beclomethasone|beclomethasone|mesh-list
56472228|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56472229|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472230|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56472231|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472232|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472233|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56472234|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
56472235|NCT01244256|Hormones|hormones|mesh-ancestor
56472236|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56472237|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334509|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
56472238|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56472239|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
56472240|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56472241|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
56472242|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56472243|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56472244|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56472245|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
56472246|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56472247|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56472248|NCT01249833|Oseltamivir|oseltamivir|mesh-list
56472249|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
56472250|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472251|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472252|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472253|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
56472254|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56472255|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56472256|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472257|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472258|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472259|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
56472260|NCT04519151|Lenvatinib|lenvatinib|mesh-list
56472261|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56472262|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472263|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56472264|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472265|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472266|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
56472267|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56472268|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56472269|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56472270|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900078|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
56919353|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56919354|NCT00284128|Losartan|losartan|mesh-list
56919355|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56919356|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56919357|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56472271|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472272|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
56472273|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472274|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472275|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56472276|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472277|NCT04511000|Atorvastatin|atorvastatin|mesh-list
56472278|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56472279|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56472280|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
56472281|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472282|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56472283|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56472284|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472285|NCT04519385|Dexamethasone|dexamethasone|mesh-list
56472286|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56472287|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
56472288|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
56472293|NCT04519385|Hormones|hormones|mesh-ancestor
56472294|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56472295|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56472296|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472297|NCT00506051|Pemetrexed|pemetrexed|mesh-list
56472298|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472299|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472300|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472301|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56472302|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56472303|NCT00504465|Dinoprostone|dinoprostone|mesh-list
56472304|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
56472305|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56472306|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472307|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
56472308|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56472309|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472310|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
56472311|NCT04510649|Rifampin|rifampin|mesh-list
56472312|NCT04510649|Rabeprazole|rabeprazole|mesh-list
56472313|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56472314|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56472315|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56472316|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472317|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472318|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56472319|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
56472320|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56472321|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472322|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
56472323|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56472324|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56472325|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56472326|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56472327|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56472328|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56472329|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56472330|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
56472331|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56472332|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472333|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472334|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56472335|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56472336|NCT01249092|Protective Agents|protective agents|mesh-ancestor
56472337|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919358|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56919359|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919360|NCT00035542|Metformin|metformin|mesh-list
56919361|NCT00035542|Glyburide|glyburide|mesh-list
56919362|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56919363|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919364|NCT01209715|Fluticasone|fluticasone|mesh-list
56919365|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56919366|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56919367|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56919368|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56919369|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
56919370|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919371|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919372|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56919373|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
56919374|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
56919375|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56919376|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56919377|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56919378|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56919379|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
56919380|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919381|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472338|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
56472339|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56472340|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
56333934|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472341|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
56472342|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56472343|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472344|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472345|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56472346|NCT02275182|Analgesics|analgesics|mesh-ancestor
56472347|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
56472348|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472349|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56472350|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56472351|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56472352|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
56472353|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472354|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472355|NCT01248780|Golimumab|golimumab|mesh-list
56472356|NCT01248780|Methotrexate|methotrexate|mesh-list
56472360|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472361|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472363|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472364|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919382|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
56919383|NCT01209715|Hormones|hormones|mesh-ancestor
56919384|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919385|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
56919386|NCT03740893|Durvalumab|durvalumab|mesh-list
56919387|NCT03740893|Olaparib|olaparib|mesh-list
56919388|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56919389|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919390|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56919391|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919392|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919393|NCT00005788|Aldesleukin|aldesleukin|mesh-list
56919394|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919395|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56919396|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56919397|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
56919398|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919399|NCT03945955|Melatonin|melatonin|mesh-list
56919400|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
56919401|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919402|NCT03945955|Protective Agents|protective agents|mesh-ancestor
56919403|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472365|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
56472366|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472367|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56472368|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472369|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
56472370|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56472371|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56472372|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56472373|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56472374|NCT01248468|Aspirin|aspirin|mesh-list
56472375|NCT01248468|Acetaminophen|acetaminophen|mesh-list
56472376|NCT01248468|Sumatriptan|sumatriptan|mesh-list
56472377|NCT01248468|Caffeine|caffeine|mesh-list
56472378|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56472379|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56472380|NCT01248468|Analgesics|analgesics|mesh-ancestor
56472381|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
56472382|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472383|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472384|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56472385|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56472386|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56472387|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56472388|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472389|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56472390|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56472391|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472392|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
56472393|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56472394|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56472395|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56919404|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919405|NCT00005608|Leucovorin|leucovorin|mesh-list
56919406|NCT00005608|Tegafur|tegafur|mesh-list
56919407|NCT00005608|Calcium|calcium|mesh-list
56919408|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
56472396|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56472397|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
56472398|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472399|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56472400|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56472401|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56472402|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
56472403|NCT02275299|Methotrexate|methotrexate|mesh-list
56472404|NCT02275299|Leflunomide|leflunomide|mesh-list
56472405|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56472406|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
56472407|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56472408|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472409|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472410|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
56472411|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472412|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472413|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
56472414|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472415|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56472416|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472417|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
56472418|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56472419|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56472420|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56472421|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472422|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56472423|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472424|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472425|NCT01246206|Tacrolimus|tacrolimus|mesh-list
56472426|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
56472429|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472430|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56472431|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472432|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472433|NCT04510610|Decitabine|decitabine|mesh-list
56472434|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472435|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
56472436|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472437|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472438|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472439|NCT01246011|Warfarin|warfarin|mesh-list
56472440|NCT01246011|Argatroban|argatroban|mesh-list
56472441|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
56472442|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
56472443|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56472444|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
56472445|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472446|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472447|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56472448|NCT01244490|Guanfacine|guanfacine|mesh-list
56472449|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56472450|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56472451|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56472452|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56472453|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472454|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
56472455|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472456|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472457|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56472458|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56472459|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56472460|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56472462|NCT01243944|Pomalidomide|pomalidomide|mesh-list
56472463|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
56472464|NCT01243944|Pipobroman|pipobroman|mesh-list
56919409|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56919410|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919411|NCT00005608|Antidotes|antidotes|mesh-ancestor
56919412|NCT00005608|Protective Agents|protective agents|mesh-ancestor
56919413|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
56919414|NCT00005608|Vitamins|vitamins|mesh-ancestor
56919415|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
56919416|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56919417|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
56919418|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919419|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919420|NCT02288338|Atorvastatin|atorvastatin|mesh-list
56919421|NCT02288338|Ezetimibe|ezetimibe|mesh-list
56919422|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56919423|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56919424|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
56919425|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919426|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56919427|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56919428|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919429|NCT00388960|Etoposide|etoposide|mesh-list
56919430|NCT00388960|Amrubicin|amrubicin|mesh-list
56919431|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919432|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56919433|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56919444|NCT00004912|Megestrol|megestrol|mesh-list
56919457|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56919458|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
56919459|NCT02529787|Lansoprazole|lansoprazole|mesh-list
56919460|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56919461|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56919462|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56919463|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919464|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919465|NCT00267592|Temozolomide|temozolomide|mesh-list
56919466|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56919467|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
56919468|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919469|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919470|NCT00267280|Atorvastatin|atorvastatin|mesh-list
56919471|NCT00267280|Simvastatin|simvastatin|mesh-list
56472465|NCT01243944|Anagrelide|anagrelide|mesh-list
56472466|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
56472467|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472468|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56472469|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56472470|NCT01243944|Growth Substances|growth substances|mesh-ancestor
56472471|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
56472472|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472473|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
56472474|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472475|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472476|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56472477|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56472478|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56472479|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56472480|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56472481|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
56472482|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
56472483|NCT00516399|Natamycin|natamycin|mesh-list
56472484|NCT00516399|Povidone|povidone|mesh-list
56472485|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56472486|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56472487|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
56472488|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
56333935|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
56472489|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56472490|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472491|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56472492|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
56472494|NCT00516438|Olaparib|olaparib|mesh-list
56472495|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56472496|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56472497|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56472498|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472499|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472500|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472512|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
56472513|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472514|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56472515|NCT00516672|Lapatinib|lapatinib|mesh-list
56472516|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472517|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56472518|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472519|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472520|NCT00516711|Sevoflurane|sevoflurane|mesh-list
56919472|NCT00267280|Torcetrapib|torcetrapib|mesh-list
56919473|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56919474|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56919475|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
56919476|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919477|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56919478|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56919479|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919480|NCT03530488|Lidocaine|lidocaine|mesh-list
56919481|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
56919482|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
56919483|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919484|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919485|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
56919486|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919487|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56919488|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56919489|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56919490|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56919491|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919492|NCT00262990|Doxorubicin|doxorubicin|mesh-list
56919493|NCT00262990|Epothilone B|epothilone b|mesh-list
56919494|NCT00262990|Epothilones|epothilones|mesh-list
56919495|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56919496|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919499|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919518|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919519|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56919520|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56919521|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56919522|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919523|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56919524|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56919525|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919527|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
56919528|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56919529|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56919530|NCT00250822|Gemcitabine|gemcitabine|mesh-list
56919531|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
56919532|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56919533|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
56919534|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919535|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919536|NCT00250822|Antiviral Agents|antiviral agents|mesh-ancestor
56919537|NCT00250822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919538|NCT00250822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919539|NCT00250822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56919540|NCT00250822|Immunologic Factors|immunologic factors|mesh-ancestor
56919541|NCT00250822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919542|NCT00004096|Carboplatin|carboplatin|mesh-list
56919543|NCT00004096|Vinorelbine|vinorelbine|mesh-list
56919544|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919545|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56919546|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
56919547|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
56919548|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
56919550|NCT00002224|Stavudine|stavudine|mesh-list
56919564|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
56919565|NCT01207921|Lenalidomide|lenalidomide|mesh-list
56919566|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
56919567|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919568|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56919569|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56919570|NCT01207921|Growth Substances|growth substances|mesh-ancestor
56919571|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
56919572|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919573|NCT01108393|S 20098|s 20098|mesh-list
56919574|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56919575|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919576|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919577|NCT01113229|Misoprostol|misoprostol|mesh-list
56919578|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56919579|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
56919580|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56919581|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919582|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56919583|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56919584|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
56919585|NCT03530176|Listerine|listerine|mesh-list
56919586|NCT03530176|Fluorides|fluorides|mesh-list
56919587|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
56919588|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
56919589|NCT03530176|Protective Agents|protective agents|mesh-ancestor
56919590|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919591|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56919592|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919593|NCT03151304|Azacitidine|azacitidine|mesh-list
56919594|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56919595|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
56919596|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919597|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919598|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919599|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
56919600|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
56919603|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919605|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56919606|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919607|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919608|NCT02288962|Cabergoline|cabergoline|mesh-list
56919609|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56919610|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56919611|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
56919612|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
56919613|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472521|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56472522|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56472523|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
56472524|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
56472525|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472526|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472527|NCT00516750|Doxorubicin|doxorubicin|mesh-list
56472528|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56472529|NCT00516750|Methotrexate|methotrexate|mesh-list
56472530|NCT00516750|Vinblastine|vinblastine|mesh-list
56472531|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472532|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56472533|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56472534|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56472535|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472536|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472537|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56472538|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
56472539|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56472540|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472541|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472542|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
56472543|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
56472544|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56472545|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472546|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
56472547|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56472548|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56472549|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56472550|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
56472551|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
56472552|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
56472553|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
56472554|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
56472555|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472556|NCT00505427|Protective Agents|protective agents|mesh-ancestor
56472557|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472558|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
56472559|NCT00505427|Vitamins|vitamins|mesh-ancestor
56472560|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
56472561|NCT00506168|Capecitabine|capecitabine|mesh-list
56472562|NCT00506168|Irinotecan|irinotecan|mesh-list
56472563|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472565|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472566|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472567|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56472568|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56472569|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472570|NCT02950038|Nivolumab|nivolumab|mesh-list
56472571|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56472572|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472573|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56472574|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472575|NCT04510220|Ofatumumab|ofatumumab|mesh-list
56919614|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919615|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919616|NCT03942991|Mepivacaine|mepivacaine|mesh-list
56919617|NCT03942991|Carticaine|carticaine|mesh-list
56919618|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
56919619|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
56919620|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919621|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472576|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472577|NCT02949648|Nicotine|nicotine|mesh-list
56472578|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56472579|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
56472580|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472581|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472582|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56472583|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56472584|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
56472585|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472586|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472587|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
56472588|NCT04510337|Rocuronium|rocuronium|mesh-list
56472589|NCT04510337|Analgesics|analgesics|mesh-ancestor
56472590|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
56472591|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472592|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472593|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
56472594|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472595|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56472596|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
56472597|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56472598|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56472599|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472600|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56472601|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
56472602|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56472603|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56472604|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56472605|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56472606|NCT00516828|Cytarabine|cytarabine|mesh-list
56472607|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56472608|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
56472609|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472610|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472611|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
56472612|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472613|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472614|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
56472615|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472617|NCT02949765|Trace Elements|trace elements|mesh-ancestor
56472618|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
56472619|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472620|NCT04518176|Oxytocin|oxytocin|mesh-list
56472621|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
56472622|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56472623|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472624|NCT00516945|Lamivudine|lamivudine|mesh-list
56472625|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56472626|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56472627|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472628|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472629|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
56472630|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472631|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56472632|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56472633|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56472634|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56919622|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
56919623|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919624|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
56919625|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56919626|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
56919627|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919628|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919629|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56919630|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
56919631|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56919632|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56919633|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56919634|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
56472635|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472636|NCT00517062|Hormones|hormones|mesh-list
56472637|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56472640|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
56472641|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56472642|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56472643|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472644|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472645|NCT00517179|Urological Agents|urological agents|mesh-ancestor
56472646|NCT00517218|Oblimersen|oblimersen|mesh-list
56472647|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472648|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
56472649|NCT00506207|Irinotecan|irinotecan|mesh-list
56472650|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472651|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56472652|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56472653|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472654|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472655|NCT00517257|Atorvastatin|atorvastatin|mesh-list
56472656|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56472657|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56472658|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
56472659|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472660|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56472661|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56472662|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472663|NCT00506246|Propofol|propofol|mesh-list
56472664|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56472665|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472666|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472667|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56472668|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
56472669|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
56472670|NCT01243242|Metadoxine|metadoxine|mesh-list
56472671|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56472672|NCT00517491|Lanreotide|lanreotide|mesh-list
56472673|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472674|NCT04517201|Insulin|insulin|mesh-list
56472675|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56472676|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56472677|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472678|NCT01241292|Elotuzumab|elotuzumab|mesh-list
56472679|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472680|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
56472681|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472682|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472683|NCT00517725|Carvedilol|carvedilol|mesh-list
56472684|NCT00517725|Nebivolol|nebivolol|mesh-list
56472685|NCT00517725|Bisoprolol|bisoprolol|mesh-list
56919635|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919636|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919637|NCT00162292|Methotrexate|methotrexate|mesh-list
56919638|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56919639|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
56919640|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56919641|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919642|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56919643|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
56919644|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919645|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919646|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
56919647|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919648|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56472686|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56472687|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56472688|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
56472689|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472690|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472691|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472692|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56472693|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
56472694|NCT00517725|Protective Agents|protective agents|mesh-ancestor
56472695|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56472696|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56472697|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56472698|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
56472699|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56472700|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56472701|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56472702|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56472703|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56472704|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
56472705|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
56472706|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472707|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56472708|NCT01240863|Hydrocodone|hydrocodone|mesh-list
56472709|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56472713|NCT01240863|Analgesics|analgesics|mesh-ancestor
56472714|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
56472715|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472716|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
56472717|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
56472718|NCT01240746|Vaccines|vaccines|mesh-list
56472719|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
56472720|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472721|NCT01240590|Cisplatin|cisplatin|mesh-list
56472722|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472723|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
56472724|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56472725|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472726|NCT00504543|Everolimus|everolimus|mesh-list
56472727|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472728|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
56472729|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472730|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472731|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
56472732|NCT02949843|Nivolumab|nivolumab|mesh-list
56472733|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56919649|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56919650|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
56919651|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56919652|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56919653|NCT00135382|Efavirenz|efavirenz|mesh-list
56919654|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56919655|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56919656|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919657|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919658|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
56919659|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919660|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56919661|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56919662|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56919663|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56919664|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56919665|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56919666|NCT03531970|Dexamethasone|dexamethasone|mesh-list
56919667|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
56472734|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472735|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56334516|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
56472736|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472737|NCT00517764|Citalopram|citalopram|mesh-list
56472738|NCT00517764|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56472739|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56472740|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56472741|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472742|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472743|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
56472744|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472745|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56472746|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
56472747|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56472748|NCT00517803|Micronutrients|micronutrients|mesh-list
56472749|NCT00517803|Trace Elements|trace elements|mesh-list
56472750|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472751|NCT04517435|Prednisone|prednisone|mesh-list
56472752|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
56472753|NCT04517435|Rituximab|rituximab|mesh-list
56472754|NCT04517435|Doxorubicin|doxorubicin|mesh-list
56472755|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56472756|NCT04517435|Vincristine|vincristine|mesh-list
56472757|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472758|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
56472759|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472760|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56472761|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56472762|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
56472763|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472764|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472765|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55900148|NCT04665856|Carboplatin|carboplatin|mesh-list
56919668|NCT03531970|Lidocaine|lidocaine|mesh-list
56919669|NCT03531970|Epinephrine|epinephrine|mesh-list
56919670|NCT03531970|BB 1101|bb 1101|mesh-list
56919671|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56919672|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
56919673|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
56919674|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919675|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919676|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56919677|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
56919679|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919680|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56919681|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919682|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
56919683|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919684|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919685|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
56919686|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
56919687|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919688|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
56919689|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56919690|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56919691|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56919692|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56472766|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56472767|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56472768|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56472769|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56472770|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472771|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56472772|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
56472773|NCT04517435|Hormones|hormones|mesh-ancestor
56472774|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56472775|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56472776|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56472777|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
56472778|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
56472779|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
56472783|NCT04516304|Estrogens|estrogens|mesh-ancestor
56472784|NCT04516304|Hormones|hormones|mesh-ancestor
56472785|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56472786|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472787|NCT01242930|Niacinamide|niacinamide|mesh-list
56220770|NCT01657513|Analgesics|analgesics|mesh-ancestor
56472788|NCT01242930|Lenalidomide|lenalidomide|mesh-list
56472789|NCT01242930|Imetelstat|imetelstat|mesh-list
56472790|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
56472791|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
56472792|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472793|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56919693|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56919694|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56919695|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
56919696|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919697|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56919698|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56919699|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56919700|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
56919701|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
56919702|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
56919703|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56919704|NCT05726110|Cytarabine|cytarabine|mesh-list
56919705|NCT05726110|Daunorubicin|daunorubicin|mesh-list
56919706|NCT05726110|Homoharringtonine|homoharringtonine|mesh-list
56919707|NCT05726110|Aclacinomycins|aclacinomycins|mesh-list
56919708|NCT05726110|Lenograstim|lenograstim|mesh-list
56919709|NCT05726110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56919710|NCT05726110|Antimetabolites|antimetabolites|mesh-ancestor
56919711|NCT05726110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919712|NCT05726110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919713|NCT05726110|Antiviral Agents|antiviral agents|mesh-ancestor
56919714|NCT05726110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182210|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472794|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56472795|NCT01242930|Growth Substances|growth substances|mesh-ancestor
56472796|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
56472797|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472798|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472799|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472800|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56472801|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
56472802|NCT01242930|Vitamins|vitamins|mesh-ancestor
56472803|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
56472804|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
56472805|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56472806|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56472807|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472808|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
56472809|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
56472810|NCT01241214|Cetirizine|cetirizine|mesh-list
56472811|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56472812|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56472813|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56472814|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
56472815|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
56472816|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472817|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472818|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472819|NCT04515836|Olaparib|olaparib|mesh-list
56472820|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56472821|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472822|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472823|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472824|NCT01240512|Vitamin D|vitamin d|mesh-list
56919715|NCT05726110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56919716|NCT05726110|Immunologic Factors|immunologic factors|mesh-ancestor
56919717|NCT05726110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919718|NCT05726110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56919719|NCT05726110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56919720|NCT05726110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56919721|NCT05726110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182234|NCT01417169|Micafungin|micafungin|mesh-list
56472825|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
56472826|NCT01240512|Vitamins|vitamins|mesh-ancestor
56472827|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
56472828|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472829|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56472830|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56472831|NCT01240629|Doxorubicin|doxorubicin|mesh-list
56472832|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56472833|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56472834|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472835|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56472836|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56472837|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472838|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472839|NCT04515641|Islatravir|islatravir|mesh-list
56472840|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
56472841|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472842|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472843|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472844|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56472845|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56472846|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56472847|NCT00518232|Methylphenidate|methylphenidate|mesh-list
56472848|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56472849|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472850|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56472851|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56472854|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
56472855|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472857|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56472858|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56472859|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472860|NCT00518271|Sirolimus|sirolimus|mesh-list
56472861|NCT00518271|Tacrolimus|tacrolimus|mesh-list
56472862|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472864|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472865|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56472866|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472867|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472868|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56472869|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472870|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56472871|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472872|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
56472873|NCT00518193|Cetuximab|cetuximab|mesh-list
56472874|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56472875|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472876|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
56472877|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56472878|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472880|NCT00518466|Phentermine|phentermine|mesh-list
56472881|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
56472882|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56472883|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472884|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56472885|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
56472886|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56472887|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
56472888|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
56919722|NCT05726110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56919723|NCT05726110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56919724|NCT05726110|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56919725|NCT01211821|Metoprolol|metoprolol|mesh-list
56919726|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56919727|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56919728|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
56919729|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
56919730|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919731|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919732|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56919733|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56919734|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56919735|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
56182237|NCT01417273|Vitamin A|vitamin a|mesh-list
56472889|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472890|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
56472891|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472892|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472893|NCT00518583|Paclitaxel|paclitaxel|mesh-list
56472894|NCT00518583|Doxorubicin|doxorubicin|mesh-list
56472895|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56472896|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56472897|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472898|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
56472899|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
56472900|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
56472901|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472902|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56472903|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56472904|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56472905|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472906|NCT00519753|Timolol|timolol|mesh-list
56472907|NCT00519753|Travoprost|travoprost|mesh-list
56472908|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56472909|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56472910|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472911|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56472912|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56472913|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
56472914|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472915|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472916|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56472917|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56472918|NCT00519870|Losartan|losartan|mesh-list
56472919|NCT00519870|Nifedipine|nifedipine|mesh-list
56472920|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56472921|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56472922|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56472923|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56472924|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472925|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56472929|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
56472930|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
56472931|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56472932|NCT00519909|Calcium|calcium|mesh-list
56472933|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56472934|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472935|NCT02949492|Interleukin-2|interleukin-2|mesh-list
56919736|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919737|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919738|NCT03527836|Lidocaine|lidocaine|mesh-list
56919739|NCT03527836|Bupivacaine|bupivacaine|mesh-list
56919740|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
56919741|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
56919742|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919743|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919744|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
56919745|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919746|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56919747|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56919748|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56919749|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56919750|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919751|NCT05642026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56919752|NCT05642026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56220917|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56472936|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472937|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56472938|NCT02949492|Analgesics|analgesics|mesh-ancestor
56472939|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
56472940|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472941|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472942|NCT04511234|Sirolimus|sirolimus|mesh-list
56334540|NCT00066612|Irinotecan|irinotecan|mesh-list
56472943|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56472944|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472945|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56472946|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472947|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
56472948|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472949|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
56472950|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472951|NCT04514588|Caffeine|caffeine|mesh-list
56472952|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56472953|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472954|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56472955|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472956|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472957|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56472958|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56472959|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
56472960|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472961|NCT00519987|Ketamine|ketamine|mesh-list
56472962|NCT00519987|Analgesics|analgesics|mesh-ancestor
56472963|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
56472964|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472965|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472966|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56472967|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56472968|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
56472969|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
56472970|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900149|NCT04665856|Etoposide|etoposide|mesh-list
56919753|NCT05642026|Ropivacaine|ropivacaine|mesh-list
56919754|NCT05642026|Anesthetics, Local|anesthetics, local|mesh-ancestor
56919755|NCT05642026|Anesthetics|anesthetics|mesh-ancestor
56919756|NCT05642026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919757|NCT05642026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919758|NCT05642026|Sensory System Agents|sensory system agents|mesh-ancestor
56919759|NCT05642026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919760|NCT05642026|Analgesics|analgesics|mesh-ancestor
56919761|NCT05642026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56919762|NCT05642026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56919763|NCT05724862|Anesthetics|anesthetics|mesh-list
56919764|NCT05724862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919765|NCT05724862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919766|NCT03940651|Anesthetics|anesthetics|mesh-list
56919767|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
56919768|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919769|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919770|NCT03152552|Empagliflozin|empagliflozin|mesh-list
56919771|NCT03152552|Licogliflozin|licogliflozin|mesh-list
56919772|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56919773|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919774|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56919775|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919776|NCT01211275|Cisplatin|cisplatin|mesh-list
56919777|NCT01211275|Pemetrexed|pemetrexed|mesh-list
56919778|NCT01211275|Axitinib|axitinib|mesh-list
56919779|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919780|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919781|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919782|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56919783|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56919784|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56919785|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56919786|NCT03529084|Gefitinib|gefitinib|mesh-list
56919787|NCT03529084|Nazartinib|nazartinib|mesh-list
56919788|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472971|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56472972|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55900150|NCT04665856|Atezolizumab|atezolizumab|mesh-list
56919789|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56919790|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919791|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919792|NCT03942757|Bilirubin|bilirubin|mesh-list
56919793|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
56919794|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919795|NCT03942757|Protective Agents|protective agents|mesh-ancestor
56919796|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919797|NCT05609578|Pembrolizumab|pembrolizumab|mesh-list
56919798|NCT05609578|Adagrasib|adagrasib|mesh-list
56182310|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472973|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56472974|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472975|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
56472976|NCT02276300|Imiquimod|imiquimod|mesh-list
56472977|NCT02276300|Sargramostim|sargramostim|mesh-list
56472978|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472979|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
56472980|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472981|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56472982|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56472983|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
56472984|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472985|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472986|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56472987|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56472988|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
56472989|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
56472990|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
56472991|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56472992|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472993|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472995|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56472996|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472997|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472998|NCT02955251|Nivolumab|nivolumab|mesh-list
56472999|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56473000|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473001|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56473002|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473003|NCT00518895|Dacarbazine|dacarbazine|mesh-list
56473004|NCT00518895|Oblimersen|oblimersen|mesh-list
56473005|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56473006|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
56473007|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473008|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221009|NCT01659281|Artesunate|artesunate|mesh-list
56473009|NCT00520104|Ketamine|ketamine|mesh-list
56473010|NCT00520104|Analgesics|analgesics|mesh-ancestor
56473011|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
56473012|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473013|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334546|NCT00070551|Cytarabine|cytarabine|mesh-list
56473014|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56473015|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56473016|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
56473017|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
56473018|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473019|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56473020|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56473021|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473022|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473023|NCT00519012|Sertraline|sertraline|mesh-list
56919799|NCT05609578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56919800|NCT05609578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919801|NCT05724628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56919802|NCT05724628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919803|NCT01208701|Atorvastatin|atorvastatin|mesh-list
56919804|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56919805|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56919806|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
56919807|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919808|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56919809|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56919810|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919811|NCT05724550|Neostigmine|neostigmine|mesh-list
56919812|NCT05724550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56919813|NCT05724550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919814|NCT05724550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919815|NCT05724550|Cholinergic Agents|cholinergic agents|mesh-ancestor
56919816|NCT05724550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919817|NCT05724550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919818|NCT05724550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56919819|NCT05724550|Autonomic Agents|autonomic agents|mesh-ancestor
56919820|NCT05724550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919821|NCT03528772|Minoxidil|minoxidil|mesh-list
56919822|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
56630459|NCT04637594|Durvalumab|durvalumab|mesh-list
56919823|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56919824|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
56919825|NCT01316744|Ketamine|ketamine|mesh-list
56919826|NCT01316744|Analgesics|analgesics|mesh-ancestor
56919827|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
56919828|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919829|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919830|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56919831|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56919832|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
56919833|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
56473024|NCT00519012|Paroxetine|paroxetine|mesh-list
56919836|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56919837|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919838|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919839|NCT01213381|Gemcitabine|gemcitabine|mesh-list
56919840|NCT01213381|Carboplatin|carboplatin|mesh-list
56919841|NCT01213381|Iniparib|iniparib|mesh-list
56919842|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919843|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56919844|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
56919845|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919846|NCT01213381|Antiviral Agents|antiviral agents|mesh-ancestor
56919847|NCT01213381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919848|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919849|NCT01213381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56919850|NCT01213381|Immunologic Factors|immunologic factors|mesh-ancestor
56919851|NCT01213381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919852|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56919853|NCT01316978|Ibuprofen|ibuprofen|mesh-list
56919854|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56919855|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56919856|NCT01316978|Analgesics|analgesics|mesh-ancestor
56919857|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
56919858|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919859|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919860|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56919861|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56919862|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56919863|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919864|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919865|NCT01317212|Carboplatin|carboplatin|mesh-list
56919866|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919867|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
56919872|NCT01211509|Montelukast|montelukast|mesh-list
56919876|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
56919877|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919878|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919879|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56919880|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56919881|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919882|NCT04791176|Lenvatinib|lenvatinib|mesh-list
56919883|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919884|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56919885|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919886|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919887|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
56919888|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56919889|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56919890|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919891|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919892|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
56919893|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56919894|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
56919895|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919896|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
56919897|NCT04441528|Protective Agents|protective agents|mesh-ancestor
56919898|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
56919899|NCT01344512|Ceftazidime|ceftazidime|mesh-list
56919900|NCT01344512|Voriconazole|voriconazole|mesh-list
56919901|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56919902|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919903|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56919904|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56919905|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919906|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919914|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919915|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919916|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56919917|NCT05064488|Metformin|metformin|mesh-list
56919918|NCT05064488|Digoxin|digoxin|mesh-list
56919919|NCT05064488|Sumatriptan|sumatriptan|mesh-list
56919920|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56919921|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56919922|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919923|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56919924|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56919925|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
56919926|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919927|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56473025|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
56473026|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56473027|NCT00519012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56473028|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56473029|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56473030|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473031|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473032|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
56473033|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473034|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56473035|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56473036|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56473037|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473038|NCT00520260|Ketorolac|ketorolac|mesh-list
56473039|NCT00520260|Bromfenac|bromfenac|mesh-list
56473040|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56473041|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56473042|NCT00520260|Analgesics|analgesics|mesh-ancestor
56473043|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
56473044|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473045|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473046|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473047|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56473048|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56473049|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473050|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473051|NCT00520338|Celecoxib|celecoxib|mesh-list
56473052|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56473053|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56473054|NCT00520338|Analgesics|analgesics|mesh-ancestor
56473055|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
56473056|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473057|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473058|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473059|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56473060|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56473061|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56473062|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473063|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473067|NCT00519051|Fluoxetine|fluoxetine|mesh-list
56473068|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
56473069|NCT00519051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56473070|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56473071|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56919928|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56919929|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919930|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56919931|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56919932|NCT05064488|Protective Agents|protective agents|mesh-ancestor
56919933|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56919934|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56919935|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56919936|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
56919937|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919938|NCT01344590|Ethanol|ethanol|mesh-list
56919939|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56919940|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919941|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919942|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919943|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
56919944|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473072|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473073|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473074|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
56473075|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473076|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56473077|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56473078|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56473079|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56473080|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473081|NCT00505700|Cytarabine|cytarabine|mesh-list
56473082|NCT00505700|Bortezomib|bortezomib|mesh-list
56473083|NCT00505700|Idarubicin|idarubicin|mesh-list
56473084|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56473085|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
56473086|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473087|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473089|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473090|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56473091|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
56473092|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473093|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56473094|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56473095|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56473096|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473097|NCT02275832|Minoxidil|minoxidil|mesh-list
56473098|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56473099|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
56473100|NCT00519207|Lidocaine|lidocaine|mesh-list
56473101|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
56473102|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
56473103|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473104|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473105|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
56473106|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473107|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56473108|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56473109|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56473110|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887137|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919945|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56919946|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919947|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919948|NCT01212133|Liraglutide|liraglutide|mesh-list
56919949|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56919950|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919951|NCT01212133|Incretins|incretins|mesh-ancestor
56473111|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473112|NCT02590094|Bevacizumab|bevacizumab|mesh-list
56473113|NCT02590094|Aflibercept|aflibercept|mesh-list
56473114|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56473115|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473116|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56473117|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56473118|NCT02590094|Growth Substances|growth substances|mesh-ancestor
56473119|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473120|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
56473121|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
56473122|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56473123|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
56473124|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56473125|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473126|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56473127|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56473128|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56473129|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
56473130|NCT02949258|Etoposide|etoposide|mesh-list
56473131|NCT02949258|Epirubicin|epirubicin|mesh-list
56473132|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473133|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56473134|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56473135|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56473136|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473140|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56473141|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
56473142|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473143|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473144|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473145|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56473146|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
56473147|NCT00519246|Narcotics|narcotics|mesh-ancestor
56473148|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473149|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473150|NCT00519246|Analgesics|analgesics|mesh-ancestor
56473151|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
56473152|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473153|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56473154|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473155|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56473156|NCT00519324|Everolimus|everolimus|mesh-list
56473157|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473158|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334548|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
56473159|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
56473160|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473161|NCT00520650|Aripiprazole|aripiprazole|mesh-list
56473162|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
56473163|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56473164|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56473165|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56473166|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473167|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473168|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
56473169|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
56473170|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473171|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473172|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56919952|NCT01212133|Hormones|hormones|mesh-ancestor
56919953|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919954|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
56919955|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
56919956|NCT04269356|Antacids|antacids|mesh-ancestor
56919957|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919958|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56919959|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56919960|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56919961|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919962|NCT01118065|Everolimus|everolimus|mesh-list
56919963|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919964|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56919965|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
56919966|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919967|NCT03528616|Propranolol|propranolol|mesh-list
56919968|NCT03528616|Digoxin|digoxin|mesh-list
56630608|NCT04238702|Losartan|losartan|mesh-list
56919969|NCT03528616|Adenosine|adenosine|mesh-list
56919970|NCT03528616|Amiodarone|amiodarone|mesh-list
56919971|NCT03528616|Flecainide|flecainide|mesh-list
56919972|NCT03528616|Procainamide|procainamide|mesh-list
56919973|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56919974|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56919975|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
56919976|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919977|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473173|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56473174|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
56473175|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56473176|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56473177|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56473178|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56473179|NCT00519363|Atorvastatin|atorvastatin|mesh-list
56473180|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56473181|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56473182|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
56473183|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473184|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56473185|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56473186|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473187|NCT00519480|Metformin|metformin|mesh-list
56473188|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56473189|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473190|NCT02955056|Teriparatide|teriparatide|mesh-list
56473191|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473192|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56473193|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56473194|NCT02954939|Prednisone|prednisone|mesh-list
56919978|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919979|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56919980|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56919981|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
56919982|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56919983|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919984|NCT03528616|Protective Agents|protective agents|mesh-ancestor
56919985|NCT03528616|Analgesics|analgesics|mesh-ancestor
56919986|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
56919987|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919988|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56919989|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
56919990|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
56919991|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56919992|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56919993|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56919994|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56919995|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56919996|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56919997|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56919998|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56919999|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56920000|NCT02529631|Orlistat|orlistat|mesh-list
56920001|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920002|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920003|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56920004|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56920005|NCT04469062|Mirikizumab|mirikizumab|mesh-list
56473195|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473196|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
56473197|NCT02954939|Hormones|hormones|mesh-ancestor
56473198|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473199|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473200|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56473201|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473202|NCT00519519|Omeprazole|omeprazole|mesh-list
56473203|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56473204|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56473205|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56473206|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473210|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56473211|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56473212|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473213|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920006|NCT04469062|Vedolizumab|vedolizumab|mesh-list
56920007|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56920008|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56920009|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56920010|NCT04469062|Analgesics|analgesics|mesh-ancestor
56182536|NCT01418651|Milnacipran|milnacipran|mesh-list
56473214|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56473215|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
56473216|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473217|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473219|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56473220|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473221|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56473222|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473223|NCT00505739|Mifepristone|mifepristone|mesh-list
56473224|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56473225|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
56473226|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56473227|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473228|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56473229|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56473230|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56473231|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
56473232|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56473233|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56473234|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
56473235|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473236|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
56473237|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56473238|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56473239|NCT02948985|Cetuximab|cetuximab|mesh-list
56473240|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56473241|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473242|NCT04513457|Liver Extracts|liver extracts|mesh-list
56473243|NCT04513457|Hematinics|hematinics|mesh-ancestor
56473244|NCT00519675|Alitretinoin|alitretinoin|mesh-list
56473245|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473246|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
56473247|NCT00521040|Levocetirizine|levocetirizine|mesh-list
56473248|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56473249|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56473250|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
56473251|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
56473252|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473253|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473254|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473255|NCT04513340|Levodopa|levodopa|mesh-list
56473256|NCT04513340|Carbidopa|carbidopa|mesh-list
56473257|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56473258|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56473259|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
56473260|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473261|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473262|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473263|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56473264|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473265|NCT05144945|Vaccines|vaccines|mesh-list
56473266|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
56473267|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473268|NCT04513379|Efavirenz|efavirenz|mesh-list
56473269|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56473270|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56473271|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473272|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473273|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
56473274|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473275|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56920011|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
56920012|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920013|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920014|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920015|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56920016|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56920017|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
56920018|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56920019|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920020|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
56920021|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56920022|NCT03145766|Antibodies|antibodies|mesh-list
56920023|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
56920024|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920025|NCT01115179|Propofol|propofol|mesh-list
56920026|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56473278|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56473279|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56473280|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56473282|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56473283|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56473284|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473285|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
56473286|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473287|NCT00505817|Leuprolide|leuprolide|mesh-list
56473288|NCT00505817|Cetrorelix|cetrorelix|mesh-list
56473289|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56473290|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
56473291|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56473292|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473293|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56473294|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473295|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
56473296|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473297|NCT00521430|Cyclosporine|cyclosporine|mesh-list
56473298|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
56473299|NCT00521430|Methotrexate|methotrexate|mesh-list
56473300|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
56473301|NCT00521430|Fludarabine|fludarabine|mesh-list
56473302|NCT00521430|Busulfan|busulfan|mesh-list
56473303|NCT00521430|Cyclosporins|cyclosporins|mesh-list
56473304|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56473305|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56473306|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
56473307|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56473308|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473309|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56473310|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
56473311|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473312|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473313|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
56473314|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473315|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56473316|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56473317|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
56473318|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56473319|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56473320|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
56473321|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920027|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56920028|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920029|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920030|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56920031|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
56920032|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
56920033|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56920034|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56920035|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56920036|NCT04468438|Estrogens|estrogens|mesh-list
56920037|NCT04468438|Hormones|hormones|mesh-ancestor
56920038|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920039|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920040|NCT04468282|Vigabatrin|vigabatrin|mesh-list
56920041|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
56182564|NCT01418794|Sirolimus|sirolimus|mesh-list
56473322|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56473323|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473324|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
56473325|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
56473326|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473327|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56473328|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
56473329|NCT00521430|Hormones|hormones|mesh-ancestor
56473330|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473331|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56473332|NCT00521430|Protective Agents|protective agents|mesh-ancestor
56473333|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
56473334|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56473335|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56473336|NCT00521274|Docetaxel|docetaxel|mesh-list
56473337|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473338|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
56473339|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
56473340|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
56473341|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473342|NCT05146778|Lidocaine|lidocaine|mesh-list
56473343|NCT05146778|Fentanyl|fentanyl|mesh-list
56473344|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
56473345|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
56473346|NCT05146778|Anesthetics|anesthetics|mesh-list
56473347|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
56473348|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473351|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473353|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56473354|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56473355|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56473356|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473357|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56473358|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56473359|NCT05146778|Analgesics|analgesics|mesh-ancestor
56473360|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56473361|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56473362|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56473363|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
56473364|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473365|NCT05146778|Narcotics|narcotics|mesh-ancestor
56473366|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56473367|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56920042|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920043|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920044|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
56920045|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920046|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920047|NCT01121731|Interferons|interferons|mesh-list
56920048|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
56920049|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920050|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
56182573|NCT01419041|Crizotinib|crizotinib|mesh-list
56473368|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
56473369|NCT05145764|Suvorexant|suvorexant|mesh-list
56473370|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56473371|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56473372|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473373|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473374|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56473375|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473376|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473377|NCT02948283|Metformin|metformin|mesh-list
56473378|NCT02948283|Ritonavir|ritonavir|mesh-list
56473379|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56473380|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473381|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56473382|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56473383|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
56473384|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473385|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473387|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56473388|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
56473389|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473390|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56473391|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56473392|NCT04512872|Denosumab|denosumab|mesh-list
56473393|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56473394|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473395|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56473396|NCT04512638|Amoxicillin|amoxicillin|mesh-list
56473397|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
56473398|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56473399|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473400|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56473401|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
56473402|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
56473403|NCT00523185|Diazepam|diazepam|mesh-list
56473404|NCT00523185|Lorazepam|lorazepam|mesh-list
56473405|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
56473406|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
56473407|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
56473408|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473409|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473410|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56473411|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56473412|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473413|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56473414|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56473415|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56473416|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
56473417|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
56473418|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473419|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473420|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56473421|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56473423|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56473424|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
56473426|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56920051|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920052|NCT01215799|Bafetinib|bafetinib|mesh-list
56920053|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56920054|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473427|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56473428|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56473429|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
56473430|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473431|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473432|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56473433|NCT04693962|Mitogens|mitogens|mesh-list
56473434|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
56473435|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473436|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56473437|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473438|NCT00521703|Lidocaine|lidocaine|mesh-list
56473439|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
56473440|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
56473441|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473442|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473443|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
56473444|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473445|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56473446|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56473447|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56473448|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56473449|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473450|NCT00521742|Pioglitazone|pioglitazone|mesh-list
56473451|NCT00521742|Glyburide|glyburide|mesh-list
56473452|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56473453|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473454|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56473455|NCT00521781|Leuprolide|leuprolide|mesh-list
56473456|NCT00521781|Bicalutamide|bicalutamide|mesh-list
56473457|NCT00521781|Androgens|androgens|mesh-list
56473458|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
56473459|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473460|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56473461|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
56473462|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56473463|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473464|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56473465|NCT00521781|Hormones|hormones|mesh-ancestor
56473466|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473467|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
56473468|NCT00521820|Pioglitazone|pioglitazone|mesh-list
56473469|NCT00521820|Glyburide|glyburide|mesh-list
56473470|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56473471|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473472|NCT00523263|Heparin|heparin|mesh-list
56473473|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
56473474|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56473475|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56473476|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473477|NCT00521859|Fludarabine|fludarabine|mesh-list
56473478|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
56473479|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473480|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56473481|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
56473482|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473483|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56473484|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
56473485|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473486|NCT02954822|Glimepiride|glimepiride|mesh-list
56473487|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56473488|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56473489|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473490|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56473491|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
56473492|NCT00522015|Rivastigmine|rivastigmine|mesh-list
56473493|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56473494|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920055|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920056|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
56920057|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920058|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56920059|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473495|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473503|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56473504|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473505|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56473506|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56473507|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473508|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473509|NCT00523458|Efavirenz|efavirenz|mesh-list
56473510|NCT00523458|Nevirapine|nevirapine|mesh-list
56473511|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56473512|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56473513|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473514|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473515|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
56473516|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473517|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56473518|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56473519|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56473520|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56473521|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56473522|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56473523|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56473524|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56473525|NCT00507065|Amphetamine|amphetamine|mesh-list
56473526|NCT00507065|Adderall|adderall|mesh-list
56473527|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56473528|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473529|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
56473530|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
56473531|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473532|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
56473533|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473534|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473535|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
56473536|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56473537|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56473538|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56473539|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56473540|NCT00522132|Artesunate|artesunate|mesh-list
56473541|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
56473542|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56473543|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56473544|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473545|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473546|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
56473547|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
56473548|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56473549|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
56473550|NCT00522210|Insulin|insulin|mesh-list
56473551|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
56473552|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56473553|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473554|NCT00522249|Interferons|interferons|mesh-list
56473555|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56473556|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
56473557|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56473558|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56473559|NCT00522249|Sunitinib|sunitinib|mesh-list
56473560|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473561|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
56473562|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473563|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56473564|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473582|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
56920060|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920061|NCT03527134|Amantadine|amantadine|mesh-list
56920062|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56920063|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56920064|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
56920065|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920066|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
56920067|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182588|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
56473583|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56473584|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473585|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56473586|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
56473587|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473588|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473589|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
56473590|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473591|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56473592|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56473593|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
56473594|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56473595|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56473596|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56473597|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56473598|NCT00523692|Analgesics|analgesics|mesh-ancestor
56473599|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
56473600|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473601|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473602|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56473603|NCT05148689|Phenylephrine|phenylephrine|mesh-list
56473604|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
56473605|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56473606|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56473607|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
56473608|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473609|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473610|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473611|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
56473612|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
56473613|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473614|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
56473615|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56473616|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
56473617|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56473618|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
56473619|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56473620|NCT05148689|Protective Agents|protective agents|mesh-ancestor
56473623|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
56473624|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473625|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473626|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
56473627|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473628|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56473629|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
56473630|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56473631|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56473632|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473633|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56473634|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
56473635|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56473636|NCT05148143|Raltitrexed|raltitrexed|mesh-list
56473637|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56473638|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
56473639|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473640|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894852|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894853|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
56894854|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894855|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894856|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
56894857|NCT03908619|Esomeprazole|esomeprazole|mesh-list
56894858|NCT03908619|Omeprazole|omeprazole|mesh-list
56894859|NCT03908619|Rabeprazole|rabeprazole|mesh-list
56894860|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56894861|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56894862|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56894863|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894864|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894865|NCT01358734|Lenalidomide|lenalidomide|mesh-list
56894866|NCT01358734|Azacitidine|azacitidine|mesh-list
56894867|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
56894868|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894869|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56894870|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56894871|NCT01358734|Growth Substances|growth substances|mesh-ancestor
56894872|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
56894873|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894874|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56894875|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
56894876|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894877|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894878|NCT03907215|Citalopram|citalopram|mesh-list
56894879|NCT03907215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56894880|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56894881|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56894882|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894883|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894884|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
56894885|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894886|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56894887|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
56894888|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56894889|NCT05335954|Norepinephrine|norepinephrine|mesh-list
56894890|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56894891|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56894892|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
56894893|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56894894|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894895|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894896|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
56894897|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
56894898|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894899|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56894900|NCT01250457|Timolol|timolol|mesh-list
56894901|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56894902|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56894903|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
56894904|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605637|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56894905|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894907|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56894908|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56894909|NCT03902925|Lidocaine|lidocaine|mesh-list
56894910|NCT03902925|Ropivacaine|ropivacaine|mesh-list
56894911|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
56894912|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
56894913|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894914|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894915|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
56894916|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894917|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56894918|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56894919|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56894920|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56920071|NCT03527134|Analgesics|analgesics|mesh-ancestor
56894921|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894922|NCT01250535|Warfarin|warfarin|mesh-list
56894923|NCT01250535|Lovastatin|lovastatin|mesh-list
56894924|NCT01250535|L 647318|l 647318|mesh-list
56894925|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
56894926|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
56894927|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56894928|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56894929|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
56894930|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894931|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56894932|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56894933|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894934|NCT02527941|Metronidazole|metronidazole|mesh-list
56894935|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894936|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56894937|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56894938|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56894939|NCT03906669|Tamoxifen|tamoxifen|mesh-list
56894940|NCT03906669|Letrozole|letrozole|mesh-list
56894941|NCT03906669|Progesterone|progesterone|mesh-list
56894942|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894943|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56894944|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56894945|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894946|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894947|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56894948|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
56894949|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56894950|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894951|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56894952|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56894953|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56894954|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56894955|NCT03906669|Progestins|progestins|mesh-ancestor
56894956|NCT03906669|Hormones|hormones|mesh-ancestor
56894957|NCT01254825|Ropivacaine|ropivacaine|mesh-list
56894958|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
56894959|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
56894960|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56894961|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894962|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
56894963|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56894964|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
56894965|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56894966|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56894967|NCT03906123|Protective Agents|protective agents|mesh-ancestor
56920074|NCT01213693|Fluticasone|fluticasone|mesh-list
56894968|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894969|NCT01341652|Molgramostim|molgramostim|mesh-list
56894970|NCT01341652|Sargramostim|sargramostim|mesh-list
56894971|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
56894972|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894973|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894974|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
56894975|NCT03563794|Vildagliptin|vildagliptin|mesh-list
56894976|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56894977|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56894978|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56894979|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
56894980|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894981|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894983|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56894984|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56894985|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894986|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894987|NCT03563950|Rifampin|rifampin|mesh-list
56894988|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56894989|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
56894990|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56894991|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56894992|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
56894993|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56894994|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56894995|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56894996|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56894997|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56894998|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56894999|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56895000|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56895001|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56895002|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
56895003|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56895004|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895005|NCT03914235|Lidocaine|lidocaine|mesh-list
56895006|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
56895007|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
56895008|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895009|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895010|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
56895011|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895012|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56895013|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56895014|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56895015|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56895016|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895017|NCT01148667|Caseins|caseins|mesh-list
56895018|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
56895019|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
56895020|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895021|NCT01254123|Exenatide|exenatide|mesh-list
56895022|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56920099|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
56895023|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895024|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56895026|NCT01254123|Hormones|hormones|mesh-ancestor
56895027|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56895028|NCT03898635|Linezolid|linezolid|mesh-list
56895029|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56895030|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895031|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56895032|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895033|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895034|NCT05116917|Nivolumab|nivolumab|mesh-list
56895035|NCT05116917|Ipilimumab|ipilimumab|mesh-list
56895036|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56895037|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895038|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56895039|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895040|NCT02528019|Glimepiride|glimepiride|mesh-list
56895041|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56895042|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56895043|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56895044|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895045|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895046|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
56895047|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895048|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
56895049|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56895050|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
56895051|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605789|NCT02567383|Docetaxel|docetaxel|mesh-list
56895052|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895053|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56895054|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
56895055|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56895056|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
56895057|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895058|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895059|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56895060|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
56895061|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
56895062|NCT01255215|Protective Agents|protective agents|mesh-ancestor
56895063|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
56895064|NCT02527785|Irinotecan|irinotecan|mesh-list
56895065|NCT02527785|Tegafur|tegafur|mesh-list
56895066|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895067|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56895068|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56895069|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895070|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895071|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56895072|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
56895073|NCT02527863|Tolvaptan|tolvaptan|mesh-list
56895074|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56895075|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895076|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
56895077|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895078|NCT01256541|Lactulose|lactulose|mesh-list
56895079|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56895080|NCT03904719|Vorolanib|vorolanib|mesh-list
56895081|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56895082|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895083|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895084|NCT01148901|Infliximab|infliximab|mesh-list
56895085|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56895086|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56895087|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895088|NCT01150617|Insulin|insulin|mesh-list
56895089|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56895090|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
56895091|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56895092|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
56895093|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895094|NCT01256619|Desogestrel|desogestrel|mesh-list
56895095|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56895096|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56895097|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56895098|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
56895099|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56895100|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895101|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56895102|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56895103|NCT01256619|Progestins|progestins|mesh-ancestor
56895104|NCT01256619|Hormones|hormones|mesh-ancestor
56895105|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56895106|NCT03898011|Lamotrigine|lamotrigine|mesh-list
56895107|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
56895108|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56895109|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56895110|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895111|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56895112|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895113|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56895114|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56895115|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895116|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56920229|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
56895117|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56895118|NCT01254513|Prednisone|prednisone|mesh-list
56895119|NCT01254513|Docetaxel|docetaxel|mesh-list
56895120|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895121|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
56895122|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
56895123|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
56895124|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895125|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56895126|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
56895127|NCT01254513|Hormones|hormones|mesh-ancestor
56895128|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56895129|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895130|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56895131|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56895132|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56895133|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895134|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
56895135|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
56895136|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56895137|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
56895138|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895139|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895140|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56895141|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895142|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56895143|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
56895144|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56895145|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895146|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895147|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895148|NCT01255371|Lopinavir|lopinavir|mesh-list
56895149|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56895150|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56895151|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56895152|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
56895153|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895154|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895155|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56895156|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56895157|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
56895158|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895159|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56895160|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56895161|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
56895162|NCT03903783|Cefotaxime|cefotaxime|mesh-list
56895163|NCT03903783|Cefoxitin|cefoxitin|mesh-list
56895164|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56895165|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895166|NCT03899337|Prednisolone|prednisolone|mesh-list
56895167|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
56895168|NCT03899337|Rituximab|rituximab|mesh-list
56895169|NCT03899337|Doxorubicin|doxorubicin|mesh-list
56895170|NCT03899337|Vincristine|vincristine|mesh-list
56895171|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
56895172|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895173|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
56895174|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895175|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895176|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56895177|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
56895178|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895179|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895180|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56895181|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56895182|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56895183|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56895184|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56895185|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895186|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56895187|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
56895188|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
56895189|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
56895190|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56895191|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
56895192|NCT03899337|Hormones|hormones|mesh-ancestor
56895193|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56895194|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56895195|NCT01586169|Azithromycin|azithromycin|mesh-list
56895196|NCT01586169|Ivermectin|ivermectin|mesh-list
56895197|NCT01586169|Albendazole|albendazole|mesh-list
56895198|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56895199|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895200|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56895201|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
56895202|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
56895203|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56895204|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56895205|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
56895206|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
56895207|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
56895208|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895209|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895210|NCT01256775|Aspirin|aspirin|mesh-list
56895211|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
56895212|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56895213|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56895214|NCT01256775|Analgesics|analgesics|mesh-ancestor
56895215|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
56895216|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895217|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895218|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56895219|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895220|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56895221|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56895222|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895223|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56895224|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56895225|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
56895226|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895227|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56895228|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
56895229|NCT03899571|Oseltamivir|oseltamivir|mesh-list
56895230|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
56895231|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895232|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895233|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895234|NCT01257009|Atorvastatin|atorvastatin|mesh-list
56895235|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56895236|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56895237|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
56895238|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895239|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56895240|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56895241|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895242|NCT01255527|Bortezomib|bortezomib|mesh-list
56895243|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895244|NCT01151787|Amitriptyline|amitriptyline|mesh-list
56895245|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
56895246|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56895247|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
56895248|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56895249|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56895250|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895251|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56895252|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895253|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56895254|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895255|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56895256|NCT01151787|Analgesics|analgesics|mesh-ancestor
56895257|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
56895258|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56895259|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56895260|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56895261|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895262|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
56895263|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895264|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
56895265|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56895266|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895267|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895268|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56895269|NCT01151865|Analgesics|analgesics|mesh-ancestor
56895270|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
56895271|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895272|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56895273|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56895274|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56895275|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
56606010|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
56895276|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920289|NCT03935815|Ropivacaine|ropivacaine|mesh-list
56895277|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895278|NCT03893097|Artesunate|artesunate|mesh-list
56895279|NCT03893097|Mefloquine|mefloquine|mesh-list
56895280|NCT03893097|Praziquantel|praziquantel|mesh-list
56895281|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
56895282|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56895283|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56895284|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895285|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895286|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
56895287|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
56895288|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56895289|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
56895290|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
56895291|NCT01258491|Niacin|niacin|mesh-list
56895292|NCT01258491|Niacinamide|niacinamide|mesh-list
56895293|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
56895294|NCT01258491|Vitamins|vitamins|mesh-ancestor
56895295|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
56895296|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895297|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56895298|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
56895299|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895300|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56895301|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
56895302|NCT01257165|Ethanol|ethanol|mesh-list
56895303|NCT01257165|Zopiclone|zopiclone|mesh-list
56895304|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56895305|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895306|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895307|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895308|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56895309|NCT01151943|Anesthetics|anesthetics|mesh-list
56895310|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
56895311|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895312|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895313|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
56895314|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895315|NCT01256151|Alprazolam|alprazolam|mesh-list
56895316|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56895317|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157606|NCT02369406|Lamivudine|lamivudine|mesh-list
56895318|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895319|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56895320|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56895321|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56895322|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
56895323|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
56895324|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895325|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895326|NCT01259973|Haloperidol|haloperidol|mesh-list
56895327|NCT01259973|Risperidone|risperidone|mesh-list
56895328|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
56895329|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56895330|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
56895331|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895332|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895333|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895334|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56895335|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56895336|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895337|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56895338|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56895339|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
56895340|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
56895341|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
56895342|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895343|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56895344|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56895345|NCT01257243|Potassium iodate|potassium iodate|mesh-list
56895346|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
56895347|NCT01257243|Guaifenesin|guaifenesin|mesh-list
56895348|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56895349|NCT01257243|Expectorants|expectorants|mesh-ancestor
56895350|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
56895351|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56895352|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56895353|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
56895354|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895355|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895356|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895357|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
56895358|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56895359|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
56895360|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
56895361|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895362|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
56895363|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56895364|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
56895365|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895366|NCT01258569|Alvimopan|alvimopan|mesh-list
56895367|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56895368|NCT01257399|Mesalamine|mesalamine|mesh-list
56895369|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56895370|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56895371|NCT01257399|Analgesics|analgesics|mesh-ancestor
56895372|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
56895373|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895374|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895375|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56895376|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895377|NCT01258959|Anesthetics|anesthetics|mesh-list
56895378|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
56920319|NCT04902040|Durvalumab|durvalumab|mesh-list
56920320|NCT04902040|Avelumab|avelumab|mesh-list
56920321|NCT04902040|Atezolizumab|atezolizumab|mesh-list
56920322|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
56895379|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895380|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895381|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
56895382|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895383|NCT01153659|Esomeprazole|esomeprazole|mesh-list
56895384|NCT01153659|Rabeprazole|rabeprazole|mesh-list
56895385|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56895386|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56895387|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56895388|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895389|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895390|NCT01260129|Silodosin|silodosin|mesh-list
56895391|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56568876|NCT02684812|Coagulants|coagulants|mesh-ancestor
56895392|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56895393|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56895394|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
56895395|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895396|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895397|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895398|NCT01260129|Urological Agents|urological agents|mesh-ancestor
56895399|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56895400|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
56895401|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56895402|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56895403|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895404|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895405|NCT01260285|Urological Agents|urological agents|mesh-ancestor
56895406|NCT03888729|Velpatasvir|velpatasvir|mesh-list
56895407|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
56895408|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895409|NCT01151241|Anesthetics|anesthetics|mesh-list
56895410|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
56895411|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895412|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895413|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
56895414|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895415|NCT02949362|Teduglutide|teduglutide|mesh-list
56895416|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56895417|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56895418|NCT02949362|Protective Agents|protective agents|mesh-ancestor
56895419|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895420|NCT03896217|Simvastatin|simvastatin|mesh-list
56895421|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56895422|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56895423|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
56895424|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895425|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56895426|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56895427|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895428|NCT05220410|Psilocybin|psilocybin|mesh-list
56895430|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895431|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56895432|NCT03892161|Ritonavir|ritonavir|mesh-list
56895433|NCT03892161|Darunavir|darunavir|mesh-list
56895434|NCT03892161|Rifampin|rifampin|mesh-list
56895435|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56895436|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56895437|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
56895438|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895439|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895440|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56895441|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56895442|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
56895443|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895444|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56895445|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56895446|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56895447|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
56895448|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56895449|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
56895450|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56895451|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56895452|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56895453|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56895454|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56895455|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56895456|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56895457|NCT01154361|Cortisone|cortisone|mesh-list
56895458|NCT01154361|Icatibant|icatibant|mesh-list
56895459|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56895460|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56895461|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56895462|NCT01154361|Analgesics|analgesics|mesh-ancestor
56895463|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
56895464|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895465|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895466|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895467|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56895468|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56895469|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895470|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56895471|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895472|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
56895473|NCT01260519|Heparin|heparin|mesh-list
56895474|NCT01260519|Calcium heparin|calcium heparin|mesh-list
56895475|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
56895476|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56895477|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56895478|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895479|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
56895480|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56895481|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56895482|NCT03891615|Niraparib|niraparib|mesh-list
56895483|NCT03891615|Osimertinib|osimertinib|mesh-list
56895484|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56895485|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895486|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895487|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895488|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56895489|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
56895490|NCT02947022|Zinc|zinc|mesh-list
56895491|NCT02947022|Edetic Acid|edetic acid|mesh-list
56895492|NCT02947022|Calcium|calcium|mesh-list
56895493|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
56895494|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56895495|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895496|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56895497|NCT02947022|Trace Elements|trace elements|mesh-ancestor
56895498|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
56895499|NCT02947022|Antidotes|antidotes|mesh-ancestor
56895500|NCT02947022|Protective Agents|protective agents|mesh-ancestor
56895501|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
56606234|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
56895502|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
56895503|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895504|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56895505|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
56895506|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56895507|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
56895509|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895510|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56895511|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895512|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895513|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56895514|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895515|NCT05182892|Dopamine|dopamine|mesh-list
56895516|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
56895517|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56895518|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
56895519|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
56895520|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895521|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895522|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
56895523|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895524|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895525|NCT05182892|Protective Agents|protective agents|mesh-ancestor
56895526|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
56895527|NCT01312376|Bevacizumab|bevacizumab|mesh-list
56895528|NCT01312376|Fludarabine|fludarabine|mesh-list
56895529|NCT01312376|Vaccines|vaccines|mesh-list
56895530|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
56895531|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895532|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895533|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895534|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56895535|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
56895536|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895537|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895538|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56895539|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56895540|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56895541|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56895542|NCT01312376|Growth Substances|growth substances|mesh-ancestor
56895543|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
56895544|NCT01260675|Buprenorphine|buprenorphine|mesh-list
56895545|NCT01260675|Naloxone|naloxone|mesh-list
56895546|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56895547|NCT01260675|Narcotics|narcotics|mesh-ancestor
56895548|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895549|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895550|NCT01260675|Analgesics|analgesics|mesh-ancestor
56895551|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
56895552|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895553|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56895554|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
56895555|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56895556|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895557|NCT03887871|Tamsulosin|tamsulosin|mesh-list
56895558|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56895559|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56895560|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56895561|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
56895562|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895563|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895564|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895565|NCT03887871|Urological Agents|urological agents|mesh-ancestor
56895566|NCT03708146|Zamicastat|zamicastat|mesh-list
56895567|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895568|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895569|NCT01260753|Fluticasone|fluticasone|mesh-list
56895571|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56895572|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56895573|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
56895574|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895575|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895576|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56895577|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
56895578|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
56895579|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56895580|NCT03895671|Azacitidine|azacitidine|mesh-list
56895581|NCT03895671|Ponatinib|ponatinib|mesh-list
56895582|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56895583|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
56895584|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895585|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895586|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895587|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56895588|NCT01152723|Nicotine|nicotine|mesh-list
56895589|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56895590|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
56895591|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895592|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895593|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56895594|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56895595|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
56895596|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895597|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895598|NCT01261065|Carvedilol|carvedilol|mesh-list
56895599|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56895600|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56895601|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
56895602|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895603|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895604|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895605|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56895606|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
56895607|NCT01261065|Protective Agents|protective agents|mesh-ancestor
56895608|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56895609|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56895610|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56895611|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
56568889|NCT01004250|Bevacizumab|bevacizumab|mesh-list
56895612|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56895613|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56895614|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
56895615|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
56895616|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56569112|NCT00641680|Xhance|xhance|mesh-list
56895617|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569183|NCT01160822|Analgesics|analgesics|mesh-ancestor
56895618|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895621|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895622|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895623|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
56895624|NCT03338972|Fludarabine|fludarabine|mesh-list
56895625|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895626|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
56569782|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895627|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895628|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895629|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56895630|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
56570076|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895631|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895632|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895633|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56895634|NCT01151397|Vitamin D|vitamin d|mesh-list
56895635|NCT01151397|Ribavirin|ribavirin|mesh-list
56895636|NCT01151397|Vitamins|vitamins|mesh-ancestor
56895637|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
56895638|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895639|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56895640|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
56895641|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895642|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
56895643|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895644|NCT01152801|Everolimus|everolimus|mesh-list
56895645|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895646|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895647|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
56895648|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895649|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
56895650|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
56895651|NCT03887169|Vitamins|vitamins|mesh-ancestor
56895652|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
56895653|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895654|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
56895656|NCT03886779|Nepafenac|nepafenac|mesh-list
56895657|NCT03886779|Bromfenac|bromfenac|mesh-list
56895658|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56895659|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56895660|NCT03886779|Analgesics|analgesics|mesh-ancestor
56895661|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
56895662|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895663|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895664|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56895665|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895667|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
56895668|NCT01261299|Carboplatin|carboplatin|mesh-list
56895669|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895670|NCT01154829|Aripiprazole|aripiprazole|mesh-list
56895671|NCT01154829|Amisulpride|amisulpride|mesh-list
56895672|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
56895673|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56895674|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56895675|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56895676|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895677|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895678|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
56895679|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
56895680|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895681|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895682|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56895683|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56895684|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
56895685|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56895686|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56920398|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895687|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56895688|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56895689|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56895690|NCT01153191|Gentamicins|gentamicins|mesh-list
56895691|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56570267|NCT04292418|Tacrolimus|tacrolimus|mesh-list
56895692|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570388|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
56895693|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56895694|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895695|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895696|NCT01259817|Aspirin|aspirin|mesh-list
56895697|NCT01259817|Interferons|interferons|mesh-list
56570479|NCT00648622|Carvedilol|carvedilol|mesh-list
56895698|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
56570553|NCT04171180|Budesonide|budesonide|mesh-list
56895700|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56895701|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570750|NCT02662426|Oseltamivir|oseltamivir|mesh-list
56895702|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
56895703|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895704|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56895705|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56570835|NCT02658838|Heparin|heparin|mesh-list
56895708|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895709|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895710|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56895711|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895712|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56895713|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56895714|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895715|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56895716|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56895717|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895718|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
56895719|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
56895720|NCT01261689|Sufentanil|sufentanil|mesh-list
56895722|NCT01261689|Ropivacaine|ropivacaine|mesh-list
56895723|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
56895724|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
56571185|NCT00700687|Aspirin|aspirin|mesh-list
56571248|NCT00707083|Hormones|hormones|mesh-ancestor
56895725|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571343|NCT02536690|Midazolam|midazolam|mesh-list
56895726|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895727|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
56571396|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
56895728|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895729|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56895730|NCT01261689|Narcotics|narcotics|mesh-ancestor
56895731|NCT01261689|Analgesics|analgesics|mesh-ancestor
56895732|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56895733|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56895734|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
56895735|NCT01154907|Praziquantel|praziquantel|mesh-list
56571616|NCT02657512|Antidotes|antidotes|mesh-ancestor
56895736|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
56920418|NCT01217359|Interferons|interferons|mesh-list
56895737|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56895738|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895739|NCT01261923|Alitretinoin|alitretinoin|mesh-list
56895740|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895741|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
56895742|NCT01157247|Fentanyl|fentanyl|mesh-list
56895743|NCT01157247|Anesthetics|anesthetics|mesh-list
56895745|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56572205|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
56895747|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895748|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895749|NCT01157247|Analgesics|analgesics|mesh-ancestor
56895750|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
56895751|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895752|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56895753|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56895754|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
56895755|NCT03881787|Cetuximab|cetuximab|mesh-list
56895756|NCT03881787|Antibodies|antibodies|mesh-list
56895757|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56895758|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
56895759|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895760|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56895761|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895762|NCT01157481|Nifedipine|nifedipine|mesh-list
56572861|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
56895763|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56572943|NCT00814333|Thrombin|thrombin|mesh-list
56573013|NCT01133756|Gemcitabine|gemcitabine|mesh-list
56895764|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56895765|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573088|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895766|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56895767|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895768|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
56895769|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
56895770|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56895771|NCT03894189|Theophylline|theophylline|mesh-list
56895773|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56895774|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
56895775|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895776|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573601|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
56895778|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
56895779|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56895780|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895781|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895782|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
56573901|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56573976|NCT03870438|Lamivudine|lamivudine|mesh-list
56895783|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56895784|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56574120|NCT03762564|Paclitaxel|paclitaxel|mesh-list
56895785|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
56895786|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895787|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56895788|NCT03886311|Nivolumab|nivolumab|mesh-list
56574273|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
56895789|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56895790|NCT03886311|Trabectedin|trabectedin|mesh-list
56574342|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56895791|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56895792|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895793|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56895794|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895795|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56895797|NCT01155453|Trametinib|trametinib|mesh-list
56895798|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574706|NCT05620784|Natriuretic Agents|natriuretic agents|mesh-ancestor
56574781|NCT05567068|Mesalamine|mesalamine|mesh-list
56574855|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895799|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56895800|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895801|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895802|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56895803|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
56895804|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895805|NCT03885219|Paclitaxel|paclitaxel|mesh-list
56895806|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56895807|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895808|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
56895809|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
56895810|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
56895811|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895812|NCT01157559|Ziprasidone|ziprasidone|mesh-list
56895813|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56895814|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
56895815|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895816|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895817|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895818|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56895819|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56895820|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895821|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56895822|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56895823|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
56895824|NCT01263951|Everolimus|everolimus|mesh-list
56895825|NCT01263951|Sorafenib|sorafenib|mesh-list
56895826|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895827|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895828|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
56895829|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895830|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56895831|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895832|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895833|NCT01265433|Molgramostim|molgramostim|mesh-list
56895834|NCT01265433|Sargramostim|sargramostim|mesh-list
56895835|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56895836|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
56895837|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895838|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895839|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56895840|NCT01265589|Vitamin A|vitamin a|mesh-list
56575056|NCT05188677|Vaccines|vaccines|mesh-list
56895841|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56895842|NCT01265589|Vitamins|vitamins|mesh-ancestor
56895843|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
56895844|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895845|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
56895846|NCT01159587|Factor VIII|factor viii|mesh-list
56895847|NCT01159587|Coagulants|coagulants|mesh-ancestor
56895848|NCT03885297|Liraglutide|liraglutide|mesh-list
56895849|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56895850|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895851|NCT03885297|Incretins|incretins|mesh-ancestor
56895852|NCT03885297|Hormones|hormones|mesh-ancestor
56895853|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56895854|NCT01159821|Paroxetine|paroxetine|mesh-list
56575114|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
56575117|NCT05142696|Etoposide|etoposide|mesh-list
56895855|NCT01159821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56895856|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56895857|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56895858|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895859|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895860|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
56895861|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895862|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56895863|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
56895864|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56895865|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56895866|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56895867|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895868|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
56895869|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
56895870|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56895871|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895872|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56895874|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56895875|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56895876|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895877|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895878|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56895879|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
56895880|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
56895881|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606617|NCT00953576|Lapatinib|lapatinib|mesh-list
56895882|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895883|NCT03879057|Antibodies|antibodies|mesh-list
56895884|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56895885|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
56895886|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895887|NCT01266057|Sirolimus|sirolimus|mesh-list
56895888|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
56895889|NCT01266057|Vorinostat|vorinostat|mesh-list
56895890|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56895891|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895892|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56895893|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895894|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
56895895|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895896|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
56895897|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895898|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
56895899|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56895900|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56895901|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895902|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895903|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895904|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56895905|NCT01266213|Fulvestrant|fulvestrant|mesh-list
56895906|NCT01266213|Anastrozole|anastrozole|mesh-list
56895907|NCT01266213|Goserelin|goserelin|mesh-list
56895908|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56895909|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895910|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56895911|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56895912|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
56904631|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575412|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904632|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56904633|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
56904634|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
56575564|NCT04055428|Valsartan|valsartan|mesh-list
56575565|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56575566|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56904635|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904636|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904637|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895913|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56895914|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895915|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56576087|NCT02081378|Vitamins|vitamins|mesh-ancestor
56904638|NCT02091388|Risperidone|risperidone|mesh-list
56576306|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895916|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56895917|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576454|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
56895918|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895919|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
56895920|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56895921|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56895922|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
56895923|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895924|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895925|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895926|NCT01262391|Urological Agents|urological agents|mesh-ancestor
56895927|NCT03880695|Doxorubicin|doxorubicin|mesh-list
56895928|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56576885|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56895929|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56576964|NCT03854019|Quinidine|quinidine|mesh-list
56895930|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895931|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56895932|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56577253|NCT04282200|Analgesics|analgesics|mesh-ancestor
56895933|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895934|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895936|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56895937|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56895938|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56577548|NCT02554812|Avelumab|avelumab|mesh-list
56895939|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56895940|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56895941|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
56895942|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895943|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895944|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895945|NCT01264341|Sirolimus|sirolimus|mesh-list
56895946|NCT01264341|Bevacizumab|bevacizumab|mesh-list
56895947|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56895948|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895949|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56577624|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
56895950|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56895951|NCT01264341|Growth Substances|growth substances|mesh-ancestor
56895952|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895953|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
56895954|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56895955|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56895956|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56895957|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
56895958|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895959|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
56895961|NCT01264497|Growth Substances|growth substances|mesh-ancestor
56895962|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895963|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
56895964|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
56895965|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895966|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56895967|NCT01262469|Capecitabine|capecitabine|mesh-list
56895968|NCT01262469|Lapatinib|lapatinib|mesh-list
56895969|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56895970|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
56895971|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895973|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56895974|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895975|NCT01155921|Risperidone|risperidone|mesh-list
56895976|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56895977|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
56895978|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56895979|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895980|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56895981|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56895982|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56895983|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56895984|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56895985|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56895986|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
56895987|NCT03884127|Orlistat|orlistat|mesh-list
56578021|NCT05519241|Paclitaxel|paclitaxel|mesh-list
56895988|NCT03884127|Ezetimibe|ezetimibe|mesh-list
56895989|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56895990|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56895991|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
56895992|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56895993|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56895994|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56895995|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56895996|NCT01158105|Bortezomib|bortezomib|mesh-list
56578236|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
56895997|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56895998|NCT03337490|Ivermectin|ivermectin|mesh-list
56895999|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56896000|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896001|NCT01158183|Interferons|interferons|mesh-list
56896002|NCT01158183|Interferon-beta|interferon-beta|mesh-list
56896003|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
56896004|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896005|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
56896006|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896007|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
56896008|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896009|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56896010|NCT01264575|Epinephrine|epinephrine|mesh-list
56896011|NCT01264575|Racepinephrine|racepinephrine|mesh-list
56896012|NCT01264575|Bupivacaine|bupivacaine|mesh-list
56896013|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
56896014|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
56896015|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
56896016|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896017|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896018|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
56896019|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896020|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56896021|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56896022|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896023|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896024|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896025|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56896026|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56896027|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
56896028|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56896029|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
56896030|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
56896031|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
56896032|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56896033|NCT04992260|Vaccines|vaccines|mesh-list
56896034|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
56896035|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896036|NCT01266681|Amiodarone|amiodarone|mesh-list
56896037|NCT01266681|Dronedarone|dronedarone|mesh-list
56896038|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56896039|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
56896040|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56896041|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56896042|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896043|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56896044|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56896045|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56896046|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896047|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56896048|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56896049|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56896050|NCT03638648|Capecitabine|capecitabine|mesh-list
56896051|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56896052|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
56579087|NCT03198741|Clopidogrel|clopidogrel|mesh-list
56896053|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579163|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
56896054|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896055|NCT01266759|NuvaRing|nuvaring|mesh-list
56896056|NCT01266759|Norethindrone|norethindrone|mesh-list
56579375|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
56896058|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56896059|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
56896060|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56896061|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896062|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56896063|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56896064|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56579449|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
56896065|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56896066|NCT03512223|Dexamethasone|dexamethasone|mesh-list
56896067|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896068|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
56896069|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
56896070|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579661|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
56896071|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896072|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56896073|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
56896074|NCT03512223|Hormones|hormones|mesh-ancestor
56904639|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56896075|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56896076|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56896077|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896078|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
56896079|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
56896080|NCT03878667|Calcium|calcium|mesh-list
56904640|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
56896081|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56896082|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896083|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56896084|NCT03878667|Antacids|antacids|mesh-ancestor
56896085|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896086|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56896087|NCT01264653|Epinephrine|epinephrine|mesh-list
56896088|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56896089|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56896090|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896091|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896092|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896093|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580548|NCT00938886|Naltrexone|naltrexone|mesh-list
56896094|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56896095|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56896096|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
56580762|NCT00685672|Epinephrine|epinephrine|mesh-list
56580831|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56896097|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896098|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56896099|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
56896100|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
56896101|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
56581057|NCT00935532|Insulin|insulin|mesh-list
56896102|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56896103|NCT01266837|Everolimus|everolimus|mesh-list
56896104|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581200|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56581276|NCT00604032|Tretinoin|tretinoin|mesh-list
56896105|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56896106|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
56896107|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896108|NCT01264731|Imiquimod|imiquimod|mesh-list
56896109|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56896110|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
56896111|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896112|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581575|NCT02624440|Clarithromycin|clarithromycin|mesh-list
56896113|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
56581655|NCT00674596|Ramipril|ramipril|mesh-list
56581723|NCT04265274|Copper|copper|mesh-list
56896114|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56581961|NCT05158374|Aspirin|aspirin|mesh-list
56896116|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896117|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896118|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
56896119|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904641|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896120|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896121|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56896122|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56896123|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56896124|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896125|NCT03879837|Fluticasone|fluticasone|mesh-list
56896126|NCT03879837|Xhance|xhance|mesh-list
56582456|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
56896127|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896128|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56896129|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
56920518|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
56896130|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896131|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896132|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56896133|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
56896134|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
56896135|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56896136|NCT05308628|Complement C3|complement c3|mesh-list
56896137|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
56896138|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896139|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
56896140|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56896141|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896142|NCT01158729|Antithrombins|antithrombins|mesh-list
56896143|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
56896144|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56896145|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
56896146|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896147|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896148|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
56896149|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56896150|NCT05303324|Choline|choline|mesh-list
56896151|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
56896152|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56896153|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
56896154|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896155|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56896156|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56896157|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
56896158|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
56896159|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
56896160|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896162|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56896163|NCT05303324|Growth Substances|growth substances|mesh-ancestor
56896164|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896165|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
56896166|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583686|NCT02617654|Hormones|hormones|mesh-ancestor
56896167|NCT01262859|Bevacizumab|bevacizumab|mesh-list
56583760|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
56896168|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56896169|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896170|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56896171|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56896172|NCT01262859|Growth Substances|growth substances|mesh-ancestor
56896173|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896174|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
56896175|NCT02527083|Ketamine|ketamine|mesh-list
56896176|NCT02527083|Remifentanil|remifentanil|mesh-list
56896177|NCT02527083|Propofol|propofol|mesh-list
56896178|NCT02527083|Sevoflurane|sevoflurane|mesh-list
56920523|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
56920524|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920525|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56920526|NCT01120561|Trastuzumab|trastuzumab|mesh-list
56920527|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56920528|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920529|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920530|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
56920531|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
56920532|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
56920533|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183007|NCT01422018|Bevacizumab|bevacizumab|mesh-list
56896179|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583841|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
56896180|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606905|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56583902|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
56896181|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896182|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56896183|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
56896184|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
56896185|NCT02527083|Analgesics|analgesics|mesh-ancestor
56896186|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
56584044|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896187|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584123|NCT00928668|Olodaterol|olodaterol|mesh-list
56896188|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56896189|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56584264|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
56896190|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56896191|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584407|NCT05608837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896192|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896193|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56584503|NCT02835729|Cytarabine|cytarabine|mesh-list
56896194|NCT02527083|Narcotics|narcotics|mesh-ancestor
56584552|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56896195|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56896196|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56896197|NCT05156684|Zinc|zinc|mesh-list
56896198|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
56896199|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
56896200|NCT05156684|Trace Elements|trace elements|mesh-ancestor
56896201|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
56896202|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896203|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56896204|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584771|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896205|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896206|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56896207|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56896209|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
56896210|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56896211|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
56896212|NCT05156684|Astringents|astringents|mesh-ancestor
56896213|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
56896214|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
56896215|NCT03883347|Remifentanil|remifentanil|mesh-list
56896216|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56896217|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896218|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896219|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896220|NCT03883347|Analgesics|analgesics|mesh-ancestor
56896221|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
56896222|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896223|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56920553|NCT03936517|Prednisolone|prednisolone|mesh-list
56920554|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
56920555|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920556|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
56920557|NCT03936517|Hormones|hormones|mesh-ancestor
56896224|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56896225|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56896226|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896227|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896228|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896229|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56896230|NCT03883347|Narcotics|narcotics|mesh-ancestor
56896232|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56896233|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56896234|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
56896235|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896236|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896237|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56896238|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56896239|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
56896240|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896241|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56896242|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56896243|NCT01159353|Insulin|insulin|mesh-list
56896244|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56896246|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
56896247|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56896248|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896249|NCT02943668|Deferasirox|deferasirox|mesh-list
56896250|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56896251|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
56896252|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
56896253|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896254|NCT01265199|Cytarabine|cytarabine|mesh-list
56896255|NCT01265199|Daunorubicin|daunorubicin|mesh-list
56896256|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56896257|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
56896258|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896259|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896260|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
56896261|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896262|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56896263|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
56896264|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896265|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56896266|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56585006|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896267|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56896268|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896270|NCT01263171|Fluorouracil|fluorouracil|mesh-list
56896271|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
56896273|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
56585304|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
56585377|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585452|NCT05251662|Bevacizumab|bevacizumab|mesh-list
56896274|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56896275|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896276|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
56896277|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896278|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56896279|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896280|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56896281|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
56896282|NCT01263171|Antidotes|antidotes|mesh-ancestor
56896283|NCT01263171|Protective Agents|protective agents|mesh-ancestor
56896284|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
56896285|NCT01263171|Vitamins|vitamins|mesh-ancestor
56896286|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
56896287|NCT01156233|Anesthetics|anesthetics|mesh-list
56585741|NCT00632268|Leucovorin|leucovorin|mesh-list
56896288|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896289|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896290|NCT03883269|Ethanol|ethanol|mesh-list
56585963|NCT00888615|Paclitaxel|paclitaxel|mesh-list
56896291|NCT03883269|Clindamycin|clindamycin|mesh-list
56896292|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
56896293|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
56896294|NCT03883269|Erythromycin|erythromycin|mesh-list
56586108|NCT02612272|Ketorolac|ketorolac|mesh-list
56896295|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
56896296|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56896297|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
56896298|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56896300|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896301|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896302|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56896303|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56586342|NCT02822937|Triazolam|triazolam|mesh-list
56896304|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896305|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896306|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56896307|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
56896308|NCT01267305|PENTA|penta|mesh-list
56896309|NCT01267305|Nadroparin|nadroparin|mesh-list
56896310|NCT01267305|Fondaparinux|fondaparinux|mesh-list
56896311|NCT01267305|Calcium|calcium|mesh-list
56896312|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56896313|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896314|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56896315|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56896316|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
56896317|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56896318|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
56896319|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896320|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896321|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
56896322|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56896323|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56896324|NCT02891408|Fenofibrate|fenofibrate|mesh-list
56896325|NCT02891408|Firsocostat|firsocostat|mesh-list
56896326|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56896327|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
56896328|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896329|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56896330|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896331|NCT01160991|Olanzapine|olanzapine|mesh-list
56896332|NCT01160991|Amisulpride|amisulpride|mesh-list
56896333|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
56896334|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
56896335|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896336|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896337|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56896339|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56896340|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896341|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896342|NCT01160991|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56896343|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56920576|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56896344|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56896345|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896346|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896347|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
56896348|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56896349|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
56896350|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56896351|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
56896352|NCT05498480|Nivolumab|nivolumab|mesh-list
56896353|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56896354|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896355|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56586795|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
56896356|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904642|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586939|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
56896357|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
56896358|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56896359|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56896360|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587175|NCT02800785|Cefuroxime|cefuroxime|mesh-list
56896361|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896363|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56896364|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896365|NCT01161147|Analgesics|analgesics|mesh-ancestor
56896366|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
56896367|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896368|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896369|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896370|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56896371|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56896372|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56896373|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896374|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896375|NCT01161927|Nizatidine|nizatidine|mesh-list
56896376|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56896377|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56896378|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56896379|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
56896380|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
56896381|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896382|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896383|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896384|NCT01267383|Sertraline|sertraline|mesh-list
56896385|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
56896386|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896387|NCT01267383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56587508|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
56896388|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56896389|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56587656|NCT00703066|Vaccines|vaccines|mesh-list
56896390|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587730|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
56896391|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896393|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896394|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
56896395|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56896396|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
56896397|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
56896398|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896399|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896400|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896401|NCT03283670|Analgesics|analgesics|mesh-ancestor
56896402|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
56896403|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896405|NCT03110432|Niacin|niacin|mesh-list
56896406|NCT03110432|Ezetimibe|ezetimibe|mesh-list
56896407|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56607130|NCT00513019|Lamotrigine|lamotrigine|mesh-list
56896408|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56896409|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56896410|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
56588255|NCT03477396|Estrogens|estrogens|mesh-list
56896411|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896412|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56896413|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
56896414|NCT03110432|Vitamins|vitamins|mesh-ancestor
56896415|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
56896416|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896417|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
56896418|NCT03205358|Vaccines|vaccines|mesh-list
56896419|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
56896420|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896421|NCT01358578|Etanercept|etanercept|mesh-list
56896422|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56896423|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896424|NCT01358578|Analgesics|analgesics|mesh-ancestor
56896425|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
56896426|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896427|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896428|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896429|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56896430|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56896431|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56588312|NCT00905034|Rituximab|rituximab|mesh-list
56896432|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
56896434|NCT01161459|Tacrolimus|tacrolimus|mesh-list
56896435|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896436|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
56896437|NCT01161459|Hormones|hormones|mesh-ancestor
56588449|NCT04302584|Vasopressins|vasopressins|mesh-list
56904643|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588572|NCT05756998|Copper|copper|mesh-list
56896438|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904644|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56896439|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896440|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56896441|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588822|NCT02848950|Metformin|metformin|mesh-list
56896442|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56896443|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
56896444|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56896445|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904645|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56896446|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896447|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
56896448|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
56896449|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
56896450|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896451|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589181|NCT05242926|Docetaxel|docetaxel|mesh-list
56896452|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
56896453|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896454|NCT03882099|Vitamin D|vitamin d|mesh-list
56896455|NCT03882099|Vitamins|vitamins|mesh-ancestor
56896456|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
56896457|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896458|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56896460|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896461|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
56896462|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
56896463|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
56896464|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896466|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
56896467|NCT04745780|Vitamins|vitamins|mesh-ancestor
56896468|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
56590225|NCT00816972|Renal Agents|renal agents|mesh-ancestor
56896469|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896470|NCT02833948|Aspirin|aspirin|mesh-list
56896471|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
56896472|NCT02833948|Clopidogrel|clopidogrel|mesh-list
56896473|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56590441|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896474|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56590515|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56896475|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56896476|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56896477|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
56896478|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590808|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56896479|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590960|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
56896480|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591044|NCT02755857|Itraconazole|itraconazole|mesh-list
56896481|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56896482|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
56896483|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56896484|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
56896485|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896486|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
56896487|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56896488|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896489|NCT02833948|Analgesics|analgesics|mesh-ancestor
56896490|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
56896491|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896492|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896493|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56896494|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56896495|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56896496|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56896497|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
56896498|NCT02527005|Azithromycin|azithromycin|mesh-list
56896499|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
56896500|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
56591387|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
56896501|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56896502|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56896503|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896504|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
56896505|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56920619|NCT04467892|Hormones|hormones|mesh-ancestor
56896506|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56896507|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56896508|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896509|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896510|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56896511|NCT02527005|Renal Agents|renal agents|mesh-ancestor
56896512|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
56896513|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896514|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56896515|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896516|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896518|NCT02404688|Dronabinol|dronabinol|mesh-list
56896519|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56896520|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896521|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896522|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896523|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
56896524|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896525|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896526|NCT02404688|Analgesics|analgesics|mesh-ancestor
56896527|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
56896528|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896529|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56896530|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56896531|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896532|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896533|NCT02404688|Hormones|hormones|mesh-ancestor
56896534|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56896535|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
56896536|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56896537|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
56896538|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896539|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
56896540|NCT04704518|Protective Agents|protective agents|mesh-ancestor
56896541|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
56896542|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896543|NCT01162941|Prednisolone|prednisolone|mesh-list
56896544|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896545|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
56896546|NCT01162941|Hormones|hormones|mesh-ancestor
56896547|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56896548|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896549|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56896550|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896551|NCT00161044|Galantamine|galantamine|mesh-list
56896552|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56896553|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896554|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896555|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
56896556|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896557|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896558|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56896559|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
56896560|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896562|NCT01156779|Exenatide|exenatide|mesh-list
56896563|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56896564|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896565|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56896566|NCT01156779|Incretins|incretins|mesh-ancestor
56896567|NCT01156779|Hormones|hormones|mesh-ancestor
56896568|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56896569|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
56896570|NCT01156857|Progestins|progestins|mesh-list
56896571|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56896572|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
56896573|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56896574|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896575|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56896576|NCT01156857|Hormones|hormones|mesh-ancestor
56904646|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896577|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56896578|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
56896579|NCT01269333|Omeprazole|omeprazole|mesh-list
56896580|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56896581|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56896582|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56896583|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896584|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896585|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56896586|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56896587|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896588|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896589|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896590|NCT01269333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56896591|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56896592|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56896593|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896594|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
56896595|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56896596|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
56896597|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56896598|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56896599|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56896600|NCT01269411|R04929097|r04929097|mesh-list
56896601|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896602|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896603|NCT03882255|Propranolol|propranolol|mesh-list
56896604|NCT03882255|Ponesimod|ponesimod|mesh-list
56896605|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56896606|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56896607|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896608|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592225|NCT03255915|Tenofovir|tenofovir|mesh-list
56904647|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896609|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896610|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896611|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56904648|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56896612|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56896613|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
56896614|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56896615|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56896616|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
56896618|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
56896619|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896620|NCT01268631|Pregabalin|pregabalin|mesh-list
56896621|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56896622|NCT01268631|Analgesics|analgesics|mesh-ancestor
56896623|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
56896624|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896625|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896626|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
56896627|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56896628|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56896629|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896630|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56896631|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56896632|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56896633|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896634|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896635|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56896636|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56896637|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896638|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
56896639|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
56896640|NCT05430230|Naproxen|naproxen|mesh-list
56896641|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56896642|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56896643|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896644|NCT05430230|Analgesics|analgesics|mesh-ancestor
56896645|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
56896646|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896647|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896648|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56592678|NCT05753722|Pembrolizumab|pembrolizumab|mesh-list
56896649|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
56896650|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56896651|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896652|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896653|NCT01268709|Doxepin|doxepin|mesh-list
56896654|NCT01268709|Nortriptyline|nortriptyline|mesh-list
56896655|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56896656|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
56896657|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896658|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56896659|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56896660|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56896661|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896662|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896663|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896664|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896665|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56896666|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56896667|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896668|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
56896669|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
56896670|NCT03881943|Aspirin|aspirin|mesh-list
56896671|NCT03881943|Ticagrelor|ticagrelor|mesh-list
56896672|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56896673|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896674|NCT03881943|Analgesics|analgesics|mesh-ancestor
56896675|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
56896676|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896677|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896678|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896679|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56896680|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56896681|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56896682|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896683|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56896684|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56896685|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592799|NCT02720601|Irinotecan|irinotecan|mesh-list
56896686|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
56896687|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56896688|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56896689|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56896690|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
56896691|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896692|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56896693|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56896694|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56896695|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56896696|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56896697|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896698|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896699|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896700|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896701|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56896702|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896703|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
56896704|NCT04722848|Blinatumomab|blinatumomab|mesh-list
56896706|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896707|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56896708|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904649|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
56904650|NCT02086942|Dexamethasone|dexamethasone|mesh-list
56896709|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896710|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56896711|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56904651|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
56593716|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
56896712|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896713|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56896714|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56896715|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56896716|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896717|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896718|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896719|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56896720|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56896721|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
56896722|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896723|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896724|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56896725|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56896726|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
56896728|NCT05363384|Alogliptin|alogliptin|mesh-list
56896729|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56594303|NCT03511846|Capsaicin|capsaicin|mesh-list
56594367|NCT00802360|Ganirelix|ganirelix|mesh-list
56896730|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896731|NCT05363384|Incretins|incretins|mesh-ancestor
56896733|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56896734|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56896735|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
56896736|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594732|NCT00614757|Antidotes|antidotes|mesh-ancestor
56896737|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594805|NCT00724243|Infliximab|infliximab|mesh-list
56896738|NCT01165125|Ketoconazole|ketoconazole|mesh-list
56896739|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
56896740|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594879|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
56896741|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56896742|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56896743|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896744|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896745|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56896746|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
56896747|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56896748|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896749|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56896751|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
56896752|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
56896753|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896754|NCT02274662|Cyclosporine|cyclosporine|mesh-list
56896755|NCT02274662|Tacrolimus|tacrolimus|mesh-list
56896756|NCT02274662|Cyclosporins|cyclosporins|mesh-list
56896757|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56896758|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
56896759|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56896760|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
56896761|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896762|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56595255|NCT04505774|Heparin|heparin|mesh-list
56896763|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896764|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896765|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
56896766|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896767|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56896768|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56896769|NCT02891174|Acetaminophen|acetaminophen|mesh-list
56896770|NCT02891174|Ibuprofen|ibuprofen|mesh-list
56896771|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896772|NCT02891174|Analgesics|analgesics|mesh-ancestor
56896773|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
56896774|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596074|NCT05194735|Aldesleukin|aldesleukin|mesh-list
56896775|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896776|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
56596283|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56896777|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56896778|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896779|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56896780|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56896781|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896782|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896784|NCT01280175|Antidotes|antidotes|mesh-ancestor
56896785|NCT01280175|Protective Agents|protective agents|mesh-ancestor
56896786|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896787|NCT01588431|Bevacizumab|bevacizumab|mesh-list
56896788|NCT01588431|Cetuximab|cetuximab|mesh-list
56896789|NCT01588431|Cisplatin|cisplatin|mesh-list
56896790|NCT01588431|Docetaxel|docetaxel|mesh-list
56896791|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56896792|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896793|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56896794|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56896795|NCT01588431|Growth Substances|growth substances|mesh-ancestor
56896796|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896797|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
56896798|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
56896799|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
56896800|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
56896801|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896802|NCT01583283|Dexamethasone|dexamethasone|mesh-list
56896803|NCT01583283|Lenalidomide|lenalidomide|mesh-list
56896804|NCT01583283|Ricolinostat|ricolinostat|mesh-list
56896805|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56896806|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896807|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
56896808|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
56896809|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896810|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896812|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
56896813|NCT01583283|Hormones|hormones|mesh-ancestor
56896814|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56896815|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56896816|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896817|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
56896818|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56896819|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56896820|NCT01583283|Growth Substances|growth substances|mesh-ancestor
56597084|NCT02787369|Idelalisib|idelalisib|mesh-list
56896822|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904653|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904654|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
56904655|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904656|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904657|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56904658|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
56904659|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597303|NCT04873453|Cannabidiol|cannabidiol|mesh-list
56597380|NCT04524871|Growth Substances|growth substances|mesh-ancestor
56597453|NCT04504123|Doxycycline|doxycycline|mesh-list
56896823|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597531|NCT01072175|Trametinib|trametinib|mesh-list
56597675|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
56597752|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896825|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56896826|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597908|NCT03141177|Nivolumab|nivolumab|mesh-list
56896827|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56896828|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56896829|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896830|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598284|NCT00772954|Vaccines|vaccines|mesh-list
56896832|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
56896833|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56896834|NCT01270737|Estrogens|estrogens|mesh-ancestor
56896835|NCT01270737|Hormones|hormones|mesh-ancestor
56598428|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56598504|NCT01038869|Azelaic acid|azelaic acid|mesh-list
56598577|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
56896836|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56896837|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896838|NCT01270815|Pregabalin|pregabalin|mesh-list
56896839|NCT01270815|Analgesics|analgesics|mesh-ancestor
56896840|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
56896841|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896842|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896843|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
56599117|NCT04594811|Nivolumab|nivolumab|mesh-list
56896845|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56599172|NCT02575885|Nicotine|nicotine|mesh-list
56896846|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599323|NCT03892785|Prednisone|prednisone|mesh-list
56599473|NCT03771651|Aspirin|aspirin|mesh-list
56599546|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56896847|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56896848|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56896849|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56599697|NCT04298541|Edotreotide|edotreotide|mesh-list
56896850|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56896851|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56896852|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56896853|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56896854|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
56599919|NCT00998738|Analgesics|analgesics|mesh-ancestor
56896855|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896856|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56896858|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56896859|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896860|NCT03330236|Anesthetics|anesthetics|mesh-list
56896861|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600279|NCT04021498|Simvastatin|simvastatin|mesh-list
56896862|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896866|NCT02831764|Dolutegravir|dolutegravir|mesh-list
56896867|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
56896868|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896869|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56896870|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56896871|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896872|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896873|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56896874|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56896875|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56896876|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56896877|NCT01271361|Sirolimus|sirolimus|mesh-list
56896878|NCT01271361|Umirolimus|umirolimus|mesh-list
56896879|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896880|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56896881|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
56896882|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896883|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56896884|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896885|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56896886|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896887|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
56896888|NCT03638726|Atropine|atropine|mesh-list
56896889|NCT03638726|Phenylephrine|phenylephrine|mesh-list
56896890|NCT03638726|Epinephrine|epinephrine|mesh-list
56896891|NCT03638726|Racepinephrine|racepinephrine|mesh-list
56896892|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
56896893|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
56896894|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
56896895|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56896896|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56896897|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896898|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896899|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896900|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896901|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56600499|NCT01034657|Panobinostat|panobinostat|mesh-list
56896902|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56896903|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
56896904|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896905|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56896906|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
56896907|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
56896908|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
56896909|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56896910|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56896911|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
56896912|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56896913|NCT03638726|Protective Agents|protective agents|mesh-ancestor
56896914|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56896915|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56600687|NCT02871869|Hormones|hormones|mesh-ancestor
56896916|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
56896917|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56896918|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56600828|NCT00603447|Hormones|hormones|mesh-ancestor
56896919|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
56896920|NCT01164189|Bevacizumab|bevacizumab|mesh-list
56896921|NCT01164189|Temozolomide|temozolomide|mesh-list
56600976|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349567|NCT00060476|Rofecoxib|rofecoxib|mesh-list
56896922|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56896923|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896924|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56896925|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56896926|NCT01164189|Growth Substances|growth substances|mesh-ancestor
56896927|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896929|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56896930|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
56896931|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896932|NCT01164267|Everolimus|everolimus|mesh-list
56896933|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896934|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56896935|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
56896936|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896937|NCT01164345|Plerixafor|plerixafor|mesh-list
56896938|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56896939|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56896940|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
56896941|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896942|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
56896943|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56896944|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56896945|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56896946|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56896947|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
56896948|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896949|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896950|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896951|NCT02259868|Ritonavir|ritonavir|mesh-list
56896952|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56896953|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56896954|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
56896955|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896956|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896957|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56896958|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56896959|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
56896960|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56896961|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56601357|NCT00714103|Adenosine|adenosine|mesh-list
56896962|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56896964|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56896965|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896966|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601402|NCT02600806|Azithromycin|azithromycin|mesh-list
56896967|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56896968|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896969|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56601478|NCT03565783|Cemiplimab|cemiplimab|mesh-list
56896970|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56896971|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
56896972|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56896973|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896974|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896975|NCT00135226|Aspirin|aspirin|mesh-list
56904660|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56896976|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56601695|NCT00718471|Heparin|heparin|mesh-list
56896977|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56896978|NCT00135226|Analgesics|analgesics|mesh-ancestor
56896979|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
56896980|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56896981|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56896982|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56601987|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
56896983|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56896984|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56896985|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56904661|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56904662|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56896986|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896987|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56904663|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
56896988|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56896989|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56896991|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
56896992|NCT01587261|Vitamins|vitamins|mesh-ancestor
56896993|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
56896994|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602726|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
56896996|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56896997|NCT01587261|Protective Agents|protective agents|mesh-ancestor
56896998|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
56896999|NCT01269021|Prednisone|prednisone|mesh-list
56897000|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897001|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
56897003|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904664|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
56603247|NCT02601040|Vaccines|vaccines|mesh-list
56897004|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897005|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56897006|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897007|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56603461|NCT05273775|Vitamin K|vitamin k|mesh-list
56897008|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56897009|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
56897010|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56897011|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603610|NCT00738829|Lenalidomide|lenalidomide|mesh-list
56897012|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904665|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897013|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897014|NCT01269099|Fentanyl|fentanyl|mesh-list
56897015|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56897016|NCT01269099|Narcotics|narcotics|mesh-ancestor
56897017|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897018|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897019|NCT01269099|Analgesics|analgesics|mesh-ancestor
56897020|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
56897021|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897022|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56603980|NCT04173039|Antibodies|antibodies|mesh-list
56897023|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56897024|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
56604051|NCT02662725|Ipilimumab|ipilimumab|mesh-list
56897025|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
56897026|NCT01164813|Nabumetone|nabumetone|mesh-list
56897027|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56897028|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56897029|NCT01164813|Analgesics|analgesics|mesh-ancestor
56897030|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
56897031|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897032|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897033|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897034|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56897035|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56897036|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56897037|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897038|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897039|NCT01165905|Gemcitabine|gemcitabine|mesh-list
56897040|NCT01165905|ON 01910|on 01910|mesh-list
56897041|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56897042|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
56897043|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897044|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604500|NCT00920803|Resveratrol|resveratrol|mesh-list
56897045|NCT01165905|Antiviral Agents|antiviral agents|mesh-ancestor
56897046|NCT01165905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897047|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897048|NCT01165905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897049|NCT01165905|Immunologic Factors|immunologic factors|mesh-ancestor
56897050|NCT01165905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897051|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56897052|NCT01339000|Vaccines|vaccines|mesh-list
56897053|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56897054|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
56897055|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897056|NCT01269255|Cisplatin|cisplatin|mesh-list
56897057|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897058|NCT03563170|Leucovorin|leucovorin|mesh-list
56897059|NCT03563170|Paclitaxel|paclitaxel|mesh-list
56897060|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
56604561|NCT02647671|Calcium|calcium|mesh-list
56897061|NCT03563170|Fluorouracil|fluorouracil|mesh-list
56897062|NCT03563170|Capecitabine|capecitabine|mesh-list
56604785|NCT02645565|Hormones|hormones|mesh-ancestor
56897063|NCT03563170|Cetuximab|cetuximab|mesh-list
56897064|NCT03563170|Sorafenib|sorafenib|mesh-list
56897065|NCT03563170|Avelumab|avelumab|mesh-list
56897066|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56897068|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
56605086|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
56897069|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
56897070|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
56897071|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897072|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897073|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
56897074|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897075|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56897076|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56897077|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
56605359|NCT04092868|Protamines|protamines|mesh-list
56897078|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56897079|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
56897080|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56897081|NCT03563170|Antidotes|antidotes|mesh-ancestor
56897082|NCT03563170|Protective Agents|protective agents|mesh-ancestor
56897083|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
56897085|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
56920743|NCT01328821|Protective Agents|protective agents|mesh-ancestor
56897086|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56897087|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56897088|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897089|NCT01281111|Aspirin|aspirin|mesh-list
56897090|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56606019|NCT02871713|Analgesics|analgesics|mesh-ancestor
56897091|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56606163|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
56897092|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56897093|NCT01281111|Analgesics|analgesics|mesh-ancestor
56897094|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
56606239|NCT00732940|Belimumab|belimumab|mesh-list
56897095|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897096|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897097|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897098|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56606452|NCT02858258|Rituximab|rituximab|mesh-list
56897100|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56897101|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897102|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56897103|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56897104|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897105|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
56897106|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
56897107|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897108|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
56897109|NCT03869931|Fenofibrate|fenofibrate|mesh-list
56897110|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56607047|NCT01667744|Citalopram|citalopram|mesh-list
56897111|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
56904666|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56897112|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897113|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56897114|NCT04876066|Ketamine|ketamine|mesh-list
56897115|NCT04876066|Analgesics|analgesics|mesh-ancestor
56607414|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
56607497|NCT00941330|Docetaxel|docetaxel|mesh-list
56897116|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
56897117|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897118|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897119|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56904667|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
56897120|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56897121|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
56897123|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897124|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56897125|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56897126|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608165|NCT00747487|Idebenone|idebenone|mesh-list
56897127|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897128|NCT01169805|Ondansetron|ondansetron|mesh-list
56897129|NCT01169805|Palonosetron|palonosetron|mesh-list
56897131|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
56897132|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
56897133|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608457|NCT00687271|Calcium|calcium|mesh-list
56897134|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897135|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56897136|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
56897137|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
56897138|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56897139|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
56897140|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608748|NCT04051567|Aspirin|aspirin|mesh-list
56615325|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
56897141|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897142|NCT01169805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56897143|NCT01169805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56897144|NCT01169805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897145|NCT01169805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56897146|NCT01169805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56897147|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56897149|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56904668|NCT02086942|Hormones|hormones|mesh-ancestor
56897150|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
56897151|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56897152|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
56904734|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56897153|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56897154|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897155|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56897156|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897157|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
56897158|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
56897159|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
56897160|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56897161|NCT01167465|Protective Agents|protective agents|mesh-ancestor
56897162|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897163|NCT01283217|Cisplatin|cisplatin|mesh-list
56897164|NCT01283217|Docetaxel|docetaxel|mesh-list
56897165|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897166|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
56897167|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
56897168|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
56897169|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897170|NCT01276431|Buprenorphine|buprenorphine|mesh-list
56897171|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56897172|NCT01276431|Narcotics|narcotics|mesh-ancestor
56897173|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897174|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897175|NCT01276431|Analgesics|analgesics|mesh-ancestor
56897176|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
56610071|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
56897177|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897178|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56610214|NCT02583958|Laxatives|laxatives|mesh-ancestor
56897179|NCT01281579|Canagliflozin|canagliflozin|mesh-list
56610287|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
56897180|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56897181|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897182|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56897183|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610436|NCT04080310|Ezetimibe|ezetimibe|mesh-list
56897184|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56897185|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56610581|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
56897186|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897187|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897188|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
56897189|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897190|NCT01166451|Iron|iron|mesh-list
56897191|NCT01166451|Trace Elements|trace elements|mesh-ancestor
56610799|NCT00606866|Sorafenib|sorafenib|mesh-list
56897192|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
56897193|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897195|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
56897196|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56897197|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897198|NCT01283763|Imiquimod|imiquimod|mesh-list
56897199|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56897200|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
56897201|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897202|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897203|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
56897204|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
56897205|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56897206|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897207|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56897208|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
56897209|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56897210|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897211|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611088|NCT00668707|Melatonin|melatonin|mesh-list
56904735|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56611237|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56611388|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
56897212|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897214|NCT03872661|Carboplatin|carboplatin|mesh-list
56897215|NCT03872661|Pemetrexed|pemetrexed|mesh-list
56897217|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611533|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
56897218|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56897219|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56897220|NCT03872661|Growth Substances|growth substances|mesh-ancestor
56897221|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897222|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
56897223|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897224|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897225|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56897226|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56897227|NCT01167699|Oxycodone|oxycodone|mesh-list
56897228|NCT01167699|Naloxone|naloxone|mesh-list
56612028|NCT00934856|Pertuzumab|pertuzumab|mesh-list
56897229|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56897230|NCT01167699|Narcotics|narcotics|mesh-ancestor
56897231|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612206|NCT00665431|Celecoxib|celecoxib|mesh-list
56897232|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897233|NCT01167699|Analgesics|analgesics|mesh-ancestor
56897234|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
56897235|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897236|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56897237|NCT02526303|Nadroparin|nadroparin|mesh-list
56897238|NCT02526303|Warfarin|warfarin|mesh-list
56897240|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56897241|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897242|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
56897243|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56897244|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56612635|NCT00663897|Mosapride|mosapride|mesh-list
56897245|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897247|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56897248|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56897249|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
56897250|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897251|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56897252|NCT01587495|Ertapenem|ertapenem|mesh-list
56897253|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56897254|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897255|NCT01170351|Cyclosporine|cyclosporine|mesh-list
56897256|NCT01170351|Cyclosporins|cyclosporins|mesh-list
56897257|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897258|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897259|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897260|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
56897261|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897262|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
56897263|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897264|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
56897266|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56897267|NCT01170429|Procaterol|procaterol|mesh-list
56897268|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56897269|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
56897270|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612942|NCT00672399|Exenatide|exenatide|mesh-list
56897271|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897272|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56897273|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
56897274|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
56897275|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56897276|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56897277|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56897278|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
56897279|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897280|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897281|NCT01170507|Vitamin D|vitamin d|mesh-list
56897282|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
56897283|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
56897284|NCT01170507|Vitamins|vitamins|mesh-list
56897285|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
56613084|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56897286|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613143|NCT00787657|Interferons|interferons|mesh-list
56897288|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56897289|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56897290|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56897291|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56897292|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
56613588|NCT00800761|Siderophores|siderophores|mesh-ancestor
56897293|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897294|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56897295|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56897296|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897297|NCT01170819|Dinoprostone|dinoprostone|mesh-list
56897298|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
56897299|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56897300|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897302|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56613949|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
56897303|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56897304|NCT03868137|Analgesics|analgesics|mesh-ancestor
56897305|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
56897306|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897307|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897308|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897309|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56614489|NCT00797017|Fentanyl|fentanyl|mesh-list
56897311|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897312|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897314|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56897315|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56897316|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56897317|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897318|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897319|NCT01167933|Simvastatin|simvastatin|mesh-list
56897320|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56614840|NCT00689949|Folic Acid|folic acid|mesh-list
56897321|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56897323|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897324|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56615131|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56897325|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56897326|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897328|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615358|NCT02620215|Dinoprostone|dinoprostone|mesh-list
56897329|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56897330|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615426|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
56897331|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897332|NCT01171209|Interferons|interferons|mesh-list
56897333|NCT01171209|Interferon-beta|interferon-beta|mesh-list
56897334|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
56897335|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
56897336|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897337|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
56897338|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897339|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
56897340|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897341|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56897342|NCT01166685|Everolimus|everolimus|mesh-list
56897343|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897344|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897345|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
56897346|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897347|NCT03870711|Lidocaine|lidocaine|mesh-list
56615642|NCT02617485|Prednisone|prednisone|mesh-list
56897348|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
56897350|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897352|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
56615852|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56616032|NCT00698607|Sirolimus|sirolimus|mesh-list
56897353|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897354|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56897355|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56897357|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616378|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56616452|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
56897358|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897359|NCT03872505|Paclitaxel|paclitaxel|mesh-list
56897360|NCT03872505|Carboplatin|carboplatin|mesh-list
56897361|NCT03872505|Durvalumab|durvalumab|mesh-list
56897362|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56616674|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
56897363|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897364|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
56897366|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
56616973|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
56897367|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897368|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56897369|NCT01171365|Ciclesonide|ciclesonide|mesh-list
56897370|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
56897371|NCT01171365|Hormones|hormones|mesh-ancestor
56897372|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56897373|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897374|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56897375|NCT01281891|Morphine|morphine|mesh-list
56897376|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56897377|NCT01281891|Narcotics|narcotics|mesh-ancestor
56617115|NCT00811915|Sirolimus|sirolimus|mesh-list
56897378|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897379|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897380|NCT01281891|Analgesics|analgesics|mesh-ancestor
56897381|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
56897382|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897383|NCT01282047|Lenalidomide|lenalidomide|mesh-list
56897385|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897386|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56617634|NCT00648895|Metoprolol|metoprolol|mesh-list
56897387|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56897388|NCT01282047|Growth Substances|growth substances|mesh-ancestor
56897389|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
56897390|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897391|NCT02525991|Loxapine|loxapine|mesh-list
56897392|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56617777|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
56183282|NCT01423487|Metformin|metformin|mesh-list
56897393|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56897394|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897395|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897396|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56897397|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56897398|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
56897399|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618220|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
56897400|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897401|NCT01171755|Gemcitabine|gemcitabine|mesh-list
56897402|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56897403|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
56618438|NCT04283435|Estrogens|estrogens|mesh-ancestor
56897404|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897405|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897406|NCT01171755|Antiviral Agents|antiviral agents|mesh-ancestor
56897407|NCT01171755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897408|NCT01171755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897409|NCT01171755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897410|NCT01171755|Immunologic Factors|immunologic factors|mesh-ancestor
56897411|NCT01171755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618955|NCT00901394|Folic Acid|folic acid|mesh-list
56897413|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56897414|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
56619099|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
56897415|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897416|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897417|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56619336|NCT00633282|Pioglitazone|pioglitazone|mesh-list
56897418|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
56619473|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897419|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56897420|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
56897421|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897422|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897423|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56897424|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
56897425|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
56897426|NCT01172691|Protective Agents|protective agents|mesh-ancestor
56897427|NCT01171833|Sevoflurane|sevoflurane|mesh-list
56897428|NCT01171833|Desflurane|desflurane|mesh-list
56897429|NCT01171833|Isoflurane|isoflurane|mesh-list
56897430|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56897431|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56897432|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
56897433|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
56897434|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620064|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56897435|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897437|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
56620138|NCT02841332|Bevacizumab|bevacizumab|mesh-list
56897438|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56897439|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897440|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56897441|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897442|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
56897443|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620511|NCT00794378|Cetirizine|cetirizine|mesh-list
56897444|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
56897445|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897446|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897447|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897448|NCT01584531|ON 01910|on 01910|mesh-list
56897449|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897450|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56897451|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897452|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897453|NCT01171911|Nicardipine|nicardipine|mesh-list
56897454|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
56897455|NCT01171911|Esmolol|esmolol|mesh-list
56620793|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56620863|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56897456|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56620942|NCT00839605|Analgesics|analgesics|mesh-ancestor
56897457|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621014|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56621087|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897458|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56608187|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
56621240|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
56897459|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56897460|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56897462|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897463|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897465|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56897466|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
56621756|NCT00961415|Bevacizumab|bevacizumab|mesh-list
56897467|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
56897468|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56897469|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
56897470|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621895|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56621968|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56897471|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897472|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56897473|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
56897474|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
56622272|NCT04041349|Mitogens|mitogens|mesh-list
56897475|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56897476|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
56897477|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897478|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897479|NCT01173003|Misoprostol|misoprostol|mesh-list
56897480|NCT01173003|Mifepristone|mifepristone|mesh-list
56897481|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56897482|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
56897483|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56622339|NCT00924079|Nalbuphine|nalbuphine|mesh-list
56897484|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897485|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56897486|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56897487|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
56897488|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56897489|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56897490|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56897491|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56897492|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
56897493|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56622723|NCT05514912|Paclitaxel|paclitaxel|mesh-list
56622773|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897494|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56622862|NCT02610153|Vitamin K|vitamin k|mesh-list
56897496|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56897497|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
56897498|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56623145|NCT00865267|Halobetasol|halobetasol|mesh-list
56897499|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56897500|NCT03435003|Dexamethasone|dexamethasone|mesh-list
56897501|NCT03435003|Fentanyl|fentanyl|mesh-list
56897502|NCT03435003|Scopolamine|scopolamine|mesh-list
56897503|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
56897504|NCT03435003|Ondansetron|ondansetron|mesh-list
56897505|NCT03435003|Aprepitant|aprepitant|mesh-list
56897506|NCT03435003|Metoclopramide|metoclopramide|mesh-list
56897507|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
56897508|NCT03435003|Propofol|propofol|mesh-list
56897509|NCT03435003|Sevoflurane|sevoflurane|mesh-list
56897510|NCT03435003|Desflurane|desflurane|mesh-list
56897511|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56897512|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897513|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
56897514|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
56897515|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897516|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897517|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56897518|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
56897519|NCT03435003|Hormones|hormones|mesh-ancestor
56904736|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897520|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56897521|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56624168|NCT05162131|Ticagrelor|ticagrelor|mesh-list
56624313|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897522|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897523|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
56897524|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897525|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56897526|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56897527|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
56897528|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56897529|NCT03435003|Analgesics|analgesics|mesh-ancestor
56897530|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
56897531|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56897532|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56897533|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56897534|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
56897535|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897536|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897537|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56897538|NCT03435003|Narcotics|narcotics|mesh-ancestor
56897539|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56897540|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56624388|NCT02787018|Analgesics|analgesics|mesh-ancestor
56897541|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56624475|NCT04200222|Vanadium|vanadium|mesh-list
56897543|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
56897544|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56897545|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
56897546|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56897547|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56897548|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56897549|NCT03435003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56897550|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56897551|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56897552|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56897553|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
56897554|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
56897555|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56897556|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
56897557|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56897558|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
56897559|NCT01172223|Paclitaxel|paclitaxel|mesh-list
56624849|NCT00880321|Dabrafenib|dabrafenib|mesh-list
56897560|NCT01172223|Doxorubicin|doxorubicin|mesh-list
56624886|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
56897561|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56897562|NCT01172223|Lapatinib|lapatinib|mesh-list
56624973|NCT02512926|Etoposide|etoposide|mesh-list
56897563|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56897564|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897565|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
56897566|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
56897567|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
56897568|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897569|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56897570|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56897571|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56897572|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625249|NCT00881413|Esomeprazole|esomeprazole|mesh-list
56897573|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56897574|NCT01173081|Teriparatide|teriparatide|mesh-list
56897575|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56897576|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897577|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56897578|NCT03866733|Narcotics|narcotics|mesh-list
56920818|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56625322|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56897579|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625389|NCT00954707|Analgesics|analgesics|mesh-ancestor
56897580|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897581|NCT03866733|Analgesics|analgesics|mesh-ancestor
56897582|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
56897583|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897585|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56897586|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
56897587|NCT01168791|Ifosfamide|ifosfamide|mesh-list
56897588|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56897589|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625751|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625828|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
56897590|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56625904|NCT04227912|Anesthetics|anesthetics|mesh-list
56897591|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56897592|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904737|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56904738|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
56904739|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56904740|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56904741|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904742|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56897593|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897594|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56897595|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
56897596|NCT01284309|Mirabegron|mirabegron|mesh-list
56897597|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56897598|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56897599|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56897600|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
56897602|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904743|NCT02092012|Analgesics|analgesics|mesh-ancestor
56897603|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897604|NCT01284309|Urological Agents|urological agents|mesh-ancestor
56626564|NCT00884767|Antidotes|antidotes|mesh-ancestor
56897606|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
56897607|NCT01169025|Fentanyl|fentanyl|mesh-list
56897608|NCT01169025|Ketamine|ketamine|mesh-list
56897609|NCT01169025|Analgesics|analgesics|mesh-ancestor
56897610|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
56897611|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897612|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897614|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56897615|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
56897616|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
56897617|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897618|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56897619|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56897620|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897621|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897622|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56897623|NCT01169025|Narcotics|narcotics|mesh-ancestor
56897624|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56897625|NCT01582347|Buprenorphine|buprenorphine|mesh-list
56920827|NCT01218217|Rifampin|rifampin|mesh-list
56626987|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56897626|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56897627|NCT01582347|Naloxone|naloxone|mesh-list
56897628|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56897629|NCT01582347|Narcotics|narcotics|mesh-ancestor
56897630|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897631|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897632|NCT01582347|Analgesics|analgesics|mesh-ancestor
56897633|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
56897634|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897635|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56897636|NCT01336634|Trametinib|trametinib|mesh-list
56897637|NCT01336634|Dabrafenib|dabrafenib|mesh-list
56897638|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897639|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56897640|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897641|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897642|NCT01284855|Antivenins|antivenins|mesh-list
56897643|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
56897644|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897645|NCT05316116|Siltuximab|siltuximab|mesh-list
56897646|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897647|NCT00785798|Doxorubicin|doxorubicin|mesh-list
56897648|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56897649|NCT00785798|Vorinostat|vorinostat|mesh-list
56897650|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56897651|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897652|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56897653|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56897654|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897655|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897656|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56897657|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
56897658|NCT01175109|Panobinostat|panobinostat|mesh-list
56897659|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627056|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56897660|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56897661|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897662|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897663|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56897664|NCT01282515|Clobetasol|clobetasol|mesh-list
56897665|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897666|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
56897667|NCT01282515|Hormones|hormones|mesh-ancestor
56897668|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56897669|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897670|NCT04732910|Ivacaftor|ivacaftor|mesh-list
56897671|NCT04732910|Elexacaftor|elexacaftor|mesh-list
56897672|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56897673|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56897674|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897675|NCT00673010|Iodine|iodine|mesh-list
56897676|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56897677|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897678|NCT00673010|Trace Elements|trace elements|mesh-ancestor
56897679|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
56897680|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897681|NCT03329846|Nivolumab|nivolumab|mesh-list
56897682|NCT03329846|Linrodostat|linrodostat|mesh-list
56897683|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56897684|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897685|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56627149|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56897686|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897687|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897688|NCT04020848|Melatonin|melatonin|mesh-list
56897689|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
56897690|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897691|NCT04020848|Protective Agents|protective agents|mesh-ancestor
56897692|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897693|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897695|NCT02823574|Ipilimumab|ipilimumab|mesh-list
56897696|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627360|NCT02760888|Tramadol|tramadol|mesh-list
56897697|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897698|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56897699|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897700|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56897701|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56897702|NCT01355302|Capecitabine|capecitabine|mesh-list
56897703|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897704|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56897705|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
56897706|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897707|NCT01355068|Phenytoin|phenytoin|mesh-list
56897708|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
56897709|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56627497|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56897711|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56897712|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897713|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56897714|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56897715|NCT03562780|Acetaminophen|acetaminophen|mesh-list
56897716|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56897717|NCT03562780|Analgesics|analgesics|mesh-ancestor
56897718|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
56897719|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897720|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897721|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
56897722|NCT02259946|Bromides|bromides|mesh-list
56897723|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
56627933|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
56897724|NCT02259946|Olodaterol|olodaterol|mesh-list
56897725|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56628006|NCT00896155|Tamoxifen|tamoxifen|mesh-list
56897726|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
56897727|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897728|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897729|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56628304|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897730|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
56897731|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
56628379|NCT04243278|Analgesics|analgesics|mesh-ancestor
56897733|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
56897734|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897735|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897736|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
56897737|NCT03756129|Ketamine|ketamine|mesh-list
56897739|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
56897740|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897741|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897742|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56897743|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56897744|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
56897745|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
56897746|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897747|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56897748|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56628664|NCT00905905|Ezetimibe|ezetimibe|mesh-list
56897749|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897750|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897751|NCT03863691|Amisulpride|amisulpride|mesh-list
56897752|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56897753|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56897754|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897755|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897756|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56897757|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56897758|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
56897759|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897760|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897761|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56897762|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
56897764|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
56904744|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
56897765|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56897766|NCT02822794|Velpatasvir|velpatasvir|mesh-list
56897767|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
56897768|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897769|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
56629161|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
56897770|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897771|NCT01173315|Vitamins|vitamins|mesh-list
56897772|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
56897773|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629298|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897775|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56629370|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897776|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897778|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897779|NCT01338298|Aripiprazole|aripiprazole|mesh-list
56897780|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
56897781|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56897782|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56897783|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56897784|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897785|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897786|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
56897787|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
56897788|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897789|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897790|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56897791|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56897792|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
56897793|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56897795|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56897797|NCT01169415|Dexamethasone|dexamethasone|mesh-list
56897799|NCT01169415|BB 1101|bb 1101|mesh-list
56897800|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897801|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
56897802|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
56897803|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897804|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897805|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56897806|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
56897807|NCT01169415|Hormones|hormones|mesh-ancestor
56897808|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56897809|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56630327|NCT00931645|Cytarabine|cytarabine|mesh-list
56897810|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897811|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
56897812|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630549|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56630626|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56630711|NCT02819648|Hormones|hormones|mesh-ancestor
56897813|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897814|NCT01173627|Fentanyl|fentanyl|mesh-list
56630778|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
56897815|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56897816|NCT01173627|Narcotics|narcotics|mesh-ancestor
56897817|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897818|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897819|NCT01173627|Analgesics|analgesics|mesh-ancestor
56897820|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
56897821|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897822|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56897823|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56897824|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
56897825|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
56897826|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
56897827|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56897828|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897829|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897830|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56897831|NCT01169571|Analgesics|analgesics|mesh-ancestor
56897832|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
56897833|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897834|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56631578|NCT05786950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56631579|NCT05786950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56631580|NCT05786950|Adrenergic Agents|adrenergic agents|mesh-ancestor
56631581|NCT05786950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897835|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56897836|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56897837|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
56897838|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897839|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897840|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
56897841|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56897842|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
56897843|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897844|NCT01354132|Expectorants|expectorants|mesh-ancestor
56897845|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
56897846|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56897847|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
56897848|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897849|NCT01354132|Protective Agents|protective agents|mesh-ancestor
56897850|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897851|NCT01354132|Antidotes|antidotes|mesh-ancestor
56897852|NCT05707936|Heparin|heparin|mesh-list
56897853|NCT05707936|Anticoagulants|anticoagulants|mesh-ancestor
56897854|NCT05707936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56897855|NCT05707936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56897856|NCT05707936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897857|NCT03863613|Progesterone|progesterone|mesh-list
56897858|NCT03863613|Progestins|progestins|mesh-ancestor
56897860|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56897861|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897862|NCT01372150|Fluoxetine|fluoxetine|mesh-list
56897863|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56897864|NCT01372150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56897865|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56897866|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56897867|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897868|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897869|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
56897870|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897871|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56897872|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
56897873|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56897874|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56897875|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56897876|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904746|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56897877|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56897878|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56897879|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56897880|NCT01175577|Carotenoids|carotenoids|mesh-list
56897881|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
56897882|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897883|NCT01175577|Protective Agents|protective agents|mesh-ancestor
56897884|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897885|NCT01175733|Panitumumab|panitumumab|mesh-list
56897886|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56897887|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897888|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
56897889|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56897890|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897891|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897892|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56897893|NCT02035930|Analgesics|analgesics|mesh-ancestor
56631870|NCT05690698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56631871|NCT05690698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56631872|NCT05690698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631873|NCT05690698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56631874|NCT05690698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56631875|NCT05690698|Dopamine Agents|dopamine agents|mesh-ancestor
56631876|NCT05690698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631877|NCT05690698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631878|NCT05690698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56631879|NCT05685628|Charcoal|charcoal|mesh-list
56631880|NCT05685628|Antidotes|antidotes|mesh-ancestor
56631881|NCT05685628|Protective Agents|protective agents|mesh-ancestor
56897894|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
56897895|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897896|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56897897|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56897898|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56897899|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
56897900|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56897901|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897902|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56897903|NCT01173939|Pravastatin|pravastatin|mesh-list
56897904|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56897905|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56897906|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
56897907|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897908|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56897909|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56897911|NCT01174017|Iodine|iodine|mesh-list
56897912|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
56897913|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56632017|NCT05613088|Topotecan|topotecan|mesh-list
56897914|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897915|NCT01174017|Trace Elements|trace elements|mesh-ancestor
56897916|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
56897917|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897918|NCT01288131|Cyclosporine|cyclosporine|mesh-list
56897919|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
56897920|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
56897921|NCT01288131|Cyclosporins|cyclosporins|mesh-list
56897922|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897923|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
56897924|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897925|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56897926|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56897927|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
56632091|NCT05571514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632093|NCT05571514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632094|NCT05571514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56632095|NCT05570305|Dapagliflozin|dapagliflozin|mesh-list
56632096|NCT05570305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56632097|NCT05570305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632098|NCT05570305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56632099|NCT05570305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632166|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
56897928|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897929|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897930|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56897931|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897932|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
56897933|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897934|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
56897935|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56632239|NCT05455320|Hormones|hormones|mesh-ancestor
56897936|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56897937|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56897938|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
56897939|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56897940|NCT02525211|Ropivacaine|ropivacaine|mesh-list
56897941|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
56897942|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
56897943|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897944|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897945|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
56897946|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897947|NCT03865563|Gemcitabine|gemcitabine|mesh-list
56897948|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
56897949|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56897950|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
56897951|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897952|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897953|NCT03865563|Antiviral Agents|antiviral agents|mesh-ancestor
56897954|NCT03865563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56897955|NCT03865563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56897956|NCT03865563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897957|NCT03865563|Immunologic Factors|immunologic factors|mesh-ancestor
56897958|NCT03865563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897959|NCT01178151|Everolimus|everolimus|mesh-list
56897960|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56897961|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56897962|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
56897963|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897964|NCT03862287|Lidocaine|lidocaine|mesh-list
56897965|NCT03862287|Bupivacaine|bupivacaine|mesh-list
56897966|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
56897967|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
56897968|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56897969|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897970|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
56632314|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632315|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
56632316|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
56632317|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
56632318|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632319|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56897972|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56897973|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56897974|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56897975|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56897976|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897977|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56897978|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56897979|NCT03749109|Quinagolide|quinagolide|mesh-list
56632394|NCT05360264|Decitabine|decitabine|mesh-list
56632395|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56632396|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
56920933|NCT03649880|Misonidazole|misonidazole|mesh-list
56632397|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632398|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632399|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632400|NCT05359237|Vincristine|vincristine|mesh-list
56632401|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56632402|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632403|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56632404|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56632405|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56632406|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632407|NCT05357482|Sirolimus|sirolimus|mesh-list
56632408|NCT05357482|Plerixafor|plerixafor|mesh-list
56632464|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632465|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632466|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56632467|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632468|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56897980|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
56897981|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
56897982|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904747|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56904749|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
56904750|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904751|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904752|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56904753|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904754|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904755|NCT00187889|Eplerenone|eplerenone|mesh-list
56632763|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897983|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56897985|NCT01287351|Fluticasone|fluticasone|mesh-list
56897987|NCT01287351|Beclomethasone|beclomethasone|mesh-list
56897988|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56897989|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56897990|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
56897991|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56897992|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56897993|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56897994|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
56897995|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
56897996|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56897997|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
56897999|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898000|NCT03864783|Curcumin|curcumin|mesh-list
56898001|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56898002|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56898003|NCT03864783|Analgesics|analgesics|mesh-ancestor
56898004|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
56898005|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898006|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633053|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633054|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56633055|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633056|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56633057|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633058|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56633059|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56633060|NCT04609046|Growth Substances|growth substances|mesh-ancestor
56633061|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
56633062|NCT04598477|Prednisone|prednisone|mesh-list
56633063|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56898007|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56898008|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56898009|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898010|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898011|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898012|NCT01287507|Lactoferrin|lactoferrin|mesh-list
56898013|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898014|NCT03864705|Metformin|metformin|mesh-list
56898015|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56898016|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633131|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
56633132|NCT04520451|Hormones|hormones|mesh-ancestor
56633134|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898017|NCT01287663|Permethrin|permethrin|mesh-list
56898018|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898019|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898020|NCT01176669|Apatinib|apatinib|mesh-list
56898021|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898022|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56898023|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898024|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898025|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
56898026|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56898027|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
56898028|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898029|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898030|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56898031|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
56898032|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56898033|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56898034|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56898035|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
56898036|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56633343|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633344|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633345|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633346|NCT04182204|Gemcitabine|gemcitabine|mesh-list
56633347|NCT04182204|Rituximab|rituximab|mesh-list
56633348|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
56633349|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633350|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633351|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
56633352|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633353|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56633354|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633355|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
56633356|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633357|NCT04182204|Antiviral Agents|antiviral agents|mesh-ancestor
56898037|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898038|NCT01174953|Finasteride|finasteride|mesh-list
56898039|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56898040|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56898041|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898042|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898043|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
56898044|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898045|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898046|NCT01174953|Urological Agents|urological agents|mesh-ancestor
56898047|NCT01286103|Canagliflozin|canagliflozin|mesh-list
56898048|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56920983|NCT03143816|Insulin|insulin|mesh-list
56898049|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633418|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633419|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56898050|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56898051|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898052|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
56898053|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
56898054|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56898056|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898057|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898058|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56898059|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
56898060|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
56898061|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56898062|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
56898063|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898064|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898065|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56898066|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56898067|NCT03863925|Propofol|propofol|mesh-list
56898068|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56898069|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56633552|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633553|NCT03845296|Rucaparib|rucaparib|mesh-list
56633554|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56633555|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633556|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633557|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633558|NCT03801876|Paclitaxel|paclitaxel|mesh-list
56633559|NCT03801876|Docetaxel|docetaxel|mesh-list
56633560|NCT03801876|Carboplatin|carboplatin|mesh-list
56633561|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56633562|NCT03801876|Fluorouracil|fluorouracil|mesh-list
56633563|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56633564|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633565|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633566|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
56633567|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633568|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633569|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
56633570|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633571|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633572|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
56633573|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898070|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898071|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56898072|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
56898073|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
56898074|NCT01178697|Triamcinolone|triamcinolone|mesh-list
56898075|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56898076|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56898077|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56898078|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56898079|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
56898080|NCT01178697|Hormones|hormones|mesh-ancestor
56898081|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898082|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898083|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56898084|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
56898085|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898086|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898087|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
56898088|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
56898089|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
56898090|NCT03328832|Thrombin|thrombin|mesh-list
56898091|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56633687|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
56898092|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56920984|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56898093|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898094|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
56898095|NCT03328832|Coagulants|coagulants|mesh-ancestor
56898096|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56898097|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
56898098|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56898099|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
56898100|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898101|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
56898102|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
56898103|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898104|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56898105|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56898106|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56898107|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898108|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898109|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56898110|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898111|NCT02942576|Warfarin|warfarin|mesh-list
56898112|NCT02942576|Edoxaban|edoxaban|mesh-list
56898114|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
56898115|NCT02942576|Fluindione|fluindione|mesh-list
56898116|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
56898117|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56898118|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
56898119|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56898120|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
56634116|NCT01856192|Prednisone|prednisone|mesh-list
56898121|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898122|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898123|NCT05707468|Hormones|hormones|mesh-list
56280235|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
56904756|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56898124|NCT05707468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898126|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
56898127|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56898128|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898129|NCT02036008|Liver Extracts|liver extracts|mesh-list
56280608|NCT00006195|Olanzapine|olanzapine|mesh-list
56898130|NCT02036008|Hematinics|hematinics|mesh-ancestor
56898131|NCT02819440|Tadalafil|tadalafil|mesh-list
56921004|NCT03133988|Margetuximab|margetuximab|mesh-list
56898132|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
56898133|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56898134|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56898135|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898136|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898137|NCT02819440|Urological Agents|urological agents|mesh-ancestor
56898138|NCT03562468|Niacinamide|niacinamide|mesh-list
56898140|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
56898141|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
56898143|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
56904757|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
56898144|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898145|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56898146|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
56898147|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898148|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56898149|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
56898150|NCT02036164|Paclitaxel|paclitaxel|mesh-list
56898151|NCT02036164|Cisplatin|cisplatin|mesh-list
56898152|NCT02036164|Carboplatin|carboplatin|mesh-list
56898153|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56898154|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898155|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
56898156|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
56898157|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
56898158|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898159|NCT02818036|Naltrexone|naltrexone|mesh-list
56898160|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56898161|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56898162|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898163|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
56898164|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898165|NCT01287741|Prednisone|prednisone|mesh-list
56898166|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
56898167|NCT01287741|Rituximab|rituximab|mesh-list
56898168|NCT01287741|Doxorubicin|doxorubicin|mesh-list
56898169|NCT01287741|Vincristine|vincristine|mesh-list
56898170|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
56898171|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56898172|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
56898173|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898174|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281172|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
56898175|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56898177|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898178|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898179|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281397|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
56898180|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56898181|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281541|NCT00005998|Hormones|hormones|mesh-ancestor
56898182|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56898183|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56898184|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898185|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56898187|NCT01287741|Hormones|hormones|mesh-ancestor
56921024|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56898188|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56281984|NCT05656027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56898189|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56898190|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56898191|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
56898192|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
56898193|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
56898194|NCT01180959|Bevacizumab|bevacizumab|mesh-list
56898195|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56898196|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56898197|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898198|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56898199|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56898200|NCT01180959|Growth Substances|growth substances|mesh-ancestor
56898201|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898202|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
56898203|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56898204|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898205|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898206|NCT01177371|Cyclosporine|cyclosporine|mesh-list
56898207|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
56898208|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56898209|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56898210|NCT01177371|Prednisolone|prednisolone|mesh-list
56282705|NCT00006049|Paclitaxel|paclitaxel|mesh-list
56898211|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
56898212|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
56898213|NCT01177371|Busulfan|busulfan|mesh-list
56898214|NCT01177371|Methotrexate|methotrexate|mesh-list
56898215|NCT01177371|Cyclosporins|cyclosporins|mesh-list
56898216|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56898217|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
56898218|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56898219|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
56898220|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282721|NCT00006055|Cyclosporine|cyclosporine|mesh-list
56898221|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56898222|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56898223|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
56898224|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898225|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898226|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56898227|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56898228|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
56898229|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56898230|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56898231|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
56898232|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
56898233|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898234|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56898235|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56898236|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
56898237|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898238|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56282782|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
56898239|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56898242|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898243|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56898244|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
56898245|NCT01177371|Hormones|hormones|mesh-ancestor
56898246|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898247|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56898248|NCT01177371|Protective Agents|protective agents|mesh-ancestor
56921045|NCT01124539|Camptothecin|camptothecin|mesh-list
56898249|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56898250|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
56898251|NCT01178931|Progesterone|progesterone|mesh-list
56898252|NCT01178931|Progestins|progestins|mesh-ancestor
56898253|NCT01178931|Hormones|hormones|mesh-ancestor
56898254|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56283155|NCT00006247|Semaxinib|semaxinib|mesh-list
56898255|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898256|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
56898257|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56898258|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
56898259|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898260|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898261|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
56898262|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898263|NCT01181193|Vitamin D|vitamin d|mesh-list
56898264|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
56898265|NCT01181193|Temozolomide|temozolomide|mesh-list
56898266|NCT01181193|Vitamins|vitamins|mesh-ancestor
56898267|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
56898268|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898269|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56898270|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56898271|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
56898272|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898273|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898274|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56898275|NCT01177683|Doxorubicin|doxorubicin|mesh-list
56898276|NCT01177683|Bortezomib|bortezomib|mesh-list
56898277|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56898278|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56898279|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898280|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56898281|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56898282|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898283|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283632|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
56898284|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56898285|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
56898286|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
56898287|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898288|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898290|NCT03855579|Milrinone|milrinone|mesh-list
56898291|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56898292|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
56898293|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56898294|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56898295|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898296|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898297|NCT03855579|Protective Agents|protective agents|mesh-ancestor
56898298|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898299|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56898300|NCT03855423|Tocotrienols|tocotrienols|mesh-list
56898301|NCT03855423|Vitamin E|vitamin e|mesh-list
56898302|NCT03855423|Tocopherols|tocopherols|mesh-list
56898303|NCT03855423|Tocovid|tocovid|mesh-list
56898304|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
56283781|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898305|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898306|NCT03855423|Protective Agents|protective agents|mesh-ancestor
56898307|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898308|NCT03855423|Vitamins|vitamins|mesh-ancestor
56898309|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
56898310|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56898311|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56898312|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56898313|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
56898314|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283979|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898315|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898316|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898317|NCT01181505|Urological Agents|urological agents|mesh-ancestor
56898318|NCT01290783|Irinotecan|irinotecan|mesh-list
56898319|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56898320|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56898321|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898322|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898323|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898324|NCT03857763|Paclitaxel|paclitaxel|mesh-list
56898325|NCT03857763|Apatinib|apatinib|mesh-list
56898326|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56898327|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898328|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
56898329|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
56898330|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
56898331|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898332|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56898333|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898334|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
56898335|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56898336|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898337|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898338|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56898339|NCT01289769|Analgesics|analgesics|mesh-ancestor
56898340|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
56898341|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284055|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898342|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56898343|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56898344|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56898345|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
56898346|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898347|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898348|NCT01185015|Nicorandil|nicorandil|mesh-list
56898349|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56898350|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56898351|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
56898352|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
56898353|NCT01185015|Vitamins|vitamins|mesh-ancestor
56898354|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
56898355|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898356|NCT01289925|Selenium|selenium|mesh-list
56898357|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
56898358|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898359|NCT01289925|Protective Agents|protective agents|mesh-ancestor
56898360|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898361|NCT01289925|Trace Elements|trace elements|mesh-ancestor
56898362|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
56898364|NCT01290939|Lomustine|lomustine|mesh-list
56898365|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56898366|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898367|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56898368|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56898369|NCT01290939|Growth Substances|growth substances|mesh-ancestor
56898370|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898371|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
56898372|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56898373|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
56898374|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898375|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
56898376|NCT01288755|Rilpivirine|rilpivirine|mesh-list
56898377|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56898378|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56898379|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
56898380|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898381|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56898382|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56898383|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898384|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898385|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56898386|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56898388|NCT01290003|Piperacillin|piperacillin|mesh-list
56898389|NCT01290003|Amikacin|amikacin|mesh-list
56898390|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56898391|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56898392|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898393|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56898394|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898395|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898396|NCT01291095|Cisplatin|cisplatin|mesh-list
56898397|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898398|NCT03739203|Cariprazine|cariprazine|mesh-list
56898399|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
56898400|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898401|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56898402|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56284295|NCT05638087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898403|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898404|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898406|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
56898407|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898408|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56898409|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56898410|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898411|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898412|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56898413|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
56898414|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898415|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898416|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56898417|NCT01182129|Nicotine|nicotine|mesh-list
56898418|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56898419|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
56898420|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898421|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898422|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56898423|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56898424|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
56898425|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898426|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898427|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
56898428|NCT01587729|Serotonin|serotonin|mesh-list
56898429|NCT01587729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56898430|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898431|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56898432|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
56898434|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898435|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898436|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56898437|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56898438|NCT03855267|Propofol|propofol|mesh-list
56898439|NCT03855267|Etomidate|etomidate|mesh-list
56898440|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56898441|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898442|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898443|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56898444|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
56898445|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
56898446|NCT01185873|Ritonavir|ritonavir|mesh-list
56898447|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56898448|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56898449|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
56898450|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898451|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898452|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56898453|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56898454|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
56898455|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898456|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56898457|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56898458|NCT01182597|Pantoprazole|pantoprazole|mesh-list
56898459|NCT01182597|Lansoprazole|lansoprazole|mesh-list
56898460|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
56898461|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56898462|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56898463|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56898464|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898465|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898466|NCT01185951|Polidocanol|polidocanol|mesh-list
56898467|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56898468|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56898469|NCT01186029|Aprepitant|aprepitant|mesh-list
56898470|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
56898471|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
56898472|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898473|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898474|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56898475|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56898476|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898477|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898478|NCT01587807|Dimercaprol|dimercaprol|mesh-list
56898479|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
56284662|NCT00000499|Diuretics|diuretics|mesh-ancestor
56898480|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
56284723|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
56898481|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898483|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56898484|NCT01180179|Lansoprazole|lansoprazole|mesh-list
56898485|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
56898486|NCT01180179|Famotidine|famotidine|mesh-list
56898487|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56284868|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898488|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56898489|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56898490|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285027|NCT00000718|Zidovudine|zidovudine|mesh-list
56898491|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898492|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56898493|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
56898494|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
56898495|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898496|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898497|NCT03856671|Metronidazole|metronidazole|mesh-list
56898498|NCT03856671|Neomycin|neomycin|mesh-list
56898499|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898500|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56898501|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56898502|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56898503|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56898504|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285391|NCT00000940|Ritonavir|ritonavir|mesh-list
56898505|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898506|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56285546|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
56609244|NCT00682435|Hydromorphone|hydromorphone|mesh-list
56898507|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56285616|NCT00001075|Ritonavir|ritonavir|mesh-list
56898508|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
56898509|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898510|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898511|NCT01186497|Rabeprazole|rabeprazole|mesh-list
56898512|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56898513|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56898514|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56286126|NCT00000258|Analgesics|analgesics|mesh-ancestor
56898515|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286199|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56898516|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898518|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
56898519|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898520|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56898521|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56898522|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898523|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898524|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
56898525|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
56898526|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286362|NCT02972476|Xhance|xhance|mesh-list
56898527|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898528|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56898529|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56898530|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
56898531|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56898532|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56898533|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56898534|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56898535|NCT01186653|Fluticasone|fluticasone|mesh-list
56898536|NCT01186653|Budesonide|budesonide|mesh-list
56898537|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
56921116|NCT01124227|Icodextrin|icodextrin|mesh-list
56898538|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56898539|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56898540|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56898541|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56898542|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
56898543|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898544|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898545|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56898546|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
56286708|NCT04862221|Hormones|hormones|mesh-ancestor
56898547|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
56898548|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56898549|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
56898550|NCT01186653|Hormones|hormones|mesh-ancestor
56286909|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286982|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287059|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
56287061|NCT00000687|Zidovudine|zidovudine|mesh-list
56898551|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898552|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56898553|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56898554|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56898555|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
56898556|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898557|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898558|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
56287508|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
56898560|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898561|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
56898562|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
56287659|NCT00000882|Stavudine|stavudine|mesh-list
56898563|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
56287809|NCT02419495|Carboplatin|carboplatin|mesh-list
56287816|NCT02419495|Nivolumab|nivolumab|mesh-list
56898564|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898565|NCT01186887|Celecoxib|celecoxib|mesh-list
56898566|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56898567|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56898568|NCT01186887|Analgesics|analgesics|mesh-ancestor
56288187|NCT00001047|Clarithromycin|clarithromycin|mesh-list
56898569|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
56288265|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898570|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288566|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
56288642|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56898571|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898572|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56898573|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56898574|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56898575|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56898576|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288788|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898577|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898578|NCT01180413|Losartan|losartan|mesh-list
56898579|NCT01180413|Amlodipine|amlodipine|mesh-list
56898580|NCT01180413|Ramipril|ramipril|mesh-list
56898582|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56898583|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56898584|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56898585|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898586|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56898587|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898588|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
56898589|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56898590|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56898591|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56898592|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56898593|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
56898594|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898595|NCT03858387|Meropenem|meropenem|mesh-list
56898596|NCT03858387|Imipenem|imipenem|mesh-list
56898597|NCT03858387|Cilastatin|cilastatin|mesh-list
56898598|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56898599|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898600|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
56898601|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898602|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898603|NCT01289301|Cyclosporine|cyclosporine|mesh-list
56898604|NCT01289301|Sirolimus|sirolimus|mesh-list
56898605|NCT01289301|Everolimus|everolimus|mesh-list
56898606|NCT01289301|Tacrolimus|tacrolimus|mesh-list
56898607|NCT01289301|Cyclosporins|cyclosporins|mesh-list
56898608|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56898609|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56898610|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
56898611|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898612|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288862|NCT00011908|Epratuzumab|epratuzumab|mesh-list
56288977|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898613|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898615|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289133|NCT00005969|Tretinoin|tretinoin|mesh-list
56898616|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
56898617|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289282|NCT00005981|Carmustine|carmustine|mesh-list
56898618|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898619|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56898620|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56898621|NCT02524899|Guanfacine|guanfacine|mesh-list
56289429|NCT00015028|Buprenorphine|buprenorphine|mesh-list
56898622|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56289497|NCT00015340|Narcotics|narcotics|mesh-ancestor
56898623|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56898624|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56898625|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56898626|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
56898627|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898628|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898629|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898631|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56898632|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289900|NCT00017134|Fenretinide|fenretinide|mesh-list
56898633|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
56898635|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898636|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898637|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56290052|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898638|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56898639|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
56898640|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56898641|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56898643|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56898644|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898645|NCT03854175|Estrogens|estrogens|mesh-ancestor
56898646|NCT03854175|Hormones|hormones|mesh-ancestor
56290135|NCT00017758|Efavirenz|efavirenz|mesh-list
56898647|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898648|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290258|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
56898649|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56898650|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
56290340|NCT05680142|Tramadol|tramadol|mesh-list
56898651|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56898652|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56898653|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
56898654|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56898655|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56898656|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898657|NCT03854175|Urological Agents|urological agents|mesh-ancestor
56898659|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
56898660|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898661|NCT01180569|Lenalidomide|lenalidomide|mesh-list
56898662|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
56898663|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898664|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56898665|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56898666|NCT01180569|Growth Substances|growth substances|mesh-ancestor
56898667|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
56898668|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898669|NCT02942264|Temozolomide|temozolomide|mesh-list
56898670|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56898671|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
56898672|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898673|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898674|NCT01180725|Psyllium|psyllium|mesh-list
56898675|NCT01180725|Cathartics|cathartics|mesh-ancestor
56898676|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56898677|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56898678|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
56898679|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898680|NCT01183767|Protective Agents|protective agents|mesh-ancestor
56898681|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898682|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56898683|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56291363|NCT03151369|Morphine|morphine|mesh-list
56291434|NCT03151096|Riboflavin|riboflavin|mesh-list
56898684|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898685|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56898686|NCT03853785|Podophyllin|podophyllin|mesh-list
56291584|NCT02122081|Methotrexate|methotrexate|mesh-list
56291657|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
56291725|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898687|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56898688|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291799|NCT00393445|Incretins|incretins|mesh-ancestor
56898689|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
56898690|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56898691|NCT01290471|U3-1565|u3-1565|mesh-list
56291870|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
56898692|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56898693|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898694|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
56898695|NCT01291563|Bedaquiline|bedaquiline|mesh-list
56898696|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
56292167|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56898697|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56921160|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
56898698|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56898699|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898702|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898703|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898704|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898705|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56898706|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
56898707|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56292758|NCT05566054|Azacitidine|azacitidine|mesh-list
56898708|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898709|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56898710|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56898711|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56898712|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
56898714|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56898715|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
56898716|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292903|NCT04556617|Prednisone|prednisone|mesh-list
56898717|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898718|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56898719|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
56293127|NCT00083902|Thalidomide|thalidomide|mesh-list
56898720|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
56898721|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56898722|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56898723|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56898724|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56898725|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
56898726|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898727|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898728|NCT01290549|Rituximab|rituximab|mesh-list
56898729|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56898730|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898731|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
56898732|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898733|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56898734|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
56898735|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
56898736|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898737|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56898738|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898739|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898741|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898742|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56898743|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898744|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898745|NCT01184391|Valproic Acid|valproic acid|mesh-list
56898746|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
56898747|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293346|NCT00084877|Irinotecan|irinotecan|mesh-list
56898748|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898749|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
56898750|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898751|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898752|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
56898753|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56898754|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898755|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898756|NCT02524743|Acetaminophen|acetaminophen|mesh-list
56898757|NCT02524743|Lidocaine|lidocaine|mesh-list
56898758|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
56898759|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
56898760|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898761|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898762|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
56898763|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898764|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56898765|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56898766|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56898767|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56898768|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898769|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56898770|NCT02524743|Analgesics|analgesics|mesh-ancestor
56898771|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
56898772|NCT01188057|Alprazolam|alprazolam|mesh-list
56898773|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56898774|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898775|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898776|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56898777|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56898778|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898779|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
56898780|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
56898781|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898782|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898783|NCT01291641|Cilostazol|cilostazol|mesh-list
56898784|NCT01291641|Probucol|probucol|mesh-list
56898785|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56898786|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56898787|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
56898788|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898789|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293477|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56898790|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56898791|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
56898793|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56898794|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898795|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56898796|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
56898797|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56898798|NCT01291641|Protective Agents|protective agents|mesh-ancestor
56293582|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
56898800|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56898801|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293740|NCT00087295|Romidepsin|romidepsin|mesh-list
56293805|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56898802|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56898804|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
56898805|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56898806|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
56898807|NCT03855501|Calcium|calcium|mesh-list
56294027|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56898808|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56898809|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898811|NCT01588587|Vildagliptin|vildagliptin|mesh-list
56898812|NCT01588587|Alogliptin|alogliptin|mesh-list
56898813|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56898814|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898815|NCT01588587|Incretins|incretins|mesh-ancestor
56898816|NCT01588587|Hormones|hormones|mesh-ancestor
56294101|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56898817|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56294175|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56898818|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56898820|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898821|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898823|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56898824|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56898825|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898826|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898827|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56294770|NCT00094432|Aripiprazole|aripiprazole|mesh-list
56898828|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56898829|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898830|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56898831|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
56898832|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
56898833|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
56898834|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
56898835|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56295139|NCT00096616|Albuterol|albuterol|mesh-list
56898836|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295215|NCT04340076|Ixekizumab|ixekizumab|mesh-list
56898837|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56898838|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56898839|NCT01293747|Estradiol|estradiol|mesh-list
56898840|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56898842|NCT01293747|Estrogens|estrogens|mesh-ancestor
56898843|NCT01293747|Hormones|hormones|mesh-ancestor
56898844|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898845|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898846|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56898847|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
56898848|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56898849|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56898850|NCT01293747|Progestins|progestins|mesh-ancestor
56898851|NCT03849729|Phentermine|phentermine|mesh-list
56898852|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56898853|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898854|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
56898855|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56898856|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
56295509|NCT00400738|Ritonavir|ritonavir|mesh-list
56898857|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
56898858|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898859|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
56898861|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898862|NCT03325556|Pimavanserin|pimavanserin|mesh-list
56898863|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56898864|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56898865|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56898866|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56898867|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898868|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898869|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898870|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56898871|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56898872|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
56921204|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56898873|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898874|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898875|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
56898876|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56898877|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56898878|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56898879|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898880|NCT03852303|Ivermectin|ivermectin|mesh-list
56898881|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
56898882|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56898883|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898884|NCT01291719|Insulin|insulin|mesh-list
56898885|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56296299|NCT00006461|Etoposide|etoposide|mesh-list
56898886|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898887|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
56898888|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56898889|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56898890|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898891|NCT03325166|Hematinics|hematinics|mesh-ancestor
56898892|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56898893|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56296664|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56898895|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56898896|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56898897|NCT03847623|Analgesics|analgesics|mesh-ancestor
56898898|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
56898899|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898900|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296898|NCT00108238|Estradiol|estradiol|mesh-list
56898902|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56898903|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898904|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898905|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898906|NCT01294059|Milnacipran|milnacipran|mesh-list
56898907|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
56898908|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56297173|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
56898909|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56898910|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56297247|NCT00110695|Paclitaxel|paclitaxel|mesh-list
56297319|NCT00111124|Analgesics|analgesics|mesh-ancestor
56898911|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297542|NCT00007592|Furosemide|furosemide|mesh-list
56898913|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898914|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56898915|NCT01294059|Analgesics|analgesics|mesh-ancestor
56297694|NCT00007787|Cyclosporine|cyclosporine|mesh-list
56898916|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
56898917|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898918|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
56297769|NCT00113698|Enalapril|enalapril|mesh-list
56898919|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898921|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56898922|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
56898923|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56898924|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898925|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56898926|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56898927|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
56898928|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898929|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898930|NCT01294215|Nifedipine|nifedipine|mesh-list
56898931|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56898932|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56898933|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898934|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56898935|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898936|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
56898937|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
56898938|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56898939|NCT01296555|Letrozole|letrozole|mesh-list
56898940|NCT01296555|Fulvestrant|fulvestrant|mesh-list
56898941|NCT01296555|Midazolam|midazolam|mesh-list
56898942|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56898943|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56898944|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56898945|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56898946|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56898947|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56898948|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56898949|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56898950|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
56898951|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
56898952|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
56898953|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
56609688|NCT04082962|Hormones|hormones|mesh-ancestor
56297966|NCT03079440|Capecitabine|capecitabine|mesh-list
56898954|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56898955|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898956|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898957|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56898958|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56898959|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898960|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56898961|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
56298408|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
56898962|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56898963|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56898964|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56898965|NCT01294293|Paclitaxel|paclitaxel|mesh-list
56898966|NCT01294293|Doxorubicin|doxorubicin|mesh-list
56898967|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56898968|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56898969|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56898971|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
56898972|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
56898973|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898974|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56298622|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
56898975|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56898976|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56898977|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898978|NCT01294605|Edetic Acid|edetic acid|mesh-list
56898979|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
56898980|NCT01294605|Antidotes|antidotes|mesh-ancestor
56898981|NCT01294605|Protective Agents|protective agents|mesh-ancestor
56898982|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299007|NCT00121147|Travoprost|travoprost|mesh-list
56898983|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
56898984|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
56898985|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898986|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56898987|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
56898988|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56898989|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
56898990|NCT01294761|Darunavir|darunavir|mesh-list
56898991|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56898992|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56898993|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
56898994|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56898995|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56898996|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56898997|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56898998|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56898999|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56899000|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56899002|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
56899003|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
56899005|NCT03942224|Bortezomib|bortezomib|mesh-list
56899006|NCT03942224|Daratumumab|daratumumab|mesh-list
56899008|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899009|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
56899010|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
56899011|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899012|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899013|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56899014|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
56899015|NCT03942224|Hormones|hormones|mesh-ancestor
56899016|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899017|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56299946|NCT00020644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56899018|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899019|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
56899020|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300096|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
56300170|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
56899021|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300246|NCT00388700|Vitamins|vitamins|mesh-ancestor
56899022|NCT03305666|Bupivacaine|bupivacaine|mesh-list
56899023|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
56899024|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
56300322|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
56899025|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899026|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899027|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
56300473|NCT00010881|Antioxidants|antioxidants|mesh-list
56899028|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899029|NCT01194843|Ropivacaine|ropivacaine|mesh-list
56899030|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
56899031|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
56300544|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899032|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56300691|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899033|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300766|NCT00023881|Bortezomib|bortezomib|mesh-list
56899034|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
56899035|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899036|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
56899037|NCT01297023|Vitamin D|vitamin d|mesh-list
56899038|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
56899039|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
56899040|NCT01297023|Vitamins|vitamins|mesh-list
56899041|NCT01297023|Calcium|calcium|mesh-list
56899042|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
56300993|NCT00024466|Vaccines|vaccines|mesh-list
56899043|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899044|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56301151|NCT00025402|Interferons|interferons|mesh-list
56899045|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56899046|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
56899047|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56899048|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56899049|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
56899050|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899051|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899052|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56899053|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301591|NCT00000461|Vitamins|vitamins|mesh-ancestor
56899054|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56899055|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899056|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301815|NCT00027898|Etoposide|etoposide|mesh-list
56899057|NCT04781426|Tenofovir|tenofovir|mesh-list
56899058|NCT04781426|Lamivudine|lamivudine|mesh-list
56899059|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
56899060|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899061|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56899062|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56899063|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302201|NCT00012324|Nolatrexed|nolatrexed|mesh-list
56302335|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56899064|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899065|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56899066|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56899067|NCT01292031|Meropenem|meropenem|mesh-list
56899068|NCT01292031|Colistin|colistin|mesh-list
56899069|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56899070|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899071|NCT04633226|Vaccines|vaccines|mesh-list
56899072|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
56899073|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899074|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
56899075|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56899076|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
56899077|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
56899078|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899079|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899080|NCT01188759|Voriconazole|voriconazole|mesh-list
56899081|NCT01188759|Anidulafungin|anidulafungin|mesh-list
56899082|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
56899084|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56899085|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56899086|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899087|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899088|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56899089|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
56303224|NCT00000620|Benazepril|benazepril|mesh-list
56303296|NCT00033319|Analgesics|analgesics|mesh-ancestor
56899090|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899091|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899092|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56899093|NCT03904550|Rocuronium|rocuronium|mesh-list
56899094|NCT03904550|Cisatracurium|cisatracurium|mesh-list
56899095|NCT03904550|Neostigmine|neostigmine|mesh-list
56899096|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56899097|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56899098|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56303519|NCT00389129|Aspirin|aspirin|mesh-list
56899099|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303594|NCT02971540|Dipyrone|dipyrone|mesh-list
56899100|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899101|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56899102|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899103|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899104|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
56899105|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899106|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56899107|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
56899109|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
56899110|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
56899111|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899112|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
56899113|NCT01292109|Cathartics|cathartics|mesh-ancestor
56899114|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56899115|NCT01191645|Remifentanil|remifentanil|mesh-list
56899116|NCT01191645|Metoclopramide|metoclopramide|mesh-list
56899117|NCT01191645|Naloxone|naloxone|mesh-list
56899118|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56899119|NCT01191645|Narcotics|narcotics|mesh-ancestor
56303724|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303796|NCT00000689|Doxorubicin|doxorubicin|mesh-list
56899120|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899121|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899122|NCT01191645|Analgesics|analgesics|mesh-ancestor
56303877|NCT00000710|Didanosine|didanosine|mesh-list
56899123|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
56899124|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899126|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
56899128|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56899129|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56899130|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56899132|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899133|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899136|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899137|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
56899138|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
56304618|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
55888652|NCT01772147|Xhance|xhance|mesh-list
56899139|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899141|NCT01295151|Etanercept|etanercept|mesh-list
56899142|NCT01295151|Golimumab|golimumab|mesh-list
56899143|NCT01295151|Rituximab|rituximab|mesh-list
56899144|NCT01295151|Abatacept|abatacept|mesh-list
56899145|NCT01295151|Infliximab|infliximab|mesh-list
56899146|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
56899147|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56899148|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899149|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
56899150|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899151|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56899152|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899153|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
56899154|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56899155|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56899156|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56899157|NCT01295151|Analgesics|analgesics|mesh-ancestor
56899158|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
56899160|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56899161|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56899162|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899163|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56899164|NCT01295307|Clofarabine|clofarabine|mesh-list
56899165|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56899166|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
56304970|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899167|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899168|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899169|NCT01292343|Listerine|listerine|mesh-list
56899170|NCT01292343|Triclosan|triclosan|mesh-list
56899171|NCT01292343|Fluorides|fluorides|mesh-list
56899172|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
56899173|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
56899174|NCT01292343|Protective Agents|protective agents|mesh-ancestor
56899175|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305037|NCT00001001|Zidovudine|zidovudine|mesh-list
56899176|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56899177|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305189|NCT00001040|Zidovudine|zidovudine|mesh-list
56305271|NCT00015951|Cytarabine|cytarabine|mesh-list
56899178|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56899179|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56899180|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
56899181|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899182|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56899183|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
56899184|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
56899186|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
56899187|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899188|NCT05671029|Moxifloxacin|moxifloxacin|mesh-list
56899189|NCT05671029|Pritelivir|pritelivir|mesh-list
56305631|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305704|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56899190|NCT05671029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56899191|NCT05671029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56899192|NCT05671029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899193|NCT05671029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56305854|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56899194|NCT05671029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56899195|NCT05671029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306003|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
56899196|NCT05671029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899197|NCT05671029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306102|NCT00040690|Leucovorin|leucovorin|mesh-list
56899198|NCT05671029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56899199|NCT05671029|Contraceptive Agents|contraceptive agents|mesh-ancestor
56899200|NCT05671029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56899201|NCT05671029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899202|NCT05671029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56899203|NCT05671029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56899204|NCT05671029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56899206|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56899207|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
56899208|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899209|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56899210|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
56899211|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899212|NCT01192503|Rasagiline|rasagiline|mesh-list
56899213|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56306290|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
56899214|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306361|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56306436|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899215|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899216|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56899217|NCT01192503|Protective Agents|protective agents|mesh-ancestor
56899218|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899219|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56899220|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
56899221|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
56899222|NCT03851289|Calcium|calcium|mesh-list
56899223|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56899224|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899225|NCT03733899|Anesthetics|anesthetics|mesh-list
56899226|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899227|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899228|NCT01196013|Clofarabine|clofarabine|mesh-list
56899229|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56899230|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
56899231|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899232|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899233|NCT01196169|Vancomycin|vancomycin|mesh-list
56899234|NCT01196169|Daptomycin|daptomycin|mesh-list
56899235|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56899236|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899237|NCT01196481|Carvedilol|carvedilol|mesh-list
56899238|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56899239|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56047874|NCT03081117|Insulin|insulin|mesh-list
56899241|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899242|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899243|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899244|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56899246|NCT01196481|Protective Agents|protective agents|mesh-ancestor
56899247|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56899248|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56899249|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56899250|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
56308210|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899251|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56899252|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56899253|NCT05283057|Empagliflozin|empagliflozin|mesh-list
56308441|NCT00053599|Simvastatin|simvastatin|mesh-list
56899254|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56899255|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899257|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899258|NCT01193595|Bevacizumab|bevacizumab|mesh-list
56899259|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56899260|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899261|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56899262|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56899263|NCT01193595|Growth Substances|growth substances|mesh-ancestor
56899264|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899265|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
56899266|NCT01196559|Gemcitabine|gemcitabine|mesh-list
56899267|NCT01196559|Vinorelbine|vinorelbine|mesh-list
56899268|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56899269|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
56308644|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56899270|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308791|NCT00055432|Pemetrexed|pemetrexed|mesh-list
56899272|NCT01196559|Antiviral Agents|antiviral agents|mesh-ancestor
56308956|NCT00056329|Vitamin E|vitamin e|mesh-list
56899273|NCT01196559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309019|NCT00056797|Interleukin-2|interleukin-2|mesh-list
56899274|NCT01196559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899275|NCT01196559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56899276|NCT01196559|Immunologic Factors|immunologic factors|mesh-ancestor
56309177|NCT00058084|Prednisone|prednisone|mesh-list
56899277|NCT01196559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309239|NCT00058318|Gemcitabine|gemcitabine|mesh-list
56309310|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
56899278|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309386|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
56899279|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
56899280|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
56899281|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
56899282|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56899284|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56899286|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899287|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56899288|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56899289|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56899290|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56309976|NCT00063076|Bexarotene|bexarotene|mesh-list
56899291|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899292|NCT01581177|Albuterol|albuterol|mesh-list
56310050|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
56899293|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56899294|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
56899295|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310197|NCT04488081|Cyproheptadine|cyproheptadine|mesh-list
56899296|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899297|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56899298|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899299|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
56899300|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56899301|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56899302|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56899303|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56899304|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
56899305|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899306|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899307|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
56899308|NCT01580007|Vitamin D|vitamin d|mesh-list
56899309|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56310498|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899310|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56899312|NCT01580007|Vitamins|vitamins|mesh-ancestor
56899313|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
56899314|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56899315|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310709|NCT02966587|Durvalumab|durvalumab|mesh-list
56899316|NCT01189695|Ritonavir|ritonavir|mesh-list
56899317|NCT01189695|Lopinavir|lopinavir|mesh-list
56899318|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56899319|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56899320|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
56899321|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899322|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899323|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56311152|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
56899325|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
56899326|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899327|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56899328|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56899331|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56899332|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899334|NCT01189773|Codeine|codeine|mesh-list
56899335|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56311523|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
56899336|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56899337|NCT01189773|Analgesics|analgesics|mesh-ancestor
56899338|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
56311743|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899339|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311899|NCT00077311|Docetaxel|docetaxel|mesh-list
56899341|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899342|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56899343|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56311979|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
56899344|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899345|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899346|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56899347|NCT01189773|Narcotics|narcotics|mesh-ancestor
56899348|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899349|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
56899350|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899351|NCT01189929|Gemcitabine|gemcitabine|mesh-list
56899352|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56899353|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56899354|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
56899355|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899356|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899357|NCT01189929|Antiviral Agents|antiviral agents|mesh-ancestor
56899358|NCT01189929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899359|NCT01189929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899360|NCT01189929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56899361|NCT01189929|Immunologic Factors|immunologic factors|mesh-ancestor
56899362|NCT01189929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899363|NCT03845673|Psyllium|psyllium|mesh-list
56899364|NCT03845673|Cathartics|cathartics|mesh-ancestor
56312094|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56899365|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56899367|NCT01190163|Dinoprostone|dinoprostone|mesh-list
56899368|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
56899369|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56312321|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
56899370|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899371|NCT01199445|Vitamin A|vitamin a|mesh-list
56899372|NCT01199445|Vitamins|vitamins|mesh-ancestor
56899373|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
56899374|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899375|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
56899376|NCT01199523|Mirabegron|mirabegron|mesh-list
56899377|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56899378|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312622|NCT00390260|Rofecoxib|rofecoxib|mesh-list
56312696|NCT00081835|Antibodies|antibodies|mesh-list
56899379|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312768|NCT00083083|Paclitaxel|paclitaxel|mesh-list
56312837|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
56899380|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56899381|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899382|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899383|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899384|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899385|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56899387|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56899388|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
56899389|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899390|NCT01199523|Urological Agents|urological agents|mesh-ancestor
56899391|NCT01190241|Everolimus|everolimus|mesh-list
56899392|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56899393|NCT01190241|Sorafenib|sorafenib|mesh-list
56899394|NCT01190241|Sunitinib|sunitinib|mesh-list
56899395|NCT01190241|Lapatinib|lapatinib|mesh-list
56899396|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313070|NCT03151239|Vitamins|vitamins|mesh-ancestor
56899397|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56899398|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
56313126|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899399|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899400|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56313280|NCT00137761|Docetaxel|docetaxel|mesh-list
56899401|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899402|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899403|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56899404|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56899405|NCT01190241|Growth Substances|growth substances|mesh-ancestor
56921445|NCT03620318|Crenolanib|crenolanib|mesh-list
56899406|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
56899407|NCT01197261|Oxycodone|oxycodone|mesh-list
56899408|NCT01197261|Naloxone|naloxone|mesh-list
56899409|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56610144|NCT05086874|Protective Agents|protective agents|mesh-ancestor
56899410|NCT01197261|Narcotics|narcotics|mesh-ancestor
56899411|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899412|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899413|NCT01197261|Analgesics|analgesics|mesh-ancestor
56313423|NCT03150732|Analgesics|analgesics|mesh-ancestor
56899414|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
56899415|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899416|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56899417|NCT01190553|Amantadine|amantadine|mesh-list
56899418|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56899419|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56899420|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
56899421|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899422|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
56899423|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899424|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899425|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899426|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56899427|NCT01190553|Analgesics|analgesics|mesh-ancestor
56899428|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
56899429|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899430|NCT01199757|Fluticasone|fluticasone|mesh-list
56899431|NCT01199757|Xhance|xhance|mesh-list
56899432|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
56899433|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899434|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56899435|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
56899436|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899437|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899438|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56899439|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899440|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
56899441|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56899442|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
56899443|NCT03302234|Ipilimumab|ipilimumab|mesh-list
56899444|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56899445|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899446|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56899447|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899448|NCT03843879|Lidocaine|lidocaine|mesh-list
56899449|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
56899450|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
56899451|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899452|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899453|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
56899454|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899455|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56899456|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56899457|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56899458|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56899459|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899460|NCT03850587|Celecoxib|celecoxib|mesh-list
56899461|NCT03850587|Tramadol|tramadol|mesh-list
56899462|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56899463|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56899464|NCT03850587|Analgesics|analgesics|mesh-ancestor
56899465|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
56899466|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313566|NCT00139555|Benazepril|benazepril|mesh-list
56899467|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899468|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899469|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56899470|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56899471|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56899472|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899473|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899475|NCT03850587|Narcotics|narcotics|mesh-ancestor
56313741|NCT00140530|Sirolimus|sirolimus|mesh-list
56899476|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899477|NCT01199835|Calcium|calcium|mesh-list
56899478|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56899479|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899480|NCT05671497|Antirheumatic Agents|antirheumatic agents|mesh-list
56899481|NCT05671497|Cilostazol|cilostazol|mesh-list
56899482|NCT05671497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56899483|NCT05671497|Autonomic Agents|autonomic agents|mesh-ancestor
56899484|NCT05671497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610219|NCT02852798|Docetaxel|docetaxel|mesh-list
56899485|NCT05671497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899486|NCT05671497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56899487|NCT05671497|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899488|NCT05671497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56899489|NCT05671497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56899490|NCT05671497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899491|NCT05671497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56899492|NCT05671497|Vasodilator Agents|vasodilator agents|mesh-ancestor
56899493|NCT05671497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56899494|NCT05671497|Protective Agents|protective agents|mesh-ancestor
56313969|NCT00141544|Estrogens|estrogens|mesh-list
56899495|NCT05671497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56899496|NCT05671497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56899497|NCT05671497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899498|NCT03915626|Rivastigmine|rivastigmine|mesh-list
56314171|NCT00143065|Rituximab|rituximab|mesh-list
56314315|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899499|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56899500|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314464|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
56899501|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899502|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
56314553|NCT05594602|Analgesics|analgesics|mesh-ancestor
56899503|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899504|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314701|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56314778|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
56899505|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56899506|NCT03915626|Protective Agents|protective agents|mesh-ancestor
56899508|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56314932|NCT01806675|Glycine|glycine|mesh-list
56899509|NCT04491968|Narcotics|narcotics|mesh-ancestor
56899510|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899511|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899512|NCT04491968|Analgesics|analgesics|mesh-ancestor
56315142|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
56899513|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
56899514|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899515|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
56899516|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899517|NCT05668455|Dexamethasone|dexamethasone|mesh-list
56899518|NCT05668455|Hydrocortisone|hydrocortisone|mesh-list
56315364|NCT01903421|Narcotics|narcotics|mesh-ancestor
56899520|NCT05668455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899521|NCT05668455|Antiemetics|antiemetics|mesh-ancestor
56899522|NCT05668455|Autonomic Agents|autonomic agents|mesh-ancestor
56899523|NCT05668455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899524|NCT05668455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899525|NCT05668455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56899526|NCT05668455|Glucocorticoids|glucocorticoids|mesh-ancestor
56899527|NCT05668455|Hormones|hormones|mesh-ancestor
56899528|NCT05668455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899529|NCT05668455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56899530|NCT05668455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899531|NCT05668455|Plasma Substitutes|plasma substitutes|mesh-ancestor
56899532|NCT05668455|Blood Substitutes|blood substitutes|mesh-ancestor
56899533|NCT03313076|Vitamin D|vitamin d|mesh-list
56899534|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
56899535|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
56899536|NCT03313076|Vitamins|vitamins|mesh-list
56899537|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
56899538|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899539|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56316187|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316262|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56899542|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
56899543|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899544|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899545|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56899546|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56899547|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
56899549|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
56899550|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
56899551|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56899553|NCT01200537|Estrogens|estrogens|mesh-ancestor
56899554|NCT01200537|Hormones|hormones|mesh-ancestor
56921516|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56899555|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899556|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899557|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56899558|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56316923|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56899559|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56316998|NCT01784159|Analgesics|analgesics|mesh-ancestor
56899560|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56899561|NCT01198353|Ziprasidone|ziprasidone|mesh-list
56317148|NCT01678586|Analgesics|analgesics|mesh-ancestor
56899563|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
56899564|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317299|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56899565|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899566|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899567|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56899568|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56899569|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899570|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56899571|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56317742|NCT00128739|Hormones|hormones|mesh-ancestor
56317817|NCT00017576|Vitamins|vitamins|mesh-ancestor
56899572|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
56899573|NCT01200693|Sirolimus|sirolimus|mesh-list
56899574|NCT01200693|Everolimus|everolimus|mesh-list
56317891|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
56899575|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899576|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317972|NCT00018200|Benztropine|benztropine|mesh-list
56899577|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
56899578|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899579|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56899580|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899581|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318111|NCT00019227|Antidotes|antidotes|mesh-ancestor
56899582|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
56921533|NCT05790044|Bupivacaine|bupivacaine|mesh-list
56921534|NCT05790044|Anesthetics, Local|anesthetics, local|mesh-ancestor
56921535|NCT05790044|Anesthetics|anesthetics|mesh-ancestor
56921536|NCT05790044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921537|NCT05790044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921538|NCT05790044|Sensory System Agents|sensory system agents|mesh-ancestor
56921539|NCT05790044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921540|NCT05790044|Analgesics|analgesics|mesh-ancestor
56921541|NCT05790044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56899583|NCT03844581|Propiverine|propiverine|mesh-list
56899584|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
56899585|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
56899586|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318409|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
56899587|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899588|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56899589|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56899590|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
56318715|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
56318795|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
56899591|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899592|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899593|NCT03844581|Urological Agents|urological agents|mesh-ancestor
56899594|NCT01202097|Fluticasone|fluticasone|mesh-list
56899595|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56899596|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56899597|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899598|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56899599|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
56899600|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899601|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899602|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56899603|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899604|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
56899605|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56899606|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56899607|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56899608|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56899609|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
56319457|NCT04857827|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56899611|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899612|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
56899613|NCT01202097|Hormones|hormones|mesh-ancestor
56921577|NCT05789680|Parathyroid Hormone|parathyroid hormone|mesh-list
56921578|NCT05789680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56921579|NCT05789680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921580|NCT05789667|Lenvatinib|lenvatinib|mesh-list
56921581|NCT05789667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899614|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899615|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
56899616|NCT05670015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56319679|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56899617|NCT05670015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56899618|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
56899619|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
56899620|NCT01201005|Hematinics|hematinics|mesh-ancestor
56899621|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
56899622|NCT01201005|Vitamins|vitamins|mesh-ancestor
56899623|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
56319992|NCT03959540|Levodopa|levodopa|mesh-list
56899624|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899625|NCT01198665|Prednisolone|prednisolone|mesh-list
56899626|NCT01198665|Doxorubicin|doxorubicin|mesh-list
56899627|NCT01198665|Vincristine|vincristine|mesh-list
56899628|NCT01198665|Everolimus|everolimus|mesh-list
56899629|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56899630|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899631|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56899632|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56610368|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56899633|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899634|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899635|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56899636|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
56899637|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
56899638|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
56899639|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56899640|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
56320649|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
56899641|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899642|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899643|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
56320799|NCT03151499|Rifampin|rifampin|mesh-list
56899645|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899646|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56899647|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56899648|NCT05030415|Ixekizumab|ixekizumab|mesh-list
56899649|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
56899650|NCT01198821|Gemcitabine|gemcitabine|mesh-list
56899651|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56899653|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321247|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
56899654|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321329|NCT01806857|Quinidine|quinidine|mesh-list
56899655|NCT01198821|Antiviral Agents|antiviral agents|mesh-ancestor
56899656|NCT01198821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899657|NCT01198821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899658|NCT01198821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56899659|NCT01198821|Immunologic Factors|immunologic factors|mesh-ancestor
56899660|NCT01198821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899661|NCT05013801|Hydroquinone|hydroquinone|mesh-list
56899662|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
56899663|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899664|NCT05013801|Protective Agents|protective agents|mesh-ancestor
56321823|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56899665|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899666|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56321971|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
56899668|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56322046|NCT00038220|Tenofovir|tenofovir|mesh-list
56322126|NCT00396747|Infliximab|infliximab|mesh-list
56899669|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56899670|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899671|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322195|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899672|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56322270|NCT05382546|Ketorolac|ketorolac|mesh-list
56899673|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56322358|NCT00277043|Taxane|taxane|mesh-list
56899674|NCT01566669|Analgesics|analgesics|mesh-ancestor
56899675|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
56899676|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899677|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899678|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899679|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56899680|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
56899681|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56899682|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
56322786|NCT00275054|Rituximab|rituximab|mesh-list
56899683|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56322933|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56899684|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56323006|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
56899685|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899686|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56899687|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899688|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56899689|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899690|NCT01201161|Ranibizumab|ranibizumab|mesh-list
56899691|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56323313|NCT05765305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56899693|NCT01201161|Growth Substances|growth substances|mesh-ancestor
56921665|NCT05789303|Hormones|hormones|mesh-ancestor
56899694|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899695|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
56899696|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899697|NCT03841383|Dipyridamole|dipyridamole|mesh-list
56899698|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56899699|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899700|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899701|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56899702|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
56899703|NCT03841305|Liver Extracts|liver extracts|mesh-list
56899704|NCT03841305|Hematinics|hematinics|mesh-ancestor
56899705|NCT05667987|Lidocaine|lidocaine|mesh-list
56899706|NCT05667987|Anesthetics, Local|anesthetics, local|mesh-ancestor
56899707|NCT05667987|Anesthetics|anesthetics|mesh-ancestor
56899708|NCT05667987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610442|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56899709|NCT05667987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899710|NCT05667987|Sensory System Agents|sensory system agents|mesh-ancestor
56899711|NCT05667987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899712|NCT05667987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56899713|NCT05667987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56899714|NCT05667987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56323620|NCT05503797|Cobicistat|cobicistat|mesh-list
56899715|NCT05667987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56323692|NCT05438043|Hormones|hormones|mesh-ancestor
56899716|NCT05667987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899717|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
56899719|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56899720|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
56899721|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899722|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56324066|NCT05071664|Golimumab|golimumab|mesh-list
56899724|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899725|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899726|NCT01199367|Letrozole|letrozole|mesh-list
56899727|NCT01199367|Lapatinib|lapatinib|mesh-list
56899728|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899729|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56899730|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56899731|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324441|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56899732|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899733|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56899734|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
56899735|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899736|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899737|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56899739|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
56899740|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
56921666|NCT05789303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899741|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324738|NCT04315948|Interferons|interferons|mesh-list
56899742|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899743|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899744|NCT01203735|Valproic Acid|valproic acid|mesh-list
56899745|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
56899746|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324885|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56899747|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899748|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
56899749|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899750|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899751|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
56325040|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
56899752|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56325192|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
56899753|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899754|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56899755|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
56899756|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
56899757|NCT03979599|Analgesics|analgesics|mesh-ancestor
56325333|NCT03456843|Vitamins|vitamins|mesh-ancestor
56899758|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
56325408|NCT03412565|Prednisone|prednisone|mesh-list
56899759|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325715|NCT02697448|Propofol|propofol|mesh-list
56899760|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947607|NCT01459679|Riboflavin|riboflavin|mesh-list
56899761|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
56899762|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899763|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56899764|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
56899765|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56325938|NCT02213757|Hormones|hormones|mesh-ancestor
56899766|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56326013|NCT02076009|Dexamethasone|dexamethasone|mesh-list
56326085|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
56326237|NCT05772871|Levamisole|levamisole|mesh-list
56899767|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899768|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56899769|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
56899770|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56899771|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
56899772|NCT03842631|Timolol|timolol|mesh-list
56899773|NCT03842631|Maleic acid|maleic acid|mesh-list
56899774|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326611|NCT05680584|Histamine Antagonists|histamine antagonists|mesh-ancestor
56899775|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899776|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56899777|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56899779|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899780|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899781|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56899782|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56899783|NCT05669781|Metoclopramide|metoclopramide|mesh-list
56899784|NCT05669781|Antiemetics|antiemetics|mesh-ancestor
56899785|NCT05669781|Autonomic Agents|autonomic agents|mesh-ancestor
56899786|NCT05669781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326780|NCT05625412|Antimetabolites|antimetabolites|mesh-ancestor
56899787|NCT05669781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899788|NCT05669781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56899789|NCT05669781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56899790|NCT05669781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56899791|NCT05669781|Dopamine Agents|dopamine agents|mesh-ancestor
56899792|NCT05669781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899793|NCT05669781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899795|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56327171|NCT05007041|Vaccines|vaccines|mesh-list
56899796|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56327336|NCT04752163|Rituximab|rituximab|mesh-list
56899797|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56899799|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56327561|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56899800|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56899801|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56899802|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56899803|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56899804|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56899805|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
56899806|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327828|NCT04240106|Niraparib|niraparib|mesh-list
56899807|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327904|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56899808|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899809|NCT01204125|Paclitaxel|paclitaxel|mesh-list
56899811|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56899812|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899813|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
56899814|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
56899815|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
56899816|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899817|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56899818|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899819|NCT03074240|Anesthetics|anesthetics|mesh-list
56899820|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
56899821|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899822|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899823|NCT03725085|Guaifenesin|guaifenesin|mesh-list
56899824|NCT03725085|Expectorants|expectorants|mesh-ancestor
56899825|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899826|NCT03755804|Prednisone|prednisone|mesh-list
56899827|NCT03755804|Prednisolone|prednisolone|mesh-list
56899828|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
56899829|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56899830|NCT03755804|Dacarbazine|dacarbazine|mesh-list
56899831|NCT03755804|Doxorubicin|doxorubicin|mesh-list
56899832|NCT03755804|Etoposide|etoposide|mesh-list
56899833|NCT03755804|Vincristine|vincristine|mesh-list
56899834|NCT03755804|Bleomycin|bleomycin|mesh-list
56899835|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56899836|NCT03755804|Vinblastine|vinblastine|mesh-list
56899837|NCT03755804|Imidazole|imidazole|mesh-list
56899838|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56899839|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
56899840|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899841|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56899842|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56899843|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
56328063|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
56899844|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899845|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899846|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56899847|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56899848|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56328368|NCT03007147|Vincristine|vincristine|mesh-list
56899849|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56899850|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899851|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56328498|NCT02752035|Azacitidine|azacitidine|mesh-list
56899852|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
56899853|NCT03755804|Hormones|hormones|mesh-ancestor
56899854|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899855|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56899856|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56899857|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
56899858|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
56899859|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56899860|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56899862|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56899863|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
56328630|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
56899864|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56899865|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56899867|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
56899868|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899869|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899870|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56899871|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56899872|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56899873|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899874|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
56899875|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899876|NCT04311099|Ropivacaine|ropivacaine|mesh-list
56329077|NCT00039351|Hormones|hormones|mesh-ancestor
56899877|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
56329229|NCT00039858|Argatroban|argatroban|mesh-list
56329295|NCT00040014|Exemestane|exemestane|mesh-list
56899878|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
56899879|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899880|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899881|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
56899882|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899883|NCT03559010|Norgestrel|norgestrel|mesh-list
56329672|NCT00021671|Metronidazole|metronidazole|mesh-list
56899884|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56899885|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56899886|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56899887|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
56329827|NCT00022022|Docetaxel|docetaxel|mesh-list
56899888|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56899889|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899890|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56899891|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56899893|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899894|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
56899895|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
56899896|NCT03297398|Androgens|androgens|mesh-list
56899897|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56899898|NCT03297398|Hormones|hormones|mesh-ancestor
56899899|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56899900|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899901|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
56330028|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899902|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899903|NCT03297398|Protective Agents|protective agents|mesh-ancestor
56899904|NCT03297398|Vitamins|vitamins|mesh-ancestor
56899905|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
56899906|NCT03297398|Estrogens|estrogens|mesh-ancestor
56899907|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56899908|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899909|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
56899910|NCT03293654|Bevacizumab|bevacizumab|mesh-list
56899911|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56899912|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899913|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56899914|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56899915|NCT03293654|Growth Substances|growth substances|mesh-ancestor
56899916|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899917|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
56899918|NCT03930615|Letermovir|letermovir|mesh-list
56899919|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56899920|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330235|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
56899921|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899922|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330313|NCT00023738|Ifosfamide|ifosfamide|mesh-list
56899923|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
56899924|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899925|NCT03838029|Etodolac|etodolac|mesh-list
56899926|NCT03838029|Propranolol|propranolol|mesh-list
56899927|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56330468|NCT00024128|Cyclosporine|cyclosporine|mesh-list
56899928|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56899929|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
56899930|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899931|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899932|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899933|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56899934|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56899935|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
56330913|NCT00053157|Sargramostim|sargramostim|mesh-list
56899936|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56899937|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56899938|NCT03838029|Analgesics|analgesics|mesh-ancestor
56331140|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56899939|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
56899940|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899941|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899942|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331292|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899943|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56899944|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56899945|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56331363|NCT00054600|Methoxsalen|methoxsalen|mesh-list
56331434|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56331507|NCT00027521|Bleomycin|bleomycin|mesh-list
56331508|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56904669|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331584|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56904670|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904671|NCT02088424|Insulin|insulin|mesh-list
56904672|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56904673|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904674|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56904675|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56904676|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56331953|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56904677|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56332030|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904678|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904679|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
56904680|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904681|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904682|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56904683|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904685|NCT02088502|Theophylline|theophylline|mesh-list
56904686|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56904687|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
56904688|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904689|NCT02088502|Expectorants|expectorants|mesh-ancestor
56904690|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899946|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
56899947|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56899948|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
56899949|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899950|NCT04708340|Protective Agents|protective agents|mesh-ancestor
56899951|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899952|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
56899953|NCT03292640|Tazarotene|tazarotene|mesh-list
56899954|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
56899955|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
56899956|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
56899957|NCT03292640|Vitamins|vitamins|mesh-ancestor
56899958|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
56332541|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
56899959|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899960|NCT01567215|Ethanol|ethanol|mesh-list
56899961|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
56899962|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56899963|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56899964|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899965|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899966|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
56899967|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56899968|NCT02722941|Panobinostat|panobinostat|mesh-list
56899969|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56899970|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56899971|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56899972|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899975|NCT01202487|Tetracaine|tetracaine|mesh-list
56332904|NCT00060567|Irinotecan|irinotecan|mesh-list
56899976|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
56899977|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
56899978|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56899979|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56899980|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
56333113|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56899981|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56899982|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56899983|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56333262|NCT00034190|Paclitaxel|paclitaxel|mesh-list
56899984|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56899985|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333407|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
56921751|NCT05789017|Prednisone|prednisone|mesh-list
56899986|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56899987|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56899988|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56899990|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56899991|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56899992|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56333777|NCT00063453|Selenium|selenium|mesh-list
56899993|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
56899994|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56899995|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
56899996|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
56899997|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
56899999|NCT01204437|Paclitaxel|paclitaxel|mesh-list
56398740|NCT00150137|Methimazole|methimazole|mesh-list
56900000|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
56900001|NCT01204437|Capecitabine|capecitabine|mesh-list
56900002|NCT01204437|Methotrexate|methotrexate|mesh-list
56900003|NCT01204437|Epirubicin|epirubicin|mesh-list
56398868|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56900004|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56900005|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56399061|NCT03777904|Iron|iron|mesh-list
56900006|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
56900007|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
56900008|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
56900009|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900010|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56900011|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
56900012|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900013|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56900014|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56900015|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
56900016|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56900017|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56900018|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
56900019|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56900020|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
56900021|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56900022|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
56900023|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900024|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56900025|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56900026|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56900027|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56900028|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56900029|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
56900030|NCT02633241|Propofol|propofol|mesh-list
56900031|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56900032|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900033|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900034|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56900036|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
56900037|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56900038|NCT02633241|Analgesics|analgesics|mesh-ancestor
56399580|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
56900039|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
56900040|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900041|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56900042|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56399721|NCT05060068|Ketamine|ketamine|mesh-list
56900043|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56900044|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
56900045|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900046|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900047|NCT03292016|Apomorphine|apomorphine|mesh-list
56900048|NCT03292016|Emetics|emetics|mesh-ancestor
56399934|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
56900049|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900050|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
56400010|NCT00165048|Rofecoxib|rofecoxib|mesh-list
56400078|NCT02935933|Bupivacaine|bupivacaine|mesh-list
56900051|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900052|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56400156|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
56900053|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
56900054|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
56400228|NCT02934919|Nalmefene|nalmefene|mesh-list
56900055|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400376|NCT00165399|Docetaxel|docetaxel|mesh-list
56900056|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900057|NCT05669391|Antidepressive Agents|antidepressive agents|mesh-list
56900058|NCT05669391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56900059|NCT01206075|Plerixafor|plerixafor|mesh-list
56400538|NCT00153881|Docetaxel|docetaxel|mesh-list
56900060|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56900061|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56400680|NCT02924233|Nivolumab|nivolumab|mesh-list
56900062|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
56900063|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900064|NCT03289676|Nicotine|nicotine|mesh-list
56900065|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56900066|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
56900067|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900068|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900069|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56900070|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56900071|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
56900072|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900073|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900074|NCT03834831|Selenium|selenium|mesh-list
56900075|NCT03834831|Ubiquinone|ubiquinone|mesh-list
56900076|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
56900077|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
56900078|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900079|NCT03834831|Protective Agents|protective agents|mesh-ancestor
56900080|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900081|NCT03834831|Trace Elements|trace elements|mesh-ancestor
56900082|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
56900083|NCT03834831|Vitamins|vitamins|mesh-ancestor
56900084|NCT01206153|Metformin|metformin|mesh-list
56900085|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56900086|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900087|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
56900088|NCT03760575|Pemetrexed|pemetrexed|mesh-list
56900089|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401109|NCT02909413|Desflurane|desflurane|mesh-list
56900090|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56401190|NCT00533299|Hydralazine|hydralazine|mesh-list
56900091|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900092|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900093|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56900094|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56900095|NCT01298271|Propranolol|propranolol|mesh-list
56900096|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56900097|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56900098|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
56900099|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900100|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900101|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900102|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56900103|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56921776|NCT05788913|Heparin|heparin|mesh-list
56900104|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
56900105|NCT03289208|Edaravone|edaravone|mesh-list
56900106|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56900107|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
56900108|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900109|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56900110|NCT03289208|Protective Agents|protective agents|mesh-ancestor
56401601|NCT05470972|Ethanol|ethanol|mesh-list
56900111|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900112|NCT05281965|Tretinoin|tretinoin|mesh-list
56900113|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900114|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
56900115|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
56900116|NCT04251884|Ropivacaine|ropivacaine|mesh-list
56900117|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
56900118|NCT04251884|Anesthetics|anesthetics|mesh-list
56900119|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900120|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900121|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
56900122|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900123|NCT01202799|Diclofenac|diclofenac|mesh-list
56900124|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56900125|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56900126|NCT01202799|Analgesics|analgesics|mesh-ancestor
56900127|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
56900128|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900129|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900130|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56900131|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56900132|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56900133|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900134|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900135|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
56900136|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
56900137|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900138|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900139|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900140|NCT01298505|Fexofenadine|fexofenadine|mesh-list
56900141|NCT01298505|Terfenadine|terfenadine|mesh-list
56900142|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56900143|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56900144|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56900145|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
56900146|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
56900147|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900148|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900149|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900150|NCT01204593|Insulin|insulin|mesh-list
56900151|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56900152|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
56900153|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
56900154|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56900155|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900156|NCT03310970|Lidocaine|lidocaine|mesh-list
56900157|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
56900158|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
56610893|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
56900159|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900160|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900161|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
56900162|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900163|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56900164|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56900165|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56900166|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56900167|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900168|NCT05281419|Triamcinolone|triamcinolone|mesh-list
56900169|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56900170|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56900171|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56900172|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56900173|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
56900174|NCT05281419|Hormones|hormones|mesh-ancestor
56900175|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900176|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900177|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56900178|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
56900179|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900180|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900181|NCT04427072|Docetaxel|docetaxel|mesh-list
56900182|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900183|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
56900184|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
56900185|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
56900186|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900188|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56900189|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56900190|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900191|NCT01203111|Insulin|insulin|mesh-list
56900192|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56900193|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
56900194|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
56900195|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56900196|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900197|NCT03420339|Adderall|adderall|mesh-list
56900198|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56900199|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900200|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
56900201|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56900202|NCT01297179|Mirabegron|mirabegron|mesh-list
56900203|NCT01297179|Estradiol|estradiol|mesh-list
56900204|NCT01297179|Estrogens|estrogens|mesh-ancestor
56900205|NCT01297179|Hormones|hormones|mesh-ancestor
56900206|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900207|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900208|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56900209|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
56900210|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56900211|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56900212|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56900213|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56900214|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56900215|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56900216|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56900217|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56900218|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
56900219|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900220|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900221|NCT01297179|Urological Agents|urological agents|mesh-ancestor
56900222|NCT01205139|Simeprevir|simeprevir|mesh-list
56900223|NCT01205139|Rilpivirine|rilpivirine|mesh-list
56900224|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
56900225|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900226|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
56900227|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900228|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900229|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56900230|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56900231|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56610967|NCT04264130|Pyronaridine|pyronaridine|mesh-list
56900232|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56900233|NCT01205217|Paclitaxel|paclitaxel|mesh-list
56900234|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
56900235|NCT01205217|Trastuzumab|trastuzumab|mesh-list
56900236|NCT01205217|Epirubicin|epirubicin|mesh-list
56900237|NCT01205217|Lapatinib|lapatinib|mesh-list
56900238|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56900239|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900240|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
56900241|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
56900242|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
56900243|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900244|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56900245|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
56900246|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900247|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56900248|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56900249|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
56900250|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56900251|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56900252|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56900253|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56921829|NCT05783219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921837|NCT05770544|Entrectinib|entrectinib|mesh-list
56921838|NCT05770544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56921839|NCT05770544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921840|NCT05770544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921841|NCT05767086|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56900254|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56900255|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900256|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56900257|NCT01203267|Paclitaxel|paclitaxel|mesh-list
56900258|NCT01203267|Carboplatin|carboplatin|mesh-list
56900259|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56900260|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900261|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
56900262|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
56900263|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
56900264|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900265|NCT01207245|Tobramycin|tobramycin|mesh-list
56900266|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56900267|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900268|NCT01297569|Ranibizumab|ranibizumab|mesh-list
56900269|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56900270|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56900271|NCT01297569|Growth Substances|growth substances|mesh-ancestor
56900272|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900273|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
56900274|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900275|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56900276|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
56900277|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900278|NCT01299597|Atorvastatin|atorvastatin|mesh-list
56900279|NCT01299597|Simvastatin|simvastatin|mesh-list
56900280|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56900281|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56900282|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
56900283|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900284|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56900285|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56900286|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900287|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
56900288|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56900289|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900290|NCT03840057|Azithromycin|azithromycin|mesh-list
56900291|NCT03840057|Metoclopramide|metoclopramide|mesh-list
56900292|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56900293|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900294|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
56900295|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
56900296|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900297|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900298|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56900299|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56900300|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56900301|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
56900302|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900303|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900304|NCT05669547|Hormones|hormones|mesh-list
56900305|NCT05669547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900306|NCT05669547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900307|NCT01297803|Mitomycins|mitomycins|mesh-list
56900308|NCT01297803|Mitomycin|mitomycin|mesh-list
56900309|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56900310|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900311|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
56900312|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900313|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56900314|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900315|NCT03824691|Durvalumab|durvalumab|mesh-list
56900316|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56900317|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900318|NCT01299831|Hormones|hormones|mesh-list
56900319|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900320|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900321|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
56900322|NCT01205997|Fentanyl|fentanyl|mesh-list
56900323|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56900324|NCT01205997|Narcotics|narcotics|mesh-ancestor
56900325|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900326|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900327|NCT01205997|Analgesics|analgesics|mesh-ancestor
56900328|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
56900329|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900330|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56900331|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56900332|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
56900334|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56900335|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
56900336|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56900337|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56900338|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900339|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56900340|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
56900341|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56900342|NCT03822663|Caffeine|caffeine|mesh-list
56900343|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56900344|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900345|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56900346|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900347|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900348|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56900349|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56900350|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
56900351|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900352|NCT03818997|Paclitaxel|paclitaxel|mesh-list
56900353|NCT03818997|Atezolizumab|atezolizumab|mesh-list
56900354|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56900355|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900356|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
56900357|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
56900358|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
56900359|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900360|NCT03818919|Acetaminophen|acetaminophen|mesh-list
56900361|NCT03818919|Celecoxib|celecoxib|mesh-list
56900362|NCT03818919|Ketorolac|ketorolac|mesh-list
56900363|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56900364|NCT03818919|Diazepam|diazepam|mesh-list
56900365|NCT03818919|Gabapentin|gabapentin|mesh-list
56900366|NCT03818919|Hydrocodone|hydrocodone|mesh-list
56900367|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56900368|NCT03818919|Analgesics|analgesics|mesh-ancestor
56900369|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
56900370|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900371|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900372|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
56900373|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56900374|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56900375|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56900376|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56900377|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56900378|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900379|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900380|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
56900381|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56900382|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56900383|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900384|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56900385|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56900386|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56900387|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900388|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
56900389|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56900390|NCT03818919|Narcotics|narcotics|mesh-ancestor
56900391|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
56900392|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
56900393|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56900394|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
56900395|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
56900396|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56900397|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56900398|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56900399|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56900400|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56900401|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
56900402|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
56900403|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
56900404|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
56900405|NCT03821493|Itraconazole|itraconazole|mesh-list
56900406|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56900407|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
56900408|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900409|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56900410|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56900411|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900412|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900413|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56900414|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
56900415|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900416|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921881|NCT05732077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56921882|NCT05732077|Sympathomimetics|sympathomimetics|mesh-ancestor
56921883|NCT05732077|Autonomic Agents|autonomic agents|mesh-ancestor
56921884|NCT05732077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921885|NCT05732077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921886|NCT05732077|Dopamine Agents|dopamine agents|mesh-ancestor
56921887|NCT05732077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921888|NCT05732077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921889|NCT05732077|Protective Agents|protective agents|mesh-ancestor
56921890|NCT05724108|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56900417|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56900418|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56900419|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56900420|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56900421|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900422|NCT05618223|Dapagliflozin|dapagliflozin|mesh-list
56900423|NCT05618223|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56900424|NCT05618223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900425|NCT05618223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56900426|NCT05618223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900427|NCT03814629|Vitamins|vitamins|mesh-list
56900428|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
56900429|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900430|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56900431|NCT01585935|SMOFlipid|smoflipid|mesh-list
56900432|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56900433|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56900434|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56900435|NCT01300377|Lidocaine|lidocaine|mesh-list
56900436|NCT01300377|Bupivacaine|bupivacaine|mesh-list
56900437|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
56900438|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
56900439|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900440|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900441|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
56900442|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900443|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56900444|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56900445|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56900446|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56900447|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900448|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
56900449|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56900450|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
56900451|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900452|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
56900453|NCT03814707|Protective Agents|protective agents|mesh-ancestor
56900454|NCT03818295|Praliciguat|praliciguat|mesh-list
56900455|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56900456|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
56611191|NCT02580448|Seviteronel|seviteronel|mesh-list
56900457|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900458|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56900459|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56900460|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56900461|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
56900462|NCT01301313|Simendan|simendan|mesh-list
56900463|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56900464|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
56900465|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56900466|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56900467|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900468|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900469|NCT01301313|Protective Agents|protective agents|mesh-ancestor
56900470|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900471|NCT03817359|Remifentanil|remifentanil|mesh-list
56900472|NCT03817359|Propofol|propofol|mesh-list
56900473|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56900474|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900475|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900476|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56900477|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
56900478|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
56921918|NCT05709821|Pembrolizumab|pembrolizumab|mesh-list
56921919|NCT05709821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56921920|NCT05709821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921921|NCT05707351|Factor VIII|factor viii|mesh-list
56921922|NCT05707351|BAX 855|bax 855|mesh-list
56921923|NCT05707351|Coagulants|coagulants|mesh-ancestor
56900479|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56900480|NCT03817359|Narcotics|narcotics|mesh-ancestor
56900481|NCT03817359|Analgesics|analgesics|mesh-ancestor
56900482|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
56900483|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900484|NCT03813927|Vitamin D|vitamin d|mesh-list
56900485|NCT03813927|Vitamins|vitamins|mesh-ancestor
56900486|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
56900487|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900488|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56900489|NCT02819518|Gemcitabine|gemcitabine|mesh-list
56900490|NCT02819518|Paclitaxel|paclitaxel|mesh-list
56900491|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56900492|NCT02819518|Carboplatin|carboplatin|mesh-list
56900493|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
56900494|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56900495|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900496|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
56900497|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
56900498|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
56900499|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900500|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56900501|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
56900502|NCT02819518|Antiviral Agents|antiviral agents|mesh-ancestor
56900503|NCT02819518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900504|NCT02819518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900505|NCT02819518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56900506|NCT02819518|Immunologic Factors|immunologic factors|mesh-ancestor
56900507|NCT02819518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900508|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56900509|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56900510|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56900511|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
56900512|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
56900513|NCT03813771|Etanercept|etanercept|mesh-list
56900514|NCT03813771|Methotrexate|methotrexate|mesh-list
56900515|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56900516|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
56900517|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56900518|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900519|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56900520|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
56900521|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900522|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900523|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
56900524|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900525|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56900526|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56900527|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
56900528|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56900529|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56900530|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
56900531|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56900532|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56900533|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900534|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56900535|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56900536|NCT03813771|Analgesics|analgesics|mesh-ancestor
56900537|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
56900538|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900539|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56900540|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56900541|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
56900542|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56900543|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56900544|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900545|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
56900546|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
56900547|NCT02036242|Sufentanil|sufentanil|mesh-list
56900548|NCT02036242|Ropivacaine|ropivacaine|mesh-list
56900549|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
56900550|NCT02036242|Anesthetics|anesthetics|mesh-list
56900551|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900552|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900553|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
56900554|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900555|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56900556|NCT02036242|Narcotics|narcotics|mesh-ancestor
56900557|NCT02036242|Analgesics|analgesics|mesh-ancestor
56900558|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56900559|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56900560|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
56900561|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
56900562|NCT05281107|Vitamin D|vitamin d|mesh-list
56900563|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
56900564|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
56900565|NCT05281107|Vitamins|vitamins|mesh-list
56900566|NCT05281107|Calcium|calcium|mesh-list
56900567|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
56900568|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900569|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56900570|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56900571|NCT02812186|Rocuronium|rocuronium|mesh-list
56900572|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56900573|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56900574|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56900575|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900576|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900577|NCT03310268|Listerine|listerine|mesh-list
56900578|NCT03310268|Fluorides|fluorides|mesh-list
56900579|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
56900580|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
56900581|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
56900582|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
56900583|NCT03310268|Protective Agents|protective agents|mesh-ancestor
56900584|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900585|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56900586|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900587|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56900588|NCT02810392|Insulin|insulin|mesh-list
56900589|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56900590|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56900591|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900592|NCT03404960|Nivolumab|nivolumab|mesh-list
56900593|NCT03404960|Ipilimumab|ipilimumab|mesh-list
56900594|NCT03404960|Niraparib|niraparib|mesh-list
56900595|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56900596|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900597|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56900598|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900599|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56900600|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900601|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
56900602|NCT03805035|Maleic acid|maleic acid|mesh-list
56900603|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
56900604|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56900605|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56900606|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900607|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611342|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
56900608|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
56900609|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900610|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900611|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
56900612|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
56900613|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56900615|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
56900616|NCT03816267|Albuterol|albuterol|mesh-list
56900617|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56900618|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
56900619|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900620|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900621|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56900622|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
56900623|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
56900624|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56900625|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56900626|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56900627|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56900628|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
56900629|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900630|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900631|NCT03280550|Omalizumab|omalizumab|mesh-list
56900632|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56900633|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56900634|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
56900635|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
56900636|NCT02036554|Everolimus|everolimus|mesh-list
56900637|NCT02036554|Tacrolimus|tacrolimus|mesh-list
56900638|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56900639|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
56900640|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900641|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56900642|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900643|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900644|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900645|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56900646|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56900647|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
56900648|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56900649|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900650|NCT05577117|Fentanyl|fentanyl|mesh-list
56900651|NCT05577117|Dexmedetomidine|dexmedetomidine|mesh-list
56900652|NCT05577117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56900653|NCT05577117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900654|NCT05577117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900655|NCT05577117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56900656|NCT05577117|Analgesics|analgesics|mesh-ancestor
56900657|NCT05577117|Sensory System Agents|sensory system agents|mesh-ancestor
56900658|NCT05577117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900659|NCT05577117|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56900660|NCT05577117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56900661|NCT05577117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56900662|NCT05577117|Adrenergic Agents|adrenergic agents|mesh-ancestor
56900663|NCT05577117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900664|NCT05577117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900665|NCT05577117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56900666|NCT05577117|Narcotics|narcotics|mesh-ancestor
56900667|NCT05577117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56900668|NCT05577117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56900669|NCT05577117|Anesthetics, General|anesthetics, general|mesh-ancestor
56900670|NCT05577117|Anesthetics|anesthetics|mesh-ancestor
56900671|NCT03813303|Fentanyl|fentanyl|mesh-list
56900672|NCT03813303|Midazolam|midazolam|mesh-list
56900673|NCT03813303|Propofol|propofol|mesh-list
56900674|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56900675|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900676|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900677|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56921996|NCT05677295|Analgesics|analgesics|mesh-ancestor
56900678|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
56900679|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
56900680|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56900681|NCT03813303|Narcotics|narcotics|mesh-ancestor
56900682|NCT03813303|Analgesics|analgesics|mesh-ancestor
56900683|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
56900684|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900685|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56900686|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56900687|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56900688|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56900689|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
56900691|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900692|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900693|NCT03384914|Vaccines|vaccines|mesh-list
56900694|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
56900695|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900696|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56900697|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56900698|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900699|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56900700|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900701|NCT03637790|Rifampin|rifampin|mesh-list
56900702|NCT03637790|Abrocitinib|abrocitinib|mesh-list
56900703|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56900704|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
56900705|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56900706|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900707|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
56900708|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56900709|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900710|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900711|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56900712|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56900713|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56900714|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56900715|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56900716|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56900717|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56900718|NCT03813069|Permethrin|permethrin|mesh-list
56900719|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900720|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900721|NCT03276026|Neostigmine|neostigmine|mesh-list
56900722|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56900723|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900724|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900725|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
56900726|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900727|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900728|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56900729|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
56900730|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900731|NCT01303497|Paclitaxel|paclitaxel|mesh-list
56900732|NCT01303497|Bevacizumab|bevacizumab|mesh-list
56900733|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56900734|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900735|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
56900736|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
56900737|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
56900738|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900739|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922031|NCT05656521|Glucocorticoids|glucocorticoids|mesh-ancestor
56900740|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56900741|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56900742|NCT01303497|Growth Substances|growth substances|mesh-ancestor
56900743|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900744|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
56900745|NCT01589523|Cholic Acids|cholic acids|mesh-list
56900746|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
56900747|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56900748|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56900749|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
56900750|NCT03804177|Melatonin|melatonin|mesh-list
56900751|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
56900752|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
56900753|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900754|NCT03804177|Protective Agents|protective agents|mesh-ancestor
56900755|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900756|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900757|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56900758|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
56900759|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
56900760|NCT03804177|Vitamins|vitamins|mesh-ancestor
56900761|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
56900762|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
56900763|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56900764|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900765|NCT01302093|Racecadotril|racecadotril|mesh-list
56900766|NCT01302093|Thiorphan|thiorphan|mesh-list
56900767|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
56900768|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56900769|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
56900770|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900771|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900772|NCT03803007|Glenzocimab|glenzocimab|mesh-list
56900773|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
56900774|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
56900775|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56900776|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
56900777|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56900778|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900779|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56900780|NCT02047552|Iron|iron|mesh-list
56900781|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56900782|NCT02047552|Oxandrolone|oxandrolone|mesh-list
56900783|NCT02047552|Trace Elements|trace elements|mesh-ancestor
56900784|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
56900785|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900786|NCT02047552|Hematinics|hematinics|mesh-ancestor
56900787|NCT02047552|Androgens|androgens|mesh-ancestor
56900789|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900790|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
56900791|NCT01303731|Fentanyl|fentanyl|mesh-list
56900792|NCT01303731|Bupivacaine|bupivacaine|mesh-list
56900793|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
56900794|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
56900795|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900796|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900797|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
56900798|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900799|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56900800|NCT01303731|Narcotics|narcotics|mesh-ancestor
56900801|NCT01303731|Analgesics|analgesics|mesh-ancestor
56900802|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56900803|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56900804|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
56900805|NCT03815487|Insulin|insulin|mesh-list
56900806|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56922038|NCT05655182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900807|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56900808|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900809|NCT03815422|Anesthetics|anesthetics|mesh-list
56900810|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900811|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900812|NCT02260024|Pramipexole|pramipexole|mesh-list
56900813|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
56900814|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900815|NCT02260024|Protective Agents|protective agents|mesh-ancestor
56900816|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900817|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56900818|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56900819|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
56900820|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
56900821|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900822|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
56900823|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
56900824|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900825|NCT03800667|Protective Agents|protective agents|mesh-ancestor
56900826|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900827|NCT03800667|Vitamins|vitamins|mesh-ancestor
56900828|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
56900829|NCT01302171|Lenograstim|lenograstim|mesh-list
56900830|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56900831|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
56900832|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900833|NCT02047630|Latanoprost|latanoprost|mesh-list
56611569|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56900834|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56900835|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56900836|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56900837|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56900838|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
56900839|NCT03799809|Voriconazole|voriconazole|mesh-list
56900840|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
56900841|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56900842|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56900843|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56900844|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900845|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900846|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56900847|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
56900848|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900849|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900850|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56900851|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56900852|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56900853|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56900854|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56900855|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900856|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900857|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900858|NCT03812523|Analgesics|analgesics|mesh-ancestor
56900859|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
56900860|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900861|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
56900862|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56900863|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
56922055|NCT05641142|Anticoagulants|anticoagulants|mesh-list
56922056|NCT05635877|Esmolol|esmolol|mesh-list
56922057|NCT05635877|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56922058|NCT05635877|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56922059|NCT05635877|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56900864|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56900865|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56900866|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56900867|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
56900869|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
56900870|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
56900871|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56900872|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900873|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
56900874|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900875|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56900876|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56900877|NCT02049970|Analgesics|analgesics|mesh-ancestor
56900878|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56900879|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56900880|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56900881|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
56900882|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56900883|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900885|NCT02048020|Carboplatin|carboplatin|mesh-list
56900886|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56900887|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900888|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
56900889|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
56900890|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
56900891|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900892|NCT03562390|Irinotecan|irinotecan|mesh-list
56900893|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56900894|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56900895|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900896|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900897|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900898|NCT02048098|Misoprostol|misoprostol|mesh-list
56900899|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56900900|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
56900901|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56900902|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900903|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56900904|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56900905|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
56900906|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
56900907|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
56900908|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56900909|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56900910|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900911|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900912|NCT02050360|Urological Agents|urological agents|mesh-ancestor
56900913|NCT02940860|Iron|iron|mesh-list
56900914|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56900915|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56900916|NCT02940860|Trace Elements|trace elements|mesh-ancestor
56900917|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
56922072|NCT05630183|Gemcitabine|gemcitabine|mesh-list
56922073|NCT05630183|Paclitaxel|paclitaxel|mesh-list
56922074|NCT05630183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56922075|NCT05630183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922076|NCT05630183|Tubulin Modulators|tubulin modulators|mesh-ancestor
56922077|NCT05630183|Antimitotic Agents|antimitotic agents|mesh-ancestor
56922078|NCT05630183|Mitosis Modulators|mitosis modulators|mesh-ancestor
56922079|NCT05630183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900918|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900919|NCT02940860|Hematinics|hematinics|mesh-ancestor
56900920|NCT01303887|Prednisolone|prednisolone|mesh-list
56900921|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
56900922|NCT01303887|Rituximab|rituximab|mesh-list
56900923|NCT01303887|Fludarabine|fludarabine|mesh-list
56900924|NCT01303887|Vincristine|vincristine|mesh-list
56900925|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56900926|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
56900927|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900928|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56900929|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56900930|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
56900931|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900932|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900933|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56900934|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56900935|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56900936|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
56900937|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
56900938|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
56900939|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56900940|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
56900941|NCT01303887|Hormones|hormones|mesh-ancestor
56900942|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900943|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56900944|NCT02050594|Ipilimumab|ipilimumab|mesh-list
56900945|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56900946|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900947|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56900948|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900949|NCT02806960|Glucagon|glucagon|mesh-list
56900950|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56900951|NCT02806960|Hormones|hormones|mesh-ancestor
56900952|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900953|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900954|NCT03718143|Adavosertib|adavosertib|mesh-list
56900955|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900956|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900957|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
56900958|NCT02955134|Antacids|antacids|mesh-ancestor
56900959|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900960|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56900961|NCT02048488|Belizatinib|belizatinib|mesh-list
56900962|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56900963|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900964|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900965|NCT05036109|Aspirin|aspirin|mesh-list
56900966|NCT05036109|Vitamin D|vitamin d|mesh-list
56900967|NCT05036109|Vitamins|vitamins|mesh-ancestor
56900968|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
56900969|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900970|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56900971|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56900972|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56900973|NCT05036109|Analgesics|analgesics|mesh-ancestor
56900974|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
56900975|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56900976|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56900977|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56900978|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56900979|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56900980|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56900981|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56900982|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56900983|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56900984|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
56611717|NCT00769405|Fluorouracil|fluorouracil|mesh-list
56900986|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
56900987|NCT02050672|Vitamins|vitamins|mesh-ancestor
56900988|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
56900989|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900990|NCT03811366|Prednisone|prednisone|mesh-list
56900991|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56900992|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
56900993|NCT03811366|Hormones|hormones|mesh-ancestor
56900994|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56900995|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56900996|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56900997|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56900998|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56900999|NCT03274466|Laxatives|laxatives|mesh-ancestor
56901000|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901001|NCT02037802|Fentanyl|fentanyl|mesh-list
56901002|NCT02037802|Meperidine|meperidine|mesh-list
56901003|NCT02037802|Bupivacaine|bupivacaine|mesh-list
56901004|NCT02037802|Propofol|propofol|mesh-list
56901005|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
56901006|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
56901007|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901008|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901009|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
56901010|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901011|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56901012|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56901013|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
56901014|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56901015|NCT02037802|Narcotics|narcotics|mesh-ancestor
56901016|NCT02037802|Analgesics|analgesics|mesh-ancestor
56901017|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56901018|NCT02051530|Tryptophan|tryptophan|mesh-list
56901019|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56901020|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
56901021|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56901022|NCT03797703|Lidocaine|lidocaine|mesh-list
56901023|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
56901024|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
56901025|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901026|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901027|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
56901028|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901029|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56901030|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56901031|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56901032|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56901033|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901034|NCT02048644|Beclomethasone|beclomethasone|mesh-list
56901035|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
56901036|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56901037|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
56901038|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901039|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901040|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56901041|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
56901042|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56901043|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56901044|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56901045|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
56901046|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901047|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901048|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56901049|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
56901050|NCT02048644|Hormones|hormones|mesh-ancestor
56901051|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901052|NCT02048800|Treosulfan|treosulfan|mesh-list
56901053|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56901054|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
56901055|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901056|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901057|NCT03797625|Cisplatin|cisplatin|mesh-list
56901058|NCT03797625|Irinotecan|irinotecan|mesh-list
56901059|NCT03797625|Endostar protein|endostar protein|mesh-list
56901060|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901061|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56901062|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56901063|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901064|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901065|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56901066|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56901067|NCT03797625|Growth Substances|growth substances|mesh-ancestor
56901068|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901069|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
56901070|NCT02051842|Metadoxine|metadoxine|mesh-list
56901071|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56901072|NCT02806414|Ivermectin|ivermectin|mesh-list
56901073|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56901074|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901075|NCT02049034|Lixisenatide|lixisenatide|mesh-list
56901076|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56901077|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901078|NCT02049190|Onapristone|onapristone|mesh-list
56901079|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901080|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56901081|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
56901082|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56901083|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901084|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
56901085|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901086|NCT03811509|Denosumab|denosumab|mesh-list
56901087|NCT03811509|Diphosphonates|diphosphonates|mesh-list
56901088|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56901089|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901090|NCT02037412|Clopidogrel|clopidogrel|mesh-list
56901091|NCT02037412|Ticagrelor|ticagrelor|mesh-list
56901092|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56901093|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56901094|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56901095|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56901096|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
56901097|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901098|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901099|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901100|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56901101|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
56901102|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901103|NCT03797079|Bupivacaine|bupivacaine|mesh-list
56901104|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
56901105|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
56901106|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901107|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901108|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
56901109|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901110|NCT02049268|Ethanol|ethanol|mesh-list
56901111|NCT02049268|Nicotine|nicotine|mesh-list
56901112|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56901113|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
56901114|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901115|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901116|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56901117|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56901118|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
56901119|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901120|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901121|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56901122|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901123|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901124|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
56901125|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
56901126|NCT02049346|Hematinics|hematinics|mesh-ancestor
56901127|NCT03564873|Azacitidine|azacitidine|mesh-list
56901128|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
56901129|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56901130|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
56901131|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901132|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901133|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901134|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56611870|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
56901135|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56901136|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
56901137|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56901138|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56901139|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901140|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
56901141|NCT02806024|Coagulants|coagulants|mesh-ancestor
56901142|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56901143|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901144|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901145|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
56901146|NCT02049580|Thiotepa|thiotepa|mesh-list
56901147|NCT02049580|Fludarabine|fludarabine|mesh-list
56901148|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56901149|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
56901150|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901151|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56901152|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56901153|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
56901154|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901155|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901156|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56901157|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
56901158|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56901159|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901160|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56901161|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56901162|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901163|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901164|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901166|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
56901167|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901168|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56901169|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56901170|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56901171|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56901172|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56901173|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901174|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901175|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56901176|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
56901177|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901178|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901179|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
56901180|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56901181|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
56901182|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56901183|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
56901184|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901185|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901186|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
56901187|NCT02049736|Telbivudine|telbivudine|mesh-list
56901188|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
56901189|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901190|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56901191|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901192|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901193|NCT01303029|Gemcitabine|gemcitabine|mesh-list
56901194|NCT01303029|Capecitabine|capecitabine|mesh-list
56901195|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56901196|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56901197|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
56901198|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901199|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901200|NCT01303029|Antiviral Agents|antiviral agents|mesh-ancestor
56901201|NCT01303029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901202|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901203|NCT01303029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56901204|NCT01303029|Immunologic Factors|immunologic factors|mesh-ancestor
56901205|NCT01303029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901206|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56901207|NCT02052388|Daptomycin|daptomycin|mesh-list
56901208|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56901209|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901211|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
56901212|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
56901213|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901214|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901215|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
56901216|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901217|NCT03795909|Dexamethasone|dexamethasone|mesh-list
56901218|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56901219|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
56901220|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
56901221|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901222|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901223|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901224|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
56901225|NCT03795909|Hormones|hormones|mesh-ancestor
56901226|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901227|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56901228|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901229|NCT03795597|Melphalan|melphalan|mesh-list
56901230|NCT03795597|Busulfan|busulfan|mesh-list
56901231|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56901232|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
56901233|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901234|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901235|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56901236|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56901237|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
56901238|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901239|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
56901240|NCT02802592|Hematinics|hematinics|mesh-ancestor
56901241|NCT03637972|Nicotine|nicotine|mesh-list
56901242|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56901243|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
56901244|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901245|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901246|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56901247|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56901248|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
56901249|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901250|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901251|NCT03383679|Capecitabine|capecitabine|mesh-list
56901252|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56901253|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
56922110|NCT05617820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922111|NCT05603702|Lacosamide|lacosamide|mesh-list
56922112|NCT05603702|Anticonvulsants|anticonvulsants|mesh-ancestor
56922113|NCT05603702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56901254|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901255|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901256|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
56901257|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56901258|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901259|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
56901260|NCT02053402|Vitamin D|vitamin d|mesh-list
56901261|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
56901262|NCT02053402|Vitamins|vitamins|mesh-ancestor
56901263|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
56901264|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901265|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56901266|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56901267|NCT04639011|Norepinephrine|norepinephrine|mesh-list
56901268|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56901269|NCT04639011|Serotonin|serotonin|mesh-list
56901270|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56901271|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56901272|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56901273|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901274|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901275|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901276|NCT04639011|Analgesics|analgesics|mesh-ancestor
56901277|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
56901278|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901279|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
56901280|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56901281|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
56901282|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56612026|NCT00934856|Docetaxel|docetaxel|mesh-list
56901283|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56901284|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
56901285|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
56901286|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
56901287|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56901288|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56901289|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
56901290|NCT02053558|Lidocaine|lidocaine|mesh-list
56901291|NCT02053558|Ropivacaine|ropivacaine|mesh-list
56901292|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
56901293|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
56901294|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901295|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901296|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
56901297|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901298|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56901299|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56901300|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56901301|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56901302|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901303|NCT03809949|Fentanyl|fentanyl|mesh-list
56901304|NCT03809949|Anesthetics|anesthetics|mesh-list
56901305|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901306|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901308|NCT03809949|Narcotics|narcotics|mesh-ancestor
56901309|NCT03809949|Analgesics|analgesics|mesh-ancestor
56901310|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
56901311|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901312|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56901313|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56901314|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
56901315|NCT02052934|Vaccines|vaccines|mesh-list
56901316|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
56901317|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901318|NCT03810261|Vitamin D|vitamin d|mesh-list
56901319|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
56901320|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
56901321|NCT03810261|Vitamins|vitamins|mesh-list
56901322|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
56901323|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901324|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56922123|NCT05596006|Domperidone|domperidone|mesh-list
56922124|NCT05596006|Antiemetics|antiemetics|mesh-ancestor
56922125|NCT05596006|Autonomic Agents|autonomic agents|mesh-ancestor
56901325|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56901326|NCT02037724|Iron|iron|mesh-list
56901327|NCT02037724|Trace Elements|trace elements|mesh-ancestor
56901328|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
56901329|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901330|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56901331|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56901332|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901333|NCT01569633|Erythromycin|erythromycin|mesh-list
56901334|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
56901335|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56901336|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
56901337|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56901338|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901339|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901340|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56901341|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901342|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901343|NCT02054182|Vitamin D|vitamin d|mesh-list
56901344|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
56901345|NCT02054182|Vitamins|vitamins|mesh-ancestor
56901346|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
56901347|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901348|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56901349|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56901350|NCT03323151|Ixazomib|ixazomib|mesh-list
56901351|NCT03323151|Glycine|glycine|mesh-list
56901352|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901353|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
56901354|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901355|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612112|NCT05153174|Sulforaphane|sulforaphane|mesh-list
56901356|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
56901357|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901358|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901359|NCT02803138|Ritonavir|ritonavir|mesh-list
56901360|NCT02803138|Ribavirin|ribavirin|mesh-list
56901361|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56901362|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56901363|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
56901364|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901365|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901366|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56901367|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56901368|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
56901369|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901370|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56901371|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56901372|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
56901373|NCT03795207|Durvalumab|durvalumab|mesh-list
56901374|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56901375|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901376|NCT02056210|Plerixafor|plerixafor|mesh-list
56901377|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56901378|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56901379|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
56901380|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901381|NCT00131235|Azithromycin|azithromycin|mesh-list
56901382|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
56901383|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
56901384|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56901385|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56901386|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901387|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
56901388|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56901389|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56901390|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56901391|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901392|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901393|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56901394|NCT00131235|Renal Agents|renal agents|mesh-ancestor
56901395|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
56901396|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56901397|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56901398|NCT03794505|Prednisolone|prednisolone|mesh-list
56901399|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
56901400|NCT03794505|Lidocaine|lidocaine|mesh-list
56901401|NCT03794505|Ropivacaine|ropivacaine|mesh-list
56901402|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56901403|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
56901404|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
56901405|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
56901406|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901407|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901408|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
56901409|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901410|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56901411|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56901412|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56901413|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56901414|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901415|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56901416|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
56901417|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
56901418|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901419|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
56901420|NCT03794505|Hormones|hormones|mesh-ancestor
56901421|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901422|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56901423|NCT03794505|Protective Agents|protective agents|mesh-ancestor
56901424|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56901425|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901426|NCT05625243|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56901427|NCT05625243|Vasodilator Agents|vasodilator agents|mesh-ancestor
56901428|NCT05625243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56901429|NCT05625243|Protective Agents|protective agents|mesh-ancestor
56901430|NCT05625243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901431|NCT03023007|Anesthetics|anesthetics|mesh-list
56901432|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901433|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901434|NCT01304901|Montelukast|montelukast|mesh-list
56901435|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56901436|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
56901437|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56901439|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901440|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901441|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56901442|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56901443|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901444|NCT05624853|Pregabalin|pregabalin|mesh-list
56901445|NCT05624853|Analgesics|analgesics|mesh-ancestor
56901446|NCT05624853|Sensory System Agents|sensory system agents|mesh-ancestor
56901447|NCT05624853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901448|NCT05624853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901449|NCT05624853|Anticonvulsants|anticonvulsants|mesh-ancestor
56901450|NCT05624853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56901451|NCT05624853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56901452|NCT05624853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901453|NCT05624853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56901454|NCT05624853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56901455|NCT05624853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56922130|NCT05596006|Dopamine Agents|dopamine agents|mesh-ancestor
56901456|NCT05624853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901457|NCT05624853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56901458|NCT03794271|Anesthetics|anesthetics|mesh-list
56901459|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901460|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901461|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
56901462|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56901463|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56901464|NCT02798523|Prednisolone|prednisolone|mesh-list
56901465|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
56901466|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
56901467|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56901468|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
56901469|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56901470|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
56901471|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
56901472|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901473|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901474|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901475|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
56901476|NCT02798523|Hormones|hormones|mesh-ancestor
56901477|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901478|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56901479|NCT02798523|Protective Agents|protective agents|mesh-ancestor
56901480|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56901481|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901482|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
56901483|NCT03792321|Testosterone|testosterone|mesh-list
56901484|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
56901485|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
56901486|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56901487|NCT03792321|Androgens|androgens|mesh-ancestor
56901488|NCT03792321|Hormones|hormones|mesh-ancestor
56901489|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901490|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901491|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56901492|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901493|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
56901494|NCT01305057|Pyridoxine|pyridoxine|mesh-list
56901495|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
56901496|NCT01305057|Vitamins|vitamins|mesh-ancestor
56901497|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
56901498|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901499|NCT03792009|Bupivacaine|bupivacaine|mesh-list
56901500|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
56901501|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
56901502|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901503|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901504|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
56901505|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901506|NCT01305135|Azacitidine|azacitidine|mesh-list
56901507|NCT01305135|Idarubicin|idarubicin|mesh-list
56901508|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56901509|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
56901510|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901511|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901512|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901513|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56901514|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56901515|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56901516|NCT01305603|Bupivacaine|bupivacaine|mesh-list
56901517|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
56901518|NCT01305603|Anesthetics|anesthetics|mesh-list
56901519|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901520|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901521|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
56901522|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901523|NCT02058706|Leuprolide|leuprolide|mesh-list
56901524|NCT02058706|Goserelin|goserelin|mesh-list
56901525|NCT02058706|Bicalutamide|bicalutamide|mesh-list
56901526|NCT02058706|Androgens|androgens|mesh-list
56901527|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56901528|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
56901529|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56901530|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901531|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56901532|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901533|NCT02058706|Hormones|hormones|mesh-ancestor
56901534|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901535|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
56901536|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
56901537|NCT03793725|Apatinib|apatinib|mesh-list
56901538|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901539|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56901540|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901541|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901542|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56901543|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56901544|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
56901545|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
56901546|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901547|NCT02056366|Protective Agents|protective agents|mesh-ancestor
56901548|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901549|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
56901550|NCT02056366|Vitamins|vitamins|mesh-ancestor
56901551|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
56901552|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
56901553|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56901554|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56901555|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901556|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
56901557|NCT02056444|Coagulants|coagulants|mesh-ancestor
56901558|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56901559|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56901560|NCT05624229|Esomeprazole|esomeprazole|mesh-list
56901561|NCT05624229|Omeprazole|omeprazole|mesh-list
56901562|NCT05624229|Rabeprazole|rabeprazole|mesh-list
56901563|NCT05624229|Pantoprazole|pantoprazole|mesh-list
56901564|NCT05624229|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56901565|NCT05624229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56901566|NCT05624229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901567|NCT05624229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901568|NCT05624229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901569|NCT05622370|Brivaracetam|brivaracetam|mesh-list
56901570|NCT05622370|Anticonvulsants|anticonvulsants|mesh-ancestor
56901571|NCT03791775|Polidocanol|polidocanol|mesh-list
56901572|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56901573|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56901574|NCT01730937|Sorafenib|sorafenib|mesh-list
56901575|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901576|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56901577|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901578|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901579|NCT03789123|Dienogest|dienogest|mesh-list
56901580|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56901581|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56901582|NCT03789123|Estradiol|estradiol|mesh-list
56901583|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56901584|NCT03789123|Nandrolone|nandrolone|mesh-list
56901585|NCT03789123|Estrogens|estrogens|mesh-ancestor
56901586|NCT03789123|Hormones|hormones|mesh-ancestor
56901587|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901588|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901589|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56901590|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
56901591|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56901592|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56901593|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56901594|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56901595|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56901596|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
56901597|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56901598|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901599|NCT03789123|Androgens|androgens|mesh-ancestor
56901600|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
56901601|NCT05471817|Dabigatran|dabigatran|mesh-list
56901602|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
56901603|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56901604|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
56901605|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901606|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901607|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
56901608|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56901609|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56901610|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
56901611|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901612|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901613|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901615|NCT03788889|Lorazepam|lorazepam|mesh-list
56901616|NCT03788889|Phenobarbital|phenobarbital|mesh-list
56901617|NCT03788889|Analgesics|analgesics|mesh-ancestor
56901618|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
56901619|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901620|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901621|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56901622|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56901623|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
56901624|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
56901625|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901626|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56901627|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56901628|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901629|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901630|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
56901631|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
56901632|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
56901633|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901634|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56901635|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56901636|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56901637|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56402041|NCT00189618|Aspirin|aspirin|mesh-list
56901638|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
56901640|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56901641|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56402180|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56402250|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
56901642|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56901643|NCT05669079|Decitabine|decitabine|mesh-list
56901644|NCT05669079|Epoetin Alfa|epoetin alfa|mesh-list
56901645|NCT05669079|Lenograstim|lenograstim|mesh-list
56901646|NCT05669079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56901647|NCT05669079|Antimetabolites|antimetabolites|mesh-ancestor
56901648|NCT05669079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901649|NCT05669079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901650|NCT05669079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901651|NCT05669079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56901652|NCT05669079|Immunologic Factors|immunologic factors|mesh-ancestor
56901653|NCT05669079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901654|NCT05669079|Hematinics|hematinics|mesh-ancestor
56901655|NCT03788733|Melatonin|melatonin|mesh-list
56901656|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
56901657|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402552|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
56901658|NCT03788733|Protective Agents|protective agents|mesh-ancestor
56901659|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402692|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
56901660|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56922147|NCT05586529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56922148|NCT05586529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922149|NCT05586529|Vitamins|vitamins|mesh-ancestor
56922150|NCT05586529|Micronutrients|micronutrients|mesh-ancestor
56901662|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901663|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901664|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901665|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56901667|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
56901668|NCT04753515|Remifentanil|remifentanil|mesh-list
56901669|NCT04753515|Propofol|propofol|mesh-list
56901670|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56901671|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901672|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901673|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56901674|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
56901675|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
56901676|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56901677|NCT04753515|Analgesics|analgesics|mesh-ancestor
56901678|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
56901679|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402908|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56901680|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56901681|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56901682|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56901683|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
56403046|NCT00540943|Irinotecan|irinotecan|mesh-list
56901684|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901685|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403119|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
56403189|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56901686|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56901687|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56901688|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56901689|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56901690|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
56901691|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
56901692|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56901693|NCT04753515|Narcotics|narcotics|mesh-ancestor
56901694|NCT01306461|Timolol|timolol|mesh-list
56403553|NCT00544063|Irinotecan|irinotecan|mesh-list
56901695|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56901696|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56901697|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
56901698|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901699|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901700|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901701|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56901702|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56901703|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
56901704|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56901705|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56901706|NCT01305837|Prednisolone|prednisolone|mesh-list
56901707|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
56922166|NCT05564377|Antibodies|antibodies|mesh-list
56901708|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56901709|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
56901710|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56901711|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
56901712|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
56901713|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901714|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901715|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901716|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
56901717|NCT01305837|Hormones|hormones|mesh-ancestor
56901718|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901719|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56901720|NCT01305837|Protective Agents|protective agents|mesh-ancestor
56901721|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56901722|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901723|NCT01306773|Oseltamivir|oseltamivir|mesh-list
56901724|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
56901725|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901726|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901727|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901728|NCT03790605|Curcumin|curcumin|mesh-list
56901729|NCT03790605|Iproplatin|iproplatin|mesh-list
56901730|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56901731|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56901732|NCT03790605|Analgesics|analgesics|mesh-ancestor
56901733|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
56901734|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901735|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901736|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56403814|NCT00160511|Levetiracetam|levetiracetam|mesh-list
56901737|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612467|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
56901738|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901739|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901740|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901742|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
56901743|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901744|NCT05590689|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56901745|NCT05590689|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56901746|NCT05590689|Dermatologic Agents|dermatologic agents|mesh-ancestor
56901747|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56901748|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
56901749|NCT01306851|Coagulants|coagulants|mesh-ancestor
56901750|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
56901751|NCT03790215|Progestins|progestins|mesh-ancestor
56901752|NCT03790215|Hormones|hormones|mesh-ancestor
56901753|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901754|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901755|NCT03790371|Misoprostol|misoprostol|mesh-list
56901756|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56901757|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
56901758|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56901759|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404256|NCT00548938|Temozolomide|temozolomide|mesh-list
56901760|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56901761|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901762|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
56901763|NCT01307475|Adenosine|adenosine|mesh-list
56901765|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
56922191|NCT05564377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56922192|NCT05564377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56922193|NCT05558280|Dinutuximab|dinutuximab|mesh-list
56922194|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922195|NCT05555303|Amikacin|amikacin|mesh-list
56922196|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56922197|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900230|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
55900231|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100853|NCT00000979|Didanosine|didanosine|mesh-list
56901766|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901767|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901768|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56901769|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
56901770|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56901771|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
56901772|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
56901773|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901774|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901775|NCT03787641|Protamines|protamines|mesh-list
56901776|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
56901777|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901778|NCT03787641|Coagulants|coagulants|mesh-ancestor
56901779|NCT03790293|Rituximab|rituximab|mesh-list
56901780|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56901781|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901782|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
56901783|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901784|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56901785|NCT03245450|Irinotecan|irinotecan|mesh-list
56901786|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56901787|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56404664|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56901789|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901790|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901791|NCT05694585|Esmolol|esmolol|mesh-list
56901792|NCT05694585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56901793|NCT05694585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56901794|NCT05694585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56901795|NCT05694585|Adrenergic Agents|adrenergic agents|mesh-ancestor
56901796|NCT05694585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901797|NCT05694585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901798|NCT05694585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901799|NCT03712917|Topiramate|topiramate|mesh-list
56901800|NCT03712917|Flunarizine|flunarizine|mesh-list
56901801|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
56901802|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56901803|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901805|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56901806|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901807|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56901808|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56901809|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
56901810|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
56901811|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901812|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
56901813|NCT03787017|Metformin|metformin|mesh-list
56901814|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56901815|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901816|NCT01307865|Mannitol|mannitol|mesh-list
56901817|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56901818|NCT01307865|Diuretics|diuretics|mesh-ancestor
56901819|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
56901820|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901821|NCT01308177|Ecabet|ecabet|mesh-list
56901822|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901823|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56901824|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901825|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
56901826|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901827|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901828|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56901829|NCT01308177|Protective Agents|protective agents|mesh-ancestor
56922210|NCT05549752|Amiodarone|amiodarone|mesh-list
56922211|NCT05549752|Flecainide|flecainide|mesh-list
56922212|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56922213|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56901830|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901831|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901832|NCT01308255|Vitamins|vitamins|mesh-list
56901833|NCT01308255|Folic Acid|folic acid|mesh-list
56901834|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
56901835|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56901837|NCT01308255|Infliximab|infliximab|mesh-list
56901838|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
56901839|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901840|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56901841|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
56901842|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56901843|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56901844|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
56901845|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404913|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
56901846|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901847|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
56901848|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901849|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56405047|NCT00162968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56901850|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56901851|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
56901852|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56901853|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56901854|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56901856|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
56901857|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56405338|NCT00163514|Hormones|hormones|mesh-ancestor
56901858|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901859|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
56901861|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901862|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56405571|NCT00193401|Topotecan|topotecan|mesh-list
56901863|NCT01308255|Protective Agents|protective agents|mesh-ancestor
56901864|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56901865|NCT01308255|Hematinics|hematinics|mesh-ancestor
56922218|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56922219|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56922220|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56922221|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922222|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56922223|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56922224|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56922225|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56922226|NCT05549180|Emtricitabine|emtricitabine|mesh-list
56901866|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
56901867|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
56901868|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56901869|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56901870|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901871|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
56901872|NCT03782025|Coagulants|coagulants|mesh-ancestor
56901873|NCT03782025|Vitamins|vitamins|mesh-ancestor
56901874|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
56901875|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901877|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
56901878|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56901879|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901881|NCT03781869|Etoposide|etoposide|mesh-list
56901882|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
56901883|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901884|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56901885|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56901886|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56901887|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405994|NCT00165230|Temozolomide|temozolomide|mesh-list
56901888|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901889|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56901890|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901891|NCT03781635|Ketamine|ketamine|mesh-list
56901892|NCT03781635|Analgesics|analgesics|mesh-ancestor
56406146|NCT00165737|Donepezil|donepezil|mesh-list
56901893|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
56901894|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901895|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901896|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56901897|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56901898|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
56901899|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
56901900|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901901|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56901902|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56901903|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901904|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901905|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
56901906|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56901907|NCT03781011|Choline|choline|mesh-list
56901908|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
56901909|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56901910|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
56901911|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901912|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56901913|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56901914|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
56901915|NCT03785613|Buprenorphine|buprenorphine|mesh-list
56901916|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56901917|NCT03785613|Narcotics|narcotics|mesh-ancestor
56901918|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56901919|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901920|NCT03785613|Analgesics|analgesics|mesh-ancestor
56901921|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
56901922|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901923|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56901924|NCT03785223|Methylphenidate|methylphenidate|mesh-list
56901925|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56901926|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901927|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56901928|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56406600|NCT00177411|Hormones|hormones|mesh-list
56901929|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56901930|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901931|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
56406811|NCT00167648|Leuprolide|leuprolide|mesh-list
56901932|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56901933|NCT01308723|Sorafenib|sorafenib|mesh-list
56901934|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56406883|NCT00167843|Renal Agents|renal agents|mesh-ancestor
56901935|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56901936|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56901937|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901938|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901939|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
56407102|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901940|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901941|NCT01561131|Calcium|calcium|mesh-list
56901942|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56901943|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901944|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
56901945|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56901946|NCT03780621|Andrographolide|andrographolide|mesh-list
56901947|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56901948|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56901949|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56901950|NCT03780621|Analgesics|analgesics|mesh-ancestor
56901951|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
56901952|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901953|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901954|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56901955|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56901956|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56901957|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56901958|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
56901959|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56901960|NCT03785067|Amlodipine|amlodipine|mesh-list
56901961|NCT03785067|Telmisartan|telmisartan|mesh-list
56901962|NCT03785067|Indapamide|indapamide|mesh-list
56407312|NCT00168740|Rituximab|rituximab|mesh-list
56901963|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56901964|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56901965|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56407462|NCT00169208|Analgesics|analgesics|mesh-ancestor
56901966|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901967|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56901968|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901970|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56407534|NCT00553618|Analgesics|analgesics|mesh-ancestor
56901971|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56901972|NCT03785067|Diuretics|diuretics|mesh-ancestor
56901973|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
56901974|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56901975|NCT05688111|Tranexamic Acid|tranexamic acid|mesh-list
56901976|NCT05688111|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56901977|NCT05688111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56901978|NCT05688111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901979|NCT05688111|Hemostatics|hemostatics|mesh-ancestor
56901980|NCT05688111|Coagulants|coagulants|mesh-ancestor
56901981|NCT02059018|Diclofenac|diclofenac|mesh-list
56901982|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
56901983|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
56901984|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56901985|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56901986|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56901987|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56901988|NCT02059018|Analgesics|analgesics|mesh-ancestor
56901989|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
56901990|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56901991|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901992|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56901993|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56901994|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56901995|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56901996|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
56901997|NCT01561209|Amitriptyline|amitriptyline|mesh-list
56922297|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56922298|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56922299|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
56922300|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
56922301|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922302|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922303|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56901998|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56901999|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
56902000|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56902001|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56902002|NCT01561209|Analgesics|analgesics|mesh-ancestor
56902003|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
56902004|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902005|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902006|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56902007|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56407738|NCT02896582|Dexamethasone|dexamethasone|mesh-list
56902008|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56902009|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902010|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
56902011|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902012|NCT02800642|Aflibercept|aflibercept|mesh-list
56902013|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56902014|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56902015|NCT02800642|Growth Substances|growth substances|mesh-ancestor
56407871|NCT02895022|Lidocaine|lidocaine|mesh-list
56902016|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902017|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
56902018|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902019|NCT02056600|Metformin|metformin|mesh-list
56902020|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56902021|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902022|NCT02056678|Acetaminophen|acetaminophen|mesh-list
56902023|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56902024|NCT02056678|Analgesics|analgesics|mesh-ancestor
56902025|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
56902026|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902027|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902028|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
56902029|NCT04662567|Acetaminophen|acetaminophen|mesh-list
56902030|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56902031|NCT04662567|Analgesics|analgesics|mesh-ancestor
56902032|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
56922336|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56922337|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922338|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922339|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56922340|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56922341|NCT05394727|Insulin|insulin|mesh-list
56922342|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56922343|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56922344|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900797|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
55900798|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
55900799|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
55900800|NCT04768439|Calcitriol|calcitriol|mesh-list
55900801|NCT04768439|Vitamins|vitamins|mesh-list
55900802|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
55900803|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900804|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55900805|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55900806|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55900807|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900808|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900809|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55900810|NCT02421042|Lenvatinib|lenvatinib|mesh-list
55900811|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900812|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55900813|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900814|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900815|NCT03181464|Lidocaine|lidocaine|mesh-list
56902033|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902034|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902035|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
56902036|NCT02799784|Albuterol|albuterol|mesh-list
56902037|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56902038|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
56612716|NCT00664677|Analgesics|analgesics|mesh-ancestor
56902039|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902040|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902041|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56902042|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
56902043|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
56902044|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56902045|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56902046|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56902047|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56902048|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
56902049|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902050|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408278|NCT01367002|Paclitaxel|paclitaxel|mesh-list
56902052|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902053|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902054|NCT03779451|Progesterone|progesterone|mesh-list
56902055|NCT03779451|Progestins|progestins|mesh-ancestor
56902056|NCT03779451|Hormones|hormones|mesh-ancestor
56902057|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56902058|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902060|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902061|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56902062|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902063|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902064|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56902065|NCT03784443|Ranibizumab|ranibizumab|mesh-list
56902066|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56902067|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56902068|NCT03784443|Growth Substances|growth substances|mesh-ancestor
56902069|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902070|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
56902071|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408473|NCT00197418|Amoxicillin|amoxicillin|mesh-list
56408535|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
56902072|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56902073|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
56922379|NCT05381948|Aflibercept|aflibercept|mesh-list
56922380|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56922381|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56922382|NCT05381948|Growth Substances|growth substances|mesh-ancestor
56922383|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922384|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
56922385|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922386|NCT05375994|Adagrasib|adagrasib|mesh-list
56922387|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922388|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
56922389|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56922390|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922391|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56922392|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922402|NCT05369832|Ozanimod|ozanimod|mesh-list
56902074|NCT03784443|Hormones|hormones|mesh-ancestor
56902075|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56902076|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
56902077|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56902078|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902079|NCT02054884|Paclitaxel|paclitaxel|mesh-list
56902080|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56902081|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56902082|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902083|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
56902084|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
56902085|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
56902086|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902087|NCT01333072|Risperidone|risperidone|mesh-list
56902088|NCT01333072|Aripiprazole|aripiprazole|mesh-list
56902089|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56902090|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
56902091|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408680|NCT04865731|Esomeprazole|esomeprazole|mesh-list
56408742|NCT02908165|Sorafenib|sorafenib|mesh-list
56902092|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902093|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902095|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56902096|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408815|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
56902097|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56902098|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56902099|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
56902100|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
56902101|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
56902102|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56902103|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56902104|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56902105|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56902106|NCT01560663|Carboplatin|carboplatin|mesh-list
56902107|NCT01560663|Docetaxel|docetaxel|mesh-list
56902108|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902109|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
56902110|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
56902111|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
56612788|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
56902112|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902114|NCT02059564|Exenatide|exenatide|mesh-list
56902115|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56902116|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902118|NCT02059564|Hormones|hormones|mesh-ancestor
56902119|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56902120|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56902121|NCT05622058|Cyclophosphamide|cyclophosphamide|mesh-list
56902122|NCT05622058|Docetaxel|docetaxel|mesh-list
56902123|NCT05622058|Doxorubicin|doxorubicin|mesh-list
56902124|NCT05622058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56902125|NCT05622058|Immunologic Factors|immunologic factors|mesh-ancestor
56902126|NCT05622058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902127|NCT05622058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409319|NCT00555022|Bromides|bromides|mesh-list
56902128|NCT05622058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56902129|NCT05622058|Alkylating Agents|alkylating agents|mesh-ancestor
56902130|NCT05622058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902131|NCT05622058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902132|NCT05622058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56902133|NCT05622058|Tubulin Modulators|tubulin modulators|mesh-ancestor
56902134|NCT05622058|Antimitotic Agents|antimitotic agents|mesh-ancestor
56902135|NCT05622058|Mitosis Modulators|mitosis modulators|mesh-ancestor
56902136|NCT05622058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56902137|NCT05622058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56902138|NCT05622058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56902139|NCT05622058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902140|NCT02055196|Irinotecan|irinotecan|mesh-list
56902141|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56902142|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56902143|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922405|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56902144|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409682|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
56409747|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56902145|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902146|NCT02055274|Rotigotine|rotigotine|mesh-list
56902147|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
56902148|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
56902149|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56409976|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56902150|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902151|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902152|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56902153|NCT03783897|Norgestimate|norgestimate|mesh-list
56902154|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
56902155|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
56902156|NCT03783897|Estradiol|estradiol|mesh-list
56902157|NCT03783897|Estrogens|estrogens|mesh-ancestor
56902158|NCT03783897|Hormones|hormones|mesh-ancestor
56902159|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56902160|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410043|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56902161|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56410139|NCT00204321|Sirolimus|sirolimus|mesh-list
56902162|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56902163|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56902164|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56902165|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56902166|NCT03779061|Propofol|propofol|mesh-list
56902167|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56902168|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902169|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902170|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56902172|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
56902174|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56410477|NCT02830360|Amiodarone|amiodarone|mesh-list
56410543|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
56902175|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56902176|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902177|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410618|NCT00176774|Leucovorin|leucovorin|mesh-list
56902178|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56902179|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56902180|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56902181|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56902182|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
56902183|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
56902184|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
56902185|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
56902186|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902187|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612864|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
56902188|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56902189|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56902190|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56902191|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902192|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902193|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56902194|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56922407|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922408|NCT05364944|Octreotide|octreotide|mesh-list
56922409|NCT05364944|Lanreotide|lanreotide|mesh-list
56922410|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56922411|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56922412|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902195|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902196|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
56411346|NCT00559741|Vitamins|vitamins|mesh-ancestor
56902198|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
56902199|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56902200|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411426|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
56902201|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56902202|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56902203|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
56902204|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902205|NCT03778359|Leuprolide|leuprolide|mesh-list
56902206|NCT03778359|Dienogest|dienogest|mesh-list
56902207|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
56902208|NCT03778359|Progestins|progestins|mesh-list
56902209|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56902210|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
56902211|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56902212|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902213|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56902214|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56902215|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56902216|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56902217|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
56902218|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56902219|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902220|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56902221|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56902222|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
56902223|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56902224|NCT03778359|Hormones|hormones|mesh-ancestor
56902225|NCT03560908|Dasatinib|dasatinib|mesh-list
56902226|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902227|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56902228|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902229|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902230|NCT05623059|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56411923|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
56902231|NCT05623059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56902232|NCT05623059|Immunologic Factors|immunologic factors|mesh-ancestor
56902233|NCT05623059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902234|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
56902236|NCT02057770|Fludarabine|fludarabine|mesh-list
56902237|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
56902238|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56902239|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
56902240|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902241|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56902242|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56902243|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
56902244|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902245|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412656|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56412729|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902246|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56412800|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
56412873|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
56902247|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56902248|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
56902249|NCT05615025|Propofol|propofol|mesh-list
56413102|NCT00216606|Topiramate|topiramate|mesh-list
56902250|NCT05615025|Sevoflurane|sevoflurane|mesh-list
56902251|NCT05615025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56922430|NCT05350501|Nivolumab|nivolumab|mesh-list
56922431|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922432|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922433|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56923711|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922435|NCT05331183|Ivacaftor|ivacaftor|mesh-list
56902253|NCT05615025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902254|NCT05615025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56902255|NCT05615025|Anesthetics, General|anesthetics, general|mesh-ancestor
56902256|NCT05615025|Anesthetics|anesthetics|mesh-ancestor
56902257|NCT05615025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56902258|NCT05615025|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56902259|NCT03778281|Baclofen|baclofen|mesh-list
56902260|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56902261|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902262|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56902263|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902264|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56902265|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
56902266|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
56902267|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902268|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902269|NCT02055586|Alovudine|alovudine|mesh-list
56902271|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
56902272|NCT02055586|Protective Agents|protective agents|mesh-ancestor
56902273|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902275|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902276|NCT03778593|Leucovorin|leucovorin|mesh-list
56902277|NCT03778593|Fluorouracil|fluorouracil|mesh-list
56902278|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
56902279|NCT03778593|Irinotecan|irinotecan|mesh-list
56902280|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
56902281|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902282|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56902283|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902284|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56902285|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
56902286|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902287|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56902288|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56902289|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902290|NCT03778593|Antidotes|antidotes|mesh-ancestor
56902291|NCT03778593|Protective Agents|protective agents|mesh-ancestor
56902292|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
56902294|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
56902295|NCT02055664|Ropivacaine|ropivacaine|mesh-list
56902296|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
56902297|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
56414632|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56902298|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902299|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902300|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
56902301|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902302|NCT01309425|Tapentadol|tapentadol|mesh-list
56902303|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56902304|NCT01309425|Narcotics|narcotics|mesh-ancestor
56902305|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902306|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902307|NCT01309425|Analgesics|analgesics|mesh-ancestor
56902308|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
56414785|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
56902309|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902310|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56902311|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56902312|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56414992|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
56902313|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415066|NCT00190034|Antidotes|antidotes|mesh-ancestor
56902314|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
56415138|NCT02963168|Docetaxel|docetaxel|mesh-list
56902315|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902316|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
56902317|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902318|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56902319|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902320|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902321|NCT05648422|Nitazoxanide|nitazoxanide|mesh-list
56902322|NCT05648422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56902323|NCT05648422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902324|NCT02057926|Tetracycline|tetracycline|mesh-list
56902325|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56902326|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902327|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56902328|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902329|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902330|NCT03777579|Paclitaxel|paclitaxel|mesh-list
56902331|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56902332|NCT03777579|Antibodies|antibodies|mesh-list
56902333|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
56902334|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56902335|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902336|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
56415930|NCT04571437|Capecitabine|capecitabine|mesh-list
56902337|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
56902338|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
56416080|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56904691|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56902339|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902341|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416294|NCT00193193|Paclitaxel|paclitaxel|mesh-list
56902343|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56902345|NCT02059876|Trastuzumab|trastuzumab|mesh-list
56902346|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56902347|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902348|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
56416591|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
56902349|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
56902350|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
56902351|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902353|NCT03777423|Cobalt|cobalt|mesh-list
56902355|NCT03777423|Trace Elements|trace elements|mesh-ancestor
56902356|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
56902357|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902359|NCT05654662|Chlorhexidine|chlorhexidine|mesh-list
56902360|NCT05654662|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56902361|NCT05654662|Sodium Fluoride|sodium fluoride|mesh-list
56902362|NCT05654662|Cariostatic Agents|cariostatic agents|mesh-ancestor
56902364|NCT05654662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902365|NCT05654662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56902366|NCT05654662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902367|NCT05654662|Disinfectants|disinfectants|mesh-ancestor
56902368|NCT05654662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56902369|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
56902370|NCT03777033|Calcium|calcium|mesh-list
56902371|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56902372|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922442|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922443|NCT05307705|Paclitaxel|paclitaxel|mesh-list
56922444|NCT05307705|Letrozole|letrozole|mesh-list
56922445|NCT05307705|Fulvestrant|fulvestrant|mesh-list
56902373|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56902374|NCT03783429|Digoxin|digoxin|mesh-list
56902375|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56902376|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56902377|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902378|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902379|NCT03783429|Protective Agents|protective agents|mesh-ancestor
56902380|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902381|NCT02060032|Atorvastatin|atorvastatin|mesh-list
56417167|NCT00224679|Aspirin|aspirin|mesh-list
56902383|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56902384|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56904692|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
56902386|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902387|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56417462|NCT00225381|Anesthetics|anesthetics|mesh-list
56417534|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417605|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902388|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56902389|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902391|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
56902392|NCT03783273|Vitamins|vitamins|mesh-ancestor
56902393|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
56902394|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417909|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
56902395|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56417977|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902396|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56902398|NCT03777345|Chromium|chromium|mesh-list
56902399|NCT03777345|Trace Elements|trace elements|mesh-ancestor
56902400|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
56418192|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
56902401|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902402|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
56902404|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
56902405|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547702|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547703|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
56547704|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56547705|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56418488|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547706|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547707|NCT02862483|Tadalafil|tadalafil|mesh-list
56547708|NCT02862483|Tamsulosin|tamsulosin|mesh-list
56547709|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
56902406|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418782|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902407|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56902409|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56902410|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56902411|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56902412|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56902413|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
56902414|NCT03710889|Abaloparatide|abaloparatide|mesh-list
56902415|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56902416|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902417|NCT02061124|Sevelamer|sevelamer|mesh-list
56902418|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
56902419|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
56902420|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902421|NCT01318941|Ranibizumab|ranibizumab|mesh-list
56902422|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56902423|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56902424|NCT01318941|Growth Substances|growth substances|mesh-ancestor
56902425|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902426|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
56902427|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902428|NCT03560440|Vancomycin|vancomycin|mesh-list
56902429|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56902430|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902431|NCT03776955|Carvedilol|carvedilol|mesh-list
56902432|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56902433|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56902434|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
56902435|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902436|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902437|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902438|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56902439|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
56902440|NCT03776955|Protective Agents|protective agents|mesh-ancestor
56902442|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56902443|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56902444|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
56902445|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56902446|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56902447|NCT05102721|Avelumab|avelumab|mesh-list
56419787|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
56902448|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56902451|NCT03308942|Niraparib|niraparib|mesh-list
56902452|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56902453|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420156|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
56420230|NCT01081132|Guanfacine|guanfacine|mesh-list
56902454|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56902455|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902456|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902457|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56902458|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56902459|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
56902460|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902461|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902463|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
56902464|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56902465|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56902466|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56902467|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
56902468|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902469|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902470|NCT03308786|Aldesleukin|aldesleukin|mesh-list
56420682|NCT00234819|Estrogens|estrogens|mesh-list
56902472|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56420796|NCT04569214|PAZ320|paz320|mesh-list
56902473|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56902474|NCT03308786|Analgesics|analgesics|mesh-ancestor
56902475|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
56902476|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420882|NCT00238173|Etoposide|etoposide|mesh-list
56902477|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902478|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56902479|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56902480|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
56902481|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421032|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56547710|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56902482|NCT03776409|Vancomycin|vancomycin|mesh-list
56902483|NCT03776409|Tazobactam|tazobactam|mesh-list
56902484|NCT03776409|Piperacillin|piperacillin|mesh-list
56902485|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56902486|NCT03776409|Lactams|lactams|mesh-list
56902487|NCT03776409|beta-Lactams|beta-lactams|mesh-list
56421370|NCT04668469|Zinc|zinc|mesh-list
56902489|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421416|NCT00211952|Celecoxib|celecoxib|mesh-list
56902490|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56902491|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421553|NCT00239421|Fluticasone|fluticasone|mesh-list
56902492|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902493|NCT05045703|Vitamin A|vitamin a|mesh-list
56902494|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
56902495|NCT05045703|Vitamins|vitamins|mesh-ancestor
56902496|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
56902497|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902498|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
56902499|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902500|NCT05045703|Protective Agents|protective agents|mesh-ancestor
56902501|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56902502|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902503|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
56902504|NCT03782805|Vitamin D|vitamin d|mesh-list
56421621|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
56902505|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56902506|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902507|NCT03782805|Vitamins|vitamins|mesh-ancestor
56902508|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
56902509|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56902510|NCT03775863|Liver Extracts|liver extracts|mesh-list
56902511|NCT03775863|Hematinics|hematinics|mesh-ancestor
56902512|NCT03274076|Tofacitinib|tofacitinib|mesh-list
56421827|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
56902513|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56902514|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902515|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902516|NCT03775707|Lenvatinib|lenvatinib|mesh-list
56902517|NCT03775707|Antibodies|antibodies|mesh-list
56902518|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
56422046|NCT00244296|Analgesics|analgesics|mesh-ancestor
56902519|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422192|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
56902520|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902521|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56902522|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902523|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902524|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56902525|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902526|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56902527|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902528|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902530|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902531|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56902532|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902533|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902535|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56902536|NCT01320111|Sorafenib|sorafenib|mesh-list
56422477|NCT04664725|Repaglinide|repaglinide|mesh-list
56902537|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56902538|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902539|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
56902540|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
56902541|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
56422617|NCT00241254|Prednisolone|prednisolone|mesh-list
56422683|NCT04662385|Protective Agents|protective agents|mesh-ancestor
56902542|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902543|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56422836|NCT00558181|Rituximab|rituximab|mesh-list
56902544|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902545|NCT01320579|Tacrolimus|tacrolimus|mesh-list
56902546|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56902547|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
56902548|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902549|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56902550|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902551|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902552|NCT05669001|Mycophenolic Acid|mycophenolic acid|mesh-list
56902553|NCT05669001|Abatacept|abatacept|mesh-list
56902554|NCT05669001|Tacrolimus|tacrolimus|mesh-list
56902555|NCT05669001|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56902556|NCT05669001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56902557|NCT05669001|Immunologic Factors|immunologic factors|mesh-ancestor
56922480|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
56922481|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56922482|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922483|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56922484|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922485|NCT05267366|Bevacizumab|bevacizumab|mesh-list
56922486|NCT05267366|Carboplatin|carboplatin|mesh-list
56902558|NCT05669001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902559|NCT05669001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56902560|NCT05669001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902561|NCT05669001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902562|NCT05669001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56902563|NCT05669001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902564|NCT05669001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56902565|NCT05669001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56902566|NCT05669001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56423276|NCT00246168|Analgesics|analgesics|mesh-ancestor
56902567|NCT05669001|Antitubercular Agents|antitubercular agents|mesh-ancestor
56902568|NCT05669001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56902569|NCT05669001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56423565|NCT00242463|Nandrolone|nandrolone|mesh-list
56902571|NCT03775395|Lenvatinib|lenvatinib|mesh-list
56902572|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56423718|NCT00242775|Budesonide|budesonide|mesh-list
56423788|NCT00247026|Ubiquinone|ubiquinone|mesh-list
56902573|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56902575|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902576|NCT02797522|Acetaminophen|acetaminophen|mesh-list
56424087|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
56902578|NCT02797522|Entecavir|entecavir|mesh-list
56424222|NCT00221312|Alendronate|alendronate|mesh-list
56902579|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
56902580|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56902581|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56902582|NCT02797522|Analgesics|analgesics|mesh-ancestor
56902583|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
56424372|NCT04615702|Analgesics|analgesics|mesh-ancestor
56424448|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
56902584|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902585|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902586|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
56902587|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
56902588|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424666|NCT00563914|Amodiaquine|amodiaquine|mesh-list
56902589|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56902590|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56902591|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424895|NCT00564538|Tacrolimus|tacrolimus|mesh-list
56902592|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902594|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56902595|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
56902597|NCT03773367|Fluorouracil|fluorouracil|mesh-list
56902598|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
56902599|NCT03773367|Irinotecan|irinotecan|mesh-list
56902600|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
56902601|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425477|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56902602|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56425630|NCT00252798|Paclitaxel|paclitaxel|mesh-list
56902604|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56902605|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
56902606|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425855|NCT04593238|Calcium|calcium|mesh-list
56902607|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56902608|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56902609|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902610|NCT02060656|Gemcitabine|gemcitabine|mesh-list
56902611|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
56902613|NCT02060656|Lenalidomide|lenalidomide|mesh-list
56902614|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56902616|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
56426218|NCT04588987|Apatinib|apatinib|mesh-list
56902617|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902618|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56902619|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56426363|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
56902620|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
56426437|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56902621|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902622|NCT02060656|Antiviral Agents|antiviral agents|mesh-ancestor
56902623|NCT02060656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902624|NCT02060656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902625|NCT02060656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56426673|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
56902626|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56426813|NCT00568711|Doxycycline|doxycycline|mesh-list
56426883|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
56902627|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56902628|NCT02060656|Growth Substances|growth substances|mesh-ancestor
56902629|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
56902630|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56902631|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
56902633|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56427254|NCT00572065|Cytarabine|cytarabine|mesh-list
56902634|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56902635|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
56902637|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56902638|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56902639|NCT02060656|Protective Agents|protective agents|mesh-ancestor
56902640|NCT03774771|Cinacalcet|cinacalcet|mesh-list
56902641|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56902642|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902643|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56902644|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
56902645|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56902646|NCT03774693|Fentanyl|fentanyl|mesh-list
56902647|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
56902648|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902649|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902650|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56427686|NCT00255372|Lactulose|lactulose|mesh-list
56902651|NCT03774693|Narcotics|narcotics|mesh-ancestor
56902652|NCT03774693|Analgesics|analgesics|mesh-ancestor
56427759|NCT04573855|Antibodies|antibodies|mesh-list
56427830|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
56902654|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902655|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56902656|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56902657|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
56902658|NCT03774615|Ferric maltol|ferric maltol|mesh-list
56902659|NCT03774615|Hematinics|hematinics|mesh-ancestor
56902660|NCT01321047|Propofol|propofol|mesh-list
56902661|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56428048|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56902662|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428116|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
56902663|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902664|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56902665|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
56902666|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
56902668|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56902669|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
56902670|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56902671|NCT01321125|Povidone|povidone|mesh-list
56428638|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902672|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902673|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
56902674|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
56922496|NCT05267288|Afatinib|afatinib|mesh-list
56902675|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
56902676|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
56902677|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
56902678|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56902679|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
56902680|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428785|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428855|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
56902681|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902682|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56902683|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
56902684|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56902685|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
56902686|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429227|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
56902687|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429301|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
56429376|NCT00201422|Amoxicillin|amoxicillin|mesh-list
56902688|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56902689|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
56902690|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
56902691|NCT03773991|Protective Agents|protective agents|mesh-ancestor
56902694|NCT05435313|Raltitrexed|raltitrexed|mesh-list
56429675|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
56429736|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56902695|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902696|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56429813|NCT00415350|Azithromycin|azithromycin|mesh-list
56902697|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56902698|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429959|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430036|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56902699|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902700|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56902701|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
56902702|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56902703|NCT05472675|Bupivacaine|bupivacaine|mesh-list
56902704|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
56902705|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
56902706|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
56902707|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902708|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902709|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
56902710|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902711|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56902712|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56902713|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902714|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
56902715|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430548|NCT04672759|Durvalumab|durvalumab|mesh-list
56902717|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
56902718|NCT01321905|Vitamins|vitamins|mesh-ancestor
56902720|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430763|NCT00234026|Antiviral Agents|antiviral agents|mesh-ancestor
56902721|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56430834|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
56902722|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56922510|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922511|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922512|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922525|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
56922526|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56648511|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
56902723|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56902724|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56902725|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56902726|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
56902727|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902728|NCT03763227|Ranibizumab|ranibizumab|mesh-list
56902729|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
56902730|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56902731|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56902732|NCT03763227|Growth Substances|growth substances|mesh-ancestor
56902733|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902734|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
56902735|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902736|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902737|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902738|NCT04929548|Maleic acid|maleic acid|mesh-list
56902739|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902740|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902741|NCT04150029|Azacitidine|azacitidine|mesh-list
56902742|NCT04150029|Venetoclax|venetoclax|mesh-list
56902743|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56902744|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
56902745|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431253|NCT00268515|Azathioprine|azathioprine|mesh-list
56431333|NCT00268554|Caffeine|caffeine|mesh-list
56902746|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902747|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902748|NCT04068597|Dexamethasone|dexamethasone|mesh-list
56902749|NCT04068597|Azacitidine|azacitidine|mesh-list
56902751|NCT04068597|Pomalidomide|pomalidomide|mesh-list
56902752|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56902753|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
56431545|NCT02213224|Perindopril|perindopril|mesh-list
56902754|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
56902755|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902756|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902757|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56902758|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
56902759|NCT04068597|Hormones|hormones|mesh-ancestor
56902760|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431920|NCT02278510|Topotecan|topotecan|mesh-list
56902761|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56902762|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432070|NCT02215447|Paclitaxel|paclitaxel|mesh-list
56902763|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56902765|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902766|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902767|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
56902768|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56902769|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56902770|NCT04068597|Growth Substances|growth substances|mesh-ancestor
56902771|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
56902772|NCT02060734|Lidocaine|lidocaine|mesh-list
56902773|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
56902774|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
56902775|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902776|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432278|NCT04543123|Citalopram|citalopram|mesh-list
56902777|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
56902778|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902779|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56432415|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56902780|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56902781|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56902782|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56432563|NCT00238082|Norflurane|norflurane|mesh-list
56902783|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902784|NCT03270644|Propranolol|propranolol|mesh-list
56902785|NCT03270644|Lasmiditan|lasmiditan|mesh-list
56613452|NCT04293887|Interferons|interferons|mesh-list
56902786|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56902787|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56902788|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
56902789|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433003|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56902790|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902791|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902792|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56902793|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56433224|NCT02218177|Ranibizumab|ranibizumab|mesh-list
56902794|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
56902795|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56902798|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
56902799|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902801|NCT03768609|Cyclosporins|cyclosporins|mesh-list
56902802|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902803|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902804|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56433703|NCT02279563|Xhance|xhance|mesh-list
56902805|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
56902806|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902807|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
56902808|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902809|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
56902811|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56902812|NCT03269552|Rituximab|rituximab|mesh-list
56902813|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56902815|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
56902816|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56902817|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
56902818|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902819|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902820|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56902821|NCT03771729|Valsartan|valsartan|mesh-list
56902822|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56902823|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56902824|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56902825|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56902826|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902827|NCT03560362|Epinephrine|epinephrine|mesh-list
56902828|NCT03560362|Bupivacaine|bupivacaine|mesh-list
56902829|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
56902830|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
56902831|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902832|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902833|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
56902834|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902835|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56902836|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56902837|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
56902838|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902839|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902840|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56434518|NCT00242918|Gefitinib|gefitinib|mesh-list
56902841|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56902842|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
56902843|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56902844|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
56902845|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
56902847|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56902849|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56435036|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
56902850|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902851|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56902852|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902853|NCT04389177|Paclitaxel|paclitaxel|mesh-list
56902854|NCT04389177|Cisplatin|cisplatin|mesh-list
56902855|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
56902856|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56902857|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435336|NCT00284583|Lidocaine|lidocaine|mesh-list
56902858|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
56902859|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
56902860|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
56902861|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902862|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56902863|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
56902864|NCT01322061|Vitamins|vitamins|mesh-ancestor
56902865|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
56902866|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902867|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
56435771|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56902868|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435853|NCT00249431|Sertraline|sertraline|mesh-list
56902871|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
56902872|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56902873|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56902874|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56902875|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902876|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436202|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902877|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902878|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
56902879|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
56436357|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902880|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902881|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
56436430|NCT02271334|Albuterol|albuterol|mesh-list
56902882|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56902883|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
56902884|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56902885|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
56902886|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56902887|NCT02062996|Protective Agents|protective agents|mesh-ancestor
56902888|NCT03762369|Latanoprost|latanoprost|mesh-list
56902889|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56902890|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56902891|NCT01321515|Famciclovir|famciclovir|mesh-list
56902892|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
56902893|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902894|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56902895|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902896|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902897|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
56902899|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56436557|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
56902900|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902901|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
56902902|NCT04233879|Tenofovir|tenofovir|mesh-list
56902903|NCT04233879|Emtricitabine|emtricitabine|mesh-list
56902904|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56902905|NCT04233879|Islatravir|islatravir|mesh-list
56902907|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902908|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56902909|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56902911|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902912|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56902913|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56902914|NCT01370356|Varenicline|varenicline|mesh-list
56902915|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56902916|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56902917|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
56902918|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902919|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922620|NCT05072249|Naloxone|naloxone|mesh-list
56902920|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902921|NCT03792334|Anesthetics|anesthetics|mesh-list
56902922|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902923|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902924|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
56902925|NCT04545411|Volagidemab|volagidemab|mesh-list
56902926|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56902927|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902928|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56902929|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902930|NCT02065492|Amlodipine|amlodipine|mesh-list
56902931|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
56902932|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56902933|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902934|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56902935|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56902936|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902938|NCT02063620|Ketamine|ketamine|mesh-list
56902939|NCT02063620|Analgesics|analgesics|mesh-ancestor
56902940|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
56902941|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56437075|NCT01683253|Dopamine|dopamine|mesh-list
56902942|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902943|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56437134|NCT04527562|Colchicine|colchicine|mesh-list
56902944|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56902945|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
56902946|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
56902947|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902948|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56902949|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56902950|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56902951|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902952|NCT03767439|Nivolumab|nivolumab|mesh-list
56902953|NCT03767439|Ipilimumab|ipilimumab|mesh-list
56902954|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56902955|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56902956|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56902957|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902958|NCT04539405|Sevoflurane|sevoflurane|mesh-list
56902959|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56902960|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56902961|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
56902962|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
56902963|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902964|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902965|NCT02065804|Bupivacaine|bupivacaine|mesh-list
56902966|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
56902967|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
56437504|NCT00253799|Hylan|hylan|mesh-list
56902968|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902969|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902970|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
56437625|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902971|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902972|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
56902973|NCT02064010|Acamprosate|acamprosate|mesh-list
56902975|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56902976|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902977|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56902978|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56902979|NCT03937713|Eszopiclone|eszopiclone|mesh-list
56902980|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56437838|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56902981|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902982|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902983|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
56902984|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
56902986|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56902987|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56902988|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
56902989|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56902990|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
56902991|NCT01322139|Nabiximols|nabiximols|mesh-list
56902992|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56902993|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56902994|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56902995|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56902996|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56902997|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56902998|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56902999|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903000|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56903001|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
56903002|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56438111|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903003|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903004|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56903005|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56903006|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56903007|NCT01322139|Analgesics|analgesics|mesh-ancestor
56903008|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
56903009|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438255|NCT00270543|Docetaxel|docetaxel|mesh-list
56903010|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56903011|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903012|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56903013|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903014|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903015|NCT03766893|Naltrexone|naltrexone|mesh-list
56903016|NCT03766893|Buprenorphine|buprenorphine|mesh-list
56903017|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56903018|NCT03766893|Naloxone|naloxone|mesh-list
56903019|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56903020|NCT03766893|Narcotics|narcotics|mesh-ancestor
56922648|NCT05020665|Cytarabine|cytarabine|mesh-list
56903021|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903022|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903023|NCT03766893|Analgesics|analgesics|mesh-ancestor
56903024|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
56903025|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56438409|NCT01609855|Bromides|bromides|mesh-list
56903027|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56903028|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
56438466|NCT02270437|Ropivacaine|ropivacaine|mesh-list
56438544|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56438613|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
56903030|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903031|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903032|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903033|NCT03760809|Analgesics|analgesics|mesh-ancestor
56903034|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
56903035|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903036|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56903037|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56903038|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56439131|NCT01603498|Dexamethasone|dexamethasone|mesh-list
56903039|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
56903040|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56439275|NCT00258245|Protective Agents|protective agents|mesh-ancestor
56439351|NCT00271518|Hormones|hormones|mesh-list
56903041|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903042|NCT01370590|Atorvastatin|atorvastatin|mesh-list
56439504|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
56903043|NCT01370590|Ezetimibe|ezetimibe|mesh-list
56903044|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56903045|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56903046|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
56903047|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903048|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56903049|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56903050|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903051|NCT01567683|Imiquimod|imiquimod|mesh-list
56903052|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56903053|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
56903054|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903055|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903056|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
56903057|NCT03766425|Aflibercept|aflibercept|mesh-list
56903058|NCT03766425|Mitomycins|mitomycins|mesh-list
56903059|NCT03766425|Mitomycin|mitomycin|mesh-list
56903060|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56903061|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56903062|NCT03766425|Growth Substances|growth substances|mesh-ancestor
56903063|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922665|NCT04998604|Omalizumab|omalizumab|mesh-list
56922666|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56922667|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56922668|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
56922669|NCT04981912|Rituximab|rituximab|mesh-list
56922670|NCT04981912|Venetoclax|venetoclax|mesh-list
56922671|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922672|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922673|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
56922674|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922675|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903064|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
56903065|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903066|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56903067|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
56903068|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903069|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56903070|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903071|NCT01561911|Antibodies|antibodies|mesh-list
56903072|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56903073|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
56903074|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903075|NCT04300647|Atezolizumab|atezolizumab|mesh-list
56903076|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903077|NCT03770637|Glucagon|glucagon|mesh-list
56440372|NCT00299364|Tibolone|tibolone|mesh-list
56903078|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56903079|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903080|NCT03770637|Hormones|hormones|mesh-ancestor
56440447|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56903081|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903082|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613750|NCT00795847|Losartan|losartan|mesh-list
56903083|NCT03770637|Incretins|incretins|mesh-ancestor
56903084|NCT03766269|Dronabinol|dronabinol|mesh-list
56903085|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
56903086|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903087|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903088|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903089|NCT03766269|Analgesics|analgesics|mesh-ancestor
56903090|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
56903091|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903092|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56903093|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56903094|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903095|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903096|NCT03766269|Hormones|hormones|mesh-ancestor
56903097|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903098|NCT03894891|Docetaxel|docetaxel|mesh-list
56903099|NCT03894891|Nivolumab|nivolumab|mesh-list
56903100|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903101|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
56903102|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
56903103|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
56903104|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903105|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56903106|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56903107|NCT03878979|Nivolumab|nivolumab|mesh-list
56903108|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56903109|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903110|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56441076|NCT00295464|Betamethasone|betamethasone|mesh-list
56903111|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903112|NCT03765645|Tazobactam|tazobactam|mesh-list
56903113|NCT03765645|Piperacillin|piperacillin|mesh-list
56903114|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56903115|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56903116|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903117|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56903118|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56441369|NCT00301782|Etoposide|etoposide|mesh-list
56903119|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903120|NCT01321671|Pregabalin|pregabalin|mesh-list
56903122|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
56903123|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903124|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903125|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
56903126|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56441743|NCT00269126|Hormones|hormones|mesh-ancestor
56903127|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56903128|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441955|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56903129|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56903130|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56903131|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56903132|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903133|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903135|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
56903136|NCT03770013|Bupivacaine|bupivacaine|mesh-list
56903137|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
56442327|NCT00307632|Estradiol|estradiol|mesh-list
56903138|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
56442401|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
56903139|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56442546|NCT00273026|Xhance|xhance|mesh-list
56903140|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903141|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
56903142|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903143|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56903144|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903146|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56442842|NCT00274235|Renal Agents|renal agents|mesh-ancestor
56903147|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56903148|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56903149|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
56903150|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443209|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903151|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903152|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56903153|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
56903154|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
56903155|NCT03769935|Etoposide|etoposide|mesh-list
56903156|NCT03769935|Cisplatin|cisplatin|mesh-list
56443584|NCT00316563|Analgesics|analgesics|mesh-ancestor
56903157|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56903159|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56903160|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56443734|NCT00316953|Dasatinib|dasatinib|mesh-list
56903161|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443880|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
56443955|NCT00317538|Etanercept|etanercept|mesh-list
56903162|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903163|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
56903164|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56903165|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56903166|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903168|NCT03765021|Coagulants|coagulants|mesh-ancestor
56903169|NCT05418699|Insulin|insulin|mesh-list
56903170|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56903171|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903172|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56903173|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
56903174|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56903175|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
56444391|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56903176|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903177|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
56903178|NCT03758859|Protective Agents|protective agents|mesh-ancestor
56903179|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56903180|NCT03759093|Thalidomide|thalidomide|mesh-list
56903181|NCT03759093|Dexamethasone|dexamethasone|mesh-list
56903182|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
56903183|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
56903184|NCT03759093|Bortezomib|bortezomib|mesh-list
56903185|NCT03759093|BB 1101|bb 1101|mesh-list
56903186|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56903187|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
56903188|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903189|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903190|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56922704|NCT04974879|Osimertinib|osimertinib|mesh-list
56444828|NCT00320229|Abciximab|abciximab|mesh-list
56903191|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
56444902|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56903192|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903193|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903194|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56445122|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903195|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903196|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
56903197|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
56903198|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56445416|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56903199|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903200|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
56903201|NCT03759093|Hormones|hormones|mesh-ancestor
56904693|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903202|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903203|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56903204|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
56903205|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445786|NCT00303771|Leucovorin|leucovorin|mesh-list
56903206|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
56903207|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904694|NCT02088502|Protective Agents|protective agents|mesh-ancestor
56903208|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903209|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56903210|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56903211|NCT03759093|Growth Substances|growth substances|mesh-ancestor
56903213|NCT03764241|Vitamin K|vitamin k|mesh-list
56903214|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
56903215|NCT03764241|Vitamins|vitamins|mesh-ancestor
56903216|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
56903217|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903218|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56903219|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
56446374|NCT00417833|Bevacizumab|bevacizumab|mesh-list
56903220|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56903221|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
56903222|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903223|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903224|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
56903225|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56903226|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56903227|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
56903228|NCT03764241|Coagulants|coagulants|mesh-ancestor
56903229|NCT03764163|Xenon|xenon|mesh-list
56903230|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56903231|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
56903232|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
56613909|NCT00796159|Olmesartan|olmesartan|mesh-list
56903233|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903234|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903236|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903237|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
56903238|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904695|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903239|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903240|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56903241|NCT01321827|Itraconazole|itraconazole|mesh-list
56903242|NCT01321827|Prednisolone|prednisolone|mesh-list
56903243|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
56903244|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903245|NCT01321827|Hormones|hormones|mesh-ancestor
56903246|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446949|NCT00327288|Docetaxel|docetaxel|mesh-list
56903247|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903248|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904696|NCT02088502|Antidotes|antidotes|mesh-ancestor
56903249|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903250|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
56447316|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903251|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903252|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56903253|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56903254|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903255|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447461|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
56447534|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
56447607|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447682|NCT00418496|Aldesleukin|aldesleukin|mesh-list
56903256|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56903257|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
56447831|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
56903258|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56903260|NCT03753477|Olmesartan|olmesartan|mesh-list
56903261|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56903262|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
56903263|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56903264|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56903265|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56903266|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56903267|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903268|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56903269|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903270|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
56903271|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56903272|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56903273|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
56903274|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56904697|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56904698|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
56903275|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56904699|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903277|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56903278|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56903279|NCT05236647|Morphine|morphine|mesh-list
56903280|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56903281|NCT05236647|Narcotics|narcotics|mesh-ancestor
56448322|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
56903282|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903284|NCT05236647|Analgesics|analgesics|mesh-ancestor
56903285|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
56903286|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448548|NCT00330252|Rituximab|rituximab|mesh-list
56903288|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56903289|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
56448691|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903290|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56448843|NCT00334464|Warfarin|warfarin|mesh-list
56903291|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448911|NCT00334854|Doxorubicin|doxorubicin|mesh-list
56903292|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
56903293|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56903294|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903295|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903296|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56903297|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56903298|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56903299|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56903300|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56903301|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56903303|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
56903304|NCT04646109|Ivermectin|ivermectin|mesh-list
56903305|NCT04646109|Favipiravir|favipiravir|mesh-list
56903306|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56903307|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903308|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
56903309|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56903310|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56903311|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903312|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903313|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903314|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
56449491|NCT00338052|Norethindrone|norethindrone|mesh-list
56903315|NCT05320107|Ketamine|ketamine|mesh-list
56903316|NCT05320107|Analgesics|analgesics|mesh-ancestor
56903317|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
56903318|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903319|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903320|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56903321|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56903322|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
56903323|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
56449864|NCT00309998|Bevacizumab|bevacizumab|mesh-list
56903324|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903325|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56903326|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56903327|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450077|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56903328|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903330|NCT03752931|Diltiazem|diltiazem|mesh-list
56903331|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56903332|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56450296|NCT00312806|Pantoprazole|pantoprazole|mesh-list
56903333|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56903334|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903335|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56903336|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903337|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
56903338|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56903339|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
56903340|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
56903341|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903342|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56903343|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56903344|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56903345|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
56903346|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903347|NCT05274633|Ravulizumab|ravulizumab|mesh-list
56903348|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56903349|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56903350|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
56903351|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903352|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56903353|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56903354|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56903355|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56903356|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903357|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903358|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56903359|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56903360|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903361|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
56903362|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903363|NCT02066350|Pancrelipase|pancrelipase|mesh-list
56903364|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903365|NCT05081583|Midazolam|midazolam|mesh-list
56903366|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56903367|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56903368|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903369|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903370|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56903371|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56903372|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903373|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56903374|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
56903376|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
56903377|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
56903378|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903379|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903380|NCT02064946|Vitamin D|vitamin d|mesh-list
56903381|NCT02064946|Vitamins|vitamins|mesh-ancestor
56903382|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
56903383|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903384|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56903385|NCT02064556|Amlodipine|amlodipine|mesh-list
56903386|NCT02064556|Candesartan|candesartan|mesh-list
56903387|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56903388|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56903389|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56903390|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903391|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56903392|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903393|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
56903394|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56903395|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56451375|NCT00317915|Irbesartan|irbesartan|mesh-list
56903397|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903398|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56903399|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56903400|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56903401|NCT05041647|Dronabinol|dronabinol|mesh-list
56903402|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
56903403|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903404|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903405|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903406|NCT05041647|Analgesics|analgesics|mesh-ancestor
56903407|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
56451600|NCT00346359|Busulfan|busulfan|mesh-list
56903408|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903409|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55952652|NCT01625013|Hylan|hylan|mesh-list
56903410|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56903411|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451810|NCT00347100|Metformin|metformin|mesh-list
56903412|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903413|NCT05041647|Hormones|hormones|mesh-ancestor
56451882|NCT00321230|Vitamins|vitamins|mesh-ancestor
56903414|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903416|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56903417|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
56903418|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
56903419|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
56903420|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903421|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903422|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903423|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56452025|NCT00322595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56903424|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56452144|NCT00323219|Cefazolin|cefazolin|mesh-list
56903425|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56903426|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56903427|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56452241|NCT00331851|Hormones|hormones|mesh-ancestor
56903428|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56903429|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903430|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56903431|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
56903432|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
56903433|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
56903434|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
56903435|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452537|NCT04705428|Fluorides|fluorides|mesh-list
56903436|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903437|NCT05359731|Dexamethasone|dexamethasone|mesh-list
56903439|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903440|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
56903441|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
56903442|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903443|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903444|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903445|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
56903446|NCT05359731|Hormones|hormones|mesh-ancestor
56903447|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903448|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56903449|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903450|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
56903451|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
56452813|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
56903452|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903453|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
56903454|NCT03695367|Acetaminophen|acetaminophen|mesh-list
56903456|NCT03695367|Ketorolac|ketorolac|mesh-list
56903457|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903459|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
56903460|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903461|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903462|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
56903463|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56903464|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903465|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903466|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56903467|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903468|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903469|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
56903470|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56903471|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56903472|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
56903473|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903474|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56903475|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56903476|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
56453483|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56903477|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903478|NCT03755427|Antacids|antacids|mesh-ancestor
56903479|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903480|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903481|NCT03758079|Gabapentin|gabapentin|mesh-list
56903482|NCT03758079|Doxepin|doxepin|mesh-list
56903483|NCT03758079|Analgesics|analgesics|mesh-ancestor
56453776|NCT00328796|Lidocaine|lidocaine|mesh-list
56903484|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
56903485|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903486|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903487|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
56903488|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56903489|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56453987|NCT00429936|Fenretinide|fenretinide|mesh-list
56903490|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56454076|NCT00330239|Paroxetine|paroxetine|mesh-list
56903491|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56454210|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56903492|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56903493|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56903494|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903495|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903496|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
56903497|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56903498|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56903499|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56922735|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56903500|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
56903501|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
56903502|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
56903503|NCT02067910|Abatacept|abatacept|mesh-list
56903504|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56903505|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903506|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903507|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56903508|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
56903509|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903510|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903512|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
56903513|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56903514|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
56903515|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56903516|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
56903517|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903518|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903519|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
56903520|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
56903521|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56903522|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56454554|NCT00332540|Timolol|timolol|mesh-list
56903524|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
56903525|NCT05280873|Pirfenidone|pirfenidone|mesh-list
56454698|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56903526|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56903527|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
56903528|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903530|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
56903531|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903532|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903533|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903534|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
56903535|NCT05280873|Hormones|hormones|mesh-ancestor
56903536|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903537|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56903538|NCT05280873|Protective Agents|protective agents|mesh-ancestor
56903539|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56903540|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903541|NCT05280873|Analgesics|analgesics|mesh-ancestor
56455059|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
56903542|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
56922745|NCT04899388|Fentanyl|fentanyl|mesh-list
56922746|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56922747|NCT04899388|Narcotics|narcotics|mesh-ancestor
56922748|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56922749|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922750|NCT04899388|Analgesics|analgesics|mesh-ancestor
56922751|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
56922752|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922753|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56922754|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56922765|NCT04894435|Vaccines|vaccines|mesh-list
56903543|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56903544|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903545|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903546|NCT02066818|Lidocaine|lidocaine|mesh-list
56903547|NCT02066818|Tetracaine|tetracaine|mesh-list
56903548|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
56903549|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
56903550|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903551|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903552|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
56903553|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903554|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56903555|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56903556|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56903557|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56903558|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903559|NCT04558125|Heparin|heparin|mesh-list
56903560|NCT04558125|Calcium heparin|calcium heparin|mesh-list
56903561|NCT04558125|Enoxaparin|enoxaparin|mesh-list
56903562|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56903563|NCT04558125|Tinzaparin|tinzaparin|mesh-list
56903564|NCT04558125|Dalteparin|dalteparin|mesh-list
56903565|NCT04558125|Tenecteplase|tenecteplase|mesh-list
56903566|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
56903567|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
56903568|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56903569|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56455564|NCT00337376|Sirolimus|sirolimus|mesh-list
56903570|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903571|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
56455701|NCT00338195|Caffeine|caffeine|mesh-list
56903572|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903573|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
56903574|NCT02793622|Piperaquine|piperaquine|mesh-list
56903575|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
56903576|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56903577|NCT02793622|Artenimol|artenimol|mesh-list
56903578|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
56903579|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56903580|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56903581|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903582|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56903583|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456057|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903584|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903585|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56903586|NCT02793622|Renal Agents|renal agents|mesh-ancestor
56903587|NCT04493931|Rifampin|rifampin|mesh-list
56903588|NCT04493931|Digoxin|digoxin|mesh-list
56903590|NCT04493931|Cimetidine|cimetidine|mesh-list
56456514|NCT00454233|Metformin|metformin|mesh-list
56903591|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56903592|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56903593|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903594|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903595|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56903596|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56456723|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
56903597|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903598|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56903599|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
56903602|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
56903603|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922778|NCT04880395|Lamivudine|lamivudine|mesh-list
56922779|NCT04880395|Emtricitabine|emtricitabine|mesh-list
56922780|NCT04880395|Dolutegravir|dolutegravir|mesh-list
56922781|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56922782|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56922783|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457089|NCT00455832|Ribavirin|ribavirin|mesh-list
56903604|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903605|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56903606|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
56903607|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56903608|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903609|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
56614278|NCT02627469|Listerine|listerine|mesh-list
56903610|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56903611|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903612|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56903613|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56903614|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56903615|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56903616|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56903617|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56903618|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56903619|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56903620|NCT04493931|Protective Agents|protective agents|mesh-ancestor
56903621|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56903622|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903623|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56903624|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
56903625|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
56903626|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56903627|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56903628|NCT02260336|Celecoxib|celecoxib|mesh-list
56903629|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56903630|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903631|NCT02260336|Analgesics|analgesics|mesh-ancestor
56903632|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
56903633|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903634|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903635|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903636|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903637|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56903638|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56903639|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903640|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903641|NCT04948203|Sirolimus|sirolimus|mesh-list
56903642|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56457313|NCT00449553|Metformin|metformin|mesh-list
56903643|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903644|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56903645|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903646|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
56903647|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56903648|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
56903649|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903650|NCT03755193|Diphosphonates|diphosphonates|mesh-list
56903651|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56903652|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903653|NCT03755115|Epirubicin|epirubicin|mesh-list
56903654|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56903655|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903656|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56903657|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56903658|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457552|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
56903659|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903660|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56457638|NCT00458055|Niacin|niacin|mesh-list
56903662|NCT03755037|Estrogens|estrogens|mesh-ancestor
56903663|NCT03755037|Hormones|hormones|mesh-ancestor
56904701|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56903664|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56922787|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56903665|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903666|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56903667|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
56457846|NCT00466518|Incretins|incretins|mesh-ancestor
56903668|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56903669|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56903670|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56903671|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56903672|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
56903673|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903674|NCT04490499|Vaccines|vaccines|mesh-list
56903675|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
56903676|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903677|NCT01332994|Rituximab|rituximab|mesh-list
56903678|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56903679|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903680|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
56903681|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458359|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
56903683|NCT03754959|Midazolam|midazolam|mesh-list
56458439|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
56903684|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56903685|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56904702|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903686|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903687|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903688|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56903689|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56903690|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903691|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56903692|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
56903693|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
56903694|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
56458947|NCT00430469|Lactoferrin|lactoferrin|mesh-list
56903695|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
56903696|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903697|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903700|NCT02067442|Acetaminophen|acetaminophen|mesh-list
56904703|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
56903702|NCT02067442|Analgesics|analgesics|mesh-ancestor
56903703|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
56903704|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903705|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903706|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
56903707|NCT02067520|Hydromorphone|hydromorphone|mesh-list
56903708|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56903709|NCT02067520|Narcotics|narcotics|mesh-ancestor
56903710|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56922795|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903711|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903712|NCT02067520|Analgesics|analgesics|mesh-ancestor
56903713|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
56459594|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
56903714|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903715|NCT03757923|Metformin|metformin|mesh-list
56903716|NCT03757923|Pioglitazone|pioglitazone|mesh-list
56903717|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56903718|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903719|NCT02071888|Dexamethasone|dexamethasone|mesh-list
56903720|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
56903721|NCT02071888|Pomalidomide|pomalidomide|mesh-list
56460233|NCT00436787|PENTA|penta|mesh-list
56903722|NCT02071888|BB 1101|bb 1101|mesh-list
56903723|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903724|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
56903725|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
56903726|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903727|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903728|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56460473|NCT00438113|Terazosin|terazosin|mesh-list
56903729|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
56903730|NCT02071888|Hormones|hormones|mesh-ancestor
56460579|NCT00475059|Cimetidine|cimetidine|mesh-list
56904704|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56904705|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56904706|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
56903731|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903732|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56903733|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903734|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
56903735|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903736|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903737|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
56903738|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56903739|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56903740|NCT02071888|Growth Substances|growth substances|mesh-ancestor
56903741|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
56903742|NCT02071966|Clopidogrel|clopidogrel|mesh-list
56903743|NCT02071966|Ticagrelor|ticagrelor|mesh-list
56903744|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56903745|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56903746|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56461052|NCT03271047|Nivolumab|nivolumab|mesh-list
56903749|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461141|NCT00106002|Pemetrexed|pemetrexed|mesh-list
56903750|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903751|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903753|NCT02072278|Citalopram|citalopram|mesh-list
56903754|NCT02072278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56461343|NCT00442403|Chloroquine|chloroquine|mesh-list
56903755|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56461491|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
56903756|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56903757|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903758|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903759|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
56903760|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903761|NCT02072278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56903762|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
56903763|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903764|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56903765|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56903766|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903767|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56903768|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56461854|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
56903769|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56903770|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56903771|NCT02072512|Fulvestrant|fulvestrant|mesh-list
56903772|NCT02072512|Anastrozole|anastrozole|mesh-list
56903773|NCT02072512|Goserelin|goserelin|mesh-list
56903774|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56903775|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903776|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56903777|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56903778|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
56462150|NCT00480363|Lenalidomide|lenalidomide|mesh-list
56903779|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56462223|NCT00443235|Thalidomide|thalidomide|mesh-list
56903780|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903781|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56462442|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903782|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56462590|NCT00444015|Dasatinib|dasatinib|mesh-list
56903783|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904707|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903784|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903786|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
56903787|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
56903788|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903789|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903790|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56903791|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56903792|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
56903793|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904708|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
56463033|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
56903794|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903795|NCT04534491|Urological Agents|urological agents|mesh-ancestor
56903796|NCT02069080|Plerixafor|plerixafor|mesh-list
56903797|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56903798|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56903799|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
56903800|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903801|NCT02077348|Hormones|hormones|mesh-list
56903802|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903803|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903804|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
56903805|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56903806|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56903808|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
56903809|NCT03694821|Ketorolac|ketorolac|mesh-list
56903810|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56463542|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
56903811|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56903812|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
56903813|NCT03694821|Hylan|hylan|mesh-list
56903814|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903816|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
56903817|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903818|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903819|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903820|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
56903821|NCT03694821|Hormones|hormones|mesh-ancestor
56903822|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903823|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56903824|NCT03694821|Protective Agents|protective agents|mesh-ancestor
56903825|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56903826|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903827|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56903828|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903829|NCT03694821|Analgesics|analgesics|mesh-ancestor
56903830|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
56614502|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
56903831|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903832|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56464336|NCT00492687|Tamoxifen|tamoxifen|mesh-list
56904709|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56464480|NCT00493077|Interferons|interferons|mesh-list
56903834|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903836|NCT02069158|Paclitaxel|paclitaxel|mesh-list
56464561|NCT00493116|Hormones|hormones|mesh-ancestor
56903837|NCT02069158|Carboplatin|carboplatin|mesh-list
56903838|NCT02069158|Gedatolisib|gedatolisib|mesh-list
56464698|NCT00469352|Growth Substances|growth substances|mesh-ancestor
56903839|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56903840|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903841|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
56903842|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
56903843|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
56903844|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903845|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56903846|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903847|NCT04531527|Butenafine|butenafine|mesh-list
56903848|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
56903849|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903850|NCT03165994|Paclitaxel|paclitaxel|mesh-list
56903851|NCT03165994|Carboplatin|carboplatin|mesh-list
56465213|NCT00623077|Etoposide|etoposide|mesh-list
56903852|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56903853|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903854|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
56903855|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
56903856|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
56903857|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903858|NCT02078440|Bromocriptine|bromocriptine|mesh-list
56465352|NCT00601198|Vitamins|vitamins|mesh-ancestor
56903859|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56903860|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56903861|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
56465498|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
56903862|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903863|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903864|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
56903865|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
56903866|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903867|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903868|NCT02070406|Aldesleukin|aldesleukin|mesh-list
56903869|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
56903870|NCT02070406|Fludarabine|fludarabine|mesh-list
56903871|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
56903872|NCT02070406|Interleukin-2|interleukin-2|mesh-list
56903873|NCT02070406|Vaccines|vaccines|mesh-list
56465797|NCT01324141|Tempol|tempol|mesh-list
56903874|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56465933|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
56903875|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56903876|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
56466013|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
56903878|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56466153|NCT00477503|Gallium citrate|gallium citrate|mesh-list
56903879|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56903880|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
56903881|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466382|NCT01247688|Fludarabine|fludarabine|mesh-list
56903882|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903883|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56903884|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56903885|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
56903886|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903887|NCT02070406|Analgesics|analgesics|mesh-ancestor
56903888|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
56903889|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903890|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56903891|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56903892|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
56903893|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56903894|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56903895|NCT04842045|Midazolam|midazolam|mesh-list
56903896|NCT04842045|Psilocybin|psilocybin|mesh-list
56903897|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56903898|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56903899|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466810|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
56903900|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903901|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56903902|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56903903|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903904|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56903905|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
56903907|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
56903908|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
56903909|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614578|NCT00988637|Calcitriol|calcitriol|mesh-list
56903910|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903911|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
56903912|NCT02078596|Valproic Acid|valproic acid|mesh-list
56903913|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
56903914|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56903915|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903916|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
56903917|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903918|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903919|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
56903920|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56903921|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903922|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56903923|NCT02070718|Pentazocine|pentazocine|mesh-list
56903924|NCT02070718|Naloxone|naloxone|mesh-list
56903925|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56903926|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903927|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
56903928|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903929|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56903930|NCT02070718|Narcotics|narcotics|mesh-ancestor
56903931|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903932|NCT02070718|Analgesics|analgesics|mesh-ancestor
56903933|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56903934|NCT02070796|Rotigotine|rotigotine|mesh-list
56903935|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
56903936|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
56903937|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56903938|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903939|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903940|NCT02079064|Propofol|propofol|mesh-list
56903941|NCT02079064|Desflurane|desflurane|mesh-list
56903942|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56467664|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
56903943|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56903944|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903945|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56903947|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
56903948|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56467818|NCT00484107|Estrogens|estrogens|mesh-list
56903949|NCT02079220|Capecitabine|capecitabine|mesh-list
56903950|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
56903951|NCT02079220|Aflibercept|aflibercept|mesh-list
56467957|NCT00484328|Ribavirin|ribavirin|mesh-list
56903952|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56903953|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
56903954|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903955|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903956|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56903957|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56903958|NCT02079220|Growth Substances|growth substances|mesh-ancestor
56903959|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903960|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
56903961|NCT02079298|Fluconazole|fluconazole|mesh-list
56903962|NCT02079298|Ibuprofen|ibuprofen|mesh-list
56468250|NCT00489593|Olanzapine|olanzapine|mesh-list
56903963|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56903964|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56903965|NCT02079298|Analgesics|analgesics|mesh-ancestor
56903966|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
56903967|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903968|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903969|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56903970|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56903971|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56903972|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904710|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56903973|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903975|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904711|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
56903976|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56903977|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56903978|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56903979|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
56904712|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904713|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903980|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56903981|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56903982|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56903983|NCT02071342|Everolimus|everolimus|mesh-list
56903984|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903985|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56903986|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
56469023|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56903987|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903988|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56469184|NCT00506259|Melatonin|melatonin|mesh-list
56903989|NCT02080078|Theophylline|theophylline|mesh-list
56903990|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56903991|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56469261|NCT00487734|Hormones|hormones|mesh-ancestor
56469330|NCT00492245|Mitomycins|mitomycins|mesh-list
56903992|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469392|NCT05149092|Caseins|caseins|mesh-list
56903993|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56903994|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56903995|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
56903996|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56903997|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56903998|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56903999|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
56904000|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56904001|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
56904002|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56904003|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56904004|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
56904005|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904006|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
56904007|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56904008|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904009|NCT02083276|Renal Agents|renal agents|mesh-ancestor
56904010|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904012|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56333917|NCT00064233|Dasatinib|dasatinib|mesh-list
56904013|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56904014|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
56922862|NCT04762758|Cathartics|cathartics|mesh-ancestor
56904016|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56904017|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904018|NCT02080234|Gemcitabine|gemcitabine|mesh-list
56904019|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
56904020|NCT02080234|Asparaginase|asparaginase|mesh-list
56904021|NCT02080234|Pegaspargase|pegaspargase|mesh-list
56904022|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56904023|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
56904024|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904025|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469866|NCT02595489|Vitamin D|vitamin d|mesh-list
56904026|NCT02080234|Antiviral Agents|antiviral agents|mesh-ancestor
56904027|NCT02080234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904028|NCT02080234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470062|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56904029|NCT02080234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904030|NCT02080234|Immunologic Factors|immunologic factors|mesh-ancestor
56904031|NCT02080234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904032|NCT05070039|Antibodies|antibodies|mesh-list
56470210|NCT00498134|Analgesics|analgesics|mesh-ancestor
56904033|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
56904034|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904036|NCT05459649|Prednisone|prednisone|mesh-list
56904037|NCT05459649|Cyclosporins|cyclosporins|mesh-list
56904038|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904039|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
56904040|NCT05459649|Hormones|hormones|mesh-ancestor
56904041|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904042|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904043|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904044|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904045|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904046|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904047|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904048|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
56904049|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
56904050|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904051|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
56470649|NCT00500006|Dasatinib|dasatinib|mesh-list
56904052|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470791|NCT00507858|Pemetrexed|pemetrexed|mesh-list
56904053|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56904054|NCT05050305|Dexamethasone|dexamethasone|mesh-list
56904055|NCT05050305|Pomalidomide|pomalidomide|mesh-list
56904056|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904057|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
56904058|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
56904059|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904060|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904061|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56904062|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
56904064|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904065|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904066|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904067|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
56904068|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56904069|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56904070|NCT05050305|Growth Substances|growth substances|mesh-ancestor
56904071|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
56904072|NCT04461795|Erenumab|erenumab|mesh-list
56904073|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56904074|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
56904075|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471242|NCT00510588|Metformin|metformin|mesh-list
56904714|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471369|NCT00510159|Sulfalene|sulfalene|mesh-list
56904076|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56904715|NCT02087098|Urological Agents|urological agents|mesh-ancestor
56904077|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904078|NCT04461795|Analgesics|analgesics|mesh-ancestor
56904716|NCT01369342|Ustekinumab|ustekinumab|mesh-list
56904079|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
56904080|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904081|NCT04461015|Insulin|insulin|mesh-list
56904082|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56904083|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56904084|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904085|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
56904086|NCT03754179|Trametinib|trametinib|mesh-list
56904087|NCT03754179|Dabrafenib|dabrafenib|mesh-list
56904088|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
56904089|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56904090|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56904091|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904092|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904093|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904094|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904095|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904096|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56904097|NCT03753867|Acitretin|acitretin|mesh-list
56904098|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
56904099|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
56904100|NCT04439253|Crizotinib|crizotinib|mesh-list
56904101|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904102|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56904103|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904104|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904105|NCT03750669|Folic Acid|folic acid|mesh-list
56904106|NCT03750669|Gemcitabine|gemcitabine|mesh-list
56904107|NCT03750669|Paclitaxel|paclitaxel|mesh-list
56904108|NCT03750669|Fluorouracil|fluorouracil|mesh-list
56904109|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
56904110|NCT03750669|Irinotecan|irinotecan|mesh-list
56904111|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56904112|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904113|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56904114|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56904115|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56472048|NCT00514527|Oritavancin|oritavancin|mesh-list
56472093|NCT01240811|Copper|copper|mesh-list
56904116|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904117|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56904118|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
56904119|NCT03750669|Antiviral Agents|antiviral agents|mesh-ancestor
56904120|NCT03750669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904121|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472461|NCT01243944|Lenalidomide|lenalidomide|mesh-list
56904122|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904123|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
56904124|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904125|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56904126|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56904127|NCT03750669|Hematinics|hematinics|mesh-ancestor
56904128|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
56904129|NCT03750669|Vitamins|vitamins|mesh-ancestor
56904130|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
56904131|NCT03757221|Daratumumab|daratumumab|mesh-list
56904132|NCT03757221|Ixazomib|ixazomib|mesh-list
56904133|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904134|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
56904135|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904136|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904137|NCT03757143|Ethanol|ethanol|mesh-list
56904138|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
56904139|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
56904140|NCT03757143|Povidone|povidone|mesh-list
56904141|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56904142|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904143|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56904144|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904145|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
56904146|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
56904147|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
56904149|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56904150|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56904151|NCT04428411|Analgesics|analgesics|mesh-ancestor
56904152|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
56904153|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904154|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904155|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56472879|NCT00518466|Topiramate|topiramate|mesh-list
56904156|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904157|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56473088|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
56904158|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904159|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
56904160|NCT03751059|Dexamethasone|dexamethasone|mesh-list
56904161|NCT03751059|Bromfenac|bromfenac|mesh-list
56904162|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904163|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
56904164|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
56904717|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
56904165|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904166|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904167|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56904168|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
56904169|NCT03751059|Hormones|hormones|mesh-ancestor
56904170|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904718|NCT00191477|Gemcitabine|gemcitabine|mesh-list
56904171|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904172|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904173|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56904174|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56904176|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
56904177|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904178|NCT04422561|Ivermectin|ivermectin|mesh-list
56904179|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56473741|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
56473815|NCT00524706|Vitamins|vitamins|mesh-ancestor
56904181|NCT03756987|Ropivacaine|ropivacaine|mesh-list
56473977|NCT04693026|Remdesivir|remdesivir|mesh-list
56904182|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
56904183|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
56904184|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56474113|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
56904185|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904186|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
56904187|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904188|NCT02072746|Zinc|zinc|mesh-list
56904189|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
56904190|NCT02072746|Trace Elements|trace elements|mesh-ancestor
56904191|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
56904192|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474556|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
56904193|NCT02072746|Astringents|astringents|mesh-ancestor
56474635|NCT04692051|Paclitaxel|paclitaxel|mesh-list
56904194|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
56904195|NCT04940338|Dexamethasone|dexamethasone|mesh-list
56474782|NCT00510263|Hormones|hormones|mesh-ancestor
56904196|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
56904197|NCT04940338|Bromfenac|bromfenac|mesh-list
56904198|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56904199|NCT04940338|BB 1101|bb 1101|mesh-list
56474931|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
56904200|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904202|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
56904203|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904204|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904205|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56904206|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
56904208|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904209|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904210|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475599|NCT05317611|Ondansetron|ondansetron|mesh-list
56904211|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
56614884|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
56904212|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475749|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56904213|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904214|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56904215|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56475826|NCT02939430|Atropine|atropine|mesh-list
56904216|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56904217|NCT04940338|Analgesics|analgesics|mesh-ancestor
56904218|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
56904219|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904220|NCT02083510|Colchicine|colchicine|mesh-list
56904221|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
56904222|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904223|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
56904224|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
56904225|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
56904226|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904228|NCT04407507|Ivermectin|ivermectin|mesh-list
56904229|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56904230|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904232|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904233|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904234|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56904235|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904236|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
56904237|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904238|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
56904239|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904240|NCT02080858|Apixaban|apixaban|mesh-list
56904241|NCT02080858|Ticagrelor|ticagrelor|mesh-list
56904242|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56904243|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56904244|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56904245|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56904246|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
56904247|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904248|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904249|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904250|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56904251|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
56904252|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56904253|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
56476712|NCT00523952|Tacrolimus|tacrolimus|mesh-list
56904254|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904255|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
56904256|NCT02073526|Adalimumab|adalimumab|mesh-list
56904257|NCT02073526|Infliximab|infliximab|mesh-list
56477154|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
56904259|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904262|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56904263|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904264|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
56477448|NCT02924766|Niraparib|niraparib|mesh-list
56904265|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225579|NCT05264896|Antidotes|antidotes|mesh-ancestor
56904267|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904268|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904270|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56904271|NCT02073916|Trastuzumab|trastuzumab|mesh-list
56904272|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56904273|NCT02073916|Lapatinib|lapatinib|mesh-list
56477881|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904274|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56904275|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904276|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
56904277|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
56904278|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
56904279|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904280|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478173|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56904282|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478459|NCT02941601|Gemcitabine|gemcitabine|mesh-list
56904283|NCT02084368|Bupivacaine|bupivacaine|mesh-list
56904284|NCT02084368|Ropivacaine|ropivacaine|mesh-list
56904285|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
56904286|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
56904287|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614952|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56904288|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904289|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
56478838|NCT05600179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56904290|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904291|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
56904292|NCT02084446|Prednisone|prednisone|mesh-list
56904293|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
56904295|NCT02084446|Tacrolimus|tacrolimus|mesh-list
56904296|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
56904297|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56904298|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904299|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
56904300|NCT02084446|Hormones|hormones|mesh-ancestor
56904301|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904302|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904303|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904304|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904305|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904306|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
56904307|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56904308|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904719|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56904720|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
56904309|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904310|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56479287|NCT02935647|Propofol|propofol|mesh-list
56904311|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56904312|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
56904313|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904314|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904315|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
56904316|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
56904317|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904318|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56904319|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56904320|NCT02084446|Protective Agents|protective agents|mesh-ancestor
56904321|NCT02801656|Vancomycin|vancomycin|mesh-list
56479419|NCT02935101|Hormones|hormones|mesh-ancestor
56904322|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904323|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904324|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56904325|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56904326|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904327|NCT02084602|Artesunate|artesunate|mesh-list
56904328|NCT02084602|Mefloquine|mefloquine|mesh-list
56904329|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
56904330|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56904331|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56904332|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904333|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904334|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
56904335|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
56904336|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56904337|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
56904338|NCT02081560|Colistin|colistin|mesh-list
56904339|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904340|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904341|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56904342|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56904343|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56904344|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904345|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904346|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56479533|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904347|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56904348|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904349|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
56904350|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904351|NCT02074228|Methylphenidate|methylphenidate|mesh-list
56479824|NCT05590936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56904352|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56904353|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479899|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904354|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56904355|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56904356|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480124|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547731|NCT00645151|Atorvastatin|atorvastatin|mesh-list
56547804|NCT00968253|Cytarabine|cytarabine|mesh-list
56904357|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904358|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
56904359|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56904360|NCT04405167|Dexamethasone|dexamethasone|mesh-list
56548027|NCT00646711|Valproic Acid|valproic acid|mesh-list
56904361|NCT04405167|Lenalidomide|lenalidomide|mesh-list
56904362|NCT04405167|Ixazomib|ixazomib|mesh-list
56548107|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
56904363|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904365|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
56548252|NCT00924898|Emtricitabine|emtricitabine|mesh-list
56904366|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904367|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904368|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56904370|NCT04405167|Hormones|hormones|mesh-ancestor
56904371|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904372|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904373|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904375|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904376|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904377|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
56904378|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56904379|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56904380|NCT04405167|Growth Substances|growth substances|mesh-ancestor
56548831|NCT00649129|Oxybutynin|oxybutynin|mesh-list
56904381|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
56904382|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
56904383|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904384|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
56904386|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56549209|NCT02536495|Docetaxel|docetaxel|mesh-list
56904387|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56904388|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904389|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549343|NCT02654665|Liraglutide|liraglutide|mesh-list
56904390|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904391|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904392|NCT02085304|Temozolomide|temozolomide|mesh-list
56549636|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
56549796|NCT02860923|Exenatide|exenatide|mesh-list
56904393|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56904394|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
56549863|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549934|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
56904395|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904396|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904397|NCT02260414|Tinzaparin|tinzaparin|mesh-list
56904398|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56904400|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
56904401|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56550154|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
56904402|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56922899|NCT04712097|Growth Substances|growth substances|mesh-ancestor
56904403|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904404|NCT02085538|Palbociclib|palbociclib|mesh-list
56550525|NCT00651859|Bimatoprost|bimatoprost|mesh-list
56904405|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904406|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56904407|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904408|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904410|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56904411|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56904412|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550600|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56904413|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904414|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904415|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56550813|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904417|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904418|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904420|NCT01562691|Emollients|emollients|mesh-ancestor
56550964|NCT04282941|Ibuprofen|ibuprofen|mesh-list
56904421|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
56904422|NCT04681677|Bevacizumab|bevacizumab|mesh-list
56904423|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56904424|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904425|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56904426|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56904427|NCT04681677|Growth Substances|growth substances|mesh-ancestor
56551330|NCT00959049|Vaccines|vaccines|mesh-list
56904428|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904429|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
56904430|NCT02792218|Teriflunomide|teriflunomide|mesh-list
56904431|NCT02792218|Ofatumumab|ofatumumab|mesh-list
56904432|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56904433|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904434|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
56904435|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904436|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56904437|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56904439|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
56615101|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551550|NCT02637973|Empagliflozin|empagliflozin|mesh-list
56904441|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904442|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56904443|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904444|NCT02075086|Bevacizumab|bevacizumab|mesh-list
56551763|NCT00903682|Efavirenz|efavirenz|mesh-list
56904445|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56904446|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904447|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56904448|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56904449|NCT02075086|Growth Substances|growth substances|mesh-ancestor
56551983|NCT02848768|Sunitinib|sunitinib|mesh-list
56904450|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904451|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
56904452|NCT02082418|Caseins|caseins|mesh-list
56904453|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
56904454|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
56904455|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904456|NCT02082496|Liraglutide|liraglutide|mesh-list
56904457|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56904458|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904459|NCT02082496|Incretins|incretins|mesh-ancestor
56904460|NCT02082496|Hormones|hormones|mesh-ancestor
56904461|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904462|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
56904463|NCT02075242|Tacrolimus|tacrolimus|mesh-list
56904464|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904465|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
56904466|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904467|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56904468|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904469|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904470|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56904471|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922902|NCT04704661|Camptothecin|camptothecin|mesh-list
56904472|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56904473|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
56904474|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56904475|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904476|NCT02082652|Etonogestrel|etonogestrel|mesh-list
56904477|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56904478|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
56904479|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56904480|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904481|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56904482|NCT00153101|Telmisartan|telmisartan|mesh-list
56904483|NCT00153101|Ramipril|ramipril|mesh-list
56904484|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56904485|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56552407|NCT03936790|Fentanyl|fentanyl|mesh-list
56904486|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56904487|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552476|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56552546|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56552624|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904488|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56904489|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
56904490|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904491|NCT03558412|Decitabine|decitabine|mesh-list
56552773|NCT00212836|Olanzapine|olanzapine|mesh-list
56904492|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56904493|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
56904494|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552996|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904495|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904496|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56904498|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
56904499|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904500|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
56904501|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56904502|NCT03558880|Anesthetics|anesthetics|mesh-list
56553287|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
56904503|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553510|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
56553511|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553512|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56553513|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
56553514|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56553515|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553516|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56553517|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56553518|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553521|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
56904504|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904505|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56904506|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56904507|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
56904509|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56904510|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56904511|NCT03749733|Estradiol|estradiol|mesh-list
56553956|NCT00670501|Vitamin D|vitamin d|mesh-list
56904512|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56904513|NCT03749733|Estrogens|estrogens|mesh-ancestor
56904515|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554182|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
56904516|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615174|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56922904|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922905|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56904517|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56904518|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
56904519|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56904520|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56904521|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56904522|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56904523|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56904524|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56904525|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554694|NCT04153201|Antimalarials|antimalarials|mesh-list
56904527|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56904528|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554836|NCT04152655|Idebenone|idebenone|mesh-list
56904529|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
56904530|NCT04160091|FX006|fx006|mesh-list
56904531|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56904532|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
56904533|NCT04160091|Hormones|hormones|mesh-ancestor
56904534|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554914|NCT00675961|Naltrexone|naltrexone|mesh-list
56904535|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904536|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56904537|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
56904538|NCT01582607|Fentanyl|fentanyl|mesh-list
56904539|NCT01582607|Bupivacaine|bupivacaine|mesh-list
56904541|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
56904542|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
56904543|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
56555273|NCT01200992|Mitomycins|mitomycins|mesh-list
56904544|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56904545|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904546|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
56904547|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904548|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56904549|NCT01582607|Narcotics|narcotics|mesh-ancestor
56904550|NCT01582607|Analgesics|analgesics|mesh-ancestor
56904551|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56904552|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56904553|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
56904554|NCT00149825|Dexetimide|dexetimide|mesh-list
56904555|NCT00149825|Citalopram|citalopram|mesh-list
56555714|NCT02821390|Nepafenac|nepafenac|mesh-list
56904557|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56904558|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56904559|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904560|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556227|NCT04329832|Azithromycin|azithromycin|mesh-list
56904561|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
56904562|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904563|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56556468|NCT04237090|Promethazine|promethazine|mesh-list
56904564|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
56904565|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56904566|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56904567|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56904568|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
56904569|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
56556677|NCT00689143|Sargramostim|sargramostim|mesh-list
56904570|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56904571|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56904572|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56904573|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
56904574|NCT02792062|Relugolix|relugolix|mesh-list
56904575|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
56904576|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
56904721|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56904577|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56904578|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56904579|NCT05027295|Riboflavin|riboflavin|mesh-list
56557261|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56904580|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56904581|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56904582|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
56904584|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
56250286|NCT01859728|Cisplatin|cisplatin|mesh-list
56557496|NCT02796196|Coal Tar|coal tar|mesh-list
56906379|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
56906719|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56906721|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56909295|NCT00121199|Doxorubicin|doxorubicin|mesh-list
56909296|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56909297|NCT00121199|Vincristine|vincristine|mesh-list
56909298|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56909299|NCT00121199|Antibodies|antibodies|mesh-list
56909300|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
56909301|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56909302|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909303|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
56909304|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909305|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909306|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56909307|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
56909308|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909309|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909310|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56909311|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56909312|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56909313|NCT00121199|Growth Substances|growth substances|mesh-ancestor
56909314|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
56909315|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56909316|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56909317|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56909318|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909319|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909320|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
56909321|NCT00121199|Hormones|hormones|mesh-ancestor
56909322|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909323|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56909324|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56909325|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
56909326|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
56909327|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
56909328|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
56909329|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909330|NCT00119015|Fluticasone|fluticasone|mesh-list
56909331|NCT00119015|Xhance|xhance|mesh-list
56909332|NCT00119015|Montelukast|montelukast|mesh-list
56909333|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909334|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56909335|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
56909336|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909337|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909338|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56909339|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
56909340|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
56909341|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56909342|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56909343|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
56909344|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909345|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56909346|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56909347|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909348|NCT03557307|Benralizumab|benralizumab|mesh-list
56909349|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56909350|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
56909351|NCT01079351|Carbamazepine|carbamazepine|mesh-list
56909352|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
56909353|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
56909452|NCT00115037|Naltrexone|naltrexone|mesh-list
56909453|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56922921|NCT04662086|Camostat|camostat|mesh-list
56922922|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
56922923|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922925|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56909454|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56909455|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909456|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
56909457|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909458|NCT02160184|Pancrelipase|pancrelipase|mesh-list
56909459|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56909460|NCT03725553|Vasopressins|vasopressins|mesh-list
56909461|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
56909462|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
56909463|NCT03725553|Coagulants|coagulants|mesh-ancestor
56909464|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56909465|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56909466|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
56909467|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909468|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56620129|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
56909469|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909470|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909472|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909475|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909476|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56909477|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56909478|NCT03604341|Analgesics|analgesics|mesh-ancestor
56909479|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
56909480|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909481|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56909482|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56909483|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56909484|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909485|NCT03604341|Hormones|hormones|mesh-ancestor
56909486|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909487|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
56909488|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56909489|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56909490|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909491|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
56909492|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
56909493|NCT03560960|Pramlintide|pramlintide|mesh-list
56909494|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56909495|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909496|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
56909497|NCT01186640|Fludarabine|fludarabine|mesh-list
56909498|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
56909499|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
56909500|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
56909501|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56909502|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
56909503|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909504|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909505|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56909506|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
56909507|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909508|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909509|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56909510|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56909511|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
56909512|NCT01186640|Analgesics|analgesics|mesh-ancestor
56909513|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
56909514|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909515|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56909516|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56909517|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909518|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56909519|NCT04949516|Aspirin|aspirin|mesh-list
56909520|NCT04949516|Colchicine|colchicine|mesh-list
56909521|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56909522|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56909523|NCT04949516|Analgesics|analgesics|mesh-ancestor
56909524|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
56909525|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909526|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909527|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909528|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909529|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56909530|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56909531|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909532|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56909533|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56909534|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909535|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
56909536|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
56909537|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
56909538|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
56909539|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
56909540|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909541|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
56909542|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
56909543|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909544|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56909545|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56909546|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909645|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
56909646|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909647|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56909648|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56909649|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
56909650|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909651|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909652|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56909653|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56909654|NCT03189446|Paclitaxel|paclitaxel|mesh-list
56909655|NCT03189446|Carboplatin|carboplatin|mesh-list
56909656|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56909657|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909658|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
56909659|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
56909660|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
56909661|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909662|NCT01314482|Minocycline|minocycline|mesh-list
56909663|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56909664|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56909665|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
56909666|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56909667|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
56909668|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909669|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909670|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56909671|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
56909672|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
56909673|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56909674|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
56909675|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56909676|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56909677|NCT02895945|Factor VIII|factor viii|mesh-list
56909678|NCT02895945|Coagulants|coagulants|mesh-ancestor
56909679|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
56909680|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56909681|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56909682|NCT03229538|Prednisolone|prednisolone|mesh-list
56909683|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
56909684|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56909685|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
56909686|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909687|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
56909688|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
56909689|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909690|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909691|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56909692|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
56909693|NCT03229538|Hormones|hormones|mesh-ancestor
56909694|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56909695|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56909697|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56909698|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56909699|NCT02777554|Thalidomide|thalidomide|mesh-list
56909700|NCT02777554|Apremilast|apremilast|mesh-list
56909701|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56909702|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56909703|NCT02777554|Analgesics|analgesics|mesh-ancestor
56909704|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
56909705|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56909706|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56909707|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56909708|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56373358|NCT00102206|Ritonavir|ritonavir|mesh-list
56909994|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56909996|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
56909997|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56909998|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56909999|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
56910000|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910001|NCT03560739|Ofatumumab|ofatumumab|mesh-list
56910002|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56910003|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910004|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
56910005|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910006|NCT01310673|Allopurinol|allopurinol|mesh-list
56910007|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
56910008|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910009|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910010|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
56910011|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56910012|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56910013|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
56910014|NCT01310673|Protective Agents|protective agents|mesh-ancestor
56910015|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910016|NCT00101686|Bevacizumab|bevacizumab|mesh-list
56910017|NCT00101686|Capecitabine|capecitabine|mesh-list
56910018|NCT00101686|Irinotecan|irinotecan|mesh-list
56910019|NCT00101686|Fluorouracil|fluorouracil|mesh-list
56910020|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56910021|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56910022|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56910023|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56910024|NCT00101686|Growth Substances|growth substances|mesh-ancestor
56910025|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910026|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
56910027|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56910028|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
56910029|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910030|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56910031|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56910032|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910033|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56910034|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
56910035|NCT02163616|Misoprostol|misoprostol|mesh-list
56910036|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56910037|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
56910038|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56910039|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910040|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56910041|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56910042|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
56910043|NCT00101452|Citalopram|citalopram|mesh-list
56910044|NCT00101452|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56910045|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56910046|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56910047|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910048|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910049|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
56910050|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910051|NCT00101452|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56910052|NCT00101452|Antidepressive Agents|antidepressive agents|mesh-ancestor
56910432|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56910433|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
56910434|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910435|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56910436|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
56910515|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56910516|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56910517|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56910518|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56910519|NCT02171182|Capsaicin|capsaicin|mesh-list
56910520|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
56910521|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
56910522|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
56910523|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910524|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910525|NCT00100828|Irinotecan|irinotecan|mesh-list
56910526|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56910527|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56910528|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910746|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56910748|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910749|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910750|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56910751|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
56910752|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
56910753|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56910754|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
56910755|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910756|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910757|NCT02757352|Ixekizumab|ixekizumab|mesh-list
56910758|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
56910759|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
56910760|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56910761|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
56910762|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910763|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910764|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56910765|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
56910766|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
56910767|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56910768|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
56910770|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910771|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
56910772|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56910773|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
56910774|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910775|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910776|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56910777|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
56910778|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
56910779|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56910780|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
56910781|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910782|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910784|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56910785|NCT02172586|Telmisartan|telmisartan|mesh-list
56910786|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56910787|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56910788|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56910789|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56910790|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910791|NCT02172586|Diuretics|diuretics|mesh-ancestor
56910792|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
56910793|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910794|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56910795|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56910796|NCT02170636|Pantoprazole|pantoprazole|mesh-list
56910797|NCT02170636|Dabigatran|dabigatran|mesh-list
56910798|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56910799|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56910800|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56910801|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56910802|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910803|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
56910804|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56910805|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
56910806|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
56910807|NCT02255734|Acyclovir|acyclovir|mesh-list
56910808|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
56910809|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910810|NCT02255812|Quinine|quinine|mesh-list
56910811|NCT02255812|Citric Acid|citric acid|mesh-list
56910812|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
56910813|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
56910814|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56910815|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56910816|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56910817|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56910818|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910819|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56910820|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56910821|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56910822|NCT02255812|Analgesics|analgesics|mesh-ancestor
56621477|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
56910823|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
56910824|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
56910825|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56910826|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
56910827|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
56910828|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910829|NCT02170792|Ranitidine|ranitidine|mesh-list
56910830|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56910831|NCT02170792|Dabigatran|dabigatran|mesh-list
56910832|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56910833|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56910834|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56910835|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
56910836|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
56910837|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56910838|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56910839|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56910840|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
56910841|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56910842|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
56911332|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
56911333|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911334|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56911335|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56911336|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
56911337|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911338|NCT02184052|Meloxicam|meloxicam|mesh-list
56911339|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911340|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911341|NCT02184052|Analgesics|analgesics|mesh-ancestor
56911342|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
56911343|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911344|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622003|NCT02809404|Everolimus|everolimus|mesh-list
56911345|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911346|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911347|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56911348|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56911349|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911350|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911351|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
56911352|NCT01083329|Niacin|niacin|mesh-list
56911353|NCT01083329|Niacinamide|niacinamide|mesh-list
56911354|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
56911355|NCT01083329|Vitamins|vitamins|mesh-ancestor
56911356|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
56911357|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911358|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56911359|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
56911360|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911361|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56911362|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
56911363|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
56911364|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56911365|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56911366|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911367|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
56911368|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
56911369|NCT02181322|Meloxicam|meloxicam|mesh-list
56911370|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56911371|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56911372|NCT02181322|Analgesics|analgesics|mesh-ancestor
56911373|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
56911374|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56911375|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56911376|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56911377|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56911378|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56911379|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56911380|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911381|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911382|NCT02184286|Nevirapine|nevirapine|mesh-list
56911383|NCT02184286|Saquinavir|saquinavir|mesh-list
56911384|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56911385|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56911386|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56911387|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56911388|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
56911389|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56911390|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56911391|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56911392|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56911393|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56382699|NCT00495898|Sirolimus|sirolimus|mesh-list
56912186|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912187|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56912188|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56912189|NCT02198248|Hormones|hormones|mesh-ancestor
56912190|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56912191|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56912192|NCT01069133|Rifaximin|rifaximin|mesh-list
56912193|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56912194|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912195|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56912196|NCT02198404|Propofol|propofol|mesh-list
56912197|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56912198|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912199|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912200|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56912201|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
56912202|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
56912203|NCT02198482|Cytarabine|cytarabine|mesh-list
56912204|NCT02198482|Daunorubicin|daunorubicin|mesh-list
56912205|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
56912206|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56912207|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
56912208|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56912209|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912210|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
56912211|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56912212|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56912213|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
56912214|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912215|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56912216|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56912217|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56912218|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56912219|NCT02198482|Analgesics|analgesics|mesh-ancestor
56912220|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
56912221|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56912222|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
56912223|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56912224|NCT02201134|Sevoflurane|sevoflurane|mesh-list
56912225|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56912226|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56912227|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
56912228|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
56912229|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56912230|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912231|NCT02201602|Gliclazide|gliclazide|mesh-list
56912232|NCT02201602|Glyburide|glyburide|mesh-list
56912233|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56912234|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912235|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56912236|NCT02201914|Clomiphene|clomiphene|mesh-list
56912237|NCT02201914|Enclomiphene|enclomiphene|mesh-list
56912238|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
56912239|NCT02201914|Cetrorelix|cetrorelix|mesh-list
56912240|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
56912241|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56912242|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
56912243|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56912244|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56912245|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56912246|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56912247|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622911|NCT00617851|Vaccines|vaccines|mesh-list
56912248|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56912249|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
56912250|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56912251|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56912252|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
56912253|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56395915|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56395916|NCT05550597|Narcotics|narcotics|mesh-ancestor
56395917|NCT05550597|Analgesics|analgesics|mesh-ancestor
56913924|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913926|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56913927|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
56913928|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56913929|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56913930|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56913931|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
56913932|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56913933|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914321|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914323|NCT00043979|Sirolimus|sirolimus|mesh-list
56914324|NCT00043979|Prednisone|prednisone|mesh-list
56914325|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
56914326|NCT00043979|Melphalan|melphalan|mesh-list
56914327|NCT00043979|Doxorubicin|doxorubicin|mesh-list
56914328|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56914329|NCT00043979|Fludarabine|fludarabine|mesh-list
56914330|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
56914331|NCT00043979|Etoposide|etoposide|mesh-list
56914332|NCT00043979|Vincristine|vincristine|mesh-list
56914333|NCT00043979|Tacrolimus|tacrolimus|mesh-list
56914334|NCT00043979|Cyclosporins|cyclosporins|mesh-list
56914335|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56914336|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914337|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
56914338|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914339|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56914485|NCT01594216|Exemestane|exemestane|mesh-list
56914486|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914487|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56914488|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56914489|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914490|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914491|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56914492|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
56914493|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56914494|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914495|NCT02263690|Lidocaine|lidocaine|mesh-list
56914496|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
56914497|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
56914498|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56914499|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914500|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
56914501|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914502|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56914503|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56914504|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56914505|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56914506|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914507|NCT02265562|Alprostadil|alprostadil|mesh-list
56914508|NCT02265562|Misoprostol|misoprostol|mesh-list
56914509|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56914510|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
56914511|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56914512|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914513|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56914514|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56914515|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
56914516|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56914517|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
56914518|NCT02265562|Urological Agents|urological agents|mesh-ancestor
56914519|NCT01399684|Leucovorin|leucovorin|mesh-list
56914520|NCT01399684|Folic Acid|folic acid|mesh-list
56914521|NCT01399684|Bevacizumab|bevacizumab|mesh-list
56914522|NCT01399684|Fluorouracil|fluorouracil|mesh-list
56914523|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
56914524|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
56914525|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56914526|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914527|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56914528|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56914529|NCT01399684|Growth Substances|growth substances|mesh-ancestor
56914530|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914531|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
56914532|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
56914533|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914534|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914535|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914536|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
56914537|NCT01399684|Antidotes|antidotes|mesh-ancestor
56914538|NCT01399684|Protective Agents|protective agents|mesh-ancestor
56914539|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
56914540|NCT01399684|Vitamins|vitamins|mesh-ancestor
56914541|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
56914542|NCT01399684|Hematinics|hematinics|mesh-ancestor
56914543|NCT01397968|Cenobamate|cenobamate|mesh-list
56914544|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
56914545|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56914546|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
56334834|NCT01349673|Budesonide|budesonide|mesh-list
56914717|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914718|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56914719|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56914720|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
56914721|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914722|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56914723|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
56914724|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
56914725|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
56914726|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56914727|NCT01337752|Dexamethasone|dexamethasone|mesh-list
56914865|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56914866|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56914867|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
56914868|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914869|NCT00039377|Antidotes|antidotes|mesh-ancestor
56914870|NCT00039377|Protective Agents|protective agents|mesh-ancestor
56914871|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
56914904|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56914905|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914906|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56914907|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914908|NCT00154102|Leucovorin|leucovorin|mesh-list
56914909|NCT00154102|Folic Acid|folic acid|mesh-list
56914910|NCT00154102|Fluorouracil|fluorouracil|mesh-list
56914911|NCT00154102|Irinotecan|irinotecan|mesh-list
56914912|NCT00154102|Cetuximab|cetuximab|mesh-list
56914913|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
56914914|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
56914915|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914916|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56914917|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914918|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56914919|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
56914920|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914921|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56914922|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56914923|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56914924|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56914925|NCT00154102|Antidotes|antidotes|mesh-ancestor
56914926|NCT00154102|Protective Agents|protective agents|mesh-ancestor
56914927|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
56914928|NCT00154102|Vitamins|vitamins|mesh-ancestor
56914929|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
56914930|NCT00154102|Hematinics|hematinics|mesh-ancestor
56914931|NCT01269658|Azithromycin|azithromycin|mesh-list
56914932|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56914933|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56914934|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56914935|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56914936|NCT01229644|Crenolanib|crenolanib|mesh-list
56914937|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56914938|NCT02267980|Ketamine|ketamine|mesh-list
56914939|NCT02267980|Sevoflurane|sevoflurane|mesh-list
56914940|NCT02267980|Analgesics|analgesics|mesh-ancestor
56914941|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
56914942|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56914943|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56914944|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56914945|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56914946|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
56914947|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
56914948|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56914949|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56914950|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56914951|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56914952|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914953|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56914954|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56914955|NCT01224262|Vaccines|vaccines|mesh-list
56914989|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56914990|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56914992|NCT01198834|Analgesics|analgesics|mesh-ancestor
56914993|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56914994|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56914995|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56915066|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915067|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915068|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56915069|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915070|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56915071|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56915072|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915073|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915074|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56915075|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
56915076|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56915077|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
56915078|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915079|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
56915080|NCT01071850|Metformin|metformin|mesh-list
56915081|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
56915082|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56915083|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915084|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56915085|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915086|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56915087|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56915088|NCT01037062|Entecavir|entecavir|mesh-list
56915089|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
56915090|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915091|NCT01167166|ON 01910|on 01910|mesh-list
56915092|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096378|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
56915515|NCT04405102|Ozanimod|ozanimod|mesh-list
56915516|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56915517|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915518|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56915519|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
56915520|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915521|NCT03209492|Leuprolide|leuprolide|mesh-list
56915522|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56915523|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
56915524|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915525|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915526|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56915527|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915528|NCT00894868|Vildagliptin|vildagliptin|mesh-list
56915529|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56923003|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
56915530|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915531|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56915532|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
56915533|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915534|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915535|NCT05097326|Misoprostol|misoprostol|mesh-list
56915536|NCT05097326|Mifepristone|mifepristone|mesh-list
56915537|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56915538|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
56915539|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915540|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915541|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56915542|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56915543|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
56915544|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56915545|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56915546|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56915547|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56915548|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
56915549|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56915550|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56915551|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
56915552|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56915553|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
56915554|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56915555|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56915556|NCT01122784|Vaccines|vaccines|mesh-list
56915557|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
56915558|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915559|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
56915560|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56915562|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915563|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915564|NCT00892762|Travoprost|travoprost|mesh-list
56915565|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56915566|NCT00892762|Latanoprost|latanoprost|mesh-list
56915567|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56915568|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56915569|NCT00890968|Triamcinolone|triamcinolone|mesh-list
56915570|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56915571|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56915572|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56915573|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915574|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
56915575|NCT00890968|Hormones|hormones|mesh-ancestor
56915890|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
56915891|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56915892|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915893|NCT00934180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56915894|NCT00934180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56915895|NCT00934180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56915896|NCT00934180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56915897|NCT00934180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56915898|NCT02576444|Olaparib|olaparib|mesh-list
56915899|NCT02576444|Adavosertib|adavosertib|mesh-list
56915900|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56915901|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915902|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915903|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56915904|NCT00929968|Fluticasone|fluticasone|mesh-list
56915905|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915906|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56915907|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
56915908|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915909|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915910|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56915911|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
56915912|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
56915913|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56915914|NCT03957083|Oxytocin|oxytocin|mesh-list
56915915|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
56923014|NCT04586023|Teriflunomide|teriflunomide|mesh-list
56915916|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56915917|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915918|NCT04945616|Aspirin|aspirin|mesh-list
56915919|NCT04945616|Clopidogrel|clopidogrel|mesh-list
56915920|NCT04945616|Ticagrelor|ticagrelor|mesh-list
56915921|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56915922|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56915923|NCT04945616|Analgesics|analgesics|mesh-ancestor
56915924|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
56915925|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56915926|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56915927|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56915928|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56915929|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56915930|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56915931|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56915933|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56915934|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56915935|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
56915936|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56915937|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56915938|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56915939|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
56172618|NCT05664217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916044|NCT03034304|Gemcitabine|gemcitabine|mesh-list
56916045|NCT03034304|Carboplatin|carboplatin|mesh-list
56916046|NCT03034304|Doxorubicin|doxorubicin|mesh-list
56916047|NCT03034304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56916048|NCT03034304|Ifosfamide|ifosfamide|mesh-list
56916049|NCT03034304|Antibodies|antibodies|mesh-list
56916050|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
56916051|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916052|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916053|NCT03034304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56916054|NCT03034304|Antimetabolites|antimetabolites|mesh-ancestor
56916055|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916056|NCT03034304|Antiviral Agents|antiviral agents|mesh-ancestor
56173194|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
56173195|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
56173196|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
56173197|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56173198|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56173199|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56916726|NCT00042289|Dolutegravir|dolutegravir|mesh-list
56178685|NCT02666794|Dsuvia|dsuvia|mesh-list
56916819|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916820|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916822|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
56916823|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56916824|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56916825|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916826|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
56916827|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56916828|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916829|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56916892|NCT05625841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916893|NCT01103401|Tobramycin|tobramycin|mesh-list
56916894|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56916895|NCT01103401|Dexamethasone|dexamethasone|mesh-list
56916896|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
56916897|NCT01103401|Ketorolac|ketorolac|mesh-list
56916898|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56916899|NCT01103401|BB 1101|bb 1101|mesh-list
56916900|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56916901|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
56916902|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
56916903|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56916904|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56916905|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56916906|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
56916907|NCT01103401|Hormones|hormones|mesh-ancestor
56916908|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56916909|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56916910|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916911|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
56916912|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56916913|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56916914|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56916915|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56916916|NCT01103401|Analgesics|analgesics|mesh-ancestor
56916917|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
56916918|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56916919|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56916920|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56916921|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56916922|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56916923|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56916924|NCT00005047|Doxorubicin|doxorubicin|mesh-list
56916925|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56916926|NCT00005047|Methotrexate|methotrexate|mesh-list
56916927|NCT00005047|Vinblastine|vinblastine|mesh-list
56916928|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56916929|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56916930|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56917792|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56917793|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56917794|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917795|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917796|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
56917797|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917798|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56917799|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
56917800|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56917801|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56917802|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56917803|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917804|NCT00658372|Paroxetine|paroxetine|mesh-list
56917805|NCT00658372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56917806|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56917807|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56917808|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917809|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917810|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
56917811|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917812|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56917813|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
56917814|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56917815|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56917816|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56917817|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917819|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56917820|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56917821|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917822|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
56917823|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
56917824|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56917825|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56917826|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917827|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56917828|NCT01106053|Pramipexole|pramipexole|mesh-list
56917829|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
56917830|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917831|NCT01106053|Protective Agents|protective agents|mesh-ancestor
56917832|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917833|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56917834|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56917835|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
56917836|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
56917837|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917838|NCT00616330|Clindamycin|clindamycin|mesh-list
56917839|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
56917840|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
56917841|NCT00616330|Butoconazole|butoconazole|mesh-list
56917842|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56917843|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917844|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56917845|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917846|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917847|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
56917848|NCT00612820|Fluticasone|fluticasone|mesh-list
56917849|NCT00612820|Xhance|xhance|mesh-list
56917850|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
56917851|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56917852|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56917853|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
56917854|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56917855|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917856|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56917857|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
56917858|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
56917917|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917918|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56917919|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917920|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917921|NCT02280070|Antidotes|antidotes|mesh-ancestor
56917922|NCT02280070|Protective Agents|protective agents|mesh-ancestor
56917923|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
56917924|NCT02280070|Vitamins|vitamins|mesh-ancestor
56917925|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
56917926|NCT01108783|Desloratadine|desloratadine|mesh-list
56917927|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56917928|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
56917929|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56917930|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917931|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917932|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56917933|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56917934|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
56917935|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
56917937|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
56917938|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917939|NCT02280148|Propofol|propofol|mesh-list
56917940|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
56917941|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56917942|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917943|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56917944|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56917945|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
56917946|NCT00602602|Gemcitabine|gemcitabine|mesh-list
56917947|NCT00602602|Bevacizumab|bevacizumab|mesh-list
56917948|NCT00602602|Fluorouracil|fluorouracil|mesh-list
56917949|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
56917950|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56917951|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917952|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56917953|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56917954|NCT00602602|Growth Substances|growth substances|mesh-ancestor
56917955|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917956|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
56917957|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56917958|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
56917959|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917960|NCT00602602|Antiviral Agents|antiviral agents|mesh-ancestor
56917961|NCT00602602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917962|NCT00602602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56917963|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56917964|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
56917965|NCT04177654|Albendazole|albendazole|mesh-list
56917966|NCT04177654|Mebendazole|mebendazole|mesh-list
56917967|NCT04177654|Benzimidazole|benzimidazole|mesh-list
56917968|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
56917969|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56917970|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56917971|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
56917972|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56917973|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56917974|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
56917975|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
56917976|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
56917977|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917978|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917979|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
56917980|NCT03726775|Durvalumab|durvalumab|mesh-list
56917981|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56917982|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917983|NCT02281396|Vaccines|vaccines|mesh-list
56917984|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
56917985|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56917986|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56917987|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56917988|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56917989|NCT02880956|Tilavonemab|tilavonemab|mesh-list
56918315|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56918317|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
56918318|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56918319|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918320|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56918321|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56918322|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56918323|NCT02286622|Deflazacort|deflazacort|mesh-list
56918324|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918325|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918326|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
56918327|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918328|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56918329|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56918330|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56918331|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
56918332|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628964|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918333|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918334|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918335|NCT00564226|Urological Agents|urological agents|mesh-ancestor
56918337|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56918338|NCT03635684|Analgesics|analgesics|mesh-ancestor
56918339|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
56918340|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918341|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918342|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
56918343|NCT00092690|Atorvastatin|atorvastatin|mesh-list
56918344|NCT00092690|Simvastatin|simvastatin|mesh-list
56918345|NCT00092690|Ezetimibe|ezetimibe|mesh-list
56918346|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56918347|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56918348|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
56918349|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918350|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56918351|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56918352|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918353|NCT02286700|Desonide|desonide|mesh-list
56918354|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56918355|NCT01338896|Rotigotine|rotigotine|mesh-list
56918356|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
56918357|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
56918358|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918359|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918360|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918361|NCT05185544|Pemetrexed|pemetrexed|mesh-list
56918362|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918363|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918364|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918365|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56918366|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56918367|NCT00382096|Metformin|metformin|mesh-list
56918460|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56918461|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
56918462|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918463|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918464|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918465|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56918467|NCT02286934|Protective Agents|protective agents|mesh-ancestor
56918468|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56918469|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56918470|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56918471|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
56918472|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56918473|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56918474|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56918475|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56918476|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56918477|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
56918478|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918479|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56918480|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
56629111|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918481|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56918482|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
56918483|NCT02282410|Factor VIII|factor viii|mesh-list
56918484|NCT02282410|Coagulants|coagulants|mesh-ancestor
56918485|NCT00092612|Ezetimibe|ezetimibe|mesh-list
56918486|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56918487|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56918488|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
56918489|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918490|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56918491|NCT00540358|Gemcitabine|gemcitabine|mesh-list
56918492|NCT00540358|Carboplatin|carboplatin|mesh-list
56918493|NCT00540358|Iniparib|iniparib|mesh-list
56918494|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918495|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56918496|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
56918497|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918498|NCT00540358|Antiviral Agents|antiviral agents|mesh-ancestor
56918499|NCT00540358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56918500|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56918501|NCT00540358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56918502|NCT00540358|Immunologic Factors|immunologic factors|mesh-ancestor
56918503|NCT00540358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918504|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56918505|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56918506|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
56918507|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56918508|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
56918509|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918510|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56918511|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56918512|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56918513|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918514|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918515|NCT02287246|Bupivacaine|bupivacaine|mesh-list
56918516|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
56918517|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
56918518|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918519|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918520|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
56918521|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918522|NCT04470544|Camostat|camostat|mesh-list
56918729|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918730|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918731|NCT02287558|Pomalidomide|pomalidomide|mesh-list
56918732|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
56918733|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918734|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56181194|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56918781|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
56918782|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56918783|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918784|NCT00523042|Insulin|insulin|mesh-list
56918785|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56918786|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
56918787|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918788|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918789|NCT05203276|Endostar protein|endostar protein|mesh-list
56918790|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56918791|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56918792|NCT05203276|Growth Substances|growth substances|mesh-ancestor
56918793|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918794|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
56918795|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56918796|NCT00338104|Insulin|insulin|mesh-list
56918797|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56918798|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
56918799|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918800|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918801|NCT00519142|Mitiglinide|mitiglinide|mesh-list
56918802|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56918803|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918804|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
56918805|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56918806|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56918807|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56918808|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56918809|NCT02284672|Analgesics|analgesics|mesh-ancestor
56918810|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
56918811|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56918812|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56918813|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56918814|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56918815|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
56918816|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56918817|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56918818|NCT02283190|Asparaginase|asparaginase|mesh-list
56918853|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
56918854|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
56918855|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56181321|NCT01410201|Dexamethasone|dexamethasone|mesh-list
56919265|NCT03943459|Atorvastatin|atorvastatin|mesh-list
56919267|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56919268|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56919269|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
56919270|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919271|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56919272|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56919273|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919274|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
56919275|NCT03943459|Protective Agents|protective agents|mesh-ancestor
56919276|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919277|NCT04832438|Carboplatin|carboplatin|mesh-list
56919278|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919279|NCT05182970|Metformin|metformin|mesh-list
56919280|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56919281|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919282|NCT01315886|Fentanyl|fentanyl|mesh-list
56919283|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56919284|NCT01315886|Narcotics|narcotics|mesh-ancestor
56919285|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919286|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919287|NCT01315886|Analgesics|analgesics|mesh-ancestor
56919288|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
56919289|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919290|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56919291|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56919292|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
56919293|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
56919294|NCT05725798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56919295|NCT05725798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56919296|NCT05725798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919297|NCT05725798|Incretins|incretins|mesh-ancestor
56919298|NCT05725798|Hormones|hormones|mesh-ancestor
56919299|NCT05725798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919300|NCT05725798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56919301|NCT05725798|Protease Inhibitors|protease inhibitors|mesh-ancestor
56629930|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
56919302|NCT05725798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919303|NCT05725798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919305|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56919306|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56919307|NCT00065728|Growth Substances|growth substances|mesh-ancestor
56919308|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919309|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
56919310|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919311|NCT00064714|Exenatide|exenatide|mesh-list
56919312|NCT00064714|Daclizumab|daclizumab|mesh-list
56919313|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56919314|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56919315|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919316|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56919317|NCT00064714|Incretins|incretins|mesh-ancestor
56919318|NCT00064714|Hormones|hormones|mesh-ancestor
56919319|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56919320|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
56919321|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56919322|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56919323|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56919324|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56919325|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56919434|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56919435|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919436|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919437|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
56919438|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
56919439|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
56919440|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919441|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919442|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
56919443|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56919445|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
56919446|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56919447|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56919448|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56919449|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
56919450|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56919451|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630080|NCT04267913|Hormones|hormones|mesh-ancestor
56919452|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56919453|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56919454|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56919455|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919456|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
56919497|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56919498|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56919500|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919501|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
56919502|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
56919503|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
56919504|NCT01110031|Ofatumumab|ofatumumab|mesh-list
56919505|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919506|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56919507|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
56919508|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919509|NCT01210339|Esomeprazole|esomeprazole|mesh-list
56919510|NCT01210339|Clopidogrel|clopidogrel|mesh-list
56919511|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56919512|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56919513|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56919514|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56919515|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
56919516|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56919517|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181984|NCT01415687|Laxatives|laxatives|mesh-ancestor
56919549|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919551|NCT00002224|Didanosine|didanosine|mesh-list
56919552|NCT00002224|Nelfinavir|nelfinavir|mesh-list
56919553|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
56919554|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919555|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56919556|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56919557|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919558|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
56919559|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56919560|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56919561|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56919562|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56919563|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56919601|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56919602|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56919834|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56919835|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56919868|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56919869|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56919870|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56919871|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56919873|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56919874|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
56919875|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56919907|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56919908|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56919909|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56919910|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
56919911|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56256367|NCT01907997|Lidocaine|lidocaine|mesh-list
56919912|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56919913|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
56182403|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
56920068|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920069|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920070|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56920072|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
56920073|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920075|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56920076|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920077|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56920078|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
56920079|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920080|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920081|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56920082|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
56920083|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
56920084|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56920085|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56920086|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56920087|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56920088|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
56920089|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920090|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920091|NCT01213849|Fluticasone|fluticasone|mesh-list
56920092|NCT01213849|Xhance|xhance|mesh-list
56920093|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920094|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56920095|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
56920096|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920097|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920098|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56920100|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
56920101|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56920102|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
56920103|NCT01121809|Etravirine|etravirine|mesh-list
56920104|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56920105|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56920106|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
56920107|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920108|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56920109|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56920110|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920111|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920112|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56920113|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56920114|NCT03937687|Caffeine|caffeine|mesh-list
56920115|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56920116|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920117|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56920118|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630768|NCT02743104|Analgesics|analgesics|mesh-ancestor
56920119|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920120|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56920121|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56920122|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
56920123|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920124|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56920125|NCT05110144|Amitriptyline|amitriptyline|mesh-list
56920126|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56920127|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56920128|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56920129|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920130|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920131|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920132|NCT05110144|Analgesics|analgesics|mesh-ancestor
56920133|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
56920134|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920135|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
56920136|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56920137|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
56920138|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56920139|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56920140|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56920141|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
56920221|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920222|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56920224|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920225|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920226|NCT01122199|Everolimus|everolimus|mesh-list
56920227|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920228|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56920230|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920231|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
56920232|NCT01118923|Antacids|antacids|mesh-ancestor
56920233|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920234|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56920235|NCT01119079|Anesthetics|anesthetics|mesh-list
56920236|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920237|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920238|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
56920239|NCT04503616|Abatacept|abatacept|mesh-list
56920240|NCT04503616|Tacrolimus|tacrolimus|mesh-list
56920241|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56920242|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
56920243|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920244|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56920245|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56920246|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
56920247|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920248|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920249|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56920250|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56920251|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920252|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56920253|NCT01119157|Vaccines|vaccines|mesh-list
56920254|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
56920255|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920256|NCT01120015|Diacetylrhein|diacetylrhein|mesh-list
56920257|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920258|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
56920259|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
56920260|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920261|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920262|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
56920263|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
56920264|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923705|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56923706|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
56923707|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
56923708|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923709|NCT03606967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923710|NCT03606967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56920266|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56920267|NCT01216579|Diuretics|diuretics|mesh-ancestor
56920268|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
56920269|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920270|NCT03528070|Tranilast|tranilast|mesh-list
56920271|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56920272|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56920273|NCT03528070|Analgesics|analgesics|mesh-ancestor
56920274|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
56920275|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920276|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920277|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920278|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56920279|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56920280|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56920281|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920282|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56920283|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56920284|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
56920285|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
56920286|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920287|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56920288|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56920290|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
56920291|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
56920292|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920293|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920294|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
56920295|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920296|NCT01216657|Sunitinib|sunitinib|mesh-list
56920297|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920298|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56920299|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56920300|NCT01216657|Growth Substances|growth substances|mesh-ancestor
56920301|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182748|NCT01420406|Vitamin A|vitamin a|mesh-list
56920302|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
56920303|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56920304|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920305|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920306|NCT04400188|Temozolomide|temozolomide|mesh-list
56920307|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56920308|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
56920309|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920310|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920311|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56920312|NCT04163458|Menotropins|menotropins|mesh-list
56920313|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56920314|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
56920315|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56920316|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920317|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
56920318|NCT04902040|Nivolumab|nivolumab|mesh-list
56920323|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56920324|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
56920325|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920326|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920327|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56920328|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920329|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
56920330|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920334|NCT01115959|Valproic Acid|valproic acid|mesh-list
56920335|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
56920336|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920337|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920338|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
56920339|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920340|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920341|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
56920342|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56633690|NCT03644667|Tacrolimus|tacrolimus|mesh-list
56185599|NCT01432028|Estradiol|estradiol|mesh-list
56920343|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920344|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56920345|NCT03936907|Nabiximols|nabiximols|mesh-list
56920346|NCT03936907|Analgesics|analgesics|mesh-ancestor
56920347|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
56920348|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920349|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920350|NCT01217125|Sirolimus|sirolimus|mesh-list
56920351|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56920352|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920353|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56920354|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920355|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
56920356|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56920357|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
56920358|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920359|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
56920360|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920361|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920362|NCT01217203|Lenalidomide|lenalidomide|mesh-list
56920363|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
56920364|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920365|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56920366|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56920367|NCT01217203|Growth Substances|growth substances|mesh-ancestor
56920368|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
56920369|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920370|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
56920371|NCT01120171|Doxorubicin|doxorubicin|mesh-list
56920372|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56920373|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56920374|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
56920375|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920376|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56920377|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56920378|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
56920379|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920380|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920381|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56920382|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56920383|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56920384|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56920385|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920386|NCT01116193|Dexamethasone|dexamethasone|mesh-list
56920387|NCT01116193|Lenalidomide|lenalidomide|mesh-list
56920388|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920389|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
56920390|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
56920391|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920392|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920393|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56920394|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
56920395|NCT01116193|Hormones|hormones|mesh-ancestor
56182852|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920396|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920397|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56920399|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
56920400|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56920401|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56920402|NCT01116193|Growth Substances|growth substances|mesh-ancestor
56920403|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
56920404|NCT01120327|Amlodipine|amlodipine|mesh-list
56920405|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56920406|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56920407|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56920408|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920409|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56920410|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920411|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
56920412|NCT01116271|Irinotecan|irinotecan|mesh-list
56920413|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56920414|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56648512|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920415|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920416|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920417|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920419|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
56920420|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
56920421|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920422|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
56920423|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920424|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
56920425|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920426|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
56920427|NCT03225664|Trametinib|trametinib|mesh-list
56920428|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920429|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920430|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56920431|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920432|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920433|NCT01212679|Mitogens|mitogens|mesh-list
56920434|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
56920435|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920436|NCT03193684|Empagliflozin|empagliflozin|mesh-list
56920437|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56920438|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920439|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56182902|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
56920440|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920441|NCT03190954|Raclopride|raclopride|mesh-list
56920442|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56920443|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56920444|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920445|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920446|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56182910|NCT01421368|Tenofovir|tenofovir|mesh-list
56920447|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56920448|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
56920449|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920450|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920451|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
56920452|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56920453|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920454|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920455|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56185618|NCT01432080|Budesonide|budesonide|mesh-list
56185619|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
56185620|NCT01432080|Montelukast|montelukast|mesh-list
56185621|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56185622|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185623|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
56185624|NCT01432080|Hormones|hormones|mesh-ancestor
56185625|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185626|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185627|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56185628|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185629|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56185630|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
55896160|NCT00078897|Selenium|selenium|mesh-list
56920456|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56920457|NCT04339270|Azithromycin|azithromycin|mesh-list
56920458|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56920459|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920460|NCT01116583|Gabapentin|gabapentin|mesh-list
56920461|NCT01116583|Analgesics|analgesics|mesh-ancestor
56920462|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
56920463|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920464|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920465|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
56920466|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56920467|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56920468|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920469|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56920470|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56920471|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56920472|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920473|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920474|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
56920475|NCT04299490|Analgesics|analgesics|mesh-list
56920476|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920477|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
56920478|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920479|NCT03935347|Vidarabine|vidarabine|mesh-list
56920480|NCT03935347|Aldesleukin|aldesleukin|mesh-list
56920481|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
56920482|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
56920483|NCT03935347|Fludarabine|fludarabine|mesh-list
56920484|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
56920485|NCT03935347|Interleukin-2|interleukin-2|mesh-list
56920486|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
56920487|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
56920488|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56920489|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
56920490|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920491|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56920492|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56920493|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
56920494|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920495|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920496|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56920497|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920498|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56920499|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
56920500|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
56920501|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920502|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56920503|NCT03935347|Analgesics|analgesics|mesh-ancestor
56920504|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
56920505|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920506|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56920507|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56920508|NCT04467346|Temozolomide|temozolomide|mesh-list
56920509|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56920510|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
56920511|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920512|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920513|NCT03939871|Vinorelbine|vinorelbine|mesh-list
56923137|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56923138|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
56923139|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923140|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923141|NCT04514497|Irinotecan|irinotecan|mesh-list
56923142|NCT04514497|Topotecan|topotecan|mesh-list
56923143|NCT04514497|Camptothecin|camptothecin|mesh-list
56920514|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56920515|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920516|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
56920517|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
56920519|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920520|NCT01122667|Anacetrapib|anacetrapib|mesh-list
56920521|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56920522|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56182988|NCT01421979|Caffeine|caffeine|mesh-list
56920558|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920559|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920560|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56920561|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920562|NCT03635372|Sucralfate|sucralfate|mesh-list
56920563|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
56920564|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56631141|NCT05303909|Gentamicins|gentamicins|mesh-list
56920565|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56920566|NCT03635372|Antacids|antacids|mesh-ancestor
56920567|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920568|NCT01116817|Ritonavir|ritonavir|mesh-list
56920569|NCT01116817|Lopinavir|lopinavir|mesh-list
56920570|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56920571|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56920572|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
56920573|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920574|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920575|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56183038|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
56920577|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
56920578|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920579|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56920580|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56920581|NCT01120795|Interferons|interferons|mesh-list
56920582|NCT01120795|Ribavirin|ribavirin|mesh-list
56920583|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56920584|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
56920585|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920586|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
56920587|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920588|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
56920589|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920590|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
56920591|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920592|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56920593|NCT03008278|Olaparib|olaparib|mesh-list
56920594|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56920595|NCT03008278|Ramucirumab|ramucirumab|mesh-list
56920596|NCT03008278|Antibodies|antibodies|mesh-list
56920597|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
56920598|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56920599|NCT03008278|Lexatumumab|lexatumumab|mesh-list
56920600|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
56920601|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920602|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920603|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920604|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920605|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
56920606|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56920607|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56920608|NCT04467892|Prednisolone|prednisolone|mesh-list
56920609|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
56923150|NCT04492891|Cyclosporine|cyclosporine|mesh-list
56920610|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56920611|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
56920612|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920613|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
56920614|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
56920615|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920616|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920617|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56920618|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
56920620|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920621|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56920622|NCT04467892|Protective Agents|protective agents|mesh-ancestor
56920623|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56920624|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920625|NCT01122979|Insulin|insulin|mesh-list
56920626|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56920627|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
56920628|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
56920629|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
56920630|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
56920631|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
56920632|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56920633|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920634|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
56920635|NCT04179110|Ramucirumab|ramucirumab|mesh-list
56920636|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920637|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920638|NCT01123057|Riboflavin|riboflavin|mesh-list
56920639|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
56920640|NCT01123057|Vitamins|vitamins|mesh-ancestor
56920641|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
56920642|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631210|NCT00928837|Naproxen|naproxen|mesh-list
56920643|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56920644|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
56920645|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
56183084|NCT01422460|Mitogens|mitogens|mesh-list
56920646|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56920647|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920648|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920649|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56920650|NCT03524950|Analgesics|analgesics|mesh-ancestor
56920651|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
56920652|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920653|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56920654|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56920655|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56920656|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
56920657|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920658|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920659|NCT04714190|Paclitaxel|paclitaxel|mesh-list
56920660|NCT04714190|Irinotecan|irinotecan|mesh-list
56920661|NCT04714190|Apatinib|apatinib|mesh-list
56920662|NCT04714190|Trastuzumab|trastuzumab|mesh-list
56920663|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56920664|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920665|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
56920666|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
56920667|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
56920668|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920669|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56920670|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56920671|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920672|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56920673|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920674|NCT03524872|Analgesics|analgesics|mesh-list
56920675|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920676|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
56920677|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920678|NCT04143724|Luspatercept|luspatercept|mesh-list
56920679|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56920680|NCT04143724|Hematinics|hematinics|mesh-ancestor
56920681|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
56920682|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920683|NCT01345370|Temozolomide|temozolomide|mesh-list
56920684|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56920685|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
56920686|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920687|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920688|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
56920689|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56920690|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
56920691|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920692|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
56920693|NCT04702802|Protective Agents|protective agents|mesh-ancestor
56920694|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
56920695|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56920696|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920697|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920698|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56920699|NCT03522688|Analgesics|analgesics|mesh-ancestor
56920700|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
56920701|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920702|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56920703|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56920704|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56920705|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
56183166|NCT01422733|Hormones|hormones|mesh-ancestor
56920706|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183178|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920707|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920708|NCT01214941|Itraconazole|itraconazole|mesh-list
56920709|NCT01214941|Ticlopidine|ticlopidine|mesh-list
56920710|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
56920711|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920712|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56923171|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923172|NCT04464798|Rituximab|rituximab|mesh-list
56923173|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
56923174|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923175|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920713|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56920714|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920715|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920716|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56920717|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
56920718|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920719|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920720|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56920721|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56920722|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56920723|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56920724|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56920725|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56920726|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55886238|NCT02488902|Mefloquine|mefloquine|mesh-list
56920727|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
56920728|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920729|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56920730|NCT05301634|Bupivacaine|bupivacaine|mesh-list
56920731|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
56920732|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
56920733|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920734|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920735|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
56920736|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920737|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
56920738|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56920739|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920740|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920741|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56920742|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56920744|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920745|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
56920746|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56920747|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
56920748|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
56920749|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920750|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920751|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56920752|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56920753|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56920754|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56920755|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56920756|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
56920757|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920758|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920759|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920760|NCT04072822|Prednisone|prednisone|mesh-list
56920761|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56920762|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920763|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
56920764|NCT04072822|Hormones|hormones|mesh-ancestor
56920765|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920766|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920767|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56920768|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920769|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56920770|NCT04001894|Clopidogrel|clopidogrel|mesh-list
56920771|NCT04001894|Ticagrelor|ticagrelor|mesh-list
56920772|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56920773|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56920774|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56920775|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56920776|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
56920777|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920778|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920779|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920780|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
56920781|NCT04066114|Prednisone|prednisone|mesh-list
56920782|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
56920783|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56920784|NCT04066114|Everolimus|everolimus|mesh-list
56920785|NCT04066114|Abatacept|abatacept|mesh-list
56920786|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
56920787|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56920788|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920789|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
56920790|NCT04066114|Hormones|hormones|mesh-ancestor
56920791|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920792|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920793|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56920794|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920795|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56920796|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
56920797|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56920798|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56920799|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
56920800|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56920801|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920802|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920803|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920804|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
56920805|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
56920806|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920807|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56920808|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56920809|NCT04066114|Protective Agents|protective agents|mesh-ancestor
56920810|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56920811|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56920813|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56920814|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
56920815|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
56920816|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
56648503|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56920817|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56920819|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920820|NCT01345604|Ropivacaine|ropivacaine|mesh-list
56920821|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
56920822|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
56648504|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
56920823|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920824|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920825|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
56920826|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920828|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56920829|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
56920830|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56920831|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920832|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
56920833|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56920834|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920835|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920836|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56923212|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923213|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56923214|NCT04387227|Carboplatin|carboplatin|mesh-list
56923215|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
56923216|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923217|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920837|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56920838|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56648505|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
56920839|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56920840|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56920841|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56920842|NCT03522532|Zinc|zinc|mesh-list
56920843|NCT03522532|Trace Elements|trace elements|mesh-ancestor
56920844|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
56920845|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920846|NCT01215019|Mannitol|mannitol|mesh-list
56920847|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56920848|NCT01215019|Diuretics|diuretics|mesh-ancestor
56920849|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
56920850|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920851|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
56920852|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
56920853|NCT01215331|Insulin|insulin|mesh-list
56920854|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56920855|NCT01215331|Metformin|metformin|mesh-list
56920856|NCT01215331|Glyburide|glyburide|mesh-list
56920857|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56920858|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920859|NCT03526276|Fluorides|fluorides|mesh-list
56920860|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
56920861|NCT03526276|Protective Agents|protective agents|mesh-ancestor
56920862|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920863|NCT04466254|Cetuximab|cetuximab|mesh-list
56920864|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920865|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920866|NCT04466176|Fluticasone|fluticasone|mesh-list
56920867|NCT04466176|Xhance|xhance|mesh-list
56920868|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56920869|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56920870|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56920871|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56920872|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
56920873|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920874|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920875|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56920876|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
56920877|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
56920878|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56920879|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56920880|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56920881|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56920882|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
56920883|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56923232|NCT04368078|Lenvatinib|lenvatinib|mesh-list
56923233|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923234|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923235|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923236|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923237|NCT04350463|Nivolumab|nivolumab|mesh-list
56923238|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
56923239|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923240|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923244|NCT04347616|Aldesleukin|aldesleukin|mesh-list
56920884|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920885|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
56920886|NCT04466176|Hormones|hormones|mesh-ancestor
56920887|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920888|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
56920889|NCT04656652|Docetaxel|docetaxel|mesh-list
56920890|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920891|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
56920892|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
56920893|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
56920894|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920895|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56920896|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
56920897|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56920898|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56920899|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920900|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920901|NCT01215409|Urological Agents|urological agents|mesh-ancestor
56920902|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
56920903|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56920904|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56920905|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920906|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56920907|NCT03936205|Analgesics|analgesics|mesh-ancestor
56920908|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
56920909|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920910|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56920911|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56920912|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56920913|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
56920914|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920915|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920916|NCT03936049|Liraglutide|liraglutide|mesh-list
56920917|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56920918|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56920919|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920920|NCT03936049|Incretins|incretins|mesh-ancestor
56920921|NCT03936049|Hormones|hormones|mesh-ancestor
56920922|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920923|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
56920924|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920925|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920926|NCT04674020|Erenumab|erenumab|mesh-list
56920927|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56920928|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920929|NCT04674020|Analgesics|analgesics|mesh-ancestor
56920930|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
56920931|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648506|NCT04179942|Protective Agents|protective agents|mesh-ancestor
56920932|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920934|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920935|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56920936|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56920937|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56920938|NCT01123525|Adenosine|adenosine|mesh-list
56631508|NCT05787743|Vitamins|vitamins|mesh-ancestor
56920939|NCT01123525|Analgesics|analgesics|mesh-ancestor
56920940|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
56920941|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920942|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920943|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56920944|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
56920945|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56920946|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
56920947|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
56920948|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920949|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920950|NCT01215565|Sunitinib|sunitinib|mesh-list
56920951|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920952|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56920953|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56920954|NCT01215565|Growth Substances|growth substances|mesh-ancestor
56920955|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920956|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
56920957|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56920958|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920959|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920960|NCT01121497|Physostigmine|physostigmine|mesh-list
56920961|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56920962|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56920963|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920964|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
56920965|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56920966|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920967|NCT01121497|Miotics|miotics|mesh-ancestor
56920968|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
56920969|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56920970|NCT01213147|Clomiphene|clomiphene|mesh-list
56920971|NCT01213147|Enclomiphene|enclomiphene|mesh-list
56920972|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
56920973|NCT01213147|Buserelin|buserelin|mesh-list
56920974|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56920975|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
56920976|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56920977|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920978|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56920979|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
56920980|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56920981|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56920982|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56920985|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920986|NCT01117129|Rituximab|rituximab|mesh-list
56920987|NCT01117129|Methotrexate|methotrexate|mesh-list
56920988|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56920989|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56920990|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
56920991|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56920992|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56920993|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56920994|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
56920995|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56920996|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56920997|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
56920998|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56920999|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
56921000|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921001|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56921002|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921003|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56921005|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921006|NCT03934411|Tramadol|tramadol|mesh-list
56921007|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56921008|NCT03934411|Narcotics|narcotics|mesh-ancestor
56921009|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921010|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921011|NCT03934411|Analgesics|analgesics|mesh-ancestor
56921012|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
56921013|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921014|NCT01218451|Vaccines|vaccines|mesh-list
56921015|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
56921016|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921017|NCT01346930|Macitentan|macitentan|mesh-list
56921018|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56921019|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56921020|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921021|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56921022|NCT01219153|Letrozole|letrozole|mesh-list
56648507|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
56648508|NCT05498766|Tegafur|tegafur|mesh-list
56921023|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
56921025|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921026|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56921027|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56921028|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921029|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921030|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56921031|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
56921032|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921033|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921034|NCT01219153|Hormones|hormones|mesh-ancestor
56921035|NCT03526042|Losartan|losartan|mesh-list
56921036|NCT03526042|Enalapril|enalapril|mesh-list
56921037|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56921038|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56921039|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56921040|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56921041|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56921042|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56921043|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921044|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
56921046|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
56921047|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56921048|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921049|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56921050|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56921051|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921052|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921053|NCT03781375|Etanercept|etanercept|mesh-list
56921054|NCT03781375|Methotrexate|methotrexate|mesh-list
56921055|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56921056|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
56921057|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56921058|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921059|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56921060|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
56921061|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921062|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921063|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
56921064|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921065|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56921066|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921067|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
56921068|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56921069|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56921070|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56921071|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56921072|NCT03781375|Analgesics|analgesics|mesh-ancestor
56921073|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
56921074|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921075|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921076|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56921077|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56921078|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56921079|NCT01123915|Protective Agents|protective agents|mesh-ancestor
56921080|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921081|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56921082|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
56921083|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921084|NCT01218529|Lapatinib|lapatinib|mesh-list
56921085|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921086|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56921087|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921088|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921089|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56921090|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921091|NCT01218607|Bosentan|bosentan|mesh-list
56921092|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56921093|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56921094|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921095|NCT03933787|Saxagliptin|saxagliptin|mesh-list
56921096|NCT03933787|Incretins|incretins|mesh-ancestor
56921097|NCT03933787|Hormones|hormones|mesh-ancestor
56921098|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921099|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921100|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56921101|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
56921102|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921103|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921104|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56921105|NCT03934333|Budesonide|budesonide|mesh-list
56921106|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921107|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56921108|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
56921109|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921110|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921111|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56921112|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
56921113|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
56921114|NCT03934333|Hormones|hormones|mesh-ancestor
56921115|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921117|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
56921118|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56921119|NCT03931915|Leuprolide|leuprolide|mesh-list
56921120|NCT03931915|Relugolix|relugolix|mesh-list
56921121|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56921122|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
56921123|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56921124|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921125|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921126|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921127|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
56921128|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
56921129|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921130|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
56921131|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56921132|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921133|NCT01124383|Lidocaine|lidocaine|mesh-list
56921134|NCT01124383|Ephedrine|ephedrine|mesh-list
56921135|NCT01124383|Midazolam|midazolam|mesh-list
56921136|NCT01124383|Sufentanil|sufentanil|mesh-list
56921137|NCT01124383|Dsuvia|dsuvia|mesh-list
56921138|NCT01124383|Anesthetics|anesthetics|mesh-list
56921139|NCT01124383|Propofol|propofol|mesh-list
56921140|NCT01124383|Sevoflurane|sevoflurane|mesh-list
56921141|NCT01124383|Rocuronium|rocuronium|mesh-list
56921142|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
56921143|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921144|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921145|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
56921146|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921147|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56921148|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56183625|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56183626|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183627|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921149|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56921150|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56923274|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
56921151|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921152|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56921153|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56921154|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
56921155|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56921156|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56921157|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56921158|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56921159|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
56921161|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921162|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56921163|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56921164|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56921165|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56921167|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56921168|NCT01124383|Narcotics|narcotics|mesh-ancestor
56921169|NCT01124383|Analgesics|analgesics|mesh-ancestor
56921170|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56921171|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
56921172|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
56921173|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56921174|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
56921175|NCT01226017|Oxytocin|oxytocin|mesh-list
56921176|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
56921177|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56921178|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921179|NCT01222819|Lenograstim|lenograstim|mesh-list
56921180|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56921181|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
56183648|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
56921182|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921183|NCT01222897|Valacyclovir|valacyclovir|mesh-list
56921184|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
56921185|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921186|NCT03150056|Prednisone|prednisone|mesh-list
56921187|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921188|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
56921189|NCT03150056|Hormones|hormones|mesh-ancestor
56921190|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921191|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921192|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921193|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921194|NCT01329367|Antioxidants|antioxidants|mesh-list
56921195|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921196|NCT01329367|Protective Agents|protective agents|mesh-ancestor
56921197|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921198|NCT01222975|Risperidone|risperidone|mesh-list
56921199|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56921200|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
56921201|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921202|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921203|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921205|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56921206|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921207|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56921208|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56921209|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
56921210|NCT01129063|Clopidogrel|clopidogrel|mesh-list
56921211|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56921212|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56921213|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56921214|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56921215|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
56921216|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921217|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183699|NCT01425580|Metformin|metformin|mesh-list
56921218|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921219|NCT01317368|Ropivacaine|ropivacaine|mesh-list
56921220|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
56921221|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
56921222|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921223|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921224|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
56921225|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921226|NCT01219699|Fulvestrant|fulvestrant|mesh-list
56921227|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921228|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921229|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56921230|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56921231|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
56921232|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921233|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921234|NCT03933319|Doxorubicin|doxorubicin|mesh-list
56921235|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56921236|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56921237|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921238|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56921239|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56921240|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921241|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921242|NCT01223053|Ketoprofen|ketoprofen|mesh-list
56921243|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56921244|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56921245|NCT01223053|Analgesics|analgesics|mesh-ancestor
56921246|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
56921247|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921248|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921249|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921250|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56921251|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56921252|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921253|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921254|NCT01223131|Insulin|insulin|mesh-list
56921255|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56921256|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
56921257|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
56921258|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
56921259|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
56921260|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56921261|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921262|NCT01125553|Insulin|insulin|mesh-list
56921263|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
56921264|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56921265|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921266|NCT02640664|Ranibizumab|ranibizumab|mesh-list
56921267|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56921268|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56921269|NCT02640664|Growth Substances|growth substances|mesh-ancestor
56921270|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921271|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
56921272|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921273|NCT01317446|Fluorides|fluorides|mesh-list
56921274|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
56921275|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
56921276|NCT01317446|Protective Agents|protective agents|mesh-ancestor
56921277|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921278|NCT02529241|Delpazolid|delpazolid|mesh-list
56921279|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
56921280|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56921281|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921282|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56921283|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921284|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921285|NCT02456012|Esomeprazole|esomeprazole|mesh-list
56921286|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56921287|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56921288|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56921289|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921290|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921291|NCT00812006|Rizatriptan|rizatriptan|mesh-list
56921292|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56921293|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
56923280|NCT04317105|Ipilimumab|ipilimumab|mesh-list
56921294|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921295|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921296|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921297|NCT03133234|Osimertinib|osimertinib|mesh-list
56921298|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921299|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56921300|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921301|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921302|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56921303|NCT01125787|Ofatumumab|ofatumumab|mesh-list
56921304|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56921305|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56921306|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
56921307|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921308|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921309|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
56921310|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921312|NCT02457442|Propofol|propofol|mesh-list
56921313|NCT02457442|Sevoflurane|sevoflurane|mesh-list
56921314|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56921315|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921316|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921317|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56921318|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
56921319|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
56921320|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56921321|NCT02457442|Narcotics|narcotics|mesh-ancestor
56921322|NCT02457442|Analgesics|analgesics|mesh-ancestor
56921323|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
56921324|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921325|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56921326|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56921327|NCT03132038|Nivolumab|nivolumab|mesh-list
56921328|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56921329|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921330|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56921331|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921332|NCT01129375|Omeprazole|omeprazole|mesh-list
56921333|NCT01129375|Clopidogrel|clopidogrel|mesh-list
56921334|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56921335|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56921336|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56921337|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56921338|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
56921339|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921340|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921341|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921342|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56921343|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56921344|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56921345|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921346|NCT01352702|Dabigatran|dabigatran|mesh-list
56921347|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
56921348|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
56921349|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56921350|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
56921351|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921352|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921353|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
56921354|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
56921355|NCT03525730|Valproic Acid|valproic acid|mesh-list
56921356|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
56921357|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56921358|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56921359|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921360|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56921361|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921362|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921363|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
56921364|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
56921365|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921366|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921367|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
56921368|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56921369|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921370|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56921371|NCT01223443|Paclitaxel|paclitaxel|mesh-list
56921372|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56921373|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921374|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
56921375|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
56921376|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
56921377|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921378|NCT03525652|Vaccines|vaccines|mesh-list
56921379|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
56921380|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921381|NCT02290054|Anesthetics|anesthetics|mesh-list
56921382|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921383|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921384|NCT01347944|Lenalidomide|lenalidomide|mesh-list
56921385|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
56921386|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921387|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56921388|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56921390|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
56921391|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921392|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
56921393|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
56921394|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921395|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921396|NCT01220245|Heparin|heparin|mesh-list
56921397|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
56921398|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56921399|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56921400|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921401|NCT03931135|Dexamethasone|dexamethasone|mesh-list
56921402|NCT03931135|Morphine|morphine|mesh-list
56921403|NCT03931135|Cyclizine|cyclizine|mesh-list
56921404|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921405|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
56921406|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
56921407|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921408|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921409|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56921410|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
56921411|NCT03931135|Hormones|hormones|mesh-ancestor
56921412|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921413|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921414|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921415|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56921416|NCT03931135|Narcotics|narcotics|mesh-ancestor
56921417|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921418|NCT03931135|Analgesics|analgesics|mesh-ancestor
56921419|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
56921420|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56921421|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
56921422|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
56921423|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921424|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921425|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
56921426|NCT01353170|Calcium|calcium|mesh-list
56923286|NCT04313634|Quercetin|quercetin|mesh-list
56923287|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923288|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923289|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923290|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923291|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
56923292|NCT04313634|Protective Agents|protective agents|mesh-ancestor
56923293|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900816|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
56100854|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
56921427|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56921428|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921429|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56921430|NCT03701308|Cytarabine|cytarabine|mesh-list
56921431|NCT03701308|Daunorubicin|daunorubicin|mesh-list
56921432|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56921433|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
56921434|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921435|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921436|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
56921437|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921438|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921439|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
56921440|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921441|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56921442|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56921443|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56921444|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921446|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921447|NCT01125943|Bevacizumab|bevacizumab|mesh-list
56921448|NCT01125943|Nitroprusside|nitroprusside|mesh-list
56921449|NCT01125943|Acetylcholine|acetylcholine|mesh-list
56921450|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56921451|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921452|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56921453|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56921454|NCT01125943|Growth Substances|growth substances|mesh-ancestor
56921455|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921456|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
56921457|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56921458|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
56921459|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56921460|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921461|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56921462|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
56921463|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921464|NCT05635708|Paclitaxel|paclitaxel|mesh-list
56921465|NCT05635708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56921466|NCT05635708|Carboplatin|carboplatin|mesh-list
56921467|NCT05635708|Pemetrexed|pemetrexed|mesh-list
56921468|NCT05635708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56921469|NCT05635708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921470|NCT05635708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56921471|NCT05635708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56921472|NCT05635708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56921473|NCT05635708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923320|NCT04278781|Ivosidenib|ivosidenib|mesh-list
56923321|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923322|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923323|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921474|NCT05635708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921475|NCT05635708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56921476|NCT05635708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56921477|NCT01223755|Sirolimus|sirolimus|mesh-list
56921478|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56921479|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921480|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56921481|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921482|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
56921483|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921484|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
56921485|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921486|NCT01126177|Interferons|interferons|mesh-list
56921487|NCT01126177|Interferon-beta|interferon-beta|mesh-list
56921488|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
56921489|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921490|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
56921491|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921492|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
56921493|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921494|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56921495|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
56921496|NCT03680092|Methotrexate|methotrexate|mesh-list
56921497|NCT03680092|Abatacept|abatacept|mesh-list
56921498|NCT03680092|Tacrolimus|tacrolimus|mesh-list
56921499|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921500|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
56921501|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921502|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56921503|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56921504|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
56921505|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921506|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921507|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56921508|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56921509|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
56921510|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56921511|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56921512|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
56921513|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
56921514|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921515|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56183990|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
56921517|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56921518|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56921519|NCT03671044|Docetaxel|docetaxel|mesh-list
56921520|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921521|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
56921522|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
56921523|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
56921524|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921525|NCT05790070|Betaine|betaine|mesh-list
56921526|NCT05790070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56921527|NCT05790070|Lipotropic Agents|lipotropic agents|mesh-ancestor
56921528|NCT05790070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56921529|NCT05790070|Antimetabolites|antimetabolites|mesh-ancestor
56921530|NCT05790070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921531|NCT05790070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56921532|NCT05790044|Clonidine|clonidine|mesh-list
56921542|NCT05790044|Sympatholytics|sympatholytics|mesh-ancestor
56921543|NCT05790044|Autonomic Agents|autonomic agents|mesh-ancestor
56921544|NCT05790044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56921545|NCT05790044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56921546|NCT05790044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56921547|NCT05790044|Adrenergic Agents|adrenergic agents|mesh-ancestor
56921548|NCT05790044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921549|NCT05790044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921550|NCT05789992|Remifentanil|remifentanil|mesh-list
56921551|NCT05789992|Propofol|propofol|mesh-list
56921552|NCT05789992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56921553|NCT05789992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921554|NCT05789992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921555|NCT05789992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56921556|NCT05789992|Anesthetics, General|anesthetics, general|mesh-ancestor
56648515|NCT04250831|Trace Elements|trace elements|mesh-ancestor
56921557|NCT05789992|Anesthetics|anesthetics|mesh-ancestor
56921558|NCT05789992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56921559|NCT05789992|Narcotics|narcotics|mesh-ancestor
56921560|NCT05789992|Analgesics|analgesics|mesh-ancestor
56921561|NCT05789992|Sensory System Agents|sensory system agents|mesh-ancestor
56921562|NCT05789992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184033|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
56921582|NCT05789667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56921583|NCT05789667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921584|NCT05789667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921585|NCT05789615|Letermovir|letermovir|mesh-list
56921586|NCT05789615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56921587|NCT05789615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921588|NCT05789615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921589|NCT05789615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921590|NCT05789615|Antiviral Agents|antiviral agents|mesh-ancestor
56921591|NCT05789615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921592|NCT05789589|Dexamethasone|dexamethasone|mesh-list
56921593|NCT05789589|Methylprednisolone|methylprednisolone|mesh-list
56921594|NCT05789589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921595|NCT05789589|Antiemetics|antiemetics|mesh-ancestor
56921596|NCT05789589|Autonomic Agents|autonomic agents|mesh-ancestor
56921597|NCT05789589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921598|NCT05789589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921599|NCT05789589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56921600|NCT05789589|Glucocorticoids|glucocorticoids|mesh-ancestor
56921601|NCT05789589|Hormones|hormones|mesh-ancestor
56921602|NCT05789589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921603|NCT05789589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921604|NCT05789589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921605|NCT05789589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56921606|NCT05789589|Protective Agents|protective agents|mesh-ancestor
56921607|NCT05789537|Protein C|protein c|mesh-list
56921608|NCT05789537|Anticoagulants|anticoagulants|mesh-ancestor
56921609|NCT05789537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56921610|NCT05789537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56184070|NCT04622020|Anesthetics|anesthetics|mesh-list
56921611|NCT05789537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921612|NCT05789524|Protein C|protein c|mesh-list
56921613|NCT05789524|Anticoagulants|anticoagulants|mesh-ancestor
56921614|NCT05789524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56921615|NCT05789524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56921616|NCT05789524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921617|NCT05789381|Magnesium Sulfate|magnesium sulfate|mesh-list
56921618|NCT05789381|Analgesics|analgesics|mesh-ancestor
56921619|NCT05789381|Sensory System Agents|sensory system agents|mesh-ancestor
56921620|NCT05789381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921621|NCT05789381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921622|NCT05789381|Anesthetics|anesthetics|mesh-ancestor
56921623|NCT05789381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921624|NCT05789381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56921625|NCT05789381|Anticonvulsants|anticonvulsants|mesh-ancestor
56921626|NCT05789381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56921627|NCT05789381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56921628|NCT05789381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921629|NCT05789381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56921630|NCT05789381|Tocolytic Agents|tocolytic agents|mesh-ancestor
56921631|NCT05789381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56921632|NCT05789342|Itraconazole|itraconazole|mesh-list
56921633|NCT05789342|Oseltamivir|oseltamivir|mesh-list
56921634|NCT05789342|Digoxin|digoxin|mesh-list
56921635|NCT05789342|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56921636|NCT05789342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56921637|NCT05789342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56921638|NCT05789342|Antimetabolites|antimetabolites|mesh-ancestor
56921639|NCT05789342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921640|NCT05789342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56921641|NCT05789342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56921642|NCT05789342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921643|NCT05789342|Antifungal Agents|antifungal agents|mesh-ancestor
56921644|NCT05789342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921645|NCT05789342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55900885|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
56057034|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057035|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56921646|NCT05789342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56921647|NCT05789342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56921648|NCT05789342|Hormone Antagonists|hormone antagonists|mesh-ancestor
56921649|NCT05789342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921650|NCT05789342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921651|NCT05789342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56921652|NCT05789342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56921653|NCT05789342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56921654|NCT05789342|Protective Agents|protective agents|mesh-ancestor
56921655|NCT05789342|Antiviral Agents|antiviral agents|mesh-ancestor
56921656|NCT05789303|Dexamethasone|dexamethasone|mesh-list
56921657|NCT05789303|Pomalidomide|pomalidomide|mesh-list
56921658|NCT05789303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921659|NCT05789303|Antiemetics|antiemetics|mesh-ancestor
56921660|NCT05789303|Autonomic Agents|autonomic agents|mesh-ancestor
56921661|NCT05789303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921662|NCT05789303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921663|NCT05789303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56921664|NCT05789303|Glucocorticoids|glucocorticoids|mesh-ancestor
56184153|NCT04203472|Hormones|hormones|mesh-ancestor
56921667|NCT05789303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921668|NCT05789303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921669|NCT05789303|Immunologic Factors|immunologic factors|mesh-ancestor
56921670|NCT05789303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56921671|NCT05789303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56921672|NCT05789303|Growth Substances|growth substances|mesh-ancestor
56921673|NCT05789303|Growth Inhibitors|growth inhibitors|mesh-ancestor
56921674|NCT05789186|Fluoxetine|fluoxetine|mesh-list
56921675|NCT05789186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56921676|NCT05789186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56921677|NCT05789186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56921678|NCT05789186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921679|NCT05789186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921680|NCT05789186|Serotonin Agents|serotonin agents|mesh-ancestor
56921681|NCT05789186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921682|NCT05789186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56921683|NCT05789186|Antidepressive Agents|antidepressive agents|mesh-ancestor
56921684|NCT05789186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56921685|NCT05789186|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56921686|NCT05789186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56921687|NCT05789186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921725|NCT05789082|Pembrolizumab|pembrolizumab|mesh-list
56921726|NCT05789082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56921727|NCT05789082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921728|NCT05789043|Apatinib|apatinib|mesh-list
56921729|NCT05789043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921730|NCT05789043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56921731|NCT05789043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921732|NCT05789043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921733|NCT05789030|Prednisone|prednisone|mesh-list
56921734|NCT05789030|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
56921735|NCT05789030|Betamethasone|betamethasone|mesh-list
56921736|NCT05789030|Leflunomide|leflunomide|mesh-list
56921737|NCT05789030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921738|NCT05789030|Glucocorticoids|glucocorticoids|mesh-ancestor
56921739|NCT05789030|Hormones|hormones|mesh-ancestor
56921740|NCT05789030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921741|NCT05789030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921742|NCT05789030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56184228|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
56921743|NCT05789030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921744|NCT05789030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921745|NCT05789030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921746|NCT05789030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921747|NCT05789030|Immunologic Factors|immunologic factors|mesh-ancestor
56921748|NCT05789030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56921749|NCT05789030|Respiratory System Agents|respiratory system agents|mesh-ancestor
56921750|NCT05789017|Mycophenolic Acid|mycophenolic acid|mesh-list
56921752|NCT05789017|Leflunomide|leflunomide|mesh-list
56921753|NCT05789017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921754|NCT05789017|Glucocorticoids|glucocorticoids|mesh-ancestor
56921755|NCT05789017|Hormones|hormones|mesh-ancestor
56921756|NCT05789017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921757|NCT05789017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921758|NCT05789017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921759|NCT05789017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921760|NCT05789017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56921761|NCT05789017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56921762|NCT05789017|Antitubercular Agents|antitubercular agents|mesh-ancestor
56921763|NCT05789017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56921764|NCT05789017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921766|NCT05789017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921767|NCT05789017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921768|NCT05789017|Immunologic Factors|immunologic factors|mesh-ancestor
56921769|NCT05788991|Metronidazole|metronidazole|mesh-list
56921770|NCT05788991|Dequalinium|dequalinium|mesh-list
56921771|NCT05788991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921772|NCT05788991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56921773|NCT05788991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56921774|NCT05788991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56921775|NCT05788991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56921777|NCT05788913|Anticoagulants|anticoagulants|mesh-ancestor
56921778|NCT05788913|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56921779|NCT05788913|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56921780|NCT05788913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921781|NCT05788900|Heparin|heparin|mesh-list
56921782|NCT05788900|Anticoagulants|anticoagulants|mesh-ancestor
56921783|NCT05788900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56921784|NCT05788900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56921785|NCT05788900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921786|NCT05788874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56921787|NCT05788874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56921788|NCT05788874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921789|NCT05788835|Chlorotrianisene|chlorotrianisene|mesh-list
56921790|NCT05788835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56921791|NCT05788835|Estrogens|estrogens|mesh-ancestor
56921792|NCT05788835|Hormones|hormones|mesh-ancestor
56921793|NCT05788835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921794|NCT05788835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921795|NCT05788835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921796|NCT05788835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921797|NCT05788705|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
56921798|NCT05788705|Boswellic acid|boswellic acid|mesh-list
56921799|NCT05788705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56921800|NCT05788705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56921801|NCT05788705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56921802|NCT05788705|Analgesics|analgesics|mesh-ancestor
56921803|NCT05788705|Sensory System Agents|sensory system agents|mesh-ancestor
56921804|NCT05788705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921805|NCT05788705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921806|NCT05788705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56921807|NCT05788679|Azacitidine|azacitidine|mesh-list
56921808|NCT05788679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56921809|NCT05788679|Antimetabolites|antimetabolites|mesh-ancestor
56921810|NCT05788679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921811|NCT05788679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921812|NCT05788679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921813|NCT05788627|Lactulose|lactulose|mesh-list
56921814|NCT05788627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56921815|NCT05788510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56921816|NCT05788510|Immunologic Factors|immunologic factors|mesh-ancestor
56921817|NCT05788510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921818|NCT05783219|Lidocaine|lidocaine|mesh-list
56921819|NCT05783219|Anesthetics, Local|anesthetics, local|mesh-ancestor
56921820|NCT05783219|Anesthetics|anesthetics|mesh-ancestor
56921821|NCT05783219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56921822|NCT05783219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921823|NCT05783219|Sensory System Agents|sensory system agents|mesh-ancestor
56921824|NCT05783219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921825|NCT05783219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56921826|NCT05783219|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56648516|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
56921827|NCT05783219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56921828|NCT05783219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56921842|NCT05767086|Medroxyprogesterone|medroxyprogesterone|mesh-list
56921843|NCT05767086|Cetrorelix|cetrorelix|mesh-list
56921844|NCT05767086|Hormones|hormones|mesh-list
56921845|NCT05767086|Dydrogesterone|dydrogesterone|mesh-list
56921846|NCT05767086|Hormone Antagonists|hormone antagonists|mesh-list
56921847|NCT05767086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921848|NCT05767086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921849|NCT05767086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56921850|NCT05767086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56921851|NCT05767086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56921852|NCT05767086|Contraceptive Agents|contraceptive agents|mesh-ancestor
56921853|NCT05767086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56921854|NCT05767086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56921855|NCT05767086|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56921856|NCT05767086|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56921857|NCT05767086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921858|NCT05767086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921859|NCT05767086|Progestins|progestins|mesh-ancestor
56921860|NCT05767086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56921861|NCT05767086|Fertility Agents|fertility agents|mesh-ancestor
56921862|NCT05763875|Ezetimibe|ezetimibe|mesh-list
56921863|NCT05763875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56921864|NCT05763875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56921865|NCT05763875|Antimetabolites|antimetabolites|mesh-ancestor
56921866|NCT05763875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921867|NCT05763875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56921868|NCT05755282|Hand Sanitizers|hand sanitizers|mesh-list
56921869|NCT05755282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56921870|NCT05755282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921871|NCT05755282|Disinfectants|disinfectants|mesh-ancestor
56921872|NCT05742841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56921873|NCT05742841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56921874|NCT05742841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56921875|NCT05742841|Antimetabolites|antimetabolites|mesh-ancestor
56921876|NCT05742841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921877|NCT05742841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56921878|NCT05742841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56921879|NCT05742841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921880|NCT05732077|Dopamine|dopamine|mesh-list
56921891|NCT05724108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921892|NCT05724108|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56921893|NCT05722886|Trastuzumab|trastuzumab|mesh-list
56921894|NCT05722886|Pertuzumab|pertuzumab|mesh-list
56921895|NCT05722886|Atezolizumab|atezolizumab|mesh-list
56921896|NCT05722886|Vemurafenib|vemurafenib|mesh-list
56921897|NCT05722886|Entrectinib|entrectinib|mesh-list
56921898|NCT05722886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56921899|NCT05722886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921900|NCT05722886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56921901|NCT05722886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921902|NCT05722886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632490|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
56921924|NCT05702905|Metformin|metformin|mesh-list
56921925|NCT05702905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56921926|NCT05702905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921927|NCT05697471|Dienogest|dienogest|mesh-list
56921928|NCT05697471|Danazol|danazol|mesh-list
56921929|NCT05697471|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56921930|NCT05697471|Contraceptive Agents|contraceptive agents|mesh-ancestor
56921931|NCT05697471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56921932|NCT05697471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921933|NCT05697471|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56921934|NCT05697471|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56921935|NCT05697471|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56921936|NCT05697471|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56921937|NCT05697471|Hormone Antagonists|hormone antagonists|mesh-ancestor
56921938|NCT05697471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56921939|NCT05697471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56921940|NCT05697471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921941|NCT05697471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56921942|NCT05696236|Tin Fluorides|tin fluorides|mesh-list
55897492|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56921943|NCT05696236|Cariostatic Agents|cariostatic agents|mesh-ancestor
56921944|NCT05696236|Protective Agents|protective agents|mesh-ancestor
56921945|NCT05696236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921946|NCT05691478|Cisplatin|cisplatin|mesh-list
56921947|NCT05691478|Doxorubicin|doxorubicin|mesh-list
56921948|NCT05691478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56921949|NCT05691478|Methotrexate|methotrexate|mesh-list
56921950|NCT05691478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921951|NCT05691478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56921952|NCT05691478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56921953|NCT05691478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56921954|NCT05691478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921955|NCT05691478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921956|NCT05691478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56921957|NCT05691478|Abortifacient Agents|abortifacient agents|mesh-ancestor
56921958|NCT05691478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56921959|NCT05691478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921960|NCT05691478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56921961|NCT05691478|Antimetabolites|antimetabolites|mesh-ancestor
56921962|NCT05691478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56921963|NCT05691478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56921964|NCT05691478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921965|NCT05691478|Immunologic Factors|immunologic factors|mesh-ancestor
56921966|NCT05691478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56921967|NCT05691478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56921968|NCT05685602|Gemcitabine|gemcitabine|mesh-list
56921969|NCT05685602|Paclitaxel|paclitaxel|mesh-list
56921970|NCT05685602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56921971|NCT05685602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56921972|NCT05685602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921973|NCT05685602|Tubulin Modulators|tubulin modulators|mesh-ancestor
56921974|NCT05685602|Antimitotic Agents|antimitotic agents|mesh-ancestor
56921975|NCT05685602|Mitosis Modulators|mitosis modulators|mesh-ancestor
56921976|NCT05685602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921977|NCT05685602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56921978|NCT05685602|Antimetabolites|antimetabolites|mesh-ancestor
56921979|NCT05685602|Antiviral Agents|antiviral agents|mesh-ancestor
56921980|NCT05685602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56921981|NCT05685602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56921982|NCT05685602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56921983|NCT05685602|Immunologic Factors|immunologic factors|mesh-ancestor
56921984|NCT05685602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921985|NCT05683977|Durvalumab|durvalumab|mesh-list
56921986|NCT05683977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56921987|NCT05683977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56921988|NCT05677295|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56921989|NCT05677295|Imipramine|imipramine|mesh-list
56921990|NCT05677295|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56921991|NCT05677295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56921992|NCT05677295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56921993|NCT05677295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56921994|NCT05677295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56921995|NCT05677295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56921997|NCT05677295|Sensory System Agents|sensory system agents|mesh-ancestor
56921998|NCT05677295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56921999|NCT05677295|Antidepressive Agents|antidepressive agents|mesh-ancestor
56922000|NCT05677295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56922001|NCT05677295|Dopamine Agents|dopamine agents|mesh-ancestor
56922002|NCT05677295|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56922003|NCT05677295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56922004|NCT05677295|Adrenergic Agents|adrenergic agents|mesh-ancestor
56922005|NCT05670561|Sufentanil|sufentanil|mesh-list
56922006|NCT05670561|Esketamine|esketamine|mesh-list
56922007|NCT05670561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56922008|NCT05670561|Narcotics|narcotics|mesh-ancestor
56922009|NCT05670561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56922010|NCT05670561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922011|NCT05670561|Analgesics|analgesics|mesh-ancestor
56922012|NCT05670561|Sensory System Agents|sensory system agents|mesh-ancestor
56922013|NCT05670561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922014|NCT05670561|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56922015|NCT05670561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56922016|NCT05670561|Anesthetics, General|anesthetics, general|mesh-ancestor
56922017|NCT05670561|Anesthetics|anesthetics|mesh-ancestor
56922018|NCT05670561|Antidepressive Agents|antidepressive agents|mesh-ancestor
56922019|NCT05670561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56922020|NCT05662865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56922021|NCT05662865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922022|NCT05662865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56922023|NCT05662865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922024|NCT05656521|Dexamethasone|dexamethasone|mesh-list
56922025|NCT05656521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56922026|NCT05656521|Antiemetics|antiemetics|mesh-ancestor
56922027|NCT05656521|Autonomic Agents|autonomic agents|mesh-ancestor
56184507|NCT01425996|Camptothecin|camptothecin|mesh-list
56922028|NCT05656521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922029|NCT05656521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922030|NCT05656521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56922032|NCT05656521|Hormones|hormones|mesh-ancestor
56922033|NCT05656521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56922034|NCT05656521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56922035|NCT05656521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922036|NCT05655182|Vaccines|vaccines|mesh-list
56922037|NCT05655182|Immunologic Factors|immunologic factors|mesh-ancestor
56922060|NCT05635877|Adrenergic Agents|adrenergic agents|mesh-ancestor
56922061|NCT05635877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56632643|NCT05125016|Cemiplimab|cemiplimab|mesh-list
56922062|NCT05635877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922063|NCT05635877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922080|NCT05630183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56922081|NCT05630183|Antimetabolites|antimetabolites|mesh-ancestor
56922082|NCT05630183|Antiviral Agents|antiviral agents|mesh-ancestor
56922083|NCT05630183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56922084|NCT05630183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922085|NCT05630183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56922086|NCT05630183|Immunologic Factors|immunologic factors|mesh-ancestor
56922087|NCT05630183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922088|NCT05629546|Nivolumab|nivolumab|mesh-list
56922089|NCT05629546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922090|NCT05629546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922091|NCT05629546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56922092|NCT05629546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922093|NCT05627245|Belinostat|belinostat|mesh-list
56922094|NCT05627245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922095|NCT05627245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56922096|NCT05627245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922097|NCT05627245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242481|NCT01788605|Ramosetron|ramosetron|mesh-list
56922098|NCT05626322|Lenalidomide|lenalidomide|mesh-list
56922099|NCT05626322|Immunologic Factors|immunologic factors|mesh-ancestor
56922100|NCT05626322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922101|NCT05626322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56922102|NCT05626322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56184612|NCT01426646|Cisplatin|cisplatin|mesh-list
56922103|NCT05626322|Growth Substances|growth substances|mesh-ancestor
56922104|NCT05626322|Growth Inhibitors|growth inhibitors|mesh-ancestor
56922105|NCT05626322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922106|NCT05617820|Estradiol|estradiol|mesh-list
56922107|NCT05617820|Estrogens|estrogens|mesh-ancestor
56922108|NCT05617820|Hormones|hormones|mesh-ancestor
56922109|NCT05617820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184618|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
56922114|NCT05603702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56922115|NCT05603702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56922116|NCT05603702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922126|NCT05596006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922127|NCT05596006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922128|NCT05596006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56922129|NCT05596006|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56923348|NCT04265950|Vaccines|vaccines|mesh-list
56923351|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
56922131|NCT05596006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922132|NCT05596006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922133|NCT05587374|Gemcitabine|gemcitabine|mesh-list
56632722|NCT05035407|Aldesleukin|aldesleukin|mesh-list
56922134|NCT05587374|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56922135|NCT05587374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922136|NCT05587374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56922137|NCT05587374|Antimetabolites|antimetabolites|mesh-ancestor
56922138|NCT05587374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922139|NCT05587374|Antiviral Agents|antiviral agents|mesh-ancestor
56922140|NCT05587374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56922141|NCT05587374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922142|NCT05587374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56922143|NCT05587374|Immunologic Factors|immunologic factors|mesh-ancestor
56922144|NCT05587374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922145|NCT05586529|Cholecalciferol|cholecalciferol|mesh-list
56922146|NCT05586529|Vitamin D|vitamin d|mesh-list
56648509|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922151|NCT05586529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56922156|NCT05564377|Leucovorin|leucovorin|mesh-list
56922157|NCT05564377|Paclitaxel|paclitaxel|mesh-list
56922158|NCT05564377|Fluorouracil|fluorouracil|mesh-list
56922159|NCT05564377|Oxaliplatin|oxaliplatin|mesh-list
56922160|NCT05564377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56922161|NCT05564377|Olaparib|olaparib|mesh-list
56922162|NCT05564377|Fulvestrant|fulvestrant|mesh-list
56922163|NCT05564377|Palbociclib|palbociclib|mesh-list
56922164|NCT05564377|Panitumumab|panitumumab|mesh-list
56922165|NCT05564377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56922167|NCT05564377|Immunoglobulins|immunoglobulins|mesh-list
56922168|NCT05564377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56922169|NCT05564377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56922170|NCT05564377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922171|NCT05564377|Tubulin Modulators|tubulin modulators|mesh-ancestor
56922172|NCT05564377|Antimitotic Agents|antimitotic agents|mesh-ancestor
56922173|NCT05564377|Mitosis Modulators|mitosis modulators|mesh-ancestor
56922174|NCT05564377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922175|NCT05564377|Immunologic Factors|immunologic factors|mesh-ancestor
56922176|NCT05564377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922177|NCT05564377|Antimetabolites|antimetabolites|mesh-ancestor
56922178|NCT05564377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56922179|NCT05564377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56922180|NCT05564377|Antidotes|antidotes|mesh-ancestor
56922181|NCT05564377|Protective Agents|protective agents|mesh-ancestor
56922182|NCT05564377|Vitamin B Complex|vitamin b complex|mesh-ancestor
56922183|NCT05564377|Vitamins|vitamins|mesh-ancestor
56922184|NCT05564377|Micronutrients|micronutrients|mesh-ancestor
56922185|NCT05564377|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56922186|NCT05564377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922187|NCT05564377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56922188|NCT05564377|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56922189|NCT05564377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56922190|NCT05564377|Hormone Antagonists|hormone antagonists|mesh-ancestor
56184673|NCT01426971|Analgesics|analgesics|mesh-ancestor
56922214|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
56922215|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56922216|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56922217|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922227|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
56922228|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56922229|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56922230|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56922231|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922232|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922233|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56922234|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56922245|NCT05538091|Atezolizumab|atezolizumab|mesh-list
56922246|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922247|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
56922248|NCT05524935|Olaparib|olaparib|mesh-list
56922249|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922250|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922251|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56922252|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184726|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56922253|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922254|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
56922255|NCT05515029|Abatacept|abatacept|mesh-list
56922256|NCT05515029|Vedolizumab|vedolizumab|mesh-list
56922257|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56922258|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56922259|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
56922260|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922261|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56922262|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56922263|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
56922264|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922265|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922266|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56922267|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56922268|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56922269|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922270|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
56922271|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56922272|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922273|NCT05499832|Tenecteplase|tenecteplase|mesh-list
56922274|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56922275|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56922276|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922277|NCT05487755|Tadalafil|tadalafil|mesh-list
56922278|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
56922279|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
56922280|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56922281|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56922282|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922283|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922284|NCT05487755|Urological Agents|urological agents|mesh-ancestor
56922285|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56922286|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56922287|NCT05487755|Protective Agents|protective agents|mesh-ancestor
56922288|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922289|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56922290|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
56922291|NCT05461755|Tretinoin|tretinoin|mesh-list
56922292|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922293|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
56922294|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
56922295|NCT05461456|Fexofenadine|fexofenadine|mesh-list
56922296|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56184790|NCT01427478|Afatinib|afatinib|mesh-list
56922304|NCT05441930|Levofloxacin|levofloxacin|mesh-list
56922305|NCT05441930|Ofloxacin|ofloxacin|mesh-list
56922306|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56922307|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56922308|NCT05441930|Renal Agents|renal agents|mesh-ancestor
56922309|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56922310|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56922311|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56922312|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922313|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922314|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922315|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56922316|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56922317|NCT05433584|Tirzepatide|tirzepatide|mesh-list
56922318|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56922319|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922320|NCT05433584|Incretins|incretins|mesh-ancestor
56922321|NCT05433584|Hormones|hormones|mesh-ancestor
56922322|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56922330|NCT05405751|Tenofovir|tenofovir|mesh-list
56922331|NCT05405751|Emtricitabine|emtricitabine|mesh-list
56922332|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56922333|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
56922334|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56922335|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56184803|NCT01427686|Dobutamine|dobutamine|mesh-list
56922403|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56922404|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922406|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
56922434|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922436|NCT05331183|Elexacaftor|elexacaftor|mesh-list
56922437|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56922438|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56922439|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922440|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56922441|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56648510|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56922446|NCT05307705|Anastrozole|anastrozole|mesh-list
56922447|NCT05307705|Exemestane|exemestane|mesh-list
56922448|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56922449|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922450|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
56922451|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
56922452|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
56922453|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922454|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56922455|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56922456|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922457|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56922458|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
56922459|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56922460|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922461|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56922462|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56922487|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56922488|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922489|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922490|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56922491|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56922492|NCT05267366|Growth Substances|growth substances|mesh-ancestor
56922493|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922494|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
56922495|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922497|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922498|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56922499|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922500|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922501|NCT05263206|Loratadine|loratadine|mesh-list
56922502|NCT05263206|Fexofenadine|fexofenadine|mesh-list
56922503|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
56922504|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
56922505|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56922506|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56633090|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
56922507|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56922508|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
56922509|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
56922527|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922528|NCT05222984|Decitabine|decitabine|mesh-list
56922529|NCT05222984|Venetoclax|venetoclax|mesh-list
56922530|NCT05222984|Navitoclax|navitoclax|mesh-list
56922531|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56922532|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
56922533|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922534|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922535|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922536|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56922537|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922538|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922539|NCT05191667|Paclitaxel|paclitaxel|mesh-list
56922540|NCT05191667|Carboplatin|carboplatin|mesh-list
56922541|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56922542|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922543|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
56922544|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
56922545|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
56922546|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922547|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
56922548|NCT05188508|Temozolomide|temozolomide|mesh-list
56922549|NCT05188508|Olaparib|olaparib|mesh-list
56922550|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922551|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922552|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56922553|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
56922554|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922555|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56922556|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922557|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
56922558|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922559|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922560|NCT05136677|Carboplatin|carboplatin|mesh-list
56922561|NCT05136677|Nivolumab|nivolumab|mesh-list
56922562|NCT05136677|Pemetrexed|pemetrexed|mesh-list
56922563|NCT05136677|Ipilimumab|ipilimumab|mesh-list
56922564|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922565|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922566|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56922567|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922568|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922569|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56922570|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56922573|NCT05112263|Cyclosporine|cyclosporine|mesh-list
56922574|NCT05112263|Cyclosporins|cyclosporins|mesh-list
56922575|NCT05112263|Tofacitinib|tofacitinib|mesh-list
56922576|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922577|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922578|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56922579|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
56922580|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922581|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
56922582|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56922583|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
56922584|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56922585|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56922586|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56922587|NCT05104281|Osimertinib|osimertinib|mesh-list
56922588|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922589|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56922590|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922591|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922592|NCT05103605|Osimertinib|osimertinib|mesh-list
56922593|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922594|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56922595|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922596|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922597|NCT05096884|Metoprolol|metoprolol|mesh-list
56922598|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56922599|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56922600|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
56922601|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
56922602|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922603|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922604|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56922605|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56922606|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56922607|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
56922608|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922609|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922610|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56922611|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
56922612|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
56922613|NCT05084378|Povidone|povidone|mesh-list
56922614|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56922615|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185063|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
56922616|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56922617|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
56922618|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
56922619|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
56922621|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56922622|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922623|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
56922624|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922625|NCT05065918|Ethanol|ethanol|mesh-list
56922626|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56922627|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56922628|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56922629|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922630|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
56922631|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56922632|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922633|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922634|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922635|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
56922636|NCT05040984|Mirabegron|mirabegron|mesh-list
56922637|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56922638|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56922639|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
56922640|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922641|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185144|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
56922642|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922643|NCT05040984|Urological Agents|urological agents|mesh-ancestor
56922644|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56922645|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56922646|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56922647|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
56922649|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56922650|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
56922651|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922652|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922653|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
56922654|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923399|NCT04188548|Trastuzumab|trastuzumab|mesh-list
56922655|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56922656|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
56922657|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922658|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
56922659|NCT05017272|Narcotics|narcotics|mesh-ancestor
56922660|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56922661|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922662|NCT05017272|Analgesics|analgesics|mesh-ancestor
56922663|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
56922664|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922705|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922706|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55893002|NCT03773484|Analgesics|analgesics|mesh-ancestor
56922707|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922708|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922709|NCT04933058|Acetaminophen|acetaminophen|mesh-list
56922710|NCT04933058|Fentanyl|fentanyl|mesh-list
56922711|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56922712|NCT04933058|Narcotics|narcotics|mesh-ancestor
56922713|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185224|NCT01430052|Gemcitabine|gemcitabine|mesh-list
56922714|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922715|NCT04933058|Analgesics|analgesics|mesh-ancestor
56922716|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
56922717|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922718|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56922719|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56922720|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
56922721|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
56922722|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56922723|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
56922724|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
56922725|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56922726|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56922727|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922728|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56922729|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922730|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56633316|NCT04300192|Vaccines|vaccines|mesh-list
56922731|NCT04918810|Docetaxel|docetaxel|mesh-list
56922732|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922733|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56922734|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56185235|NCT01430065|Tacrolimus|tacrolimus|mesh-list
56922736|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922755|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
56922756|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
56922757|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
56922758|NCT04894864|Anesthetics|anesthetics|mesh-list
56922759|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56922760|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922761|NCT04894864|Narcotics|narcotics|mesh-ancestor
56922762|NCT04894864|Analgesics|analgesics|mesh-ancestor
56922763|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
56922764|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922766|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
56922767|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922784|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922785|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
56922786|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185290|NCT01430689|Vaccines|vaccines|mesh-list
56922788|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56922789|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56922790|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56922791|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
56922792|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922793|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922794|NCT04857138|Atezolizumab|atezolizumab|mesh-list
56922796|NCT04854499|Carboplatin|carboplatin|mesh-list
56922797|NCT04854499|Docetaxel|docetaxel|mesh-list
56922798|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
56922799|NCT04854499|Magrolimab|magrolimab|mesh-list
56922800|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922801|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
56922802|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
56922803|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
56922804|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922805|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922806|NCT04849013|Ketanserin|ketanserin|mesh-list
56922807|NCT04849013|Mescaline|mescaline|mesh-list
56922808|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56922809|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56922810|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56922811|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
56922812|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922813|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922814|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922815|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
56922816|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56922817|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56922818|NCT04827576|Docetaxel|docetaxel|mesh-list
56922819|NCT04827576|Magrolimab|magrolimab|mesh-list
56922820|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922821|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
56922822|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
56922823|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56922824|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922825|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922826|NCT04808245|Atezolizumab|atezolizumab|mesh-list
56922827|NCT04808245|Imiquimod|imiquimod|mesh-list
56922828|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922829|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56922830|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
56922831|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922832|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
56922833|NCT04790513|Evolocumab|evolocumab|mesh-list
56922834|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56922835|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56922836|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
56922837|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922838|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56922839|NCT04777071|Edetic Acid|edetic acid|mesh-list
56922840|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56922841|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
56922842|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
56922843|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922844|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
56922845|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56922846|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56922847|NCT04762758|Naltrexone|naltrexone|mesh-list
56922848|NCT04762758|Baclofen|baclofen|mesh-list
56922849|NCT04762758|Sorbitol|sorbitol|mesh-list
56923414|NCT04183101|Enalapril|enalapril|mesh-list
56922850|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56922851|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56922852|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922853|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
56922854|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922855|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56922856|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56922857|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56922858|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
56922859|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
56922860|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922861|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922863|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56922864|NCT04759833|Prucalopride|prucalopride|mesh-list
56922865|NCT04759833|Laxatives|laxatives|mesh-ancestor
56185361|NCT01431326|Vancomycin|vancomycin|mesh-list
56922866|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56922867|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56922868|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56922869|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
56922870|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922871|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922872|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922873|NCT04751383|Dinutuximab|dinutuximab|mesh-list
56922874|NCT04751383|Magrolimab|magrolimab|mesh-list
56922875|NCT04751383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56922876|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922877|NCT04751383|Immunologic Factors|immunologic factors|mesh-ancestor
56185366|NCT01431326|Amikacin|amikacin|mesh-list
56922878|NCT04751383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185383|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56922879|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922880|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56922881|NCT04747847|Atorvastatin|atorvastatin|mesh-list
56922882|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56185384|NCT01431326|Clozapine|clozapine|mesh-list
56922883|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56185391|NCT01431326|Sevelamer|sevelamer|mesh-list
56922884|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
56923712|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56922885|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922886|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56922887|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56922888|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922889|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56922890|NCT04712097|Rituximab|rituximab|mesh-list
56922891|NCT04712097|Lenalidomide|lenalidomide|mesh-list
56922892|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922893|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922894|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
56922895|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922896|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56922897|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56922898|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56185399|NCT01431326|Hormones|hormones|mesh-ancestor
56922900|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
56922901|NCT04704661|Trastuzumab|trastuzumab|mesh-list
56922903|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
56922906|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56922907|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56922908|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56922909|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922910|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922911|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
56922912|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250057|NCT01858207|Doxorubicin|doxorubicin|mesh-list
56922924|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922926|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56922927|NCT04646837|Paclitaxel|paclitaxel|mesh-list
56922928|NCT04646837|Carboplatin|carboplatin|mesh-list
56922929|NCT04646837|Durvalumab|durvalumab|mesh-list
56922930|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56922931|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56922932|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
56922933|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
56250500|NCT01860833|Ibuprofen|ibuprofen|mesh-list
56922934|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
56922935|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922936|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922937|NCT04640636|Midazolam|midazolam|mesh-list
56922938|NCT04640636|Ketamine|ketamine|mesh-list
56922939|NCT04640636|Analgesics|analgesics|mesh-ancestor
56922940|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
56922941|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56922942|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922943|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56922944|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56922945|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
56922946|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
56922947|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56922948|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56922949|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56922950|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56922951|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922952|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56922953|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56922954|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56922955|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56922956|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56922957|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
56922958|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
56922959|NCT04628767|Gemcitabine|gemcitabine|mesh-list
56922960|NCT04628767|Cisplatin|cisplatin|mesh-list
56922961|NCT04628767|Doxorubicin|doxorubicin|mesh-list
56922962|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56922963|NCT04628767|Methotrexate|methotrexate|mesh-list
56922964|NCT04628767|Durvalumab|durvalumab|mesh-list
56922965|NCT04628767|Vinblastine|vinblastine|mesh-list
56922966|NCT04628767|Lenograstim|lenograstim|mesh-list
56922967|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
56922968|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56922969|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
56922970|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923434|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923435|NCT04155632|Protective Agents|protective agents|mesh-ancestor
56923436|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923437|NCT04155632|Antidotes|antidotes|mesh-ancestor
56923438|NCT04138706|Vancomycin|vancomycin|mesh-list
56923439|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56923440|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923441|NCT04136756|Rituximab|rituximab|mesh-list
56923442|NCT04136756|Daratumumab|daratumumab|mesh-list
56923443|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923444|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923445|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
56923446|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923447|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56923464|NCT04090398|Paclitaxel|paclitaxel|mesh-list
56923465|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56922971|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56922972|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
56922973|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56922974|NCT04628767|Antiviral Agents|antiviral agents|mesh-ancestor
56922975|NCT04628767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56922976|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56922977|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56922978|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
56922979|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56922980|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56922981|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56922982|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56922983|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56922984|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
56922985|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56922986|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
56922987|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56922988|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56922989|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56922990|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56922991|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56922992|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56922993|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
56922994|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
56922995|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
56922996|NCT04600167|Isoniazid|isoniazid|mesh-list
56922997|NCT04600167|Rifapentine|rifapentine|mesh-list
56922998|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
56922999|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56923000|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185496|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
56923001|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56923002|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56923004|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923005|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56923006|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56923007|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
56923008|NCT04593927|Siponimod|siponimod|mesh-list
56923009|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56923010|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923011|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923012|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
56923013|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923015|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56923016|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56923017|NCT04586023|Analgesics|analgesics|mesh-ancestor
56923018|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
56923019|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923020|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923021|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923022|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56923023|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923024|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
56923025|NCT04562090|Mirabegron|mirabegron|mesh-list
56923026|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56923027|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56923028|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56923029|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
56923030|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56923471|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
56923031|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923032|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923033|NCT04562090|Urological Agents|urological agents|mesh-ancestor
56923034|NCT04560725|Choline|choline|mesh-list
56923035|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
56923036|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56923037|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
56923038|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923039|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56923040|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56923041|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
56923042|NCT04546009|Letrozole|letrozole|mesh-list
56923043|NCT04546009|Palbociclib|palbociclib|mesh-list
56923044|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923045|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56923046|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56923047|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923048|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923049|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56923050|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
56923051|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923052|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923053|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923054|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
56923055|NCT04541017|Magrolimab|magrolimab|mesh-list
56923056|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
56923057|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
56923058|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
56923059|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923060|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923061|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923062|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
56923063|NCT04539366|Fludarabine|fludarabine|mesh-list
56923064|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
56923065|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
56923066|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923067|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923068|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56923069|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56923070|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
56923071|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923072|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923073|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56923074|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56923075|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
56257957|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56257958|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56257959|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257960|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
56923144|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56923145|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56923146|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923147|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923148|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923149|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56923151|NCT04492891|Cyclosporins|cyclosporins|mesh-list
56923152|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923153|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923154|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923155|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
56923156|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923157|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
56923158|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923159|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
56923160|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56923161|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56923162|NCT04489888|Paclitaxel|paclitaxel|mesh-list
56923163|NCT04489888|Carboplatin|carboplatin|mesh-list
56923164|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
56923165|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56923166|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923167|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56923168|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56923169|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56923170|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923176|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
56923177|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923178|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56923179|NCT04443309|Lenvatinib|lenvatinib|mesh-list
56923180|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923181|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923182|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923183|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923184|NCT04435834|Propofol|propofol|mesh-list
56923185|NCT04435834|Sevoflurane|sevoflurane|mesh-list
56923186|NCT04435834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56923187|NCT04435834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56923188|NCT04435834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923189|NCT04435834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56923190|NCT04435834|Anesthetics, General|anesthetics, general|mesh-ancestor
56923191|NCT04435834|Anesthetics|anesthetics|mesh-ancestor
56923192|NCT04435834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56923193|NCT04435834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56923194|NCT04431258|Folfirinox|folfirinox|mesh-list
56923195|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923201|NCT04401800|Lenvatinib|lenvatinib|mesh-list
56923202|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923203|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923204|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923205|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923206|NCT04400110|Amoxicillin|amoxicillin|mesh-list
56923207|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
56923208|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
56923209|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56923210|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923211|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648513|NCT04250831|Chromium|chromium|mesh-list
56923241|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56923242|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923243|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923245|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923246|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56923247|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56923248|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
56923249|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185726|NCT01432665|Testosterone|testosterone|mesh-list
56923255|NCT04338763|Gemcitabine|gemcitabine|mesh-list
56923256|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56923257|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
56923258|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923259|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923260|NCT04338763|Antiviral Agents|antiviral agents|mesh-ancestor
56923261|NCT04338763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923262|NCT04338763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923263|NCT04338763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633847|NCT02987257|Analgesics|analgesics|mesh-ancestor
56923264|NCT04338763|Immunologic Factors|immunologic factors|mesh-ancestor
56923265|NCT04338763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923266|NCT04329728|Dexamethasone|dexamethasone|mesh-list
56923267|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56923268|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923269|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
56923270|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
56923271|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923272|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923273|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56923275|NCT04329728|Hormones|hormones|mesh-ancestor
56923713|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
56648514|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56923276|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923277|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56923278|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923279|NCT04317105|Nivolumab|nivolumab|mesh-list
56923281|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923282|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923283|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56923284|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923285|NCT04313634|Dasatinib|dasatinib|mesh-list
56923349|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
56923350|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923352|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56923353|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185852|NCT01433757|Ampicillin|ampicillin|mesh-list
56923354|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56923355|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923356|NCT04247815|Methotrexate|methotrexate|mesh-list
56923357|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56923358|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
56923359|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56923360|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923361|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56923362|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
56923363|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923364|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923365|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56923366|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923367|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56923368|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923369|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
56923370|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56923371|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56923372|NCT04227522|Rucaparib|rucaparib|mesh-list
56185863|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
56923373|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56923374|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923375|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923376|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923377|NCT04216953|Atezolizumab|atezolizumab|mesh-list
56923378|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923379|NCT04211168|Lenvatinib|lenvatinib|mesh-list
56923380|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923381|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923382|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923383|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923384|NCT04196257|Paclitaxel|paclitaxel|mesh-list
56923385|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56923386|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923387|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
56923388|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
56923389|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
56923390|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923391|NCT04193553|Lenvatinib|lenvatinib|mesh-list
56923392|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923393|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923394|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923395|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923396|NCT04192981|GDC-0084|gdc-0084|mesh-list
55897890|NCT05681260|Prednisone|prednisone|mesh-list
56923397|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923398|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923400|NCT04188548|Pertuzumab|pertuzumab|mesh-list
56923401|NCT04188548|Everolimus|everolimus|mesh-list
56923402|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56923501|NCT04073134|Evolocumab|evolocumab|mesh-list
56923403|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923404|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923405|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923406|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
56923407|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923408|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56923409|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923410|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923411|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56923412|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
56923413|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923415|NCT04183101|Enalaprilat|enalaprilat|mesh-list
56923416|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56923417|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
56923418|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923419|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923420|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56923421|NCT04165772|Capecitabine|capecitabine|mesh-list
56923422|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56923423|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
56923424|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923425|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923426|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
56923427|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56923428|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
56923429|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923430|NCT04155632|Expectorants|expectorants|mesh-ancestor
56923431|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
56923432|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56923433|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
56185938|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56923466|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56923467|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56923468|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923469|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
56923470|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
56923472|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923473|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56923474|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56923475|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923476|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923477|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
56923478|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923479|NCT04075136|Triamcinolone|triamcinolone|mesh-list
56923505|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923506|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56923510|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
56923480|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56923481|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56923482|NCT04075136|Ranibizumab|ranibizumab|mesh-list
56923483|NCT04075136|Verteporfin|verteporfin|mesh-list
56923484|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56923485|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56923486|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56923487|NCT04075136|Growth Substances|growth substances|mesh-ancestor
56923488|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923489|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
56923490|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923491|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923492|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
56923493|NCT04075136|Hormones|hormones|mesh-ancestor
56923494|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923495|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923496|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
56923497|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923498|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923499|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56923500|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
56923502|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56923503|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56923504|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
56923511|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56923512|NCT04044690|Antibodies|antibodies|mesh-list
56923513|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
56923514|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
56923515|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923516|NCT04037254|Niraparib|niraparib|mesh-list
56923517|NCT04037254|Hormones|hormones|mesh-list
56923518|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56923519|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56923520|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923521|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923522|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56923523|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923524|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923525|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923526|NCT04034485|Evolocumab|evolocumab|mesh-list
56923527|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56923528|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56923529|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
56923530|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923531|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56923532|NCT04019327|Temozolomide|temozolomide|mesh-list
56923533|NCT04019327|Talazoparib|talazoparib|mesh-list
56923534|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56923535|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
56186713|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186714|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186715|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56186716|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56186717|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186718|NCT05343507|Ketamine|ketamine|mesh-list
56186719|NCT05343507|Analgesics|analgesics|mesh-ancestor
56186720|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
56186721|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186722|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186723|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56186724|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56186725|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
56186726|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
56186727|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56186728|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56186729|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56186730|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848359|NCT04123288|ACT-709478|act-709478|mesh-list
56532831|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532832|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923536|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923537|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923538|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56923539|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923540|NCT04010071|Axitinib|axitinib|mesh-list
56923541|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923542|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923543|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923544|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923545|NCT03989414|Dexamethasone|dexamethasone|mesh-list
56923546|NCT03989414|Bortezomib|bortezomib|mesh-list
56532833|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532834|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532835|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56532836|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532837|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532838|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56532839|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56532840|NCT02850211|Narcotics|narcotics|mesh-ancestor
56532841|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532842|NCT03248167|Cannabidiol|cannabidiol|mesh-list
56532843|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
56532844|NCT02850289|Interferons|interferons|mesh-list
56532845|NCT02850289|Ribavirin|ribavirin|mesh-list
56532846|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532847|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
56532848|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532849|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
56532850|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532851|NCT03217669|Sirolimus|sirolimus|mesh-list
56532852|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56532853|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547729|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56532854|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56532855|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532856|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
56532857|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532858|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
56532859|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532861|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56532863|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532864|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532865|NCT05331781|Analgesics|analgesics|mesh-ancestor
56532866|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
56532867|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532868|NCT04202887|Fentanyl|fentanyl|mesh-list
56532869|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56532870|NCT04202887|Narcotics|narcotics|mesh-ancestor
56532871|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532872|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532873|NCT04202887|Analgesics|analgesics|mesh-ancestor
56532874|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
56532875|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532876|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56532877|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56532878|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
56532879|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
56532880|NCT05324215|Fentanyl|fentanyl|mesh-list
56532881|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56532882|NCT05324215|Narcotics|narcotics|mesh-ancestor
56532883|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532884|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532885|NCT05324215|Analgesics|analgesics|mesh-ancestor
56532886|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
56532887|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923547|NCT03989414|Daratumumab|daratumumab|mesh-list
56923548|NCT03989414|Elotuzumab|elotuzumab|mesh-list
56923549|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923550|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
56923551|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
56923552|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923553|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923554|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56923555|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
56923556|NCT03989414|Hormones|hormones|mesh-ancestor
56923557|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923558|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56923559|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923560|NCT03988920|Sevelamer|sevelamer|mesh-list
56923561|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
56923562|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
56923563|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634154|NCT01849146|Temozolomide|temozolomide|mesh-list
56923564|NCT03986034|Venetoclax|venetoclax|mesh-list
56923565|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923566|NCT03954041|Glyburide|glyburide|mesh-list
56923567|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56923568|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923569|NCT03925402|Ertapenem|ertapenem|mesh-list
56923570|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56923571|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923572|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
56923573|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923574|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532888|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56532889|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56532890|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
56532891|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
56532892|NCT02131753|Cladribine|cladribine|mesh-list
56532893|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532894|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532895|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
56532896|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532897|NCT00905437|Pregabalin|pregabalin|mesh-list
56532898|NCT00905437|Analgesics|analgesics|mesh-ancestor
56532899|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
56533541|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533542|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533543|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
56533544|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533545|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
56533546|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56533547|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533548|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56533549|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533550|NCT02846935|Decitabine|decitabine|mesh-list
56533551|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
56533552|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56533553|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
56533554|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533555|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533556|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533557|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
56533558|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533559|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
56533653|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
56533654|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56533655|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56533656|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
56533657|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
56533658|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
56533659|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
56533660|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
56533661|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56534232|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56534233|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534234|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
56534235|NCT01227707|Antidotes|antidotes|mesh-ancestor
56534236|NCT01227707|Protective Agents|protective agents|mesh-ancestor
56534237|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
56534413|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534414|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56534415|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
56534416|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534417|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534418|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56534419|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56534421|NCT00968812|Glimepiride|glimepiride|mesh-list
56534422|NCT00968812|Canagliflozin|canagliflozin|mesh-list
56534423|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56282648|NCT00006864|Aldesleukin|aldesleukin|mesh-list
56534424|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534425|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56534426|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534427|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
56534428|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56534429|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534430|NCT02834845|Sevoflurane|sevoflurane|mesh-list
56534431|NCT02834845|Desflurane|desflurane|mesh-list
56534432|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56534433|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56534434|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
56534435|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
56534436|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56534437|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534438|NCT05197192|Venetoclax|venetoclax|mesh-list
56534439|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
56534440|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
56534441|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534442|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56534443|NCT00992056|Metoprolol|metoprolol|mesh-list
56534444|NCT00992056|Nebivolol|nebivolol|mesh-list
56534445|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56534446|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56534447|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
56534448|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
56534449|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534450|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534451|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56534452|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56534453|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56534454|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
56534455|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534456|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923583|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
56923584|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
56923585|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923586|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56534457|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
56534458|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56534459|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56534460|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56534461|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56534462|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56534463|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534464|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56534465|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56534466|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56534467|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534468|NCT00967798|Incretins|incretins|mesh-ancestor
56534469|NCT00967798|Hormones|hormones|mesh-ancestor
56534470|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534471|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56534472|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
56534473|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534474|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534475|NCT04248205|Ketamine|ketamine|mesh-list
56534476|NCT04248205|Analgesics|analgesics|mesh-ancestor
56534477|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
56534478|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534479|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534480|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56534481|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56534482|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
56534483|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
56534484|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56534485|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56534541|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534542|NCT05333419|Latanoprost|latanoprost|mesh-list
56534543|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56534544|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56534545|NCT02836795|Antibodies|antibodies|mesh-list
56534546|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56534547|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
56534548|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534549|NCT02836483|Linezolid|linezolid|mesh-list
56534550|NCT02836483|Delpazolid|delpazolid|mesh-list
56534551|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
56534552|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56534553|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534554|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56534555|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534556|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534557|NCT02836171|Itraconazole|itraconazole|mesh-list
56534558|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56534559|NCT02836171|Apatinib|apatinib|mesh-list
56534560|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534561|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56534562|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534563|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534564|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
56534565|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534566|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56534567|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56534568|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56534569|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
56534570|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534571|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282795|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
56534572|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56534573|NCT00971932|Carboplatin|carboplatin|mesh-list
56534574|NCT00971932|Fluorouracil|fluorouracil|mesh-list
56923587|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56923588|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
56923589|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56923590|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923591|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56534575|NCT00971932|Cetuximab|cetuximab|mesh-list
56534576|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534578|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534579|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56534580|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534581|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
56534582|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534583|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56534584|NCT04400929|Molgramostim|molgramostim|mesh-list
56534585|NCT04400929|Sargramostim|sargramostim|mesh-list
56534586|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
56534587|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534588|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534589|NCT05170672|Abatacept|abatacept|mesh-list
56534590|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56534591|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534592|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534593|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534594|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
56534595|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189210|NCT01448772|Hormones|hormones|mesh-ancestor
56535579|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535581|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535582|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535815|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
56535816|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
56535817|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535818|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535819|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56535820|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
56535821|NCT02816905|Hormones|hormones|mesh-ancestor
56535822|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56535823|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56535824|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535825|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56535826|NCT01072539|Tigecycline|tigecycline|mesh-list
56547713|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535827|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56535828|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535829|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56535830|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536054|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536055|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536056|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56536057|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
56536058|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56536059|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56536060|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56536061|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
56536062|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56536063|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
56536064|NCT01236560|Bevacizumab|bevacizumab|mesh-list
56536065|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56536066|NCT01236560|Temozolomide|temozolomide|mesh-list
56536067|NCT01236560|Vorinostat|vorinostat|mesh-list
56536068|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
56536069|NCT01236560|Antibodies|antibodies|mesh-list
56536070|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
56536071|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56536072|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
56536073|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536074|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56386955|NCT00161811|Vaccines|vaccines|mesh-list
56536075|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56536076|NCT01236560|Growth Substances|growth substances|mesh-ancestor
56536077|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536078|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
56536079|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
56536080|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56536081|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
56536082|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536083|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56536084|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536085|NCT04303377|Evolocumab|evolocumab|mesh-list
56536086|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56536087|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56536088|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
56536089|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536090|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56536091|NCT00948766|Rivastigmine|rivastigmine|mesh-list
56536092|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56536093|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536094|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536095|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
56536096|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536097|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536098|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56536099|NCT00948766|Protective Agents|protective agents|mesh-ancestor
56536100|NCT01053663|Oseltamivir|oseltamivir|mesh-list
56536101|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
56536102|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536103|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536104|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536105|NCT01235546|Azithromycin|azithromycin|mesh-list
56536106|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56536107|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536108|NCT01053429|Ziprasidone|ziprasidone|mesh-list
56536109|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56536110|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
56536111|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536112|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536113|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536114|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56536115|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56536116|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547714|NCT02862483|Urological Agents|urological agents|mesh-ancestor
56547715|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56547716|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56547717|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56547718|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
56547719|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547720|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547721|NCT02667535|Isosorbide|isosorbide|mesh-list
56547722|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56547723|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56547724|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56547725|NCT02667535|Diuretics|diuretics|mesh-ancestor
56547726|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
56547727|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923624|NCT03769298|Tacrolimus|tacrolimus|mesh-list
56923625|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56531948|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56531949|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531950|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531951|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56531953|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
56531954|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536117|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56536118|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56536119|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
56536120|NCT01233284|Bromides|bromides|mesh-list
56536121|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
56536122|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56536123|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
56536124|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536125|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536126|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56536127|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
56536128|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
56538092|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56538093|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
56538094|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
56538095|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538096|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56538097|NCT02776813|Rituximab|rituximab|mesh-list
56538098|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56538099|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538100|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
56538101|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538102|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56538103|NCT02774005|Idebenone|idebenone|mesh-list
56538104|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
56538105|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538106|NCT02774005|Protective Agents|protective agents|mesh-ancestor
56538107|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538108|NCT05157997|Antibodies|antibodies|mesh-list
56538295|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531955|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56531956|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56531957|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56531958|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
56531959|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531960|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531962|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
56192483|NCT01481454|Vaccines|vaccines|mesh-list
56538983|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538984|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56538985|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
56193164|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539021|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56539022|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539023|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56539024|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
56539026|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
56539027|NCT02751619|Lidocaine|lidocaine|mesh-list
56539028|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
56539029|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
56539030|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56539031|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539032|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
56539033|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539034|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56539035|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56539036|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56539037|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56539038|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539039|NCT01734928|Thalidomide|thalidomide|mesh-list
56539040|NCT01734928|Dexamethasone|dexamethasone|mesh-list
56539041|NCT01734928|Bortezomib|bortezomib|mesh-list
56539042|NCT01734928|Pomalidomide|pomalidomide|mesh-list
56539043|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56539044|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
56539045|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
56539046|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539047|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539048|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56539049|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
56539050|NCT01734928|Hormones|hormones|mesh-ancestor
56539051|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539052|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56539053|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539054|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
56539055|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56539056|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56539057|NCT01734928|Growth Substances|growth substances|mesh-ancestor
56539058|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
56539059|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539060|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
56539061|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56539062|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539063|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
56539064|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56539065|NCT02751541|Protective Agents|protective agents|mesh-ancestor
56539066|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539067|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
56539068|NCT02755753|Lansoprazole|lansoprazole|mesh-list
56539069|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
56539070|NCT02755753|Rebamipide|rebamipide|mesh-list
56539071|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56539072|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56539073|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56539075|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539076|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
56539077|NCT02755753|Protective Agents|protective agents|mesh-ancestor
56531963|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56531964|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
56531965|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531966|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56531967|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56531968|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
56531969|NCT01096017|Albuterol|albuterol|mesh-list
56531970|NCT01096017|Terbutaline|terbutaline|mesh-list
56531971|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56531972|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
56531973|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531974|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531975|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56531976|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
56531977|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
56531978|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56531979|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56531980|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56539078|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539079|NCT02755909|Anesthetics|anesthetics|mesh-list
56539080|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56539081|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539082|NCT02761291|Gemcitabine|gemcitabine|mesh-list
56539083|NCT02761291|Valganciclovir|valganciclovir|mesh-list
56539084|NCT02761291|Valproic Acid|valproic acid|mesh-list
56539113|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539114|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539116|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
56539117|NCT02855866|Hormones|hormones|mesh-ancestor
56539118|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539119|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56539120|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539121|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56539122|NCT02855866|Analgesics|analgesics|mesh-ancestor
56539123|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
56539124|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
56539125|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
56539126|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539127|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539128|NCT02751307|Metformin|metformin|mesh-list
56539129|NCT02751307|Clozapine|clozapine|mesh-list
56539130|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539131|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539132|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56539228|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539230|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56539231|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
56539232|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56539233|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
56539234|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539235|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539236|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
56539237|NCT01723774|Anastrozole|anastrozole|mesh-list
56539238|NCT01723774|Goserelin|goserelin|mesh-list
56539239|NCT01723774|Palbociclib|palbociclib|mesh-list
56539240|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56539241|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531981|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56531982|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
56531983|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531984|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531985|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
56531986|NCT00626223|Folic Acid|folic acid|mesh-list
56531987|NCT00626223|Hematinics|hematinics|mesh-ancestor
56531988|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
56531989|NCT00626223|Vitamins|vitamins|mesh-ancestor
56531990|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
56531991|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531992|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
56531993|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
56531994|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531995|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56531996|NCT04828005|Naloxone|naloxone|mesh-list
56531997|NCT04828005|Nalmefene|nalmefene|mesh-list
56531998|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56531999|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532000|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
56532001|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532002|NCT02878161|Prednisone|prednisone|mesh-list
56532003|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
56532004|NCT02878161|Adalimumab|adalimumab|mesh-list
56532005|NCT02878161|Etanercept|etanercept|mesh-list
56532006|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56532007|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56532008|NCT02878161|Methotrexate|methotrexate|mesh-list
56532009|NCT02878161|Infliximab|infliximab|mesh-list
56532010|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
56532011|NCT02878161|Leflunomide|leflunomide|mesh-list
56539242|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56539243|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56539244|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539245|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539246|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56539247|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
56539248|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539249|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539250|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56539251|NCT02855788|Leucovorin|leucovorin|mesh-list
56539252|NCT02855788|Paclitaxel|paclitaxel|mesh-list
56539253|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
56539254|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56539255|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539256|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
56539257|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
56539258|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
56473641|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56532012|NCT02878161|Hormones|hormones|mesh-ancestor
56532013|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532014|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532015|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56532016|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532017|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56532018|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
56532019|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56532020|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56532021|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
56532022|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532023|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
56382895|NCT00127868|Ketoconazole|ketoconazole|mesh-list
56539259|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539260|NCT02855788|Antidotes|antidotes|mesh-ancestor
56539261|NCT02855788|Protective Agents|protective agents|mesh-ancestor
56539262|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539263|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
56539264|NCT02855788|Vitamins|vitamins|mesh-ancestor
56539265|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
56539266|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56539267|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56539268|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56539269|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56539270|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539271|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539272|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539273|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
56539274|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56539275|NCT01190436|Bisoprolol|bisoprolol|mesh-list
56539276|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56539277|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
56539278|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
56539279|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539280|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539281|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56539282|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56539283|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56539284|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
56540398|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540399|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56540400|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540401|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
56540887|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
56540888|NCT02742805|Vitamins|vitamins|mesh-list
56540889|NCT02742805|Omalizumab|omalizumab|mesh-list
56540890|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
56540891|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540892|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56540893|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56540895|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56540896|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
56540897|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56540898|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
56195099|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
56540912|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540913|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56540914|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
56540915|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
56532024|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532025|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56532026|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532027|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
56540916|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
56540917|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
56540918|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540919|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540921|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56540922|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56540923|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540924|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540925|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56540926|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56540927|NCT02729935|Analgesics|analgesics|mesh-ancestor
56540928|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
56540929|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540930|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540931|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540932|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56540933|NCT02729467|Itraconazole|itraconazole|mesh-list
56540934|NCT02729467|Rifampin|rifampin|mesh-list
56540935|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
56540936|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540937|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56540938|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56540939|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540940|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540941|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56540942|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
56540943|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540944|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540945|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56540946|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56540947|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
56540948|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56540949|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
56540950|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56540951|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56540952|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56540953|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56540954|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56540955|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56540956|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56540958|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
56540959|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
56541192|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
56289521|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
56542128|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542130|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290392|NCT05573191|Anesthetics|anesthetics|mesh-ancestor
56542131|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542132|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56542133|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56542134|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542135|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56542136|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56542137|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
56542139|NCT02709265|Fosfomycin|fosfomycin|mesh-list
56542140|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56542141|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542142|NCT00611845|Aprotinin|aprotinin|mesh-list
56542143|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
56542144|NCT00611845|Coagulants|coagulants|mesh-ancestor
56542145|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56542146|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56542147|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
56542148|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542149|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532028|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532029|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56532031|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
56532032|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532033|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56532034|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56532035|NCT02878161|Protective Agents|protective agents|mesh-ancestor
56532036|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532038|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
56532039|NCT01093755|Omeprazole|omeprazole|mesh-list
56532040|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
56532041|NCT01093755|Lansoprazole|lansoprazole|mesh-list
56532042|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56532043|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56532044|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56532045|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532046|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532047|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56532048|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56532049|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56532050|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532051|NCT01092663|Incretins|incretins|mesh-ancestor
56532052|NCT01092663|Hormones|hormones|mesh-ancestor
56532053|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532054|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56542150|NCT01216163|Acetaminophen|acetaminophen|mesh-list
56542151|NCT01216163|Ibuprofen|ibuprofen|mesh-list
56542152|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56542153|NCT01216163|Analgesics|analgesics|mesh-ancestor
56542154|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
56542155|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542156|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542157|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
56542158|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56542159|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542160|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56542161|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56542162|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542163|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542164|NCT05260255|Vitamin D|vitamin d|mesh-list
56542165|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
56542166|NCT05260255|Vitamins|vitamins|mesh-ancestor
56542167|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
56542168|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542169|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56542170|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56542171|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
56542172|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56542173|NCT00612469|Listerine|listerine|mesh-list
56542174|NCT00612469|Vancomycin|vancomycin|mesh-list
56542175|NCT00612469|Fluorides|fluorides|mesh-list
56532055|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
56532056|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532057|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532058|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56532059|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56532060|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
56532061|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56532062|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
56532063|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56532064|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
56532065|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532066|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532067|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56532068|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
56186257|NCT01435954|Doxazosin|doxazosin|mesh-list
56542176|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
56542177|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
56542178|NCT00612469|Protective Agents|protective agents|mesh-ancestor
56542179|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542180|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56542181|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542182|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
56542183|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
56542184|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56542185|NCT00933244|Vitamin D|vitamin d|mesh-list
56542186|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
56542187|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
56542188|NCT00933244|Vitamins|vitamins|mesh-list
56542189|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
56542190|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542191|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56542192|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56542193|NCT02709187|Candesartan|candesartan|mesh-list
56542194|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
56542195|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56542196|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56542197|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56542198|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
56542199|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542200|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56542201|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56542202|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542203|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56542204|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56542837|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
56542838|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542839|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542840|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542841|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56542842|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542843|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56542844|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
56543111|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543112|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56543113|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56543114|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543115|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543116|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56532069|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56532070|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56532071|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56532072|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
56532073|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532074|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532075|NCT01092507|Vaccines|vaccines|mesh-list
56532076|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
56532077|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532078|NCT01078545|Leuprolide|leuprolide|mesh-list
56532079|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56532080|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
56532081|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56532082|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532083|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56532084|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532085|NCT01091259|Bevacizumab|bevacizumab|mesh-list
56543118|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
56543119|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56543120|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
56543121|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56543122|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
56543123|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543124|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
56543125|NCT02698813|Protective Agents|protective agents|mesh-ancestor
56543126|NCT02702323|Apatinib|apatinib|mesh-list
56543127|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543128|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543129|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543130|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543131|NCT01007253|Fluticasone|fluticasone|mesh-list
56543132|NCT01007253|Xhance|xhance|mesh-list
56543133|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56543134|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56543135|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56543136|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543137|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56543138|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
56543139|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543140|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543141|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56543142|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
56543143|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
56543144|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56543145|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56543146|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56543147|NCT01007253|Analgesics|analgesics|mesh-ancestor
56543148|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
56543149|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56543150|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56543151|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56543152|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
56543153|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
56543154|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543155|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543156|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
56543157|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56543158|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532086|NCT01091259|Irinotecan|irinotecan|mesh-list
56532087|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56532088|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532089|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56532090|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56543159|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56543160|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
56543161|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56543162|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543163|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543164|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543165|NCT04738123|Xanomeline|xanomeline|mesh-list
56543166|NCT04738123|Trospium chloride|trospium chloride|mesh-list
56543167|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
56543168|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
56543169|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543170|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543171|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56543172|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56543173|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
56543174|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543175|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543176|NCT04738123|Urological Agents|urological agents|mesh-ancestor
56543177|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56543178|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56543179|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56543180|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56543181|NCT01006707|Ondansetron|ondansetron|mesh-list
56543794|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543795|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
56543796|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543798|NCT02052193|Dabrafenib|dabrafenib|mesh-list
56544578|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544580|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56544581|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56544582|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544693|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544695|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544696|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544697|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544698|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
56544699|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544700|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
56544701|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
56544702|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
56544704|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
56544705|NCT05392127|Repaglinide|repaglinide|mesh-list
56544706|NCT05392127|Midazolam|midazolam|mesh-list
56544707|NCT05392127|Omeprazole|omeprazole|mesh-list
56544708|NCT05392127|Warfarin|warfarin|mesh-list
56544709|NCT05392127|Vitamins|vitamins|mesh-ancestor
56544710|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
56544711|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544712|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56544713|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56544714|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56544715|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56544716|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56544717|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56544718|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56544719|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
56544720|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
56544721|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
56544722|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
56544723|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544724|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544725|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
56544726|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56544727|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56544728|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56544729|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544730|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56532091|NCT01091259|Growth Substances|growth substances|mesh-ancestor
56532092|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532093|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
56532094|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56532095|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56544731|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56544732|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
56544733|NCT05392127|Coagulants|coagulants|mesh-ancestor
56544734|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56544735|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56544736|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56544737|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56544738|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56544739|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544740|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544741|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
56544742|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544743|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56544744|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56544745|NCT04379011|Brivaracetam|brivaracetam|mesh-list
56293011|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
56544746|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
56544747|NCT02685163|Antioxidants|antioxidants|mesh-list
56544748|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544749|NCT02685163|Protective Agents|protective agents|mesh-ancestor
56544750|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544752|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56544753|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544754|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56544755|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544756|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56544757|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
56544758|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
56544759|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544760|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544761|NCT01201343|Interferons|interferons|mesh-list
56544762|NCT01201343|Interferon-beta|interferon-beta|mesh-list
56544763|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
56544764|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544765|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
56544766|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544767|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
56544768|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544769|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56544770|NCT04185649|Capecitabine|capecitabine|mesh-list
56544771|NCT04185649|Lapatinib|lapatinib|mesh-list
56544772|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544773|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
56544774|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544775|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544776|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56544777|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544778|NCT01201265|Gemcitabine|gemcitabine|mesh-list
56544779|NCT01201265|Bevacizumab|bevacizumab|mesh-list
56544899|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544901|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544902|NCT02688361|Antidotes|antidotes|mesh-ancestor
56544903|NCT01199861|Vaccines|vaccines|mesh-list
56544904|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56199022|NCT01516060|Efavirenz|efavirenz|mesh-list
56545020|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56545021|NCT01158534|Analgesics|analgesics|mesh-ancestor
56545022|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
56545023|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545024|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545025|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545026|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56545027|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56545028|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545029|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532096|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532097|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532098|NCT01078389|Febuxostat|febuxostat|mesh-list
56382989|NCT00402623|Quercetin|quercetin|mesh-list
56532099|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
56532100|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532101|NCT01090323|Deferasirox|deferasirox|mesh-list
56532102|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56545030|NCT02687971|Miltefosine|miltefosine|mesh-list
56545031|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
56545032|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545033|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545034|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56545035|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56545036|NCT05272878|Irbesartan|irbesartan|mesh-list
56545037|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56545038|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56545195|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56545327|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545328|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
56545329|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56545330|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545366|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545367|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
56545368|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545369|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545370|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56545371|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
56545372|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545373|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545374|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56545375|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56545818|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
56545819|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
56545820|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56545821|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56545822|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
56546104|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
56546106|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546107|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56546108|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56546109|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56546110|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
56546111|NCT04315194|Clarithromycin|clarithromycin|mesh-list
56546112|NCT04315194|Oseltamivir|oseltamivir|mesh-list
56546113|NCT04315194|Naproxen|naproxen|mesh-list
56546114|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56546115|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546116|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56546117|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546118|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546119|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56546120|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56546121|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56546122|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546123|NCT04315194|Analgesics|analgesics|mesh-ancestor
56546124|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
56546125|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546126|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546127|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546128|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546129|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
56546130|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56546131|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
56546132|NCT04066491|Gemcitabine|gemcitabine|mesh-list
56546133|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546134|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56532103|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
56532104|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
56648517|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546135|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
56546136|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546137|NCT04066491|Antiviral Agents|antiviral agents|mesh-ancestor
56546138|NCT04066491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546139|NCT04066491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546140|NCT04066491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546141|NCT04066491|Immunologic Factors|immunologic factors|mesh-ancestor
56546142|NCT04066491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546143|NCT01149486|Losartan|losartan|mesh-list
56546144|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56546145|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56546146|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56546147|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56546148|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56546149|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546150|NCT01149486|Diuretics|diuretics|mesh-ancestor
56546151|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
56546152|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546153|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56546154|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56546155|NCT00640471|Cetuximab|cetuximab|mesh-list
56546156|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546157|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546158|NCT00601705|Fluorouracil|fluorouracil|mesh-list
56546159|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
56546160|NCT00601705|Epirubicin|epirubicin|mesh-list
56634310|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56546776|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546777|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546779|NCT00610948|Antidotes|antidotes|mesh-ancestor
56546780|NCT00610948|Protective Agents|protective agents|mesh-ancestor
56546781|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
56546782|NCT00610948|Vitamins|vitamins|mesh-ancestor
56547014|NCT00642733|Antiviral Agents|antiviral agents|mesh-ancestor
56547015|NCT00642733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547016|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547017|NCT00642733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547018|NCT00642733|Immunologic Factors|immunologic factors|mesh-ancestor
56547019|NCT00642733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547104|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201219|NCT01527747|Saxagliptin|saxagliptin|mesh-list
56547140|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547141|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56201253|NCT01527890|Fentanyl|fentanyl|mesh-list
56547292|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56547293|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
56547294|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547295|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56547296|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56547297|NCT00644137|Pregabalin|pregabalin|mesh-list
56547298|NCT00644137|Analgesics|analgesics|mesh-ancestor
56547299|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
56201390|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
56547325|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547326|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547328|NCT04176367|Nicergoline|nicergoline|mesh-list
56547329|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56547330|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56547331|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
56547332|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547333|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547334|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547335|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
56547336|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
56547337|NCT04259476|Ketamine|ketamine|mesh-list
56547338|NCT04259476|Analgesics|analgesics|mesh-ancestor
56547339|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
56547340|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547341|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547342|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56648518|NCT04250831|Cathartics|cathartics|mesh-ancestor
56547343|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56547519|NCT03449901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201625|NCT01529541|Anagliptin|anagliptin|mesh-list
56547555|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547556|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547558|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56547559|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547560|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56547561|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56129379|NCT03204786|Coagulants|coagulants|mesh-ancestor
56634343|NCT05590598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56634344|NCT05590598|Autonomic Agents|autonomic agents|mesh-ancestor
56634345|NCT05590598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634346|NCT05590598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634347|NCT05590598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56634348|NCT05590598|Respiratory System Agents|respiratory system agents|mesh-ancestor
56634349|NCT05590598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56634350|NCT05590598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201728|NCT01530230|Oxytocin|oxytocin|mesh-list
56634404|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
56634405|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634406|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634407|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
56634408|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634409|NCT04253964|Paclitaxel|paclitaxel|mesh-list
56634410|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56634411|NCT04253964|Carboplatin|carboplatin|mesh-list
56634412|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
56634413|NCT04253964|Pemetrexed|pemetrexed|mesh-list
56634414|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56634415|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634416|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
56634417|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
56634418|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
56634419|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634420|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634421|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634422|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56634423|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56634424|NCT02810132|Metformin|metformin|mesh-list
56634425|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56634426|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634427|NCT02734524|Carboplatin|carboplatin|mesh-list
56634428|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634429|NCT04174196|Lenalidomide|lenalidomide|mesh-list
56634430|NCT04174196|Cc-486|cc-486|mesh-list
56634443|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634444|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56634445|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56634446|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
56634447|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
56634448|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634449|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56634450|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56634451|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634452|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634453|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56634454|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56634455|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56634456|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56634457|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56634458|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
56634459|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
56634461|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56634462|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634463|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56634464|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56634465|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56634466|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634467|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56547598|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634468|NCT03333408|Clindamycin|clindamycin|mesh-list
56634469|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
56532105|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532106|NCT02876991|Listerine|listerine|mesh-list
56532107|NCT02876991|Fluorides|fluorides|mesh-list
56532108|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
56532109|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
56532110|NCT02876991|Protective Agents|protective agents|mesh-ancestor
56532111|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532112|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56532113|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532114|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56186302|NCT01436422|Vaccines|vaccines|mesh-list
56634470|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
56634471|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56634472|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634473|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56634474|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634475|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634476|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56634477|NCT04262999|Levetiracetam|levetiracetam|mesh-list
56634478|NCT04262999|Valproic Acid|valproic acid|mesh-list
56634479|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
56634480|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
56634481|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634482|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634483|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
56634484|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634485|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634486|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
56634487|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56634488|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634489|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56634490|NCT05582174|Esomeprazole|esomeprazole|mesh-list
56634491|NCT05582174|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56634492|NCT05582174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56634507|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634508|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56634509|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634510|NCT02812940|Everolimus|everolimus|mesh-list
56634511|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634512|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634513|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
56634514|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634515|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56634516|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56634517|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56634518|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634519|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634520|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634521|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634522|NCT00933439|Analgesics|analgesics|mesh-ancestor
56634523|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
56634524|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634525|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
56634526|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56634527|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
56634528|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
56634529|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
56634530|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56634531|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634532|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634533|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
56634534|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56634535|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532115|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56532116|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532117|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532118|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
56532119|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532120|NCT00637611|Fexofenadine|fexofenadine|mesh-list
56532121|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56532122|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56532123|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56532124|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
56532125|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
56532126|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532127|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532128|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532129|NCT00626535|Esomeprazole|esomeprazole|mesh-list
56532130|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56532131|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56532132|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56532133|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532134|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532135|NCT01200810|Bicalutamide|bicalutamide|mesh-list
56532136|NCT01200810|R04929097|r04929097|mesh-list
56532137|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
56634536|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634537|NCT02809742|Ropivacaine|ropivacaine|mesh-list
56634538|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
56634539|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
56634540|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634541|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634542|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
56280377|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56634543|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634544|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
56634545|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56634546|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
56634547|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634548|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634549|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56634557|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
56634558|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634559|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634560|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
56634561|NCT00933517|Docetaxel|docetaxel|mesh-list
56634562|NCT00933517|Panitumumab|panitumumab|mesh-list
56634563|NCT00933517|Epirubicin|epirubicin|mesh-list
56634564|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634565|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
56634566|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634567|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532138|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
56532139|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532140|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634568|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56634569|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
56634570|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634571|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634572|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56634573|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
56634574|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
56634575|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
56634576|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634577|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56634578|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56634579|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56634580|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634581|NCT00926341|Pioglitazone|pioglitazone|mesh-list
56634582|NCT00926341|Telmisartan|telmisartan|mesh-list
56634583|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56634584|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634585|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56634586|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56634587|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56634588|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634589|NCT00926419|Vaccines|vaccines|mesh-list
56634590|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
56634591|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634592|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
56634593|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56634594|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634595|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634596|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56634597|NCT00608231|Analgesics|analgesics|mesh-ancestor
56634598|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
56634599|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634600|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56634601|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56634602|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56634603|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
56634604|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634605|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634606|NCT05623592|Methotrexate|methotrexate|mesh-list
56634607|NCT05623592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56634608|NCT05623592|Abortifacient Agents|abortifacient agents|mesh-ancestor
56634609|NCT05623592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56634610|NCT05623592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634611|NCT05623592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56634612|NCT05623592|Antimetabolites|antimetabolites|mesh-ancestor
56634613|NCT05623592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736948|NCT03424733|Prednisone|prednisone|mesh-list
56634616|NCT05623592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634617|NCT05623592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56634618|NCT05623592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634619|NCT05623592|Immunologic Factors|immunologic factors|mesh-ancestor
56634620|NCT05623592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56634621|NCT05623592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56634622|NCT02739204|Celecoxib|celecoxib|mesh-list
56634623|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56634624|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56634625|NCT02739204|Analgesics|analgesics|mesh-ancestor
56634626|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
56634627|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634628|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634629|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634630|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56634631|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56634632|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56634633|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473642|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900103|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
56634634|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634635|NCT00927485|Curcumin|curcumin|mesh-list
56634636|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56634637|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56634638|NCT00927485|Analgesics|analgesics|mesh-ancestor
56634639|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
56634640|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634641|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634642|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634643|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56634644|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634645|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634646|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634647|NCT00926653|Citalopram|citalopram|mesh-list
56634648|NCT00926653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56634649|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56634650|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634651|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634652|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634653|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
56634654|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634655|NCT00926653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56634656|NCT00926653|Antidepressive Agents|antidepressive agents|mesh-ancestor
56634657|NCT00926653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56634658|NCT02733822|Naloxone|naloxone|mesh-list
56634659|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56634660|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634661|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
56634662|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634663|NCT00930241|Tacrolimus|tacrolimus|mesh-list
56634664|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634665|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
56634666|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634667|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56634668|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634669|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634670|NCT04260269|Trifluridine|trifluridine|mesh-list
56634671|NCT04260269|Fluorouracil|fluorouracil|mesh-list
56634672|NCT04260269|Capecitabine|capecitabine|mesh-list
56634673|NCT04260269|Tegafur|tegafur|mesh-list
56634674|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
56634675|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634676|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56634677|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634678|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634679|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
56634680|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634681|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
56634682|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634683|NCT02738970|Trastuzumab|trastuzumab|mesh-list
56634684|NCT02738970|Pertuzumab|pertuzumab|mesh-list
56634696|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634697|NCT00926809|Amoxicillin|amoxicillin|mesh-list
56634698|NCT00926809|Clarithromycin|clarithromycin|mesh-list
56634699|NCT00926809|Lansoprazole|lansoprazole|mesh-list
56634700|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
56634701|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56634702|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56634703|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634704|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56634705|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634706|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634707|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56634708|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56634709|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56634710|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56634711|NCT02805920|Bupivacaine|bupivacaine|mesh-list
56634712|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
56634713|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
56634714|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634715|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634716|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
56634717|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532141|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634719|NCT04262765|Ramipril|ramipril|mesh-list
56634720|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56634721|NCT04262765|Atorvastatin|atorvastatin|mesh-list
56634722|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56634723|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56634724|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
56634725|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634726|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56634727|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56634728|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634729|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56634730|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56634731|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634732|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56634733|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634734|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
56634735|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56634736|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
56634737|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
56634738|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56634739|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56634740|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56634741|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634742|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634743|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
56634744|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634745|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634780|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634782|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56634783|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634784|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56634785|NCT00926965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56635165|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635167|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635168|NCT02727738|Trace Elements|trace elements|mesh-ancestor
56635169|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
56635170|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
56635171|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
56635172|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635173|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56635174|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
56635175|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
56635176|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56635177|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635178|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56635179|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56635180|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56635181|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56635182|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635183|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56635184|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56635185|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56635186|NCT02811692|Aflibercept|aflibercept|mesh-list
56635187|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56635188|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56635189|NCT02811692|Growth Substances|growth substances|mesh-ancestor
56635190|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635191|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
56635192|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635193|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
56635194|NCT04004078|Clotrimazole|clotrimazole|mesh-list
56635195|NCT04004078|Miconazole|miconazole|mesh-list
56635196|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635197|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56635198|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56635199|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56635200|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635201|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635202|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56532142|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532143|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532144|NCT01200342|Paclitaxel|paclitaxel|mesh-list
56532145|NCT01200342|Carboplatin|carboplatin|mesh-list
56635203|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
56635204|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635205|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635206|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56635207|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56635209|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56635210|NCT02732262|Narcotics|narcotics|mesh-ancestor
56635211|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635212|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635213|NCT02732262|Analgesics|analgesics|mesh-ancestor
56635214|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
56635215|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635216|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56635217|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
56635218|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56635219|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56635220|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56635221|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635222|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635223|NCT02737254|Oxytocin|oxytocin|mesh-list
56635224|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
56635225|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56635343|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
56635344|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635345|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
56635346|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635347|NCT02726490|Metformin|metformin|mesh-list
56635544|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56635545|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
56635546|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635547|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635548|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56635549|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
56635550|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
56635551|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635552|NCT02795546|Alendronate|alendronate|mesh-list
56635553|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56635554|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635625|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635626|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635627|NCT02800694|Analgesics|analgesics|mesh-ancestor
56635628|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
56635629|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635630|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56635631|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56635632|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
56635633|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
56635701|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
56635702|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635703|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635704|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
56635705|NCT02719392|Minocycline|minocycline|mesh-list
56635706|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56635707|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
56635740|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635741|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56635742|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635744|NCT02715960|Tretinoin|tretinoin|mesh-list
56635745|NCT02715960|Acitretin|acitretin|mesh-list
56635746|NCT02715960|Vitamins|vitamins|mesh-ancestor
56635747|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
56635748|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635749|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635750|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
56635751|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
56635752|NCT03983018|Rituximab|rituximab|mesh-list
56480440|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
56635788|NCT00563797|Mecamylamine|mecamylamine|mesh-list
56635789|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56635790|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56635791|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
56635792|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635793|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480472|NCT04736901|Enoxaparin|enoxaparin|mesh-list
56635827|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
56635859|NCT02715336|Leuprolide|leuprolide|mesh-list
56635860|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56635861|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
56635862|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56635863|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635864|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56635865|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635866|NCT02794610|Tacrolimus|tacrolimus|mesh-list
56635867|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56635868|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
56635869|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635870|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56635871|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635872|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635944|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635945|NCT00939757|Urological Agents|urological agents|mesh-ancestor
56635946|NCT05415644|Metformin|metformin|mesh-list
56636062|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56636063|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636064|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636065|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56636066|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
56636067|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636068|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56636069|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56636070|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636071|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636072|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56636103|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
56636104|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56636105|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
56636106|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56636107|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636108|NCT00941161|Metformin|metformin|mesh-list
56636109|NCT00941161|Glimepiride|glimepiride|mesh-list
56636110|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56636111|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636112|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56636113|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56636114|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
56636115|NCT00944515|Azithromycin|azithromycin|mesh-list
56636116|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56636117|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636156|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636191|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636193|NCT00925769|Capecitabine|capecitabine|mesh-list
56636194|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56480922|NCT00532688|Expectorants|expectorants|mesh-ancestor
56480923|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
56636261|NCT02798510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636262|NCT02798510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636263|NCT02798510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56636264|NCT02798510|Immunologic Factors|immunologic factors|mesh-ancestor
56636265|NCT02798510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636266|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56636267|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56636268|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
56636269|NCT00941473|Hormones|hormones|mesh-ancestor
56636270|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636271|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480966|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
56636305|NCT00770679|Atorvastatin|atorvastatin|mesh-list
56636306|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56636307|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56636308|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
56636309|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636310|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56636311|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56532146|NCT01200342|Oblimersen|oblimersen|mesh-list
56532147|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56636347|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
56636348|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636349|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636351|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56636352|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
56636353|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636354|NCT04964843|Expectorants|expectorants|mesh-ancestor
56481032|NCT00534261|Interferons|interferons|mesh-list
56636389|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56636391|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56636392|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481059|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56481060|NCT05201300|Propofol|propofol|mesh-list
56481061|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56481062|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481063|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481064|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56481065|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
56481091|NCT05132153|Milrinone|milrinone|mesh-list
56636523|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636525|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56636526|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56636527|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56636528|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56481232|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
56636597|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636632|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56636633|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56636634|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56636635|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636704|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
56636705|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636706|NCT00943501|Liraglutide|liraglutide|mesh-list
56636707|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56636708|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636709|NCT00943501|Incretins|incretins|mesh-ancestor
56636711|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636712|NCT04258241|Bupivacaine|bupivacaine|mesh-list
56636713|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
56636714|NCT04258241|Anesthetics|anesthetics|mesh-list
56636715|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56636716|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636717|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636718|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
56636719|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636826|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636861|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636862|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56636863|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56636864|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636865|NCT04236050|Rocuronium|rocuronium|mesh-list
56636866|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56636867|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56481587|NCT00536276|Vitamin D|vitamin d|mesh-list
56636902|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636903|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
56636905|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56636906|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56636978|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636979|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
56636980|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56636981|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56636982|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56636983|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56636984|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636985|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
56636986|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636987|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532148|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532149|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
56186343|NCT01436825|Factor VIII|factor viii|mesh-list
56637048|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
56637049|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
56637050|NCT03083678|Afatinib|afatinib|mesh-list
56637051|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637052|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56637053|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637054|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637055|NCT04232150|Midazolam|midazolam|mesh-list
56637056|NCT04232150|Anesthetics|anesthetics|mesh-list
56637057|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637058|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637059|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56637060|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56637061|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56637062|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56637063|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637064|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56637194|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637196|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
56637197|NCT02783144|BB 1101|bb 1101|mesh-list
56637198|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637199|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
56637200|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
56637201|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637202|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637235|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56637236|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56637237|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637238|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637239|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
56637240|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56637241|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637242|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56637275|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637276|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637277|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56637278|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56637279|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
56637280|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56637281|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
56637282|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
56637283|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
56637284|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56637285|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
56637407|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637408|NCT02546934|Gemcitabine|gemcitabine|mesh-list
56637409|NCT02546934|Cisplatin|cisplatin|mesh-list
56637410|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637411|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56637412|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
56637413|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482307|NCT02503839|Etoricoxib|etoricoxib|mesh-list
56637472|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
56637474|NCT02600247|Celecoxib|celecoxib|mesh-list
56637475|NCT02600247|Pregabalin|pregabalin|mesh-list
56637476|NCT02600247|Oxycodone|oxycodone|mesh-list
56637477|NCT02600247|Tramadol|tramadol|mesh-list
56637478|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56637479|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56637480|NCT02600247|Analgesics|analgesics|mesh-ancestor
56637481|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
56637482|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637483|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637484|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
56637485|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
56637486|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56637487|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56637488|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637489|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56637490|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56532150|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
56532151|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
56532152|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532153|NCT05392452|Insulin|insulin|mesh-list
56532154|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56532155|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532156|NCT01198548|Vitamin D|vitamin d|mesh-list
56532157|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
56532158|NCT01198548|Leucovorin|leucovorin|mesh-list
56532159|NCT01198548|Bevacizumab|bevacizumab|mesh-list
56532160|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56532161|NCT01198548|Fluorouracil|fluorouracil|mesh-list
56637491|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56637492|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637493|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637494|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56637495|NCT02600247|Narcotics|narcotics|mesh-ancestor
56482377|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637532|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56637533|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
56637534|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637573|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56637574|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56637607|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637608|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56637609|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56637610|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
56637611|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637612|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56637613|NCT02721888|Liraglutide|liraglutide|mesh-list
56637614|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56637615|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637616|NCT02721888|Incretins|incretins|mesh-ancestor
56637617|NCT02721888|Hormones|hormones|mesh-ancestor
56482476|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637870|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
56637871|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
56637872|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637873|NCT00917397|Sertraline|sertraline|mesh-list
56637874|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
56482812|NCT04656951|Daratumumab|daratumumab|mesh-list
56637946|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56637947|NCT00555217|Protective Agents|protective agents|mesh-ancestor
56637948|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637949|NCT02711904|Remifentanil|remifentanil|mesh-list
56637950|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56637951|NCT02711904|Narcotics|narcotics|mesh-ancestor
56637952|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637990|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
56637991|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637992|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637993|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56638090|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
56638091|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56638092|NCT00554515|Aldesleukin|aldesleukin|mesh-list
56638093|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638094|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56638095|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56638096|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
56638097|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638132|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56638133|NCT02711670|Diuretics|diuretics|mesh-ancestor
56638134|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
56638135|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638136|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56638137|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532162|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
56532163|NCT01198548|Antibodies|antibodies|mesh-list
56532164|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
56532165|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56532166|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
56532167|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532168|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56532169|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56532170|NCT01198548|Growth Substances|growth substances|mesh-ancestor
56532171|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532172|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
56532173|NCT01198548|Vitamins|vitamins|mesh-ancestor
56532174|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
56280392|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
56532175|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
56186358|NCT01436916|Vitamins|vitamins|mesh-ancestor
56638138|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638175|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638200|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56638201|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638202|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
56638203|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
56638204|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56638205|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638206|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56638207|NCT02711358|Indomethacin|indomethacin|mesh-list
56638208|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56638209|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56638210|NCT02711358|Analgesics|analgesics|mesh-ancestor
56638211|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
56638212|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638213|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638214|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56638215|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638216|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
56638217|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
56638218|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56638219|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56638220|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638221|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638222|NCT04962152|Nalbuphine|nalbuphine|mesh-list
56638223|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56638224|NCT04962152|Narcotics|narcotics|mesh-ancestor
56638225|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483149|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
56638358|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
56638359|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56638360|NCT00952159|Narcotics|narcotics|mesh-ancestor
56638361|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638362|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638363|NCT00952159|Analgesics|analgesics|mesh-ancestor
56638364|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
56638365|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638366|NCT05200988|Nivolumab|nivolumab|mesh-list
56638367|NCT05200988|Ipilimumab|ipilimumab|mesh-list
56638368|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56638369|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638370|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56638371|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638372|NCT00948727|Cyclosporine|cyclosporine|mesh-list
56638373|NCT00948727|Cyclosporins|cyclosporins|mesh-list
56638374|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532176|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56532177|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56532178|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
56638375|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638408|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638409|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638410|NCT00562159|Fluticasone|fluticasone|mesh-list
56638412|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
56638413|NCT00562159|Loratadine|loratadine|mesh-list
56638414|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56638415|NCT00562159|Prednisone|prednisone|mesh-list
56638416|NCT00562159|Albuterol|albuterol|mesh-list
56638417|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56638418|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
56638419|NCT00562159|Hormones|hormones|mesh-ancestor
56638420|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56638452|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
56638453|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638454|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638456|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56638457|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
56638458|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638459|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
56638460|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638461|NCT00952627|Protective Agents|protective agents|mesh-ancestor
56638462|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56638463|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56638528|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56638529|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
56638530|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638531|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638532|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
56638533|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638534|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56638535|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56638536|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
56638537|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56638538|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638539|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638540|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
56638541|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56638542|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
56638543|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56638571|NCT02709720|Vinorelbine|vinorelbine|mesh-list
56638572|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638573|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56638574|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
56638575|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
56638576|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
56638577|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638578|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
56638579|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
56638580|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638581|NCT02779634|Vitamins|vitamins|mesh-ancestor
56638582|NCT04255589|Ethanol|ethanol|mesh-list
56638583|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56638584|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638585|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638586|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638587|NCT00744471|Tanezumab|tanezumab|mesh-list
56638588|NCT00744471|Analgesics|analgesics|mesh-ancestor
56638589|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
56638590|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638591|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638592|NCT02776436|Dexamethasone|dexamethasone|mesh-list
56638661|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638662|NCT02775734|Expectorants|expectorants|mesh-ancestor
56638663|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
56638664|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56638665|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
56638666|NCT02775734|Protective Agents|protective agents|mesh-ancestor
56638667|NCT02775734|Antidotes|antidotes|mesh-ancestor
56532179|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532180|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56532181|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532182|NCT01198548|Antidotes|antidotes|mesh-ancestor
56532183|NCT01198548|Protective Agents|protective agents|mesh-ancestor
56638668|NCT02772926|Benphothiamine|benphothiamine|mesh-list
56638669|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56638670|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
56638671|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638672|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
56638673|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
56638674|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638675|NCT02709564|Misoprostol|misoprostol|mesh-list
56638676|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56638677|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
56638678|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56638679|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638680|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56638681|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56638682|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
56638683|NCT04688814|Morphine|morphine|mesh-list
56638684|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56638685|NCT04688814|Narcotics|narcotics|mesh-ancestor
56483521|NCT03910998|Rocuronium|rocuronium|mesh-list
56638709|NCT04821284|Leucovorin|leucovorin|mesh-list
56638710|NCT04821284|Gemcitabine|gemcitabine|mesh-list
56638711|NCT04821284|Paclitaxel|paclitaxel|mesh-list
56638712|NCT04821284|Fluorouracil|fluorouracil|mesh-list
56638713|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
56638714|NCT04821284|Irinotecan|irinotecan|mesh-list
56638715|NCT04821284|Calcium|calcium|mesh-list
56638716|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
56638717|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56638718|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638719|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
56638720|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
56638721|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
56284605|NCT00388882|Bromides|bromides|mesh-list
56638722|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638723|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56638724|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
56638725|NCT04821284|Antiviral Agents|antiviral agents|mesh-ancestor
56638726|NCT04821284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638727|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638728|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638729|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
56638730|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638731|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56638732|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56638733|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56638734|NCT04821284|Antidotes|antidotes|mesh-ancestor
56638735|NCT04821284|Protective Agents|protective agents|mesh-ancestor
56638736|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
56638737|NCT04821284|Vitamins|vitamins|mesh-ancestor
56483543|NCT04246684|Leucovorin|leucovorin|mesh-list
56638769|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638770|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56638771|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56638772|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
56638773|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
56638774|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638775|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56638776|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56638777|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638778|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638779|NCT00743145|Naltrexone|naltrexone|mesh-list
56638780|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56638781|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56638782|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638783|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
56638805|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638806|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56532184|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
56532186|NCT00977938|Clopidogrel|clopidogrel|mesh-list
56532187|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56532188|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56532189|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532190|NCT00977938|Analgesics|analgesics|mesh-ancestor
56532191|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
56532192|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532193|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532194|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532195|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532196|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56532197|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56532198|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532199|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56532200|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56532201|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532202|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
56532203|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56532204|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56532205|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56532206|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
56532207|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532208|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56532209|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532210|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532211|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532212|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532213|NCT04290208|Acetaminophen|acetaminophen|mesh-list
56532214|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532215|NCT04290208|Analgesics|analgesics|mesh-ancestor
56532216|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
56186379|NCT01437046|Doxazosin|doxazosin|mesh-list
56638808|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638809|NCT02775500|Apremilast|apremilast|mesh-list
56638810|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56638811|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56638812|NCT02775500|Analgesics|analgesics|mesh-ancestor
56638813|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
56638814|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532217|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532218|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532219|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
56532220|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56532221|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532222|NCT01090011|Cetuximab|cetuximab|mesh-list
56532223|NCT01090011|Afatinib|afatinib|mesh-list
56638815|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638816|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56638817|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638818|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56638819|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56638820|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638821|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638822|NCT04251845|Melatonin|melatonin|mesh-list
56638823|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
56638824|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638825|NCT04251845|Protective Agents|protective agents|mesh-ancestor
56638826|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638827|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638828|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
56638829|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
56638830|NCT05207358|Rituximab|rituximab|mesh-list
56638831|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638832|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
56638833|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638923|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638924|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56638925|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56638926|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
56638927|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
56638959|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638961|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56638962|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
56638963|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
56638964|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638965|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638966|NCT04181385|Bromocriptine|bromocriptine|mesh-list
56638967|NCT04181385|Olanzapine|olanzapine|mesh-list
56638968|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
56638969|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
56483743|NCT05239182|Gemcitabine|gemcitabine|mesh-list
56638999|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639000|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639002|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56639003|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
56639004|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639005|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639006|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56639007|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
56639008|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56639009|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639010|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639011|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
56483776|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
56639042|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56639043|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
56639044|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639045|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56639046|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56639047|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
56639048|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56639049|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
56639050|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
56639051|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
56639052|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56639053|NCT03521232|Niclosamide|niclosamide|mesh-list
56639054|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
56639055|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56639056|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
56532224|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56532225|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532226|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532227|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532228|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532229|NCT03923725|Artesunate|artesunate|mesh-list
56532230|NCT03923725|Lumefantrine|lumefantrine|mesh-list
56532231|NCT03923725|Artemether|artemether|mesh-list
56532232|NCT03923725|Piperaquine|piperaquine|mesh-list
56532233|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56532234|NCT03923725|Amodiaquine|amodiaquine|mesh-list
56532235|NCT03923725|Mefloquine|mefloquine|mesh-list
56532236|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
56532237|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56639123|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
56639124|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639125|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56639126|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56639127|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
56639128|NCT02773472|Morphine|morphine|mesh-list
56639129|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56639130|NCT02773472|Narcotics|narcotics|mesh-ancestor
56639131|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639132|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639133|NCT02773472|Analgesics|analgesics|mesh-ancestor
56639134|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
56639135|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639136|NCT04891770|Tenofovir|tenofovir|mesh-list
56639137|NCT04891770|Nivolumab|nivolumab|mesh-list
56639138|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56639139|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639140|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56639141|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639142|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
56639143|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483879|NCT00537966|Abacavir|abacavir|mesh-list
56639203|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
56639204|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56639205|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
56639206|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639207|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639208|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56639209|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
56639210|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
56639211|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56639212|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
56639213|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639214|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639215|NCT02696720|Lidocaine|lidocaine|mesh-list
56639216|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
56639217|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
56639218|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639219|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639220|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
56639221|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639222|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56639223|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56483950|NCT00545493|Tacrolimus|tacrolimus|mesh-list
56639251|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
56639252|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639253|NCT00643149|Amoxicillin|amoxicillin|mesh-list
56639254|NCT00643149|Azithromycin|azithromycin|mesh-list
56473643|NCT00523887|Fentanyl|fentanyl|mesh-list
56532238|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56532239|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532240|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532241|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
56532242|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
56532243|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56532244|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
56532245|NCT02877615|S44819|s44819|mesh-list
56532246|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
56532247|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
56532248|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
56532249|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532250|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532251|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532253|NCT02437279|Ipilimumab|ipilimumab|mesh-list
56532254|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56532255|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532256|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56532257|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532258|NCT01251653|Gemcitabine|gemcitabine|mesh-list
56532259|NCT01251653|Docetaxel|docetaxel|mesh-list
56532260|NCT01251653|Afatinib|afatinib|mesh-list
56532261|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56532262|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
56532263|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532264|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532265|NCT01251653|Antiviral Agents|antiviral agents|mesh-ancestor
56532266|NCT01251653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639255|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56639256|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639257|NCT05141682|Azacitidine|azacitidine|mesh-list
56639258|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56639259|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
56639260|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639261|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639262|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639263|NCT00643227|Azithromycin|azithromycin|mesh-list
56639264|NCT00643227|Clarithromycin|clarithromycin|mesh-list
56639265|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56639266|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639267|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56639268|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639269|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639296|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56639297|NCT02767154|Diuretics|diuretics|mesh-ancestor
56639298|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
56639299|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639300|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
56532267|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532268|NCT01251653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532269|NCT01251653|Immunologic Factors|immunologic factors|mesh-ancestor
56532270|NCT01251653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532271|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
56532272|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
56532273|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
56532274|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532275|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
56532276|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56639301|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
56639302|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
56639303|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56639304|NCT02767232|Plasminogen|plasminogen|mesh-list
56639305|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56639306|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56639307|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639308|NCT02767076|Anesthetics|anesthetics|mesh-list
56639309|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639310|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639311|NCT04325802|Naltrexone|naltrexone|mesh-list
56639312|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56639313|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56639314|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639315|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
56639316|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639317|NCT02766764|Hormones|hormones|mesh-list
56484002|NCT01266148|Cyclosporine|cyclosporine|mesh-list
56639352|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
56639353|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56639354|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639355|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56639356|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56639357|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
56639358|NCT02770430|Infliximab|infliximab|mesh-list
56639359|NCT02770430|Basiliximab|basiliximab|mesh-list
56639424|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56639425|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
56639426|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
56639427|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56639428|NCT02770274|Protective Agents|protective agents|mesh-ancestor
56639453|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639454|NCT04224350|Tacrolimus|tacrolimus|mesh-list
56639455|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56639456|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
56639457|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639458|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56639459|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639460|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639461|NCT02770716|Terlipressin|terlipressin|mesh-list
56639462|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56639463|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56639464|NCT04846829|Citalopram|citalopram|mesh-list
56639465|NCT04846829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56639466|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56639467|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56639468|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639469|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639470|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
56639471|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639472|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56639473|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
56639474|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56639475|NCT02672241|Temozolomide|temozolomide|mesh-list
56639476|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
56639477|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56532277|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532278|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56532279|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
56532280|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56532281|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532282|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532283|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532284|NCT01077375|Milnacipran|milnacipran|mesh-list
56532285|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
56532286|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56186470|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639478|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
56639509|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639510|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
56639511|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
56639512|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
56639513|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639515|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639516|NCT04177641|Protective Agents|protective agents|mesh-ancestor
56639517|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639518|NCT04178109|Acetaminophen|acetaminophen|mesh-list
56639519|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56639520|NCT04178109|Tramadol|tramadol|mesh-list
56639521|NCT04178109|Ropivacaine|ropivacaine|mesh-list
56639522|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
56639595|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639596|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56639597|NCT00915473|Protective Agents|protective agents|mesh-ancestor
56639598|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56639599|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639600|NCT04691726|Dipyrone|dipyrone|mesh-list
56639601|NCT04691726|Lidocaine|lidocaine|mesh-list
56639602|NCT04691726|Morphine|morphine|mesh-list
56639634|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639635|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639636|NCT04177173|Methotrexate|methotrexate|mesh-list
56639637|NCT04177173|Simvastatin|simvastatin|mesh-list
56639638|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56639639|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
56639640|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56639641|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639642|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56639643|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
56639644|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639645|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639646|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
56639647|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639648|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56639674|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639675|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639676|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
56639677|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56639678|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639679|NCT03479502|Doxycycline|doxycycline|mesh-list
56639680|NCT03479502|Prednisone|prednisone|mesh-list
56639681|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
56639682|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56639683|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56639684|NCT03479502|Prednisolone|prednisolone|mesh-list
56639685|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
56639686|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56639687|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
56639688|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532287|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56532288|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532289|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532290|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532291|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532292|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532293|NCT01077375|Analgesics|analgesics|mesh-ancestor
56639689|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
56639690|NCT03479502|Hormones|hormones|mesh-ancestor
56639691|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639692|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639693|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56639694|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639695|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
56639696|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
56639697|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639698|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56639731|NCT00644943|Amoxicillin|amoxicillin|mesh-list
56639732|NCT00644943|Cefdinir|cefdinir|mesh-list
56639733|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56639734|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639735|NCT02762006|Durvalumab|durvalumab|mesh-list
56639736|NCT02762006|Tremelimumab|tremelimumab|mesh-list
56639737|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56639738|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639739|NCT02769884|Pancrelipase|pancrelipase|mesh-list
56639740|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56639741|NCT05213507|Amikacin|amikacin|mesh-list
56639742|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56484329|NCT01310192|Choline|choline|mesh-list
56639806|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639807|NCT02769572|Diclofenac|diclofenac|mesh-list
56639808|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56639809|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56639810|NCT02769572|Analgesics|analgesics|mesh-ancestor
56639811|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
56639812|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639813|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484409|NCT00546741|Metformin|metformin|mesh-list
56639848|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56639849|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56639850|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
56639851|NCT02765204|Saxagliptin|saxagliptin|mesh-list
56639852|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56639853|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639854|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56484440|NCT02231723|Leucovorin|leucovorin|mesh-list
56639883|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639884|NCT03342456|Expectorants|expectorants|mesh-ancestor
56639885|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
56639886|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56639887|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56639888|NCT03342456|Renal Agents|renal agents|mesh-ancestor
56639889|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56639890|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56639891|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639892|NCT04666649|Venetoclax|venetoclax|mesh-list
56639893|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639894|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56639895|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
56639896|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56639897|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
56639898|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639899|NCT02769104|Docetaxel|docetaxel|mesh-list
56639900|NCT02769104|Letrozole|letrozole|mesh-list
56639901|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56639902|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639903|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
56639934|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532294|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
56532295|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532296|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
56532297|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56639935|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56639936|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56639937|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56639938|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56639939|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56639941|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56639942|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
56639943|NCT04679012|Hormones|hormones|mesh-ancestor
56639944|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639945|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56639946|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56639947|NCT00910455|SRX246|srx246|mesh-list
56484498|NCT04681937|Protective Agents|protective agents|mesh-ancestor
56640015|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640016|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
56640017|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
56640018|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
56640019|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640020|NCT00647049|Cytarabine|cytarabine|mesh-list
56640021|NCT00647049|Rituximab|rituximab|mesh-list
56640022|NCT00647049|Methotrexate|methotrexate|mesh-list
56640023|NCT00647049|Thiotepa|thiotepa|mesh-list
56640024|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640025|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640026|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
56640051|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
56640052|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640053|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640054|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640055|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
56640056|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56640057|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56640058|NCT04172727|Bupivacaine|bupivacaine|mesh-list
56640059|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
56640060|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
56640061|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640062|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640063|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
56640064|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640065|NCT04648319|Nivolumab|nivolumab|mesh-list
56640066|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56547612|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56640068|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56640069|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640070|NCT00647127|Fentanyl|fentanyl|mesh-list
56640071|NCT00647127|Buprenorphine|buprenorphine|mesh-list
56640072|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56640073|NCT00647127|Narcotics|narcotics|mesh-ancestor
56640074|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640075|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640135|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56640136|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56640137|NCT02760992|Baclofen|baclofen|mesh-list
56640138|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56640139|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640140|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56547613|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
56640141|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640142|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56640143|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
56640144|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
56640145|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640146|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484682|NCT00534846|Toremifene|toremifene|mesh-list
56640175|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56640176|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640177|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56532298|NCT02877771|Insulin|insulin|mesh-list
56640178|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56640179|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640180|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56640181|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56640182|NCT02536989|Omeprazole|omeprazole|mesh-list
56640183|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56640184|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640185|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56640186|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640187|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640188|NCT00647829|Valdecoxib|valdecoxib|mesh-list
56640189|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56640190|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56640191|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640192|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640193|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56640278|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56640279|NCT00648141|Analgesics|analgesics|mesh-ancestor
56640280|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
56640281|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640282|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640283|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640284|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640285|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56640286|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56640287|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640288|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640289|NCT00953641|Misoprostol|misoprostol|mesh-list
56640290|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56640291|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
56640292|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640293|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640294|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56640295|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640296|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
56640297|NCT02763098|Remifentanil|remifentanil|mesh-list
56640298|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56640299|NCT02763098|Narcotics|narcotics|mesh-ancestor
56640300|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640301|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640302|NCT02763098|Analgesics|analgesics|mesh-ancestor
56640303|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
56640304|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640305|NCT00648219|Olmesartan|olmesartan|mesh-list
56640306|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56640307|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56640308|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56640309|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56640334|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640335|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640336|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640337|NCT00549445|Azithromycin|azithromycin|mesh-list
56640338|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56640339|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640341|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640342|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56640343|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640344|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640345|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
56640346|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56640347|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640348|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56640349|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56640350|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640351|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640352|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640353|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56640354|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56640355|NCT02758340|Misoprostol|misoprostol|mesh-list
56640356|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56640357|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
56532299|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56532300|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640447|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56640448|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56640449|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640450|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
56640451|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56640452|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56640453|NCT02659293|Growth Substances|growth substances|mesh-ancestor
56640454|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
56640455|NCT03039036|Misoprostol|misoprostol|mesh-list
56640456|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56640457|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
56640458|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640459|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640460|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56640461|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640462|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
56640463|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56640464|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
56640465|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56640466|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56640467|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484963|NCT04043494|Hormones|hormones|mesh-ancestor
56640500|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
56640501|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640502|NCT00954811|Progesterone|progesterone|mesh-list
56640503|NCT00954811|Progestins|progestins|mesh-ancestor
56640504|NCT00954811|Hormones|hormones|mesh-ancestor
56640505|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56640506|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640507|NCT00954889|Tamsulosin|tamsulosin|mesh-list
56640541|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
56640542|NCT02692248|Hormones|hormones|mesh-ancestor
56640543|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56640544|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56640545|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56640546|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
56485009|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
56640575|NCT00955045|Istradefylline|istradefylline|mesh-list
56640576|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56640577|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56640578|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56640579|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
56640580|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640581|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640582|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286510|NCT00423475|Goserelin|goserelin|mesh-list
56640583|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56640584|NCT00601107|Vitamins|vitamins|mesh-ancestor
56640585|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
56640586|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640587|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56640588|NCT00957385|Lenalidomide|lenalidomide|mesh-list
56640589|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
56485043|NCT00535353|Irinotecan|irinotecan|mesh-list
56640645|NCT00649311|Diuretics|diuretics|mesh-ancestor
56640646|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
56640647|NCT02704494|Losartan|losartan|mesh-list
56640648|NCT02704494|Resveratrol|resveratrol|mesh-list
56640649|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56640650|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56640651|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56640652|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56640653|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640654|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
56640655|NCT02704494|Protective Agents|protective agents|mesh-ancestor
56640656|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547615|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56640684|NCT02658435|Tafenoquine|tafenoquine|mesh-list
56640685|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
56640686|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56640687|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56532301|NCT04306653|Betamethasone|betamethasone|mesh-list
56186495|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
56640688|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640689|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
56640690|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
56640691|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
56640692|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56640693|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
56640694|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640695|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640696|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56640697|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
56640698|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640699|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640700|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56640701|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640702|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
56640703|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56640704|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56640705|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640706|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640707|NCT02752724|Ketamine|ketamine|mesh-list
56640708|NCT02752724|Methohexital|methohexital|mesh-list
56640709|NCT02752724|Analgesics|analgesics|mesh-ancestor
56485157|NCT03126591|Olaratumab|olaratumab|mesh-list
56640744|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
56640745|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640746|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56640747|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56485184|NCT02897765|Nivolumab|nivolumab|mesh-list
56640776|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56640777|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56640779|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
56640780|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640781|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640782|NCT02756000|Protective Agents|protective agents|mesh-ancestor
56640783|NCT02759510|Phenylephrine|phenylephrine|mesh-list
56640784|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
56640785|NCT02759510|Norepinephrine|norepinephrine|mesh-list
56640786|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56640787|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
56640788|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
56640789|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640790|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640791|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
56640792|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56640846|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
56640847|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56640848|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640849|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640850|NCT02755298|Diuretics|diuretics|mesh-ancestor
56640851|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
56640852|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640853|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56640854|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56640855|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56640856|NCT02759198|Celecoxib|celecoxib|mesh-list
56640857|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56640858|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56640859|NCT02759198|Analgesics|analgesics|mesh-ancestor
56640860|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
56640861|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640862|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640863|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640864|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640865|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56640866|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56640867|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640868|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640869|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
56640870|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
56640871|NCT02755064|Erythromycin|erythromycin|mesh-list
56640872|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
56640873|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56640874|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
56640875|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
56532302|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532303|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
56640876|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56640877|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286791|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640878|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640879|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56640880|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640881|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640907|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56640908|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56640909|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56640910|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56640911|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56640912|NCT02754596|Timolol|timolol|mesh-list
56640913|NCT02754596|Travoprost|travoprost|mesh-list
56640914|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56640915|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56640916|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640917|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56640918|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56640919|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56640920|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640921|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640922|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56640923|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56640924|NCT02706054|Meloxicam|meloxicam|mesh-list
56640925|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56640926|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56640927|NCT02706054|Analgesics|analgesics|mesh-ancestor
56640928|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
56640929|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640930|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640931|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640932|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640967|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
56640968|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
56640969|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
56640970|NCT03373188|Nivolumab|nivolumab|mesh-list
56640971|NCT03373188|Ipilimumab|ipilimumab|mesh-list
56640972|NCT03373188|Antibodies|antibodies|mesh-list
56640973|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56640974|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
56640975|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640976|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640977|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640978|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56641045|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641046|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56641048|NCT02753738|Citalopram|citalopram|mesh-list
56641049|NCT02753738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56641050|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56641051|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641052|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641053|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641054|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
56641055|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641056|NCT02753738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56641057|NCT02753738|Antidepressive Agents|antidepressive agents|mesh-ancestor
56641124|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641125|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641126|NCT04486118|Lisinopril|lisinopril|mesh-list
56641127|NCT04486118|Benazepril|benazepril|mesh-list
56641128|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56641129|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
56641130|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641131|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641132|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56641164|NCT00914849|Plerixafor|plerixafor|mesh-list
56641165|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56641166|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56532304|NCT04306653|Hormones|hormones|mesh-ancestor
56532305|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532306|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532307|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56532308|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
56532309|NCT04306731|Trimethoprim|trimethoprim|mesh-list
56532310|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56532311|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532312|NCT04306731|Renal Agents|renal agents|mesh-ancestor
56532313|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
56532314|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56532315|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56532316|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56532317|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532318|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532319|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56532320|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56641167|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
56641168|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641169|NCT02704962|Olanzapine|olanzapine|mesh-list
56641170|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
56641171|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
56641172|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641173|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641174|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56641175|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56641176|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56641177|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641273|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641274|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56641275|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56641276|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56641277|NCT04643093|Ezetimibe|ezetimibe|mesh-list
56641278|NCT04643093|Pitavastatin|pitavastatin|mesh-list
56641279|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56641280|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56641281|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
56641368|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56641369|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56641370|NCT04417049|Protective Agents|protective agents|mesh-ancestor
56641371|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641372|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
56641373|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56641374|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
56641375|NCT04911062|Epinephrine|epinephrine|mesh-list
56641376|NCT04911062|Bupivacaine|bupivacaine|mesh-list
56641377|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
56641378|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
56641379|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641380|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641381|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
56641382|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641383|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56641384|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56641385|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
56641386|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641387|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532321|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56532322|NCT02877537|Albuterol|albuterol|mesh-list
56270808|NCT01998763|Vitamin D|vitamin d|mesh-list
56641388|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56485743|NCT05427383|Paclitaxel|paclitaxel|mesh-list
56641414|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641415|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56641416|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56641417|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641418|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641419|NCT02700906|Lidocaine|lidocaine|mesh-list
56641420|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
56641421|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
56641422|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641423|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641424|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
56641425|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641426|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56641427|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56641428|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56641429|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641430|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641431|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
56641432|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56641433|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56641434|NCT00636038|Beta Carotene|beta carotene|mesh-list
56641435|NCT00636038|Carotenoids|carotenoids|mesh-list
56641436|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
56641437|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485770|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
56641515|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56641516|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56641517|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
56641518|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56641519|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
56641520|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56641521|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56641522|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56641523|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641524|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641525|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641526|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
56641527|NCT02749292|Rituximab|rituximab|mesh-list
56641528|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641529|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641530|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
56641531|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641532|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56641533|NCT04217096|Paclitaxel|paclitaxel|mesh-list
56641534|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641535|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641536|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641537|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641538|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
56641539|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641540|NCT04219982|Scopolamine|scopolamine|mesh-list
56641576|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641577|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641578|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641605|NCT02749136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641606|NCT02749136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641607|NCT02749136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56641608|NCT02749136|Immunologic Factors|immunologic factors|mesh-ancestor
56641609|NCT02749136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641610|NCT00631631|Mifamurtide|mifamurtide|mesh-list
56641611|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56641612|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
56641613|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641614|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
56641615|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
56641616|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56641617|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532323|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56532324|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
56532325|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532326|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532327|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56532328|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
56186517|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56641618|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641619|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
56641620|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56641621|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641622|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641623|NCT04238741|Anesthetics|anesthetics|mesh-list
56641624|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641625|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641626|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
56641663|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641664|NCT05411978|Protective Agents|protective agents|mesh-ancestor
56641665|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641666|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
56641667|NCT00617370|Paclitaxel|paclitaxel|mesh-list
56641668|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
56641669|NCT00617370|Epirubicin|epirubicin|mesh-list
56641670|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641671|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641672|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641728|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56641729|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56641730|NCT00617448|Anesthetics|anesthetics|mesh-list
56641731|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641732|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641733|NCT04308863|Chitosan|chitosan|mesh-list
56641734|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641735|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56641736|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56641737|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
56641738|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56641739|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
56641740|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
56641741|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
56641742|NCT04308863|Coagulants|coagulants|mesh-ancestor
56641743|NCT00615810|Efavirenz|efavirenz|mesh-list
56641744|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56641745|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56641746|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56641747|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641831|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641832|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
56641833|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641834|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641835|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641836|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641838|NCT04677504|Bevacizumab|bevacizumab|mesh-list
56641839|NCT04677504|Atezolizumab|atezolizumab|mesh-list
56641840|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641841|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641842|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56641843|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56641844|NCT04677504|Growth Substances|growth substances|mesh-ancestor
56641845|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641846|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
56641847|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56641848|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
56641849|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641850|NCT04677504|Antiviral Agents|antiviral agents|mesh-ancestor
56641877|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56532330|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56532331|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56532332|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56532333|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56532334|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
56532335|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532336|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532337|NCT01250873|Sertraline|sertraline|mesh-list
56532338|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
56532339|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56532340|NCT01250873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56532341|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56532342|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56186527|NCT01437826|Selenium|selenium|mesh-list
56641878|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641879|NCT02477826|Gemcitabine|gemcitabine|mesh-list
56641880|NCT02477826|Paclitaxel|paclitaxel|mesh-list
56641881|NCT02477826|Carboplatin|carboplatin|mesh-list
56641882|NCT02477826|Nivolumab|nivolumab|mesh-list
56641883|NCT02477826|Pemetrexed|pemetrexed|mesh-list
56641884|NCT02477826|Ipilimumab|ipilimumab|mesh-list
56641885|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641886|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641887|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641888|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641889|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
56641890|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641891|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56641892|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
56641893|NCT02477826|Antiviral Agents|antiviral agents|mesh-ancestor
56641894|NCT02477826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641895|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641896|NCT02477826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56641897|NCT02477826|Immunologic Factors|immunologic factors|mesh-ancestor
56641898|NCT02477826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641899|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641900|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56641901|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56486205|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56641955|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641956|NCT02022098|Cisplatin|cisplatin|mesh-list
56641957|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641958|NCT02746250|Amitriptyline|amitriptyline|mesh-list
56641959|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
56641960|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
56641961|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56641962|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56486296|NCT02465606|Hormones|hormones|mesh-ancestor
56641988|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
56641989|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56641990|NCT04216550|Apatinib|apatinib|mesh-list
56641991|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641992|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641993|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641994|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287924|NCT00001002|Foscarnet|foscarnet|mesh-list
56641995|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
56641996|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56641997|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
56641998|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56641999|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
56642000|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532343|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532344|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532345|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
56532346|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532347|NCT02888327|Oseltamivir|oseltamivir|mesh-list
56532348|NCT02888327|Digoxin|digoxin|mesh-list
56532349|NCT02888327|Midazolam|midazolam|mesh-list
56532350|NCT02888327|Pitavastatin|pitavastatin|mesh-list
56532351|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56532352|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56532353|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532354|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532355|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56532356|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56532357|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56532358|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56532359|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
56532360|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
56642001|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642002|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
56642003|NCT00909857|Dienogest|dienogest|mesh-list
56642004|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56642005|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56642006|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
56642007|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56642008|NCT00909857|Estradiol|estradiol|mesh-list
56642009|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56642010|NCT00909857|Estrogens|estrogens|mesh-ancestor
56642011|NCT00909857|Hormones|hormones|mesh-ancestor
56642034|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56642035|NCT00911807|Protective Agents|protective agents|mesh-ancestor
56642036|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56642037|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56642038|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642039|NCT04117763|Empagliflozin|empagliflozin|mesh-list
56642040|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56642041|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642042|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56642043|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642044|NCT04117451|Propolis|propolis|mesh-list
56642045|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642046|NCT03690089|Atropine|atropine|mesh-list
56642047|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56642048|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56642049|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56642050|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
56642051|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642052|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642053|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56642054|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
56642055|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
56642056|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
56642057|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56642058|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56642059|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
56642060|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642061|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642096|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532361|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
56532362|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
56532363|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532364|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642097|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642099|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56642100|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642101|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56642102|NCT02741414|Amoxicillin|amoxicillin|mesh-list
56486371|NCT03177291|Paclitaxel|paclitaxel|mesh-list
56642128|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56642129|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56642130|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56642131|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56642132|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642134|NCT05629598|Hematinics|hematinics|mesh-ancestor
56642135|NCT02744690|Mitomycins|mitomycins|mesh-list
56642136|NCT02744690|Mitomycin|mitomycin|mesh-list
56642137|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56642138|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642139|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
56642140|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642141|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56642142|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642143|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
56642144|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56642145|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642146|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56642147|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56642148|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56642149|NCT02736032|Estradiol|estradiol|mesh-list
56642150|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56642151|NCT02736032|Progesterone|progesterone|mesh-list
56642152|NCT02736032|Estrogens|estrogens|mesh-ancestor
56642153|NCT02736032|Hormones|hormones|mesh-ancestor
56486405|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56288155|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642220|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642221|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
56642222|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56642223|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56642224|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56642225|NCT02744456|Diuretics|diuretics|mesh-ancestor
56642226|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
56642227|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56642283|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642284|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
56642285|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
56642286|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
56642287|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642288|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56642289|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
56642290|NCT03943667|Antiviral Agents|antiviral agents|mesh-ancestor
56642291|NCT03943667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642292|NCT03943667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642293|NCT03943667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547618|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642326|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56642327|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56642329|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56642330|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642331|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56642332|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56642333|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56642334|NCT02740712|Protective Agents|protective agents|mesh-ancestor
56642335|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56642336|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56642337|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
56642338|NCT02740712|Coagulants|coagulants|mesh-ancestor
56642339|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56642340|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532365|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56532366|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56532367|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532368|NCT02888327|Protective Agents|protective agents|mesh-ancestor
56532369|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
56532370|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532371|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56532372|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56532373|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56532374|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
56532375|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56532376|NCT01248065|Vitamin D|vitamin d|mesh-list
56532377|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
56532378|NCT01248065|Ciclesonide|ciclesonide|mesh-list
56532379|NCT01248065|Vitamins|vitamins|mesh-ancestor
56532380|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
56532381|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532382|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56532383|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56532384|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
56642341|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
56642380|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
56642606|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56642607|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642608|NCT00636428|Midazolam|midazolam|mesh-list
56642609|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56642610|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56642611|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642612|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642613|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56642666|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
56642667|NCT02733458|Antiviral Agents|antiviral agents|mesh-ancestor
56642668|NCT02733458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642669|NCT02733458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288605|NCT00009958|Vaccines|vaccines|mesh-list
56487450|NCT01206439|Nebivolol|nebivolol|mesh-list
56642701|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642702|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642703|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
56642704|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
56642705|NCT02728700|Sirolimus|sirolimus|mesh-list
56642706|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56642707|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642708|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56642709|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
56642710|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56642711|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642712|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642713|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642714|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
56235510|NCT01744379|Lesinurad|lesinurad|mesh-list
56642751|NCT02733380|Doxorubicin|doxorubicin|mesh-list
56642752|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56642753|NCT02733380|Vinorelbine|vinorelbine|mesh-list
56642852|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56642854|NCT02732132|Fentanyl|fentanyl|mesh-list
56642855|NCT02732132|Midazolam|midazolam|mesh-list
56642856|NCT02732132|Ketamine|ketamine|mesh-list
56532385|NCT01248065|Hormones|hormones|mesh-ancestor
56532386|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532387|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56532388|NCT01250756|Vaccines|vaccines|mesh-list
56532389|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56532390|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
56532391|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532392|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
56532393|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56532394|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532395|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532396|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532397|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642857|NCT02732132|Propofol|propofol|mesh-list
56642858|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56642889|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
56642890|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642891|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56642892|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56642893|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56642894|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56642895|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642896|NCT02737124|Acetaminophen|acetaminophen|mesh-list
56642897|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56642898|NCT02737124|Analgesics|analgesics|mesh-ancestor
56642899|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
56642900|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642901|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642902|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
56642903|NCT02721290|Ropivacaine|ropivacaine|mesh-list
56643001|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643036|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643037|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
56643038|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
56643039|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56643040|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643041|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643042|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
56643043|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56643044|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487831|NCT01205581|Vaccines|vaccines|mesh-list
56643102|NCT02718950|Hormones|hormones|mesh-ancestor
56487910|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56643135|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643136|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643137|NCT02718482|Antiviral Agents|antiviral agents|mesh-ancestor
56643138|NCT02718482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643139|NCT02718482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643140|NCT02718482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643141|NCT02718482|Immunologic Factors|immunologic factors|mesh-ancestor
56643142|NCT02718482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643218|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
56643219|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643220|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56643221|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56643222|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56643223|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
56643224|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643225|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532398|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
56532399|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56532400|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56643226|NCT04138316|Candesartan|candesartan|mesh-list
56643227|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56643228|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56643229|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56643230|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643231|NCT05291390|Pyronaridine|pyronaridine|mesh-list
56643232|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
56643233|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56643234|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56643235|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643236|NCT04189484|Evolocumab|evolocumab|mesh-list
56643237|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56643238|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56643239|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56643240|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
56643241|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643242|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56643338|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643339|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643340|NCT00650481|Urological Agents|urological agents|mesh-ancestor
56643341|NCT02712476|Furosemide|furosemide|mesh-list
56643342|NCT02712476|Mannitol|mannitol|mesh-list
56643343|NCT02712476|Diuretics|diuretics|mesh-ancestor
56643344|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
56643345|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643346|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56643347|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56643348|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643349|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56643350|NCT02722538|Gemcitabine|gemcitabine|mesh-list
56643351|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56643352|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
56643353|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643436|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56643438|NCT02650479|Hormones|hormones|mesh-ancestor
56488327|NCT01239394|Ofatumumab|ofatumumab|mesh-list
56643530|NCT02649075|Antibodies|antibodies|mesh-list
56643531|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
56643532|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643533|NCT02644785|Protamines|protamines|mesh-list
56643534|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
56643535|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643536|NCT02644785|Coagulants|coagulants|mesh-ancestor
56643537|NCT02644707|Selenium|selenium|mesh-list
56643710|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643711|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643713|NCT02643147|Diuretics|diuretics|mesh-list
56643714|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56643715|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
56643716|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643717|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56643718|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643719|NCT02642913|Sorafenib|sorafenib|mesh-list
56643720|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643721|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56643722|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643723|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643725|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56643726|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56643727|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56643728|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56643729|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
56643730|NCT04002362|Hormones|hormones|mesh-ancestor
56643731|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643732|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643733|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643734|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
56643735|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532401|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532402|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532403|NCT02865304|Endostar protein|endostar protein|mesh-list
56643736|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643737|NCT04165629|Aspirin|aspirin|mesh-list
56643738|NCT04165629|Clopidogrel|clopidogrel|mesh-list
56643739|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56643740|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56643741|NCT04165629|Analgesics|analgesics|mesh-ancestor
56643742|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
56643743|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488937|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
56643806|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56643807|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56643808|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56643809|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643810|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643811|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56643812|NCT00653445|Ezetimibe|ezetimibe|mesh-list
56643813|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56643814|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56643815|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
56643816|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643817|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56643818|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56643819|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643820|NCT02641899|Acetaminophen|acetaminophen|mesh-list
56643821|NCT02641899|Exenatide|exenatide|mesh-list
56643822|NCT02641899|Digoxin|digoxin|mesh-list
56643823|NCT02641899|Lisinopril|lisinopril|mesh-list
56643824|NCT02641899|Warfarin|warfarin|mesh-list
56643825|NCT02641899|Atorvastatin|atorvastatin|mesh-list
56643826|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56644014|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
56644015|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56644016|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644017|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644018|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56644019|NCT02709200|Analgesics|analgesics|mesh-ancestor
56644125|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56644126|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
56644127|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
56644128|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644129|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56644130|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56644132|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
56644133|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644134|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56644135|NCT05024006|Interferons|interferons|mesh-list
56644136|NCT05024006|Ritonavir|ritonavir|mesh-list
56644137|NCT05024006|Lopinavir|lopinavir|mesh-list
56644138|NCT05024006|Interferon-beta|interferon-beta|mesh-list
56644139|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
56644140|NCT05024006|Remdesivir|remdesivir|mesh-list
56644141|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
56644142|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
56644143|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644144|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
56644145|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644146|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56644147|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56644148|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
56644149|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644150|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644151|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56644152|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56644153|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56644154|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56644155|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
56644156|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56644157|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56644158|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644159|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
56644160|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644161|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56532404|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56532405|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56532406|NCT02865304|Growth Substances|growth substances|mesh-ancestor
56532407|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532408|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
56532409|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644162|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
56644163|NCT02707250|Meperidine|meperidine|mesh-list
56644164|NCT02707250|Bupivacaine|bupivacaine|mesh-list
56644165|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
56644166|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
56644167|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644168|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547625|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56644169|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
56644345|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56644346|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
56644347|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
56644348|NCT00884793|Efavirenz|efavirenz|mesh-list
56644349|NCT00884793|Etravirine|etravirine|mesh-list
56644350|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56644351|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56644352|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
56644353|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644354|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644355|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56644356|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56644357|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
56644358|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644359|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56644360|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56644361|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56644362|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56644363|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56644364|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56644365|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56644366|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56644367|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56644368|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56644369|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56644370|NCT00656331|Amlodipine|amlodipine|mesh-list
56644930|NCT02630511|Mannitol|mannitol|mesh-list
56644963|NCT00666393|Fentanyl|fentanyl|mesh-list
56644964|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56644965|NCT00666393|Narcotics|narcotics|mesh-ancestor
56644966|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644967|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644968|NCT00666393|Analgesics|analgesics|mesh-ancestor
56644969|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
56644970|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644971|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56644972|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56644973|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
56644974|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
56645593|NCT02703740|Lidocaine|lidocaine|mesh-list
56645594|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
56645595|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
56645596|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
56645597|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645598|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645599|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
56645600|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645601|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56645602|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56645603|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56645604|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56645716|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645717|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56645718|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56532411|NCT04075474|Fluorides|fluorides|mesh-list
56532412|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
56532413|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
56532414|NCT04075474|Protective Agents|protective agents|mesh-ancestor
56645719|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56645720|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645721|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
56645722|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645723|NCT04215770|Penicillins|penicillins|mesh-list
56645724|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56645725|NCT04215770|Penicillin G|penicillin g|mesh-list
56645726|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56645727|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
56645728|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56645729|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645730|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56645731|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645732|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645733|NCT02699138|Trazodone|trazodone|mesh-list
56645734|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56645735|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56645736|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645737|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645738|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56645739|NCT02699138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56645740|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56645741|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56645742|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645743|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645744|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
56645745|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56645746|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
56645747|NCT04215536|Empagliflozin|empagliflozin|mesh-list
56645748|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56645749|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56645750|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645751|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56645752|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645753|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
56645754|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645755|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
56645756|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56645757|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56645758|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645759|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56645760|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56645761|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
56645762|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645763|NCT01831076|Tamoxifen|tamoxifen|mesh-list
56645764|NCT01831076|Exemestane|exemestane|mesh-list
56645765|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56645766|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
56645767|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645768|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645769|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56645770|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645771|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56645772|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56645773|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56645774|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56645775|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56645776|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495745|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
56649381|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56649382|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
56649383|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649384|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649385|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
56649386|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532415|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532416|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56532417|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532418|NCT02866396|Pregabalin|pregabalin|mesh-list
56532419|NCT02866396|Analgesics|analgesics|mesh-ancestor
56532420|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
56532421|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532422|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532423|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
56532424|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56532425|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532426|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532427|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56532428|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56532429|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56532430|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649387|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55790374|NCT03044873|BMS-986165|bms-986165|mesh-list
56653028|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
56653029|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653030|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653031|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
56653032|NCT02807441|Aspirin|aspirin|mesh-list
56653033|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56653034|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56653035|NCT02807441|Analgesics|analgesics|mesh-ancestor
56653036|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
56653037|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653038|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653039|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653040|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56653041|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56653042|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56653043|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653044|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56653045|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56653046|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653047|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
56653048|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
56653049|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
56653050|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653051|NCT02682680|Ezetimibe|ezetimibe|mesh-list
56653052|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56653053|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56653054|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56653055|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
56653056|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653057|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56653058|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
56653059|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56653060|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653061|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56653347|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
56215881|NCT01621256|Ancrod|ancrod|mesh-list
56655071|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655072|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56655073|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56655074|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
56532431|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56532432|NCT01087203|Tanezumab|tanezumab|mesh-list
56532433|NCT01087203|Analgesics|analgesics|mesh-ancestor
56532434|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
56186624|NCT05554393|Azacitidine|azacitidine|mesh-list
56655075|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
56655076|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56655077|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655078|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56655079|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56655080|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655081|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655082|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655083|NCT00659412|Methotrexate|methotrexate|mesh-list
56655085|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56655086|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
56655087|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56655088|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655089|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655090|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
56655091|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656330|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
56302429|NCT00012558|Inositol|inositol|mesh-list
56656331|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656332|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656333|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56656334|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
56656335|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
56656336|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56656337|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56656338|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56656339|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56656340|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
56656341|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656342|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656343|NCT00969631|Metformin|metformin|mesh-list
56656344|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56656345|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656346|NCT02782481|Levodopa|levodopa|mesh-list
56656347|NCT02782481|Carbidopa|carbidopa|mesh-list
56656348|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56656349|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56656350|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56656351|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
56656352|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656353|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656354|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656355|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56656356|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656357|NCT00648128|Clarithromycin|clarithromycin|mesh-list
56656358|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56656359|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656360|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56656361|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656362|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656363|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56656364|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56656365|NCT05342597|Edaravone|edaravone|mesh-list
56656366|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56656367|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
56656368|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656369|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56656370|NCT05342597|Protective Agents|protective agents|mesh-ancestor
56657644|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657645|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56657647|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657648|NCT02671864|Hormones|hormones|mesh-ancestor
56657649|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657650|NCT00867009|Pemetrexed|pemetrexed|mesh-list
56657651|NCT00867009|Cetuximab|cetuximab|mesh-list
56532435|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532436|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657652|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657653|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657654|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657655|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56659424|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659425|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56659426|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56660203|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660205|NCT04071262|Hormones|hormones|mesh-ancestor
56660206|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661662|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56661663|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56661664|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661665|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56661666|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56661667|NCT00719758|Beraprost|beraprost|mesh-list
56661668|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56661669|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
56661670|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
56661671|NCT02647268|Oxytocin|oxytocin|mesh-list
56661672|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
56661673|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56661674|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662105|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662106|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
56662107|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
56662108|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56662109|NCT00711256|Protective Agents|protective agents|mesh-ancestor
56662110|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662415|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56662416|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
56662417|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662418|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662419|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56662420|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
56662421|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662422|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56662423|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56662424|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56662425|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
56662426|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56662838|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662839|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56662840|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56662841|NCT00690768|Growth Substances|growth substances|mesh-ancestor
56662842|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224182|NCT01684982|Sirolimus|sirolimus|mesh-list
56663012|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663013|NCT01564303|Antidotes|antidotes|mesh-ancestor
56224641|NCT01691677|Hormones|hormones|mesh-ancestor
56663364|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663365|NCT04001959|Fluorides|fluorides|mesh-list
56663366|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
56663367|NCT04001959|Protective Agents|protective agents|mesh-ancestor
56663368|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309504|NCT00060385|Hormones|hormones|mesh-ancestor
56663369|NCT00721240|Montelukast|montelukast|mesh-list
56224691|NCT01692210|Analgesics|analgesics|mesh-ancestor
56663453|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663454|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56663455|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
56663456|NCT02732249|Metronidazole|metronidazole|mesh-list
56663457|NCT02732249|Clarithromycin|clarithromycin|mesh-list
56663458|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
56663459|NCT02732249|Esomeprazole|esomeprazole|mesh-list
56663460|NCT02732249|Bismuth|bismuth|mesh-list
56663461|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663462|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663463|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56532437|NCT01246583|Tofacitinib|tofacitinib|mesh-list
56532438|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532439|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532440|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532441|NCT00626613|Risperidone|risperidone|mesh-list
56663464|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56663465|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56663466|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56663467|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56663468|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56663469|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663470|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56663471|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56663472|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56663473|NCT02732249|Antacids|antacids|mesh-ancestor
56663474|NCT02732249|Diuretics|diuretics|mesh-ancestor
56663475|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
56663476|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663477|NCT02732249|Expectorants|expectorants|mesh-ancestor
56663478|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
56663479|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
56663480|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
56663481|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
56663482|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663483|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56663484|NCT02732093|Lidocaine|lidocaine|mesh-list
56663485|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
56663486|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
56663487|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663488|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663489|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
56663490|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663491|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56663870|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663872|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
56663873|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663874|NCT02626104|Lactoferrin|lactoferrin|mesh-list
56663933|NCT02728037|Lidocaine|lidocaine|mesh-list
56663934|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
56663935|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
56663936|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
56663937|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663938|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663939|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
56663940|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663941|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56663942|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56663943|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56663944|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56663945|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663946|NCT02728037|Analgesics|analgesics|mesh-ancestor
56663947|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
56663948|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56663949|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56663950|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
56663951|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56663952|NCT03635749|Atorvastatin|atorvastatin|mesh-list
56663953|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56663954|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663955|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663956|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56663957|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56663958|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
56663959|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56663960|NCT03752216|Niraparib|niraparib|mesh-list
56663961|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56663962|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663963|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663964|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663965|NCT00691548|Cetuximab|cetuximab|mesh-list
56532442|NCT00626613|Galantamine|galantamine|mesh-list
56532443|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56532444|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
56532445|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532446|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532447|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532448|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56532449|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56532450|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532451|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56532452|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56532453|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
56532454|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56532455|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532456|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
56532457|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56532458|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
56532459|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532460|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
56532461|NCT01080807|Modafinil|modafinil|mesh-list
56532462|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56532463|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532464|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56532465|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56532466|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56532467|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532468|NCT01079949|Cetrorelix|cetrorelix|mesh-list
56532469|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56186648|NCT05525013|Calcium|calcium|mesh-list
56663966|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56663967|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663968|NCT00712738|Nifedipine|nifedipine|mesh-list
56663969|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56663970|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56664101|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664102|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
56664103|NCT00723658|Hormones|hormones|mesh-ancestor
56664104|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664105|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664106|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56225407|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56664191|NCT02645864|Apatinib|apatinib|mesh-list
56664192|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56664193|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56664194|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532470|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56532471|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56532472|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
56532473|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56532474|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532475|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
56532476|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532477|NCT01079949|Hormones|hormones|mesh-ancestor
56532478|NCT00910429|Riociguat|riociguat|mesh-list
56532479|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
56532480|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532481|NCT03432949|Dexamethasone|dexamethasone|mesh-list
56532482|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
56532483|NCT03432949|BB 1101|bb 1101|mesh-list
56532484|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532485|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
56532486|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
56186662|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
56186663|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186664|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56186666|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664195|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664196|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664197|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56664198|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56664199|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56664200|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664251|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664252|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664253|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664254|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56664255|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56664256|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56664257|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
56664258|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
56664259|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56664260|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56664261|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664262|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56664263|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310405|NCT04258488|Vitamin K|vitamin k|mesh-list
56664264|NCT00712894|Verapamil|verapamil|mesh-list
56664265|NCT00712894|Diltiazem|diltiazem|mesh-list
56664266|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
56664267|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
56664268|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56664269|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56664270|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56664271|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664272|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56664273|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664274|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56532487|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532488|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532489|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56532490|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
56532491|NCT03432949|Hormones|hormones|mesh-ancestor
56532492|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532493|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56532494|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532495|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
56532496|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532497|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532498|NCT00909727|Ivacaftor|ivacaftor|mesh-list
56532499|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56532500|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532501|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532502|NCT00977080|Cinacalcet|cinacalcet|mesh-list
56532503|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56532504|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532505|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56532506|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56532507|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532508|NCT03755791|Sorafenib|sorafenib|mesh-list
56532509|NCT03755791|Atezolizumab|atezolizumab|mesh-list
56532510|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532511|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532512|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532513|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532514|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56186678|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
56186679|NCT05418088|Fludarabine|fludarabine|mesh-list
56186680|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
56186681|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56664275|NCT04164368|Lenalidomide|lenalidomide|mesh-list
56664276|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
56664328|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56664330|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
56664331|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
56664332|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
56664333|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664334|NCT00692016|Naproxen|naproxen|mesh-list
56532515|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56532516|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532517|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
56532518|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56532519|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
56532520|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532521|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56532522|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56532523|NCT04083157|Imiquimod|imiquimod|mesh-list
56532524|NCT04083157|Vaccines|vaccines|mesh-list
56532525|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
56532526|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532527|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56532528|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532529|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
56532530|NCT00975286|Metformin|metformin|mesh-list
56532531|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
56532532|NCT00975286|Lixisenatide|lixisenatide|mesh-list
56532533|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56532534|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56532535|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532536|NCT00907777|Vaccines|vaccines|mesh-list
56532537|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56532538|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
56186709|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186710|NCT05371275|Palbociclib|palbociclib|mesh-list
56186711|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186712|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532539|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532540|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56532541|NCT03741517|Edotreotide|edotreotide|mesh-list
56532542|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56532543|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532544|NCT02864758|Vitamin K|vitamin k|mesh-list
56532545|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
56532546|NCT02864758|Dabigatran|dabigatran|mesh-list
56532547|NCT02864758|Vitamins|vitamins|mesh-ancestor
56532548|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
56532549|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532550|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56280756|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
56532551|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
56532552|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56532553|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
56532554|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547728|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
56532555|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532557|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56532558|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56532559|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
56532560|NCT02864758|Coagulants|coagulants|mesh-ancestor
56186731|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186732|NCT05295927|Prednisone|prednisone|mesh-list
56186733|NCT05295927|Prednisolone|prednisolone|mesh-list
56186734|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
56186735|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56186736|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
56186737|NCT05295927|Hormones|hormones|mesh-ancestor
56186738|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186739|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186740|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56186747|NCT05213832|Isoflurane|isoflurane|mesh-list
56664335|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56547645|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56664336|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56664337|NCT00692016|Analgesics|analgesics|mesh-ancestor
56664338|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
56664339|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664340|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664341|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532561|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56532562|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
56532563|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532564|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
56664342|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664701|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664703|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
56664704|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56664705|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
56666098|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56666099|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
56666100|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666101|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56666102|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56666103|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56666104|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56666105|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
56666250|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666251|NCT02716259|Fluorides|fluorides|mesh-list
56666252|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
56666253|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
56666254|NCT02716259|Protective Agents|protective agents|mesh-ancestor
56227488|NCT02333292|Velpatasvir|velpatasvir|mesh-list
56666398|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56666399|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56666400|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666401|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666402|NCT00994825|Protective Agents|protective agents|mesh-ancestor
56666403|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666426|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
56666427|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
56666428|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
56666429|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666430|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666431|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56666432|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56666433|NCT02620800|Growth Substances|growth substances|mesh-ancestor
56666434|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666435|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
56666436|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56666437|NCT02620800|Antidotes|antidotes|mesh-ancestor
56666438|NCT02620800|Protective Agents|protective agents|mesh-ancestor
56666439|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
56666441|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
56666442|NCT04135014|Midazolam|midazolam|mesh-list
56666443|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
56666444|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56666445|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56666446|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666447|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56666448|NCT04135014|Analgesics|analgesics|mesh-ancestor
56666449|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
56666450|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666451|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56666452|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56666453|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56666454|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
56666455|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312591|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
56666456|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666457|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56666509|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56666510|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
56666511|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56666512|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666513|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56666515|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666516|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666517|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
56532565|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56532566|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532567|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532568|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532569|NCT04204798|Analgesics|analgesics|mesh-ancestor
56532570|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
56532571|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532572|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56532573|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56532574|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56532575|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
56532576|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532577|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532578|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56532579|NCT00908011|Ezetimibe|ezetimibe|mesh-list
56532580|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56532581|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56532582|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
56532583|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532584|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56532585|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56532586|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532587|NCT05580523|Aspirin|aspirin|mesh-list
56532588|NCT05580523|Metformin|metformin|mesh-list
56532589|NCT05580523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56532590|NCT05580523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532591|NCT05580523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56186758|NCT05197439|Analgesics|analgesics|mesh-ancestor
56666518|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666519|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56666520|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666521|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
56666522|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666523|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56666524|NCT00856323|Tenofovir|tenofovir|mesh-list
56666525|NCT00856323|Emtricitabine|emtricitabine|mesh-list
56666526|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56666527|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
56666528|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666529|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56666530|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56666531|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666532|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666533|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56532592|NCT05580523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532593|NCT05580523|Analgesics|analgesics|mesh-ancestor
56532594|NCT05580523|Sensory System Agents|sensory system agents|mesh-ancestor
56532595|NCT05580523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532596|NCT05580523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666534|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56666535|NCT00856245|Rituximab|rituximab|mesh-list
56666536|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666537|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666538|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
56666539|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666540|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666541|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
56666542|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56666543|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666544|NCT00994903|Simvastatin|simvastatin|mesh-list
56666545|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56666546|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56666547|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
56666548|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666549|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56666614|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666615|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666616|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
56666617|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56666618|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56666619|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56666621|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
56666622|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666623|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666624|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56666625|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666626|NCT00997087|Flumazenil|flumazenil|mesh-list
56666627|NCT00997087|Antidotes|antidotes|mesh-ancestor
56666628|NCT00997087|Protective Agents|protective agents|mesh-ancestor
56666629|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666701|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666702|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56666703|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666704|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
56666705|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666706|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
56666707|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666709|NCT01001143|Bexarotene|bexarotene|mesh-list
56666710|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56666711|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
56666712|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666713|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666714|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666715|NCT02715167|Budesonide|budesonide|mesh-list
56666716|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312894|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312895|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312896|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56666748|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666749|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666751|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56666752|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666753|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666754|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
56666755|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56666756|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
56666811|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56666812|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56666813|NCT02714231|Analgesics|analgesics|mesh-ancestor
56666814|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
56666815|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666816|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666817|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532597|NCT05580523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532598|NCT05580523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56532599|NCT05580523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56532600|NCT05580523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532601|NCT05580523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56532602|NCT05580523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56532603|NCT05580523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532604|NCT05580523|Antipyretics|antipyretics|mesh-ancestor
56532605|NCT00976456|Bevacizumab|bevacizumab|mesh-list
56532606|NCT00976456|Carboplatin|carboplatin|mesh-list
56532607|NCT00976456|Pemetrexed|pemetrexed|mesh-list
56532608|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56532609|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532610|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56186793|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
56666818|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666819|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56666820|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666821|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666822|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
56666823|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56666824|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
56666825|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
56666826|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56666828|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56666829|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
56666830|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56666831|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56666879|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
56666880|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666881|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56666882|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666883|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666884|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
56666885|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666887|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
56666888|NCT01001845|Tocopherols|tocopherols|mesh-list
56666889|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
56666890|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666891|NCT01001845|Protective Agents|protective agents|mesh-ancestor
56666892|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666893|NCT01001845|Vitamins|vitamins|mesh-ancestor
56666894|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
56666895|NCT02635334|Montelukast|montelukast|mesh-list
56666896|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56666897|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
56666898|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56666899|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
56313050|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
56228140|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
56666962|NCT05429567|Analgesics|analgesics|mesh-ancestor
56666963|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56666964|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56666965|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
56666966|NCT00868296|Pantoprazole|pantoprazole|mesh-list
56666967|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56666968|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56666969|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56666970|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666971|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666972|NCT01002157|Vitamin K|vitamin k|mesh-list
56666973|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
56532611|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56532612|NCT00976456|Growth Substances|growth substances|mesh-ancestor
56273968|NCT02503358|Paclitaxel|paclitaxel|mesh-list
56666974|NCT01002157|Vitamin MK 7|vitamin mk 7|mesh-list
56666975|NCT01002157|Vitamins|vitamins|mesh-ancestor
56666976|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
56666977|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666978|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56666979|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56667028|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
56667029|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56667030|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667032|NCT01004575|Chromium|chromium|mesh-list
56667033|NCT01004575|Trace Elements|trace elements|mesh-ancestor
56667034|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
56667035|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667036|NCT02615730|Paclitaxel|paclitaxel|mesh-list
56667037|NCT02615730|GSK2636771|gsk2636771|mesh-list
56667038|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56667039|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667040|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
56667041|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
56667042|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
56667043|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667044|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667045|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667046|NCT02711891|Loperamide|loperamide|mesh-list
56667047|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
56313190|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56667048|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56667151|NCT04191863|Valproic Acid|valproic acid|mesh-list
56667152|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
56667153|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667154|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667155|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
56667156|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667157|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667158|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
56667159|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56667160|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667161|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56667162|NCT02636348|Vitamin D|vitamin d|mesh-list
56667163|NCT02636348|Calcium|calcium|mesh-list
56667164|NCT02636348|Vitamins|vitamins|mesh-ancestor
56667165|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
56667166|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667167|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56667168|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56667169|NCT04219865|Edaravone|edaravone|mesh-list
56228403|NCT01380938|Ribavirin|ribavirin|mesh-list
56667197|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56667198|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667199|NCT00654290|Propranolol|propranolol|mesh-list
56667200|NCT00654290|Amiodarone|amiodarone|mesh-list
56313341|NCT00138229|Aldesleukin|aldesleukin|mesh-list
56667201|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56667202|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56667203|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
56667204|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667205|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667206|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667207|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56667208|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56667209|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
56667210|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56667211|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56667212|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56667213|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56667272|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56313413|NCT00138736|Lectins|lectins|mesh-list
56667273|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56667274|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
56667275|NCT01008709|Hormones|hormones|mesh-ancestor
56667276|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228529|NCT01093196|Prednisone|prednisone|mesh-list
56532613|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532614|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
56532615|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186807|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
56667327|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
56667328|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667329|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56667330|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56667331|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56667332|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56667333|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667334|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667335|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
56667336|NCT02708693|Hormones|hormones|mesh-ancestor
56667337|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667338|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56667339|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
56667340|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667341|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56667342|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56667343|NCT02638922|Trisequens|trisequens|mesh-list
56667344|NCT02638922|Norethindrone|norethindrone|mesh-list
56667345|NCT02638922|Estradiol|estradiol|mesh-list
56313490|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667346|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56668305|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56668306|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56668307|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56668308|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668309|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
56668310|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668311|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668312|NCT00712270|Risperidone|risperidone|mesh-list
56668313|NCT00712270|Aripiprazole|aripiprazole|mesh-list
56668314|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56668315|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
56668419|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
56668420|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668421|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
56668422|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56668423|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56668424|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56668425|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
56668426|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668427|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668519|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668520|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668521|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56668522|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668576|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668577|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
56668578|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668579|NCT05011357|Phenylephrine|phenylephrine|mesh-list
56668580|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
56668581|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56668582|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
56668583|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
56668584|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668585|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230052|NCT01702974|Vitamin D|vitamin d|mesh-list
56669337|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669338|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669339|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
56669340|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669341|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669342|NCT04865939|Gemcitabine|gemcitabine|mesh-list
56669343|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56669344|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
56669444|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532616|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532617|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56532618|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56532619|NCT01243151|Bococizumab|bococizumab|mesh-list
56532620|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56532621|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56532622|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
56532623|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532624|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56532625|NCT00629512|Esomeprazole|esomeprazole|mesh-list
56532626|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56532627|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56532628|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56923626|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
56532629|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532630|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532631|NCT01711021|Amphetamine|amphetamine|mesh-list
56532632|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
56186822|NCT05060731|Iron|iron|mesh-list
56669577|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669579|NCT03640949|Protective Agents|protective agents|mesh-ancestor
56669580|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
56669581|NCT03640949|Coagulants|coagulants|mesh-ancestor
56547654|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56669657|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669658|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56669659|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669660|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669661|NCT05741866|Chlorhexidine|chlorhexidine|mesh-list
56669662|NCT05741866|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56669663|NCT05741866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56669664|NCT05741866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669665|NCT05741866|Disinfectants|disinfectants|mesh-ancestor
56669666|NCT05741866|Dermatologic Agents|dermatologic agents|mesh-ancestor
56669667|NCT03916601|Insulin|insulin|mesh-list
56669668|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56669748|NCT00880334|Docetaxel|docetaxel|mesh-list
56669749|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669750|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
56669751|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
56669752|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
56669753|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669754|NCT01033565|Melatonin|melatonin|mesh-list
56669755|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
56669756|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669757|NCT01033565|Protective Agents|protective agents|mesh-ancestor
56669758|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669759|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669760|NCT00658892|Antibodies|antibodies|mesh-list
56669761|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
56669762|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669831|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56669833|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669872|NCT00737542|Lidocaine|lidocaine|mesh-list
56669873|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
56669874|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
56532633|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56532634|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532635|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
56274294|NCT00092222|Hormones|hormones|mesh-ancestor
56669875|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669876|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669877|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
56669991|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56669993|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669994|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56669995|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56669996|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56669997|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231175|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56670050|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
56670051|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56670052|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56670053|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56670054|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56670055|NCT02633618|Neurotropin|neurotropin|mesh-list
56670056|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56670057|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
56670058|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670059|NCT02633618|Analgesics|analgesics|mesh-ancestor
56670060|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
56670061|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670062|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
56670063|NCT00865020|Telmisartan|telmisartan|mesh-list
56670064|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56670065|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56670066|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56670067|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670128|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
56670264|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
56670306|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
56670307|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56670308|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56670309|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56670310|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56670311|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
56670312|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56670313|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56670314|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
56670315|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670439|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670440|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670441|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56670442|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56670443|NCT00881504|Growth Substances|growth substances|mesh-ancestor
56670444|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670599|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56670600|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56670601|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56670602|NCT00613769|Renal Agents|renal agents|mesh-ancestor
56670603|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
56670604|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56670605|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231769|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56232059|NCT01714427|Hormones|hormones|mesh-ancestor
56671086|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671088|NCT00667160|Tacrolimus|tacrolimus|mesh-list
56232253|NCT01715597|Vitamins|vitamins|mesh-ancestor
56671121|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56671122|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
56671123|NCT02701673|Vitamins|vitamins|mesh-ancestor
56671124|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
56671125|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56671126|NCT00522379|Rotigotine|rotigotine|mesh-list
56671127|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
56671128|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
56532636|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
56532637|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532638|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
56532639|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532640|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532641|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
56532642|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56532643|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56532644|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532645|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56532646|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
56532647|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532648|NCT02864602|Dexamethasone|dexamethasone|mesh-list
56671129|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671130|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671131|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671132|NCT00856830|Carboplatin|carboplatin|mesh-list
56671805|NCT02701205|Analgesics|analgesics|mesh-ancestor
56671806|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
56671807|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671808|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232960|NCT01719692|Rituximab|rituximab|mesh-list
56671910|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
56671911|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671912|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56671914|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56672081|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56672082|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56672083|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672084|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672085|NCT01015417|Amoxicillin|amoxicillin|mesh-list
56672086|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56672087|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
56672088|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
56672089|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56672090|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672122|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56672124|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
56672125|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672126|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56672127|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56672128|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672129|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672130|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56672131|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56672132|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56672133|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56672134|NCT00663884|Voglibose|voglibose|mesh-list
56672135|NCT00663884|Mitiglinide|mitiglinide|mesh-list
56672136|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672137|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672192|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56672194|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
56672195|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56672196|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56672197|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56672198|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
56672199|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672200|NCT01015495|Ranibizumab|ranibizumab|mesh-list
56672201|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56532649|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
56532650|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56532651|NCT02864602|BB 1101|bb 1101|mesh-list
56532652|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532653|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
56532654|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
56532655|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532656|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532657|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56532658|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
56532659|NCT02864602|Hormones|hormones|mesh-ancestor
56648519|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672202|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56672203|NCT01015495|Growth Substances|growth substances|mesh-ancestor
56672204|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672205|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
56672206|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672571|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56672572|NCT05255146|Analgesics|analgesics|mesh-ancestor
56672573|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
56672574|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672575|NCT02628080|Atovaquone|atovaquone|mesh-list
56672576|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672577|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
56672578|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56672579|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56672580|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672581|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672582|NCT04810078|Nivolumab|nivolumab|mesh-list
56672583|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56672584|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673101|NCT00685100|Hormones|hormones|mesh-ancestor
56673102|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673103|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673104|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
56673105|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56673106|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673134|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673135|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673136|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56673137|NCT00709137|Diuretics|diuretics|mesh-ancestor
56673138|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
56673139|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56673140|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56673141|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56673142|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673143|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56673145|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56673146|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56673147|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
56673148|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673149|NCT04150172|Protective Agents|protective agents|mesh-ancestor
56673150|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673151|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673190|NCT00577096|Tinzaparin|tinzaparin|mesh-list
56673191|NCT00577096|Dalteparin|dalteparin|mesh-list
56673192|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
56673229|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
56673230|NCT02625506|Tramadol|tramadol|mesh-list
56673231|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
56673301|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673302|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56673303|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532660|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532661|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56532662|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532663|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
56673304|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
56673305|NCT04897919|Lumefantrine|lumefantrine|mesh-list
56673306|NCT04897919|Artemether|artemether|mesh-list
56673307|NCT04897919|Piperaquine|piperaquine|mesh-list
56673308|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56673368|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56673369|NCT00742768|Vitamins|vitamins|mesh-list
56673370|NCT00742768|Vitamin K|vitamin k|mesh-list
56673371|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
56673372|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
56673373|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673374|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56673577|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
56673578|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673579|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56673580|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56673581|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56673582|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56673583|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673584|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56673585|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56673586|NCT04138472|Analgesics|analgesics|mesh-ancestor
56673674|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
56673675|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
56673676|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673677|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56673678|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673679|NCT01015729|Esomeprazole|esomeprazole|mesh-list
56673680|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673681|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673682|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56319901|NCT03959969|Narcotics|narcotics|mesh-ancestor
56673683|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56319973|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
56673684|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56673685|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
56673686|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56673687|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
56673688|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56673903|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56673904|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56673906|NCT01010581|Methotrexate|methotrexate|mesh-list
56673907|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56673908|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
56673938|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673939|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
56673940|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
56673941|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
56673942|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673943|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673944|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
56673945|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673946|NCT00622115|Enoxaparin|enoxaparin|mesh-list
56673947|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
56673948|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56673949|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56673950|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673951|NCT05662397|Cemiplimab|cemiplimab|mesh-list
56673952|NCT05662397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56235090|NCT01742429|Antacids|antacids|mesh-ancestor
56673994|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673995|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673996|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673997|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56673998|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
56673999|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56532664|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674000|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674001|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56674002|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56674003|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56674005|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
56674006|NCT00049595|Dacarbazine|dacarbazine|mesh-list
56674007|NCT00049595|Doxorubicin|doxorubicin|mesh-list
56674008|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56674009|NCT00049595|Etoposide|etoposide|mesh-list
56674010|NCT00049595|Vincristine|vincristine|mesh-list
56674011|NCT00049595|Bleomycin|bleomycin|mesh-list
56674012|NCT00049595|Vinblastine|vinblastine|mesh-list
56674191|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56674259|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674260|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56674262|NCT02624726|Fluorouracil|fluorouracil|mesh-list
56674263|NCT02624726|Irinotecan|irinotecan|mesh-list
56674264|NCT02624726|Aflibercept|aflibercept|mesh-list
56674265|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
56674387|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56674388|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56674389|NCT01014481|Tenofovir|tenofovir|mesh-list
56674390|NCT01014481|Lamivudine|lamivudine|mesh-list
56674391|NCT01014481|Efavirenz|efavirenz|mesh-list
56674392|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
56674393|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674394|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56674395|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56674396|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674397|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674398|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56674399|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56674400|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56235527|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56674547|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56674548|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56674549|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56674550|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56674551|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56674552|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56674553|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56674554|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56674555|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
56674556|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56674557|NCT00489853|Budesonide|budesonide|mesh-list
56674558|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
56674559|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56674560|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56674561|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
56674562|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674563|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674564|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56674565|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
56674566|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
56674567|NCT00489853|Hormones|hormones|mesh-ancestor
56674568|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674569|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56674570|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56674571|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56674572|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
56674573|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674574|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674575|NCT00682136|Ropivacaine|ropivacaine|mesh-list
56674576|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
56674577|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
56674578|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674579|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674580|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
56674581|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320816|NCT00032019|Prednisone|prednisone|mesh-list
56674582|NCT00693056|beta-Lactams|beta-lactams|mesh-list
56674596|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
56674597|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
56674598|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56532665|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532666|NCT03667651|Decanoic acid|decanoic acid|mesh-list
56532667|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
56532668|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532669|NCT00993148|Ritonavir|ritonavir|mesh-list
56532670|NCT00993148|Darunavir|darunavir|mesh-list
56532671|NCT00993148|Maraviroc|maraviroc|mesh-list
56532672|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56532673|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56532674|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
56532675|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114611|NCT00000629|Zidovudine|zidovudine|mesh-list
56674599|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56674600|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674601|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674603|NCT00499681|Lapatinib|lapatinib|mesh-list
56674604|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674605|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56674606|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56674607|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674608|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674609|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56674610|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
56674611|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674612|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674613|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56674614|NCT02687009|Niclosamide|niclosamide|mesh-list
56674615|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
56674616|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56674617|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
56674618|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56674619|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674620|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
56674621|NCT00693212|Methylphenidate|methylphenidate|mesh-list
56674622|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56674623|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674624|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56674625|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56674626|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674627|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674628|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
56674629|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674630|NCT00688298|Imidacloprid|imidacloprid|mesh-list
56674631|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
56674632|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674633|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674634|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674635|NCT00499603|Paclitaxel|paclitaxel|mesh-list
56674636|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
56674637|NCT00499603|Fluorouracil|fluorouracil|mesh-list
56674638|NCT00499603|Epirubicin|epirubicin|mesh-list
56674639|NCT00499603|Everolimus|everolimus|mesh-list
56674640|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56674641|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674642|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674643|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
56674644|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674672|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674673|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
56674674|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674675|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56674676|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674677|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674678|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56532676|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532677|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56532678|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56532679|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
56532680|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186876|NCT04922567|Prednisone|prednisone|mesh-list
56674679|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674680|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56674681|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674682|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
56674683|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
56674685|NCT00693524|Tacrolimus|tacrolimus|mesh-list
56674686|NCT00693524|Daclizumab|daclizumab|mesh-list
56674687|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56674688|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
56674689|NCT00693524|Hormones|hormones|mesh-ancestor
56674690|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674691|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674692|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56674707|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
56674708|NCT00682214|Vitamins|vitamins|mesh-ancestor
56674709|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
56674710|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674711|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56674712|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56674713|NCT04137380|Mirikizumab|mirikizumab|mesh-list
56674714|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56674715|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56674716|NCT04137380|Analgesics|analgesics|mesh-ancestor
56674717|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
56674718|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674719|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674720|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56674721|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56674722|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56674723|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56674724|NCT00693680|Imipramine|imipramine|mesh-list
56674725|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56674726|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
56674727|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56674728|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56674729|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56674730|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674731|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674732|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
56674733|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674734|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674735|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
56674736|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56674737|NCT00682292|Daclizumab|daclizumab|mesh-list
56674738|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
56674739|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674740|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674741|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56674742|NCT00810069|Citalopram|citalopram|mesh-list
56674743|NCT00810069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56674744|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56674745|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674746|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674747|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674748|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
56674749|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674750|NCT00810069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56674751|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
56674752|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56674763|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56674764|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
56674765|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56674766|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
56532681|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56532682|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56674767|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
56674768|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674769|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674770|NCT02625740|Paclitaxel|paclitaxel|mesh-list
56674771|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56674772|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674773|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674774|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
56674775|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674776|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674777|NCT00688922|Pravastatin|pravastatin|mesh-list
56674778|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56674779|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56674780|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
56674781|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674782|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56674783|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56674784|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674785|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56674786|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56674787|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674788|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674789|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56674790|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674791|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674792|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
56674793|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674794|NCT02626364|Crenolanib|crenolanib|mesh-list
56674795|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674796|NCT00694460|Vaccines|vaccines|mesh-list
56674797|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
56674798|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674799|NCT04776525|Doxorubicin|doxorubicin|mesh-list
56674800|NCT04776525|Ifosfamide|ifosfamide|mesh-list
56674801|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56674802|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674803|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56674804|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56321026|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56674805|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674806|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674807|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56674808|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
56674809|NCT00689000|Tosedostat|tosedostat|mesh-list
56674810|NCT00689000|Glycine|glycine|mesh-list
56674811|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674812|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674813|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
56674814|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674815|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674825|NCT00689156|Epirubicin|epirubicin|mesh-list
56674826|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674827|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
56674828|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674829|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56674830|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56674831|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
56674832|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674833|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674834|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56674835|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674836|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
56674837|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674838|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56674839|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56674840|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56674841|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674842|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
56674843|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
56532683|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56532684|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56532685|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56532686|NCT03401047|Estradiol|estradiol|mesh-list
56532687|NCT03401047|Estrogens|estrogens|mesh-ancestor
56532688|NCT03401047|Hormones|hormones|mesh-ancestor
56532689|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532690|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532691|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56532692|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
56532693|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532694|NCT03531073|Methotrexate|methotrexate|mesh-list
56532695|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56674844|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56674845|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674846|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674847|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
56674848|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56674849|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674850|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674851|NCT01016821|Oxycodone|oxycodone|mesh-list
56674852|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56674853|NCT01016821|Narcotics|narcotics|mesh-ancestor
56674854|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674855|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674856|NCT01016821|Analgesics|analgesics|mesh-ancestor
56674857|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
56674858|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674859|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
56674860|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
56674861|NCT01011205|Tacrolimus|tacrolimus|mesh-list
56674862|NCT01011205|Basiliximab|basiliximab|mesh-list
56674863|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674864|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
56674865|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674866|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56674867|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674868|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674869|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56674870|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674871|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56674872|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
56674873|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56674874|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674875|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56674876|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
56674877|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
56674878|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674879|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56674880|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
56674881|NCT01011205|Hormones|hormones|mesh-ancestor
56235791|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674897|NCT01014559|Naloxone|naloxone|mesh-list
56674898|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56674899|NCT01014559|Narcotics|narcotics|mesh-ancestor
56674900|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674901|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674902|NCT01014559|Analgesics|analgesics|mesh-ancestor
56674903|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
56674904|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674905|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56674906|NCT00853242|Sevelamer|sevelamer|mesh-list
56532696|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
56532697|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56532698|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532699|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56532700|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
56532701|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532702|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532703|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
56532704|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532705|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56532706|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532707|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
56532708|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532709|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56532710|NCT00907153|Vitamin D|vitamin d|mesh-list
56532711|NCT00907153|Vitamins|vitamins|mesh-ancestor
56532712|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
56532713|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532714|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56532715|NCT00904033|Calcitriol|calcitriol|mesh-list
56532716|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56532717|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674907|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
56674908|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
56674909|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674910|NCT04704063|Vitamin E|vitamin e|mesh-list
56674911|NCT04704063|Tocopherols|tocopherols|mesh-list
56674912|NCT04704063|Tocotrienols|tocotrienols|mesh-list
56674913|NCT04704063|Tocovid|tocovid|mesh-list
56674914|NCT04704063|Vitamins|vitamins|mesh-ancestor
56674915|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
56674916|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674917|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
56674918|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674919|NCT04704063|Protective Agents|protective agents|mesh-ancestor
56674920|NCT02609061|Alendronate|alendronate|mesh-list
56674921|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56674922|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674923|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56674924|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56674925|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674926|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
56674927|NCT00694694|Azithromycin|azithromycin|mesh-list
56674928|NCT00694694|Artesunate|artesunate|mesh-list
56674929|NCT00694694|Lumefantrine|lumefantrine|mesh-list
56674930|NCT00694694|Artemether|artemether|mesh-list
56674931|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56674932|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56674933|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674934|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
56674935|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56674936|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56674937|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532718|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56532719|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532720|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532721|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56532722|NCT00904033|Vitamins|vitamins|mesh-ancestor
56532723|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
56532724|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56532725|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
56532726|NCT05175625|Paraproteins|paraproteins|mesh-list
56532727|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
56275756|NCT02018965|Niacin|niacin|mesh-list
56674938|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
56674939|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
56674940|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56674941|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
56674942|NCT00700362|Insulin|insulin|mesh-list
56674943|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56674947|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674949|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56674950|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
56674951|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674952|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674953|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56321178|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56674954|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
56674955|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
56674956|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56674957|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56674958|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56674959|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56674960|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
56674961|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674962|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674963|NCT00594464|Rotigotine|rotigotine|mesh-list
56674964|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
56674965|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
56674966|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674967|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674968|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674969|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
56674970|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56674971|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56674972|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56674973|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674974|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674975|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
56674976|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674977|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674978|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56674979|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674980|NCT00689624|Leucovorin|leucovorin|mesh-list
56674981|NCT00689624|Fluorouracil|fluorouracil|mesh-list
56674982|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
56674983|NCT00689624|Irinotecan|irinotecan|mesh-list
56674984|NCT00689624|Cetuximab|cetuximab|mesh-list
56674985|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
56674986|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674987|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56674988|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674989|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674990|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
56674991|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674992|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56674993|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56674994|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532728|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674995|NCT00689624|Antidotes|antidotes|mesh-ancestor
56674996|NCT00689624|Protective Agents|protective agents|mesh-ancestor
56674997|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
56674998|NCT00689624|Vitamins|vitamins|mesh-ancestor
56674999|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
56675000|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56675001|NCT05755035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56675002|NCT05755035|Immunoglobulins|immunoglobulins|mesh-list
56675003|NCT05755035|Antibodies|antibodies|mesh-list
56675004|NCT05755035|gamma-Globulins|gamma-globulins|mesh-list
56675005|NCT05755035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56675006|NCT05755035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56675007|NCT05755035|Immunoglobulin G|immunoglobulin g|mesh-list
56675008|NCT05755035|Immunologic Factors|immunologic factors|mesh-ancestor
56675009|NCT05755035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675010|NCT05326269|Terbutaline|terbutaline|mesh-list
56675011|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56675012|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
56675013|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675014|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675015|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56675019|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56675020|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56675021|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56675022|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56675023|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
56675024|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675025|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675027|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675028|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56675029|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675030|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675031|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
56675032|NCT04665453|Melatonin|melatonin|mesh-list
56675033|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56675034|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675035|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675037|NCT04665453|Analgesics|analgesics|mesh-ancestor
56675038|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
56675039|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675040|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56675041|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56675042|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56675043|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
56675044|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675045|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675046|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
56675047|NCT04665453|Protective Agents|protective agents|mesh-ancestor
56675048|NCT00695240|Bupivacaine|bupivacaine|mesh-list
56675049|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
56675050|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
56675051|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675052|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675053|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
56675054|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675055|NCT00689702|Capecitabine|capecitabine|mesh-list
56675056|NCT00689702|Cetuximab|cetuximab|mesh-list
56675057|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56675058|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
56675059|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675060|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675061|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56675062|NCT00689780|Midazolam|midazolam|mesh-list
56675063|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56675064|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56675065|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675066|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675067|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56675068|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56675069|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56675070|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56675071|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
56675072|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
56532729|NCT02555839|Thalidomide|thalidomide|mesh-list
56532730|NCT02555839|Dexamethasone|dexamethasone|mesh-list
56532731|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
56532732|NCT02555839|Bortezomib|bortezomib|mesh-list
56532733|NCT02555839|Pomalidomide|pomalidomide|mesh-list
56532734|NCT02555839|BB 1101|bb 1101|mesh-list
56532735|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532736|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
56532737|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
56532738|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532739|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532740|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56532741|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
56532742|NCT02555839|Hormones|hormones|mesh-ancestor
56675073|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
56675074|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
56675075|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675076|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675077|NCT00689858|Cilostazol|cilostazol|mesh-list
56675078|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56675079|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
56675080|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675081|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675082|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56675083|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
56675084|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56675085|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56675086|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675087|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56675123|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56675124|NCT00690014|Renal Agents|renal agents|mesh-ancestor
56675125|NCT00683306|Gefitinib|gefitinib|mesh-list
56675126|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675127|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56675128|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675135|NCT01475123|Vitamins|vitamins|mesh-ancestor
56675136|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
56675137|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675138|NCT04135898|Bevacizumab|bevacizumab|mesh-list
56675139|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56675140|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675141|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56675142|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56675143|NCT04135898|Growth Substances|growth substances|mesh-ancestor
56675144|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675145|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
56675146|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
56675147|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
56675148|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675149|NCT00912392|Carboplatin|carboplatin|mesh-list
56675150|NCT00912392|Etoposide|etoposide|mesh-list
56675151|NCT00912392|Endostar protein|endostar protein|mesh-list
56675152|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675153|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56675154|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56675155|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56675156|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675157|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675158|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56675159|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56675160|NCT00912392|Growth Substances|growth substances|mesh-ancestor
56675161|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675162|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
56675163|NCT00690170|Ketamine|ketamine|mesh-list
56675164|NCT00690170|Nicotine|nicotine|mesh-list
56473644|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56532743|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56532744|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56532745|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276041|NCT02020603|Epinephrine|epinephrine|mesh-list
56675165|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56675166|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
56675167|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675168|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675169|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56675170|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56675171|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
56675172|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675173|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675174|NCT00690170|Analgesics|analgesics|mesh-ancestor
56675175|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
56675176|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56675177|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56675178|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
56675179|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
56675180|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675181|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56675182|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56675183|NCT00696098|Butyric Acid|butyric acid|mesh-list
56675184|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
56675185|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
56675186|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675187|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675188|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675189|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
56675190|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56675191|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675192|NCT00684164|Conivaptan|conivaptan|mesh-list
56675193|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56675194|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675195|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
56675196|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675197|NCT04135508|Adalimumab|adalimumab|mesh-list
56675208|NCT00499369|Cetuximab|cetuximab|mesh-list
56675209|NCT00499369|Fluorouracil|fluorouracil|mesh-list
56675210|NCT00499369|Irinotecan|irinotecan|mesh-list
56675211|NCT00499369|Antibodies|antibodies|mesh-list
56675212|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
56675213|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56675214|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
56675215|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675216|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56675217|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56675218|NCT00499369|Growth Substances|growth substances|mesh-ancestor
56675219|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675220|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
56675221|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
56675222|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
56675223|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675224|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56675225|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56675226|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56675227|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56675228|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675229|NCT00499369|Antidotes|antidotes|mesh-ancestor
56675230|NCT00499369|Protective Agents|protective agents|mesh-ancestor
56675231|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
56675232|NCT00499369|Vitamins|vitamins|mesh-ancestor
56675233|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
56675234|NCT02616692|Sorafenib|sorafenib|mesh-list
56675235|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675236|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56675237|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675238|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675239|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
56675240|NCT01014637|Clotrimazole|clotrimazole|mesh-list
56675241|NCT01014637|Miconazole|miconazole|mesh-list
56675242|NCT01014637|Amorolfine|amorolfine|mesh-list
56532746|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
56532747|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532748|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532749|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
56532750|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56532751|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56532752|NCT02555839|Growth Substances|growth substances|mesh-ancestor
56532753|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
56532754|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56675243|NCT01014637|Ciclopirox|ciclopirox|mesh-list
56675244|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
56675245|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675246|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56675247|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56675248|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56675249|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675250|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675251|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56675252|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
56675253|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56675254|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675255|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56675256|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56675257|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
56675258|NCT00696566|Rifampin|rifampin|mesh-list
56675259|NCT00696566|Clopidogrel|clopidogrel|mesh-list
56675260|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56675261|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56675262|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56675263|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56675264|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
56235861|NCT01746875|Aflibercept|aflibercept|mesh-list
56675270|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56675271|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675272|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
56675273|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56675274|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675275|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56675276|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56675277|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56675278|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56675279|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56675280|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56675281|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
56675282|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56675283|NCT01017133|Fluorides|fluorides|mesh-list
56675284|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56675285|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675286|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
56675287|NCT01017133|Protective Agents|protective agents|mesh-ancestor
56675288|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675289|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
56675290|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
56675291|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675292|NCT00869258|Gemcitabine|gemcitabine|mesh-list
56675293|NCT00869258|Capecitabine|capecitabine|mesh-list
56675294|NCT00869258|Docetaxel|docetaxel|mesh-list
56675295|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56675296|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
56675297|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675298|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675299|NCT00869258|Antiviral Agents|antiviral agents|mesh-ancestor
56675300|NCT00869258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675301|NCT00869258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532755|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
56532756|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56532757|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532758|NCT01241591|Etanercept|etanercept|mesh-list
56532759|NCT01241591|Tofacitinib|tofacitinib|mesh-list
56532760|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56532761|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532762|NCT01241591|Analgesics|analgesics|mesh-ancestor
56532763|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
56532764|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532765|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532766|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532767|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532768|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56532769|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532770|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
56532771|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532772|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648520|NCT00643500|Levetiracetam|levetiracetam|mesh-list
56675302|NCT00869258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56675303|NCT00869258|Immunologic Factors|immunologic factors|mesh-ancestor
56675304|NCT00869258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675305|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
56675306|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
56675307|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
56675308|NCT00696644|Teriparatide|teriparatide|mesh-list
56675309|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56675310|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675311|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56675312|NCT01017367|Antibodies|antibodies|mesh-list
56675313|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
56675314|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675315|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56675316|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56675317|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56675318|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
56675319|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675320|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675321|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56675322|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56675323|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
56675324|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675325|NCT00696956|Paclitaxel|paclitaxel|mesh-list
56675326|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56675327|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675328|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
56675329|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
56675330|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
56675331|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675332|NCT02616848|Everolimus|everolimus|mesh-list
56675333|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675338|NCT02620124|Hormones|hormones|mesh-list
56675339|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56675340|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675341|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
56675342|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56532773|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532774|NCT03464461|Ketorolac|ketorolac|mesh-list
56532775|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56532776|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56532777|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532778|NCT03464461|Analgesics|analgesics|mesh-ancestor
56532779|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
56532780|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532781|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532782|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532783|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532784|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56675343|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
56675344|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56675345|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56675346|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56675347|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675348|NCT04134650|Metformin|metformin|mesh-list
56675349|NCT04134650|Linagliptin|linagliptin|mesh-list
56675350|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56675351|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675352|NCT04134650|Incretins|incretins|mesh-ancestor
56675353|NCT04134650|Hormones|hormones|mesh-ancestor
56675354|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56675355|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56675356|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
56675357|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675358|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675359|NCT00488683|Vaccines|vaccines|mesh-list
56675360|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
56675361|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675362|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
56675363|NCT02563288|Esmolol|esmolol|mesh-list
56675364|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
56675365|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
56675366|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
56675367|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
56675368|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56675369|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675370|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675371|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56675372|NCT02563288|Analgesics|analgesics|mesh-ancestor
56675373|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
56675374|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675375|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56675376|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675377|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675378|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56675379|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56675380|NCT00711269|Risperidone|risperidone|mesh-list
56675381|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56675382|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56675383|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
56675384|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675385|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675386|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675387|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56675388|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56675389|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675390|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56675391|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56532785|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532786|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532787|NCT04319705|Azithromycin|azithromycin|mesh-list
56532788|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56532789|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532790|NCT00906373|Sorafenib|sorafenib|mesh-list
56532791|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56532792|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532793|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532794|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675392|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
56675393|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56675394|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56675395|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56675396|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
56675397|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56675398|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56675399|NCT01014793|Cabergoline|cabergoline|mesh-list
56675400|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56675401|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56675405|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675406|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321628|NCT00035958|Analgesics|analgesics|mesh-ancestor
56675407|NCT00286169|Amrubicin|amrubicin|mesh-list
56675408|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675409|NCT00693472|Propranolol|propranolol|mesh-list
56675410|NCT00693472|Haloperidol|haloperidol|mesh-list
56675411|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
56675412|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56675413|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
56675414|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
56675415|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675416|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675417|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56675418|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56675419|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56675420|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675421|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56675422|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56675423|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
56675424|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675425|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675426|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56675427|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
56675428|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56675429|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56675430|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
56675431|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56675432|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56675433|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
56675434|NCT00498433|Amlodipine|amlodipine|mesh-list
56675435|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56675436|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56675437|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56675438|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675439|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56675440|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675441|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
56675442|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56675443|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56675444|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675445|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
56675446|NCT00746746|Interferons|interferons|mesh-list
56675447|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
56675448|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
56532795|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532796|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
56675449|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56675450|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675451|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
56675452|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675453|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
56675454|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675455|NCT00498355|Ranibizumab|ranibizumab|mesh-list
56675456|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56675457|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56675458|NCT00498355|Growth Substances|growth substances|mesh-ancestor
56675459|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675460|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
56675461|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675462|NCT04539223|Evolocumab|evolocumab|mesh-list
56675463|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56675464|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56675465|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
56675466|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675467|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56675468|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56675469|NCT01011751|Leuprolide|leuprolide|mesh-list
56675470|NCT01011751|Flutamide|flutamide|mesh-list
56675471|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
56675472|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56675473|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
56675474|NCT01011751|Cyproterone|cyproterone|mesh-list
56675498|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56675501|NCT02686619|Cyclosporine|cyclosporine|mesh-list
56675502|NCT02686619|Sirolimus|sirolimus|mesh-list
56675503|NCT02686619|Prednisolone|prednisolone|mesh-list
56675504|NCT02686619|Cyclosporins|cyclosporins|mesh-list
56675505|NCT02686619|Daclizumab|daclizumab|mesh-list
56675506|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675507|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675508|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56675509|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
56675510|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675511|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
56675512|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675513|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
56675514|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56675515|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56675516|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56675517|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56675518|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675519|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56675520|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
56675521|NCT02686619|Hormones|hormones|mesh-ancestor
56675522|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56675523|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56675524|NCT00688636|Infliximab|infliximab|mesh-list
56675525|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56675526|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56675527|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56675543|NCT00870740|Daclizumab|daclizumab|mesh-list
56675544|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56675545|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
56675546|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675547|NCT02686853|Amphotericin B|amphotericin b|mesh-list
56675548|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56675549|NCT02686853|Amebicides|amebicides|mesh-ancestor
56675550|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56675551|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56675552|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675553|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56675554|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
56675555|NCT01017679|Gefitinib|gefitinib|mesh-list
56321770|NCT01466231|Everolimus|everolimus|mesh-list
56675556|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675557|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56675558|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675559|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675560|NCT04130672|Hemostatics|hemostatics|mesh-list
56675561|NCT04130672|Coagulants|coagulants|mesh-ancestor
56532797|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532798|NCT02850445|Olanzapine|olanzapine|mesh-list
56532799|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
56532800|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
56675562|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56675563|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56675564|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675565|NCT02685449|Insulin|insulin|mesh-list
56675566|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56675567|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
56675597|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675598|NCT04185077|Heparin|heparin|mesh-list
56675599|NCT04185077|Calcium heparin|calcium heparin|mesh-list
56675600|NCT04185077|Bivalirudin|bivalirudin|mesh-list
56675601|NCT04185077|Antithrombins|antithrombins|mesh-list
56675602|NCT04185077|Thrombin|thrombin|mesh-list
56675603|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
56675604|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56675605|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56675606|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675607|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
56675608|NCT04185077|Coagulants|coagulants|mesh-ancestor
56675609|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56675610|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
56675611|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675612|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
56675613|NCT02686385|Prednisolone|prednisolone|mesh-list
56675614|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56675615|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56675616|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
56675629|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675631|NCT02686151|Dexamethasone|dexamethasone|mesh-list
56675632|NCT02686151|Letrozole|letrozole|mesh-list
56675633|NCT02686151|Polygeline|polygeline|mesh-list
56675634|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56675635|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
56675636|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
56675637|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675638|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675639|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56675641|NCT02686151|Hormones|hormones|mesh-ancestor
56675642|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56675643|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56675644|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675645|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56675646|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56675647|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675648|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675649|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56675650|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
56675651|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
56675652|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
56675653|NCT00868790|Metformin|metformin|mesh-list
56675654|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56675655|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675656|NCT00496483|Tacrolimus|tacrolimus|mesh-list
56675657|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56675658|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
56675659|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675660|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56675661|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675662|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675663|NCT02614352|Candesartan|candesartan|mesh-list
56675664|NCT02614352|Atorvastatin|atorvastatin|mesh-list
56675665|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56675666|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56675667|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
56675668|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675669|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56675670|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56675671|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675672|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56675673|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56675674|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56532801|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532802|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675675|NCT01018225|Darifenacin|darifenacin|mesh-list
56675676|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56675677|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56675678|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
56235919|NCT01747044|Analgesics|analgesics|mesh-ancestor
56675681|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675682|NCT01018225|Urological Agents|urological agents|mesh-ancestor
56675683|NCT03528551|Factor VIII|factor viii|mesh-list
56675684|NCT03528551|Coagulants|coagulants|mesh-ancestor
56675685|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56675686|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675687|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675688|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
56675689|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56675690|NCT01012063|Hematinics|hematinics|mesh-ancestor
56675691|NCT03242915|Carboplatin|carboplatin|mesh-list
56675692|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
56675693|NCT03242915|Pemetrexed|pemetrexed|mesh-list
56675694|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675695|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56675696|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675697|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675698|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56675699|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56675700|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56675701|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
56675702|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675703|NCT02685059|Paclitaxel|paclitaxel|mesh-list
56675704|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
56675705|NCT02685059|Durvalumab|durvalumab|mesh-list
56675706|NCT02685059|Epirubicin|epirubicin|mesh-list
56675707|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56675708|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675709|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
56675710|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
56675711|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
56321924|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
56675712|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675713|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56675714|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
56675715|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675716|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56675717|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56675718|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
56675719|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56675720|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56675721|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56675722|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56675723|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56675724|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675725|NCT00603239|Exenatide|exenatide|mesh-list
56675726|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56675727|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675728|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56675729|NCT00603239|Incretins|incretins|mesh-ancestor
56675730|NCT00603239|Hormones|hormones|mesh-ancestor
56675731|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56675732|NCT00699114|Acetaminophen|acetaminophen|mesh-list
56675733|NCT00699114|Ibuprofen|ibuprofen|mesh-list
56675734|NCT00699114|Codeine|codeine|mesh-list
56675735|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56675736|NCT00699114|Analgesics|analgesics|mesh-ancestor
56675737|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
56675738|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675739|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675740|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
56675741|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56675742|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56675743|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56675744|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56675745|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675746|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532803|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56532804|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56532805|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56532806|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532807|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56532808|NCT02850445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56532809|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56532810|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532811|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532812|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56532813|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
56532814|NCT04220203|Capecitabine|capecitabine|mesh-list
56532815|NCT04220203|Trastuzumab|trastuzumab|mesh-list
56532816|NCT04220203|Tucatinib|tucatinib|mesh-list
56532817|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56532818|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
56532819|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532820|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532821|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56532822|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56532823|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532824|NCT02850211|Ibuprofen|ibuprofen|mesh-list
56532825|NCT02850211|Celecoxib|celecoxib|mesh-list
56675747|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56675748|NCT00699114|Narcotics|narcotics|mesh-ancestor
56675749|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675750|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
56235927|NCT01747135|Betadex|betadex|mesh-list
56675755|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56675756|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56675757|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
56675758|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
56675759|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675760|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675761|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675762|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
56675763|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
56675764|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
56675765|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
56675766|NCT00852540|Linezolid|linezolid|mesh-list
56675767|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56675768|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675769|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56675770|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675771|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675772|NCT00701220|Atorvastatin|atorvastatin|mesh-list
56675773|NCT00701220|Calcium|calcium|mesh-list
56675774|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56675775|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675776|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56675777|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56532826|NCT02850211|Tramadol|tramadol|mesh-list
56532827|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56532828|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532829|NCT02850211|Analgesics|analgesics|mesh-ancestor
56532830|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
56532900|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532901|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532902|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
56675778|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
56675779|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675780|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56675781|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56675782|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675783|NCT00701298|Interferons|interferons|mesh-list
56675784|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
56675785|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
56675786|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56675787|NCT00701298|Decitabine|decitabine|mesh-list
56675788|NCT00701298|Azacitidine|azacitidine|mesh-list
56675789|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675790|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
56675791|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675792|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
56675793|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675794|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56675795|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
56675796|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675797|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675798|NCT00860574|Methotrexate|methotrexate|mesh-list
56675799|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
56675800|NCT00860574|Fludarabine|fludarabine|mesh-list
56675801|NCT00860574|Treosulfan|treosulfan|mesh-list
56675802|NCT00860574|Tacrolimus|tacrolimus|mesh-list
56675803|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56675804|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
56675805|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56675806|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675807|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56675808|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
56675809|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675810|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675811|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
56675812|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675813|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56675814|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56675815|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
56675816|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56675817|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56675818|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56675819|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56675820|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
56675821|NCT00496015|Acetaminophen|acetaminophen|mesh-list
56675822|NCT00496015|Vaccines|vaccines|mesh-list
56235930|NCT01747148|Radavirsen|radavirsen|mesh-list
56675828|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
56675829|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675831|NCT01018381|Ethanol|ethanol|mesh-list
56675832|NCT01018381|Entecavir|entecavir|mesh-list
56675833|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56675834|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675835|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675836|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675837|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
56675838|NCT00487825|Methotrexate|methotrexate|mesh-list
56675839|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56675840|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
56675841|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56675842|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675843|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56675844|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
56675845|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675846|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675847|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
56675848|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675849|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56675850|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56675851|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
56675852|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532903|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56532904|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532905|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532906|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56532907|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56532908|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56532909|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56532910|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56532911|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
56532912|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532913|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
56532914|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
56675853|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56675854|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56675855|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
56675856|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675857|NCT01012141|Docetaxel|docetaxel|mesh-list
56675858|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675859|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
56675860|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
56675861|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
56322073|NCT00847418|Esketamine|esketamine|mesh-list
56675862|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675863|NCT00487435|Tapentadol|tapentadol|mesh-list
56675864|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56675865|NCT00487435|Narcotics|narcotics|mesh-ancestor
56675866|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675867|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675868|NCT00487435|Analgesics|analgesics|mesh-ancestor
56675869|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
56675870|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675871|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56675872|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56675873|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56675874|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675875|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
56675876|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675877|NCT00495625|Sunitinib|sunitinib|mesh-list
56675878|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675879|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56675880|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56675881|NCT00495625|Growth Substances|growth substances|mesh-ancestor
56675882|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675883|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
56675884|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56675885|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675886|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675887|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
56675888|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56675889|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56675890|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56675894|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
56675895|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675896|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56675897|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56675899|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56675900|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56675901|NCT04115904|Analgesics|analgesics|mesh-ancestor
56675902|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
56675903|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532915|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
56532916|NCT01238861|Benralizumab|benralizumab|mesh-list
56532917|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56532918|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
56532919|NCT02888561|Dobutamine|dobutamine|mesh-list
56532920|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56532921|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
56532922|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
56532923|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532924|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532925|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56532926|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56675904|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675905|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56675906|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56675907|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56675908|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675909|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675910|NCT05297994|Vaccines|vaccines|mesh-list
56675911|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
56675912|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675913|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
56675914|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
56675915|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56675916|NCT00860262|Amlodipine|amlodipine|mesh-list
56675917|NCT00860262|Telmisartan|telmisartan|mesh-list
56675918|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56675919|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56675920|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56675921|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56675922|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675923|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56675924|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675925|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
56675926|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56675927|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56675928|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
56675929|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56675930|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675931|NCT00860028|Varenicline|varenicline|mesh-list
56675932|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56675933|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56675934|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
56322150|NCT00396747|Hormones|hormones|mesh-ancestor
56675935|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675936|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675937|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675938|NCT00701532|Modafinil|modafinil|mesh-list
56675939|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56675940|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675941|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56675942|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56675943|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56675944|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675945|NCT00846768|Olodaterol|olodaterol|mesh-list
56675946|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56675947|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
56675948|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675949|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675950|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56675951|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
56675952|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56532927|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56281131|NCT00005878|Celecoxib|celecoxib|mesh-list
56532928|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
56532929|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383802|NCT00503815|Laxatives|laxatives|mesh-ancestor
56532930|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532931|NCT02888561|Protective Agents|protective agents|mesh-ancestor
56532932|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56532933|NCT04319549|Eusol|eusol|mesh-list
56532934|NCT04319549|Ketorolac|ketorolac|mesh-list
56532935|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56532936|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56532937|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56532938|NCT04319549|Analgesics|analgesics|mesh-ancestor
56648521|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
56675953|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56675954|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56675955|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56675956|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235937|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
56675959|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
56675960|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56675961|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56675962|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56675963|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56675964|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675965|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675966|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56675967|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56675968|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56675969|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
56675970|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675971|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675972|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56675973|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56675974|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
56675975|NCT00699426|Esomeprazole|esomeprazole|mesh-list
56675976|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56675977|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56675978|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56675979|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675980|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675981|NCT00593606|Rotigotine|rotigotine|mesh-list
56675982|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
56675983|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
56675984|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675985|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675986|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675987|NCT02614118|Acetaminophen|acetaminophen|mesh-list
56675988|NCT02614118|Ketorolac|ketorolac|mesh-list
56675989|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56675990|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56675991|NCT02614118|Analgesics|analgesics|mesh-ancestor
56675992|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
56675993|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675994|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675995|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
56675996|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56675997|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56675998|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56675999|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56532939|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
56532940|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56532941|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532942|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56532943|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532944|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56532945|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532946|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532947|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
56532948|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56532949|NCT00903409|Simvastatin|simvastatin|mesh-list
56676000|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676001|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676002|NCT04134416|Donepezil|donepezil|mesh-list
56676003|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56676004|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676005|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676006|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
56676007|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676008|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676009|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
56676010|NCT04134182|Nivolumab|nivolumab|mesh-list
56676011|NCT04134182|Ipilimumab|ipilimumab|mesh-list
56676012|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56676013|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676014|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56676015|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676016|NCT00870584|Omalizumab|omalizumab|mesh-list
56676017|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56676018|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56676019|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
56676020|NCT02614508|Ofatumumab|ofatumumab|mesh-list
56676021|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56676022|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676023|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
56676024|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676025|NCT02616068|Loxoprofen|loxoprofen|mesh-list
56676026|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676027|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676028|NCT02616068|Analgesics|analgesics|mesh-ancestor
56235941|NCT01747174|Nitroprusside|nitroprusside|mesh-list
56676035|NCT04127084|Canagliflozin|canagliflozin|mesh-list
56676036|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56676037|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676038|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56676039|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676040|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56676041|NCT00870194|Exenatide|exenatide|mesh-list
56676042|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56676043|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676044|NCT00870194|Incretins|incretins|mesh-ancestor
56676045|NCT00870194|Hormones|hormones|mesh-ancestor
56676046|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56676047|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56676048|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
56676049|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676050|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676051|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56676052|NCT00690430|Octreotide|octreotide|mesh-list
56676053|NCT00690430|Pasireotide|pasireotide|mesh-list
56676054|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56676055|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56676056|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532950|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56532951|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56532952|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
56648522|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
56676057|NCT00690430|Hormones|hormones|mesh-ancestor
56676058|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56676059|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676060|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56676061|NCT04126304|Azithromycin|azithromycin|mesh-list
56676062|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676063|NCT02563054|Fluorouracil|fluorouracil|mesh-list
56676064|NCT02563054|Capecitabine|capecitabine|mesh-list
56676065|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676066|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
56676067|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676068|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56676069|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676070|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
56676071|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676072|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
56676073|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56676074|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56676075|NCT00743470|Ritonavir|ritonavir|mesh-list
56676076|NCT00743470|Lopinavir|lopinavir|mesh-list
56676077|NCT00743470|Rifabutin|rifabutin|mesh-list
56676078|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56676079|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56676080|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
56676081|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676082|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676083|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56676084|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56676085|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
56676086|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676087|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56676088|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56676089|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56676090|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56676091|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
56676092|NCT00688324|Acamprosate|acamprosate|mesh-list
56676093|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56676094|NCT02619578|Remifentanil|remifentanil|mesh-list
56676095|NCT02619578|Propofol|propofol|mesh-list
56676096|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
56676097|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56676098|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676103|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56676105|NCT02619578|Analgesics|analgesics|mesh-ancestor
56676106|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
56676107|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676108|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56676109|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56676110|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56676111|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56676112|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56676113|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
56676114|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676115|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676116|NCT02615912|Castor Oil|castor oil|mesh-list
56676117|NCT02615912|Cathartics|cathartics|mesh-ancestor
56676118|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56676119|NCT04123652|Lidocaine|lidocaine|mesh-list
56676120|NCT04123652|Ketamine|ketamine|mesh-list
56676121|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
56676122|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
56676123|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676124|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676125|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
56676126|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676127|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56676128|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56676129|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56676130|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532953|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532954|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56532955|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56532956|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532957|NCT01237223|Amlodipine|amlodipine|mesh-list
56532958|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56532959|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56532960|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56532961|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532962|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56532963|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532964|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
56532965|NCT01236365|Atorvastatin|atorvastatin|mesh-list
56532966|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56532967|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56532968|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
56532969|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532970|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56532971|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56532972|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532973|NCT00903331|Macitentan|macitentan|mesh-list
56532974|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56532975|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56532976|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56532977|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56532978|NCT01235741|Pramlintide|pramlintide|mesh-list
56532979|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56532980|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532981|NCT01235507|Methotrexate|methotrexate|mesh-list
56532982|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56532983|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
56532984|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56532985|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56532986|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56532987|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
56532988|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676131|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676132|NCT04123652|Analgesics|analgesics|mesh-ancestor
56676133|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56676134|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56676135|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
56676136|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56676137|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56676138|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676139|NCT00862940|Memantine|memantine|mesh-list
56676140|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56676141|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56676142|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
56676143|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676144|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676145|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676146|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56676147|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56676148|NCT04122716|Liraglutide|liraglutide|mesh-list
56676149|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56676150|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676151|NCT04122716|Incretins|incretins|mesh-ancestor
56676152|NCT04122716|Hormones|hormones|mesh-ancestor
56676153|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56676154|NCT00868166|Riluzole|riluzole|mesh-list
56676155|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
56676156|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56676157|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56322385|NCT00396786|Enoxaparin|enoxaparin|mesh-list
56676158|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676159|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676160|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676161|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56676162|NCT00868166|Protective Agents|protective agents|mesh-ancestor
56676164|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676165|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676166|NCT00858780|Analgesics|analgesics|mesh-ancestor
56676167|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
56676168|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676177|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56676178|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56676179|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56676180|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
56676181|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56676182|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676183|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56676184|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56676185|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56676186|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676187|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
56676188|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56676189|NCT00699062|Montelukast|montelukast|mesh-list
56676190|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56676191|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
56676192|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56676193|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
56676194|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56676195|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676196|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56676197|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56676198|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676199|NCT02619032|Fentanyl|fentanyl|mesh-list
56676200|NCT02619032|Remifentanil|remifentanil|mesh-list
56676201|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56676202|NCT02619032|Narcotics|narcotics|mesh-ancestor
56676203|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676204|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676205|NCT02619032|Analgesics|analgesics|mesh-ancestor
56676206|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
56532989|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56532990|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
56532991|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56532992|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56532993|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56532994|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
56532995|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56532996|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56532997|NCT01868269|Dexamethasone|dexamethasone|mesh-list
56532998|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
56532999|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
56533000|NCT01868269|Rituximab|rituximab|mesh-list
56533001|NCT01868269|BB 1101|bb 1101|mesh-list
56533002|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676207|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676208|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56676209|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56676210|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
56676211|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
56676212|NCT00858234|Bortezomib|bortezomib|mesh-list
56676213|NCT00858234|Vorinostat|vorinostat|mesh-list
56676214|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676215|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56676216|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676217|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676218|NCT00697814|Clomiphene|clomiphene|mesh-list
56676219|NCT00697814|Enclomiphene|enclomiphene|mesh-list
56676220|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
56676221|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56676222|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
56676223|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56676224|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676225|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56676226|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
56676227|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56676228|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56676229|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56676230|NCT00862082|Sorafenib|sorafenib|mesh-list
56322449|NCT00276770|Fluorides|fluorides|mesh-list
56676231|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56676232|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676233|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56235955|NCT01747226|Fluorides|fluorides|mesh-list
56676259|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
56676260|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676262|NCT02618876|Bupivacaine|bupivacaine|mesh-list
56676263|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
56676264|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
56676265|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676266|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676267|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
56676268|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676269|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56676270|NCT02618876|Narcotics|narcotics|mesh-ancestor
56676271|NCT02618876|Analgesics|analgesics|mesh-ancestor
56676272|NCT04119752|Curcumin|curcumin|mesh-list
56676273|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676274|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676275|NCT04119752|Analgesics|analgesics|mesh-ancestor
56676276|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
56676277|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676278|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676279|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676280|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56473645|NCT00523887|Narcotics|narcotics|mesh-ancestor
56634279|NCT03405090|Fentanyl|fentanyl|mesh-list
56533004|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533005|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533006|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56533007|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
56533008|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676281|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676282|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235962|NCT01747252|Protective Agents|protective agents|mesh-ancestor
56676289|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
56676290|NCT00866918|Idarubicin|idarubicin|mesh-list
56676291|NCT00866918|Tretinoin|tretinoin|mesh-list
56676292|NCT00866918|Retinol palmitate|retinol palmitate|mesh-list
56676293|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
56676294|NCT00866918|Micronutrients|micronutrients|mesh-ancestor
56676295|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676296|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56676297|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
56676298|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56676299|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56676300|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
56676301|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322523|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56676302|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676303|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
56676304|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676305|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56676306|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676307|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
56676308|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676309|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56676310|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
56676311|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676312|NCT00866918|Analgesics|analgesics|mesh-ancestor
56676313|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
56676314|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676315|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56676316|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56676317|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56676318|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
56676319|NCT00866918|Antioxidants|antioxidants|mesh-ancestor
56676320|NCT00866918|Protective Agents|protective agents|mesh-ancestor
56676321|NCT00866918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56676322|NCT00861692|Argatroban|argatroban|mesh-list
56676323|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
56676324|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56676325|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
56676326|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676327|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676328|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
56676329|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56676330|NCT03131765|Poly I-C|poly i-c|mesh-list
56676331|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
56676332|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676333|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
56676334|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
56676335|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676336|NCT02689037|Aspirin|aspirin|mesh-list
56676337|NCT02689037|Clopidogrel|clopidogrel|mesh-list
56676338|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676339|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676340|NCT02689037|Analgesics|analgesics|mesh-ancestor
56676341|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
56676342|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676343|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676344|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676345|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676346|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56676347|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56676348|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533009|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533010|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56533011|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187212|NCT03512496|Caffeine|caffeine|mesh-list
56676349|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56676350|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56676351|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676352|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
56676353|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56676368|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56676369|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56676370|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676371|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56676372|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56676373|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676374|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
56676375|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676376|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56676377|NCT00602927|Varenicline|varenicline|mesh-list
56676378|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56676379|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56676380|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
56676381|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676382|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676383|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676385|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56676386|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56676387|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676388|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
56676389|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56676390|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676391|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676392|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56676393|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56676394|NCT04186559|Protective Agents|protective agents|mesh-ancestor
56676395|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676396|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
56676397|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56676398|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
56676399|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
56676400|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56676401|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
56676402|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56676403|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676404|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676405|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
56676406|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56676407|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676408|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676409|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56676410|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56676411|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56676412|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235989|NCT01747590|Zolpidem|zolpidem|mesh-list
56676417|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
56676419|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56676420|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56676421|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676422|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
56676423|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
56676424|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
56676425|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676426|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676427|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
56676428|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676429|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676430|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56676431|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
56676432|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56533012|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533013|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
56533014|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
56533015|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533016|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56676433|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56676434|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56676435|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56676436|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676437|NCT02684669|Naloxone|naloxone|mesh-list
56676438|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56676439|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676440|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
56676441|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676442|NCT02976935|Xenon|xenon|mesh-list
56676443|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56676444|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
56676445|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
56676446|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676447|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676448|NCT00861614|Ipilimumab|ipilimumab|mesh-list
56676449|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56676450|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676451|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56676452|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676453|NCT00861380|Vaccines|vaccines|mesh-list
56322668|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
56676454|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56676455|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
56676456|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676457|NCT00495391|Ribavirin|ribavirin|mesh-list
56676458|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56676459|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
56676460|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
56676461|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676462|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
56676463|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676464|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56676465|NCT04378621|Adalimumab|adalimumab|mesh-list
56676466|NCT04378621|Etanercept|etanercept|mesh-list
56676467|NCT04378621|Golimumab|golimumab|mesh-list
56676468|NCT04378621|Infliximab|infliximab|mesh-list
56676469|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
56676470|NCT04378621|Tofacitinib|tofacitinib|mesh-list
56676471|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56676472|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676473|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676474|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
56676475|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56676476|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676477|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676478|NCT04378621|Analgesics|analgesics|mesh-ancestor
56676479|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
56676480|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676481|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676482|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676483|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
56676484|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56676501|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56676502|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56676503|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56676504|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56676506|NCT02618564|Laxatives|laxatives|mesh-ancestor
56676507|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56676508|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
56676509|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56676510|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56676511|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676512|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
56676513|NCT02615366|Coagulants|coagulants|mesh-ancestor
56676514|NCT00699296|Panobinostat|panobinostat|mesh-list
56533017|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
56533018|NCT01868269|Hormones|hormones|mesh-ancestor
56648523|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
56676515|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676516|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56676517|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676518|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676519|NCT04119674|Temozolomide|temozolomide|mesh-list
56676520|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56676521|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
56676522|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676523|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676524|NCT00494299|Sorafenib|sorafenib|mesh-list
56676525|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676526|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56676527|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676528|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676529|NCT05298176|Carboplatin|carboplatin|mesh-list
56676530|NCT05298176|Pemetrexed|pemetrexed|mesh-list
56322821|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
56676531|NCT05298176|Osimertinib|osimertinib|mesh-list
56676532|NCT05298176|Afatinib|afatinib|mesh-list
56676533|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676534|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676535|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676536|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56676537|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56676538|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56676539|NCT02615288|Vitamin D|vitamin d|mesh-list
56676540|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
56676541|NCT02615288|Vitamins|vitamins|mesh-ancestor
56676542|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
56676550|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676551|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
56676552|NCT04134026|Hematinics|hematinics|mesh-ancestor
56676553|NCT02963831|Cyclophosphamide|cyclophosphamide|mesh-list
56676554|NCT02963831|Durvalumab|durvalumab|mesh-list
56676555|NCT02963831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676556|NCT02963831|Immunologic Factors|immunologic factors|mesh-ancestor
56676557|NCT02963831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676558|NCT02963831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676559|NCT02963831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56676560|NCT02963831|Alkylating Agents|alkylating agents|mesh-ancestor
56676561|NCT02963831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676562|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676563|NCT02963831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56676564|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56676565|NCT00859898|Metformin|metformin|mesh-list
56676566|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
56676567|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56676568|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676569|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56676570|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676571|NCT02684123|Apremilast|apremilast|mesh-list
56676572|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676573|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676574|NCT02684123|Analgesics|analgesics|mesh-ancestor
56676575|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
56676576|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676577|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676578|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676579|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676580|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56676581|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56676582|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676583|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676584|NCT00638729|Clonidine|clonidine|mesh-list
56676585|NCT00638729|Midazolam|midazolam|mesh-list
56676586|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56676587|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56676588|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676589|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676590|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56533019|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533020|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56676591|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56676592|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56676593|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56676594|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
56676595|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
56676596|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
56676597|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
56676598|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676599|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676600|NCT00638729|Analgesics|analgesics|mesh-ancestor
56676601|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
56676602|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676603|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56676604|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
56676605|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
56676606|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56676607|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56676608|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56676609|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
56676610|NCT00697892|Ritonavir|ritonavir|mesh-list
56676611|NCT00697892|Lopinavir|lopinavir|mesh-list
56676615|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56676616|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56676617|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56676618|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
56676619|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676620|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676621|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56676622|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56676623|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
56676624|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676625|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56676626|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56676627|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56676628|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56676629|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56676630|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56676631|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56676632|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56676633|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56676634|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
56676635|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56676636|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56676637|NCT00699452|Candesartan|candesartan|mesh-list
56676638|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56676639|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56676640|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56676641|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676642|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56676643|NCT02683733|Curcumin|curcumin|mesh-list
56676644|NCT02683733|Mesalamine|mesalamine|mesh-list
56676645|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676646|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676647|NCT02683733|Analgesics|analgesics|mesh-ancestor
56676648|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
56676649|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676650|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676651|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676652|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676653|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676654|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676655|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676656|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
56676657|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56676658|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676659|NCT02683655|Apatinib|apatinib|mesh-list
56676660|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676661|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56676662|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533021|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
56533022|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533023|NCT01235351|Clopidogrel|clopidogrel|mesh-list
56533024|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56533025|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56533026|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56533027|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56533028|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
56533029|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533030|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533031|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533032|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
56533033|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56533034|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56533035|NCT01234649|Metformin|metformin|mesh-list
56533036|NCT01234649|Liraglutide|liraglutide|mesh-list
56533037|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56676663|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676664|NCT00494221|Leucovorin|leucovorin|mesh-list
56676665|NCT00494221|Fluorouracil|fluorouracil|mesh-list
56676666|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
56676667|NCT00494221|Cediranib|cediranib|mesh-list
56676668|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
56676669|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
56676670|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676671|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56676672|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676673|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676674|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
56676675|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676676|NCT00494221|Antidotes|antidotes|mesh-ancestor
56676677|NCT00494221|Protective Agents|protective agents|mesh-ancestor
56322894|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56676678|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
56676679|NCT00494221|Vitamins|vitamins|mesh-ancestor
56676680|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
56676681|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56676682|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746015|NCT05035953|Edaravone|edaravone|mesh-list
56676704|NCT02688491|Growth Substances|growth substances|mesh-ancestor
56676705|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676706|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
56676707|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56676708|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676709|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676710|NCT00857792|Regadenoson|regadenoson|mesh-list
56676711|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56676712|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56676713|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
56676714|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
56676715|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676716|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676717|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676718|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
56676719|NCT02613494|Scopolamine|scopolamine|mesh-list
56676720|NCT02613494|Bromides|bromides|mesh-list
56676721|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56676722|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
56676723|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56533038|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533039|NCT01234649|Incretins|incretins|mesh-ancestor
56533040|NCT01234649|Hormones|hormones|mesh-ancestor
56533041|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533042|NCT02876679|Cyclosporine|cyclosporine|mesh-list
56533043|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
56533044|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
56533045|NCT02876679|Cyclosporins|cyclosporins|mesh-list
56533046|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56533047|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533048|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
56676724|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56676725|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56676726|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
56676727|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676728|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676729|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676730|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
56676731|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
56676732|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676733|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56676734|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
56676735|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
56676736|NCT00699530|Cabergoline|cabergoline|mesh-list
56676746|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676748|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
56676749|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676750|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56676751|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56676752|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56676753|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676754|NCT00697502|Capecitabine|capecitabine|mesh-list
56676755|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56676756|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
56676757|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676758|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676759|NCT00857246|Irinotecan|irinotecan|mesh-list
56676760|NCT00857246|Cetuximab|cetuximab|mesh-list
56676761|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676762|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56676763|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56676764|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676765|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676766|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56676767|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
56676768|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
56676769|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56676770|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676771|NCT00640679|Clopidogrel|clopidogrel|mesh-list
56676772|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56676773|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56676774|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56676775|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56676776|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
56676777|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676778|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676779|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676780|NCT02682953|Plerixafor|plerixafor|mesh-list
56676781|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56676782|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56676783|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
56676784|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676785|NCT02683031|Ionophores|ionophores|mesh-list
56676786|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56533049|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533050|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533051|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56533052|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
56533053|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533054|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533055|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56533056|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533057|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
56533058|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533059|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
56533060|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56533061|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56533062|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56533063|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
56533064|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56533065|NCT01075815|Hormones|hormones|mesh-list
56533066|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56533067|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533068|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676787|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676788|NCT04184141|Alprazolam|alprazolam|mesh-list
56676789|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
56676790|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56676791|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676792|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676793|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56676794|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56676795|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56676796|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
56676797|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
56676798|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676799|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676800|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
56676808|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676809|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56676810|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56676811|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56676812|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56676813|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56676814|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676815|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676816|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676817|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56676818|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56676819|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56676820|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56676821|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
56676822|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56676823|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676824|NCT00640991|Insulin|insulin|mesh-list
56676825|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
56533069|NCT01072149|Fluticasone|fluticasone|mesh-list
56533070|NCT01072149|Xhance|xhance|mesh-list
56533071|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533072|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56533073|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
56533074|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533075|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281281|NCT00005938|Exatecan|exatecan|mesh-list
56533076|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56634280|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
56676826|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
56676827|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56676828|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676829|NCT00638807|Celecoxib|celecoxib|mesh-list
56676830|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676831|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676832|NCT00638807|Analgesics|analgesics|mesh-ancestor
56676833|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
56676834|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676835|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676836|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676837|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676838|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56676839|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56676840|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676841|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676842|NCT00856856|Everolimus|everolimus|mesh-list
56676843|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676844|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676845|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
56676846|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676847|NCT00782327|Losartan|losartan|mesh-list
56676848|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56676849|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56676850|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56676851|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56676852|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676853|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56676854|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56676855|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56676856|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676857|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676858|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56676859|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56676860|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676861|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
56676862|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676863|NCT00559091|Ribavirin|ribavirin|mesh-list
56676864|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
56676865|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676866|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
56676867|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676868|NCT02682017|Fucoidan|fucoidan|mesh-list
56676869|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56676872|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676874|NCT04076579|Trabectedin|trabectedin|mesh-list
56676875|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56676876|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676877|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676878|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676879|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56676880|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
56676881|NCT00603473|Gabapentin|gabapentin|mesh-list
56676882|NCT00603473|Analgesics|analgesics|mesh-ancestor
56676883|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
56533077|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
56676884|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676885|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676886|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
56676887|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56676888|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56676889|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676890|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56676891|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56676892|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56676893|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676894|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676895|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
56676896|NCT02688023|Leucovorin|leucovorin|mesh-list
56676897|NCT02688023|Fluorouracil|fluorouracil|mesh-list
56676898|NCT02688023|Capecitabine|capecitabine|mesh-list
56676899|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
56676900|NCT02688023|Irinotecan|irinotecan|mesh-list
56676901|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
56676902|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323119|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56323120|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56323121|NCT00128453|Colchicine|colchicine|mesh-list
56676903|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56676904|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676905|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676906|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
56676907|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676908|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56676909|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56676910|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676911|NCT02688023|Antidotes|antidotes|mesh-ancestor
56676912|NCT02688023|Protective Agents|protective agents|mesh-ancestor
56676913|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
56676914|NCT02688023|Vitamins|vitamins|mesh-ancestor
56676915|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
56676916|NCT00910013|Ropivacaine|ropivacaine|mesh-list
56676917|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
56676918|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
56676919|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676920|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676921|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
56676922|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676923|NCT04182191|Tenoxicam|tenoxicam|mesh-list
56676924|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676925|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676926|NCT04182191|Analgesics|analgesics|mesh-ancestor
56676927|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
56676928|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676929|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676930|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676931|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676932|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56676933|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676934|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676935|NCT02577406|Cytarabine|cytarabine|mesh-list
56676936|NCT02577406|Azacitidine|azacitidine|mesh-list
56676937|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56676938|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
56676939|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676940|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676947|NCT02680379|Minocycline|minocycline|mesh-list
56676948|NCT02680379|Lovastatin|lovastatin|mesh-list
56676949|NCT02680379|L 647318|l 647318|mesh-list
56676950|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
56676951|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56676952|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676953|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56676954|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56676955|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
56676956|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676957|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56676958|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56676959|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676960|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
56533078|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
56533079|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56533081|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56676961|NCT03996421|Trace Elements|trace elements|mesh-ancestor
56676962|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
56676963|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676964|NCT00641693|Budesonide|budesonide|mesh-list
56676965|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676966|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56676967|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
56676968|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676969|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676970|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56676971|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
56676972|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
56676973|NCT00641693|Hormones|hormones|mesh-ancestor
56676974|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56676975|NCT04183361|Cortisone|cortisone|mesh-list
56323194|NCT05770375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56323195|NCT05770375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56676976|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676977|NCT02503774|Durvalumab|durvalumab|mesh-list
56676978|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56676979|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676980|NCT02687867|Vitamin K|vitamin k|mesh-list
56676981|NCT02687867|Dabigatran|dabigatran|mesh-list
56676982|NCT02687867|Vitamins|vitamins|mesh-ancestor
56676983|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
56676984|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676985|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
56676986|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56676987|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
56676988|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676989|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676990|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
56676991|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56676992|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56676993|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
56676994|NCT02687867|Coagulants|coagulants|mesh-ancestor
56676995|NCT02681783|Aflibercept|aflibercept|mesh-list
56676996|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56676997|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56676998|NCT02681783|Growth Substances|growth substances|mesh-ancestor
56676999|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677000|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
56677001|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677002|NCT00486811|Oxycodone|oxycodone|mesh-list
56677003|NCT00486811|Tapentadol|tapentadol|mesh-list
56677004|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56677005|NCT00486811|Narcotics|narcotics|mesh-ancestor
56677006|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677007|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677008|NCT00486811|Analgesics|analgesics|mesh-ancestor
56677009|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
56677010|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677022|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
56677023|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677024|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677025|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
56677026|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56677027|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677028|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56677029|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56677030|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677031|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677032|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56677033|NCT00921700|Narcotics|narcotics|mesh-ancestor
56677034|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677035|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
56677036|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
56677037|NCT02678195|Amoxicillin|amoxicillin|mesh-list
56677038|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56677039|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677041|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
56677042|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
56677043|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677044|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677045|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
56677046|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677047|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56677048|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56677049|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56677050|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677051|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323269|NCT05769478|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56677052|NCT02681705|Temozolomide|temozolomide|mesh-list
56677053|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56677054|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
56677055|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677056|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677057|NCT00921622|Vitamin D|vitamin d|mesh-list
56677058|NCT00921622|Vitamins|vitamins|mesh-list
56677059|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
56677060|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677061|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56677062|NCT02681471|Mannitol|mannitol|mesh-list
56677063|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56677064|NCT02681471|Diuretics|diuretics|mesh-ancestor
56677065|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
56677066|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677067|NCT00642395|Bortezomib|bortezomib|mesh-list
56677068|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677069|NCT01018615|Silymarin|silymarin|mesh-list
56677070|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
56677071|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677072|NCT01018615|Protective Agents|protective agents|mesh-ancestor
56236075|NCT01747993|Tamsulosin|tamsulosin|mesh-list
56677076|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677078|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56677079|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
56677080|NCT02678117|Pregabalin|pregabalin|mesh-list
56677081|NCT02678117|Analgesics|analgesics|mesh-ancestor
56677082|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
56677083|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677084|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677085|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
56677086|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56677087|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677088|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677089|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56677090|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56677091|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56677092|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677093|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56677094|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
56677095|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56677096|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
56677097|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56677098|NCT01018849|Vitamin D|vitamin d|mesh-list
56677099|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
56677100|NCT01018849|Vitamins|vitamins|mesh-ancestor
56677101|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
56677102|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677103|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56677104|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56677105|NCT04102319|Hepcidins|hepcidins|mesh-list
56677106|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677107|NCT00743860|Darapladib|darapladib|mesh-list
56677108|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56677109|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677110|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677111|NCT00747526|Rabeprazole|rabeprazole|mesh-list
56677112|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56677113|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56677114|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56677115|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677116|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677117|NCT00747604|Mecasermin|mecasermin|mesh-list
56677118|NCT00747604|Growth Substances|growth substances|mesh-ancestor
56533082|NCT04413253|Lifitegrast|lifitegrast|mesh-list
56533083|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56279967|NCT04833387|Antibodies|antibodies|mesh-list
56677119|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677120|NCT02151604|Xenon|xenon|mesh-list
56677121|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56677122|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
56677123|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
56677124|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677125|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677126|NCT00466921|Lenalidomide|lenalidomide|mesh-list
56323343|NCT05760612|Trastuzumab|trastuzumab|mesh-list
56677127|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
56677128|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677129|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56677130|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56677131|NCT00466921|Growth Substances|growth substances|mesh-ancestor
56677132|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
56677133|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677134|NCT00601523|Pramipexole|pramipexole|mesh-list
56677135|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
56677136|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677137|NCT00601523|Protective Agents|protective agents|mesh-ancestor
56677138|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677139|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56677140|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56677141|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
56677142|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
56677143|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677148|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56677149|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56677150|NCT00466687|Growth Substances|growth substances|mesh-ancestor
56677151|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677152|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
56677153|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56677154|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677155|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677156|NCT01522768|Paclitaxel|paclitaxel|mesh-list
56677157|NCT01522768|Afatinib|afatinib|mesh-list
56677158|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56677159|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677160|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
56677161|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
56677162|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
56677163|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677164|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56677165|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677166|NCT01759459|Lidocaine|lidocaine|mesh-list
56677167|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
56677168|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
56677169|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677170|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677171|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
56677172|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677173|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56677174|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56677175|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56677176|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677177|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677178|NCT02562742|Ribavirin|ribavirin|mesh-list
56677179|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
56677180|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677181|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
56677182|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677183|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
56677184|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56677185|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
56677186|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677187|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56677188|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56677189|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
56677190|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057036|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
56533084|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533085|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
56533086|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
56533087|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533088|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533089|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56533090|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
56533092|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533093|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56533094|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533095|NCT01679119|Gemcitabine|gemcitabine|mesh-list
56677191|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677192|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56677193|NCT00744016|Mesalamine|mesalamine|mesh-list
56677194|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56677195|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56677196|NCT00744016|Analgesics|analgesics|mesh-ancestor
56677197|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
56677198|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677199|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677200|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677201|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56677203|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56677204|NCT04182737|Antibodies|antibodies|mesh-list
56677205|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
56677206|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
56677207|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
56677208|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677209|NCT04181645|Gemcitabine|gemcitabine|mesh-list
56677210|NCT04181645|Paclitaxel|paclitaxel|mesh-list
56677211|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56677212|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677213|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
56677214|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
56677215|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
56677222|NCT04181645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56677223|NCT04181645|Immunologic Factors|immunologic factors|mesh-ancestor
56677224|NCT04181645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677225|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
56677226|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
56677227|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
56677228|NCT02679833|Vitamins|vitamins|mesh-ancestor
56677229|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
56677230|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677231|NCT02679833|Hematinics|hematinics|mesh-ancestor
56677232|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
56677233|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56677234|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
56677235|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56677236|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677237|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677238|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
56677239|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56677240|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677241|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677242|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56677243|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56677244|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677245|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677246|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56677247|NCT02677571|Morphine|morphine|mesh-list
56677248|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
56677249|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56677250|NCT02677571|Narcotics|narcotics|mesh-ancestor
56533096|NCT01679119|Prednisolone|prednisolone|mesh-list
56533097|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
56533098|NCT01679119|Rituximab|rituximab|mesh-list
56533099|NCT01679119|Vincristine|vincristine|mesh-list
56677251|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677252|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677253|NCT02677571|Analgesics|analgesics|mesh-ancestor
56677254|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
56677255|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677256|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
56677257|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
56677258|NCT04181567|S 20098|s 20098|mesh-list
56677259|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56677260|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677261|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677262|NCT05664191|Simendan|simendan|mesh-list
56677263|NCT05664191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56677264|NCT05664191|Vasodilator Agents|vasodilator agents|mesh-ancestor
56677265|NCT05664191|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56677266|NCT05664191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56677267|NCT05664191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677268|NCT05664191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677269|NCT05664191|Protective Agents|protective agents|mesh-ancestor
56677270|NCT05664191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677271|NCT02676011|Atropine|atropine|mesh-list
56677272|NCT02676011|Succinylcholine|succinylcholine|mesh-list
56677273|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56677274|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56677275|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56323491|NCT05642962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56677276|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
56677277|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677278|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677279|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56677280|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
56677281|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
56677282|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
56677283|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56677284|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56677285|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
56677286|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677287|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677288|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56677289|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56677290|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56677291|NCT05662943|Aflibercept|aflibercept|mesh-list
56677292|NCT05662943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56677293|NCT05662943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56677294|NCT05662943|Growth Substances|growth substances|mesh-ancestor
56677295|NCT05662943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677296|NCT05662943|Growth Inhibitors|growth inhibitors|mesh-ancestor
56677297|NCT05662943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677298|NCT05663255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56677299|NCT05663255|Azithromycin|azithromycin|mesh-list
56677300|NCT05663255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677301|NCT02678975|Copper|copper|mesh-list
56677302|NCT02678975|Temozolomide|temozolomide|mesh-list
56677303|NCT02678975|Lomustine|lomustine|mesh-list
56677304|NCT02678975|Disulfiram|disulfiram|mesh-list
56677305|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
56677306|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56677307|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677308|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677309|NCT02678975|Trace Elements|trace elements|mesh-ancestor
56677310|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
56677311|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677312|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56677313|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56677314|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677315|NCT02677415|Anesthetics|anesthetics|mesh-list
56677316|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56677317|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677318|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533100|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56533101|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533102|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
56533103|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533104|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533105|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56533106|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
56533107|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533108|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533109|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56533110|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56533111|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56533112|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
56533113|NCT01679119|Antiviral Agents|antiviral agents|mesh-ancestor
56533114|NCT01679119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533115|NCT01679119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533116|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56533117|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
56533118|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
56533119|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
56677319|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
56677320|NCT00454051|Omalizumab|omalizumab|mesh-list
56677321|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56677322|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56677323|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
56677324|NCT04181489|Prednisolone|prednisolone|mesh-list
56677325|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
56677326|NCT04181489|Rituximab|rituximab|mesh-list
56677327|NCT04181489|Doxorubicin|doxorubicin|mesh-list
56677328|NCT04181489|Vincristine|vincristine|mesh-list
56677329|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56677330|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
56677331|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677332|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56677333|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56677334|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
56677335|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677336|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677337|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56677338|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56677339|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56677340|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56677341|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56677342|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677343|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56677344|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56677345|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56677346|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56677347|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677348|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
56677349|NCT04181489|Hormones|hormones|mesh-ancestor
56323567|NCT05579626|Antimetabolites|antimetabolites|mesh-ancestor
56677350|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677351|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56533120|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533121|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
56533122|NCT01679119|Hormones|hormones|mesh-ancestor
56677352|NCT02537561|Gemcitabine|gemcitabine|mesh-list
56677353|NCT02537561|Cisplatin|cisplatin|mesh-list
56677354|NCT02537561|Talazoparib|talazoparib|mesh-list
56677355|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677356|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56677357|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
56677358|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677364|NCT02537561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677365|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56677367|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56677368|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
56677369|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677370|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677371|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56677372|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
56677373|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
56677374|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56677375|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
56677376|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677377|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677378|NCT02679131|Belinostat|belinostat|mesh-list
56677379|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677380|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56677381|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677382|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677383|NCT00484939|Bevacizumab|bevacizumab|mesh-list
56677384|NCT00484939|Capecitabine|capecitabine|mesh-list
56677385|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56677386|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677387|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56677388|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56677389|NCT00484939|Growth Substances|growth substances|mesh-ancestor
56677390|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677391|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
56677392|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56677393|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
56677394|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677395|NCT00642161|Budesonide|budesonide|mesh-list
56677396|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677397|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56677398|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
56677399|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677400|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677401|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56677402|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
56677403|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
56677404|NCT00642161|Hormones|hormones|mesh-ancestor
56677405|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677406|NCT05663177|Vinorelbine|vinorelbine|mesh-list
56677407|NCT05663177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56677408|NCT05663177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677409|NCT05663177|Tubulin Modulators|tubulin modulators|mesh-ancestor
56677410|NCT05663177|Antimitotic Agents|antimitotic agents|mesh-ancestor
56677411|NCT05663177|Mitosis Modulators|mitosis modulators|mesh-ancestor
56677412|NCT05663177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677413|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
56677414|NCT00642551|Vitamin K|vitamin k|mesh-list
56677415|NCT00642551|Vitamin MK 7|vitamin mk 7|mesh-list
56677416|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56677417|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56677418|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677419|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
56677420|NCT00642551|Coagulants|coagulants|mesh-ancestor
56677421|NCT00642551|Vitamins|vitamins|mesh-ancestor
56677422|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
56677423|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677424|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56677425|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56677426|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533123|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533124|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56533125|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56533126|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
56533127|NCT04778787|Digoxin|digoxin|mesh-list
56533128|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56533129|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
56533130|NCT04778787|Diuretics|diuretics|mesh-list
56533131|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56533132|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56533133|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533134|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56533135|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533136|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56533137|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56533138|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533139|NCT04778787|Protective Agents|protective agents|mesh-ancestor
56533140|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
56533141|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56533142|NCT05263453|Vemurafenib|vemurafenib|mesh-list
56533143|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677427|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56677433|NCT00643409|Azithromycin|azithromycin|mesh-list
56677434|NCT00643409|Levofloxacin|levofloxacin|mesh-list
56677435|NCT00643409|Ofloxacin|ofloxacin|mesh-list
56677436|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56677437|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677438|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56677439|NCT00643409|Renal Agents|renal agents|mesh-ancestor
56677440|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56677441|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56677442|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677443|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677444|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677445|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56677446|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56677447|NCT04180007|Apatinib|apatinib|mesh-list
56677448|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677449|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56677450|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677451|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677452|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56677453|NCT02675309|Simvastatin|simvastatin|mesh-list
56677454|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56677455|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56677456|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
56677457|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677458|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56677459|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56677460|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677461|NCT01025245|Remifentanil|remifentanil|mesh-list
56677462|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56533144|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56533145|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533146|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533147|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
56533148|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56533149|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533150|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533151|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56533152|NCT04304157|Analgesics|analgesics|mesh-ancestor
56533153|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
56533154|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533155|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56533156|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56533157|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56533158|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
56533159|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677463|NCT01025245|Narcotics|narcotics|mesh-ancestor
56677464|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677465|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677466|NCT01025245|Analgesics|analgesics|mesh-ancestor
56677467|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
56677468|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677469|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56677470|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56677471|NCT02677259|Estradiol|estradiol|mesh-list
56677472|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56677473|NCT02677259|Progesterone|progesterone|mesh-list
56677474|NCT02677259|Estrogens|estrogens|mesh-ancestor
56677475|NCT02677259|Hormones|hormones|mesh-ancestor
56677476|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677477|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677478|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56677479|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
56677480|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56677481|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56677482|NCT02677259|Progestins|progestins|mesh-ancestor
56677483|NCT02675387|Lidocaine|lidocaine|mesh-list
56677484|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
56677485|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
56677486|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677487|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677488|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
56677489|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677490|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56677491|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56677492|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56677493|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677494|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236102|NCT01748253|Amlodipine|amlodipine|mesh-list
56677506|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677507|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677509|NCT05658887|Analgesics|analgesics|mesh-ancestor
56677510|NCT05658887|Sensory System Agents|sensory system agents|mesh-ancestor
56677511|NCT05658887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677512|NCT05658887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677513|NCT05658887|Anticonvulsants|anticonvulsants|mesh-ancestor
56533160|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533161|NCT04937413|Evolocumab|evolocumab|mesh-list
56533162|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56533163|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56677514|NCT05658887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56677515|NCT05658887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56677516|NCT05658887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677517|NCT05658887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56677518|NCT05658887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56677519|NCT05658887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56677520|NCT05658887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677521|NCT05658887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677522|NCT05658887|Antimanic Agents|antimanic agents|mesh-ancestor
56677523|NCT02678585|Lidocaine|lidocaine|mesh-list
56677524|NCT02678585|Nalbuphine|nalbuphine|mesh-list
56677525|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
56677526|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
56677527|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677528|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677529|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
56677530|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677531|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56677532|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56677533|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56677534|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677535|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677536|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56677537|NCT02678585|Narcotics|narcotics|mesh-ancestor
56677538|NCT02678585|Analgesics|analgesics|mesh-ancestor
56677539|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
56677540|NCT00453349|Metronidazole|metronidazole|mesh-list
56677541|NCT00453349|Levofloxacin|levofloxacin|mesh-list
56677542|NCT00453349|Ofloxacin|ofloxacin|mesh-list
56677543|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56677544|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56677545|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677546|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56677547|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56677548|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677549|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677550|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677551|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56677552|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
56677553|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56677554|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677555|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56677556|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56677557|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56677562|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56677563|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56677565|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56677566|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677567|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56677568|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677569|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
56677570|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56677571|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
56677572|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677573|NCT02673359|Progesterone|progesterone|mesh-list
56677574|NCT02673359|Progestins|progestins|mesh-ancestor
56323797|NCT05351801|Nabiximols|nabiximols|mesh-list
56677575|NCT02673359|Hormones|hormones|mesh-ancestor
56677576|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677577|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677578|NCT04179617|Nicotine|nicotine|mesh-list
56677579|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56677580|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
56677581|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677582|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677583|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56533164|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
56533165|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533166|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56677584|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56677585|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
56677586|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677587|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677588|NCT00464269|Brivaracetam|brivaracetam|mesh-list
56677589|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
56677590|NCT00642863|Vitamin D|vitamin d|mesh-list
56677591|NCT00642863|Vitamins|vitamins|mesh-list
56677592|NCT00642863|Vitamin A|vitamin a|mesh-list
56677593|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
56677594|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
56677595|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677596|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
56677597|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677598|NCT00642863|Protective Agents|protective agents|mesh-ancestor
56677599|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56677600|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677601|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56677602|NCT02674997|Factor VIII|factor viii|mesh-list
56677603|NCT02674997|Coagulants|coagulants|mesh-ancestor
56677604|NCT04178291|Erythritol|erythritol|mesh-list
56677605|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
56677606|NCT05372315|Dexamethasone|dexamethasone|mesh-list
56677607|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
56677608|NCT05372315|BB 1101|bb 1101|mesh-list
56677609|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677610|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
56677611|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
56677612|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677613|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677614|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56677615|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
56677616|NCT05372315|Hormones|hormones|mesh-ancestor
56677617|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677618|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56677619|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677620|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
56677621|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677622|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677623|NCT00643643|Maraviroc|maraviroc|mesh-list
56677624|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56677625|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56677626|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677627|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56677628|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56677629|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
56677635|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
56677636|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56677637|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56677638|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56677639|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677640|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677641|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
56677642|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677643|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677644|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56677645|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677646|NCT05584319|Empagliflozin|empagliflozin|mesh-list
56677647|NCT05584319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56677648|NCT05584319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677649|NCT05584319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56323872|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
56677650|NCT05584319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677652|NCT02676323|Cytarabine|cytarabine|mesh-list
56677653|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
56677654|NCT02676323|Methotrexate|methotrexate|mesh-list
56677655|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
56677656|NCT02676323|Fludarabine|fludarabine|mesh-list
56677657|NCT02676323|Panobinostat|panobinostat|mesh-list
56677658|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
56057391|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
56533167|NCT02875587|Cabergoline|cabergoline|mesh-list
56533168|NCT02875587|Calcium|calcium|mesh-list
56533169|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56677659|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677660|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56677661|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
56677662|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56677663|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56677664|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
56677665|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677666|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677667|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
56677668|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677669|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56677670|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56677671|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
56677672|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56677673|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56677674|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
56677675|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677676|NCT02676323|Antidotes|antidotes|mesh-ancestor
56677677|NCT02676323|Protective Agents|protective agents|mesh-ancestor
56677678|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
56677679|NCT02676323|Vitamins|vitamins|mesh-ancestor
56677680|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
56677681|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677682|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56677683|NCT00643799|Celecoxib|celecoxib|mesh-list
56677684|NCT00643799|Naproxen|naproxen|mesh-list
56677685|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56677686|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56677687|NCT00643799|Analgesics|analgesics|mesh-ancestor
56677688|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
56677689|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677690|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677691|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677692|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56677693|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56677694|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56677695|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677696|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677697|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
56677698|NCT05348213|Decitabine|decitabine|mesh-list
56677699|NCT05348213|Pomalidomide|pomalidomide|mesh-list
56677705|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677706|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677707|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
56677708|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677709|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56677710|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56677711|NCT05348213|Growth Substances|growth substances|mesh-ancestor
56677712|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
56677713|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56677714|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
56677715|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677716|NCT02674295|Esketamine|esketamine|mesh-list
56677717|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
56677718|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56677719|NCT04179071|Famotidine|famotidine|mesh-list
56677720|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56677721|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56677722|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56677723|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
56677724|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
56677725|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677726|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677727|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677729|NCT02674139|Trace Elements|trace elements|mesh-ancestor
56677730|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
56677731|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677732|NCT00644033|Frovatriptan|frovatriptan|mesh-list
56677733|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56677734|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
56677735|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533170|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533171|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56533172|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56533173|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
56533174|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
56533175|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533176|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533177|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56533178|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56533179|NCT01070979|Estradiol|estradiol|mesh-list
56533180|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56533181|NCT01070979|Estrogens|estrogens|mesh-list
56533182|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56533183|NCT01070979|Hormones|hormones|mesh-ancestor
56533184|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533185|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533186|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56533187|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
56533188|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56533189|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56533190|NCT01234337|Capecitabine|capecitabine|mesh-list
56533191|NCT01234337|Sorafenib|sorafenib|mesh-list
56533192|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56533193|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
56533194|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533195|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533196|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56677736|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677737|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677738|NCT05325593|Dexamethasone|dexamethasone|mesh-list
56677739|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
56677740|NCT05325593|BB 1101|bb 1101|mesh-list
56677741|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677742|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
56677743|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
56677744|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677745|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677746|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56677747|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
56677748|NCT05325593|Hormones|hormones|mesh-ancestor
56677749|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677750|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56677751|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677752|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
56677753|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677754|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533197|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533198|NCT02848963|Ketamine|ketamine|mesh-list
56533199|NCT02848963|Propofol|propofol|mesh-list
56533200|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56533201|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533202|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533203|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56533204|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
56533205|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
56533206|NCT02848963|Analgesics|analgesics|mesh-ancestor
56533207|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
56533208|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533209|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56533210|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56533211|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56533212|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533213|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533214|NCT01070043|Amlodipine|amlodipine|mesh-list
56533215|NCT01070043|Valsartan|valsartan|mesh-list
56677755|NCT00484315|Paclitaxel|paclitaxel|mesh-list
56677756|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56677757|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56677758|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677759|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
56677760|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
56677761|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56677762|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677763|NCT01019083|Zinc|zinc|mesh-list
56677764|NCT01019083|Albendazole|albendazole|mesh-list
56677765|NCT01019083|Secnidazole|secnidazole|mesh-list
56677766|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
56677767|NCT01019083|Trace Elements|trace elements|mesh-ancestor
56677768|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
56677769|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677770|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
56677771|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56677776|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
56677777|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
56677778|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
56677779|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677780|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677781|NCT01019083|Astringents|astringents|mesh-ancestor
56677782|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
56677783|NCT00463801|Daptomycin|daptomycin|mesh-list
56677784|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56677785|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677786|NCT02672345|Sevoflurane|sevoflurane|mesh-list
56677787|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56677788|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56677789|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
56677790|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
56677791|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677792|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677793|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
56677794|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56677795|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677796|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677797|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56533216|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56533217|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56533218|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56533219|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533220|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56533221|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533222|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
56533223|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56533224|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56533226|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
56533227|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
56533228|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533229|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533230|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56533231|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56187426|NCT01781468|Modafinil|modafinil|mesh-list
56677798|NCT02537249|Analgesics|analgesics|mesh-ancestor
56677799|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
56677800|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677801|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56677802|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56677803|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56324026|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
56677804|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
56677805|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677806|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677807|NCT00644111|Hydromorphone|hydromorphone|mesh-list
56677808|NCT00644111|Bupivacaine|bupivacaine|mesh-list
56677809|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
56677810|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
56677811|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677812|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677813|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
56677814|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677815|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56677816|NCT00644111|Narcotics|narcotics|mesh-ancestor
56677817|NCT00644111|Analgesics|analgesics|mesh-ancestor
56677818|NCT00644891|Amoxicillin|amoxicillin|mesh-list
56677819|NCT00644891|Cefdinir|cefdinir|mesh-list
56677820|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56677821|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677822|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
56677823|NCT05203445|Olaparib|olaparib|mesh-list
56677824|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56677825|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677826|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56677827|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677828|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677829|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56677830|NCT04178057|Antibodies|antibodies|mesh-list
56677831|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
56677832|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56677833|NCT04178057|Mitogens|mitogens|mesh-list
56677834|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
56677835|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
56677836|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677837|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533232|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533233|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533235|NCT02962063|Carboplatin|carboplatin|mesh-list
56533236|NCT02962063|Durvalumab|durvalumab|mesh-list
56533237|NCT02962063|Tremelimumab|tremelimumab|mesh-list
56533238|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56533239|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533240|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
56533241|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
56533242|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
56533243|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533244|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56533245|NCT01073943|Bisacodyl|bisacodyl|mesh-list
56533246|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
56533247|NCT01073943|Cathartics|cathartics|mesh-ancestor
56533248|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56533249|NCT01073943|Laxatives|laxatives|mesh-ancestor
56533250|NCT01073865|Goserelin|goserelin|mesh-list
56533251|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56533252|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533253|NCT04899583|Sirolimus|sirolimus|mesh-list
56533254|NCT04899583|Paclitaxel|paclitaxel|mesh-list
56533255|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56533256|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533257|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
56533258|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
56533259|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
56533260|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533261|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56533262|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677838|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56677839|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677840|NCT04178057|Growth Substances|growth substances|mesh-ancestor
56677841|NCT04177043|Antibodies|antibodies|mesh-list
56677842|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
56677843|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
56677848|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56677850|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
56677851|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677852|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56677853|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56677854|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56677855|NCT05179733|Growth Substances|growth substances|mesh-ancestor
56677856|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
56677857|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56677858|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533263|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56533264|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
56533265|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533266|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
56533267|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533268|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
56533269|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
56533270|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533271|NCT01064635|Letrozole|letrozole|mesh-list
56533272|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533273|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56533274|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56533275|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533276|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533277|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56533278|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
56533279|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187468|NCT01438359|Furosemide|furosemide|mesh-list
56677859|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677860|NCT02670785|Estradiol|estradiol|mesh-list
56677861|NCT02670785|Estrogens|estrogens|mesh-ancestor
56677862|NCT02670785|Hormones|hormones|mesh-ancestor
56677863|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677864|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677865|NCT02670317|Prednisone|prednisone|mesh-list
56677866|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
56677867|NCT02670317|Doxorubicin|doxorubicin|mesh-list
56677868|NCT02670317|Vincristine|vincristine|mesh-list
56677869|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
56677870|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56677871|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
56677872|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677873|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56677874|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56677875|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
56677876|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677877|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677878|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56677879|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56677880|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56324175|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56677881|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56677882|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677883|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677884|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
56677885|NCT02670317|Hormones|hormones|mesh-ancestor
56677886|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677887|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56677888|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56677889|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
56677890|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
56677891|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
56677892|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56677893|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
56677894|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56533280|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533281|NCT04697485|Eplerenone|eplerenone|mesh-list
56533282|NCT04697485|Bumetanide|bumetanide|mesh-list
56533283|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56533284|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
56533285|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533286|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533287|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56533288|NCT04697485|Diuretics|diuretics|mesh-ancestor
56533289|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
56533290|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56533291|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56533292|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56533293|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533294|NCT01073631|Voriconazole|voriconazole|mesh-list
56533295|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
56533296|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533297|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56533298|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56533299|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648524|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56677895|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
56677896|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677897|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
56677898|NCT02671565|Protective Agents|protective agents|mesh-ancestor
56677899|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
56677900|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56677901|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
56677902|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56677903|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
56677904|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677905|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677906|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
56677907|NCT04175171|Trastuzumab|trastuzumab|mesh-list
56677908|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56677909|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677910|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
56677911|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677912|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677913|NCT00645125|Amoxicillin|amoxicillin|mesh-list
56677925|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
56677926|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
56677927|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56677928|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56677929|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677930|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677931|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56677932|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56677933|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56677934|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533300|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533301|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56533302|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
56533303|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533304|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533305|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56533307|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56533308|NCT00626769|Protective Agents|protective agents|mesh-ancestor
56533309|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533310|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533311|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56533312|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533313|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187508|NCT01438567|Oxycodone|oxycodone|mesh-list
56677936|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56677937|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677938|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
56677939|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56677940|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56677941|NCT02669303|Prednisolone|prednisolone|mesh-list
56677942|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
56677943|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56677944|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
56677945|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56677946|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
56677947|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
56677948|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677949|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677950|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56324176|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324183|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
56324184|NCT04921189|Thiamine|thiamine|mesh-list
56324185|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
56324186|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
56324188|NCT04921189|Protective Agents|protective agents|mesh-ancestor
56677952|NCT02669303|Hormones|hormones|mesh-ancestor
56677953|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677954|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56677955|NCT02669303|Protective Agents|protective agents|mesh-ancestor
56677956|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56677957|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677958|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56677959|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56677960|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56677961|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
56677962|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677963|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677964|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677965|NCT00645281|Urological Agents|urological agents|mesh-ancestor
56677966|NCT02668679|Hormones|hormones|mesh-list
56677967|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56677968|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677969|NCT00645437|Levofloxacin|levofloxacin|mesh-list
56677970|NCT00645437|Ofloxacin|ofloxacin|mesh-list
56677971|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56677972|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677973|NCT00645437|Renal Agents|renal agents|mesh-ancestor
56677974|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56533314|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
56533315|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56677975|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56677976|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56677977|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677978|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677979|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677980|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56677981|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56677983|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677984|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56677985|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677986|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677987|NCT00645515|Risperidone|risperidone|mesh-list
56677988|NCT00645515|Ziprasidone|ziprasidone|mesh-list
56677989|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56677990|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
56677991|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677992|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677993|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677994|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56677995|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56677996|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677997|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56677998|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56677999|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
56678000|NCT05076149|Ivacaftor|ivacaftor|mesh-list
56678001|NCT05076149|Elexacaftor|elexacaftor|mesh-list
56678002|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56678003|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678004|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678005|NCT00644735|Esomeprazole|esomeprazole|mesh-list
56678006|NCT00644735|Lansoprazole|lansoprazole|mesh-list
56678007|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
56678008|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56678009|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56678010|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56678011|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678012|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678013|NCT02667743|Paclitaxel|paclitaxel|mesh-list
56678014|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56678015|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56678016|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678017|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
56678018|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
56678019|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
56678020|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678021|NCT02666651|Tolvaptan|tolvaptan|mesh-list
56678022|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56678023|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678024|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
56678025|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678027|NCT02671175|Artenimol|artenimol|mesh-list
56678028|NCT02671175|Artemisinins|artemisinins|mesh-list
56678029|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
56678030|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56678031|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56678032|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678033|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56678034|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56678035|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56678036|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
56678037|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678038|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56678039|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56678040|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678041|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
56678042|NCT02667197|Narcotics|narcotics|mesh-ancestor
56678043|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678044|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678045|NCT02667197|Analgesics|analgesics|mesh-ancestor
56678046|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
56533316|NCT00626769|Estrogens|estrogens|mesh-ancestor
56533317|NCT00626769|Hormones|hormones|mesh-ancestor
56533318|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533319|NCT02875743|Posaconazole|posaconazole|mesh-list
56533320|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
56533321|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533322|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56533323|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56533324|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56533325|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56533326|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56533327|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533328|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533329|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56533330|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
56533331|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533332|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533333|NCT01073163|Rituximab|rituximab|mesh-list
56533334|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56533335|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56648525|NCT00633269|Olaparib|olaparib|mesh-list
56678047|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678048|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
56678049|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
56678055|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
56678056|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56678057|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56678058|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56678059|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
56678060|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678061|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678062|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
56678063|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56678064|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
56678065|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56678066|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
56678067|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
56678068|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678069|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678070|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56678071|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56678072|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
56678073|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678074|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678075|NCT00646841|Doxazosin|doxazosin|mesh-list
56678076|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56678077|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56678078|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56678079|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56678080|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
56678081|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533336|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533337|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
56533338|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533339|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533340|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56533341|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
56533342|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533343|NCT02875821|Metformin|metformin|mesh-list
56533344|NCT02875821|Pioglitazone|pioglitazone|mesh-list
56533345|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
56533346|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56533347|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533348|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56187552|NCT01438736|Progestins|progestins|mesh-ancestor
56678082|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678083|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678084|NCT04786067|Abatacept|abatacept|mesh-list
56678085|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56678086|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678087|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678088|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56678089|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
56678090|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678091|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56678092|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
56678093|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678094|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678095|NCT00484159|Lidocaine|lidocaine|mesh-list
56678096|NCT00484159|Bupivacaine|bupivacaine|mesh-list
56324326|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
56678097|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
56678098|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
56678099|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678100|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678101|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
56678102|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678103|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56678104|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56678105|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56678106|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678107|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678109|NCT02666417|Trace Elements|trace elements|mesh-ancestor
56678110|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
56678111|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678112|NCT00910637|Gestodene|gestodene|mesh-list
56678113|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56678114|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56678115|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56678116|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
56678124|NCT00462865|Gemcitabine|gemcitabine|mesh-list
56678125|NCT00462865|Bevacizumab|bevacizumab|mesh-list
56678126|NCT00462865|Capecitabine|capecitabine|mesh-list
56678127|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56678128|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678129|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56678130|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56678131|NCT00462865|Growth Substances|growth substances|mesh-ancestor
56678132|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678133|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
56678134|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56187559|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
56678135|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
56678136|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678137|NCT00462865|Antiviral Agents|antiviral agents|mesh-ancestor
56678138|NCT00462865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678139|NCT00462865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678140|NCT00462865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56678141|NCT00462865|Immunologic Factors|immunologic factors|mesh-ancestor
56678142|NCT02667353|Anesthetics|anesthetics|mesh-list
56678143|NCT02667353|Etomidate|etomidate|mesh-list
56678144|NCT02667353|Succinylcholine|succinylcholine|mesh-list
56678145|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678146|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678147|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56678148|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56678149|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
56678150|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56678151|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56678152|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56678153|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678154|NCT00462709|Complement C1s|complement c1s|mesh-list
56678155|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56678156|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56678157|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
56678158|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678159|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56678160|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56678161|NCT02664857|Vitamin D|vitamin d|mesh-list
56678162|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
56678163|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
56678164|NCT02664857|Vitamins|vitamins|mesh-list
56678165|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
56678166|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678167|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56678168|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56678169|NCT02665871|Vaccines|vaccines|mesh-list
56678170|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
56678171|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678172|NCT00647543|Atorvastatin|atorvastatin|mesh-list
56678173|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56678174|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56678175|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
56678176|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678177|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56678178|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56678179|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678180|NCT00647621|Phenytoin|phenytoin|mesh-list
56678181|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
56678182|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56678183|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56678186|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56678187|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56678188|NCT00461305|Drospirenone|drospirenone|mesh-list
56678189|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56678190|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
56678191|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56678192|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678193|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56678194|NCT00461305|Diuretics|diuretics|mesh-ancestor
56678195|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
56678196|NCT01022671|Belotecan|belotecan|mesh-list
56678197|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56678198|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56678199|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678200|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678201|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678202|NCT01022749|Vaccines|vaccines|mesh-list
56678203|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
56678204|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678205|NCT00645905|Adalimumab|adalimumab|mesh-list
56678206|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56678207|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56678208|NCT00647777|Olanzapine|olanzapine|mesh-list
56678209|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
56678210|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
56533349|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533350|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
56533351|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533352|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
56533353|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56533354|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56533355|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533356|NCT04304313|Urological Agents|urological agents|mesh-ancestor
56533357|NCT01072929|Modafinil|modafinil|mesh-list
56533358|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56533359|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533360|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56533361|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56187572|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
56678211|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678212|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678213|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56678214|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56678215|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56678216|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678217|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56678218|NCT00647777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56678219|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56678220|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678221|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678222|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678223|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
56678224|NCT04173611|Bupivacaine|bupivacaine|mesh-list
56678225|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
56678226|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
56678227|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678228|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678229|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
56678230|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678231|NCT02665637|Trastuzumab|trastuzumab|mesh-list
56678232|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56678233|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678234|NCT04733183|Dacarbazine|dacarbazine|mesh-list
56678235|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56678236|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
56678237|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678238|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678239|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56678240|NCT00648011|Quinapril|quinapril|mesh-list
56678241|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56678242|NCT00648011|Diuretics|diuretics|mesh-ancestor
56678243|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
56678244|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678245|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56324553|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
56678246|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678247|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678248|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56678249|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
56678250|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678251|NCT00646529|Budesonide|budesonide|mesh-list
56678252|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
56533362|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56533363|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533364|NCT04753749|Aspirin|aspirin|mesh-list
56533365|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56533366|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56533367|NCT04753749|Analgesics|analgesics|mesh-ancestor
56533368|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
56236150|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678281|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678282|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56678283|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
56678284|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678285|NCT00646607|Antidotes|antidotes|mesh-ancestor
56678286|NCT00646607|Protective Agents|protective agents|mesh-ancestor
56678287|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
56678288|NCT00646607|Vitamins|vitamins|mesh-ancestor
56678289|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
56678290|NCT00856544|Tofacitinib|tofacitinib|mesh-list
56678291|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56678292|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678293|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678294|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56678295|NCT00648323|Doxazosin|doxazosin|mesh-list
56678296|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56678297|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56236151|NCT01748370|Vitamin D|vitamin d|mesh-list
56678303|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678305|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
56678306|NCT00856388|Melphalan|melphalan|mesh-list
56678307|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
56678308|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56678309|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
56678310|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678311|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56678312|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
56678313|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678314|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56678315|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
56678316|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678317|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56678318|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
56678319|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56678321|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56678322|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56678323|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678324|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678325|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56678326|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678327|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
56678329|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56678330|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
56678331|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
56678332|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
56678333|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678334|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678335|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56678336|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56678337|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678338|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56678339|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56678340|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56678341|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56678342|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56678343|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56678344|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
56678345|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
56678346|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
56678347|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
56533369|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533370|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994365|NCT02174419|Analgesics|analgesics|mesh-ancestor
56678348|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678349|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678350|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
56678351|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
56678352|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56678353|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678354|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678355|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
56678356|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56678357|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678358|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678359|NCT04171739|Itraconazole|itraconazole|mesh-list
56678360|NCT04171739|Olorofim|olorofim|mesh-list
56678361|NCT04171739|Rifampin|rifampin|mesh-list
56678362|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
56678363|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678364|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56678365|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56678366|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678367|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678370|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56678371|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678372|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56678374|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
56678375|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56678376|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
56678377|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56678378|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56678379|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56678380|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56678381|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56678382|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56678383|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56678384|NCT02656121|Vitamin D|vitamin d|mesh-list
56678385|NCT02656121|Clomiphene|clomiphene|mesh-list
56678386|NCT02656121|Vitamins|vitamins|mesh-ancestor
56678387|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
56678388|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678389|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56678390|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56678391|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
56324634|NCT04494425|Paclitaxel|paclitaxel|mesh-list
56678392|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56678393|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56678395|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56678396|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56678397|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56678398|NCT00648713|Terbinafine|terbinafine|mesh-list
56678399|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
56678400|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678401|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678402|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678403|NCT00649883|Vaccines|vaccines|mesh-list
56678404|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
56678405|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678406|NCT00648791|Finasteride|finasteride|mesh-list
56678407|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56678408|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56678409|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678410|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678411|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
56678412|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56678413|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678414|NCT00648791|Urological Agents|urological agents|mesh-ancestor
56678415|NCT00649181|Metolazone|metolazone|mesh-list
56678416|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56533371|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533372|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533373|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56533374|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56533375|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533376|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56533377|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56533378|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533379|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
56533380|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
56533381|NCT04305015|Narcotics|narcotics|mesh-ancestor
56533382|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533383|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533384|NCT04305015|Analgesics|analgesics|mesh-ancestor
56533385|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
56533386|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533387|NCT01231607|Finasteride|finasteride|mesh-list
56533388|NCT01231607|Dutasteride|dutasteride|mesh-list
56533389|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56533390|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56533391|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533392|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533393|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
56187583|NCT01438944|Nicotine|nicotine|mesh-list
56678417|NCT00649181|Diuretics|diuretics|mesh-ancestor
56678418|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
56678419|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678420|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56678421|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678422|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678423|NCT02655965|Clonidine|clonidine|mesh-list
56678424|NCT02655965|Ropivacaine|ropivacaine|mesh-list
56678425|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
56678426|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
56678427|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678428|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678429|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
56678430|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678431|NCT02655965|Analgesics|analgesics|mesh-ancestor
56678432|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56678433|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
56678434|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
56678435|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56678436|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56678437|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56678449|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678450|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678451|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56678452|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56678454|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
56533394|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533395|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533396|NCT01231607|Urological Agents|urological agents|mesh-ancestor
56533397|NCT01231373|Polidocanol|polidocanol|mesh-list
56678455|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678456|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56678457|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56678458|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678459|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678460|NCT04171193|Isoflurane|isoflurane|mesh-list
56678461|NCT04171193|Sertraline|sertraline|mesh-list
56678462|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
56678463|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56324707|NCT04345913|Halichondrin B|halichondrin b|mesh-list
56678464|NCT04171193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56678465|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56678466|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678467|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678468|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678469|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
56678470|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678471|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56678472|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
56678473|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
56678474|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678475|NCT02663141|Bevacizumab|bevacizumab|mesh-list
56678476|NCT02663141|Losartan|losartan|mesh-list
56678477|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56678478|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678479|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56678480|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56678481|NCT02663141|Growth Substances|growth substances|mesh-ancestor
56678482|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678483|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
56678484|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56678485|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56678486|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56678487|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56678488|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678489|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
56678490|NCT04171349|Carticaine|carticaine|mesh-list
56678491|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56678492|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678493|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678494|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56678495|NCT04171349|Analgesics|analgesics|mesh-ancestor
56678496|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
56678497|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236189|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
56678503|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678504|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
56678505|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
56678506|NCT00650039|Valdecoxib|valdecoxib|mesh-list
56678507|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56678508|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56678509|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678510|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678511|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56678512|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56678513|NCT00650039|Analgesics|analgesics|mesh-ancestor
56678514|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
56678515|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678516|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678517|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56678518|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56678519|NCT00649259|Oxybutynin|oxybutynin|mesh-list
56678520|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
56678521|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
56057392|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
56533398|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56533399|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56533401|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56533402|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56533403|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533404|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533405|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
56533406|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533407|NCT01230827|Golimumab|golimumab|mesh-list
56533408|NCT01230827|Methotrexate|methotrexate|mesh-list
56533409|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56533410|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
56533411|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56533412|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533413|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56678522|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678523|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678524|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56678525|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56678526|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
56678527|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678528|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678529|NCT00649259|Urological Agents|urological agents|mesh-ancestor
56678530|NCT04401059|Gefitinib|gefitinib|mesh-list
56678531|NCT04401059|Osimertinib|osimertinib|mesh-list
56678532|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678533|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56678534|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678535|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324781|NCT04291105|Cemiplimab|cemiplimab|mesh-list
56678536|NCT02658773|Lidocaine|lidocaine|mesh-list
56678537|NCT02658773|Prilocaine|prilocaine|mesh-list
56678538|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56678539|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
56678540|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
56678541|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678542|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678543|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
56678544|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678545|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56678546|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56678547|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56678548|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678549|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678550|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56678551|NCT00648869|Metformin|metformin|mesh-list
56678552|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56678553|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678554|NCT04169945|Erythritol|erythritol|mesh-list
56678555|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
56678556|NCT04169867|Nivolumab|nivolumab|mesh-list
56678557|NCT04169867|Ipilimumab|ipilimumab|mesh-list
56678558|NCT04169867|Atezolizumab|atezolizumab|mesh-list
56678559|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56678560|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678561|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56678562|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678563|NCT02655029|Amlodipine|amlodipine|mesh-list
56678564|NCT02655029|Perindopril|perindopril|mesh-list
56678565|NCT02655029|Indapamide|indapamide|mesh-list
56533414|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
56533415|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678566|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56678570|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56678571|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678573|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56678574|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
56678575|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678576|NCT02655029|Diuretics|diuretics|mesh-ancestor
56678577|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
56678578|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56678579|NCT02536859|Insulin|insulin|mesh-list
56678580|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56678581|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
56678582|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56678583|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678584|NCT02536937|Eliglustat|eliglustat|mesh-list
56678585|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678586|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678587|NCT02654561|Heparin|heparin|mesh-list
56678588|NCT02654561|Calcium heparin|calcium heparin|mesh-list
56678589|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
56678590|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56678591|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56678592|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678593|NCT02654405|Butyric Acid|butyric acid|mesh-list
56678594|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
56678595|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
56678596|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678597|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678598|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678599|NCT00649415|Valdecoxib|valdecoxib|mesh-list
56678600|NCT00649415|Piroxicam|piroxicam|mesh-list
56678601|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56678602|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56678603|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678604|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678605|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56678606|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56678607|NCT00649415|Analgesics|analgesics|mesh-ancestor
56678608|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
56678609|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678610|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678612|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56678613|NCT00650117|Fentanyl|fentanyl|mesh-list
56678614|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56678615|NCT00650117|Narcotics|narcotics|mesh-ancestor
56678616|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678617|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678618|NCT00650117|Analgesics|analgesics|mesh-ancestor
56678619|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
56678620|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678621|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56678622|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56678623|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
56678624|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
56678625|NCT00648947|Clopidogrel|clopidogrel|mesh-list
56678626|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56678627|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56678628|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56678629|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56678630|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
56678631|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678632|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678633|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678634|NCT00649493|Rabeprazole|rabeprazole|mesh-list
56678635|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56678636|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56236202|NCT01748500|Pantoprazole|pantoprazole|mesh-list
56678642|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56678643|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56678644|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533416|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533417|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
56533418|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533419|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56533420|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533421|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
56533422|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533423|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56533424|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56533425|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56678645|NCT02654093|Vitamins|vitamins|mesh-ancestor
56678646|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
56678647|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56678648|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56678649|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
56678650|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56678651|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56678652|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56678653|NCT04168619|Methotrexate|methotrexate|mesh-list
56678654|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56678655|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
56678656|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56678657|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678658|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56678659|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
56678660|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678661|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678662|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
56678663|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678664|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56678665|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56678666|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
56678667|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56678668|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56678669|NCT02654171|Ziresovir|ziresovir|mesh-list
56678670|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
56678671|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678672|NCT00650195|Metolazone|metolazone|mesh-list
56678673|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56678674|NCT00650195|Diuretics|diuretics|mesh-ancestor
56678675|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
56678676|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678677|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56678678|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678679|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678680|NCT04170959|Metformin|metformin|mesh-list
56678681|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56678682|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678683|NCT00848354|Etanercept|etanercept|mesh-list
56678684|NCT00848354|Methotrexate|methotrexate|mesh-list
56678685|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56678686|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
56678687|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56678688|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678689|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56678690|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
56678691|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678692|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678693|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
56678694|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678695|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56678696|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56678697|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
56678698|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533426|NCT01230749|Pioglitazone|pioglitazone|mesh-list
56678699|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56678700|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56678701|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56678702|NCT00848354|Analgesics|analgesics|mesh-ancestor
56678703|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
56678704|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236208|NCT01748526|Canagliflozin|canagliflozin|mesh-list
56678709|NCT00600821|Bevacizumab|bevacizumab|mesh-list
56678710|NCT00600821|Carboplatin|carboplatin|mesh-list
56678711|NCT00600821|Axitinib|axitinib|mesh-list
56678712|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56678713|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678714|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
56678715|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
56678716|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
56678717|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678718|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56678719|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56678720|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56678721|NCT00600821|Growth Substances|growth substances|mesh-ancestor
56678722|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678723|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
56678724|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56678725|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678726|NCT00699764|Vaccines|vaccines|mesh-list
56678727|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
56678728|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678729|NCT02653703|Ethanol|ethanol|mesh-list
56678730|NCT02653703|Menthol|menthol|mesh-list
56678731|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56678732|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678733|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678734|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678735|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
56678736|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
56678737|NCT00649571|Doxycycline|doxycycline|mesh-list
56678738|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56678739|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678740|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
56678741|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56678742|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56678743|NCT02662283|Acteoside|acteoside|mesh-list
56678744|NCT02662283|Prednisolone|prednisolone|mesh-list
56678745|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56678746|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
56678747|NCT02662283|Hormones|hormones|mesh-ancestor
56678748|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56678749|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678750|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56678751|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678752|NCT02662283|Protective Agents|protective agents|mesh-ancestor
56678753|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678754|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56678755|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
56678756|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678757|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
56678758|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
56678759|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56325039|NCT03862859|Warfarin|warfarin|mesh-list
56678760|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
56678761|NCT02657603|Lidocaine|lidocaine|mesh-list
56678762|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
56678763|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
56678764|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678765|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678766|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
56678767|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678768|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56678769|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56678770|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56678771|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678772|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678773|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56533427|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56533428|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533429|NCT00903175|Everolimus|everolimus|mesh-list
56533430|NCT00903175|Sunitinib|sunitinib|mesh-list
56533431|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533432|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533433|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
56533434|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678774|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
56678775|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
56678783|NCT02657291|Ropivacaine|ropivacaine|mesh-list
56678784|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
56678785|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
56678786|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678787|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678788|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
56678789|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678790|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56678791|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
56678792|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56678793|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56678794|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678795|NCT02661893|Rifampin|rifampin|mesh-list
56678796|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56678797|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
56678798|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56678799|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678800|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
56678801|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56678802|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678803|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678804|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56678805|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56678806|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56678807|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56678808|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56678809|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56678810|NCT00855920|Indomethacin|indomethacin|mesh-list
56678811|NCT00855920|Rilonacept|rilonacept|mesh-list
56678812|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56678813|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56678814|NCT00855920|Analgesics|analgesics|mesh-ancestor
56678815|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
56678816|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678817|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678818|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56678819|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56678820|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
56678821|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
56678822|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56678823|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56678824|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678825|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678826|NCT02657213|Insulin|insulin|mesh-list
56678827|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56678828|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56678829|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678830|NCT00649727|Oxybutynin|oxybutynin|mesh-list
56678831|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
56325085|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56678832|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
56678833|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678834|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678835|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56678836|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56678837|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
56678838|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533435|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56533436|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56533437|NCT00903175|Growth Substances|growth substances|mesh-ancestor
56533438|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
56533439|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56533440|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533441|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533442|NCT01229735|Topiramate|topiramate|mesh-list
56533443|NCT01229735|Levetiracetam|levetiracetam|mesh-list
56533444|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
56533445|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56533446|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533448|NCT03866200|Resveratrol|resveratrol|mesh-list
56533449|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
56678839|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678840|NCT00649727|Urological Agents|urological agents|mesh-ancestor
56678846|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
56678847|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
56678848|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56678849|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678850|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
56678851|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
56678852|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678853|NCT02656901|Anesthetics|anesthetics|mesh-list
56678854|NCT02656901|Sevoflurane|sevoflurane|mesh-list
56678855|NCT02656901|Desflurane|desflurane|mesh-list
56678856|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678857|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678858|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56678859|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56678860|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
56678861|NCT00847886|Methotrexate|methotrexate|mesh-list
56678862|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56678863|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
56678864|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56678865|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678866|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56678867|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
56678868|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678869|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678870|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
56678871|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678872|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56678873|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56678874|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
56678875|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56678876|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56678877|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
56678878|NCT00847808|Lansoprazole|lansoprazole|mesh-list
56678879|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56678880|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56678881|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56678882|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678883|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678884|NCT02656979|Latanoprost|latanoprost|mesh-list
56678885|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56678886|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56678887|NCT04017455|Bevacizumab|bevacizumab|mesh-list
56678888|NCT04017455|Atezolizumab|atezolizumab|mesh-list
56678889|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56678890|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678891|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56533450|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533451|NCT03866200|Protective Agents|protective agents|mesh-ancestor
56533452|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533453|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533454|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56533455|NCT02848183|Cytarabine|cytarabine|mesh-list
56533456|NCT02848183|Etoposide|etoposide|mesh-list
56533457|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
56533458|NCT02848183|Idarubicin|idarubicin|mesh-list
56533459|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56533460|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533461|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56533462|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56533463|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187667|NCT01439438|Topiramate|topiramate|mesh-list
56678892|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56678893|NCT04017455|Growth Substances|growth substances|mesh-ancestor
56678894|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678895|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
56678896|NCT05298020|Gemcitabine|gemcitabine|mesh-list
56678897|NCT05298020|Paclitaxel|paclitaxel|mesh-list
56678898|NCT05298020|Endostar protein|endostar protein|mesh-list
56678899|NCT05298020|Endostatins|endostatins|mesh-list
56678900|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56678901|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678902|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
56678903|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
56678904|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
56678905|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325162|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
56678906|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56678907|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
56678908|NCT05298020|Antiviral Agents|antiviral agents|mesh-ancestor
56678909|NCT05298020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678910|NCT05298020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678911|NCT05298020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56678912|NCT05298020|Immunologic Factors|immunologic factors|mesh-ancestor
56678913|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678928|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56678929|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56678930|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56678931|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56678932|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56678933|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
56678934|NCT00649805|Verapamil|verapamil|mesh-list
56678935|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56678936|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56678937|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678938|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678939|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56678940|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678941|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
56678942|NCT02656589|Capecitabine|capecitabine|mesh-list
56678943|NCT02656589|Trastuzumab|trastuzumab|mesh-list
56678944|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56678945|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
56678946|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678947|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678948|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56678949|NCT00600353|Dexamethasone|dexamethasone|mesh-list
56678950|NCT00600353|Aprepitant|aprepitant|mesh-list
56678951|NCT00600353|Palonosetron|palonosetron|mesh-list
56533464|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678952|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56678953|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
56678954|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
56678955|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678956|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678957|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56678958|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
56678959|NCT00600353|Hormones|hormones|mesh-ancestor
56678960|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56678961|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56678962|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678963|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56678964|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678965|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678966|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56678967|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56678968|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
56678969|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
56678970|NCT02661191|Vitamin D|vitamin d|mesh-list
56678971|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56678972|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678982|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678983|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56678984|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56678985|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678986|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678987|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56678988|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
56678990|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
56678991|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678992|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56678993|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
56678994|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56678995|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
56678996|NCT02652065|Acetylcholine|acetylcholine|mesh-list
56678997|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
56678998|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56678999|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
56679000|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679001|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679002|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679003|NCT00650429|Ziprasidone|ziprasidone|mesh-list
56679004|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56679005|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
56679006|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679007|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679008|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679009|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56679010|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56679011|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679012|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679013|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56679014|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
56679015|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
56679016|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679017|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679018|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56679019|NCT00691132|Protective Agents|protective agents|mesh-ancestor
56679020|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679021|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679022|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
56679023|NCT02651753|Atorvastatin|atorvastatin|mesh-list
56679024|NCT02651753|Fenofibrate|fenofibrate|mesh-list
56679025|NCT02651753|Calcium|calcium|mesh-list
56679026|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56679027|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679028|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56679029|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56679030|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56679031|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
56473646|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533465|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56533466|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
56533467|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
56533468|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533469|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533470|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
56533471|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533472|NCT02848183|Analgesics|analgesics|mesh-ancestor
56533473|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
56533474|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533475|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56533476|NCT00974974|Levodopa|levodopa|mesh-list
56533477|NCT00974974|Carbidopa|carbidopa|mesh-list
56533478|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56533479|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56533480|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56533481|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
56533482|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533483|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533484|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533485|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56533486|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533487|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56533488|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
56679032|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679033|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56679034|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56679035|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679036|NCT00855218|Sorafenib|sorafenib|mesh-list
56679037|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679038|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56679039|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679040|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679041|NCT00748150|Vaccines|vaccines|mesh-list
56679048|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679049|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
56679050|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679051|NCT02651441|Gemcitabine|gemcitabine|mesh-list
56679052|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679053|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56679054|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
56679055|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679056|NCT02651441|Antiviral Agents|antiviral agents|mesh-ancestor
56679057|NCT02651441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679058|NCT02651441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679059|NCT02651441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56679060|NCT02651441|Immunologic Factors|immunologic factors|mesh-ancestor
56679061|NCT02651441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679062|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
56533489|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
56533490|NCT02848417|Curcumin|curcumin|mesh-list
56679063|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56679064|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
56679065|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679066|NCT01063348|Expectorants|expectorants|mesh-ancestor
56679067|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
56679068|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56679069|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
56679070|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679071|NCT01063348|Protective Agents|protective agents|mesh-ancestor
56679072|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679073|NCT01063348|Antidotes|antidotes|mesh-ancestor
56679074|NCT00855062|Minocycline|minocycline|mesh-list
56679075|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56679076|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679077|NCT00744250|Pancrelipase|pancrelipase|mesh-list
56679078|NCT00744250|Pancreatin|pancreatin|mesh-list
56679079|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56679080|NCT02651207|Lidocaine|lidocaine|mesh-list
56679081|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
56679082|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
56679083|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
56679084|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
56679085|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679086|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679087|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
56679088|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679089|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56679090|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56679091|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56679092|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56679093|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679094|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56679095|NCT02564536|Decitabine|decitabine|mesh-list
56679096|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56679097|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
56679098|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679099|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679100|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679101|NCT00600119|Naloxegol|naloxegol|mesh-list
56679102|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56679103|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679104|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
56679105|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679106|NCT00866294|Paroxetine|paroxetine|mesh-list
56679107|NCT00866294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56679108|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56679109|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56679110|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679116|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679117|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56679118|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56679119|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679120|NCT02660255|Cannabidiol|cannabidiol|mesh-list
56679121|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
56679123|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56679124|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
56679125|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679126|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679127|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56679128|NCT02660177|Dipyrone|dipyrone|mesh-list
56679129|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56325399|NCT03427463|Morphine|morphine|mesh-list
56679130|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56679131|NCT02660177|Analgesics|analgesics|mesh-ancestor
56679132|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
56679133|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679134|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679135|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679136|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56679137|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
56679138|NCT00701246|Folic Acid|folic acid|mesh-list
56679139|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
56533491|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56679140|NCT00701246|Hematinics|hematinics|mesh-ancestor
56679141|NCT00701246|Vitamins|vitamins|mesh-ancestor
56679142|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
56679143|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679144|NCT02648711|Leucovorin|leucovorin|mesh-list
56679145|NCT02648711|Bevacizumab|bevacizumab|mesh-list
56679146|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
56679147|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56679148|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679149|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56679150|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56679151|NCT02648711|Growth Substances|growth substances|mesh-ancestor
56679152|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679153|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
56679154|NCT02648711|Antidotes|antidotes|mesh-ancestor
56679155|NCT02648711|Protective Agents|protective agents|mesh-ancestor
56679156|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
56679157|NCT02648711|Vitamins|vitamins|mesh-ancestor
56679158|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
56679159|NCT00854360|Beclomethasone|beclomethasone|mesh-list
56679160|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679161|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
56679162|NCT00854360|Hormones|hormones|mesh-ancestor
56679163|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679164|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679165|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56679166|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
56679167|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
56679168|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56679169|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679170|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56679171|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56679172|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679173|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679174|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679175|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56679176|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56679177|NCT02648633|Nivolumab|nivolumab|mesh-list
56679178|NCT02648633|Valproic Acid|valproic acid|mesh-list
56679179|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56679180|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679187|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679188|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
56679189|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56679190|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679191|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679192|NCT00853970|Bromfenac|bromfenac|mesh-list
56679193|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56679194|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56679195|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56679196|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56679197|NCT00853970|Analgesics|analgesics|mesh-ancestor
56679198|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
56679199|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679200|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679201|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679202|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56679203|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56679204|NCT00651287|Quinapril|quinapril|mesh-list
56679205|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56679206|NCT00651287|Diuretics|diuretics|mesh-ancestor
56679207|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
56679208|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679209|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56679210|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56679211|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679212|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56679213|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
56679214|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679215|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56679216|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56679217|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679218|NCT02650427|Incretins|incretins|mesh-ancestor
56679219|NCT02650427|Hormones|hormones|mesh-ancestor
56533492|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56533493|NCT02848417|Analgesics|analgesics|mesh-ancestor
56679220|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679221|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56679222|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
56679223|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679224|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679225|NCT02644811|Anesthetics|anesthetics|mesh-list
56679226|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679227|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679228|NCT00651443|Galiximab|galiximab|mesh-list
56679229|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679230|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679231|NCT00650897|Citalopram|citalopram|mesh-list
56679232|NCT00650897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56679233|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56679234|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56679235|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679236|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679237|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
56679238|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679239|NCT00650897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56679240|NCT00650897|Antidepressive Agents|antidepressive agents|mesh-ancestor
56679241|NCT00650897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679242|NCT02644499|Folic Acid|folic acid|mesh-list
56679243|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
56679244|NCT02644499|Prednisolone|prednisolone|mesh-list
56679245|NCT02644499|Methotrexate|methotrexate|mesh-list
56679246|NCT02644499|Leflunomide|leflunomide|mesh-list
56679247|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
56679248|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56679258|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56679259|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56679260|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
56679261|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56679262|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56679263|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679264|NCT02644499|Hormones|hormones|mesh-ancestor
56679265|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679266|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56679267|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
56679268|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56679269|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56679270|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679271|NCT02644499|Hematinics|hematinics|mesh-ancestor
56679272|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
56679273|NCT02644499|Vitamins|vitamins|mesh-ancestor
56679274|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
56679275|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
56679276|NCT00652691|Carboplatin|carboplatin|mesh-list
56679277|NCT00652691|Topotecan|topotecan|mesh-list
56679278|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56679279|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
56679280|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679281|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325541|NCT03217812|Melphalan|melphalan|mesh-list
56679282|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56679283|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
56679284|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679285|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679286|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56679287|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56679288|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56679289|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679290|NCT02649179|Ropivacaine|ropivacaine|mesh-list
56679291|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
56679292|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
56679293|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679294|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679295|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
56679296|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679297|NCT02644577|Metformin|metformin|mesh-list
56679298|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56679299|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533494|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
56533495|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533496|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533497|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533498|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533499|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533500|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533501|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533502|NCT02847403|Exenatide|exenatide|mesh-list
56533503|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56533504|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533505|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56533506|NCT02847403|Incretins|incretins|mesh-ancestor
56533507|NCT02847403|Hormones|hormones|mesh-ancestor
56533508|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533509|NCT02848339|Aspirin|aspirin|mesh-list
56533510|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56533511|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56679300|NCT02644421|Lidocaine|lidocaine|mesh-list
56679301|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
56679302|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
56679303|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679304|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679305|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
56679306|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679307|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56679308|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56679309|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56679310|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56679311|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679312|NCT00651599|Drospirenone|drospirenone|mesh-list
56679313|NCT00651599|Estradiol|estradiol|mesh-list
56679318|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56679319|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
56679320|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56679321|NCT00651599|Diuretics|diuretics|mesh-ancestor
56679322|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
56679323|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56679324|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56679325|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56679326|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
56679327|NCT02649335|Propranolol|propranolol|mesh-list
56679328|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56679329|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56679330|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
56679331|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679332|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679333|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679334|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56679335|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56679336|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
56679337|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56679338|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56679339|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
56679340|NCT00651131|Daptomycin|daptomycin|mesh-list
56679341|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56533512|NCT02848339|Analgesics|analgesics|mesh-ancestor
56533513|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
56187719|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56679342|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679343|NCT04167137|Atezolizumab|atezolizumab|mesh-list
56679344|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679345|NCT02649413|Prednisone|prednisone|mesh-list
56679346|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679347|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
56679348|NCT02649413|Hormones|hormones|mesh-ancestor
56679349|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679350|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679351|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56679352|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679353|NCT02643563|Epinephrine|epinephrine|mesh-list
56679354|NCT02643563|Bupivacaine|bupivacaine|mesh-list
56679355|NCT02643563|Ropivacaine|ropivacaine|mesh-list
56679356|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
56679357|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
56679358|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679359|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679360|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
56679361|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679362|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56679363|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56679364|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
56679365|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679366|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679367|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56679368|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56679369|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
56679370|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56679371|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
56679372|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
56679373|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
56679374|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56679375|NCT00651209|Tenofovir|tenofovir|mesh-list
56679376|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
56679377|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679378|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56679379|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56679380|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679381|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679382|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56679383|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56679384|NCT00652925|Celecoxib|celecoxib|mesh-list
56679385|NCT00652925|Naproxen|naproxen|mesh-list
56679389|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
56679390|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679391|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679392|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679393|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56679394|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56679395|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56679396|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679397|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679398|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
56679400|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679401|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679402|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56679403|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
56679404|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679405|NCT02643719|Topiramate|topiramate|mesh-list
56679406|NCT02643719|Naproxen|naproxen|mesh-list
56679407|NCT02643719|Sumatriptan|sumatriptan|mesh-list
56679408|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56679409|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56679410|NCT02643719|Analgesics|analgesics|mesh-ancestor
56679411|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
56679412|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679413|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679414|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679415|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533514|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533515|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533516|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533517|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533518|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56533519|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56533520|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533521|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56533522|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56533523|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533524|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
56533525|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56533526|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56533527|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533528|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
56533529|NCT04216303|Chrysarobin|chrysarobin|mesh-list
56533530|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56533531|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56533532|NCT04216303|Analgesics|analgesics|mesh-ancestor
56533533|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
56533534|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533535|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533536|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533537|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533538|NCT02847013|Bupivacaine|bupivacaine|mesh-list
56533539|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
56533540|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
56533560|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533561|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533562|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56679416|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
56679417|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56679418|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679419|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679420|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
56679421|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56679422|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56679423|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56679424|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56679425|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
56679426|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679427|NCT02649101|Thalidomide|thalidomide|mesh-list
56679428|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56679429|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
56679430|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679431|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
56679432|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56679433|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679434|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56679435|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56679436|NCT02649101|Growth Substances|growth substances|mesh-ancestor
56679437|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
56679438|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679439|NCT00700154|Insulin|insulin|mesh-list
56679440|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56679441|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
56679442|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56679443|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679444|NCT00651911|Rasburicase|rasburicase|mesh-list
56679445|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
56679446|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56679447|NCT02643407|Docetaxel|docetaxel|mesh-list
56679448|NCT02643407|Nedaplatin|nedaplatin|mesh-list
56679449|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679450|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
56679451|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
56679452|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
56679453|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679454|NCT02643329|Gliclazide|gliclazide|mesh-list
56679455|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56679456|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679457|NCT03245489|Aspirin|aspirin|mesh-list
56679458|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
56679460|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56679461|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679462|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56679463|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56679464|NCT03245489|Analgesics|analgesics|mesh-ancestor
56679465|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
56679466|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679467|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679468|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679469|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56679470|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56679471|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56679472|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679473|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56679474|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56679475|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679476|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
56679477|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56679478|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56679479|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56679480|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
56679481|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679482|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
56679483|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56679484|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533563|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
56533564|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533565|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
56533566|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56533567|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56533568|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533569|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
56533570|NCT04201951|Coagulants|coagulants|mesh-ancestor
56533571|NCT04753723|Gentamicins|gentamicins|mesh-list
56187751|NCT01440361|Belimumab|belimumab|mesh-list
56679485|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679486|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56679487|NCT02643017|Analgesics|analgesics|mesh-ancestor
56679488|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
56679489|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679490|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56679491|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56679492|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56679493|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
56679494|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679495|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679496|NCT02643173|Anesthetics|anesthetics|mesh-list
56679497|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56679498|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679499|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679500|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
56679501|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
56679502|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56679503|NCT02646137|Estrogens|estrogens|mesh-ancestor
56679504|NCT02646137|Hormones|hormones|mesh-ancestor
56679505|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679506|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679507|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56679508|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679509|NCT00653549|Torsemide|torsemide|mesh-list
56679510|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56679511|NCT00653549|Diuretics|diuretics|mesh-ancestor
56679512|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
56679513|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679514|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56679515|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56679516|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679517|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
56679518|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
56679519|NCT02642861|Calcium|calcium|mesh-list
56679520|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56679521|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679522|NCT02642861|Antacids|antacids|mesh-ancestor
56679523|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679524|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56679525|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56679526|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
56679527|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679528|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56679529|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56679530|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679536|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56679537|NCT02641457|Growth Substances|growth substances|mesh-ancestor
56679538|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679539|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
56679540|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679541|NCT02642939|Mifepristone|mifepristone|mesh-list
56679542|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56679543|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
56679544|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56533572|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56533573|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533574|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56533575|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533576|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533577|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
56533578|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56679545|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679546|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56679547|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56679548|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56679549|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
56679550|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56679551|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56679552|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
56679553|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679554|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
56679555|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56679556|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56679558|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56679559|NCT02641301|Narcotics|narcotics|mesh-ancestor
56679560|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679561|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679562|NCT02641301|Analgesics|analgesics|mesh-ancestor
56679563|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
56679564|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679565|NCT03679949|Oxycodone|oxycodone|mesh-list
56679566|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56679567|NCT03679949|Narcotics|narcotics|mesh-ancestor
56679568|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679569|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679570|NCT03679949|Analgesics|analgesics|mesh-ancestor
56679571|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
56679572|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679573|NCT02640989|Vaccines|vaccines|mesh-list
56679574|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
56679575|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679576|NCT02645747|Aflibercept|aflibercept|mesh-list
56679577|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56679578|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56679579|NCT02645747|Growth Substances|growth substances|mesh-ancestor
56679580|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679581|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
56679582|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679583|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
56679584|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56679585|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679586|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
56679587|NCT00653315|Tramadol|tramadol|mesh-list
56679588|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56679589|NCT00653315|Narcotics|narcotics|mesh-ancestor
56679590|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679591|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679592|NCT00653315|Analgesics|analgesics|mesh-ancestor
56679593|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
56679594|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679595|NCT02640833|Venetoclax|venetoclax|mesh-list
56679596|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679597|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
56679598|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
56679599|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679600|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56679601|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679610|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56679611|NCT02645903|Narcotics|narcotics|mesh-ancestor
56679612|NCT02645903|Analgesics|analgesics|mesh-ancestor
56679613|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
56679614|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533579|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56533580|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
56533581|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187766|NCT01440582|Bortezomib|bortezomib|mesh-list
56679615|NCT02645981|Sorafenib|sorafenib|mesh-list
56679616|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679617|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56679618|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679619|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679620|NCT02535767|Primaquine|primaquine|mesh-list
56679621|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
56679622|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56679623|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56679624|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679625|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
56679626|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679627|NCT02640365|Leucovorin|leucovorin|mesh-list
56679628|NCT02640365|Bevacizumab|bevacizumab|mesh-list
56679629|NCT02640365|Irinotecan|irinotecan|mesh-list
56679630|NCT02640365|Camptothecin|camptothecin|mesh-list
56679631|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56679632|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679633|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56679634|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56679635|NCT02640365|Growth Substances|growth substances|mesh-ancestor
56679636|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679637|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
56679638|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56679639|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56679640|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679641|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679642|NCT02640365|Antidotes|antidotes|mesh-ancestor
56679643|NCT02640365|Protective Agents|protective agents|mesh-ancestor
56679644|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
56679645|NCT02640365|Vitamins|vitamins|mesh-ancestor
56679646|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
56679647|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56679648|NCT02642003|Lenograstim|lenograstim|mesh-list
56679649|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56679650|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
56679651|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679652|NCT02641847|Gemcitabine|gemcitabine|mesh-list
56679653|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
56679654|NCT02641847|Docetaxel|docetaxel|mesh-list
56679655|NCT02641847|Doxorubicin|doxorubicin|mesh-list
56679656|NCT02641847|Epirubicin|epirubicin|mesh-list
56679657|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56679658|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
56679659|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679660|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56679661|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56679662|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
56679663|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679664|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679665|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56679666|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56679668|NCT02641847|Antiviral Agents|antiviral agents|mesh-ancestor
56679669|NCT02641847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679670|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679687|NCT00652379|Hormones|hormones|mesh-ancestor
56679688|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679689|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679690|NCT04164797|Endostar protein|endostar protein|mesh-list
56679691|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56679692|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56679693|NCT04164797|Growth Substances|growth substances|mesh-ancestor
56679694|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679695|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
56679696|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679697|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
56679698|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
56679699|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56679700|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56679701|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533582|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533583|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533584|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
56533585|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
56533586|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533587|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
56533588|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56533589|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
56533590|NCT02844517|Pancrelipase|pancrelipase|mesh-list
56533591|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56533592|NCT03901729|Furosemide|furosemide|mesh-list
56533593|NCT03901729|Diuretics|diuretics|mesh-ancestor
56533594|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
56533595|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533596|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56533597|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56533598|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533599|NCT02846857|Insulin|insulin|mesh-list
56533600|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56679702|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679703|NCT00654017|Urological Agents|urological agents|mesh-ancestor
56679704|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
56679705|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56679706|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56679707|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679708|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
56679709|NCT02639819|Coagulants|coagulants|mesh-ancestor
56679710|NCT02639741|Vitamins|vitamins|mesh-list
56679711|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
56679712|NCT02639741|Melatonin|melatonin|mesh-list
56679713|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
56679714|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679715|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
56679716|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679717|NCT02639741|Protective Agents|protective agents|mesh-ancestor
56679718|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679719|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
56679720|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56679721|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
56679722|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679723|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56679724|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679725|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56679726|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679727|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56679728|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679729|NCT01149083|Carboplatin|carboplatin|mesh-list
56679730|NCT01149083|Veliparib|veliparib|mesh-list
56236290|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
56326075|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
56679736|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56679737|NCT00654173|Simvastatin|simvastatin|mesh-list
56679738|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56679739|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56679740|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
56057393|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
56533601|NCT02846857|Glucagon|glucagon|mesh-list
56533602|NCT02846857|Hormones|hormones|mesh-list
56679741|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679742|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56679743|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56679744|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679745|NCT02645279|Midazolam|midazolam|mesh-list
56679746|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56679747|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56679748|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679749|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679750|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56679751|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56679752|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679753|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56679754|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
56679755|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
56679756|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
56679757|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
56679758|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679759|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679760|NCT04164329|Anesthetics|anesthetics|mesh-list
56679761|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
56679762|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679763|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679764|NCT02639039|Cortisone|cortisone|mesh-list
56679765|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679766|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56679767|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56679768|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56679769|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
56679770|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679771|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56679772|NCT02562664|Metformin|metformin|mesh-list
56679773|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56679774|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679775|NCT00654407|Atorvastatin|atorvastatin|mesh-list
56679776|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56679777|NCT00654407|Simvastatin|simvastatin|mesh-list
56679778|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56679779|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56679780|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
56679781|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679782|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56679783|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56679784|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679785|NCT00691054|Paclitaxel|paclitaxel|mesh-list
56679786|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56679787|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56679788|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679789|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
56679790|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
56679791|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
56679792|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679793|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56679794|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56679795|NCT00744406|Sertraline|sertraline|mesh-list
56679796|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56679797|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
56679798|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679799|NCT00744406|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56679805|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679806|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56679807|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56679808|NCT00690820|Pancrelipase|pancrelipase|mesh-list
56679809|NCT00690820|Pancreatin|pancreatin|mesh-list
56679810|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56679811|NCT02562508|Vaccines|vaccines|mesh-list
56679812|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
56679813|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679814|NCT00689338|Fluconazole|fluconazole|mesh-list
56679815|NCT00689338|Voriconazole|voriconazole|mesh-list
56679816|NCT00689338|Anidulafungin|anidulafungin|mesh-list
56679817|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
56679818|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533603|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56533604|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679819|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56679820|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56679821|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679822|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679823|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56679824|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
56679825|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679826|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679827|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56679828|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56679829|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56679830|NCT00686998|Olanzapine|olanzapine|mesh-list
56679831|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
56679832|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
56679833|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679834|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679835|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56679836|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56679837|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56679838|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679839|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56679840|NCT00686998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56679841|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56679842|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56679843|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679844|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679845|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
56679846|NCT00744640|Gemcitabine|gemcitabine|mesh-list
56679847|NCT00744640|Capecitabine|capecitabine|mesh-list
56679848|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
56679849|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56679850|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
56679851|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679852|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679853|NCT00744640|Antiviral Agents|antiviral agents|mesh-ancestor
56679854|NCT00744640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679855|NCT00744640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679856|NCT00744640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56679857|NCT00744640|Immunologic Factors|immunologic factors|mesh-ancestor
56679858|NCT00744640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679859|NCT00848718|Paclitaxel|paclitaxel|mesh-list
56679860|NCT00848718|Docetaxel|docetaxel|mesh-list
56679861|NCT00848718|Carboplatin|carboplatin|mesh-list
56679862|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56679863|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56679864|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679865|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
56679866|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
56679867|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
56679868|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679870|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679871|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
56679872|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56679873|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679874|NCT00883337|Interferons|interferons|mesh-list
56679875|NCT00883337|Interferon-beta|interferon-beta|mesh-list
56679876|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
56679877|NCT00883337|Teriflunomide|teriflunomide|mesh-list
56679878|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679879|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
56679880|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679881|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56679882|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56679883|NCT00883337|Analgesics|analgesics|mesh-ancestor
56679884|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
56326150|NCT01604135|Vitamins|vitamins|mesh-ancestor
56679885|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679886|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679887|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679889|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533605|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533606|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56533607|NCT04672525|Rifampin|rifampin|mesh-list
56533608|NCT04672525|Rifabutin|rifabutin|mesh-list
56533609|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56533610|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
56533611|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56533612|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533613|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
56533614|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56679890|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
56679891|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56679892|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
56679893|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679894|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56679895|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679896|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679897|NCT00654485|Atorvastatin|atorvastatin|mesh-list
56679898|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56679899|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56679900|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56679901|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
56679902|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679903|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56679904|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56679905|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679906|NCT00837876|Sorafenib|sorafenib|mesh-list
56679907|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679908|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56679909|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679910|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679911|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
56679912|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
56679913|NCT00655421|Coagulants|coagulants|mesh-ancestor
56679914|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
56679915|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679916|NCT00707070|Acitretin|acitretin|mesh-list
56679917|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56679918|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
56679919|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679920|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
56679921|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
56679922|NCT00686920|Rifaximin|rifaximin|mesh-list
56679923|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56679924|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679925|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56679926|NCT02562118|Letrozole|letrozole|mesh-list
56679927|NCT02562118|Lenvatinib|lenvatinib|mesh-list
56679928|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679929|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56679930|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56679931|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679932|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679933|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56679934|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
56679935|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679936|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679937|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56679938|NCT00744718|Bevacizumab|bevacizumab|mesh-list
56679939|NCT00744718|Carboplatin|carboplatin|mesh-list
56679940|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56679941|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679942|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56679946|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
56679947|NCT00741910|Semapimod|semapimod|mesh-list
56533615|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533616|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533617|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56533618|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56679948|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56679949|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56679950|NCT00741910|Analgesics|analgesics|mesh-ancestor
56679951|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
56679952|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56679953|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679954|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679955|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56679956|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56679957|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
56679958|NCT00845832|Rituximab|rituximab|mesh-list
56326225|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
56679959|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56679960|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679961|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
56679962|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679963|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56679965|NCT00703482|Ubiquinone|ubiquinone|mesh-list
56679966|NCT00703482|Fenofibrate|fenofibrate|mesh-list
56679967|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56679968|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
56679969|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679970|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56679971|NCT00703482|Vitamins|vitamins|mesh-ancestor
56679972|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
56679973|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679974|NCT00885755|Capecitabine|capecitabine|mesh-list
56679975|NCT00885755|Trastuzumab|trastuzumab|mesh-list
56679976|NCT00885755|Taxane|taxane|mesh-list
56679977|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56679978|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
56679979|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679980|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679981|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56679982|NCT00749710|Clopidogrel|clopidogrel|mesh-list
56679983|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56679984|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56679985|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56679986|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56679987|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
56679988|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679989|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679990|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679991|NCT00749866|Gentamicins|gentamicins|mesh-list
56679992|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56679993|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56679994|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56679995|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679996|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679997|NCT04058236|Polygeline|polygeline|mesh-list
56679998|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
56679999|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
56680000|NCT00742066|Felodipine|felodipine|mesh-list
56680001|NCT00742066|Irbesartan|irbesartan|mesh-list
56680002|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56680003|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56680004|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56680005|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680006|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56680007|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56680008|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680009|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56680010|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680011|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
56680012|NCT00742144|Ofatumumab|ofatumumab|mesh-list
56533619|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56533620|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56533621|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56533622|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56533623|NCT00992446|Cytarabine|cytarabine|mesh-list
56533624|NCT00992446|Rituximab|rituximab|mesh-list
56533625|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56533626|NCT00992446|Etoposide|etoposide|mesh-list
56533627|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
56533628|NCT00992446|Bortezomib|bortezomib|mesh-list
56533629|NCT00992446|Melphalan|melphalan|mesh-list
56533630|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
56533631|NCT00992446|Vorinostat|vorinostat|mesh-list
56533632|NCT00992446|Carmustine|carmustine|mesh-list
56533633|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
56533634|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56533635|NCT00992446|Antibodies|antibodies|mesh-list
56533636|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
56533637|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56533638|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
56533639|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533640|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533641|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533642|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56533643|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56533644|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56533645|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533646|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533647|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56533648|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
56533649|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
56533650|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533651|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533652|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56533662|NCT04452565|Dexamethasone|dexamethasone|mesh-list
56533663|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
56533664|NCT04452565|BB 1101|bb 1101|mesh-list
56533665|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533666|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
56533667|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
56533668|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533669|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533670|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56533671|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
56533672|NCT04452565|Hormones|hormones|mesh-ancestor
56533673|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533674|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56533675|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533676|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
56533677|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187848|NCT01440933|Analgesics|analgesics|mesh-ancestor
56680013|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680014|NCT00845676|Interferons|interferons|mesh-list
56680032|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
56680033|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680034|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680035|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56680037|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56680038|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680039|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56680040|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56680041|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56680042|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56680043|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
56680044|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680045|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56680046|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56680047|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680048|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56680049|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56680050|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56680051|NCT00655655|Everolimus|everolimus|mesh-list
56680052|NCT00655655|Vatalanib|vatalanib|mesh-list
56680053|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680054|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680055|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
56680056|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680057|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56680058|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680059|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680060|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
56680061|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680062|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680063|NCT05483400|Atezolizumab|atezolizumab|mesh-list
56680064|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680065|NCT00837330|Ranibizumab|ranibizumab|mesh-list
56680066|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56680067|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56680068|NCT00837330|Growth Substances|growth substances|mesh-ancestor
56680069|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680070|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
56680077|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56533678|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533679|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56533680|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56533681|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56533682|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56533683|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
56533684|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533685|NCT02863120|Bupivacaine|bupivacaine|mesh-list
56533686|NCT02863120|Ropivacaine|ropivacaine|mesh-list
56533687|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
56533688|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
56533689|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533690|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533691|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
56533692|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680078|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56680079|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56680080|NCT02581943|Paclitaxel|paclitaxel|mesh-list
56680081|NCT02581943|Carboplatin|carboplatin|mesh-list
56680082|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
56680083|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56680084|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56680085|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680086|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
56680087|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
56680088|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
56680089|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680090|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56680091|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
56680092|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56680093|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
56680094|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680095|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
56680096|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680097|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56680098|NCT00885365|Tobramycin|tobramycin|mesh-list
56680099|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56680100|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680101|NCT00827112|Ritonavir|ritonavir|mesh-list
56680102|NCT00827112|Lopinavir|lopinavir|mesh-list
56680103|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56680104|NCT00827112|Darunavir|darunavir|mesh-list
56680105|NCT00827112|Tenofovir|tenofovir|mesh-list
56680106|NCT00827112|Emtricitabine|emtricitabine|mesh-list
56326373|NCT05771480|Paclitaxel|paclitaxel|mesh-list
56680107|NCT00827112|Maraviroc|maraviroc|mesh-list
56680108|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56680109|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56680110|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
56680111|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680112|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680113|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56680114|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56680115|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
56680116|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680117|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56680118|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56680119|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56680120|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56680121|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56680122|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56533693|NCT03823534|Acetaminophen|acetaminophen|mesh-list
56533694|NCT03823534|Ketorolac|ketorolac|mesh-list
56533695|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56533696|NCT03823534|Morphine|morphine|mesh-list
56533697|NCT03823534|Oxycodone|oxycodone|mesh-list
56533698|NCT03823534|Hydrocodone|hydrocodone|mesh-list
56533699|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56533700|NCT03823534|Narcotics|narcotics|mesh-ancestor
56533701|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533702|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533703|NCT03823534|Analgesics|analgesics|mesh-ancestor
56533704|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
56533705|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533706|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56533707|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
56187884|NCT01441128|Crizotinib|crizotinib|mesh-list
56680123|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56680124|NCT00689104|Mirabegron|mirabegron|mesh-list
56680125|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56680126|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56680127|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56680128|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56680129|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
56680130|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680131|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680132|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680133|NCT00689104|Urological Agents|urological agents|mesh-ancestor
56680134|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56680135|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56680136|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
56680137|NCT02118467|Phenylephrine|phenylephrine|mesh-list
56680138|NCT02118467|Vasopressins|vasopressins|mesh-list
56680139|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
56680140|NCT02118467|Epinephrine|epinephrine|mesh-list
56680141|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
56680149|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680150|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56680151|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56680152|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
56680153|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680154|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56680155|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
56680156|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
56680157|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
56680158|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56680159|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56680160|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
56680161|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56680162|NCT02118467|Protective Agents|protective agents|mesh-ancestor
56680163|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
56680164|NCT02118467|Coagulants|coagulants|mesh-ancestor
56680165|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56680166|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
56680167|NCT00702156|Bisoprolol|bisoprolol|mesh-list
56680168|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56680169|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
56680170|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
56680171|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680172|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680173|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56680174|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56680175|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56680176|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
56533708|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56533709|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998888|NCT04904562|Giapreza|giapreza|mesh-list
56680177|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680178|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680179|NCT02638415|Carvedilol|carvedilol|mesh-list
56680180|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56326450|NCT05766800|Pemetrexed|pemetrexed|mesh-list
56680181|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56680182|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
56680183|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680184|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680185|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680186|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56680188|NCT02638415|Protective Agents|protective agents|mesh-ancestor
56680189|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56680190|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680191|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56680192|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
56680193|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56680194|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56680195|NCT00703872|Interferons|interferons|mesh-list
56680196|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680197|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
56680198|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680199|NCT00689026|Lubiprostone|lubiprostone|mesh-list
56680200|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56680201|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680202|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680203|NCT00598559|Acetaminophen|acetaminophen|mesh-list
56680204|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56680205|NCT00598559|Analgesics|analgesics|mesh-ancestor
56680206|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
56680207|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680208|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680209|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
56680215|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56680216|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680217|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56680219|NCT04057300|Clopidogrel|clopidogrel|mesh-list
56680220|NCT04057300|Ticagrelor|ticagrelor|mesh-list
56680221|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56680222|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56680223|NCT04057300|Analgesics|analgesics|mesh-ancestor
56680224|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
56680225|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680226|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680227|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56680228|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680229|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56680230|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56680231|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680232|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56680233|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56680234|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680235|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
56680236|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56680237|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56680238|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56680239|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
56680240|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680241|NCT00655967|Acamprosate|acamprosate|mesh-list
56680242|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56680243|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56680244|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56680245|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680246|NCT00655109|Fluticasone|fluticasone|mesh-list
56680247|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56680248|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
56680249|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56680250|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56533710|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533711|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56533712|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533713|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533714|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
56533715|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
56533716|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56533717|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56533718|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56533719|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56533720|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533721|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533722|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533723|NCT02846701|Analgesics|analgesics|mesh-ancestor
56533724|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
56533725|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533726|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
56533727|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56533728|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
56533729|NCT04327063|Ropivacaine|ropivacaine|mesh-list
56533730|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
56533731|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
56533732|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533733|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533734|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
56533735|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533736|NCT04191616|Dexamethasone|dexamethasone|mesh-list
56533737|NCT04191616|Pomalidomide|pomalidomide|mesh-list
56533738|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533739|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
56533740|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
56533741|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533742|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533743|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56680251|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
56680252|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680253|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680254|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56533744|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
56533745|NCT04191616|Hormones|hormones|mesh-ancestor
56533746|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533747|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56533748|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533749|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
56533750|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56533751|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56533752|NCT04191616|Growth Substances|growth substances|mesh-ancestor
56533753|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
56533754|NCT04565431|Natalizumab|natalizumab|mesh-list
56533755|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
56533756|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533757|NCT04292704|Clotrimazole|clotrimazole|mesh-list
56533758|NCT04292704|Miconazole|miconazole|mesh-list
56533759|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56533760|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533761|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
56533762|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56533763|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56533764|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533765|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680255|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
56680256|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
56326525|NCT05750875|Dermatologic Agents|dermatologic agents|mesh-ancestor
56680257|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56680258|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56680259|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56680260|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56680261|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56680262|NCT00655109|Analgesics|analgesics|mesh-ancestor
56680263|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
56680264|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680265|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56680266|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56680267|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
56680268|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
56680269|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680270|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680271|NCT02632877|Pirfenidone|pirfenidone|mesh-list
56680272|NCT02632877|Ketanserin|ketanserin|mesh-list
56680273|NCT02632877|Analgesics|analgesics|mesh-ancestor
56680274|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
56680275|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680276|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680277|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56680278|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56680279|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56680290|NCT00656123|Sargramostim|sargramostim|mesh-list
56680291|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
56680292|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680293|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533766|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56533767|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
56533768|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533769|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533770|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56533771|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56533772|NCT05242783|Terlipressin|terlipressin|mesh-list
56533773|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56533774|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56533775|NCT04191421|Spartalizumab|spartalizumab|mesh-list
56533776|NCT04191421|Siltuximab|siltuximab|mesh-list
56533777|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56533778|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533779|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533780|NCT03987685|Topotecan|topotecan|mesh-list
56533781|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56533782|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56533783|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533784|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533785|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533786|NCT00900757|Palonosetron|palonosetron|mesh-list
56533787|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
56680294|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680295|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56680296|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
56680297|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680298|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680299|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56680300|NCT04163471|Hemostatics|hemostatics|mesh-list
56680301|NCT04163471|Coagulants|coagulants|mesh-ancestor
56680302|NCT00657449|Valdecoxib|valdecoxib|mesh-list
56680303|NCT00657449|Rofecoxib|rofecoxib|mesh-list
56680304|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56680305|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56680306|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680307|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680308|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56680309|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56680310|NCT00657449|Analgesics|analgesics|mesh-ancestor
56680311|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
56680312|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680313|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680314|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56680315|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680316|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
56680317|NCT04160195|Fludarabine|fludarabine|mesh-list
56680318|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680319|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
56680320|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680321|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680322|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56533788|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
56533789|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533790|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533791|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56533792|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56533793|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56533794|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
56533795|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533796|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533797|NCT03733132|Metformin|metformin|mesh-list
56533798|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56533799|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533800|NCT04136743|Dexamethasone|dexamethasone|mesh-list
56680323|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
56680324|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680325|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680326|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56680327|NCT00911261|Oxymorphone|oxymorphone|mesh-list
56680328|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56680329|NCT00911261|Narcotics|narcotics|mesh-ancestor
56680330|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326601|NCT05680584|Melatonin|melatonin|mesh-list
56680331|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680332|NCT00911261|Analgesics|analgesics|mesh-ancestor
56680333|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
56680334|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680335|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56680336|NCT00686374|Adalimumab|adalimumab|mesh-list
56680337|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56680338|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680339|NCT00750178|Vorinostat|vorinostat|mesh-list
56680340|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680341|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56680342|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680343|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681006|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56681007|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56681008|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
56681009|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
56681010|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681011|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
56681012|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
56681013|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56681568|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681569|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681570|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56681571|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
56681572|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
56681573|NCT00665327|Levofloxacin|levofloxacin|mesh-list
56681574|NCT00665327|Ofloxacin|ofloxacin|mesh-list
56681844|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681846|NCT02628197|Calcium|calcium|mesh-list
56237616|NCT01757587|Metformin|metformin|mesh-list
56237617|NCT01757587|Vildagliptin|vildagliptin|mesh-list
56237618|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237619|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237620|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56237621|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
56237622|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237623|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682050|NCT00912275|Lapatinib|lapatinib|mesh-list
56682051|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56533801|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533802|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
56533803|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
56533804|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533805|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533806|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56533807|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
56533808|NCT04136743|Hormones|hormones|mesh-ancestor
56533809|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533810|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56187990|NCT01441557|Amifampridine|amifampridine|mesh-list
56682052|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682053|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682054|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682055|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682056|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682057|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56682058|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682059|NCT00882557|Daptomycin|daptomycin|mesh-list
56682060|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682061|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682062|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
56682193|NCT04276857|Vitamins|vitamins|mesh-ancestor
56682194|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
56682195|NCT00807573|Paclitaxel|paclitaxel|mesh-list
56682196|NCT00807573|Bevacizumab|bevacizumab|mesh-list
56682197|NCT00807573|Pemetrexed|pemetrexed|mesh-list
56682198|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56682199|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682200|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682201|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682202|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682203|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682204|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56682332|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682333|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682334|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
56682335|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682338|NCT00823212|Clopidogrel|clopidogrel|mesh-list
56682339|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56238074|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
56682399|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682400|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682401|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682402|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56682403|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
56682443|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682444|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
56682445|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682446|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56682447|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56682448|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56682449|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
56682450|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682451|NCT00680836|Rifaximin|rifaximin|mesh-list
56682452|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682453|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682454|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56682455|NCT05434546|Pregnanolone|pregnanolone|mesh-list
56682456|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
56682457|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682458|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682459|NCT05403580|Olanzapine|olanzapine|mesh-list
56682460|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
56682461|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
56533811|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533812|NCT03931057|Midazolam|midazolam|mesh-list
56533813|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56533814|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56533815|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533816|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533817|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56533818|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56533819|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56533820|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56533822|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
56533823|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
56533824|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
56634281|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56533825|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533826|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533827|NCT02846155|Simethicone|simethicone|mesh-list
56682462|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682463|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682464|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56682496|NCT00757198|Analgesics|analgesics|mesh-ancestor
56682497|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
56682498|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682499|NCT00679432|Budesonide|budesonide|mesh-list
56682500|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56682501|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56682502|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
56682503|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682504|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682505|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56682506|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
56682507|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
56682660|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
56682661|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682662|NCT05370040|Vaccines|vaccines|mesh-list
56682663|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
56682664|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682665|NCT05354674|Bevacizumab|bevacizumab|mesh-list
56682666|NCT05354674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56682667|NCT05354674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682668|NCT05354674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56682669|NCT05354674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56682670|NCT05354674|Growth Substances|growth substances|mesh-ancestor
56682671|NCT05354674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682672|NCT05354674|Growth Inhibitors|growth inhibitors|mesh-ancestor
56682673|NCT00758134|Trastuzumab|trastuzumab|mesh-list
56682674|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56682675|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682676|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
56682677|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56682678|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682679|NCT00758212|Vaccines|vaccines|mesh-list
56682680|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
56682681|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682682|NCT00679042|Exenatide|exenatide|mesh-list
56682683|NCT00679042|Sirolimus|sirolimus|mesh-list
56682684|NCT00679042|Etanercept|etanercept|mesh-list
56682685|NCT00679042|Tacrolimus|tacrolimus|mesh-list
56682686|NCT00679042|Basiliximab|basiliximab|mesh-list
56682687|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533828|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
56533829|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533830|NCT02846155|Emollients|emollients|mesh-ancestor
56533831|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
56533832|NCT02845843|Interferons|interferons|mesh-list
56533834|NCT02845843|Lopinavir|lopinavir|mesh-list
56533835|NCT02845843|Interferon-beta|interferon-beta|mesh-list
56533836|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
56533837|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533838|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
56533839|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56533840|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56533841|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56533842|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
56533843|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533844|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533845|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56533846|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56533847|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56533848|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56188020|NCT01441908|Pravastatin|pravastatin|mesh-list
56682688|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
56682689|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682690|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56682691|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682692|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682693|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682694|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682695|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56682696|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682697|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
56682698|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56329100|NCT00019721|Aldesleukin|aldesleukin|mesh-list
56682699|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56682700|NCT00679042|Analgesics|analgesics|mesh-ancestor
56682701|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
56682702|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682703|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56682704|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682705|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56682706|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56682806|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682808|NCT05747469|Anesthetics, Local|anesthetics, local|mesh-list
56682809|NCT05747469|Anesthetics|anesthetics|mesh-list
56682810|NCT05747469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682811|NCT05747469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682940|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
56238661|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683024|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683025|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56683026|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56683027|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
56683028|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533849|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
56533850|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533851|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56533852|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
56533853|NCT02845999|Fludarabine|fludarabine|mesh-list
56533854|NCT02845999|Cetuximab|cetuximab|mesh-list
56533855|NCT02845999|Interleukin-2|interleukin-2|mesh-list
56533856|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56533857|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
56188037|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
56683029|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56683030|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56683031|NCT04741438|Nivolumab|nivolumab|mesh-list
56683032|NCT04741438|Ipilimumab|ipilimumab|mesh-list
56683033|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683034|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683035|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56683036|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683037|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56683038|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
56683039|NCT03321201|Coagulants|coagulants|mesh-ancestor
56683040|NCT02612220|Hemostatics|hemostatics|mesh-list
56683041|NCT02612220|Coagulants|coagulants|mesh-ancestor
56683042|NCT04627246|Vaccines|vaccines|mesh-list
56683043|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
56683044|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683045|NCT00761644|Sirolimus|sirolimus|mesh-list
56683046|NCT00761644|Bevacizumab|bevacizumab|mesh-list
56683047|NCT00761644|Doxorubicin|doxorubicin|mesh-list
56683048|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56683049|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683081|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683082|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683083|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683084|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683085|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56683086|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56683087|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238807|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683113|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
56683114|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56683115|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683116|NCT00762658|Betamethasone|betamethasone|mesh-list
56683117|NCT00762658|Tacrolimus|tacrolimus|mesh-list
56683118|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56683119|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683120|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
56683121|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683122|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56683123|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683124|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683125|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683126|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
56683127|NCT00762658|Hormones|hormones|mesh-ancestor
56683128|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56683129|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56683130|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
56683131|NCT02558452|Tacrolimus|tacrolimus|mesh-list
56683132|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683133|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
56683134|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683135|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56683170|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
56683171|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683189|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
56683190|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683191|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533858|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533859|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533860|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56533861|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
56533862|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533863|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533864|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56533865|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56533866|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56533867|NCT02845999|Analgesics|analgesics|mesh-ancestor
56533868|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
56533869|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533870|NCT05337085|Midazolam|midazolam|mesh-list
56533871|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
56533872|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56533873|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533874|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683192|NCT00763204|Betamethasone|betamethasone|mesh-list
56683193|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56683194|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683195|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
56683196|NCT00763204|Hormones|hormones|mesh-ancestor
56683197|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56683198|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683199|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56683200|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
56683201|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56683202|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683203|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683204|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683205|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
56683206|NCT02558218|Hormones|hormones|mesh-ancestor
56683207|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56683208|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683209|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56683210|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56683211|NCT00763438|Sertindole|sertindole|mesh-list
56683212|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56683213|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56683214|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683215|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683216|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56329636|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683225|NCT01737502|Sirolimus|sirolimus|mesh-list
56683226|NCT01737502|Auranofin|auranofin|mesh-list
56683257|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56683258|NCT00764062|Amoxicillin|amoxicillin|mesh-list
56683259|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683260|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683261|NCT00758914|Vitamin E|vitamin e|mesh-list
56683262|NCT00758914|Vitamins|vitamins|mesh-ancestor
56683263|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
56683264|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683265|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
56683266|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683267|NCT00758914|Protective Agents|protective agents|mesh-ancestor
56683268|NCT00759070|Ritonavir|ritonavir|mesh-list
56533875|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56533876|NCT05337085|Analgesics|analgesics|mesh-ancestor
56533877|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
56533878|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533879|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56533880|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56533881|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56188065|NCT01442272|Vitamins|vitamins|mesh-ancestor
56683269|NCT00759070|Lopinavir|lopinavir|mesh-list
56683270|NCT00759070|Tenofovir|tenofovir|mesh-list
56683271|NCT00759070|Emtricitabine|emtricitabine|mesh-list
56683272|NCT00759070|Efavirenz|efavirenz|mesh-list
56329715|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
56683295|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
56683296|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56683297|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56683298|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56683299|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683300|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683301|NCT00672958|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56683302|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56683303|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56683304|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683305|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683306|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
56683307|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56683308|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56683309|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56683310|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56683311|NCT00764374|Z 338|z 338|mesh-list
56683312|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56683313|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683314|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683315|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
56683316|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683317|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683318|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56683319|NCT00759226|Leucovorin|leucovorin|mesh-list
56683434|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56683435|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683436|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683437|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56683438|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56683439|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56239166|NCT01765790|Antibodies|antibodies|mesh-list
56683476|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56683477|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683478|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
56683479|NCT04049344|Decitabine|decitabine|mesh-list
56683562|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683564|NCT00766402|Diclofenac|diclofenac|mesh-list
56683565|NCT00766402|Tramadol|tramadol|mesh-list
56683566|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56683567|NCT00766402|Analgesics|analgesics|mesh-ancestor
56683568|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
56683569|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683570|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683571|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
56683572|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56683573|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683574|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683575|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56683576|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683577|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239290|NCT01766258|Carbidopa|carbidopa|mesh-list
56683605|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683606|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
56533882|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
56533883|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533884|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683607|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683608|NCT00772174|Metformin|metformin|mesh-list
56683609|NCT00772174|Pioglitazone|pioglitazone|mesh-list
56683610|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683611|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683612|NCT00772564|Atorvastatin|atorvastatin|mesh-list
56683613|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56683614|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56683615|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
56683616|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683617|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56683618|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56683619|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683620|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56683621|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56683622|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56683623|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56683653|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
56683654|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
56683655|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
56683656|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683657|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56683658|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683659|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
56683660|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56683661|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56683662|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56683663|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
56683664|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683665|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683666|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683667|NCT00775372|Clarithromycin|clarithromycin|mesh-list
56683697|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56683698|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56683699|NCT00773188|Growth Substances|growth substances|mesh-ancestor
56683700|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683701|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
56683702|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56683703|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56683704|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56683705|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56683706|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683708|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683709|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683710|NCT00767494|Travoprost|travoprost|mesh-list
56683711|NCT00767494|Brinzolamide|brinzolamide|mesh-list
56683712|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56683736|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
56683737|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683738|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683739|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683740|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683741|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56683742|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56683743|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683744|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56683745|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56683746|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683748|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56683749|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56683750|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56683751|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
56683752|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683753|NCT00775840|Candesartan|candesartan|mesh-list
56683754|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56683755|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56533885|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56533886|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56533887|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56533888|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56533889|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56533890|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
56533891|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
56533892|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
56533893|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
56533894|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56533895|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56533896|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533897|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533898|NCT01723579|Estradiol|estradiol|mesh-list
56533899|NCT01723579|Estrogens|estrogens|mesh-ancestor
56533900|NCT01723579|Hormones|hormones|mesh-ancestor
56533901|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533902|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533903|NCT00901927|Rituximab|rituximab|mesh-list
56533904|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56683756|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56683757|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683758|NCT00775918|Doxycycline|doxycycline|mesh-list
56683759|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683760|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683761|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
56683785|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683786|NCT00767728|Mesalamine|mesalamine|mesh-list
56683787|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56683788|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56683789|NCT00767728|Analgesics|analgesics|mesh-ancestor
56683790|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
56683791|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683792|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683793|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683794|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683795|NCT00776074|Leuprolide|leuprolide|mesh-list
56683796|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56683797|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
56683798|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56683799|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683800|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56683801|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683802|NCT02628587|Clopidogrel|clopidogrel|mesh-list
56683803|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56683804|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56683805|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56683806|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56683807|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
56683808|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683809|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683810|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683811|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
56239514|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057528|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56533905|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
56533906|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683843|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56683844|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56683845|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683846|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
56683847|NCT00774280|Busulfan|busulfan|mesh-list
56683848|NCT00774280|Fludarabine|fludarabine|mesh-list
56683849|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683850|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
56683851|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683852|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683853|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56683854|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
56239569|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683886|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56683887|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683888|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683889|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
56683890|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683891|NCT00679679|Metformin|metformin|mesh-list
56683892|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683893|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330314|NCT00023738|Dacarbazine|dacarbazine|mesh-list
56683895|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56683896|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56683897|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683898|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683931|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56683932|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56683933|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
56683934|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
56683935|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683936|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56683937|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683938|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683939|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
56239653|NCT01768364|Renal Agents|renal agents|mesh-ancestor
56683987|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56683988|NCT02556970|Analgesics|analgesics|mesh-ancestor
56683989|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
56683990|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683991|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683992|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
56683993|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56683994|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683995|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683996|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56683997|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683998|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683999|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
56684000|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
56684001|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684097|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56684098|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56684099|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56684100|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
56684101|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56684102|NCT02634203|Riociguat|riociguat|mesh-list
56684103|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
56684104|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684105|NCT00681005|Rabeprazole|rabeprazole|mesh-list
56684106|NCT00681005|Pantoprazole|pantoprazole|mesh-list
56684107|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56684108|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684109|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56684110|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684111|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684112|NCT02633969|Indomethacin|indomethacin|mesh-list
56684113|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56684114|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56684115|NCT02633969|Analgesics|analgesics|mesh-ancestor
56684116|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
56533907|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533908|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
56533909|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533910|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533911|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56533912|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
56533913|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533914|NCT00901927|Analgesics|analgesics|mesh-ancestor
56533915|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
56533916|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533917|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56533918|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56533919|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533920|NCT05335837|Anesthetics|anesthetics|mesh-list
56684117|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330546|NCT00024518|Interferons|interferons|mesh-list
56684118|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684119|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56684120|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56684121|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
56684122|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
56684123|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56684124|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56684410|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56684411|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684412|NCT00671788|Dasatinib|dasatinib|mesh-list
56684413|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684414|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56684415|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684416|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684417|NCT02626481|Dexamethasone|dexamethasone|mesh-list
56684418|NCT02626481|Daratumumab|daratumumab|mesh-list
56330863|NCT00025142|Leucovorin|leucovorin|mesh-list
56684419|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56684420|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
56684421|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
56684422|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684423|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684424|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684425|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
56684426|NCT02626481|Hormones|hormones|mesh-ancestor
56684427|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684428|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56684429|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684430|NCT00777166|Oxytocin|oxytocin|mesh-list
56684431|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
56684432|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56684433|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684434|NCT00681941|Sevelamer|sevelamer|mesh-list
56684435|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
56684436|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
56240143|NCT01770769|Cloxacillin|cloxacillin|mesh-list
56684470|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56684472|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56684473|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56684474|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684475|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684476|NCT00682019|Urological Agents|urological agents|mesh-ancestor
56684477|NCT00779896|Tazarotene|tazarotene|mesh-list
56684478|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
56684479|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
56684502|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684503|NCT02626559|Bupivacaine|bupivacaine|mesh-list
56684504|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
56684505|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
56684506|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684507|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684508|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
56684509|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684510|NCT00768508|Naltrexone|naltrexone|mesh-list
56684511|NCT00768508|Ondansetron|ondansetron|mesh-list
56684512|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56684513|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56684514|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684515|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
56684516|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684517|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
56684518|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
56684519|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684520|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
56684521|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
56684522|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56684523|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
56684524|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684525|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684526|NCT00768508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56684527|NCT00768508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56684528|NCT00768508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684556|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684557|NCT00780832|Caffeine|caffeine|mesh-list
56684558|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56684559|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56684560|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684561|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56684562|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684563|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684564|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56684565|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56684566|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
56684567|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684568|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
56684569|NCT00597701|Lorazepam|lorazepam|mesh-list
56684570|NCT00597701|Baclofen|baclofen|mesh-list
56684571|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56684572|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684573|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56684638|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684639|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684640|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56684641|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
56684642|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
56684643|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684644|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684646|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
56684647|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
56684648|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684649|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684650|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
56684651|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684652|NCT00922649|Insulin|insulin|mesh-list
56684653|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56684654|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684655|NCT04142411|Insulin|insulin|mesh-list
56684656|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56684657|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
56684658|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56240361|NCT01772381|Dexamethasone|dexamethasone|mesh-list
56684731|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
56684867|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56684868|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56684869|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684870|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
56684871|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331313|NCT00054522|Calcitriol|calcitriol|mesh-list
56684872|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56684873|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
56684874|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533921|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56533922|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533923|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
56533924|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533925|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
56533926|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56533927|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56188110|NCT01442519|Mitomycin|mitomycin|mesh-list
56684875|NCT00666562|Protective Agents|protective agents|mesh-ancestor
56684876|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684877|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56684878|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56684916|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684918|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56684919|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684920|NCT00690911|Adalimumab|adalimumab|mesh-list
56684921|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56684922|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56684923|NCT00781846|Sirolimus|sirolimus|mesh-list
56684924|NCT00781846|Bevacizumab|bevacizumab|mesh-list
56684925|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56684926|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684927|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56684928|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56684929|NCT00781846|Growth Substances|growth substances|mesh-ancestor
56684930|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684931|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
56684932|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684933|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684934|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56684935|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
56684936|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56684937|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
56684938|NCT00853580|Lovastatin|lovastatin|mesh-list
56684939|NCT00853580|L 647318|l 647318|mesh-list
56684940|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
56685002|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
56685003|NCT04136639|Protective Agents|protective agents|mesh-ancestor
56685004|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685005|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685006|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56685007|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685008|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
56685009|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685159|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685160|NCT00695045|Analgesics|analgesics|mesh-ancestor
56685161|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
56685162|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685163|NCT02624453|Fluconazole|fluconazole|mesh-list
56685164|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56685165|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
56685166|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685167|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56685168|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56685169|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685170|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685171|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56685172|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
56685173|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685174|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240877|NCT01777100|Sufentanil|sufentanil|mesh-list
56685239|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331699|NCT00028028|Sirolimus|sirolimus|mesh-list
56685240|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
56685241|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56685242|NCT00769990|Estrogens|estrogens|mesh-ancestor
56533928|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56188118|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56685243|NCT00769990|Hormones|hormones|mesh-ancestor
56685244|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685245|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
56685246|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56685247|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56685248|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
56685249|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685250|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56685326|NCT02624531|Taxane|taxane|mesh-list
56685327|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685328|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
56685329|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56685330|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
56241035|NCT01778413|Efavirenz|efavirenz|mesh-list
56685370|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
56685371|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56685372|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56685373|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685374|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
56685375|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
56685376|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56685377|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
56685378|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
56685379|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685380|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685381|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56685382|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
56685383|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
56685384|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56685385|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56685386|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
56685387|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
56685388|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56685389|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56685390|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685391|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331855|NCT00028886|Melphalan|melphalan|mesh-list
56685392|NCT00853112|Urological Agents|urological agents|mesh-ancestor
56685393|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
56241092|NCT01779232|Danazol|danazol|mesh-list
56685429|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685430|NCT02621489|Metformin|metformin|mesh-list
56685431|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
56685432|NCT02621489|Exenatide|exenatide|mesh-list
56685433|NCT02621489|Biguanides|biguanides|mesh-list
56685434|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56685513|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685514|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56685515|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
56685516|NCT02623673|Hormones|hormones|mesh-ancestor
56685517|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685518|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56685519|NCT04117178|Memantine|memantine|mesh-list
56685520|NCT04117178|Donepezil|donepezil|mesh-list
56685521|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56685522|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685523|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685524|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
56685525|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685526|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685527|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
56685528|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56685529|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56685530|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
56685531|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56685578|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685579|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685580|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56685581|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56685582|NCT00828672|Growth Substances|growth substances|mesh-ancestor
56685583|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685584|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
56057529|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56533929|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56533930|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
56533931|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56533932|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533933|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56533934|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56533935|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56533936|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56533937|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56533938|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56533939|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56533940|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56533941|NCT00968968|Trastuzumab|trastuzumab|mesh-list
56533942|NCT00968968|Lapatinib|lapatinib|mesh-list
56533943|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56533944|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533945|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56533946|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56533947|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533948|NCT00973102|Estrogens|estrogens|mesh-list
56533949|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56533950|NCT00973102|Hormones|hormones|mesh-ancestor
56533951|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56533952|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533953|NCT03691090|Paclitaxel|paclitaxel|mesh-list
56533954|NCT03691090|Cisplatin|cisplatin|mesh-list
56533955|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56533956|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56533957|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
56685585|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56685586|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
56685587|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685588|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56241285|NCT01780233|Fentanyl|fentanyl|mesh-list
56685671|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56685672|NCT00784966|Analgesics|analgesics|mesh-ancestor
56685673|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
56685674|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685923|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
56685924|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56685925|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56685926|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533958|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
56533959|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
56533960|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533961|NCT00783211|Fexofenadine|fexofenadine|mesh-list
56533962|NCT00783211|Desloratadine|desloratadine|mesh-list
56533963|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56685927|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56685928|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56685929|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56685930|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685931|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56685932|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56685933|NCT04015908|Narcotics|narcotics|mesh-ancestor
56685934|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56685935|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685936|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685937|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56685938|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56685969|NCT00785434|Antidepressive Agents|antidepressive agents|mesh-ancestor
56685970|NCT00785434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56685972|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
56685973|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
56685974|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
56685975|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685976|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685977|NCT02623127|Sunitinib|sunitinib|mesh-list
56685978|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685979|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56685980|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56241680|NCT01782976|Bevacizumab|bevacizumab|mesh-list
56686077|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
56686078|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686079|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686080|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56686082|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56686083|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56686084|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686085|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56686086|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56686123|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
56686124|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56686192|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686193|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686194|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56686195|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56686196|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56686197|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
56686198|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686199|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686221|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56332669|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56686222|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56686223|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686224|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686225|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56686226|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56686227|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56686228|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
56686229|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686230|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686231|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56686232|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56686233|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
56686234|NCT00814632|Apremilast|apremilast|mesh-list
56686235|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56686236|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56686237|NCT00814632|Analgesics|analgesics|mesh-ancestor
56533964|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
56533965|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533966|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533967|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533968|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56533970|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
56533971|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
56533972|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56533973|NCT03679546|Infliximab|infliximab|mesh-list
56533974|NCT03679546|Vedolizumab|vedolizumab|mesh-list
56533975|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
56533976|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56533977|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56533978|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
56686238|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
56686239|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686240|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686241|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686242|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686243|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56686244|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56686245|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686246|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686247|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56686248|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56686249|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56686250|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
56686251|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686252|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56686253|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56686254|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686255|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
56686256|NCT02620007|Rifaximin|rifaximin|mesh-list
56686257|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56686258|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686259|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56686260|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56686261|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686262|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686263|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686264|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56686265|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56686266|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56686267|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
56686268|NCT02554942|Hematinics|hematinics|mesh-ancestor
56686269|NCT02619773|Mupirocin|mupirocin|mesh-list
56686270|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56686271|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686272|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56686273|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686274|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686275|NCT02555488|Methylene Blue|methylene blue|mesh-list
56686276|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686277|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686278|NCT02554864|Lidocaine|lidocaine|mesh-list
56686279|NCT02554864|Ropivacaine|ropivacaine|mesh-list
56686280|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
56686281|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
56686282|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686283|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533979|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56533980|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
56533981|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56533982|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
56686284|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
56686285|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686286|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56686287|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56686288|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56686289|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56686290|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686378|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56686380|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686381|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686424|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
56686425|NCT00851084|Hematinics|hematinics|mesh-ancestor
56686426|NCT02617199|Fentanyl|fentanyl|mesh-list
56686427|NCT02617199|Analgesics|analgesics|mesh-list
56686428|NCT02617199|Ropivacaine|ropivacaine|mesh-list
56686429|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
56686430|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686431|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686432|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
56686433|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
56686434|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686435|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56686436|NCT02617199|Narcotics|narcotics|mesh-ancestor
56686437|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56686438|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56686439|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
56686440|NCT00845858|Metoclopramide|metoclopramide|mesh-list
56686441|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
56686442|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
56686443|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686444|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686445|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56686446|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56686447|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56686448|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
56686449|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686450|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686451|NCT02619149|Tazobactam|tazobactam|mesh-list
56686452|NCT02619149|Piperacillin|piperacillin|mesh-list
56686453|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56686454|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56686455|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686456|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56686457|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686458|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686459|NCT04134065|Vitamin D|vitamin d|mesh-list
56686460|NCT04134065|Vitamins|vitamins|mesh-ancestor
56686461|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
56686462|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686463|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56686464|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
56686465|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56686466|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56686467|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686468|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
56686469|NCT02616731|Coagulants|coagulants|mesh-ancestor
56686470|NCT00850460|Atorvastatin|atorvastatin|mesh-list
56686471|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56686472|NCT00850460|Simvastatin|simvastatin|mesh-list
56686473|NCT00850460|Pravastatin|pravastatin|mesh-list
56686474|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56686475|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56686476|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
56686477|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686478|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56686479|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56686480|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686481|NCT00661492|Cetuximab|cetuximab|mesh-list
56533983|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56533984|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
56533985|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56533986|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56533987|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56533988|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
56533989|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56533990|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
56533991|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56533992|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56533993|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56533994|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
56533995|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
56686482|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
56242157|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56686516|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686517|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686518|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686519|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686520|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56686521|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686578|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
56686579|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686580|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686581|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686582|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56686583|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56686584|NCT00797836|Interferons|interferons|mesh-list
56686585|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686586|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
56686587|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686588|NCT00693407|Capsaicin|capsaicin|mesh-list
56686589|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
56686590|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
56686591|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
56333040|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
56686592|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686645|NCT05755854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56686646|NCT05755854|Alkylating Agents|alkylating agents|mesh-ancestor
56686647|NCT05755854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686648|NCT05755854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686649|NCT05755854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56242354|NCT01787669|Hormones|hormones|mesh-ancestor
56686681|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686683|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56686684|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686685|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686686|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686687|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
56686688|NCT00798070|Fluorouracil|fluorouracil|mesh-list
56686689|NCT00798070|Docetaxel|docetaxel|mesh-list
56686690|NCT00798070|Epirubicin|epirubicin|mesh-list
56686727|NCT00787462|Pregabalin|pregabalin|mesh-list
56686728|NCT00787462|Analgesics|analgesics|mesh-ancestor
56686729|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
56686730|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686731|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686732|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
56686733|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56686734|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56057627|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
56533996|NCT03679312|Protective Agents|protective agents|mesh-ancestor
56533997|NCT02842567|Vitamin E|vitamin e|mesh-list
56533998|NCT02842567|Tocopherols|tocopherols|mesh-list
56533999|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
56534000|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
56534001|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
56534002|NCT02842567|Vitamins|vitamins|mesh-ancestor
56534003|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
56534004|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534005|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
56534006|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534007|NCT02842567|Protective Agents|protective agents|mesh-ancestor
56534008|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534009|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56534010|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56534011|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
56534012|NCT00705211|Ezetimibe|ezetimibe|mesh-list
56534013|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56534014|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56188192|NCT01442818|Hydromorphone|hydromorphone|mesh-list
56686735|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686736|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56686737|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56686738|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56686739|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686740|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56686741|NCT00792766|Everolimus|everolimus|mesh-list
56686742|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686743|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686744|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
56686745|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686746|NCT00798460|Lamivudine|lamivudine|mesh-list
56686747|NCT00798460|Adefovir|adefovir|mesh-list
56686748|NCT00798460|Clevudine|clevudine|mesh-list
56686749|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56686833|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
56242532|NCT01788982|Nintedanib|nintedanib|mesh-list
56686935|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56686936|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56686937|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686939|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
56686940|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686941|NCT04133051|Bupivacaine|bupivacaine|mesh-list
56686942|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
56686943|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
56686944|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242634|NCT01789710|Nicotine|nicotine|mesh-list
56687029|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687030|NCT02608710|Verinurad|verinurad|mesh-list
56687031|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
56687032|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56687033|NCT04030260|Antibodies|antibodies|mesh-list
56687034|NCT04030260|Immunoglobulins|immunoglobulins|mesh-list
56687035|NCT04030260|Immunologic Factors|immunologic factors|mesh-ancestor
56687036|NCT04030260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687037|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
56687073|NCT05754684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56687074|NCT05754684|Antiviral Agents|antiviral agents|mesh-ancestor
56687075|NCT05754684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534015|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
56534016|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534017|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56534018|NCT02839213|Scopolamine|scopolamine|mesh-list
56534019|NCT02839213|Bromides|bromides|mesh-list
56534020|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56534021|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
56534022|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56534023|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
56534024|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
56534025|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534026|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534027|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56534028|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
56534029|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56534030|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
56534031|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534032|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534033|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56534034|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
56534035|NCT05334043|Curcumin|curcumin|mesh-list
56534036|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56534037|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56534038|NCT05334043|Analgesics|analgesics|mesh-ancestor
56687076|NCT05754684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56687077|NCT05754684|Hormone Antagonists|hormone antagonists|mesh-ancestor
56242770|NCT01793038|Enclomiphene|enclomiphene|mesh-list
56687214|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687216|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
56687217|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687218|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56687219|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56687220|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56687221|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687222|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687223|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687224|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
56687225|NCT02613455|Hormones|hormones|mesh-ancestor
56687226|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56687227|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56687228|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
56687229|NCT00703586|Maraviroc|maraviroc|mesh-list
56687230|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56687231|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56687294|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56687295|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
56687296|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
56687297|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
56687298|NCT00702260|Ramipril|ramipril|mesh-list
56687299|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56534039|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
56534040|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534041|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534042|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534043|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534044|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534045|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534046|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634282|NCT03405090|Narcotics|narcotics|mesh-ancestor
56534048|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56534049|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56534050|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
56534051|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
56534052|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534053|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534054|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56534055|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
56534056|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56534057|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
56534058|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188235|NCT01442935|Vitamins|vitamins|mesh-ancestor
56687300|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
56687301|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687302|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687303|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56687304|NCT00702416|Acetaminophen|acetaminophen|mesh-list
56687305|NCT00702416|Fentanyl|fentanyl|mesh-list
56687306|NCT00702416|Morphine|morphine|mesh-list
56687361|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56687363|NCT00807846|Analgesics|analgesics|mesh-ancestor
56687364|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
56243056|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
56687394|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687395|NCT04016220|Budesonide|budesonide|mesh-list
56687396|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687397|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56687398|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
56687399|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687400|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687401|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56687402|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
56687403|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
56687404|NCT04016220|Hormones|hormones|mesh-ancestor
56687405|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56687406|NCT00663052|Etanercept|etanercept|mesh-list
56687407|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56687541|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687542|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687543|NCT00658684|Urological Agents|urological agents|mesh-ancestor
56687544|NCT00660400|Azacitidine|azacitidine|mesh-list
56243234|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
56687549|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687550|NCT00826514|Tanezumab|tanezumab|mesh-list
56687551|NCT00826514|Analgesics|analgesics|mesh-ancestor
56687552|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
56534059|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534060|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56534061|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
56534062|NCT02838823|Antibodies|antibodies|mesh-list
56534063|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56534064|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
56534065|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534066|NCT00156091|Olanzapine|olanzapine|mesh-list
56534067|NCT00156091|Asenapine|asenapine|mesh-list
56534068|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
56534069|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
56534070|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534071|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534072|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56534073|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56534074|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56534075|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56534076|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56534077|NCT00156091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56534078|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56534079|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56534080|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534081|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534082|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
56687553|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687554|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687555|NCT00800566|Clofarabine|clofarabine|mesh-list
56687556|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56687557|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
56687558|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687559|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687560|NCT00793858|Ciclesonide|ciclesonide|mesh-list
56687561|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
56687562|NCT00793858|Hormones|hormones|mesh-ancestor
56687563|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56687564|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687565|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56687566|NCT00800722|Sirolimus|sirolimus|mesh-list
56687567|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56687568|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687569|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56687570|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687571|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
56687572|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56687573|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
56687574|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687575|NCT00826280|Caffeine|caffeine|mesh-list
56687576|NCT00826280|Regadenoson|regadenoson|mesh-list
56687577|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56687578|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534083|NCT00140959|Losartan|losartan|mesh-list
56534084|NCT00140959|Atenolol|atenolol|mesh-list
56534085|NCT00140959|Amlodipine|amlodipine|mesh-list
56534086|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56534087|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56534088|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56534089|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534090|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56534091|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534092|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
56534093|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56534094|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56534095|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56534096|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
56534097|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534098|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
56534099|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534100|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
56534101|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56534102|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56534103|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56534104|NCT00095017|Etoricoxib|etoricoxib|mesh-list
56534105|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56534106|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56534107|NCT00095017|Analgesics|analgesics|mesh-ancestor
56188282|NCT01443065|Vitamins|vitamins|mesh-ancestor
56687579|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56687580|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687581|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687582|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56687583|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56687584|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
56687585|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687586|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56687587|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56687588|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
56687589|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56687590|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56687591|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56687592|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
56687593|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687594|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56687595|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56687596|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687597|NCT00703898|Nevirapine|nevirapine|mesh-list
56687598|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56534108|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
56534109|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534110|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534111|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534112|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534113|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56534114|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56534115|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534116|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534117|NCT00092755|Ibuprofen|ibuprofen|mesh-list
56534118|NCT00092755|Etoricoxib|etoricoxib|mesh-list
56282344|NCT03771157|Vaccines|vaccines|mesh-list
56534119|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56534120|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56534121|NCT00092755|Analgesics|analgesics|mesh-ancestor
56534122|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
56534123|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923714|NCT03606967|Laxatives|laxatives|mesh-ancestor
56534124|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534125|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534126|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534127|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56534128|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534129|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534130|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56534132|NCT00899431|Fludarabine|fludarabine|mesh-list
56534133|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
56687599|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56687600|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687601|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687602|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
56687603|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687604|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56687605|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56687606|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56687607|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56687608|NCT04030442|Morphine|morphine|mesh-list
56687609|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56687610|NCT04030442|Narcotics|narcotics|mesh-ancestor
56687611|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687612|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687613|NCT04030442|Analgesics|analgesics|mesh-ancestor
56687722|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56687723|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687724|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687725|NCT04951492|Olaparib|olaparib|mesh-list
56057628|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
56534134|NCT00899431|Lenalidomide|lenalidomide|mesh-list
56534135|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56534136|NCT00899431|Allopurinol|allopurinol|mesh-list
56534137|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
56534138|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56534139|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56534140|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534141|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
56534142|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534143|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534144|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56534145|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
56534146|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534147|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534148|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56534149|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56534150|NCT00899431|Growth Substances|growth substances|mesh-ancestor
56534151|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
56534152|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56534153|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
56534154|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534155|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
56534156|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56534157|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
56534158|NCT00899431|Protective Agents|protective agents|mesh-ancestor
56534159|NCT00898807|Citalopram|citalopram|mesh-list
56534160|NCT00898807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56534161|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56687726|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56687727|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687728|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687729|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687730|NCT00805194|Docetaxel|docetaxel|mesh-list
56687731|NCT00805194|Nintedanib|nintedanib|mesh-list
56687732|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687733|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
56687734|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
56687735|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
56687736|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687737|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56687738|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687739|NCT00657046|Droxidopa|droxidopa|mesh-list
56687740|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56687741|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56687742|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56687743|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
56687744|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534162|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56534163|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534164|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534165|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
56534166|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534167|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56534168|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
56534169|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56534170|NCT01229267|Vaccines|vaccines|mesh-list
56534171|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
56534172|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534173|NCT00897715|Rilonacept|rilonacept|mesh-list
56534174|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534175|NCT01229111|Leucovorin|leucovorin|mesh-list
56534176|NCT01229111|Fluorouracil|fluorouracil|mesh-list
56534177|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
56534178|NCT01229111|Cediranib|cediranib|mesh-list
56534179|NCT01229111|Calcium|calcium|mesh-list
56534180|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
56534181|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56188361|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687745|NCT00801736|Paclitaxel|paclitaxel|mesh-list
56687801|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56687802|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
56687803|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
56687804|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56687805|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56687806|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56687807|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
56687808|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687809|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687810|NCT00914394|Protective Agents|protective agents|mesh-ancestor
56687811|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687812|NCT04045678|Rotigotine|rotigotine|mesh-list
56687813|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
56687814|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
56687930|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687931|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687932|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687933|NCT00802906|Bevacizumab|bevacizumab|mesh-list
56687934|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56687935|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687936|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56687937|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56687938|NCT00802906|Growth Substances|growth substances|mesh-ancestor
56687939|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687940|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
56687941|NCT00803218|Fluticasone|fluticasone|mesh-list
56687942|NCT00803218|Xhance|xhance|mesh-list
56687943|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687944|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56687945|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
56687971|NCT00803530|Vitamins|vitamins|mesh-ancestor
56687972|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
56687973|NCT00803764|Naproxen|naproxen|mesh-list
56687974|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56534182|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534183|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
56534184|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534185|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56534186|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534187|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534188|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
56534189|NCT01229111|Antidotes|antidotes|mesh-ancestor
56534190|NCT01229111|Protective Agents|protective agents|mesh-ancestor
56534191|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
56534192|NCT01229111|Vitamins|vitamins|mesh-ancestor
56534193|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
56534194|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188380|NCT01443572|Anesthetics|anesthetics|mesh-list
56687975|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56687976|NCT00803764|Analgesics|analgesics|mesh-ancestor
56687977|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
56687978|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687979|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687980|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687981|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56687982|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
56687983|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56687984|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687985|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687986|NCT00704366|Saracatinib|saracatinib|mesh-list
56687987|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687988|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687989|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687990|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56687991|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56687992|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56243677|NCT01807832|Capsaicin|capsaicin|mesh-list
56688029|NCT05753436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56688030|NCT05753436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56688031|NCT05753436|Analgesics|analgesics|mesh-ancestor
56688032|NCT05753436|Sensory System Agents|sensory system agents|mesh-ancestor
56688033|NCT05753436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688034|NCT05753436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688035|NCT05753436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688036|NCT05753436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688037|NCT05753436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688068|NCT00708344|Irbesartan|irbesartan|mesh-list
56688069|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56688070|NCT00708344|Diuretics|diuretics|mesh-ancestor
56688071|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
56688072|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688073|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56688074|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56688075|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688076|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56688077|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56688078|NCT00866333|Entinostat|entinostat|mesh-list
56688079|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243763|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
56688173|NCT00708656|Analgesics|analgesics|mesh-ancestor
56688174|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
56688175|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688176|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688177|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534195|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56534197|NCT01228175|Varenicline|varenicline|mesh-list
56534198|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56534199|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56534200|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
56534201|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534202|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534203|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534204|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
56534206|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
56534207|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56534208|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
56534209|NCT01228019|Niacin|niacin|mesh-list
56534210|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56534211|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
56534212|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534213|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56534214|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
56534215|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
56534216|NCT01228019|Vitamins|vitamins|mesh-ancestor
56534217|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
56534218|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534219|NCT01227707|Leucovorin|leucovorin|mesh-list
56534220|NCT01227707|Bevacizumab|bevacizumab|mesh-list
56534221|NCT01227707|Fluorouracil|fluorouracil|mesh-list
56534222|NCT01227707|Capecitabine|capecitabine|mesh-list
56534223|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56534224|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534225|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56534226|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56534227|NCT01227707|Growth Substances|growth substances|mesh-ancestor
56534228|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534229|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
56534230|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
56534231|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534238|NCT01227707|Vitamins|vitamins|mesh-ancestor
56534239|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
56534240|NCT00633373|Cyclosporine|cyclosporine|mesh-list
56534241|NCT00633373|Cyclosporins|cyclosporins|mesh-list
56534242|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534243|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534244|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534245|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
56534246|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534247|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
56534248|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534249|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
56534250|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534251|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56534252|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
56534253|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56534254|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
56688178|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688179|NCT00913328|Montelukast|montelukast|mesh-list
56688180|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56688181|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
56688182|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56688183|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
56688184|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688185|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243872|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
56688216|NCT04118777|Ropivacaine|ropivacaine|mesh-list
56688217|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
56688218|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
56688219|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688220|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688221|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
56688222|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688223|NCT00708812|Paclitaxel|paclitaxel|mesh-list
56688224|NCT00708812|Carboplatin|carboplatin|mesh-list
56688225|NCT00708812|Endostar protein|endostar protein|mesh-list
56688226|NCT00708812|Endostatins|endostatins|mesh-list
56688227|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56688228|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688282|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688283|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56688284|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56688285|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56688286|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56688287|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688288|NCT00822692|Renal Agents|renal agents|mesh-ancestor
56688289|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56688290|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
56688291|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56688292|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56688294|NCT02607111|Tinzaparin|tinzaparin|mesh-list
56688295|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56243989|NCT01810458|Lidocaine|lidocaine|mesh-list
56688321|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688323|NCT00704756|Ribavirin|ribavirin|mesh-list
56688324|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56688325|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
56688326|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
56688327|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688328|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
56534255|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534256|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
56534257|NCT05334745|Protective Agents|protective agents|mesh-ancestor
56534258|NCT02838589|Exenatide|exenatide|mesh-list
56534259|NCT02838589|Glucagon|glucagon|mesh-list
56534260|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56534261|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56534262|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534263|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56534264|NCT02838589|Incretins|incretins|mesh-ancestor
56534265|NCT02838589|Hormones|hormones|mesh-ancestor
56534266|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534267|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56534268|NCT00895843|Ibuprofen|ibuprofen|mesh-list
56534269|NCT00895843|Epinephrine|epinephrine|mesh-list
56534270|NCT00895843|Bupivacaine|bupivacaine|mesh-list
56534271|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
56282493|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56534272|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
56688329|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688330|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
56688331|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688332|NCT00806442|Borage oil|borage oil|mesh-list
56688333|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688334|NCT02608242|Amlodipine|amlodipine|mesh-list
56688335|NCT02608242|Telmisartan|telmisartan|mesh-list
56688336|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56688337|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56688338|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56688339|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56688340|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56688341|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688342|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56688343|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688344|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
56688345|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56688370|NCT02604849|Neomycin|neomycin|mesh-list
56688371|NCT02604849|Streptomycin|streptomycin|mesh-list
56688372|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56688373|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688374|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56688375|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688376|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688377|NCT00709046|Pantoprazole|pantoprazole|mesh-list
56688378|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56688379|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56688380|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56688381|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688382|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688383|NCT00820898|Gemcitabine|gemcitabine|mesh-list
56688384|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56688385|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
56688386|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688387|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688388|NCT00820898|Antiviral Agents|antiviral agents|mesh-ancestor
56688389|NCT00820898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688390|NCT00820898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688391|NCT00820898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56688392|NCT00820898|Immunologic Factors|immunologic factors|mesh-ancestor
56534273|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56534274|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688393|NCT00820898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688394|NCT00865709|Leucovorin|leucovorin|mesh-list
56688395|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
56688411|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56688412|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688414|NCT00839306|Ranitidine|ranitidine|mesh-list
56688415|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56688416|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56688417|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56688418|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56688419|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688420|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688421|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56688422|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
56688423|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
56688424|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688425|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688426|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56688427|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56688428|NCT00839072|Trazodone|trazodone|mesh-list
56688429|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56688430|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56688431|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688432|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688433|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56688434|NCT00839072|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56688435|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56688436|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56688437|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688438|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688439|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
56688440|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56688441|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
56688442|NCT00704990|Vitamins|vitamins|mesh-list
56688443|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
56688444|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
56688445|NCT00704990|Pyridoxal|pyridoxal|mesh-list
56688446|NCT00704990|Pyridoxine|pyridoxine|mesh-list
56688447|NCT00704990|Zinc|zinc|mesh-list
56688448|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
56688449|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
56688450|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688451|NCT00704990|Trace Elements|trace elements|mesh-ancestor
56688452|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
56688453|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399632|NCT00164736|Ritonavir|ritonavir|mesh-list
56688454|NCT00704990|Protective Agents|protective agents|mesh-ancestor
56688455|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
56688456|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688457|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688469|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
56688470|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
56688471|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688472|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688473|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
56688474|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
56688475|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56688476|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688477|NCT00838916|Incretins|incretins|mesh-ancestor
56688478|NCT00838916|Hormones|hormones|mesh-ancestor
56688479|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688480|NCT00838682|Omeprazole|omeprazole|mesh-list
56688481|NCT00838682|Rabeprazole|rabeprazole|mesh-list
56688482|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56688483|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56688484|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56688485|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688486|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688487|NCT00913484|Disulfiram|disulfiram|mesh-list
56688488|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56688489|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56688490|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057819|NCT00002331|Ethambutol|ethambutol|mesh-list
56534275|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
56688491|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688492|NCT00803712|Vitamin D|vitamin d|mesh-list
56688493|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
56688494|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
56688495|NCT00803712|Vitamins|vitamins|mesh-list
56688496|NCT00803712|Cinacalcet|cinacalcet|mesh-list
56688497|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
56688498|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688499|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56688500|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56688501|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56688502|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
56688503|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688504|NCT05756972|Carboplatin|carboplatin|mesh-list
56688505|NCT05756972|Pemetrexed|pemetrexed|mesh-list
56688506|NCT05756972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688507|NCT05756972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688508|NCT05756972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688509|NCT05756972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56688510|NCT05756972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56688511|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
56688512|NCT00803634|Diltiazem|diltiazem|mesh-list
56688513|NCT00803634|Nitroprusside|nitroprusside|mesh-list
56688514|NCT00803634|Nicardipine|nicardipine|mesh-list
56688515|NCT00803634|Clevidipine|clevidipine|mesh-list
56688516|NCT00803634|Isosorbide|isosorbide|mesh-list
56688517|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56688518|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
56688519|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
56688520|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56688521|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56688522|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244190|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688540|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688541|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688543|NCT00914472|Calcium heparin|calcium heparin|mesh-list
56688544|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
56688545|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56688546|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56688547|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688548|NCT02611466|Naproxen|naproxen|mesh-list
56688549|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56688550|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56688551|NCT02611466|Analgesics|analgesics|mesh-ancestor
56688552|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
56688553|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688554|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688555|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688556|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688557|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
56688558|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56688559|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688560|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688561|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
56688562|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
56688563|NCT02610920|Iron|iron|mesh-list
56688564|NCT02610920|Trace Elements|trace elements|mesh-ancestor
56688565|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
56688566|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688567|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56688568|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56688569|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56688570|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
56688571|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688572|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56688573|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56688574|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688575|NCT00818168|Infliximab|infliximab|mesh-list
56688576|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
56688577|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56688578|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688579|NCT02607540|Cisplatin|cisplatin|mesh-list
56688580|NCT02607540|Fluorouracil|fluorouracil|mesh-list
56688581|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688598|NCT05756504|Tramadol|tramadol|mesh-list
56534276|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56010874|NCT05776940|Antiemetics|antiemetics|mesh-ancestor
56688599|NCT05756504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56688600|NCT05756504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56688601|NCT05756504|Analgesics|analgesics|mesh-ancestor
56688602|NCT05756504|Sensory System Agents|sensory system agents|mesh-ancestor
56688603|NCT05756504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688604|NCT05756504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688605|NCT05756504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688606|NCT05756504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688607|NCT05756504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56688608|NCT05756504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688609|NCT05756504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688610|NCT05756504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56688611|NCT05756504|Narcotics|narcotics|mesh-ancestor
56688612|NCT05756504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688613|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
56688614|NCT00705770|Anecortave|anecortave|mesh-list
56688615|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56688616|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56688617|NCT00705770|Growth Substances|growth substances|mesh-ancestor
56688618|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688619|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
56688620|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688621|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688622|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
56688623|NCT00796653|Olodaterol|olodaterol|mesh-list
56688624|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56688625|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
56688626|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688627|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688628|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56688629|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
56688630|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56688631|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56688632|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56688633|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
56688634|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688635|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688636|NCT00806286|Paclitaxel|paclitaxel|mesh-list
56688637|NCT00806286|Carboplatin|carboplatin|mesh-list
56688638|NCT00806286|Efatutazone|efatutazone|mesh-list
56688639|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56688640|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244315|NCT01812382|Retapamulin|retapamulin|mesh-list
56688666|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688668|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56688669|NCT02608320|Narcotics|narcotics|mesh-ancestor
56688670|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688671|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688672|NCT02608320|Analgesics|analgesics|mesh-ancestor
56688673|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
56688674|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688675|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56688676|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56688677|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
56688678|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
56688679|NCT01731444|Phenylephrine|phenylephrine|mesh-list
56688680|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
56688681|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56688682|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
56688683|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
56688684|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688685|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688686|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
56688687|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56688688|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
56688689|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
56688690|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56688700|NCT05728944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56688701|NCT05728944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56688702|NCT05728944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56688703|NCT05728944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56534277|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56385164|NCT00141258|Pregabalin|pregabalin|mesh-list
56534278|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56534280|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534281|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534282|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56534283|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534284|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534285|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56534286|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56534287|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
56534288|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188475|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
56188476|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188477|NCT01444469|Azithromycin|azithromycin|mesh-list
56188478|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56188480|NCT01444521|Irinotecan|irinotecan|mesh-list
56688704|NCT05728944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56688705|NCT05728944|Adrenergic Agents|adrenergic agents|mesh-ancestor
56688706|NCT05728944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688707|NCT05728944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688708|NCT05728944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688710|NCT05728944|Autonomic Agents|autonomic agents|mesh-ancestor
56688711|NCT05728944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688712|NCT05728944|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56688713|NCT05728788|Antineoplastic Agents|antineoplastic agents|mesh-list
56688714|NCT02608164|Vitamin D|vitamin d|mesh-list
56688715|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
56688716|NCT02608164|Vitamins|vitamins|mesh-ancestor
56688717|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
56688718|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688719|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56688720|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56688721|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56688722|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
56688723|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
56688724|NCT04110873|Ubiquinone|ubiquinone|mesh-list
56688725|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
56688726|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688727|NCT02604615|Capecitabine|capecitabine|mesh-list
56688728|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
56688729|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56688730|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
56688731|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688732|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688733|NCT00796107|Letrozole|letrozole|mesh-list
56688734|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688735|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56688736|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56688737|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688738|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688739|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56688740|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
56688741|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688742|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688743|NCT00805740|Caspofungin|caspofungin|mesh-list
56688744|NCT00805740|Anidulafungin|anidulafungin|mesh-list
56688745|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
56534289|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56534290|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56534291|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
56534292|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56534293|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
56534294|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
56534295|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
56534296|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56534297|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
56534298|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56534299|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534300|NCT05333731|Oxytocin|oxytocin|mesh-list
56534301|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
56534302|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56534303|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534304|NCT04201561|Selenious Acid|selenious acid|mesh-list
56534305|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
56534306|NCT04201561|Paclitaxel|paclitaxel|mesh-list
56534307|NCT04201561|Carboplatin|carboplatin|mesh-list
56534308|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56534309|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534310|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
56534311|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
56534312|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
56534313|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188488|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56188494|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
56688746|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688747|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688748|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688749|NCT05613075|Hyaluronic Acid|hyaluronic acid|mesh-list
56688750|NCT05613075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56688751|NCT05613075|Immunologic Factors|immunologic factors|mesh-ancestor
56688752|NCT05613075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688753|NCT05613075|Viscosupplements|viscosupplements|mesh-ancestor
56688754|NCT05613075|Protective Agents|protective agents|mesh-ancestor
56688755|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56688756|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
56688777|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688779|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56688780|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56688781|NCT05297292|Growth Substances|growth substances|mesh-ancestor
56688782|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688783|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
56688784|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688785|NCT02604459|Fentanyl|fentanyl|mesh-list
56688786|NCT02604459|Anesthetics|anesthetics|mesh-list
56688787|NCT02604459|Propofol|propofol|mesh-list
56688788|NCT02604459|Sevoflurane|sevoflurane|mesh-list
56688789|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56534314|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534315|NCT04201561|Trace Elements|trace elements|mesh-ancestor
56688790|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688791|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56688792|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56688793|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
56688794|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56688795|NCT02604459|Narcotics|narcotics|mesh-ancestor
56688796|NCT02604459|Analgesics|analgesics|mesh-ancestor
56688797|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
56688798|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688799|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56688800|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56688801|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56688802|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
56688803|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56688804|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
56688805|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
56688806|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688807|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688808|NCT02607072|Aspirin|aspirin|mesh-list
56688809|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56688810|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56688811|NCT02607072|Analgesics|analgesics|mesh-ancestor
56688834|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
56688835|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688836|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56688837|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
56688838|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
56688839|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688840|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
56688841|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688842|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688843|NCT03161652|Protective Agents|protective agents|mesh-ancestor
56688844|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56688845|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56688846|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688847|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56688848|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56688849|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56688850|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
56688851|NCT00588237|Paclitaxel|paclitaxel|mesh-list
56688852|NCT00588237|Bevacizumab|bevacizumab|mesh-list
56688853|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56688854|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688855|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56688856|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56688857|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56688858|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688859|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688860|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56688861|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56688862|NCT00588237|Growth Substances|growth substances|mesh-ancestor
56688896|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688897|NCT05563467|Pembrolizumab|pembrolizumab|mesh-list
56688898|NCT05563467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688899|NCT05563467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688900|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56688901|NCT00589914|Risperidone|risperidone|mesh-list
56688902|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56244596|NCT01814059|Sirolimus|sirolimus|mesh-list
56688968|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56688969|NCT01026415|Midazolam|midazolam|mesh-list
56688970|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56688971|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56688972|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56688973|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688974|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688975|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56688976|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56688977|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56688978|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56688979|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
56688980|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
56688981|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
56534316|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
56688982|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
56244668|NCT01814319|Probenecid|probenecid|mesh-list
56688998|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688999|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689000|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
56689001|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
56689002|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56689003|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56689004|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56689005|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
56689006|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689007|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56689008|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56689009|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
56689010|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689012|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
56689013|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56689014|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56689015|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689016|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689017|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
56689018|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
56689019|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56689020|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
56689021|NCT00914160|Diclofenac|diclofenac|mesh-list
56689022|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56689023|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56689024|NCT00914160|Analgesics|analgesics|mesh-ancestor
56689025|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
56689026|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689027|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689028|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689029|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689030|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56689031|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689032|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689033|NCT00450619|Metronidazole|metronidazole|mesh-list
56689034|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
56689035|NCT00450619|Vaccines|vaccines|mesh-list
56689036|NCT00450619|Sargramostim|sargramostim|mesh-list
56244715|NCT01814475|Vidarabine|vidarabine|mesh-list
56689062|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56689063|NCT04112394|Anesthetics|anesthetics|mesh-list
56689064|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
56689065|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689066|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689067|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
56689068|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689069|NCT00450385|Prednisone|prednisone|mesh-list
56689070|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
56689071|NCT00450385|Rituximab|rituximab|mesh-list
56689072|NCT00450385|Doxorubicin|doxorubicin|mesh-list
56689073|NCT00450385|Vincristine|vincristine|mesh-list
56689074|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689075|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
56689076|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689077|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689078|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56689079|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
56689080|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689081|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689082|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56689083|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56689084|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56689085|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56689086|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56689102|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56689103|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
56689104|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
56689105|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689106|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689107|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
56689108|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689109|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56534317|NCT00895453|Iron|iron|mesh-list
56534318|NCT00895453|Itraconazole|itraconazole|mesh-list
56534319|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
56689110|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56689111|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56689112|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56689113|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689114|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689115|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
56689116|NCT00588354|Hormones|hormones|mesh-ancestor
56689117|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689118|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689119|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
56689120|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689121|NCT00588354|Analgesics|analgesics|mesh-ancestor
56689122|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56689123|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
56689124|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
56689125|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56689126|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56689127|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56689128|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
56689129|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689130|NCT00449761|Panobinostat|panobinostat|mesh-list
56689131|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689132|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56689133|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689134|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689135|NCT00800982|Etanercept|etanercept|mesh-list
56689136|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56689137|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400301|NCT02934022|Maraviroc|maraviroc|mesh-list
56689138|NCT00800982|Analgesics|analgesics|mesh-ancestor
56689139|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
56689140|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689141|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689142|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689143|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689144|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56689145|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689170|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689172|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
56689173|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
56689174|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
56689175|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56689176|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
56689177|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
56689178|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56689179|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56689180|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56689181|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
56689182|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689183|NCT01026961|Protective Agents|protective agents|mesh-ancestor
56689184|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
56689185|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
56689186|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56689187|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
56689188|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
56689189|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56689190|NCT01566253|Acetaminophen|acetaminophen|mesh-list
56689191|NCT01566253|Ketoprofen|ketoprofen|mesh-list
56689192|NCT01566253|Morphine|morphine|mesh-list
56689193|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56689194|NCT01566253|Narcotics|narcotics|mesh-ancestor
56689195|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689196|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689197|NCT01566253|Analgesics|analgesics|mesh-ancestor
56689219|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
56689220|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
56689221|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
56689222|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689223|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56689224|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689225|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56534320|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534321|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56534322|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56534323|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534324|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534325|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56534326|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
56534327|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534328|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534329|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56534330|NCT00895453|Trace Elements|trace elements|mesh-ancestor
56534331|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
56534332|NCT00893737|Naproxen|naproxen|mesh-list
56534333|NCT00893737|Sumatriptan|sumatriptan|mesh-list
56534334|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56534335|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56534336|NCT00893737|Analgesics|analgesics|mesh-ancestor
56534337|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
56534338|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534339|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534340|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534341|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534342|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
56534343|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56534344|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534345|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188527|NCT01444807|Sorafenib|sorafenib|mesh-list
56689226|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
56689227|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689228|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
56689229|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689230|NCT04028622|Anesthetics|anesthetics|mesh-list
56689231|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689232|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689234|NCT00830804|Darunavir|darunavir|mesh-list
56689235|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
56689236|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56689237|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56689238|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
56689239|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689240|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689241|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56689242|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56689243|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
56689244|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534346|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56534347|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56534348|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56534349|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
56534350|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534351|NCT00893113|Alfuzosin|alfuzosin|mesh-list
56534352|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56534353|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56534354|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56534355|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
56534356|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689245|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56689246|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56689247|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56689248|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56689249|NCT00789477|Aflibercept|aflibercept|mesh-list
56689250|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56689277|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
56689278|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56689279|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689280|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56689281|NCT00796614|Tamsulosin|tamsulosin|mesh-list
56689282|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56689283|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56689284|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56689285|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
56689286|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689287|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689288|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689289|NCT00796614|Urological Agents|urological agents|mesh-ancestor
56689290|NCT02603445|Idelalisib|idelalisib|mesh-list
56689291|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689292|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689293|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689294|NCT02603679|Tamoxifen|tamoxifen|mesh-list
56689295|NCT02603679|Paclitaxel|paclitaxel|mesh-list
56689296|NCT02603679|Letrozole|letrozole|mesh-list
56689297|NCT02603679|Palbociclib|palbociclib|mesh-list
56689298|NCT02603679|Anastrozole|anastrozole|mesh-list
56689299|NCT02603679|Exemestane|exemestane|mesh-list
56689327|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
56689328|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689329|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689330|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689331|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56689332|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689333|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56689334|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
56689335|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
56689336|NCT00863681|Riociguat|riociguat|mesh-list
56689337|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
56689338|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689339|NCT05758298|Nicotine|nicotine|mesh-list
56689340|NCT05758298|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56689341|NCT05758298|Autonomic Agents|autonomic agents|mesh-ancestor
56689342|NCT05758298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689343|NCT05758298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689344|NCT05758298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56689345|NCT05758298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56689371|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56689372|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56689373|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56689375|NCT00448669|Emtricitabine|emtricitabine|mesh-list
56689376|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
56689377|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534357|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534358|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534359|NCT00893113|Urological Agents|urological agents|mesh-ancestor
56534360|NCT02840929|Esomeprazole|esomeprazole|mesh-list
56534361|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56534362|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56534363|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56534364|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534365|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534366|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
56534367|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56689378|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56689379|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56689380|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689381|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689382|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56689383|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56689384|NCT00591734|Bevacizumab|bevacizumab|mesh-list
56689385|NCT00591734|Everolimus|everolimus|mesh-list
56689386|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56689387|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689388|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56689420|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
56689421|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
56689422|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689423|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56689424|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56689425|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56689426|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689427|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689428|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
56689429|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
56689430|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
56689431|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
56689457|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689459|NCT00848393|Narcotics|narcotics|mesh-ancestor
56689460|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56689461|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56689462|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
56689463|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
56689464|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
56689465|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56689466|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
56689467|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
56689468|NCT00815516|Amphotericin B|amphotericin b|mesh-list
56689469|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56689470|NCT00815516|Micafungin|micafungin|mesh-list
56689471|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56689472|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
56689473|NCT00815516|Amebicides|amebicides|mesh-ancestor
56689474|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56689475|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56689476|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689477|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56689478|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
56689479|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56689480|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56689508|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689510|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56689511|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56689512|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56689513|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56689514|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534368|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534369|NCT02837965|Doxycycline|doxycycline|mesh-list
56534370|NCT02837965|Prednisone|prednisone|mesh-list
56534371|NCT02837965|Methotrexate|methotrexate|mesh-list
56534372|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534373|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
56534374|NCT02837965|Hormones|hormones|mesh-ancestor
56534375|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534376|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534377|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56534378|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534379|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56534380|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
56534381|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56534382|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56534383|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
56534384|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534385|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
56689515|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56689516|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689517|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
56689518|NCT00787605|Diuretics|diuretics|mesh-ancestor
56689519|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
56689520|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56689521|NCT00448591|Bevacizumab|bevacizumab|mesh-list
56689522|NCT00448591|Taxane|taxane|mesh-list
56689523|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56689524|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689552|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689553|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56689554|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56689555|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
56689556|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
56689557|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
56689558|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56689559|NCT00804388|Vitamin E|vitamin e|mesh-list
56689560|NCT00804388|Vitamins|vitamins|mesh-ancestor
56689561|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
56689562|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689563|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
56689564|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689565|NCT00804388|Protective Agents|protective agents|mesh-ancestor
56689566|NCT00806962|Vaccines|vaccines|mesh-list
56689567|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
56689568|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689569|NCT02553226|Oxytocin|oxytocin|mesh-list
56689570|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
56689571|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56689572|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689573|NCT00810316|Clonazepam|clonazepam|mesh-list
56689574|NCT00810316|Alprazolam|alprazolam|mesh-list
56689596|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
56689597|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
56689598|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56689599|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56689600|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56534386|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534387|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56188590|NCT01445210|Ropivacaine|ropivacaine|mesh-list
56689601|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56689602|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
56689603|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689604|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689605|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
56689606|NCT00448435|Hormones|hormones|mesh-ancestor
56689607|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689608|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
56689609|NCT00804622|Tenofovir|tenofovir|mesh-list
56689610|NCT00804622|Telbivudine|telbivudine|mesh-list
56689611|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
56689612|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689613|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56689614|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56689615|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689616|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689617|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56689618|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56689619|NCT02603055|Vaccines|vaccines|mesh-list
56689620|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
56689621|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689622|NCT02602743|Ketamine|ketamine|mesh-list
56689623|NCT02602743|Remifentanil|remifentanil|mesh-list
56689624|NCT02602743|Propofol|propofol|mesh-list
56689625|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56689626|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689627|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689660|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
56689661|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689662|NCT00810706|Exemestane|exemestane|mesh-list
56689663|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689664|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56689665|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56689666|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689667|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689668|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56689669|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
56689698|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689699|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
56689700|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689701|NCT00805012|Docetaxel|docetaxel|mesh-list
56689702|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689703|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56689704|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56689705|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56689706|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689707|NCT00447499|Lanreotide|lanreotide|mesh-list
56689708|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689709|NCT00805090|Itraconazole|itraconazole|mesh-list
56689710|NCT00805090|Diclofenac|diclofenac|mesh-list
56689711|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56689712|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56689713|NCT00805090|Analgesics|analgesics|mesh-ancestor
56245405|NCT01819220|Diuretics|diuretics|mesh-ancestor
56689735|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400901|NCT00180843|Bromides|bromides|mesh-list
56689736|NCT00810862|Analgesics|analgesics|mesh-ancestor
56689737|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
56689738|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689739|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689740|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689741|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689742|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
56689743|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689744|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
56689745|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56689746|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689747|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689748|NCT00800436|Trastuzumab|trastuzumab|mesh-list
56689749|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56689750|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534388|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534389|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
56534390|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534391|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56689751|NCT00810940|Mannitol|mannitol|mesh-list
56689752|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56689753|NCT00810940|Diuretics|diuretics|mesh-ancestor
56689754|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
56689755|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689756|NCT00655564|Alefacept|alefacept|mesh-list
56689757|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
56689758|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
56689759|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689760|NCT00447421|Pemetrexed|pemetrexed|mesh-list
56689761|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689762|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689763|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689764|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56689800|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56689801|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689802|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689803|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689804|NCT00657358|Lidocaine|lidocaine|mesh-list
56689836|NCT00811096|Chloroquine|chloroquine|mesh-list
56689837|NCT00811096|Tinidazole|tinidazole|mesh-list
56689838|NCT00811096|Amebicides|amebicides|mesh-ancestor
56689839|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56689840|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56689841|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689842|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
56689843|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689844|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
56689845|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689846|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56689877|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56689879|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689880|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689881|NCT00457015|Ecallantide|ecallantide|mesh-list
56689882|NCT00457015|Analgesics|analgesics|mesh-ancestor
56689883|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
56689884|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689885|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401056|NCT02918812|Analgesics|analgesics|mesh-ancestor
56689886|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56689887|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56689888|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689910|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56689912|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689913|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
56689914|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56689915|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
56689916|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689917|NCT00588666|Antiviral Agents|antiviral agents|mesh-ancestor
56689918|NCT00588666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689919|NCT00588666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689920|NCT00588666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689921|NCT00588666|Immunologic Factors|immunologic factors|mesh-ancestor
56689922|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
56689923|NCT00805558|Metronidazole|metronidazole|mesh-list
56689924|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
56689925|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56689926|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56689927|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689928|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56689929|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56689930|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689931|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689932|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689933|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56689934|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
56689935|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56534392|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56534393|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534394|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
56689936|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689937|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56689938|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56689939|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56245625|NCT01820767|Vitamins|vitamins|mesh-ancestor
56689970|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
56689971|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
56689972|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56689973|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56689974|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56689975|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
56689976|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689977|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689978|NCT01024543|Protective Agents|protective agents|mesh-ancestor
56689979|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56689980|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
56689981|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689982|NCT00811330|Atorvastatin|atorvastatin|mesh-list
56689983|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56689984|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56689985|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
56690004|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690005|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690006|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56690007|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56690008|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690009|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690010|NCT00855335|Ritonavir|ritonavir|mesh-list
56690011|NCT00855335|Darunavir|darunavir|mesh-list
56690012|NCT00855335|Cobicistat|cobicistat|mesh-list
56690013|NCT00855335|Rilpivirine|rilpivirine|mesh-list
56690014|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56690015|NCT00855335|Etravirine|etravirine|mesh-list
56690016|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56690017|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56690018|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
56690019|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690020|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690021|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56690022|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56690023|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
56690024|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690025|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56690026|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56690027|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56690028|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56690029|NCT00811486|Spironolactone|spironolactone|mesh-list
56690030|NCT00811486|Conivaptan|conivaptan|mesh-list
56690031|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56690032|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
56690033|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690034|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690035|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56690036|NCT00811486|Diuretics|diuretics|mesh-ancestor
56690037|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
56690038|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56690039|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690056|NCT04114188|Hormones|hormones|mesh-ancestor
56690057|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690058|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56690059|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690060|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56690061|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690062|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690063|NCT00811876|Leuprolide|leuprolide|mesh-list
56690064|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56690065|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
56690066|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56690067|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690068|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56690069|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690070|NCT00915252|Cytarabine|cytarabine|mesh-list
56690071|NCT00915252|Azacitidine|azacitidine|mesh-list
56690072|NCT00915252|Daunorubicin|daunorubicin|mesh-list
56690073|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56690074|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
56690075|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690076|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690077|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
56690078|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690079|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690080|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
56690081|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690082|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690083|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56690084|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56690085|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56690086|NCT00593489|Insulin|insulin|mesh-list
56690087|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56690088|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690089|NCT00446641|Cilostazol|cilostazol|mesh-list
56690090|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56690091|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
56690092|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690093|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690094|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56690095|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
56690096|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56690097|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56690098|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690099|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56690100|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
56690127|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56690128|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
56690129|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690131|NCT00446563|Amlodipine|amlodipine|mesh-list
56690132|NCT00446563|Valsartan|valsartan|mesh-list
56690133|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56690134|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56690135|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56690136|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56690137|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690138|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56690139|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690140|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
56690141|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56690142|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56690143|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56690144|NCT00446563|Diuretics|diuretics|mesh-ancestor
56690145|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
56690146|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56690147|NCT00650806|Canagliflozin|canagliflozin|mesh-list
56690160|NCT00863057|Analgesics|analgesics|mesh-ancestor
56690161|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
56690162|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690163|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
56690164|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56690165|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
56690166|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56690167|NCT00863057|Narcotics|narcotics|mesh-ancestor
56690168|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690169|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
56690170|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
56690171|NCT00814216|Fluticasone|fluticasone|mesh-list
56690172|NCT00814216|Xhance|xhance|mesh-list
56690173|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690174|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56690175|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
56690176|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690177|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690178|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56690179|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
56690180|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690181|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56534395|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56534396|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56534397|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56534398|NCT00892957|Thrombin|thrombin|mesh-list
56690182|NCT00829166|Capecitabine|capecitabine|mesh-list
56690183|NCT00829166|Trastuzumab|trastuzumab|mesh-list
56690184|NCT00829166|Lapatinib|lapatinib|mesh-list
56690185|NCT00829166|Maytansine|maytansine|mesh-list
56690186|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56690187|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56690188|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
56690189|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690190|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690191|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56690192|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56690193|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690194|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56690195|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
56690196|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
56690197|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
56690198|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
56690199|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56690200|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690201|NCT00650104|Ropinirole|ropinirole|mesh-list
56690202|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56690203|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56690204|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
56690205|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
56690206|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690207|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690243|NCT05652660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690244|NCT05652660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56690245|NCT05652660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56690246|NCT05652660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690279|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690280|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56690281|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
56690282|NCT02605356|Hormones|hormones|mesh-ancestor
56690283|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690284|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56690285|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690286|NCT00812266|Carboplatin|carboplatin|mesh-list
56690287|NCT00812266|Etoposide|etoposide|mesh-list
56690288|NCT00812266|Topotecan|topotecan|mesh-list
56690289|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690290|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56690291|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56690292|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56245969|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
56690326|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56690327|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56690328|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
56690329|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56690330|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246021|NCT01823081|Bevacizumab|bevacizumab|mesh-list
56690355|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690357|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56690358|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
56690359|NCT00812578|Vitamin D|vitamin d|mesh-list
56690360|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56690361|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690362|NCT00812578|Vitamins|vitamins|mesh-ancestor
56690363|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
56690364|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56690365|NCT00796224|Azithromycin|azithromycin|mesh-list
56690366|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56690367|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690368|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
56690369|NCT00808366|Clotrimazole|clotrimazole|mesh-list
56690370|NCT00808366|Miconazole|miconazole|mesh-list
56690371|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
56690372|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534399|NCT00892957|Aprotinin|aprotinin|mesh-list
56534400|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
56534401|NCT00892957|Coagulants|coagulants|mesh-ancestor
56534402|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56534403|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56534404|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
56534405|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534406|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534407|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
56534408|NCT05322733|Fludarabine|fludarabine|mesh-list
56534409|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
56534410|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534411|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
56534412|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690373|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56690374|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56690375|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56690376|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690377|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690378|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56690403|NCT00848081|Tadalafil|tadalafil|mesh-list
56690404|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
56401581|NCT05471479|Charcoal|charcoal|mesh-list
56690405|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56690406|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56690407|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690408|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690409|NCT00848081|Urological Agents|urological agents|mesh-ancestor
56690410|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
56690411|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690412|NCT04111380|Paclitaxel|paclitaxel|mesh-list
56690413|NCT04111380|Cisplatin|cisplatin|mesh-list
56690414|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56690415|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690416|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56690417|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56690418|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56690419|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690420|NCT04117919|Triamcinolone|triamcinolone|mesh-list
56690421|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56690422|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56690423|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
56690424|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56246103|NCT01823965|Ranibizumab|ranibizumab|mesh-list
56690453|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690455|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
56690456|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56690457|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690458|NCT00791778|Sorafenib|sorafenib|mesh-list
56690459|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690460|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56690461|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690462|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690463|NCT02604576|Bromopride|bromopride|mesh-list
56690464|NCT02604576|Metoclopramide|metoclopramide|mesh-list
56690465|NCT02604576|Simethicone|simethicone|mesh-list
56690466|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
56690467|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690468|NCT02604576|Emollients|emollients|mesh-ancestor
56690485|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690486|NCT05645406|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56690487|NCT05645406|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56690489|NCT05645406|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56534420|NCT00968812|Metformin|metformin|mesh-list
56534486|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56534487|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534488|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534489|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
56534490|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56534491|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534492|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56534493|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56534494|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534495|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534496|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534497|NCT02833987|Warfarin|warfarin|mesh-list
56534498|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
56534499|NCT02833987|Dabigatran|dabigatran|mesh-list
56534500|NCT02833987|Apixaban|apixaban|mesh-list
56534501|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
56534502|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56188696|NCT01445639|Analgesics|analgesics|mesh-ancestor
56690490|NCT05645406|Estrogens|estrogens|mesh-ancestor
56690491|NCT05645406|Hormones|hormones|mesh-ancestor
56690492|NCT05645406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690493|NCT05645406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690494|NCT05645406|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56690495|NCT05645406|Contraceptive Agents|contraceptive agents|mesh-ancestor
56690496|NCT05645406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56690497|NCT05645406|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56690498|NCT00795600|Insulin|insulin|mesh-list
56690499|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56690500|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
56690501|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
56690502|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
56690503|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
56690504|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56690505|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690506|NCT00795132|Cyclosporine|cyclosporine|mesh-list
56690507|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
56690508|NCT00795132|Fludarabine|fludarabine|mesh-list
56690509|NCT00795132|Busulfan|busulfan|mesh-list
56690510|NCT00795132|Cyclosporins|cyclosporins|mesh-list
56690511|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
56690512|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56690513|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690514|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690515|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690516|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
56690517|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690518|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690519|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
56690520|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690521|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690522|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690523|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56690524|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56690525|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56690526|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
56690527|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56690528|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
56690561|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56690562|NCT00646906|Analgesics|analgesics|mesh-ancestor
56690563|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
56534503|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
56534504|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56534505|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
56534506|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534507|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534508|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
56534509|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56534510|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56534511|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534512|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
56534513|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690564|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690565|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690566|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690567|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690568|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56690569|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56690570|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690571|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56690572|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56690573|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690641|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690642|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
56690643|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690644|NCT00818038|Natalizumab|natalizumab|mesh-list
56690645|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
56690646|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690647|NCT00482053|Acetaminophen|acetaminophen|mesh-list
56690648|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
56690649|NCT00482053|Promethazine|promethazine|mesh-list
56690650|NCT00482053|Cyclosporine|cyclosporine|mesh-list
56690651|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
56690652|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
56246348|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
56690721|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690722|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
56690723|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690724|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690725|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56690727|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56690728|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690729|NCT00809068|Tibolone|tibolone|mesh-list
56690730|NCT00809068|Fenofibrate|fenofibrate|mesh-list
56690731|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56690732|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
56690733|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690734|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56690735|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
56690764|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690765|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56690766|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690767|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
56690768|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
56690769|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690770|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
56690772|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56690773|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690774|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56690775|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690776|NCT00445003|Triamcinolone|triamcinolone|mesh-list
56690777|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56534514|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534515|NCT00965458|Alefacept|alefacept|mesh-list
56534516|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
56534517|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
56534518|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534519|NCT04249531|Amikacin|amikacin|mesh-list
56534520|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56534521|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534522|NCT02836639|Etoposide|etoposide|mesh-list
56534523|NCT02836639|Busulfan|busulfan|mesh-list
56534524|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56534525|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56534526|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534527|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56534528|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56534529|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188723|NCT01445860|Simvastatin|simvastatin|mesh-list
56690778|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56690779|NCT00445003|Ranibizumab|ranibizumab|mesh-list
56690780|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56246465|NCT01826526|Taurolidine|taurolidine|mesh-list
56690808|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56690809|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690810|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
56690811|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690812|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56690813|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56690814|NCT00642460|Analgesics|analgesics|mesh-ancestor
56690815|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
56690816|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690817|NCT00814658|Nimodipine|nimodipine|mesh-list
56690818|NCT00814658|Galantamine|galantamine|mesh-list
56690819|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56690820|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690821|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690822|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
56690823|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690824|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690825|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56690826|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
56690827|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690830|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56690831|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56690832|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56690833|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
56690834|NCT00816634|Paclitaxel|paclitaxel|mesh-list
56690835|NCT00816634|Capecitabine|capecitabine|mesh-list
56690836|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56690837|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690838|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
56690839|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
56690840|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
56690841|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690842|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56690843|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
56690844|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
56690845|NCT00642304|Hematinics|hematinics|mesh-ancestor
56690846|NCT00814580|Oxycodone|oxycodone|mesh-list
56690847|NCT00814580|Tapentadol|tapentadol|mesh-list
56690848|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56690849|NCT00814580|Narcotics|narcotics|mesh-ancestor
56534530|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534531|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
56188736|NCT01445964|Atenolol|atenolol|mesh-list
56690850|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690851|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690852|NCT00814580|Analgesics|analgesics|mesh-ancestor
56690853|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
56690854|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690855|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56690856|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56690857|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56690858|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690860|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690861|NCT00643162|Citalopram|citalopram|mesh-list
56690862|NCT00643162|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56690863|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56690864|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56690865|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690866|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690867|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
56690868|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690869|NCT00643162|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56690870|NCT00643162|Antidepressive Agents|antidepressive agents|mesh-ancestor
56690871|NCT00643162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56690872|NCT00814502|Zolpidem|zolpidem|mesh-list
56690873|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56690874|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56690875|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690876|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690877|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56690878|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
56690879|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
56690880|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690881|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690882|NCT00653224|Levocetirizine|levocetirizine|mesh-list
56690883|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56690884|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56690885|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
56690886|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
56690887|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690888|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690889|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690890|NCT00444925|Fesoterodine|fesoterodine|mesh-list
56690891|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56690892|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56690893|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56690894|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
56690895|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690896|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690897|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690898|NCT00444925|Urological Agents|urological agents|mesh-ancestor
56690899|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
56690900|NCT00641056|Exenatide|exenatide|mesh-list
56690920|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
56690922|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
56690923|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
56690924|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56690925|NCT00816712|Androgens|androgens|mesh-ancestor
56690926|NCT00816712|Hormones|hormones|mesh-ancestor
56690927|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690928|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690929|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56690931|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
56690932|NCT00818194|Cyclosporine|cyclosporine|mesh-list
56690933|NCT00818194|Tacrolimus|tacrolimus|mesh-list
56690934|NCT00818194|Cyclosporins|cyclosporins|mesh-list
56690935|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690936|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
56690937|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690938|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56534532|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534533|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
56534534|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534535|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56534536|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56534537|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
56534538|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56534539|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534540|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56534596|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534597|NCT04249063|Lidocaine|lidocaine|mesh-list
56534598|NCT04249063|Anesthetics|anesthetics|mesh-list
56534599|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
56534600|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690939|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690940|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690941|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
56690942|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690943|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690944|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690945|NCT02610686|Chloroquine|chloroquine|mesh-list
56690946|NCT02610686|Amebicides|amebicides|mesh-ancestor
56690947|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56690948|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56690949|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690950|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
56690951|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690952|NCT00816790|Tazobactam|tazobactam|mesh-list
56690953|NCT00816790|Piperacillin|piperacillin|mesh-list
56690954|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56690955|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56246624|NCT01827722|Ranibizumab|ranibizumab|mesh-list
56690974|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690976|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690977|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690978|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690979|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56690980|NCT00816868|Capecitabine|capecitabine|mesh-list
56690981|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56690982|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56690983|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
56690984|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690985|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690986|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56690987|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690988|NCT05500586|Glucagon|glucagon|mesh-list
56690989|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56690990|NCT05500586|Hormones|hormones|mesh-ancestor
56690991|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690992|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690993|NCT00791700|Maraviroc|maraviroc|mesh-list
56690994|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56690995|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56690996|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690997|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56690998|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56690999|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
56691000|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691001|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56691002|NCT00628108|Levocetirizine|levocetirizine|mesh-list
56691003|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56691004|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56691005|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
56691006|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
56691007|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691008|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691009|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691041|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56691042|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
56691043|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691044|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691045|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56691046|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56691047|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56691048|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
56691049|NCT00455533|Paclitaxel|paclitaxel|mesh-list
56691050|NCT00455533|Epothilones|epothilones|mesh-list
56691051|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
56691052|NCT00455533|Doxorubicin|doxorubicin|mesh-list
56057820|NCT00002331|Clofazimine|clofazimine|mesh-list
56534601|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534602|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
56534603|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534604|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56534605|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56534606|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56534607|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56534608|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534609|NCT00970684|Gemcitabine|gemcitabine|mesh-list
56534610|NCT00970684|Bevacizumab|bevacizumab|mesh-list
56534611|NCT00970684|Docetaxel|docetaxel|mesh-list
56188805|NCT01446328|Olanzapine|olanzapine|mesh-list
56691053|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56691091|NCT00642850|Hematinics|hematinics|mesh-ancestor
56691092|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56691093|NCT00913952|Clomipramine|clomipramine|mesh-list
56691124|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56691125|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56691127|NCT05755334|Anesthetics, Local|anesthetics, local|mesh-ancestor
56691128|NCT05755334|Anesthetics|anesthetics|mesh-ancestor
56691129|NCT05755334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691130|NCT05755334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691131|NCT05755334|Sensory System Agents|sensory system agents|mesh-ancestor
56691132|NCT05755334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691133|NCT00640510|Olanzapine|olanzapine|mesh-list
56691134|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
56691135|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
56691168|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691169|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691170|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
56691171|NCT00627016|Lansoprazole|lansoprazole|mesh-list
56691172|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56691203|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56691205|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691206|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
56691207|NCT05753852|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56691208|NCT05753852|Antiviral Agents|antiviral agents|mesh-ancestor
56691209|NCT05753852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691210|NCT05753852|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56691211|NCT05753852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56691212|NCT00821782|Azithromycin|azithromycin|mesh-list
56691213|NCT00821782|Levofloxacin|levofloxacin|mesh-list
56691214|NCT00821782|Ofloxacin|ofloxacin|mesh-list
56691215|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56691244|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56691245|NCT04112550|Analgesics|analgesics|mesh-ancestor
56691246|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
56691247|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691248|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691249|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
56691250|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56691251|NCT04112550|Narcotics|narcotics|mesh-ancestor
56691252|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691253|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
56691254|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
56691255|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56691256|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56691257|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56246950|NCT01830907|Vitamins|vitamins|mesh-list
56691289|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
56691290|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691291|NCT04109742|Curcumin|curcumin|mesh-list
56691292|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56691293|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56534612|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56534613|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534614|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56534615|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56534616|NCT00970684|Growth Substances|growth substances|mesh-ancestor
56534617|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534618|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
56534619|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56534620|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
56188817|NCT01446328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56691294|NCT04109742|Analgesics|analgesics|mesh-ancestor
56691295|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
56691296|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691297|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691298|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56691299|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691300|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691301|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247057|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
56691394|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56691395|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691396|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
56691397|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56691399|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691400|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691401|NCT05538312|Itraconazole|itraconazole|mesh-list
56691402|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
56691403|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691404|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56691405|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56691406|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691407|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691408|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56691409|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
56691410|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691411|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691412|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56691413|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
56691414|NCT05537766|Fludarabine|fludarabine|mesh-list
56691415|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56691416|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
56691417|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691418|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691462|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
56691464|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
56691465|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691466|NCT00913796|Expectorants|expectorants|mesh-ancestor
56691467|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
56691468|NCT00633880|Droxidopa|droxidopa|mesh-list
56691469|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56691470|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56691471|NCT04029428|Octreotide|octreotide|mesh-list
56691472|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56691473|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56691474|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691475|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56691476|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56691477|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691478|NCT00819520|Ivermectin|ivermectin|mesh-list
56691479|NCT00819520|Malathion|malathion|mesh-list
56691480|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56691481|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691482|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56534621|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534622|NCT00970684|Antiviral Agents|antiviral agents|mesh-ancestor
56534623|NCT00970684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534624|NCT00970684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691483|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691484|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691485|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
56691486|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691487|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691488|NCT00631696|Pregabalin|pregabalin|mesh-list
56691489|NCT00631696|Analgesics|analgesics|mesh-ancestor
56691490|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
56691491|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691492|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691493|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
56691494|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56691495|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691496|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691497|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56691527|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56691528|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
56691529|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56691530|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
56691531|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691532|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691533|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56691534|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
56691535|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56691536|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
56691537|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691538|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691539|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56691540|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
56691541|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
56247247|NCT01841008|Tacrolimus|tacrolimus|mesh-list
56691570|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
56691571|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56691572|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691573|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691574|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56691575|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56691576|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56691577|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691578|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691579|NCT00827554|Nadroparin|nadroparin|mesh-list
56691580|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
56691581|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56691582|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56691583|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691584|NCT00847145|Vaccines|vaccines|mesh-list
56691585|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
56691586|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691587|NCT00701597|Bosentan|bosentan|mesh-list
56691588|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56691589|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56247267|NCT01841125|Citalopram|citalopram|mesh-list
56691645|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56691646|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56691647|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691648|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
56691649|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56691650|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56691651|NCT00790842|Growth Substances|growth substances|mesh-ancestor
56691652|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
56691654|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56691655|NCT04104204|Narcotics|narcotics|mesh-ancestor
56691656|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691657|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691658|NCT04104204|Analgesics|analgesics|mesh-ancestor
56534625|NCT00970684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56534626|NCT00970684|Immunologic Factors|immunologic factors|mesh-ancestor
56691659|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
56691660|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691661|NCT05572476|Carboplatin|carboplatin|mesh-list
56691662|NCT05572476|Etoposide|etoposide|mesh-list
56691663|NCT05572476|Durvalumab|durvalumab|mesh-list
56691664|NCT05572476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691665|NCT05572476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56691666|NCT05572476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56691667|NCT05572476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56691668|NCT05572476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691669|NCT05572476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691670|NCT05572476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56691671|NCT00574288|Dexamethasone|dexamethasone|mesh-list
56691672|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
56691673|NCT00574288|Daratumumab|daratumumab|mesh-list
56691674|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56691675|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56691677|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
56691678|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691679|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691680|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56691681|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
56691682|NCT00574288|Hormones|hormones|mesh-ancestor
56247356|NCT01841502|Paroxetine|paroxetine|mesh-list
56691716|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56691717|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56691718|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691719|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691720|NCT00823186|Paclitaxel|paclitaxel|mesh-list
56691721|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56691722|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691723|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
56691724|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
56691752|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
56691753|NCT00820690|Doxorubicin|doxorubicin|mesh-list
56691754|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56691755|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691756|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56691757|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56691758|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56691759|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691760|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56691761|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
56691762|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691763|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691764|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56691765|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
56691766|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56691767|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56691768|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56691769|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56691770|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691771|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56691772|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691773|NCT00624052|Amlodipine|amlodipine|mesh-list
56691807|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56691808|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
56691809|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691810|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56247496|NCT01842373|Lidocaine|lidocaine|mesh-list
56691845|NCT00830830|Protective Agents|protective agents|mesh-ancestor
56691846|NCT00828958|Risperidone|risperidone|mesh-list
56691847|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56691848|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
56691849|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691869|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691870|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56691871|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691872|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691873|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
56691874|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56691875|NCT04105023|Estrogens|estrogens|mesh-ancestor
56534627|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
56534628|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
56534629|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
56534630|NCT00967330|Bevacizumab|bevacizumab|mesh-list
56534631|NCT00967330|Irinotecan|irinotecan|mesh-list
56534632|NCT00967330|Temozolomide|temozolomide|mesh-list
56534633|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56534634|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534635|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56534636|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56534637|NCT00967330|Growth Substances|growth substances|mesh-ancestor
56534638|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534639|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
56534640|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56534641|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56534642|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534643|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534644|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56691876|NCT04105023|Hormones|hormones|mesh-ancestor
56691877|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691878|NCT04104867|Domperidone|domperidone|mesh-list
56691879|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
56691880|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
56691881|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691882|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691883|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56691884|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56691885|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
56691886|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691887|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691888|NCT00789828|Everolimus|everolimus|mesh-list
56691889|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691890|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56691891|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
56691892|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691893|NCT02550262|Fentanyl|fentanyl|mesh-list
56691894|NCT02550262|Bupivacaine|bupivacaine|mesh-list
56691895|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
56691896|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
56403090|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691897|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691898|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691899|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
56691900|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691901|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56691902|NCT02550262|Narcotics|narcotics|mesh-ancestor
56691903|NCT02550262|Analgesics|analgesics|mesh-ancestor
56691936|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691937|NCT00829192|Afamelanotide|afamelanotide|mesh-list
56691938|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
56691939|NCT00623194|Insulin|insulin|mesh-list
56691940|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56691941|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
56691942|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
56691943|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56691944|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247629|NCT01843296|Narcotics|narcotics|mesh-ancestor
56691973|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56534645|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
56534646|NCT02863276|Insulin|insulin|mesh-list
56534647|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56534648|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56534649|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534650|NCT04286152|Mirabegron|mirabegron|mesh-list
56534651|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56534652|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56534653|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56534654|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
56534655|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534656|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534657|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534658|NCT04286152|Urological Agents|urological agents|mesh-ancestor
56691974|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691976|NCT00915564|Methadone|methadone|mesh-list
56691977|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56691978|NCT00915564|Narcotics|narcotics|mesh-ancestor
56691979|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691980|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691981|NCT00915564|Analgesics|analgesics|mesh-ancestor
56691982|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
56691983|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691984|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
56691985|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
56691986|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
56691987|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691988|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
56691989|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691990|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692019|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692020|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56692021|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56692022|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56692023|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56692024|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56692025|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56692026|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56692027|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
56692028|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692029|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692030|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692031|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692032|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
56692034|NCT05567406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56692035|NCT05567406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692036|NCT05567406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692037|NCT00824200|Tamsulosin|tamsulosin|mesh-list
56692060|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692061|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56692062|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56692063|NCT00622726|Growth Substances|growth substances|mesh-ancestor
56692064|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692065|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
56692066|NCT00830050|Naproxen|naproxen|mesh-list
56692067|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56692068|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56692069|NCT00830050|Analgesics|analgesics|mesh-ancestor
56692070|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
56692071|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534660|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56534661|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56534662|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56534663|NCT00965848|Doripenem|doripenem|mesh-list
56534664|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56534665|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534666|NCT03447574|Ethanol|ethanol|mesh-list
56692072|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692073|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692074|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692075|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
56692076|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56692077|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692078|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692079|NCT00623428|Ribavirin|ribavirin|mesh-list
56692080|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56692081|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
56692082|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692083|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
56692084|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692085|NCT00824668|Insulin|insulin|mesh-list
56692086|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56247776|NCT01843998|Sirolimus|sirolimus|mesh-list
56692119|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
56692120|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56692121|NCT00837850|Protective Agents|protective agents|mesh-ancestor
56692122|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692123|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56692124|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56692125|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56692126|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692127|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56247817|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
56692188|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56692189|NCT00782418|Exenatide|exenatide|mesh-list
56692190|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56692191|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692192|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56692193|NCT00782418|Incretins|incretins|mesh-ancestor
56692194|NCT00782418|Hormones|hormones|mesh-ancestor
56692195|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56692196|NCT00782340|Droxidopa|droxidopa|mesh-list
56692197|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56692198|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56692199|NCT00774852|Prednisone|prednisone|mesh-list
56692200|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
56692201|NCT00774852|Abatacept|abatacept|mesh-list
56692202|NCT00774852|Azathioprine|azathioprine|mesh-list
56692203|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56692204|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
56692205|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692206|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692207|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56692208|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
56692209|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247895|NCT01844804|Infliximab|infliximab|mesh-list
56692242|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692243|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
56692244|NCT04105920|Protective Agents|protective agents|mesh-ancestor
56692245|NCT04105764|Bromides|bromides|mesh-list
56692246|NCT04105764|Rocuronium|rocuronium|mesh-list
56692247|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
56692248|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
56692249|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56692250|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56692251|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692274|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692275|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56692276|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692277|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692278|NCT00787644|Pioglitazone|pioglitazone|mesh-list
56534667|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56534668|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534669|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56534670|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534671|NCT04284826|Mitomycins|mitomycins|mesh-list
56534672|NCT04284826|Mitomycin|mitomycin|mesh-list
56534673|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56534674|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534675|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
56534676|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534677|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56534678|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534679|NCT04285528|Lidocaine|lidocaine|mesh-list
56534680|NCT04285528|Fentanyl|fentanyl|mesh-list
56692279|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56692280|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692281|NCT02602002|Remifentanil|remifentanil|mesh-list
56692282|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56692283|NCT02602002|Narcotics|narcotics|mesh-ancestor
56692284|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692285|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692286|NCT02602002|Analgesics|analgesics|mesh-ancestor
56692287|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
56692288|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692289|NCT00787566|Granisetron|granisetron|mesh-list
56692290|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
56692291|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
56692292|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692293|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692294|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692295|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56692296|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
56692297|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692298|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692299|NCT02602938|Aspirin|aspirin|mesh-list
56692300|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56692301|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56692302|NCT02602938|Analgesics|analgesics|mesh-ancestor
56692303|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
56692336|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692337|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
56692338|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
56692339|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56692340|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56692341|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56692342|NCT04105374|Flucytosine|flucytosine|mesh-list
56692343|NCT04105374|Temozolomide|temozolomide|mesh-list
56692344|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56692345|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
56692364|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56692365|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692366|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56692367|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56692368|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
56692369|NCT04102878|Anesthetics|anesthetics|mesh-list
56692370|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
56692371|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692372|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692373|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
56692374|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692375|NCT00838240|Cytarabine|cytarabine|mesh-list
56692376|NCT00838240|Clofarabine|clofarabine|mesh-list
56534681|NCT04285528|Ketamine|ketamine|mesh-list
56534682|NCT04285528|Propofol|propofol|mesh-list
56534683|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
56534684|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
56534685|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56534686|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188884|NCT01446679|Atorvastatin|atorvastatin|mesh-list
56692377|NCT00838240|Idarubicin|idarubicin|mesh-list
56692378|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56692379|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
56692380|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692381|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692382|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
56692383|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692384|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56692385|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
56692386|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692387|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56692388|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56692389|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56692390|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692391|NCT00773292|Cyclosporine|cyclosporine|mesh-list
56692392|NCT00773292|Cyclosporins|cyclosporins|mesh-list
56692393|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692394|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692395|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56692396|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
56692397|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692398|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
56692399|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692400|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
56692423|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692425|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56692426|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
56692427|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692428|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692429|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56692430|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56692431|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
56692432|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692433|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692434|NCT00621322|Vaccines|vaccines|mesh-list
56692435|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
56692436|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692437|NCT00839488|Pantoprazole|pantoprazole|mesh-list
56692438|NCT00839488|Famotidine|famotidine|mesh-list
56692439|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56692440|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692441|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56692442|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692443|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692444|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56692445|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
56692446|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
56692447|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692448|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692449|NCT00834184|Nikkomycin|nikkomycin|mesh-list
56692450|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
56692451|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692452|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692453|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692454|NCT00834262|Insulin|insulin|mesh-list
56692481|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
56692482|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56692483|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56692484|NCT00846365|Diuretics|diuretics|mesh-ancestor
56692485|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
56692486|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692487|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56058228|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534687|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
56534688|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534689|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56534690|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56534691|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56534692|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56534693|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534694|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56534695|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56534696|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
56534697|NCT04285528|Analgesics|analgesics|mesh-ancestor
56692488|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56692489|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692490|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56692491|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56692492|NCT00834730|Ketamine|ketamine|mesh-list
56692493|NCT00834730|Analgesics|analgesics|mesh-ancestor
56692494|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
56692495|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692496|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692497|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56692498|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56403681|NCT02963181|Protective Agents|protective agents|mesh-ancestor
56692499|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
56692500|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
56692501|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692518|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
56692519|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692520|NCT00840112|Protective Agents|protective agents|mesh-ancestor
56692521|NCT04101474|Ketamine|ketamine|mesh-list
56692522|NCT04101474|Analgesics|analgesics|mesh-ancestor
56692523|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
56692524|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692525|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692526|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56692527|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56692528|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
56692529|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
56692530|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692531|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56692532|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56692533|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692534|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692535|NCT04101708|Amoxicillin|amoxicillin|mesh-list
56692536|NCT04101708|Clarithromycin|clarithromycin|mesh-list
56692537|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56692538|NCT04101708|Lansoprazole|lansoprazole|mesh-list
56692539|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
56692540|NCT04101708|Bismuth|bismuth|mesh-list
56692541|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56692542|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692543|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56692544|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692545|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692546|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56692547|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56692548|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56692549|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692550|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56692551|NCT04101708|Antacids|antacids|mesh-ancestor
56692552|NCT00779142|Methotrexate|methotrexate|mesh-list
56059513|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
56534698|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56534699|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56534700|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56534701|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534702|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56188901|NCT01446900|Rituximab|rituximab|mesh-list
56692553|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56692554|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
56692555|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56692556|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692557|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56692558|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
56692559|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692588|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692590|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56692591|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
56692592|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56692593|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692594|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56692595|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56692596|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56692597|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56692598|NCT00840580|Renal Agents|renal agents|mesh-ancestor
56692599|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56692600|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56692601|NCT00773136|Bimatoprost|bimatoprost|mesh-list
56692602|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56692603|NCT02602860|Levetiracetam|levetiracetam|mesh-list
56692604|NCT02602860|Brivaracetam|brivaracetam|mesh-list
56692605|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
56692639|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692640|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
56692641|NCT00772668|Hormones|hormones|mesh-ancestor
56692642|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56692643|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56692644|NCT00786474|Dalteparin|dalteparin|mesh-list
56692645|NCT00786474|Tinzaparin|tinzaparin|mesh-list
56692646|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56248342|NCT01847677|Carboplatin|carboplatin|mesh-list
56692675|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56692676|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56692677|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692678|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692679|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56692680|NCT00701909|Narcotics|narcotics|mesh-ancestor
56692681|NCT00699023|Simvastatin|simvastatin|mesh-list
56692682|NCT00699023|Ezetimibe|ezetimibe|mesh-list
56692683|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56692684|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56692685|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
56692686|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692687|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56692688|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56692689|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692690|NCT00853229|Pregabalin|pregabalin|mesh-list
56692691|NCT00853229|Analgesics|analgesics|mesh-ancestor
56692692|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
56692715|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692717|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692718|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692719|NCT04120337|Lidocaine|lidocaine|mesh-list
56692720|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
56692721|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
56692722|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56403906|NCT00191256|Gemcitabine|gemcitabine|mesh-list
56692724|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
56692725|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692726|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56534703|NCT04285528|Narcotics|narcotics|mesh-ancestor
56534704|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56534705|NCT00629824|Interferons|interferons|mesh-list
56534706|NCT00629824|Ribavirin|ribavirin|mesh-list
56534707|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
56534708|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56534709|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534710|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
56534711|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534712|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
56534713|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534714|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
56692727|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56692728|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56692729|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56692730|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692731|NCT00592319|Celecoxib|celecoxib|mesh-list
56692732|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56692733|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56692734|NCT00592319|Analgesics|analgesics|mesh-ancestor
56692735|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
56692736|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692737|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692738|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692739|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56248429|NCT01848132|Hormones|hormones|mesh-ancestor
56692773|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
56692774|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692775|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56692776|NCT00700583|Terazosin|terazosin|mesh-list
56692777|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56692778|NCT00700583|Diuretics|diuretics|mesh-ancestor
56692779|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
56692780|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692781|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56692803|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692804|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692805|NCT00851903|Metformin|metformin|mesh-list
56692806|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
56692807|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56692808|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56692809|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692810|NCT00851903|Incretins|incretins|mesh-ancestor
56692811|NCT00851903|Hormones|hormones|mesh-ancestor
56692812|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56692813|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56692814|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
56692815|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692816|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692817|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
56692818|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692819|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
56692820|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56692821|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692822|NCT04099563|Abrocitinib|abrocitinib|mesh-list
56692823|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56692824|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692825|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692826|NCT00767325|Methotrexate|methotrexate|mesh-list
56692827|NCT00767325|Abatacept|abatacept|mesh-list
56692828|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56692829|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
56692830|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56692831|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534715|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534716|NCT00961636|Niacin|niacin|mesh-list
56534717|NCT00961636|Niacinamide|niacinamide|mesh-list
56534718|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
56534719|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56534720|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
56534721|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534722|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56534723|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
56534724|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
56534725|NCT00961636|Vitamins|vitamins|mesh-ancestor
56534726|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
56385602|NCT00134888|Naloxone|naloxone|mesh-list
56188917|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
56692832|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56692833|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
56692861|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56692862|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56692863|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56692864|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56692865|NCT00912899|Noscapine|noscapine|mesh-list
56692866|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
56692867|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
56692868|NCT00700895|Warfarin|warfarin|mesh-list
56692869|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
56404056|NCT00547768|Fexofenadine|fexofenadine|mesh-list
56692870|NCT00861341|Aspirin|aspirin|mesh-list
56692871|NCT00861341|Pioglitazone|pioglitazone|mesh-list
56692872|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56692873|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56692874|NCT00861341|Analgesics|analgesics|mesh-ancestor
56692875|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
56692876|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692877|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692878|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692879|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692899|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692900|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
56692901|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692902|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692903|NCT00844805|Naproxen|naproxen|mesh-list
56692904|NCT00844805|Infliximab|infliximab|mesh-list
56692905|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
56692906|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692907|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692908|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56692909|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56692910|NCT00844805|Analgesics|analgesics|mesh-ancestor
56692911|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
56692912|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692913|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692914|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692915|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
56692916|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56692917|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692918|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692919|NCT00765999|Linaclotide|linaclotide|mesh-list
56692920|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56692921|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
56692922|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692923|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692924|NCT04099407|Pirfenidone|pirfenidone|mesh-list
56692925|NCT04099407|Analgesics|analgesics|mesh-ancestor
56692926|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
56059765|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
56534727|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534728|NCT00964678|Carvedilol|carvedilol|mesh-list
56534729|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56534730|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56534731|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
56534732|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534733|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534734|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534735|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56534736|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
56534737|NCT00964678|Protective Agents|protective agents|mesh-ancestor
56534738|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56534739|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56534740|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56534741|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
56534742|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56188932|NCT01447069|Albuterol|albuterol|mesh-list
56692927|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692928|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692929|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56692930|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56692931|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692932|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692933|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692984|NCT00763269|Protective Agents|protective agents|mesh-ancestor
56692985|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692986|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56692987|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692988|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56692989|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56692990|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
56692991|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692992|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56692993|NCT00763269|Trace Elements|trace elements|mesh-ancestor
56692994|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
56692995|NCT00763035|Dobutamine|dobutamine|mesh-list
56692996|NCT00763035|Regadenoson|regadenoson|mesh-list
56692997|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56692998|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
56692999|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
56693000|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248691|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56693032|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56693033|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56693034|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
56693035|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693036|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693037|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693038|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56693039|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56693040|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56248735|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
56693067|NCT00843635|Urological Agents|urological agents|mesh-ancestor
56693069|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
56693070|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56534743|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56534744|NCT03263650|Prednisone|prednisone|mesh-list
56534745|NCT03263650|Carboplatin|carboplatin|mesh-list
56534746|NCT03263650|Olaparib|olaparib|mesh-list
56534747|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534748|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534749|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
56534750|NCT03263650|Hormones|hormones|mesh-ancestor
56534751|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534752|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693071|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56693072|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693073|NCT04116827|Tamoxifen|tamoxifen|mesh-list
56693074|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56693075|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
56693076|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693077|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693078|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56693079|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693080|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56693081|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56693082|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56693083|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
56693084|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56693085|NCT00849017|Incretins|incretins|mesh-ancestor
56693086|NCT00849017|Hormones|hormones|mesh-ancestor
56733195|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693102|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693104|NCT00841763|Vaccines|vaccines|mesh-list
56693105|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
56693106|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693107|NCT05603429|Antioxidants|antioxidants|mesh-list
56693108|NCT05603429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693109|NCT05603429|Protective Agents|protective agents|mesh-ancestor
56693110|NCT05603429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693111|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56693112|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
56693113|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693114|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
56693115|NCT02602704|Calcium|calcium|mesh-list
56693116|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56693117|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693118|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56693119|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56693120|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
56693121|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693122|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56693123|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56693124|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
56693125|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
56693126|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
56693127|NCT00703313|Levofloxacin|levofloxacin|mesh-list
56693128|NCT00703313|Ofloxacin|ofloxacin|mesh-list
56693129|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
56693130|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56693131|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56693132|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56693133|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56693134|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693135|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56693136|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56693137|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693138|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534753|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56534754|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56534755|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534756|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534757|NCT00964366|Clindamycin|clindamycin|mesh-list
56534758|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
56534759|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
56534760|NCT00964366|Dapsone|dapsone|mesh-list
56534761|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56534762|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56534763|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534764|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56534765|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534766|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534767|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
56534768|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
56534769|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56693139|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693140|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56248826|NCT01851278|Hormones|hormones|mesh-ancestor
56693169|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56693170|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56693171|NCT00840827|Growth Substances|growth substances|mesh-ancestor
56693172|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
56693173|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693174|NCT00703469|Nivolumab|nivolumab|mesh-list
56693175|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693176|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693177|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56693178|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693179|NCT02612207|Bilirubin|bilirubin|mesh-list
56693180|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
56693181|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693182|NCT02612207|Protective Agents|protective agents|mesh-ancestor
56693183|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693184|NCT00859937|Dasatinib|dasatinib|mesh-list
56693185|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693207|NCT00591851|Paclitaxel|paclitaxel|mesh-list
56693208|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
56693209|NCT00591851|Doxorubicin|doxorubicin|mesh-list
56693210|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56693211|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56693212|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693213|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
56693214|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
56693215|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
56693216|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693217|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693218|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
56693219|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693220|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693221|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56693222|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
56693223|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56693224|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56693225|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56693226|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56534770|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56534771|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56534772|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
56534773|NCT03545464|Prednisone|prednisone|mesh-list
56534774|NCT03545464|Levocetirizine|levocetirizine|mesh-list
56534775|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534776|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
56534777|NCT03545464|Hormones|hormones|mesh-ancestor
56534778|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534779|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534780|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56534781|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534782|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56693227|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693228|NCT00839423|Vortioxetine|vortioxetine|mesh-list
56693229|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56693230|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56693231|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56693232|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56693233|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693234|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248931|NCT01851941|Leucovorin|leucovorin|mesh-list
56693243|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
56693244|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56693245|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56693246|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56693247|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56693248|NCT00859469|Gemcitabine|gemcitabine|mesh-list
56693249|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
56693250|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56693251|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
56693252|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693253|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693254|NCT00859469|Antiviral Agents|antiviral agents|mesh-ancestor
56693255|NCT00859469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693256|NCT00859469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693257|NCT00859469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693258|NCT00859469|Immunologic Factors|immunologic factors|mesh-ancestor
56693259|NCT00859469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693260|NCT00703625|Sirolimus|sirolimus|mesh-list
56693261|NCT00703625|Docetaxel|docetaxel|mesh-list
56693262|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693263|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
56693264|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
56693265|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
56693266|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693267|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56693268|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693269|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56693270|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
56693271|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693272|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
56693273|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693274|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56693275|NCT00703703|Darifenacin|darifenacin|mesh-list
56693276|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56693277|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56693278|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
56693279|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693280|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693281|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534783|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56534784|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
56534785|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
56534786|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534787|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534788|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56534789|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56534790|NCT02966782|Azacitidine|azacitidine|mesh-list
56534791|NCT02966782|Venetoclax|venetoclax|mesh-list
56534792|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56534793|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
56188993|NCT01447485|Valsartan|valsartan|mesh-list
56693282|NCT00703703|Urological Agents|urological agents|mesh-ancestor
56693283|NCT00859313|Sufentanil|sufentanil|mesh-list
56693284|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56693285|NCT00859313|Narcotics|narcotics|mesh-ancestor
56693286|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693287|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693288|NCT00859313|Analgesics|analgesics|mesh-ancestor
56693289|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
56693290|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693291|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56693292|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56693293|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
56693294|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
56693295|NCT02611973|Aspirin|aspirin|mesh-list
56693296|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
56693297|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56693298|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56693299|NCT02611973|Analgesics|analgesics|mesh-ancestor
56693300|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
56693301|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693316|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56693317|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
56693318|NCT00836927|Sirolimus|sirolimus|mesh-list
56693319|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56693320|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693321|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56693322|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693323|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
56693324|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693325|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
56693326|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693327|NCT00703235|Bevacizumab|bevacizumab|mesh-list
56693328|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693329|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693330|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56693331|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56693332|NCT00703235|Growth Substances|growth substances|mesh-ancestor
56693333|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693334|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
56693335|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56693336|NCT00771030|Brodalumab|brodalumab|mesh-list
56693337|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
56693338|NCT00768300|Ambrisentan|ambrisentan|mesh-list
56693339|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56693340|NCT00768222|Triclosan|triclosan|mesh-list
56693341|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56693342|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693343|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56693344|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56693345|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
56693346|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693347|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56693348|NCT00768144|Sunitinib|sunitinib|mesh-list
56693349|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534794|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534795|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534796|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534797|NCT02860936|Lenvatinib|lenvatinib|mesh-list
56534798|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283024|NCT00006205|Topiramate|topiramate|mesh-list
56534799|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56534801|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534803|NCT00630214|Vitamin D|vitamin d|mesh-list
56534804|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
56534805|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
56534806|NCT00630214|Vitamins|vitamins|mesh-list
56534807|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
56534808|NCT00630214|Calcium|calcium|mesh-list
56534809|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
56534810|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534811|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56534812|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56534813|NCT00630214|Antacids|antacids|mesh-ancestor
56534814|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534815|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56534816|NCT02860858|Aflibercept|aflibercept|mesh-list
56534817|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56534818|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56534819|NCT02860858|Growth Substances|growth substances|mesh-ancestor
56693350|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56693351|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56693352|NCT00768144|Growth Substances|growth substances|mesh-ancestor
56693353|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693354|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
56693355|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56693356|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693357|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693358|NCT05540574|Zolpidem|zolpidem|mesh-list
56693359|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56693360|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56693361|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693362|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693363|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56693452|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56693453|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
56693454|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693455|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693456|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56693457|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693458|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693459|NCT00766506|Fentanyl|fentanyl|mesh-list
56693460|NCT00766506|Morphine|morphine|mesh-list
56693461|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56693462|NCT00766506|Narcotics|narcotics|mesh-ancestor
56534820|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534821|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
56534822|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534823|NCT00960076|Metformin|metformin|mesh-list
56534824|NCT00960076|Saxagliptin|saxagliptin|mesh-list
56534825|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56534826|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534827|NCT00960076|Incretins|incretins|mesh-ancestor
56534828|NCT00960076|Hormones|hormones|mesh-ancestor
56534829|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534830|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56534831|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
56534832|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534833|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534834|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56534835|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56534836|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56534837|NCT04284202|Dasatinib|dasatinib|mesh-list
56534838|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534839|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56534840|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534841|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534842|NCT01227629|Warfarin|warfarin|mesh-list
56534843|NCT01227629|Dabigatran|dabigatran|mesh-list
56534844|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
56693463|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693464|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693466|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
56693467|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693468|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56693469|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56693470|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
56693471|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
56693472|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
56693473|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56693474|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693475|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693476|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56693477|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56693478|NCT00770328|Protective Agents|protective agents|mesh-ancestor
56693479|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693480|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
56693481|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56693482|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
56693483|NCT05500092|Gemcitabine|gemcitabine|mesh-list
56693484|NCT05500092|Cisplatin|cisplatin|mesh-list
56693485|NCT05500092|Docetaxel|docetaxel|mesh-list
56693486|NCT05500092|Nivolumab|nivolumab|mesh-list
56693487|NCT05500092|Pemetrexed|pemetrexed|mesh-list
56693488|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693489|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56534845|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
56534846|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56534847|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
56534848|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534849|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534850|NCT00963820|Ixazomib|ixazomib|mesh-list
56534851|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534852|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534853|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
56534854|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56534855|NCT03241186|Nivolumab|nivolumab|mesh-list
56534856|NCT03241186|Ipilimumab|ipilimumab|mesh-list
56534857|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56189039|NCT01447862|Ibutilide|ibutilide|mesh-list
56693490|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
56693491|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693492|NCT05500092|Antiviral Agents|antiviral agents|mesh-ancestor
56693527|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693529|NCT00913367|Insulin|insulin|mesh-list
56693530|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56693531|NCT00913367|Metformin|metformin|mesh-list
56693532|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
56693533|NCT00913367|Glimepiride|glimepiride|mesh-list
56249234|NCT01854216|Rotigotine|rotigotine|mesh-list
56693559|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693560|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693561|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693563|NCT00818753|Calcium heparin|calcium heparin|mesh-list
56693564|NCT00818753|Dabigatran|dabigatran|mesh-list
56693565|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
56693566|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56693567|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56693568|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693569|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
56693570|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56693571|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
56693572|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693573|NCT00704249|Nevirapine|nevirapine|mesh-list
56693574|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56693575|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56693576|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693577|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693578|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
56693579|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693580|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56693581|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56693582|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56693583|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56693602|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
56693603|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693604|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693605|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56693606|NCT00818519|Diuretics|diuretics|mesh-ancestor
56693607|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
56693609|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693610|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693611|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
56693612|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693613|NCT00765102|Bortezomib|bortezomib|mesh-list
56693614|NCT00765102|Romidepsin|romidepsin|mesh-list
56693615|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693616|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56534858|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534859|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56534860|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534861|NCT01227395|Azithromycin|azithromycin|mesh-list
56534862|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56534863|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534864|NCT03237286|Ketamine|ketamine|mesh-list
56534865|NCT03237286|Analgesics|analgesics|mesh-ancestor
56534866|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
56534867|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534868|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534869|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56534870|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56534871|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
56534872|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
56534873|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56283109|NCT00006229|Paclitaxel|paclitaxel|mesh-list
56189052|NCT01448018|Ranibizumab|ranibizumab|mesh-list
56189053|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56693617|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56693618|NCT00809354|Tanezumab|tanezumab|mesh-list
56693619|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56693620|NCT00809354|Analgesics|analgesics|mesh-ancestor
56693621|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
56693622|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693623|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693624|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56693625|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693626|NCT00834899|Eptifibatide|eptifibatide|mesh-list
56693627|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56693628|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
56693629|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56693630|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56693631|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
56693632|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693633|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56693634|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56693635|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693636|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693637|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56693638|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56693639|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693640|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56249323|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56693659|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693660|NCT00756444|Panitumumab|panitumumab|mesh-list
56693661|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693662|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693663|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56693664|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56693665|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693666|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56693667|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56693668|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56693669|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534874|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56534875|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56534876|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693670|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
56693671|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693672|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
56693673|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693674|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56693675|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56693676|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693677|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693678|NCT00764478|Asenapine|asenapine|mesh-list
56693679|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56693680|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56693681|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693682|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693683|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56693684|NCT00805766|Infliximab|infliximab|mesh-list
56693685|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
56693686|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56693687|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693688|NCT00764322|Tamoxifen|tamoxifen|mesh-list
56693689|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56404887|NCT04355143|Colchicine|colchicine|mesh-list
56693690|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
56733196|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693707|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
56693708|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
56693709|NCT00752856|Ritonavir|ritonavir|mesh-list
56693710|NCT00752856|Lopinavir|lopinavir|mesh-list
56693711|NCT00752856|Tenofovir|tenofovir|mesh-list
56693712|NCT00752856|Emtricitabine|emtricitabine|mesh-list
56693713|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
56693714|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56693715|NCT00752856|Efavirenz|efavirenz|mesh-list
56693716|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56693717|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56693718|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
56693719|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693720|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693721|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56693722|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56693723|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
56693724|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693725|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56693726|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56693727|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56693728|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56693729|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56693730|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56693731|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56693732|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56693733|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56693734|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56693735|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56693736|NCT00805142|Tapentadol|tapentadol|mesh-list
56693737|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56693738|NCT00805142|Narcotics|narcotics|mesh-ancestor
56693739|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693740|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693741|NCT00805142|Analgesics|analgesics|mesh-ancestor
56693742|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
56693743|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693744|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56693745|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56693746|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56693778|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56693779|NCT00761319|Latanoprost|latanoprost|mesh-list
56693780|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56693781|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56693782|NCT00704639|Carboplatin|carboplatin|mesh-list
56693783|NCT00704639|Cetuximab|cetuximab|mesh-list
56534877|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534879|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56534880|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
56693784|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693785|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693786|NCT00826943|Cetirizine|cetirizine|mesh-list
56693787|NCT00826943|Levocetirizine|levocetirizine|mesh-list
56693788|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56693789|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56693790|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56249498|NCT01855724|Gemcitabine|gemcitabine|mesh-list
56693894|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56693895|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693896|NCT00833027|Incretins|incretins|mesh-ancestor
56693897|NCT00833027|Hormones|hormones|mesh-ancestor
56693898|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693930|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693931|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56693932|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693933|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
56693934|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693935|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56693936|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
56693937|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693938|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56693939|NCT04095312|Pancrelipase|pancrelipase|mesh-list
56693961|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
56693962|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56693963|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56693964|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56693965|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693966|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693967|NCT04016051|Clarithromycin|clarithromycin|mesh-list
56693968|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56693969|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693970|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56693971|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693972|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693973|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56693974|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56693975|NCT00761514|Adalimumab|adalimumab|mesh-list
56693976|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56693977|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693978|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
56693979|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56693980|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693981|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56693982|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693983|NCT00758043|Ribavirin|ribavirin|mesh-list
56693984|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56693985|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
56693986|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693987|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
56405175|NCT00192660|Ritonavir|ritonavir|mesh-list
56693988|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693990|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56693991|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56694025|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
56694026|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
56694027|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694028|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694029|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
56694030|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56694031|NCT05438277|Triamcinolone|triamcinolone|mesh-list
56694032|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56694033|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56694034|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56694066|NCT00916890|Analgesics|analgesics|mesh-ancestor
56694067|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
56694068|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534881|NCT01225991|Milnacipran|milnacipran|mesh-list
56534882|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
56694069|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56694070|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56694071|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
56694072|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
56694073|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56694074|NCT02599701|Gabapentin|gabapentin|mesh-list
56694075|NCT02599701|Analgesics|analgesics|mesh-ancestor
56694076|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
56694077|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694078|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694098|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
56694099|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56694100|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
56694101|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694102|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56694103|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56694104|NCT00760266|Diuretics|diuretics|mesh-ancestor
56694105|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
56694106|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694107|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56694108|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694109|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694110|NCT00753714|Gemcitabine|gemcitabine|mesh-list
56694111|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56694112|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
56694113|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694114|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694115|NCT00753714|Antiviral Agents|antiviral agents|mesh-ancestor
56694116|NCT00753714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694117|NCT00753714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694118|NCT00753714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56694119|NCT00753714|Immunologic Factors|immunologic factors|mesh-ancestor
56694120|NCT00753714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694121|NCT00759954|Morphine|morphine|mesh-list
56694122|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56694123|NCT00759954|Narcotics|narcotics|mesh-ancestor
56694124|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694125|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694126|NCT00759954|Analgesics|analgesics|mesh-ancestor
56694127|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
56694128|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694129|NCT00804908|Temozolomide|temozolomide|mesh-list
56694130|NCT00804908|Veliparib|veliparib|mesh-list
56694158|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56694159|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56694160|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56694161|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56694162|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694163|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56694165|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
56694166|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694167|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56694168|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56694169|NCT00589784|Growth Substances|growth substances|mesh-ancestor
56249885|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
56694191|NCT05742854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56694192|NCT05742854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694194|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56694195|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56694196|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694197|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694198|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
56694199|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694200|NCT02606864|Nifurtimox|nifurtimox|mesh-list
56694201|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56694202|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56694203|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56694204|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694205|NCT05741372|Metformin|metformin|mesh-list
56694206|NCT05741372|Digoxin|digoxin|mesh-list
56694207|NCT05741372|Furosemide|furosemide|mesh-list
56694208|NCT05741372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56694209|NCT05741372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56534883|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56534884|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56534885|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56534886|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534887|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534888|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534889|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56534890|NCT01225991|Analgesics|analgesics|mesh-ancestor
56534891|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
56534892|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534893|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
56534894|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56534895|NCT04283110|Midazolam|midazolam|mesh-list
56534896|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56534897|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56534898|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56534899|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534900|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56534901|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56534902|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56534903|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56534904|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
56534905|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
56534906|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
56534907|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
56534908|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694210|NCT05741372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694211|NCT05741372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56694212|NCT05741372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56694213|NCT05741372|Antimetabolites|antimetabolites|mesh-ancestor
56694214|NCT05741372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694215|NCT05741372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56694216|NCT05741372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56694217|NCT05741372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694218|NCT05741372|Diuretics|diuretics|mesh-ancestor
56694219|NCT05741372|Natriuretic Agents|natriuretic agents|mesh-ancestor
56694220|NCT05741372|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56694221|NCT05741372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694292|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694294|NCT04093206|Vitamins|vitamins|mesh-list
56694295|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
56694296|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
56694297|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694298|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
56694299|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694372|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
56534909|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534910|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56534911|NCT01225835|Cetrorelix|cetrorelix|mesh-list
56534912|NCT01225835|Menotropins|menotropins|mesh-list
56534913|NCT01225835|Progesterone|progesterone|mesh-list
56534914|NCT01225835|Progestins|progestins|mesh-ancestor
56534915|NCT01225835|Hormones|hormones|mesh-ancestor
56534916|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534917|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534918|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56534919|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56534920|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
56534921|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
56534922|NCT04282096|Caseins|caseins|mesh-list
56534923|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
56534924|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
56694373|NCT00758394|Protective Agents|protective agents|mesh-ancestor
56694374|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694375|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56694376|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694377|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56694378|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56694408|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56694409|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694411|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56694412|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56694413|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56694414|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
56694415|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694416|NCT02852486|Pioglitazone|pioglitazone|mesh-list
56694417|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
56694418|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56694419|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694420|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694452|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56694453|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694455|NCT02607410|Hormones|hormones|mesh-ancestor
56694456|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694457|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
56694458|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694459|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694460|NCT05694260|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56694461|NCT05694260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56250182|NCT01858831|Atovaquone|atovaquone|mesh-list
56694489|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56694490|NCT02607488|Lidocaine|lidocaine|mesh-list
56694491|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
56694492|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
56694493|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694494|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694495|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
56694496|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694497|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56694498|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56694499|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56694500|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694501|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694502|NCT00914498|Lidocaine|lidocaine|mesh-list
56694503|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
56534925|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534926|NCT02899000|Doxycycline|doxycycline|mesh-list
56534927|NCT02899000|Adapalene|adapalene|mesh-list
56534928|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56534929|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56534930|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56534931|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
56534932|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56018001|NCT00305162|Cangrelor|cangrelor|mesh-list
56694504|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
56694505|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694506|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694507|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
56694508|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694526|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56694527|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694528|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56694529|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56694530|NCT02386826|Growth Substances|growth substances|mesh-ancestor
56694531|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694532|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
56694533|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
56694534|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56694535|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694536|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
56694537|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56694538|NCT05407662|Hormones|hormones|mesh-ancestor
56694539|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694540|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694541|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
56694542|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56694543|NCT05407662|Diuretics|diuretics|mesh-ancestor
56694544|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
56694545|NCT02597556|Albendazole|albendazole|mesh-list
56694546|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
56694547|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56694548|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694549|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
56694550|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56694551|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56694552|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56694553|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56694554|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56694555|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694556|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694557|NCT02599857|Bisoprolol|bisoprolol|mesh-list
56694558|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56694559|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
56694560|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
56694561|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694562|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694563|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56694564|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56694565|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56250270|NCT01859624|Albuterol|albuterol|mesh-list
56694620|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56694622|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694623|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694624|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56694625|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56694626|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
56694627|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694628|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694629|NCT00751101|Nicotine|nicotine|mesh-list
56694630|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56694631|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
56694632|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534933|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56534934|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
56534935|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56534936|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56534937|NCT02899000|Analgesics|analgesics|mesh-ancestor
56534938|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
56534939|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534940|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534941|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534942|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56534943|NCT04281862|Prednisolone|prednisolone|mesh-list
56534944|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56534945|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
56694633|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694634|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56694635|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56694636|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
56694637|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694638|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694639|NCT04092309|Valsartan|valsartan|mesh-list
56694640|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56694641|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56694642|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56694643|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56694644|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56694645|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694646|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
56694647|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694648|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
56694649|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
56694650|NCT02598414|Protective Agents|protective agents|mesh-ancestor
56694651|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56405848|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694652|NCT04020003|Simendan|simendan|mesh-list
56694653|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56694654|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
56694673|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56694674|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56694675|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56694676|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694678|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
56694679|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
56694680|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56694681|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694682|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694683|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694684|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56694685|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
56694686|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56694687|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56694688|NCT04091412|Protective Agents|protective agents|mesh-ancestor
56694689|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694690|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56694691|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56694692|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56694693|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
56694694|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694695|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694696|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283177|NCT00006250|Hormones|hormones|mesh-ancestor
56534946|NCT04281862|Hormones|hormones|mesh-ancestor
56534947|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56534948|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534949|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56534950|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56534951|NCT03122002|Clopidogrel|clopidogrel|mesh-list
56534952|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534953|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534954|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56534955|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56534956|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56534957|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56534958|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
56534959|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534961|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
56534962|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
56534963|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56534964|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534965|NCT02861716|Fentanyl|fentanyl|mesh-list
56534966|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
56694697|NCT02599311|Urological Agents|urological agents|mesh-ancestor
56694698|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
56694699|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56694700|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56694701|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56694702|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694703|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56694704|NCT00591773|Diuretics|diuretics|mesh-ancestor
56694705|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
56694706|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250417|NCT01860508|Carboplatin|carboplatin|mesh-list
56694737|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
56694738|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56694739|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
56694740|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56694741|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694742|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56694743|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56694744|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56694745|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56694746|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56694747|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
56694748|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694749|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56694750|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694752|NCT00829283|Sibutramine|sibutramine|mesh-list
56694789|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56694790|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
56694791|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733197|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56534967|NCT02861716|Bupivacaine|bupivacaine|mesh-list
56534968|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
56534969|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
56534970|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56534971|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534972|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
56534973|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56534974|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56534975|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56534976|NCT02861716|Analgesics|analgesics|mesh-ancestor
56534977|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56534978|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56534979|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56534980|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
56534981|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56534982|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534983|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56534984|NCT02861716|Narcotics|narcotics|mesh-ancestor
56534985|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56534986|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56534987|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
56534988|NCT00960934|Vitamin D|vitamin d|mesh-list
56534989|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
56534990|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
56534991|NCT00960934|Calcium|calcium|mesh-list
56534992|NCT00960934|Vitamins|vitamins|mesh-ancestor
56534993|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
56534994|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56534995|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56534996|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56534997|NCT00960934|Antacids|antacids|mesh-ancestor
56534998|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56534999|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56535000|NCT00892177|Bevacizumab|bevacizumab|mesh-list
56535001|NCT00892177|Dasatinib|dasatinib|mesh-list
56189163|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56694826|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
56694827|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56694828|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56694829|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56535002|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56535003|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535004|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56535005|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56694867|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56694868|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
56250615|NCT01862003|Leucovorin|leucovorin|mesh-list
56694904|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694905|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694906|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56694907|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56694908|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56694933|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56694935|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
56694936|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694937|NCT00743106|Fenoldopam|fenoldopam|mesh-list
56694938|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56694939|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
56694940|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
56694941|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
56694942|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694943|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694944|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694945|NCT05403450|Decitabine|decitabine|mesh-list
56694946|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56694947|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
56694948|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694949|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694950|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694951|NCT02597322|Axitinib|axitinib|mesh-list
56694952|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694953|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56694954|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694955|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694956|NCT00738699|Paclitaxel|paclitaxel|mesh-list
56250674|NCT01862354|Anesthetics|anesthetics|mesh-list
56694984|NCT00748098|Analgesics|analgesics|mesh-ancestor
56694985|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
56694986|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694987|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694988|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
56694989|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56694990|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56694991|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694992|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56694993|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56694994|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56694995|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694996|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694997|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
56694998|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56694999|NCT00813995|Metformin|metformin|mesh-list
56695000|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56695001|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695002|NCT00813995|Incretins|incretins|mesh-ancestor
56695003|NCT00813995|Hormones|hormones|mesh-ancestor
56695026|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56695027|NCT02598102|Analgesics|analgesics|mesh-ancestor
56695028|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
56695029|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695030|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695031|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695032|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695033|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56695034|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695035|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695036|NCT02610647|Anesthetics|anesthetics|mesh-list
56695037|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695038|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695040|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56535006|NCT00892177|Growth Substances|growth substances|mesh-ancestor
56535007|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535008|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
56535009|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56018477|NCT05385432|Tacrolimus|tacrolimus|mesh-list
56695041|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695042|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56695043|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695044|NCT02595840|Pemetrexed|pemetrexed|mesh-list
56695045|NCT02595840|Afatinib|afatinib|mesh-list
56695046|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695047|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695048|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695049|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56695050|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56695051|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56695052|NCT05756777|Ivosidenib|ivosidenib|mesh-list
56695089|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
56695090|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250816|NCT01863355|Analgesics|analgesics|mesh-ancestor
56695123|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695124|NCT00734097|Esomeprazole|esomeprazole|mesh-list
56695125|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56695126|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695127|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56695128|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695164|NCT05756621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695166|NCT05756621|Anesthetics, General|anesthetics, general|mesh-ancestor
56695167|NCT05756621|Analgesics|analgesics|mesh-ancestor
56695168|NCT05756621|Sensory System Agents|sensory system agents|mesh-ancestor
56695169|NCT05756621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695170|NCT05756621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56250905|NCT01863706|Oxytocin|oxytocin|mesh-list
56695195|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695196|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
56695197|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56695199|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695200|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695201|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695202|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56695203|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56695204|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56695205|NCT00732069|Valsartan|valsartan|mesh-list
56695206|NCT00732069|Ramipril|ramipril|mesh-list
56695207|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56695208|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56695209|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56695210|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695211|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56695212|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
56695213|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695214|NCT02593383|Clindamycin|clindamycin|mesh-list
56695215|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
56695216|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
56695217|NCT02593383|Adapalene|adapalene|mesh-list
56695218|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56695219|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695226|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
56695227|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695228|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695229|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695231|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
56695233|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56695234|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695235|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695236|NCT02609087|Propofol|propofol|mesh-list
56695293|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56695294|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695295|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56695296|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56695297|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535010|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535011|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535012|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56535013|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56535014|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56535015|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535016|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535017|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
56535018|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535019|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535020|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
56535021|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56535022|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535023|NCT02860624|Esomeprazole|esomeprazole|mesh-list
56535024|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56535025|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56535026|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56535027|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535028|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535030|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
56535031|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
56535032|NCT00892099|Vitamins|vitamins|mesh-list
56535033|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
56535034|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535035|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56535036|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56535037|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
56535038|NCT00960856|Fenofibrate|fenofibrate|mesh-list
56535039|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56535040|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56535041|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
56535042|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535043|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56535044|NCT00958438|Rilonacept|rilonacept|mesh-list
56535045|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56535046|NCT02835469|Menotropins|menotropins|mesh-list
56535047|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56535048|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
56535049|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56535050|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535051|NCT05324059|Pregabalin|pregabalin|mesh-list
56535052|NCT05324059|Tramadol|tramadol|mesh-list
56535053|NCT05324059|Analgesics|analgesics|mesh-ancestor
56695298|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695299|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56695300|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
56695301|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695302|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695303|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56695304|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56695305|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56695306|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56695307|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56695331|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
56695332|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695333|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695334|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56695335|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
56695336|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
56695337|NCT00728481|Hormones|hormones|mesh-ancestor
56695338|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695339|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56695340|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695341|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56695342|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695343|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695344|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
56695345|NCT02593227|Vaccines|vaccines|mesh-list
56695346|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
56695347|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695348|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56695349|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695350|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56695351|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
56695352|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695353|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695354|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56695355|NCT04030481|Anesthetics|anesthetics|mesh-list
56695356|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695357|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695393|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56695394|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56695395|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56695396|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56695428|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695429|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695430|NCT00808028|Vaccines|vaccines|mesh-list
56695431|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
56695432|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695433|NCT03466346|Fluoxetine|fluoxetine|mesh-list
56695434|NCT03466346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56695435|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56695436|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873252|NCT01863953|Bimatoprost|bimatoprost|mesh-list
56695470|NCT05675462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695471|NCT05675462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695472|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
56695473|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56695495|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56695496|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56695497|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
56695498|NCT00807248|Analgesics|analgesics|mesh-ancestor
56535054|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
56535055|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535056|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535057|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
56535058|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56535059|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535060|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535061|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56535062|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56535063|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56535064|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535065|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56535066|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56535067|NCT05324059|Narcotics|narcotics|mesh-ancestor
56535068|NCT02832973|Ramipril|ramipril|mesh-list
56695499|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
56695500|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
56695501|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
56695502|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
56695503|NCT02607332|Paclitaxel|paclitaxel|mesh-list
56695504|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56695505|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695506|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
56695507|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
56695508|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
56695509|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695510|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56695511|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56695512|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695513|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
56695514|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56695515|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56695516|NCT05297669|Analgesics|analgesics|mesh-ancestor
56695517|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
56695518|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695519|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695520|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695521|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695522|NCT00589628|Infliximab|infliximab|mesh-list
56695523|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
56695525|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695526|NCT00914576|Vitamins|vitamins|mesh-list
56695527|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
56695528|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873331|NCT01117948|Lornoxicam|lornoxicam|mesh-list
56695563|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
56695564|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695565|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
56695566|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
56695567|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695568|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695603|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695604|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56695605|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56695606|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
56695607|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695608|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695609|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56695642|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56535069|NCT02832973|Bisoprolol|bisoprolol|mesh-list
56535070|NCT02832973|Amiloride|amiloride|mesh-list
56535071|NCT02832973|Furosemide|furosemide|mesh-list
56535072|NCT02832973|Spironolactone|spironolactone|mesh-list
56695643|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
56695644|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
56695645|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695646|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695647|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695648|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
56695649|NCT00742560|Hormones|hormones|mesh-ancestor
56695650|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695651|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56695652|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695653|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
56695654|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251403|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
56695686|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56695687|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695688|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695689|NCT04025840|Dexamethasone|dexamethasone|mesh-list
56695690|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
56695691|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695692|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
56695693|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
56695694|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695695|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695722|NCT02608931|Analgesics|analgesics|mesh-ancestor
56695723|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
56695724|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695725|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56695726|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56695727|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695728|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695729|NCT02608931|Hormones|hormones|mesh-ancestor
56695730|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695731|NCT04618289|Vitamin D|vitamin d|mesh-list
56695732|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
56695733|NCT04618289|Vitamins|vitamins|mesh-ancestor
56695734|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
56695735|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695736|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56695737|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56695738|NCT00744978|Varenicline|varenicline|mesh-list
56695739|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56695740|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56695741|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
56695742|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733198|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695812|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695813|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
56695814|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695815|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56695816|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56695817|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56695818|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733199|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
56695850|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
56695851|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695852|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56695853|NCT00793598|Brincidofovir|brincidofovir|mesh-list
56695854|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
56695855|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695856|NCT04115072|Praziquantel|praziquantel|mesh-list
56695857|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
56695858|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56695859|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695860|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
56695861|NCT00796562|Busulfan|busulfan|mesh-list
56695890|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56695891|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56695892|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695893|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
56695894|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
56535073|NCT02832973|Diuretics|diuretics|mesh-list
56535074|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56535075|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
56535076|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535077|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56535078|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535079|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535080|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56535081|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
56535082|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56535083|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56535084|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
56535085|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535086|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56535087|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
56535088|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
56535089|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535090|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56535091|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56535092|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56535093|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
56695895|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695896|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695897|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56407113|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56695898|NCT00801632|Protective Agents|protective agents|mesh-ancestor
56695899|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
56695900|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56695901|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56695902|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
56695903|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695904|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695905|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56695906|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
56695937|NCT00806819|Dexamethasone|dexamethasone|mesh-list
56695938|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
56695939|NCT00806819|Pemetrexed|pemetrexed|mesh-list
56695940|NCT00806819|Nintedanib|nintedanib|mesh-list
56695941|NCT00806819|BB 1101|bb 1101|mesh-list
56695942|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695943|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
56695944|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
56695945|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695946|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695947|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695948|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
56695949|NCT00806819|Hormones|hormones|mesh-ancestor
56695950|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695951|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56695952|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535094|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535095|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56535096|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56535097|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56535098|NCT02831491|Docetaxel|docetaxel|mesh-list
56535099|NCT02831491|Ramucirumab|ramucirumab|mesh-list
56535100|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535116|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535118|NCT04281706|Propofol|propofol|mesh-list
56695953|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
56695954|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695955|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695956|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56695988|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56695989|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695990|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
56695991|NCT05326139|Coagulants|coagulants|mesh-ancestor
56695992|NCT02605694|Prednisone|prednisone|mesh-list
56695993|NCT02605694|Rituximab|rituximab|mesh-list
56695994|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56695995|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695996|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
56695997|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695998|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695999|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56696000|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
56696026|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56696028|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56696029|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696030|NCT00796328|Phenylephrine|phenylephrine|mesh-list
56696031|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
56696032|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56696033|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
56696034|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
56696035|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696036|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696037|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
56696038|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56696039|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
56696040|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
56696041|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56696042|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56696043|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56696044|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
56696045|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696046|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696047|NCT00796328|Protective Agents|protective agents|mesh-ancestor
56696048|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
56696049|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56696082|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
56696083|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696084|NCT00915200|Expectorants|expectorants|mesh-ancestor
56696085|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
56696086|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56696087|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
56733200|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
56696121|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
56696122|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56696123|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56696124|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696125|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56696126|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56696127|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56696128|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733201|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696165|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56696166|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
56535119|NCT04281706|Etomidate|etomidate|mesh-list
56535120|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56535121|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535122|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535123|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56535124|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
56535125|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
56535126|NCT02835391|Surgiflo|surgiflo|mesh-list
56535127|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
56535128|NCT02835391|Coagulants|coagulants|mesh-ancestor
56535129|NCT02831101|Sufentanil|sufentanil|mesh-list
56696167|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696232|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696234|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56696235|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696236|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696237|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56696238|NCT00455143|Analgesics|analgesics|mesh-ancestor
56696239|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
56696240|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696241|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56696242|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56696243|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56696244|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
56696245|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696246|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696247|NCT05559476|Vaccines|vaccines|mesh-list
56696248|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
56252014|NCT01871662|Interferons|interferons|mesh-list
56696284|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56696285|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56696286|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
56696287|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696321|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696322|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
56696323|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696324|NCT01020253|Alendronate|alendronate|mesh-list
56696325|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
56696326|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56696327|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56696346|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56696347|NCT00738894|Dipyridamole|dipyridamole|mesh-list
56407562|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56696348|NCT00738894|Clopidogrel|clopidogrel|mesh-list
56696349|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696350|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696351|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56696352|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696353|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56696354|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56696355|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56696356|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
56696357|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696358|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56696359|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
56696361|NCT00734994|Mitomycin|mitomycin|mesh-list
56696362|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56696363|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696364|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
56696365|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696366|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56696367|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696368|NCT02593734|Olanzapine|olanzapine|mesh-list
56696369|NCT02593734|Risperidone|risperidone|mesh-list
56696370|NCT02593734|Fluoxetine|fluoxetine|mesh-list
56696371|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56535130|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56535131|NCT02831101|Narcotics|narcotics|mesh-ancestor
56535132|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535133|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535134|NCT02831101|Analgesics|analgesics|mesh-ancestor
56535135|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
56535136|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535137|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56535138|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56535139|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
56535140|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
56535157|NCT04245787|Fluorides|fluorides|mesh-list
56535158|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
56535159|NCT04245787|Protective Agents|protective agents|mesh-ancestor
56535160|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535161|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56535162|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56535163|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535164|NCT02831179|Capecitabine|capecitabine|mesh-list
56535165|NCT02831179|Temozolomide|temozolomide|mesh-list
56535166|NCT02831179|Veliparib|veliparib|mesh-list
56535167|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56696372|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
56696373|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696374|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696375|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696376|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56696377|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56696378|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696379|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56696380|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56696381|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
56696382|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
56696383|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
56696409|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56696410|NCT00791648|Atorvastatin|atorvastatin|mesh-list
56696411|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56696412|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56696413|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
56696414|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696415|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56696416|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56696417|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696418|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
56696419|NCT05366595|Astringents|astringents|mesh-ancestor
56696420|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696421|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
56696422|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56696423|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
56696424|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696425|NCT04017338|Ezetimibe|ezetimibe|mesh-list
56696426|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56696427|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56696428|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
56473647|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535168|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
56535169|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535170|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535171|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56535172|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
56535173|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56535174|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535175|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
56535176|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
56535178|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56189334|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696429|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696455|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696456|NCT02603822|Indomethacin|indomethacin|mesh-list
56696457|NCT02603822|Mannitol|mannitol|mesh-list
56696458|NCT02603822|Lactulose|lactulose|mesh-list
56696459|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56696460|NCT02603822|Diuretics|diuretics|mesh-ancestor
56696461|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
56696462|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696463|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56696464|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56696465|NCT02603822|Analgesics|analgesics|mesh-ancestor
56696466|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
56696467|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696468|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56696469|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56696470|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
56696471|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
56696472|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56696473|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56696474|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696475|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696476|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56696477|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
56696478|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
56696479|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696480|NCT00723801|Losartan|losartan|mesh-list
56696481|NCT00723801|Atenolol|atenolol|mesh-list
56696502|NCT00797966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56696503|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56696504|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56696505|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696506|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696508|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696509|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56696510|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
56696511|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56696512|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56696513|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56696514|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696515|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56696516|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
56696517|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
56696518|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
56696519|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56696520|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696521|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696522|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56696523|NCT05361837|Analgesics|analgesics|mesh-ancestor
56696524|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
56535179|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535180|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56535181|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535182|NCT02830789|Antacids|antacids|mesh-ancestor
56535183|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56535184|NCT04243993|Calcium|calcium|mesh-list
56535185|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56535186|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535187|NCT04245319|Acitretin|acitretin|mesh-list
56535188|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
56696525|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696526|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56696527|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56696528|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56696529|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
56696530|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696531|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696566|NCT00808067|Dabigatran|dabigatran|mesh-list
56696567|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
56696568|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56696569|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
56696570|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696571|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696601|NCT04087317|Analgesics|analgesics|mesh-ancestor
56696602|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
56696603|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696604|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696605|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
56696606|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56696607|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56696608|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56696609|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56696610|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696611|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696612|NCT04309409|Nivolumab|nivolumab|mesh-list
56696613|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56696614|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696615|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56696616|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696617|NCT04086537|Hepcidins|hepcidins|mesh-list
56696646|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696647|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696648|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56696649|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
56696651|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696652|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56696653|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696654|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
56696655|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696656|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696657|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
56696658|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56696659|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56696660|NCT00807599|Growth Substances|growth substances|mesh-ancestor
56696661|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
56696662|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56696694|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
56696695|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696696|NCT00918411|Ramosetron|ramosetron|mesh-list
56696697|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
56696698|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
56696699|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535189|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
56535190|NCT02828059|Ropivacaine|ropivacaine|mesh-list
56535191|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
56535192|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
56535193|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535194|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535195|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
56535196|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535197|NCT02827903|Metformin|metformin|mesh-list
56535198|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56535199|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189356|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
56696700|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696701|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56696702|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56696703|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
56696704|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696705|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696736|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
56696737|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56696738|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696739|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696740|NCT00790868|Cycloserine|cycloserine|mesh-list
56696741|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56696742|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696743|NCT00790868|Renal Agents|renal agents|mesh-ancestor
56696744|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56696745|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
56696746|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56696747|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
56696748|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696749|NCT00719901|Bortezomib|bortezomib|mesh-list
56696750|NCT00719901|Obatoclax|obatoclax|mesh-list
56696751|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696752|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696753|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696754|NCT02603276|Red yeast rice|red yeast rice|mesh-list
56696755|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56696756|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56696757|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56696758|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
56696759|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696760|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696761|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56696762|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56696763|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
56696764|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696765|NCT00807365|Hormones|hormones|mesh-list
56696766|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56696788|NCT05748665|Anesthetics|anesthetics|mesh-ancestor
56696789|NCT04016207|Guanfacine|guanfacine|mesh-list
56696790|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56696791|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56696792|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56696793|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56696794|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
56696795|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696796|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696797|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696799|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56696800|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
56696801|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56696802|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535200|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535201|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56535202|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56535203|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
56535204|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535205|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56535206|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56535207|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535208|NCT01243424|Glimepiride|glimepiride|mesh-list
56535209|NCT01243424|Linagliptin|linagliptin|mesh-list
56535210|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56535211|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56535212|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535213|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535214|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
56535215|NCT01243424|Incretins|incretins|mesh-ancestor
56535216|NCT01243424|Hormones|hormones|mesh-ancestor
56535217|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56535218|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56535219|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
56535220|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535221|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535222|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
56535223|NCT02831023|Piperaquine|piperaquine|mesh-list
56535224|NCT02831023|Primaquine|primaquine|mesh-list
56189374|NCT01449617|Aspirin|aspirin|mesh-list
56696803|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
56696804|NCT00734604|Tadalafil|tadalafil|mesh-list
56696805|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696806|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
56696807|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56696808|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56696809|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696810|NCT00734604|Urological Agents|urological agents|mesh-ancestor
56696811|NCT00590681|Bevacizumab|bevacizumab|mesh-list
56696812|NCT00590681|Temozolomide|temozolomide|mesh-list
56696813|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56696814|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696815|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56696816|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56696817|NCT00590681|Growth Substances|growth substances|mesh-ancestor
56696818|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696848|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696849|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56696850|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696851|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56696852|NCT00727272|Analgesics|analgesics|mesh-ancestor
56696853|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
56696854|NCT02609477|Phentermine|phentermine|mesh-list
56535225|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
56535226|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56535227|NCT02831023|Amodiaquine|amodiaquine|mesh-list
56535228|NCT02831023|Artenimol|artenimol|mesh-list
56535229|NCT02831023|Methylene Blue|methylene blue|mesh-list
56535230|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
56535231|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56535232|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56535233|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189396|NCT01449799|Fluticasone|fluticasone|mesh-list
56696855|NCT02609477|Istradefylline|istradefylline|mesh-list
56696856|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56696857|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696858|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
56696859|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56696860|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
56696861|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
56696862|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696929|NCT05753189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696930|NCT05753189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56696931|NCT04088448|Metformin|metformin|mesh-list
56696978|NCT05738135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56696979|NCT05738135|Respiratory System Agents|respiratory system agents|mesh-ancestor
56696980|NCT05738135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56696981|NCT05738135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56696982|NCT05738135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696983|NCT05738135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696984|NCT05738135|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56696985|NCT05738135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56696986|NCT05738135|Purinergic Agents|purinergic agents|mesh-ancestor
56696987|NCT05738135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696988|NCT05738135|Protective Agents|protective agents|mesh-ancestor
56696989|NCT00733902|Tanezumab|tanezumab|mesh-list
56696990|NCT00733902|Analgesics|analgesics|mesh-ancestor
56697122|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56697123|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697124|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697125|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697127|NCT04085913|Epinephrine|epinephrine|mesh-list
56697218|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56697266|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697267|NCT00589667|Antiviral Agents|antiviral agents|mesh-ancestor
56697268|NCT00589667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697269|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697270|NCT00589667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56697271|NCT00589667|Immunologic Factors|immunologic factors|mesh-ancestor
56697272|NCT00589667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697273|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56697274|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56697275|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56697276|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56697277|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56697278|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697279|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697280|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
56697308|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56697309|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56697310|NCT00732498|Prednisolone|prednisolone|mesh-list
56697311|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
56697312|NCT00732498|Rituximab|rituximab|mesh-list
56697313|NCT00732498|Etoposide|etoposide|mesh-list
56697314|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56697315|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56697316|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
56697317|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56697318|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697319|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
56535234|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56535235|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535236|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535237|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56535238|NCT02831023|Renal Agents|renal agents|mesh-ancestor
56535239|NCT04244695|Dexamethasone|dexamethasone|mesh-list
56535240|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56535241|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
56535242|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
56189403|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697320|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697321|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56697322|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56697323|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56697324|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56697325|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697326|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697327|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56697328|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
56697329|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
56253072|NCT01878201|Valsartan|valsartan|mesh-list
56697429|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697430|NCT00589979|Lidocaine|lidocaine|mesh-list
56697431|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
56697432|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
56697433|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698143|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
56698144|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698145|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56698146|NCT04083417|Penicillins|penicillins|mesh-list
56698147|NCT04083417|Penicillin V|penicillin v|mesh-list
56409348|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
56698148|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698150|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
56698151|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698152|NCT04083105|Midazolam|midazolam|mesh-list
56698153|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
56698154|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56698155|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56698156|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698157|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698158|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56698159|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56698160|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56253894|NCT01884857|Metoprolol|metoprolol|mesh-list
56698594|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
56698595|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698634|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56698635|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
56699150|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56699151|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
56699152|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56699153|NCT04078659|Narcotics|narcotics|mesh-ancestor
56699154|NCT04078659|Analgesics|analgesics|mesh-ancestor
56699155|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56699156|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
56699157|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56699158|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56699159|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
56699160|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56699161|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56699162|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56699163|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56699164|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56699165|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56699166|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
56699167|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699168|NCT02583243|Buprenorphine|buprenorphine|mesh-list
56535243|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535244|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535245|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56535246|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
56535247|NCT04244695|Hormones|hormones|mesh-ancestor
56019829|NCT00462644|Fentanyl|fentanyl|mesh-list
56699169|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56699170|NCT02583243|Narcotics|narcotics|mesh-ancestor
56699171|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699172|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699173|NCT02583243|Analgesics|analgesics|mesh-ancestor
56699174|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
56699175|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699176|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56699177|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56699178|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56699179|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56699180|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699181|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699182|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699200|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56699201|NCT04078425|Diuretics|diuretics|mesh-ancestor
56699202|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
56699203|NCT00638391|Anastrozole|anastrozole|mesh-list
56699204|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56699205|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699206|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56699207|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56699208|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699209|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699210|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56699211|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
56699212|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56699213|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699215|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
56699216|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56699217|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699218|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699219|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56699220|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699221|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
56699222|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
56699223|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56699224|NCT04487067|Bevacizumab|bevacizumab|mesh-list
56699225|NCT04487067|Atezolizumab|atezolizumab|mesh-list
56699226|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56699227|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699228|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56699229|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56699230|NCT04487067|Growth Substances|growth substances|mesh-ancestor
56699231|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699232|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
56699233|NCT05353257|Carboplatin|carboplatin|mesh-list
56699234|NCT05353257|Etoposide|etoposide|mesh-list
56699235|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699236|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56699512|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
56699514|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56699515|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
56699516|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56699517|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699518|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56255136|NCT01900405|Analgesics|analgesics|mesh-ancestor
56699577|NCT02581683|Analgesics|analgesics|mesh-ancestor
56699578|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56699579|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
56699580|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56699581|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535248|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56283480|NCT00006376|Tipifarnib|tipifarnib|mesh-list
56535249|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56535250|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535251|NCT00887809|Gemcitabine|gemcitabine|mesh-list
56535252|NCT00887809|Bevacizumab|bevacizumab|mesh-list
56535253|NCT00887809|Docetaxel|docetaxel|mesh-list
56535254|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56535255|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535256|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56020158|NCT05157672|Letrozole|letrozole|mesh-list
56699582|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699583|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56699584|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
56699585|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56699586|NCT04170855|Furosemide|furosemide|mesh-list
56699587|NCT04170855|Diuretics|diuretics|mesh-ancestor
56699588|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
56699589|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699590|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56699591|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699592|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699593|NCT04076709|Anesthetics|anesthetics|mesh-list
56699594|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699595|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699596|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
56699597|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56699598|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56699599|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699603|NCT04186299|Clonidine|clonidine|mesh-list
56699604|NCT04186299|Epinephrine|epinephrine|mesh-list
56699605|NCT04186299|Carticaine|carticaine|mesh-list
56699606|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56699607|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56699608|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
56699609|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699610|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699611|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699642|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699643|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699645|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
56699646|NCT04266249|Paclitaxel|paclitaxel|mesh-list
56699647|NCT04266249|Maytansine|maytansine|mesh-list
56699648|NCT04266249|Docetaxel|docetaxel|mesh-list
56699649|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56699650|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56699651|NCT04266249|Trastuzumab|trastuzumab|mesh-list
56699652|NCT04266249|Pertuzumab|pertuzumab|mesh-list
56699653|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56699654|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56699655|NCT04266249|Antibodies|antibodies|mesh-list
56699656|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
56699657|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56699658|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
56699659|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56699660|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699665|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
56699666|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699667|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56699668|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
56699669|NCT04113005|Coagulants|coagulants|mesh-ancestor
56699670|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56699671|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
56699672|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535257|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56535258|NCT00887809|Growth Substances|growth substances|mesh-ancestor
56535259|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535260|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
56535261|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56535262|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
56699673|NCT00588341|Temozolomide|temozolomide|mesh-list
56699674|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56699675|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
56699676|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255277|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
56699999|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56700000|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700001|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700003|NCT02604719|Ethamsylate|ethamsylate|mesh-list
56700004|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56700005|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56700006|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700007|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
56700008|NCT02604719|Coagulants|coagulants|mesh-ancestor
56700009|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
56700010|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
56700011|NCT02604797|Sufentanil|sufentanil|mesh-list
56700202|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700203|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56700204|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
56700205|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700206|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700207|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56700208|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56700209|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56700210|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56700211|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
56700212|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700213|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56700214|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
56700215|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700216|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700242|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700243|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
56700244|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56700245|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700246|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56700247|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
56700248|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700249|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700250|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700251|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700252|NCT05600387|Empagliflozin|empagliflozin|mesh-list
56700253|NCT05600387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56700254|NCT05600387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700255|NCT05600387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56700256|NCT05600387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700260|NCT03725007|Upadacitinib|upadacitinib|mesh-list
56700261|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56700262|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56700361|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
56700362|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700363|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700364|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56700365|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
56700366|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56700367|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56700368|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56700369|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56700370|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535263|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535264|NCT00887809|Antiviral Agents|antiviral agents|mesh-ancestor
56535265|NCT00887809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535266|NCT00887809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535267|NCT00887809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535268|NCT00887809|Immunologic Factors|immunologic factors|mesh-ancestor
56535269|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
56535270|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
56535271|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
56535272|NCT02827747|Vitamin A|vitamin a|mesh-list
56535273|NCT02827747|Antioxidants|antioxidants|mesh-list
56535274|NCT02827747|Vitamins|vitamins|mesh-ancestor
56535275|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
56535276|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535277|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535278|NCT02827747|Protective Agents|protective agents|mesh-ancestor
56535279|NCT04281628|Ketamine|ketamine|mesh-list
56535280|NCT04281628|Analgesics|analgesics|mesh-ancestor
56535281|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
56535282|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535283|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535284|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56535285|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56535286|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
56535287|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
56189437|NCT01450163|Pregabalin|pregabalin|mesh-list
56700371|NCT00717756|Lenalidomide|lenalidomide|mesh-list
56700372|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
56700373|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700374|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56700375|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56700376|NCT00717756|Growth Substances|growth substances|mesh-ancestor
56700377|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
56700378|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700379|NCT04111289|Tirofiban|tirofiban|mesh-list
56700380|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56700381|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56700382|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700383|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56700384|NCT04108637|Penicillins|penicillins|mesh-list
56700385|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700386|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700387|NCT05674539|Vidarabine|vidarabine|mesh-list
56700388|NCT05674539|Fludarabine|fludarabine|mesh-list
56700389|NCT05674539|Fludarabine phosphate|fludarabine phosphate|mesh-list
56700390|NCT05674539|Melphalan|melphalan|mesh-list
56700391|NCT05674539|Busulfan|busulfan|mesh-list
56700392|NCT05674539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700393|NCT05674539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56700394|NCT05674539|Antimetabolites|antimetabolites|mesh-ancestor
56700395|NCT05674539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700396|NCT05674539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535288|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535289|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56535290|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56535291|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535292|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535293|NCT00886795|Abatacept|abatacept|mesh-list
56535294|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56535295|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535296|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535297|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535298|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
56189456|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56700397|NCT05674539|Immunologic Factors|immunologic factors|mesh-ancestor
56700398|NCT05674539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700399|NCT05674539|Antiviral Agents|antiviral agents|mesh-ancestor
56700715|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56700716|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56700717|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700718|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700719|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700721|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
56700722|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700723|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
56700724|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56700725|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
56700726|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56700727|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56700728|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
56700730|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700731|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700732|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700733|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700734|NCT01028443|Cyclosporine|cyclosporine|mesh-list
56700735|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
56700736|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700737|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
56700738|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700739|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700740|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700741|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
56700742|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700743|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700744|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56700745|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
56700746|NCT03116997|Neostigmine|neostigmine|mesh-list
56700747|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56700748|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700749|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700750|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
56700751|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700752|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700753|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56700754|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
56700755|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700756|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56700757|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56700791|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700792|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535299|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535300|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56535301|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
56535302|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
56535303|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56535304|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56535305|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
56535306|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535307|NCT00953680|Losartan|losartan|mesh-list
56535308|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56535309|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56535310|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56535311|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56700794|NCT01816971|Lenalidomide|lenalidomide|mesh-list
56700795|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700796|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
56700797|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
56700798|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700799|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700800|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700801|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
56700956|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56700957|NCT05457998|Flutemetamol|flutemetamol|mesh-list
56700958|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56700959|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700960|NCT00752726|Orlistat|orlistat|mesh-list
56700961|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700962|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700963|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56700964|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56700965|NCT04072497|Vaccines|vaccines|mesh-list
56700966|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
56700967|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700968|NCT04072263|Interferons|interferons|mesh-list
56700969|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
56700970|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
56700971|NCT04072263|Paclitaxel|paclitaxel|mesh-list
56701187|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701188|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701189|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56701190|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
56701191|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56701192|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701193|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56701194|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
56701195|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56701196|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
56701197|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56701198|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701199|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56701200|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56701201|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701202|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56701203|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701204|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56701205|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56701206|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
56701207|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701209|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701210|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701211|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56701212|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56535312|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56535313|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535314|NCT00953680|Diuretics|diuretics|mesh-ancestor
56535315|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
56535316|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535317|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56535318|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535319|NCT00890929|Lenalidomide|lenalidomide|mesh-list
56535320|NCT00890929|Azacitidine|azacitidine|mesh-list
56535321|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
56189483|NCT01451853|Analgesics|analgesics|mesh-ancestor
56701213|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701214|NCT00723450|Lamotrigine|lamotrigine|mesh-list
56701215|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
56701244|NCT00751400|Naproxen|naproxen|mesh-list
56701245|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56701246|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56701247|NCT00751400|Analgesics|analgesics|mesh-ancestor
56701248|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
56701249|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701250|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701251|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56701252|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56701253|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
56701254|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56701255|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701256|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701257|NCT05420948|Paclitaxel|paclitaxel|mesh-list
56701258|NCT05420948|Carboplatin|carboplatin|mesh-list
56701259|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
56701287|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56701288|NCT00720096|Topotecan|topotecan|mesh-list
56701289|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56701290|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701291|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56701292|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56701293|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701294|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701295|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56701296|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
56701297|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
56701298|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701299|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701300|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701301|NCT02577783|Dexamethasone|dexamethasone|mesh-list
56701302|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
56701303|NCT02577783|Doxorubicin|doxorubicin|mesh-list
56701304|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56701305|NCT02577783|BB 1101|bb 1101|mesh-list
56701306|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56701333|NCT04090112|Lidocaine|lidocaine|mesh-list
56701334|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
56701335|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
56701336|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701337|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701338|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
56701339|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701340|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56701341|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56701342|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56701343|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56701344|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701345|NCT00747344|Ustekinumab|ustekinumab|mesh-list
56701346|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
56535322|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535323|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56535324|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56535325|NCT00890929|Growth Substances|growth substances|mesh-ancestor
56535326|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
56535327|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634283|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535328|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56535329|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
56535330|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535331|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701347|NCT00580983|Paclitaxel|paclitaxel|mesh-list
56701348|NCT00580983|Carboplatin|carboplatin|mesh-list
56701349|NCT00580983|Fluorouracil|fluorouracil|mesh-list
56701350|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56701351|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701352|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701353|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
56701388|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701389|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
56701390|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56412575|NCT00209313|Acyclovir|acyclovir|mesh-list
56701391|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701393|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
56701394|NCT00743444|Lesogaberan|lesogaberan|mesh-list
56701430|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56701431|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56701433|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701434|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56701435|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701542|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56701568|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
56701569|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701570|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
56701571|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701572|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701573|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56701574|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56701575|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56701576|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701577|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56701578|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
56701579|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56701580|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
56701581|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56701582|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701583|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56701584|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701585|NCT00749684|Interferons|interferons|mesh-list
56701586|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701587|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
56701588|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701589|NCT02575755|Azithromycin|azithromycin|mesh-list
56701590|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
56701591|NCT02575755|Piperaquine|piperaquine|mesh-list
56701592|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
56701593|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56701594|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56701595|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701596|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
56701597|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56701631|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56701632|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56535332|NCT04246567|Fentanyl|fentanyl|mesh-list
56535333|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56535334|NCT04246567|Narcotics|narcotics|mesh-ancestor
56535335|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535336|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535337|NCT04246567|Analgesics|analgesics|mesh-ancestor
56535338|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
56535339|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535340|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56535341|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56535342|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
56535343|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
56535344|NCT02830243|Sevoflurane|sevoflurane|mesh-list
56535345|NCT02830243|Desflurane|desflurane|mesh-list
56701633|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701634|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56701635|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56701636|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
56701637|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56701638|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56701639|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56257196|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
56701657|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701658|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701659|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701660|NCT04756401|Dexamethasone|dexamethasone|mesh-list
56701661|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
56701662|NCT04756401|Daratumumab|daratumumab|mesh-list
56701664|NCT04756401|BB 1101|bb 1101|mesh-list
56701665|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56701666|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
56701667|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
56701668|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701669|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701670|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701671|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
56701672|NCT04756401|Hormones|hormones|mesh-ancestor
56701673|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56701674|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56701675|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701676|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
56701677|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701678|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701679|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
56701680|NCT00719862|Azelastine|azelastine|mesh-list
56701681|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56701682|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
56701683|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701684|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701685|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56701686|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
56701687|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56701688|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701689|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701690|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56701691|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56701692|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56701693|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
56701694|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
56701695|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701696|NCT02578953|Dutasteride|dutasteride|mesh-list
56701697|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56701698|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56535346|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56535347|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56701714|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
56701715|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701716|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701717|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701718|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56701720|NCT00742508|Protective Agents|protective agents|mesh-ancestor
56701721|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56701722|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56701723|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56701724|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
56701725|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56701726|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56701727|NCT02590614|Vitamin D|vitamin d|mesh-list
56701728|NCT02590614|Vitamins|vitamins|mesh-ancestor
56701729|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
56701730|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701731|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56701732|NCT02575443|Rocuronium|rocuronium|mesh-list
56701733|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56701734|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56701735|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56701736|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701737|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701738|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
56701739|NCT05382650|Antibodies|antibodies|mesh-list
56701740|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
56701741|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56701742|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56701743|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
56701744|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701745|NCT05297448|Rifaximin|rifaximin|mesh-list
56701746|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56701747|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701748|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701749|NCT02596334|Lamivudine|lamivudine|mesh-list
56701750|NCT02596334|Abacavir|abacavir|mesh-list
56701751|NCT02596334|Dolutegravir|dolutegravir|mesh-list
56701752|NCT02596334|Triumeq|triumeq|mesh-list
56701753|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56701754|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56701755|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701756|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701988|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701989|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701990|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56701992|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701993|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
56701994|NCT00709449|Urological Agents|urological agents|mesh-ancestor
56701995|NCT00746252|Risperidone|risperidone|mesh-list
56701996|NCT00746252|Aripiprazole|aripiprazole|mesh-list
56701997|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56413167|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56701998|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
56702182|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
56702183|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
56702184|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702185|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702186|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56702187|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56702188|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
56702189|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56702190|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56702191|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56702192|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56702193|NCT00468169|Cetuximab|cetuximab|mesh-list
56702194|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
56702195|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702196|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702197|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
56702198|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473648|NCT00523887|Analgesics|analgesics|mesh-ancestor
56535348|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
56535349|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
56535350|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535351|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535352|NCT00889603|Donepezil|donepezil|mesh-list
56535353|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56535354|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702199|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702200|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56702201|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56702202|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56702203|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
56702204|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702373|NCT02574663|Vitamins|vitamins|mesh-ancestor
56702374|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
56702375|NCT02574663|Hematinics|hematinics|mesh-ancestor
56702376|NCT04069845|Doxorubicin|doxorubicin|mesh-list
56702377|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56702378|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56702379|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702380|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56702381|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56702382|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702383|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702384|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56702385|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
56702386|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702387|NCT00710229|Bevacizumab|bevacizumab|mesh-list
56702388|NCT00710229|Ranibizumab|ranibizumab|mesh-list
56702389|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702390|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702391|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56702392|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56702393|NCT00710229|Growth Substances|growth substances|mesh-ancestor
56702394|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702395|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
56702396|NCT00715689|Hormones|hormones|mesh-list
56702397|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56702398|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702399|NCT00919542|Cyclosporine|cyclosporine|mesh-list
56702400|NCT00919542|Prednisolone|prednisolone|mesh-list
56702401|NCT00919542|Cyclosporins|cyclosporins|mesh-list
56702402|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702403|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702404|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56702405|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
56702406|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702407|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
56702408|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257937|NCT01917721|Doxycycline|doxycycline|mesh-list
56702439|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56702440|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56702441|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56702442|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702443|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702444|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
56702445|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
56702446|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
56702447|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
56702448|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
56702450|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
56702451|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
56702452|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56702453|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
56702454|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56702455|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
56702456|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56702457|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
56535355|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535356|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
56535357|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535358|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535359|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
56535360|NCT05660941|Insulin Lispro|insulin lispro|mesh-list
56535361|NCT05660941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56535362|NCT05660941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535363|NCT02829385|Apatinib|apatinib|mesh-list
56535364|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535365|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56535366|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535367|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535368|NCT02826343|Xenon|xenon|mesh-list
56535369|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56535370|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56535371|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
56535372|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
56535373|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535374|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535375|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56535376|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
56535377|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535378|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56535379|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
56535380|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
56535381|NCT02826343|Hormones|hormones|mesh-ancestor
56535382|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56535383|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
56702458|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56702633|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56702634|NCT00919776|Cyclosporine|cyclosporine|mesh-list
56702635|NCT00919776|Prednisolone|prednisolone|mesh-list
56702636|NCT00919776|Cyclosporins|cyclosporins|mesh-list
56702637|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702638|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702639|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56702640|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
56702641|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702642|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
56702643|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702644|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
56702645|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702646|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56535384|NCT05660785|Cyclosporine|cyclosporine|mesh-list
56535385|NCT05660785|Cyclosporins|cyclosporins|mesh-list
56535386|NCT05660785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535387|NCT05660785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535388|NCT05660785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535389|NCT05660785|Immunologic Factors|immunologic factors|mesh-ancestor
56535390|NCT05660785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535391|NCT05660785|Antifungal Agents|antifungal agents|mesh-ancestor
56535392|NCT05660785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535393|NCT05660785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56535394|NCT05660785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189562|NCT01455636|Micronutrients|micronutrients|mesh-list
56702647|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702648|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
56702649|NCT00919776|Hormones|hormones|mesh-ancestor
56702650|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56702651|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56702652|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702653|NCT00720135|Rituximab|rituximab|mesh-list
56702654|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56702655|NCT00720135|Interleukin-2|interleukin-2|mesh-list
56702656|NCT00720135|Antibodies|antibodies|mesh-list
56702657|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
56702658|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56702659|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
56702660|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702729|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702730|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702731|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56702733|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
56702734|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56702735|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
56702736|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702737|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
56702738|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702739|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702740|NCT00720291|Metronidazole|metronidazole|mesh-list
56702741|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702742|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56702743|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56702744|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56702745|NCT00578643|Cyclosporine|cyclosporine|mesh-list
56702746|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
56702747|NCT00578643|Busulfan|busulfan|mesh-list
56702748|NCT00578643|Fludarabine|fludarabine|mesh-list
56702749|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
56702750|NCT00578643|Cyclosporins|cyclosporins|mesh-list
56702751|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56702752|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
56702753|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702754|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702755|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56702756|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
56702757|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702758|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702759|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56702760|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702761|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
56702762|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702763|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
56702764|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56702765|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702766|NCT04082286|Antibodies|antibodies|mesh-list
56702767|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56702768|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
56702769|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535395|NCT05660785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56535396|NCT04246255|Lidocaine|lidocaine|mesh-list
56535397|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
56535398|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
56535399|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535400|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535401|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
56535402|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535404|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56702770|NCT00720447|Cytarabine|cytarabine|mesh-list
56702771|NCT00720447|Etoposide|etoposide|mesh-list
56702772|NCT00720447|Melphalan|melphalan|mesh-list
56702773|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
56702807|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56702808|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56702809|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702810|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56702811|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56702812|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702915|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702916|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56702917|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56702918|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56702919|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702920|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56702946|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56702947|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56702948|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56702949|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56702950|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56702951|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56702952|NCT00720915|Anticoagulants|anticoagulants|mesh-list
56702953|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
56702954|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56702955|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56702956|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702957|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
56702958|NCT00720915|Coagulants|coagulants|mesh-ancestor
56702959|NCT00712101|Abciximab|abciximab|mesh-list
56702960|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
56702961|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56702962|NCT00712257|Heparin|heparin|mesh-list
56702963|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
56702964|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56702965|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56702966|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702967|NCT00740792|Fluticasone|fluticasone|mesh-list
56702969|NCT00740792|Azelastine|azelastine|mesh-list
56702970|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702971|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56703012|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56703013|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703014|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703015|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56703016|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56703017|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
56703018|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703019|NCT00712491|Sirolimus|sirolimus|mesh-list
56703020|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56703021|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703022|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56703023|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703024|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
56703025|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703026|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
56703027|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703028|NCT04083066|Cytarabine|cytarabine|mesh-list
56535405|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56535406|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535407|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535408|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56535409|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
56535410|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56535411|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56535412|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
56535413|NCT05217589|Hormones|hormones|mesh-ancestor
56535414|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56535415|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535416|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535417|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535418|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
56535419|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56535420|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
56535421|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56535422|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
56535423|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535424|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535425|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
56535426|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
56703029|NCT04083066|Dexamethasone|dexamethasone|mesh-list
56703030|NCT04083066|Rituximab|rituximab|mesh-list
56703031|NCT04083066|Methotrexate|methotrexate|mesh-list
56703032|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56703033|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703034|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
56703035|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703036|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703037|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703038|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
56703039|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
56703040|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703041|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56703042|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
56703043|NCT04083066|Hormones|hormones|mesh-ancestor
56703044|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703045|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56703046|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56703047|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
56703048|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56258504|NCT01930019|Thiopental|thiopental|mesh-list
56703071|NCT00740714|Vitamins|vitamins|mesh-list
56703072|NCT00740714|Vitamin E|vitamin e|mesh-list
56703073|NCT00740714|Tocopherols|tocopherols|mesh-list
56703074|NCT00740714|Tocotrienols|tocotrienols|mesh-list
56703075|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
56703076|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
56703077|NCT00740714|Ubiquinone|ubiquinone|mesh-list
56703078|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
56703079|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703080|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
56535427|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56535428|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
56535429|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535430|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
56535431|NCT02826031|Protective Agents|protective agents|mesh-ancestor
56535432|NCT02829697|Ropivacaine|ropivacaine|mesh-list
56535433|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
56535434|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
56535435|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535436|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535437|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
56535438|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535439|NCT02829151|Aspirin|aspirin|mesh-list
56535440|NCT02829151|Cilostazol|cilostazol|mesh-list
56535441|NCT02829151|Clopidogrel|clopidogrel|mesh-list
56535442|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56703081|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703082|NCT00740714|Protective Agents|protective agents|mesh-ancestor
56703083|NCT00721773|Valsartan|valsartan|mesh-list
56703084|NCT00721773|Benazepril|benazepril|mesh-list
56703085|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56703086|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56703087|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56703088|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703089|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56703090|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
56703091|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703092|NCT05676684|Dapagliflozin|dapagliflozin|mesh-list
56703093|NCT05676684|Spironolactone|spironolactone|mesh-list
56703094|NCT05676684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56703095|NCT05676684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703096|NCT05676684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56703097|NCT05676684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703098|NCT05676684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56703099|NCT05676684|Hormone Antagonists|hormone antagonists|mesh-ancestor
56703100|NCT05676684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703101|NCT05676684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56703102|NCT05676684|Diuretics|diuretics|mesh-ancestor
56703173|NCT05615051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56703174|NCT05615051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703175|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56703176|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56703177|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56703178|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
56703179|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703180|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703181|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703182|NCT00795509|Urological Agents|urological agents|mesh-ancestor
56703183|NCT02603003|Pemetrexed|pemetrexed|mesh-list
56703184|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703185|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258650|NCT01930812|Listerine|listerine|mesh-list
56703206|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56703207|NCT05656599|Letermovir|letermovir|mesh-list
56703208|NCT05656599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56703209|NCT05656599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703210|NCT05656599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703211|NCT05656599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535443|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56535444|NCT02829151|Analgesics|analgesics|mesh-ancestor
56535445|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
56703212|NCT05656599|Antiviral Agents|antiviral agents|mesh-ancestor
56703213|NCT05656599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703214|NCT00787787|Capecitabine|capecitabine|mesh-list
56703215|NCT00787787|Sunitinib|sunitinib|mesh-list
56703216|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56703217|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
56703218|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703219|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703220|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56703221|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56703222|NCT00787787|Growth Substances|growth substances|mesh-ancestor
56703223|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703224|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
56703225|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56703226|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703227|NCT05590793|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56703228|NCT05590793|Luteolytic Agents|luteolytic agents|mesh-ancestor
56703229|NCT05590793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56703230|NCT05590793|Contraceptive Agents|contraceptive agents|mesh-ancestor
56703231|NCT05590793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56703232|NCT05590793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703233|NCT05590793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56703234|NCT05590793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56703235|NCT05590793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703236|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
56703237|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56703260|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
56703261|NCT02604095|Melatonin|melatonin|mesh-list
56703262|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
56703263|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703264|NCT02604095|Protective Agents|protective agents|mesh-ancestor
56703265|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703266|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56703267|NCT02571543|Ibuprofen|ibuprofen|mesh-list
56703268|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56703269|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56703270|NCT02571543|Analgesics|analgesics|mesh-ancestor
56703271|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
56703272|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703273|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703274|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703275|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703276|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56703277|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703278|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703279|NCT05583617|Lenalidomide|lenalidomide|mesh-list
56703280|NCT05583617|Immunologic Factors|immunologic factors|mesh-ancestor
56703281|NCT05583617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703282|NCT05583617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56703283|NCT05583617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56703284|NCT05583617|Growth Substances|growth substances|mesh-ancestor
56703285|NCT05583617|Growth Inhibitors|growth inhibitors|mesh-ancestor
56703286|NCT05583617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703287|NCT00713193|Cyclosporine|cyclosporine|mesh-list
56703288|NCT00713193|Prednisone|prednisone|mesh-list
56703289|NCT00713193|Cyclosporins|cyclosporins|mesh-list
56703290|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703291|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
56703292|NCT00713193|Hormones|hormones|mesh-ancestor
56703337|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703338|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56703339|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
56703340|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703341|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56703342|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56703343|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56703344|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703345|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56703346|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56189620|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703347|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56703348|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56703349|NCT00713271|AZD-3199|azd-3199|mesh-list
56703350|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56703351|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56703352|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56703353|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
56703401|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56703403|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703404|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703405|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56703406|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
56703407|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56703408|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
56703409|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703410|NCT02586636|Metformin|metformin|mesh-list
56703411|NCT02586636|Omeprazole|omeprazole|mesh-list
56703412|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56703413|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703414|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56703415|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56703416|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56703417|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703418|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703419|NCT00713739|Prazosin|prazosin|mesh-list
56703420|NCT00713739|Doxazosin|doxazosin|mesh-list
56703421|NCT00713739|Nifedipine|nifedipine|mesh-list
56703422|NCT00713739|Alfuzosin|alfuzosin|mesh-list
56703423|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56703424|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56703425|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703426|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56703427|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703428|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
56703429|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
56258895|NCT01932320|Ketoconazole|ketoconazole|mesh-list
56703451|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
56703452|NCT02586402|Hematinics|hematinics|mesh-ancestor
56703453|NCT00734630|Losartan|losartan|mesh-list
56703454|NCT00734630|Lisinopril|lisinopril|mesh-list
56703455|NCT00734630|Nebivolol|nebivolol|mesh-list
56703456|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56703457|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56703458|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56703459|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56703460|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703461|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56703462|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
56703463|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703464|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56703465|NCT00734630|Protective Agents|protective agents|mesh-ancestor
56703466|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703467|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
56703468|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56703469|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56703470|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56703471|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
56703472|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703473|NCT05636514|Decitabine|decitabine|mesh-list
56703474|NCT05636514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56703475|NCT05636514|Antimetabolites|antimetabolites|mesh-ancestor
56703476|NCT05636514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703477|NCT05636514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703478|NCT05636514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703479|NCT04586010|Teriflunomide|teriflunomide|mesh-list
56703480|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56703481|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56703482|NCT04586010|Analgesics|analgesics|mesh-ancestor
56703483|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
56703484|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703519|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
56703520|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56703521|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535446|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535447|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703522|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56703523|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56703524|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56703525|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703526|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56703559|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
56703560|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56703561|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703562|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
56703563|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703564|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56703566|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56703567|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56703568|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
56703616|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
56703617|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
56703618|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
56703619|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
56703620|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56703621|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703623|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56703624|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
56703625|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56703626|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56703627|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703628|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56703629|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56703630|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56703631|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703632|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56703633|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56703634|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56703635|NCT02570841|Capsaicin|capsaicin|mesh-list
56703636|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
56703637|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
56703638|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
56703639|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703640|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703641|NCT04067037|Vincristine|vincristine|mesh-list
56703642|NCT04067037|Epirubicin|epirubicin|mesh-list
56703643|NCT04067037|Dacarbazine|dacarbazine|mesh-list
56703644|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56703645|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703646|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
56703647|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
56703648|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
56703649|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703650|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56703651|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56703652|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56703653|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703654|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56703655|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
56703656|NCT04730544|Nivolumab|nivolumab|mesh-list
56414832|NCT00189371|Paclitaxel|paclitaxel|mesh-list
56703657|NCT04730544|Ipilimumab|ipilimumab|mesh-list
56703658|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56703659|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703660|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56703661|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703662|NCT04666038|Rituximab|rituximab|mesh-list
56703663|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56703664|NCT04666038|Idelalisib|idelalisib|mesh-list
56703665|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56703666|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703681|NCT04956627|Phenytoin|phenytoin|mesh-list
56703682|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
56703683|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
56703684|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059852|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56535448|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56535449|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56535450|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56535451|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56535452|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535453|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56535454|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56189625|NCT01459445|Metformin|metformin|mesh-list
56703685|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56703686|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56703687|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703688|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703689|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56703690|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
56703691|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703692|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703693|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56703694|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
56703695|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56703696|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56703697|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56703698|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56703699|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56703700|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56703701|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
56703702|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56703703|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56703704|NCT00920088|Ritonavir|ritonavir|mesh-list
56703705|NCT00920088|Lopinavir|lopinavir|mesh-list
56703706|NCT00920088|Darunavir|darunavir|mesh-list
56703707|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
56703708|NCT00920088|Midazolam|midazolam|mesh-list
56703709|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
56703710|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56703711|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56703712|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56703713|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703714|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56703715|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56703716|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56703717|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56703718|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
56703719|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
56703720|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
56703721|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
56703722|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703723|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703724|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56703725|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56703726|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
56703750|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56703751|NCT04018833|Growth Substances|growth substances|mesh-ancestor
56703752|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703753|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
56703754|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703756|NCT04066803|Hematinics|hematinics|mesh-ancestor
56703757|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
56703758|NCT04066803|Vitamins|vitamins|mesh-ancestor
56703759|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
56703760|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703761|NCT04921371|Listerine|listerine|mesh-list
56703762|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56703763|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703764|NCT03149211|UB-421|ub-421|mesh-list
56703765|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56703766|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
56703767|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535455|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535456|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
56535457|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56535458|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56535459|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56535460|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
56535461|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535462|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56535463|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
56535464|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56535465|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
56535466|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
56535467|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56535468|NCT02829151|Protective Agents|protective agents|mesh-ancestor
56703768|NCT00725439|R 115866|r 115866|mesh-list
56703769|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56703770|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703771|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703772|NCT03205761|Olaparib|olaparib|mesh-list
56703773|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56703774|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703775|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703776|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703777|NCT00725517|Icodextrin|icodextrin|mesh-list
56703778|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
56703779|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56703837|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703838|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56703839|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56703840|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703841|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56703842|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56703843|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703844|NCT02583438|Saxagliptin|saxagliptin|mesh-list
56703845|NCT02583438|Incretins|incretins|mesh-ancestor
56703846|NCT02583438|Hormones|hormones|mesh-ancestor
56703847|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703848|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703849|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56703850|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
56703851|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703852|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703853|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56703854|NCT02603861|Modafinil|modafinil|mesh-list
56703855|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56703856|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703857|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56703858|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56703859|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56703860|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703861|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
56703862|NCT02569905|Parecoxib|parecoxib|mesh-list
56703863|NCT02569905|Analgesics|analgesics|mesh-ancestor
56703864|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
56703865|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703866|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703867|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56703868|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56535469|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56535470|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56535471|NCT05660395|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56535472|NCT05660395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56535473|NCT05660395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703908|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56703909|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56703910|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
56703911|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703912|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
56703913|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56703914|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56703915|NCT04110275|Plasminogen|plasminogen|mesh-list
56703916|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56703917|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56703918|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56703919|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703920|NCT04250883|Iodine|iodine|mesh-list
56703921|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56703922|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703923|NCT04250883|Trace Elements|trace elements|mesh-ancestor
56703924|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
56703925|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703926|NCT04469634|Antibodies|antibodies|mesh-list
56703927|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
56703928|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703929|NCT04209543|Progesterone|progesterone|mesh-list
56703930|NCT04209543|Progestins|progestins|mesh-ancestor
56703931|NCT04209543|Hormones|hormones|mesh-ancestor
56703932|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703933|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703934|NCT04465500|Androgens|androgens|mesh-list
56703935|NCT04465500|Hormones|hormones|mesh-ancestor
56703936|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703937|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703938|NCT04080726|Esomeprazole|esomeprazole|mesh-list
56703939|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56703940|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56703941|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56703942|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703943|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703944|NCT04639986|Gemcitabine|gemcitabine|mesh-list
56703963|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56703964|NCT04126317|Growth Substances|growth substances|mesh-ancestor
56703965|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703966|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
56703967|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703968|NCT02583516|Vemurafenib|vemurafenib|mesh-list
56703969|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703970|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56703971|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703972|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703973|NCT00790907|Heparin|heparin|mesh-list
56703974|NCT00790907|PENTA|penta|mesh-list
56703975|NCT00790907|Fondaparinux|fondaparinux|mesh-list
56703976|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
56703977|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56703978|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56703979|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703980|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56703981|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
56703982|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56703983|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
56703984|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703985|NCT05429268|Lenalidomide|lenalidomide|mesh-list
56703986|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
56703987|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703988|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56703989|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56535474|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
56535475|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
56535476|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56535477|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56535478|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535480|NCT02825719|Coagulants|coagulants|mesh-ancestor
56535481|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56535482|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
56535483|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56535484|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535485|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56535486|NCT04241653|Sevoflurane|sevoflurane|mesh-list
56535487|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56703990|NCT05429268|Growth Substances|growth substances|mesh-ancestor
56703991|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
56703992|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703993|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56703994|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56703995|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
56703996|NCT04066179|Prednisolone|prednisolone|mesh-list
56703997|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703998|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
56703999|NCT04066179|Hormones|hormones|mesh-ancestor
56704000|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704001|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704061|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56704062|NCT00793871|Growth Substances|growth substances|mesh-ancestor
56704063|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704064|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
56704065|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56704066|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704067|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704069|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56704070|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
56704071|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704072|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704073|NCT00727233|Sorafenib|sorafenib|mesh-list
56704074|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704075|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56704076|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704077|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704078|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
56704277|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704278|NCT00728559|Bupivacaine|bupivacaine|mesh-list
56704279|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
56704280|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
56704281|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704282|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704283|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
56704284|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704285|NCT00735813|Heparin|heparin|mesh-list
56704286|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
56704287|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56704288|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56704289|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704318|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
56704319|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704320|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704321|NCT00731289|Triamcinolone|triamcinolone|mesh-list
56535488|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56535489|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
56535490|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
56535491|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535492|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535493|NCT04241731|Cetuximab|cetuximab|mesh-list
56535494|NCT04241731|Raltitrexed|raltitrexed|mesh-list
56535495|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56535496|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535497|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56535498|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
56535499|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535500|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56535501|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535502|NCT04241887|Anesthetics|anesthetics|mesh-list
56535503|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535504|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535505|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56535506|NCT02825797|Antibodies|antibodies|mesh-list
56535507|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
56535508|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56535509|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
56535510|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704322|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56704323|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56704324|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
56704325|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56704326|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704327|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
56704328|NCT00731289|Hormones|hormones|mesh-ancestor
56704329|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704330|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704331|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704332|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
56704333|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704334|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259806|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
56704366|NCT05601531|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56704367|NCT05601531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56704368|NCT05601531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704369|NCT05601531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56704370|NCT05601531|Vitamins|vitamins|mesh-ancestor
56704371|NCT05601531|Micronutrients|micronutrients|mesh-ancestor
56704372|NCT05601531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56704373|NCT02569125|Everolimus|everolimus|mesh-list
56704374|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704375|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704376|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
56704377|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704378|NCT00731601|Pantoprazole|pantoprazole|mesh-list
56704379|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56535511|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535512|NCT02824315|Simeprevir|simeprevir|mesh-list
56535513|NCT02824315|Odalasvir|odalasvir|mesh-list
56535514|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
56535515|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535516|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
56535517|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535518|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535519|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
56535520|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535521|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
56535522|NCT02823925|Pamidronate|pamidronate|mesh-list
56535523|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56535524|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535525|NCT05659927|Antibodies|antibodies|mesh-list
56535526|NCT05659927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56535527|NCT05659927|Immunologic Factors|immunologic factors|mesh-ancestor
56704380|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56704381|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56704382|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704383|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704384|NCT00736905|Rilpivirine|rilpivirine|mesh-list
56704406|NCT00729339|Mosapride|mosapride|mesh-list
56704408|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56704409|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
56704410|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704411|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704412|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704413|NCT00737139|Epinephrine|epinephrine|mesh-list
56704414|NCT00737139|Bupivacaine|bupivacaine|mesh-list
56704415|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56704416|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56704417|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
56704418|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704419|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704420|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704421|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56704422|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56704423|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
56704424|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704425|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56704426|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
56704427|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
56704428|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
56704429|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56704430|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
56704431|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
56704432|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704433|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
56704434|NCT00732147|Pramlintide|pramlintide|mesh-list
56704435|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56704436|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704526|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704527|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704528|NCT00737997|Analgesics|analgesics|mesh-ancestor
56704529|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
56704530|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704531|NCT00732927|Aspirin|aspirin|mesh-list
56704532|NCT00732927|Parnaparin|parnaparin|mesh-list
56704533|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56535528|NCT05659927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535529|NCT04201249|Piroxicam|piroxicam|mesh-list
56535530|NCT04201249|Lidocaine|lidocaine|mesh-list
56535531|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
56535532|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
56535533|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535534|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535535|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
56535536|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535537|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56535538|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56535539|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56535540|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535541|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535542|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56535543|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56535544|NCT04201249|Analgesics|analgesics|mesh-ancestor
56704534|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56704535|NCT00732927|Analgesics|analgesics|mesh-ancestor
56704536|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
56704537|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704538|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704539|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704540|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704541|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56704542|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56704543|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704544|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56704545|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56704546|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704547|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
56704548|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
56704549|NCT00733083|Dexamethasone|dexamethasone|mesh-list
56704550|NCT00733083|Morphine|morphine|mesh-list
56704551|NCT00733083|Oxycodone|oxycodone|mesh-list
56704552|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704553|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
56704554|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
56704555|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56415699|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56704556|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704557|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56704558|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
56704559|NCT00733083|Hormones|hormones|mesh-ancestor
56704560|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704561|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56704562|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704563|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56704564|NCT00733083|Narcotics|narcotics|mesh-ancestor
56704565|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704566|NCT00733083|Analgesics|analgesics|mesh-ancestor
56260018|NCT01939054|Docetaxel|docetaxel|mesh-list
56704590|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56704591|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56704592|NCT00738621|Dexamethasone|dexamethasone|mesh-list
56704593|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
56704594|NCT00738621|Ondansetron|ondansetron|mesh-list
56704595|NCT00738621|Aprepitant|aprepitant|mesh-list
56535545|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704596|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
56704597|NCT00738621|BB 1101|bb 1101|mesh-list
56704598|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704599|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
56704600|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
56704601|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704602|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704603|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56704604|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
56704605|NCT00738621|Hormones|hormones|mesh-ancestor
56704606|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704607|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56704608|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704609|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
56704610|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704611|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704612|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
56704613|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
56704614|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56704615|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
56704616|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704617|NCT00738621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56260077|NCT01939379|Acetaminophen|acetaminophen|mesh-list
56704697|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
56704698|NCT00733317|Hormones|hormones|mesh-ancestor
56704699|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704700|NCT02568735|Etoricoxib|etoricoxib|mesh-list
56704701|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56704702|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56704703|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56704704|NCT02568735|Analgesics|analgesics|mesh-ancestor
56704705|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
56704706|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704707|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704708|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704709|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704710|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56704711|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56704870|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
56704871|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704872|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704873|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704874|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704875|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704876|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
56704877|NCT05714865|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56704878|NCT05714865|Respiratory System Agents|respiratory system agents|mesh-ancestor
56704879|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
56704880|NCT02583828|Letrozole|letrozole|mesh-list
56704881|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704882|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
56704883|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704884|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704885|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56704886|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
56704887|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704888|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704889|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56704890|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56704891|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56704892|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704893|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56704894|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
56260349|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56704932|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
56704933|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705072|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705073|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
56705074|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705075|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
56705076|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
56705077|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56705078|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56535546|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56535547|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56535548|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283778|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535550|NCT00633685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56535551|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56535552|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535553|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535554|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535555|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
56535556|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535557|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56535558|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
56535559|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56535560|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56535561|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56535562|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535563|NCT02823691|Metformin|metformin|mesh-list
56535564|NCT02823691|Lanreotide|lanreotide|mesh-list
56535565|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56535566|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535567|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535568|NCT02825095|Lidocaine|lidocaine|mesh-list
56535569|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
56535570|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
56535571|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535572|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535573|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
56535574|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535575|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56535576|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56535577|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56535578|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535580|NCT04195009|Anesthetics|anesthetics|mesh-list
56535583|NCT05660083|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56535584|NCT05660083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535585|NCT05660083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535586|NCT02822131|Sevelamer|sevelamer|mesh-list
56535587|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
56535588|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
56535589|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535590|NCT04239625|Vitamin A|vitamin a|mesh-list
56535591|NCT04239625|Retinol acetate|retinol acetate|mesh-list
56535592|NCT04239625|Vitamins|vitamins|mesh-ancestor
56535593|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
56535594|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535595|NCT04239625|Protective Agents|protective agents|mesh-ancestor
56535596|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56535597|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535598|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56535599|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
56535600|NCT02821897|Anesthetics|anesthetics|mesh-list
56535601|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535602|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535603|NCT02820493|Vedolizumab|vedolizumab|mesh-list
56535604|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56535605|NCT05659459|Pioglitazone|pioglitazone|mesh-list
56535606|NCT05659459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56535607|NCT05659459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535608|NCT02820259|Tacrolimus|tacrolimus|mesh-list
56535609|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535610|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
56535611|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535612|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56535613|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535614|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535615|NCT00633763|Fallypride|fallypride|mesh-list
56535616|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56535617|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56705079|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56705080|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
56705081|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
56705082|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705083|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705084|NCT00740415|Dexamethasone|dexamethasone|mesh-list
56535618|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
56535619|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535620|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535621|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535622|NCT02820025|Doxapram|doxapram|mesh-list
56283854|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
56535623|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56535624|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535625|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
56535626|NCT02819869|Metformin|metformin|mesh-list
56535627|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56535628|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535629|NCT02820883|Vaccines|vaccines|mesh-list
56535630|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
56535631|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535632|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
56535633|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56535634|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535635|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535636|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56705085|NCT00740415|Rituximab|rituximab|mesh-list
56705086|NCT00740415|Bortezomib|bortezomib|mesh-list
56705087|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56705088|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705089|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705091|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705092|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56705093|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56705094|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
56705095|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
56705096|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705097|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56705098|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
56705099|NCT00740415|Hormones|hormones|mesh-ancestor
56705100|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56705101|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56705102|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56705103|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
56705135|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56705136|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56705137|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56705138|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705139|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56705140|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56705141|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
56705142|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56705143|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56705144|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56705145|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
56705146|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705147|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
56705148|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56705149|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705150|NCT02593526|Bumetanide|bumetanide|mesh-list
56535637|NCT02819089|Analgesics|analgesics|mesh-ancestor
56535638|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
56535639|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535640|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56535641|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56705151|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
56705152|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56705153|NCT02593526|Diuretics|diuretics|mesh-ancestor
56705154|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
56705155|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705156|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56705157|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56705158|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705159|NCT04339140|Zafirlukast|zafirlukast|mesh-list
56705160|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56705161|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
56705162|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56705163|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
56705164|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56705165|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705166|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
56705167|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
56705540|NCT05674656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705541|NCT05674656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56705542|NCT05674656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56705543|NCT02567799|Paclitaxel|paclitaxel|mesh-list
56705544|NCT02567799|Carboplatin|carboplatin|mesh-list
56705545|NCT02567799|Genistein|genistein|mesh-list
56705546|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56705547|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705548|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
56705549|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
56705550|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
56705551|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705552|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56705553|NCT02567799|Protective Agents|protective agents|mesh-ancestor
56705554|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705555|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56705556|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705557|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
56705558|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56705559|NCT02567799|Estrogens|estrogens|mesh-ancestor
56705560|NCT02567799|Hormones|hormones|mesh-ancestor
56705561|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56705562|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
56705563|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56705564|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
56705565|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705566|NCT00921219|Ivermectin|ivermectin|mesh-list
56705567|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56705568|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705569|NCT02567331|Capecitabine|capecitabine|mesh-list
56260987|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
56705605|NCT00698841|Cetuximab|cetuximab|mesh-list
56705606|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705607|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705608|NCT03789240|Rituximab|rituximab|mesh-list
56261040|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
56705718|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705719|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
56705720|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705722|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56705723|NCT04064073|Metformin|metformin|mesh-list
56705724|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56705725|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705726|NCT04137354|Vitamins|vitamins|mesh-list
56705727|NCT04137354|Vitamin A|vitamin a|mesh-list
56705728|NCT04137354|Iron|iron|mesh-list
56705729|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
56705730|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
56060859|NCT01611571|Teriparatide|teriparatide|mesh-list
56535642|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56535643|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
56535644|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535645|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535646|NCT04657003|Tirzepatide|tirzepatide|mesh-list
56535647|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56535648|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535649|NCT04657003|Incretins|incretins|mesh-ancestor
56535650|NCT04657003|Hormones|hormones|mesh-ancestor
56535651|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56535652|NCT04238923|Vancomycin|vancomycin|mesh-list
56535653|NCT04238923|Gentamicins|gentamicins|mesh-list
56535654|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56535655|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535656|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56535657|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535658|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535659|NCT05659537|Dulaglutide|dulaglutide|mesh-list
56535660|NCT05659537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56535661|NCT05659537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535662|NCT02815657|Valsartan|valsartan|mesh-list
56535663|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56189825|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
56705731|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705732|NCT04137354|Trace Elements|trace elements|mesh-ancestor
56705733|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
56705734|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705735|NCT04137354|Protective Agents|protective agents|mesh-ancestor
56705736|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56705852|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56705853|NCT00737048|Acetaminophen|acetaminophen|mesh-list
56705854|NCT00737048|Tramadol|tramadol|mesh-list
56705855|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56705856|NCT00737048|Analgesics|analgesics|mesh-ancestor
56706175|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706176|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56706177|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56706178|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56706180|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56706181|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706182|NCT00729326|Incretins|incretins|mesh-ancestor
56706183|NCT00729326|Hormones|hormones|mesh-ancestor
56706184|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706185|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56706186|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
56706187|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706188|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706189|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56706190|NCT02565303|Ropivacaine|ropivacaine|mesh-list
56706191|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
56706192|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
56706193|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535664|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56535665|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56025021|NCT00703976|Bevacizumab|bevacizumab|mesh-list
56706194|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706330|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56706331|NCT00695955|Diuretics|diuretics|mesh-ancestor
56706332|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
56706333|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706334|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56706335|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706336|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706337|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56706338|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56706339|NCT00693225|Omeprazole|omeprazole|mesh-list
56706340|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56706341|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56706342|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56706343|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56706344|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706345|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706346|NCT00735644|Vaccines|vaccines|mesh-list
56706347|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
56706348|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706349|NCT02591888|Bupivacaine|bupivacaine|mesh-list
56417505|NCT00207675|Infliximab|infliximab|mesh-list
56706350|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
56706351|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
56261755|NCT05411887|Olmesartan|olmesartan|mesh-list
56706410|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706411|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
56706412|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706413|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56706414|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
56706415|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706417|NCT00742911|Disulfiram|disulfiram|mesh-list
56706418|NCT00742911|Trace Elements|trace elements|mesh-ancestor
56706419|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
56706420|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706487|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56706488|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706489|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706491|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706492|NCT00720356|Bevacizumab|bevacizumab|mesh-list
56706493|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56706494|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56706495|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706496|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56706529|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
56706530|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706532|NCT00746031|Cetrorelix|cetrorelix|mesh-list
56706533|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56706958|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
56706959|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706960|NCT04085120|Dexamethasone|dexamethasone|mesh-list
56706961|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
56706962|NCT04085120|Lidocaine|lidocaine|mesh-list
56706963|NCT04085120|Ropivacaine|ropivacaine|mesh-list
56706964|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56706965|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
56706966|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
56706967|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706968|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706969|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56706970|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
56706971|NCT04085120|Hormones|hormones|mesh-ancestor
56706972|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706973|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56706974|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262367|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
56707072|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56707073|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707074|NCT00749385|Analgesics|analgesics|mesh-ancestor
56535666|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707075|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
56707076|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707077|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707078|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707313|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707314|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707315|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707316|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
56707317|NCT00755859|Hormones|hormones|mesh-ancestor
56707318|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707319|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56707320|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56262731|NCT04524663|Camostat|camostat|mesh-list
56707414|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56707415|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56707416|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56707417|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
56707418|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707419|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56707420|NCT00718640|Dexamethasone|dexamethasone|mesh-list
56707421|NCT00718640|Bortezomib|bortezomib|mesh-list
56707422|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707423|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
56707424|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
56707425|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707426|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262829|NCT03783013|Lycopene|lycopene|mesh-list
56707520|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56707521|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
56707522|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707523|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707524|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56707525|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707526|NCT00756873|Etoricoxib|etoricoxib|mesh-list
56707527|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56707528|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707529|NCT00756873|Analgesics|analgesics|mesh-ancestor
56707530|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
56707531|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707532|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707533|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707534|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707535|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56707536|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56707572|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707573|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56707574|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
56707575|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707606|NCT02589782|Bedaquiline|bedaquiline|mesh-list
56707607|NCT02589782|Clofazimine|clofazimine|mesh-list
56707608|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56707609|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707610|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56707611|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56707612|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707613|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707614|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707615|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56707616|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
56707617|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707618|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
56707619|NCT00918554|Methotrexate|methotrexate|mesh-list
56707655|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707657|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56707688|NCT02589158|Darunavir|darunavir|mesh-list
56707689|NCT02589158|Cobicistat|cobicistat|mesh-list
56707690|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56707691|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56707692|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
56707693|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707694|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707695|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56535667|NCT04597333|Dinoprostone|dinoprostone|mesh-list
56535668|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
56707696|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56707697|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
56707698|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707699|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56707700|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56707701|NCT00916253|Modafinil|modafinil|mesh-list
56707702|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56707769|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
56707770|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707771|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707772|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707773|NCT02561169|Oseltamivir|oseltamivir|mesh-list
56707774|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
56707775|NCT02561169|Antacids|antacids|mesh-ancestor
56707776|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707777|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707778|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
56707779|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707780|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707781|NCT00753597|Rituximab|rituximab|mesh-list
56707782|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56707783|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707784|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
56707785|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707786|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707787|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
56707788|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56707789|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707790|NCT00757419|Lesogaberan|lesogaberan|mesh-list
56707791|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707792|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56707793|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
56707794|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
56707795|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707796|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707797|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707798|NCT00757731|Milnacipran|milnacipran|mesh-list
56707799|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
56707800|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56707801|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56707802|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56707803|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707804|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707805|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707806|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707807|NCT00757731|Analgesics|analgesics|mesh-ancestor
56707808|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
56707809|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707810|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
56707811|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56707812|NCT00753909|Paclitaxel|paclitaxel|mesh-list
56707813|NCT00753909|Bevacizumab|bevacizumab|mesh-list
56707814|NCT00753909|Carboplatin|carboplatin|mesh-list
56707815|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56707816|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707817|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
56707818|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
56707847|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56707848|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
56707849|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707850|NCT05266040|Valacyclovir|valacyclovir|mesh-list
56707851|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
56707852|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707853|NCT00773747|Bortezomib|bortezomib|mesh-list
56707854|NCT00773747|Vorinostat|vorinostat|mesh-list
56707855|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707856|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56707857|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707858|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707900|NCT05684744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707901|NCT05684744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56707902|NCT02588534|Etanercept|etanercept|mesh-list
56535669|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56535670|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535671|NCT00957580|Niacinamide|niacinamide|mesh-list
56535672|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
56535673|NCT00957580|Vitamins|vitamins|mesh-ancestor
56535674|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
56535675|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535676|NCT00957424|Nicotine|nicotine|mesh-list
56535677|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56535678|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
56535679|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535680|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535681|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56535682|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56535683|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
56535684|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535685|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535686|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
56535687|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56535688|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535689|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535690|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56535691|NCT02818621|Analgesics|analgesics|mesh-ancestor
56535692|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
56535693|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535694|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56535695|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56535696|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56535697|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
56535698|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535699|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707903|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56707904|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707905|NCT02588534|Analgesics|analgesics|mesh-ancestor
56707906|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
56707934|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707935|NCT00682929|Analgesics|analgesics|mesh-ancestor
56707936|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
56707937|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707938|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56707939|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56535700|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
56535701|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56535702|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535703|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535704|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56535705|NCT04642651|Analgesics|analgesics|mesh-ancestor
56535706|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
56535707|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535708|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56535709|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56535710|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56535711|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
56535712|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535713|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535714|NCT01061151|Ritonavir|ritonavir|mesh-list
56535715|NCT01061151|Lopinavir|lopinavir|mesh-list
56535716|NCT01061151|Tenofovir|tenofovir|mesh-list
56535717|NCT01061151|Lamivudine|lamivudine|mesh-list
56535718|NCT01061151|Zidovudine|zidovudine|mesh-list
56707940|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707941|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707942|NCT00682929|Hormones|hormones|mesh-ancestor
56707943|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707944|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
56707945|NCT00758199|Prednisolone|prednisolone|mesh-list
56707946|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56707947|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
56707948|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56707949|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
56707950|NCT00758199|Bromfenac|bromfenac|mesh-list
56707951|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56707952|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56708023|NCT05428293|Ibuprofen|ibuprofen|mesh-list
56708024|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56708025|NCT05428293|Analgesics|analgesics|mesh-ancestor
56708026|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
56708055|NCT00754689|Hormones|hormones|mesh-ancestor
56708056|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708057|NCT00767819|Everolimus|everolimus|mesh-list
56708058|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708059|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708060|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
56708061|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708062|NCT00758277|Levetiracetam|levetiracetam|mesh-list
56708063|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
56708064|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
56708065|NCT00584870|Naproxen|naproxen|mesh-list
56708066|NCT00584870|Tanezumab|tanezumab|mesh-list
56708067|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56708068|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56708069|NCT00584870|Analgesics|analgesics|mesh-ancestor
56708070|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
56263470|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
56708142|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56708144|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56708145|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708146|NCT00755157|Bevacizumab|bevacizumab|mesh-list
56708172|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
56535719|NCT01061151|Emtricitabine|emtricitabine|mesh-list
56535720|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56535721|NCT01061151|Nevirapine|nevirapine|mesh-list
56535722|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56535723|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56535724|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56535725|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
56535726|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535727|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025940|NCT00744380|Midazolam|midazolam|mesh-list
56708173|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708174|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708175|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708176|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708177|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56708178|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56708179|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
56708180|NCT00755313|Carboplatin|carboplatin|mesh-list
56708182|NCT00755313|Doxorubicin|doxorubicin|mesh-list
56708183|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56708184|NCT00755313|Trastuzumab|trastuzumab|mesh-list
56708185|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56708186|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56708187|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708188|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
56708189|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708190|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708191|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56708192|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
56708193|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708194|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708195|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56708196|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
56708197|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708233|NCT05683574|Cyclobenzaprine|cyclobenzaprine|mesh-list
56708234|NCT05683574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56708235|NCT05683574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56708236|NCT05683574|Analgesics|analgesics|mesh-ancestor
56263650|NCT01949168|Ribavirin|ribavirin|mesh-list
56708250|NCT05683574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56708251|NCT05683574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56708252|NCT05683574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56708253|NCT05683574|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56708254|NCT05683574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56708255|NCT05683574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56708256|NCT05683574|Adrenergic Agents|adrenergic agents|mesh-ancestor
56708257|NCT05683574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708258|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
56708259|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708260|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708261|NCT00679029|Gemcitabine|gemcitabine|mesh-list
56708262|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
56708263|NCT00679029|Bevacizumab|bevacizumab|mesh-list
56708264|NCT00679029|Doxorubicin|doxorubicin|mesh-list
56708265|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56708266|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56708267|NCT00679029|Antibodies|antibodies|mesh-list
56708268|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
56708269|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56708270|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708271|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708272|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708273|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
56708274|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708275|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56535728|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56535729|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56535730|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
56535731|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708276|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56708277|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
56708278|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56708279|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56708280|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56708281|NCT00679029|Growth Substances|growth substances|mesh-ancestor
56708282|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
56708283|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56708284|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
56708285|NCT00679029|Antiviral Agents|antiviral agents|mesh-ancestor
56708286|NCT00679029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708287|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708288|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56708289|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56708290|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56708291|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
56708292|NCT00919022|Cyproterone|cyproterone|mesh-list
56708293|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
56708294|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
56708295|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708296|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708328|NCT05122221|Analgesics|analgesics|mesh-ancestor
56708329|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
56708330|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708331|NCT03802305|Anesthetics|anesthetics|mesh-list
56708332|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56708333|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708334|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56708335|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56708336|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
56708337|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708338|NCT02587052|Tacrolimus|tacrolimus|mesh-list
56263752|NCT01949818|Hormones|hormones|mesh-ancestor
56708357|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708358|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708359|NCT02559141|Dobutamine|dobutamine|mesh-list
56708360|NCT02559141|Norepinephrine|norepinephrine|mesh-list
56708361|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56708362|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56708363|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
56708364|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708365|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708366|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708367|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
56708368|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
56708369|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708370|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56708371|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56708372|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56708373|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56708374|NCT02559141|Protective Agents|protective agents|mesh-ancestor
56708375|NCT02561013|Monensin|monensin|mesh-list
56708376|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
56708377|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708378|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56708379|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56708380|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
56708381|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
56708382|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
56708383|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708384|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708385|NCT02561013|Ionophores|ionophores|mesh-ancestor
56708386|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56708387|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
56708388|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
56708389|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56708390|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708391|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56535732|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56535733|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56535734|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56535735|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56535736|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
56535737|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56535738|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56535739|NCT04493203|Nivolumab|nivolumab|mesh-list
56535740|NCT04493203|Axitinib|axitinib|mesh-list
56535741|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56535742|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535743|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56708392|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56708393|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263782|NCT01950000|Analgesics|analgesics|mesh-ancestor
56708432|NCT03205137|Telmisartan|telmisartan|mesh-list
56708452|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708453|NCT04732286|Bevacizumab|bevacizumab|mesh-list
56419595|NCT00207701|Infliximab|infliximab|mesh-list
56708454|NCT04732286|Atezolizumab|atezolizumab|mesh-list
56708455|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708456|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708457|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56708458|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56708459|NCT04732286|Growth Substances|growth substances|mesh-ancestor
56708460|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708461|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
56708462|NCT04949828|Pancrelipase|pancrelipase|mesh-list
56708463|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56708464|NCT04941716|Venetoclax|venetoclax|mesh-list
56708465|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
56708466|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708467|NCT04939142|Dexamethasone|dexamethasone|mesh-list
56708468|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
56708469|NCT04939142|Bortezomib|bortezomib|mesh-list
56708470|NCT04939142|BB 1101|bb 1101|mesh-list
56708471|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708472|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
56708473|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
56708474|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708475|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708476|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56708477|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
56708478|NCT04939142|Hormones|hormones|mesh-ancestor
56708479|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708480|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56708481|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708482|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
56708483|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708484|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263877|NCT01950611|Bortezomib|bortezomib|mesh-list
56708505|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708506|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708507|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56708508|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56708509|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708510|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56708511|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56708512|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
56708513|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56708514|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708515|NCT04081376|Hydromorphone|hydromorphone|mesh-list
56708516|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56535744|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535745|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56535746|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535747|NCT04472143|Granisetron|granisetron|mesh-list
56535748|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
56535749|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
56535750|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535751|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535752|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56535753|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56535754|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
56535755|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535756|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535757|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56189941|NCT01463215|Ambroxol|ambroxol|mesh-list
56708517|NCT04081376|Narcotics|narcotics|mesh-ancestor
56708518|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56708519|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708520|NCT04081376|Analgesics|analgesics|mesh-ancestor
56708521|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
56708522|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708523|NCT02584400|Imidazole|imidazole|mesh-list
56708524|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708525|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419669|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
56708526|NCT04586660|Denosumab|denosumab|mesh-list
56708527|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56708528|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708529|NCT04585022|Cimetidine|cimetidine|mesh-list
56708530|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56708531|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56708532|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56708533|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
56708534|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
56708535|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708536|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708537|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708538|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56708566|NCT04569032|Prednisone|prednisone|mesh-list
56708567|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
56708568|NCT04569032|Doxorubicin|doxorubicin|mesh-list
56708569|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56708570|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708571|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
56708572|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708573|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708574|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56708575|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
56708576|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708577|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708578|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56708579|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56708580|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56708581|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56708582|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708583|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708584|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
56708585|NCT04569032|Hormones|hormones|mesh-ancestor
56708586|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56535758|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
56535759|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535760|NCT04748523|Mirtazapine|mirtazapine|mesh-list
56535761|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
56535762|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56535763|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56535764|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
56535765|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
56535766|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535767|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535768|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535769|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56535770|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56535771|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535772|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56535775|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
56535776|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56535777|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56535778|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
56535779|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56535780|NCT02817217|Valsartan|valsartan|mesh-list
56535781|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56535782|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56535783|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56535784|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263984|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708615|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708617|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708618|NCT02583464|Tenofovir|tenofovir|mesh-list
56708619|NCT02583464|Emtricitabine|emtricitabine|mesh-list
56708620|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
56708621|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708622|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56708623|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56708624|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708625|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708626|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56708627|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56708628|NCT00675597|Bevacizumab|bevacizumab|mesh-list
56708629|NCT00675597|Docetaxel|docetaxel|mesh-list
56264047|NCT01951677|Antacids|antacids|mesh-ancestor
56708646|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56708648|NCT02677545|Analgesics|analgesics|mesh-ancestor
56708649|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
56708650|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708651|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535785|NCT00948922|Fludarabine|fludarabine|mesh-list
56535786|NCT00948922|Bortezomib|bortezomib|mesh-list
56535787|NCT00948922|Melphalan|melphalan|mesh-list
56535788|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535789|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535790|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535791|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
56535792|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535793|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56535794|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
56535795|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56535796|NCT00634309|Candesartan|candesartan|mesh-list
56535797|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56535798|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56535799|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56535800|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535801|NCT01239992|Niacin|niacin|mesh-list
56535802|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56535803|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
56535804|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535805|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56535806|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
56535807|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
56535808|NCT01239992|Vitamins|vitamins|mesh-ancestor
56535809|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
56535810|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535811|NCT02816905|Fluorometholone|fluorometholone|mesh-list
56535812|NCT02816905|Dexamethasone|dexamethasone|mesh-list
56535813|NCT02816905|Rimexolone|rimexolone|mesh-list
56535814|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56535831|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535832|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
56535833|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56535834|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56535835|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535836|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
56708652|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708653|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708654|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56708655|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56708656|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708657|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56708658|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56708659|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708660|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
56708661|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56708662|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56708663|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56708664|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
56708665|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708666|NCT04079426|Dimercaprol|dimercaprol|mesh-list
56708667|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
56708668|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
56708669|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708670|NCT04557020|Gemcitabine|gemcitabine|mesh-list
56708671|NCT04557020|Cisplatin|cisplatin|mesh-list
56708672|NCT04557020|Antibodies|antibodies|mesh-list
56708673|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
56708674|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708675|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56708676|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
56708677|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708678|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708679|NCT04557020|Antiviral Agents|antiviral agents|mesh-ancestor
56708680|NCT04557020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708681|NCT04557020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708682|NCT04557020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708683|NCT00675441|Lenalidomide|lenalidomide|mesh-list
56708684|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
56708685|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708686|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56708687|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56708722|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56708724|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708725|NCT00673179|Antiviral Agents|antiviral agents|mesh-ancestor
56708726|NCT00673179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708727|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708728|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708729|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
56708730|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708748|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56708749|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708750|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708751|NCT00758433|Capsaicin|capsaicin|mesh-list
56708752|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
56708753|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
56708754|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
56708755|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708756|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708757|NCT00584012|Docetaxel|docetaxel|mesh-list
56708758|NCT00584012|Lovastatin|lovastatin|mesh-list
56708759|NCT00584012|L 647318|l 647318|mesh-list
56708760|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
56708761|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708762|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56708763|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708764|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708765|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708766|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56535837|NCT05517590|Coagulants|coagulants|mesh-ancestor
56535838|NCT05654077|Cyclophosphamide|cyclophosphamide|mesh-list
56535839|NCT05654077|Fludarabine|fludarabine|mesh-list
56535840|NCT05654077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535841|NCT05654077|Immunologic Factors|immunologic factors|mesh-ancestor
56535842|NCT05654077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535843|NCT05654077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56535844|NCT05654077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56535845|NCT05654077|Alkylating Agents|alkylating agents|mesh-ancestor
56535846|NCT05654077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535847|NCT05654077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535848|NCT05654077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56708767|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56708768|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
56708769|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56708770|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56708771|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708772|NCT05435846|Trametinib|trametinib|mesh-list
56708773|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708774|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56708775|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708776|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708777|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56708778|NCT00920270|Colistin|colistin|mesh-list
56708779|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708780|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
56708781|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56708782|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
56708783|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56708784|NCT02585882|Fluorides|fluorides|mesh-list
56708785|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
56708786|NCT02585882|Protective Agents|protective agents|mesh-ancestor
56708787|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708788|NCT04521686|Gemcitabine|gemcitabine|mesh-list
56708789|NCT04521686|Durvalumab|durvalumab|mesh-list
56708790|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708816|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708817|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
56708818|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708819|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56708820|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708821|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
56708822|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708823|NCT04430738|Antidotes|antidotes|mesh-ancestor
56708824|NCT04430738|Protective Agents|protective agents|mesh-ancestor
56708825|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
56708826|NCT04430738|Vitamins|vitamins|mesh-ancestor
56708827|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
56708828|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56708829|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708830|NCT02584010|Silicon|silicon|mesh-list
56708831|NCT02584010|Trace Elements|trace elements|mesh-ancestor
56708832|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
56708833|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708834|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
56708835|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56708836|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708837|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56708838|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708839|NCT04509674|Empagliflozin|empagliflozin|mesh-list
56708840|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56708841|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708858|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56535850|NCT04303767|Caseins|caseins|mesh-list
56535851|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56535852|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535853|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
56535854|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
56535855|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535856|NCT02874963|Ethanol|ethanol|mesh-list
56535857|NCT02874963|Listerine|listerine|mesh-list
56535858|NCT02874963|Thymol|thymol|mesh-list
56535859|NCT02874963|Eucalyptol|eucalyptol|mesh-list
56535860|NCT02874963|Salicylates|salicylates|mesh-list
56535861|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
56535862|NCT02874963|Menthol|menthol|mesh-list
56535863|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56535864|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535865|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56535866|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535867|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
56708859|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56708860|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
56708861|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708863|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
56708864|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56708865|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56708866|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56708867|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
56708868|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56708869|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
56708870|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
56708871|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
56708872|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708873|NCT04078880|Protective Agents|protective agents|mesh-ancestor
56708874|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708875|NCT04078880|Vitamins|vitamins|mesh-ancestor
56708876|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
56708877|NCT02585570|Phenylephrine|phenylephrine|mesh-list
56708878|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
56708879|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56708880|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
56708881|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
56708882|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708883|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708884|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
56708885|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56708886|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
56708887|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
56708888|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56708889|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56708890|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56708891|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
56708892|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708893|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708894|NCT02585570|Protective Agents|protective agents|mesh-ancestor
56708895|NCT02583854|Hemostatics|hemostatics|mesh-list
56708896|NCT02583854|Coagulants|coagulants|mesh-ancestor
56708897|NCT00764907|Leucovorin|leucovorin|mesh-list
56708898|NCT00764907|Cytarabine|cytarabine|mesh-list
56708899|NCT00764907|Dexamethasone|dexamethasone|mesh-list
56708900|NCT00764907|Prednisone|prednisone|mesh-list
56708901|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
56708902|NCT00764907|Ifosfamide|ifosfamide|mesh-list
56708903|NCT00764907|Doxorubicin|doxorubicin|mesh-list
56535868|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
56535869|NCT02874963|Protective Agents|protective agents|mesh-ancestor
56027679|NCT05168462|Norepinephrine|norepinephrine|mesh-list
56708932|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56708933|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56708934|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56708935|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708936|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56708937|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
56708938|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56708939|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56708940|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
56708941|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
56708942|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56708943|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56708944|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56708945|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
56708946|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708947|NCT00764907|Antidotes|antidotes|mesh-ancestor
56708948|NCT00764907|Protective Agents|protective agents|mesh-ancestor
56708949|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
56708950|NCT00764907|Vitamins|vitamins|mesh-ancestor
56708951|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
56708981|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708982|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56708983|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708984|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708985|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708986|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708987|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56708988|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708989|NCT00762099|Pregabalin|pregabalin|mesh-list
56708990|NCT00762099|Analgesics|analgesics|mesh-ancestor
56708991|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
56708992|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708993|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708994|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
56708995|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56708996|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56708997|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264379|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
56709030|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56709031|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709033|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56709034|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56709035|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56709036|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56709037|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
56709065|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56709066|NCT00765921|Growth Substances|growth substances|mesh-ancestor
56709067|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709068|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
56709069|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709070|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56709071|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56709072|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709073|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
56709074|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56709075|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709076|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
56709077|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709078|NCT00766155|Capecitabine|capecitabine|mesh-list
56709079|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
56709080|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56709081|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
56709082|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709083|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709084|NCT02585258|Prednisolone|prednisolone|mesh-list
56709085|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56709119|NCT00923234|Azacitidine|azacitidine|mesh-list
56709120|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
56709121|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709122|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56535870|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56535871|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56709123|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56709124|NCT00923234|Growth Substances|growth substances|mesh-ancestor
56709125|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
56264514|NCT01954784|Lenalidomide|lenalidomide|mesh-list
56709158|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
56709159|NCT04323956|Hormones|hormones|mesh-ancestor
56709160|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709161|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56709162|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56709163|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56709164|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
56709165|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
56709166|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
56709167|NCT00674661|Riboflavin|riboflavin|mesh-list
56709168|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56709169|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56709170|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
56709201|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
56709202|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709203|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709204|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56709205|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709207|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56709208|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
56709209|NCT00766857|Exenatide|exenatide|mesh-list
56709210|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56709211|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709212|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56709213|NCT00766857|Incretins|incretins|mesh-ancestor
56709214|NCT00766857|Hormones|hormones|mesh-ancestor
56264600|NCT01955187|Prednisolone|prednisolone|mesh-list
56709239|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709240|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
56709241|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709242|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709243|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56709244|NCT00767091|Protective Agents|protective agents|mesh-ancestor
56709245|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
56709246|NCT00767169|Pamidronate|pamidronate|mesh-list
56709247|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56709248|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709249|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
56709250|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56709251|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709252|NCT00767481|Travoprost|travoprost|mesh-list
56709253|NCT00767481|Brinzolamide|brinzolamide|mesh-list
56709254|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56709255|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56709256|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709257|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709258|NCT04305236|Fulvestrant|fulvestrant|mesh-list
56709259|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56709260|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709261|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56709326|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56709327|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
56709328|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709329|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56709330|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
56709331|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56709332|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
56709333|NCT00763347|Alogliptin|alogliptin|mesh-list
56709334|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56709335|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709336|NCT00763347|Incretins|incretins|mesh-ancestor
56709337|NCT00763347|Hormones|hormones|mesh-ancestor
56709338|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709339|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56709340|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
56709341|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709342|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535872|NCT02874963|Analgesics|analgesics|mesh-ancestor
56535873|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
56535874|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535875|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56535876|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56535877|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56535878|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535879|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535880|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
56535881|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
56535882|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
56535883|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
56535884|NCT02818309|Lesogaberan|lesogaberan|mesh-list
56535885|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56535886|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56709343|NCT00767871|Citalopram|citalopram|mesh-list
56709344|NCT00767871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56709345|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56709368|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56709370|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
56709371|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56709372|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56709373|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56709374|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709375|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709376|NCT00768183|Ethanol|ethanol|mesh-list
56709377|NCT00768183|Morphine|morphine|mesh-list
56709378|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56709379|NCT00768183|Narcotics|narcotics|mesh-ancestor
56709380|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709381|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709382|NCT00768183|Analgesics|analgesics|mesh-ancestor
56709383|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
56709384|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709385|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56709386|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709387|NCT02557581|Terbutaline|terbutaline|mesh-list
56709388|NCT02557581|Clenbuterol|clenbuterol|mesh-list
56709389|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56709390|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
56709391|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709392|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709416|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
56709417|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709418|NCT02807636|Antiviral Agents|antiviral agents|mesh-ancestor
56709419|NCT02807636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709420|NCT02807636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709421|NCT02807636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56709422|NCT02807636|Immunologic Factors|immunologic factors|mesh-ancestor
56709423|NCT02807636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709424|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
56709425|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
56709426|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56709427|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56709428|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709429|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709430|NCT00768573|Urological Agents|urological agents|mesh-ancestor
56709431|NCT02558361|Apremilast|apremilast|mesh-list
56709432|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56709433|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56535887|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
56535888|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
56535889|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535890|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535891|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535892|NCT01238822|Methylphenidate|methylphenidate|mesh-list
56535893|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56535894|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535895|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56535896|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56535897|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56535898|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535899|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
56535900|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535901|NCT02818387|Midazolam|midazolam|mesh-list
56535902|NCT02818387|Remifentanil|remifentanil|mesh-list
56535903|NCT02818387|Propofol|propofol|mesh-list
56535904|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56535905|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56190078|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56709434|NCT02558361|Analgesics|analgesics|mesh-ancestor
56709435|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
56709436|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709437|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709438|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56709439|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56709440|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56709441|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56709442|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709443|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709477|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
56709478|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709479|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56709480|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56709481|NCT02582372|Analgesics|analgesics|mesh-ancestor
56709482|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56709483|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56709484|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56709485|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
56709486|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709523|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709524|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709525|NCT00770445|Insulin|insulin|mesh-list
56709534|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709535|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709537|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709538|NCT04239716|Anesthetics|anesthetics|mesh-list
56709539|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709540|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709541|NCT04048707|Octreotide|octreotide|mesh-list
56709542|NCT04048707|Midodrine|midodrine|mesh-list
56709543|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
56709544|NCT04048707|Giapreza|giapreza|mesh-list
56535906|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535907|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56535908|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
56535909|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
56535910|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56535911|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56535912|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56535913|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56535914|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
56535915|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
56535916|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535917|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535918|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56535919|NCT02818387|Narcotics|narcotics|mesh-ancestor
56535920|NCT02818387|Analgesics|analgesics|mesh-ancestor
56535921|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
56709545|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
56709546|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56709547|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56709548|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709549|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
56709550|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
56709551|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709552|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709553|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56709554|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56709555|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56709556|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56709557|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
56709558|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709559|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709560|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56709561|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
56709562|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709563|NCT00763893|Losartan|losartan|mesh-list
56709564|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56709565|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56709566|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56709567|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56709568|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709569|NCT00770835|Metformin|metformin|mesh-list
56709570|NCT00770835|Pioglitazone|pioglitazone|mesh-list
56709571|NCT00770835|Glyburide|glyburide|mesh-list
56709572|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56709573|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709574|NCT00769587|Thalidomide|thalidomide|mesh-list
56709575|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56709576|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
56709577|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709578|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
56709579|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56709580|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709581|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56709582|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56709583|NCT00769587|Growth Substances|growth substances|mesh-ancestor
56709584|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
56709585|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709586|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
56709587|NCT04610528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56709588|NCT04610528|Immunologic Factors|immunologic factors|mesh-ancestor
56535922|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535924|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56535925|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535926|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
56535927|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56535928|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56535930|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
56535931|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
56535932|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535933|NCT00627003|Cabergoline|cabergoline|mesh-list
56190123|NCT01464476|Azimilide|azimilide|mesh-list
56709589|NCT04610528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709590|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56709591|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709592|NCT00570921|Everolimus|everolimus|mesh-list
56709593|NCT00570921|Fulvestrant|fulvestrant|mesh-list
56709594|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709615|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709616|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56709617|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56709618|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709619|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709620|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
56709621|NCT04353986|Ledipasvir|ledipasvir|mesh-list
56709622|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56709623|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
56709624|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709625|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56709626|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56709627|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709628|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56709629|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
56709630|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709631|NCT00771147|Sorafenib|sorafenib|mesh-list
56709632|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709633|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56709634|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709635|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709636|NCT04155710|Interleukin-2|interleukin-2|mesh-list
56709637|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709638|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56709639|NCT04155710|Analgesics|analgesics|mesh-ancestor
56709640|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
56709641|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709642|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709643|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56709644|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
56709667|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709668|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56709669|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56709670|NCT02557503|Fluorouracil|fluorouracil|mesh-list
56709671|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
56709672|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
56709673|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709674|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56709675|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709676|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56709677|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
56709678|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709679|NCT00764439|Nicotine|nicotine|mesh-list
56709680|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56709681|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
56709682|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060860|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
56535934|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56535935|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56535936|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
56535937|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
56535938|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56535939|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535940|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535941|NCT04238221|Doxofylline|doxofylline|mesh-list
56709683|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709684|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56709685|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56709686|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
56709687|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709688|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709689|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
56709690|NCT04130516|Antibodies|antibodies|mesh-list
56709691|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
56709692|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709693|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56709694|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709695|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
56709696|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56709730|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56709731|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56709732|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56709733|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56709734|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709735|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709736|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56265127|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
56709763|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56709764|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
56709765|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
56709766|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709767|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
56709768|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56709770|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56709771|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56709772|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
56709773|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56709774|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709775|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56709776|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56709777|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56709778|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56709779|NCT02556411|Estrogens|estrogens|mesh-ancestor
56709780|NCT02556411|Hormones|hormones|mesh-ancestor
56709781|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709782|NCT04085276|Paclitaxel|paclitaxel|mesh-list
56709783|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56265163|NCT01959074|Analgesics|analgesics|mesh-ancestor
56709810|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56709811|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709812|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
56709814|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56709815|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709816|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56709817|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56709818|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56709819|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709820|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
56709821|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709822|NCT00776139|Cetirizine|cetirizine|mesh-list
56709823|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56709824|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56535942|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
56535943|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
56535944|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56535945|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
56535946|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535947|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535948|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56535949|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56535950|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535951|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535952|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56535953|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56535954|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56535955|NCT01238120|Ibuprofen|ibuprofen|mesh-list
56535956|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56190139|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
56709825|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56709826|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
56709827|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
56709828|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709843|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56709845|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
56709846|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709847|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56709848|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56709849|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709850|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709851|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709852|NCT02580344|Ibuprofen|ibuprofen|mesh-list
56709853|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56709854|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56709855|NCT02580344|Analgesics|analgesics|mesh-ancestor
56709856|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
56709857|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709858|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709859|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56709860|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56709861|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56709862|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709863|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709864|NCT00779649|Bisacodyl|bisacodyl|mesh-list
56709865|NCT00779649|Cathartics|cathartics|mesh-ancestor
56709866|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56709867|NCT00779649|Laxatives|laxatives|mesh-ancestor
56709868|NCT00776217|Loratadine|loratadine|mesh-list
56709869|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
56709870|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
56709871|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56709872|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56709873|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56709874|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
56709875|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
56709876|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709877|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709878|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709879|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56709880|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56535957|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56535958|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56535959|NCT01238120|Analgesics|analgesics|mesh-ancestor
56535960|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
56535961|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535962|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535963|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56535964|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56535965|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535966|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535967|NCT00634231|Valacyclovir|valacyclovir|mesh-list
56535968|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
56535969|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535970|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56535971|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
56535972|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56535973|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535974|NCT04237987|Cyclosporine|cyclosporine|mesh-list
56535975|NCT04237987|Aldesleukin|aldesleukin|mesh-list
56535976|NCT04237987|Interleukin-2|interleukin-2|mesh-list
56709881|NCT00667875|Naltrexone|naltrexone|mesh-list
56709882|NCT00667875|Aripiprazole|aripiprazole|mesh-list
56709883|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56709884|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56709885|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709886|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
56709887|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709913|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709914|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56709916|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709917|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709918|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
56709919|NCT00779805|Ephedrine|ephedrine|mesh-list
56709920|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56709921|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
56709922|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709923|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709924|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56709925|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
56709926|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
56709927|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56709928|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56709929|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
56709930|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
56709931|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709932|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709965|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709966|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56709967|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56709968|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
56709969|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709970|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709971|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56709972|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710037|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56535977|NCT04237987|Cyclosporins|cyclosporins|mesh-list
56535978|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56535979|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56535980|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56535981|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
56535982|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56535983|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
56535984|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56535985|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
56535986|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56190174|NCT01466712|Hormones|hormones|mesh-ancestor
56710038|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56710039|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710040|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56710041|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710042|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
56710043|NCT00667719|Diuretics|diuretics|mesh-ancestor
56710044|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
56710045|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56710046|NCT04032704|Pembrolizumab|pembrolizumab|mesh-list
56710047|NCT04032704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56710048|NCT04032704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710049|NCT00669669|Plerixafor|plerixafor|mesh-list
56710050|NCT00669669|Temozolomide|temozolomide|mesh-list
56710051|NCT00669669|Carmustine|carmustine|mesh-list
56710052|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56710053|NCT00669669|Lenograstim|lenograstim|mesh-list
56710054|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56710055|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
56710056|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265450|NCT01961739|Lidocaine|lidocaine|mesh-list
56710089|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56710091|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
56710092|NCT00467779|Midazolam|midazolam|mesh-list
56710093|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
56710094|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56710095|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56710096|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56710097|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710098|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56710099|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56710127|NCT01021891|Insulin|insulin|mesh-list
56710128|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56710129|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710130|NCT01029223|Metoprolol|metoprolol|mesh-list
56710131|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56710132|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56710133|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
56710134|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
56710135|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710136|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710137|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56710138|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56710139|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56710140|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
56710141|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710142|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710143|NCT02556723|Aflibercept|aflibercept|mesh-list
56710144|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56710145|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56710146|NCT02556723|Growth Substances|growth substances|mesh-ancestor
56710159|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
56710160|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56710161|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56710162|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56535987|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56535988|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56535989|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56535990|NCT04237987|Analgesics|analgesics|mesh-ancestor
56535991|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
56535992|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56535993|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56535994|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56535995|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
56535996|NCT04551547|Vaccines|vaccines|mesh-list
56535997|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
56710163|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56710164|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
56710165|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710166|NCT00777543|Protective Agents|protective agents|mesh-ancestor
56710167|NCT03410654|Tacrolimus|tacrolimus|mesh-list
56710168|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56710169|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
56710170|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710171|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56710172|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710173|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710174|NCT04006262|Nivolumab|nivolumab|mesh-list
56710175|NCT04006262|Ipilimumab|ipilimumab|mesh-list
56710176|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56710177|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710178|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56710179|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710180|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
56710181|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56710182|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710183|NCT01022047|Budesonide|budesonide|mesh-list
56710184|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56710185|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56421321|NCT04669366|Sunitinib|sunitinib|mesh-list
56710186|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
56710187|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710188|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710189|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56710190|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
56710191|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
56710192|NCT01022047|Hormones|hormones|mesh-ancestor
56710193|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56710200|NCT01022125|Simeprevir|simeprevir|mesh-list
56710201|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
56710202|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710203|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
56710204|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710205|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710206|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
56710207|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56710208|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56710209|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710210|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
56710211|NCT03385928|Coagulants|coagulants|mesh-ancestor
56710212|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
56710213|NCT03384836|Propranolol|propranolol|mesh-list
56710214|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56710227|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56710228|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710230|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710231|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
56710232|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710233|NCT05673980|Vitamin D|vitamin d|mesh-list
56710234|NCT05673980|Cholecalciferol|cholecalciferol|mesh-list
56710235|NCT05673980|Ergocalciferols|ergocalciferols|mesh-list
56535998|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536000|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56536002|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
56536003|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536004|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536005|NCT04533997|Furosemide|furosemide|mesh-list
56536006|NCT04533997|Diuretics|diuretics|mesh-ancestor
56536007|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
56536008|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536009|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56536010|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56536011|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536012|NCT02874807|Empagliflozin|empagliflozin|mesh-list
56536013|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56536014|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536015|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536016|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536017|NCT01054599|Memantine|memantine|mesh-list
56710236|NCT05673980|Vitamins|vitamins|mesh-ancestor
56710237|NCT05673980|Micronutrients|micronutrients|mesh-ancestor
56710238|NCT05673980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710239|NCT05673980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56710240|NCT05673980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56710241|NCT02581124|Lapatinib|lapatinib|mesh-list
56710242|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710243|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56710244|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710245|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710246|NCT02580968|Flunarizine|flunarizine|mesh-list
56710247|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
56710248|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56710249|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56710250|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710251|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56710252|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710253|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56710254|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
56710255|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
56710256|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710257|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
56710258|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
56710259|NCT00441103|Interferon-beta|interferon-beta|mesh-list
56547667|NCT00922480|Losartan|losartan|mesh-list
56710260|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56710261|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
56710262|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710263|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710264|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
56710265|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710266|NCT01029613|Adalimumab|adalimumab|mesh-list
56710267|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56710268|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56710269|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
56710270|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
56710271|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710272|NCT03268057|Avelumab|avelumab|mesh-list
56536018|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56536019|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56536020|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
56536021|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536022|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536023|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536024|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56536025|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56536026|NCT05635201|Anesthetics|anesthetics|mesh-list
56536027|NCT05635201|Propofol|propofol|mesh-list
56536028|NCT05635201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536029|NCT05635201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536030|NCT05635201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56536031|NCT05635201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56536032|NCT05635201|Anesthetics, General|anesthetics, general|mesh-ancestor
56536033|NCT02813863|Metformin|metformin|mesh-list
56710273|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56710274|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710275|NCT03339128|Eluxadoline|eluxadoline|mesh-list
56710294|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710295|NCT00433537|Dexamethasone|dexamethasone|mesh-list
56710296|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
56710297|NCT00433537|Rituximab|rituximab|mesh-list
56710298|NCT00433537|Doxorubicin|doxorubicin|mesh-list
56710299|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56710300|NCT00433537|Vincristine|vincristine|mesh-list
56710301|NCT00433537|Bortezomib|bortezomib|mesh-list
56710302|NCT00433537|Lenograstim|lenograstim|mesh-list
56710303|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56710304|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
56710305|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710306|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56710307|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56710308|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
56710309|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710310|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710311|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56710312|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56710313|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56710314|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
56710315|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
56710316|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710317|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56710318|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
56710319|NCT00433537|Hormones|hormones|mesh-ancestor
56710320|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56710321|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56710322|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56710323|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56710324|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56710325|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710326|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56710327|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56710328|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
56710329|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
56710330|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
56710331|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56710332|NCT00570765|Cathartics|cathartics|mesh-ancestor
56710333|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56536034|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536035|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536036|NCT02874729|Dimercaprol|dimercaprol|mesh-list
56536037|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
56536038|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
56421469|NCT00212108|Celecoxib|celecoxib|mesh-list
56710352|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710353|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710354|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56710355|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56710356|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710357|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
56710358|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710359|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56710360|NCT00667095|Protective Agents|protective agents|mesh-ancestor
56710361|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56710362|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
56710363|NCT00777933|Cyclosporine|cyclosporine|mesh-list
56710364|NCT00777933|Tacrolimus|tacrolimus|mesh-list
56710365|NCT00777933|Cyclosporins|cyclosporins|mesh-list
56710366|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56710367|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
56710368|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710369|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56710370|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710371|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710372|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
56710373|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710374|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
56710375|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56710376|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
56710377|NCT00773331|Hematinics|hematinics|mesh-ancestor
56710378|NCT00778011|Ondansetron|ondansetron|mesh-list
56710379|NCT00778011|Metoclopramide|metoclopramide|mesh-list
56710380|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
56710381|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
56710382|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710383|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710384|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56710385|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
56710386|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
56710387|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56710388|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
56265764|NCT01964079|Losartan|losartan|mesh-list
56710414|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710415|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56710416|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56710417|NCT00433381|Growth Substances|growth substances|mesh-ancestor
56710418|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710419|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
56710420|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
56710421|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56710422|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56710423|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710424|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710425|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56710426|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
56710427|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56710428|NCT00667017|Immunotoxins|immunotoxins|mesh-list
56710429|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
56710430|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710431|NCT00781131|Pregabalin|pregabalin|mesh-list
56710432|NCT00781131|Analgesics|analgesics|mesh-ancestor
56710433|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
56710434|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710435|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710436|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
56710437|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56710438|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56710462|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
56710463|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
56710464|NCT00666705|Maraviroc|maraviroc|mesh-list
56710465|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56536039|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536040|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
56536041|NCT04275661|Ketamine|ketamine|mesh-list
56536042|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
56536043|NCT04275661|Analgesics|analgesics|mesh-ancestor
56536044|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
56536045|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536046|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536047|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56536048|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56536049|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
56536050|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
56536051|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536052|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56536053|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56710466|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56710467|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
56710468|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710469|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56710470|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56710471|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710472|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710473|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56710474|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56710475|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56710476|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56710477|NCT04047849|Amoxicillin|amoxicillin|mesh-list
56710478|NCT04047849|Azithromycin|azithromycin|mesh-list
56710479|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710480|NCT00778557|Cefprozil|cefprozil|mesh-list
56710481|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56710482|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710483|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56710484|NCT00778713|Fosinopril|fosinopril|mesh-list
56710485|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56421634|NCT00212654|Landiolol|landiolol|mesh-list
56710486|NCT00778713|Diuretics|diuretics|mesh-ancestor
56710487|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
56710488|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265871|NCT01964404|Dronabinol|dronabinol|mesh-list
56710518|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710519|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56710521|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710522|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56710523|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56710524|NCT00774423|Riluzole|riluzole|mesh-list
56710525|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
56710526|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56710527|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56710528|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710529|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710530|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710531|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56710532|NCT00774423|Protective Agents|protective agents|mesh-ancestor
56710533|NCT00781521|Ofloxacin|ofloxacin|mesh-list
56710546|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56710547|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710548|NCT00784485|Omalizumab|omalizumab|mesh-list
56710549|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56710550|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56536129|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56536130|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
56710551|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
56710552|NCT00781755|Varenicline|varenicline|mesh-list
56710553|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56710554|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56710555|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
56710556|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710557|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710558|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710559|NCT00774735|Dolutegravir|dolutegravir|mesh-list
56421694|NCT00239889|Calcitonin|calcitonin|mesh-list
56710560|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56710561|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56710562|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710563|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710564|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56710565|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56710566|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
56710567|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710569|NCT00666237|Mitomycin|mitomycin|mesh-list
56710570|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56710571|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710572|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
56710573|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710574|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56710575|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710576|NCT00774813|Citalopram|citalopram|mesh-list
56710577|NCT00774813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56710578|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56710579|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56710580|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710581|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710582|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
56710583|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710584|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56710585|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
56710586|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56710587|NCT00784797|Oxytocin|oxytocin|mesh-list
56710588|NCT00784797|Mifepristone|mifepristone|mesh-list
56710589|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
56710590|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56710591|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710592|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56710593|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
56710594|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56710620|NCT00662025|Sunitinib|sunitinib|mesh-list
56710621|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56710622|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
56710623|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710624|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710625|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56710626|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56710627|NCT00662025|Growth Substances|growth substances|mesh-ancestor
56710628|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710629|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
56710630|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56710631|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710632|NCT00789945|Insulin|insulin|mesh-list
56710633|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56421769|NCT00243711|Glycerol|glycerol|mesh-list
56710634|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56710635|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710636|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
56710637|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56710638|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56710639|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56710640|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710641|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56710642|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710677|NCT00785421|Immunologic Factors|immunologic factors|mesh-ancestor
56710678|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536131|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536132|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536133|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
56536134|NCT00948688|Vorinostat|vorinostat|mesh-list
56536135|NCT00948688|Fluorouracil|fluorouracil|mesh-list
56536136|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536137|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56536138|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536139|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536140|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
56536141|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56536142|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56536143|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
56536144|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536145|NCT02188264|Cyclosporine|cyclosporine|mesh-list
56536146|NCT02188264|Cyclosporins|cyclosporins|mesh-list
56536147|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536148|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710679|NCT00785421|Antidotes|antidotes|mesh-ancestor
56710680|NCT00785421|Protective Agents|protective agents|mesh-ancestor
56710681|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
56710682|NCT00785421|Vitamins|vitamins|mesh-ancestor
56710683|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
56710684|NCT00785421|Hematinics|hematinics|mesh-ancestor
56710685|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
56710686|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56710717|NCT00440947|Ritonavir|ritonavir|mesh-list
56710718|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56710719|NCT00440947|Lamivudine|lamivudine|mesh-list
56710720|NCT00440947|Abacavir|abacavir|mesh-list
56710721|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
56710722|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56710723|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56710724|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
56710725|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710726|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710727|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56710728|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56266121|NCT01965977|Bortezomib|bortezomib|mesh-list
56710761|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
56710762|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56710763|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
56710764|NCT02557945|Gabapentin|gabapentin|mesh-list
56710765|NCT02557945|Analgesics|analgesics|mesh-ancestor
56710766|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
56710767|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710768|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710769|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
56710770|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56710794|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
56710795|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56710796|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710797|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56710798|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56710799|NCT03929666|Growth Substances|growth substances|mesh-ancestor
56710800|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710801|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
56710802|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56710803|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
56536149|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030746|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
56710804|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710805|NCT03929666|Antiviral Agents|antiviral agents|mesh-ancestor
56710806|NCT03929666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710807|NCT03929666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710808|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56710809|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
56710810|NCT03929666|Antidotes|antidotes|mesh-ancestor
56710811|NCT03929666|Protective Agents|protective agents|mesh-ancestor
56710812|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
56710813|NCT03929666|Vitamins|vitamins|mesh-ancestor
56710814|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
56710815|NCT00664521|Rituximab|rituximab|mesh-list
56710816|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56710817|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710818|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
56710819|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710820|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56710821|NCT02581046|Dexamethasone|dexamethasone|mesh-list
56710822|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56710823|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
56710824|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
56710825|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710831|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56710832|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710833|NCT00664209|Amoxicillin|amoxicillin|mesh-list
56710834|NCT00664209|Omeprazole|omeprazole|mesh-list
56710835|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56710836|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710837|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56710838|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56710839|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56710840|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710841|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710842|NCT03192332|Plasminogen|plasminogen|mesh-list
56710843|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56710844|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56710845|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56710846|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710847|NCT02555943|Ritonavir|ritonavir|mesh-list
56710848|NCT02555943|Tenofovir|tenofovir|mesh-list
56710849|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
56710850|NCT02555943|Entecavir|entecavir|mesh-list
56710851|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56710852|NCT02555943|Ledipasvir|ledipasvir|mesh-list
56710853|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56710854|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56710855|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
56710856|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710857|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710858|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56421990|NCT00214955|Fentanyl|fentanyl|mesh-list
56710859|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56710860|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
56710861|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710862|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56710863|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56710864|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56710865|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56710866|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
56710867|NCT00782847|Cyproterone|cyproterone|mesh-list
56710868|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
56710869|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
56710870|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56710871|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710872|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710873|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56710874|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
56710875|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56710876|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56710877|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
56710878|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710879|NCT02607722|Nintedanib|nintedanib|mesh-list
56710880|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536150|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
56536151|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536152|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
56536153|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536154|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
56536155|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56536156|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56536158|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
56536159|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56536160|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56536161|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536162|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536163|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536164|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
56536165|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
56536166|NCT01049217|Pregabalin|pregabalin|mesh-list
56536167|NCT01049217|Analgesics|analgesics|mesh-ancestor
56536168|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
56536169|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536170|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536171|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
56536172|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56536173|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56536174|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536175|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56536176|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56536177|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56536178|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536179|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56536180|NCT01232738|Rasagiline|rasagiline|mesh-list
56190346|NCT01467648|Doripenem|doripenem|mesh-list
56710881|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56710882|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710883|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710884|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
56710885|NCT00440557|Hematinics|hematinics|mesh-ancestor
56710886|NCT05673590|Docetaxel|docetaxel|mesh-list
56710887|NCT05673590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710888|NCT05673590|Tubulin Modulators|tubulin modulators|mesh-ancestor
56710889|NCT05673590|Antimitotic Agents|antimitotic agents|mesh-ancestor
56710890|NCT05673590|Mitosis Modulators|mitosis modulators|mesh-ancestor
56710891|NCT05673590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710892|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
56710893|NCT03139370|Fludarabine|fludarabine|mesh-list
56536181|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56536182|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536183|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536184|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56536185|NCT01232738|Protective Agents|protective agents|mesh-ancestor
56536186|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266250|NCT01966783|Analgesics|analgesics|mesh-ancestor
56710899|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
56710900|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710901|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710902|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56710903|NCT01029847|Adalimumab|adalimumab|mesh-list
56710904|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56710905|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56710906|NCT02452268|Spartalizumab|spartalizumab|mesh-list
56710907|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56710908|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710909|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710910|NCT02524249|Caffeine|caffeine|mesh-list
56710911|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56710912|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710913|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56710914|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710915|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710916|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56710917|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56710918|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
56710919|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710920|NCT01033981|Sunitinib|sunitinib|mesh-list
56710921|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710922|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56710923|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56710924|NCT01033981|Growth Substances|growth substances|mesh-ancestor
56710925|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710926|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
56710927|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56710928|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710929|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710930|NCT02430194|Interferons|interferons|mesh-list
56710931|NCT02430194|Ritonavir|ritonavir|mesh-list
56710932|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
56710933|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
56547668|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56710934|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56710935|NCT02430194|Lonafarnib|lonafarnib|mesh-list
56710936|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710937|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
56710938|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710939|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56710940|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56710941|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
56710942|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710943|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710944|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56710945|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56710946|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56710947|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56710948|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
56710949|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710950|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
56710951|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56710952|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710953|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710954|NCT02400242|Dexamethasone|dexamethasone|mesh-list
56710955|NCT02400242|Pomalidomide|pomalidomide|mesh-list
56710956|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56710957|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56536187|NCT00957268|Alogliptin|alogliptin|mesh-list
56536188|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536189|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536190|NCT00957268|Incretins|incretins|mesh-ancestor
56536191|NCT00957268|Hormones|hormones|mesh-ancestor
56190379|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
56710958|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
56710959|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
56710960|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710961|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710972|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56710973|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710974|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710975|NCT03087656|Levofloxacin|levofloxacin|mesh-list
56710976|NCT03087656|Ofloxacin|ofloxacin|mesh-list
56710977|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
56710978|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56710979|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710980|NCT03087656|Renal Agents|renal agents|mesh-ancestor
56710981|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56710982|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56710983|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56710984|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710985|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710986|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710987|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56710988|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56710989|NCT03068624|Aldesleukin|aldesleukin|mesh-list
56710990|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
56710991|NCT03068624|Ipilimumab|ipilimumab|mesh-list
56710992|NCT03068624|Interleukin-2|interleukin-2|mesh-list
56710993|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56710994|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
56710995|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710996|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56710997|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56710998|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
56710999|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711000|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711001|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56711002|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711003|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56711004|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56711005|NCT03068624|Analgesics|analgesics|mesh-ancestor
56711006|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
56711007|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711008|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56711009|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56711010|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
56711011|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711012|NCT03025256|Nivolumab|nivolumab|mesh-list
56711013|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711014|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711015|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56711016|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711017|NCT03005366|Flecainide|flecainide|mesh-list
56711018|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56711019|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56711020|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56711021|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56711022|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711023|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
56266384|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56711041|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711042|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56711043|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
56711045|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711046|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56711047|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536192|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56536193|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56536194|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
56536195|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711048|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56711049|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56711050|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711051|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711052|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56711053|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56711054|NCT00427999|Analgesics|analgesics|mesh-ancestor
56711055|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
56711056|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56711057|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56711058|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56711059|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
56711060|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56711061|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711062|NCT00661713|Vaccines|vaccines|mesh-list
56711063|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
56711064|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711065|NCT02578472|Zolpidem|zolpidem|mesh-list
56711066|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56711067|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56711068|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711069|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711070|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56711071|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
56711072|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
56711073|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711074|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711075|NCT03840902|Paclitaxel|paclitaxel|mesh-list
56711076|NCT03840902|Etoposide|etoposide|mesh-list
56711077|NCT03840902|Carboplatin|carboplatin|mesh-list
56711078|NCT03840902|Pemetrexed|pemetrexed|mesh-list
56711079|NCT03840902|Durvalumab|durvalumab|mesh-list
56711080|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56711081|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711082|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
56711104|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711105|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56711106|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56711107|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711108|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711109|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56711110|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
56711111|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711112|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711113|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56711115|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56711116|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56711117|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56711118|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56711119|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56711120|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56711121|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
56711122|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56711123|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56711124|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56711125|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711126|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711127|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56711128|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56711129|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711130|NCT02576288|Incretins|incretins|mesh-ancestor
56711131|NCT02576288|Hormones|hormones|mesh-ancestor
56711132|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711133|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56536196|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536197|NCT02888444|Varenicline|varenicline|mesh-list
56536198|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56536199|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56536200|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
56536201|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536202|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536203|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536204|NCT01230788|Rituximab|rituximab|mesh-list
56190388|NCT01468025|Naproxen|naproxen|mesh-list
56266503|NCT01968239|Ranibizumab|ranibizumab|mesh-list
56711148|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711149|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711151|NCT00580970|L 647318|l 647318|mesh-list
56711152|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
56711153|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56711154|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56711155|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
56422285|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
56711156|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711157|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56711158|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56711159|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711160|NCT01030081|Amlodipine|amlodipine|mesh-list
56711161|NCT01030081|Nifedipine|nifedipine|mesh-list
56711162|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56711163|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56711164|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56711165|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711166|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56711167|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711168|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
56711169|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
56711170|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56711171|NCT00903110|Mecasermin|mecasermin|mesh-list
56711172|NCT00903110|Growth Substances|growth substances|mesh-ancestor
56711173|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711174|NCT00426751|Abciximab|abciximab|mesh-list
56711175|NCT00426751|Eptifibatide|eptifibatide|mesh-list
56711176|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
56711177|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56711178|NCT02576366|Rifampin|rifampin|mesh-list
56711179|NCT02576366|Voriconazole|voriconazole|mesh-list
56711180|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56711181|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
56711182|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56711183|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711184|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
56711185|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56711186|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711187|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711188|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56711189|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56711190|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56711191|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56711192|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56711223|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711225|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56711226|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
56422360|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56711228|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
56711229|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
56711230|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56711231|NCT00791271|Decitabine|decitabine|mesh-list
56711232|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536205|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56536206|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711233|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
56711256|NCT00440401|Hemostatics|hemostatics|mesh-list
56711257|NCT00440401|Coagulants|coagulants|mesh-ancestor
56711258|NCT04992507|Anesthetics|anesthetics|mesh-list
56711259|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711260|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711261|NCT00791427|Ranibizumab|ranibizumab|mesh-list
56711262|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56711263|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56711264|NCT00791427|Growth Substances|growth substances|mesh-ancestor
56711265|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711266|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
56711267|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711268|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
56711269|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56711270|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
56711271|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56711272|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
56711273|NCT00791505|Trimethoprim|trimethoprim|mesh-list
56711274|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
56711275|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56711276|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711277|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56711278|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56711279|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711280|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711281|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711282|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56711283|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56711284|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56711320|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711321|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56711351|NCT01853826|Afatinib|afatinib|mesh-list
56711352|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711353|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56711354|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711355|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711356|NCT00425503|Bortezomib|bortezomib|mesh-list
56711357|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711358|NCT00786669|Cefixime|cefixime|mesh-list
56711359|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
56711360|NCT00786669|Bevacizumab|bevacizumab|mesh-list
56711361|NCT00786669|Irinotecan|irinotecan|mesh-list
56711362|NCT00786669|Vincristine|vincristine|mesh-list
56711363|NCT00786669|Temozolomide|temozolomide|mesh-list
56711364|NCT00786669|Camptothecin|camptothecin|mesh-list
56711365|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711366|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711367|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56711368|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56711369|NCT00786669|Growth Substances|growth substances|mesh-ancestor
56711370|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711393|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711394|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56711395|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56711396|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56711397|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711398|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56711399|NCT00791739|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56711400|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56711401|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711402|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
56711403|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56711404|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
56711405|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
56711406|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
56711407|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56711408|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56711409|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711410|NCT02503722|Osimertinib|osimertinib|mesh-list
56536207|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
56536208|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711411|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711412|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56711413|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711414|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711415|NCT00430573|Cycloserine|cycloserine|mesh-list
56711416|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56711417|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711418|NCT00430573|Renal Agents|renal agents|mesh-ancestor
56711419|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56711420|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
56266795|NCT01970046|Metformin|metformin|mesh-list
56711450|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711452|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711453|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56711454|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711455|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711456|NCT02554695|Denosumab|denosumab|mesh-list
56711457|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56711458|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711459|NCT00792363|Irinotecan|irinotecan|mesh-list
56711460|NCT00792363|Panitumumab|panitumumab|mesh-list
56711461|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56711462|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56711463|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266847|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56711494|NCT04895280|Analgesics|analgesics|mesh-ancestor
56711495|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56711496|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56711497|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
56711498|NCT03994783|Rituximab|rituximab|mesh-list
56711499|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
56711500|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56711501|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
56711502|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56711503|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711504|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711505|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
56711506|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711507|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56711520|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56711521|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56711522|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56711523|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56711524|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
56711525|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711526|NCT01997840|Dexamethasone|dexamethasone|mesh-list
56711527|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
56711528|NCT01997840|Pomalidomide|pomalidomide|mesh-list
56711529|NCT01997840|Ricolinostat|ricolinostat|mesh-list
56711530|NCT01997840|BB 1101|bb 1101|mesh-list
56711531|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56711532|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
56711533|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
56711534|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711535|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711536|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56711537|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
56711538|NCT01997840|Hormones|hormones|mesh-ancestor
56711539|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711540|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56711541|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711542|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
56711543|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711544|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711545|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
56711546|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56711547|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56711548|NCT01997840|Growth Substances|growth substances|mesh-ancestor
56711549|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
56711550|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56711551|NCT01937468|Interleukin-2|interleukin-2|mesh-list
56711552|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536209|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56536210|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56536211|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711553|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56711554|NCT01937468|Analgesics|analgesics|mesh-ancestor
56711555|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
56711556|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711557|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711558|NCT00663117|Naltrexone|naltrexone|mesh-list
56711559|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56711560|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56711561|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711562|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
56711563|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711564|NCT04072328|Midazolam|midazolam|mesh-list
56711565|NCT04072328|Propofol|propofol|mesh-list
56711566|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56711567|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711568|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711569|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56711570|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
56711571|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
56711572|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56711573|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56711593|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711594|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56711595|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56711596|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
56711597|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711598|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56711599|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
56711600|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
56711601|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
56711602|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56711603|NCT04074122|Analgesics|analgesics|mesh-ancestor
56711604|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
56711605|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56711606|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
56711607|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56711608|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
56711609|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
56711610|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56711611|NCT04074122|Protective Agents|protective agents|mesh-ancestor
56711612|NCT02578550|Tenofovir|tenofovir|mesh-list
56711613|NCT02578550|Emtricitabine|emtricitabine|mesh-list
56711614|NCT02578550|Darunavir|darunavir|mesh-list
56711615|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56711616|NCT02578550|Cobicistat|cobicistat|mesh-list
56711617|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56711618|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56711619|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
56711620|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711621|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56711622|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56711623|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711624|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711625|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56711626|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56711627|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56711628|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56711629|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
56711630|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56711631|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56711661|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56711662|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711663|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56711664|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
56711665|NCT04941144|Vaccines|vaccines|mesh-list
56711666|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
56711667|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711668|NCT03099174|Letrozole|letrozole|mesh-list
56711669|NCT03099174|Fulvestrant|fulvestrant|mesh-list
56711670|NCT03099174|Anastrozole|anastrozole|mesh-list
56711671|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536212|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56536213|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536214|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536215|NCT00627081|Remifentanil|remifentanil|mesh-list
56536216|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56536217|NCT00627081|Narcotics|narcotics|mesh-ancestor
56536218|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536219|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536220|NCT00627081|Analgesics|analgesics|mesh-ancestor
56284459|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56536221|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
56536222|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536224|NCT02888054|Lesinurad|lesinurad|mesh-list
56536225|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
56536226|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536227|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536228|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
56536229|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56536230|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56536231|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
56536232|NCT02888054|Protective Agents|protective agents|mesh-ancestor
56536233|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536234|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
56536235|NCT02888054|Renal Agents|renal agents|mesh-ancestor
56536236|NCT02811289|Mirabegron|mirabegron|mesh-list
56536237|NCT02811289|Glycerol|glycerol|mesh-list
56536238|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56536239|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56536240|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56536241|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
56190416|NCT01468051|Vaccines|vaccines|mesh-list
56711672|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56711673|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56711674|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711675|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711676|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56711709|NCT02577848|Liraglutide|liraglutide|mesh-list
56711710|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56711711|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711712|NCT02577848|Incretins|incretins|mesh-ancestor
56711713|NCT02577848|Hormones|hormones|mesh-ancestor
56711714|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711715|NCT00582426|Octreotide|octreotide|mesh-list
56711716|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56711738|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
56711739|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56536242|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536243|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536244|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536245|NCT02811289|Urological Agents|urological agents|mesh-ancestor
56190436|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
56711740|NCT00710138|Vitamins|vitamins|mesh-list
56711741|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
56711742|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
56711743|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
56711744|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
56711745|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711746|NCT00710138|Hematinics|hematinics|mesh-ancestor
56711747|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
56711748|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711749|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711750|NCT00710216|Lamivudine|lamivudine|mesh-list
56711751|NCT00710216|Telbivudine|telbivudine|mesh-list
56711752|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56711753|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56711754|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711755|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711756|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
56711758|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56711759|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56711760|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
56711761|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
56711762|NCT00773513|Hematinics|hematinics|mesh-ancestor
56711763|NCT00710528|Idelalisib|idelalisib|mesh-list
56711764|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711765|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711766|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711767|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
56711768|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56711769|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711770|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56711771|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56711772|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
56711802|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711803|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711804|NCT00711620|Thymalfasin|thymalfasin|mesh-list
56711805|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56711806|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
56711807|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711808|NCT00581828|Vitamin D|vitamin d|mesh-list
56711809|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
56711810|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
56711811|NCT00581828|Vitamins|vitamins|mesh-list
56711812|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
56711813|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711814|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56711815|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56711816|NCT02577614|Coagulants|coagulants|mesh-list
56711817|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
56711818|NCT02577458|Everolimus|everolimus|mesh-list
56711819|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711820|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56711821|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
56711822|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711852|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
56711853|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
56711854|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
56711855|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711856|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56711857|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56711858|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56711859|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711860|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711861|NCT02574338|Alprostadil|alprostadil|mesh-list
56711862|NCT02574338|Misoprostol|misoprostol|mesh-list
56536246|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56536247|NCT02811289|Protective Agents|protective agents|mesh-ancestor
56536248|NCT01040793|Olodaterol|olodaterol|mesh-list
56536249|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56536250|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
56536251|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536252|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536253|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56536254|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
56536255|NCT02811055|Aprepitant|aprepitant|mesh-list
56536256|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
56536257|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
56536258|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536259|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536260|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56711863|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56711864|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
56711865|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56267245|NCT01973400|Tocotrienols|tocotrienols|mesh-list
56711899|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56711900|NCT00795171|Growth Substances|growth substances|mesh-ancestor
56711901|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711902|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
56711903|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56711904|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711905|NCT00711854|Rifampin|rifampin|mesh-list
56711906|NCT00711854|Linezolid|linezolid|mesh-list
56711907|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56711908|NCT00711854|Trimethoprim|trimethoprim|mesh-list
56711923|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56711924|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56711925|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56711927|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
56711928|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56711929|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56711930|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56711931|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56711932|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56711933|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56711935|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56711936|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
56711937|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56711938|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
56711939|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711940|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711941|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
56711942|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
56711943|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56711944|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711945|NCT00712400|Latanoprost|latanoprost|mesh-list
56711946|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56711947|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56711948|NCT00712478|Insulin|insulin|mesh-list
56711949|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56711950|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711951|NCT03015792|Dexamethasone|dexamethasone|mesh-list
56711952|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
56711953|NCT03015792|Lenalidomide|lenalidomide|mesh-list
56711954|NCT03015792|Ichthammol|ichthammol|mesh-list
56711955|NCT03015792|BB 1101|bb 1101|mesh-list
56711956|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56711957|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
56536261|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56536262|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536263|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536264|NCT04192903|Cisplatin|cisplatin|mesh-list
56536265|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536266|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
56536267|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56536268|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536269|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536270|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56536271|NCT02810899|Analgesics|analgesics|mesh-ancestor
56536272|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
56536273|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536274|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56536275|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56536276|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56536277|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
56536278|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711958|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
56711959|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711960|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711961|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56711962|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
56711963|NCT03015792|Hormones|hormones|mesh-ancestor
56711964|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711965|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56711966|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711967|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
56267340|NCT01973855|Ribavirin|ribavirin|mesh-list
56711993|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56711994|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56711995|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56711996|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56711998|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
56711999|NCT00712556|Protective Agents|protective agents|mesh-ancestor
56712000|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712001|NCT00772967|Naproxen|naproxen|mesh-list
56712002|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56712003|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56712004|NCT00772967|Analgesics|analgesics|mesh-ancestor
56712005|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
56712006|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712007|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712008|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56712009|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712010|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
56712011|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56712012|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712013|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712014|NCT00793377|Tamoxifen|tamoxifen|mesh-list
56712078|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712079|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712080|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56712081|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56536279|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536280|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
56536281|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536282|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536283|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56536284|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536285|NCT02810275|Leucovorin|leucovorin|mesh-list
56536286|NCT02810275|Folic Acid|folic acid|mesh-list
56536287|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
56536288|NCT02810275|Antidotes|antidotes|mesh-ancestor
56536289|NCT02810275|Protective Agents|protective agents|mesh-ancestor
56536290|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033621|NCT01600703|Hormones|hormones|mesh-ancestor
56712082|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712083|NCT00582114|Atenolol|atenolol|mesh-list
56712084|NCT00582114|Lisinopril|lisinopril|mesh-list
56712085|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56712086|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
56712087|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712088|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712089|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56712090|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56712091|NCT00582114|Protective Agents|protective agents|mesh-ancestor
56712092|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712093|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56712094|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
56712095|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
56712096|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712097|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56712098|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56712128|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712129|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
56423257|NCT00559429|Analgesics|analgesics|mesh-ancestor
56712130|NCT00660387|Levodopa|levodopa|mesh-list
56712131|NCT00660387|Carbidopa|carbidopa|mesh-list
56712132|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56712133|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56712134|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56712135|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
56712136|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712137|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712138|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712139|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56712140|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712141|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56712142|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
56712156|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712158|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56712159|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
56712160|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56712161|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712162|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56712163|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56712164|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56712165|NCT00789711|Insulin|insulin|mesh-list
56712166|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56712167|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
56712168|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
56712169|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
56712170|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56712171|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56712172|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712173|NCT00713726|Fentanyl|fentanyl|mesh-list
56712174|NCT00713726|Tramadol|tramadol|mesh-list
56536291|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
56536292|NCT02810275|Vitamins|vitamins|mesh-ancestor
56536293|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
56536294|NCT02810275|Hematinics|hematinics|mesh-ancestor
56536295|NCT00948064|Azacitidine|azacitidine|mesh-list
56536296|NCT00948064|Vorinostat|vorinostat|mesh-list
56536297|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56536298|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
56536299|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536300|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536301|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536302|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56536303|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56536304|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56536305|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
56536306|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56536307|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
56536308|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56536309|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536310|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56712175|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56712176|NCT00713726|Narcotics|narcotics|mesh-ancestor
56712177|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712178|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712179|NCT00713726|Analgesics|analgesics|mesh-ancestor
56712180|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
56712181|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712182|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56712183|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56712184|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
56712185|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
56712186|NCT00800553|Donepezil|donepezil|mesh-list
56712187|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56712188|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712189|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712190|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
56712191|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712192|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712193|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
56712194|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
56712195|NCT00793767|Hematinics|hematinics|mesh-ancestor
56712196|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56712197|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56712198|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56712199|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712200|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712201|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56712202|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56712203|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56712224|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56712226|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56712227|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712228|NCT00800709|Memantine|memantine|mesh-list
56712229|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56712230|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56712231|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
56536311|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56536312|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536313|NCT02858206|Paclitaxel|paclitaxel|mesh-list
56536314|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
56536315|NCT02858206|Nedaplatin|nedaplatin|mesh-list
56536316|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56536317|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536318|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56536319|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56536320|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56536321|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536322|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56536323|NCT02815189|Acetaminophen|acetaminophen|mesh-list
56536324|NCT02815189|Ibuprofen|ibuprofen|mesh-list
56536325|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56536326|NCT02815189|Analgesics|analgesics|mesh-ancestor
56190512|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
56712232|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712233|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712234|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712235|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56712236|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56712237|NCT00793923|Dexamethasone|dexamethasone|mesh-list
56712238|NCT00793923|Ranibizumab|ranibizumab|mesh-list
56712239|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56712240|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
56712241|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
56712242|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712243|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712244|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56712245|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
56712246|NCT00793923|Hormones|hormones|mesh-ancestor
56712247|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712248|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56712249|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712250|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56712251|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56712252|NCT00793923|Growth Substances|growth substances|mesh-ancestor
56712253|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
56712254|NCT01247324|Interferons|interferons|mesh-list
56712255|NCT01247324|Interferon-beta|interferon-beta|mesh-list
56712256|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
56712257|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
56267630|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712278|NCT02345850|Tacrolimus|tacrolimus|mesh-list
56423403|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56712279|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56712280|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
56712281|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712282|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712283|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56712284|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
56712285|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712286|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712287|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56712288|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56712289|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
56712290|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56712291|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56536327|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
56536328|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536329|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536330|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
56536331|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56536332|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56536333|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56536334|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56536335|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536336|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536337|NCT02809963|Eplerenone|eplerenone|mesh-list
56536338|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56536339|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
56536340|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190518|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
56190519|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190520|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56190521|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56190529|NCT01468740|Prednisone|prednisone|mesh-list
56712292|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
56712293|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
56712294|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712295|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56712296|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56712297|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56712298|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
56712299|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
56712300|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712301|NCT05485805|Naproxen|naproxen|mesh-list
56712302|NCT05485805|Caffeine|caffeine|mesh-list
56712303|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56712304|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712305|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56712306|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712307|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712308|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56712309|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56712310|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
56712335|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56712336|NCT02576600|Narcotics|narcotics|mesh-ancestor
56712337|NCT02576600|Analgesics|analgesics|mesh-ancestor
56712338|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
56712339|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712340|NCT02863770|Pancrelipase|pancrelipase|mesh-list
56712341|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56712342|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56712343|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56712344|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56712345|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712346|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712347|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56712348|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56712349|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56536341|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536342|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56536343|NCT02809963|Diuretics|diuretics|mesh-ancestor
56536344|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
56536345|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56536346|NCT02815111|Acetaminophen|acetaminophen|mesh-list
56536347|NCT02815111|Lidocaine|lidocaine|mesh-list
56536348|NCT02815111|Ketamine|ketamine|mesh-list
56536349|NCT02815111|Gabapentin|gabapentin|mesh-list
56536350|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
56536351|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
56536352|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536353|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536354|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
56536355|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712350|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
56712351|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712352|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712353|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56712354|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56712355|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
56712356|NCT00660309|Irbesartan|irbesartan|mesh-list
56712357|NCT00660309|Captopril|captopril|mesh-list
56712358|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56712359|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56712360|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56267747|NCT01977209|Gossypol|gossypol|mesh-list
56712391|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712393|NCT00794235|Dacarbazine|dacarbazine|mesh-list
56712394|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712395|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56712396|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712397|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712398|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56712399|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
56712400|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
56712401|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56267806|NCT01977417|Analgesics|analgesics|mesh-ancestor
56712419|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
56712420|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56712421|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
56712422|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712423|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712424|NCT00796497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56712425|NCT00796497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56712426|NCT00796497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712427|NCT00796497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56712428|NCT00796497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56423556|NCT04626973|Ezetimibe|ezetimibe|mesh-list
56712429|NCT04330820|Venetoclax|venetoclax|mesh-list
56712431|NCT00801177|Necitumumab|necitumumab|mesh-list
56712432|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56712433|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56712434|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712435|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
56712436|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712437|NCT00581100|Etanercept|etanercept|mesh-list
56712438|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56712439|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56712440|NCT00581100|Analgesics|analgesics|mesh-ancestor
56712441|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
56712442|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536356|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56536357|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56712443|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712444|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56712445|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712446|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56712447|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56712448|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
56712449|NCT00579098|Atorvastatin|atorvastatin|mesh-list
56712450|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56712451|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56712452|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
56712453|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712454|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56712455|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56712456|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712457|NCT00772109|Vaccines|vaccines|mesh-list
56712458|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
56712459|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712460|NCT00801255|Lactams|lactams|mesh-list
56712461|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56712481|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56712482|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56712483|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56712484|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56712486|NCT02577432|Bupivacaine|bupivacaine|mesh-list
56712487|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
56712488|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
56712489|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712490|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712491|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
56712492|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712493|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56712494|NCT02577432|Narcotics|narcotics|mesh-ancestor
56712495|NCT02577432|Analgesics|analgesics|mesh-ancestor
56712496|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56712497|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56712498|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
56712499|NCT00794703|Itraconazole|itraconazole|mesh-list
56712500|NCT00794703|Micafungin|micafungin|mesh-list
56712501|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
56712502|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712503|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56712504|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56712505|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712506|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712507|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56712508|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
56712509|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712510|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712511|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56712512|NCT00772031|Topiramate|topiramate|mesh-list
56712513|NCT00772031|Propranolol|propranolol|mesh-list
56712514|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56712515|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56712516|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
56712517|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267902|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
56712545|NCT00794859|Sorafenib|sorafenib|mesh-list
56712546|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712547|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56712548|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712549|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712550|NCT04940013|Misoprostol|misoprostol|mesh-list
56712551|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56712552|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
56712553|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56712554|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712555|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56712556|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56712557|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
56712558|NCT00771953|Docetaxel|docetaxel|mesh-list
56712559|NCT00771953|Pemetrexed|pemetrexed|mesh-list
56536358|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56536359|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56712560|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712561|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56712562|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56712563|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56712564|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712565|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712596|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712597|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712598|NCT00659529|Urological Agents|urological agents|mesh-ancestor
56712599|NCT02575508|Fluorouracil|fluorouracil|mesh-list
56712600|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
56712601|NCT02575508|Irinotecan|irinotecan|mesh-list
56712602|NCT02575508|Camptothecin|camptothecin|mesh-list
56712603|NCT02575508|Infigratinib|infigratinib|mesh-list
56712604|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
56712605|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712606|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56712607|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712608|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56712627|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
56712629|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
56712630|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712631|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
56712632|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56712633|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712634|NCT00843934|Epirubicin|epirubicin|mesh-list
56712635|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712636|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56712637|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56712638|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56712639|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712640|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712641|NCT00805701|Dutasteride|dutasteride|mesh-list
56712642|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56712643|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56712644|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712645|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712646|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
56712647|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712648|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712649|NCT04042948|Acetaminophen|acetaminophen|mesh-list
56712650|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56712651|NCT04042948|Analgesics|analgesics|mesh-ancestor
56712652|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
56712653|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56423776|NCT00220064|Vitamins|vitamins|mesh-ancestor
56712654|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712655|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
56712656|NCT00765245|Rituximab|rituximab|mesh-list
56712657|NCT00765245|Lenalidomide|lenalidomide|mesh-list
56712658|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56712659|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712660|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
56712661|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712662|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712663|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56712664|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55843205|NCT01677442|Anesthetics|anesthetics|mesh-list
56712701|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
56712702|NCT00801957|Tacrolimus|tacrolimus|mesh-list
56712703|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56268079|NCT01980082|Cefazolin|cefazolin|mesh-list
56712732|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712733|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56712735|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56712736|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
56712737|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712738|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712739|NCT00656799|Bromides|bromides|mesh-list
56712740|NCT00656799|Rocuronium|rocuronium|mesh-list
56712741|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
56060861|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
56536360|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712742|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56712743|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56712744|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56712745|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712746|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712747|NCT00764699|Mecasermin|mecasermin|mesh-list
56712773|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
56712774|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712775|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712776|NCT00836212|Efavirenz|efavirenz|mesh-list
56712777|NCT00836212|Lopinavir|lopinavir|mesh-list
56712778|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56712779|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56712780|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712781|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712782|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
56712783|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712784|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56712785|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56712786|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56712787|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56712788|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56712789|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56712790|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56712791|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56712792|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
56712793|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56712794|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56712809|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56712810|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712811|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
56712812|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
56712813|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712814|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56712815|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56712816|NCT00782717|Protective Agents|protective agents|mesh-ancestor
56712817|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56712818|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56712819|NCT00782717|Analgesics|analgesics|mesh-ancestor
56712820|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
56712821|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712822|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
56712823|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56712824|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56712825|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
56712826|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712827|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56712828|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56712829|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712830|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712831|NCT02601677|Fluoxetine|fluoxetine|mesh-list
56712832|NCT02601677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56712833|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56712834|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56712835|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712836|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712837|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
56712838|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712839|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56712840|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
56712841|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56712842|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56712843|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56712844|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712845|NCT04558112|Levodopa|levodopa|mesh-list
56712846|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56712847|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56712848|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
56712849|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712850|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536361|NCT02815111|Analgesics|analgesics|mesh-ancestor
56536362|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56536363|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56536364|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
56035093|NCT03018626|Hormones|hormones|mesh-ancestor
56712851|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712852|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56712853|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55843357|NCT03813160|Hormones|hormones|mesh-ancestor
56712879|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712881|NCT00836368|Tocopherols|tocopherols|mesh-list
56712882|NCT00836368|Tocotrienols|tocotrienols|mesh-list
56712883|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
56712884|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
56712885|NCT00836368|Vitamins|vitamins|mesh-ancestor
56712886|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
56712887|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712888|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
56712889|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712890|NCT00836368|Protective Agents|protective agents|mesh-ancestor
56712891|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
56712892|NCT00718796|Ubiquinone|ubiquinone|mesh-list
56712893|NCT00718796|Atorvastatin|atorvastatin|mesh-list
56712894|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56712895|NCT00718796|Simvastatin|simvastatin|mesh-list
56712896|NCT00718796|Pravastatin|pravastatin|mesh-list
56712897|NCT00718796|Lovastatin|lovastatin|mesh-list
56712898|NCT00718796|L 647318|l 647318|mesh-list
56712899|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
56712900|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
56712901|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56712902|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
56712903|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712904|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56712905|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56712906|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712907|NCT00718796|Vitamins|vitamins|mesh-ancestor
56712942|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712943|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712944|NCT04263922|Valsartan|valsartan|mesh-list
56712945|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56712946|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56712947|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56712979|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56712980|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
56712981|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712982|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56712983|NCT00842140|Diuretics|diuretics|mesh-ancestor
56712984|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
56712985|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56712986|NCT00806169|Triamcinolone|triamcinolone|mesh-list
56712987|NCT00806169|Bevacizumab|bevacizumab|mesh-list
56712988|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56712989|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712990|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56712991|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56424145|NCT00243399|Androgens|androgens|mesh-ancestor
56713025|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713026|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713027|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713028|NCT00844402|Atorvastatin|atorvastatin|mesh-list
56713029|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56713030|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56713065|NCT00659373|Tamoxifen|tamoxifen|mesh-list
56713066|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56713067|NCT00659373|Exemestane|exemestane|mesh-list
56713068|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56713069|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
56713094|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56713095|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713096|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713097|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56536365|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56536366|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56536367|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536368|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56536369|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
56536370|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
56713098|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56713099|NCT02552745|Analgesics|analgesics|mesh-ancestor
56713100|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
56713101|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713102|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713103|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713104|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56713105|NCT02547844|Tenofovir|tenofovir|mesh-list
56713106|NCT02547844|Efavirenz|efavirenz|mesh-list
56713107|NCT02547844|Emtricitabine|emtricitabine|mesh-list
56713108|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
56713109|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713110|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56713111|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56713112|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713113|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713114|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56713115|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56713136|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713137|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56713138|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56713139|NCT00842686|Growth Substances|growth substances|mesh-ancestor
56713140|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713141|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
56713142|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56713143|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
56713144|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713145|NCT04045821|Plerixafor|plerixafor|mesh-list
56713146|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56713147|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56713148|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
56713149|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713150|NCT00803439|Clobetasol|clobetasol|mesh-list
56713151|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713152|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
56713153|NCT00803439|Hormones|hormones|mesh-ancestor
56713154|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713155|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713156|NCT00806481|Sevelamer|sevelamer|mesh-list
56713157|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
56713158|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
56713159|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713160|NCT00709436|Ketamine|ketamine|mesh-list
56713161|NCT00709436|Analgesics|analgesics|mesh-ancestor
56713162|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
56713163|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713164|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713165|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56713166|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56713167|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
56713168|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
56713169|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56713202|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56713203|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713204|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713205|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56713206|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56713207|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56713208|NCT00803829|Sulfalene|sulfalene|mesh-list
56713209|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713210|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56713211|NCT00803829|Renal Agents|renal agents|mesh-ancestor
56713212|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
56536371|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56536372|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56536373|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56536374|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
56536376|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536377|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536378|NCT02809729|Cefazolin|cefazolin|mesh-list
56536379|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56536380|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536381|NCT00953524|Vaccines|vaccines|mesh-list
56536382|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
56536383|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536384|NCT02809573|Prednisone|prednisone|mesh-list
56713213|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56713214|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56713249|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56713250|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424369|NCT04615702|Bilirubin|bilirubin|mesh-list
56713251|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56713252|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
56713253|NCT00716924|Clopidogrel|clopidogrel|mesh-list
56713254|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56268629|NCT01984008|Antacids|antacids|mesh-ancestor
56713291|NCT00792948|Dasatinib|dasatinib|mesh-list
56713292|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
56713293|NCT00792948|Tacrolimus|tacrolimus|mesh-list
56713294|NCT00792948|Lenograstim|lenograstim|mesh-list
56713295|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56713296|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
56713297|NCT00792948|BB 1101|bb 1101|mesh-list
56713298|NCT00792948|Calcium|calcium|mesh-list
56713299|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
56268673|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
56713330|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
56713331|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56713332|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56713333|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56713334|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
56713335|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713336|NCT00792948|Antidotes|antidotes|mesh-ancestor
56713337|NCT00792948|Protective Agents|protective agents|mesh-ancestor
56713338|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
56713339|NCT00792948|Vitamins|vitamins|mesh-ancestor
56713375|NCT04068506|Analgesics|analgesics|mesh-ancestor
56713376|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
56713377|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713378|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713379|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
56713411|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56713413|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
56713414|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56713415|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
56713416|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713417|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
56713418|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
56713419|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713447|NCT00845104|Bevacizumab|bevacizumab|mesh-list
56713448|NCT00845104|Rituximab|rituximab|mesh-list
56713449|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56713450|NCT00845104|Fludarabine|fludarabine|mesh-list
56713451|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
56713452|NCT00845104|Antibodies|antibodies|mesh-list
56713453|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
56713454|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56713455|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713456|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56713457|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56713458|NCT00845104|Growth Substances|growth substances|mesh-ancestor
56536385|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
56536386|NCT02809573|Vincristine|vincristine|mesh-list
56536387|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56536388|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
56536389|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536390|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56536391|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56536392|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
56536393|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536394|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536395|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56536396|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56536397|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
56536398|NCT02809573|Hormones|hormones|mesh-ancestor
56536399|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56536400|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56536401|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56536402|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
56536403|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
56536404|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
56536405|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
56536406|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56536407|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
56536408|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536409|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536410|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56536411|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
56713459|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713460|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
56713461|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
56713462|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56713463|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56713464|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
56713465|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713466|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713467|NCT00763451|Metformin|metformin|mesh-list
56713494|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56713495|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56713496|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
56713497|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713498|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713499|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56713500|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713501|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
56713502|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
56713503|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536412|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56536413|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
56536414|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536415|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536416|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56536417|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
56536418|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
56536419|NCT04388683|Protective Agents|protective agents|mesh-ancestor
56536420|NCT01040403|Bromides|bromides|mesh-list
56536421|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
56536422|NCT01040403|Olodaterol|olodaterol|mesh-list
56536423|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56536424|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
56536425|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713504|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56713505|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
56713506|NCT00424489|Hormones|hormones|mesh-ancestor
56713507|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713508|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56713509|NCT00424489|Protective Agents|protective agents|mesh-ancestor
56713510|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56713511|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
56713512|NCT00578864|Doxorubicin|doxorubicin|mesh-list
56713513|NCT00578864|Etoposide|etoposide|mesh-list
56713514|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
56713515|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713516|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
56713517|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713548|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713549|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
56713550|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56713551|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713552|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713553|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56713554|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56713555|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
56713556|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56713557|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713558|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
56713559|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
56713560|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713561|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56713562|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56713563|NCT00717470|Protective Agents|protective agents|mesh-ancestor
56713565|NCT00631566|Triclosan|triclosan|mesh-list
56713566|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
56713567|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56713568|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713569|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56713570|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713571|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713572|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56713573|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56713574|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56713575|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
56713576|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56713577|NCT00722852|Ketoprofen|ketoprofen|mesh-list
56713578|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56713579|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56713580|NCT00722852|Analgesics|analgesics|mesh-ancestor
56713581|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
56713582|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536426|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536427|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56190619|NCT01469520|Lamivudine|lamivudine|mesh-list
56713583|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713584|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713585|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56713586|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56713587|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713588|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713589|NCT05657444|Tenecteplase|tenecteplase|mesh-list
56713590|NCT05657444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56713591|NCT05657444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56713592|NCT05657444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713593|NCT01410942|Methylphenidate|methylphenidate|mesh-list
56713594|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56713595|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713596|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56713597|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56713598|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56713599|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713600|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
56713601|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713602|NCT04833426|Testosterone|testosterone|mesh-list
56713603|NCT04833426|Androgens|androgens|mesh-ancestor
56713604|NCT04833426|Hormones|hormones|mesh-ancestor
56713605|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713606|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713607|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56713608|NCT02576964|Capecitabine|capecitabine|mesh-list
56713609|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56713610|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
56713611|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713612|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713613|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
56713614|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713615|NCT00763139|Pioglitazone|pioglitazone|mesh-list
56713616|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56713617|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713618|NCT01366092|Interleukin-2|interleukin-2|mesh-list
56713619|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713620|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56713621|NCT01366092|Analgesics|analgesics|mesh-ancestor
56713622|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
56713623|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713624|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713625|NCT00781859|Plasminogen|plasminogen|mesh-list
56713626|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56713627|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56713628|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713629|NCT01344252|Lidocaine|lidocaine|mesh-list
56713630|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
56424746|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
56713631|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
56713632|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56713633|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713634|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
56713635|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713636|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56713671|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713672|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56713673|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713674|NCT00417079|Analgesics|analgesics|mesh-ancestor
56713675|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
56713676|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713706|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
56713707|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713708|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713709|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713710|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56713711|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56713712|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56536428|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
56713713|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713714|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56713715|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56713716|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713717|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
56713718|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56713734|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56713735|NCT04745832|Rituximab|rituximab|mesh-list
56713736|NCT04745832|Vincristine|vincristine|mesh-list
56713737|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713738|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
56713739|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713740|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56713741|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56713742|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
56713743|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713744|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713745|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56713746|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56713747|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713748|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
56713749|NCT04745832|Hormones|hormones|mesh-ancestor
56713750|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713751|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56713752|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56713753|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
56713754|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
56713755|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
56713756|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
56713757|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56713758|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
56713759|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713760|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56713761|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713762|NCT02576340|Octylonium|octylonium|mesh-list
56713763|NCT02576340|Bromides|bromides|mesh-list
56713764|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
56713765|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56713766|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56713767|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713768|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56713769|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713770|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56713771|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
56713772|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
56713773|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713774|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56713775|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56713776|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
56713777|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713778|NCT02578602|Edetic Acid|edetic acid|mesh-list
56713779|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
56713780|NCT02578602|Antidotes|antidotes|mesh-ancestor
56713804|NCT00128856|Immunologic Factors|immunologic factors|mesh-ancestor
56713805|NCT00128856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713806|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56713807|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56713808|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56713809|NCT00128778|Doxorubicin|doxorubicin|mesh-list
56713810|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56713811|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56713812|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713813|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56713814|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56713815|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713816|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713817|NCT00709488|Talaporfin|talaporfin|mesh-list
56713818|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713819|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56713820|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
56713821|NCT00714246|Carboplatin|carboplatin|mesh-list
56713822|NCT00714246|Docetaxel|docetaxel|mesh-list
56713823|NCT00714246|Bortezomib|bortezomib|mesh-list
56536429|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
56536430|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56536431|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
56536432|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536433|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536434|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
56536435|NCT00957034|Testosterone|testosterone|mesh-list
56536436|NCT00957034|Androgens|androgens|mesh-ancestor
56536437|NCT00957034|Hormones|hormones|mesh-ancestor
56536438|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56536439|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536440|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
56536441|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
56536442|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56536443|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536444|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56536445|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713824|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713825|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
56713826|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
56713827|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
56713828|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713829|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56713830|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56713831|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713832|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
56269201|NCT01987323|Latanoprost|latanoprost|mesh-list
56713864|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713865|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56713866|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56713867|NCT04454658|Navitoclax|navitoclax|mesh-list
56713868|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713869|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
56713870|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56713871|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
56713872|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713873|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713874|NCT00714558|Fentanyl|fentanyl|mesh-list
56713875|NCT00714558|Naltrexone|naltrexone|mesh-list
56713876|NCT00714558|Naloxone|naloxone|mesh-list
56713877|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56713878|NCT00714558|Narcotics|narcotics|mesh-ancestor
56713879|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56713947|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56713948|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
56713949|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56713950|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56713951|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56713952|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56713953|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
56269330|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713989|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269370|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56714015|NCT00845338|Urological Agents|urological agents|mesh-ancestor
56714016|NCT00923962|Adenosine|adenosine|mesh-list
56714017|NCT00923962|Glucagon|glucagon|mesh-list
56714018|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56714019|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56714020|NCT00923962|Hormones|hormones|mesh-ancestor
56536446|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536447|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
56536448|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56714021|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56714022|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714023|NCT00923962|Incretins|incretins|mesh-ancestor
56714024|NCT00923962|Analgesics|analgesics|mesh-ancestor
56714025|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
56714026|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714027|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56714028|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
56714029|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56714030|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
56714031|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
56714032|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714033|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714034|NCT02575092|Folic Acid|folic acid|mesh-list
56714035|NCT02575092|Enalapril|enalapril|mesh-list
56714036|NCT02575092|Enalaprilat|enalaprilat|mesh-list
56714037|NCT02575092|Maleic acid|maleic acid|mesh-list
56714038|NCT02575092|Hematinics|hematinics|mesh-ancestor
56714039|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
56714040|NCT02575092|Vitamins|vitamins|mesh-ancestor
56714041|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
56714042|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714074|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
56714075|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
56714076|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56714077|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56714078|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
56714079|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56714080|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56714081|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714082|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56714083|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269456|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56714110|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56714111|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714112|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714113|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
56714114|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56714115|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714116|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714117|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56714118|NCT00852046|Analgesics|analgesics|mesh-ancestor
56714119|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
56714120|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714121|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56714122|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56714123|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56714124|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
56714125|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714126|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714127|NCT02573064|Vancomycin|vancomycin|mesh-list
56714128|NCT02573064|Colistin|colistin|mesh-list
56714129|NCT02573064|Tigecycline|tigecycline|mesh-list
56714130|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56714131|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714132|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56714166|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56714167|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56714168|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714169|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714170|NCT00712062|Pemetrexed|pemetrexed|mesh-list
56714171|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714172|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714173|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714174|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56714175|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56714176|NCT00712140|Trastuzumab|trastuzumab|mesh-list
56269545|NCT01990690|Antioxidants|antioxidants|mesh-list
56473649|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
56536449|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
56536450|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536451|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
56536452|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56536453|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536454|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536455|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536457|NCT02090998|Amitriptyline|amitriptyline|mesh-list
56536458|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
56536459|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
56536460|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536461|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536462|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
56536463|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714207|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714209|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56714210|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
56714211|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
56714212|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56714213|NCT00712374|Amodiaquine|amodiaquine|mesh-list
56714214|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
56714215|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56714216|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56714217|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714218|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56714219|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714255|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
56714256|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714257|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714258|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56714286|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714287|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714288|NCT00856570|Urological Agents|urological agents|mesh-ancestor
56714289|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
56714290|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56714291|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714292|NCT00856804|Ribavirin|ribavirin|mesh-list
56714293|NCT00856804|Thalidomide|thalidomide|mesh-list
56714294|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
56714295|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714296|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
56714297|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714298|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714299|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
56714300|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714301|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
56714302|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56714303|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56714304|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56714305|NCT00856804|Growth Substances|growth substances|mesh-ancestor
56714306|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
56714328|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
56714329|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
56714330|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
56714331|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
56536464|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56536465|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56536466|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56536467|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56714332|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56714333|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56714334|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56714335|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56714336|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56714337|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56714338|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
56714339|NCT04041856|Povidone|povidone|mesh-list
56714340|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
56714341|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
56714342|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56714343|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714344|NCT00856960|Losartan|losartan|mesh-list
56714345|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56714346|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56714347|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56714348|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56714349|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714350|NCT00712764|Adenosine|adenosine|mesh-list
56714351|NCT00712764|Analgesics|analgesics|mesh-ancestor
56714352|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
56714353|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714354|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714355|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56714356|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
56714357|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56714358|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
56714359|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
56714384|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56714385|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
56714386|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714387|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714388|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714389|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
56714390|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
56714391|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714392|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56714393|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56714394|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56714395|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56714397|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714398|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56714399|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714400|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714401|NCT00620074|Voriconazole|voriconazole|mesh-list
56714402|NCT00620074|Anidulafungin|anidulafungin|mesh-list
56714403|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
56714404|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714405|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56714406|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56714407|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269775|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714439|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56714440|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714441|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
56714442|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714443|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714444|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
56714445|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
56714446|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56714447|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56714448|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714449|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714480|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56060862|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
56536468|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536469|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56536470|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
56536471|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56714482|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
56714483|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714484|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714485|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
56714486|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56714487|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56714488|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714489|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56714490|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714491|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714492|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56714493|NCT04018768|Narcotics|narcotics|mesh-ancestor
56714494|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714495|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
56714496|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56714522|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56714523|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56714524|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56714525|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714526|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56714527|NCT00720512|Leucovorin|leucovorin|mesh-list
56714528|NCT00720512|Bevacizumab|bevacizumab|mesh-list
56714529|NCT00720512|Fluorouracil|fluorouracil|mesh-list
56714530|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
56714531|NCT00720512|Irinotecan|irinotecan|mesh-list
56714532|NCT00720512|Calcium|calcium|mesh-list
56714533|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
56425641|NCT02961660|Odalasvir|odalasvir|mesh-list
56714534|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714535|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714536|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56714537|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56714538|NCT00720512|Growth Substances|growth substances|mesh-ancestor
56714539|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714540|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
56714541|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56714542|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
56714543|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714544|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56714545|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714546|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
56714547|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56714581|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714583|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714584|NCT00720018|Sumatriptan|sumatriptan|mesh-list
56714585|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56714586|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56714587|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56714588|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
56714589|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269975|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
56714610|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
56714611|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
56714612|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
56714613|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714614|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56714616|NCT00618826|Antiviral Agents|antiviral agents|mesh-ancestor
56714617|NCT00618826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714618|NCT00618826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714619|NCT00618826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714620|NCT00618826|Immunologic Factors|immunologic factors|mesh-ancestor
56714621|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714622|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714623|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56714624|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56536472|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56536473|NCT02090998|Analgesics|analgesics|mesh-ancestor
56536474|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56536475|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56536476|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
56714625|NCT00618826|Growth Substances|growth substances|mesh-ancestor
56714626|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
56714627|NCT00720174|Doxorubicin|doxorubicin|mesh-list
56714628|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56714629|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56714630|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56714631|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714632|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56714633|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56714634|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714635|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714636|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
56714637|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714638|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56714639|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
56714640|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714641|NCT03834740|Everolimus|everolimus|mesh-list
56714642|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714643|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714644|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
56270011|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
56714663|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56714664|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
56714665|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714666|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714667|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56714668|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56714669|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
56714670|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714671|NCT00720590|Ritonavir|ritonavir|mesh-list
56714672|NCT00720590|Lopinavir|lopinavir|mesh-list
56714673|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56714674|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56714675|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56714676|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
56714677|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714678|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714679|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56714680|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56714681|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
56714682|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714683|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56425801|NCT00566761|Hormones|hormones|mesh-ancestor
56714684|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56714686|NCT00718406|Morphine|morphine|mesh-list
56714687|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56714688|NCT00718406|Narcotics|narcotics|mesh-ancestor
56714689|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714690|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714691|NCT00718406|Analgesics|analgesics|mesh-ancestor
56714692|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
56714693|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714694|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56714695|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56714696|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
56714697|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
56714698|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56714699|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56714700|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56714701|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
56714729|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714730|NCT00852670|Ponesimod|ponesimod|mesh-list
56714731|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56714732|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714733|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714734|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
56536477|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536478|NCT02689999|Rabeprazole|rabeprazole|mesh-list
56190673|NCT01469650|Vitamins|vitamins|mesh-list
56714735|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714736|NCT00717210|Temozolomide|temozolomide|mesh-list
56714737|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56714738|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
56714739|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714740|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714741|NCT00723086|Docetaxel|docetaxel|mesh-list
56714742|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714743|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
56714744|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
56714745|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
56714746|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714781|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56714782|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56714783|NCT03816488|Analgesics|analgesics|mesh-ancestor
56714784|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
56714785|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714786|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56714787|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714822|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714824|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714825|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
56714826|NCT02545426|Calcium|calcium|mesh-list
56714827|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56714828|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714851|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
56714852|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714853|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56714854|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56714855|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714856|NCT00578448|Abatacept|abatacept|mesh-list
56714857|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56714858|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714859|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714860|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714861|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
56714862|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714863|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714864|NCT00720564|Temozolomide|temozolomide|mesh-list
56714865|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
56714866|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56714867|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
56714868|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714869|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714870|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56714871|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56714872|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56714873|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56714874|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714875|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714876|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714877|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56714878|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
56270258|NCT01995344|Analgesics|analgesics|mesh-ancestor
56714915|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
56714916|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56714945|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56714946|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714947|NCT05145296|Daratumumab|daratumumab|mesh-list
56714948|NCT05145296|Abatacept|abatacept|mesh-list
56714949|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714950|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56714951|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714952|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714953|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
56714954|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536479|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56536480|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56714955|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714956|NCT00859534|Afamelanotide|afamelanotide|mesh-list
56714957|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
56714958|NCT04078152|Durvalumab|durvalumab|mesh-list
56714959|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714960|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714961|NCT04230304|Daratumumab|daratumumab|mesh-list
56714962|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714963|NCT05036408|Coal Tar|coal tar|mesh-list
56714995|NCT00853216|Narcotics|narcotics|mesh-ancestor
56714996|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714997|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714998|NCT00853216|Analgesics|analgesics|mesh-ancestor
56714999|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
56715000|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715001|NCT04961528|Terlipressin|terlipressin|mesh-list
56715002|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
56715003|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56715004|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56270387|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
56715030|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715031|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
56715032|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715033|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
56715034|NCT00853294|Hydrocodone|hydrocodone|mesh-list
56715035|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715036|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56715037|NCT00853294|Narcotics|narcotics|mesh-ancestor
56715038|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56715039|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715040|NCT00853294|Analgesics|analgesics|mesh-ancestor
56715041|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
56715042|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715043|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
56715044|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
56715045|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
56715046|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
56715047|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56715048|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
56715049|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
56270441|NCT01996488|Olanzapine|olanzapine|mesh-list
56715088|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56715123|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715125|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715126|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715127|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715128|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
56715129|NCT00724022|Hormones|hormones|mesh-ancestor
56270514|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715163|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715164|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715165|NCT00853684|Capecitabine|capecitabine|mesh-list
56715166|NCT00853684|Endostar protein|endostar protein|mesh-list
56715167|NCT00853684|Endostatins|endostatins|mesh-list
56715168|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56715196|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56715197|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715199|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
56715200|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
56715201|NCT00724178|Calcium|calcium|mesh-list
56715202|NCT00724178|Vitamins|vitamins|mesh-ancestor
56715203|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
56715204|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715205|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56715206|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56715208|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715209|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715210|NCT02546050|Metformin|metformin|mesh-list
56715211|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56715212|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715213|NCT04800224|Propolis|propolis|mesh-list
56715214|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715282|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536481|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56536482|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536483|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536484|NCT02809105|Linaclotide|linaclotide|mesh-list
56715283|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
56715284|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715286|NCT00861016|Felodipine|felodipine|mesh-list
56715287|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56715288|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56715289|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
56715290|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
56715291|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715292|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715293|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56715294|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56715295|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56715296|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
56715297|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715298|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715328|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56715329|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715330|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715331|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
56715332|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
56715333|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56715334|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
56715335|NCT00861094|Leucovorin|leucovorin|mesh-list
56715336|NCT00861094|Folic Acid|folic acid|mesh-list
56715337|NCT00861094|Fluorouracil|fluorouracil|mesh-list
56715338|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
56715339|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
56715340|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715341|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
56715342|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715343|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56715344|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56715345|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
56715346|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715347|NCT00861094|Antidotes|antidotes|mesh-ancestor
55845853|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
56715376|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
56715377|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
56715378|NCT04019106|Hormones|hormones|mesh-ancestor
56715379|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715380|NCT02571608|Metformin|metformin|mesh-list
56715381|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56715382|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715383|NCT00865072|Metformin|metformin|mesh-list
56715384|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56715385|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715386|NCT00804297|Octreotide|octreotide|mesh-list
56715387|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715388|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56715389|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715390|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
56715391|NCT00861328|Irinotecan|irinotecan|mesh-list
56715392|NCT00861328|Camptothecin|camptothecin|mesh-list
56715393|NCT00861328|ON 01910|on 01910|mesh-list
56715394|NCT00861328|Glycine|glycine|mesh-list
56715395|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715396|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56715397|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56715398|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715399|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715431|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56715432|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56715433|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
56715434|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56715435|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56715436|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
56715437|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56715438|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
56715439|NCT00578292|Busulfan|busulfan|mesh-list
56715440|NCT00578292|Fludarabine|fludarabine|mesh-list
56536485|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56536486|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
56536487|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536488|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56536489|NCT00953056|Vaccines|vaccines|mesh-list
56536490|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
56536491|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536492|NCT02808949|Dapivirine|dapivirine|mesh-list
56536493|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56536494|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56536495|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
56536496|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536497|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
56536498|NCT04207177|Tacrolimus|tacrolimus|mesh-list
56536499|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56536500|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
56536501|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715441|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
56715442|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56715458|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715459|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715461|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56715462|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56715463|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56715464|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715465|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56715466|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56715467|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715468|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
56715469|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56715470|NCT00724724|Protective Agents|protective agents|mesh-ancestor
56715471|NCT00865462|Bupropion|bupropion|mesh-list
56715472|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56715473|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
56715474|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56715475|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56715476|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56715477|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56715478|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715479|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
56715480|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715481|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715482|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56715483|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56715484|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715485|NCT04042558|Bevacizumab|bevacizumab|mesh-list
56715486|NCT04042558|Carboplatin|carboplatin|mesh-list
56715487|NCT04042558|Pemetrexed|pemetrexed|mesh-list
56715488|NCT04042558|Atezolizumab|atezolizumab|mesh-list
56715489|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56715490|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56715491|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715492|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56715493|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56715494|NCT04042558|Growth Substances|growth substances|mesh-ancestor
56715495|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715496|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
56715497|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536502|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56536503|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190696|NCT01469975|Edetic Acid|edetic acid|mesh-list
56715498|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270860|NCT01999413|Cytarabine|cytarabine|mesh-list
56715530|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715532|NCT00865540|Hormones|hormones|mesh-ancestor
56715533|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715534|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715535|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56715536|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715537|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
56715538|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
56715539|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715540|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715541|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56715542|NCT00865540|Protective Agents|protective agents|mesh-ancestor
56715543|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56715574|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715576|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56715577|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56715578|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56715579|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56715580|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56715581|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56715582|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
56715583|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56270967|NCT02000336|Hormones|hormones|mesh-ancestor
56715613|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56715614|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56715615|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715616|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56715617|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715618|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715619|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56715620|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
56715621|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715623|NCT00798525|Lepirudin|lepirudin|mesh-list
56715624|NCT00798525|Argatroban|argatroban|mesh-list
56715625|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
56715626|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56715627|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
56715651|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56715652|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56715653|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715654|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56715655|NCT00725036|Insulin|insulin|mesh-list
56715656|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56715657|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
56715658|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
56715659|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
56426774|NCT04581967|Doxorubicin|doxorubicin|mesh-list
56715660|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
56715661|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56715662|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715663|NCT00724386|Paclitaxel|paclitaxel|mesh-list
56715664|NCT00724386|Vinorelbine|vinorelbine|mesh-list
56715665|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56715666|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715667|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
56715668|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
56715669|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
56715670|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715671|NCT00865852|Metformin|metformin|mesh-list
56715672|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56715673|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715674|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
56715675|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
56715676|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
56715677|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56715678|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715679|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
56536504|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536505|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56536506|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536507|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56536508|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
56536509|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56536510|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536511|NCT02812147|Droxidopa|droxidopa|mesh-list
56536512|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56536513|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56536514|NCT04303065|Dexamethasone|dexamethasone|mesh-list
56536515|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56536516|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
56536517|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
56536518|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536519|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536520|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56536521|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
56536522|NCT04303065|Hormones|hormones|mesh-ancestor
56634284|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536523|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56536524|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56715711|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56715713|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56715714|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
56715715|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
56715716|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56715717|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56715718|NCT03491540|Gentamicins|gentamicins|mesh-list
56715719|NCT03491540|Ornidazole|ornidazole|mesh-list
56715720|NCT03491540|Sennosides|sennosides|mesh-list
56715753|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715754|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56715755|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56715756|NCT04067856|Growth Substances|growth substances|mesh-ancestor
56715757|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715758|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
56715759|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715760|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
56715761|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
56715762|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715788|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56715789|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715790|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715792|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
56715793|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
56715794|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56715795|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715796|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
56715797|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715798|NCT00861952|Mineral Oil|mineral oil|mesh-list
56715799|NCT00861952|Emollients|emollients|mesh-ancestor
56715800|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
56536525|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536526|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56536527|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536528|NCT00952822|Factor VIII|factor viii|mesh-list
56536529|NCT00952822|Coagulants|coagulants|mesh-ancestor
56715801|NCT00655551|Lacosamide|lacosamide|mesh-list
56715802|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
56715803|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56715804|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56715805|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56715806|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715807|NCT00855088|Ritonavir|ritonavir|mesh-list
56715808|NCT00855088|Darunavir|darunavir|mesh-list
56715809|NCT00855088|Etravirine|etravirine|mesh-list
56426924|NCT00569335|Bevacizumab|bevacizumab|mesh-list
56715810|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56715811|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56271186|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
56715829|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715831|NCT02553603|Growth Substances|growth substances|mesh-ancestor
56715832|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56715833|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
56715834|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56715835|NCT00804531|Prednisolone|prednisolone|mesh-list
56715836|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
56715837|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56715838|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
56715839|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715840|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
56715841|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
56715842|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715843|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715844|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715845|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
56715846|NCT00804531|Hormones|hormones|mesh-ancestor
56715847|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715848|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56715849|NCT00804531|Protective Agents|protective agents|mesh-ancestor
56715850|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56715851|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715852|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
56715853|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56715854|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
56715855|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715856|NCT00866866|Expectorants|expectorants|mesh-ancestor
56715857|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
56715858|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56715859|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
56715860|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715861|NCT00866866|Protective Agents|protective agents|mesh-ancestor
56715862|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715863|NCT00866866|Antidotes|antidotes|mesh-ancestor
56715864|NCT00312728|Bevacizumab|bevacizumab|mesh-list
56715865|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56715866|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715867|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56715868|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56715900|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56715901|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715902|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56715903|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
56715904|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715905|NCT00866944|Antidotes|antidotes|mesh-ancestor
56715906|NCT00866944|Protective Agents|protective agents|mesh-ancestor
56715907|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
56715908|NCT00866944|Vitamins|vitamins|mesh-ancestor
56715909|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
56715910|NCT00577824|Exenatide|exenatide|mesh-list
56715911|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56715912|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715913|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56715948|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
56715949|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536530|NCT02854072|Gemcitabine|gemcitabine|mesh-list
56536531|NCT02854072|Capecitabine|capecitabine|mesh-list
56536532|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56536533|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
56536534|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536535|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536536|NCT02854072|Antiviral Agents|antiviral agents|mesh-ancestor
56536537|NCT02854072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536538|NCT02854072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536539|NCT02854072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56536540|NCT02854072|Immunologic Factors|immunologic factors|mesh-ancestor
56536541|NCT02854072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536542|NCT02537314|Benzocaine|benzocaine|mesh-list
56536543|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
56536544|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
56536545|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536546|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536547|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
56536548|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536549|NCT00631150|Levetiracetam|levetiracetam|mesh-list
56536550|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
56536551|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
56536552|NCT04278040|Melphalan|melphalan|mesh-list
56536553|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56536554|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
56536555|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536556|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536557|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56536558|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56536559|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
56536560|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536561|NCT02856724|Dinoprostone|dinoprostone|mesh-list
56536562|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
56715950|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56715951|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56715952|NCT03011814|Growth Substances|growth substances|mesh-ancestor
56715953|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
56715954|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715955|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56715956|NCT00870298|Trimethoprim|trimethoprim|mesh-list
56715983|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56715984|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
56715985|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536563|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56536564|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536565|NCT02808325|Polygeline|polygeline|mesh-list
56536566|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
56536567|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
56536568|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56536569|NCT00955474|Citalopram|citalopram|mesh-list
56536570|NCT00955474|Sertraline|sertraline|mesh-list
56536571|NCT00955474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56536572|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56536573|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56536574|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536575|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536576|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
56536577|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190759|NCT01470157|Analgesics|analgesics|mesh-ancestor
56715986|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715987|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715988|NCT00805233|Bromfenac|bromfenac|mesh-list
56715989|NCT00805233|Ranibizumab|ranibizumab|mesh-list
56715990|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56715991|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56715992|NCT00805233|Growth Substances|growth substances|mesh-ancestor
56715993|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715994|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
56715995|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715996|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56715997|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56715998|NCT00805233|Analgesics|analgesics|mesh-ancestor
56715999|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
56716000|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716001|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716002|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716003|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
56716004|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56271375|NCT02002325|Plasminogen|plasminogen|mesh-list
56716039|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
56716040|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716041|NCT00862264|Beclomethasone|beclomethasone|mesh-list
56716042|NCT00862264|Norflurane|norflurane|mesh-list
56716043|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
56716068|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716070|NCT00870532|Sorafenib|sorafenib|mesh-list
56716071|NCT00870532|Vinorelbine|vinorelbine|mesh-list
56716072|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716073|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56716074|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716075|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716076|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56716077|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
56716078|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
56716079|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
56716080|NCT00725478|Piribedil|piribedil|mesh-list
56716081|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56716082|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56716083|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
56716084|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
56716085|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716086|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716087|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536578|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56536579|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
56536580|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56536581|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56536582|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56536583|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536584|NCT02808247|Ifosfamide|ifosfamide|mesh-list
56716088|NCT03289650|Tacrolimus|tacrolimus|mesh-list
56716089|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716090|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
56716091|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716092|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56716093|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271464|NCT02002741|Acetaminophen|acetaminophen|mesh-list
56716096|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56716097|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716098|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716099|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716100|NCT03355794|Everolimus|everolimus|mesh-list
56716101|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716102|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716103|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
56716104|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716105|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56716106|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716107|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56716108|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716109|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716110|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56716111|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56716112|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716113|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56716114|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716115|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716116|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
56716117|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716118|NCT00617344|Vaccines|vaccines|mesh-list
56716119|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
56716120|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716121|NCT00862342|Bevacizumab|bevacizumab|mesh-list
56716122|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56716123|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716124|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56716125|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56716126|NCT00862342|Growth Substances|growth substances|mesh-ancestor
56716127|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716128|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
56716129|NCT00732212|Hemostatics|hemostatics|mesh-list
56716130|NCT00732212|Coagulants|coagulants|mesh-ancestor
56716131|NCT02544724|Interleukin-12|interleukin-12|mesh-list
56716132|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56716133|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
56716134|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716135|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56716136|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56716137|NCT02544724|Growth Substances|growth substances|mesh-ancestor
56716138|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
56716139|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716140|NCT00862420|Ticlopidine|ticlopidine|mesh-list
56716141|NCT00862420|Clopidogrel|clopidogrel|mesh-list
56716142|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56716143|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56716144|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56716145|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56716146|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
56716147|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716148|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536585|NCT02808247|Nintedanib|nintedanib|mesh-list
56536586|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56536587|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
56536588|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536589|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536590|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56536591|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536592|NCT02808091|Bortezomib|bortezomib|mesh-list
56716149|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716150|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56716151|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56716152|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56716153|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56716154|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716155|NCT00321698|Docetaxel|docetaxel|mesh-list
56716156|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716157|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
56716158|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
56716159|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
56716160|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716161|NCT02569970|Fluoxetine|fluoxetine|mesh-list
56716162|NCT02569970|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56716163|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56716164|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56716195|NCT02569346|Triumeq|triumeq|mesh-list
56716196|NCT02569346|Lamivudine|lamivudine|mesh-list
56716197|NCT02569346|Abacavir|abacavir|mesh-list
56716198|NCT02569346|Dolutegravir|dolutegravir|mesh-list
56716199|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56716200|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56716201|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
56716202|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716203|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56716204|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56716205|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716206|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716207|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56271596|NCT02004067|Cathartics|cathartics|mesh-ancestor
56716230|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716231|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56716232|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
56716233|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
56716234|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56716235|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56716236|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716237|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716238|NCT00727038|Ranibizumab|ranibizumab|mesh-list
56716239|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56716240|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56716241|NCT00727038|Growth Substances|growth substances|mesh-ancestor
56716242|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716243|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
56716244|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716245|NCT00726258|Ketamine|ketamine|mesh-list
56716246|NCT00726258|Analgesics|analgesics|mesh-ancestor
56716247|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
56716248|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716249|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716250|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56716251|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56716252|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
56716253|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
56716254|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56716255|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56716256|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56716257|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473650|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536593|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536594|NCT02811991|Acetaminophen|acetaminophen|mesh-list
56536595|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56536596|NCT02811991|Analgesics|analgesics|mesh-ancestor
56536597|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
56536598|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536599|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536600|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
56536601|NCT04237675|Anesthetics|anesthetics|mesh-list
56536602|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536603|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536604|NCT05598853|Nivolumab|nivolumab|mesh-list
56716258|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716259|NCT02950766|Ipilimumab|ipilimumab|mesh-list
56716260|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56271630|NCT02004301|Diclofenac|diclofenac|mesh-list
56716283|NCT00726570|Calcium heparin|calcium heparin|mesh-list
56716284|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56716285|NCT00726570|Tinzaparin|tinzaparin|mesh-list
56716286|NCT00726570|Dalteparin|dalteparin|mesh-list
56716287|NCT00726570|Anticoagulants|anticoagulants|mesh-list
56716288|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56716289|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56716290|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716291|NCT00726726|Vitamin K|vitamin k|mesh-list
56716292|NCT00726726|Midazolam|midazolam|mesh-list
56716293|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
56716294|NCT00726726|Caffeine|caffeine|mesh-list
56716295|NCT00726726|Omeprazole|omeprazole|mesh-list
56716296|NCT00726726|Warfarin|warfarin|mesh-list
56716297|NCT00726726|Vitamins|vitamins|mesh-ancestor
56716298|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
56716299|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716300|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56716301|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56716302|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56716303|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56716304|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56716305|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56716306|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56716307|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
56716308|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
56716309|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
56716310|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
56716311|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716312|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716313|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
56716314|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56716315|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56716340|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716342|NCT00654381|Linagliptin|linagliptin|mesh-list
56716343|NCT00654381|Voglibose|voglibose|mesh-list
56716344|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56716345|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716346|NCT00654381|Incretins|incretins|mesh-ancestor
56716347|NCT00654381|Hormones|hormones|mesh-ancestor
56716348|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56716349|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56716350|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
56716351|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716352|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716353|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56716354|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
56716355|NCT00654381|Vitamins|vitamins|mesh-ancestor
56716356|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
56716357|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
56716358|NCT04018482|Povidone|povidone|mesh-list
56536605|NCT05598853|Ipilimumab|ipilimumab|mesh-list
56536606|NCT05598853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56536607|NCT05598853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536608|NCT05598853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56536609|NCT05598853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716359|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
56716360|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
56716361|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56716362|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716363|NCT00805311|Aspirin|aspirin|mesh-list
56716364|NCT00805311|Losartan|losartan|mesh-list
56716365|NCT00805311|Amlodipine|amlodipine|mesh-list
56716366|NCT00805311|Atorvastatin|atorvastatin|mesh-list
56271735|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56716380|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716381|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
56716382|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56716383|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56716384|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
56716385|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56716386|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56716387|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56716388|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56716389|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56716390|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56716391|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
56716392|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56716393|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56716394|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56716395|NCT00732290|Fluoxetine|fluoxetine|mesh-list
56716396|NCT00732290|Clopidogrel|clopidogrel|mesh-list
56716397|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56716398|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56716399|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56716400|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56716401|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
56716402|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716403|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716404|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716405|NCT00732290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56716406|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56716407|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56716408|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
56716409|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56716410|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
56716411|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56716412|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56716413|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56716414|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716415|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56716416|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
56716417|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716418|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
56716419|NCT00732446|Dexamethasone|dexamethasone|mesh-list
56716420|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
56716421|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56716422|NCT00732446|BB 1101|bb 1101|mesh-list
56716423|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716424|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
56716425|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
56716453|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716454|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716456|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56716457|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
56716458|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716459|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716460|NCT00733850|Antiviral Agents|antiviral agents|mesh-ancestor
56716461|NCT00733850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716462|NCT00733850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536610|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56536611|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536612|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56536613|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716463|NCT00733850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716464|NCT00733850|Immunologic Factors|immunologic factors|mesh-ancestor
56716465|NCT00733850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716466|NCT00727766|Clofarabine|clofarabine|mesh-list
56716467|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56716468|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
56716469|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716501|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56716502|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56716503|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56716504|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56716505|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56716506|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716507|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716508|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
56716509|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56716510|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56716511|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716512|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56271902|NCT02005822|Valganciclovir|valganciclovir|mesh-list
56716545|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716546|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716547|NCT00728000|Antiviral Agents|antiviral agents|mesh-ancestor
56716548|NCT00728000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716549|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716550|NCT00728000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716551|NCT00728000|Immunologic Factors|immunologic factors|mesh-ancestor
56716552|NCT00728000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716553|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56716554|NCT04065230|Tenofovir|tenofovir|mesh-list
56716589|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716590|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56716591|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56716592|NCT00728078|Growth Substances|growth substances|mesh-ancestor
56716593|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
56716594|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716628|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716629|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716630|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716631|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56716632|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
56716633|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
56716634|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
56716635|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56716636|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
56716659|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716660|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56716661|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56716662|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716663|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
56716664|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56716665|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
56716666|NCT00652899|Protective Agents|protective agents|mesh-ancestor
56716667|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
56716668|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56716669|NCT04066452|Antibodies|antibodies|mesh-list
56716670|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
56716671|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716672|NCT00728520|Azacitidine|azacitidine|mesh-list
56716673|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56716674|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
56716675|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716676|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716677|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716678|NCT04065308|Daratumumab|daratumumab|mesh-list
56716679|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536614|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716680|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
56716681|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56716682|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716683|NCT00728156|Clopidogrel|clopidogrel|mesh-list
56716684|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56716685|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56716686|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56716687|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56716688|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
56716689|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716690|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716725|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
56716726|NCT00728832|Morphine|morphine|mesh-list
56716727|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56716728|NCT00728832|Narcotics|narcotics|mesh-ancestor
56716729|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56716766|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
56716767|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56272168|NCT02008019|Everolimus|everolimus|mesh-list
56716788|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56716789|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
56716790|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716791|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56716792|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56716793|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56716794|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
56716795|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716796|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56716797|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56716798|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716800|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
56716801|NCT04066296|Anesthetics|anesthetics|mesh-list
56716802|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56716803|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716804|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
56716805|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716806|NCT02341014|Lenalidomide|lenalidomide|mesh-list
56716807|NCT02341014|Romidepsin|romidepsin|mesh-list
56716808|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
56716809|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716810|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56716811|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56716812|NCT02341014|Growth Substances|growth substances|mesh-ancestor
56716813|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
56716814|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716815|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56716816|NCT00868426|Budesonide|budesonide|mesh-list
56716817|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
56716818|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56716819|NCT00868426|Charcoal|charcoal|mesh-list
56716820|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716821|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56716846|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
56716847|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716848|NCT02569866|Cephalexin|cephalexin|mesh-list
56716849|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56716850|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716851|NCT00868894|Latanoprost|latanoprost|mesh-list
56716852|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56716853|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56716854|NCT00730938|Cefuroxime|cefuroxime|mesh-list
56716855|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
56716856|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56716857|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716858|NCT00712010|Caseins|caseins|mesh-list
56716859|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
56716860|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
56716861|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716862|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
56716863|NCT00731016|Pravastatin|pravastatin|mesh-list
56716864|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56716865|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716866|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56716867|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56536615|NCT02804815|Aspirin|aspirin|mesh-list
56042052|NCT03349281|Hormones|hormones|mesh-ancestor
56716868|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
56716869|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716870|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56716871|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56716872|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716900|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56716901|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
56716902|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716903|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716904|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716906|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56716907|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716908|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56716909|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56716910|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716911|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716912|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716913|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56716914|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56716915|NCT00729222|Rolofylline|rolofylline|mesh-list
56716916|NCT00729222|Diuretics|diuretics|mesh-ancestor
56716917|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
56716918|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716942|NCT00869596|Albuterol|albuterol|mesh-list
56716943|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716944|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56716945|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
56716946|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716947|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716948|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56716949|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
56716950|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
56716951|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56716952|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
56716953|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56716954|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56716955|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56716956|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56716957|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56716958|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716959|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716960|NCT03743376|UB-421|ub-421|mesh-list
56716961|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56716962|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
56716963|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716964|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
56716965|NCT03728478|Etanercept|etanercept|mesh-list
56716966|NCT03728478|Methotrexate|methotrexate|mesh-list
56716967|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56716968|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
56716969|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56272348|NCT02009215|Artenimol|artenimol|mesh-list
56717004|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56717005|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56717006|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56717007|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717008|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717041|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56717042|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56717043|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717044|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717045|NCT00862888|Urological Agents|urological agents|mesh-ancestor
56717046|NCT00729170|Calcium|calcium|mesh-list
56717047|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56717048|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717071|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
56717072|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717073|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717074|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
56717075|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56536616|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56536617|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56536618|NCT02804815|Analgesics|analgesics|mesh-ancestor
56536619|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
56717076|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56717077|NCT02569320|Growth Substances|growth substances|mesh-ancestor
56717078|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
56717079|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
56717080|NCT00739466|Alendronate|alendronate|mesh-list
56717081|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56717082|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717083|NCT00869908|Insulin|insulin|mesh-list
56717084|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56717085|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
56717086|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
56717087|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56717088|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
56717089|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
56717090|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56717091|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717092|NCT00739622|Rilpivirine|rilpivirine|mesh-list
56717093|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56717094|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56717095|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717096|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717097|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
56717098|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717099|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56717100|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56717101|NCT00731562|Varenicline|varenicline|mesh-list
56717102|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56717103|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56717127|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56717128|NCT00729768|Cyclosporine|cyclosporine|mesh-list
56717129|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
56717130|NCT00729768|Cyclosporins|cyclosporins|mesh-list
56717131|NCT00729768|Basiliximab|basiliximab|mesh-list
56717132|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717133|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717134|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56717135|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
56717136|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717137|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
56717138|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717139|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
56717140|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56717141|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56717142|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56717143|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717144|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56717145|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
56717146|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56717147|NCT00871156|Chloroquine|chloroquine|mesh-list
56717148|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56717149|NCT00871156|Tafenoquine|tafenoquine|mesh-list
56717150|NCT00871156|Amebicides|amebicides|mesh-ancestor
56717151|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56717152|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56272526|NCT05750745|Fluorides|fluorides|mesh-list
56717179|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56717180|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
56717181|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56717183|NCT00734526|Sorafenib|sorafenib|mesh-list
56717184|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56717185|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
56717186|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717187|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717188|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56717189|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717190|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56717191|NCT00729404|Gestodene|gestodene|mesh-list
56717192|NCT00729404|Femovan|femovan|mesh-list
56060971|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
56536620|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536621|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536622|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56536623|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56536624|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56536625|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56536626|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536627|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56536628|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56536629|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717193|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56717194|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56717195|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56717196|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
56717197|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56717198|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717199|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56717226|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56717227|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
56717228|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717229|NCT00740090|Antacids|antacids|mesh-ancestor
56717230|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717231|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56717232|NCT00738660|Telmisartan|telmisartan|mesh-list
56717233|NCT00738660|Ramipril|ramipril|mesh-list
56717234|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56717235|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56717236|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56717237|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717238|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56717239|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
56717240|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717242|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56717243|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717244|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56717245|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56717246|NCT00740168|Growth Substances|growth substances|mesh-ancestor
56717247|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272627|NCT05624151|Anticonvulsants|anticonvulsants|mesh-ancestor
56717275|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56717276|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717277|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717278|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717279|NCT00732108|Topiramate|topiramate|mesh-list
56717280|NCT00732108|Lactulose|lactulose|mesh-list
56717281|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
56717282|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56717283|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717284|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56717285|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
56717286|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
56717287|NCT00876616|Tacrolimus|tacrolimus|mesh-list
56717288|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56717289|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
56717290|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717291|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56717292|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56717293|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
56717294|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717295|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717296|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56717331|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536630|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
56536631|NCT04017247|Oxytocin|oxytocin|mesh-list
56536632|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
56536633|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56536634|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536635|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56536636|NCT02814409|Plasminogen|plasminogen|mesh-list
56536637|NCT02814409|Tenecteplase|tenecteplase|mesh-list
56536638|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56536639|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56536640|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536641|NCT01227902|Ezogabine|ezogabine|mesh-list
56536642|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
56536643|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56536644|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536645|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56536646|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56536647|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56536648|NCT00946192|Desogestrel|desogestrel|mesh-list
56717332|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56717333|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
56717334|NCT00729794|Hormones|hormones|mesh-ancestor
56717335|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717336|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56717337|NCT00729794|Protective Agents|protective agents|mesh-ancestor
56717338|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56717339|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56717340|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
56717341|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717418|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
56717419|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
56717420|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56717421|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56717422|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717423|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717424|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717425|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56717426|NCT00876850|Linezolid|linezolid|mesh-list
56717427|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56717428|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717429|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56717430|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717431|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717432|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56717433|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56717434|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56717435|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56717436|NCT05157412|Doxycycline|doxycycline|mesh-list
56717437|NCT05157412|Prednisolone|prednisolone|mesh-list
56717438|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56717439|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
56717440|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56717441|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
56717442|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56717443|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
56717444|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56717445|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
56717446|NCT05157412|Hormones|hormones|mesh-ancestor
56536649|NCT00946192|Estradiol|estradiol|mesh-list
56536650|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56536651|NCT00946192|Progesterone|progesterone|mesh-list
56536652|NCT00946192|Estrogens|estrogens|mesh-ancestor
56536653|NCT00946192|Hormones|hormones|mesh-ancestor
56536654|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56536655|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536656|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56536657|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
56536658|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56536659|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56536660|NCT00946192|Progestins|progestins|mesh-ancestor
56536661|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56536662|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56536663|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56717479|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56717480|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
56717481|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
56717482|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717483|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56717484|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717485|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717486|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56717487|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56717520|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56717521|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
56717522|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717523|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717524|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56717525|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717526|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
56717527|NCT00732888|Calcium|calcium|mesh-list
56717528|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56717552|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717553|NCT00424021|Ambrisentan|ambrisentan|mesh-list
56717554|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56717555|NCT00735930|Lenalidomide|lenalidomide|mesh-list
56717556|NCT00735930|Alvocidib|alvocidib|mesh-list
56717557|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
56717558|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717559|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56717560|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56717561|NCT00735930|Growth Substances|growth substances|mesh-ancestor
56717562|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
56717563|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717564|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56717565|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717566|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717567|NCT00617734|Cetuximab|cetuximab|mesh-list
56717568|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56717569|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56717570|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717571|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
56717572|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717573|NCT00577460|Pramipexole|pramipexole|mesh-list
56717574|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
56717575|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717576|NCT00577460|Protective Agents|protective agents|mesh-ancestor
56717599|NCT05741294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536664|NCT01037127|Trametinib|trametinib|mesh-list
56536665|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536666|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56536667|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536668|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536669|NCT02806999|Insulin|insulin|mesh-list
56536670|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56536671|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536672|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634285|NCT03405090|Analgesics|analgesics|mesh-ancestor
56536673|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
56536674|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
56536675|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56536676|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56536677|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536678|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536679|NCT00946114|Urological Agents|urological agents|mesh-ancestor
56536680|NCT00627471|Insulin|insulin|mesh-list
56536681|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56536682|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
56536683|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536684|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536685|NCT04302441|Capecitabine|capecitabine|mesh-list
56536686|NCT04302441|Vinorelbine|vinorelbine|mesh-list
56536687|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56536688|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
56536689|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536690|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536691|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56717600|NCT02568176|Midazolam|midazolam|mesh-list
56717601|NCT02568176|Bupropion|bupropion|mesh-list
56717602|NCT02568176|Esketamine|esketamine|mesh-list
56717603|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56717604|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56717605|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717606|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717607|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56717608|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56717609|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56717610|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56717611|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
56717612|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
56717613|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
56428717|NCT00229775|Renal Agents|renal agents|mesh-ancestor
56717615|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717616|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060972|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
56536692|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
56536693|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
56536694|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
56536695|NCT02800447|Procarbazine|procarbazine|mesh-list
56536696|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536697|NCT05520619|Paclitaxel|paclitaxel|mesh-list
56536698|NCT05520619|Cisplatin|cisplatin|mesh-list
56536699|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56536700|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536701|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
56536702|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
56536703|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
56536704|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536705|NCT01038921|Melatonin|melatonin|mesh-list
56536706|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
56536707|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536708|NCT01038921|Protective Agents|protective agents|mesh-ancestor
56536709|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536710|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536711|NCT02023996|Trastuzumab|trastuzumab|mesh-list
56190880|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
56717617|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56717618|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
56717619|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56717620|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56717621|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56717622|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
56717623|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56717624|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56717625|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717626|NCT00741182|Teriparatide|teriparatide|mesh-list
56717627|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56717628|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717661|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56717662|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56717663|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717664|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717665|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
56717666|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
56717705|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
56717737|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717739|NCT00864526|Ibuprofen|ibuprofen|mesh-list
56717740|NCT00864526|Oxycodone|oxycodone|mesh-list
56717741|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56717742|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56717743|NCT00864526|Analgesics|analgesics|mesh-ancestor
56717744|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
56717745|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717746|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273140|NCT04711109|Denosumab|denosumab|mesh-list
56717776|NCT00711594|Afatinib|afatinib|mesh-list
56717777|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717778|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56717779|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536712|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56536713|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536714|NCT02856568|Gemcitabine|gemcitabine|mesh-list
56536715|NCT02856568|Cisplatin|cisplatin|mesh-list
56536716|NCT02856568|Ricolinostat|ricolinostat|mesh-list
56536717|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536718|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56536719|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
56536720|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536721|NCT02856568|Antiviral Agents|antiviral agents|mesh-ancestor
56536722|NCT02856568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536723|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536724|NCT02856568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56536725|NCT02856568|Immunologic Factors|immunologic factors|mesh-ancestor
56536726|NCT02856568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536727|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56536728|NCT04081831|Aspirin|aspirin|mesh-list
56536729|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56536730|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56536731|NCT04081831|Analgesics|analgesics|mesh-ancestor
56190906|NCT01471262|Liver Extracts|liver extracts|mesh-list
56717780|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717781|NCT00864760|Gabapentin|gabapentin|mesh-list
56717782|NCT00864760|Analgesics|analgesics|mesh-ancestor
56717783|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
56717784|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717800|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56717801|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56717802|NCT03743662|Growth Substances|growth substances|mesh-ancestor
56717803|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717804|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
56717805|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56717806|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717807|NCT00710762|Nintedanib|nintedanib|mesh-list
56717808|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717809|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56717810|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717811|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717812|NCT00736814|Gemcitabine|gemcitabine|mesh-list
56717813|NCT00736814|Carboplatin|carboplatin|mesh-list
56717814|NCT00736814|Docetaxel|docetaxel|mesh-list
56717815|NCT00736814|Vinorelbine|vinorelbine|mesh-list
56717816|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717817|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56717818|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
56717819|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717820|NCT00736814|Antiviral Agents|antiviral agents|mesh-ancestor
56717821|NCT00736814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717822|NCT00736814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717823|NCT00736814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56717824|NCT00736814|Immunologic Factors|immunologic factors|mesh-ancestor
56717825|NCT00736814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717826|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
56717827|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
56536732|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
56536733|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536734|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536735|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56536736|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56536737|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56536738|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56536739|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536740|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56536741|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56536742|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536743|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
56536744|NCT01081912|Hydrocodone|hydrocodone|mesh-list
56536745|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56536746|NCT01081912|Narcotics|narcotics|mesh-ancestor
56717828|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
56717829|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56717830|NCT04063904|Misoprostol|misoprostol|mesh-list
56717831|NCT04063904|Mifepristone|mifepristone|mesh-list
56717832|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56717833|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
56717834|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56717835|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717836|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56717837|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56717838|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
56717839|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56717840|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56717841|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56717842|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56717843|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
56717857|NCT00711516|Modafinil|modafinil|mesh-list
56717858|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56717859|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717860|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56717861|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56717862|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56717863|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717864|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56717865|NCT00864838|Acetazolamide|acetazolamide|mesh-list
56717866|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56717867|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56717868|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56717869|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56717870|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
56717871|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717872|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717873|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717874|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
56717875|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56717876|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717877|NCT00864838|Diuretics|diuretics|mesh-ancestor
56717878|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
56717879|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56717880|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56717881|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717882|NCT00615550|Progesterone|progesterone|mesh-list
56717883|NCT00615550|Progestins|progestins|mesh-ancestor
56717884|NCT00615550|Hormones|hormones|mesh-ancestor
56536747|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634286|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
56536748|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536749|NCT01081912|Analgesics|analgesics|mesh-ancestor
56536750|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
56536751|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536752|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
56536753|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
56536754|NCT01038609|Acetaminophen|acetaminophen|mesh-list
56536755|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56536756|NCT01038609|Morphine|morphine|mesh-list
56536757|NCT01038609|Hydrocodone|hydrocodone|mesh-list
56536758|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56536759|NCT01038609|Narcotics|narcotics|mesh-ancestor
56536760|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717885|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717886|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717887|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
56717888|NCT00186888|Carboplatin|carboplatin|mesh-list
56717889|NCT00186888|Doxorubicin|doxorubicin|mesh-list
56717890|NCT00186888|Etoposide|etoposide|mesh-list
56717891|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
56717892|NCT00186888|Vincristine|vincristine|mesh-list
56717893|NCT00186888|Topotecan|topotecan|mesh-list
56717894|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56717895|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
56717896|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717897|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56717898|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56717899|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
56717900|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717901|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717928|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56717929|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717930|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56717931|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56717932|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56717933|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56717934|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717935|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
56717936|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56717937|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56717938|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717939|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56717940|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
56717941|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56717942|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
56717943|NCT00577382|Sunitinib|sunitinib|mesh-list
56717944|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717945|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56717946|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56717947|NCT00577382|Growth Substances|growth substances|mesh-ancestor
56717948|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717949|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
56717950|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56717980|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56717981|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56717982|NCT00873262|Estropipate|estropipate|mesh-list
56717983|NCT00873262|Estradiol|estradiol|mesh-list
56717984|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56536761|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536762|NCT01038609|Analgesics|analgesics|mesh-ancestor
56536763|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
56536764|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536765|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56536766|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
56536767|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
56536768|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
56536769|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56536770|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56536771|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56536772|NCT02857582|Metronidazole|metronidazole|mesh-list
56536773|NCT02857582|Vancomycin|vancomycin|mesh-list
56717985|NCT00873262|Estrone|estrone|mesh-list
56717986|NCT00873262|Progesterone|progesterone|mesh-list
56717987|NCT00873262|Estrogens|estrogens|mesh-ancestor
56717988|NCT00873262|Hormones|hormones|mesh-ancestor
56717989|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717990|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717991|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56717992|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
56717993|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56717994|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56717995|NCT00873262|Progestins|progestins|mesh-ancestor
56718029|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56718030|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56718032|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718033|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
56718034|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718035|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56718036|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56718037|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56718038|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56718068|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56718069|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56718070|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56718071|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718072|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718073|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718075|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
56718076|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718077|NCT00423319|Enoxaparin|enoxaparin|mesh-list
56718078|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
56718079|NCT00423319|Apixaban|apixaban|mesh-list
56718080|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
56718081|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56718082|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56718083|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718084|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56718122|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56718123|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718124|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56273512|NCT04059770|Amphotericin B|amphotericin b|mesh-list
56718152|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718153|NCT00874042|Antiviral Agents|antiviral agents|mesh-ancestor
56718154|NCT00874042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718155|NCT00874042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718156|NCT00874042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718157|NCT00874042|Immunologic Factors|immunologic factors|mesh-ancestor
56718158|NCT00874042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718159|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
56718160|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56718161|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
56536774|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536775|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56536776|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56536777|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56536778|NCT04301895|Remifentanil|remifentanil|mesh-list
56718162|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718163|NCT00736866|Expectorants|expectorants|mesh-ancestor
56718164|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
56718165|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56718166|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
56718167|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718168|NCT00736866|Protective Agents|protective agents|mesh-ancestor
56718169|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718170|NCT00736866|Antidotes|antidotes|mesh-ancestor
56718171|NCT00879424|Vitamin D|vitamin d|mesh-list
56718172|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
56718204|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56718206|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
56718207|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718208|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429320|NCT00171925|Vitamin D|vitamin d|mesh-list
56718209|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56718210|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56718228|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718230|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56718231|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56718232|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56718233|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
56718234|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718235|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718236|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56718237|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
56718238|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
56718239|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
56718240|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56718241|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56718242|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
56718243|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718244|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718245|NCT00740922|Becaplermin|becaplermin|mesh-list
56718246|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
56718247|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56718248|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56718249|NCT00740922|Growth Substances|growth substances|mesh-ancestor
56718250|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718251|NCT05523440|Bevacizumab|bevacizumab|mesh-list
56718252|NCT05523440|Niraparib|niraparib|mesh-list
56718253|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56718254|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718255|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56718256|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56718257|NCT05523440|Growth Substances|growth substances|mesh-ancestor
56718258|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718259|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
56718260|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56718261|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273644|NCT03737968|Tremelimumab|tremelimumab|mesh-list
56273650|NCT03725202|Upadacitinib|upadacitinib|mesh-list
56718295|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718296|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718297|NCT02567942|Propofol|propofol|mesh-list
56718298|NCT02567942|Sevoflurane|sevoflurane|mesh-list
56718299|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56273693|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56718332|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56718333|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718334|NCT01608451|Vitamins|vitamins|mesh-ancestor
56718335|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
56718336|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56718337|NCT01608451|Progestins|progestins|mesh-ancestor
56718338|NCT01608451|Hormones|hormones|mesh-ancestor
56473651|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56536779|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56536780|NCT04301895|Narcotics|narcotics|mesh-ancestor
56536781|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536782|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536783|NCT04301895|Analgesics|analgesics|mesh-ancestor
56536784|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
56536785|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536786|NCT02853526|Propranolol|propranolol|mesh-list
56536787|NCT02853526|Warfarin|warfarin|mesh-list
56536788|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
56536789|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56536790|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56536791|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56536792|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536793|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536794|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536795|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56536796|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56536797|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
56536798|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
56536799|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56536800|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536801|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56718339|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718340|NCT00405067|Ezetimibe|ezetimibe|mesh-list
56718341|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56718342|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56718372|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
56718373|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56718374|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56718375|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718376|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56718377|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56718378|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
56718379|NCT03904381|Fluorouracil|fluorouracil|mesh-list
56718380|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
56718381|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718382|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56718383|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718384|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718385|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
56273775|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56718413|NCT00614614|Vaccines|vaccines|mesh-list
56718414|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
56718415|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718416|NCT00713310|Mesalamine|mesalamine|mesh-list
56718417|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56718418|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56718419|NCT00713310|Analgesics|analgesics|mesh-ancestor
56718420|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
56718421|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536802|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56536803|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56536804|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536805|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
56536806|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536807|NCT04269460|Bupivacaine|bupivacaine|mesh-list
56536808|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
56536809|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
56536810|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536811|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190991|NCT01471847|Lapatinib|lapatinib|mesh-list
56718422|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718423|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273826|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56273827|NCT03145272|Narcotics|narcotics|mesh-ancestor
56718456|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56718458|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56718459|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56718487|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
56718488|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718489|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718490|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56718491|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
56718492|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56718493|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718494|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718495|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56718496|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56718497|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56718498|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
56718499|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
56718500|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718501|NCT00874744|Triamcinolone|triamcinolone|mesh-list
56718502|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56718503|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56718504|NCT00874744|Bevacizumab|bevacizumab|mesh-list
56718505|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56718531|NCT05736744|Anesthetics|anesthetics|mesh-ancestor
56718532|NCT05736744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718533|NCT05736744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56718534|NCT05736744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56718535|NCT05736744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56718536|NCT05736744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718537|NCT05736744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56718538|NCT05736744|Tocolytic Agents|tocolytic agents|mesh-ancestor
56718539|NCT05736744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56718540|NCT05736744|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56718541|NCT05736744|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56718542|NCT05736744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56718543|NCT05736744|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56718544|NCT05736744|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56718545|NCT05736744|Cholinergic Agents|cholinergic agents|mesh-ancestor
56718546|NCT05736744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718547|NCT00920868|Bevacizumab|bevacizumab|mesh-list
56718548|NCT00920868|Capecitabine|capecitabine|mesh-list
56718549|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
56718550|NCT00920868|Dasatinib|dasatinib|mesh-list
56718551|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56718552|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718553|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56718554|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56718555|NCT00920868|Growth Substances|growth substances|mesh-ancestor
56536812|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
56536813|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536814|NCT04236115|Felypressin|felypressin|mesh-list
56536815|NCT04236115|Carticaine|carticaine|mesh-list
56536816|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
56536817|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
56536818|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536819|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536820|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
56634287|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536821|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536822|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56536823|NCT02853370|Rituximab|rituximab|mesh-list
56536824|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56536825|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56536826|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536827|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
56536828|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536829|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56191002|NCT01471886|Naproxen|naproxen|mesh-list
56718556|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718589|NCT00881140|Mifepristone|mifepristone|mesh-list
56718590|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56718591|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
56718592|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56718593|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718594|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56718595|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56718596|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56718597|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
56718598|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56718599|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56718600|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
56718601|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718603|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56718604|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56718605|NCT05733078|Vitamins|vitamins|mesh-list
56718606|NCT05733078|Ascorbic Acid|ascorbic acid|mesh-list
56718607|NCT05733078|Micronutrients|micronutrients|mesh-ancestor
56718608|NCT05733078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718609|NCT05733078|Antioxidants|antioxidants|mesh-ancestor
56718610|NCT05733078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718611|NCT05733078|Protective Agents|protective agents|mesh-ancestor
56718612|NCT00874978|Lenalidomide|lenalidomide|mesh-list
56718613|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
56718614|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718615|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56718616|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56718617|NCT00874978|Growth Substances|growth substances|mesh-ancestor
56718618|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
56718619|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718620|NCT00737880|Pancrelipase|pancrelipase|mesh-list
56718621|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56718622|NCT05728632|Nebivolol|nebivolol|mesh-list
56718623|NCT05728632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56536830|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56536831|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
56536832|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536833|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56536834|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56536835|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56536836|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718624|NCT05728632|Vasodilator Agents|vasodilator agents|mesh-ancestor
56718625|NCT05728632|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56718626|NCT05728632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56718627|NCT05728632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56718628|NCT05728632|Adrenergic Agents|adrenergic agents|mesh-ancestor
56718629|NCT05728632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718630|NCT05728632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718631|NCT05728632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718632|NCT05741658|Dapagliflozin|dapagliflozin|mesh-list
56718633|NCT05741658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56718634|NCT05741658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718635|NCT05741658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56718636|NCT05741658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718637|NCT05741502|Olanzapine|olanzapine|mesh-list
56718638|NCT05741502|Risperidone|risperidone|mesh-list
56718639|NCT05741502|Aripiprazole|aripiprazole|mesh-list
56718640|NCT05741502|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56718641|NCT05741502|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56718642|NCT05741502|Ziprasidone|ziprasidone|mesh-list
56718643|NCT05741502|Antipsychotic Agents|antipsychotic agents|mesh-list
56718644|NCT05741502|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56718645|NCT05741502|Clozapine|clozapine|mesh-list
56718646|NCT05741502|Cariprazine|cariprazine|mesh-list
56718647|NCT05741502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56718648|NCT05741502|Serotonin Agents|serotonin agents|mesh-ancestor
56718649|NCT05741502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718650|NCT05741502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718651|NCT05741502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718652|NCT05741502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56718653|NCT05741502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718654|NCT05741502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56718655|NCT05741502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56718656|NCT05741502|Dopamine Agents|dopamine agents|mesh-ancestor
56718657|NCT05741502|Antiemetics|antiemetics|mesh-ancestor
56718658|NCT05741502|Autonomic Agents|autonomic agents|mesh-ancestor
56718659|NCT05741502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718660|NCT05741502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56718661|NCT05741502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56718662|NCT05741502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56718663|NCT05741502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56718664|NCT05741502|Antidepressive Agents|antidepressive agents|mesh-ancestor
56718665|NCT05741502|Dopamine Agonists|dopamine agonists|mesh-ancestor
56718666|NCT05741502|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56718667|NCT05741502|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56718668|NCT05741502|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56718669|NCT05741502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56718670|NCT05741502|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56718671|NCT05741502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56718672|NCT05741502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56718673|NCT05741502|Adrenergic Agents|adrenergic agents|mesh-ancestor
56718674|NCT05741502|GABA Antagonists|gaba antagonists|mesh-ancestor
56718708|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56718709|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56718710|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718711|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56718712|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718713|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
56718714|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56536837|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536838|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56536839|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56536840|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536841|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
56536842|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536843|NCT02690155|Vitamin K|vitamin k|mesh-list
56536844|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
56536845|NCT02690155|Vitamins|vitamins|mesh-ancestor
56536846|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
56536847|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536848|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56536849|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
56191029|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
56718715|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56718716|NCT00738192|Fentanyl|fentanyl|mesh-list
56718717|NCT00738192|Sufentanil|sufentanil|mesh-list
56718718|NCT00738192|Dsuvia|dsuvia|mesh-list
56718719|NCT00738192|Butorphanol|butorphanol|mesh-list
56718747|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
56718748|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56718749|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
56718750|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718751|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56718752|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
56718753|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
56718754|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56718755|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56718756|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
56718757|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718758|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718759|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718760|NCT00884104|Urological Agents|urological agents|mesh-ancestor
56718761|NCT04140214|Carbocysteine|carbocysteine|mesh-list
56718762|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56718763|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718764|NCT04140214|Expectorants|expectorants|mesh-ancestor
56718765|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
56718766|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56718767|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56718768|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56718769|NCT00612508|Etonogestrel|etonogestrel|mesh-list
56718770|NCT00612508|Desogestrel|desogestrel|mesh-list
56718771|NCT00612508|NuvaRing|nuvaring|mesh-list
56718802|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56718803|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56718804|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56718805|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718806|NCT00875368|Maraviroc|maraviroc|mesh-list
56718807|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56718808|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56718809|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718810|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56718811|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56718812|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
56718813|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718836|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718837|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718839|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
56718840|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718841|NCT02543710|Taxane|taxane|mesh-list
56718842|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536850|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56536851|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
56718843|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
56718844|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56718845|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
56718846|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56718847|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718848|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56718849|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56718850|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56718851|NCT00881296|Gemcitabine|gemcitabine|mesh-list
56718852|NCT00881296|Carboplatin|carboplatin|mesh-list
56718853|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718854|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56718855|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
56718856|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718857|NCT00881296|Antiviral Agents|antiviral agents|mesh-ancestor
56718858|NCT00881296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718859|NCT00881296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718860|NCT00881296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718861|NCT00881296|Immunologic Factors|immunologic factors|mesh-ancestor
56718862|NCT00881296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718863|NCT00613366|Misoprostol|misoprostol|mesh-list
56718864|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
56718865|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56718866|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
56718894|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56718895|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
56718896|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
56718897|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718898|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718899|NCT00885508|Lenalidomide|lenalidomide|mesh-list
56718900|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
56718901|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718902|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56718903|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56718904|NCT00885508|Growth Substances|growth substances|mesh-ancestor
56718905|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
56718906|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718907|NCT02543086|Piperaquine|piperaquine|mesh-list
56718908|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
56718909|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56718910|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56718911|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718912|NCT00885586|Gabapentin|gabapentin|mesh-list
56718913|NCT00885586|Analgesics|analgesics|mesh-ancestor
56718914|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
56718915|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718942|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718944|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
56718945|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718946|NCT02542852|Ritonavir|ritonavir|mesh-list
56718947|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56718948|NCT02542852|Dolutegravir|dolutegravir|mesh-list
56718949|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56718950|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56718951|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
56718952|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718953|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718954|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56718955|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56718956|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
56718957|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718958|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56718959|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56718960|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56718961|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56718962|NCT00651261|Cytarabine|cytarabine|mesh-list
56718963|NCT00651261|Dexamethasone|dexamethasone|mesh-list
56718964|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
56719001|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719002|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719003|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
56719026|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56536852|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536853|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536854|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
56536855|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56536856|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56536857|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
56536858|NCT02690155|Coagulants|coagulants|mesh-ancestor
56536859|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
56536860|NCT02806375|Busulfan|busulfan|mesh-list
56536861|NCT02806375|Fludarabine|fludarabine|mesh-list
56536862|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
56536863|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56536864|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
56536865|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536866|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56536867|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56536868|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
56719027|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
56719028|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719029|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719030|NCT05093322|Antiviral Agents|antiviral agents|mesh-ancestor
56719031|NCT05093322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719032|NCT05093322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719033|NCT05093322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719034|NCT05093322|Immunologic Factors|immunologic factors|mesh-ancestor
56719035|NCT05093322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719036|NCT00651183|Pramipexole|pramipexole|mesh-list
56719037|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
56719038|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719039|NCT00651183|Protective Agents|protective agents|mesh-ancestor
56719040|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719041|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56719042|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56719043|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
56719044|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
56719045|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719046|NCT00810381|Nitroprusside|nitroprusside|mesh-list
56719047|NCT00810381|Isosorbide|isosorbide|mesh-list
56719048|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56719049|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56719050|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
56719051|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
56719052|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56719053|NCT00810381|Diuretics|diuretics|mesh-ancestor
56719054|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
56719055|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719084|NCT00811005|Methoxsalen|methoxsalen|mesh-list
56719085|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56719086|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
56719087|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56719088|NCT00813735|Dexetimide|dexetimide|mesh-list
56719089|NCT00813735|Eszopiclone|eszopiclone|mesh-list
56719090|NCT00813735|Citalopram|citalopram|mesh-list
56719091|NCT00813735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56719092|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56719093|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719094|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719095|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719096|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
56719097|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061096|NCT01621477|Clofarabine|clofarabine|mesh-list
56536869|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536870|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536871|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56536872|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56536873|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
56536874|NCT04273984|Misoprostol|misoprostol|mesh-list
56536875|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56536876|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
56536877|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56536878|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536879|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56536880|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56536881|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
56536882|NCT00943852|Losartan|losartan|mesh-list
56536883|NCT00943852|Isosorbide|isosorbide|mesh-list
56536884|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56719098|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56719099|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
56274520|NCT02011126|Imetelstat|imetelstat|mesh-list
56719132|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
56719133|NCT00813891|Ranibizumab|ranibizumab|mesh-list
56719134|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56719135|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56719136|NCT00813891|Growth Substances|growth substances|mesh-ancestor
56719137|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719138|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
56719139|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719140|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56719141|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56274547|NCT02011620|Isosorbide|isosorbide|mesh-list
56719176|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719177|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56719178|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719179|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56719180|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56719181|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56719215|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719216|NCT00814359|Benzydamine|benzydamine|mesh-list
56719217|NCT00814359|Sucralfate|sucralfate|mesh-list
56719218|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56719219|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56719220|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56719221|NCT00612040|Insulin|insulin|mesh-list
56719222|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56719250|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56719251|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719252|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56719253|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56719254|NCT00422227|Analgesics|analgesics|mesh-ancestor
56719255|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
56719256|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719257|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56719258|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56719259|NCT00811785|Copper|copper|mesh-list
56719260|NCT00811785|Trace Elements|trace elements|mesh-ancestor
56719261|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
56719262|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719263|NCT00814515|Cyclosporine|cyclosporine|mesh-list
56719264|NCT00814515|Cyclosporins|cyclosporins|mesh-list
56719265|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061097|NCT01621477|Tacrolimus|tacrolimus|mesh-list
56536885|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56536886|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56536887|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56536888|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56536889|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56536890|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719266|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719267|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719268|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
56719269|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719270|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
56719271|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719272|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
56719303|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719304|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56719305|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56719306|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
56719307|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56719308|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56719309|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56719310|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56719311|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
56719312|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56719313|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
56719314|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719315|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56719316|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719350|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56719351|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56719352|NCT00814905|Clindamycin|clindamycin|mesh-list
56719353|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
56719354|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
56719355|NCT00814905|Gentamicins|gentamicins|mesh-list
56719356|NCT00814905|Ampicillin|ampicillin|mesh-list
56719357|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56719358|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719359|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56719360|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274758|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
56719396|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719397|NCT01040455|Lansoprazole|lansoprazole|mesh-list
56719398|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
56719399|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56719400|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56719401|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56719420|NCT00610714|Carboplatin|carboplatin|mesh-list
56719421|NCT00610714|Saracatinib|saracatinib|mesh-list
56719422|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56719423|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719424|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
56719425|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
56719426|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
56719427|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719428|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719429|NCT00403585|Adefovir|adefovir|mesh-list
56719430|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56719431|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
56719432|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719433|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56719434|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56719435|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719436|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719437|NCT00645411|Vaccines|vaccines|mesh-list
56719438|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
56719439|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719440|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
56719441|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56536891|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56719442|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56719443|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56719444|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719445|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719446|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
56719447|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719448|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719449|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56719450|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719451|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
56719452|NCT00885274|Citric Acid|citric acid|mesh-list
56719453|NCT00885274|Antacids|antacids|mesh-ancestor
56719454|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719455|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56719456|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
56719457|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56719491|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56719492|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56719493|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
56719494|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719495|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719496|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719497|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56719512|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56719513|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56719514|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56719515|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719516|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719517|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719518|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719519|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
56719520|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56719521|NCT00886990|Ritonavir|ritonavir|mesh-list
56719522|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56719523|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56719524|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
56719525|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719526|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719527|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56719528|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56719529|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
56719530|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719531|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56719532|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56719533|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
56719534|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56719535|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
56719536|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719537|NCT00650091|Expectorants|expectorants|mesh-ancestor
56719538|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
56719539|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56719540|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
56719541|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719542|NCT00650091|Protective Agents|protective agents|mesh-ancestor
56719543|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719544|NCT00650091|Antidotes|antidotes|mesh-ancestor
56719545|NCT00889018|Carboplatin|carboplatin|mesh-list
56719546|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719547|NCT00889096|Propranolol|propranolol|mesh-list
56719548|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56719549|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56719550|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
56719551|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719552|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719553|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719554|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56719555|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56719556|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
56719593|NCT00889642|Epinephrine|epinephrine|mesh-list
56719594|NCT00889642|Racepinephrine|racepinephrine|mesh-list
56719595|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
56719596|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
56536892|NCT00943852|Diuretics|diuretics|mesh-ancestor
56536893|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
56536894|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536895|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
56536896|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56536897|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
56536898|NCT02853136|BI 409306|bi 409306|mesh-list
56536899|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56536900|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56536901|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536902|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536903|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56536904|NCT02853136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56536905|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56536906|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56536907|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536908|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536909|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
56536910|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56719597|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
56719598|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719633|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56719634|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56719635|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56719660|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56719661|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
56719662|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
56719663|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719664|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719665|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56719666|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56719667|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56719668|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719669|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56719670|NCT00645099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56719671|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56719672|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719673|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719674|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719675|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
56719676|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56719677|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56719678|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56719679|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56719680|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
56719681|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56719682|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56719683|NCT00889876|Metformin|metformin|mesh-list
56275078|NCT02014545|Lucanthone|lucanthone|mesh-list
56719715|NCT01038505|Sirolimus|sirolimus|mesh-list
56719716|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
56719717|NCT01038505|Tacrolimus|tacrolimus|mesh-list
56719718|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719719|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
56275125|NCT02014714|Analgesics|analgesics|mesh-ancestor
56719755|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
56536911|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
56191099|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
56719756|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719778|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56719779|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56719780|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
56719781|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719782|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430892|NCT00234455|Sirolimus|sirolimus|mesh-list
56719784|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56719785|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
56719786|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719787|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719788|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56719789|NCT00420199|Abatacept|abatacept|mesh-list
56719790|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56719791|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719792|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719793|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719794|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
56719795|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719796|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56719797|NCT00649389|Amlodipine|amlodipine|mesh-list
56719798|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56719799|NCT00649389|Olmesartan|olmesartan|mesh-list
56719800|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56719801|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56719802|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56719803|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719804|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719805|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56719806|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719807|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
56719808|NCT00649389|Diuretics|diuretics|mesh-ancestor
56719832|NCT00815373|Latanoprost|latanoprost|mesh-list
56719833|NCT00815373|Maleic acid|maleic acid|mesh-list
56719834|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719835|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719836|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56719837|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56719838|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
56719839|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719840|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719841|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56719842|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56719843|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56719844|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56719845|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56719846|NCT00641667|Fentanyl|fentanyl|mesh-list
56719847|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56719848|NCT00641667|Narcotics|narcotics|mesh-ancestor
56719849|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719850|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719851|NCT00641667|Analgesics|analgesics|mesh-ancestor
56719852|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
56719853|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719854|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56719855|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56719856|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
56719857|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
56719858|NCT00704184|Interferons|interferons|mesh-list
56719859|NCT00704184|Ribavirin|ribavirin|mesh-list
56719890|NCT00609622|Bevacizumab|bevacizumab|mesh-list
56719891|NCT00609622|Sunitinib|sunitinib|mesh-list
56719892|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56719893|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719894|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56719895|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56719896|NCT00609622|Growth Substances|growth substances|mesh-ancestor
56719897|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719898|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
56719899|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56536912|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56536913|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56536914|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536915|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56536916|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56536917|NCT02806141|Colistin|colistin|mesh-list
56536918|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56536919|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536920|NCT02802631|Minocycline|minocycline|mesh-list
56536921|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56536922|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536923|NCT04235959|Tirzepatide|tirzepatide|mesh-list
56536924|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56536925|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536926|NCT04235959|Incretins|incretins|mesh-ancestor
56536927|NCT04235959|Hormones|hormones|mesh-ancestor
56536928|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56536929|NCT00952276|Vaccines|vaccines|mesh-list
56536930|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
56536931|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536932|NCT02805829|Trastuzumab|trastuzumab|mesh-list
56536933|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56536934|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536935|NCT02856178|Caspofungin|caspofungin|mesh-list
56536936|NCT02856178|Olorofim|olorofim|mesh-list
56536937|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
56536938|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536939|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191111|NCT01472406|Pancrelipase|pancrelipase|mesh-list
56719900|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719901|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719902|NCT00818415|Naproxen|naproxen|mesh-list
56719903|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56719926|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719927|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56719928|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56719929|NCT03897192|Growth Substances|growth substances|mesh-ancestor
56719930|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719931|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
56719934|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56719935|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
56719936|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719937|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719938|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56719939|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
56719940|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
56061098|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
56536940|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536941|NCT02800135|Furosemide|furosemide|mesh-list
56536942|NCT02800135|Diuretics|diuretics|mesh-ancestor
56536943|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
56536944|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536945|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56536946|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56536947|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536948|NCT00494728|Nicotine|nicotine|mesh-list
56536949|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56536950|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
56536951|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536952|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536953|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56719941|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56719942|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
56719943|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719944|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719945|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56719946|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56719947|NCT00890110|Sunitinib|sunitinib|mesh-list
56719948|NCT00890110|Vaccines|vaccines|mesh-list
56719949|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
56719950|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719951|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719952|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56719953|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56719980|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
56719981|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56719982|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719983|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56719984|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56719985|NCT00890188|Growth Substances|growth substances|mesh-ancestor
56719986|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
56719987|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719989|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56719990|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
56719991|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
56719992|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719993|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719994|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56719995|NCT05388942|Analgesics|analgesics|mesh-ancestor
56719996|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
56719997|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719998|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
56719999|NCT04037566|Fludarabine|fludarabine|mesh-list
56720000|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275403|NCT02016443|Tizanidine|tizanidine|mesh-list
56720027|NCT00921102|Atropine|atropine|mesh-list
56720028|NCT00921102|Morphine|morphine|mesh-list
56720029|NCT00921102|Bupivacaine|bupivacaine|mesh-list
56720030|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
56720031|NCT00921102|Anesthetics|anesthetics|mesh-list
56720032|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720033|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720034|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
56720035|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720036|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56720037|NCT00921102|Narcotics|narcotics|mesh-ancestor
56720038|NCT00921102|Analgesics|analgesics|mesh-ancestor
56720039|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56536954|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56536955|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
56536956|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56536957|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536958|NCT02799901|Nivolumab|nivolumab|mesh-list
56536959|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56536960|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536961|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56536962|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536963|NCT02802163|Dexamethasone|dexamethasone|mesh-list
56536964|NCT02802163|Lenalidomide|lenalidomide|mesh-list
56191151|NCT01472783|Veliparib|veliparib|mesh-list
56720040|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56720041|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56720042|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
56720043|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56720044|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
56720045|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
56720046|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
56720047|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56720048|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56720049|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
56720087|NCT04061772|Hormones|hormones|mesh-ancestor
56720088|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56720108|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
56720109|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
56720110|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56720111|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56720112|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720113|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720114|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56720115|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56720116|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
56720117|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720118|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720119|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
56720120|NCT00699348|Hematinics|hematinics|mesh-ancestor
56720121|NCT00643851|Metformin|metformin|mesh-list
56720122|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
56720123|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56720124|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720125|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56720126|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720127|NCT00821457|Mitogens|mitogens|mesh-list
56720128|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
56720129|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720130|NCT03667690|Fluconazole|fluconazole|mesh-list
56720131|NCT03667690|Caspofungin|caspofungin|mesh-list
56720132|NCT03667690|Rezafungin|rezafungin|mesh-list
56720133|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
56720134|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720135|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56720136|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56720137|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720138|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720139|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56720140|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
56720141|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56720142|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720143|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56275536|NCT02017600|Fluorouracil|fluorouracil|mesh-list
56720159|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
56536965|NCT02802163|Panobinostat|panobinostat|mesh-list
56536966|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56536967|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
56536968|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
56720160|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720161|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720162|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56720163|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56720164|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
56720165|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720166|NCT04872582|Bevacizumab|bevacizumab|mesh-list
56720167|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56720168|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56720169|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720170|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56720171|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56720172|NCT04872582|Growth Substances|growth substances|mesh-ancestor
56720173|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720174|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
56720175|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720176|NCT04061538|Zinc|zinc|mesh-list
56720177|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
56720178|NCT04061538|Trace Elements|trace elements|mesh-ancestor
56720179|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
56720180|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720181|NCT04061538|Astringents|astringents|mesh-ancestor
56720182|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
56720183|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
56720184|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
56720185|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56720186|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56720187|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720188|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720189|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720190|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720191|NCT00888394|Imidacloprid|imidacloprid|mesh-list
56720192|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
56720193|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720194|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720195|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720196|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
56720197|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56720198|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
56720199|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56720200|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
56720201|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56720202|NCT00627393|Dexamethasone|dexamethasone|mesh-list
56720203|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56720229|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
56720230|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56720231|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56720233|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
56720234|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720235|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56720236|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56720237|NCT00577122|Progestins|progestins|mesh-ancestor
56720238|NCT00577122|Hormones|hormones|mesh-ancestor
56720239|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56720240|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56720241|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56720242|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56720243|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
56720244|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56720245|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56720246|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56720247|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56720248|NCT00822081|Timolol|timolol|mesh-list
56720249|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56720250|NCT00822081|Dorzolamide|dorzolamide|mesh-list
56720251|NCT00822081|Maleic acid|maleic acid|mesh-list
56720274|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
56720275|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720276|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
56536969|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56536970|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56536971|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56634288|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56536972|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
56536974|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56536975|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56536976|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56536977|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
56536978|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56536979|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56536980|NCT02802163|Growth Substances|growth substances|mesh-ancestor
56536981|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
56536982|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56720277|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56720278|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
56720279|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
56720280|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56720281|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56720282|NCT00626925|Topiramate|topiramate|mesh-list
56720283|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
56720284|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56720285|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720286|NCT00816543|Docetaxel|docetaxel|mesh-list
56720287|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
56720288|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720289|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
56720290|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
56720291|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
56720292|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720293|NCT00698646|Valsartan|valsartan|mesh-list
56720294|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56720295|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56720296|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56720297|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56720298|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720300|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
56720301|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720302|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56720303|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56720304|NCT04625907|Dactinomycin|dactinomycin|mesh-list
56720305|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
56720306|NCT04625907|Temozolomide|temozolomide|mesh-list
56720308|NCT04625907|Doxorubicin|doxorubicin|mesh-list
56720309|NCT04625907|Irinotecan|irinotecan|mesh-list
56720310|NCT04625907|Vincristine|vincristine|mesh-list
56720311|NCT04625907|Vinorelbine|vinorelbine|mesh-list
56720312|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720313|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
56720314|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720315|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720316|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56720317|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
56720318|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720319|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720320|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56720321|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56720322|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56720323|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56536983|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536984|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536985|NCT02805049|Caspofungin|caspofungin|mesh-list
56536986|NCT02805049|Micafungin|micafungin|mesh-list
56536987|NCT02805049|Echinocandins|echinocandins|mesh-list
56536988|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
56536989|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56536990|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56536991|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56536992|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
56536993|NCT02799589|Remifentanil|remifentanil|mesh-list
56536994|NCT02799589|Ropivacaine|ropivacaine|mesh-list
56536995|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56536996|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56536997|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720324|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720325|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56720326|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56720327|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
56720328|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
56720329|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
56720330|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56720331|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720332|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56720333|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56720334|NCT02565888|Ritonavir|ritonavir|mesh-list
56720335|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56720336|NCT02565888|Cobicistat|cobicistat|mesh-list
56720337|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56720338|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56720339|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
56720340|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720341|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720342|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56720343|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56720344|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
56720345|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720346|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56720347|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56720348|NCT00609466|Morphine|morphine|mesh-list
56720349|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56720350|NCT00609466|Narcotics|narcotics|mesh-ancestor
56720351|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720352|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720353|NCT00609466|Analgesics|analgesics|mesh-ancestor
56720354|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
56720355|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720356|NCT00822315|Efavirenz|efavirenz|mesh-list
56720357|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
56720358|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56720359|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56720360|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720361|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720362|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
56720363|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720364|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56720365|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56720366|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56720367|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56536998|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56536999|NCT02799589|Analgesics|analgesics|mesh-ancestor
56537000|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
56537001|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537002|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56537003|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56537004|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56537005|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
56537006|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537007|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537008|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
56537009|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
56537010|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56537011|NCT02799589|Narcotics|narcotics|mesh-ancestor
56537012|NCT04020913|Hormones|hormones|mesh-list
56537013|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537014|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537015|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56537016|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537017|NCT02801383|Interferons|interferons|mesh-list
56537018|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537019|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
56720368|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56720369|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56720370|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56720371|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56720372|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56720401|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
56720402|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720403|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720404|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720405|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
56720406|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
56720407|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56720408|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56720409|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56720410|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720411|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56720412|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56720413|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720414|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720415|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720416|NCT00892996|Dexamethasone|dexamethasone|mesh-list
56720417|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
56720418|NCT00892996|BB 1101|bb 1101|mesh-list
56720419|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56720420|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
56720456|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56720457|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
56720489|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720490|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
56720491|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720492|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
56537020|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537021|NCT02799355|Interferons|interferons|mesh-list
56537022|NCT02799355|Ribavirin|ribavirin|mesh-list
56537023|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
56537024|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537025|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
56537026|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537027|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
56537028|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537029|NCT02801305|Diltiazem|diltiazem|mesh-list
56537030|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
56537031|NCT02801305|Petrolatum|petrolatum|mesh-list
56537032|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
56537033|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56537034|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56537035|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56537036|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537037|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56537038|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537039|NCT02801305|Emollients|emollients|mesh-ancestor
56537040|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
56537041|NCT00637975|Pregabalin|pregabalin|mesh-list
56537042|NCT00637975|Oxycodone|oxycodone|mesh-list
56537043|NCT00637975|Analgesics|analgesics|mesh-ancestor
56537044|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
56537045|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537046|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387912|NCT00506272|Insulin|insulin|mesh-list
56537048|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56537049|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56191209|NCT01473251|Bevacizumab|bevacizumab|mesh-list
56720493|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56720494|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720495|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56720496|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
56720497|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56720498|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720499|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275914|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720514|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56720515|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720516|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720517|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720518|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
56720519|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56720520|NCT04661280|Donepezil|donepezil|mesh-list
56537050|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537051|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56537052|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56537053|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56537054|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537055|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56537056|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56537057|NCT00637975|Narcotics|narcotics|mesh-ancestor
56537058|NCT02801227|Oxytocin|oxytocin|mesh-list
56537059|NCT02801227|Dinoprostone|dinoprostone|mesh-list
56537060|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
56537061|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56537062|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537063|NCT02795299|Folic Acid|folic acid|mesh-list
56537064|NCT02795299|Methotrexate|methotrexate|mesh-list
56537065|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56537066|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
56537067|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56537068|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537069|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56537070|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
56537071|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537072|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537073|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
56537074|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537075|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56537076|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537077|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
56720521|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56720522|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720523|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720524|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
56720525|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720526|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720527|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
56720528|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
56720529|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
56720530|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56720531|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56720532|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56720533|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720534|NCT00696384|Diuretics|diuretics|mesh-ancestor
56720535|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
56720536|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720537|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56537078|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213199|NCT02650271|Entecavir|entecavir|mesh-list
56720538|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56720539|NCT00569127|Interferons|interferons|mesh-list
56720540|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
56720541|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
56720542|NCT00569127|Bevacizumab|bevacizumab|mesh-list
56720543|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56720544|NCT00569127|Octreotide|octreotide|mesh-list
56720545|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
56720546|NCT00569127|Antibodies|antibodies|mesh-list
56720547|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
56720548|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56720549|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
56720550|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720551|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56720552|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56720553|NCT00569127|Growth Substances|growth substances|mesh-ancestor
56720554|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720555|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
56720556|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
56720579|NCT00892450|Darifenacin|darifenacin|mesh-list
56720580|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
56720581|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
56720582|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720583|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720584|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56720585|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56720586|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
56720587|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720588|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720589|NCT00892450|Urological Agents|urological agents|mesh-ancestor
56720590|NCT01566565|Theophylline|theophylline|mesh-list
56720591|NCT01566565|Bambuterol|bambuterol|mesh-list
56720592|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56720593|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
56720594|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720595|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720596|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56720597|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
56720598|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56720599|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720600|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720601|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
56720602|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56720603|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56720604|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
56720605|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720606|NCT01039363|Cytarabine|cytarabine|mesh-list
56720607|NCT01039363|Vorinostat|vorinostat|mesh-list
56720609|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
56276014|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720615|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720616|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720617|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
56720618|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720619|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56720620|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720621|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56720622|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56720623|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56720624|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56720625|NCT00655993|Simvastatin|simvastatin|mesh-list
56720626|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56720627|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56720628|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
56720629|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720630|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56720631|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56720632|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720633|NCT01039441|Bupivacaine|bupivacaine|mesh-list
56720634|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
56720635|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
56720636|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720637|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537079|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56537080|NCT02795299|Hematinics|hematinics|mesh-ancestor
56537081|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
56537082|NCT02795299|Vitamins|vitamins|mesh-ancestor
56537083|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
56537084|NCT02795143|Isotretinoin|isotretinoin|mesh-list
56537085|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
56537086|NCT02799277|Testosterone|testosterone|mesh-list
56537087|NCT02799277|Androgens|androgens|mesh-ancestor
56537088|NCT02799277|Hormones|hormones|mesh-ancestor
56537089|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537090|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537091|NCT01198002|Methotrexate|methotrexate|mesh-list
56537092|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56537093|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
56537094|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56537095|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191270|NCT01473472|Tenofovir|tenofovir|mesh-list
56720638|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
56720639|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720640|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56720641|NCT01034917|Etravirine|etravirine|mesh-list
56720642|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
56720643|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720644|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56720645|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56720646|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720647|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720648|NCT00816699|Anesthetics|anesthetics|mesh-list
56720649|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720650|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720651|NCT00822549|Morphine|morphine|mesh-list
56720652|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56720653|NCT00822549|Narcotics|narcotics|mesh-ancestor
56720654|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720655|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720656|NCT00822549|Analgesics|analgesics|mesh-ancestor
56720657|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
56720658|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720659|NCT00819351|Asparaginase|asparaginase|mesh-list
56720660|NCT00819351|Pegaspargase|pegaspargase|mesh-list
56720661|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720662|NCT00699998|Aspirin|aspirin|mesh-list
56720663|NCT00699998|Clopidogrel|clopidogrel|mesh-list
56720664|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56720665|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56720666|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56720667|NCT00699998|Analgesics|analgesics|mesh-ancestor
56720668|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
56720669|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720670|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720671|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56720672|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720673|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56720674|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56720675|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720676|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56720677|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56276068|NCT02020694|Vitamin D|vitamin d|mesh-list
56537096|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56537097|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
56537098|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191287|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
56720692|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56720693|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
56720694|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56720695|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720696|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56720697|NCT00816855|Docetaxel|docetaxel|mesh-list
56720698|NCT00816855|Fluorouracil|fluorouracil|mesh-list
56720699|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720700|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
56720701|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
56720702|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
56720703|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720704|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
56720705|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56720706|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720707|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
56720708|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720709|NCT00822783|Omalizumab|omalizumab|mesh-list
56720710|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56720711|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56720712|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
56720713|NCT00634647|Prednisone|prednisone|mesh-list
56720714|NCT00634647|Satraplatin|satraplatin|mesh-list
56720715|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56720716|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
56720717|NCT00634647|Hormones|hormones|mesh-ancestor
56720718|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56720719|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720720|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56720721|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720722|NCT00576732|Risperidone|risperidone|mesh-list
56720723|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56720724|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
56720725|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720726|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720727|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720728|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56720729|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56720730|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720731|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56720732|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56720733|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
56720734|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56720735|NCT00817011|Mirtazapine|mirtazapine|mesh-list
56720736|NCT00817011|Trazodone|trazodone|mesh-list
56720737|NCT00817011|Bupropion|bupropion|mesh-list
56720764|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
56720766|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56720767|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56720768|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720769|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56720770|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56720771|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56720772|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
56720773|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56720774|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56720775|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56720776|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56720777|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56720778|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
56720779|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56720780|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720781|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720782|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56720783|NCT00697788|Analgesics|analgesics|mesh-ancestor
56720800|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
56537099|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537100|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
56537101|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537102|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56537103|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537104|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
56537105|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56537106|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56537107|NCT02795065|Enoxaparin|enoxaparin|mesh-list
56537108|NCT02795065|Bemiparin|bemiparin|mesh-list
56537109|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
56537110|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56537111|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56537112|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537113|NCT04233697|Romidepsin|romidepsin|mesh-list
56537114|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56537115|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537116|NCT05470699|Fluorides|fluorides|mesh-list
56720801|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720802|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720803|NCT04062890|Vigabatrin|vigabatrin|mesh-list
56720804|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
56720805|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720806|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720807|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
56720808|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720809|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720810|NCT00817245|Amoxicillin|amoxicillin|mesh-list
56720811|NCT00817245|Metronidazole|metronidazole|mesh-list
56720812|NCT00817245|Omeprazole|omeprazole|mesh-list
56720813|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56720814|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720815|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56720816|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56720817|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56720818|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56720819|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56720820|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720821|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720822|NCT02550483|Beta Carotene|beta carotene|mesh-list
56720823|NCT02550483|Lycopene|lycopene|mesh-list
56720824|NCT02550483|Carotenoids|carotenoids|mesh-list
56720825|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56720826|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
56720827|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720828|NCT02550483|Protective Agents|protective agents|mesh-ancestor
56720829|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720830|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56720831|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56720832|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720833|NCT02550483|Provitamins|provitamins|mesh-ancestor
56720834|NCT02550483|Vitamins|vitamins|mesh-ancestor
56720835|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
56720836|NCT04608318|Venetoclax|venetoclax|mesh-list
56720837|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
56720838|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720839|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56720840|NCT04063358|Ranibizumab|ranibizumab|mesh-list
56720841|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56720842|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56537117|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
56537118|NCT05470699|Protective Agents|protective agents|mesh-ancestor
56537119|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537120|NCT03826303|Ethanol|ethanol|mesh-list
56537121|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56537122|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537123|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537124|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537125|NCT02798653|Progesterone|progesterone|mesh-list
56537126|NCT02798653|Progestins|progestins|mesh-ancestor
56537127|NCT02798653|Hormones|hormones|mesh-ancestor
56537128|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56720873|NCT01034995|Citalopram|citalopram|mesh-list
56720874|NCT01034995|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56720875|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56720876|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56720877|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720878|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720879|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
56720880|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720881|NCT01034995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56720882|NCT01034995|Antidepressive Agents|antidepressive agents|mesh-ancestor
56720883|NCT01034995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56720884|NCT00921414|Rituximab|rituximab|mesh-list
56720885|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56720886|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720920|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720921|NCT02094625|Antidotes|antidotes|mesh-ancestor
56720922|NCT05324904|Vitamin D|vitamin d|mesh-list
56720923|NCT05324904|Acyclovir|acyclovir|mesh-list
56720924|NCT05324904|Vitamins|vitamins|mesh-ancestor
56720925|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
56720955|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720957|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56720958|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56720959|NCT05403086|Ketamine|ketamine|mesh-list
56720960|NCT05403086|Psilocybin|psilocybin|mesh-list
56720961|NCT05403086|Hallucinogens|hallucinogens|mesh-list
56720962|NCT05403086|Analgesics|analgesics|mesh-ancestor
56720963|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
56720964|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720965|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720966|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56720967|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56720968|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
56720969|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
56720996|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720997|NCT00607048|Paclitaxel|paclitaxel|mesh-list
56720998|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56720999|NCT00607048|Carboplatin|carboplatin|mesh-list
56721000|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56721001|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56721002|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721003|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
56721004|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
56721005|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
56721006|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721007|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
56721008|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721009|NCT03592576|Venetoclax|venetoclax|mesh-list
56721010|NCT03592576|Navitoclax|navitoclax|mesh-list
56721011|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721012|NCT04035850|Vortioxetine|vortioxetine|mesh-list
56721013|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
56537129|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537130|NCT03863587|Ramucirumab|ramucirumab|mesh-list
56721014|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56721015|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56721016|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56721017|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721018|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721019|NCT04035850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56721046|NCT00893854|Triamcinolone|triamcinolone|mesh-list
56721047|NCT00893854|Diclofenac|diclofenac|mesh-list
56721048|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721049|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
56721050|NCT00893854|Hormones|hormones|mesh-ancestor
56721051|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56721052|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721053|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721054|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721055|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56721056|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721057|NCT00893854|Analgesics|analgesics|mesh-ancestor
56721058|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
56721059|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721060|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721061|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56721062|NCT00895804|Pindolol|pindolol|mesh-list
56721093|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
56721094|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
56721095|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56721096|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721097|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721098|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56721099|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721100|NCT00894010|Analgesics|analgesics|mesh-ancestor
56721101|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
56721102|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721103|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56721104|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56721105|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721106|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56721133|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721134|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721135|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721136|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
56721137|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56721138|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721139|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56721140|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56721141|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721142|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721143|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721144|NCT00896428|Gallopamil|gallopamil|mesh-list
56721145|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56721146|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56721147|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721148|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56721149|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721150|NCT02962050|Capsaicin|capsaicin|mesh-list
56721151|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
56721152|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
56276575|NCT02024009|Nelfinavir|nelfinavir|mesh-list
56721171|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
56721172|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721173|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
56721174|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
56721175|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721176|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56721177|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
56721179|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56721180|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56721181|NCT00742638|Valproic Acid|valproic acid|mesh-list
56721182|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56061099|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56721183|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
56721184|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56721185|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56721186|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56721187|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721188|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721189|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
56721190|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721191|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721192|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
56721193|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721194|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
56721195|NCT00418717|Etanercept|etanercept|mesh-list
56721196|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56721197|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721198|NCT00418717|Analgesics|analgesics|mesh-ancestor
56721199|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
56721200|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721201|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721202|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721203|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721204|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56721205|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56721206|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
56721207|NCT00572572|Aprepitant|aprepitant|mesh-list
56721208|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
56721209|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
56721210|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276616|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
56721241|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
56721242|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56721243|NCT00409747|Minocycline|minocycline|mesh-list
56721244|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56721245|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721246|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
56721247|NCT04016740|Ketamine|ketamine|mesh-list
56721248|NCT04016740|Remifentanil|remifentanil|mesh-list
56721249|NCT04016740|Propofol|propofol|mesh-list
56721250|NCT04016740|Ropivacaine|ropivacaine|mesh-list
56721251|NCT04016740|Sevoflurane|sevoflurane|mesh-list
56721252|NCT04016740|Rocuronium|rocuronium|mesh-list
56721253|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56721254|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721255|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721292|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
56721313|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56721314|NCT00894712|Protective Agents|protective agents|mesh-ancestor
56721315|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721316|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721317|NCT00823641|Infliximab|infliximab|mesh-list
56721318|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
56721319|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56721320|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721321|NCT04017598|Iron|iron|mesh-list
56721322|NCT04017598|Trace Elements|trace elements|mesh-ancestor
56721323|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
56721324|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721325|NCT00823875|Cilostazol|cilostazol|mesh-list
56721326|NCT00823875|Probucol|probucol|mesh-list
56721327|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56721328|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
56721329|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721330|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721331|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56721332|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
56721333|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56721334|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56721335|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721336|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56721337|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
56721338|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56721339|NCT00823875|Protective Agents|protective agents|mesh-ancestor
56721340|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56721341|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56721342|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721343|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56721344|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56721345|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
56721346|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56537131|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537132|NCT04233463|Budesonide|budesonide|mesh-list
56049220|NCT03744663|Naloxone|naloxone|mesh-list
56721347|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
56721348|NCT00397189|Melatonin|melatonin|mesh-list
56721349|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
56721379|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56721380|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
56721381|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721382|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56721383|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56721384|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721385|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56721386|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721387|NCT04044417|Analgesics|analgesics|mesh-ancestor
56721388|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
56721389|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721390|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721391|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721392|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721393|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721394|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56721395|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56721430|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721431|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56721432|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56721433|NCT00699374|Growth Substances|growth substances|mesh-ancestor
56721434|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721457|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
56721458|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56721459|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
56721460|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56721461|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721462|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
56721463|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56721464|NCT03680053|Progestins|progestins|mesh-ancestor
56721465|NCT03680053|Hormones|hormones|mesh-ancestor
56721466|NCT04667078|Cangrelor|cangrelor|mesh-list
56721467|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56721468|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56721469|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56721470|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56721471|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
56721472|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721473|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721474|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721475|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
56721476|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721477|NCT01042561|Vitamin D|vitamin d|mesh-list
56721478|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
56721479|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
56721480|NCT01042561|Vitamins|vitamins|mesh-list
56721481|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
56721482|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721483|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56721484|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56721485|NCT01035853|Colistin|colistin|mesh-list
56721486|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56721487|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721488|NCT05268614|Cisplatin|cisplatin|mesh-list
56721490|NCT01042717|Plerixafor|plerixafor|mesh-list
56721491|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56721492|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56721493|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
56721494|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721495|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56721496|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56721497|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
56721498|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721499|NCT00898846|Tegafur|tegafur|mesh-list
56721500|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56721501|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
56721502|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721503|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721504|NCT00826371|Ranibizumab|ranibizumab|mesh-list
56721505|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56721506|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56721507|NCT00826371|Growth Substances|growth substances|mesh-ancestor
56721508|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721509|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
56721510|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721511|NCT02540824|Apatinib|apatinib|mesh-list
56721512|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721513|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56721514|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721515|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721516|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
56721517|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56721518|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56721519|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
56721520|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721521|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721522|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721523|NCT00826527|Urological Agents|urological agents|mesh-ancestor
56721524|NCT02550717|Aspirin|aspirin|mesh-list
56721525|NCT02550717|Anticoagulants|anticoagulants|mesh-list
56721526|NCT02550717|Clopidogrel|clopidogrel|mesh-list
56721527|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56721528|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721529|NCT02550717|Analgesics|analgesics|mesh-ancestor
56721530|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
56721531|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721532|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721533|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721534|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721535|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56721536|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56721537|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721538|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56721539|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56721540|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721541|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
56721542|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56721543|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56721544|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56721545|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
56721546|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721547|NCT02550249|Nivolumab|nivolumab|mesh-list
56721548|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56721549|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721550|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56721551|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721552|NCT00824811|Fluorometholone|fluorometholone|mesh-list
56721553|NCT00824811|Cyclosporine|cyclosporine|mesh-list
56721554|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56721555|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
56721556|NCT00824811|Cyclosporins|cyclosporins|mesh-list
56721557|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721558|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721559|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56721560|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
56721561|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721562|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
56721588|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
56721589|NCT02550327|Antiviral Agents|antiviral agents|mesh-ancestor
56721590|NCT02550327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721591|NCT02550327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721592|NCT02550327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56721593|NCT02550327|Immunologic Factors|immunologic factors|mesh-ancestor
56721594|NCT02550327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721595|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721596|NCT00825045|Risperidone|risperidone|mesh-list
56721597|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56721598|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
56721599|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721600|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721601|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721602|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56721603|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56191323|NCT01474265|Varenicline|varenicline|mesh-list
56721604|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721605|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56721606|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56721607|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
56721609|NCT00625131|Nicotine|nicotine|mesh-list
56721610|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56721611|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
56721612|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721645|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56721646|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
56721647|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
56721648|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721649|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721650|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56721651|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56721652|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56721653|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
56277084|NCT02026817|Metformin|metformin|mesh-list
56721678|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721679|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
56721680|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
56721681|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
56721682|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721683|NCT00820911|Cyclosporine|cyclosporine|mesh-list
56721685|NCT00820911|Cyclosporins|cyclosporins|mesh-list
56721686|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721687|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721688|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56721689|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
56721690|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721691|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
56721692|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721693|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
56721694|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721695|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56721696|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721697|NCT00605722|Bevacizumab|bevacizumab|mesh-list
56721698|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56721699|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56721700|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721701|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56277110|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
56721733|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
56721734|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721735|NCT00825591|Protective Agents|protective agents|mesh-ancestor
56721736|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721737|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721738|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
56721739|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56721740|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
56721741|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721742|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
56721743|NCT00882232|Protective Agents|protective agents|mesh-ancestor
56277160|NCT02027298|Abatacept|abatacept|mesh-list
56721768|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56721769|NCT00900172|Growth Substances|growth substances|mesh-ancestor
56721770|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721771|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
56721772|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
56721773|NCT00605566|Sorafenib|sorafenib|mesh-list
56721774|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56721775|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
56721776|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721777|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721778|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56721779|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
56721780|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721781|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721782|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56721783|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56721784|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721785|NCT00882388|Aspirin|aspirin|mesh-list
56721786|NCT00882388|Celecoxib|celecoxib|mesh-list
56721787|NCT00882388|Clopidogrel|clopidogrel|mesh-list
56061659|NCT04342247|Androgens|androgens|mesh-ancestor
56537133|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537134|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56721788|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56721789|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721790|NCT00882388|Analgesics|analgesics|mesh-ancestor
56721791|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
56721792|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721793|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721808|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56721810|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56721811|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56721812|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56721813|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56721814|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
56721815|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721816|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721817|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721818|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56721819|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
56721820|NCT00882466|Hematinics|hematinics|mesh-ancestor
56721821|NCT00628251|Doxorubicin|doxorubicin|mesh-list
56721822|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56721824|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56721825|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721826|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56721827|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56721828|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721829|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721830|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56721831|NCT01036399|Lenalidomide|lenalidomide|mesh-list
56721832|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
56721833|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721834|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56721835|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56721836|NCT01036399|Growth Substances|growth substances|mesh-ancestor
56721837|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
56721838|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721848|NCT00901654|Vaccines|vaccines|mesh-list
56721849|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
56721850|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721851|NCT00901732|Calcium|calcium|mesh-list
56721852|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56277258|NCT02027870|Sirolimus|sirolimus|mesh-list
56721867|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
56721868|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
56721869|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721870|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721871|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721872|NCT00900874|Albuterol|albuterol|mesh-list
56721873|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
56721874|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56721875|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
56721876|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721877|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721878|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56721879|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
56721880|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56721881|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56721882|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56721883|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
56721884|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721885|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721886|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
56721887|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56721888|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
56721889|NCT00901888|Nitroprusside|nitroprusside|mesh-list
56721890|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56721891|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
56721892|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56721893|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721894|NCT00908362|Fluticasone|fluticasone|mesh-list
56721895|NCT00908362|Xhance|xhance|mesh-list
56537135|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
56537136|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537137|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537138|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56537139|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
56537140|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
56537141|NCT04233463|Hormones|hormones|mesh-ancestor
56537142|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537143|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
56537144|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56537145|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
56537146|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537147|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
56537148|NCT02793739|Protective Agents|protective agents|mesh-ancestor
56537149|NCT02793505|Metformin|metformin|mesh-list
56721896|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56721897|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56721898|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721899|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56721900|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
56721901|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721902|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721903|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56721904|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
56721905|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
56721906|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56721907|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56721908|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56721909|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56721910|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
56721911|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277315|NCT02028260|Modafinil|modafinil|mesh-list
56721937|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721938|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721939|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
56721940|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721941|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56721942|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56721943|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56721944|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56721945|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721946|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56721947|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56721948|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
56721949|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721950|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56721951|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56721952|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
56721953|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56721954|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
56721955|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
56433071|NCT00414323|Citalopram|citalopram|mesh-list
56721956|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
56721957|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56721958|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56721960|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56722017|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56722018|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
56722019|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537150|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56055133|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722020|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722021|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56722022|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722023|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56722024|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56722025|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56722027|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
56722028|NCT00837915|Ephedrine|ephedrine|mesh-list
56722029|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
56722030|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
56722031|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56722032|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56722033|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56722034|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
56722035|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
56722036|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722037|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722038|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722046|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56722048|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
56722049|NCT00908986|Rituximab|rituximab|mesh-list
56722050|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56722051|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722052|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
56722053|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722054|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722055|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
56722056|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56722057|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722058|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
56722059|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56722060|NCT00838071|Antibodies|antibodies|mesh-list
56722061|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
56722062|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722063|NCT02547519|Insulin|insulin|mesh-list
56722064|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56722065|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722066|NCT00909454|Vitamin D|vitamin d|mesh-list
56722067|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
56722068|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
56722069|NCT00909454|Vitamins|vitamins|mesh-list
56722070|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
56722071|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722072|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56722073|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56722074|NCT04035070|Clindamycin|clindamycin|mesh-list
56722075|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
56722076|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
56722077|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56722078|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56722079|NCT04035070|Eusol|eusol|mesh-list
56722080|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56722081|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722082|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56722083|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722084|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722085|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
56722086|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56722087|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56722088|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56722089|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56722090|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722091|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722092|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722093|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722094|NCT00408421|Analgesics|analgesics|mesh-ancestor
56722095|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
56722096|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722097|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
56722098|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56537151|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537152|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56537153|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56537154|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537155|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
56537156|NCT04234321|Mitogens|mitogens|mesh-list
56537157|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
56537158|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537159|NCT02797717|Prednisone|prednisone|mesh-list
56537160|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
56537161|NCT02797717|Dacarbazine|dacarbazine|mesh-list
56537162|NCT02797717|Doxorubicin|doxorubicin|mesh-list
56537163|NCT02797717|Etoposide|etoposide|mesh-list
56537164|NCT02797717|Vincristine|vincristine|mesh-list
56537165|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537166|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
56537167|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537168|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56537169|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56537170|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
56537171|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537172|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722099|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
56722100|NCT00604786|Omalizumab|omalizumab|mesh-list
56722101|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56722102|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56722103|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
56433220|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
56722105|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56722106|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
56722132|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722133|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56722134|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722135|NCT00903214|Riluzole|riluzole|mesh-list
56722136|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
56722137|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56722138|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56722139|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722140|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722141|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722142|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56722143|NCT00903214|Protective Agents|protective agents|mesh-ancestor
56722144|NCT04034836|Parecoxib|parecoxib|mesh-list
56722145|NCT04034836|Ropivacaine|ropivacaine|mesh-list
56722146|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
56722147|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
56722148|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722149|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722150|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
56722151|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722152|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56722153|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56722154|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277568|NCT02029599|Analgesics|analgesics|mesh-ancestor
56537173|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56537174|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56537175|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56722180|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56722181|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56722182|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56722184|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
56722185|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722186|NCT00903838|Protective Agents|protective agents|mesh-ancestor
56722187|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722188|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56722189|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56722190|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
56722191|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
56722192|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722193|NCT00924430|Simvastatin|simvastatin|mesh-list
56722194|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56722195|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56722196|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
56722197|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722198|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56722199|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56722200|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722201|NCT00924586|Landiolol|landiolol|mesh-list
56722202|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56722205|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722206|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722207|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722208|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56722209|NCT00903994|Ketoprofen|ketoprofen|mesh-list
56722210|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56722211|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56722212|NCT00903994|Analgesics|analgesics|mesh-ancestor
56722213|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
56722214|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722215|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722216|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56722217|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722218|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56722219|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722220|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722221|NCT00924742|Tazobactam|tazobactam|mesh-list
56722222|NCT00924742|Piperacillin|piperacillin|mesh-list
56722223|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56722224|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722225|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56722226|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722227|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722228|NCT05014282|Nicotine|nicotine|mesh-list
56722229|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56722230|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
56722231|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722232|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722233|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56722234|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56722235|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
56722236|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722237|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722238|NCT00407563|Paclitaxel|paclitaxel|mesh-list
56722239|NCT00407563|Bevacizumab|bevacizumab|mesh-list
56722240|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56722241|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56722242|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722243|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
56722244|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
56722245|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
56722246|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722247|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56722248|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56722249|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56537176|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56537177|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537178|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537179|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
56537180|NCT02797717|Hormones|hormones|mesh-ancestor
56537181|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537182|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56537183|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56537184|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
56537185|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
56537186|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
56537187|NCT04235569|Enoxaparin|enoxaparin|mesh-list
56537188|NCT04235569|Warfarin|warfarin|mesh-list
56537189|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
56537190|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
56537191|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56537192|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56537193|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537194|NCT01197378|Cysteamine|cysteamine|mesh-list
56537195|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56537196|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537197|NCT02792491|Prednisone|prednisone|mesh-list
56537198|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
56537199|NCT02792491|Rituximab|rituximab|mesh-list
56722250|NCT00407563|Growth Substances|growth substances|mesh-ancestor
56722251|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722253|NCT00906724|Insulin|insulin|mesh-list
56722254|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56722255|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722256|NCT01037101|Cycloserine|cycloserine|mesh-list
56722257|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56722258|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722259|NCT01037101|Renal Agents|renal agents|mesh-ancestor
56722260|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56722261|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
56722262|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56722263|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
56722264|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722265|NCT00904306|Chromium|chromium|mesh-list
56722266|NCT00904306|Picolinic acid|picolinic acid|mesh-list
56722267|NCT00904306|Trace Elements|trace elements|mesh-ancestor
56722268|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
56722269|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722270|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56722271|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
56722272|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
56722273|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722274|NCT00623103|Rivastigmine|rivastigmine|mesh-list
56722275|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56722276|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722309|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722310|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56061660|NCT04852887|Tamoxifen|tamoxifen|mesh-list
56537200|NCT02792491|Doxorubicin|doxorubicin|mesh-list
56722311|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56722312|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56722313|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722314|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722316|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56722317|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
56722318|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
56722319|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277753|NCT02035891|Colchicine|colchicine|mesh-list
56722345|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56722346|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56722347|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722348|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722350|NCT00906880|Nifurtimox|nifurtimox|mesh-list
56722351|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722352|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56722353|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56722354|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56722355|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722356|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56722357|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722358|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722359|NCT00904852|Bevacizumab|bevacizumab|mesh-list
56722360|NCT00904852|Temozolomide|temozolomide|mesh-list
56722361|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56722362|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722363|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56722364|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56722365|NCT00904852|Growth Substances|growth substances|mesh-ancestor
56722388|NCT00396409|Omalizumab|omalizumab|mesh-list
56722389|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56722390|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56722391|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
56722392|NCT03653832|Clonidine|clonidine|mesh-list
56722393|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
56722394|NCT03653832|Propofol|propofol|mesh-list
56722395|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56722396|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722397|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722398|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56722399|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
56433516|NCT00239954|Citalopram|citalopram|mesh-list
56722400|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
56722401|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56722402|NCT03653832|Analgesics|analgesics|mesh-ancestor
56722403|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
56722404|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722405|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56722406|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56722407|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56722408|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
56722409|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722410|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722411|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56722412|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
56722413|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
56722414|NCT00567580|Leuprolide|leuprolide|mesh-list
56722415|NCT00567580|Goserelin|goserelin|mesh-list
56722416|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56722417|NCT00567580|Flutamide|flutamide|mesh-list
56722446|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722447|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
56722448|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722450|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56722451|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722452|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722453|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
56722454|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722455|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722456|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
56722457|NCT00921570|Amlodipine|amlodipine|mesh-list
56722458|NCT00921570|Valsartan|valsartan|mesh-list
56722459|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56722460|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56537201|NCT02792491|Vincristine|vincristine|mesh-list
56537202|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537203|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
56537204|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537205|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56285446|NCT00000973|Calcium|calcium|mesh-list
56537206|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56537207|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
56537208|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537209|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537210|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56537211|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56056814|NCT04344041|Vitamins|vitamins|mesh-ancestor
56722461|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722462|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722463|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56722464|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722495|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56722496|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
56722497|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722498|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722499|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
56722500|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722501|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
56722502|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722503|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56722504|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56722505|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
56722506|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56722507|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56722527|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56722528|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722529|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56722530|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722531|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722532|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
56722533|NCT02564094|Hematinics|hematinics|mesh-ancestor
56722534|NCT00745914|Pioglitazone|pioglitazone|mesh-list
56722535|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56722536|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722537|NCT00746070|Spironolactone|spironolactone|mesh-list
56722538|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56722539|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
56722540|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56722541|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722542|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56722543|NCT00746070|Diuretics|diuretics|mesh-ancestor
56722544|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
56722545|NCT00396331|Plerixafor|plerixafor|mesh-list
56722546|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56722547|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56722548|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
56722549|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722550|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
56722551|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
56722552|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56722553|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722554|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722556|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56722557|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537212|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56537213|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56537214|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56537215|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537216|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537217|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
56537219|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537220|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56537221|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56537222|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
56191415|NCT01475032|Hormones|hormones|mesh-ancestor
56722558|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722559|NCT00926926|Oxybutynin|oxybutynin|mesh-list
56722560|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
56722561|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
56722562|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722563|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722589|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722590|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56722591|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56722592|NCT00931450|Growth Substances|growth substances|mesh-ancestor
56722593|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722594|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
56722595|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56722596|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722597|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722598|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56722599|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56722600|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56722601|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
56722602|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56722603|NCT00928330|Trastuzumab|trastuzumab|mesh-list
56722604|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56722605|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56722606|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722607|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
56722608|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
56722609|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
56722610|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722641|NCT00907270|Vitamins|vitamins|mesh-ancestor
56722642|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
56722643|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56722644|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
56722645|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56722646|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722647|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56722648|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722649|NCT00907504|Gemcitabine|gemcitabine|mesh-list
56722650|NCT00907504|Cisplatin|cisplatin|mesh-list
56722651|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722652|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56722653|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
56722671|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56722672|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
56722673|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722674|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722675|NCT00932542|Lidocaine|lidocaine|mesh-list
56722676|NCT00932542|Prilocaine|prilocaine|mesh-list
56722677|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
56722678|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
56722679|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722680|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537223|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
56537224|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
56537225|NCT02792803|Latanoprost|latanoprost|mesh-list
56537226|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56537227|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56537228|NCT02797249|Aspirin|aspirin|mesh-list
56537229|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
56537230|NCT02797249|Salicylates|salicylates|mesh-list
56537231|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56537232|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56537233|NCT02797249|Analgesics|analgesics|mesh-ancestor
56537234|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
56537235|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537236|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537237|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537238|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56537239|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56722681|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
56722682|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722683|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56722684|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56722685|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56722686|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722687|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722688|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
56722689|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56722690|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722691|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
56722692|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56722693|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56722694|NCT04014634|Prednisolone|prednisolone|mesh-list
56722695|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
56722696|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56722697|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
56433815|NCT00240656|Diuretics|diuretics|mesh-ancestor
56722698|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56722699|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
56722700|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
56722701|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722702|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722703|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56722704|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
56722705|NCT04014634|Hormones|hormones|mesh-ancestor
56722706|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56722707|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56722708|NCT04014634|Protective Agents|protective agents|mesh-ancestor
56722732|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722733|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56722734|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722736|NCT00567268|Analgesics|analgesics|mesh-ancestor
56722737|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
56722738|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722739|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722740|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
56722741|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56722742|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56722743|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722744|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56061661|NCT04852887|Letrozole|letrozole|mesh-list
56537240|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56537241|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191437|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
56722745|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56722746|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56722747|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722748|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722749|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
56722750|NCT00907894|Telbivudine|telbivudine|mesh-list
56722751|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
56722752|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722753|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56722754|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722755|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722756|NCT04014556|Aflibercept|aflibercept|mesh-list
56722789|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722790|NCT00933634|Propafenone|propafenone|mesh-list
56722791|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56722792|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56722793|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56722794|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722795|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722796|NCT00933790|Rifampin|rifampin|mesh-list
56722797|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
56722824|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722825|NCT00393367|Prednisone|prednisone|mesh-list
56722826|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
56722827|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56722828|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56722829|NCT00393367|Prednisolone|prednisolone|mesh-list
56722830|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
56722831|NCT00393367|Budesonide|budesonide|mesh-list
56722832|NCT00393367|Bromides|bromides|mesh-list
56722833|NCT00393367|Albuterol|albuterol|mesh-list
56722834|NCT00393367|Ipratropium|ipratropium|mesh-list
56722835|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56722836|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
56722837|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56722838|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
56722839|NCT00393367|Hormones|hormones|mesh-ancestor
56722840|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56722841|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278270|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
56722872|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56722873|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722874|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56722875|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56722876|NCT00392665|Growth Substances|growth substances|mesh-ancestor
56722877|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722878|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
56722879|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56722880|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722881|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722882|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56722883|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56722884|NCT00392665|Analgesics|analgesics|mesh-ancestor
56722885|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
56722886|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278333|NCT02043977|Propofol|propofol|mesh-list
56722917|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434035|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56722918|NCT00366457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56722919|NCT00366457|Immunologic Factors|immunologic factors|mesh-ancestor
56722920|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56722921|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56722922|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
56722923|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722924|NCT01049347|Amitriptyline|amitriptyline|mesh-list
56722925|NCT01049347|Paroxetine|paroxetine|mesh-list
56722926|NCT01049347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56722927|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56537242|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56537243|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56057237|NCT05270057|Prednisone|prednisone|mesh-list
56722928|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722929|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722990|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722991|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
56722992|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722993|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722994|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56722995|NCT00622713|Protective Agents|protective agents|mesh-ancestor
56722996|NCT01046227|Vaccines|vaccines|mesh-list
56722997|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
56722998|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722999|NCT00392197|Aripiprazole|aripiprazole|mesh-list
56723000|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
56723001|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56723002|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56723003|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56723004|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723005|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723006|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
56723007|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
56723008|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723009|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723010|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56723040|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723041|NCT00831597|Rituximab|rituximab|mesh-list
56723042|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56723043|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56723044|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723045|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
56723046|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723047|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723048|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56723049|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
56723050|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723051|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56723052|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56723053|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
56723054|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723055|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723079|NCT04018365|Empagliflozin|empagliflozin|mesh-list
56723080|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56723081|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723082|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56723083|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723084|NCT00828087|Cobalt|cobalt|mesh-list
56723085|NCT00828087|Chromium|chromium|mesh-list
56723086|NCT00828087|Everolimus|everolimus|mesh-list
56723087|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723088|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723089|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
56723090|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723091|NCT00828087|Trace Elements|trace elements|mesh-ancestor
56723092|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
56723093|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
56723094|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
56723095|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
56723096|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723097|NCT00839085|Protective Agents|protective agents|mesh-ancestor
56723098|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723099|NCT00839085|Vitamins|vitamins|mesh-ancestor
56723100|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
56723101|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56723102|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723103|NCT00839163|Vitamin K|vitamin k|mesh-list
56723104|NCT00839163|Enoxaparin|enoxaparin|mesh-list
56723105|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
56723106|NCT00839163|Vitamins|vitamins|mesh-ancestor
56723107|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
56723108|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537244|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537245|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
56723109|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56723144|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
56723145|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56723146|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
56723147|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723148|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
56723149|NCT02548923|Propofol|propofol|mesh-list
56723150|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56723151|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723152|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723181|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56723182|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723183|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723184|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
56723185|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723186|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56723187|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
56723188|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56723189|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56723190|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56723191|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723192|NCT00828477|Nepafenac|nepafenac|mesh-list
56723193|NCT00828477|Bromfenac|bromfenac|mesh-list
56723194|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56723195|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56723196|NCT00828477|Analgesics|analgesics|mesh-ancestor
56278627|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723215|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56723216|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56723217|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56723218|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56723220|NCT00621309|Protective Agents|protective agents|mesh-ancestor
56723221|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723222|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723223|NCT00839553|Minocycline|minocycline|mesh-list
56723224|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56723225|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723226|NCT00832689|Gemcitabine|gemcitabine|mesh-list
56723227|NCT00832689|Irinotecan|irinotecan|mesh-list
56723228|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56723229|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
56723230|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723231|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723232|NCT00832689|Antiviral Agents|antiviral agents|mesh-ancestor
56723233|NCT00832689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723234|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723235|NCT00832689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723236|NCT00832689|Immunologic Factors|immunologic factors|mesh-ancestor
56723237|NCT00832689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723238|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56723239|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56723240|NCT00567190|Docetaxel|docetaxel|mesh-list
56723241|NCT00567190|Trastuzumab|trastuzumab|mesh-list
56723242|NCT00567190|Pertuzumab|pertuzumab|mesh-list
56723243|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723244|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
56723245|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
56723246|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
56723247|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723248|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56723249|NCT00922389|Lenograstim|lenograstim|mesh-list
56723250|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56723287|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56723288|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723289|NCT01046461|Dexamethasone|dexamethasone|mesh-list
56278761|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
56723360|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56723361|NCT00839787|Narcotics|narcotics|mesh-ancestor
56723362|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723363|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723364|NCT00839787|Analgesics|analgesics|mesh-ancestor
56723365|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
56537246|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537247|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
56537248|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
56537249|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
56537250|NCT02792335|Warfarin|warfarin|mesh-list
56537251|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
56537252|NCT02792335|Dabigatran|dabigatran|mesh-list
56537253|NCT02792335|Apixaban|apixaban|mesh-list
56537254|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
56537255|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56537256|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
56537257|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56537258|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
56537259|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537260|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537261|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
56537262|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56537263|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537264|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
56537265|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56537266|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537267|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537268|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56537269|NCT04200235|Analgesics|analgesics|mesh-ancestor
56537270|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
56537271|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537272|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56537273|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56537274|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56723393|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
56723394|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723395|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56723396|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56723397|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723399|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56723400|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
56723401|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56723402|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56723403|NCT00934570|Metformin|metformin|mesh-list
56723404|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56723405|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723406|NCT00930670|Esomeprazole|esomeprazole|mesh-list
56723407|NCT00930670|Omeprazole|omeprazole|mesh-list
56723408|NCT00930670|Pantoprazole|pantoprazole|mesh-list
56723409|NCT00930670|Ranitidine|ranitidine|mesh-list
56723410|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56723411|NCT00930670|Atorvastatin|atorvastatin|mesh-list
56537275|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
56537277|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537278|NCT02791243|Finasteride|finasteride|mesh-list
56537279|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56285549|NCT00001033|Vitamins|vitamins|mesh-ancestor
56537281|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537282|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537283|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
56537284|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537285|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723443|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723444|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
56723446|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
56723447|NCT00937300|Interleukin-2|interleukin-2|mesh-list
56723448|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723449|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
56723450|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723451|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723452|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56723487|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723488|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723489|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723490|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56723491|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56723492|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278925|NCT02047175|Vitamins|vitamins|mesh-ancestor
56723526|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56723527|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
56723528|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723529|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723530|NCT00574275|Antiviral Agents|antiviral agents|mesh-ancestor
56723531|NCT00574275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723532|NCT00574275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723533|NCT00574275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723534|NCT00574275|Immunologic Factors|immunologic factors|mesh-ancestor
56278965|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
56723568|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723569|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723571|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56723572|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56723595|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
56723596|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56723597|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56723598|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56723600|NCT04285671|Necitumumab|necitumumab|mesh-list
56723601|NCT04285671|Osimertinib|osimertinib|mesh-list
56723602|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56723603|NCT04285671|Antibodies|antibodies|mesh-list
56723604|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
56723605|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56723606|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
56723607|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723608|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723609|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723610|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56723611|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723612|NCT00931372|Lixisenatide|lixisenatide|mesh-list
56723613|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56723614|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723615|NCT00829257|Fluticasone|fluticasone|mesh-list
56723616|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56723617|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723618|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56537286|NCT02791243|Urological Agents|urological agents|mesh-ancestor
56537287|NCT02797015|Ozanimod|ozanimod|mesh-list
56537288|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56537289|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537290|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537291|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
56537292|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537293|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
56537294|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56537295|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537296|NCT02796859|Siltuximab|siltuximab|mesh-list
56537297|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537298|NCT03803761|Fulvestrant|fulvestrant|mesh-list
56537299|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56537300|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537301|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56537302|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56723619|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
56723620|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723621|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723622|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56723658|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723660|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723661|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
56723688|NCT00691704|Bortezomib|bortezomib|mesh-list
56723689|NCT00691704|Melphalan|melphalan|mesh-list
56723690|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723691|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
56723692|NCT00691704|Hormones|hormones|mesh-ancestor
56723693|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723694|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723695|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56723696|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723697|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723698|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
56723699|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56723700|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56723701|NCT00691704|Growth Substances|growth substances|mesh-ancestor
56723702|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
56723703|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56723704|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
56723705|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56723706|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723707|NCT00829647|Lenalidomide|lenalidomide|mesh-list
56723708|NCT00829647|Dasatinib|dasatinib|mesh-list
56723709|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
56723710|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723711|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56723742|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56723743|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723744|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
56723746|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723747|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723748|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723749|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
56723750|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537303|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
56537304|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537305|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537306|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
56537307|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
56723751|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723752|NCT02548611|Clopidogrel|clopidogrel|mesh-list
56723753|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56723788|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
56723789|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723790|NCT00830193|Expectorants|expectorants|mesh-ancestor
56723791|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
56723792|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56723793|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
56723822|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723823|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56723824|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56723825|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723826|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56723827|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56723828|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
56723829|NCT00841113|Goserelin|goserelin|mesh-list
56723830|NCT00841113|Bicalutamide|bicalutamide|mesh-list
56723831|NCT00841113|Abarelix|abarelix|mesh-list
56723832|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56723833|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723834|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
56723835|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
56723836|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723837|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723838|NCT00830505|Fluticasone|fluticasone|mesh-list
56723839|NCT00830505|Xhance|xhance|mesh-list
56723869|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56723870|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723871|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56723872|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56723873|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
56723875|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723876|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
56723877|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723878|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56723879|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723880|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279319|NCT00005946|Etoposide|etoposide|mesh-list
56723904|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
56723905|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723906|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723907|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723908|NCT00938236|Cyclosporine|cyclosporine|mesh-list
56723909|NCT00938236|Cyclosporins|cyclosporins|mesh-list
56723910|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723911|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723912|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723913|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
56723914|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723915|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
56723916|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723917|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
56723918|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723919|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56723920|NCT00741780|Plerixafor|plerixafor|mesh-list
56723921|NCT00741780|Lenograstim|lenograstim|mesh-list
56723922|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56723923|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
56723924|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723925|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56723926|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56723927|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
56723928|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723929|NCT00936442|Anastrozole|anastrozole|mesh-list
56723930|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56537308|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
56537309|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537310|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723931|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723932|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56723933|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56723934|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279354|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723965|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723967|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
56723968|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723969|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723970|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56723971|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56723972|NCT00835107|Ziprasidone|ziprasidone|mesh-list
56723973|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56723974|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
56723975|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854542|NCT00368290|Modafinil|modafinil|mesh-list
56724001|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56724002|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
56724003|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724004|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56724005|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56724006|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724007|NCT00841581|Ranibizumab|ranibizumab|mesh-list
56724008|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56724009|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56724010|NCT00841581|Growth Substances|growth substances|mesh-ancestor
56724011|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724012|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
56724013|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724014|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
56724015|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56724016|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
56724017|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724018|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724019|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56724020|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
56724021|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56724056|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724057|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56724058|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
56279497|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56724093|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
56724094|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
56724124|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56724125|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724126|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56724127|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56724128|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56724129|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724131|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724132|NCT00835965|Dexamethasone|dexamethasone|mesh-list
56724133|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
56724134|NCT00835965|Aprepitant|aprepitant|mesh-list
56724135|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
56724136|NCT00835965|BB 1101|bb 1101|mesh-list
56724163|NCT00738296|Simvastatin|simvastatin|mesh-list
56724165|NCT00738296|Pravastatin|pravastatin|mesh-list
56724166|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56724167|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56724168|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
56724169|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724170|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56724171|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56724172|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724173|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
56724174|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56724175|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537311|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
56058208|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724176|NCT02567396|Talazoparib|talazoparib|mesh-list
56724177|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56724178|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724179|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724180|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724181|NCT00738452|Antibodies|antibodies|mesh-list
56724182|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56724183|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
56724216|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724217|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724218|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56724219|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
56724220|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724221|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724222|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56724223|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56724243|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56724244|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56724246|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
56724247|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
56724248|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724249|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56724250|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
56724251|NCT00842595|Analgesics|analgesics|mesh-ancestor
56724252|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
56724253|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724254|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56724255|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56724256|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724257|NCT00938626|Antibodies|antibodies|mesh-list
56724258|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56724259|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
56724260|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724262|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
56724263|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724264|NCT04013386|Dexamethasone|dexamethasone|mesh-list
56724265|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
56724266|NCT04013386|Aprepitant|aprepitant|mesh-list
56724267|NCT04013386|Mirtazapine|mirtazapine|mesh-list
56724268|NCT04013386|BB 1101|bb 1101|mesh-list
56724269|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724270|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
56724271|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
56724272|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724273|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724274|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724275|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
56724276|NCT04013386|Hormones|hormones|mesh-ancestor
56724277|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724278|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56724279|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724280|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
56724281|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279716|NCT00006036|Lurtotecan|lurtotecan|mesh-list
56724317|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724318|NCT00940654|Acetaminophen|acetaminophen|mesh-list
56724319|NCT00940654|Antipyretics|antipyretics|mesh-list
56724320|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56724353|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724354|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724355|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56724356|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724357|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56724358|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
56724359|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724360|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724361|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
56724362|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
56724396|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724397|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
56537312|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537313|NCT01196988|Vaccines|vaccines|mesh-list
56537314|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
56537315|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537316|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
56537317|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56537318|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537319|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537320|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56537321|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56537322|NCT02796469|Protective Agents|protective agents|mesh-ancestor
56537323|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537324|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
56537325|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56537326|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
56537327|NCT02796157|Everolimus|everolimus|mesh-list
56537328|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537329|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537330|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
56724398|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724399|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724401|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
56724402|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724403|NCT00372619|Cytarabine|cytarabine|mesh-list
56724433|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724434|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56724435|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56724436|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56724437|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
56724438|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724440|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724441|NCT02566226|Morphine|morphine|mesh-list
56724442|NCT02566226|Bupivacaine|bupivacaine|mesh-list
56724443|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
56724444|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
56724445|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724446|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724447|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
56279886|NCT05597163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56724472|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56724473|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56724474|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724475|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56724476|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
56724477|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724478|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724479|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56724480|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
56724481|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
56724482|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56724483|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
56724484|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56724486|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724487|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724488|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56537331|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724489|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56724490|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56724491|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724492|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
56724494|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724495|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
56724496|NCT00851487|Amoxicillin|amoxicillin|mesh-list
56724497|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56724498|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724499|NCT00372385|Interferons|interferons|mesh-list
56724529|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724531|NCT00390013|Analgesics|analgesics|mesh-ancestor
56724532|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
56724533|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724534|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724535|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
56724536|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56724537|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56724538|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724539|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56724540|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56724541|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56724542|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724543|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724544|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
56724545|NCT00562120|Fexofenadine|fexofenadine|mesh-list
56724546|NCT00562120|Terfenadine|terfenadine|mesh-list
56724547|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56724556|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56724557|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724558|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56724559|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435675|NCT00248456|Calcipotriene|calcipotriene|mesh-list
56724560|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724561|NCT00697112|Sirolimus|sirolimus|mesh-list
56724562|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56724563|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724564|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56724565|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724566|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
56724567|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56724568|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
56724569|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724570|NCT00621855|Dabigatran|dabigatran|mesh-list
56724571|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
56724572|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56724573|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
56724574|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724575|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724576|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
56724577|NCT00851565|Infliximab|infliximab|mesh-list
56724578|NCT00851565|Antibodies|antibodies|mesh-list
56724579|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
56724580|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724581|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
56724582|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724583|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724584|NCT04222088|Chloroquine|chloroquine|mesh-list
56724585|NCT04222088|Lumefantrine|lumefantrine|mesh-list
56724586|NCT04222088|Primaquine|primaquine|mesh-list
56724587|NCT04222088|Amebicides|amebicides|mesh-ancestor
56724588|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56724589|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56724590|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724591|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
56724592|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724593|NCT00561574|Mirtazapine|mirtazapine|mesh-list
56724594|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
56724595|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56724596|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56724597|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
56724598|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
56724599|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724600|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724601|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537332|NCT01196052|Trastuzumab|trastuzumab|mesh-list
56537333|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56537334|NCT01196052|Maytansine|maytansine|mesh-list
56537335|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56537336|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537337|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56537338|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
56537339|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
56537340|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
56191533|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56724602|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56724603|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56724604|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724605|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56724606|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56724607|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56724608|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724609|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56724610|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56724611|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
56724612|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56724613|NCT00687804|Ranibizumab|ranibizumab|mesh-list
56724614|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56724641|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724642|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724643|NCT05604170|Ganaxolone|ganaxolone|mesh-list
56724644|NCT05604170|Neurosteroids|neurosteroids|mesh-ancestor
56724645|NCT05604170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724646|NCT05604170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724647|NCT05604170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724648|NCT05604170|GABA Modulators|gaba modulators|mesh-ancestor
56724649|NCT05604170|GABA Agents|gaba agents|mesh-ancestor
56724650|NCT00742404|Dexamethasone|dexamethasone|mesh-list
56724651|NCT00742404|Doxorubicin|doxorubicin|mesh-list
56724652|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56724653|NCT00742404|Bortezomib|bortezomib|mesh-list
56724654|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724655|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
56724656|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
56724657|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724658|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724659|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724660|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
56724661|NCT00742404|Hormones|hormones|mesh-ancestor
56724662|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724663|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56724664|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724665|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56724699|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
56724700|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724701|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724702|NCT00749112|Rituximab|rituximab|mesh-list
56724703|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
56724704|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56724705|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724731|NCT05565560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56724732|NCT05565560|Analgesics|analgesics|mesh-ancestor
56724733|NCT05565560|Sensory System Agents|sensory system agents|mesh-ancestor
56724734|NCT05565560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724735|NCT05565560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724736|NCT05565560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724737|NCT05565560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724738|NCT05565560|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56724739|NCT05565560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56724740|NCT05565560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061662|NCT04852887|Exemestane|exemestane|mesh-list
56537341|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537342|NCT02689921|Trastuzumab|trastuzumab|mesh-list
56537343|NCT02689921|Pertuzumab|pertuzumab|mesh-list
56537344|NCT02689921|Letrozole|letrozole|mesh-list
56537345|NCT02689921|Anastrozole|anastrozole|mesh-list
56537346|NCT02689921|Leuprolide|leuprolide|mesh-list
56537347|NCT02689921|Exemestane|exemestane|mesh-list
56537348|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56537349|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537350|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56537351|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56537352|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285604|NCT00001066|Lamivudine|lamivudine|mesh-list
56537353|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724741|NCT05565560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724742|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
56724743|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56724744|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56724745|NCT02545959|Prednisolone|prednisolone|mesh-list
56724746|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
56724747|NCT02545959|Rituximab|rituximab|mesh-list
56724748|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56724749|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
56724750|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56724751|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724784|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
56724785|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
56724786|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724788|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724789|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724790|NCT00945022|Anesthetics|anesthetics|mesh-list
56724791|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902213|NCT02551744|Famotidine|famotidine|mesh-list
56724821|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724823|NCT02562300|Oxytocin|oxytocin|mesh-list
56724824|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
56724825|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56724826|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724827|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56724828|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
56724829|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56724830|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724831|NCT00945178|Naproxen|naproxen|mesh-list
56724866|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56724867|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56724868|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724869|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
56724870|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56724871|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724901|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
56724902|NCT00749736|Vitamin D|vitamin d|mesh-list
56724903|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56724904|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56724905|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724906|NCT00749736|Vitamins|vitamins|mesh-ancestor
56724907|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
56724908|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56724909|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
56724910|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
56724911|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56724912|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56724913|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537354|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56537355|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
56537356|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537357|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537358|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56537359|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56537361|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56537362|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
56537363|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
56537364|NCT03116425|Vitamins|vitamins|mesh-ancestor
56537365|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
56537366|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537367|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
56537368|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56537369|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537370|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56191558|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
56724914|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724944|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724945|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
56724946|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
56724947|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56724948|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
56724949|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724950|NCT00619359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56724951|NCT00619359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56724952|NCT00619359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724953|NCT00619359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56724954|NCT00619359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56724955|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56724956|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
56724957|NCT00848991|Propofol|propofol|mesh-list
56724958|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56724959|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724960|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724961|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56724995|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724996|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
56724997|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
56724998|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
56724999|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725000|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
56725001|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56725002|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
56725003|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56725035|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56725036|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725037|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56725038|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725039|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725040|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56725041|NCT04012294|Allopurinol|allopurinol|mesh-list
56725042|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
56725043|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725044|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537371|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537372|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
56058945|NCT00360815|Insulin|insulin|mesh-list
56725045|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
56725046|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725071|NCT00852423|Artenimol|artenimol|mesh-list
56725072|NCT00852423|Mefloquine|mefloquine|mesh-list
56725073|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
56725074|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56725075|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56725076|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725077|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725078|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
56725079|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
56725080|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56725081|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
56725082|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
56725083|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56725084|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725085|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56436205|NCT00279903|Cortisone|cortisone|mesh-list
56725086|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
56725087|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725088|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725089|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725090|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725091|NCT00849537|Triamcinolone|triamcinolone|mesh-list
56725092|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56725093|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
56725094|NCT00849537|Hormones|hormones|mesh-ancestor
56725095|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56725096|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725097|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
56725098|NCT01049815|Calcium|calcium|mesh-list
56725099|NCT01049815|Sevelamer|sevelamer|mesh-list
56725100|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56725135|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725136|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725137|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
56725138|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725139|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
56725140|NCT00688740|Docetaxel|docetaxel|mesh-list
56725141|NCT00688740|Doxorubicin|doxorubicin|mesh-list
56725142|NCT00688740|Fluorouracil|fluorouracil|mesh-list
56725143|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725144|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
56725145|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725179|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725181|NCT00942136|Omeprazole|omeprazole|mesh-list
56725182|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56725183|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56725184|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56725185|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725186|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725220|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56725221|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725223|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56725224|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56725225|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725226|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56725227|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
56725228|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
56725259|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56725260|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56725261|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
56725262|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725263|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725264|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
56725265|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725266|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56725267|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
56725268|NCT00560404|Hematinics|hematinics|mesh-ancestor
56725269|NCT00942526|Nystatin|nystatin|mesh-list
56061663|NCT04852887|Anastrozole|anastrozole|mesh-list
56537373|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56537374|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56537375|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56537376|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725270|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725271|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725272|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
56725301|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56725302|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725303|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725304|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
56725305|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56725306|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56725307|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725308|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
56725309|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
56725310|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56725311|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725312|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
56725313|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
56725314|NCT00942682|Sorafenib|sorafenib|mesh-list
56725315|NCT00942682|Everolimus|everolimus|mesh-list
56725316|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725317|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56725318|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991664|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725352|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
56725353|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725354|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56725355|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725356|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725357|NCT00854139|Cyclosporine|cyclosporine|mesh-list
56725358|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
56725359|NCT00854139|Cyclosporins|cyclosporins|mesh-list
56725360|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56725361|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725395|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725396|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
56725397|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56725398|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725399|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56725400|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
56725401|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725464|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
56725465|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725466|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725467|NCT00854451|Amoxicillin|amoxicillin|mesh-list
56725468|NCT00854451|Omeprazole|omeprazole|mesh-list
56725469|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725470|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725471|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56725472|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56725473|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56725474|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725475|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725476|NCT00854529|Bevacizumab|bevacizumab|mesh-list
56725477|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56725478|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725479|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56725480|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56725481|NCT00854529|Growth Substances|growth substances|mesh-ancestor
56725482|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725483|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
56725484|NCT00952432|Carbamazepine|carbamazepine|mesh-list
56725485|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
56725486|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
56725515|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56725516|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56725517|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56725518|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56725519|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
56537377|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537378|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
56537379|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191581|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
56725520|NCT00861627|Paclitaxel|paclitaxel|mesh-list
56725521|NCT00861627|Carboplatin|carboplatin|mesh-list
56725522|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56725523|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725524|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
56725525|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
56725526|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
56725527|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725528|NCT00943930|Dronabinol|dronabinol|mesh-list
56725529|NCT00943930|Amphetamine|amphetamine|mesh-list
56725530|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
56725531|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56725532|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725563|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725564|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
56725565|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56725566|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56725567|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725568|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725569|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
56725571|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56725572|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56725617|NCT00947128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725618|NCT00947128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56725619|NCT00861861|Atorvastatin|atorvastatin|mesh-list
56725620|NCT00861861|Pitavastatin|pitavastatin|mesh-list
56725621|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56725622|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56725623|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
56725624|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725625|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56725626|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56725627|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725628|NCT00686166|Capecitabine|capecitabine|mesh-list
56725629|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
56725630|NCT00686166|Cetuximab|cetuximab|mesh-list
56725631|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56725632|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
56725633|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725634|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725635|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56725636|NCT03963375|Cladribine|cladribine|mesh-list
56725637|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725638|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725639|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
56725640|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725641|NCT04280536|Trifluridine|trifluridine|mesh-list
56725642|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
56725643|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725644|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
56725645|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725646|NCT00944242|Sertraline|sertraline|mesh-list
56725647|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
56725648|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725649|NCT00944242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56725650|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56725651|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725652|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725653|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725654|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
56725655|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725656|NCT00363649|Interferons|interferons|mesh-list
56725657|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
56725658|NCT00363649|Sargramostim|sargramostim|mesh-list
56725659|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725660|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
56725661|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537380|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537381|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56537382|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537383|NCT03028519|Vitamin D|vitamin d|mesh-list
56537384|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
56537385|NCT03028519|Vitamins|vitamins|mesh-ancestor
56537386|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
56537387|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537388|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56537389|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56537390|NCT02786641|Cisplatin|cisplatin|mesh-list
56537391|NCT02786641|Docetaxel|docetaxel|mesh-list
56537392|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537393|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
56537394|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
56537395|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
56537396|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537397|NCT02787967|Beclomethasone|beclomethasone|mesh-list
56725662|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
56725663|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725664|NCT00855153|Cycloserine|cycloserine|mesh-list
56725665|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56725666|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725667|NCT00855153|Renal Agents|renal agents|mesh-ancestor
56725668|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56725669|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
56725670|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725671|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
55991997|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56725703|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
56725704|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
56725705|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
56725706|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725707|NCT00944398|Trace Elements|trace elements|mesh-ancestor
56725708|NCT00944398|Astringents|astringents|mesh-ancestor
56725709|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
56725710|NCT00855387|Pancrelipase|pancrelipase|mesh-list
56725711|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56725713|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56725714|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56725715|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56725716|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
56725779|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725780|NCT00865215|Propranolol|propranolol|mesh-list
56725781|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56725782|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56725783|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
56725784|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725785|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725786|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725787|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56725788|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56725789|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
56725790|NCT00865371|Bupropion|bupropion|mesh-list
56725791|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56725792|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
56725793|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725794|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56061956|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
56537398|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
56537399|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56537400|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
56537401|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537402|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537403|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56537404|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
56537405|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56537406|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56537407|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56537408|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
56537409|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191604|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56725795|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56725796|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725797|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725851|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56725852|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56725853|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56725854|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725855|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56725856|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
56725857|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
56725858|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
56725859|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56725861|NCT00554788|Thiotepa|thiotepa|mesh-list
56725862|NCT00554788|Cisplatin|cisplatin|mesh-list
56725863|NCT00554788|Carboplatin|carboplatin|mesh-list
56725864|NCT00554788|Etoposide|etoposide|mesh-list
56725865|NCT00554788|Vincristine|vincristine|mesh-list
56725866|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
56725867|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
56725868|NCT00554788|Lenograstim|lenograstim|mesh-list
56725869|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725870|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
56725871|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725872|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992214|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
56725909|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725910|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725942|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
56725943|NCT02565836|Coagulants|coagulants|mesh-ancestor
56725944|NCT00865761|Alprazolam|alprazolam|mesh-list
56725945|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56725946|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56725947|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725948|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56725949|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56725950|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725951|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
56725952|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
56725953|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725988|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
56725989|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725990|NCT00866073|Decitabine|decitabine|mesh-list
56725991|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56725992|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
56725993|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725994|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726011|NCT00957190|Dorzolamide|dorzolamide|mesh-list
56726012|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56726013|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56537410|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537411|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537412|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
56537413|NCT02787967|Hormones|hormones|mesh-ancestor
56537414|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537415|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56537416|NCT02788123|Pantoprazole|pantoprazole|mesh-list
56537417|NCT02788123|Bismuth|bismuth|mesh-list
56537418|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56537419|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56537420|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56537421|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537422|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537423|NCT02788123|Antacids|antacids|mesh-ancestor
56537424|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726014|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
56726015|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726016|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726017|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726018|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56726019|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56726020|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56726021|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726022|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56726023|NCT00866229|Simvastatin|simvastatin|mesh-list
56726024|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56726025|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56726026|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
56726027|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726028|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56726029|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56726030|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726031|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56726032|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56726033|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726034|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726035|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
56726036|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726037|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726038|NCT00948220|Ribavirin|ribavirin|mesh-list
56726039|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56726040|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
56726041|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726042|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
56726043|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726044|NCT00756990|Naltrexone|naltrexone|mesh-list
56726045|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56726046|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56726047|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726048|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
56726049|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726050|NCT00957346|Misoprostol|misoprostol|mesh-list
56726051|NCT00957346|Mifepristone|mifepristone|mesh-list
56726052|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56726053|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
56726083|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726084|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726086|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56537425|NCT02864953|Glyburide|glyburide|mesh-list
56285693|NCT00001105|Antibodies|antibodies|mesh-list
56537426|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56537427|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537428|NCT01194804|Eculizumab|eculizumab|mesh-list
56537429|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56537430|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537431|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
56537432|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537433|NCT02785549|Acetaminophen|acetaminophen|mesh-list
56537434|NCT02785549|Amoxicillin|amoxicillin|mesh-list
56537435|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
56537436|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
56537437|NCT02785549|Ibuprofen|ibuprofen|mesh-list
56537438|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56537439|NCT02785549|Analgesics|analgesics|mesh-ancestor
56726087|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56726088|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56726089|NCT04030052|Factor VIII|factor viii|mesh-list
56726090|NCT04030052|Coagulants|coagulants|mesh-ancestor
56726091|NCT00751374|Gentamicins|gentamicins|mesh-list
56726092|NCT00751374|Mupirocin|mupirocin|mesh-list
56726093|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56726094|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726095|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56726096|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992437|NCT03544281|Bortezomib|bortezomib|mesh-list
56726132|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726133|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726134|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56726135|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
56726136|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
56726137|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56726158|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56726159|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726160|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726161|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56726162|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
56726163|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
56726164|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
56726165|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56726166|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
56726167|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
56726168|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726169|NCT00757458|Antidotes|antidotes|mesh-ancestor
56726170|NCT00757458|Protective Agents|protective agents|mesh-ancestor
56726171|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56726172|NCT00923247|Bortezomib|bortezomib|mesh-list
56726173|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726174|NCT02866136|Carboplatin|carboplatin|mesh-list
56726175|NCT02866136|Etoposide|etoposide|mesh-list
56726176|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
56726177|NCT02866136|Melphalan|melphalan|mesh-list
56726178|NCT02866136|Vincristine|vincristine|mesh-list
56726179|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726180|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56726181|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56726182|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56726183|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726184|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726185|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56726186|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
56726187|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56726188|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537440|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
56537441|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537442|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537443|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
56537444|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56537445|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537446|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56537447|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56537448|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537449|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191649|NCT01476787|Rituximab|rituximab|mesh-list
56726189|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
56726190|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726191|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992528|NCT03192826|Dipivefrin|dipivefrin|mesh-list
56726223|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726224|NCT00866463|Urological Agents|urological agents|mesh-ancestor
56726225|NCT00695864|Ondansetron|ondansetron|mesh-list
56726226|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
56726227|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
56726228|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726229|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726230|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56726231|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
56726232|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
56726233|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56726234|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
56726270|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726271|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56726272|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
56726273|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55992620|NCT03421210|Nicotine|nicotine|mesh-list
56726304|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726305|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56726306|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
56726307|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56726308|NCT00683592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56726309|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56726310|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56726311|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726312|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726313|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
56726314|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726315|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56726316|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56726317|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
56726386|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56726387|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56726388|NCT00753792|Prednisolone|prednisolone|mesh-list
55992743|NCT01000285|Hormones|hormones|mesh-ancestor
56726418|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56726419|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726420|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726421|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
56726422|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726423|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726424|NCT00958204|Fluoxetine|fluoxetine|mesh-list
56726425|NCT00958204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56726426|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56726427|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56726428|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537450|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56537451|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537452|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56537453|NCT02785705|Vaccines|vaccines|mesh-list
56537454|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
56537455|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537456|NCT02821507|Sirolimus|sirolimus|mesh-list
56537457|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
56537458|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537459|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
56537460|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726429|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726430|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
56726431|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992776|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56726446|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
56726447|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56726448|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56726449|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56726452|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56726453|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726454|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56726455|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726456|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56726457|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726458|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726459|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56726460|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726461|NCT03529448|Temozolomide|temozolomide|mesh-list
56726462|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56726463|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
56726464|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726465|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726466|NCT05396898|Tacrolimus|tacrolimus|mesh-list
56726467|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56726468|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
56726469|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726470|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56726471|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726472|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726473|NCT00694304|Vortioxetine|vortioxetine|mesh-list
56726474|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
56726475|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56726476|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56726477|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56726478|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726479|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726480|NCT00694304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56726481|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56726482|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56726483|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726484|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726485|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
56726486|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56726487|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56726488|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55992823|NCT03210376|Neostigmine|neostigmine|mesh-list
56726562|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726563|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56726564|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56726565|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56537461|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56537462|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56537463|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
56537464|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537465|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726614|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56726616|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56726617|NCT00955162|Naloxone|naloxone|mesh-list
56726618|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56726619|NCT00955162|Narcotics|narcotics|mesh-ancestor
56726620|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726621|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726622|NCT00955162|Analgesics|analgesics|mesh-ancestor
56726623|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
56726624|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726625|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56726626|NCT00949546|Etanercept|etanercept|mesh-list
56726649|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56726650|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
56726651|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726652|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726653|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56726654|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726656|NCT00949624|Axitinib|axitinib|mesh-list
56726657|NCT00949624|Crenolanib|crenolanib|mesh-list
56726658|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726659|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
56726660|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
56726661|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
56726662|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726663|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56726664|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726665|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
56726666|NCT04019379|Calcium|calcium|mesh-list
56437793|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
56726667|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56726668|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726669|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56726670|NCT05351788|Carboplatin|carboplatin|mesh-list
56726671|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726672|NCT04005339|Leucovorin|leucovorin|mesh-list
56726673|NCT04005339|Fluorouracil|fluorouracil|mesh-list
56726674|NCT04005339|Irinotecan|irinotecan|mesh-list
56726675|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
56726676|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726677|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56726713|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56726715|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726716|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56726783|NCT03387085|Avelumab|avelumab|mesh-list
56726784|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56726785|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726786|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
56726787|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
56726788|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
56726789|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726790|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56726791|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
56726792|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726793|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56726794|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56726795|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
56726813|NCT00955318|Apomorphine|apomorphine|mesh-list
56726814|NCT00955318|Emetics|emetics|mesh-ancestor
56726815|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726816|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
56726817|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726818|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56726819|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
56537466|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56537467|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56537468|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537469|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56537470|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
56537471|NCT02785393|Doxazosin|doxazosin|mesh-list
56537472|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56537473|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56537474|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56537475|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56537476|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
56537477|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537478|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537479|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726820|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
56726821|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726822|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726824|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56726825|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56726826|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726827|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726828|NCT00860223|Protective Agents|protective agents|mesh-ancestor
56726829|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726830|NCT00698204|Celecoxib|celecoxib|mesh-list
56726831|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56726832|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56726833|NCT00698204|Analgesics|analgesics|mesh-ancestor
56726834|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
56726835|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726836|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726837|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56726838|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56726839|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56726840|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56726841|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726842|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726843|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56726844|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56726845|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56726846|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726847|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726848|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56726849|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56726850|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56726851|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56726852|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
56726853|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726854|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726877|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
56726879|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
56726880|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
56726881|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56726882|NCT00371761|Adefovir|adefovir|mesh-list
56726883|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56726884|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726885|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
56726886|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726887|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
56537480|NCT02787031|Anesthetics|anesthetics|mesh-list
56537481|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537482|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537483|NCT03683251|Ranibizumab|ranibizumab|mesh-list
56726888|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726889|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56726890|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56726891|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726892|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726893|NCT00754962|Protriptyline|protriptyline|mesh-list
56726894|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56438031|NCT01588756|Goralatide|goralatide|mesh-list
56726896|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56726897|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56726898|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56726899|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56726900|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726901|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
56726902|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726903|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726904|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
56726905|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56726906|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
55993241|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56726938|NCT00755118|Bevacizumab|bevacizumab|mesh-list
56726939|NCT00755118|Cetuximab|cetuximab|mesh-list
56726940|NCT00755118|Fluorouracil|fluorouracil|mesh-list
56726941|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
56726942|NCT00755118|Irinotecan|irinotecan|mesh-list
56726943|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56726944|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726945|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56726971|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726973|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56726974|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726975|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56726976|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56726977|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56726978|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726979|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
56726980|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726981|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
56726982|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56726983|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
56726984|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
56726985|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56726986|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
56726987|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56726988|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
56726989|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726990|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726991|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
56726992|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
56726993|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56727087|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56727088|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56727089|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
56727090|NCT00860925|Clonidine|clonidine|mesh-list
56727091|NCT00860925|Analgesics|analgesics|mesh-ancestor
56727092|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
56727093|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727094|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727095|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56727096|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
56727097|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
56727098|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56727099|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55993443|NCT01921790|Gemcitabine|gemcitabine|mesh-list
56727137|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
56727138|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727166|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537484|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56537485|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56537486|NCT03683251|Growth Substances|growth substances|mesh-ancestor
56537487|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537488|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
56537489|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537490|NCT02784223|Choline|choline|mesh-list
56537491|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
56537492|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56537493|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
56537494|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537495|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56537496|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56727168|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727169|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56727170|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56727171|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56727172|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727173|NCT00864045|Olanzapine|olanzapine|mesh-list
56727174|NCT00864045|Sertindole|sertindole|mesh-list
56727175|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
56727176|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
56727177|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727178|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727179|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56727180|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56727181|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56727182|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727211|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727212|NCT00864201|Bosentan|bosentan|mesh-list
56727213|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56727214|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56727215|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727216|NCT00864279|Cetirizine|cetirizine|mesh-list
56727217|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56727218|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56727219|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56727220|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
56727221|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
56727222|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727223|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727224|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727225|NCT02559648|Denosumab|denosumab|mesh-list
56727226|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55720910|NCT00153179|Acipimox|acipimox|mesh-list
56727250|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727251|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56727252|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
56727253|NCT00864435|Protective Agents|protective agents|mesh-ancestor
56727254|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56727255|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727256|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56727257|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
56727258|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56727259|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56727260|NCT00755664|Vitamins|vitamins|mesh-list
56727261|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
56727262|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
56727263|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727264|NCT00956098|Oltipraz|oltipraz|mesh-list
56727265|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
56537497|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
56537498|NCT05262751|Nintedanib|nintedanib|mesh-list
56537499|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537500|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56537501|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191701|NCT01477034|Vitamin D|vitamin d|mesh-list
56727266|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727267|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
56727268|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56727269|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
56727270|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56727271|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56727272|NCT00956098|Protective Agents|protective agents|mesh-ancestor
56727273|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727274|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727275|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56727276|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55993619|NCT02153541|Analgesics|analgesics|mesh-ancestor
56727308|NCT05350384|Protective Agents|protective agents|mesh-ancestor
56727309|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56727310|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727312|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
56727313|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727314|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56727315|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
56727316|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727317|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56727318|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56727353|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727354|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56727355|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56727356|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
56727357|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56727385|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727386|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56727387|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56727388|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727389|NCT00371683|Enoxaparin|enoxaparin|mesh-list
56727390|NCT00371683|Apixaban|apixaban|mesh-list
56727391|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
56727392|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56727393|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56727394|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727395|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56727396|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
56727397|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56727398|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
56727399|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727400|NCT00876135|Albuterol|albuterol|mesh-list
56727401|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56727402|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
56727403|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727432|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
56727433|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727434|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
56727435|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727436|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
56727437|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56727438|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56727439|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727440|NCT00871065|Urological Agents|urological agents|mesh-ancestor
56727441|NCT00962026|Rilonacept|rilonacept|mesh-list
56727442|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727443|NCT05212012|Methadone|methadone|mesh-list
56727444|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56727445|NCT05212012|Narcotics|narcotics|mesh-ancestor
56727446|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727447|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727448|NCT05212012|Analgesics|analgesics|mesh-ancestor
56727449|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
56537502|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537503|NCT04231123|Anesthetics|anesthetics|mesh-list
56537504|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
56537505|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537506|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537507|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
56537508|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537509|NCT04231279|Secretin|secretin|mesh-list
56537510|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56537511|NCT04231279|Hormones|hormones|mesh-ancestor
56537512|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537513|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537514|NCT02782273|Ketorolac|ketorolac|mesh-list
56537515|NCT02782273|Morphine|morphine|mesh-list
56537516|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56537517|NCT02782273|Narcotics|narcotics|mesh-ancestor
56537518|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537519|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537520|NCT02782273|Analgesics|analgesics|mesh-ancestor
56537521|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
56537522|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537523|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56537524|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56537525|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537526|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56537527|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56537528|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537529|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537530|NCT05342389|Apatinib|apatinib|mesh-list
56537531|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537532|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56537533|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537534|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727450|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727451|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
56727452|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
56727483|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727484|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56061957|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
56537535|NCT02268175|Prednisone|prednisone|mesh-list
56537536|NCT02268175|Leuprolide|leuprolide|mesh-list
56537537|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
56537538|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537539|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
56537540|NCT02268175|Hormones|hormones|mesh-ancestor
56727485|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727486|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56727487|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
56727488|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
56727489|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727490|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727491|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
56727492|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
56727493|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56727494|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56727495|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
56727496|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727551|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56727553|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727554|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56727555|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
56727556|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727557|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
56727558|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56727559|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56727560|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727561|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
56727562|NCT00872469|Coagulants|coagulants|mesh-ancestor
56727563|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
56727564|NCT00872625|Docetaxel|docetaxel|mesh-list
56727565|NCT00872625|Fluorouracil|fluorouracil|mesh-list
56727566|NCT00872625|Epirubicin|epirubicin|mesh-list
56727567|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56727568|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
56727569|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727570|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56727571|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56727572|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
56727573|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727606|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56727607|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727608|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56727609|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56727610|NCT00361231|Growth Substances|growth substances|mesh-ancestor
56727611|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727612|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
56727613|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56727614|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
56727615|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727616|NCT00361231|Antiviral Agents|antiviral agents|mesh-ancestor
56727617|NCT00361231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727618|NCT00361231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727650|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
56727652|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56727653|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
56727654|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727655|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727656|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56727657|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727658|NCT00383149|Cetuximab|cetuximab|mesh-list
56727659|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56727690|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
56727691|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727692|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727693|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
56727694|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727695|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56727696|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56727697|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
56537541|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537542|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537543|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56537544|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537545|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56537546|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
56537547|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56537548|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56537549|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537550|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537551|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
56191746|NCT01477203|Antidepressive Agents|antidepressive agents|mesh-ancestor
56727698|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56727699|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56727700|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
56727701|NCT00369967|NuvaRing|nuvaring|mesh-list
56727702|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56727703|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727740|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56727741|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
56727742|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
56727743|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
56727778|NCT00879021|Pregabalin|pregabalin|mesh-list
56727779|NCT00879021|Analgesics|analgesics|mesh-ancestor
56727780|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
56727781|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994137|NCT03378076|Triamcinolone|triamcinolone|mesh-list
56727813|NCT00369655|Aflibercept|aflibercept|mesh-list
56727814|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
56727815|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56727816|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56727817|NCT00369655|Growth Substances|growth substances|mesh-ancestor
56727818|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727819|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
56727820|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727821|NCT00879177|Varenicline|varenicline|mesh-list
56727890|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56727891|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727892|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56727893|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56727894|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56727895|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727896|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56727897|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56727898|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56727899|NCT00874107|Growth Substances|growth substances|mesh-ancestor
56727900|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727901|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
56727902|NCT00761358|Z 338|z 338|mesh-list
56727903|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56727932|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
56727933|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727934|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727935|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56727936|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727937|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56727938|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
56727939|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56727940|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
56727941|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56439066|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
56537552|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56537553|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
56537554|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56537555|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
56537556|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537557|NCT02783989|Protective Agents|protective agents|mesh-ancestor
56537558|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537559|NCT02584309|Doxorubicin|doxorubicin|mesh-list
56537560|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56537561|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
56537562|NCT02584309|Razoxane|razoxane|mesh-list
56537563|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56537564|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537565|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56537566|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56537567|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537568|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537569|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56537570|NCT02584309|Protective Agents|protective agents|mesh-ancestor
56634289|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56537571|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191758|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191759|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191760|NCT01477242|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56191761|NCT01477242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56191762|NCT01477242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56191763|NCT01477242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56191764|NCT01477242|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56727942|NCT00614991|Ritonavir|ritonavir|mesh-list
56727943|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
56727944|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
56727945|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56727946|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56727947|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
56727948|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727949|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727950|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56727976|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56727977|NCT00369577|Loxapine|loxapine|mesh-list
56727978|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56727979|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56727980|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727981|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727982|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727983|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56727984|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
56537572|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
56537573|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
56537574|NCT02782429|Ketamine|ketamine|mesh-list
56727985|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727986|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727987|NCT00879957|Heparin|heparin|mesh-list
56727988|NCT00879957|Calcium heparin|calcium heparin|mesh-list
56727989|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
56727990|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56727991|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56727992|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727993|NCT00874809|Insulin|insulin|mesh-list
56727994|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
56727995|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56727996|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727997|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
56727998|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56727999|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56728000|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728065|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56728066|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56728067|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
56728068|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
56728069|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728070|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728071|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728072|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56728073|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
56728074|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728075|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56728076|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
56728077|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
56728078|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56728107|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
56728108|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728109|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56728110|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56728111|NCT00368875|Growth Substances|growth substances|mesh-ancestor
56728112|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728113|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
56728114|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
56728115|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56728116|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728117|NCT04474483|Melatonin|melatonin|mesh-list
56728118|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
56728119|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728120|NCT04474483|Protective Agents|protective agents|mesh-ancestor
56728121|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728122|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728123|NCT00614055|Insulin|insulin|mesh-list
56728124|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56728125|NCT00614055|Metformin|metformin|mesh-list
56728126|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
56728127|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
56728128|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
56728129|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56728149|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56728150|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728151|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728152|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
56728153|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56728154|NCT00882765|Estrogens|estrogens|mesh-ancestor
56728155|NCT00882765|Hormones|hormones|mesh-ancestor
56728156|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728157|NCT00548548|Bevacizumab|bevacizumab|mesh-list
56728158|NCT00548548|Fluorouracil|fluorouracil|mesh-list
56728159|NCT00548548|Capecitabine|capecitabine|mesh-list
56728160|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56728161|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728162|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56728163|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56728164|NCT00548548|Growth Substances|growth substances|mesh-ancestor
56537575|NCT02782429|Analgesics|analgesics|mesh-ancestor
56537576|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
56537577|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537578|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537579|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56537580|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56061596|NCT04659603|Maytansine|maytansine|mesh-list
56728165|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728166|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
56728167|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
56728168|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728170|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56728171|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
56728172|NCT00613509|Interferons|interferons|mesh-list
56728173|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
56728174|NCT00613509|Vaccines|vaccines|mesh-list
56728175|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728176|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
56728177|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728178|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
56728179|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728180|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
56728181|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
56728182|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728183|NCT00881595|Temozolomide|temozolomide|mesh-list
56728184|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55994522|NCT03032315|Amlodipine|amlodipine|mesh-list
56728207|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
56728208|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728209|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728210|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56728211|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
56728212|NCT00881673|Hormones|hormones|mesh-ancestor
56728213|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728214|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56728215|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728216|NCT04638465|Cisplatin|cisplatin|mesh-list
56728217|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728218|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56728219|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56728220|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728221|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
56728222|NCT04487925|Hormones|hormones|mesh-list
56728223|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56728224|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728225|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728226|NCT00547300|Metoprolol|metoprolol|mesh-list
56728227|NCT00547300|Nebivolol|nebivolol|mesh-list
56728228|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56728229|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56728230|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
56728231|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
56728232|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728233|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728234|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56728250|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
56728251|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728252|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56728253|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56728254|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728255|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728256|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
56728257|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728258|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728259|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56728260|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56728261|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062513|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
56537581|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
56537582|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
56537583|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56191785|NCT01477385|Fluorides|fluorides|mesh-list
56728262|NCT00612807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56728263|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
56728264|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56728265|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728266|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56728267|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56728268|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56728269|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
56728270|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56728271|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56728272|NCT00958750|Minoxidil|minoxidil|mesh-list
56728273|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56728274|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
56728275|NCT00958906|Infliximab|infliximab|mesh-list
56728276|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56728277|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56728278|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56728279|NCT00959062|Clonidine|clonidine|mesh-list
56728280|NCT00959062|Analgesics|analgesics|mesh-ancestor
56728281|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
56728282|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728283|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728284|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56728285|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
56728286|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
56728287|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56728288|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56728289|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56728290|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
56728291|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728292|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994621|NCT03587428|Zinc|zinc|mesh-list
56728315|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
56728316|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728317|NCT00882375|Nicotine|nicotine|mesh-list
56728318|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56728319|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
56728320|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728321|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728322|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56728323|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56728324|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
56728325|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728326|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728327|NCT00882453|Interferons|interferons|mesh-list
56728328|NCT00882453|Interferon-beta|interferon-beta|mesh-list
56728329|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
56728330|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728331|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
56728332|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728333|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
56728334|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728335|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56728336|NCT00882531|Isotretinoin|isotretinoin|mesh-list
56728337|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
56728338|NCT00963274|Bortezomib|bortezomib|mesh-list
56728339|NCT00963274|Romidepsin|romidepsin|mesh-list
56728340|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728341|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56728342|NCT00882609|Fluorides|fluorides|mesh-list
56728343|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
56728344|NCT00882609|Protective Agents|protective agents|mesh-ancestor
56728345|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728346|NCT00883623|Lenalidomide|lenalidomide|mesh-list
56728347|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
56728376|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728377|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728378|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56728379|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56728380|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56537584|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56537585|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56537586|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537587|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537588|NCT04229719|Melatonin|melatonin|mesh-list
56537589|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
56537590|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537591|NCT04229719|Protective Agents|protective agents|mesh-ancestor
56537592|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537593|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537594|NCT01855867|Tenofovir|tenofovir|mesh-list
56537595|NCT01855867|Emtricitabine|emtricitabine|mesh-list
56537596|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
56537597|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537598|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56537599|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56537600|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537601|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537602|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56728381|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
56728382|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728383|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728385|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56728386|NCT04722718|Carboplatin|carboplatin|mesh-list
56728387|NCT04722718|Apatinib|apatinib|mesh-list
56728388|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56728389|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728390|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
56728391|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
56728417|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728418|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
56728419|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728420|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
56728421|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728422|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56728423|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56728424|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
56728425|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728426|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56728427|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56728428|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728429|NCT00611559|PENTA|penta|mesh-list
56728430|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
56728431|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56728432|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56728433|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728434|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56728435|NCT00761904|Simvastatin|simvastatin|mesh-list
56728436|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56728437|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56728438|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
56728439|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728440|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56537603|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56537604|NCT02689843|Metformin|metformin|mesh-list
56537605|NCT02689843|Pioglitazone|pioglitazone|mesh-list
56537606|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
56728441|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56728442|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728443|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56728470|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728471|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56728472|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56728473|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728474|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728475|NCT00611247|Temozolomide|temozolomide|mesh-list
56728476|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56728477|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
56728478|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728479|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728481|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56728482|NCT00883935|Dolutegravir|dolutegravir|mesh-list
56728483|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56728484|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56728485|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
56728486|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728487|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728488|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56728489|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56728490|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
56728491|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728557|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56728559|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728560|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56728561|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
56728562|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
56728563|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
56728564|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56728565|NCT00886275|Midazolam|midazolam|mesh-list
56728566|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
56728567|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56728568|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728598|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728599|NCT00886509|Lenograstim|lenograstim|mesh-list
56728600|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56728601|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
56728602|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728603|NCT02543385|Ketamine|ketamine|mesh-list
56728604|NCT02543385|Esketamine|esketamine|mesh-list
56728605|NCT02543385|Analgesics|analgesics|mesh-ancestor
56728606|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
56728607|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728608|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728609|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56728610|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56728611|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
56728612|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
56728613|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728614|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56728647|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56728648|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728649|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
56728650|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56728651|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
56728652|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728653|NCT00887367|Ethanol|ethanol|mesh-list
56728654|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56728655|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728656|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995003|NCT02245451|Narcotics|narcotics|mesh-ancestor
56728683|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56728684|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56728685|NCT00612105|Ezogabine|ezogabine|mesh-list
56728686|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
56728687|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062710|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
56537607|NCT02689843|Spironolactone|spironolactone|mesh-list
56537608|NCT02689843|Cyproterone|cyproterone|mesh-list
56537609|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56537610|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537611|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56537612|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
56537613|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537614|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56537615|NCT02689843|Diuretics|diuretics|mesh-ancestor
56537616|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
56537617|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
56537618|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537619|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56537620|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
56537621|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56537622|NCT05166577|Valganciclovir|valganciclovir|mesh-list
56537623|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
56537624|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56537625|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537626|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
56537627|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537628|NCT05341999|Ibuprofen|ibuprofen|mesh-list
56537629|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56537630|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56728688|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728689|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
56728690|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56728692|NCT04017741|Prednisolone|prednisolone|mesh-list
56728693|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
56728694|NCT04017741|Lidocaine|lidocaine|mesh-list
56728695|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56728696|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
56728697|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
56728698|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
56728699|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728700|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728701|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
56728702|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728703|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56728704|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56728730|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728732|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56728733|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728734|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728735|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
56728736|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728737|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728738|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
56728739|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
56728740|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56537631|NCT05341999|Analgesics|analgesics|mesh-ancestor
56537632|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
56537633|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537634|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537635|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537636|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56728741|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728742|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728743|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
56728744|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728745|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728746|NCT00887757|Gemcitabine|gemcitabine|mesh-list
56728747|NCT00887757|Navitoclax|navitoclax|mesh-list
56728748|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56728749|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
55995092|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56728779|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728780|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728781|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
56728782|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728783|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56728784|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56728785|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
56728786|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56728787|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56728788|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55995139|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
56728853|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56728854|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728855|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728856|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728857|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
56728858|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56728859|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
56728861|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
56728862|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
56728863|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728864|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728865|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728866|NCT00610155|Pregabalin|pregabalin|mesh-list
56728867|NCT00610155|Tramadol|tramadol|mesh-list
56728868|NCT00610155|Analgesics|analgesics|mesh-ancestor
55995219|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
56728904|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728905|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56728975|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
56728976|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56728977|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
56728978|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728979|NCT00609765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56729012|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
56729013|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729015|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56729016|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56729017|NCT00889161|Analgesics|analgesics|mesh-ancestor
56729018|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
56729019|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729020|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729047|NCT00961480|Metformin|metformin|mesh-list
56729048|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56729049|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56729050|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729051|NCT00961480|Incretins|incretins|mesh-ancestor
56729052|NCT00961480|Hormones|hormones|mesh-ancestor
56729053|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729054|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56729055|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
56537637|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56537638|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191842|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56729056|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729057|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729058|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
56729059|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
56729060|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56729062|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56729063|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56729064|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729065|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56729066|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729067|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729068|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56729088|NCT00966004|Urological Agents|urological agents|mesh-ancestor
56729089|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56729090|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56729091|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
56729093|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56729094|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56729095|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
56729096|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729097|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729098|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729099|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56729100|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56729101|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
56729102|NCT04095442|Benzocaine|benzocaine|mesh-list
56729103|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
56729104|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
56729105|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56729106|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729107|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
56729108|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729109|NCT00889629|Vitamin D|vitamin d|mesh-list
56729110|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
56729111|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56729112|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
56729113|NCT00889629|Vitamins|vitamins|mesh-ancestor
56729114|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
56729115|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729116|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56729117|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56729118|NCT00966160|Ritonavir|ritonavir|mesh-list
56729119|NCT00966160|Lopinavir|lopinavir|mesh-list
56729120|NCT00966160|Lamivudine|lamivudine|mesh-list
56729121|NCT00966160|Zidovudine|zidovudine|mesh-list
56729122|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56729123|NCT00966160|Efavirenz|efavirenz|mesh-list
55995470|NCT02981615|Renal Agents|renal agents|mesh-ancestor
56729146|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
56729147|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729148|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729149|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56729150|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56729151|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
56729152|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729153|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56729154|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56729155|NCT00966316|Aspirin|aspirin|mesh-list
56729156|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56729157|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56729158|NCT00966316|Analgesics|analgesics|mesh-ancestor
56729159|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
56729160|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729161|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729162|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729163|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56729164|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56729165|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56729166|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537639|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537640|NCT02781805|Alendronate|alendronate|mesh-list
56537641|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56537642|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537643|NCT02781493|Prucalopride|prucalopride|mesh-list
56537644|NCT02781493|Laxatives|laxatives|mesh-ancestor
56729167|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56729168|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56729169|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729170|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
56729171|NCT00892827|Rituximab|rituximab|mesh-list
56729172|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56729204|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729205|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56729206|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729207|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56729208|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729209|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
56729210|NCT04018131|Cimetidine|cimetidine|mesh-list
56729211|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56729212|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729213|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56729214|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
56729215|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
55995577|NCT01006655|Beclomethasone|beclomethasone|mesh-list
56729248|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56729249|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
56729250|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729251|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
56729252|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
56729253|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995619|NCT01010009|Protective Agents|protective agents|mesh-ancestor
55995657|NCT00377104|Growth Substances|growth substances|mesh-ancestor
56729306|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
56729307|NCT00674154|Vitamins|vitamins|mesh-ancestor
56729308|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
56729309|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729310|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56729311|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56729312|NCT00967954|Hormones|hormones|mesh-list
56729313|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
56729314|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729315|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729316|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
56729317|NCT00767286|Cobalt|cobalt|mesh-list
56729318|NCT00767286|Goserelin|goserelin|mesh-list
56729319|NCT00767286|Flutamide|flutamide|mesh-list
56729320|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56729321|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729322|NCT00767286|Trace Elements|trace elements|mesh-ancestor
56729323|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
56729324|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729325|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
56729326|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
56729327|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729328|NCT00968110|Omalizumab|omalizumab|mesh-list
56729329|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56729330|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56729331|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56729332|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
56729333|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
56729334|NCT00608517|Fludarabine|fludarabine|mesh-list
56729335|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
56729336|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56729337|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729338|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
56729339|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729340|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56729341|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56729342|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
55740563|NCT04446403|Anesthetics|anesthetics|mesh-list
56537645|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729343|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729344|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729345|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56729346|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56729347|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
56729348|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729349|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
56729350|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
55995695|NCT01041781|Gemcitabine|gemcitabine|mesh-list
56729380|NCT00893061|Anastrozole|anastrozole|mesh-list
56729381|NCT00893061|Exemestane|exemestane|mesh-list
56729382|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729383|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729384|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56729385|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56729386|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729387|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56729388|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
56729389|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729390|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729391|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56729392|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56729393|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56729394|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56729395|NCT00974272|Exenatide|exenatide|mesh-list
55995753|NCT00953849|Vitamins|vitamins|mesh-ancestor
56729419|NCT00974584|Growth Substances|growth substances|mesh-ancestor
56729420|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729421|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
56729422|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729423|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56729424|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56729426|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729427|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
56729428|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729429|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56729430|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729431|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
56729432|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729433|NCT00974740|Atorvastatin|atorvastatin|mesh-list
56729434|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56729435|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56729436|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
56729437|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729438|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56729439|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56729440|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729441|NCT00967096|Rifaximin|rifaximin|mesh-list
56729442|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56729443|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729444|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729445|NCT05227300|Lidocaine|lidocaine|mesh-list
56729446|NCT05227300|Epinephrine|epinephrine|mesh-list
55995812|NCT03889444|Hormones|hormones|mesh-ancestor
56729491|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
56729492|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729493|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729494|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729495|NCT00893217|Interferons|interferons|mesh-list
56729496|NCT00893217|Interferon-beta|interferon-beta|mesh-list
56729497|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
56729498|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729499|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
56729500|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729501|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
56729502|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729503|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56729504|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
56729505|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56729506|NCT00767598|Udenafil|udenafil|mesh-list
56729532|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
56729533|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729534|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537646|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56537647|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56537648|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
56537649|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537650|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537651|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537652|NCT02783053|Metformin|metformin|mesh-list
56537653|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56537654|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537655|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56537656|NCT02781415|Morphine|morphine|mesh-list
56537657|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56537658|NCT02781415|Narcotics|narcotics|mesh-ancestor
56537659|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537660|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729535|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56729536|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729537|NCT02557542|Polidocanol|polidocanol|mesh-list
56729538|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
56729539|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56729540|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56729541|NCT00767754|Paroxetine|paroxetine|mesh-list
56729542|NCT00767754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56729543|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56729544|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56729545|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729546|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729547|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
56729548|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729549|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56729550|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
56729551|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56729552|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56729566|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729567|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729568|NCT00770640|Insulin|insulin|mesh-list
56729569|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56729570|NCT00770640|Pioglitazone|pioglitazone|mesh-list
56729571|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56729572|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729573|NCT00770718|Thrombin|thrombin|mesh-list
56729574|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
56729575|NCT00770718|Coagulants|coagulants|mesh-ancestor
56729576|NCT00770796|Atorvastatin|atorvastatin|mesh-list
56729577|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56729578|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56729579|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
56729580|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729581|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56729582|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56729583|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729584|NCT00545740|Mesalamine|mesalamine|mesh-list
56729585|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56729586|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56729587|NCT00545740|Analgesics|analgesics|mesh-ancestor
56729588|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
56729589|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729590|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729591|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537661|NCT02781415|Analgesics|analgesics|mesh-ancestor
56537662|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
56537663|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537664|NCT02785003|Acetaminophen|acetaminophen|mesh-list
56537665|NCT02785003|Ketamine|ketamine|mesh-list
56537666|NCT02785003|Morphine|morphine|mesh-list
56537667|NCT02785003|Narcotics|narcotics|mesh-list
56537668|NCT02785003|Alvimopan|alvimopan|mesh-list
56537669|NCT02785003|Analgesics|analgesics|mesh-ancestor
56537670|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
56537671|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537672|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537673|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56537674|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56537675|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
56537676|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
56537677|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537678|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56729592|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56729593|NCT05208190|Clozapine|clozapine|mesh-list
56729594|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56729595|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
56729596|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729597|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729598|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729599|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56729600|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56729601|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56729602|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56729603|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
56729604|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
56729605|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
56729606|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56729607|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56729608|NCT00609609|Prednisolone|prednisolone|mesh-list
56729609|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
56729610|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56729611|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
56729612|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729613|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
56729614|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
56729615|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729650|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56729651|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
55996018|NCT03018821|Entecavir|entecavir|mesh-list
55996027|NCT03866434|Anagrelide|anagrelide|mesh-list
56729683|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729684|NCT00770952|Pioglitazone|pioglitazone|mesh-list
56729685|NCT00770952|Glimepiride|glimepiride|mesh-list
56729686|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56729687|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729688|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56729689|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729690|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
56729691|NCT00764556|Insulin|insulin|mesh-list
56729692|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56729693|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729714|NCT00893373|Sorafenib|sorafenib|mesh-list
56729715|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729716|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56729717|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537679|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56537680|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537681|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537682|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56537683|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56537684|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
56537685|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56537686|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56537687|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56537688|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537689|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537690|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56729718|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729719|NCT00891267|Amlodipine|amlodipine|mesh-list
56729720|NCT00891267|Olmesartan|olmesartan|mesh-list
56729721|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56729722|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56729723|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56729724|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56729725|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729726|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56729727|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729728|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
56729729|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56729730|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56729731|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56729732|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56729733|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729734|NCT00545584|Incretins|incretins|mesh-ancestor
56729736|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729737|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56729738|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
56729739|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729740|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729741|NCT00378703|Sirolimus|sirolimus|mesh-list
56729742|NCT00378703|Bevacizumab|bevacizumab|mesh-list
56729743|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56729744|NCT00378703|Sorafenib|sorafenib|mesh-list
56729745|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
56729746|NCT00378703|Antibodies|antibodies|mesh-list
56729747|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
56729748|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56729775|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56729776|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729777|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729778|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
56729779|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729780|NCT00967408|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56729781|NCT00967408|Antidepressive Agents|antidepressive agents|mesh-ancestor
56729782|NCT00967408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56729784|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56729785|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729786|NCT04035382|Misoprostol|misoprostol|mesh-list
56729787|NCT04035382|Oxytocin|oxytocin|mesh-list
56729788|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
56729789|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56729790|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729791|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56729792|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
56729793|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56537691|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
56537692|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537693|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537694|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
56537695|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56537696|NCT02782897|Antibodies|antibodies|mesh-list
56537697|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
56537698|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537699|NCT00638131|Bosentan|bosentan|mesh-list
56537700|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56537701|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56537702|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537703|NCT05161195|Tamoxifen|tamoxifen|mesh-list
56537704|NCT05161195|Letrozole|letrozole|mesh-list
56729794|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729795|NCT02541045|Metadoxine|metadoxine|mesh-list
56729796|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56729816|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56729817|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56729818|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
56729819|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729820|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729821|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56729822|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729823|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729824|NCT04008316|Colchicine|colchicine|mesh-list
56729825|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
56729826|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56729827|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
56729828|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
56729829|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
56729830|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729831|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729832|NCT00893607|Methoxamine|methoxamine|mesh-list
56729833|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
56729834|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
56729835|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729836|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729837|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56729838|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56729839|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56729840|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56729841|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
56729842|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729843|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729844|NCT00969046|Epothilone B|epothilone b|mesh-list
56729845|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729846|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
56729847|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
56729848|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
56729849|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729850|NCT05008354|Pyridoxine|pyridoxine|mesh-list
56729851|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
56729852|NCT05008354|Vitamins|vitamins|mesh-ancestor
56729877|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
56729878|NCT01045681|Hormones|hormones|mesh-ancestor
56441027|NCT00265967|Irbesartan|irbesartan|mesh-list
56729879|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729880|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56729881|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537705|NCT05161195|Fulvestrant|fulvestrant|mesh-list
56537706|NCT05161195|Anastrozole|anastrozole|mesh-list
56537707|NCT05161195|Goserelin|goserelin|mesh-list
56537708|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537709|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56537710|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56537711|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537712|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537713|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56537714|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
56537715|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537716|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537717|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56537718|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56537719|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56537720|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56537721|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56537722|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
56191914|NCT01478022|Diuretics|diuretics|mesh-ancestor
56729882|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
56729883|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729884|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729885|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56729886|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
56729887|NCT00975910|Lidocaine|lidocaine|mesh-list
56729888|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
56729889|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
56729890|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56729891|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729892|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
56729893|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729894|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56729895|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56729896|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56729897|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56729898|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729899|NCT03617913|Cisplatin|cisplatin|mesh-list
56729900|NCT03617913|Fluorouracil|fluorouracil|mesh-list
56729901|NCT03617913|Mitomycins|mitomycins|mesh-list
56729902|NCT03617913|Mitomycin|mitomycin|mesh-list
56729903|NCT03617913|Avelumab|avelumab|mesh-list
55996278|NCT04822363|Aspirin|aspirin|mesh-list
56729925|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729926|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
56729927|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729928|NCT03557619|Venetoclax|venetoclax|mesh-list
56729929|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
56729930|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56729931|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56729932|NCT03557619|Estradiol|estradiol|mesh-list
56729933|NCT03557619|Estrogens|estrogens|mesh-ancestor
56729934|NCT03557619|Hormones|hormones|mesh-ancestor
56729935|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729936|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062811|NCT03990363|Protective Agents|protective agents|mesh-ancestor
56537723|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56537724|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56537725|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537727|NCT02780245|Coagulants|coagulants|mesh-ancestor
56537728|NCT05340985|Vitamin D|vitamin d|mesh-list
56537729|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
56537730|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
56537731|NCT05340985|Calcifediol|calcifediol|mesh-list
56537732|NCT05340985|Vitamins|vitamins|mesh-list
56537733|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
56537734|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
56537735|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
56191933|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
56729937|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56729938|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
56729939|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56729940|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56729941|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729942|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56729943|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56729944|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56729945|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56729946|NCT00969592|Insulin|insulin|mesh-list
56729947|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56729948|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
56729949|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
56729950|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56729951|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
56729952|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56729953|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729954|NCT00368641|Icodextrin|icodextrin|mesh-list
56729955|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
55996314|NCT01126099|Prazosin|prazosin|mesh-list
56729989|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56729990|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729991|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729992|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56729993|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729994|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56729995|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
56729996|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729997|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
56730060|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56730061|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
56730062|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730063|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
56730064|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56730065|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56730066|NCT00970138|Apatinib|apatinib|mesh-list
56730067|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730068|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56730069|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730070|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730071|NCT00892125|Carbamazepine|carbamazepine|mesh-list
56730072|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56730073|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56730074|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56730075|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730076|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730077|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55996435|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56730120|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730122|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56730123|NCT00378079|Narcotics|narcotics|mesh-ancestor
56537736|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537737|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56537738|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56537739|NCT05340985|Provitamins|provitamins|mesh-ancestor
56537740|NCT02784457|Cetrorelix|cetrorelix|mesh-list
56537741|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56537742|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
56537743|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56537744|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537745|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
56537746|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537747|NCT05124691|Ivermectin|ivermectin|mesh-list
56537748|NCT05124691|Albendazole|albendazole|mesh-list
56537749|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56537750|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537751|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
56730124|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730125|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730126|NCT00378079|Analgesics|analgesics|mesh-ancestor
56730127|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
56730128|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730129|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
56730130|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
56730131|NCT00970450|Acetaminophen|acetaminophen|mesh-list
56730132|NCT00970450|Tropisetron|tropisetron|mesh-list
56730133|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56730134|NCT00970450|Analgesics|analgesics|mesh-ancestor
56730135|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
56730136|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730137|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730138|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
56730139|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
56730140|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
56730141|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56730142|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56730143|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56730144|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
56730145|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730146|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730147|NCT00970528|Acarbose|acarbose|mesh-list
56730148|NCT00970528|Voglibose|voglibose|mesh-list
56730149|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56730150|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730151|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730152|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56730153|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730154|NCT00970762|Rocuronium|rocuronium|mesh-list
56730155|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
56730178|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56730179|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
56730180|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730181|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730182|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56730184|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
56730185|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56730186|NCT00608907|Rifampin|rifampin|mesh-list
56730187|NCT00608907|Dexamethasone|dexamethasone|mesh-list
56730188|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
56730189|NCT00608907|Bortezomib|bortezomib|mesh-list
56730190|NCT00608907|BB 1101|bb 1101|mesh-list
56537752|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
56537753|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56537754|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56537755|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
56537756|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
56537757|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
56537758|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537759|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537760|NCT02780323|Celecoxib|celecoxib|mesh-list
56537761|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56537762|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56537763|NCT02780323|Analgesics|analgesics|mesh-ancestor
56537764|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
56537765|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537766|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730191|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56730192|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
56730193|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
56730194|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730195|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730196|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56730197|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
56730198|NCT00608907|Hormones|hormones|mesh-ancestor
56730199|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730200|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56730201|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730202|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
56730203|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730204|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730205|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56730206|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
56730207|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56730208|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730387|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730388|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56730389|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
56730390|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730391|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730392|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
56730393|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56730394|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56730395|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56730396|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56730397|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730398|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
56730399|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730400|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730401|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56730402|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730403|NCT00978718|Selenium|selenium|mesh-list
56730404|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
56730405|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730406|NCT00978718|Protective Agents|protective agents|mesh-ancestor
56730407|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730409|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
56730410|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
56730411|NCT00895713|Antibodies|antibodies|mesh-list
56730412|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
56537767|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537768|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064030|NCT01673867|Docetaxel|docetaxel|mesh-list
56730413|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56730414|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56730415|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
56730416|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730417|NCT01051765|Irinotecan|irinotecan|mesh-list
56730418|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730419|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56730420|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56730421|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730422|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730423|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56730424|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55996784|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
56730441|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56730442|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
56730443|NCT03472365|Capecitabine|capecitabine|mesh-list
56730444|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
56730445|NCT03472365|Apatinib|apatinib|mesh-list
56730446|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56730447|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
56730448|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730449|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730450|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56730451|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730452|NCT00894621|Norepinephrine|norepinephrine|mesh-list
56730453|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56730454|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56730455|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
56730456|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730457|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730458|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730459|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
56730460|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
56730461|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730462|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56730463|NCT00376675|Methylphenidate|methylphenidate|mesh-list
56730464|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56730465|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730466|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56730467|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56730468|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56730469|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730470|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
56730471|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730472|NCT00979186|Hemostatics|hemostatics|mesh-list
56730473|NCT00979186|Coagulants|coagulants|mesh-ancestor
56730474|NCT05178628|Gemcitabine|gemcitabine|mesh-list
56730475|NCT05178628|Paclitaxel|paclitaxel|mesh-list
56730476|NCT05178628|Tinzaparin|tinzaparin|mesh-list
56730477|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56730478|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730479|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
56730480|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
56441668|NCT00268814|Heroin|heroin|mesh-list
56730497|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56730498|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
56730499|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56730500|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730501|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56730503|NCT00896571|Hormones|hormones|mesh-ancestor
56730504|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730505|NCT00896727|Antibodies|antibodies|mesh-list
56730506|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
56730507|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730508|NCT00981838|Rituximab|rituximab|mesh-list
56730509|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56730510|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730511|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
56730512|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730513|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56730514|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
56537769|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56537770|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56537771|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537772|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537773|NCT05331859|Insulin|insulin|mesh-list
56537774|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56537775|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537776|NCT04229407|Vitamins|vitamins|mesh-list
56537777|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
56537778|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
56537779|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537780|NCT04231435|Metformin|metformin|mesh-list
56537781|NCT04231435|Digoxin|digoxin|mesh-list
56537782|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56537783|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56537784|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537785|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56537786|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56537787|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
56537788|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537789|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56537790|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56537791|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537792|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56537793|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56730515|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56730516|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56730517|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730518|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
56730519|NCT04910464|Coagulants|coagulants|mesh-ancestor
56730520|NCT02533765|Olaparib|olaparib|mesh-list
56730521|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56730522|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730523|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730524|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730525|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56730526|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730527|NCT00367237|Methotrexate|methotrexate|mesh-list
56730528|NCT00367237|Infliximab|infliximab|mesh-list
56730529|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56730530|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
56730531|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56730532|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730533|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56730534|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
56730535|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730536|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730537|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
56730538|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537794|NCT04231435|Protective Agents|protective agents|mesh-ancestor
56537795|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56537796|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56634290|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
56537797|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537798|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537799|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56537800|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56537801|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537802|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
56537803|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537804|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
56537805|NCT05028829|Atorvastatin|atorvastatin|mesh-list
56537806|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56537807|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56537808|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
56537809|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537810|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56537811|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56537812|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537813|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56730539|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56730569|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
56730570|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730571|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730572|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56730573|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56730574|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
56730575|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730576|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730577|NCT00901719|Nitroprusside|nitroprusside|mesh-list
56730578|NCT00901719|Acetylcholine|acetylcholine|mesh-list
56730579|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56730580|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
55996951|NCT00981656|Mitomycin|mitomycin|mesh-list
56730677|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730678|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
56730679|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56730680|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730681|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730682|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56730715|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56730716|NCT00902031|Laxatives|laxatives|mesh-ancestor
56730717|NCT00902031|Cathartics|cathartics|mesh-ancestor
56730718|NCT00985348|Levetiracetam|levetiracetam|mesh-list
56730719|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
56730720|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
56730721|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
56730722|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56730723|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730725|NCT00973336|Calcium|calcium|mesh-list
56730726|NCT00973336|Vitamins|vitamins|mesh-ancestor
56730727|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
56537814|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56537815|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56537816|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537817|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537818|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56537819|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56537820|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537821|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
56537822|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537823|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
56537824|NCT05103631|Cyclophosphamide|cyclophosphamide|mesh-list
56537825|NCT05103631|Fludarabine|fludarabine|mesh-list
56537826|NCT05103631|Fludarabine phosphate|fludarabine phosphate|mesh-list
56730728|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730729|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56730778|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56730779|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56730780|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
56730781|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730782|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730783|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56730784|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56730785|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56730786|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56730787|NCT00366535|Neurotropin|neurotropin|mesh-list
56730788|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56730789|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
56730790|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730791|NCT00366535|Analgesics|analgesics|mesh-ancestor
56730792|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
56730793|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730794|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
56730796|NCT00982618|Morphine|morphine|mesh-list
56730797|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
56730798|NCT00982618|Anesthetics|anesthetics|mesh-list
56730799|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730800|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730801|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
56730802|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730803|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56730804|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56730805|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56730806|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56730807|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730808|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55997170|NCT05604638|Tirofiban|tirofiban|mesh-list
56730836|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56730837|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56730838|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56730839|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730840|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56730841|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730842|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
56730843|NCT00350545|Cyclosporine|cyclosporine|mesh-list
56730845|NCT00350545|Rituximab|rituximab|mesh-list
56730846|NCT00350545|Tacrolimus|tacrolimus|mesh-list
56730847|NCT00350545|Cyclosporins|cyclosporins|mesh-list
56730848|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56730849|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537827|NCT05103631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537828|NCT05103631|Immunologic Factors|immunologic factors|mesh-ancestor
56537829|NCT05103631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537830|NCT05103631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56537831|NCT05103631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56537832|NCT05103631|Alkylating Agents|alkylating agents|mesh-ancestor
56537833|NCT05103631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537834|NCT05103631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537835|NCT05103631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56537836|NCT05103631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56537837|NCT05103631|Antimetabolites|antimetabolites|mesh-ancestor
56537838|NCT05322031|Aripiprazole|aripiprazole|mesh-list
56537839|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
56537840|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56537841|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56537842|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56537843|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537844|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730850|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
56730851|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730852|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56730853|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56730854|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
56730855|NCT00350545|Hormones|hormones|mesh-ancestor
56730917|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
56730918|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
56730919|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56730920|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56730921|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56730922|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56730923|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56730924|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56730925|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56730926|NCT00895323|Antibodies|antibodies|mesh-list
56730927|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56730928|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56730929|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
56730930|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730932|NCT00349921|Clonidine|clonidine|mesh-list
56730970|NCT01052623|Analgesics|analgesics|mesh-ancestor
56730988|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730989|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
56730990|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
56730991|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56730992|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
56730993|NCT00898287|Gemcitabine|gemcitabine|mesh-list
56730994|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56730995|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
56730996|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730997|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730998|NCT00898287|Antiviral Agents|antiviral agents|mesh-ancestor
56730999|NCT00898287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731000|NCT00898287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731001|NCT00898287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731002|NCT00898287|Immunologic Factors|immunologic factors|mesh-ancestor
56731003|NCT00898287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731004|NCT04034823|Docetaxel|docetaxel|mesh-list
56537845|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
56537846|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
56192056|NCT01478685|Cc-486|cc-486|mesh-list
56731005|NCT04034823|Trastuzumab|trastuzumab|mesh-list
56731006|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731007|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
56731008|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
56731009|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
56731010|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731011|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56731012|NCT00606021|Pemetrexed|pemetrexed|mesh-list
56731013|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731014|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731015|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731016|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56731017|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56731018|NCT00337675|Montelukast|montelukast|mesh-list
56731019|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56731020|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
56731021|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56731022|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
56731023|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731024|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731025|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56731026|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56731027|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731044|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731045|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731046|NCT00903045|Urological Agents|urological agents|mesh-ancestor
56731047|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56731048|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56731049|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731050|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56731051|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56731052|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56731053|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731054|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
56731055|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731056|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
56731058|NCT04035525|Vitamins|vitamins|mesh-ancestor
56731059|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
56731060|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731061|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56731062|NCT00905853|Amiodarone|amiodarone|mesh-list
56731063|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
56731064|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56731065|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56731066|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731067|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56731068|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56731069|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56731070|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731071|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56731072|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56731073|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56731074|NCT00905931|Lycopene|lycopene|mesh-list
56731075|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731076|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
56442211|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
56731077|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731078|NCT00905931|Protective Agents|protective agents|mesh-ancestor
56731079|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731080|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56731081|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56731082|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731140|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56731141|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56731142|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062971|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56537847|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56537848|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537849|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56537850|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56537851|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
56537852|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56537853|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56537854|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56537855|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56537856|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56537857|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56537858|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537859|NCT02780479|Dexamethasone|dexamethasone|mesh-list
56537861|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56537862|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
56537863|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
56537864|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537865|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537866|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56537867|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
56537868|NCT02780479|Hormones|hormones|mesh-ancestor
56537869|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56634291|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
56537870|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56192066|NCT01478724|Caseins|caseins|mesh-list
56731143|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731144|NCT00904059|Asunaprevir|asunaprevir|mesh-list
56731145|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
56731146|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731147|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731148|NCT00337207|Bevacizumab|bevacizumab|mesh-list
56731149|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56731150|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731151|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56731152|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56731153|NCT00337207|Growth Substances|growth substances|mesh-ancestor
56731154|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731155|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
56731156|NCT01055743|Fluorouracil|fluorouracil|mesh-list
56731157|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
56731158|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731159|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56731160|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731161|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731162|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
56731163|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731164|NCT00604695|Tenecteplase|tenecteplase|mesh-list
56537871|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537872|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56537873|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
56537874|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56537875|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
56537876|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537877|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56537878|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56537879|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56537880|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56537881|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537882|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
56537883|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56537884|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56537885|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56537886|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56537887|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537888|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
56537889|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731165|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56731222|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
56731223|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56731224|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731225|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56731227|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731228|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731229|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
56731230|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731231|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56731232|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731233|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
56731234|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56731235|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56731236|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
56731237|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731238|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56731239|NCT00905229|Vitamins|vitamins|mesh-list
56731240|NCT00905229|Vitamin K|vitamin k|mesh-list
56731241|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
56731242|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
56731243|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731244|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56731245|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56731246|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731247|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
56731248|NCT00905229|Coagulants|coagulants|mesh-ancestor
56731249|NCT00905541|Simvastatin|simvastatin|mesh-list
56731250|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56731251|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56731252|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
56731253|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731254|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55997617|NCT04759196|Topiramate|topiramate|mesh-list
56731279|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56537890|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537891|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56537892|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537894|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56537895|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537896|NCT04228315|Primaquine|primaquine|mesh-list
56537897|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
56537898|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56537899|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56537900|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537901|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
56537902|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
56731280|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
56731281|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
56731282|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731283|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731284|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
56731285|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731286|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731287|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
56731288|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
56731289|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731290|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56731291|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
56731292|NCT00336583|Hormones|hormones|mesh-ancestor
56731293|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731294|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56731295|NCT00336583|Protective Agents|protective agents|mesh-ancestor
56731296|NCT00336505|Clarithromycin|clarithromycin|mesh-list
56731297|NCT00336505|Cethromycin|cethromycin|mesh-list
56731298|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56731299|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731300|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56731301|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731302|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731303|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56731304|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56731340|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56731341|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56731342|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731343|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56731344|NCT01059955|Dexamethasone|dexamethasone|mesh-list
56731345|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
56731371|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56731372|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56731373|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
56731374|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731375|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56731376|NCT01060267|Erythromycin|erythromycin|mesh-list
56731377|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
56731378|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56731379|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
56731380|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731381|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56731382|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56731383|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731384|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731385|NCT01060423|Irinotecan|irinotecan|mesh-list
56731386|NCT01060423|Cetuximab|cetuximab|mesh-list
56731387|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56731388|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56731389|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731390|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731391|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537903|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731392|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56731393|NCT01060501|Leucovorin|leucovorin|mesh-list
56731394|NCT01060501|Folic Acid|folic acid|mesh-list
56731395|NCT01060501|Interferons|interferons|mesh-list
55997771|NCT04393610|Narcotics|narcotics|mesh-ancestor
56731512|NCT04048200|Narcotics|narcotics|mesh-ancestor
56731513|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56731514|NCT04034589|Fulvestrant|fulvestrant|mesh-list
56731515|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56731516|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731517|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56731518|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56731519|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
56731520|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731521|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731522|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56731523|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
56731524|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731525|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
56731526|NCT00906867|Miotics|miotics|mesh-ancestor
56731527|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
56731528|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731529|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731530|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56731531|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56731532|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
56731533|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56731534|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56731535|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
56731536|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731589|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
56731590|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731591|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
56731592|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731593|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
56731594|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56731595|NCT00986128|Topiramate|topiramate|mesh-list
56731596|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
56731597|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56731598|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731599|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
56731600|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56731601|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
56731602|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731603|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442734|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731604|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56731605|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
56731606|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56731607|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
56731626|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
56731627|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
56731628|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731629|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731630|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56731631|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
56731632|NCT04767256|Hormones|hormones|mesh-ancestor
56731633|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731634|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56731635|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731636|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56731637|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731638|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56731639|NCT04767256|Analgesics|analgesics|mesh-ancestor
56731640|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
56731641|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56731642|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56731643|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56731644|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
56731645|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731646|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731647|NCT00771498|Lopinavir|lopinavir|mesh-list
56731648|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56537904|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56537905|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537906|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56537907|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
56537908|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537909|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56537910|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537911|NCT02779777|Tipifarnib|tipifarnib|mesh-list
56537912|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537913|NCT05069545|Insulin|insulin|mesh-list
56537914|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56537915|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
56537916|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56537917|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537918|NCT05279833|Sotalol|sotalol|mesh-list
56537919|NCT05279833|Dronedarone|dronedarone|mesh-list
56537920|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56537921|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56731649|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56731650|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
56731651|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731652|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731653|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56731654|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56731655|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
56731656|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731657|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56731658|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56731659|NCT00986284|Gefitinib|gefitinib|mesh-list
56731660|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731661|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56731662|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731663|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998025|NCT04393220|Growth Substances|growth substances|mesh-ancestor
56731678|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56731679|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56731680|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56731681|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56731682|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56731683|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56731684|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56731685|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56731686|NCT00775242|Estradiol|estradiol|mesh-list
56731687|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56731688|NCT00775242|Estrogens|estrogens|mesh-list
56731689|NCT00775242|Progesterone|progesterone|mesh-list
56731690|NCT00775242|Progestins|progestins|mesh-list
56731691|NCT00775242|Hormones|hormones|mesh-ancestor
56731692|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731693|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731694|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56731695|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
56731696|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56731697|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56731698|NCT00769158|Topiramate|topiramate|mesh-list
56731699|NCT00769158|Naltrexone|naltrexone|mesh-list
56731700|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56731701|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56537922|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
56537923|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731702|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731703|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
56731704|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731705|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
56731706|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56731707|NCT00983164|Antioxidants|antioxidants|mesh-list
56731708|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731709|NCT00983164|Protective Agents|protective agents|mesh-ancestor
56731710|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731711|NCT00333775|Bevacizumab|bevacizumab|mesh-list
56731712|NCT00333775|Docetaxel|docetaxel|mesh-list
56731713|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56731714|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731715|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56731716|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56731717|NCT00333775|Growth Substances|growth substances|mesh-ancestor
56731718|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731719|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
56731720|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
56731721|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
56731722|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
56731781|NCT00983398|Carboplatin|carboplatin|mesh-list
56731782|NCT00983398|Melphalan|melphalan|mesh-list
56731783|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
56731784|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56731785|NCT00983398|Mannitol|mannitol|mesh-list
56731786|NCT00983398|Antidotes|antidotes|mesh-list
56731787|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731788|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56731789|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
56731790|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731791|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56731792|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731793|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
56731794|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731795|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56731796|NCT00983398|Diuretics|diuretics|mesh-ancestor
56731797|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
56731798|NCT00983398|Protective Agents|protective agents|mesh-ancestor
56731799|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
56731800|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
56731801|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56731802|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731803|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
56731804|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
56731805|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
56731806|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56731807|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731852|NCT05004987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56731853|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56731854|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56731855|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731856|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731857|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
56731858|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731859|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56731860|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
56731861|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56731862|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56731863|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56731864|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
56731865|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
56731866|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731867|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56731868|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56731869|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
56731870|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
56731871|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56731872|NCT00908817|Triamcinolone|triamcinolone|mesh-list
56731873|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56731874|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56731875|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56537924|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537925|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537926|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56537927|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
56065883|NCT00365339|Ritonavir|ritonavir|mesh-list
56731876|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56731877|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731878|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
56731879|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
56731901|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731902|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
56731903|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56731904|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731905|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56443044|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
56731907|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
56731908|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56731909|NCT00927147|Cetuximab|cetuximab|mesh-list
56731910|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56731911|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731912|NCT05712616|Strontium ranelate|strontium ranelate|mesh-list
56731913|NCT05712616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56731914|NCT05712616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731915|NCT00927225|Ropivacaine|ropivacaine|mesh-list
56731916|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
56731917|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
56731918|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731919|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731920|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
56731921|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731922|NCT00357097|Ropinirole|ropinirole|mesh-list
56731923|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56731924|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56731925|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
56731926|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
56731927|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731928|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731929|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731930|NCT00983788|Bezafibrate|bezafibrate|mesh-list
56731931|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56731932|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
56731933|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731961|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56731963|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731964|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
56731965|NCT00983944|Hormones|hormones|mesh-ancestor
56731966|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731967|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56731968|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56731969|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
56731970|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
56731971|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
56731972|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56731973|NCT00927537|Telmisartan|telmisartan|mesh-list
56731974|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56731975|NCT00927537|Diuretics|diuretics|mesh-ancestor
56731976|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
56731977|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731978|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56731979|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56443115|NCT00277706|Vitamin D|vitamin d|mesh-list
55998346|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56732031|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
56732032|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
56732033|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732034|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56732035|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56732036|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56732037|NCT03990103|Growth Substances|growth substances|mesh-ancestor
56062972|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
56537928|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
56537929|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537930|NCT01880359|Nimorazole|nimorazole|mesh-list
56537931|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56537932|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56537933|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56537934|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56537935|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56537936|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56537937|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56537938|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
56537939|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537940|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56537941|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56537942|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537943|NCT04975555|Siltuximab|siltuximab|mesh-list
56537944|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56537945|NCT05338489|Itraconazole|itraconazole|mesh-list
56537946|NCT05338489|Rifampin|rifampin|mesh-list
56634292|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
56537947|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
56732038|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732039|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
56732040|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56732041|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
56732042|NCT00927693|Calcium|calcium|mesh-list
56732043|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56732044|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732045|NCT00987220|Donepezil|donepezil|mesh-list
56732046|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56732047|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732048|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732049|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
56732050|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732051|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732052|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
56732053|NCT01581151|Dexamethasone|dexamethasone|mesh-list
56732054|NCT01581151|Ranibizumab|ranibizumab|mesh-list
56732055|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56732056|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
56732057|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
56732058|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732059|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732095|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732096|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732098|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56732099|NCT01053637|Narcotics|narcotics|mesh-ancestor
56732153|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56732154|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732155|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
56732156|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
56732157|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
56732158|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732159|NCT01053871|Fentanyl|fentanyl|mesh-list
56732160|NCT01053871|Midazolam|midazolam|mesh-list
56732161|NCT01053871|Propofol|propofol|mesh-list
56537948|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286196|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
56732162|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56732163|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56732164|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732165|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56732166|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
56732167|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
56732168|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56732169|NCT01053871|Narcotics|narcotics|mesh-ancestor
56732170|NCT01053871|Analgesics|analgesics|mesh-ancestor
56732171|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
56732172|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732173|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56732174|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56732175|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56732176|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56732177|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
56732178|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
56732179|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732180|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732181|NCT01053949|Thalidomide|thalidomide|mesh-list
56732182|NCT01053949|Pomalidomide|pomalidomide|mesh-list
56732183|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
55998549|NCT03826550|Diclofenac|diclofenac|mesh-list
56732311|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732312|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56732313|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56732314|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
56732315|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732316|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732317|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732318|NCT03986905|Scopolamine|scopolamine|mesh-list
56732402|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56732403|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56732404|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732405|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732406|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56732407|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
56732408|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732409|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56732410|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56732411|NCT04690504|Melatonin|melatonin|mesh-list
56732412|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
56732413|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732414|NCT04690504|Protective Agents|protective agents|mesh-ancestor
56732415|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732416|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56732417|NCT03150004|Cytarabine|cytarabine|mesh-list
56732418|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
56732419|NCT03150004|Cladribine|cladribine|mesh-list
56732420|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56732421|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
56732422|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732423|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732424|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
56732425|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732426|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998798|NCT02899052|Hormones|hormones|mesh-ancestor
56732451|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
56732452|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732454|NCT05677126|Trace Elements|trace elements|mesh-list
56732455|NCT05677126|Selenious Acid|selenious acid|mesh-list
56732456|NCT05677126|Micronutrients|micronutrients|mesh-list
56732457|NCT05677126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732458|NCT04613830|Tramadol|tramadol|mesh-list
56732459|NCT04613830|Bupivacaine|bupivacaine|mesh-list
56732460|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
56732461|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
56732462|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56732463|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732464|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
56732465|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732466|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56732467|NCT04613830|Narcotics|narcotics|mesh-ancestor
56732468|NCT04613830|Analgesics|analgesics|mesh-ancestor
56537949|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56537950|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56537951|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537952|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537953|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56537954|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
56537955|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56537956|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537957|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56537958|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56537959|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
56537960|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56537961|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
56537962|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56537963|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56537964|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56537965|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56732469|NCT00689936|Thalidomide|thalidomide|mesh-list
56732470|NCT00689936|Dexamethasone|dexamethasone|mesh-list
56732471|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
56732472|NCT00689936|Prednisone|prednisone|mesh-list
56732473|NCT00689936|Lenalidomide|lenalidomide|mesh-list
56732474|NCT00689936|Melphalan|melphalan|mesh-list
56732475|NCT00689936|BB 1101|bb 1101|mesh-list
56732476|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56732477|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
56732478|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
56732479|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998847|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
56732504|NCT05661682|Manganese|manganese|mesh-list
56732505|NCT05661682|Trace Elements|trace elements|mesh-list
56732506|NCT05661682|Selenious Acid|selenious acid|mesh-list
56732507|NCT05661682|Micronutrients|micronutrients|mesh-list
56732508|NCT05661682|Copper Sulfate|copper sulfate|mesh-list
56732509|NCT05661682|Zinc Sulfate|zinc sulfate|mesh-list
56732510|NCT05661682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732511|NCT05661682|Astringents|astringents|mesh-ancestor
56732512|NCT05661682|Dermatologic Agents|dermatologic agents|mesh-ancestor
56732513|NCT05661682|Antidotes|antidotes|mesh-ancestor
56732514|NCT05661682|Protective Agents|protective agents|mesh-ancestor
56732515|NCT05661682|Emetics|emetics|mesh-ancestor
56732516|NCT05661682|Autonomic Agents|autonomic agents|mesh-ancestor
56732517|NCT05661682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732518|NCT05661682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732519|NCT04545736|Metformin|metformin|mesh-list
56732520|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732521|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732522|NCT01563718|Naltrexone|naltrexone|mesh-list
56732523|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56732524|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56732525|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732526|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
56732527|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732528|NCT05655598|Palbociclib|palbociclib|mesh-list
56732529|NCT05655598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732530|NCT05655598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56732531|NCT05655598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56537966|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56537967|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56537968|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56732532|NCT05655598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732608|NCT04425070|Carboplatin|carboplatin|mesh-list
56732609|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
56732610|NCT04425070|Etoposide|etoposide|mesh-list
56732611|NCT04425070|Ifosfamide|ifosfamide|mesh-list
55999001|NCT01146457|Morphine|morphine|mesh-list
56732642|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56732643|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732644|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732645|NCT00775632|Cyclosporine|cyclosporine|mesh-list
56732646|NCT00775632|Methotrexate|methotrexate|mesh-list
56732647|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
56732648|NCT00775632|Cyclosporins|cyclosporins|mesh-list
56732649|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56732650|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
56732651|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56732652|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732653|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56732654|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
56732655|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732708|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56732709|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56732710|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
56732711|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56732712|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56732713|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56732714|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56732715|NCT05386576|Venetoclax|venetoclax|mesh-list
56732716|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732717|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
56732718|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56732719|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
56732720|NCT05325580|Analgesics|analgesics|mesh-ancestor
56732721|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
56732722|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732723|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732724|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
56732725|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56732726|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56732727|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
56732728|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56732729|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56732730|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732731|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56732732|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
56732733|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56732734|NCT01196390|Paclitaxel|paclitaxel|mesh-list
56732735|NCT01196390|Carboplatin|carboplatin|mesh-list
56732736|NCT01196390|Trastuzumab|trastuzumab|mesh-list
56732737|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56732738|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56732739|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56732740|NCT01196390|Antibodies|antibodies|mesh-list
56732741|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
56732742|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56732743|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56732744|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732746|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
56732747|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
55999094|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732781|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732782|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732783|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56732784|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732785|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56732786|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
56732828|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56732829|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56732830|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56537969|NCT05266417|Insulin|insulin|mesh-list
56537970|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56537971|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537972|NCT02779465|Vitamin D|vitamin d|mesh-list
56537973|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
56537974|NCT02779465|Vitamins|vitamins|mesh-ancestor
56537975|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
56537976|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56537977|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56537978|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56537979|NCT02776189|Midazolam|midazolam|mesh-list
56537980|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
56537981|NCT02776189|Propofol|propofol|mesh-list
56537982|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56537983|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56537984|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192188|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732832|NCT00329641|Carboplatin|carboplatin|mesh-list
56732833|NCT00329641|Sorafenib|sorafenib|mesh-list
56732834|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56732835|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732836|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
56732837|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
56732838|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
56732839|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732840|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56732841|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732842|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56732843|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
56732844|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732845|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732846|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732847|NCT00743990|Camphor|camphor|mesh-list
56732848|NCT00743990|Menthol|menthol|mesh-list
56732849|NCT00743990|Petrolatum|petrolatum|mesh-list
56732850|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
56732851|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
56732852|NCT00743990|Emollients|emollients|mesh-ancestor
56732853|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56732854|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732855|NCT00329407|Topiramate|topiramate|mesh-list
56732856|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
56732857|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732858|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732859|NCT01056757|Ribavirin|ribavirin|mesh-list
56732860|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
56732861|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732862|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
56732863|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732864|NCT01056835|Epoprostenol|epoprostenol|mesh-list
56732865|NCT01056835|Tezosentan|tezosentan|mesh-list
56732866|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56732867|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56732868|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
56732869|NCT03986515|Apatinib|apatinib|mesh-list
56732870|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732871|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56732872|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732873|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732874|NCT00567489|Icodextrin|icodextrin|mesh-list
56732875|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
56732876|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56537985|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56537986|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
56537987|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
56537988|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56537989|NCT02776189|Analgesics|analgesics|mesh-ancestor
56537990|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
56537991|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56537992|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56537993|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56537994|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56537995|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
56537996|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192204|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192205|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56192206|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56732877|NCT02538393|Sorafenib|sorafenib|mesh-list
56732878|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732879|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56732880|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999219|NCT01453400|Acetaminophen|acetaminophen|mesh-list
56732912|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732913|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56732914|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56732915|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56732917|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732918|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
56733019|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
56733020|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
56733021|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733022|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56733023|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56733024|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56733025|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733026|NCT00776802|Dexamethasone|dexamethasone|mesh-list
56733028|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733029|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
56733030|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
55999390|NCT02994576|Atezolizumab|atezolizumab|mesh-list
56733063|NCT00780780|Hormones|hormones|mesh-ancestor
56733064|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733065|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733066|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56733067|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
55999432|NCT04423926|Hormones|hormones|mesh-ancestor
56733121|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56733122|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733123|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733156|NCT02556060|Lamotrigine|lamotrigine|mesh-list
56733157|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
56733158|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56733159|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733160|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733161|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56733162|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733163|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56733235|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733236|NCT00354770|Expectorants|expectorants|mesh-ancestor
56733237|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
56733238|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56733239|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
56733240|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733241|NCT00354770|Protective Agents|protective agents|mesh-ancestor
56733242|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733243|NCT00354770|Antidotes|antidotes|mesh-ancestor
56733245|NCT00744224|Prednisolone|prednisolone|mesh-list
56733246|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56733247|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
56733248|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56733249|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
56733283|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733285|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
56733286|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
56733287|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733288|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56733289|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
56733290|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733321|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733322|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733323|NCT00781482|Zolpidem|zolpidem|mesh-list
56733324|NCT00781482|Eszopiclone|eszopiclone|mesh-list
56733325|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56733326|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56733327|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56733328|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733329|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56733330|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
56733331|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
56733332|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733333|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733366|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56733368|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
56733369|NCT04034199|Denosumab|denosumab|mesh-list
56733370|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56733371|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733372|NCT02538237|Ibuprofen|ibuprofen|mesh-list
56733373|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56733374|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56733375|NCT02538237|Analgesics|analgesics|mesh-ancestor
56733376|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
56733413|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
56733443|NCT00744536|Growth Substances|growth substances|mesh-ancestor
56733444|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733445|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733446|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56733447|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
56733448|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733449|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56733450|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56733451|NCT00929799|Hormones|hormones|mesh-list
56733452|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733453|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733454|NCT00777738|Bortezomib|bortezomib|mesh-list
56733455|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733456|NCT00744770|Rilpivirine|rilpivirine|mesh-list
56733457|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56006073|NCT00199082|Cytarabine|cytarabine|mesh-list
56733481|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56733482|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733483|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56733484|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733485|NCT02556840|Insulin|insulin|mesh-list
56733486|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56733487|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733488|NCT00929877|Ketoprofen|ketoprofen|mesh-list
56733489|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56733490|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56733491|NCT00929877|Analgesics|analgesics|mesh-ancestor
56733492|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
56733493|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733494|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733495|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733496|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063331|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
56537997|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067100|NCT02658461|Trastuzumab|trastuzumab|mesh-list
56733497|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56733498|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733499|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733500|NCT00741884|Varenicline|varenicline|mesh-list
56733501|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56733502|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56733503|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
56733504|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733505|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733523|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
56733524|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733525|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
56733526|NCT00782106|Antibodies|antibodies|mesh-list
56733527|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
56733528|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56733529|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56733530|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
56733531|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
56733532|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733533|NCT00929955|Ondansetron|ondansetron|mesh-list
56733534|NCT00929955|Simvastatin|simvastatin|mesh-list
56733535|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56733536|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56733537|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
56733538|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733539|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56733540|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56733541|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733542|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
56733543|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
56733544|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733545|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733546|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56733547|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
56733548|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
56733549|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56733550|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
56733551|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733552|NCT00929955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56733553|NCT00929955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56733554|NCT00929955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56733555|NCT00929955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56733556|NCT00929955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56733557|NCT00784914|Sirolimus|sirolimus|mesh-list
56733558|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56733559|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733560|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56733561|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733562|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
56733563|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56733564|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
56622929|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
56733592|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56733593|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56733594|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56733595|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56733596|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56733597|NCT04060550|Omalizumab|omalizumab|mesh-list
56733598|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56733599|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56733600|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
56733601|NCT00921674|Ivermectin|ivermectin|mesh-list
56733602|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56733603|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733604|NCT00667446|Leuprolide|leuprolide|mesh-list
56733605|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56733606|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
56733607|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56733608|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733609|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56733610|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733611|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56733612|NCT00777972|Fosinopril|fosinopril|mesh-list
56537998|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56537999|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56067359|NCT02697071|Ketamine|ketamine|mesh-list
56733642|NCT00778128|Antiviral Agents|antiviral agents|mesh-ancestor
56733643|NCT00778128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733644|NCT00778128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733645|NCT00778128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56733646|NCT00778128|Immunologic Factors|immunologic factors|mesh-ancestor
56733647|NCT00778128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733648|NCT00778284|Amoxicillin|amoxicillin|mesh-list
56733649|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56733650|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733652|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56733653|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
56733654|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733655|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733691|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733692|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56733693|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56733733|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733735|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56733736|NCT00567567|Vitamins|vitamins|mesh-ancestor
56006357|NCT00002692|Vitamins|vitamins|mesh-ancestor
56733770|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733771|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56733772|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733773|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733774|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56006391|NCT01895348|Narcotics|narcotics|mesh-ancestor
56733805|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
56733806|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
56733807|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733808|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56733809|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56733810|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
56733811|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56733812|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
56733813|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56733814|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56733815|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733816|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56733817|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56733818|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56733819|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
56733820|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56733853|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56733854|NCT00664560|Analgesics|analgesics|mesh-ancestor
56733855|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
56733856|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733857|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733858|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733859|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733889|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733890|NCT00930189|Growth Substances|growth substances|mesh-ancestor
56733891|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733892|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733893|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733894|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733895|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
56733896|NCT00930189|Hormones|hormones|mesh-ancestor
56733897|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733898|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
56733899|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56733900|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56733901|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
56733902|NCT00931827|Etonogestrel|etonogestrel|mesh-list
56006516|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
56733935|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733936|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56733937|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733938|NCT00930345|Growth Substances|growth substances|mesh-ancestor
56538000|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56538001|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56538002|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
56538003|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
56538004|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
56538005|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56538006|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
56538007|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538008|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538009|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56538010|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
56538011|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56538012|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
56733939|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733940|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733941|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56733942|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733943|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733944|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
56733970|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56733971|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733972|NCT00665652|Growth Substances|growth substances|mesh-ancestor
56733973|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733974|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733975|NCT00752024|Hemostatics|hemostatics|mesh-list
56733976|NCT00752024|Coagulants|coagulants|mesh-ancestor
56733977|NCT00937677|Natalizumab|natalizumab|mesh-list
56733978|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
56733979|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733980|NCT00786240|Fesoterodine|fesoterodine|mesh-list
56733981|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56733982|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56733983|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
56733984|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733985|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733986|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733987|NCT00786240|Urological Agents|urological agents|mesh-ancestor
56733988|NCT04498923|Dexamethasone|dexamethasone|mesh-list
56733989|NCT04498923|Epinephrine|epinephrine|mesh-list
56733990|NCT04498923|Bupivacaine|bupivacaine|mesh-list
56733991|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733992|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
56733993|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
56006604|NCT04783610|Ethanol|ethanol|mesh-list
56734028|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734029|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734030|NCT00932217|Lenograstim|lenograstim|mesh-list
56734031|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56734032|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
56006658|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734066|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734067|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
56734069|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56734070|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734071|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56734072|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56734103|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734104|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734105|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56734106|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
56734107|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
56734108|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
56734109|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734110|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56538013|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538014|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538015|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56538016|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
56538017|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
56634293|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56538018|NCT05052229|Protective Agents|protective agents|mesh-ancestor
56538019|NCT01194258|Insulin|insulin|mesh-list
56538020|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56538021|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
56538022|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
56538023|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
56538024|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
56538025|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56538026|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538027|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
56538028|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
56538029|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56538030|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538031|NCT02775877|Letrozole|letrozole|mesh-list
56538032|NCT02775877|Clomiphene|clomiphene|mesh-list
56538033|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538034|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56538035|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56538036|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734111|NCT00932529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56734112|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56734113|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56734114|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
56734115|NCT00783744|Insulin|insulin|mesh-list
56734116|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56734117|NCT00783744|Metformin|metformin|mesh-list
56734118|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
56734154|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734155|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56734156|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734185|NCT00786552|Paclitaxel|paclitaxel|mesh-list
56734186|NCT00786552|Pemetrexed|pemetrexed|mesh-list
56734187|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56734188|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734189|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
56734190|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
56734191|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
56734192|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734193|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734194|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56734195|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56734196|NCT04047186|Nivolumab|nivolumab|mesh-list
56734197|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56734198|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734199|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56473652|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56538037|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538038|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56538039|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
56538040|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56538041|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538042|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56538043|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
56538044|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56538045|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56538046|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56538047|NCT02777671|Gliclazide|gliclazide|mesh-list
56538048|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56538049|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
56538050|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56538051|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56538052|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56538053|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538054|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56538055|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538056|NCT02778919|Leuprolide|leuprolide|mesh-list
56538057|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56538058|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
56538059|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56538060|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538061|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56192256|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
56734200|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734201|NCT00931203|Celecoxib|celecoxib|mesh-list
56734202|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56734203|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56734237|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
56734238|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
56734239|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56734241|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56734242|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56734243|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
56734244|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734245|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734303|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56734305|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
56734306|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
56734307|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
56734308|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734309|NCT00752180|Insulin|insulin|mesh-list
56538062|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538063|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56538064|NCT02779153|Hormones|hormones|mesh-ancestor
56538065|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56538066|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538067|NCT04226443|Midazolam|midazolam|mesh-list
56538068|NCT04226443|Remifentanil|remifentanil|mesh-list
56538069|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56538070|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56538071|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538072|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538073|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56538074|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56538075|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56538076|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56538077|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
56538078|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
56538079|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
56538080|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
56538081|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538082|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538083|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56538084|NCT04226443|Narcotics|narcotics|mesh-ancestor
56538085|NCT04226443|Analgesics|analgesics|mesh-ancestor
56538086|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
56538087|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538088|NCT02776891|Citric Acid|citric acid|mesh-list
56538089|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
56538090|NCT02776891|Gallium citrate|gallium citrate|mesh-list
56538091|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
56538109|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
56538110|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538111|NCT02773147|Pyridoxine|pyridoxine|mesh-list
56734310|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56734311|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56734312|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734313|NCT00784290|Orantinib|orantinib|mesh-list
56734314|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56734315|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734316|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734317|NCT00752414|Levofloxacin|levofloxacin|mesh-list
56734318|NCT00752414|Ofloxacin|ofloxacin|mesh-list
56734319|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56734320|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734321|NCT00752414|Renal Agents|renal agents|mesh-ancestor
56734322|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56734323|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56734324|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56734351|NCT03374956|Liraglutide|liraglutide|mesh-list
56734352|NCT03374956|Topiramate|topiramate|mesh-list
56734353|NCT03374956|Phentermine|phentermine|mesh-list
56734354|NCT03374956|Naltrexone|naltrexone|mesh-list
56734355|NCT03374956|Bupropion|bupropion|mesh-list
56734356|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56734357|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56734358|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734359|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
56734360|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734361|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56734362|NCT03374956|Incretins|incretins|mesh-ancestor
56734363|NCT03374956|Hormones|hormones|mesh-ancestor
56734364|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734365|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56734366|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
56734367|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734368|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56734369|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56734370|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56734371|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734372|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
56734373|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734407|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56734408|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
56734409|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56734410|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
56734411|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007038|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
56734477|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734478|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56734479|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734480|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734481|NCT03989557|Aspirin|aspirin|mesh-list
56734482|NCT03989557|Clopidogrel|clopidogrel|mesh-list
56734483|NCT03989557|Ticagrelor|ticagrelor|mesh-list
56734484|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56734485|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56734486|NCT03989557|Analgesics|analgesics|mesh-ancestor
56734487|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
56734488|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734489|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734490|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734491|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734492|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56734493|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56734494|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007115|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
56734526|NCT00540514|Paclitaxel|paclitaxel|mesh-list
56734527|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56734528|NCT00540514|Carboplatin|carboplatin|mesh-list
56734529|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56734530|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734531|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
56734532|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
56538112|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
56538113|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
56538114|NCT02773147|Hematinics|hematinics|mesh-ancestor
56538115|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
56538116|NCT02773147|Vitamins|vitamins|mesh-ancestor
56538117|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
56538118|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538119|NCT02773927|Metformin|metformin|mesh-list
56538120|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56538121|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538122|NCT02773459|Capecitabine|capecitabine|mesh-list
56538123|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56538124|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
56538125|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734533|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
56734534|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734535|NCT00663702|Abatacept|abatacept|mesh-list
56734536|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56734537|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734565|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56734566|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56734567|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734568|NCT03290794|Aflibercept|aflibercept|mesh-list
56734569|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56734570|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56734571|NCT03290794|Growth Substances|growth substances|mesh-ancestor
56734572|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734573|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
56734574|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734575|NCT03816358|Gemcitabine|gemcitabine|mesh-list
56734576|NCT03816358|Nivolumab|nivolumab|mesh-list
56734577|NCT03816358|Ipilimumab|ipilimumab|mesh-list
56734578|NCT03816358|Maytansine|maytansine|mesh-list
56734579|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56734580|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
56734581|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734582|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734583|NCT03816358|Antiviral Agents|antiviral agents|mesh-ancestor
56734584|NCT03816358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734585|NCT03816358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734586|NCT03816358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734623|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56734624|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56734625|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56734626|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56734652|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56734654|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734655|NCT04058522|Triamcinolone|triamcinolone|mesh-list
56734656|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734657|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
56734658|NCT04058522|Hormones|hormones|mesh-ancestor
56734659|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734660|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734661|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56734662|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56734663|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56734664|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734665|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734666|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734667|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56734668|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56538126|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538127|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
56538128|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56538129|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56538130|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538131|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56538132|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56538133|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538134|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538135|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538136|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56734669|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
56734670|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734671|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734672|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56734673|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56007301|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
56734709|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56007387|NCT04882072|Ustekinumab|ustekinumab|mesh-list
56734779|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56734781|NCT00663234|Atorvastatin|atorvastatin|mesh-list
56734782|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56734783|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56734784|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
56734785|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734786|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56734787|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56734822|NCT00326911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734823|NCT00326911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734824|NCT00326911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734825|NCT00326911|Immunologic Factors|immunologic factors|mesh-ancestor
56734826|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56734827|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56734857|NCT00796458|Docetaxel|docetaxel|mesh-list
56734858|NCT00796458|Hormones|hormones|mesh-list
56734859|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734860|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
56734861|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
56734862|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
56734863|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734864|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734865|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734866|NCT04046016|Paclitaxel|paclitaxel|mesh-list
56734867|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56734868|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734869|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
56734870|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
56734871|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
56734900|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734901|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734902|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56734903|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734904|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
56734905|NCT00796692|Heparin|heparin|mesh-list
56734906|NCT00796692|Calcium heparin|calcium heparin|mesh-list
56734907|NCT00796692|Nadroparin|nadroparin|mesh-list
56734908|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
56734909|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56734910|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56734911|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734912|NCT00540436|Ambrisentan|ambrisentan|mesh-list
56538137|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
56538138|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56538139|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538140|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56538141|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56538142|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56538143|NCT04771741|Acetaminophen|acetaminophen|mesh-list
56538144|NCT04771741|Ketorolac|ketorolac|mesh-list
56538145|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56538146|NCT04771741|Meloxicam|meloxicam|mesh-list
56538147|NCT04771741|Pregabalin|pregabalin|mesh-list
56538148|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
56734913|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56734914|NCT00788580|Sirolimus|sirolimus|mesh-list
56734915|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56734916|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734917|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56734955|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56734956|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56734985|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734986|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734987|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734988|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56734989|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734990|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56734991|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
56734992|NCT00990496|Fludarabine|fludarabine|mesh-list
56734993|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734994|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
56734995|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734996|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734997|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56734998|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
56734999|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735000|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735001|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56735031|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56735032|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735033|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735087|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56735088|NCT00662532|Minocycline|minocycline|mesh-list
56735089|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735090|NCT00792324|Efavirenz|efavirenz|mesh-list
56735091|NCT00792324|Etravirine|etravirine|mesh-list
56735092|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56735093|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56735094|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735127|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56735128|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56735129|NCT04003792|Growth Substances|growth substances|mesh-ancestor
56735130|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735131|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
56735133|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
56735134|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
56735166|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56735167|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56735168|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
56735169|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56735170|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56735171|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56735172|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735173|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735174|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
56735175|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56538149|NCT04771741|Analgesics|analgesics|mesh-ancestor
56538150|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
56538151|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538152|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538153|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
56735176|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
56735177|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735178|NCT00539188|Expectorants|expectorants|mesh-ancestor
56735179|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
56007826|NCT00002920|Tamoxifen|tamoxifen|mesh-list
56735216|NCT00326599|Gemcitabine|gemcitabine|mesh-list
56735217|NCT00326599|Carboplatin|carboplatin|mesh-list
56446338|NCT00294086|Valsartan|valsartan|mesh-list
56735248|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735249|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735250|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56735251|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
56735252|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56735253|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56735254|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735255|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56735256|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
56735257|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56735258|NCT00685802|Protective Agents|protective agents|mesh-ancestor
56735259|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56735260|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56735261|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735262|NCT01054651|Artesunate|artesunate|mesh-list
56735263|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
56735264|NCT01054651|Sulfalene|sulfalene|mesh-list
56735299|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735300|NCT00750620|Mirabegron|mirabegron|mesh-list
56735301|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56735302|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56735303|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56735304|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
56735305|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007940|NCT02945800|Paclitaxel|paclitaxel|mesh-list
56735335|NCT03827473|Vitamins|vitamins|mesh-ancestor
56735336|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
56735337|NCT03827473|Estrogens|estrogens|mesh-ancestor
56735338|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
56735339|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
56735340|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
56735341|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56735342|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56735343|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735344|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735345|NCT00800592|Urological Agents|urological agents|mesh-ancestor
56735346|NCT00797784|Etanercept|etanercept|mesh-list
56735347|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56735348|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56735349|NCT00797784|Analgesics|analgesics|mesh-ancestor
56735350|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
56735351|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735352|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735386|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735387|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56735388|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56735389|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56735390|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735391|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56735392|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
56735393|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56735394|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735396|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56735397|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56735398|NCT00326209|Analgesics|analgesics|mesh-ancestor
56735464|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735465|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
56735466|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56538154|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56538155|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56735467|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735468|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735469|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56735470|NCT00800826|Analgesics|analgesics|mesh-ancestor
56735471|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
56735472|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735473|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56735474|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56735475|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56735476|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
56735477|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735478|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735479|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
56008104|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
56735513|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
56735514|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735515|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735516|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56735517|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
56735518|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
56735519|NCT01055041|Hormones|hormones|mesh-ancestor
56735520|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735545|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735547|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56735548|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735549|NCT00748436|Betahistine|betahistine|mesh-list
56735550|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
56735551|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
56735552|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
56735553|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735554|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735555|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735556|NCT00756860|Sevelamer|sevelamer|mesh-list
56735557|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
56735558|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
56735559|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735560|NCT00757016|Triamcinolone|triamcinolone|mesh-list
56735561|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56735562|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56735563|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56735564|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735565|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
56735566|NCT00757016|Hormones|hormones|mesh-ancestor
56735567|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735568|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735569|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735601|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56735602|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735603|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735604|NCT00660816|Docetaxel|docetaxel|mesh-list
56735605|NCT00660816|Pemetrexed|pemetrexed|mesh-list
56735606|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56735607|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735608|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
56735609|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
56735610|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
56735611|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735612|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735613|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56735614|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56735647|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735649|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56735650|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56735651|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735652|NCT00344461|Tenofovir|tenofovir|mesh-list
56735653|NCT00344461|Nevirapine|nevirapine|mesh-list
56735654|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
56735655|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735656|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56538156|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538157|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56538158|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56538159|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56538160|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538161|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56735683|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56735684|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56735685|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56735686|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56735687|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
56735688|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56735689|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56735692|NCT00933309|Exemestane|exemestane|mesh-list
56735693|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56735694|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735695|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735696|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56735697|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56735698|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735699|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735700|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56735701|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
56735702|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735703|NCT00352885|Citalopram|citalopram|mesh-list
56735704|NCT00352885|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56735705|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56735706|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56735737|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735738|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56735739|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56735740|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56735741|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735742|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735743|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
56735744|NCT00933465|Loperamide|loperamide|mesh-list
56735745|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
56735746|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56735747|NCT00757874|Clobetasol|clobetasol|mesh-list
56735748|NCT00757874|Tacrolimus|tacrolimus|mesh-list
56735749|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008382|NCT00002998|Gemcitabine|gemcitabine|mesh-list
56735775|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56735776|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56735777|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56735778|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735779|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
56735780|NCT00801450|Hormones|hormones|mesh-ancestor
56735781|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735782|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735783|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735784|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
56735785|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735786|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735787|NCT00801528|Diclofenac|diclofenac|mesh-list
56735788|NCT00801528|Ropivacaine|ropivacaine|mesh-list
56735789|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
56735790|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
56735791|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735792|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735793|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
56735794|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735795|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56735796|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56735797|NCT00801528|Analgesics|analgesics|mesh-ancestor
56735798|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473653|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
56538162|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56538163|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56538164|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56538165|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56538166|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56538167|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538168|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
56538169|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56538170|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56538171|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
56538172|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56538173|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56286422|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
56735828|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735829|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
56735830|NCT05360602|Vitamins|vitamins|mesh-ancestor
56735831|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
56735832|NCT00991744|Cytarabine|cytarabine|mesh-list
56735833|NCT00991744|Cortisone|cortisone|mesh-list
56735834|NCT00991744|Prednisolone|prednisolone|mesh-list
56735835|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56735836|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
56735837|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56735838|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
56735839|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56735840|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
56735841|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56735842|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
56735843|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735844|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735872|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735874|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56735875|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56735876|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735877|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735878|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56735879|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56735880|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56735881|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
56735882|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735883|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735884|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56735885|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56735886|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
56735887|NCT00991822|Timolol|timolol|mesh-list
56735888|NCT00991822|Dorzolamide|dorzolamide|mesh-list
56735889|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56735890|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56735891|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
56008522|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
56735942|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
56735943|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735944|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
56735945|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735946|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56735947|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56735948|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
56735949|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735950|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735951|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56735952|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56735953|NCT00934323|Metformin|metformin|mesh-list
56538174|NCT02772601|Metoprolol|metoprolol|mesh-list
56538175|NCT02772601|Midazolam|midazolam|mesh-list
56538176|NCT02772601|Caffeine|caffeine|mesh-list
56538177|NCT02772601|Omeprazole|omeprazole|mesh-list
56538178|NCT02772601|Warfarin|warfarin|mesh-list
56538179|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56538180|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56538181|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538182|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538183|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56538184|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56538185|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56538186|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56538187|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
56538188|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
56538189|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
56538190|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
56735954|NCT00934323|Glimepiride|glimepiride|mesh-list
56735991|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
56735992|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736030|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
56736031|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736032|NCT00571688|Risperidone|risperidone|mesh-list
56008674|NCT00003562|Carboplatin|carboplatin|mesh-list
56736099|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
56736100|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56736101|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56736102|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736103|NCT05407636|Aflibercept|aflibercept|mesh-list
56736104|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56736105|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56736106|NCT05407636|Growth Substances|growth substances|mesh-ancestor
56736107|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736108|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
56736109|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736111|NCT00658788|Clobetasol|clobetasol|mesh-list
56736143|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736144|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56736145|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
56736146|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736147|NCT00799890|Protective Agents|protective agents|mesh-ancestor
56736148|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736149|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56736150|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56736151|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736186|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
56736187|NCT00562965|Rituximab|rituximab|mesh-list
56736188|NCT00562965|Fludarabine|fludarabine|mesh-list
56736189|NCT00562965|Vincristine|vincristine|mesh-list
56736190|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
56736191|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56736192|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736193|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
56736224|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736225|NCT00794898|Infliximab|infliximab|mesh-list
56736226|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
56736227|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736228|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736229|NCT00800280|Cimetidine|cimetidine|mesh-list
56736230|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56736231|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736232|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56736233|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
56736234|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
56538191|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538192|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538193|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
56538194|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56538195|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56538196|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538197|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56538198|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56538199|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
56192403|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
56736235|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736236|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008873|NCT00062738|Paroxetine|paroxetine|mesh-list
56736284|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56736285|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56736286|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56736287|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56736288|NCT00794976|Dexamethasone|dexamethasone|mesh-list
56736289|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
56736290|NCT00794976|BB 1101|bb 1101|mesh-list
56736291|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736292|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
56736293|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
56736294|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736295|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736296|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736297|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
56736298|NCT00794976|Hormones|hormones|mesh-ancestor
56736299|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736300|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56736301|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736302|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
56736303|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736304|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736337|NCT00324961|Adefovir|adefovir|mesh-list
56736338|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56736339|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
56736340|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56736341|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56736342|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56736343|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736344|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736345|NCT00941109|Decitabine|decitabine|mesh-list
56736366|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736367|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56736368|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
56736369|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
56736370|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56736371|NCT00935571|Narcotics|narcotics|mesh-ancestor
56736372|NCT00935571|Analgesics|analgesics|mesh-ancestor
56736373|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
56736374|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736375|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56736376|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56736377|NCT00324649|Lamivudine|lamivudine|mesh-list
56736378|NCT00324649|Zidovudine|zidovudine|mesh-list
56736379|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56736380|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56736381|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56736382|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736383|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736384|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
56736385|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538200|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56538201|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56538202|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56538203|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56538204|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56538205|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
56538206|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
56538207|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538208|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56538209|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56538210|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56538211|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
56538212|NCT02772211|Cycloserine|cycloserine|mesh-list
56538213|NCT02772211|Ketamine|ketamine|mesh-list
56192405|NCT01480869|Vitamin D|vitamin d|mesh-list
56736386|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56736387|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56736388|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
56736389|NCT03743259|Charcoal|charcoal|mesh-list
56736390|NCT03743259|Antidotes|antidotes|mesh-ancestor
56736391|NCT03743259|Protective Agents|protective agents|mesh-ancestor
56736392|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736393|NCT03983239|Efavirenz|efavirenz|mesh-list
56736394|NCT03983239|Rifampin|rifampin|mesh-list
56736395|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56736396|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56736397|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009019|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736426|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56736427|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736428|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56736429|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56736430|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56736431|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736432|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56736433|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
56736434|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
56736435|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56736436|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56736437|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56736438|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
56736439|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736440|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56736441|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56736479|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736480|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56736481|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56736482|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
56736483|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56736484|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56736555|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736556|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009211|NCT00003172|Docetaxel|docetaxel|mesh-list
56736584|NCT03988075|Acetaminophen|acetaminophen|mesh-list
56736585|NCT03988075|Ibuprofen|ibuprofen|mesh-list
56736586|NCT03988075|Hydrocodone|hydrocodone|mesh-list
56736587|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56736588|NCT03988075|Analgesics|analgesics|mesh-ancestor
56736589|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
56736590|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736591|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538214|NCT02772211|Analgesics|analgesics|mesh-ancestor
56538215|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
56538216|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538217|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538218|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56538219|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56538220|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
56538221|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
56538222|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538223|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56538224|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56538225|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538226|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538227|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56538228|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538229|NCT02772211|Renal Agents|renal agents|mesh-ancestor
56538230|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56538231|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
56538232|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56538233|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
56538234|NCT04225195|Amphotericin B|amphotericin b|mesh-list
56538235|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56538236|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
56538237|NCT04225195|Amebicides|amebicides|mesh-ancestor
56538238|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56538239|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56192421|NCT01481194|Dexamethasone|dexamethasone|mesh-list
56736592|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
56736593|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56736594|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736595|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736596|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56736597|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736598|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736599|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56736600|NCT03988075|Narcotics|narcotics|mesh-ancestor
56009240|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736636|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56736637|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
56736638|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736639|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
56736640|NCT02559908|Protective Agents|protective agents|mesh-ancestor
56736641|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56736692|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56736693|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
56736694|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56736695|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
56538240|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538241|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56538242|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
56538243|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56538244|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
56538245|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634294|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
56538246|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538247|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56538248|NCT04225195|Protective Agents|protective agents|mesh-ancestor
56538249|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538250|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538251|NCT02771509|Mitogens|mitogens|mesh-list
56538252|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
56538253|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538254|NCT02696941|Metformin|metformin|mesh-list
56538255|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56538256|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56538257|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538258|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736696|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736697|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736698|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56736699|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56736700|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736701|NCT00537316|Azathioprine|azathioprine|mesh-list
56736702|NCT00537316|Infliximab|infliximab|mesh-list
56736703|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
56736704|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736705|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736706|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
56736707|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736708|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56736709|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736710|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736711|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
56736712|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736713|NCT00803868|Varenicline|varenicline|mesh-list
56736714|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56736715|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56736716|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
56736717|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736718|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736719|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736720|NCT00655980|Folic Acid|folic acid|mesh-list
56736721|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
56736753|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56736754|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736755|NCT00809796|Pentamidine|pentamidine|mesh-list
56736756|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
56736757|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538259|NCT02767375|Fluorouracil|fluorouracil|mesh-list
56538260|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
56538261|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
56538262|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538263|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56538264|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538265|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56538266|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
56538267|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538268|NCT02767219|Dexamethasone|dexamethasone|mesh-list
56538269|NCT02767219|Bevacizumab|bevacizumab|mesh-list
56538270|NCT02767219|Fluorouracil|fluorouracil|mesh-list
56538271|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56538272|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538273|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56538274|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56538275|NCT02767219|Growth Substances|growth substances|mesh-ancestor
56538276|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538277|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
56538278|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56538279|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
56538280|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
56538281|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538282|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56538283|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
56538284|NCT02767219|Hormones|hormones|mesh-ancestor
56538285|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56538286|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56538287|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
56538288|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538289|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56538290|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56538291|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
56538292|NCT02771587|Ethanol|ethanol|mesh-list
56538293|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56538294|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538296|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538297|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
56538298|NCT02771743|Ifosfamide|ifosfamide|mesh-list
56538299|NCT02771743|Carboplatin|carboplatin|mesh-list
56538300|NCT02771743|Doxorubicin|doxorubicin|mesh-list
56538301|NCT02771743|Etoposide|etoposide|mesh-list
56538302|NCT02771743|Interleukin-2|interleukin-2|mesh-list
56538303|NCT02771743|Isotretinoin|isotretinoin|mesh-list
56538304|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56538305|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
56538306|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538307|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56538308|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56538309|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
56538310|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538311|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538312|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56736758|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56736759|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56736760|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56736761|NCT05589454|Calcium, Dietary|calcium, dietary|mesh-list
56736762|NCT05589454|Atorvastatin|atorvastatin|mesh-list
56736763|NCT05589454|Calcium|calcium|mesh-list
56736764|NCT05589454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56736765|NCT05589454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736766|NCT05589454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56009411|NCT00003664|Gemcitabine|gemcitabine|mesh-list
56736801|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56736802|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56736803|NCT00809874|Caseins|caseins|mesh-list
56736804|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
56736805|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
56736806|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736839|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56736840|NCT00921830|Ibuprofen|ibuprofen|mesh-list
56736841|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56736842|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56736843|NCT00921830|Analgesics|analgesics|mesh-ancestor
56736844|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
56736845|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736846|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736847|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56009493|NCT00003214|Carboplatin|carboplatin|mesh-list
56736882|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736884|NCT05589220|Nicotine|nicotine|mesh-list
56736885|NCT05589220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56736886|NCT05589220|Autonomic Agents|autonomic agents|mesh-ancestor
56736887|NCT05589220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736917|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56736918|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
56736919|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736921|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
56736922|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736923|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736924|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736925|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
56736926|NCT00309907|Hormones|hormones|mesh-ancestor
56736927|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736928|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56736929|NCT00309907|Protective Agents|protective agents|mesh-ancestor
56538313|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56538314|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56538315|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56538316|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538317|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56538318|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56538319|NCT02771743|Analgesics|analgesics|mesh-ancestor
56538320|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
56538321|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538322|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
56538324|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
56736930|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56736931|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736959|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736960|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56736961|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736962|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736964|NCT00575588|Saxagliptin|saxagliptin|mesh-list
56736965|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56736966|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736967|NCT00575588|Incretins|incretins|mesh-ancestor
56736968|NCT00575588|Hormones|hormones|mesh-ancestor
56736969|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736970|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56736971|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
56736972|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736973|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736974|NCT01058317|Propranolol|propranolol|mesh-list
56736975|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56736976|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56737002|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56737003|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56737004|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56737005|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56737006|NCT00761228|Apomorphine|apomorphine|mesh-list
56737007|NCT00761228|Emetics|emetics|mesh-ancestor
56737008|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737009|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
56737010|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737011|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56737012|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
56737013|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
56737014|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737015|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737016|NCT00758732|Carboplatin|carboplatin|mesh-list
56448132|NCT00304811|Vancomycin|vancomycin|mesh-list
56737017|NCT00758732|Docetaxel|docetaxel|mesh-list
56737018|NCT00758732|Doxorubicin|doxorubicin|mesh-list
56737019|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56737020|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737021|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
56737022|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
56737023|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
56737024|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737025|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56737053|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56737054|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56737055|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737056|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737057|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737058|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56737059|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
56538325|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538326|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
56538328|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
56538329|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538330|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
56538331|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538332|NCT04756063|Protective Agents|protective agents|mesh-ancestor
56538333|NCT02767063|Pioglitazone|pioglitazone|mesh-list
56538334|NCT02767063|Avelumab|avelumab|mesh-list
56538335|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56538336|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538337|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56538338|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538339|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
56538340|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56538341|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
56538342|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538343|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538344|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56538345|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
56538346|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56538347|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
56538348|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538349|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538350|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56192537|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
56737060|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56737061|NCT00759200|Interferons|interferons|mesh-list
56737062|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
56737063|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
56737064|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737065|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
56737066|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737067|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
56737068|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737069|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
56737070|NCT02558816|Venetoclax|venetoclax|mesh-list
56737071|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56009716|NCT00003262|Etoposide|etoposide|mesh-list
56737103|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56737104|NCT02559440|Protective Agents|protective agents|mesh-ancestor
56737105|NCT00674570|Cycloserine|cycloserine|mesh-list
56737106|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
56737107|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56737108|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56737109|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737110|NCT00674570|Renal Agents|renal agents|mesh-ancestor
56737111|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56737112|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
56538351|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
56538352|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
56538353|NCT04224103|Protective Agents|protective agents|mesh-ancestor
56737113|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56737114|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
56622930|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737138|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56737139|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
56737140|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
56737141|NCT00940953|Hormones|hormones|mesh-ancestor
56737142|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56737143|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56737144|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737145|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737146|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56737147|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56737148|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56737149|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
56737150|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
56737151|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737152|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
56737153|NCT00759824|Doxorubicin|doxorubicin|mesh-list
56737154|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56737155|NCT00759824|Vindesine|vindesine|mesh-list
56737156|NCT00759824|Valproic Acid|valproic acid|mesh-list
56737157|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737158|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
56737159|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737160|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56737161|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56737162|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
56737163|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737164|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009822|NCT00003712|Sirolimus|sirolimus|mesh-list
56737197|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737198|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737199|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56737200|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56737201|NCT00762632|Everolimus|everolimus|mesh-list
56737202|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737203|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737204|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
56737205|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737235|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737237|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737238|NCT00941343|Alfuzosin|alfuzosin|mesh-list
56737239|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56737240|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56737241|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56737242|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
56737243|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737244|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56448347|NCT00329628|Enoxaparin|enoxaparin|mesh-list
56737245|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737247|NCT00561795|Paclitaxel|paclitaxel|mesh-list
56737248|NCT00561795|Carboplatin|carboplatin|mesh-list
56737249|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56737250|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737251|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
56737252|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
56737253|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
56737289|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
56737290|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737291|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56737292|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737293|NCT00941499|Antidotes|antidotes|mesh-ancestor
56737294|NCT00941499|Protective Agents|protective agents|mesh-ancestor
56737295|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
56737316|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
56737317|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737318|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56448421|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
56473654|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
56538354|NCT02766439|Etanercept|etanercept|mesh-list
56538355|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56538356|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56538357|NCT02766439|Analgesics|analgesics|mesh-ancestor
56538358|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
56538359|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538360|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538361|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56538362|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070679|NCT01969201|Hormones|hormones|mesh-list
56737319|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56737320|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
56737321|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56737322|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
56737323|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737324|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737325|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56737326|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
56737327|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
56737328|NCT00945789|Protective Agents|protective agents|mesh-ancestor
56737329|NCT00945789|Hematinics|hematinics|mesh-ancestor
56737330|NCT00941811|Imiquimod|imiquimod|mesh-list
56737331|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56737332|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
56737333|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737334|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737335|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
56737336|NCT02553018|Methotrexate|methotrexate|mesh-list
56737337|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56737338|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
56737339|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56737340|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737341|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56737342|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
56737343|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737344|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737345|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
56737346|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737347|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56737348|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737349|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
56737350|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56737351|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56737386|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
56737387|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737388|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737389|NCT00338455|Protective Agents|protective agents|mesh-ancestor
56737390|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
56737391|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56737392|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
56010047|NCT00003316|Gemcitabine|gemcitabine|mesh-list
56737423|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737424|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737426|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
56737427|NCT00942201|Hormones|hormones|mesh-ancestor
56737428|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56737429|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56737430|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737431|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
56737432|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737433|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737434|NCT00942435|Darexaban|darexaban|mesh-list
56737435|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56737436|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
56737437|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56538363|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56538364|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56538365|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
56538366|NCT04701307|Niraparib|niraparib|mesh-list
56737484|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737485|NCT00762944|Cimetidine|cimetidine|mesh-list
56737486|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56737487|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56737488|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56737489|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
56737490|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
56737491|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737492|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737493|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737494|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56737495|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56737526|NCT00678080|Metformin|metformin|mesh-list
56737527|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56737528|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737529|NCT00658320|Cyclosporine|cyclosporine|mesh-list
56737530|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
56737531|NCT00658320|Everolimus|everolimus|mesh-list
56737532|NCT00658320|Cyclosporins|cyclosporins|mesh-list
56737533|NCT00658320|Basiliximab|basiliximab|mesh-list
56737534|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737535|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737536|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737537|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
56737538|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737539|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
56737570|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
56737571|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56737572|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737573|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737574|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56737575|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56737576|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
56737577|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
56737578|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737579|NCT00764816|Caseins|caseins|mesh-list
56737580|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
56737581|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
56622931|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737650|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56737651|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737682|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
56737683|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56737684|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56737685|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56737686|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
56737687|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737689|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737690|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
56737691|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
56737692|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
56737693|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737694|NCT00763880|Lidocaine|lidocaine|mesh-list
56737746|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56737747|NCT00646776|Rifabutin|rifabutin|mesh-list
56737748|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56737749|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56737750|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
56737751|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737752|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737753|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56737754|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56737755|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
56737756|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737757|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56010413|NCT00003370|Irofulven|irofulven|mesh-list
56737791|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56737792|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538367|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
56538368|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
56538369|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
56737793|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737794|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
56737795|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
56737796|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56737797|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
56737798|NCT00811122|Corticosterone|corticosterone|mesh-list
56737831|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737832|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56737833|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56737834|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56737835|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737836|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56737837|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56737838|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56737873|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737875|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56737876|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
56737877|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56737904|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
56737905|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
56737906|NCT00764582|Levofloxacin|levofloxacin|mesh-list
56737907|NCT00764582|Ofloxacin|ofloxacin|mesh-list
56737908|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56737909|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56737910|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56737911|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737912|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56737913|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56737914|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737915|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737916|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737917|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56737918|NCT00764582|Renal Agents|renal agents|mesh-ancestor
56737919|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56737920|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56737921|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
56737922|NCT04048226|Ketamine|ketamine|mesh-list
56737923|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56737924|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737953|NCT04048070|Analgesics|analgesics|mesh-ancestor
56737954|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
56737955|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737956|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56737957|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56737958|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
56737959|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
56737960|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56737961|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56737962|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56737963|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56737964|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56737965|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737966|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737968|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56737969|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737982|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56737983|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
56737984|NCT00775034|Coagulants|coagulants|mesh-ancestor
56737985|NCT00813696|Gemcitabine|gemcitabine|mesh-list
56737986|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737987|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56737988|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
56737989|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737990|NCT00813696|Antiviral Agents|antiviral agents|mesh-ancestor
56737991|NCT00813696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737992|NCT00813696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737993|NCT00813696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737994|NCT00813696|Immunologic Factors|immunologic factors|mesh-ancestor
56737995|NCT00813696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737996|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
56737997|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56538370|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538371|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56538372|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538373|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737998|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
56737999|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738000|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56738002|NCT02557490|Raltitrexed|raltitrexed|mesh-list
56738003|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738004|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56738005|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
56738006|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738007|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56738008|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738009|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
56738010|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56738011|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56738012|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56738013|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56738014|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56738015|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738016|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
56738017|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738018|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738019|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56738020|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738021|NCT00807534|Bromides|bromides|mesh-list
56738022|NCT00807534|Ipratropium|ipratropium|mesh-list
56738023|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
56738024|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56738025|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
56738026|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738027|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738028|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56738029|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
56738030|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56738031|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
56738032|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56010670|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
56738052|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738053|NCT00814086|Paclitaxel|paclitaxel|mesh-list
56738054|NCT00814086|Cisplatin|cisplatin|mesh-list
56738055|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56738056|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738057|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
56738058|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
56738059|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
56738060|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738061|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56738062|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56738063|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56738064|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56738065|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738066|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738067|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738068|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
56738069|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56738070|NCT00654732|Rituximab|rituximab|mesh-list
56738071|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56738072|NCT00654732|Doxorubicin|doxorubicin|mesh-list
56738073|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56738074|NCT00654732|Dacarbazine|dacarbazine|mesh-list
56738075|NCT00654732|Bleomycin|bleomycin|mesh-list
56738076|NCT00654732|Vinblastine|vinblastine|mesh-list
56738077|NCT00654732|Antibodies|antibodies|mesh-list
56738078|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
56738079|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56738080|NCT00654732|Imidazole|imidazole|mesh-list
56738081|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
56738082|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538374|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538375|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
56538376|NCT02765971|Cathartics|cathartics|mesh-ancestor
56192589|NCT01481870|Growth Substances|growth substances|mesh-ancestor
56738083|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738084|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56738085|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56738086|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56738087|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56738088|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010734|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738122|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56738124|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738125|NCT00767468|Sorafenib|sorafenib|mesh-list
56738126|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738127|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56010793|NCT00004906|Etoposide|etoposide|mesh-list
56738155|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738156|NCT00654498|Pramipexole|pramipexole|mesh-list
56738157|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
56738158|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738159|NCT00654498|Protective Agents|protective agents|mesh-ancestor
56738160|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738161|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56738162|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56738163|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
56738164|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
56738165|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738166|NCT00670046|Valproic Acid|valproic acid|mesh-list
56738167|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
56738168|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738169|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738170|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
56738205|NCT00560391|Growth Substances|growth substances|mesh-ancestor
56738206|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
56738207|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56738208|NCT00775736|Insulin|insulin|mesh-list
56738209|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56738210|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
56738211|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
56738212|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56738234|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56738235|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56738236|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738237|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56738238|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
56738239|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
56738240|NCT03982771|Bortezomib|bortezomib|mesh-list
56738241|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738242|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
56738243|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738244|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56738245|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56738246|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
56738247|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738248|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738249|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56738250|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56738251|NCT00775814|Candesartan|candesartan|mesh-list
56738252|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56738253|NCT00775814|Diuretics|diuretics|mesh-ancestor
56738254|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
56738255|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738256|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56738257|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56738258|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738259|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56738260|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56738261|NCT00942747|Sirolimus|sirolimus|mesh-list
56738262|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738263|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738300|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538377|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56538378|NCT02765815|Ketorolac|ketorolac|mesh-list
56538379|NCT02765815|Epinephrine|epinephrine|mesh-list
56538380|NCT02765815|Racepinephrine|racepinephrine|mesh-list
56538381|NCT02765815|Morphine|morphine|mesh-list
56010974|NCT05776290|Hyaluronic Acid|hyaluronic acid|mesh-list
56738329|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738330|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56738331|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738332|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738333|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
56738334|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738335|NCT00772616|Sufentanil|sufentanil|mesh-list
56738336|NCT00772616|Remifentanil|remifentanil|mesh-list
56738337|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56738338|NCT00772616|Narcotics|narcotics|mesh-ancestor
56738339|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738340|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738341|NCT00772616|Analgesics|analgesics|mesh-ancestor
56738342|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
56738343|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738344|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56738345|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56738346|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
56738347|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
56738348|NCT05488678|Ceftibuten|ceftibuten|mesh-list
56738349|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738380|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56738381|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56738382|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
56738383|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
56738384|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738385|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738386|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738387|NCT00943293|Fludarabine|fludarabine|mesh-list
56738388|NCT00943293|Melphalan|melphalan|mesh-list
56738389|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
56738390|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738391|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738392|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738425|NCT00776438|Vaccines|vaccines|mesh-list
56738426|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
56738427|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738428|NCT00943449|Sorafenib|sorafenib|mesh-list
56738429|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738430|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56738431|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738432|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738433|NCT00952029|Leucovorin|leucovorin|mesh-list
56738434|NCT00952029|Bevacizumab|bevacizumab|mesh-list
56738435|NCT00952029|Fluorouracil|fluorouracil|mesh-list
56738470|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56738472|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738473|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738474|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
56011147|NCT05775289|Paclitaxel|paclitaxel|mesh-list
56738507|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56738508|NCT00535132|Risperidone|risperidone|mesh-list
56738509|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56738510|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56738511|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
56011173|NCT05774964|Folic Acid|folic acid|mesh-list
56738548|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
56622933|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56738615|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738652|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56738653|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
56011349|NCT05635227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56738707|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56738708|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56738709|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
56738710|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56738711|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738776|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538382|NCT02765815|Bupivacaine|bupivacaine|mesh-list
56538383|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
56538384|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
56538385|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
56538386|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538387|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538388|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
56538389|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538390|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56538391|NCT02765815|Narcotics|narcotics|mesh-ancestor
56538392|NCT02765815|Analgesics|analgesics|mesh-ancestor
56538393|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56192594|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
56738777|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56738778|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
56738779|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56738780|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56738781|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738782|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56738783|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
56738784|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56738785|NCT00773630|Protective Agents|protective agents|mesh-ancestor
56738786|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56738787|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56738788|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738789|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56738790|NCT04016922|Hematinics|hematinics|mesh-ancestor
56738791|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
56738792|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56738849|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738850|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738851|NCT00762359|Lansoprazole|lansoprazole|mesh-list
56738852|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
56738853|NCT00762359|Gefarnate|gefarnate|mesh-list
56738854|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56738855|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56738856|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56738890|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738891|NCT03275818|Paclitaxel|paclitaxel|mesh-list
56738892|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56738893|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738894|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
56738895|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
56738911|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738912|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
56738913|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56738914|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738915|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
56738916|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56738917|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56738918|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738919|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
56738920|NCT04100447|Coagulants|coagulants|mesh-ancestor
56738921|NCT03274804|Maraviroc|maraviroc|mesh-list
56738922|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
56738923|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56738924|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738925|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56738926|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56738927|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738928|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56738929|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56738930|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
56538394|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56538395|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
56538396|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538397|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389279|NCT00469768|Dapivirine|dapivirine|mesh-list
56538398|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56538399|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56538400|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
56538401|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56538402|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
56538403|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
56538404|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
56538405|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56192607|NCT01482117|Cilostazol|cilostazol|mesh-list
56738931|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738932|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56738933|NCT00761891|Aspirin|aspirin|mesh-list
56738934|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56738935|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56738936|NCT00761891|Analgesics|analgesics|mesh-ancestor
56738937|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
56738938|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738939|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738940|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56738941|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56011652|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738974|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738976|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738977|NCT00321685|Antidotes|antidotes|mesh-ancestor
56738978|NCT00321685|Protective Agents|protective agents|mesh-ancestor
56738979|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
56738980|NCT00321685|Vitamins|vitamins|mesh-ancestor
56738981|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
56738982|NCT00321685|Hematinics|hematinics|mesh-ancestor
56738983|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
56738984|NCT00777998|Thalidomide|thalidomide|mesh-list
56738985|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739043|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739045|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56739046|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56739047|NCT00774488|Incretins|incretins|mesh-ancestor
56739048|NCT00774488|Hormones|hormones|mesh-ancestor
56739049|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739050|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739051|NCT01066195|Pemetrexed|pemetrexed|mesh-list
56739052|NCT01066195|Gefitinib|gefitinib|mesh-list
56739053|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739054|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739055|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739056|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56739057|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56739058|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56739059|NCT00774644|Clarithromycin|clarithromycin|mesh-list
56739060|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56739061|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739062|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56739063|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739064|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739065|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56739066|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56739108|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56538406|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56538407|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56538408|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56538409|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56538410|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56538411|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538412|NCT02765347|Metformin|metformin|mesh-list
56538413|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56538414|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538415|NCT02770885|Dulaglutide|dulaglutide|mesh-list
56538416|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56538417|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538418|NCT02770651|Everolimus|everolimus|mesh-list
56538419|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538420|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56538421|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
56739109|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56739110|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
56739111|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739112|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739142|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739143|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739144|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56739145|NCT04001374|Ticagrelor|ticagrelor|mesh-list
56739146|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56739147|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56739148|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56739149|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56739150|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
56739151|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739152|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739153|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739154|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
56739155|NCT05265910|Loratadine|loratadine|mesh-list
56739156|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56739157|NCT05265910|Dextrans|dextrans|mesh-list
56739188|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56739189|NCT00991978|Growth Substances|growth substances|mesh-ancestor
56739190|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739191|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
56739193|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739194|NCT00645528|Insulin|insulin|mesh-list
56739195|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56739196|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739197|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56739198|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
56739199|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739200|NCT00812448|Protective Agents|protective agents|mesh-ancestor
56739201|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739202|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56739229|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56739231|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56739232|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739233|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56739234|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739235|NCT00808314|Dipyridamole|dipyridamole|mesh-list
56739236|NCT00808314|Regadenoson|regadenoson|mesh-list
56739237|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56538422|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538423|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
56538424|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56192636|NCT01482299|Everolimus|everolimus|mesh-list
56739238|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739239|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739240|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56739241|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
56739242|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56739243|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56739244|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
56739245|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
56739246|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739247|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739248|NCT04992052|Bone wax|bone wax|mesh-list
56739249|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
56739250|NCT04992052|Coagulants|coagulants|mesh-ancestor
56011959|NCT04779320|Vedolizumab|vedolizumab|mesh-list
56739284|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739285|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56739286|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
56739287|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
56739288|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739289|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739290|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
56739291|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739292|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56739293|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
56739329|NCT00779792|Protective Agents|protective agents|mesh-ancestor
56739330|NCT00779792|Emollients|emollients|mesh-ancestor
56739331|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
56739332|NCT00992134|Cytarabine|cytarabine|mesh-list
56739333|NCT00992134|Rituximab|rituximab|mesh-list
56739334|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56012052|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
56739365|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739367|NCT00815022|Morphine|morphine|mesh-list
56739368|NCT00815022|Bupivacaine|bupivacaine|mesh-list
56739369|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
56739370|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
56739371|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56739372|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739373|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
56739374|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739375|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56739404|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56739406|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
56739407|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739408|NCT04045548|Dinoprostone|dinoprostone|mesh-list
56739409|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
56739410|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56739411|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739412|NCT00780104|Cytarabine|cytarabine|mesh-list
56739413|NCT00780104|Sirolimus|sirolimus|mesh-list
56739414|NCT00780104|Etoposide|etoposide|mesh-list
56739415|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
56739416|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56739417|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739418|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56739419|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56739420|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739421|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739422|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012157|NCT04569747|Tamoxifen|tamoxifen|mesh-list
56739487|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739488|NCT00812994|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56739489|NCT00812994|Antidepressive Agents|antidepressive agents|mesh-ancestor
56739490|NCT00812994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56739491|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56739492|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56739493|NCT00784394|Protective Agents|protective agents|mesh-ancestor
56739494|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538425|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56538426|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538427|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56538428|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56538429|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538430|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538431|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739495|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739497|NCT00305695|Imidazole|imidazole|mesh-list
56739498|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56739499|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739500|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739501|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739502|NCT00784472|Morphine|morphine|mesh-list
56739503|NCT00784472|Oxycodone|oxycodone|mesh-list
56739504|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56739533|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56739534|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
56739535|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
56739536|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739537|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739538|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56739539|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
56739540|NCT03978559|Hormones|hormones|mesh-ancestor
56739541|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739542|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56739543|NCT03978559|Protective Agents|protective agents|mesh-ancestor
56739544|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56739545|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739546|NCT03978559|Renal Agents|renal agents|mesh-ancestor
56739547|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
56739548|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56739549|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56739550|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56739551|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739552|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739553|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56739554|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56739581|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739582|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739583|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56739584|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56739586|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
56739587|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56739588|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739589|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56739590|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739591|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56739592|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56739593|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56739594|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739595|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
56739596|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56739597|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
56739598|NCT00815568|Fludarabine|fludarabine|mesh-list
56739599|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
56739600|NCT00815568|Busulfan|busulfan|mesh-list
56739601|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739602|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56739603|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
56739635|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739637|NCT01062139|Levocetirizine|levocetirizine|mesh-list
56739638|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56739639|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56739640|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
56739641|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
56473655|NCT05145218|Paclitaxel|paclitaxel|mesh-list
56538432|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56538433|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
56538434|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56538435|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538436|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56538437|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56538438|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56538439|NCT02770261|Candesartan|candesartan|mesh-list
56538440|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
56538441|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56538442|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56538443|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56538444|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
56538445|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538446|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56538447|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56538448|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538449|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56739642|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739643|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739644|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739670|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
56739672|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
56739673|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56739674|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
56739675|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739676|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56739677|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56739678|NCT01664182|Growth Substances|growth substances|mesh-ancestor
56739679|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739680|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
56739681|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
56739682|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56739683|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739684|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739685|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
56739686|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
56739687|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56739688|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56739689|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739690|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739691|NCT00780728|Urological Agents|urological agents|mesh-ancestor
56739692|NCT00809172|Cyclosporine|cyclosporine|mesh-list
56739730|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56739819|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56739820|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56739821|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739822|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
56739823|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
56739824|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
56739825|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56739826|NCT00775684|Exenatide|exenatide|mesh-list
56739827|NCT00775684|Glimepiride|glimepiride|mesh-list
56739828|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56739829|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739830|NCT00775684|Incretins|incretins|mesh-ancestor
56538450|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56538451|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56538452|NCT02770105|Caffeine|caffeine|mesh-list
56538453|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56538454|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538455|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56538456|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538457|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538458|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56538459|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56538460|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
56192666|NCT01482416|Estrogens|estrogens|mesh-list
56739831|NCT00775684|Hormones|hormones|mesh-ancestor
56739832|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739833|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56739834|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
56739835|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739836|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739837|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56739838|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56739839|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012575|NCT02856594|Analgesics|analgesics|mesh-ancestor
56739873|NCT00998920|Hormones|hormones|mesh-ancestor
56739874|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739875|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739876|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
56739877|NCT00992758|Antibodies|antibodies|mesh-list
56739878|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
56739879|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739880|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739881|NCT00641706|Bortezomib|bortezomib|mesh-list
56739882|NCT00641706|Vorinostat|vorinostat|mesh-list
56739883|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739884|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56012630|NCT02342782|Cytarabine|cytarabine|mesh-list
56740075|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56740076|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56740077|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56740078|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56740079|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
56740080|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
56740081|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
56740082|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
56740083|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740084|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740085|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
56740086|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
56740087|NCT00994006|Levulinic acid|levulinic acid|mesh-list
56740088|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740122|NCT00627042|Ramucirumab|ramucirumab|mesh-list
56740123|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56740124|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740125|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
56740126|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740127|NCT00319111|Bosentan|bosentan|mesh-list
56012868|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
56740192|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56740193|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
56740194|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56740226|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740227|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740228|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56538461|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538462|NCT02769793|Levodopa|levodopa|mesh-list
56538463|NCT02769793|Benserazide|benserazide|mesh-list
56538464|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
56538465|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56538466|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56538467|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
56538468|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192676|NCT01482468|Palonosetron|palonosetron|mesh-list
56740229|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56740230|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56740231|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740232|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56740233|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56740234|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740235|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
56740236|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
56740237|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56740270|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740271|NCT01064557|Tretinoin|tretinoin|mesh-list
56740272|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740273|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
56740274|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740275|NCT01001962|Metformin|metformin|mesh-list
56740276|NCT01001962|Empagliflozin|empagliflozin|mesh-list
56740277|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56740278|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740279|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56740301|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740302|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740303|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
56740304|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56740305|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56740306|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740307|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56740308|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56740309|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56740310|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740311|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56740312|NCT00994942|Morphine|morphine|mesh-list
56740313|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56740314|NCT00994942|Narcotics|narcotics|mesh-ancestor
56740315|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740316|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740317|NCT00994942|Analgesics|analgesics|mesh-ancestor
56740318|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
56740319|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740320|NCT01002898|Ritonavir|ritonavir|mesh-list
56740321|NCT01002898|Lopinavir|lopinavir|mesh-list
56740322|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56740323|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56740324|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
56740325|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740326|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740327|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56740328|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56740329|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
56740330|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740331|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56740332|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56740365|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
56740366|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740367|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740368|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56740369|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56740370|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
56740371|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538469|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389348|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
56634295|NCT00939185|Azithromycin|azithromycin|mesh-list
56538470|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538472|NCT02769325|Ketorolac|ketorolac|mesh-list
56538473|NCT02769325|Atropine|atropine|mesh-list
56538474|NCT02769325|Morphine|morphine|mesh-list
56538475|NCT02769325|Propofol|propofol|mesh-list
56538476|NCT02769325|Sevoflurane|sevoflurane|mesh-list
56538477|NCT02769325|Rocuronium|rocuronium|mesh-list
56286720|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
56538478|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56538479|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538480|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538481|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56538482|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
56538484|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56538485|NCT02769325|Narcotics|narcotics|mesh-ancestor
56538486|NCT02769325|Analgesics|analgesics|mesh-ancestor
56538487|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
56538488|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538489|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56538490|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56538491|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56538492|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56538493|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740372|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56740373|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56740374|NCT01004380|Carboplatin|carboplatin|mesh-list
56013113|NCT00004192|Hormones|hormones|mesh-ancestor
56740456|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740457|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56740458|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56740459|NCT00768755|Pemetrexed|pemetrexed|mesh-list
56740460|NCT00768755|Axitinib|axitinib|mesh-list
56740461|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740462|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740463|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740464|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56740465|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56740466|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56740468|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740469|NCT00530842|Fluticasone|fluticasone|mesh-list
56740470|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
56740471|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56740520|NCT05733598|Atezolizumab|atezolizumab|mesh-list
56740521|NCT05733598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56740522|NCT05733598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740523|NCT05733598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56740524|NCT05733598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56538494|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56538495|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56538496|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538497|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538498|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56538499|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56538500|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56538501|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56740525|NCT05733598|Growth Substances|growth substances|mesh-ancestor
56740526|NCT05733598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740527|NCT05733598|Growth Inhibitors|growth inhibitors|mesh-ancestor
56740528|NCT05733364|Vitamin B Complex|vitamin b complex|mesh-list
56740529|NCT05733364|Vitamins|vitamins|mesh-ancestor
56740530|NCT05733364|Micronutrients|micronutrients|mesh-ancestor
56740531|NCT05733364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740532|NCT01006720|Neostigmine|neostigmine|mesh-list
56740533|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56740534|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013273|NCT00005578|Prednisone|prednisone|mesh-list
56740570|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
56740571|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
56740572|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740573|NCT05732506|Edoxaban|edoxaban|mesh-list
56013321|NCT00386230|Zidovudine|zidovudine|mesh-list
56740655|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740656|NCT00816660|Factor VIII|factor viii|mesh-list
56740657|NCT00816660|Coagulants|coagulants|mesh-ancestor
56740658|NCT05713630|Tranexamic Acid|tranexamic acid|mesh-list
56740659|NCT05713630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56740660|NCT05713630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56740661|NCT05713630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740662|NCT05713630|Hemostatics|hemostatics|mesh-ancestor
56740663|NCT05713630|Coagulants|coagulants|mesh-ancestor
56740664|NCT00819000|Interferon-beta|interferon-beta|mesh-list
56740665|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
56740666|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
56740667|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
56740668|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56740669|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
56740670|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740699|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56740700|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740701|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740703|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
56740704|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56740705|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56740706|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740707|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
56740708|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740709|NCT01008046|Expectorants|expectorants|mesh-ancestor
56740710|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
56740711|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56740712|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
56740713|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740714|NCT01008046|Protective Agents|protective agents|mesh-ancestor
56740715|NCT01008046|Antidotes|antidotes|mesh-ancestor
56740716|NCT00317473|Vaccines|vaccines|mesh-list
56740717|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
56740781|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740782|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740783|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56740784|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56740785|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
56740786|NCT01008358|Tremelimumab|tremelimumab|mesh-list
56740787|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740788|NCT01008592|Levocetirizine|levocetirizine|mesh-list
56740789|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56740790|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56538502|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56538503|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56538504|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
56073249|NCT05065736|Clofarabine|clofarabine|mesh-list
56740791|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
56740792|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
56740793|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740794|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740795|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740796|NCT01062529|Somatostatin|somatostatin|mesh-list
56740797|NCT01062529|Hormones|hormones|mesh-ancestor
56740798|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740799|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013538|NCT00005614|Gemcitabine|gemcitabine|mesh-list
56740837|NCT05559112|Vitamins|vitamins|mesh-ancestor
56451955|NCT00322166|Calcium|calcium|mesh-list
56740868|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56740869|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740870|NCT00316225|Pemetrexed|pemetrexed|mesh-list
56740871|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740872|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740873|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740874|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56740875|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56740876|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
56740877|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56740878|NCT00636168|Ipilimumab|ipilimumab|mesh-list
56013622|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56740902|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740904|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56740905|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740906|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56740907|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56740908|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56740909|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56740910|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56740911|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740913|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740914|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740915|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56740916|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740917|NCT00779675|Infliximab|infliximab|mesh-list
56740918|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740919|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56740920|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56740921|NCT04102943|Tacrolimus|tacrolimus|mesh-list
56740922|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56740923|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
56740924|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740925|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56740926|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740927|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740928|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56013660|NCT00030992|Promethazine|promethazine|mesh-list
56740962|NCT05774249|Bupivacaine|bupivacaine|mesh-list
56740963|NCT05774249|Anesthetics, Local|anesthetics, local|mesh-ancestor
56740964|NCT05774249|Anesthetics|anesthetics|mesh-ancestor
56740965|NCT05774249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740966|NCT05774249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740967|NCT05774249|Sensory System Agents|sensory system agents|mesh-ancestor
56740968|NCT05774249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740969|NCT05774236|Dinoprostone|dinoprostone|mesh-list
56740970|NCT05774236|Oxytocics|oxytocics|mesh-ancestor
56740971|NCT05774236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56013710|NCT00004390|Analgesics|analgesics|mesh-ancestor
56740996|NCT05774028|Immunologic Factors|immunologic factors|mesh-ancestor
56740997|NCT05774028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56740998|NCT05774028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56740999|NCT05774028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56741001|NCT05774028|Sensory System Agents|sensory system agents|mesh-ancestor
56741002|NCT05774015|Magnesium Oxide|magnesium oxide|mesh-list
56741003|NCT05774015|Antacids|antacids|mesh-ancestor
56538505|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56538506|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
56538507|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
56538508|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
56741004|NCT05774015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741005|NCT05774015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56741006|NCT05773989|Clopidogrel|clopidogrel|mesh-list
56741007|NCT05773989|Ticagrelor|ticagrelor|mesh-list
56741008|NCT05773989|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56741009|NCT05773989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741010|NCT05773989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741011|NCT05773989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56741012|NCT05773989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56741013|NCT05773989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56741014|NCT05773989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56741015|NCT05773989|Purinergic Agents|purinergic agents|mesh-ancestor
56741016|NCT05773989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741017|NCT05773911|Chitosan|chitosan|mesh-list
56741018|NCT05773911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56741019|NCT05773911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56741020|NCT05773911|Antimetabolites|antimetabolites|mesh-ancestor
56741021|NCT05773911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741022|NCT05773911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56013757|NCT00004426|Leuprolide|leuprolide|mesh-list
56741054|NCT05773664|Glucocorticoids|glucocorticoids|mesh-ancestor
56741055|NCT05773664|Hormones|hormones|mesh-ancestor
56741056|NCT05773664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741057|NCT05773664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56741058|NCT05773664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741059|NCT05773664|Protease Inhibitors|protease inhibitors|mesh-ancestor
56741060|NCT05773664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741061|NCT05773664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741062|NCT05773664|Dermatologic Agents|dermatologic agents|mesh-ancestor
56741063|NCT05773365|Anesthetics|anesthetics|mesh-list
56741064|NCT05773365|Anesthetics, Local|anesthetics, local|mesh-list
56741065|NCT05773365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741066|NCT05773365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741067|NCT05773365|Sensory System Agents|sensory system agents|mesh-ancestor
56741068|NCT05773365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741069|NCT05773326|Sirolimus|sirolimus|mesh-list
56741106|NCT05767398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56741120|NCT05742438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56741121|NCT05742438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56741122|NCT05742438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741123|NCT05742438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56741124|NCT05742438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56741125|NCT05742438|Analgesics|analgesics|mesh-ancestor
56741126|NCT05742438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56741127|NCT05742438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56741128|NCT05742438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56741129|NCT05742438|Adrenergic Agents|adrenergic agents|mesh-ancestor
56741130|NCT05742438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741131|NCT05742438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56741132|NCT05742438|Narcotics|narcotics|mesh-ancestor
56741133|NCT05732051|Niacinamide|niacinamide|mesh-list
56741134|NCT05732051|Niacin|niacin|mesh-list
56741135|NCT05732051|Nicotinic Acids|nicotinic acids|mesh-list
56741136|NCT05732051|Vitamin B Complex|vitamin b complex|mesh-ancestor
56741137|NCT05732051|Vitamins|vitamins|mesh-ancestor
56741138|NCT05732051|Micronutrients|micronutrients|mesh-ancestor
56741139|NCT05732051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741140|NCT05732051|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56741141|NCT05732051|Antimetabolites|antimetabolites|mesh-ancestor
56741142|NCT05732051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741143|NCT05732051|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56741144|NCT05732051|Vasodilator Agents|vasodilator agents|mesh-ancestor
56741145|NCT05712278|Cytarabine|cytarabine|mesh-list
56741146|NCT05712278|Fludarabine|fludarabine|mesh-list
56741147|NCT05712278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741148|NCT05712278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56741149|NCT05712278|Antimetabolites|antimetabolites|mesh-ancestor
56063515|NCT02210559|Paclitaxel|paclitaxel|mesh-list
56538509|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56538510|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56538511|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
56538512|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538513|NCT04224649|Lidocaine|lidocaine|mesh-list
56538514|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
56538515|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
56538516|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
56192727|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741150|NCT05712278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741151|NCT05712278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741152|NCT05712278|Immunologic Factors|immunologic factors|mesh-ancestor
56741153|NCT05712278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741154|NCT05712278|Antiviral Agents|antiviral agents|mesh-ancestor
56741155|NCT05712278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741156|NCT05709977|Histamine Antagonists|histamine antagonists|mesh-list
56741157|NCT05709977|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56741158|NCT05709977|Histamine Agents|histamine agents|mesh-ancestor
56741159|NCT05709977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741160|NCT05709977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741161|NCT05709977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741162|NCT05696782|Durvalumab|durvalumab|mesh-list
56741163|NCT05696782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741164|NCT05696782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741165|NCT05695027|Niacinamide|niacinamide|mesh-list
56741166|NCT05695027|Niacin|niacin|mesh-list
56741167|NCT05695027|Nicotinic Acids|nicotinic acids|mesh-list
56741168|NCT05695027|Vitamin B Complex|vitamin b complex|mesh-ancestor
56741169|NCT05695027|Vitamins|vitamins|mesh-ancestor
56741199|NCT05667922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741201|NCT05667909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741202|NCT05667909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741203|NCT05667909|Immunologic Factors|immunologic factors|mesh-ancestor
56741204|NCT05667909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741205|NCT05667909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741206|NCT05667896|Tacrolimus|tacrolimus|mesh-list
56741207|NCT05667896|Glucocorticoids|glucocorticoids|mesh-list
56741208|NCT05667896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741209|NCT05667896|Immunologic Factors|immunologic factors|mesh-ancestor
56741210|NCT05667896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741211|NCT05667896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56741212|NCT05667896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741213|NCT05667896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741282|NCT05592613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56741283|NCT05585398|Botulinum Toxins|botulinum toxins|mesh-list
56741284|NCT05585398|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56741285|NCT05585398|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56741286|NCT05585398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56741287|NCT05585398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56741288|NCT05585398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56741289|NCT05585398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741290|NCT05585398|Cholinergic Agents|cholinergic agents|mesh-ancestor
56741291|NCT05585398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741292|NCT05585398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741293|NCT05585398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56741294|NCT05585398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741316|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56741317|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56741318|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
56741319|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741320|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741321|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741322|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56741323|NCT05554627|Aripiprazole|aripiprazole|mesh-list
56741324|NCT05554627|Esketamine|esketamine|mesh-list
56741325|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
56741326|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56538517|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538518|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741327|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56741328|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56741329|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741330|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741331|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
56741332|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
56741333|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741334|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741335|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56741336|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56741337|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
56741338|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56741339|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56741340|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56741341|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56741342|NCT05554380|Paclitaxel|paclitaxel|mesh-list
56741343|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56741344|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56741345|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741389|NCT05525247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741391|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
56741392|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741393|NCT05476770|Cytarabine|cytarabine|mesh-list
56741394|NCT05476770|Dexamethasone|dexamethasone|mesh-list
56741395|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
56741396|NCT05476770|Methotrexate|methotrexate|mesh-list
56741397|NCT05476770|Fludarabine|fludarabine|mesh-list
56741398|NCT05476770|Vincristine|vincristine|mesh-list
56741399|NCT05476770|Azacitidine|azacitidine|mesh-list
56741400|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56741401|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
56741402|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
56741403|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741404|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741405|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56741406|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
56741407|NCT05476770|Hormones|hormones|mesh-ancestor
56741408|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741409|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56741410|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741411|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56741412|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
56741413|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56741414|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56741415|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
56741416|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741417|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
56741435|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
56741436|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741437|NCT05471947|Glycolic acid|glycolic acid|mesh-list
56741438|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
56741439|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
56741440|NCT05468320|Prednisone|prednisone|mesh-list
56741441|NCT05468320|Prednisolone|prednisolone|mesh-list
56741442|NCT05468320|Antibodies|antibodies|mesh-list
56741443|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
56741444|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741445|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741446|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56741447|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
56741448|NCT05468320|Hormones|hormones|mesh-ancestor
56741449|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741450|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56741451|NCT05458401|Trastuzumab|trastuzumab|mesh-list
56741452|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741453|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741454|NCT05453500|Prednisone|prednisone|mesh-list
56741455|NCT05453500|Cortisone|cortisone|mesh-list
56741456|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
56741457|NCT05453500|Rituximab|rituximab|mesh-list
56741458|NCT05453500|Doxorubicin|doxorubicin|mesh-list
56741459|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56538519|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
56538520|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538521|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56538522|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56538523|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56538524|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56538525|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538526|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56538527|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
56538528|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
56538529|NCT04224649|Protective Agents|protective agents|mesh-ancestor
56538530|NCT02769169|Ranibizumab|ranibizumab|mesh-list
56538531|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56741460|NCT05453500|Etoposide|etoposide|mesh-list
56741461|NCT05453500|Vincristine|vincristine|mesh-list
56741462|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
56741463|NCT05453500|Daunorubicin|daunorubicin|mesh-list
56741464|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
56741465|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56741466|NCT05453500|Antibodies|antibodies|mesh-list
56741467|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
56741468|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56741469|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741470|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
56741471|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741472|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741473|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56741474|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
56741475|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741476|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741477|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56741478|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56741479|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56741501|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741502|NCT05430074|Calpastatin|calpastatin|mesh-list
56741503|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56741504|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
56741505|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741506|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741507|NCT05418972|Nivolumab|nivolumab|mesh-list
56741508|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741509|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741510|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56741511|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452632|NCT04714242|Ranibizumab|ranibizumab|mesh-list
56741512|NCT05414136|Trastuzumab|trastuzumab|mesh-list
56741513|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741514|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741520|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56741521|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56741522|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56741523|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741524|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741525|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56741526|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56741527|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56741528|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56741529|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
56741530|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063621|NCT00003141|Lenograstim|lenograstim|mesh-list
56538532|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56538533|NCT02769169|Growth Substances|growth substances|mesh-ancestor
56538534|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538535|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
56538536|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538537|NCT02769013|Praziquantel|praziquantel|mesh-list
56538538|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
56538539|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56538540|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538541|NCT02768545|Ezetimibe|ezetimibe|mesh-list
56538542|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56538543|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56538544|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
56741531|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741532|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56741557|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741558|NCT05325281|Antiviral Agents|antiviral agents|mesh-ancestor
56741559|NCT05325281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741560|NCT05325281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741561|NCT05325281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741562|NCT05325281|Immunologic Factors|immunologic factors|mesh-ancestor
56741563|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741564|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
56741565|NCT05325281|Protective Agents|protective agents|mesh-ancestor
56741566|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
56741567|NCT05325281|Vitamins|vitamins|mesh-ancestor
56741568|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
56741569|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56741570|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741571|NCT05303064|Olanzapine|olanzapine|mesh-list
56741572|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
56741573|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
56741574|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741575|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741576|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56741577|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56741578|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56741579|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741580|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56741581|NCT05303064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56741582|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56741583|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56014309|NCT01407523|Levetiracetam|levetiracetam|mesh-list
56741615|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
56741616|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741617|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56741618|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56741619|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741620|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741621|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56741622|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
56741623|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741624|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741625|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56014359|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56741654|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56741655|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56741656|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741657|NCT05241873|Carboplatin|carboplatin|mesh-list
56741658|NCT05241873|Pemetrexed|pemetrexed|mesh-list
56741659|NCT05241873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741660|NCT05241873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538545|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741661|NCT05241873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741662|NCT05241873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56741663|NCT05241873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56741667|NCT05236673|Empagliflozin|empagliflozin|mesh-list
56741668|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56741703|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741705|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56741706|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
56741707|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014392|NCT01411501|Mosapride|mosapride|mesh-list
56741723|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56741724|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56741725|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56741726|NCT05201248|Growth Substances|growth substances|mesh-ancestor
56741727|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
56741728|NCT05195996|Propranolol|propranolol|mesh-list
56741729|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56741730|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56741731|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56741732|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741733|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452869|NCT00426933|Vancomycin|vancomycin|mesh-list
56741734|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741736|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56741737|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
56741738|NCT05194397|Niacinamide|niacinamide|mesh-list
56741739|NCT05194397|Niacin|niacin|mesh-list
56741740|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
56741741|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
56741742|NCT05194397|Vitamins|vitamins|mesh-ancestor
56741743|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
56741744|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741745|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56741746|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
56741747|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741748|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56741749|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
56741750|NCT05178862|Fluconazole|fluconazole|mesh-list
56741751|NCT05178862|Caspofungin|caspofungin|mesh-list
56741752|NCT05178862|Micafungin|micafungin|mesh-list
56741753|NCT05178862|Anidulafungin|anidulafungin|mesh-list
56741754|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
56741755|NCT05178862|Echinocandins|echinocandins|mesh-list
56741756|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
56741757|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741758|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56741759|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56741760|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741761|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741762|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56741763|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
56741764|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741765|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741766|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56452926|NCT00425841|Gemcitabine|gemcitabine|mesh-list
56741808|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741809|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56741810|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56741811|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56741812|NCT05101564|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56741813|NCT05076617|Alprazolam|alprazolam|mesh-list
56741814|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56741815|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741845|NCT05061550|Antimitotic Agents|antimitotic agents|mesh-ancestor
56741846|NCT05061550|Mitosis Modulators|mitosis modulators|mesh-ancestor
56741847|NCT05061550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741848|NCT05061550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741849|NCT05061550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56741850|NCT05061550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56741851|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741853|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
56538546|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56538548|NCT02764723|Ropivacaine|ropivacaine|mesh-list
56538549|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
56538550|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
56538551|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538552|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538553|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
56538554|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538555|NCT04664959|Denosumab|denosumab|mesh-list
56538556|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56538557|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538558|NCT00951496|Paclitaxel|paclitaxel|mesh-list
56538559|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56538560|NCT00951496|Bevacizumab|bevacizumab|mesh-list
56538561|NCT00951496|Cisplatin|cisplatin|mesh-list
56538562|NCT00951496|Carboplatin|carboplatin|mesh-list
56741854|NCT05047172|Clopidogrel|clopidogrel|mesh-list
56741855|NCT05047172|Ticagrelor|ticagrelor|mesh-list
56741856|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56741857|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56741858|NCT05047172|Analgesics|analgesics|mesh-ancestor
56741859|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
56741860|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741861|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741862|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56741924|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741925|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741926|NCT04995029|Analgesics|analgesics|mesh-ancestor
56741927|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
56741928|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741929|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56741930|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56741931|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56741932|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56741933|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741964|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
56741965|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
56741985|NCT04972552|Ubiquinone|ubiquinone|mesh-list
56741986|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
56741987|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
56741988|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741989|NCT04972552|Vitamins|vitamins|mesh-ancestor
56741990|NCT04936685|Vaccines|vaccines|mesh-list
56741991|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
56741992|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741993|NCT04924699|Trastuzumab|trastuzumab|mesh-list
56741994|NCT04924699|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56741995|NCT04924699|Maytansine|maytansine|mesh-list
56741996|NCT04924699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741997|NCT04924699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741998|NCT04924699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56741999|NCT04924699|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742000|NCT04924699|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742001|NCT04924699|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742002|NCT04924699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742003|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56742004|NCT04915729|Tenecteplase|tenecteplase|mesh-list
56742005|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56742006|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56742007|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742008|NCT04907539|Denosumab|denosumab|mesh-list
56742009|NCT04907539|Nivolumab|nivolumab|mesh-list
56538563|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56538564|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
56538565|NCT00951496|Antibodies|antibodies|mesh-list
56538566|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
56538567|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56538568|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
56538569|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56538570|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538571|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
56538572|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
56538573|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
56538574|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538575|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56192778|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
56742010|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742011|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742012|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56742013|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742014|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56742015|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742016|NCT04907227|Dexamethasone|dexamethasone|mesh-list
56742017|NCT04907227|Prednisone|prednisone|mesh-list
56742018|NCT04907227|Docetaxel|docetaxel|mesh-list
56742019|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
56742020|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56742021|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
56742022|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
56742047|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742049|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56742050|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56742051|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742052|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742053|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742054|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
56742055|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56742056|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
56742057|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56742058|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56742059|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56742060|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
56742061|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56742062|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742063|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56742064|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56742065|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56742066|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56742067|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742068|NCT04877288|Cyclosporine|cyclosporine|mesh-list
56742069|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
56742070|NCT04877288|Abatacept|abatacept|mesh-list
56742071|NCT04877288|Tacrolimus|tacrolimus|mesh-list
56742072|NCT04877288|Cyclosporins|cyclosporins|mesh-list
56742073|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742101|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
56742102|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
56742103|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742104|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742105|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56742106|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
56742108|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742109|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56538576|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56538577|NCT00951496|Growth Substances|growth substances|mesh-ancestor
56538578|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538579|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
56538580|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
56538581|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56538582|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56538583|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56538584|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56742110|NCT04873583|Protective Agents|protective agents|mesh-ancestor
56742111|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56742112|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742113|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56742114|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742115|NCT04830397|Timolol|timolol|mesh-list
56742116|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742117|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56742118|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56742119|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
56742164|NCT04776993|Methimazole|methimazole|mesh-list
56742165|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
56742166|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
56742167|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742168|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742169|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
56742170|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56742171|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56742172|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56742173|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56742174|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56742175|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742176|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
56742177|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56742178|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742179|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56742180|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742181|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56742182|NCT04750954|Peposertib|peposertib|mesh-list
56742183|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742184|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56742185|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742186|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742204|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742205|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56742206|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742207|NCT04702893|Nintedanib|nintedanib|mesh-list
56742208|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742209|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742210|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742211|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742226|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
56742227|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
56742228|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56742229|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742230|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742231|NCT04671875|Antibodies|antibodies|mesh-list
56742232|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56742233|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
56742234|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742235|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
56742236|NCT04664972|Docetaxel|docetaxel|mesh-list
56742237|NCT04664972|Doxorubicin|doxorubicin|mesh-list
56742238|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742239|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
56538585|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56538586|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
56538587|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538588|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538589|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538590|NCT02768077|Melatonin|melatonin|mesh-list
56538591|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
56538592|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538593|NCT02768077|Protective Agents|protective agents|mesh-ancestor
56538594|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538595|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56742240|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742241|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742242|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56742243|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
56742244|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742245|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742246|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56742247|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742248|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742249|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742250|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56742251|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56742252|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56742253|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742276|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742277|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
56742278|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56742279|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
56742280|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742281|NCT04632069|Expectorants|expectorants|mesh-ancestor
56742282|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
56742283|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56742284|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
56742285|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742286|NCT04632069|Protective Agents|protective agents|mesh-ancestor
56742287|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742288|NCT04632069|Antidotes|antidotes|mesh-ancestor
56742289|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
56742290|NCT04618913|Apixaban|apixaban|mesh-list
56742291|NCT04618913|Edoxaban|edoxaban|mesh-list
56742292|NCT04618913|Dabigatran|dabigatran|mesh-list
56742293|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56742294|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
56742295|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56742296|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
56742297|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742298|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742299|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
56742300|NCT04616196|Cetuximab|cetuximab|mesh-list
56742301|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742302|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742303|NCT04613518|BMS-986165|bms-986165|mesh-list
56742304|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
56742305|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742306|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742307|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742414|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742416|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742417|NCT04429555|Ibudilast|ibudilast|mesh-list
56742418|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56742419|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
56742420|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538596|NCT01193244|Prednisone|prednisone|mesh-list
56538597|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56538598|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
56538599|NCT01193244|Hormones|hormones|mesh-ancestor
56192810|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742421|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742422|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56742423|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
56742424|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56742450|NCT04379596|Capecitabine|capecitabine|mesh-list
56742451|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
56742452|NCT04379596|Trastuzumab|trastuzumab|mesh-list
56742453|NCT04379596|Durvalumab|durvalumab|mesh-list
56742454|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742455|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742456|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
56742457|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742458|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742459|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742460|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
56742461|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742462|NCT04374799|Heparin|heparin|mesh-list
56742463|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
56742464|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56742465|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56742466|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742467|NCT04367311|Docetaxel|docetaxel|mesh-list
56742468|NCT04367311|Pemetrexed|pemetrexed|mesh-list
56742469|NCT04367311|Atezolizumab|atezolizumab|mesh-list
56742470|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742471|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742472|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742538|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56742539|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742540|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742541|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742542|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742544|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56742545|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742546|NCT04252742|Analgesics|analgesics|mesh-ancestor
56742547|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
56742548|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742549|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742550|NCT04241185|Gemcitabine|gemcitabine|mesh-list
56742551|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
56742552|NCT04241185|Fluorouracil|fluorouracil|mesh-list
56742553|NCT04241185|Mitomycins|mitomycins|mesh-list
56742554|NCT04241185|Mitomycin|mitomycin|mesh-list
56742588|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56742589|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742590|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56742591|NCT04210115|Antidotes|antidotes|mesh-ancestor
56742592|NCT04210115|Protective Agents|protective agents|mesh-ancestor
56742593|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
56742594|NCT04210115|Vitamins|vitamins|mesh-ancestor
56742595|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
56742596|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
56742613|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
56742614|NCT04194359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742615|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742616|NCT04194359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56742617|NCT04194359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56742618|NCT04194359|Growth Substances|growth substances|mesh-ancestor
56742619|NCT04194359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742620|NCT04194359|Growth Inhibitors|growth inhibitors|mesh-ancestor
56742621|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742622|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
56742623|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742624|NCT04192955|Salicylates|salicylates|mesh-list
56742625|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56742626|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56742627|NCT04192955|Analgesics|analgesics|mesh-ancestor
56538600|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56538601|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538602|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56742628|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
56742629|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742630|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742631|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56742632|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742633|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56742634|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742635|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742641|NCT04172532|Peposertib|peposertib|mesh-list
56742642|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742643|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742644|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742645|NCT04118010|Vitamin D|vitamin d|mesh-list
56742646|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
56742647|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
56742648|NCT04118010|Vitamins|vitamins|mesh-list
56742649|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
56742650|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742651|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56742652|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56742653|NCT04113863|Anastrozole|anastrozole|mesh-list
56742654|NCT04113863|Tretinoin|tretinoin|mesh-list
56742655|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56742688|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
56742689|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56742690|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56742691|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56742692|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56742693|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56742694|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742695|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
56742696|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56742718|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
56742719|NCT03952637|Hormones|hormones|mesh-ancestor
56742720|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742721|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56742722|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56742723|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742724|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56742725|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
56742726|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742727|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
56742728|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
56742729|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742730|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56742731|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56742732|NCT03952637|Protective Agents|protective agents|mesh-ancestor
56742733|NCT03944941|Cetuximab|cetuximab|mesh-list
56742734|NCT03944941|Avelumab|avelumab|mesh-list
56742735|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742736|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742737|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
56742738|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742739|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742743|NCT03921866|Palbociclib|palbociclib|mesh-list
56742744|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742745|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742746|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742747|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742748|NCT03919955|Oxybutynin|oxybutynin|mesh-list
56742749|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56742750|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56742769|NCT03919071|Dabrafenib|dabrafenib|mesh-list
56742770|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56742771|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742772|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742773|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740583|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
56538603|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742774|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742775|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56742776|NCT03919071|Protective Agents|protective agents|mesh-ancestor
56742777|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742778|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56742779|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
56742780|NCT03885089|Infliximab|infliximab|mesh-list
56742781|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
56742782|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56742783|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742784|NCT03884439|Infliximab|infliximab|mesh-list
56742785|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
56742786|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56742787|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742789|NCT03864042|Midazolam|midazolam|mesh-list
56742790|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
56742791|NCT03864042|Caffeine|caffeine|mesh-list
56742792|NCT03864042|Modafinil|modafinil|mesh-list
56742793|NCT03864042|Bupropion|bupropion|mesh-list
56742794|NCT03864042|Omeprazole|omeprazole|mesh-list
56742795|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56742796|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56742797|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56742798|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56742799|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742800|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56742801|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56742802|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56742803|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56742804|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
56742805|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
56742806|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
56742807|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
56742808|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56742809|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742838|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56742840|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
56742841|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56742842|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56742843|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
56742844|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742845|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742846|NCT03765918|Cisplatin|cisplatin|mesh-list
56742847|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
56742848|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742849|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742850|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56742913|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
56742914|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742915|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742916|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56742917|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
56742918|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742919|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742920|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56742921|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742922|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
56742923|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
56742924|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742925|NCT03640481|Belumosudil|belumosudil|mesh-list
56742926|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742927|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742928|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742929|NCT03637660|Penicillins|penicillins|mesh-list
56742930|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56742931|NCT03637660|Penicillin G|penicillin g|mesh-list
56015610|NCT00265850|Hematinics|hematinics|mesh-ancestor
56742967|NCT03598257|Olaparib|olaparib|mesh-list
56742968|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56742969|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742970|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742971|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742972|NCT03581292|Temozolomide|temozolomide|mesh-list
56742973|NCT03581292|Veliparib|veliparib|mesh-list
56743008|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56743009|NCT03530371|Analgesics|analgesics|mesh-ancestor
56538604|NCT02768389|Bevacizumab|bevacizumab|mesh-list
56538605|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56538606|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538607|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56538608|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56538609|NCT02768389|Growth Substances|growth substances|mesh-ancestor
56538610|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538611|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
56538612|NCT04224337|Doxorubicin|doxorubicin|mesh-list
56538613|NCT04224337|Durvalumab|durvalumab|mesh-list
56538614|NCT04224337|Ifosfamide|ifosfamide|mesh-list
56538615|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56538616|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56454112|NCT00430443|Annamycin|annamycin|mesh-list
56743010|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
56743011|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743035|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56743036|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743038|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
56743039|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743040|NCT03464097|Ozanimod|ozanimod|mesh-list
56743041|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56743042|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743043|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743044|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
56743045|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743046|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
56743047|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56743048|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56743049|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56743050|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743051|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56743052|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56743053|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
56743054|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56743055|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743056|NCT03448783|Apixaban|apixaban|mesh-list
56743057|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56743058|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
56743059|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56743060|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
56743061|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743062|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743063|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
56743064|NCT03440385|Ozanimod|ozanimod|mesh-list
56743085|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56743086|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743087|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56743088|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
56743089|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56743090|NCT03418649|Eplerenone|eplerenone|mesh-list
56743091|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56743092|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
56743093|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56743094|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743095|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56743096|NCT03418649|Diuretics|diuretics|mesh-ancestor
56743097|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
56743098|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56743145|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56743146|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538617|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56538618|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56743147|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743148|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743149|NCT03371017|Gemcitabine|gemcitabine|mesh-list
56743150|NCT03371017|Carboplatin|carboplatin|mesh-list
56743151|NCT03371017|Capecitabine|capecitabine|mesh-list
56743152|NCT03371017|Atezolizumab|atezolizumab|mesh-list
56743153|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743154|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547670|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56743155|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
56743156|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743157|NCT03371017|Antiviral Agents|antiviral agents|mesh-ancestor
56743158|NCT03371017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743159|NCT03371017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743160|NCT03371017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743161|NCT03371017|Immunologic Factors|immunologic factors|mesh-ancestor
56743162|NCT03371017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743164|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743165|NCT03315832|Valsartan|valsartan|mesh-list
56743166|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56743167|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56743168|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56743169|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743170|NCT03260920|Oxytocin|oxytocin|mesh-list
56743171|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
56743172|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56743173|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743174|NCT03258593|Durvalumab|durvalumab|mesh-list
56743175|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743176|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743177|NCT03164616|Gemcitabine|gemcitabine|mesh-list
56743178|NCT03164616|Cisplatin|cisplatin|mesh-list
56743179|NCT03164616|Carboplatin|carboplatin|mesh-list
56743180|NCT03164616|Pemetrexed|pemetrexed|mesh-list
56743181|NCT03164616|Durvalumab|durvalumab|mesh-list
56015841|NCT00182000|Cycloserine|cycloserine|mesh-list
56743205|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743206|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56743207|NCT03150693|Cytarabine|cytarabine|mesh-list
56743208|NCT03150693|Dexamethasone|dexamethasone|mesh-list
56743209|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
56743210|NCT03150693|Rituximab|rituximab|mesh-list
56743211|NCT03150693|Doxorubicin|doxorubicin|mesh-list
56743212|NCT03150693|Methotrexate|methotrexate|mesh-list
56743213|NCT03150693|Vincristine|vincristine|mesh-list
56743214|NCT03150693|Daunorubicin|daunorubicin|mesh-list
56743215|NCT03150693|Asparaginase|asparaginase|mesh-list
56743216|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
56743217|NCT03150693|Thioguanine|thioguanine|mesh-list
56743218|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56743219|NCT03150693|Pegaspargase|pegaspargase|mesh-list
56743220|NCT03150693|Allopurinol|allopurinol|mesh-list
56743221|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743222|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
56743223|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743224|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743225|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743226|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
56743227|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743228|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743229|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56743230|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743231|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743232|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
56743233|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
56743234|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743235|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56743265|NCT03126916|Busulfan|busulfan|mesh-list
56743266|NCT03126916|Thiotepa|thiotepa|mesh-list
56743267|NCT03126916|Cisplatin|cisplatin|mesh-list
56743268|NCT03126916|Carboplatin|carboplatin|mesh-list
56743269|NCT03126916|Doxorubicin|doxorubicin|mesh-list
56743270|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56743271|NCT03126916|Etoposide|etoposide|mesh-list
56743272|NCT03126916|Vincristine|vincristine|mesh-list
56743273|NCT03126916|Topotecan|topotecan|mesh-list
56743274|NCT03126916|Tretinoin|tretinoin|mesh-list
56538619|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538620|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538621|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56538622|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56538623|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
56538625|NCT02767999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56538626|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56538627|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56538628|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192839|NCT01484184|Levodopa|levodopa|mesh-list
56743275|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
56743276|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56743277|NCT03126916|Dinutuximab|dinutuximab|mesh-list
56743278|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
56743279|NCT03126916|Razoxane|razoxane|mesh-list
56743280|NCT03126916|Isotretinoin|isotretinoin|mesh-list
56743281|NCT03126916|Sargramostim|sargramostim|mesh-list
56743282|NCT03126916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56743283|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743284|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
56743285|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743286|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015961|NCT01047527|Nicotine|nicotine|mesh-list
56743315|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
56743316|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56743317|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743318|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56743319|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
56743320|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743321|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
56743322|NCT03122652|Teriflunomide|teriflunomide|mesh-list
56743323|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56743324|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56743325|NCT03122652|Analgesics|analgesics|mesh-ancestor
56743326|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
56743327|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743328|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743329|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743330|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743331|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016008|NCT01094717|Tazarotene|tazarotene|mesh-list
56743362|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
56743363|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56743364|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
56743365|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743366|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56743367|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56743368|NCT02997228|Growth Substances|growth substances|mesh-ancestor
56743369|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743370|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
56743371|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
56743372|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
56743373|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743374|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743375|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743376|NCT02997228|Antidotes|antidotes|mesh-ancestor
56743377|NCT02997228|Protective Agents|protective agents|mesh-ancestor
56743378|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
56743379|NCT02997228|Vitamins|vitamins|mesh-ancestor
56743380|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
56743401|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56743402|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56743403|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56743404|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56538629|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538630|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
56538631|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538632|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56538633|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
56538634|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56538635|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56538636|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56538637|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538638|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56538639|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538640|NCT02762617|Tenofovir|tenofovir|mesh-list
56538641|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
56538642|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538643|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56743405|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
56743406|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56743407|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743408|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
56743409|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
56743410|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743411|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56743412|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56743413|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
56743414|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743415|NCT02981628|Antidotes|antidotes|mesh-ancestor
56743416|NCT02981628|Protective Agents|protective agents|mesh-ancestor
56743417|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
56743418|NCT02981628|Vitamins|vitamins|mesh-ancestor
56743419|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
56743420|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56743421|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
56743422|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
56743423|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
56743424|NCT02981628|Hematinics|hematinics|mesh-ancestor
56743425|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743426|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56743427|NCT02968212|Clofazimine|clofazimine|mesh-list
56743428|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743429|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
56743430|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56743431|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743432|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
56743433|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743434|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743435|NCT02960022|Prednisone|prednisone|mesh-list
56743436|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
56743437|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743438|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
56743439|NCT02960022|Hormones|hormones|mesh-ancestor
56622934|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56743464|NCT02889523|Doxorubicin|doxorubicin|mesh-list
56743465|NCT02889523|Vincristine|vincristine|mesh-list
56743466|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743467|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
56743468|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743469|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743470|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743471|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
56743472|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743473|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538644|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56538645|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538646|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538647|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56538648|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56538649|NCT01192152|Metformin|metformin|mesh-list
56538650|NCT01192152|Saxagliptin|saxagliptin|mesh-list
56538651|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56538652|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538653|NCT01192152|Incretins|incretins|mesh-ancestor
56538654|NCT01192152|Hormones|hormones|mesh-ancestor
56538655|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56538656|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56538657|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
56538658|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538659|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538660|NCT04572451|Nivolumab|nivolumab|mesh-list
56538661|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56538662|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538663|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56538664|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743474|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56743475|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743476|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56743477|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56743478|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56743479|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743480|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56743481|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
56743482|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
56743483|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
56743484|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743485|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
56743487|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56743518|NCT02724579|Vincristine|vincristine|mesh-list
56743519|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743520|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
56743521|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743522|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743523|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743524|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
56743525|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743526|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743527|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56743528|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56743529|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
56743530|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
56743531|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
56743532|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
56016201|NCT00145418|Docetaxel|docetaxel|mesh-list
56743565|NCT02469753|Analgesics|analgesics|mesh-ancestor
56538665|NCT02758249|Propofol|propofol|mesh-list
56538666|NCT02758249|Sevoflurane|sevoflurane|mesh-list
56743566|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
56743567|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743568|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743569|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743570|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743571|NCT02375204|Paclitaxel|paclitaxel|mesh-list
56743572|NCT02375204|Etoposide|etoposide|mesh-list
56743573|NCT02375204|Carboplatin|carboplatin|mesh-list
56743574|NCT02375204|Ifosfamide|ifosfamide|mesh-list
56743575|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
56743576|NCT02375204|Lenograstim|lenograstim|mesh-list
56743577|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56743578|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743579|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
55743435|NCT02516059|Naloxone|naloxone|mesh-list
56743608|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56743609|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56743610|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743611|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
56743612|NCT02314988|Coagulants|coagulants|mesh-ancestor
56743613|NCT02272790|Gemcitabine|gemcitabine|mesh-list
56743615|NCT02272790|Carboplatin|carboplatin|mesh-list
56743616|NCT02272790|Adavosertib|adavosertib|mesh-list
56743617|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56743618|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743619|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
56743620|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
56743621|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56743622|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743623|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743625|NCT02272790|Antiviral Agents|antiviral agents|mesh-ancestor
56743626|NCT02272790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743627|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743649|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56743650|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56743651|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743652|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56743653|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56743654|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
56743655|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56743656|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743657|NCT01582776|Lenalidomide|lenalidomide|mesh-list
56743658|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
56743659|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
56743660|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743661|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56743662|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56743663|NCT01582776|Growth Substances|growth substances|mesh-ancestor
56743664|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
56743665|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743666|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743667|NCT01566695|Azacitidine|azacitidine|mesh-list
56743668|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743669|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
56743670|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743671|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743672|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743746|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743747|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
56743748|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743749|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743750|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743751|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743752|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743753|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
56743754|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743755|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
56743756|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56743757|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56743758|NCT00769379|Trastuzumab|trastuzumab|mesh-list
56743759|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56743760|NCT00769379|Antibodies|antibodies|mesh-list
56743761|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
56538667|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56538668|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538669|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192882|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
56743762|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56743763|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
56743764|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622935|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
56743778|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743779|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743780|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
56743781|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743782|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743783|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56743784|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743785|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
56743786|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56743787|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56743788|NCT00602459|Growth Substances|growth substances|mesh-ancestor
56743789|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
56743790|NCT00199069|Cytarabine|cytarabine|mesh-list
56743791|NCT00199069|Dexamethasone|dexamethasone|mesh-list
56743792|NCT00199069|Prednisolone|prednisolone|mesh-list
56743793|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
56743794|NCT00199069|Ifosfamide|ifosfamide|mesh-list
56743795|NCT00199069|Methotrexate|methotrexate|mesh-list
56743796|NCT00199069|Vincristine|vincristine|mesh-list
56743797|NCT00199069|Doxorubicin|doxorubicin|mesh-list
56743798|NCT00199069|Daunorubicin|daunorubicin|mesh-list
56743799|NCT00199069|Asparaginase|asparaginase|mesh-list
56743800|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
56743801|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
56743802|NCT00199069|Thioguanine|thioguanine|mesh-list
56743803|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743804|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
56743805|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743806|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743807|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743808|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
56743809|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743810|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743811|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56743812|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743813|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
56743814|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
56743815|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743816|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56743817|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
56743818|NCT00199069|Hormones|hormones|mesh-ancestor
56743819|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56743820|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56743821|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56743822|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
56743823|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56743824|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743825|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
56743826|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
56743827|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743828|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56743829|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56743830|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
56743840|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
56743841|NCT00199043|Allopurinol|allopurinol|mesh-list
56743842|NCT00199043|Rasburicase|rasburicase|mesh-list
56743843|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
56743844|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743845|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743846|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
56743847|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743848|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56743849|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
56743850|NCT00199043|Protective Agents|protective agents|mesh-ancestor
56743851|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538670|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56538671|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
56538672|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
56538673|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56538674|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56538675|NCT02758405|Fentanyl|fentanyl|mesh-list
56538676|NCT02758405|Bupivacaine|bupivacaine|mesh-list
56538677|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
56538678|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
56538679|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538680|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538681|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
56743853|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
56743854|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56743855|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56743856|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743857|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743858|NCT02601989|Urological Agents|urological agents|mesh-ancestor
56743859|NCT01067053|Bevacizumab|bevacizumab|mesh-list
56743860|NCT01067053|Capecitabine|capecitabine|mesh-list
56743861|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
56743862|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743863|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743864|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56743865|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56743866|NCT01067053|Growth Substances|growth substances|mesh-ancestor
56743867|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743868|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
56743869|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743870|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
56743871|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743872|NCT02601365|Molgramostim|molgramostim|mesh-list
56743873|NCT02601365|Sargramostim|sargramostim|mesh-list
56743874|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
56743875|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743876|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743877|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
56743878|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56743879|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56743880|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56743881|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56743882|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743883|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
56743884|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56743885|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743886|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56743887|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743888|NCT01067365|Citric Acid|citric acid|mesh-list
56743889|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
56743890|NCT01067365|Enclomiphene|enclomiphene|mesh-list
56743891|NCT01067365|Clomiphene|clomiphene|mesh-list
56743892|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
56743893|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
56743894|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56743895|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
56743896|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
56743897|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743898|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56743930|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743931|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
56743932|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56743933|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743934|NCT00822666|Clopidogrel|clopidogrel|mesh-list
56743935|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56538682|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538683|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56538684|NCT02758405|Narcotics|narcotics|mesh-ancestor
56538685|NCT02758405|Analgesics|analgesics|mesh-ancestor
56538686|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56538687|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56538688|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
56538689|NCT04549207|Denosumab|denosumab|mesh-list
56538690|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
56538691|NCT04549207|Pamidronate|pamidronate|mesh-list
56538692|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56538693|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538694|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56538696|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
56743936|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56743937|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56743938|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56743939|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
56743940|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56743941|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743967|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56743968|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743969|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56743970|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
56743972|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
56743973|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56743974|NCT00635154|BB 1101|bb 1101|mesh-list
56743975|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743976|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
56743977|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
56743978|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743979|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743980|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56743981|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
56743982|NCT00635154|Hormones|hormones|mesh-ancestor
56743983|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56743984|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56743985|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743986|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743987|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
56743988|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743989|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743990|NCT00822744|Citalopram|citalopram|mesh-list
56744027|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744048|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744049|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
56744050|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56744051|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
56744052|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56744053|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
56744054|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744055|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744056|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
56744057|NCT00298831|Rocuronium|rocuronium|mesh-list
56744058|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56744059|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56744060|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56744061|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744062|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744063|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56538697|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56538698|NCT02758327|Laxatives|laxatives|mesh-ancestor
56538699|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56538700|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
56538701|NCT02763475|Fludarabine|fludarabine|mesh-list
56744064|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56744065|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744066|NCT00758069|Incretins|incretins|mesh-ancestor
56744067|NCT00758069|Hormones|hormones|mesh-ancestor
56744068|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744069|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56744070|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
56744071|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744072|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56455162|NCT00437229|Hormones|hormones|mesh-ancestor
56744074|NCT01067677|Promethazine|promethazine|mesh-list
56744075|NCT01067677|Ondansetron|ondansetron|mesh-list
56744076|NCT01067677|Metoclopramide|metoclopramide|mesh-list
56744077|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
56744078|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
56744079|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744080|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744081|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56744082|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
56744118|NCT02600741|Pimozide|pimozide|mesh-list
56744119|NCT02600741|Olanzapine|olanzapine|mesh-list
56744120|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
56744121|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
56744122|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
56744123|NCT02600741|Risperidone|risperidone|mesh-list
56744124|NCT02600741|Aripiprazole|aripiprazole|mesh-list
56744125|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56744154|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56744155|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744156|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
56744157|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
56744158|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56744159|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56744160|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56744161|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56744162|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56744164|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
56744165|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56744166|NCT01065649|Nortriptyline|nortriptyline|mesh-list
56744167|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56744168|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
56744169|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744170|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56744171|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56744172|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744173|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744174|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
56744175|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622936|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744199|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56744200|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
56744201|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744202|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
56744203|NCT01067989|Pamidronate|pamidronate|mesh-list
56744204|NCT01067989|Celecoxib|celecoxib|mesh-list
56744205|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
56744206|NCT01067989|Capecitabine|capecitabine|mesh-list
56744207|NCT01067989|Methotrexate|methotrexate|mesh-list
56744208|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56744209|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
56744210|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744211|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56744212|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56744213|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
56744214|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744215|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744216|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063845|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
56538702|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56538703|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
56744217|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56744218|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
56744219|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56744220|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
56744221|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56744222|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
56744223|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744224|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56744225|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56744226|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56547671|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56744227|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56744264|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
56744265|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
56744266|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56744287|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
56744288|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744289|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
56744290|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56744291|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56744292|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56744293|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744294|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744295|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744296|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744297|NCT00755807|Analgesics|analgesics|mesh-ancestor
56455395|NCT00335933|Gabapentin|gabapentin|mesh-list
56744298|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
56744299|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744300|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
56744302|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
56744303|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
56744304|NCT05372224|Vitamin D|vitamin d|mesh-list
56744305|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56744306|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744307|NCT05372224|Vitamins|vitamins|mesh-ancestor
56744308|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
56744309|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56744310|NCT00631410|Sunitinib|sunitinib|mesh-list
56744311|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744312|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56744313|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56744314|NCT00631410|Growth Substances|growth substances|mesh-ancestor
56744315|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744316|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
56016958|NCT03660683|Saxagliptin|saxagliptin|mesh-list
56744331|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56744332|NCT00817284|Growth Substances|growth substances|mesh-ancestor
56744333|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744334|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
56744335|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56744336|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56744337|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744338|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744339|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56744340|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
56744341|NCT04096157|Isavuconazole|isavuconazole|mesh-list
56744342|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
56744343|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744344|NCT00823290|Sorafenib|sorafenib|mesh-list
56744345|NCT00823290|Panobinostat|panobinostat|mesh-list
56744346|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744347|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56744348|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744349|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744350|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56744351|NCT00755417|Gabapentin|gabapentin|mesh-list
56744352|NCT00755417|Analgesics|analgesics|mesh-ancestor
56744353|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
56744354|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063850|NCT04062097|Dabigatran|dabigatran|mesh-list
56538704|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744355|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744356|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
56744357|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56744358|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56744359|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744360|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744361|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56744362|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56744363|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744364|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744365|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
56744366|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56744367|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
56744368|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744369|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
56744370|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56744371|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56744372|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56744373|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56744374|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744375|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744376|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
56744415|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
56744427|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
56744428|NCT00820092|Hormones|hormones|mesh-ancestor
56744429|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744430|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744431|NCT00823602|Buserelin|buserelin|mesh-list
56744432|NCT00823602|Ganirelix|ganirelix|mesh-list
56744433|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
56744434|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744435|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744436|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56744437|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
56744438|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56744439|NCT00820326|Dolasetron|dolasetron|mesh-list
56744440|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
56744441|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
56744442|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744443|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744444|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56744445|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56744446|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
56744447|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744448|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744449|NCT00916097|Docetaxel|docetaxel|mesh-list
56744450|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744451|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
56744452|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
56744453|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
56744454|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744455|NCT00629772|Infliximab|infliximab|mesh-list
56744456|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
56744457|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56744458|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56744459|NCT00526630|Methylphenidate|methylphenidate|mesh-list
56744460|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56744461|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744462|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56744463|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56744464|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744465|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744466|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
56744467|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744468|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
56744469|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56744470|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56744471|NCT00755183|Testosterone|testosterone|mesh-list
56744472|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
56744473|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
56744474|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56744475|NCT00755183|Androgens|androgens|mesh-ancestor
56538705|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56538706|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56538707|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
56538708|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538709|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538710|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56538711|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56538712|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
56538713|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538714|NCT02758015|Betaine|betaine|mesh-list
56538715|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56538716|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
56538717|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56538718|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
56538719|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538720|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56538721|NCT02757703|Terlipressin|terlipressin|mesh-list
56538722|NCT02757703|Pantoprazole|pantoprazole|mesh-list
56538723|NCT02757703|Somatostatin|somatostatin|mesh-list
56538724|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56538725|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56538726|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56538727|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744476|NCT00755183|Hormones|hormones|mesh-ancestor
56744477|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744478|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744509|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744510|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744511|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744512|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
56744513|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744514|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56744515|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
56744516|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744517|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56744518|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56744519|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
56744520|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
56744521|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744522|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56744532|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56744533|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
56744534|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744535|NCT03999190|Raclopride|raclopride|mesh-list
56744536|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
56744537|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56744538|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744539|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56744540|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56744541|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744542|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744543|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
56744544|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744545|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56744546|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56744547|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744548|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744549|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56744550|NCT05244694|Insulin|insulin|mesh-list
56744551|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56744552|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744553|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
56744554|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56744555|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
56744556|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744557|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744558|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56744559|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
56744560|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56744561|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
56744562|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744563|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744564|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56744565|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
56744566|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
56744567|NCT00626028|Protective Agents|protective agents|mesh-ancestor
56744568|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
56017229|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017231|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017257|NCT01479127|Silicon|silicon|mesh-list
56744632|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56744633|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
56744634|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56744636|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744637|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744638|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56017306|NCT03783416|Ixazomib|ixazomib|mesh-list
56744652|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
56744653|NCT02600585|Vaccines|vaccines|mesh-list
56744654|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
56744655|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744656|NCT00525148|Afatinib|afatinib|mesh-list
56744657|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744658|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56744659|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744660|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744661|NCT00754325|Dasatinib|dasatinib|mesh-list
56744662|NCT00754325|Fulvestrant|fulvestrant|mesh-list
56744663|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744664|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56744665|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744666|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744667|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56744668|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56744669|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56744670|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
56744671|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744672|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744673|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
56744674|NCT00524680|Vitamin D|vitamin d|mesh-list
56744675|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56744676|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744677|NCT00524680|Vitamins|vitamins|mesh-ancestor
56744678|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
56744679|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56744680|NCT00298363|Tenofovir|tenofovir|mesh-list
56744681|NCT00298363|Emtricitabine|emtricitabine|mesh-list
56744682|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56744683|NCT00298363|Entecavir|entecavir|mesh-list
56744684|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
56744685|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744686|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56744687|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56744688|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744689|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744690|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56538728|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538729|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56744691|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56744692|NCT00821262|Propofol|propofol|mesh-list
56744693|NCT00821262|Sevoflurane|sevoflurane|mesh-list
56744694|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56744695|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744696|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744697|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56744698|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
56744699|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
56017334|NCT00248534|Hormones|hormones|mesh-ancestor
56744714|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56744715|NCT00777101|Capecitabine|capecitabine|mesh-list
56744716|NCT00777101|Lapatinib|lapatinib|mesh-list
56744717|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56744718|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
56744719|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744720|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744721|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56744722|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744723|NCT00830856|Lamivudine|lamivudine|mesh-list
56744724|NCT00830856|Nevirapine|nevirapine|mesh-list
56744725|NCT00830856|Stavudine|stavudine|mesh-list
56744726|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
56744727|NCT00830856|Fluconazole|fluconazole|mesh-list
56744728|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56744729|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56744730|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744731|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744732|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
56744733|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744734|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56744735|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56744736|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
56744737|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56744738|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56455826|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
56744739|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56744740|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
56744741|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744742|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744743|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56744744|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56744745|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56744746|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56744747|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
56744748|NCT01068067|Tacrolimus|tacrolimus|mesh-list
56744749|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56744750|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
56744751|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744752|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56744753|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744754|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744755|NCT04904536|Atorvastatin|atorvastatin|mesh-list
56744756|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56744757|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56744758|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
56744781|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
56744782|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744783|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744784|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
56744785|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56744786|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56744787|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744788|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744789|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56744790|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56744791|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744792|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744793|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
56538730|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56538731|NCT02757703|Hormones|hormones|mesh-ancestor
56538732|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56538733|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538734|NCT02763007|Pioglitazone|pioglitazone|mesh-list
56744794|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56744795|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56744796|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
56744797|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56744798|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56744799|NCT00297037|Analgesics|analgesics|mesh-ancestor
56744800|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
56744801|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744802|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744803|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56744804|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56744805|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
56744806|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56744807|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
56744808|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56744860|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
56744861|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744862|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56744863|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56744899|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56744900|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744901|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
56744928|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
56744929|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56744930|NCT03979625|Heparin|heparin|mesh-list
56744931|NCT03979625|Antibodies|antibodies|mesh-list
56744932|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
56744933|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744934|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
56744935|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56744936|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56744937|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744938|NCT02548494|Insulin|insulin|mesh-list
56744939|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
56744940|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56744941|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744942|NCT00752219|Metronidazole|metronidazole|mesh-list
56744943|NCT00752219|Meropenem|meropenem|mesh-list
56744944|NCT00752219|Ceftazidime|ceftazidime|mesh-list
56744945|NCT00752219|Avibactam|avibactam|mesh-list
56744946|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744947|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56744948|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56744949|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56744950|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56745031|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745067|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745068|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745070|NCT00296491|Xhance|xhance|mesh-list
56745071|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56745072|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56745098|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56745099|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745101|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56745102|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
56745103|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56745104|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745105|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
56745106|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56745107|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745108|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745109|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56745110|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56745111|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56538735|NCT02763007|Alogliptin|alogliptin|mesh-list
56538736|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56538737|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538738|NCT02763007|Incretins|incretins|mesh-ancestor
56538739|NCT02763007|Hormones|hormones|mesh-ancestor
56192942|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56745112|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56745113|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56745114|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56745116|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
56745117|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745118|NCT00296335|Mitomycins|mitomycins|mesh-list
56745119|NCT00296335|Mitomycin|mitomycin|mesh-list
56745120|NCT00296335|Doxifluridine|doxifluridine|mesh-list
56745148|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745149|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56745150|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745151|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
56745152|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745153|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745155|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56745156|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56745157|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56745158|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
56745159|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
56745160|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745161|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745162|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745163|NCT04234360|Prednisone|prednisone|mesh-list
56745164|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745165|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
56745166|NCT04234360|Hormones|hormones|mesh-ancestor
56745167|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745198|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56745199|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56745200|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56745201|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
56745202|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745203|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
56745204|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56745205|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745206|NCT01068301|Plerixafor|plerixafor|mesh-list
56745207|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56745208|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56745209|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
56745210|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745211|NCT04999228|Mesalamine|mesalamine|mesh-list
56745212|NCT04999228|Infliximab|infliximab|mesh-list
56745213|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56745247|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56745248|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745249|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745250|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56745251|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56745252|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56745253|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017911|NCT01192139|Metformin|metformin|mesh-list
56745269|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
56745270|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745271|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745272|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
56745273|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745274|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745275|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
56745276|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745277|NCT00750737|Amphotericin B|amphotericin b|mesh-list
56745278|NCT00750737|Posaconazole|posaconazole|mesh-list
56745279|NCT00750737|Amebicides|amebicides|mesh-ancestor
56745280|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56745281|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56538740|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56538741|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56538742|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
56745282|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745283|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56745284|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
56745285|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56745286|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56745287|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56745288|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745289|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745290|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56745291|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
56745292|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745293|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745294|NCT02629120|Sirolimus|sirolimus|mesh-list
56745295|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
56745296|NCT02629120|Busulfan|busulfan|mesh-list
56745297|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
56745298|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745299|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
56745300|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745301|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56745302|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56745303|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
56745304|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745305|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745306|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56745307|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56745308|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745309|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56745310|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
56745311|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56745312|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
56745313|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56017954|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56745347|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745348|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745349|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
56745350|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745351|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745352|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56745353|NCT00744653|Bleomycin|bleomycin|mesh-list
56745354|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56745355|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745376|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745377|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745378|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56745379|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56745380|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
56745381|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56745382|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745383|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
56745384|NCT04089605|Dexamethasone|dexamethasone|mesh-list
56745385|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
56745386|NCT04089605|Ranibizumab|ranibizumab|mesh-list
56745387|NCT04089605|BB 1101|bb 1101|mesh-list
56745388|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745389|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
56745390|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
56745391|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745392|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745393|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745394|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
56745395|NCT04089605|Hormones|hormones|mesh-ancestor
56745396|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745397|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56745398|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745399|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
56538743|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538744|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538745|NCT00635323|Capecitabine|capecitabine|mesh-list
56538746|NCT00635323|Irinotecan|irinotecan|mesh-list
56538747|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56538748|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
56745400|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745401|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745402|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56745403|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56745404|NCT04089605|Growth Substances|growth substances|mesh-ancestor
56745405|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
56745406|NCT00521404|Gemcitabine|gemcitabine|mesh-list
56745407|NCT00521404|Antibodies|antibodies|mesh-list
56745408|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
56745409|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745410|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56745411|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
56745446|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56745448|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745449|NCT00274261|Nonoxynol|nonoxynol|mesh-list
56745450|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56018111|NCT01792388|Vitamin D|vitamin d|mesh-list
56745484|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
56745485|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
56745486|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56745487|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56745488|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745508|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745510|NCT01070875|Calcium heparin|calcium heparin|mesh-list
56745511|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
56745512|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56745513|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56745514|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745515|NCT04043676|Ponatinib|ponatinib|mesh-list
56745516|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745517|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56745518|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745519|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745520|NCT01325935|Clopidogrel|clopidogrel|mesh-list
56745521|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56745522|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56745523|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56745524|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56745525|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
56745526|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745527|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745528|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745529|NCT02549742|Bleomycin|bleomycin|mesh-list
56745530|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56745531|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745532|NCT00521014|Cytarabine|cytarabine|mesh-list
56745533|NCT00521014|Rituximab|rituximab|mesh-list
56745534|NCT00521014|Etoposide|etoposide|mesh-list
56745535|NCT00521014|Melphalan|melphalan|mesh-list
56745536|NCT00521014|Carmustine|carmustine|mesh-list
56745537|NCT00521014|Sargramostim|sargramostim|mesh-list
56745538|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56745539|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745540|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
56745541|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745542|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56745543|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56745544|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56745545|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56745546|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745398|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745557|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56745559|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063851|NCT04062097|Vitamins|vitamins|mesh-ancestor
56538749|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538750|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538751|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56538752|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56538753|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538754|NCT01191840|Vancomycin|vancomycin|mesh-list
56538755|NCT01191840|Cefazolin|cefazolin|mesh-list
56538756|NCT01191840|Daptomycin|daptomycin|mesh-list
56538757|NCT01191840|Cloxacillin|cloxacillin|mesh-list
56538758|NCT01191840|Oxacillin|oxacillin|mesh-list
56538759|NCT01191840|Nafcillin|nafcillin|mesh-list
56538760|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56538761|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745560|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745561|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456650|NCT00448461|Heparin|heparin|mesh-list
56745562|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56745563|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56745564|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56745565|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56745566|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56745567|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
56745568|NCT00291577|Docetaxel|docetaxel|mesh-list
56745569|NCT00291577|Sunitinib|sunitinib|mesh-list
56745570|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745571|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
56745572|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
56745573|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
56745574|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745575|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56745576|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56745577|NCT00291577|Growth Substances|growth substances|mesh-ancestor
56745578|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745579|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
56745580|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56745581|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745582|NCT00520936|Pemetrexed|pemetrexed|mesh-list
56745583|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745584|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745585|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745586|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56745587|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56745588|NCT02549430|Letrozole|letrozole|mesh-list
56745589|NCT02549430|Fulvestrant|fulvestrant|mesh-list
56745590|NCT02549430|Palbociclib|palbociclib|mesh-list
56745591|NCT02549430|Anastrozole|anastrozole|mesh-list
56745592|NCT02549430|Exemestane|exemestane|mesh-list
56745593|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745594|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56745595|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56745596|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745597|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745598|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56745599|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
56018254|NCT00318812|Trace Elements|trace elements|mesh-ancestor
56018257|NCT00318812|Hematinics|hematinics|mesh-ancestor
56745635|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745636|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
56745668|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745669|NCT00944385|Urinastatin|urinastatin|mesh-list
56745670|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56745671|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56745672|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
56745673|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745674|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745675|NCT00953355|Metformin|metformin|mesh-list
56538762|NCT02752555|Antioxidants|antioxidants|mesh-list
56538763|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538764|NCT02752555|Protective Agents|protective agents|mesh-ancestor
56538765|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538766|NCT00624546|Lansoprazole|lansoprazole|mesh-list
56538767|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
56538768|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56538769|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56538770|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56538771|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538772|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538773|NCT02757469|Drospirenone|drospirenone|mesh-list
56538774|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56538775|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56538776|NCT02757469|Estradiol|estradiol|mesh-list
56745676|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56745677|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745678|NCT00944463|Gemcitabine|gemcitabine|mesh-list
56745679|NCT00944463|Simvastatin|simvastatin|mesh-list
56745680|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56745681|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
56018338|NCT00367016|Omalizumab|omalizumab|mesh-list
56745703|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745705|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
56745706|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56745707|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
56745708|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
56745709|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745710|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745711|NCT00953589|Ribavirin|ribavirin|mesh-list
56745712|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
56745713|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456866|NCT00346970|Niacin|niacin|mesh-list
56745714|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
56745715|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745716|NCT00947739|Camptothecin|camptothecin|mesh-list
56745717|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56745718|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745719|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56745720|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56745721|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745722|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745723|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
56745724|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56745725|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745726|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
56745727|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56745728|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56745729|NCT00947895|Prednisolone|prednisolone|mesh-list
56745730|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
56745731|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56745732|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
56745733|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56745749|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
56745750|NCT00623766|Prednisolone|prednisolone|mesh-list
56745751|NCT00623766|Triamcinolone|triamcinolone|mesh-list
56745752|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
56745753|NCT00623766|Betamethasone|betamethasone|mesh-list
56745754|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
56745755|NCT00623766|Ipilimumab|ipilimumab|mesh-list
56745756|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745757|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
56538777|NCT02757469|Estrogens|estrogens|mesh-ancestor
56538778|NCT02757469|Hormones|hormones|mesh-ancestor
56538779|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745758|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
56745759|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745760|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745761|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745762|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
56745763|NCT00623766|Hormones|hormones|mesh-ancestor
56745764|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745765|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56745766|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745767|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56745768|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56745769|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745770|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56745771|NCT00623766|Protective Agents|protective agents|mesh-ancestor
56745772|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56745773|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
56745774|NCT00832494|Paclitaxel|paclitaxel|mesh-list
56745775|NCT00832494|Carboplatin|carboplatin|mesh-list
56745776|NCT00832494|Vadimezan|vadimezan|mesh-list
56745777|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56745778|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745779|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
56745780|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
56745781|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
56745782|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745783|NCT00837564|Citalopram|citalopram|mesh-list
56745784|NCT00837564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56745785|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56745786|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745787|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745788|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745789|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
56745790|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745791|NCT00837564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56745792|NCT00837564|Antidepressive Agents|antidepressive agents|mesh-ancestor
56745793|NCT00837564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56018442|NCT00369746|Citalopram|citalopram|mesh-list
56745824|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56745825|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745827|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
56745828|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745829|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56745830|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56745831|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56745832|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745833|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56745834|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56745835|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745836|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745855|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745856|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745858|NCT00828594|Everolimus|everolimus|mesh-list
56745859|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745860|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56745861|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745862|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745863|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745864|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
56745865|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745866|NCT00550407|Lamotrigine|lamotrigine|mesh-list
56745867|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
56745868|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56745869|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745870|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745871|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56287029|NCT00000681|Zidovudine|zidovudine|mesh-list
56538780|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538781|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56538782|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
56538783|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56538784|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56538785|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56538786|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56538787|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56538788|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
56538789|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56538790|NCT02757469|Diuretics|diuretics|mesh-ancestor
56538791|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
56538792|NCT02757391|Aldesleukin|aldesleukin|mesh-list
56538793|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
56538794|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
56538795|NCT02757391|Interleukin-2|interleukin-2|mesh-list
56538796|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
56538797|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56538798|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538799|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56745872|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745873|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56745874|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56745875|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56745876|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56745877|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56745878|NCT00957411|Cetuximab|cetuximab|mesh-list
56745879|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745880|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56745881|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
56745882|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
56745883|NCT00837954|Coagulants|coagulants|mesh-ancestor
56745884|NCT00954525|Gemcitabine|gemcitabine|mesh-list
56745885|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56745886|NCT00954525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745887|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56745888|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
56745889|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745890|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745891|NCT00954525|Antiviral Agents|antiviral agents|mesh-ancestor
56745914|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745916|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56745917|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
56745918|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745919|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745920|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56745921|NCT00954603|Haloperidol|haloperidol|mesh-list
56745922|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56745923|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
56745924|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
56745925|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56745926|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56745927|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56745928|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538800|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56538801|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
56538802|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538803|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538804|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56538805|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56538806|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56538807|NCT02757391|Analgesics|analgesics|mesh-ancestor
56538808|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
56538809|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538810|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56538811|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56538812|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
56538813|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538814|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
56538815|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56538816|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538817|NCT05656170|Bupivacaine|bupivacaine|mesh-list
56538818|NCT05656170|Anesthetics, Local|anesthetics, local|mesh-ancestor
56538819|NCT05656170|Anesthetics|anesthetics|mesh-ancestor
56538820|NCT05656170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538821|NCT05656170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538822|NCT05656170|Sensory System Agents|sensory system agents|mesh-ancestor
56538823|NCT05656170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538824|NCT02757079|Melatonin|melatonin|mesh-list
56538825|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
56193011|NCT01485445|Xhance|xhance|mesh-list
56745929|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745930|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
56745931|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
56745932|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745933|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745934|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56745935|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
56745936|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745937|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745938|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56745939|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56745940|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745941|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56745942|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745943|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745944|NCT02548806|Clonidine|clonidine|mesh-list
56745945|NCT02548806|Analgesics|analgesics|mesh-ancestor
56018599|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56745955|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
56745956|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745957|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745958|NCT00549939|Alfuzosin|alfuzosin|mesh-list
56745959|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56745960|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56745961|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56745962|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
56745963|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745964|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745965|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745966|NCT00549939|Urological Agents|urological agents|mesh-ancestor
56745967|NCT00272779|Emtricitabine|emtricitabine|mesh-list
56745968|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56745969|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
56745970|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745971|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56745972|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56745973|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745974|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745975|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56745976|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56745977|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56745978|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56745979|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
56745980|NCT00957879|Calcitriol|calcitriol|mesh-list
56745981|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
56745982|NCT00957879|Vitamin D|vitamin d|mesh-list
56745983|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56745984|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745985|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56745986|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745987|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745988|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56745989|NCT00957879|Vitamins|vitamins|mesh-ancestor
56745990|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
56745991|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56745992|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
56745993|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56745994|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745995|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
56745996|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745997|NCT00838266|Protective Agents|protective agents|mesh-ancestor
56745998|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745999|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
56746000|NCT04011033|Interleukin-2|interleukin-2|mesh-list
56746001|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746002|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
56746003|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746004|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746005|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56746006|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
56746007|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746008|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746009|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56746028|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746029|NCT04011813|Protective Agents|protective agents|mesh-ancestor
56746030|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746031|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56746032|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56746033|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746035|NCT00998686|Hormones|hormones|mesh-ancestor
56746036|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746037|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56746038|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
56746039|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746040|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746041|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56746042|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56746043|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746044|NCT00958269|Incretins|incretins|mesh-ancestor
56746045|NCT00958269|Hormones|hormones|mesh-ancestor
56746046|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746047|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56746048|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
56538826|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538827|NCT02757079|Protective Agents|protective agents|mesh-ancestor
56538828|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538829|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538830|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
56538831|NCT04529005|Giapreza|giapreza|mesh-list
56538832|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
56538833|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56538834|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56538835|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
56538836|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538837|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538838|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
56538839|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56538840|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
56538841|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
56538842|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538843|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538844|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56538845|NCT05357040|Analgesics|analgesics|mesh-ancestor
56193036|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
56746049|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746050|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746051|NCT02547402|CXA-10|cxa-10|mesh-list
56746052|NCT02547402|Simvastatin|simvastatin|mesh-list
56746053|NCT02547402|Ezetimibe|ezetimibe|mesh-list
56746054|NCT02547402|Pravastatin|pravastatin|mesh-list
56746055|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56746056|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56746057|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56746058|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
56746059|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746060|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56746061|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56746062|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746063|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56746064|NCT01068925|Dolutegravir|dolutegravir|mesh-list
56018715|NCT05320068|Vancomycin|vancomycin|mesh-list
56746100|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746101|NCT00838656|Gemcitabine|gemcitabine|mesh-list
56746102|NCT00838656|Paclitaxel|paclitaxel|mesh-list
56746103|NCT00838656|Carboplatin|carboplatin|mesh-list
56746104|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56746136|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
56746137|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746138|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
56746139|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746140|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
56746141|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746142|NCT04010955|Edoxaban|edoxaban|mesh-list
56746143|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56746144|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
56746145|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56746146|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
56746147|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538846|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
56538847|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538848|NCT00943072|Aflibercept|aflibercept|mesh-list
56538849|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56538850|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56538851|NCT00943072|Growth Substances|growth substances|mesh-ancestor
56538852|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538853|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
56538854|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538855|NCT05346588|Propofol|propofol|mesh-list
56538857|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56018812|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746178|NCT00744497|Dasatinib|dasatinib|mesh-list
56746179|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746180|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
56746181|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
56746182|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
56746183|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746184|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56746185|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
56746186|NCT00744497|Hormones|hormones|mesh-ancestor
56746187|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746188|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746189|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56746190|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56746221|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746222|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56746223|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56746224|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56746225|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56746226|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
56746227|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746228|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56746229|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56746230|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746231|NCT00271609|Bevacizumab|bevacizumab|mesh-list
56746232|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56746233|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746234|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56746235|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56746264|NCT02597387|Analgesics|analgesics|mesh-ancestor
56746265|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
56746266|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746267|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746268|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746269|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56746270|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56746271|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746272|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746273|NCT01069081|Cisplatin|cisplatin|mesh-list
56746274|NCT01069081|Docetaxel|docetaxel|mesh-list
56746275|NCT01069081|Esomeprazole|esomeprazole|mesh-list
56746276|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746277|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
56746278|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
56746279|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
56746280|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746281|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56746282|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56746283|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56746284|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746285|NCT00949455|Lapatinib|lapatinib|mesh-list
56746286|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063852|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
56538858|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538859|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746287|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56746306|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746307|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746309|NCT00549549|Indomethacin|indomethacin|mesh-list
56746310|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56746311|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56746312|NCT00549549|Analgesics|analgesics|mesh-ancestor
56746313|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
56746314|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56457400|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
56746315|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746316|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56746317|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746318|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56746319|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56746320|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746321|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746322|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
56746323|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
56746324|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56746325|NCT00622284|Glimepiride|glimepiride|mesh-list
56746326|NCT00622284|Linagliptin|linagliptin|mesh-list
56746327|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56746328|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56746329|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746330|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746331|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
56746332|NCT00622284|Incretins|incretins|mesh-ancestor
56746333|NCT00622284|Hormones|hormones|mesh-ancestor
56746334|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746335|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56746336|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
56746337|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746338|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746339|NCT00269113|Rituximab|rituximab|mesh-list
56746340|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56746341|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746342|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
56746375|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
56746376|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
56746377|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
56746378|NCT00956163|Protective Agents|protective agents|mesh-ancestor
56746379|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746380|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56746381|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746382|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56746383|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746384|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56746385|NCT00956319|Estazolam|estazolam|mesh-list
56746411|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746412|NCT00961857|Incretins|incretins|mesh-ancestor
56746413|NCT00961857|Hormones|hormones|mesh-ancestor
56746414|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746415|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56746416|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
56746417|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746418|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746419|NCT02547792|Vaccines|vaccines|mesh-list
56746420|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
56746421|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746422|NCT00830466|Sirolimus|sirolimus|mesh-list
56746423|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56746424|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746425|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56746426|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746427|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
56746428|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746429|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
56746430|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538860|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56538861|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
56538862|NCT04222855|Diltiazem|diltiazem|mesh-list
56538863|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56538864|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56538865|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56538866|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538867|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56193072|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
56746431|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56746432|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56746433|NCT00843570|Nafarelin|nafarelin|mesh-list
56746434|NCT00843570|Estradiol|estradiol|mesh-list
56746435|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56746436|NCT00843570|Progesterone|progesterone|mesh-list
56746437|NCT00843570|Estrogens|estrogens|mesh-ancestor
56746472|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
56746473|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746474|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56746475|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
56746476|NCT00621504|Clarithromycin|clarithromycin|mesh-list
56746477|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
56746478|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56746479|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56746480|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746532|NCT00962637|Androgens|androgens|mesh-ancestor
56746533|NCT00962637|Hormones|hormones|mesh-ancestor
56746534|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746535|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746536|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56746537|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
56746538|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56746539|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
56746540|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56457631|NCT00351884|Vildagliptin|vildagliptin|mesh-list
56746541|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56746542|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56746543|NCT00839358|Midodrine|midodrine|mesh-list
56746544|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
56746545|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
56746546|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746547|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746548|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56746549|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56746550|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56746551|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56746552|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
56746553|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746554|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746555|NCT00962715|Interferons|interferons|mesh-list
56746556|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
56746557|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
56746558|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56746559|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746560|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
56746561|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746562|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
56746563|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746564|NCT00963027|Treprostinil|treprostinil|mesh-list
56746565|NCT00963027|Esomeprazole|esomeprazole|mesh-list
56746566|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56746567|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56746568|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56746569|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746570|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746571|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56746572|NCT04170153|Niraparib|niraparib|mesh-list
56538868|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538869|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
56538870|NCT00942994|Amlodipine|amlodipine|mesh-list
56538871|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56538872|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56538873|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56538874|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56538875|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538876|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56538877|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538878|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
56538879|NCT00942994|Diuretics|diuretics|mesh-ancestor
56538880|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
56538881|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56538882|NCT04268602|Anesthetics|anesthetics|mesh-list
56538883|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
56538884|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538885|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538886|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
56538887|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538888|NCT04314336|Coal Tar|coal tar|mesh-list
56538889|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
56538890|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
56538891|NCT00624702|Maleic acid|maleic acid|mesh-list
56538892|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746573|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56746574|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746575|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746576|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746577|NCT00837174|Bortezomib|bortezomib|mesh-list
56746605|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56746606|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56746607|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
56746608|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746609|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
56746610|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746611|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746612|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56746613|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
56746614|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457696|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
56746615|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746616|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56746617|NCT00839826|Enoxaparin|enoxaparin|mesh-list
56746618|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
56746619|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56746620|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
56746621|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56746622|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
56538893|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538894|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
56538895|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56538896|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
56538897|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56538898|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538899|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
56538900|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
56538901|NCT02199184|Prednisone|prednisone|mesh-list
56538902|NCT02199184|Cortisone|cortisone|mesh-list
56538903|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
56538904|NCT02199184|Rituximab|rituximab|mesh-list
56538905|NCT02199184|Doxorubicin|doxorubicin|mesh-list
56538906|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56538907|NCT02199184|Etoposide|etoposide|mesh-list
56538908|NCT02199184|Vincristine|vincristine|mesh-list
56538909|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
56538910|NCT02199184|Ofatumumab|ofatumumab|mesh-list
56538911|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
56538912|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56538913|NCT02199184|Antibodies|antibodies|mesh-list
56538914|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
56538915|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56193112|NCT01485744|Antidotes|antidotes|mesh-ancestor
56746623|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746624|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746644|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
56746645|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56746646|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56746647|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56746648|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
56746649|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
56746650|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746651|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746652|NCT05299593|Timolol|timolol|mesh-list
56746653|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56746654|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56746655|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
56746656|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746657|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746658|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746659|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56746660|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56746661|NCT00844740|Cinacalcet|cinacalcet|mesh-list
56746662|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56746663|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746664|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56746665|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
56746666|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746667|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
56746668|NCT00963729|Docetaxel|docetaxel|mesh-list
56746669|NCT00963729|Fluorouracil|fluorouracil|mesh-list
56746670|NCT00963729|Letrozole|letrozole|mesh-list
56746671|NCT00963729|Epirubicin|epirubicin|mesh-list
56746672|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746673|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
56538916|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56538917|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
56538918|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538919|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56538920|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56538921|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
56538922|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538923|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538924|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56538925|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56538926|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56538927|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56746674|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746675|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746676|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56746677|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
56746678|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746679|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746680|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56746681|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
56746712|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746713|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746715|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746716|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56746717|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
56746718|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746719|NCT00851370|Omalizumab|omalizumab|mesh-list
56746720|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56746721|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56746722|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
56746734|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
56746735|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746736|NCT00840606|Buspirone|buspirone|mesh-list
56746737|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56746738|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56746739|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56746740|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746741|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56746742|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56746743|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
56746744|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746745|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746746|NCT00840684|Cytarabine|cytarabine|mesh-list
56746747|NCT00840684|Melphalan|melphalan|mesh-list
56746748|NCT00840684|Busulfan|busulfan|mesh-list
56746749|NCT00840684|Daunorubicin|daunorubicin|mesh-list
56746750|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
56746751|NCT00840684|Amsacrine|amsacrine|mesh-list
56746752|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56746753|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
56746754|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746755|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746756|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
56746757|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746758|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746759|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
56746760|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746761|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56746762|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
56746763|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56746764|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56538928|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746765|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56746766|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56746767|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746768|NCT00840684|Analgesics|analgesics|mesh-ancestor
56746769|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
56746770|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746771|NCT00574080|Cytarabine|cytarabine|mesh-list
56746772|NCT00574080|Thalidomide|thalidomide|mesh-list
56746773|NCT00574080|Dexamethasone|dexamethasone|mesh-list
56746774|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
56746775|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
56746776|NCT00574080|Melphalan|melphalan|mesh-list
56746777|NCT00574080|Carmustine|carmustine|mesh-list
56746778|NCT00574080|Cisplatin|cisplatin|mesh-list
56746779|NCT00574080|Etoposide|etoposide|mesh-list
56746780|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
56746781|NCT00574080|Doxorubicin|doxorubicin|mesh-list
56746782|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56746783|NCT00574080|Bortezomib|bortezomib|mesh-list
56746784|NCT00574080|BB 1101|bb 1101|mesh-list
56746785|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746786|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
56746787|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746788|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746789|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56019420|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
56746816|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56746817|NCT00574080|Growth Substances|growth substances|mesh-ancestor
56746818|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
56746819|NCT00845364|Perhexiline|perhexiline|mesh-list
56746820|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56746821|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56746822|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746823|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56746824|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746825|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
56746826|NCT00546351|Lacosamide|lacosamide|mesh-list
56746827|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
56746828|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56746829|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56746830|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56746831|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746832|NCT00267865|Leucovorin|leucovorin|mesh-list
56746833|NCT00267865|Rituximab|rituximab|mesh-list
56746834|NCT00267865|Methotrexate|methotrexate|mesh-list
56746835|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56746836|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746857|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
56746859|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56746860|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746861|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
56746862|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746863|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56746864|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56746865|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56746866|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56746867|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746868|NCT00546117|Lansoprazole|lansoprazole|mesh-list
56746869|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
56746870|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56746871|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56746872|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56746873|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746874|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746875|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56746876|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56746877|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56746878|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
56746879|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746880|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56746881|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56746882|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746883|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
56746884|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56538929|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56538930|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
56538931|NCT02199184|Hormones|hormones|mesh-ancestor
56193146|NCT01485926|Carboplatin|carboplatin|mesh-list
56746885|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56746886|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746887|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
56746888|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
56746913|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56746914|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
56746915|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56746916|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56746917|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746918|NCT00845598|Fluticasone|fluticasone|mesh-list
56746920|NCT00845598|Azelastine|azelastine|mesh-list
56746921|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56746922|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56746923|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
56746924|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746925|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746926|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56746927|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
56746928|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
56746929|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56746930|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56746931|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746932|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746933|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56746934|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56746935|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
56746936|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
56746972|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56746973|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
56746974|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
56746975|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56746976|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746977|NCT00621192|Meropenem|meropenem|mesh-list
56019632|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
56746992|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
56746993|NCT00852228|Irinotecan|irinotecan|mesh-list
56746994|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56746995|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746996|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56746997|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56746998|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746999|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747000|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
56747001|NCT00267007|Hematinics|hematinics|mesh-ancestor
56747002|NCT00841854|Metronidazole|metronidazole|mesh-list
56747003|NCT00841854|Tetracycline|tetracycline|mesh-list
56747004|NCT00841854|Pantoprazole|pantoprazole|mesh-list
56747005|NCT00841854|Bismuth|bismuth|mesh-list
56747006|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747007|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56747008|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56747009|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56747010|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56747011|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56747012|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56747013|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747014|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747015|NCT00841854|Antacids|antacids|mesh-ancestor
56747016|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56747017|NCT00848562|Nicorandil|nicorandil|mesh-list
56747018|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56747019|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56747020|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
56747021|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
56747022|NCT00848562|Vitamins|vitamins|mesh-ancestor
56747023|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
56747024|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747025|NCT02879409|Insulin|insulin|mesh-list
56747026|NCT02879409|Metformin|metformin|mesh-list
56747027|NCT02879409|Pioglitazone|pioglitazone|mesh-list
56747028|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56747029|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
56538932|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56538933|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56538934|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56538935|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
56538936|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
56538937|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
56538938|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
56538939|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
56538940|NCT05378100|Midazolam|midazolam|mesh-list
56538941|NCT05378100|Ketamine|ketamine|mesh-list
56538942|NCT05378100|Analgesics|analgesics|mesh-ancestor
56538943|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
56747030|NCT02879409|Liraglutide|liraglutide|mesh-list
56747031|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56747032|NCT02879409|Gliclazide|gliclazide|mesh-list
56747033|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747034|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747035|NCT02879409|Incretins|incretins|mesh-ancestor
56747036|NCT02879409|Hormones|hormones|mesh-ancestor
56747037|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747038|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56747039|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
56747040|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747041|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019674|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
56747069|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56747070|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747071|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
56747072|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747073|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747075|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56747076|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747077|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56747078|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747079|NCT00251641|Methotrexate|methotrexate|mesh-list
56747080|NCT00251641|Infliximab|infliximab|mesh-list
56747081|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56747082|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
56747083|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56747084|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747085|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56747086|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
56747087|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747088|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747104|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
56747105|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
56747106|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747107|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747108|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56747109|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56747110|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
56747111|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56747112|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56747113|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56747114|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56747115|NCT00849030|Tamoxifen|tamoxifen|mesh-list
56747116|NCT00849030|Anastrozole|anastrozole|mesh-list
56747117|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56747118|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
56747119|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747120|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538944|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538945|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538946|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56538947|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56747121|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56747122|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747123|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56747124|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56747125|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56747126|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56747127|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56747128|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747129|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747130|NCT00842400|Metformin|metformin|mesh-list
56747131|NCT00842400|Probenecid|probenecid|mesh-list
56747132|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747133|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747134|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
56747135|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
56747136|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747137|NCT00842400|Renal Agents|renal agents|mesh-ancestor
56747138|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
56747139|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747140|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747141|NCT00849264|Fluorouracil|fluorouracil|mesh-list
56747142|NCT00849264|Endostar protein|endostar protein|mesh-list
56747143|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
56747144|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747145|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56747147|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747148|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
56747181|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747182|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56747183|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56747184|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747185|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747187|NCT00853008|Dexamethasone|dexamethasone|mesh-list
56747188|NCT00853008|Prednisone|prednisone|mesh-list
56747189|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
56747223|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56747224|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56747225|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56747226|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56747227|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56747228|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56747229|NCT00853008|Analgesics|analgesics|mesh-ancestor
56747230|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
56747232|NCT02545530|Analgesics|analgesics|mesh-ancestor
56019882|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
56747259|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56747261|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747262|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747263|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
56747264|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747265|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56747266|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747267|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
56747268|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747269|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56747270|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56747271|NCT00850044|Ritonavir|ritonavir|mesh-list
56747272|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56747273|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56747274|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
56747275|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747276|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747277|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56747278|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56747279|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
56747306|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56538948|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
56538949|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
56538950|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538951|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56538952|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56538953|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56538954|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538955|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56538956|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56538957|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56538958|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56538959|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56538960|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
56538961|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
56538962|NCT02752477|Anesthetics|anesthetics|mesh-list
56538963|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
56538964|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56538965|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538966|NCT04204096|Vaccines|vaccines|mesh-list
56538967|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
56538968|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538969|NCT05376852|Decitabine|decitabine|mesh-list
56538970|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56538971|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
56538972|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56538973|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56538974|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538975|NCT00061282|Clotrimazole|clotrimazole|mesh-list
56538976|NCT00061282|Miconazole|miconazole|mesh-list
56538977|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56538978|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56538979|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
56538980|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56538981|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56538982|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56538986|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56538987|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538988|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56538989|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56538990|NCT05657496|Triamcinolone|triamcinolone|mesh-list
56538991|NCT05657496|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56538992|NCT05657496|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56538993|NCT05657496|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56538994|NCT05657496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56538995|NCT05657496|Glucocorticoids|glucocorticoids|mesh-ancestor
56538996|NCT05657496|Hormones|hormones|mesh-ancestor
56538997|NCT05657496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747307|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56747308|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56747309|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
56747310|NCT00968877|Vitamin D|vitamin d|mesh-list
56747311|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56747312|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747313|NCT00968877|Vitamins|vitamins|mesh-ancestor
56747314|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
56747315|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56747316|NCT00850122|Cefazolin|cefazolin|mesh-list
56747317|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56747318|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747319|NCT00968955|Ropivacaine|ropivacaine|mesh-list
56747320|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
56747321|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
56747322|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747323|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747324|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
56019974|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
56747359|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
56747360|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747361|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747363|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
56747397|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747398|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56747399|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
56747400|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747401|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020099|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
56747450|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747451|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56747453|NCT00855972|Naltrexone|naltrexone|mesh-list
56747454|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56747455|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56747456|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747457|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
56747458|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747459|NCT02544906|Propofol|propofol|mesh-list
56747460|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56747461|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747462|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747463|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56747464|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
56747465|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
56747466|NCT00861276|Nicotine|nicotine|mesh-list
56747467|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56747468|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
56747469|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56538998|NCT05657496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56538999|NCT05657496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539000|NCT05657496|Immunologic Factors|immunologic factors|mesh-ancestor
56539001|NCT05657496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539002|NCT05657496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539004|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
56287258|NCT04038346|Acetaminophen|acetaminophen|mesh-list
56539005|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539006|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539007|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56539008|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56539009|NCT02855632|Hormones|hormones|mesh-list
56539010|NCT02855632|Progesterone|progesterone|mesh-list
56539011|NCT02855632|Lenograstim|lenograstim|mesh-list
56539012|NCT02855632|Estrogens|estrogens|mesh-list
56539013|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747470|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747471|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56747472|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56747473|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
56747474|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747475|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747476|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56747477|NCT02544828|Hematinics|hematinics|mesh-ancestor
56747478|NCT00861510|ON 01910|on 01910|mesh-list
56747479|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747480|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56747481|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747482|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747483|NCT01095003|Capecitabine|capecitabine|mesh-list
56747484|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56747485|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
56747486|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747487|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747488|NCT00854646|ON 01910|on 01910|mesh-list
56747489|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747490|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56747491|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747492|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747493|NCT00856362|Moxidectin|moxidectin|mesh-list
56747494|NCT00856362|Midazolam|midazolam|mesh-list
56747495|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56747496|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56747497|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747498|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747499|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56747500|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56747501|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56020137|NCT00538616|Propofol|propofol|mesh-list
56747537|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747539|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56747540|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
56747541|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747542|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747543|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56747576|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747577|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747578|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56064209|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
56539014|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539015|NCT02855632|Progestins|progestins|mesh-ancestor
56539016|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56539017|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
56539018|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
56539019|NCT04220281|Propofol|propofol|mesh-list
56539020|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56539025|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
56539085|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56539086|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
56539087|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539088|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539089|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
56539090|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539091|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539092|NCT02761291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539093|NCT02761291|Immunologic Factors|immunologic factors|mesh-ancestor
56539094|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539095|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
56539096|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
56539097|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539098|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
56539099|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56539100|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56539101|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56539102|NCT01187550|Hormones|hormones|mesh-list
56539103|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539104|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539105|NCT02855866|Acetaminophen|acetaminophen|mesh-list
56539106|NCT02855866|Dexamethasone|dexamethasone|mesh-list
56539107|NCT02855866|Cortisone|cortisone|mesh-list
56539108|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
56539109|NCT02855866|BB 1101|bb 1101|mesh-list
56539110|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56539111|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
56539112|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
56539115|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56539133|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
56539134|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539135|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539136|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56539137|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56539138|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56539139|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56539140|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
56539141|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
56747579|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
56747580|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
56747581|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56747582|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
56747583|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747584|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747585|NCT00970905|Ondansetron|ondansetron|mesh-list
56747586|NCT00970905|Aprepitant|aprepitant|mesh-list
56747587|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
56747588|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
56747589|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747623|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747624|NCT00857142|Oxymorphone|oxymorphone|mesh-list
56747625|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56747626|NCT00857142|Narcotics|narcotics|mesh-ancestor
56747627|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747628|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747629|NCT00857142|Analgesics|analgesics|mesh-ancestor
56747630|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
56747631|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747656|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56747657|NCT00959439|Analgesics|analgesics|mesh-ancestor
56747658|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
56747659|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747660|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747661|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56747662|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747663|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
56747664|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56747665|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747666|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747667|NCT04041492|Vitamin D|vitamin d|mesh-list
56747668|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
56747669|NCT04041492|Vitamins|vitamins|mesh-ancestor
56747670|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
56747671|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747672|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56747673|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56747674|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
56747675|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
56747676|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747677|NCT00857376|Protective Agents|protective agents|mesh-ancestor
56747678|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747679|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
56747680|NCT00857376|Vitamins|vitamins|mesh-ancestor
56747713|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
56747714|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747715|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56747716|NCT00865410|Bupropion|bupropion|mesh-list
56747717|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56747718|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
56747719|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56747720|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56747721|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56747722|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56747723|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747724|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
56539142|NCT00638209|Insulin|insulin|mesh-list
56539143|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56539144|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539145|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539146|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56539147|NCT05429671|Gentamicins|gentamicins|mesh-list
56539148|NCT05429671|Tobramycin|tobramycin|mesh-list
56747725|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747754|NCT00971685|Hormones|hormones|mesh-ancestor
56747755|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747756|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56747757|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747758|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
56747759|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56747760|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56747761|NCT00971685|Growth Substances|growth substances|mesh-ancestor
56747762|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
56747763|NCT03861052|Dulaglutide|dulaglutide|mesh-list
56747764|NCT03861052|Tirzepatide|tirzepatide|mesh-list
56747765|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747766|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747767|NCT03861052|Incretins|incretins|mesh-ancestor
56747768|NCT03861052|Hormones|hormones|mesh-ancestor
56747769|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747770|NCT00971763|Gemcitabine|gemcitabine|mesh-list
56747784|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56747785|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56747787|NCT00971763|Antiviral Agents|antiviral agents|mesh-ancestor
56747788|NCT00971763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747789|NCT00971763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747790|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56747791|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
56747792|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
56747793|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
56747794|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56747795|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
56747796|NCT00971763|Hormones|hormones|mesh-ancestor
56747797|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747798|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56747799|NCT00781196|Folic Acid|folic acid|mesh-list
56747800|NCT00781196|Hematinics|hematinics|mesh-ancestor
56747801|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
56747802|NCT00781196|Vitamins|vitamins|mesh-ancestor
56747803|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
56747804|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747805|NCT00865644|Imiquimod|imiquimod|mesh-list
56747806|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56747807|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
56747808|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747809|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747810|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
56747811|NCT00785330|Rituximab|rituximab|mesh-list
56747812|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56747813|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747814|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
56747815|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747816|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747817|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56747818|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56458913|NCT00430196|Tizanidine|tizanidine|mesh-list
56747819|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747820|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56747821|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56747822|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56747823|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747824|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
56747825|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747826|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
56747827|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56747828|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56539149|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539150|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56539151|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539152|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539154|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56539155|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539156|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
56539157|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539158|NCT02754817|Liraglutide|liraglutide|mesh-list
56539159|NCT02754817|Xultophy|xultophy|mesh-list
56539160|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539161|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539162|NCT02754817|Incretins|incretins|mesh-ancestor
56539163|NCT02754817|Hormones|hormones|mesh-ancestor
56539164|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539165|NCT04230031|Daratumumab|daratumumab|mesh-list
56539166|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539167|NCT01186458|Rituximab|rituximab|mesh-list
56747829|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747831|NCT05279469|Coagulants|coagulants|mesh-ancestor
56747832|NCT00790946|Valsartan|valsartan|mesh-list
56747858|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56747859|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
56747860|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
56747861|NCT00974805|Hormones|hormones|mesh-ancestor
56747862|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747863|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
56747864|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
56747865|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56747866|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
56747867|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
56747868|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747869|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747870|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56747871|NCT00781352|Analgesics|analgesics|mesh-ancestor
56747872|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
56747873|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747874|NCT00791024|Lidocaine|lidocaine|mesh-list
56747875|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
56747876|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
56747877|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747878|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747879|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
56747900|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747902|NCT00666536|Amlodipine|amlodipine|mesh-list
56747903|NCT00666536|Valsartan|valsartan|mesh-list
56747904|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56747905|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56747906|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56747907|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56747908|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747909|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56747910|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747911|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
56747912|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56747913|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56539168|NCT01186458|Fludarabine|fludarabine|mesh-list
56539169|NCT01186458|Bortezomib|bortezomib|mesh-list
56083422|NCT02247804|Timolol|timolol|mesh-list
56747914|NCT00519532|Rotigotine|rotigotine|mesh-list
56747915|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
56747916|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
56747917|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747918|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747919|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747920|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56747921|NCT00666458|Saxagliptin|saxagliptin|mesh-list
56747922|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747923|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747924|NCT00666458|Incretins|incretins|mesh-ancestor
56747925|NCT00666458|Hormones|hormones|mesh-ancestor
56747926|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747927|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56747928|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
56747929|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747930|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747961|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56747962|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
56747963|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
56747964|NCT00510952|Protamines|protamines|mesh-list
56747965|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747966|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747967|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
56747968|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747969|NCT00510952|Coagulants|coagulants|mesh-ancestor
56747970|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
56747971|NCT00617604|Alefacept|alefacept|mesh-list
56747972|NCT00617604|Tacrolimus|tacrolimus|mesh-list
56747973|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747974|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
56748002|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56748003|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748004|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56748005|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56748006|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56748007|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748008|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56748009|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748010|NCT00791804|Fentanyl|fentanyl|mesh-list
56748011|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56748012|NCT00791804|Narcotics|narcotics|mesh-ancestor
56748013|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748014|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748015|NCT00791804|Analgesics|analgesics|mesh-ancestor
56748016|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
56748017|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748018|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56748019|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56748020|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
56748021|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
56748022|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
56748023|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
56748024|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
56020669|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
56748047|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56748048|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56748049|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56748050|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56748051|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56748052|NCT00792662|Methylphenidate|methylphenidate|mesh-list
56748053|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56748054|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748055|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56748056|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56748057|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56748058|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748059|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
56748060|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748061|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56064210|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
56539170|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56539171|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539172|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
56539173|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539174|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56539175|NCT01185366|Everolimus|everolimus|mesh-list
56539176|NCT01185366|Sunitinib|sunitinib|mesh-list
56539177|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539178|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539179|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
56539180|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539181|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56539182|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56539183|NCT01185366|Growth Substances|growth substances|mesh-ancestor
56539184|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
56539185|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56539186|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748062|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56748063|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748064|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748066|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
56748067|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748068|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
56748069|NCT04093752|Tirzepatide|tirzepatide|mesh-list
56748070|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56748071|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748086|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56748087|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
56748088|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
56748089|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56748090|NCT02544282|Analgesics|analgesics|mesh-ancestor
56748091|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
56748092|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748093|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
56748094|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56748095|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56748096|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56748097|NCT02544282|Narcotics|narcotics|mesh-ancestor
56748098|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56748099|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
56748100|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56748101|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56748102|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56748103|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56748104|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56748105|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
56748106|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748107|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748108|NCT04041648|Treprostinil|treprostinil|mesh-list
56748109|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56748110|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56748111|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
56748112|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
56748113|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56748114|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
56748115|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748116|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748117|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56748118|NCT00663962|Pregabalin|pregabalin|mesh-list
56539187|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539188|NCT01185288|Adalimumab|adalimumab|mesh-list
56539189|NCT01185288|Methotrexate|methotrexate|mesh-list
56539190|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56539191|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
56539192|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56539193|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539194|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56539195|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
56539196|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539197|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539198|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
56539199|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539200|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56539201|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539202|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
56539203|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56539204|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56539205|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56539206|NCT01184118|Fluticasone|fluticasone|mesh-list
56748119|NCT00663962|Analgesics|analgesics|mesh-ancestor
56748120|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
56748121|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748122|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748123|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
56748124|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56748125|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56748126|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748127|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56748128|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56748129|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56748130|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748131|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56748132|NCT00858624|Ketamine|ketamine|mesh-list
56748133|NCT00858624|Analgesics|analgesics|mesh-ancestor
56748134|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
56748135|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020762|NCT00555464|Vincristine|vincristine|mesh-list
56748160|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56748161|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56748162|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748163|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748164|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56748165|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
56748166|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748167|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748168|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56748169|NCT00972387|Prednisone|prednisone|mesh-list
56748170|NCT00972387|Prednisolone|prednisolone|mesh-list
56748171|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
56748172|NCT00972387|Doxorubicin|doxorubicin|mesh-list
56748173|NCT00972387|Vincristine|vincristine|mesh-list
56748174|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539207|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56539208|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56539209|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
56539210|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539211|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539212|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56539213|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
56539214|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
56539215|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56539216|NCT01183884|Tretinoin|tretinoin|mesh-list
56539217|NCT01183884|Isotretinoin|isotretinoin|mesh-list
56539218|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748175|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
56748176|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748177|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56748178|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56748179|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
56748180|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748181|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748182|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56748183|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56748206|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748208|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748209|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56748210|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748211|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748212|NCT00792818|Ibuprofen|ibuprofen|mesh-list
56748213|NCT00792818|Curcumin|curcumin|mesh-list
56748214|NCT00792818|Turmeric extract|turmeric extract|mesh-list
56748215|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56748216|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56748217|NCT00792818|Analgesics|analgesics|mesh-ancestor
56748218|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
56748219|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748220|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748221|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56748222|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56748223|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56748224|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748225|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748226|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748227|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
56748228|NCT00792818|Protective Agents|protective agents|mesh-ancestor
56748229|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
56748230|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56748231|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748232|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
56748233|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748248|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56748249|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748250|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56748251|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748252|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
56748253|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56748254|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56748256|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56748257|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
56748258|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748259|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748260|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56748261|NCT00793052|Dexamethasone|dexamethasone|mesh-list
56539219|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
56539220|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
56539221|NCT05344248|Antibodies|antibodies|mesh-list
56539222|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56539223|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
56539224|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539225|NCT01191762|Sevelamer|sevelamer|mesh-list
56539226|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
56539227|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
56539229|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
56539285|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193501|NCT01488136|Diazoxide|diazoxide|mesh-list
56748262|NCT00793052|Etoricoxib|etoricoxib|mesh-list
56748263|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56748264|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
56748265|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
56748266|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748267|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748268|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56748269|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
56748271|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748272|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56748273|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748274|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56748275|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56748276|NCT00793052|Analgesics|analgesics|mesh-ancestor
56748277|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
56748278|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56748279|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56748280|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56748281|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748282|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748283|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56748284|NCT02555852|Esomeprazole|esomeprazole|mesh-list
56748285|NCT02555852|Omeprazole|omeprazole|mesh-list
56748286|NCT02555852|Rabeprazole|rabeprazole|mesh-list
56748287|NCT02555852|Pantoprazole|pantoprazole|mesh-list
56748288|NCT02555852|Lansoprazole|lansoprazole|mesh-list
56748289|NCT02555852|Famotidine|famotidine|mesh-list
56748290|NCT02555852|Ranitidine|ranitidine|mesh-list
56748291|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56748292|NCT02555852|Cimetidine|cimetidine|mesh-list
56748293|NCT02555852|Nizatidine|nizatidine|mesh-list
56748294|NCT02555852|Lafutidine|lafutidine|mesh-list
56748295|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
56748296|NCT02555852|Bismuth|bismuth|mesh-list
56748297|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56748329|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748330|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748332|NCT00545571|Hematinics|hematinics|mesh-ancestor
56748333|NCT00783380|Vaccines|vaccines|mesh-list
56748334|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
56748335|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748336|NCT04008225|Dimercaprol|dimercaprol|mesh-list
56748337|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
56748338|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
56748339|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748340|NCT00748709|Afatinib|afatinib|mesh-list
56748341|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748367|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748368|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748369|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56748370|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
56748371|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56748372|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748373|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748374|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56748375|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56748376|NCT00867126|Pioglitazone|pioglitazone|mesh-list
56748377|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56748378|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748379|NCT00748553|Paclitaxel|paclitaxel|mesh-list
56748380|NCT00748553|Azacitidine|azacitidine|mesh-list
56748381|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56748382|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56748383|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748384|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
56748385|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
56748386|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
56748387|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748388|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56748389|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
56748407|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748408|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748410|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
56748411|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539286|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539287|NCT02852122|Choline|choline|mesh-list
56539288|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
56539289|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56539290|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
56539291|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539292|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56539293|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56539294|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
56539295|NCT01035255|Enalapril|enalapril|mesh-list
56539296|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56539297|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56539298|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
56748412|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56748413|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56748414|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
56748415|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
56748416|NCT00975663|Tacrolimus|tacrolimus|mesh-list
56748417|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748418|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
56748419|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748420|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56748421|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748422|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748424|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56748425|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748426|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748427|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
56748428|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748429|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748430|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
56748431|NCT00960921|Iron|iron|mesh-list
56748432|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56748433|NCT00960921|Trace Elements|trace elements|mesh-ancestor
56748434|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
56748435|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748436|NCT00960921|Hematinics|hematinics|mesh-ancestor
56748437|NCT00863460|Cytarabine|cytarabine|mesh-list
56748438|NCT00863460|Prednisone|prednisone|mesh-list
56748439|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
56748440|NCT00863460|Busulfan|busulfan|mesh-list
56748441|NCT00863460|Thiotepa|thiotepa|mesh-list
56748442|NCT00863460|Carmustine|carmustine|mesh-list
56748443|NCT00863460|Methotrexate|methotrexate|mesh-list
56748444|NCT00863460|Etoposide|etoposide|mesh-list
56748445|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748446|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
56748447|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748448|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56748449|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56748450|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
56748471|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
56748472|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748473|NCT00262951|Interferons|interferons|mesh-list
56748474|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
56748475|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
56748476|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56748477|NCT00262951|Cisplatin|cisplatin|mesh-list
56748478|NCT00262951|Fluorouracil|fluorouracil|mesh-list
56748479|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748480|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
56748481|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748482|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56748483|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539299|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539300|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748484|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
56748485|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748486|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
56748487|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748488|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
56748489|NCT02597153|Analgesics|analgesics|mesh-ancestor
56748490|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
56748491|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748492|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748493|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748494|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56748495|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56748496|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748497|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748498|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
56748499|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56748500|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
56748501|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56748502|NCT00262873|Bortezomib|bortezomib|mesh-list
56748503|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748533|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56748534|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748535|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
56748536|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
56748537|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
56748538|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748539|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
56748540|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748541|NCT05147493|Dexamethasone|dexamethasone|mesh-list
56748542|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
56748543|NCT05147493|Lenalidomide|lenalidomide|mesh-list
56748544|NCT05147493|Bortezomib|bortezomib|mesh-list
56748545|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748546|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
56748547|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748548|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56748549|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56748550|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
56021192|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
56748579|NCT03974425|Growth Substances|growth substances|mesh-ancestor
56748580|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748581|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
56748582|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748584|NCT00975897|Bevacizumab|bevacizumab|mesh-list
56748585|NCT00975897|Cetuximab|cetuximab|mesh-list
56748586|NCT00975897|Fluorouracil|fluorouracil|mesh-list
56748587|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
56748588|NCT00975897|Irinotecan|irinotecan|mesh-list
56748589|NCT00975897|Calcium|calcium|mesh-list
56748590|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
56748591|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56748592|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021251|NCT04216524|Hormones|hormones|mesh-ancestor
56748628|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748629|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56748631|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
56748632|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
56021287|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56748645|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56748646|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
56748647|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748648|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748649|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56748650|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
56748651|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56748652|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56748653|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56748654|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
56748655|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748656|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748657|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56748658|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
56473656|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56539302|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56539303|NCT00602524|Pilocarpine|pilocarpine|mesh-list
56539304|NCT00602524|Miotics|miotics|mesh-ancestor
56539305|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
56539306|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539307|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539308|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56539309|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56539310|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
56539311|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539312|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539313|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56539314|NCT01189890|Glimepiride|glimepiride|mesh-list
56539315|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539316|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539317|NCT01189890|Incretins|incretins|mesh-ancestor
56539318|NCT01189890|Hormones|hormones|mesh-ancestor
56748659|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748660|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56748661|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56748662|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56748663|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56748664|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56748665|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56748666|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748667|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
56748668|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748669|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748670|NCT00973245|Warfarin|warfarin|mesh-list
56748671|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
56748672|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
56748673|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56748674|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
56748675|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56748676|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
56748677|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748678|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748679|NCT00793754|Aspirin|aspirin|mesh-list
56748680|NCT00793754|Atorvastatin|atorvastatin|mesh-list
56748681|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56748682|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56748683|NCT00793754|Analgesics|analgesics|mesh-ancestor
56748684|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
56748685|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748686|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748687|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56748688|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56748689|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56748690|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56748691|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748692|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56748693|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56748694|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748730|NCT00787436|Timolol|timolol|mesh-list
56748731|NCT00787436|Propranolol|propranolol|mesh-list
56748732|NCT00787436|Nadolol|nadolol|mesh-list
56748733|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748734|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
56539319|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56193537|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
56748735|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748736|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
56748770|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748771|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748772|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56748773|NCT00979563|Irinotecan|irinotecan|mesh-list
56748774|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56748775|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56748776|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748777|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748813|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56748814|NCT00860340|Diuretics|diuretics|mesh-ancestor
56748815|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
56748847|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748848|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56748849|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
56748850|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748851|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748852|NCT00665444|Aripiprazole|aripiprazole|mesh-list
56748853|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
56748854|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56748855|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56748856|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56748857|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748890|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748891|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
56748892|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748893|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
56748894|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56748895|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56748897|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56748898|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
56748899|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748931|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748932|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
56748933|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
56748934|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
56748935|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748936|NCT00864318|Paclitaxel|paclitaxel|mesh-list
56748937|NCT00864318|Etoposide|etoposide|mesh-list
56748938|NCT00864318|Ifosfamide|ifosfamide|mesh-list
56748939|NCT00864318|Carboplatin|carboplatin|mesh-list
56748940|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56748941|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748942|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
56748943|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
56748944|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
56021602|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56748979|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56748980|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56748981|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
56748982|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748983|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56021650|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
56749008|NCT00961467|Growth Substances|growth substances|mesh-ancestor
56749009|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
56749010|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
56749011|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56749012|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749013|NCT00980031|Eplerenone|eplerenone|mesh-list
56749014|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56749015|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
56749016|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749017|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749018|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56749019|NCT00980031|Diuretics|diuretics|mesh-ancestor
56749020|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
56749021|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56749022|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
56460079|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
56539320|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56539321|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
56539322|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539323|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539324|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56539325|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539326|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
56539327|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
56539328|NCT01189812|Citalopram|citalopram|mesh-list
56539329|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
56539330|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56539331|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539332|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539333|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
56193543|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
56749023|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56749024|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749025|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56749026|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749027|NCT00980109|Oseltamivir|oseltamivir|mesh-list
56749028|NCT00980109|Zanamivir|zanamivir|mesh-list
56749029|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
56749030|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749031|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749067|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56749068|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
56749069|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
56749070|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56749071|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56460155|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
56749097|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749098|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
56749099|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56749100|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
56749101|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749102|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56749103|NCT00788294|Tanezumab|tanezumab|mesh-list
56749104|NCT00788294|Analgesics|analgesics|mesh-ancestor
56749105|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
56749106|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749107|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749108|NCT00795548|Azacitidine|azacitidine|mesh-list
56749109|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56749110|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
56749111|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749112|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749113|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749114|NCT00282919|Azithromycin|azithromycin|mesh-list
56749115|NCT00282919|Chloroquine|chloroquine|mesh-list
56749116|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56749117|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749118|NCT00282919|Amebicides|amebicides|mesh-ancestor
56749119|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56749120|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56749192|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
56749193|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749194|NCT01070407|Cloricromen|cloricromen|mesh-list
56749195|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56749196|NCT00801086|Ethanol|ethanol|mesh-list
56749197|NCT00801086|Tempol|tempol|mesh-list
56749198|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56539334|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56539335|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56539336|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539337|NCT01189812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56539338|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56749199|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749200|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749201|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749236|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56749237|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749238|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749239|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
56749240|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749310|NCT00796250|Protective Agents|protective agents|mesh-ancestor
56749311|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56749312|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749313|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
56749314|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749315|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56749316|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749317|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
56749318|NCT00788918|Interferons|interferons|mesh-list
56749319|NCT00788918|Ribavirin|ribavirin|mesh-list
56749320|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749321|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
56749322|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749323|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
56749351|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749352|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749353|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56749355|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56749356|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56749357|NCT00861042|Lacosamide|lacosamide|mesh-list
56749358|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
56749359|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56749360|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56749361|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56749362|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749363|NCT04088903|Daratumumab|daratumumab|mesh-list
56749364|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749365|NCT00861120|Doxorubicin|doxorubicin|mesh-list
56749366|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56749367|NCT00861120|Panitumumab|panitumumab|mesh-list
56749368|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56749369|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749395|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
56749396|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56749397|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749398|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749399|NCT00868764|Granisetron|granisetron|mesh-list
56749400|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
56749401|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
56749402|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749403|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749404|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749405|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56749406|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
56749407|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749408|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749409|NCT00518986|Modafinil|modafinil|mesh-list
56749410|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56749411|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749412|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56749413|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56749414|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56749415|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749416|NCT00864942|Lenalidomide|lenalidomide|mesh-list
56539339|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56539340|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539341|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
56539342|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56539343|NCT01189500|Tamoxifen|tamoxifen|mesh-list
56539344|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56539345|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56539346|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
56539347|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539348|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539349|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56539350|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539351|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56749451|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
56749452|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56749453|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
56749454|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749455|NCT04730362|Propofol|propofol|mesh-list
56749481|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
56749483|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56749484|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56749485|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749486|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749487|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
56749488|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749489|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749490|NCT00870480|Urological Agents|urological agents|mesh-ancestor
56749491|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
56749492|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749493|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56749494|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56749495|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56749496|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56749497|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
56749498|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56749499|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749500|NCT00616902|Vitamins|vitamins|mesh-ancestor
56022189|NCT01556425|Naltrexone|naltrexone|mesh-list
56749536|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56749566|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749567|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56749568|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56749569|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
56749571|NCT00662558|Tramadol|tramadol|mesh-list
56749572|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56749573|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56749574|NCT00662558|Analgesics|analgesics|mesh-ancestor
56749575|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
56749576|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749577|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749578|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56749579|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749580|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56749581|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56749582|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749617|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
56749618|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749619|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539352|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56539353|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56539354|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56539355|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56539356|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56539357|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539358|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539359|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
56539360|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56539361|NCT00938860|Cyclosporine|cyclosporine|mesh-list
56539362|NCT00938860|Tacrolimus|tacrolimus|mesh-list
56539363|NCT00938860|Cyclosporins|cyclosporins|mesh-list
56539364|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539365|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
56539366|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539367|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56539368|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539369|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539370|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
56749620|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56460676|NCT00439049|Naltrexone|naltrexone|mesh-list
56749621|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56749622|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
56749651|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749652|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56749653|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
56749654|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749655|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749656|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
56749657|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749658|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
56749659|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56749660|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56749661|NCT00802646|Epinephrine|epinephrine|mesh-list
56749662|NCT00802646|Fentanyl|fentanyl|mesh-list
56749663|NCT00802646|Bupivacaine|bupivacaine|mesh-list
56749664|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
56749665|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
56749666|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749667|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749668|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
56749669|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749670|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56749703|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56749704|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
56749705|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56749706|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
56749707|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56749708|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56749709|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56749710|NCT00802958|Clobetasol|clobetasol|mesh-list
56749711|NCT00802958|Halobetasol|halobetasol|mesh-list
56749739|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
56749740|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539371|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539372|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
56539374|NCT00604396|Insulin|insulin|mesh-list
56539375|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56539376|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
56539377|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
56539378|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
56539379|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
56539380|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539381|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539382|NCT00938470|Docetaxel|docetaxel|mesh-list
56539383|NCT00938470|Fluorouracil|fluorouracil|mesh-list
56539384|NCT00938470|Capecitabine|capecitabine|mesh-list
56539385|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
56539386|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539387|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56539388|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56539389|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56539390|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539391|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
56539392|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56539393|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539394|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
56539395|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539397|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56539398|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539399|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539400|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
56539401|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539402|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539403|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
56539404|NCT00938392|Vaccines|vaccines|mesh-list
56539405|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
56539406|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539407|NCT02851888|Ropivacaine|ropivacaine|mesh-list
56749741|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749742|NCT00789308|Cyclosporine|cyclosporine|mesh-list
56749744|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
56749745|NCT00789308|Etanercept|etanercept|mesh-list
56749746|NCT00789308|Heparin|heparin|mesh-list
56749747|NCT00789308|Dextrans|dextrans|mesh-list
56749748|NCT00789308|Tacrolimus|tacrolimus|mesh-list
56749749|NCT00789308|Cyclosporins|cyclosporins|mesh-list
56539408|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
56539409|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56539410|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539411|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
56539412|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
56749750|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
56749751|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56749752|NCT00789308|Basiliximab|basiliximab|mesh-list
56749753|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749754|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
56749755|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749756|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56749757|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749758|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749824|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56749825|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749826|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56749827|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
56749828|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
56749829|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749830|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749831|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749832|NCT00544557|Etanercept|etanercept|mesh-list
56749833|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56749834|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56749835|NCT00544557|Analgesics|analgesics|mesh-ancestor
56749836|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
56749837|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749838|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749839|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56749840|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749841|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749842|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749872|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56749873|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749874|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749875|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56749876|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56749877|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56749878|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56749879|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
56749880|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
56749881|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
56749882|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
56749883|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749884|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749885|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56749886|NCT00789386|Narcotics|narcotics|mesh-ancestor
56749887|NCT00789386|Analgesics|analgesics|mesh-ancestor
56749888|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
56749889|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022572|NCT01568905|Nicotine|nicotine|mesh-list
56749923|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56749924|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749925|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56460965|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749926|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56749927|NCT00877266|Mepivacaine|mepivacaine|mesh-list
56749928|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
56749929|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
56022614|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
56749960|NCT04045730|Gemcitabine|gemcitabine|mesh-list
56749961|NCT04045730|Paclitaxel|paclitaxel|mesh-list
56749962|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
56749963|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56749964|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749965|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
56749966|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
56749967|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
56749968|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539413|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539414|NCT05381428|Indomethacin|indomethacin|mesh-list
56539415|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56539416|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56539417|NCT05381428|Analgesics|analgesics|mesh-ancestor
56539418|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
56539419|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539420|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539421|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56539422|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56539423|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
56539424|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
56539425|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56539426|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56539427|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539428|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539429|NCT01022853|Nintedanib|nintedanib|mesh-list
56539430|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539431|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56749969|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56749970|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
56749971|NCT04045730|Antiviral Agents|antiviral agents|mesh-ancestor
56749972|NCT04045730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749973|NCT04045730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749974|NCT04045730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022669|NCT01571557|Hormones|hormones|mesh-ancestor
56750008|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56750009|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
56750010|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750011|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56750012|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56750013|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
56750014|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
56750015|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750016|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750017|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56750051|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
56750052|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750053|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750054|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56750055|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56750090|NCT04006821|Antibodies|antibodies|mesh-list
56750091|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
56750092|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750093|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750094|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56750095|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750130|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750131|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750132|NCT05279391|Dexamethasone|dexamethasone|mesh-list
56750133|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56750134|NCT05279391|Heparin|heparin|mesh-list
56750170|NCT00877656|Zanolimumab|zanolimumab|mesh-list
56022853|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56750198|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750199|NCT00872274|Sumatriptan|sumatriptan|mesh-list
56539432|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539433|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539434|NCT00937768|Leuprolide|leuprolide|mesh-list
56539435|NCT00937768|Goserelin|goserelin|mesh-list
56539436|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56539437|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
56750200|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56750201|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56750202|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56750203|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
56750204|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750205|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750206|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750207|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56750208|NCT00872586|Olmesartan|olmesartan|mesh-list
56750209|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56750210|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56750211|NCT00872586|Diuretics|diuretics|mesh-ancestor
56750212|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
56750213|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022891|NCT05245604|Cyclosporins|cyclosporins|mesh-list
56750243|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56750244|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
56750245|NCT04812366|Prednisone|prednisone|mesh-list
56750246|NCT04812366|Docetaxel|docetaxel|mesh-list
56750247|NCT04812366|Atezolizumab|atezolizumab|mesh-list
56750248|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
56750249|NCT04812366|Niraparib|niraparib|mesh-list
56750250|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750251|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
56750252|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
56750253|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
56750254|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750255|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750256|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
56750257|NCT04812366|Hormones|hormones|mesh-ancestor
56750258|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56750293|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
56750294|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750295|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750296|NCT00981591|Iloprost|iloprost|mesh-list
56023001|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
56750330|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750331|NCT00738881|Pemetrexed|pemetrexed|mesh-list
56750332|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56750333|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750334|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750335|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750336|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56750337|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56750338|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56750339|NCT00657020|Nicotine|nicotine|mesh-list
56750376|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
56750377|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56750379|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56750415|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750416|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56750417|NCT00659438|Bicalutamide|bicalutamide|mesh-list
56023108|NCT04856228|Lidocaine|lidocaine|mesh-list
56750451|NCT00880854|Tremelimumab|tremelimumab|mesh-list
56750452|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750453|NCT00543855|Donepezil|donepezil|mesh-list
56750454|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56023143|NCT00587132|Secretin|secretin|mesh-list
56750481|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750482|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56750483|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
56750484|NCT00797810|Hormones|hormones|mesh-ancestor
56750485|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56750486|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56750487|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56539438|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56539439|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539440|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56539441|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539442|NCT00631228|Everolimus|everolimus|mesh-list
56085943|NCT02659501|Epinephrine|epinephrine|mesh-list
56750488|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
56750489|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
56750490|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750491|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56750492|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56750493|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56750494|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56750495|NCT00873210|Sunitinib|sunitinib|mesh-list
56750496|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750497|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56750498|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56750499|NCT00873210|Growth Substances|growth substances|mesh-ancestor
56750500|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750501|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
56750502|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56750503|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023182|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750534|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750535|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
56750536|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
56750537|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56750538|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750539|NCT00656084|Gemcitabine|gemcitabine|mesh-list
56750540|NCT00656084|Rituximab|rituximab|mesh-list
56750541|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
56750542|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750543|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750544|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
56750545|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750546|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750547|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56750548|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
56750549|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750587|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750588|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750589|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
56750590|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750681|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750682|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
56750683|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
56750684|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
56750685|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750720|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750721|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750722|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56750723|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56750724|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56750725|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
56750726|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
56750754|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
56750755|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750756|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750757|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750758|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750759|NCT00586157|Methylphenidate|methylphenidate|mesh-list
56750760|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56750761|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750762|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56750763|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56750764|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56750765|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539443|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539444|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539445|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
56750766|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
56750767|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750768|NCT04087421|Glycerol|glycerol|mesh-list
56750769|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56750770|NCT04087421|Protective Agents|protective agents|mesh-ancestor
56750771|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750772|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
56750773|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750774|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
56750775|NCT00809744|Vitamin D|vitamin d|mesh-list
56750802|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56750804|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56750805|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56750806|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
56750807|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750808|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750809|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750810|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56750811|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
56750812|NCT01070641|Protective Agents|protective agents|mesh-ancestor
56750813|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56750814|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56750815|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56750816|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
56750817|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56750818|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56750819|NCT00982449|Fialuridine|fialuridine|mesh-list
56750820|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
56750821|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750822|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56750857|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750858|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750859|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750860|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
56750861|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56750897|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750898|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
56750899|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750900|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56023589|NCT00676676|Testosterone|testosterone|mesh-list
56750931|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56750932|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56750934|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750935|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56750936|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56750937|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56750938|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56750939|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56750940|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
56751005|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56751006|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56751007|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56751008|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56751009|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56751010|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751011|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751012|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751013|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56751014|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
56751015|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751017|NCT00652028|Midazolam|midazolam|mesh-list
56751052|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56751053|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
56751054|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
56751055|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
56751056|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539446|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539447|NCT05381038|Paclitaxel|paclitaxel|mesh-list
56539448|NCT05381038|Docetaxel|docetaxel|mesh-list
56751057|NCT02592395|Folfirinox|folfirinox|mesh-list
56751058|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751091|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751093|NCT00613080|Protective Agents|protective agents|mesh-ancestor
56751094|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
56751095|NCT00613080|Vitamins|vitamins|mesh-ancestor
56751096|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
56751097|NCT00917891|Dapivirine|dapivirine|mesh-list
56751098|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56751099|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56751100|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
56751101|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751102|NCT00732875|Methotrexate|methotrexate|mesh-list
56751103|NCT00732875|Infliximab|infliximab|mesh-list
56751140|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56751141|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56751172|NCT03829020|Bortezomib|bortezomib|mesh-list
56751173|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56751174|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751175|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751176|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56751177|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56751178|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
56751179|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751180|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751181|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56751182|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56751183|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
56751184|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751185|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56751186|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
56751187|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56751188|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
56751189|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751190|NCT00874926|Factor VIII|factor viii|mesh-list
56751191|NCT00874926|Coagulants|coagulants|mesh-ancestor
56751225|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56751226|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56751227|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751228|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
56751229|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56751230|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56751231|NCT02552342|Prednisolone|prednisolone|mesh-list
56751232|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
56751233|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56751303|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56751304|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
56751305|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
56751373|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751374|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56751375|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751376|NCT01072747|Heparin|heparin|mesh-list
56751377|NCT01072747|Calcium heparin|calcium heparin|mesh-list
56751378|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
56751379|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56751380|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56751381|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751382|NCT00879372|Tianeptine|tianeptine|mesh-list
56751383|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56751384|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
56024063|NCT04386811|Vitamins|vitamins|mesh-ancestor
56751416|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
56751417|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56751418|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751419|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56751420|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751421|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56751422|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56751423|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56751424|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56751425|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751459|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539449|NCT05381038|Irinotecan|irinotecan|mesh-list
56539450|NCT05381038|Azacitidine|azacitidine|mesh-list
56539451|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56539452|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539453|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
56539454|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
56539455|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56539456|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539457|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56213205|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086409|NCT05448001|Lansoprazole|lansoprazole|mesh-list
56086410|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
56086449|NCT00369811|Analgesics|analgesics|mesh-ancestor
56751460|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56751461|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56751462|NCT00724061|Interferons|interferons|mesh-list
56751463|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
56751464|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
56751465|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56751466|NCT00724061|Furocoumarins|furocoumarins|mesh-list
56751467|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751502|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751503|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56751504|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56751541|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
56751542|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751543|NCT00888732|Insulin|insulin|mesh-list
56751618|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
56751619|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751654|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56751655|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56751656|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
56751657|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
56751658|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
56751659|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751660|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56751695|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56751697|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751698|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751699|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56751700|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56024397|NCT02137538|Letrozole|letrozole|mesh-list
56751725|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
56751726|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751727|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56751728|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56751729|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
56751730|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
56751731|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56751732|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
56751733|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56751734|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
56751735|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56751736|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751737|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56751738|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56751739|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56751740|NCT00883818|Azithromycin|azithromycin|mesh-list
56751741|NCT00883818|Doxycycline|doxycycline|mesh-list
56751742|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56751743|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751744|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
56751745|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56751746|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56539458|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56287712|NCT00000903|Lamivudine|lamivudine|mesh-list
56539459|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539460|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56751747|NCT00889356|Clindamycin|clindamycin|mesh-list
56751748|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
56751749|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
56751750|NCT00889356|Amphotericin B|amphotericin b|mesh-list
56751766|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56751767|NCT00889356|Amebicides|amebicides|mesh-ancestor
56751768|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56751769|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56751770|NCT00889434|Tocotrienols|tocotrienols|mesh-list
56751772|NCT00889434|Tocopherols|tocopherols|mesh-list
56751773|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
56751774|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751775|NCT00889434|Protective Agents|protective agents|mesh-ancestor
56751776|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751777|NCT00889434|Vitamins|vitamins|mesh-ancestor
56751778|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
56751779|NCT00612534|Sufentanil|sufentanil|mesh-list
56751780|NCT00612534|Dsuvia|dsuvia|mesh-list
56751781|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56751782|NCT00612534|Narcotics|narcotics|mesh-ancestor
56751783|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751784|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751785|NCT00612534|Analgesics|analgesics|mesh-ancestor
56751786|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
56751787|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751788|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56751789|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56751790|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
56751791|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
56751792|NCT02542254|Albuterol|albuterol|mesh-list
56751793|NCT02542254|Ipratropium|ipratropium|mesh-list
56751794|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56751795|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
56751796|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751797|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751798|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56751799|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
56751800|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
56751801|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56751802|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56751803|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56751804|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56751805|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
56751806|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751807|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751808|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56751809|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
56751844|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
56751845|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751846|NCT04034004|Naloxone|naloxone|mesh-list
56751847|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56751848|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751849|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
56751850|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751878|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56751879|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751880|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56751881|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
56751883|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
56751884|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
56751885|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751886|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751887|NCT00890214|Epoprostenol|epoprostenol|mesh-list
56751888|NCT00890214|Heparin|heparin|mesh-list
56751889|NCT00890214|Calcium heparin|calcium heparin|mesh-list
56751890|NCT00890214|Tezosentan|tezosentan|mesh-list
56751891|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
56751892|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56751893|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56751894|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751895|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56539461|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
56539462|NCT01473628|Rituximab|rituximab|mesh-list
56539463|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56539464|NCT01473628|Antibodies|antibodies|mesh-list
56539465|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
56751896|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56751897|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
56751898|NCT03627468|Bromides|bromides|mesh-list
56751930|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
56751931|NCT00884442|Nifedipine|nifedipine|mesh-list
56751932|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56751933|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56751934|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751935|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56751936|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751937|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
56751938|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
56024653|NCT01799486|Adefovir|adefovir|mesh-list
56752003|NCT03973957|Analgesics|analgesics|mesh-ancestor
56752004|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
56752005|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752006|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56752007|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56752008|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
56752009|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
56752010|NCT00658658|Panitumumab|panitumumab|mesh-list
56752011|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56752012|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752013|NCT00723203|Panobinostat|panobinostat|mesh-list
56752014|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752015|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56752016|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752017|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752018|NCT00891072|Acetic Acid|acetic acid|mesh-list
56752020|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
56752021|NCT00891072|Carboplatin|carboplatin|mesh-list
56752022|NCT00891072|Retinol acetate|retinol acetate|mesh-list
56752023|NCT00891072|Gossypol|gossypol|mesh-list
56752024|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56752055|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
56752056|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752057|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752058|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56752059|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56752060|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
56752061|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752062|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752063|NCT00800462|Urological Agents|urological agents|mesh-ancestor
56752064|NCT00233389|Rebamipide|rebamipide|mesh-list
56752065|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56752066|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56752067|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
56752068|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752069|NCT00233389|Protective Agents|protective agents|mesh-ancestor
56752070|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752106|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752107|NCT00813722|Losartan|losartan|mesh-list
56752108|NCT00813722|Atenolol|atenolol|mesh-list
56752109|NCT00813722|Amlodipine|amlodipine|mesh-list
56752110|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56752111|NCT00813722|Calcium|calcium|mesh-list
56752112|NCT00813722|Diuretics|diuretics|mesh-list
56752141|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752143|NCT00812396|Testosterone|testosterone|mesh-list
56752144|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
56752145|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
56752146|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56752147|NCT00812396|Androgens|androgens|mesh-ancestor
56752148|NCT00812396|Hormones|hormones|mesh-ancestor
56752149|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56752150|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752151|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56752152|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539466|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56539467|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
56539468|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539469|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539470|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56539471|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
56539472|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56539473|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56539474|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539475|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
56539476|NCT05380960|Coagulants|coagulants|mesh-ancestor
56539477|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
56539478|NCT00604630|Hematinics|hematinics|mesh-ancestor
56539479|NCT01189266|Vorinostat|vorinostat|mesh-list
56539480|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539481|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56539482|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193674|NCT01488955|Analgesics|analgesics|mesh-ancestor
56752153|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
56752154|NCT00807950|Simvastatin|simvastatin|mesh-list
56752155|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56752188|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56752189|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
56752190|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752192|NCT00654368|Methotrexate|methotrexate|mesh-list
56752193|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56752194|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
56752195|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56752230|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
56752231|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
56752232|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
56752233|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
56752234|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752272|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752273|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752302|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56752303|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56752304|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56752306|NCT00646958|Radezolid|radezolid|mesh-list
56752307|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
56752308|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752309|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752310|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56752311|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752312|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752313|NCT00813410|Insulin|insulin|mesh-list
56752314|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56752315|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752316|NCT00642746|Leucovorin|leucovorin|mesh-list
56752317|NCT00642746|Fluorouracil|fluorouracil|mesh-list
56752318|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
56752330|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752331|NCT00642746|Antidotes|antidotes|mesh-ancestor
56752332|NCT00642746|Protective Agents|protective agents|mesh-ancestor
56752333|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
56463370|NCT00490464|Nicardipine|nicardipine|mesh-list
56752334|NCT00642746|Vitamins|vitamins|mesh-ancestor
56752335|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
56752336|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56752337|NCT00814268|Aspirin|aspirin|mesh-list
56752338|NCT00814268|Clopidogrel|clopidogrel|mesh-list
56752339|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56064440|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
56539483|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539484|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56539485|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56539486|NCT01188798|Methotrexate|methotrexate|mesh-list
56539487|NCT01188798|Pentostatin|pentostatin|mesh-list
56087386|NCT00370591|Xhance|xhance|mesh-list
56752340|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56752341|NCT00814268|Analgesics|analgesics|mesh-ancestor
56752342|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
56752343|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752344|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752345|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56752346|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56752347|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56752348|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56752349|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752350|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56752351|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56752352|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752353|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
56752354|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56752355|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56752356|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56752357|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
56752358|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752359|NCT00817622|Vitamin E|vitamin e|mesh-list
56752360|NCT00817622|Vitamins|vitamins|mesh-ancestor
56752361|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
56752362|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752363|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
56752364|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752365|NCT00817622|Protective Agents|protective agents|mesh-ancestor
56752366|NCT00808418|Docetaxel|docetaxel|mesh-list
56752367|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752368|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752369|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752370|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752371|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752372|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
56752373|NCT00642668|Hematinics|hematinics|mesh-ancestor
56752374|NCT00817934|Bisacodyl|bisacodyl|mesh-list
56752375|NCT00817934|Cathartics|cathartics|mesh-ancestor
56752376|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56752377|NCT00817934|Laxatives|laxatives|mesh-ancestor
56752378|NCT00729833|Sunitinib|sunitinib|mesh-list
56752379|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752380|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56752381|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56752382|NCT00729833|Growth Substances|growth substances|mesh-ancestor
56752383|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752412|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752413|NCT00642356|Levodopa|levodopa|mesh-list
56752414|NCT00642356|Carbidopa|carbidopa|mesh-list
56752415|NCT00642356|Entacapone|entacapone|mesh-list
56752416|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56752417|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56752418|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56752419|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
56752420|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752421|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752422|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752423|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56752424|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752425|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56752426|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56752427|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
56752455|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
56752456|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56752457|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56752458|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
56752459|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56539488|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56539489|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
56539490|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56539491|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539492|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56539493|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
56539494|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539495|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539496|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
56539497|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539498|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56539499|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539500|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
56539501|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56539502|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56539503|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56539504|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56539505|NCT01183104|Glimepiride|glimepiride|mesh-list
56539506|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539507|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539508|NCT01183104|Incretins|incretins|mesh-ancestor
56539509|NCT01183104|Hormones|hormones|mesh-ancestor
56539510|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539511|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56539512|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
56752460|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
56752461|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
56752462|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
56752463|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56752464|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56752465|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
56752466|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752467|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752468|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56752469|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56752470|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56752471|NCT02551796|Levofloxacin|levofloxacin|mesh-list
56752472|NCT02551796|Ofloxacin|ofloxacin|mesh-list
56752473|NCT02551796|Tobramycin|tobramycin|mesh-list
56752474|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56752475|NCT02551796|Dexamethasone|dexamethasone|mesh-list
56752476|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
56752504|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
56752505|NCT02551796|Protective Agents|protective agents|mesh-ancestor
56752506|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56752507|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
56752508|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752509|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56539513|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539514|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539515|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56752510|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56752511|NCT00723125|Paclitaxel|paclitaxel|mesh-list
56752512|NCT00723125|Bevacizumab|bevacizumab|mesh-list
56752513|NCT00723125|Carboplatin|carboplatin|mesh-list
56752514|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56752515|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56752516|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752517|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752518|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752519|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752520|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752521|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56752522|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56752523|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56752524|NCT00723125|Growth Substances|growth substances|mesh-ancestor
56025180|NCT01028846|Diazoxide|diazoxide|mesh-list
56752560|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
56752561|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752562|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752595|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56752596|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56752597|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56752598|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752599|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752600|NCT00254293|Abatacept|abatacept|mesh-list
56752601|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56752602|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56752603|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752604|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752605|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752606|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
56752642|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752643|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
56752644|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025323|NCT00727298|Infliximab|infliximab|mesh-list
56752682|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
56025345|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
56463754|NCT00491517|Sirolimus|sirolimus|mesh-list
56752714|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752715|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
56752716|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56752717|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752718|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752719|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
56752720|NCT00252499|Fenofibrate|fenofibrate|mesh-list
56752721|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56752722|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752723|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56752724|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
56752725|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752791|NCT00891384|Lenalidomide|lenalidomide|mesh-list
56752792|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
56752793|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752794|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56752795|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56752796|NCT00891384|Growth Substances|growth substances|mesh-ancestor
56752797|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
56752798|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752799|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56752800|NCT00887328|Plasminogen|plasminogen|mesh-list
56752801|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56752802|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56752803|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752804|NCT00609336|Gemcitabine|gemcitabine|mesh-list
56752805|NCT00609336|Capecitabine|capecitabine|mesh-list
56752806|NCT00609336|Docetaxel|docetaxel|mesh-list
56752841|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56752842|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56752844|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
56539516|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539517|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
56539518|NCT02885688|Insulin|insulin|mesh-list
56539519|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56752845|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752846|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752873|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752874|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56752875|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
56752876|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56752877|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752878|NCT00640328|Ofatumumab|ofatumumab|mesh-list
56752879|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56752880|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752881|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
56752882|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752883|NCT04036890|Minocycline|minocycline|mesh-list
56752884|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752885|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752886|NCT00162097|Efavirenz|efavirenz|mesh-list
56752887|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56752888|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56752889|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56752890|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752891|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752892|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
56752893|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752894|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56752895|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56025548|NCT02992652|Allopurinol|allopurinol|mesh-list
56752931|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752932|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752933|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56752961|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752962|NCT02542098|Analgesics|analgesics|mesh-ancestor
56752963|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
56752964|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752965|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
56752966|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
56752967|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56752968|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
56752969|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752970|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
56752971|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56752972|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752973|NCT00885066|Gemcitabine|gemcitabine|mesh-list
56752974|NCT00885066|Capecitabine|capecitabine|mesh-list
56752975|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56752976|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56752977|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
56752978|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025629|NCT01278290|Hormones|hormones|mesh-ancestor
56753012|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56753013|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56464035|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
56753014|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56753015|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753016|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753017|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56753018|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56753110|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753111|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753113|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56753114|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56753115|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56753116|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753117|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56753118|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753119|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
56753120|NCT03324984|Bupivacaine|bupivacaine|mesh-list
56539520|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539521|NCT00950248|Idebenone|idebenone|mesh-list
56539522|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
56753121|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
56753122|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
56753123|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
56753158|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753159|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56753160|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
56753198|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56753199|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
56753200|NCT00638690|Hormones|hormones|mesh-ancestor
56753201|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56753230|NCT00893724|Protective Agents|protective agents|mesh-ancestor
56753231|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56753232|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753233|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
56753234|NCT00893724|Expectorants|expectorants|mesh-ancestor
56753235|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
56753236|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56753237|NCT00893724|Antidotes|antidotes|mesh-ancestor
56753238|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
56753239|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56753240|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
56753241|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56753242|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
56753244|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56753245|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
56753246|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753247|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753248|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56753249|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
56753250|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56753286|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753287|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753289|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753290|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
56753291|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
56753323|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753324|NCT00983151|Tramadol|tramadol|mesh-list
56753325|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56753326|NCT00983151|Narcotics|narcotics|mesh-ancestor
56753327|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753328|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753329|NCT00983151|Analgesics|analgesics|mesh-ancestor
56753330|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
56753331|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753363|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753364|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753365|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56753366|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56753367|NCT04035876|Apatinib|apatinib|mesh-list
56753368|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753369|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753370|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753371|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753372|NCT00902070|Rocuronium|rocuronium|mesh-list
56753403|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753404|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56753405|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56753406|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56753407|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
56753408|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56753409|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56753410|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
56753411|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56753412|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
56753413|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56753448|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56753449|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
56753450|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753451|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
56539523|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753452|NCT00809198|Protective Agents|protective agents|mesh-ancestor
56753453|NCT00809198|Laxatives|laxatives|mesh-ancestor
56753489|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
56753490|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56753491|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56753492|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753493|NCT00721409|Letrozole|letrozole|mesh-list
56753494|NCT00721409|Palbociclib|palbociclib|mesh-list
56753521|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
56753522|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753523|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753524|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56753525|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
56753526|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
56753527|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56753528|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
56753529|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753530|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753531|NCT02591771|Epinephrine|epinephrine|mesh-list
56753532|NCT02591771|Racepinephrine|racepinephrine|mesh-list
56753533|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
56753534|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56753535|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56753536|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
56753537|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56923652|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56753538|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753539|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753577|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753578|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026242|NCT01274624|Vitamins|vitamins|mesh-ancestor
56753640|NCT00627926|Interferons|interferons|mesh-list
56753641|NCT00627926|Ribavirin|ribavirin|mesh-list
56753642|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
56753643|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
56753644|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56753645|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753646|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
56026306|NCT00762320|Ritonavir|ritonavir|mesh-list
56753679|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56753680|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56753681|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56753682|NCT00895128|Dasatinib|dasatinib|mesh-list
56753683|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753684|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56026387|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56753752|NCT02540070|Narcotics|narcotics|mesh-ancestor
56753753|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
56753754|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
56753755|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56753756|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56753757|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
56753758|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56753759|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
56753761|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
56753794|NCT00906048|Levofloxacin|levofloxacin|mesh-list
56753796|NCT00906048|Rifampin|rifampin|mesh-list
56753797|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56753798|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753799|NCT00906048|Renal Agents|renal agents|mesh-ancestor
56753800|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56753801|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56753802|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56753837|NCT00643760|Gabapentin|gabapentin|mesh-list
56753838|NCT00643760|Analgesics|analgesics|mesh-ancestor
56026508|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
56753871|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753872|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753873|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56753874|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56753875|NCT00906360|Growth Substances|growth substances|mesh-ancestor
56753876|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
56753877|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753878|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753879|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539524|NCT00950248|Protective Agents|protective agents|mesh-ancestor
56539525|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539527|NCT04269928|Racepinephrine|racepinephrine|mesh-list
56753948|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56753949|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
56753950|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753951|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753952|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56753953|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56753954|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56753955|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56753956|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56753957|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
56753958|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753959|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753960|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56753998|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753999|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754000|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56754001|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56754037|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56026702|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56754073|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754074|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
56754075|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56754076|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56754077|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754078|NCT00159913|Urological Agents|urological agents|mesh-ancestor
56754079|NCT05498259|Rituximab|rituximab|mesh-list
56754109|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56754110|NCT00604188|Buprenorphine|buprenorphine|mesh-list
56754111|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56754112|NCT00604188|Narcotics|narcotics|mesh-ancestor
56754113|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754114|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754115|NCT00604188|Analgesics|analgesics|mesh-ancestor
56754116|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
56754117|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754118|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56754119|NCT00820352|Bosentan|bosentan|mesh-list
56754120|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56754121|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56754122|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754123|NCT00927654|Iloprost|iloprost|mesh-list
56754124|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56754143|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56754144|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56754145|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
56754146|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56754147|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56754148|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56754149|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56754150|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56754151|NCT00227539|Pemetrexed|pemetrexed|mesh-list
56754152|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56754153|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754154|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754155|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754156|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56754157|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56754158|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56754159|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56754160|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
56754161|NCT04414761|Cetrorelix|cetrorelix|mesh-list
56754162|NCT04414761|Progesterone|progesterone|mesh-list
56754163|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
56754164|NCT04414761|Ganirelix|ganirelix|mesh-list
56754165|NCT04414761|Progestins|progestins|mesh-ancestor
56754166|NCT04414761|Hormones|hormones|mesh-ancestor
56754167|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56754168|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539528|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
56539529|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56539530|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56088622|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
56754169|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56754170|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56754171|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56754172|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
56754173|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56754174|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56754175|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56754176|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56754177|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56754178|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754179|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
56754180|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56754181|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
56754208|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56754209|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56754210|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754211|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754213|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754214|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56754215|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56754216|NCT00720941|Growth Substances|growth substances|mesh-ancestor
56754217|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754218|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
56754219|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56754220|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754221|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754222|NCT00924222|Propofol|propofol|mesh-list
56754223|NCT00924222|Sevoflurane|sevoflurane|mesh-list
56754224|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56754225|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754226|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754227|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56754228|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
56754229|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
56754266|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56754267|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56754298|NCT05698407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56754299|NCT05698407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754300|NCT05698407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754301|NCT05698407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56754302|NCT05698407|Analgesics|analgesics|mesh-ancestor
56754303|NCT05698407|Sensory System Agents|sensory system agents|mesh-ancestor
56754304|NCT05698407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754305|NCT05698407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56754306|NCT05698407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56754307|NCT05698407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56754308|NCT05698407|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754309|NCT05698407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026968|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754344|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754345|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754347|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754348|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56754387|NCT00568958|Naltrexone|naltrexone|mesh-list
56754388|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56027062|NCT05742698|Nabilone|nabilone|mesh-list
56754422|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754423|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56754424|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754425|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
56754426|NCT00821054|Lapatinib|lapatinib|mesh-list
56754427|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754428|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56754429|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754430|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754431|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
56539531|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
56539532|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539533|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539534|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539535|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56539536|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56539537|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
56539538|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539539|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56539540|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
56539541|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
56539542|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
56539543|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56539544|NCT00950170|Factor VIII|factor viii|mesh-list
56754432|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754458|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56754459|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754460|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
56754461|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754462|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754463|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56754464|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56754465|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754466|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
56754467|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56754468|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56754469|NCT04085627|Amlodipine|amlodipine|mesh-list
56754470|NCT04085627|Valsartan|valsartan|mesh-list
56754471|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56754472|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56754473|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56754474|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56754475|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754476|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56754505|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56754506|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56923654|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
56465527|NCT00475553|NuvaRing|nuvaring|mesh-list
56754507|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56754508|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56754509|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56754510|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56754511|NCT01075789|Lidocaine|lidocaine|mesh-list
56754512|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
56754513|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
56754514|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754515|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754516|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
56754517|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754546|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56754547|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754548|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754550|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56754551|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754552|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754553|NCT00929058|Bevacizumab|bevacizumab|mesh-list
56754554|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064534|NCT02525549|Analgesics|analgesics|mesh-ancestor
56539545|NCT00950170|Coagulants|coagulants|mesh-ancestor
56539546|NCT00604864|Infliximab|infliximab|mesh-list
56539547|NCT00604864|Antibodies|antibodies|mesh-list
56539548|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56539549|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
56754555|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754556|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56754557|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56754558|NCT00929058|Growth Substances|growth substances|mesh-ancestor
56754559|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754560|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
56754561|NCT05346393|Terlipressin|terlipressin|mesh-list
56754619|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56754620|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754621|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56754622|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56754623|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
56754624|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754625|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56754626|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
56754627|NCT05313477|Vitamin D|vitamin d|mesh-list
56754628|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
56754629|NCT05313477|Calcium|calcium|mesh-list
56754630|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56754631|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754632|NCT05313477|Antacids|antacids|mesh-ancestor
56027297|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
56754663|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
56754664|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
56754665|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
56754666|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754668|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56754669|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754670|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
56754671|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754672|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56754673|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56754674|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56027344|NCT00789776|Fludarabine|fludarabine|mesh-list
56754769|NCT02538432|Antiviral Agents|antiviral agents|mesh-ancestor
56754770|NCT02538432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754771|NCT02538432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754772|NCT02538432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754773|NCT02538432|Immunologic Factors|immunologic factors|mesh-ancestor
56754774|NCT02538432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754775|NCT00719849|Cyclosporine|cyclosporine|mesh-list
56754776|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
56754833|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754834|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56754835|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56754836|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56754837|NCT02592941|Deflazacort|deflazacort|mesh-list
56754838|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56754839|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754840|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
56754841|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754842|NCT00822614|Fentanyl|fentanyl|mesh-list
56754843|NCT00822614|Morphine|morphine|mesh-list
56754844|NCT00822614|Oxycodone|oxycodone|mesh-list
56754845|NCT00822614|Hydromorphone|hydromorphone|mesh-list
56754846|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56754847|NCT00822614|Narcotics|narcotics|mesh-ancestor
56754848|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754849|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754850|NCT00822614|Analgesics|analgesics|mesh-ancestor
56754851|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
56754852|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754853|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56754854|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56754855|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
56754856|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
56754857|NCT04087967|Cytarabine|cytarabine|mesh-list
56754858|NCT04087967|Decitabine|decitabine|mesh-list
56754859|NCT04087967|Idarubicin|idarubicin|mesh-list
56027515|NCT01318967|Furosemide|furosemide|mesh-list
56539550|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539551|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
56539552|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56539553|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56539554|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
56754892|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754894|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56754895|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56754896|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
56754897|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754898|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56754899|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
56754900|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
56754963|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754965|NCT00822848|Epirubicin|epirubicin|mesh-list
56754966|NCT00822848|Ifosfamide|ifosfamide|mesh-list
56754967|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754968|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56754969|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754970|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754971|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56754972|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56754973|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56754974|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56754975|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
56755002|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56755003|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56755004|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755005|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755006|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56755007|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
56755008|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755009|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755010|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56755011|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56755012|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56755013|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
56755014|NCT00827450|Caffeine|caffeine|mesh-list
56755015|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56755016|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755017|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56755018|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755019|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755020|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56755021|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56755022|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
56755023|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755024|NCT03612960|Nicotine|nicotine|mesh-list
56755058|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56755059|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56755060|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56755061|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56755063|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56755064|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
56755065|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027734|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56755092|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
56755093|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755094|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
56755095|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755096|NCT00927030|Melatonin|melatonin|mesh-list
56755097|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
56755098|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755099|NCT00927030|Protective Agents|protective agents|mesh-ancestor
56755100|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755101|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755102|NCT00931866|Diclofenac|diclofenac|mesh-list
56755103|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56539555|NCT01227824|Dolutegravir|dolutegravir|mesh-list
56539556|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56539557|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56539558|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
56193763|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755104|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56755105|NCT00931866|Analgesics|analgesics|mesh-ancestor
56755106|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
56755107|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755108|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755109|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56755110|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56755111|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56755112|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027775|NCT01355705|Lenalidomide|lenalidomide|mesh-list
56755143|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755144|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755146|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755147|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56755148|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56755149|NCT00932100|Heparin|heparin|mesh-list
56755150|NCT00932100|Calcium heparin|calcium heparin|mesh-list
56755151|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56755152|NCT00932100|Tinzaparin|tinzaparin|mesh-list
56755153|NCT00932100|Dalteparin|dalteparin|mesh-list
56755154|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
56755155|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56755156|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56755157|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755190|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56755192|NCT04469556|Protective Agents|protective agents|mesh-ancestor
56755193|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
56755194|NCT04469556|Vitamins|vitamins|mesh-ancestor
56755195|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
56755196|NCT03125811|Ethanol|ethanol|mesh-list
56755197|NCT03125811|Ondansetron|ondansetron|mesh-list
56755198|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56755199|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755200|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755201|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027895|NCT04645550|Heparin|heparin|mesh-list
56755233|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56755234|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755235|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56755236|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755237|NCT05046639|Lidocaine|lidocaine|mesh-list
56755238|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
56755239|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
56755240|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755241|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755242|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
56755243|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755244|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56755245|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56027936|NCT04699838|Etoposide|etoposide|mesh-list
56755271|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56755272|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56755273|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56755274|NCT00932880|Amlodipine|amlodipine|mesh-list
56755275|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56755276|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56755277|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56755278|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755279|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56755280|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755281|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
56755282|NCT00937482|Cediranib|cediranib|mesh-list
56755283|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755284|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755285|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755286|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56755287|NCT03401853|Rituximab|rituximab|mesh-list
56539559|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539560|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56755288|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56755289|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
56755290|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
56755291|NCT03401853|Antibodies|antibodies|mesh-list
56755327|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755328|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755329|NCT02549066|Protective Agents|protective agents|mesh-ancestor
56755359|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56755360|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755361|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755362|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56755363|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56755364|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56755365|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56755366|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56755367|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56755368|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
56755369|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56755405|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56755407|NCT00933582|Analgesics|analgesics|mesh-ancestor
56755439|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755440|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755441|NCT01563939|Analgesics|analgesics|mesh-ancestor
56755442|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
56755443|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755444|NCT03287271|Paclitaxel|paclitaxel|mesh-list
56755445|NCT03287271|Carboplatin|carboplatin|mesh-list
56755446|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56755447|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755448|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
56755449|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
56755450|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
56755451|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755452|NCT00990405|Amoxicillin|amoxicillin|mesh-list
56755482|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
56755483|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755484|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
56755485|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755486|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
56755487|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56755488|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56755489|NCT00622700|Teriflunomide|teriflunomide|mesh-list
56755490|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56755491|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56755492|NCT00622700|Analgesics|analgesics|mesh-ancestor
56755493|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
56755494|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755526|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56755527|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56755528|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755529|NCT00622466|Paclitaxel|paclitaxel|mesh-list
56755530|NCT00622466|Sorafenib|sorafenib|mesh-list
56755531|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56755532|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755533|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
56755534|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
56755535|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
56755536|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755537|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56755538|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755602|NCT03823911|Grazoprevir|grazoprevir|mesh-list
56755604|NCT03823911|Velpatasvir|velpatasvir|mesh-list
56755605|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56755606|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56755607|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
56755608|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755609|NCT00829634|Methamphetamine|methamphetamine|mesh-list
56755610|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56755611|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539561|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56539562|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539563|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539564|NCT00949702|Vemurafenib|vemurafenib|mesh-list
56539565|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539566|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56755612|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
56755613|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
56755614|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755615|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
56755616|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755617|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755618|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56755649|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56755650|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56755651|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56755652|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
56755653|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56755654|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755655|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56755656|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56755657|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755658|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755659|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755660|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56755661|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56755662|NCT00832364|Etanercept|etanercept|mesh-list
56755663|NCT00832364|Acitretin|acitretin|mesh-list
56755696|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56755697|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56755698|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56755699|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
56755700|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56755701|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56755702|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56755703|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56755704|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56755705|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
56755706|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56755739|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755740|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56755742|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
56755743|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56755744|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755745|NCT02550080|Dapsone|dapsone|mesh-list
56755746|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755782|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
56755783|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755784|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56755821|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
56755839|NCT05359341|Empagliflozin|empagliflozin|mesh-list
56755840|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56755841|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56755842|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56755843|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755844|NCT05359341|Incretins|incretins|mesh-ancestor
56755846|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755847|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
56755848|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755849|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755850|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56755851|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56755852|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
56755853|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755854|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755855|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539567|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539568|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539569|NCT01034631|Everolimus|everolimus|mesh-list
56539570|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193773|NCT01489566|Mitomycins|mitomycins|mesh-list
56755856|NCT00838760|Darunavir|darunavir|mesh-list
56755857|NCT00838760|TMC-310911|tmc-310911|mesh-list
56755858|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56755859|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56755860|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
56755861|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755862|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755863|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56755864|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56755865|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
56755866|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755867|NCT03791398|Nivolumab|nivolumab|mesh-list
56755868|NCT03791398|TIC10 compound|tic10 compound|mesh-list
56755869|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56755870|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755871|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56755872|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755873|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
56755874|NCT00838838|Testosterone|testosterone|mesh-list
56755875|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
56755876|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
56755877|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56755878|NCT00838838|Androgens|androgens|mesh-ancestor
56028544|NCT02203565|Eusol|eusol|mesh-list
56755913|NCT05591001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755914|NCT05591001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56755915|NCT05591001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56755916|NCT05591001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56755917|NCT05591001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755918|NCT05591001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755946|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755947|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56755948|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755950|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
56755951|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56755952|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
56755953|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
56755954|NCT00839462|Vitamins|vitamins|mesh-ancestor
56755955|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
56755956|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755957|NCT05590221|Cyclophosphamide|cyclophosphamide|mesh-list
56755958|NCT05590221|Fludarabine|fludarabine|mesh-list
56755959|NCT05590221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755960|NCT05590221|Immunologic Factors|immunologic factors|mesh-ancestor
56755961|NCT05590221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755962|NCT05590221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56755963|NCT05590221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56755964|NCT05590221|Alkylating Agents|alkylating agents|mesh-ancestor
56755965|NCT05590221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755966|NCT05590221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755998|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
56755999|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756000|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467019|NCT04518735|Anticoagulants|anticoagulants|mesh-list
56756001|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
56756002|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756003|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56756004|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56756005|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56756006|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56756007|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756008|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
56756009|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56756043|NCT05589441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56065043|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56539571|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539572|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
56539573|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539574|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
56539575|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
56756044|NCT05589441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756045|NCT05589441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56756046|NCT05589441|Autonomic Agents|autonomic agents|mesh-ancestor
56756047|NCT05589441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756048|NCT05589441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56756049|NCT05589441|Respiratory System Agents|respiratory system agents|mesh-ancestor
56756050|NCT05589441|Tocolytic Agents|tocolytic agents|mesh-ancestor
56756051|NCT05589441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56756081|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56756082|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56756083|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56756084|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
56756085|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756086|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756087|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56756088|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
56756089|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
56756090|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
56756091|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56756092|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56756093|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
56756094|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756125|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
56756126|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
56756127|NCT05407233|Insulin|insulin|mesh-list
56756128|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56756129|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56756130|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756131|NCT02549846|Atorvastatin|atorvastatin|mesh-list
56756132|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56756133|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56756134|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56756135|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
56756136|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756172|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756173|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756174|NCT00537303|Insulin|insulin|mesh-list
56756175|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56756176|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
56756177|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
56756213|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
56756214|NCT04696575|Atezolizumab|atezolizumab|mesh-list
56756215|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
56756216|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56756217|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756249|NCT05558007|Urological Agents|urological agents|mesh-ancestor
56756250|NCT00505414|Morphine|morphine|mesh-list
56756251|NCT00505414|Tapentadol|tapentadol|mesh-list
56756252|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56756253|NCT00505414|Narcotics|narcotics|mesh-ancestor
56756254|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756255|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756256|NCT00505414|Analgesics|analgesics|mesh-ancestor
56756257|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
56028941|NCT00825266|Pioglitazone|pioglitazone|mesh-list
56756313|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
56756314|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56756315|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756316|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
56756317|NCT02548052|Hormones|hormones|mesh-ancestor
56756318|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756319|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756320|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56756321|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
56756322|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
56756323|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56756324|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56756325|NCT04590417|Estradiol|estradiol|mesh-list
56539576|NCT01409200|Axitinib|axitinib|mesh-list
56539577|NCT01409200|Hormones|hormones|mesh-list
56539578|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56539579|NCT01409200|Androgens|androgens|mesh-list
56539580|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
56539581|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539582|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539583|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
56193782|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56756326|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56756327|NCT04590417|Cyproterone|cyproterone|mesh-list
56756328|NCT04590417|Estrogens|estrogens|mesh-ancestor
56756329|NCT04590417|Hormones|hormones|mesh-ancestor
56756330|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756331|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756332|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56756333|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
56756334|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56756335|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56756363|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
56756364|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756366|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56756367|NCT00841256|Protective Agents|protective agents|mesh-ancestor
56756368|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756369|NCT00989703|Methotrexate|methotrexate|mesh-list
56467391|NCT01240941|Exemestane|exemestane|mesh-list
56756370|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56756371|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
56756373|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756374|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56756375|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
56756376|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756377|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756378|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
56756379|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756380|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56756381|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756382|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
56756405|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756406|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
56756407|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56756408|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756409|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756410|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56756411|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56756412|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56756413|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56756414|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56756415|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56756416|NCT02549690|Testosterone|testosterone|mesh-list
56756417|NCT02549690|Androgens|androgens|mesh-ancestor
56756419|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756420|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756421|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
56756422|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56756423|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756424|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756425|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56756426|NCT02549768|Analgesics|analgesics|mesh-ancestor
56756427|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
56756428|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756429|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56756430|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56756431|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56539584|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539585|NCT01409200|Protective Agents|protective agents|mesh-ancestor
56539586|NCT01409200|Vitamins|vitamins|mesh-ancestor
56539587|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
56539588|NCT01409200|Estrogens|estrogens|mesh-ancestor
56539589|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56539590|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539591|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
56539592|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56539593|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539594|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
56539595|NCT01227668|Aripiprazole|aripiprazole|mesh-list
56539596|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
56539597|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193791|NCT01489631|Sufentanil|sufentanil|mesh-list
56756432|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
56756466|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56756467|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756468|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56756469|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756470|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756471|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
56756576|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
56756577|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56756578|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756579|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56756580|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56756581|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56756582|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756583|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756584|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56029272|NCT04411446|Vitamin D|vitamin d|mesh-list
56756618|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
56756619|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756620|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756621|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756623|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
56756624|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756640|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756641|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56756642|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56756643|NCT00509236|Glipizide|glipizide|mesh-list
56756644|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56756645|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756646|NCT00509236|Incretins|incretins|mesh-ancestor
56756647|NCT00509236|Hormones|hormones|mesh-ancestor
56756648|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756649|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56756650|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
56756651|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756652|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756653|NCT00842894|Insulin|insulin|mesh-list
56756654|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56756655|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
56756656|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
56756657|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
56756658|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56756659|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56756660|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756661|NCT00508924|Heparin|heparin|mesh-list
56756662|NCT00508924|Argatroban|argatroban|mesh-list
56539598|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56539599|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56539600|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56539601|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539602|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
56539603|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
56539604|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539605|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539606|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56539607|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56756663|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
56756664|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56756665|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56756666|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756667|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
56756668|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56756669|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
56756670|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756671|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56756672|NCT00836576|Benazepril|benazepril|mesh-list
56756673|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56756674|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
56756675|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756676|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756677|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56756678|NCT00836654|Catumaxomab|catumaxomab|mesh-list
56756679|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56756680|NCT00844064|Trabedersen|trabedersen|mesh-list
56756681|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756682|NCT04688788|Fexofenadine|fexofenadine|mesh-list
56756683|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
56756684|NCT04688788|Rituximab|rituximab|mesh-list
56756714|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56756715|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756716|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756717|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
56756718|NCT00844142|Etanercept|etanercept|mesh-list
56756719|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56756720|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56756721|NCT00844142|Analgesics|analgesics|mesh-ancestor
56756722|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
56756723|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756724|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756725|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756726|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756727|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56756728|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756763|NCT04232085|Fludarabine|fludarabine|mesh-list
56756764|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
56756765|NCT04232085|Tacrolimus|tacrolimus|mesh-list
56756766|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756767|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
56756768|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756769|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029455|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756803|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
56756804|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756805|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756806|NCT03541486|Antiviral Agents|antiviral agents|mesh-ancestor
56756807|NCT03541486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756808|NCT03541486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756834|NCT02547896|Codeine|codeine|mesh-list
56756835|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56756836|NCT02547896|Analgesics|analgesics|mesh-ancestor
56756837|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
56539608|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
56539609|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56756838|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756839|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756840|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756841|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756842|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56756843|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756844|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756845|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56756846|NCT02547896|Narcotics|narcotics|mesh-ancestor
56756847|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756848|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
56756849|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
56756850|NCT01564251|Gemcitabine|gemcitabine|mesh-list
56756851|NCT01564251|GDC-0575|gdc-0575|mesh-list
56756852|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56756853|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
56756854|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756855|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756856|NCT01564251|Antiviral Agents|antiviral agents|mesh-ancestor
56756857|NCT01564251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756858|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756859|NCT01564251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756885|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
56756886|NCT02545712|Sorbitol|sorbitol|mesh-list
56756887|NCT02545712|Glycerol|glycerol|mesh-list
56756888|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56756889|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756890|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756891|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756892|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56756893|NCT02545712|Protective Agents|protective agents|mesh-ancestor
56756894|NCT02545712|Cathartics|cathartics|mesh-ancestor
56756895|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56756896|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
56756898|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
56756899|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756900|NCT01011010|Doxorubicin|doxorubicin|mesh-list
56756901|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56756902|NCT01011010|Mitomycins|mitomycins|mesh-list
56756903|NCT01011010|Mitomycin|mitomycin|mesh-list
56756904|NCT01011010|Sorafenib|sorafenib|mesh-list
56756905|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56756906|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756907|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56756908|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56756909|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029587|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756977|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56756978|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
56756979|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756980|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756981|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56756982|NCT00844688|Gemcitabine|gemcitabine|mesh-list
56756984|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56756985|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
56756986|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756987|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756988|NCT00844688|Antiviral Agents|antiviral agents|mesh-ancestor
56029676|NCT02476968|Olaparib|olaparib|mesh-list
56757016|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757017|NCT00851942|Cosyntropin|cosyntropin|mesh-list
56757019|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757020|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757021|NCT00503776|Amifostine|amifostine|mesh-list
56757022|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56757023|NCT00503776|Protective Agents|protective agents|mesh-ancestor
56757024|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757025|NCT02545634|Sulfalene|sulfalene|mesh-list
56757026|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757027|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56757028|NCT02545634|Renal Agents|renal agents|mesh-ancestor
56757029|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
56539610|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56539611|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56539612|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56539613|NCT01227512|Tolvaptan|tolvaptan|mesh-list
56539614|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56539615|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539616|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
56539617|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539618|NCT01227278|Benralizumab|benralizumab|mesh-list
56539619|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56539620|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
56539621|NCT01227044|Naltrexone|naltrexone|mesh-list
56539622|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56539623|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56757030|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56757031|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56757032|NCT05260671|Cetuximab|cetuximab|mesh-list
56757033|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56757034|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757035|NCT00855686|Memantine|memantine|mesh-list
56757036|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56757037|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56757054|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
56757055|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757056|NCT00845156|Protective Agents|protective agents|mesh-ancestor
56757057|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757058|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
56757059|NCT00845156|Vitamins|vitamins|mesh-ancestor
56757060|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
56757061|NCT03262935|Capecitabine|capecitabine|mesh-list
56757062|NCT03262935|Trastuzumab|trastuzumab|mesh-list
56757063|NCT03262935|Vinorelbine|vinorelbine|mesh-list
56757064|NCT03262935|Lapatinib|lapatinib|mesh-list
56757065|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757066|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
56757067|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757068|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757069|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56757070|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56757071|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
56757072|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
56757073|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
56757074|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56757075|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757076|NCT00852332|Curcumin|curcumin|mesh-list
56757077|NCT00852332|Docetaxel|docetaxel|mesh-list
56757078|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757079|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
56757080|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
56757081|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
56757082|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757083|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56757084|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56757085|NCT00852332|Analgesics|analgesics|mesh-ancestor
56757086|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
56757087|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757088|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757089|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757090|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56757091|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757092|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
56757093|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56539624|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539625|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
56539626|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539627|NCT01034163|Panobinostat|panobinostat|mesh-list
56539628|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539629|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56539630|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539631|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539632|NCT01162122|Vaccines|vaccines|mesh-list
56539633|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
56539634|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539635|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56539636|NCT01033071|Olmesartan|olmesartan|mesh-list
56539637|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56539638|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
56193832|NCT01489696|Tamsulosin|tamsulosin|mesh-list
56757094|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56757120|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56757121|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
56757122|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
56757123|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
56757124|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56757125|NCT00992121|Bevacizumab|bevacizumab|mesh-list
56757126|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56757127|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757128|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56757129|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56757130|NCT00992121|Growth Substances|growth substances|mesh-ancestor
56757131|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757132|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
56757133|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56757134|NCT04420299|Bemiparin|bemiparin|mesh-list
56757135|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
56757136|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56757137|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56757138|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757139|NCT00992199|Fluorouracil|fluorouracil|mesh-list
56757140|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757141|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
56757142|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757143|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757177|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
56757178|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757179|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757180|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56757181|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
56757182|NCT00992355|Hormones|hormones|mesh-ancestor
56757183|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757184|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56757185|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757186|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
56757187|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757219|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757220|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757222|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
56757223|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56757224|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56757225|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56539639|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56539640|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56539641|NCT01033071|Diuretics|diuretics|mesh-ancestor
56539642|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
56539643|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539644|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56539645|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56539646|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539647|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56539648|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56539649|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56539650|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
56539651|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539652|NCT04589325|Ixekizumab|ixekizumab|mesh-list
56539653|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
56539654|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56539655|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539656|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56539657|NCT02873559|Testosterone|testosterone|mesh-list
56539658|NCT02873559|Androgens|androgens|mesh-ancestor
56539659|NCT02873559|Hormones|hormones|mesh-ancestor
56757226|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757227|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757228|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757259|NCT00852956|Betahistine|betahistine|mesh-list
56757260|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
56757261|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
56757262|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
56757263|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757264|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757265|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757266|NCT00716417|Afatinib|afatinib|mesh-list
56757267|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757268|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56757269|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757270|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757271|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
56757272|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56757273|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757304|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757306|NCT00853190|Narcotics|narcotics|mesh-ancestor
56757307|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757308|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757309|NCT00853190|Analgesics|analgesics|mesh-ancestor
56757310|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
56757311|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757312|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
56757313|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
56757314|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
56757315|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
56029991|NCT01541735|Pantoprazole|pantoprazole|mesh-list
56757351|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56539660|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539661|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539662|NCT01029795|Glyburide|glyburide|mesh-list
56539663|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539664|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539665|NCT02885454|Simeprevir|simeprevir|mesh-list
56539666|NCT02885454|Odalasvir|odalasvir|mesh-list
56539667|NCT02885454|Drospirenone|drospirenone|mesh-list
56539668|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56539669|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56539670|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56539671|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56539672|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56539673|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
56539674|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56539675|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539676|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56539677|NCT02885454|Estrogens|estrogens|mesh-ancestor
56539678|NCT02885454|Hormones|hormones|mesh-ancestor
56539679|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539680|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56539681|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
56539682|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56539683|NCT02885454|Diuretics|diuretics|mesh-ancestor
56539684|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
56539685|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
56539686|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539687|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
56539688|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539689|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757352|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757353|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56757355|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56757356|NCT00853268|Narcotics|narcotics|mesh-ancestor
56757420|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757421|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56757422|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
56757423|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757424|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757425|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56757426|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56757427|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
56539691|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
56539692|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539693|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539694|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757428|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757465|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56757466|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56757468|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
56757535|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
56757536|NCT00849368|Protective Agents|protective agents|mesh-ancestor
56757537|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757538|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757539|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757540|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757541|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
56757542|NCT02544932|Warfarin|warfarin|mesh-list
56757543|NCT02544932|Dabigatran|dabigatran|mesh-list
56757544|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
56757545|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
56757576|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
56757577|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56757578|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56757579|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56757580|NCT00859118|Axitinib|axitinib|mesh-list
56757581|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757582|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56757583|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757584|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757585|NCT00849602|Chloroquine|chloroquine|mesh-list
56757586|NCT00849602|Amebicides|amebicides|mesh-ancestor
56030255|NCT04380818|Dalteparin|dalteparin|mesh-list
56757621|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56757622|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
56757623|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757624|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757625|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56757626|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
56757627|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56757628|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56757660|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56757661|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
56757662|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757663|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757664|NCT00862472|Timolol|timolol|mesh-list
56757665|NCT00862472|Cloprostenol|cloprostenol|mesh-list
56757666|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
56757667|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56757668|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
56757669|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56757670|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757671|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56757704|NCT00860366|Protective Agents|protective agents|mesh-ancestor
56757705|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757706|NCT00862628|Rebamipide|rebamipide|mesh-list
56757707|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56757708|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56757709|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
56757710|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757711|NCT00862628|Protective Agents|protective agents|mesh-ancestor
56757712|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757713|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757774|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
56757775|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757777|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56757778|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
56757779|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56757780|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757781|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56757782|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56757783|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
56757784|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
56539695|NCT01180296|Progesterone|progesterone|mesh-list
56539696|NCT01180296|Progestins|progestins|mesh-ancestor
56539697|NCT01180296|Hormones|hormones|mesh-ancestor
56539698|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539699|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539700|NCT01160640|Metronidazole|metronidazole|mesh-list
56539701|NCT01160640|Doxycycline|doxycycline|mesh-list
56539702|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
56539703|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539704|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56539705|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56539706|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56539707|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
56539708|NCT01160484|Lenalidomide|lenalidomide|mesh-list
56539709|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
56539710|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539711|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56539712|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56539713|NCT01160484|Growth Substances|growth substances|mesh-ancestor
56539714|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
56539715|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539716|NCT01032291|Lenalidomide|lenalidomide|mesh-list
56757785|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56757786|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757787|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56757788|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
56757789|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56757790|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757791|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757792|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757793|NCT00502996|Rituximab|rituximab|mesh-list
56757794|NCT00502996|Methotrexate|methotrexate|mesh-list
56030464|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757828|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56757829|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56757830|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757831|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
56757832|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
56757833|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757834|NCT00864188|Beta Carotene|beta carotene|mesh-list
56757835|NCT00864188|Carotenoids|carotenoids|mesh-list
56757871|NCT00864812|Xhance|xhance|mesh-list
56757872|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
56757873|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56757874|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56757875|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757876|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56757877|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
56757913|NCT00864890|Citalopram|citalopram|mesh-list
56757914|NCT00864890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56757915|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56757916|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56757943|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757944|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56757945|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56539717|NCT01032291|Cetuximab|cetuximab|mesh-list
56539718|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
56539719|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539720|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56539721|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56757946|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56757947|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
56923656|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468944|NCT00487032|Fluticasone|fluticasone|mesh-list
56757948|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56757949|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56757950|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
56757951|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56757953|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56757954|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757955|NCT00865982|Docetaxel|docetaxel|mesh-list
56757956|NCT00865982|Capecitabine|capecitabine|mesh-list
56757957|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757958|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
56757959|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
56757960|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
56757961|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757999|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56758000|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56758035|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
56758036|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758037|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56758038|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758039|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758040|NCT00713609|Clindamycin|clindamycin|mesh-list
56758041|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
56758042|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
56758043|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56758044|NCT00713609|Tazarotene|tazarotene|mesh-list
56758076|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758077|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
56758078|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758079|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56758080|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758081|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758082|NCT05330429|Leucovorin|leucovorin|mesh-list
56758083|NCT05330429|Bevacizumab|bevacizumab|mesh-list
56758084|NCT05330429|Magrolimab|magrolimab|mesh-list
56758085|NCT05330429|Fluorouracil|fluorouracil|mesh-list
56758086|NCT05330429|Irinotecan|irinotecan|mesh-list
56758087|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56758088|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758089|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56758125|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56758126|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56758127|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
56758128|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
56758129|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758130|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
56758131|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
56758161|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758162|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758164|NCT00617708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758165|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758166|NCT00617708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758167|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
56758168|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758169|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56758170|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
56758171|NCT04083209|Narcotics|narcotics|mesh-ancestor
56758172|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758173|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758174|NCT04083209|Analgesics|analgesics|mesh-ancestor
56758175|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
56030836|NCT01839734|Lubiprostone|lubiprostone|mesh-list
56539722|NCT01032291|Growth Substances|growth substances|mesh-ancestor
56539723|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
56539724|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539725|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56539726|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
56539727|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539728|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539729|NCT02873871|Hemostatics|hemostatics|mesh-list
56539730|NCT02873871|Coagulants|coagulants|mesh-ancestor
56539731|NCT04301739|Paclitaxel|paclitaxel|mesh-list
56539732|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
56539733|NCT04301739|Carboplatin|carboplatin|mesh-list
56539734|NCT04301739|Doxorubicin|doxorubicin|mesh-list
56539735|NCT04301739|Epirubicin|epirubicin|mesh-list
56539736|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56539737|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539738|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
56539739|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
56539740|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
56539741|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539742|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539743|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
56539744|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539745|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56758202|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56758203|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56758204|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56758205|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
56758206|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
56758207|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56758208|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758209|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758210|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56758211|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56758212|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56758213|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758214|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758215|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758216|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758217|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56758218|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
56758219|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56758289|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758291|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
56758292|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758293|NCT00992667|Acetovanillone|acetovanillone|mesh-list
56758294|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56758295|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56758296|NCT00992667|Analgesics|analgesics|mesh-ancestor
56758297|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
56065044|NCT04969627|Incretins|incretins|mesh-ancestor
56539746|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56539747|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
56758298|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030966|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
56758336|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
56758337|NCT00866684|Cyclosporine|cyclosporine|mesh-list
56758338|NCT00866684|Sirolimus|sirolimus|mesh-list
56758369|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
56758370|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758371|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56758372|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758373|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
56758374|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758375|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
56758376|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56758377|NCT00876902|Protective Agents|protective agents|mesh-ancestor
56758378|NCT00993135|Methotrexate|methotrexate|mesh-list
56758379|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56758380|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
56758381|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56758382|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758383|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56758384|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
56758455|NCT05213481|Carbamazepine|carbamazepine|mesh-list
56758456|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
56758457|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
56758458|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56758459|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758460|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758496|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
56758497|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758498|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56758499|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56758500|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56758501|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758502|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758536|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758537|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56758538|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758539|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56758540|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56758541|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758542|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758543|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56758544|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56758545|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56758547|NCT00872144|Analgesics|analgesics|mesh-ancestor
56758575|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56758577|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758578|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56758579|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56758580|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56758581|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56758582|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56758583|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56758584|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56758585|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
56758586|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758587|NCT05007821|Linezolid|linezolid|mesh-list
56758588|NCT05007821|Bedaquiline|bedaquiline|mesh-list
56758589|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
56758590|NCT05007821|Clofazimine|clofazimine|mesh-list
56758591|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758592|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758593|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56758594|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758595|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758596|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
56469616|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
56758630|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
56758631|NCT00573248|Nicotine|nicotine|mesh-list
56758632|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56539748|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56539749|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56539750|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56539751|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56539752|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539753|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
56539754|NCT04301583|Procyanidin|procyanidin|mesh-list
56539755|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
56539756|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539757|NCT04301583|Protective Agents|protective agents|mesh-ancestor
56539758|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539759|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56539760|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56539761|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539762|NCT01021683|Itraconazole|itraconazole|mesh-list
56539763|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
56539764|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539765|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56539766|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56539767|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539768|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539769|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56539770|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
56539771|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539772|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539773|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56539774|NCT01021215|Celecoxib|celecoxib|mesh-list
56539775|NCT01021215|Zileuton|zileuton|mesh-list
56539776|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56758633|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
56758634|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758635|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031308|NCT01573169|Enoxaparin|enoxaparin|mesh-list
56758672|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
56758673|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758674|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758675|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56758676|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56031351|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
56758711|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56758712|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758713|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
56758714|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
56539777|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56539778|NCT01021215|Analgesics|analgesics|mesh-ancestor
56539779|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
56539780|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539781|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539782|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56539783|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56539784|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56539785|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56539786|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539787|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539788|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56539789|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56539790|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
56539791|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539792|NCT02760979|Denosumab|denosumab|mesh-list
56539793|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56539794|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539795|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
56193984|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
56758715|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758716|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
56758717|NCT00532935|Metformin|metformin|mesh-list
56758718|NCT00532935|Pioglitazone|pioglitazone|mesh-list
56758754|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56758755|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56758756|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56758789|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
56758790|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758791|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
56758792|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758793|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
56758794|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56758795|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56758796|NCT05683535|Atropine|atropine|mesh-list
56758832|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56758833|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
56758834|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758863|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
56758864|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758865|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758866|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56758867|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56758868|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56758869|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
56758870|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758871|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758872|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758873|NCT02589041|Ropivacaine|ropivacaine|mesh-list
56758874|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
56758875|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
56758876|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758877|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539796|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539797|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
56758878|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
56758879|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758915|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56758916|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56031586|NCT03405584|Esomeprazole|esomeprazole|mesh-list
56758939|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56758941|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758942|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758943|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56758944|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
56758945|NCT00615836|Coagulants|coagulants|mesh-ancestor
56758946|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56758947|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
56758948|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758949|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
56758950|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56758951|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758952|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758953|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56758954|NCT05139212|Analgesics|analgesics|mesh-ancestor
56758955|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
56758956|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758957|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56758958|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56758959|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56758960|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56758961|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758962|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758963|NCT00872924|Sumatriptan|sumatriptan|mesh-list
56758964|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56758965|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56031628|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547682|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547684|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295953|NCT00101764|Triamcinolone|triamcinolone|mesh-list
56547685|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547686|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
56547687|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758986|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
56758987|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56758988|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56759024|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759025|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56759026|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56759027|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759028|NCT00617240|Metformin|metformin|mesh-list
56759066|NCT05683301|Amlodipine|amlodipine|mesh-list
56759067|NCT05683301|Perindopril|perindopril|mesh-list
56759135|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759136|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759138|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759139|NCT04657289|Ranibizumab|ranibizumab|mesh-list
56759140|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56759141|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56759142|NCT04657289|Growth Substances|growth substances|mesh-ancestor
56759143|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759144|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
56759145|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759146|NCT04603001|Azacitidine|azacitidine|mesh-list
56759180|NCT05487599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759181|NCT05487599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759182|NCT05487599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56759183|NCT05487599|Protective Agents|protective agents|mesh-ancestor
56759184|NCT04729049|Morphine|morphine|mesh-list
56759185|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56759186|NCT04729049|Narcotics|narcotics|mesh-ancestor
56759187|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759188|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759189|NCT04729049|Analgesics|analgesics|mesh-ancestor
56759222|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539798|NCT02760901|Mannitol|mannitol|mesh-list
56539799|NCT02760901|Acetazolamide|acetazolamide|mesh-list
56539800|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56539801|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
56539802|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539803|NCT02760901|Expectorants|expectorants|mesh-ancestor
56539804|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
56539805|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56539806|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
56539807|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539808|NCT02760901|Protective Agents|protective agents|mesh-ancestor
56759223|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759224|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759225|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
56759227|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759228|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56759229|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759302|NCT04081805|Hormones|hormones|mesh-ancestor
56759303|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759304|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759305|NCT04460885|Insulin|insulin|mesh-list
56759306|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56759307|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
56759308|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56759309|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759310|NCT05519189|Ropivacaine|ropivacaine|mesh-list
56759311|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
56759342|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56759343|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759344|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759345|NCT04079231|Aflibercept|aflibercept|mesh-list
56759346|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56759347|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56759348|NCT04079231|Growth Substances|growth substances|mesh-ancestor
56759349|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759350|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
56759351|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759352|NCT00994695|Vaccines|vaccines|mesh-list
56759353|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
56759354|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759355|NCT04521803|Rifampin|rifampin|mesh-list
56759356|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56032035|NCT01041638|Vitamin A|vitamin a|mesh-list
56759422|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
56759423|NCT03084237|Docetaxel|docetaxel|mesh-list
56759452|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
56759453|NCT00996099|Insulin|insulin|mesh-list
56759454|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56759455|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56759456|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759457|NCT04515329|Cyclosporine|cyclosporine|mesh-list
56759458|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
56759459|NCT04515329|Cyclosporins|cyclosporins|mesh-list
56759460|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759461|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759462|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56759463|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
56759464|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759465|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
56759466|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759467|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
56759468|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56759536|NCT05371223|Gemcitabine|gemcitabine|mesh-list
56759537|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56759538|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56759539|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
56065045|NCT04969627|Hormones|hormones|mesh-ancestor
56539809|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539810|NCT02760901|Antidotes|antidotes|mesh-ancestor
56539811|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56539812|NCT02760901|Diuretics|diuretics|mesh-ancestor
56539813|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
56539814|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
56539815|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56539816|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539817|NCT00635713|Fulvestrant|fulvestrant|mesh-list
56539818|NCT00635713|Anastrozole|anastrozole|mesh-list
56539819|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56539820|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539821|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56539822|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56539823|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
56539824|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539825|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539826|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56539827|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56539828|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539829|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634296|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56759540|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759541|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759542|NCT05371223|Antiviral Agents|antiviral agents|mesh-ancestor
56759543|NCT05371223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759544|NCT05371223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759573|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56759574|NCT00996567|Cetuximab|cetuximab|mesh-list
56759575|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759576|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759577|NCT04120805|Hemostatics|hemostatics|mesh-list
56759578|NCT04120805|Coagulants|coagulants|mesh-ancestor
56759579|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
56759580|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759581|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759582|NCT00500110|Docetaxel|docetaxel|mesh-list
56759583|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
56759584|NCT00500110|Leuprolide|leuprolide|mesh-list
56759585|NCT00500110|Goserelin|goserelin|mesh-list
56759586|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759587|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56759588|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56759589|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56032267|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56759619|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759620|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759621|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56759623|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759624|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759625|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
56759626|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759627|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56539830|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
56539831|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
56759628|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56759629|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
56759630|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56759631|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56759632|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56759633|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56759634|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56759635|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
56759636|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759637|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759638|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56759669|NCT05674487|Misoprostol|misoprostol|mesh-list
56759670|NCT05674487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56759671|NCT05674487|Abortifacient Agents|abortifacient agents|mesh-ancestor
56759672|NCT05674487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759673|NCT05674487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759674|NCT05674487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56759675|NCT05674487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759676|NCT05674487|Oxytocics|oxytocics|mesh-ancestor
56759677|NCT00534495|Rilonacept|rilonacept|mesh-list
56759678|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759679|NCT04077827|Propofol|propofol|mesh-list
56759680|NCT04077827|Desflurane|desflurane|mesh-list
56759681|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56759715|NCT00996879|Midazolam|midazolam|mesh-list
56759716|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56759717|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56759718|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759719|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759720|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56759721|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56759722|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56759723|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56759752|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
56759753|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759754|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759755|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56759756|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
56759757|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
56759758|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759759|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56759760|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56759761|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56759762|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
56759763|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56759764|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56759765|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56759766|NCT02626715|Vidarabine|vidarabine|mesh-list
56759767|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
56759768|NCT02626715|Fludarabine|fludarabine|mesh-list
56759769|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
56759770|NCT02626715|Thiotepa|thiotepa|mesh-list
56759771|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56759772|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
56759798|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56759799|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56759800|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56759801|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56759802|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759803|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
56759804|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759805|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759806|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56759807|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759808|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56759809|NCT00997191|Triamcinolone|triamcinolone|mesh-list
56759810|NCT00997191|Bevacizumab|bevacizumab|mesh-list
56759811|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759812|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759813|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56759814|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56759815|NCT00997191|Growth Substances|growth substances|mesh-ancestor
56539832|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539833|NCT02760823|Protective Agents|protective agents|mesh-ancestor
56539834|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539835|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
56539836|NCT02760823|Vitamins|vitamins|mesh-ancestor
56539837|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
56539838|NCT01020747|Bevacizumab|bevacizumab|mesh-list
56539839|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56539840|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539841|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56539842|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56539843|NCT01020747|Growth Substances|growth substances|mesh-ancestor
56539844|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539845|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
56539846|NCT02754739|Pravastatin|pravastatin|mesh-list
56539847|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56539848|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56539849|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
56539850|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759816|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759817|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
56759818|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759819|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
56759849|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
56759850|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759851|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
56759852|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56759853|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56759854|NCT00997581|Apremilast|apremilast|mesh-list
56759855|NCT00997581|Indomethacin|indomethacin|mesh-list
56759856|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56759857|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56759858|NCT00997581|Analgesics|analgesics|mesh-ancestor
56759859|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
56759860|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759861|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759862|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759863|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56759864|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56759902|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759929|NCT03827213|Bupivacaine|bupivacaine|mesh-list
56759930|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
56759931|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
56759932|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759933|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759934|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
56759935|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759936|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
56759937|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56759938|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56759939|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56759940|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56759941|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759942|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
56539851|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56539852|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56539853|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539854|NCT02754583|Azithromycin|azithromycin|mesh-list
56539855|NCT02754583|Tetracycline|tetracycline|mesh-list
56539856|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56539857|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539858|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56539859|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539860|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539861|NCT01031979|Yohimbine|yohimbine|mesh-list
56539862|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
56539863|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
56539864|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092841|NCT03336853|Hybenx|hybenx|mesh-list
56759943|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759944|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759945|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56759946|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759947|NCT04077983|Gemcitabine|gemcitabine|mesh-list
56759948|NCT04077983|Paclitaxel|paclitaxel|mesh-list
56759949|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56759950|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760056|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56760057|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760058|NCT04276259|Analgesics|analgesics|mesh-ancestor
56760059|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
56760060|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760061|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56760062|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56760063|NCT00499486|Sirolimus|sirolimus|mesh-list
56760064|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760065|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760066|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56760067|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760068|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
56760069|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760070|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
56760071|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760072|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
56760073|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56760074|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56760075|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56760076|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56760112|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760113|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56760114|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
56760172|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56760173|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760174|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760175|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760176|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760177|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760178|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56760179|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56760180|NCT00532155|Growth Substances|growth substances|mesh-ancestor
56760181|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
56760182|NCT01019668|Verteporfin|verteporfin|mesh-list
56760183|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56760184|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
56760185|NCT01019746|Propofol|propofol|mesh-list
56539865|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539866|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56539867|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56760186|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56760187|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56760188|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760189|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56760216|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760217|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760218|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56760219|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
56760220|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56760221|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
56760222|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760223|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56760224|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56760225|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56760226|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56760227|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760228|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56760229|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
56760230|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760231|NCT00483574|Vaccines|vaccines|mesh-list
56760232|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
56760233|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760234|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56760235|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56760236|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56760274|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56760302|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760303|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
56760304|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56760305|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56760306|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
56760307|NCT02581553|Protective Agents|protective agents|mesh-ancestor
56760308|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760309|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
56760310|NCT02581553|Renal Agents|renal agents|mesh-ancestor
56760311|NCT03666065|Insulin|insulin|mesh-list
56760312|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56760313|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
56760314|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56760315|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760316|NCT03944915|Paclitaxel|paclitaxel|mesh-list
56760317|NCT03944915|Carboplatin|carboplatin|mesh-list
56760318|NCT03944915|Fluorouracil|fluorouracil|mesh-list
56760319|NCT03944915|Nivolumab|nivolumab|mesh-list
56760320|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
56760321|NCT03944915|Lenograstim|lenograstim|mesh-list
56760322|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56760323|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760353|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
56760354|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
56760355|NCT05228249|Melphalan|melphalan|mesh-list
56760356|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
56760357|NCT05228249|Carmustine|carmustine|mesh-list
56760358|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56760359|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56760360|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56760361|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760362|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56760363|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56760364|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760365|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760366|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56760367|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
56760368|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
56760369|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760370|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760425|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
56760426|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56760427|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760428|NCT01001247|Rilpivirine|rilpivirine|mesh-list
56539868|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56539869|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
56539870|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539871|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539872|NCT01031979|Urological Agents|urological agents|mesh-ancestor
56539873|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
56539874|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539875|NCT02753803|Pioglitazone|pioglitazone|mesh-list
56539876|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539877|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539878|NCT04219579|Antithrombins|antithrombins|mesh-list
56539879|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
56539880|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56760429|NCT01001247|Omeprazole|omeprazole|mesh-list
56760430|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56760431|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56760432|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56760433|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760434|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760435|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56760436|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56760437|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
56760438|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760439|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56760440|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56760441|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
56760442|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760443|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56760444|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56760445|NCT04205357|Analgesics|analgesics|mesh-ancestor
56760446|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
56760477|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56760478|NCT01001637|Analgesics|analgesics|mesh-ancestor
56760479|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
56760480|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760481|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760482|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56760483|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56760484|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760485|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760486|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760487|NCT03623321|Pimavanserin|pimavanserin|mesh-list
56760488|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56760489|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56760527|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
56760528|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760529|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56760566|NCT05733741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760568|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56760600|NCT05733117|Micronutrients|micronutrients|mesh-ancestor
56760601|NCT05733117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760602|NCT05733117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56760604|NCT05732961|Hematinics|hematinics|mesh-ancestor
56760605|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
56760606|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56760607|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760608|NCT00615056|Leucovorin|leucovorin|mesh-list
56760609|NCT00615056|Bevacizumab|bevacizumab|mesh-list
56760610|NCT00615056|Fluorouracil|fluorouracil|mesh-list
56760611|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
56760612|NCT00615056|Irinotecan|irinotecan|mesh-list
56760613|NCT00615056|Axitinib|axitinib|mesh-list
56760614|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
56760645|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56539881|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
56539882|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539883|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539884|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
56539885|NCT00635401|Varenicline|varenicline|mesh-list
56539886|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56539887|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56539888|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
56539889|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539890|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194090|NCT01490762|Insulin|insulin|mesh-list
56760646|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56760647|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
56760648|NCT05732727|Antihypertensive Agents|antihypertensive agents|mesh-list
56760649|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
56760650|NCT00873626|Levofloxacin|levofloxacin|mesh-list
56760651|NCT00873626|Ofloxacin|ofloxacin|mesh-list
56760652|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
56760653|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760654|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760655|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56760656|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56760657|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760658|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760688|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760689|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56760691|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760692|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760693|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
56760694|NCT05232357|Methylene Blue|methylene blue|mesh-list
56760695|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760696|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760697|NCT05232357|Antidotes|antidotes|mesh-ancestor
56760698|NCT05232357|Protective Agents|protective agents|mesh-ancestor
56760699|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760700|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
56760701|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
56033370|NCT01555697|Memantine|memantine|mesh-list
56760730|NCT03595553|Vancomycin|vancomycin|mesh-list
56760731|NCT03595553|Benzimidazole|benzimidazole|mesh-list
56760732|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760733|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760734|NCT03595553|Anthelmintics|anthelmintics|mesh-ancestor
56760735|NCT03595553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56760736|NCT00874172|Analgesics|analgesics|mesh-list
56760737|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
56760738|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760739|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760740|NCT00614822|Bevacizumab|bevacizumab|mesh-list
56760741|NCT00614822|Carboplatin|carboplatin|mesh-list
56760742|NCT00614822|Pemetrexed|pemetrexed|mesh-list
56760743|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760744|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760745|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56033408|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56760777|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56760778|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760779|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760781|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760782|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56760783|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56760784|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760785|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760786|NCT00874406|Leucovorin|leucovorin|mesh-list
56760787|NCT00874406|Fluorouracil|fluorouracil|mesh-list
56760819|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56539891|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539892|NCT02753725|Fentanyl|fentanyl|mesh-list
56539893|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56760820|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760821|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56760822|NCT04194203|Paclitaxel|paclitaxel|mesh-list
56760823|NCT04194203|Bevacizumab|bevacizumab|mesh-list
56760824|NCT04194203|Carboplatin|carboplatin|mesh-list
56760825|NCT04194203|Pemetrexed|pemetrexed|mesh-list
56760826|NCT04194203|Atezolizumab|atezolizumab|mesh-list
56760827|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56760828|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760829|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760830|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760831|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760832|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760833|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760865|NCT01006863|Phenylephrine|phenylephrine|mesh-list
56760866|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
56760867|NCT01006863|Ephedrine|ephedrine|mesh-list
56760868|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56760869|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
56760870|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
56760871|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760872|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760873|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
56760874|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56760875|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
56471820|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
56760904|NCT03535727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760905|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56760906|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56760908|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56760909|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56760910|NCT03529955|Analgesics|analgesics|mesh-ancestor
56760911|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
56760912|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760913|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760914|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56760915|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56760916|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56760917|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56760918|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760919|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760920|NCT00142909|Lofexidine|lofexidine|mesh-list
56760921|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56760981|NCT03498521|Bevacizumab|bevacizumab|mesh-list
56760982|NCT03498521|Carboplatin|carboplatin|mesh-list
56760983|NCT03498521|Trastuzumab|trastuzumab|mesh-list
56760984|NCT03498521|Atezolizumab|atezolizumab|mesh-list
56760985|NCT03498521|Olaparib|olaparib|mesh-list
56760986|NCT03498521|Pertuzumab|pertuzumab|mesh-list
56760987|NCT03498521|Vemurafenib|vemurafenib|mesh-list
56760988|NCT03498521|Ivosidenib|ivosidenib|mesh-list
56760989|NCT03498521|Entrectinib|entrectinib|mesh-list
56760990|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760991|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760992|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760993|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56760994|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56033657|NCT02233751|Androgens|androgens|mesh-ancestor
56761031|NCT05618925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761090|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
56761091|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761093|NCT02798471|Enoxaparin|enoxaparin|mesh-list
56761094|NCT02798471|Warfarin|warfarin|mesh-list
56761095|NCT02798471|Edoxaban|edoxaban|mesh-list
56761096|NCT02798471|Fondaparinux|fondaparinux|mesh-list
56761097|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
56761098|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56761099|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56761100|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761101|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56761102|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
56761103|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56761104|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
56539894|NCT02753725|Narcotics|narcotics|mesh-ancestor
56194100|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761105|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761106|NCT03443765|Vitamin D|vitamin d|mesh-list
56761107|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
56761108|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56761109|NCT03443765|Antibodies|antibodies|mesh-list
56761110|NCT03443765|Vitamins|vitamins|mesh-ancestor
56761111|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
56761112|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761113|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56033771|NCT00942578|Prednisone|prednisone|mesh-list
56761140|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56761141|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56761142|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56761144|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56761145|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56761146|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56761147|NCT00617084|Everolimus|everolimus|mesh-list
56761148|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761149|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761150|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
56761151|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761152|NCT02758847|Paclitaxel|paclitaxel|mesh-list
56761153|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56761154|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56761155|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761156|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
56761157|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
56761158|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
56761159|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761160|NCT01016860|Irinotecan|irinotecan|mesh-list
56761184|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761186|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56761187|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761188|NCT05127304|Bromides|bromides|mesh-list
56761189|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
56761190|NCT05127304|Olodaterol|olodaterol|mesh-list
56761191|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56761192|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
56761193|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761194|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761195|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56761196|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
56761197|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
56761198|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56761199|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
56761200|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761201|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761202|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
56761203|NCT00880412|Etazolate|etazolate|mesh-list
56761204|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56761205|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761206|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761207|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56761208|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56761209|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56761210|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761211|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56761212|NCT01020136|Axitinib|axitinib|mesh-list
56761240|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56761241|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56761242|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761243|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56761244|NCT01020214|Olmesartan|olmesartan|mesh-list
56761245|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56761246|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56761247|NCT01020214|Diuretics|diuretics|mesh-ancestor
56761248|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
56761249|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472209|NCT04519463|Lidocaine|lidocaine|mesh-list
56761250|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56761251|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56761252|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539895|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56539896|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539897|NCT02753725|Analgesics|analgesics|mesh-ancestor
56539898|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
56539899|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539900|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56539901|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56539902|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
56539903|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
56539904|NCT01020123|Glipizide|glipizide|mesh-list
56634297|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539905|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539906|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539907|NCT04300959|Gemcitabine|gemcitabine|mesh-list
56539908|NCT04300959|Cisplatin|cisplatin|mesh-list
56539909|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539910|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56539911|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
56539912|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539913|NCT04300959|Antiviral Agents|antiviral agents|mesh-ancestor
56539914|NCT04300959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539915|NCT04300959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539916|NCT04300959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539917|NCT04300959|Immunologic Factors|immunologic factors|mesh-ancestor
56539918|NCT04300959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539919|NCT02760355|Ribavirin|ribavirin|mesh-list
56539920|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
56761253|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56761254|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56761255|NCT03970824|Adalimumab|adalimumab|mesh-list
56761256|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761257|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56761258|NCT00933894|Citalopram|citalopram|mesh-list
56761325|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761326|NCT00934752|Paclitaxel|paclitaxel|mesh-list
56761327|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56761328|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761329|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
56761330|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
56761331|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
56761332|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761334|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56761335|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56761336|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
56761337|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761338|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761339|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56761340|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56761353|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
56539921|NCT02760355|Ledipasvir|ledipasvir|mesh-list
56539922|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
56539923|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539924|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
56539925|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56539926|NCT01028391|Metformin|metformin|mesh-list
56539927|NCT01028391|Pioglitazone|pioglitazone|mesh-list
56539928|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56539929|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56539930|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539931|NCT01028391|Incretins|incretins|mesh-ancestor
56539932|NCT01028391|Hormones|hormones|mesh-ancestor
56539933|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539934|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56539935|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
56539936|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56539937|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539938|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56194129|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56761354|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761355|NCT00564018|Coagulants|coagulants|mesh-ancestor
56761356|NCT00935298|Tacrolimus|tacrolimus|mesh-list
56761357|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761358|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
56761359|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761360|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56761361|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761362|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761363|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
56761364|NCT04014192|Empagliflozin|empagliflozin|mesh-list
56761365|NCT04014192|Canagliflozin|canagliflozin|mesh-list
56761366|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56761367|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761368|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56761369|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761370|NCT00935610|Caseins|caseins|mesh-list
56761371|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
56761372|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
56761373|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761374|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
56761375|NCT04013646|Hematinics|hematinics|mesh-ancestor
56761376|NCT04074473|Propranolol|propranolol|mesh-list
56761377|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56761378|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56761379|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
56761380|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761381|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761382|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761383|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56761384|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56761385|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
56761386|NCT03356483|Niacin|niacin|mesh-list
56761387|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
56761388|NCT03356483|Psilocybin|psilocybin|mesh-list
56761389|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56034047|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
56539939|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56093925|NCT03577171|Entecavir|entecavir|mesh-list
56761422|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
56761424|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56761425|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761426|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56761427|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761428|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56761429|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
56761430|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761431|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56761432|NCT00870038|Paclitaxel|paclitaxel|mesh-list
56761433|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56034097|NCT01658657|Diuretics|diuretics|mesh-ancestor
56761462|NCT00142519|Morphine|morphine|mesh-list
56761463|NCT00142519|Methadone|methadone|mesh-list
56761464|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56761465|NCT00142519|Narcotics|narcotics|mesh-ancestor
56761466|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56761467|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761468|NCT00142519|Analgesics|analgesics|mesh-ancestor
56761469|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
56761470|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761471|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
56761472|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
56761473|NCT03713294|Dexamethasone|dexamethasone|mesh-list
56761474|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
56761475|NCT03713294|Pomalidomide|pomalidomide|mesh-list
56761476|NCT03713294|Elotuzumab|elotuzumab|mesh-list
56761477|NCT03713294|Ichthammol|ichthammol|mesh-list
56761478|NCT03713294|BB 1101|bb 1101|mesh-list
56761479|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761480|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
56761511|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56761512|NCT03967327|Narcotics|narcotics|mesh-ancestor
56761513|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56761514|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761515|NCT03967327|Analgesics|analgesics|mesh-ancestor
56761516|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
56761517|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761518|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56761519|NCT01075945|Lumefantrine|lumefantrine|mesh-list
56761520|NCT01075945|Artemether|artemether|mesh-list
56761521|NCT01075945|Piperaquine|piperaquine|mesh-list
56761522|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56761523|NCT01075945|Artenimol|artenimol|mesh-list
56761524|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
56761525|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56761526|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56034181|NCT00939536|Zolpidem|zolpidem|mesh-list
56761603|NCT01073995|Bupivacaine|bupivacaine|mesh-list
56761604|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56761605|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
56761606|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
56761607|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56761608|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761609|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
56761610|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761611|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761612|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
56761613|NCT01073995|Hormones|hormones|mesh-ancestor
56761614|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56761640|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761641|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761643|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
56761644|NCT04489628|Vitamins|vitamins|mesh-ancestor
56761645|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
56761646|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761647|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56761648|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56761649|NCT00130039|Cilostazol|cilostazol|mesh-list
56761650|NCT00130039|Clopidogrel|clopidogrel|mesh-list
56761651|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56761652|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56761653|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56761654|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56539940|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56539941|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56539942|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539943|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56539944|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539945|NCT01179672|Analgesics|analgesics|mesh-ancestor
56539946|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
56539947|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56539948|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
56539949|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56761655|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
56761656|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761657|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761658|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761659|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56761697|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56761732|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
56761733|NCT00496054|Vaccines|vaccines|mesh-list
56761734|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
56761735|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761736|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
56761737|NCT05014646|Leflunomide|leflunomide|mesh-list
56761738|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034417|NCT05361395|Carboplatin|carboplatin|mesh-list
56761774|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761775|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56761776|NCT00613730|Gemcitabine|gemcitabine|mesh-list
56761777|NCT00613730|Panitumumab|panitumumab|mesh-list
56761778|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56761807|NCT00883532|Budesonide|budesonide|mesh-list
56761808|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56761809|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761810|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56761811|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
56761812|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761813|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761814|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56761815|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
56761816|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
56761817|NCT00883532|Hormones|hormones|mesh-ancestor
56761818|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56761819|NCT00881582|Interferons|interferons|mesh-list
56761820|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
56761821|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
56761822|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56761823|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761824|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
56761825|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761826|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
56761827|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761853|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
56761854|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
56761855|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761856|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56761857|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
56761858|NCT03712904|Aflibercept|aflibercept|mesh-list
56761859|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
56761860|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56761861|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56761862|NCT03712904|Growth Substances|growth substances|mesh-ancestor
56761863|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761864|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
56761865|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761866|NCT04634162|Cangrelor|cangrelor|mesh-list
56539950|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
56194163|NCT01491061|Ranolazine|ranolazine|mesh-list
56761867|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56761868|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56761869|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56761870|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56761871|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
56761872|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761873|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034533|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761907|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56761908|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56761909|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56761910|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56761911|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56761912|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56761913|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
56761914|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56761915|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
56761916|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56761917|NCT01582555|Antidotes|antidotes|mesh-ancestor
56761950|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56761951|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56761952|NCT00885794|Growth Substances|growth substances|mesh-ancestor
56761953|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761954|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
56761955|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761956|NCT00888602|Psyllium|psyllium|mesh-list
56761957|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
56761958|NCT00888602|Cathartics|cathartics|mesh-ancestor
56034621|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
56761993|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56761994|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56761995|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56761996|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56761997|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56761998|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
56761999|NCT02543606|Esomeprazole|esomeprazole|mesh-list
56762000|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56762067|NCT00528567|Growth Substances|growth substances|mesh-ancestor
56762068|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762069|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
56762070|NCT00936234|Vildagliptin|vildagliptin|mesh-list
56762071|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56762072|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762073|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56762074|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
56034741|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56762100|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762102|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
56762103|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
56762104|NCT00138151|Paclitaxel|paclitaxel|mesh-list
56762105|NCT00138151|Isotretinoin|isotretinoin|mesh-list
56762106|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56762107|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762108|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
56762109|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
56762110|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
56762111|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762112|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
56762113|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762114|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
56762115|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762116|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
56762117|NCT02543060|Fluorides|fluorides|mesh-list
56762118|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
56762119|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
56762120|NCT02543060|Protective Agents|protective agents|mesh-ancestor
56034778|NCT02448810|Fluorouracil|fluorouracil|mesh-list
56762155|NCT00886106|Remifentanil|remifentanil|mesh-list
56762156|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56762157|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56762158|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56762159|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762160|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56539951|NCT04301349|Misoprostol|misoprostol|mesh-list
56539952|NCT04301349|Dinoprostone|dinoprostone|mesh-list
56539953|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56539954|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
56539955|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56539956|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539957|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56539958|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56539959|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
56539960|NCT02753647|Prednisone|prednisone|mesh-list
56539961|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
56539962|NCT02753647|Rituximab|rituximab|mesh-list
56539963|NCT02753647|Doxorubicin|doxorubicin|mesh-list
56762161|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56762187|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762188|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56762190|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
56762191|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762192|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762193|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
56762194|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
56762195|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56762196|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56762197|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762198|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762199|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762200|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762201|NCT02578043|Clindamycin|clindamycin|mesh-list
56762202|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
56762203|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
56762204|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56762205|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56762206|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762207|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56762208|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762209|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762210|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
56762211|NCT04895709|Docetaxel|docetaxel|mesh-list
56762212|NCT04895709|Nivolumab|nivolumab|mesh-list
56762213|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762214|NCT04895709|Tubulin Modulators|tubulin modulators|mesh-ancestor
56762247|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56762248|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56762249|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762250|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762251|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762252|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762253|NCT00609674|Fluticasone|fluticasone|mesh-list
56762254|NCT00609674|Xhance|xhance|mesh-list
56762255|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762256|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56762257|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
56762258|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762259|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762260|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56762261|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
56762294|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762296|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56762297|NCT00563316|Irinotecan|irinotecan|mesh-list
56762298|NCT00563316|Panitumumab|panitumumab|mesh-list
56762299|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56762300|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56762325|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762326|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539964|NCT02753647|Vincristine|vincristine|mesh-list
56539965|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56539966|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
56539967|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539968|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56539969|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56539970|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
56539971|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56539972|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56539973|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56539974|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762328|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
56762329|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762330|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56762331|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56762332|NCT00941616|Factor VIII|factor viii|mesh-list
56762333|NCT00941616|Coagulants|coagulants|mesh-ancestor
56762334|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
56762335|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56762336|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56762337|NCT02542592|Prednisolone|prednisolone|mesh-list
56762338|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
56762339|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56762340|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
56762341|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762342|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
56762343|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
56762344|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762345|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762346|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762347|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
56762348|NCT02542592|Hormones|hormones|mesh-ancestor
56035003|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762375|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
56762376|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762377|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56762378|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56762379|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762380|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762381|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56762382|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56762383|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
56762384|NCT00890630|Oxytocin|oxytocin|mesh-list
56762385|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
56762386|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56762387|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762388|NCT00890708|Voriconazole|voriconazole|mesh-list
56762389|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
56762390|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762391|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56762392|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56762393|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762394|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762395|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56762396|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
56035068|NCT03018626|Prednisone|prednisone|mesh-list
56762432|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
56762433|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56762434|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762463|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762464|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56762466|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762467|NCT01007799|Vitamin D|vitamin d|mesh-list
56539975|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56539976|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56762468|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
56762469|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
56762470|NCT01007799|Vitamins|vitamins|mesh-list
56762471|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
56762472|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762473|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56762474|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56762475|NCT00609518|Folic Acid|folic acid|mesh-list
56762476|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
56762477|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
56762478|NCT00609518|Dexamethasone|dexamethasone|mesh-list
56762479|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
56762480|NCT00609518|Pemetrexed|pemetrexed|mesh-list
56762481|NCT00609518|BB 1101|bb 1101|mesh-list
56762482|NCT00609518|Vitamins|vitamins|mesh-ancestor
56762483|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
56035147|NCT03018236|Ethanol|ethanol|mesh-list
56762509|NCT00884858|Maraviroc|maraviroc|mesh-list
56762510|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56762511|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56762512|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762513|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56762514|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56762515|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
56762516|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762517|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56762518|NCT00891332|Leucovorin|leucovorin|mesh-list
56762519|NCT00891332|Antidotes|antidotes|mesh-ancestor
56762520|NCT00891332|Protective Agents|protective agents|mesh-ancestor
56762521|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762522|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
56762523|NCT00891332|Vitamins|vitamins|mesh-ancestor
56762524|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
56762525|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
56762526|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56762527|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762528|NCT04038008|Fluconazole|fluconazole|mesh-list
56762529|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
56762530|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762531|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56762532|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56762533|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035190|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
56762559|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
56762560|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56762561|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
56762562|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
56762563|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56762564|NCT00886574|Protective Agents|protective agents|mesh-ancestor
56762565|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56762566|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56762567|NCT00611858|Fluorouracil|fluorouracil|mesh-list
56762568|NCT00611858|Cetuximab|cetuximab|mesh-list
56762569|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
56762570|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762571|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56762572|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762573|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56762574|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
56762575|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762576|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762577|NCT00137449|Sunitinib|sunitinib|mesh-list
56762578|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762579|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56762615|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762616|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
56762617|NCT00887120|Ritonavir|ritonavir|mesh-list
56762618|NCT00887120|Lopinavir|lopinavir|mesh-list
56762651|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56762652|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762653|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762654|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
56762655|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
56762656|NCT00887276|Amoxicillin|amoxicillin|mesh-list
56762657|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
56762658|NCT00887276|Ampicillin|ampicillin|mesh-list
56539977|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56539978|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762659|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56762660|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762691|NCT00892346|Melphalan|melphalan|mesh-list
56762692|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56762693|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
56762694|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762695|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762696|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56762697|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56762698|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
56762699|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762700|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
56762701|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56762702|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762703|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56762737|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56762738|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56762739|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762740|NCT03965052|Travoprost|travoprost|mesh-list
56762741|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56762742|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56762743|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56762744|NCT00892658|Sorafenib|sorafenib|mesh-list
56762745|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762811|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
56762812|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762813|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762814|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762815|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762816|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56762817|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56762818|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762819|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56762820|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56762821|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762822|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
56762823|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56762824|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56762825|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56762863|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
56762864|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
56762865|NCT00560352|Dexamethasone|dexamethasone|mesh-list
56762866|NCT00560352|Bortezomib|bortezomib|mesh-list
56762867|NCT00560352|Dasatinib|dasatinib|mesh-list
56762898|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762899|NCT00944814|Zinc|zinc|mesh-list
56762900|NCT00944814|Trace Elements|trace elements|mesh-ancestor
56762901|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
56762902|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762903|NCT00527787|Naproxen|naproxen|mesh-list
56762904|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56762905|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56762906|NCT00527787|Analgesics|analgesics|mesh-ancestor
56762907|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
56762908|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762909|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762947|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56762984|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56762985|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56762986|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
56762987|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56763020|NCT00186121|Anastrozole|anastrozole|mesh-list
56763021|NCT00186121|Goserelin|goserelin|mesh-list
56763022|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763023|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763024|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56763025|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56763026|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763027|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763028|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56763029|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
56035688|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
56539979|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56539980|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
56539981|NCT02753647|Hormones|hormones|mesh-ancestor
56539982|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56539983|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56539984|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56539985|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
56539986|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
56539987|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
56539988|NCT02872389|Sevoflurane|sevoflurane|mesh-list
56539989|NCT02872389|Desflurane|desflurane|mesh-list
56539990|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56288243|NCT00001074|Didanosine|didanosine|mesh-list
56539991|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56539992|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
56539993|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
56539994|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194196|NCT01491191|Hormones|hormones|mesh-ancestor
56763066|NCT00127933|Docetaxel|docetaxel|mesh-list
56763067|NCT00127933|Trastuzumab|trastuzumab|mesh-list
56763099|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763100|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
56763101|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763102|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56763103|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56763104|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56763105|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56763106|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763107|NCT05225961|Aspirin|aspirin|mesh-list
56763108|NCT05225961|Tirofiban|tirofiban|mesh-list
56763173|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763174|NCT00527397|Insulin|insulin|mesh-list
56763175|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56763176|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763177|NCT00943956|Everolimus|everolimus|mesh-list
56763207|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
56763209|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56763210|NCT00940836|Analgesics|analgesics|mesh-ancestor
56763211|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
56474136|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
56763212|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763213|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763214|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
56763215|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56763216|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
56763217|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
56763218|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
56763219|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56763220|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
56763221|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
56035888|NCT02416908|Cytarabine|cytarabine|mesh-list
56763256|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763257|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
56763258|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763259|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56763260|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56763292|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763293|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763294|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
56539995|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56539996|NCT01179516|Vortioxetine|vortioxetine|mesh-list
56539997|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
56539998|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56539999|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56540000|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56540001|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540002|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540003|NCT01179516|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56540004|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56540005|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56540006|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763295|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763296|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56763297|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763298|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
56763299|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763300|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
56763301|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56763302|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
56763327|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763328|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
56763329|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
56763330|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
56763331|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763332|NCT00525915|Fluorouracil|fluorouracil|mesh-list
56763333|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
56763334|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
56763335|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763336|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56763337|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763338|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763339|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
56763340|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763341|NCT03143153|Fluorouracil|fluorouracil|mesh-list
56763342|NCT03143153|Nivolumab|nivolumab|mesh-list
56763343|NCT03143153|Ipilimumab|ipilimumab|mesh-list
56763344|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763345|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
56763346|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763347|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56763348|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763349|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
56763350|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763351|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56763352|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56763353|NCT00521001|Everolimus|everolimus|mesh-list
56036020|NCT02174432|Nalbuphine|nalbuphine|mesh-list
56763388|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763389|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56763390|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56763391|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763421|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763423|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56763424|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56763425|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56763426|NCT00185731|Atorvastatin|atorvastatin|mesh-list
56763427|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56763428|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56763429|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
56473657|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540007|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540008|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
56540009|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56540010|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56540011|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56540012|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56540013|NCT02695771|Gemcitabine|gemcitabine|mesh-list
56540014|NCT02695771|Mitomycins|mitomycins|mesh-list
56540015|NCT02695771|Mitomycin|mitomycin|mesh-list
56540016|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56540017|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
56540018|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540019|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540020|NCT02695771|Antiviral Agents|antiviral agents|mesh-ancestor
56540021|NCT02695771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540022|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540023|NCT02695771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56540024|NCT02695771|Immunologic Factors|immunologic factors|mesh-ancestor
56540025|NCT02695771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540026|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56540027|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
56540028|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56540029|NCT00635791|Sorafenib|sorafenib|mesh-list
56763430|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763431|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56763432|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56763433|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763434|NCT00582491|Modafinil|modafinil|mesh-list
56036098|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
56763460|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763461|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56763463|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56763464|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763465|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
56763466|NCT03873987|Oritavancin|oritavancin|mesh-list
56763467|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56763468|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763469|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56763470|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
56763471|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763472|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
56763473|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763474|NCT00528645|Saracatinib|saracatinib|mesh-list
56763475|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763476|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763477|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763478|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
56763479|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
56763480|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56763481|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
56763482|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036145|NCT01083368|Sirolimus|sirolimus|mesh-list
56540030|NCT00635791|Vorinostat|vorinostat|mesh-list
56540031|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540032|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540033|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540034|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540035|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56540036|NCT02760043|Dexamethasone|dexamethasone|mesh-list
56540037|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540038|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
56763517|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
56763518|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56763519|NCT04073537|Paclitaxel|paclitaxel|mesh-list
56763520|NCT04073537|Carboplatin|carboplatin|mesh-list
56763521|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56763522|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763523|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
56763524|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
56763525|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
56763526|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763527|NCT01020994|Octenidine|octenidine|mesh-list
56763607|NCT00493636|Capecitabine|capecitabine|mesh-list
56763608|NCT00493636|Sorafenib|sorafenib|mesh-list
56763609|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56763637|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56763638|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763639|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763640|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
56763641|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56763642|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763643|NCT01018342|Renal Agents|renal agents|mesh-ancestor
56763644|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56763645|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
56763646|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56763647|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56763648|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763649|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
56763650|NCT03965767|Coagulants|coagulants|mesh-ancestor
56763651|NCT00133705|Mifepristone|mifepristone|mesh-list
56763652|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56763653|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
56763654|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56763655|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763689|NCT00132691|Cyclosporins|cyclosporins|mesh-list
56763690|NCT00132691|Daclizumab|daclizumab|mesh-list
56763691|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56763692|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
56763693|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
56763694|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763695|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56763696|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56763697|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763698|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763742|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763743|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763744|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56763745|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56763746|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56763747|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
56763748|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763749|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763750|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56763751|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56763752|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
56763753|NCT01076803|Lanreotide|lanreotide|mesh-list
56763754|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763755|NCT00523419|Pemetrexed|pemetrexed|mesh-list
56763756|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540039|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
56540040|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540041|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540042|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56540043|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
56540044|NCT02760043|Hormones|hormones|mesh-ancestor
56540045|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540046|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56540047|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540048|NCT02760121|Acetazolamide|acetazolamide|mesh-list
56540049|NCT02760121|Methazolamide|methazolamide|mesh-list
56540050|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
56540051|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56540052|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540053|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540054|NCT02760121|Diuretics|diuretics|mesh-ancestor
56540055|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
56540056|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540058|NCT05215873|Oxytocin|oxytocin|mesh-list
56540059|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
56540060|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56194257|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56763757|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763758|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763759|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56763760|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56763761|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
56763762|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56763763|NCT03868059|Testosterone|testosterone|mesh-list
56763764|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
56763765|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
56763766|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763767|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763768|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
56763769|NCT03868059|Hormones|hormones|mesh-ancestor
56763770|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763771|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763772|NCT03868059|Androgens|androgens|mesh-ancestor
56763773|NCT04028115|Ixazomib|ixazomib|mesh-list
56763774|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763775|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
56763776|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763777|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763778|NCT03865407|Allopurinol|allopurinol|mesh-list
56763779|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
56763780|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763781|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763782|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
56763783|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56763784|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56763785|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
56763786|NCT03865407|Protective Agents|protective agents|mesh-ancestor
56763787|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540061|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540062|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56540063|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
56763788|NCT00487942|Modafinil|modafinil|mesh-list
56763789|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56763790|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763791|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56763792|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56763819|NCT04187703|Decitabine|decitabine|mesh-list
56763820|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56763821|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
56763822|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763823|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763824|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763825|NCT00131911|Sorafenib|sorafenib|mesh-list
56763826|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763827|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56763828|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763829|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763830|NCT00184093|Gemcitabine|gemcitabine|mesh-list
56763831|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56763832|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
56763833|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763834|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763835|NCT00184093|Antiviral Agents|antiviral agents|mesh-ancestor
56763836|NCT00184093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763837|NCT00184093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763838|NCT00184093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763866|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56763867|NCT00183625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56763868|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56763869|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56763870|NCT00511875|Doxycycline|doxycycline|mesh-list
56763871|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56763872|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763873|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
56763874|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56763875|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56763876|NCT02576327|Dexamethasone|dexamethasone|mesh-list
56763877|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
56763878|NCT02576327|Aprepitant|aprepitant|mesh-list
56763879|NCT02576327|Tropisetron|tropisetron|mesh-list
56763880|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56763881|NCT02576327|BB 1101|bb 1101|mesh-list
56763882|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763883|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
56763884|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
56763885|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763886|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474814|NCT02950935|Progesterone|progesterone|mesh-list
56763917|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763918|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763920|NCT01021150|Cisplatin|cisplatin|mesh-list
56763921|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763922|NCT03997006|Atropine|atropine|mesh-list
56763923|NCT03997006|Aminophylline|aminophylline|mesh-list
56763924|NCT03997006|Neostigmine|neostigmine|mesh-list
56763925|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56763926|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56763927|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56763928|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
56763929|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763966|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763967|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763968|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
56763969|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763993|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56763994|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
56763995|NCT02578121|Hormones|hormones|mesh-ancestor
56763996|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763997|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763998|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540064|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56540065|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56540066|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56540067|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56540068|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540070|NCT02750917|Lornoxicam|lornoxicam|mesh-list
56540071|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56540072|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56540073|NCT02750917|Analgesics|analgesics|mesh-ancestor
56540074|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
56540075|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540076|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540077|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540078|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56540079|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56540080|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56540081|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540082|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763999|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
56764000|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56764001|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56764002|NCT02578121|Growth Substances|growth substances|mesh-ancestor
56764003|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
56764004|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
56764005|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764006|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764007|NCT00487240|Insulin|insulin|mesh-list
56764008|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56764009|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
56764010|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
56764011|NCT00487240|Protamines|protamines|mesh-list
56764012|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56764013|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764014|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
56764015|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764016|NCT00487240|Coagulants|coagulants|mesh-ancestor
56764017|NCT02577809|Indomethacin|indomethacin|mesh-list
56764018|NCT02577809|Fentanyl|fentanyl|mesh-list
56764019|NCT02577809|Morphine|morphine|mesh-list
56764020|NCT02577809|Bupivacaine|bupivacaine|mesh-list
56764021|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
56764022|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
56764051|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764052|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764053|NCT00487162|Insulin|insulin|mesh-list
56764054|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56764055|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764056|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
56764057|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56764058|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764059|NCT00487084|Lidocaine|lidocaine|mesh-list
56764060|NCT00487084|Morphine|morphine|mesh-list
56764061|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
56764062|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
56764063|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56764064|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764065|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
56540083|NCT02750995|Azacitidine|azacitidine|mesh-list
56540084|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56540085|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
56540086|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540087|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540088|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540089|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56540090|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
56540091|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540092|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56540093|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56540094|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
56540095|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194297|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56764066|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036734|NCT03013322|Physostigmine|physostigmine|mesh-list
56764101|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56764102|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56764103|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56764104|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56764105|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
56764133|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56764134|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56764135|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764136|NCT01021696|Acetaminophen|acetaminophen|mesh-list
56764137|NCT01021696|Pregabalin|pregabalin|mesh-list
56764138|NCT01021696|Morphine|morphine|mesh-list
56764139|NCT01021696|Buprenorphine|buprenorphine|mesh-list
56764140|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56764141|NCT01021696|Narcotics|narcotics|mesh-ancestor
56764142|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56764143|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764144|NCT01021696|Analgesics|analgesics|mesh-ancestor
56764145|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
56764146|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764147|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
56764148|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56764149|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56764150|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764186|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
56764187|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764188|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764189|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56764190|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
56764191|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
56764192|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56036861|NCT02481219|Bisacodyl|bisacodyl|mesh-list
56764280|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764282|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56764283|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56764284|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56764285|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764286|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56764287|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56764288|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764289|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
56764290|NCT01412333|Interferons|interferons|mesh-list
56764291|NCT01412333|Interferon-beta|interferon-beta|mesh-list
56036963|NCT02557035|Hormones|hormones|mesh-ancestor
56764325|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56540096|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540097|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540098|NCT04299633|Calcium|calcium|mesh-list
56540099|NCT04299633|Sevelamer|sevelamer|mesh-list
56540100|NCT04299633|Calcium acetate|calcium acetate|mesh-list
56540101|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56764326|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56764327|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56764328|NCT00519285|Growth Substances|growth substances|mesh-ancestor
56764329|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
56764330|NCT00464620|Dasatinib|dasatinib|mesh-list
56764331|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764332|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56036997|NCT02486211|Analgesics|analgesics|mesh-ancestor
56764355|NCT02099123|Atorvastatin|atorvastatin|mesh-list
56764356|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56764357|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56764358|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
56764359|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764360|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56764361|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56764362|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764363|NCT00464542|Metronidazole|metronidazole|mesh-list
56764364|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764365|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56764366|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56764367|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56764368|NCT02578823|Antipyretics|antipyretics|mesh-list
56764369|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764370|NCT01969643|Trastuzumab|trastuzumab|mesh-list
56764371|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56764372|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764373|NCT00464308|Esomeprazole|esomeprazole|mesh-list
56764374|NCT00464308|Rabeprazole|rabeprazole|mesh-list
56764375|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56764376|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56764377|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56764378|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764379|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764380|NCT00463840|Fluorouracil|fluorouracil|mesh-list
56764381|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
56764382|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
56764383|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764384|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56764414|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56764415|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56764416|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764417|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764419|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
56764420|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764421|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56764422|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56764423|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56764424|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
56764425|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764426|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764427|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56764429|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56764430|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56764456|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56764457|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764458|NCT04073927|Butyric Acid|butyric acid|mesh-list
56764459|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
56764460|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
56764461|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764462|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764463|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540102|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540103|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
56540104|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
56540105|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540106|NCT02695459|Everolimus|everolimus|mesh-list
56540107|NCT02695459|Cisplatin|cisplatin|mesh-list
56540108|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764464|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56764465|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764466|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764467|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764468|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764469|NCT02578277|BMS-955176|bms-955176|mesh-list
56764470|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56764471|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56764472|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
56764473|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764474|NCT00555906|Dexamethasone|dexamethasone|mesh-list
56764475|NCT00555906|Bortezomib|bortezomib|mesh-list
56764476|NCT00555906|Palbociclib|palbociclib|mesh-list
56764477|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764478|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
56764479|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
56764480|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764505|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764506|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56764507|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764508|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
56764509|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764510|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56764511|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56764512|NCT00555672|Growth Substances|growth substances|mesh-ancestor
56764513|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
56764514|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764515|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764517|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764518|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764519|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764520|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764521|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764522|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
56764523|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
56764524|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764525|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764526|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56764527|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
56764528|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
56764529|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56037187|NCT01138124|Gabapentin|gabapentin|mesh-list
56764553|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764554|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56764555|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56764556|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
56764557|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764558|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764559|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56764560|NCT00453154|Cisplatin|cisplatin|mesh-list
56764561|NCT00453154|Carboplatin|carboplatin|mesh-list
56764562|NCT00453154|Etoposide|etoposide|mesh-list
56764563|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
56764564|NCT00453154|Sunitinib|sunitinib|mesh-list
56764565|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
56764566|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764567|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56764568|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56764569|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56764570|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764571|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764572|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56540109|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56540110|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
56540111|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540112|NCT04288713|Eculizumab|eculizumab|mesh-list
56540113|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56540114|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56540115|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
56540116|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540117|NCT05112991|Lenvatinib|lenvatinib|mesh-list
56540118|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540119|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540120|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540121|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540122|NCT01030341|Insulin|insulin|mesh-list
56540123|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56540124|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56095962|NCT00000326|Heroin|heroin|mesh-list
56764573|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56764574|NCT00453154|Growth Substances|growth substances|mesh-ancestor
56764575|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764576|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
56764577|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764578|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
56764579|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
56764580|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764581|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764601|NCT00561678|Analgesics|analgesics|mesh-ancestor
56764602|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
56764603|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764604|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56764605|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56764606|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56764607|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
56764608|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764609|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764610|NCT00946608|Loratadine|loratadine|mesh-list
56764611|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
56764612|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
56764613|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56764614|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56764615|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56764616|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
56764617|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
56764618|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764619|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764620|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764621|NCT00463684|Vaccines|vaccines|mesh-list
56764622|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
56764623|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764624|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
56764625|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56764626|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
56764627|NCT00463606|Calcium|calcium|mesh-list
56764628|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56764629|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764630|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56764631|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56764632|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56764633|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
56194339|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
56764634|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764635|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56764636|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56764669|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764670|NCT02531737|Docetaxel|docetaxel|mesh-list
56764671|NCT02531737|Nintedanib|nintedanib|mesh-list
56764672|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764673|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764674|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764675|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764676|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764677|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764678|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764679|NCT01326559|Docetaxel|docetaxel|mesh-list
56764711|NCT00001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764712|NCT00001247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56764713|NCT00001247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764715|NCT00001247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764716|NCT00001247|Immunologic Factors|immunologic factors|mesh-ancestor
56764717|NCT00001247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764718|NCT03944044|Acetaminophen|acetaminophen|mesh-list
56764719|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764720|NCT03944044|Analgesics|analgesics|mesh-ancestor
56764721|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
56037386|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
56764750|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56764751|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764752|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764753|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764754|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764755|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764756|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56764757|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764758|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56764759|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
56764760|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764761|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
56764762|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764763|NCT00946764|Imipramine|imipramine|mesh-list
56764764|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56764765|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
56764766|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56764767|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56764768|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56764803|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56764804|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764805|NCT00467584|Analgesics|analgesics|mesh-ancestor
56764806|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
56764807|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764898|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56764900|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
56764901|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
56764902|NCT01079923|Vitamins|vitamins|mesh-list
56764903|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
56764904|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764905|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56764906|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56764907|NCT00947076|Fluoxetine|fluoxetine|mesh-list
56764908|NCT00947076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56764909|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56764910|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56764911|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764912|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764913|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
56764914|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764915|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56764916|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
56764917|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56764944|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
56764945|NCT05300958|Deferoxamine|deferoxamine|mesh-list
56764946|NCT05300958|Siderophores|siderophores|mesh-ancestor
56764947|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56540125|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540126|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
56540127|NCT02750293|Vitamin D|vitamin d|mesh-list
56764948|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
56764949|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
56764950|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764951|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
56764952|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56764953|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
56764954|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764955|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
56764956|NCT04070729|Protective Agents|protective agents|mesh-ancestor
56764958|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56764959|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764960|NCT00956982|Interferons|interferons|mesh-list
56764961|NCT00956982|Ribavirin|ribavirin|mesh-list
56764962|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
56764963|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
56764964|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56764965|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764966|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
56764992|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56764993|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56764994|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
56764995|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764996|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764997|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56764998|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764999|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
56765001|NCT02573519|Donepezil|donepezil|mesh-list
56765002|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56765003|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56765004|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765005|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765006|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
56765007|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765008|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765009|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
56765010|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
56765011|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56765012|NCT02572583|Oseltamivir|oseltamivir|mesh-list
56765013|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
56037685|NCT01149434|Everolimus|everolimus|mesh-list
56765048|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
56765049|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765050|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765051|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56765052|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
56765053|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765087|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765088|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56765089|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56765090|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765091|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765092|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56765093|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
56765124|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
56765125|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765126|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765127|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765128|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56765129|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56765130|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765131|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765132|NCT00718913|Docetaxel|docetaxel|mesh-list
56765133|NCT00718913|Capecitabine|capecitabine|mesh-list
56765134|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765135|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
56765136|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
56765137|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
56037799|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56765174|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
56473658|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
56540128|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56540129|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540130|NCT02750293|Vitamins|vitamins|mesh-ancestor
56540131|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
56540132|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56540133|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56540134|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56540135|NCT01026831|Timolol|timolol|mesh-list
56540136|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56540137|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56540138|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
56540139|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56288398|NCT00017407|Paclitaxel|paclitaxel|mesh-list
56540140|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540141|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540142|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56540143|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56540145|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
56540146|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
56540147|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540148|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540149|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
56540150|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540151|NCT02750059|Tenofovir|tenofovir|mesh-list
56540152|NCT02750059|Lamivudine|lamivudine|mesh-list
56540153|NCT02750059|Efavirenz|efavirenz|mesh-list
56765175|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56765176|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
56765177|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765178|NCT00549198|Tenofovir|tenofovir|mesh-list
56765200|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765201|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
56765202|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765203|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765204|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56765205|NCT00506415|Protective Agents|protective agents|mesh-ancestor
56765207|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
56765208|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765209|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56765210|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
56765211|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765212|NCT01009437|Ritonavir|ritonavir|mesh-list
56765213|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56765214|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56765215|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
56765216|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765217|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765218|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56765219|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56540154|NCT02750059|Telmisartan|telmisartan|mesh-list
56540155|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
56540156|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540157|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56765220|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
56765221|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765222|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56765223|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56765224|NCT00719381|Pioglitazone|pioglitazone|mesh-list
56765225|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765226|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765227|NCT00510783|Phenytoin|phenytoin|mesh-list
56765228|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
56765229|NCT00510783|Levetiracetam|levetiracetam|mesh-list
56765230|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
56765231|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
56765294|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56765295|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56765296|NCT02541734|Exenatide|exenatide|mesh-list
56765297|NCT02541734|Polygeline|polygeline|mesh-list
56765298|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765299|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765300|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56765301|NCT02541734|Incretins|incretins|mesh-ancestor
56765302|NCT02541734|Hormones|hormones|mesh-ancestor
56765303|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56765304|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
56765305|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
56765306|NCT00462670|Tolvaptan|tolvaptan|mesh-list
56765307|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56765308|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765309|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
56765310|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765311|NCT01009593|Sorafenib|sorafenib|mesh-list
56765312|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765313|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56765349|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
56765350|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765351|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56765352|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56765353|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765354|NCT00948402|Metformin|metformin|mesh-list
56765386|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
56765387|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476322|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
56765388|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56765389|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56765390|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765391|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
56765392|NCT03753555|Protective Agents|protective agents|mesh-ancestor
56765393|NCT00606086|Interferons|interferons|mesh-list
56765394|NCT00606086|Ribavirin|ribavirin|mesh-list
56765395|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56765396|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
56765397|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765398|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
56765399|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765427|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765428|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
56765429|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765430|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765431|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
56765432|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765433|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56765434|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56765435|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56765436|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765437|NCT05300490|Prednisolone|prednisolone|mesh-list
56765438|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765439|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
56765440|NCT05300490|Hormones|hormones|mesh-ancestor
56765441|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473659|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
56540158|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56540159|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540160|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540161|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56540162|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56540163|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56540164|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56540165|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56540166|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56194368|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56765442|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765443|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56765444|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765445|NCT00893594|Naproxen|naproxen|mesh-list
56765446|NCT00893594|Sumatriptan|sumatriptan|mesh-list
56765447|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56765478|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765479|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56765481|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
56765482|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765483|NCT00720161|Metformin|metformin|mesh-list
56765484|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765485|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765486|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
56765487|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56765488|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
56765524|NCT00712049|Niacinamide|niacinamide|mesh-list
56765525|NCT00712049|Simvastatin|simvastatin|mesh-list
56765526|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56765527|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56765528|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
56765529|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765626|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56765627|NCT00115765|Bevacizumab|bevacizumab|mesh-list
56765628|NCT00115765|Panitumumab|panitumumab|mesh-list
56765629|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
56765630|NCT00115765|Irinotecan|irinotecan|mesh-list
56765631|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56765632|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765633|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56765634|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56765635|NCT00115765|Growth Substances|growth substances|mesh-ancestor
56765636|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765637|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
56765638|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56765639|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56765640|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765641|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765642|NCT00606008|Sunitinib|sunitinib|mesh-list
56765643|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765644|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56765722|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765723|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56765724|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56765726|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56765727|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56765771|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
56765773|NCT01022632|Fluoxetine|fluoxetine|mesh-list
56765774|NCT01022632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56765775|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56765776|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56765777|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540167|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096700|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56765778|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765779|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
56765780|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765781|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56765782|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
56765783|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56765784|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56765785|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56765786|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765787|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56765788|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56765789|NCT01022632|Analgesics|analgesics|mesh-ancestor
56765790|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
56765896|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765897|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56765898|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765899|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56765900|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765901|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
56765902|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56765903|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56765904|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56765905|NCT02573051|Isosorbide|isosorbide|mesh-list
56765906|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56765907|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56765968|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765969|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56765970|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
56765971|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56765972|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765973|NCT00901784|Topiramate|topiramate|mesh-list
56765974|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
56765975|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765976|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766006|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766007|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56766008|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
56766009|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56766010|NCT02573987|Analgesics|analgesics|mesh-ancestor
56766011|NCT00906386|Varenicline|varenicline|mesh-list
56766012|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56766013|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56766014|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
56766015|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766016|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766017|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766018|NCT00722579|Cobalt|cobalt|mesh-list
56766019|NCT00722579|Chromium|chromium|mesh-list
56766020|NCT00722579|Trace Elements|trace elements|mesh-ancestor
56766021|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
56766049|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56766050|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766051|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766052|NCT00894920|Biotin|biotin|mesh-list
56766053|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
56766054|NCT00894920|Vitamins|vitamins|mesh-ancestor
56766055|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
56766056|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766057|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
56766058|NCT00722735|Finafloxacin|finafloxacin|mesh-list
56766059|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56766060|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766061|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56766063|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766064|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766065|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766066|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56766067|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56038716|NCT01292798|Growth Substances|growth substances|mesh-ancestor
56766124|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766125|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
56540168|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56540169|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56540170|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56540171|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56540172|NCT03893617|Propranolol|propranolol|mesh-list
56540173|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56540174|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56540175|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
56540176|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194381|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766126|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
56766127|NCT00717821|Hematinics|hematinics|mesh-ancestor
56766128|NCT03476369|Fentanyl|fentanyl|mesh-list
56766129|NCT03476369|Ticagrelor|ticagrelor|mesh-list
56766130|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56766131|NCT03476369|Narcotics|narcotics|mesh-ancestor
56038784|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766219|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766250|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56766251|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56766252|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56766253|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766254|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766255|NCT02572505|Tenofovir|tenofovir|mesh-list
56766256|NCT02572505|Emtricitabine|emtricitabine|mesh-list
56766257|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56766258|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
56766259|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766260|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56766261|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56766300|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766301|NCT01010295|Doxycycline|doxycycline|mesh-list
56766302|NCT01010295|Tetracycline|tetracycline|mesh-list
56766378|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
56766379|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766380|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766381|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766382|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
56477447|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
56766507|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56766508|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56766540|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766541|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
56766542|NCT02540720|Hormones|hormones|mesh-ancestor
56766543|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56766544|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56766545|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766546|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
56766547|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
56766548|NCT02540642|Vitamins|vitamins|mesh-ancestor
56766549|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
56766550|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766551|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
56766602|NCT00907166|Immunologic Factors|immunologic factors|mesh-ancestor
56766603|NCT00907166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766604|NCT04984811|Atezolizumab|atezolizumab|mesh-list
56766605|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766606|NCT00460798|Sunitinib|sunitinib|mesh-list
56766607|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766608|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56766609|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56766610|NCT00460798|Growth Substances|growth substances|mesh-ancestor
56766611|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766612|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
56766613|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540177|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766614|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039265|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766874|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766875|NCT00908024|Cetuximab|cetuximab|mesh-list
56766876|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56766877|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766878|NCT00730223|Efavirenz|efavirenz|mesh-list
56766879|NCT00730223|Nevirapine|nevirapine|mesh-list
56766880|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56766881|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56766882|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766883|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766884|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
56766885|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766886|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56766887|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56766888|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56766889|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56766890|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56766891|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56766892|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56766893|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56766928|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766929|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56766930|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
56766931|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
56766932|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766933|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56766934|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
56766935|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766936|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
56766937|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
56766985|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
56766986|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
56766987|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766988|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766989|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766990|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56766991|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56766992|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766993|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56766994|NCT00728195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56766995|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56766996|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56766997|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766998|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766999|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
56767000|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56767001|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56767002|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
56767003|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
56767004|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56767071|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767072|NCT00904280|Analgesics|analgesics|mesh-ancestor
56767073|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
56767074|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767075|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56767076|NCT04237103|Methotrexate|methotrexate|mesh-list
56767077|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56767078|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
56767079|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56767080|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767081|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56767082|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
56767083|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767084|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767115|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
56767116|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56767117|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
56767118|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540178|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540179|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56540180|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56540181|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
56540182|NCT02749825|Goserelin|goserelin|mesh-list
56540183|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56540184|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56540185|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540186|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56540187|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540188|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
56194395|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
56767119|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767120|NCT00728585|Mitogens|mitogens|mesh-list
56767121|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767122|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767123|NCT00730769|Valganciclovir|valganciclovir|mesh-list
56767124|NCT00730769|Ganciclovir|ganciclovir|mesh-list
56767125|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56767126|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
56767127|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039781|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
56767322|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56767323|NCT04018703|Analgesics|analgesics|mesh-ancestor
56767324|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
56767325|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767326|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56767327|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56767328|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56767329|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
56767330|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767331|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767332|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56767333|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56767334|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56767335|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56767336|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56767337|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
56767338|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
56767339|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
56767340|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
56767341|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56767342|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56767369|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56767370|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56767371|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
56767372|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767373|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767374|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767375|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56767376|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56767377|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56767378|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
56767379|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56767380|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56767381|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
56767382|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767383|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56767384|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56767385|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767386|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767387|NCT04644627|Gentamicins|gentamicins|mesh-list
56767388|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56540189|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56540190|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
56767389|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767390|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56767416|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767417|NCT00732485|Fenofibrate|fenofibrate|mesh-list
56767418|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56767419|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
56767420|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767421|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56767422|NCT02569073|Dronabinol|dronabinol|mesh-list
56767423|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
56767424|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767425|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56767426|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56767427|NCT02569073|Analgesics|analgesics|mesh-ancestor
56767428|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
56767429|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767430|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56767431|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56767432|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767433|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767434|NCT02569073|Hormones|hormones|mesh-ancestor
56767435|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767436|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56767531|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56767532|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
56767533|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
56767534|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56767535|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56767536|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56767537|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56767538|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
56767539|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040180|NCT01763645|Bevacizumab|bevacizumab|mesh-list
56767628|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56767630|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767631|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767632|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767633|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478568|NCT02915796|Lenograstim|lenograstim|mesh-list
56767634|NCT01023100|Tofacitinib|tofacitinib|mesh-list
56767635|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56767636|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767637|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767638|NCT00515463|Denosumab|denosumab|mesh-list
56767639|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56767640|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767641|NCT01082731|Artesunate|artesunate|mesh-list
56767713|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56767714|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56767715|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
56767716|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
56767717|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040386|NCT01323140|Hormones|hormones|mesh-ancestor
56767776|NCT00449176|Narcotics|narcotics|mesh-ancestor
56767777|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56767778|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767779|NCT00449176|Analgesics|analgesics|mesh-ancestor
56767780|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
56767781|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767782|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56767837|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56767838|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767839|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767840|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56767841|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56767842|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767843|NCT00740363|Incretins|incretins|mesh-ancestor
56767844|NCT00740363|Hormones|hormones|mesh-ancestor
56767845|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767846|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56540191|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56540192|NCT02759107|Dulaglutide|dulaglutide|mesh-list
56540193|NCT02759107|Tirzepatide|tirzepatide|mesh-list
56540194|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56540195|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540196|NCT02759107|Incretins|incretins|mesh-ancestor
56540197|NCT02759107|Hormones|hormones|mesh-ancestor
56540198|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540199|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56540200|NCT02758873|Montelukast|montelukast|mesh-list
56540201|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56540202|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
56540203|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767847|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
56767848|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767849|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040496|NCT04769297|Ketamine|ketamine|mesh-list
56767899|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
56767900|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56767901|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
56767902|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767903|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
56767904|NCT00503997|Pemetrexed|pemetrexed|mesh-list
56767905|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767906|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767907|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767908|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56767909|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56767910|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
56767911|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56767912|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
56767913|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
56767914|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767915|NCT00736463|Atorvastatin|atorvastatin|mesh-list
56767916|NCT00736463|Simvastatin|simvastatin|mesh-list
56767917|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56767918|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56767919|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
56767920|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767951|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56767952|NCT01082809|Growth Substances|growth substances|mesh-ancestor
56767953|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767954|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
56767955|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56767956|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767957|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767958|NCT01080469|Tacrolimus|tacrolimus|mesh-list
56767959|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767960|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
56767961|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767962|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56767963|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767964|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768055|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768088|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56768089|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
56768090|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56768091|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
56768092|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
56768093|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
56768094|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56768095|NCT00930020|Minocycline|minocycline|mesh-list
56634298|NCT02808104|Mazindol|mazindol|mesh-list
56540204|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540205|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56540206|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
56540207|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56194425|NCT01493050|Antacids|antacids|mesh-ancestor
56768096|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56768097|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768098|NCT00930098|Clofarabine|clofarabine|mesh-list
56768099|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56768100|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
56768140|NCT05704985|Mitosis Modulators|mitosis modulators|mesh-ancestor
56768141|NCT05704985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768142|NCT05704985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768143|NCT05704985|Antimetabolites|antimetabolites|mesh-ancestor
56768144|NCT05704985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56768145|NCT05704985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768146|NCT05704985|Immunologic Factors|immunologic factors|mesh-ancestor
56768147|NCT05704985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768148|NCT02568839|Docetaxel|docetaxel|mesh-list
56768149|NCT02568839|Trastuzumab|trastuzumab|mesh-list
56768150|NCT02568839|Pertuzumab|pertuzumab|mesh-list
56768151|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768152|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768153|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
56768154|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
56768155|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768156|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768157|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
56768158|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56768159|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56768160|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768161|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56768162|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56768163|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040806|NCT01786967|Urological Agents|urological agents|mesh-ancestor
56768195|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768196|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768197|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56768198|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56768199|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768200|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56768201|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56768202|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768203|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
56768204|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
56768205|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768206|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768207|NCT05669339|Irinotecan|irinotecan|mesh-list
56768208|NCT05669339|Sorafenib|sorafenib|mesh-list
56768342|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
56768343|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768344|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
56768345|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56768346|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768347|NCT05518877|Ketamine|ketamine|mesh-list
56768348|NCT05518877|Analgesics|analgesics|mesh-ancestor
56768349|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
56768350|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768351|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768352|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56768353|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56768354|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
56768355|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
56768356|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768357|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56768358|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56768359|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768360|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540208|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56540209|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56540210|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
56540211|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540212|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540213|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56540214|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
56540215|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540216|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56540217|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56540219|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56540220|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56540221|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540222|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540223|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768361|NCT00737789|Mesalamine|mesalamine|mesh-list
56768362|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56768363|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56768364|NCT00737789|Analgesics|analgesics|mesh-ancestor
56768421|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56768422|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56041080|NCT01794455|Sertraline|sertraline|mesh-list
56768457|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
56768458|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
56768459|NCT00566696|Melphalan|melphalan|mesh-list
56768490|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768491|NCT00926900|Cycloserine|cycloserine|mesh-list
56768492|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56768493|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768494|NCT00926900|Renal Agents|renal agents|mesh-ancestor
56768495|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56768496|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
56768497|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56768498|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
56768499|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768500|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56768501|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768502|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56768503|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768504|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768536|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
56768537|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768539|NCT01028638|Bevacizumab|bevacizumab|mesh-list
56768540|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
56768541|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768542|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768543|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56768544|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56768545|NCT01028638|Growth Substances|growth substances|mesh-ancestor
56768546|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768547|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
56768548|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56768549|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768577|NCT00938522|Protective Agents|protective agents|mesh-ancestor
56768578|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56768579|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56768580|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540224|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56540225|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
56540226|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540227|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540228|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56540229|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
56540230|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
56540231|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56540232|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56540233|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56540234|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56540235|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540236|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
56540237|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540238|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540239|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56540240|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540241|NCT04359979|Tamsulosin|tamsulosin|mesh-list
56540242|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56540243|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56540244|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56540245|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
56540246|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540247|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540248|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540249|NCT04359979|Urological Agents|urological agents|mesh-ancestor
56540250|NCT04180813|Linagliptin|linagliptin|mesh-list
56540251|NCT04180813|Acarbose|acarbose|mesh-list
56540252|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194447|NCT01493115|Insulin|insulin|mesh-list
56768581|NCT00938600|Vitamin D|vitamin d|mesh-list
56768582|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
56768583|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
56768584|NCT00938600|Vitamins|vitamins|mesh-list
56768585|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
56768586|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768587|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56768588|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56041242|NCT01335620|Tenofovir|tenofovir|mesh-list
56768633|NCT00737867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768634|NCT00737867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768635|NCT00737867|Immunologic Factors|immunologic factors|mesh-ancestor
56768636|NCT00737867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540253|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540254|NCT04180813|Incretins|incretins|mesh-ancestor
56540255|NCT04180813|Hormones|hormones|mesh-ancestor
56540256|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540257|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56540258|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
56540259|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540260|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540261|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56540262|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
56540263|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56540264|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540265|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
56194487|NCT01493336|Capecitabine|capecitabine|mesh-list
56768637|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56768699|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768701|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56768702|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768703|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56768704|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
56768705|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
56768706|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
56768707|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
56768708|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768709|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768710|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
56768711|NCT00933998|Pyridoxal|pyridoxal|mesh-list
56768712|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
56768713|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
56768714|NCT00933998|Vitamins|vitamins|mesh-ancestor
56768715|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
56768716|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768717|NCT00447226|Lapatinib|lapatinib|mesh-list
56768718|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041363|NCT01383200|Lidocaine|lidocaine|mesh-list
56768786|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56768787|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768788|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768789|NCT00934154|Thalidomide|thalidomide|mesh-list
56768790|NCT00934154|Prednisolone|prednisolone|mesh-list
56768791|NCT00934154|Melphalan|melphalan|mesh-list
56768792|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56768793|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
56768794|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768795|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768796|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56768797|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768798|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
56768799|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768800|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56768801|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
56768802|NCT00934154|Hormones|hormones|mesh-ancestor
56768803|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56768850|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768851|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56768853|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56768854|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
56768855|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
56768856|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56768857|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768858|NCT00514449|Valacyclovir|valacyclovir|mesh-list
56540266|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56540267|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540268|NCT02749123|Lidocaine|lidocaine|mesh-list
56540269|NCT02749123|Menthol|menthol|mesh-list
56540270|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
56540271|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
56540272|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540273|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540274|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
56391161|NCT02953405|Clopidogrel|clopidogrel|mesh-list
56540275|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540276|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56540277|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56540278|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56540279|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56540280|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540282|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
56540283|NCT00635557|Carboplatin|carboplatin|mesh-list
56540284|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768859|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
56768860|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768861|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
56768862|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768863|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
56768864|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768865|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768866|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56768867|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
56768868|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768869|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768870|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56768871|NCT00738257|Pamidronate|pamidronate|mesh-list
56768872|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56768873|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041514|NCT00368121|Hormones|hormones|mesh-ancestor
56768956|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
56768957|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768958|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768992|NCT04835129|Elotuzumab|elotuzumab|mesh-list
56768993|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56768994|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56768995|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
56768996|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
56768997|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768998|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768999|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56041659|NCT03008252|Caseins|caseins|mesh-list
56769059|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56769060|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
56769061|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
56769062|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769063|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56769064|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56769065|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
56769066|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56540285|NCT02748265|Epoprostenol|epoprostenol|mesh-list
56540286|NCT02748265|Phenylephrine|phenylephrine|mesh-list
56540287|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
56540288|NCT02748265|Tezosentan|tezosentan|mesh-list
56540289|NCT02748265|Propofol|propofol|mesh-list
56540290|NCT02748265|Sevoflurane|sevoflurane|mesh-list
56540291|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56540292|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540293|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540294|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56540295|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
56540296|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
56540297|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56540298|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56540299|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56540300|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
56540301|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
56540302|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540303|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
56540304|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56769067|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56769068|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
56769069|NCT04013438|Estradiol|estradiol|mesh-list
56769070|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56769071|NCT04013438|Estrogens|estrogens|mesh-ancestor
56769072|NCT04013438|Hormones|hormones|mesh-ancestor
56769132|NCT03962881|Vaccines|vaccines|mesh-list
56769133|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
56769134|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769135|NCT00935246|Dexetimide|dexetimide|mesh-list
56769136|NCT00935246|Citalopram|citalopram|mesh-list
56769137|NCT00935246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56769138|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56769139|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769140|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769209|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56769210|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769211|NCT00939926|Risperidone|risperidone|mesh-list
56769212|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56769213|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
56769214|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769215|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769267|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56769269|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
56769270|NCT02566733|Remifentanil|remifentanil|mesh-list
56769271|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56769272|NCT02566733|Narcotics|narcotics|mesh-ancestor
56769273|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769274|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769275|NCT02566733|Analgesics|analgesics|mesh-ancestor
56769276|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
56769277|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769278|NCT01028950|Darexaban|darexaban|mesh-list
56769279|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56769280|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
56769309|NCT01023490|Vitamins|vitamins|mesh-ancestor
56769310|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
56769311|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769312|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56769313|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
56540305|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
56540306|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
56540307|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56540308|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56540309|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56540310|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
56540311|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540312|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194529|NCT01493648|Vitamin D|vitamin d|mesh-list
56769314|NCT00698009|Fludarabine|fludarabine|mesh-list
56769315|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
56769316|NCT00698009|Interleukin-2|interleukin-2|mesh-list
56769317|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56769318|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
56769319|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769320|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56769321|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56769322|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
56769323|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769324|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769325|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56041972|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56769359|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56769360|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56480282|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
56769361|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769362|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769363|NCT00921167|Bevacizumab|bevacizumab|mesh-list
56769364|NCT00921167|Irinotecan|irinotecan|mesh-list
56769365|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56769366|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769392|NCT05472779|Hormones|hormones|mesh-ancestor
56769393|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769394|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769395|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56769396|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
56769397|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56769398|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56769399|NCT02565953|Paclitaxel|paclitaxel|mesh-list
56769400|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56769401|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769402|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56769403|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56769404|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56769405|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769406|NCT00562718|Capecitabine|capecitabine|mesh-list
56769407|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56769408|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
56769409|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769410|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769411|NCT05222165|Infigratinib|infigratinib|mesh-list
56769412|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769413|NCT04555811|Rituximab|rituximab|mesh-list
56769440|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56769441|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56769442|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56769443|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769444|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769445|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56769446|NCT05324891|Narcotics|narcotics|mesh-ancestor
56769447|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56769448|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56769449|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
56769450|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
56540313|NCT02748265|Protective Agents|protective agents|mesh-ancestor
56540314|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56540315|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
56540316|NCT01015833|Doxorubicin|doxorubicin|mesh-list
56540317|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56540318|NCT01015833|Sorafenib|sorafenib|mesh-list
56540319|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56540320|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540321|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56540322|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56540323|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194538|NCT01493674|Hematinics|hematinics|mesh-ancestor
56769451|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56769452|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56769453|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
56769454|NCT04482803|Hormones|hormones|mesh-ancestor
56769455|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769456|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769457|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769458|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769459|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56769488|NCT02565641|Immunologic Factors|immunologic factors|mesh-ancestor
56769489|NCT02565641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769490|NCT04036721|Prednisone|prednisone|mesh-list
56769491|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56769492|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
56769493|NCT04036721|Hormones|hormones|mesh-ancestor
56769494|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769495|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769496|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56769497|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769498|NCT00441142|Temozolomide|temozolomide|mesh-list
56769499|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56769500|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
56769501|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769502|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769503|NCT03848416|Ixekizumab|ixekizumab|mesh-list
56769504|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
56769505|NCT01029418|Sorafenib|sorafenib|mesh-list
56769506|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769507|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56769508|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042157|NCT02722239|Metformin|metformin|mesh-list
56769584|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56769585|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769586|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769587|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56769588|NCT00443872|Protective Agents|protective agents|mesh-ancestor
56769589|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769590|NCT01323244|Simeprevir|simeprevir|mesh-list
56769591|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
56769592|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769593|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
56769594|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769595|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769596|NCT03034642|Dimercaprol|dimercaprol|mesh-list
56769597|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
56769598|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
56769599|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769600|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
56769601|NCT03840226|Antacids|antacids|mesh-ancestor
56769602|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769603|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56769604|NCT03962738|Lasmiditan|lasmiditan|mesh-list
56540324|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540325|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540326|NCT03523273|Liraglutide|liraglutide|mesh-list
56540327|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56540328|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540329|NCT03523273|Incretins|incretins|mesh-ancestor
56540330|NCT03523273|Hormones|hormones|mesh-ancestor
56540331|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540332|NCT02695381|Etodolac|etodolac|mesh-list
56540333|NCT02695381|Lidocaine|lidocaine|mesh-list
56540334|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
56540335|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
56540336|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540337|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540338|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
56540339|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540340|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56540341|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56540342|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56540343|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769605|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56769606|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
56769607|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769608|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769609|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769610|NCT00561392|Rivastigmine|rivastigmine|mesh-list
56769611|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56769612|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769649|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769650|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56769651|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56769652|NCT04012424|Curcumin|curcumin|mesh-list
56769801|NCT00944996|Clomipramine|clomipramine|mesh-list
56769802|NCT00944996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56769803|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56769804|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769805|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769806|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769807|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
56042468|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
56769820|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56769821|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769822|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769823|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56769824|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769825|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
56769826|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56769827|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56769828|NCT01031212|Acetic Acid|acetic acid|mesh-list
56769829|NCT01031212|Paclitaxel|paclitaxel|mesh-list
56769830|NCT01031212|Carboplatin|carboplatin|mesh-list
56769831|NCT01031212|Cetuximab|cetuximab|mesh-list
56769832|NCT01031212|Vadimezan|vadimezan|mesh-list
56540344|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540345|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56540346|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56540347|NCT02695381|Analgesics|analgesics|mesh-ancestor
56540348|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540349|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56540350|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56540351|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56540352|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540353|NCT02746783|Vaccines|vaccines|mesh-list
56540354|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
56540355|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540356|NCT02747953|Afatinib|afatinib|mesh-list
56540357|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540358|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540359|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194570|NCT01493986|Ropivacaine|ropivacaine|mesh-list
56769833|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56769834|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769835|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
56769836|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
56769837|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
56769838|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769839|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56769840|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56769841|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769842|NCT01024348|Acetaminophen|acetaminophen|mesh-list
56769843|NCT01024348|Tramadol|tramadol|mesh-list
56769844|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56769845|NCT01024348|Analgesics|analgesics|mesh-ancestor
56769846|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
56769847|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769848|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769849|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
56769850|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56769851|NCT01024348|Narcotics|narcotics|mesh-ancestor
56042523|NCT01860521|Sufentanil|sufentanil|mesh-list
56042524|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
56769883|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56769884|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56769885|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769886|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769887|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
56769888|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56769889|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769890|NCT00941252|Imiquimod|imiquimod|mesh-list
56769891|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56769892|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
56769893|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769894|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769895|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
56769896|NCT01031368|Cytarabine|cytarabine|mesh-list
56769897|NCT01031368|Clofarabine|clofarabine|mesh-list
56769898|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56769978|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56770006|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56770007|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770009|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
56540360|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540361|NCT02735239|Leucovorin|leucovorin|mesh-list
56540362|NCT02735239|Paclitaxel|paclitaxel|mesh-list
56540363|NCT02735239|Docetaxel|docetaxel|mesh-list
56540364|NCT02735239|Carboplatin|carboplatin|mesh-list
56540365|NCT02735239|Fluorouracil|fluorouracil|mesh-list
56540366|NCT02735239|Capecitabine|capecitabine|mesh-list
56540367|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
56540368|NCT02735239|Durvalumab|durvalumab|mesh-list
56540369|NCT02735239|Tremelimumab|tremelimumab|mesh-list
56540370|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56540371|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540372|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
56540373|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
56540374|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
56540375|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540376|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
56540377|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56540378|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56540379|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
56540380|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540381|NCT02735239|Antidotes|antidotes|mesh-ancestor
56540382|NCT02735239|Protective Agents|protective agents|mesh-ancestor
56540383|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
56540384|NCT02735239|Vitamins|vitamins|mesh-ancestor
56540385|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
56540386|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56540387|NCT02655523|Dexamethasone|dexamethasone|mesh-list
56540388|NCT02655523|Triamcinolone|triamcinolone|mesh-list
56540389|NCT02655523|Bupivacaine|bupivacaine|mesh-list
56540390|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540391|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
56540392|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
56540393|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540394|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540395|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56540396|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
56540397|NCT02655523|Hormones|hormones|mesh-ancestor
56540402|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
56540403|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540404|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
56770010|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770011|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770012|NCT00952016|Methotrexate|methotrexate|mesh-list
56770013|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56770014|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
56770015|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56770016|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770017|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56770018|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
56770019|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770020|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770021|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
56770022|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770057|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
56770090|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56770091|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770092|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770093|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
56770094|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770095|NCT00953108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56770096|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
56770097|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56770098|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56770099|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56770197|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
56770198|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56770199|NCT00436618|Everolimus|everolimus|mesh-list
56770200|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770201|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770202|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
56770203|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770344|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770345|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56770346|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
56770347|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56770348|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770349|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56770350|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
56770351|NCT00949728|Coagulants|coagulants|mesh-ancestor
56770352|NCT00954902|Antioxidants|antioxidants|mesh-list
56770353|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770389|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
56770390|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770391|NCT00110305|Efavirenz|efavirenz|mesh-list
56770392|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56770435|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56770436|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
56770437|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770438|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770439|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770440|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56770441|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56770442|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770443|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56770444|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56770445|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
56770446|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
56770447|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
56770448|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770449|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56770477|NCT00118417|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56770478|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56770479|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56770480|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770481|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770482|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
56540405|NCT02644291|Mebendazole|mebendazole|mesh-list
56540406|NCT02644291|Piperazine|piperazine|mesh-list
56540407|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
56540408|NCT02644291|DMP 777|dmp 777|mesh-list
56540409|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
56540410|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
56540411|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56540412|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540413|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
56540414|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
56540415|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
56540416|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540417|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540418|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540419|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56540420|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56540421|NCT01015677|Estradiol|estradiol|mesh-list
56540422|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56540423|NCT01015677|Estrogens|estrogens|mesh-ancestor
56770483|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770484|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
56770485|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
56770487|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56770488|NCT01079455|Corticosterone|corticosterone|mesh-list
56770489|NCT01079455|Bupivacaine|bupivacaine|mesh-list
56770490|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
56770491|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
56770493|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770494|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770495|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
56043152|NCT02683707|Narcotics|narcotics|mesh-ancestor
56770534|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770535|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56770536|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
56770537|NCT00549848|Hormones|hormones|mesh-ancestor
56770538|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56770539|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56770540|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
56770644|NCT02768363|Valacyclovir|valacyclovir|mesh-list
56770645|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
56770646|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770647|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
56770648|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56770649|NCT02759861|Ledipasvir|ledipasvir|mesh-list
56770650|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
56770651|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770652|NCT00548262|Voriconazole|voriconazole|mesh-list
56770653|NCT00548262|Anidulafungin|anidulafungin|mesh-list
56770654|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
56770655|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770656|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56770657|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56043314|NCT05441631|Insulin|insulin|mesh-list
56770682|NCT02730923|Anastrozole|anastrozole|mesh-list
56770683|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56770684|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770685|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56770686|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56770687|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770688|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634299|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56540424|NCT01015677|Hormones|hormones|mesh-ancestor
56540425|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540426|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540427|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56540428|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
56540429|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56540430|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56540432|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56540433|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56540434|NCT02281981|Analgesics|analgesics|mesh-ancestor
56540435|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
56540436|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540437|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540438|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540439|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56540440|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540441|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540442|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540443|NCT04297839|Heparin|heparin|mesh-list
56540444|NCT04297839|Calcium heparin|calcium heparin|mesh-list
56540445|NCT04297839|Citric Acid|citric acid|mesh-list
56540446|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
56540447|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
56540448|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56540449|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
56540450|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
56770689|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56770690|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
56770691|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56770692|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770693|NCT04619082|Tenofovir|tenofovir|mesh-list
56770694|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
56770695|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770696|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56770697|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56770698|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770699|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770700|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56770701|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56770702|NCT03717623|Posaconazole|posaconazole|mesh-list
56770703|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
56770704|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770733|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56770734|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
56770735|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540451|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098244|NCT00002618|Cobalt|cobalt|mesh-list
56770736|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56770737|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56770738|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770739|NCT03954834|Tirzepatide|tirzepatide|mesh-list
56770740|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56770741|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770742|NCT03954834|Incretins|incretins|mesh-ancestor
56770743|NCT03954834|Hormones|hormones|mesh-ancestor
56770744|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56770745|NCT00693017|Zonisamide|zonisamide|mesh-list
56770746|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
56770747|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56770779|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56770780|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56770781|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
56770782|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770783|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770784|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770785|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
56770786|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
56770787|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770788|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
56770789|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56043457|NCT04375605|Antidotes|antidotes|mesh-ancestor
56770822|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770824|NCT02611037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770825|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770826|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770827|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
56770828|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770829|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56770830|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
56770831|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56770868|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770901|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56770902|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770903|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770904|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56770905|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770906|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770907|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56770908|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56770909|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56770910|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56770936|NCT00555620|Capecitabine|capecitabine|mesh-list
56770937|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
56770939|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770940|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56770941|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
56770942|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770943|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56770944|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56770945|NCT00555620|Growth Substances|growth substances|mesh-ancestor
56770946|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770947|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
56770948|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56770949|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770951|NCT00433966|Heparin|heparin|mesh-list
56770952|NCT00433966|Calcium heparin|calcium heparin|mesh-list
56770953|NCT00433966|Bivalirudin|bivalirudin|mesh-list
56770954|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56770955|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770956|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
56770957|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
56770958|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
56770959|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770995|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56770996|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56043666|NCT02421588|Doxorubicin|doxorubicin|mesh-list
56540452|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56540453|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56540480|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56540481|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56540482|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
56540483|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
56540484|NCT04216459|Vitamin D|vitamin d|mesh-list
56540485|NCT04216459|Thiamine|thiamine|mesh-list
56540486|NCT04216459|Vitamins|vitamins|mesh-ancestor
56540487|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
56540488|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540489|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56540490|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56540491|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
56540492|NCT04216771|Cytarabine|cytarabine|mesh-list
56540493|NCT04216771|Idarubicin|idarubicin|mesh-list
56540494|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56540495|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
56540496|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540497|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540498|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
56540499|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540500|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56540501|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
56771033|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
56771034|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
56771061|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
56771062|NCT03952650|Filaricides|filaricides|mesh-ancestor
56540502|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098327|NCT00002642|Cobalt|cobalt|mesh-list
56771063|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
56771064|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
56771065|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56771066|NCT00955526|Istradefylline|istradefylline|mesh-list
56771067|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56771068|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56771069|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56771070|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
56771071|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771072|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771073|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771074|NCT00955604|Rasagiline|rasagiline|mesh-list
56771075|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
56771076|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56771077|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56771078|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771079|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771080|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56771081|NCT00955604|Protective Agents|protective agents|mesh-ancestor
56043732|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
56043783|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
56771149|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771150|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771151|NCT00956306|Udenafil|udenafil|mesh-list
56771152|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56771153|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56771154|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771155|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771156|NCT00775229|Naltrexone|naltrexone|mesh-list
56771157|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56771158|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56771159|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771160|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
56771161|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771192|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56771193|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56771195|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
56771196|NCT03047070|Lidocaine|lidocaine|mesh-list
56771197|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
56771198|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
56771199|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56771200|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771201|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
56771202|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771203|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56771204|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56771205|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56771206|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56771207|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771236|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771237|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
56771238|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482165|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
56771239|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56771240|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923663|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56771241|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771242|NCT04184622|Tirzepatide|tirzepatide|mesh-list
56771243|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56771244|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771245|NCT04184622|Incretins|incretins|mesh-ancestor
56771246|NCT04184622|Hormones|hormones|mesh-ancestor
56771247|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56771248|NCT00744185|Propranolol|propranolol|mesh-list
56771249|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56771250|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56771251|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
56771252|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771282|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771283|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194725|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
56771284|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
56771285|NCT00741767|Hormones|hormones|mesh-ancestor
56771286|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56771287|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
56771288|NCT05317403|Cytarabine|cytarabine|mesh-list
56771289|NCT05317403|Fludarabine|fludarabine|mesh-list
56771290|NCT05317403|Venetoclax|venetoclax|mesh-list
56771291|NCT05317403|Vorinostat|vorinostat|mesh-list
56771292|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771293|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56771294|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
56771295|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771296|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771328|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56771329|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56771330|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771331|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771332|NCT00549302|Urological Agents|urological agents|mesh-ancestor
56771333|NCT04277858|Cisplatin|cisplatin|mesh-list
56771334|NCT04277858|Docetaxel|docetaxel|mesh-list
56771335|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771336|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
56771337|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
56771338|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
56771339|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771340|NCT00957866|Interferons|interferons|mesh-list
56771375|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771376|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56771377|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56771378|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56771379|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56771380|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
56771381|NCT00948584|Insulin|insulin|mesh-list
56771382|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56771383|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
56771384|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56771414|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56771415|NCT01084369|Testosterone|testosterone|mesh-list
56771416|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
56771417|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
56771418|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56771419|NCT01084369|Androgens|androgens|mesh-ancestor
56771420|NCT01084369|Hormones|hormones|mesh-ancestor
56771421|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56771422|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771423|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56771424|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771425|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
56771426|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
56771427|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56771428|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56771488|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56771489|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56771490|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
56771491|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771492|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771493|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56771494|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
56771495|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56771496|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56771497|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56771498|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56771499|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
56771500|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56771501|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56771502|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771504|NCT00963222|Vitamins|vitamins|mesh-ancestor
56771505|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
56771506|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771507|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56771508|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56771509|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771510|NCT00968682|Trastuzumab|trastuzumab|mesh-list
56473660|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
56540503|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56391378|NCT00518908|Sevoflurane|sevoflurane|mesh-list
56540504|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56540505|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56540506|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540507|NCT00636259|Bicalutamide|bicalutamide|mesh-list
56540508|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
56771511|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56771512|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482463|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
56771542|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771543|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771544|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
56771545|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771547|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56771548|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56771549|NCT02465138|Analgesics|analgesics|mesh-ancestor
56771550|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
56771551|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771552|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771553|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56771554|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56771555|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56771556|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771557|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771585|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56771586|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56771587|NCT00963534|Growth Substances|growth substances|mesh-ancestor
56771588|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
56771589|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56771590|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
56771591|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771592|NCT00963690|Hemostatics|hemostatics|mesh-list
56771593|NCT00963690|Coagulants|coagulants|mesh-ancestor
56771594|NCT01079767|Sirolimus|sirolimus|mesh-list
56771595|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771596|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771597|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56771598|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771599|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
56771600|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771601|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
56771602|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771603|NCT00969306|Chloroquine|chloroquine|mesh-list
56771604|NCT00969306|Amebicides|amebicides|mesh-ancestor
56044264|NCT05450913|Lidocaine|lidocaine|mesh-list
56771631|NCT00969696|Galantamine|galantamine|mesh-list
56771632|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56771633|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771634|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771635|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
56771636|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771637|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771638|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56771639|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
56771640|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771641|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
56771642|NCT00958854|Thalidomide|thalidomide|mesh-list
56771643|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
56771644|NCT00958854|Fludarabine|fludarabine|mesh-list
56771645|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
56771646|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771647|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
56771648|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771649|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56771680|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
56771681|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56771682|NCT00969852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55792222|NCT05036005|Pertuzumab|pertuzumab|mesh-list
56540509|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
56540510|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540511|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540512|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540513|NCT02736019|Celecoxib|celecoxib|mesh-list
56540514|NCT02736019|Tramadol|tramadol|mesh-list
56540515|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56288776|NCT00001191|Omeprazole|omeprazole|mesh-list
56540516|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56540517|NCT02736019|Analgesics|analgesics|mesh-ancestor
56540518|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
56098633|NCT00002744|Cobalt|cobalt|mesh-list
56771683|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56771684|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56771685|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771686|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771687|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
56771688|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771689|NCT04170738|Amphetamine|amphetamine|mesh-list
56771690|NCT04170738|Adderall|adderall|mesh-list
56771691|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
56771692|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56771693|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771694|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
56771695|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
56771727|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56771728|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
56771729|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771730|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
56771731|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56771732|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771733|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
56771734|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771735|NCT00970086|Bupivacaine|bupivacaine|mesh-list
56771736|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
56044398|NCT02209610|Fentanyl|fentanyl|mesh-list
56771764|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56923664|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
56482690|NCT00552461|Rituximab|rituximab|mesh-list
56771765|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771766|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56771767|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56771768|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56771769|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56771770|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56771771|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56771772|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56771773|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
56771774|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771775|NCT00746681|Urological Agents|urological agents|mesh-ancestor
56771776|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
56771777|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56771778|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771779|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56771812|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56771813|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56771814|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56771815|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56771816|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
56771817|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771818|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
56540519|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540520|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540521|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540522|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56540523|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56540524|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56771819|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
56771820|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771821|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
56771822|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771823|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771824|NCT00964626|Paclitaxel|paclitaxel|mesh-list
56771825|NCT00964626|Cisplatin|cisplatin|mesh-list
56771859|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
56771860|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56771861|NCT02562053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56771862|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56771863|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56771864|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771865|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771866|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
56771867|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771891|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56771892|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56771893|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771894|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
56771895|NCT00744809|Efavirenz|efavirenz|mesh-list
56771896|NCT00744809|Rilpivirine|rilpivirine|mesh-list
56771897|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771898|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771899|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56771900|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56771901|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771902|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771903|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771904|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56771905|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56771906|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
56771907|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56771908|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56771909|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56771910|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56482837|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771911|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56771912|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56771913|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56771914|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56771915|NCT00744887|Darunavir|darunavir|mesh-list
56044576|NCT01562678|Incretins|incretins|mesh-ancestor
56771948|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
56771949|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56771950|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56771951|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56771952|NCT00949364|Pomalidomide|pomalidomide|mesh-list
56771953|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
56771954|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771955|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56771989|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56771990|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56771992|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771993|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771994|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56771995|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
56771996|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56771997|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771998|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
56540525|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540526|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540527|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56540528|NCT02736019|Narcotics|narcotics|mesh-ancestor
56540529|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540530|NCT04284397|Aspirin|aspirin|mesh-list
56540531|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56540532|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56540533|NCT04284397|Analgesics|analgesics|mesh-ancestor
56540534|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
56540535|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540536|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540537|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540538|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56771999|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772000|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56772033|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56772034|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56772035|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772036|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56772037|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
56772038|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772039|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772040|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56772041|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56772042|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56772068|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56772069|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
56772070|NCT00686855|Hormones|hormones|mesh-ancestor
56772071|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772072|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56772073|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772074|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772075|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
56772076|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56772077|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772078|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772079|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
56772080|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
56772081|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772082|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772083|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56772084|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
56772085|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
56772086|NCT00949832|Vitamin D|vitamin d|mesh-list
56772087|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
56772088|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
56772089|NCT00949832|Vitamins|vitamins|mesh-list
56772090|NCT00949832|Calcium|calcium|mesh-list
56772091|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
56772092|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772120|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
56772121|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772122|NCT04009772|Metronidazole|metronidazole|mesh-list
56772123|NCT04009772|Cefuroxime|cefuroxime|mesh-list
56772124|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
56772125|NCT04009772|Cefepime|cefepime|mesh-list
56772126|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772127|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56772128|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56540539|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56540540|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56540541|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540542|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56540543|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56540544|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540545|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
56772129|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56772130|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56772131|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56483064|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
56772132|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772133|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56772134|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
56772135|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
56772137|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
56772138|NCT00747305|Sunitinib|sunitinib|mesh-list
56772139|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772140|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56772162|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56772164|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772165|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772166|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56772167|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772168|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
56772169|NCT00106639|Tacrolimus|tacrolimus|mesh-list
56772170|NCT00106639|Tofacitinib|tofacitinib|mesh-list
56772171|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772172|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
56772173|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772174|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56772175|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772176|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772177|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56772178|NCT00747539|Interferons|interferons|mesh-list
56772179|NCT00747539|Ribavirin|ribavirin|mesh-list
56772180|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
56772181|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772182|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
56772183|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772184|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
56772185|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772186|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
56772187|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772188|NCT00745433|Metformin|metformin|mesh-list
56772189|NCT00745433|Repaglinide|repaglinide|mesh-list
56772190|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56772191|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772192|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
56772228|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772229|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772230|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
56772231|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772232|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56044902|NCT00373503|Analgesics|analgesics|mesh-ancestor
56772267|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56772268|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
56772269|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56772270|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56772303|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56772304|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772305|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772306|NCT00547118|Hormones|hormones|mesh-ancestor
56772307|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772308|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772309|NCT00962936|Pidilizumab|pidilizumab|mesh-list
56772310|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56540546|NCT05595889|Irinotecan|irinotecan|mesh-list
56540547|NCT05595889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56540548|NCT05595889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56540549|NCT05595889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540550|NCT05595889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540551|NCT05595889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540552|NCT02735395|Amoxicillin|amoxicillin|mesh-list
56540553|NCT02735395|Metronidazole|metronidazole|mesh-list
56194772|NCT01495039|Nystatin|nystatin|mesh-list
56772311|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772312|NCT01087099|Albendazole|albendazole|mesh-list
56772313|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
56772314|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56772334|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772335|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56772336|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56772337|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56772338|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56772339|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56772340|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772341|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772342|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56772343|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
56772344|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772345|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772346|NCT00750113|Telmisartan|telmisartan|mesh-list
56772347|NCT00750113|Nifedipine|nifedipine|mesh-list
56772348|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56772349|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56772350|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56772351|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772352|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56772353|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56772354|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56772355|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772356|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
56772357|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
56772358|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56772360|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56772361|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772362|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56772363|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56772364|NCT00745511|Growth Substances|growth substances|mesh-ancestor
56772365|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772366|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
56772367|NCT00545688|Docetaxel|docetaxel|mesh-list
56772368|NCT00545688|Trastuzumab|trastuzumab|mesh-list
56772369|NCT00545688|Pertuzumab|pertuzumab|mesh-list
56772396|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56772397|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56772398|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56772399|NCT00967850|Verteporfin|verteporfin|mesh-list
56772400|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56772401|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
56772402|NCT00967928|Everolimus|everolimus|mesh-list
56772403|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772404|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772405|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
56772406|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772407|NCT00546000|Fluticasone|fluticasone|mesh-list
56772408|NCT00546000|Xhance|xhance|mesh-list
56772409|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772410|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56772411|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
56772412|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772413|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540554|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56540555|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540556|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56540557|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56540558|NCT02741947|Levodopa|levodopa|mesh-list
56540559|NCT02741947|Benserazide|benserazide|mesh-list
56540560|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
56540561|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56540562|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56540563|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
56540564|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540565|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540566|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540567|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540568|NCT02740933|Demeclocycline|demeclocycline|mesh-list
56540569|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56540570|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540571|NCT04307485|Ticagrelor|ticagrelor|mesh-list
56540572|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56540573|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56540574|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56540575|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56540576|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
56194790|NCT01495117|Iodine|iodine|mesh-list
56772414|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56772415|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
56772416|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
56772417|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56045127|NCT01469234|Fexofenadine|fexofenadine|mesh-list
56772505|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772507|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772508|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56772509|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
56772510|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
56772511|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772512|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56772513|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56772514|NCT00104299|Protective Agents|protective agents|mesh-ancestor
56772515|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
56772516|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56772517|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56772518|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56772519|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772520|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772521|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56772522|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56772523|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772524|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
56772525|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772526|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
56772527|NCT00082381|Exenatide|exenatide|mesh-list
56540577|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540578|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540579|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540580|NCT02739685|Everolimus|everolimus|mesh-list
56540581|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540582|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56540583|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
56540584|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540585|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
56540586|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
56540587|NCT02735317|Gentamicins|gentamicins|mesh-list
56540588|NCT02735317|Dexamethasone|dexamethasone|mesh-list
56540589|NCT02735317|Procaine|procaine|mesh-list
56540590|NCT02735317|Vitamins|vitamins|mesh-ancestor
56772528|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56772529|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772530|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56772531|NCT00082381|Incretins|incretins|mesh-ancestor
56772532|NCT00082381|Hormones|hormones|mesh-ancestor
56772533|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772534|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
56772535|NCT00964106|Rifampin|rifampin|mesh-list
56772536|NCT00964106|Fluconazole|fluconazole|mesh-list
56772537|NCT00964106|Ketoconazole|ketoconazole|mesh-list
56772538|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
56772539|NCT00964106|Midazolam|midazolam|mesh-list
56772540|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
56772541|NCT00964106|Caffeine|caffeine|mesh-list
56772542|NCT00964106|Omeprazole|omeprazole|mesh-list
56772543|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56772544|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56772545|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56772546|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56772547|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772548|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56772549|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56772550|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56772551|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56772552|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
56772553|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
56772554|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
56772586|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56772587|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56772588|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56772589|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
56772590|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772591|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56772592|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56772606|NCT00960336|Doxorubicin|doxorubicin|mesh-list
56772607|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56772608|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56772609|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772610|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56772611|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56772612|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772613|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772614|NCT00965172|Calcium|calcium|mesh-list
56772615|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56772616|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772617|NCT01084837|Bortezomib|bortezomib|mesh-list
56772618|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772619|NCT00545844|Montelukast|montelukast|mesh-list
56772620|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56772621|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
56540591|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
56540592|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288849|NCT00011635|Silymarin|silymarin|mesh-list
56540593|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540595|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
56540596|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540597|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56540598|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
56540599|NCT02735317|Hormones|hormones|mesh-ancestor
56540600|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540601|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56540602|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540603|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
56540604|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56540605|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194816|NCT01495195|Selegiline|selegiline|mesh-list
56772622|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56772623|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
56772624|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772625|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772626|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56772627|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56772628|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772629|NCT01084993|Heparin|heparin|mesh-list
56772630|NCT01084993|Bivalirudin|bivalirudin|mesh-list
56772631|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
56772632|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56772633|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56772634|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772635|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
56772636|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56772637|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
56772638|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772639|NCT00492063|Vaccines|vaccines|mesh-list
56772640|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
56772641|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772642|NCT00960492|Temozolomide|temozolomide|mesh-list
56772643|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56772644|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
56772645|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772646|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772647|NCT00971724|Prednisolone|prednisolone|mesh-list
56772648|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772649|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
56772650|NCT00971724|Hormones|hormones|mesh-ancestor
56772651|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772674|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56772675|NCT00093145|Paclitaxel|paclitaxel|mesh-list
56772676|NCT00093145|Carboplatin|carboplatin|mesh-list
56772677|NCT00093145|Trastuzumab|trastuzumab|mesh-list
56772678|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56772679|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56772680|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772681|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
56772682|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
56772683|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
56772684|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772685|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56772686|NCT00965406|Insulin|insulin|mesh-list
56540606|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56540607|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540608|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540609|NCT02735317|Hematinics|hematinics|mesh-ancestor
56540610|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
56540611|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
56540612|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540613|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
56540614|NCT05554237|Ceftibuten|ceftibuten|mesh-list
56540615|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56540616|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540617|NCT05544721|Ropivacaine|ropivacaine|mesh-list
56540618|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
56540619|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
56540620|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540621|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540622|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
56540623|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540624|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56540625|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540626|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540627|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540628|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540629|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
56540630|NCT02739061|Sertraline|sertraline|mesh-list
56540631|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
56194832|NCT01495208|Aflibercept|aflibercept|mesh-list
56772687|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56772688|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772689|NCT00513357|Melatonin|melatonin|mesh-list
56772690|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
56772691|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772692|NCT00513357|Protective Agents|protective agents|mesh-ancestor
56772693|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772694|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56772695|NCT05181735|Luspatercept|luspatercept|mesh-list
56772696|NCT05181735|Hematinics|hematinics|mesh-ancestor
56772697|NCT00960960|Paclitaxel|paclitaxel|mesh-list
56772698|NCT00960960|Bevacizumab|bevacizumab|mesh-list
56772699|NCT00960960|Trastuzumab|trastuzumab|mesh-list
56772700|NCT00960960|Letrozole|letrozole|mesh-list
56772701|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56772702|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772703|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
56772704|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
56772705|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
56772706|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772707|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56065182|NCT02505269|Doxorubicin|doxorubicin|mesh-list
56540632|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56540633|NCT02739061|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56540634|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56540635|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56540636|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772732|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772733|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772734|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56772735|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56772738|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
56772739|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772740|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772741|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56772742|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56772743|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
56772744|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
56772745|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56772746|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56772747|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56772748|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772749|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772750|NCT05279586|Colistin|colistin|mesh-list
56772751|NCT05279586|Lactulose|lactulose|mesh-list
56772752|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56772753|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56772754|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772755|NCT00965796|Lidocaine|lidocaine|mesh-list
56772775|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
56772776|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772777|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772778|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
56772779|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56772780|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56772781|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
56772782|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56772783|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56772784|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772785|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56772786|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
56772787|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56772788|NCT00972426|Timolol|timolol|mesh-list
56772789|NCT00972426|Carteolol|carteolol|mesh-list
56772790|NCT00972426|Latanoprost|latanoprost|mesh-list
56772791|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56772792|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56772793|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
56772794|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772795|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772796|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772797|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56772798|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56772799|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56772800|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56772801|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
56772802|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
56772803|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772804|NCT00972660|Cyclosporine|cyclosporine|mesh-list
56772805|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
56772806|NCT00972660|Prednisone|prednisone|mesh-list
56772807|NCT00972660|Cyclosporins|cyclosporins|mesh-list
56772808|NCT00972660|Tacrolimus|tacrolimus|mesh-list
56772809|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772843|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56772844|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772845|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56772846|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
56772847|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
56772879|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56540637|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540638|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
56540639|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540640|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56540641|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56540642|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540643|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56540644|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56540645|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56540646|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540647|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56540648|NCT02745925|Ibuprofen|ibuprofen|mesh-list
56540649|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56483811|NCT03778931|Fulvestrant|fulvestrant|mesh-list
56772880|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56772881|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772883|NCT00966576|Brinzolamide|brinzolamide|mesh-list
56772884|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772885|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772886|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56772887|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56772888|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
56772889|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772890|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772891|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56772942|NCT01033084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56772943|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56772944|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56772945|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772946|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772947|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
56772948|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772949|NCT00979758|Atorvastatin|atorvastatin|mesh-list
56772950|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56772951|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56772952|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
56772953|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772954|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56772955|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56772957|NCT00545064|Timolol|timolol|mesh-list
56772958|NCT00545064|Dorzolamide|dorzolamide|mesh-list
56772959|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772960|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772961|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56772962|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56772963|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
56772964|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772965|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772966|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56772967|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56772968|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56772969|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
56772970|NCT00979836|Calcium|calcium|mesh-list
56772971|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56772972|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772973|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
56772974|NCT00979836|Coagulants|coagulants|mesh-ancestor
56772975|NCT01588912|Tenofovir|tenofovir|mesh-list
56772976|NCT01588912|Entecavir|entecavir|mesh-list
56540650|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56634300|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540651|NCT02745925|Analgesics|analgesics|mesh-ancestor
56540652|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
56540653|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540654|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540655|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540657|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56540658|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540659|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540660|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56540661|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
56540662|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540663|NCT02738905|Rifaximin|rifaximin|mesh-list
56540664|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56540665|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540666|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56540667|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
56540668|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56540669|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540670|NCT02745691|Gefitinib|gefitinib|mesh-list
56540671|NCT02745691|Crizotinib|crizotinib|mesh-list
56540672|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540673|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540674|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540675|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540676|NCT02745769|Ramucirumab|ramucirumab|mesh-list
56540677|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540678|NCT02734069|Carboplatin|carboplatin|mesh-list
56540679|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772977|NCT01588912|Telbivudine|telbivudine|mesh-list
56772978|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
56772979|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772980|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56772981|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56045639|NCT00373815|Everolimus|everolimus|mesh-list
56773029|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773030|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56773032|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773033|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773034|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56773035|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
56773036|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
56773037|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
56540680|NCT02737813|Bupivacaine|bupivacaine|mesh-list
56540681|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
56540682|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
56540683|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540684|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540685|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
56540686|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540687|NCT00636415|Morphine|morphine|mesh-list
56540688|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56540689|NCT00636415|Narcotics|narcotics|mesh-ancestor
56540690|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540691|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540692|NCT00636415|Analgesics|analgesics|mesh-ancestor
56540693|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
56540694|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540695|NCT02733835|Remifentanil|remifentanil|mesh-list
56540696|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56540697|NCT02733835|Narcotics|narcotics|mesh-ancestor
56540698|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540699|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540700|NCT02733835|Analgesics|analgesics|mesh-ancestor
56540701|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
56540702|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540703|NCT02737423|Vitamin D|vitamin d|mesh-list
56540704|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
56540705|NCT02737423|Vitamins|vitamins|mesh-ancestor
56540706|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
56540707|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540708|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56540709|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56540710|NCT02733679|Metformin|metformin|mesh-list
56540711|NCT02733679|Pioglitazone|pioglitazone|mesh-list
56540712|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56773038|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56773039|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56773040|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56773041|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773042|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56773043|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56773044|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56773045|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
56773046|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773047|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56540713|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540714|NCT03289741|Octreotide|octreotide|mesh-list
56540715|NCT03289741|Lanreotide|lanreotide|mesh-list
56540716|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56540717|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56540718|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540719|NCT05473585|Nicotine|nicotine|mesh-list
56540720|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56540721|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
56540722|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540723|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540724|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56540725|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56540726|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
56540727|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391602|NCT00520000|Carboplatin|carboplatin|mesh-list
56540728|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540730|NCT05629429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56540731|NCT05629429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540732|NCT05629429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540733|NCT05629429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540734|NCT02744131|Metformin|metformin|mesh-list
56540735|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
56540736|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
56540737|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
56540738|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56540739|NCT02744131|Estradiol|estradiol|mesh-list
56540740|NCT02744131|Cyproterone|cyproterone|mesh-list
56540741|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56540742|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773048|NCT01034410|Cytarabine|cytarabine|mesh-list
56773049|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56773050|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
56773051|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773052|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773053|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
56773054|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773055|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773056|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
56773057|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773058|NCT00415168|Pemetrexed|pemetrexed|mesh-list
56773059|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773060|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773061|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773062|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56540743|NCT02744131|Estrogens|estrogens|mesh-ancestor
56540744|NCT02744131|Hormones|hormones|mesh-ancestor
56540745|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540746|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56540747|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56540748|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
56540749|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
56540750|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540751|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56540752|NCT03326791|Aspirin|aspirin|mesh-list
56540753|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56540754|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56540755|NCT03326791|Analgesics|analgesics|mesh-ancestor
56540756|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
56540757|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540758|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540759|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540760|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56540761|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56540762|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56540763|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540764|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56540765|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56540766|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194979|NCT01496105|Lidocaine|lidocaine|mesh-list
56773063|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56773064|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
56773065|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56773066|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773067|NCT02624518|Bombesin|bombesin|mesh-list
56773068|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773069|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773070|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773071|NCT00980304|Rituximab|rituximab|mesh-list
56773072|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56773073|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773074|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
56773075|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773076|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773109|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56773110|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56773111|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773112|NCT00967512|Cytarabine|cytarabine|mesh-list
56773113|NCT00967512|Idarubicin|idarubicin|mesh-list
56773114|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56773115|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
56773116|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773117|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540767|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
56540768|NCT02743975|Bevacizumab|bevacizumab|mesh-list
56540769|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56540770|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540771|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56540772|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56540773|NCT02743975|Growth Substances|growth substances|mesh-ancestor
56540774|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540775|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
56540776|NCT02743663|Albuterol|albuterol|mesh-list
56540777|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
56540778|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
56540779|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540780|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540781|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56540782|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
56540783|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
56540784|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56540785|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56540786|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56540787|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56773118|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
56773132|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773133|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56773134|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56773135|NCT04082910|Analgesics|analgesics|mesh-ancestor
56773136|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
56773137|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773138|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773139|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773140|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773141|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
56773142|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56773143|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56773144|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
56773145|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
56773146|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56773147|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56773148|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56773149|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
56773150|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773151|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773152|NCT00975078|Prednisone|prednisone|mesh-list
56773153|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773154|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
56773155|NCT00975078|Hormones|hormones|mesh-ancestor
56773156|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773157|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773158|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56773159|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773160|NCT00980616|Ropivacaine|ropivacaine|mesh-list
56773161|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
56773162|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
56065183|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56540788|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
56540789|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540790|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540791|NCT02733445|Dasatinib|dasatinib|mesh-list
56540792|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540793|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540794|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540795|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540796|NCT02731105|Clindamycin|clindamycin|mesh-list
56540797|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
56540798|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
56540799|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56540800|NCT02731105|Tretinoin|tretinoin|mesh-list
56540801|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56540802|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540803|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56540804|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773163|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773164|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773165|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
56773166|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773167|NCT00980850|Vaccines|vaccines|mesh-list
56773168|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
56773169|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773206|NCT04974996|Doxorubicin|doxorubicin|mesh-list
56773207|NCT04974996|Vincristine|vincristine|mesh-list
56773208|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56773209|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773210|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
56773211|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773212|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773281|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045961|NCT05470985|Ozanimod|ozanimod|mesh-list
56773385|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56773386|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
56773387|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773388|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773389|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56773390|NCT00976092|Heparin|heparin|mesh-list
56773391|NCT00976092|Calcium heparin|calcium heparin|mesh-list
56773392|NCT00976092|Bivalirudin|bivalirudin|mesh-list
56046091|NCT00551213|Irinotecan|irinotecan|mesh-list
56773428|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773429|NCT03927144|Erenumab|erenumab|mesh-list
56773430|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56773431|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773457|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773459|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56773460|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
56773461|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
56773462|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56773463|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56773464|NCT04007328|Prednisolone|prednisolone|mesh-list
56773465|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
56773466|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56773467|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
56195032|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56773468|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773469|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
56773470|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
56773471|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773472|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773473|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773474|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
56484415|NCT02540330|Fulvestrant|fulvestrant|mesh-list
56773475|NCT04007328|Hormones|hormones|mesh-ancestor
56773476|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773477|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56046151|NCT03008889|Antidotes|antidotes|mesh-ancestor
56773516|NCT04008186|Verapamil|verapamil|mesh-list
56773549|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56773550|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56773551|NCT04008186|Protective Agents|protective agents|mesh-ancestor
56773552|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56773553|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56773554|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56773555|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
56773556|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56773557|NCT00982566|Navitoclax|navitoclax|mesh-list
56773576|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
56773577|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773578|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56773579|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56773580|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
56773581|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56773582|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
56773583|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
56773584|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
56773585|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56773586|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
56773587|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
56773588|NCT00982722|Vitamin D|vitamin d|mesh-list
56773589|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
56773590|NCT00982722|Calcium|calcium|mesh-list
56773591|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56773592|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773593|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56773594|NCT00982722|Vitamins|vitamins|mesh-ancestor
56773595|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
56773596|NCT00982722|Antacids|antacids|mesh-ancestor
56773597|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773598|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773599|NCT00982800|Gabapentin|gabapentin|mesh-list
56773600|NCT00982800|Analgesics|analgesics|mesh-ancestor
56773601|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
56773602|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773603|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773604|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
56773605|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56773606|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56773607|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773608|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56773609|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56773610|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56773611|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773612|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773613|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
56773614|NCT00986076|Enoxaparin|enoxaparin|mesh-list
56046294|NCT02247362|Vaccines|vaccines|mesh-list
56773710|NCT00429364|Losartan|losartan|mesh-list
56773711|NCT00429364|Atenolol|atenolol|mesh-list
56773712|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56773713|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56773714|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56773715|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56773716|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773717|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
56773718|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
56773719|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773720|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773721|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56065184|NCT02505269|Dacarbazine|dacarbazine|mesh-list
56540805|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540806|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540807|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
56540808|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
56540809|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56540810|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56540811|NCT02731105|Analgesics|analgesics|mesh-ancestor
56540812|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
56540813|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540814|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540815|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773722|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56773723|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56773724|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
56773725|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773726|NCT00978354|Furosemide|furosemide|mesh-list
56773727|NCT00978354|Diuretics|diuretics|mesh-ancestor
56773728|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
56773729|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773752|NCT04006080|Vedolizumab|vedolizumab|mesh-list
56773753|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773754|NCT00984438|Bevacizumab|bevacizumab|mesh-list
56773755|NCT00984438|Irinotecan|irinotecan|mesh-list
56773756|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56773757|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773758|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56773759|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56773760|NCT00984438|Growth Substances|growth substances|mesh-ancestor
56773761|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773762|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
56773763|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56773764|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56773765|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773766|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773767|NCT00424372|Pregabalin|pregabalin|mesh-list
56773768|NCT00424372|Analgesics|analgesics|mesh-ancestor
56773769|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
56773770|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773771|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773772|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
56773773|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56773774|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56773775|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773776|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56773777|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56773778|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56773779|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773818|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
56046530|NCT05672810|Hemostatics|hemostatics|mesh-ancestor
56773843|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
56773844|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773845|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773846|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
56773847|NCT00414076|Letrozole|letrozole|mesh-list
56773848|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773849|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56773850|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56773851|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773852|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773853|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56484792|NCT04682132|Antibodies|antibodies|mesh-list
56773854|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
56065185|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56540816|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56540817|NCT02743429|Dinutuximab|dinutuximab|mesh-list
56540819|NCT02730949|Folic Acid|folic acid|mesh-list
56540820|NCT02730949|Inositol|inositol|mesh-list
56540821|NCT02730949|Hematinics|hematinics|mesh-ancestor
56540822|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
56540823|NCT02730949|Vitamins|vitamins|mesh-ancestor
56540824|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
56540825|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540826|NCT04205929|Curcumin|curcumin|mesh-list
56540827|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56540828|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56540829|NCT04205929|Analgesics|analgesics|mesh-ancestor
56540830|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
56540831|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540832|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540833|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540834|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773855|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773856|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773857|NCT01033318|Losartan|losartan|mesh-list
56773858|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56773859|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56773860|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56773861|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56773862|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773863|NCT01033396|Fexofenadine|fexofenadine|mesh-list
56773864|NCT01033396|Terfenadine|terfenadine|mesh-list
56773865|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56046557|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56773901|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773902|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
56773903|NCT00987636|Diphosphonates|diphosphonates|mesh-list
56773904|NCT00987636|Busulfan|busulfan|mesh-list
56046690|NCT05672342|Hormones|hormones|mesh-ancestor
56774003|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774004|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56774005|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
56774006|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
56774007|NCT00988026|Minocycline|minocycline|mesh-list
56774008|NCT00988026|Lymecycline|lymecycline|mesh-list
56774009|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56774010|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774011|NCT05578170|Pembrolizumab|pembrolizumab|mesh-list
56774046|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774047|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56774083|NCT01326871|Antiviral Agents|antiviral agents|mesh-ancestor
56774084|NCT01326871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774118|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774119|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774120|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56774121|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
56774122|NCT04508790|Hormones|hormones|mesh-ancestor
56774123|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774124|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56774125|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774126|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
56774127|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774128|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540835|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540836|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540837|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540838|NCT03259867|Nivolumab|nivolumab|mesh-list
56540839|NCT03259867|Tirapazamine|tirapazamine|mesh-list
56540840|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56540841|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774129|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
56774130|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56774131|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56774235|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774236|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56774237|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56774238|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
56774239|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56774240|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56774241|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56774242|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56774243|NCT00485589|Methotrexate|methotrexate|mesh-list
56774244|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
56774245|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56774261|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56774262|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
56774263|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
56774264|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774265|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774266|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56774267|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56774268|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56774269|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56774270|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56774271|NCT00490971|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56774272|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56774273|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56774274|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774275|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774276|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
56774277|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56774278|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56774279|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56774280|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56774281|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
56774282|NCT04286295|Nicotine|nicotine|mesh-list
56774283|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56774284|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
56774285|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774286|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774287|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56774288|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56774289|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
56774290|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774291|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774292|NCT00750347|Acetaminophen|acetaminophen|mesh-list
56774293|NCT00750347|Rimonabant|rimonabant|mesh-list
56774294|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56774295|NCT00750347|Analgesics|analgesics|mesh-ancestor
56774296|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
56774297|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774298|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774299|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
56774300|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56774301|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56485236|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56774302|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56774303|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774338|NCT00685763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774339|NCT00685763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540842|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56540843|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540844|NCT03854929|Azithromycin|azithromycin|mesh-list
56540845|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
56540846|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56540847|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540848|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56099906|NCT04476446|Esketamine|esketamine|mesh-list
56774340|NCT00685763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774341|NCT00685763|Immunologic Factors|immunologic factors|mesh-ancestor
56774376|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774378|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56774379|NCT01087567|Metformin|metformin|mesh-list
56774380|NCT01087567|Pioglitazone|pioglitazone|mesh-list
56774381|NCT01087567|Glimepiride|glimepiride|mesh-list
56774414|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774415|NCT04475835|Heparin|heparin|mesh-list
56774416|NCT04475835|Bivalirudin|bivalirudin|mesh-list
56774417|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
56774418|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56774419|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56774420|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774421|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
56774422|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56774423|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
56774460|NCT01016223|Beclomethasone|beclomethasone|mesh-list
56774496|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774497|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774498|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56774499|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
56774500|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774501|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774502|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56774503|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56774504|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56774505|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
56047214|NCT02987465|Norepinephrine|norepinephrine|mesh-list
56774540|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
56774541|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56774542|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56774543|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56774544|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56774577|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56774578|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56774579|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774580|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774582|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774583|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
56774584|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56774585|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56774586|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
56774619|NCT00751205|Hormones|hormones|mesh-ancestor
56774620|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774621|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774622|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56774623|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774624|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
56774625|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
56774626|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774627|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56774628|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56774629|NCT00751205|Protective Agents|protective agents|mesh-ancestor
56774630|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
56774631|NCT00751205|Vitamins|vitamins|mesh-ancestor
56774664|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
56774665|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56774666|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774667|NCT00752375|Renal Agents|renal agents|mesh-ancestor
56540849|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56540850|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540851|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540852|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540853|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56540854|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56540855|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
55827167|NCT01586338|Hylan|hylan|mesh-list
56774668|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
56774669|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56774670|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56774671|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56774672|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774673|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774674|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56774705|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56774706|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56774707|NCT00684515|Analgesics|analgesics|mesh-ancestor
56774708|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
56774709|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774710|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774711|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774712|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774713|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56774714|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56774715|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774716|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56774717|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56774748|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
56774749|NCT03855189|Hormones|hormones|mesh-ancestor
56774750|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774751|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774752|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56774753|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
56774754|NCT03853551|Osimertinib|osimertinib|mesh-list
56774755|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774756|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56774757|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774758|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774759|NCT00423670|Ribavirin|ribavirin|mesh-list
56774760|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56774761|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
56774762|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774784|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774785|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774786|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56774787|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56774788|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56774789|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56774790|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774791|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
56774792|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774793|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774794|NCT01037842|Mitiglinide|mitiglinide|mesh-list
56774795|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56774796|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774797|NCT00483405|Capecitabine|capecitabine|mesh-list
56774798|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
56774799|NCT00483405|Cetuximab|cetuximab|mesh-list
56774800|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56774801|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
56774802|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774803|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065744|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540856|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56540857|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
56540858|NCT00636493|Hormones|hormones|mesh-ancestor
56540859|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540860|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540861|NCT02730481|Paclitaxel|paclitaxel|mesh-list
56540862|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56540863|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540864|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
56540865|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
56540866|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
56540867|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540868|NCT02730091|Letrozole|letrozole|mesh-list
56540869|NCT02730091|Vinorelbine|vinorelbine|mesh-list
56540870|NCT02730091|Anastrozole|anastrozole|mesh-list
56540871|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540872|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56540873|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56540874|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56540875|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540876|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56540877|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
56540878|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56540879|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540880|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56540881|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
56540882|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
56540883|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
56540884|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56540885|NCT02742805|Vitamin D|vitamin d|mesh-list
56540886|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
56540899|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56540900|NCT02690389|Flumazenil|flumazenil|mesh-list
56540901|NCT02690389|Antidotes|antidotes|mesh-ancestor
56540902|NCT02690389|Protective Agents|protective agents|mesh-ancestor
56540903|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540904|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
56540905|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
56540906|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540907|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540908|NCT02732197|Thiopental|thiopental|mesh-list
56540909|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
56540910|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56540911|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540920|NCT02729935|Parecoxib|parecoxib|mesh-list
56540960|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56540961|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540962|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540963|NCT02721433|Denosumab|denosumab|mesh-list
56540964|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
56540965|NCT02721433|Pamidronate|pamidronate|mesh-list
56540966|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56540967|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540968|NCT02721043|Lenalidomide|lenalidomide|mesh-list
56540969|NCT02721043|Vaccines|vaccines|mesh-list
56540970|NCT02721043|Poly ICLC|poly iclc|mesh-list
56540971|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
56540972|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774804|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56774805|NCT00483327|Megestrol|megestrol|mesh-list
56774806|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
56774807|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56774808|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56774809|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56774810|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
56774811|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774812|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774813|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56774814|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56774881|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
56774882|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56774946|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56774947|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
56774948|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774949|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
56774950|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774951|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56774952|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56774953|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774954|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774955|NCT00482703|Dasatinib|dasatinib|mesh-list
56774956|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774957|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56774958|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774959|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774960|NCT04052867|Lidocaine|lidocaine|mesh-list
56774992|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56774993|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56774994|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774995|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56774996|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56774997|NCT00753779|Simvastatin|simvastatin|mesh-list
56774998|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56774999|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56775000|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56775001|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
56775002|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775036|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56775037|NCT00496587|Growth Substances|growth substances|mesh-ancestor
56775038|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775039|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
56047769|NCT01698710|Paclitaxel|paclitaxel|mesh-list
56775064|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775066|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56775067|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775068|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
56540973|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56540974|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56540975|NCT02721043|Growth Substances|growth substances|mesh-ancestor
56540976|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
56195207|NCT01497483|Cyclosporine|cyclosporine|mesh-list
56775069|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56775070|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775071|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56775072|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
56775073|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775074|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775075|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775076|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775077|NCT01324180|Metformin|metformin|mesh-list
56775078|NCT01324180|Dexamethasone|dexamethasone|mesh-list
56775079|NCT01324180|Doxorubicin|doxorubicin|mesh-list
56775080|NCT01324180|Vincristine|vincristine|mesh-list
56775081|NCT01324180|Asparaginase|asparaginase|mesh-list
56775082|NCT01324180|Pegaspargase|pegaspargase|mesh-list
56775083|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775084|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
56775085|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
56775086|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775087|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047801|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
56775106|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56775107|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
56775108|NCT02560649|Entecavir|entecavir|mesh-list
56775109|NCT02560649|Adefovir|adefovir|mesh-list
56775110|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56775111|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
56775112|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775113|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56775114|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56775115|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775116|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775117|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56775118|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56775119|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
56775120|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775121|NCT00754403|Metformin|metformin|mesh-list
56775122|NCT00754403|Pioglitazone|pioglitazone|mesh-list
56775123|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775124|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775125|NCT00758225|Idebenone|idebenone|mesh-list
56775126|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
56775127|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775128|NCT00758225|Protective Agents|protective agents|mesh-ancestor
56775129|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775130|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
56775131|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56775132|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775133|NCT00422734|Tadalafil|tadalafil|mesh-list
56775134|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
56775135|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56775136|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56775137|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775138|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775139|NCT00422734|Urological Agents|urological agents|mesh-ancestor
56775140|NCT00422422|Brivaracetam|brivaracetam|mesh-list
56775141|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
56775142|NCT00413374|Enoxaparin|enoxaparin|mesh-list
56775143|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
56775144|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56775145|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56775166|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56775167|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
56775168|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56775169|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775170|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56775171|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56775172|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56775173|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56540977|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540978|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
56540979|NCT02728843|Deferiprone|deferiprone|mesh-list
56540980|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56540981|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
56540982|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
56540983|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540984|NCT02726503|Lenvatinib|lenvatinib|mesh-list
56540985|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56540986|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56540987|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195212|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775174|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
56775175|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775176|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56775177|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775178|NCT00754871|Androgens|androgens|mesh-ancestor
56775179|NCT00754871|Hormones|hormones|mesh-ancestor
56775180|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
56775181|NCT00755027|Rasagiline|rasagiline|mesh-list
56775182|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56775183|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775184|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775185|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56775186|NCT00755027|Protective Agents|protective agents|mesh-ancestor
56775187|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775188|NCT05435729|Levodopa|levodopa|mesh-list
56775189|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56775190|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56775191|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
56775192|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775193|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775194|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775195|NCT01038388|Dexamethasone|dexamethasone|mesh-list
56775196|NCT01038388|Lenalidomide|lenalidomide|mesh-list
56775197|NCT01038388|Bortezomib|bortezomib|mesh-list
56775198|NCT01038388|Vorinostat|vorinostat|mesh-list
56775199|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775200|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
56486132|NCT03639389|Morphine|morphine|mesh-list
56775202|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775203|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775251|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56775252|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
56775254|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775255|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56775256|NCT00421174|Protective Agents|protective agents|mesh-ancestor
56775257|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56775258|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56775259|NCT00421174|Analgesics|analgesics|mesh-ancestor
56775288|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
56775289|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775290|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775291|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
56775292|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775293|NCT00404092|Caspofungin|caspofungin|mesh-list
56775294|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
56775295|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775296|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775297|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775298|NCT00481767|Vaccines|vaccines|mesh-list
56775299|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
56775300|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775301|NCT00489489|Interferons|interferons|mesh-list
56540988|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56540989|NCT02720965|Anesthetics|anesthetics|mesh-list
56540990|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
56540991|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56540992|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540993|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
56540994|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56540995|NCT02792413|Denosumab|denosumab|mesh-list
56540996|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56540997|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56540998|NCT02726737|Lidocaine|lidocaine|mesh-list
56540999|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
56541000|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
56541001|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541002|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541003|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
56541004|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541005|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56541006|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56541007|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56541008|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56541009|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541010|NCT02720575|Vitamin D|vitamin d|mesh-list
56541011|NCT02720575|Vitamins|vitamins|mesh-ancestor
56541012|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
56541013|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541014|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56541015|NCT02720341|Armin|armin|mesh-list
56775314|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
56775315|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775316|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775317|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775318|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775319|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56775320|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56775321|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56775322|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56775323|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775324|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775325|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775326|NCT00489411|Analgesics|analgesics|mesh-ancestor
56775327|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
56775328|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065824|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56541016|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56541017|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541018|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541019|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
56541020|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541021|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541022|NCT02728453|Empagliflozin|empagliflozin|mesh-list
56541023|NCT02728453|Glimepiride|glimepiride|mesh-list
56541024|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56541025|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775329|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
56775330|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56775331|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
56775332|NCT00420784|Interferons|interferons|mesh-list
56775334|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
56775335|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
56775336|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56775337|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775338|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
56775339|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775340|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
56775341|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775342|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
56775343|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775344|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56775345|NCT00420628|Tobramycin|tobramycin|mesh-list
56775346|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775347|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775348|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56775349|NCT00413218|Voriconazole|voriconazole|mesh-list
56775350|NCT00413218|Caspofungin|caspofungin|mesh-list
56775351|NCT00413218|Isavuconazole|isavuconazole|mesh-list
56775352|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
56775353|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775354|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56775355|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56775356|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775357|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775358|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56775359|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
56775360|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775361|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775362|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56775363|NCT00494871|Warfarin|warfarin|mesh-list
56775364|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
56775398|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775399|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
56775400|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775401|NCT00420004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56775402|NCT00420004|Antidepressive Agents|antidepressive agents|mesh-ancestor
56775403|NCT00420004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56775404|NCT00494481|Docetaxel|docetaxel|mesh-list
56775405|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775406|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
56775407|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
56775408|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
56775409|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775410|NCT00097591|Clopidogrel|clopidogrel|mesh-list
56775411|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56775412|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56775413|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56775414|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56775415|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56541026|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56541027|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541028|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56541029|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56541030|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
56541031|NCT02728687|Mannitol|mannitol|mesh-list
56541032|NCT02728687|Menthol|menthol|mesh-list
56541033|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56541034|NCT02728687|Diuretics|diuretics|mesh-ancestor
56541035|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
56541036|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541037|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
56541038|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
56541039|NCT02726269|Ofloxacin|ofloxacin|mesh-list
56541040|NCT02726269|Levofloxacin|levofloxacin|mesh-list
56541041|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56541042|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541043|NCT02726269|Renal Agents|renal agents|mesh-ancestor
56541044|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56541045|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56541046|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56541047|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541048|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541049|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541050|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56541051|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56775416|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
56775417|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775418|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775419|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775420|NCT01082029|Lansoprazole|lansoprazole|mesh-list
56486363|NCT03230565|Ropivacaine|ropivacaine|mesh-list
56775422|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56775423|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56775424|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56775425|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048132|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
56775462|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
56775463|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775513|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56775514|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56775515|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
56775516|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56775517|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56775518|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775519|NCT00494091|Sirolimus|sirolimus|mesh-list
56775520|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775521|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775522|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56541052|NCT02694289|Metformin|metformin|mesh-list
56541053|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56541054|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541055|NCT02719795|Ropivacaine|ropivacaine|mesh-list
56541056|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
56541057|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
56541058|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541059|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541060|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
56541061|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541062|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56541063|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
56541064|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541065|NCT02726035|Naltrexone|naltrexone|mesh-list
56541066|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56541067|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56541068|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541069|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
56541070|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541071|NCT02719405|Caseins|caseins|mesh-list
56541072|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
56541073|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
56541074|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541075|NCT02725255|Albendazole|albendazole|mesh-list
56541076|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
56541077|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56541078|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195306|NCT01497977|Hormones|hormones|mesh-ancestor
56775523|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775524|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
56775525|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775526|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
56775527|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775528|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
56775529|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56775530|NCT01017159|Antibodies|antibodies|mesh-list
56775531|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
56775532|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775533|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
56775534|NCT00494013|Protamines|protamines|mesh-list
56775535|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775536|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775537|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
56775538|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775539|NCT00494013|Coagulants|coagulants|mesh-ancestor
56775540|NCT00079339|Tipifarnib|tipifarnib|mesh-list
56775541|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775542|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
56775543|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56541079|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
56541080|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56541081|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56541082|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
56541083|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
56541084|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
56541085|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541086|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541087|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
56541088|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56541089|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541090|NCT02725489|Durvalumab|durvalumab|mesh-list
56541091|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56541092|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541093|NCT02718547|Timolol|timolol|mesh-list
56541094|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56541095|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56541096|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
56541097|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56541098|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541099|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56541100|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56541101|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
56775544|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
56775545|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775546|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
56775547|NCT01088191|Protective Agents|protective agents|mesh-ancestor
56775548|NCT01082341|Vaccines|vaccines|mesh-list
56775549|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
56775550|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775551|NCT00541866|Cytarabine|cytarabine|mesh-list
56775586|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56775587|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56775588|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56775589|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
56775590|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775625|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775626|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
56775627|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56775628|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56775629|NCT04113018|Growth Substances|growth substances|mesh-ancestor
56775630|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
56775631|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56775632|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56775819|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
56775820|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775821|NCT00974324|Endostar protein|endostar protein|mesh-list
56775883|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56775884|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56775885|NCT00539838|Protective Agents|protective agents|mesh-ancestor
56775886|NCT00970892|Warfarin|warfarin|mesh-list
56541102|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541103|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541104|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56541105|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56541106|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56541107|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56541108|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56775887|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
56775888|NCT00964808|Oxycodone|oxycodone|mesh-list
56775889|NCT00964808|Buprenorphine|buprenorphine|mesh-list
56775890|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56775891|NCT00964808|Narcotics|narcotics|mesh-ancestor
56775892|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775893|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775894|NCT00964808|Analgesics|analgesics|mesh-ancestor
56775895|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
56775896|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775897|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56775898|NCT00970970|Bevacizumab|bevacizumab|mesh-list
56775916|NCT04004988|Incretins|incretins|mesh-ancestor
56775917|NCT04004988|Hormones|hormones|mesh-ancestor
56775918|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775919|NCT00971126|Thalidomide|thalidomide|mesh-list
56775920|NCT00971126|Sorafenib|sorafenib|mesh-list
56775921|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775922|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56775923|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775924|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775925|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775926|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
56775927|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775928|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
56775929|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775930|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775931|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56775932|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56775933|NCT00971126|Growth Substances|growth substances|mesh-ancestor
56775934|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
56775935|NCT00964964|Insulin|insulin|mesh-list
56775936|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56775937|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
56775938|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775939|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775940|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
56775941|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56775942|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775943|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775944|NCT03676764|Azithromycin|azithromycin|mesh-list
56775945|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775946|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775947|NCT00974792|Leucovorin|leucovorin|mesh-list
56775948|NCT00974792|Cytarabine|cytarabine|mesh-list
56775949|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
56775950|NCT00974792|Ifosfamide|ifosfamide|mesh-list
56775951|NCT00974792|Rituximab|rituximab|mesh-list
56775952|NCT00974792|Doxorubicin|doxorubicin|mesh-list
56775953|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56775954|NCT00974792|Methotrexate|methotrexate|mesh-list
56775955|NCT00974792|Etoposide|etoposide|mesh-list
56775956|NCT00974792|Vincristine|vincristine|mesh-list
56775957|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
56775958|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
56775959|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775990|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
56775991|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
56775992|NCT00965120|Bradykinin|bradykinin|mesh-list
56775993|NCT00965120|Kininogens|kininogens|mesh-list
56775994|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
56775995|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
56775996|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56775997|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
56775998|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066066|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56541109|NCT02725099|Ticagrelor|ticagrelor|mesh-list
56541110|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56541111|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56541112|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56541113|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56541114|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
56289376|NCT00014755|Prednisone|prednisone|mesh-list
56541115|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541116|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541117|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541118|NCT01225211|Ivacaftor|ivacaftor|mesh-list
56775999|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776000|NCT00679289|Interferons|interferons|mesh-list
56776001|NCT00679289|Ecromeximab|ecromeximab|mesh-list
56776002|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776003|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
56776004|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776005|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776006|NCT00679211|Trastuzumab|trastuzumab|mesh-list
56776007|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56776008|NCT00679211|Maytansine|maytansine|mesh-list
56776009|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776010|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776011|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56776012|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
56776013|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
56776014|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
56776015|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776016|NCT00545948|Cisplatin|cisplatin|mesh-list
56776017|NCT00545948|Pemetrexed|pemetrexed|mesh-list
56776018|NCT00545948|Vinorelbine|vinorelbine|mesh-list
56776071|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56776072|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
56776073|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776074|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776075|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56776076|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
56776077|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56776078|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56776079|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56776080|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
56776081|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776082|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776084|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776085|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776086|NCT05230901|Dihydralazine|dihydralazine|mesh-list
56776143|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776144|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776145|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776146|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776147|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56776148|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56776149|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
56776150|NCT00975728|Antioxidants|antioxidants|mesh-list
56776151|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776152|NCT00975728|Protective Agents|protective agents|mesh-ancestor
56776153|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776154|NCT04049747|Bicalutamide|bicalutamide|mesh-list
56776155|NCT04049747|Finasteride|finasteride|mesh-list
56776156|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
56776157|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
56776207|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56776208|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066067|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
56541119|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56541120|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56541121|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541122|NCT02685709|Octreotide|octreotide|mesh-list
56541123|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56541124|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56541125|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541126|NCT02265367|Milnacipran|milnacipran|mesh-list
56541127|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
56541128|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56541129|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56541130|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56541131|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541132|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541133|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541134|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
56541135|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56541136|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56776209|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776339|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56776340|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
56776341|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776342|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
56776343|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
56776344|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
56776345|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56776346|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
56776347|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56776348|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
56776349|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56776350|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56776402|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776403|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
56776404|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
56776405|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
56776406|NCT00990600|Tenofovir|tenofovir|mesh-list
56776407|NCT00990600|Emtricitabine|emtricitabine|mesh-list
56776408|NCT00990600|Efavirenz|efavirenz|mesh-list
56776409|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
56776410|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776411|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56776412|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56776413|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776414|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776482|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776483|NCT00990990|Linezolid|linezolid|mesh-list
56776484|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
56776485|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56776486|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776487|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56776488|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776489|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776490|NCT05589402|Lidocaine|lidocaine|mesh-list
56776491|NCT05589402|Anesthetics, Local|anesthetics, local|mesh-ancestor
56541137|NCT02265367|Analgesics|analgesics|mesh-ancestor
56541138|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
56541139|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541140|NCT02718469|Vaccines|vaccines|mesh-list
56541141|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
56541142|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541143|NCT02716285|Peppermint oil|peppermint oil|mesh-list
56541144|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
56541145|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
56541146|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541147|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541148|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56541149|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
56541150|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
56541151|NCT01224821|Antibodies|antibodies|mesh-list
56541152|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
56541153|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776492|NCT05589402|Anesthetics|anesthetics|mesh-ancestor
56776493|NCT05589402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56776494|NCT05589402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776495|NCT05589402|Sensory System Agents|sensory system agents|mesh-ancestor
56776496|NCT05589402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776497|NCT05589402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56776498|NCT05589402|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56776499|NCT05589402|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56776500|NCT05589402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56776501|NCT05589402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776502|NCT00466947|Vaccines|vaccines|mesh-list
56776503|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56776504|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
56776505|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776506|NCT00537810|Sibutramine|sibutramine|mesh-list
56776716|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56776717|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
56776718|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776719|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776720|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776755|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
56776756|NCT00977054|Ribavirin|ribavirin|mesh-list
56776757|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
56776758|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56776759|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
56776760|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777022|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56777023|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56777174|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
56777175|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
56777176|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56777177|NCT00989300|Omeprazole|omeprazole|mesh-list
56777178|NCT00989300|Rabeprazole|rabeprazole|mesh-list
56777179|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56777180|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56777181|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56777182|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777183|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777184|NCT01563614|Cytarabine|cytarabine|mesh-list
56777185|NCT01563614|Lomustine|lomustine|mesh-list
56777186|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56777215|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
56777216|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541154|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541155|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56541156|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
56541157|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
56541158|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56541159|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541160|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
56541161|NCT02684851|Coagulants|coagulants|mesh-ancestor
56541162|NCT01224431|Lidocaine|lidocaine|mesh-list
56541163|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
56541164|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
56541165|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541166|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541167|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
56541168|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541169|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56541170|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56541171|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56541172|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56541173|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541174|NCT02716129|Morphine|morphine|mesh-list
56541175|NCT02716129|Nalbuphine|nalbuphine|mesh-list
56541176|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56541178|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541179|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541180|NCT02716129|Analgesics|analgesics|mesh-ancestor
56541181|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
56541182|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541183|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56541184|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
56541185|NCT02718079|Mannitol|mannitol|mesh-list
56541186|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56541187|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289449|NCT00015106|Lamotrigine|lamotrigine|mesh-list
56541188|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56541189|NCT02718079|Diuretics|diuretics|mesh-ancestor
56541191|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289522|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
56777217|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56777218|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56777219|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56777220|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777221|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56777222|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56777223|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
56777224|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777225|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56777226|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56777227|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777228|NCT00986804|Decitabine|decitabine|mesh-list
56777229|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56777230|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
56777231|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777269|NCT04003350|Metaxalone|metaxalone|mesh-list
56049977|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
56778088|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778090|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56778091|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
56050777|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778288|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
56778289|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778290|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778291|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778292|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778293|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56778294|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778295|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
56778884|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778885|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
56778886|NCT01415882|Hormones|hormones|mesh-ancestor
56778887|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778888|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56778889|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
56778890|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778891|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
56778892|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
56778893|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778894|NCT00068419|Tamoxifen|tamoxifen|mesh-list
56778895|NCT00068419|Sulindac|sulindac|mesh-list
56778896|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778897|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56778898|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
56778899|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778900|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778901|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56778902|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778903|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56778904|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56778905|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56778906|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56778907|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56778908|NCT00068419|Analgesics|analgesics|mesh-ancestor
56051522|NCT01774604|Indomethacin|indomethacin|mesh-list
56779044|NCT01589146|Dalteparin|dalteparin|mesh-list
56779045|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
56779046|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56779047|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56779064|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779065|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
56779066|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56779067|NCT04694300|Narcotics|narcotics|mesh-ancestor
56779068|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779069|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56779070|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56779071|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779072|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
56779073|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56779074|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779075|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779076|NCT04642820|Methamphetamine|methamphetamine|mesh-list
56066068|NCT01644474|Ezetimibe|ezetimibe|mesh-list
56289523|NCT00015808|Idebenone|idebenone|mesh-list
56289524|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
56289525|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289526|NCT00015808|Protective Agents|protective agents|mesh-ancestor
56289527|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289528|NCT00015886|Docetaxel|docetaxel|mesh-list
56289529|NCT00015886|Fluorouracil|fluorouracil|mesh-list
56289530|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289531|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289532|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289533|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
56779077|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56490073|NCT00553488|Insulin|insulin|mesh-list
56779078|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779080|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
56779081|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779082|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
56779083|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779084|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779085|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
56779086|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56779087|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56779088|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56779089|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56779090|NCT00771641|Cobalt|cobalt|mesh-list
56779091|NCT00771641|Trace Elements|trace elements|mesh-ancestor
56779092|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
56779093|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779094|NCT05408000|Propofol|propofol|mesh-list
56779095|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56779096|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779097|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779098|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56779099|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
56779100|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
56779101|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
56779102|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56779103|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56779104|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779105|NCT00673361|Temozolomide|temozolomide|mesh-list
56779106|NCT00673361|Sorafenib|sorafenib|mesh-list
56779220|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779222|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56779223|NCT02556437|Antibodies|antibodies|mesh-list
56779224|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
56779225|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779226|NCT04946006|Oxytocin|oxytocin|mesh-list
56779227|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
56779228|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56779229|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779230|NCT01837862|Mebendazole|mebendazole|mesh-list
56779231|NCT01837862|Piperazine|piperazine|mesh-list
56779232|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
56779233|NCT01837862|Bevacizumab|bevacizumab|mesh-list
56779234|NCT01837862|Carboplatin|carboplatin|mesh-list
56779235|NCT01837862|Irinotecan|irinotecan|mesh-list
56779236|NCT01837862|Vincristine|vincristine|mesh-list
56779237|NCT01837862|Temozolomide|temozolomide|mesh-list
56779238|NCT01837862|DMP 777|dmp 777|mesh-list
56779239|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779333|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779334|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56779335|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56779478|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56779479|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56779480|NCT00776633|Analgesics|analgesics|mesh-ancestor
56779481|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
56779482|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289534|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289535|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
56289536|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289537|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289538|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
56779483|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779484|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56779485|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779486|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56779487|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56779488|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779489|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56779490|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56779491|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779492|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
56052077|NCT01813214|Vemurafenib|vemurafenib|mesh-list
56780032|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
56780033|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56780034|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
56780035|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780036|NCT00778115|Emollients|emollients|mesh-ancestor
56780037|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
56780067|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56780068|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
56780070|NCT00778271|Analgesics|analgesics|mesh-ancestor
56780071|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
56780072|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780073|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780074|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
56780075|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56780076|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56780077|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780078|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56780079|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56780080|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56780081|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780082|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780355|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56780356|NCT05343260|Propofol|propofol|mesh-list
56780357|NCT05343260|Sevoflurane|sevoflurane|mesh-list
56780358|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56780359|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780360|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780361|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56780362|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
56780363|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
56780364|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56780365|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56780366|NCT00664859|Atorvastatin|atorvastatin|mesh-list
56780367|NCT00664859|Fenofibrate|fenofibrate|mesh-list
56780368|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56780369|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56780370|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
56780371|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780372|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56780373|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56780374|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780375|NCT00996788|Rebamipide|rebamipide|mesh-list
56780376|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56780377|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56780378|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
56780517|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
56780518|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780519|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
56780520|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780521|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
56780522|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780523|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56780524|NCT00534404|Nicotine|nicotine|mesh-list
56289539|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289540|NCT00006002|Dexamethasone|dexamethasone|mesh-list
56289541|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56780525|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56780526|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
56780527|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780528|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780529|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56780530|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56780531|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
56780532|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780560|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780561|NCT01044004|Modafinil|modafinil|mesh-list
56780562|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56780563|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780564|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56780565|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56780566|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56780567|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780568|NCT00786383|Ramucirumab|ramucirumab|mesh-list
56780569|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780570|NCT00790595|Sunitinib|sunitinib|mesh-list
56780571|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780572|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56780573|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56780574|NCT00790595|Growth Substances|growth substances|mesh-ancestor
56780575|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491540|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780576|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
56780782|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780784|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780951|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
56780952|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780953|NCT00395746|Liraglutide|liraglutide|mesh-list
56780954|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56780955|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780956|NCT00395746|Incretins|incretins|mesh-ancestor
56780957|NCT00395746|Hormones|hormones|mesh-ancestor
56780958|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56780959|NCT01004900|Timolol|timolol|mesh-list
56780960|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56780996|NCT00395512|Alogliptin|alogliptin|mesh-list
56780997|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56780998|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780999|NCT00395512|Incretins|incretins|mesh-ancestor
56781000|NCT00395512|Hormones|hormones|mesh-ancestor
56053573|NCT00553514|Hormones|hormones|mesh-ancestor
56781656|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
56781658|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781659|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781660|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
56781661|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781662|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56781663|NCT00801047|Narcotics|narcotics|mesh-ancestor
56781664|NCT00801047|Analgesics|analgesics|mesh-ancestor
56781665|NCT00801125|Natalizumab|natalizumab|mesh-list
56781666|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
56781667|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781668|NCT00801281|Prednisone|prednisone|mesh-list
56781669|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
56781670|NCT00801281|Rituximab|rituximab|mesh-list
56781933|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
56781934|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781935|NCT00803465|Fluticasone|fluticasone|mesh-list
56781937|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782166|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56782167|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56782168|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56782169|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56782170|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56782171|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56782172|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
56782173|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
56782174|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289542|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
56289543|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
56289544|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289545|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289546|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56289547|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
56289548|NCT00006002|Hormones|hormones|mesh-ancestor
56289549|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195454|NCT01499069|Fesoterodine|fesoterodine|mesh-list
56782175|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782176|NCT00807053|Ciclesonide|ciclesonide|mesh-list
56782177|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
56782178|NCT00807053|Hormones|hormones|mesh-ancestor
56782179|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782180|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782181|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56782182|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
56782183|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56782184|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56782185|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782186|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
56782187|NCT00809393|Coagulants|coagulants|mesh-ancestor
56782188|NCT00658775|Esomeprazole|esomeprazole|mesh-list
56782189|NCT00658775|Rabeprazole|rabeprazole|mesh-list
56782190|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56782191|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56782192|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56782193|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782194|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782195|NCT00488631|Golimumab|golimumab|mesh-list
56782593|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
56782594|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782595|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56782596|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782597|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
56782598|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782599|NCT00814229|Vaccines|vaccines|mesh-list
56782600|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
56782601|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
56782602|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782603|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56782604|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56782605|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56782606|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56782607|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56782608|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782769|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782770|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782771|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782772|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782804|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782805|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56782806|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782807|NCT00365716|Vaccines|vaccines|mesh-list
56782808|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
56782809|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782810|NCT01049542|Astressin|astressin|mesh-list
56782811|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56782812|NCT01049542|Protective Agents|protective agents|mesh-ancestor
56055304|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56783372|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783373|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
56783374|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783375|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56783376|NCT00814541|Dexamethasone|dexamethasone|mesh-list
56783377|NCT00814541|Doxorubicin|doxorubicin|mesh-list
56289550|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56289551|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101322|NCT00002341|Itraconazole|itraconazole|mesh-list
56783438|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56783439|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
56783440|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56783441|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
56783442|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783443|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783444|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56783445|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
56783446|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56783447|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56783448|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56783449|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783450|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783451|NCT02551133|Dexamethasone|dexamethasone|mesh-list
56055939|NCT00000117|Antibodies|antibodies|mesh-list
56783598|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56783599|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56056100|NCT01692717|Losartan|losartan|mesh-list
56783743|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
56783744|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
56783745|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56783746|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
56783747|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
56783932|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56783934|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783935|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
56783936|NCT00812669|Rituximab|rituximab|mesh-list
56783937|NCT00812669|Fludarabine|fludarabine|mesh-list
56783938|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
56783939|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783940|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
56783941|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783942|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783943|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56783944|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
56783945|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783946|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783947|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56783948|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783949|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783950|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
56783951|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
56783952|NCT00820547|Bevacizumab|bevacizumab|mesh-list
56783953|NCT00820547|Docetaxel|docetaxel|mesh-list
56783954|NCT00820547|Fluorouracil|fluorouracil|mesh-list
56783955|NCT00820547|Epirubicin|epirubicin|mesh-list
56783956|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783957|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
56783958|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783959|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783960|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56783961|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
56783962|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783963|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783964|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56783994|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783995|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56783997|NCT00628355|Lidocaine|lidocaine|mesh-list
56783998|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
56783999|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
56784000|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784001|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784002|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
56784003|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784004|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56784005|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56784006|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56056414|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
56784033|NCT00467649|Pramlintide|pramlintide|mesh-list
56784034|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
56784035|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56289552|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
56289553|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
56289554|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
56289555|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56289556|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56541193|NCT02718079|Expectorants|expectorants|mesh-ancestor
56541194|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
56541195|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56541196|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
56541197|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541198|NCT02718079|Protective Agents|protective agents|mesh-ancestor
56541199|NCT02718079|Antidotes|antidotes|mesh-ancestor
56541200|NCT02717923|Capecitabine|capecitabine|mesh-list
56541201|NCT02717923|Cetuximab|cetuximab|mesh-list
56541202|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56541203|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
56195462|NCT01499069|Urological Agents|urological agents|mesh-ancestor
56784036|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784037|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
56784038|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56784039|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784040|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56784041|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784042|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
56784043|NCT00450333|Hematinics|hematinics|mesh-ancestor
56784044|NCT00643565|Bevacizumab|bevacizumab|mesh-list
56784045|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784046|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784047|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56784048|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56784049|NCT00643565|Growth Substances|growth substances|mesh-ancestor
56784050|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784051|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784052|NCT00450255|Aflibercept|aflibercept|mesh-list
56784053|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
56784054|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56784055|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56784056|NCT00450255|Growth Substances|growth substances|mesh-ancestor
56056455|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
56784074|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
56784075|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784076|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56784077|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56784078|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784079|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56784080|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
56784081|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56784082|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56784083|NCT00813137|Endostar protein|endostar protein|mesh-list
56784084|NCT00813137|Endostatins|endostatins|mesh-list
56784085|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56784086|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56784087|NCT00813137|Growth Substances|growth substances|mesh-ancestor
56784088|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784089|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784090|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784091|NCT01024179|Sirolimus|sirolimus|mesh-list
56784092|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56784093|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541204|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541205|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541206|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56541207|NCT02724163|Cytarabine|cytarabine|mesh-list
56541208|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
56541209|NCT02724163|Busulfan|busulfan|mesh-list
56541210|NCT02724163|Fludarabine|fludarabine|mesh-list
56541211|NCT02724163|Daunorubicin|daunorubicin|mesh-list
56541212|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
56541213|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
56541214|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56541215|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
56784094|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56784095|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784096|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
56784097|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56784098|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
56784099|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784100|NCT00821483|Frovatriptan|frovatriptan|mesh-list
56784101|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56784102|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
56784103|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784104|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784105|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784106|NCT02551367|Letrozole|letrozole|mesh-list
56784107|NCT02551367|Clomiphene|clomiphene|mesh-list
56784108|NCT02551367|Enclomiphene|enclomiphene|mesh-list
56784109|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
56784110|NCT02551367|Hormones|hormones|mesh-list
56784111|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784112|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56784113|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784148|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784149|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784150|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56784151|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
56784152|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56056556|NCT00000291|Labetalol|labetalol|mesh-list
56784177|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
56784178|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56784179|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784180|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784181|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56784182|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56784183|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56784184|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
56784185|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784186|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56784187|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784188|NCT01566279|Everolimus|everolimus|mesh-list
56784189|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784190|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56784191|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
56784192|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784193|NCT00449163|Leucovorin|leucovorin|mesh-list
56784194|NCT00449163|Bevacizumab|bevacizumab|mesh-list
56784195|NCT00449163|Irinotecan|irinotecan|mesh-list
56495154|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
56784196|NCT00449163|Floxuridine|floxuridine|mesh-list
56784197|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
56784198|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784199|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784200|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56784201|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56784202|NCT00449163|Growth Substances|growth substances|mesh-ancestor
56784221|NCT00448539|Rufinamide|rufinamide|mesh-list
56541216|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541217|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56541218|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56541219|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
56541220|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541221|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784222|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
56784223|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56784224|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56784225|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56784226|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784227|NCT00457665|Efavirenz|efavirenz|mesh-list
56784228|NCT00457665|Nelfinavir|nelfinavir|mesh-list
56784229|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56784230|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56784231|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784232|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784233|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
56784234|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784235|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56784236|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56784237|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56784238|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56784239|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56784240|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56784241|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56784242|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56784243|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
56784244|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56784245|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56784246|NCT00447603|Losartan|losartan|mesh-list
56784247|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56784248|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56784249|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56784250|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56784251|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56784252|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784253|NCT00447603|Diuretics|diuretics|mesh-ancestor
56784254|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
56784255|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784256|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56784257|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56784258|NCT00447057|Pemetrexed|pemetrexed|mesh-list
56784289|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56784290|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56784291|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56784292|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784293|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56784294|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
56784295|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784297|NCT01024491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56784298|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56784346|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784347|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56784349|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
56784350|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784351|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56784352|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
56784353|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784355|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
56784356|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784357|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56784358|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56784359|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
56541222|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56541223|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56541224|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
56541225|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
56541226|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541227|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56541228|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56541229|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56541230|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541232|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
56541233|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541234|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56541235|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
56541236|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56541237|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
56195497|NCT01499407|Abciximab|abciximab|mesh-list
56784360|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
56784361|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56784362|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56784363|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784364|NCT01027065|Tenofovir|tenofovir|mesh-list
56784365|NCT01027065|Entecavir|entecavir|mesh-list
56784366|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
56784367|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784368|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56784369|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56784370|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784371|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784372|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56784373|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56784374|NCT00456495|Ranibizumab|ranibizumab|mesh-list
56784375|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56784376|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56784377|NCT00456495|Growth Substances|growth substances|mesh-ancestor
56784378|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784379|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784380|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784381|NCT00445341|Alvocidib|alvocidib|mesh-list
56784382|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784383|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784384|NCT00445341|Growth Substances|growth substances|mesh-ancestor
56784385|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784386|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56784387|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784388|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784389|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56784390|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56784391|NCT00444951|Vaccines|vaccines|mesh-list
56784418|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784419|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56784421|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56784422|NCT00455325|Amebicides|amebicides|mesh-ancestor
56784423|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56784424|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56784425|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784426|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
56784427|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784428|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56784429|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56541238|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541239|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56541240|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56541241|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
56541242|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541243|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195516|NCT01499485|Acetazolamide|acetazolamide|mesh-list
56784430|NCT00455325|Analgesics|analgesics|mesh-ancestor
56784431|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
56784432|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784433|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784434|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056838|NCT05322707|Hormones|hormones|mesh-ancestor
56784447|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784448|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56784449|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56784450|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784451|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56784452|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56784453|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784454|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
56784455|NCT00443781|Anesthetics|anesthetics|mesh-list
56784456|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784457|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784458|NCT00443703|Ritonavir|ritonavir|mesh-list
56784459|NCT00443703|Lopinavir|lopinavir|mesh-list
56784460|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
56784461|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56784462|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56784463|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
56784464|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784465|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784466|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56784467|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56784468|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
56784469|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784470|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56784471|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56784472|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56784473|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56784474|NCT00381706|Leucovorin|leucovorin|mesh-list
56784475|NCT00381706|Cisplatin|cisplatin|mesh-list
56784476|NCT00381706|Fluorouracil|fluorouracil|mesh-list
56784477|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
56784478|NCT00381706|Irinotecan|irinotecan|mesh-list
56784479|NCT00381706|Cetuximab|cetuximab|mesh-list
56784480|NCT00381706|Epirubicin|epirubicin|mesh-list
56784481|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784482|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
56784483|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784484|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56784485|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56784486|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
56784487|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784488|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56784489|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56784490|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784491|NCT00381706|Antidotes|antidotes|mesh-ancestor
56784492|NCT00381706|Protective Agents|protective agents|mesh-ancestor
56784493|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
56784494|NCT00381706|Vitamins|vitamins|mesh-ancestor
56784495|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
56784496|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784497|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56784498|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56784499|NCT01045642|Omeprazole|omeprazole|mesh-list
56784500|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56784533|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784534|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541244|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56541245|NCT02723461|Oxytocin|oxytocin|mesh-list
56541246|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
56541247|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56541248|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541249|NCT02715193|Volagidemab|volagidemab|mesh-list
56541250|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56541251|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541252|NCT01223027|Sorafenib|sorafenib|mesh-list
56541253|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541254|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56541255|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541256|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541257|NCT02714959|Aldesleukin|aldesleukin|mesh-list
56541258|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541259|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56541260|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56541261|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
56541262|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541263|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
56541264|NCT02714725|Propofol|propofol|mesh-list
56784535|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
56784536|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784537|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784538|NCT04928820|Edetic Acid|edetic acid|mesh-list
56784539|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56784540|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
56784541|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
56784542|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784543|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
56784578|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784580|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784581|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784628|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56784629|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
56784630|NCT00268476|Hormones|hormones|mesh-ancestor
56784631|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56784632|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56784633|NCT00268476|Estrogens|estrogens|mesh-ancestor
56784634|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784635|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56784636|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56784637|NCT00268476|Analgesics|analgesics|mesh-ancestor
56784638|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
56784639|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784640|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56784641|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56784642|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784643|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56784644|NCT05281068|Danazol|danazol|mesh-list
56784645|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56784646|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
56923703|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
56784647|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56784648|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541265|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56101875|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
56784649|NCT00380068|Ambrisentan|ambrisentan|mesh-list
56784650|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56784651|NCT00991926|Orlistat|orlistat|mesh-list
56784652|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784653|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784654|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56784655|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56784656|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
56784657|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784658|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784659|NCT00536484|Fesoterodine|fesoterodine|mesh-list
56784660|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56784683|NCT03862716|Incretins|incretins|mesh-ancestor
56784684|NCT03862716|Hormones|hormones|mesh-ancestor
56784685|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56784686|NCT00992082|Ketorolac|ketorolac|mesh-list
56784687|NCT00992082|Epinephrine|epinephrine|mesh-list
56784688|NCT00992082|Morphine|morphine|mesh-list
56784689|NCT00992082|Ropivacaine|ropivacaine|mesh-list
56784690|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56784691|NCT00992082|Narcotics|narcotics|mesh-ancestor
56784692|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784693|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784694|NCT00992082|Analgesics|analgesics|mesh-ancestor
56784695|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
56784696|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784697|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
56784698|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
56784699|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56784700|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56784701|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
56784702|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784703|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784704|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56784705|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56784706|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
56784707|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56784708|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
56784709|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
56784710|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
56784711|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56784712|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56784713|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56784714|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56784744|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784745|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784746|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56784747|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56784748|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
56784749|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784751|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
56784752|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784753|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
56784754|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
56784755|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56784756|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56784757|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56784758|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56784759|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
56784760|NCT05254548|Midazolam|midazolam|mesh-list
56784761|NCT05254548|Omeprazole|omeprazole|mesh-list
56784787|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56784788|NCT00363142|Ritonavir|ritonavir|mesh-list
56784789|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
56784790|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56784791|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56784792|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
56784793|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784794|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784795|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56784796|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56784797|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
56784798|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066069|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56541266|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784799|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56784800|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56784801|NCT05246982|Capecitabine|capecitabine|mesh-list
56784802|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
56784803|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56784804|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
56784805|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784806|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784807|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
56784808|NCT04002024|Salicylates|salicylates|mesh-list
56784809|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784810|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
56784811|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
56784822|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784823|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784824|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
56784825|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56784826|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56784827|NCT01028313|Prednisolone|prednisolone|mesh-list
56784828|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
56784829|NCT01028313|Panobinostat|panobinostat|mesh-list
56784830|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56784831|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
56784832|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56784833|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
56784834|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
56784835|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784836|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784837|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56784838|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
56784839|NCT01028313|Hormones|hormones|mesh-ancestor
56784840|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56784841|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56784842|NCT01028313|Protective Agents|protective agents|mesh-ancestor
56784843|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56784844|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784845|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56784846|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784847|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784848|NCT04001712|Caffeine|caffeine|mesh-list
56784849|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
56784850|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784851|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56784852|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784853|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56784854|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784855|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56784856|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56784857|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
56784858|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784859|NCT01027377|Factor VIII|factor viii|mesh-list
56784860|NCT01027377|Coagulants|coagulants|mesh-ancestor
56784861|NCT00992160|Vestipitant|vestipitant|mesh-list
56784862|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56784863|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784864|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784865|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784866|NCT00379912|Azacitidine|azacitidine|mesh-list
56784867|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
56784868|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56784869|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
56784870|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784871|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784872|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784873|NCT00379912|Hematinics|hematinics|mesh-ancestor
56784874|NCT00992238|Flavoxate|flavoxate|mesh-list
56784875|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
56784901|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56784902|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56784903|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784904|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56784905|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56541267|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541268|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56541269|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
56541270|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
56541271|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56541272|NCT02714725|Analgesics|analgesics|mesh-ancestor
56541273|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
56541274|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541275|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56541276|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56541277|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56541278|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
56541279|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541280|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541281|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56541282|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56541283|NCT02714179|Acetaminophen|acetaminophen|mesh-list
56195551|NCT01499641|Hormones|hormones|mesh-ancestor
56784906|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
56784907|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784908|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784910|NCT03453840|Artemether|artemether|mesh-list
56784911|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56784912|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
56784913|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56784914|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56784915|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784916|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56784917|NCT03439254|Cathartics|cathartics|mesh-ancestor
56784918|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56784919|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
56784920|NCT03405792|Temozolomide|temozolomide|mesh-list
56784921|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784922|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784923|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56784924|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
56784925|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784957|NCT00454779|Cisplatin|cisplatin|mesh-list
56784958|NCT00454779|Docetaxel|docetaxel|mesh-list
56784959|NCT00454779|Panitumumab|panitumumab|mesh-list
56784960|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784961|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
56784962|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
56784963|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
56784964|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784965|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784966|NCT00992862|Moexipril|moexipril|mesh-list
56785000|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56785001|NCT03994107|Trastuzumab|trastuzumab|mesh-list
56785002|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56785003|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56785004|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785005|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785006|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56785035|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785036|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56785037|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
56785038|NCT01028547|Hormones|hormones|mesh-ancestor
56541284|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56541285|NCT02714179|Analgesics|analgesics|mesh-ancestor
56541286|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
56541287|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541288|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785039|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785040|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56785041|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785042|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
56785043|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
56785044|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56785045|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56785046|NCT01031355|Calcium|calcium|mesh-list
56785047|NCT01031355|Estradiol|estradiol|mesh-list
56785048|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56785049|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56785050|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785072|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785073|NCT00437073|Capecitabine|capecitabine|mesh-list
56785074|NCT00437073|Topotecan|topotecan|mesh-list
56785075|NCT00437073|Lapatinib|lapatinib|mesh-list
56785076|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56785077|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
56785078|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785079|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785080|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56785081|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56785082|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785083|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56785084|NCT00425373|Amlodipine|amlodipine|mesh-list
56785085|NCT00425373|Valsartan|valsartan|mesh-list
56785086|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56785087|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56785088|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56785089|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785090|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56785091|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785092|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
56785093|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56785094|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56785095|NCT01031589|Rilpivirine|rilpivirine|mesh-list
56785096|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56785097|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56785098|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785099|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785100|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
56785101|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785102|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56785103|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56785105|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
56785135|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56785136|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56785138|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
56785139|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785140|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785141|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785142|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785143|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56785144|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56785145|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057511|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
56785180|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785181|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56785182|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785184|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56785185|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56785220|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56541289|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
56541290|NCT01015131|Alovudine|alovudine|mesh-list
56541291|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
56541292|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785222|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56785223|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
56057602|NCT05210465|Dobutamine|dobutamine|mesh-list
56785250|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56785251|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56785252|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56785253|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785254|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56785255|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
56785256|NCT03887442|Paclitaxel|paclitaxel|mesh-list
56785257|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56785258|NCT03887442|Cetuximab|cetuximab|mesh-list
56785259|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56785260|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785261|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785262|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56785263|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56785264|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785265|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785266|NCT00996060|Hydralazine|hydralazine|mesh-list
56785267|NCT00996060|Valproic Acid|valproic acid|mesh-list
56785268|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
56785269|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785270|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785271|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
56785272|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785295|NCT00996684|Plasminogen|plasminogen|mesh-list
56785296|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56785297|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56785298|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785299|NCT00996762|Lapatinib|lapatinib|mesh-list
56785300|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785301|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56785302|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785303|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785304|NCT05162196|Niraparib|niraparib|mesh-list
56785305|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56785306|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785307|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785308|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785309|NCT00997074|Ibuprofen|ibuprofen|mesh-list
56785310|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56785311|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56785312|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56785313|NCT00997074|Analgesics|analgesics|mesh-ancestor
56785314|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
56785315|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785316|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785317|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785318|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56785319|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785320|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785321|NCT05249712|Androgens|androgens|mesh-list
56785322|NCT05249712|Hormones|hormones|mesh-ancestor
56785323|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785355|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785356|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56785357|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
56785358|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
56785359|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56785360|NCT00424827|Gemcitabine|gemcitabine|mesh-list
56785361|NCT00424827|Fluorouracil|fluorouracil|mesh-list
56785362|NCT00424827|Cetuximab|cetuximab|mesh-list
56785363|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56785364|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
56785365|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785366|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785367|NCT00424827|Antiviral Agents|antiviral agents|mesh-ancestor
56541293|NCT02723383|Baclofen|baclofen|mesh-list
56541294|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56785368|NCT00424827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785369|NCT00424827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785370|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785425|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56785426|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56785427|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785428|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785429|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56785430|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
56785431|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56785432|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785433|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
56785434|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56785435|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56785436|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56785457|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785459|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785460|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785461|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
56785462|NCT00998088|Hematinics|hematinics|mesh-ancestor
56785463|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
56785464|NCT00377962|Everolimus|everolimus|mesh-list
56785465|NCT00377962|Azathioprine|azathioprine|mesh-list
56785466|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56785467|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785468|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785469|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
56785470|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785471|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785472|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785473|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
56785474|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56785475|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785476|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56785477|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56785478|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
56785479|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56785480|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785481|NCT00424749|Prednisone|prednisone|mesh-list
56785482|NCT00424749|Rituximab|rituximab|mesh-list
56785483|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785484|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785485|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
56785486|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785487|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785488|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785515|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785516|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
56785517|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785518|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56785519|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785520|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56785521|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56785522|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785524|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785525|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56785526|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785527|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785528|NCT05131204|Eculizumab|eculizumab|mesh-list
56785529|NCT05131204|Ravulizumab|ravulizumab|mesh-list
56785530|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56785531|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785532|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
56785533|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785534|NCT00377260|Amoxicillin|amoxicillin|mesh-list
56785535|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
56785563|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785564|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56785565|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56785566|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785567|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541295|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541296|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56541297|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541298|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56541299|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
56541300|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
56541301|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541302|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541303|NCT05269537|Ephedrine|ephedrine|mesh-list
56541304|NCT05269537|Fentanyl|fentanyl|mesh-list
56541305|NCT05269537|Bupivacaine|bupivacaine|mesh-list
56541307|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
56541308|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
56541309|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541310|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541311|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
56541312|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541313|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56541314|NCT05269537|Narcotics|narcotics|mesh-ancestor
56541315|NCT05269537|Analgesics|analgesics|mesh-ancestor
56785568|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56785569|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
56785570|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785571|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785572|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56785574|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785575|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56785576|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785577|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785578|NCT01034787|Tremelimumab|tremelimumab|mesh-list
56785579|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785580|NCT01028781|Thalidomide|thalidomide|mesh-list
56785581|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785582|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
56785615|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56785617|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785618|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
56785619|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
56785620|NCT00376246|Ezetimibe|ezetimibe|mesh-list
56785621|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56785623|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
56785624|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785625|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56785626|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56785664|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785665|NCT01050322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785695|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56785696|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785697|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785698|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56785699|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
56785700|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56785701|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785702|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
56785703|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
56541316|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56541317|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56541318|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
56541319|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
56541320|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56541321|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56541322|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
56541323|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
56541324|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56541325|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
56541326|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541327|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541328|NCT01222715|Sirolimus|sirolimus|mesh-list
56541329|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
56541330|NCT01222715|Bevacizumab|bevacizumab|mesh-list
56541331|NCT01222715|Vinorelbine|vinorelbine|mesh-list
56541332|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56541333|NCT01222715|Antibodies|antibodies|mesh-list
56541334|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
56541335|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56541336|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
56541337|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
56541338|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785704|NCT01001754|Ribavirin|ribavirin|mesh-list
56785705|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56785706|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
56785707|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785708|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
56785709|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785710|NCT00825851|Nicotine|nicotine|mesh-list
56785736|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56785737|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785738|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
56785739|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785740|NCT00826163|Budesonide|budesonide|mesh-list
56785741|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785742|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56785743|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
56785744|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785745|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785746|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56785747|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
56785748|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
56785749|NCT00826163|Hormones|hormones|mesh-ancestor
56785750|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785751|NCT00998166|Bevacizumab|bevacizumab|mesh-list
56785752|NCT00998166|Pemetrexed|pemetrexed|mesh-list
56785753|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785754|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785755|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56785756|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56785757|NCT00998166|Growth Substances|growth substances|mesh-ancestor
56785758|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785779|NCT00822263|Expectorants|expectorants|mesh-ancestor
56541339|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
56541340|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541341|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56541342|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56541343|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
56541344|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541345|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541346|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56541347|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56541348|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56541349|NCT01222715|Growth Substances|growth substances|mesh-ancestor
56541350|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
56541351|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56541352|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541353|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56785780|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
56785781|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56785782|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
56785783|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785784|NCT00822263|Protective Agents|protective agents|mesh-ancestor
56785785|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785786|NCT00822263|Antidotes|antidotes|mesh-ancestor
56785787|NCT03992170|Daratumumab|daratumumab|mesh-list
56785788|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785789|NCT00817037|Nifedipine|nifedipine|mesh-list
56785790|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
56785791|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56785792|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56785793|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785794|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56785795|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785796|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
56785797|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
56785798|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56785799|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56785800|NCT00998322|Gemcitabine|gemcitabine|mesh-list
56785801|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56785802|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
56785803|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785804|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785805|NCT00998322|Antiviral Agents|antiviral agents|mesh-ancestor
56785806|NCT00998322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785807|NCT00998322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785808|NCT00998322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785809|NCT00998322|Immunologic Factors|immunologic factors|mesh-ancestor
56785810|NCT00998322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785811|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
56785812|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56058167|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
56785836|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56785837|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785838|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56785839|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
56785840|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56785841|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56785842|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785843|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785844|NCT01002534|Urological Agents|urological agents|mesh-ancestor
56541354|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
56541355|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56541356|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
56541357|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
56541358|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
56541359|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
56541360|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
56541361|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541362|NCT02722759|Chrysarobin|chrysarobin|mesh-list
56541363|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56541364|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56541365|NCT02722759|Analgesics|analgesics|mesh-ancestor
56541366|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
56541367|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195625|NCT01500161|Cytarabine|cytarabine|mesh-list
56785845|NCT00817271|Glucagon|glucagon|mesh-list
56785846|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56785847|NCT00817271|Hormones|hormones|mesh-ancestor
56785848|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785849|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785850|NCT01052896|Gabapentin|gabapentin|mesh-list
56785851|NCT01052896|Analgesics|analgesics|mesh-ancestor
56785852|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
56785853|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785854|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785855|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
56785856|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56785857|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56785858|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56785859|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56785860|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56785861|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56058223|NCT00002451|Lamivudine|lamivudine|mesh-list
56785887|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785888|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56785889|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56785890|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56785891|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56785892|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785893|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56785894|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56785895|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56785896|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
56785897|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785898|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785899|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56785900|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56785901|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
56785902|NCT00998556|Bromocriptine|bromocriptine|mesh-list
56785903|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56785904|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56785905|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
56785906|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785907|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785908|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
56785909|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
56785910|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785937|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785938|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785939|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
56541368|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541369|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56541370|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56541371|NCT02722603|Gabapentin|gabapentin|mesh-list
56541372|NCT02722603|Tramadol|tramadol|mesh-list
56541373|NCT02722603|Analgesics|analgesics|mesh-ancestor
56541374|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
56541375|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541376|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541377|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
56785940|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
56785941|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785942|NCT03883386|Loratadine|loratadine|mesh-list
56785943|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
56785944|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
56785945|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56785946|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56785947|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56785948|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
56785949|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
56785950|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785951|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785952|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785953|NCT00530946|Amlodipine|amlodipine|mesh-list
56785954|NCT00530946|Atorvastatin|atorvastatin|mesh-list
56785955|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56785956|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56785957|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
56785988|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56785990|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
56785991|NCT00530790|Ropinirole|ropinirole|mesh-list
56496948|NCT01190449|Ofatumumab|ofatumumab|mesh-list
56785992|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56785993|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56785994|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
56785995|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
56785996|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785997|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058372|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
56786026|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
56786027|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56786028|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56786029|NCT00360568|Levodopa|levodopa|mesh-list
56786030|NCT00360568|Carbidopa|carbidopa|mesh-list
56786031|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56786032|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56786033|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56786034|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
56786035|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786036|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786037|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786038|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56786039|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786040|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56786041|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
56786042|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
56786043|NCT00436215|Bevacizumab|bevacizumab|mesh-list
56786044|NCT00436215|Sorafenib|sorafenib|mesh-list
56786045|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786074|NCT05586360|Antimetabolites|antimetabolites|mesh-ancestor
56786075|NCT05586360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786076|NCT05586360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56786077|NCT05586360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56786078|NCT05586360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786080|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56786081|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541378|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56786082|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56786083|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786084|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786085|NCT00826553|Midazolam|midazolam|mesh-list
56786086|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
56786087|NCT00826553|Lorazepam|lorazepam|mesh-list
56786088|NCT00826553|Propofol|propofol|mesh-list
56786089|NCT00826553|GABA Agonists|gaba agonists|mesh-list
56786090|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56786119|NCT00626561|Bevacizumab|bevacizumab|mesh-list
56786120|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56786121|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786122|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
56786123|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
56786124|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
56786125|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786126|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786127|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56786128|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56786129|NCT00626561|Growth Substances|growth substances|mesh-ancestor
56786130|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786131|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
56786132|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
56786133|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56786134|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56786135|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56786136|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
56786137|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786138|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786160|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786161|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786163|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786164|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786165|NCT02549651|Durvalumab|durvalumab|mesh-list
56786166|NCT02549651|Tremelimumab|tremelimumab|mesh-list
56786167|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786168|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786169|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
56786170|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56786171|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
56786172|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786173|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
56786174|NCT03999372|Protective Agents|protective agents|mesh-ancestor
56786175|NCT05733546|Psilocybin|psilocybin|mesh-list
56786176|NCT05733546|Hallucinogens|hallucinogens|mesh-ancestor
56786177|NCT05733546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786178|NCT05733546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786179|NCT05733468|Calcium, Dietary|calcium, dietary|mesh-list
56786180|NCT05733468|Calcium|calcium|mesh-list
56786181|NCT05733468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56786182|NCT05733468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786183|NCT05733468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56786184|NCT00830843|Propofol|propofol|mesh-list
56786185|NCT00830843|Isoflurane|isoflurane|mesh-list
56786186|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56786187|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786188|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786189|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56786190|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
56786191|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
56786192|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56786193|NCT00826787|Levetiracetam|levetiracetam|mesh-list
56786194|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
56786220|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786222|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56786223|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
56786224|NCT00826865|Levetiracetam|levetiracetam|mesh-list
56786225|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
56786226|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
56786227|NCT00358150|Eliglustat|eliglustat|mesh-list
56786228|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786229|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786230|NCT05427630|Dronabinol|dronabinol|mesh-list
56786231|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
56786232|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541379|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56541380|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56289639|NCT00016198|Vitamins|vitamins|mesh-ancestor
56541381|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56541382|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56541383|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56541384|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541385|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541386|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
56541387|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56541388|NCT02722603|Narcotics|narcotics|mesh-ancestor
56541389|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
56541390|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56541391|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
56541392|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56541393|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
56541394|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541395|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786233|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786234|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56786235|NCT05427630|Analgesics|analgesics|mesh-ancestor
56786236|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
56786237|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786238|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56786239|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56786240|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786241|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786242|NCT05427630|Hormones|hormones|mesh-ancestor
56786243|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56786244|NCT01050556|Folic Acid|folic acid|mesh-list
56786277|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786278|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786279|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56786280|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786281|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56786282|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
56786283|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
56786284|NCT00823433|Penicillins|penicillins|mesh-list
56786285|NCT00823433|Penicillin V|penicillin v|mesh-list
56786286|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56058662|NCT04832087|Teduglutide|teduglutide|mesh-list
56786313|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
56786314|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786315|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
56786316|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786317|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786319|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786320|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56786321|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
56786322|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786323|NCT02550119|Dexamethasone|dexamethasone|mesh-list
56786324|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
56786325|NCT02550119|Aprepitant|aprepitant|mesh-list
56786326|NCT02550119|Dolasetron|dolasetron|mesh-list
56786327|NCT02550119|Ichthammol|ichthammol|mesh-list
56786328|NCT02550119|BB 1101|bb 1101|mesh-list
56786329|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56541396|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
56541397|NCT01222403|Vaccines|vaccines|mesh-list
56541398|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56541399|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
56195669|NCT01500538|Vorinostat|vorinostat|mesh-list
56786330|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
56786331|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
56786332|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786333|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786334|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786335|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
56786336|NCT02550119|Hormones|hormones|mesh-ancestor
56786337|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058703|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786357|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56786358|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56786360|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786361|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786362|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786363|NCT00827177|Sorafenib|sorafenib|mesh-list
56786364|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786365|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56786366|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786367|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786368|NCT00423267|Fluconazole|fluconazole|mesh-list
56786369|NCT00423267|Posaconazole|posaconazole|mesh-list
56786370|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
56786371|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786372|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56786373|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56786374|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786375|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786376|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56786377|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
56786378|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56786379|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786380|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56786381|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56786382|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56786383|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56786384|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56786386|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
56786387|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786388|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56786389|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56786390|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56786391|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058750|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
56786414|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56786415|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56786416|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786417|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786418|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56786420|NCT03742336|Dabigatran|dabigatran|mesh-list
56786421|NCT03742336|Abrocitinib|abrocitinib|mesh-list
56786422|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
56786423|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56786424|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
56786425|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786426|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786427|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
56786428|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56786429|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56786430|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
56786431|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786432|NCT00824057|Midazolam|midazolam|mesh-list
56786433|NCT00824057|Caffeine|caffeine|mesh-list
56786434|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56786435|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56786436|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786437|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541400|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541401|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56541402|NCT02722369|Gemcitabine|gemcitabine|mesh-list
56541403|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
56541404|NCT02722369|Carboplatin|carboplatin|mesh-list
56541405|NCT02722369|Etoposide|etoposide|mesh-list
56541406|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541407|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56541408|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
56541409|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541410|NCT02722369|Antiviral Agents|antiviral agents|mesh-ancestor
56541411|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541412|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541413|NCT02722369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56541414|NCT02722369|Immunologic Factors|immunologic factors|mesh-ancestor
56195674|NCT01500577|Nimesulide|nimesulide|mesh-list
56786438|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56786439|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56786440|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786441|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56786442|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
56786443|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
56786468|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56786469|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56786470|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786472|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
56786473|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
56786474|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
56786475|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786476|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56786477|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
56786478|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
56786479|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786480|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56786481|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
56786482|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
56786483|NCT00423189|Ranibizumab|ranibizumab|mesh-list
56786484|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56786485|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56786486|NCT00423189|Growth Substances|growth substances|mesh-ancestor
56786487|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786488|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
56786489|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786490|NCT00831545|Temozolomide|temozolomide|mesh-list
56786491|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56786524|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786526|NCT00827411|Aspirin|aspirin|mesh-list
56786527|NCT00827411|Clopidogrel|clopidogrel|mesh-list
56786528|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56786529|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56786530|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56786531|NCT00827411|Analgesics|analgesics|mesh-ancestor
56786532|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
56786533|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058912|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786562|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786563|NCT00831857|Bevacizumab|bevacizumab|mesh-list
56786564|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
56786565|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786566|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786567|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56786568|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56541415|NCT02722369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541416|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56541417|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56541418|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56541419|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
56541420|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56541421|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56541422|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56541423|NCT01222247|Betamethasone|betamethasone|mesh-list
56541424|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56541425|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
56541426|NCT01222247|Hormones|hormones|mesh-ancestor
56541427|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56541428|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541429|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56541430|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
56541431|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
56541432|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56541433|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56786569|NCT00831857|Growth Substances|growth substances|mesh-ancestor
56786570|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786571|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
56786572|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56786573|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786574|NCT00832013|Propofol|propofol|mesh-list
56786575|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56786576|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786577|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786602|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56786604|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56786605|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
56786606|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56786607|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786608|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56786609|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786610|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
56786611|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
56786612|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56786613|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786614|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56786615|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786616|NCT00825071|Dexamethasone|dexamethasone|mesh-list
56786617|NCT00825071|Ondansetron|ondansetron|mesh-list
56786618|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56786619|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
56786620|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
56786621|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786622|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786623|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786624|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
56786625|NCT00825071|Hormones|hormones|mesh-ancestor
56786626|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56786627|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56786647|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541434|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541435|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56541436|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
56786648|NCT00574847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56786649|NCT00574847|Antidepressive Agents|antidepressive agents|mesh-ancestor
56786651|NCT00348790|Vatalanib|vatalanib|mesh-list
56786652|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56786653|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786654|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786655|NCT00825149|Prednisone|prednisone|mesh-list
56786656|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
56786657|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56786658|NCT00825149|Doxorubicin|doxorubicin|mesh-list
56786659|NCT00825149|Fludarabine|fludarabine|mesh-list
56786660|NCT00825149|Vincristine|vincristine|mesh-list
56786661|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
56786662|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56786663|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
56786664|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786665|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56786666|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56786667|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
56786668|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786669|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786670|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56786671|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56786672|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56786673|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56786674|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786675|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56497629|NCT04612998|Atropine|atropine|mesh-list
56786676|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
56786677|NCT00825149|Hormones|hormones|mesh-ancestor
56786678|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56786679|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56786680|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56786704|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786706|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786707|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56786708|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56786709|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56786710|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56786711|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786712|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56786713|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
56786714|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56786715|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
56786716|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786717|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786718|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56786719|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
56786720|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
56786721|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56786722|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
56786723|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786724|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786725|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
56786726|NCT02549963|Anticoagulants|anticoagulants|mesh-list
56786727|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56786728|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
56059128|NCT00002649|Aldesleukin|aldesleukin|mesh-list
56786748|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56786749|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56786750|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56786751|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
56786752|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786753|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56786754|NCT00833339|Mifepristone|mifepristone|mesh-list
56786755|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56786756|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
56786757|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56541437|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
56541438|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541439|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541440|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56541441|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56541442|NCT00195091|Growth Substances|growth substances|mesh-ancestor
56541443|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541444|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
56541445|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541446|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
56541447|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56541448|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
56541449|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786758|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786759|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56786760|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56786761|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56786762|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
56786763|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56786764|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56786765|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
56786766|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56786767|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
56786768|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56786769|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56786770|NCT00825617|Hormones|hormones|mesh-list
56786771|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56786772|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786773|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
56786774|NCT00360334|Exenatide|exenatide|mesh-list
56786775|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56786776|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786777|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56786778|NCT00360334|Incretins|incretins|mesh-ancestor
56786779|NCT00360334|Hormones|hormones|mesh-ancestor
56786780|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56786781|NCT00422097|Epothilones|epothilones|mesh-list
56786803|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786804|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56786805|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
56786806|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786807|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56786809|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
56786810|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56786811|NCT00434967|Diuretics|diuretics|mesh-ancestor
56786812|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
56786813|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786814|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56786815|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56786816|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786817|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56786818|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56786819|NCT00833729|Etanercept|etanercept|mesh-list
56786820|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56497779|NCT04611438|Cannabidiol|cannabidiol|mesh-list
56786821|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56786822|NCT00833729|Analgesics|analgesics|mesh-ancestor
56786823|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
56786824|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541450|NCT03982537|Expectorants|expectorants|mesh-ancestor
56541451|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
56541452|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56541453|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
56541454|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541455|NCT03982537|Protective Agents|protective agents|mesh-ancestor
56541456|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541457|NCT03982537|Antidotes|antidotes|mesh-ancestor
56541458|NCT05260593|Vitamins|vitamins|mesh-list
56541459|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
56786825|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786826|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56786827|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56786828|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786829|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56786830|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
56786831|NCT00837239|Gemcitabine|gemcitabine|mesh-list
56786832|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56786870|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786871|NCT00356590|Etanercept|etanercept|mesh-list
56786872|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56786908|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56786909|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
56786910|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56786911|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56786912|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56786943|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56786944|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56786945|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786946|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
56786948|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786949|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
56786950|NCT00837941|Promethazine|promethazine|mesh-list
56786951|NCT00837941|Pregabalin|pregabalin|mesh-list
56786952|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56786953|NCT00837941|Analgesics|analgesics|mesh-ancestor
56786954|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
56786955|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786956|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786957|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
56786958|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56786959|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56786989|NCT00356200|Fluphenazine|fluphenazine|mesh-list
56786990|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
56786991|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
56786992|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56786993|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56786994|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786995|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786996|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786997|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56786998|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
56786999|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787000|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787001|NCT00356122|Bevacizumab|bevacizumab|mesh-list
56787002|NCT00356122|Docetaxel|docetaxel|mesh-list
56787003|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
56787004|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56787005|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787006|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56787033|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
56787034|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56787035|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56787036|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787037|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56787038|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56787039|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541460|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
56541461|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
56541462|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
56541463|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541464|NCT05260593|Hematinics|hematinics|mesh-ancestor
56541465|NCT02713477|Insulin|insulin|mesh-list
56541466|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56541467|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
56541468|NCT02713477|Lixisenatide|lixisenatide|mesh-list
56541469|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56541470|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541471|NCT01014585|Milnacipran|milnacipran|mesh-list
56541472|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
56541473|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56541474|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56541475|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56541476|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541477|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787040|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787041|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787042|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56787043|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
56787044|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547693|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56787045|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787046|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56787047|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56787048|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56787050|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
56787051|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56787052|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
56059447|NCT01625923|Olanzapine|olanzapine|mesh-list
56787077|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
56787078|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56787079|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56787080|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56787081|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56787082|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
56787084|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56787085|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787086|NCT05416476|Analgesics|analgesics|mesh-ancestor
56787087|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
56787088|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787089|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787090|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787091|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56787092|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
56787093|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
56787094|NCT00623597|Ritonavir|ritonavir|mesh-list
56787095|NCT00623597|Saquinavir|saquinavir|mesh-list
56787096|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56787097|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56787098|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
56787099|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787100|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787101|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56059512|NCT00002763|Interferons|interferons|mesh-list
56541478|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541479|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56541480|NCT01014585|Analgesics|analgesics|mesh-ancestor
56541481|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
56541482|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541483|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
56541484|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56541485|NCT00611143|Atorvastatin|atorvastatin|mesh-list
56541486|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56541487|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56541488|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
56541489|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541490|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56541491|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56787127|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56787128|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787129|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56787130|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787131|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787132|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56787133|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56787134|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787135|NCT00829205|Rituximab|rituximab|mesh-list
56787136|NCT00829205|Carboplatin|carboplatin|mesh-list
56787137|NCT00829205|Etoposide|etoposide|mesh-list
56787138|NCT00829205|Ifosfamide|ifosfamide|mesh-list
56787139|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
56787140|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56787141|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787142|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
56787143|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787144|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56787145|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56787146|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56787147|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56787148|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787149|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059544|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56787200|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56787201|NCT02547155|Anesthetics|anesthetics|mesh-list
56787202|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56787203|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787204|NCT00836849|Sertraline|sertraline|mesh-list
56787205|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
56787206|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56787207|NCT00836849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56787208|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56787209|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787210|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787211|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787212|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
56787213|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787214|NCT00839345|Clopidogrel|clopidogrel|mesh-list
56787215|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56787216|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56787217|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56787218|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56787219|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
56541492|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541493|NCT02712619|Metformin|metformin|mesh-list
56541494|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56541495|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541496|NCT01220609|Epothilones|epothilones|mesh-list
56541497|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
56541498|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
56541499|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
56541500|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541501|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541502|NCT02713087|Phenylephrine|phenylephrine|mesh-list
56541503|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
56541504|NCT02713087|Ephedrine|ephedrine|mesh-list
56541505|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56541506|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
56541507|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
56541508|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541509|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541510|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
56541511|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56541512|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
56541513|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
56541514|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56787220|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787221|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787222|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787223|NCT00839501|Acetazolamide|acetazolamide|mesh-list
56787224|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
56787225|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56787249|NCT00839657|Warfarin|warfarin|mesh-list
56787250|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
56787251|NCT05262270|Naltrexone|naltrexone|mesh-list
56787252|NCT05262270|Buprenorphine|buprenorphine|mesh-list
56787253|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56787254|NCT05262270|Narcotics|narcotics|mesh-ancestor
56787255|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56787256|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787257|NCT05262270|Analgesics|analgesics|mesh-ancestor
56787258|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
56787259|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787260|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56787261|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56787262|NCT05259696|Cemiplimab|cemiplimab|mesh-list
56787263|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56787264|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787265|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
56787266|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
56787267|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
56787268|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
56787269|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56787270|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787271|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
56787272|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56787273|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541515|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56541516|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56541517|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
56541518|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787274|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56787275|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787276|NCT00840125|Docetaxel|docetaxel|mesh-list
56787307|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56787308|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56787309|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
56787310|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56787311|NCT00840671|Protective Agents|protective agents|mesh-ancestor
56787312|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787313|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
56787314|NCT02546531|Gemcitabine|gemcitabine|mesh-list
56787315|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
56787316|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56787317|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
56787318|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787319|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787389|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787390|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787391|NCT00841841|Acetaminophen|acetaminophen|mesh-list
56787392|NCT00841841|Dipyrone|dipyrone|mesh-list
56787393|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787394|NCT00841841|Analgesics|analgesics|mesh-ancestor
56787395|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
56787396|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059808|NCT05749575|Paclitaxel|paclitaxel|mesh-list
56787430|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787431|NCT00844727|Analgesics|analgesics|mesh-ancestor
56787432|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
56787433|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787434|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787435|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56059841|NCT05614089|Insulin|insulin|mesh-list
56787467|NCT02546141|Caseins|caseins|mesh-list
56787468|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
56787469|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
56787470|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787471|NCT00845819|Iodine|iodine|mesh-list
56787472|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
56787473|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56787474|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
56787475|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
56787476|NCT00845819|Nystatin|nystatin|mesh-list
56787477|NCT00845819|Povidone|povidone|mesh-list
56787478|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56787479|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787480|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
56787481|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
56059879|NCT05571735|Vaccines|vaccines|mesh-list
56787511|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787512|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56787513|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
56787514|NCT03998982|Hormones|hormones|mesh-ancestor
56787515|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56787516|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56787517|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787518|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56787519|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
56787520|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787521|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56787522|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56787523|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787524|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787525|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56787526|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56787560|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787561|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56787562|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
56787563|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
56787564|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56541519|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541520|NCT02713087|Protective Agents|protective agents|mesh-ancestor
56541521|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56541522|NCT02712697|Prednisone|prednisone|mesh-list
56541523|NCT02712697|Hormones|hormones|mesh-list
56541524|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56541525|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
56541526|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56541527|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541528|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56541529|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541530|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
56541531|NCT01220297|Sirolimus|sirolimus|mesh-list
56541532|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
56541533|NCT01220297|Carmustine|carmustine|mesh-list
56541534|NCT01220297|Etoposide|etoposide|mesh-list
56541538|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541539|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56541540|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56541541|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
56541542|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541543|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541544|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56541545|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56541546|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56541547|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56541548|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541549|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56541550|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56541551|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
56541552|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56541553|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541554|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
56541555|NCT02712775|Minocycline|minocycline|mesh-list
56541556|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56541557|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787565|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56541558|NCT04318847|Ondansetron|ondansetron|mesh-list
56541559|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
56541560|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
56541561|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541562|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541563|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56541564|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
56541565|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
56541566|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56541567|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
56541568|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541569|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541570|NCT04318847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56541571|NCT04318847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56541572|NCT04318847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541573|NCT04318847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56541574|NCT04318847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56787566|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56787567|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56787568|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
56787569|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
56787570|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787571|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787629|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56787630|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56787631|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56787632|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787633|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787634|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56787635|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787636|NCT00527904|Analgesics|analgesics|mesh-ancestor
56787637|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
56787638|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787639|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787640|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787641|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56787642|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
56787643|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56787644|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56787645|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56787646|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56787647|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787648|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787649|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787650|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787651|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
56787652|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56787653|NCT00848939|Treprostinil|treprostinil|mesh-list
56060053|NCT05242965|Vaccines|vaccines|mesh-list
56787672|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56787673|NCT00842933|Protective Agents|protective agents|mesh-ancestor
56787675|NCT00849095|Terbutaline|terbutaline|mesh-list
56787676|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
56787677|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56787678|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787679|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56787680|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
56541575|NCT02721511|Furosemide|furosemide|mesh-list
56541576|NCT02721511|Diuretics|diuretics|mesh-ancestor
56541577|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
56541578|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541579|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56541580|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56541581|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541582|NCT02712307|Penicillins|penicillins|mesh-list
56541583|NCT02712307|Penicillin V|penicillin v|mesh-list
56541584|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56541585|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787681|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787682|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787683|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56787684|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
56787685|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
56787686|NCT00849095|Hormones|hormones|mesh-ancestor
56787687|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56787688|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56787689|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56787690|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56787691|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
56787692|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787693|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787694|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
56787695|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
56787696|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56787697|NCT00527826|Fluticasone|fluticasone|mesh-list
56787699|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56787700|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787701|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56787702|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
56787703|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787704|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787705|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56787706|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
56787707|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
56787708|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56787709|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56787710|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56787729|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787731|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787732|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787733|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
56787734|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56787735|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56787736|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787737|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56787738|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56787739|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56787740|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
56787741|NCT00852683|Pregabalin|pregabalin|mesh-list
56787742|NCT00852683|Analgesics|analgesics|mesh-ancestor
56787743|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
56787744|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787745|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787746|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
56787747|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56787748|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787749|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787750|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56541586|NCT02708251|Lidocaine|lidocaine|mesh-list
56541587|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
56541588|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
56541589|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
56541590|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541591|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787751|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56787752|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56787753|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56787754|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56787755|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
56787756|NCT00619307|Ibuprofen|ibuprofen|mesh-list
56787757|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56787758|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787759|NCT00619307|Analgesics|analgesics|mesh-ancestor
56787760|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
56787761|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787762|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787763|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787764|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56060148|NCT01437709|Ofatumumab|ofatumumab|mesh-list
56787858|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56787859|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
56787860|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56787861|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787862|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787863|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787864|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
56787865|NCT02544893|Bupivacaine|bupivacaine|mesh-list
56787866|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
56787867|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
56787868|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56787869|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787870|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
56787871|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787872|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56787873|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787874|NCT02544893|Analgesics|analgesics|mesh-ancestor
56787875|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56787876|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56787877|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56787878|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
56787879|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787880|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787881|NCT00520572|Etanercept|etanercept|mesh-list
56060273|NCT05735756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56787903|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56787904|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787905|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
56787906|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56787907|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56787908|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787909|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787910|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
56787911|NCT00861419|Niacinamide|niacinamide|mesh-list
56787912|NCT00861419|Bevacizumab|bevacizumab|mesh-list
56787913|NCT00861419|Sunitinib|sunitinib|mesh-list
56787914|NCT00861419|Trebananib|trebananib|mesh-list
56787915|NCT00861419|Sorafenib|sorafenib|mesh-list
56787916|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
56787917|NCT00861419|Imetelstat|imetelstat|mesh-list
56787918|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56787919|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787920|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56787921|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56787922|NCT00861419|Growth Substances|growth substances|mesh-ancestor
56787923|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787924|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
56787925|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56787926|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887138|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541592|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
56541593|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541594|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56541595|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56541596|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56541597|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56541598|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541599|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
56541600|NCT02708173|Vaccines|vaccines|mesh-list
56541601|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
56541602|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541603|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56541604|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
56541605|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541606|NCT00612625|Glucagon|glucagon|mesh-list
56541607|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56541608|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56541609|NCT00612625|Hormones|hormones|mesh-ancestor
56541610|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56541611|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541612|NCT00612625|Incretins|incretins|mesh-ancestor
56541613|NCT03971071|Erenumab|erenumab|mesh-list
56541614|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56541615|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56541616|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541617|NCT03971071|Analgesics|analgesics|mesh-ancestor
56541618|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
56541619|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541620|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787927|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787928|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
56787929|NCT00861419|Vitamins|vitamins|mesh-ancestor
56787930|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
56787931|NCT00527514|Amlodipine|amlodipine|mesh-list
56787932|NCT00527514|Olmesartan|olmesartan|mesh-list
56787933|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56787934|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56787935|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56787936|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787970|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787971|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56787972|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541621|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
56541622|NCT02711917|Propofol|propofol|mesh-list
56541623|NCT02711917|Etomidate|etomidate|mesh-list
56541624|NCT02711917|Rocuronium|rocuronium|mesh-list
56787973|NCT03998592|Vaccines|vaccines|mesh-list
56787974|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
56788003|NCT00857597|Esomeprazole|esomeprazole|mesh-list
56788004|NCT00857597|Omeprazole|omeprazole|mesh-list
56788005|NCT00857597|Rabeprazole|rabeprazole|mesh-list
56788006|NCT00857597|Pantoprazole|pantoprazole|mesh-list
56788007|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56788008|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56788009|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56788010|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788011|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788012|NCT00857753|Fentanyl|fentanyl|mesh-list
56788013|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56788014|NCT00857753|Narcotics|narcotics|mesh-ancestor
56788015|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788016|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788017|NCT00857753|Analgesics|analgesics|mesh-ancestor
56788018|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
56788019|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788020|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56788021|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56788051|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56788052|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56788054|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788055|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788056|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56788057|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
56788058|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56788059|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56788060|NCT00857909|Amiloride|amiloride|mesh-list
56788061|NCT00857909|Spironolactone|spironolactone|mesh-list
56788062|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56788063|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
56788064|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56788065|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788066|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56788067|NCT00857909|Diuretics|diuretics|mesh-ancestor
56788068|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
56788069|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56788091|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56788092|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788093|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788094|NCT00858299|Valsartan|valsartan|mesh-list
56788095|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56788096|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56788097|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56499049|NCT04598061|Analgesics|analgesics|mesh-ancestor
56788098|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788099|NCT00526890|Selenium|selenium|mesh-list
56788100|NCT00526890|Paclitaxel|paclitaxel|mesh-list
56788101|NCT00526890|Carboplatin|carboplatin|mesh-list
56788102|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56788103|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788104|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56788105|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56788106|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56788107|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788108|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
56788109|NCT00526890|Protective Agents|protective agents|mesh-ancestor
56788110|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788111|NCT00526890|Trace Elements|trace elements|mesh-ancestor
56788112|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
56788113|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
56788114|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
56788115|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788116|NCT04041167|Protective Agents|protective agents|mesh-ancestor
56788117|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788118|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
56788119|NCT04041167|Vitamins|vitamins|mesh-ancestor
56788120|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
56541625|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56541626|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541627|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541628|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56541629|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
56541630|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
56541631|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56541632|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56541633|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56541634|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788121|NCT00858377|Complement Factor H|complement factor h|mesh-list
56788122|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56788177|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
56788178|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788179|NCT00617903|Azelaic acid|azelaic acid|mesh-list
56788180|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788181|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
56788182|NCT00526110|Docetaxel|docetaxel|mesh-list
56788183|NCT00526110|Fluorouracil|fluorouracil|mesh-list
56788184|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
56788185|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788186|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56788187|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56788188|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56788189|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788190|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
56788191|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56788192|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56788193|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
56788194|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788195|NCT04565730|Anesthetics|anesthetics|mesh-list
56060579|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56788228|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56788229|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
56788230|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56788231|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56788232|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
56788234|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56788235|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56788236|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788237|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
56788238|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
56788267|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788268|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56788269|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56788270|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788271|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788272|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56788273|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
56788274|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56788275|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788276|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56788278|NCT00573755|Letrozole|letrozole|mesh-list
56788279|NCT00573755|Anastrozole|anastrozole|mesh-list
56788280|NCT00573755|Exemestane|exemestane|mesh-list
56788305|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56788306|NCT00524316|Growth Substances|growth substances|mesh-ancestor
56788307|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788308|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
56788309|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56788310|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56788311|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
56788312|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541635|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
56541636|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56541637|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56541638|NCT02711449|Prednisolone|prednisolone|mesh-list
56788313|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56788314|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
56788315|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788316|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788317|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56788318|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56788319|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788320|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788321|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
56788323|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56788324|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56788325|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788326|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788327|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
56788328|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788387|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56788388|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
56788389|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56788390|NCT04732182|Donepezil|donepezil|mesh-list
56788391|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56788392|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788393|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788394|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
56788395|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499342|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
56788396|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788398|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
56788399|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56788400|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788401|NCT04718220|Antibodies|antibodies|mesh-list
56788402|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
56788403|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788440|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788441|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788442|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56788443|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
56788444|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788445|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
56788476|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56788478|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
56788479|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788480|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56788481|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56788482|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56788483|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788484|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788485|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788486|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56788487|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56788488|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56788489|NCT00865241|Metformin|metformin|mesh-list
56788522|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788523|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56788524|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56788525|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788526|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788527|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788528|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56788529|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
56788530|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56788531|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060926|NCT01951118|Donepezil|donepezil|mesh-list
56788563|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788565|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56541639|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
56541640|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56541641|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
56541642|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56541643|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
56541644|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
56788566|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788567|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788568|NCT00865631|Gabapentin|gabapentin|mesh-list
56788569|NCT00865631|Analgesics|analgesics|mesh-ancestor
56788570|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
56788571|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788572|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788573|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
56788628|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56788629|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788630|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788631|NCT00864149|Carvedilol|carvedilol|mesh-list
56788632|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56788633|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56788634|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788635|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788636|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788637|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788638|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56788639|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
56788640|NCT00864149|Protective Agents|protective agents|mesh-ancestor
56788641|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56788642|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788643|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56788644|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
56788645|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56788646|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56788647|NCT01010100|Acarbose|acarbose|mesh-list
56788648|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56788649|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788650|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788651|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56788652|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788653|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56788654|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56788655|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
56788656|NCT01010178|Theophylline|theophylline|mesh-list
56788657|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56788658|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
56788659|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788660|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788661|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56061037|NCT01621009|Bupropion|bupropion|mesh-list
56788688|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56788689|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788690|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788691|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
56788692|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56788693|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56788694|NCT00617591|Growth Substances|growth substances|mesh-ancestor
56788695|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
56788697|NCT00864305|Analgesics|analgesics|mesh-ancestor
56788698|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
56788699|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788700|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788701|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
56788702|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56788703|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56788704|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788705|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56788706|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56788707|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56788708|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541645|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541646|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541647|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56541648|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
56541649|NCT02711449|Hormones|hormones|mesh-ancestor
56541650|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56541651|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56541652|NCT02711449|Protective Agents|protective agents|mesh-ancestor
56541653|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56541654|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541655|NCT00612079|Sertindole|sertindole|mesh-list
56541656|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56541657|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56541658|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541659|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541660|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56541661|NCT00940498|Gedatolisib|gedatolisib|mesh-list
56541662|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56541663|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541664|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541665|NCT03820531|Pancrelipase|pancrelipase|mesh-list
56541666|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56541667|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
56541668|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
56195901|NCT01501214|Atosiban|atosiban|mesh-list
56788740|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788741|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788743|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788744|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56788745|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
56788746|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56788747|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56788779|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56788780|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56788781|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
56788782|NCT00871247|Finasteride|finasteride|mesh-list
56788783|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56788784|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56788785|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788786|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788787|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
56788788|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56788789|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788818|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56788819|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788820|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56788822|NCT00516048|Hormones|hormones|mesh-ancestor
56473661|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541669|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56541670|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56195922|NCT01501370|BB 1101|bb 1101|mesh-list
56788823|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56788824|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
56788825|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788826|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56788827|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788828|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788829|NCT00865007|Ritonavir|ritonavir|mesh-list
56788830|NCT00865007|Lopinavir|lopinavir|mesh-list
56788831|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56788832|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56788833|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
56788834|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061223|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788854|NCT00876317|Analgesics|analgesics|mesh-ancestor
56788855|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
56788856|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788857|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788858|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56788859|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56788860|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56788861|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56788862|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788863|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788864|NCT00866645|Haloperidol|haloperidol|mesh-list
56788865|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
56788867|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56788868|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
56788869|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
56788870|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788871|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788872|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56788873|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56788874|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56788875|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788876|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56788877|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56788878|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
56788879|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788880|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788881|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56788882|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56788883|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
56788884|NCT00872651|Timolol|timolol|mesh-list
56788885|NCT00872651|Travoprost|travoprost|mesh-list
56788886|NCT00872651|Latanoprost|latanoprost|mesh-list
56788887|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56788888|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56788904|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788905|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56788906|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56788907|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
56788908|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788909|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788910|NCT00873353|Capecitabine|capecitabine|mesh-list
56788911|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56788912|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56788913|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
56788914|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788915|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788916|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56788917|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788918|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
56788919|NCT00877097|Trisequens|trisequens|mesh-list
56788920|NCT00877097|Norethindrone|norethindrone|mesh-list
56788921|NCT00877097|Estradiol|estradiol|mesh-list
56788922|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56788923|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788924|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56788925|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56541671|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541672|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541673|NCT02850718|Urological Agents|urological agents|mesh-ancestor
56541674|NCT02707393|Cyclosporine|cyclosporine|mesh-list
56541675|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
56541676|NCT02707393|Fludarabine|fludarabine|mesh-list
56541677|NCT02707393|Melphalan|melphalan|mesh-list
56541678|NCT02707393|Thiotepa|thiotepa|mesh-list
56541679|NCT02707393|Cyclosporins|cyclosporins|mesh-list
56541680|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
56541681|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289940|NCT00006035|Bleomycin|bleomycin|mesh-list
56541682|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541683|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56541684|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
56541685|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541686|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541687|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
56541688|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541689|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
56541690|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56541691|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56541692|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56788926|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56788927|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
56788928|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56788929|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56788930|NCT00877097|Estrogens|estrogens|mesh-ancestor
56788931|NCT00877097|Hormones|hormones|mesh-ancestor
56788932|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56788933|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56788934|NCT00877175|Phenylephrine|phenylephrine|mesh-list
56788935|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
56788936|NCT00877175|Tropicamide|tropicamide|mesh-list
56788937|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56788938|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
56788939|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
56788940|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788941|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788942|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
56788943|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56788944|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
56788966|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
56788967|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788968|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56788969|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56788970|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
56788971|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56788972|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56788973|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56788974|NCT00573443|Quinidine|quinidine|mesh-list
56788975|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
56788976|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
56788977|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
56788978|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
56541693|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56541694|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
56541695|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56541696|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56788979|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56788980|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56788981|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788982|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788983|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788984|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56788985|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56788986|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788987|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56788988|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
56788989|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56788990|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56788991|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788992|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788993|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56788994|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56788995|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
56061377|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
56789026|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789027|NCT05225753|Analgesics|analgesics|mesh-ancestor
56789028|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
56789029|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789030|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789031|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789032|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789033|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56789034|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56789035|NCT00874133|Domperidone|domperidone|mesh-list
56789036|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
56789037|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
56061431|NCT04340193|Ipilimumab|ipilimumab|mesh-list
56789064|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56789065|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56789067|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789068|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789069|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
56789070|NCT04551677|Vaccines|vaccines|mesh-list
56789071|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
56789072|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789073|NCT04040465|Aspirin|aspirin|mesh-list
56789074|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56789075|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789076|NCT04040465|Analgesics|analgesics|mesh-ancestor
56789077|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
56789078|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789079|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789080|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789081|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789082|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56789083|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56789084|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789137|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
56789138|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789139|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789140|NCT00420303|Etanercept|etanercept|mesh-list
56789141|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56789142|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789143|NCT00420303|Analgesics|analgesics|mesh-ancestor
56789144|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
56789145|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789146|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789147|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789148|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789149|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789150|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789151|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
56789152|NCT00617123|Vorapaxar|vorapaxar|mesh-list
56541697|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
56541698|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56541699|NCT00940342|Rituximab|rituximab|mesh-list
56541700|NCT00940342|Molgramostim|molgramostim|mesh-list
56541701|NCT00940342|Sargramostim|sargramostim|mesh-list
56541702|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56541703|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541704|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
56541705|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541706|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56541707|NCT00936910|Amphotericin B|amphotericin b|mesh-list
56541708|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56541709|NCT00936910|Amebicides|amebicides|mesh-ancestor
56541710|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56541711|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56789153|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56789154|NCT00877955|Alprazolam|alprazolam|mesh-list
56789155|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56789156|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789157|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789158|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56789159|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56789160|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56789161|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
56789162|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
56789163|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789164|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789165|NCT00419757|Budesonide|budesonide|mesh-list
56789166|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
56789167|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56789168|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789169|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56789170|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
56789171|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789189|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789191|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56789192|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789193|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789194|NCT00875069|Ethanol|ethanol|mesh-list
56789195|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56789196|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789197|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789198|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789199|NCT01029639|Insulin|insulin|mesh-list
56789200|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
56789201|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56789202|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56789203|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789204|NCT00875147|Bevacizumab|bevacizumab|mesh-list
56789205|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56789206|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789207|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56789208|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56789209|NCT00875147|Growth Substances|growth substances|mesh-ancestor
56789210|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789211|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
56789212|NCT00433329|Bosentan|bosentan|mesh-list
56789213|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
56789215|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56789216|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56789217|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789218|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541712|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541713|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56541714|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
56541715|NCT02707315|Gemcitabine|gemcitabine|mesh-list
56541716|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56541717|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
56541718|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541719|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541720|NCT02707315|Antiviral Agents|antiviral agents|mesh-ancestor
56541721|NCT02707315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541722|NCT02707315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541723|NCT02707315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56541724|NCT02707315|Immunologic Factors|immunologic factors|mesh-ancestor
56541725|NCT02707315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541726|NCT00604942|Domperidone|domperidone|mesh-list
56541727|NCT00604942|Esomeprazole|esomeprazole|mesh-list
56541728|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56541729|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56541730|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56541731|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541732|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541733|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
56541734|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
56541735|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541736|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541737|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56541738|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
56541739|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56195977|NCT01501422|Hormones|hormones|mesh-ancestor
56789219|NCT00433329|Urological Agents|urological agents|mesh-ancestor
56789220|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56789221|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56789253|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789254|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56789255|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
56789257|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
56789258|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56789259|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
56789260|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789261|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789262|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56789263|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
56789264|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
56789292|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789293|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
56789294|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56789295|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
56541740|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
56541741|NCT02711683|Donepezil|donepezil|mesh-list
56541742|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56541743|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541744|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541745|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
56789296|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789297|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56789298|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56789299|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789300|NCT00875849|Cetuximab|cetuximab|mesh-list
56789301|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789302|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56789304|NCT00875927|Propolis|propolis|mesh-list
56789305|NCT00875927|Trace Elements|trace elements|mesh-ancestor
56789306|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
56789307|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789308|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789309|NCT00878657|Gemcitabine|gemcitabine|mesh-list
56789310|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56789311|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
56789312|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061699|NCT05738564|Oxymetazoline|oxymetazoline|mesh-list
56789341|NCT00868985|Laxatives|laxatives|mesh-ancestor
56789342|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789343|NCT00869063|Diclofenac|diclofenac|mesh-list
56789344|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56789345|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789346|NCT00869063|Analgesics|analgesics|mesh-ancestor
56789347|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
56789348|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789349|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789350|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789351|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789352|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56789353|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789354|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789355|NCT00869219|Nepafenac|nepafenac|mesh-list
56789356|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56789357|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789358|NCT00869219|Analgesics|analgesics|mesh-ancestor
56789359|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
56789379|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
56789380|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
56789381|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789382|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789383|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789384|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
56789385|NCT00531284|Hormones|hormones|mesh-ancestor
56789386|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789387|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56789388|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789389|NCT00531206|Ritonavir|ritonavir|mesh-list
56789390|NCT00531206|Tipranavir|tipranavir|mesh-list
56789391|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56789392|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56789393|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
56789394|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789395|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789396|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56789397|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56789398|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
56789399|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789400|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56789401|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56789402|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
56789403|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
56789404|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
56789405|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56541746|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541747|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541748|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
56541749|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56541750|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56541751|NCT02711683|Protective Agents|protective agents|mesh-ancestor
56541752|NCT05079061|Misoprostol|misoprostol|mesh-list
56541753|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56541754|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
56541755|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56541756|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541757|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56541758|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56541759|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
56541761|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56541762|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
56541763|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
56541764|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56541765|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
56541766|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
56541767|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56541768|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541769|NCT02707081|Lidocaine|lidocaine|mesh-list
56541770|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
56541771|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
56789406|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789407|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
56789408|NCT00994994|Coagulants|coagulants|mesh-ancestor
56789409|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
56789410|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56789411|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56789412|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789413|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56789414|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56789441|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
56789442|NCT01005758|Doxorubicin|doxorubicin|mesh-list
56789443|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56789444|NCT01005758|Methotrexate|methotrexate|mesh-list
56789445|NCT01005758|Etoposide|etoposide|mesh-list
56789446|NCT01005758|Vincristine|vincristine|mesh-list
56789447|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
56789448|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
56789449|NCT01005758|Pegaspargase|pegaspargase|mesh-list
56789450|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
56789451|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789452|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
56789453|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789454|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789455|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56789456|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
56789457|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789458|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541772|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541773|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541774|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
56541775|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541776|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56541777|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56541778|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56541779|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56541780|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541781|NCT00605098|Ritonavir|ritonavir|mesh-list
56541782|NCT00605098|Lopinavir|lopinavir|mesh-list
56541783|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56541784|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56541785|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
56541786|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541787|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541788|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56789459|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56789460|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789461|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
56789462|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
56789463|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789464|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789465|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
56789484|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
56789485|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
56789486|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
56789487|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56789488|NCT01005758|Protective Agents|protective agents|mesh-ancestor
56789489|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56789490|NCT05152472|Atezolizumab|atezolizumab|mesh-list
56789491|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
56789492|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789493|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56789494|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789495|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789496|NCT00879047|Ethanol|ethanol|mesh-list
56789497|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56789498|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789499|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789500|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789501|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
56789502|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789503|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
56789504|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789505|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789506|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56789507|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
56789508|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789509|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789510|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56789511|NCT01000220|Omeprazole|omeprazole|mesh-list
56789512|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56500471|NCT00569400|Insulin|insulin|mesh-list
56789513|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789514|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56541789|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56541790|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
56541791|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541792|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56541793|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56541794|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56541795|NCT02711215|Mirtazapine|mirtazapine|mesh-list
56541796|NCT02711215|Citalopram|citalopram|mesh-list
56541797|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56541798|NCT02711215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56541799|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56541800|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56541801|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541802|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541803|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
56541804|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541805|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56541806|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
56196028|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
56196029|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56196030|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
56196031|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
56196032|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196033|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196035|NCT01501669|Capecitabine|capecitabine|mesh-list
56789515|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789516|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789517|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
56789518|NCT05147558|Lenvatinib|lenvatinib|mesh-list
56061894|NCT05058872|Estrogens|estrogens|mesh-ancestor
56789554|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56789555|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56789556|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789557|NCT01007084|Propranolol|propranolol|mesh-list
56789576|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56789577|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56789578|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789579|NCT01000688|Vildagliptin|vildagliptin|mesh-list
56789580|NCT01000688|Acarbose|acarbose|mesh-list
56789581|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56789582|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789583|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56789584|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
56789585|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789586|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789587|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56789588|NCT00879983|Azithromycin|azithromycin|mesh-list
56541807|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56541808|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541809|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56541810|NCT02711215|Analgesics|analgesics|mesh-ancestor
56541811|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
56541812|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
56541813|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56541814|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
56541815|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
56541816|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56541817|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56541818|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541819|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56541820|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56541821|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56541822|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
56541823|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56541824|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56541825|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56541826|NCT00603772|Tretinoin|tretinoin|mesh-list
56541827|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541828|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
56541830|NCT02706769|Acetaminophen|acetaminophen|mesh-list
56541831|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56541832|NCT02706769|Analgesics|analgesics|mesh-ancestor
56541833|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
56541834|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541835|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789589|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56789590|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789591|NCT00869765|Cycloserine|cycloserine|mesh-list
56789592|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56789593|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789594|NCT00869765|Renal Agents|renal agents|mesh-ancestor
56789595|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56789596|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
56789597|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56789598|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
56789599|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789600|NCT05076110|Acetaminophen|acetaminophen|mesh-list
56789601|NCT05076110|Ibuprofen|ibuprofen|mesh-list
56789602|NCT05076110|Oxycodone|oxycodone|mesh-list
56789603|NCT05076110|Gabapentin|gabapentin|mesh-list
56789604|NCT05076110|Methocarbamol|methocarbamol|mesh-list
56789605|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789606|NCT05076110|Analgesics|analgesics|mesh-ancestor
56789607|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
56473662|NCT00523926|Bedaquiline|bedaquiline|mesh-list
56541836|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
56541837|NCT05044117|Capecitabine|capecitabine|mesh-list
56541838|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56541839|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
56541840|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541841|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541842|NCT03961165|Scopolamine|scopolamine|mesh-list
56541843|NCT03961165|Bromides|bromides|mesh-list
56541844|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56541845|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
56541846|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
56541847|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
56541848|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541849|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541850|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56541851|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56541852|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
56541853|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196058|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196059|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56196060|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56196061|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196062|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196063|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56196064|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
56196068|NCT01501708|Amebicides|amebicides|mesh-ancestor
56789608|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789609|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789610|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
56789611|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56789612|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789613|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789650|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789651|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56062051|NCT03543839|Belimumab|belimumab|mesh-list
56789680|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56789681|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56789682|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
56789683|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789684|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789685|NCT00530348|Interferons|interferons|mesh-list
56789686|NCT00530348|Interferon-beta|interferon-beta|mesh-list
56789687|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
56789688|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
56789689|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789690|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
56789691|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789692|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56541854|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541855|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56541856|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
56541857|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789693|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
56789694|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789695|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56789696|NCT01007864|Pramipexole|pramipexole|mesh-list
56789697|NCT01007864|Ropinirole|ropinirole|mesh-list
56789698|NCT01007864|Piribedil|piribedil|mesh-list
56789730|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
56789731|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
56789732|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789733|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789734|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789735|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
56789737|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789738|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56062132|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
56789766|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56789767|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789768|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789769|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
56789770|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789771|NCT03885596|Acetaminophen|acetaminophen|mesh-list
56789772|NCT03885596|Celecoxib|celecoxib|mesh-list
56789773|NCT03885596|Ketorolac|ketorolac|mesh-list
56789774|NCT03885596|Lidocaine|lidocaine|mesh-list
56789775|NCT03885596|Fentanyl|fentanyl|mesh-list
56789776|NCT03885596|Bupivacaine|bupivacaine|mesh-list
56789777|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
56789778|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
56789779|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789780|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789781|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
56789782|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789783|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56789784|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56789785|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56789786|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56789816|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789817|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
56789818|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56789819|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56789820|NCT00529100|Cisplatin|cisplatin|mesh-list
56789821|NCT00529100|Pemetrexed|pemetrexed|mesh-list
56789822|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789823|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789824|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789825|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56789826|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56789827|NCT05732948|Cyclophosphamide|cyclophosphamide|mesh-list
56789828|NCT05732948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789829|NCT05732948|Immunologic Factors|immunologic factors|mesh-ancestor
56789830|NCT05732948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789831|NCT05732948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789832|NCT05732948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56789833|NCT05732948|Alkylating Agents|alkylating agents|mesh-ancestor
56789867|NCT05730920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56789868|NCT05730920|Narcotics|narcotics|mesh-ancestor
56789869|NCT05730920|Analgesics|analgesics|mesh-ancestor
56789870|NCT05730920|Antitussive Agents|antitussive agents|mesh-ancestor
56789871|NCT05730920|Respiratory System Agents|respiratory system agents|mesh-ancestor
56789872|NCT03999008|Budesonide|budesonide|mesh-list
56789873|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789874|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56789908|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789909|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789911|NCT00614393|Cetuximab|cetuximab|mesh-list
56789912|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56789913|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56789914|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56541858|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
56541859|NCT02706535|Itraconazole|itraconazole|mesh-list
56541860|NCT02706535|Rifampin|rifampin|mesh-list
56541861|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
56541862|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541863|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56541864|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56541865|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541866|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541867|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56541868|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
56541869|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56541870|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541871|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56541872|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56196087|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
56789950|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789951|NCT04366115|Dexamethasone|dexamethasone|mesh-list
56789952|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
56789953|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56789954|NCT04366115|BB 1101|bb 1101|mesh-list
56789955|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789956|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
56789984|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789985|NCT00885833|Fludarabine|fludarabine|mesh-list
56789986|NCT00885833|Busulfan|busulfan|mesh-list
56789987|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
56789988|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789989|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789990|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789991|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
56789992|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789993|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
56789994|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56789995|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56789996|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
56789997|NCT00612677|Pemetrexed|pemetrexed|mesh-list
56789998|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789999|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790000|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790001|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56790002|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56790003|NCT04038749|Cabergoline|cabergoline|mesh-list
56790038|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790039|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
56790040|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790041|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790042|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56790075|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
56790076|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790077|NCT02543645|Atezolizumab|atezolizumab|mesh-list
56790078|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790079|NCT02543411|Lidocaine|lidocaine|mesh-list
56790080|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
56790081|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
56790082|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790083|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790084|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
56541873|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
56541874|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56541875|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
56541876|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56790085|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790086|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56062474|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
56790118|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
56790119|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790120|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56790121|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
56790122|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790123|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790124|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
56790125|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56790126|NCT04038671|Charcoal|charcoal|mesh-list
56790127|NCT04038671|Antidotes|antidotes|mesh-ancestor
56790128|NCT04038671|Protective Agents|protective agents|mesh-ancestor
56790129|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790160|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790161|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790162|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790163|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56790164|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56790165|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
56790166|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56790167|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56790168|NCT00888797|Analgesics|analgesics|mesh-ancestor
56790169|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
56790170|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790171|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790172|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790173|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56790174|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56790175|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790209|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56790210|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56790211|NCT00887003|Protective Agents|protective agents|mesh-ancestor
56790212|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56790213|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790214|NCT00887081|Ribavirin|ribavirin|mesh-list
56790215|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
56790216|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
56790217|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56790218|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56790219|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56790252|NCT05695352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56790253|NCT05695352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56790255|NCT05695352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56790256|NCT05695352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56790257|NCT05695352|Analgesics|analgesics|mesh-ancestor
56790258|NCT05695352|Sensory System Agents|sensory system agents|mesh-ancestor
56790259|NCT05695352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790289|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
56790290|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790291|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56790292|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56790293|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790294|NCT00889343|Antidotes|antidotes|mesh-ancestor
56790295|NCT00889343|Protective Agents|protective agents|mesh-ancestor
56790296|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
56790297|NCT00889343|Vitamins|vitamins|mesh-ancestor
56790298|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
56790299|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56790300|NCT00884819|Fenofibrate|fenofibrate|mesh-list
56790301|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56790302|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
56790303|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790304|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56790305|NCT04974398|Gemcitabine|gemcitabine|mesh-list
56790306|NCT04974398|Cisplatin|cisplatin|mesh-list
56541877|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56541878|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56196096|NCT01501760|Bevacizumab|bevacizumab|mesh-list
56062697|NCT02245087|Atorvastatin|atorvastatin|mesh-list
56790374|NCT04641338|Dipyrone|dipyrone|mesh-list
56790375|NCT04641338|Codeine|codeine|mesh-list
56790376|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56790377|NCT04641338|Narcotics|narcotics|mesh-ancestor
56790378|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790379|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790380|NCT04641338|Analgesics|analgesics|mesh-ancestor
56790381|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
56790382|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790383|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
56790409|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790410|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790411|NCT00520676|Carboplatin|carboplatin|mesh-list
56790412|NCT00520676|Docetaxel|docetaxel|mesh-list
56790413|NCT00520676|Pemetrexed|pemetrexed|mesh-list
56790414|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790415|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
56790416|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
56790417|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
56790418|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790419|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790420|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56790421|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56790422|NCT00889733|Cisplatin|cisplatin|mesh-list
56790423|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790424|NCT00887627|Conivaptan|conivaptan|mesh-list
56790425|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56790426|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790427|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
56790428|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790429|NCT00885287|Lumefantrine|lumefantrine|mesh-list
56790430|NCT00885287|Artemether|artemether|mesh-list
56790431|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56790432|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
56790458|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
56790459|NCT00890279|Imidapril|imidapril|mesh-list
56790460|NCT00890279|Cilnidipine|cilnidipine|mesh-list
56790461|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56790462|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56790463|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790464|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56790465|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790466|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56790467|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
56790468|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790469|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56790470|NCT00608543|Aripiprazole|aripiprazole|mesh-list
56790471|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
56790472|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56790473|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56790474|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56790475|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790476|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790477|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
56790478|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
56790479|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790480|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790501|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
56790503|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56790504|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56790505|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790506|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
56790507|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790508|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790509|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790510|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
56790511|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
56541879|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56541880|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56541881|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56541882|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56541883|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
56541884|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56541885|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541886|NCT04993027|Vancomycin|vancomycin|mesh-list
56541887|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56196104|NCT01501786|Ketamine|ketamine|mesh-list
56790512|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56790513|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790514|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56790515|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56790516|NCT02541383|Growth Substances|growth substances|mesh-ancestor
56790517|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
56790518|NCT04036487|Propofol|propofol|mesh-list
56790519|NCT04036487|Desflurane|desflurane|mesh-list
56790520|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56790521|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790522|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790523|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56790524|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
56790525|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
56790526|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56790527|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
56790528|NCT05278793|Trace Elements|trace elements|mesh-ancestor
56790529|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
56790530|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790531|NCT04037657|Propofol|propofol|mesh-list
56790532|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56790533|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790534|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790535|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56790536|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
56790537|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
56790565|NCT04017845|Diltiazem|diltiazem|mesh-list
56790566|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
56790567|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
56790568|NCT04017845|Bisacodyl|bisacodyl|mesh-list
56790569|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
56790570|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
56501527|NCT04596488|Efavirenz|efavirenz|mesh-list
56790571|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790572|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790573|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
56790574|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790575|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56790576|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56790577|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56790578|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56790579|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790580|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56790581|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
56790582|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56790613|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790614|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56790615|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56790616|NCT00519896|Growth Substances|growth substances|mesh-ancestor
56790617|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790618|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56790619|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56790620|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790621|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541888|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541889|NCT03796273|Ketoconazole|ketoconazole|mesh-list
56541890|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
56107907|NCT00003577|Methotrexate|methotrexate|mesh-list
56790622|NCT00527618|Valacyclovir|valacyclovir|mesh-list
56790623|NCT00527618|Acyclovir|acyclovir|mesh-list
56790624|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
56790625|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790626|NCT00527072|Infliximab|infliximab|mesh-list
56790627|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
56790628|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56790629|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790630|NCT00519428|Dexetimide|dexetimide|mesh-list
56790631|NCT00519428|Citalopram|citalopram|mesh-list
56790663|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790664|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
56790665|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56790666|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
56790667|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
56790668|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790669|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790670|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56790671|NCT00430989|Analgesics|analgesics|mesh-ancestor
56790672|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
56790673|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790674|NCT00518882|Liraglutide|liraglutide|mesh-list
56790675|NCT00518882|Exenatide|exenatide|mesh-list
56790709|NCT00430677|Abatacept|abatacept|mesh-list
56790710|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790711|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
56790712|NCT00430677|Hormones|hormones|mesh-ancestor
56790713|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56790714|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790715|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56790716|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790717|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56790718|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56790719|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
56790754|NCT03656666|Apremilast|apremilast|mesh-list
56790755|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56790756|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56790757|NCT03656666|Analgesics|analgesics|mesh-ancestor
56790758|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
56790759|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790760|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790783|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56790784|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
56790785|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790786|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790787|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790788|NCT01036035|Urological Agents|urological agents|mesh-ancestor
56790789|NCT01036035|Miotics|miotics|mesh-ancestor
56790790|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
56790791|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790792|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56790793|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56790794|NCT01036659|Ecallantide|ecallantide|mesh-list
56790795|NCT01036659|Bradykinin|bradykinin|mesh-list
56790796|NCT01036659|Kallikreins|kallikreins|mesh-list
56790797|NCT01036659|Kininogens|kininogens|mesh-list
56790798|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
56790799|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56790801|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790802|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790803|NCT01036659|Analgesics|analgesics|mesh-ancestor
56790804|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
56790805|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790806|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790807|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56790808|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56790809|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790810|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790811|NCT01036659|Coagulants|coagulants|mesh-ancestor
56790845|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56541891|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108049|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
56790846|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56790847|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56790848|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56790849|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56790850|NCT00346216|Ibuprofen|ibuprofen|mesh-list
56790851|NCT00346216|Celecoxib|celecoxib|mesh-list
56790852|NCT00346216|Naproxen|naproxen|mesh-list
56790853|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56790854|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56790855|NCT00346216|Analgesics|analgesics|mesh-ancestor
56790887|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790889|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790890|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56790891|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56790892|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56790893|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56790925|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56790926|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790927|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790928|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56790929|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56790930|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56790931|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
56790932|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56790933|NCT01036893|Prucalopride|prucalopride|mesh-list
56790934|NCT01036893|Laxatives|laxatives|mesh-ancestor
56790935|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56790936|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56790937|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56790938|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
56790957|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56790958|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56790959|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56790960|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
56790961|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790962|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790963|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56790964|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
56790965|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56790966|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
56790967|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
56790968|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56790969|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56790970|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790971|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790972|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790973|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790974|NCT03989830|Endostatins|endostatins|mesh-list
56790975|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56790976|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56790977|NCT03989830|Growth Substances|growth substances|mesh-ancestor
56790978|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790979|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
56790980|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790981|NCT02533648|Allopurinol|allopurinol|mesh-list
56790982|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
56790983|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790984|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790985|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
56790986|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790987|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56790988|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
56790989|NCT02533648|Protective Agents|protective agents|mesh-ancestor
56790990|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790991|NCT02533492|Triclosan|triclosan|mesh-list
56790992|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56790993|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790994|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56790995|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56790996|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
56791053|NCT01057264|Immunologic Factors|immunologic factors|mesh-ancestor
56541892|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56541893|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56541894|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541895|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541896|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56541897|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
56541898|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56541899|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392802|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541900|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56791054|NCT03991312|Itraconazole|itraconazole|mesh-list
56791055|NCT03991312|Rifampin|rifampin|mesh-list
56791056|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
56791057|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791058|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56791059|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56791060|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791061|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791062|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56791063|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
56791064|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791065|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791066|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56791067|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56791068|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
56791069|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56791070|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
56791071|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56791072|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56791073|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56791074|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56791075|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56791076|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56791077|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56791078|NCT01057342|Paclitaxel|paclitaxel|mesh-list
56791079|NCT01057342|Carboplatin|carboplatin|mesh-list
56791080|NCT01057342|Vadimezan|vadimezan|mesh-list
56791081|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791082|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791083|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
56791084|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
56791085|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
56791086|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791114|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791115|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791116|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56791117|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56791118|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56791119|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56791120|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791121|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791122|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
56791123|NCT03742258|Hormones|hormones|mesh-ancestor
56791124|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791125|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56791126|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791127|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
56791128|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
56791129|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
56541901|NCT00612157|Eszopiclone|eszopiclone|mesh-list
56541902|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56541903|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541904|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541906|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56541907|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56541908|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541909|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541910|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56541911|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
56791130|NCT00354172|Cyclosporine|cyclosporine|mesh-list
56791131|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
56791132|NCT00354172|Aldesleukin|aldesleukin|mesh-list
56791133|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
56791134|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56791135|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56791136|NCT00354172|Prednisolone|prednisolone|mesh-list
56791137|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
56791174|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791175|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56791176|NCT00354172|Protective Agents|protective agents|mesh-ancestor
56791245|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791246|NCT00512096|Paclitaxel|paclitaxel|mesh-list
56791247|NCT00512096|Cisplatin|cisplatin|mesh-list
56791248|NCT00512096|Ifosfamide|ifosfamide|mesh-list
56791249|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791250|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502188|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
56791251|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
56791252|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
56791253|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
56791254|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063639|NCT04867135|Amikacin|amikacin|mesh-list
56791279|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791280|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791281|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56791282|NCT00523718|Protective Agents|protective agents|mesh-ancestor
56791283|NCT00523640|Gemcitabine|gemcitabine|mesh-list
56791284|NCT00523640|Bevacizumab|bevacizumab|mesh-list
56791285|NCT00523640|Capecitabine|capecitabine|mesh-list
56791286|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56791287|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791288|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56791289|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56791290|NCT00523640|Growth Substances|growth substances|mesh-ancestor
56791291|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791292|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
56791293|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56791294|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
56791295|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791296|NCT00523640|Antiviral Agents|antiviral agents|mesh-ancestor
56791297|NCT00523640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791298|NCT00523640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791299|NCT00523640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791300|NCT00523640|Immunologic Factors|immunologic factors|mesh-ancestor
56791301|NCT03457142|Dexamethasone|dexamethasone|mesh-list
56791302|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
56791303|NCT03457142|Abatacept|abatacept|mesh-list
56791304|NCT03457142|Ixazomib|ixazomib|mesh-list
56791305|NCT03457142|Ichthammol|ichthammol|mesh-list
56791326|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56791327|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
56791328|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791329|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56791330|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
56791331|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541912|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
56541913|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541914|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541915|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
56541916|NCT01025817|Everolimus|everolimus|mesh-list
56541917|NCT01025817|Tacrolimus|tacrolimus|mesh-list
56541918|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56541919|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
56541920|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541921|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56541922|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541923|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541924|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541925|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56541926|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56541927|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
56541928|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56541929|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541930|NCT00636883|Gemcitabine|gemcitabine|mesh-list
56541931|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
56791332|NCT00516074|Exenatide|exenatide|mesh-list
56791333|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56791334|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791335|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56791336|NCT00516074|Incretins|incretins|mesh-ancestor
56791337|NCT00516074|Hormones|hormones|mesh-ancestor
56791338|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791339|NCT01057654|Pravastatin|pravastatin|mesh-list
56791340|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56791341|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56791342|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
56791343|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791344|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56791345|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56791346|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791347|NCT00515294|Caffeine|caffeine|mesh-list
56791348|NCT00515294|Methamphetamine|methamphetamine|mesh-list
56791349|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56791350|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791351|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56791352|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791353|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791354|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56791355|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56791356|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
56791357|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063748|NCT01754389|Sirolimus|sirolimus|mesh-list
56791395|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791434|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791435|NCT01033305|Cyclosporine|cyclosporine|mesh-list
56791436|NCT01033305|Cyclosporins|cyclosporins|mesh-list
56791437|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791464|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56791465|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56541932|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56541933|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
56108541|NCT00004039|Interferons|interferons|mesh-list
56791466|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56791468|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56791469|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56791470|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791471|NCT01033461|Calcium|calcium|mesh-list
56791472|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56791473|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791474|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
56791475|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56791476|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56502407|NCT04591743|Nicotine|nicotine|mesh-list
56791477|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791478|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
56791479|NCT00416715|Vitamin D|vitamin d|mesh-list
56791480|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
56791481|NCT00416715|Letrozole|letrozole|mesh-list
56791482|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
56791483|NCT00416715|Citric Acid|citric acid|mesh-list
56791484|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
56791485|NCT00416715|Calcium|calcium|mesh-list
56791516|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791518|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
56791519|NCT00514514|Everolimus|everolimus|mesh-list
56791520|NCT00514514|Cyclosporins|cyclosporins|mesh-list
56791521|NCT00514514|Basiliximab|basiliximab|mesh-list
56791522|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791523|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791524|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791525|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
56791526|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791527|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
56791528|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791529|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
56791530|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791559|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
56791560|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56791561|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
56791562|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791563|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791564|NCT03336216|Leucovorin|leucovorin|mesh-list
56791565|NCT03336216|Gemcitabine|gemcitabine|mesh-list
56791566|NCT03336216|Paclitaxel|paclitaxel|mesh-list
56791567|NCT03336216|Fluorouracil|fluorouracil|mesh-list
56791568|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
56791569|NCT03336216|Nivolumab|nivolumab|mesh-list
56791570|NCT03336216|Irinotecan|irinotecan|mesh-list
56791571|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791572|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791573|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
56791574|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
56791575|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
56791576|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791577|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56791598|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
56791599|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791600|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
56791601|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791602|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
56791603|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791604|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791605|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
56791606|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56791607|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791608|NCT00515112|Testosterone|testosterone|mesh-list
56791609|NCT00515112|Androgens|androgens|mesh-ancestor
56791611|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791612|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791613|NCT03742557|Ketamine|ketamine|mesh-list
56791614|NCT03742557|Analgesics|analgesics|mesh-ancestor
56791615|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
56791616|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791617|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541934|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541935|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541936|NCT00636883|Antiviral Agents|antiviral agents|mesh-ancestor
56541937|NCT00636883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541938|NCT00636883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541939|NCT00636883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56541940|NCT00636883|Immunologic Factors|immunologic factors|mesh-ancestor
56541941|NCT00636883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541942|NCT00605410|Bromides|bromides|mesh-list
56541943|NCT00605410|Ipratropium|ipratropium|mesh-list
56541944|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
56541945|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56541946|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
56541947|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541948|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541949|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56541950|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
56541951|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56541952|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
56541953|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791618|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56791619|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56791620|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
56791621|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
56791622|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56791623|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56791624|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56791625|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791626|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791627|NCT01324089|Resveratrol|resveratrol|mesh-list
56791628|NCT01324089|Piperine|piperine|mesh-list
56791629|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
56791630|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502574|NCT00568568|Hormones|hormones|mesh-list
56791631|NCT01324089|Protective Agents|protective agents|mesh-ancestor
56791632|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791633|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791662|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56791663|NCT00509262|Glipizide|glipizide|mesh-list
56791664|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56791665|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791666|NCT00509262|Incretins|incretins|mesh-ancestor
56791667|NCT00509262|Hormones|hormones|mesh-ancestor
56791668|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791669|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56791670|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
56791671|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791672|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791673|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
56791674|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56791675|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56791676|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791677|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56791678|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56334566|NCT01349595|Bortezomib|bortezomib|mesh-list
56541954|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541955|NCT04300881|Eplerenone|eplerenone|mesh-list
56541956|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56541957|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
56541958|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56541959|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541960|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56541961|NCT04300881|Diuretics|diuretics|mesh-ancestor
56541962|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
56541963|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56541964|NCT03873493|Venetoclax|venetoclax|mesh-list
56541965|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541966|NCT04300309|Lumefantrine|lumefantrine|mesh-list
56541967|NCT04300309|Artemether|artemether|mesh-list
56541968|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
56791679|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56791680|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56791717|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
56791718|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56791719|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791757|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791758|NCT00895505|Warfarin|warfarin|mesh-list
56064140|NCT02041533|Paclitaxel|paclitaxel|mesh-list
56791796|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
56791797|NCT03233724|Decitabine|decitabine|mesh-list
56791798|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
56064169|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791833|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791834|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56791835|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
56791836|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791837|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791868|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791869|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791870|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791871|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
56791872|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791873|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
56791874|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791875|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
56791876|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791877|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56791878|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56791879|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791880|NCT01058902|Aspirin|aspirin|mesh-list
56791881|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56791882|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56791918|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
56791919|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
56791920|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56791921|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
56791952|NCT00891605|Navitoclax|navitoclax|mesh-list
56791953|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791954|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791955|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
56791956|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
56791957|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
56791958|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791959|NCT00893711|Vitamin D|vitamin d|mesh-list
56541969|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56541970|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56541971|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56541972|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
56791960|NCT00893711|Vitamins|vitamins|mesh-ancestor
56791961|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
56791962|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791963|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56791964|NCT00514020|Leucovorin|leucovorin|mesh-list
56791986|NCT03570827|Hormones|hormones|mesh-ancestor
56791987|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791988|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791989|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
56791990|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791991|NCT03570827|Protective Agents|protective agents|mesh-ancestor
56791992|NCT03570827|Vitamins|vitamins|mesh-ancestor
56791993|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
56791994|NCT03570827|Estrogens|estrogens|mesh-ancestor
56791995|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56791996|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791997|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
56791998|NCT03560531|Palbociclib|palbociclib|mesh-list
56791999|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792000|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56792001|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792002|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792003|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
56792004|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792005|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792006|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56792007|NCT00896285|Analgesics|analgesics|mesh-list
56792008|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
56792009|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
56792010|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792011|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792013|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792014|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792015|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56792016|NCT00896285|Narcotics|narcotics|mesh-ancestor
56792017|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792018|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
56792019|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56792020|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792021|NCT00891761|Dexamethasone|dexamethasone|mesh-list
56792022|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
56792056|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792057|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792058|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56792059|NCT01012830|Protective Agents|protective agents|mesh-ancestor
56792060|NCT00513474|Cyclosporine|cyclosporine|mesh-list
56792061|NCT00513474|Sirolimus|sirolimus|mesh-list
56792062|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
56792063|NCT00513474|Busulfan|busulfan|mesh-list
56792064|NCT00513474|Methotrexate|methotrexate|mesh-list
56792065|NCT00513474|Fludarabine|fludarabine|mesh-list
56792100|NCT00513474|Protective Agents|protective agents|mesh-ancestor
56792101|NCT01010958|Valproic Acid|valproic acid|mesh-list
56792102|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
56792103|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792104|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792105|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
56064476|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792142|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56792143|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56792175|NCT00892073|Diazoxide|diazoxide|mesh-list
56792176|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56792177|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792178|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56792179|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
56792180|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
56792181|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56792182|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56792183|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792184|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541973|NCT00611689|Vatalanib|vatalanib|mesh-list
56541974|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56541975|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56541976|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634301|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56541977|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541978|NCT05264077|Midazolam|midazolam|mesh-list
56541979|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
56541980|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56541981|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56541982|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541983|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56541984|NCT05264077|Analgesics|analgesics|mesh-ancestor
56541985|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
56541986|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56541987|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56541988|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56196189|NCT01502046|Hormones|hormones|mesh-ancestor
56792185|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792186|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
56792187|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56792215|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
56792216|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
56792217|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56792218|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792219|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56792220|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56792221|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792222|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792223|NCT00892229|Misoprostol|misoprostol|mesh-list
56792224|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56792225|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
56792226|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56792227|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792228|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56792229|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56792230|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
56792231|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56792232|NCT00897221|Deferiprone|deferiprone|mesh-list
56792233|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56792234|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
56792266|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792267|NCT00337168|Cytarabine|cytarabine|mesh-list
56792268|NCT00337168|Clofarabine|clofarabine|mesh-list
56792269|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56792270|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
56792271|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792272|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792273|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
56792274|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56792275|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56792301|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792302|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
56792303|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
56792304|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792305|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56541989|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56541990|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
56541991|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56541992|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56541993|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56196204|NCT01502267|Rituximab|rituximab|mesh-list
56792306|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792307|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
56792308|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56792309|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792310|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792311|NCT03063762|Bevacizumab|bevacizumab|mesh-list
56792312|NCT03063762|Atezolizumab|atezolizumab|mesh-list
56792313|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792314|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792315|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56792316|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56792317|NCT03063762|Growth Substances|growth substances|mesh-ancestor
56792318|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792319|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
56792320|NCT05278637|Aspirin|aspirin|mesh-list
56792321|NCT05278637|Ticagrelor|ticagrelor|mesh-list
56792322|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56064689|NCT02533505|Budesonide|budesonide|mesh-list
56792357|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56792358|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56792359|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56792360|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792361|NCT02539745|Vitamin D|vitamin d|mesh-list
56792362|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56792363|NCT02539745|Vitamins|vitamins|mesh-ancestor
56792390|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
56792391|NCT00901745|Giapreza|giapreza|mesh-list
56792392|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
56792393|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56792394|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56792395|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
56792396|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792397|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792398|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792399|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
56792400|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
56792401|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792402|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56792403|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56792404|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
56792405|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792406|NCT02540837|Bupivacaine|bupivacaine|mesh-list
56792407|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
56792408|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
56792409|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792410|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792411|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
56792412|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792413|NCT00901823|Diazoxide|diazoxide|mesh-list
56792437|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792439|NCT02540369|Aflibercept|aflibercept|mesh-list
56792440|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56792441|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56792442|NCT02540369|Growth Substances|growth substances|mesh-ancestor
56792443|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792444|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
56792445|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792446|NCT00605267|Tamoxifen|tamoxifen|mesh-list
56792447|NCT00605267|Goserelin|goserelin|mesh-list
56792448|NCT00605267|Anastrozole|anastrozole|mesh-list
56792449|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56792450|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
56792451|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792452|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56541994|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56541995|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56541996|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56541997|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56541998|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
56541999|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
56542000|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
56542001|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
56542002|NCT00612859|Levetiracetam|levetiracetam|mesh-list
56542003|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
56109507|NCT00004873|Epirubicin|epirubicin|mesh-list
56792453|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56792454|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792455|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56792456|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56792457|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56792458|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56792459|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56792460|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792461|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792462|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56792463|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
56792464|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792465|NCT00902603|Iloprost|iloprost|mesh-list
56792466|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56792498|NCT00605813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56792499|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56792500|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792501|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792502|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792503|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
56792504|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792505|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
56792506|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
56792507|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56792508|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56792509|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792533|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792534|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792535|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56792536|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
56792537|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
56792538|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
56792539|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503506|NCT00197106|Xhance|xhance|mesh-list
56792540|NCT04034771|Protective Agents|protective agents|mesh-ancestor
56792541|NCT00899483|Insulin|insulin|mesh-list
56792542|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56792543|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792544|NCT02539199|Misoprostol|misoprostol|mesh-list
56792545|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56792546|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
56792547|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56792548|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792549|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56792550|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56792551|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
56792552|NCT00903227|Fluticasone|fluticasone|mesh-list
56792554|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792555|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56792556|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
56792557|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792558|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792559|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56792560|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
56792561|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
56542004|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
56542005|NCT03872401|Evolocumab|evolocumab|mesh-list
56542006|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56542007|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56542008|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
56542009|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196217|NCT01502280|Vitamins|vitamins|mesh-ancestor
56792562|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56792582|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56792583|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56792584|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
56792585|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
56792586|NCT02539979|Acetaminophen|acetaminophen|mesh-list
56792587|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56792588|NCT02539979|Analgesics|analgesics|mesh-ancestor
56792589|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
56792590|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792591|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792592|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
56792593|NCT05277701|Lazertinib|lazertinib|mesh-list
56792594|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56792595|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792596|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792597|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
56792598|NCT00605345|Hematinics|hematinics|mesh-ancestor
56792599|NCT00903851|Lidocaine|lidocaine|mesh-list
56792600|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
56792601|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
56792602|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792603|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792604|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
56792605|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792606|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56792607|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56792608|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56792609|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792610|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792611|NCT00900887|Ketorolac|ketorolac|mesh-list
56792612|NCT00900887|Nepafenac|nepafenac|mesh-list
56792613|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56792614|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56792615|NCT00900887|Analgesics|analgesics|mesh-ancestor
56792616|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
56792617|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792618|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792619|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792650|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
56792651|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
56792652|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792653|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792654|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
56792655|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792656|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56792657|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56792658|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56792659|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792660|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792661|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56792684|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792685|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56792686|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
56792687|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
56792688|NCT00904631|Salicylates|salicylates|mesh-list
56792689|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56792690|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
56792691|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
56792692|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
56792693|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56542010|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56542011|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
56542012|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
56542013|NCT01010217|Melphalan|melphalan|mesh-list
56542014|NCT01010217|Thiotepa|thiotepa|mesh-list
56542015|NCT01010217|Rituximab|rituximab|mesh-list
56542016|NCT01010217|Fludarabine|fludarabine|mesh-list
56542017|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
56542018|NCT01010217|Tacrolimus|tacrolimus|mesh-list
56542019|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542020|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
56542021|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542022|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792694|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56792695|NCT00904631|Analgesics|analgesics|mesh-ancestor
56792696|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
56792697|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792698|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792699|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792700|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792701|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56792702|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792703|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792704|NCT00909077|Dexamethasone|dexamethasone|mesh-list
56792705|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
56792707|NCT00909077|BB 1101|bb 1101|mesh-list
56792708|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792709|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792710|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
56792711|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792712|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792713|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792742|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792744|NCT01057966|Vitamins|vitamins|mesh-list
56792745|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
56792746|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792747|NCT00603941|Paclitaxel|paclitaxel|mesh-list
56792748|NCT00603941|Efatutazone|efatutazone|mesh-list
56792749|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56792750|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792751|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
56792752|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
56792753|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
56792754|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792755|NCT00340678|Losartan|losartan|mesh-list
56792756|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56792757|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56792758|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56792791|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792792|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792793|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56792794|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56792795|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
56792796|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56792797|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56065161|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
56792831|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
56792832|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792833|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56792834|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56792835|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56065203|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
56792864|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56792865|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473663|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
56542023|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56542024|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
56542025|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542026|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542027|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56542028|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542029|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56542030|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
56542031|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542032|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56542033|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542034|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56542035|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56542036|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
56542037|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56542038|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
56542039|NCT04558359|Giapreza|giapreza|mesh-list
56542040|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
56542041|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56542042|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56542043|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
56542044|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542045|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542046|NCT00604006|Spironolactone|spironolactone|mesh-list
56542047|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56542048|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
56792866|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792867|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56792868|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
56792869|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792870|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792871|NCT00905723|Estradiol|estradiol|mesh-list
56792872|NCT00905723|Estrogens|estrogens|mesh-ancestor
56792873|NCT00905723|Hormones|hormones|mesh-ancestor
56792874|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792875|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792876|NCT00907985|Lamotrigine|lamotrigine|mesh-list
56792877|NCT00907985|Vofopitant|vofopitant|mesh-list
56792878|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
56065248|NCT02508077|Vitamins|vitamins|mesh-ancestor
56792906|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792907|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792908|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56792909|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56792910|NCT00908219|Growth Substances|growth substances|mesh-ancestor
56792911|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792912|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
56542049|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542050|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542051|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56542053|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
56542054|NCT00604084|Ivermectin|ivermectin|mesh-list
56542055|NCT00604084|Permethrin|permethrin|mesh-list
56542056|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56542058|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542059|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542060|NCT05379478|Antibodies|antibodies|mesh-list
56542061|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
56542062|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542063|NCT04267042|Budesonide|budesonide|mesh-list
56542064|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542065|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56542066|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
56792913|NCT00908297|Ubiquinone|ubiquinone|mesh-list
56792914|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
56792915|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
56792916|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792917|NCT00908297|Vitamins|vitamins|mesh-ancestor
56792918|NCT00927407|Malathion|malathion|mesh-list
56792919|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56792920|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792921|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792922|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
56792923|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792924|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792949|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56792950|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792951|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
56792952|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792953|NCT00338962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56792954|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56792955|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792956|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792957|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792958|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
56792959|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56792960|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
56792961|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792962|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56792963|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56792964|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792965|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56792966|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56792967|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
56792968|NCT00931775|Pindolol|pindolol|mesh-list
56792969|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56792970|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56792971|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
56792972|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792973|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792974|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792975|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56793006|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56793007|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887139|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56542067|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542068|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542069|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56542070|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
56542071|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
56542072|NCT04267042|Hormones|hormones|mesh-ancestor
56542073|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542074|NCT01013961|Rituximab|rituximab|mesh-list
56542075|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
56542076|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542077|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542078|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
56542079|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542080|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56542081|NCT01217957|Dexamethasone|dexamethasone|mesh-list
56542082|NCT01217957|Lenalidomide|lenalidomide|mesh-list
56542083|NCT01217957|Ixazomib|ixazomib|mesh-list
56542084|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542085|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
56542086|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
56793008|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56793009|NCT03547427|Analgesics|analgesics|mesh-ancestor
56793010|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
56793011|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793012|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
56793013|NCT00338884|Sunitinib|sunitinib|mesh-list
56793014|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793015|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56793016|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56793017|NCT00338884|Growth Substances|growth substances|mesh-ancestor
56793018|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793019|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
56793020|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56793021|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793049|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
56793050|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793051|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793052|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56793054|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56793055|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
56793056|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793057|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793058|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56793059|NCT01059136|Diuretics|diuretics|mesh-ancestor
56793060|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
56793062|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56793063|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793064|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793065|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
56793066|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793067|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793098|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
56793099|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56793100|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887140|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56542087|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542088|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542089|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56542090|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
56542091|NCT01217957|Hormones|hormones|mesh-ancestor
56542092|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542093|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56542094|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542095|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
56542096|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56542097|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56542098|NCT01217957|Growth Substances|growth substances|mesh-ancestor
56542099|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
56542100|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
56542101|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196294|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
56793101|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793102|NCT00928655|Diuretics|diuretics|mesh-ancestor
56793103|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
56793104|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793105|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56793106|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
56793107|NCT00504582|Coagulants|coagulants|mesh-ancestor
56793109|NCT01011426|Cathartics|cathartics|mesh-ancestor
56793110|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56793111|NCT01011426|Laxatives|laxatives|mesh-ancestor
56793112|NCT00932555|Factor VIII|factor viii|mesh-list
56793113|NCT00932555|Coagulants|coagulants|mesh-ancestor
56793114|NCT04722575|Atezolizumab|atezolizumab|mesh-list
56793115|NCT04722575|Vemurafenib|vemurafenib|mesh-list
56065541|NCT00555061|Retapamulin|retapamulin|mesh-list
56793180|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793181|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793183|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
56793184|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793185|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793186|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56793187|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56793188|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
56793189|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793190|NCT00929279|Abciximab|abciximab|mesh-list
56793191|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
56793192|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56793193|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
56793194|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56793195|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065583|NCT05249153|Dsuvia|dsuvia|mesh-list
56793226|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793227|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
56793228|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
56793229|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56793230|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793231|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793232|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
56793233|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56793234|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56793235|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793237|NCT00492726|Ertapenem|ertapenem|mesh-list
56793238|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56793305|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542102|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542103|NCT01217801|Ondansetron|ondansetron|mesh-list
56542104|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
56793306|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
56793307|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56793308|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56793309|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
56793310|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56793311|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56793312|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793313|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56793314|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56065768|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793416|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56793417|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
56793418|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793419|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793420|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56793421|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56793422|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
56793423|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
56793424|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793425|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56793426|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
56793427|NCT00934739|Hormones|hormones|mesh-ancestor
56793428|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065805|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56793463|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
56793464|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793465|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
56793466|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56793467|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793468|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
56793469|NCT00934817|Metformin|metformin|mesh-list
56793470|NCT00934817|Glimepiride|glimepiride|mesh-list
56793471|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56793498|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
56793499|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56793500|NCT01013532|Protective Agents|protective agents|mesh-ancestor
56793501|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56793502|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56793503|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56793504|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56793505|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
56793506|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56793507|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
56793508|NCT00934895|Paclitaxel|paclitaxel|mesh-list
56793509|NCT00934895|Everolimus|everolimus|mesh-list
56793510|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56793511|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56793512|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793513|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
56793514|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
56793515|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
56793516|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793517|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793518|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
56793519|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793520|NCT00926705|Fentanyl|fentanyl|mesh-list
56793521|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
56793555|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56793556|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56793557|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793558|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
56793559|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56793560|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793561|NCT01018836|Riluzole|riluzole|mesh-list
56793562|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
56793563|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56793595|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
56793596|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793598|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
56542105|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
56542106|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542107|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542108|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56542109|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
56542110|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
56542111|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56542112|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
56542113|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542114|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542115|NCT01217801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56542116|NCT01217801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56542117|NCT01217801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542118|NCT01217801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56542119|NCT01217801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56542120|NCT00935818|Bupropion|bupropion|mesh-list
56542121|NCT00935818|Varenicline|varenicline|mesh-list
56542122|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56542123|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
56793599|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
56793600|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56793601|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793602|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
56065977|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56793634|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56793635|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
56793636|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
56793637|NCT00930839|Vitamins|vitamins|mesh-ancestor
56793638|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
56793639|NCT01015794|Ephedrine|ephedrine|mesh-list
56793640|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
56793641|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56793642|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793643|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
56793644|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
56793645|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793646|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56793647|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
56793648|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793671|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
56793672|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56793673|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56793674|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56793675|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
56793676|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793677|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793678|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56793679|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56793680|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56793682|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56793683|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56793684|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56793685|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793686|NCT00931073|Ketoconazole|ketoconazole|mesh-list
56542124|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56542125|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56542126|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56542127|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393024|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56793688|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56793689|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56793690|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56793691|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793692|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793693|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
56793694|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793695|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56793696|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56793716|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793717|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793718|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56793719|NCT00936689|Estrogens|estrogens|mesh-ancestor
56793720|NCT00936689|Hormones|hormones|mesh-ancestor
56793721|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793722|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793723|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56793724|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
56793725|NCT01018914|Tacrolimus|tacrolimus|mesh-list
56793726|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793727|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
56793728|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793729|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56793730|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793731|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793732|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56793733|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793734|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56793735|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
56793760|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56793761|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56793762|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793764|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56793765|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
56793766|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793767|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793768|NCT01019382|Antiviral Agents|antiviral agents|mesh-ancestor
56793769|NCT01019382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793770|NCT01019382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793771|NCT01019382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793772|NCT01019382|Immunologic Factors|immunologic factors|mesh-ancestor
56793773|NCT01019382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793774|NCT00935675|Citalopram|citalopram|mesh-list
56793775|NCT00935675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56793776|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56793777|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56793778|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793779|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793780|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
56793781|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793782|NCT00935675|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56793783|NCT00935675|Antidepressive Agents|antidepressive agents|mesh-ancestor
56793784|NCT00935675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56793785|NCT01016184|Vitamin D|vitamin d|mesh-list
56793786|NCT01016184|Vitamins|vitamins|mesh-ancestor
56793787|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
56793788|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793820|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56793821|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
56793822|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793823|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
56542138|NCT02709265|Amikacin|amikacin|mesh-list
56542205|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56542207|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
56542208|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
56542209|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542210|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542211|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
56542212|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542213|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
56542214|NCT05244031|Narcotics|narcotics|mesh-ancestor
56542215|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542216|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793825|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
56793826|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56793827|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56793828|NCT00937079|Exenatide|exenatide|mesh-list
56793829|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56793830|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793831|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56793852|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
56793853|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56793854|NCT00937625|Analgesics|analgesics|mesh-ancestor
56793855|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
56793856|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793857|NCT04014101|Apatinib|apatinib|mesh-list
56793858|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793859|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56793860|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793861|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793862|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56793863|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56793864|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56793865|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56793866|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793867|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793868|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793869|NCT00071708|Analgesics|analgesics|mesh-ancestor
56793870|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
56793871|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793872|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
56793873|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56793874|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
56793875|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56793876|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56793877|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
56793878|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56793879|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56793880|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793881|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
56793882|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793883|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793884|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56793908|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56793909|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793910|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56793911|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
56793912|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56793913|NCT00938171|Anesthetics|anesthetics|mesh-list
56793914|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56793915|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793916|NCT05280275|Dexamethasone|dexamethasone|mesh-list
56793917|NCT05280275|Lenalidomide|lenalidomide|mesh-list
56793918|NCT05280275|Daratumumab|daratumumab|mesh-list
56542217|NCT05244031|Analgesics|analgesics|mesh-ancestor
56542218|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
56542219|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542220|NCT04712071|Ketamine|ketamine|mesh-list
56542221|NCT04712071|Analgesics|analgesics|mesh-ancestor
56542222|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
56542223|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542224|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542225|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56542226|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56542227|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
56542228|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
56542229|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542230|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56542231|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56542232|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542233|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793919|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56793920|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
56793921|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
56793922|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793923|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793924|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56793925|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
56793926|NCT05280275|Hormones|hormones|mesh-ancestor
56793927|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793928|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56793929|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793930|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
56793931|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56793932|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56793933|NCT05280275|Growth Substances|growth substances|mesh-ancestor
56793934|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
56793935|NCT00939497|Risperidone|risperidone|mesh-list
56793936|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56793937|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
56793971|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793972|NCT03972137|Nicotine|nicotine|mesh-list
56793973|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56793974|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
56793975|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794000|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794001|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56794002|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56794003|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
56794004|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56794005|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56794006|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
56794007|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
56794008|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794009|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794010|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794011|NCT04013477|Donepezil|donepezil|mesh-list
56794012|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56794013|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794014|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542234|NCT05151328|Plecanatide|plecanatide|mesh-list
56542235|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56542236|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
56542237|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542238|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56542239|NCT00609388|Tacrolimus|tacrolimus|mesh-list
56542240|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542241|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
56542242|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542243|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56542244|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542245|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542246|NCT02709031|Cicletanine|cicletanine|mesh-list
56542247|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56542248|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56542249|NCT02709031|Diuretics|diuretics|mesh-ancestor
56794015|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
56794016|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794017|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794018|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
56794019|NCT00940667|Losartan|losartan|mesh-list
56794020|NCT00940667|Amlodipine|amlodipine|mesh-list
56794021|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56794022|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56794023|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56794024|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794053|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794054|NCT00511004|Filaricides|filaricides|mesh-ancestor
56794055|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
56794056|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56794057|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794058|NCT02550197|Vaccines|vaccines|mesh-list
56794059|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
56794060|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794061|NCT00939965|Isotretinoin|isotretinoin|mesh-list
56794062|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
56794063|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56794064|NCT02877134|Ustekinumab|ustekinumab|mesh-list
56794065|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
56794066|NCT00563381|Bromides|bromides|mesh-list
56794067|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
56794068|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56794069|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56794070|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
56794071|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794072|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794073|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56066437|NCT05688215|Folic Acid|folic acid|mesh-list
56794103|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794104|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794105|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794106|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56794107|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56794108|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
56794109|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
56794110|NCT00941057|Dienogest|dienogest|mesh-list
56794111|NCT00941057|Calcium|calcium|mesh-list
56794112|NCT00941057|Nandrolone|nandrolone|mesh-list
56794113|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56794114|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794115|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56542250|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
56542251|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542252|NCT05225545|Iron|iron|mesh-list
56542253|NCT05225545|Trace Elements|trace elements|mesh-ancestor
56542254|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
56542255|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542256|NCT05378932|Melatonin|melatonin|mesh-list
56542257|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
56542258|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542259|NCT05378932|Protective Agents|protective agents|mesh-ancestor
56542260|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542261|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542262|NCT05222971|Durvalumab|durvalumab|mesh-list
56542263|NCT05222971|Olaparib|olaparib|mesh-list
56542264|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542265|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542266|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56542267|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542268|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542269|NCT00612547|Artesunate|artesunate|mesh-list
56542270|NCT00612547|Amodiaquine|amodiaquine|mesh-list
56542271|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
56794116|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56794117|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
56794149|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56794150|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56794152|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56794153|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
56794154|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794155|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794156|NCT03684044|Baloxavir|baloxavir|mesh-list
56794157|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
56794158|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794159|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794224|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794225|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56794226|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
56794227|NCT00335140|Hormones|hormones|mesh-ancestor
56794228|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794229|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794230|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
56794231|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794232|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794233|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56794234|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
56794235|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56794236|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56794237|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
56794238|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
56794239|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56794240|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794241|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56794242|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
56542272|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56794243|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794244|NCT00335140|Antidotes|antidotes|mesh-ancestor
56794245|NCT00335140|Protective Agents|protective agents|mesh-ancestor
56794246|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
56794247|NCT00335140|Vitamins|vitamins|mesh-ancestor
56794280|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56794282|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794283|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794284|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794285|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
56794286|NCT00309244|Insulin|insulin|mesh-list
56794287|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56794288|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
56794289|NCT00309244|Protamines|protamines|mesh-list
56794290|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56794291|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794324|NCT01063816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794325|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56794326|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
56794327|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
56794328|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56794329|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
56794330|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794331|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794332|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56794333|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
56794334|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
56794335|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56794399|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794400|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56794402|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56794403|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56794404|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
56794405|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
56794406|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
56794407|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56794409|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794410|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
56794411|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56794412|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56794413|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794414|NCT01014156|Epoprostenol|epoprostenol|mesh-list
56794415|NCT01014156|Tezosentan|tezosentan|mesh-list
56794416|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56794417|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56794418|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
56794419|NCT00322348|Goserelin|goserelin|mesh-list
56794420|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794457|NCT00308620|Filaricides|filaricides|mesh-ancestor
56794458|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
56794459|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
56794460|NCT00492752|Sorafenib|sorafenib|mesh-list
56794461|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794481|NCT02532790|Hormones|hormones|mesh-ancestor
56794482|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505409|NCT03452306|Metformin|metformin|mesh-list
56794483|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794484|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794485|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794486|NCT00505778|Mesalamine|mesalamine|mesh-list
56794487|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56794488|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56794489|NCT00505778|Analgesics|analgesics|mesh-ancestor
56794490|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
56794491|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794492|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794493|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794494|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794495|NCT00308074|Aripiprazole|aripiprazole|mesh-list
56794496|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
56794497|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56794498|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56794499|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56794500|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542273|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56542274|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542275|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111232|NCT02019420|Linezolid|linezolid|mesh-list
56794501|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794502|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
56794503|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
56794504|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794505|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794506|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56066878|NCT05588297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56794565|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794566|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56794567|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56794568|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56794569|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794571|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794572|NCT00489918|Teriparatide|teriparatide|mesh-list
56794573|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56794574|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794575|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56794576|NCT01061788|Everolimus|everolimus|mesh-list
56794577|NCT01061788|Panitumumab|panitumumab|mesh-list
56794578|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794579|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794580|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
56794581|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794582|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794583|NCT00307294|Thalidomide|thalidomide|mesh-list
56794584|NCT00307294|Doxorubicin|doxorubicin|mesh-list
56794585|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56794586|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794587|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56794588|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56794589|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066953|NCT03559049|Carboplatin|carboplatin|mesh-list
56794616|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56794617|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56794618|NCT04410965|Analgesics|analgesics|mesh-ancestor
56794619|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
56794620|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794621|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794622|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794623|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794624|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794625|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
56794626|NCT04012775|Insulin|insulin|mesh-list
56794627|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56794628|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56794629|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794630|NCT00944723|Vitamins|vitamins|mesh-list
56794631|NCT00944723|Zinc|zinc|mesh-list
56794632|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
56794634|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
56794635|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794636|NCT00944723|Trace Elements|trace elements|mesh-ancestor
56794637|NCT00944723|Astringents|astringents|mesh-ancestor
56794638|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
56794639|NCT00944801|Doxorubicin|doxorubicin|mesh-list
56794668|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794669|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794670|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
56794671|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794672|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794673|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794674|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
56794675|NCT00306670|Hormones|hormones|mesh-ancestor
56794676|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794677|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794678|NCT00306592|Natalizumab|natalizumab|mesh-list
56794679|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
56794680|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542276|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
56542277|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
56196470|NCT01503671|Atorvastatin|atorvastatin|mesh-list
56794681|NCT00321646|Bevacizumab|bevacizumab|mesh-list
56794682|NCT00321646|Docetaxel|docetaxel|mesh-list
56794683|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794684|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794685|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56794686|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56794721|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56794722|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
56794724|NCT01013012|Ramosetron|ramosetron|mesh-list
56794725|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794726|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
56794727|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
56794728|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794755|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56794756|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56794757|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56794758|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794759|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794760|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
56794761|NCT01009970|Hormones|hormones|mesh-ancestor
56794762|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794763|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794764|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56794765|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
56794766|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
56794767|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
56794768|NCT01015352|Azacitidine|azacitidine|mesh-list
56794769|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
56794770|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56794771|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
56794772|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794773|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794774|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794775|NCT01015352|Hematinics|hematinics|mesh-ancestor
56794776|NCT05102162|Meropenem|meropenem|mesh-list
56794810|NCT03563157|Protective Agents|protective agents|mesh-ancestor
56794811|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
56794812|NCT03563157|Vitamins|vitamins|mesh-ancestor
56794813|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
56794814|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794815|NCT01010048|Nifedipine|nifedipine|mesh-list
56794816|NCT01010048|Bromides|bromides|mesh-list
56794817|NCT01010048|Propantheline|propantheline|mesh-list
56794818|NCT01010048|Tamsulosin|tamsulosin|mesh-list
56794819|NCT01010048|Progesterone|progesterone|mesh-list
56794820|NCT01010048|Progestins|progestins|mesh-ancestor
56794821|NCT01010048|Hormones|hormones|mesh-ancestor
56067193|NCT05649228|Capsaicin|capsaicin|mesh-list
56794857|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
56794858|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794887|NCT00320788|Growth Substances|growth substances|mesh-ancestor
56794888|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794889|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
56794890|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794891|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
56794892|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
56794893|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
56794894|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56794895|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
56794897|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
56794898|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794899|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
56794900|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56794901|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56794902|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794903|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56794904|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
56794935|NCT03996564|Ketorolac|ketorolac|mesh-list
56794936|NCT03996564|Diclofenac|diclofenac|mesh-list
56794937|NCT03996564|Diazepam|diazepam|mesh-list
56794938|NCT03996564|Hydrocodone|hydrocodone|mesh-list
56794939|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56794940|NCT03996564|Analgesics|analgesics|mesh-ancestor
56794941|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
56794942|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542278|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56542279|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
56542280|NCT00606268|Micafungin|micafungin|mesh-list
56542281|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
56542282|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542283|NCT05342857|Aflibercept|aflibercept|mesh-list
56542284|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56542285|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56542286|NCT05342857|Growth Substances|growth substances|mesh-ancestor
56542287|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542288|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
56542289|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542290|NCT04264624|Erythritol|erythritol|mesh-list
56542291|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
56542292|NCT04188691|Vaccines|vaccines|mesh-list
56542293|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
56542294|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542295|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
56542296|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
56542297|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56542298|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542299|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56542300|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56542301|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542302|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542303|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196472|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56794943|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794944|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
56794945|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56794946|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794947|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794948|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56794949|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794950|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067319|NCT02680301|Hormones|hormones|mesh-ancestor
56794986|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794987|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
56794988|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794989|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56794990|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56794991|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56794992|NCT00565409|Analgesics|analgesics|mesh-ancestor
56794993|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
56795025|NCT02532400|Goserelin|goserelin|mesh-list
56795026|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56795027|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795028|NCT00394095|Topiramate|topiramate|mesh-list
56795029|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
56795030|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56542304|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
56542305|NCT00613093|Temozolomide|temozolomide|mesh-list
56542306|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56542307|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56542308|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
56542309|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542310|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542311|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542312|NCT05278351|Irinotecan|irinotecan|mesh-list
56542313|NCT05278351|Cetuximab|cetuximab|mesh-list
56542314|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56542315|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56542316|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542317|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542318|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542319|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795031|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795032|NCT00503906|Gemcitabine|gemcitabine|mesh-list
56795033|NCT00503906|Paclitaxel|paclitaxel|mesh-list
56795034|NCT00503906|Bevacizumab|bevacizumab|mesh-list
56795035|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56067405|NCT02268864|Simeprevir|simeprevir|mesh-list
56795066|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795068|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56795069|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56795070|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56795071|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
56795072|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795073|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795074|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795075|NCT01060618|Maraviroc|maraviroc|mesh-list
56795076|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56795077|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56795078|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795115|NCT00499746|Hydromorphone|hydromorphone|mesh-list
56795116|NCT00499746|Methylphenidate|methylphenidate|mesh-list
56795117|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56795118|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795119|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56067489|NCT04868838|Daratumumab|daratumumab|mesh-list
56795153|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56795154|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56795155|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56795156|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56795157|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56795158|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56795159|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795160|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795161|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
56795182|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56795184|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795185|NCT00499590|Ranibizumab|ranibizumab|mesh-list
56795186|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795187|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795188|NCT00499590|Growth Substances|growth substances|mesh-ancestor
56795189|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795190|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
56542320|NCT00607750|Mecamylamine|mecamylamine|mesh-list
56542321|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56542322|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56542323|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
56542324|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542325|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542326|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56542327|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56542328|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196514|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
56795191|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795192|NCT00510146|Olanzapine|olanzapine|mesh-list
56795193|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
56795194|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
56795195|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795196|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795197|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56795198|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56795199|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56795200|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56795201|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56795202|NCT00510146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56795203|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56795204|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56795205|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795206|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795207|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
56795208|NCT04250064|Bevacizumab|bevacizumab|mesh-list
56795209|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795210|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067570|NCT02721017|Analgesics|analgesics|mesh-ancestor
56795235|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795237|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56795238|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
56795239|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
56506145|NCT00177164|Olanzapine|olanzapine|mesh-list
56795240|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
56795241|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56795242|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56795243|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56795244|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795246|NCT00393939|Sunitinib|sunitinib|mesh-list
56795247|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795248|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
56795249|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
56795250|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
56795251|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795252|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795253|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795254|NCT00393939|Growth Substances|growth substances|mesh-ancestor
56795255|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795256|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
56795257|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56795258|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795259|NCT00488982|Docetaxel|docetaxel|mesh-list
56795260|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795261|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
56795287|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56795289|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795290|NCT01020396|Metronidazole|metronidazole|mesh-list
56795291|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795292|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56795293|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56795294|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56795295|NCT00488592|Molgramostim|molgramostim|mesh-list
56795296|NCT00488592|Sargramostim|sargramostim|mesh-list
56542329|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542330|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542331|NCT00609544|Rilonacept|rilonacept|mesh-list
56542332|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542333|NCT04908475|Apremilast|apremilast|mesh-list
56542334|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56542335|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56542336|NCT04908475|Analgesics|analgesics|mesh-ancestor
56542337|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
56542338|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795297|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56795298|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
56795299|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795300|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795301|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56795302|NCT00488514|Naproxen|naproxen|mesh-list
56795303|NCT00488514|Sumatriptan|sumatriptan|mesh-list
56795304|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56795305|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56795306|NCT00488514|Analgesics|analgesics|mesh-ancestor
56795307|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
56795308|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795309|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795310|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067674|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
56795334|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56795335|NCT00498186|Rotigotine|rotigotine|mesh-list
56795336|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
56795337|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
56795338|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795339|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795340|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795341|NCT03984526|Atropine|atropine|mesh-list
56795342|NCT03984526|Ephedrine|ephedrine|mesh-list
56795343|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56795344|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56795345|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56795346|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
56795347|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795348|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795349|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56795350|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
56795351|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
56795352|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
56795353|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56795354|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56795355|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
56795356|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795357|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795358|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56795359|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
56795360|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56795361|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56067719|NCT00369395|Volociximab|volociximab|mesh-list
56795377|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795379|NCT00304954|Sirolimus|sirolimus|mesh-list
56795380|NCT00304954|Infliximab|infliximab|mesh-list
56795381|NCT00304954|Daclizumab|daclizumab|mesh-list
56795382|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56795383|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795384|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56795385|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795386|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
56795387|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795388|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
56542339|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542340|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542341|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56542342|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56542343|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56795389|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795390|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
56795391|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56795392|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56795393|NCT00475176|Ribavirin|ribavirin|mesh-list
56795394|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56795395|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
56795396|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795397|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
56795398|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795399|NCT00393705|Insulin|insulin|mesh-list
56795400|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56795401|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
56795402|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56795403|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795404|NCT00303628|Leucovorin|leucovorin|mesh-list
56795405|NCT00303628|Bevacizumab|bevacizumab|mesh-list
56795406|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56795407|NCT00303628|Fluorouracil|fluorouracil|mesh-list
56795408|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
56795409|NCT00303628|Antibodies|antibodies|mesh-list
56795410|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
56795411|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56795412|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
56795413|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795414|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795415|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795416|NCT00303628|Growth Substances|growth substances|mesh-ancestor
56795417|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795418|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
56795419|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
56795453|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795454|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
56795455|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
56795456|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
56795457|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795458|NCT00332488|Insulin|insulin|mesh-list
56795459|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56795460|NCT00332488|Metformin|metformin|mesh-list
56795461|NCT00332488|Secretagogues|secretagogues|mesh-list
56795462|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56795498|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795499|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795501|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
56795530|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56795531|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56795532|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795533|NCT01064752|Minocycline|minocycline|mesh-list
56795534|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56795535|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795536|NCT00392379|Nicotine|nicotine|mesh-list
56795537|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56795538|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
56795539|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795540|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795541|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56795542|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56795543|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
56506453|NCT00476996|Methotrexate|methotrexate|mesh-list
56795544|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795578|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795579|NCT00318370|Farletuzumab|farletuzumab|mesh-list
56795580|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795581|NCT00510068|Everolimus|everolimus|mesh-list
56795582|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795583|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795620|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56795621|NCT00402987|Analgesics|analgesics|mesh-ancestor
56067997|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
56542344|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542345|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542346|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
56542347|NCT03513211|Itraconazole|itraconazole|mesh-list
56542348|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
56542349|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56542350|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56542351|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542352|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542353|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634302|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56542355|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
56542356|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56542357|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56542358|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56290616|NCT05156905|Docetaxel|docetaxel|mesh-list
56542359|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
56795655|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
56795656|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56795657|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56795659|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56795660|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795661|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56795662|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795663|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
56795664|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795696|NCT01017822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795697|NCT01017822|Immunologic Factors|immunologic factors|mesh-ancestor
56795698|NCT01017822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795699|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795700|NCT00496782|Maraviroc|maraviroc|mesh-list
56795701|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56795702|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56795703|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795704|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56795705|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56795706|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
56795743|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56795744|NCT04428372|Diuretics|diuretics|mesh-ancestor
56795745|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
56795746|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795780|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56795781|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56795782|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795783|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795784|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
56795785|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795786|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56795787|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55795398|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
56795858|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795859|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
56795888|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56795889|NCT01016054|Gemcitabine|gemcitabine|mesh-list
56795890|NCT01016054|Carboplatin|carboplatin|mesh-list
56795891|NCT01016054|Doxorubicin|doxorubicin|mesh-list
56795892|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56795893|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542360|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542361|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542362|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56542363|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
56542364|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542365|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542366|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56542367|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56542368|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
56542369|NCT05198791|Eplerenone|eplerenone|mesh-list
56542370|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56542371|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
56542372|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124332|NCT01442064|Ranibizumab|ranibizumab|mesh-list
56795894|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56795895|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
56795896|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795897|NCT01016054|Antiviral Agents|antiviral agents|mesh-ancestor
56795898|NCT01016054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795899|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795900|NCT01016054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795901|NCT01016054|Immunologic Factors|immunologic factors|mesh-ancestor
56795902|NCT01016054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795903|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56795904|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56795905|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56795907|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
56795908|NCT00499694|Bevacizumab|bevacizumab|mesh-list
56795936|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
56795937|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56795938|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56795939|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56795940|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56795942|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795943|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56795944|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795945|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795947|NCT00486330|Tipranavir|tipranavir|mesh-list
56795948|NCT00486330|Buprenorphine|buprenorphine|mesh-list
56795949|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56795950|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56795951|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
56795952|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795953|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795954|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56068322|NCT01491815|Abatacept|abatacept|mesh-list
56795984|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56795985|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56795986|NCT00493974|Analgesics|analgesics|mesh-ancestor
56795987|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
56795988|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795989|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795990|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56795991|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56795992|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56795993|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795994|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542373|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542374|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56542375|NCT05198791|Diuretics|diuretics|mesh-ancestor
56542376|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
56795995|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56795996|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
56795997|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56795998|NCT01018446|Busulfan|busulfan|mesh-list
56068364|NCT04338191|Leucovorin|leucovorin|mesh-list
56796022|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
56796023|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796024|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796025|NCT00469092|Insulin|insulin|mesh-list
56796026|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56796027|NCT00469092|Metformin|metformin|mesh-list
56796028|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
56796029|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
56796030|NCT00469092|Glimepiride|glimepiride|mesh-list
56796031|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
56796032|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56796033|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796034|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56796035|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796036|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
56796037|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
56796038|NCT00499616|Carboplatin|carboplatin|mesh-list
56796039|NCT00499616|Doxorubicin|doxorubicin|mesh-list
56796040|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56796041|NCT00499616|Etoposide|etoposide|mesh-list
56796042|NCT00499616|Topotecan|topotecan|mesh-list
56796043|NCT00499616|Isotretinoin|isotretinoin|mesh-list
56796044|NCT00499616|Lenograstim|lenograstim|mesh-list
56796045|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796046|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
56796047|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796048|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796049|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56796050|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
56796078|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796080|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796081|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796082|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
56796083|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796084|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56796085|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
56796086|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56796087|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56796088|NCT00493038|Amoxicillin|amoxicillin|mesh-list
56796089|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
56796090|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
56796091|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
56796092|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56796093|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56796094|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56796095|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796096|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56796131|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796132|NCT00413283|Antiviral Agents|antiviral agents|mesh-ancestor
56796133|NCT00413283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796134|NCT00413283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796135|NCT00413283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796136|NCT00413283|Immunologic Factors|immunologic factors|mesh-ancestor
56796172|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
56796173|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
56796174|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56796175|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56068542|NCT00370565|Insulin|insulin|mesh-list
56796213|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56796241|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796242|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796243|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56796244|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56542377|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56542378|NCT01010061|Rituximab|rituximab|mesh-list
56542379|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
56542380|NCT01010061|Chlorambucil|chlorambucil|mesh-list
56542381|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542382|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542383|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
56542384|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542385|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56542386|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56542387|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
56542388|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542389|NCT00607984|Melphalan|melphalan|mesh-list
56542390|NCT00607984|Thiotepa|thiotepa|mesh-list
56542391|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56542392|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
56196581|NCT01504126|Propranolol|propranolol|mesh-list
56796245|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56796246|NCT00468546|Methotrexate|methotrexate|mesh-list
56796247|NCT00468546|Rituximab|rituximab|mesh-list
56796248|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56796249|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
56796250|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56796251|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796252|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796253|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
56796254|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796255|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796256|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
56796257|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796258|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56796259|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796296|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796297|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56068665|NCT05005403|Pembrolizumab|pembrolizumab|mesh-list
56796328|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796329|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
56796330|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796331|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796332|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56796333|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
56796334|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796335|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796336|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56796337|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56796338|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56796339|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56796340|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796341|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56796342|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796343|NCT00331006|Rituximab|rituximab|mesh-list
56796344|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56796377|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56796378|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796379|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796380|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
56796381|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542393|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542394|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542395|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56796382|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796383|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
56796384|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796385|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56796417|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
56796418|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
56796419|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796420|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56796421|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
56796422|NCT00466440|Hormones|hormones|mesh-ancestor
56796423|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56796424|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796425|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56796426|NCT00465972|Doxepin|doxepin|mesh-list
56796427|NCT00465972|Temazepam|temazepam|mesh-list
56796428|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56068791|NCT01910311|Rifampin|rifampin|mesh-list
56796446|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56796447|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
56796448|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796449|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796450|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796451|NCT03926754|Urological Agents|urological agents|mesh-ancestor
56796452|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56796453|NCT00465894|Estradiol|estradiol|mesh-list
56796454|NCT00465894|Estrogens|estrogens|mesh-ancestor
56796455|NCT00465894|Hormones|hormones|mesh-ancestor
56796456|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56796457|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796458|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56796459|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56796460|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
56796461|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796462|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796463|NCT00465894|Urological Agents|urological agents|mesh-ancestor
56796464|NCT00330460|Denosumab|denosumab|mesh-list
56796465|NCT00330460|Alendronate|alendronate|mesh-list
56796466|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56796467|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796468|NCT01062490|Treosulfan|treosulfan|mesh-list
56796469|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56796470|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
56796471|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796472|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796473|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
56796474|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56796475|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56796476|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56796477|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56796478|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796479|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796480|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
56796481|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796482|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796483|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56796484|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796512|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796513|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507419|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
56796514|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56796515|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
56796516|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56796517|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796518|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56796519|NCT00412737|Oseltamivir|oseltamivir|mesh-list
56796520|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
56796521|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542396|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542397|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
56542398|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542399|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56542400|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56542401|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56542402|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56542403|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
56542404|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542405|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56542406|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542407|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
56542408|NCT00609856|Pioglitazone|pioglitazone|mesh-list
56542409|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56542410|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796522|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796523|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796524|NCT00508742|Vaccines|vaccines|mesh-list
56796591|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
56796592|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796593|NCT01014650|Glycine|glycine|mesh-list
56796594|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
56796595|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796596|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796597|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796598|NCT00411645|Maribavir|maribavir|mesh-list
56796599|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
56796600|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796601|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56796602|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
56068975|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56796633|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
56796634|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56796635|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56796636|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56796637|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56796638|NCT01039545|Norfloxacin|norfloxacin|mesh-list
56796639|NCT01039545|Diclofenac|diclofenac|mesh-list
56796640|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56796641|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56796642|NCT01039545|Analgesics|analgesics|mesh-ancestor
56796643|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
56796644|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796645|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069018|NCT05725135|Propofol|propofol|mesh-list
56796680|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56796681|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796682|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56796684|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
56069061|NCT02287909|Clopidogrel|clopidogrel|mesh-list
56796705|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56796706|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
56796707|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796708|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56796709|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56796710|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796711|NCT00941135|Docetaxel|docetaxel|mesh-list
56796712|NCT00941135|Cetuximab|cetuximab|mesh-list
56796713|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796714|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
56542411|NCT04527757|Anesthetics|anesthetics|mesh-list
56542412|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196601|NCT01504178|Levodopa|levodopa|mesh-list
56796715|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
56796716|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
56796717|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796718|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56796719|NCT00556439|Abatacept|abatacept|mesh-list
56796720|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56796721|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796722|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796723|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796724|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
56796725|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796726|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796727|NCT04012307|Candesartan|candesartan|mesh-list
56796728|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
56796729|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56796730|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56796731|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56796732|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796733|NCT00387465|Azacitidine|azacitidine|mesh-list
56796734|NCT00387465|Entinostat|entinostat|mesh-list
56796735|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56796774|NCT00456261|Carboplatin|carboplatin|mesh-list
56796775|NCT00456261|Pemetrexed|pemetrexed|mesh-list
56796776|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56069151|NCT05448547|Hormones|hormones|mesh-list
56796805|NCT00410163|Fludarabine|fludarabine|mesh-list
56796807|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56796808|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796809|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
56796810|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507733|NCT02214498|Enalapril|enalapril|mesh-list
56796811|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796812|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56796813|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
56796814|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796815|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796816|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56796817|NCT03617523|Vaccines|vaccines|mesh-list
56796818|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
56796819|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796849|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796850|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56796851|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56796852|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56796853|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796854|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796855|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56796856|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56796857|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
56796858|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796859|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56796860|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56796861|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
56796862|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56796863|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
56796864|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
56796865|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
56796866|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56796895|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56796896|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796897|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796898|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
56796899|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56796900|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
56796901|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796902|NCT00507728|Bupropion|bupropion|mesh-list
56796903|NCT00507728|Varenicline|varenicline|mesh-list
56796904|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56796905|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
56542413|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542414|NCT00613249|Dapivirine|dapivirine|mesh-list
56542415|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56542416|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56542417|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
56542418|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542419|NCT00613561|Fludarabine|fludarabine|mesh-list
56542420|NCT00613561|Busulfan|busulfan|mesh-list
56542421|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56542422|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542423|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542424|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542425|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
56796906|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56796907|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56796908|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56796909|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796910|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796911|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
56796912|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069298|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56796949|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796950|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56796983|NCT00490490|Lugol's solution|lugol's solution|mesh-list
56796984|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56796985|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56796986|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796987|NCT00490490|Trace Elements|trace elements|mesh-ancestor
56796988|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
56796989|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796990|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
56796991|NCT00490490|Coagulants|coagulants|mesh-ancestor
56796992|NCT05049980|Mifepristone|mifepristone|mesh-list
56797020|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56797021|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797022|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56797023|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
56797024|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797025|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797026|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56797027|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
56797028|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
56797029|NCT00385593|Hormones|hormones|mesh-ancestor
56797030|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797031|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56797032|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56797033|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56797034|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
56797035|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069422|NCT02295553|Ketamine|ketamine|mesh-list
56797069|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797070|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56797071|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
56797072|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56797073|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56797074|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56797101|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
56797102|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797103|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56797104|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56797105|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797106|NCT00395343|Incretins|incretins|mesh-ancestor
56393332|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
56542426|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542427|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
56196613|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
56797107|NCT00395343|Hormones|hormones|mesh-ancestor
56508028|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
56797108|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797109|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56797110|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
56797111|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797112|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797113|NCT00560573|Gemcitabine|gemcitabine|mesh-list
56797114|NCT00560573|Pemetrexed|pemetrexed|mesh-list
56797115|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797116|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56797117|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
56797118|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797119|NCT00560573|Antiviral Agents|antiviral agents|mesh-ancestor
56797148|NCT00946595|Lopinavir|lopinavir|mesh-list
56797149|NCT00946595|Tenofovir|tenofovir|mesh-list
56797150|NCT00946595|Efavirenz|efavirenz|mesh-list
56797151|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56797152|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56797153|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
56797154|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797155|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797156|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56797157|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56797158|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
56797159|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797160|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56797161|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56797162|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56797163|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56797164|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56797165|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56797196|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
56797197|NCT01011452|Montelukast|montelukast|mesh-list
56797198|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56797199|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
56797200|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56797201|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
56797202|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797203|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797204|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56797205|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56797206|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797207|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
56797208|NCT00490022|Androgens|androgens|mesh-ancestor
56797232|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797233|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56797234|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
56797235|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
56797236|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797237|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797239|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797240|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797241|NCT00946673|Vorinostat|vorinostat|mesh-list
56797242|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797243|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56797244|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797245|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797246|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
56797247|NCT00394953|Hematinics|hematinics|mesh-ancestor
56797248|NCT00946751|Levetiracetam|levetiracetam|mesh-list
56797249|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
56797250|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
56797251|NCT00485732|Vaccines|vaccines|mesh-list
56797252|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
56797253|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542428|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56542429|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56542431|NCT01009983|Carboplatin|carboplatin|mesh-list
56542432|NCT01009983|Panitumumab|panitumumab|mesh-list
56542433|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56542434|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542435|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
56542436|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
56542437|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
56542438|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542439|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542440|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
56542441|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56797254|NCT00946829|Telmisartan|telmisartan|mesh-list
56797255|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56797256|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56508171|NCT04545801|Ketamine|ketamine|mesh-list
56797290|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797291|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56797292|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56797293|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56797294|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56797295|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56797296|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56797297|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56797333|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
56797334|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56069739|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56797369|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797371|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56797372|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56797373|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56797406|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56797407|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56797408|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56797409|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797410|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
56797411|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56797412|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797445|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
56797446|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56797447|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
56797448|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797449|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797450|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56797451|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56797452|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797453|NCT00942773|Voriconazole|voriconazole|mesh-list
56797454|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
56797481|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797483|NCT01045083|Citalopram|citalopram|mesh-list
56797484|NCT01045083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56797485|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56797486|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56797487|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797488|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797489|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
56797490|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542442|NCT04297215|Chitosan|chitosan|mesh-list
56542443|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56542444|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56542445|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
56542446|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542447|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56542448|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
56542449|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
56542450|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
56542451|NCT04297215|Coagulants|coagulants|mesh-ancestor
56542452|NCT02873091|Sufentanil|sufentanil|mesh-list
56542453|NCT02873091|Ropivacaine|ropivacaine|mesh-list
56124405|NCT01467492|Ribavirin|ribavirin|mesh-list
56797491|NCT01045083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56797492|NCT01045083|Antidepressive Agents|antidepressive agents|mesh-ancestor
56797493|NCT01045083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797494|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56797495|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56797496|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
56797497|NCT01040325|Vaccines|vaccines|mesh-list
56797498|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
56069903|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
56797531|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
56797532|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56797533|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56797534|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797535|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56797536|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56797537|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56069949|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
56797574|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
56797575|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56797576|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797578|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797599|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56797601|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
56797602|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797603|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56797604|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56797605|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797606|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797607|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56797608|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56797609|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56797610|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56797611|NCT00943943|Plerixafor|plerixafor|mesh-list
56797612|NCT00943943|Sorafenib|sorafenib|mesh-list
56797613|NCT00943943|Lenograstim|lenograstim|mesh-list
56797614|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797615|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56797616|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797617|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797618|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56797619|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
56797620|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797621|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56797622|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56797623|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
56797624|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797625|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56797626|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56797627|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797628|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
56797629|NCT00453102|Rituximab|rituximab|mesh-list
55887141|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
56542454|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
56542455|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
56542456|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542457|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542458|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
56542459|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542460|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56542461|NCT02873091|Narcotics|narcotics|mesh-ancestor
56542462|NCT02873091|Analgesics|analgesics|mesh-ancestor
56542463|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56542464|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56542465|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
56542466|NCT04827745|Blinatumomab|blinatumomab|mesh-list
56542467|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542468|NCT04298775|Morphine|morphine|mesh-list
56542469|NCT04298775|Anesthetics|anesthetics|mesh-list
56542470|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196642|NCT01504256|Vitamins|vitamins|mesh-ancestor
56797630|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797631|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797632|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
56797633|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797662|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56797663|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56797664|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797665|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56797666|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
56797667|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56797668|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56797669|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
56797670|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
56797671|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56797672|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56797673|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
56797674|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797675|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56797676|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
56797677|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
56797678|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
56797679|NCT00467142|Leucovorin|leucovorin|mesh-list
56797680|NCT00467142|Bevacizumab|bevacizumab|mesh-list
56797681|NCT00467142|Fluorouracil|fluorouracil|mesh-list
56797712|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797713|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797714|NCT00944177|Metformin|metformin|mesh-list
56797715|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56797716|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797717|NCT00553475|Pregabalin|pregabalin|mesh-list
56797718|NCT00553475|Analgesics|analgesics|mesh-ancestor
56797719|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
56797720|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797721|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797722|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
56797723|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56797724|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56797725|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797726|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56070131|NCT00373607|Mefloquine|mefloquine|mesh-list
56542471|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542472|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56542473|NCT04298775|Narcotics|narcotics|mesh-ancestor
56797756|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56797757|NCT01060696|Analgesics|analgesics|mesh-ancestor
56797758|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
56797759|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797760|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797761|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56797762|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797763|NCT01065610|Oxytocin|oxytocin|mesh-list
56797764|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
56797765|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56797766|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797767|NCT00463866|Budesonide|budesonide|mesh-list
56797768|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
56797769|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797770|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56797771|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
56797772|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797796|NCT00949247|Carboplatin|carboplatin|mesh-list
56797797|NCT00949247|Docetaxel|docetaxel|mesh-list
56797798|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797799|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797800|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56797801|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56797802|NCT00949247|Growth Substances|growth substances|mesh-ancestor
56797803|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797804|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
56797805|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
56797806|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
56797807|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
56797808|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797809|NCT00551135|Pregabalin|pregabalin|mesh-list
56797810|NCT00551135|Analgesics|analgesics|mesh-ancestor
56797811|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
56797812|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797813|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797814|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
56797815|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56797816|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56797817|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797818|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56797819|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56797820|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56797821|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797822|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797823|NCT00944333|Clopidogrel|clopidogrel|mesh-list
56797824|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56797861|NCT03979456|Rituximab|rituximab|mesh-list
56797898|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797899|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56070312|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797925|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797927|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
56797928|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
56797929|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
56797930|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797931|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56797932|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56797933|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56797934|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797935|NCT00957203|Istradefylline|istradefylline|mesh-list
56797936|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56797937|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56797938|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56797939|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
56797940|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797941|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797942|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797943|NCT00952913|Lansoprazole|lansoprazole|mesh-list
56797944|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
56542474|NCT04298775|Analgesics|analgesics|mesh-ancestor
56542475|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
56542476|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542477|NCT01215227|Rasagiline|rasagiline|mesh-list
56542478|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56542479|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542480|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542481|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56542482|NCT01215227|Protective Agents|protective agents|mesh-ancestor
56542483|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542484|NCT01009515|Paclitaxel|paclitaxel|mesh-list
56542485|NCT01009515|Carboplatin|carboplatin|mesh-list
56542486|NCT01009515|Temozolomide|temozolomide|mesh-list
56542487|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56542488|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542489|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
56542490|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
56542491|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
56542492|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542493|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56542494|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
56797945|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56797946|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797947|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56797948|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797983|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56797984|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56797985|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
56797986|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56797987|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
56797988|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56797989|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56798025|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798027|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
56798028|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798029|NCT00953459|Sunitinib|sunitinib|mesh-list
56798030|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56798057|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56798059|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798060|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798061|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798062|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56798063|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56798064|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56798065|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798066|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
56798067|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56798068|NCT01025466|Protective Agents|protective agents|mesh-ancestor
56798069|NCT01025544|Vaccines|vaccines|mesh-list
56798070|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
56798071|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798072|NCT03839940|Dexamethasone|dexamethasone|mesh-list
56798073|NCT03839940|Everolimus|everolimus|mesh-list
56542495|NCT04550481|Lisinopril|lisinopril|mesh-list
56542496|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56542497|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
56542498|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542499|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542500|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56542501|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56542502|NCT04550481|Protective Agents|protective agents|mesh-ancestor
56542503|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542504|NCT01214915|Anagrelide|anagrelide|mesh-list
56542505|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56542506|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56542507|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542508|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56798074|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798075|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
56798076|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
56508997|NCT01121575|Crizotinib|crizotinib|mesh-list
56798077|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798078|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070493|NCT02301416|Topiramate|topiramate|mesh-list
56798100|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
56798101|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
56798102|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798103|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798104|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798105|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
56798106|NCT01027494|Hormones|hormones|mesh-ancestor
56798107|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798108|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56798109|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798110|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56798111|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798112|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56798113|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56798114|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798115|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798116|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56798117|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56798118|NCT01025700|Nabilone|nabilone|mesh-list
56798119|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
56798120|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
56798121|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798122|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798123|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798124|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56798125|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56798126|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56798127|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56798128|NCT00462462|Ethanol|ethanol|mesh-list
56798129|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56798130|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798131|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509068|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
56798153|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798154|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56798155|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56798156|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798157|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56542509|NCT01009203|Sirolimus|sirolimus|mesh-list
56542510|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56542511|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542512|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56542513|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542514|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542515|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56542516|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542517|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56542518|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
56542519|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542520|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
56196696|NCT01504542|Vaccines|vaccines|mesh-list
56798158|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798159|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
56798160|NCT01025778|Thiotepa|thiotepa|mesh-list
56798161|NCT01025778|Etoposide|etoposide|mesh-list
56798162|NCT01025778|Clofarabine|clofarabine|mesh-list
56798163|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798164|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
56798165|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798166|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798167|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56798168|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
56798169|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798170|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798171|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56798172|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56798173|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56798174|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56798175|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798176|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798177|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
56798178|NCT00443430|Prednisone|prednisone|mesh-list
56798179|NCT00443430|Prednisolone|prednisolone|mesh-list
56798180|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56798181|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
56798182|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56798183|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
56798184|NCT00443430|Etanercept|etanercept|mesh-list
56798185|NCT00443430|Methotrexate|methotrexate|mesh-list
56798186|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56798187|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
56798215|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56798217|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
56798218|NCT03540420|Atezolizumab|atezolizumab|mesh-list
56798219|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798220|NCT03898986|Vaccines|vaccines|mesh-list
56798221|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
56798222|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798223|NCT01022658|Insulin|insulin|mesh-list
56798224|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
56798225|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
56798226|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56798227|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798228|NCT01022736|Gabapentin|gabapentin|mesh-list
56798229|NCT01022736|Analgesics|analgesics|mesh-ancestor
56798230|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
56798231|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798232|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798233|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
56798260|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798261|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56798262|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56798263|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
56542521|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542522|NCT01009047|Aripiprazole|aripiprazole|mesh-list
56542523|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56542524|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
56542525|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56542526|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56798264|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798265|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56798266|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56798267|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56798268|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56798269|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
56798270|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56798271|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56798272|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798273|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56798274|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798275|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56798276|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798277|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798279|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798280|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56798281|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798309|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798310|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56798311|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
56798312|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56798313|NCT01026636|Cephalosporins|cephalosporins|mesh-list
56798314|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56798315|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798316|NCT00313300|Apixaban|apixaban|mesh-list
56798317|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56798318|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
56798319|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56798320|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
56798321|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798353|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56798354|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56798356|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
56798357|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56798358|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
56798359|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56798360|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56798361|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56798394|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798395|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798396|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56798397|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56798398|NCT00459108|Dasatinib|dasatinib|mesh-list
56798399|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798400|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56798401|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070808|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56798433|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56798435|NCT03440892|Analgesics|analgesics|mesh-ancestor
56798436|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
56798437|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798438|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798439|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798440|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56798441|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
56798442|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070864|NCT02012192|Paclitaxel|paclitaxel|mesh-list
56798478|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56798479|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
56798480|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
56798481|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
56798482|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
56798483|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798508|NCT00297778|Protective Agents|protective agents|mesh-ancestor
56542527|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56798509|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798510|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56798511|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56798512|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
56798513|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
56798514|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798515|NCT03848832|Cannabidiol|cannabidiol|mesh-list
56798516|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
56798517|NCT00327340|Docetaxel|docetaxel|mesh-list
56798518|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
56798519|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798520|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
56798521|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
56798522|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
56798523|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798524|NCT00327340|Analgesics|analgesics|mesh-ancestor
56798525|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
56798526|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798527|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798528|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56798529|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56798530|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798532|NCT03824704|Rucaparib|rucaparib|mesh-list
56798533|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56798534|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798535|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56798564|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798565|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798566|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
56798567|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56798568|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56798569|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798570|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56798571|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
56798572|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56798573|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798574|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798575|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798576|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56798577|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
56798578|NCT00958451|Vitamin D|vitamin d|mesh-list
56798579|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56070980|NCT02839889|Naloxegol|naloxegol|mesh-list
56798616|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798617|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798648|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798649|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56798650|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56798651|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798652|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
56798654|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56798655|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798656|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56798657|NCT03824561|Vedolizumab|vedolizumab|mesh-list
56798658|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798659|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
56798660|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
56798691|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56798693|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56798694|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798695|NCT01060774|Lidocaine|lidocaine|mesh-list
56798696|NCT01060774|Bupivacaine|bupivacaine|mesh-list
56798697|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
56798698|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
56798699|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56798700|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798701|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
56798702|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798703|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56071104|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
56798733|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
56798734|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542528|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542529|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542530|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
56542531|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
56542532|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798735|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
56798736|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798738|NCT00441168|Vincristine|vincristine|mesh-list
56798739|NCT00441168|Doxorubicin|doxorubicin|mesh-list
56798740|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56798741|NCT00441168|Bortezomib|bortezomib|mesh-list
56798742|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798743|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
56798744|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
56798745|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798746|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798747|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798769|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
56798770|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
56798771|NCT01028976|Vitamins|vitamins|mesh-ancestor
56798772|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
56798773|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798774|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
56798775|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798776|NCT01028976|Protective Agents|protective agents|mesh-ancestor
56798777|NCT01024140|Citalopram|citalopram|mesh-list
56798778|NCT01024140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56798779|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56798780|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56798781|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798782|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798783|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
56798784|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798785|NCT01024140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56798786|NCT01024140|Antidepressive Agents|antidepressive agents|mesh-ancestor
56798787|NCT01024140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56798788|NCT00457626|Valsartan|valsartan|mesh-list
56798789|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56798790|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56798791|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56798792|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798793|NCT02748707|Celecoxib|celecoxib|mesh-list
56798794|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56798795|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798796|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56798797|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798798|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798799|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56798800|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56798814|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56798815|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
56798816|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56798817|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
56798818|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
56798819|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798820|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798821|NCT00373113|Capecitabine|capecitabine|mesh-list
56798822|NCT00373113|Sunitinib|sunitinib|mesh-list
56798823|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798824|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
56798825|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798826|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798827|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56798828|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56798829|NCT00373113|Growth Substances|growth substances|mesh-ancestor
56798830|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798831|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
56798832|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56542533|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542534|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56542535|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56542536|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
56542537|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56542538|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56542539|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56542540|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56798833|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798834|NCT01045941|Gemcitabine|gemcitabine|mesh-list
56798835|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798836|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
56798837|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798838|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798839|NCT01045941|Antiviral Agents|antiviral agents|mesh-ancestor
56798840|NCT01045941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798841|NCT01045941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798842|NCT01045941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798843|NCT01045941|Immunologic Factors|immunologic factors|mesh-ancestor
56798844|NCT01045941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798845|NCT00407511|Pregabalin|pregabalin|mesh-list
56798846|NCT00407511|Analgesics|analgesics|mesh-ancestor
56798847|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
56798848|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798849|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798850|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
56798851|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56798852|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56798853|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798854|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56798855|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56798856|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56798857|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56798858|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56798859|NCT00384189|Ciclesonide|ciclesonide|mesh-list
56798860|NCT00384189|Albuterol|albuterol|mesh-list
56798861|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56798885|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798886|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798887|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56798888|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56798889|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
56798890|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798891|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56798892|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56798893|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56798894|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56798895|NCT01063192|Leucovorin|leucovorin|mesh-list
56798896|NCT01063192|Gemcitabine|gemcitabine|mesh-list
56798897|NCT01063192|Fluorouracil|fluorouracil|mesh-list
56798898|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
56798899|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798900|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
56798901|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798902|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798903|NCT01063192|Antiviral Agents|antiviral agents|mesh-ancestor
56798904|NCT01063192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798905|NCT01063192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798906|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798907|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
56798908|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798909|NCT01063192|Antidotes|antidotes|mesh-ancestor
56798910|NCT01063192|Protective Agents|protective agents|mesh-ancestor
56798911|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
56798933|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56542541|NCT04205097|Neostigmine|neostigmine|mesh-list
56542542|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56542543|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542544|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542545|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
56542546|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542547|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542548|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56542549|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
56542550|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798934|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56798935|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
56798936|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798937|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56798938|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56798939|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798940|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
56798941|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56798942|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56798943|NCT00548405|Interferons|interferons|mesh-list
56798944|NCT00548405|Interferon-beta|interferon-beta|mesh-list
56798945|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
56798946|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
56798947|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798948|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
56798949|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798950|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56798951|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
56798952|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798953|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56798954|NCT04919369|Vitamins|vitamins|mesh-list
56798955|NCT04919369|Vitamin A|vitamin a|mesh-list
56798956|NCT04919369|Atezolizumab|atezolizumab|mesh-list
56798957|NCT04919369|Tretinoin|tretinoin|mesh-list
56798958|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
56798959|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56798960|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
56798961|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798962|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798963|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
56798964|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
56798965|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
56798966|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
56798967|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798554|NCT02497287|Citalopram|citalopram|mesh-list
56798995|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798996|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56798997|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798998|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
56798999|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799000|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
56799001|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799002|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
56799003|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56799004|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56799005|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56799006|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
56799007|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56799008|NCT03948581|Vedolizumab|vedolizumab|mesh-list
56799009|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56799010|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56799011|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56799012|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56799013|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56799014|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799015|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
56542551|NCT04205565|Oxiracetam|oxiracetam|mesh-list
56542552|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56542553|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
56542554|NCT01025193|Belimumab|belimumab|mesh-list
56542555|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542556|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
56542557|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542558|NCT01008423|Budesonide|budesonide|mesh-list
56542559|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542560|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56542561|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
56542562|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542563|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542564|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56542565|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
56542566|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
56542567|NCT01008423|Hormones|hormones|mesh-ancestor
56542568|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799016|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799051|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56799053|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
56799054|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799090|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799091|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
56799092|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799118|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56799119|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56799120|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56799121|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799122|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56799124|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56510043|NCT01203787|Sorafenib|sorafenib|mesh-list
56799125|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799126|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
56799127|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799128|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799129|NCT04009889|Silicon|silicon|mesh-list
56799130|NCT04009889|Trace Elements|trace elements|mesh-ancestor
56799131|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
56799132|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799133|NCT00962507|Everolimus|everolimus|mesh-list
56799134|NCT00962507|Panobinostat|panobinostat|mesh-list
56799135|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799136|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799137|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
56799138|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799139|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56799140|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799141|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799142|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56799167|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799168|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56799169|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
56799170|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799171|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
56799172|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
56799173|NCT00075387|Carboplatin|carboplatin|mesh-list
56799174|NCT00075387|Etoposide|etoposide|mesh-list
56542569|NCT04735861|Bevacizumab|bevacizumab|mesh-list
56542570|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542571|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542572|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56542573|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56542574|NCT04735861|Growth Substances|growth substances|mesh-ancestor
56542575|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542576|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
56542577|NCT03685747|Vancomycin|vancomycin|mesh-list
56542578|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56542579|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542581|NCT03651271|Ipilimumab|ipilimumab|mesh-list
56542582|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542583|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799175|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
56799176|NCT00075387|Antidotes|antidotes|mesh-list
56799177|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799178|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
56799179|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799180|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799181|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56799182|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
56799183|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799184|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799185|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56799186|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56799187|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56799188|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56799189|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799190|NCT00075387|Protective Agents|protective agents|mesh-ancestor
56799219|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799220|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799222|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56799223|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56799224|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799225|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56799226|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56799227|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799228|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
56799229|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56799230|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
56799231|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56799232|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
56799233|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
56799234|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56071623|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
56799263|NCT00546377|Sargramostim|sargramostim|mesh-list
56799264|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799265|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
56799266|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799267|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799268|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56799269|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
56799270|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799271|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799272|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56799273|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799274|NCT00546377|Analgesics|analgesics|mesh-ancestor
56799275|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
56799276|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542584|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56542585|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542586|NCT03586687|Triamcinolone|triamcinolone|mesh-list
56542587|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542588|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
56799277|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56799278|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56799279|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799280|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56799281|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
56799282|NCT00967967|Desloratadine|desloratadine|mesh-list
56799283|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799308|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
56799309|NCT00964535|Hormones|hormones|mesh-ancestor
56799310|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799311|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56799312|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56799313|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56799314|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
56799315|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799316|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799317|NCT00964691|Chloroquine|chloroquine|mesh-list
56799318|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
56799319|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
56799320|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56799321|NCT00964691|Amebicides|amebicides|mesh-ancestor
56799322|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56799323|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56799324|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799325|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
56799326|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799327|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56799328|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799329|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799330|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56799331|NCT00964691|Renal Agents|renal agents|mesh-ancestor
56071716|NCT02955329|Nicotine|nicotine|mesh-list
56799364|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56799365|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
56799366|NCT00968903|Hormones|hormones|mesh-ancestor
56799367|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799368|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56799369|NCT00968903|Protective Agents|protective agents|mesh-ancestor
56799370|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56799371|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799372|NCT00969137|Nicotine|nicotine|mesh-list
56799373|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56799374|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
56799375|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799406|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799407|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799408|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799409|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
56799410|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56799411|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799412|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799413|NCT00965393|Bradykinin|bradykinin|mesh-list
56799414|NCT00965393|Kininogens|kininogens|mesh-list
56799415|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
56799416|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
56799417|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56799418|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
56799450|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799452|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56799453|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799454|NCT00967109|Chrysarobin|chrysarobin|mesh-list
56799455|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56799456|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56799457|NCT00967109|Analgesics|analgesics|mesh-ancestor
56799458|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
56114571|NCT00001991|Atovaquone|atovaquone|mesh-list
56799459|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799460|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799461|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799462|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799463|NCT00545753|Permethrin|permethrin|mesh-list
56071848|NCT02043704|Acetaminophen|acetaminophen|mesh-list
56799493|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
56799494|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799495|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56799497|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56799498|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799499|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56799500|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799502|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
56799503|NCT00971165|Amiloride|amiloride|mesh-list
56799504|NCT00971165|Diuretics|diuretics|mesh-list
56799505|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56799506|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56071891|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
56799537|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56799538|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799539|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56799540|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799541|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799542|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56799543|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
56799544|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799545|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799546|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56799547|NCT00973583|Vitamin D|vitamin d|mesh-list
56799577|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56799578|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
56799579|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56799580|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56799582|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56799583|NCT00325468|Denosumab|denosumab|mesh-list
56799584|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56799585|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799586|NCT00972257|Timolol|timolol|mesh-list
56799587|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56799588|NCT00972257|Dorzolamide|dorzolamide|mesh-list
56799589|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56799590|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56799591|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
56799592|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799593|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799594|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799595|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56071983|NCT02975297|Exenatide|exenatide|mesh-list
56799613|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56799614|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
56799615|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799616|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799617|NCT00383331|Antiviral Agents|antiviral agents|mesh-ancestor
56799618|NCT00383331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799619|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799620|NCT00383331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799621|NCT00383331|Immunologic Factors|immunologic factors|mesh-ancestor
56799622|NCT00383331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799623|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56799624|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56799625|NCT03934541|Vaccines|vaccines|mesh-list
56799626|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
56799627|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799628|NCT00325234|Gemcitabine|gemcitabine|mesh-list
56799629|NCT00325234|Carboplatin|carboplatin|mesh-list
56799630|NCT00325234|Pemetrexed|pemetrexed|mesh-list
56799631|NCT00325234|Vinorelbine|vinorelbine|mesh-list
56799632|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799633|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56799634|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
56799635|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799636|NCT00325234|Antiviral Agents|antiviral agents|mesh-ancestor
56799637|NCT00325234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542589|NCT03586687|Hormones|hormones|mesh-ancestor
56542590|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542591|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542592|NCT01212185|Oxytocin|oxytocin|mesh-list
56799638|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799639|NCT00325234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799640|NCT00325234|Immunologic Factors|immunologic factors|mesh-ancestor
56799641|NCT00325234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799642|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56799643|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56799644|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56799645|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
56799646|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
56799647|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
56799648|NCT01063504|Teriparatide|teriparatide|mesh-list
56799649|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56799650|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799651|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56799653|NCT00366249|Tigecycline|tigecycline|mesh-list
56799654|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56799688|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799689|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799690|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56799691|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56799692|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799693|NCT03978286|Vortioxetine|vortioxetine|mesh-list
56799694|NCT03978286|Sertraline|sertraline|mesh-list
56799695|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
56799696|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56799724|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799725|NCT00974441|Valproic Acid|valproic acid|mesh-list
56799726|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
56799727|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799728|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799729|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
56799730|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799731|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799732|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
56799733|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56799734|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56799735|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56799736|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
56799737|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56799738|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56799739|NCT01049451|Prednisolone|prednisolone|mesh-list
56799740|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
56799741|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56072122|NCT03145259|Analgesics|analgesics|mesh-ancestor
56799776|NCT02908269|Vaccines|vaccines|mesh-list
56799777|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
56799778|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799779|NCT00974987|Temozolomide|temozolomide|mesh-list
56799780|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56799781|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
56799815|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799816|NCT00975299|Bombesin|bombesin|mesh-list
56799817|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799818|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799819|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799820|NCT01060930|Epinephrine|epinephrine|mesh-list
56799821|NCT01060930|Norepinephrine|norepinephrine|mesh-list
56799855|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56799857|NCT00973193|Panitumumab|panitumumab|mesh-list
56799858|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56072248|NCT00375245|Sirolimus|sirolimus|mesh-list
56799885|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56799886|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799887|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
56799888|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
56799889|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
56799890|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542593|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
56542594|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56542595|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542596|NCT00613717|Vitamin D|vitamin d|mesh-list
56542597|NCT00613717|Vitamins|vitamins|mesh-list
56542598|NCT00613717|Folic Acid|folic acid|mesh-list
56542599|NCT00613717|Vitamin A|vitamin a|mesh-list
56542600|NCT00613717|Iron|iron|mesh-list
56542601|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
56542602|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
56542603|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
56542604|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542605|NCT00613717|Trace Elements|trace elements|mesh-ancestor
56542606|NCT00613717|Hematinics|hematinics|mesh-ancestor
56542607|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
56542608|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542609|NCT00613717|Protective Agents|protective agents|mesh-ancestor
56542610|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56542611|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542612|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56542613|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
56542614|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542615|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799891|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56799892|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799894|NCT00365547|Topotecan|topotecan|mesh-list
56799895|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799896|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799897|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56799898|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56799899|NCT00365547|Growth Substances|growth substances|mesh-ancestor
56799900|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799901|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
56799902|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56799903|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56799904|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799905|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799906|NCT00979589|Aspirin|aspirin|mesh-list
56799907|NCT00979589|Clopidogrel|clopidogrel|mesh-list
56072287|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56799939|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
56799940|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799941|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799942|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799943|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56799944|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
56799945|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799946|NCT03978052|Protective Agents|protective agents|mesh-ancestor
56799947|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799948|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56799949|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56799977|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799978|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799980|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
56067332|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
56542616|NCT04477759|Atezolizumab|atezolizumab|mesh-list
56542617|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542618|NCT04457089|Simvastatin|simvastatin|mesh-list
56542619|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56542620|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56542621|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
56542622|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542623|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56542624|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56542625|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542626|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
56542627|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56542628|NCT03369301|Antibodies|antibodies|mesh-list
56542629|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
56542630|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542631|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
56542632|NCT04865887|Lenvatinib|lenvatinib|mesh-list
56542633|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542634|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542635|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56542636|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542637|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542638|NCT04177693|Letrozole|letrozole|mesh-list
56542639|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56542640|NCT04177693|Clomiphene|clomiphene|mesh-list
56542641|NCT04177693|Enclomiphene|enclomiphene|mesh-list
56542642|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
56542643|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542644|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542645|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56799981|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799982|NCT00980603|Docetaxel|docetaxel|mesh-list
56799983|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799984|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
56799985|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
56799986|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
56799987|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799988|NCT00274456|Paclitaxel|paclitaxel|mesh-list
56799989|NCT00274456|Docetaxel|docetaxel|mesh-list
56799990|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56799991|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56799992|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799993|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
56799994|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
56799995|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
56800022|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542646|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56542647|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115058|NCT05752409|Ketamine|ketamine|mesh-list
56800023|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800024|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800025|NCT01069822|Midazolam|midazolam|mesh-list
56800026|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56800027|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56800028|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56800029|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800030|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56800031|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56800032|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56800033|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56800034|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
56800035|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
56800036|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
56800037|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
56800038|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800039|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800040|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
56800041|NCT00364923|Aminopterin|aminopterin|mesh-list
56800042|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56800043|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800076|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
56800077|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800078|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
56800079|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
56800080|NCT00290290|Povidone|povidone|mesh-list
56800081|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56800082|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800083|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
56800084|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
56800085|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
56800117|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800119|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56800120|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
56800121|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800122|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800123|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800124|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
56800125|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56800126|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800127|NCT00977405|Gentamicins|gentamicins|mesh-list
56800128|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800129|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072512|NCT03810703|Amphetamine|amphetamine|mesh-list
56800166|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56072555|NCT02068027|Clonidine|clonidine|mesh-list
56800196|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56800197|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800198|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
56800199|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800200|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
56800201|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800202|NCT00978263|Metformin|metformin|mesh-list
56800203|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56800204|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800205|NCT00981851|Albuterol|albuterol|mesh-list
56800206|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
56800207|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56800208|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
56800209|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800210|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800211|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56800212|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
56800213|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
56800246|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56800247|NCT00981929|Analgesics|analgesics|mesh-ancestor
56800248|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
56800249|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800250|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
56800251|NCT00364845|Hematinics|hematinics|mesh-ancestor
56800252|NCT00978653|Allopurinol|allopurinol|mesh-list
56800253|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
56542648|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56542649|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
56542650|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542651|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542652|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56542653|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
56542654|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56542655|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56542656|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56542657|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
56542658|NCT04177693|Protective Agents|protective agents|mesh-ancestor
56542659|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56290920|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
56542660|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56542661|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56800254|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072652|NCT02393378|Vitamins|vitamins|mesh-ancestor
56800288|NCT00364689|Lactulose|lactulose|mesh-list
56800289|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800290|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800291|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56800292|NCT00545129|Tanezumab|tanezumab|mesh-list
56800293|NCT00545129|Analgesics|analgesics|mesh-ancestor
56800294|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
56800295|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800296|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800297|NCT00956111|Vaccines|vaccines|mesh-list
56072684|NCT05717582|Androgens|androgens|mesh-list
56800324|NCT00956189|Amisulpride|amisulpride|mesh-list
56800325|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
56800326|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56800327|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56800328|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56800329|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56800330|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800331|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
56800332|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
56800333|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800334|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800335|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56800336|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56800337|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
56800338|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56800339|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56800340|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56800341|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56800342|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56800343|NCT00956267|Letrozole|letrozole|mesh-list
56800344|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800345|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56072721|NCT05423834|Tenofovir|tenofovir|mesh-list
56800374|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
56800375|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800376|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56800377|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56800378|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800379|NCT00984737|Insulin|insulin|mesh-list
56800380|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56800381|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542662|NCT05345119|Sirolimus|sirolimus|mesh-list
56542663|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
56542664|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56542665|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56542666|NCT05345119|Prednisolone|prednisolone|mesh-list
56542667|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
56542668|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56542669|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
56542670|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800382|NCT01047579|Rivastigmine|rivastigmine|mesh-list
56800383|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56800384|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800385|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800386|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
56800387|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800388|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072792|NCT02049307|Losartan|losartan|mesh-list
56800424|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800425|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56800426|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800427|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56800428|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56800460|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800461|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56800462|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56800463|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800464|NCT00543725|Efavirenz|efavirenz|mesh-list
56800465|NCT00543725|Rilpivirine|rilpivirine|mesh-list
56800466|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56800467|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56800468|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800469|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800470|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
56800471|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800472|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56072863|NCT02051335|Scopolamine|scopolamine|mesh-list
56800500|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56800501|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
56800502|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800503|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800504|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
56800505|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800506|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800507|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
56800508|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800509|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
56800510|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800511|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56800512|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56800513|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56800514|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
56800515|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800516|NCT03975166|Fluticasone|fluticasone|mesh-list
56800517|NCT03975166|Xhance|xhance|mesh-list
56800518|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56800519|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56800520|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56800552|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800553|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56800554|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56800555|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56800556|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
56800557|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56800558|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
56800559|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56542671|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542672|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56542673|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542674|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
56542675|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542676|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
56542677|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542678|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542679|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
56542680|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
56542681|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542682|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56542683|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
56542684|NCT05345119|Hormones|hormones|mesh-ancestor
56542685|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542686|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56542687|NCT05345119|Protective Agents|protective agents|mesh-ancestor
56542688|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56542689|NCT03529123|Insulin|insulin|mesh-list
56542690|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56542691|NCT03529123|Metformin|metformin|mesh-list
56542692|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
56542693|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
56115696|NCT00002267|Rifabutin|rifabutin|mesh-list
56800560|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56800562|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
56800563|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56800595|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
56800596|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800597|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56800598|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56800599|NCT00379353|Thalidomide|thalidomide|mesh-list
56800600|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800601|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
56800602|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800603|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
56800604|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800605|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800606|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56800607|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56800608|NCT00379353|Growth Substances|growth substances|mesh-ancestor
56800647|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800675|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
56800676|NCT00378105|Hormones|hormones|mesh-ancestor
56800677|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56800678|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56800679|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800680|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
56800681|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56800682|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56800683|NCT00378105|Growth Substances|growth substances|mesh-ancestor
56800684|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
56542694|NCT03529123|Lixisenatide|lixisenatide|mesh-list
56542695|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56542696|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542697|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
56542698|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56542699|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56542700|NCT04074187|Prednisolone|prednisolone|mesh-list
56542701|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
56542702|NCT04074187|Rituximab|rituximab|mesh-list
56542703|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56542704|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
56542705|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56542706|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542707|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800685|NCT00457002|Enoxaparin|enoxaparin|mesh-list
56800686|NCT00457002|Apixaban|apixaban|mesh-list
56800687|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
56800688|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56800689|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56800690|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800691|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56800692|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
56800693|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56800694|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
56800695|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800696|NCT00362115|Olmesartan|olmesartan|mesh-list
56800697|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56800698|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56800731|NCT03975010|Naltrexone|naltrexone|mesh-list
56800732|NCT03975010|Buprenorphine|buprenorphine|mesh-list
56800733|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56800734|NCT03975010|Narcotics|narcotics|mesh-ancestor
56800735|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56800736|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800737|NCT03975010|Analgesics|analgesics|mesh-ancestor
56800738|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
56800739|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073124|NCT02366819|Leucovorin|leucovorin|mesh-list
56800765|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800767|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56800768|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56800769|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800770|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
56800771|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56800772|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
56800773|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800775|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56800776|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800777|NCT00484094|Sirolimus|sirolimus|mesh-list
56800778|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800779|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800780|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56800781|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800782|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
56800783|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800784|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
56800785|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800786|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56073168|NCT03308669|Topiramate|topiramate|mesh-list
56800815|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800817|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800818|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800819|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56542708|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
56542709|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542710|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56542711|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542712|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
56542713|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
56542714|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542715|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56542716|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
56542717|NCT04074187|Hormones|hormones|mesh-ancestor
56542718|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542719|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56542720|NCT04074187|Protective Agents|protective agents|mesh-ancestor
56542721|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56542722|NCT03128905|Prednisone|prednisone|mesh-list
56800820|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800821|NCT01565772|Etoposide|etoposide|mesh-list
56800822|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800823|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56800824|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56800825|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56800826|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800827|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800828|NCT00456300|Exenatide|exenatide|mesh-list
56073222|NCT02344225|Ibuprofen|ibuprofen|mesh-list
56800858|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56800859|NCT00267046|Vincristine|vincristine|mesh-list
56800860|NCT00267046|Ifosfamide|ifosfamide|mesh-list
56800861|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800862|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56800863|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56800864|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56800865|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800866|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800867|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56800868|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
56800869|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
56800870|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
56800871|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56800872|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
56800873|NCT01029678|Vinorelbine|vinorelbine|mesh-list
56073267|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
56800905|NCT01019174|Lenalidomide|lenalidomide|mesh-list
56800906|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800907|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
56800908|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800909|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800910|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56800911|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
56800912|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800913|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800914|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56073303|NCT03323801|Tretinoin|tretinoin|mesh-list
56800945|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56800946|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
56800947|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56800948|NCT03976102|Rituximab|rituximab|mesh-list
56800949|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56800950|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800951|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
56067935|NCT05446805|Corticosterone|corticosterone|mesh-list
56542723|NCT03128905|Colchicine|colchicine|mesh-list
56542724|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542725|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
56542726|NCT03128905|Hormones|hormones|mesh-ancestor
56542727|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542728|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542729|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56542730|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800952|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800953|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800954|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
56800955|NCT00506948|Sirolimus|sirolimus|mesh-list
56800956|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
56800957|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56800958|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56800966|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
56800967|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800968|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
56800969|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800971|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
56800972|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56800973|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
56800974|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800975|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56800976|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
56800977|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
56800978|NCT00286234|Vitamins|vitamins|mesh-ancestor
56800979|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
56800980|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800981|NCT01019408|Chloroquine|chloroquine|mesh-list
56800982|NCT01019408|Amebicides|amebicides|mesh-ancestor
56800983|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56800984|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56800985|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800986|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
56800987|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800988|NCT01067950|Pancrelipase|pancrelipase|mesh-list
56800989|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56800990|NCT00445848|Bevacizumab|bevacizumab|mesh-list
56800991|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56800992|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56800993|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800994|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56800995|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56800996|NCT00445848|Growth Substances|growth substances|mesh-ancestor
56800997|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800998|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
56800999|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56801000|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801001|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801002|NCT00286156|Sirolimus|sirolimus|mesh-list
56801003|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56801004|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801005|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56801006|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801007|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
56801008|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801037|NCT00293020|Analgesics|analgesics|mesh-ancestor
56801038|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
56801039|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801040|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56801041|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56801042|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
56801043|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
56801044|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
56801045|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
56801046|NCT00377637|Azathioprine|azathioprine|mesh-list
56801047|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542731|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
56542733|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
56542734|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
56542735|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
56542736|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542737|NCT02430181|Interferons|interferons|mesh-list
56542738|NCT02430181|Ritonavir|ritonavir|mesh-list
56542739|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
56542740|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56542741|NCT02430181|Lonafarnib|lonafarnib|mesh-list
56542742|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542743|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
56542744|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542745|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56542746|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56542747|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
56542748|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542749|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801048|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
56801049|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801050|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801051|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56801052|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
56801053|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801054|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801092|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
56801127|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801129|NCT00370071|Interferon-beta|interferon-beta|mesh-list
56801130|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
56801131|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801132|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
56801133|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801134|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
56801135|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801136|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56801137|NCT00369915|Scopolamine|scopolamine|mesh-list
56073527|NCT00356954|Vitamins|vitamins|mesh-ancestor
56801167|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801168|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801170|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56801171|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56801172|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801173|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801174|NCT00369681|Rituximab|rituximab|mesh-list
56801175|NCT00369681|Doxorubicin|doxorubicin|mesh-list
56801176|NCT00369681|Dacarbazine|dacarbazine|mesh-list
56801177|NCT00369681|Bleomycin|bleomycin|mesh-list
56801178|NCT00369681|Vinblastine|vinblastine|mesh-list
56801179|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56801180|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801181|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
56801182|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801183|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801215|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56801216|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801217|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801218|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56801219|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56542750|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56542751|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56542752|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56542753|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56542754|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
56542755|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542756|NCT00614653|Bevacizumab|bevacizumab|mesh-list
56542757|NCT00614653|Capecitabine|capecitabine|mesh-list
56542758|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56542759|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542760|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542761|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56542762|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56542763|NCT00614653|Growth Substances|growth substances|mesh-ancestor
56542764|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801221|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56801222|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56801223|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801224|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801225|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
56801257|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801258|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
56801259|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
56801260|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56801261|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
56801262|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801263|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
56801264|NCT02534415|Protective Agents|protective agents|mesh-ancestor
56801265|NCT00488618|Cariprazine|cariprazine|mesh-list
56801266|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56801267|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56801268|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801269|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801270|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56801297|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56801298|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801299|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56801300|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
56801301|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801302|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801303|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801304|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801305|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56512220|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801306|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801307|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
56801308|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801309|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56801310|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56801311|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56801312|NCT00445770|Analgesics|analgesics|mesh-ancestor
56801313|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
56801314|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801315|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801316|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801317|NCT00266032|Drospirenone|drospirenone|mesh-list
56801378|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512294|NCT01680185|Insulin|insulin|mesh-list
56801379|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
56542765|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
56542766|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56542767|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
56542768|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542769|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56542770|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542771|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56542772|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56542773|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542774|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56542775|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542776|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
56542777|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56542778|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
56542779|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542780|NCT03596125|Expectorants|expectorants|mesh-ancestor
56801380|NCT00445692|Clarithromycin|clarithromycin|mesh-list
56801381|NCT00445692|Dexamethasone|dexamethasone|mesh-list
56801382|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
56801383|NCT00445692|Lenalidomide|lenalidomide|mesh-list
56801384|NCT00445692|Ichthammol|ichthammol|mesh-list
56801385|NCT00445692|BB 1101|bb 1101|mesh-list
56801386|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801387|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
56801388|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
56801389|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801390|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801391|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801392|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
56801393|NCT00445692|Hormones|hormones|mesh-ancestor
56801394|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801395|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56801396|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801397|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
56801398|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56801399|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56801470|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56801471|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801472|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56801473|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56801474|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
56801475|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
56801477|NCT00543569|Tacrolimus|tacrolimus|mesh-list
56801478|NCT00543569|Basiliximab|basiliximab|mesh-list
56801479|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801480|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
56073868|NCT03224351|Ivacaftor|ivacaftor|mesh-list
56801518|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
56073914|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
56801554|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
56801555|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801556|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801557|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56801558|NCT00988949|Diuretics|diuretics|mesh-ancestor
56801559|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
56801560|NCT00989027|Oxytocin|oxytocin|mesh-list
56801561|NCT00989027|Carboprost|carboprost|mesh-list
56073957|NCT05419297|Buprenorphine|buprenorphine|mesh-list
56542781|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
56542782|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56542783|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
56542784|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542785|NCT03596125|Protective Agents|protective agents|mesh-ancestor
56542786|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542787|NCT03596125|Antidotes|antidotes|mesh-ancestor
56542788|NCT02118727|Memantine|memantine|mesh-list
56542789|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56542790|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56542791|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
56542792|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542793|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542794|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542795|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56542796|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56542797|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56542798|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
56542799|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56542800|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56542801|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542802|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542803|NCT05343637|Urological Agents|urological agents|mesh-ancestor
56542804|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56801591|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
56801592|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801593|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
56801595|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801596|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
56801597|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801598|NCT00281320|Asenapine|asenapine|mesh-list
56801599|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56801600|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56801601|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801602|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801603|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56801604|NCT00541307|Heparin|heparin|mesh-list
56801605|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
56801606|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56801607|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56801608|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512522|NCT01645826|Diltiazem|diltiazem|mesh-list
56801637|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801638|NCT00541229|Incretins|incretins|mesh-ancestor
56801639|NCT00541229|Hormones|hormones|mesh-ancestor
56801640|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542805|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56542806|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542807|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56542808|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542809|NCT00614809|Gefitinib|gefitinib|mesh-list
56542810|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542811|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56542812|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542813|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542814|NCT02964013|Carboplatin|carboplatin|mesh-list
56542815|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
56542816|NCT02964013|Etoposide|etoposide|mesh-list
56542817|NCT02964013|Pemetrexed|pemetrexed|mesh-list
56542818|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542819|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542820|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56542821|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56542822|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56542823|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542824|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542825|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56542826|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56542827|NCT05343169|Naloxone|naloxone|mesh-list
56542828|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56542829|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542830|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
56542831|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542832|NCT02480803|Levodopa|levodopa|mesh-list
56542833|NCT02480803|Carbidopa|carbidopa|mesh-list
56542834|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56542835|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56542836|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56542845|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
56542846|NCT02699437|Antibodies|antibodies|mesh-list
56542847|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
56542848|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
56542849|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542850|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56542851|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542852|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56542853|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542854|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801641|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56801642|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
56801643|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801644|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801645|NCT04006691|Mitomycins|mitomycins|mesh-list
56801646|NCT04006691|Mitomycin|mitomycin|mesh-list
56801647|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56801648|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801649|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
56801650|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801651|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56801652|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801653|NCT00986765|Aspirin|aspirin|mesh-list
56801654|NCT00986765|Enoxaparin|enoxaparin|mesh-list
56801655|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56074042|NCT05418049|Memantine|memantine|mesh-list
56801689|NCT05463419|Immunologic Factors|immunologic factors|mesh-ancestor
56801690|NCT05463419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801692|NCT01017770|Lumefantrine|lumefantrine|mesh-list
56801693|NCT01017770|Artemether|artemether|mesh-list
56801694|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56801722|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801724|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
56801725|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
56801726|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801727|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801728|NCT00481832|Cyclosporine|cyclosporine|mesh-list
56801729|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
56801730|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
56801731|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56801732|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56801733|NCT00481832|Prednisolone|prednisolone|mesh-list
56801734|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
56801735|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
56801736|NCT00481832|Carmustine|carmustine|mesh-list
56801737|NCT00481832|Rituximab|rituximab|mesh-list
56801738|NCT00481832|Etoposide|etoposide|mesh-list
56801739|NCT00481832|Cyclosporins|cyclosporins|mesh-list
56801740|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56801741|NCT00481832|Lenograstim|lenograstim|mesh-list
56801742|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56801743|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
56801744|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801777|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56801778|NCT00481676|Omalizumab|omalizumab|mesh-list
56801779|NCT00481676|Loratadine|loratadine|mesh-list
56801780|NCT00481676|Clemastine|clemastine|mesh-list
56801781|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56801782|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56801783|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56074176|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
56801813|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801815|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56801816|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56801817|NCT04377503|Prednisolone|prednisolone|mesh-list
56801818|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
56801819|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56542855|NCT00615823|Atorvastatin|atorvastatin|mesh-list
56542856|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56542857|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56542858|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
56542859|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542860|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56542861|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56542862|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542863|NCT02699281|Palmidrol|palmidrol|mesh-list
56542864|NCT02699281|Analgesics|analgesics|mesh-ancestor
56542865|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
56801820|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
56801821|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801822|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
56801823|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
56801824|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801825|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801855|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
56801856|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56801857|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56801858|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801859|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56801860|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56801861|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56801862|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801863|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801864|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
56801865|NCT01018160|Rabeprazole|rabeprazole|mesh-list
56801866|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56801867|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801868|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56801869|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074259|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56801902|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56801903|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56801904|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
56801905|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801906|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56801907|NCT00540449|Efavirenz|efavirenz|mesh-list
56801908|NCT00540449|Rilpivirine|rilpivirine|mesh-list
56801909|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56801910|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56801911|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801912|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801913|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
56801946|NCT03911843|Vitamin D|vitamin d|mesh-list
56801947|NCT03911843|Vitamins|vitamins|mesh-ancestor
56801948|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
56801949|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801950|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56801951|NCT00361335|Golimumab|golimumab|mesh-list
56801952|NCT00361335|Methotrexate|methotrexate|mesh-list
56801953|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56801954|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
56801955|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56801983|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56801984|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801985|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
56801986|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801987|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56801988|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56801989|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801991|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56801992|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56068039|NCT05442905|Sevoflurane|sevoflurane|mesh-list
56542866|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542867|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542868|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56542869|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56542870|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542871|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56542872|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
56542873|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56542874|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56801993|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56801994|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56801995|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
56801996|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801997|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801998|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801999|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56802001|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
56802033|NCT01070524|Hormones|hormones|mesh-ancestor
56802034|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802035|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
56802036|NCT01071304|Midazolam|midazolam|mesh-list
56802037|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56802038|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56802039|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802040|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802041|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56802042|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56802043|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56802044|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56802045|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
56802074|NCT00540293|Atorvastatin|atorvastatin|mesh-list
56802075|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56802076|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56802077|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
56802078|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802079|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56802080|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56802081|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802082|NCT00375609|Enoxaparin|enoxaparin|mesh-list
56802083|NCT00375609|Betrixaban|betrixaban|mesh-list
56802084|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
56802085|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56802086|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56802087|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074482|NCT02265510|Paclitaxel|paclitaxel|mesh-list
56802113|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56802114|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802115|NCT00368745|Pregabalin|pregabalin|mesh-list
56802116|NCT00368745|Analgesics|analgesics|mesh-ancestor
56802117|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
56802118|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802119|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802120|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
56802121|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56802122|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56802123|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802124|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56802125|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56802126|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56802127|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802128|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56802129|NCT03235739|Naloxegol|naloxegol|mesh-list
56802130|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56802131|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542875|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56542876|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542877|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542878|NCT02699281|Hormones|hormones|mesh-ancestor
56542879|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542880|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
56542881|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56542882|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542883|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
56542884|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56542885|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
56542886|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542887|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56542888|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56542889|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
56542890|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542891|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542892|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56542894|NCT02704507|Tretinoin|tretinoin|mesh-list
56542895|NCT02704507|Emollients|emollients|mesh-list
56802132|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
56802133|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513059|NCT01689129|Insulin|insulin|mesh-list
56802135|NCT04573673|Cathartics|cathartics|mesh-ancestor
56802151|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
56802152|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802153|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56802154|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56802155|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56802156|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
56802157|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802158|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802159|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56802160|NCT01050699|Narcotics|narcotics|mesh-ancestor
56802161|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56802162|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56802163|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
56802164|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
56802165|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56802166|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56802167|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56802168|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
56802169|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
56802170|NCT02408315|Misoprostol|misoprostol|mesh-list
56802171|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56802172|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
56802173|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56802174|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802175|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56802176|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802177|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
56802178|NCT05711693|Bepridil|bepridil|mesh-list
56802179|NCT05711693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56802180|NCT05711693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56542896|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56542897|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
56542898|NCT02704507|Hormones|hormones|mesh-ancestor
56542899|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542900|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542901|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56542902|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
56542903|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
56542904|NCT01210001|Empagliflozin|empagliflozin|mesh-list
56542905|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56542906|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542907|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56542908|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542909|NCT00624455|Gabapentin|gabapentin|mesh-list
56542910|NCT00624455|Analgesics|analgesics|mesh-ancestor
56542911|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
56802181|NCT05711693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56802182|NCT05711693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56802183|NCT05711693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802184|NCT05711693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56802185|NCT05711693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802186|NCT05711693|Vasodilator Agents|vasodilator agents|mesh-ancestor
56802187|NCT04005365|Propranolol|propranolol|mesh-list
56802188|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56802189|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56802190|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
56802191|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802192|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802193|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802194|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56802195|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56802196|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
56802197|NCT05711615|Doxorubicin|doxorubicin|mesh-list
56802229|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56802230|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56802231|NCT01048515|Caffeine|caffeine|mesh-list
56802232|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56802233|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802234|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56802235|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802236|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802237|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56802238|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56802239|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
56802272|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
56802273|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802274|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56802275|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56802276|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
56802277|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802278|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802279|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56802280|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56802281|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
56802282|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
56542912|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542913|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542914|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
56542915|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56542916|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56542917|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542918|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56542919|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56542920|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56542921|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542922|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542923|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
56542924|NCT01127659|Testosterone|testosterone|mesh-list
56542925|NCT01127659|Androgens|androgens|mesh-ancestor
56542926|NCT01127659|Hormones|hormones|mesh-ancestor
56542927|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116937|NCT04431635|Rituximab|rituximab|mesh-list
56802283|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074672|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56802318|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56802319|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802320|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56802321|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802322|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
56802323|NCT00368277|Diuretics|diuretics|mesh-ancestor
56547695|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56802357|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
56802358|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802359|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802361|NCT02534337|Gemcitabine|gemcitabine|mesh-list
56802362|NCT02534337|Fluorouracil|fluorouracil|mesh-list
56802363|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
56074762|NCT04469491|Interferons|interferons|mesh-list
56802398|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802400|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802401|NCT00262834|Vorinostat|vorinostat|mesh-list
56802402|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802403|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56802404|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074798|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802434|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
56802435|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802436|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802437|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56802438|NCT05699603|Fluorouracil|fluorouracil|mesh-list
56802439|NCT05699603|Calcipotriene|calcipotriene|mesh-list
56802440|NCT05699603|Antimetabolites|antimetabolites|mesh-ancestor
56802441|NCT05699603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802442|NCT05699603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56802443|NCT05699603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802444|NCT05699603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802445|NCT05699603|Immunologic Factors|immunologic factors|mesh-ancestor
56802446|NCT05699603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802447|NCT05699603|Dermatologic Agents|dermatologic agents|mesh-ancestor
56802449|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56802478|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56542928|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542929|NCT02698969|Atropine|atropine|mesh-list
56542930|NCT02698969|Fentanyl|fentanyl|mesh-list
56542931|NCT02698969|Propofol|propofol|mesh-list
56542932|NCT02698969|Sevoflurane|sevoflurane|mesh-list
56542933|NCT02698969|Rocuronium|rocuronium|mesh-list
56542934|NCT02698969|Neostigmine|neostigmine|mesh-list
56542935|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56542936|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56542937|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542938|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56542939|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
56542940|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
56542941|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56542942|NCT02698969|Narcotics|narcotics|mesh-ancestor
56542943|NCT02698969|Analgesics|analgesics|mesh-ancestor
56542944|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
56802480|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802481|NCT00539513|Protective Agents|protective agents|mesh-ancestor
56802482|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802483|NCT00539513|Antidotes|antidotes|mesh-ancestor
56802484|NCT04188119|Aspirin|aspirin|mesh-list
56802485|NCT04188119|Avelumab|avelumab|mesh-list
56802486|NCT04188119|Lansoprazole|lansoprazole|mesh-list
56802487|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
56802488|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56802489|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56802490|NCT04188119|Analgesics|analgesics|mesh-ancestor
56802491|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
56802492|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802493|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802494|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802495|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56802496|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56802497|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56802522|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56802523|NCT00454584|Analgesics|analgesics|mesh-ancestor
56802524|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
56802525|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802526|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802527|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802528|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56802529|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802530|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802531|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
56802532|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
56802533|NCT02583893|Cytarabine|cytarabine|mesh-list
56802534|NCT02583893|Sirolimus|sirolimus|mesh-list
56802535|NCT02583893|Etoposide|etoposide|mesh-list
56802536|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
56802537|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
56802538|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56802539|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802540|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56802541|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56802562|NCT04204343|Bupivacaine|bupivacaine|mesh-list
56802563|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
56802564|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
56802565|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802566|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802567|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
56802568|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802569|NCT02845271|Acetaminophen|acetaminophen|mesh-list
56542945|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542946|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56542947|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56542948|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56542949|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56542950|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56542951|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56542952|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56542953|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56542955|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56542956|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
56802570|NCT02845271|Tramadol|tramadol|mesh-list
56802571|NCT02845271|Codeine|codeine|mesh-list
56802572|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56802573|NCT02845271|Analgesics|analgesics|mesh-ancestor
56802574|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
56802575|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802576|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802577|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
56802578|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56802579|NCT02845271|Narcotics|narcotics|mesh-ancestor
56802580|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802581|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
56802582|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
56802583|NCT00445068|Panobinostat|panobinostat|mesh-list
56802584|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802585|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56802586|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513494|NCT02271360|Cabergoline|cabergoline|mesh-list
56802587|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802589|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802590|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
56802591|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56802592|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
56802593|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802594|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56802595|NCT05360147|Metformin|metformin|mesh-list
56802596|NCT05360147|Liraglutide|liraglutide|mesh-list
56802597|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56802628|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802629|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56802630|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802631|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
56802632|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56802633|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56802634|NCT00538733|Growth Substances|growth substances|mesh-ancestor
56802635|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
56802636|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56802637|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802638|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56802639|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802640|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802641|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56802642|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56802643|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802644|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
56802677|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802678|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802679|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
56802680|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802681|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56542957|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
56542958|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
56291209|NCT05637567|Antipyretics|antipyretics|mesh-ancestor
56542959|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56542960|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56542961|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
56802682|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802683|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56802685|NCT02023463|Goserelin|goserelin|mesh-list
56802686|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56802687|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
56075078|NCT05041322|Buspirone|buspirone|mesh-list
56802715|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802716|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56802717|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802718|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56802719|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56802720|NCT01048983|Analgesics|analgesics|mesh-ancestor
56802721|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
56802722|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802723|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802724|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56802725|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802726|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56802727|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56802728|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56802729|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56802730|NCT00990275|Ethanol|ethanol|mesh-list
56802731|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56802732|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075122|NCT05647356|Bicalutamide|bicalutamide|mesh-list
56802761|NCT01051167|Cetuximab|cetuximab|mesh-list
56802762|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56802763|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802764|NCT01325441|Paclitaxel|paclitaxel|mesh-list
56802765|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56802766|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802767|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
56802768|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
56802769|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
56802770|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802771|NCT00616967|Paclitaxel|paclitaxel|mesh-list
56802772|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56802773|NCT00616967|Carboplatin|carboplatin|mesh-list
56802774|NCT00616967|Vorinostat|vorinostat|mesh-list
56802775|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56802776|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075172|NCT04866108|Capecitabine|capecitabine|mesh-list
56802807|NCT00989651|Cisplatin|cisplatin|mesh-list
56802808|NCT00989651|Carboplatin|carboplatin|mesh-list
56802809|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56802810|NCT00989651|Veliparib|veliparib|mesh-list
56802811|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56802812|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
56802813|NCT00989651|Antibodies|antibodies|mesh-list
56802814|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
56802815|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56802816|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
56802817|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56802818|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802819|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
56802820|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
56802821|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
56075207|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
56802849|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56802850|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56802852|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
56802853|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56802854|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
56802855|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802856|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
56802857|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
56802858|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542962|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542963|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542964|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56542965|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56542966|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56542968|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56542969|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
56542970|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56542971|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542972|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56802859|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802860|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802861|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
56802862|NCT00989729|Hormones|hormones|mesh-ancestor
56802863|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802864|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56802865|NCT00989729|Protective Agents|protective agents|mesh-ancestor
56802866|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56802867|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802868|NCT00989807|Aztreonam|aztreonam|mesh-list
56802905|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56802906|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
56802907|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
56802939|NCT00348933|Betaine|betaine|mesh-list
56802940|NCT00348933|Vitamins|vitamins|mesh-ancestor
56802941|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
56802942|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802943|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
56802944|NCT00348933|Hematinics|hematinics|mesh-ancestor
56802945|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802946|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
56802947|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56802948|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
56802949|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802950|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56802951|NCT01051479|Choline|choline|mesh-list
56075346|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
56802975|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56802976|NCT00444600|Growth Substances|growth substances|mesh-ancestor
56802977|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802978|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
56802979|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802980|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802981|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
56802983|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802984|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802985|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
56802986|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802987|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802988|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
56802989|NCT05357027|Fludarabine|fludarabine|mesh-list
56802990|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802991|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
56802992|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802993|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56802994|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56802995|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
56802996|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802997|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802998|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56802999|NCT00443898|Terbinafine|terbinafine|mesh-list
56803000|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
56803026|NCT04403165|Norepinephrine|norepinephrine|mesh-list
56803027|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56542973|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
56542974|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56542975|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
56542976|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56542977|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56542978|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56542979|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
56542980|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
56542981|NCT00848731|Protective Agents|protective agents|mesh-ancestor
56542982|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
56803028|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56803029|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
56803030|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803031|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803032|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803033|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
56803034|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
56803035|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803036|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56803037|NCT05440487|Chelating Agents|chelating agents|mesh-list
56803038|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
56513937|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56803039|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803040|NCT00440310|Talaporfin|talaporfin|mesh-list
56803041|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803042|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56803043|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
56803044|NCT01055847|Aztreonam|aztreonam|mesh-list
56803045|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56803046|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803047|NCT02533791|Vaccines|vaccines|mesh-list
56803081|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
56803082|NCT02533323|Pegaspargase|pegaspargase|mesh-list
56803083|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56803084|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
56803085|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803086|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803087|NCT02533323|Antiviral Agents|antiviral agents|mesh-ancestor
56803088|NCT02533323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803089|NCT02533323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803124|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803125|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56803126|NCT00356889|Bevacizumab|bevacizumab|mesh-list
56803127|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56075546|NCT04486352|Letrozole|letrozole|mesh-list
56803161|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803162|NCT04715022|Protective Agents|protective agents|mesh-ancestor
56803163|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803164|NCT04715022|Vitamins|vitamins|mesh-ancestor
56803165|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
56803166|NCT00356811|Paclitaxel|paclitaxel|mesh-list
56803167|NCT00356811|Lapatinib|lapatinib|mesh-list
56803168|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56803169|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803170|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
56803203|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803205|NCT04994561|Metformin|metformin|mesh-list
56803206|NCT04994561|Dasatinib|dasatinib|mesh-list
56803207|NCT04994561|Resveratrol|resveratrol|mesh-list
56803208|NCT04994561|Quercetin|quercetin|mesh-list
56803209|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803210|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803211|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803212|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56803213|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803245|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
56803246|NCT03994692|Ether|ether|mesh-list
56542983|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56542984|NCT01209143|Norethindrone|norethindrone|mesh-list
56542985|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
56542986|NCT01209143|Estradiol|estradiol|mesh-list
56542987|NCT01209143|Estrogens|estrogens|mesh-ancestor
56542988|NCT01209143|Hormones|hormones|mesh-ancestor
56542989|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56542990|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56542991|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56542992|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
56803247|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56803248|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
56803249|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
56803250|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803251|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803252|NCT01030926|Insulin|insulin|mesh-list
56803253|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56803254|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
56803255|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803256|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803257|NCT04198805|Vitamins|vitamins|mesh-list
56803258|NCT04198805|Vitamin E|vitamin e|mesh-list
56803291|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803293|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56803294|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56803295|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56803296|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56803297|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803298|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
56803299|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803300|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803301|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56803332|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
56803333|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56803334|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56803335|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56803336|NCT01052025|Curcumin|curcumin|mesh-list
56803337|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56803338|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56803339|NCT01052025|Analgesics|analgesics|mesh-ancestor
56803340|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
56803341|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803342|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514244|NCT04396587|Sufentanil|sufentanil|mesh-list
56803343|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56803344|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56803345|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803381|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803409|NCT04002635|Estrogens|estrogens|mesh-ancestor
56803410|NCT04002635|Hormones|hormones|mesh-ancestor
56803411|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56803412|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514315|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56803413|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56803414|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
56803415|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56803416|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56803417|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803418|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56803419|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56803420|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803421|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803422|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56803423|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
56803425|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
56542993|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56542994|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56542995|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56542996|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56542997|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56542998|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56542999|NCT00454285|Amoxicillin|amoxicillin|mesh-list
56543000|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56543001|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543002|NCT00614965|Irinotecan|irinotecan|mesh-list
56543003|NCT00614965|Pemetrexed|pemetrexed|mesh-list
56543004|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543005|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56543006|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56543007|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803426|NCT01052181|Vitamin D|vitamin d|mesh-list
56803427|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56075809|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
56803456|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803457|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803458|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
56803459|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803460|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56803461|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56803462|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56803463|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56803464|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803465|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56803466|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56803467|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
56803468|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803469|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56803470|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56803471|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
56803472|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56803473|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
56803474|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
56803475|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
56803512|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803513|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803525|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56803526|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56803527|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
56803528|NCT01056627|Valproic Acid|valproic acid|mesh-list
56803529|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
56803530|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803531|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803532|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
56803533|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803534|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803535|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
56803536|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56803537|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803538|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56803539|NCT04273061|Atezolizumab|atezolizumab|mesh-list
56803540|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803541|NCT01053585|Baclofen|baclofen|mesh-list
56803542|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56803543|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803544|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56543008|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803545|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803546|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56803547|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
56803548|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
56803549|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803550|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803551|NCT01564355|Triamcinolone|triamcinolone|mesh-list
56803585|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803586|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56803587|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803588|NCT05355467|Tenofovir|tenofovir|mesh-list
56803589|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
56803619|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56803620|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
56803621|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803622|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803624|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56803625|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
56803626|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803627|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56803628|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56803629|NCT03229499|Anastrozole|anastrozole|mesh-list
56803630|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56803631|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803632|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56803633|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56803634|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076017|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
56803665|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56803666|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803667|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803669|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
56803670|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
56803671|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
56803672|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56803673|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56803674|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56803675|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56803676|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56803710|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56803711|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56547696|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803712|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56803713|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56803714|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803715|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56803716|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
56803717|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
56803745|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56803746|NCT04001855|Protective Agents|protective agents|mesh-ancestor
56803747|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803748|NCT00335829|Bevacizumab|bevacizumab|mesh-list
56803749|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56803750|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803751|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56803752|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56803753|NCT00335829|Growth Substances|growth substances|mesh-ancestor
56803754|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803755|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
56803756|NCT02533011|Heparin|heparin|mesh-list
56803757|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
56803758|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56803759|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56803760|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803761|NCT05262257|Metformin|metformin|mesh-list
56803762|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
56803763|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803764|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803765|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56803766|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543009|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56543010|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56543011|NCT00390325|Sorafenib|sorafenib|mesh-list
56543012|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543013|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56803798|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803800|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803801|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
56803802|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803803|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
56803804|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803805|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
56803806|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56803807|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56803808|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803809|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
56803828|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56803829|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56803830|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56803831|NCT01057875|Caffeine|caffeine|mesh-list
56803832|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56803833|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803834|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56803835|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803836|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803837|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56803838|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56803839|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
56803840|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803841|NCT04001387|Anesthetics|anesthetics|mesh-list
56803842|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803843|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803844|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
56803845|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
56803846|NCT00334737|Hematinics|hematinics|mesh-ancestor
56803847|NCT03986073|Linagliptin|linagliptin|mesh-list
56803848|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803849|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803850|NCT03986073|Incretins|incretins|mesh-ancestor
56803851|NCT03986073|Hormones|hormones|mesh-ancestor
56803852|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56803853|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56803854|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
56803855|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803856|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803857|NCT05347199|Amisulpride|amisulpride|mesh-list
56803858|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56803859|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56803860|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803861|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803862|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56803863|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56803864|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
56803865|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803866|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803867|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56803896|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
56803897|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803898|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56803899|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56803900|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56803901|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56803902|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56803903|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56803904|NCT01060293|Dopamine|dopamine|mesh-list
56803905|NCT01060293|Furosemide|furosemide|mesh-list
56803906|NCT01060293|Diuretics|diuretics|mesh-ancestor
56803907|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
56543014|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543015|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543016|NCT00405613|Aspirin|aspirin|mesh-list
56543017|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56543018|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56543019|NCT00405613|Analgesics|analgesics|mesh-ancestor
56543020|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
56543021|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543022|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803908|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803909|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56803910|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56803911|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803912|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56803932|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56803934|NCT00416598|Etoposide|etoposide|mesh-list
56803935|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
56803936|NCT00416598|Daunorubicin|daunorubicin|mesh-list
56803937|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
56803938|NCT00416598|Busulfan|busulfan|mesh-list
56803939|NCT00416598|Decitabine|decitabine|mesh-list
56803940|NCT00416598|Lenograstim|lenograstim|mesh-list
56803941|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56803942|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803943|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56803944|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56803946|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803947|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56803948|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
56803949|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
56803950|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803951|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56803952|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
56803953|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803954|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56803955|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
56803956|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56803957|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56803958|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56803959|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
56803960|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
56803961|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
56803962|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
56803963|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
56803964|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56803965|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
56803966|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56803967|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56803968|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56803969|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803970|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803971|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
56803972|NCT04001465|Miotics|miotics|mesh-ancestor
56803994|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56803995|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803996|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803998|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56803999|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
56804000|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
56804001|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56804002|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56804003|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804004|NCT00992693|Ribavirin|ribavirin|mesh-list
56804005|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
56473664|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56543023|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543024|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56543025|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56543026|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56804006|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804007|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
56804008|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804009|NCT00992771|Varenicline|varenicline|mesh-list
56804010|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56804011|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56804012|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
56804013|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804014|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804015|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804016|NCT00992849|Bevacizumab|bevacizumab|mesh-list
56804017|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56804018|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804019|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56804020|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56804021|NCT00992849|Growth Substances|growth substances|mesh-ancestor
56804022|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804023|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
56804024|NCT04001231|Exenatide|exenatide|mesh-list
56804045|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56804046|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56804047|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56804048|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56804049|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
56804050|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56804051|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
56804052|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804053|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
56804054|NCT00993707|Protective Agents|protective agents|mesh-ancestor
56804055|NCT00473330|Ranibizumab|ranibizumab|mesh-list
56804056|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56804057|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56804058|NCT00473330|Growth Substances|growth substances|mesh-ancestor
56804059|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804060|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
56804061|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804062|NCT00416520|Sevelamer|sevelamer|mesh-list
56804063|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
56804064|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
56804065|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804066|NCT00533429|Bevacizumab|bevacizumab|mesh-list
56804067|NCT00533429|Carboplatin|carboplatin|mesh-list
56804068|NCT00533429|Pemetrexed|pemetrexed|mesh-list
56804069|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56804070|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804071|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56804072|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56804073|NCT00533429|Growth Substances|growth substances|mesh-ancestor
56804074|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804075|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
56804076|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804077|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804078|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56804108|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56804109|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804110|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56804111|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804112|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
56804113|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804114|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
56804115|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804116|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
56804117|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804118|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
56804119|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804120|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804121|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56543027|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543028|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56543030|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543031|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
56804122|NCT00993863|Ibuprofen|ibuprofen|mesh-list
56804123|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56804124|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56804125|NCT00993863|Analgesics|analgesics|mesh-ancestor
56804126|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
56804127|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804156|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
56804157|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804158|NCT00994097|Antiviral Agents|antiviral agents|mesh-ancestor
56804159|NCT00994097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804160|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804161|NCT00994097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804162|NCT00994097|Immunologic Factors|immunologic factors|mesh-ancestor
56804163|NCT00994097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804164|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56804165|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56804166|NCT04000919|Carbidopa|carbidopa|mesh-list
56804167|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56804168|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56804169|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
56804170|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804171|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804172|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804173|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56804174|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804204|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56804205|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56804206|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804207|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
56804208|NCT00332709|Letrozole|letrozole|mesh-list
56804209|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804210|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56804211|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56804212|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804213|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804214|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56804215|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
56804216|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804217|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804218|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56804219|NCT03988725|Vitamin E|vitamin e|mesh-list
56804220|NCT03988725|Vitamins|vitamins|mesh-ancestor
56804246|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804248|NCT03983889|Fentanyl|fentanyl|mesh-list
56804249|NCT03983889|Midazolam|midazolam|mesh-list
56804250|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
56804251|NCT03983889|Remifentanil|remifentanil|mesh-list
56804252|NCT03983889|Propofol|propofol|mesh-list
56804253|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56804254|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56804255|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804256|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56804257|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
56804258|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
56804259|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56804260|NCT03983889|Analgesics|analgesics|mesh-ancestor
56804261|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
56804262|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804263|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56804264|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56804265|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56804266|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
56804267|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804295|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804296|NCT00352755|Antidotes|antidotes|mesh-ancestor
56804297|NCT00352755|Protective Agents|protective agents|mesh-ancestor
56543032|NCT02703961|Cisplatin|cisplatin|mesh-list
56543033|NCT02703961|Docetaxel|docetaxel|mesh-list
56543034|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804298|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
56804299|NCT00352755|Vitamins|vitamins|mesh-ancestor
56804300|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
56804301|NCT00533897|Abatacept|abatacept|mesh-list
56804302|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56804303|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804304|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804305|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804306|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
56804307|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804308|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56804309|NCT00426660|Maraviroc|maraviroc|mesh-list
56804310|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56804311|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56515216|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56804312|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804313|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56804314|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56804315|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
56804316|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076649|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56804348|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804349|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804350|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804352|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56804353|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
56804354|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
56804355|NCT00324987|Antibodies|antibodies|mesh-list
56804356|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
56804357|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56804358|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
56804359|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804360|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56804392|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56804393|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804394|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
56804395|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
56804396|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
56804397|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804398|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804399|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
56804400|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804401|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56804402|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56804403|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
56804404|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56804429|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804430|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
56804431|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804432|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56804433|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56804434|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
56804435|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804436|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804437|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56804438|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56804439|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
56804440|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
56804441|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804442|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56804443|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
56804445|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804446|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56804447|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56804448|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56804449|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56804450|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804451|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56804452|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56543036|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
56543037|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
56543038|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804453|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56804454|NCT01055301|Growth Substances|growth substances|mesh-ancestor
56804455|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
56804456|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
56804457|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56804458|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804489|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56804490|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56804491|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804492|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
56804493|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
56804494|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
56804495|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804496|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804497|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56804498|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56804499|NCT00532493|Prazosin|prazosin|mesh-list
56804500|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56804501|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56076856|NCT05369052|Linezolid|linezolid|mesh-list
56804524|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56804525|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
56804526|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804527|NCT00352053|Tenofovir|tenofovir|mesh-list
56804528|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
56804529|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804530|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56804531|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56804532|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804533|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804534|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56804535|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56804536|NCT00995033|Varenicline|varenicline|mesh-list
56804537|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56804538|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56804539|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
56804540|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804541|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804542|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804543|NCT00997061|Topotecan|topotecan|mesh-list
56804544|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56804545|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56804546|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804547|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804548|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804549|NCT00351819|Testosterone|testosterone|mesh-list
56804550|NCT00351819|Androgens|androgens|mesh-ancestor
56804551|NCT00351819|Hormones|hormones|mesh-ancestor
56804552|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804574|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804575|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804576|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56804577|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56804578|NCT00436332|Bevacizumab|bevacizumab|mesh-list
56804579|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56804580|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56804581|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804582|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56804583|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56804584|NCT00436332|Growth Substances|growth substances|mesh-ancestor
56804585|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804586|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56804587|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804588|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804589|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804590|NCT00532259|Pidilizumab|pidilizumab|mesh-list
56543039|NCT02703649|Letrozole|letrozole|mesh-list
56543040|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543041|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56543042|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55717751|NCT02344095|Paclitaxel|paclitaxel|mesh-list
56804591|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56804592|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804593|NCT00322491|Plerixafor|plerixafor|mesh-list
56804594|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56804595|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56804596|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
56804597|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804598|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
56804599|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56804600|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804601|NCT00997607|Vaccines|vaccines|mesh-list
56804602|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
56804603|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804604|NCT00997685|Capecitabine|capecitabine|mesh-list
56804605|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
56804640|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56804641|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076999|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804667|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56804668|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804669|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56804670|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56804671|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56804672|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
56804673|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804674|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804675|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804676|NCT01004315|Urological Agents|urological agents|mesh-ancestor
56804678|NCT05239637|Calcium heparin|calcium heparin|mesh-list
56804679|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
56804680|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56804681|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56804682|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804683|NCT01005095|Vitamin D|vitamin d|mesh-list
56804684|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
56804685|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
56804686|NCT01005095|Vitamins|vitamins|mesh-list
56804687|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
56804688|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804720|NCT01006031|Interferons|interferons|mesh-list
56804721|NCT01006031|Ribavirin|ribavirin|mesh-list
56804722|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
56804723|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
56804724|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56804725|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804726|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
56804727|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804728|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
56804729|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804730|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
56804754|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804755|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
56804756|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56804757|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
56804758|NCT03882047|Fluticasone|fluticasone|mesh-list
56804759|NCT03882047|Xhance|xhance|mesh-list
56804760|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
56804761|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56804762|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56804763|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
56804764|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804765|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804766|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56804767|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
56804768|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
56804769|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56804770|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56804771|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56543043|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543044|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543045|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56543046|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
56543047|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543048|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543049|NCT02703571|Trametinib|trametinib|mesh-list
56543050|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543051|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543052|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543053|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543054|NCT02703415|Tramadol|tramadol|mesh-list
56543055|NCT02703415|Bupivacaine|bupivacaine|mesh-list
56543056|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
56543057|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
56543058|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56804772|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56804773|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
56804774|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804775|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56804776|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56804777|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804778|NCT00530621|Pemetrexed|pemetrexed|mesh-list
56804779|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077126|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
56804805|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804806|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56804807|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
56804808|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56804809|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56804810|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56804811|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56804812|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56804813|NCT00999479|Trace Elements|trace elements|mesh-ancestor
56804814|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
56804815|NCT00999557|Bimatoprost|bimatoprost|mesh-list
56804816|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56804817|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56804818|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56804819|NCT01008137|Vaccines|vaccines|mesh-list
56804820|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
56804821|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804822|NCT00999791|Diclofenac|diclofenac|mesh-list
56804823|NCT00999791|Bevacizumab|bevacizumab|mesh-list
56804824|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56804825|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804826|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56804827|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56804855|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
56804857|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804858|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804859|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
56804860|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804861|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56804862|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804863|NCT01008293|Lactulose|lactulose|mesh-list
56804864|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56804865|NCT01008527|Poly ICLC|poly iclc|mesh-list
56543059|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543060|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
56543061|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543062|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56543063|NCT02703415|Narcotics|narcotics|mesh-ancestor
56543064|NCT02703415|Analgesics|analgesics|mesh-ancestor
56543065|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
56543066|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56543067|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543068|NCT04215835|Letrozole|letrozole|mesh-list
56543069|NCT04215835|Misoprostol|misoprostol|mesh-list
56543070|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543071|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56543072|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56543073|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543074|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543075|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56543076|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
56543077|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197235|NCT01506921|Ketamine|ketamine|mesh-list
56804866|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
56804867|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
56804868|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804869|NCT01000415|Cisplatin|cisplatin|mesh-list
56804870|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804871|NCT01008761|Azithromycin|azithromycin|mesh-list
56804872|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56804873|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804898|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804899|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56804900|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804901|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804902|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
56804903|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56804904|NCT00530075|Protective Agents|protective agents|mesh-ancestor
56804905|NCT01001585|Sevoflurane|sevoflurane|mesh-list
56804906|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56804907|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56804908|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
56804909|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
56804910|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56804911|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804912|NCT01001897|Misoprostol|misoprostol|mesh-list
56804913|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56804914|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
56804915|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56804916|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804917|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56804918|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56804919|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
56804920|NCT05734001|Hemostatics|hemostatics|mesh-list
56804921|NCT05734001|Coagulants|coagulants|mesh-ancestor
56804922|NCT05733923|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56804924|NCT05733923|Disinfectants|disinfectants|mesh-ancestor
56804925|NCT05733923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804962|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804963|NCT01003613|Tranilast|tranilast|mesh-list
56543078|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543079|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56543080|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
56543081|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56543082|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56543083|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56543084|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
56543085|NCT01208207|Naproxen|naproxen|mesh-list
56543086|NCT01208207|Etoricoxib|etoricoxib|mesh-list
56543087|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56543088|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56543089|NCT01208207|Analgesics|analgesics|mesh-ancestor
56543090|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
56804964|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56804965|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56804966|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56804967|NCT01003613|Analgesics|analgesics|mesh-ancestor
56805003|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56077357|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
56805038|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56805040|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805041|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077411|NCT02446496|Cefadroxil|cefadroxil|mesh-list
56805070|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56805071|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
56805072|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805073|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805074|NCT05685953|Vaccines|vaccines|mesh-list
56805075|NCT05685953|Immunologic Factors|immunologic factors|mesh-ancestor
56805076|NCT05685953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805077|NCT00486434|Calcitonin|calcitonin|mesh-list
56805078|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
56805079|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56805080|NCT00486434|Katacalcin|katacalcin|mesh-list
56805081|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56805082|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805083|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56805084|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
56805085|NCT00529451|Ramipril|ramipril|mesh-list
56805086|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56805087|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
56805122|NCT05638217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805123|NCT05637281|Indomethacin|indomethacin|mesh-list
56805124|NCT05637281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56805125|NCT05637281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56805126|NCT05637281|Analgesics|analgesics|mesh-ancestor
56805127|NCT05637281|Sensory System Agents|sensory system agents|mesh-ancestor
56077480|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
56805151|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56805152|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805153|NCT00351273|Azithromycin|azithromycin|mesh-list
56805154|NCT00351273|Doxycycline|doxycycline|mesh-list
56805155|NCT00351273|Rifampin|rifampin|mesh-list
56805156|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56805157|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805158|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
56805159|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56805160|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56805161|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56805162|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
56805163|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
56805164|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56805165|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543091|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543092|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543093|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56197266|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
56805166|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805167|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56805168|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56805169|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56805170|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56805171|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56805172|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56805173|NCT00327717|Zonisamide|zonisamide|mesh-list
56805174|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
56805175|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56805176|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56077522|NCT00363350|Rituximab|rituximab|mesh-list
56805207|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805208|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56805209|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56805210|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
56805211|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
56805212|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
56805213|NCT00424476|Belimumab|belimumab|mesh-list
56805214|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56805215|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
56805216|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805217|NCT01037634|Oseltamivir|oseltamivir|mesh-list
56805218|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
56805219|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805220|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805221|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805252|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805253|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805254|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56805255|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56805257|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805258|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56805259|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805260|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805261|NCT01032486|Rasagiline|rasagiline|mesh-list
56805262|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56805263|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077620|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805297|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56805298|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
56805299|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805300|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805301|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56805302|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
56077666|NCT02454296|Lidocaine|lidocaine|mesh-list
56805330|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
56805331|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805332|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56805333|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
56805335|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56805336|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56805337|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
56805338|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805339|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805340|NCT00461708|Antiviral Agents|antiviral agents|mesh-ancestor
56805341|NCT00461708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805342|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805343|NCT00461708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56805344|NCT00461708|Immunologic Factors|immunologic factors|mesh-ancestor
56805345|NCT00461708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805346|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56805347|NCT00327171|Aflibercept|aflibercept|mesh-list
56805348|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56077717|NCT05710783|Vaccines|vaccines|mesh-list
56543094|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56805418|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
56805419|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56805420|NCT01025570|Gemcitabine|gemcitabine|mesh-list
56805421|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56805422|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
56805423|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805424|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805425|NCT01025570|Antiviral Agents|antiviral agents|mesh-ancestor
56805426|NCT01025570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805427|NCT01025570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805462|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
56805463|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805464|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56805465|NCT00468728|Vancomycin|vancomycin|mesh-list
56805466|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56805500|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56805501|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805502|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56805503|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56805504|NCT01022918|Growth Substances|growth substances|mesh-ancestor
56805505|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805506|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
56077862|NCT04782804|Capecitabine|capecitabine|mesh-list
56805535|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
56805537|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
56805538|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
56805539|NCT00467870|Testosterone|testosterone|mesh-list
56805540|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
56805541|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
56805542|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56805543|NCT00467870|Androgens|androgens|mesh-ancestor
56805544|NCT00467870|Hormones|hormones|mesh-ancestor
56805545|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805546|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805547|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56805548|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805549|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
56805577|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805578|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
56805579|NCT00452348|Hormones|hormones|mesh-ancestor
56805580|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805581|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
56805582|NCT01323062|Bavituximab|bavituximab|mesh-list
56805583|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56805584|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805585|NCT00320541|Gemcitabine|gemcitabine|mesh-list
56805586|NCT00320541|Paclitaxel|paclitaxel|mesh-list
56805587|NCT00320541|Bevacizumab|bevacizumab|mesh-list
56805588|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56805589|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805591|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
56805592|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
56805593|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805594|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56805595|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56805596|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56805597|NCT00320541|Growth Substances|growth substances|mesh-ancestor
56077945|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
56805630|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805632|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
56805633|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56805634|NCT00319839|Paclitaxel|paclitaxel|mesh-list
56805635|NCT00319839|Cetuximab|cetuximab|mesh-list
56805636|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56805637|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56805638|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805639|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
56805640|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
56805674|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56805675|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56805676|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56805677|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56805678|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
56543095|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
56543096|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56543097|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543098|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543099|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56543100|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
56543101|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56543102|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543104|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543105|NCT01012713|Calcitriol|calcitriol|mesh-list
56543106|NCT01012713|Clobetasol|clobetasol|mesh-list
56291361|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
56197271|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
56805679|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805710|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805711|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
56805712|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56805713|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56805714|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
56805715|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
56805716|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56805717|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56805718|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56805719|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
56805720|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805721|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805722|NCT01064115|Cetirizine|cetirizine|mesh-list
56805723|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56078076|NCT00359905|Tamsulosin|tamsulosin|mesh-list
56805755|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805756|NCT01038570|Oxytocin|oxytocin|mesh-list
56805757|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
56805758|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56805759|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805760|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56805761|NCT00420342|Drospirenone|drospirenone|mesh-list
56805762|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56805763|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56805764|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
56805797|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805798|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56805799|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56805800|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805801|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805802|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56805803|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56805837|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56805838|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56805839|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
56805840|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56805841|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56805842|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56805843|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56805844|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805868|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56805869|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
56805870|NCT01023230|Entecavir|entecavir|mesh-list
56805871|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
56805872|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805873|NCT01027832|Tazobactam|tazobactam|mesh-list
56805874|NCT01027832|Piperacillin|piperacillin|mesh-list
56068040|NCT05442905|Atracurium|atracurium|mesh-list
56543107|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543108|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
56543109|NCT01012713|Hormones|hormones|mesh-ancestor
56197283|NCT01507272|Liraglutide|liraglutide|mesh-list
56805875|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56805876|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56805877|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805878|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56805879|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805880|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805881|NCT00413010|Pregabalin|pregabalin|mesh-list
56805882|NCT00413010|Analgesics|analgesics|mesh-ancestor
56805883|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
56805884|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805885|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805886|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
56805887|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56805888|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56805889|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805890|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56805891|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56805892|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56805893|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56805894|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56805895|NCT00459290|Mifepristone|mifepristone|mesh-list
56805896|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56805897|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
56805898|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56805923|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56805925|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56805926|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
56805927|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805928|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805929|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56805930|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
56805931|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
56805932|NCT00419952|Hormones|hormones|mesh-ancestor
56805933|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805934|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56805935|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56805936|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56805937|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
56805938|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805939|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805940|NCT00443456|Amlodipine|amlodipine|mesh-list
56805941|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56805942|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56805943|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56078301|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56078350|NCT00361075|Estrogens|estrogens|mesh-list
56806015|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806016|NCT00431496|Cinacalcet|cinacalcet|mesh-list
56806017|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56806018|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806019|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56806020|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
56806055|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806056|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
56806057|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806058|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806059|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56806060|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
56806061|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806092|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
56806093|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
56806094|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806095|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806096|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56806097|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56543110|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543117|NCT01012713|Vitamins|vitamins|mesh-ancestor
56543182|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
56543183|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
56806098|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
56806099|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56806100|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56806101|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56806102|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56806103|NCT01023464|Emollients|emollients|mesh-list
56806104|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56806133|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56806134|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806135|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806136|NCT00441584|Ribavirin|ribavirin|mesh-list
56806137|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56806138|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
56806139|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
56806140|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806141|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
56806142|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806143|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
56806144|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806145|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
56806146|NCT00430716|Citric Acid|citric acid|mesh-list
56806147|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
56806148|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
56806149|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56806150|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
56078509|NCT03654768|Dasatinib|dasatinib|mesh-list
56806180|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56806181|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56806182|NCT00430638|Olmesartan|olmesartan|mesh-list
56806183|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56806184|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56806185|NCT00430638|Diuretics|diuretics|mesh-ancestor
56806186|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
56806187|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806188|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56806189|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56806190|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806191|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56806192|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56806193|NCT03671330|Letrozole|letrozole|mesh-list
56806194|NCT03671330|Goserelin|goserelin|mesh-list
56806195|NCT03671330|Anastrozole|anastrozole|mesh-list
56806196|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806197|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56806230|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806231|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806232|NCT00441116|Dutasteride|dutasteride|mesh-list
56806233|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56806234|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56806235|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806236|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806237|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
56806265|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56806266|NCT01024322|Protective Agents|protective agents|mesh-ancestor
56806267|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56806268|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806269|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56806270|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806271|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806273|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56806274|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806275|NCT00430248|Allopurinol|allopurinol|mesh-list
56806276|NCT00430248|Febuxostat|febuxostat|mesh-list
56806277|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
56806278|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806279|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806280|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
56806281|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806282|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56806283|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
56806313|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806315|NCT00428844|Daptomycin|daptomycin|mesh-list
56806316|NCT00428844|Teicoplanin|teicoplanin|mesh-list
56543184|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543185|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543186|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56543187|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
56543188|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
56543189|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56543190|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
56197367|NCT01507519|Sirolimus|sirolimus|mesh-list
56806317|NCT00428844|Floxacillin|floxacillin|mesh-list
56806318|NCT00428844|Oxacillin|oxacillin|mesh-list
56806319|NCT00428844|Nafcillin|nafcillin|mesh-list
56806320|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56806321|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806322|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56806323|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
56806324|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806325|NCT01039194|Galantamine|galantamine|mesh-list
56806326|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56806327|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806328|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078696|NCT00589316|Iodine|iodine|mesh-list
56806360|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56806361|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56806362|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56806363|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56806364|NCT00418938|Leucovorin|leucovorin|mesh-list
56806365|NCT00418938|Bevacizumab|bevacizumab|mesh-list
56806366|NCT00418938|Panitumumab|panitumumab|mesh-list
56806367|NCT00418938|Fluorouracil|fluorouracil|mesh-list
56806368|NCT00418938|Irinotecan|irinotecan|mesh-list
56806369|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56806370|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806371|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56806408|NCT01039506|Irinotecan|irinotecan|mesh-list
56806409|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56806410|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56806411|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806412|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806413|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806445|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
56806446|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806447|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806448|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
56806449|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806450|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56806451|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806452|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
56806453|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806454|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56806455|NCT01039740|Mirtazapine|mirtazapine|mesh-list
56806456|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
56806457|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56806489|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
56806490|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806491|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806492|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56806493|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56806494|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
56806495|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806496|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56806497|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56806498|NCT00307437|Ustekinumab|ustekinumab|mesh-list
56806499|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
56806532|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
56806533|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806534|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56806536|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806537|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56806538|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
56543191|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543192|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543193|NCT01006707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56543194|NCT01006707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56543195|NCT01006707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543196|NCT01006707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56543197|NCT01006707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56543198|NCT01006629|Palivizumab|palivizumab|mesh-list
56543199|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
56543200|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543201|NCT04214977|Anesthetics|anesthetics|mesh-list
56543202|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543203|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543205|NCT02701933|Analgesics|analgesics|mesh-ancestor
56543206|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
56543207|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543208|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543209|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56543210|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56543211|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
56543212|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
56543213|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543214|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56543215|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56543216|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806539|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
56806540|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
56806541|NCT01030016|Atenolol|atenolol|mesh-list
56806542|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56806543|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56806578|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56806579|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56806580|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56806581|NCT01030094|Analgesics|analgesics|mesh-ancestor
56806582|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
56078945|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806615|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56806616|NCT00405756|Analgesics|analgesics|mesh-ancestor
56806617|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
56806618|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806619|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806620|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56806621|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56806622|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806623|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56806624|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56806662|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
56806699|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56543217|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543218|NCT04295967|Formaldehyde|formaldehyde|mesh-list
56543219|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
56543220|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543221|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
56543222|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
56543223|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543224|NCT02871765|Warfarin|warfarin|mesh-list
56543225|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
56543226|NCT02549209|Paclitaxel|paclitaxel|mesh-list
56806700|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
56806737|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56806775|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56806777|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806778|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56806813|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56806814|NCT03802058|Paclitaxel|paclitaxel|mesh-list
56806815|NCT03802058|Carboplatin|carboplatin|mesh-list
56806816|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56806817|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806818|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
56806819|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
56806820|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
56806855|NCT00455312|Protective Agents|protective agents|mesh-ancestor
56806856|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56806857|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
56806858|NCT01031030|Fluorouracil|fluorouracil|mesh-list
56806859|NCT01031030|Methotrexate|methotrexate|mesh-list
56806861|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806862|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
56806896|NCT00444626|Lidocaine|lidocaine|mesh-list
56806897|NCT00444626|Prilocaine|prilocaine|mesh-list
56806898|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56806899|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
56806900|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
56806901|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
56806902|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56806903|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806936|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806937|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
56806938|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806939|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
56806940|NCT00439244|Teriparatide|teriparatide|mesh-list
56806941|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56806942|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806943|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56806975|NCT01033760|Maraviroc|maraviroc|mesh-list
56806976|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56806977|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56806978|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
56806979|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806980|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806981|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56806982|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56806983|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
56806984|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806985|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56806986|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56806987|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56806988|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56807023|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807024|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
56807025|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807027|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56807028|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
56807029|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807030|NCT00410046|Etanercept|etanercept|mesh-list
56543227|NCT02549209|Carboplatin|carboplatin|mesh-list
56543228|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
56543229|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56543230|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543231|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
56120614|NCT01852812|Montelukast|montelukast|mesh-list
56807031|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56807062|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56807063|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56807064|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56807065|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807066|NCT01037322|Cannabidiol|cannabidiol|mesh-list
56807067|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
56807068|NCT01070758|Lanreotide|lanreotide|mesh-list
56807069|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807070|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
56807071|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56807072|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807073|NCT01031966|Thymalfasin|thymalfasin|mesh-list
56807074|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56807075|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
56807076|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807077|NCT00436436|Temozolomide|temozolomide|mesh-list
56807078|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56079433|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56807109|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807110|NCT00436280|Antiviral Agents|antiviral agents|mesh-ancestor
56807111|NCT00436280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807112|NCT00436280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807113|NCT00436280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807114|NCT00394836|Ofatumumab|ofatumumab|mesh-list
56807115|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56807116|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807117|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
56807118|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807119|NCT01040598|Omalizumab|omalizumab|mesh-list
56807120|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56807121|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56807122|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
56807157|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
56807158|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807191|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
56807192|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
56807193|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807194|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56807195|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56807196|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56807197|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56807198|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56807199|NCT03741478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56807234|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56807235|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807236|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56807237|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56807238|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
56807239|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807265|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807266|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
56807267|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807268|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807269|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56807270|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
56807271|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807272|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807273|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56807274|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
56807275|NCT00434954|Exenatide|exenatide|mesh-list
56807276|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56807277|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807278|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56543232|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
56543233|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
56120749|NCT01848210|Troxerutin|troxerutin|mesh-list
56807279|NCT00434954|Incretins|incretins|mesh-ancestor
56807280|NCT00434954|Hormones|hormones|mesh-ancestor
56807281|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807282|NCT00276484|Atorvastatin|atorvastatin|mesh-list
56807283|NCT00276484|Ezetimibe|ezetimibe|mesh-list
56807284|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56807285|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56807286|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
56807287|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807288|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56807317|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
56807318|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807319|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807320|NCT00276094|Tamoxifen|tamoxifen|mesh-list
56807321|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56807322|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
56807323|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807324|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807325|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56807326|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807327|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56807328|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56807329|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56807330|NCT03975088|Ranibizumab|ranibizumab|mesh-list
56807363|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807364|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807365|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56807366|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56807367|NCT00434642|Growth Substances|growth substances|mesh-ancestor
56807368|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807369|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
56807370|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56807371|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
56807372|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807373|NCT00434642|Antiviral Agents|antiviral agents|mesh-ancestor
56807405|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
56807406|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
56807407|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
56807408|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807409|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807410|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56807411|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56807412|NCT00434252|Growth Substances|growth substances|mesh-ancestor
56807413|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807414|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
56807415|NCT00425750|Docetaxel|docetaxel|mesh-list
56807446|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56807447|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
56807448|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
56807449|NCT00240994|Sirolimus|sirolimus|mesh-list
56807450|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
56807451|NCT00240994|Tacrolimus|tacrolimus|mesh-list
56807452|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807453|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
56807454|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807455|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56807456|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807457|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807490|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56807491|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807492|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
56807493|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
56807494|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807495|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807496|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56807497|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56807564|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56068135|NCT01951339|Incretins|incretins|mesh-ancestor
56543234|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543235|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807565|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807566|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56807567|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56807569|NCT02732288|Melatonin|melatonin|mesh-list
56807570|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
56807571|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807572|NCT02732288|Protective Agents|protective agents|mesh-ancestor
56807573|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807574|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56807606|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807607|NCT01041378|Dexamethasone|dexamethasone|mesh-list
56807608|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56807609|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
56807610|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
56807611|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807612|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807613|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56807614|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
56807615|NCT01041378|Hormones|hormones|mesh-ancestor
56807616|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807655|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807656|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56807657|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56807689|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
56807690|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807692|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
56807693|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807694|NCT03970798|Midazolam|midazolam|mesh-list
56807695|NCT03970798|Caffeine|caffeine|mesh-list
56807696|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56807697|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56807698|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56807699|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56807700|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807701|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56807702|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56807733|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56807734|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
56807735|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807736|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56807737|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56807738|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807739|NCT01037660|Metformin|metformin|mesh-list
56807740|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56807741|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807742|NCT00236080|Modafinil|modafinil|mesh-list
56807743|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56807744|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807745|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56080115|NCT00004077|Paclitaxel|paclitaxel|mesh-list
56807769|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807770|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807771|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807772|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56807773|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56807774|NCT00234052|Bevacizumab|bevacizumab|mesh-list
56807775|NCT00234052|Carboplatin|carboplatin|mesh-list
56807776|NCT00234052|Pemetrexed|pemetrexed|mesh-list
56807777|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807778|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807779|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56807780|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56807781|NCT00234052|Growth Substances|growth substances|mesh-ancestor
56807782|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807783|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
56807784|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807785|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807786|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56543236|NCT02698267|Itraconazole|itraconazole|mesh-list
56543237|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
56543238|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543239|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56543240|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56543241|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543242|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543243|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56543244|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
56543245|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543246|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543247|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56543248|NCT01011465|Oxytocin|oxytocin|mesh-list
56807787|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56807788|NCT00408408|Gemcitabine|gemcitabine|mesh-list
56807789|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
56807790|NCT00408408|Bevacizumab|bevacizumab|mesh-list
56807791|NCT00408408|Docetaxel|docetaxel|mesh-list
56807792|NCT00408408|Doxorubicin|doxorubicin|mesh-list
56807793|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56807794|NCT00408408|Capecitabine|capecitabine|mesh-list
56807795|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807821|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
56807822|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807823|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
56807824|NCT03973840|Testosterone|testosterone|mesh-list
56807825|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
56807826|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
56807827|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56807828|NCT03973840|Androgens|androgens|mesh-ancestor
56807829|NCT03973840|Hormones|hormones|mesh-ancestor
56807830|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807831|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807832|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56807833|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807834|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
56807835|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56807836|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807837|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807838|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518728|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
56807839|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56807840|NCT00413972|Simvastatin|simvastatin|mesh-list
56807841|NCT00413972|Ezetimibe|ezetimibe|mesh-list
56807842|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56807843|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56807844|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
56807865|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807866|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
56807867|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807868|NCT00209170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56807869|NCT00209170|Antidepressive Agents|antidepressive agents|mesh-ancestor
56807870|NCT00209170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56807871|NCT01071694|Interferons|interferons|mesh-list
56807872|NCT01071694|Interferon-beta|interferon-beta|mesh-list
56807873|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
56807874|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807875|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
56807876|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807877|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
56807878|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807879|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56543249|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
56543250|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56543251|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543252|NCT02494141|Curcumin|curcumin|mesh-list
56543253|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56543254|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56543255|NCT02494141|Analgesics|analgesics|mesh-ancestor
56291514|NCT05597553|Pemetrexed|pemetrexed|mesh-list
56543256|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
56543257|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543258|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543259|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543260|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56197432|NCT01507792|Loratadine|loratadine|mesh-list
56807880|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
56807881|NCT00413894|Hematinics|hematinics|mesh-ancestor
56807882|NCT03972748|Itraconazole|itraconazole|mesh-list
56807883|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
56807884|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807885|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56807886|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56807887|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807888|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807889|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56807890|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
56807891|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807892|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807893|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56807894|NCT01581814|Metformin|metformin|mesh-list
56807895|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56807928|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807929|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56807930|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
56807931|NCT03972982|Insulin|insulin|mesh-list
56807932|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56807933|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56807934|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807935|NCT00403494|Verapamil|verapamil|mesh-list
56807936|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56807937|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56080315|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
56807967|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807968|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
56807969|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56807970|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
56807971|NCT00406692|Zonisamide|zonisamide|mesh-list
56807972|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
56807973|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56807974|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807975|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807976|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56807977|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807978|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
56807979|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56807980|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
56807981|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56807982|NCT00004494|Protective Agents|protective agents|mesh-ancestor
56807983|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808010|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56808012|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56543261|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543262|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718886|NCT03503227|Analgesics|analgesics|mesh-ancestor
56808013|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808014|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
56808015|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808016|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808017|NCT01066299|Oxytocin|oxytocin|mesh-list
56808018|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
56808019|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56808020|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808021|NCT00307047|Paclitaxel|paclitaxel|mesh-list
56808022|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56808023|NCT00307047|Everolimus|everolimus|mesh-list
56808024|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56808025|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808026|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
56808027|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
56808028|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
56808029|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808030|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808031|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
56808032|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808033|NCT01066377|Sulfalene|sulfalene|mesh-list
56080405|NCT00005031|Irofulven|irofulven|mesh-list
56808063|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808064|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56808065|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
56808066|NCT00391170|Hormones|hormones|mesh-ancestor
56808067|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808068|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808069|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808070|NCT00402324|Valproic Acid|valproic acid|mesh-list
56808071|NCT00402324|Olanzapine|olanzapine|mesh-list
56808072|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
56808073|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
56808074|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808075|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080451|NCT00004221|Paclitaxel|paclitaxel|mesh-list
56808108|NCT00306189|Denosumab|denosumab|mesh-list
56808109|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56808110|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808111|NCT00305877|Gemcitabine|gemcitabine|mesh-list
56808112|NCT00305877|Bevacizumab|bevacizumab|mesh-list
56808113|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56808114|NCT00305877|Cetuximab|cetuximab|mesh-list
56808115|NCT00305877|Capecitabine|capecitabine|mesh-list
56808116|NCT00305877|Antibodies|antibodies|mesh-list
56808117|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
56808118|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56808119|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808153|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56808155|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808156|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808157|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56808158|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56808159|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
56808189|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808190|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56808191|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
56808192|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56808193|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808194|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56808195|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56808196|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56808197|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56808198|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808199|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56808200|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56808201|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808202|NCT01063101|Fucoidan|fucoidan|mesh-list
56808235|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808237|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
56808238|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56543263|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543264|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56543265|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56808239|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808240|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56808241|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56808242|NCT01063179|Growth Substances|growth substances|mesh-ancestor
56808243|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
56808244|NCT00293709|Etanercept|etanercept|mesh-list
56808245|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56808273|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
56808274|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808275|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808276|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808277|NCT03980379|Rituximab|rituximab|mesh-list
56808278|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808279|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808280|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
56808281|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808282|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808283|NCT01064271|Risperidone|risperidone|mesh-list
56808284|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56808285|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
56808286|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808287|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808288|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808289|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56808290|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56808366|NCT01067391|Urological Agents|urological agents|mesh-ancestor
56808367|NCT00402168|Cyclosporine|cyclosporine|mesh-list
56808368|NCT00402168|Abatacept|abatacept|mesh-list
56808403|NCT01067547|Iron|iron|mesh-list
56808404|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56808405|NCT01067547|Trace Elements|trace elements|mesh-ancestor
56808406|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
56808407|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808408|NCT01067547|Hematinics|hematinics|mesh-ancestor
56808409|NCT00290511|Dexamethasone|dexamethasone|mesh-list
56808410|NCT00290511|Rituximab|rituximab|mesh-list
56808446|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808447|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808448|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56808449|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
56080837|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
56808476|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56808477|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
56808478|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
56808479|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
56808480|NCT00304083|Doxorubicin|doxorubicin|mesh-list
56808481|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56808482|NCT00304083|Etoposide|etoposide|mesh-list
56808483|NCT00304083|Ifosfamide|ifosfamide|mesh-list
56808484|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56808485|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808486|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56808487|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56808488|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808489|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808490|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56808491|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56808492|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
56808493|NCT01069965|BGP 15|bgp 15|mesh-list
56808494|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808495|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808496|NCT00391092|Bevacizumab|bevacizumab|mesh-list
56808524|NCT00374556|Eszopiclone|eszopiclone|mesh-list
56808525|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56808526|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56808527|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808528|NCT01064973|Baclofen|baclofen|mesh-list
56808529|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56808530|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808531|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56543266|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56543267|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543268|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
56543269|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56543270|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
56543271|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
56543272|NCT04214821|Levofloxacin|levofloxacin|mesh-list
56543273|NCT04214821|Ofloxacin|ofloxacin|mesh-list
56543274|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56543275|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56543276|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56197446|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
56808532|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808533|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56808534|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
56808535|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
56808536|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808537|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808538|NCT00374322|Lapatinib|lapatinib|mesh-list
56808539|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808540|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56808541|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808542|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808571|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808572|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56808573|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808575|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56808576|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56808577|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56808578|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56808579|NCT00288639|Pregabalin|pregabalin|mesh-list
56808580|NCT00288639|Analgesics|analgesics|mesh-ancestor
56808581|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
56808582|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808583|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808584|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
56808585|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56808586|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56808587|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080969|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
56808613|NCT00390546|Propranolol|propranolol|mesh-list
56808614|NCT00390546|Digoxin|digoxin|mesh-list
56808615|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56808616|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56808617|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56808618|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808619|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808620|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808621|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56808622|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56808623|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
56808624|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56808625|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808626|NCT00390546|Protective Agents|protective agents|mesh-ancestor
56808627|NCT00400764|Rituximab|rituximab|mesh-list
56808628|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808629|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808630|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
56808631|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808632|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808633|NCT00302211|Bosentan|bosentan|mesh-list
56808634|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
56808663|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56808664|NCT01041690|Bevacizumab|bevacizumab|mesh-list
56068136|NCT01951339|Hormones|hormones|mesh-ancestor
56543277|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543278|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56543279|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56543280|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543281|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543282|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543283|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56543284|NCT04214821|Renal Agents|renal agents|mesh-ancestor
56543285|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56543286|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56543287|NCT00616213|Lenograstim|lenograstim|mesh-list
56808665|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808666|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808667|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56808668|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56808669|NCT01041690|Growth Substances|growth substances|mesh-ancestor
56808670|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808671|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
56808672|NCT00288015|Bevacizumab|bevacizumab|mesh-list
56808673|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808674|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808675|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56808676|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56808677|NCT00288015|Growth Substances|growth substances|mesh-ancestor
56808678|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808718|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
56808719|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808752|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56808753|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808754|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
56808755|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808756|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808757|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56808758|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56808759|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808760|NCT01324284|Lubiprostone|lubiprostone|mesh-list
56081143|NCT00004755|Allopurinol|allopurinol|mesh-list
56808788|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56808789|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
56808790|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56808791|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56808792|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56808793|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
56808794|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
56808795|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808796|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56808797|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56808798|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
56808799|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56808800|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
56808801|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
56808802|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56808803|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081187|NCT00004785|Hormones|hormones|mesh-ancestor
56808837|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
56808838|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808839|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808840|NCT00430352|Rituximab|rituximab|mesh-list
56808841|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808842|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808870|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
56543288|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56808871|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56808872|NCT00429494|Leuprolide|leuprolide|mesh-list
56808873|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56808874|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
56808875|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56808876|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808877|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808878|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808879|NCT00429416|Cytarabine|cytarabine|mesh-list
56808880|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
56808881|NCT00429416|Fludarabine|fludarabine|mesh-list
56808882|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
56808883|NCT00429416|Molgramostim|molgramostim|mesh-list
56808884|NCT00429416|Tacrolimus|tacrolimus|mesh-list
56808885|NCT00429416|Sargramostim|sargramostim|mesh-list
56808886|NCT00429416|Mesna|mesna|mesh-list
56808887|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808888|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
56808889|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081277|NCT00005601|Hormones|hormones|mesh-ancestor
56808925|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
56808926|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808927|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808928|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56808965|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56808966|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
56081359|NCT00005649|Capecitabine|capecitabine|mesh-list
56808999|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56809000|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809001|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56809002|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56809003|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56081397|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809032|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809033|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809034|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809035|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809036|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
56809037|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
56809038|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809040|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56809041|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809042|NCT00300495|Amiodarone|amiodarone|mesh-list
56809043|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56809044|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
56809045|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56809046|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56809047|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081439|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
56809078|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56809079|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809080|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809081|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56809082|NCT00386022|Estrogens|estrogens|mesh-list
56809083|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
56809084|NCT00386022|Hormones|hormones|mesh-ancestor
56809085|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809086|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809087|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
56809088|NCT01068795|Enoxaparin|enoxaparin|mesh-list
56809111|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809112|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809113|NCT00286221|Fentanyl|fentanyl|mesh-list
56809114|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56809115|NCT00286221|Narcotics|narcotics|mesh-ancestor
56809116|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56809117|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809118|NCT00286221|Analgesics|analgesics|mesh-ancestor
56809119|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
56809120|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809121|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56809122|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56809123|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
56543289|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
56543290|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543291|NCT00615667|Tacrolimus|tacrolimus|mesh-list
56543292|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56543293|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
56543294|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543295|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56543296|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543297|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543298|NCT02697955|Epinephrine|epinephrine|mesh-list
56543299|NCT02697955|Bupivacaine|bupivacaine|mesh-list
56543300|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
56543301|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
56543302|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543303|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543304|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
56543305|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543306|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56543307|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56543308|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
56543309|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543310|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543311|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56543312|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56809124|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
56809125|NCT00398112|Sunitinib|sunitinib|mesh-list
56809126|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809127|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56809128|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56809129|NCT00398112|Growth Substances|growth substances|mesh-ancestor
56809130|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809131|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
56809132|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809133|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809134|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809135|NCT01065129|Plerixafor|plerixafor|mesh-list
56809136|NCT01065129|Azacitidine|azacitidine|mesh-list
56809137|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56809170|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56809171|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
56809172|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809173|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809174|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809176|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56809177|NCT00283803|Protective Agents|protective agents|mesh-ancestor
56809178|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56809179|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809209|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56809210|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56543313|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
56543314|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56543315|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
56809211|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809212|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
56809213|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56809214|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56809216|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
56809217|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56809218|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
56081630|NCT04824417|Itraconazole|itraconazole|mesh-list
56809248|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56809249|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809250|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
56809252|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809253|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56809254|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56809255|NCT00397488|Growth Substances|growth substances|mesh-ancestor
56809256|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809257|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
56809258|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809259|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809260|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809261|NCT01581411|Plasminogen|plasminogen|mesh-list
56081665|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56809295|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56809296|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809297|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56809298|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56809299|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56809300|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809301|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56809302|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
56809303|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
56809338|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809339|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
56809340|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809341|NCT00423800|Interferons|interferons|mesh-list
56809342|NCT00423800|Ribavirin|ribavirin|mesh-list
56809343|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
56809344|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
56809345|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56809346|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809369|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809370|NCT00282087|Gemcitabine|gemcitabine|mesh-list
56809371|NCT00282087|Docetaxel|docetaxel|mesh-list
56809372|NCT00282087|Doxorubicin|doxorubicin|mesh-list
56809373|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56809374|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
56809375|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809376|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809377|NCT00282087|Antiviral Agents|antiviral agents|mesh-ancestor
56809378|NCT00282087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809379|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809380|NCT00282087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809381|NCT00282087|Immunologic Factors|immunologic factors|mesh-ancestor
56809382|NCT00282087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809383|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
56809384|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
56809385|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
56809386|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56809387|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56809388|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56809389|NCT00281697|Bevacizumab|bevacizumab|mesh-list
56809390|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809391|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809392|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56809393|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56809394|NCT00281697|Growth Substances|growth substances|mesh-ancestor
56809428|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56809429|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56809430|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56543316|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
56543317|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
56809431|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
56809432|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809433|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56809434|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56081841|NCT02421211|Simeprevir|simeprevir|mesh-list
56809461|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809462|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
56809463|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809464|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56809465|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56809466|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809467|NCT00268983|Trace Elements|trace elements|mesh-ancestor
56809468|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
56809469|NCT01070511|Tadalafil|tadalafil|mesh-list
56809470|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
56809471|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56809472|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56520394|NCT01081834|Canagliflozin|canagliflozin|mesh-list
56809473|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809474|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809475|NCT01070511|Urological Agents|urological agents|mesh-ancestor
56809476|NCT01070667|Dronedarone|dronedarone|mesh-list
56809477|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56809478|NCT00257608|Bevacizumab|bevacizumab|mesh-list
56809479|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56809480|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809481|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809482|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56809483|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56081883|NCT02424968|Cyclosporins|cyclosporins|mesh-list
56809510|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809511|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56809512|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56809514|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809515|NCT00206518|Docetaxel|docetaxel|mesh-list
56809516|NCT00206518|Doxorubicin|doxorubicin|mesh-list
56809517|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56809518|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
56809519|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809520|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
56809521|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
56809522|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
56809523|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809524|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56809525|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56809526|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56809527|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809528|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809529|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
56809530|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809531|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56809532|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56809557|NCT03972592|Sirolimus|sirolimus|mesh-list
56809558|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56809559|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809560|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56809561|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809562|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
56809563|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809564|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
56809565|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809566|NCT00404066|Dexamethasone|dexamethasone|mesh-list
56809567|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
56809568|NCT00404066|Docetaxel|docetaxel|mesh-list
56809569|NCT00404066|Doxorubicin|doxorubicin|mesh-list
56809570|NCT00404066|Trastuzumab|trastuzumab|mesh-list
56809571|NCT00404066|Lapatinib|lapatinib|mesh-list
56809572|NCT00404066|Lenograstim|lenograstim|mesh-list
56809573|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809574|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
56809575|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809576|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56809577|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56809578|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
56543318|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56543319|NCT04294329|Bupivacaine|bupivacaine|mesh-list
56543320|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
56543321|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
56543322|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543323|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543324|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
56543325|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543326|NCT02701309|Iron|iron|mesh-list
56543327|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
56543328|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
56543329|NCT02701309|Trace Elements|trace elements|mesh-ancestor
56543330|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
56543331|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543332|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56543333|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
56543334|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543335|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543336|NCT03250507|Bupivacaine|bupivacaine|mesh-list
56543337|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
56809579|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809580|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809581|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56809582|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56809613|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809615|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
56809616|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56809617|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56809618|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809619|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56809620|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56809621|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809622|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
56809623|NCT01040702|Methylphenidate|methylphenidate|mesh-list
56809624|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56809625|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809654|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809655|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56809657|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56809658|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56809659|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
56809660|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56809661|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809662|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809663|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809664|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
56809665|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
56809666|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809667|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56809668|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56809669|NCT00423098|Protective Agents|protective agents|mesh-ancestor
56809670|NCT01042704|Aspirin|aspirin|mesh-list
56809700|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56809701|NCT01042704|Growth Substances|growth substances|mesh-ancestor
56809702|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
56543338|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
56543339|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543340|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543341|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
56543342|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543343|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56543344|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56543345|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56543346|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
56543347|NCT00997893|Estradiol|estradiol|mesh-list
56543348|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56543349|NCT00997893|Estrogens|estrogens|mesh-list
56543350|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
56543351|NCT00997893|Hormones|hormones|mesh-ancestor
56543352|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543353|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543354|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56543355|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
56543356|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56543357|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56197519|NCT01508195|Metformin|metformin|mesh-list
56809703|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809704|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56809705|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
56809706|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56809707|NCT00750698|Entinostat|entinostat|mesh-list
56809708|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809709|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809710|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809711|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809712|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56809713|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
56809714|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
56082119|NCT02498522|Metformin|metformin|mesh-list
56809747|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
56809748|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809749|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56809750|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56809751|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809752|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56809753|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56809754|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
56082165|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809783|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56809784|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56809786|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809787|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
56809788|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809789|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56809790|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809791|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56809792|NCT01039142|Acitretin|acitretin|mesh-list
56809793|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
56543358|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56543359|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56543360|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56543361|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56543362|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56543363|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543364|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56543365|NCT02697877|Regadenoson|regadenoson|mesh-list
56543366|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56809794|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56809795|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56809796|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56809832|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56809833|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809834|NCT00421928|Analgesics|analgesics|mesh-ancestor
56809835|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
56809836|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809837|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56082253|NCT02535806|Analgesics|analgesics|mesh-ancestor
56809864|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56809865|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
56809866|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56809867|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809868|NCT00372060|Pioglitazone|pioglitazone|mesh-list
56809869|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56809870|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56809871|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809872|NCT00372060|Incretins|incretins|mesh-ancestor
56809873|NCT00372060|Hormones|hormones|mesh-ancestor
56809874|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809875|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56809876|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
56809877|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809878|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809879|NCT01043172|Gemcitabine|gemcitabine|mesh-list
56809880|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56809881|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
56809882|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809883|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809884|NCT01043172|Antiviral Agents|antiviral agents|mesh-ancestor
56809885|NCT01043172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809886|NCT01043172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809922|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56809924|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
56809925|NCT00280293|Lamotrigine|lamotrigine|mesh-list
56809926|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
56082352|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
56809950|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56809951|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
56809952|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56809953|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56809954|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56809955|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
56809956|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809957|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809958|NCT00280059|Pregabalin|pregabalin|mesh-list
56809959|NCT00280059|Lamotrigine|lamotrigine|mesh-list
56809960|NCT00280059|Analgesics|analgesics|mesh-ancestor
56809961|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
56809962|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809963|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809964|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
56809965|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56809966|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56473665|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543367|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56543368|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
56543369|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
56543370|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809967|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809968|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56809969|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56809970|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56809971|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56809972|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56809973|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56809974|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56809975|NCT00403130|Gemcitabine|gemcitabine|mesh-list
56810006|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56810007|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56810008|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810010|NCT00267189|Everolimus|everolimus|mesh-list
56810011|NCT00267189|Azathioprine|azathioprine|mesh-list
56810012|NCT00267189|Tacrolimus|tacrolimus|mesh-list
56810013|NCT00267189|Cyclosporins|cyclosporins|mesh-list
56810014|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56810015|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810016|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810017|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
56810018|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810019|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082434|NCT02439164|Midazolam|midazolam|mesh-list
56810054|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56810055|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810056|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56810079|NCT00396084|Levofloxacin|levofloxacin|mesh-list
56810080|NCT00396084|Ofloxacin|ofloxacin|mesh-list
56810081|NCT00396084|Isoniazid|isoniazid|mesh-list
56810082|NCT00396084|Linezolid|linezolid|mesh-list
56810083|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
56810084|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56810085|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810086|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56810087|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56810088|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810089|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810090|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810091|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56810092|NCT00396084|Renal Agents|renal agents|mesh-ancestor
56810093|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56810094|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56810095|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
56810096|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56810097|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56810098|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
56810099|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56810100|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56810101|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56810102|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56810103|NCT00395850|Disulfiram|disulfiram|mesh-list
56810104|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56810105|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56810106|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810107|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810108|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56810109|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810110|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810111|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
56810112|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810135|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56810137|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56810138|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810139|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810140|NCT00420056|Palbociclib|palbociclib|mesh-list
56810141|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810142|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543371|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543372|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543373|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
56810143|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810144|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810145|NCT00411554|Inositol|inositol|mesh-list
56810146|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56810147|NCT00411554|Voglibose|voglibose|mesh-list
56810148|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56810149|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810150|NCT00411554|Incretins|incretins|mesh-ancestor
56810151|NCT00411554|Hormones|hormones|mesh-ancestor
56810152|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56810153|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56810154|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
56810155|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810156|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810157|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56810158|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
56810159|NCT00411554|Vitamins|vitamins|mesh-ancestor
56810160|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
56810161|NCT00380718|Pemetrexed|pemetrexed|mesh-list
56810192|NCT00419744|Budesonide|budesonide|mesh-list
56810193|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
56810194|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56810195|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56810196|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56810197|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
56810198|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810199|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810200|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56082639|NCT02568644|Ketoprofen|ketoprofen|mesh-list
56810233|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810234|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810235|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56810236|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
56810237|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56810238|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56810239|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56810240|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
56810269|NCT00378534|Cyclosporins|cyclosporins|mesh-list
56810270|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810271|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
56810272|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810273|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810274|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56810275|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
56810276|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810277|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810278|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56810279|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810280|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
56810281|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810282|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810283|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56810284|NCT00377676|Bromocriptine|bromocriptine|mesh-list
56810285|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56810286|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56810287|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
56810288|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56810324|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56810325|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810326|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56082760|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810340|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810341|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810342|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810343|NCT00410072|Tenofovir|tenofovir|mesh-list
56810344|NCT00410072|Entecavir|entecavir|mesh-list
56810345|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
56543374|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
56543375|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543376|NCT04214665|Protective Agents|protective agents|mesh-ancestor
56810346|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810347|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56810348|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56810349|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810350|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810351|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56810352|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56810353|NCT00409838|Methotrexate|methotrexate|mesh-list
56810354|NCT00409838|Abatacept|abatacept|mesh-list
56810355|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56810356|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
56810357|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56810358|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810359|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56810360|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
56810361|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810362|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810363|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810364|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810365|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56810366|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810367|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
56810368|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810369|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56810370|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56810371|NCT01041872|Lidocaine|lidocaine|mesh-list
56810372|NCT01041872|Propofol|propofol|mesh-list
56810373|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
56810374|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
56810375|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810376|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810377|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
56810378|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810379|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56810380|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56810381|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56810382|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810383|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810384|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56810385|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56810386|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
56810387|NCT00399542|Lubiprostone|lubiprostone|mesh-list
56810419|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
56810420|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810421|NCT03993626|Nivolumab|nivolumab|mesh-list
56810422|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56810423|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810424|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56810425|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810426|NCT00398216|Edoxaban|edoxaban|mesh-list
56810427|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
56810428|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
56810429|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56810430|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
56810431|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810462|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56810463|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
56810464|NCT00397982|Antibodies|antibodies|mesh-list
56810465|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
56810466|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56810467|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
56810468|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810469|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56810470|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56810471|NCT00397982|Growth Substances|growth substances|mesh-ancestor
56810472|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810473|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
56810474|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
56543377|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543378|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
56543379|NCT04214665|Vitamins|vitamins|mesh-ancestor
56543380|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
56543381|NCT02870673|Triamcinolone|triamcinolone|mesh-list
56543382|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56543383|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56543384|NCT02870673|Lidocaine|lidocaine|mesh-list
56543385|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56543386|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543387|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
56810475|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56810476|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810477|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56810508|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56810510|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810511|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56810512|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56810513|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810514|NCT01042730|Pitavastatin|pitavastatin|mesh-list
56810515|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56810516|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56810517|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56810518|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
56082943|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
56810554|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810556|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
56810557|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810592|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56810593|NCT00406640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56810594|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56810627|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810628|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810629|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810630|NCT00395486|Atorvastatin|atorvastatin|mesh-list
56810631|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56810632|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56810633|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56810634|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
56083059|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
56810670|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56810671|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
56810672|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810673|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810674|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810675|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56810712|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
56810713|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810714|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
56810715|NCT00203242|Valproic Acid|valproic acid|mesh-list
56810716|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
56810717|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083141|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810750|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810751|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810753|NCT00256282|Vinorelbine|vinorelbine|mesh-list
56810754|NCT00256282|Sargramostim|sargramostim|mesh-list
56810755|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810756|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
56810757|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
56810758|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
56810759|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810760|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56810792|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543388|NCT02870673|Hormones|hormones|mesh-ancestor
56543389|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543390|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543391|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56543392|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
56543393|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543394|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543395|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
56543396|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
56543397|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543398|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
56543399|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634303|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543401|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56543402|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56543403|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543404|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56543405|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56543406|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56543407|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810793|NCT01073332|Protective Agents|protective agents|mesh-ancestor
56810794|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810795|NCT03972046|Trametinib|trametinib|mesh-list
56810796|NCT03972046|Dabrafenib|dabrafenib|mesh-list
56810797|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56810798|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810799|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56810800|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810801|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810841|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56083267|NCT02629094|Eplerenone|eplerenone|mesh-list
56810872|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
56810873|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810874|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810875|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56810876|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56810877|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56810878|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56810879|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810880|NCT00296517|Bupropion|bupropion|mesh-list
56810881|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56810882|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
56810883|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810884|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56810885|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56083300|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
56810914|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56810915|NCT02532153|Ketamine|ketamine|mesh-list
56810916|NCT02532153|Analgesics|analgesics|mesh-ancestor
56543408|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543409|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
56123068|NCT01554618|Exenatide|exenatide|mesh-list
56810917|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
56810918|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810919|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810920|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56810921|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56810922|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
56810923|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
56810924|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810925|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56810926|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56810927|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810958|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810959|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810960|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56810961|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56810962|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56810963|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810964|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810965|NCT00275301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56810966|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56810967|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810968|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810969|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810970|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
56810971|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56810972|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083394|NCT02472223|Povidone|povidone|mesh-list
56811002|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
56811003|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811004|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811005|NCT02286414|Vitamins|vitamins|mesh-list
56811006|NCT02286414|Vitamin K|vitamin k|mesh-list
56811007|NCT02286414|Warfarin|warfarin|mesh-list
56811008|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
56811009|NCT02286414|Dabigatran|dabigatran|mesh-list
56811010|NCT02286414|Apixaban|apixaban|mesh-list
56811011|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
56811012|NCT02286414|Fluindione|fluindione|mesh-list
56811013|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
56811014|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811015|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
56811016|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56811017|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
56811018|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56811019|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
56811020|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083433|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56811057|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083481|NCT04050410|Moxonidine|moxonidine|mesh-list
56811090|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
56811092|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811093|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56811094|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811095|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811096|NCT00358644|Decitabine|decitabine|mesh-list
56811097|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56811098|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
56811099|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811100|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083532|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56811129|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56811130|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56811131|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56811132|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
56811133|NCT00369486|Hormones|hormones|mesh-ancestor
56811134|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56811135|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811136|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811137|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
56543410|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543411|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56811138|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811139|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811140|NCT00363480|Fluticasone|fluticasone|mesh-list
56811141|NCT00363480|Albuterol|albuterol|mesh-list
56811142|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56811143|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56811144|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56811145|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
56083555|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
56811174|NCT01073644|Sunitinib|sunitinib|mesh-list
56811175|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811176|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56811177|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56811178|NCT01073644|Growth Substances|growth substances|mesh-ancestor
56811179|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811180|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
56811181|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56811182|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811183|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811184|NCT03992586|Methamphetamine|methamphetamine|mesh-list
56811185|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56811186|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811187|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
56811188|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
56811189|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811190|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
56811191|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811215|NCT01071928|Docetaxel|docetaxel|mesh-list
56811216|NCT01071928|Vadimezan|vadimezan|mesh-list
56811217|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811218|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
56811219|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
56811220|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
56811221|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811222|NCT00187486|Temozolomide|temozolomide|mesh-list
56811223|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56811224|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56811225|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
56811226|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811227|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811228|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56811229|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811230|NCT00220636|Aripiprazole|aripiprazole|mesh-list
56811231|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
56811232|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56811233|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56811234|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56811235|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56811236|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811237|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
56811238|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
56811239|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811273|NCT00219544|Analgesics|analgesics|mesh-ancestor
56811274|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
56811275|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811276|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811277|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
56811278|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56811302|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56811303|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56811304|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
56811305|NCT00187096|Fludarabine|fludarabine|mesh-list
56811306|NCT00187096|Etoposide|etoposide|mesh-list
56811307|NCT00187096|Interleukin-2|interleukin-2|mesh-list
56811308|NCT00187096|Clofarabine|clofarabine|mesh-list
56811309|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811310|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
56811311|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811312|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56811313|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56811314|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
56811315|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543412|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56543413|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
56543414|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56543415|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56543416|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56543417|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543418|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543419|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
56543420|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543421|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543422|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56543423|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543424|NCT02700685|Methylphenidate|methylphenidate|mesh-list
56543425|NCT02700685|Pycnogenols|pycnogenols|mesh-list
56543426|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56543427|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543428|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56543429|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56543430|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543431|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543432|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
56543433|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543434|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56543435|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
56543436|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
56811316|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811317|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56811318|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56811319|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
56811320|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56811321|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56811322|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56811323|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811324|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56811325|NCT00187096|Analgesics|analgesics|mesh-ancestor
56811326|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
56811327|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811359|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
56811360|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811361|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56811362|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56811363|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811364|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811365|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811366|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
56811367|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811368|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
56543437|NCT02700685|Protective Agents|protective agents|mesh-ancestor
56543438|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56543439|NCT02700763|Dabrafenib|dabrafenib|mesh-list
56543440|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123414|NCT01516008|Tapentadol|tapentadol|mesh-list
56811369|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56811370|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56811371|NCT00186628|Analgesics|analgesics|mesh-ancestor
56811372|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
56811373|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811374|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
56811375|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56811376|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
56811444|NCT01048632|Oxandrolone|oxandrolone|mesh-list
56811445|NCT01048632|Androgens|androgens|mesh-ancestor
56811446|NCT01048632|Hormones|hormones|mesh-ancestor
56811447|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56811448|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811449|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
56811450|NCT00165646|Rabeprazole|rabeprazole|mesh-list
56811451|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56811452|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56811453|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56083875|NCT02581111|Naloxone|naloxone|mesh-list
56811486|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811487|NCT00185614|Cyclosporine|cyclosporine|mesh-list
56811488|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
56811489|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
56811490|NCT00185614|Melphalan|melphalan|mesh-list
56811491|NCT00185614|Cyclosporins|cyclosporins|mesh-list
56811492|NCT00185614|Lenograstim|lenograstim|mesh-list
56811493|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811494|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
56811495|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811496|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56811497|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56811498|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
56811528|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56811529|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56811530|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811531|NCT01050348|Atorvastatin|atorvastatin|mesh-list
56811532|NCT01050348|Calcium|calcium|mesh-list
56811533|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56811534|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811535|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56811536|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56811537|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
56811538|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811539|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56811540|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56811541|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811542|NCT01053390|Leucovorin|leucovorin|mesh-list
56811543|NCT01053390|Fluorouracil|fluorouracil|mesh-list
56811544|NCT01053390|Epirubicin|epirubicin|mesh-list
56811577|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811578|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811579|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
56811580|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811581|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56811582|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
56811583|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56811584|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56811586|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56811616|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
56811617|NCT01050426|Antidotes|antidotes|mesh-ancestor
56811618|NCT01050426|Protective Agents|protective agents|mesh-ancestor
56811619|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811620|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
56811621|NCT01050426|Vitamins|vitamins|mesh-ancestor
56811622|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
56811623|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56811624|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543441|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543442|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543443|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543444|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
56543445|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56543446|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56543447|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543448|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56543449|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543450|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
56543451|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543452|NCT03151681|Propranolol|propranolol|mesh-list
56197622|NCT01508663|Everolimus|everolimus|mesh-list
56811625|NCT00367458|Atorvastatin|atorvastatin|mesh-list
56811626|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56811627|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56811628|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
56811629|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084051|NCT02632045|Fulvestrant|fulvestrant|mesh-list
56811654|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56811655|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56811656|NCT01582672|Growth Substances|growth substances|mesh-ancestor
56811657|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811658|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
56811659|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56811660|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811661|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811663|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56811664|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
56811665|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811666|NCT01049178|Silymarin|silymarin|mesh-list
56811667|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
56811668|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811669|NCT01049178|Protective Agents|protective agents|mesh-ancestor
56811670|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811671|NCT02534454|Nicotine|nicotine|mesh-list
56811672|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56811673|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
56811674|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811675|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811676|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56811677|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56811678|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
56811703|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811704|NCT00373880|Cocaine|cocaine|mesh-list
56811705|NCT00373880|Aripiprazole|aripiprazole|mesh-list
56811706|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
56811707|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56811708|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56811709|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56811710|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56811711|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811712|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
56811713|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
56811714|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811715|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811716|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56811717|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56811718|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
56811719|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56543453|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56543454|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56543455|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
56543456|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543457|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543458|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543459|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56543460|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56543461|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
56543462|NCT04215445|Empagliflozin|empagliflozin|mesh-list
56543463|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56543464|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543465|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56543466|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811720|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56811721|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56811722|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56811723|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
56811724|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
56811725|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
56811759|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56811760|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811761|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811762|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56811763|NCT00265239|Edaravone|edaravone|mesh-list
56811764|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56811765|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
56811794|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811795|NCT00184054|Protective Agents|protective agents|mesh-ancestor
56811796|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811797|NCT02533908|Fentanyl|fentanyl|mesh-list
56811798|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56811799|NCT02533908|Narcotics|narcotics|mesh-ancestor
56811800|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56811801|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811802|NCT02533908|Analgesics|analgesics|mesh-ancestor
56811803|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
56811804|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811805|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56811806|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56811807|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
56811808|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
56811809|NCT00183430|Prazosin|prazosin|mesh-list
56811810|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56811811|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56811812|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56811813|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56811814|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
56811848|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56811849|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56811850|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56811851|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56811852|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084272|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811890|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
56811921|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56811922|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
56811923|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543467|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56543468|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
56394366|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543469|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56543470|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
56543471|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543472|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543473|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56811924|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811925|NCT01051284|Antiviral Agents|antiviral agents|mesh-ancestor
56811926|NCT01051284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811927|NCT01051284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811928|NCT01051284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811929|NCT01051284|Immunologic Factors|immunologic factors|mesh-ancestor
56811930|NCT01051284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811931|NCT01051362|Carboplatin|carboplatin|mesh-list
56811932|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811934|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56084361|NCT05619289|Vitamin D|vitamin d|mesh-list
56811971|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
56812002|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812003|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812004|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
56812005|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812006|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812007|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
56812008|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56812009|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56812010|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812011|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56812012|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
56812013|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812014|NCT00171730|Pasireotide|pasireotide|mesh-list
56812015|NCT00171730|Hormones|hormones|mesh-ancestor
56522930|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56812049|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56812050|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812051|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56812052|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56812053|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56812054|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812055|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
56812056|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
56812057|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56084480|NCT05552287|Infliximab|infliximab|mesh-list
56812075|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812076|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812077|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56812078|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
56812079|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56812080|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56812081|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56812082|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56812083|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56812084|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56812085|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56812086|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812087|NCT01056042|Progestins|progestins|mesh-ancestor
56812088|NCT00373256|Paclitaxel|paclitaxel|mesh-list
56812089|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56812090|NCT00373256|Bevacizumab|bevacizumab|mesh-list
56812091|NCT00373256|Sunitinib|sunitinib|mesh-list
56812092|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56812093|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812094|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812095|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56543475|NCT02691871|Apatinib|apatinib|mesh-list
56543476|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543477|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
56543478|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
56543479|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
56543480|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543481|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543482|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543483|NCT02700217|Remifentanil|remifentanil|mesh-list
56543485|NCT02700217|Bupivacaine|bupivacaine|mesh-list
56543486|NCT02700217|Propofol|propofol|mesh-list
56543487|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
56543488|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
56812096|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56812126|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56812127|NCT00394082|Growth Substances|growth substances|mesh-ancestor
56812128|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812129|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
56812131|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
56812132|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812133|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56812134|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56812135|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812136|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812137|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56812138|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
56084559|NCT00365755|Melphalan|melphalan|mesh-list
56812166|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56812167|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
56812168|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523077|NCT01257204|Ribavirin|ribavirin|mesh-list
56812169|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56812170|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56812171|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
56812172|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812173|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812174|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56812175|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56812176|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56812177|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56812178|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56812179|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812180|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56812181|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
56812182|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56812183|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56812184|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
56812185|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
56812216|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56812217|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56812218|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56812219|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
56812220|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
56812221|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812222|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812223|NCT00417482|Risperidone|risperidone|mesh-list
56812224|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56812225|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
56812226|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812227|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812228|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812229|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56812230|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56543489|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543490|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543491|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
56543492|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543493|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56543494|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56543495|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
56543496|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56543497|NCT02700217|Narcotics|narcotics|mesh-ancestor
56543498|NCT02700217|Analgesics|analgesics|mesh-ancestor
56543499|NCT05323981|Pertuzumab|pertuzumab|mesh-list
56543500|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56543501|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543502|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
56543503|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
56543504|NCT02699827|Analgesics|analgesics|mesh-ancestor
56543505|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
56543506|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543507|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543508|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
56197671|NCT01508897|Liraglutide|liraglutide|mesh-list
56812262|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56812263|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56812264|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56812265|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812266|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56812267|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812268|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
56812269|NCT01840592|Doxorubicin|doxorubicin|mesh-list
56812271|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56812272|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812273|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56084713|NCT02619799|Midazolam|midazolam|mesh-list
56812304|NCT01046630|Ketamine|ketamine|mesh-list
56812305|NCT01046630|Analgesics|analgesics|mesh-ancestor
56812306|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
56812307|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812308|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812309|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56812310|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56812311|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
56812312|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
56812313|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812314|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56812315|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56812341|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56812342|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812344|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56812345|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812346|NCT00762554|Fentanyl|fentanyl|mesh-list
56812347|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56812348|NCT00762554|Narcotics|narcotics|mesh-ancestor
56812349|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812350|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812351|NCT00762554|Analgesics|analgesics|mesh-ancestor
56543509|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543510|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56812352|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
56812353|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812354|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56812355|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56812356|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
56812357|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
56812358|NCT00391898|Levodopa|levodopa|mesh-list
56812359|NCT00391898|Carbidopa|carbidopa|mesh-list
56812360|NCT00391898|Entacapone|entacapone|mesh-list
56812361|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56812362|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56812363|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
56812364|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812365|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812366|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812396|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56812397|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56812398|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56812399|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56812400|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812401|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56812402|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56812403|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812404|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
56812405|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56812406|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56812407|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56812408|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
56812409|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812410|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56812411|NCT01049438|Doxycycline|doxycycline|mesh-list
56812412|NCT01049438|Minocycline|minocycline|mesh-list
56812446|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812447|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
56812448|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
56812449|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812450|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56812451|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
56812452|NCT00391586|Antiviral Agents|antiviral agents|mesh-ancestor
56812453|NCT00391586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812454|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812455|NCT00391586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56812456|NCT00391586|Immunologic Factors|immunologic factors|mesh-ancestor
56812457|NCT00391586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812458|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56812492|NCT00390884|Vaccines|vaccines|mesh-list
56812493|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
56812494|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812495|NCT01047488|Pregabalin|pregabalin|mesh-list
56812496|NCT01047488|Imipramine|imipramine|mesh-list
56812497|NCT01047488|Analgesics|analgesics|mesh-ancestor
56812498|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
56812499|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812500|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812501|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
56812524|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56812525|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812526|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812527|NCT01047566|Protective Agents|protective agents|mesh-ancestor
56812528|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56812529|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
56812530|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812531|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56812532|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
56812533|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56812534|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812535|NCT00264537|Golimumab|golimumab|mesh-list
56812536|NCT00264537|Methotrexate|methotrexate|mesh-list
56812537|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56812538|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56812539|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
56812540|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56543511|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
56543512|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56543513|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543514|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543515|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56543516|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
56543517|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56543518|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
56543519|NCT02705989|Branebrutinib|branebrutinib|mesh-list
56543520|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543521|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543522|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543523|NCT02706067|Orlistat|orlistat|mesh-list
56543524|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543525|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812541|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812542|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56812543|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
56812544|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812545|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812546|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
56812547|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812548|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56812549|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56812550|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
56812551|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56812580|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812581|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56812582|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56812583|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56812584|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56812585|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812586|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56812587|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
56812588|NCT01071369|Hormones|hormones|mesh-ancestor
56812589|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812590|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56812591|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
56812592|NCT00370682|Vaccines|vaccines|mesh-list
56812593|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
56812594|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812595|NCT00264147|Diclofenac|diclofenac|mesh-list
56812596|NCT00264147|Etoricoxib|etoricoxib|mesh-list
56812597|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56812623|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56812624|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56812625|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812626|NCT03974685|Niacinamide|niacinamide|mesh-list
56812627|NCT03974685|Niacin|niacin|mesh-list
56812628|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
56812629|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
56812630|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
56812631|NCT03974685|Vitamins|vitamins|mesh-ancestor
56812632|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
56812633|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812634|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56812635|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
56543526|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56543527|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56543528|NCT02939287|Olanzapine|olanzapine|mesh-list
56543529|NCT02939287|Aprepitant|aprepitant|mesh-list
56543530|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
56812636|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812637|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56812638|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
56812639|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812640|NCT00263211|Aspirin|aspirin|mesh-list
56812641|NCT00263211|Clopidogrel|clopidogrel|mesh-list
56812642|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56812643|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56812644|NCT00263211|Analgesics|analgesics|mesh-ancestor
56812645|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
56812646|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812647|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812681|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812682|NCT01326117|Urological Agents|urological agents|mesh-ancestor
56812683|NCT03970239|Ketanserin|ketanserin|mesh-list
56812684|NCT03970239|Fluorides|fluorides|mesh-list
56812685|NCT03970239|Altanserin|altanserin|mesh-list
56812686|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
56812687|NCT03970239|Protective Agents|protective agents|mesh-ancestor
56812688|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812689|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56812707|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56812708|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56812709|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
56812710|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812711|NCT00262041|Vaccines|vaccines|mesh-list
56812712|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
56812713|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812714|NCT00208767|Valsartan|valsartan|mesh-list
56812715|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56812716|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56812717|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56812718|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812719|NCT02531529|Fentanyl|fentanyl|mesh-list
56812720|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56812721|NCT02531529|Narcotics|narcotics|mesh-ancestor
56812722|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812723|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812724|NCT02531529|Analgesics|analgesics|mesh-ancestor
56812725|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
56812726|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812727|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56812728|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56812729|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
56812730|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
56812731|NCT01071525|Niacin|niacin|mesh-list
56812732|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56812733|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
56812734|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812735|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56812736|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
56812737|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
56812738|NCT01071525|Vitamins|vitamins|mesh-ancestor
56812739|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
56812740|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812741|NCT01072695|Ribavirin|ribavirin|mesh-list
56812742|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56812743|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
56812744|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812745|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
56812746|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812747|NCT00390806|Topotecan|topotecan|mesh-list
56812748|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56812784|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
56812785|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812786|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
56812787|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56085228|NCT03213457|Estradiol|estradiol|mesh-list
56543531|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
56543532|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
56543533|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543534|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543535|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56543536|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56543537|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56543538|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543539|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56543540|NCT02939287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56812818|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
56812819|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812820|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812821|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56812822|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56812823|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812824|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56812825|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56812826|NCT01047956|Methadone|methadone|mesh-list
56812827|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56812828|NCT01047956|Narcotics|narcotics|mesh-ancestor
56812829|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812830|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812831|NCT01047956|Analgesics|analgesics|mesh-ancestor
56812832|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
56812833|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812868|NCT00370292|Pemetrexed|pemetrexed|mesh-list
56812869|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812870|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812871|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812872|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56812873|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56812874|NCT01049672|Alfentanil|alfentanil|mesh-list
56812875|NCT01049672|Heroin|heroin|mesh-list
56812876|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56812877|NCT01049672|Narcotics|narcotics|mesh-ancestor
56085305|NCT03206047|Poly ICLC|poly iclc|mesh-list
56812897|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56812898|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56812899|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
56812900|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812901|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56812902|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56812903|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812904|NCT00388154|Gemcitabine|gemcitabine|mesh-list
56812905|NCT00388154|Cisplatin|cisplatin|mesh-list
56812906|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812907|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56812908|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
56812909|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812910|NCT00388154|Antiviral Agents|antiviral agents|mesh-ancestor
56812911|NCT00388154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812912|NCT00388154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812913|NCT00388154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56812914|NCT00388154|Immunologic Factors|immunologic factors|mesh-ancestor
56812915|NCT00388154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812916|NCT02535104|Ranpirnase|ranpirnase|mesh-list
56812917|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812918|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56812919|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523827|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812920|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812921|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
56812922|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56543541|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56543542|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543543|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543544|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543545|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
56543546|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56543547|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
56543548|NCT05323201|Fludarabine|fludarabine|mesh-list
56543549|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56543550|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
56543551|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543552|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56543553|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56543554|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
56543555|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543556|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543557|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56543558|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
56543559|NCT01208051|Lenalidomide|lenalidomide|mesh-list
56543560|NCT01208051|Cediranib|cediranib|mesh-list
56543561|NCT01208051|Maleic acid|maleic acid|mesh-list
56812923|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56812924|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812925|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56812926|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812927|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56812928|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
56812929|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56812930|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085361|NCT01632306|Antidotes|antidotes|mesh-ancestor
56812958|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812959|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56812960|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56812961|NCT00369122|Growth Substances|growth substances|mesh-ancestor
56812962|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812963|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
56812964|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
56812965|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
56812966|NCT03999203|Citric Acid|citric acid|mesh-list
56812967|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
56812968|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56812969|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
56812970|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812971|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812972|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56812973|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
56812974|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56812975|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
56812976|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812977|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812978|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56543562|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
56543563|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812979|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
56085413|NCT02168478|Neomycin|neomycin|mesh-list
56813013|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56813014|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56813015|NCT03872843|Ibuprofen|ibuprofen|mesh-list
56813016|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56813017|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56813018|NCT03872843|Analgesics|analgesics|mesh-ancestor
56813019|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
56813020|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085464|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
56813046|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56813047|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813048|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
56813049|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813050|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813051|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56813052|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56813053|NCT03999125|Growth Substances|growth substances|mesh-ancestor
56813054|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
56813055|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
56813056|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56813057|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
56813058|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813059|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56813060|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813062|NCT00166114|Desipramine|desipramine|mesh-list
56813063|NCT00166114|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56813064|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56813065|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56813066|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813067|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813068|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
56813069|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524003|NCT04290793|Taxane|taxane|mesh-list
56813105|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813107|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813108|NCT03998969|Pantoprazole|pantoprazole|mesh-list
56085549|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
56813137|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
56813138|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56813139|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56813140|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813141|NCT03686813|Urological Agents|urological agents|mesh-ancestor
56813142|NCT04754945|Dexamethasone|dexamethasone|mesh-list
56813143|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
56813144|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
56813145|NCT04754945|Bortezomib|bortezomib|mesh-list
56813147|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56813148|NCT04754945|BB 1101|bb 1101|mesh-list
56813149|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56813150|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
56813151|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813152|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813153|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56813154|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
56085588|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
56813185|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56813187|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
56813188|NCT01074892|Progestins|progestins|mesh-list
56813189|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56813190|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
56813191|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56813192|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813193|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56813194|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56813195|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56813196|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56085630|NCT05441761|Antiviral Agents|antiviral agents|mesh-ancestor
56813224|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813225|NCT01074970|Cisplatin|cisplatin|mesh-list
56813226|NCT01074970|Rucaparib|rucaparib|mesh-list
56543564|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56543565|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56543566|NCT01208051|Growth Substances|growth substances|mesh-ancestor
56543567|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
56543568|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813227|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813228|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56813229|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813230|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813231|NCT03968146|Acetaminophen|acetaminophen|mesh-list
56813232|NCT03968146|Ketorolac|ketorolac|mesh-list
56813233|NCT03968146|Fentanyl|fentanyl|mesh-list
56813234|NCT03968146|Meperidine|meperidine|mesh-list
56813235|NCT03968146|Morphine|morphine|mesh-list
56813236|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56813237|NCT03968146|Narcotics|narcotics|mesh-ancestor
56813238|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56813239|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813240|NCT03968146|Analgesics|analgesics|mesh-ancestor
56813266|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
56813267|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56813268|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813269|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56813270|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813271|NCT01075126|Valproic Acid|valproic acid|mesh-list
56813272|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56813273|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813274|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813275|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
56813276|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56813277|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56813278|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813279|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
56813280|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
56813281|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813282|NCT03823378|Upadacitinib|upadacitinib|mesh-list
56813283|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56813284|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56813285|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813286|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813287|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813288|NCT00141778|Ramipril|ramipril|mesh-list
56813289|NCT00141778|Spironolactone|spironolactone|mesh-list
56085718|NCT02643979|Analgesics|analgesics|mesh-ancestor
56813316|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813317|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813318|NCT01076062|Misoprostol|misoprostol|mesh-list
56813319|NCT01076062|Oxytocin|oxytocin|mesh-list
56813320|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
56813321|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56813322|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813323|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56813324|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
56813325|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56813326|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813327|NCT00115336|Ibuprofen|ibuprofen|mesh-list
56813328|NCT00115336|Ketorolac|ketorolac|mesh-list
56813329|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56813330|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56813331|NCT00115336|Analgesics|analgesics|mesh-ancestor
56813332|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
56813333|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813334|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813335|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813336|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813337|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56813362|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813363|NCT00127192|Incretins|incretins|mesh-ancestor
56813364|NCT00127192|Hormones|hormones|mesh-ancestor
56813365|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56813366|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56543569|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543570|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543571|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543572|NCT05322889|Telmisartan|telmisartan|mesh-list
56543573|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56543574|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56543575|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56543576|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543577|NCT00616915|Bupropion|bupropion|mesh-list
56543578|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56543579|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
56543580|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56543581|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56197750|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
56813367|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
56813368|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524281|NCT01211769|Naltrexone|naltrexone|mesh-list
56813369|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813370|NCT00127036|Bevacizumab|bevacizumab|mesh-list
56813371|NCT00127036|Capecitabine|capecitabine|mesh-list
56813372|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
56813373|NCT00127036|Irinotecan|irinotecan|mesh-list
56813374|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813375|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813376|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56813377|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56813378|NCT00127036|Growth Substances|growth substances|mesh-ancestor
56813379|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813380|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
56813381|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56813382|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
56813383|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813384|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56813385|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813415|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813417|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56813418|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
56813419|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
56813420|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813421|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
56813422|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813423|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
56813424|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813425|NCT00126490|Aldesleukin|aldesleukin|mesh-list
56813426|NCT00126490|Bevacizumab|bevacizumab|mesh-list
56813427|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56813428|NCT00126490|Interleukin-2|interleukin-2|mesh-list
56813457|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56813458|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56813459|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56813460|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
56813461|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813462|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813463|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813464|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
56813466|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56813467|NCT02533440|Anesthetics|anesthetics|mesh-list
56813468|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
56543582|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56543583|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543584|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543585|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
56543586|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813469|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56813470|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813471|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
56813472|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813473|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56813474|NCT00354432|Caseins|caseins|mesh-list
56813475|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56813509|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813511|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
56813512|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
56813513|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56813514|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813545|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56813546|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56813547|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56813548|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56813549|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56813550|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
56813551|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
56813552|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
56813553|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813554|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813555|NCT00337662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56813556|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56813583|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813584|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56813585|NCT00113386|Docetaxel|docetaxel|mesh-list
56813586|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813587|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813588|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
56524503|NCT04294966|Hormones|hormones|mesh-ancestor
56813589|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813590|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813591|NCT00353262|Capecitabine|capecitabine|mesh-list
56813593|NCT00353262|Bevacizumab|bevacizumab|mesh-list
56813594|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56813595|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
56813596|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813597|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813598|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813599|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56813600|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56813601|NCT00353262|Growth Substances|growth substances|mesh-ancestor
56813602|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813603|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56813604|NCT00125164|Mecasermin|mecasermin|mesh-list
56813605|NCT00125164|Growth Substances|growth substances|mesh-ancestor
56086038|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
56813628|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56813629|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
56813630|NCT00136318|Ribavirin|ribavirin|mesh-list
56813631|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56813632|NCT00136318|Citalopram|citalopram|mesh-list
56813633|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
56813634|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813635|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
56813636|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813637|NCT00136318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56813638|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56813639|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56813640|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813641|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
56813642|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473666|NCT05146271|Anesthetics|anesthetics|mesh-list
56543587|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543588|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56543589|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56813643|NCT00136318|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56813644|NCT00136318|Antidepressive Agents|antidepressive agents|mesh-ancestor
56813645|NCT00136318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56813646|NCT01058850|Rindopepimut|rindopepimut|mesh-list
56813647|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813648|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813649|NCT00136084|Cytarabine|cytarabine|mesh-list
56813650|NCT00136084|Dexamethasone|dexamethasone|mesh-list
56813651|NCT00136084|Prednisone|prednisone|mesh-list
56813652|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
56813653|NCT00136084|Methotrexate|methotrexate|mesh-list
56813654|NCT00136084|Etoposide|etoposide|mesh-list
56813655|NCT00136084|Vincristine|vincristine|mesh-list
56813656|NCT00136084|Daunorubicin|daunorubicin|mesh-list
56813657|NCT00136084|Asparaginase|asparaginase|mesh-list
56813658|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
56813659|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
56813660|NCT00136084|Cladribine|cladribine|mesh-list
56813681|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
56813682|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56813683|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56813684|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
56813685|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
56813686|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813687|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56813688|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56813689|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56813690|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56813691|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813692|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
56813693|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813694|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813695|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
56813696|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813697|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56813698|NCT00136084|Analgesics|analgesics|mesh-ancestor
56813699|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
56813700|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813701|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
56813702|NCT00364832|Hematinics|hematinics|mesh-ancestor
56813703|NCT00235755|Ezogabine|ezogabine|mesh-list
56813704|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
56813705|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56813706|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813707|NCT01581879|Ziprasidone|ziprasidone|mesh-list
56813708|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56813709|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
56813710|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813711|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813712|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086101|NCT02730247|Paclitaxel|paclitaxel|mesh-list
56813748|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813749|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813750|NCT00385736|Adalimumab|adalimumab|mesh-list
56086138|NCT03697850|Atezolizumab|atezolizumab|mesh-list
56813787|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813789|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813795|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813796|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813797|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
56813798|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813799|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813800|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813801|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56813802|NCT00364286|Dasatinib|dasatinib|mesh-list
56813803|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813804|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56813805|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813806|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813807|NCT00336492|Infliximab|infliximab|mesh-list
56813808|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
56543590|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543591|NCT02860039|Vaccines|vaccines|mesh-list
56543592|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
56543593|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543594|NCT05410223|Amoxicillin|amoxicillin|mesh-list
56543595|NCT05410223|Clarithromycin|clarithromycin|mesh-list
56543596|NCT05410223|Doxycycline|doxycycline|mesh-list
56543597|NCT05410223|Furazolidone|furazolidone|mesh-list
56543598|NCT05410223|Bismuth|bismuth|mesh-list
56543599|NCT05410223|Antibodies|antibodies|mesh-list
56543600|NCT05410223|Immunoglobulins|immunoglobulins|mesh-list
56543601|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
56543602|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543603|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56813809|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813810|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813811|NCT00194025|Valproic Acid|valproic acid|mesh-list
56813812|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
56813813|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813814|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813815|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
56813816|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813817|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813818|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
56813819|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56813820|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56813821|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56813822|NCT00521339|Apremilast|apremilast|mesh-list
56813823|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56813824|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56813825|NCT00521339|Analgesics|analgesics|mesh-ancestor
56813826|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
56813827|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813828|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813829|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813830|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813831|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56813832|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56813833|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813834|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813835|NCT00363896|Bromides|bromides|mesh-list
56813836|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
56813837|NCT00527423|Aflibercept|aflibercept|mesh-list
56813838|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56813839|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56813860|NCT00336024|Vincristine|vincristine|mesh-list
56813861|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
56813862|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
56813863|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56813864|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
56813865|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813866|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813867|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56813868|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
56813869|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813870|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813871|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56813872|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56813873|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
56813874|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56813875|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56813876|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
56813877|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
56813878|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068225|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
56543604|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543605|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56543606|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543607|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543608|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56543609|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56543610|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
56543611|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56543612|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56543613|NCT05410223|Antacids|antacids|mesh-ancestor
56543614|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813879|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56813880|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56813881|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56813882|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56813883|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813884|NCT00336024|Antidotes|antidotes|mesh-ancestor
56813885|NCT00336024|Protective Agents|protective agents|mesh-ancestor
56813886|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
56813887|NCT00336024|Vitamins|vitamins|mesh-ancestor
56813888|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
56813889|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813890|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
56813891|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813892|NCT00384956|Azacitidine|azacitidine|mesh-list
56813893|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56524816|NCT01193517|Decitabine|decitabine|mesh-list
56813894|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
56813895|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086267|NCT02736175|Dexamethasone|dexamethasone|mesh-list
56813926|NCT00526799|Topotecan|topotecan|mesh-list
56813927|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813928|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56813929|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813930|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813931|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56813932|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813933|NCT01059084|Valacyclovir|valacyclovir|mesh-list
56813934|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
56813935|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813936|NCT03992144|Amoxicillin|amoxicillin|mesh-list
56813937|NCT03992144|Metronidazole|metronidazole|mesh-list
56813938|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56813939|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813940|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56813941|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56813942|NCT02534870|Ritonavir|ritonavir|mesh-list
56813975|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56813976|NCT01259648|Narcotics|narcotics|mesh-ancestor
56813977|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56813978|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813979|NCT01259648|Analgesics|analgesics|mesh-ancestor
56813980|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
56813981|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813982|NCT01049048|Vitamin D|vitamin d|mesh-list
56813983|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
56813984|NCT01049048|Vitamins|vitamins|mesh-ancestor
56813985|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
56814016|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814017|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814018|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814019|NCT00520013|Paclitaxel|paclitaxel|mesh-list
56814020|NCT00520013|Bevacizumab|bevacizumab|mesh-list
56814021|NCT00520013|Carboplatin|carboplatin|mesh-list
56814022|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56814023|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56543615|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56543616|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56543617|NCT05410223|Renal Agents|renal agents|mesh-ancestor
56543618|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56543619|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56543620|NCT01206101|Liraglutide|liraglutide|mesh-list
56543621|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56543622|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543623|NCT01206101|Incretins|incretins|mesh-ancestor
56543624|NCT01206101|Hormones|hormones|mesh-ancestor
56543625|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543626|NCT00997503|Aspirin|aspirin|mesh-list
56291890|NCT01466530|Misoprostol|misoprostol|mesh-list
56543627|NCT00997503|Paclitaxel|paclitaxel|mesh-list
56543628|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56543629|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56543630|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543631|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814024|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814025|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814026|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814027|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814028|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814029|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814063|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814064|NCT00135694|Prednisone|prednisone|mesh-list
56814065|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56814066|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56814067|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
56814068|NCT00135694|Hormones|hormones|mesh-ancestor
56814069|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814070|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814071|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56814072|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814073|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814094|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814095|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814096|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56814097|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814098|NCT00519077|Gefitinib|gefitinib|mesh-list
56814099|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814100|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56814101|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814102|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814103|NCT00124618|Cetuximab|cetuximab|mesh-list
56814104|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814105|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814106|NCT00124072|Folic Acid|folic acid|mesh-list
56814107|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
56814108|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
56814109|NCT00124072|Simvastatin|simvastatin|mesh-list
56814110|NCT00124072|Vitamins|vitamins|mesh-ancestor
56814111|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
56814112|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814113|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56814114|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56814115|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
56068457|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
56543632|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
56543633|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
56543634|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543635|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56543636|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56543637|NCT00997503|Analgesics|analgesics|mesh-ancestor
56543638|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
56543639|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543640|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543641|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543642|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56543643|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56543644|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56814116|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814117|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56525024|NCT04317183|Miconazole|miconazole|mesh-list
56086520|NCT05315947|Brivaracetam|brivaracetam|mesh-list
56814155|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
56814156|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814157|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56814158|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56814192|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56814193|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56814194|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56814195|NCT00518531|Denosumab|denosumab|mesh-list
56814196|NCT00518531|Alendronate|alendronate|mesh-list
56814197|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56814198|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814234|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
56814235|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814236|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814237|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56814238|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56814239|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
56814240|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814241|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56814252|NCT01059396|Carvedilol|carvedilol|mesh-list
56814253|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56814254|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56814255|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
56814256|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56814257|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814258|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814259|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56814260|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56814261|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
56814262|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
56814263|NCT01059396|Protective Agents|protective agents|mesh-ancestor
56814264|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56814265|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56814266|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56814267|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56814268|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56814269|NCT01059552|Vorinostat|vorinostat|mesh-list
56814270|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814271|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56814272|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814273|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814274|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
56543645|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56543646|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56543647|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814275|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56814276|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814277|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
56814278|NCT03755765|Amoxicillin|amoxicillin|mesh-list
56814279|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
56814280|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
56814281|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56814282|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56814283|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814284|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56814285|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814286|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814287|NCT01061112|Tolbutamide|tolbutamide|mesh-list
56814288|NCT01061112|Fluconazole|fluconazole|mesh-list
56814289|NCT01061112|Ketoprofen|ketoprofen|mesh-list
56086689|NCT04338373|Atropine|atropine|mesh-list
56814313|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56814314|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56814315|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
56814316|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56814317|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814318|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814319|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56814320|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56814321|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
56814322|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56814323|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814325|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
56814326|NCT00517829|Cetuximab|cetuximab|mesh-list
56814327|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814328|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814329|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814330|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814331|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814332|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814333|NCT00343512|Docetaxel|docetaxel|mesh-list
56814334|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814335|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814336|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814337|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814361|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56814362|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56814363|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56814364|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814365|NCT00234039|Gemcitabine|gemcitabine|mesh-list
56814366|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56814367|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
56814368|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814369|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814370|NCT00234039|Antiviral Agents|antiviral agents|mesh-ancestor
56814371|NCT00234039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814372|NCT00234039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814373|NCT00234039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814374|NCT00234039|Immunologic Factors|immunologic factors|mesh-ancestor
56814375|NCT00234039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814376|NCT02531451|Aspirin|aspirin|mesh-list
56814377|NCT02531451|Ibuprofen|ibuprofen|mesh-list
56814378|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56814379|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56814380|NCT02531451|Analgesics|analgesics|mesh-ancestor
56814381|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
56814382|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814383|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814384|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56814385|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56814386|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56814387|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814388|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814389|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56543648|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
56543649|NCT02705053|Insulin|insulin|mesh-list
56543650|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56543651|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543652|NCT01204775|Metformin|metformin|mesh-list
56086776|NCT05061901|Lisinopril|lisinopril|mesh-list
56814454|NCT03968835|Bacitracin|bacitracin|mesh-list
56814455|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56814456|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814457|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56814458|NCT00322842|Plerixafor|plerixafor|mesh-list
56814459|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56814460|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56814461|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
56814462|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814463|NCT04726085|Ibuprofen|ibuprofen|mesh-list
56814464|NCT04726085|Indomethacin|indomethacin|mesh-list
56814465|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56814466|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56814467|NCT04726085|Analgesics|analgesics|mesh-ancestor
56814468|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
56814469|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814470|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814471|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56814472|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56814473|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56814474|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086863|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56814500|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814502|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814503|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814504|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56814505|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
56814506|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56814507|NCT00517361|Bevacizumab|bevacizumab|mesh-list
56814508|NCT00517361|Carboplatin|carboplatin|mesh-list
56814509|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814510|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814511|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56814512|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56814513|NCT00517361|Growth Substances|growth substances|mesh-ancestor
56814514|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814515|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
56814516|NCT00516893|Natalizumab|natalizumab|mesh-list
56814517|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
56814518|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814519|NCT03677141|Prednisone|prednisone|mesh-list
56814520|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
56814521|NCT03677141|Doxorubicin|doxorubicin|mesh-list
56814522|NCT03677141|Vincristine|vincristine|mesh-list
56814523|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814524|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
56814556|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
56814557|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56814558|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
56814559|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814560|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814561|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56814562|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814563|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56814564|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814565|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814566|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
56814567|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56814597|NCT03540485|Protective Agents|protective agents|mesh-ancestor
56814598|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814599|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56814601|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56814602|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56814603|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814604|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814605|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
56543653|NCT01204775|Saxagliptin|saxagliptin|mesh-list
56543654|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56814606|NCT02531841|Dexamethasone|dexamethasone|mesh-list
56814607|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
56814608|NCT02531841|Etoposide|etoposide|mesh-list
56814609|NCT02531841|Ifosfamide|ifosfamide|mesh-list
56814610|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
56814611|NCT02531841|Thiotepa|thiotepa|mesh-list
56814612|NCT02531841|Carmustine|carmustine|mesh-list
56814613|NCT02531841|Busulfan|busulfan|mesh-list
56814614|NCT02531841|BB 1101|bb 1101|mesh-list
56814615|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56814616|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
56814617|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
56814618|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814648|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56814649|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
56814650|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56814651|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525543|NCT00630019|Ofloxacin|ofloxacin|mesh-list
56814652|NCT03973047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56814653|NCT03973047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56814654|NCT03973047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56814655|NCT03973047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56814656|NCT03973047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56814657|NCT00522275|Lacosamide|lacosamide|mesh-list
56814658|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
56814659|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56814660|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56814661|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56814662|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814697|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56814698|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56814699|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56814700|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
56814701|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56814702|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087093|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814734|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56814735|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814736|NCT00231777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56814737|NCT00231777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56814738|NCT00231777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56814739|NCT00231777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56814740|NCT00231777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56814741|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56814743|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56814744|NCT01076842|Exenatide|exenatide|mesh-list
56814745|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
56814776|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56814777|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814779|NCT00254163|Rituximab|rituximab|mesh-list
56814780|NCT00254163|Fludarabine|fludarabine|mesh-list
56814781|NCT00254163|Pentostatin|pentostatin|mesh-list
56814782|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814783|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
56814784|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814785|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56814786|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56814787|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
56814788|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814789|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814823|NCT01072071|Furosemide|furosemide|mesh-list
56814824|NCT01072071|Diuretics|diuretics|mesh-ancestor
56814825|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
56814826|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814827|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56814828|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56814829|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814863|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814864|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
56814865|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56814866|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56814867|NCT03367871|Paclitaxel|paclitaxel|mesh-list
56814868|NCT03367871|Bevacizumab|bevacizumab|mesh-list
56543655|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543656|NCT01204775|Incretins|incretins|mesh-ancestor
56543657|NCT01204775|Hormones|hormones|mesh-ancestor
56543658|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543659|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56543660|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
56543661|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543662|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543663|NCT02844907|Dexamethasone|dexamethasone|mesh-list
56543664|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543665|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
56543666|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
56814869|NCT03367871|Carboplatin|carboplatin|mesh-list
56814870|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
56814871|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814872|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814903|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814904|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56814905|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56814906|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56814907|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56814908|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56814909|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
56814910|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
56814912|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56814913|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56814914|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56814915|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814916|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814917|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56814949|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814950|NCT00366548|Vaccines|vaccines|mesh-list
56814951|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56814952|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
56525839|NCT00966355|Octreotide|octreotide|mesh-list
56814953|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814955|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
56814956|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814957|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56814958|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56814978|NCT01045304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814979|NCT01045304|Immunologic Factors|immunologic factors|mesh-ancestor
56814980|NCT01045304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814981|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56814982|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56814983|NCT01080742|Bisoprolol|bisoprolol|mesh-list
56814984|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56814985|NCT01080742|Diuretics|diuretics|mesh-ancestor
56814986|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
56814987|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814988|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56814989|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56814990|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814991|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
56814992|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
56814993|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814994|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56814995|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56814996|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56814997|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
56814998|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543667|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543668|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814999|NCT00131248|Metoclopramide|metoclopramide|mesh-list
56815000|NCT00131248|Ranitidine|ranitidine|mesh-list
56815001|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56815002|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
56815003|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
56815004|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815005|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815006|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815007|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56815008|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56815009|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
56815010|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815011|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815012|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56815013|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56815035|NCT00096382|Fludarabine|fludarabine|mesh-list
56815036|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
56815037|NCT00096382|Interleukin-2|interleukin-2|mesh-list
56815038|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815039|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
56815040|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815041|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815042|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56815043|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
56815044|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815045|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815046|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56815047|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56815048|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
56815049|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56815050|NCT00096382|Analgesics|analgesics|mesh-ancestor
56815051|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
56815052|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815053|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56815054|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56815055|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
56815056|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815057|NCT00384332|Olanzapine|olanzapine|mesh-list
56815058|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
56815059|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
56815060|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815061|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815062|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815063|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56815064|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56815065|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815066|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56815067|NCT00384332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56815068|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56815098|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815099|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815100|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56815101|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
56815102|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
56815103|NCT03964324|Protective Agents|protective agents|mesh-ancestor
56815104|NCT01082848|Aripiprazole|aripiprazole|mesh-list
56815105|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
56815106|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56815107|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56815108|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56815109|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815110|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815136|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815137|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56815138|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815139|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815140|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56815142|NCT01078870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56815143|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56815144|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543669|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56543670|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
56543671|NCT02844907|Hormones|hormones|mesh-ancestor
56543672|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543673|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56543674|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543675|NCT00628719|Amphotericin B|amphotericin b|mesh-list
56543676|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56543677|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56543678|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
56543679|NCT00628719|Amebicides|amebicides|mesh-ancestor
56543680|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56543681|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56543682|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543683|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56543684|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
56543685|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56543686|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56543687|NCT00616993|Difluprednate|difluprednate|mesh-list
56815145|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815146|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815147|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
56815148|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815149|NCT01078870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56815150|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
56815151|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56815152|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815153|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56815154|NCT01078870|Analgesics|analgesics|mesh-ancestor
56815155|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
56815156|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
56815157|NCT00105196|Aripiprazole|aripiprazole|mesh-list
56815158|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
56815193|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56815194|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
56815195|NCT00514943|Cetuximab|cetuximab|mesh-list
56815196|NCT00514943|Afatinib|afatinib|mesh-list
56815231|NCT03330821|Pevonedistat|pevonedistat|mesh-list
56815232|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56815233|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
56087616|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815266|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815267|NCT00251979|Esomeprazole|esomeprazole|mesh-list
56815268|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56815269|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815270|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56815271|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815272|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815297|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56815298|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56815299|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56815300|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56815301|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
56815302|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815303|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543688|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
56543689|NCT00616993|Hormones|hormones|mesh-ancestor
56543690|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815304|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815306|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
56815307|NCT00513695|Doxorubicin|doxorubicin|mesh-list
56815308|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56815309|NCT00513695|Sunitinib|sunitinib|mesh-list
56815310|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56815311|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815312|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
56815313|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
56815314|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
56815315|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815316|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815317|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
56815318|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815319|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815320|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56815321|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
56815355|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815356|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56815357|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
56815358|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
56815359|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56815360|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
56815361|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56815362|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56815394|NCT02834975|Paclitaxel|paclitaxel|mesh-list
56815395|NCT02834975|Carboplatin|carboplatin|mesh-list
56815396|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
56815397|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56815398|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815399|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
56815400|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
56815401|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
56815402|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815403|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56815404|NCT00120874|Memantine|memantine|mesh-list
56815405|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56815406|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56815513|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56815514|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
56815515|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
56815516|NCT00358826|Atreleuton|atreleuton|mesh-list
56815517|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56815550|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56815551|NCT01009853|Narcotics|narcotics|mesh-ancestor
56815552|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815553|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815554|NCT01009853|Analgesics|analgesics|mesh-ancestor
56815555|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
56815556|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815557|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
56087941|NCT05349032|Curcumin|curcumin|mesh-list
56815589|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815590|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815591|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815592|NCT00505661|Letrozole|letrozole|mesh-list
56815593|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815594|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56815595|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56815596|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815597|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815598|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56815599|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
56087970|NCT05057689|Narcotics|narcotics|mesh-ancestor
56815632|NCT01010243|Growth Substances|growth substances|mesh-ancestor
56815633|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
56815634|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56815635|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56815636|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
56473667|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543691|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543692|NCT02870361|Insulin|insulin|mesh-list
56543693|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56543694|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634304|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543695|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
56543696|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
56543697|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56543698|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56543699|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56543700|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543701|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56543702|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56543703|NCT00997035|Voriconazole|voriconazole|mesh-list
56543704|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
56543705|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543706|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56543707|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56543708|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543709|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543710|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56543711|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
56543712|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543713|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543714|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56543716|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56543717|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815637|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815639|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815640|NCT00504881|Brivaracetam|brivaracetam|mesh-list
56815641|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
56815642|NCT00504725|Ketamine|ketamine|mesh-list
56815643|NCT00504725|Analgesics|analgesics|mesh-ancestor
56815664|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56815665|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56815666|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56815667|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
56815668|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815669|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815670|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815671|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
56815672|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56543718|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
56543719|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
56543720|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
56197900|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815673|NCT05130788|Nicotine|nicotine|mesh-list
56815674|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56815675|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
56815676|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815677|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815678|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56815679|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56815680|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
56815681|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815682|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815683|NCT00362180|Mipomersen|mipomersen|mesh-list
56815684|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56815685|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56815686|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
56815687|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815688|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56815689|NCT00383162|Naproxen|naproxen|mesh-list
56815690|NCT00383162|Sumatriptan|sumatriptan|mesh-list
56815691|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56815692|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56815693|NCT00383162|Analgesics|analgesics|mesh-ancestor
56815694|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
56815695|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815726|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
56815727|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815728|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815729|NCT01052870|Urological Agents|urological agents|mesh-ancestor
56815730|NCT00358436|Bromides|bromides|mesh-list
56815731|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
56815732|NCT01053026|Olmesartan|olmesartan|mesh-list
56815733|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56815734|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56815735|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56815736|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815764|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815765|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815766|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815767|NCT00357656|Factor VIII|factor viii|mesh-list
56815768|NCT00357656|Coagulants|coagulants|mesh-ancestor
56815769|NCT00357500|Thalidomide|thalidomide|mesh-list
56815770|NCT00357500|Celecoxib|celecoxib|mesh-list
56815771|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
56815772|NCT00357500|Etoposide|etoposide|mesh-list
56815773|NCT00357500|Fenofibrate|fenofibrate|mesh-list
56815774|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815775|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
56815776|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815777|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815778|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56815779|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
56815780|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815781|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815782|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56815783|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56815809|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56815811|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
56815812|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815813|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815814|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56815815|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56815816|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815817|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815818|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56815819|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56815820|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068561|NCT03970655|BB 1101|bb 1101|mesh-list
56543721|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815821|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56815822|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56815823|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56815824|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815825|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
56815826|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815827|NCT00098722|Maraviroc|maraviroc|mesh-list
56815828|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56815829|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56088202|NCT04336904|Favipiravir|favipiravir|mesh-list
56815862|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815864|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
56815865|NCT00381680|Leucovorin|leucovorin|mesh-list
56815866|NCT00381680|Cytarabine|cytarabine|mesh-list
56815867|NCT00381680|Dexamethasone|dexamethasone|mesh-list
56815868|NCT00381680|Prednisone|prednisone|mesh-list
56815869|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
56815870|NCT00381680|Doxorubicin|doxorubicin|mesh-list
56815871|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56815872|NCT00381680|Methotrexate|methotrexate|mesh-list
56815873|NCT00381680|Etoposide|etoposide|mesh-list
56815874|NCT00381680|Vincristine|vincristine|mesh-list
56815907|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56815908|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56815909|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56815910|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56815911|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
56815912|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815913|NCT00381680|Antidotes|antidotes|mesh-ancestor
56815914|NCT00381680|Protective Agents|protective agents|mesh-ancestor
56815915|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
56815916|NCT00381680|Vitamins|vitamins|mesh-ancestor
56815917|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
56815948|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
56815949|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
56815950|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815951|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56815952|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
56815953|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
56815954|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815955|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56815956|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
56815957|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
56815958|NCT01050374|Albendazole|albendazole|mesh-list
56815959|NCT01050374|Praziquantel|praziquantel|mesh-list
56815960|NCT01050374|Mebendazole|mebendazole|mesh-list
56815961|NCT01050374|Piperazine|piperazine|mesh-list
56815962|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
56815963|NCT01050374|DMP 777|dmp 777|mesh-list
56815964|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
56815965|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56088336|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
56815996|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815997|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815999|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
56816000|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816001|NCT00162123|Ipilimumab|ipilimumab|mesh-list
56816002|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56816003|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816004|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56816005|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816007|NCT00227721|Docetaxel|docetaxel|mesh-list
56816008|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816009|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
56816010|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816011|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816012|NCT00227721|Antiviral Agents|antiviral agents|mesh-ancestor
56816046|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56816047|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816048|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
56816049|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
56816050|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
56816051|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816052|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
56816053|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
56816054|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56088429|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816089|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
56816090|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816091|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816092|NCT00509795|Ranibizumab|ranibizumab|mesh-list
56816093|NCT00509795|Aflibercept|aflibercept|mesh-list
56816094|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56816095|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56816096|NCT00509795|Growth Substances|growth substances|mesh-ancestor
56816134|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
56088506|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
56816162|NCT01050452|Ivermectin|ivermectin|mesh-list
56816163|NCT01050452|Albendazole|albendazole|mesh-list
56816164|NCT01050452|Mebendazole|mebendazole|mesh-list
56816165|NCT01050452|Piperazine|piperazine|mesh-list
56816166|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
56816167|NCT01050452|DMP 777|dmp 777|mesh-list
56816168|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56816169|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816170|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
56816171|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
56816172|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56816173|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56816174|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
56816175|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
56816176|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
56816177|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816178|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816179|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
56816209|NCT00355784|Hormones|hormones|mesh-list
56816210|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816211|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816212|NCT02534636|Interferons|interferons|mesh-list
56816213|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
56816214|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
56816215|NCT02534636|BMS-986165|bms-986165|mesh-list
56816216|NCT02534636|Famotidine|famotidine|mesh-list
56816217|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816218|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
56816219|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816220|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
56816221|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816222|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56088589|NCT04367090|Docetaxel|docetaxel|mesh-list
56816258|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816259|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816260|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
56816261|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816262|NCT01053884|Anidulafungin|anidulafungin|mesh-list
56816296|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816297|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816298|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56816299|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56816300|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56816301|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56816328|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816329|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
56816330|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816331|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816332|NCT01010945|Gemcitabine|gemcitabine|mesh-list
56816333|NCT01010945|Paclitaxel|paclitaxel|mesh-list
56816334|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56816335|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56816336|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816337|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
56816338|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
56816339|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
56816340|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816341|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816342|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
56816343|NCT01010945|Antiviral Agents|antiviral agents|mesh-ancestor
56816344|NCT01010945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816345|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816346|NCT01010945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816347|NCT01010945|Immunologic Factors|immunologic factors|mesh-ancestor
56816348|NCT01010945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816349|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816381|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56543722|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543723|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543724|NCT01203917|Gefitinib|gefitinib|mesh-list
56543725|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543726|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543727|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543728|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543729|NCT04213495|Anesthetics|anesthetics|mesh-list
56543730|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543731|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543732|NCT04318223|Palbociclib|palbociclib|mesh-list
56816382|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
56816383|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56816384|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816385|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816387|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816388|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816389|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
56816390|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816391|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56816426|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816427|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816428|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816429|NCT00507455|Urological Agents|urological agents|mesh-ancestor
56816454|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56816456|NCT01015937|Turmeric extract|turmeric extract|mesh-list
56816457|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56816458|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56816459|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56816460|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56816461|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816462|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
56816463|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816464|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
56816465|NCT01015937|Protective Agents|protective agents|mesh-ancestor
56816466|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816467|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56816468|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56816469|NCT04266353|Resveratrol|resveratrol|mesh-list
56816470|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
56816471|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816472|NCT04266353|Protective Agents|protective agents|mesh-ancestor
56816473|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816474|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816475|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56816476|NCT01012193|Cilostazol|cilostazol|mesh-list
56816477|NCT01012193|Clopidogrel|clopidogrel|mesh-list
56816478|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56816479|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56816480|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56088842|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
56816509|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56816510|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
56816511|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816512|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816513|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
56816514|NCT00503009|Fluticasone|fluticasone|mesh-list
56816516|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56816517|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56816518|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56816519|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
56816520|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543733|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543734|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543735|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543736|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816521|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816522|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56816523|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
56816524|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
56816525|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56816544|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56816545|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816546|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816547|NCT00378014|Everolimus|everolimus|mesh-list
56816548|NCT00378014|Basiliximab|basiliximab|mesh-list
56816549|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816550|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816551|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
56816552|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816553|NCT00485303|Prednisone|prednisone|mesh-list
56816554|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
56816555|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56816556|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
56816557|NCT00485303|Hormones|hormones|mesh-ancestor
56816558|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816559|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816560|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56816561|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816562|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56816563|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816564|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816565|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
56816566|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56816567|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
56816568|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56816569|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816570|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56816571|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816572|NCT01016249|Epinephrine|epinephrine|mesh-list
56816573|NCT01016249|Racepinephrine|racepinephrine|mesh-list
56816574|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
56816575|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56816576|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56816577|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
56816578|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816579|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816580|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088927|NCT00373412|Vaccines|vaccines|mesh-list
56816655|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816657|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
56816658|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816659|NCT00355082|Lamotrigine|lamotrigine|mesh-list
56816660|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
56816661|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56816662|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56816663|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816664|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56816665|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816666|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56816667|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56816668|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56816669|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56816694|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56816695|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816696|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56816698|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56816699|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816700|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56543737|NCT01202903|Omalizumab|omalizumab|mesh-list
56543738|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56543739|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56543740|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
56543741|NCT00618631|Carfentanil|carfentanil|mesh-list
56543742|NCT00618631|Nicotine|nicotine|mesh-list
56543743|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56543744|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
56543745|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543746|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543747|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56543748|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56543749|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
56543750|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543751|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543752|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56543753|NCT00618631|Narcotics|narcotics|mesh-ancestor
56543754|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543755|NCT00618631|Analgesics|analgesics|mesh-ancestor
56543756|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
56816701|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816702|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
56816703|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816704|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
56816705|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816706|NCT00376220|Riluzole|riluzole|mesh-list
56816707|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
56816708|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56816709|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56816710|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816711|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816712|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816713|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56816714|NCT00376220|Protective Agents|protective agents|mesh-ancestor
56816715|NCT00375752|Letrozole|letrozole|mesh-list
56089067|NCT04233229|Insulin|insulin|mesh-list
56816743|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816744|NCT01013987|Ritonavir|ritonavir|mesh-list
56816745|NCT01013987|Darunavir|darunavir|mesh-list
56816747|NCT01013987|Maraviroc|maraviroc|mesh-list
56816748|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56816749|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56816750|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
56816751|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816752|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816753|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56816754|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56816755|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
56816756|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816757|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56816758|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56816759|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56816760|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56816761|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56816783|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56816784|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
56543757|NCT04213573|Fluorides|fluorides|mesh-list
56543758|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
56543759|NCT04213573|Protective Agents|protective agents|mesh-ancestor
56816785|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816786|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816787|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56816788|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56816790|NCT00333840|Cytarabine|cytarabine|mesh-list
56816791|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
56816792|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
56816793|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
56816794|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816795|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
56816796|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816797|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816798|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
56816799|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816800|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816801|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
56816802|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816803|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816804|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816805|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
56816806|NCT01019603|Tazarotene|tazarotene|mesh-list
56816807|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
56816808|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
56816809|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
56816810|NCT01019603|Vitamins|vitamins|mesh-ancestor
56816811|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
56816812|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816813|NCT00321906|Sirolimus|sirolimus|mesh-list
56816814|NCT00321906|Azathioprine|azathioprine|mesh-list
56816815|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56816816|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816817|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56816836|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
56816837|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56816838|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816839|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56816840|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56816841|NCT00321828|Growth Substances|growth substances|mesh-ancestor
56816842|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816843|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
56816844|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
56816845|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816846|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816847|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816848|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
56816849|NCT00321828|Antidotes|antidotes|mesh-ancestor
56816850|NCT00321828|Protective Agents|protective agents|mesh-ancestor
56816851|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
56816852|NCT00321828|Vitamins|vitamins|mesh-ancestor
56816853|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
56816854|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56816855|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56816856|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816857|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816858|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
56816859|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816860|NCT01061658|Vaccines|vaccines|mesh-list
56816861|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
56816862|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816863|NCT01058382|Progesterone|progesterone|mesh-list
56816864|NCT01058382|Progestins|progestins|mesh-ancestor
56816865|NCT01058382|Hormones|hormones|mesh-ancestor
56816866|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816867|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816868|NCT01061814|Mipomersen|mipomersen|mesh-list
56816869|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56816870|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56816871|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
56816872|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089213|NCT01821781|Thiotepa|thiotepa|mesh-list
56816895|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543760|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543761|NCT02595931|Irinotecan|irinotecan|mesh-list
56543762|NCT02595931|Camptothecin|camptothecin|mesh-list
56543763|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56543764|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56543765|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543766|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543767|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543768|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56543769|NCT00620269|Irinotecan|irinotecan|mesh-list
56543770|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56543771|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543772|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56543773|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56543774|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292035|NCT04201457|Protective Agents|protective agents|mesh-ancestor
56543775|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543776|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543778|NCT04212403|Ofloxacin|ofloxacin|mesh-list
56543779|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56543780|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543781|NCT04212403|Renal Agents|renal agents|mesh-ancestor
56543782|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56543783|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56543784|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56543785|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543786|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543787|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543788|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56543789|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56543790|NCT00637117|Interferons|interferons|mesh-list
56543791|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
56543792|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543793|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
56543797|NCT02052193|Vemurafenib|vemurafenib|mesh-list
56543799|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543800|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543801|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543802|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543803|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
56543804|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56543805|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56543806|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
56543807|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543808|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543809|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816896|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56816897|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56816898|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816899|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816900|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
56816901|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
56816902|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
56816903|NCT00321672|Capsaicin|capsaicin|mesh-list
56816904|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
56816905|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
56816906|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
56816907|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816908|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816909|NCT00330174|Acamprosate|acamprosate|mesh-list
56816910|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56816911|NCT00320424|PENTA|penta|mesh-list
56816912|NCT00320424|Fondaparinux|fondaparinux|mesh-list
56816913|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56816914|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
56816915|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56816916|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
56816917|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816918|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816919|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
56816920|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56816921|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56816922|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
56816923|NCT00338286|Hematinics|hematinics|mesh-ancestor
56816924|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
56816925|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816926|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
56816963|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56816999|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817000|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56817086|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56817087|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
56817088|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
56817089|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56817090|NCT00483119|Antibodies|antibodies|mesh-list
55816670|NCT01896232|Cinacalcet|cinacalcet|mesh-list
56527995|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
56817121|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817122|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817123|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56817124|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817125|NCT00482729|Metformin|metformin|mesh-list
56817126|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56817127|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56817128|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817129|NCT00482729|Incretins|incretins|mesh-ancestor
56817130|NCT00482729|Hormones|hormones|mesh-ancestor
56817131|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817161|NCT01055522|Dacarbazine|dacarbazine|mesh-list
56543810|NCT00619021|Gemcitabine|gemcitabine|mesh-list
56543811|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56543812|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
56543813|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543814|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543815|NCT00619021|Antiviral Agents|antiviral agents|mesh-ancestor
56543816|NCT00619021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543817|NCT00619021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543818|NCT00619021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56543819|NCT00619021|Immunologic Factors|immunologic factors|mesh-ancestor
56543820|NCT00619021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817162|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817163|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56817164|NCT01055522|Analgesics|analgesics|mesh-ancestor
56817165|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
56817166|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817167|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817168|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56817169|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
56817170|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817171|NCT03987152|Sirolimus|sirolimus|mesh-list
56817172|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56817173|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817174|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56817175|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817176|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
56817177|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817203|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56817204|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817205|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817206|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56817207|NCT00347360|Carvedilol|carvedilol|mesh-list
56817208|NCT00347360|Lisinopril|lisinopril|mesh-list
56817209|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56817210|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56817211|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
56817212|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817213|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817214|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817215|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56817216|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
56817217|NCT00347360|Protective Agents|protective agents|mesh-ancestor
56817218|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56817219|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817220|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56817221|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
56817222|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56817223|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56817224|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56817225|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
56817250|NCT03982680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817251|NCT00352118|Docetaxel|docetaxel|mesh-list
56817252|NCT00352118|Fluorouracil|fluorouracil|mesh-list
56817253|NCT00352118|Lenograstim|lenograstim|mesh-list
56817254|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817255|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56817256|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56817257|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56817258|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817259|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
56817260|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56817261|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56543821|NCT00620347|Sunitinib|sunitinib|mesh-list
56543822|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543823|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56543824|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56543825|NCT00620347|Growth Substances|growth substances|mesh-ancestor
56543826|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543827|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
56543828|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543829|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543830|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543831|NCT04213105|Denosumab|denosumab|mesh-list
56543832|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56543833|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543834|NCT01887301|Nabiximols|nabiximols|mesh-list
56543835|NCT01887301|Analgesics|analgesics|mesh-ancestor
56543836|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
56543837|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817262|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
56817263|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817264|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56817265|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
56817266|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56817267|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56817268|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56528146|NCT02850913|Doxycycline|doxycycline|mesh-list
56817269|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817270|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56817271|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
56817272|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56817273|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817274|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817275|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
56817310|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56817311|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
56817312|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817313|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817314|NCT00350636|Urological Agents|urological agents|mesh-ancestor
56817315|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56817316|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817362|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56817363|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56817364|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817365|NCT00337610|Incretins|incretins|mesh-ancestor
56817366|NCT00337610|Hormones|hormones|mesh-ancestor
56817367|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817368|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56817369|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
56817370|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817371|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817372|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56817373|NCT01062204|Laxatives|laxatives|mesh-ancestor
56817374|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56817375|NCT01062282|Iloprost|iloprost|mesh-list
56817376|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56817377|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
56817378|NCT03985280|Anesthetics|anesthetics|mesh-list
56817379|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
56543838|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543839|NCT00996801|Vitamin D|vitamin d|mesh-list
56543840|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
56543841|NCT00996801|Alendronate|alendronate|mesh-list
56817380|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817381|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817382|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
56817383|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817384|NCT01058876|Nicotine|nicotine|mesh-list
56817385|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56817386|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
56817387|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817388|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817389|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56817390|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56817391|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
56817392|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817393|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817394|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
56817395|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
56817396|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56089723|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
56817435|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56817436|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
56817437|NCT00335972|Remifentanil|remifentanil|mesh-list
56817438|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56817439|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817440|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817441|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56817442|NCT00335972|Analgesics|analgesics|mesh-ancestor
56817443|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
56817444|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817445|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56817446|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56817447|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56817448|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
56817449|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817450|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817451|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56817452|NCT00335972|Narcotics|narcotics|mesh-ancestor
56817453|NCT03983460|Betamethasone|betamethasone|mesh-list
56817454|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
56817455|NCT03983460|Clobetasol|clobetasol|mesh-list
56817456|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817457|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
56817458|NCT03983460|Hormones|hormones|mesh-ancestor
56817459|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817460|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817461|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56817462|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
56817496|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56817497|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817498|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817499|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56817501|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56817502|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817503|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56817504|NCT00345878|Vaccines|vaccines|mesh-list
56817551|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817552|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
56817553|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
56817554|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
56817555|NCT02533076|Capsaicin|capsaicin|mesh-list
56817556|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
56817557|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
56817558|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
56817559|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817560|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817561|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56817562|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817563|NCT01056926|Nicotine|nicotine|mesh-list
56543842|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
56543843|NCT00996801|Calcium|calcium|mesh-list
56543844|NCT00996801|Vitamins|vitamins|mesh-ancestor
56543845|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
56543846|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817564|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56817598|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56817599|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56817600|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817601|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817602|NCT00326898|Sorafenib|sorafenib|mesh-list
56817603|NCT00326898|Sunitinib|sunitinib|mesh-list
56817604|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817605|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56089946|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
56817675|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817676|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817677|NCT00334802|Gemcitabine|gemcitabine|mesh-list
56817678|NCT00334802|Paclitaxel|paclitaxel|mesh-list
56817777|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56817778|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817779|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817780|NCT00314808|Hormones|hormones|mesh-ancestor
56817781|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817782|NCT01060514|Vinorelbine|vinorelbine|mesh-list
56817783|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56817784|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817785|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
56817786|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
56817787|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
56817788|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817789|NCT01061216|Insulin|insulin|mesh-list
56817790|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56817791|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56817792|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817793|NCT00314574|Omalizumab|omalizumab|mesh-list
56817817|NCT00314340|Amphetamine|amphetamine|mesh-list
56817818|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56817819|NCT00314340|Narcotics|narcotics|mesh-ancestor
56817820|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817821|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817822|NCT00314340|Analgesics|analgesics|mesh-ancestor
56817823|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
56817824|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817825|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56817826|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
56817827|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
56817828|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
56817829|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56817830|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
56817831|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
56817832|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
56817833|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817834|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817835|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
56817836|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56817837|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56817838|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817839|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56817840|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
56817841|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56817842|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56817843|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56817844|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
56817845|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
56817846|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56817847|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56817874|NCT00333866|Analgesics|analgesics|mesh-ancestor
56817875|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
56817876|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817877|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543847|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56543848|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56543849|NCT00996801|Antacids|antacids|mesh-ancestor
56543850|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543851|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56543852|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56543854|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56543855|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543856|NCT04212793|Bevacizumab|bevacizumab|mesh-list
56817878|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
56817879|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56817880|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817881|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817882|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56817883|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56817884|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56817885|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817886|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56817887|NCT00324740|Vorinostat|vorinostat|mesh-list
56817888|NCT00324740|Isotretinoin|isotretinoin|mesh-list
56817889|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817890|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56817891|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817892|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817919|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817920|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
56817921|NCT00313716|Hematinics|hematinics|mesh-ancestor
56817922|NCT00313170|Fulvestrant|fulvestrant|mesh-list
56817923|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56817924|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817925|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56817926|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56817927|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
56817928|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817929|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817930|NCT00332462|Cyclosporine|cyclosporine|mesh-list
56817931|NCT00332462|Cyclosporins|cyclosporins|mesh-list
56817932|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817933|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817934|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817935|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
56817936|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817937|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
56817938|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817939|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
56817940|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817941|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56817942|NCT00324038|Acetaminophen|acetaminophen|mesh-list
56817977|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56817978|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56817980|NCT00159861|Urological Agents|urological agents|mesh-ancestor
56817981|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
56817982|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56090310|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
56818004|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56818006|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818007|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818008|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56818009|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56818010|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
56818011|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818012|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543857|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56543858|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543859|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56543860|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56543861|NCT04212793|Growth Substances|growth substances|mesh-ancestor
56818013|NCT01077453|Letrozole|letrozole|mesh-list
56818014|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818015|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56818016|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56818017|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818018|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818019|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56818021|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818022|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818023|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
56818024|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818025|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
56818026|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818027|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818028|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56818029|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
56818030|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818031|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818032|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56818033|NCT00312858|Vaccines|vaccines|mesh-list
56818034|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56818035|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
56818071|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818072|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818089|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818090|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56818091|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56818092|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818093|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818095|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
56818096|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818097|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818098|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56818099|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
56818100|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56818101|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
56818102|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56818103|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
56818104|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818105|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818106|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
56818107|NCT01077609|Fluticasone|fluticasone|mesh-list
56818108|NCT01077609|Xhance|xhance|mesh-list
56818109|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56818110|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56818111|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
56818112|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818113|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818114|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56818115|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
56818116|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
56818117|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56818118|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
56818119|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
56818120|NCT00223977|Hematinics|hematinics|mesh-ancestor
56818121|NCT00148941|Vaccines|vaccines|mesh-list
56818122|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
56818123|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818124|NCT01073553|Cephalexin|cephalexin|mesh-list
56818125|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56818126|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818127|NCT00148317|Dexamethasone|dexamethasone|mesh-list
56818128|NCT00148317|Doxorubicin|doxorubicin|mesh-list
56543862|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543863|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
56543864|NCT04924621|Midazolam|midazolam|mesh-list
56543865|NCT04924621|Sufentanil|sufentanil|mesh-list
56543866|NCT04924621|Propofol|propofol|mesh-list
56543867|NCT04924621|Tetracaine|tetracaine|mesh-list
56543868|NCT04924621|Rocuronium|rocuronium|mesh-list
56543869|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56543870|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543871|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543872|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56543873|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
56543874|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
56543875|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56543876|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56543877|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56543878|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56543879|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
56818129|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56818130|NCT00148317|Bortezomib|bortezomib|mesh-list
56818131|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56818132|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
56818133|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
56818134|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818135|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090440|NCT03123614|Protective Agents|protective agents|mesh-ancestor
56818186|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818188|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56818189|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818190|NCT00306384|Incretins|incretins|mesh-ancestor
56818191|NCT00306384|Hormones|hormones|mesh-ancestor
56818192|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818193|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56818194|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
56818195|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818196|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818197|NCT01062906|Lidocaine|lidocaine|mesh-list
56818198|NCT01062906|Fentanyl|fentanyl|mesh-list
56818199|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
56818200|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
56818201|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818202|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818203|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
56818204|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818205|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56818206|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56818207|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56818208|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818209|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818210|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56818211|NCT01062906|Narcotics|narcotics|mesh-ancestor
56818212|NCT01062906|Analgesics|analgesics|mesh-ancestor
56818213|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56818214|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56818215|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
56818216|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56818217|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56818218|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818219|NCT00305604|Incretins|incretins|mesh-ancestor
56818220|NCT00305604|Hormones|hormones|mesh-ancestor
56543880|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
56543881|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543882|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198064|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
56818221|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818280|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818282|NCT00481871|Folic Acid|folic acid|mesh-list
56818283|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
56818284|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
56818285|NCT00481871|Gemcitabine|gemcitabine|mesh-list
56818286|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
56818287|NCT00481871|Aminopterin|aminopterin|mesh-list
56818288|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
56818289|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818290|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56818291|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
56818292|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818293|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818294|NCT00481871|Antiviral Agents|antiviral agents|mesh-ancestor
56818295|NCT00481871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818296|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818297|NCT00481871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818357|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818358|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56818360|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56818361|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818362|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56818363|NCT00328094|Insulin|insulin|mesh-list
56818364|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56818365|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56818366|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818367|NCT00295932|Prednisone|prednisone|mesh-list
56818368|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
56818369|NCT00295932|Rituximab|rituximab|mesh-list
56818370|NCT00295932|Bortezomib|bortezomib|mesh-list
56818371|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818372|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
56818373|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818374|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818375|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56818376|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
56818377|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818378|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818379|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56818380|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56818381|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56818382|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
56818383|NCT00295932|Hormones|hormones|mesh-ancestor
56818384|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818385|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56818386|NCT01063140|Vaccines|vaccines|mesh-list
56818387|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
56818414|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56818416|NCT03986294|Leucovorin|leucovorin|mesh-list
56818417|NCT03986294|Antidotes|antidotes|mesh-ancestor
56818418|NCT03986294|Protective Agents|protective agents|mesh-ancestor
56818419|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818420|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
56818421|NCT03986294|Vitamins|vitamins|mesh-ancestor
56818422|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
56818423|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
56818424|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56818425|NCT00322556|Antibodies|antibodies|mesh-list
56818426|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
56818427|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818428|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
56818429|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
56818430|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
56818431|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
56818432|NCT00321932|Calcium|calcium|mesh-list
56818433|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56818434|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543883|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56543884|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56543885|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56543886|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543887|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56543888|NCT04924621|Narcotics|narcotics|mesh-ancestor
56543889|NCT04924621|Analgesics|analgesics|mesh-ancestor
56543890|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
56543891|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
56543892|NCT00516373|Olaparib|olaparib|mesh-list
56543893|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56543894|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543895|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818435|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56090744|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
56818461|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56818462|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56818463|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56818464|NCT01060826|Somatostatin|somatostatin|mesh-list
56818465|NCT01060826|Hormones|hormones|mesh-ancestor
56818466|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818467|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818468|NCT00321854|Pramipexole|pramipexole|mesh-list
56529333|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818469|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
56818470|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818471|NCT00321854|Protective Agents|protective agents|mesh-ancestor
56818472|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818473|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56818474|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56818475|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
56818476|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
56818477|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818478|NCT03982862|Triamcinolone|triamcinolone|mesh-list
56818479|NCT03982862|Lidocaine|lidocaine|mesh-list
56818480|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
56818481|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56818482|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56818483|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
56818484|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
56818485|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818486|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818487|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
56818539|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56818540|NCT01058174|Amebicides|amebicides|mesh-ancestor
56818541|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56818542|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56818543|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56818544|NCT01058252|Indomethacin|indomethacin|mesh-list
56529410|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56818546|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818547|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56818548|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56818549|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818550|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818551|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56818552|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
56818553|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818554|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818555|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56818556|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56818557|NCT01058252|Analgesics|analgesics|mesh-ancestor
56543896|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543897|NCT02213497|Paclitaxel|paclitaxel|mesh-list
56543898|NCT02213497|Carboplatin|carboplatin|mesh-list
56543899|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56543900|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56543901|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543902|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
56543903|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
56543904|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
56543905|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543906|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56543907|NCT02193841|Calcium|calcium|mesh-list
56543908|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56543909|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543910|NCT00618163|Meloxicam|meloxicam|mesh-list
56543911|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56543912|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56543913|NCT00618163|Analgesics|analgesics|mesh-ancestor
56543914|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
56543915|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543916|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543917|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543918|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818558|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
56818559|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818560|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56818561|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818562|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
56818563|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
56818564|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56818565|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56818566|NCT01058408|Cisplatin|cisplatin|mesh-list
56818567|NCT01058408|Everolimus|everolimus|mesh-list
56818568|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818569|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818570|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
56090880|NCT00375284|Protective Agents|protective agents|mesh-ancestor
56818612|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56818613|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
56818614|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818615|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818616|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56818617|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56818618|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
56529484|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56818619|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818620|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
56818621|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818622|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
56818623|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56818624|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56068763|NCT01909141|Androgens|androgens|mesh-ancestor
56543919|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56543920|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56543921|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543922|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543923|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
56543925|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56543926|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56543927|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
56543928|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56543929|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56543930|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56543931|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198102|NCT01511302|Hormones|hormones|mesh-ancestor
56818625|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56818626|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
56818627|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56818628|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
56818629|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56818630|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56818631|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56818632|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818633|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818634|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
56818635|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818636|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818637|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56090946|NCT03624062|Insulin|insulin|mesh-list
56818669|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56818671|NCT00309608|Linagliptin|linagliptin|mesh-list
56818672|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56818673|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56818674|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818675|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818676|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
56818677|NCT00309608|Incretins|incretins|mesh-ancestor
56818678|NCT00309608|Hormones|hormones|mesh-ancestor
56818679|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818680|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56818681|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
56090996|NCT03447782|Naltrexone|naltrexone|mesh-list
56818708|NCT04101461|Iron|iron|mesh-list
56818709|NCT04101461|Hepcidins|hepcidins|mesh-list
56818710|NCT04101461|Trace Elements|trace elements|mesh-ancestor
56818711|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
56818712|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818713|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818714|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56818715|NCT01017107|Protein C|protein c|mesh-list
56818716|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
56818717|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56818718|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56818719|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818720|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818721|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
56818722|NCT03997019|Narcotics|narcotics|mesh-ancestor
56818723|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818724|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818725|NCT03997019|Analgesics|analgesics|mesh-ancestor
56818726|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
56818727|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818728|NCT00480857|Docetaxel|docetaxel|mesh-list
56818729|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818730|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
56818731|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
56543932|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543933|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
56543934|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56543935|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818782|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56818783|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818784|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818786|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
56818787|NCT01063530|Protective Agents|protective agents|mesh-ancestor
56091098|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
56818858|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818859|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
56818860|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56818861|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
56818862|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818863|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
56818864|NCT03979586|Protective Agents|protective agents|mesh-ancestor
56818865|NCT00294762|Paclitaxel|paclitaxel|mesh-list
56818866|NCT00294762|Carboplatin|carboplatin|mesh-list
56818867|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56818868|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56818869|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818870|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
56818871|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
56818872|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
56818873|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818874|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56818875|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818876|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
56818877|NCT00294684|Prednisolone|prednisolone|mesh-list
56818878|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56818879|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
56818880|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
56818881|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818882|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818883|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56818884|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
56818885|NCT00294684|Hormones|hormones|mesh-ancestor
56818886|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818887|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56818888|NCT00294684|Protective Agents|protective agents|mesh-ancestor
56818889|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56818924|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818925|NCT00320216|Ustekinumab|ustekinumab|mesh-list
56818926|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
56818927|NCT00290706|Gemcitabine|gemcitabine|mesh-list
56818928|NCT00290706|Bortezomib|bortezomib|mesh-list
56818952|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818953|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56818954|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56818955|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56818956|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818957|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818958|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
56818959|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818960|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818961|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56818962|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818963|NCT01066494|Cytarabine|cytarabine|mesh-list
56818964|NCT01066494|Amonafide|amonafide|mesh-list
56818965|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56818966|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
56818967|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818968|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818969|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
56818970|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818971|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818972|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
56818973|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818974|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543936|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56198119|NCT01511367|Hormones|hormones|mesh-ancestor
56818975|NCT01069770|Sunitinib|sunitinib|mesh-list
56818976|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818977|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56818978|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56819001|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
56819002|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819003|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56819004|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56819005|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819006|NCT01066572|Lisinopril|lisinopril|mesh-list
56819007|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56819008|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
56819009|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819010|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819011|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56819012|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56819013|NCT01066572|Protective Agents|protective agents|mesh-ancestor
56819014|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819015|NCT01066650|Everolimus|everolimus|mesh-list
56819016|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819017|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819018|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
56819019|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819020|NCT01066728|Theophylline|theophylline|mesh-list
56819021|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56819022|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
56819023|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819024|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819025|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56819026|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
56819027|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56819028|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819029|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819030|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
56819031|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56819057|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56819058|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819059|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56819060|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819061|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819062|NCT02532270|Phenylephrine|phenylephrine|mesh-list
56819063|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
56819064|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56819065|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
56819066|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
56819067|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819068|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819069|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
56819070|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56819071|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
56819072|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
56819073|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56819074|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56819075|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56819076|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
56819077|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819078|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819079|NCT02532270|Protective Agents|protective agents|mesh-ancestor
56819080|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
56819108|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56819109|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
56819110|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819111|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819112|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56819113|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56819114|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
56819115|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819116|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56819117|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56543937|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543938|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56819118|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56819119|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56819120|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56819121|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56819123|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56819124|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
56819125|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56819126|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819127|NCT01067274|Cytarabine|cytarabine|mesh-list
56819128|NCT01067274|Azacitidine|azacitidine|mesh-list
56819129|NCT01067274|Tretinoin|tretinoin|mesh-list
56819130|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56819131|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
56819163|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56819164|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
56819165|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819166|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819167|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56819168|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819169|NCT03982784|Morphine|morphine|mesh-list
56819170|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56819171|NCT03982784|Narcotics|narcotics|mesh-ancestor
56819172|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56819173|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819174|NCT03982784|Analgesics|analgesics|mesh-ancestor
56819204|NCT03980990|Metformin|metformin|mesh-list
56819205|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56819206|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819207|NCT03980756|Esomeprazole|esomeprazole|mesh-list
56819208|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56819209|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819210|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56819211|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819212|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819213|NCT03978494|Tacrolimus|tacrolimus|mesh-list
56530091|NCT01258595|Vaccines|vaccines|mesh-list
56819214|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819215|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
56819216|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819233|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819234|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56819235|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56819236|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819237|NCT00303602|Olanzapine|olanzapine|mesh-list
56819238|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
56819239|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
56819240|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819241|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819242|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819243|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56819244|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56819245|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56819246|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56819247|NCT00303602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56819248|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56819249|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56819250|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819251|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819252|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
56819253|NCT03979976|Ramipril|ramipril|mesh-list
56819254|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56819255|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56819256|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
56819257|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819258|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56819259|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
56819260|NCT00299130|Rituximab|rituximab|mesh-list
56819261|NCT00299130|Methotrexate|methotrexate|mesh-list
56819262|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56819263|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819264|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
56819265|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543939|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56543940|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543941|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56819266|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819267|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56819268|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
56819269|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56819270|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56819271|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
56819272|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819273|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819274|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819275|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56819314|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819352|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56819377|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
56819378|NCT00284934|Hormones|hormones|mesh-ancestor
56819379|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819380|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819381|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56819382|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819383|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819384|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
56819385|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56819386|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819387|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819388|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56819389|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56819390|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
56819391|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56819392|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819393|NCT00284856|Fluticasone|fluticasone|mesh-list
56819394|NCT00284856|Montelukast|montelukast|mesh-list
56819395|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819396|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56819397|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
56819398|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819399|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819400|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56819401|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
56819402|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819403|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56819424|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
56819425|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819426|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819427|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819428|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56819429|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819430|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56819431|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819432|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
56819433|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
56819434|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819435|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819436|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
56819437|NCT00298272|Hormones|hormones|mesh-ancestor
56819438|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530308|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56819439|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56819440|NCT00298272|Protective Agents|protective agents|mesh-ancestor
56819441|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56819442|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56819443|NCT00298272|Analgesics|analgesics|mesh-ancestor
56819444|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
56819445|NCT01068054|Cyclosporine|cyclosporine|mesh-list
56819446|NCT01068054|Tacrolimus|tacrolimus|mesh-list
56819447|NCT01068054|Cyclosporins|cyclosporins|mesh-list
56819448|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819449|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
56819450|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819451|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56543942|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56543944|NCT00618397|Analgesics|analgesics|mesh-ancestor
56543945|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
56543946|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819452|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819453|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819454|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
56819455|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819481|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56819482|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819483|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819484|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
56819485|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
56819486|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56819487|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
56819488|NCT01065870|Gemcitabine|gemcitabine|mesh-list
56819489|NCT01065870|Capecitabine|capecitabine|mesh-list
56819490|NCT01065870|Docetaxel|docetaxel|mesh-list
56819491|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56819492|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
56819493|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819494|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819495|NCT01065870|Antiviral Agents|antiviral agents|mesh-ancestor
56819496|NCT01065870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819497|NCT01065870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819498|NCT01065870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819499|NCT01065870|Immunologic Factors|immunologic factors|mesh-ancestor
56819500|NCT01065870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819501|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
56819502|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
56819503|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
56819504|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
56819505|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819506|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
56819507|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819529|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819530|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819531|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819532|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56819533|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56819534|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819535|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56819536|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56819537|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819538|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
56819539|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56819540|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
56819541|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56819542|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
56819543|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
56819545|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
56819546|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819547|NCT00488345|Tigecycline|tigecycline|mesh-list
56819548|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56819549|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819550|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56819551|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819552|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819553|NCT00283062|Docetaxel|docetaxel|mesh-list
56819554|NCT00283062|Leuprolide|leuprolide|mesh-list
56819555|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819556|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
56819557|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
56819558|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
56819559|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091854|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
56819593|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819594|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819595|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
56819596|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56819597|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091898|NCT03424681|Modafinil|modafinil|mesh-list
56819615|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56543947|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543948|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56543949|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56543950|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
56819616|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819617|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819618|NCT00474539|Vaccines|vaccines|mesh-list
56819619|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56819620|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
56819621|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819622|NCT01017809|Aprepitant|aprepitant|mesh-list
56819623|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
56819624|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
56819625|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819626|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819627|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819628|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56819629|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819630|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819631|NCT01020539|Fludarabine|fludarabine|mesh-list
56819632|NCT01020539|Busulfan|busulfan|mesh-list
56819633|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
56819634|NCT01020539|Isotretinoin|isotretinoin|mesh-list
56819635|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
56819636|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56819637|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819638|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819639|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819640|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
56819641|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819642|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
56819643|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56819644|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56819645|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819646|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56819647|NCT00281580|Amlodipine|amlodipine|mesh-list
56819648|NCT00281580|Telmisartan|telmisartan|mesh-list
56819649|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56819650|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56819651|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56819652|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819653|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56819654|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819689|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56819690|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819691|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
56819692|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
56819693|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530607|NCT01252355|Analgesics|analgesics|mesh-ancestor
56819739|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
56819740|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819767|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56819768|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
56819769|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
56819770|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819771|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819772|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819773|NCT01070472|Misoprostol|misoprostol|mesh-list
56819774|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56819775|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
56819776|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56819777|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819778|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56819779|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819780|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
56819781|NCT00280566|Ziprasidone|ziprasidone|mesh-list
56819782|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56819783|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
56819784|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092078|NCT03245762|Oxytocin|oxytocin|mesh-list
56092096|NCT03324451|Insulin|insulin|mesh-list
56543951|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
56543952|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543953|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56543954|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56543955|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543956|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543957|NCT04211545|Rabeprazole|rabeprazole|mesh-list
56543958|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56543959|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56543960|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56543961|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543962|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543963|NCT00620581|Paroxetine|paroxetine|mesh-list
56543964|NCT00620581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56819805|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56819806|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
56819807|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
56819808|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
56819809|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56819810|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56819811|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56819812|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56819813|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819814|NCT01070628|Levodopa|levodopa|mesh-list
56819815|NCT01070628|Carbidopa|carbidopa|mesh-list
56819816|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56819817|NCT01070628|Entacapone|entacapone|mesh-list
56819818|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56819819|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56819820|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
56819821|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819822|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819823|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819824|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56819825|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819826|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56819827|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
56819828|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
56819829|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56819830|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56819831|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819832|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819833|NCT00317642|Cytarabine|cytarabine|mesh-list
56819834|NCT00317642|Clofarabine|clofarabine|mesh-list
56819835|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56819836|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
56819837|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092125|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
56819868|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56819870|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819871|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819872|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56819873|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56819874|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819875|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56819876|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56819877|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
56198144|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56819878|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
56819879|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819880|NCT01062152|Lenalidomide|lenalidomide|mesh-list
56819881|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
56819882|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819941|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819942|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
56819943|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
56819944|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
56819945|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819946|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56819947|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
56819948|NCT01070706|Antiviral Agents|antiviral agents|mesh-ancestor
56819949|NCT01070706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819950|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819951|NCT01070706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819952|NCT01070706|Immunologic Factors|immunologic factors|mesh-ancestor
56819953|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819954|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56819955|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56819956|NCT01070706|Growth Substances|growth substances|mesh-ancestor
56819957|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
56819958|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56819959|NCT00268242|Gemcitabine|gemcitabine|mesh-list
56819960|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
56819961|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56819962|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
56819963|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819964|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819965|NCT00268242|Antiviral Agents|antiviral agents|mesh-ancestor
56819966|NCT00268242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819967|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819968|NCT00268242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819969|NCT00268242|Immunologic Factors|immunologic factors|mesh-ancestor
56819970|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819971|NCT00268242|Analgesics|analgesics|mesh-ancestor
56819972|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
56820000|NCT00279708|Atorvastatin|atorvastatin|mesh-list
56820001|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56820002|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56820003|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
56820004|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820005|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56820006|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56820007|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820008|NCT03976518|Atezolizumab|atezolizumab|mesh-list
56820009|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820010|NCT00299702|Aripiprazole|aripiprazole|mesh-list
56820011|NCT00299702|Risperidone|risperidone|mesh-list
56820012|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
56820013|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56820014|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56820015|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56820016|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56820017|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820018|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
56820019|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
56820020|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820053|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
56820054|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820055|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820056|NCT00278148|Paclitaxel|paclitaxel|mesh-list
56820057|NCT00278148|Carboplatin|carboplatin|mesh-list
56820058|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56820059|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56820095|NCT01066676|Ibuprofen|ibuprofen|mesh-list
56820096|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56820097|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56820098|NCT01066676|Analgesics|analgesics|mesh-ancestor
56092406|NCT02136576|Listerine|listerine|mesh-list
56820122|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56820123|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
56820124|NCT01065272|Hormones|hormones|mesh-ancestor
56820125|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198145|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
56820126|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56820127|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820128|NCT00299156|Clofarabine|clofarabine|mesh-list
56820129|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56820130|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
56820131|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820132|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820133|NCT00277212|Lamotrigine|lamotrigine|mesh-list
56820134|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
56820135|NCT00277212|Aripiprazole|aripiprazole|mesh-list
56820136|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
56820137|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56820138|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56820139|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56820140|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56820141|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820142|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
56820143|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
56820144|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820145|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820146|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56820177|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820178|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820179|NCT00276744|Antiviral Agents|antiviral agents|mesh-ancestor
56820180|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820181|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820182|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820183|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
56820184|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820185|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
56531059|NCT04187144|Renal Agents|renal agents|mesh-ancestor
56820186|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
56820187|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
56820188|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56820189|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56820190|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56820191|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56820212|NCT02532192|Belinostat|belinostat|mesh-list
56820213|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56820214|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820215|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
56820216|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820217|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820218|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56820219|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
56820220|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
56820221|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820222|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56820223|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
56820224|NCT02532192|Hormones|hormones|mesh-ancestor
56820225|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820226|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56820227|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56820228|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
56820229|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820230|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
56820231|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820232|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820233|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56820234|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56820235|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56820236|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820237|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56820238|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56820239|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
56820240|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56820241|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56820242|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
56820243|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56820244|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56820245|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56820246|NCT00293462|Sargramostim|sargramostim|mesh-list
56543965|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56543966|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56198146|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
56092539|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56820283|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56820315|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56820316|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820317|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820318|NCT01581242|Adefovir|adefovir|mesh-list
56820319|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56820320|NCT01581242|Clevudine|clevudine|mesh-list
56820321|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
56820322|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820323|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56820324|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56820325|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820326|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820327|NCT03982238|Metformin|metformin|mesh-list
56820328|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
56820365|NCT00297830|Alendronate|alendronate|mesh-list
56820366|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56820473|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820474|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56820475|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820476|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56820477|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56820478|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
56820479|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56820480|NCT00275262|Leuprolide|leuprolide|mesh-list
56820481|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56820482|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
56820483|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56820484|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820485|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56820486|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820487|NCT00275028|Cediranib|cediranib|mesh-list
56820488|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820489|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820490|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820491|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56820492|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
56820493|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820494|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56820495|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820496|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820497|NCT04357457|Almitrine|almitrine|mesh-list
56820498|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
56820499|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
56820500|NCT00493649|Docetaxel|docetaxel|mesh-list
56820523|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820524|NCT01021163|Protective Agents|protective agents|mesh-ancestor
56820525|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820526|NCT01021163|Antidotes|antidotes|mesh-ancestor
56820527|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56820528|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56820529|NCT01022333|Protective Agents|protective agents|mesh-ancestor
56820530|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820531|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820532|NCT00117598|Sirolimus|sirolimus|mesh-list
56820533|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56820534|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820535|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56820536|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820537|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
56820538|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820539|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
56820540|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820541|NCT01082458|Lidocaine|lidocaine|mesh-list
56820542|NCT01082458|Remifentanil|remifentanil|mesh-list
56820543|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
56820544|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
56820545|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068764|NCT01909141|Progestins|progestins|mesh-ancestor
56543967|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56543968|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56543969|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
56543970|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543971|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56543972|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
56543973|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56543974|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56543975|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56543976|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56543977|NCT01000311|Vaccines|vaccines|mesh-list
56820546|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820547|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
56820548|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820549|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56820550|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56820551|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56820552|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56820553|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820597|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
56820598|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56820599|NCT00093808|Capecitabine|capecitabine|mesh-list
56820600|NCT00093808|Trastuzumab|trastuzumab|mesh-list
56820601|NCT00093808|Vinorelbine|vinorelbine|mesh-list
56820602|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56820603|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
56820604|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820605|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820606|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56820607|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56820608|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
56820609|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
56820610|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
56820611|NCT00469079|Nicotine|nicotine|mesh-list
56820612|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56820613|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
56820614|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820615|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820616|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56820617|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56820618|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
56820619|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820620|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820621|NCT01326754|Artesunate|artesunate|mesh-list
56820622|NCT01326754|Lumefantrine|lumefantrine|mesh-list
56820623|NCT01326754|Artemether|artemether|mesh-list
56820624|NCT01326754|Piperaquine|piperaquine|mesh-list
56820625|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56820626|NCT01326754|Amodiaquine|amodiaquine|mesh-list
56820627|NCT01326754|Artenimol|artenimol|mesh-list
56820628|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
56820629|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
56820630|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56820631|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56820632|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820633|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820654|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56820655|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56820656|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820657|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820658|NCT01073748|Acetaminophen|acetaminophen|mesh-list
56820659|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56543978|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56543979|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
56543980|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820660|NCT01073748|Analgesics|analgesics|mesh-ancestor
56820661|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
56820662|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820663|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820664|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
56820665|NCT00468845|Pregabalin|pregabalin|mesh-list
56820666|NCT00468845|Analgesics|analgesics|mesh-ancestor
56820667|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
56820668|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820669|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820670|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
56820671|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56820672|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56820673|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820674|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56820675|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56820676|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56820677|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56820678|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56820679|NCT00468299|Misoprostol|misoprostol|mesh-list
56820680|NCT00468299|Mifepristone|mifepristone|mesh-list
56820681|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56820682|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
56820683|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56820684|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820685|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56820686|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56820687|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
56092982|NCT03233737|Tetracaine|tetracaine|mesh-list
56820721|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
56820722|NCT00467831|Zileuton|zileuton|mesh-list
56820723|NCT00467831|Losartan|losartan|mesh-list
56820724|NCT00467831|Pravastatin|pravastatin|mesh-list
56820725|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56820726|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56093025|NCT03717506|Clindamycin|clindamycin|mesh-list
56820748|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56820749|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56820750|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56820751|NCT00467831|Analgesics|analgesics|mesh-ancestor
56820752|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
56820753|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820754|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56820755|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820756|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56820757|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56820758|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
56820759|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820760|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
56820761|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
56820762|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56820763|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56820764|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56820765|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820766|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56820767|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56820768|NCT01021943|Spironolactone|spironolactone|mesh-list
56820769|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56820770|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
56820771|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820772|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820773|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56820774|NCT01021943|Diuretics|diuretics|mesh-ancestor
56820775|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
56820776|NCT00116272|Etanercept|etanercept|mesh-list
56820777|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56820813|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56093120|NCT03248947|Naloxone|naloxone|mesh-list
56543981|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56543982|NCT04209439|Bupivacaine|bupivacaine|mesh-list
56820834|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820835|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
56820836|NCT00467363|Hematinics|hematinics|mesh-ancestor
56820837|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
56820838|NCT00467363|Vitamins|vitamins|mesh-ancestor
56820839|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
56820840|NCT01071174|Dapivirine|dapivirine|mesh-list
56820841|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56820842|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56820843|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
56820844|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820845|NCT00466505|Celecoxib|celecoxib|mesh-list
56820846|NCT00466505|Cetuximab|cetuximab|mesh-list
56820847|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56820848|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820849|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56820850|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56820851|NCT00466505|Analgesics|analgesics|mesh-ancestor
56820852|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
56820853|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820854|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820855|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56820856|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820857|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56820858|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56820859|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820860|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820862|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
56820863|NCT00467051|Paclitaxel|paclitaxel|mesh-list
56820864|NCT00467051|Carboplatin|carboplatin|mesh-list
56820865|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56820866|NCT00467051|Ifosfamide|ifosfamide|mesh-list
56820867|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
56820868|NCT00467051|Lenograstim|lenograstim|mesh-list
56820869|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56093163|NCT03857750|Rocuronium|rocuronium|mesh-list
56820897|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56820898|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820899|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56820900|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
56820901|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
56820902|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820903|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820904|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
56820905|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56820906|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820907|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56820908|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820909|NCT01072734|Vaccines|vaccines|mesh-list
56820910|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
56820911|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820912|NCT03970668|Insulin|insulin|mesh-list
56820913|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56820914|NCT03970668|Linagliptin|linagliptin|mesh-list
56820915|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56820916|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820959|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56820960|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56820961|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56820963|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56820964|NCT00465647|Narcotics|narcotics|mesh-ancestor
56820965|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56820966|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820967|NCT00465647|Analgesics|analgesics|mesh-ancestor
56820968|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
56820969|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820970|NCT00090766|Valganciclovir|valganciclovir|mesh-list
56820971|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
56820972|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820973|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
56820974|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56820975|NCT03961828|Ledipasvir|ledipasvir|mesh-list
56820976|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
56820977|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820978|NCT00465179|Sunitinib|sunitinib|mesh-list
56543983|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
56543984|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
56543985|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56543986|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56543987|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
56543988|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56543989|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56543990|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56543991|NCT04209439|Analgesics|analgesics|mesh-ancestor
56543992|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56543993|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56543994|NCT05228041|Benralizumab|benralizumab|mesh-list
56543995|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56543996|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
56543997|NCT01003899|Afatinib|afatinib|mesh-list
56543998|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56543999|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56198162|NCT01511692|Hormones|hormones|mesh-ancestor
56820979|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820980|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56820981|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56820982|NCT00465179|Growth Substances|growth substances|mesh-ancestor
56820983|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820984|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
56820985|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56820986|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820987|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820988|NCT00084136|Tenofovir|tenofovir|mesh-list
56820989|NCT00084136|Lamivudine|lamivudine|mesh-list
56820990|NCT00084136|Zidovudine|zidovudine|mesh-list
56820991|NCT00084136|Emtricitabine|emtricitabine|mesh-list
56820992|NCT00084136|Efavirenz|efavirenz|mesh-list
56820993|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56820994|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56820995|NCT00084136|Didanosine|didanosine|mesh-list
56820996|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56923744|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
56923774|NCT03515837|Carboplatin|carboplatin|mesh-list
56923775|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
56923776|NCT03515837|Pemetrexed|pemetrexed|mesh-list
56923777|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56923778|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923779|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923780|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923781|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923782|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56923783|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56923789|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
56923826|NCT03411031|Growth Substances|growth substances|mesh-ancestor
56923827|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
56923828|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923863|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56923864|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923865|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923866|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56923867|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56544000|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544001|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544002|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
56544003|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544004|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544005|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56544006|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56544007|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56544008|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544009|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56923868|NCT03251300|Mirabegron|mirabegron|mesh-list
56335004|NCT02358187|Poly ICLC|poly iclc|mesh-list
56923892|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923893|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56923895|NCT03108690|Tazobactam|tazobactam|mesh-list
56923896|NCT03108690|Piperacillin|piperacillin|mesh-list
56923897|NCT03108690|Ampicillin|ampicillin|mesh-list
56923898|NCT03108690|Cefuroxime|cefuroxime|mesh-list
56923899|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56923900|NCT03108690|Lactams|lactams|mesh-list
56923901|NCT03108690|beta-Lactams|beta-lactams|mesh-list
56923902|NCT03108690|Penicillin G|penicillin g|mesh-list
56923903|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
56923904|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56923905|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923906|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
56923907|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56923908|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923909|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923910|NCT03103152|Aspirin|aspirin|mesh-list
56923911|NCT03103152|Vitamin D|vitamin d|mesh-list
56923912|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
56923913|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
56923914|NCT03103152|Vitamins|vitamins|mesh-list
56923915|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
56923916|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923917|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56923918|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56923919|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56923920|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56923940|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923941|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335076|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56923942|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923943|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56923944|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56923945|NCT02937285|Interferons|interferons|mesh-list
56923946|NCT02937285|Interferon-beta|interferon-beta|mesh-list
56923947|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
56923948|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
56923949|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923950|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
56923951|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923952|NCT02937285|Analgesics|analgesics|mesh-ancestor
56923953|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
56923954|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923955|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923956|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56923957|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56923958|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923959|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923960|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
56923961|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56923962|NCT02878785|Decitabine|decitabine|mesh-list
56923963|NCT02878785|Talazoparib|talazoparib|mesh-list
56923964|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544010|NCT04160377|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56544011|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56544012|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56544013|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544014|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
56544015|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56544016|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
56544017|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56544018|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56544019|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56923965|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
56923966|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923967|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923968|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923969|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56923970|NCT02867813|Evolocumab|evolocumab|mesh-list
56923971|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56923972|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56923973|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
56923974|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924008|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
56924009|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56924010|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
56924011|NCT02825576|Neostigmine|neostigmine|mesh-list
56924012|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56924013|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924014|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924015|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
56924016|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093597|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
56924049|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56924050|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56924051|NCT02719613|Growth Substances|growth substances|mesh-ancestor
56924052|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
56924053|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56924054|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56924055|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
56924056|NCT02659930|Doxorubicin|doxorubicin|mesh-list
56924057|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56924058|NCT02659930|Pomalidomide|pomalidomide|mesh-list
56924059|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56093638|NCT00378872|Coagulants|coagulants|mesh-ancestor
56924158|NCT02016924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56924160|NCT01917877|Bevacizumab|bevacizumab|mesh-list
56924161|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924162|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924163|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56924164|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56924165|NCT01917877|Growth Substances|growth substances|mesh-ancestor
56924205|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924206|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56924207|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56924208|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56924209|NCT01199575|Growth Substances|growth substances|mesh-ancestor
56924210|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
56924211|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
56924212|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56924213|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924214|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
56924215|NCT00496873|Rituximab|rituximab|mesh-list
56339456|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
56339529|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
56557603|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544020|NCT01000155|Vorinostat|vorinostat|mesh-list
56544021|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544022|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56544023|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544024|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544025|NCT00999921|Tamoxifen|tamoxifen|mesh-list
56544026|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
56544027|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56544028|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
56544029|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544030|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544031|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56544032|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544033|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56544034|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56544035|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56544036|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56544037|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56544038|NCT00999921|Analgesics|analgesics|mesh-ancestor
56544039|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
56544040|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544041|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544042|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544043|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56544044|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
56544045|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544046|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56544047|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
56557604|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56557620|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557621|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56342073|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342149|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
56557622|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557624|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56342519|NCT00082563|Analgesics|analgesics|mesh-ancestor
56557625|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56342592|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
56342676|NCT00082797|Antidotes|antidotes|mesh-ancestor
56342751|NCT00043680|Celecoxib|celecoxib|mesh-list
56557626|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56557627|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56342892|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56544048|NCT02869347|Complement C1s|complement c1s|mesh-list
56544049|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56544050|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56544051|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
56544052|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544053|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55908737|NCT00391443|Bosentan|bosentan|mesh-list
56557628|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56557629|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557630|NCT01149473|Diuretics|diuretics|mesh-ancestor
56557631|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
56343559|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
56557632|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343637|NCT00044265|Ramipril|ramipril|mesh-list
56557633|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56344014|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557634|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56344240|NCT00161239|Prednisone|prednisone|mesh-list
56557635|NCT00872989|Docetaxel|docetaxel|mesh-list
56344388|NCT00053105|Prednisolone|prednisolone|mesh-list
56557636|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557637|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
56557638|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
56344537|NCT00044811|Fexofenadine|fexofenadine|mesh-list
56344630|NCT00163384|Hormones|hormones|mesh-ancestor
56344693|NCT02970383|Narcotics|narcotics|mesh-list
56557639|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
56344912|NCT00053807|Interferons|interferons|mesh-list
56557649|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347071|NCT00179725|Doxorubicin|doxorubicin|mesh-list
56557652|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557653|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56347292|NCT00181870|Analgesics|analgesics|mesh-ancestor
56347515|NCT02965248|Antidotes|antidotes|mesh-ancestor
56347743|NCT00185068|Diuretics|diuretics|mesh-ancestor
56557654|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347815|NCT03784014|Olaparib|olaparib|mesh-list
56347888|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56557655|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348125|NCT00187525|Memantine|memantine|mesh-list
56557656|NCT00693355|Butyric Acid|butyric acid|mesh-list
56557657|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
56557658|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
56348421|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56557659|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557660|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557661|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557663|NCT00693433|Dexamethasone|dexamethasone|mesh-list
56557664|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56557665|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
56557666|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
56349070|NCT00193024|Docetaxel|docetaxel|mesh-list
56349148|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56557667|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557668|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557669|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56349369|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
56557670|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
56557671|NCT00693433|Hormones|hormones|mesh-ancestor
56349517|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
56557672|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56557673|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56557693|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557694|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557695|NCT00872599|Fenofibrate|fenofibrate|mesh-list
56557696|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56557697|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
56557698|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557699|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56557700|NCT02623621|Bevacizumab|bevacizumab|mesh-list
56557701|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56544054|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544055|NCT00621673|Factor VIII|factor viii|mesh-list
56544056|NCT00621673|Coagulants|coagulants|mesh-ancestor
56544057|NCT01002573|Acetaminophen|acetaminophen|mesh-list
56544058|NCT01002573|Ibuprofen|ibuprofen|mesh-list
56544059|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56544060|NCT01002573|Analgesics|analgesics|mesh-ancestor
56544061|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
56544062|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544063|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544064|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
56544065|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56544066|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544067|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198236|NCT01511822|Inositol|inositol|mesh-list
56557702|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557703|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56557704|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56557705|NCT02623621|Growth Substances|growth substances|mesh-ancestor
56557706|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557707|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
56557708|NCT00693589|Folic Acid|folic acid|mesh-list
56557709|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
56557710|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
56557711|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56557712|NCT00693589|Vitamins|vitamins|mesh-ancestor
56351884|NCT00228865|Insulin|insulin|mesh-list
56351952|NCT00229450|Hormones|hormones|mesh-ancestor
56557713|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
56352099|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352173|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56352263|NCT00230815|Hormones|hormones|mesh-ancestor
56352402|NCT00232375|Insulin|insulin|mesh-list
56352553|NCT02958566|Methadone|methadone|mesh-list
56557727|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56557728|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557729|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56355243|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355318|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
56355468|NCT00250978|Bevacizumab|bevacizumab|mesh-list
56557730|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56557731|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557732|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355620|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
56355840|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56355913|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557733|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557734|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56557736|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56557737|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557738|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56557739|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56557740|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56557741|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56557742|NCT01148537|Narcotics|narcotics|mesh-ancestor
56356658|NCT00258232|Analgesics|analgesics|mesh-ancestor
56356733|NCT00104910|Cetuximab|cetuximab|mesh-list
56557743|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56356874|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
56557744|NCT01148537|Analgesics|analgesics|mesh-ancestor
56357023|NCT00071942|Metronidazole|metronidazole|mesh-list
56357099|NCT00072059|Hematinics|hematinics|mesh-ancestor
56557764|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56557766|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56557767|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557768|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544068|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56557769|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
56557770|NCT02793544|Protective Agents|protective agents|mesh-ancestor
56557771|NCT02793388|Primaquine|primaquine|mesh-list
56557772|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
56557773|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56557774|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56557775|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557776|NCT02689882|Niacinamide|niacinamide|mesh-list
56557777|NCT02689882|Niacin|niacin|mesh-list
56557778|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
56557779|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
56557780|NCT02689882|Vitamins|vitamins|mesh-ancestor
56557781|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
56557782|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557783|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56557784|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
56557785|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358075|NCT00268840|Gemcitabine|gemcitabine|mesh-list
56557786|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56557787|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
56557788|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56557789|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56557790|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56557792|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56557793|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557794|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557795|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
56557796|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557797|NCT04234594|Panitumumab|panitumumab|mesh-list
56557798|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557799|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557800|NCT04233346|Ponatinib|ponatinib|mesh-list
56557801|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557802|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56557803|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094102|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557840|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
56557841|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
56557858|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557859|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
56557860|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557862|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557863|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557864|NCT04234516|Morphine|morphine|mesh-list
56557865|NCT04234516|Buprenorphine|buprenorphine|mesh-list
56557866|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56557867|NCT04234516|Naloxone|naloxone|mesh-list
56557868|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56557869|NCT04234516|Narcotics|narcotics|mesh-ancestor
56557870|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557871|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557872|NCT04234516|Analgesics|analgesics|mesh-ancestor
56557873|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
56557874|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557875|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56557876|NCT02789566|Primaquine|primaquine|mesh-list
56557877|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
56557878|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56557879|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56557880|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557882|NCT00697021|Clopidogrel|clopidogrel|mesh-list
56557883|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56557884|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56557885|NCT00697021|Analgesics|analgesics|mesh-ancestor
56557886|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
56557887|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557888|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557889|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56557890|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56557891|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56557892|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56557893|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557894|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56557895|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56557896|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292333|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544069|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544070|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557897|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
56557898|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56557899|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56557919|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557920|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56557921|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56557922|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
56557923|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557924|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557925|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56557926|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56557927|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56557928|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56557929|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557930|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56557931|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56557932|NCT02790580|Growth Substances|growth substances|mesh-ancestor
56557933|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
56557934|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56557935|NCT02788864|Piperaquine|piperaquine|mesh-list
56557936|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
56557937|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56557938|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56557939|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557940|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
56557941|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56557942|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
56557943|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56557944|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557945|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
56557946|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
56557947|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
56557948|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56557949|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557950|NCT00693979|Paclitaxel|paclitaxel|mesh-list
56557951|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56557952|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557953|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56094260|NCT00793520|Milnacipran|milnacipran|mesh-list
56557985|NCT01190813|Carbidopa|carbidopa|mesh-list
56557986|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56557987|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56557988|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
56557989|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557990|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557991|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557992|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56557993|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557994|NCT03641326|Sunitinib|sunitinib|mesh-list
56557995|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557996|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56557997|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56557998|NCT03641326|Growth Substances|growth substances|mesh-ancestor
56557999|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558000|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
56306371|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558031|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56558032|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558033|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558034|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
56558035|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558036|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558037|NCT02788552|Vitamins|vitamins|mesh-list
56558038|NCT02788552|Thiamine|thiamine|mesh-list
56558039|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
56558040|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558041|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
56558042|NCT01147055|Rifampin|rifampin|mesh-list
56558063|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56544071|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
56544072|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56544073|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56544074|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56544075|NCT04293549|Mitogens|mitogens|mesh-list
56544076|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56558064|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558065|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558066|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
56558067|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558068|NCT02623231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56558069|NCT02623231|Antidepressive Agents|antidepressive agents|mesh-ancestor
56558070|NCT02623231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56558071|NCT02623153|Docetaxel|docetaxel|mesh-list
56558072|NCT02623153|Capecitabine|capecitabine|mesh-list
56558073|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
56558074|NCT02623153|Tegafur|tegafur|mesh-list
56558075|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558076|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
56558077|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
56558078|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
56558079|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558080|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56558081|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
56558082|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
56558083|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558084|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558085|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56558086|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56558087|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558088|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558089|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558090|NCT02884037|Rifaximin|rifaximin|mesh-list
56558091|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558092|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558093|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558094|NCT04233502|Melatonin|melatonin|mesh-list
56558126|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
56558127|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56558128|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56558129|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558130|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558131|NCT00625079|Urological Agents|urological agents|mesh-ancestor
56558132|NCT02786992|Misoprostol|misoprostol|mesh-list
56558133|NCT02786992|Oxytocin|oxytocin|mesh-list
56558134|NCT02786992|Carbetocin|carbetocin|mesh-list
56558135|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
56558136|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56558137|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558166|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
56558167|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
56558168|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558169|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56558170|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
56558171|NCT04133155|Antiviral Agents|antiviral agents|mesh-ancestor
56558172|NCT04133155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558173|NCT04133155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558174|NCT04133155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56558175|NCT04133155|Immunologic Factors|immunologic factors|mesh-ancestor
56558176|NCT04133155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558178|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56558179|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56558180|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558181|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558182|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56558183|NCT00869089|Apremilast|apremilast|mesh-list
56558274|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56558275|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56558276|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558277|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558278|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56544077|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544078|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56558280|NCT03365752|Mepivacaine|mepivacaine|mesh-list
56558281|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
56558282|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
56558283|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558284|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558285|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
56558286|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
56558287|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558288|NCT02785666|Ribavirin|ribavirin|mesh-list
56558289|NCT02785666|Grazoprevir|grazoprevir|mesh-list
56558290|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56558291|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
56558292|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558293|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
56558294|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558295|NCT01145417|Pregabalin|pregabalin|mesh-list
56558296|NCT01145417|Analgesics|analgesics|mesh-ancestor
56558297|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
56558298|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094582|NCT00610532|Probenecid|probenecid|mesh-list
56558316|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558317|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
56558318|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558319|NCT04316039|Temozolomide|temozolomide|mesh-list
56558320|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56558321|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
56558322|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558323|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558324|NCT00696631|Dronedarone|dronedarone|mesh-list
56558325|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56558326|NCT02615977|Ethanol|ethanol|mesh-list
56558327|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56558328|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558329|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558330|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558331|NCT01189487|Ampicillin|ampicillin|mesh-list
56558332|NCT01189487|Sulbactam|sulbactam|mesh-list
56558333|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558334|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558335|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56558336|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558337|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558338|NCT02621905|Itraconazole|itraconazole|mesh-list
56558339|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56558340|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
56558341|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558342|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56558343|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56558344|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558345|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558346|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56558347|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
56558348|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56558349|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558350|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56558351|NCT01106352|Docetaxel|docetaxel|mesh-list
56558352|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56558353|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558374|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558375|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56558376|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56558377|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558378|NCT03071926|Doxorubicin|doxorubicin|mesh-list
56558379|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56558380|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56558381|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558382|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56558383|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56558384|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473668|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544079|NCT00996333|Gemcitabine|gemcitabine|mesh-list
56544080|NCT00996333|Capecitabine|capecitabine|mesh-list
56544081|NCT00996333|Docetaxel|docetaxel|mesh-list
56544082|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544083|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
56544084|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544085|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544086|NCT00996333|Antiviral Agents|antiviral agents|mesh-ancestor
56544087|NCT00996333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544088|NCT00996333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544089|NCT00996333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544090|NCT00996333|Immunologic Factors|immunologic factors|mesh-ancestor
56544091|NCT00996333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544092|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
56544093|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
56544094|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
56544095|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
56544096|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
56544097|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
56198255|NCT01511822|Vitamins|vitamins|mesh-ancestor
56558385|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558387|NCT02883647|Entecavir|entecavir|mesh-list
56558388|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
56558389|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558390|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56558391|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56558392|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558393|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558394|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56558395|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56558396|NCT02621827|Calcifediol|calcifediol|mesh-list
56558397|NCT02621827|Vitamins|vitamins|mesh-ancestor
56558398|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
56558399|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558400|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56558401|NCT01143389|Riboflavin|riboflavin|mesh-list
56558402|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
56558403|NCT01143389|Vitamins|vitamins|mesh-ancestor
56558404|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
56558405|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558406|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56558407|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
56558408|NCT00868231|Bromides|bromides|mesh-list
56558409|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
56558410|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56558443|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
56558444|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558445|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56558446|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56558447|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56558448|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56558449|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558450|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558451|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56558452|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56558473|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56558474|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56544098|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558475|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56558476|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558477|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306820|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56558478|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56558479|NCT02786446|Analgesics|analgesics|mesh-ancestor
56558480|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56558481|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56558482|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
56558483|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56558484|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558485|NCT02619019|Dexamethasone|dexamethasone|mesh-list
56558486|NCT02619019|Meperidine|meperidine|mesh-list
56558487|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56558488|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
56558489|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
56558490|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558491|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558492|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558493|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
56558494|NCT02619019|Hormones|hormones|mesh-ancestor
56558495|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56558496|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56558497|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558498|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56558499|NCT02619019|Narcotics|narcotics|mesh-ancestor
56558500|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558501|NCT02619019|Analgesics|analgesics|mesh-ancestor
56558502|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
56558503|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56558504|NCT02957032|Cytarabine|cytarabine|mesh-list
56558505|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56558538|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
56558539|NCT02897050|Docetaxel|docetaxel|mesh-list
56558540|NCT02897050|Fluorouracil|fluorouracil|mesh-list
56558541|NCT02897050|Capecitabine|capecitabine|mesh-list
56558542|NCT02897050|Epirubicin|epirubicin|mesh-list
56558543|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56558544|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
56558545|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558546|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56558547|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56558548|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
56558549|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558580|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558581|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558582|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
56558583|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558585|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56558586|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56558587|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
56558588|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558589|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094877|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
56558615|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56558616|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56558617|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558618|NCT02784340|Dexamethasone|dexamethasone|mesh-list
56558619|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
56558620|NCT02784340|Bupivacaine|bupivacaine|mesh-list
56558621|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56558622|NCT02784340|BB 1101|bb 1101|mesh-list
56558623|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56558624|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
56558625|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
56558626|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558627|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558628|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558629|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
56558630|NCT02784340|Hormones|hormones|mesh-ancestor
56558631|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56558632|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56558633|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558634|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
56544099|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558635|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558636|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558637|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
56558638|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
56094920|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
56558676|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56558677|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558699|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56558701|NCT04229758|Anticoagulants|anticoagulants|mesh-list
56558702|NCT00698425|Citric Acid|citric acid|mesh-list
56558703|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
56558704|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
56558705|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56558706|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
56558707|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
56558708|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558709|NCT05342272|Lactoferrin|lactoferrin|mesh-list
56558710|NCT05342272|Muramidase|muramidase|mesh-list
56558711|NCT05342272|Betaine|betaine|mesh-list
56558712|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558713|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558714|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
56558715|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56558716|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
56558717|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558718|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56558719|NCT04230460|Ethanol|ethanol|mesh-list
56558720|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56558721|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558722|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558723|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558724|NCT02783638|Pregabalin|pregabalin|mesh-list
56558725|NCT02783638|Analgesics|analgesics|mesh-ancestor
56558726|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
56558727|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095011|NCT00448682|Antidotes|antidotes|mesh-ancestor
56558739|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56558740|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
56558741|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56558742|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56558744|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56558745|NCT04230070|Estrogens|estrogens|mesh-ancestor
56558746|NCT04230070|Hormones|hormones|mesh-ancestor
56558747|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56558748|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558749|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56558750|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
56558751|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56558752|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56558753|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56558754|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56558755|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56558756|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56558757|NCT02782078|Clindamycin|clindamycin|mesh-list
56558758|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
56558759|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
56558760|NCT02782078|Rifampin|rifampin|mesh-list
56558761|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558762|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558763|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56558764|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558765|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558766|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56558767|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
56558768|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
56558769|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56558770|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56558771|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56558772|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56558773|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56558774|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56558775|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56544100|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
56544101|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544102|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
56544103|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
56544104|NCT01349101|Busulfan|busulfan|mesh-list
56544105|NCT01349101|Fludarabine|fludarabine|mesh-list
56544106|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
56544107|NCT01349101|Tacrolimus|tacrolimus|mesh-list
56544108|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544109|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
56544110|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544111|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544112|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56544113|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
56198275|NCT01511874|Leuprolide|leuprolide|mesh-list
56558776|NCT01293682|Calcitriol|calcitriol|mesh-list
56307120|NCT04731766|Listerine|listerine|mesh-list
56558777|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56558778|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358229|NCT00269737|Analgesics|analgesics|mesh-ancestor
56558779|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56558780|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558781|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558782|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56558784|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
56558785|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56558786|NCT00864097|Diclofenac|diclofenac|mesh-list
56558843|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
56558844|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
56558845|NCT01183013|Pioglitazone|pioglitazone|mesh-list
56558846|NCT01183013|Linagliptin|linagliptin|mesh-list
56558847|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56558848|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558849|NCT01183013|Incretins|incretins|mesh-ancestor
56558850|NCT01183013|Hormones|hormones|mesh-ancestor
56558851|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56558852|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56558853|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
56558854|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558855|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558856|NCT04229212|Cimetidine|cimetidine|mesh-list
56558857|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56558858|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558859|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56558860|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
56558861|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
56558862|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558863|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558864|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558865|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56558866|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56558867|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558868|NCT02615041|Meropenem|meropenem|mesh-list
56558869|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558870|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558871|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56558872|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56558873|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56558874|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56095154|NCT00218036|Citalopram|citalopram|mesh-list
56558897|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
56544114|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544115|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544116|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56544117|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544118|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
56544119|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544120|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56544121|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544122|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56544123|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56544124|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
56544125|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56544126|NCT00620971|Gemcitabine|gemcitabine|mesh-list
56544127|NCT00620971|Bevacizumab|bevacizumab|mesh-list
56544128|NCT00620971|Cisplatin|cisplatin|mesh-list
56544129|NCT00620971|Docetaxel|docetaxel|mesh-list
56544130|NCT00620971|Vinorelbine|vinorelbine|mesh-list
55725080|NCT02258074|Niacin|niacin|mesh-list
56558898|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558899|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56558900|NCT05340946|Anesthetics|anesthetics|mesh-list
56558901|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558902|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558903|NCT00863707|Regadenoson|regadenoson|mesh-list
56558904|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56558905|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56558906|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
56558907|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
56558908|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558909|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558910|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558911|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
56558912|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
55992469|NCT05406388|Analgesics|analgesics|mesh-ancestor
56558914|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558915|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56558916|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56558917|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558918|NCT04187807|Melatonin|melatonin|mesh-list
56558919|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
56558920|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558921|NCT04187807|Protective Agents|protective agents|mesh-ancestor
56558922|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558923|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558924|NCT01094184|Paclitaxel|paclitaxel|mesh-list
56558934|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56558935|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56558936|NCT01094184|Growth Substances|growth substances|mesh-ancestor
56558937|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558938|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
56558939|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56558940|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558941|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558942|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56558943|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56558944|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558945|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56473669|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
56544131|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56544132|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544133|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56544134|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56544135|NCT00620971|Growth Substances|growth substances|mesh-ancestor
56544136|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544137|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
56544138|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544139|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
56544140|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544141|NCT00620971|Antiviral Agents|antiviral agents|mesh-ancestor
56558946|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558947|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558948|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56558949|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56558950|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56558951|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
56558952|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558953|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56558954|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56558955|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
56558956|NCT04132063|Levetiracetam|levetiracetam|mesh-list
56558957|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
56558958|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
56558959|NCT02618317|Minocycline|minocycline|mesh-list
56558960|NCT02618317|Heparin|heparin|mesh-list
56558961|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
56558962|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558963|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56558964|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56558965|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558966|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558967|NCT01140503|Apremilast|apremilast|mesh-list
56558968|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56558969|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56558970|NCT01140503|Analgesics|analgesics|mesh-ancestor
56558971|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
56558972|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558973|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558974|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56558975|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56558976|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56558977|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56558978|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358252|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
56558979|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558981|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56558982|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
56558983|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558984|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558985|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
56558986|NCT00863317|Montelukast|montelukast|mesh-list
56558987|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56558988|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
56558989|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56559011|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559012|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56559013|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56559015|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56559016|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
56559017|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559018|NCT04125121|Propofol|propofol|mesh-list
56559019|NCT04125121|Sevoflurane|sevoflurane|mesh-list
56559020|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56559021|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559022|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559023|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56559024|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
56559025|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
56559026|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56559027|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56559028|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56559029|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56559030|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
56559031|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559032|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559033|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56559034|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
56559035|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56559036|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56559037|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56559038|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
56559039|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559040|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559042|NCT01078974|Rituximab|rituximab|mesh-list
56559043|NCT01078974|Pomalidomide|pomalidomide|mesh-list
56559044|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56559045|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559046|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
56559174|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56559175|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56559176|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56559177|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559178|NCT05338606|Bimatoprost|bimatoprost|mesh-list
56559179|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56559180|NCT01092702|Varenicline|varenicline|mesh-list
56559181|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56559182|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56559183|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
56559184|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559185|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559186|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559187|NCT01092546|Flutemetamol|flutemetamol|mesh-list
56559188|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56559189|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559190|NCT02779348|Warfarin|warfarin|mesh-list
56559191|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
56559192|NCT02779582|Progesterone|progesterone|mesh-list
56559193|NCT02779582|Progestins|progestins|mesh-ancestor
56559194|NCT02779582|Hormones|hormones|mesh-ancestor
56559195|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56095489|NCT00000914|Ritonavir|ritonavir|mesh-list
56559219|NCT01078662|Olaparib|olaparib|mesh-list
56559220|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56559221|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358304|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56559222|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559223|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559224|NCT04227886|Capecitabine|capecitabine|mesh-list
56559226|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56559227|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
56559228|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559229|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559230|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56559231|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56559232|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559233|NCT02200978|Cytarabine|cytarabine|mesh-list
56559234|NCT02200978|Methotrexate|methotrexate|mesh-list
56559235|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
56559236|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
56559237|NCT02200978|Tretinoin|tretinoin|mesh-list
56559238|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
56559239|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56559240|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
56559241|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56559242|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559243|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544142|NCT00620971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544143|NCT00620971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544144|NCT00620971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544145|NCT00620971|Immunologic Factors|immunologic factors|mesh-ancestor
56544146|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
56544147|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
56198313|NCT01512017|Petrolatum|petrolatum|mesh-list
56559244|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
56559245|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559268|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559269|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559270|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559271|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56559272|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56559274|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559275|NCT02779192|Protective Agents|protective agents|mesh-ancestor
56559276|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56559277|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559278|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56559279|NCT05020210|Sivelestat|sivelestat|mesh-list
56559280|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56559281|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
56559282|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559283|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559284|NCT04227808|Lenvatinib|lenvatinib|mesh-list
56559285|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559286|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56559287|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559288|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559289|NCT05017246|Lidocaine|lidocaine|mesh-list
56559290|NCT05017246|Morphine|morphine|mesh-list
56559291|NCT05017246|Bupivacaine|bupivacaine|mesh-list
56559292|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
56559293|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
56559294|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559295|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559296|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
56559297|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559298|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56559321|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559323|NCT02883569|Aceclofenac|aceclofenac|mesh-list
56559324|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
56559325|NCT02883569|Tramadol|tramadol|mesh-list
56559326|NCT02883569|Codeine|codeine|mesh-list
56559327|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559328|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559329|NCT02883569|Analgesics|analgesics|mesh-ancestor
56559330|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
56559331|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559332|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559333|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559334|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559335|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56559336|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559337|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559338|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56559339|NCT02883569|Narcotics|narcotics|mesh-ancestor
56559340|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559341|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
56559342|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
56559343|NCT02883023|Bleomycin|bleomycin|mesh-list
56559344|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56559345|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559346|NCT02778958|Acetaminophen|acetaminophen|mesh-list
56559347|NCT02778958|Ibuprofen|ibuprofen|mesh-list
56559348|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559349|NCT02778958|Analgesics|analgesics|mesh-ancestor
56559350|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
56559351|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544148|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
56544149|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56544150|NCT04223661|Dexamethasone|dexamethasone|mesh-list
56544151|NCT04223661|Lenalidomide|lenalidomide|mesh-list
56544152|NCT04223661|Daratumumab|daratumumab|mesh-list
56544153|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544154|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
56544155|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
56544156|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544157|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544158|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56544159|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
56544160|NCT04223661|Hormones|hormones|mesh-ancestor
56559352|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559353|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
56559379|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56559380|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56559381|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56559382|NCT01197560|Growth Substances|growth substances|mesh-ancestor
56559383|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
56559384|NCT04940572|Valproic Acid|valproic acid|mesh-list
56559385|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
56559386|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559387|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559388|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
56559389|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559390|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559391|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
56559392|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56559393|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559394|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56559395|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56559396|NCT01196078|Vinorelbine|vinorelbine|mesh-list
56559397|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559398|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56559399|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559400|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559434|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56559435|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56559436|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
56559437|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
56559438|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559439|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559440|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559441|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56559442|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
56559443|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56559444|NCT01194830|Linagliptin|linagliptin|mesh-list
56559477|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559478|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559479|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56559480|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
56559481|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559482|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559483|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56559485|NCT04823052|Gaboxadol|gaboxadol|mesh-list
56559486|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559522|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56559579|NCT00602901|Naproxen|naproxen|mesh-list
56559580|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559581|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559582|NCT00602901|Analgesics|analgesics|mesh-ancestor
56559583|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
56544161|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544162|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56544163|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544164|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
56544165|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56544166|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56544167|NCT04223661|Growth Substances|growth substances|mesh-ancestor
56544168|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
56544169|NCT04268277|Rituximab|rituximab|mesh-list
56544170|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
56544171|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56544172|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544173|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
56544174|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544175|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544176|NCT00622141|Saquinavir|saquinavir|mesh-list
56544177|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56544178|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56544179|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
56544180|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544181|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544182|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56544183|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56559584|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559585|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559586|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559587|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559588|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
56559589|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56559590|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559591|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559592|NCT01076088|Metformin|metformin|mesh-list
56559593|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56559594|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56559595|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559596|NCT01076088|Incretins|incretins|mesh-ancestor
56559597|NCT01076088|Hormones|hormones|mesh-ancestor
56559598|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559599|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56559600|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
56559601|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559602|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559604|NCT02777320|Ibuprofen|ibuprofen|mesh-list
56559605|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559606|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559607|NCT02777320|Analgesics|analgesics|mesh-ancestor
56559608|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
56095881|NCT00000290|Cocaine|cocaine|mesh-list
56559631|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559633|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56544184|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
56544185|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544186|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56544187|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56559634|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559635|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559636|NCT04872790|Prednisone|prednisone|mesh-list
56559637|NCT04872790|Cortisone|cortisone|mesh-list
56559638|NCT04872790|Rituximab|rituximab|mesh-list
56559639|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56559640|NCT04872790|Methotrexate|methotrexate|mesh-list
56559641|NCT04872790|Venetoclax|venetoclax|mesh-list
56559642|NCT04872790|Dasatinib|dasatinib|mesh-list
56559643|NCT04872790|Antibodies|antibodies|mesh-list
56559644|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
56559645|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56559646|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
56559647|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559648|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559649|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559650|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559651|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
56559652|NCT04872790|Hormones|hormones|mesh-ancestor
56559653|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559654|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56559655|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56559656|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
56559657|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56559658|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56559659|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
56559660|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559697|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56559722|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559724|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56559725|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
56559726|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559727|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56559728|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559729|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559730|NCT04045171|Tacrolimus|tacrolimus|mesh-list
56559731|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559732|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
56559733|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559734|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56559735|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559736|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559737|NCT01075152|Lamivudine|lamivudine|mesh-list
56559738|NCT01075152|Zidovudine|zidovudine|mesh-list
56559739|NCT01075152|Efavirenz|efavirenz|mesh-list
56559740|NCT01075152|Stavudine|stavudine|mesh-list
56559741|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56559742|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56559743|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559744|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559745|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
56559769|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
56559770|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
56559771|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559772|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56559773|NCT00950859|Dolutegravir|dolutegravir|mesh-list
56559774|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56559775|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56559776|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559777|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559778|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56559779|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56559780|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
56559781|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559782|NCT02775292|Aldesleukin|aldesleukin|mesh-list
56559783|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
56559784|NCT02775292|Nivolumab|nivolumab|mesh-list
56544188|NCT04210765|Clomiphene|clomiphene|mesh-list
56544189|NCT04210765|Enclomiphene|enclomiphene|mesh-list
55910769|NCT01470989|Hormones|hormones|mesh-ancestor
56559785|NCT02775292|Fludarabine|fludarabine|mesh-list
56559786|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
56559787|NCT02775292|Interleukin-2|interleukin-2|mesh-list
56559788|NCT02775292|Vaccines|vaccines|mesh-list
56559789|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
56559790|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559791|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559792|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559793|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56559794|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
56559795|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559796|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559797|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56559798|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56559823|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559824|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559825|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
56559827|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559828|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559829|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56559830|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56559831|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56559832|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
56559833|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559834|NCT02775370|Apatinib|apatinib|mesh-list
56559835|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559836|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56559837|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559838|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559839|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
56559840|NCT04225468|Narcotics|narcotics|mesh-ancestor
56559841|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559842|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559843|NCT04225468|Analgesics|analgesics|mesh-ancestor
56559844|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
56559845|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559846|NCT02855307|Insulin|insulin|mesh-list
56559847|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56559848|NCT02855307|Hormones|hormones|mesh-list
56559849|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56559850|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559851|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559904|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56559905|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
56559906|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56559907|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56559908|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56559909|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56559910|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559911|NCT04778410|Cytarabine|cytarabine|mesh-list
56559912|NCT04778410|Etoposide|etoposide|mesh-list
56559913|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
56559914|NCT04778410|Azacitidine|azacitidine|mesh-list
56559915|NCT04778410|Venetoclax|venetoclax|mesh-list
56559916|NCT04778410|Cc-486|cc-486|mesh-list
56559917|NCT04778410|Magrolimab|magrolimab|mesh-list
56559918|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56559919|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559920|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56559921|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56559922|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559923|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096188|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56559946|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56559947|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56559948|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559949|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56559950|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
56559951|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559952|NCT00866281|Midostaurin|midostaurin|mesh-list
56559953|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544190|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
56544191|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56544192|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
56198358|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559954|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56559955|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559956|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559957|NCT04121611|Aspirin|aspirin|mesh-list
56559958|NCT04121611|Heparin|heparin|mesh-list
56559959|NCT04121611|Calcium heparin|calcium heparin|mesh-list
56559960|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
56559961|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56559962|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56559963|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559964|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559965|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559967|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
56559968|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559969|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559970|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559971|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559972|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56559973|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56308327|NCT00052936|Prednisone|prednisone|mesh-list
56559974|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559975|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
56559976|NCT02771860|Denosumab|denosumab|mesh-list
56559977|NCT02771860|Calcium|calcium|mesh-list
56560027|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560028|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
56560029|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560030|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56560031|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56560032|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56560033|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560034|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560036|NCT02770378|Itraconazole|itraconazole|mesh-list
56560037|NCT02770378|Minocycline|minocycline|mesh-list
56560038|NCT02770378|Celecoxib|celecoxib|mesh-list
56560039|NCT02770378|Temozolomide|temozolomide|mesh-list
56560040|NCT02770378|Auranofin|auranofin|mesh-list
56560041|NCT02770378|Captopril|captopril|mesh-list
56560042|NCT02770378|Disulfiram|disulfiram|mesh-list
56560043|NCT02770378|Aprepitant|aprepitant|mesh-list
56560044|NCT02770378|Sertraline|sertraline|mesh-list
56560045|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56560046|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56560047|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
56560048|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358435|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56560073|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560074|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
56560075|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56560076|NCT02770378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56560077|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56560078|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560079|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560080|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
56560081|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56560082|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
56560083|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
56560084|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56560085|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56560086|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56560087|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56560088|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56560089|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56560090|NCT02770222|Rifampin|rifampin|mesh-list
56560091|NCT02770222|Selexipag|selexipag|mesh-list
56560092|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
56560093|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56560122|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56560123|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56544193|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544194|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560124|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560125|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
56560126|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
56560127|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
56560128|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560129|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56560130|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
56560131|NCT02769832|Antiviral Agents|antiviral agents|mesh-ancestor
56560132|NCT02769832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560133|NCT02769832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560134|NCT02769832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560135|NCT02769832|Immunologic Factors|immunologic factors|mesh-ancestor
56560136|NCT02769832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560137|NCT02876250|Cyclosporine|cyclosporine|mesh-list
56560156|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56560157|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56560158|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56560159|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
56560160|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560161|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56560162|NCT02876484|Cathartics|cathartics|mesh-ancestor
56560163|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56560164|NCT02876094|Celecoxib|celecoxib|mesh-list
56560165|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56560166|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56560167|NCT02876094|Analgesics|analgesics|mesh-ancestor
56560168|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
56560169|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560170|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560171|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560172|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560173|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56560174|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56560175|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560176|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560177|NCT00603135|Levetiracetam|levetiracetam|mesh-list
56560178|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
56560179|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
56560180|NCT02769286|Osimertinib|osimertinib|mesh-list
56560181|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560182|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56560183|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560184|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560185|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
56560186|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56560187|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
56560188|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560189|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
56560190|NCT02855073|Protective Agents|protective agents|mesh-ancestor
56560191|NCT02769130|Losartan|losartan|mesh-list
56560192|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56560193|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56560194|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56560229|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
56560230|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
56560231|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560232|NCT02768116|Sirolimus|sirolimus|mesh-list
56560233|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56560260|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
56560262|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56560263|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56560264|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
56560265|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560266|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560267|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560268|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56560269|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56560270|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
56560271|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560272|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56544195|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56544196|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
56544197|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56544198|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56544199|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56544200|NCT03735901|Levodopa|levodopa|mesh-list
56544201|NCT03735901|Carbidopa|carbidopa|mesh-list
56544202|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56544203|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56544204|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
56544205|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544206|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544207|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544208|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56544209|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544210|NCT00621283|Secretin|secretin|mesh-list
56544211|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56544212|NCT00621283|Hormones|hormones|mesh-ancestor
56544213|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544214|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544215|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56544216|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
56560273|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
56560274|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
56560275|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
56560276|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56560277|NCT00943761|Interferons|interferons|mesh-list
56560278|NCT00943761|Ribavirin|ribavirin|mesh-list
56560279|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560280|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
56560281|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560316|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560317|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560319|NCT02696512|Minocycline|minocycline|mesh-list
56560320|NCT02696512|Lamotrigine|lamotrigine|mesh-list
56560321|NCT02696512|Flumazenil|flumazenil|mesh-list
56560322|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56560323|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560345|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
56560346|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560347|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560348|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560349|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
56560350|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56560351|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56560353|NCT02854761|Vitamins|vitamins|mesh-ancestor
56560355|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560356|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56560357|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56560358|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56560359|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560360|NCT01706692|Cyclosporine|cyclosporine|mesh-list
56560361|NCT01706692|Adalimumab|adalimumab|mesh-list
56544217|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544218|NCT05662189|Exenatide|exenatide|mesh-list
56544219|NCT05662189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56544220|NCT05662189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544221|NCT05662189|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56544223|NCT05662189|Hormones|hormones|mesh-ancestor
56544224|NCT05662189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544225|NCT00629031|Paromomycin|paromomycin|mesh-list
56544226|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56544227|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544228|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56544229|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56544230|NCT00621361|Etoposide|etoposide|mesh-list
56544231|NCT00621361|Cediranib|cediranib|mesh-list
56544232|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198382|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56560362|NCT01706692|Etanercept|etanercept|mesh-list
56560363|NCT01706692|Methotrexate|methotrexate|mesh-list
56560364|NCT01706692|Infliximab|infliximab|mesh-list
56560365|NCT01706692|Ustekinumab|ustekinumab|mesh-list
56560366|NCT01706692|Cyclosporins|cyclosporins|mesh-list
56560367|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56560368|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
56560369|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56560370|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560371|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56560372|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
56560373|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560374|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560375|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
56560376|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560377|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56560378|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560379|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
56096627|NCT02973464|Ganciclovir|ganciclovir|mesh-list
56560394|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56560395|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560397|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560398|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560399|NCT02767102|Melatonin|melatonin|mesh-list
56560400|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
56560401|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560402|NCT02767102|Protective Agents|protective agents|mesh-ancestor
56560403|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560404|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560405|NCT02774902|Clarithromycin|clarithromycin|mesh-list
56560406|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56560407|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560408|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56560409|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560410|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560411|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56560412|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56560413|NCT04225312|Natalizumab|natalizumab|mesh-list
56560414|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
56560415|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560416|NCT02767024|Nitroprusside|nitroprusside|mesh-list
56560417|NCT02767024|Dobutamine|dobutamine|mesh-list
56560418|NCT02767024|Furosemide|furosemide|mesh-list
56560419|NCT02767024|Diuretics|diuretics|mesh-ancestor
56560420|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
56473670|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
56544233|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56544234|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56544235|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56544236|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198399|NCT01512511|Analgesics|analgesics|mesh-ancestor
56560421|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560422|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56560423|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560424|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560425|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56560426|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
56560427|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
56560428|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560429|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56560430|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56560431|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56560432|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
56560433|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560434|NCT02767024|Protective Agents|protective agents|mesh-ancestor
56560435|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56560436|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
56560437|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56560438|NCT02774200|Apatinib|apatinib|mesh-list
56560439|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560440|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56096685|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
56560466|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
56560468|NCT01191944|Pramipexole|pramipexole|mesh-list
56560469|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
56560470|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560471|NCT01191944|Protective Agents|protective agents|mesh-ancestor
56560472|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560473|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56560474|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56560475|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
56560476|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
56560477|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560478|NCT00940875|Gemcitabine|gemcitabine|mesh-list
56560479|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56560480|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56560481|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
56560482|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560483|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560484|NCT00940875|Antiviral Agents|antiviral agents|mesh-ancestor
56560485|NCT00940875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096746|NCT00000638|Vitamins|vitamins|mesh-ancestor
56560511|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560513|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56560514|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
56560515|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560516|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560517|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56560518|NCT05655338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56560519|NCT05655338|Amoxicillin|amoxicillin|mesh-list
56560520|NCT05655338|Metronidazole|metronidazole|mesh-list
56560521|NCT05655338|Anti-Infective Agents|anti-infective agents|mesh-list
56560522|NCT05655338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56560523|NCT05655338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56560524|NCT01132313|Ribavirin|ribavirin|mesh-list
56560525|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
56560526|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560527|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
56560528|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560529|NCT05658146|Sulconazole|sulconazole|mesh-list
56560530|NCT05658146|Antifungal Agents|antifungal agents|mesh-ancestor
56560531|NCT05658146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560532|NCT00422565|Sirolimus|sirolimus|mesh-list
56560533|NCT00422565|Paclitaxel|paclitaxel|mesh-list
56560534|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56560535|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560536|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
56544237|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544238|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56544239|NCT05661643|Temozolomide|temozolomide|mesh-list
56544240|NCT05661643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56544241|NCT05661643|Alkylating Agents|alkylating agents|mesh-ancestor
56544242|NCT05661643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544243|NCT05661643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544244|NCT04208581|Fluticasone|fluticasone|mesh-list
56544245|NCT04208581|Xhance|xhance|mesh-list
56544246|NCT04208581|Budesonide|budesonide|mesh-list
56544247|NCT04208581|Bromides|bromides|mesh-list
56544248|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
56544249|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
56544250|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56544251|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56544252|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544253|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56544254|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
56544255|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544256|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544257|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56544258|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
56198402|NCT01512537|Vitamin D|vitamin d|mesh-list
56560537|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
56560570|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
56560571|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56560572|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56560573|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560574|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560575|NCT00861757|Urological Agents|urological agents|mesh-ancestor
56358544|NCT00271492|Atrasentan|atrasentan|mesh-list
56560576|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56560577|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56560578|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56096851|NCT00002180|Tenofovir|tenofovir|mesh-list
56560611|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560612|NCT02762344|Heparin|heparin|mesh-list
56560613|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
56560614|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56560615|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56560616|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560617|NCT04663282|Insulin|insulin|mesh-list
56560618|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56560619|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560620|NCT01130597|Spironolactone|spironolactone|mesh-list
56560621|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56560622|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
56096881|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56560646|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56560647|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56560648|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56544259|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
56544260|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56544261|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
56544262|NCT04208581|Hormones|hormones|mesh-ancestor
56544263|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544264|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56198426|NCT01512862|Vitamins|vitamins|mesh-ancestor
56560649|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56560650|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56560651|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56560652|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560654|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
56560655|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560657|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
56560658|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
56560659|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560660|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560662|NCT00865189|Folic Acid|folic acid|mesh-list
56560663|NCT00865189|Bevacizumab|bevacizumab|mesh-list
56560664|NCT00865189|Fluorouracil|fluorouracil|mesh-list
56560665|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
56560666|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
56560667|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56560668|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560669|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56560670|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56560671|NCT00865189|Growth Substances|growth substances|mesh-ancestor
56560672|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560673|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
56096924|NCT00002294|Fluconazole|fluconazole|mesh-list
56560698|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56560699|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56560700|NCT05362292|Mirabegron|mirabegron|mesh-list
56560701|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56560702|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56560703|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56560704|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56560705|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
56560706|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560707|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560708|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560709|NCT05362292|Urological Agents|urological agents|mesh-ancestor
56560710|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56560711|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56560712|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
56560713|NCT00698269|Insulin|insulin|mesh-list
56560714|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56560715|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
56560716|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
56560717|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56560718|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
56560719|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
56560720|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56560721|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56560722|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560723|NCT01182194|Drospirenone|drospirenone|mesh-list
56560724|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56560725|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56560755|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56358590|NCT00272584|Risperidone|risperidone|mesh-list
56560756|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
56560757|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56560758|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56560759|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56560760|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56560761|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56560762|NCT01137071|Antibodies|antibodies|mesh-list
56560763|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56544265|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56544266|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56544267|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
56544268|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544269|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544270|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
56544271|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56544272|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
56544273|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
56544274|NCT05368753|Lidocaine|lidocaine|mesh-list
56544275|NCT05368753|Ropivacaine|ropivacaine|mesh-list
56544276|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
56544277|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
56544278|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560764|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
56560765|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560766|NCT00603759|Celecoxib|celecoxib|mesh-list
56560767|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56560768|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56560769|NCT00603759|Analgesics|analgesics|mesh-ancestor
56560770|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
56560771|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560801|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560802|NCT01186796|Fulvestrant|fulvestrant|mesh-list
56560803|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56560804|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560805|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56560806|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56560807|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
56560808|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560809|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560810|NCT05383131|Pirfenidone|pirfenidone|mesh-list
56560811|NCT05383131|Nintedanib|nintedanib|mesh-list
56560812|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560813|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56560814|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560863|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56560864|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560865|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560866|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
56560867|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560868|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560869|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56560870|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560871|NCT01186328|Cytarabine|cytarabine|mesh-list
56560872|NCT01186328|Prednisone|prednisone|mesh-list
56560873|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
56560874|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56560875|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56560876|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56309226|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
56560877|NCT01186328|Cortisone|cortisone|mesh-list
56560878|NCT01186328|Doxorubicin|doxorubicin|mesh-list
56560879|NCT01186328|Methotrexate|methotrexate|mesh-list
56560880|NCT01186328|Vincristine|vincristine|mesh-list
56560881|NCT01186328|Asparaginase|asparaginase|mesh-list
56560882|NCT01186328|Pegaspargase|pegaspargase|mesh-list
56560883|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56560884|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560885|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56560886|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56560887|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068900|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
56544279|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544280|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
56544281|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544282|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56544283|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56544284|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56544285|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56544286|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544287|NCT05368675|Buprenorphine|buprenorphine|mesh-list
56544288|NCT05368675|Methadone|methadone|mesh-list
56560888|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560889|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560890|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
56560891|NCT01186328|Hormones|hormones|mesh-ancestor
56560892|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560893|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560894|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56560895|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56560896|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
56560897|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56560898|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56560899|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
56560900|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
56560901|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56560902|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560948|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56560949|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
56560950|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56560952|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56560953|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56560954|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56560955|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56560956|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56560957|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
56560958|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560959|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560960|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560961|NCT02882555|Capsaicin|capsaicin|mesh-list
56560962|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
56561020|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561021|NCT01185548|Tolbutamide|tolbutamide|mesh-list
56561022|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56309376|NCT00059761|Irinotecan|irinotecan|mesh-list
56561023|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561024|NCT01128569|Fluticasone|fluticasone|mesh-list
56561025|NCT01128569|Xhance|xhance|mesh-list
56561026|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56561027|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56561028|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
56561029|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561030|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561031|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56561032|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
56561033|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
56561034|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56561035|NCT04582942|Lactulose|lactulose|mesh-list
56561036|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561037|NCT02883179|Lidocaine|lidocaine|mesh-list
56561038|NCT02883179|Prilocaine|prilocaine|mesh-list
56561039|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56561040|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
56561041|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
56561042|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561043|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544289|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56544290|NCT05368675|Naloxone|naloxone|mesh-list
56634305|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
56544291|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56544292|NCT05368675|Narcotics|narcotics|mesh-ancestor
56544293|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56544294|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544295|NCT05368675|Analgesics|analgesics|mesh-ancestor
56544296|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
56544297|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544298|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56544299|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
56544300|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
56544301|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
56544302|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56544303|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544304|NCT05368051|Capecitabine|capecitabine|mesh-list
56544306|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56561044|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
56561045|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561046|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56561047|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56097301|NCT00002282|Miconazole|miconazole|mesh-list
56561073|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56561074|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
56561075|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56561076|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561077|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56561078|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56561079|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56561080|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561081|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
56561082|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56561084|NCT01185080|Analgesics|analgesics|mesh-ancestor
56561085|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
56561086|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561087|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561088|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56561089|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
56561090|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56561091|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
56097342|NCT00378313|Gemcitabine|gemcitabine|mesh-list
56561110|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56561111|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56561112|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561113|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56561114|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
56561115|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56561116|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
56561117|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561118|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
56561119|NCT00858637|Simvastatin|simvastatin|mesh-list
56561120|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56561121|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56561122|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
56561123|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561124|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56544307|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
56544308|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544309|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544310|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
56544311|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544312|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544313|NCT02641873|Leucovorin|leucovorin|mesh-list
56544314|NCT02641873|Bevacizumab|bevacizumab|mesh-list
56544315|NCT02641873|Irinotecan|irinotecan|mesh-list
56544316|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
56544317|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56544318|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544319|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56544320|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56544321|NCT02641873|Growth Substances|growth substances|mesh-ancestor
56544322|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544323|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
56544324|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56544325|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56544326|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544327|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198480|NCT01513070|Aspirin|aspirin|mesh-list
56561125|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56561126|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561127|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561128|NCT02760316|Prednisolone|prednisolone|mesh-list
56561129|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56561130|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
56561131|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56561132|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
56561133|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56561134|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
56561135|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56561136|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
56561137|NCT02760316|Hormones|hormones|mesh-ancestor
56561138|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56561139|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561140|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56561141|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561142|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
56561143|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
56561144|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561145|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561146|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56097401|NCT02589145|Pyridoxine|pyridoxine|mesh-list
56561166|NCT04480918|Analgesics|analgesics|mesh-ancestor
56561167|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
56561168|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561169|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561170|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56561171|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56561172|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
56544328|NCT02641873|Antidotes|antidotes|mesh-ancestor
56544329|NCT02641873|Protective Agents|protective agents|mesh-ancestor
56544330|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
56544331|NCT02641873|Vitamins|vitamins|mesh-ancestor
56544332|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
56544333|NCT00998985|Grazoprevir|grazoprevir|mesh-list
56544334|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
56544335|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544336|NCT05240391|Midodrine|midodrine|mesh-list
56544337|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
56544338|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
56544339|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544340|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198492|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56561174|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561175|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56561176|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56561177|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561178|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561179|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
56561180|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56561181|NCT04222348|Metformin|metformin|mesh-list
56561182|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
56561183|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56561184|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561185|NCT04222114|Catumaxomab|catumaxomab|mesh-list
56561186|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561187|NCT00838435|Verapamil|verapamil|mesh-list
56561188|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56561189|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56561190|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56561191|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561192|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56561193|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561194|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
56561195|NCT02757508|Vitamins|vitamins|mesh-list
56561196|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
56561197|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561198|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
56561199|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56561200|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
56561201|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561202|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561203|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561212|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56561213|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561214|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
56561215|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561216|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561217|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56561218|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
56561219|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
56561220|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561221|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561222|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
56561224|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56561225|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56561226|NCT02757196|Protective Agents|protective agents|mesh-ancestor
56561227|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56561228|NCT04403698|Alendronate|alendronate|mesh-list
56561229|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56561230|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544341|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56544342|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56544343|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56561231|NCT02759926|Quinine|quinine|mesh-list
56561232|NCT02759926|Denatonium|denatonium|mesh-list
56561233|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
56561234|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56561235|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56561236|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561237|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56561238|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561239|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56561240|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561241|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56561242|NCT02759926|Analgesics|analgesics|mesh-ancestor
56561243|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
56561244|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
56561245|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309598|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
56561246|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
56561248|NCT04221256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56561249|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56561250|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56561251|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358682|NCT00107874|Misoprostol|misoprostol|mesh-list
56561252|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561253|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
56561254|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561255|NCT04221256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56561256|NCT04221256|Antidepressive Agents|antidepressive agents|mesh-ancestor
56561257|NCT04221256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56561258|NCT00838201|Denosumab|denosumab|mesh-list
56561259|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56561260|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561261|NCT00837967|Terbutaline|terbutaline|mesh-list
56561262|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56561263|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56561264|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
56561265|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56561266|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
56561267|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561268|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561269|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
56561286|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
56561287|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56561288|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561289|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561291|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561292|NCT02759224|Irsogladine|irsogladine|mesh-list
56561293|NCT02759224|Lafutidine|lafutidine|mesh-list
56561294|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561295|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56561296|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561297|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56561298|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
56561299|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
56561300|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561301|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561302|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561303|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56561304|NCT02759224|Protective Agents|protective agents|mesh-ancestor
56561305|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56561306|NCT02756728|Melphalan|melphalan|mesh-list
56561307|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56561308|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
56561309|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561310|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561311|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56561312|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56561313|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
56544344|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56544345|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
56544346|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561314|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561315|NCT04586920|Itraconazole|itraconazole|mesh-list
56561316|NCT04586920|Midazolam|midazolam|mesh-list
56561317|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56561318|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56561319|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561320|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561321|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56561322|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56561323|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56561324|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56561325|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
56097566|NCT04331210|Analgesics|analgesics|mesh-ancestor
56561345|NCT02758990|Tocopherols|tocopherols|mesh-list
56561346|NCT02758990|Vitamin A|vitamin a|mesh-list
56561347|NCT02758990|Niacinamide|niacinamide|mesh-list
56561348|NCT02758990|Niacin|niacin|mesh-list
56561349|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
56561350|NCT02758990|Pyridoxine|pyridoxine|mesh-list
56561351|NCT02758990|Pyridoxal|pyridoxal|mesh-list
56561352|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
56561353|NCT02758990|Caffeine|caffeine|mesh-list
56561354|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
56561355|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561356|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56561357|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56561358|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
56561359|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561360|NCT02758990|Protective Agents|protective agents|mesh-ancestor
56561361|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56561362|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56561363|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561364|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56561365|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56561366|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
56561367|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561368|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
56561369|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56561370|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
56561371|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56561372|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
56561373|NCT02756104|Vitamin D|vitamin d|mesh-list
56561374|NCT02756104|Vitamins|vitamins|mesh-ancestor
56561375|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
56561376|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561377|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56561378|NCT02756026|Micronutrients|micronutrients|mesh-list
56561379|NCT02756026|Trace Elements|trace elements|mesh-list
56561380|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561381|NCT02755714|Bromides|bromides|mesh-list
56561382|NCT02755714|Ipratropium|ipratropium|mesh-list
56561383|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
56561384|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56561385|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
56561386|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561395|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56561396|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56561397|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561399|NCT00942357|Cisplatin|cisplatin|mesh-list
56561400|NCT00942357|Carboplatin|carboplatin|mesh-list
56561401|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56561402|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56561403|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561404|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
56561405|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
56561406|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
56561407|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561408|NCT04583956|Remdesivir|remdesivir|mesh-list
56561409|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
56561410|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561411|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
56561412|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561413|NCT02752828|Insulin|insulin|mesh-list
56561414|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56544347|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544348|NCT00628953|Esomeprazole|esomeprazole|mesh-list
56544349|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56544350|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561415|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
56561416|NCT02752828|Lixisenatide|lixisenatide|mesh-list
56561417|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56561418|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561419|NCT02753062|Rituximab|rituximab|mesh-list
56561420|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56561421|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56561422|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561423|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
56561424|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561425|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561426|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56561427|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
56561428|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561429|NCT02752204|Rituximab|rituximab|mesh-list
56561430|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56561431|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561432|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
56561433|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561434|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561435|NCT04220398|Hormones|hormones|mesh-list
56561436|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56561437|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561438|NCT04220632|Prednisone|prednisone|mesh-list
56561439|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
56561440|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56561441|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56561442|NCT04220632|Prednisolone|prednisolone|mesh-list
56561443|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
56561444|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56561445|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
56561446|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56561447|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
56561448|NCT04220632|Hormones|hormones|mesh-ancestor
56561449|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56561450|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561451|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56561452|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561476|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561477|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56561478|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56561479|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561480|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561481|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56561482|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
56561483|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56561484|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561485|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56561486|NCT02695810|Metformin|metformin|mesh-list
56561487|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
56561488|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56561489|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561490|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56561491|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561492|NCT02753764|Prednisone|prednisone|mesh-list
56561493|NCT02753764|AZD7624|azd7624|mesh-list
56561494|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56561495|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
56561496|NCT02753764|Hormones|hormones|mesh-ancestor
56561497|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56561498|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561499|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56561500|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561501|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56561502|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544351|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56544352|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198509|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56561503|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561504|NCT02695654|Clonidine|clonidine|mesh-list
56561505|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
56561514|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56561515|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56561516|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
56561517|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561518|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561519|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
56561521|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561522|NCT02696122|Anesthetics|anesthetics|mesh-list
56561523|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561524|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561525|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56561526|NCT01135511|Tofacitinib|tofacitinib|mesh-list
56561527|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
56561528|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56561529|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56561530|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561531|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561532|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56561533|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
56561534|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561535|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
56561536|NCT01135511|Protective Agents|protective agents|mesh-ancestor
56561537|NCT02753140|Docetaxel|docetaxel|mesh-list
56561538|NCT02753140|Cetuximab|cetuximab|mesh-list
56561539|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561540|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
56561541|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
56561542|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
56561543|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561544|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56561545|NCT02753218|Midazolam|midazolam|mesh-list
56561546|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56561547|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56561548|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561549|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561550|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56561551|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56561552|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56561553|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56561554|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
56561555|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
56561556|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
56561557|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
56561558|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561559|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561560|NCT05429554|Vildagliptin|vildagliptin|mesh-list
56561561|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56561562|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561563|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56561564|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
56561565|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561566|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561567|NCT05429086|Propofol|propofol|mesh-list
56561568|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56561569|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561570|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561571|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56097844|NCT00002516|Cobalt|cobalt|mesh-list
56561582|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56561583|NCT01180790|Interferons|interferons|mesh-list
56561584|NCT01180790|Ribavirin|ribavirin|mesh-list
56561585|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
56561586|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
56561587|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56561588|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561589|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
56561590|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544353|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561591|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
56561592|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561593|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
56561594|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561595|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
56561596|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56561597|NCT01184846|Antibodies|antibodies|mesh-list
56561598|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
56561599|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561600|NCT01191086|Topiramate|topiramate|mesh-list
56561601|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
56561602|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56561603|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561604|NCT01191008|Timolol|timolol|mesh-list
56561605|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56561606|NCT01191008|Latanoprost|latanoprost|mesh-list
56561607|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56561608|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561609|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56561610|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56561611|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
56561612|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561613|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561614|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56561615|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56561616|NCT01076400|Topotecan|topotecan|mesh-list
56561617|NCT01076400|Adavosertib|adavosertib|mesh-list
56561618|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561619|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56561620|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56561621|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561622|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561623|NCT05318560|Lidocaine|lidocaine|mesh-list
56561624|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
56561625|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
56561626|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561627|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561628|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
56561629|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561630|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56561631|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56561632|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56561633|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56561634|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561635|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
56561645|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561646|NCT01086384|Fluticasone|fluticasone|mesh-list
56561648|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56561649|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56561650|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
56561651|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561652|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561653|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56561654|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
56561655|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
56561656|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56561657|NCT04115644|Triamcinolone|triamcinolone|mesh-list
56561658|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56561659|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56561660|NCT04115644|Ketorolac|ketorolac|mesh-list
56561661|NCT04115644|Bupivacaine|bupivacaine|mesh-list
56561662|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56561663|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
56561664|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
56561665|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561666|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561667|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
56561668|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561669|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56561670|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
56561671|NCT04115644|Hormones|hormones|mesh-ancestor
56561672|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544354|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56544355|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56561673|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56561674|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
56561675|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561676|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561677|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56561678|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56561679|NCT04115644|Analgesics|analgesics|mesh-ancestor
56561680|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561681|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56561682|NCT00635986|Fentanyl|fentanyl|mesh-list
56561683|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56561684|NCT00635986|Narcotics|narcotics|mesh-ancestor
56561685|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561686|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561687|NCT00635986|Analgesics|analgesics|mesh-ancestor
56561688|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
56561689|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561690|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56561691|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56561692|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
56561693|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
56561694|NCT04799626|Levofloxacin|levofloxacin|mesh-list
56561695|NCT04799626|Ofloxacin|ofloxacin|mesh-list
56561696|NCT04799626|Meropenem|meropenem|mesh-list
56561697|NCT04799626|Tazobactam|tazobactam|mesh-list
56561698|NCT04799626|Piperacillin|piperacillin|mesh-list
56561699|NCT04799626|Tigecycline|tigecycline|mesh-list
56561700|NCT04799626|Biapenem|biapenem|mesh-list
56561701|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56561702|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561737|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56561738|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56561739|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561751|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
56561752|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56561753|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56561754|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561755|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56561756|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561757|NCT04335292|Pemetrexed|pemetrexed|mesh-list
56561758|NCT04335292|Osimertinib|osimertinib|mesh-list
56561759|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561760|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561761|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561762|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56561763|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56561764|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56561765|NCT04278508|Progesterone|progesterone|mesh-list
56561766|NCT04278508|Progestins|progestins|mesh-ancestor
56561767|NCT04278508|Hormones|hormones|mesh-ancestor
56561768|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56561769|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561770|NCT05382351|Tenofovir|tenofovir|mesh-list
56561771|NCT05382351|Entecavir|entecavir|mesh-list
56561772|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
56561773|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561774|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56561775|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56561776|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561777|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561778|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56561779|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56561780|NCT04218760|Isosorbide|isosorbide|mesh-list
56561781|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56561782|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56561783|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56561784|NCT04218760|Diuretics|diuretics|mesh-ancestor
56561785|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
56561786|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561787|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
56561788|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56544356|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56544357|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56198515|NCT01513174|Gefitinib|gefitinib|mesh-list
56561789|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561790|NCT02750254|Plerixafor|plerixafor|mesh-list
56561791|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
56561792|NCT02750254|Melphalan|melphalan|mesh-list
56561793|NCT02750254|Busulfan|busulfan|mesh-list
56561794|NCT02750254|Fludarabine|fludarabine|mesh-list
56561795|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
56561796|NCT02750254|Azacitidine|azacitidine|mesh-list
56561797|NCT02750254|Lenograstim|lenograstim|mesh-list
56561798|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56561799|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
56561800|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561801|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561802|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56561803|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
56561804|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561805|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561819|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
56561820|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561821|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56561822|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561823|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56561824|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
56561825|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561826|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56561827|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56561828|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561830|NCT00941655|Protective Agents|protective agents|mesh-ancestor
56561831|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
56561833|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
56561834|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
56561835|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
56561836|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561837|NCT00605787|Protective Agents|protective agents|mesh-ancestor
56561838|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561839|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56561840|NCT00936117|Posaconazole|posaconazole|mesh-list
56561841|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
56561842|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561843|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56561844|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56561845|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56561846|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56561847|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56561848|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561849|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561850|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56561851|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
56561852|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56561853|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561854|NCT04267653|Lactoferrin|lactoferrin|mesh-list
56561855|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561856|NCT04088500|Nivolumab|nivolumab|mesh-list
56561857|NCT04088500|Ipilimumab|ipilimumab|mesh-list
56561858|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56561859|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561860|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56561861|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561862|NCT01082874|Clonidine|clonidine|mesh-list
56561863|NCT01082874|Analgesics|analgesics|mesh-ancestor
56561864|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
56561865|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561866|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561867|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561868|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56561869|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
56561885|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561886|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544358|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544359|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913093|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
56561888|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
56561889|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
56561890|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
56561891|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56561892|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56561893|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56561894|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56561895|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
56561896|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561897|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561898|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
56561899|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56561900|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561901|NCT04217512|Pantoprazole|pantoprazole|mesh-list
56561902|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56561903|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561904|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56561905|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561906|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561907|NCT01079988|Cyclosporine|cyclosporine|mesh-list
56561908|NCT01079988|Methotrexate|methotrexate|mesh-list
56561909|NCT01079988|Cyclosporins|cyclosporins|mesh-list
56561910|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56561911|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
56561912|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56561913|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561914|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56561915|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
56561916|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561917|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561918|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
56561919|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561920|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56561921|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56561922|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
56561923|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310273|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56561924|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56561925|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
56561926|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098167|NCT00002588|Etoposide|etoposide|mesh-list
56561938|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
56561939|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56561940|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
56561941|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56561942|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
56561943|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561944|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561945|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
56561946|NCT03508570|Nivolumab|nivolumab|mesh-list
56561947|NCT03508570|Ipilimumab|ipilimumab|mesh-list
56561948|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56561949|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561950|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56561951|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561952|NCT01074216|Vitamin D|vitamin d|mesh-list
56561953|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
56561954|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
56561955|NCT01074216|Vitamins|vitamins|mesh-list
56561956|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
56561957|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561958|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56561959|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56561960|NCT03141034|Irinotecan|irinotecan|mesh-list
56561961|NCT03141034|Ramucirumab|ramucirumab|mesh-list
56561962|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56561963|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56561964|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561965|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544360|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544361|NCT04294953|Analgesics|analgesics|mesh-ancestor
56544362|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
56544363|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544364|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
56544365|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56544366|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
56544367|NCT02869815|Methylene Blue|methylene blue|mesh-list
56544368|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544369|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544370|NCT04293081|Maleic acid|maleic acid|mesh-list
56544371|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544372|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544374|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
56544375|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56544376|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544377|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
56544378|NCT02870907|Thiotepa|thiotepa|mesh-list
56544379|NCT02870907|Carboplatin|carboplatin|mesh-list
56544380|NCT02870907|Etoposide|etoposide|mesh-list
56544381|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
56544382|NCT02870907|Vincristine|vincristine|mesh-list
56544383|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544384|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
56544385|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544386|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198520|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56561966|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561967|NCT00636142|Infliximab|infliximab|mesh-list
56561968|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56561969|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561970|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561971|NCT02499562|Entecavir|entecavir|mesh-list
56561972|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
56561973|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561974|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
56561975|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56561976|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56561977|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561978|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56561979|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561980|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
56561981|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561982|NCT02875002|Belinostat|belinostat|mesh-list
56561983|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561984|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56561985|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561986|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561987|NCT02749396|Interferons|interferons|mesh-list
56561988|NCT02749396|Interferon-beta|interferon-beta|mesh-list
56544387|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56544388|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
56544389|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544390|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544391|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56544392|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56544393|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56544394|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56544395|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544396|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
56544397|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
56544398|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
56544399|NCT02868801|Pregabalin|pregabalin|mesh-list
56544400|NCT02868801|Analgesics|analgesics|mesh-ancestor
56544401|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
56544402|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561989|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
56561990|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
56561991|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562002|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562004|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562005|NCT02749162|Acetaminophen|acetaminophen|mesh-list
56562006|NCT02749162|Dexamethasone|dexamethasone|mesh-list
56562007|NCT02749162|Lidocaine|lidocaine|mesh-list
56562008|NCT02749162|Morphine|morphine|mesh-list
56562009|NCT02749162|Ropivacaine|ropivacaine|mesh-list
56562010|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56562011|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56562012|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
56562013|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
56562014|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562015|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562016|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56562017|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
56562018|NCT02749162|Hormones|hormones|mesh-ancestor
56480203|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56562019|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562020|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56562021|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562023|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
56562024|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562025|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
56562026|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56562027|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56562028|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56562029|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56562030|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562031|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56562032|NCT02749162|Narcotics|narcotics|mesh-ancestor
56562033|NCT02749162|Analgesics|analgesics|mesh-ancestor
56562034|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56562035|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
56562036|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56562037|NCT02041234|Liraglutide|liraglutide|mesh-list
56562038|NCT02041234|Empagliflozin|empagliflozin|mesh-list
56562039|NCT02041234|Linagliptin|linagliptin|mesh-list
56562040|NCT02041234|Canagliflozin|canagliflozin|mesh-list
56562041|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56562042|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56544403|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544404|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
56544405|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56544406|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56544407|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544408|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56544409|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56544410|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56544411|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56544412|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56544413|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
56544414|NCT01002339|Cyclosporine|cyclosporine|mesh-list
56544415|NCT01002339|Prednisone|prednisone|mesh-list
56544416|NCT01002339|Tacrolimus|tacrolimus|mesh-list
56544417|NCT01002339|Basiliximab|basiliximab|mesh-list
55913428|NCT05246631|Hormones|hormones|mesh-ancestor
56562043|NCT02041234|Orlistat|orlistat|mesh-list
56562044|NCT02041234|Incretins|incretins|mesh-list
56562045|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56562046|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562047|NCT02041234|Hormones|hormones|mesh-ancestor
56562048|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562049|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
56562050|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562051|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562052|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56562053|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56562054|NCT02695732|Carvedilol|carvedilol|mesh-list
56562055|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56562056|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56562057|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
56562058|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562068|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56562069|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56562071|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
56562072|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
56562073|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562074|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562075|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
56562076|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562077|NCT02748772|Thalidomide|thalidomide|mesh-list
56562078|NCT02748772|Endostar protein|endostar protein|mesh-list
56562079|NCT02748772|Endostatins|endostatins|mesh-list
56562080|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562081|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
56562082|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562083|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
56562084|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56562085|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562086|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56562087|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56562088|NCT02748772|Growth Substances|growth substances|mesh-ancestor
56562089|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
56562090|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562091|NCT04406272|Bevacizumab|bevacizumab|mesh-list
56562092|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56562093|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562094|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56562095|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56562096|NCT04406272|Growth Substances|growth substances|mesh-ancestor
56544418|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544419|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
56562097|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562098|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
56562100|NCT04216888|Analgesics|analgesics|mesh-ancestor
56562101|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
56562102|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562103|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562104|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56562105|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56562106|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
56562107|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
56562108|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562109|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56562110|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56562111|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562112|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562113|NCT02746744|Rituximab|rituximab|mesh-list
56562114|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56562115|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56562116|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562117|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
56562118|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562119|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562120|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562121|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562122|NCT02748304|Aspirin|aspirin|mesh-list
56562123|NCT02748304|Sorafenib|sorafenib|mesh-list
56562137|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562138|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
56562139|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562140|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56562141|NCT02746276|Metronidazole|metronidazole|mesh-list
56562142|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
56562143|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562144|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56562145|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56562146|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56562147|NCT02745886|Metformin|metformin|mesh-list
56562148|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56562154|NCT05629234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562155|NCT02742142|Fluorides|fluorides|mesh-list
56562156|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
56562157|NCT02742142|Protective Agents|protective agents|mesh-ancestor
56562158|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562159|NCT00636298|Bevacizumab|bevacizumab|mesh-list
56562160|NCT00636298|Cetuximab|cetuximab|mesh-list
56562161|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56562162|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562163|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56562164|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56562165|NCT00636298|Growth Substances|growth substances|mesh-ancestor
56562166|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562167|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
56562173|NCT02744716|Aspirin|aspirin|mesh-list
56562174|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56562175|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56562176|NCT02744716|Analgesics|analgesics|mesh-ancestor
56562177|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
56562178|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562179|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562180|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56562181|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562182|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56562183|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56562184|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562185|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56562186|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56562187|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562188|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
56562189|NCT02744872|Felodipine|felodipine|mesh-list
56562190|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56562191|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56562192|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56068901|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
56544420|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544421|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56544422|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544423|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544424|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56544425|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544426|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56544427|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
56544428|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56544429|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544430|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544431|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
56544432|NCT01002339|Hormones|hormones|mesh-ancestor
56544433|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544434|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56562193|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56098422|NCT00002678|Hormones|hormones|mesh-ancestor
56562205|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56562206|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562207|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562208|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
56562210|NCT00857389|Thiotepa|thiotepa|mesh-list
56562211|NCT00857389|Methotrexate|methotrexate|mesh-list
56562212|NCT00857389|Clofarabine|clofarabine|mesh-list
56562213|NCT00857389|Tacrolimus|tacrolimus|mesh-list
56562214|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
56562215|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56562216|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562217|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
56562218|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562219|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562220|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56562221|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
56562222|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562223|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562224|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56562225|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56562226|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
56562227|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56562228|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56562229|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
56562230|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562231|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562232|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56562233|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56562234|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56562235|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
56562236|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56562237|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56562238|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562239|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56562240|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562241|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56562242|NCT01071798|Rituximab|rituximab|mesh-list
56562243|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56562244|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562245|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
56544435|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
56544436|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
56544437|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544438|NCT01002105|Baclofen|baclofen|mesh-list
56544439|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56544440|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544441|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56544442|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544443|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56544444|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
56544445|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
56544446|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544447|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544449|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56544450|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544451|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
56544452|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544453|NCT00995085|Pyridoxine|pyridoxine|mesh-list
56544454|NCT00995085|Metadoxine|metadoxine|mesh-list
56544455|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56544456|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
56544457|NCT00995085|Vitamins|vitamins|mesh-ancestor
56544458|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
56544459|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544460|NCT05662111|Etidronic Acid|etidronic acid|mesh-list
56544461|NCT05662111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56544462|NCT05662111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544463|NCT00603733|Mesalamine|mesalamine|mesh-list
56544464|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56544465|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56544466|NCT00603733|Analgesics|analgesics|mesh-ancestor
56198599|NCT01513772|Analgesics|analgesics|mesh-ancestor
56562246|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562247|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562248|NCT00857311|Vaccines|vaccines|mesh-list
56562249|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
56562250|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562251|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
56562252|NCT02874768|Propofol|propofol|mesh-list
56562253|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56562254|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562255|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562256|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56562276|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56562277|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56198624|NCT01513941|Ribavirin|ribavirin|mesh-list
56562278|NCT02740426|Pirarubicin|pirarubicin|mesh-list
56562279|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562280|NCT02743234|Vancomycin|vancomycin|mesh-list
56562281|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
56562282|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56562283|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562284|NCT02740270|Spartalizumab|spartalizumab|mesh-list
56562285|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56562286|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562287|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562288|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56562289|NCT00856843|Laxatives|laxatives|mesh-ancestor
56562290|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56562291|NCT02740192|Bupivacaine|bupivacaine|mesh-list
56562292|NCT02740192|Ropivacaine|ropivacaine|mesh-list
56562293|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
56562294|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
56562295|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562296|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562297|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
56562298|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562299|NCT02743390|Infliximab|infliximab|mesh-list
56562300|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562301|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56562302|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562303|NCT00856609|Exenatide|exenatide|mesh-list
56562304|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56562305|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562306|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56562307|NCT00856609|Incretins|incretins|mesh-ancestor
56562308|NCT00856609|Hormones|hormones|mesh-ancestor
56562309|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562310|NCT02739958|Propofol|propofol|mesh-list
56562311|NCT02739958|Isoflurane|isoflurane|mesh-list
56562312|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56098559|NCT00002720|Tamoxifen|tamoxifen|mesh-list
56562344|NCT01070784|Budesonide|budesonide|mesh-list
56562345|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
56562346|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56562347|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56358869|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
56562348|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56562350|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562351|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562352|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56562353|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
56098605|NCT05599555|Vaccines|vaccines|mesh-list
56562382|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
56562383|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56562384|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
56562385|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56562386|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562387|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56562388|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56562389|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562391|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56562392|NCT03823768|Tacrolimus|tacrolimus|mesh-list
56562393|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562394|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
56562395|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562396|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56562397|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098645|NCT00002744|Vincristine|vincristine|mesh-list
56562407|NCT05620108|Rocuronium|rocuronium|mesh-list
56562408|NCT05620108|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56562409|NCT05620108|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56562410|NCT05620108|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56562411|NCT05620108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562412|NCT05620108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562413|NCT00856297|Vaccines|vaccines|mesh-list
56562414|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
56562415|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562416|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
56562417|NCT02736604|Anesthetics|anesthetics|mesh-list
56562418|NCT02736604|Sevoflurane|sevoflurane|mesh-list
56562419|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562420|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544467|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
56544468|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544469|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544470|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55727360|NCT04468139|Quercetin|quercetin|mesh-list
56562421|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56562422|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56562423|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
56562424|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56562425|NCT02736604|Analgesics|analgesics|mesh-ancestor
56562426|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
56562427|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562428|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
56562429|NCT02613013|Pilocarpine|pilocarpine|mesh-list
56562430|NCT02613013|Miotics|miotics|mesh-ancestor
56562431|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
56562432|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562433|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562434|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56562435|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56562436|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
56562437|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562438|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562439|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
56562440|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
56562441|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562442|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
56562443|NCT04306510|Antibodies|antibodies|mesh-list
56562444|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
56562445|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56562446|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
56562447|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562448|NCT02611921|Ketamine|ketamine|mesh-list
56562449|NCT02611921|Analgesics|analgesics|mesh-ancestor
56562450|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
56562451|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562452|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562453|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56562454|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56562455|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
56562456|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
56562457|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562458|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56562459|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56562460|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562461|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562462|NCT02736448|Capecitabine|capecitabine|mesh-list
56562463|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098699|NCT01788475|Hormones|hormones|mesh-ancestor
56562481|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
56562482|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56562483|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
56562484|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
56562485|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562486|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
56562487|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56562488|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56562489|NCT02736682|Metronidazole|metronidazole|mesh-list
56562490|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56562491|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562492|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
56562493|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56562494|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56562495|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
56562496|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56562497|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562498|NCT02874690|Methylphenidate|methylphenidate|mesh-list
56562499|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56562500|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562501|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56562502|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56544471|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544472|NCT02471911|Dexamethasone|dexamethasone|mesh-list
56544473|NCT02471911|Rituximab|rituximab|mesh-list
56544474|NCT02471911|Carboplatin|carboplatin|mesh-list
56544475|NCT02471911|Etoposide|etoposide|mesh-list
56544476|NCT02471911|Ifosfamide|ifosfamide|mesh-list
56544477|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56562503|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56562504|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562505|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
56562506|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562507|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
56562508|NCT04304352|Capecitabine|capecitabine|mesh-list
56562509|NCT04304352|Vinorelbine|vinorelbine|mesh-list
56562510|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562511|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
56562512|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562513|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562514|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56562515|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
56562516|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562517|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562518|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56562519|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56562520|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
56098771|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
56562533|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56562534|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562535|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
56562537|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
56562538|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56562539|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56562540|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56562541|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56562542|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56562543|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562544|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56562545|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56562546|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56562547|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562548|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
56562549|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562550|NCT00703807|Everolimus|everolimus|mesh-list
56562551|NCT00703807|Topotecan|topotecan|mesh-list
56562552|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562553|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562554|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
56562555|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562556|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56562557|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56562558|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562559|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562560|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56562561|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562562|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562563|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562564|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56562565|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
56562566|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56562567|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56562568|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562569|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
56562570|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562571|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562573|NCT03633058|Analgesics|analgesics|mesh-ancestor
56562574|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
56562575|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544478|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544479|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
56544480|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544481|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544482|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544483|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
56544484|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
56544485|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544486|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56562576|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562577|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56562578|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56562579|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
56562592|NCT02737774|Pemetrexed|pemetrexed|mesh-list
56562593|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562594|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562595|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562596|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56562597|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56562598|NCT02735590|Isoniazid|isoniazid|mesh-list
56562599|NCT02735590|Rifapentine|rifapentine|mesh-list
56562600|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
56562601|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56562602|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562603|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56562604|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56562605|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
56562606|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562607|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56562608|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56562609|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
56562610|NCT05626348|Hydroxychloroquine|hydroxychloroquine|mesh-list
56562611|NCT05626348|Adalimumab|adalimumab|mesh-list
56562612|NCT05626348|Methotrexate|methotrexate|mesh-list
56562613|NCT05626348|Leflunomide|leflunomide|mesh-list
56562614|NCT05626348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56562615|NCT05626348|Abortifacient Agents|abortifacient agents|mesh-ancestor
56562616|NCT05626348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56562617|NCT05626348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562618|NCT05626348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56562619|NCT05626348|Antimetabolites|antimetabolites|mesh-ancestor
56562620|NCT05626348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562621|NCT05626348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562622|NCT05626348|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562623|NCT05626348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562624|NCT05626348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56562625|NCT05626348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562626|NCT05626348|Immunologic Factors|immunologic factors|mesh-ancestor
56562627|NCT05626348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562628|NCT05626348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56562629|NCT05626348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56562630|NCT05626348|Antimalarials|antimalarials|mesh-ancestor
56562631|NCT05626348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56562632|NCT05626348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56562633|NCT05626348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562634|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
56562635|NCT02737696|Narcotics|narcotics|mesh-ancestor
56562636|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562637|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562638|NCT02737696|Analgesics|analgesics|mesh-ancestor
56562639|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
56562640|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562641|NCT02737228|Gemcitabine|gemcitabine|mesh-list
56562642|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56562665|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562666|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56069358|NCT05602207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544487|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
56544488|NCT02471911|Hormones|hormones|mesh-ancestor
56544489|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544490|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56544491|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56544492|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56544493|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56544494|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544495|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544496|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56544497|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
56544498|NCT00622375|Mesalamine|mesalamine|mesh-list
56198643|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56562667|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56562668|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562669|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562670|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56562671|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
56562672|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562673|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562674|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56562675|NCT00625469|Bosentan|bosentan|mesh-list
56562676|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56562677|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56562678|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562679|NCT05577910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56562680|NCT05577910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56562681|NCT00637481|Atorvastatin|atorvastatin|mesh-list
56562682|NCT00637481|Calcium|calcium|mesh-list
56562683|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56562684|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562685|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56562686|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56562687|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
56562688|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562689|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56562690|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56562691|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098946|NCT01122511|Hormones|hormones|mesh-ancestor
56562710|NCT00836875|Voriconazole|voriconazole|mesh-list
56562711|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
56562712|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562713|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56562714|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56562715|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562716|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562717|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56562718|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
56562719|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562720|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562721|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56562722|NCT02732314|Desonide|desonide|mesh-list
56562723|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56562724|NCT01125917|Buprenorphine|buprenorphine|mesh-list
56562725|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56562727|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562728|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544499|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56544500|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56562729|NCT01125917|Analgesics|analgesics|mesh-ancestor
56562730|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
56562731|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562732|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56562733|NCT02732236|Rituximab|rituximab|mesh-list
56562734|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56562735|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562736|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
56562737|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562738|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562739|NCT01121549|Exemestane|exemestane|mesh-list
56562740|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562741|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56562742|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56562743|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562744|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562745|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56562746|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
56562747|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562748|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562761|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56562762|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
56562763|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562764|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562765|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56562766|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
56562767|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562768|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56562769|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
56562770|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56562771|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56562772|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56562773|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56562774|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
56562775|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562776|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562778|NCT04248712|Famotidine|famotidine|mesh-list
56562779|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56562780|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56562781|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56562782|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
56562783|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
56562784|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562785|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562786|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562787|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
56562788|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562789|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56562790|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56358943|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
56562791|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56562793|NCT02734732|Trimethoprim|trimethoprim|mesh-list
56562794|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
56562795|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56562796|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562797|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56562798|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56562799|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562800|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562801|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562802|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56562803|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56562804|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56562805|NCT02734732|Renal Agents|renal agents|mesh-ancestor
56562806|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
56562807|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56562808|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56562809|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56562810|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56544501|NCT00622375|Analgesics|analgesics|mesh-ancestor
56544502|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
56544503|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544504|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544505|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544506|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544507|NCT02691325|Charcoal|charcoal|mesh-list
56544508|NCT02691325|Nemiralisib|nemiralisib|mesh-list
56544509|NCT02691325|Antidotes|antidotes|mesh-ancestor
56544510|NCT02691325|Protective Agents|protective agents|mesh-ancestor
56544511|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544512|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56544513|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544514|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544515|NCT01678027|Clarithromycin|clarithromycin|mesh-list
56544516|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56544517|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544518|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56544519|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544520|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544521|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56544522|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56544524|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56099055|NCT05594407|Anesthetics, Local|anesthetics, local|mesh-ancestor
56562831|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56562832|NCT00704275|Cyclosporins|cyclosporins|mesh-list
56562833|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562834|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562835|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562836|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
56562837|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562838|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
56562839|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562840|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562841|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562842|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56562843|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56562844|NCT00847015|Gemcitabine|gemcitabine|mesh-list
56562845|NCT00847015|Sunitinib|sunitinib|mesh-list
56562846|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562847|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56562848|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
56562849|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562850|NCT00847015|Antiviral Agents|antiviral agents|mesh-ancestor
56562851|NCT00847015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562852|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562853|NCT00847015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562854|NCT00847015|Immunologic Factors|immunologic factors|mesh-ancestor
56562855|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562856|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56562857|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56544525|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56544526|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544527|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
56544528|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544529|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56544530|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56544531|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56544532|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
56544533|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544534|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544535|NCT04340947|Nicotine|nicotine|mesh-list
56544536|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56544537|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
56544538|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544539|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544540|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56544541|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56544542|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
56544543|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562858|NCT00847015|Growth Substances|growth substances|mesh-ancestor
56562859|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
56562860|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56562861|NCT00627354|Prednisone|prednisone|mesh-list
56562862|NCT00627354|Etoposide|etoposide|mesh-list
56562863|NCT00627354|Vinorelbine|vinorelbine|mesh-list
56562864|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
56358949|NCT00274807|Analgesics|analgesics|mesh-ancestor
56562865|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56562866|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
56562867|NCT00627354|Hormones|hormones|mesh-ancestor
56562868|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562869|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562880|NCT00627354|Analgesics|analgesics|mesh-ancestor
56562881|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
56562882|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562883|NCT00704431|Darapladib|darapladib|mesh-list
56562884|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56562885|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562886|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562887|NCT02734186|Praziquantel|praziquantel|mesh-list
56562888|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
56562889|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56562890|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562891|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56562892|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
56562893|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56562894|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56562895|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56562896|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562897|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562898|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
56562899|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56562901|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562902|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
56562903|NCT02733952|Coagulants|coagulants|mesh-ancestor
56562904|NCT02733640|Pantoprazole|pantoprazole|mesh-list
56562905|NCT02733640|Ranitidine|ranitidine|mesh-list
56544544|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544545|NCT00188539|Anesthetics|anesthetics|mesh-list
56544546|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56544547|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544548|NCT02697331|Progesterone|progesterone|mesh-list
56544549|NCT02697331|Progestins|progestins|mesh-ancestor
56544550|NCT02697331|Hormones|hormones|mesh-ancestor
56544551|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544552|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544553|NCT04278625|Acetaminophen|acetaminophen|mesh-list
56544554|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56544555|NCT04278625|Analgesics|analgesics|mesh-ancestor
56544556|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
56544557|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544558|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544559|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
56544560|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56544561|NCT02689141|Ofatumumab|ofatumumab|mesh-list
56544562|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56544563|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
56544564|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544565|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544566|NCT00622687|Iloprost|iloprost|mesh-list
56544567|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56544568|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
56544569|NCT02691403|Bupivacaine|bupivacaine|mesh-list
56544570|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
56544571|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
56544572|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
56544573|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56544574|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544575|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
56544576|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544577|NCT00995007|Carboplatin|carboplatin|mesh-list
56544579|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
56544583|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
56544584|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544585|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544586|NCT00639925|Gemcitabine|gemcitabine|mesh-list
56544587|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544588|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
56544589|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544590|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544591|NCT00639925|Antiviral Agents|antiviral agents|mesh-ancestor
56544592|NCT00639925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544593|NCT00639925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544594|NCT00639925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562906|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56562907|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56562908|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56562909|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56562910|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562911|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562912|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56562913|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
56562914|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
56562915|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562916|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562917|NCT02730676|Menthol|menthol|mesh-list
56562918|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
56562919|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562920|NCT00855595|Metronidazole|metronidazole|mesh-list
56562921|NCT00855595|Doxycycline|doxycycline|mesh-list
56562922|NCT00855595|Azelaic acid|azelaic acid|mesh-list
56562923|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562924|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56562925|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56562926|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56562927|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
56562928|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562929|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562930|NCT05433532|Azacitidine|azacitidine|mesh-list
56562931|NCT05433532|Venetoclax|venetoclax|mesh-list
56562932|NCT05433532|HH-GV-678|hh-gv-678|mesh-list
56562933|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56562934|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
56562935|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562936|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562953|NCT02730442|Olorofim|olorofim|mesh-list
56562954|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562955|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56562956|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56562957|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562958|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562959|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56562960|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
56562961|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562962|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562963|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56562964|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56562965|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56562966|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56562967|NCT02733874|Betamethasone|betamethasone|mesh-list
56562968|NCT02733874|Clobetasol|clobetasol|mesh-list
56562969|NCT02733874|Calcipotriene|calcipotriene|mesh-list
56562970|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56562971|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
56562972|NCT02733874|Hormones|hormones|mesh-ancestor
56311336|NCT04827953|Paclitaxel|paclitaxel|mesh-list
56544595|NCT00639925|Immunologic Factors|immunologic factors|mesh-ancestor
56544596|NCT00639925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544597|NCT00994461|Celecoxib|celecoxib|mesh-list
56544598|NCT00994461|Loxoprofen|loxoprofen|mesh-list
56544599|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56544600|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56544601|NCT00994461|Analgesics|analgesics|mesh-ancestor
56544602|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
56544603|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544604|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544605|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544606|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544607|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56544608|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56544609|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544610|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544611|NCT00993915|Atorvastatin|atorvastatin|mesh-list
56544612|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56544613|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56544614|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
56562973|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562974|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562975|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56562976|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
56562977|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562978|NCT02730364|Acetaminophen|acetaminophen|mesh-list
56562979|NCT02730364|Pheniramine|pheniramine|mesh-list
56562980|NCT02730364|Phenylephrine|phenylephrine|mesh-list
56562981|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
56562982|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562983|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56562984|NCT02730364|Analgesics|analgesics|mesh-ancestor
56562985|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
56562986|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562987|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
56562988|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562989|NCT02730364|Protective Agents|protective agents|mesh-ancestor
56562990|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56562991|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
56562992|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
56562993|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
56562994|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56562995|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
56562996|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
56099240|NCT00539617|Antidotes|antidotes|mesh-ancestor
56563027|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563028|NCT00913315|Urological Agents|urological agents|mesh-ancestor
56563029|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56563030|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56563031|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
56563033|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563034|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563035|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563036|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56563037|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56544615|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544616|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56544617|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56544618|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544619|NCT01202591|Fulvestrant|fulvestrant|mesh-list
56544620|NCT01202591|Exemestane|exemestane|mesh-list
56544621|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56544622|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544623|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56544624|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56544625|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
56544626|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544627|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544628|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56544629|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56544630|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544631|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544632|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
56544633|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
56544634|NCT01202279|Guaifenesin|guaifenesin|mesh-list
56544635|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56544636|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56544637|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
56544638|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544639|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544640|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56544641|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
56544642|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
56544643|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56544644|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
56544645|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
56544646|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544647|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544648|NCT01202279|Expectorants|expectorants|mesh-ancestor
56544649|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56544650|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56544651|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
56544652|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56544653|NCT03877315|Cimetidine|cimetidine|mesh-list
56544654|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56544655|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56544656|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56544657|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
56544658|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
56544659|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544660|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198811|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
56563038|NCT02729662|Tolvaptan|tolvaptan|mesh-list
56099300|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
56563069|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56563070|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56563071|NCT01064310|Growth Substances|growth substances|mesh-ancestor
56563072|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563073|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
56563074|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56563075|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563076|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563077|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
56563078|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56563079|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
56563092|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56563093|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563094|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
56563095|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
56563096|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
56563097|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563098|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56563099|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
56563100|NCT02728492|Antiviral Agents|antiviral agents|mesh-ancestor
56563101|NCT02728492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563102|NCT02728492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563103|NCT02728492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563104|NCT02728492|Immunologic Factors|immunologic factors|mesh-ancestor
56563105|NCT02728492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563106|NCT02726308|Dexamethasone|dexamethasone|mesh-list
56563107|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56563108|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
56563109|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
56563110|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563111|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563112|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56563113|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
56563114|NCT02726308|Hormones|hormones|mesh-ancestor
56563115|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563116|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56563117|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563118|NCT01037244|Udenafil|udenafil|mesh-list
56563119|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56563120|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56563121|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563122|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563123|NCT03100786|Dexamethasone|dexamethasone|mesh-list
56563124|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56311489|NCT00392691|Rituximab|rituximab|mesh-list
56563126|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
56563127|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563128|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563129|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56563130|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
56544661|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544662|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56544663|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56544664|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544665|NCT02687347|Morphine|morphine|mesh-list
56544666|NCT02687347|Methadone|methadone|mesh-list
56544667|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56544668|NCT02687347|Narcotics|narcotics|mesh-ancestor
56544669|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56544670|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544671|NCT02687347|Analgesics|analgesics|mesh-ancestor
56544672|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
56544673|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544674|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
56544675|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
56544676|NCT02687425|Pioglitazone|pioglitazone|mesh-list
56544677|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
56544678|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56544679|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544680|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544681|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56544682|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544683|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544684|NCT02687269|Ranolazine|ranolazine|mesh-list
56544685|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56544686|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56544687|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544688|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
56544689|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
56544690|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
56544691|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544692|NCT01201811|Azacitidine|azacitidine|mesh-list
56544694|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
56544703|NCT05392127|Vitamin K|vitamin k|mesh-list
56544780|NCT01201265|Carboplatin|carboplatin|mesh-list
56544781|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56544782|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544783|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56544784|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56544785|NCT01201265|Growth Substances|growth substances|mesh-ancestor
56544786|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544787|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
56544788|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544789|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
56544790|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544791|NCT01201265|Antiviral Agents|antiviral agents|mesh-ancestor
56544792|NCT01201265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544793|NCT01201265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544794|NCT01201265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544795|NCT01201265|Immunologic Factors|immunologic factors|mesh-ancestor
56544796|NCT04246801|Clobetasol|clobetasol|mesh-list
56544797|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544798|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
56544799|NCT04246801|Hormones|hormones|mesh-ancestor
56544800|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544801|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544802|NCT00638677|Sorbitol|sorbitol|mesh-list
56544803|NCT00638677|Cathartics|cathartics|mesh-ancestor
56544804|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56544805|NCT01200485|Allopurinol|allopurinol|mesh-list
56544806|NCT01200485|Rasburicase|rasburicase|mesh-list
56544807|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
56544808|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544809|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544810|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
56544811|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544812|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56544813|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
56544814|NCT01200485|Protective Agents|protective agents|mesh-ancestor
56544815|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563131|NCT03100786|Hormones|hormones|mesh-ancestor
56563132|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563133|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56544816|NCT02688907|Adavosertib|adavosertib|mesh-list
56544817|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544818|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544819|NCT02686645|Metronidazole|metronidazole|mesh-list
56544820|NCT02686645|Vancomycin|vancomycin|mesh-list
56544821|NCT02686645|Loperamide|loperamide|mesh-list
56544822|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
56544823|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544825|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56544826|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56544827|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56544829|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
56544830|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544831|NCT04318067|Protective Agents|protective agents|mesh-ancestor
56544832|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544833|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56544834|NCT01200407|Amlodipine|amlodipine|mesh-list
56544835|NCT01200407|Olmesartan|olmesartan|mesh-list
56544836|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56544837|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56544838|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56544839|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56544840|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544841|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56544842|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544843|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
56544844|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56563134|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563135|NCT00627432|Gemcitabine|gemcitabine|mesh-list
56563136|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
56563137|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56563138|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
56563139|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563140|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563141|NCT00627432|Antiviral Agents|antiviral agents|mesh-ancestor
56099391|NCT00911053|Melatonin|melatonin|mesh-list
56563155|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563156|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563157|NCT01042236|Urological Agents|urological agents|mesh-ancestor
56563158|NCT02725918|Pemetrexed|pemetrexed|mesh-list
56563159|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563160|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563161|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563162|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56563163|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56563164|NCT00592501|Fluorouracil|fluorouracil|mesh-list
56563165|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544845|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56544846|NCT02685085|Misoprostol|misoprostol|mesh-list
56544847|NCT02685085|Dinoprostone|dinoprostone|mesh-list
56544848|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56544849|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
56544850|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56544851|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544852|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56544853|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56544854|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
56544855|NCT02688595|Anesthetics|anesthetics|mesh-list
56544856|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56544857|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544858|NCT01200329|Gemcitabine|gemcitabine|mesh-list
56544859|NCT01200329|Melphalan|melphalan|mesh-list
56544860|NCT01200329|Busulfan|busulfan|mesh-list
56544861|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544862|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
56544863|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544864|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915246|NCT01436305|Hormones|hormones|mesh-ancestor
56563166|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
56563167|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563168|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56563169|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563170|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
56563171|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563172|NCT01040832|Cetuximab|cetuximab|mesh-list
56563173|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56563174|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563175|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
56563176|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56563177|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56563178|NCT04304196|TEMPO|tempo|mesh-list
56563179|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
56563180|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563181|NCT04304196|Protective Agents|protective agents|mesh-ancestor
56563182|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563183|NCT02720770|Hormones|hormones|mesh-list
56563184|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563186|NCT02720926|Capecitabine|capecitabine|mesh-list
56563187|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
56563188|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56563189|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
56563190|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563191|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563192|NCT00854581|Interferons|interferons|mesh-list
56563193|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
56563194|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
56563195|NCT00854581|Zidovudine|zidovudine|mesh-list
56563196|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56563197|NCT00854581|Valproic Acid|valproic acid|mesh-list
56563198|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563199|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
56563200|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563201|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
56544865|NCT01200329|Antiviral Agents|antiviral agents|mesh-ancestor
56544866|NCT01200329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544867|NCT01200329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544868|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544869|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
56544870|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544871|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56544872|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
56544873|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56544874|NCT01199939|Ritonavir|ritonavir|mesh-list
56544875|NCT01199939|Darunavir|darunavir|mesh-list
56544876|NCT01199939|Etravirine|etravirine|mesh-list
56544877|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56544878|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56544879|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
56544880|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56544881|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544882|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56544883|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56544884|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
56544885|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544886|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56544887|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56544888|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56544889|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56544890|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
56544891|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56544892|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56544893|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
56544894|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544895|NCT02688361|Expectorants|expectorants|mesh-ancestor
56544896|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
56544897|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56544898|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
56544900|NCT02688361|Protective Agents|protective agents|mesh-ancestor
56544905|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
56544906|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544907|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56544908|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544909|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544910|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
56544911|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56544912|NCT00640081|Leucovorin|leucovorin|mesh-list
56544913|NCT00640081|Fluorouracil|fluorouracil|mesh-list
56544914|NCT00640081|Capecitabine|capecitabine|mesh-list
56544915|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
56544916|NCT00640081|Cetuximab|cetuximab|mesh-list
56544917|NCT00640081|Calcium|calcium|mesh-list
56544918|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
56544919|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56544920|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544921|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
56544922|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563202|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563203|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
56099447|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56563215|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563217|NCT02720692|Meloxicam|meloxicam|mesh-list
56563218|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56563219|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56563220|NCT02720692|Analgesics|analgesics|mesh-ancestor
56563221|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
56563222|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563223|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563224|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56563225|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56563226|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56563227|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56563228|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563229|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563230|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56563231|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563232|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563233|NCT00833911|Tramadol|tramadol|mesh-list
56563234|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56563235|NCT00833911|Narcotics|narcotics|mesh-ancestor
56563236|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563237|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563238|NCT00833911|Analgesics|analgesics|mesh-ancestor
56563239|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
56563240|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563241|NCT02719756|Metformin|metformin|mesh-list
56563242|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
56563243|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56563244|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563245|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56563246|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563247|NCT01125293|Rituximab|rituximab|mesh-list
56563248|NCT01125293|Everolimus|everolimus|mesh-list
56563249|NCT01125293|Bortezomib|bortezomib|mesh-list
56563250|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56544923|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56544924|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544925|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56544926|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
56544927|NCT00640081|Antidotes|antidotes|mesh-ancestor
56544928|NCT00640081|Protective Agents|protective agents|mesh-ancestor
56544929|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
56544930|NCT00640081|Vitamins|vitamins|mesh-ancestor
56544931|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
56544932|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56544933|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
56544934|NCT01199705|Antibodies|antibodies|mesh-list
56544935|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
56563251|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563252|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
56563253|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563254|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56563255|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563256|NCT02719834|Acetaminophen|acetaminophen|mesh-list
56563257|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56563258|NCT02719834|Analgesics|analgesics|mesh-ancestor
56563259|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
56563260|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563261|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563262|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
56563263|NCT02719210|Mannitol|mannitol|mesh-list
56563264|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56563265|NCT02719210|Diuretics|diuretics|mesh-ancestor
56563266|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
56099510|NCT05033522|Lenvatinib|lenvatinib|mesh-list
56563285|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
56563286|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
56563287|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563288|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563289|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
56563290|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563291|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56563292|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56563293|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56563294|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56563295|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563296|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56563297|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56563298|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
56563299|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563300|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56563301|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56563302|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
56563303|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56563304|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
56563305|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
56563306|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
56563307|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56563308|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
56563309|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
56563310|NCT02718742|Paclitaxel|paclitaxel|mesh-list
56563311|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56563312|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56563313|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563314|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
56563315|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
56563316|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
56563317|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563318|NCT02717884|Cytarabine|cytarabine|mesh-list
56563319|NCT02717884|Tretinoin|tretinoin|mesh-list
56563320|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
56544936|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56544937|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56544938|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
56544939|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544940|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
56544941|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56544942|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56544943|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544944|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
56544945|NCT02688127|Coagulants|coagulants|mesh-ancestor
56544946|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56544947|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544948|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56544949|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544950|NCT00638833|Memantine|memantine|mesh-list
56544951|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56544952|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56544953|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
56544954|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544955|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544956|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544957|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56544958|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56544959|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
56544960|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56544961|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56544962|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56544963|NCT01198145|Analgesics|analgesics|mesh-ancestor
56563333|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56563334|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56563335|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563336|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56563337|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56563338|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563339|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56563340|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56563341|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563342|NCT01121393|Gemcitabine|gemcitabine|mesh-list
56563343|NCT01121393|Afatinib|afatinib|mesh-list
56563344|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563345|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56563346|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
56563347|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563348|NCT01121393|Antiviral Agents|antiviral agents|mesh-ancestor
56544964|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
56544965|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544966|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544967|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56544968|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56544969|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56544970|NCT01179048|Liraglutide|liraglutide|mesh-list
56544971|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56293240|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56544972|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544973|NCT01179048|Incretins|incretins|mesh-ancestor
56544974|NCT01179048|Hormones|hormones|mesh-ancestor
56544975|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544976|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56544977|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56544978|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56544979|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56544980|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56544981|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544982|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544983|NCT00603265|Analgesics|analgesics|mesh-ancestor
56544984|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
56544985|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56544986|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
56544987|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56544988|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
56544989|NCT02686177|Metformin|metformin|mesh-list
56544990|NCT02686177|Liraglutide|liraglutide|mesh-list
56544991|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56563349|NCT01121393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563350|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563351|NCT01121393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563352|NCT01121393|Immunologic Factors|immunologic factors|mesh-ancestor
56563353|NCT01121393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563354|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56563355|NCT02882477|Metformin|metformin|mesh-list
56563356|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56563357|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
56563358|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56563359|NCT02882477|Deferiprone|deferiprone|mesh-list
56563360|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56563361|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563362|NCT02882477|Incretins|incretins|mesh-ancestor
56563363|NCT02882477|Hormones|hormones|mesh-ancestor
55887142|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56544992|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56544993|NCT02686177|Incretins|incretins|mesh-ancestor
56544994|NCT02686177|Hormones|hormones|mesh-ancestor
56544995|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56544996|NCT02686021|Dipyrone|dipyrone|mesh-list
56544997|NCT02686021|Ibuprofen|ibuprofen|mesh-list
56544998|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56544999|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56545000|NCT02686021|Analgesics|analgesics|mesh-ancestor
56545001|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
56545002|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545003|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545004|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545005|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545006|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56545007|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545008|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545009|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
56545010|NCT01158534|Interferons|interferons|mesh-list
56545011|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
56545012|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
56545013|NCT01158534|Celecoxib|celecoxib|mesh-list
56545014|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545015|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
56545016|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545017|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
56545018|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545019|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56545039|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56545040|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545041|NCT02683213|Fluoxetine|fluoxetine|mesh-list
56545042|NCT02683213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56545043|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56545044|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56545045|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545046|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545047|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
56545048|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545049|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56545050|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
56545051|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56545052|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56545053|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56545054|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545055|NCT04185103|Valsartan|valsartan|mesh-list
56545056|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56545057|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56545058|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56545059|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56545060|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545061|NCT04033939|Propofol|propofol|mesh-list
56545062|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56545063|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545064|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545065|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56545066|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
56545067|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
56545068|NCT00639691|Omalizumab|omalizumab|mesh-list
56563364|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563365|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56563366|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
56563367|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563368|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563369|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
56563370|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563371|NCT02882477|Expectorants|expectorants|mesh-ancestor
56545069|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56545070|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56545071|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
56545072|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
56545073|NCT02684071|Methotrexate|methotrexate|mesh-list
56545074|NCT02684071|Topotecan|topotecan|mesh-list
56545075|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545076|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
56545077|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545078|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545079|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56545080|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
56545081|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545082|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545083|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56545084|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56545085|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
56563372|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
56563373|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56563374|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
56563375|NCT02882477|Protective Agents|protective agents|mesh-ancestor
56359037|NCT00108537|Bupropion|bupropion|mesh-list
56563376|NCT02882477|Antidotes|antidotes|mesh-ancestor
56563377|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56563378|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
56563379|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
56563380|NCT04163224|Imidacloprid|imidacloprid|mesh-list
56563381|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
56563382|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099643|NCT00746239|Dexetimide|dexetimide|mesh-list
56563389|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563391|NCT04916002|Cemiplimab|cemiplimab|mesh-list
56563392|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56563393|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563394|NCT02716090|Adapalene|adapalene|mesh-list
56563395|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56563396|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
56563397|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56563398|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56563399|NCT02716090|Analgesics|analgesics|mesh-ancestor
56563400|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
56563401|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563402|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563403|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56563404|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56563405|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56563406|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56563407|NCT01227616|Hematinics|hematinics|mesh-ancestor
56563408|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56563409|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56563410|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56563411|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
56563412|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563413|NCT02714998|Methotrexate|methotrexate|mesh-list
56563414|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56563415|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
56563416|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56563417|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563418|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545086|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56545087|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545088|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
56545089|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
56545090|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545091|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56545092|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56545093|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56545094|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56545095|NCT00640159|Selegiline|selegiline|mesh-list
56545096|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
56545097|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56545098|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56545099|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56545100|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56545101|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545102|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545103|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56545104|NCT00640159|Protective Agents|protective agents|mesh-ancestor
56545105|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545106|NCT00640861|Vaccines|vaccines|mesh-list
56545107|NCT00640861|Sargramostim|sargramostim|mesh-list
56545108|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
56545109|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
56545110|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545111|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56545112|NCT00602797|Paclitaxel|paclitaxel|mesh-list
56545113|NCT00602797|Vinorelbine|vinorelbine|mesh-list
56545114|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56545115|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56545116|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545117|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
56545118|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
56545119|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
56545120|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563419|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
56563420|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563421|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563422|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
56293389|NCT00400114|Irinotecan|irinotecan|mesh-list
56545121|NCT01158222|Sunitinib|sunitinib|mesh-list
56545122|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545123|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56545124|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56545125|NCT01158222|Growth Substances|growth substances|mesh-ancestor
56545126|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563423|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311792|NCT00076609|Capecitabine|capecitabine|mesh-list
56563424|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56563425|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563427|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56563428|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56563429|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
56563430|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
56563431|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563432|NCT00765310|Protective Agents|protective agents|mesh-ancestor
56563433|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563434|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
56563435|NCT00765310|Vitamins|vitamins|mesh-ancestor
56563436|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
56563437|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
56563438|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56563439|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563440|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563441|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56563442|NCT02715154|Analgesics|analgesics|mesh-ancestor
56563443|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
56563444|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563445|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56563446|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56563447|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56563448|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
56563449|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563464|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56563465|NCT02715232|Androgens|androgens|mesh-ancestor
56563466|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56563467|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563468|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
56563469|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
56563470|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
56563471|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56563472|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56563473|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56563474|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56563475|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56563476|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
56563477|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563478|NCT02714842|Diclofenac|diclofenac|mesh-list
56563479|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56563480|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56563481|NCT02714842|Analgesics|analgesics|mesh-ancestor
56563482|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
56563483|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563484|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563485|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56563486|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56563487|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56563488|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563489|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563490|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56563491|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563492|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56563493|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563494|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563495|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
56563496|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56563497|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545127|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56545128|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56545129|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545130|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545131|NCT02684305|Oxytocin|oxytocin|mesh-list
56545132|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
56545133|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56545134|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545135|NCT02940769|Methamphetamine|methamphetamine|mesh-list
56545136|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56545137|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545138|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
56545139|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
56545140|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545141|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
56563498|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56563500|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
56563501|NCT04000906|Paclitaxel|paclitaxel|mesh-list
56563502|NCT04000906|Cisplatin|cisplatin|mesh-list
56563503|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56563504|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563505|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
56563506|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
56563507|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
56563508|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563509|NCT00636766|Metformin|metformin|mesh-list
56563510|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
56563511|NCT00636766|Rimonabant|rimonabant|mesh-list
56563512|NCT00636766|Atorvastatin|atorvastatin|mesh-list
56563537|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56563538|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56563539|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56563540|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56563541|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56563542|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563543|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563544|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56563545|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56563546|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56563547|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
56563548|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563549|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563550|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56563551|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56563552|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
56563553|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56563554|NCT00611416|Caffeine|caffeine|mesh-list
56563555|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56563556|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563557|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56563558|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099825|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56563582|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56563583|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
56563584|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563585|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563586|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
56563587|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56563588|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563589|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56545142|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545143|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545144|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
56545145|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56545146|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56545147|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56545148|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56545149|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
56545150|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56545151|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56545152|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56545153|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545154|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545155|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
56545156|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
56199317|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
56563590|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
56563591|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56563592|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563593|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563594|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563595|NCT02712502|Amoxicillin|amoxicillin|mesh-list
56563596|NCT02712502|Levofloxacin|levofloxacin|mesh-list
56563597|NCT02712502|Ofloxacin|ofloxacin|mesh-list
56563598|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
56563599|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
56563600|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56563601|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56563602|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563603|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56563604|NCT02712502|Renal Agents|renal agents|mesh-ancestor
56563605|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56563606|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56563607|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563608|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563609|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563610|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56563620|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56563621|NCT02711410|Clopidogrel|clopidogrel|mesh-list
56563622|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56563623|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56563624|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56563625|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56563626|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
56563627|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563628|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563629|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563630|NCT02711176|Amoxicillin|amoxicillin|mesh-list
56563631|NCT02711176|Clarithromycin|clarithromycin|mesh-list
56563632|NCT02711176|Tinidazole|tinidazole|mesh-list
56563633|NCT02711176|Esomeprazole|esomeprazole|mesh-list
56563634|NCT02711176|Lansoprazole|lansoprazole|mesh-list
56563635|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56563636|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563637|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56563638|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56563639|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56545157|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545158|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
56545159|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545160|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
56545161|NCT02683291|Sirolimus|sirolimus|mesh-list
56545162|NCT02683291|Prednisone|prednisone|mesh-list
56545163|NCT02683291|Tacrolimus|tacrolimus|mesh-list
56545164|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
56545165|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56545166|NCT02683291|Basiliximab|basiliximab|mesh-list
56545167|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545168|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
56545169|NCT02683291|Hormones|hormones|mesh-ancestor
56545170|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56545171|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545172|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56545173|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545174|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545175|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
56545176|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56545177|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545178|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545179|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56545180|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56545181|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
56545182|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56545183|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545184|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
56545185|NCT02685397|Leuprolide|leuprolide|mesh-list
56545186|NCT02685397|Goserelin|goserelin|mesh-list
56545187|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56545188|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56545189|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
56545190|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56545191|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545192|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56545193|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545194|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
56293465|NCT00006080|Fenretinide|fenretinide|mesh-list
56545196|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
56545197|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56545199|NCT02683837|Sevoflurane|sevoflurane|mesh-list
56545200|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56545201|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56545202|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
56545203|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
56545204|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545205|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545206|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56545207|NCT02683837|Narcotics|narcotics|mesh-ancestor
56545208|NCT02683837|Analgesics|analgesics|mesh-ancestor
56545209|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
56545210|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545211|NCT02680951|Cytarabine|cytarabine|mesh-list
56545212|NCT02680951|Fludarabine|fludarabine|mesh-list
56545213|NCT02680951|Dasatinib|dasatinib|mesh-list
56563640|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563641|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563642|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56563643|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56563644|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56563645|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
56563646|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56563647|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56563648|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56563649|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56563650|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
56563651|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563652|NCT00611650|Protective Agents|protective agents|mesh-ancestor
56563653|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563654|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56563655|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56563656|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563657|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56563658|NCT02710552|Amlodipine|amlodipine|mesh-list
56563659|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
56563660|NCT02710552|Perindopril|perindopril|mesh-list
56563661|NCT02710552|Indapamide|indapamide|mesh-list
56563662|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56563663|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56563664|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563665|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56563666|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563667|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
56563668|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56563669|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
56563670|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563671|NCT02710552|Diuretics|diuretics|mesh-ancestor
56563672|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
56563673|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56563674|NCT02710396|Paclitaxel|paclitaxel|mesh-list
56563675|NCT02710396|Carboplatin|carboplatin|mesh-list
56563702|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56563704|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563705|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
56563706|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56563707|NCT02709304|Lidocaine|lidocaine|mesh-list
56545214|NCT02680951|Idarubicin|idarubicin|mesh-list
56545215|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545216|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545217|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
56545218|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545219|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545220|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
56545221|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545222|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
56545223|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545224|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56545225|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545226|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56545227|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56545228|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56545229|NCT02680717|Clobetasol|clobetasol|mesh-list
56545230|NCT02680717|Calcipotriene|calcipotriene|mesh-list
56563708|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
56563709|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
56563710|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563711|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563712|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
56563713|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563714|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56563715|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56563716|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56563717|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56563718|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563719|NCT04189666|Melatonin|melatonin|mesh-list
56563720|NCT04189666|Rivastigmine|rivastigmine|mesh-list
56563721|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
56563722|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563750|NCT02708992|Azithromycin|azithromycin|mesh-list
56563751|NCT02708992|Cefixime|cefixime|mesh-list
56563752|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56563753|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563754|NCT00611962|Paclitaxel|paclitaxel|mesh-list
56563755|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
56563756|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56563757|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563758|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
56563759|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
56563760|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
56359085|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
56563761|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563762|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
56563764|NCT05380713|Tremelimumab|tremelimumab|mesh-list
56563765|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563766|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
56563767|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563768|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56563769|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56563770|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
56563817|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56563818|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563819|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563820|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
56563821|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545231|NCT02680717|Tacrolimus|tacrolimus|mesh-list
56545232|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545233|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
56545234|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545235|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56545236|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545237|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545238|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545239|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
56563822|NCT05378919|Hematinics|hematinics|mesh-ancestor
56563823|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
56563824|NCT05378919|Vitamins|vitamins|mesh-ancestor
56563825|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
56563826|NCT05378919|Antidotes|antidotes|mesh-ancestor
56563827|NCT05378919|Protective Agents|protective agents|mesh-ancestor
56563828|NCT00607581|Dexamethasone|dexamethasone|mesh-list
56563830|NCT00607581|Lenalidomide|lenalidomide|mesh-list
56563831|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563832|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
56563833|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563834|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56563835|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56563836|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
56563837|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563838|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563839|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56563840|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56563841|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
56563842|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
56563843|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563844|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56563845|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
56563846|NCT00607581|Hormones|hormones|mesh-ancestor
56563847|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563848|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56563849|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56563850|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56563851|NCT00607581|Growth Substances|growth substances|mesh-ancestor
56563852|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
56563853|NCT02707900|Vorinostat|vorinostat|mesh-list
56563854|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563855|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56563856|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563857|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563858|NCT05380479|Megestrol|megestrol|mesh-list
56563859|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
56563860|NCT05380479|Mirtazapine|mirtazapine|mesh-list
56563861|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
56563862|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56563863|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56563864|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
56563865|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
56563866|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563867|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563868|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563869|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56563870|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56312252|NCT00079261|Hormones|hormones|mesh-ancestor
56100125|NCT04246723|Ritonavir|ritonavir|mesh-list
56563879|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56563880|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56563882|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56563883|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
56563884|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56563885|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56563886|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56069446|NCT05455073|Hematinics|hematinics|mesh-ancestor
56545240|NCT02680717|Hormones|hormones|mesh-ancestor
56545241|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56545242|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
56545243|NCT02680795|Belinostat|belinostat|mesh-list
56545244|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545245|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56545246|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545247|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563887|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56563888|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563889|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
56563890|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56563891|NCT00936975|Listerine|listerine|mesh-list
56563892|NCT00936975|Fluorides|fluorides|mesh-list
56563893|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
56563894|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
56563895|NCT00936975|Protective Agents|protective agents|mesh-ancestor
56563896|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563897|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56563898|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563899|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
56563900|NCT02707666|Pemetrexed|pemetrexed|mesh-list
56563901|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563902|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56563903|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563904|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563905|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56563906|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56563907|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56563908|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
56563909|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56563910|NCT02693470|Ustekinumab|ustekinumab|mesh-list
56563911|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
56563912|NCT00936897|Denosumab|denosumab|mesh-list
56563913|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
56563914|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56563915|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563916|NCT05265676|Enoxaparin|enoxaparin|mesh-list
56563917|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
56563918|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
56563919|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56563920|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56563921|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563922|NCT00606333|Sirolimus|sirolimus|mesh-list
56563923|NCT00606333|Paclitaxel|paclitaxel|mesh-list
56563924|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56563925|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56563926|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563927|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
56563928|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
56563929|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
56563930|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563931|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56563932|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563933|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56563934|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
56563935|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563936|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
56563937|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563954|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563955|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
56563956|NCT01120691|Albuterol|albuterol|mesh-list
56563957|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
56563958|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56563959|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
56563960|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563961|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545248|NCT00640237|Calcifediol|calcifediol|mesh-list
56545249|NCT00640237|Vitamins|vitamins|mesh-ancestor
56545250|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
56545251|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545252|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56545253|NCT02683759|Curcumin|curcumin|mesh-list
56545254|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56545255|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56545256|NCT02683759|Analgesics|analgesics|mesh-ancestor
56545257|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
56545258|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545259|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545260|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56563962|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56563963|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
56563964|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
56563965|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56563966|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
56563967|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480204|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563968|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563969|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
56563970|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56563971|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56563972|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56563973|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56563974|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
56563975|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56563976|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56563977|NCT04231318|Triamcinolone|triamcinolone|mesh-list
56563978|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56563979|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56563980|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56563981|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56563982|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
56563983|NCT04231318|Hormones|hormones|mesh-ancestor
56563984|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563985|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563986|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563987|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
56563988|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563989|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563990|NCT00612274|Sirolimus|sirolimus|mesh-list
56563991|NCT00612274|Methotrexate|methotrexate|mesh-list
56563992|NCT00612274|Tacrolimus|tacrolimus|mesh-list
56563993|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56563994|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
56563995|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56563996|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564016|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564017|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564018|NCT05263882|Antiviral Agents|antiviral agents|mesh-ancestor
56564019|NCT05263882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564020|NCT05263882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564021|NCT05263882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564022|NCT05263882|Immunologic Factors|immunologic factors|mesh-ancestor
56564023|NCT05263882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564024|NCT02724904|Methotrexate|methotrexate|mesh-list
56564025|NCT02724904|Fludarabine|fludarabine|mesh-list
56564026|NCT02724904|Thiotepa|thiotepa|mesh-list
56564027|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56564028|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
56545261|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545262|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545263|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545264|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545265|NCT04292691|Ropivacaine|ropivacaine|mesh-list
56545266|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
56545267|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
56545268|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545269|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545270|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
56293540|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545271|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545272|NCT00990249|Busulfan|busulfan|mesh-list
56545273|NCT00990249|Clofarabine|clofarabine|mesh-list
56545274|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
56545275|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56545276|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
56545277|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545278|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545279|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
56545280|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545281|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56545282|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545283|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56545284|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545285|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
56545286|NCT02846545|Golimumab|golimumab|mesh-list
56545287|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56545288|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545289|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545290|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
56545291|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564029|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56564030|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564031|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56564032|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
56564033|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564034|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564035|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
56564036|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564037|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56545292|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
56545293|NCT04291755|Nivolumab|nivolumab|mesh-list
56545294|NCT04291755|Ipilimumab|ipilimumab|mesh-list
56545295|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56545296|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545297|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56545298|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545299|NCT04292769|Decitabine|decitabine|mesh-list
56545300|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545301|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
56545302|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545303|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545304|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545305|NCT00640939|Diclofenac|diclofenac|mesh-list
56545306|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56545307|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56545308|NCT00640939|Analgesics|analgesics|mesh-ancestor
56545309|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
56545310|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545311|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545312|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545313|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545314|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56545315|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545316|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545317|NCT05663749|Metformin|metformin|mesh-list
56545318|NCT05663749|Topiramate|topiramate|mesh-list
56545319|NCT05663749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56545320|NCT05663749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545321|NCT05663749|Anticonvulsants|anticonvulsants|mesh-ancestor
56545322|NCT02867553|Rituximab|rituximab|mesh-list
56545323|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56545324|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545325|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
56545326|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545331|NCT00642577|Leucovorin|leucovorin|mesh-list
56545332|NCT00642577|Bevacizumab|bevacizumab|mesh-list
56545333|NCT00642577|Fluorouracil|fluorouracil|mesh-list
56545334|NCT00642577|Irinotecan|irinotecan|mesh-list
56545335|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56545336|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545337|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56545338|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56545339|NCT00642577|Growth Substances|growth substances|mesh-ancestor
56545340|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545341|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
56545342|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
56545343|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545344|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545345|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293619|NCT00006098|Bortezomib|bortezomib|mesh-list
56545347|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56545348|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56545349|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545350|NCT00642577|Antidotes|antidotes|mesh-ancestor
56545351|NCT00642577|Protective Agents|protective agents|mesh-ancestor
56545352|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
56545354|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
56545355|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56545356|NCT02682121|Metformin|metformin|mesh-list
56545357|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56545358|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545359|NCT02683603|Imipenem|imipenem|mesh-list
56545360|NCT02683603|Colistin|colistin|mesh-list
56545361|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56545362|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545363|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
56545364|NCT00641095|Rituximab|rituximab|mesh-list
56545365|NCT00641095|Fludarabine|fludarabine|mesh-list
56545376|NCT01196975|Vaccines|vaccines|mesh-list
56545377|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
56545378|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545379|NCT00992589|Rabeprazole|rabeprazole|mesh-list
56545380|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56545381|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56545382|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56545383|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545384|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545385|NCT01196741|Paclitaxel|paclitaxel|mesh-list
56545386|NCT01196741|Saracatinib|saracatinib|mesh-list
56545387|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56545388|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545389|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
56545390|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
56545391|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
56545392|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545393|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545394|NCT00629187|Temozolomide|temozolomide|mesh-list
56545395|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56545396|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
56564038|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564039|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
56564040|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564041|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564042|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56564043|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
56564044|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56564045|NCT00935493|Guanfacine|guanfacine|mesh-list
56564046|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56564047|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56564048|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56564049|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56564050|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
56564051|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564061|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56564062|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56564063|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
56564064|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56564065|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56564066|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
56564067|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564068|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564069|NCT04267497|Amphotericin B|amphotericin b|mesh-list
56564070|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56564071|NCT04267497|Amebicides|amebicides|mesh-ancestor
56564072|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56564073|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56564074|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564075|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564076|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
56564077|NCT00935259|Simvastatin|simvastatin|mesh-list
56564078|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56564079|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56545397|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545398|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545399|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56545400|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56545401|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545402|NCT00983385|Tapentadol|tapentadol|mesh-list
56545403|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56545404|NCT00983385|Narcotics|narcotics|mesh-ancestor
56545405|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545406|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545407|NCT00983385|Analgesics|analgesics|mesh-ancestor
56545408|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
56545409|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545410|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56545411|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56545412|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56545413|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545414|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
56545415|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545416|NCT00992511|Vaccines|vaccines|mesh-list
56545417|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
56545418|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545419|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56545420|NCT02869035|Citalopram|citalopram|mesh-list
56293709|NCT00087217|Paclitaxel|paclitaxel|mesh-list
56564080|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
56564081|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564082|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56564083|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56564084|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564085|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56564086|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56564087|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56564088|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
56564089|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564090|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564091|NCT02937766|Progestins|progestins|mesh-ancestor
56564092|NCT02937766|Hormones|hormones|mesh-ancestor
56564093|NCT00607971|Renzapride|renzapride|mesh-list
56564094|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56564095|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
56564096|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564097|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564098|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564099|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
56564100|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56564101|NCT02724358|Estrogens|estrogens|mesh-ancestor
56564102|NCT02724358|Hormones|hormones|mesh-ancestor
56545421|NCT02869035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56564103|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564104|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564105|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56564106|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564107|NCT02724202|Curcumin|curcumin|mesh-list
56564108|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56564109|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56564110|NCT02724202|Analgesics|analgesics|mesh-ancestor
56564111|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
56564112|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564113|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564114|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56564128|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564129|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564130|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
56564131|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56564132|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564133|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564134|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
56564135|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564136|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564137|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56564138|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56564139|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997721|NCT02979548|Aprepitant|aprepitant|mesh-list
56564140|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564141|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564142|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56564143|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56564144|NCT01124045|Prednisolone|prednisolone|mesh-list
56564145|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56564146|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
56564147|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56564148|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
56564149|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56564150|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
56564151|NCT01124045|Difluprednate|difluprednate|mesh-list
56564152|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56564153|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
56564154|NCT01124045|Hormones|hormones|mesh-ancestor
56564155|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564156|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564157|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56564158|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564159|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
56564160|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
56564161|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564162|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56564163|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56564164|NCT01124045|Protective Agents|protective agents|mesh-ancestor
56564165|NCT05295784|Caffeine|caffeine|mesh-list
56564166|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
56564167|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564168|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56564169|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564170|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56564171|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564172|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56564173|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56564205|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56564206|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
56564207|NCT02723578|Pemetrexed|pemetrexed|mesh-list
56564208|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56564209|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564210|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564211|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564212|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56100500|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56564226|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564227|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545422|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56545423|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56545424|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545425|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545426|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
56545427|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545428|NCT02869035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56545429|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
56545430|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56545431|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545432|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56545434|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
56545435|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
56545436|NCT04290819|Caffeine|caffeine|mesh-list
56545437|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56545438|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545439|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56564228|NCT02723500|Xenon|xenon|mesh-list
56564229|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56564230|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
56564231|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
56564232|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564233|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564234|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
56564235|NCT00934791|Sirolimus|sirolimus|mesh-list
56564236|NCT00934791|Prednisone|prednisone|mesh-list
56564237|NCT00934791|Tacrolimus|tacrolimus|mesh-list
56564238|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56564239|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
56564240|NCT00934791|Hormones|hormones|mesh-ancestor
56564241|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56359208|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56564242|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564243|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56564245|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564246|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
56564247|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56564248|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564249|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564250|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56564251|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56564252|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
56564253|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564254|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564255|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
56564256|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56564257|NCT00607035|Olmesartan|olmesartan|mesh-list
56564258|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56564259|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56564260|NCT00607035|Diuretics|diuretics|mesh-ancestor
56564261|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
56564262|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564263|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56564264|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56564265|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545440|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545441|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545442|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56545443|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56545444|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
56545445|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545446|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
56545447|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56545448|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545449|NCT01196429|Sirolimus|sirolimus|mesh-list
56545450|NCT01196429|Paclitaxel|paclitaxel|mesh-list
56545451|NCT01196429|Docetaxel|docetaxel|mesh-list
56545452|NCT01196429|Carboplatin|carboplatin|mesh-list
56545453|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56545454|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56545455|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545456|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
56545457|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
56545458|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
56545459|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545460|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56545461|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545462|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56545463|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
56545464|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545465|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
56545466|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545467|NCT01157364|Bimatoprost|bimatoprost|mesh-list
56564266|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56564267|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56564268|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
56564269|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
56564270|NCT02723266|Protective Agents|protective agents|mesh-ancestor
56564271|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564272|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
56564273|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56100542|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
56564295|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564296|NCT03808090|Calcium|calcium|mesh-list
56564297|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56359225|NCT00108849|Estradiol|estradiol|mesh-list
56564298|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564299|NCT01111019|Hormones|hormones|mesh-list
56564300|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564301|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564302|NCT02883400|Spironolactone|spironolactone|mesh-list
56545468|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56545469|NCT01195415|Gemcitabine|gemcitabine|mesh-list
56545470|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545471|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
56545472|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545473|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545474|NCT01195415|Antiviral Agents|antiviral agents|mesh-ancestor
56545475|NCT01195415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545476|NCT01195415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545477|NCT01195415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545478|NCT01195415|Immunologic Factors|immunologic factors|mesh-ancestor
56564303|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56564304|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
56564305|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564306|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564307|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56564308|NCT02883400|Diuretics|diuretics|mesh-ancestor
56564309|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
56564310|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56564311|NCT01119287|Dexamethasone|dexamethasone|mesh-list
56564312|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56564313|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56564314|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
56564315|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
56564316|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564317|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564318|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56564319|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
56564320|NCT01119287|Hormones|hormones|mesh-ancestor
56564321|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564322|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56100622|NCT00000901|Lamivudine|lamivudine|mesh-list
56564334|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
56564335|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564336|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564338|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56564339|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564340|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564341|NCT04931368|Rituximab|rituximab|mesh-list
56564342|NCT04931368|Methotrexate|methotrexate|mesh-list
56564343|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56564344|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564345|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
56564346|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564347|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564348|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56564349|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
56564350|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56564351|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56564352|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
56564353|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564354|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56564355|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564356|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56564357|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564358|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564359|NCT01119131|Vitamin D|vitamin d|mesh-list
56564360|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
56564361|NCT01119131|Calcium|calcium|mesh-list
56564362|NCT01119131|Vitamins|vitamins|mesh-ancestor
56564363|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
56564364|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564365|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56545479|NCT01195415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545480|NCT01195103|Fentanyl|fentanyl|mesh-list
56545481|NCT01195103|Midazolam|midazolam|mesh-list
56545482|NCT01195103|Propofol|propofol|mesh-list
56545483|NCT01195103|Fospropofol|fospropofol|mesh-list
56545484|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56545485|NCT01195103|Narcotics|narcotics|mesh-ancestor
56545486|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545487|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545488|NCT01195103|Analgesics|analgesics|mesh-ancestor
56545489|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
56545490|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545491|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56545492|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56545493|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
56545494|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
56545495|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56545496|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56545497|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56545498|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56545499|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
56545500|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
56545501|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396394|NCT05111262|Budesonide|budesonide|mesh-list
56634306|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564366|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56564367|NCT00636922|Everolimus|everolimus|mesh-list
56564368|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564369|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564370|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
56564371|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564372|NCT02722096|Lidocaine|lidocaine|mesh-list
56564373|NCT02722096|Ropivacaine|ropivacaine|mesh-list
56564374|NCT02722096|Anesthetics|anesthetics|mesh-list
56564375|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
56564376|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564377|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564378|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
56564379|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564380|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56564381|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56564382|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56564383|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56564384|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564395|NCT01118975|Vorinostat|vorinostat|mesh-list
56564396|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564397|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564398|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564399|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564400|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56564401|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
56564402|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56564403|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545502|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545504|NCT01194869|Cisplatin|cisplatin|mesh-list
56545505|NCT01194869|Sorafenib|sorafenib|mesh-list
56545506|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56545507|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545508|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
56545509|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
56545510|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
56545511|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545512|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56545513|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545514|NCT01177800|Infliximab|infliximab|mesh-list
56545515|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
56545516|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56545517|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545518|NCT01177722|Vaccines|vaccines|mesh-list
56545519|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
56545520|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545521|NCT02884986|Etoricoxib|etoricoxib|mesh-list
56545522|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56545523|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56545524|NCT02884986|Analgesics|analgesics|mesh-ancestor
56564404|NCT04829422|Lazertinib|lazertinib|mesh-list
56564405|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564406|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564407|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564408|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56564409|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56564410|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56564411|NCT00612898|Lamivudine|lamivudine|mesh-list
56564412|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56564413|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564414|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564415|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564416|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
56564417|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564418|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56564419|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56564420|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
56564421|NCT01118663|Edetic Acid|edetic acid|mesh-list
56564422|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56564423|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
56564424|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
56564425|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564426|NCT01118663|Expectorants|expectorants|mesh-ancestor
56564427|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
56564428|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56564429|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
56564430|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564431|NCT01118663|Protective Agents|protective agents|mesh-ancestor
56564432|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564433|NCT01118663|Antidotes|antidotes|mesh-ancestor
56564434|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
56564435|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56564436|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
56545525|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
56545526|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545527|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545528|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545529|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545530|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56545531|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56545532|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545533|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545534|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
56545535|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56545536|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
56545537|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
56545538|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545539|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545540|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56545541|NCT04124562|Analgesics|analgesics|mesh-ancestor
56564437|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
56564438|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56564440|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564441|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56564442|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56564443|NCT01118351|Growth Substances|growth substances|mesh-ancestor
56564444|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564445|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
56564446|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564447|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564448|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564464|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
56564465|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564466|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
56564467|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564469|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
56564470|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564471|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564472|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564473|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564474|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
56564475|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564476|NCT00613132|Everolimus|everolimus|mesh-list
56564477|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
56564478|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
56564479|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564480|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564481|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
56564482|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564483|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564484|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564485|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564486|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
56564487|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564488|NCT03917914|Bisoprolol|bisoprolol|mesh-list
56564489|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56564490|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
56564491|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
56564492|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545542|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
56545543|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545544|NCT01177410|Mesalamine|mesalamine|mesh-list
56545545|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56545546|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56545547|NCT01177410|Analgesics|analgesics|mesh-ancestor
56545548|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
56199717|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
56564493|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564494|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56564495|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56564496|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56564497|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
56564498|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564499|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564500|NCT04558216|Rifampin|rifampin|mesh-list
56564501|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56564502|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
56564503|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564504|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564505|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
56564506|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564507|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564508|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564509|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56564510|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56564511|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56564512|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56100787|NCT00000655|Atovaquone|atovaquone|mesh-list
56564546|NCT03747484|Interferons|interferons|mesh-list
56564547|NCT03747484|Interferon-gamma|interferon-gamma|mesh-list
56564548|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
56564549|NCT03747484|Avelumab|avelumab|mesh-list
56564550|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
56564551|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
56564568|NCT01061736|Folic Acid|folic acid|mesh-list
56564569|NCT01061736|Methotrexate|methotrexate|mesh-list
56564570|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56564571|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
56564572|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56564573|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564574|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56564575|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
56564576|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564577|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564578|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
56564579|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564580|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56564581|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564582|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
56564583|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564584|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564585|NCT01061736|Hematinics|hematinics|mesh-ancestor
56564586|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
56564587|NCT01061736|Vitamins|vitamins|mesh-ancestor
56564588|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
56564589|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
56564590|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56564591|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564592|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564593|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56564594|NCT02874378|Analgesics|analgesics|mesh-ancestor
56564595|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
56564596|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564597|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56564598|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56564599|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56545549|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545550|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545551|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545552|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545553|NCT02884596|Serotonin|serotonin|mesh-list
56545554|NCT02884596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56545555|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56545556|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
56545557|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545558|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545559|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545560|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56545561|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56545562|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
56545563|NCT04205916|Dexamethasone|dexamethasone|mesh-list
56545564|NCT04205916|Ketorolac|ketorolac|mesh-list
56545565|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545566|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
56545567|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
56545568|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545569|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545570|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56545571|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
56545572|NCT04205916|Hormones|hormones|mesh-ancestor
56545573|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56545574|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56545575|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545576|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56634307|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56545577|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545578|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56545579|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56545580|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545581|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564600|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
56564601|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564602|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564603|NCT01117181|Methylphenidate|methylphenidate|mesh-list
56545582|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56545583|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56545584|NCT04205916|Analgesics|analgesics|mesh-ancestor
56545585|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
56545586|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545587|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56545588|NCT01176240|Mannitol|mannitol|mesh-list
56545589|NCT01176240|Droxidopa|droxidopa|mesh-list
56545590|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56545591|NCT01176240|Diuretics|diuretics|mesh-ancestor
56545592|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
56545593|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545594|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56545595|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56545596|NCT01149096|Lenograstim|lenograstim|mesh-list
56545597|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56545598|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
56545599|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545600|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
56545601|NCT02867397|Epirubicin|epirubicin|mesh-list
56545602|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564604|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56564605|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564606|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56100893|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
56564621|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56564622|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56564623|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564624|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564625|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56564626|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56564627|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56564628|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
56564629|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564630|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56564631|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56564632|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564634|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56564635|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
56564636|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56564637|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564638|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56564639|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
56564640|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564641|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564642|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
56564643|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564644|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56564645|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564646|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
56564647|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564648|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564649|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
56564650|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56545603|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56545604|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56545605|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56545606|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545607|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545608|NCT01175382|Tamsulosin|tamsulosin|mesh-list
56545609|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56199779|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564651|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564652|NCT01040130|Olodaterol|olodaterol|mesh-list
56564653|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56564654|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
56564655|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564656|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564657|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56359310|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56564658|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
56564659|NCT00932451|Crizotinib|crizotinib|mesh-list
56564660|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564661|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564662|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564663|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564664|NCT01039584|Butoconazole|butoconazole|mesh-list
56564690|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
56564691|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564692|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564693|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564694|NCT01107743|Amlodipine|amlodipine|mesh-list
56564695|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56564696|NCT01107743|Atorvastatin|atorvastatin|mesh-list
56564697|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56564698|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56564699|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
56564700|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564701|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56564702|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56564703|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564704|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56564705|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56564706|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56564707|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56564708|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564709|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
56564710|NCT01059864|Atorvastatin|atorvastatin|mesh-list
56564711|NCT01059864|Tofacitinib|tofacitinib|mesh-list
56564719|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564720|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56564722|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56564723|NCT04302402|Rifaximin|rifaximin|mesh-list
56564724|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564725|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564726|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56564727|NCT03931408|Gentamicins|gentamicins|mesh-list
56564728|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564729|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564730|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56564731|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564732|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564733|NCT03398824|Metformin|metformin|mesh-list
56564734|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56564735|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564736|NCT01033734|Oseltamivir|oseltamivir|mesh-list
56564737|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
56564738|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564739|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564740|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545610|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56545611|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56545612|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56545613|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
56564741|NCT03792256|Cytarabine|cytarabine|mesh-list
56564742|NCT03792256|Prednisone|prednisone|mesh-list
56564743|NCT03792256|Prednisolone|prednisolone|mesh-list
56564744|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
56564745|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56564746|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56564747|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56564748|NCT03792256|Doxorubicin|doxorubicin|mesh-list
56564749|NCT03792256|Methotrexate|methotrexate|mesh-list
56564750|NCT03792256|Vincristine|vincristine|mesh-list
56564751|NCT03792256|Palbociclib|palbociclib|mesh-list
56564752|NCT03792256|Pegaspargase|pegaspargase|mesh-list
56564753|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56564754|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564755|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56564756|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56564757|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564758|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564759|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56564760|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
56564761|NCT03792256|Hormones|hormones|mesh-ancestor
56564762|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564763|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564764|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56564765|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56564766|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
56564767|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56564768|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56564769|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
56564770|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
56564771|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56564772|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564773|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
56564774|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564775|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564776|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
56564777|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564778|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56564808|NCT01115855|Eplerenone|eplerenone|mesh-list
56564809|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56564810|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
56564811|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564812|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564813|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56564814|NCT01115855|Diuretics|diuretics|mesh-ancestor
56564815|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
56564816|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56564817|NCT03615508|Phenylephrine|phenylephrine|mesh-list
56564818|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
56564819|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56564820|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
56564821|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
56564822|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564823|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564824|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
56564825|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56564826|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
56101135|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
56564838|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564839|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564840|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56564841|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56564842|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
56564843|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564844|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564845|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56564846|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
56545614|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545615|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545616|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545617|NCT01175382|Urological Agents|urological agents|mesh-ancestor
56545618|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56545619|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56545620|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
56545621|NCT01194245|Insulin|insulin|mesh-list
56545622|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56545623|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
56545624|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
56545625|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
56545626|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
56545627|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56545628|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545629|NCT00979407|Vaccines|vaccines|mesh-list
56545630|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
56545631|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545632|NCT04290429|Teduglutide|teduglutide|mesh-list
56545633|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56545634|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56545635|NCT04290429|Protective Agents|protective agents|mesh-ancestor
56545636|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545637|NCT00975975|Basiliximab|basiliximab|mesh-list
56545638|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545639|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
56545640|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545641|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56545642|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56545643|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56199791|NCT01520298|Analgesics|analgesics|mesh-ancestor
56564847|NCT03522064|Carboplatin|carboplatin|mesh-list
56564848|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
56564849|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56564850|NCT03522064|Testosterone|testosterone|mesh-list
56564851|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
56564852|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
56564853|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56564854|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564855|NCT03522064|Androgens|androgens|mesh-ancestor
56564856|NCT03522064|Hormones|hormones|mesh-ancestor
56564857|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564858|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564859|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56564860|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
56564861|NCT04310579|Midazolam|midazolam|mesh-list
56564862|NCT04310579|Oxycodone|oxycodone|mesh-list
56545644|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545645|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545646|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56545647|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56545648|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56545650|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545651|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545652|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56545653|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56545654|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
56545655|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
56545656|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545657|NCT04289883|Calcium|calcium|mesh-list
56545658|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56545659|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545660|NCT02865369|Asunaprevir|asunaprevir|mesh-list
56545661|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
56545662|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545663|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545664|NCT01192295|Oxycodone|oxycodone|mesh-list
56545665|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56545666|NCT01192295|Narcotics|narcotics|mesh-ancestor
56564863|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56564864|NCT04310579|Paroxetine|paroxetine|mesh-list
56564865|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56564866|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56564867|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564868|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564869|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56564870|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56564871|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56564872|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56564873|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
56564874|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
56564875|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
56564876|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
56564877|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564878|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564879|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56564880|NCT04310579|Narcotics|narcotics|mesh-ancestor
56564881|NCT04310579|Analgesics|analgesics|mesh-ancestor
56564882|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
56564883|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564884|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
56564885|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56564886|NCT04310579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56564887|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56564888|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56564889|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
56564890|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56564945|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
56564946|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545667|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545668|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545669|NCT01192295|Analgesics|analgesics|mesh-ancestor
56564947|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564948|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
56564949|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564950|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56564951|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56564952|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56564953|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56564954|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564955|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
56564956|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564958|NCT04409860|Cisplatin|cisplatin|mesh-list
56564959|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56564960|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564961|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
56564962|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
56564963|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
56564964|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564965|NCT00614536|Rabeprazole|rabeprazole|mesh-list
56564966|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56564967|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56564968|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56564969|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564970|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564971|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
56564972|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
56564973|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56564974|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56564975|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564976|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101279|NCT00001891|Protective Agents|protective agents|mesh-ancestor
56564997|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564999|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56565000|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56565001|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56565002|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56565003|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565004|NCT03903016|Insulin|insulin|mesh-list
56565005|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56565006|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
56565007|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56565008|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565009|NCT03514732|Melatonin|melatonin|mesh-list
56565010|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
56565011|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565012|NCT03514732|Protective Agents|protective agents|mesh-ancestor
56565013|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565014|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565015|NCT03800836|Paclitaxel|paclitaxel|mesh-list
56565016|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56565017|NCT03800836|Atezolizumab|atezolizumab|mesh-list
56565018|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56565019|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565020|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
56565021|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
56565022|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
56565023|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565024|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
56565025|NCT01976182|Methotrexate|methotrexate|mesh-list
56565026|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565027|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
56101334|NCT00002347|Zidovudine|zidovudine|mesh-list
56565062|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
56565063|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565064|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565065|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565082|NCT01055496|Vincristine|vincristine|mesh-list
56565083|NCT01055496|Cisplatin|cisplatin|mesh-list
56565084|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56545670|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
56545671|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545672|NCT04289103|Inolimomab|inolimomab|mesh-list
56545673|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545674|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
56545675|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565085|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565086|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
56565087|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565088|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565089|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56565090|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
56565091|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565092|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565093|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56565094|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56565095|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565096|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
56565097|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
56565098|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565099|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56565100|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
56565101|NCT01055496|Hormones|hormones|mesh-ancestor
56565102|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565103|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56565104|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56565105|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
56565106|NCT01055496|Antiviral Agents|antiviral agents|mesh-ancestor
56565107|NCT01055496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565108|NCT01055496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565109|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56565110|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
56565111|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
56565112|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
56565113|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56565114|NCT03436498|Insulin|insulin|mesh-list
56565115|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56565116|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
56565117|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
56565118|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56565119|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56565120|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565121|NCT03435952|Doxycycline|doxycycline|mesh-list
56565122|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
56101425|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
56565135|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56565136|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565137|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565139|NCT00609531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56565140|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56565141|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565142|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565143|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565144|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
56565145|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565146|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56565147|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
56565148|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56565149|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
56565150|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56565151|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565152|NCT01052844|Gabapentin|gabapentin|mesh-list
56565154|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
56565155|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565156|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565157|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
56565158|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56565159|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56545676|NCT01154166|Ropinirole|ropinirole|mesh-list
56545677|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56545678|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56545679|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
56545680|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
56545681|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545682|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545683|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545684|NCT04290195|Aflibercept|aflibercept|mesh-list
56545685|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56545686|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56545687|NCT04290195|Growth Substances|growth substances|mesh-ancestor
56545688|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545689|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
56545690|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545691|NCT05656703|Anesthetics|anesthetics|mesh-list
56545692|NCT05656703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545693|NCT05656703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545694|NCT05656079|Cyclophosphamide|cyclophosphamide|mesh-list
56545695|NCT05656079|Docetaxel|docetaxel|mesh-list
56545696|NCT05656079|Doxorubicin|doxorubicin|mesh-list
56545697|NCT05656079|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56565160|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565161|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56565162|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56565163|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56565164|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565165|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565166|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
56565167|NCT02932618|Factor VIII|factor viii|mesh-list
56565168|NCT02932618|Coagulants|coagulants|mesh-ancestor
56565169|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
56565170|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56565171|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565172|NCT02584426|Cefazolin|cefazolin|mesh-list
56565173|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56565174|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565175|NCT00934089|Latanoprost|latanoprost|mesh-list
56565176|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56565177|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56565178|NCT01032174|Azithromycin|azithromycin|mesh-list
56565179|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56565180|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565181|NCT02704780|Misoprostol|misoprostol|mesh-list
56565182|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56565183|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
56565184|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56101485|NCT00002017|Interleukin-2|interleukin-2|mesh-list
56565199|NCT01032018|Citalopram|citalopram|mesh-list
56565200|NCT01032018|Sertraline|sertraline|mesh-list
56565201|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56565202|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
56565203|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56565204|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56565205|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56545698|NCT05656079|Trastuzumab|trastuzumab|mesh-list
56545699|NCT05656079|Epirubicin|epirubicin|mesh-list
56545700|NCT05656079|Pertuzumab|pertuzumab|mesh-list
56545701|NCT05656079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545702|NCT05656079|Immunologic Factors|immunologic factors|mesh-ancestor
56545703|NCT05656079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545704|NCT05656079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545705|NCT05656079|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56545706|NCT05656079|Alkylating Agents|alkylating agents|mesh-ancestor
56545707|NCT05656079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545708|NCT05656079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545709|NCT05656079|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56545710|NCT05656079|Tubulin Modulators|tubulin modulators|mesh-ancestor
56545711|NCT05656079|Antimitotic Agents|antimitotic agents|mesh-ancestor
56545712|NCT05656079|Mitosis Modulators|mitosis modulators|mesh-ancestor
56545713|NCT05656079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56545714|NCT05656079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56545715|NCT05656079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56545716|NCT05656079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545717|NCT05656079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56545718|NCT01181921|Galantamine|galantamine|mesh-list
56565206|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565207|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565208|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
56565209|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565210|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565211|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56565212|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56565213|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359433|NCT00280540|Valsartan|valsartan|mesh-list
56565214|NCT01032018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56565215|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
56565217|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56565218|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565219|NCT02330926|Analgesics|analgesics|mesh-ancestor
56565220|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
56565221|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565222|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565223|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565224|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565225|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56565226|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565227|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565228|NCT03606694|Metformin|metformin|mesh-list
56565229|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56565230|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565231|NCT00927069|Adalimumab|adalimumab|mesh-list
56565232|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565233|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565234|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
56565235|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565236|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56565237|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069447|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
56545719|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56545720|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545721|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545722|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
56545723|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293994|NCT00088894|Antibodies|antibodies|mesh-list
56545724|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545725|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56545726|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
56545727|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545728|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
56545729|NCT00932698|Ixazomib|ixazomib|mesh-list
56545730|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545731|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
56545732|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545733|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545734|NCT00978627|Insulin|insulin|mesh-list
56545735|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56545736|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
56545737|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
56545738|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56545739|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
56199896|NCT01520831|Insulin|insulin|mesh-list
56565238|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565239|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
56565240|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565241|NCT00608673|Betamethasone|betamethasone|mesh-list
56565242|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
56565243|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56565255|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565257|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
56565258|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565259|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565260|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
56565261|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565262|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
56565263|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56565264|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565265|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565266|NCT04263519|Tacrolimus|tacrolimus|mesh-list
56565267|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565268|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
56565269|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565270|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56565271|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565272|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565273|NCT00637767|Melphalan|melphalan|mesh-list
56565274|NCT00637767|Antibodies|antibodies|mesh-list
56565275|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56565276|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
56565277|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565278|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56565279|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
56545740|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56545741|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545742|NCT01181609|Bevacizumab|bevacizumab|mesh-list
56545743|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56545744|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545745|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56545746|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56545747|NCT01181609|Growth Substances|growth substances|mesh-ancestor
56545748|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545749|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
56545750|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
56545751|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56545752|NCT04261426|Antibodies|antibodies|mesh-list
56545753|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
56545754|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56545755|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
56545756|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545757|NCT04264078|Fludarabine|fludarabine|mesh-list
56545758|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
56545759|NCT04264078|Melphalan|melphalan|mesh-list
56545760|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545761|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545762|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545763|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
56545764|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545765|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545766|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56199921|NCT01521130|Levetiracetam|levetiracetam|mesh-list
56480207|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56565280|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565281|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565282|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56565283|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565284|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
56565285|NCT05101629|Lenvatinib|lenvatinib|mesh-list
56565286|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56565287|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565288|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56565289|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565290|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565291|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56565292|NCT00609999|Dasatinib|dasatinib|mesh-list
56565293|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565294|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56565295|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565296|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565297|NCT00627250|Amantadine|amantadine|mesh-list
56545767|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
56545768|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56545769|NCT01153698|Dabigatran|dabigatran|mesh-list
56545770|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
56545771|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56545772|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
56545773|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545774|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545775|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
56545776|NCT00608218|Ciclesonide|ciclesonide|mesh-list
56545777|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
56545778|NCT00608218|Hormones|hormones|mesh-ancestor
56545779|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56545780|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545781|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56545782|NCT02884050|Topiramate|topiramate|mesh-list
56545783|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
56565298|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56565299|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56565300|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
56565301|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565302|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
56565303|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565304|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565320|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56565321|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565323|NCT00610077|Clomiphene|clomiphene|mesh-list
56565324|NCT00610077|Enclomiphene|enclomiphene|mesh-list
56565325|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
56480208|NCT01282216|Vaccines|vaccines|mesh-list
56565326|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565327|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565328|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56565329|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56565330|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565331|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56565332|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
56565333|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565334|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565335|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56565336|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
56565337|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56565338|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56565339|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56565341|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
56565342|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
56565343|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565344|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565345|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
56565346|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565347|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56565348|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56565349|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56565350|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565351|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565352|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565353|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545784|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56545785|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545786|NCT02884440|Ropivacaine|ropivacaine|mesh-list
56545787|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
56545788|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545789|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545790|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
56545791|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
56545792|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545793|NCT00609934|Sorafenib|sorafenib|mesh-list
56545794|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545795|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56545796|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545797|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545798|NCT01147926|Prucalopride|prucalopride|mesh-list
56294071|NCT00089089|Decitabine|decitabine|mesh-list
56545799|NCT01147926|Laxatives|laxatives|mesh-ancestor
56545800|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56545801|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56545802|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56545803|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
56545804|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545805|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545806|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545807|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
56545808|NCT05115136|Promethazine|promethazine|mesh-list
56545809|NCT05115136|Doxepin|doxepin|mesh-list
56545810|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56545811|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56545812|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545813|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545814|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
56545815|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
56545816|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
56545817|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545823|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
56545824|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545825|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545826|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56545827|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
56545828|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
56545829|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56545830|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
56545831|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56545832|NCT00608374|Fludarabine|fludarabine|mesh-list
56545833|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
56199992|NCT01521624|Metformin|metformin|mesh-list
56565354|NCT01028352|Analgesics|analgesics|mesh-ancestor
56565355|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
56313762|NCT00140647|Ramipril|ramipril|mesh-list
56565356|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565357|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
56565358|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56565360|NCT03172780|Diclofenac|diclofenac|mesh-list
56565361|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56565362|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565384|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565385|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56565386|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565387|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565388|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
56565389|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56565390|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565391|NCT00926367|Analgesics|analgesics|mesh-ancestor
56565392|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
56565393|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565394|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565395|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565396|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565398|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56565399|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565400|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565401|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565402|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
56565403|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565404|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565405|NCT01114529|Cyclosporine|cyclosporine|mesh-list
56565406|NCT01114529|Everolimus|everolimus|mesh-list
56565407|NCT01114529|Tacrolimus|tacrolimus|mesh-list
56565408|NCT01114529|Cyclosporins|cyclosporins|mesh-list
56565409|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565410|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
56565411|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565412|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56565413|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565414|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565415|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
56565416|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565417|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
56565429|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56565430|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56565431|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
56565432|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56565433|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
56565434|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
56565435|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56565436|NCT04309643|Estradiol|estradiol|mesh-list
56565437|NCT04309643|Estrogens|estrogens|mesh-ancestor
56565438|NCT04309643|Hormones|hormones|mesh-ancestor
56359506|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56545834|NCT00608374|Chlorambucil|chlorambucil|mesh-list
56545835|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545836|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545837|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
56545838|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545839|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545840|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
56545841|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545842|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56545843|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
56545844|NCT00625014|Haloperidol|haloperidol|mesh-list
56545845|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
56565439|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565440|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565441|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56565442|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56565443|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56565444|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56565445|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56565446|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56565447|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56565448|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565449|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565450|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56565451|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565452|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565453|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
56565454|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565455|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56565456|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56565457|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56565459|NCT04259073|Analgesics|analgesics|mesh-ancestor
56565460|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
56565461|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565462|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565463|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
56565464|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56565465|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565466|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565467|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56565468|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56565469|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56565470|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565471|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56565472|NCT00609063|Atorvastatin|atorvastatin|mesh-list
56565473|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56565474|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56565475|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
56101788|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565491|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565492|NCT02601586|Oxycodone|oxycodone|mesh-list
56565493|NCT02601586|Levodopa|levodopa|mesh-list
56565494|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56565495|NCT02601586|Narcotics|narcotics|mesh-ancestor
56565496|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565497|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565498|NCT02601586|Analgesics|analgesics|mesh-ancestor
56359516|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
56565499|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
56565500|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545846|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
56545847|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
56545848|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545849|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545850|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56545851|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56545852|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56545853|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545854|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56545855|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56565501|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56565502|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56565503|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
56565504|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565505|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565506|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56565507|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
56565508|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565509|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56565510|NCT01114217|Hematinics|hematinics|mesh-ancestor
56565511|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56565512|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56565513|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
56565514|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565515|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
56565516|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56565517|NCT02549170|Antibodies|antibodies|mesh-list
56565518|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
56565519|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
56565520|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56565521|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
56565522|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565523|NCT01030458|Amlodipine|amlodipine|mesh-list
56565524|NCT01030458|Valsartan|valsartan|mesh-list
56565525|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56565526|NCT01030458|Bisoprolol|bisoprolol|mesh-list
56565527|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56565528|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56565529|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565530|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565531|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56565532|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101853|NCT00002149|Ephedrine|ephedrine|mesh-list
56565543|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56565544|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56565545|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
56565546|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565547|NCT02702674|Propranolol|propranolol|mesh-list
56565549|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
56565550|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56565551|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565552|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56565553|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56565554|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
56565555|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565556|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565557|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56565558|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56565559|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
56565560|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56565561|NCT01114139|Hematinics|hematinics|mesh-ancestor
56565562|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56565563|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56565564|NCT01027884|Idebenone|idebenone|mesh-list
56565565|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
56565566|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545856|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
56200023|NCT01521936|Vitamin D|vitamin d|mesh-list
56565567|NCT01027884|Protective Agents|protective agents|mesh-ancestor
56565568|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565569|NCT02699008|Clopidogrel|clopidogrel|mesh-list
56565570|NCT02699008|Ticagrelor|ticagrelor|mesh-list
56565571|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56565572|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56565573|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56565574|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56565575|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
56565576|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565577|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565578|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565579|NCT00627666|Leucovorin|leucovorin|mesh-list
56565580|NCT00627666|Methotrexate|methotrexate|mesh-list
56565581|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
56565582|NCT00627666|Fludarabine|fludarabine|mesh-list
56565583|NCT00627666|Busulfan|busulfan|mesh-list
56565584|NCT00627666|Calcium|calcium|mesh-list
56565585|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56565586|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
56565587|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56565588|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565589|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56565590|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
56565591|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56565592|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56565593|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
56565594|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565595|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565596|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
56565606|NCT00627666|Vitamins|vitamins|mesh-ancestor
56565607|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
56565608|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
56565609|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56565610|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56565611|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56565612|NCT01022580|Calfactant|calfactant|mesh-list
56565613|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
56565614|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
56565615|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56565616|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565617|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565618|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565619|NCT02698930|Analgesics|analgesics|mesh-ancestor
56565620|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
56565621|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565622|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56565623|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56565624|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56565625|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
56565626|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565627|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565628|NCT01107353|Imipramine|imipramine|mesh-list
56565629|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56565630|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
56565631|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56565632|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56565633|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56565634|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565635|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565636|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
56565637|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565638|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565640|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
56565641|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565642|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
56565643|NCT02702206|Hormones|hormones|mesh-ancestor
56565644|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565645|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565646|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
56565647|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56545857|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545858|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545859|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56545860|NCT01147848|Fluticasone|fluticasone|mesh-list
56545861|NCT01147848|Xhance|xhance|mesh-list
56545862|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56545863|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56545864|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56545865|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
56545866|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545867|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545868|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56565648|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
56565649|NCT02702206|Protective Agents|protective agents|mesh-ancestor
56565650|NCT04216186|Ubiquinone|ubiquinone|mesh-list
56565651|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
56565652|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56565653|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56565654|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56565655|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565656|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565657|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
56565658|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565659|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565660|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
56565661|NCT04216186|Vitamins|vitamins|mesh-ancestor
56565662|NCT01989598|Trametinib|trametinib|mesh-list
56565663|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565674|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565675|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56565676|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56565677|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56565678|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565679|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565680|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
56565681|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56565682|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
56565684|NCT00615160|Vatalanib|vatalanib|mesh-list
56565685|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56565686|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
56565687|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565688|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565689|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56565690|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565691|NCT01112267|Acetaminophen|acetaminophen|mesh-list
56565692|NCT01112267|Tramadol|tramadol|mesh-list
56565693|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565694|NCT01112267|Analgesics|analgesics|mesh-ancestor
56565695|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
56565696|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565697|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565698|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
56565699|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56565700|NCT01112267|Narcotics|narcotics|mesh-ancestor
56565701|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565702|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
56565703|NCT00925587|Hematinics|hematinics|mesh-ancestor
56565704|NCT02698306|Dexamethasone|dexamethasone|mesh-list
56565705|NCT02698306|Diclofenac|diclofenac|mesh-list
56565706|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565707|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
56565708|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
56565709|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565710|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545869|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
56545870|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
56545871|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56545872|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56545873|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56545874|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56545875|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
56545876|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545877|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545878|NCT04261270|Ritonavir|ritonavir|mesh-list
56545879|NCT04261270|Oseltamivir|oseltamivir|mesh-list
56545880|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56545881|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56545882|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
56545883|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200041|NCT01521975|Adefovir|adefovir|mesh-list
56565711|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56565712|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
56565713|NCT02698306|Hormones|hormones|mesh-ancestor
56565714|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565715|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56565716|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565717|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56565718|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565719|NCT02698306|Analgesics|analgesics|mesh-ancestor
56565720|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
56565721|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565722|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56565723|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565724|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565725|NCT02698228|Morphine|morphine|mesh-list
56314119|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
56565726|NCT02698228|Bupivacaine|bupivacaine|mesh-list
56565727|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
56565754|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565755|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565756|NCT00193414|Antiviral Agents|antiviral agents|mesh-ancestor
56565757|NCT00193414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565758|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565759|NCT00193414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565760|NCT00193414|Immunologic Factors|immunologic factors|mesh-ancestor
56565761|NCT00193414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565762|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56565763|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56565764|NCT04260711|Interferons|interferons|mesh-list
56565765|NCT04260711|Teriflunomide|teriflunomide|mesh-list
56565766|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
56565767|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56565768|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
56565769|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565770|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
56565771|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565772|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56565773|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
56565774|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565775|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565776|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102103|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56565804|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56565805|NCT04956705|Vitamin D|vitamin d|mesh-list
56565806|NCT04956705|Calcium|calcium|mesh-list
56545884|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545885|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56545886|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56545887|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
56545888|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56545889|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56545890|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56545891|NCT01152996|Vortioxetine|vortioxetine|mesh-list
56545892|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
56545893|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56545894|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56545895|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56545896|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545897|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545898|NCT01152996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56545899|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56545900|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56545901|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545902|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545903|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
56545904|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56545905|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56200055|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
56565807|NCT04956705|Vitamins|vitamins|mesh-ancestor
56565808|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
56565809|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565810|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56565811|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56565812|NCT02705950|Baclofen|baclofen|mesh-list
56565813|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56565814|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565815|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56565816|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565817|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56565818|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
56565819|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
56565820|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565821|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565822|NCT04951323|Vaccines|vaccines|mesh-list
56565823|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
56102161|NCT00003086|Melphalan|melphalan|mesh-list
56565837|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
56565838|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
56565839|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
56565840|NCT02701348|Letrozole|letrozole|mesh-list
56565841|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56565842|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565843|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56565844|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887291|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545906|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56545907|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56545908|NCT05241288|Albuterol|albuterol|mesh-list
56545909|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56545910|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
56545911|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565845|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565846|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56565847|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
56565848|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565849|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565850|NCT05324800|Turmeric extract|turmeric extract|mesh-list
56565851|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
56565852|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565853|NCT05324800|Protective Agents|protective agents|mesh-ancestor
56565854|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565855|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
56565856|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56565857|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565858|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56565859|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565860|NCT00930579|Metformin|metformin|mesh-list
56565861|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56565862|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565863|NCT03367156|Dexamethasone|dexamethasone|mesh-list
56565864|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
56565865|NCT03367156|Ichthammol|ichthammol|mesh-list
56565866|NCT03367156|BB 1101|bb 1101|mesh-list
56565867|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565868|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
56565869|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
56565870|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565871|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565872|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56565873|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
56565874|NCT03367156|Hormones|hormones|mesh-ancestor
56565875|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565876|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56565877|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565878|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
56565879|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565880|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565882|NCT02700568|Axitinib|axitinib|mesh-list
56565883|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565884|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56565885|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565886|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565887|NCT00925353|Lidocaine|lidocaine|mesh-list
56565898|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565900|NCT02705482|Tremelimumab|tremelimumab|mesh-list
56565901|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56565902|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565903|NCT02705638|Rituximab|rituximab|mesh-list
56565904|NCT02705638|Lenalidomide|lenalidomide|mesh-list
56565905|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56565906|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565907|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
56565908|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565909|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565910|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56565911|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56565912|NCT02705638|Growth Substances|growth substances|mesh-ancestor
56565913|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
56565914|NCT02691910|Chloroquine|chloroquine|mesh-list
56565915|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56565916|NCT02691910|Primaquine|primaquine|mesh-list
56565917|NCT02691910|Amebicides|amebicides|mesh-ancestor
56565918|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56565919|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56545912|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545913|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56545914|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56545915|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
56545916|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56545917|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56545918|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56545919|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56545920|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
56545921|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545922|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545923|NCT00624936|Azacitidine|azacitidine|mesh-list
56545924|NCT00624936|Bortezomib|bortezomib|mesh-list
56545925|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545926|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
56545927|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545928|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545929|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545930|NCT00979953|Oxycodone|oxycodone|mesh-list
56545931|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56545932|NCT00979953|Narcotics|narcotics|mesh-ancestor
56545933|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56545934|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545935|NCT00979953|Analgesics|analgesics|mesh-ancestor
56545936|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
56545937|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545938|NCT01181531|Vitamin D|vitamin d|mesh-list
56565920|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565921|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
56565922|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565923|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56565924|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565925|NCT02691910|Analgesics|analgesics|mesh-ancestor
56565926|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
56565927|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565928|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565929|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565930|NCT02691910|Filaricides|filaricides|mesh-ancestor
56565931|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
56565932|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
56565933|NCT02705014|Hormones|hormones|mesh-list
56565934|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565935|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565936|NCT02704624|Vitamin D|vitamin d|mesh-list
56565937|NCT02704624|Vitamins|vitamins|mesh-ancestor
56565938|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
56565939|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565940|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56545939|NCT01181531|Cinacalcet|cinacalcet|mesh-list
56545940|NCT01181531|Vitamins|vitamins|mesh-ancestor
56545941|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
56545942|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545943|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56545944|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56545945|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56545946|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
56545947|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56545948|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
56545949|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56545950|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
56545951|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56545952|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545953|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56634308|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
56545954|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
56565941|NCT02700022|Prednisone|prednisone|mesh-list
56565942|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
56565943|NCT02700022|Doxorubicin|doxorubicin|mesh-list
56565944|NCT02700022|Etoposide|etoposide|mesh-list
56565945|NCT02700022|Vincristine|vincristine|mesh-list
56565946|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565947|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
56565948|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565949|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565950|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56565951|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
56565952|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565953|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565989|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
56565990|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56565991|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56565992|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56565993|NCT04214626|Prednisone|prednisone|mesh-list
56566027|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56566028|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56566029|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56566030|NCT04214626|Growth Substances|growth substances|mesh-ancestor
56566031|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
56566032|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56566033|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56566034|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56566044|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566045|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566046|NCT02691754|Acetaminophen|acetaminophen|mesh-list
56566047|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56566048|NCT02691754|Analgesics|analgesics|mesh-ancestor
56566049|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
56566050|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566051|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566052|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
56566053|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
56566054|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56566055|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56566056|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56566057|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56566058|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56069448|NCT05455073|Vitamins|vitamins|mesh-ancestor
56545955|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
56545956|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56545957|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
56545958|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56545959|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545960|NCT00610246|Sorafenib|sorafenib|mesh-list
56545961|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545962|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56545963|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545964|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545965|NCT01181141|Enoxaparin|enoxaparin|mesh-list
56545966|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
56545967|NCT01181141|Edoxaban|edoxaban|mesh-list
56545968|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
56545969|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56545970|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56545971|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545972|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56545973|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
56545974|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56545975|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
56545976|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56545977|NCT00606814|Docetaxel|docetaxel|mesh-list
56545978|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545979|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
56566059|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566060|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566061|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56566062|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56566063|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56566064|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
56566065|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566066|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566067|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56566068|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56566069|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
56566070|NCT01106651|Canagliflozin|canagliflozin|mesh-list
56566071|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56566072|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56566073|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566074|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566075|NCT00637078|Amlodipine|amlodipine|mesh-list
56566076|NCT00637078|Spironolactone|spironolactone|mesh-list
56566077|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56566078|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56566079|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359603|NCT00416962|Analgesics|analgesics|mesh-ancestor
56566080|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566081|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56545980|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
56545981|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
56545982|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545983|NCT01173120|Abatacept|abatacept|mesh-list
56200156|NCT01522729|Analgesics|analgesics|mesh-ancestor
56566082|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566083|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
56566084|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56566085|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
56566086|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566087|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56566088|NCT00637078|Diuretics|diuretics|mesh-ancestor
56566089|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
56566099|NCT00625781|Insulin|insulin|mesh-list
56566116|NCT00616876|Lactulose|lactulose|mesh-list
56566117|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56566118|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
56566119|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56566120|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
56566121|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566122|NCT01106027|Eculizumab|eculizumab|mesh-list
56566123|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56566124|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56566125|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
56566126|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566127|NCT01027416|Tamoxifen|tamoxifen|mesh-list
56566128|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56566129|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
56566130|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566131|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566132|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56566133|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566134|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56566135|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56566136|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56566137|NCT05026203|Midazolam|midazolam|mesh-list
56566138|NCT05026203|Ketamine|ketamine|mesh-list
56566139|NCT05026203|Analgesics|analgesics|mesh-ancestor
56359613|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566140|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
56566141|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566142|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566143|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56566144|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56566145|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
56566147|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566148|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56566149|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56566150|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566151|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566152|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56566153|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56566154|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56566155|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56566156|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56566157|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
56566158|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
56566159|NCT01015638|Clindamycin|clindamycin|mesh-list
55870835|NCT00946270|Hormones|hormones|mesh-ancestor
56566185|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56566186|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56566187|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566188|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56566189|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566190|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
56566191|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
56566192|NCT00924729|Besifloxacin|besifloxacin|mesh-list
56566193|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56566194|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56566195|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56545984|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56545985|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545986|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545987|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56545988|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
56545989|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56545990|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56545991|NCT00977379|Capecitabine|capecitabine|mesh-list
56545992|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56545993|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
56545994|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56545995|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56545996|NCT04263844|Midazolam|midazolam|mesh-list
56545997|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
56545998|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56545999|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56546000|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546001|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546002|NCT04263844|Analgesics|analgesics|mesh-ancestor
56546003|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
56546004|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546005|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56546006|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56546007|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56546008|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
56200162|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
56566196|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566197|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56566198|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56566199|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566200|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566201|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566202|NCT01099709|Oxycodone|oxycodone|mesh-list
56566203|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56566204|NCT01099709|Narcotics|narcotics|mesh-ancestor
56566205|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566206|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566207|NCT01099709|Analgesics|analgesics|mesh-ancestor
56566208|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
56566209|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566210|NCT04907721|Glucagon|glucagon|mesh-list
56102546|NCT00003134|Irinotecan|irinotecan|mesh-list
56566233|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56566234|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566236|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566237|NCT05329857|Metformin|metformin|mesh-list
56566238|NCT05329857|Vildagliptin|vildagliptin|mesh-list
56546009|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546010|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566239|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566240|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566241|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56566242|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
56566243|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566244|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566245|NCT04981041|Clopidogrel|clopidogrel|mesh-list
56566246|NCT04981041|Ticagrelor|ticagrelor|mesh-list
56566247|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56566248|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56566249|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56566250|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56566251|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56566252|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
56566253|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566254|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566255|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566256|NCT01026948|Dinoprostone|dinoprostone|mesh-list
56566257|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
56566258|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56566284|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56566285|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56566287|NCT04939467|Nintedanib|nintedanib|mesh-list
56566288|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566289|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56566290|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566291|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566292|NCT04939467|Analgesics|analgesics|mesh-ancestor
56566293|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
56566294|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566295|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566296|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56566297|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56566298|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566299|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566300|NCT01015560|Antibodies|antibodies|mesh-list
56566301|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56566302|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
56566303|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566304|NCT04253223|Volagidemab|volagidemab|mesh-list
56566305|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566306|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566335|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566337|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56566338|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
56566339|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566340|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566341|NCT01098539|Incretins|incretins|mesh-ancestor
56566342|NCT01098539|Hormones|hormones|mesh-ancestor
56566343|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566344|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56566345|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
56566346|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566347|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566348|NCT04922723|Daratumumab|daratumumab|mesh-list
56566349|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566350|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
56102676|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
56566374|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56566375|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
56566376|NCT00833833|Hormones|hormones|mesh-ancestor
56566377|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566378|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56566379|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566380|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
56566381|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566382|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566383|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56546011|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56546012|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56546013|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56546014|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56566384|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56566385|NCT00833833|Analgesics|analgesics|mesh-ancestor
56566386|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
56566387|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566388|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56566389|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56566390|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56566391|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56566392|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
56566393|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
56566394|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56566395|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56566396|NCT00833833|Growth Substances|growth substances|mesh-ancestor
56566397|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
56566398|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
56566399|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566400|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
56566401|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56314807|NCT00425425|Cetuximab|cetuximab|mesh-list
56566402|NCT02612545|Piperaquine|piperaquine|mesh-list
56566403|NCT02612545|Artenimol|artenimol|mesh-list
56566425|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56566426|NCT01097057|Lenograstim|lenograstim|mesh-list
56566427|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
56566428|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566429|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566430|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566431|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56566432|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56566433|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56566434|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566435|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566436|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56566437|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56566438|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
56566439|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56566440|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56566441|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
56566442|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566443|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
56566444|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
56566445|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
56566446|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56566447|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56566448|NCT02612701|Nicotine|nicotine|mesh-list
56566449|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56566450|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
56566451|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566452|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566453|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56566454|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56566455|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
56566456|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566457|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566458|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
56566459|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56566460|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56566461|NCT01096667|Diuretics|diuretics|mesh-ancestor
56566462|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
56566463|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566519|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
56566520|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566521|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566522|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566523|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566524|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56566525|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56566526|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
56566527|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
56566528|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56546015|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56546016|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
56546017|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
56546018|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
56546019|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
56546020|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
56546021|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56546022|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56546023|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546024|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
56294300|NCT00090025|Vitamins|vitamins|mesh-ancestor
56546025|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
56546026|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
56546027|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
56546028|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634309|NCT05165771|Tofacitinib|tofacitinib|mesh-list
55919327|NCT01270347|Ofloxacin|ofloxacin|mesh-list
56566529|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56566530|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566531|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566532|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566534|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566535|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
56566536|NCT02872584|Hormones|hormones|mesh-ancestor
56566537|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566538|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566539|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56566540|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566541|NCT00704821|Docetaxel|docetaxel|mesh-list
56566542|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566543|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
56566544|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
56566545|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
56566578|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566579|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56566580|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56566581|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566582|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566584|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
56566585|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56566586|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56566618|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56566619|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566621|NCT01021020|Colchicine|colchicine|mesh-list
56566622|NCT01021020|Probenecid|probenecid|mesh-list
56566623|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
56566624|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566625|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
56566642|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
56566643|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566644|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56566645|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56566646|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
56566647|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566648|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56566649|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56566651|NCT01020786|Pemetrexed|pemetrexed|mesh-list
56566652|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566653|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566654|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546029|NCT04261036|Protective Agents|protective agents|mesh-ancestor
56546030|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546031|NCT04261036|Vitamins|vitamins|mesh-ancestor
56546032|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
56546033|NCT04067115|Alovudine|alovudine|mesh-list
56546034|NCT04067115|Irinotecan|irinotecan|mesh-list
56546035|NCT04067115|Trabectedin|trabectedin|mesh-list
56546036|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56546037|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56546038|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546039|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546040|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546041|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56546042|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
56546043|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
56546044|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546045|NCT02884128|Leucovorin|leucovorin|mesh-list
56546046|NCT02884128|Fluorouracil|fluorouracil|mesh-list
56546047|NCT02884128|Irinotecan|irinotecan|mesh-list
56546048|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
56546049|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546050|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56546051|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566655|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56566656|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56566657|NCT04831047|Phenylephrine|phenylephrine|mesh-list
56566658|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
56566659|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56566660|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56566661|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56566662|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56566663|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
56566664|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566665|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566666|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566667|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
56566668|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
56566669|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566670|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
56566671|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56566672|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
56566673|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56566674|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
56566675|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56566676|NCT04831047|Protective Agents|protective agents|mesh-ancestor
56566678|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56566679|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566680|NCT01020474|Pregabalin|pregabalin|mesh-list
56566681|NCT01020474|Analgesics|analgesics|mesh-ancestor
56566682|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
56566683|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103001|NCT00002846|Aldesleukin|aldesleukin|mesh-list
56566697|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56566698|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
56546052|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546053|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
56546054|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546055|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56546056|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56546057|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546058|NCT02884128|Antidotes|antidotes|mesh-ancestor
56546059|NCT02884128|Protective Agents|protective agents|mesh-ancestor
56546060|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
56546061|NCT02884128|Vitamins|vitamins|mesh-ancestor
56546062|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
56546063|NCT00629343|Azacitidine|azacitidine|mesh-list
56546064|NCT00629343|Temozolomide|temozolomide|mesh-list
56546065|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56546066|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
56546067|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546068|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546069|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546070|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56566699|NCT02872818|Estradiol|estradiol|mesh-list
56566700|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56566701|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566702|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566704|NCT02872818|Hormones|hormones|mesh-ancestor
56566705|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566706|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56566707|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
56566708|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56566709|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56566710|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56566711|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56566712|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56566713|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56566714|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56566715|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566716|NCT00922779|Ribavirin|ribavirin|mesh-list
56566717|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56566718|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
56566719|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566720|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
56566721|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566722|NCT04528680|Paclitaxel|paclitaxel|mesh-list
56566723|NCT04528680|Carboplatin|carboplatin|mesh-list
56566724|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56566725|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56566726|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566727|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
56566728|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
56566729|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
56566730|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566731|NCT04570410|Gemcitabine|gemcitabine|mesh-list
56359765|NCT00281983|Cyclosporine|cyclosporine|mesh-list
56566732|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566733|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56566735|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566736|NCT04570410|Antiviral Agents|antiviral agents|mesh-ancestor
56546071|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
56546072|NCT01180049|Sirolimus|sirolimus|mesh-list
56546073|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56546074|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546075|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56546076|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546077|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
56546078|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546079|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
56546080|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546081|NCT01147458|Naproxen|naproxen|mesh-list
56546082|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56566737|NCT04570410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566738|NCT04570410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566739|NCT04570410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56566740|NCT04570410|Immunologic Factors|immunologic factors|mesh-ancestor
56566741|NCT04570410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566742|NCT04203771|Ibuprofen|ibuprofen|mesh-list
56566743|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56566744|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56566764|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566765|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
56566766|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566767|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
56566768|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56566769|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56566770|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566771|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
56566772|NCT05321199|Coagulants|coagulants|mesh-ancestor
56566773|NCT04300452|Carbetocin|carbetocin|mesh-list
56566774|NCT04300452|Ergonovine|ergonovine|mesh-list
56566775|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
56566776|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56566777|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566778|NCT01025154|Cytarabine|cytarabine|mesh-list
56566779|NCT01025154|Clofarabine|clofarabine|mesh-list
56566780|NCT01025154|Idarubicin|idarubicin|mesh-list
56566781|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56566782|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
56566783|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566784|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566785|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
56566786|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566787|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56566788|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
56566789|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566790|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56566791|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56566792|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56566793|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566794|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
56566795|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56566796|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566797|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
56566798|NCT04252443|Analgesics|analgesics|mesh-list
56566799|NCT04252443|Narcotics|narcotics|mesh-ancestor
56566800|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830173|NCT02128490|Naproxen|naproxen|mesh-list
56566838|NCT01096589|Monensin|monensin|mesh-list
56566839|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
56103171|NCT00002876|Etoposide|etoposide|mesh-list
56566863|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566864|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56566865|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56566866|NCT04252521|Analgesics|analgesics|mesh-ancestor
56546083|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546084|NCT01147458|Analgesics|analgesics|mesh-ancestor
56546085|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
56546086|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546087|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546088|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546089|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546090|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
56546091|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56546092|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546093|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546094|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
56566867|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
56566868|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566869|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566870|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56566871|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566873|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56566874|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
56566875|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566876|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
56566877|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566878|NCT04772001|Carboplatin|carboplatin|mesh-list
56566879|NCT04772001|Cisplatin|cisplatin|mesh-list
56566880|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566881|NCT00702091|Ramipril|ramipril|mesh-list
56566882|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56566883|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
56566884|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566885|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566886|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56566887|NCT00832585|Alefacept|alefacept|mesh-list
56566888|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
56566889|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
56566890|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566891|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56566892|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56566917|NCT01024920|Nintedanib|nintedanib|mesh-list
56566918|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566919|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56566920|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56566921|NCT01024920|Growth Substances|growth substances|mesh-ancestor
56566922|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566923|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
56566924|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56566925|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566926|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566927|NCT00832117|Cisplatin|cisplatin|mesh-list
56566929|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566930|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
56566931|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
56566932|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
56566933|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566934|NCT02872272|Amikacin|amikacin|mesh-list
56566935|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56566936|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566937|NCT00831493|Vorinostat|vorinostat|mesh-list
56566938|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566939|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56566940|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566941|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566979|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546095|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56546096|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56546097|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
56546098|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546099|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546100|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56546101|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
56546102|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
56546103|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56546161|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546162|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
56546163|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546164|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56546165|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546166|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
56546167|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546168|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56546169|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56546170|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56546171|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546172|NCT05663515|Insulin|insulin|mesh-list
56546173|NCT05663515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56546174|NCT05663515|Exenatide|exenatide|mesh-list
56546175|NCT05663515|Biguanides|biguanides|mesh-list
56546176|NCT05663515|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56546177|NCT05663515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566980|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
56567068|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567069|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567070|NCT00920829|Naltrexone|naltrexone|mesh-list
56567071|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56567072|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56567073|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567074|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
56567075|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103416|NCT00003950|Irinotecan|irinotecan|mesh-list
56567102|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
56567103|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
56567104|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567105|NCT02878265|Trace Elements|trace elements|mesh-ancestor
56567107|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567108|NCT02878265|Protective Agents|protective agents|mesh-ancestor
56567109|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56567110|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567111|NCT00831181|Leucovorin|leucovorin|mesh-list
56567112|NCT00831181|Fluorouracil|fluorouracil|mesh-list
56567113|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
56567114|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
56567115|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567116|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56567117|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567118|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567119|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
56567120|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567121|NCT00831181|Antidotes|antidotes|mesh-ancestor
56567122|NCT00831181|Protective Agents|protective agents|mesh-ancestor
56567123|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
56567124|NCT00831181|Vitamins|vitamins|mesh-ancestor
56567125|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
56567157|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
56567158|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
56567159|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56567160|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56567161|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56567162|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567163|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567164|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
56567165|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546178|NCT05663515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546180|NCT05663515|Incretins|incretins|mesh-ancestor
56546181|NCT05663515|Hormones|hormones|mesh-ancestor
56200356|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567166|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567182|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56567183|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567185|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56567186|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56567187|NCT04255251|Fluorides|fluorides|mesh-list
56567188|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
56567189|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
56567190|NCT04255251|Protective Agents|protective agents|mesh-ancestor
56567191|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567192|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56567193|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56567194|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56567195|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567196|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567197|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567198|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567199|NCT01018680|Analgesics|analgesics|mesh-ancestor
56567200|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
56567201|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567202|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
56567203|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56567204|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
56567205|NCT04255017|Ritonavir|ritonavir|mesh-list
56567206|NCT04255017|Lopinavir|lopinavir|mesh-list
56567207|NCT04255017|Oseltamivir|oseltamivir|mesh-list
56567208|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56567209|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56567210|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
56567211|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567212|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567213|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56567214|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56567215|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
56567216|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567217|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56567218|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56567219|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56567220|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
56567221|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
56567222|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567223|NCT01017120|Tazarotene|tazarotene|mesh-list
56315631|NCT00001832|Analgesics|analgesics|mesh-ancestor
56567224|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
56567225|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
56567256|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56567257|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56567258|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
56567259|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567260|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56567261|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567262|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567263|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56567264|NCT01103063|Renal Agents|renal agents|mesh-ancestor
56567265|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
56567266|NCT02987998|Etoposide|etoposide|mesh-list
56567267|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567268|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56567269|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56567270|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56567271|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56567272|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567273|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567293|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56567294|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567295|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546182|NCT05663515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546183|NCT00641173|Paroxetine|paroxetine|mesh-list
56546184|NCT00641173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56546185|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56546186|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56546187|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546188|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546189|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
56546190|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546191|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56546192|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
56546193|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56546194|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56546195|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56567296|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56567297|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56567299|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315695|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
56567300|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567301|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56567302|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567303|NCT00616720|Interferons|interferons|mesh-list
56567304|NCT00616720|Aldesleukin|aldesleukin|mesh-list
56567305|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
56567306|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567307|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
56567308|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567309|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56567310|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56567311|NCT01091675|Etoricoxib|etoricoxib|mesh-list
56567312|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56567313|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56567314|NCT01091675|Analgesics|analgesics|mesh-ancestor
56567315|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
56567316|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567317|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567318|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56567319|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567320|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56567321|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56567322|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567323|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567324|NCT02739412|Aldesleukin|aldesleukin|mesh-list
56567325|NCT02739412|Interleukin-2|interleukin-2|mesh-list
56567326|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567327|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56567328|NCT02739412|Analgesics|analgesics|mesh-ancestor
56567357|NCT01091519|Fesoterodine|fesoterodine|mesh-list
56567358|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56567359|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56567360|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
56567361|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567362|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567363|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567364|NCT01091519|Urological Agents|urological agents|mesh-ancestor
56567365|NCT02703220|Acetazolamide|acetazolamide|mesh-list
56567366|NCT02703220|Finasteride|finasteride|mesh-list
56567367|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
56546196|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546197|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
56546198|NCT00929110|Bromides|bromides|mesh-list
56546199|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
56546200|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56546201|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
56546202|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546203|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546204|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56546205|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56546206|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
56546207|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56546208|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
56546209|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546210|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546211|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
56546212|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56546213|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56546214|NCT00922519|Listerine|listerine|mesh-list
56546215|NCT00922519|Fluorides|fluorides|mesh-list
56546216|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
56546217|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
56546218|NCT00922519|Protective Agents|protective agents|mesh-ancestor
56567368|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56567369|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567370|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567371|NCT02703220|Diuretics|diuretics|mesh-ancestor
56567372|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
56567373|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567374|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56103637|NCT00002653|Hormones|hormones|mesh-ancestor
56567404|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567405|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567406|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567407|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567408|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567409|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56567410|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
56567411|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567412|NCT00918333|Everolimus|everolimus|mesh-list
56567413|NCT00918333|Panobinostat|panobinostat|mesh-list
56567414|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56567415|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567416|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567417|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
56567418|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103650|NCT00002659|Cisplatin|cisplatin|mesh-list
56567444|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56567445|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567446|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56567447|NCT02871648|Diuretics|diuretics|mesh-ancestor
56567448|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
56567449|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56546219|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546220|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56546221|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546222|NCT00640549|Atorvastatin|atorvastatin|mesh-list
56546223|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56546224|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56546225|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
56546226|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546227|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56546228|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56546229|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546231|NCT02683369|Trace Elements|trace elements|mesh-ancestor
56546232|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
56567450|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56567451|NCT00637845|Esomeprazole|esomeprazole|mesh-list
56567452|NCT00637845|Lansoprazole|lansoprazole|mesh-list
56567453|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
56567454|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56567455|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56567456|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56567457|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567458|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567459|NCT04738695|Antibodies|antibodies|mesh-list
56567460|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
56567461|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567462|NCT02497300|Amiloride|amiloride|mesh-list
56567463|NCT02497300|Spironolactone|spironolactone|mesh-list
56567464|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56567465|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
56567466|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56567467|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567468|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56567469|NCT02497300|Diuretics|diuretics|mesh-ancestor
56567502|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
56359898|NCT00282997|Pregabalin|pregabalin|mesh-list
56567504|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56567505|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
56567506|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
56567507|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56567508|NCT00620620|Zaleplon|zaleplon|mesh-list
56567509|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
56567510|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56103747|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
56567530|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
56567531|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
56567532|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567533|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567534|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
56567535|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567536|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56567537|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56567538|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56567539|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567540|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567541|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56567542|NCT04254081|Narcotics|narcotics|mesh-ancestor
56567543|NCT04254081|Analgesics|analgesics|mesh-ancestor
56567544|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56567546|NCT04209478|Tramadol|tramadol|mesh-list
56567547|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56567548|NCT04209478|Narcotics|narcotics|mesh-ancestor
56069449|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
56546233|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546234|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
56546235|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
56546236|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
56546237|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546238|NCT00640627|Celecoxib|celecoxib|mesh-list
56546239|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56546240|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546241|NCT00640627|Analgesics|analgesics|mesh-ancestor
56546242|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
56546243|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546244|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567549|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567550|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567551|NCT04209478|Analgesics|analgesics|mesh-ancestor
56567552|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
56567553|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567554|NCT05252715|Vaccines|vaccines|mesh-list
56567555|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
56567556|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567557|NCT04209166|Norepinephrine|norepinephrine|mesh-list
56567558|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56567559|NCT04209166|Serotonin|serotonin|mesh-list
56567560|NCT04209166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56567561|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
56567562|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
56567563|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56567564|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56103803|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
56567636|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103875|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56567659|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56567660|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56567661|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56567662|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56567663|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56567664|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56567665|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56567666|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567667|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56567668|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56567669|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567671|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56567672|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567673|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56567674|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56567675|NCT04213222|Growth Substances|growth substances|mesh-ancestor
56567676|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567677|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56567678|NCT00621166|Ritonavir|ritonavir|mesh-list
56567679|NCT00621166|Lopinavir|lopinavir|mesh-list
56567680|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56567681|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56567682|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
56567683|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567684|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567685|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56567686|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56567687|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
56567688|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567689|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56567690|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56567691|NCT04555798|Meropenem|meropenem|mesh-list
56546245|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546246|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200422|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56567716|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56567717|NCT00621400|Growth Substances|growth substances|mesh-ancestor
56567718|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
56567719|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56567720|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
56567721|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567722|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56567723|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567724|NCT04208854|Vinorelbine|vinorelbine|mesh-list
56567725|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56567726|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567727|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567728|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567729|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567730|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567731|NCT01090427|Ustekinumab|ustekinumab|mesh-list
56567732|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
56567733|NCT04208776|Propranolol|propranolol|mesh-list
56567734|NCT04208776|Midodrine|midodrine|mesh-list
56567735|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56567736|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56567737|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
56567738|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567739|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567740|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567741|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56567742|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56567775|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56567776|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56567777|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56567778|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567779|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
56567780|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56567781|NCT04309552|Alovudine|alovudine|mesh-list
56567782|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
56567783|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567784|NCT00621478|Diazepam|diazepam|mesh-list
56567805|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
56567807|NCT00621556|Secretin|secretin|mesh-list
56567808|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56567809|NCT00621556|Hormones|hormones|mesh-ancestor
56567810|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56567811|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567812|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
56567813|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
56567814|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56567815|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56567816|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567817|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567818|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56567819|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56567820|NCT04308551|Aspirin|aspirin|mesh-list
56567821|NCT04308551|Indobufen|indobufen|mesh-list
56567822|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56567823|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56567824|NCT04308551|Analgesics|analgesics|mesh-ancestor
56567825|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
56567826|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316224|NCT00012311|Etoposide|etoposide|mesh-list
56567827|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567828|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56567829|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567830|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56567831|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56567832|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567833|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56567834|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56567835|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567836|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
56546247|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56546248|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56546249|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546250|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546251|NCT02681887|Melatonin|melatonin|mesh-list
56546252|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
56546253|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546254|NCT02681887|Protective Agents|protective agents|mesh-ancestor
56546255|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567837|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
56567838|NCT04306913|Esmolol|esmolol|mesh-list
56567915|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
56567916|NCT04188184|Coagulants|coagulants|mesh-ancestor
56567917|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56567918|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56567919|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
56567920|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567921|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567922|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56567923|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56567924|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
56567925|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567926|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56567927|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
56567928|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
56567929|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
56567930|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56567931|NCT02296684|Cisplatin|cisplatin|mesh-list
56567932|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
56567933|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567934|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56567935|NCT04480086|Navitoclax|navitoclax|mesh-list
56567936|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567937|NCT01006590|Metformin|metformin|mesh-list
56567938|NCT01006590|Saxagliptin|saxagliptin|mesh-list
56567939|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56567940|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567941|NCT01006590|Incretins|incretins|mesh-ancestor
56567942|NCT01006590|Hormones|hormones|mesh-ancestor
56567943|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56567944|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56567945|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
56567946|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567947|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567948|NCT04212832|Bupivacaine|bupivacaine|mesh-list
56567949|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
56567950|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
56104166|NCT00003326|Paclitaxel|paclitaxel|mesh-list
56568009|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56568010|NCT01001598|Danazol|danazol|mesh-list
56568011|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56568012|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
56362060|NCT00301483|Chrysarobin|chrysarobin|mesh-list
56568058|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
56568059|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362225|NCT00201721|Rituximab|rituximab|mesh-list
56362358|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
56362435|NCT00080990|Antidotes|antidotes|mesh-ancestor
56362733|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56362806|NCT00081848|Metronidazole|metronidazole|mesh-list
56568060|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56568061|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
56568062|NCT01190930|Hormones|hormones|mesh-ancestor
56480209|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56480210|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
56480211|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480212|NCT01281865|Everolimus|everolimus|mesh-list
56480213|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
56363554|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56480214|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546256|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56546258|NCT01134042|Xhance|xhance|mesh-list
56546259|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546260|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56546261|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
56546262|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920318|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
56480215|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56480216|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
56363857|NCT00088686|Capsaicin|capsaicin|mesh-list
56363925|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
56364000|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480217|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568063|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56568064|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56568065|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
56568066|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568067|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56364306|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
56364372|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
56568083|NCT01190930|Protective Agents|protective agents|mesh-ancestor
56568084|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
56568085|NCT01190930|Vitamins|vitamins|mesh-ancestor
56568086|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
56367146|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56568087|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56568088|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
56367387|NCT00084695|Hormones|hormones|mesh-ancestor
56568089|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
56568090|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
56568092|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
56568093|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56568094|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367735|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56568095|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56367882|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56568096|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
56568097|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368028|NCT00086099|Amifostine|amifostine|mesh-list
56368099|NCT00086294|Levodopa|levodopa|mesh-list
56368182|NCT00094341|Etanercept|etanercept|mesh-list
56368246|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
56568098|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568099|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568100|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568101|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
56568102|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
56568103|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568104|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568105|NCT00618202|Balsalazide|balsalazide|mesh-list
56371836|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
56568126|NCT05662306|Antidepressive Agents|antidepressive agents|mesh-ancestor
56568127|NCT05662306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56568128|NCT05662306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56568129|NCT05662306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56568130|NCT05662306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56372357|NCT00433225|Prednisolone|prednisolone|mesh-list
56372431|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
56372509|NCT00433927|Growth Substances|growth substances|mesh-ancestor
56568131|NCT05662306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568132|NCT05662306|Dopamine Agonists|dopamine agonists|mesh-ancestor
56568133|NCT05662306|Dopamine Agents|dopamine agents|mesh-ancestor
56372737|NCT04621149|Famotidine|famotidine|mesh-list
56568134|NCT05662306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56104383|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56373315|NCT00135759|Naltrexone|naltrexone|mesh-list
56568156|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56373609|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568157|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568158|NCT01101191|Analgesics|analgesics|mesh-ancestor
56568159|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
56373834|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56546263|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546264|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56546265|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
56546266|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
56546267|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56546268|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
56546269|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56546270|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
56546271|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546272|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546273|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56546274|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
56546275|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
56568160|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373983|NCT00134394|Analgesics|analgesics|mesh-ancestor
56568161|NCT00622258|Everolimus|everolimus|mesh-list
56568162|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568163|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568164|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
56568165|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568167|NCT01812616|Analgesics|analgesics|mesh-ancestor
56568168|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
56374278|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568169|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374503|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
56568170|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568172|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56568173|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
56568174|NCT00618358|Coagulants|coagulants|mesh-ancestor
56568175|NCT03664180|Heparin|heparin|mesh-list
56568176|NCT03664180|Calcium heparin|calcium heparin|mesh-list
56568177|NCT03664180|Enoxaparin|enoxaparin|mesh-list
56568178|NCT03664180|Hirudins|hirudins|mesh-list
56568179|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
56568180|NCT03664180|Bivalirudin|bivalirudin|mesh-list
56375028|NCT00107432|Sorafenib|sorafenib|mesh-list
56375173|NCT00142896|Analgesics|analgesics|mesh-ancestor
56568182|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56375354|NCT00442234|Monteplase|monteplase|mesh-list
56375408|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
56375467|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
56568183|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56104425|NCT00003650|Methotrexate|methotrexate|mesh-list
56378060|NCT00444574|Methylphenidate|methylphenidate|mesh-list
56568214|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56378208|NCT00445900|Thalidomide|thalidomide|mesh-list
56568216|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56568217|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56568291|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
56568292|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568294|NCT01008696|Lansoprazole|lansoprazole|mesh-list
56381737|NCT04957329|Latanoprost|latanoprost|mesh-list
56381808|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
56568295|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
56568296|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56568297|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56568298|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56568299|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382180|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382253|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
56382329|NCT00493129|Interleukin-2|interleukin-2|mesh-list
56568300|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568301|NCT01955980|Budesonide|budesonide|mesh-list
56568302|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568303|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56568304|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
56568305|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546276|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56546277|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
56546278|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546279|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546280|NCT01146288|Furosemide|furosemide|mesh-list
56546281|NCT01146288|Acetazolamide|acetazolamide|mesh-list
56546282|NCT01146288|Diuretics|diuretics|mesh-ancestor
56546283|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
56546284|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546285|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56546286|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200449|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200450|NCT01523860|Analgesics|analgesics|mesh-ancestor
56200451|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
56568306|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568307|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56568308|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
56568309|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
56568311|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56568312|NCT02870478|Atropine|atropine|mesh-list
56568313|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56568314|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56568315|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56568316|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56568317|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56568318|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
56568319|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382994|NCT04520490|Exenatide|exenatide|mesh-list
56568320|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568321|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56568322|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
56316760|NCT00276276|Topotecan|topotecan|mesh-list
56385342|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56568357|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568358|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56568359|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56568360|NCT00622570|Pentobarbital|pentobarbital|mesh-list
56568361|NCT00622570|Thiopental|thiopental|mesh-list
56568362|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
56385422|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
56568363|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56568364|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56568365|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568366|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56568367|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
56568368|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
56568369|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
56568370|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
56385561|NCT00142038|Capecitabine|capecitabine|mesh-list
56385634|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
56568371|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568372|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568373|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56568375|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
56568376|NCT00890266|Vitamins|vitamins|mesh-ancestor
56568377|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
56568378|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568379|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56568380|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
56568381|NCT01430572|Everolimus|everolimus|mesh-list
56568382|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568383|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546287|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546288|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
56546289|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56546290|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546291|NCT01146054|Gemcitabine|gemcitabine|mesh-list
56546292|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56546293|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56546294|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
56546295|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546296|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546297|NCT01146054|Antiviral Agents|antiviral agents|mesh-ancestor
56546298|NCT01146054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546299|NCT01146054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546300|NCT01146054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546301|NCT01146054|Immunologic Factors|immunologic factors|mesh-ancestor
56546302|NCT01146054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546303|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56546304|NCT00640705|Diclofenac|diclofenac|mesh-list
56546305|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56546306|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546307|NCT00640705|Analgesics|analgesics|mesh-ancestor
56546308|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
56546309|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546310|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546311|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568384|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
56568385|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568386|NCT01370512|Droxidopa|droxidopa|mesh-list
56568387|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56568388|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56568389|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56104646|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568469|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56568470|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56568471|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56568472|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568473|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56568474|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568476|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56568477|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56568478|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56568479|NCT01176032|Diuretics|diuretics|mesh-ancestor
56568480|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
56568481|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56568482|NCT01008618|Fentanyl|fentanyl|mesh-list
56568483|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56568484|NCT01008618|Narcotics|narcotics|mesh-ancestor
56568485|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56546312|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546313|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56546314|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546315|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546316|NCT01145898|Timolol|timolol|mesh-list
56546317|NCT01145898|Dorzolamide|dorzolamide|mesh-list
56546318|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56546319|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56546320|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
56546321|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546322|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200486|NCT01524094|Leucovorin|leucovorin|mesh-list
56386647|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386936|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56387574|NCT00505492|Paclitaxel|paclitaxel|mesh-list
56568526|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56568527|NCT01193842|Etoposide|etoposide|mesh-list
56568528|NCT01193842|Vincristine|vincristine|mesh-list
56568529|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
56568530|NCT01193842|Vorinostat|vorinostat|mesh-list
56568531|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
56568532|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56568533|NCT01193842|Antibodies|antibodies|mesh-list
56568534|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
56387641|NCT00141908|Castor Oil|castor oil|mesh-list
56568535|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56387724|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
56568536|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568537|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
56568538|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568539|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56568540|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568541|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
56388386|NCT00144326|Bromides|bromides|mesh-list
56568542|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568543|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388603|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568544|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56568545|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56568546|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56568547|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56568548|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568549|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568550|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
56568551|NCT01193842|Hormones|hormones|mesh-ancestor
56568552|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56568553|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56568554|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56568555|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
56568556|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
56568557|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
56568558|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56388757|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
56395151|NCT00170976|Amlodipine|amlodipine|mesh-list
56395152|NCT00170976|Valsartan|valsartan|mesh-list
56568611|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
56568612|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568613|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56568614|NCT02537860|Narcotics|narcotics|mesh-ancestor
56568615|NCT02537860|Analgesics|analgesics|mesh-ancestor
56568616|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56568617|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56568618|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
56568619|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
56568620|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546323|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546324|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56395295|NCT05786066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395296|NCT05786066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56395297|NCT05786066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56395298|NCT05786066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395299|NCT05786066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395300|NCT05786040|Rituximab|rituximab|mesh-list
56395301|NCT05786040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56395302|NCT05786040|Antibodies|antibodies|mesh-list
56395303|NCT05786040|Immunoglobulins|immunoglobulins|mesh-list
56395304|NCT05786040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56395305|NCT05786040|Immunologic Factors|immunologic factors|mesh-ancestor
56395306|NCT05786040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395307|NCT05786040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395308|NCT05786040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395327|NCT05785832|Insulin|insulin|mesh-list
56395328|NCT05785832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56395329|NCT05785832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568622|NCT03797014|Tenofovir|tenofovir|mesh-list
56568623|NCT03797014|Emtricitabine|emtricitabine|mesh-list
56568624|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56395685|NCT05700422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56395686|NCT05700422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56395687|NCT05700422|Cholinergic Agents|cholinergic agents|mesh-ancestor
56395688|NCT05700422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568626|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568627|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56568628|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56568629|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568630|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568631|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56568632|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56568633|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
56568634|NCT04521946|Fludarabine|fludarabine|mesh-list
56568635|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
56568636|NCT04521946|Etoposide|etoposide|mesh-list
56568637|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
56568638|NCT04521946|Melphalan|melphalan|mesh-list
56568639|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
56568640|NCT04521946|Thiotepa|thiotepa|mesh-list
56568641|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
56568642|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56568643|NCT04521946|Tacrolimus|tacrolimus|mesh-list
56568644|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
56568645|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56568646|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
56568647|NCT04521946|Antibodies|antibodies|mesh-list
56568648|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
56395809|NCT05622201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395892|NCT05564039|Incretins|incretins|mesh-ancestor
56395893|NCT05564039|Hormones|hormones|mesh-ancestor
56395894|NCT05564039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395907|NCT05550597|Fentanyl|fentanyl|mesh-list
56395908|NCT05550597|Bupivacaine|bupivacaine|mesh-list
56396036|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56396037|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
56396038|NCT05425940|Atezolizumab|atezolizumab|mesh-list
56396039|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396040|NCT05415215|Trastuzumab|trastuzumab|mesh-list
56396041|NCT05415215|Pertuzumab|pertuzumab|mesh-list
56396042|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56396563|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56396564|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56396566|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56396567|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56396568|NCT04923841|Atropine|atropine|mesh-list
56396569|NCT04923841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56396574|NCT04923841|Autonomic Agents|autonomic agents|mesh-ancestor
56568652|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56568653|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
56568696|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568697|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56568698|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56568700|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56568701|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56546325|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56546326|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56568702|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56568703|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56568704|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
56568705|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568706|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568707|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568708|NCT04314674|Mannitol|mannitol|mesh-list
56568709|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56568710|NCT04314674|Diuretics|diuretics|mesh-ancestor
56568711|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
56568712|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568713|NCT00639262|Temozolomide|temozolomide|mesh-list
56568714|NCT00639262|Sorafenib|sorafenib|mesh-list
56568715|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568716|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
56044461|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146338|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
56568717|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568718|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146486|NCT01043094|Pitavastatin|pitavastatin|mesh-list
56146563|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
56568719|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56568720|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568721|NCT02885558|Efonidipine|efonidipine|mesh-list
56105152|NCT00003734|Flutamide|flutamide|mesh-list
56568760|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56568761|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149213|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56568762|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56568764|NCT04186936|Loperamide|loperamide|mesh-list
56568765|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
56568766|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56568767|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
56568768|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568769|NCT04186936|Emollients|emollients|mesh-ancestor
56568770|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
56568771|NCT02689180|Furosemide|furosemide|mesh-list
56568772|NCT02689180|Diuretics|diuretics|mesh-ancestor
56568773|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
56568774|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568775|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56568776|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56568777|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568778|NCT02689336|Temozolomide|temozolomide|mesh-list
56568779|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56568780|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568781|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
56568782|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568783|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568784|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56568785|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568786|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
56568787|NCT03650764|Ramucirumab|ramucirumab|mesh-list
56568788|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56568789|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568790|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56568791|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56568792|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
56568793|NCT01007448|Bexarotene|bexarotene|mesh-list
56568794|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568795|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56568796|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
56568797|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568798|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
56149471|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
56568799|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568800|NCT04294056|Propofol|propofol|mesh-list
56568801|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56149994|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
56568802|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150221|NCT01678794|Candesartan|candesartan|mesh-list
56078001|NCT05649085|Cobalt|cobalt|mesh-list
56069707|NCT04365049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397243|NCT04187833|Nivolumab|nivolumab|mesh-list
56546328|NCT02681653|Atorvastatin|atorvastatin|mesh-list
56546329|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56546330|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56546331|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
56546332|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546333|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56546334|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56546335|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546336|NCT04315116|Loperamide|loperamide|mesh-list
56568803|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568804|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56568805|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
56568807|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
56568808|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
56568809|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56568810|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56150449|NCT05471076|Complement C4b|complement c4b|mesh-list
56568811|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568812|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
56568814|NCT02686840|Misoprostol|misoprostol|mesh-list
56568815|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56568816|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
56151120|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
56568817|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56151496|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56151573|NCT01870596|Cytarabine|cytarabine|mesh-list
56151644|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56152989|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
56568836|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
56153365|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56568837|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568838|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56568840|NCT02689024|Analgesics|analgesics|mesh-ancestor
56568841|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56153664|NCT02148588|Lidocaine|lidocaine|mesh-list
56568842|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56153736|NCT02160990|Exenatide|exenatide|mesh-list
56568843|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
56153810|NCT02196168|Cisplatin|cisplatin|mesh-list
56568844|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56568845|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
56153881|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568846|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56568847|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153960|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
56568849|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56568850|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154171|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56480241|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56568851|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568852|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
56154462|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
56568853|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56568854|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56568855|NCT00638482|Diuretics|diuretics|mesh-ancestor
56568856|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
56568857|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154916|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56154991|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
56568858|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56155139|NCT05719506|Anesthetics|anesthetics|mesh-ancestor
56155290|NCT05570292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56568859|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56568860|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155600|NCT04579380|Tucatinib|tucatinib|mesh-list
56568861|NCT00638560|Vitamins|vitamins|mesh-list
56568862|NCT00638560|Vitamin E|vitamin e|mesh-list
56546337|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
56546338|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56546339|NCT02883114|Itraconazole|itraconazole|mesh-list
56546340|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
56546341|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546342|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56546343|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56546344|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546345|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546346|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56546347|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
56546348|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546349|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546350|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56546351|NCT04183387|Simvastatin|simvastatin|mesh-list
56546352|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56546353|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56546354|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
56546355|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546356|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56546357|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56546358|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546359|NCT00625092|Leucovorin|leucovorin|mesh-list
56200516|NCT01524315|Vitamins|vitamins|mesh-list
56568863|NCT00638560|Antioxidants|antioxidants|mesh-list
56568864|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
56568865|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568977|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56568978|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
56568979|NCT02685670|Fludarabine|fludarabine|mesh-list
56568980|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568981|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
56568982|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568983|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56568984|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568985|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
56568986|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568987|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568988|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56568989|NCT02687932|Valsartan|valsartan|mesh-list
56568990|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56568991|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56568992|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56568993|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56568994|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568995|NCT00641602|Esomeprazole|esomeprazole|mesh-list
56568996|NCT00641602|Lansoprazole|lansoprazole|mesh-list
56568997|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
56546360|NCT00625092|Fluorouracil|fluorouracil|mesh-list
56546361|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
56546362|NCT00625092|Calcium|calcium|mesh-list
56546363|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
56546364|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56546365|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546366|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
56546367|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546368|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56546369|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546370|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546371|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
56546372|NCT00625092|Antidotes|antidotes|mesh-ancestor
56546373|NCT00625092|Protective Agents|protective agents|mesh-ancestor
56546374|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
56546375|NCT00625092|Vitamins|vitamins|mesh-ancestor
56546376|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
56546377|NCT00931918|Prednisone|prednisone|mesh-list
56546378|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
56568998|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56568999|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56569000|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56569001|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569002|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569003|NCT05663944|Sirolimus|sirolimus|mesh-list
56569004|NCT05663944|Liver Extracts|liver extracts|mesh-list
56569005|NCT05663944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56569039|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56569040|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56569041|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
56569042|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569043|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569044|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569045|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56569046|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56569047|NCT02031250|Carboplatin|carboplatin|mesh-list
56569048|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569080|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569081|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56569082|NCT01174238|Paclitaxel|paclitaxel|mesh-list
56569083|NCT01174238|Carboplatin|carboplatin|mesh-list
56569084|NCT01174238|Axitinib|axitinib|mesh-list
56569085|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56569086|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569087|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
56569088|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
56569089|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
56569090|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569091|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56569092|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569093|NCT05663710|Nivolumab|nivolumab|mesh-list
56569125|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56569127|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56569128|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56569129|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56569130|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56569131|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569132|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546379|NCT00931918|Rituximab|rituximab|mesh-list
56546380|NCT00931918|Doxorubicin|doxorubicin|mesh-list
56546381|NCT00931918|Vincristine|vincristine|mesh-list
56546382|NCT00931918|Bortezomib|bortezomib|mesh-list
56546383|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546384|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
56569133|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56569134|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56569135|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56569136|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
56569137|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569138|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569139|NCT01173692|Minocycline|minocycline|mesh-list
56569140|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56569176|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
56569177|NCT01101035|Protective Agents|protective agents|mesh-ancestor
56569178|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569179|NCT01160822|Naproxen|naproxen|mesh-list
56569180|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56569251|NCT05664568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56569252|NCT05664568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569253|NCT05664568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569254|NCT02682082|Bupivacaine|bupivacaine|mesh-list
56569255|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
56569256|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
56569257|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569258|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569259|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
56569260|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569261|NCT00640432|Celecoxib|celecoxib|mesh-list
56569262|NCT00640432|Diclofenac|diclofenac|mesh-list
56569263|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56569264|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56569307|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569309|NCT00997386|Busulfan|busulfan|mesh-list
56569310|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
56105698|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569369|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
56569370|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56569371|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
56569372|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
56569373|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56569374|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56569375|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569376|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
56569377|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56569378|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56569379|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56569380|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569381|NCT04183114|Vaccines|vaccines|mesh-list
56569382|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
56569383|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569384|NCT00996996|Iodine|iodine|mesh-list
56569385|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
56569386|NCT00996996|Antibodies|antibodies|mesh-list
56569387|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
56569388|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
56569389|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569390|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56569391|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569392|NCT00996996|Trace Elements|trace elements|mesh-ancestor
56569393|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
56569394|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569395|NCT04182568|Paclitaxel|paclitaxel|mesh-list
56569396|NCT04182568|Docetaxel|docetaxel|mesh-list
56569397|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
56569398|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56569399|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569427|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56569429|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569430|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569431|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546385|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546386|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546387|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56546388|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
56546389|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546390|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546391|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56546392|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546393|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56546394|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56569432|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56569433|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569434|NCT02679040|Trastuzumab|trastuzumab|mesh-list
56569435|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569436|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569437|NCT05663242|Anesthetics|anesthetics|mesh-list
56569438|NCT05663242|Propofol|propofol|mesh-list
56569439|NCT05663242|Sevoflurane|sevoflurane|mesh-list
56569440|NCT05663242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569441|NCT05663242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569442|NCT05663242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56569443|NCT05663242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56569444|NCT05663242|Anesthetics, General|anesthetics, general|mesh-ancestor
56569445|NCT05663242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56569467|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56569468|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
56569469|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569470|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569471|NCT04180072|Bevacizumab|bevacizumab|mesh-list
56569472|NCT04180072|Atezolizumab|atezolizumab|mesh-list
56569473|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569474|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569475|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56569476|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56569477|NCT04180072|Growth Substances|growth substances|mesh-ancestor
56569478|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569479|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
56569480|NCT02678650|Anesthetics|anesthetics|mesh-list
56569481|NCT02678650|Propofol|propofol|mesh-list
56569482|NCT02678650|Isoflurane|isoflurane|mesh-list
56569483|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569484|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569485|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56569486|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56569487|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
56569488|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56569489|NCT04180150|Entecavir|entecavir|mesh-list
56569490|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
56569491|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569492|NCT02678338|Magrolimab|magrolimab|mesh-list
56569493|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569494|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569495|NCT00642226|Triamcinolone|triamcinolone|mesh-list
56569496|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569497|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
56569498|NCT00642226|Hormones|hormones|mesh-ancestor
56105819|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569523|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56569524|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56569525|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
56569526|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
56569527|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569528|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569529|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546395|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56546396|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546397|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546398|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
56546399|NCT00931918|Hormones|hormones|mesh-ancestor
56546400|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546401|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56546402|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56546403|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
56546404|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
56546405|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
56569530|NCT02678260|Spartalizumab|spartalizumab|mesh-list
56569531|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56569532|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569533|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569534|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
56569535|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569536|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569537|NCT04179604|Simendan|simendan|mesh-list
56569538|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56569539|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
56569540|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56569541|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56569542|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569543|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569544|NCT04179604|Protective Agents|protective agents|mesh-ancestor
56569545|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569546|NCT02675140|Vitamins|vitamins|mesh-list
56569569|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569571|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56569572|NCT01160744|Gemcitabine|gemcitabine|mesh-list
56569573|NCT01160744|Carboplatin|carboplatin|mesh-list
56569574|NCT01160744|Pemetrexed|pemetrexed|mesh-list
56569575|NCT01160744|Ramucirumab|ramucirumab|mesh-list
56569576|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56569577|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569578|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56569579|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
56569580|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569581|NCT01160744|Antiviral Agents|antiviral agents|mesh-ancestor
56569582|NCT01160744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569583|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569584|NCT01160744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569585|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
56569586|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569587|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56569588|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56569589|NCT02677246|Denosumab|denosumab|mesh-list
56569590|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56569591|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569592|NCT01160354|Plerixafor|plerixafor|mesh-list
56569593|NCT01160354|Clofarabine|clofarabine|mesh-list
56569594|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56569595|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
56569596|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569597|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569598|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56569599|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56569600|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
56569601|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569602|NCT04178512|Dexamethasone|dexamethasone|mesh-list
56569659|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56569660|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
56546406|NCT04183075|Vitamins|vitamins|mesh-list
56546407|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
56546408|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
56546409|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546410|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
56546411|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546412|NCT04183075|Protective Agents|protective agents|mesh-ancestor
56546413|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56546414|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546415|NCT02678221|Aspirin|aspirin|mesh-list
56546416|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
56546417|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56546418|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546419|NCT02678221|Analgesics|analgesics|mesh-ancestor
56546420|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
56546421|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546422|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546423|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546424|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546425|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56546426|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56546427|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546428|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56546429|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56546430|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546431|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
56546432|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
56546433|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56546434|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56546435|NCT02678221|Urological Agents|urological agents|mesh-ancestor
56546436|NCT00641329|Clonidine|clonidine|mesh-list
56546437|NCT00641329|Analgesics|analgesics|mesh-ancestor
56546438|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
56546439|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546440|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569661|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
56569662|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569663|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569664|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
56546441|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56546442|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
56546443|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
56546444|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56546445|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56569665|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56569666|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
56569667|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
56569668|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56569669|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56569670|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56569671|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
56569672|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569673|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569674|NCT02885168|Protective Agents|protective agents|mesh-ancestor
56569675|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
56569676|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56569677|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56569678|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569679|NCT01159574|Clarithromycin|clarithromycin|mesh-list
56569725|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56569726|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56569728|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569729|NCT01172288|Protective Agents|protective agents|mesh-ancestor
56569730|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569731|NCT01172288|Antidotes|antidotes|mesh-ancestor
56569732|NCT02676622|Aldesleukin|aldesleukin|mesh-list
56569733|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
56569734|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
56569735|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569736|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
56569737|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569738|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569739|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56569740|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
56569741|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569742|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569743|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56569744|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56569745|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56569746|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
56569747|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569748|NCT00644020|Fluorouracil|fluorouracil|mesh-list
56569749|NCT00644020|Mitomycins|mitomycins|mesh-list
56569750|NCT00644020|Mitomycin|mitomycin|mesh-list
56569751|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
56569752|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569753|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56569754|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569755|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569756|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
56569757|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569758|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56569759|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
56569794|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569795|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569796|NCT00644176|Azithromycin|azithromycin|mesh-list
56569797|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56569798|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569799|NCT04178200|Lidocaine|lidocaine|mesh-list
56569800|NCT04178200|Bupivacaine|bupivacaine|mesh-list
56569801|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56569802|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
56569803|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
56569804|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569839|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
56569840|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
56569863|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56569865|NCT04176328|Teicoplanin|teicoplanin|mesh-list
56569866|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56569867|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546446|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56546447|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
56546448|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546449|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546450|NCT01179191|Naltrexone|naltrexone|mesh-list
56546451|NCT01179191|Morphine|morphine|mesh-list
56546452|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56546453|NCT01179191|Narcotics|narcotics|mesh-ancestor
56546454|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56546455|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546456|NCT01179191|Analgesics|analgesics|mesh-ancestor
56546457|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
56569868|NCT04177342|Fentanyl|fentanyl|mesh-list
56569869|NCT04177342|Oxycodone|oxycodone|mesh-list
56569870|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56569871|NCT04177342|Narcotics|narcotics|mesh-ancestor
56569872|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569873|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569874|NCT04177342|Analgesics|analgesics|mesh-ancestor
56569875|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
56569876|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569877|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56569878|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56569879|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
56569880|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
56569881|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
56569882|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569883|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
56569884|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569885|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569886|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56569887|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
56569888|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569889|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569890|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56569891|NCT04175158|Bevacizumab|bevacizumab|mesh-list
56569892|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
56569893|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569894|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569923|NCT00644800|Ziprasidone|ziprasidone|mesh-list
56569924|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56569925|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
56569926|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569927|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157989|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
56569928|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569929|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56569930|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56569931|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569932|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56569933|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56569934|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
56569935|NCT02670616|Prednisolone|prednisolone|mesh-list
56569936|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
56569937|NCT02670616|Rituximab|rituximab|mesh-list
56569938|NCT02670616|Doxorubicin|doxorubicin|mesh-list
56569939|NCT02670616|Vincristine|vincristine|mesh-list
56569940|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569941|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
56106233|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56569970|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56569971|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569972|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56569973|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56569974|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
56569975|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
56546458|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546459|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56546460|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56546461|NCT00642421|Octreotide|octreotide|mesh-list
56546462|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56546463|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56546464|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546465|NCT00642187|Budesonide|budesonide|mesh-list
56546466|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546467|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56546468|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
56546469|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546470|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546471|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56546472|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
56546473|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
56546474|NCT00642187|Hormones|hormones|mesh-ancestor
56200626|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
56569976|NCT00644956|Tadalafil|tadalafil|mesh-list
56569977|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
56569978|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56569979|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56569980|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569981|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569982|NCT00644956|Urological Agents|urological agents|mesh-ancestor
56569983|NCT04175002|Progesterone|progesterone|mesh-list
56569984|NCT04175002|Progestins|progestins|mesh-ancestor
56569985|NCT04175002|Hormones|hormones|mesh-ancestor
56570006|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570007|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
56570008|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56570009|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570010|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570011|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56570012|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56570013|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570014|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570015|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
56570016|NCT04294992|Ondansetron|ondansetron|mesh-list
56570017|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
56570018|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
56570019|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570020|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570021|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56570022|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
56570023|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
56570024|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56570025|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
56570026|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570027|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570028|NCT04294992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56570029|NCT04294992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56570030|NCT04294992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570031|NCT04294992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56570032|NCT04294992|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56570033|NCT00628914|Dexetimide|dexetimide|mesh-list
56570034|NCT00628914|Eszopiclone|eszopiclone|mesh-list
56570035|NCT00628914|Citalopram|citalopram|mesh-list
56570036|NCT00628914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56546475|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546476|NCT05663125|Temozolomide|temozolomide|mesh-list
56546477|NCT05663125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56546478|NCT05663125|Alkylating Agents|alkylating agents|mesh-ancestor
56546479|NCT05663125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546480|NCT05663125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546481|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
56546482|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
56546483|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56546484|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56546485|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546486|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546487|NCT01132482|Urological Agents|urological agents|mesh-ancestor
56546488|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56546489|NCT02678767|Hematinics|hematinics|mesh-ancestor
56546490|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56546491|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56546492|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56546493|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56546494|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56546495|NCT00931762|Panobinostat|panobinostat|mesh-list
56546496|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546497|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56570037|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56570038|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570039|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106331|NCT04536337|Entecavir|entecavir|mesh-list
56570067|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56570068|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570069|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570070|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570071|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
56570072|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56570073|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
56570074|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56570075|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56570077|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56570078|NCT02670304|Aspirin|aspirin|mesh-list
56570079|NCT02670304|Letrozole|letrozole|mesh-list
56570080|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56570081|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56570082|NCT02670304|Analgesics|analgesics|mesh-ancestor
56570083|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
56570084|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570085|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570086|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106382|NCT00005648|Tipifarnib|tipifarnib|mesh-list
56070138|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
56546498|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546499|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546500|NCT00641407|Insulin|insulin|mesh-list
56546501|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56546502|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
56546503|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56570122|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570146|NCT00645658|Testosterone|testosterone|mesh-list
56570147|NCT00645658|Androgens|androgens|mesh-ancestor
56570148|NCT00645658|Hormones|hormones|mesh-ancestor
56570149|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570150|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570151|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
56570152|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
56570153|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570154|NCT02666170|Protective Agents|protective agents|mesh-ancestor
56570155|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570156|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
56570157|NCT02666170|Vitamins|vitamins|mesh-ancestor
56570158|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
56570159|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
56570160|NCT02667262|Narcotics|narcotics|mesh-ancestor
56570161|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570162|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570163|NCT02667262|Analgesics|analgesics|mesh-ancestor
56570164|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
56570165|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570166|NCT00646126|Artesunate|artesunate|mesh-list
56570167|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
56570168|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
56570169|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
56570170|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56570171|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56570172|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570173|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570174|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
56318563|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
56570175|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
56570207|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
56570208|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56570209|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570210|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56570211|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56570212|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570213|NCT00645892|Adalimumab|adalimumab|mesh-list
56570214|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570215|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570216|NCT00645190|Galantamine|galantamine|mesh-list
56570217|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56570218|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106514|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56570250|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
56570251|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570252|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
56570253|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
56570254|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56570255|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570256|NCT04292886|Tamoxifen|tamoxifen|mesh-list
56570257|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570258|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56570259|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
56570260|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570261|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56570286|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570287|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56570288|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
56570289|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570290|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570291|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56546504|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546505|NCT02677597|Paclitaxel|paclitaxel|mesh-list
56546506|NCT02677597|Cisplatin|cisplatin|mesh-list
56546507|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56546508|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546509|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
56570292|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56570293|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56570294|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56570295|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56570296|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570297|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570298|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56570299|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56570300|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56570301|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
56570302|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570303|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570304|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56570305|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56570306|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
56570307|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
56570308|NCT02669368|Rocuronium|rocuronium|mesh-list
56570309|NCT02669368|Analgesics|analgesics|mesh-ancestor
56570310|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
56570329|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56570330|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570331|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570332|NCT00645268|Urological Agents|urological agents|mesh-ancestor
56570334|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56570335|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570336|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570337|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
56570338|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570339|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570340|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56570341|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
56570342|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570343|NCT02665702|Cisplatin|cisplatin|mesh-list
56570344|NCT02665702|Vinorelbine|vinorelbine|mesh-list
56570345|NCT02665702|Endostar protein|endostar protein|mesh-list
56570346|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570347|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56570348|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
56570349|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
56570350|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
56570351|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570352|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56570353|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56570354|NCT02665702|Growth Substances|growth substances|mesh-ancestor
56570355|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570356|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
56570357|NCT00646750|Rituximab|rituximab|mesh-list
56570358|NCT00646750|Melphalan|melphalan|mesh-list
56570359|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56570360|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570361|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
56570362|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570389|NCT02665624|Sennosides|sennosides|mesh-list
56570390|NCT02665624|Senna Extract|senna extract|mesh-list
56570391|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56570392|NCT02665624|Calcium|calcium|mesh-list
56570393|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56570394|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570395|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56318800|NCT00022737|Hormones|hormones|mesh-ancestor
56570396|NCT02665624|Laxatives|laxatives|mesh-ancestor
56570397|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56570398|NCT02665624|Cathartics|cathartics|mesh-ancestor
56570399|NCT00646594|Fluticasone|fluticasone|mesh-list
56570400|NCT00646594|Budesonide|budesonide|mesh-list
56546510|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
56546511|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
56546512|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546513|NCT01132326|Droxidopa|droxidopa|mesh-list
56546514|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56546515|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56546516|NCT02681263|Temocillin|temocillin|mesh-list
56546517|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56546518|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546519|NCT02677519|Methylphenidate|methylphenidate|mesh-list
56546520|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56546521|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546522|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56546523|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56546524|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200678|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56570401|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
56570402|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56570403|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56570404|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56570405|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570406|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56570407|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
56570408|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106695|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56570440|NCT00647218|Paclitaxel|paclitaxel|mesh-list
56570441|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56570442|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570443|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
56570444|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
56570445|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
56570446|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570447|NCT00994890|Tanezumab|tanezumab|mesh-list
56570448|NCT00994890|Analgesics|analgesics|mesh-ancestor
56570449|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
56570450|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570451|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570505|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
56570506|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570507|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570509|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56570510|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56570511|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
56570512|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570513|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56570514|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56570515|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570516|NCT04172740|Calcium|calcium|mesh-list
56570517|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56570518|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570519|NCT02663596|Vancomycin|vancomycin|mesh-list
56570520|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56570521|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570522|NCT00647530|Fluorouracil|fluorouracil|mesh-list
56570523|NCT00647530|Capecitabine|capecitabine|mesh-list
56570524|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
56158059|NCT04968054|Propofol|propofol|mesh-list
56570525|NCT00647530|Panitumumab|panitumumab|mesh-list
56546525|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546526|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
56546527|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546528|NCT01145508|Metronidazole|metronidazole|mesh-list
56546529|NCT01145508|Prednisone|prednisone|mesh-list
56546530|NCT01145508|Cortisone|cortisone|mesh-list
56546531|NCT01145508|Docetaxel|docetaxel|mesh-list
56570526|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
56570527|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570528|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56570529|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570530|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56570531|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
56570532|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570533|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56570534|NCT00647608|Propranolol|propranolol|mesh-list
56570535|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56570536|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56570537|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
56570538|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570564|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570565|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56570566|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56570567|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56570568|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
56570569|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570570|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570572|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56570573|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56570574|NCT02660008|Hormones|hormones|mesh-ancestor
56570575|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570576|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570577|NCT02660008|Incretins|incretins|mesh-ancestor
56570578|NCT00649168|Bromocriptine|bromocriptine|mesh-list
56570579|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56570580|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56570581|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
56570582|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570583|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570584|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
56570585|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
56106838|NCT04173793|Ezetimibe|ezetimibe|mesh-list
56570594|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570596|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
56570598|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570599|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570600|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
56570601|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570602|NCT00647686|Fentanyl|fentanyl|mesh-list
56570603|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56570604|NCT00647686|Narcotics|narcotics|mesh-ancestor
56570605|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570606|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570607|NCT00647686|Analgesics|analgesics|mesh-ancestor
56570608|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
56570609|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570610|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56570611|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56570612|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
56570613|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
56570614|NCT02663050|Diclofenac|diclofenac|mesh-list
56570615|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56570616|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56319020|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
56570617|NCT02663050|Analgesics|analgesics|mesh-ancestor
56570618|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
56570619|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570620|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546532|NCT01145508|Vaccines|vaccines|mesh-list
56546533|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
56546534|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546535|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546536|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
56546537|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
56546538|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
56546539|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546540|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546541|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
56546542|NCT01145508|Hormones|hormones|mesh-ancestor
56546543|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546544|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56546545|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546546|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56546547|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56546548|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56546549|NCT00931528|Tadalafil|tadalafil|mesh-list
56546550|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
56200705|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
56570621|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570622|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570623|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56570624|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570625|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570626|NCT00648856|Sertraline|sertraline|mesh-list
56570627|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
56570628|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56570629|NCT00648856|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56570630|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56570631|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570632|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570633|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570634|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
56570635|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570636|NCT01171976|Ranibizumab|ranibizumab|mesh-list
56570637|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56570638|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56570639|NCT01171976|Growth Substances|growth substances|mesh-ancestor
56570640|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570641|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
56570642|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570643|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
56570644|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570645|NCT00647842|Fentanyl|fentanyl|mesh-list
56570646|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56570647|NCT00647842|Narcotics|narcotics|mesh-ancestor
56570648|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570649|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106866|NCT04909801|Adalimumab|adalimumab|mesh-list
56570685|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
56570712|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
56570713|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570714|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570716|NCT02662504|Pemetrexed|pemetrexed|mesh-list
56546551|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56546552|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56546553|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546554|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546555|NCT00931528|Urological Agents|urological agents|mesh-ancestor
56546556|NCT04181749|Aspirin|aspirin|mesh-list
56546557|NCT04181749|Atorvastatin|atorvastatin|mesh-list
56546558|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56200716|NCT01525537|Dsuvia|dsuvia|mesh-list
56570717|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56570718|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570719|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570720|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570721|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56570722|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56570723|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
56570724|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56570725|NCT00648934|Topiramate|topiramate|mesh-list
56570726|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
56570727|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56570728|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570729|NCT02659228|Anesthetics|anesthetics|mesh-list
56570730|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56570731|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570732|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570733|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
56570734|NCT00844519|Maraviroc|maraviroc|mesh-list
56570735|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56570736|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56570758|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570760|NCT02662348|Interleukin-2|interleukin-2|mesh-list
56570761|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570762|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56570763|NCT02662348|Analgesics|analgesics|mesh-ancestor
56570764|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
56570765|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570766|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570767|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56570768|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56570769|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
56570770|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570771|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
56570772|NCT02868372|Povidone|povidone|mesh-list
56570773|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
56570774|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
56570775|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56570776|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570777|NCT00629148|Capecitabine|capecitabine|mesh-list
56570778|NCT00629148|Vinorelbine|vinorelbine|mesh-list
56570779|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56570780|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
56570781|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570782|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570783|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56570784|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
56570785|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
56570786|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
56570787|NCT01157234|Metoprolol|metoprolol|mesh-list
56570788|NCT01157234|Nebivolol|nebivolol|mesh-list
56570789|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56570790|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56570791|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
56570809|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56570810|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570811|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570812|NCT04170790|Urological Agents|urological agents|mesh-ancestor
56570813|NCT04170790|Incretins|incretins|mesh-ancestor
56570814|NCT04170790|Hormones|hormones|mesh-ancestor
56546559|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546560|NCT04181749|Analgesics|analgesics|mesh-ancestor
56546561|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
56546562|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546563|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570815|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570816|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570817|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56570818|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
56570819|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56570820|NCT00995670|Sevoflurane|sevoflurane|mesh-list
56570821|NCT00995670|Simvastatin|simvastatin|mesh-list
56570822|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570823|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56570824|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56570825|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
56570826|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570827|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56570828|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56570829|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570830|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56570831|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56570832|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
56570833|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
56570834|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570836|NCT02658838|Calcium heparin|calcium heparin|mesh-list
56570837|NCT02658838|Enoxaparin|enoxaparin|mesh-list
56570838|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56570839|NCT02658838|Tinzaparin|tinzaparin|mesh-list
56570840|NCT02658838|Dalteparin|dalteparin|mesh-list
56570841|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
56570842|NCT02658838|Ticagrelor|ticagrelor|mesh-list
56570843|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56570844|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
56570845|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56570846|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56570847|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107003|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56570895|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56570896|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
56570897|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570898|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570899|NCT02664142|Anesthetics|anesthetics|mesh-list
56570900|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570901|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570902|NCT04169854|Lidocaine|lidocaine|mesh-list
56570903|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
56570904|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
56570905|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570906|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570907|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
56570908|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570909|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56570910|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56570911|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56570912|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570913|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107096|NCT00002911|Marimastat|marimastat|mesh-list
56570973|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570974|NCT00992394|Etanercept|etanercept|mesh-list
56570975|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56570976|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56570977|NCT00992394|Analgesics|analgesics|mesh-ancestor
56570978|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
56570979|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570980|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570981|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570982|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570983|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56546564|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546565|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546566|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56546567|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56546568|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546569|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56546570|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56200730|NCT01525706|Ethanol|ethanol|mesh-list
56570984|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56570985|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
56570986|NCT00829933|Warfarin|warfarin|mesh-list
56570987|NCT00829933|Edoxaban|edoxaban|mesh-list
56570988|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
56570989|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56570990|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
56570991|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56570992|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
56570993|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570994|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570996|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56570997|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
56570998|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570999|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
56571000|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571147|NCT00706225|Hormones|hormones|mesh-ancestor
56571148|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571149|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571150|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56571151|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56571152|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
56571153|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56571154|NCT04117009|Remifentanil|remifentanil|mesh-list
56571155|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56571156|NCT04117009|Narcotics|narcotics|mesh-ancestor
56571157|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571158|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571159|NCT04117009|Analgesics|analgesics|mesh-ancestor
56571160|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
56571161|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571162|NCT04117243|Misoprostol|misoprostol|mesh-list
56571163|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
56571164|NCT04117243|Oxytocin|oxytocin|mesh-list
56571165|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
56571166|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56571167|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571168|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56571169|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56571170|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571171|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
56571172|NCT04117243|Coagulants|coagulants|mesh-ancestor
56158084|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56571173|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56571195|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56571196|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56571197|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571198|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56571199|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56571200|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571201|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
56571202|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56571203|NCT00840463|Ambrisentan|ambrisentan|mesh-list
56571204|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56571205|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
56571206|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571207|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571208|NCT00839527|Metformin|metformin|mesh-list
56571209|NCT00839527|Pioglitazone|pioglitazone|mesh-list
56546571|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546572|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
56546573|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56546574|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56546575|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
56546576|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56546577|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56546578|NCT04312152|Vitamins|vitamins|mesh-list
56546579|NCT04312152|Vitamin E|vitamin e|mesh-list
56546580|NCT04312152|Tocopherols|tocopherols|mesh-list
56546581|NCT04312152|Folic Acid|folic acid|mesh-list
56546582|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
56546583|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
56546584|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571210|NCT00839527|Glimepiride|glimepiride|mesh-list
56571211|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
56571212|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56571213|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571214|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571215|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56571216|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56571217|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
56571218|NCT00839527|Incretins|incretins|mesh-ancestor
56571220|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571221|NCT00706927|Timolol|timolol|mesh-list
56571222|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56571223|NCT00706927|Latanoprost|latanoprost|mesh-list
56571224|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56571225|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56571226|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
56571227|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571228|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571229|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571230|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56571260|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56571261|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56571262|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
56571263|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56571264|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56571265|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56571266|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
56571267|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
56571268|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
56571269|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
56571270|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56571271|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571272|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571273|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56571274|NCT05500261|Analgesics|analgesics|mesh-ancestor
56571275|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
56571276|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571369|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571370|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571371|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56571372|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
56571373|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571374|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571376|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56571377|NCT00838903|Glimepiride|glimepiride|mesh-list
56571378|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
56571379|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56571380|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571381|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546585|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
56546586|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546587|NCT04312152|Protective Agents|protective agents|mesh-ancestor
56546588|NCT04312152|Hematinics|hematinics|mesh-ancestor
56546589|NCT00975195|Fluticasone|fluticasone|mesh-list
56546591|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
56546592|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56546593|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546594|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56546595|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
56546596|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546597|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546598|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56546599|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
56546600|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
56546601|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56546602|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
56546603|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56546604|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
56546605|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546606|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571382|NCT00838903|Incretins|incretins|mesh-ancestor
56571384|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571385|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56571386|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
56571422|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56571423|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571424|NCT02656342|Cycloserine|cycloserine|mesh-list
56107507|NCT00003013|Tamoxifen|tamoxifen|mesh-list
56571459|NCT00649558|Pioglitazone|pioglitazone|mesh-list
56571460|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571461|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571462|NCT02658526|Anesthetics|anesthetics|mesh-list
56571463|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571464|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571465|NCT00650494|Valacyclovir|valacyclovir|mesh-list
56571466|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
56571499|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
56571500|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56571501|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571502|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
56571503|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
56571504|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
56571505|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571506|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56571507|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
56571508|NCT02658214|Antiviral Agents|antiviral agents|mesh-ancestor
56571509|NCT02658214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571510|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571511|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56571512|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
56571513|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571514|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319923|NCT00028353|Toremifene|toremifene|mesh-list
55834587|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
56546607|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56546608|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56546609|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56546610|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
56546611|NCT00642499|Dronabinol|dronabinol|mesh-list
56546612|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
56546613|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546614|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56546615|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546616|NCT00642499|Analgesics|analgesics|mesh-ancestor
56546617|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
56546618|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546619|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56546620|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56546621|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546622|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546623|NCT00642499|Hormones|hormones|mesh-ancestor
56546624|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546625|NCT00644215|Mitomycins|mitomycins|mesh-list
56546626|NCT00644215|Mitomycin|mitomycin|mesh-list
56546627|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56546628|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546629|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
56546630|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571550|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571551|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571553|NCT02651350|Hormones|hormones|mesh-ancestor
56107626|NCT00788125|Dasatinib|dasatinib|mesh-list
56571575|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56571576|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571577|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571579|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
56571580|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571581|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56571582|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
56571583|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56571584|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56571585|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56571586|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571587|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
56571588|NCT04030663|Papaverine|papaverine|mesh-list
56571589|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
56571590|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56571591|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571592|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571593|NCT04030663|Urological Agents|urological agents|mesh-ancestor
56571594|NCT00700921|Lovastatin|lovastatin|mesh-list
56571595|NCT00700921|L 647318|l 647318|mesh-list
56571596|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
56546631|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56546632|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546633|NCT01145352|Etanercept|etanercept|mesh-list
56546634|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56546635|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546636|NCT01145352|Analgesics|analgesics|mesh-ancestor
56546637|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
56546638|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546639|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546640|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571597|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56571598|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56571599|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
56571600|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571601|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56571602|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56571603|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571604|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56571605|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571606|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571627|NCT05487859|Acarbose|acarbose|mesh-list
56571628|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56571629|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571630|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571631|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571632|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571633|NCT00649714|Zonisamide|zonisamide|mesh-list
56571634|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
56571635|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56571636|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571637|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571638|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56571639|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571640|NCT00600028|Thalidomide|thalidomide|mesh-list
56571641|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56571642|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
56571643|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571644|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
56571645|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56571646|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571647|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56571648|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56571649|NCT00600028|Growth Substances|growth substances|mesh-ancestor
56571650|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
56571651|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571652|NCT02650102|Olanzapine|olanzapine|mesh-list
56571653|NCT02650102|Risperidone|risperidone|mesh-list
56571654|NCT02650102|Aripiprazole|aripiprazole|mesh-list
56571655|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56571656|NCT02650102|Ziprasidone|ziprasidone|mesh-list
56571657|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56571658|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
56571659|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571660|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571661|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571662|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56571693|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
56571694|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56571695|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56571696|NCT00910780|Olanzapine|olanzapine|mesh-list
56571697|NCT00910780|Aripiprazole|aripiprazole|mesh-list
56571698|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
56571699|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56571700|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56571701|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56546641|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546642|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56546643|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546644|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
56546645|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56546646|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56546647|NCT02673463|Spironolactone|spironolactone|mesh-list
56546648|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56546649|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
56546650|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546651|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546652|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56546653|NCT02673463|Diuretics|diuretics|mesh-ancestor
56546654|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
56546655|NCT01169532|Vorinostat|vorinostat|mesh-list
56546656|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546657|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56546658|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200806|NCT01526096|Melphalan|melphalan|mesh-list
56571702|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571703|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571704|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
56571705|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
56571706|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571707|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571708|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56571736|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56571737|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56571738|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56571739|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56571740|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56571741|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
56571742|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571743|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571744|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
56571745|NCT02649478|Hormones|hormones|mesh-ancestor
56571746|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571747|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
56571748|NCT04167592|Benzydamine|benzydamine|mesh-list
56571749|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571750|NCT04168294|Propofol|propofol|mesh-list
56571751|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55834811|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56571782|NCT04167280|Ipratropium|ipratropium|mesh-list
56571783|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56571784|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
56571785|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571786|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571787|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56571788|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
56571789|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56571790|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
56571791|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571792|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571793|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
56546659|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546660|NCT02537353|Epinephrine|epinephrine|mesh-list
56546661|NCT02537353|Racepinephrine|racepinephrine|mesh-list
56546662|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
56546663|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56546664|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56546665|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
56546666|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546667|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546668|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571794|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571795|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571796|NCT02648854|Metformin|metformin|mesh-list
56571819|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571820|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571821|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56571822|NCT02645032|Vaccines|vaccines|mesh-list
56571823|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
56571824|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571825|NCT02644954|Metformin|metformin|mesh-list
56571826|NCT02644954|Calcipotriene|calcipotriene|mesh-list
56571827|NCT02644954|Coal Tar|coal tar|mesh-list
56571828|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571829|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571830|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
56571831|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
56571832|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56571833|NCT00650338|Latanoprost|latanoprost|mesh-list
56571834|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56571835|NCT02644720|Dexamethasone|dexamethasone|mesh-list
56571836|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571837|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
56571838|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
56571839|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571840|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571841|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571842|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
56571843|NCT02644720|Hormones|hormones|mesh-ancestor
56571844|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571845|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56571846|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571847|NCT03542266|Azacitidine|azacitidine|mesh-list
56571848|NCT03542266|Cc-486|cc-486|mesh-list
56571867|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
56571868|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571869|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571870|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571871|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
56571872|NCT03201250|Hormones|hormones|mesh-ancestor
56571873|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571874|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56571875|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571876|NCT04166578|Lidocaine|lidocaine|mesh-list
56571877|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
56571878|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
56571879|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571880|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571881|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
56571882|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571883|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56571884|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56571885|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56571886|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571887|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571888|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
56546669|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56546670|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56546671|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
56546672|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546673|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56546674|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
56546675|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
56546676|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
56546677|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56546678|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
56546679|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56546680|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
56546681|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
56546682|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56546683|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546684|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56546685|NCT00643357|Analgesics|analgesics|mesh-ancestor
56546686|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
56546687|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546688|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56571889|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56571890|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571891|NCT00651352|Nicotine|nicotine|mesh-list
56571892|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56571893|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
56571894|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571895|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571896|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56571897|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56571898|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
56571899|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571900|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571901|NCT02641210|Albendazole|albendazole|mesh-list
56571902|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
56107961|NCT00003589|Gemcitabine|gemcitabine|mesh-list
56571931|NCT05758597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56571932|NCT05758597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56571933|NCT05758597|Anesthetics, General|anesthetics, general|mesh-ancestor
56571934|NCT05758597|Anesthetics|anesthetics|mesh-ancestor
56571935|NCT05758597|GABA Modulators|gaba modulators|mesh-ancestor
56571936|NCT05758597|GABA Agents|gaba agents|mesh-ancestor
56571937|NCT05758597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571938|NCT05758597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571939|NCT02644486|Irbesartan|irbesartan|mesh-list
56571940|NCT02644486|Sevelamer|sevelamer|mesh-list
56571941|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56571942|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56571943|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56571944|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571945|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
56571946|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
56571947|NCT00827359|Everolimus|everolimus|mesh-list
56108016|NCT00003079|Cytarabine|cytarabine|mesh-list
56571995|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
56571996|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
56571997|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
56070276|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
56546689|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56546690|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56546691|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56546692|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546693|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
56546694|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56546695|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546696|NCT04178785|Remifentanil|remifentanil|mesh-list
56546697|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56546698|NCT04178785|Narcotics|narcotics|mesh-ancestor
56546699|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571998|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571999|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
56572000|NCT02644252|Protective Agents|protective agents|mesh-ancestor
56572001|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572002|NCT02644252|Vitamins|vitamins|mesh-ancestor
56572003|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
56572004|NCT00818389|Riluzole|riluzole|mesh-list
56572005|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
56572006|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
56572007|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56572008|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572009|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572010|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
56572011|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56572012|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572013|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572014|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
56572015|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56572016|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56572017|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572018|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56572019|NCT00818389|Protective Agents|protective agents|mesh-ancestor
56572067|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
56572068|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572069|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
56572070|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56572071|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
56572072|NCT00849901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56572073|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
56572074|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56572075|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56572076|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56572077|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572079|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56572080|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56572081|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
56572082|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572083|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572084|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572085|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56572086|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56572087|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56572088|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
56572089|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572090|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56572091|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56572092|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572093|NCT04166890|Epinephrine|epinephrine|mesh-list
56572094|NCT04166890|Carticaine|carticaine|mesh-list
56572095|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56572096|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56546700|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546701|NCT04178785|Analgesics|analgesics|mesh-ancestor
56546702|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
56546703|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546704|NCT00928486|Dexamethasone|dexamethasone|mesh-list
56546705|NCT00928486|Lenalidomide|lenalidomide|mesh-list
56572097|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
56572098|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572099|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572100|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572101|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56572102|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56572103|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
56572104|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572105|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56108160|NCT00003937|Etoposide|etoposide|mesh-list
56572133|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
56572134|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572135|NCT01168232|Epothilones|epothilones|mesh-list
56572136|NCT01168232|Epothilone B|epothilone b|mesh-list
56572137|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
56572138|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
56572139|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
56572140|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572141|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572142|NCT00817531|Dasatinib|dasatinib|mesh-list
56572143|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572144|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56572145|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572146|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572147|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
56572148|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
56572149|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56572150|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56572151|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56572152|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572153|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56572154|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56572155|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108218|NCT00003943|Paclitaxel|paclitaxel|mesh-list
56572186|NCT02640118|Lixisenatide|lixisenatide|mesh-list
56572187|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56572188|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572189|NCT00826267|Trastuzumab|trastuzumab|mesh-list
56572190|NCT00826267|Lapatinib|lapatinib|mesh-list
56572191|NCT00826267|Afatinib|afatinib|mesh-list
56572192|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56572193|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572194|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56572196|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572197|NCT00653848|Docetaxel|docetaxel|mesh-list
56572198|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572199|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
56572200|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
56572201|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108264|NCT00003103|Docetaxel|docetaxel|mesh-list
56572231|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572233|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
56572234|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56572235|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
56572236|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572237|NCT00653926|Epinephrine|epinephrine|mesh-list
56572238|NCT00653926|Ropivacaine|ropivacaine|mesh-list
56572239|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
56572240|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
56572241|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572242|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572243|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
56572244|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572245|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56572246|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56546706|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546707|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
56546708|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
56546709|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546710|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572247|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
56572271|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
56572272|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572273|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572274|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
56572275|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572276|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56572277|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56572278|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56572279|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572280|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572281|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56572282|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56572283|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
56572285|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56572286|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
56572287|NCT02646904|Hormones|hormones|mesh-ancestor
56572288|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572289|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572290|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56572291|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
56572292|NCT00848965|Fluticasone|fluticasone|mesh-list
56572294|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56572295|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56572296|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
56572297|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572298|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572321|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56572322|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
56572323|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56572324|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56572325|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572327|NCT00654160|Protective Agents|protective agents|mesh-ancestor
56572328|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
56572329|NCT00654160|Vitamins|vitamins|mesh-ancestor
56572330|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
56572331|NCT02642380|Dexamethasone|dexamethasone|mesh-list
56572332|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
56572333|NCT02642380|BB 1101|bb 1101|mesh-list
56572334|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56572335|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
56572336|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
56572337|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572338|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572339|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56320753|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56572340|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
56572341|NCT02642380|Hormones|hormones|mesh-ancestor
56572342|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572343|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56572344|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572345|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
56572346|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572347|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572348|NCT01154036|Atorvastatin|atorvastatin|mesh-list
56572349|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56572350|NCT01154036|Ezetimibe|ezetimibe|mesh-list
56572351|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56572376|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56572377|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572378|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
56572380|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
56572381|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56572382|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56572383|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56546711|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56546712|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
56546713|NCT00928486|Hormones|hormones|mesh-ancestor
56546714|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546715|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56546716|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546717|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
56546718|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56546719|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56546720|NCT00928486|Growth Substances|growth substances|mesh-ancestor
56572384|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572385|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572386|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
56572387|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572388|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572389|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56572390|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572391|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56572392|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56572393|NCT01166438|Urological Agents|urological agents|mesh-ancestor
56572394|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
56572395|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
56572396|NCT00707707|Paclitaxel|paclitaxel|mesh-list
56572397|NCT00707707|Olaparib|olaparib|mesh-list
56572398|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56572399|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572400|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
56572427|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56572428|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572429|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56572430|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
56572431|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
56572432|NCT02642146|Calcium|calcium|mesh-list
56572433|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
56572434|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56572435|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572436|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572437|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572438|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572439|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56572440|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56572441|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56572442|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
56572443|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572444|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56572445|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56572446|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572447|NCT00653302|Metformin|metformin|mesh-list
56572448|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
56572478|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56572480|NCT02646592|Propofol|propofol|mesh-list
56572481|NCT02646592|Sevoflurane|sevoflurane|mesh-list
56572482|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56572483|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572484|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572485|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56572486|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
56572487|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
56572488|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56572489|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56572490|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56320896|NCT00032175|Capecitabine|capecitabine|mesh-list
56572491|NCT02646592|Narcotics|narcotics|mesh-ancestor
56572492|NCT02646592|Analgesics|analgesics|mesh-ancestor
56108565|NCT00004039|Hormones|hormones|mesh-ancestor
56546721|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
56546722|NCT03867357|Goserelin|goserelin|mesh-list
56546723|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56546724|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546725|NCT05655221|Mitogens|mitogens|mesh-list
56546726|NCT05655221|Mitosis Modulators|mitosis modulators|mesh-ancestor
56546727|NCT05655221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546728|NCT00610792|Doxorubicin|doxorubicin|mesh-list
56546729|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56546730|NCT00610792|Bortezomib|bortezomib|mesh-list
56546731|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56546732|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546733|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56546734|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56546735|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546736|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546737|NCT00610870|Atorvastatin|atorvastatin|mesh-list
56546738|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56546739|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56546740|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
56546741|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572518|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572519|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56572520|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56572522|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572523|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56572524|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
56572525|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572526|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572527|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56572528|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56572529|NCT02884388|Anesthetics|anesthetics|mesh-list
56572530|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572531|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572532|NCT02885948|Naloxone|naloxone|mesh-list
56572533|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56572534|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572535|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
56572536|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572537|NCT01152788|Dacarbazine|dacarbazine|mesh-list
56572538|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56572539|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
56572599|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
56572600|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
56572601|NCT04292184|Antidotes|antidotes|mesh-ancestor
56572602|NCT04292184|Protective Agents|protective agents|mesh-ancestor
56572603|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572604|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
56572605|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572606|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
56572607|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56572608|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546742|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56546743|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56546744|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546745|NCT01168596|Rasagiline|rasagiline|mesh-list
56546746|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56546747|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546748|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546749|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56546750|NCT01168596|Protective Agents|protective agents|mesh-ancestor
56546751|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546752|NCT02675647|Heparin|heparin|mesh-list
56546753|NCT02675647|Protamines|protamines|mesh-list
56546754|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
56546755|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56546756|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56546757|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546758|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
56546759|NCT02675647|Coagulants|coagulants|mesh-ancestor
56546760|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
56546761|NCT05370898|Antacids|antacids|mesh-ancestor
56546762|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546763|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56546764|NCT00610948|Leucovorin|leucovorin|mesh-list
56546765|NCT00610948|Fluorouracil|fluorouracil|mesh-list
56546766|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
56546767|NCT00610948|Everolimus|everolimus|mesh-list
56546768|NCT00610948|Panitumumab|panitumumab|mesh-list
56546769|NCT00610948|Calcium|calcium|mesh-list
56546770|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
56546771|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56546772|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546773|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
56546774|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546775|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56546778|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
56546783|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
56546784|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546785|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56546786|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
56546787|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56572609|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
56572610|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
56572611|NCT01147640|Metronidazole|metronidazole|mesh-list
56572612|NCT01147640|Meropenem|meropenem|mesh-list
56572613|NCT01147640|Tazobactam|tazobactam|mesh-list
56572614|NCT01147640|Ceftolozane|ceftolozane|mesh-list
56572615|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572616|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56572617|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56572618|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56572619|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56572620|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572621|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572622|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56572623|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572624|NCT01121900|Trazodone|trazodone|mesh-list
56572625|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56572626|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56108691|NCT00003739|Lenograstim|lenograstim|mesh-list
56572650|NCT00629226|Cetuximab|cetuximab|mesh-list
56572651|NCT00629226|Bortezomib|bortezomib|mesh-list
56572652|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572653|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56572654|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
56572655|NCT00629304|Antithrombins|antithrombins|mesh-list
56572656|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56572657|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
56572658|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572659|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572660|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
56572661|NCT05297929|Irbesartan|irbesartan|mesh-list
56572662|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56572663|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56572664|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56572665|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572666|NCT00826111|Eszopiclone|eszopiclone|mesh-list
56572667|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56572668|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572669|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572670|NCT05269615|Valsartan|valsartan|mesh-list
56572671|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56572672|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56572673|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56108740|NCT00003175|Fluorouracil|fluorouracil|mesh-list
56572706|NCT02867904|Protective Agents|protective agents|mesh-ancestor
56572707|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56572708|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572709|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
56572710|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
56572711|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572712|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
56572713|NCT04290936|Tenofovir|tenofovir|mesh-list
56572714|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
56572716|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56108798|NCT00003187|Cytarabine|cytarabine|mesh-list
56572765|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572766|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56572768|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56572769|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56572770|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
56572771|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56572772|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
56572773|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56572774|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56572775|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56572776|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56546788|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
56546789|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546790|NCT00928408|Cinacalcet|cinacalcet|mesh-list
56546791|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56546792|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546793|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56546794|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
56546795|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546796|NCT00928252|Fluorides|fluorides|mesh-list
56546797|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
56572777|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56572778|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56572779|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56572780|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56572781|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56572782|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
56572808|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
56572809|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572811|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572812|NCT02610829|Protective Agents|protective agents|mesh-ancestor
56572813|NCT04104672|Gemcitabine|gemcitabine|mesh-list
56572814|NCT04104672|Paclitaxel|paclitaxel|mesh-list
56572815|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56572816|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572817|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
56572818|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
56572819|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
56572820|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572821|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56572822|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
56572823|NCT04104672|Antiviral Agents|antiviral agents|mesh-ancestor
56572824|NCT04104672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572825|NCT04104672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572826|NCT04104672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56572827|NCT04104672|Immunologic Factors|immunologic factors|mesh-ancestor
56572828|NCT04104672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572829|NCT02865564|Gentamicins|gentamicins|mesh-list
56572830|NCT02865564|Ampicillin|ampicillin|mesh-list
56108885|NCT00004141|Dacarbazine|dacarbazine|mesh-list
56572891|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572892|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572893|NCT00812461|Nalmefene|nalmefene|mesh-list
56572894|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56572895|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572896|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
56572897|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572898|NCT00599326|Deferasirox|deferasirox|mesh-list
56572899|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56572900|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
56572901|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
56572902|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572903|NCT00978432|Everolimus|everolimus|mesh-list
56572904|NCT00978432|Panobinostat|panobinostat|mesh-list
56572905|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572906|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56572907|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
56572908|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572909|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56572910|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572911|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572912|NCT05756569|Pembrolizumab|pembrolizumab|mesh-list
56572913|NCT05756569|Immunoconjugates|immunoconjugates|mesh-list
56572914|NCT05756569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56572915|NCT05756569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546798|NCT00928252|Protective Agents|protective agents|mesh-ancestor
56546799|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546800|NCT02673229|Bacitracin|bacitracin|mesh-list
56546801|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56546802|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546803|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56546804|NCT00644293|Azithromycin|azithromycin|mesh-list
56546805|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56546806|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546807|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
56546808|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56546809|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546810|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56546811|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56546812|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546813|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546814|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546815|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56546816|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56546817|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
56546818|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56200967|NCT01526564|Vitamins|vitamins|mesh-ancestor
56572916|NCT05756569|Immunologic Factors|immunologic factors|mesh-ancestor
56108978|NCT00004177|Antibodies|antibodies|mesh-list
56572934|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56572936|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
56572937|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572938|NCT00708799|Azithromycin|azithromycin|mesh-list
56572939|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56572940|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572941|NCT02610127|Factor VIII|factor viii|mesh-list
56572942|NCT02610127|Coagulants|coagulants|mesh-ancestor
56572944|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
56572945|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
56572946|NCT00814333|Coagulants|coagulants|mesh-ancestor
56572947|NCT01147250|Lixisenatide|lixisenatide|mesh-list
56572948|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56572949|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572950|NCT00813943|Temozolomide|temozolomide|mesh-list
56572951|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56572952|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
56572953|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572954|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572955|NCT00821509|Disinfectants|disinfectants|mesh-list
56572956|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572957|NCT01134614|Ipilimumab|ipilimumab|mesh-list
56572958|NCT01134614|Sargramostim|sargramostim|mesh-list
56572959|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56572960|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572961|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56572962|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572963|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
56572964|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572965|NCT00913861|Fentanyl|fentanyl|mesh-list
56546819|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
56546820|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546821|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
56546822|NCT01176773|Protective Agents|protective agents|mesh-ancestor
56546823|NCT02887625|Insulin|insulin|mesh-list
56546824|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
56546825|NCT02887625|Pioglitazone|pioglitazone|mesh-list
56546826|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
56546827|NCT02887625|Exenatide|exenatide|mesh-list
56546828|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56546829|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546830|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56546831|NCT02887625|Incretins|incretins|mesh-ancestor
56572966|NCT00913861|Propofol|propofol|mesh-list
56572967|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56572968|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572969|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572970|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56572971|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
56572972|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
56572973|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56572974|NCT00913861|Narcotics|narcotics|mesh-ancestor
56572975|NCT00913861|Analgesics|analgesics|mesh-ancestor
56573009|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56573010|NCT00978120|Vaccines|vaccines|mesh-list
56573011|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
56573012|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573014|NCT01133756|Carboplatin|carboplatin|mesh-list
56573015|NCT01133756|Lenvatinib|lenvatinib|mesh-list
56573016|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573017|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56573018|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
56573019|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573020|NCT01133756|Antiviral Agents|antiviral agents|mesh-ancestor
56573021|NCT01133756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109080|NCT00003223|Retinamide|retinamide|mesh-list
56573047|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573048|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
56573049|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56573050|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573051|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
56573052|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
56573053|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
56573054|NCT00655174|Sertraline|sertraline|mesh-list
56573055|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
56573056|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56573057|NCT00655174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56573058|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56573059|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56573060|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573061|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573062|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
56573063|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573064|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56573065|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56573066|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573067|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56573068|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56573069|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56573070|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573071|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56573095|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573096|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
56573097|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
56573098|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
56546832|NCT02887625|Hormones|hormones|mesh-ancestor
56546833|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546834|NCT02886377|Antibodies|antibodies|mesh-list
56546835|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
56546836|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546837|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56546838|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56546839|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546840|NCT02675335|Incretins|incretins|mesh-ancestor
56546841|NCT02675335|Hormones|hormones|mesh-ancestor
56546842|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546843|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56546844|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
56546845|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546846|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546847|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
56546848|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56546849|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56546850|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
56546851|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546852|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56546853|NCT00928018|Cyclosporine|cyclosporine|mesh-list
56546854|NCT00928018|Sirolimus|sirolimus|mesh-list
56546855|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
56546856|NCT00928018|Methotrexate|methotrexate|mesh-list
56634311|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546857|NCT00928018|Tacrolimus|tacrolimus|mesh-list
56573099|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573101|NCT02645734|Aflibercept|aflibercept|mesh-list
56573102|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573103|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573104|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56573105|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56573106|NCT02645734|Growth Substances|growth substances|mesh-ancestor
56573107|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573108|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
56573109|NCT01133522|Evolocumab|evolocumab|mesh-list
56573110|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56573111|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56573112|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
56573113|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573114|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56573115|NCT00682318|Ethanol|ethanol|mesh-list
56573116|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56573117|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573118|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573119|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573120|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
56546858|NCT00928018|Cyclosporins|cyclosporins|mesh-list
56546859|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56546860|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
56546861|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56546862|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546863|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56546864|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
56546865|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546866|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546867|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
56546868|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546869|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56546870|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56546871|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
56546872|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546873|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56546874|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56546875|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
56546876|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546877|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56546878|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56546879|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
56546880|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56546881|NCT02672839|Betadex|betadex|mesh-list
56546882|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
56546883|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546884|NCT02672995|Bevacizumab|bevacizumab|mesh-list
56546885|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546886|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573121|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56573122|NCT00655252|Everolimus|everolimus|mesh-list
56573123|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573124|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573125|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
56109181|NCT00003859|Etoposide|etoposide|mesh-list
56573192|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
56573193|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
56573194|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56573195|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573196|NCT00911092|Fluorouracil|fluorouracil|mesh-list
56573197|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573198|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
56109243|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
56573259|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56573260|NCT02634970|Ranibizumab|ranibizumab|mesh-list
56546887|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56546888|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56546889|NCT02672995|Growth Substances|growth substances|mesh-ancestor
56546890|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546891|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
56546892|NCT00609154|Glucagon|glucagon|mesh-list
56546893|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56546894|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56546895|NCT00609154|Hormones|hormones|mesh-ancestor
56546896|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546897|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546898|NCT00609154|Incretins|incretins|mesh-ancestor
56546899|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
56546900|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546901|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546902|NCT00927862|Warfarin|warfarin|mesh-list
56546903|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
56546904|NCT02672527|Dexamethasone|dexamethasone|mesh-list
56546905|NCT02672527|Trabectedin|trabectedin|mesh-list
56546906|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56201045|NCT01526980|Insulin|insulin|mesh-list
56573261|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56573262|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56573263|NCT02634970|Growth Substances|growth substances|mesh-ancestor
56573264|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573265|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
56573266|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573267|NCT00885352|Metformin|metformin|mesh-list
56573268|NCT00885352|Pioglitazone|pioglitazone|mesh-list
56573269|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56573270|NCT00885352|Glipizide|glipizide|mesh-list
56573271|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56573272|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573273|NCT00885352|Incretins|incretins|mesh-ancestor
56573274|NCT00885352|Hormones|hormones|mesh-ancestor
56573275|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573276|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56573277|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
56573347|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56573348|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56573349|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573350|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573351|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
56573379|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573381|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56573382|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573383|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56573384|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
56573385|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56573386|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573387|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573388|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321786|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
56573389|NCT00882310|Gemcitabine|gemcitabine|mesh-list
56573390|NCT00882310|Capecitabine|capecitabine|mesh-list
56573391|NCT00882310|Docetaxel|docetaxel|mesh-list
56546907|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
56546908|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
56546909|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56546910|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546911|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56546912|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
56546913|NCT02672527|Hormones|hormones|mesh-ancestor
56546914|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56546915|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56546916|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546917|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56546918|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
56546919|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546920|NCT00976989|Docetaxel|docetaxel|mesh-list
56546921|NCT00976989|Trastuzumab|trastuzumab|mesh-list
56573392|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56573393|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
56573394|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573395|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573396|NCT00882310|Antiviral Agents|antiviral agents|mesh-ancestor
56573423|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
56573424|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56573425|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56573426|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56573427|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56573428|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
56573429|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56573430|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573431|NCT00656422|Insulin|insulin|mesh-list
56573432|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56573433|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
56573434|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56573435|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573436|NCT02634034|Pitavastatin|pitavastatin|mesh-list
56573437|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56573438|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56573439|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56573440|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
56573441|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573442|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573443|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56573444|NCT00657748|Triacetin|triacetin|mesh-list
56573464|NCT02636218|Analgesics|analgesics|mesh-ancestor
56573465|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
56573466|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573467|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573468|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56573469|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56573470|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
56573472|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573473|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56573474|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56573475|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573476|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573477|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
56573478|NCT04161508|Neostigmine|neostigmine|mesh-list
56573479|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56573480|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546922|NCT00976989|Pertuzumab|pertuzumab|mesh-list
56546923|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546924|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
56546925|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
56546926|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
56546927|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546928|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546929|NCT05463133|Sirolimus|sirolimus|mesh-list
56546930|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
56546931|NCT05463133|Busulfan|busulfan|mesh-list
56295207|NCT00096967|Bevacizumab|bevacizumab|mesh-list
56546932|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
56546933|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573481|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573482|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
56573483|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573484|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573485|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56573486|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
56573487|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573488|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56573489|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56573490|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56573491|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
56573492|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56573493|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56573494|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
56573495|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
56573496|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573497|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573498|NCT00883558|Insulin|insulin|mesh-list
56573499|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56573500|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
56573501|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
56573529|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573530|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
56573531|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573532|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56573533|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56573534|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56573535|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56573536|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573537|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56573538|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
56573539|NCT00597766|Hormones|hormones|mesh-ancestor
56573540|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573541|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573542|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
56573543|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573544|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
56573545|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56573546|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573547|NCT00657982|Everolimus|everolimus|mesh-list
56573548|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573576|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
56573577|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56573578|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573579|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56573580|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
56573581|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573582|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
56573583|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
56573584|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573585|NCT00979992|Sunitinib|sunitinib|mesh-list
56546934|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
56546935|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546936|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546937|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56546938|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
56546939|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546940|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546941|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56546942|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56546943|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546944|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56546945|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
56546946|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546947|NCT05449171|Vitamin D|vitamin d|mesh-list
56546948|NCT05449171|Vitamins|vitamins|mesh-list
56546949|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
56546950|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
56546951|NCT05449171|Pyridoxal|pyridoxal|mesh-list
56546952|NCT05449171|Pyridoxine|pyridoxine|mesh-list
56546953|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
56546954|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
56546955|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201092|NCT01527097|Atorvastatin|atorvastatin|mesh-list
56573586|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573587|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56573588|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56573589|NCT00979992|Growth Substances|growth substances|mesh-ancestor
56573590|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573591|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
56573592|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56573593|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573594|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573595|NCT01079741|Poly I-C|poly i-c|mesh-list
56573596|NCT01079741|Mineral Oil|mineral oil|mesh-list
56573597|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56573598|NCT01079741|Poly ICLC|poly iclc|mesh-list
56573599|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56573627|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
56573628|NCT03946878|Venetoclax|venetoclax|mesh-list
56573629|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
56573630|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573631|NCT02867046|Dexamethasone|dexamethasone|mesh-list
56573632|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56573633|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
56573634|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
56573635|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573636|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573637|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56573638|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
56573639|NCT02867046|Hormones|hormones|mesh-ancestor
56573640|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573641|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56573642|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573643|NCT02865174|Heparin|heparin|mesh-list
56573644|NCT02865174|Enoxaparin|enoxaparin|mesh-list
56546956|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56546957|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56546958|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
56546959|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
56546960|NCT05449171|Protective Agents|protective agents|mesh-ancestor
56546961|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
56546962|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
56573645|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56573646|NCT02865174|Tinzaparin|tinzaparin|mesh-list
56573647|NCT02865174|Dalteparin|dalteparin|mesh-list
56573648|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
56573649|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
56573650|NCT02865174|Thrombin|thrombin|mesh-list
56573651|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
56573652|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56573653|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56109681|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56573705|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56573706|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573707|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56573709|NCT00820027|Etoricoxib|etoricoxib|mesh-list
56573710|NCT00820027|Morphine|morphine|mesh-list
56573711|NCT00820027|Oxycodone|oxycodone|mesh-list
56573712|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56573713|NCT00820027|Narcotics|narcotics|mesh-ancestor
56573714|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573715|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573716|NCT00820027|Analgesics|analgesics|mesh-ancestor
56573717|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
56573718|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573719|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56573720|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56573721|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56573722|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56573723|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56573724|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573725|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573726|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56573727|NCT02876549|Chloroquine|chloroquine|mesh-list
56573728|NCT02876549|Primaquine|primaquine|mesh-list
56573729|NCT02876549|Amebicides|amebicides|mesh-ancestor
56573730|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56573760|NCT01076075|Incretins|incretins|mesh-ancestor
56573761|NCT01076075|Hormones|hormones|mesh-ancestor
56573762|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573763|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56573764|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
56573765|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573766|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573767|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56573768|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573769|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
56573770|NCT01075763|Interferons|interferons|mesh-list
56573771|NCT01075763|Interferon-beta|interferon-beta|mesh-list
56573772|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
56573773|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573774|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
56573775|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573776|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
56573777|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573845|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
56573846|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56573847|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
56573848|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573849|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573850|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56573914|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573915|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573916|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56573917|NCT02876081|Afatinib|afatinib|mesh-list
56546963|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546964|NCT02675023|Adalimumab|adalimumab|mesh-list
56546965|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56546966|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546967|NCT00644371|Rituximab|rituximab|mesh-list
56546968|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56546969|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56546970|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
56546971|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56546972|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56546973|NCT02864199|Ribavirin|ribavirin|mesh-list
56546974|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56546975|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
56546976|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546977|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
56546978|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56546979|NCT00607282|Udenafil|udenafil|mesh-list
56546980|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56573918|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573919|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56573920|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573921|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573922|NCT02631616|Somatostatin|somatostatin|mesh-list
56573923|NCT02631616|Hormones|hormones|mesh-ancestor
56573924|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573925|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573926|NCT00661648|Pancrelipase|pancrelipase|mesh-list
56573927|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56573928|NCT00659074|Ondansetron|ondansetron|mesh-list
56573929|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
56573930|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
56573931|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573932|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573933|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56573957|NCT01077713|Antiviral Agents|antiviral agents|mesh-ancestor
56573958|NCT01077713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573959|NCT01077713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573960|NCT01077713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573961|NCT01077713|Immunologic Factors|immunologic factors|mesh-ancestor
56573962|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
56573963|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56573964|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
56573965|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573966|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573967|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
56573968|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573969|NCT01077323|Exenatide|exenatide|mesh-list
56573970|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56573971|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573972|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56573973|NCT01077323|Incretins|incretins|mesh-ancestor
56573974|NCT01077323|Hormones|hormones|mesh-ancestor
56573975|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573977|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56573978|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56573979|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573980|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546981|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56546982|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546983|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546984|NCT05212311|Chitosan|chitosan|mesh-list
56546985|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56546986|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56546987|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
56546988|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546989|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56546990|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
56546991|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
56546992|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
56546993|NCT05212311|Coagulants|coagulants|mesh-ancestor
56546994|NCT00927472|Permethrin|permethrin|mesh-list
56546995|NCT00927472|Malathion|malathion|mesh-list
56546996|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56546997|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56546998|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56546999|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
56547000|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547001|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547002|NCT00642655|Rituximab|rituximab|mesh-list
56547003|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56547004|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923627|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547005|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
56547006|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547007|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295273|NCT00006326|Ritonavir|ritonavir|mesh-list
56547009|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56547010|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547011|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
56547012|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547013|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547020|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56547021|NCT00927394|Valsartan|valsartan|mesh-list
56547022|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56547023|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56547024|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56547025|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547026|NCT00643825|Temozolomide|temozolomide|mesh-list
56547027|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56547028|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
56547029|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547030|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547031|NCT04178863|Timolol|timolol|mesh-list
56547032|NCT04178863|Latanoprost|latanoprost|mesh-list
56547033|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56547034|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56547035|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
56201169|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
56573981|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
56573982|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573983|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56573984|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56573985|NCT02865018|Cetirizine|cetirizine|mesh-list
56574020|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56574021|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56574022|NCT04047576|Sirolimus|sirolimus|mesh-list
56574023|NCT04047576|Prednisone|prednisone|mesh-list
56574024|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56574043|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574044|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56574045|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56574046|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
56574047|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165355|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56574048|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56574049|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56574050|NCT00629382|Polymyxins|polymyxins|mesh-list
56574051|NCT00629382|Polymyxin B|polymyxin b|mesh-list
56574052|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56574053|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574054|NCT02866032|Ciclopirox|ciclopirox|mesh-list
56574055|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
56574056|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574057|NCT00976716|Celecoxib|celecoxib|mesh-list
56574058|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56574059|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574060|NCT00976716|Analgesics|analgesics|mesh-ancestor
56574061|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
56574062|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574063|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574064|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56574065|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574066|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56574067|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56574068|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574069|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574070|NCT00973674|Estrogens|estrogens|mesh-list
56574071|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56574072|NCT00973674|Hormones|hormones|mesh-ancestor
56547036|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547037|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547038|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547039|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56547040|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56547041|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56547042|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56547043|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
56547044|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56547045|NCT04264858|Antibodies|antibodies|mesh-list
56547046|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
56547047|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
56547048|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547049|NCT00976911|Paclitaxel|paclitaxel|mesh-list
56547050|NCT00976911|Bevacizumab|bevacizumab|mesh-list
56547051|NCT00976911|Doxorubicin|doxorubicin|mesh-list
56547052|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56547053|NCT00976911|Topotecan|topotecan|mesh-list
56547054|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56547055|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547056|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
56547057|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547058|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
56547059|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547060|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56547061|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56547062|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56547063|NCT00976911|Growth Substances|growth substances|mesh-ancestor
56547064|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547065|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
56547066|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56201183|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
56574073|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574074|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574075|NCT00819091|Linagliptin|linagliptin|mesh-list
56574076|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56574077|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574078|NCT00819091|Incretins|incretins|mesh-ancestor
56574079|NCT00819091|Hormones|hormones|mesh-ancestor
56574080|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574112|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547067|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56547068|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56547069|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547070|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56547071|NCT05336968|Triamcinolone|triamcinolone|mesh-list
56547072|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56547073|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56547074|NCT05336968|Ketorolac|ketorolac|mesh-list
56547075|NCT05336968|Ropivacaine|ropivacaine|mesh-list
56547076|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56547077|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
56547078|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
56547079|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547080|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547081|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
56547082|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547083|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56547085|NCT05336968|Hormones|hormones|mesh-ancestor
56547086|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547087|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547088|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
56547089|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547090|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547091|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56547092|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56547093|NCT05336968|Analgesics|analgesics|mesh-ancestor
56547094|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56547095|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56547096|NCT02674555|Naquotinib|naquotinib|mesh-list
56547097|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547098|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56547099|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547100|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547101|NCT00934648|Rituximab|rituximab|mesh-list
56547102|NCT00934648|Methotrexate|methotrexate|mesh-list
56547103|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56547105|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
56547106|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547107|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56547108|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56547109|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
56547110|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547111|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547112|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
56547113|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547114|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
56547115|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547116|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56547117|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547118|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56547119|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56547120|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
56547121|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56547122|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
56547123|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547124|NCT00644449|Azithromycin|azithromycin|mesh-list
56547125|NCT00644449|Levofloxacin|levofloxacin|mesh-list
56547126|NCT00644449|Ofloxacin|ofloxacin|mesh-list
56547127|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56547128|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547129|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56547130|NCT00644449|Renal Agents|renal agents|mesh-ancestor
56547131|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56547132|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56547133|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547134|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547135|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547136|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56547137|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56547138|NCT04287777|Mupirocin|mupirocin|mesh-list
56547139|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56547142|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547143|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547144|NCT04180657|Protein C|protein c|mesh-list
56547145|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
56547146|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56547147|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56547148|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547149|NCT05603065|Paclitaxel|paclitaxel|mesh-list
56547150|NCT05603065|Cisplatin|cisplatin|mesh-list
56547151|NCT05603065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56547152|NCT05603065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547153|NCT05603065|Tubulin Modulators|tubulin modulators|mesh-ancestor
56547154|NCT05603065|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547155|NCT05603065|Mitosis Modulators|mitosis modulators|mesh-ancestor
56547156|NCT05603065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547158|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
56547159|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547160|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
56547161|NCT02674243|Povidone|povidone|mesh-list
56547162|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56547163|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
56574113|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574114|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
56574115|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574116|NCT02865642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56574117|NCT02865642|Antidepressive Agents|antidepressive agents|mesh-ancestor
56574118|NCT02865642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56574119|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56574121|NCT03762564|Ramucirumab|ramucirumab|mesh-list
56574122|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56110175|NCT00004699|Mitogens|mitogens|mesh-list
56574186|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
56574187|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56574188|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56574189|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56574190|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
56574191|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574192|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574193|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574194|NCT02882828|Tacrolimus|tacrolimus|mesh-list
56574195|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56574196|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
56574197|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574198|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56574199|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574200|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574201|NCT02882126|Treprostinil|treprostinil|mesh-list
56574202|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56574225|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574226|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574227|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574229|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56574230|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887292|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56547164|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
56547165|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56547166|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547167|NCT04256200|Dienogest|dienogest|mesh-list
56547168|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
56547169|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
56547170|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56547171|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547172|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547173|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56547174|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56547175|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56547176|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56547177|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
56547178|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547179|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56547180|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547181|NCT02676739|Adderall|adderall|mesh-list
56547182|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56547183|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547184|NCT00976677|Paclitaxel|paclitaxel|mesh-list
56547185|NCT00976677|Bevacizumab|bevacizumab|mesh-list
56547186|NCT00976677|Carboplatin|carboplatin|mesh-list
56547187|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56547188|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56547189|NCT00976677|Antibodies|antibodies|mesh-list
56547190|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
56547191|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56547192|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56547193|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547194|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
56547195|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547196|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
56547197|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547198|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56574231|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574232|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
56574233|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547199|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56547200|NCT00976677|Growth Substances|growth substances|mesh-ancestor
56547201|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547202|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
56547203|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
56547204|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56547205|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547206|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56547207|NCT05332444|Amoxicillin|amoxicillin|mesh-list
56547208|NCT05332444|Metronidazole|metronidazole|mesh-list
56547209|NCT05332444|Clarithromycin|clarithromycin|mesh-list
56547210|NCT05332444|Levofloxacin|levofloxacin|mesh-list
56547211|NCT05332444|Tetracycline|tetracycline|mesh-list
56547212|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56547213|NCT05332444|Rabeprazole|rabeprazole|mesh-list
56547214|NCT05332444|Bismuth|bismuth|mesh-list
56547215|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56547216|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547217|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
56547218|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56547219|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56547220|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56547221|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547222|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547223|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56547224|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56547225|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56547226|NCT05332444|Renal Agents|renal agents|mesh-ancestor
56574234|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574235|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56574236|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
56574237|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574238|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
56574239|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56574240|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56574241|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56574242|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56574243|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574244|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
56574245|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574246|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574247|NCT02864472|Ranibizumab|ranibizumab|mesh-list
56574248|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56574249|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56574250|NCT02864472|Growth Substances|growth substances|mesh-ancestor
56574251|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574252|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
56547227|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56547228|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56547229|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547230|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56295499|NCT00400621|Analgesics|analgesics|mesh-ancestor
56547231|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56547232|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56547233|NCT05332444|Antacids|antacids|mesh-ancestor
56547234|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
56547235|NCT00642967|Hematinics|hematinics|mesh-ancestor
56547236|NCT05284747|Evolocumab|evolocumab|mesh-list
56547237|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56547238|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56547239|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
56547240|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547241|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56547242|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
56547243|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56547244|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547245|NCT04287543|Melatonin|melatonin|mesh-list
56547246|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
56547247|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547248|NCT04287543|Protective Agents|protective agents|mesh-ancestor
56547249|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547250|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547251|NCT04287387|Pioglitazone|pioglitazone|mesh-list
56547252|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56547253|NCT04287387|Metformin|metformin|mesh-list
56547254|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
56547255|NCT04287387|Glimepiride|glimepiride|mesh-list
56547256|NCT04287387|Acarbose|acarbose|mesh-list
56547257|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56547258|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547259|NCT04287387|Incretins|incretins|mesh-ancestor
56547260|NCT04287387|Hormones|hormones|mesh-ancestor
56201355|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574253|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574254|NCT00975000|Cinacalcet|cinacalcet|mesh-list
56574314|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574315|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
56574316|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56574317|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574318|NCT00969150|Analgesics|analgesics|mesh-ancestor
56547261|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547262|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56547263|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
56547264|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547265|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547266|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56547267|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56547268|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547269|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
56547270|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56547271|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
56547272|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
56547273|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56547274|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56547275|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547276|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547277|NCT00644605|Urological Agents|urological agents|mesh-ancestor
56547278|NCT02865681|Letrozole|letrozole|mesh-list
56547279|NCT02865681|Clomiphene|clomiphene|mesh-list
56547280|NCT02865681|Enclomiphene|enclomiphene|mesh-list
56547281|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
56547282|NCT02865681|Menotropins|menotropins|mesh-list
56547283|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547284|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547285|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56547286|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56547287|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547288|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56547289|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
56547290|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547291|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547300|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547301|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547302|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
56547303|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56547304|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56547305|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634312|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547306|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56547307|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56547308|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56547309|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547310|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56547311|NCT04982614|Vaccines|vaccines|mesh-list
56547312|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
56547313|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547314|NCT00910195|Acetaminophen|acetaminophen|mesh-list
56547315|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56547316|NCT00910195|Analgesics|analgesics|mesh-ancestor
56547317|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
56547318|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547319|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547320|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
56547321|NCT03749187|Temozolomide|temozolomide|mesh-list
56547322|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56547323|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56547324|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
56547327|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547344|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
56547345|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
56547346|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547347|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56547348|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56547349|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547350|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547351|NCT00970281|Olanzapine|olanzapine|mesh-list
56547352|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
56547353|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
56547354|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547355|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547356|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56547357|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56547358|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56547359|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547360|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56547361|NCT00970281|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56547362|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56547363|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56547364|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547365|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574319|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
56574320|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574321|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56574322|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574324|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56574325|NCT00974220|Narcotics|narcotics|mesh-ancestor
56574326|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574327|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574328|NCT00974220|Analgesics|analgesics|mesh-ancestor
56574329|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
56574330|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574331|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56574332|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56574333|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
56574334|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
56574335|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
56574336|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56574337|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574338|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574339|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574340|NCT00971178|Analgesics|analgesics|mesh-ancestor
56574341|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
56574343|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56574367|NCT05780723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574368|NCT05780723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574369|NCT05780723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56574370|NCT05780723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56547366|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
56547367|NCT00607438|Paclitaxel|paclitaxel|mesh-list
56547368|NCT00607438|Sorafenib|sorafenib|mesh-list
56547369|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56547370|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56547371|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547372|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
56547373|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547374|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
56547375|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547376|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56547377|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574371|NCT05780710|Antihypertensive Agents|antihypertensive agents|mesh-list
56574372|NCT05780567|Tamoxifen|tamoxifen|mesh-list
56574373|NCT05780567|Letrozole|letrozole|mesh-list
56574374|NCT05780567|Anastrozole|anastrozole|mesh-list
56574375|NCT05780567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574376|NCT05780567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56574377|NCT05780567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56574378|NCT05780567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574379|NCT05780567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574380|NCT05780567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56574381|NCT05780567|Hormone Antagonists|hormone antagonists|mesh-ancestor
56574382|NCT05780567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574383|NCT05780567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574384|NCT05780567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56574385|NCT05780567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56574386|NCT05780567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56574387|NCT05780567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56574388|NCT05780515|Immunoglobulins|immunoglobulins|mesh-list
56574389|NCT05780515|Immunoglobulin G|immunoglobulin g|mesh-list
56574390|NCT05780515|Immunologic Factors|immunologic factors|mesh-ancestor
56574391|NCT05780515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574392|NCT05780489|Estradiol|estradiol|mesh-list
56574393|NCT05780489|Progesterone|progesterone|mesh-list
56574416|NCT05780294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574417|NCT05780229|Analgesics|analgesics|mesh-list
56574418|NCT05780229|Sensory System Agents|sensory system agents|mesh-ancestor
56574419|NCT05780229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574420|NCT05780229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574421|NCT05780216|Harmine|harmine|mesh-list
56574422|NCT05780216|Hallucinogens|hallucinogens|mesh-ancestor
56574423|NCT05780216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574424|NCT05780216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56574425|NCT05780216|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56574426|NCT05780216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574427|NCT05780216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574428|NCT05780151|Insulin Glargine|insulin glargine|mesh-list
56574429|NCT05780151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56574430|NCT05780151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574431|NCT05780086|Icodextrin|icodextrin|mesh-list
56574432|NCT05780086|Dialysis Solutions|dialysis solutions|mesh-ancestor
56574433|NCT05780086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56574434|NCT05780073|Dasatinib|dasatinib|mesh-list
56574435|NCT05780073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574436|NCT05780073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56574437|NCT05780073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574438|NCT05780073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574439|NCT05779943|Furosemide|furosemide|mesh-list
56574440|NCT05779943|Fluorides|fluorides|mesh-list
56574441|NCT05779943|Diuretics|diuretics|mesh-ancestor
56574442|NCT05779943|Natriuretic Agents|natriuretic agents|mesh-ancestor
56574443|NCT05779943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574444|NCT05779943|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56547378|NCT00976209|Phenylephrine|phenylephrine|mesh-list
56547379|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
56547380|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56547381|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
56547382|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
56547383|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547384|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547385|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
56547386|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56547387|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
56547388|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
56547389|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56547390|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56547391|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56547392|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
56547393|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547394|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547395|NCT00976209|Protective Agents|protective agents|mesh-ancestor
56547396|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
56547397|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56547398|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
56547399|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56547400|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
56547401|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547402|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547403|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
56547404|NCT00925990|Ribavirin|ribavirin|mesh-list
56547405|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
56547406|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547407|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
56547408|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547409|NCT02670655|Lidocaine|lidocaine|mesh-list
56547410|NCT02670655|Prilocaine|prilocaine|mesh-list
56547411|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56547412|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
56574482|NCT05779254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56574483|NCT05779254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56110517|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
56574507|NCT05779059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574508|NCT05779059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574509|NCT05779059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547413|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
56547414|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547415|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547416|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
56547417|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547418|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56547419|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56547420|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56547421|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56547422|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547423|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56547424|NCT01131078|Bevacizumab|bevacizumab|mesh-list
56574510|NCT05779020|Vaccines|vaccines|mesh-list
56574511|NCT05779020|Immunologic Factors|immunologic factors|mesh-ancestor
56574512|NCT05779020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574513|NCT05778422|Anesthetics|anesthetics|mesh-list
56574514|NCT05778422|Anesthetics, Local|anesthetics, local|mesh-list
56574515|NCT05778422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56322941|NCT00129857|HU 211|hu 211|mesh-list
56574516|NCT05778422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574517|NCT05778422|Sensory System Agents|sensory system agents|mesh-ancestor
56574518|NCT05778422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574519|NCT05775380|Pioglitazone|pioglitazone|mesh-list
56574520|NCT05775380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56574521|NCT05775380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574522|NCT05775237|Vitamins|vitamins|mesh-list
56574523|NCT05775237|Ascorbic Acid|ascorbic acid|mesh-list
56574524|NCT05775237|Curcumin|curcumin|mesh-list
56574525|NCT05775237|Micronutrients|micronutrients|mesh-ancestor
56574526|NCT05775237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574527|NCT05775237|Antioxidants|antioxidants|mesh-ancestor
56574528|NCT05775237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574529|NCT05775237|Protective Agents|protective agents|mesh-ancestor
56574530|NCT05775237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56574531|NCT05775237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574532|NCT05775237|Analgesics|analgesics|mesh-ancestor
56574533|NCT05775237|Sensory System Agents|sensory system agents|mesh-ancestor
56574534|NCT05775237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574552|NCT05774067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574553|NCT05774067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574555|NCT05774067|Autonomic Agents|autonomic agents|mesh-ancestor
56574556|NCT05774067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574557|NCT05774067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56574558|NCT05774067|Hemostatics|hemostatics|mesh-ancestor
56574559|NCT05774067|Coagulants|coagulants|mesh-ancestor
56574560|NCT05774067|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56574561|NCT05774067|Natriuretic Agents|natriuretic agents|mesh-ancestor
56574562|NCT05774067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56574563|NCT05769842|Propofol|propofol|mesh-list
56574564|NCT05769842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56574565|NCT05769842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574566|NCT05769842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574567|NCT05769842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56574568|NCT05769842|Anesthetics, General|anesthetics, general|mesh-ancestor
56574569|NCT05769842|Anesthetics|anesthetics|mesh-ancestor
56574570|NCT05768932|Paclitaxel|paclitaxel|mesh-list
56574571|NCT05768932|Carboplatin|carboplatin|mesh-list
56574572|NCT05768932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56574573|NCT05768932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574574|NCT05768932|Tubulin Modulators|tubulin modulators|mesh-ancestor
56574575|NCT05768932|Antimitotic Agents|antimitotic agents|mesh-ancestor
56574576|NCT05768932|Mitosis Modulators|mitosis modulators|mesh-ancestor
55887293|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547425|NCT01131078|Capecitabine|capecitabine|mesh-list
56547426|NCT01131078|Irinotecan|irinotecan|mesh-list
56547427|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56547428|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547429|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56547430|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56547431|NCT01131078|Growth Substances|growth substances|mesh-ancestor
56547432|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547433|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
56547434|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547435|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
56547436|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547437|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56547438|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56547439|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547440|NCT03711279|Apatinib|apatinib|mesh-list
56547441|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547442|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56547443|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547444|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547445|NCT03709017|Ponatinib|ponatinib|mesh-list
56201562|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
56574577|NCT05768932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574578|NCT05761574|Acetaminophen|acetaminophen|mesh-list
56574579|NCT05761574|Naproxen|naproxen|mesh-list
56574580|NCT05761574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574581|NCT05761574|Analgesics|analgesics|mesh-ancestor
56574582|NCT05761574|Sensory System Agents|sensory system agents|mesh-ancestor
56574583|NCT05761574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574584|NCT05761574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574585|NCT05761574|Antipyretics|antipyretics|mesh-ancestor
56574586|NCT05761574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56574587|NCT05761574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56574588|NCT05761574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574589|NCT05761574|Gout Suppressants|gout suppressants|mesh-ancestor
56574590|NCT05761574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56574591|NCT05761574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574592|NCT05761574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574594|NCT05755997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56574595|NCT05755997|Protective Agents|protective agents|mesh-ancestor
56574624|NCT05731895|Nootropic Agents|nootropic agents|mesh-ancestor
56574625|NCT05712265|Fluvoxamine|fluvoxamine|mesh-list
56574626|NCT05712265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56574627|NCT05712265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56574628|NCT05712265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574629|NCT05712265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574630|NCT05712265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56574631|NCT05712265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56574632|NCT05712265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56574633|NCT05712265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56574634|NCT05712265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547446|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547447|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56547448|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547449|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547450|NCT03695445|Norepinephrine|norepinephrine|mesh-list
56547451|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56547452|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56547453|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
56547454|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547455|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547456|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547457|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
56547458|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
56547459|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547460|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56547462|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56547463|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547464|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
56547465|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
56547466|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56547467|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
56547468|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547469|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547470|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56547471|NCT02862873|Ondansetron|ondansetron|mesh-list
56547472|NCT02862873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547473|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547474|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
56547475|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
56547476|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547477|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56547478|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
56547479|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
56547480|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56547481|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
56129307|NCT03249558|Morphine|morphine|mesh-list
56574635|NCT05712265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574636|NCT05712265|Serotonin Agents|serotonin agents|mesh-ancestor
56574637|NCT05712265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56547482|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547483|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547484|NCT02862873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56547485|NCT02862873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56547486|NCT02862873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56547487|NCT02862873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56547488|NCT03814005|Paclitaxel|paclitaxel|mesh-list
56547489|NCT03814005|Docetaxel|docetaxel|mesh-list
56547490|NCT03814005|Carboplatin|carboplatin|mesh-list
56547491|NCT03814005|Azacitidine|azacitidine|mesh-list
56547492|NCT03814005|Pevonedistat|pevonedistat|mesh-list
56547493|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56547494|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547495|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56547496|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547497|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
56547498|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547499|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547500|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
56547501|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547502|NCT03683433|Azacitidine|azacitidine|mesh-list
56547503|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547504|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
56547505|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547506|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547507|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547508|NCT03449901|Gemcitabine|gemcitabine|mesh-list
56547509|NCT03449901|Docetaxel|docetaxel|mesh-list
56547510|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547511|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
56547512|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547513|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547514|NCT03449901|Antiviral Agents|antiviral agents|mesh-ancestor
56547515|NCT03449901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547516|NCT03449901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547517|NCT03449901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547518|NCT03449901|Immunologic Factors|immunologic factors|mesh-ancestor
56547520|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
56547521|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547522|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
56547523|NCT00968799|Cisplatin|cisplatin|mesh-list
56547524|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547525|NCT04016233|Tenofovir|tenofovir|mesh-list
56547526|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
56547527|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547528|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56547529|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56547530|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547531|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547532|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56547533|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56547534|NCT04033471|Midazolam|midazolam|mesh-list
56547535|NCT04033471|Morphine|morphine|mesh-list
56547536|NCT04033471|Bupivacaine|bupivacaine|mesh-list
56547537|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
56547538|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
56547539|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547540|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547541|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
56547542|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547543|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56547544|NCT04033471|Narcotics|narcotics|mesh-ancestor
56547545|NCT04033471|Analgesics|analgesics|mesh-ancestor
56547546|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56547547|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56547548|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56547549|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56547550|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56547551|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56547552|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
56547553|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
56547554|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
56547557|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
56547562|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547563|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547564|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547565|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56547566|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56547567|NCT04175587|Tretinoin|tretinoin|mesh-list
56547568|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
56547569|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547570|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
56547571|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
56547572|NCT02668159|Vitamin D|vitamin d|mesh-list
56547573|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
56547574|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
56547575|NCT02668159|Vitamins|vitamins|mesh-list
56547576|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
56547577|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547578|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56547579|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56547580|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
56547581|NCT02670109|Busulfan|busulfan|mesh-list
56547582|NCT02670109|Carmustine|carmustine|mesh-list
56547583|NCT02670109|Carboplatin|carboplatin|mesh-list
56547584|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547585|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
56547586|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547587|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56547588|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56547589|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
56547590|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547591|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547592|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56547593|NCT00922636|Methylphenidate|methylphenidate|mesh-list
56634313|NCT02730624|Tazobactam|tazobactam|mesh-list
56634314|NCT02730624|Piperacillin|piperacillin|mesh-list
56201695|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
56574638|NCT05712265|Antidepressive Agents|antidepressive agents|mesh-ancestor
56574639|NCT05712265|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56574640|NCT05712265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56574641|NCT05712265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574667|NCT05687266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574668|NCT05687266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634315|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56634316|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56634317|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634318|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56634319|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634320|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634321|NCT02807870|Methylphenidate|methylphenidate|mesh-list
56547594|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56547595|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547596|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56634322|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56634323|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634324|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56634325|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56634326|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634327|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634328|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
56634329|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634330|NCT00925873|Vidarabine|vidarabine|mesh-list
56634331|NCT00925873|Fludarabine|fludarabine|mesh-list
56634332|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
56634333|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634334|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56634335|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
56634336|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634337|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634338|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
56634339|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634340|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
56634341|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634342|NCT05590598|Azelastine|azelastine|mesh-list
56634351|NCT05590598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634352|NCT05590598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56634353|NCT05590598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56634354|NCT05590598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56634355|NCT05590598|Histamine Antagonists|histamine antagonists|mesh-ancestor
56634356|NCT05590598|Histamine Agents|histamine agents|mesh-ancestor
56574669|NCT05687266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56574670|NCT05687266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56574671|NCT05670106|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56574672|NCT05670106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56574673|NCT05670106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574674|NCT05661851|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56574675|NCT05661851|Lubricant Eye Drops|lubricant eye drops|mesh-list
56574676|NCT05661851|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56574677|NCT05659654|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56574678|NCT05659654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56574679|NCT05659654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56574680|NCT05653258|Dasatinib|dasatinib|mesh-list
56574681|NCT05653258|Quercetin|quercetin|mesh-list
56574682|NCT05653258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574683|NCT05653258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56574684|NCT05653258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574685|NCT05653258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574686|NCT05653258|Antioxidants|antioxidants|mesh-ancestor
56574687|NCT05653258|Protective Agents|protective agents|mesh-ancestor
56574688|NCT05653258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574689|NCT05637060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56574690|NCT05637060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56574691|NCT05637060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56574713|NCT05617859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574714|NCT05617859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574715|NCT05616494|Docetaxel|docetaxel|mesh-list
56574716|NCT05616494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574717|NCT05616494|Tubulin Modulators|tubulin modulators|mesh-ancestor
56574718|NCT05616494|Antimitotic Agents|antimitotic agents|mesh-ancestor
56574719|NCT05616494|Mitosis Modulators|mitosis modulators|mesh-ancestor
56574720|NCT05616494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574721|NCT05614609|Lidocaine|lidocaine|mesh-list
56574722|NCT05614609|Anesthetics, Local|anesthetics, local|mesh-ancestor
56574723|NCT05614609|Anesthetics|anesthetics|mesh-ancestor
56574724|NCT05614609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574725|NCT05614609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574726|NCT05614609|Sensory System Agents|sensory system agents|mesh-ancestor
56574727|NCT05614609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574728|NCT05614609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56574729|NCT05614609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56574730|NCT05614609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56574731|NCT05614609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56574732|NCT05614609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574733|NCT05605093|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56574734|NCT05605093|Protease Inhibitors|protease inhibitors|mesh-list
56574735|NCT05605093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574736|NCT05605093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574737|NCT05605093|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56574738|NCT05605093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56574739|NCT05605093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56574740|NCT05605093|Antiviral Agents|antiviral agents|mesh-ancestor
56574741|NCT05605093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574771|NCT05598957|Vitamins|vitamins|mesh-ancestor
56574772|NCT05598957|Micronutrients|micronutrients|mesh-ancestor
56574773|NCT05598957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574774|NCT05598957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56574775|NCT05575063|Hyaluronic Acid|hyaluronic acid|mesh-list
56574776|NCT05575063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56574777|NCT05575063|Immunologic Factors|immunologic factors|mesh-ancestor
56574778|NCT05575063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574779|NCT05575063|Viscosupplements|viscosupplements|mesh-ancestor
56634357|NCT05590598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634358|NCT00925951|Acetaminophen|acetaminophen|mesh-list
56634359|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56634360|NCT00925951|Analgesics|analgesics|mesh-ancestor
56634361|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
56634362|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634363|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634364|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
56634365|NCT00933205|Tipranavir|tipranavir|mesh-list
56634366|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56201776|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
56574780|NCT05575063|Protective Agents|protective agents|mesh-ancestor
56574782|NCT05567068|Atorvastatin|atorvastatin|mesh-list
56574783|NCT05567068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56574784|NCT05567068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56574785|NCT05567068|Antimetabolites|antimetabolites|mesh-ancestor
56574786|NCT05567068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574787|NCT05567068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56574788|NCT05567068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56574789|NCT05567068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574816|NCT05556512|Tirzepatide|tirzepatide|mesh-list
56574817|NCT05556512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56574818|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574819|NCT05556512|Incretins|incretins|mesh-ancestor
56574820|NCT05556512|Hormones|hormones|mesh-ancestor
56574821|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574822|NCT05550402|Bromides|bromides|mesh-list
56574823|NCT05550402|Albuterol|albuterol|mesh-list
56574824|NCT05550402|Ipratropium|ipratropium|mesh-list
56574825|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
56574826|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56574827|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
56574828|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574829|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574830|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56574831|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
56574832|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
56574833|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56574834|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56574835|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56574836|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56574837|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56574870|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56574871|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56574872|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56574873|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574874|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56574875|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574876|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574878|NCT05480384|Trastuzumab|trastuzumab|mesh-list
56574879|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574906|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56574907|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
56574908|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574909|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574910|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56574911|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56574912|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56574913|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
56574914|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56574915|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56574916|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
56574917|NCT05444946|Itraconazole|itraconazole|mesh-list
56574918|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56574919|NCT05444946|Prednisone|prednisone|mesh-list
56574920|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634367|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56634368|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
56634369|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634370|NCT05546658|Psilocybin|psilocybin|mesh-list
56634371|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
56634372|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634373|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56634374|NCT02813486|Vaccines|vaccines|mesh-list
56634375|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
56201786|NCT01530503|Mitomycin|mitomycin|mesh-list
56574921|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
56574922|NCT05444946|Hormones|hormones|mesh-ancestor
56574923|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574924|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574925|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56574926|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574951|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
56574952|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574953|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574954|NCT05377242|Curcumin|curcumin|mesh-list
56574955|NCT05377242|Resveratrol|resveratrol|mesh-list
56574956|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56574957|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574958|NCT05377242|Analgesics|analgesics|mesh-ancestor
56574959|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
56574960|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574961|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574962|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56574963|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574964|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574966|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574967|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
56574968|NCT05377242|Protective Agents|protective agents|mesh-ancestor
56574969|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56574970|NCT05362955|Fluorouracil|fluorouracil|mesh-list
56574971|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
56574972|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574973|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56574974|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574975|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56574976|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
56574977|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574978|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
56574979|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
56574980|NCT05355311|Vitamins|vitamins|mesh-ancestor
56574981|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
56110980|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
56575011|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575013|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
56575014|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
56575015|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575016|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56575017|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56575018|NCT05269706|Cannabidiol|cannabidiol|mesh-list
56575019|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
56575020|NCT05267613|Esomeprazole|esomeprazole|mesh-list
56575021|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56575022|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575023|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56575024|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575025|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575026|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
56575027|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56575042|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56575043|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575044|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575045|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
56634376|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634377|NCT02739516|Letrozole|letrozole|mesh-list
56634378|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56634379|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634380|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56201795|NCT01530542|Oxycodone|oxycodone|mesh-list
56575046|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56575047|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56575048|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56575049|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56575050|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575051|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
56575052|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56575053|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575054|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56575055|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575057|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
56575058|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575060|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575061|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575062|NCT05183035|Cytarabine|cytarabine|mesh-list
56575063|NCT05183035|Fludarabine|fludarabine|mesh-list
56575064|NCT05183035|Azacitidine|azacitidine|mesh-list
56575065|NCT05183035|Venetoclax|venetoclax|mesh-list
56575066|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
56575067|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575068|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56575069|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
56575070|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575071|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575072|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
56575073|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575074|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
56575075|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575076|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575077|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575078|NCT05178849|Anesthetics|anesthetics|mesh-list
56575079|NCT05178849|Anesthetics, Local|anesthetics, local|mesh-list
56575080|NCT05178849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575081|NCT05178849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575082|NCT05178849|Sensory System Agents|sensory system agents|mesh-ancestor
56575083|NCT05178849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575084|NCT05172908|Dexamethasone|dexamethasone|mesh-list
56575085|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575086|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
56575087|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
56575088|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111081|NCT04182984|Prednisone|prednisone|mesh-list
56575147|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575148|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
56575149|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
56575150|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56575151|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575152|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575153|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
56575154|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56575155|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575156|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575157|NCT05108649|Nicotine|nicotine|mesh-list
56575158|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56575159|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
56575160|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575161|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575162|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56575163|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56575164|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
56575165|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56575166|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575167|NCT05050916|Vitamin D|vitamin d|mesh-list
56575168|NCT05050916|Vitamins|vitamins|mesh-ancestor
56575169|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
56634381|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56634382|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634383|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634384|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56634385|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
56634386|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56634387|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634388|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56634389|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
56634390|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634391|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634392|NCT00933283|Methadone|methadone|mesh-list
56634393|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56634394|NCT00933283|Narcotics|narcotics|mesh-ancestor
56634395|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547597|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56634396|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634397|NCT00933283|Analgesics|analgesics|mesh-ancestor
56634398|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
56634399|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634400|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
56634401|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
56634402|NCT02813018|Ropivacaine|ropivacaine|mesh-list
56634403|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
56634431|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
56634432|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634433|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56634434|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56634435|NCT04174196|Growth Substances|growth substances|mesh-ancestor
56634436|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
56634437|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634438|NCT04173962|Midazolam|midazolam|mesh-list
56634439|NCT04173962|Ketamine|ketamine|mesh-list
56634440|NCT04173962|Analgesics|analgesics|mesh-ancestor
56634441|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
56634442|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634460|NCT00772005|Modafinil|modafinil|mesh-list
56634493|NCT05582174|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56634494|NCT05582174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634495|NCT05582174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634496|NCT00926107|Sirolimus|sirolimus|mesh-list
56634497|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56634498|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634499|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56634500|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634501|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
56634502|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634503|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
56634504|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634505|NCT02729766|Empagliflozin|empagliflozin|mesh-list
56634506|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56634550|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
56634551|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56634552|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56634553|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56634554|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
56634555|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634556|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280454|NCT00006105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634614|NCT05623592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634615|NCT05623592|Dermatologic Agents|dermatologic agents|mesh-ancestor
56634685|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634686|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634687|NCT00926731|Cytarabine|cytarabine|mesh-list
56280530|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
56634688|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56634689|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
56634690|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634691|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634692|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
56634693|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634694|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634695|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
56634746|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56634747|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634748|NCT02738814|Propofol|propofol|mesh-list
56634749|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56634750|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634751|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634752|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56634753|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
56634754|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
56634755|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56634756|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56634757|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634758|NCT02729064|Insulin|insulin|mesh-list
56634759|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56547599|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634760|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56634761|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634763|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634764|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56634765|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634766|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634767|NCT02805842|Tacrolimus|tacrolimus|mesh-list
56634768|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634769|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
56634770|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634771|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56634772|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634773|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634774|NCT00926965|Olanzapine|olanzapine|mesh-list
56634775|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
56634776|NCT00926965|Amisulpride|amisulpride|mesh-list
56634777|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
56634778|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
56634779|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634781|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56634786|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56634787|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634788|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634789|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634790|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
56634791|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56575170|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575171|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56575172|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
56575187|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56575188|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
56575189|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56575190|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575191|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158207|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56158208|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56158209|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158210|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56575192|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
56575194|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
56575195|NCT05003713|Prednisone|prednisone|mesh-list
56575196|NCT05003713|Cortisone|cortisone|mesh-list
56575197|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575198|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
56575199|NCT05003713|Hormones|hormones|mesh-ancestor
56575200|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575201|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575202|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575203|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575204|NCT04990128|Triamcinolone|triamcinolone|mesh-list
56575205|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575206|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
56575207|NCT04990128|Hormones|hormones|mesh-ancestor
56575208|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575209|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575210|NCT04960709|Durvalumab|durvalumab|mesh-list
56575211|NCT04960709|Tremelimumab|tremelimumab|mesh-list
56575212|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575213|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575214|NCT04907370|Gemcitabine|gemcitabine|mesh-list
56575215|NCT04907370|Cisplatin|cisplatin|mesh-list
56575216|NCT04907370|Antibodies|antibodies|mesh-list
56575217|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
56575218|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
56575219|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575220|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575221|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56575222|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
56575223|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575224|NCT04907370|Antiviral Agents|antiviral agents|mesh-ancestor
56575225|NCT04907370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575226|NCT04907370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575227|NCT04907370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575228|NCT04906395|Tamoxifen|tamoxifen|mesh-list
56575229|NCT04906395|Letrozole|letrozole|mesh-list
56575230|NCT04906395|Anastrozole|anastrozole|mesh-list
56575231|NCT04906395|Exemestane|exemestane|mesh-list
56575232|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575233|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56575242|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56575243|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56575244|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56575245|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
56575246|NCT04903054|Prednisone|prednisone|mesh-list
56575247|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
56575248|NCT04903054|Tacrolimus|tacrolimus|mesh-list
56575249|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
56575250|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56575251|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575252|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
56575253|NCT04903054|Hormones|hormones|mesh-ancestor
56634792|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
56634793|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56634794|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
56634795|NCT04260113|Apatinib|apatinib|mesh-list
56634796|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634797|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56634798|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634799|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634800|NCT02738658|Everolimus|everolimus|mesh-list
56634801|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634802|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634803|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
56634804|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634805|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
56634806|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56634807|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56634808|NCT02733510|Prednisolone|prednisolone|mesh-list
56634809|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
56634810|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56575254|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575255|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575256|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575257|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575258|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575259|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
56575260|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56575261|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575262|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575263|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56575264|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56575265|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
56575266|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56575267|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575268|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
56575269|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
56575270|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575271|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575272|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56575273|NCT04903054|Protective Agents|protective agents|mesh-ancestor
56575274|NCT04901702|Irinotecan|irinotecan|mesh-list
56575275|NCT04901702|Temozolomide|temozolomide|mesh-list
56575276|NCT04901702|Talazoparib|talazoparib|mesh-list
56575277|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56575278|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56575279|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575280|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575281|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575282|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56575283|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
56575284|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56575285|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
56575286|NCT04897321|Fludarabine|fludarabine|mesh-list
56575287|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575288|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
56575289|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634811|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
56634812|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634813|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
56634814|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
56634815|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634816|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634817|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56634818|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
56575290|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56575291|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56575292|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
56575293|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575294|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575295|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56575296|NCT04879225|Menthol|menthol|mesh-list
56575297|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
56575298|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
56575304|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575305|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56575306|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56575307|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575309|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56575310|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56575311|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56575312|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575313|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575314|NCT04834557|Protective Agents|protective agents|mesh-ancestor
56575315|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575316|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56575317|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575318|NCT04825093|Vitamin D|vitamin d|mesh-list
56575319|NCT04825093|Vitamins|vitamins|mesh-ancestor
56575320|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
56575321|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575322|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56575323|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56575324|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56575325|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56575326|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575327|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
56575328|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56575329|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575330|NCT04793152|Vancomycin|vancomycin|mesh-list
56575331|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56575332|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575333|NCT04770493|Lamotrigine|lamotrigine|mesh-list
56575334|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
56575335|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56575336|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56575337|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575338|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56575339|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575340|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56575341|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56575342|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575343|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56575344|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56575345|NCT04765059|Cisplatin|cisplatin|mesh-list
56575346|NCT04765059|Carboplatin|carboplatin|mesh-list
56575347|NCT04765059|Pemetrexed|pemetrexed|mesh-list
56575348|NCT04765059|Osimertinib|osimertinib|mesh-list
56575349|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575350|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575351|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575352|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56575353|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56634819|NCT02733510|Hormones|hormones|mesh-ancestor
56634820|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56634821|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56634822|NCT02733510|Protective Agents|protective agents|mesh-ancestor
56634823|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56634824|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634825|NCT03663504|Metronidazole|metronidazole|mesh-list
56634826|NCT03663504|Neomycin|neomycin|mesh-list
56634827|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634828|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56634829|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56634830|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56634831|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56634832|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547600|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
56634833|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634834|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56634835|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56575354|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56575355|NCT04741464|Tinzaparin|tinzaparin|mesh-list
56575356|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56575357|NCT04741464|Dalteparin|dalteparin|mesh-list
56575358|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
56575359|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56575360|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56575361|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575362|NCT04711252|Palbociclib|palbociclib|mesh-list
56575363|NCT04711252|Anastrozole|anastrozole|mesh-list
56575364|NCT04711252|Hormones|hormones|mesh-list
56575365|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56575366|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575367|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575368|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575380|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575382|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575383|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
56575384|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
56575385|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575386|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575387|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575388|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
56575389|NCT04663555|Hormones|hormones|mesh-ancestor
56575390|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575391|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575392|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575393|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
56575394|NCT04637763|Fludarabine|fludarabine|mesh-list
56575395|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575396|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
56575397|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575398|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56575399|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56575400|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
56575401|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070466|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
56634836|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634838|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56634839|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
56575402|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575403|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56575404|NCT04567784|Cannabidiol|cannabidiol|mesh-list
56575405|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
56575406|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56575407|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56575408|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56575409|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56575410|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575411|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
56575413|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575414|NCT04519619|Aflibercept|aflibercept|mesh-list
56575415|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56575416|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56575417|NCT04519619|Growth Substances|growth substances|mesh-ancestor
56575418|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575419|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
56575420|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575421|NCT04501861|Vasopressins|vasopressins|mesh-list
56575422|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
56575423|NCT04501861|Norepinephrine|norepinephrine|mesh-list
56575424|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56575425|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56575426|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
56575427|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56575428|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575429|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575430|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
56575431|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
56575442|NCT04496024|Renal Agents|renal agents|mesh-ancestor
56575443|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56575444|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56575445|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56575446|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575447|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575448|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575449|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56575450|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56575451|NCT04425473|Esketamine|esketamine|mesh-list
56575452|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
56575453|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56575454|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56575455|NCT04387071|Antibodies|antibodies|mesh-list
56575456|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
56575457|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56575458|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
56575459|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575460|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575461|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56575462|NCT04350502|Amoxicillin|amoxicillin|mesh-list
56575463|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
56575464|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
56575465|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56575466|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575467|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575468|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575469|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56575470|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
56575471|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56575472|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
56575473|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575474|NCT04300920|Expectorants|expectorants|mesh-ancestor
56575475|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
56575476|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56575477|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
56575478|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575479|NCT04300920|Protective Agents|protective agents|mesh-ancestor
56575480|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575481|NCT04300920|Antidotes|antidotes|mesh-ancestor
56575482|NCT04267926|Ubiquinone|ubiquinone|mesh-list
56634840|NCT00933985|Vincristine|vincristine|mesh-list
56634841|NCT00933985|Razoxane|razoxane|mesh-list
56634842|NCT00933985|Obatoclax|obatoclax|mesh-list
56634843|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56634844|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634845|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56634846|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56634847|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201889|NCT01531114|Ticagrelor|ticagrelor|mesh-list
56575483|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
56575484|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575485|NCT04252768|Paclitaxel|paclitaxel|mesh-list
56575486|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56575487|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575488|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
56575489|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
56575490|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
56575491|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575492|NCT04222010|Anesthetics|anesthetics|mesh-list
56575493|NCT04222010|Ropivacaine|ropivacaine|mesh-list
56575494|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575495|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575496|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
56575497|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
56575498|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575529|NCT04145700|Docetaxel|docetaxel|mesh-list
56575530|NCT04145700|Ramucirumab|ramucirumab|mesh-list
56575531|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56575532|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
56575533|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575534|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575535|NCT04145700|Antiviral Agents|antiviral agents|mesh-ancestor
56575536|NCT04145700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575537|NCT04145700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575538|NCT04145700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575539|NCT04145700|Immunologic Factors|immunologic factors|mesh-ancestor
56575540|NCT04145700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575541|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56575542|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56575543|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56575544|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
56575545|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575546|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575547|NCT04098081|Gemcitabine|gemcitabine|mesh-list
56575548|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
56575549|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56575569|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575572|NCT04047706|Linrodostat|linrodostat|mesh-list
56575573|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575574|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575575|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56575576|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575577|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56575578|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
56575579|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575580|NCT04034251|Paclitaxel|paclitaxel|mesh-list
56575581|NCT04034251|Capecitabine|capecitabine|mesh-list
56575582|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56575583|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575584|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
56575585|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
56575586|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
56575587|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575588|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56575589|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
56575590|NCT04002947|Rituximab|rituximab|mesh-list
56575591|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
56634848|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634849|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56634850|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
56634851|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
56634852|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
56634853|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56634854|NCT00933985|Protective Agents|protective agents|mesh-ancestor
56634855|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634856|NCT02812394|Levodopa|levodopa|mesh-list
56575592|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575593|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575594|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
56575595|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575596|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56575597|NCT03997123|Paclitaxel|paclitaxel|mesh-list
56575598|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56575599|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575600|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
56575601|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
56575602|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
56575603|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575604|NCT03983824|Cytarabine|cytarabine|mesh-list
56575605|NCT03983824|Etoposide|etoposide|mesh-list
56575606|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
56575607|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
56575608|NCT03983824|Peposertib|peposertib|mesh-list
56575609|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56575610|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575611|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56575622|NCT03983824|Analgesics|analgesics|mesh-ancestor
56575623|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
56575624|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575625|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56575626|NCT03967249|Octreotide|octreotide|mesh-list
56575627|NCT03967249|Lanreotide|lanreotide|mesh-list
56575628|NCT03967249|Somatostatin|somatostatin|mesh-list
56575629|NCT03967249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575630|NCT03967249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575631|NCT03967249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575632|NCT03967249|Hormones|hormones|mesh-ancestor
56575633|NCT03967249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575634|NCT03967249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575638|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
56575639|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
56575640|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
56575641|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575642|NCT03935139|Glycerol|glycerol|mesh-list
56575643|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56575644|NCT03935139|Protective Agents|protective agents|mesh-ancestor
56575645|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575646|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56575647|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56575648|NCT03927079|Dimercaprol|dimercaprol|mesh-list
56575649|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575650|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
56575651|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
56575652|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
56575653|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575654|NCT03926403|Anesthetics|anesthetics|mesh-list
56575655|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575656|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575657|NCT03905694|Lumasiran|lumasiran|mesh-list
56575658|NCT03905694|Renal Agents|renal agents|mesh-ancestor
56575659|NCT03884101|Paclitaxel|paclitaxel|mesh-list
56575660|NCT03884101|Carboplatin|carboplatin|mesh-list
56575661|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
56575662|NCT03884101|Lenvatinib|lenvatinib|mesh-list
56575663|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56634857|NCT02812394|Carbidopa|carbidopa|mesh-list
56634858|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56634859|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56634860|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56634861|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
56634862|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634863|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634864|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634865|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56634866|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634867|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56575664|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575665|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
56575666|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
56575667|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
56575668|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575669|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575670|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56575671|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575672|NCT03880019|Temozolomide|temozolomide|mesh-list
56575673|NCT03880019|Olaparib|olaparib|mesh-list
56575674|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56575675|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56575676|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
56575677|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575678|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575679|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575680|NCT03871621|Metformin|metformin|mesh-list
56575711|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56575713|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
56575714|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
56575715|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575716|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575717|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
56575718|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575719|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56575720|NCT03740737|Hormones|hormones|mesh-ancestor
56575721|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575722|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575733|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56575734|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56575735|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575736|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56575737|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575738|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575740|NCT03657810|Promethazine|promethazine|mesh-list
56575741|NCT03657810|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56575742|NCT03657810|Hydrocodone|hydrocodone|mesh-list
56575743|NCT03657810|Oxycodone|oxycodone|mesh-list
56575744|NCT03657810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56575745|NCT03657810|Analgesics|analgesics|mesh-ancestor
56575746|NCT03657810|Sensory System Agents|sensory system agents|mesh-ancestor
56575747|NCT03657810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575748|NCT03657810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575749|NCT03657810|Antipyretics|antipyretics|mesh-ancestor
56575750|NCT03657810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56575751|NCT03657810|Narcotics|narcotics|mesh-ancestor
56575752|NCT03657810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575753|NCT03657810|Antitussive Agents|antitussive agents|mesh-ancestor
56575754|NCT03657810|Respiratory System Agents|respiratory system agents|mesh-ancestor
56575755|NCT03657810|Antipruritics|antipruritics|mesh-ancestor
56634868|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
56634869|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
56634870|NCT00930475|Carboplatin|carboplatin|mesh-list
56634871|NCT00930475|Everolimus|everolimus|mesh-list
56634872|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634873|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634874|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
56634875|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634876|NCT02728518|Amikacin|amikacin|mesh-list
56634877|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56634878|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634879|NCT00634400|Candesartan|candesartan|mesh-list
56634880|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56634881|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56201918|NCT01531192|Ionophores|ionophores|mesh-ancestor
56575756|NCT03657810|Dermatologic Agents|dermatologic agents|mesh-ancestor
56575757|NCT03657810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56575758|NCT03657810|Histamine Antagonists|histamine antagonists|mesh-ancestor
56575759|NCT03657810|Histamine Agents|histamine agents|mesh-ancestor
56575760|NCT03657810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56575761|NCT03657810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575762|NCT03657810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56575763|NCT03657810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56575764|NCT03657810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575765|NCT03657810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56575766|NCT03640026|Tacrolimus|tacrolimus|mesh-list
56575767|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575768|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
56575769|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575770|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56575771|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575772|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575773|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
56575774|NCT03638297|Antibodies|antibodies|mesh-list
56575775|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
56575776|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575777|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575778|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575779|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56575780|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56575781|NCT03638297|Analgesics|analgesics|mesh-ancestor
56575782|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
56575783|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575784|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575785|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56575786|NCT03594110|Empagliflozin|empagliflozin|mesh-list
56575787|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56111628|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56575819|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575820|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56575821|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56575822|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56575823|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56575824|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575825|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575826|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56575827|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56575828|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56575829|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575830|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
56575831|NCT03326245|Methylphenidate|methylphenidate|mesh-list
56634882|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56634883|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634884|NCT04262375|Durvalumab|durvalumab|mesh-list
56634885|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634886|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634887|NCT00936793|Ritonavir|ritonavir|mesh-list
56634888|NCT00936793|Darunavir|darunavir|mesh-list
56634889|NCT00936793|Beclomethasone|beclomethasone|mesh-list
56634890|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56634891|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56634892|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
56634893|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634894|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634895|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56634896|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56575847|NCT03289962|Atezolizumab|atezolizumab|mesh-list
56575848|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575849|NCT03280563|Tamoxifen|tamoxifen|mesh-list
56575850|NCT03280563|Bevacizumab|bevacizumab|mesh-list
56575851|NCT03280563|Atezolizumab|atezolizumab|mesh-list
56575852|NCT03280563|Fulvestrant|fulvestrant|mesh-list
56575853|NCT03280563|Exemestane|exemestane|mesh-list
56575854|NCT03280563|Entinostat|entinostat|mesh-list
56575855|NCT03280563|Antibodies|antibodies|mesh-list
56575856|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575857|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575858|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56575859|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56575860|NCT03280563|Growth Substances|growth substances|mesh-ancestor
56575861|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575862|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
56575863|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
56575864|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56575865|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
56575866|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575867|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575868|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56575869|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56575870|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56575871|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56575872|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56575873|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56575874|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575875|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575876|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56575878|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575879|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575880|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56575881|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
56575882|NCT03255174|Coagulants|coagulants|mesh-ancestor
56575883|NCT03236987|Azithromycin|azithromycin|mesh-list
56575884|NCT03236987|Clarithromycin|clarithromycin|mesh-list
56575885|NCT03236987|Rifampin|rifampin|mesh-list
56575886|NCT03236987|Ethambutol|ethambutol|mesh-list
56575887|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56575888|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575889|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56575890|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111709|NCT02023866|Cysteamine|cysteamine|mesh-list
56575912|NCT03055507|Acetaminophen|acetaminophen|mesh-list
56575913|NCT03055507|Ibuprofen|ibuprofen|mesh-list
56575914|NCT03055507|Oxycodone|oxycodone|mesh-list
56634897|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
56634898|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634899|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56634900|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56634901|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634902|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
56634903|NCT00936793|Hormones|hormones|mesh-ancestor
56634904|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56634905|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634906|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56634907|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
56634908|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
56634909|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56634910|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56634911|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
56575915|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56575916|NCT03055507|Analgesics|analgesics|mesh-ancestor
56575917|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
56575918|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575919|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575920|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
56575921|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56575922|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575923|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56575924|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56575925|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575926|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575927|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56575928|NCT03055507|Narcotics|narcotics|mesh-ancestor
56575929|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575930|NCT03038256|Capecitabine|capecitabine|mesh-list
56575931|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56575932|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
56575933|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575934|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575935|NCT03009981|Prednisone|prednisone|mesh-list
56575936|NCT03009981|Leuprolide|leuprolide|mesh-list
56575937|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
56575938|NCT03009981|Bicalutamide|bicalutamide|mesh-list
56575939|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575940|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
56575972|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575973|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575974|NCT02841995|Belumosudil|belumosudil|mesh-list
56575975|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56575976|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575977|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575978|NCT02789982|Propranolol|propranolol|mesh-list
56575979|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
56575980|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
56575981|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56575982|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56575983|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575984|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576070|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56576071|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576073|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634912|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634913|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634914|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634915|NCT02805452|Urological Agents|urological agents|mesh-ancestor
56634916|NCT00937027|Aminopterin|aminopterin|mesh-list
56634917|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56634918|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634919|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634920|NCT02738502|Ritonavir|ritonavir|mesh-list
56634921|NCT02738502|Darunavir|darunavir|mesh-list
56634922|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56576074|NCT02135133|Ofatumumab|ofatumumab|mesh-list
56576075|NCT02135133|Idelalisib|idelalisib|mesh-list
56576076|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576077|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576078|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576079|NCT02081378|Niacinamide|niacinamide|mesh-list
56576084|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576085|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576086|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
56576088|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
56576089|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576090|NCT01993836|Anesthetics|anesthetics|mesh-list
56576091|NCT01993836|Propofol|propofol|mesh-list
56576092|NCT01993836|Isoflurane|isoflurane|mesh-list
56576093|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56324499|NCT04598815|Sirolimus|sirolimus|mesh-list
56576094|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576095|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56576096|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56576097|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
56576098|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56576099|NCT01909453|Vemurafenib|vemurafenib|mesh-list
56576100|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576101|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56576102|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576103|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576104|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56576105|NCT01717586|Pravastatin|pravastatin|mesh-list
56576106|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56576107|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56576108|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
56576109|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576110|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56576111|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56576112|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576113|NCT01665677|Atorvastatin|atorvastatin|mesh-list
56576114|NCT01665677|Calcium|calcium|mesh-list
56576115|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56576116|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576117|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56576118|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56576119|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
56576120|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576121|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56576122|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56576123|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576124|NCT01523977|Prednisone|prednisone|mesh-list
56576125|NCT01523977|Doxorubicin|doxorubicin|mesh-list
56576126|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
56576127|NCT01523977|Vincristine|vincristine|mesh-list
56576128|NCT01523977|Everolimus|everolimus|mesh-list
56576129|NCT01523977|Asparaginase|asparaginase|mesh-list
56576130|NCT01523977|Pegaspargase|pegaspargase|mesh-list
56576131|NCT01523977|Razoxane|razoxane|mesh-list
56070638|NCT00374621|Diuretics|diuretics|mesh-ancestor
56634923|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56634924|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
56634925|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634926|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634927|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56634928|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56634929|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
56634930|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634931|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56634932|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56634933|NCT04261907|Ritonavir|ritonavir|mesh-list
56634934|NCT04261907|Lopinavir|lopinavir|mesh-list
56634935|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56634936|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56634937|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
56634938|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634939|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634940|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56634941|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56576132|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56576133|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576134|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56576135|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56576136|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576137|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576138|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576139|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
56576140|NCT01523977|Hormones|hormones|mesh-ancestor
56576141|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56576142|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576143|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56576144|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56576145|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
56576146|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
56576147|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
56576148|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576149|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
56576150|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56576151|NCT01523977|Protective Agents|protective agents|mesh-ancestor
56576152|NCT01107717|Metformin|metformin|mesh-list
56576184|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576185|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576186|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
56576187|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576188|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
56576189|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56576190|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56576191|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56576192|NCT00278915|Fulvestrant|fulvestrant|mesh-list
56576193|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56576194|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576217|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
56576219|NCT00970632|Tamsulosin|tamsulosin|mesh-list
56576220|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
56634942|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
56634943|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634944|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56634945|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56634946|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
56634947|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56634948|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56634949|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56634950|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634951|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634952|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
56634953|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201993|NCT01531647|Ritonavir|ritonavir|mesh-list
56576221|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56576222|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56576223|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576224|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576225|NCT00970632|Urological Agents|urological agents|mesh-ancestor
56576226|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56576227|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56576228|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56576229|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
56576230|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576231|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576232|NCT01144364|Rituximab|rituximab|mesh-list
56576233|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56576234|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576235|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
56576236|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576237|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576238|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
56576239|NCT00965094|Everolimus|everolimus|mesh-list
56576240|NCT00965094|Tacrolimus|tacrolimus|mesh-list
56576241|NCT00965094|Basiliximab|basiliximab|mesh-list
56576242|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576243|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
56111951|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
56576264|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576265|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
56576266|NCT01131104|Tadalafil|tadalafil|mesh-list
56576267|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56576268|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56576269|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
56576270|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56576271|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576272|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576273|NCT01131104|Urological Agents|urological agents|mesh-ancestor
56576274|NCT04264884|Daratumumab|daratumumab|mesh-list
56576275|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576276|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56576277|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56576278|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56576279|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56576280|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576281|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576282|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576283|NCT01118780|Analgesics|analgesics|mesh-ancestor
56576284|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
56576285|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576286|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
56634954|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634955|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56634956|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634957|NCT02738346|Carboplatin|carboplatin|mesh-list
56634958|NCT02738346|Etoposide|etoposide|mesh-list
56634959|NCT02738346|Topotecan|topotecan|mesh-list
56634960|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634961|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56634962|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56634963|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56634964|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634965|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576287|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56576288|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
56576289|NCT00629928|Esomeprazole|esomeprazole|mesh-list
56576290|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56576291|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56576292|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56576293|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576294|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576295|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
56576296|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
56576297|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56576321|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
56576322|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
56576323|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56576324|NCT03262116|Insulin|insulin|mesh-list
56576325|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56576326|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
56576327|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
56576328|NCT03262116|Pancrelipase|pancrelipase|mesh-list
56576329|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56576330|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576331|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56576332|NCT01130168|Amlodipine|amlodipine|mesh-list
56576333|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56576334|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56576335|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56576336|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576337|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56576338|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576339|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
56576340|NCT04284852|Niraparib|niraparib|mesh-list
56576341|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56576342|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576343|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576344|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576345|NCT04283292|Capsaicin|capsaicin|mesh-list
56576346|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
56576347|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
56576348|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
56576349|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576350|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576399|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576401|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56576402|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56576403|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56576404|NCT01129622|Letrozole|letrozole|mesh-list
56576405|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576406|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56576407|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56576408|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887367|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634966|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56634967|NCT00932165|Exemestane|exemestane|mesh-list
56634968|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634969|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56202015|NCT01531712|Antiviral Agents|antiviral agents|mesh-ancestor
56576409|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576410|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56576411|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
56576412|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56576413|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576414|NCT01128842|Capecitabine|capecitabine|mesh-list
56576415|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56576416|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
56576417|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576418|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576419|NCT00625274|Esomeprazole|esomeprazole|mesh-list
56576420|NCT00625274|Pantoprazole|pantoprazole|mesh-list
56576421|NCT00625274|Lansoprazole|lansoprazole|mesh-list
56576453|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56576455|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576456|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56576457|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56576458|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576459|NCT05132595|Ketorolac|ketorolac|mesh-list
56576460|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56576461|NCT05132595|Esketamine|esketamine|mesh-list
56576462|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56576463|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56576464|NCT05132595|Analgesics|analgesics|mesh-ancestor
56576474|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56576475|NCT01074047|Azacitidine|azacitidine|mesh-list
56576476|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56576477|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
56576478|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576479|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576480|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576481|NCT01142726|Methotrexate|methotrexate|mesh-list
56576483|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56576484|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
56576485|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56576486|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576487|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56576488|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
56576489|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576490|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576491|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
56576492|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576493|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56576494|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576495|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
56576496|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576497|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56576498|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56576499|NCT04472637|Atorvastatin|atorvastatin|mesh-list
56576500|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56576501|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56576502|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
56576503|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576504|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56576505|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56576506|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576507|NCT01142336|Simvastatin|simvastatin|mesh-list
56576508|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56576509|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56576510|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
56576511|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576512|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56576513|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56576514|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634970|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56634971|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634972|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634973|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56634974|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
56634975|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56634976|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576515|NCT00915681|Silybin|silybin|mesh-list
56576516|NCT00915681|Protective Agents|protective agents|mesh-ancestor
56576517|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576518|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56576519|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576520|NCT01128296|Gemcitabine|gemcitabine|mesh-list
56576521|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
56576522|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56576523|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
56576524|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576525|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576526|NCT01128296|Antiviral Agents|antiviral agents|mesh-ancestor
56576544|NCT04240509|Emtricitabine|emtricitabine|mesh-list
56576545|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
56576546|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576547|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56576548|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56576549|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576550|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576551|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56576552|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56576553|NCT04450329|Aflibercept|aflibercept|mesh-list
56576554|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56576555|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56576556|NCT04450329|Growth Substances|growth substances|mesh-ancestor
56576557|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576558|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
56576559|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576560|NCT01115738|Clopidogrel|clopidogrel|mesh-list
56576561|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56576562|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56576563|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56576564|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56576565|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56576566|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
56576567|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576568|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576569|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576570|NCT00632073|Maleic acid|maleic acid|mesh-list
56576571|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576572|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576573|NCT01141478|Sorafenib|sorafenib|mesh-list
56576574|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576575|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56576576|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576577|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576578|NCT01114880|Adalimumab|adalimumab|mesh-list
56576579|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576580|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576581|NCT00625352|Gemcitabine|gemcitabine|mesh-list
56576582|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56576583|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
56576584|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576609|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576610|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576611|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
56576612|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325038|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
56634977|NCT04208178|Trastuzumab|trastuzumab|mesh-list
56634978|NCT04208178|Pertuzumab|pertuzumab|mesh-list
56634979|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634980|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634981|NCT00937183|Vaccines|vaccines|mesh-list
56547601|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634982|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
56634983|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634985|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56576613|NCT04282902|Pirfenidone|pirfenidone|mesh-list
56576614|NCT04282902|Analgesics|analgesics|mesh-ancestor
56576615|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
56576616|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576617|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576618|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56576619|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56576620|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576621|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576622|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576623|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
56576624|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
56576625|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
56576626|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56576627|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56576628|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576629|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576630|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576631|NCT04432623|Benserazide|benserazide|mesh-list
56576632|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56576633|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56576634|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576655|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576656|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576657|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56576658|NCT03432897|Olaparib|olaparib|mesh-list
56576659|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56576660|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576661|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576662|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576663|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
56576664|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56576665|NCT00659386|Antibodies|antibodies|mesh-list
56576666|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
56576667|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56576668|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
56010172|NCT00003760|Irofulven|irofulven|mesh-list
56576669|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576670|NCT04160325|Azathioprine|azathioprine|mesh-list
56576671|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
56576672|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576673|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56576674|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576675|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576676|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
56576677|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576678|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576679|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56576680|NCT04155814|Hematinics|hematinics|mesh-ancestor
56576681|NCT04547439|Melatonin|melatonin|mesh-list
56576682|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
56576683|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576684|NCT04547439|Protective Agents|protective agents|mesh-ancestor
56576685|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325107|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56576686|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56576780|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56576781|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
56634986|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56634987|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
56634988|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634989|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634990|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634991|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56634992|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56634993|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56634994|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56634995|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56634996|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
56634997|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56576782|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576783|NCT04155658|Fluorides|fluorides|mesh-list
56576784|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
56576785|NCT04155658|Protective Agents|protective agents|mesh-ancestor
56576786|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576787|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
56576788|NCT02861976|Narcotics|narcotics|mesh-ancestor
56576789|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56576790|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576791|NCT02861976|Analgesics|analgesics|mesh-ancestor
56576792|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
56576793|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576794|NCT00666484|Prednisolone|prednisolone|mesh-list
56576795|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
56576796|NCT00666484|Doxorubicin|doxorubicin|mesh-list
56576797|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56576798|NCT00666484|Etoposide|etoposide|mesh-list
56576799|NCT00666484|Vincristine|vincristine|mesh-list
56576800|NCT00666484|Procarbazine|procarbazine|mesh-list
56576801|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576802|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
56576803|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576804|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576805|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56576823|NCT01126736|Pemetrexed|pemetrexed|mesh-list
56576824|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576825|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576826|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576827|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56576828|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56576829|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56576830|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56576831|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56576832|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56576833|NCT00663130|Tadalafil|tadalafil|mesh-list
56576834|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56576835|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
56576836|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56576837|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56576838|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576839|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576840|NCT00663130|Urological Agents|urological agents|mesh-ancestor
56576841|NCT00965562|Fluoxetine|fluoxetine|mesh-list
56576842|NCT00965562|Calcium|calcium|mesh-list
56576843|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56576844|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576845|NCT00965562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56576846|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56576847|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887368|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
56634998|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56634999|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56635000|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56635001|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56635002|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56635003|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635004|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576848|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576849|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576850|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
56576851|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56576852|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
56576853|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56576854|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56576855|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56576856|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576857|NCT00659698|Pancrelipase|pancrelipase|mesh-list
56576858|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56576859|NCT00666796|Ethanol|ethanol|mesh-list
56576860|NCT00666796|Gabapentin|gabapentin|mesh-list
56576883|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576884|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576886|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56576887|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56576888|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576889|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56576890|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576891|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
56576892|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56576893|NCT00659776|Hematinics|hematinics|mesh-ancestor
56576894|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56576895|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56576896|NCT03500484|Liraglutide|liraglutide|mesh-list
56576897|NCT03500484|Glucagon|glucagon|mesh-list
56576898|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56576899|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56576900|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576901|NCT03500484|Incretins|incretins|mesh-ancestor
56576902|NCT03500484|Hormones|hormones|mesh-ancestor
56576903|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56576904|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56576905|NCT03929601|Rituximab|rituximab|mesh-list
56576906|NCT03929601|Abatacept|abatacept|mesh-list
56576907|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56576908|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576909|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
56576910|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576911|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112521|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576937|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576939|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576940|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576941|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
56576942|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56576943|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56576944|NCT04094961|Growth Substances|growth substances|mesh-ancestor
56576945|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
56576946|NCT04282824|Edetic Acid|edetic acid|mesh-list
56576947|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56576948|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
56576949|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
56576950|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576951|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
56576952|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56576953|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56635005|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635006|NCT00609557|Analgesics|analgesics|mesh-ancestor
56635007|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
56635008|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635009|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
56635010|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56635011|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
56635012|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
56635013|NCT05122481|Vitamins|vitamins|mesh-ancestor
56635014|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
56635015|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635016|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
56202056|NCT01531829|Nadroparin|nadroparin|mesh-list
56576954|NCT00663286|Clindamycin|clindamycin|mesh-list
56576955|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
56576956|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
56576957|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56576958|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56576959|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576960|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56576961|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576986|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56576987|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56576988|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56576989|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56576990|NCT03237702|Carotenoids|carotenoids|mesh-list
56576991|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
56576992|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576993|NCT03237702|Protective Agents|protective agents|mesh-ancestor
56576994|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576995|NCT00667108|Gabapentin|gabapentin|mesh-list
56576996|NCT00667108|Analgesics|analgesics|mesh-ancestor
56576997|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
56576998|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576999|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577000|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
56577001|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56577002|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56577003|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577004|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56577005|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56577006|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56577007|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577008|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577009|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
56577010|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
56112621|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
56577014|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
56577015|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56577016|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
56577017|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577018|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56577019|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56577020|NCT04158388|Tryptophan|tryptophan|mesh-list
56577021|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56577022|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
56577023|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56577024|NCT04283058|Ketamine|ketamine|mesh-list
56577025|NCT04283058|Anesthetics|anesthetics|mesh-list
56577026|NCT04283058|Analgesics|analgesics|mesh-ancestor
56577027|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
56577028|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577029|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158285|NCT05430750|Sevoflurane|sevoflurane|mesh-list
56577030|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56635017|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635018|NCT05122481|Protective Agents|protective agents|mesh-ancestor
56635019|NCT00937417|Docetaxel|docetaxel|mesh-list
56635020|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635021|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
56635022|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
56635023|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
56635024|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635025|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56577031|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56577032|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
56577033|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577034|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56577035|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56577036|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577037|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577038|NCT00631995|Vaccines|vaccines|mesh-list
56577039|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
56577040|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577041|NCT00663442|Methylphenidate|methylphenidate|mesh-list
56577042|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56577043|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577044|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56577045|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56577046|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56577047|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577048|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
56577049|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577050|NCT00912015|Tramadol|tramadol|mesh-list
56577051|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56577052|NCT00912015|Narcotics|narcotics|mesh-ancestor
56577053|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577054|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577055|NCT00912015|Analgesics|analgesics|mesh-ancestor
56577056|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
56577057|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577058|NCT00960804|Tanezumab|tanezumab|mesh-list
56577059|NCT00960804|Analgesics|analgesics|mesh-ancestor
56577060|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
56577061|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577062|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577064|NCT01126580|Dulaglutide|dulaglutide|mesh-list
56577065|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56577066|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577067|NCT00911157|Heparin|heparin|mesh-list
56577068|NCT00911157|Calcium heparin|calcium heparin|mesh-list
56577069|NCT00911157|PENTA|penta|mesh-list
56577070|NCT00911157|Fondaparinux|fondaparinux|mesh-list
56577071|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
56577072|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56577073|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56577074|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577075|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56577076|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
56577077|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56577078|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
56577079|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577080|NCT00960570|Efavirenz|efavirenz|mesh-list
56577081|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
56577082|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56577083|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56577137|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
56577138|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577139|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
56577140|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577141|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56635026|NCT02728440|Menotropins|menotropins|mesh-list
56635027|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56635028|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577142|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56577143|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
56577144|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577145|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577146|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56577147|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
56577148|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577150|NCT03773445|Antibodies|antibodies|mesh-list
56577151|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56577152|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
56577153|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577154|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56577155|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577156|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577157|NCT00630084|Interferons|interferons|mesh-list
56577158|NCT00630084|Ribavirin|ribavirin|mesh-list
56577159|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
56577160|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
56577161|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56577162|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577163|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
56577164|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577165|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
56577166|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577167|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
56577168|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577169|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
56577170|NCT01126424|Oxybutynin|oxybutynin|mesh-list
56577171|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56112723|NCT03822377|Ticagrelor|ticagrelor|mesh-list
56577174|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577175|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577176|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577178|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
56577179|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
56577180|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577181|NCT04204902|Tepotinib|tepotinib|mesh-list
56577182|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577183|NCT01126268|Retapamulin|retapamulin|mesh-list
56577184|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56577185|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577186|NCT04284150|Midazolam|midazolam|mesh-list
56577187|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
56577188|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56577189|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577190|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577191|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56577192|NCT04284150|Analgesics|analgesics|mesh-ancestor
56577193|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
56577194|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577195|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56577196|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56577197|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56577198|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
56577199|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577200|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577201|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56577202|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56577203|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56577204|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56577205|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56577206|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
56577207|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
56577208|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
56577209|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
56577210|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
56577211|NCT03311334|Nivolumab|nivolumab|mesh-list
56577212|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56577213|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577214|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55887369|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
56635029|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56635030|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
56635031|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56635032|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
56635033|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
56577215|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577216|NCT04313036|Defibrotide|defibrotide|mesh-list
56577217|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56577218|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56577219|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577220|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56577221|NCT00879658|Siponimod|siponimod|mesh-list
56577222|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56577223|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577224|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577225|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
56577226|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577227|NCT00959946|Capecitabine|capecitabine|mesh-list
56577228|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577229|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
56577230|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577231|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577232|NCT00667264|Ropivacaine|ropivacaine|mesh-list
56577233|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
56577234|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
56577235|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577236|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577237|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
56577238|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577239|NCT00660244|Anastrozole|anastrozole|mesh-list
56577240|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56577241|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577242|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56577243|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56577258|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56577259|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56577260|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577261|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577262|NCT00667498|Metformin|metformin|mesh-list
56577263|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56577264|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577265|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56577266|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
56577267|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56577268|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56577269|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577270|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577271|NCT00667966|Urological Agents|urological agents|mesh-ancestor
56577272|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
56577273|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56577274|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56577275|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577276|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
56577277|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577278|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577279|NCT00911937|Fesoterodine|fesoterodine|mesh-list
56577280|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56577281|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56325716|NCT02697448|Sevoflurane|sevoflurane|mesh-list
56577282|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
56577283|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577284|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577285|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577286|NCT00911937|Urological Agents|urological agents|mesh-ancestor
56577287|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56577288|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
56577289|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56577290|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56635034|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56635035|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56635036|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635037|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635038|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635039|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56635040|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
56635041|NCT00930865|Bumetanide|bumetanide|mesh-list
56635042|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56635043|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635044|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56577291|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577292|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577293|NCT00663598|Urological Agents|urological agents|mesh-ancestor
56577294|NCT02946996|Metformin|metformin|mesh-list
56577295|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56577296|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577297|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
56577298|NCT04166877|Analgesics|analgesics|mesh-ancestor
56577299|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
56577300|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112810|NCT03796013|Entrectinib|entrectinib|mesh-list
56577439|NCT02858622|Fentanyl|fentanyl|mesh-list
56577440|NCT02858622|Meperidine|meperidine|mesh-list
56577441|NCT02858622|Bupivacaine|bupivacaine|mesh-list
56577442|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
56577468|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577469|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56577470|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
56577471|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56577472|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56577473|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56577474|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577475|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56577476|NCT05143164|Gentamicins|gentamicins|mesh-list
56577477|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56577478|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577479|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56577480|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577481|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577482|NCT00664144|Rasburicase|rasburicase|mesh-list
56577483|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
56577484|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56577485|NCT02819856|Ebselen|ebselen|mesh-list
56577486|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56577487|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56577488|NCT02819856|Analgesics|analgesics|mesh-ancestor
56577489|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
56577490|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577491|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577492|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577572|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56577573|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577574|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
56577575|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56577576|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
56577577|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577579|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56577580|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577581|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56577582|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577583|NCT00911625|Insulin|insulin|mesh-list
56577584|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56635045|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635046|NCT00930865|Diuretics|diuretics|mesh-ancestor
56635047|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
56635048|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56577585|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
56577586|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
56577606|NCT00660868|Protective Agents|protective agents|mesh-ancestor
56577607|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577608|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
56577609|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56577610|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
56577611|NCT00664690|Celecoxib|celecoxib|mesh-list
56577612|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56577613|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56577614|NCT00664690|Analgesics|analgesics|mesh-ancestor
56577615|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
56577616|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577617|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577618|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577619|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56577620|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56577621|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56577622|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577623|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577625|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56577626|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
56577627|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56577628|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
56577629|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577630|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577631|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
56577632|NCT04338165|Evolocumab|evolocumab|mesh-list
56577633|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56577634|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56577635|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
56577636|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577637|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56577638|NCT00664846|Aspirin|aspirin|mesh-list
56577639|NCT00664846|Clopidogrel|clopidogrel|mesh-list
56577640|NCT00664846|Atorvastatin|atorvastatin|mesh-list
56577641|NCT00664846|Simvastatin|simvastatin|mesh-list
56577642|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56577651|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56577652|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577653|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56326095|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56577654|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56577655|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577656|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
56577657|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56577658|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56577659|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
56577660|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56577661|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56577662|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56577663|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56577664|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56577665|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
56577666|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577667|NCT00913783|Clomipramine|clomipramine|mesh-list
56577668|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56577669|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
56577670|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56577671|NCT00913783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56577672|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56577673|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56577674|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577675|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577676|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
56070639|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
56635049|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56635050|NCT00930943|Oxymorphone|oxymorphone|mesh-list
56635051|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56635052|NCT00930943|Narcotics|narcotics|mesh-ancestor
56635053|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635054|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635055|NCT00930943|Analgesics|analgesics|mesh-ancestor
56577677|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577678|NCT00661102|Capecitabine|capecitabine|mesh-list
56577679|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577680|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
56577681|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577682|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577683|NCT00669370|Docetaxel|docetaxel|mesh-list
56577684|NCT00669370|Capecitabine|capecitabine|mesh-list
56577685|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577686|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
56577687|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
56577688|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
56577689|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577690|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577691|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
56577692|NCT04248829|Gefitinib|gefitinib|mesh-list
56577693|NCT04248829|Lazertinib|lazertinib|mesh-list
56577694|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577695|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56577696|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577697|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577698|NCT00665314|Plerixafor|plerixafor|mesh-list
56577699|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56577700|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56577701|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
56577702|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577703|NCT04154722|Azithromycin|azithromycin|mesh-list
56577704|NCT04154722|Meropenem|meropenem|mesh-list
56577705|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56577706|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577707|NCT02631928|Insulin|insulin|mesh-list
56113122|NCT00716807|Nalbuphine|nalbuphine|mesh-list
56577721|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56577722|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
56577723|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577724|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577725|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577726|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56577727|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56577728|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
56577729|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
56577730|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
56577731|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577732|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
56577733|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56577734|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577735|NCT04669717|Amoxicillin|amoxicillin|mesh-list
56158302|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158303|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56158304|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
56158307|NCT05274048|Trastuzumab|trastuzumab|mesh-list
56577736|NCT04669717|Azithromycin|azithromycin|mesh-list
56577737|NCT04669717|Metronidazole|metronidazole|mesh-list
56577738|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56577739|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577740|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56577741|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56577742|NCT00809341|Prednisone|prednisone|mesh-list
56577743|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
56577744|NCT00809341|Ifosfamide|ifosfamide|mesh-list
56577745|NCT00809341|Rituximab|rituximab|mesh-list
56577746|NCT00809341|Carboplatin|carboplatin|mesh-list
56577747|NCT00809341|Doxorubicin|doxorubicin|mesh-list
56577748|NCT00809341|Etoposide|etoposide|mesh-list
56577749|NCT00809341|Vincristine|vincristine|mesh-list
56577750|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56635056|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
56635057|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635058|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56635059|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56635060|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
56635061|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56635062|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
56635063|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56202107|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56577751|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
56577752|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577753|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56577754|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56577755|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
56577756|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577757|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577758|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56577759|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56577760|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56577761|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56577762|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56577763|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577764|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577765|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
56577766|NCT00809341|Hormones|hormones|mesh-ancestor
56577767|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56577791|NCT00811057|Analgesics|analgesics|mesh-ancestor
56577792|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
56577793|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577794|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577795|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
56577796|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577797|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56577798|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
56577799|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56577800|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56577801|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577802|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56577803|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
56577804|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56577805|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
56577806|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56577807|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56577808|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577809|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56577810|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
56577811|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56577812|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577813|NCT00879970|Vitamin D|vitamin d|mesh-list
56577814|NCT00879970|Pioglitazone|pioglitazone|mesh-list
56577815|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
56577816|NCT00879970|Vitamins|vitamins|mesh-ancestor
56577817|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
56577818|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577819|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56577866|NCT05754853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577868|NCT05754853|Antiviral Agents|antiviral agents|mesh-ancestor
56577869|NCT05754853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577870|NCT05754853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577871|NCT05754853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577872|NCT05754853|Immunologic Factors|immunologic factors|mesh-ancestor
56577873|NCT05754853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577874|NCT05754853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56577875|NCT05754853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56577876|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
56635064|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635065|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56635066|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56635067|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635068|NCT00934531|Donepezil|donepezil|mesh-list
56635069|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56635070|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202116|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56577877|NCT03007329|Exenatide|exenatide|mesh-list
56577878|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56577879|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577880|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56577881|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577882|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56577883|NCT03007329|Incretins|incretins|mesh-ancestor
56577884|NCT03007329|Hormones|hormones|mesh-ancestor
56577885|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56577886|NCT04072341|Propolis|propolis|mesh-list
56577887|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577888|NCT04030039|Interferons|interferons|mesh-list
56577889|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577890|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
56577891|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577892|NCT02628574|Gemcitabine|gemcitabine|mesh-list
56577893|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
56577894|NCT02628574|Nivolumab|nivolumab|mesh-list
56577895|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577896|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
56577897|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577898|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577899|NCT02628574|Antiviral Agents|antiviral agents|mesh-ancestor
56577900|NCT02628574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577901|NCT02628574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577902|NCT02628574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577903|NCT02628574|Immunologic Factors|immunologic factors|mesh-ancestor
56577904|NCT02628574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577905|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56577929|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577930|NCT00676156|Protective Agents|protective agents|mesh-ancestor
56577931|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577932|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
56577933|NCT00676156|Vitamins|vitamins|mesh-ancestor
56577934|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
56577935|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
56577936|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577937|NCT00914017|Atorvastatin|atorvastatin|mesh-list
56577938|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56577939|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56577940|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
56577941|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577942|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56577943|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56011493|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
56577944|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577945|NCT00671320|Diclofenac|diclofenac|mesh-list
56577946|NCT00671320|Valdecoxib|valdecoxib|mesh-list
56577947|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56577948|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56577949|NCT00671320|Analgesics|analgesics|mesh-ancestor
56577950|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
56577951|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577952|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577953|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577954|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56578004|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
56578005|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56578006|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635071|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635072|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
56635073|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635074|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635075|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
56578007|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
56578008|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578009|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56578010|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578012|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
56578013|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578014|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578015|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
56578016|NCT00908583|Hormones|hormones|mesh-ancestor
56578017|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578018|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56578019|NCT00908583|Protective Agents|protective agents|mesh-ancestor
56578020|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56578022|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56578023|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578024|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578025|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578026|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578027|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578028|NCT00671632|Triazolam|triazolam|mesh-list
56578029|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56578030|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56578031|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56578032|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56578033|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578035|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
56578036|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
56578037|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578038|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578039|NCT04973605|Dexamethasone|dexamethasone|mesh-list
56578040|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578041|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
56578042|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
56578043|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578044|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578045|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578046|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
56578105|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56578106|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578107|NCT04031872|Capecitabine|capecitabine|mesh-list
56578108|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56578109|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
56578110|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578111|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578112|NCT00670696|Tetracaine|tetracaine|mesh-list
56578113|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
56578114|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
56578115|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56578116|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578117|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
56578118|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578119|NCT00677248|Ezetimibe|ezetimibe|mesh-list
56578120|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56578121|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56578122|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
56578123|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578177|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56578178|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56578179|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
56578180|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578181|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56578182|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56326631|NCT05672173|Nivolumab|nivolumab|mesh-list
56578183|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578185|NCT00680602|Fluoxetine|fluoxetine|mesh-list
56635076|NCT00931021|Nicotine|nicotine|mesh-list
56635077|NCT00931021|Varenicline|varenicline|mesh-list
56635078|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56635079|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
56635080|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635081|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635082|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56635083|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56635084|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
56635085|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635086|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635087|NCT00937807|Sevoflurane|sevoflurane|mesh-list
56635088|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56635089|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56578186|NCT00680602|Paroxetine|paroxetine|mesh-list
56578203|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56578204|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578205|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578206|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
56578207|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578208|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578209|NCT00808015|Varenicline|varenicline|mesh-list
56578210|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56578211|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56578212|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
56578213|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578214|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578215|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578216|NCT00680758|Paclitaxel|paclitaxel|mesh-list
56578217|NCT00680758|Everolimus|everolimus|mesh-list
56578218|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56578219|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578220|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578221|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578222|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578223|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578224|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578225|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
56578226|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578227|NCT00678106|Dalbavancin|dalbavancin|mesh-list
56578228|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56578229|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578230|NCT00810199|Methotrexate|methotrexate|mesh-list
56578231|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56578232|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
56578233|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56578234|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578235|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56578237|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578238|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578239|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
56578240|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578241|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56113612|NCT00000809|Antacids|antacids|mesh-ancestor
56578268|NCT00877006|Hormones|hormones|mesh-ancestor
56578269|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578270|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56578271|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56578272|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578273|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
56635090|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
56635091|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
56635092|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635093|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635094|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
56635095|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56635096|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56578274|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578275|NCT00678184|Atorvastatin|atorvastatin|mesh-list
56578276|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56578277|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56578278|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
56578279|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578280|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56578281|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56578282|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578283|NCT00876928|Vitamin D|vitamin d|mesh-list
56578284|NCT00876928|Vitamins|vitamins|mesh-ancestor
56578285|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
56578286|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578287|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56578288|NCT02627950|Metoclopramide|metoclopramide|mesh-list
56578289|NCT02627950|Ticagrelor|ticagrelor|mesh-list
56578290|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56578316|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56578317|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
56578318|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
56578319|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578320|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578321|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56578322|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56578323|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578324|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578325|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56578326|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56578327|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578328|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
56578329|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56326773|NCT05625412|Nivolumab|nivolumab|mesh-list
56578331|NCT04935229|Ipilimumab|ipilimumab|mesh-list
56578332|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56578333|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578334|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56578335|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578336|NCT00681226|Ramipril|ramipril|mesh-list
56578337|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56578338|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
56578398|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56578399|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578400|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578401|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56326848|NCT05552508|Benralizumab|benralizumab|mesh-list
56578403|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
56578404|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
56578405|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
56578406|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578407|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578408|NCT00906945|Cytarabine|cytarabine|mesh-list
56578409|NCT00906945|Plerixafor|plerixafor|mesh-list
56578410|NCT00906945|Etoposide|etoposide|mesh-list
56578411|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
56578412|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56578439|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56578440|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578441|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56578442|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56578443|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
56578444|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635097|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56578445|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578446|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56578447|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
56578448|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56578449|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56578450|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56578451|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
56578452|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578453|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578454|NCT05752903|Dexmedetomidine|dexmedetomidine|mesh-list
56578456|NCT05752903|Propofol|propofol|mesh-list
56578457|NCT05752903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56578458|NCT05752903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56578459|NCT05752903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578460|NCT05752903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56578482|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578483|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
56578484|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
56578485|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56578486|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
56578487|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578488|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578489|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56578490|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56578491|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56578492|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56578493|NCT00590317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56578494|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56578495|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
56578496|NCT01139762|Tadalafil|tadalafil|mesh-list
56578497|NCT01139762|Finasteride|finasteride|mesh-list
56578498|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
56578499|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56578500|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56578501|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578502|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578503|NCT01139762|Urological Agents|urological agents|mesh-ancestor
56578504|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56578505|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56578506|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
56578507|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578508|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578509|NCT00805285|Budesonide|budesonide|mesh-list
56578510|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
56578511|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578512|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56578513|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
56578545|NCT05715229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56578546|NCT05715229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578547|NCT05715229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56578548|NCT05715229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56578549|NCT01139450|Tacrolimus|tacrolimus|mesh-list
56578550|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578551|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
56578552|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578553|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56578554|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578555|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578556|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
56578557|NCT05110742|Fludarabine|fludarabine|mesh-list
56578584|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56578585|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56578586|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578587|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578588|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56578589|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56578590|NCT03958201|Rocuronium|rocuronium|mesh-list
56578591|NCT03958201|Neostigmine|neostigmine|mesh-list
56578592|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56578593|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56578594|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56635098|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56635099|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635100|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
56635101|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635102|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635103|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56635104|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578595|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578596|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578597|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56578598|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578599|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578600|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
56578601|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578602|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56578603|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
56578604|NCT00589303|Metoprolol|metoprolol|mesh-list
56578605|NCT00589303|Amiodarone|amiodarone|mesh-list
56578606|NCT00589303|Verapamil|verapamil|mesh-list
56578607|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56578608|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56578633|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
56578634|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56578635|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578636|NCT02606617|Mosapride|mosapride|mesh-list
56578637|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578638|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56578639|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
56578640|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578641|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578642|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578643|NCT00914095|Methylphenidate|methylphenidate|mesh-list
56578644|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56578645|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578646|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56578647|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56578648|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56578649|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578650|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
56578651|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578652|NCT03903835|Prednisone|prednisone|mesh-list
56578653|NCT03903835|Carboplatin|carboplatin|mesh-list
56578654|NCT03903835|Docetaxel|docetaxel|mesh-list
56578655|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
56578656|NCT03903835|Niraparib|niraparib|mesh-list
56578682|NCT05745337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578683|NCT05745337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56578684|NCT05745337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56578685|NCT05745337|Sympatholytics|sympatholytics|mesh-ancestor
56578686|NCT05745337|Autonomic Agents|autonomic agents|mesh-ancestor
56578687|NCT05745337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578688|NCT05745337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56578689|NCT05745337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56578690|NCT05745337|Adrenergic Agents|adrenergic agents|mesh-ancestor
56578691|NCT05745337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578692|NCT05745337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578693|NCT05745337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56578694|NCT05745337|Vasodilator Agents|vasodilator agents|mesh-ancestor
56578695|NCT00952380|Dalteparin|dalteparin|mesh-list
56578696|NCT00952380|Tinzaparin|tinzaparin|mesh-list
56578697|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56578698|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
56578699|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56578700|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56578701|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578702|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
56578703|NCT03859921|Progestins|progestins|mesh-ancestor
56635105|NCT02808728|Bupivacaine|bupivacaine|mesh-list
56635106|NCT02808728|Ropivacaine|ropivacaine|mesh-list
56635107|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
56635108|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
56635109|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56578704|NCT03859921|Hormones|hormones|mesh-ancestor
56114081|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
56578737|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
56578738|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
56578739|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56578740|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578741|NCT02857842|Prednisolone|prednisolone|mesh-list
56578742|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578743|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
56578744|NCT02857842|Hormones|hormones|mesh-ancestor
56578745|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578746|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578766|NCT03635437|Alprazolam|alprazolam|mesh-list
56578767|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
56578768|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56578769|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56578770|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578771|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56578772|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56578773|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56578774|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
56578775|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
56578776|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578777|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578778|NCT00803179|Hormones|hormones|mesh-list
56578779|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578780|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578782|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
56578783|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578784|NCT05697211|Ferric maltol|ferric maltol|mesh-list
56578785|NCT05697211|Hematinics|hematinics|mesh-ancestor
56578786|NCT00957996|Peramivir|peramivir|mesh-list
56578787|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
56578788|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578789|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578790|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578791|NCT02606539|Leucovorin|leucovorin|mesh-list
56578792|NCT02606539|Folic Acid|folic acid|mesh-list
56578793|NCT02606539|Methotrexate|methotrexate|mesh-list
56578794|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
56578795|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56578796|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
56578797|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56578798|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578799|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56578800|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
56578801|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578802|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578803|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
56578804|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578832|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56578833|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
56578834|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578835|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578836|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56578837|NCT05734495|Venetoclax|venetoclax|mesh-list
56578838|NCT05734495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578841|NCT05660473|Cytarabine|cytarabine|mesh-list
56578842|NCT05660473|Dexamethasone|dexamethasone|mesh-list
56578843|NCT05660473|Prednisone|prednisone|mesh-list
56578844|NCT05660473|Cyclophosphamide|cyclophosphamide|mesh-list
56578845|NCT05660473|Methotrexate|methotrexate|mesh-list
56578846|NCT05660473|Vincristine|vincristine|mesh-list
56578847|NCT05660473|Daunorubicin|daunorubicin|mesh-list
56578848|NCT05660473|Venetoclax|venetoclax|mesh-list
56578849|NCT05660473|Mercaptopurine|mercaptopurine|mesh-list
56578850|NCT05660473|Pegaspargase|pegaspargase|mesh-list
56578851|NCT05660473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578852|NCT05660473|Immunologic Factors|immunologic factors|mesh-ancestor
56635110|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635111|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
56635112|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635113|NCT05331053|Atorvastatin|atorvastatin|mesh-list
56635114|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56635115|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56635116|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
56635117|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578853|NCT05660473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578854|NCT05660473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56114228|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
56578872|NCT05660473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56578874|NCT05660473|Dermatologic Agents|dermatologic agents|mesh-ancestor
56578875|NCT05660473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578876|NCT05660473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56578877|NCT05660473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56578878|NCT05660473|Antiviral Agents|antiviral agents|mesh-ancestor
56578879|NCT05660473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578880|NCT05660473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56578881|NCT05660473|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578882|NCT05660473|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578883|NCT05660473|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578884|NCT05660473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56578885|NCT05660473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56578886|NCT05660473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56578887|NCT00803101|Protein C|protein c|mesh-list
56578888|NCT00803101|Protein S|protein s|mesh-list
56578889|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
56578890|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56578891|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56578892|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578893|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56578894|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56578895|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578896|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56578897|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56578898|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56578899|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578900|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
56578901|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578902|NCT01964430|Gemcitabine|gemcitabine|mesh-list
56578903|NCT01964430|Paclitaxel|paclitaxel|mesh-list
56578904|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56578905|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578906|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578907|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578937|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
56578938|NCT01254864|Hormones|hormones|mesh-ancestor
56578939|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578940|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578941|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56578942|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578943|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56578944|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56578945|NCT01254864|Growth Substances|growth substances|mesh-ancestor
56578946|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
56578947|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56578948|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578949|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578950|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56578951|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
56578952|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56578953|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
56578954|NCT02854722|Vitamin D|vitamin d|mesh-list
56578955|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
56635118|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56635119|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56635120|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635121|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56635122|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56635123|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56635124|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635125|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635126|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
56635127|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578956|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
56578998|NCT00906399|Interferons|interferons|mesh-list
56578999|NCT00906399|Interferon-beta|interferon-beta|mesh-list
56579000|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
56579001|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579002|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
56579003|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579004|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
56579005|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579006|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56579007|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56579008|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56579009|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579010|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56579011|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579013|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56579014|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579015|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
56579016|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
56579017|NCT00947154|Aripiprazole|aripiprazole|mesh-list
56579018|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
56579019|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56579020|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56579021|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56579022|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579046|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56579047|NCT00951912|Protective Agents|protective agents|mesh-ancestor
56579048|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579049|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579050|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56579051|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579052|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579053|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
56579054|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56579056|NCT00951912|Hormones|hormones|mesh-ancestor
56579057|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579058|NCT02882594|Anesthetics|anesthetics|mesh-list
56579059|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579060|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579061|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56579062|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
56579063|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56579064|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
56579065|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56579066|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579067|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56579068|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56579069|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579070|NCT03844815|Decitabine|decitabine|mesh-list
56579071|NCT03844815|Venetoclax|venetoclax|mesh-list
56579072|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56579073|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
56635128|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56635129|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56635130|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
56635131|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56635132|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
56635133|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635134|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635135|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56635136|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
56635137|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56635138|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
56635139|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635140|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635141|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56635142|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
56635143|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
56635144|NCT04996667|Protective Agents|protective agents|mesh-ancestor
56635145|NCT00929669|Pasireotide|pasireotide|mesh-list
56635146|NCT00929669|Hormones|hormones|mesh-ancestor
56579144|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56579145|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
56579146|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579147|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579148|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579149|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56579150|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56579151|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56579152|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579153|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56579154|NCT03525795|Ipilimumab|ipilimumab|mesh-list
56480243|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480244|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158379|NCT04519944|Edoxaban|edoxaban|mesh-list
56579155|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
56579156|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56579157|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579158|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56579159|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579160|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579162|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56579164|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579165|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579166|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56579167|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
56579168|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
56579169|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56579170|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56579171|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56579172|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56579173|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
56579200|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579201|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
56635147|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635148|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635149|NCT02804360|Dexamethasone|dexamethasone|mesh-list
56635150|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
56635151|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635152|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
56635153|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
56635154|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635155|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635156|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56635157|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
56635158|NCT02804360|Hormones|hormones|mesh-ancestor
56202202|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
56579202|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56579203|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56579204|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
56579205|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
56579206|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
56579207|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579208|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579209|NCT02855502|Prednisolone|prednisolone|mesh-list
56579210|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56579211|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
56579212|NCT02855502|Hormones|hormones|mesh-ancestor
56579213|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579214|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579215|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56579216|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579217|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
56579218|NCT02853864|Propofol|propofol|mesh-list
56579219|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56579220|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114578|NCT00001997|Zidovudine|zidovudine|mesh-list
56579245|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
56579246|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
56579247|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579248|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56579249|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579250|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
56579251|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56579252|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579253|NCT02350764|Nivolumab|nivolumab|mesh-list
56579254|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56579255|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579256|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56579257|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579258|NCT00876460|Docetaxel|docetaxel|mesh-list
56579259|NCT00876460|Nintedanib|nintedanib|mesh-list
56579260|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579261|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
56579262|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
56579263|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
56579264|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579265|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56579266|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579267|NCT01137812|Metformin|metformin|mesh-list
56579268|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56579269|NCT01137812|Canagliflozin|canagliflozin|mesh-list
56579270|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56579271|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579272|NCT01137812|Incretins|incretins|mesh-ancestor
56579328|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
56635159|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635160|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56635161|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635162|NCT02727738|Selenium|selenium|mesh-list
56635163|NCT02727738|Methimazole|methimazole|mesh-list
56635164|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
56635166|NCT02727738|Protective Agents|protective agents|mesh-ancestor
56635226|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635227|NCT00938197|Amlodipine|amlodipine|mesh-list
56635228|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56635229|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56579329|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579330|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579331|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56579332|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579333|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
56579334|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56579335|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56579336|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579337|NCT00681928|Letrozole|letrozole|mesh-list
56579338|NCT00681928|Anastrozole|anastrozole|mesh-list
56579339|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579340|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56579341|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56579342|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579343|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579344|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56579345|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
56579346|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579347|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579348|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56579349|NCT00594646|Tenofovir|tenofovir|mesh-list
56579350|NCT00594646|Emtricitabine|emtricitabine|mesh-list
56579351|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
56579352|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56579353|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
56579354|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579355|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56579356|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56579357|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579358|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579359|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56579360|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56579361|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56579401|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114743|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56579471|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
56579472|NCT01111292|Vitamins|vitamins|mesh-ancestor
56579473|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
56579474|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579475|NCT02853630|Metformin|metformin|mesh-list
56579476|NCT02853630|Vildagliptin|vildagliptin|mesh-list
56579477|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56579478|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579479|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56579480|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
56579481|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579482|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579483|NCT04309838|Treprostinil|treprostinil|mesh-list
56579484|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56579485|NCT00936936|Gemcitabine|gemcitabine|mesh-list
56579486|NCT00936936|Carboplatin|carboplatin|mesh-list
56579487|NCT00936936|Docetaxel|docetaxel|mesh-list
56579488|NCT00936936|Etoposide|etoposide|mesh-list
56579489|NCT00936936|Melphalan|melphalan|mesh-list
56579490|NCT00936936|Ifosfamide|ifosfamide|mesh-list
56579491|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579492|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56579493|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
56579494|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579495|NCT00936936|Antiviral Agents|antiviral agents|mesh-ancestor
56579496|NCT00936936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579497|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579498|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56579499|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
56579500|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579501|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
56579502|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
56635230|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56635231|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635232|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56635233|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635234|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
56635235|NCT02727504|Dobutamine|dobutamine|mesh-list
55739824|NCT02421263|Psilocybin|psilocybin|mesh-list
56579503|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
56579504|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56579505|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56579506|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56579507|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56579569|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
56579570|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56579571|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579572|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579573|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56579574|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579575|NCT01108094|Itraconazole|itraconazole|mesh-list
56579576|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
56579577|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579578|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56579579|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56579580|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579581|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579582|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56579583|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
56579584|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579585|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579586|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56579587|NCT00954174|Paclitaxel|paclitaxel|mesh-list
56579588|NCT00954174|Carboplatin|carboplatin|mesh-list
56579589|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56579590|NCT00954174|Ifosfamide|ifosfamide|mesh-list
56579591|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
56114923|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
56579622|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579623|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56579624|NCT01136408|Warfarin|warfarin|mesh-list
56579625|NCT01136408|Dabigatran|dabigatran|mesh-list
56579626|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
56579627|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
56579628|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56579629|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
56579630|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579631|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579632|NCT01136174|Nintedanib|nintedanib|mesh-list
56579633|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579634|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56579635|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114972|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56579666|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56579667|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56579668|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579669|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579670|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
56579671|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
56579672|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56579673|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
56579674|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579675|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56579676|NCT00904215|Telmisartan|telmisartan|mesh-list
56579677|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56579678|NCT00904215|Diuretics|diuretics|mesh-ancestor
56115016|NCT00002357|Zidovudine|zidovudine|mesh-list
56579699|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635236|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56635237|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
56635238|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
56635239|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635240|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635241|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56635242|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56635243|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56635244|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
56635245|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635246|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202299|NCT01533389|Silodosin|silodosin|mesh-list
56579701|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
56579702|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
56579703|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579704|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579705|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56579706|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56579707|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
56579708|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56579709|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56579710|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56579711|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56579712|NCT00904839|Bevacizumab|bevacizumab|mesh-list
56579713|NCT00904839|Nintedanib|nintedanib|mesh-list
56579714|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56579715|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579716|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56579717|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56579718|NCT00904839|Growth Substances|growth substances|mesh-ancestor
56579719|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579720|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
56579721|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56579722|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579723|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579724|NCT04985955|Tofacitinib|tofacitinib|mesh-list
56579725|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56579726|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579727|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579728|NCT02821923|Erythritol|erythritol|mesh-list
56579729|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
56579730|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
56579731|NCT00903357|Montelukast|montelukast|mesh-list
56579780|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
56579781|NCT01889199|Flutamide|flutamide|mesh-list
56579782|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
56579783|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
56579784|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579785|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579786|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56579787|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579788|NCT01730313|Pyridoxine|pyridoxine|mesh-list
56579789|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
56579790|NCT01730313|Phenytoin|phenytoin|mesh-list
56579791|NCT01730313|Valproic Acid|valproic acid|mesh-list
56579792|NCT01730313|Vitamins|vitamins|mesh-ancestor
56579793|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
56579794|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579819|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56579820|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579821|NCT01103960|Amlodipine|amlodipine|mesh-list
56579822|NCT01103960|Telmisartan|telmisartan|mesh-list
56579823|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56579824|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56635247|NCT02727504|Protective Agents|protective agents|mesh-ancestor
56635248|NCT02727348|Anesthetics|anesthetics|mesh-list
56635249|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635250|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579825|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579826|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579827|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56579828|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579829|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
56579830|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56579831|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56579832|NCT04413279|Dexamethasone|dexamethasone|mesh-list
56579833|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56579834|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
56579835|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
56579836|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579837|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579838|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56579839|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
56579840|NCT04413279|Hormones|hormones|mesh-ancestor
56579841|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579842|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56579843|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579844|NCT04975256|Adagrasib|adagrasib|mesh-list
56115174|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
56579914|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579915|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579916|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56115266|NCT02973581|Analgesics|analgesics|mesh-ancestor
56579948|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56579949|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
56579950|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56579951|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
56579952|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579953|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579954|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56579955|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
56579956|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
56579957|NCT03576885|Protective Agents|protective agents|mesh-ancestor
56580033|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56580035|NCT04268472|Darunavir|darunavir|mesh-list
56580036|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56580070|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580071|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56580072|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
56580073|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56580074|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56580075|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56580076|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
56580077|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580079|NCT00941304|Buprenorphine|buprenorphine|mesh-list
56580080|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56580081|NCT00941304|Narcotics|narcotics|mesh-ancestor
56580082|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56580083|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580084|NCT00941304|Analgesics|analgesics|mesh-ancestor
56580085|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
56580086|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580087|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56580088|NCT02846025|Folic Acid|folic acid|mesh-list
56580089|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
56580090|NCT02846025|Antioxidants|antioxidants|mesh-list
56580091|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580092|NCT02846025|Protective Agents|protective agents|mesh-ancestor
56580093|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580094|NCT02846025|Hematinics|hematinics|mesh-ancestor
56580095|NCT02846025|Vitamins|vitamins|mesh-ancestor
56580096|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
56580097|NCT02880410|Temozolomide|temozolomide|mesh-list
56580098|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56580099|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
56635251|NCT02804126|Acetaminophen|acetaminophen|mesh-list
56635252|NCT02804126|Dipyrone|dipyrone|mesh-list
56635253|NCT02804126|Ketoprofen|ketoprofen|mesh-list
56635254|NCT02804126|Morphine|morphine|mesh-list
56635255|NCT02804126|Bupivacaine|bupivacaine|mesh-list
56635256|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
56635257|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
56635258|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635259|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635260|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
56635261|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635262|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56635263|NCT02804126|Narcotics|narcotics|mesh-ancestor
56635264|NCT02804126|Analgesics|analgesics|mesh-ancestor
56635265|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56635266|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
56635267|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56635268|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635269|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56635270|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56635271|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635272|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635273|NCT04013815|Ropivacaine|ropivacaine|mesh-list
56635274|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
56635275|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
56635276|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56281155|NCT00006339|Ritonavir|ritonavir|mesh-list
56202309|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
56580100|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580136|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580137|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580138|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56580140|NCT04956302|Hormones|hormones|mesh-ancestor
56580141|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56580142|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56115472|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580201|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56580202|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
56580203|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580205|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56580206|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580207|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56580208|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56580209|NCT02844309|Growth Substances|growth substances|mesh-ancestor
56580210|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
56580211|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580213|NCT02845713|Albendazole|albendazole|mesh-list
56580214|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
56580215|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56635277|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635278|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
56635279|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635281|NCT00610103|Emetics|emetics|mesh-ancestor
56635282|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635283|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
56635284|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635285|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56635286|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
56635287|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
56635288|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635289|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635290|NCT05624190|Plasminogen|plasminogen|mesh-list
56635291|NCT05624190|Tenecteplase|tenecteplase|mesh-list
56580216|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580217|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
56580218|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
56580219|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56580220|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56580221|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
56580222|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
56580252|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580253|NCT05242419|Huperzine A|huperzine a|mesh-list
56580254|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56580255|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580256|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580257|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
56580258|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580259|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580260|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56580261|NCT05242419|Protective Agents|protective agents|mesh-ancestor
56580263|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580264|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580265|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56580266|NCT02690883|Incretins|incretins|mesh-ancestor
56580267|NCT02690883|Hormones|hormones|mesh-ancestor
56580301|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
56580302|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56580303|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56580304|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580305|NCT00653913|Ezetimibe|ezetimibe|mesh-list
56580306|NCT00653913|Pitavastatin|pitavastatin|mesh-list
56580307|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56580308|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56580309|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
56115628|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56580328|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
56580329|NCT00652431|Vitamins|vitamins|mesh-ancestor
56580330|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
56580331|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580332|NCT00380523|Etoricoxib|etoricoxib|mesh-list
56580333|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56580334|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56580335|NCT00380523|Analgesics|analgesics|mesh-ancestor
56580336|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
56580337|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580338|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580339|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56580340|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580341|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56580342|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56580343|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635292|NCT05624190|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56580344|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580345|NCT00319995|Loratadine|loratadine|mesh-list
56580346|NCT00319995|Montelukast|montelukast|mesh-list
56580347|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56580348|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
56580349|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56580350|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
56580351|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56580352|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580353|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56580355|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580356|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
56580357|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
56580358|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56580359|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56580360|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56580361|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
56580362|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
56580363|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580364|NCT03304821|Sargramostim|sargramostim|mesh-list
56580365|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
56580389|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580391|NCT00157911|Ezetimibe|ezetimibe|mesh-list
56580392|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56580393|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56580394|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
56580395|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580396|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56580397|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56580398|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580399|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56580400|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56580401|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
56580402|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
56580403|NCT02842125|Nivolumab|nivolumab|mesh-list
56580404|NCT02842125|Capecitabine|capecitabine|mesh-list
56580405|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56580406|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580407|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56580408|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
56580409|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580410|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56580411|NCT03708549|Metformin|metformin|mesh-list
56580412|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580413|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580414|NCT00156117|Olanzapine|olanzapine|mesh-list
56580415|NCT00156117|Asenapine|asenapine|mesh-list
56580450|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56580452|NCT00132717|Ezetimibe|ezetimibe|mesh-list
56580453|NCT00132717|Pravastatin|pravastatin|mesh-list
56580454|NCT00132717|Lovastatin|lovastatin|mesh-list
56580455|NCT00132717|L 647318|l 647318|mesh-list
56580456|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
56580457|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56580458|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56580459|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
56580460|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580461|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56580462|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56580463|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580464|NCT00127179|Finasteride|finasteride|mesh-list
56580465|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580466|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480248|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
56580467|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56580468|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56580469|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580470|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
56580471|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56580472|NCT00127179|Urological Agents|urological agents|mesh-ancestor
56580473|NCT00953706|Ivacaftor|ivacaftor|mesh-list
56580474|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56070640|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
56635293|NCT05624190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56635294|NCT05624190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56635295|NCT05624190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635296|NCT00938353|Beclomethasone|beclomethasone|mesh-list
56635297|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635298|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
56635299|NCT00938353|Hormones|hormones|mesh-ancestor
56635300|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635301|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635302|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56635303|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
56635304|NCT03994796|Entrectinib|entrectinib|mesh-list
56635305|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56635306|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580475|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56580476|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580477|NCT02852382|Morphine|morphine|mesh-list
56580478|NCT02852382|Bupivacaine|bupivacaine|mesh-list
56580546|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56580547|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580549|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56580550|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56580551|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580552|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
56580553|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580554|NCT02852070|Dimercaprol|dimercaprol|mesh-list
56580555|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
56580556|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
56580557|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580558|NCT00602862|Bevacizumab|bevacizumab|mesh-list
56580559|NCT00602862|Sorafenib|sorafenib|mesh-list
56580560|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56580561|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580562|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56580563|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56580564|NCT00602862|Growth Substances|growth substances|mesh-ancestor
56580565|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580566|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
56580567|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56580568|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580569|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580570|NCT00942708|Fluoxetine|fluoxetine|mesh-list
56580571|NCT00942708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56580572|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56580573|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56329053|NCT00019487|Aldesleukin|aldesleukin|mesh-list
56580574|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580575|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580576|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
56580577|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580578|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56580579|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
56580580|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56580581|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56115890|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
56580600|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56580601|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56635307|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635308|NCT04259333|Acetaminophen|acetaminophen|mesh-list
56635309|NCT04259333|Celecoxib|celecoxib|mesh-list
56635310|NCT04259333|Codeine|codeine|mesh-list
56635311|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56635312|NCT04259333|Analgesics|analgesics|mesh-ancestor
56635313|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
56635314|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635315|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635316|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
56635317|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56635318|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635319|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56635320|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56635321|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56635322|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635323|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635324|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56635325|NCT04259333|Narcotics|narcotics|mesh-ancestor
56635326|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635327|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
56635328|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
56635329|NCT02721420|Piperaquine|piperaquine|mesh-list
56635330|NCT02721420|Artenimol|artenimol|mesh-list
56635331|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
56635332|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56635333|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56635334|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635335|NCT00608699|Niacin|niacin|mesh-list
56635336|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56635337|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
56635338|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635339|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56635340|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
56635341|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
56635342|NCT00608699|Vitamins|vitamins|mesh-ancestor
56580602|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
56580603|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56580604|NCT00941928|Analgesics|analgesics|mesh-ancestor
56580605|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
56580606|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580607|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56580608|NCT02852694|Adalimumab|adalimumab|mesh-list
56580609|NCT02852694|Methotrexate|methotrexate|mesh-list
56580610|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
56580611|NCT02852694|Azathioprine|azathioprine|mesh-list
56580612|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56580613|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
56580614|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56580615|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580616|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56580617|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
56580618|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580619|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580620|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
56580621|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580622|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56580623|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56580624|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
56580625|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580626|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56580627|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56580628|NCT00604578|Pioglitazone|pioglitazone|mesh-list
56580629|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580630|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580631|NCT00937560|Paclitaxel|paclitaxel|mesh-list
56580632|NCT00937560|Bevacizumab|bevacizumab|mesh-list
56580633|NCT00937560|Carboplatin|carboplatin|mesh-list
56580634|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56580635|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580636|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
56580637|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
56580638|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
56580639|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580665|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56580666|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56580667|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
56580668|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580669|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56580670|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56580671|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56580672|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56580673|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56580674|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56580675|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56580676|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56580677|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
56580678|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
56580679|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
56580680|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
56580681|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580682|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56580683|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56580684|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56580685|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56580686|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
56158422|NCT04176354|Letrozole|letrozole|mesh-list
56580687|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580688|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56580689|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56580690|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56580691|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
56580708|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56580709|NCT04268394|Analgesics|analgesics|mesh-ancestor
56580710|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
56580711|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580712|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56580713|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56580715|NCT02851212|Canagliflozin|canagliflozin|mesh-list
56580716|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580717|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580718|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56635348|NCT02726490|Glyburide|glyburide|mesh-list
56635349|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56635350|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635351|NCT02726646|Doxycycline|doxycycline|mesh-list
56281203|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
56635352|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56635353|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635354|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
56635355|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56635356|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56635357|NCT02803892|Vildagliptin|vildagliptin|mesh-list
56635358|NCT02803892|Sirolimus|sirolimus|mesh-list
56635359|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56635360|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635361|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56635362|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635363|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
56635364|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56580719|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580720|NCT04143802|Dulaglutide|dulaglutide|mesh-list
56580721|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56329206|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
56580722|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580723|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56580724|NCT00685126|Albuterol|albuterol|mesh-list
56580725|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56580726|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
56580727|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580728|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580729|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56580730|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
56580731|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
56580732|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56580733|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56580734|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56580735|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56580736|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
56580737|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580738|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580739|NCT00682630|Artesunate|artesunate|mesh-list
56580740|NCT00682630|Pyronaridine|pyronaridine|mesh-list
56580741|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
56580742|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56580743|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56580744|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580745|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580763|NCT00685672|Racepinephrine|racepinephrine|mesh-list
56580764|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
56580765|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56580766|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56580767|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
56580768|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580769|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580770|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580771|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56580772|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56580773|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
56580774|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580775|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56580776|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
56635365|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
56635366|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635367|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56635368|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56635369|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
56635370|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635371|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635372|NCT02803502|Thrombin|thrombin|mesh-list
56635373|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
56635374|NCT02803502|Coagulants|coagulants|mesh-ancestor
56635375|NCT02721186|Piperaquine|piperaquine|mesh-list
56635376|NCT02721186|Primaquine|primaquine|mesh-list
56635377|NCT02721186|Artenimol|artenimol|mesh-list
56635378|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
56635379|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56635380|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56635381|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635382|NCT02716428|Ribavirin|ribavirin|mesh-list
56635383|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
56635384|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635385|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
56635386|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635387|NCT05511428|Daratumumab|daratumumab|mesh-list
56635388|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56635389|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635390|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
56635391|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635392|NCT00931463|Ritonavir|ritonavir|mesh-list
56635393|NCT00931463|Lopinavir|lopinavir|mesh-list
56635394|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
56202426|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580777|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
56580778|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
56580779|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56580780|NCT00683176|Choline|choline|mesh-list
56580781|NCT00683176|Fenofibrate|fenofibrate|mesh-list
56580782|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56580783|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
56580784|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580785|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56580786|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
56580787|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56580788|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
56580789|NCT02626234|Digoxin|digoxin|mesh-list
56580790|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56580791|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56580792|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56580793|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
56580794|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635395|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56635396|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56635397|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
56635398|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635399|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635400|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56635401|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56635402|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
56635403|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635404|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56635405|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56635406|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56635407|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56635408|NCT03974594|Trifluridine|trifluridine|mesh-list
56635409|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
56635410|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635411|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
56635412|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635413|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
56635414|NCT03964688|Vitamins|vitamins|mesh-ancestor
56635415|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
56635416|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635417|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
56635418|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635419|NCT03964688|Protective Agents|protective agents|mesh-ancestor
56635420|NCT00929201|Metformin|metformin|mesh-list
56635421|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56635422|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56635423|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635424|NCT00929201|Incretins|incretins|mesh-ancestor
56635425|NCT00929201|Hormones|hormones|mesh-ancestor
56547602|NCT02667925|Cisplatin|cisplatin|mesh-list
56635426|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635427|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56580795|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56580796|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56580797|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580798|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56580799|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56580800|NCT02626234|Protective Agents|protective agents|mesh-ancestor
56635428|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
56635429|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923628|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56635430|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635431|NCT02800772|Acetic Acid|acetic acid|mesh-list
56635432|NCT02800772|Retinol acetate|retinol acetate|mesh-list
56635433|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56635434|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635435|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56635436|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
56635437|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635438|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56635439|NCT02800772|Protective Agents|protective agents|mesh-ancestor
56635440|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635441|NCT02773212|Amphetamine|amphetamine|mesh-list
56635442|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
56635443|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56635444|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635445|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
56635446|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
56635447|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635448|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
56635449|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635450|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635451|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56635452|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56635453|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56635454|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56580801|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580802|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
56580803|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580804|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56580805|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116114|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
56580830|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580832|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56580833|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56580834|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56580835|NCT04139824|Naproxen|naproxen|mesh-list
56580836|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56580837|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56580838|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56580839|NCT04139824|Analgesics|analgesics|mesh-ancestor
56580840|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
56635455|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56635456|NCT00610493|Sirolimus|sirolimus|mesh-list
56635457|NCT00610493|Bevacizumab|bevacizumab|mesh-list
56635458|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56635459|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635460|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56635461|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56635462|NCT00610493|Growth Substances|growth substances|mesh-ancestor
56635463|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635464|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
56635465|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56635466|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635467|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56635468|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
56635469|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56635470|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
56635471|NCT02716272|Nivolumab|nivolumab|mesh-list
56635472|NCT02716272|Ipilimumab|ipilimumab|mesh-list
56635473|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56635474|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635475|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56635476|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635477|NCT02720406|Ketamine|ketamine|mesh-list
56635478|NCT02720406|Analgesics|analgesics|mesh-ancestor
56635479|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
56635480|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635481|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635482|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56635483|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56635484|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
56202524|NCT01534806|Ketorolac|ketorolac|mesh-list
56580841|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580842|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580843|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580844|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
56580845|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56580846|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580847|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580848|NCT00940602|Deferasirox|deferasirox|mesh-list
56580849|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56580850|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
56580851|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
56580895|NCT00875524|Vaccines|vaccines|mesh-list
56580896|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
56635485|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
56635486|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635487|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56635488|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56635489|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635490|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635491|NCT05504876|Midazolam|midazolam|mesh-list
56635492|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56635493|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56635494|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635495|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635496|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56635497|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56635498|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56635499|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56635500|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
56635501|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
56635502|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
56635503|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
56635504|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635505|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635507|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
56635508|NCT02802722|Vitamins|vitamins|mesh-ancestor
56635509|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
56635510|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635511|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56580897|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580898|NCT01094288|Docetaxel|docetaxel|mesh-list
56580899|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580900|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
56580901|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
56580902|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
56580903|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580904|NCT05380986|Apatinib|apatinib|mesh-list
56580905|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580906|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56580907|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580908|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580909|NCT00684112|Gabapentin|gabapentin|mesh-list
56580941|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
56580942|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580943|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580944|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56580945|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56580946|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580947|NCT00874120|Phenylephrine|phenylephrine|mesh-list
56580948|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
56580949|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56580950|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
56635512|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56635513|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56635514|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56635515|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635516|NCT02802644|Incretins|incretins|mesh-ancestor
56635517|NCT02802644|Hormones|hormones|mesh-ancestor
56635518|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635519|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56635520|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
56635521|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635522|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635523|NCT02744976|Metformin|metformin|mesh-list
56635524|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56635525|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635526|NCT00928889|Acarbose|acarbose|mesh-list
56635527|NCT00928889|Nateglinide|nateglinide|mesh-list
56635528|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56635529|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635530|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635531|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56635532|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635533|NCT02725398|Scopolamine|scopolamine|mesh-list
56635534|NCT02725398|Bromides|bromides|mesh-list
56635535|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56635536|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
56635537|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56635538|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
56635539|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
56635540|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635541|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635542|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56635543|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
56635555|NCT03978091|Ceftazidime|ceftazidime|mesh-list
56635556|NCT03978091|Avibactam|avibactam|mesh-list
56635557|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
56635558|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56635559|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635560|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56635561|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635562|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635563|NCT00610571|Temozolomide|temozolomide|mesh-list
56635564|NCT00610571|Topotecan|topotecan|mesh-list
56635565|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56635566|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
56635567|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635568|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635569|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56635570|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56635571|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635572|NCT02725242|Budesonide|budesonide|mesh-list
56635573|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
56635574|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635575|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56635576|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
56635577|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635578|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635579|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56635580|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
56635581|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
56635582|NCT02725242|Hormones|hormones|mesh-ancestor
56635583|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635584|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56635585|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56635586|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56635587|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
56635588|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635589|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580951|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
56580952|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580971|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56635590|NCT00564733|Gemcitabine|gemcitabine|mesh-list
56635591|NCT00564733|Paclitaxel|paclitaxel|mesh-list
56635592|NCT00564733|Docetaxel|docetaxel|mesh-list
56635593|NCT00564733|Carboplatin|carboplatin|mesh-list
56635594|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56635595|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56635596|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635597|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
56635598|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
56635599|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
56635600|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635601|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56635602|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
56635603|NCT00564733|Antiviral Agents|antiviral agents|mesh-ancestor
56635604|NCT00564733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635605|NCT00564733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635606|NCT00564733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56635607|NCT00564733|Immunologic Factors|immunologic factors|mesh-ancestor
56635608|NCT00564733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635609|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56635610|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
56635611|NCT02725164|Sevoflurane|sevoflurane|mesh-list
56635612|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56635613|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56635614|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
56635615|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
56635616|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635617|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635618|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56635619|NCT02725164|Analgesics|analgesics|mesh-ancestor
56635620|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
56635621|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635622|NCT02800694|Fentanyl|fentanyl|mesh-list
56635623|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56635624|NCT02800694|Narcotics|narcotics|mesh-ancestor
56635634|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
56635635|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56635636|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
56635637|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635638|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635639|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56635640|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
56635641|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56635642|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56635643|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56635644|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
56635645|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635646|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635647|NCT00938509|Ibuprofen|ibuprofen|mesh-list
56635648|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56635649|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56635650|NCT00938509|Analgesics|analgesics|mesh-ancestor
56635651|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
56635652|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635653|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635654|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635655|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56635656|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56635657|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635658|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635659|NCT02724618|Curcumin|curcumin|mesh-list
56635660|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56635661|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56635662|NCT02724618|Analgesics|analgesics|mesh-ancestor
56635663|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
56635664|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635665|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635666|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635667|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56635668|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635669|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480385|NCT02920190|Hormones|hormones|mesh-ancestor
56635670|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635671|NCT02801786|Tamoxifen|tamoxifen|mesh-list
56635672|NCT02801786|Lidocaine|lidocaine|mesh-list
56635673|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
56635674|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
56635675|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635676|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635677|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
56635678|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635679|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56635680|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56635681|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56635682|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56635683|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635684|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56635685|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
56635686|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635687|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56635688|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635689|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56635690|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56635691|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56635692|NCT04258553|Antioxidants|antioxidants|mesh-list
56635693|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635694|NCT04258553|Protective Agents|protective agents|mesh-ancestor
56635695|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635696|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56635697|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56635698|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56635699|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56635700|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635708|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635709|NCT02719392|Expectorants|expectorants|mesh-ancestor
56635710|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
56635711|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56635712|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
56635713|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635714|NCT02719392|Protective Agents|protective agents|mesh-ancestor
56635715|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635716|NCT02719392|Antidotes|antidotes|mesh-ancestor
56635717|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56635718|NCT02802098|Bevacizumab|bevacizumab|mesh-list
56635719|NCT02802098|Durvalumab|durvalumab|mesh-list
56635720|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56635721|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635722|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56635723|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56635724|NCT02802098|Growth Substances|growth substances|mesh-ancestor
56635725|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635726|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
56635727|NCT00938821|Morphine|morphine|mesh-list
56635728|NCT00938821|Bupivacaine|bupivacaine|mesh-list
56635729|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
56635730|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
56635731|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56635732|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635733|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
56635734|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635735|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56635736|NCT00938821|Narcotics|narcotics|mesh-ancestor
56635737|NCT00938821|Analgesics|analgesics|mesh-ancestor
56635738|NCT04013581|Empagliflozin|empagliflozin|mesh-list
56635739|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56635743|NCT02715960|Vitamin A|vitamin a|mesh-list
56635753|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56635754|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635755|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
56635756|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635757|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56635758|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
56635759|NCT02794922|Vitamins|vitamins|mesh-ancestor
56635760|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
56635761|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635762|NCT00935467|Saxagliptin|saxagliptin|mesh-list
56635763|NCT00935467|Incretins|incretins|mesh-ancestor
56635764|NCT00935467|Hormones|hormones|mesh-ancestor
56635765|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635766|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635767|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56635768|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
56635769|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635770|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635771|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56635772|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56635773|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56635774|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
56635775|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635776|NCT04235816|Azithromycin|azithromycin|mesh-list
56635777|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56635778|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635779|NCT00936013|Oseltamivir|oseltamivir|mesh-list
56635780|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
56635781|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635782|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635783|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635784|NCT00936091|Vitamin A|vitamin a|mesh-list
56635785|NCT00936091|Vitamins|vitamins|mesh-ancestor
56635786|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
56635787|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635794|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56635795|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56635796|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
56635797|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635798|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635799|NCT01192698|Interferons|interferons|mesh-list
56635800|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635801|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
56635802|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635803|NCT04014361|Itraconazole|itraconazole|mesh-list
56635804|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
56635805|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923629|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281736|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56635806|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56635807|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56635808|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635809|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635810|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56635811|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
56635812|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635813|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635814|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56635815|NCT00771927|Lacosamide|lacosamide|mesh-list
56635816|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
56635817|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56635818|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56635819|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56635820|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635821|NCT04014283|Selenium|selenium|mesh-list
56635822|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
56635823|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635824|NCT04014283|Protective Agents|protective agents|mesh-ancestor
56635825|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635826|NCT04014283|Trace Elements|trace elements|mesh-ancestor
56635828|NCT02715492|Enoxaparin|enoxaparin|mesh-list
56635829|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
56635830|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56635831|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56635832|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635833|NCT03940196|Paclitaxel|paclitaxel|mesh-list
56635834|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56635835|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56635836|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635837|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
56635838|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
56635839|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
56635840|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635841|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
56635842|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635843|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635844|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
56635845|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635846|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635847|NCT02724150|Omeprazole|omeprazole|mesh-list
56635848|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56635849|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56635850|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56635851|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635852|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635853|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56635854|NCT04042740|Ribavirin|ribavirin|mesh-list
56635855|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
56635856|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635857|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
56635858|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635873|NCT02799758|Pitavastatin|pitavastatin|mesh-list
56635874|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56635875|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56635876|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56635877|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
56547603|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635878|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635879|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635880|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56635881|NCT00938899|Simeprevir|simeprevir|mesh-list
56635882|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
56635883|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635884|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
56635885|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635886|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635887|NCT03259165|Diuretics|diuretics|mesh-list
56635888|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56635889|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
56635890|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635891|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56635892|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635893|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56635894|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56635895|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635899|NCT00939133|Tretinoin|tretinoin|mesh-list
56635900|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635901|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
56635902|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
56635903|NCT02799446|Reslizumab|reslizumab|mesh-list
56635904|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56635905|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
56635906|NCT00564889|Dexamethasone|dexamethasone|mesh-list
56635907|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
56635908|NCT00564889|Lenalidomide|lenalidomide|mesh-list
56480574|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
56580973|NCT00687388|Celecoxib|celecoxib|mesh-list
56580974|NCT00687388|Doxazosin|doxazosin|mesh-list
56580975|NCT00687388|Prazosin|prazosin|mesh-list
56580976|NCT00687388|Tamsulosin|tamsulosin|mesh-list
56580977|NCT00687388|Alfuzosin|alfuzosin|mesh-list
56635909|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56635910|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
56635911|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635912|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56635913|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56635914|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
56635915|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635916|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635917|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56635918|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635919|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
56635920|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
56635921|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635922|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56635923|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
56635924|NCT00564889|Hormones|hormones|mesh-ancestor
56635925|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635926|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56635927|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56635928|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56635929|NCT00564889|Growth Substances|growth substances|mesh-ancestor
56635930|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
56635931|NCT02790164|Rocuronium|rocuronium|mesh-list
56635932|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56635933|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56635934|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56635935|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635936|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635937|NCT00939757|Mirabegron|mirabegron|mesh-list
56635938|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56635939|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56635940|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56635941|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
56635942|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635943|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635947|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56635948|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635949|NCT00939835|Dexetimide|dexetimide|mesh-list
56635950|NCT00939835|Citalopram|citalopram|mesh-list
56635951|NCT00939835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56635952|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56635953|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56635954|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635955|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56635956|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
56635957|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635958|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56635959|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
56635960|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56635961|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56635962|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56635963|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
56635964|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
56635965|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56635966|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56635967|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56635968|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
56635969|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
56635970|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
56635971|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635972|NCT02690012|Cathartics|cathartics|mesh-ancestor
56635973|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56635974|NCT02690012|Antacids|antacids|mesh-ancestor
56635975|NCT02256865|Ketoconazole|ketoconazole|mesh-list
56480652|NCT00532584|Hormones|hormones|mesh-ancestor
56580978|NCT00687388|Terazosin|terazosin|mesh-list
56580979|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56580980|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56580981|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56580982|NCT00687388|Analgesics|analgesics|mesh-ancestor
56580983|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
56580984|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580985|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580986|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56580987|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580988|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56580989|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56580990|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580991|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580992|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56635976|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
56635977|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56635978|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56635979|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56635980|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
56635981|NCT02256865|Testosterone|testosterone|mesh-list
56635982|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
56635983|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
56635984|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56635985|NCT02256865|Androgens|androgens|mesh-ancestor
56635986|NCT02256865|Hormones|hormones|mesh-ancestor
56635987|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56635988|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56635989|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56635990|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56635991|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
56635992|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56635993|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
56635994|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56635995|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56635996|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56635997|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56635998|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56635999|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56636000|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
56636001|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56636002|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
56636003|NCT02793986|Propofol|propofol|mesh-list
56636004|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56636005|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636006|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480694|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
56580993|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56580994|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
56580995|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580996|NCT00687388|Urological Agents|urological agents|mesh-ancestor
56580997|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56580998|NCT05382390|Cytarabine|cytarabine|mesh-list
56580999|NCT05382390|Decitabine|decitabine|mesh-list
56581000|NCT05382390|Aclarubicin|aclarubicin|mesh-list
56581001|NCT05382390|Lenograstim|lenograstim|mesh-list
56581002|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56581003|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
56636007|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56636008|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
56636009|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
56636010|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56636011|NCT02793986|Analgesics|analgesics|mesh-ancestor
56636012|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
56636013|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636014|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56636015|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56636016|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56636017|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
56636018|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636019|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636020|NCT00940069|Pemetrexed|pemetrexed|mesh-list
56636021|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636022|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636023|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636024|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56636025|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56636027|NCT00940303|Bevacizumab|bevacizumab|mesh-list
56636028|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
56636029|NCT00940303|Irinotecan|irinotecan|mesh-list
56480736|NCT05467436|Anesthetics|anesthetics|mesh-list
56581004|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581005|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581006|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
56581007|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581008|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581023|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
56581024|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581026|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56581027|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581028|NCT04266288|Ketamine|ketamine|mesh-list
56581029|NCT04266288|Analgesics|analgesics|mesh-ancestor
56581030|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
56581031|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581032|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581033|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56581034|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56581035|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
56581036|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
56581037|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56581038|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56581039|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56581040|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581041|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581042|NCT00687622|Trametinib|trametinib|mesh-list
56581043|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581044|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56581045|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581046|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581047|NCT00687700|Propranolol|propranolol|mesh-list
56636030|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56636031|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636032|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56636033|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56636034|NCT00940303|Growth Substances|growth substances|mesh-ancestor
56636035|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636036|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
56636037|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56636038|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56636039|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636040|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636041|NCT00940303|Antidotes|antidotes|mesh-ancestor
56636042|NCT00940303|Protective Agents|protective agents|mesh-ancestor
56636043|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
56636044|NCT00940303|Vitamins|vitamins|mesh-ancestor
56636045|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
56636046|NCT02794220|Nicotine|nicotine|mesh-list
56636047|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56636048|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
56636049|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636050|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636051|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56636052|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56636053|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
56636054|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636055|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636056|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
56636057|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56636058|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56636059|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
56636060|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636061|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56636073|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56636074|NCT04405999|Bromhexine|bromhexine|mesh-list
56636075|NCT04405999|Expectorants|expectorants|mesh-ancestor
56636076|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
56636077|NCT02793908|Progesterone|progesterone|mesh-list
56636078|NCT02793908|Progestins|progestins|mesh-ancestor
56636079|NCT02793908|Hormones|hormones|mesh-ancestor
56636080|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636081|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636082|NCT02789930|Anesthetics|anesthetics|mesh-list
56636083|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636084|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636085|NCT00560833|Mirtazapine|mirtazapine|mesh-list
56636086|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636087|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
56636088|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56636089|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56636090|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
56636091|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
56636092|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636093|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636094|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56636095|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56636096|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636097|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56636098|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56636099|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56636100|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
56636101|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56636102|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56636118|NCT00771654|Phentermine|phentermine|mesh-list
56636119|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56636120|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636121|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
56636122|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56636123|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
56636124|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
56636125|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636126|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
56636127|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636128|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636129|NCT00941239|Metformin|metformin|mesh-list
56636130|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56636131|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636132|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
56636133|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
56636134|NCT04235426|Diclofenac|diclofenac|mesh-list
56636135|NCT04235426|Vitamins|vitamins|mesh-ancestor
56636136|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
56636137|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636138|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56636139|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56636140|NCT04235426|Analgesics|analgesics|mesh-ancestor
56636141|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
56636142|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636143|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56636144|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56636145|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56636146|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636147|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636148|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
56636149|NCT04235426|Hematinics|hematinics|mesh-ancestor
56636150|NCT02793440|Cortivazol|cortivazol|mesh-list
56636151|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56636152|NCT02723838|Gemcitabine|gemcitabine|mesh-list
56636153|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636154|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56636155|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
56636157|NCT02723838|Antiviral Agents|antiviral agents|mesh-ancestor
56636158|NCT02723838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636159|NCT02723838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636160|NCT02723838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56636161|NCT02723838|Immunologic Factors|immunologic factors|mesh-ancestor
56636162|NCT02723838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636163|NCT02789150|Norepinephrine|norepinephrine|mesh-list
56636164|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56636165|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56636166|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
56636167|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636168|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636169|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636170|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
56636171|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
56636172|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636173|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56636174|NCT02715024|Tamsulosin|tamsulosin|mesh-list
56636175|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
56282076|NCT05413018|Cc-486|cc-486|mesh-list
56636176|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56636177|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56636178|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56636179|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
56636180|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636181|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636182|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636183|NCT02715024|Urological Agents|urological agents|mesh-ancestor
56636184|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56636185|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56636186|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
56636187|NCT02798744|Empagliflozin|empagliflozin|mesh-list
56636188|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56636189|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636190|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56636192|NCT00925769|Bevacizumab|bevacizumab|mesh-list
56636195|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56636196|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636197|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56636198|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56636199|NCT00925769|Growth Substances|growth substances|mesh-ancestor
56636200|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636201|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
56636202|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56636203|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
56636204|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636205|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56636206|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636207|NCT00770913|Rabeprazole|rabeprazole|mesh-list
56636208|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56636209|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56636210|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56636211|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636212|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636213|NCT00562861|Lamotrigine|lamotrigine|mesh-list
56636214|NCT00562861|Carbamazepine|carbamazepine|mesh-list
56636215|NCT00562861|Valproic Acid|valproic acid|mesh-list
56636217|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
56636218|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56636219|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56636220|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636221|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56636222|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636223|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56636224|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56636225|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636226|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56636227|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56636228|NCT00562861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56636229|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56480921|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636230|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636231|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
56636232|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56636233|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
56636234|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636235|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636236|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
56636237|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
56636238|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56636239|NCT00562861|Analgesics|analgesics|mesh-ancestor
56636240|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
56636241|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56636242|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56636243|NCT02723448|Aclarubicin|aclarubicin|mesh-list
56636244|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
56636245|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56636246|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636247|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56636248|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56547604|NCT02669719|Carboplatin|carboplatin|mesh-list
56547605|NCT02669719|Pemetrexed|pemetrexed|mesh-list
56636249|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636250|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636251|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56636252|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
56636253|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636255|NCT02798510|Capecitabine|capecitabine|mesh-list
56636256|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56636257|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
56636258|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636259|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636260|NCT02798510|Antiviral Agents|antiviral agents|mesh-ancestor
56636272|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56636273|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
56636274|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
56636275|NCT04258475|Calcium|calcium|mesh-list
56636276|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56636277|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636278|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56636279|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56636280|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
56636281|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636282|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56636283|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56636284|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636285|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636286|NCT03944954|Dronabinol|dronabinol|mesh-list
56636287|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
56636288|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636289|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56636290|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56636291|NCT03944954|Analgesics|analgesics|mesh-ancestor
56636292|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
56636293|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636294|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56636295|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56636296|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636297|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636298|NCT03944954|Hormones|hormones|mesh-ancestor
56636299|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636300|NCT00609011|Temozolomide|temozolomide|mesh-list
56636301|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56636302|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
56636303|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636304|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636312|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636313|NCT04042116|Nivolumab|nivolumab|mesh-list
56636314|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56636315|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636316|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56636317|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636318|NCT04260581|Amantadine|amantadine|mesh-list
56636319|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56636320|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56636321|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
56636323|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
56636324|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636325|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636326|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636327|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56636328|NCT04260581|Analgesics|analgesics|mesh-ancestor
56636329|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
56636330|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636331|NCT00770367|Pioglitazone|pioglitazone|mesh-list
56636332|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56636333|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636334|NCT00941785|Amodiaquine|amodiaquine|mesh-list
56636335|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
56636336|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56636337|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56636338|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636339|NCT05502081|Remdesivir|remdesivir|mesh-list
56636340|NCT05502081|Favipiravir|favipiravir|mesh-list
56636341|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
56636342|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636343|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
56636344|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636345|NCT02793050|Trabectedin|trabectedin|mesh-list
56636346|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56636350|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
56636355|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
56636356|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56636357|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
56636358|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636359|NCT04964843|Protective Agents|protective agents|mesh-ancestor
56636360|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636361|NCT04964843|Antidotes|antidotes|mesh-ancestor
56636362|NCT00942253|Dopamine|dopamine|mesh-list
56636363|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
56636364|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56636365|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
56636366|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
56636367|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636368|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636369|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
56636370|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636371|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636372|NCT00942253|Protective Agents|protective agents|mesh-ancestor
56636373|NCT02792816|Artesunate|artesunate|mesh-list
56636374|NCT02792816|Artemether|artemether|mesh-list
56636375|NCT02792816|Piperaquine|piperaquine|mesh-list
56636376|NCT02792816|Artenimol|artenimol|mesh-list
56636377|NCT02792816|Mefloquine|mefloquine|mesh-list
56636378|NCT02792816|Antimalarials|antimalarials|mesh-list
56636379|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56636380|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56636381|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636382|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636383|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
56636384|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
56636385|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56636386|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
56636387|NCT00940381|Sirolimus|sirolimus|mesh-list
56636388|NCT00940381|Cetuximab|cetuximab|mesh-list
56636390|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636393|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56636394|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
56636395|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56636396|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
56636397|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636398|NCT00637988|Aspirin|aspirin|mesh-list
56636399|NCT00637988|Rofecoxib|rofecoxib|mesh-list
56636400|NCT00637988|Esomeprazole|esomeprazole|mesh-list
56636401|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56636402|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56636403|NCT00637988|Analgesics|analgesics|mesh-ancestor
56636404|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
56636405|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636406|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636407|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56636408|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56636409|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56636410|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56636411|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636412|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56636413|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56636414|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636415|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
56636416|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56636417|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56636418|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56636419|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56636420|NCT04258163|Gemcitabine|gemcitabine|mesh-list
56636421|NCT04258163|Capecitabine|capecitabine|mesh-list
56636422|NCT04258163|Doxorubicin|doxorubicin|mesh-list
56636423|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56636425|NCT04258163|Fulvestrant|fulvestrant|mesh-list
56636426|NCT04258163|Anastrozole|anastrozole|mesh-list
56636427|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56481101|NCT00534378|Midazolam|midazolam|mesh-list
56581048|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56581049|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56581050|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
56581051|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581052|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581053|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581054|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56581055|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56636428|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
56636429|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636430|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636431|NCT04258163|Antiviral Agents|antiviral agents|mesh-ancestor
56636432|NCT04258163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636433|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636434|NCT04258163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56636435|NCT04258163|Immunologic Factors|immunologic factors|mesh-ancestor
56636436|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636437|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56636438|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56636439|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56636440|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56636441|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56636442|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56636443|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
56636444|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636445|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56636446|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56636447|NCT00942487|Nebivolol|nebivolol|mesh-list
56636448|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56636449|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
56636450|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56636451|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56636452|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56636453|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
56636454|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636455|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636456|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636457|NCT00611039|Ritonavir|ritonavir|mesh-list
56636458|NCT00611039|Darunavir|darunavir|mesh-list
56636459|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56636460|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56581056|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
56581058|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56581059|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
56581060|NCT00935532|Exenatide|exenatide|mesh-list
56581061|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56581062|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581063|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56581064|NCT00935532|Incretins|incretins|mesh-ancestor
56581065|NCT00935532|Hormones|hormones|mesh-ancestor
56636461|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
56636462|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636463|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636464|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56636465|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56636466|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
56636467|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636468|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56636469|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56636470|NCT00942565|Acetaminophen|acetaminophen|mesh-list
56636471|NCT00942565|Tramadol|tramadol|mesh-list
56636472|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56636473|NCT00942565|Analgesics|analgesics|mesh-ancestor
56636474|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
56636475|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636476|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636477|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
56636478|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56636479|NCT00942565|Narcotics|narcotics|mesh-ancestor
56636480|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636481|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
56636482|NCT00945373|Calcium|calcium|mesh-list
56636483|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56636484|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636485|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
56636486|NCT00945373|Coagulants|coagulants|mesh-ancestor
56636487|NCT04100655|Molgramostim|molgramostim|mesh-list
56581066|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581067|NCT04138420|Bevacizumab|bevacizumab|mesh-list
56581068|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116373|NCT05749367|Ropivacaine|ropivacaine|mesh-list
56581098|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56581099|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
56581100|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581101|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581102|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56581103|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581104|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
56581105|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581106|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
56581107|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56581108|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56581109|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56581110|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
56581111|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56581112|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581114|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
56581115|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581116|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56636488|NCT04100655|Estradiol|estradiol|mesh-list
56636489|NCT04100655|Sargramostim|sargramostim|mesh-list
56636490|NCT04100655|Estrogens|estrogens|mesh-ancestor
56636491|NCT04100655|Hormones|hormones|mesh-ancestor
56636492|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636493|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636494|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
56636495|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636496|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
56636497|NCT00556933|Sirolimus|sirolimus|mesh-list
56636498|NCT00556933|Tacrolimus|tacrolimus|mesh-list
56636499|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
56636500|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56636501|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56636502|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
56636503|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636504|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56636505|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636506|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636507|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56636508|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636509|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56636510|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
56636511|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56636512|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636513|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
56636514|NCT02792426|Nicotine|nicotine|mesh-list
56636515|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56636516|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
56636517|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636518|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636519|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56636520|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56636521|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
56636522|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636524|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
56636529|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56636530|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636531|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
56636532|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636533|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636534|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56636535|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636536|NCT02792036|Carboplatin|carboplatin|mesh-list
56636537|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636538|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
56636539|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56636540|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
56636541|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636542|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636543|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56636544|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
56636545|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56636546|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
56636547|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636548|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636549|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56636550|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
56636551|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
56636552|NCT00945529|Protective Agents|protective agents|mesh-ancestor
56636554|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56636555|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636556|NCT00928187|Ritonavir|ritonavir|mesh-list
56636557|NCT00928187|Lopinavir|lopinavir|mesh-list
56636558|NCT00928187|Darunavir|darunavir|mesh-list
56636559|NCT00928187|Tenofovir|tenofovir|mesh-list
56636560|NCT00928187|Emtricitabine|emtricitabine|mesh-list
56581117|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
56581143|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581144|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581145|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581147|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56581148|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56581149|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581150|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581151|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581152|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
56581153|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
56581154|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56581155|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581156|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56636561|NCT00928187|Abacavir|abacavir|mesh-list
56636562|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56636563|NCT00928187|Didanosine|didanosine|mesh-list
56636564|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56636565|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56636566|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
56636567|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636568|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636569|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56636570|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56636571|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
56636572|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636573|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56636574|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56636575|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56636576|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56636577|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
56636578|NCT04235270|Tadalafil|tadalafil|mesh-list
56636579|NCT04235270|Macitentan|macitentan|mesh-list
56636580|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
56636581|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56636582|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56636583|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636584|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636585|NCT04235270|Urological Agents|urological agents|mesh-ancestor
56636586|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56636587|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56636588|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56636589|NCT04256525|Aspirin|aspirin|mesh-list
56636590|NCT04256525|Heparin|heparin|mesh-list
56636591|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
56636592|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56636593|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56636594|NCT04256525|Analgesics|analgesics|mesh-ancestor
56636595|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
56636596|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070641|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56636598|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56636599|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56636600|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56636601|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56636602|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636603|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56636604|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56636605|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636606|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
56636607|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
56636608|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56636609|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
56636610|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56636611|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
56636612|NCT02791958|Ramipril|ramipril|mesh-list
56636613|NCT02791958|Atorvastatin|atorvastatin|mesh-list
56636614|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56636615|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56636616|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
56636617|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636618|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56636619|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56636620|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636621|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56636622|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
56636623|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56636624|NCT02601651|Lidocaine|lidocaine|mesh-list
56636625|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
56636626|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
56636627|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547606|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636628|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636629|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
56636630|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636631|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56636636|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56636637|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636638|NCT00945919|Oxymorphone|oxymorphone|mesh-list
56636639|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56636640|NCT00945919|Narcotics|narcotics|mesh-ancestor
56636641|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636642|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636643|NCT00945919|Analgesics|analgesics|mesh-ancestor
56636644|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
56636645|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636646|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56636647|NCT00945997|Misoprostol|misoprostol|mesh-list
56636648|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56636649|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
56636650|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56636651|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636652|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56636653|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56636654|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
56636655|NCT00943345|Indomethacin|indomethacin|mesh-list
56636656|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56636657|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56636658|NCT00943345|Analgesics|analgesics|mesh-ancestor
56636659|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
56636660|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636661|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636662|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56636663|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56636664|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
56636665|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
56636666|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56636667|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56636668|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636669|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636670|NCT02797028|Allopurinol|allopurinol|mesh-list
56636671|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
56636672|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581157|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56636673|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636674|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
56636675|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56636676|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56636677|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
56636678|NCT02797028|Protective Agents|protective agents|mesh-ancestor
56636679|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636680|NCT00916461|Minocycline|minocycline|mesh-list
56636681|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56636682|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636683|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
56636684|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56636685|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
56636686|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56636687|NCT04260035|Protective Agents|protective agents|mesh-ancestor
56636688|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636689|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56636690|NCT00768651|Pantoprazole|pantoprazole|mesh-list
56636691|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56636692|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636693|NCT00768651|Incretins|incretins|mesh-ancestor
56636694|NCT00768651|Hormones|hormones|mesh-ancestor
56636695|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636696|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56636697|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
56636698|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636699|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636700|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56636702|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56636703|NCT05378750|Diuretics|diuretics|mesh-list
56636710|NCT00943501|Hormones|hormones|mesh-ancestor
56636720|NCT02796794|Genistein|genistein|mesh-list
56636721|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56636722|NCT02796794|Protective Agents|protective agents|mesh-ancestor
56636723|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636724|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636725|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56636726|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636727|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636728|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
56636729|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56636730|NCT02796794|Estrogens|estrogens|mesh-ancestor
56636731|NCT02796794|Hormones|hormones|mesh-ancestor
56636732|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636733|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
56636734|NCT04097613|Budesonide|budesonide|mesh-list
56636735|NCT04097613|Povidone|povidone|mesh-list
56636736|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56636737|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56636738|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
56636739|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636740|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636741|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56636742|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
56636743|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
56636744|NCT04097613|Hormones|hormones|mesh-ancestor
56636745|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636746|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
56636747|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
56636748|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56636749|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636750|NCT00946387|Ondansetron|ondansetron|mesh-list
56636751|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
56636752|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
56636753|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636754|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636755|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56636756|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
56636757|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
56581158|NCT00606450|Growth Substances|growth substances|mesh-ancestor
56636758|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56636759|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
56636760|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636761|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636762|NCT00946387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56636763|NCT00946387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56636764|NCT00946387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636765|NCT00946387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56636766|NCT00946387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56636767|NCT00916695|Everolimus|everolimus|mesh-list
56636768|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636769|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56636770|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
56636771|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636772|NCT00946465|Ramipril|ramipril|mesh-list
56636773|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56636774|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
56636775|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282640|NCT00006825|Trastuzumab|trastuzumab|mesh-list
56636776|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636778|NCT00946621|Ramipril|ramipril|mesh-list
56636779|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56636780|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
56636781|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636782|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636783|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56636784|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56636785|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56636786|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636787|NCT04235894|Propofol|propofol|mesh-list
56581159|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
56581160|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581161|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56581162|NCT04138888|Olmesartan|olmesartan|mesh-list
56581163|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56581164|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56581165|NCT04138888|Diuretics|diuretics|mesh-ancestor
56581166|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
56116492|NCT05215691|Morphine|morphine|mesh-list
56581192|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
56581193|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581194|NCT00688480|Allopurinol|allopurinol|mesh-list
56581195|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
56581196|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581197|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581198|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
56636788|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56636789|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636790|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636791|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56636792|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
56636793|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
56636794|NCT04096599|Fluorides|fluorides|mesh-list
56636795|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
56636796|NCT04096599|Protective Agents|protective agents|mesh-ancestor
56636797|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636798|NCT00923351|Vaccines|vaccines|mesh-list
56636799|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
56636800|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636801|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
56636802|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56636803|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
56636804|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636805|NCT02788292|Expectorants|expectorants|mesh-ancestor
56636806|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
56636807|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56636808|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
56636809|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636810|NCT02788292|Protective Agents|protective agents|mesh-ancestor
56636811|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636812|NCT02788292|Antidotes|antidotes|mesh-ancestor
56636813|NCT00944359|Zinc|zinc|mesh-list
56636814|NCT00944359|Trace Elements|trace elements|mesh-ancestor
56636815|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
56636816|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636817|NCT02791256|Ribavirin|ribavirin|mesh-list
56636818|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56636819|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
56636820|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636821|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
56636822|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636823|NCT04258007|Neostigmine|neostigmine|mesh-list
56636824|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56636825|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481544|NCT04885686|Hormones|hormones|mesh-ancestor
56636827|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
56636828|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636829|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636830|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56636831|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
56636832|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636833|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56636834|NCT02787824|Hematinics|hematinics|mesh-ancestor
56636835|NCT02796950|Acipimox|acipimox|mesh-list
56636836|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56636837|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
56636838|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636839|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56636840|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
56636841|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
56636842|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636843|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636844|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636845|NCT00950209|Heparin|heparin|mesh-list
56636846|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
56636847|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56636848|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56636849|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636850|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
56636851|NCT05370326|Narcotics|narcotics|mesh-ancestor
56636852|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56636853|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636854|NCT05370326|Analgesics|analgesics|mesh-ancestor
56636855|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
56636856|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636857|NCT00947323|Simvastatin|simvastatin|mesh-list
56636858|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56636859|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56636860|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
56636868|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56636869|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636870|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636871|NCT02790632|Nimodipine|nimodipine|mesh-list
56636872|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56636873|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56636874|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56636875|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636876|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56636877|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636878|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
56636879|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
56636880|NCT03633110|Nivolumab|nivolumab|mesh-list
56636881|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56636882|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636883|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56636884|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636885|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56636886|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56636887|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636888|NCT02788058|Gefitinib|gefitinib|mesh-list
56636889|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636890|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56636891|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636892|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636893|NCT04200092|Granisetron|granisetron|mesh-list
56636894|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
56636895|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
56636896|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636897|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636898|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56636899|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56636900|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
56636901|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636904|NCT00754065|Dienogest|dienogest|mesh-list
56636907|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56636908|NCT00754065|Estradiol|estradiol|mesh-list
56636909|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56636910|NCT00754065|Estrogens|estrogens|mesh-ancestor
56636911|NCT00754065|Hormones|hormones|mesh-ancestor
56636912|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636913|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581199|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581201|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
56581202|NCT00688480|Protective Agents|protective agents|mesh-ancestor
56581203|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581204|NCT01092728|Dasatinib|dasatinib|mesh-list
56581205|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581206|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56581207|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581208|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581209|NCT00688558|Simvastatin|simvastatin|mesh-list
56581210|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
56581211|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56581212|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56581213|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
56116537|NCT05168423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581265|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56581266|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581313|NCT00689806|L 647318|l 647318|mesh-list
56581314|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
56581315|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56581316|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56581317|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
56581318|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581319|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56581320|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56581321|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581322|NCT00594958|Vaccines|vaccines|mesh-list
56581323|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
56581324|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581325|NCT04204044|Folic Acid|folic acid|mesh-list
56581326|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
56581327|NCT04204044|Inositol|inositol|mesh-list
56581328|NCT04204044|Metformin|metformin|mesh-list
56581329|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56581330|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581331|NCT04204044|Hematinics|hematinics|mesh-ancestor
56581332|NCT04204044|Vitamins|vitamins|mesh-ancestor
56581333|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
56581334|NCT04267614|Etanercept|etanercept|mesh-list
56581335|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56581336|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56581337|NCT04267614|Analgesics|analgesics|mesh-ancestor
56581338|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
56581357|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581358|NCT00694252|Lapatinib|lapatinib|mesh-list
56581359|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581360|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56581361|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581362|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581363|NCT00871858|Fulvestrant|fulvestrant|mesh-list
56581364|NCT00871858|Anastrozole|anastrozole|mesh-list
56581365|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56581366|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581367|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56581368|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56581369|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
56581370|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581371|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581372|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56581373|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56581374|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581375|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636914|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56636915|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
56636916|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56636917|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56636918|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56636919|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56636920|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56636921|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
56636922|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56636923|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282833|NCT00006106|Dl1520|dl1520|mesh-list
56636924|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56636925|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56636926|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56636927|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56636928|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56636929|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636930|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636931|NCT02787746|Donepezil|donepezil|mesh-list
56636932|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56636933|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636934|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636935|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
56636936|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56636937|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636938|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
56636939|NCT03254654|Apatinib|apatinib|mesh-list
56636940|NCT03254654|Vinorelbine|vinorelbine|mesh-list
56636941|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636942|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56636943|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56636944|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481714|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56581376|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
56581377|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56581378|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56581379|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56581380|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
56581381|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581382|NCT00871780|Natalizumab|natalizumab|mesh-list
56581383|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
56636945|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56636946|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
56636947|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
56636948|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
56636949|NCT02785718|Hemostatics|hemostatics|mesh-list
56636950|NCT02785718|Coagulants|coagulants|mesh-ancestor
56636951|NCT04094805|Calcitriol|calcitriol|mesh-list
56636952|NCT04094805|Dexamethasone|dexamethasone|mesh-list
56636953|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56636954|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
56636955|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
56636956|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636957|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636958|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56636959|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
56636960|NCT04094805|Hormones|hormones|mesh-ancestor
56636961|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56636962|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56636963|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56636964|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56636965|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56636966|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56636967|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56636968|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56636969|NCT04094805|Vitamins|vitamins|mesh-ancestor
56636970|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
56636971|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56636972|NCT04094727|Lumefantrine|lumefantrine|mesh-list
56636973|NCT04094727|Artemether|artemether|mesh-list
56636974|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56636975|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
56636976|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56636977|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56636988|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56636989|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56636990|NCT02786732|Ustekinumab|ustekinumab|mesh-list
56636991|NCT02786732|Brodalumab|brodalumab|mesh-list
56636992|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56636993|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
56636994|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
56636995|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56636996|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
56636997|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56636998|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
56282869|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
56636999|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637000|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56637001|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56637002|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
56637003|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637004|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637005|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56637006|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
56637007|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56637008|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56637009|NCT03110822|Prednisolone|prednisolone|mesh-list
56637010|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
56637011|NCT03110822|Lenalidomide|lenalidomide|mesh-list
56637012|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56637013|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
56637014|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
56637015|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637016|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56637017|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56637018|NCT03110822|Growth Substances|growth substances|mesh-ancestor
56581384|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581385|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
56581386|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56581387|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56581388|NCT00694408|Prednisolone|prednisolone|mesh-list
56581389|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
56581390|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
56581391|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56581392|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56581393|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56581394|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56581395|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
56581396|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637019|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
56637020|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637021|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637022|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
56637023|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
56637024|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637025|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56637026|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
56637028|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637029|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56637030|NCT03110822|Protective Agents|protective agents|mesh-ancestor
56637031|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56637032|NCT02787356|Lidocaine|lidocaine|mesh-list
56637033|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
56637034|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
56637035|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637036|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637037|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
56637038|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637039|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56637040|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56637041|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56637042|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56637043|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637044|NCT02787278|Otaplimastat|otaplimastat|mesh-list
56637045|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56637046|NCT02787278|Protective Agents|protective agents|mesh-ancestor
56637047|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637065|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
56637066|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
56637067|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
56637068|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637069|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637070|NCT04197752|Anesthetics|anesthetics|mesh-list
56637071|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547607|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637072|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637073|NCT02336750|Aprepitant|aprepitant|mesh-list
56637074|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
56637075|NCT02336750|Mirtazapine|mirtazapine|mesh-list
56637076|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
56637077|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
56637078|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637079|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637080|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56637081|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56637082|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637083|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637084|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
56637085|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637086|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56637087|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
56637088|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
56637089|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56637090|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56637091|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637092|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56637093|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56637094|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56637095|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
56637096|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56637097|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56637098|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
56581426|NCT04137640|Letrozole|letrozole|mesh-list
56581427|NCT04137640|Epirubicin|epirubicin|mesh-list
56581428|NCT04137640|Palbociclib|palbociclib|mesh-list
56581429|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581430|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
56581431|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637099|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56637100|NCT02784392|Metoclopramide|metoclopramide|mesh-list
56637101|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
56637102|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
56637103|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637104|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637105|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56637106|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56637107|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56637108|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
56637109|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637110|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637111|NCT00634556|Levodopa|levodopa|mesh-list
56637112|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56637113|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56637114|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56637115|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
56637116|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637117|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637118|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637119|NCT02784080|Isoantibodies|isoantibodies|mesh-list
56637120|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
56637121|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637122|NCT02784860|Lidocaine|lidocaine|mesh-list
56637123|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
56637124|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
56637125|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637126|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581432|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581433|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56581434|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
56581435|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581436|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581437|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56581438|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
56581439|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
56581440|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
56581441|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56581442|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56581443|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581444|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56581445|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
56116772|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
56581500|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56581501|NCT00673504|Growth Substances|growth substances|mesh-ancestor
56581502|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
56581503|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56637127|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
56637128|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637129|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56637130|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56637131|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56637132|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56637133|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637134|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
56637135|NCT02783924|Vitamin D|vitamin d|mesh-list
56637136|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56637137|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637138|NCT02783924|Vitamins|vitamins|mesh-ancestor
56637139|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
56637140|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56637141|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
56637142|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56637143|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637144|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637145|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56637147|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
56637148|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637149|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56637150|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56637151|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56637152|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
56637153|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637154|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637155|NCT02786264|Fentanyl|fentanyl|mesh-list
56637156|NCT02786264|Midazolam|midazolam|mesh-list
56637157|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
56637158|NCT02786264|Propofol|propofol|mesh-list
56637159|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56637160|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481957|NCT05312866|Hormones|hormones|mesh-ancestor
56581504|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56581505|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56581506|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56581507|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
56581508|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581509|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56637161|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637162|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56637163|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
56637164|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
56637165|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56637166|NCT02786264|Analgesics|analgesics|mesh-ancestor
56637167|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
56637168|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637169|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56637170|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56637171|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56637172|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
56637173|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637174|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637175|NCT02786264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56637176|NCT02786264|Narcotics|narcotics|mesh-ancestor
56637177|NCT02786264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56637178|NCT02786264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56637179|NCT02786264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56637180|NCT02786264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637181|NCT02786264|GABA Modulators|gaba modulators|mesh-ancestor
56637182|NCT02786264|GABA Agents|gaba agents|mesh-ancestor
56637183|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
56637184|NCT02783378|Antacids|antacids|mesh-ancestor
56637185|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637186|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56637187|NCT05237726|Heparin|heparin|mesh-list
56637188|NCT05237726|Enoxaparin|enoxaparin|mesh-list
56637189|NCT05237726|Calcium heparin|calcium heparin|mesh-list
56637190|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
56637191|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
56637192|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56637193|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56637195|NCT02783144|Dexamethasone|dexamethasone|mesh-list
56637203|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56637204|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
56637205|NCT02783144|Hormones|hormones|mesh-ancestor
56637206|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637207|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56637208|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637209|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
56637210|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637211|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637212|NCT05260320|Anesthetics|anesthetics|mesh-list
56637213|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637214|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637215|NCT02783222|Paclitaxel|paclitaxel|mesh-list
56637216|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56637217|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637218|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
56637219|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
56637220|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
56637221|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637222|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
56637223|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56637224|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56637225|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56637226|NCT02689856|Lidocaine|lidocaine|mesh-list
56637227|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
56637228|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
56637229|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637230|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637231|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
56637232|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637233|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56637234|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56637243|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56637244|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56637245|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56637246|NCT05206448|Letrozole|letrozole|mesh-list
56637247|NCT05206448|Clomiphene|clomiphene|mesh-list
56637248|NCT05206448|Enclomiphene|enclomiphene|mesh-list
56637249|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
56637250|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637251|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637252|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56637253|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56637254|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637255|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56637256|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
56637257|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637258|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637259|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56637260|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
56637261|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56637262|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56637263|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56637264|NCT02722746|Epinephrine|epinephrine|mesh-list
56637265|NCT02722746|Ropivacaine|ropivacaine|mesh-list
56637266|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
56637267|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
56637268|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637269|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637270|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
56637271|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637272|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56637273|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56637274|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
56637286|NCT02784626|Propofol|propofol|mesh-list
56637287|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56637288|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637289|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637290|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56637291|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
56283172|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
56637292|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
56637293|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56637294|NCT02784626|Analgesics|analgesics|mesh-ancestor
56637295|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
56482091|NCT00598195|Analgesics|analgesics|mesh-ancestor
56581510|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56581511|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581512|NCT00912574|Molgramostim|molgramostim|mesh-list
56581513|NCT00912574|Sargramostim|sargramostim|mesh-list
56581514|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56581515|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
56581516|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
56581517|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581518|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581519|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56581520|NCT00695032|Ifosfamide|ifosfamide|mesh-list
56581521|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581522|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56581523|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
56581524|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581525|NCT04137328|Liraglutide|liraglutide|mesh-list
56581526|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56581527|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581528|NCT04137328|Incretins|incretins|mesh-ancestor
56581529|NCT04137328|Hormones|hormones|mesh-ancestor
56581556|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
56581557|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56581558|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581559|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
56581560|NCT00607542|Baclofen|baclofen|mesh-list
56581561|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56581562|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581563|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56581564|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581565|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56581566|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
56581567|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
56581568|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581569|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581570|NCT00936858|Everolimus|everolimus|mesh-list
56581571|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581572|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581573|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
56581574|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116903|NCT04882241|Antidotes|antidotes|mesh-ancestor
56581622|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
56581623|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56581624|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56581625|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56581626|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56581627|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
56581628|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581629|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581630|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
56581631|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
56581632|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56581633|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56581634|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070856|NCT02829983|Clarithromycin|clarithromycin|mesh-list
56637296|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637297|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56637298|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56637299|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56637300|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
56637301|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637302|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637303|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
56637304|NCT02782754|Carboplatin|carboplatin|mesh-list
56637305|NCT02782754|Etoposide|etoposide|mesh-list
56637306|NCT02782754|Bleomycin|bleomycin|mesh-list
56637307|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637308|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
56637309|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637310|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56637311|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56637312|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
56637313|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637314|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581635|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581636|NCT00872170|Urological Agents|urological agents|mesh-ancestor
56581637|NCT00936702|Paclitaxel|paclitaxel|mesh-list
56581661|NCT00674674|Topotecan|topotecan|mesh-list
56581662|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56581663|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56581664|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581665|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581666|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581667|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56581668|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
56581669|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581670|NCT04265508|Hemostatics|hemostatics|mesh-list
56581671|NCT04265508|Coagulants|coagulants|mesh-ancestor
56581672|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56581673|NCT02623738|Latanoprost|latanoprost|mesh-list
56581674|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56581675|NCT00607074|Albendazole|albendazole|mesh-list
56581676|NCT00607074|Anthelmintics|anthelmintics|mesh-list
56581677|NCT00607074|Secnidazole|secnidazole|mesh-list
56581678|NCT00607074|Metronidazole|metronidazole|mesh-list
56581679|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56581680|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581681|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
56581682|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56581683|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56581684|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
56581685|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
56581686|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
56581687|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581688|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581689|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56581690|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
56117015|NCT03185819|Midazolam|midazolam|mesh-list
56581770|NCT02623036|Protective Agents|protective agents|mesh-ancestor
56581771|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581772|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56581773|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56637315|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56637316|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56637317|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56637318|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56637319|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637320|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56637321|NCT00634634|Sorafenib|sorafenib|mesh-list
56637322|NCT00634634|Letrozole|letrozole|mesh-list
56637323|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637324|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56637325|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637326|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637327|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56637328|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56637329|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56637330|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
56637331|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637332|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637333|NCT03539822|Durvalumab|durvalumab|mesh-list
56637334|NCT03539822|Tremelimumab|tremelimumab|mesh-list
56637335|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56637336|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56637337|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637338|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637339|NCT05341076|Oxytocin|oxytocin|mesh-list
56637340|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
56637341|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56637342|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637343|NCT05133518|Midazolam|midazolam|mesh-list
56637344|NCT05133518|Ketamine|ketamine|mesh-list
56637345|NCT05133518|Analgesics|analgesics|mesh-ancestor
56637346|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
56637347|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482210|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56581774|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581776|NCT00696826|Hormones|hormones|mesh-ancestor
56581777|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581778|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56581779|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
56581780|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887371|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637348|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637349|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56637350|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56637351|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
56637352|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
56637353|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637354|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56637355|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56637356|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637357|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637358|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56637359|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56637360|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56637361|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56637362|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637363|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
56637364|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
56637365|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56637366|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
56637367|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637368|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
56637369|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56637370|NCT02714166|Protective Agents|protective agents|mesh-ancestor
56637371|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637372|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
56581781|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581782|NCT01092182|Prednisone|prednisone|mesh-list
56581783|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
56581784|NCT01092182|Rituximab|rituximab|mesh-list
56581785|NCT01092182|Doxorubicin|doxorubicin|mesh-list
56581786|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56581787|NCT01092182|Etoposide|etoposide|mesh-list
56581788|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
56581789|NCT01092182|Vincristine|vincristine|mesh-list
56581790|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581791|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
56581792|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581793|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581794|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56581795|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
56581796|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581797|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581798|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56581799|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56581800|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56581801|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56581802|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56581803|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581804|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581805|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
56581806|NCT01092182|Hormones|hormones|mesh-ancestor
56637373|NCT04231682|Denosumab|denosumab|mesh-list
56637374|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56637375|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637376|NCT02722356|Oxytocin|oxytocin|mesh-list
56637377|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
56637378|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56637379|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637380|NCT00753675|Gemcitabine|gemcitabine|mesh-list
56637381|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56637382|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
56637383|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637384|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637385|NCT00753675|Antiviral Agents|antiviral agents|mesh-ancestor
56637386|NCT00753675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637387|NCT00753675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637388|NCT00753675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637389|NCT00753675|Immunologic Factors|immunologic factors|mesh-ancestor
56637390|NCT00753675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637391|NCT05224050|Nicotine|nicotine|mesh-list
56637392|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56637393|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
56637394|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637395|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637396|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56637397|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56637398|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
56637399|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637400|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637401|NCT05131178|Bupivacaine|bupivacaine|mesh-list
56637402|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
56637403|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
56637404|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637405|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637406|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
56637414|NCT02546934|Antiviral Agents|antiviral agents|mesh-ancestor
56637415|NCT02546934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637416|NCT02546934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637417|NCT02546934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637418|NCT02546934|Immunologic Factors|immunologic factors|mesh-ancestor
56637419|NCT02546934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637420|NCT00586521|Factor VIII|factor viii|mesh-list
56637421|NCT00586521|Coagulants|coagulants|mesh-ancestor
56637422|NCT02782286|Ketorolac|ketorolac|mesh-list
56637423|NCT02782286|Morphine|morphine|mesh-list
56637424|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56637425|NCT02782286|Narcotics|narcotics|mesh-ancestor
56637426|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637427|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637428|NCT02782286|Analgesics|analgesics|mesh-ancestor
56637429|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
56637430|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637431|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56637432|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56637433|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637434|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56637435|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56637436|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637437|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283320|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
56637445|NCT04231448|Prednisone|prednisone|mesh-list
56637446|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
56581807|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581808|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56581809|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56581810|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
56581811|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
56581835|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56581836|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56581837|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581838|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56581839|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56581840|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581841|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
56581842|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56581843|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
56581844|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56637447|NCT04231448|Rituximab|rituximab|mesh-list
56637448|NCT04231448|Doxorubicin|doxorubicin|mesh-list
56637449|NCT04231448|Vincristine|vincristine|mesh-list
56637450|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637451|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
56637452|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637453|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56637454|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56637455|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
56637456|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637457|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637458|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56637459|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56637460|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56637461|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56637462|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56637463|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637464|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637465|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
56637466|NCT04231448|Hormones|hormones|mesh-ancestor
56637467|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637468|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56637469|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56637470|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
56637471|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
56637473|NCT02600247|Acetaminophen|acetaminophen|mesh-list
56637496|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56637497|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637498|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56637499|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56637500|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56637501|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637502|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56637503|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56637504|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637505|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
56637506|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
56637507|NCT05453253|Vaccines|vaccines|mesh-list
56637508|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
56637509|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637510|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56637511|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637512|NCT02717052|Ketamine|ketamine|mesh-list
56637513|NCT02717052|Esketamine|esketamine|mesh-list
56637514|NCT02717052|Analgesics|analgesics|mesh-ancestor
56637515|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
56637516|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637517|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637518|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56637519|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56637520|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
56637521|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
56637522|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637523|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56637524|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56637525|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637526|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637527|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
56637528|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637529|NCT05342558|Fluticasone|fluticasone|mesh-list
56637530|NCT05342558|Xhance|xhance|mesh-list
56637531|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637535|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637536|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56637537|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
56637538|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
56637539|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56637540|NCT00923273|Folic Acid|folic acid|mesh-list
56637541|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
56637542|NCT00923273|Sirolimus|sirolimus|mesh-list
56637543|NCT00923273|Dexamethasone|dexamethasone|mesh-list
56637544|NCT00923273|Pemetrexed|pemetrexed|mesh-list
56637545|NCT00923273|Vitamins|vitamins|mesh-ancestor
56637546|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
56637547|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637548|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637549|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
56637550|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
56637551|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637552|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56637553|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
56637554|NCT00923273|Hormones|hormones|mesh-ancestor
56637555|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637556|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56637557|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637558|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637559|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637560|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56637561|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56637562|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56637563|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637564|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56637565|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
56637566|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637567|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
56637568|NCT00923273|Hematinics|hematinics|mesh-ancestor
56637569|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
56637570|NCT04231370|Lenalidomide|lenalidomide|mesh-list
56637571|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
56637572|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637575|NCT04231370|Growth Substances|growth substances|mesh-ancestor
56637576|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56637577|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637578|NCT05340530|Meropenem|meropenem|mesh-list
56637579|NCT05340530|Avibactam|avibactam|mesh-list
56637580|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56637581|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637582|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56637583|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637584|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637585|NCT00634712|Candesartan|candesartan|mesh-list
56637586|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56637587|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56637588|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56637589|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637590|NCT00923195|Aldesleukin|aldesleukin|mesh-list
56637591|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
56637592|NCT00923195|Fludarabine|fludarabine|mesh-list
56637593|NCT00923195|Interleukin-2|interleukin-2|mesh-list
56637594|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56637595|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637596|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
56637597|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637598|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56637599|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56637600|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
56637601|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637602|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637603|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56637604|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56637605|NCT00923195|Analgesics|analgesics|mesh-ancestor
56637606|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
56637618|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637619|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
56637620|NCT04256057|Analgesics|analgesics|mesh-ancestor
56637621|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
56637622|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637623|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637624|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
56637625|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637626|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56637627|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
56637628|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56637629|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56637630|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637631|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56637632|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
56637633|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56637634|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
56637635|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
56637636|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
56637637|NCT02714010|Gefitinib|gefitinib|mesh-list
56637638|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637639|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56637640|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637641|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637642|NCT00917241|Dexamethasone|dexamethasone|mesh-list
56637643|NCT00917241|Methimazole|methimazole|mesh-list
56637644|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637645|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
56637646|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
56637647|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637648|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637649|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56637650|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
56637651|NCT00917241|Hormones|hormones|mesh-ancestor
56637652|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637653|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56581845|NCT02878772|Protective Agents|protective agents|mesh-ancestor
56581846|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
56637654|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637655|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
56637656|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
56637657|NCT00919061|Gemcitabine|gemcitabine|mesh-list
56637658|NCT00919061|Sorafenib|sorafenib|mesh-list
56637659|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637660|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56637661|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
56637662|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637663|NCT00919061|Antiviral Agents|antiviral agents|mesh-ancestor
56637664|NCT00919061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637665|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637666|NCT00919061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637667|NCT00919061|Immunologic Factors|immunologic factors|mesh-ancestor
56637668|NCT00919061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637669|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56283547|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
56637670|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
56637671|NCT05106296|Etoposide|etoposide|mesh-list
56637672|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637673|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
56637674|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637675|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56637676|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56637677|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
56637678|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637679|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637680|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56637681|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56637682|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56637683|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56637684|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637685|NCT02598687|Paclitaxel|paclitaxel|mesh-list
56637686|NCT02598687|Carboplatin|carboplatin|mesh-list
56637687|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56482552|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
56330348|NCT00023816|Carbendazim|carbendazim|mesh-list
56581847|NCT02623114|Methylphenidate|methylphenidate|mesh-list
56581848|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56581849|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56070947|NCT02068820|Protective Agents|protective agents|mesh-ancestor
56637688|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637689|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
56637690|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
56637691|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
56637692|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637693|NCT05338190|Rituximab|rituximab|mesh-list
56637694|NCT05338190|Belimumab|belimumab|mesh-list
56637695|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56637696|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637697|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
56637698|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637699|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56637700|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637701|NCT04908605|Melatonin|melatonin|mesh-list
56637702|NCT04908605|Mirtazapine|mirtazapine|mesh-list
56637703|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
56637704|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637705|NCT04908605|Protective Agents|protective agents|mesh-ancestor
56637706|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637707|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637708|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
56637709|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637710|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56637711|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
56637712|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
56637713|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637714|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56637715|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56637716|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56637717|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56637718|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56637719|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
56637720|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56637721|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56637722|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
56581850|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581851|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56581852|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56581853|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887372|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56637723|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56637724|NCT02782208|Acipimox|acipimox|mesh-list
56637725|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56637726|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
56637727|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637728|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56637729|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
56637730|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56637731|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637732|NCT00611286|Sirolimus|sirolimus|mesh-list
56637733|NCT00611286|Paclitaxel|paclitaxel|mesh-list
56637734|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56637735|NCT00611286|Everolimus|everolimus|mesh-list
56637736|NCT00611286|Clopidogrel|clopidogrel|mesh-list
56637737|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
56637738|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56637739|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637740|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
56637741|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
56637742|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
56637743|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637744|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56637745|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
56637746|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637747|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56637748|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56637749|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56637750|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
56637751|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637752|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56637753|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581854|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581855|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
56581856|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581857|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56581858|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
56581859|NCT00932646|Olodaterol|olodaterol|mesh-list
56581860|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
56581861|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56581862|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
56581885|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
56581886|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581887|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887373|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
56637754|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56637755|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
56637756|NCT04257851|Sumatriptan|sumatriptan|mesh-list
56637757|NCT04257851|Theophylline|theophylline|mesh-list
56637758|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56637759|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56637760|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56637761|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
56637762|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637763|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637764|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637765|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56637766|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
56637767|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637768|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56637769|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
56637770|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56637771|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637772|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
56637773|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56637774|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56637775|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
56637776|NCT02780102|Methylphenidate|methylphenidate|mesh-list
56637777|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56637778|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637779|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56637780|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56637781|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56637782|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581888|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581889|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
56581890|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56581891|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581892|NCT04264260|Colchicine|colchicine|mesh-list
56581893|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
56581894|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581895|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
56581896|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
56581897|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
56581898|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581899|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581900|NCT04267146|Nivolumab|nivolumab|mesh-list
56581901|NCT04267146|Temozolomide|temozolomide|mesh-list
56581902|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56637783|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
56637784|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637785|NCT04197050|Valsartan|valsartan|mesh-list
56637786|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56637787|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56637788|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56637789|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56637790|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637791|NCT04090047|Itraconazole|itraconazole|mesh-list
56637792|NCT04090047|PF-06700841|pf-06700841|mesh-list
56637793|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
56637794|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637795|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56637796|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56637797|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637798|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637799|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56637800|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
56637801|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637802|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637803|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56637804|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56637805|NCT02782052|Bromides|bromides|mesh-list
56637806|NCT02782052|Albuterol|albuterol|mesh-list
56637807|NCT02782052|Ipratropium|ipratropium|mesh-list
56637808|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
56637809|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56637810|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
56482724|NCT00552656|Sirolimus|sirolimus|mesh-list
56581903|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581904|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56581905|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581906|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56581907|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
56581908|NCT02691078|Octreotide|octreotide|mesh-list
56581909|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56581910|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117238|NCT03850067|Carboplatin|carboplatin|mesh-list
56581946|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
56581947|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56581948|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
56581974|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581975|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55887374|NCT01857232|Hormones|hormones|mesh-ancestor
56637811|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637812|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637813|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56637814|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
56637815|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
56637816|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56637817|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56637818|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56637819|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56637820|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
56637821|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637822|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637823|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56637824|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
56637826|NCT02708628|Allantoin|allantoin|mesh-list
56637827|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
56637828|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56637829|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56637830|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637831|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
56637832|NCT00746733|Amphetamine|amphetamine|mesh-list
56637833|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56637834|NCT00746733|Adderall|adderall|mesh-list
56637835|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56637836|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581976|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56581977|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581978|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
56581979|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56581980|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
56581981|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56581982|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
56581983|NCT00675688|Estrogens|estrogens|mesh-list
56581984|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56581985|NCT00675688|Hormones|hormones|mesh-ancestor
56581986|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581987|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581988|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56581989|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
56581990|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56581991|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56581992|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56581993|NCT02622334|Latanoprost|latanoprost|mesh-list
56581994|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56581995|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56581997|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
56581998|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
56581999|NCT00696514|Vitamins|vitamins|mesh-list
56582000|NCT00696514|Folic Acid|folic acid|mesh-list
56582001|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
56637837|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
56637838|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
56637839|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637840|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
56637841|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637842|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637843|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
56637844|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56637845|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56637846|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56637847|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56637848|NCT00636870|Fexofenadine|fexofenadine|mesh-list
56637849|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56637850|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56637851|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56637852|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
56637853|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
56637854|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637855|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637856|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637857|NCT00634790|Alprazolam|alprazolam|mesh-list
56637858|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56637859|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637860|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637861|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56637862|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56637863|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637864|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
56637865|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
56637866|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637867|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637868|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
56637869|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637875|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56637876|NCT00917397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56637877|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56637878|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56637879|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637880|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637881|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
56637882|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637883|NCT02708160|Fluorides|fluorides|mesh-list
56637884|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
56637885|NCT02708160|Protective Agents|protective agents|mesh-ancestor
56637886|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637887|NCT04257461|Capecitabine|capecitabine|mesh-list
56637888|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
56637889|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56637890|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
56283774|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637891|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637892|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637894|NCT02712528|Remifentanil|remifentanil|mesh-list
56637895|NCT02712528|Sevoflurane|sevoflurane|mesh-list
56637896|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56637897|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56637898|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
56637899|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
56637900|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56637901|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637902|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56637903|NCT02712528|Narcotics|narcotics|mesh-ancestor
56637904|NCT02712528|Analgesics|analgesics|mesh-ancestor
56637905|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
56637906|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637907|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56637908|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56637909|NCT04089657|Apatinib|apatinib|mesh-list
56637910|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637911|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56637912|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637913|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637914|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
56637915|NCT02713074|Povidone|povidone|mesh-list
56637916|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
56637917|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
56637918|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56637919|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56637920|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
56637921|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56637922|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56637923|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
56637924|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56637925|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637926|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637927|NCT00745875|Pemetrexed|pemetrexed|mesh-list
56637928|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637929|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637930|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637931|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56637932|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56637933|NCT04089813|Metformin|metformin|mesh-list
56637934|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56637935|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637936|NCT00555217|Losartan|losartan|mesh-list
56637937|NCT00555217|Lisinopril|lisinopril|mesh-list
56637938|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56637939|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56637940|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56637941|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56637942|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637943|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56637944|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
56637945|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637953|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637954|NCT02711904|Analgesics|analgesics|mesh-ancestor
56637955|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
56637956|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637957|NCT05326490|Metformin|metformin|mesh-list
56637958|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56637959|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637960|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
56637961|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56637962|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
56637963|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637964|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
56637965|NCT02693808|Protective Agents|protective agents|mesh-ancestor
56637967|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56637968|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56637969|NCT02711982|Prednisolone|prednisolone|mesh-list
56637970|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
56637971|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56637972|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
56637973|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56637974|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
56637975|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
56637976|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637977|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56637978|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56637979|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
56637980|NCT02711982|Hormones|hormones|mesh-ancestor
56637981|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56637982|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56637983|NCT02711982|Protective Agents|protective agents|mesh-ancestor
56637984|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56637985|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637986|NCT00745095|Neostigmine|neostigmine|mesh-list
56637987|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56637988|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56637989|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56637994|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
56637995|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56637996|NCT05181462|Gemcitabine|gemcitabine|mesh-list
56637997|NCT05181462|Carboplatin|carboplatin|mesh-list
56637998|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56637999|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56638000|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
56638001|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638002|NCT05181462|Antiviral Agents|antiviral agents|mesh-ancestor
56638003|NCT05181462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638004|NCT05181462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638005|NCT05181462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638006|NCT05181462|Immunologic Factors|immunologic factors|mesh-ancestor
56638007|NCT05181462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638008|NCT00612612|Rituximab|rituximab|mesh-list
56638009|NCT00612612|Fludarabine|fludarabine|mesh-list
56638010|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
56638011|NCT00612612|Obatoclax|obatoclax|mesh-list
56638012|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56638013|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638014|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
56638015|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638016|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638017|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56638018|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
56638019|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638020|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638021|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638022|NCT03822468|Letrozole|letrozole|mesh-list
56582034|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56582035|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56582036|NCT00696592|Growth Substances|growth substances|mesh-ancestor
56582037|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582038|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
56582039|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56582040|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
56582041|NCT02622022|Morphine|morphine|mesh-list
56582042|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56582043|NCT02622022|Narcotics|narcotics|mesh-ancestor
56582044|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582045|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582094|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56582095|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56582096|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56582097|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56582098|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582099|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56638023|NCT03822468|Anastrozole|anastrozole|mesh-list
56638024|NCT03822468|Goserelin|goserelin|mesh-list
56638025|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638026|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56638027|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56638028|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638029|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638030|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56638031|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
56638032|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56638033|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638034|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56638035|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56638036|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56638037|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638038|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56638039|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56638040|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56638041|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56638042|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638043|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638044|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638045|NCT00940693|Analgesics|analgesics|mesh-ancestor
56638046|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
56638047|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638048|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
56638049|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56638050|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
56638051|NCT02598063|Lamivudine|lamivudine|mesh-list
56638052|NCT02598063|Adefovir|adefovir|mesh-list
56638053|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56638054|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56638055|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56582100|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56582101|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
56582102|NCT00931944|Pramipexole|pramipexole|mesh-list
56582103|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
56582104|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582105|NCT00931944|Protective Agents|protective agents|mesh-ancestor
56117443|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
56638056|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56638057|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638058|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638059|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
56638060|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638061|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56638062|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56638063|NCT02707458|Probucol|probucol|mesh-list
56638064|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56638065|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56638066|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
56638067|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638068|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56638069|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
56638070|NCT02707458|Protective Agents|protective agents|mesh-ancestor
56638071|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638072|NCT00950677|Exenatide|exenatide|mesh-list
56638073|NCT00950677|Pramlintide|pramlintide|mesh-list
56638074|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56638075|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638076|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56638077|NCT00950677|Incretins|incretins|mesh-ancestor
56638078|NCT00950677|Hormones|hormones|mesh-ancestor
56638079|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56638080|NCT05174598|Calcitriol|calcitriol|mesh-list
56638081|NCT05174598|Calcipotriene|calcipotriene|mesh-list
56638082|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
56638083|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56638084|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638085|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56638086|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56638087|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638088|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56638089|NCT05174598|Vitamins|vitamins|mesh-ancestor
56638098|NCT05341856|Isosorbide|isosorbide|mesh-list
56638099|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56638100|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56638101|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56638102|NCT05341856|Diuretics|diuretics|mesh-ancestor
56638103|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
56638104|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638105|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
56638106|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56638107|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638108|NCT00951223|Interferons|interferons|mesh-list
56638109|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
56638110|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638111|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
56638112|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638113|NCT02711592|Analgesics|analgesics|mesh-list
56638114|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
56638115|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638116|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284084|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
56638117|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
56638118|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56638119|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
56638120|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
56638121|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638122|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638123|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56638124|NCT00948103|Analgesics|analgesics|mesh-ancestor
56638125|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
56638126|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638127|NCT02012114|Cysteamine|cysteamine|mesh-list
56638128|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56638129|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638130|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56638131|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
56638139|NCT05301205|Gabapentin|gabapentin|mesh-list
56638140|NCT05301205|Analgesics|analgesics|mesh-ancestor
56638141|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
56638142|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638143|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638144|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
56638145|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56638146|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56638147|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638148|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56638149|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56638150|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56638151|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638152|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638153|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
56638154|NCT02707224|Candesartan|candesartan|mesh-list
56638155|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
56638156|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56638157|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56638158|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56638159|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
56638160|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638161|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56638162|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56638163|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638164|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56638165|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56638166|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56638167|NCT04229264|Apixaban|apixaban|mesh-list
56638168|NCT04229264|Clopidogrel|clopidogrel|mesh-list
56638169|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56638170|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56638171|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56638172|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56638173|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
56638174|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638176|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638177|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56638178|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
56638179|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56638180|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
56638181|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638182|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
56638183|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
56638184|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638185|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
56638186|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638187|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638188|NCT02711202|Sirolimus|sirolimus|mesh-list
56638189|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
56638190|NCT02711202|Infliximab|infliximab|mesh-list
56547608|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638191|NCT02711202|Tacrolimus|tacrolimus|mesh-list
56638192|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638193|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
56638194|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638195|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56638196|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638197|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638198|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56638199|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638226|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638227|NCT04962152|Analgesics|analgesics|mesh-ancestor
56638228|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
56638229|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638230|NCT00744627|Vortioxetine|vortioxetine|mesh-list
56638231|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
56638232|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56638233|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56638234|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56638235|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638236|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638237|NCT00744627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56638238|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56638239|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56638240|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638241|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638242|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
56638243|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56638244|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56638245|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56638246|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56638247|NCT04942886|Entecavir|entecavir|mesh-list
56638248|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
56638249|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638250|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
56638251|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
56638252|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56638253|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56638254|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56638255|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638256|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56638257|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56638258|NCT02711280|Propofol|propofol|mesh-list
56582137|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
56582138|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56582139|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56582140|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582141|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
56582142|NCT02616874|Romidepsin|romidepsin|mesh-list
56582143|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56638259|NCT02711280|Sevoflurane|sevoflurane|mesh-list
56638260|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56638261|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638262|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638263|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56638264|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
56638265|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
56638266|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56638267|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56638268|NCT00948493|Insulin|insulin|mesh-list
56638269|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56638270|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56638271|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638272|NCT00952003|Bevacizumab|bevacizumab|mesh-list
56638273|NCT00952003|Docetaxel|docetaxel|mesh-list
56638274|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
56638275|NCT00952003|Irinotecan|irinotecan|mesh-list
56638276|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56638277|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638278|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56638279|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56638280|NCT00952003|Growth Substances|growth substances|mesh-ancestor
56638281|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638282|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
56638283|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
56638284|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
56638285|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
56638286|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638287|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56638288|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56638289|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638290|NCT00612144|Metformin|metformin|mesh-list
56638291|NCT00612144|Glimepiride|glimepiride|mesh-list
56638292|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56638293|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638294|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56582144|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582145|NCT04133428|Valsartan|valsartan|mesh-list
56582146|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56330647|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
56582147|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56071503|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638295|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638296|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
56638297|NCT02597361|Irbesartan|irbesartan|mesh-list
56638298|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56638299|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56638300|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56638301|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638302|NCT00562627|Ketorolac|ketorolac|mesh-list
56638303|NCT00562627|Epinephrine|epinephrine|mesh-list
56638304|NCT00562627|Racepinephrine|racepinephrine|mesh-list
56638305|NCT00562627|Fentanyl|fentanyl|mesh-list
56638306|NCT00562627|Morphine|morphine|mesh-list
56638307|NCT00562627|Bupivacaine|bupivacaine|mesh-list
56638308|NCT00562627|Ropivacaine|ropivacaine|mesh-list
56638309|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
56638310|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
56638311|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
56638312|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638313|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638314|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
56638315|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638316|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56638317|NCT00562627|Narcotics|narcotics|mesh-ancestor
56638318|NCT00562627|Analgesics|analgesics|mesh-ancestor
56638319|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56638320|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56638321|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
56638322|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56638323|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56638324|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
56638325|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638326|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638327|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56483255|NCT03534284|Trazodone|trazodone|mesh-list
56582148|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56582176|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56582177|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582178|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582179|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56582180|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
56582181|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582182|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582183|NCT04133194|Mesalamine|mesalamine|mesh-list
56582184|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56638328|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56638329|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
56638330|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56638331|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
56638332|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
56638333|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
56638334|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56638335|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56638336|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56638337|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56638338|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638339|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56638340|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638342|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56638343|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638344|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56638345|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638346|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
56638347|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638348|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
56638349|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638350|NCT00948649|Varenicline|varenicline|mesh-list
56638351|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56638352|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56638353|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
56638354|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638355|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638356|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638357|NCT00952159|Tramadol|tramadol|mesh-list
56638376|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638377|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
56638378|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638379|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
56638380|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638381|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
56638382|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638383|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56638384|NCT02778776|Metformin|metformin|mesh-list
56638385|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56638386|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638387|NCT00948805|Goserelin|goserelin|mesh-list
56638388|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56638389|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56638390|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638391|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56638392|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638393|NCT02710656|Paclitaxel|paclitaxel|mesh-list
56638394|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56638395|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638396|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
56638397|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
56638398|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
56638399|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638400|NCT02780882|Pasireotide|pasireotide|mesh-list
56638401|NCT02780882|Hormones|hormones|mesh-ancestor
56638402|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56638403|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638404|NCT02710266|Gabexate|gabexate|mesh-list
56638405|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
56638406|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56638407|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
56638411|NCT00562159|Xhance|xhance|mesh-list
56638421|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638422|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56638423|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638424|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56638425|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
56638426|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638427|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56638428|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
56638429|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
56638430|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56638431|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
56638432|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56638433|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56638434|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56638435|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56638436|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
56638437|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638438|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638439|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
56638440|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56638441|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56638442|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
56638443|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
56638444|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56638445|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56638446|NCT00562159|Analgesics|analgesics|mesh-ancestor
56638447|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
56638448|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638449|NCT02710110|Capsaicin|capsaicin|mesh-list
56638450|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
56638451|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
56638455|NCT00952627|Pycnogenols|pycnogenols|mesh-list
56638464|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56638465|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56638466|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56638467|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638468|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638469|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638470|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56638471|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
56638472|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56638473|NCT04848714|Antivenins|antivenins|mesh-list
56638474|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
56638475|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638476|NCT00952861|Doxycycline|doxycycline|mesh-list
56638477|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56638478|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638479|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
56638480|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56638481|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56638482|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
56638483|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638484|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56638485|NCT04889066|Durvalumab|durvalumab|mesh-list
56638486|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56638487|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638488|NCT04223778|Islatravir|islatravir|mesh-list
56638489|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
56638490|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284379|NCT00000136|Foscarnet|foscarnet|mesh-list
56638491|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638492|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638493|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56638494|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56638495|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56638496|NCT05109416|Bupivacaine|bupivacaine|mesh-list
56638497|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
56582185|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56582186|NCT04133194|Analgesics|analgesics|mesh-ancestor
56582187|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
56071504|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56638498|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
56638499|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638500|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638501|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
56638502|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638503|NCT04074564|Apatinib|apatinib|mesh-list
56638504|NCT04074564|Antibodies|antibodies|mesh-list
56638505|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
56638506|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638507|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638508|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56638509|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638510|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638511|NCT02778308|Gemcitabine|gemcitabine|mesh-list
56638512|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638513|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56638514|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
56638515|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638516|NCT02778308|Antiviral Agents|antiviral agents|mesh-ancestor
56638517|NCT02778308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638518|NCT02778308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638519|NCT02778308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638520|NCT02778308|Immunologic Factors|immunologic factors|mesh-ancestor
56638521|NCT02778308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638522|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
56638523|NCT02776202|Sirolimus|sirolimus|mesh-list
56638524|NCT02776202|Fludarabine|fludarabine|mesh-list
56638525|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
56638526|NCT02776202|Melphalan|melphalan|mesh-list
56638527|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638544|NCT00921557|Vitamin D|vitamin d|mesh-list
56638545|NCT00921557|Alendronate|alendronate|mesh-list
56638546|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
56638547|NCT00921557|Calcium|calcium|mesh-list
56638548|NCT00921557|Vitamins|vitamins|mesh-ancestor
56638549|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
56638550|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638551|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56638552|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56638553|NCT00921557|Antacids|antacids|mesh-ancestor
56638554|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638555|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56638556|NCT00611754|Fluorouracil|fluorouracil|mesh-list
56638557|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
56638558|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
56638559|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638560|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56638561|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638562|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638563|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
56638564|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638565|NCT00550615|Dasatinib|dasatinib|mesh-list
56638566|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284530|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
56638567|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56638568|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638569|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638570|NCT02709720|Cisplatin|cisplatin|mesh-list
56638593|NCT02776436|Prednisone|prednisone|mesh-list
56638594|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56638595|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
56638596|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
56638597|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638598|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638599|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56638600|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
56638601|NCT02776436|Hormones|hormones|mesh-ancestor
56638602|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56638603|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56638604|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638634|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56582188|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582189|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582190|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56582191|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582192|NCT00698464|Pasireotide|pasireotide|mesh-list
56582193|NCT00698464|Hormones|hormones|mesh-ancestor
56582194|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117526|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582222|NCT00927186|Teriparatide|teriparatide|mesh-list
56582223|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56582224|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582225|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56582226|NCT04862234|Dulaglutide|dulaglutide|mesh-list
56582227|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56582228|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582229|NCT00593554|Fludarabine|fludarabine|mesh-list
56582230|NCT00593554|Thiotepa|thiotepa|mesh-list
56582231|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
56582232|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56582233|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582234|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582235|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117580|NCT00003149|Interleukin-12|interleukin-12|mesh-list
56638635|NCT02775968|Azithromycin|azithromycin|mesh-list
56638636|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
56638637|NCT02775968|Erythromycin|erythromycin|mesh-list
56638638|NCT02775968|Cephalosporins|cephalosporins|mesh-list
56638639|NCT02775968|Cefamandole|cefamandole|mesh-list
56638640|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638641|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56638642|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56638643|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638644|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638645|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
56638646|NCT02775734|Clomiphene|clomiphene|mesh-list
56638647|NCT02775734|Enclomiphene|enclomiphene|mesh-list
56638648|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
56638649|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56638650|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638651|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56638652|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
56638653|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56638654|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638655|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56638656|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
56638657|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56638658|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56638659|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56638660|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
56638686|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638687|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638688|NCT04688814|Analgesics|analgesics|mesh-ancestor
56638689|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
56638690|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638691|NCT00744237|Metoprolol|metoprolol|mesh-list
56638692|NCT00744237|Nebivolol|nebivolol|mesh-list
56638693|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56638694|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56638695|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
56638696|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
56638697|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638698|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638699|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56638700|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56638701|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56638702|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
56638703|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638704|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638705|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
56638706|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56638707|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56638708|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56638738|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
56638739|NCT05260554|Fosfomycin|fosfomycin|mesh-list
56638740|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56638741|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638742|NCT04089345|Ustekinumab|ustekinumab|mesh-list
56638743|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
56638744|NCT02693574|Amoxicillin|amoxicillin|mesh-list
56638745|NCT02693574|Clarithromycin|clarithromycin|mesh-list
56638746|NCT02693574|Levofloxacin|levofloxacin|mesh-list
56638747|NCT02693574|Ofloxacin|ofloxacin|mesh-list
56638748|NCT02693574|Esomeprazole|esomeprazole|mesh-list
56638749|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56638750|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638751|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56638752|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56638753|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56638754|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638755|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638756|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56638757|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56638758|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56638759|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56638760|NCT02693574|Renal Agents|renal agents|mesh-ancestor
56638761|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56638762|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56638763|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638764|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56638765|NCT04179266|Ketamine|ketamine|mesh-list
56638766|NCT04179266|Analgesics|analgesics|mesh-ancestor
56638767|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
56638768|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638784|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638785|NCT04875728|Cefazolin|cefazolin|mesh-list
56638786|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56638787|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638788|NCT00611910|Sirolimus|sirolimus|mesh-list
56638789|NCT00611910|Paclitaxel|paclitaxel|mesh-list
56638790|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56638791|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638792|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
56638793|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547609|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56284685|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
56638794|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
56638795|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638796|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56638797|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638798|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56638799|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
56638800|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56638801|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
56638802|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638803|NCT00920855|Bortezomib|bortezomib|mesh-list
56638804|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56638807|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
56638834|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638835|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56638836|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
56638837|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638838|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638839|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56638840|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56638841|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56638842|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56638843|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
56638844|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56638845|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56638846|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638847|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56638848|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638849|NCT05387031|Ustekinumab|ustekinumab|mesh-list
56638850|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
56638851|NCT04570644|Ibuprofen|ibuprofen|mesh-list
56638852|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
56638853|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56638854|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56638855|NCT04570644|Analgesics|analgesics|mesh-ancestor
56638856|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
56638857|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638858|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638859|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56638860|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56638861|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56483622|NCT01250002|Lidocaine|lidocaine|mesh-list
56582259|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56582260|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582261|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56582263|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56582264|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582265|NCT00696982|Incretins|incretins|mesh-ancestor
56582266|NCT00696982|Hormones|hormones|mesh-ancestor
56582267|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56582268|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56582269|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
56582270|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582271|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582272|NCT01087736|Topiramate|topiramate|mesh-list
56582273|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
56582274|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56582275|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582276|NCT04262388|Durvalumab|durvalumab|mesh-list
56638862|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638863|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638864|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56638865|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
56638866|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56638867|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
56638868|NCT02775110|Natalizumab|natalizumab|mesh-list
56638869|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
56284830|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638870|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638871|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
56638872|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
56638873|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638874|NCT02775266|Protective Agents|protective agents|mesh-ancestor
56638875|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638876|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
56638877|NCT02775266|Vitamins|vitamins|mesh-ancestor
56638878|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
56638879|NCT01524926|Crizotinib|crizotinib|mesh-list
56638880|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638881|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56638882|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56638883|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638884|NCT03738228|Cisplatin|cisplatin|mesh-list
56638885|NCT03738228|Atezolizumab|atezolizumab|mesh-list
56638886|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56638887|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582277|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56582278|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582279|NCT00608712|Esomeprazole|esomeprazole|mesh-list
56582280|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56582281|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56582282|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56582283|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582284|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582285|NCT01079936|Lenalidomide|lenalidomide|mesh-list
56582286|NCT01079936|Melphalan|melphalan|mesh-list
56582287|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
56582326|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
56582327|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582329|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56582330|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
56582331|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
56582332|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56582333|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582334|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
56582335|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56582336|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
56582337|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582338|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638888|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
56638889|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638890|NCT04756232|Mecamylamine|mecamylamine|mesh-list
56638891|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56638892|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56638893|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
56638894|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638895|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638896|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56638897|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56638898|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
56638899|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638900|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638901|NCT02774876|Insulin|insulin|mesh-list
56638902|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56638903|NCT02774876|Hormones|hormones|mesh-list
56638904|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56638905|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638906|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56638907|NCT04225364|Paclitaxel|paclitaxel|mesh-list
56638908|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56638909|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56638910|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638911|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
56638912|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
56638913|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
56638914|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638915|NCT02771834|Vitamin D|vitamin d|mesh-list
56638916|NCT02771834|Vitamins|vitamins|mesh-ancestor
56638917|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
56638918|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638919|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56638920|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56638921|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56638922|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
56638928|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638929|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638930|NCT00613470|Citalopram|citalopram|mesh-list
56638931|NCT00613470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56638932|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56638933|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56638934|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638935|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638936|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
56638937|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638938|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56638939|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
56638940|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56638941|NCT02771912|Propofol|propofol|mesh-list
56638942|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56638943|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56638944|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638945|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638946|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56638947|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
56638948|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
56638949|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56638950|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56638951|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56638952|NCT00741819|Treprostinil|treprostinil|mesh-list
56638953|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56638954|NCT04457466|Mitogens|mitogens|mesh-list
56638955|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
56638956|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638957|NCT04954742|Riociguat|riociguat|mesh-list
56638958|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
56638960|NCT02774096|Xenon|xenon|mesh-list
56638970|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56638971|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56638972|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56638973|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56638974|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56638975|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56638976|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56638977|NCT04181385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56638978|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56638979|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56638980|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638981|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56638982|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
56638983|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56638984|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56638985|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
56638986|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56638987|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
56638988|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
56638989|NCT00924443|Clofarabine|clofarabine|mesh-list
56638990|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56638991|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
56638992|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56638993|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638994|NCT02677155|Rituximab|rituximab|mesh-list
56638995|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
56638996|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56638997|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56638998|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
56639001|NCT02537691|Theophylline|theophylline|mesh-list
56639012|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56639013|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56639014|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
56639015|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639016|NCT04225052|Varenicline|varenicline|mesh-list
56639017|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56639018|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56639019|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
56639020|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639021|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639022|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639023|NCT03693300|Durvalumab|durvalumab|mesh-list
56639024|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56639025|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639026|NCT04255121|Lidocaine|lidocaine|mesh-list
56639027|NCT04255121|Epinephrine|epinephrine|mesh-list
56639028|NCT04255121|Racepinephrine|racepinephrine|mesh-list
56639029|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
56639030|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
56639031|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
56639032|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639033|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639034|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
56639035|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639036|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56639037|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56639038|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56639039|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56639040|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639041|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56639057|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56639058|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639059|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
56639060|NCT00924287|Aldesleukin|aldesleukin|mesh-list
56639061|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
56639062|NCT00924287|Fludarabine|fludarabine|mesh-list
56639063|NCT00924287|Interleukin-2|interleukin-2|mesh-list
56639064|NCT00924287|Mesna|mesna|mesh-list
56639065|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56639066|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
56639067|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639068|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639069|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56639070|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
56639071|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639072|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639073|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56639074|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56639075|NCT00924287|Analgesics|analgesics|mesh-ancestor
56639076|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
56639077|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639078|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56639079|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56639080|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
56639081|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639082|NCT00924287|Protective Agents|protective agents|mesh-ancestor
56639083|NCT02696954|Lumefantrine|lumefantrine|mesh-list
56639084|NCT02696954|Artemether|artemether|mesh-list
56639085|NCT02696954|Primaquine|primaquine|mesh-list
56639086|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56639087|NCT02696954|Amodiaquine|amodiaquine|mesh-list
56639088|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
56639089|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56639090|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56639091|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639092|NCT02677077|Natalizumab|natalizumab|mesh-list
56639093|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
56639094|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639095|NCT02771600|Anesthetics|anesthetics|mesh-list
56483872|NCT00537966|Ritonavir|ritonavir|mesh-list
56582339|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56639096|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
56639097|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639098|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639099|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
56639100|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639101|NCT02773316|Morphine|morphine|mesh-list
56639102|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56639103|NCT02773316|Narcotics|narcotics|mesh-ancestor
56639104|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639105|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639106|NCT02773316|Analgesics|analgesics|mesh-ancestor
56639107|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
56639108|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639109|NCT00642681|Insulin|insulin|mesh-list
56639110|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56639111|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639112|NCT02773550|Prednisone|prednisone|mesh-list
56639113|NCT02773550|Bortezomib|bortezomib|mesh-list
56639114|NCT02773550|Melphalan|melphalan|mesh-list
56639115|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56639116|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
56639117|NCT02773550|Hormones|hormones|mesh-ancestor
56639118|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639119|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639120|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56639121|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639122|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56639144|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56639145|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56639146|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639147|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56639148|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56639149|NCT00637871|Tamoxifen|tamoxifen|mesh-list
56639150|NCT00637871|Bicalutamide|bicalutamide|mesh-list
56639151|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56639152|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
56639153|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639154|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639155|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56639156|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639157|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56639158|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56639159|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56639160|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
56639161|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56639162|NCT00635258|Ganirelix|ganirelix|mesh-list
56639163|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639164|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639165|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
56639166|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56639167|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
56639168|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56639169|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56547610|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56639170|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56639171|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639172|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
56639173|NCT00642837|Acetaminophen|acetaminophen|mesh-list
56639174|NCT00642837|Tramadol|tramadol|mesh-list
56639175|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56639176|NCT00642837|Analgesics|analgesics|mesh-ancestor
56582340|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
56582341|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56582342|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
56582343|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582344|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639177|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
56639178|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639179|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639180|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
56639181|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56639182|NCT00642837|Narcotics|narcotics|mesh-ancestor
56639183|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639184|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56639185|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56639186|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56639187|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639188|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639189|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
56639190|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639191|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56639192|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56639193|NCT02676609|Insulin|insulin|mesh-list
56639194|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56639195|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639196|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
56639197|NCT00642915|Glimepiride|glimepiride|mesh-list
56639198|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56639199|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639200|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56639201|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56639202|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
56639224|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56639225|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56639226|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639227|NCT00643071|Tacrolimus|tacrolimus|mesh-list
56639228|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56639229|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
56639230|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639231|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56639232|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639233|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639234|NCT03728634|Vitamin A|vitamin a|mesh-list
56639235|NCT03728634|Vitamins|vitamins|mesh-ancestor
56639236|NCT03728634|Micronutrients|micronutrients|mesh-ancestor
56639237|NCT03728634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639238|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56639239|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56639240|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56639241|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
56639242|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639243|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56285134|NCT00000793|Mexiletine|mexiletine|mesh-list
56639244|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56639245|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639246|NCT04353414|Bupivacaine|bupivacaine|mesh-list
56639247|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
56639248|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
56639249|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639250|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639270|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56639271|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56639272|NCT00613392|Antioxidants|antioxidants|mesh-list
56639273|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639274|NCT00613392|Protective Agents|protective agents|mesh-ancestor
56639275|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639276|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
56639277|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56639278|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
56639279|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56639280|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
56639281|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639282|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639283|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
56639284|NCT02762864|Clopidogrel|clopidogrel|mesh-list
56639285|NCT02762864|Ticagrelor|ticagrelor|mesh-list
56639286|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639287|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639288|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56639289|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56639290|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56639291|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56639292|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
56639293|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639294|NCT02767154|Mannitol|mannitol|mesh-list
56639295|NCT02767154|Dextrans|dextrans|mesh-list
56639318|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639319|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639321|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56639322|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
56639323|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56639324|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639325|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639326|NCT04891068|Azacitidine|azacitidine|mesh-list
56639327|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56639328|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
56639329|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639330|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639331|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639332|NCT02770508|Ritonavir|ritonavir|mesh-list
56639333|NCT02770508|Darunavir|darunavir|mesh-list
56639334|NCT02770508|Tenofovir|tenofovir|mesh-list
56639335|NCT02770508|Lamivudine|lamivudine|mesh-list
56639336|NCT02770508|Emtricitabine|emtricitabine|mesh-list
56639337|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56639338|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56639339|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
56639340|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639341|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639342|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56639343|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56639344|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
56639345|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639346|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56639347|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56639348|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56639349|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56639350|NCT02762942|Misoprostol|misoprostol|mesh-list
56639351|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56639360|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
56639361|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56639362|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639363|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56639364|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
56639365|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639366|NCT00918203|Paclitaxel|paclitaxel|mesh-list
56639367|NCT00918203|Carboplatin|carboplatin|mesh-list
56639368|NCT00918203|Olaratumab|olaratumab|mesh-list
56639369|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56639370|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639371|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
56639372|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
56639373|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
56639374|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639375|NCT00644319|Ibuprofen|ibuprofen|mesh-list
56639376|NCT00644319|Morphine|morphine|mesh-list
56639377|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56639378|NCT00644319|Narcotics|narcotics|mesh-ancestor
56639379|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639380|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639381|NCT00644319|Analgesics|analgesics|mesh-ancestor
56639382|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
56639383|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639384|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56639385|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56639386|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56639387|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639388|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56639389|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582345|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56582346|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
56582347|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
56582348|NCT00931632|Protective Agents|protective agents|mesh-ancestor
56582349|NCT00608790|Albuterol|albuterol|mesh-list
56582350|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56582375|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582376|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56582377|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582378|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582379|NCT00608946|Copper|copper|mesh-list
56582380|NCT00608946|Trace Elements|trace elements|mesh-ancestor
56582381|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
56582382|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582383|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
56582384|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
56582385|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56582386|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56639390|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639391|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
56639392|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56639393|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56285294|NCT00000898|Ritonavir|ritonavir|mesh-list
56639394|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639395|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
56639396|NCT04224116|Coagulants|coagulants|mesh-ancestor
56639397|NCT02672709|Apixaban|apixaban|mesh-list
56639398|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56639399|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
56639400|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56639401|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
56639402|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639403|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639404|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
56639405|NCT02770274|Aspirin|aspirin|mesh-list
56639406|NCT02770274|Cilostazol|cilostazol|mesh-list
56639407|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56639408|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56639409|NCT02770274|Analgesics|analgesics|mesh-ancestor
56639410|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
56639411|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639412|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639413|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56639414|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639415|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56639416|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56639417|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639418|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56639419|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56639420|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639421|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
56639422|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56639423|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
56484110|NCT01265056|Gabapentin|gabapentin|mesh-list
56639429|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56639430|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56639431|NCT00910221|Atorvastatin|atorvastatin|mesh-list
56639432|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56639433|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56639434|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
56639435|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639436|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56639437|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56639438|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639439|NCT04657562|Tacrolimus|tacrolimus|mesh-list
56639440|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56639441|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
56639442|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639443|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56639444|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639445|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639446|NCT05252117|Mepivacaine|mepivacaine|mesh-list
56639447|NCT05252117|Carticaine|carticaine|mesh-list
56639448|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
56639449|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
56639450|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639451|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639452|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
56639479|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639480|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639481|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56639483|NCT04177875|Docetaxel|docetaxel|mesh-list
56639484|NCT04177875|Cisplatin|cisplatin|mesh-list
56639485|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56639486|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56639487|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639488|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
56639489|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
56639490|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
56639491|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639492|NCT00917579|Atorvastatin|atorvastatin|mesh-list
56639493|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56639494|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56639495|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
56639496|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639497|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56639498|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56639499|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639500|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56639501|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56639502|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56639503|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56639504|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639505|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56639506|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639507|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639508|NCT02766140|Docetaxel|docetaxel|mesh-list
56639514|NCT04177641|Antioxidants|antioxidants|mesh-list
56639523|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
56639524|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
56639525|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639526|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639527|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
56639528|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639529|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56639530|NCT04178109|Analgesics|analgesics|mesh-ancestor
56639531|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
56639532|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56639533|NCT04178109|Narcotics|narcotics|mesh-ancestor
56639534|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56639535|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56639536|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639537|NCT00644475|Candesartan|candesartan|mesh-list
56639538|NCT00644475|Imidapril|imidapril|mesh-list
56639539|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56639540|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56639541|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56639542|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639543|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56639545|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639546|NCT04177719|Oxytocin|oxytocin|mesh-list
56639547|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
56639548|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56639549|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639550|NCT00644553|Amoxicillin|amoxicillin|mesh-list
56639551|NCT00644553|Clarithromycin|clarithromycin|mesh-list
56639552|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
56639553|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56639554|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56639555|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639556|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56639557|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639558|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639559|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56639560|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56639561|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56639562|NCT02762474|Paclitaxel|paclitaxel|mesh-list
56639563|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56639564|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639565|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
56639566|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
56639567|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
56639568|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639569|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
56639570|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56639571|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56639572|NCT00915473|Prednisolone|prednisolone|mesh-list
56639573|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
56639574|NCT00915473|Lidocaine|lidocaine|mesh-list
56639575|NCT00915473|Bupivacaine|bupivacaine|mesh-list
56639576|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56639577|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
56639578|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
56639579|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
56639580|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639581|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639582|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
56639583|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639584|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56639585|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56639586|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56639587|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56639588|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639589|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56639590|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
56639591|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
56639592|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56639593|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
56639594|NCT00915473|Hormones|hormones|mesh-ancestor
56639603|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
56639604|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
56639605|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639606|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639607|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
56639608|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639609|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56639610|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56639611|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56639612|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56639613|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639614|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56639615|NCT04691726|Narcotics|narcotics|mesh-ancestor
56639616|NCT04691726|Analgesics|analgesics|mesh-ancestor
56639617|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56639619|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56639620|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639621|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
56639622|NCT00614328|Naltrexone|naltrexone|mesh-list
56639623|NCT00614328|Baclofen|baclofen|mesh-list
56639624|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56639625|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56639626|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639627|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
56639628|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639629|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56639630|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56639631|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56639632|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
56639633|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
56639649|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56639650|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
56639651|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639652|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56639653|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56639654|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56639655|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56639656|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56639657|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56639658|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56639659|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
56639660|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56639661|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
56639662|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56639663|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639664|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56639665|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56639666|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639667|NCT03651804|Acetaminophen|acetaminophen|mesh-list
56639668|NCT03651804|Diphosphonates|diphosphonates|mesh-list
56639669|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56639670|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56639671|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56639672|NCT03651804|Analgesics|analgesics|mesh-ancestor
56639673|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
56639699|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56639700|NCT03479502|Protective Agents|protective agents|mesh-ancestor
56639701|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56639702|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639703|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
56639704|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56639705|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56639706|NCT03606642|Clopidogrel|clopidogrel|mesh-list
56639707|NCT03606642|Ticagrelor|ticagrelor|mesh-list
56639708|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56639709|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639710|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639711|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56639712|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56639713|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56639714|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56639715|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
56639716|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639717|NCT00917267|Exenatide|exenatide|mesh-list
56639718|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56639719|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639720|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56639721|NCT00917267|Incretins|incretins|mesh-ancestor
56639722|NCT00917267|Hormones|hormones|mesh-ancestor
56639723|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639724|NCT02670759|Bupivacaine|bupivacaine|mesh-list
56639725|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
56639726|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
56639727|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639728|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639729|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
56639730|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639743|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639744|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56639745|NCT04253873|Temozolomide|temozolomide|mesh-list
56639746|NCT04253873|Apatinib|apatinib|mesh-list
56639747|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56639748|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
56639749|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639750|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639751|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56639752|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639753|NCT05147727|Fluconazole|fluconazole|mesh-list
56639754|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
56639755|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639756|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56639757|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56639758|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639759|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639760|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56639761|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
56639762|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639763|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639764|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56639765|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56639766|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
56639767|NCT02765594|Valsartan|valsartan|mesh-list
56639768|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56639769|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56639770|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56582387|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582388|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582389|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582390|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582391|NCT00926328|Triclosan|triclosan|mesh-list
56582392|NCT00926328|Fluorides|fluorides|mesh-list
56582393|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
56582394|NCT00926328|Protective Agents|protective agents|mesh-ancestor
56582395|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582396|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56582397|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582398|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56582424|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56582425|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56582427|NCT02619994|Ofloxacin|ofloxacin|mesh-list
56582428|NCT02619994|Linezolid|linezolid|mesh-list
56639771|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639772|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
56639773|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56639774|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56639775|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639776|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639777|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639778|NCT00920699|Ubiquinone|ubiquinone|mesh-list
56639779|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
56639780|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
56639781|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639782|NCT00920699|Vitamins|vitamins|mesh-ancestor
56639783|NCT02670135|Triclosan|triclosan|mesh-list
56639784|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56639785|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639786|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56639787|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56639788|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
56639789|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639790|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56639791|NCT02769494|Riboflavin|riboflavin|mesh-list
56639792|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
56639793|NCT02769494|Mesalamine|mesalamine|mesh-list
56639794|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
56639795|NCT02769494|Vitamins|vitamins|mesh-ancestor
56639796|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
56639797|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639798|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56639799|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
56639800|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56639801|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56639802|NCT02769494|Analgesics|analgesics|mesh-ancestor
56639803|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
56639804|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639805|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56639814|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56639815|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639816|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56639817|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639818|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639819|NCT05116293|Acetaminophen|acetaminophen|mesh-list
56639820|NCT05116293|Digoxin|digoxin|mesh-list
56639821|NCT05116293|Midazolam|midazolam|mesh-list
56639822|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56639823|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56639824|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56639825|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639826|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56639827|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56639828|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56639829|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56639830|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
56639831|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
56639832|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
56639833|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
56639834|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639835|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639836|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56639837|NCT05116293|Analgesics|analgesics|mesh-ancestor
56639838|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
56639839|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56639840|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
56639841|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56547611|NCT00644761|Adefovir|adefovir|mesh-list
56639842|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56639843|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639844|NCT05116293|Protective Agents|protective agents|mesh-ancestor
56639845|NCT02669589|Heparin|heparin|mesh-list
56639846|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
56639847|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639855|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639856|NCT02765204|Incretins|incretins|mesh-ancestor
56639857|NCT02765204|Hormones|hormones|mesh-ancestor
56639858|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639859|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56639860|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
56639861|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639862|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
56639863|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
56639864|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639865|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56639866|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56639867|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
56639868|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639869|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639870|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56639871|NCT03342456|Amoxicillin|amoxicillin|mesh-list
56639872|NCT03342456|Doxycycline|doxycycline|mesh-list
56639873|NCT03342456|Furazolidone|furazolidone|mesh-list
56639874|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
56639875|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639876|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56639877|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639878|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
56639879|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56639880|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56639881|NCT03342456|Diuretics|diuretics|mesh-ancestor
56639882|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
56639904|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
56639905|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
56639906|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639907|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56639908|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639909|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56639910|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
56639911|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639912|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639913|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
56639914|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56639915|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639916|NCT00645255|Sibutramine|sibutramine|mesh-list
56639917|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
56639918|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56639919|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
56639920|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56639921|NCT04679012|Prednisone|prednisone|mesh-list
56639922|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
56639923|NCT04679012|Rituximab|rituximab|mesh-list
56639924|NCT04679012|Doxorubicin|doxorubicin|mesh-list
56639925|NCT04679012|Etoposide|etoposide|mesh-list
56639926|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56639927|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56639928|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
56639929|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639930|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56639931|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56639932|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
56639933|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639940|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639948|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56639949|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639950|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
56639951|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639952|NCT02765126|Vaccines|vaccines|mesh-list
56639953|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
56639954|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639955|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56639956|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56639957|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639958|NCT00916721|Propranolol|propranolol|mesh-list
56639959|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56639960|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56639961|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
56639962|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56639963|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639964|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639965|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56639966|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56639967|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
56639968|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
56639969|NCT00613782|Testosterone|testosterone|mesh-list
56639970|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
56639971|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
56639972|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56639973|NCT00613782|Androgens|androgens|mesh-ancestor
56639974|NCT00613782|Hormones|hormones|mesh-ancestor
56639975|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56639976|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56639977|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56639978|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639979|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
56639980|NCT04962503|Afamelanotide|afamelanotide|mesh-list
56639981|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
56639982|NCT02764736|Atorvastatin|atorvastatin|mesh-list
56639983|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56484531|NCT00547170|Doxycycline|doxycycline|mesh-list
56582429|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
56639984|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56639985|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
56639986|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639987|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56639988|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56639989|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56639990|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
56639991|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56639992|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56639993|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56285900|NCT00001507|Antibodies|antibodies|mesh-list
56639994|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
56639995|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56639996|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56639998|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56639999|NCT00646815|Hormones|hormones|mesh-list
56640000|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56640001|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640002|NCT00915005|Paclitaxel|paclitaxel|mesh-list
56640003|NCT00915005|Carboplatin|carboplatin|mesh-list
56640004|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56640005|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640006|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56640007|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56640008|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
56640009|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640010|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
56640011|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56640012|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640013|NCT02696642|Maytansine|maytansine|mesh-list
56640014|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56640027|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640028|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640029|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56640030|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
56640031|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640032|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56640033|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
56640034|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640035|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
56640036|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640037|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56640038|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56640039|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56640040|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
56640041|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640042|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56640043|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
56640044|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56640045|NCT02696330|Enoxaparin|enoxaparin|mesh-list
56640046|NCT02696330|Clopidogrel|clopidogrel|mesh-list
56640047|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56640048|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56640049|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56640050|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56640076|NCT00647127|Analgesics|analgesics|mesh-ancestor
56640077|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
56640078|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640079|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56640080|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56640081|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
56640082|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
56640083|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56640084|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56640085|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56640086|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56640087|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640088|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
56640089|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640090|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640091|NCT04750070|Dopamine|dopamine|mesh-list
56640092|NCT04750070|Epinephrine|epinephrine|mesh-list
56640093|NCT04750070|Racepinephrine|racepinephrine|mesh-list
56640094|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
56640095|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56640096|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56640097|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
56640098|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640099|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640100|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640101|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56640102|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56640103|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
56484626|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
56582430|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56582431|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582432|NCT02619994|Renal Agents|renal agents|mesh-ancestor
56582433|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56582434|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56582435|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56582436|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582437|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582438|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582439|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56582440|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56582441|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56582442|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
56582443|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
56582444|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56582445|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56582446|NCT04263402|Prednisolone|prednisolone|mesh-list
56640104|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640105|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56640106|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
56640107|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
56640108|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
56640109|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56640110|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56640111|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
56640112|NCT04750070|Protective Agents|protective agents|mesh-ancestor
56640113|NCT02763722|Emollients|emollients|mesh-list
56640114|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
56640115|NCT01143246|Terlipressin|terlipressin|mesh-list
56640116|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56640117|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56640118|NCT00647673|Verapamil|verapamil|mesh-list
56640119|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56640120|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56640121|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56640122|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640123|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56640124|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640125|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
56640126|NCT00561925|Nevirapine|nevirapine|mesh-list
56640127|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56640128|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56640129|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640130|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640131|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
56640132|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640133|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56640134|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56640147|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
56640148|NCT04172259|Docetaxel|docetaxel|mesh-list
56640149|NCT04172259|Doxorubicin|doxorubicin|mesh-list
56640150|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56640151|NCT04172259|Trastuzumab|trastuzumab|mesh-list
56640152|NCT04172259|Epirubicin|epirubicin|mesh-list
56640153|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56640154|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
56640155|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640156|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640157|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56640158|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
56640159|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640160|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640161|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56640162|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
56640163|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
56640164|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
56640165|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56640166|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56640167|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56640168|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640169|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640170|NCT00647751|Lamotrigine|lamotrigine|mesh-list
56640171|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
56640172|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56640173|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56640174|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640194|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56640195|NCT00647829|Analgesics|analgesics|mesh-ancestor
56640196|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
56640197|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640198|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640199|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640200|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640201|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
56640202|NCT02517918|Sirolimus|sirolimus|mesh-list
56640203|NCT02517918|Methotrexate|methotrexate|mesh-list
56640204|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56640205|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
56640206|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640207|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640208|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56640209|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
56640210|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640211|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640212|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
56640213|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286119|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
56640214|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56640215|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56640216|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
56640217|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640218|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56640219|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56640220|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640221|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56640222|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
56582447|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
56117787|NCT00003461|Antibodies|antibodies|mesh-list
56582560|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582561|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56582562|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582564|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56582565|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56582566|NCT00867490|Diuretics|diuretics|mesh-ancestor
56582567|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
56582568|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56582569|NCT00697060|Docetaxel|docetaxel|mesh-list
56582570|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582571|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
56582572|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
56582573|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
56640223|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56640224|NCT00647907|Voriconazole|voriconazole|mesh-list
56640225|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
56640226|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640227|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56640228|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56640229|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640230|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640231|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56640232|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
56640233|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56640234|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640235|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56640236|NCT04017546|Venetoclax|venetoclax|mesh-list
56640237|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640238|NCT04171791|Venetoclax|venetoclax|mesh-list
56640239|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640240|NCT04003818|Teicoplanin|teicoplanin|mesh-list
56640241|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56640242|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640243|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56640244|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640245|NCT00949663|Incretins|incretins|mesh-ancestor
56640246|NCT00949663|Hormones|hormones|mesh-ancestor
56640247|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56640248|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640249|NCT00647985|Fexofenadine|fexofenadine|mesh-list
56640250|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56640251|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56640252|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56640253|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
56640254|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
56640255|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640256|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582574|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582575|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
56582576|NCT00867334|Panitumumab|panitumumab|mesh-list
56582577|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640257|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640258|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
56640259|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56640260|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
56640261|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640262|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640263|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56640264|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
56640265|NCT00648063|Letrozole|letrozole|mesh-list
56640266|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640267|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56640268|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56640269|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640270|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640271|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56640272|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
56640273|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56640274|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640275|NCT00648141|Celecoxib|celecoxib|mesh-list
56640276|NCT00648141|Diclofenac|diclofenac|mesh-list
56640277|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56640310|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640311|NCT00648297|Nadolol|nadolol|mesh-list
56640312|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
56640313|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56640314|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56640315|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
56640316|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640317|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640318|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640319|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56640320|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56640321|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
56640322|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
56640323|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640324|NCT00648297|Diuretics|diuretics|mesh-ancestor
56640325|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
56640326|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56640327|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56640328|NCT00648453|Clopidogrel|clopidogrel|mesh-list
56640329|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56640330|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56640331|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56640332|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56640333|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
56640340|NCT00637026|Gefitinib|gefitinib|mesh-list
56640358|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640359|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640360|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56640361|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640362|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
56640363|NCT02768168|Dezocine|dezocine|mesh-list
56640364|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56640365|NCT02768168|Narcotics|narcotics|mesh-ancestor
56640366|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640367|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640368|NCT02768168|Analgesics|analgesics|mesh-ancestor
56640369|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
56640370|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640371|NCT03739554|Venetoclax|venetoclax|mesh-list
56640372|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640373|NCT02659683|Esomeprazole|esomeprazole|mesh-list
56640374|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56640375|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640376|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56640377|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640378|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640379|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
56640380|NCT04701476|Tirapazamine|tirapazamine|mesh-list
56640381|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640382|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640383|NCT05343702|Rocuronium|rocuronium|mesh-list
56640384|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56582578|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56117918|NCT00003941|Etoposide|etoposide|mesh-list
56582610|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56582611|NCT00609960|Midazolam|midazolam|mesh-list
56582612|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56582613|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56582614|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582615|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582616|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56582617|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56582618|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56582619|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56582620|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
56582621|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
56582622|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
56582623|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
56582624|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56582625|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582626|NCT04879134|Apomorphine|apomorphine|mesh-list
56582627|NCT04879134|Emetics|emetics|mesh-ancestor
56582628|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582629|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
56582630|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582631|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640385|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56640386|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56640387|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640388|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640389|NCT02659761|Lamivudine|lamivudine|mesh-list
56640390|NCT02659761|Abacavir|abacavir|mesh-list
56640391|NCT02659761|Dolutegravir|dolutegravir|mesh-list
56640392|NCT02659761|Triumeq|triumeq|mesh-list
56640393|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56640394|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56640395|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640396|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640397|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
56640398|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640399|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56640400|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56640401|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56640402|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56640403|NCT05343546|Copper|copper|mesh-list
56640404|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
56640405|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56640406|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
56640407|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640408|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640409|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56640410|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56640411|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56640412|NCT05343546|Trace Elements|trace elements|mesh-ancestor
56640413|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
56640414|NCT02659917|Methamphetamine|methamphetamine|mesh-list
56640415|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56640416|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640417|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
56640418|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
56640419|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640420|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
56582632|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
56582633|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
56582634|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56582635|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582636|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
56640421|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640422|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640423|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
56640424|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56640425|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56640426|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56640427|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56640428|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56640429|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640430|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640431|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56640432|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56640433|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640434|NCT04500236|Anesthetics|anesthetics|mesh-list
56640435|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640436|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640437|NCT02659293|Dexamethasone|dexamethasone|mesh-list
56640438|NCT02659293|Lenalidomide|lenalidomide|mesh-list
56640439|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640440|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
56640441|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
56640442|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640443|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640444|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640445|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
56640446|NCT02659293|Hormones|hormones|mesh-ancestor
56640468|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
56640469|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56640470|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56640471|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640472|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56640473|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56640474|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640475|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640476|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640477|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56640478|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
56640479|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640480|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640481|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56640482|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56640483|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56640484|NCT00649233|Metoprolol|metoprolol|mesh-list
56640485|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56640486|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56640487|NCT00649233|Diuretics|diuretics|mesh-ancestor
56640488|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
56640489|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640490|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56640491|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56640492|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640493|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56640494|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
56640495|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
56640496|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640497|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56640498|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56640499|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56640508|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56640509|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56640510|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56640511|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
56547614|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640512|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640513|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640514|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640515|NCT00954889|Urological Agents|urological agents|mesh-ancestor
56640516|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
56640517|NCT03666000|Fludarabine|fludarabine|mesh-list
56640518|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56640519|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
56640520|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640521|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640522|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56640523|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
56640524|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640525|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640526|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56640527|NCT02692248|Gemcitabine|gemcitabine|mesh-list
56640528|NCT02692248|Dexamethasone|dexamethasone|mesh-list
56640529|NCT02692248|Rituximab|rituximab|mesh-list
56640530|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
56640531|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640532|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640533|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
56640534|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640535|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640536|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640537|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
56640538|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
56640539|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640540|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640547|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640548|NCT02692248|Antiviral Agents|antiviral agents|mesh-ancestor
56640549|NCT02692248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640550|NCT02692248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640551|NCT02692248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56640552|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
56640553|NCT04370509|Axitinib|axitinib|mesh-list
56640554|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640555|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640556|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56640557|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640558|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640559|NCT04477772|Antibodies|antibodies|mesh-list
56640560|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56640561|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
56640562|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640563|NCT02851290|Anesthetics|anesthetics|mesh-list
56640564|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640565|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640566|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56640567|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56640568|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640569|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640570|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56640571|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56640572|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640573|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
56640574|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640590|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640591|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56640592|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56640593|NCT00957385|Growth Substances|growth substances|mesh-ancestor
56640594|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
56640595|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640596|NCT04169841|Durvalumab|durvalumab|mesh-list
56640597|NCT04169841|Olaparib|olaparib|mesh-list
56640598|NCT04169841|Tremelimumab|tremelimumab|mesh-list
56640599|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640600|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640601|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56640602|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640603|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640604|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
56640605|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56640606|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640607|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56640608|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640609|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640610|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640611|NCT02752646|Ketorolac|ketorolac|mesh-list
56640612|NCT02752646|Nepafenac|nepafenac|mesh-list
56640613|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56640614|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56582637|NCT04134130|Testosterone|testosterone|mesh-list
56582638|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
56582658|NCT02619448|Paclitaxel|paclitaxel|mesh-list
56582659|NCT02619448|Carboplatin|carboplatin|mesh-list
56582660|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56582661|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582662|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
56582663|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
56582664|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
56582665|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582666|NCT00610038|Glyburide|glyburide|mesh-list
56582667|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56582668|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582669|NCT02619526|Carvedilol|carvedilol|mesh-list
56582670|NCT02619526|Nebivolol|nebivolol|mesh-list
56582671|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56582672|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56582673|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56582674|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56582675|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582676|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582677|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56582678|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
56582679|NCT02619526|Protective Agents|protective agents|mesh-ancestor
56582680|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56640615|NCT02752646|Analgesics|analgesics|mesh-ancestor
56640616|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
56640617|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640618|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640619|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640620|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640621|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56640622|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640623|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640624|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
56640625|NCT04169919|Povidone|povidone|mesh-list
56640626|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
56640627|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
56640628|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56640629|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640630|NCT02757248|Romidepsin|romidepsin|mesh-list
56640631|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56640632|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640633|NCT00649311|Losartan|losartan|mesh-list
56640634|NCT00649311|Eplerenone|eplerenone|mesh-list
56640635|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56640636|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56640637|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56640638|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56640639|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640640|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56640641|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
56640642|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56640643|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640644|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56640657|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640658|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56640660|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
56640661|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56640662|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640663|NCT00649545|Adalimumab|adalimumab|mesh-list
56640664|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56640665|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640666|NCT04169763|Nelfinavir|nelfinavir|mesh-list
56640667|NCT04169763|Cisplatin|cisplatin|mesh-list
56640668|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640669|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56640670|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56640671|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
56640672|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640673|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640674|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56640675|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56640676|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
56640677|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640678|NCT00635414|Esomeprazole|esomeprazole|mesh-list
56640679|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56640680|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56640681|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56640682|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640683|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640710|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
56640711|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640712|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640713|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56640714|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56640715|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
56640716|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
56640717|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640718|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56640719|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56640720|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640721|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640722|NCT00649623|Olmesartan|olmesartan|mesh-list
56640723|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56640724|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56640725|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56640726|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56640727|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640728|NCT02756312|Anesthetics|anesthetics|mesh-list
56640729|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640730|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640731|NCT02657187|Rocuronium|rocuronium|mesh-list
56640732|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56640733|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56640735|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640736|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640737|NCT00649779|Albuterol|albuterol|mesh-list
56640738|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56640739|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
56640740|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640741|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640742|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56640743|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
56640748|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56640749|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56640750|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640751|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640752|NCT00615186|Temozolomide|temozolomide|mesh-list
56640753|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56640754|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
56640755|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640756|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640757|NCT00616044|Anesthetics|anesthetics|mesh-list
56640758|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640759|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640760|NCT02536911|Eliglustat|eliglustat|mesh-list
56640761|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640762|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640763|NCT04221152|Empagliflozin|empagliflozin|mesh-list
56640764|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56640765|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640766|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56640767|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640768|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56640769|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640770|NCT02756000|Dobutamine|dobutamine|mesh-list
56640771|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56640772|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
56640773|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
56640774|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640775|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640778|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56640793|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
56640794|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
56640795|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56640796|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56640797|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56640798|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
56640799|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56640800|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640801|NCT02759510|Protective Agents|protective agents|mesh-ancestor
56640802|NCT04220528|Capecitabine|capecitabine|mesh-list
56640803|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56640804|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
56640805|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640806|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640807|NCT02759042|Leronlimab|leronlimab|mesh-list
56640808|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56640809|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56640810|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640811|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56640812|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56640813|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
56640814|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56640815|NCT02755532|Bupivacaine|bupivacaine|mesh-list
56640816|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
56640817|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
56640818|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640819|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640820|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
56640821|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640822|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
56640823|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56640824|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
56640825|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640826|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
56582681|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56582682|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56582683|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
56582684|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56582685|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56640827|NCT02755376|Protective Agents|protective agents|mesh-ancestor
56640828|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
56640829|NCT02752334|Bupivacaine|bupivacaine|mesh-list
56640830|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
56640831|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
56640832|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640833|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640834|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
56640835|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640836|NCT02752334|Analgesics|analgesics|mesh-ancestor
56640837|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56640838|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
56640839|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56640840|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56640841|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640842|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56640843|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
56640844|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56640845|NCT02755298|Acetazolamide|acetazolamide|mesh-list
56640882|NCT00003042|Tamoxifen|tamoxifen|mesh-list
56640883|NCT00003042|Paclitaxel|paclitaxel|mesh-list
56640884|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
56640885|NCT00003042|Doxorubicin|doxorubicin|mesh-list
56640886|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56640887|NCT00003042|Melphalan|melphalan|mesh-list
56640888|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56640889|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640890|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56640891|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
56640892|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56640893|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640894|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56640895|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
56640896|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640897|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56640898|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56640899|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
56640900|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56640901|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56640902|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56640903|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56640904|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640905|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56640906|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
56640933|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56640934|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56640935|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56640936|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640937|NCT02705976|Warfarin|warfarin|mesh-list
56640938|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
56640939|NCT02752412|Insulin|insulin|mesh-list
56640940|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56640941|NCT02752412|Metformin|metformin|mesh-list
56640942|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
56640943|NCT02752412|Lixisenatide|lixisenatide|mesh-list
56640944|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56640945|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640946|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
56640947|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640948|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640949|NCT02703090|Remifentanil|remifentanil|mesh-list
56640950|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56640951|NCT02703090|Narcotics|narcotics|mesh-ancestor
56640952|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640953|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640954|NCT02703090|Analgesics|analgesics|mesh-ancestor
56640955|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
56640956|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640957|NCT02754362|Bevacizumab|bevacizumab|mesh-list
56640959|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56640960|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
56640961|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56640962|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56640963|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56640964|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56640965|NCT02754362|Growth Substances|growth substances|mesh-ancestor
56640966|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640979|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56640980|NCT02698098|Methadone|methadone|mesh-list
56640981|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56640982|NCT02698098|Narcotics|narcotics|mesh-ancestor
56640983|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640984|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640985|NCT02698098|Analgesics|analgesics|mesh-ancestor
56640986|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
56640987|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56640988|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
56640989|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
56640990|NCT04220996|Vortioxetine|vortioxetine|mesh-list
56640991|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
56640992|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56640993|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56640994|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56640995|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56640996|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56640997|NCT04220996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56640998|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56640999|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641000|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641001|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641002|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
56641003|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56641004|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56641005|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56641006|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56641007|NCT02702700|Verteporfin|verteporfin|mesh-list
56641008|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56641009|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
56641010|NCT02702622|Provitamins|provitamins|mesh-list
56641011|NCT02702622|Beta Carotene|beta carotene|mesh-list
56641012|NCT02702622|Vitamins|vitamins|mesh-ancestor
56641013|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
56641014|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641015|NCT04214808|Dutasteride|dutasteride|mesh-list
56582686|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56641016|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56641017|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56641018|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641019|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641020|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
56641021|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56641022|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641023|NCT02705508|Gemcitabine|gemcitabine|mesh-list
56641024|NCT02705508|Etoposide|etoposide|mesh-list
56641025|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
56641026|NCT02705508|Pegaspargase|pegaspargase|mesh-list
56641027|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56641028|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
56547616|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56641029|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641030|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641032|NCT02705508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641033|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641034|NCT02705508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56641035|NCT02705508|Immunologic Factors|immunologic factors|mesh-ancestor
56641036|NCT02705508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641037|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641038|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56641039|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56641040|NCT02702778|Prednisone|prednisone|mesh-list
56641041|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56641042|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
56641043|NCT02702778|Hormones|hormones|mesh-ancestor
56641044|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56641047|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641058|NCT02753738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56641059|NCT02751632|Fluoxetine|fluoxetine|mesh-list
56641060|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
56641061|NCT02751632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56641062|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56641063|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641064|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641065|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641066|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
56641067|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641068|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56641069|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56641070|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56641071|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56641072|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641073|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56641074|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56641075|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641076|NCT02751476|Disinfectants|disinfectants|mesh-list
56641077|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641078|NCT02705664|Amorolfine|amorolfine|mesh-list
56641079|NCT02705664|Bifonazole|bifonazole|mesh-list
56641080|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
56641081|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641082|NCT02753426|Doxycycline|doxycycline|mesh-list
56641083|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56641084|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641085|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
56641086|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56641087|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56641088|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
56641089|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56641090|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641091|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56485422|NCT03455764|Dabrafenib|dabrafenib|mesh-list
56582687|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56582688|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56582689|NCT04119622|Capecitabine|capecitabine|mesh-list
56582690|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
56582691|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56641092|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641093|NCT02702076|Apomorphine|apomorphine|mesh-list
56641094|NCT02702076|Emetics|emetics|mesh-ancestor
56641095|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641096|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
56641097|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641098|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56641099|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
56641100|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
56547617|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641101|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641102|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641104|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56641105|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641106|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56641107|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641108|NCT02753114|Ketamine|ketamine|mesh-list
56641109|NCT02753114|Analgesics|analgesics|mesh-ancestor
56641110|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
56641111|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641112|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641113|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56641114|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56641115|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
56641116|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
56641117|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641118|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56641119|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56641120|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641121|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641122|NCT03288324|Tofacitinib|tofacitinib|mesh-list
56641123|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641133|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56641134|NCT04486118|Protective Agents|protective agents|mesh-ancestor
56641135|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641136|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
56641137|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56641138|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56641139|NCT05324748|Prednisolone|prednisolone|mesh-list
56641140|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
56641141|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56641142|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
56641143|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56641144|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
56641145|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
56641146|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641147|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641148|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56641149|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
56641150|NCT05324748|Hormones|hormones|mesh-ancestor
56641151|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56641152|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56641153|NCT05324748|Protective Agents|protective agents|mesh-ancestor
56641154|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56641155|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641156|NCT02705274|Bevacizumab|bevacizumab|mesh-list
56641157|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641158|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641159|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56641160|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56641161|NCT02705274|Growth Substances|growth substances|mesh-ancestor
56641162|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641163|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
56641178|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56641179|NCT02704962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56641180|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56641181|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641182|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641183|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641184|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
56641185|NCT00631943|Pregabalin|pregabalin|mesh-list
56641186|NCT00631943|Analgesics|analgesics|mesh-ancestor
56641187|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
56641188|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641189|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641190|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
56641191|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56641192|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641193|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641194|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56641195|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56641196|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56641197|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641198|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56641199|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56641200|NCT05429684|Capecitabine|capecitabine|mesh-list
56641201|NCT05429684|Trastuzumab|trastuzumab|mesh-list
56641202|NCT05429684|Everolimus|everolimus|mesh-list
56641203|NCT05429684|Letrozole|letrozole|mesh-list
56641204|NCT05429684|Palbociclib|palbociclib|mesh-list
56582692|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
56582693|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582780|NCT02613676|Bilirubin|bilirubin|mesh-list
56582781|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
56582782|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582783|NCT02613676|Protective Agents|protective agents|mesh-ancestor
56582784|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582785|NCT00860158|Dasatinib|dasatinib|mesh-list
56582786|NCT00860158|Leuprolide|leuprolide|mesh-list
56582787|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582788|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56582789|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582790|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582791|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56582792|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
56582793|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56582794|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582795|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56582796|NCT02878538|Deferiprone|deferiprone|mesh-list
56582797|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56582798|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
56641205|NCT05429684|Pertuzumab|pertuzumab|mesh-list
56641206|NCT05429684|Antibodies|antibodies|mesh-list
56641207|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56641208|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641209|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641210|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641211|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
56641212|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641213|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
56641214|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641215|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56641216|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
56641217|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641218|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56641219|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56641220|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56641221|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641222|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56641223|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
56641224|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56641225|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641226|NCT05324592|Aflibercept|aflibercept|mesh-list
56641227|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56641228|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56641229|NCT05324592|Growth Substances|growth substances|mesh-ancestor
56641230|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641231|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
56641232|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641233|NCT04433858|Psilocybin|psilocybin|mesh-list
56641234|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
56641235|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641236|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56641237|NCT02750696|Acetaminophen|acetaminophen|mesh-list
56641238|NCT02750696|Tramadol|tramadol|mesh-list
56641239|NCT02750696|Codeine|codeine|mesh-list
56582826|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
56582827|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
56582828|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582829|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56582830|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56582831|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051405|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56641240|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56641241|NCT02750696|Analgesics|analgesics|mesh-ancestor
56641242|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
56641243|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641244|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641245|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
56641246|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56641247|NCT02750696|Narcotics|narcotics|mesh-ancestor
56641248|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641249|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
56641250|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
56641251|NCT02695550|Conteltinib|conteltinib|mesh-list
56641252|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641253|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641254|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641255|NCT00912743|Olaparib|olaparib|mesh-list
56641256|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56641257|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641258|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641259|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641260|NCT04432610|Nebivolol|nebivolol|mesh-list
56641261|NCT04432610|Bisoprolol|bisoprolol|mesh-list
56641262|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56641263|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
56641264|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56641265|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56641266|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56641267|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
56641268|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641269|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641270|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641271|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
56641272|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
56641282|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641283|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56641284|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56641285|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641286|NCT00914459|Factor VIII|factor viii|mesh-list
56641287|NCT00914459|Coagulants|coagulants|mesh-ancestor
56641288|NCT02701608|Levofloxacin|levofloxacin|mesh-list
56641289|NCT02701608|Ofloxacin|ofloxacin|mesh-list
56641290|NCT02701608|Rifampin|rifampin|mesh-list
56641291|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
56641292|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56641293|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641294|NCT02701608|Renal Agents|renal agents|mesh-ancestor
56641295|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56641296|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56641297|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56641298|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641299|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641300|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641301|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56641302|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56641303|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56641304|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
56641305|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
56641306|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56641307|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56485656|NCT00551343|Incretins|incretins|mesh-ancestor
56582832|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582833|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56582834|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56582835|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56582836|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56582837|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56582838|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
56582839|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
56582840|NCT02615080|Pemirolast|pemirolast|mesh-list
56582841|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
56582842|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
56582843|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56118187|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
56582871|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
56582872|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582873|NCT00799903|Darapladib|darapladib|mesh-list
56582874|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56582875|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582876|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582877|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
56582878|NCT01075256|Calcium|calcium|mesh-list
56641308|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56641309|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56641310|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56641311|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56641312|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56641313|NCT00635960|Hormones|hormones|mesh-list
56641314|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56641315|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641316|NCT05429294|Paclitaxel|paclitaxel|mesh-list
56641317|NCT05429294|Trastuzumab|trastuzumab|mesh-list
56641318|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641319|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641320|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641321|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641322|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
56641323|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287241|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
56287315|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
56641324|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641325|NCT04219046|Naloxegol|naloxegol|mesh-list
56641326|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56641327|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641328|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
56641329|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641330|NCT00912509|Riboflavin|riboflavin|mesh-list
56641331|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
56641332|NCT00912509|Vitamins|vitamins|mesh-ancestor
56641333|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
56641334|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641335|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56641336|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
56641337|NCT02873598|Gemcitabine|gemcitabine|mesh-list
56641338|NCT02873598|Paclitaxel|paclitaxel|mesh-list
56641339|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56641340|NCT02873598|Folfirinox|folfirinox|mesh-list
56641341|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56582879|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56582880|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582881|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56641342|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641343|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641344|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641345|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
56641346|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641347|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56641348|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
56641349|NCT02873598|Antiviral Agents|antiviral agents|mesh-ancestor
56641350|NCT02873598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641351|NCT02873598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641352|NCT02873598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56641353|NCT02873598|Immunologic Factors|immunologic factors|mesh-ancestor
56641354|NCT02873598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641355|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56641356|NCT02749994|Ezetimibe|ezetimibe|mesh-list
56641357|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56641358|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56641359|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
56641360|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641361|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56641362|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56641363|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641364|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
56641365|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56641366|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641367|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641389|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56641390|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
56641391|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56641392|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
56641393|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
56641394|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
56287343|NCT00000789|Zidovudine|zidovudine|mesh-list
56641395|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56641396|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
56641397|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
56641398|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56641399|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641400|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641401|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
56641402|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56641403|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641404|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641406|NCT05323422|Analgesics|analgesics|mesh-ancestor
56641407|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
56641408|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641409|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641410|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56641411|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56641412|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
56641413|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
56641438|NCT00636038|Protective Agents|protective agents|mesh-ancestor
56641439|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641440|NCT00636038|Provitamins|provitamins|mesh-ancestor
56641441|NCT00636038|Vitamins|vitamins|mesh-ancestor
56641442|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
56641443|NCT04723004|Bevacizumab|bevacizumab|mesh-list
56641444|NCT04723004|Sorafenib|sorafenib|mesh-list
56641445|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641446|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641447|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56641448|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56641449|NCT04723004|Growth Substances|growth substances|mesh-ancestor
56641450|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641451|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
56641452|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641453|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641454|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641455|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
56641456|NCT04213716|Calcium|calcium|mesh-list
56641457|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56641458|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641459|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56641460|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
56641461|NCT04218890|Thromboplastin|thromboplastin|mesh-list
56641462|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56641463|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56641464|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641465|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
56641466|NCT04218890|Coagulants|coagulants|mesh-ancestor
56641467|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
56641468|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56641469|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
56641470|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287389|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
56641471|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56641472|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
56582882|NCT02876432|Diclofenac|diclofenac|mesh-list
56582883|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56582884|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56582885|NCT02876432|Analgesics|analgesics|mesh-ancestor
56582886|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
56641473|NCT00636116|Antivenins|antivenins|mesh-list
56641474|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
56641475|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641476|NCT04772196|Vitamin D|vitamin d|mesh-list
56641477|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
56641478|NCT04772196|Vitamins|vitamins|mesh-ancestor
56641479|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
56641480|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641481|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56641482|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56641483|NCT05428670|Rituximab|rituximab|mesh-list
56641484|NCT05428670|Lenalidomide|lenalidomide|mesh-list
56641485|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
56641486|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641487|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641488|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
56641489|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485861|NCT01211665|Hormones|hormones|mesh-ancestor
56582887|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582888|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582889|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56582890|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582928|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582929|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582930|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56582931|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
56582932|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582933|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582934|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56582935|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
56582936|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
56582937|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
56582938|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56582939|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56582940|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56582941|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582942|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56582943|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56582945|NCT04028323|Terlipressin|terlipressin|mesh-list
56582946|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56582947|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56582948|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582949|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56582950|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56582951|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
56582952|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56582953|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582954|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582955|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56582956|NCT02607163|Analgesics|analgesics|mesh-ancestor
56118297|NCT00004067|Paclitaxel|paclitaxel|mesh-list
56582983|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582984|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56582985|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582986|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
56582987|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582988|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56582989|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56641490|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56641491|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56641492|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56641493|NCT05428670|Growth Substances|growth substances|mesh-ancestor
56641494|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
56641495|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641496|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641497|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641498|NCT00635726|Gemcitabine|gemcitabine|mesh-list
56641499|NCT00635726|Cisplatin|cisplatin|mesh-list
56641500|NCT00635726|Doxorubicin|doxorubicin|mesh-list
56641501|NCT00635726|Methotrexate|methotrexate|mesh-list
56641502|NCT00635726|Vinblastine|vinblastine|mesh-list
56641503|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641504|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56641505|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
56641506|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641507|NCT00635726|Antiviral Agents|antiviral agents|mesh-ancestor
56641508|NCT00635726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641509|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641510|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56641511|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
56641512|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641513|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56641514|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56641541|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56641542|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56641543|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
56641544|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
56641545|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287462|NCT03729271|Rifaximin|rifaximin|mesh-list
56641546|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641547|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56641548|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
56641549|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56641550|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
56641551|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641552|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641553|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56641554|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
56641555|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
56641556|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
56641557|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
56641558|NCT04216706|Sympatholytics|sympatholytics|mesh-list
56641559|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56641560|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641561|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641562|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641563|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
56641564|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641565|NCT00913835|Doxorubicin|doxorubicin|mesh-list
56641566|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56641567|NCT00913835|Olaratumab|olaratumab|mesh-list
56641568|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56641569|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641570|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56641571|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56641572|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641573|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641574|NCT05322720|Paclitaxel|paclitaxel|mesh-list
56641575|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56641579|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641580|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
56641581|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641582|NCT04213170|Bevacizumab|bevacizumab|mesh-list
56641583|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641584|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641585|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56641586|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56641587|NCT04213170|Growth Substances|growth substances|mesh-ancestor
56641588|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641589|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
56641590|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
56641591|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56641592|NCT05322564|Narcotics|narcotics|mesh-ancestor
56641593|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641594|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641595|NCT05322564|Analgesics|analgesics|mesh-ancestor
56641596|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
56641597|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641598|NCT02749136|Gemcitabine|gemcitabine|mesh-list
56641599|NCT02749136|Folfirinox|folfirinox|mesh-list
56641600|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56641601|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
56641602|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641603|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641604|NCT02749136|Antiviral Agents|antiviral agents|mesh-ancestor
56287544|NCT00000831|Lamivudine|lamivudine|mesh-list
56641627|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56641628|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56641629|NCT04218500|Niacinamide|niacinamide|mesh-list
56641631|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
56641632|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
56641633|NCT04218500|Vitamins|vitamins|mesh-ancestor
56641634|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
56641635|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641636|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56641637|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
56641638|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641639|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56641640|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
56641641|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56641642|NCT04264208|Bombesin|bombesin|mesh-list
56641643|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56641644|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641645|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641646|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641647|NCT05412056|Metformin|metformin|mesh-list
56641648|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56641649|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641650|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
56641651|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56641652|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641653|NCT04710030|Valacyclovir|valacyclovir|mesh-list
56641654|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
56641655|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641656|NCT04216628|Oxytocin|oxytocin|mesh-list
56641657|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
56641658|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56641659|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641660|NCT05411978|Ubiquinone|ubiquinone|mesh-list
56641661|NCT05411978|Idebenone|idebenone|mesh-list
56641662|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
56641673|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641674|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
56641675|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641676|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56641677|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
56641678|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641679|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56641680|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56641681|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
56641682|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56641683|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56641684|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56641685|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56641686|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641687|NCT02699658|Levofloxacin|levofloxacin|mesh-list
56641688|NCT02699658|Ofloxacin|ofloxacin|mesh-list
56641689|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56641690|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641691|NCT02699658|Renal Agents|renal agents|mesh-ancestor
56641692|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56641693|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56641694|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56641695|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641696|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641697|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641698|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56582990|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
56582991|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582992|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
56582993|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56582994|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56582995|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
56582996|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
56582997|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582998|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582999|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
56583000|NCT03076021|Isotretinoin|isotretinoin|mesh-list
56583001|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
56583002|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
56583003|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56118346|NCT00004097|Antiviral Agents|antiviral agents|mesh-ancestor
56583026|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
56583027|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56583028|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583029|NCT01071512|Natalizumab|natalizumab|mesh-list
56583030|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
56583031|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583032|NCT00626834|Vigabatrin|vigabatrin|mesh-list
56583033|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
56641699|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56641701|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56641702|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641703|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56641704|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56641705|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
56641706|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641707|NCT04496063|Ustekinumab|ustekinumab|mesh-list
56641708|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
56641709|NCT04032626|Lenalidomide|lenalidomide|mesh-list
56641710|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
56641711|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641712|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56641713|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56641714|NCT04032626|Growth Substances|growth substances|mesh-ancestor
56641715|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
56641716|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641717|NCT04214106|Thiamine|thiamine|mesh-list
56641718|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
56641719|NCT04214106|Vitamins|vitamins|mesh-ancestor
56641720|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
56641721|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641722|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56641723|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641724|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56641725|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
56641726|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641727|NCT02695862|Terlipressin|terlipressin|mesh-list
56641748|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641749|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
56641750|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641751|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56641752|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56641753|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56641754|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56641755|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56641756|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56641757|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56641758|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56641759|NCT03355157|Tamoxifen|tamoxifen|mesh-list
56641760|NCT03355157|Paclitaxel|paclitaxel|mesh-list
56641761|NCT03355157|Vinorelbine|vinorelbine|mesh-list
56641762|NCT03355157|Capecitabine|capecitabine|mesh-list
56641763|NCT03355157|Letrozole|letrozole|mesh-list
56641764|NCT03355157|Epirubicin|epirubicin|mesh-list
56641765|NCT03355157|Fulvestrant|fulvestrant|mesh-list
56641766|NCT03355157|Palbociclib|palbociclib|mesh-list
56641767|NCT03355157|Exemestane|exemestane|mesh-list
56641768|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641769|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583034|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583035|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583036|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
56583037|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583038|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583039|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
56583040|NCT04255992|Vitamin D|vitamin d|mesh-list
56583041|NCT04255992|Calcium|calcium|mesh-list
56583042|NCT04255992|Vitamins|vitamins|mesh-ancestor
56583043|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
56583044|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583045|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56583046|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56583048|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56583049|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
56583050|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583051|NCT00610350|Simendan|simendan|mesh-list
56583052|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56583053|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
56583054|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56583055|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56583056|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583084|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56583086|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56583087|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
56583088|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583089|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583090|NCT00857896|Fesoterodine|fesoterodine|mesh-list
56583091|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56583092|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56583093|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
56583094|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583095|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641770|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641771|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641772|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
56287695|NCT00000891|Didanosine|didanosine|mesh-list
56641773|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641774|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56641775|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
56641776|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56641777|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56641778|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641779|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56641780|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
56641781|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56641782|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641783|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56641784|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56641785|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56641786|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56641787|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56641788|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56641789|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56641790|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56641791|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56641792|NCT04215432|Propolis|propolis|mesh-list
56641793|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641794|NCT03324035|Tramadol|tramadol|mesh-list
56641795|NCT03324035|Amitriptyline|amitriptyline|mesh-list
56641796|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56641797|NCT03324035|Narcotics|narcotics|mesh-ancestor
56641798|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641799|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641800|NCT03324035|Analgesics|analgesics|mesh-ancestor
56641801|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
56641802|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641803|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56641804|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
56583096|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641805|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56641806|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56641807|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56641808|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56641809|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641810|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641811|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
56641812|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641813|NCT00616746|Ethanol|ethanol|mesh-list
56641814|NCT00616746|Nicotine|nicotine|mesh-list
56641815|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56641816|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
56641817|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641818|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641819|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56641820|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56641821|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
56641822|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641823|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641824|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56641825|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641826|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641827|NCT00777582|Olaparib|olaparib|mesh-list
56641828|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56641829|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641830|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641837|NCT04677504|Gemcitabine|gemcitabine|mesh-list
56641851|NCT04677504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56641852|NCT04677504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641853|NCT04677504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56641854|NCT04677504|Immunologic Factors|immunologic factors|mesh-ancestor
56641855|NCT05271578|Nicotine|nicotine|mesh-list
56641856|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56641857|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
56641858|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641859|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641860|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56641861|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56641862|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
56641863|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641864|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641865|NCT04203485|Paclitaxel|paclitaxel|mesh-list
56641866|NCT04203485|Carboplatin|carboplatin|mesh-list
56641867|NCT04203485|Pemetrexed|pemetrexed|mesh-list
56641868|NCT04203485|Apatinib|apatinib|mesh-list
56641869|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641870|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641871|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
56641872|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
56641873|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
56641874|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641875|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641876|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56641902|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56641903|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
56641904|NCT03851627|Testosterone|testosterone|mesh-list
56641905|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
56641906|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
56641907|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56641908|NCT03851627|Androgens|androgens|mesh-ancestor
56641909|NCT03851627|Hormones|hormones|mesh-ancestor
56641910|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56641911|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641912|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56641913|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641914|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
56641915|NCT03116126|Guanfacine|guanfacine|mesh-list
56641916|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56641917|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56641918|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56641919|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56641920|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
56641921|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641922|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583097|NCT00857896|Urological Agents|urological agents|mesh-ancestor
56583098|NCT05652673|Nivolumab|nivolumab|mesh-list
56583099|NCT05652673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583100|NCT05652673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118448|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
56583123|NCT02618668|Ketamine|ketamine|mesh-list
56583124|NCT02618668|Propofol|propofol|mesh-list
56583125|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583126|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583127|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583128|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56583129|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
56583130|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
56583131|NCT02618668|Analgesics|analgesics|mesh-ancestor
56583132|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
56583133|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583134|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56583135|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56583136|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56583137|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583138|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583139|NCT01074944|Eliglustat|eliglustat|mesh-list
56583140|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583141|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583142|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
56583143|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583144|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56583145|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56583146|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583147|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583169|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56583170|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56641923|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641924|NCT02983682|Lidocaine|lidocaine|mesh-list
56641925|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
56641926|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
56641927|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56641928|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641929|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
56641930|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641931|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56641932|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56641933|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56641934|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641935|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641936|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56641937|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
56641938|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56641939|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56641940|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641941|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641942|NCT04217798|Etoposide|etoposide|mesh-list
56641943|NCT04217798|Niraparib|niraparib|mesh-list
56641944|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56641945|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56641946|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56641947|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56641948|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56641949|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641950|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56641951|NCT02742038|Fluorides|fluorides|mesh-list
56641952|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
56641953|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
56641954|NCT02742038|Protective Agents|protective agents|mesh-ancestor
56641963|NCT02746250|Analgesics|analgesics|mesh-ancestor
56641964|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
56641965|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56641966|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641967|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56641968|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56641969|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56641970|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56641971|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
56641972|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56641973|NCT02741960|Metformin|metformin|mesh-list
56641974|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56641975|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641976|NCT00910091|Megestrol|megestrol|mesh-list
56641977|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
56641978|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56641979|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56641980|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56641981|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
56641982|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56641983|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56641984|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56641985|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56641986|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56641987|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642012|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642013|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642014|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56642015|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
56642016|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56642017|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56642018|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56642019|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56642020|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56642021|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56642022|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
56642023|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56642024|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642025|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
56642026|NCT00911807|Donepezil|donepezil|mesh-list
56642027|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56642028|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642029|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642030|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
56642031|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642032|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642033|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
56642062|NCT03812588|Citalopram|citalopram|mesh-list
56642063|NCT03812588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56642064|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56642065|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56642066|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642067|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642068|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
56642069|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642070|NCT03812588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56642071|NCT03812588|Antidepressive Agents|antidepressive agents|mesh-ancestor
56642072|NCT03812588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56642073|NCT02387099|Everolimus|everolimus|mesh-list
56642074|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642075|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642076|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
56642077|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642078|NCT02745860|Selexipag|selexipag|mesh-list
56642079|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56642080|NCT04788641|Cyclosporine|cyclosporine|mesh-list
56642081|NCT04788641|Tacrolimus|tacrolimus|mesh-list
56642082|NCT04788641|Cyclosporins|cyclosporins|mesh-list
56642083|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642084|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
56642085|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642086|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56642087|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642088|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642089|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
56642090|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642091|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
56642092|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56642093|NCT04331288|Ethanol|ethanol|mesh-list
56642094|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56642095|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642098|NCT02745470|Lixisenatide|lixisenatide|mesh-list
56642103|NCT02741414|Metronidazole|metronidazole|mesh-list
56642104|NCT02741414|Clarithromycin|clarithromycin|mesh-list
56642105|NCT02741414|Levofloxacin|levofloxacin|mesh-list
56642106|NCT02741414|Ofloxacin|ofloxacin|mesh-list
56642107|NCT02741414|Tetracycline|tetracycline|mesh-list
56642108|NCT02741414|Furazolidone|furazolidone|mesh-list
56642109|NCT02741414|Esomeprazole|esomeprazole|mesh-list
56642110|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642111|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56642112|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56642113|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56642114|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642115|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56642116|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642117|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642118|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56642119|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56642120|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56642121|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56642122|NCT02741414|Renal Agents|renal agents|mesh-ancestor
56642123|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56642124|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56642125|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642126|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56642127|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56642133|NCT05629598|Epoetin Alfa|epoetin alfa|mesh-list
56642154|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642155|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642156|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56642157|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
56642158|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56642159|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56642160|NCT02736032|Progestins|progestins|mesh-ancestor
56642161|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
56642162|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56642163|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642164|NCT02744768|Dasatinib|dasatinib|mesh-list
56642165|NCT02744768|Blinatumomab|blinatumomab|mesh-list
56642166|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642167|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56642168|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642169|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642170|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
56642171|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56642172|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
56642173|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642174|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642175|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56642176|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
56642177|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56642178|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56642179|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56642180|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56642181|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642182|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642183|NCT04096391|Analgesics|analgesics|mesh-list
56642184|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
56642185|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642186|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642187|NCT02744378|Clobetasol|clobetasol|mesh-list
56583171|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56583172|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56583173|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56583174|NCT00857584|Sertraline|sertraline|mesh-list
56583175|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
56642188|NCT02744378|Tacrolimus|tacrolimus|mesh-list
56642189|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642190|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
56642191|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642192|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56642193|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642194|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642195|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642196|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
56642197|NCT02744378|Hormones|hormones|mesh-ancestor
56642198|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642199|NCT04318730|Apatinib|apatinib|mesh-list
56642200|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642201|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56642202|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642203|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642204|NCT00632333|Fluorouracil|fluorouracil|mesh-list
56642205|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642206|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
56642207|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642208|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56642209|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642210|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
56642211|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642212|NCT02744456|Losartan|losartan|mesh-list
56642213|NCT02744456|Amlodipine|amlodipine|mesh-list
56642214|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56642215|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56642216|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56642217|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56642218|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642219|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56642228|NCT02744222|Interferons|interferons|mesh-list
56642229|NCT02744222|Interferon-beta|interferon-beta|mesh-list
56642230|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
56642231|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642232|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
56642233|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642234|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
56642235|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642236|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56642237|NCT02741024|Artesunate|artesunate|mesh-list
56642238|NCT02741024|Lumefantrine|lumefantrine|mesh-list
56642239|NCT02741024|Artemether|artemether|mesh-list
56642240|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56642241|NCT02741024|Amodiaquine|amodiaquine|mesh-list
56642242|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
56642243|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56642244|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56642245|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642246|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642247|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
56642248|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
56642249|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56642250|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
56583176|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583177|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56583178|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56583179|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583180|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583181|NCT00857584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56583182|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56583183|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56583184|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583185|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583186|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
56583187|NCT00798967|Teduglutide|teduglutide|mesh-list
56583188|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583189|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56583190|NCT00798967|Protective Agents|protective agents|mesh-ancestor
56583191|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583192|NCT04132102|Afatinib|afatinib|mesh-list
56583193|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583194|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583195|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583196|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583197|NCT02618356|Raltitrexed|raltitrexed|mesh-list
56583198|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56583199|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
56583233|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583234|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583235|NCT00798889|Sunitinib|sunitinib|mesh-list
56583236|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583237|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56583238|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56583259|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583260|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
56642251|NCT02735876|Rituximab|rituximab|mesh-list
56642252|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
56642253|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56642254|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642255|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
56642256|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642257|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56642258|NCT00910871|Bedaquiline|bedaquiline|mesh-list
56642259|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
56642260|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56642261|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642262|NCT04346654|Dexamethasone|dexamethasone|mesh-list
56642263|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642264|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
56642265|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
56642266|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642267|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642268|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642269|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
56642270|NCT04346654|Hormones|hormones|mesh-ancestor
56642271|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642272|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56642273|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642274|NCT04230707|Melatonin|melatonin|mesh-list
56642275|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
56642276|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642277|NCT04230707|Protective Agents|protective agents|mesh-ancestor
56642278|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642279|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642280|NCT03943667|Gemcitabine|gemcitabine|mesh-list
56642281|NCT03943667|Paclitaxel|paclitaxel|mesh-list
56642282|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56642294|NCT03943667|Immunologic Factors|immunologic factors|mesh-ancestor
56642295|NCT03943667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642296|NCT02735798|Trastuzumab|trastuzumab|mesh-list
56642297|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56642298|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642299|NCT02740712|Vitamin K|vitamin k|mesh-list
56642300|NCT02740712|Rucaparib|rucaparib|mesh-list
56642301|NCT02740712|Digoxin|digoxin|mesh-list
56642302|NCT02740712|Midazolam|midazolam|mesh-list
56642303|NCT02740712|Caffeine|caffeine|mesh-list
56642304|NCT02740712|Omeprazole|omeprazole|mesh-list
56642305|NCT02740712|Warfarin|warfarin|mesh-list
56642306|NCT02740712|Vitamins|vitamins|mesh-ancestor
56642307|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
56642308|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642309|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56642310|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56642311|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642312|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56642313|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56642314|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56642315|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56642316|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
56642317|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
56642318|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
56642319|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
56642320|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642321|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642322|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
56642323|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56642324|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56642325|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642328|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
56642342|NCT03760718|Procaine|procaine|mesh-list
56642343|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
56642344|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
56642345|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642346|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642347|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
56642348|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642349|NCT05590286|Amoxicillin|amoxicillin|mesh-list
56642350|NCT05590286|Esomeprazole|esomeprazole|mesh-list
56642351|NCT05590286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56642352|NCT05590286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642353|NCT05590286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56642354|NCT05590286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642355|NCT05590286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56642356|NCT05590286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642357|NCT05590286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642358|NCT05580029|Triamcinolone|triamcinolone|mesh-list
56642359|NCT05580029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642360|NCT05580029|Glucocorticoids|glucocorticoids|mesh-ancestor
56642361|NCT05580029|Hormones|hormones|mesh-ancestor
56642362|NCT05580029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642363|NCT05580029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642364|NCT03724994|Gemcitabine|gemcitabine|mesh-list
56642365|NCT03724994|Paclitaxel|paclitaxel|mesh-list
56642366|NCT03724994|Fluorouracil|fluorouracil|mesh-list
56642367|NCT03724994|Folfirinox|folfirinox|mesh-list
56642368|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56642369|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642370|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
56642371|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
56642372|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
56642373|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642374|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56642375|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
56642376|NCT03724994|Antiviral Agents|antiviral agents|mesh-ancestor
56642377|NCT03724994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642378|NCT03724994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642379|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642381|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642382|NCT02735330|Ethanol|ethanol|mesh-list
56642383|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56642384|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642385|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642386|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642387|NCT02631941|Budesonide|budesonide|mesh-list
56642388|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
56486654|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
56583261|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583262|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583263|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583264|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
56583265|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
56583266|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583267|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583268|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583269|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
56583270|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56583271|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583272|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583273|NCT00914797|Terbutaline|terbutaline|mesh-list
56583274|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56583275|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
56583276|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583277|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583278|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56583279|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
56583280|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
56583281|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
56583282|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56583283|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56583284|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56583285|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56583286|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
56583287|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583288|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583289|NCT00798655|Cisplatin|cisplatin|mesh-list
56583290|NCT00798655|Panitumumab|panitumumab|mesh-list
56583291|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583292|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583319|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
56583320|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583321|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583322|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56583323|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
56583324|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56583325|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583326|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56583327|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56583328|NCT00856492|Growth Substances|growth substances|mesh-ancestor
56583329|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
56583330|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56583331|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56583332|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56583333|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583334|NCT04111159|Propofol|propofol|mesh-list
56583335|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583336|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583337|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583338|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56583339|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
56583340|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
56583341|NCT00697372|Sirolimus|sirolimus|mesh-list
56583342|NCT00697372|Everolimus|everolimus|mesh-list
56583364|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
56642389|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56642390|NCT02631941|Charcoal|charcoal|mesh-list
56642391|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642392|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56642393|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
56642394|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642395|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642396|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56642397|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
56642398|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
56642399|NCT02631941|Hormones|hormones|mesh-ancestor
56642400|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642401|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56642402|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56642403|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56642404|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
56642405|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642406|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642407|NCT02631941|Antidotes|antidotes|mesh-ancestor
56642408|NCT02631941|Protective Agents|protective agents|mesh-ancestor
56642409|NCT02690987|Exenatide|exenatide|mesh-list
56642410|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56642411|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642412|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56642413|NCT02690987|Incretins|incretins|mesh-ancestor
56642414|NCT02690987|Hormones|hormones|mesh-ancestor
56642415|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642416|NCT02740166|Propranolol|propranolol|mesh-list
56642417|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56642418|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56583365|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583366|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583367|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56583368|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583369|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56583370|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56583371|NCT00856180|Growth Substances|growth substances|mesh-ancestor
56583372|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
56583374|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56583375|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583376|NCT00900627|Paclitaxel|paclitaxel|mesh-list
56583377|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56583378|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583379|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
56642419|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
56642420|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642421|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642422|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642423|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56642424|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56642425|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
56642426|NCT02735018|Epinephrine|epinephrine|mesh-list
56642427|NCT02735018|Racepinephrine|racepinephrine|mesh-list
56642428|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
56642429|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56583380|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
56583381|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
56583382|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583383|NCT05624281|Nintedanib|nintedanib|mesh-list
56583384|NCT05624281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583385|NCT05624281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583386|NCT05624281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583387|NCT05624281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583388|NCT00866320|Sorafenib|sorafenib|mesh-list
56583389|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583390|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56016944|NCT03886649|Venetoclax|venetoclax|mesh-list
56583391|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583392|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583393|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
56118748|NCT00003353|Melphalan|melphalan|mesh-list
56583422|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583423|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583424|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56583425|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
56583426|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583427|NCT00914953|Oxytocin|oxytocin|mesh-list
56583428|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
56583429|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56583430|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583431|NCT00869518|Trimethoprim|trimethoprim|mesh-list
56583432|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56583433|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
56583434|NCT00869518|Rifabutin|rifabutin|mesh-list
56583435|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56583436|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583437|NCT00869518|Renal Agents|renal agents|mesh-ancestor
56583438|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
56583439|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56583440|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56583471|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
56583472|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583473|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
56583474|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583475|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56583476|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
56583477|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583478|NCT02841579|Osimertinib|osimertinib|mesh-list
56583479|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583480|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583481|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583482|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583483|NCT00588445|Gefitinib|gefitinib|mesh-list
56583484|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583485|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583514|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583515|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56583517|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
56583518|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
56642430|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56642431|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
56642432|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642433|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642434|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642435|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56642436|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56642437|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
56642438|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642439|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56642440|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
56642441|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
56642442|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
56642443|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56642444|NCT00908375|Pregabalin|pregabalin|mesh-list
56642445|NCT00908375|Analgesics|analgesics|mesh-ancestor
56642446|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
56642447|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642448|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642449|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
56547619|NCT00645073|Levofloxacin|levofloxacin|mesh-list
56642450|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56642451|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56486848|NCT01230814|Miconazole|miconazole|mesh-list
56583519|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583520|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583521|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583522|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56583523|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56583524|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583525|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583526|NCT00699946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56583527|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56583528|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56583529|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583555|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583556|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56583557|NCT00854620|Sorafenib|sorafenib|mesh-list
56583558|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583559|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583560|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583561|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583562|NCT00793585|Allopurinol|allopurinol|mesh-list
56583563|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
56583564|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583565|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583566|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
56583567|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583568|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56583569|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
56583570|NCT00793585|Protective Agents|protective agents|mesh-ancestor
56642452|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642453|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56642454|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56642455|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56642456|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642457|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56642458|NCT04247867|Psyllium|psyllium|mesh-list
56642459|NCT04247867|Cathartics|cathartics|mesh-ancestor
56642460|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642461|NCT02731664|Glucagon|glucagon|mesh-list
56642462|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56642463|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642464|NCT02731664|Hormones|hormones|mesh-ancestor
56486878|NCT00556634|Efavirenz|efavirenz|mesh-list
56583571|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583572|NCT02013141|Telavancin|telavancin|mesh-list
56583573|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56583574|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583575|NCT04107103|Nivolumab|nivolumab|mesh-list
56583576|NCT04107103|Pemetrexed|pemetrexed|mesh-list
56583577|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583578|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583579|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56118934|NCT00004925|Doxorubicin|doxorubicin|mesh-list
56583604|NCT02614612|Prednisone|prednisone|mesh-list
56583605|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
56583606|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56583607|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56583608|NCT02614612|Prednisolone|prednisolone|mesh-list
56583609|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
56583610|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56583611|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
56583612|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583613|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
56583614|NCT02614612|Hormones|hormones|mesh-ancestor
56583615|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583616|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583617|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56583618|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583619|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
56583620|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
56583621|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583622|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583623|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56583624|NCT02614612|Protective Agents|protective agents|mesh-ancestor
56583625|NCT00900159|Eszopiclone|eszopiclone|mesh-list
56583626|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583627|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583628|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583629|NCT01689909|Zolpidem|zolpidem|mesh-list
56583630|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56583652|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56583653|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
56583654|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583655|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56583656|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56583657|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583658|NCT00895245|Dexamethasone|dexamethasone|mesh-list
56583659|NCT00895245|Palonosetron|palonosetron|mesh-list
56583660|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
56583661|NCT00895245|Aprepitant|aprepitant|mesh-list
56583662|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583663|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
56583664|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
56071636|NCT02403830|Ticagrelor|ticagrelor|mesh-list
56642465|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642466|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642467|NCT02731664|Incretins|incretins|mesh-ancestor
56642468|NCT02543255|Prednisone|prednisone|mesh-list
56642469|NCT02543255|Leuprolide|leuprolide|mesh-list
56642470|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
56642471|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642472|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
56642473|NCT02543255|Hormones|hormones|mesh-ancestor
56642474|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642475|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642476|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56642477|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642478|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56642479|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
56642480|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56642481|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56642482|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642483|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642484|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
56583665|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583666|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583667|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583668|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
56583669|NCT00895245|Hormones|hormones|mesh-ancestor
56583670|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583671|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56583672|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583673|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56583674|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56583675|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
56583676|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583677|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583678|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56583679|NCT03172377|Adalimumab|adalimumab|mesh-list
56583680|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583704|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56583705|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
56583706|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583707|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583708|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583710|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56583711|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583712|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
56583713|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
56583714|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
56583715|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332244|NCT00057798|Gemcitabine|gemcitabine|mesh-list
56583716|NCT04110535|Midazolam|midazolam|mesh-list
56583717|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56583718|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583719|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642485|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56642486|NCT02695004|Donepezil|donepezil|mesh-list
56642487|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56642488|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642489|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642490|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
56642491|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642492|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642493|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
56642494|NCT00909389|Simvastatin|simvastatin|mesh-list
56642495|NCT00909389|Ezetimibe|ezetimibe|mesh-list
56583720|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583721|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56583722|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56583723|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583724|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56583725|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
56583726|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
56583727|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
56583728|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
56583729|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583730|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583731|NCT04025203|Ibuprofen|ibuprofen|mesh-list
56583732|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
56583733|NCT04025203|Gabapentin|gabapentin|mesh-list
56119086|NCT00005051|Paclitaxel|paclitaxel|mesh-list
56583759|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017300|NCT01791374|Rilotumumab|rilotumumab|mesh-list
56583761|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583762|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
56583763|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583764|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56583765|NCT00899847|Acetaminophen|acetaminophen|mesh-list
56583766|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
56583767|NCT00899847|Promethazine|promethazine|mesh-list
56583768|NCT00899847|Cyclosporine|cyclosporine|mesh-list
56583769|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
56583770|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
56583771|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56583772|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
56583773|NCT00899847|Melphalan|melphalan|mesh-list
56583774|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
56583775|NCT00899847|Cyclosporins|cyclosporins|mesh-list
56583776|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
56583777|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56583778|NCT00899847|Lenograstim|lenograstim|mesh-list
56583779|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56583780|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
56583781|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583782|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583783|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56583784|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
56583817|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
56583818|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
56583819|NCT00899847|Hormones|hormones|mesh-ancestor
56583820|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583821|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56583822|NCT00899847|Protective Agents|protective agents|mesh-ancestor
56583823|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56583824|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56583825|NCT00529113|Gemcitabine|gemcitabine|mesh-list
56583826|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56583827|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
56583828|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583829|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583853|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56583854|NCT04117750|Antacids|antacids|mesh-ancestor
56583855|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642496|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56642497|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56642498|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56642499|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
56642500|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642501|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56642502|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56642503|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642504|NCT00910715|Doxycycline|doxycycline|mesh-list
56642505|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56642506|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642507|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
56642508|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56642509|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56642510|NCT02731430|Morphine|morphine|mesh-list
56642511|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56642512|NCT02731430|Narcotics|narcotics|mesh-ancestor
56583856|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583857|NCT04131322|Adalimumab|adalimumab|mesh-list
56583858|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56583859|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583860|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583861|NCT02840175|Adalimumab|adalimumab|mesh-list
56583862|NCT02840175|Etanercept|etanercept|mesh-list
56583863|NCT02840175|Abatacept|abatacept|mesh-list
56583864|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583865|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583866|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56583867|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56583868|NCT02840175|Analgesics|analgesics|mesh-ancestor
56583869|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
56583870|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583871|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583872|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583873|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56583874|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
56583875|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56583876|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583877|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583878|NCT02603497|Peficitinib|peficitinib|mesh-list
56583879|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583880|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583881|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56583882|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
56583883|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583884|NCT02840409|Bevacizumab|bevacizumab|mesh-list
56583885|NCT02840409|Vinblastine|vinblastine|mesh-list
56583923|NCT02839785|Ibuprofen|ibuprofen|mesh-list
56583924|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56583925|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56583926|NCT02839785|Analgesics|analgesics|mesh-ancestor
56583927|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
56583928|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583929|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583930|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583931|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583932|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56583933|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583934|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642513|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642514|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642515|NCT02731430|Analgesics|analgesics|mesh-ancestor
56642516|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
56642517|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642518|NCT04232969|Exenatide|exenatide|mesh-list
56642519|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56642520|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642521|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56547620|NCT00645073|Ofloxacin|ofloxacin|mesh-list
56642522|NCT04232969|Incretins|incretins|mesh-ancestor
56642523|NCT04232969|Hormones|hormones|mesh-ancestor
56923630|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642524|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642525|NCT03364868|Insulin|insulin|mesh-list
56583935|NCT02843061|Rituximab|rituximab|mesh-list
56583936|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583937|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583938|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
56583939|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583940|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583941|NCT04551495|Letrozole|letrozole|mesh-list
56583942|NCT04551495|Goserelin|goserelin|mesh-list
56583943|NCT04551495|Entrectinib|entrectinib|mesh-list
56332465|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56583944|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583945|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56583946|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56583947|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583948|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583949|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56583950|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
56583951|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583952|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583953|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56583954|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583955|NCT02839239|Vitamin D|vitamin d|mesh-list
56583956|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
56583957|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
56583958|NCT02839239|Vitamins|vitamins|mesh-list
56583959|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
56583960|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583961|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56583962|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56583963|NCT02837835|Ceftazidime|ceftazidime|mesh-list
56583964|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56583965|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119308|NCT00005585|Hormones|hormones|mesh-ancestor
56584023|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584025|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56584026|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584027|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56584028|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584029|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584030|NCT00610584|Cetirizine|cetirizine|mesh-list
56584031|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56584032|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56584033|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56584034|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
56584035|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
56071637|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56642526|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56642527|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642528|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
56642529|NCT03695510|Afatinib|afatinib|mesh-list
56642530|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56642531|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642532|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56642533|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642534|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642535|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
56642536|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
56642537|NCT02731040|Diphosphonates|diphosphonates|mesh-list
56642538|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
56642539|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56642540|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642541|NCT05501600|Lidocaine|lidocaine|mesh-list
56642542|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
56642543|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
56487185|NCT04662125|Analgesics|analgesics|mesh-ancestor
56584036|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584037|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584038|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584039|NCT00894543|Citalopram|citalopram|mesh-list
56584040|NCT00894543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56584041|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56158500|NCT03737604|Bupivacaine|bupivacaine|mesh-list
56584042|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56584043|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584045|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
56584080|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
56584081|NCT04988256|Hormones|hormones|mesh-ancestor
56584082|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119447|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584111|NCT04260516|Expectorants|expectorants|mesh-ancestor
56584112|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
56584113|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56584114|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
56584115|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584116|NCT04260516|Protective Agents|protective agents|mesh-ancestor
56584117|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584118|NCT04260516|Antidotes|antidotes|mesh-ancestor
56584119|NCT00921024|Ceftazidime|ceftazidime|mesh-list
56584120|NCT00921024|Ceftolozane|ceftolozane|mesh-list
56584121|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56584122|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584124|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56584125|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
56584126|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584127|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584128|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56584129|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
56584130|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
56584131|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56584132|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584133|NCT00700492|Progesterone|progesterone|mesh-list
56584134|NCT00700492|Progestins|progestins|mesh-ancestor
56584135|NCT00700492|Hormones|hormones|mesh-ancestor
56584136|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642544|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642545|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642546|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
56642547|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642548|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56642549|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56642550|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56642551|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56584137|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584138|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
56584139|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56584140|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584141|NCT00703300|Bortezomib|bortezomib|mesh-list
56584142|NCT00703300|Decitabine|decitabine|mesh-list
56584143|NCT00703300|Azacitidine|azacitidine|mesh-list
56584144|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584145|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56584146|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
56119491|NCT00386399|Mitomycin|mitomycin|mesh-list
56584171|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
56584172|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584173|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56584174|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56584175|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
56584176|NCT02613052|Propofol|propofol|mesh-list
56584177|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56584178|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56584179|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584180|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56584181|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
56584182|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
56584183|NCT01073930|Bisacodyl|bisacodyl|mesh-list
56584184|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
56584185|NCT01073930|Cathartics|cathartics|mesh-ancestor
56584186|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584187|NCT01073930|Laxatives|laxatives|mesh-ancestor
56584188|NCT01073618|Voriconazole|voriconazole|mesh-list
56584189|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
56017750|NCT02352948|Durvalumab|durvalumab|mesh-list
56584190|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584191|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56584192|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56584193|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584194|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584195|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56584196|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
56119548|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584223|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56584224|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56584225|NCT00592072|Decanoic acid|decanoic acid|mesh-list
56584226|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
56584227|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584229|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56584230|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56584231|NCT00626288|Analgesics|analgesics|mesh-ancestor
56584232|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
56584233|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584234|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584235|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56584236|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584237|NCT00792571|Epoprostenol|epoprostenol|mesh-list
56584238|NCT00792571|Beraprost|beraprost|mesh-list
56584239|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56584240|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
56584241|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56584242|NCT00794365|Varenicline|varenicline|mesh-list
56584243|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56584305|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56642552|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642553|NCT02734160|Durvalumab|durvalumab|mesh-list
56642554|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56642555|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642556|NCT02730572|Methylphenidate|methylphenidate|mesh-list
56642557|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56642558|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642559|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56642560|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56642561|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56642562|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642563|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
56642564|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642565|NCT04225988|Tacrolimus|tacrolimus|mesh-list
56642566|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642567|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
56642568|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642569|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56642570|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642571|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642572|NCT02730026|Ketoprofen|ketoprofen|mesh-list
56642573|NCT02730026|Omeprazole|omeprazole|mesh-list
56584306|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56584307|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56584308|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56584309|NCT00793819|Silodosin|silodosin|mesh-list
56584310|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56584311|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56584312|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56584313|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
56584314|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584315|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584316|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584317|NCT00793819|Urological Agents|urological agents|mesh-ancestor
56584318|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56584319|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584321|NCT02836821|Rifampin|rifampin|mesh-list
56584322|NCT02836821|Apatinib|apatinib|mesh-list
56584323|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584324|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56584325|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584326|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584327|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56584328|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
56584329|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56584330|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584331|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
56584363|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56584364|NCT00892437|Cobicistat|cobicistat|mesh-list
56584365|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56584366|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56642574|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56642575|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642576|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56642577|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642578|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642579|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56642580|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56642581|NCT02730026|Analgesics|analgesics|mesh-ancestor
56642582|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
56642583|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642584|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642585|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642586|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56642587|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56642588|NCT02738918|Abatacept|abatacept|mesh-list
56642589|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56642590|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642591|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642592|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642593|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
56642594|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288531|NCT00009763|Paclitaxel|paclitaxel|mesh-list
56642595|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56642596|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
56642597|NCT03195374|Narcotics|narcotics|mesh-ancestor
56642598|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642599|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642600|NCT03195374|Analgesics|analgesics|mesh-ancestor
56642601|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
56642602|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642603|NCT02739386|Ipilimumab|ipilimumab|mesh-list
56642604|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56642605|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642614|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56642615|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56642616|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56642617|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
56642618|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
56642619|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
56642620|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
56642621|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642622|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642623|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56642624|NCT02729870|Laxatives|laxatives|mesh-ancestor
56642625|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642626|NCT05628662|Insulin|insulin|mesh-list
56642627|NCT05628662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56642628|NCT05628662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642629|NCT02694848|Aspirin|aspirin|mesh-list
56642630|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56584367|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584368|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584369|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
56584370|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584405|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584406|NCT05608837|Dexamethasone|dexamethasone|mesh-list
56017953|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56584408|NCT05608837|Antiemetics|antiemetics|mesh-ancestor
56584409|NCT05608837|Autonomic Agents|autonomic agents|mesh-ancestor
56584410|NCT05608837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584411|NCT05608837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584412|NCT05608837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584413|NCT05608837|Glucocorticoids|glucocorticoids|mesh-ancestor
56584414|NCT05608837|Hormones|hormones|mesh-ancestor
56584415|NCT05608837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584416|NCT05608837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56584417|NCT05608837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584418|NCT05304663|Lomustine|lomustine|mesh-list
56584419|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56584420|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
56584421|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584422|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584423|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
56584424|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56584425|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584426|NCT04248309|Progesterone|progesterone|mesh-list
56584427|NCT04248309|Progestins|progestins|mesh-ancestor
56584428|NCT04248309|Hormones|hormones|mesh-ancestor
56584429|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584430|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584431|NCT00892281|Doxycycline|doxycycline|mesh-list
56584432|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56584433|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584434|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
56584435|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56584436|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56584437|NCT02836353|Rifaximin|rifaximin|mesh-list
56584438|NCT02836353|Somatostatin|somatostatin|mesh-list
56584439|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56584458|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584460|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56584461|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051406|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56642631|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56642632|NCT02694848|Analgesics|analgesics|mesh-ancestor
56642633|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
56642634|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642635|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642636|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642637|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56642638|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56642639|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56642640|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642641|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56642642|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56642643|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642644|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
56642645|NCT02729324|Protective Agents|protective agents|mesh-list
56642646|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
56642647|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642648|NCT02733458|Gemcitabine|gemcitabine|mesh-list
56642649|NCT02733458|Dexamethasone|dexamethasone|mesh-list
56642650|NCT02733458|Etoposide|etoposide|mesh-list
56642651|NCT02733458|Pegaspargase|pegaspargase|mesh-list
56642652|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642653|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
56642654|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
56642655|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642656|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642657|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642658|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
56642659|NCT02733458|Hormones|hormones|mesh-ancestor
56642660|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642661|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56642662|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642663|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642664|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642665|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56642670|NCT02733458|Immunologic Factors|immunologic factors|mesh-ancestor
56642671|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56642672|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56642673|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56642674|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
56642675|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56642676|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642677|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56642678|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
56642679|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56642680|NCT02728856|Protective Agents|protective agents|mesh-ancestor
56642681|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642682|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
56642683|NCT02728934|Golimumab|golimumab|mesh-list
56642684|NCT02728934|Infliximab|infliximab|mesh-list
56642685|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
56642686|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642687|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56642688|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56642689|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642690|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642691|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
56642692|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642693|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
56642694|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
56642695|NCT04179500|Bedaquiline|bedaquiline|mesh-list
56642696|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56642697|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642698|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56642699|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56642700|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642715|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642716|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
56642717|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642718|NCT02728622|Tamoxifen|tamoxifen|mesh-list
56642719|NCT02728622|Paclitaxel|paclitaxel|mesh-list
56642720|NCT02728622|Doxorubicin|doxorubicin|mesh-list
56642721|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56642722|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56642723|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642724|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
56642725|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
56642726|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
56642727|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642728|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56642729|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56642730|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56642731|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642732|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56642733|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
56642734|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642735|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642736|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56642737|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56642738|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56642739|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56642740|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
56642741|NCT02728466|Procyanidin|procyanidin|mesh-list
56642742|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
56642743|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642744|NCT02728466|Protective Agents|protective agents|mesh-ancestor
56642745|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642746|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56642747|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56642748|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642749|NCT02733380|Thalidomide|thalidomide|mesh-list
56642750|NCT02733380|Dexamethasone|dexamethasone|mesh-list
56642754|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
56642755|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642756|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
56642757|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
56642758|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642759|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642760|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642761|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
56642762|NCT02733380|Hormones|hormones|mesh-ancestor
56642763|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642764|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56642765|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642766|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56642767|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56642768|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56642769|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642770|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642771|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56642772|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56642773|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56642774|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56642775|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642776|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
56642777|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
56642778|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56642779|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642780|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56642781|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56642782|NCT02733380|Growth Substances|growth substances|mesh-ancestor
56487551|NCT00541047|Leuprolide|leuprolide|mesh-list
56584462|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584463|NCT00784693|Tanezumab|tanezumab|mesh-list
56584464|NCT00784693|Analgesics|analgesics|mesh-ancestor
56584465|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
56584466|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584467|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584468|NCT00915811|Fludarabine|fludarabine|mesh-list
56584469|NCT00915811|Busulfan|busulfan|mesh-list
56584470|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
56584471|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56584472|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584473|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584474|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584475|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
56584476|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642783|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
56642784|NCT02733380|Analgesics|analgesics|mesh-ancestor
56642785|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
56642786|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56642787|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
56642788|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56642789|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
56642790|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642791|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56642792|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56642793|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56642794|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56642795|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642796|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
56642797|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
56642798|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
56642799|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642800|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642801|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
56642802|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642803|NCT00636584|Nitroprusside|nitroprusside|mesh-list
56642804|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56642805|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
56642806|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56642807|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642808|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
56642809|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56642810|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56642811|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
56642812|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642813|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642814|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642815|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
56642816|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
56642817|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487600|NCT00541125|Leucovorin|leucovorin|mesh-list
56584477|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
56584478|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56584479|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56642818|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
56642819|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56288756|NCT00010699|Vitamin E|vitamin e|mesh-list
56642820|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
56642821|NCT02732522|Misoprostol|misoprostol|mesh-list
56642822|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56642823|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
56642824|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56642825|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642826|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56642827|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642828|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
56642829|NCT02732678|Propranolol|propranolol|mesh-list
56642830|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56642831|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56642832|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
56642833|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642834|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642835|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642836|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56642837|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56642838|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
56642839|NCT02727608|Eculizumab|eculizumab|mesh-list
56642840|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56642841|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56642842|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
56642843|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642844|NCT02727296|Propofol|propofol|mesh-list
56642845|NCT02727296|Sevoflurane|sevoflurane|mesh-list
56642846|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56642847|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642848|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642849|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56642850|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
56642851|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
56642853|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56642859|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642860|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642861|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56642862|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
56642863|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
56642864|NCT02732132|Analgesics|analgesics|mesh-ancestor
56642865|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
56642866|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642867|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56642868|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56642869|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56642870|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642871|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642872|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56642873|NCT02732132|Narcotics|narcotics|mesh-ancestor
56642874|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56642875|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56642876|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56642877|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56642878|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
56642879|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
56642880|NCT02737202|Saracatinib|saracatinib|mesh-list
56642881|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642882|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56642883|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642884|NCT02721368|Lidocaine|lidocaine|mesh-list
56642885|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
56642886|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
56642887|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642888|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642904|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
56642905|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
56642906|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642907|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642908|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
56642909|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642911|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
56642912|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56642913|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642914|NCT02726984|Listerine|listerine|mesh-list
56642915|NCT02726984|Fluorides|fluorides|mesh-list
56642916|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
56642917|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
56642918|NCT02726984|Protective Agents|protective agents|mesh-ancestor
56642919|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642920|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56642921|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56642922|NCT02726828|Ketamine|ketamine|mesh-list
56642923|NCT02726828|Morphine|morphine|mesh-list
56642924|NCT02726828|Analgesics|analgesics|mesh-ancestor
56642925|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
56642926|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642927|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642928|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56642929|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56584480|NCT00892047|Aripiprazole|aripiprazole|mesh-list
56584481|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56584482|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
56584483|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56584484|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56584485|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56584486|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56584487|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584488|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
56584489|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
56584490|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584491|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584492|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56584493|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56584524|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584526|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584527|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56584528|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584529|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584530|NCT02838615|Dexamethasone|dexamethasone|mesh-list
56584531|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56584532|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
56584533|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
56584534|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584535|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119894|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
56642930|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
56642931|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
56642932|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642933|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56642934|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56642935|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56642936|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642937|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56642938|NCT02726828|Narcotics|narcotics|mesh-ancestor
56642939|NCT02799134|Dexamethasone|dexamethasone|mesh-list
56642940|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642941|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56642942|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
56642943|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
56642944|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642945|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642946|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
56642947|NCT02799134|Hormones|hormones|mesh-ancestor
56642948|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56642949|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56642950|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642951|NCT02720822|Morphine|morphine|mesh-list
56642952|NCT02720822|Laxatives|laxatives|mesh-list
56642953|NCT02720822|Cathartics|cathartics|mesh-list
56642954|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56642955|NCT02720822|Narcotics|narcotics|mesh-ancestor
56642956|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642957|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642958|NCT02720822|Analgesics|analgesics|mesh-ancestor
56642959|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
56642960|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642961|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56642962|NCT02757872|Vitamin D|vitamin d|mesh-list
56642963|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
56584568|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584569|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584570|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56584571|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
56584572|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584573|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584574|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56584575|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
56584576|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
56642964|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
56642965|NCT02757872|Vitamins|vitamins|mesh-list
56642966|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
56642967|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642968|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56642969|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56642970|NCT02746796|Capecitabine|capecitabine|mesh-list
56642971|NCT02746796|Tegafur|tegafur|mesh-list
56642972|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
56288906|NCT00005945|Cytarabine|cytarabine|mesh-list
56642973|NCT02746796|Nivolumab|nivolumab|mesh-list
56642974|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56642975|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
56642976|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642977|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56642978|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56642979|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56642981|NCT04167176|Bupivacaine|bupivacaine|mesh-list
56642982|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
56642983|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
56642984|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56642985|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642986|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
56642987|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56642988|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56642989|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56642990|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56642991|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56642992|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642993|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
56642994|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
56642995|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56642996|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
56642997|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
56642998|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56642999|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
56643000|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643002|NCT02726126|Fentanyl|fentanyl|mesh-list
56643003|NCT02726126|Melatonin|melatonin|mesh-list
56643004|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56643005|NCT02726126|Narcotics|narcotics|mesh-ancestor
56643006|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643007|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643008|NCT02726126|Analgesics|analgesics|mesh-ancestor
56643009|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
56643010|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643011|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56643012|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56643013|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
56643014|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
56643015|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
56643016|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643017|NCT02726126|Protective Agents|protective agents|mesh-ancestor
56643018|NCT02694458|Vancomycin|vancomycin|mesh-list
56643019|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56643020|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643021|NCT02719808|Tenofovir|tenofovir|mesh-list
56643022|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
56643023|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643024|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56643025|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56643026|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643027|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643028|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56643029|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56643030|NCT02719418|Tinzaparin|tinzaparin|mesh-list
56643031|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56643032|NCT02719418|Dalteparin|dalteparin|mesh-list
56643033|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
56643034|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56643035|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56643045|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643046|NCT02725736|Nifedipine|nifedipine|mesh-list
56643047|NCT02725736|Atosiban|atosiban|mesh-list
56643048|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56547622|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56643049|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56643050|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643051|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56643052|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643053|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
56643054|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
56643055|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56643056|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
56643057|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643058|NCT02716142|Misoprostol|misoprostol|mesh-list
56643059|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56643060|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
56643061|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56643062|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643063|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56643064|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584577|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
56584578|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56584579|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56584580|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56584606|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56584607|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56584608|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
56584609|NCT00784459|Abatacept|abatacept|mesh-list
56584610|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56584611|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584612|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584613|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584614|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
56584615|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584616|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584617|NCT04255134|Adalimumab|adalimumab|mesh-list
56584618|NCT04255134|Abatacept|abatacept|mesh-list
56584619|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56584620|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584621|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56584622|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584623|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584624|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584625|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
56584626|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584627|NCT02835183|Insulin|insulin|mesh-list
56584628|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56584629|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584630|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
56584631|NCT02602483|Ibuprofen|ibuprofen|mesh-list
56119978|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643065|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
56643066|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
56643067|NCT03015974|Prednisone|prednisone|mesh-list
56643068|NCT03015974|Prednisolone|prednisolone|mesh-list
56643069|NCT03015974|Deflazacort|deflazacort|mesh-list
56643070|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
56643071|NCT03015974|Dipyridamole|dipyridamole|mesh-list
56643072|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56643073|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56643074|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643075|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
56643076|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643077|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643078|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56643079|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
56643080|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643081|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643082|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56643083|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56643084|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
56643085|NCT03015974|Hormones|hormones|mesh-ancestor
56643086|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643087|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56643088|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56643089|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56643090|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
56643091|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56643092|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643093|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643094|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
56643095|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56643096|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56643097|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
56643098|NCT02718950|Liraglutide|liraglutide|mesh-list
56643099|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643100|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643101|NCT02718950|Incretins|incretins|mesh-ancestor
56643103|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643104|NCT02725502|Linagliptin|linagliptin|mesh-list
56643105|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643106|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643107|NCT02725502|Incretins|incretins|mesh-ancestor
56643108|NCT02725502|Hormones|hormones|mesh-ancestor
56643109|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643110|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56643111|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
56643112|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643113|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643114|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
56643115|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643116|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
56643117|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643118|NCT04153136|Valsartan|valsartan|mesh-list
56643119|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56643120|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56643121|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56643122|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56643123|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643124|NCT01959464|Progesterone|progesterone|mesh-list
56643125|NCT01959464|Progestins|progestins|mesh-ancestor
56643126|NCT01959464|Hormones|hormones|mesh-ancestor
56643127|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643128|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643129|NCT02718482|Gemcitabine|gemcitabine|mesh-list
56643130|NCT02718482|Docetaxel|docetaxel|mesh-list
56643131|NCT02718482|Ifosfamide|ifosfamide|mesh-list
56643132|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
56643133|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56643134|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
56643143|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
56643144|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
56643145|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
56643146|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56643147|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
56643148|NCT01921166|Leuprolide|leuprolide|mesh-list
56643149|NCT01921166|Clomiphene|clomiphene|mesh-list
56643150|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56643151|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
56643152|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56643153|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643154|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56643155|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643156|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56643157|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
56643158|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643159|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56487984|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
56584662|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56584663|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56584664|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
56584665|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584666|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584667|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584668|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56584669|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
56584670|NCT04254822|Protective Agents|protective agents|mesh-ancestor
56584671|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56584672|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56584673|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56584674|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
56584675|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56584676|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56584703|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56584704|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584706|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584707|NCT04254744|Sevoflurane|sevoflurane|mesh-list
56584708|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56584709|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56584710|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
56584711|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
56584712|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56584713|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584714|NCT02831361|Metformin|metformin|mesh-list
56584715|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56584716|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584717|NCT04103905|Antibodies|antibodies|mesh-list
56584718|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56584719|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
56584720|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584721|NCT02831205|Cobalt|cobalt|mesh-list
56584722|NCT02831205|Chromium|chromium|mesh-list
56584723|NCT02831205|Everolimus|everolimus|mesh-list
56120073|NCT01618266|Hormones|hormones|mesh-ancestor
56584751|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56584752|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56584753|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56643160|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56643161|NCT05087030|Denosumab|denosumab|mesh-list
56643162|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56643163|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643164|NCT02717858|Liraglutide|liraglutide|mesh-list
56643165|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643166|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643167|NCT02717858|Incretins|incretins|mesh-ancestor
56643168|NCT02717858|Hormones|hormones|mesh-ancestor
56643169|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643170|NCT02725112|Pregabalin|pregabalin|mesh-list
56643171|NCT02725112|Analgesics|analgesics|mesh-ancestor
56643172|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
56643173|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643174|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643175|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
56643176|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56643177|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56643178|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643179|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56643180|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56643181|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56643182|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643183|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56643184|NCT02724332|Sirolimus|sirolimus|mesh-list
56643185|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56643186|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643187|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56643188|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643189|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
56643190|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643191|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
56488043|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
56584754|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56584755|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
56584756|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
56584757|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
56584758|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
56584759|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584760|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584761|NCT02833155|Exemestane|exemestane|mesh-list
56584762|NCT02833155|Entinostat|entinostat|mesh-list
56584763|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643192|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643193|NCT02717780|Fentanyl|fentanyl|mesh-list
56643194|NCT02717780|Remifentanil|remifentanil|mesh-list
56643195|NCT02717780|Sevoflurane|sevoflurane|mesh-list
56643196|NCT02717780|Desflurane|desflurane|mesh-list
56643197|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56643198|NCT02717780|Narcotics|narcotics|mesh-ancestor
56643199|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643200|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643201|NCT02717780|Analgesics|analgesics|mesh-ancestor
56643202|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
56643203|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643204|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56643205|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56643206|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
56643207|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
56643208|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56643209|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56643210|NCT04070378|Daratumumab|daratumumab|mesh-list
56643211|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643212|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
56643213|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56643214|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643215|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643216|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56643217|NCT02724098|Analgesics|analgesics|mesh-ancestor
56643243|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
56643244|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643245|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
56643246|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56643247|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643248|NCT02716766|Capecitabine|capecitabine|mesh-list
56643249|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
56643250|NCT02716766|Sorafenib|sorafenib|mesh-list
56643251|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56643252|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
56643253|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643254|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643255|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56643256|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643257|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
56643258|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643259|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643260|NCT02694224|Paclitaxel|paclitaxel|mesh-list
56643261|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
56643262|NCT02694224|Epirubicin|epirubicin|mesh-list
56643263|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56643264|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643265|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
56643266|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
56643267|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
56643268|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289213|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
56643269|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643270|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
56643271|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643272|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56488109|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584764|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56584765|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56584766|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333290|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
56584767|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584768|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56584769|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
56480249|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584789|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584790|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584791|NCT00850564|Growth Substances|growth substances|mesh-ancestor
56584793|NCT00837148|Dacarbazine|dacarbazine|mesh-list
56643273|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56643274|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
56643275|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56643276|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56643277|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56643278|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56643279|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643280|NCT00782288|Digitoxin|digitoxin|mesh-list
56643281|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56643282|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56643283|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643284|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643285|NCT00782288|Protective Agents|protective agents|mesh-ancestor
56643286|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643287|NCT04189094|Etoposide|etoposide|mesh-list
56643288|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643289|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56643290|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56643291|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56643292|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643293|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643294|NCT02712944|Testosterone|testosterone|mesh-list
56643295|NCT02712944|Androgens|androgens|mesh-ancestor
56643296|NCT02712944|Hormones|hormones|mesh-ancestor
56643297|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643298|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643299|NCT02712866|Vedolizumab|vedolizumab|mesh-list
56643300|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56643301|NCT00600483|Gentamicins|gentamicins|mesh-list
56643302|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56643303|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643304|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56643305|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643306|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643307|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
56643308|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
56584794|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584795|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56643309|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643310|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
56643311|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643312|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643313|NCT00649857|Cetirizine|cetirizine|mesh-list
56643314|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56643315|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56643316|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56643317|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
56643318|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
56643319|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643320|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643321|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643322|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
56643323|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
56643324|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643325|NCT00764270|Protective Agents|protective agents|mesh-ancestor
56643326|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643327|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
56643328|NCT00764270|Vitamins|vitamins|mesh-ancestor
56643329|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
56643330|NCT00650481|Oxybutynin|oxybutynin|mesh-list
56643331|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
56643332|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
56643333|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643334|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643335|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56643336|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56643337|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
56643354|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643355|NCT02722538|Antiviral Agents|antiviral agents|mesh-ancestor
56643356|NCT02722538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643357|NCT02722538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643358|NCT02722538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643359|NCT02722538|Immunologic Factors|immunologic factors|mesh-ancestor
56643360|NCT02722538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643361|NCT02651727|Gemcitabine|gemcitabine|mesh-list
56643362|NCT02651727|Paclitaxel|paclitaxel|mesh-list
56643363|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56643364|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56643365|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643366|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
56643367|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
56643368|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
56643369|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643370|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56488223|NCT04649723|Rifampin|rifampin|mesh-list
56584796|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584797|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584798|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56584799|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
56584800|NCT00703690|Fenofibrate|fenofibrate|mesh-list
56584801|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56584802|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
56584803|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584804|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56584805|NCT05297968|Oseltamivir|oseltamivir|mesh-list
56584806|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
56584807|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584808|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584809|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584810|NCT02613130|Fluorides|fluorides|mesh-list
56584811|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
56584812|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
56584813|NCT02613130|Protective Agents|protective agents|mesh-ancestor
56584814|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584815|NCT00849472|Paclitaxel|paclitaxel|mesh-list
56584816|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
56584817|NCT00849472|Doxorubicin|doxorubicin|mesh-list
56584818|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56584819|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584820|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56584821|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56584822|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56584823|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584824|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584854|NCT00706888|Vitamins|vitamins|mesh-ancestor
56584855|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
56584856|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584857|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
56584858|NCT05019534|Cetuximab|cetuximab|mesh-list
56584859|NCT05019534|Vemurafenib|vemurafenib|mesh-list
56584860|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56584861|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584862|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56584863|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584864|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584865|NCT04254042|Perindopril|perindopril|mesh-list
56643371|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
56643372|NCT02651727|Antiviral Agents|antiviral agents|mesh-ancestor
56643373|NCT02651727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643374|NCT02651727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643375|NCT02651727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643376|NCT02651727|Immunologic Factors|immunologic factors|mesh-ancestor
56643377|NCT02651727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643378|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
56643379|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56643380|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56643381|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643382|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
56643383|NCT02650791|Coagulants|coagulants|mesh-ancestor
56643384|NCT02650713|Atezolizumab|atezolizumab|mesh-list
56643385|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643386|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
56643387|NCT02650635|Lenograstim|lenograstim|mesh-list
56643388|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643389|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
56643390|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643391|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643392|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56643393|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
56643394|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643395|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643396|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56643397|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56643398|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
56584866|NCT04254042|Zofenopril|zofenopril|mesh-list
56584867|NCT04254042|Captopril|captopril|mesh-list
56584868|NCT04254042|Calcium|calcium|mesh-list
56584869|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56584870|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584895|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56584896|NCT00782275|Growth Substances|growth substances|mesh-ancestor
56584897|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584898|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
56584899|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56584900|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584901|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56584902|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
56584903|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584904|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
56584905|NCT00791557|Infliximab|infliximab|mesh-list
56584906|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
56584907|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584908|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584909|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
56584910|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643399|NCT00650637|Lamivudine|lamivudine|mesh-list
56643400|NCT00650637|Zidovudine|zidovudine|mesh-list
56643401|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56643402|NCT00650637|Nelfinavir|nelfinavir|mesh-list
56643403|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
56643404|NCT00650637|Loperamide|loperamide|mesh-list
56643405|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
56643406|NCT00650637|Calcium|calcium|mesh-list
56643407|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56643408|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643409|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56643410|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56643411|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56643412|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643413|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643414|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
56643415|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643416|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56643417|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56643418|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
56643419|NCT00650637|Antacids|antacids|mesh-ancestor
56643420|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56643421|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56643422|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56643423|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
56643424|NCT02650479|Exenatide|exenatide|mesh-list
56643425|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
56643426|NCT02650479|Palonosetron|palonosetron|mesh-list
56643427|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56643428|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643429|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56643430|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56643431|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643432|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643433|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643434|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643435|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643437|NCT02650479|Incretins|incretins|mesh-ancestor
56643439|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643440|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
56643441|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
56643442|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643443|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56643444|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56643445|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56643446|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
56643447|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643448|NCT02722772|Etanercept|etanercept|mesh-list
56643449|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56643450|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56643451|NCT02722772|Analgesics|analgesics|mesh-ancestor
56643452|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
56643453|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643454|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643455|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56643456|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643457|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56643458|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643459|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
56584911|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56584912|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56584913|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56584914|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
56584915|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584916|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56584917|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56584918|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584920|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584952|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56584953|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56584954|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
56584955|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584956|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584957|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56584958|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56584959|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
56584960|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584961|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56584962|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56584963|NCT04669782|Teriparatide|teriparatide|mesh-list
56584964|NCT04669782|Vitamin K|vitamin k|mesh-list
56333518|NCT00062244|Oblimersen|oblimersen|mesh-list
56584991|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584992|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584993|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584994|NCT00891735|Ranibizumab|ranibizumab|mesh-list
56584995|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56584996|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56584997|NCT00891735|Growth Substances|growth substances|mesh-ancestor
56584998|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584999|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
56643460|NCT02650245|Lactulose|lactulose|mesh-list
56643461|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56643462|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56643463|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56643464|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56643465|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643466|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643467|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56643468|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56643469|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56643470|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
56643471|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643472|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643473|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56643474|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56643475|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
56643476|NCT00910767|Insulin|insulin|mesh-list
56585000|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585002|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56585003|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
56585004|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585005|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158567|NCT03086616|Irinotecan|irinotecan|mesh-list
56585007|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
56585008|NCT04808934|Apixaban|apixaban|mesh-list
56585009|NCT04808934|Dabigatran|dabigatran|mesh-list
56585010|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56585011|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
56585012|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56585013|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
56585014|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585037|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
56585038|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56585039|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56585040|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585041|NCT00915018|Paclitaxel|paclitaxel|mesh-list
56585042|NCT00915018|Trastuzumab|trastuzumab|mesh-list
56585043|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56585044|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56585045|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585046|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56585047|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56585048|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56585049|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585050|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56585051|NCT04246905|Sulforaphane|sulforaphane|mesh-list
56585052|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56585053|NCT04246905|Protective Agents|protective agents|mesh-ancestor
56585054|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585055|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585056|NCT02830347|Amoxicillin|amoxicillin|mesh-list
56585057|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56585058|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585059|NCT00916578|Capecitabine|capecitabine|mesh-list
56585060|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56585061|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
56585062|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585063|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585064|NCT04675866|Paclitaxel|paclitaxel|mesh-list
56585065|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56643477|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643478|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643479|NCT02722694|Methotrexate|methotrexate|mesh-list
56643480|NCT02722694|Abatacept|abatacept|mesh-list
56643481|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56643482|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
56643483|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56643484|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643485|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56643486|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
56643487|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643488|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643489|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
56643490|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643491|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56643492|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289436|NCT00015028|Analgesics|analgesics|mesh-ancestor
56643493|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
56643494|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643495|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56643496|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56643497|NCT00650871|Casopitant|casopitant|mesh-list
56643498|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
56585066|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56120407|NCT01876446|Irinotecan|irinotecan|mesh-list
56585098|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56585099|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56585101|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
56585102|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585103|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585104|NCT00914940|Fludarabine|fludarabine|mesh-list
56585105|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
56585106|NCT00914940|Thiotepa|thiotepa|mesh-list
56585107|NCT00914940|Tacrolimus|tacrolimus|mesh-list
56585108|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585109|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56585110|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
56585111|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120454|NCT01876368|Olmesartan|olmesartan|mesh-list
56585164|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
56585165|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585166|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585167|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
56585168|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585169|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56585170|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56585171|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56585172|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56585173|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585174|NCT00704080|Temozolomide|temozolomide|mesh-list
56585175|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56643499|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
56643500|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643501|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643502|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56643503|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56643504|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643505|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643506|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56643507|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56643508|NCT02649465|Glimepiride|glimepiride|mesh-list
56643509|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
56643510|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56643511|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643512|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643513|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643514|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
56643515|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56643516|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643517|NCT00651105|Vildagliptin|vildagliptin|mesh-list
56643518|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643519|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643520|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56643521|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
56643522|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643523|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643524|NCT02694146|Hylan|hylan|mesh-list
56643525|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
56643526|NCT02694146|Protective Agents|protective agents|mesh-ancestor
56643527|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643528|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
56643529|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56643538|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
56643539|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643540|NCT02644707|Protective Agents|protective agents|mesh-ancestor
56643541|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643542|NCT02644707|Trace Elements|trace elements|mesh-ancestor
56643543|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
56643544|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
56643545|NCT02711228|Antibodies|antibodies|mesh-list
56643546|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
56643547|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56643548|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56643549|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
56643550|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643551|NCT02644863|Paclitaxel|paclitaxel|mesh-list
56643552|NCT02644863|Cisplatin|cisplatin|mesh-list
56643553|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56643554|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643555|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
56643556|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
56643557|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
56643558|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643559|NCT03524235|Rituximab|rituximab|mesh-list
56643560|NCT03524235|Fludarabine|fludarabine|mesh-list
56643561|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56643562|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56643563|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643564|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
56643565|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643566|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643567|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643568|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56643569|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
56643570|NCT00302744|Niacin|niacin|mesh-list
56585176|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
56585177|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585178|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585179|NCT05253066|Docetaxel|docetaxel|mesh-list
56585180|NCT05253066|Epirubicin|epirubicin|mesh-list
56585181|NCT05253066|Exemestane|exemestane|mesh-list
56585182|NCT05253066|Goserelin|goserelin|mesh-list
56585183|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585184|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56585185|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56585186|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56071638|NCT02403830|Narcotics|narcotics|mesh-ancestor
56643571|NCT00302744|Psilocybin|psilocybin|mesh-list
56643572|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56643573|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
56643574|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643575|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56643576|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
56643577|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
56643578|NCT00302744|Vitamins|vitamins|mesh-ancestor
56643579|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
56643580|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643581|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
56643582|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56643583|NCT02644629|Ketamine|ketamine|mesh-list
56643584|NCT02644629|Analgesics|analgesics|mesh-ancestor
56643585|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
56643586|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643587|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643588|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56643589|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56643590|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
56643591|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
56585187|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585188|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56585189|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56585190|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56585191|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585192|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56585193|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56585194|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56585195|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
56585196|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56585197|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585198|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56585232|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56585233|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585234|NCT04636086|Vitamins|vitamins|mesh-ancestor
56585235|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
56585236|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56585237|NCT00827242|Tadalafil|tadalafil|mesh-list
56585238|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
56585239|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56585240|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56585241|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585242|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585243|NCT00827242|Urological Agents|urological agents|mesh-ancestor
56585244|NCT01077362|Ustekinumab|ustekinumab|mesh-list
56585245|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
56585246|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
56585247|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56585248|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
56585249|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585250|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585251|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56585280|NCT00704314|Simvastatin|simvastatin|mesh-list
56585281|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56585282|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56643592|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643593|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56643594|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56643595|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643596|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643597|NCT00652665|Leflunomide|leflunomide|mesh-list
56643598|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643599|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643600|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643601|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
56643602|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643603|NCT02644551|Ciclopirox|ciclopirox|mesh-list
56643604|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
56585283|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
56585284|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585285|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56585286|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56585287|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585288|NCT00704392|XL647|xl647|mesh-list
56585289|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585290|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56585291|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585292|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585293|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
56585294|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56585295|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
56585296|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585297|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
56585331|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56585332|NCT04303130|Growth Substances|growth substances|mesh-ancestor
56585333|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585334|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
56585335|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585336|NCT02875262|Deferoxamine|deferoxamine|mesh-list
56585337|NCT02875262|Siderophores|siderophores|mesh-ancestor
56585338|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56585339|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
56585340|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
56585341|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585342|NCT00626600|Oxycodone|oxycodone|mesh-list
56585361|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56585362|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56585363|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56585364|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56585365|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585366|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585367|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585368|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56585369|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
56585370|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56585372|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56585373|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56585374|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
56585375|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480250|NCT00623857|Trace Elements|trace elements|mesh-ancestor
56585376|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585378|NCT02611336|Tadalafil|tadalafil|mesh-list
56585379|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
56585380|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56643605|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643606|NCT02644395|Amlodipine|amlodipine|mesh-list
56643607|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
56643608|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56643609|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56643610|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56643611|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643612|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56643613|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643614|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
56643615|NCT02644395|Diuretics|diuretics|mesh-ancestor
56643616|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
56643617|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56643618|NCT04166565|Dexamethasone|dexamethasone|mesh-list
56643619|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
56643620|NCT04166565|Bortezomib|bortezomib|mesh-list
56643621|NCT04166565|Daratumumab|daratumumab|mesh-list
56643622|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643623|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
56643624|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643625|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643626|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56643627|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
56643628|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585381|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56585382|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585383|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585384|NCT02611336|Urological Agents|urological agents|mesh-ancestor
56585385|NCT00704704|Thalidomide|thalidomide|mesh-list
56585386|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56585387|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
56585388|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585389|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
56585390|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56585391|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585392|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56585393|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56585394|NCT00704704|Growth Substances|growth substances|mesh-ancestor
56585395|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
56585396|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585442|NCT04309773|Bezafibrate|bezafibrate|mesh-list
56585443|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56585444|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56585445|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56585446|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
56585447|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585448|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56585449|NCT02829333|Anesthetics|anesthetics|mesh-list
56585450|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585451|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072132|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
56643629|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643630|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56643631|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56643632|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
56643633|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
56643634|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643635|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56643636|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
56643637|NCT04166565|Hormones|hormones|mesh-ancestor
56643638|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56643639|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56643640|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
56643641|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56585453|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56585454|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585455|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56585456|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56585457|NCT05251662|Growth Substances|growth substances|mesh-ancestor
56585458|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585459|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
56585460|NCT02829177|Allopurinol|allopurinol|mesh-list
56585461|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
56585462|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585463|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585464|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
56585465|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56585466|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56585467|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
56585468|NCT02829177|Protective Agents|protective agents|mesh-ancestor
56585469|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585470|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
56585471|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56585472|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56585473|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56585474|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56120798|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56585505|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56585507|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
56585508|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
56585509|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585510|NCT00915733|Aspirin|aspirin|mesh-list
56585511|NCT00915733|Cilostazol|cilostazol|mesh-list
56585512|NCT00915733|Clopidogrel|clopidogrel|mesh-list
56585513|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56585514|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56585515|NCT00915733|Analgesics|analgesics|mesh-ancestor
56585516|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
56334041|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
56585517|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585555|NCT00912912|Growth Substances|growth substances|mesh-ancestor
56585556|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585557|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
56585558|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56585559|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585560|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585561|NCT00913692|Glycine|glycine|mesh-list
56585562|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
56585563|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585564|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585565|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585566|NCT00784927|Dexamethasone|dexamethasone|mesh-list
56585567|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
56643642|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56643643|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643644|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
56643645|NCT02644473|Coagulants|coagulants|mesh-ancestor
56643646|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56643647|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
56643648|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643649|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
56643650|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643651|NCT04005872|Calcium|calcium|mesh-list
56643652|NCT04005872|Fluorides|fluorides|mesh-list
56643653|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56643654|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643655|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
56643656|NCT04005872|Protective Agents|protective agents|mesh-ancestor
56643657|NCT00652821|Tramadol|tramadol|mesh-list
56643658|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56643659|NCT00652821|Narcotics|narcotics|mesh-ancestor
56643660|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643661|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643662|NCT00652821|Analgesics|analgesics|mesh-ancestor
56643663|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
56643664|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643665|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
56643666|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56643667|NCT02710604|Tenofovir|tenofovir|mesh-list
56488834|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585568|NCT00784927|Rituximab|rituximab|mesh-list
56585569|NCT00784927|Lenalidomide|lenalidomide|mesh-list
56585570|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56585571|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
56585572|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585573|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56585574|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56585575|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
56585576|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585577|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585600|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585601|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585602|NCT04203342|Ketoconazole|ketoconazole|mesh-list
56585603|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
56585604|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585605|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56585606|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56585607|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585608|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585609|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56585610|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
56051407|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56643668|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
56643669|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
56643670|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643671|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56643672|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56643673|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643674|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643675|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56643676|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56643677|NCT02535975|Metformin|metformin|mesh-list
56643678|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643679|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643680|NCT02714036|Ibudilast|ibudilast|mesh-list
56643681|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56643682|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
56643683|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643684|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643685|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56643686|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
56643687|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56643688|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585611|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56585612|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585613|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56585614|NCT05539729|Vancomycin|vancomycin|mesh-list
56585615|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56585616|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585617|NCT04706130|Artesunate|artesunate|mesh-list
56585618|NCT04706130|Primaquine|primaquine|mesh-list
56585619|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
56585620|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56585621|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56585622|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585623|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585624|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
56585625|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
56585626|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56585627|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
56585628|NCT04834206|Docetaxel|docetaxel|mesh-list
56120959|NCT01797432|Hormones|hormones|mesh-ancestor
56158599|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
56585663|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
56585664|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
56585665|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56585666|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
56585667|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121009|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56585703|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585704|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
56585726|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
56585727|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56585728|NCT00776659|Exemestane|exemestane|mesh-list
56585729|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585730|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56051408|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
56643689|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643690|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56643691|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
56643692|NCT02710448|Metformin|metformin|mesh-list
56643693|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643694|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643695|NCT04602026|Coal Tar|coal tar|mesh-list
56643696|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
56643697|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
56643698|NCT04166253|Vitamin D|vitamin d|mesh-list
56643699|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
56643700|NCT04166253|Vitamins|vitamins|mesh-ancestor
56643701|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
56643702|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643703|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56643704|NCT00653055|Cabergoline|cabergoline|mesh-list
56643705|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56643706|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56643707|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
56643708|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
56643709|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643712|NCT02643147|Furosemide|furosemide|mesh-list
56643744|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643745|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56643746|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643747|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56643748|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56643749|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643750|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56643751|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56643752|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643753|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
56585731|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56585732|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585733|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585734|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56585735|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
56480252|NCT01280968|Vaccines|vaccines|mesh-list
56585736|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56585737|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585742|NCT00632268|Everolimus|everolimus|mesh-list
56585743|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585744|NCT00632268|Antidotes|antidotes|mesh-ancestor
56585745|NCT00632268|Protective Agents|protective agents|mesh-ancestor
56585746|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585747|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
56585748|NCT00632268|Vitamins|vitamins|mesh-ancestor
56585749|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
56585750|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56585751|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
56585752|NCT04145076|Citalopram|citalopram|mesh-list
56585753|NCT04145076|Tianeptine|tianeptine|mesh-list
56585754|NCT04145076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56585755|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56585756|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56585757|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585758|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585759|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
56585760|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585761|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56585762|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
56121093|NCT01793688|Ampicillin|ampicillin|mesh-list
56585820|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56585821|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
56585822|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585823|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585824|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56585825|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56585826|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
56585827|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56585828|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
56585829|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
56585830|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
56585831|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56585833|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56585834|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56585835|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585836|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585837|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56585838|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
56585839|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
56585840|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585841|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585842|NCT00916045|Vidarabine|vidarabine|mesh-list
56585843|NCT00916045|Cyclosporine|cyclosporine|mesh-list
56585844|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
56585882|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56643754|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56643755|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56643756|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56643757|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
56643758|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56643759|NCT02642523|Insulin|insulin|mesh-list
56643760|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56643761|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56643762|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643763|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643764|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
56643765|NCT02713802|Propofol|propofol|mesh-list
56643766|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56643767|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643768|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643769|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56643770|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
56643771|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
56643772|NCT02642601|Indomethacin|indomethacin|mesh-list
56643773|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56643774|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56643775|NCT02642601|Analgesics|analgesics|mesh-ancestor
56643776|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
56643777|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643778|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489026|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
56585883|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
56585884|NCT00916123|Hormones|hormones|mesh-ancestor
56585885|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56585886|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585887|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56585889|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56585890|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
56585891|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56585892|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585893|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
56585894|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334427|NCT00070278|Paclitaxel|paclitaxel|mesh-list
56585895|NCT00916201|Cannabidiol|cannabidiol|mesh-list
56585896|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
56585898|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
56585899|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56585900|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56585901|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585902|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585903|NCT00833638|Urological Agents|urological agents|mesh-ancestor
56585904|NCT01041404|Fluorouracil|fluorouracil|mesh-list
56585905|NCT01041404|Capecitabine|capecitabine|mesh-list
56585906|NCT01041404|Trastuzumab|trastuzumab|mesh-list
56643779|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56643780|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643781|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
56643782|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
56643783|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56643784|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56643785|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643786|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643787|NCT02709902|Adapalene|adapalene|mesh-list
56643788|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56643789|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56643790|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
56643791|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56643792|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56643793|NCT02709902|Analgesics|analgesics|mesh-ancestor
56643794|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
56289770|NCT00016861|Irinotecan|irinotecan|mesh-list
56643795|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643796|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643797|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56643798|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643799|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
56643800|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56643801|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56643802|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643803|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
56643804|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
56643805|NCT02642367|Rocuronium|rocuronium|mesh-list
56643827|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56643828|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
56643829|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643830|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56643831|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56643832|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643833|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56643834|NCT02641899|Analgesics|analgesics|mesh-ancestor
56643835|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
56643836|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643837|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643838|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
56643839|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
56643840|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56643841|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56643842|NCT02641899|Protective Agents|protective agents|mesh-ancestor
56643843|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56643844|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
56643845|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56643846|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56643847|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56643848|NCT02641899|Incretins|incretins|mesh-ancestor
56643849|NCT02641899|Hormones|hormones|mesh-ancestor
56643850|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56585907|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585908|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
56585909|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585910|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56585911|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56585912|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
56585944|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
56585945|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585946|NCT04991493|Tramadol|tramadol|mesh-list
56585947|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56585948|NCT04991493|Narcotics|narcotics|mesh-ancestor
56585949|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585950|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585951|NCT04991493|Analgesics|analgesics|mesh-ancestor
56585952|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
56585953|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585954|NCT01059812|Insulin|insulin|mesh-list
56585955|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56585987|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
56585988|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585989|NCT00888381|Vaccines|vaccines|mesh-list
56585990|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
56585991|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585992|NCT00833560|Dexamethasone|dexamethasone|mesh-list
56585993|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
56585994|NCT00833560|Bortezomib|bortezomib|mesh-list
56585995|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643851|NCT02641821|Nifedipine|nifedipine|mesh-list
56643852|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56643853|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56643854|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643855|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56643856|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643857|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
56643858|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
56643859|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56643860|NCT01320345|Fenofibrate|fenofibrate|mesh-list
56643861|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56643862|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
56643863|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643864|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56643865|NCT04164615|Capecitabine|capecitabine|mesh-list
56489151|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
56585996|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
56585997|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585998|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56585999|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56586000|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
56586029|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586030|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586031|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
56586032|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586033|NCT00887679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56586034|NCT00887679|Antidepressive Agents|antidepressive agents|mesh-ancestor
56586035|NCT00887679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56586036|NCT04241523|Lenvatinib|lenvatinib|mesh-list
56586037|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586038|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56586039|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586040|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586041|NCT00833482|Ritonavir|ritonavir|mesh-list
56586042|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56586043|NCT00833482|Voriconazole|voriconazole|mesh-list
56586044|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56586045|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56334579|NCT02958501|Vitamin D|vitamin d|mesh-list
56586046|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
56586066|NCT00845182|Incretins|incretins|mesh-ancestor
56586067|NCT00845182|Hormones|hormones|mesh-ancestor
56586068|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586069|NCT00833248|Goserelin|goserelin|mesh-list
56586070|NCT00833248|Bicalutamide|bicalutamide|mesh-list
56586071|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56586072|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586073|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
56586074|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
56586075|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586076|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586077|NCT00702130|Pravastatin|pravastatin|mesh-list
56586078|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56586079|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56586080|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
56586081|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586082|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56586083|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56643866|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56643867|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
56643868|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643869|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643870|NCT04164459|Latanoprost|latanoprost|mesh-list
56643872|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56643873|NCT04164693|Heparin|heparin|mesh-list
56643874|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56643875|NCT04164693|Tinzaparin|tinzaparin|mesh-list
56643876|NCT04164693|Dalteparin|dalteparin|mesh-list
56643877|NCT04164693|Warfarin|warfarin|mesh-list
56643878|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
56643879|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56586084|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586085|NCT00823264|Charcoal|charcoal|mesh-list
56586086|NCT00823264|Antidotes|antidotes|mesh-ancestor
56586087|NCT00823264|Protective Agents|protective agents|mesh-ancestor
56586088|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586089|NCT04241211|Denosumab|denosumab|mesh-list
56586090|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56586091|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586092|NCT00702442|Droperidol|droperidol|mesh-list
56586093|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56586094|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
56586095|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
56586096|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586097|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586098|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56586099|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56586100|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56334654|NCT00066885|Vitamins|vitamins|mesh-ancestor
56586120|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586122|NCT02612272|Hormones|hormones|mesh-ancestor
56586123|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586124|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56586125|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
56586126|NCT02611258|Tadalafil|tadalafil|mesh-list
56586127|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
56586128|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56586129|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56586130|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586131|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586132|NCT02611258|Urological Agents|urological agents|mesh-ancestor
56586133|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56586134|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56586135|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586136|NCT00832624|Incretins|incretins|mesh-ancestor
56586137|NCT00832624|Hormones|hormones|mesh-ancestor
56586138|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586139|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56586140|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
56586141|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586142|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586143|NCT00913120|Enoxaparin|enoxaparin|mesh-list
56586144|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
56586145|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56586146|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56586147|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586148|NCT00822172|Cilostazol|cilostazol|mesh-list
56586149|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56586150|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
56586151|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586152|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586153|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56643880|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56643881|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643882|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
56643883|NCT00602667|Cisplatin|cisplatin|mesh-list
56643884|NCT00602667|Carboplatin|carboplatin|mesh-list
56643885|NCT00602667|Methotrexate|methotrexate|mesh-list
56643886|NCT00602667|Etoposide|etoposide|mesh-list
56643887|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
56643888|NCT00602667|Vincristine|vincristine|mesh-list
56643889|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56643890|NCT00602667|Topotecan|topotecan|mesh-list
56643891|NCT00602667|Vinblastine|vinblastine|mesh-list
56643892|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643893|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
56643894|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643895|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643896|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56643897|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
56643898|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643899|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643900|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56643901|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56586154|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
56586155|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56586171|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
56586172|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
56586173|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586174|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
56586175|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586176|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
56586177|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
56586178|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
56586179|NCT04166292|Lidocaine|lidocaine|mesh-list
56586180|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
56586181|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
56586182|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586183|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586184|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
56586185|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586186|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56586187|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56586188|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56586189|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586190|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586191|NCT04099771|Ketamine|ketamine|mesh-list
56586192|NCT04099771|Analgesics|analgesics|mesh-ancestor
56586193|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
56586194|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586195|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586196|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56586197|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56586198|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
56586199|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
56586200|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586201|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56643902|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
56643903|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56643904|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56643905|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
56643906|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
56643907|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643908|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56643909|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56643910|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56643911|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56643912|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56643913|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
56643914|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
56643915|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
56643916|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56643917|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56643918|NCT00655785|Gemcitabine|gemcitabine|mesh-list
56643919|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56643920|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
56643921|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643922|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643923|NCT00655785|Antiviral Agents|antiviral agents|mesh-ancestor
56586202|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56586203|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586204|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586205|NCT00768469|Paclitaxel|paclitaxel|mesh-list
56586206|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56586207|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586208|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
56586209|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
56586210|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
56586211|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586212|NCT02825121|Iodine|iodine|mesh-list
56586256|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586258|NCT04848597|Paclitaxel|paclitaxel|mesh-list
56586259|NCT04848597|Antibodies|antibodies|mesh-list
56586260|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56586261|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56586262|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586263|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
56586264|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
56586265|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
56586266|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586267|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586268|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
56586269|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56586270|NCT05037045|Incretins|incretins|mesh-ancestor
56586271|NCT05037045|Hormones|hormones|mesh-ancestor
56586272|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586273|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586274|NCT05660811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56586275|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
56643924|NCT00655785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643925|NCT00655785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643926|NCT00655785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643927|NCT00655785|Immunologic Factors|immunologic factors|mesh-ancestor
56643928|NCT00655785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643929|NCT00885495|Ritonavir|ritonavir|mesh-list
56643930|NCT00885495|Darunavir|darunavir|mesh-list
56643931|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56643932|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56643933|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56643934|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
56643935|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643936|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643937|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56643938|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56586276|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56586277|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586278|NCT02823249|Erythritol|erythritol|mesh-list
56586279|NCT02823249|Tryptophan|tryptophan|mesh-list
56586280|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56586281|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
56586282|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56586283|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
56586284|NCT00768079|Benralizumab|benralizumab|mesh-list
56586285|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56586286|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
56586287|NCT02603575|Caspofungin|caspofungin|mesh-list
56586288|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
56586289|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
56586290|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
56586291|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56586292|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
56586293|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
56586294|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121613|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56586312|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
56586313|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56586314|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586315|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586317|NCT02822157|Paclitaxel|paclitaxel|mesh-list
56586318|NCT02822157|Carboplatin|carboplatin|mesh-list
56586319|NCT02822157|Doxorubicin|doxorubicin|mesh-list
56586320|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56586321|NCT02822157|Topotecan|topotecan|mesh-list
56586322|NCT02822157|Olaparib|olaparib|mesh-list
56586323|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56586324|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586325|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
56586326|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
56586327|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
56480253|NCT01280968|Nicotine|nicotine|mesh-list
56586328|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586329|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56586330|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
56586331|NCT02822157|Antiviral Agents|antiviral agents|mesh-ancestor
56586332|NCT02822157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586333|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586334|NCT02822157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56586335|NCT02822157|Immunologic Factors|immunologic factors|mesh-ancestor
56586336|NCT02822157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586337|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56586338|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56586339|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56051409|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
56643939|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
56643940|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643941|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56643942|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56289921|NCT04734418|Narcotics|narcotics|mesh-ancestor
56643943|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56643944|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56643945|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
56489444|NCT02904369|Tenofovir|tenofovir|mesh-list
56586340|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56586341|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56586343|NCT02822937|Methylphenidate|methylphenidate|mesh-list
56334876|NCT03338621|Rifampin|rifampin|mesh-list
56586344|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56586345|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586346|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56586347|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56586348|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586349|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586365|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586366|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586367|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56586368|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
56586369|NCT04200885|Hormones|hormones|mesh-ancestor
56586370|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586371|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56586372|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586373|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56586374|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56586375|NCT04200885|Analgesics|analgesics|mesh-ancestor
56586376|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
56586377|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586378|NCT05659251|Paclitaxel|paclitaxel|mesh-list
56586379|NCT05659251|Carboplatin|carboplatin|mesh-list
56586380|NCT05659251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56586381|NCT05659251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586382|NCT05659251|Tubulin Modulators|tubulin modulators|mesh-ancestor
56586383|NCT05659251|Antimitotic Agents|antimitotic agents|mesh-ancestor
56586384|NCT05659251|Mitosis Modulators|mitosis modulators|mesh-ancestor
56586385|NCT05659251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586386|NCT00766831|Hydromorphone|hydromorphone|mesh-list
56586387|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56586388|NCT00766831|Narcotics|narcotics|mesh-ancestor
56586389|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586390|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586391|NCT00766831|Analgesics|analgesics|mesh-ancestor
56586392|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
56586393|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586394|NCT02821689|Pirfenidone|pirfenidone|mesh-list
56586395|NCT02821689|Analgesics|analgesics|mesh-ancestor
56586396|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
56586397|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586398|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586399|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56586400|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56586401|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56586402|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586403|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586404|NCT02821533|Cisplatin|cisplatin|mesh-list
56586405|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
56586406|NCT05659407|Rituximab|rituximab|mesh-list
56586407|NCT05659407|Belimumab|belimumab|mesh-list
56586408|NCT05659407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56586409|NCT05659407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586410|NCT05659407|Immunologic Factors|immunologic factors|mesh-ancestor
56586411|NCT05659407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643946|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56547623|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56643947|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56643948|NCT02637375|Paclitaxel|paclitaxel|mesh-list
56643949|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
56643950|NCT02637375|Doxorubicin|doxorubicin|mesh-list
56643951|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56643952|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643953|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
56643954|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
56643955|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
56643956|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643957|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56643958|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
56586412|NCT05659407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121724|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56586460|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56586461|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586462|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
56586463|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
56586464|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
56586465|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121801|NCT01755234|Sevoflurane|sevoflurane|mesh-list
56586477|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
56586478|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56586479|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56586480|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586481|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56586483|NCT02818725|Doxorubicin|doxorubicin|mesh-list
56586484|NCT02818725|Methotrexate|methotrexate|mesh-list
56586485|NCT02818725|Panitumumab|panitumumab|mesh-list
56586486|NCT02818725|Vinblastine|vinblastine|mesh-list
56586487|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586488|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56586489|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56586490|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56586491|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586492|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586493|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56586494|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
56586495|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56586496|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586497|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56586498|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
56586499|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
56586500|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56586501|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56586502|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
56586503|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586504|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56586505|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56480254|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
56586506|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56586507|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
56586508|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
56586509|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
56586510|NCT02818803|Propolis|propolis|mesh-list
56586511|NCT02818803|Miconazole|miconazole|mesh-list
56586512|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586513|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
56586514|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56643959|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643960|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56643961|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56643962|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
56643963|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56643964|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56643965|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56643966|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56643967|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643968|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
56643969|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56643970|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56643971|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56643972|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56643973|NCT00885105|Vaccines|vaccines|mesh-list
56643974|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
56643975|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643976|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
56643977|NCT02709668|Vitamins|vitamins|mesh-ancestor
56643978|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
56643979|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586515|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56586516|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586517|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586518|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56586519|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
56586520|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586521|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586522|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56586523|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56586524|NCT03539952|Penicillamine|penicillamine|mesh-list
56586525|NCT03539952|Trientine|trientine|mesh-list
56586534|NCT02820051|Midazolam|midazolam|mesh-list
56586535|NCT02820051|Nalbuphine|nalbuphine|mesh-list
56586536|NCT02820051|Propofol|propofol|mesh-list
56586537|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
56586538|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
56586539|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586540|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586541|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
56586542|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586543|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56586544|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56586545|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56586546|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586547|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586548|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56586549|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56586550|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
56586551|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56586552|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56586553|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56586554|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56643980|NCT04188782|Sevoflurane|sevoflurane|mesh-list
56643981|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56643982|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56643983|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
56643984|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
56643985|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643986|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643987|NCT02709590|Diclofenac|diclofenac|mesh-list
56643988|NCT02709590|Lidocaine|lidocaine|mesh-list
56643989|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
56643990|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
56643991|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56643992|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56643993|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
56643994|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56643995|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56643996|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56643997|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56643998|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56643999|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644000|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56644001|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56644002|NCT02709590|Analgesics|analgesics|mesh-ancestor
56644003|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644004|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644005|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56644006|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644007|NCT02707874|Ropivacaine|ropivacaine|mesh-list
56644008|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
56644009|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
56644010|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644011|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644012|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
56644013|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644020|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
56644021|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644022|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56644023|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56644024|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56644025|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
56644026|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644027|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644028|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56644029|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56644030|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56644031|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56644032|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644033|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
56644034|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644035|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644036|NCT04414748|Cetrorelix|cetrorelix|mesh-list
56644037|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
56644038|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56644039|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
56644040|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56644041|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644042|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
56644043|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644044|NCT04414748|Progestins|progestins|mesh-ancestor
56644045|NCT04414748|Hormones|hormones|mesh-ancestor
56644046|NCT02707484|Thalidomide|thalidomide|mesh-list
56644047|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644048|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
56644049|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644050|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
56644051|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56644052|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644053|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56644054|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56586555|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
56586556|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
56586557|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644055|NCT02707484|Growth Substances|growth substances|mesh-ancestor
56644056|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
56644057|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644058|NCT02707328|Gemcitabine|gemcitabine|mesh-list
56586558|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56586559|NCT02820051|Narcotics|narcotics|mesh-ancestor
56586560|NCT02820051|Analgesics|analgesics|mesh-ancestor
56586561|NCT02817243|Simvastatin|simvastatin|mesh-list
56586562|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56586563|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56586564|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
56586565|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586566|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56586567|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56586568|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586570|NCT00766363|Donepezil|donepezil|mesh-list
56586571|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56586572|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586573|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586574|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
56586575|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586576|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586577|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
56586578|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56586579|NCT00766363|Protective Agents|protective agents|mesh-ancestor
56586580|NCT02636946|Bimatoprost|bimatoprost|mesh-list
56586581|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56586582|NCT02819661|Morphine|morphine|mesh-list
56586583|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586584|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586585|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56586586|NCT02819661|Narcotics|narcotics|mesh-ancestor
56586587|NCT02819661|Analgesics|analgesics|mesh-ancestor
56586588|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
56586589|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586590|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
56586591|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
56586592|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56586593|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
56586594|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586595|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56586642|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586643|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
56586644|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
56335178|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56586645|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56586646|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56586647|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586648|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586649|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56586650|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56586652|NCT05658861|Chelating Agents|chelating agents|mesh-ancestor
56586653|NCT05658861|Sequestering Agents|sequestering agents|mesh-ancestor
56586654|NCT05658861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586655|NCT00772447|Vancomycin|vancomycin|mesh-list
56586656|NCT00772447|Daptomycin|daptomycin|mesh-list
56586657|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56586658|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586659|NCT05656443|Ritonavir|ritonavir|mesh-list
56586660|NCT05656443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56586661|NCT05656443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56586662|NCT05656443|Protease Inhibitors|protease inhibitors|mesh-ancestor
56586678|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
56586679|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56586680|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
56586681|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586682|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56586683|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56586684|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56586685|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
56586686|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56586687|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644059|NCT02707328|Paclitaxel|paclitaxel|mesh-list
56644060|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56644061|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644062|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
56644063|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644064|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644065|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644066|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56644067|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
56644068|NCT02707328|Antiviral Agents|antiviral agents|mesh-ancestor
56644069|NCT02707328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644070|NCT02707328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644071|NCT02707328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644072|NCT02707328|Immunologic Factors|immunologic factors|mesh-ancestor
56644073|NCT02707328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644074|NCT00612638|Irinotecan|irinotecan|mesh-list
56644075|NCT00612638|Temozolomide|temozolomide|mesh-list
56644076|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56644077|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56644078|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56644079|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644080|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644081|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644082|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56586688|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56586689|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56586690|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56586691|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56586692|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56586693|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56586694|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56586695|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56586696|NCT05385406|Acetic Acid|acetic acid|mesh-list
56586697|NCT05385406|Retinol acetate|retinol acetate|mesh-list
56586698|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56586699|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586700|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56586701|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
56586702|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586703|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56586704|NCT05385406|Protective Agents|protective agents|mesh-ancestor
56586705|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586706|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56586707|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
56586708|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56586709|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56586710|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56586711|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586712|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586713|NCT02817477|Ketamine|ketamine|mesh-list
56586714|NCT02817477|Morphine|morphine|mesh-list
56644083|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
56644084|NCT05151848|Adalimumab|adalimumab|mesh-list
56644085|NCT05151848|Tofacitinib|tofacitinib|mesh-list
56644086|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644087|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644088|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56644089|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644090|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644091|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
56644092|NCT05134688|Analgesics|analgesics|mesh-ancestor
56644093|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
56547624|NCT00645073|Renal Agents|renal agents|mesh-ancestor
56644094|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644095|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644096|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
56644097|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644098|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56644099|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
56644100|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56644101|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56644102|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644103|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56644104|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
56644105|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56644106|NCT02693288|Anesthetics|anesthetics|mesh-list
56644107|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644108|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586715|NCT02817477|Analgesics|analgesics|mesh-ancestor
56586716|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
56335255|NCT00203320|Etanercept|etanercept|mesh-list
56586717|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586718|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586741|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586743|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56586744|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56586745|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586746|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586747|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56586748|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586749|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586750|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
56586751|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586752|NCT04101019|Lidocaine|lidocaine|mesh-list
56586753|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
56586754|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
56586755|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586756|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644109|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
56644111|NCT02693210|Methotrexate|methotrexate|mesh-list
56644112|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644113|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
56644114|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644115|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644116|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56644117|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
56644118|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644119|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644120|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56644121|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56644122|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56644123|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
56644124|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56644131|NCT05029466|Psilocybin|psilocybin|mesh-list
56644170|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644171|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56644172|NCT02707250|Narcotics|narcotics|mesh-ancestor
56644173|NCT02707250|Analgesics|analgesics|mesh-ancestor
56644174|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56644175|NCT03781544|Acetaminophen|acetaminophen|mesh-list
56644176|NCT03781544|Diclofenac|diclofenac|mesh-list
56644177|NCT03781544|Tramadol|tramadol|mesh-list
56644178|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56644179|NCT03781544|Analgesics|analgesics|mesh-ancestor
56644180|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
56644181|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644182|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644183|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
56644184|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56644185|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644186|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644187|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56644188|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644189|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644190|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56644191|NCT03781544|Narcotics|narcotics|mesh-ancestor
56644192|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644193|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
56644194|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644195|NCT02707016|Sevoflurane|sevoflurane|mesh-list
56644196|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56644197|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56644198|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
56644199|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
56644200|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644201|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644202|NCT02706704|Adalimumab|adalimumab|mesh-list
56586757|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
56586758|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586759|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56586760|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56586761|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56586762|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586763|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586764|NCT02817321|Morphine|morphine|mesh-list
56586765|NCT02817321|Ropivacaine|ropivacaine|mesh-list
56586766|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56586767|NCT02817321|Narcotics|narcotics|mesh-ancestor
56644203|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644204|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644205|NCT04956146|Carboplatin|carboplatin|mesh-list
56644206|NCT04956146|Pemetrexed|pemetrexed|mesh-list
56644207|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644208|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644209|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644210|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56644211|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56644212|NCT00612794|Exenatide|exenatide|mesh-list
56644213|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56644214|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644215|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56586768|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586769|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586797|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56586798|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
56586799|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586800|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56586801|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586802|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586803|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56586804|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586805|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56586806|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
56586807|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56586808|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586809|NCT04480125|Azacitidine|azacitidine|mesh-list
56586810|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56586811|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
56586812|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586813|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586814|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586815|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
56586816|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56586817|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
56586839|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56586841|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586842|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586843|NCT00820222|Capecitabine|capecitabine|mesh-list
56586844|NCT00820222|Trastuzumab|trastuzumab|mesh-list
56586845|NCT00820222|Lapatinib|lapatinib|mesh-list
56586846|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56586847|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
56586848|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586849|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586850|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56586851|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56586852|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586853|NCT02815449|Iron|iron|mesh-list
56586854|NCT02815449|Trace Elements|trace elements|mesh-ancestor
56586855|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
56586856|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586857|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
56586858|NCT01039688|Tofacitinib|tofacitinib|mesh-list
56586859|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56586860|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586861|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586862|NCT02237508|Budesonide|budesonide|mesh-list
56586863|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
56586864|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56586865|NCT02237508|Charcoal|charcoal|mesh-list
56644216|NCT00612794|Incretins|incretins|mesh-ancestor
56644217|NCT00612794|Hormones|hormones|mesh-ancestor
56644218|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644219|NCT03773276|Norepinephrine|norepinephrine|mesh-list
56644220|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56644221|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56644222|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
56644223|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644224|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644225|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644226|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
56644227|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
56644228|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644229|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56644230|NCT02706860|Atorvastatin|atorvastatin|mesh-list
56586866|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56586867|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56158673|NCT04978584|Vincristine|vincristine|mesh-list
56586869|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586870|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586871|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56586900|NCT05579574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586901|NCT05579574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56586902|NCT05579574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56586903|NCT05579574|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
56586904|NCT05579574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56586905|NCT03954366|Rucaparib|rucaparib|mesh-list
56586906|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56586907|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
56586908|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
56586909|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56586910|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56586911|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
56586912|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586938|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
56586940|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56586941|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56586943|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
56586944|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586945|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586946|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56586947|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586948|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56586949|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586950|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586951|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
56586952|NCT02876978|Fludarabine|fludarabine|mesh-list
56586953|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56586954|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
56586955|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586956|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586957|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56586958|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
56586959|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586960|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586985|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56586986|NCT02812641|Growth Substances|growth substances|mesh-ancestor
56586987|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644231|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56586988|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
56586989|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
56586990|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586991|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56586992|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56586993|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
56586994|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
56586995|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56586996|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
56586997|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586998|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
56586999|NCT04219722|Protective Agents|protective agents|mesh-ancestor
56587001|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56587002|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56587003|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587004|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587005|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56587006|NCT00626990|Temozolomide|temozolomide|mesh-list
56587007|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56587008|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
56587009|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587010|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587011|NCT01057862|Naltrexone|naltrexone|mesh-list
56587012|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56587020|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
56587021|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587022|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587023|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587024|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56587025|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56587026|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
56587027|NCT04303520|Fludarabine|fludarabine|mesh-list
56587028|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587029|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
56587030|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587031|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587032|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56587033|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
56587034|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587035|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587036|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56587037|NCT02562378|Doxorubicin|doxorubicin|mesh-list
56587038|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56587039|NCT02562378|Trastuzumab|trastuzumab|mesh-list
56587040|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56587041|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587042|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56587043|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56587044|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587045|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587046|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56587047|NCT00842530|Vaccines|vaccines|mesh-list
56587048|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
56587049|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587050|NCT05580510|Empagliflozin|empagliflozin|mesh-list
56587051|NCT05580510|Valsartan|valsartan|mesh-list
56587052|NCT05580510|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56587053|NCT05580510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56587054|NCT05580510|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56587055|NCT05580510|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56587056|NCT05580510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587057|NCT05580510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56587058|NCT05580510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56587059|NCT05580510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587060|NCT02811627|Memantine|memantine|mesh-list
56587061|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56587062|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56587063|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
56587064|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587065|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587066|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644232|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56644233|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
56644234|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644235|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56644236|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56644237|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644238|NCT02706470|Cyclosporine|cyclosporine|mesh-list
56644239|NCT02706470|Cyclosporins|cyclosporins|mesh-list
56644240|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
56644241|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644242|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587067|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56587068|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56587069|NCT00634413|Budesonide|budesonide|mesh-list
56587070|NCT00634413|Theophylline|theophylline|mesh-list
56587071|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56587072|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56587073|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
56587074|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587075|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587076|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56587077|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
56587078|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
56587079|NCT00634413|Hormones|hormones|mesh-ancestor
56122391|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587091|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56587093|NCT02815059|Hormones|hormones|mesh-ancestor
56587094|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56587095|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587096|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56587097|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587098|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56587099|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587100|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587101|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
56587102|NCT00819910|Fenofibrate|fenofibrate|mesh-list
56587103|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56587104|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587105|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56587106|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
56587107|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587108|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56587109|NCT02808117|Micronutrients|micronutrients|mesh-list
56587110|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587111|NCT04321395|Vigabatrin|vigabatrin|mesh-list
56587112|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
56587113|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587114|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587115|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
56587116|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587117|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587118|NCT02814669|Atezolizumab|atezolizumab|mesh-list
56587119|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56587120|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587121|NCT02808741|Olorofim|olorofim|mesh-list
56587122|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
56587123|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587124|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56587125|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56587126|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56587127|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56587128|NCT02807571|Anesthetics|anesthetics|mesh-list
56587129|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072133|NCT00354692|Hematinics|hematinics|mesh-ancestor
56644243|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644244|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
56644245|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644264|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644265|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644267|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56644268|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644269|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56644270|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644271|NCT03764540|Prednisone|prednisone|mesh-list
56644272|NCT03764540|Docetaxel|docetaxel|mesh-list
56644273|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644274|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
56644275|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644276|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644277|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644278|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644279|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
56644280|NCT03764540|Hormones|hormones|mesh-ancestor
56644281|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644282|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238222|NCT01760642|Rifampin|rifampin|mesh-list
56587130|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587131|NCT02807415|Ivacaftor|ivacaftor|mesh-list
56587132|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56587133|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56587134|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587135|NCT02804841|Vitamin D|vitamin d|mesh-list
56587136|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
56587137|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
56587138|NCT02804841|Vitamins|vitamins|mesh-list
56587139|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
56587140|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122448|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
56587192|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56587193|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56587194|NCT02800785|Renal Agents|renal agents|mesh-ancestor
56587195|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56587196|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56587197|NCT00830128|Pregabalin|pregabalin|mesh-list
56587198|NCT00830128|Analgesics|analgesics|mesh-ancestor
56587199|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
56587200|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587201|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587202|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
56587203|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56587204|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56587205|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122547|NCT01568112|Aspirin|aspirin|mesh-list
56587234|NCT03730194|Melatonin|melatonin|mesh-list
56587235|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
56587236|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644283|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56644284|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
56644285|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
56644286|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644287|NCT02706236|Pancrelipase|pancrelipase|mesh-list
56644288|NCT02706236|Pancreatin|pancreatin|mesh-list
56644289|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56644290|NCT04863248|Docetaxel|docetaxel|mesh-list
56644291|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644292|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56644293|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644294|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644295|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644296|NCT00613496|Irbesartan|irbesartan|mesh-list
56644297|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56644298|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56644299|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56644300|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290297|NCT03346135|Melphalan|melphalan|mesh-list
56644339|NCT00612950|Hormones|hormones|mesh-ancestor
56644340|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644341|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644342|NCT00612950|Incretins|incretins|mesh-ancestor
56644343|NCT00884793|Ritonavir|ritonavir|mesh-list
56644344|NCT00884793|Lopinavir|lopinavir|mesh-list
56644371|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56644372|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56644373|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56644374|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644375|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56644376|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644377|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
56644378|NCT02636829|Calcium|calcium|mesh-list
56644379|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56644380|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644381|NCT00884325|Levocetirizine|levocetirizine|mesh-list
56490249|NCT05424393|Etanercept|etanercept|mesh-list
56587237|NCT03730194|Protective Agents|protective agents|mesh-ancestor
56587238|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587239|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587240|NCT03893175|Acetaminophen|acetaminophen|mesh-list
56587241|NCT03893175|Ibuprofen|ibuprofen|mesh-list
56587242|NCT03893175|Oxycodone|oxycodone|mesh-list
56587243|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56587244|NCT03893175|Analgesics|analgesics|mesh-ancestor
56587245|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
56587246|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587247|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587248|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
56587249|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56587250|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56587276|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56587277|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56587278|NCT03865290|Ondansetron|ondansetron|mesh-list
56587279|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
56587280|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
56587281|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587282|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587283|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56587284|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
56587285|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
56587286|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56587287|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
56587288|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587289|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587290|NCT03865290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56587291|NCT03865290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56587292|NCT03865290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587293|NCT03865290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56587294|NCT03865290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56587295|NCT05333250|Modafinil|modafinil|mesh-list
56587296|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56587297|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587298|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56587323|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587324|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56587325|NCT00763555|Vitamins|vitamins|mesh-ancestor
56587326|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
56587327|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56587328|NCT02804373|Oxytocin|oxytocin|mesh-list
56587329|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
56587330|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56587331|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587332|NCT05477953|Nifurtimox|nifurtimox|mesh-list
56587333|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56587334|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56587335|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56587336|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644382|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56644383|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56644384|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
56644385|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
56644386|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644387|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644388|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644389|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56644390|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
56290372|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
56547626|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56644391|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644392|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56644393|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
56644394|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644395|NCT04705844|Adalimumab|adalimumab|mesh-list
56644396|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644397|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644398|NCT00636896|Olanzapine|olanzapine|mesh-list
56644399|NCT00636896|Modafinil|modafinil|mesh-list
56644400|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
56644401|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
56644402|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490318|NCT05468359|Sorafenib|sorafenib|mesh-list
56587337|NCT00763321|Acetaminophen|acetaminophen|mesh-list
56587338|NCT00763321|Hydrocodone|hydrocodone|mesh-list
56587339|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56587340|NCT00763321|Analgesics|analgesics|mesh-ancestor
56587341|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
56587342|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587343|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587344|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
56587345|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56587346|NCT00763321|Narcotics|narcotics|mesh-ancestor
56587347|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587348|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
56587411|NCT05549115|Levofloxacin|levofloxacin|mesh-list
56587412|NCT05549115|Ofloxacin|ofloxacin|mesh-list
56587413|NCT05549115|Furazolidone|furazolidone|mesh-list
56587414|NCT05549115|Bismuth|bismuth|mesh-list
56587415|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56587416|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587417|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56587418|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587419|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587420|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56587421|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56587422|NCT05549115|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56587423|NCT05549115|Renal Agents|renal agents|mesh-ancestor
56587424|NCT05549115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56587425|NCT05549115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56587426|NCT05549115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587427|NCT05549115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56644403|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644404|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56644405|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56644406|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56644407|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644408|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56644409|NCT00636896|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56644410|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56644411|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56644412|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644413|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644414|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
56644415|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56644416|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56644417|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56644418|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56644419|NCT04470674|Carboplatin|carboplatin|mesh-list
56644420|NCT04470674|Pemetrexed|pemetrexed|mesh-list
56644421|NCT04470674|Durvalumab|durvalumab|mesh-list
56587428|NCT05549115|Antacids|antacids|mesh-ancestor
56587429|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56587430|NCT05549115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56587431|NCT05549115|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56587432|NCT05549115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56587433|NCT05549115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56587434|NCT05549115|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56587435|NCT04236219|Rasburicase|rasburicase|mesh-list
56587436|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
56587437|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587501|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587502|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56587503|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
56587504|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587505|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587506|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
56587507|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587509|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56587510|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56587511|NCT02798913|Clopidogrel|clopidogrel|mesh-list
56587512|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56587513|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56587514|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56587515|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56587516|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
56587517|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587518|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587519|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587520|NCT00762463|Celecoxib|celecoxib|mesh-list
56587521|NCT00762463|Diclofenac|diclofenac|mesh-list
56587522|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56587523|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56587524|NCT00762463|Analgesics|analgesics|mesh-ancestor
56587525|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
56587526|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644422|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644423|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644424|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644425|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56644426|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56644427|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56644428|NCT00883779|Gemcitabine|gemcitabine|mesh-list
56644429|NCT00883779|Carboplatin|carboplatin|mesh-list
56587527|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587528|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56587529|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587530|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56587531|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56587548|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
56587549|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587550|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587551|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56587552|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56587553|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
56587554|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587555|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56587556|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56587557|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56587558|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
56587559|NCT00906282|Carboplatin|carboplatin|mesh-list
56587560|NCT00906282|Pemetrexed|pemetrexed|mesh-list
56587561|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587562|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587563|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587564|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56587565|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56587566|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
56587567|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56587568|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587569|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56587570|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587571|NCT02798367|Melatonin|melatonin|mesh-list
56587572|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
56587573|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587574|NCT02798367|Protective Agents|protective agents|mesh-ancestor
56587575|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587576|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587577|NCT00762229|Ezetimibe|ezetimibe|mesh-list
56587578|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56587579|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56587580|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
56587581|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587582|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56587583|NCT00907374|Benazepril|benazepril|mesh-list
56587584|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56587585|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
56587586|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587587|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587588|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56587589|NCT02805231|Vitamin D|vitamin d|mesh-list
56587590|NCT02805231|Vitamins|vitamins|mesh-ancestor
56587611|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587613|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
56587614|NCT02640222|Apixaban|apixaban|mesh-list
56587615|NCT02640222|Dabigatran|dabigatran|mesh-list
56587616|NCT02640222|Vitamins|vitamins|mesh-ancestor
56587617|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
56587618|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587619|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56587620|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
56587621|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56644430|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56644431|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644432|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56644433|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
56644434|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644435|NCT00883779|Antiviral Agents|antiviral agents|mesh-ancestor
56644436|NCT00883779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644437|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644438|NCT00883779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644439|NCT00883779|Immunologic Factors|immunologic factors|mesh-ancestor
56644440|NCT00883779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644441|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56490486|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56587622|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
56587623|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587624|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587625|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
56587626|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56587627|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56587628|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
56587629|NCT02640222|Coagulants|coagulants|mesh-ancestor
56587630|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56587631|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
56587632|NCT00818662|Antibodies|antibodies|mesh-list
56587633|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
56587634|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56587635|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56587636|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
56587637|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
56587638|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587639|NCT03983031|Rituximab|rituximab|mesh-list
56587640|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56587641|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587642|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
56587643|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587644|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587645|NCT02797977|Gemcitabine|gemcitabine|mesh-list
56587686|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587687|NCT00913588|Fluoxetine|fluoxetine|mesh-list
56587688|NCT00913588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56587689|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56587690|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56587691|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587692|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587693|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
56587694|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587695|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56587696|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
56587697|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56587698|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56587699|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56587700|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587701|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
56587702|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56587703|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587704|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56587705|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587706|NCT02797587|Nicotine|nicotine|mesh-list
56587707|NCT02797587|Varenicline|varenicline|mesh-list
56587708|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56587709|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
56587710|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644442|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56644443|NCT05263778|Ezetimibe|ezetimibe|mesh-list
56644444|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56644445|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56587711|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587712|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56587713|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56587735|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587736|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587737|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56587739|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
56587740|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
56587741|NCT03843645|Anesthetics|anesthetics|mesh-list
56587742|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587743|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587744|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
56587745|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56587746|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56587747|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56587748|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56587749|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56587750|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587751|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
56587752|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587753|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587754|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56587755|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587756|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
56587757|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56587758|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56587759|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587760|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
56587761|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
56587762|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
56587763|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587764|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
56587797|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56587798|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56587799|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56587800|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587802|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587803|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587804|NCT00760669|Methotrexate|methotrexate|mesh-list
56587805|NCT00760669|Infliximab|infliximab|mesh-list
56587806|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56587807|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
56587853|NCT02795949|Trimethoprim|trimethoprim|mesh-list
56587854|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
56587855|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587856|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
56587857|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56587858|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56587859|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587860|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587861|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587862|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56587863|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56587864|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56587865|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56587866|NCT02795949|Renal Agents|renal agents|mesh-ancestor
56158713|NCT04095624|Narcotics|narcotics|mesh-ancestor
56587867|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
56587868|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56587869|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56587870|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56587871|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56587872|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56587873|NCT00769483|Gemcitabine|gemcitabine|mesh-list
56587874|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56072134|NCT02989727|Lamotrigine|lamotrigine|mesh-list
56644446|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
56644447|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644448|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56644449|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644450|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56644451|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644452|NCT02693444|Lidocaine|lidocaine|mesh-list
56644453|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
56644454|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
56644455|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644456|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644457|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
56644458|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644459|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56644460|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56644461|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56644462|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56490617|NCT00450203|Bevacizumab|bevacizumab|mesh-list
56587875|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56587876|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
56587877|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587878|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587879|NCT00769483|Antiviral Agents|antiviral agents|mesh-ancestor
56587880|NCT00769483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587881|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587882|NCT00769483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587883|NCT00769483|Immunologic Factors|immunologic factors|mesh-ancestor
56587884|NCT00769483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587885|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56587886|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
56587887|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56587911|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
56587912|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587913|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587914|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56587915|NCT04234191|Buprenorphine|buprenorphine|mesh-list
56587916|NCT04234191|Hydromorphone|hydromorphone|mesh-list
56587917|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56587918|NCT04234191|Naloxone|naloxone|mesh-list
56587919|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56587920|NCT04234191|Narcotics|narcotics|mesh-ancestor
56587921|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587922|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587923|NCT04234191|Analgesics|analgesics|mesh-ancestor
56587924|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
56587925|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587926|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56587927|NCT02801799|Ropivacaine|ropivacaine|mesh-list
56587928|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
56587929|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
56587930|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587931|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587932|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
56587933|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587934|NCT02690103|Ribavirin|ribavirin|mesh-list
56587935|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
56051410|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644463|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644464|NCT04162743|Trazodone|trazodone|mesh-list
56644465|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56644466|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56644467|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644468|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587936|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587937|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
56587968|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587969|NCT02793843|Dexamethasone|dexamethasone|mesh-list
56587970|NCT02793843|Ondansetron|ondansetron|mesh-list
56587971|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56587972|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
56587973|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
56587974|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587975|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587976|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56587977|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
56587978|NCT02793843|Hormones|hormones|mesh-ancestor
56587979|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56587980|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56587981|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587982|NCT02793843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587983|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588013|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588015|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588016|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588017|NCT03787251|Apatinib|apatinib|mesh-list
56588018|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588019|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56588020|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588021|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588022|NCT02789865|Metronidazole|metronidazole|mesh-list
56588023|NCT02789865|Levofloxacin|levofloxacin|mesh-list
56588024|NCT02789865|Ofloxacin|ofloxacin|mesh-list
56588025|NCT02789865|Ertapenem|ertapenem|mesh-list
56588026|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588027|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56588028|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56588029|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56588051|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
56588052|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
56588053|NCT02535936|Anesthetics|anesthetics|mesh-list
56588054|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588055|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588056|NCT05332470|Lamivudine|lamivudine|mesh-list
56588057|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56588058|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56588059|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588060|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588061|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
56336618|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
56588062|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588063|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56588064|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56588066|NCT02791815|Midazolam|midazolam|mesh-list
56588067|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56588068|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56588069|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588070|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588071|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56588072|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56588073|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56588074|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56588075|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
56588076|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
56588077|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
56588078|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
56644469|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56644470|NCT04162743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56644471|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56644472|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56644473|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644474|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644475|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
56644476|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56644477|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
56644478|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
56644479|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
56644480|NCT05263700|FAPI-46|fapi-46|mesh-list
56644481|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56644482|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644483|NCT04302896|Tenofovir|tenofovir|mesh-list
56644484|NCT04302896|Lamivudine|lamivudine|mesh-list
56644485|NCT04302896|Emtricitabine|emtricitabine|mesh-list
56644486|NCT04302896|Dolutegravir|dolutegravir|mesh-list
56644487|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56644488|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
56644489|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644490|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56644491|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56490741|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
56588079|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588080|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588081|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56588082|NCT02389374|Chloroquine|chloroquine|mesh-list
56588083|NCT02389374|Lumefantrine|lumefantrine|mesh-list
56588084|NCT02389374|Artemether|artemether|mesh-list
56588108|NCT03889743|Dexamethasone|dexamethasone|mesh-list
56588109|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588110|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
56588111|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
56588112|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588113|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588114|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56588115|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
56588116|NCT03889743|Hormones|hormones|mesh-ancestor
56588117|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588118|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56588119|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588120|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
56588121|NCT04202484|Tegafur|tegafur|mesh-list
56588122|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588123|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56588124|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
56588125|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588126|NCT03068910|Spironolactone|spironolactone|mesh-list
56588127|NCT03068910|Progesterone|progesterone|mesh-list
56588128|NCT03068910|Progestins|progestins|mesh-ancestor
56588129|NCT03068910|Hormones|hormones|mesh-ancestor
56072135|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
56644492|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644493|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644494|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56644495|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56644496|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56644497|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56644498|NCT00656643|Sirolimus|sirolimus|mesh-list
56644499|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56644500|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644501|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56644502|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644503|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
56588130|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588131|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588132|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56588133|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
56588134|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56123435|NCT01489020|Vaccines|vaccines|mesh-list
56588197|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56588198|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588199|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588200|NCT03485274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56588201|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56588202|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56588203|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588204|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588205|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
56588206|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56123514|NCT01512108|Liraglutide|liraglutide|mesh-list
56588227|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56588228|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56588230|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
56588231|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588232|NCT02788851|Guanfacine|guanfacine|mesh-list
56588233|NCT02788851|Methylphenidate|methylphenidate|mesh-list
56588234|NCT02788851|Amphetamine|amphetamine|mesh-list
56588235|NCT02788851|Adderall|adderall|mesh-list
56588236|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
56588237|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56588238|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56588239|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588240|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56588241|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56588242|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56588243|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588244|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
56588245|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588246|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
56588247|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
56588248|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588249|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
56588250|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56588251|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56588252|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56588253|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56588254|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56588256|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56588257|NCT03477396|Hormones|hormones|mesh-ancestor
56588258|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588259|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588301|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644504|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644505|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
56644506|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644507|NCT04291820|Anesthetics|anesthetics|mesh-list
56644508|NCT04291820|Sevoflurane|sevoflurane|mesh-list
56644509|NCT04291820|Desflurane|desflurane|mesh-list
56644510|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644511|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644512|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56644513|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56644514|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
56644515|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56644516|NCT03712202|Nivolumab|nivolumab|mesh-list
56644517|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56644518|NCT03712202|Doxorubicin|doxorubicin|mesh-list
56644519|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56644520|NCT03712202|Daunorubicin|daunorubicin|mesh-list
56644521|NCT03712202|Bleomycin|bleomycin|mesh-list
56644522|NCT03712202|Dacarbazine|dacarbazine|mesh-list
56644523|NCT03712202|Vinblastine|vinblastine|mesh-list
56644524|NCT03712202|Antibodies|antibodies|mesh-list
56644525|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
56644526|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56644527|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
56644528|NCT03712202|Imidazole|imidazole|mesh-list
56644529|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
56644530|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644531|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644532|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56588302|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56588303|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56588304|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
56588305|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
56588306|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588307|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56158727|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
56588308|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56588309|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588310|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588311|NCT00905034|Dexamethasone|dexamethasone|mesh-list
56588313|NCT00905034|Methotrexate|methotrexate|mesh-list
56588341|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56588342|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56588343|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
56588344|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
56588345|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
56588347|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56588348|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56588349|NCT02611804|Analgesics|analgesics|mesh-ancestor
56588350|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
56588351|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644533|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56644534|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56644535|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644536|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644537|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56644538|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56644539|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
56290593|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644540|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56644542|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644543|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644544|NCT02635971|Gemcitabine|gemcitabine|mesh-list
56588352|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588353|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588354|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588355|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56588356|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588357|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588358|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
56588359|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56588400|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56588401|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
56588402|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588403|NCT00706576|Mitogens|mitogens|mesh-list
56588404|NCT00706576|Enkephalins|enkephalins|mesh-list
56588405|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588406|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56588407|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588408|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588409|NCT00828568|Imiquimod|imiquimod|mesh-list
56588410|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56588411|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
56588412|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588413|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588414|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
56588415|NCT01038752|Suramin|suramin|mesh-list
56588490|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588491|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588492|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56588493|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56588494|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
56588495|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56588496|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56588497|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
56588520|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56588521|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588522|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56588523|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56588524|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
56588525|NCT05758012|Oxytocin|oxytocin|mesh-list
56588526|NCT05758012|Carbetocin|carbetocin|mesh-list
56588527|NCT05758012|Oxytocics|oxytocics|mesh-ancestor
56588528|NCT05758012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56588529|NCT05758012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588530|NCT02786667|Rotigotine|rotigotine|mesh-list
56588531|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
56588532|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
56588533|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588534|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588535|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588536|NCT00913276|Propofol|propofol|mesh-list
56588537|NCT00913276|Sevoflurane|sevoflurane|mesh-list
56588538|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56644545|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
56644546|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56644547|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
56644548|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644549|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644550|NCT02635971|Antiviral Agents|antiviral agents|mesh-ancestor
56644551|NCT02635971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644552|NCT02635971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644553|NCT02635971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644554|NCT02635971|Immunologic Factors|immunologic factors|mesh-ancestor
56644555|NCT02635971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644556|NCT00657423|Cisplatin|cisplatin|mesh-list
56588539|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588540|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588541|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56588542|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
56588543|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
56588544|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56588545|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56588546|NCT04302116|Prednisolone|prednisolone|mesh-list
56588547|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56588548|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
56588549|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56588573|NCT05756998|Trace Elements|trace elements|mesh-ancestor
56588574|NCT05756998|Micronutrients|micronutrients|mesh-ancestor
56588575|NCT05756998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588577|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
56588578|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588579|NCT02890212|Protective Agents|protective agents|mesh-ancestor
56588580|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588581|NCT02890212|Trace Elements|trace elements|mesh-ancestor
56588582|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
56588583|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56588584|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56588585|NCT05387577|Estradiol|estradiol|mesh-list
56337133|NCT00214864|Docetaxel|docetaxel|mesh-list
56588586|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56588587|NCT05387577|Estrogens|estrogens|mesh-ancestor
56588588|NCT05387577|Hormones|hormones|mesh-ancestor
56588589|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588590|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588591|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56588592|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
56588593|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56588594|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56588595|NCT03044613|Paclitaxel|paclitaxel|mesh-list
56588596|NCT03044613|Carboplatin|carboplatin|mesh-list
56588597|NCT03044613|Nivolumab|nivolumab|mesh-list
56588598|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56588599|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588600|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
56588601|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
56588602|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
56123890|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
56588635|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
56588636|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588637|NCT00904722|Rituximab|rituximab|mesh-list
56588638|NCT00904722|Pidilizumab|pidilizumab|mesh-list
56588639|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588640|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588641|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
56588642|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123954|NCT01496976|Hormones|hormones|mesh-ancestor
56588668|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56588669|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644557|NCT00657423|Docetaxel|docetaxel|mesh-list
56644558|NCT00657423|Endostar protein|endostar protein|mesh-list
56644559|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644560|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
56644561|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644562|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644563|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644564|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56644565|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56644566|NCT00657423|Growth Substances|growth substances|mesh-ancestor
56644567|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644568|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
56644569|NCT03765788|Prednisolone|prednisolone|mesh-list
56644570|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588670|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
56588671|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
56588672|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588673|NCT01029782|Renal Agents|renal agents|mesh-ancestor
56588674|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56588675|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56588676|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56588677|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588678|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
56588679|NCT02849730|Fentanyl|fentanyl|mesh-list
56588680|NCT02849730|Analgesics|analgesics|mesh-list
56588681|NCT02849730|Ropivacaine|ropivacaine|mesh-list
56588682|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
56588683|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
56588684|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588685|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588686|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
56588687|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588688|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56588689|NCT02849730|Narcotics|narcotics|mesh-ancestor
56588690|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56588691|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56588692|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
56588693|NCT03936192|Meloxicam|meloxicam|mesh-list
56588706|NCT00930228|Flutamide|flutamide|mesh-list
56588707|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
56588708|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
56588709|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588710|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588711|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56588712|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588713|NCT05309655|Adenosine|adenosine|mesh-list
56588714|NCT05309655|Analgesics|analgesics|mesh-ancestor
56588715|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
56588716|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588717|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588718|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56588719|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
56588720|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56588721|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
56588722|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
56588723|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588724|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588725|NCT05043870|Infliximab|infliximab|mesh-list
56588726|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56588727|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
56588728|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56588729|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588730|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
56072346|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644571|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
56644572|NCT03765788|Hormones|hormones|mesh-ancestor
56644573|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644574|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644575|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56644576|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644577|NCT00911235|Fluconazole|fluconazole|mesh-list
56644578|NCT00911235|Fesoterodine|fesoterodine|mesh-list
56644579|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
56644580|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644581|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56644582|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56644583|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644584|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644585|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56644586|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
56644587|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644588|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644589|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56644590|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56644591|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56644592|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56644593|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
56644594|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644595|NCT00911235|Urological Agents|urological agents|mesh-ancestor
56588731|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588732|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56588733|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588734|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56588735|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588736|NCT02786979|Aspirin|aspirin|mesh-list
56588737|NCT02786979|Beraprost|beraprost|mesh-list
56588738|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56588739|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56588740|NCT02786979|Analgesics|analgesics|mesh-ancestor
56588741|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
56588742|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588743|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588744|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588745|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588746|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56588747|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56588748|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588749|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56588750|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56644596|NCT00636974|Anesthetics|anesthetics|mesh-list
56644597|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644598|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644599|NCT02535351|Sunitinib|sunitinib|mesh-list
56644600|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644601|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56644602|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56644603|NCT02535351|Growth Substances|growth substances|mesh-ancestor
56644604|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644605|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
56644606|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56644607|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644608|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644609|NCT00613964|Diuretics|diuretics|mesh-list
56644610|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56644611|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
56644612|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644613|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56588751|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588752|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
56588753|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
56588790|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588792|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588793|NCT02690922|Dexamethasone|dexamethasone|mesh-list
56588794|NCT02690922|Prednisone|prednisone|mesh-list
56588795|NCT02690922|Methotrexate|methotrexate|mesh-list
56588796|NCT02690922|Dasatinib|dasatinib|mesh-list
56588797|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588798|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
56588799|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
56588800|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588801|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588802|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56588803|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
56588804|NCT02690922|Hormones|hormones|mesh-ancestor
56588805|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588806|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56588807|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588808|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56588809|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
56588810|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56588811|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56588812|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
56588813|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588814|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
56588815|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588816|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56588817|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56588818|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
56588819|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588820|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56588821|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56588823|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56588824|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588850|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051411|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
56644614|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644615|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
56644616|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56644617|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644618|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644619|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56644620|NCT05342870|Analgesics|analgesics|mesh-ancestor
56644621|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
56644622|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644623|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56644624|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56644625|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56644626|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
56644627|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644628|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644629|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56644630|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56644631|NCT05342792|Capecitabine|capecitabine|mesh-list
56644632|NCT05342792|Antibodies|antibodies|mesh-list
56644633|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
56644634|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644635|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56644636|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
56644637|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644638|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644639|NCT03616886|Paclitaxel|paclitaxel|mesh-list
56644640|NCT03616886|Carboplatin|carboplatin|mesh-list
56644641|NCT03616886|Durvalumab|durvalumab|mesh-list
56491198|NCT00553995|Analgesics|analgesics|mesh-ancestor
56588851|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588852|NCT00839956|Bortezomib|bortezomib|mesh-list
56588853|NCT00839956|Vorinostat|vorinostat|mesh-list
56588854|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588855|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56588856|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588857|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588858|NCT00839800|Terbutaline|terbutaline|mesh-list
56588859|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56588860|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56588861|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
56588862|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56588863|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
56588864|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588865|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588866|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
56644642|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56644643|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644644|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
56644645|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644646|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644647|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644648|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56644649|NCT03842696|Cyclosporine|cyclosporine|mesh-list
56644650|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
56644651|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
56644652|NCT03842696|Methotrexate|methotrexate|mesh-list
56644653|NCT03842696|Vorinostat|vorinostat|mesh-list
56644654|NCT03842696|Tacrolimus|tacrolimus|mesh-list
56644655|NCT03842696|Cyclosporins|cyclosporins|mesh-list
56588867|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
56588868|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56588869|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56588870|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56588871|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56588872|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
56588873|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851194|NCT01475721|Xhance|xhance|mesh-list
56588901|NCT05756764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56588902|NCT05756764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588904|NCT05756764|Hormones|hormones|mesh-ancestor
56588905|NCT05756764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588906|NCT05756764|Anticonvulsants|anticonvulsants|mesh-ancestor
56588907|NCT05756764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56588908|NCT05756764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56588909|NCT05756764|Appetite Depressants|appetite depressants|mesh-ancestor
56588910|NCT05756764|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56588911|NCT05756764|Sympathomimetics|sympathomimetics|mesh-ancestor
56588912|NCT05756764|Autonomic Agents|autonomic agents|mesh-ancestor
56588913|NCT05756764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588914|NCT05756764|Adrenergic Agents|adrenergic agents|mesh-ancestor
56588915|NCT05756764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588916|NCT05756764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588917|NCT05190471|Decitabine|decitabine|mesh-list
56588918|NCT05190471|Oblimersen|oblimersen|mesh-list
56588919|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56588920|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
56588921|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588922|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588923|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588942|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56588943|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588944|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
56588945|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56588946|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56588947|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56588948|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
56588949|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588950|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
56588951|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56588952|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
56588953|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56588954|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
56588955|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588956|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588957|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
56588959|NCT00902304|Valsartan|valsartan|mesh-list
56588960|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56588961|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56644656|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644657|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
56644658|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644659|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644660|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56644661|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
56644662|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644663|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644664|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56644665|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56588962|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56588963|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56588964|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56588965|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588966|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56588967|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588968|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
56588969|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56588970|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56588971|NCT00902304|Diuretics|diuretics|mesh-ancestor
56588972|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
56588973|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56588974|NCT02784795|Gemcitabine|gemcitabine|mesh-list
56588975|NCT02784795|Carboplatin|carboplatin|mesh-list
56588976|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588977|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56588978|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
56124268|NCT01439880|Evolocumab|evolocumab|mesh-list
56589028|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56589029|NCT00638079|Megestrol|megestrol|mesh-list
56589030|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
56589031|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56589032|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56589033|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56589034|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
56589035|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56589036|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589037|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56589038|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56589039|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56589041|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
56589042|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56589043|NCT00759031|Listerine|listerine|mesh-list
56589044|NCT00759031|Triclosan|triclosan|mesh-list
56589045|NCT00759031|Fluorides|fluorides|mesh-list
56589046|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
56589047|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
56589069|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
56589070|NCT02512497|Busulfan|busulfan|mesh-list
56589071|NCT02512497|Romidepsin|romidepsin|mesh-list
56589072|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
56589073|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56589074|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589075|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56589076|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
56589077|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589078|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589079|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
56589080|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589081|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
56589082|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56589083|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56589084|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56589085|NCT00916669|Etoposide|etoposide|mesh-list
56589086|NCT00916669|Enoxaparin|enoxaparin|mesh-list
56644666|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
56644667|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56644668|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56644669|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
56644670|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
56644671|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644672|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56644673|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56644674|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56644675|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
56644676|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644677|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56644678|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56644679|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
56644680|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56644681|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56644682|NCT00657891|Omalizumab|omalizumab|mesh-list
56644683|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56644684|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56644685|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
56644686|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
56491366|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589087|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
56589088|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589089|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56589090|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56589091|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56589092|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589093|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589094|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
56589095|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56589096|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56589097|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
56589098|NCT02784015|Melphalan|melphalan|mesh-list
56589099|NCT02784015|Ifosfamide|ifosfamide|mesh-list
56589100|NCT02784015|Thiotepa|thiotepa|mesh-list
56589101|NCT02784015|Carboplatin|carboplatin|mesh-list
56589102|NCT02784015|Doxorubicin|doxorubicin|mesh-list
56589130|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589132|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56589133|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
56589134|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56589135|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
56589136|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56589137|NCT02601235|Protective Agents|protective agents|mesh-ancestor
56589138|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56589139|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56589140|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56589141|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56589142|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
56589143|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
56589144|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56589145|NCT02783937|Lenograstim|lenograstim|mesh-list
56589146|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56589147|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
56644687|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56644688|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56644689|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644690|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
56644691|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644692|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644693|NCT04159077|Tamsulosin|tamsulosin|mesh-list
56644694|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56644695|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56644696|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56644697|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
56644698|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644699|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644700|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644701|NCT04159077|Urological Agents|urological agents|mesh-ancestor
56589148|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589149|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
56589168|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56589169|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56589170|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
56589171|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589172|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589173|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56589174|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56589175|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
56589176|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589177|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56589178|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56589179|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56589180|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56589182|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589183|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
56589184|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
56589185|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
56589186|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589187|NCT02782221|Hormones|hormones|mesh-list
56589188|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589189|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589190|NCT04231617|Glyburide|glyburide|mesh-list
56589191|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56589192|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589193|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56589194|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56589195|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56589196|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56589197|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589198|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56589199|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56589200|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56589201|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
56589202|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589203|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589204|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56589205|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56589206|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
56589208|NCT02845908|Fluorouracil|fluorouracil|mesh-list
56644702|NCT02690480|Fulvestrant|fulvestrant|mesh-list
56644703|NCT02690480|Palbociclib|palbociclib|mesh-list
56644704|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56644705|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644706|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56644707|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56644708|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
56644709|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644710|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644711|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56644712|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644713|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644714|NCT00658593|Gemcitabine|gemcitabine|mesh-list
56644715|NCT00658593|Capecitabine|capecitabine|mesh-list
56644716|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56644717|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
56644718|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644719|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644720|NCT00658593|Antiviral Agents|antiviral agents|mesh-ancestor
56644721|NCT00658593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644722|NCT00658593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644723|NCT00658593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644724|NCT00658593|Immunologic Factors|immunologic factors|mesh-ancestor
56644725|NCT00658593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644726|NCT00880269|Panobinostat|panobinostat|mesh-list
56644727|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589262|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589264|NCT01023308|Dexamethasone|dexamethasone|mesh-list
56589265|NCT01023308|Bortezomib|bortezomib|mesh-list
56589266|NCT01023308|Panobinostat|panobinostat|mesh-list
56589267|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56337817|NCT00219856|Propofol|propofol|mesh-list
56589268|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
56589269|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
56589270|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589271|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589272|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56589273|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
56589275|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589276|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56589277|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589278|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56589279|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589280|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589281|NCT02781909|Ibuprofen|ibuprofen|mesh-list
56589282|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56589283|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589284|NCT02781909|Analgesics|analgesics|mesh-ancestor
56644728|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56644729|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644730|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644731|NCT00880191|Dexamethasone|dexamethasone|mesh-list
56644732|NCT00880191|Gabapentin|gabapentin|mesh-list
56644733|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644734|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
56644735|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
56644736|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644737|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644738|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56644739|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
56644740|NCT00880191|Hormones|hormones|mesh-ancestor
56644741|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644742|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56644743|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644744|NCT00880191|Analgesics|analgesics|mesh-ancestor
56644745|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
56644746|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
56644747|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56644748|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56644749|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644750|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56644751|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56644752|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56589285|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
56589300|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56589301|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589302|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
56589303|NCT02781597|Coagulants|coagulants|mesh-ancestor
56589304|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56589305|NCT00757237|Tobramycin|tobramycin|mesh-list
56589306|NCT00757237|Aztreonam|aztreonam|mesh-list
56589307|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56589308|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56589309|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589310|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
56589311|NCT01029392|Vitamin D|vitamin d|mesh-list
56589312|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
56589313|NCT01029392|Vitamins|vitamins|mesh-ancestor
56589314|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
56589315|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589316|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56589317|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56589318|NCT02781753|Interferons|interferons|mesh-list
56589319|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
56589320|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
56589321|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589322|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
56589323|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589324|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
56072666|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
56644753|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644754|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644755|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
56644756|NCT00659451|Losartan|losartan|mesh-list
56644757|NCT00659451|Amlodipine|amlodipine|mesh-list
56644758|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56290744|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
56644759|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56644760|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56644761|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644762|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56644763|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644764|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
56644765|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56644766|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56644767|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56644768|NCT00911313|Metformin|metformin|mesh-list
56644769|NCT00911313|Letrozole|letrozole|mesh-list
56644770|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56644771|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644772|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644773|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56589325|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589326|NCT00903006|Dasatinib|dasatinib|mesh-list
56589327|NCT00903006|Fulvestrant|fulvestrant|mesh-list
56589328|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589329|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56589330|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589331|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589332|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56589333|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56589334|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56589335|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
56589336|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589337|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589338|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
56589339|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56589340|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
56589341|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589342|NCT00839332|Gemcitabine|gemcitabine|mesh-list
56589343|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56589344|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
56589345|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589346|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589379|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56589380|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589381|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56589382|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589383|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589384|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56589385|NCT04229355|Estrogens|estrogens|mesh-ancestor
56589386|NCT04229355|Hormones|hormones|mesh-ancestor
56644774|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56644775|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644776|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644777|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56644778|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
56644779|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644780|NCT00659685|Ondansetron|ondansetron|mesh-list
56644781|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
56644782|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
56644783|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644784|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644785|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56644786|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
56644787|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
56644788|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56644789|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
56589387|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589388|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902343|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
56589410|NCT05341401|Hormones|hormones|mesh-ancestor
56589411|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589412|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589413|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56589414|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589415|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
56589416|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589417|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56589419|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
56589420|NCT05340153|Lumefantrine|lumefantrine|mesh-list
56589421|NCT05340153|Artemether|artemether|mesh-list
56589422|NCT05340153|Piperaquine|piperaquine|mesh-list
56589423|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56589424|NCT05340153|Artenimol|artenimol|mesh-list
56589425|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
56589426|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56589427|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56589428|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589429|NCT05078502|Vitamin D|vitamin d|mesh-list
56589430|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
56589431|NCT05078502|Vitamins|vitamins|mesh-ancestor
56589432|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
56589433|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589434|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56589435|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56589436|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
56589437|NCT02844894|Esmolol|esmolol|mesh-list
56589438|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56589439|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56589440|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589441|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589442|NCT02844894|Analgesics|analgesics|mesh-ancestor
56589443|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
56589460|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56589462|NCT02339922|Antibodies|antibodies|mesh-list
56589463|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
56589464|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56589465|NCT02339922|Glycine|glycine|mesh-list
56589466|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
56589467|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589468|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644790|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644791|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644792|NCT00659685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56644793|NCT00659685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56644794|NCT00659685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644795|NCT00659685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56644796|NCT00659685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56644797|NCT00659841|Ciclesonide|ciclesonide|mesh-list
56644798|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
56644799|NCT00659841|Hormones|hormones|mesh-ancestor
56589469|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589470|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589471|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
56589472|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589473|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
56589474|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589475|NCT00634725|Gemcitabine|gemcitabine|mesh-list
56589476|NCT00634725|Capecitabine|capecitabine|mesh-list
56589477|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56589478|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56589479|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
56589480|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589481|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589482|NCT00634725|Antiviral Agents|antiviral agents|mesh-ancestor
56589483|NCT00634725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589484|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589485|NCT00634725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589486|NCT00634725|Immunologic Factors|immunologic factors|mesh-ancestor
56589487|NCT00634725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589488|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56589489|NCT05325489|Budesonide|budesonide|mesh-list
56589490|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56589491|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56589492|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
56589493|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589494|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589495|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56589496|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
56589497|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
56589498|NCT05325489|Hormones|hormones|mesh-ancestor
56589499|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589519|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56589520|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589521|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
56589522|NCT02780505|Vitamins|vitamins|mesh-ancestor
56589523|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
56589524|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589525|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
56589526|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589527|NCT02780505|Protective Agents|protective agents|mesh-ancestor
56589528|NCT02690844|Clonazepam|clonazepam|mesh-list
56589529|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
56589530|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
56589531|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
56589532|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589533|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589534|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589535|NCT04201860|Hemostatics|hemostatics|mesh-list
56589536|NCT04201860|Coagulants|coagulants|mesh-ancestor
56589537|NCT02847702|Naproxen|naproxen|mesh-list
56589538|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56589539|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589540|NCT02847702|Analgesics|analgesics|mesh-ancestor
56589541|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
56589542|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589543|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644800|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56644801|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644802|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56644803|NCT00659919|Trazodone|trazodone|mesh-list
56644804|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56644805|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56644806|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56644807|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644808|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56644809|NCT00659919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56644810|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56644811|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56644812|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644813|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644814|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
56644815|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56644816|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
56644817|NCT00659997|Albendazole|albendazole|mesh-list
56644818|NCT00659997|Levamisole|levamisole|mesh-list
56644819|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
56644820|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56644821|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644822|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
56644823|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56644824|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56644825|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
56589544|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56589545|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589546|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
56589547|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56589548|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589549|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589550|NCT02779413|Insulin|insulin|mesh-list
56589551|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56589552|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589553|NCT04887402|Clomiphene|clomiphene|mesh-list
56589554|NCT04887402|Enclomiphene|enclomiphene|mesh-list
56589580|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589581|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56589582|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56589583|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
56589584|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589585|NCT04793490|Acetaminophen|acetaminophen|mesh-list
56589586|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589587|NCT04793490|Analgesics|analgesics|mesh-ancestor
56589588|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
56589589|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589590|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589591|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
56644826|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644827|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644828|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644829|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644830|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56644831|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
56290817|NCT04604782|Regadenoson|regadenoson|mesh-list
56644832|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644833|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
56644834|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644835|NCT00660231|Gemcitabine|gemcitabine|mesh-list
56644836|NCT00660231|Bexarotene|bexarotene|mesh-list
56644837|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56644838|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
56644839|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644840|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644841|NCT00660231|Antiviral Agents|antiviral agents|mesh-ancestor
56644842|NCT00660231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491810|NCT02052648|Bevacizumab|bevacizumab|mesh-list
56589592|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
56589593|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56589594|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56589595|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589596|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56589597|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56589598|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589599|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589600|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589601|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56589602|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
56589603|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56589604|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589632|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589633|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589634|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56589635|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56589636|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
56589637|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589638|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56589639|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
56589640|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
56589641|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
56589642|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56589643|NCT00751218|Cetirizine|cetirizine|mesh-list
56589644|NCT00751218|Desloratadine|desloratadine|mesh-list
56589645|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56589646|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56589647|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56589648|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
56589649|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
56589650|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589651|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589652|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902608|NCT03801304|Atezolizumab|atezolizumab|mesh-list
56589671|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589672|NCT04095013|Analgesics|analgesics|mesh-ancestor
56644843|NCT00660231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644844|NCT00660231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644845|NCT00660231|Immunologic Factors|immunologic factors|mesh-ancestor
56644846|NCT00660231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644847|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
56644848|NCT00597519|Fludarabine|fludarabine|mesh-list
56644849|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644850|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
56644851|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644852|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644853|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56644854|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
56644855|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644856|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644857|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56644858|NCT00660621|Bevacizumab|bevacizumab|mesh-list
56644859|NCT00660621|Temozolomide|temozolomide|mesh-list
56644860|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56644861|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644862|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56644863|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56491880|NCT02912702|Dexamethasone|dexamethasone|mesh-list
56589673|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56589674|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56589675|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56589676|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
56589677|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589678|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589679|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56589680|NCT04095013|Narcotics|narcotics|mesh-ancestor
56589681|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56589682|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56589683|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
56589684|NCT02779881|Caseins|caseins|mesh-list
56589685|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
56589686|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
56589687|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589688|NCT00651378|Atorvastatin|atorvastatin|mesh-list
56589689|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56589690|NCT00651378|Ezetimibe|ezetimibe|mesh-list
56589691|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56589692|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56589693|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
56589694|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589695|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56589696|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56589697|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589698|NCT00747643|Varenicline|varenicline|mesh-list
56589699|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56589700|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56589701|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
56589702|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589703|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644864|NCT00660621|Growth Substances|growth substances|mesh-ancestor
56644865|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644866|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
56644867|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56644868|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
56644869|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644870|NCT02632305|Gemcitabine|gemcitabine|mesh-list
56644871|NCT02632305|Paclitaxel|paclitaxel|mesh-list
56644872|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56644873|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644874|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
56589704|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589705|NCT00627692|Prucalopride|prucalopride|mesh-list
56589706|NCT00627692|Laxatives|laxatives|mesh-ancestor
56589707|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56589708|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56589709|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56589710|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
56589737|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589738|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56589739|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56589740|NCT04300322|Progesterone|progesterone|mesh-list
56589741|NCT04300322|Progestins|progestins|mesh-ancestor
56589742|NCT04300322|Hormones|hormones|mesh-ancestor
56589743|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589744|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589745|NCT01022762|Repaglinide|repaglinide|mesh-list
56589746|NCT01022762|Gliclazide|gliclazide|mesh-list
56589747|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56589748|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589749|NCT05338671|Anesthetics|anesthetics|mesh-list
56589750|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
56589751|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56589752|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589753|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
56589754|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589755|NCT00311844|Desloratadine|desloratadine|mesh-list
56589756|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56589757|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
56589758|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589784|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
56589785|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589786|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589787|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589788|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
56589789|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56589790|NCT00212784|Olanzapine|olanzapine|mesh-list
56589791|NCT00212784|Asenapine|asenapine|mesh-list
56589792|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
56589793|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
56589794|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589795|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589796|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56589797|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56589798|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56589799|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56589800|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56589801|NCT00212784|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56589802|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56589803|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56589804|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589805|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589806|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
56589807|NCT00751933|Vaccines|vaccines|mesh-list
56644875|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644876|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644877|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644878|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56644879|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
56644880|NCT02632305|Antiviral Agents|antiviral agents|mesh-ancestor
56644881|NCT02632305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56644882|NCT02632305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644883|NCT02632305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644884|NCT02632305|Immunologic Factors|immunologic factors|mesh-ancestor
56644885|NCT02632305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644886|NCT02631993|Furocoumarins|furocoumarins|mesh-list
56644887|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
56644888|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56644889|NCT00660855|Parecoxib|parecoxib|mesh-list
56644890|NCT00660855|Valdecoxib|valdecoxib|mesh-list
56644891|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56644892|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56644893|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589808|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
55902755|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56589887|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589888|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56589889|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56589890|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56589891|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56589892|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56589893|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56589894|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
56589895|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589896|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589897|NCT05335278|Nintedanib|nintedanib|mesh-list
56589898|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589899|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56589900|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589901|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589902|NCT00092898|Ezetimibe|ezetimibe|mesh-list
56589903|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56589904|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56589905|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
56589906|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589907|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56589908|NCT04094467|Leuprolide|leuprolide|mesh-list
56589909|NCT04094467|Cetrorelix|cetrorelix|mesh-list
56589910|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56589911|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
56589912|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56589913|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589914|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56589915|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589916|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
56589964|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56589965|NCT02844270|Sirolimus|sirolimus|mesh-list
56589966|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56589967|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589968|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56589969|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589970|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
56644894|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644895|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56644896|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56644897|NCT00660855|Analgesics|analgesics|mesh-ancestor
56644898|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
56644899|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644900|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644901|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644902|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644903|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56644904|NCT00660933|Hematinics|hematinics|mesh-ancestor
56644905|NCT02632071|Paclitaxel|paclitaxel|mesh-list
56290891|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644906|NCT02632071|Ricolinostat|ricolinostat|mesh-list
56644907|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56644908|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644909|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
56644910|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644911|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644912|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644913|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56644914|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644915|NCT00879333|Everolimus|everolimus|mesh-list
56644916|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644917|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644918|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
56644919|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644920|NCT02630823|Paclitaxel|paclitaxel|mesh-list
56644921|NCT02630823|Carboplatin|carboplatin|mesh-list
56644922|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
56644923|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56644924|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56644925|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
56644926|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
56644927|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
56644928|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644929|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56644931|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
56644932|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56644933|NCT02630511|Diuretics|diuretics|mesh-ancestor
56644934|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
56644935|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644936|NCT02630511|Miotics|miotics|mesh-ancestor
56644937|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
56644938|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644939|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56644940|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56644941|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
56644942|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56644943|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56644944|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
56644945|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644946|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644947|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
56644948|NCT00666159|Tacrolimus|tacrolimus|mesh-list
56644949|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56644950|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
56644951|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644952|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56644953|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56644954|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644955|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56644956|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56644957|NCT00666159|Analgesics|analgesics|mesh-ancestor
56644958|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
56644959|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644960|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56644961|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56644962|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
56644975|NCT00666627|Alendronate|alendronate|mesh-list
56644976|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
56644977|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
56644978|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56644979|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644980|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56644981|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56644982|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290974|NCT03959488|Palivizumab|palivizumab|mesh-list
56644983|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56644984|NCT00666783|Palonosetron|palonosetron|mesh-list
56644985|NCT00666783|Granisetron|granisetron|mesh-list
56644986|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
56644987|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
56644988|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56644989|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56644990|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56644991|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56644992|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56644993|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
56589971|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589972|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
56589973|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589974|NCT00634959|Maraviroc|maraviroc|mesh-list
56590049|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590050|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590051|NCT02776059|Prednisolone|prednisolone|mesh-list
56590052|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590053|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
56590054|NCT02776059|Hormones|hormones|mesh-ancestor
56590055|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590056|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590057|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56590058|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590059|NCT00774930|Lanreotide|lanreotide|mesh-list
56590060|NCT00774930|Somatostatin|somatostatin|mesh-list
56590061|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590062|NCT00774930|Hormones|hormones|mesh-ancestor
56590063|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590064|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590065|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56590066|NCT02841774|Pravastatin|pravastatin|mesh-list
56590067|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56590068|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56590069|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
56480256|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56590099|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56590100|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56590101|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590102|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590103|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
56590105|NCT03205956|Carbidopa|carbidopa|mesh-list
56590106|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56590107|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56590108|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
56644994|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56644995|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56644996|NCT00666939|Gabapentin|gabapentin|mesh-list
56644997|NCT00666939|Analgesics|analgesics|mesh-ancestor
56644998|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
56644999|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645000|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645001|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
56590109|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590110|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590111|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590112|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56590113|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590114|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
56590115|NCT02840994|Nivolumab|nivolumab|mesh-list
56590176|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56590178|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56590179|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590180|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590181|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590182|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
56590183|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590184|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56590185|NCT01034462|Analgesics|analgesics|mesh-ancestor
56590186|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
56590187|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590188|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56590189|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
56590190|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590191|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
56590192|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590258|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
56590259|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590260|NCT02774187|Antidotes|antidotes|mesh-ancestor
56590261|NCT02774187|Protective Agents|protective agents|mesh-ancestor
56590262|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
56590263|NCT02774187|Vitamins|vitamins|mesh-ancestor
56590264|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
56590265|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56590266|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590267|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
56590268|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56590269|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590270|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590271|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56590272|NCT02773797|Analgesics|analgesics|mesh-ancestor
56590273|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
56590274|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590275|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56590276|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56590277|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56590278|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
56590279|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590313|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
56590314|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590315|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590316|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590317|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56590318|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56590319|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590320|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590321|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56590322|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
56590323|NCT02773407|Azithromycin|azithromycin|mesh-list
56590324|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56590325|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56645002|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56645003|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56645004|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645005|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56645006|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56645007|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56645008|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645009|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645010|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
56645011|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56645012|NCT00667407|Albuterol|albuterol|mesh-list
56645013|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56645014|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
56645015|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645016|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590326|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590327|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56590328|NCT02773407|Renal Agents|renal agents|mesh-ancestor
56590329|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
56590330|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56590331|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56590332|NCT00715611|Carboplatin|carboplatin|mesh-list
56590333|NCT00715611|Pemetrexed|pemetrexed|mesh-list
56590334|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590335|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590336|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590337|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56590338|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56590339|NCT04224675|Atenolol|atenolol|mesh-list
56590396|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56590397|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590398|NCT02767245|Thiamine|thiamine|mesh-list
56590399|NCT02767245|Vitamins|vitamins|mesh-ancestor
56590400|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
56590401|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590402|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
56590403|NCT02767401|Aspirin|aspirin|mesh-list
56590404|NCT02767401|Metoprolol|metoprolol|mesh-list
56590405|NCT02767401|Clopidogrel|clopidogrel|mesh-list
56590406|NCT02767401|Ticagrelor|ticagrelor|mesh-list
56590407|NCT02767401|Atorvastatin|atorvastatin|mesh-list
56590408|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56590409|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56590410|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56590411|NCT02767401|Analgesics|analgesics|mesh-ancestor
56590412|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
56590413|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590414|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590415|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590416|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56590417|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56590418|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56590419|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590420|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56590421|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56590422|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590423|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
56590424|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56590425|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56590426|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
56590427|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56645017|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56645018|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
56645019|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
56645020|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56645021|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56645022|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56645023|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56645024|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
56645025|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645026|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645027|NCT00667485|Sirolimus|sirolimus|mesh-list
56645028|NCT00667485|Bevacizumab|bevacizumab|mesh-list
56645029|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56645030|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645031|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56645032|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56645033|NCT00667485|Growth Substances|growth substances|mesh-ancestor
56645034|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903367|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590438|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56590439|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56590440|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56590442|NCT02767479|Esomeprazole|esomeprazole|mesh-list
56590443|NCT02767479|Rabeprazole|rabeprazole|mesh-list
56590444|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56590445|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590446|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56590447|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590448|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590449|NCT02767635|Triamcinolone|triamcinolone|mesh-list
56590450|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56590451|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56590452|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56590453|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56590454|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56590455|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56590456|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590457|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590458|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56590459|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56590460|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590461|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
56590462|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590463|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590464|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
56590465|NCT02767635|Hormones|hormones|mesh-ancestor
56590466|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590467|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56590468|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
56590469|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590470|NCT04224441|Temozolomide|temozolomide|mesh-list
56338995|NCT00127270|Urological Agents|urological agents|mesh-ancestor
56590471|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
56590472|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56590473|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
56051412|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56645035|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
56645036|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56645037|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645038|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56645039|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
56645040|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645041|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
56645042|NCT00667641|Paclitaxel|paclitaxel|mesh-list
56645043|NCT00667641|Bortezomib|bortezomib|mesh-list
56645044|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56645045|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645046|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
56645047|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
56590474|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590475|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590476|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
56590477|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
56590478|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590479|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590480|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590481|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56590482|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56590483|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590484|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590485|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56590486|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
56590487|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590488|NCT02767089|Prednisone|prednisone|mesh-list
56590489|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590490|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
56590491|NCT02767089|Hormones|hormones|mesh-ancestor
56590519|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56590520|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56590521|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590522|NCT04532463|Fluconazole|fluconazole|mesh-list
56590523|NCT04532463|Amphotericin B|amphotericin b|mesh-list
56590524|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56590525|NCT04532463|Flucytosine|flucytosine|mesh-list
56590526|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
56590527|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590528|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56590529|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56590530|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590531|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590532|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56590533|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
56590534|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590535|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590536|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56590537|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56590538|NCT04532463|Amebicides|amebicides|mesh-ancestor
56590572|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56590573|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590574|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590575|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
56590576|NCT04090021|Amoxicillin|amoxicillin|mesh-list
56590577|NCT04090021|Metronidazole|metronidazole|mesh-list
56590578|NCT04090021|Clarithromycin|clarithromycin|mesh-list
56590579|NCT04090021|Levofloxacin|levofloxacin|mesh-list
56590580|NCT04090021|Ofloxacin|ofloxacin|mesh-list
56590581|NCT04090021|Rifabutin|rifabutin|mesh-list
56590582|NCT04090021|Esomeprazole|esomeprazole|mesh-list
56590583|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56590584|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590585|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56645048|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
56645049|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645050|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56645051|NCT00667797|Albuterol|albuterol|mesh-list
56645052|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56645053|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
56645054|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645055|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645056|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56291043|NCT03958981|Castor Oil|castor oil|mesh-list
56645057|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
56645058|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
56645059|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56645060|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56645061|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56645062|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56645063|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
56645064|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645065|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645066|NCT03481556|Dexamethasone|dexamethasone|mesh-list
56645067|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
56645068|NCT03481556|Bortezomib|bortezomib|mesh-list
56645069|NCT03481556|Melphalan|melphalan|mesh-list
56645070|NCT03481556|Daratumumab|daratumumab|mesh-list
56645071|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645072|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
56492406|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
56492407|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492408|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56492409|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56492410|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56492429|NCT05287568|Cc-486|cc-486|mesh-list
56590586|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56590587|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56590588|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590589|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56590590|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590591|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590592|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56590593|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56590594|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56590595|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56590596|NCT04090021|Renal Agents|renal agents|mesh-ancestor
56590597|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56645073|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
56645074|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645075|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645076|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56645077|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
56645078|NCT03481556|Hormones|hormones|mesh-ancestor
56645079|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645080|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56645081|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645082|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56590598|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56590599|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590600|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56590601|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56590602|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
56590630|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590631|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590632|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590633|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56590634|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
56590635|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
56590636|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56590637|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
56590638|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56590639|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
56590640|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590641|NCT02761395|Deferasirox|deferasirox|mesh-list
56590642|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56590643|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
56590644|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
56590645|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590646|NCT02761317|Bisacodyl|bisacodyl|mesh-list
56590647|NCT02761317|Cathartics|cathartics|mesh-ancestor
56590648|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590649|NCT02761317|Laxatives|laxatives|mesh-ancestor
56590686|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
56590687|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56590688|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590689|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590690|NCT04223739|Amiodarone|amiodarone|mesh-list
56590691|NCT04223739|Landiolol|landiolol|mesh-list
56590692|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56590693|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
56590694|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56590695|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56590696|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590697|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56590698|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56590699|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56590700|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590701|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56590702|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56590703|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56590704|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56590705|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56590706|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
56590707|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590708|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590709|NCT02765373|Letrozole|letrozole|mesh-list
56590739|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
56590740|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590741|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645083|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
56645084|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645085|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56645086|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645087|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
56645088|NCT00668031|Aprotinin|aprotinin|mesh-list
56645089|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
56645090|NCT00668031|Coagulants|coagulants|mesh-ancestor
56645091|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56645092|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56645093|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
56645094|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645095|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645096|NCT03480776|Aspirin|aspirin|mesh-list
56645097|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56645098|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56645099|NCT03480776|Analgesics|analgesics|mesh-ancestor
56645100|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
56645101|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645102|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645103|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645104|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645105|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56590742|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56590743|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56590744|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56590745|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56590746|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56590747|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56590748|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590749|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56590750|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56590751|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
56590752|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56590753|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590754|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56590755|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
56590756|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
56590782|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56590783|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590784|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56590785|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
56590786|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590787|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56590788|NCT02760381|Protective Agents|protective agents|mesh-ancestor
56590789|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590790|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
56590791|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56590792|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590793|NCT00744757|Decitabine|decitabine|mesh-list
56590794|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56590795|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
56645106|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56645107|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645108|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56645109|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56645110|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645111|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
56645112|NCT00668109|Tadalafil|tadalafil|mesh-list
56645113|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56645114|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
56645115|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56645116|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56645117|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645118|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645119|NCT00668109|Urological Agents|urological agents|mesh-ancestor
56645120|NCT00668343|Simvastatin|simvastatin|mesh-list
56645121|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56645122|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56645123|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
56645124|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645125|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56645126|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56645127|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645128|NCT04717700|Dexamethasone|dexamethasone|mesh-list
56645129|NCT04717700|Lenalidomide|lenalidomide|mesh-list
56645130|NCT04717700|Bortezomib|bortezomib|mesh-list
56645131|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645132|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
56645133|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
56590796|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590797|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590798|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590799|NCT00917527|Atorvastatin|atorvastatin|mesh-list
56590800|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56590801|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56590802|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
56590803|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590804|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56590805|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55903752|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
56590835|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56590836|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56590837|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590838|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590839|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56590840|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56590841|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56645134|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645135|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645136|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56645137|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
56645138|NCT04717700|Hormones|hormones|mesh-ancestor
56645139|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645140|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56645141|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645142|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
56645143|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56645144|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56645145|NCT04717700|Growth Substances|growth substances|mesh-ancestor
56645146|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
56645147|NCT02630277|Aflibercept|aflibercept|mesh-list
56645148|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56645149|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56645150|NCT02630277|Growth Substances|growth substances|mesh-ancestor
56492627|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
56590842|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56590843|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590844|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
56590845|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
56339366|NCT00044681|Risperidone|risperidone|mesh-list
56590846|NCT02764515|Methotrexate|methotrexate|mesh-list
56590847|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56590848|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
56590849|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56590850|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590851|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56590852|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
55903801|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590898|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590899|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590900|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56590901|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
56590902|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56590903|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56590904|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
56590905|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
56590906|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56590907|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56590908|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
56590909|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56590910|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56590911|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56590912|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56590944|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56590945|NCT02758509|Ledipasvir|ledipasvir|mesh-list
56590946|NCT02758509|Simeprevir|simeprevir|mesh-list
56590947|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56590948|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590949|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
56590950|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590951|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56590952|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56590953|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
56590954|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645151|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645152|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
56645153|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645154|NCT00668499|Pemetrexed|pemetrexed|mesh-list
56645155|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645156|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645157|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645158|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56645159|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56645160|NCT05201846|Insulin|insulin|mesh-list
56645161|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56645162|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56645163|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590955|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590956|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56590957|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56590958|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56590959|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56590961|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
56590978|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
56590979|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590980|NCT04479579|Apixaban|apixaban|mesh-list
56590981|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56590982|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
56590983|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56590984|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
56590985|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590986|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590987|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
56590988|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
56590989|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56590990|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590991|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590992|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56590993|NCT02757495|Analgesics|analgesics|mesh-ancestor
56590994|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
56590995|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590996|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56590997|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56590998|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56590999|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
56591000|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591001|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591002|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
56591003|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591004|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
56591005|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
56591006|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
56591007|NCT02752113|Metformin|metformin|mesh-list
56591008|NCT02752113|Empagliflozin|empagliflozin|mesh-list
56591009|NCT02752113|Linagliptin|linagliptin|mesh-list
56591010|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56591011|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591012|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56591013|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591014|NCT02752113|Incretins|incretins|mesh-ancestor
56591015|NCT02752113|Hormones|hormones|mesh-ancestor
56591016|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591017|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56591018|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
56051413|NCT01768520|Celecoxib|celecoxib|mesh-list
56645164|NCT00668967|Verapamil|verapamil|mesh-list
56645165|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56645166|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56645167|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56645168|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645169|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56645170|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645171|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
56645172|NCT03583658|Ambroxol|ambroxol|mesh-list
56645173|NCT03583658|Expectorants|expectorants|mesh-ancestor
56645174|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
56645175|NCT03555968|Dronabinol|dronabinol|mesh-list
56645176|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
56645177|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645178|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56645179|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591035|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56591037|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
56591038|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56591039|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56591040|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591041|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
56591042|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591043|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591045|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
56591046|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591047|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56591048|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56591049|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591050|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591051|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56591052|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
56591053|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591054|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591055|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56591056|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
56591057|NCT02755545|Adapalene|adapalene|mesh-list
56591058|NCT02755545|Salicylates|salicylates|mesh-list
56591059|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56591060|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591061|NCT02755545|Analgesics|analgesics|mesh-ancestor
56591062|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
56591063|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591064|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591065|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591066|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591067|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
56591068|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591069|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
56591070|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
56591071|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56591072|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591073|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591074|NCT02695797|Prednisolone|prednisolone|mesh-list
56591075|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591076|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
56591121|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56645180|NCT03555968|Analgesics|analgesics|mesh-ancestor
56645181|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
56645182|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645183|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56645184|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56645185|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645186|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645187|NCT03555968|Hormones|hormones|mesh-ancestor
56645188|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645189|NCT04593680|Tenofovir|tenofovir|mesh-list
56645190|NCT04593680|Emtricitabine|emtricitabine|mesh-list
56645191|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
56645192|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591122|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591123|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591124|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591125|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56591126|NCT02754765|Renal Agents|renal agents|mesh-ancestor
56591127|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56591128|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56591129|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56591130|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
56591131|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591132|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
56591133|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
56591134|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56591135|NCT04090801|Ethanol|ethanol|mesh-list
56591136|NCT04090801|Minoxidil|minoxidil|mesh-list
56591137|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56591138|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591139|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591140|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591141|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56591142|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
56591143|NCT04089631|Capecitabine|capecitabine|mesh-list
56591144|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56591145|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
56591146|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591181|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591182|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904142|NCT02691702|Melatonin|melatonin|mesh-list
56591207|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56591208|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
56591210|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591211|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56591212|NCT04219995|Protective Agents|protective agents|mesh-ancestor
56591213|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56591214|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591215|NCT04544475|Estrogens|estrogens|mesh-list
56591216|NCT04544475|Estradiol|estradiol|mesh-list
56591217|NCT04544475|Hormones|hormones|mesh-ancestor
56591218|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591219|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591220|NCT04200417|Mitomycins|mitomycins|mesh-list
56591221|NCT04200417|Mitomycin|mitomycin|mesh-list
56591222|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
56591223|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56591224|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591225|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
56591226|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591227|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56645193|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56645194|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56645195|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645196|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645197|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56645198|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56645199|NCT00669435|Losartan|losartan|mesh-list
56645200|NCT00669435|Amlodipine|amlodipine|mesh-list
56645201|NCT00669435|Simvastatin|simvastatin|mesh-list
56645202|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56645203|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56645204|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56645205|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591228|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591229|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
56591230|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56591231|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591232|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591233|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591234|NCT02753205|Analgesics|analgesics|mesh-ancestor
56591235|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
56591236|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591250|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591251|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56591252|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591253|NCT02752971|Analgesics|analgesics|mesh-ancestor
56591254|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591255|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591256|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56591257|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591258|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591259|NCT04188873|Varenicline|varenicline|mesh-list
56591260|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591261|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591262|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591263|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56591264|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56591265|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
56591266|NCT05289687|Daratumumab|daratumumab|mesh-list
56591267|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56591268|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591269|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
56591270|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591271|NCT02695641|Bevacizumab|bevacizumab|mesh-list
56591272|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56591273|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591274|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56591275|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56591276|NCT02695641|Growth Substances|growth substances|mesh-ancestor
56591277|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591278|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
56591279|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
56591280|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56591281|NCT02750475|Protective Agents|protective agents|mesh-ancestor
56591282|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591283|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
56591284|NCT04217265|Letrozole|letrozole|mesh-list
56591285|NCT04217265|Misoprostol|misoprostol|mesh-list
56591286|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591287|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56591288|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56645206|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56645208|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
56645209|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56645210|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56645211|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
56645212|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56645213|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56645214|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645215|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56645216|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56645217|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56645218|NCT00669591|Bavituximab|bavituximab|mesh-list
56645219|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56645220|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645221|NCT00669747|Carboplatin|carboplatin|mesh-list
56645222|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645223|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56645224|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56645225|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56645226|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
56645227|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645228|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56645229|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
56591289|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591290|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591291|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56591292|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
56591293|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591294|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591295|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56591296|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
56591326|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
56591327|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
56591329|NCT04036929|Hormones|hormones|mesh-ancestor
56591330|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591331|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591332|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56591333|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56591334|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
56591335|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56591336|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56591337|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591338|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
56591339|NCT04218981|Paroxetine|paroxetine|mesh-list
56591340|NCT04218981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56591341|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56591342|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55904285|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591370|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56645230|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56645231|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645232|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56645233|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56645234|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645235|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645236|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645237|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56645238|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56645239|NCT00670293|Raclopride|raclopride|mesh-list
56645240|NCT00670293|Methylphenidate|methylphenidate|mesh-list
56591371|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56591372|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591373|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
56591374|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591375|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591376|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56591377|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
56591378|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591379|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56591380|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
56591381|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591382|NCT04001829|Paclitaxel|paclitaxel|mesh-list
56591383|NCT04001829|Docetaxel|docetaxel|mesh-list
56591384|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55904340|NCT02691468|Silicon|silicon|mesh-list
56591415|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591416|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56591417|NCT04217733|Ethosuximide|ethosuximide|mesh-list
56591418|NCT04217733|Mebeverine|mebeverine|mesh-list
56591419|NCT04217733|Alverine|alverine|mesh-list
56591420|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
56591421|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
56591422|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
56591423|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591424|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591425|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56591426|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56591427|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56591428|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56591429|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591430|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
56591457|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591458|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591459|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56591460|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
56591461|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591462|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591463|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56591464|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
56591465|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56591466|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56591467|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56591468|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591469|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56591470|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
56591471|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591472|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56591473|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56591474|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56591475|NCT03879135|Factor VIII|factor viii|mesh-list
56591476|NCT03879135|Coagulants|coagulants|mesh-ancestor
56645241|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56645242|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645243|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56645244|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56645245|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56645246|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645247|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
56645248|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645249|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56645250|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56645251|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645252|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56645253|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56645254|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
56645255|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56645256|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645257|NCT00670761|Misoprostol|misoprostol|mesh-list
56645258|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56645259|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
56645260|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56645261|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645262|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56645263|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56591477|NCT02741817|Aspirin|aspirin|mesh-list
56591478|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56591479|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591480|NCT02741817|Analgesics|analgesics|mesh-ancestor
56591481|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
56591499|NCT02745873|Protective Agents|protective agents|mesh-ancestor
56591501|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
56591502|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56591503|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
56591504|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591505|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591506|NCT02745717|Cyclosporine|cyclosporine|mesh-list
56591507|NCT02745717|Cyclosporins|cyclosporins|mesh-list
56591508|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
56591509|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56591510|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591511|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591512|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56591513|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
56591514|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591515|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
56591516|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591517|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
56591518|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591519|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56591520|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
56591521|NCT02745561|Endostatins|endostatins|mesh-list
56340042|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
56645264|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
56645265|NCT04537208|Vaccines|vaccines|mesh-list
56645266|NCT04537208|Immunologic Factors|immunologic factors|mesh-ancestor
56645267|NCT04537208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645268|NCT00680433|Ketamine|ketamine|mesh-list
56645269|NCT00680433|Analgesics|analgesics|mesh-ancestor
56645270|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
56645271|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645272|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645273|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56645274|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56645275|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
56645276|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
56645277|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591522|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591523|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56591524|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56591525|NCT02745561|Growth Substances|growth substances|mesh-ancestor
56591526|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591527|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
56591528|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
56591529|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56591530|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591531|NCT02745093|Misoprostol|misoprostol|mesh-list
56591532|NCT02745093|Mifepristone|mifepristone|mesh-list
56591533|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56591534|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
56591535|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56591536|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591537|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56591538|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56591560|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591562|NCT02740803|Fluorides|fluorides|mesh-list
56591563|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
56591564|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
56591565|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
56591566|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
56591567|NCT02740803|Protective Agents|protective agents|mesh-ancestor
56591568|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591569|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56591570|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591571|NCT02740647|Amoxicillin|amoxicillin|mesh-list
56591572|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
56591573|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
56591574|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56591575|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56591576|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591577|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56591578|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591579|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591580|NCT03737253|Menotropins|menotropins|mesh-list
56591581|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56591582|NCT03737253|Hormones|hormones|mesh-ancestor
56591583|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591584|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591585|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56591586|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
56591587|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56591588|NCT00812968|Lenalidomide|lenalidomide|mesh-list
56591589|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
56591612|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56591613|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291264|NCT03152149|Fluticasone|fluticasone|mesh-list
56645278|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56645279|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56645280|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645281|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645282|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
56645283|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56645284|NCT03322280|Estrogens|estrogens|mesh-ancestor
56645285|NCT03322280|Hormones|hormones|mesh-ancestor
56645286|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645287|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645288|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56645289|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645290|NCT04150965|Thalidomide|thalidomide|mesh-list
56645291|NCT04150965|Dexamethasone|dexamethasone|mesh-list
56645292|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
56645293|NCT04150965|Pomalidomide|pomalidomide|mesh-list
56645294|NCT04150965|Elotuzumab|elotuzumab|mesh-list
56591614|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56591615|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56591616|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591617|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
56591618|NCT05394337|Atezolizumab|atezolizumab|mesh-list
56591619|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591620|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56591621|NCT02744625|Propofol|propofol|mesh-list
56591622|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56591623|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591624|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591625|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56591626|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
56591627|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
56591628|NCT02610556|Cisplatin|cisplatin|mesh-list
56591629|NCT02610556|Docetaxel|docetaxel|mesh-list
56591630|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591631|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56591632|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56591633|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56591634|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591635|NCT02740101|Oxytocin|oxytocin|mesh-list
56591636|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
56591637|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56591638|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591639|NCT02612116|Ticagrelor|ticagrelor|mesh-list
56591640|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56591641|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55904586|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56591677|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
56591678|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591679|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56591681|NCT02739633|Antiviral Agents|antiviral agents|mesh-ancestor
56591682|NCT02739633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591683|NCT02739633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591684|NCT02739633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56591685|NCT02739633|Immunologic Factors|immunologic factors|mesh-ancestor
56591686|NCT02739633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591687|NCT02739477|Favipiravir|favipiravir|mesh-list
56591688|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
56591689|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645295|NCT04150965|BB 1101|bb 1101|mesh-list
56645296|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645297|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
56645298|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
56645299|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645300|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645301|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56645302|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
56645303|NCT04150965|Hormones|hormones|mesh-ancestor
56645304|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645305|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56645306|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645307|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
56645308|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645309|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645310|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
56645311|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56645312|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56645313|NCT04150965|Growth Substances|growth substances|mesh-ancestor
56493215|NCT04667910|Ranibizumab|ranibizumab|mesh-list
56591690|NCT02739399|Phenylephrine|phenylephrine|mesh-list
56591743|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591744|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56591745|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
56591746|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56591747|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56591748|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56591750|NCT02742285|Lumefantrine|lumefantrine|mesh-list
56591751|NCT02742285|Artemether|artemether|mesh-list
56591752|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56591753|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
56591754|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56591755|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56591756|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591757|NCT03673527|Tacrolimus|tacrolimus|mesh-list
56591758|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56591759|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
56591760|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591761|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56591762|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591763|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591764|NCT02738931|Lamivudine|lamivudine|mesh-list
56591765|NCT02738931|Dolutegravir|dolutegravir|mesh-list
56591766|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56591767|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56591768|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591769|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591770|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
56591771|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591772|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56591773|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56591774|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56591775|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56591776|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
56591777|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56645314|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
56645315|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645316|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
56645317|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56645318|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645319|NCT04150575|Paclitaxel|paclitaxel|mesh-list
56645320|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56645321|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56645322|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645323|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
56645324|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
56591778|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591779|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591780|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591781|NCT05208892|Analgesics|analgesics|mesh-ancestor
56591782|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
56591783|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591784|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56591785|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56591786|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56591787|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
56591788|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591789|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591790|NCT02609386|Zinc|zinc|mesh-list
56591791|NCT02609386|Indomethacin|indomethacin|mesh-list
56591792|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
56591793|NCT02609386|Omeprazole|omeprazole|mesh-list
56591794|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55904723|NCT01581931|Hormones|hormones|mesh-ancestor
56591818|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56591820|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
56591821|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
56591822|NCT02738619|Vitamins|vitamins|mesh-list
56591823|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
56158828|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
56591824|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591825|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56591826|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56591827|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
56591828|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56591829|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591830|NCT02736591|Hormones|hormones|mesh-list
56591831|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56591832|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591833|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591834|NCT05757466|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56591835|NCT05757466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56591836|NCT05757466|Alkylating Agents|alkylating agents|mesh-ancestor
56591837|NCT05757466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591838|NCT05757466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591839|NCT02736513|Osimertinib|osimertinib|mesh-list
56591840|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591841|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56591842|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904787|NCT01535287|Analgesics|analgesics|mesh-ancestor
56591862|NCT05757388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591863|NCT05757388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56591864|NCT05757388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591865|NCT05757388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591866|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56591867|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
56591868|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56591869|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
56591870|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591871|NCT00748189|Ofatumumab|ofatumumab|mesh-list
56645325|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
56645326|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591872|NCT00748189|Chlorambucil|chlorambucil|mesh-list
56591873|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591874|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56591875|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
56591876|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591877|NCT02609230|TIC10 compound|tic10 compound|mesh-list
56158831|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
56591878|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591879|NCT00913822|Desipramine|desipramine|mesh-list
56591880|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56591881|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
56591882|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56591883|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591884|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591885|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56591886|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56591887|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56591888|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
56591889|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591890|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591891|NCT02736123|Nivolumab|nivolumab|mesh-list
56591892|NCT02736123|Ipilimumab|ipilimumab|mesh-list
56591893|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56591894|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591895|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56591896|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591951|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56591952|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
56591953|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
56591954|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591955|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591956|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591957|NCT00743509|Sirolimus|sirolimus|mesh-list
56591958|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
56591959|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56591960|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
56591961|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591962|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591963|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56591964|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
56591965|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591966|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591967|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56591968|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56591969|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340506|NCT00046826|Docetaxel|docetaxel|mesh-list
56591970|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56591971|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
56591973|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
56592006|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
56592007|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
56592008|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592009|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56592010|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56592011|NCT00734851|Growth Substances|growth substances|mesh-ancestor
56592012|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592013|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
56592014|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56592015|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592016|NCT00734617|Nicotine|nicotine|mesh-list
56592017|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56592018|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
56592019|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592020|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592021|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56592022|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56592023|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
56592024|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592025|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645327|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
56645328|NCT05345132|Nifedipine|nifedipine|mesh-list
56645329|NCT05345132|Analgesics|analgesics|mesh-ancestor
56645330|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
56645331|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645332|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645333|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
56645334|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645335|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56645336|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
56645337|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56645338|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56592026|NCT00743431|Doxorubicin|doxorubicin|mesh-list
56592027|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56592028|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592029|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56592030|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56592031|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592032|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592033|NCT03593655|Tenofovir|tenofovir|mesh-list
56592034|NCT03593655|Emtricitabine|emtricitabine|mesh-list
56592035|NCT03593655|Dapivirine|dapivirine|mesh-list
56592036|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
56592037|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592038|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56592039|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56592040|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592041|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592042|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56592043|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56592044|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56592045|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
56592046|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592066|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592067|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592068|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56592069|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
56592070|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592071|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592072|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56592073|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56592074|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
56592075|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592076|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
56592077|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592078|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592079|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
56592080|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592081|NCT00734539|Fluconazole|fluconazole|mesh-list
56592082|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
56592083|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592084|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56592085|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56592086|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592087|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592088|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56592089|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
56592090|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592091|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592092|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56592093|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56645339|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645340|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56645341|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
56592094|NCT02737059|Codeine|codeine|mesh-list
56592095|NCT02737059|Naloxegol|naloxegol|mesh-list
56592096|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56592097|NCT02737059|Narcotics|narcotics|mesh-ancestor
56592098|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905053|NCT02689518|Aflibercept|aflibercept|mesh-list
56592118|NCT00734149|Prednisone|prednisone|mesh-list
56592119|NCT00734149|Bortezomib|bortezomib|mesh-list
56592120|NCT00734149|Melphalan|melphalan|mesh-list
56592121|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56592122|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
56592123|NCT00734149|Hormones|hormones|mesh-ancestor
56592124|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592125|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592126|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56592127|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592128|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56592129|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
56592130|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592131|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56592132|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56592133|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
56592134|NCT04089163|Flucytosine|flucytosine|mesh-list
56592135|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
56592136|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592137|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
56592138|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592139|NCT00743197|Aspirin|aspirin|mesh-list
56592140|NCT00743197|Lisinopril|lisinopril|mesh-list
56592141|NCT00743197|Simvastatin|simvastatin|mesh-list
56592142|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56592143|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56592144|NCT00743197|Analgesics|analgesics|mesh-ancestor
56592145|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
56592146|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592147|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592148|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56592149|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56592150|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56592151|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56592152|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592153|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55905101|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
56592192|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
56592193|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56592195|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56592196|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56592197|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56592198|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
56592199|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
56592200|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592201|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56592202|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592203|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592204|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
56592205|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592206|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592207|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56592208|NCT00734071|Vortioxetine|vortioxetine|mesh-list
56592209|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
56592210|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56592211|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56592212|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56592213|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592214|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592215|NCT00734071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56592216|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56592217|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56645342|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56592218|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592219|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592220|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
56592221|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56592247|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592248|NCT05430243|Empagliflozin|empagliflozin|mesh-list
56592250|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56592251|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592252|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56592253|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592254|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
56592255|NCT02730117|Cephalosporins|cephalosporins|mesh-list
56592256|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56592257|NCT02730117|Dobutamine|dobutamine|mesh-list
56592258|NCT02730117|Dopamine|dopamine|mesh-list
56592259|NCT02730117|Milrinone|milrinone|mesh-list
56592260|NCT02730117|Norepinephrine|norepinephrine|mesh-list
56592261|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56592262|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56592263|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56592264|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
56592265|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340808|NCT00080847|Hormones|hormones|mesh-ancestor
56592266|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592267|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592268|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
56592269|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
56592289|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56592290|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56592291|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56592292|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56592293|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592294|NCT02597257|Lidocaine|lidocaine|mesh-list
56592295|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592296|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
56592297|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592298|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592299|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
56592300|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592301|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56592302|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56592303|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56592304|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56592305|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592306|NCT02593669|Dexamethasone|dexamethasone|mesh-list
56592307|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56592308|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
56592309|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
56592310|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592311|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592312|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56592313|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
56592314|NCT02593669|Hormones|hormones|mesh-ancestor
56592315|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592316|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56592317|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592318|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56592319|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56592320|NCT02729961|Ceritinib|ceritinib|mesh-list
56592321|NCT02729961|Antibodies|antibodies|mesh-list
56592322|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
56592323|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56592377|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
56592378|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592379|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592380|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56592381|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56592382|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
56592383|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
56592384|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592385|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56072789|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645343|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
56645344|NCT04349306|Rasburicase|rasburicase|mesh-list
56592386|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56592387|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592388|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592389|NCT05377333|Dulaglutide|dulaglutide|mesh-list
56592390|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56592391|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592392|NCT00811954|Ritonavir|ritonavir|mesh-list
56592393|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56592394|NCT00811954|Darunavir|darunavir|mesh-list
56592395|NCT00811954|Tenofovir|tenofovir|mesh-list
56592396|NCT00811954|Emtricitabine|emtricitabine|mesh-list
56592397|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
56592398|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56592399|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56592415|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
56592416|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56592417|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56592418|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592419|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56592420|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592421|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56592422|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56592423|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592424|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56592425|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56592426|NCT01032200|Modafinil|modafinil|mesh-list
56592427|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56592428|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592429|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56592430|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56592431|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56592432|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592433|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
56592434|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56592435|NCT00586105|Sorafenib|sorafenib|mesh-list
56592436|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592437|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56592438|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592439|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592440|NCT05510427|Bevacizumab|bevacizumab|mesh-list
56592441|NCT05510427|Atezolizumab|atezolizumab|mesh-list
56592442|NCT05510427|Infigratinib|infigratinib|mesh-list
56592443|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56592444|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592445|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56592446|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56592447|NCT05510427|Growth Substances|growth substances|mesh-ancestor
56592448|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592449|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
56592450|NCT05757310|Vidarabine|vidarabine|mesh-list
56592451|NCT05757310|Cyclophosphamide|cyclophosphamide|mesh-list
56592452|NCT05757310|Pentostatin|pentostatin|mesh-list
56592453|NCT05757310|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56592454|NCT05757310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56592455|NCT05757310|Immunologic Factors|immunologic factors|mesh-ancestor
56592456|NCT05757310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905416|NCT01531205|Hormones|hormones|mesh-ancestor
56592529|NCT00813124|Azacitidine|azacitidine|mesh-list
56592530|NCT00813124|Busulfan|busulfan|mesh-list
56592531|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
56592532|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56592533|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592534|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56592535|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
56592536|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592537|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56592538|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
56592539|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592540|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592541|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
56592542|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56592543|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56645345|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
56645346|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645347|NCT00614588|Anesthetics|anesthetics|mesh-list
56645348|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645349|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645350|NCT03421652|Nivolumab|nivolumab|mesh-list
56645351|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56645352|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645353|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56645354|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645355|NCT02699840|Vaccines|vaccines|mesh-list
56645356|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
56645357|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645358|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
56645359|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56645360|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
56645361|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645362|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645363|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56645364|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
56645365|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56645366|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
56645367|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493693|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56592544|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56592545|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56592546|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56592547|NCT03133221|Idelalisib|idelalisib|mesh-list
56592548|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592549|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592550|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592551|NCT02728869|Vaccines|vaccines|mesh-list
56592552|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
56592553|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592554|NCT02594761|Trastuzumab|trastuzumab|mesh-list
56592555|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56592556|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592557|NCT02728947|Rotigotine|rotigotine|mesh-list
56592558|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
55905523|NCT00121719|Lenvatinib|lenvatinib|mesh-list
56592585|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
56592586|NCT02733471|Lidocaine|lidocaine|mesh-list
56592587|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592588|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
56592589|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592590|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592591|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
56592592|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592593|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56592594|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56592595|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56645368|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645369|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56592596|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56592597|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592598|NCT02733237|Oxytocin|oxytocin|mesh-list
56592599|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
56592600|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56592601|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592602|NCT04206813|Vaccines|vaccines|mesh-list
56592603|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
56592604|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592605|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
56592606|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592607|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
55905574|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56592629|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592631|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
56592632|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592633|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592634|NCT02609152|Esmolol|esmolol|mesh-list
56592635|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56592636|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56592637|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56341190|NCT00145522|Tibolone|tibolone|mesh-list
56592638|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
56592639|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592640|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592641|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592642|NCT02733393|Lidocaine|lidocaine|mesh-list
56592643|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592644|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
56592645|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592646|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592647|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
56592648|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592649|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56592650|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56592651|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56592652|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56592653|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592654|NCT00809926|Valsartan|valsartan|mesh-list
56592655|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56592656|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56592657|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56592658|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592659|NCT02728245|Dienogest|dienogest|mesh-list
56592660|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56592661|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
56592662|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56592663|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592664|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56592665|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56592666|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56592667|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56592668|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
56158928|NCT02775240|Protective Agents|protective agents|mesh-ancestor
56592669|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592670|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56592671|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592672|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56592673|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55905631|NCT00266799|Doxorubicin|doxorubicin|mesh-list
56592715|NCT05755204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592716|NCT05755204|Antiviral Agents|antiviral agents|mesh-ancestor
56592717|NCT05755204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592718|NCT05755204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56592719|NCT05755204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56592721|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158952|NCT05348148|Cetirizine|cetirizine|mesh-list
56592722|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56645370|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
56645371|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
56645372|NCT00613808|Protective Agents|protective agents|mesh-ancestor
56645373|NCT05344742|Paclitaxel|paclitaxel|mesh-list
56645374|NCT05344742|Capecitabine|capecitabine|mesh-list
56493842|NCT00538187|Bortezomib|bortezomib|mesh-list
56592723|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592724|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592725|NCT05755750|Genipin|genipin|mesh-list
56592726|NCT05755750|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56592727|NCT05755750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56592728|NCT02732067|Anesthetics|anesthetics|mesh-list
56592729|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592730|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592731|NCT02609932|Interferons|interferons|mesh-list
56592732|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
56592733|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592734|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
56592735|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592736|NCT02726919|Clobazam|clobazam|mesh-list
56592737|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
56592738|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56592739|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56592740|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592741|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592742|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56592743|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56592744|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
56592745|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
56592746|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592747|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592748|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56592776|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592777|NCT02720991|Misoprostol|misoprostol|mesh-list
56592778|NCT02720991|Mifepristone|mifepristone|mesh-list
56592779|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56592780|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
56592781|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56592782|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341331|NCT00047723|Minocycline|minocycline|mesh-list
56592783|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56592784|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56592785|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
56592786|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56592787|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56592788|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56592789|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56592790|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
56158966|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56592791|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55905769|NCT01535053|Hematinics|hematinics|mesh-ancestor
56592879|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592880|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
56592881|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592882|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592883|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
56592884|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592885|NCT02725359|Analgesics|analgesics|mesh-ancestor
56592886|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
56592887|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56592888|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56592889|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
56592890|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
56592891|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56592892|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56592893|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56592894|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
56592895|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592896|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592897|NCT00731731|Temozolomide|temozolomide|mesh-list
56592898|NCT00731731|Vorinostat|vorinostat|mesh-list
56592899|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56645375|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
56645376|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56645377|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645378|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
56645379|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
56645380|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
56645381|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645382|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56592900|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
56592901|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592902|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592903|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56592904|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592905|NCT05755048|Trastuzumab|trastuzumab|mesh-list
56026509|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
56592906|NCT05755048|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56592908|NCT05755048|Antibodies|antibodies|mesh-list
56592909|NCT05755048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56592910|NCT05755048|Immunologic Factors|immunologic factors|mesh-ancestor
56592911|NCT05755048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592912|NCT05755048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56592913|NCT05755048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592914|NCT05755048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56592915|NCT05755048|Tubulin Modulators|tubulin modulators|mesh-ancestor
56592916|NCT05755048|Antimitotic Agents|antimitotic agents|mesh-ancestor
56592917|NCT05755048|Mitosis Modulators|mitosis modulators|mesh-ancestor
56592918|NCT05755048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592919|NCT02719431|Warfarin|warfarin|mesh-list
56592948|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
56592949|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56592950|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
56592951|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56592952|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56592953|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592954|NCT00811252|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56592955|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
56592956|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56592957|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56592958|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56592959|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56592960|NCT05753098|Estrogens|estrogens|mesh-list
56592961|NCT05753098|Hormones|hormones|mesh-ancestor
56592962|NCT05753098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592963|NCT05753098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592993|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592994|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
56592995|NCT05294523|Rocuronium|rocuronium|mesh-list
56592996|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56592997|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56592998|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56592999|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593000|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593001|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
56593002|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56593003|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593004|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56593005|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593006|NCT02718261|Pantoprazole|pantoprazole|mesh-list
56593007|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56593008|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593009|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56593010|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593042|NCT02717871|Besifloxacin|besifloxacin|mesh-list
56593043|NCT02717871|Prednisolone|prednisolone|mesh-list
56593044|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56645383|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
56645384|NCT05344742|Analgesics|analgesics|mesh-ancestor
56645385|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
56645386|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645387|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493959|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
56593045|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
56593046|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56593047|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
56593048|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56593049|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56593050|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
56593051|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
56593052|NCT02717871|Mydriatics|mydriatics|mesh-list
56593053|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56593054|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
56593055|NCT02717871|Hormones|hormones|mesh-ancestor
56593056|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56593057|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593058|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56593059|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593075|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56593076|NCT02717871|Renal Agents|renal agents|mesh-ancestor
56593077|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56593078|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56593079|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
56593080|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56593081|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56593082|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
56593083|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593084|NCT02723253|Raltitrexed|raltitrexed|mesh-list
56593085|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593086|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56593087|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
56593088|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593089|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56593090|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593091|NCT00730405|Albaconazole|albaconazole|mesh-list
56593092|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
56593093|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593095|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56593096|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593097|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
56593098|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56593099|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593100|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
56593101|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593102|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
56593103|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
56593104|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56593105|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
56593106|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
56593107|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593108|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593109|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56593110|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
56593111|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56593112|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593113|NCT00736645|Selenium|selenium|mesh-list
56593114|NCT00736645|Finasteride|finasteride|mesh-list
56593115|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56593116|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56593117|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593118|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593119|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
56593162|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56593164|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593165|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56593166|NCT02715687|Amiodarone|amiodarone|mesh-list
56593167|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56645388|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56645389|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56645390|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645391|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56593168|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
56593169|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56593170|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56593171|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593172|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56593173|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56593174|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56593175|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593176|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56593177|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56593178|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56593179|NCT04068831|Avelumab|avelumab|mesh-list
56593180|NCT04068831|Talazoparib|talazoparib|mesh-list
56593181|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56593182|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593183|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56593184|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593185|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593186|NCT02715531|Leucovorin|leucovorin|mesh-list
56593187|NCT02715531|Gemcitabine|gemcitabine|mesh-list
56593188|NCT02715531|Paclitaxel|paclitaxel|mesh-list
56593189|NCT02715531|Bevacizumab|bevacizumab|mesh-list
56593190|NCT02715531|Capecitabine|capecitabine|mesh-list
56593191|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
56593192|NCT02715531|Atezolizumab|atezolizumab|mesh-list
56593193|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56593194|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593224|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593225|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56593226|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56593227|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
56593228|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
56593229|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593230|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56593231|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56341780|NCT00405808|Hormones|hormones|mesh-ancestor
56593232|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593233|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593234|NCT00914056|Lactulose|lactulose|mesh-list
56593235|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593236|NCT00730171|Linaclotide|linaclotide|mesh-list
56593237|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56593238|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
55906213|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56593270|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56593271|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
56593272|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
56593273|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593274|NCT04227093|Acetazolamide|acetazolamide|mesh-list
56593275|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
56593276|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56593277|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593278|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593279|NCT04227093|Diuretics|diuretics|mesh-ancestor
56593280|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
56593281|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593282|NCT00805792|Donepezil|donepezil|mesh-list
56593283|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56593284|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593285|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593286|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
56593287|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593288|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593289|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
56593290|NCT04783935|Cladribine|cladribine|mesh-list
56593291|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593292|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645392|NCT02046434|Glycerol|glycerol|mesh-list
56645393|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56645394|NCT02046434|Protective Agents|protective agents|mesh-ancestor
56645395|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645396|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645397|NCT03930446|Ethanol|ethanol|mesh-list
56645398|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56645399|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494097|NCT00539123|Analgesics|analgesics|mesh-ancestor
56593293|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
56593294|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593295|NCT04777929|Progesterone|progesterone|mesh-list
56593296|NCT04777929|Estrogens|estrogens|mesh-list
56593297|NCT04777929|Progestins|progestins|mesh-ancestor
56593298|NCT04777929|Hormones|hormones|mesh-ancestor
56593299|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56593300|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593301|NCT00590044|Insulin|insulin|mesh-list
55906267|NCT02386488|Vortioxetine|vortioxetine|mesh-list
56593330|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
56593331|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56593332|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593334|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
56593335|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
56593336|NCT00729937|Cephalexin|cephalexin|mesh-list
56593337|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56593338|NCT00729937|Trimethoprim|trimethoprim|mesh-list
56593339|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
56593340|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56593341|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593342|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56593343|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593344|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593345|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56593346|NCT00729937|Renal Agents|renal agents|mesh-ancestor
56593347|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
56593348|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55906318|NCT01511939|Analgesics|analgesics|mesh-ancestor
56593367|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
56593368|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56593369|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56593370|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593371|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593372|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56593373|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
56593375|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593376|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56593377|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593378|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593379|NCT00736333|Doxorubicin|doxorubicin|mesh-list
56593380|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56593381|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56593382|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593383|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56593384|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56593385|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593386|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593388|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
56593389|NCT00736255|Nicotine|nicotine|mesh-list
56593390|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56593391|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
56593392|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593393|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593394|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56593395|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56593396|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
56593397|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887573|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56645400|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645401|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645402|NCT00614666|Nikkomycin|nikkomycin|mesh-list
56645403|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
56645404|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645405|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645406|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645407|NCT03794336|Aspirin|aspirin|mesh-list
56645408|NCT03794336|Metformin|metformin|mesh-list
56593398|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593399|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56593400|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56593401|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56593402|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56593403|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
56593404|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
55906371|NCT01510769|Febuxostat|febuxostat|mesh-list
56593436|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
56593437|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593438|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593439|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56593441|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56593442|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56593443|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593444|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56593445|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56593446|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593447|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
56593448|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56593449|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56593450|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56593451|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
56593452|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593453|NCT05750134|Pancrelipase|pancrelipase|mesh-list
56593454|NCT05750134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593455|NCT05749822|Fenofibrate|fenofibrate|mesh-list
56593456|NCT05749822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56593457|NCT05749822|Antimetabolites|antimetabolites|mesh-ancestor
56341992|NCT00149578|Antiviral Agents|antiviral agents|mesh-ancestor
56593458|NCT05749822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593459|NCT05749822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56593460|NCT02713191|Fentanyl|fentanyl|mesh-list
56593461|NCT02713191|Midazolam|midazolam|mesh-list
56593462|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
56593463|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56593498|NCT05754502|Tubulin Modulators|tubulin modulators|mesh-ancestor
56593499|NCT05754502|Antimitotic Agents|antimitotic agents|mesh-ancestor
56593500|NCT05754502|Mitosis Modulators|mitosis modulators|mesh-ancestor
56593501|NCT05754502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593502|NCT02712957|Naproxen|naproxen|mesh-list
56593503|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56593504|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56593505|NCT02712957|Analgesics|analgesics|mesh-ancestor
56593506|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
56593507|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593508|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593509|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56593510|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56593511|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
56593512|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56593513|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593514|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593515|NCT04226625|Propofol|propofol|mesh-list
56593516|NCT04226625|Desflurane|desflurane|mesh-list
56593517|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56593518|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645409|NCT03794336|Alogliptin|alogliptin|mesh-list
56645410|NCT03794336|Acarbose|acarbose|mesh-list
56645411|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56645412|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645413|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56645414|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56494246|NCT00540605|Tenofovir|tenofovir|mesh-list
56593519|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593520|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56593521|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
56593522|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
56593523|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56593524|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
56593525|NCT02777619|Propofol|propofol|mesh-list
56593526|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56593527|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593528|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593529|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56593530|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
56593531|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
56593532|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56342075|NCT04725448|Paclitaxel|paclitaxel|mesh-list
56593533|NCT02777619|Analgesics|analgesics|mesh-ancestor
56593534|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
56593535|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593572|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56593574|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
56593604|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593605|NCT00635037|Bupivacaine|bupivacaine|mesh-list
56593606|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
56342148|NCT00082251|Vitamins|vitamins|mesh-ancestor
56593607|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
56593608|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593609|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593610|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
56593611|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593612|NCT02777151|Atoltivimab|atoltivimab|mesh-list
56593613|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
56593614|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
56593615|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593616|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
56593617|NCT02777073|Liraglutide|liraglutide|mesh-list
56593635|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56593636|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593637|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593638|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593639|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56593640|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56593641|NCT02776761|Vaccines|vaccines|mesh-list
56593642|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
56593643|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593644|NCT04848753|Paclitaxel|paclitaxel|mesh-list
56593645|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56593646|NCT04848753|Cisplatin|cisplatin|mesh-list
56593647|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56593648|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593649|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
56593650|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
56593651|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
56593652|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593653|NCT00736099|Pioglitazone|pioglitazone|mesh-list
56593654|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56593655|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593656|NCT04616547|Edetic Acid|edetic acid|mesh-list
56593657|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
56593658|NCT04616547|Antidotes|antidotes|mesh-ancestor
56593659|NCT04616547|Protective Agents|protective agents|mesh-ancestor
56593660|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593661|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
56593662|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
56593663|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645415|NCT03794336|Analgesics|analgesics|mesh-ancestor
56645416|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
56645417|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645418|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645419|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56593664|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56593665|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
56593666|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56593667|NCT02711241|Dipyrone|dipyrone|mesh-list
56593668|NCT02711241|Papaverine|papaverine|mesh-list
56593669|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56593670|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56593671|NCT02711241|Analgesics|analgesics|mesh-ancestor
56593672|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
56593673|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593674|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593675|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56593698|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56593699|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
56593700|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593701|NCT02710539|Diuretics|diuretics|mesh-ancestor
56593702|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
56593703|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56593704|NCT00735709|Vortioxetine|vortioxetine|mesh-list
56593705|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
56593706|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56593707|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56593708|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56593709|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593710|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593711|NCT00735709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56593712|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56593713|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56593714|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593715|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593717|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56593718|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56593719|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56593720|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56593721|NCT02776527|Apatinib|apatinib|mesh-list
56593722|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593723|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56593724|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593725|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593726|NCT04843761|Remdesivir|remdesivir|mesh-list
56593727|NCT04843761|Phentolamine|phentolamine|mesh-list
56593754|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56593755|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
56342291|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
56593756|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
56593757|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593758|NCT02710305|Lidocaine|lidocaine|mesh-list
56593759|NCT02710305|Scopolamine|scopolamine|mesh-list
56593760|NCT02710305|Bromides|bromides|mesh-list
56593761|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56593762|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
56593763|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
56593764|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593765|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593766|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
56593767|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593768|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56593769|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56593770|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56593771|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56593772|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593773|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
56593774|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56593813|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593814|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56645420|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56645421|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56645422|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645423|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56645424|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56645425|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645426|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
56645427|NCT03794336|Incretins|incretins|mesh-ancestor
56291417|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
56494379|NCT04659642|Fentanyl|fentanyl|mesh-list
56593815|NCT00726895|Quinine|quinine|mesh-list
56593816|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
56593817|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56593818|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56593819|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593820|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56593821|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593822|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56593823|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593824|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56593825|NCT00726895|Analgesics|analgesics|mesh-ancestor
56593826|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
56593827|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56593828|NCT02593201|Cefazolin|cefazolin|mesh-list
56593829|NCT02593201|Ceftazidime|ceftazidime|mesh-list
56593830|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56593831|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593832|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
56593833|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
56593834|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56593835|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593836|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593837|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56593839|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
56593840|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593841|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56593842|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56593861|NCT02716857|Narcotics|narcotics|mesh-ancestor
56593862|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593863|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593864|NCT02716857|Analgesics|analgesics|mesh-ancestor
56593865|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
56593866|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593867|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
56593868|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56593869|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56593870|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593871|NCT03944577|Evolocumab|evolocumab|mesh-list
56593872|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56593873|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56593874|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
56593875|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593876|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56593877|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56593878|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
56593879|NCT00917761|Entecavir|entecavir|mesh-list
56593880|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
56593881|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593882|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
56593883|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593884|NCT02709603|Scopolamine|scopolamine|mesh-list
56593885|NCT02709603|Bromides|bromides|mesh-list
56593886|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56593887|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
56593888|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56593889|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
56593890|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
56593891|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547627|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56645428|NCT03794336|Hormones|hormones|mesh-ancestor
56645429|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645430|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56645431|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
56494437|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593892|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593893|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593894|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
56593895|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56593896|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
56593897|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593898|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906847|NCT02379000|Hormones|hormones|mesh-ancestor
56593925|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
56593926|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593927|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
56593928|NCT02709525|Protective Agents|protective agents|mesh-ancestor
56593929|NCT05087589|Tofacitinib|tofacitinib|mesh-list
56593930|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56159033|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
56593931|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593932|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593933|NCT05375929|Abrocitinib|abrocitinib|mesh-list
56593934|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56593935|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593936|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593937|NCT00612651|Temozolomide|temozolomide|mesh-list
56593938|NCT00612651|Lonafarnib|lonafarnib|mesh-list
56593939|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56593940|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
56593941|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593942|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593943|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593944|NCT00918307|Varenicline|varenicline|mesh-list
56593945|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56593979|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56593980|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56593981|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56593982|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593983|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593984|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
56593985|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56593986|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
56593987|NCT00808132|Estrogens|estrogens|mesh-list
56594012|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
56594013|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594014|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594015|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56594016|NCT00914368|Clopidogrel|clopidogrel|mesh-list
56594017|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56594018|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56594019|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56594020|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56594021|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
56594022|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594023|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594024|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594025|NCT02607982|Paclitaxel|paclitaxel|mesh-list
56594026|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
56594027|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56594028|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594029|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
56594030|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
56594031|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
55906989|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56594059|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56594060|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
56645432|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56645433|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
56645434|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56645435|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645436|NCT03743636|Niacinamide|niacinamide|mesh-list
56645437|NCT03743636|Niacin|niacin|mesh-list
56645438|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
56645439|NCT03743636|Resveratrol|resveratrol|mesh-list
56645440|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
56645441|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645442|NCT03743636|Protective Agents|protective agents|mesh-ancestor
56645443|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645444|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645445|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56645446|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
56645447|NCT03743636|Vitamins|vitamins|mesh-ancestor
56645448|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
56645449|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56645450|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
56645451|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56645452|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
56645453|NCT03681158|Valproic Acid|valproic acid|mesh-list
56645454|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
56645455|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645456|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645457|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
56645458|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645459|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645460|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
56594061|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594062|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56594063|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56594064|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
56594065|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594066|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594067|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56594068|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56594070|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
56594071|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594072|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56594073|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
56594074|NCT03643276|Hormones|hormones|mesh-ancestor
56594075|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56594076|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56594077|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56594078|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56594079|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56594080|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645461|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56645462|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645463|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56645464|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
56645465|NCT05343806|Nifedipine|nifedipine|mesh-list
56645466|NCT05343806|Analgesics|analgesics|mesh-ancestor
56645467|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
56594081|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56594082|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
56594083|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55907039|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56594102|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56594103|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594104|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
56594105|NCT02608060|Hematinics|hematinics|mesh-ancestor
56594106|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
56594107|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56594108|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56594109|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594110|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
56594111|NCT04085575|Coagulants|coagulants|mesh-ancestor
56594112|NCT00585169|Memantine|memantine|mesh-list
56594113|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56594114|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56594115|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
56594116|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594117|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594118|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594119|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56594120|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56594121|NCT00807742|Nicotine|nicotine|mesh-list
56594122|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56594123|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
56594124|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594125|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594126|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56594127|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56594128|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
56594129|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594130|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594131|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
56594132|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56594133|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594134|NCT05738434|Apatinib|apatinib|mesh-list
56342666|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
56594135|NCT05738434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594136|NCT05738434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56594137|NCT05738434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594138|NCT05738434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594139|NCT00803452|Azithromycin|azithromycin|mesh-list
56594159|NCT05737342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594161|NCT05737342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56594162|NCT00914212|Sibutramine|sibutramine|mesh-list
56594163|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
56594164|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56594165|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
56594166|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56594167|NCT03747939|Thalidomide|thalidomide|mesh-list
56594168|NCT03747939|Apremilast|apremilast|mesh-list
56594169|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56594170|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56594171|NCT03747939|Analgesics|analgesics|mesh-ancestor
56594172|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
56594173|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594174|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594175|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56594176|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56594177|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56594178|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56645468|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645469|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645470|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
56645471|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645472|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56645473|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
56645474|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56645475|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56645476|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645477|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56645478|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
56645479|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56645480|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
56645481|NCT05343728|Hemostatics|hemostatics|mesh-list
56645482|NCT05343728|Coagulants|coagulants|mesh-ancestor
56645483|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
56645484|NCT00436748|Hematinics|hematinics|mesh-ancestor
56645485|NCT02704598|Warfarin|warfarin|mesh-list
56645486|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
56645487|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
56645488|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56645489|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
56645490|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56645491|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
56645492|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645493|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645494|NCT03342404|Luspatercept|luspatercept|mesh-list
56645495|NCT03342404|Hematinics|hematinics|mesh-ancestor
56645496|NCT03094052|Trastuzumab|trastuzumab|mesh-list
56594179|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594180|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594181|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56594182|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
56594183|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
56594184|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56594185|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594186|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56594187|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56594188|NCT03747939|Growth Substances|growth substances|mesh-ancestor
56594189|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
56594190|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594191|NCT05753956|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56594192|NCT05753956|Hallucinogens|hallucinogens|mesh-ancestor
56594193|NCT05753956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594194|NCT05753956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56594195|NCT05753956|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56594238|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56594239|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56645497|NCT03094052|Atropine|atropine|mesh-list
56645498|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
56594241|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56594242|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56594243|NCT05731960|Dexamethasone|dexamethasone|mesh-list
56594244|NCT05731960|Metoclopramide|metoclopramide|mesh-list
56594245|NCT05731960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56594246|NCT05731960|Antiemetics|antiemetics|mesh-ancestor
56594247|NCT05731960|Autonomic Agents|autonomic agents|mesh-ancestor
56594248|NCT05731960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594249|NCT05731960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594250|NCT05731960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56594251|NCT05731960|Glucocorticoids|glucocorticoids|mesh-ancestor
56594252|NCT05731960|Hormones|hormones|mesh-ancestor
56594253|NCT05731960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56594254|NCT05731960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56594255|NCT05731960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594256|NCT05731960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56594257|NCT05731960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56594258|NCT05731960|Dopamine Agents|dopamine agents|mesh-ancestor
56594259|NCT05731960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594260|NCT05731960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594261|NCT04393311|Urinastatin|urinastatin|mesh-list
56594301|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594302|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56594304|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
56594305|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
56594306|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
56594307|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594308|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594309|NCT04331145|Ticagrelor|ticagrelor|mesh-list
56594310|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56594311|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56594312|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56594313|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56594314|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
56594315|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594316|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594317|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594318|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56594319|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56594320|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594321|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56594322|NCT02605720|Piperaquine|piperaquine|mesh-list
56594368|NCT00802360|Progestins|progestins|mesh-ancestor
56594369|NCT00802360|Hormones|hormones|mesh-ancestor
56594370|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56594371|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594372|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
56594373|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56594374|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
56594375|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594376|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56594377|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56594378|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594379|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594380|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56594381|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55907349|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
56594401|NCT02764593|Nivolumab|nivolumab|mesh-list
56594402|NCT02764593|Cetuximab|cetuximab|mesh-list
56594403|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594404|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56594405|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56594406|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594407|NCT04028596|Acetaminophen|acetaminophen|mesh-list
56594408|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56594409|NCT04028596|Analgesics|analgesics|mesh-ancestor
56594410|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
56594411|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594412|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594413|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
56594414|NCT04594551|Vaccines|vaccines|mesh-list
56645499|NCT03094052|Loperamide|loperamide|mesh-list
56594415|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
56594416|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56594417|NCT04594551|Antibodies|antibodies|mesh-list
56594418|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
56594419|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594420|NCT02692599|Vaccines|vaccines|mesh-list
56594421|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
56594422|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594423|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56594424|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
56594425|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594426|NCT02606266|Valganciclovir|valganciclovir|mesh-list
56594427|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
56594428|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594429|NCT04115020|Naltrexone|naltrexone|mesh-list
56594430|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56594431|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56594432|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594433|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
56342986|NCT00153283|Gabapentin|gabapentin|mesh-list
56594434|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594435|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
55907403|NCT04561206|Antibodies|antibodies|mesh-list
56594484|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594485|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56594487|NCT02607202|Antiviral Agents|antiviral agents|mesh-ancestor
56594488|NCT02607202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594489|NCT02607202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594490|NCT02607202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56594491|NCT02607202|Immunologic Factors|immunologic factors|mesh-ancestor
56594492|NCT02607202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594493|NCT03896685|Linezolid|linezolid|mesh-list
56594494|NCT03896685|Bedaquiline|bedaquiline|mesh-list
56594495|NCT03896685|Clofazimine|clofazimine|mesh-list
56594496|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56594497|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594498|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56594499|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594500|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594501|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
56594502|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56594503|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
56594504|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56594505|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56594506|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56594507|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56594508|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594532|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56594533|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594535|NCT00589420|Sorafenib|sorafenib|mesh-list
56594536|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594537|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
56594538|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
56594539|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
56594540|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594541|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56594542|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594543|NCT03815019|Megestrol|megestrol|mesh-list
56594544|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
56594545|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56594546|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56594547|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56594548|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
56594549|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594550|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594551|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56594552|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56594553|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56594554|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594555|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
56594556|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56594573|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56594575|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
56594576|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56645500|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
56645501|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
56645502|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56645503|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645504|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56594577|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56594578|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594579|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56594580|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594581|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56594582|NCT00796978|Trastuzumab|trastuzumab|mesh-list
56594583|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56594584|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594585|NCT03779295|Clindamycin|clindamycin|mesh-list
56594586|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
56594587|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
56594588|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56594589|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594590|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56594591|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594592|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594593|NCT00613665|Vaccines|vaccines|mesh-list
56594594|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
56594595|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594596|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56594597|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594598|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594599|NCT03746769|Gastrins|gastrins|mesh-list
56594600|NCT03746769|Hormones|hormones|mesh-ancestor
56594601|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56594602|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594603|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
56594604|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56594605|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594606|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594607|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56594608|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56594609|NCT00796822|Protective Agents|protective agents|mesh-ancestor
56594610|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594629|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56594630|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
56594631|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56594632|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56594633|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56594634|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594635|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
56594636|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594637|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594638|NCT00614679|Tigecycline|tigecycline|mesh-list
56594639|NCT00614679|Heparin|heparin|mesh-list
56594640|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
56594641|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56594642|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56594643|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594644|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56594645|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594646|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56594647|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594648|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56594649|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56594650|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594651|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56594652|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645505|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56645506|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56645507|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
56645508|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645509|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645510|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56645511|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
56645512|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
56645513|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
56645514|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56645515|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56645516|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
56645517|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645518|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645519|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56645520|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56645521|NCT03094052|Narcotics|narcotics|mesh-ancestor
56645522|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56594653|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
56594654|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56594655|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594656|NCT01024946|Everolimus|everolimus|mesh-list
56594657|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594658|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56594659|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
56594660|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594661|NCT00724867|Belimumab|belimumab|mesh-list
56594662|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56594663|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
56594664|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594758|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
56594759|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594760|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56594761|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56594762|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594763|NCT03462069|Empagliflozin|empagliflozin|mesh-list
56594764|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56594765|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56594766|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594767|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56594768|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594769|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56594770|NCT03414723|Ramipril|ramipril|mesh-list
56594785|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56594786|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56594787|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594788|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56594790|NCT00720499|Bromides|bromides|mesh-list
56594791|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
56594792|NCT00720499|Olodaterol|olodaterol|mesh-list
56594793|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56594794|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
56594795|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645523|NCT03094052|Analgesics|analgesics|mesh-ancestor
56645524|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
56645525|NCT05343338|Sivelestat|sivelestat|mesh-list
56645526|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56645527|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
56494954|NCT04645914|Nicotine|nicotine|mesh-list
56594796|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594797|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56343335|NCT00154726|Paclitaxel|paclitaxel|mesh-list
56594799|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
56594800|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56594801|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
56594802|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594803|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594804|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
56594806|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
56594807|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56594808|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56594809|NCT02590705|Lidocaine|lidocaine|mesh-list
56594810|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
56594811|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
56594812|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56594813|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594814|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
56594815|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594816|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56594817|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56594818|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56594819|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56594820|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594821|NCT00720343|Choline|choline|mesh-list
56594822|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
56594823|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56594824|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
56594825|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907797|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
56594842|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56594844|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56594845|NCT00720109|Cortisone|cortisone|mesh-list
56594846|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
56594847|NCT00720109|Ifosfamide|ifosfamide|mesh-list
56594848|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
56594849|NCT00720109|Methotrexate|methotrexate|mesh-list
56594850|NCT00720109|Etoposide|etoposide|mesh-list
56594851|NCT00720109|Vincristine|vincristine|mesh-list
56594852|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
56594853|NCT00720109|Daunorubicin|daunorubicin|mesh-list
56594854|NCT00720109|Asparaginase|asparaginase|mesh-list
56594855|NCT00720109|Dasatinib|dasatinib|mesh-list
56594856|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
56594857|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
56594858|NCT00720109|Pegaspargase|pegaspargase|mesh-list
56594859|NCT00720109|Lenograstim|lenograstim|mesh-list
56594860|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56594861|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
56594862|NCT00720109|BB 1101|bb 1101|mesh-list
56594863|NCT00720109|Calcium|calcium|mesh-list
56594864|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
56594865|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56594866|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
56594867|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594868|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56594869|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56594870|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
56594871|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594872|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594873|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56343412|NCT00051116|Growth Substances|growth substances|mesh-ancestor
56594874|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56594875|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
56594876|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
56594877|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594878|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56594880|NCT00720109|Hormones|hormones|mesh-ancestor
56645528|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645529|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645530|NCT02704520|Leucovorin|leucovorin|mesh-list
56645531|NCT02704520|Folic Acid|folic acid|mesh-list
56645532|NCT02704520|Fluorouracil|fluorouracil|mesh-list
56645533|NCT02704520|Capecitabine|capecitabine|mesh-list
56645534|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
56645535|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
56645536|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645537|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
56645538|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645539|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56645540|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645541|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645542|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
56645543|NCT02704520|Antidotes|antidotes|mesh-ancestor
56645544|NCT02704520|Protective Agents|protective agents|mesh-ancestor
56645545|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
56645546|NCT02704520|Vitamins|vitamins|mesh-ancestor
56645547|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
56645548|NCT02704520|Hematinics|hematinics|mesh-ancestor
56645549|NCT02704052|Enoxaparin|enoxaparin|mesh-list
56645550|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
56645551|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
56645552|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56645553|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56645554|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594881|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56594882|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56594883|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
56594884|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594885|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56594886|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56594887|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56594888|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
56594889|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594890|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56594921|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56594922|NCT02590627|Artenimol|artenimol|mesh-list
56594923|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
56594924|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56594925|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56594926|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594927|NCT01015118|Paclitaxel|paclitaxel|mesh-list
56594928|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56594929|NCT01015118|Carboplatin|carboplatin|mesh-list
56594930|NCT01015118|Nintedanib|nintedanib|mesh-list
56594931|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56594932|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594933|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56594934|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56594935|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56645555|NCT02703896|Esomeprazole|esomeprazole|mesh-list
56645556|NCT02703896|Omeprazole|omeprazole|mesh-list
56645557|NCT02703896|Pantoprazole|pantoprazole|mesh-list
56645558|NCT02703896|Lansoprazole|lansoprazole|mesh-list
56645559|NCT02703896|Famotidine|famotidine|mesh-list
56645560|NCT02703896|Ranitidine|ranitidine|mesh-list
56594936|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594937|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56594938|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594939|NCT02415153|Pomalidomide|pomalidomide|mesh-list
56595012|NCT02606032|Doxycycline|doxycycline|mesh-list
56595013|NCT02606032|Terbinafine|terbinafine|mesh-list
56595014|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595015|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56595016|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56595036|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595037|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
56595038|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595040|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
56595041|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595042|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
56595043|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56595044|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595045|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595046|NCT01030718|Dasatinib|dasatinib|mesh-list
56595047|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595048|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56595049|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595050|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595051|NCT00722761|Drospirenone|drospirenone|mesh-list
56595052|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56595053|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56595054|NCT00722761|Estradiol|estradiol|mesh-list
56595055|NCT00722761|Estrogens|estrogens|mesh-ancestor
56595056|NCT00722761|Hormones|hormones|mesh-ancestor
56595057|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595058|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595059|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56595060|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
56595061|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56595062|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56595063|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56595064|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56595065|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56595066|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
56595067|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56595068|NCT00722761|Diuretics|diuretics|mesh-ancestor
56595069|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
56595070|NCT00628238|Rituximab|rituximab|mesh-list
56595071|NCT00628238|Lenalidomide|lenalidomide|mesh-list
56595072|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595073|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595106|NCT02803203|Osimertinib|osimertinib|mesh-list
56595107|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595108|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595109|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56595110|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56595111|NCT02803203|Growth Substances|growth substances|mesh-ancestor
56595112|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595113|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
56595114|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56595115|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595116|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595117|NCT00714493|Infliximab|infliximab|mesh-list
56595118|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
56595119|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56595120|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56595121|NCT01013870|Atorvastatin|atorvastatin|mesh-list
56595122|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56595123|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56595124|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
56595125|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645561|NCT02703896|Cimetidine|cimetidine|mesh-list
56645562|NCT02703896|Nizatidine|nizatidine|mesh-list
56645563|NCT02703896|Lafutidine|lafutidine|mesh-list
56645564|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56645565|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56645566|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56645567|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645568|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645569|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56645570|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
56645571|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
56645572|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645573|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645574|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56645575|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56645576|NCT02737436|Oxytocin|oxytocin|mesh-list
56645577|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
56645578|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56645579|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645580|NCT03552692|Venetoclax|venetoclax|mesh-list
56645581|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645582|NCT00614978|Temozolomide|temozolomide|mesh-list
56645583|NCT00614978|Lapatinib|lapatinib|mesh-list
56645584|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56645585|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
56645586|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645587|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645588|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56645589|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645590|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56645591|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56645592|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645605|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645606|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56645607|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
56645608|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
56645609|NCT02703740|Protective Agents|protective agents|mesh-ancestor
56645610|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
56645611|NCT00615368|Hematinics|hematinics|mesh-ancestor
56645612|NCT00615446|Gemcitabine|gemcitabine|mesh-list
56595126|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56595127|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56595128|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595129|NCT05020184|Cimetidine|cimetidine|mesh-list
56595130|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56595131|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56595132|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56595133|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
56595134|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
56595135|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595155|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595156|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56595157|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
56595158|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56595159|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595160|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595161|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56595162|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56595163|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56595164|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
56595165|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
56595166|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595167|NCT01018394|Nicotine|nicotine|mesh-list
56595168|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56595169|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
56595170|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595171|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595172|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56595173|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56595174|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
56595175|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595176|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595177|NCT04301336|Zinc|zinc|mesh-list
56595178|NCT04301336|Folic Acid|folic acid|mesh-list
56595179|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
56595180|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
56595181|NCT04301336|Morphine|morphine|mesh-list
56595182|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
56595183|NCT04301336|Simvastatin|simvastatin|mesh-list
56595184|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56595185|NCT04301336|Narcotics|narcotics|mesh-ancestor
56595186|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56595187|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595188|NCT04301336|Analgesics|analgesics|mesh-ancestor
56595189|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
56595210|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595211|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
56595212|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595213|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595214|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56595215|NCT00627848|Protective Agents|protective agents|mesh-ancestor
56595216|NCT04299854|Dinoprostone|dinoprostone|mesh-list
56595217|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
56595218|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56595219|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595220|NCT01017146|Tazarotene|tazarotene|mesh-list
56595221|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
56595222|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
56595223|NCT02872064|Verteporfin|verteporfin|mesh-list
56595224|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56595225|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
56595226|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
56645613|NCT00615446|Sunitinib|sunitinib|mesh-list
56495238|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
56595227|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
56595228|NCT04205240|Melphalan|melphalan|mesh-list
56595229|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
56595230|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56595231|NCT04205240|Fludarabine|fludarabine|mesh-list
56595232|NCT04205240|Daratumumab|daratumumab|mesh-list
56595233|NCT04205240|Tacrolimus|tacrolimus|mesh-list
56595234|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595235|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
56595236|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595237|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56595238|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56595239|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
56595240|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595241|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595242|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56595243|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56595244|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595245|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56595246|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56595264|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56595265|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56595266|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56595267|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56595268|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
56595269|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595270|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595271|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595272|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
56595273|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56595274|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56595275|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56595276|NCT01010750|Amphetamine|amphetamine|mesh-list
56595277|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56595278|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56595279|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595280|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
56595281|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
56595282|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595283|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
56595284|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595285|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595286|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
56595287|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56595288|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56595289|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56595290|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56595291|NCT01012622|Methylphenidate|methylphenidate|mesh-list
56595292|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56595293|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595294|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56595295|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56595296|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56595297|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595298|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
56595299|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595300|NCT00722371|Metformin|metformin|mesh-list
56595301|NCT00722371|Pioglitazone|pioglitazone|mesh-list
56595302|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56595303|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56595304|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595305|NCT00722371|Incretins|incretins|mesh-ancestor
56595306|NCT00722371|Hormones|hormones|mesh-ancestor
56595307|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595308|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56595309|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
56595323|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
56595324|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595325|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56595326|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56645614|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56645615|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
56645616|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645617|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645618|NCT00615446|Antiviral Agents|antiviral agents|mesh-ancestor
56645619|NCT00615446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645620|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645621|NCT00615446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645622|NCT00615446|Immunologic Factors|immunologic factors|mesh-ancestor
56645623|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595327|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
56595328|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595329|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595330|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56595331|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595332|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56595333|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56595334|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56595335|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595336|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56595337|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
56595338|NCT00722137|Hormones|hormones|mesh-ancestor
56595339|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595340|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56595341|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56595342|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
56595343|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
56595344|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
56595345|NCT02281084|Azacitidine|azacitidine|mesh-list
56595346|NCT02281084|Durvalumab|durvalumab|mesh-list
56595347|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56595348|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
56595349|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595350|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595351|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595352|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595353|NCT04114396|Antibodies|antibodies|mesh-list
56595354|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
56595355|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595356|NCT05633602|Pembrolizumab|pembrolizumab|mesh-list
56595357|NCT05633602|Ramucirumab|ramucirumab|mesh-list
56595358|NCT05633602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595359|NCT05633602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595360|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
56595361|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
56595362|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
56595363|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56595364|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56595365|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595366|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595367|NCT00796666|Urological Agents|urological agents|mesh-ancestor
56595368|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56595369|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56595370|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56595371|NCT00799708|Estradiol|estradiol|mesh-list
56595372|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56595398|NCT00588640|D-methadone|d-methadone|mesh-list
56595399|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56595400|NCT00588640|Narcotics|narcotics|mesh-ancestor
56595401|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56595402|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595403|NCT00588640|Analgesics|analgesics|mesh-ancestor
56595404|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
56595405|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645624|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56645625|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56645626|NCT00615446|Growth Substances|growth substances|mesh-ancestor
56645627|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
56645628|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56645629|NCT02703272|Dexamethasone|dexamethasone|mesh-list
56645630|NCT02703272|Rituximab|rituximab|mesh-list
56645631|NCT02703272|Carboplatin|carboplatin|mesh-list
56645632|NCT02703272|Etoposide|etoposide|mesh-list
56645633|NCT02703272|Vincristine|vincristine|mesh-list
56645634|NCT02703272|Ifosfamide|ifosfamide|mesh-list
56645635|NCT02703272|Idarubicin|idarubicin|mesh-list
56645636|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56645637|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645638|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
56645639|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645640|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645641|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645642|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
56645643|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
56645644|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645645|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56645646|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
56645647|NCT02703272|Hormones|hormones|mesh-ancestor
56645648|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595406|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
56595407|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
56595408|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56595409|NCT01016912|Ribavirin|ribavirin|mesh-list
56343959|NCT00044538|Taxane|taxane|mesh-list
56595410|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56595411|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
56595412|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595413|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
56595414|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595415|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
56595416|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56595417|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56595418|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595419|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55908389|NCT01570387|BB 1101|bb 1101|mesh-list
56595437|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595438|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
56595439|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
56595440|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595441|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56595442|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595443|NCT04115800|Sirolimus|sirolimus|mesh-list
56595444|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56595445|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595446|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56595447|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595448|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
56072909|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
56645649|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56645650|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56645651|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56645652|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56645653|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645654|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645655|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
56645656|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
56645657|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
56547628|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645658|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56645659|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
56645660|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56645661|NCT02703194|Prednisone|prednisone|mesh-list
56595449|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595450|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
56595451|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595452|NCT04115410|Gemcitabine|gemcitabine|mesh-list
56595453|NCT04115410|Cisplatin|cisplatin|mesh-list
56595454|NCT04115410|Carboplatin|carboplatin|mesh-list
56595455|NCT04115410|Docetaxel|docetaxel|mesh-list
56595456|NCT04115410|Pemetrexed|pemetrexed|mesh-list
56595457|NCT04115410|Vinorelbine|vinorelbine|mesh-list
56595458|NCT04115410|Gefitinib|gefitinib|mesh-list
56595459|NCT04115410|Mitomycins|mitomycins|mesh-list
56595460|NCT04115410|Mitomycin|mitomycin|mesh-list
56595461|NCT04115410|Osimertinib|osimertinib|mesh-list
56595462|NCT04115410|Vinblastine|vinblastine|mesh-list
56595463|NCT04115410|Afatinib|afatinib|mesh-list
56595464|NCT04115410|Crizotinib|crizotinib|mesh-list
56595465|NCT04115410|Ceritinib|ceritinib|mesh-list
56595466|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
56595467|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56595468|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56595469|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
56595470|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595471|NCT04115410|Antiviral Agents|antiviral agents|mesh-ancestor
56595472|NCT04115410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595473|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595474|NCT04115410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595475|NCT04115410|Immunologic Factors|immunologic factors|mesh-ancestor
56595476|NCT04115410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595477|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
56595478|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
56595479|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
56595480|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55908421|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
56595492|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595493|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56595494|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56595495|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56595496|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595497|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595498|NCT04110808|Phentolamine|phentolamine|mesh-list
56595499|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
56595500|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
56595501|NCT04110808|Anesthetics|anesthetics|mesh-list
56595502|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56595503|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595504|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
56595505|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56595506|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56595507|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
56595508|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645662|NCT02703194|Prednisolone|prednisolone|mesh-list
56645663|NCT02703194|Leflunomide|leflunomide|mesh-list
56645664|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645665|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
56645666|NCT02703194|Hormones|hormones|mesh-ancestor
56645667|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645668|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645669|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56645670|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645671|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645672|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645673|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645674|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
56645675|NCT02402660|Vitamin A|vitamin a|mesh-list
56645676|NCT02402660|Retinol acetate|retinol acetate|mesh-list
56595509|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595510|NCT00714259|Fludarabine|fludarabine|mesh-list
56595511|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595512|NCT00796120|Doxorubicin|doxorubicin|mesh-list
56595513|NCT00796120|Ifosfamide|ifosfamide|mesh-list
56595514|NCT00796120|Trabectedin|trabectedin|mesh-list
56595515|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56595516|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595517|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56595518|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56595519|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595520|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595521|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56595522|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
56595523|NCT00795886|Sirolimus|sirolimus|mesh-list
56595524|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56595525|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595526|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56595527|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595528|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
56595529|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595530|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
56595531|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595532|NCT04110418|Terlipressin|terlipressin|mesh-list
56595533|NCT04110418|Methylene Blue|methylene blue|mesh-list
56595534|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595535|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595536|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56595537|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56595538|NCT04110028|Niacinamide|niacinamide|mesh-list
56595539|NCT04110028|Niacin|niacin|mesh-list
56595540|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
56595541|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
56595542|NCT04110028|Vitamins|vitamins|mesh-ancestor
56595543|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
56595544|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595545|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56595546|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
56595569|NCT05310643|Nivolumab|nivolumab|mesh-list
56595570|NCT05310643|Ipilimumab|ipilimumab|mesh-list
56595571|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595572|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595573|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56595574|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595575|NCT05269459|Cannabidiol|cannabidiol|mesh-list
56595576|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
56595577|NCT05260021|Tirzepatide|tirzepatide|mesh-list
56645677|NCT02402660|Vitamins|vitamins|mesh-ancestor
56645678|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
56645679|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645680|NCT02402660|Protective Agents|protective agents|mesh-ancestor
56645681|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56645682|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645683|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56645684|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
56645685|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
56645686|NCT02702960|Prednisone|prednisone|mesh-list
56645687|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
56645688|NCT02702960|Fludarabine|fludarabine|mesh-list
56645689|NCT02702960|Tacrolimus|tacrolimus|mesh-list
56645690|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56645691|NCT02702960|Mesna|mesna|mesh-list
56645692|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595578|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56595579|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595580|NCT05260021|Incretins|incretins|mesh-ancestor
56595581|NCT05260021|Hormones|hormones|mesh-ancestor
56595582|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595583|NCT05257213|Heparin|heparin|mesh-list
56595584|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
56595585|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56595586|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56595587|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595588|NCT00918853|Pancrelipase|pancrelipase|mesh-list
56595589|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56595590|NCT01016600|Lenalidomide|lenalidomide|mesh-list
56595591|NCT01016600|Azacitidine|azacitidine|mesh-list
56595592|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
56595593|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595594|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56595595|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56595596|NCT01016600|Growth Substances|growth substances|mesh-ancestor
56595597|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
56595598|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595618|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595619|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56595621|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595622|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595623|NCT04298372|Lenalidomide|lenalidomide|mesh-list
56595624|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
56595625|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595626|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56595627|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56595628|NCT04298372|Growth Substances|growth substances|mesh-ancestor
56595629|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
56595630|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595631|NCT01010204|Varenicline|varenicline|mesh-list
56595632|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56595633|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56595634|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
56595635|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595636|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595637|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595638|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
56595639|NCT00718549|Rituximab|rituximab|mesh-list
56595640|NCT00718549|Cladribine|cladribine|mesh-list
56595641|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595642|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
56595643|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595644|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645693|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
56645694|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645695|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645696|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56645697|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
56645698|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595645|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56595646|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
56595647|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595648|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595649|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56595650|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595721|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56595722|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56595723|NCT00794950|Growth Substances|growth substances|mesh-ancestor
56595724|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595725|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
56595726|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56595727|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595728|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595729|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56595730|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
56595731|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
56595732|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56595733|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
56595734|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56595735|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56595736|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
56595737|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595738|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595739|NCT00793546|Exemestane|exemestane|mesh-list
56595740|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595741|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56595742|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56595743|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595744|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595745|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56595746|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
56595747|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595748|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595749|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56595750|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56595751|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56595752|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595773|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
56595774|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595776|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
56595777|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595778|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56595779|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56595780|NCT04109872|Growth Substances|growth substances|mesh-ancestor
56595781|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
56595782|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595783|NCT05609968|Pembrolizumab|pembrolizumab|mesh-list
56595784|NCT05609968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595785|NCT05609968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595786|NCT05152147|Fluorouracil|fluorouracil|mesh-list
56595787|NCT05152147|Capecitabine|capecitabine|mesh-list
56595788|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
56595789|NCT05152147|Trastuzumab|trastuzumab|mesh-list
56595790|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595791|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
56595792|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595793|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56595794|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595795|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
56645699|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645700|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56645701|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645702|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
56645703|NCT02702960|Hormones|hormones|mesh-ancestor
56645704|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645705|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56645706|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56645707|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645708|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56645709|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56645710|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
56595796|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595797|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595798|NCT00793780|Naltrexone|naltrexone|mesh-list
56595799|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56595800|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56595801|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595802|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
56595803|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595804|NCT05650996|Calpastatin|calpastatin|mesh-list
56595805|NCT05650996|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56595806|NCT05650996|Protease Inhibitors|protease inhibitors|mesh-ancestor
56595807|NCT05650996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595808|NCT05650996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595837|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
56595838|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56595839|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
56595840|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
56595841|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
56595842|NCT02591017|Coagulants|coagulants|mesh-ancestor
56595843|NCT02591095|Navitoclax|navitoclax|mesh-list
56595844|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595845|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
56595846|NCT02588755|Tegafur|tegafur|mesh-list
56595847|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56595848|NCT02588755|Estrogens|estrogens|mesh-ancestor
56595849|NCT02588755|Hormones|hormones|mesh-ancestor
56595850|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595851|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595852|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56595853|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908806|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56595897|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595898|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56595899|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56595900|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56595901|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56595902|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56595903|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56595904|NCT00790036|Everolimus|everolimus|mesh-list
56595905|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595906|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595907|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
56595908|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595909|NCT05563168|Diltiazem|diltiazem|mesh-list
56595910|NCT05563168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56595911|NCT05563168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56595912|NCT05563168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56595913|NCT05563168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595914|NCT05563168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56595915|NCT05563168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645711|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56645712|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645713|NCT02702960|Protective Agents|protective agents|mesh-ancestor
56645714|NCT02699528|Methylphenidate|methylphenidate|mesh-list
56645715|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56645777|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645778|NCT02698982|Anesthetics|anesthetics|mesh-list
56645779|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645780|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645781|NCT00615524|Exemestane|exemestane|mesh-list
56645782|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645783|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56645784|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56645785|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645786|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645787|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56645788|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
56645789|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56645790|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645791|NCT00908141|Sargramostim|sargramostim|mesh-list
56595916|NCT05563168|Vasodilator Agents|vasodilator agents|mesh-ancestor
56595917|NCT00789958|Gemcitabine|gemcitabine|mesh-list
56595918|NCT00789958|Capecitabine|capecitabine|mesh-list
56595919|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56595920|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
56595921|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595922|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595923|NCT00789958|Antiviral Agents|antiviral agents|mesh-ancestor
56595924|NCT00789958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595925|NCT00789958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595926|NCT00789958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595927|NCT00789958|Immunologic Factors|immunologic factors|mesh-ancestor
56595928|NCT00789958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595929|NCT00789880|Vitamin D|vitamin d|mesh-list
56595930|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
56595931|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
56595932|NCT00789880|Vitamins|vitamins|mesh-list
56595933|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
56595934|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595935|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56595936|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56595937|NCT00915616|Melatonin|melatonin|mesh-list
56595967|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56595968|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56595969|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56595970|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595971|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56595972|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595973|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595974|NCT04108468|Golimumab|golimumab|mesh-list
56595975|NCT04108468|Methotrexate|methotrexate|mesh-list
56595976|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56596000|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596001|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596002|NCT02603068|Treprostinil|treprostinil|mesh-list
56596003|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56596004|NCT00718081|Sufentanil|sufentanil|mesh-list
56596005|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56596006|NCT00718081|Narcotics|narcotics|mesh-ancestor
56596007|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596008|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596009|NCT00718081|Analgesics|analgesics|mesh-ancestor
56596010|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
56596011|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645792|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
56645793|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645794|NCT01246310|Inositol|inositol|mesh-list
56645795|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
56645796|NCT01246310|Vitamins|vitamins|mesh-ancestor
56645797|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
56495808|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
56596012|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56596013|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56596014|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
56596015|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
56596017|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56596018|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56596019|NCT00788710|Analgesics|analgesics|mesh-ancestor
56596020|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
56596021|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596022|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596023|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56596024|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56596025|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56596026|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56596027|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596028|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908978|NCT02348268|Analgesics|analgesics|mesh-list
56596051|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
56596052|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596053|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56596054|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56596055|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56596056|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56596057|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596059|NCT00588094|Carboplatin|carboplatin|mesh-list
56596060|NCT00588094|Etoposide|etoposide|mesh-list
56596061|NCT00588094|Ifosfamide|ifosfamide|mesh-list
56596062|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56596063|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596064|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
56596065|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596066|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56596067|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56596068|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56596069|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56596070|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596071|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596072|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56596073|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
56596075|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596076|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56596077|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56596078|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
56596079|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596080|NCT05590624|Phentermine|phentermine|mesh-list
56596081|NCT05590624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55909026|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
56596117|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56596118|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56596119|NCT02706015|Analgesics|analgesics|mesh-ancestor
56596140|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596141|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56596142|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596143|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56596144|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56596145|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56596146|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56596147|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56596148|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596149|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596150|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56645798|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645799|NCT01773707|Abatacept|abatacept|mesh-list
56645800|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56645801|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645802|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645803|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645804|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
56645805|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645806|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645807|NCT00700076|Ketamine|ketamine|mesh-list
56645809|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
56645810|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645811|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645812|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56645813|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56645814|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
56645815|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
56645816|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645817|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56645818|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56645819|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645820|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645821|NCT02698514|Sevoflurane|sevoflurane|mesh-list
56645822|NCT02698514|Desflurane|desflurane|mesh-list
56495878|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596151|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56596152|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596153|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56596154|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56596155|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56596156|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596157|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
56596158|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596159|NCT02588287|Tenofovir|tenofovir|mesh-list
56596160|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
56596161|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344690|NCT00053378|Calcium|calcium|mesh-list
56596162|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56596163|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56596164|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596165|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596166|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56596167|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56596168|NCT02707263|Heparin|heparin|mesh-list
56596169|NCT02707263|Calcium heparin|calcium heparin|mesh-list
56596170|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
56596187|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
56596188|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596189|NCT00615303|Simethicone|simethicone|mesh-list
56645823|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56645824|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56645825|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
56645826|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
56645827|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645828|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645829|NCT02706158|Vitamin D|vitamin d|mesh-list
56645830|NCT02706158|Calcium|calcium|mesh-list
56645831|NCT02706158|Vitamins|vitamins|mesh-ancestor
56645832|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
56645833|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645834|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56645835|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56645836|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
56645837|NCT03739853|Adalimumab|adalimumab|mesh-list
56645838|NCT03739853|Methotrexate|methotrexate|mesh-list
56645839|NCT03739853|Leflunomide|leflunomide|mesh-list
56495924|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
56596190|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
56596191|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596192|NCT00615303|Emollients|emollients|mesh-ancestor
56596193|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
56596194|NCT00787150|Warfarin|warfarin|mesh-list
56596195|NCT00787150|Apixaban|apixaban|mesh-list
56596196|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
56596197|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56596198|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
56596199|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56596200|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
56596201|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596202|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596203|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56596204|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56596205|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596206|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56596207|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56596208|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596209|NCT00786838|Trabectedin|trabectedin|mesh-list
56596210|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56596211|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
56596212|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596213|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596214|NCT05683171|Rituximab|rituximab|mesh-list
56596215|NCT05683171|Lenalidomide|lenalidomide|mesh-list
56596216|NCT05683171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56596217|NCT05683171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596218|NCT05683171|Immunologic Factors|immunologic factors|mesh-ancestor
56596219|NCT05683171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596220|NCT05683171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56596221|NCT05683171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56596222|NCT05683171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56596223|NCT05683171|Growth Substances|growth substances|mesh-ancestor
56596224|NCT05683171|Growth Inhibitors|growth inhibitors|mesh-ancestor
56596225|NCT02604004|Lamivudine|lamivudine|mesh-list
56596226|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56596227|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56596261|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596262|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596263|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56645840|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56645841|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
56645842|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56645843|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645844|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56645845|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
56645846|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645847|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645848|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
56645849|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596264|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
56596295|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596296|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56596297|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596298|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596300|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56596301|NCT02587273|Narcotics|narcotics|mesh-ancestor
56596302|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596303|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596304|NCT02587273|Analgesics|analgesics|mesh-ancestor
56596305|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
56596306|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596307|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56596308|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56596309|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
56596344|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596346|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56596347|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
56596348|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
56596349|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596350|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56596351|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56596352|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
56596353|NCT05018221|Coagulants|coagulants|mesh-ancestor
56596354|NCT05018221|Antidotes|antidotes|mesh-ancestor
56596355|NCT05018221|Protective Agents|protective agents|mesh-ancestor
56596356|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
56596357|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
56596358|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56596359|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596361|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56596362|NCT00615381|Insulin|insulin|mesh-list
56596363|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56596364|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56596365|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596366|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
56596367|NCT00785980|Quinine|quinine|mesh-list
56596368|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56596369|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596370|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56596371|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56596372|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596373|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596374|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596375|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56596376|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56596377|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
56596378|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56596379|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56596380|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56596381|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596382|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56596383|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596384|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56645850|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56645851|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645852|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
56645853|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645854|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56645855|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645856|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645857|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56645858|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56645859|NCT03739853|Analgesics|analgesics|mesh-ancestor
56645860|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
56645861|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645862|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56645863|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
56645864|NCT00615602|Docetaxel|docetaxel|mesh-list
56645865|NCT00615602|Trastuzumab|trastuzumab|mesh-list
56645866|NCT00615602|Epirubicin|epirubicin|mesh-list
56645867|NCT00615602|Fluorouracil|fluorouracil|mesh-list
56645868|NCT00615602|Lenograstim|lenograstim|mesh-list
56344919|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596385|NCT00785980|Analgesics|analgesics|mesh-ancestor
56596386|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
56596387|NCT04805073|Promethazine|promethazine|mesh-list
56596388|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
56596389|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
56596390|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
56596391|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56596392|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
56596393|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
56596394|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596395|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596396|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596397|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56596398|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55909336|NCT02330796|Bucillamine|bucillamine|mesh-list
56596417|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596418|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56596419|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56596420|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
56596421|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596423|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56596424|NCT04799431|Poly ICLC|poly iclc|mesh-list
56596425|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
56596426|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
56596427|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596428|NCT04799431|Laxatives|laxatives|mesh-ancestor
56596429|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56596430|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
56596431|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596432|NCT02703051|Lenograstim|lenograstim|mesh-list
56480259|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56596433|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56596434|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
56596435|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596436|NCT00785512|Nebivolol|nebivolol|mesh-list
56596437|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56596438|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
56596439|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56596440|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56596441|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56645869|NCT00615602|Mitogens|mitogens|mesh-list
56645870|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56645871|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
56496106|NCT04656249|Lenvatinib|lenvatinib|mesh-list
56596442|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
56596443|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596444|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596445|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596446|NCT02702817|Naproxen|naproxen|mesh-list
56596447|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56596448|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56596449|NCT02702817|Analgesics|analgesics|mesh-ancestor
56596450|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
56596451|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596452|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596453|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56596454|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56596455|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
56596470|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56596471|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56596473|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
56596474|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596475|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596476|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596477|NCT02702661|Anesthetics|anesthetics|mesh-list
56596478|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
56596479|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
56596480|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596481|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596482|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
56596483|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596484|NCT05065021|Paclitaxel|paclitaxel|mesh-list
56596485|NCT05065021|Bevacizumab|bevacizumab|mesh-list
56596486|NCT05065021|Niraparib|niraparib|mesh-list
56596487|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56596488|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596489|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
56596490|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
56596491|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
56596492|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596493|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56596494|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56596495|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56596496|NCT05065021|Growth Substances|growth substances|mesh-ancestor
56596497|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596498|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
56596499|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56596500|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596501|NCT02702349|Penicillins|penicillins|mesh-list
56596502|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56596503|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596504|NCT04104334|Remifentanil|remifentanil|mesh-list
56596505|NCT04104334|Desflurane|desflurane|mesh-list
56596506|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
56596507|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596508|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596509|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56596510|NCT04104334|Narcotics|narcotics|mesh-ancestor
56596511|NCT04104334|Analgesics|analgesics|mesh-ancestor
56596512|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
56596513|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596514|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56596515|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
56596516|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56596517|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56596518|NCT02602600|Liraglutide|liraglutide|mesh-list
56596539|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596541|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
56596542|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
56596544|NCT02603770|L 647318|l 647318|mesh-list
56596545|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
56596546|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56645872|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645873|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645874|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56645875|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
56645876|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645877|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645878|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56645879|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
56645880|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
56645881|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
56291863|NCT04477343|Nivolumab|nivolumab|mesh-list
56645882|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56645883|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56645884|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56645885|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56645887|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
56645888|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56645889|NCT00615602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56645890|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
56645891|NCT00588185|Testosterone|testosterone|mesh-list
56645892|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
56645893|NCT00588185|Androgens|androgens|mesh-ancestor
56645894|NCT00588185|Hormones|hormones|mesh-ancestor
56645895|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56596547|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56596548|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
56596549|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596550|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56596551|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56596552|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596553|NCT04081909|Fentanyl|fentanyl|mesh-list
56596554|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
56596555|NCT04081909|Ketamine|ketamine|mesh-list
56596556|NCT04081909|Remifentanil|remifentanil|mesh-list
56596557|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56596558|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596559|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596560|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56596561|NCT04081909|Analgesics|analgesics|mesh-ancestor
56596562|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
56596563|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596564|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56596565|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56596566|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56596567|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
56596568|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596569|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596570|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56596571|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56596572|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
56596573|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
56645896|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645897|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
56645898|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645899|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
56645900|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645901|NCT02698748|Chloroquine|chloroquine|mesh-list
56645902|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56596574|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56596575|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56596594|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56596595|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56596596|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56596597|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596598|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596599|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
56596600|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596601|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56596602|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56596603|NCT04989283|Paclitaxel|paclitaxel|mesh-list
56596604|NCT04989283|Etoposide|etoposide|mesh-list
56596605|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
56596606|NCT04989283|Cisplatin|cisplatin|mesh-list
56596607|NCT04989283|Carboplatin|carboplatin|mesh-list
56596608|NCT04989283|Pemetrexed|pemetrexed|mesh-list
56596609|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56596610|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
56596611|NCT04989283|Atezolizumab|atezolizumab|mesh-list
56596612|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56596613|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56596614|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596615|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
56596616|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
56596617|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
56596618|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596619|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56596620|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56596621|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596622|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56596623|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56596624|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
56596625|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596626|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
56596627|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
56596628|NCT05344443|Lemborexant|lemborexant|mesh-list
56596629|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56596630|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596631|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909571|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
56596667|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596668|NCT00776230|Vaccines|vaccines|mesh-list
56596669|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
56596670|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596671|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
56596672|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
56596673|NCT02586259|Budesonide|budesonide|mesh-list
56596674|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56596675|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56596676|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
56596677|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596678|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596679|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56596680|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
56596681|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
56596682|NCT02586259|Hormones|hormones|mesh-ancestor
56596683|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56596684|NCT00775606|Ritonavir|ritonavir|mesh-list
56596685|NCT00775606|Lopinavir|lopinavir|mesh-list
56596686|NCT00775606|Efavirenz|efavirenz|mesh-list
56596687|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56645903|NCT02698748|Amebicides|amebicides|mesh-ancestor
56645904|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56645905|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56645906|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645907|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
56645908|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645909|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56645910|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56645911|NCT02698748|Analgesics|analgesics|mesh-ancestor
56645912|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
56596688|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56596689|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
56596690|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596691|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596737|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596738|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56596739|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56596740|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596741|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
56596742|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56596743|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56596744|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
56596745|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56596746|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56596747|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56596748|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56596749|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
56596750|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56596751|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56596752|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
56596753|NCT00775528|Pancrelipase|pancrelipase|mesh-list
56596754|NCT00775528|Pancreatin|pancreatin|mesh-list
56596755|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56596756|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56596757|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56596758|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56596759|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56596760|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596761|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345296|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
56596762|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596763|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56596765|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56596766|NCT02701179|Lidocaine|lidocaine|mesh-list
56596767|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56596768|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
56596794|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56596795|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56596796|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
56596797|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480261|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
56596798|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596799|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56596800|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56596801|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
56596802|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596803|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
56596804|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
56596805|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56596806|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56596807|NCT02700711|Methylphenidate|methylphenidate|mesh-list
56596808|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56596809|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596810|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56072910|NCT05272826|Hormones|hormones|mesh-ancestor
56645913|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645914|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645915|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645916|NCT02698748|Filaricides|filaricides|mesh-ancestor
56645917|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
56645918|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
56645919|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56645920|NCT04214990|Aspirin|aspirin|mesh-list
56645921|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56645922|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56596811|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56596812|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56596813|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596814|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
56596835|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56596837|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56596838|NCT04965493|Rituximab|rituximab|mesh-list
56596839|NCT04965493|Venetoclax|venetoclax|mesh-list
56596840|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56596841|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596842|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
56596843|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596844|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56596845|NCT00775450|Vaccines|vaccines|mesh-list
56596846|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
56596847|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596848|NCT05572684|Pembrolizumab|pembrolizumab|mesh-list
56596849|NCT05572684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56596850|NCT05572684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596851|NCT02699385|Domperidone|domperidone|mesh-list
56596852|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
56596853|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
56596854|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596855|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596856|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56596857|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56596858|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
56596859|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596860|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596861|NCT02700087|Famotidine|famotidine|mesh-list
56596862|NCT02700087|Ranitidine|ranitidine|mesh-list
56596863|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56596864|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56596865|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56596866|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56596867|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
56596868|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
56596869|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596870|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909818|NCT01516879|Ezetimibe|ezetimibe|mesh-list
56596908|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56596910|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
56596970|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596971|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596972|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56596974|NCT02698527|Lidocaine|lidocaine|mesh-list
56596975|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
56596976|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
56596977|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596978|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596979|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
56596980|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596981|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56596982|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56596983|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56645923|NCT04214990|Analgesics|analgesics|mesh-ancestor
56645924|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
56645925|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645926|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645927|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645928|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645929|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56645930|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56645931|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645932|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56496424|NCT04652427|Analgesics|analgesics|mesh-ancestor
56596984|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56345523|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
56596985|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597016|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597017|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56597018|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56597019|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56597020|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56597021|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597022|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56597023|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56597024|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
56597025|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56597026|NCT04213833|Analgesics|analgesics|mesh-ancestor
56597027|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56597028|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56597029|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56597030|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
56597031|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597064|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56597065|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56597066|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597067|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
56597068|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
56597069|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56597083|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597085|NCT02787369|Ricolinostat|ricolinostat|mesh-list
56597086|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597087|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597088|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597089|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56597090|NCT05300451|Daratumumab|daratumumab|mesh-list
56597091|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597092|NCT04589845|Trastuzumab|trastuzumab|mesh-list
56597093|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56597094|NCT04589845|Atezolizumab|atezolizumab|mesh-list
56597095|NCT04589845|Maytansine|maytansine|mesh-list
56597096|NCT04589845|Pralsetinib|pralsetinib|mesh-list
56597097|NCT04589845|Entrectinib|entrectinib|mesh-list
56597098|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56597099|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597100|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56597101|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
56597102|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
56597103|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
56597104|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597105|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56597106|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597107|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
56597108|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
56597120|NCT00617253|Sunitinib|sunitinib|mesh-list
56597121|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56645933|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56645934|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645935|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
56645936|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
56645937|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
56645938|NCT00615212|Midazolam|midazolam|mesh-list
56645939|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56645940|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56645941|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645942|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645943|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56645944|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56645945|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56645946|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56645947|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
56645948|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
56645949|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
56645950|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
56496488|NCT00562224|Abexinostat|abexinostat|mesh-list
56597122|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56597123|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56597124|NCT00617253|Growth Substances|growth substances|mesh-ancestor
56597125|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597126|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
56597127|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56597128|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597129|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597130|NCT02585947|Tenofovir|tenofovir|mesh-list
56345678|NCT00169468|Rituximab|rituximab|mesh-list
56597131|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
56597132|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597133|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56597134|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56597135|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597136|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597137|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56597138|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56597139|NCT02607891|Cannabidiol|cannabidiol|mesh-list
56597140|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
56597141|NCT02607813|Spartalizumab|spartalizumab|mesh-list
56597142|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55910068|NCT00426153|Octreotide|octreotide|mesh-list
56597181|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
56597182|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
56597183|NCT04572295|Fulvestrant|fulvestrant|mesh-list
56597184|NCT04572295|Exemestane|exemestane|mesh-list
56597185|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56597186|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597187|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56597188|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56597189|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
56597190|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597191|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597207|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56597208|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597210|NCT00915460|Interferon-beta|interferon-beta|mesh-list
56597211|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
56597212|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597213|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
56597214|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56645951|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56645952|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645953|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56645954|NCT00615212|Analgesics|analgesics|mesh-ancestor
56645955|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
56645956|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645957|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56645958|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56645959|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56645960|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56645961|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56645962|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56645963|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
56645964|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56645965|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
56645966|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
56645967|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597215|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
56597216|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597217|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56597218|NCT00617643|Nevirapine|nevirapine|mesh-list
56597219|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56597220|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56597221|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597222|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597223|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
56597224|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597226|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56597227|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56597228|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56597229|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
56597230|NCT04566133|Trametinib|trametinib|mesh-list
56597231|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
56597232|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56597233|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56597234|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597235|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597236|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597237|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597238|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597239|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56597240|NCT02584075|Metformin|metformin|mesh-list
56597241|NCT02584075|Exenatide|exenatide|mesh-list
56597242|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56597243|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597244|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56597245|NCT02584075|Incretins|incretins|mesh-ancestor
56597246|NCT02584075|Hormones|hormones|mesh-ancestor
56597247|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597248|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
56597249|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
56597250|NCT02585479|Pirarubicin|pirarubicin|mesh-list
56597251|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56597252|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597253|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
56597254|NCT02585479|Coagulants|coagulants|mesh-ancestor
56597284|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597285|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597286|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56645968|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645969|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56645970|NCT02701478|Analgesics|analgesics|mesh-ancestor
56645971|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
56645972|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56645973|NCT03314363|Trace Elements|trace elements|mesh-list
56645974|NCT03314363|Micronutrients|micronutrients|mesh-list
56645975|NCT03314363|Citric Acid|citric acid|mesh-list
56645976|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
56645977|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645978|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
56645979|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56645980|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
56645981|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
56645982|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56645983|NCT00906347|Misoprostol|misoprostol|mesh-list
56645984|NCT00906347|Oxytocin|oxytocin|mesh-list
56645985|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
56645986|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56645987|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645988|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56645989|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
56645990|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56645991|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56645992|NCT02705768|Carbamazepine|carbamazepine|mesh-list
56645993|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
56645994|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
56645995|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
56645996|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56597287|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
56597288|NCT02584153|Coagulants|coagulants|mesh-ancestor
56597289|NCT02585401|Aflibercept|aflibercept|mesh-list
56597290|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56597291|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56597292|NCT02585401|Growth Substances|growth substances|mesh-ancestor
56597293|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597294|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
56597295|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597296|NCT04874311|Doxorubicin|doxorubicin|mesh-list
56597297|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56597298|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597336|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
56597337|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910276|NCT00379197|Naltrexone|naltrexone|mesh-list
56597370|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56597371|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
56597372|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56597373|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597374|NCT04524871|Bevacizumab|bevacizumab|mesh-list
56597375|NCT04524871|Atezolizumab|atezolizumab|mesh-list
56597376|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56645997|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56645998|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56645999|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56646000|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56646001|NCT02705768|Analgesics|analgesics|mesh-ancestor
56646002|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
56646003|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646004|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56646005|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56646006|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646007|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56646008|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56646009|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56646010|NCT00616070|Difluprednate|difluprednate|mesh-list
56646011|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
56646012|NCT00616070|Hormones|hormones|mesh-ancestor
56646013|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646014|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646015|NCT03153527|Prednisone|prednisone|mesh-list
56646016|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646017|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
56646018|NCT03153527|Hormones|hormones|mesh-ancestor
56597377|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597378|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56597379|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56597381|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597382|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
56597383|NCT02583451|Lemborexant|lemborexant|mesh-list
56597384|NCT02583451|Zopiclone|zopiclone|mesh-list
56597385|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56597386|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597387|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597388|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56597389|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56597390|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597391|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597392|NCT05435911|Propofol|propofol|mesh-list
56597393|NCT05435911|Flumazenil|flumazenil|mesh-list
56597394|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56597395|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597396|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597449|NCT04504825|Hormones|hormones|mesh-ancestor
56597450|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597451|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56597452|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56597454|NCT04504123|Tetracycline|tetracycline|mesh-list
56597455|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597456|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
56597457|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56597458|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56597459|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56646019|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646020|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646021|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56646022|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646023|NCT02705534|Ribavirin|ribavirin|mesh-list
56646024|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
56646025|NCT02705534|Ledipasvir|ledipasvir|mesh-list
56646026|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
56646027|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646028|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
56646029|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646030|NCT02701166|Bezafibrate|bezafibrate|mesh-list
56597460|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597461|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597462|NCT02584543|Vaccines|vaccines|mesh-list
56597463|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
56597464|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597465|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56597466|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56597467|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56597468|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
56597469|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597470|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597471|NCT04077853|Progestins|progestins|mesh-ancestor
56597472|NCT04077853|Hormones|hormones|mesh-ancestor
56597473|NCT04502407|Cisplatin|cisplatin|mesh-list
56597474|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597475|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56597476|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56597477|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56597478|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56597479|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56597480|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597481|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
56597482|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597483|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597484|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56597485|NCT00583219|Protective Agents|protective agents|mesh-ancestor
56597486|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56597487|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
55910399|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
56597514|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597515|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597516|NCT04116073|Antibodies|antibodies|mesh-list
56597517|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
56597518|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597519|NCT02581501|Gemcitabine|gemcitabine|mesh-list
56597520|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56597521|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56597522|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
56597523|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597524|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597525|NCT02581501|Antiviral Agents|antiviral agents|mesh-ancestor
56597526|NCT02581501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597527|NCT02581501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597528|NCT02581501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597529|NCT02581501|Immunologic Factors|immunologic factors|mesh-ancestor
56597530|NCT02581501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597532|NCT01072175|Dabrafenib|dabrafenib|mesh-list
56597533|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597534|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56597535|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597536|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646031|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56646032|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
56646033|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646034|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56646035|NCT03141203|Romidepsin|romidepsin|mesh-list
56646036|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56646037|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646038|NCT05320991|Ketamine|ketamine|mesh-list
56646039|NCT05320991|Analgesics|analgesics|mesh-ancestor
56646040|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
56646041|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646042|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597569|NCT04426669|Interleukin-2|interleukin-2|mesh-list
56597570|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597571|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
56597572|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597573|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597574|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56597575|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
56597576|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597577|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597578|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56597579|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56597597|NCT01071317|Sumatriptan|sumatriptan|mesh-list
56597598|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56597599|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56597600|NCT01071317|Analgesics|analgesics|mesh-ancestor
56597601|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
56597602|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597603|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597604|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56597605|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597606|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
56597607|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56597608|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597609|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597610|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56597611|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56597612|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56597613|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
56597614|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597615|NCT00783094|Tadalafil|tadalafil|mesh-list
56597616|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
56597617|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56597618|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56597619|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597620|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597621|NCT00783094|Urological Agents|urological agents|mesh-ancestor
56597622|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56597623|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56597624|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56597625|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
56597626|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
56597627|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56597628|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597629|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597630|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
56597631|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56597632|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597633|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597634|NCT05568550|Pembrolizumab|pembrolizumab|mesh-list
56597635|NCT05568550|Olaparib|olaparib|mesh-list
56597636|NCT05568550|Androgens|androgens|mesh-list
56646043|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56646044|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56646045|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
56646046|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
56646047|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646048|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56646049|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56646050|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646051|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646052|NCT04215614|Lidocaine|lidocaine|mesh-list
56646053|NCT04215614|Bupivacaine|bupivacaine|mesh-list
56646054|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
56646055|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
56646056|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646057|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646058|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
56646059|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646060|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56646061|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56646062|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56646063|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56646064|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646065|NCT00906035|Aspirin|aspirin|mesh-list
56646066|NCT00906035|Dipyridamole|dipyridamole|mesh-list
56646067|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56646068|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56646069|NCT00906035|Analgesics|analgesics|mesh-ancestor
56496844|NCT04620720|Gabapentin|gabapentin|mesh-list
56597637|NCT05568550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56597638|NCT05568550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597650|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597651|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56597652|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
56597654|NCT02583217|Analgesics|analgesics|mesh-ancestor
56597655|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
56597656|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597657|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56597658|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56597659|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56597660|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597661|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597662|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56597663|NCT02583217|Narcotics|narcotics|mesh-ancestor
56597665|NCT00774046|Etoposide|etoposide|mesh-list
56597666|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
56597667|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56646070|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
56646071|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646072|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646073|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646074|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56646075|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56646076|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56646077|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646078|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56646079|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56646080|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646081|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
56646082|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56646083|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
56646084|NCT02698280|Bevacizumab|bevacizumab|mesh-list
56646085|NCT02698280|Nimustine|nimustine|mesh-list
56496876|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597668|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597669|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56597670|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56597671|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597672|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597673|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56597674|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
56597676|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597677|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597678|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
56597679|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597680|NCT00774046|Analgesics|analgesics|mesh-ancestor
56597681|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
56597682|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597683|NCT01046903|Dalteparin|dalteparin|mesh-list
56597684|NCT01046903|Tinzaparin|tinzaparin|mesh-list
56597685|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56597686|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
56597687|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56597688|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56597689|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597690|NCT02581423|Capecitabine|capecitabine|mesh-list
56597691|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56597692|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
56597693|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597694|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597695|NCT04102072|Dobutamine|dobutamine|mesh-list
56597696|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56597697|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
56597698|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
56597699|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597700|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597701|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56597702|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56597718|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56597720|NCT00773968|Hematinics|hematinics|mesh-ancestor
56597721|NCT04060381|Ibuprofen|ibuprofen|mesh-list
56597722|NCT04060381|Dopamine|dopamine|mesh-list
56597723|NCT04060381|Epinephrine|epinephrine|mesh-list
56597724|NCT04060381|Norepinephrine|norepinephrine|mesh-list
56597725|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56597726|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56646086|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56646087|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646088|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56646089|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56646090|NCT02698280|Growth Substances|growth substances|mesh-ancestor
56646091|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646092|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
56646093|NCT03087773|Empagliflozin|empagliflozin|mesh-list
56646094|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56646095|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646096|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56646097|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646098|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
56646099|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646100|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56646101|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
56646102|NCT05333159|Empagliflozin|empagliflozin|mesh-list
56646103|NCT05333159|Canagliflozin|canagliflozin|mesh-list
56646104|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56646105|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646106|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56646107|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646108|NCT03654989|Treprostinil|treprostinil|mesh-list
56646109|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56646110|NCT02698124|Decitabine|decitabine|mesh-list
56646111|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56646112|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
56496939|NCT04618965|Analgesics|analgesics|mesh-ancestor
56597727|NCT04060381|Analgesics|analgesics|mesh-ancestor
56597728|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
56597729|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597730|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597731|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56597732|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597733|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56597734|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597735|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597736|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56597737|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56597738|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
56597739|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597740|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56597741|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56597742|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
56597743|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56597744|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
56646113|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646114|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646115|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646116|NCT00905489|Nevirapine|nevirapine|mesh-list
56646117|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56646118|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56646119|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646120|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646121|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
56646122|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646123|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56646124|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56646125|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56646126|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56646127|NCT02705378|Naloxegol|naloxegol|mesh-list
56646128|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56646129|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646130|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
56646131|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597745|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
56597746|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
56597747|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56597748|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56597749|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
56597750|NCT04060381|Protective Agents|protective agents|mesh-ancestor
56597751|NCT00782626|Everolimus|everolimus|mesh-list
56597753|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597754|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
56597755|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597756|NCT04076371|Olanzapine|olanzapine|mesh-list
56597757|NCT04076371|Risperidone|risperidone|mesh-list
56597758|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56597759|NCT04076371|Ziprasidone|ziprasidone|mesh-list
56597760|NCT04076371|Sertraline|sertraline|mesh-list
56597761|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56597762|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
56597763|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597764|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910666|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
56597777|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56597778|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56597779|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
56597780|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56597781|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56597782|NCT03994627|Olaratumab|olaratumab|mesh-list
56597783|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597784|NCT03977467|Atezolizumab|atezolizumab|mesh-list
56597785|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597786|NCT01071083|Interferons|interferons|mesh-list
56597787|NCT01071083|Interferon-beta|interferon-beta|mesh-list
56597788|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
56597789|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
56597790|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
56597791|NCT01071083|Natalizumab|natalizumab|mesh-list
56597792|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
56597793|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597794|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
56597795|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646132|NCT03059147|Nivolumab|nivolumab|mesh-list
56646133|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56646134|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646135|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56646136|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646137|NCT03356834|Tenofovir|tenofovir|mesh-list
56646138|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
56497035|NCT01189201|Hormones|hormones|mesh-ancestor
56597796|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56597797|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
56597798|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
56597799|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597800|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597801|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56597802|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
56597803|NCT01071083|Hormones|hormones|mesh-ancestor
56597804|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597805|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56597806|NCT01071083|Protective Agents|protective agents|mesh-ancestor
56597807|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
56597808|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56597809|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597810|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597811|NCT03973333|Atezolizumab|atezolizumab|mesh-list
56597812|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597813|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56597814|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597815|NCT04078399|Interferons|interferons|mesh-list
56597816|NCT04078399|Azacitidine|azacitidine|mesh-list
56597817|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597818|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
56597819|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597820|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56597821|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
56597822|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597823|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597824|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
56597825|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597826|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56597827|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597828|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597829|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
56597854|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597855|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
56597856|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
56597857|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56597858|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597859|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56597860|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
56597861|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597862|NCT03897127|Cytarabine|cytarabine|mesh-list
56597863|NCT03897127|Daunorubicin|daunorubicin|mesh-list
56597864|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56597865|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
56597866|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597867|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597868|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
56597869|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597870|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597871|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
56597872|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597873|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56597874|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56597875|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56597876|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597877|NCT04076137|Decitabine|decitabine|mesh-list
56597878|NCT04076137|Antibodies|antibodies|mesh-list
56597879|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56597880|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
56646139|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646140|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56646141|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56646142|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646143|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646144|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56646145|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56646146|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56646147|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
56646148|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56497115|NCT01165216|Paclitaxel|paclitaxel|mesh-list
56597881|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597905|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56597906|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56597907|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56597909|NCT03141177|Ipilimumab|ipilimumab|mesh-list
56597910|NCT03141177|Sunitinib|sunitinib|mesh-list
56597911|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56597912|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597913|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56597914|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597915|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56597916|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56597917|NCT03141177|Growth Substances|growth substances|mesh-ancestor
56597918|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597919|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
56597920|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56597921|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597922|NCT03862495|Azithromycin|azithromycin|mesh-list
56597923|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56597924|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597928|NCT00617799|Aldesleukin|aldesleukin|mesh-list
56597929|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597930|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56597931|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56597932|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
56597933|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597964|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597966|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
56597967|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597968|NCT05674201|Dexmedetomidine|dexmedetomidine|mesh-list
56597969|NCT05674201|Remifentanil|remifentanil|mesh-list
56597970|NCT05674201|Propofol|propofol|mesh-list
56597971|NCT05674201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56597972|NCT05674201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597973|NCT05674201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597974|NCT05674201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56597975|NCT05674201|Anesthetics, General|anesthetics, general|mesh-ancestor
56597976|NCT05674201|Anesthetics|anesthetics|mesh-ancestor
56031595|NCT03405584|Antacids|antacids|mesh-ancestor
55910891|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
56598042|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598043|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598044|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598045|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
56598046|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
56598047|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56598048|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598049|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56598050|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56598051|NCT00773734|Growth Substances|growth substances|mesh-ancestor
56598052|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
56598053|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598056|NCT02280525|Rituximab|rituximab|mesh-list
56598057|NCT02280525|Fludarabine|fludarabine|mesh-list
56646149|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646150|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56646151|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646152|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646153|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56646154|NCT02704754|Suvorexant|suvorexant|mesh-list
56646155|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56646156|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56497168|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
56598058|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
56598059|NCT02280525|Lenalidomide|lenalidomide|mesh-list
56598060|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910981|NCT00531453|Hormones|hormones|mesh-ancestor
56598080|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56598081|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598082|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598083|NCT02691897|Melatonin|melatonin|mesh-list
56598084|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
56598085|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598086|NCT02691897|Protective Agents|protective agents|mesh-ancestor
56598087|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598088|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598089|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
56598090|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598091|NCT03485209|Carboplatin|carboplatin|mesh-list
56598092|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
56598093|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
56598094|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598095|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598096|NCT01009580|Insulin|insulin|mesh-list
56598097|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56598098|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
56598099|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
56598100|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56598101|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
56598102|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56598103|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56598104|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598105|NCT01009346|Cisplatin|cisplatin|mesh-list
56598106|NCT01009346|Carboplatin|carboplatin|mesh-list
56598107|NCT01009346|Cetuximab|cetuximab|mesh-list
56598108|NCT01009346|Everolimus|everolimus|mesh-list
56598109|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598110|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598111|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598112|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
56598113|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598114|NCT04101682|Bupivacaine|bupivacaine|mesh-list
56598115|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
56598116|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
56598172|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598173|NCT04101760|Lenograstim|lenograstim|mesh-list
56598174|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56598175|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
56598176|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598177|NCT00616551|Octreotide|octreotide|mesh-list
56598178|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56598179|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56598180|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598181|NCT04478942|Misoprostol|misoprostol|mesh-list
56598182|NCT04478942|Oxytocin|oxytocin|mesh-list
56598183|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
56598184|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56598185|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598186|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56598187|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
56598188|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56598189|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646157|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646158|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646159|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56646160|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497239|NCT04617561|Hormones|hormones|mesh-ancestor
56598190|NCT04214145|Phenylephrine|phenylephrine|mesh-list
56598191|NCT04214145|Vasopressins|vasopressins|mesh-list
56598192|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
56598193|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
56598194|NCT04214145|Norepinephrine|norepinephrine|mesh-list
56598195|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56598196|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
56598197|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
56598198|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598199|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598200|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
56598201|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56598202|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
56598203|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
56598204|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56598231|NCT01068665|Insulin|insulin|mesh-list
56598232|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56598233|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
56598234|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56598235|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598236|NCT00618501|Leucovorin|leucovorin|mesh-list
56598237|NCT00618501|Cytarabine|cytarabine|mesh-list
56598238|NCT00618501|Prednisolone|prednisolone|mesh-list
56598239|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
56598240|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56598241|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56598242|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56598243|NCT00618501|Methotrexate|methotrexate|mesh-list
56598244|NCT00618501|Etoposide|etoposide|mesh-list
56598245|NCT00618501|Vincristine|vincristine|mesh-list
56598246|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
56598247|NCT00618501|Daunorubicin|daunorubicin|mesh-list
56598248|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
56598249|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598250|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56598251|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
56598252|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56598253|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598254|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
55911153|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
56598270|NCT00618501|Protective Agents|protective agents|mesh-ancestor
56598271|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
56598272|NCT00618501|Vitamins|vitamins|mesh-ancestor
56598273|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
56598274|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
56598275|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
56598276|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
56598277|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598278|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
56598279|NCT00618501|Hormones|hormones|mesh-ancestor
56598280|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56598281|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56598282|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56598283|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56598285|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
56598286|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598287|NCT05322681|Pregabalin|pregabalin|mesh-list
56598288|NCT05322681|Analgesics|analgesics|mesh-ancestor
56598289|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
56598290|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598291|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598292|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
56598293|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56598294|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56598295|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598296|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56598297|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56598298|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56646161|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646162|NCT03351998|Atorvastatin|atorvastatin|mesh-list
56646163|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56646164|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56646165|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
56646166|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646167|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56646168|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56646169|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646170|NCT05182658|Empagliflozin|empagliflozin|mesh-list
56646171|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56646172|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646173|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56646174|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646175|NCT04214054|Calcium|calcium|mesh-list
56598299|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598300|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56598301|NCT05322603|Diclofenac|diclofenac|mesh-list
56598302|NCT05322603|Morphine|morphine|mesh-list
56598303|NCT05322603|Analgesics|analgesics|mesh-list
56598304|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56598305|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56598306|NCT05322603|Narcotics|narcotics|mesh-ancestor
56598307|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598308|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598309|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
56598310|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598311|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56598312|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598313|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598314|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56598343|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346868|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598345|NCT01005680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598346|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598348|NCT01005680|Immunologic Factors|immunologic factors|mesh-ancestor
56598349|NCT01005680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598350|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56598351|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56598352|NCT04101370|Bosentan|bosentan|mesh-list
56598353|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56598354|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56598355|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598356|NCT00618657|Paclitaxel|paclitaxel|mesh-list
56598357|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56598358|NCT00618657|Bevacizumab|bevacizumab|mesh-list
56598359|NCT00618657|Carboplatin|carboplatin|mesh-list
56598360|NCT00618657|Trastuzumab|trastuzumab|mesh-list
56598361|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56598362|NCT00618657|Antibodies|antibodies|mesh-list
56598363|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
56598364|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56598365|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56598366|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598367|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
56598368|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
56598369|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
56598370|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646176|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56646177|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646178|NCT02909036|Melphalan|melphalan|mesh-list
56646179|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56646180|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
56646181|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646182|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646183|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56646184|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56646185|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
56646186|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646187|NCT04213898|Paclitaxel|paclitaxel|mesh-list
56646188|NCT04213898|Epirubicin|epirubicin|mesh-list
56646189|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56646190|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56646191|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646192|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
56598371|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56598372|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56598373|NCT00618657|Growth Substances|growth substances|mesh-ancestor
56598374|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598375|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
56598376|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
56598377|NCT04188249|Golimumab|golimumab|mesh-list
56598378|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56598379|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598380|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598381|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
56598382|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598383|NCT01005602|Digoxin|digoxin|mesh-list
56598397|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56598398|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598399|NCT04103398|Sorafenib|sorafenib|mesh-list
56598400|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
56598401|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598402|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56598403|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598404|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598405|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56598406|NCT04103398|Estrogens|estrogens|mesh-ancestor
56598407|NCT04103398|Hormones|hormones|mesh-ancestor
56598408|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56598409|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598410|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56598411|NCT00768430|Midazolam|midazolam|mesh-list
56598412|NCT00768430|Ketamine|ketamine|mesh-list
56598413|NCT00768430|Analgesics|analgesics|mesh-ancestor
56598414|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
56598415|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598416|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598417|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56598418|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56598419|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
56598420|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
56598421|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598422|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56598424|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646193|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
56646194|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
56646195|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646196|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56646197|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56646198|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56646199|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646200|NCT03170882|Dexamethasone|dexamethasone|mesh-list
56646201|NCT03170882|Pomalidomide|pomalidomide|mesh-list
56646202|NCT03170882|Ixazomib|ixazomib|mesh-list
56646203|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646204|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
56646205|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
56646206|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497424|NCT04616313|Xenon|xenon|mesh-list
56598425|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598426|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56598427|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56598429|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56598430|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56598431|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
56598432|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
56598433|NCT04101136|Atorvastatin|atorvastatin|mesh-list
56598434|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56598435|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56598436|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
56598437|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598438|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56598439|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56598440|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598441|NCT00618969|Busulfan|busulfan|mesh-list
56598442|NCT00618969|Melphalan|melphalan|mesh-list
56598443|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
56598444|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598445|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598446|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
56598447|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598471|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56598472|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598473|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56598474|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56598475|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56598476|NCT04716881|Naltrexone|naltrexone|mesh-list
56598477|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56598478|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56598479|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598480|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
56598481|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598482|NCT00582907|Rilonacept|rilonacept|mesh-list
56598483|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598484|NCT01062113|Celecoxib|celecoxib|mesh-list
56598485|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56598486|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56598487|NCT01062113|Analgesics|analgesics|mesh-ancestor
56598488|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
56598489|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598490|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598491|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598492|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598493|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56598494|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56598495|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646207|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646208|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646209|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
56646210|NCT03170882|Hormones|hormones|mesh-ancestor
56646211|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646212|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56646213|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646214|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
56646215|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56646216|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56646217|NCT03170882|Growth Substances|growth substances|mesh-ancestor
56646218|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
56646219|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
56646220|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646221|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646222|NCT00616850|Lidocaine|lidocaine|mesh-list
56646223|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
56646224|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
56646225|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646226|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646227|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
56598496|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598497|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56598498|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56598529|NCT02582203|Vancomycin|vancomycin|mesh-list
56598530|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56598531|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56598532|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598533|NCT05035927|Psilocybin|psilocybin|mesh-list
56598534|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
56598535|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598536|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56598537|NCT00771472|Vorinostat|vorinostat|mesh-list
56598538|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598539|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56598540|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598541|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598542|NCT00771316|Meropenem|meropenem|mesh-list
56598543|NCT00771316|Ertapenem|ertapenem|mesh-list
56598544|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56598545|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598546|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56347089|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598570|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598571|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598573|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56598574|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598575|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
56598576|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598578|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598579|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
56598580|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
56598581|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598582|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
56646228|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646229|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56646230|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56646231|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56646232|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56646233|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646234|NCT00618644|Ranibizumab|ranibizumab|mesh-list
56646235|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56646236|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56646237|NCT00618644|Growth Substances|growth substances|mesh-ancestor
56646238|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646239|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
56646240|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646241|NCT05324774|Aflibercept|aflibercept|mesh-list
56646242|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56646243|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56646244|NCT05324774|Growth Substances|growth substances|mesh-ancestor
56646245|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646246|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
56646247|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646248|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
56646249|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56646250|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56646251|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56646252|NCT05324618|Tacrolimus|tacrolimus|mesh-list
56646253|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56646254|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
56646255|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646256|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56598583|NCT03277729|Fludarabine|fludarabine|mesh-list
56598584|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
56598585|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598586|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
56598587|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598588|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598589|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56598590|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
56598591|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598592|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598593|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56598594|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598595|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
56598596|NCT04952389|Budesonide|budesonide|mesh-list
56598613|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
56598614|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
56646257|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646258|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646259|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646261|NCT02821832|Isoniazid|isoniazid|mesh-list
56646262|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
56646263|NCT02821832|Ethambutol|ethambutol|mesh-list
56646264|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56646265|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
56646266|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56646267|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646268|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
56646269|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56646270|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646271|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598615|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598616|NCT02816203|Hemostatics|hemostatics|mesh-list
56598617|NCT02816203|Coagulants|coagulants|mesh-ancestor
56598619|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56598620|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56598621|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56598622|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
56598623|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598624|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56598625|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56598626|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598627|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
56598628|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56598629|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
56598630|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
56598631|NCT03183115|Lugol's solution|lugol's solution|mesh-list
56598632|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
56598633|NCT03183115|Coagulants|coagulants|mesh-ancestor
56598634|NCT03564691|Paclitaxel|paclitaxel|mesh-list
56598635|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56598636|NCT03564691|Cisplatin|cisplatin|mesh-list
56598637|NCT03564691|Carboplatin|carboplatin|mesh-list
56598638|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
56598639|NCT03564691|Pemetrexed|pemetrexed|mesh-list
56598640|NCT03564691|Lenvatinib|lenvatinib|mesh-list
56598641|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56598642|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347164|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
56598643|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
56598644|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
56598645|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
56598646|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598647|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598648|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598649|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56598650|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56598651|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56598652|NCT02759419|Riociguat|riociguat|mesh-list
56598653|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
56598654|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598655|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56598666|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598667|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56598669|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598670|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598671|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598672|NCT02713009|Vitamin D|vitamin d|mesh-list
56598673|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
56646272|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56646273|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56646274|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56646275|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56646276|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56646277|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56646278|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56646279|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56646280|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
56646281|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56646282|NCT05300594|Vitamins|vitamins|mesh-list
56646283|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
56646284|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646285|NCT00907517|Cytarabine|cytarabine|mesh-list
56646286|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56646287|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
56646288|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497647|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
56598674|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
56598675|NCT02713009|Vitamins|vitamins|mesh-list
56598676|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
56598677|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598678|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56598679|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56598680|NCT03085225|Durvalumab|durvalumab|mesh-list
56598681|NCT03085225|Trabectedin|trabectedin|mesh-list
56598682|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598683|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598684|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56598685|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
56598686|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598687|NCT02705287|Vitamin D|vitamin d|mesh-list
56598688|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
56598689|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
56598690|NCT02705287|Vitamins|vitamins|mesh-list
56598691|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
56598692|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598693|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56598694|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56598695|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
56598696|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
56598697|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56598698|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
56598699|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598700|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
56598701|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598702|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598703|NCT04295408|Ropivacaine|ropivacaine|mesh-list
56598704|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
56598705|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
56598706|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598707|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598708|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
56598709|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598710|NCT02578537|Clopidogrel|clopidogrel|mesh-list
56598711|NCT02578537|Ticagrelor|ticagrelor|mesh-list
56598712|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56646289|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646290|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
56646291|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646292|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56646293|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
56646294|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646295|NCT03043547|Leucovorin|leucovorin|mesh-list
56646296|NCT03043547|Antidotes|antidotes|mesh-ancestor
56646297|NCT03043547|Protective Agents|protective agents|mesh-ancestor
56646298|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646299|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
56598713|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56598714|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56598715|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56598716|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
56598717|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598718|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598719|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598720|NCT03011671|Temozolomide|temozolomide|mesh-list
56598735|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56598736|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56598737|NCT00628706|Analgesics|analgesics|mesh-ancestor
56598738|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
56598739|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598740|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56598741|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56598742|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598743|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598744|NCT00628706|Hormones|hormones|mesh-ancestor
56598745|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56598746|NCT01892371|Cytarabine|cytarabine|mesh-list
56598747|NCT01892371|Azacitidine|azacitidine|mesh-list
56598748|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598749|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
56598750|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598751|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598752|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
56598753|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598754|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598755|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
56598756|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598757|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598758|NCT01001234|Rizatriptan|rizatriptan|mesh-list
56598759|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56598760|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
56598761|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598762|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598763|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598764|NCT04462328|Durvalumab|durvalumab|mesh-list
56598765|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
56598766|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598767|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598768|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
56598769|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56598770|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598771|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
56598772|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598773|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598774|NCT04073953|Primaquine|primaquine|mesh-list
56598775|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
56598776|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56598777|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56598778|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598779|NCT04679389|Acetazolamide|acetazolamide|mesh-list
56598780|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
56646300|NCT03043547|Vitamins|vitamins|mesh-ancestor
56646301|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
56646302|NCT00905255|Lixisenatide|lixisenatide|mesh-list
56646303|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56646304|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646305|NCT00905021|Sunitinib|sunitinib|mesh-list
56646306|NCT00905021|Exemestane|exemestane|mesh-list
56646307|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646308|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56646309|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56646310|NCT00905021|Growth Substances|growth substances|mesh-ancestor
56646311|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646312|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
56646313|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56646314|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646315|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598781|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56598782|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598783|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598784|NCT04679389|Diuretics|diuretics|mesh-ancestor
56598840|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598841|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598842|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
56598843|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598844|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598845|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56598846|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
56598847|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598848|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
56598849|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56598850|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56598851|NCT01000610|Prednisolone|prednisolone|mesh-list
56598852|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
56598853|NCT01000610|Rituximab|rituximab|mesh-list
56598854|NCT01000610|Methotrexate|methotrexate|mesh-list
56598855|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56598856|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
56598857|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598858|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598859|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
56598860|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598861|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598862|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56598863|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
56598864|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56598865|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598866|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
56598867|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598882|NCT01000610|Protective Agents|protective agents|mesh-ancestor
56598883|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56598885|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598886|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598887|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56598888|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598889|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
56598890|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598891|NCT04211961|Scopolamine|scopolamine|mesh-list
56598892|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56598893|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56646316|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56646317|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56646318|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56646319|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
56646320|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646321|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
56598894|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
56598895|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
56598896|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598897|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598898|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56598899|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
56598900|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56598901|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
56598902|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598903|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598904|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56598905|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
56598906|NCT01000376|Ketoconazole|ketoconazole|mesh-list
56598907|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
56598908|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598909|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56598910|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56598911|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598912|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598913|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56598914|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
56598915|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56598916|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598917|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56598918|NCT01038635|Lenalidomide|lenalidomide|mesh-list
56598919|NCT01038635|Azacitidine|azacitidine|mesh-list
56598920|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
56598921|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598922|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56598923|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56598924|NCT01038635|Growth Substances|growth substances|mesh-ancestor
56598925|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
56598926|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598982|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56598983|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56598984|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598985|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56598986|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598987|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
56598988|NCT00580801|Interferons|interferons|mesh-list
56599013|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599014|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599015|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56599016|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56599017|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
56599018|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599019|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56599020|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
56599021|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
56599022|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
56599023|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56599024|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
56599025|NCT00628550|Coagulants|coagulants|mesh-ancestor
56599026|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56599027|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
56599028|NCT01059539|Cariprazine|cariprazine|mesh-list
56599029|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56599030|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56599031|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56599032|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599033|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56646322|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56646323|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646324|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56646325|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646326|NCT02685605|Temozolomide|temozolomide|mesh-list
56646327|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56646328|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
56646329|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646330|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646331|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
56497900|NCT02046395|Diuretics|diuretics|mesh-ancestor
56599034|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
56599035|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56599036|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
56599037|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599038|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599039|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56599040|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
56599041|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
56599058|NCT02871518|Cisplatin|cisplatin|mesh-list
56599059|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599060|NCT04304144|Dexamethasone|dexamethasone|mesh-list
56599061|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
56599062|NCT04304144|Bortezomib|bortezomib|mesh-list
56599063|NCT04304144|Daratumumab|daratumumab|mesh-list
56599064|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599065|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
56599066|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599067|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599068|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56599069|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
56599070|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599071|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599072|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56599073|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599074|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
56599075|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
56599076|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599077|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599078|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
56599079|NCT04304144|Hormones|hormones|mesh-ancestor
56599080|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599081|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56599082|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
56599083|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56599084|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56599085|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
56599086|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599087|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56599088|NCT00770224|Prednisone|prednisone|mesh-list
56599089|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
56599090|NCT00770224|Rituximab|rituximab|mesh-list
56599091|NCT00770224|Doxorubicin|doxorubicin|mesh-list
56599092|NCT00770224|Vincristine|vincristine|mesh-list
56599093|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
56599094|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599095|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
56599096|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599097|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599098|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56599099|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
56599100|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599101|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599118|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56646332|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56646333|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56646334|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56646335|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56646336|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646337|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
56646338|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646339|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646340|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56646341|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646342|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56646343|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646344|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
56599119|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599120|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56599121|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599122|NCT02399215|Nintedanib|nintedanib|mesh-list
56599123|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599124|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56599125|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599126|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599127|NCT02389465|Celecoxib|celecoxib|mesh-list
56599128|NCT02389465|Dexetimide|dexetimide|mesh-list
56599129|NCT02389465|Citalopram|citalopram|mesh-list
56599130|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56599131|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56599132|NCT02389465|Analgesics|analgesics|mesh-ancestor
56599133|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
56599134|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599135|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599136|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599137|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599138|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56599139|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56599140|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599141|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599142|NCT02389465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56599143|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56599144|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56599145|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599146|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
56599147|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56599148|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
56599149|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56599150|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56599151|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56599152|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
56599153|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
56599154|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56599155|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56599156|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
56599157|NCT01057589|Folic Acid|folic acid|mesh-list
56599158|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
56599159|NCT01057589|Pemetrexed|pemetrexed|mesh-list
56599160|NCT01057589|Cetuximab|cetuximab|mesh-list
56599161|NCT01057589|Vitamins|vitamins|mesh-ancestor
56599162|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
55912041|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
56599214|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
56599215|NCT01716117|Antacids|antacids|mesh-ancestor
56599216|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599217|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599218|NCT00579553|Progesterone|progesterone|mesh-list
56646345|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56646346|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646347|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
56646348|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
56646349|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646350|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646351|NCT00632645|Olanzapine|olanzapine|mesh-list
56646352|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
56646353|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
56646354|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
56646355|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
56646356|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498023|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
56599219|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56599220|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56599291|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56599292|NCT02334865|Growth Substances|growth substances|mesh-ancestor
56599293|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
56599294|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599330|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56599332|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56599333|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
56599334|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56599335|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56599358|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599359|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
56599360|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599361|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56599362|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599363|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599364|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56599365|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56599366|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
56599367|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56599368|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56599369|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56599370|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
56599371|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599372|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599374|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56599375|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56599376|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
56599377|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599378|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56599379|NCT04064697|Valganciclovir|valganciclovir|mesh-list
56599380|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
56599381|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599382|NCT00915850|Cisplatin|cisplatin|mesh-list
56599383|NCT00915850|Docetaxel|docetaxel|mesh-list
56599384|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599385|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
56599386|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
56599387|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
56599388|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599389|NCT04208763|Imipenem|imipenem|mesh-list
56599390|NCT04208763|Colistin|colistin|mesh-list
56599391|NCT04208763|Tigecycline|tigecycline|mesh-list
56599392|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56599393|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646357|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646358|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646359|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56498084|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
56599394|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56599395|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599396|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599397|NCT00620919|Secretin|secretin|mesh-list
56159142|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
56599398|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599399|NCT00620919|Hormones|hormones|mesh-ancestor
56599400|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599401|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599402|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
56599403|NCT00916552|Hematinics|hematinics|mesh-ancestor
56599404|NCT03950037|Albendazole|albendazole|mesh-list
56599405|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
56599406|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56599407|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599408|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
56599488|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
56599489|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56599490|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
56599491|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56599492|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56599493|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56599494|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56599495|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599496|NCT01056341|Propranolol|propranolol|mesh-list
56599497|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56599498|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56599499|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
56599500|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599501|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599502|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599503|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56599504|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56599505|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
56599506|NCT00999518|Tanezumab|tanezumab|mesh-list
56599507|NCT00999518|Analgesics|analgesics|mesh-ancestor
56599508|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
56599509|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599510|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599511|NCT00621387|Ofloxacin|ofloxacin|mesh-list
56599512|NCT00621387|Roxithromycin|roxithromycin|mesh-list
56599513|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56599514|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599515|NCT00621387|Renal Agents|renal agents|mesh-ancestor
56599516|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56599517|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56599518|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56599519|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599520|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599521|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599522|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56599523|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56599524|NCT02873273|Dexamethasone|dexamethasone|mesh-list
56599525|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599526|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
56599527|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
56599528|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599529|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599530|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599564|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599566|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599567|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599568|NCT01056107|Incretins|incretins|mesh-ancestor
56599569|NCT03548805|Mitomycins|mitomycins|mesh-list
56599570|NCT03548805|Mitomycin|mitomycin|mesh-list
56599571|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56599572|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599573|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
56646360|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56646361|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646362|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56646363|NCT00632645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56646364|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56646365|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56646366|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646367|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646368|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
56646369|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56599574|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599575|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56599576|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599577|NCT01003886|Doxazosin|doxazosin|mesh-list
56599578|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56599579|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56599580|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56599581|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56599582|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56599583|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599584|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599585|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599586|NCT03244059|Belimumab|belimumab|mesh-list
56599587|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599588|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
56599589|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599590|NCT04138641|Cangrelor|cangrelor|mesh-list
56599591|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56599592|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56599593|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56599594|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56599595|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
56599596|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599597|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599598|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599599|NCT01003184|Exenatide|exenatide|mesh-list
56599600|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
56599601|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56599602|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599603|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56599604|NCT01003184|Incretins|incretins|mesh-ancestor
56599605|NCT01003184|Hormones|hormones|mesh-ancestor
56599606|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599607|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
56599608|NCT04314219|Methotrexate|methotrexate|mesh-list
56599609|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599610|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
56599664|NCT01972035|Valganciclovir|valganciclovir|mesh-list
56599665|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
56599666|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599667|NCT00622479|Sorafenib|sorafenib|mesh-list
56599668|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599669|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56599670|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599671|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599672|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
56599673|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56599674|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56599675|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599676|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
56599677|NCT04304625|Coagulants|coagulants|mesh-ancestor
56599678|NCT01207011|Docetaxel|docetaxel|mesh-list
56599679|NCT01207011|Amrubicin|amrubicin|mesh-list
56646370|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
56646371|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56646372|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
56646373|NCT02849873|Tazarotene|tazarotene|mesh-list
56646374|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
56646375|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
56646376|NCT02304809|Vemurafenib|vemurafenib|mesh-list
56646377|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646378|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56646379|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646380|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646381|NCT02849483|Ramosetron|ramosetron|mesh-list
56646382|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
56646383|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
56646384|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646385|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498220|NCT01163617|Adalimumab|adalimumab|mesh-list
56599680|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599681|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
56599682|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
56599683|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
56599684|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599685|NCT05264883|Azacitidine|azacitidine|mesh-list
56599686|NCT05264883|Decitabine|decitabine|mesh-list
56599687|NCT05264883|Venetoclax|venetoclax|mesh-list
56599688|NCT05264883|Aclarubicin|aclarubicin|mesh-list
56599689|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56599690|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
56599691|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599692|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599693|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599694|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56599695|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56599696|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56599698|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56599699|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599700|NCT05264805|Bupivacaine|bupivacaine|mesh-list
56599701|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
56599702|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
56599703|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56599704|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599705|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
56599731|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
56599732|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599733|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599734|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56599735|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
56599736|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599737|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599738|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56599739|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56599740|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
56599741|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56599742|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56599744|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
56599745|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599746|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56599747|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56599748|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
56599749|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646386|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646387|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56646388|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
56646389|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498289|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
56599750|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56599751|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56599752|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56599753|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599754|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56599755|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56599756|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56599757|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56599758|NCT02697045|Aripiprazole|aripiprazole|mesh-list
56599759|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
56599760|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56599761|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56599762|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56599763|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56599764|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599765|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
56599766|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
56599767|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599768|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599769|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56599770|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56599771|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
56599772|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56599773|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56599774|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56599775|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56599776|NCT01007942|Trastuzumab|trastuzumab|mesh-list
56599777|NCT01007942|Everolimus|everolimus|mesh-list
56599778|NCT01007942|Vinorelbine|vinorelbine|mesh-list
56599779|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56599780|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599781|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599782|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
56599783|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599784|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56599829|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56599830|NCT00627731|Protective Agents|protective agents|mesh-ancestor
56599831|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56599832|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599833|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56599834|NCT01028027|Tobramycin|tobramycin|mesh-list
56599835|NCT01028027|Dexamethasone|dexamethasone|mesh-list
56599836|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599837|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
56599838|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
56599839|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599840|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599841|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599842|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
56599843|NCT01028027|Hormones|hormones|mesh-ancestor
56599844|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599845|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56599846|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599920|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
56599921|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599922|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
56599923|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56599924|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56599925|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
56599926|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56599927|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56599928|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599929|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
56599930|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56073032|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
56646390|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646391|NCT02432274|Etoposide|etoposide|mesh-list
56646392|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
56646393|NCT02432274|Ifosfamide|ifosfamide|mesh-list
56646394|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
56646395|NCT02432274|Lenvatinib|lenvatinib|mesh-list
56646396|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56646397|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646398|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56498357|NCT01847573|Halofuginone|halofuginone|mesh-list
56599931|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56599932|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599933|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56599934|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599935|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599936|NCT04369664|Atorvastatin|atorvastatin|mesh-list
56599937|NCT04369664|Ezetimibe|ezetimibe|mesh-list
56599938|NCT04369664|Evolocumab|evolocumab|mesh-list
56599939|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56599940|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56599941|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
56599942|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599943|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56599944|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56599945|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599946|NCT04296578|Selenious Acid|selenious acid|mesh-list
56599947|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
56599948|NCT04296578|Prednisone|prednisone|mesh-list
56599949|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
56599950|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599951|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
56599952|NCT04296578|Hormones|hormones|mesh-ancestor
56599953|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599954|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599955|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56599956|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599957|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56599958|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599959|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599960|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
56599961|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56599962|NCT04296578|Trace Elements|trace elements|mesh-ancestor
56599963|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
56599964|NCT00996944|Ropinirole|ropinirole|mesh-list
55912823|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
56599982|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56599983|NCT01038323|Analgesics|analgesics|mesh-ancestor
56599984|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
56599985|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599986|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
56599987|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56599988|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
56599989|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56599990|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599991|NCT04301375|Paclitaxel|paclitaxel|mesh-list
56599992|NCT04301375|Trastuzumab|trastuzumab|mesh-list
56599993|NCT04301375|Pertuzumab|pertuzumab|mesh-list
56599994|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56599995|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599996|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
56599997|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
56348517|NCT00189982|Coagulants|coagulants|mesh-ancestor
56599998|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
56599999|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600000|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600001|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
56600002|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56646399|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56646400|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646401|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646402|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56292389|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646403|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
56646404|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56646405|NCT04500665|Colchicine|colchicine|mesh-list
56600003|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600004|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56600005|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
56600006|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
56600007|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600008|NCT01025843|Candesartan|candesartan|mesh-list
56600009|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
56600010|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56600011|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56600012|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56600013|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600014|NCT02873351|Levodopa|levodopa|mesh-list
56600015|NCT02873351|Carbidopa|carbidopa|mesh-list
56600016|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56600017|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55912882|NCT01447927|Metformin|metformin|mesh-list
56600043|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56600044|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56600045|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56600046|NCT01020305|Sirolimus|sirolimus|mesh-list
56600047|NCT01020305|Bicalutamide|bicalutamide|mesh-list
56600048|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56600049|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600050|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56600051|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600052|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
56600053|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600054|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
56600055|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600056|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
56600057|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
56600058|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600059|NCT00627575|Lamotrigine|lamotrigine|mesh-list
56600060|NCT00627575|Phenytoin|phenytoin|mesh-list
56600061|NCT00627575|Atorvastatin|atorvastatin|mesh-list
56600062|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56600063|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56600064|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
56600065|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600066|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56600067|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56600068|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600069|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
56600070|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55912935|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56600113|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56600114|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
56600115|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600116|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600117|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600118|NCT01018511|Urological Agents|urological agents|mesh-ancestor
56600119|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56600120|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56600121|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
56600158|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
56600159|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
56600160|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600161|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
56646406|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
56646407|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56646408|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
56646409|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
56646410|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
56646411|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646412|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646413|NCT05116007|Carboplatin|carboplatin|mesh-list
56646414|NCT05116007|Etoposide|etoposide|mesh-list
56646415|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646416|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56646417|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56646418|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56646419|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646420|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646421|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56646422|NCT00618696|Antibodies|antibodies|mesh-list
56646423|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
56600162|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
56600163|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56600164|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56600165|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
56600166|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
56600167|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600168|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56600169|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
56600170|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
56600171|NCT02575183|Varenicline|varenicline|mesh-list
56600172|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56600173|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56600174|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
56600175|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600176|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600177|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600178|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
56600179|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56600180|NCT00779584|Gemcitabine|gemcitabine|mesh-list
56600181|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56600182|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
56600183|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600184|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600185|NCT00779584|Antiviral Agents|antiviral agents|mesh-ancestor
56600186|NCT00779584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600187|NCT00779584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600188|NCT00779584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600189|NCT00779584|Immunologic Factors|immunologic factors|mesh-ancestor
56600190|NCT00779584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600191|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56600192|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
56600193|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56600194|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56600195|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56600196|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600197|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600198|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
56600199|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56600200|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
56600201|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646424|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56646425|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
56646426|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646427|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646428|NCT00618852|Furosemide|furosemide|mesh-list
56646429|NCT00618852|Diuretics|diuretics|mesh-ancestor
56646430|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
56646431|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646432|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56646433|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56646434|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498538|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498539|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498540|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56498541|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498542|NCT04608981|Analgesics|analgesics|mesh-ancestor
56498543|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
56498544|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56498545|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56498546|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498547|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498548|NCT01746836|Ponatinib|ponatinib|mesh-list
56600202|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600203|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56600204|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
56600205|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56600233|NCT04100434|Evolocumab|evolocumab|mesh-list
56600234|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56600235|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56600236|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
56600237|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600238|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56600239|NCT00991952|Irinotecan|irinotecan|mesh-list
56600240|NCT00991952|Alvocidib|alvocidib|mesh-list
56600251|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56600252|NCT00779038|Narcotics|narcotics|mesh-ancestor
56600253|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600254|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600255|NCT00779038|Analgesics|analgesics|mesh-ancestor
56600256|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
56600257|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600258|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56600259|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56600260|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
56600261|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
56600262|NCT04292990|Fentanyl|fentanyl|mesh-list
56600263|NCT04292990|Morphine|morphine|mesh-list
56600264|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56600265|NCT04292990|Narcotics|narcotics|mesh-ancestor
56600266|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600267|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600268|NCT04292990|Analgesics|analgesics|mesh-ancestor
56073368|NCT00356486|Ribavirin|ribavirin|mesh-list
56646435|NCT02073474|Nabiximols|nabiximols|mesh-list
56646436|NCT02073474|Analgesics|analgesics|mesh-ancestor
56646437|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
56646438|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646439|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646440|NCT00637104|Chromium|chromium|mesh-list
56646441|NCT00637104|Trace Elements|trace elements|mesh-ancestor
56646442|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
56646443|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646444|NCT00617760|Vaccines|vaccines|mesh-list
56498600|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56600269|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
56600270|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600271|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56600272|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56600273|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
56600274|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
56600275|NCT02868632|Durvalumab|durvalumab|mesh-list
56600276|NCT02868632|Tremelimumab|tremelimumab|mesh-list
56600277|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600278|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600280|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56600281|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56600282|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
56600283|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600284|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56600285|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56600286|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600287|NCT00994682|Pioglitazone|pioglitazone|mesh-list
56600288|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56600289|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600290|NCT00994448|Bupropion|bupropion|mesh-list
56600291|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56600292|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
56600293|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56600294|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56600295|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56600296|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56600297|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600298|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
56600299|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600300|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600301|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56600302|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56600303|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600304|NCT04292444|Oxytocin|oxytocin|mesh-list
56600305|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
56600306|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56600350|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56159160|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
56600351|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600352|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600353|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56600354|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56600355|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56600356|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600357|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56600358|NCT02576665|Flucytosine|flucytosine|mesh-list
56600359|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
56600360|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600361|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
56600362|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600363|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
56600364|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646445|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56646446|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
56646447|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646448|NCT00620490|Ropivacaine|ropivacaine|mesh-list
56646449|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
56646450|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
56646451|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646452|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646453|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
56646454|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646455|NCT04212078|Levofloxacin|levofloxacin|mesh-list
56646456|NCT04212078|Ofloxacin|ofloxacin|mesh-list
56646457|NCT04212078|Cefuroxime|cefuroxime|mesh-list
56646458|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
56646459|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56646460|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646461|NCT04212078|Renal Agents|renal agents|mesh-ancestor
56646462|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56646463|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56646464|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56646465|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646466|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646467|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646468|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56646469|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55913239|NCT03121677|Laxatives|laxatives|mesh-ancestor
56600501|NCT01034657|Hematinics|hematinics|mesh-ancestor
56600502|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600503|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56600504|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600505|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600506|NCT01014767|Leucovorin|leucovorin|mesh-list
56600507|NCT01014767|Dactinomycin|dactinomycin|mesh-list
56600508|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
56600509|NCT01014767|Temozolomide|temozolomide|mesh-list
56600510|NCT01014767|Cisplatin|cisplatin|mesh-list
56600511|NCT01014767|Carboplatin|carboplatin|mesh-list
56600512|NCT01014767|Doxorubicin|doxorubicin|mesh-list
56600513|NCT01014767|Methotrexate|methotrexate|mesh-list
56600514|NCT01014767|Irinotecan|irinotecan|mesh-list
56600515|NCT01014767|Etoposide|etoposide|mesh-list
56600516|NCT01014767|Vincristine|vincristine|mesh-list
56600517|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600518|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
56600519|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600520|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56600521|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56600522|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
56600523|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600524|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600525|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56600526|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56646470|NCT05059860|Insulin|insulin|mesh-list
56646471|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56646472|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646473|NCT01898520|Nabiximols|nabiximols|mesh-list
56646474|NCT01898520|Analgesics|analgesics|mesh-ancestor
56646475|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
56646476|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600527|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56600528|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56600529|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600530|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56600531|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
56600532|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56600533|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56600534|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
56600535|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
56600536|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56600537|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56600538|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56600539|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56600540|NCT01014767|Antidotes|antidotes|mesh-ancestor
56600541|NCT01014767|Protective Agents|protective agents|mesh-ancestor
56600542|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
56600544|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
56600545|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
56600546|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
56600547|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
56600548|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56600567|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600568|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600569|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
56600570|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56600571|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56600572|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600573|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56600574|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56600575|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56600576|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600577|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600578|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
56600579|NCT02013427|Naproxen|naproxen|mesh-list
56600580|NCT02013427|Omeprazole|omeprazole|mesh-list
56600581|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56600582|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56600583|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56600584|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600585|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600586|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56600587|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56600588|NCT02013427|Analgesics|analgesics|mesh-ancestor
56600589|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
56600590|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600591|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600592|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56600593|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56600594|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
56600595|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56600596|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
56600597|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56600598|NCT01014143|Triclosan|triclosan|mesh-list
56600599|NCT01014143|Fluorides|fluorides|mesh-list
56600600|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
56600601|NCT01014143|Protective Agents|protective agents|mesh-ancestor
56600602|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600603|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56600604|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600606|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
55913431|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600705|NCT00715273|Niacinamide|niacinamide|mesh-list
56600706|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
56646477|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646478|NCT00903617|Niacin|niacin|mesh-list
56646479|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
56646481|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
56646482|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646483|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56646484|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
56646485|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
56646486|NCT00903617|Vitamins|vitamins|mesh-ancestor
56646487|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
56646488|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646489|NCT02848937|Citric Acid|citric acid|mesh-list
56646490|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
56646491|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
56646492|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56646493|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
56646494|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
56600707|NCT00715273|Atorvastatin|atorvastatin|mesh-list
56600708|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56600709|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56600710|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56600711|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
56600712|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600724|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600725|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56600726|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56600727|NCT01013285|Growth Substances|growth substances|mesh-ancestor
56600728|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600729|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
56600730|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56600731|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
56600732|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600733|NCT00715351|Insulin|insulin|mesh-list
56600734|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56600735|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
56600736|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
56600737|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
56600738|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
56600739|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56600740|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600741|NCT04245085|Paclitaxel|paclitaxel|mesh-list
56600742|NCT04245085|Bevacizumab|bevacizumab|mesh-list
56600743|NCT04245085|Carboplatin|carboplatin|mesh-list
56600744|NCT04245085|Pemetrexed|pemetrexed|mesh-list
56600745|NCT04245085|Atezolizumab|atezolizumab|mesh-list
56600746|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56600747|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600748|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
56600749|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
56600750|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
56600751|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600752|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600753|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56600754|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56600755|NCT04245085|Growth Substances|growth substances|mesh-ancestor
56600756|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600757|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
56600758|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600759|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56600760|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56600761|NCT00711841|Dexamethasone|dexamethasone|mesh-list
56646495|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646496|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56646497|NCT00343824|Laxatives|laxatives|mesh-ancestor
56646498|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646499|NCT01428089|Progesterone|progesterone|mesh-list
56600762|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
56600763|NCT00711841|BB 1101|bb 1101|mesh-list
56600764|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56600765|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
56600766|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
56600767|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600768|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600769|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56600770|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
56600771|NCT00711841|Hormones|hormones|mesh-ancestor
56600772|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600773|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56600774|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600775|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
56600776|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913597|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56600792|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56600793|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56600794|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600795|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600796|NCT00712465|Protective Agents|protective agents|mesh-ancestor
56600797|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600798|NCT00715975|Clobetasol|clobetasol|mesh-list
56600799|NCT00715975|Halobetasol|halobetasol|mesh-list
56600800|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56600801|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
56600802|NCT00715975|Hormones|hormones|mesh-ancestor
56600803|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600804|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600805|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56600806|NCT02572687|Durvalumab|durvalumab|mesh-list
56600807|NCT02572687|Ramucirumab|ramucirumab|mesh-list
56600808|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600809|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600810|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56600811|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56600812|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56600813|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56600814|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56600815|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
56600816|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600817|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600818|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600819|NCT00603447|Dexamethasone|dexamethasone|mesh-list
56600820|NCT00603447|Lenalidomide|lenalidomide|mesh-list
56600821|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56600822|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
56600823|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
56600824|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600825|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600826|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56600827|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
56600829|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600830|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56600831|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600832|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
56600833|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913661|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
56600854|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56600855|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
56600856|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600857|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600858|NCT00639015|Protective Agents|protective agents|mesh-ancestor
56600860|NCT00712855|Mapatumumab|mapatumumab|mesh-list
56600861|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646500|NCT01428089|Progestins|progestins|mesh-ancestor
56646501|NCT01428089|Hormones|hormones|mesh-ancestor
56646502|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646503|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646504|NCT04212000|Ketoconazole|ketoconazole|mesh-list
56646505|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
56646506|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646507|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56646508|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56600862|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56600863|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600864|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600865|NCT02537925|Celecoxib|celecoxib|mesh-list
56600866|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
56600867|NCT02537925|Nedaplatin|nedaplatin|mesh-list
56600868|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56600869|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56600870|NCT02537925|Analgesics|analgesics|mesh-ancestor
56600871|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
56600872|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600873|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600874|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56600875|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56600876|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56600877|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600878|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600879|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600880|NCT00713011|Nifedipine|nifedipine|mesh-list
56600881|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56600882|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56600883|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600884|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56600885|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600886|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
56600887|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
56600888|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56600924|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56600925|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56600927|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
56600928|NCT00639249|SA 4503|sa 4503|mesh-list
56600984|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600985|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56600986|NCT02686827|Vitamin D|vitamin d|mesh-list
56600987|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
56600988|NCT02686827|Vitamins|vitamins|mesh-ancestor
56600989|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
56600990|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600991|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56600992|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56600993|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
56600994|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56600995|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600996|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
56600997|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600998|NCT00713167|Protective Agents|protective agents|mesh-ancestor
56600999|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601000|NCT00716521|Zolpidem|zolpidem|mesh-list
56601001|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56601002|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56601003|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601004|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601005|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56601006|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
56601007|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
56646509|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646510|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646511|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56646512|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
56646513|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646514|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646515|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56646516|NCT00619398|Tacrolimus|tacrolimus|mesh-list
56646517|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56646518|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
56646519|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646520|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56646521|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646522|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646523|NCT00620646|Aspirin|aspirin|mesh-list
56646524|NCT00620646|Cilostazol|cilostazol|mesh-list
56646525|NCT00620646|Clopidogrel|clopidogrel|mesh-list
56498978|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56601008|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601009|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601010|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
56601011|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601012|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
56601013|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601014|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601015|NCT00778102|Leucovorin|leucovorin|mesh-list
56601016|NCT00778102|Bevacizumab|bevacizumab|mesh-list
56601017|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
56601018|NCT00778102|Irinotecan|irinotecan|mesh-list
56601019|NCT00778102|Fluorouracil|fluorouracil|mesh-list
56601020|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
56601021|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913845|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
56601074|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
56601075|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
56601077|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56601078|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56601079|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
56601080|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601081|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601082|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
56601083|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56601084|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
56601085|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
56601086|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
56601087|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56601088|NCT00716911|Ganciclovir|ganciclovir|mesh-list
56601089|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56601090|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
56601091|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601092|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56601093|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601094|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601095|NCT00612495|Fluorouracil|fluorouracil|mesh-list
56601096|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
56601097|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
55887574|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56646526|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56646527|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56646528|NCT00620646|Analgesics|analgesics|mesh-ancestor
56646529|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
56646530|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646531|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646532|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646533|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56646534|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56499038|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
56601098|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913929|NCT01549652|Analgesics|analgesics|mesh-ancestor
56601123|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56601124|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
56601125|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601126|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56601127|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56601128|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601129|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56601130|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56601131|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56601132|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
56601133|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601134|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601135|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56601136|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56601137|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
56601138|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601140|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56601141|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601142|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56601143|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601144|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601145|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56601146|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56601147|NCT00984620|Interferons|interferons|mesh-list
56601148|NCT00984620|Ribavirin|ribavirin|mesh-list
56601164|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56601166|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56601167|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601168|NCT00639483|Analgesics|analgesics|mesh-ancestor
56601169|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
56601170|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601171|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601172|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56601173|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601174|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56601175|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56601176|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601177|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601178|NCT00777946|Amlodipine|amlodipine|mesh-list
56601179|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56601180|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56601181|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56601182|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601183|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56601184|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601185|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
56601186|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
56601187|NCT02686047|Hylan|hylan|mesh-list
56601188|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56601189|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
56601190|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646535|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56646536|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646537|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56646538|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56646539|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646540|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
56646541|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56646542|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56646543|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56646544|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
56646545|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646546|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56646547|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
56646548|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56601191|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
56601192|NCT02686047|Protective Agents|protective agents|mesh-ancestor
56601193|NCT00713947|Amoxicillin|amoxicillin|mesh-list
56601194|NCT00713947|Metronidazole|metronidazole|mesh-list
56601195|NCT00713947|Clarithromycin|clarithromycin|mesh-list
56601196|NCT00713947|Pantoprazole|pantoprazole|mesh-list
56601197|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56601198|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601199|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56601200|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56601201|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56601202|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601203|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601204|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56601205|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56601232|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
56601233|NCT00717379|Tacrolimus|tacrolimus|mesh-list
56601234|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56601235|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
56601236|NCT00717379|Hormones|hormones|mesh-ancestor
56601237|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56601238|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601239|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56601240|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601241|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601242|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
56601243|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56601244|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601245|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601246|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56601247|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56601248|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
56601249|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56601250|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601251|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
56601252|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
56601253|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601254|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56601255|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55914096|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
56601273|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
56601274|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56601275|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
56601276|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56601277|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601278|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56646549|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
56646550|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
56646551|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56646552|NCT00620646|Protective Agents|protective agents|mesh-ancestor
56292538|NCT00276757|Vinblastine|vinblastine|mesh-list
56292613|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646553|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56646554|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56646555|NCT00810017|Trastuzumab|trastuzumab|mesh-list
56646556|NCT00810017|Etoposide|etoposide|mesh-list
56646557|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56646558|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646559|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56646560|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56646561|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56646562|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499160|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601279|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56601280|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56601281|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
56601282|NCT02685657|Docetaxel|docetaxel|mesh-list
56601283|NCT02685657|Doxorubicin|doxorubicin|mesh-list
56601284|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601285|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
56601286|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601287|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601288|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56601289|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
56601290|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601291|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601292|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56601293|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
56601294|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
56601295|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
56601296|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56601297|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56601298|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56601299|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601300|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
56601301|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56601302|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56601303|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601304|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
56601305|NCT04290884|Coagulants|coagulants|mesh-ancestor
56601306|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
56601307|NCT00719407|Hematinics|hematinics|mesh-ancestor
56601320|NCT00714025|Everolimus|everolimus|mesh-list
56601321|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601322|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601323|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
56601324|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601325|NCT02685345|Firuglipel|firuglipel|mesh-list
56601362|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56601363|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
56601364|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56601365|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
56601366|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
56601367|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601368|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601369|NCT00993044|Bevacizumab|bevacizumab|mesh-list
56646563|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646564|NCT00620724|Nifedipine|nifedipine|mesh-list
56646565|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56646566|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56646567|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646568|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56646569|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646570|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
56646571|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
56646572|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56646573|NCT04209426|Tacrine|tacrine|mesh-list
56646574|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56646575|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646576|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646577|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
56646578|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646579|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646580|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56646581|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
56646582|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646583|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
56646584|NCT00620802|Clopidogrel|clopidogrel|mesh-list
56601370|NCT00993044|Irinotecan|irinotecan|mesh-list
56601371|NCT00993044|Vincristine|vincristine|mesh-list
56601372|NCT00993044|Temozolomide|temozolomide|mesh-list
56601373|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56601374|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601397|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56159229|NCT00800514|Analgesics|analgesics|mesh-ancestor
56601398|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56601399|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601400|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601401|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601403|NCT02600806|Levofloxacin|levofloxacin|mesh-list
56601405|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56601406|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601407|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56601408|NCT02600806|Renal Agents|renal agents|mesh-ancestor
56601409|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56601410|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56601411|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601412|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601413|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601414|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56601415|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56601416|NCT00639873|Doxycycline|doxycycline|mesh-list
56601417|NCT00639873|Artesunate|artesunate|mesh-list
56601418|NCT00639873|Quinine|quinine|mesh-list
56601419|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56601420|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601421|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
56601422|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56601423|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56646585|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56646586|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56646587|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56646588|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56646589|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
56646590|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646591|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646592|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646593|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
56646594|NCT02848157|Ropivacaine|ropivacaine|mesh-list
56646595|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56646596|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646597|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646598|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56646599|NCT02848157|Analgesics|analgesics|mesh-ancestor
56646600|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
56646601|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646602|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56646603|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56646604|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56646605|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
56601424|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601425|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
56601426|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
56601456|NCT02868944|Analgesics|analgesics|mesh-ancestor
56601457|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
56601458|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601459|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56601460|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56601461|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
56601462|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56601463|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56601464|NCT00722839|Vaccines|vaccines|mesh-list
56601465|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
56601466|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601467|NCT04096690|Pegaspargase|pegaspargase|mesh-list
56601468|NCT04096690|Antibodies|antibodies|mesh-list
56601469|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56601470|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
56601471|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601472|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601473|NCT01748149|Vemurafenib|vemurafenib|mesh-list
56601474|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601475|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56601502|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56601503|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601504|NCT00719797|Antidotes|antidotes|mesh-ancestor
56601505|NCT00719797|Protective Agents|protective agents|mesh-ancestor
56601506|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
56601507|NCT00719797|Vitamins|vitamins|mesh-ancestor
56601508|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
56601509|NCT00979628|Insulin|insulin|mesh-list
56601510|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56601511|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
56601512|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
56646606|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646607|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646608|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
56646609|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
56646610|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
56646611|NCT04211844|Ledipasvir|ledipasvir|mesh-list
56646612|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
56646613|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646614|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56646615|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56646616|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646617|NCT00619710|Meropenem|meropenem|mesh-list
56646618|NCT00619710|Imipenem|imipenem|mesh-list
56646619|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
56646620|NCT00619710|Cilastatin|cilastatin|mesh-list
56646621|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56646622|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646623|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
56646624|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499322|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
56601513|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56601514|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601515|NCT00719875|Vorinostat|vorinostat|mesh-list
56601516|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56601517|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601518|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601519|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601520|NCT02685111|Lenograstim|lenograstim|mesh-list
56601521|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56601522|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
56601523|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601524|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56601525|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56601526|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601527|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56601562|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601563|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56601564|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56601565|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56601566|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
56601567|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601568|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56601569|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601570|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601571|NCT00992108|Lidocaine|lidocaine|mesh-list
56601572|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
56601573|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
56601574|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601575|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601576|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
56601577|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601578|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56601579|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56601580|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56601609|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56601610|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56601611|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
56646625|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646626|NCT05036226|Metformin|metformin|mesh-list
56646627|NCT05036226|Sirolimus|sirolimus|mesh-list
56646628|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
56646629|NCT05036226|Nelfinavir|nelfinavir|mesh-list
56646630|NCT05036226|Dasatinib|dasatinib|mesh-list
56646631|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56646632|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646633|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56646634|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646635|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56646636|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646637|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
56646638|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56646639|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
56646640|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
56646641|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56646642|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56646643|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646644|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646645|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56646646|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56646647|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56646648|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56646649|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
56646650|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56646651|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56646652|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
56646653|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56499380|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601612|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601613|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56601614|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56601615|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601616|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601617|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56601618|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56601619|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56601620|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56601621|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56601622|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56601623|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
56601641|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601642|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
56601643|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56601644|NCT00629252|Risperidone|risperidone|mesh-list
56601645|NCT00629252|Sertindole|sertindole|mesh-list
56646654|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646655|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646656|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
56646657|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646658|NCT04019015|Thrombin|thrombin|mesh-list
56646659|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
56646660|NCT04019015|Coagulants|coagulants|mesh-ancestor
56646661|NCT02846909|Progesterone|progesterone|mesh-list
56646662|NCT02846909|Progestins|progestins|mesh-ancestor
56646663|NCT02846909|Hormones|hormones|mesh-ancestor
56646664|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646665|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646666|NCT00632723|Gefitinib|gefitinib|mesh-list
56499429|NCT04604223|Pioglitazone|pioglitazone|mesh-list
56601646|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56601647|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
56601648|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601649|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601650|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601651|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56601652|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56601653|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601654|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56601655|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56601656|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
56601657|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
56601658|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56601659|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601660|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601661|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
56601662|NCT04095754|Anesthetics|anesthetics|mesh-list
56601663|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601664|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601665|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56601666|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601667|NCT04095754|Analgesics|analgesics|mesh-ancestor
56601668|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
56601669|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601670|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56601671|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56601672|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56601673|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
56601674|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601675|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601676|NCT00720265|Tacrolimus|tacrolimus|mesh-list
56601677|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601678|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
56601679|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601680|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56601681|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914479|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56601718|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
56601719|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601720|NCT00754936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56601721|NCT00754936|Antidepressive Agents|antidepressive agents|mesh-ancestor
56601747|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
56601748|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
56601749|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
56601750|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601751|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601752|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56601753|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56646667|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646668|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56646669|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646670|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646671|NCT02847143|Oxytocin|oxytocin|mesh-list
56646672|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
56646673|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56646674|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646675|NCT02847455|Rabeprazole|rabeprazole|mesh-list
56646676|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56646677|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646678|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56646679|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646680|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646681|NCT03897335|Aminophylline|aminophylline|mesh-list
56646682|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56646683|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
56499488|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
56601754|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601755|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56601756|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56601757|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56601758|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
56601759|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
56601760|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601761|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601762|NCT02689713|Voriconazole|voriconazole|mesh-list
56601763|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
56601764|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601765|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56601766|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56601767|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601768|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601860|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601861|NCT02865668|Metformin|metformin|mesh-list
56601862|NCT02865668|Canagliflozin|canagliflozin|mesh-list
56601863|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56601864|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601865|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56601866|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601867|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
56601868|NCT02867930|Ketamine|ketamine|mesh-list
56601869|NCT02867930|Propofol|propofol|mesh-list
56601870|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56601871|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601872|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601873|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56601874|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
56601875|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
56601900|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601901|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601902|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601903|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56601904|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56601905|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601906|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56601907|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56646684|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646685|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646686|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56646687|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
56646688|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56646689|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56646690|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646691|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646692|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56601908|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
56601909|NCT02570971|Mannitol|mannitol|mesh-list
56601910|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56601911|NCT02570971|Diuretics|diuretics|mesh-ancestor
56601912|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
56601913|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601914|NCT02866214|Febuxostat|febuxostat|mesh-list
56601915|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
56601916|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601917|NCT02866448|Aspirin|aspirin|mesh-list
56601918|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56601919|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601920|NCT02866448|Analgesics|analgesics|mesh-ancestor
56601921|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
56601922|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601923|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914727|NCT00639717|Analgesics|analgesics|mesh-ancestor
56601952|NCT05373277|Ticagrelor|ticagrelor|mesh-list
56601953|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56601954|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56601955|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56601956|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
56601957|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601958|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56601959|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56601960|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601961|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56601962|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56601963|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56601964|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56601965|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
56601966|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601967|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601968|NCT00724321|Iloprost|iloprost|mesh-list
56602006|NCT00577993|Bleomycin|bleomycin|mesh-list
56602007|NCT00577993|Procarbazine|procarbazine|mesh-list
56602008|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56602009|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
56602010|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602011|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
56602012|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602013|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602014|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56602015|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
55914820|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602034|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
56602035|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602036|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56602037|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
56602038|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56602039|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56602040|NCT00577993|Protective Agents|protective agents|mesh-ancestor
56602041|NCT00577993|Analgesics|analgesics|mesh-ancestor
56602042|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
56602043|NCT00975806|Lenalidomide|lenalidomide|mesh-list
56602045|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
56602046|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646693|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56646694|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
56646695|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646696|NCT03897335|Protective Agents|protective agents|mesh-ancestor
56646697|NCT01617096|Dapivirine|dapivirine|mesh-list
56646698|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56646699|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56646700|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
56292689|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
56646701|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602047|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56602048|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56602049|NCT00975806|Growth Substances|growth substances|mesh-ancestor
56602050|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
56602051|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602052|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56602053|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602054|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602055|NCT00721201|Mifepristone|mifepristone|mesh-list
56602056|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56602057|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
56602058|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56602059|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602060|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56602061|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56602062|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56602063|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
56602064|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56602065|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56602066|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
56602067|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56602101|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
56602102|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602103|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56602104|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56602105|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56602106|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56602107|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56602108|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56602110|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55914914|NCT00588159|Promethazine|promethazine|mesh-list
56602171|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602195|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56602196|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
56602197|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56602198|NCT02689401|Hematinics|hematinics|mesh-ancestor
56602199|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56602200|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56602201|NCT04541407|Temozolomide|temozolomide|mesh-list
56602202|NCT04541407|Osimertinib|osimertinib|mesh-list
56602203|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56602204|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
56602205|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602206|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602207|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56602208|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602209|NCT00640575|Triamcinolone|triamcinolone|mesh-list
56602210|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56602211|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56602212|NCT00640575|Lidocaine|lidocaine|mesh-list
56602213|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56602214|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
56602215|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
56602216|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56602217|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646702|NCT00619944|Ritonavir|ritonavir|mesh-list
56646703|NCT00619944|Lopinavir|lopinavir|mesh-list
56646704|NCT00619944|Lumefantrine|lumefantrine|mesh-list
56646705|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56646706|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56646707|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56646708|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56646709|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499682|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602218|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
56602219|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602220|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56602221|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56602222|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56602223|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56602288|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602289|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602290|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56602291|NCT00722215|Nifedipine|nifedipine|mesh-list
56602292|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
56602293|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56602294|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56602295|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602296|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56602297|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602298|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
56602299|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
56602300|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56602301|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56602302|NCT00640809|Ibuprofen|ibuprofen|mesh-list
56602303|NCT00640809|Celecoxib|celecoxib|mesh-list
56602304|NCT00640809|Omeprazole|omeprazole|mesh-list
56602305|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56602306|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56602328|NCT05630209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602329|NCT05630209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602330|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
56602331|NCT04477629|Abatacept|abatacept|mesh-list
56350879|NCT00061919|Etoposide|etoposide|mesh-list
56602332|NCT04477629|Tacrolimus|tacrolimus|mesh-list
56602333|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602334|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
56602335|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602336|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56602337|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602338|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602339|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56602340|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602341|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56602342|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
56602343|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56602344|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602345|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56602346|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602347|NCT00722293|Doxorubicin|doxorubicin|mesh-list
56602348|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56602349|NCT00722293|Epirubicin|epirubicin|mesh-list
56602350|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56602351|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602352|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56602353|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602354|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602355|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602356|NCT04095832|Anesthetics|anesthetics|mesh-list
56602357|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56602358|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646710|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646711|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56646712|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56646713|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
56646714|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646715|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56646716|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56646717|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
56646718|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56646719|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56646720|NCT04570631|Dexamethasone|dexamethasone|mesh-list
56646721|NCT04570631|Bortezomib|bortezomib|mesh-list
56646722|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646723|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
56646724|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
56646725|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646726|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602373|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602374|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602375|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56602376|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56602377|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
56602378|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602379|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
56602380|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
56602381|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56602382|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56602383|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
56602384|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602386|NCT02571283|Bupivacaine|bupivacaine|mesh-list
56602387|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
56602388|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
56602389|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56602390|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602391|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
56602392|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602393|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602394|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
56602395|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56602396|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56602397|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
56602398|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602399|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56602400|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56602401|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56602402|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
56602403|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
56602404|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
56602405|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56602406|NCT02682693|Denosumab|denosumab|mesh-list
56602407|NCT02682693|Paclitaxel|paclitaxel|mesh-list
56602408|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
56602409|NCT02682693|Carboplatin|carboplatin|mesh-list
56602410|NCT02682693|Trastuzumab|trastuzumab|mesh-list
56602411|NCT02682693|Epirubicin|epirubicin|mesh-list
56602412|NCT02682693|Pertuzumab|pertuzumab|mesh-list
56602413|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56602414|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602415|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
56602416|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
56646727|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646728|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
56646729|NCT04570631|Hormones|hormones|mesh-ancestor
56646730|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646731|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56646732|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646733|NCT00621036|Methotrexate|methotrexate|mesh-list
56646734|NCT00621036|Thiotepa|thiotepa|mesh-list
56646735|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
56646736|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56646737|NCT00621036|Antibodies|antibodies|mesh-list
56646738|NCT00621036|Sargramostim|sargramostim|mesh-list
56646739|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56646740|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56646741|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
56646742|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56646743|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646744|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56646745|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
56646746|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646747|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646748|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
56602417|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
56602418|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602419|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602438|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
56602439|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
56602440|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602441|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
56602442|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
56602443|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602444|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602445|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602446|NCT02571517|Hormones|hormones|mesh-ancestor
56602447|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56602448|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56602449|NCT02571517|Protective Agents|protective agents|mesh-ancestor
56602450|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56602451|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602452|NCT00586846|Doxorubicin|doxorubicin|mesh-list
56602453|NCT00586846|Methotrexate|methotrexate|mesh-list
56602454|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602455|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56602456|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56602457|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602458|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602459|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602460|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56602461|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
56602462|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56602463|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602464|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56646749|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646750|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56646751|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56646752|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
56646753|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56646754|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56646755|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56646756|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
56646757|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56646758|NCT02846831|Insulin|insulin|mesh-list
56602465|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
56602466|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
56602467|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56602468|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602469|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
56602470|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602471|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56602472|NCT04144465|Phenylephrine|phenylephrine|mesh-list
56602473|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
56602474|NCT04144465|Norepinephrine|norepinephrine|mesh-list
56602475|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56602494|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602495|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56602497|NCT04066621|Sulbactam|sulbactam|mesh-list
56602498|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56602499|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602500|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56602501|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602502|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602503|NCT00629564|Esomeprazole|esomeprazole|mesh-list
56602504|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56602505|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602506|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56602507|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602508|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602509|NCT02227927|Domperidone|domperidone|mesh-list
56602510|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
56602511|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
56602512|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602513|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602514|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602515|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56602516|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
56602517|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602518|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602519|NCT02865824|Aspirin|aspirin|mesh-list
56602520|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56602521|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56602522|NCT02865824|Analgesics|analgesics|mesh-ancestor
56602523|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
56602524|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602525|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602526|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602527|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602528|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56602529|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55915316|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602541|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602543|NCT02570035|Urological Agents|urological agents|mesh-ancestor
56602544|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
56602545|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56602546|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602547|NCT04098796|Antibodies|antibodies|mesh-list
56602548|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
56602549|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602550|NCT00522145|XL647|xl647|mesh-list
56646759|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56646760|NCT02846831|Hormones|hormones|mesh-list
56646761|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56646762|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646763|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646764|NCT01497509|Epinephrine|epinephrine|mesh-list
56646765|NCT01497509|Racepinephrine|racepinephrine|mesh-list
56646766|NCT01497509|Fentanyl|fentanyl|mesh-list
56646767|NCT01497509|Bupivacaine|bupivacaine|mesh-list
56646768|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
56646769|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
56646770|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
56646771|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646772|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646773|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
56646774|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646775|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56646776|NCT01497509|Narcotics|narcotics|mesh-ancestor
56646777|NCT01497509|Analgesics|analgesics|mesh-ancestor
56646778|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56602551|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602552|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56602553|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602554|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602555|NCT00726973|Ranibizumab|ranibizumab|mesh-list
56602556|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56602557|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56602558|NCT00726973|Growth Substances|growth substances|mesh-ancestor
56602559|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602560|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
56602561|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602562|NCT01924533|Paclitaxel|paclitaxel|mesh-list
56602563|NCT01924533|Olaparib|olaparib|mesh-list
56602564|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56602565|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602566|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
56602567|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
56602568|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
56602569|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602570|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56602571|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602572|NCT02571361|Acetaminophen|acetaminophen|mesh-list
56602573|NCT02571361|Ibuprofen|ibuprofen|mesh-list
56602574|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56602575|NCT02571361|Analgesics|analgesics|mesh-ancestor
56602576|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
56602577|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602578|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602579|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
56602580|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56602581|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602582|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602583|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56602584|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602585|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602586|NCT04290104|Ampicillin|ampicillin|mesh-list
56602587|NCT04290104|Sulbactam|sulbactam|mesh-list
56602588|NCT04290104|Sultamicillin|sultamicillin|mesh-list
56646779|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56646780|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
56646781|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56646782|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56646783|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
56646784|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646785|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646786|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56646787|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56646788|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
56602589|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56602590|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602591|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56602592|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602679|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56602680|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56602681|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602682|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56602683|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602684|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602686|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56602687|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56602688|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56602689|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
56602690|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602691|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602692|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602693|NCT00727207|Everolimus|everolimus|mesh-list
56602694|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602695|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602696|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
56602697|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602698|NCT02682459|Lisinopril|lisinopril|mesh-list
56602699|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56602700|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
56602701|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602702|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602703|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56602704|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56602705|NCT02682459|Protective Agents|protective agents|mesh-ancestor
56602706|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602708|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56602709|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56602710|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
56602711|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602729|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56602730|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602731|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602732|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
56602733|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56602734|NCT03900793|Sunitinib|sunitinib|mesh-list
56602735|NCT03900793|Losartan|losartan|mesh-list
56602736|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602737|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56602738|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56602739|NCT03900793|Growth Substances|growth substances|mesh-ancestor
56602740|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602741|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
56602742|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56602743|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602744|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602745|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56602746|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56646789|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56646790|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
56646791|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
56646792|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
56646793|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56646794|NCT02844881|Apatinib|apatinib|mesh-list
56646795|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646796|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56646797|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646798|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646799|NCT02846519|Rifampin|rifampin|mesh-list
56646800|NCT02846519|Esketamine|esketamine|mesh-list
56646801|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56646802|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
56646803|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56646804|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56646805|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
56646806|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56602747|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56602748|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56602749|NCT00365157|Halichondrin B|halichondrin b|mesh-list
56602750|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
56602751|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
56602752|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
56602753|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602754|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602755|NCT04066231|Erythromycin|erythromycin|mesh-list
56602756|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
56602757|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56602758|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
56602759|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
56602760|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56602761|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602762|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602763|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56602764|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602765|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602766|NCT04183491|Interferons|interferons|mesh-list
56602767|NCT04183491|Interferon-beta|interferon-beta|mesh-list
56602768|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
56602769|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602789|NCT00727831|Calcium|calcium|mesh-list
56602790|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
56602791|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56602792|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602793|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56602794|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
56602795|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56602796|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56602797|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
56602798|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602799|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602800|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
56602801|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602802|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56602803|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602804|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
56602805|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56646807|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646808|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646809|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56646810|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56646811|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56646812|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56646813|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56646814|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56646815|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
56602806|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56602807|NCT00727831|Antidotes|antidotes|mesh-ancestor
56602808|NCT00727831|Protective Agents|protective agents|mesh-ancestor
56602809|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
56602810|NCT00727831|Vitamins|vitamins|mesh-ancestor
56602811|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
56602812|NCT00727987|Golimumab|golimumab|mesh-list
56602813|NCT00727987|Methotrexate|methotrexate|mesh-list
56602814|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56602815|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
56602816|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56602817|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602818|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56602819|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
56602820|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602821|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602822|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
56602823|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602824|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55915607|NCT04973826|Avibactam|avibactam|mesh-list
56602846|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56602847|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56602848|NCT02681679|Analgesics|analgesics|mesh-ancestor
56602849|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
56602850|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602851|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602852|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602853|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602854|NCT04183257|Vitamin D|vitamin d|mesh-list
56602855|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
56351352|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
56602857|NCT04183257|Vitamins|vitamins|mesh-list
56602858|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
56602859|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602860|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56602861|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56602862|NCT02543983|Ketamine|ketamine|mesh-list
56602863|NCT02543983|Analgesics|analgesics|mesh-ancestor
56602864|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
56602865|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602866|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602867|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56602868|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56602869|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
56602870|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
56159271|NCT02815644|Empagliflozin|empagliflozin|mesh-list
56602871|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56602872|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56602873|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56602874|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602875|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602876|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
56602877|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56602899|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56602900|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
55887575|NCT02047578|Busulfan|busulfan|mesh-list
56646816|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56646817|NCT00618228|Balsalazide|balsalazide|mesh-list
56646818|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56646819|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56646820|NCT00618228|Analgesics|analgesics|mesh-ancestor
56646821|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
56646822|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646823|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646824|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646825|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56646826|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646827|NCT03711305|Carboplatin|carboplatin|mesh-list
56646828|NCT03711305|Etoposide|etoposide|mesh-list
56646829|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646830|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56646831|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56646832|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602901|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602902|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602903|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602904|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602905|NCT00734695|Vitamins|vitamins|mesh-list
56602906|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
56602907|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
56602908|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602909|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
56602910|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602911|NCT00734695|Protective Agents|protective agents|mesh-ancestor
56602912|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56602913|NCT00586690|Antibodies|antibodies|mesh-list
56602914|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
56602915|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56602916|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
56602917|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602918|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602919|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
56602920|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56602921|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
56602922|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602923|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
56602924|NCT00728611|Protective Agents|protective agents|mesh-ancestor
56602925|NCT05663775|Mesalamine|mesalamine|mesh-list
56602926|NCT05663775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56602927|NCT05663775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56602928|NCT05663775|Analgesics|analgesics|mesh-ancestor
56602929|NCT05663775|Sensory System Agents|sensory system agents|mesh-ancestor
56602930|NCT05663775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602931|NCT05663775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602932|NCT05663775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602933|NCT05663775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602961|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56602962|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56602963|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56602964|NCT02680119|Esomeprazole|esomeprazole|mesh-list
56602965|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56602966|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602967|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56602968|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602969|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646833|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646834|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646835|NCT00618384|Sorafenib|sorafenib|mesh-list
56646836|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646837|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56646838|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646839|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646840|NCT03608657|Apremilast|apremilast|mesh-list
56646841|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56646842|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56646843|NCT03608657|Analgesics|analgesics|mesh-ancestor
56646844|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
56646845|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646846|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646847|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646848|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56646849|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56646850|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56646851|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923715|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602970|NCT00734773|Cytarabine|cytarabine|mesh-list
56602971|NCT00734773|Rituximab|rituximab|mesh-list
56602972|NCT00734773|Methotrexate|methotrexate|mesh-list
56602973|NCT00734773|Vincristine|vincristine|mesh-list
56602974|NCT00734773|Procarbazine|procarbazine|mesh-list
56602975|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
56602976|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56602977|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602978|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
56602979|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602997|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
56602998|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56602999|NCT04289090|Propofol|propofol|mesh-list
56603000|NCT04289090|Sevoflurane|sevoflurane|mesh-list
56603001|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56603002|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603003|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603004|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56603005|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
56603006|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
56603007|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56603008|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56603009|NCT00975416|Oxytocin|oxytocin|mesh-list
56603010|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
56603011|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56603012|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603013|NCT02679963|Olaparib|olaparib|mesh-list
56603014|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56603015|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603016|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603017|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603018|NCT00760084|Decitabine|decitabine|mesh-list
56603019|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56603020|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
56603021|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292838|NCT00390000|Pemetrexed|pemetrexed|mesh-list
56646852|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646853|NCT05000658|Dexamethasone|dexamethasone|mesh-list
56646854|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56646855|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646856|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
56646857|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
56646858|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646859|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646860|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646861|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
56646863|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646864|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56646865|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646866|NCT02844803|Metformin|metformin|mesh-list
56646867|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56646868|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603022|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603023|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603024|NCT00735241|Leucovorin|leucovorin|mesh-list
56603025|NCT00735241|Folic Acid|folic acid|mesh-list
56603026|NCT00735241|Bevacizumab|bevacizumab|mesh-list
56603027|NCT00735241|Fluorouracil|fluorouracil|mesh-list
56603028|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
56603029|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
56603030|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56603031|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603032|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56603033|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56603034|NCT00735241|Growth Substances|growth substances|mesh-ancestor
56603035|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603036|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
55915834|NCT01430611|Vaccines|vaccines|mesh-list
56603069|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56603070|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56603071|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56603072|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603073|NCT02679261|Atorvastatin|atorvastatin|mesh-list
56603074|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56603075|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56603076|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
56603077|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603078|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56603098|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56603099|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56603100|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56603101|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56603102|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
56603103|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603104|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603106|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
56603107|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56603108|NCT00642135|Tropicamide|tropicamide|mesh-list
56603109|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56603110|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
56603111|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
56603112|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603113|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603114|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
56646869|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
56646870|NCT04211298|Propofol|propofol|mesh-list
56646871|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56646872|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646873|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646874|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56646875|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
56646876|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
56646877|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56646878|NCT04211298|Analgesics|analgesics|mesh-ancestor
56646879|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
56646880|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646881|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56646882|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56646883|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56646884|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
56646885|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603115|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56603116|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
56603117|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
56603118|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56603119|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56603120|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56603121|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
56603122|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603123|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603124|NCT00642135|Protective Agents|protective agents|mesh-ancestor
56603125|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56603126|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56603127|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56603128|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
56603129|NCT00642291|Emtricitabine|emtricitabine|mesh-list
56603130|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
56603131|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603132|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56603154|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603155|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56603156|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56603157|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56603158|NCT05446870|Growth Substances|growth substances|mesh-ancestor
56603159|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603160|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
56603162|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
56603163|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603164|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
56603165|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603167|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
56603168|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603169|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
56603170|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603171|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
56603172|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56603173|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56603174|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603175|NCT04179747|Urological Agents|urological agents|mesh-ancestor
56603176|NCT04204772|Charcoal|charcoal|mesh-list
56603177|NCT04204772|Antidotes|antidotes|mesh-ancestor
56646886|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646887|NCT04212702|Everolimus|everolimus|mesh-list
56646888|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646889|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56646890|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
56646891|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646892|NCT02691780|Sorafenib|sorafenib|mesh-list
56646893|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646894|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56646895|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646896|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646897|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56646898|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56646899|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646900|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56500392|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
56603178|NCT04204772|Protective Agents|protective agents|mesh-ancestor
56603179|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603180|NCT02675205|Aspirin|aspirin|mesh-list
56603181|NCT02675205|Clopidogrel|clopidogrel|mesh-list
56603182|NCT02675205|Ticagrelor|ticagrelor|mesh-list
56603183|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56603184|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56603185|NCT02675205|Analgesics|analgesics|mesh-ancestor
56603186|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
56603187|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915978|NCT03425292|Nivolumab|nivolumab|mesh-list
56603212|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
56603213|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56603214|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56603215|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56603216|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56603217|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603218|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56603219|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56603220|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603221|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603222|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603223|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56603224|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
56603225|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56603226|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603227|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56603228|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56603229|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56603230|NCT00910065|Aspirin|aspirin|mesh-list
56603231|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
56603232|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56603233|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56603234|NCT00910065|Analgesics|analgesics|mesh-ancestor
56603235|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
56603236|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603256|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
56603257|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603258|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603259|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
56603260|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603261|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56646901|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56646902|NCT03377387|Capecitabine|capecitabine|mesh-list
56646903|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56646904|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
56646905|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646906|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646907|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
56646908|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56646909|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56646910|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646911|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56646912|NCT02845661|Analgesics|analgesics|mesh-ancestor
56646913|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
56646914|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646915|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56646916|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56646917|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56603262|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603263|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
56603264|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603265|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56603266|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
56603267|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56603268|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603269|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603270|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56603271|NCT02675049|Analgesics|analgesics|mesh-ancestor
56603272|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
56603273|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603274|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56603275|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56603276|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56603277|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
56603278|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603279|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603280|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
56603281|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
56603282|NCT02674737|Tramadol|tramadol|mesh-list
56603283|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56603284|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603285|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603286|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56603287|NCT02674737|Analgesics|analgesics|mesh-ancestor
56603288|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
56603289|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603290|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56603291|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56603320|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56603321|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603322|NCT04065919|Epinephrine|epinephrine|mesh-list
56603323|NCT04065919|Bupivacaine|bupivacaine|mesh-list
56603324|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603325|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
56603326|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603327|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603328|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
56646918|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
56646919|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646920|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646921|NCT04375787|Atorvastatin|atorvastatin|mesh-list
56646922|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56646923|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56646924|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
56292912|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646925|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646926|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56500507|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56603329|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603330|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56603331|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56603332|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
56603333|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916134|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
56603363|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
56603364|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603366|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56603367|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603368|NCT00644085|Aspirin|aspirin|mesh-list
56603369|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56603370|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56603371|NCT00644085|Analgesics|analgesics|mesh-ancestor
56603372|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
56603373|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603374|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603375|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603376|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603377|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56603378|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56603379|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916182|NCT00663039|Oxytocin|oxytocin|mesh-list
56603411|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56603412|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603413|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56603414|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603415|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603416|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
56603417|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
56603418|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56603419|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603420|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
56603421|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603422|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603423|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
56603424|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603425|NCT00736021|Citalopram|citalopram|mesh-list
56603440|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
56603441|NCT04178655|Coagulants|coagulants|mesh-ancestor
56603442|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
56603443|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56603444|NCT00738517|Antibodies|antibodies|mesh-list
56603445|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
56603446|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603447|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56603448|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56603449|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56603450|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603451|NCT00738595|Nicotine|nicotine|mesh-list
56603452|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56603453|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
55887576|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
56646927|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56646928|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646929|NCT00825630|Esomeprazole|esomeprazole|mesh-list
56646930|NCT00825630|Pantoprazole|pantoprazole|mesh-list
56646931|NCT00825630|Lansoprazole|lansoprazole|mesh-list
56646932|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
56646933|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56646934|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646935|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56646936|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56646937|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603454|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603455|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603456|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56603457|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56603458|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
56603459|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603460|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603462|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
56603463|NCT05273775|Digoxin|digoxin|mesh-list
56603464|NCT05273775|Midazolam|midazolam|mesh-list
56603465|NCT05273775|Omeprazole|omeprazole|mesh-list
56603466|NCT05273775|Warfarin|warfarin|mesh-list
56603467|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56603468|NCT05273775|Vitamins|vitamins|mesh-ancestor
56603469|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
56603470|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603471|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56603472|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56603473|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603474|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56603475|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56603476|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56603477|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56603478|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
56603479|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
56603480|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
56603481|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
56603482|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603483|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603484|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56603485|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56603486|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
56603499|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
56603500|NCT05273775|Coagulants|coagulants|mesh-ancestor
56603501|NCT02671851|Acetaminophen|acetaminophen|mesh-list
56603502|NCT02671851|Dipyrone|dipyrone|mesh-list
56603503|NCT02671851|Fentanyl|fentanyl|mesh-list
56603504|NCT02671851|Tramadol|tramadol|mesh-list
56603505|NCT02671851|Bupivacaine|bupivacaine|mesh-list
56603506|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603507|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
56603508|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603509|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603510|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
56603511|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603512|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56603513|NCT02671851|Narcotics|narcotics|mesh-ancestor
56603514|NCT02671851|Analgesics|analgesics|mesh-ancestor
56603515|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56603516|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56603517|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
56603518|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56603519|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
56603520|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56603521|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603522|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603523|NCT02135419|Fluorouracil|fluorouracil|mesh-list
56603524|NCT02135419|Imiquimod|imiquimod|mesh-list
56646938|NCT00620100|Docetaxel|docetaxel|mesh-list
56646939|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646940|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
56646941|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
56646942|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
56646943|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646944|NCT02845349|Vortioxetine|vortioxetine|mesh-list
56646945|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
56646946|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56646947|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56646948|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56646949|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603525|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
56603526|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603527|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56603528|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603529|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603530|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
56603531|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603532|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56603533|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
56603534|NCT04177095|Sirolimus|sirolimus|mesh-list
56603535|NCT04177095|Prednisone|prednisone|mesh-list
56603536|NCT04177095|Everolimus|everolimus|mesh-list
56603537|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603538|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
56603539|NCT04177095|Hormones|hormones|mesh-ancestor
56603540|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603541|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603542|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56603543|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603544|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603545|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
56603546|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56603547|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56603548|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603549|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
56603550|NCT02671695|Amlodipine|amlodipine|mesh-list
56603551|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56603552|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56603665|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603667|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603668|NCT02568943|Panobinostat|panobinostat|mesh-list
56603669|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603670|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56603671|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603672|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603673|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
56603674|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56603675|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56603676|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56603677|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603678|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56603679|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603680|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56603681|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603682|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603683|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
56603684|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56603685|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56603686|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56603687|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56603688|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56646950|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646951|NCT02845349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56646952|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56646953|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56646954|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646955|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56646956|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
56646957|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56646958|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56646959|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56646960|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56646961|NCT03852251|Capecitabine|capecitabine|mesh-list
56646962|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
56646963|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56646964|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
56646965|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603689|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603690|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
56603691|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603692|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603693|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56603694|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603695|NCT00737113|Hormones|hormones|mesh-list
56603696|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603697|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603698|NCT00737191|Olanzapine|olanzapine|mesh-list
56603699|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
56603700|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
56603701|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603702|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603703|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56603704|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56603705|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56603706|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603707|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56603708|NCT00737191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56603709|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56603710|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56603711|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603736|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603737|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
56603738|NCT02667561|Testosterone|testosterone|mesh-list
56603739|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
56603740|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
56603741|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56603742|NCT02667561|Androgens|androgens|mesh-ancestor
56603743|NCT02667561|Hormones|hormones|mesh-ancestor
56603744|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603745|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603746|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56603747|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603748|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
56603749|NCT00732511|Metoprolol|metoprolol|mesh-list
56603750|NCT00732511|Carvedilol|carvedilol|mesh-list
56603751|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56646966|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646967|NCT00620178|Losartan|losartan|mesh-list
56646968|NCT00620178|Candesartan|candesartan|mesh-list
56646969|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
56646970|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56646971|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56646972|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56646973|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56646974|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500757|NCT00570882|Sunitinib|sunitinib|mesh-list
56603752|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56603753|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
56603754|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
56603755|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603756|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603757|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56603758|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56603759|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56603761|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603762|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603789|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56603790|NCT00645723|Colistin|colistin|mesh-list
56603791|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56603792|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603793|NCT00645801|Lubiprostone|lubiprostone|mesh-list
56603794|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56603795|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56603796|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603797|NCT00711529|Gabapentin|gabapentin|mesh-list
56603798|NCT00711529|Analgesics|analgesics|mesh-ancestor
56603799|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
56603800|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603801|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603802|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
56603803|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56603804|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56603805|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603806|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56603807|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56603808|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56603809|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603830|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603831|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
56603832|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56603833|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603834|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56603835|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
56603836|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56603837|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603838|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603839|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603840|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
56603841|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56603842|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56603843|NCT02666703|Prednisolone|prednisolone|mesh-list
56603844|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
56603845|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56603846|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
56603847|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603848|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
56603849|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
56603850|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603851|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603852|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56646975|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
56646976|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56646977|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56646978|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646979|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
56646980|NCT04349982|Coagulants|coagulants|mesh-ancestor
56646981|NCT04474847|Abatacept|abatacept|mesh-list
56646982|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56646983|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56646984|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56646985|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56646986|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
56646987|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646988|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56646989|NCT04315350|Prednisolone|prednisolone|mesh-list
56646990|NCT04315350|Curcumin|curcumin|mesh-list
56646991|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56646992|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
56646993|NCT04315350|Hormones|hormones|mesh-ancestor
56646994|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56646995|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56646996|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56646997|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923716|NCT03595124|Nivolumab|nivolumab|mesh-list
56603853|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
56603854|NCT02666703|Hormones|hormones|mesh-ancestor
56603855|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603856|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56603857|NCT02666703|Protective Agents|protective agents|mesh-ancestor
56603858|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56603859|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603860|NCT05560009|Levodopa|levodopa|mesh-list
56603861|NCT05560009|Fluorides|fluorides|mesh-list
56603862|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
55916667|NCT03137316|Hormones|hormones|mesh-list
56603881|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56603882|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603884|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
56603885|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
56603886|NCT04174131|Protective Agents|protective agents|mesh-ancestor
56603887|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
56603888|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56603889|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603890|NCT00646035|Vitamins|vitamins|mesh-ancestor
56603891|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
56603892|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56603893|NCT00646191|Adalimumab|adalimumab|mesh-list
56603894|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603895|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603896|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
56603897|NCT02666157|Apixaban|apixaban|mesh-list
56603898|NCT02666157|Dabigatran|dabigatran|mesh-list
56603899|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56603900|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
56646998|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56646999|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56647000|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56647002|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
56647003|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56647004|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647005|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647006|NCT04288206|Cefazolin|cefazolin|mesh-list
56647007|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56647008|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647009|NCT04958772|Lenograstim|lenograstim|mesh-list
56603901|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56603902|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
56603903|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603904|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603905|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
56603906|NCT02666001|Fostemsavir|fostemsavir|mesh-list
56603907|NCT02666001|Buprenorphine|buprenorphine|mesh-list
56603908|NCT02666001|Methadone|methadone|mesh-list
56603909|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56603910|NCT02666001|Narcotics|narcotics|mesh-ancestor
56603911|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603912|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603913|NCT02666001|Analgesics|analgesics|mesh-ancestor
56603914|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
56603915|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603916|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56603917|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
56603918|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
56603919|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56603944|NCT02665533|Dexamethasone|dexamethasone|mesh-list
56603945|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
56603946|NCT02665533|Diclofenac|diclofenac|mesh-list
56603947|NCT02665533|Codeine|codeine|mesh-list
56603948|NCT02665533|BB 1101|bb 1101|mesh-list
56603949|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603950|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
56603951|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
56603952|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603953|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603954|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56603955|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
56603956|NCT02665533|Hormones|hormones|mesh-ancestor
56603957|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603958|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56603959|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603960|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
56603961|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603962|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603963|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56603964|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56603965|NCT02665533|Analgesics|analgesics|mesh-ancestor
56603966|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
56603967|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603968|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56603969|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56604007|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56604026|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
56604027|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604028|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604029|NCT00648843|Urological Agents|urological agents|mesh-ancestor
56604030|NCT02662959|Irinotecan|irinotecan|mesh-list
56604031|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56604032|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56604033|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647010|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56647011|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
56647012|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647013|NCT02771249|Pyridoxine|pyridoxine|mesh-list
56647014|NCT02771249|Isoniazid|isoniazid|mesh-list
56647015|NCT02771249|Darunavir|darunavir|mesh-list
56647016|NCT02771249|Cobicistat|cobicistat|mesh-list
56647017|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56647018|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
56647019|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56647020|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647021|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56647022|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56647023|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
56647024|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647025|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56500935|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604034|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604035|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604036|NCT02662647|Cytarabine|cytarabine|mesh-list
56604037|NCT02662647|Decitabine|decitabine|mesh-list
56604038|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
56604039|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56604040|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
56604041|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604042|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604043|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
56604044|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604045|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604046|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
56604047|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604048|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604049|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56604050|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56604052|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56604053|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604054|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56604055|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604056|NCT00648921|Olanzapine|olanzapine|mesh-list
56604057|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
56604058|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
56352554|NCT02958566|Hydrocodone|hydrocodone|mesh-list
56604059|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604060|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604061|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56604062|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56604063|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56604064|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56604065|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56604066|NCT00648921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56604067|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56604068|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56604069|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604070|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604071|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
56604072|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
56604073|NCT02662491|Vitamin D|vitamin d|mesh-list
56604074|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
56604075|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
56604076|NCT02662491|Vitamins|vitamins|mesh-list
56647026|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56647027|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56647028|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
56647029|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647030|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56647031|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56647032|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
56647033|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56647034|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56647035|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
56647036|NCT02771249|Vitamins|vitamins|mesh-ancestor
56647037|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
56647038|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604107|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
56604108|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604109|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
56604110|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604111|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
56604112|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604114|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56604115|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56604116|NCT00649077|Analgesics|analgesics|mesh-ancestor
56604117|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
56604118|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604119|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604120|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56604121|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604138|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56604139|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604140|NCT00649935|Azithromycin|azithromycin|mesh-list
56604141|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56604142|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604143|NCT02655705|Cyclosporine|cyclosporine|mesh-list
56604144|NCT02655705|Methotrexate|methotrexate|mesh-list
56604145|NCT02655705|Cyclosporins|cyclosporins|mesh-list
56604146|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56604147|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
56604148|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56604149|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604150|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56604151|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
56604152|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604153|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604154|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
56604155|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604156|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56604157|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604158|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
56604159|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604160|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56604161|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
56604162|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604163|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56604164|NCT02655471|Zidovudine|zidovudine|mesh-list
56604165|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
56604166|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
56604167|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604168|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56604169|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56604170|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604171|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
56604172|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604173|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56647039|NCT04208958|Vancomycin|vancomycin|mesh-list
56647040|NCT04208958|Nivolumab|nivolumab|mesh-list
56647041|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56647042|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647043|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56647044|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647045|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56647046|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647047|NCT04048278|Lidocaine|lidocaine|mesh-list
56647048|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
56647049|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
56647050|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647051|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604174|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56604175|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56604176|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56604177|NCT00650013|Midodrine|midodrine|mesh-list
56604178|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
56604179|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
56604180|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916969|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56604197|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604198|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604199|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604201|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
56604202|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604203|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56604204|NCT02536209|Oxycodone|oxycodone|mesh-list
56604205|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56604206|NCT02536209|Narcotics|narcotics|mesh-ancestor
56604207|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56604208|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604209|NCT02536209|Analgesics|analgesics|mesh-ancestor
56604210|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
56604211|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604212|NCT00732745|Docetaxel|docetaxel|mesh-list
56604213|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
56604214|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604215|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
56604216|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
56604217|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
56604218|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604219|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
56604220|NCT00737815|Cathartics|cathartics|mesh-ancestor
56604221|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56604222|NCT02654379|Rituximab|rituximab|mesh-list
56604223|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56604224|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604225|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
56604226|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604227|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604228|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56604229|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
56604230|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
56604231|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604232|NCT00712543|Lactulose|lactulose|mesh-list
56604233|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56604234|NCT00650169|Clopidogrel|clopidogrel|mesh-list
56604235|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56604236|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56604237|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56604259|NCT00740467|Cyclosporins|cyclosporins|mesh-list
56647052|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
56647053|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647054|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56647055|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56647056|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56647057|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56647058|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647059|NCT02697318|Timolol|timolol|mesh-list
56647060|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56647061|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56647062|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647063|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56647064|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56647065|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
56647066|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604260|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56604261|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604262|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
56604263|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604264|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604265|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56604266|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
56604267|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604268|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604269|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56604270|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56604271|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
56604272|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604273|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
56604274|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604275|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
56604276|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56604277|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56604278|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56604279|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
56604280|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56604281|NCT00740545|Enoxaparin|enoxaparin|mesh-list
56604282|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
56604283|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56604284|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56604285|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604287|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
56604288|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56604289|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56604290|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604291|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604292|NCT02653833|Urological Agents|urological agents|mesh-ancestor
56604320|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
56604321|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604322|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604323|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604324|NCT02568709|Oxytocin|oxytocin|mesh-list
56604325|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
56604326|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56604327|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604328|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
56604329|NCT04316169|Letrozole|letrozole|mesh-list
56604330|NCT04316169|Fulvestrant|fulvestrant|mesh-list
56647067|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647068|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56647069|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56647070|NCT05242133|Interferons|interferons|mesh-list
56647071|NCT05242133|Interferon-beta|interferon-beta|mesh-list
56647072|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
56647073|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647074|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
56647075|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647076|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
56647077|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647078|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56647079|NCT00621816|Nitroprusside|nitroprusside|mesh-list
56501202|NCT04600271|Analgesics|analgesics|mesh-list
56604331|NCT04316169|Anastrozole|anastrozole|mesh-list
56604332|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604333|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56604334|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56604335|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604336|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604337|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56604338|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
55917141|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604358|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604359|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604360|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56604362|NCT00733525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56604363|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56604364|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56604365|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604366|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604367|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
56604368|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604369|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56604370|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
56604371|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56604372|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56604373|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56604374|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604375|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56604376|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56604377|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56604378|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604379|NCT02653131|Incretins|incretins|mesh-ancestor
56604380|NCT02653131|Hormones|hormones|mesh-ancestor
56604381|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604382|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
56604383|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604384|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604385|NCT02652585|Naltrexone|naltrexone|mesh-list
56604386|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56604387|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56604388|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604389|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
56604390|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604391|NCT00741169|Rifampin|rifampin|mesh-list
56604392|NCT00741169|Simeprevir|simeprevir|mesh-list
56604413|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604414|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56604415|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56604416|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
56647080|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56647081|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
56647082|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56647083|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647084|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
56604417|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604418|NCT02652741|Enalapril|enalapril|mesh-list
56604419|NCT02652741|Enalaprilat|enalaprilat|mesh-list
56604420|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56604421|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
56604422|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604423|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604424|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56604425|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
56604426|NCT02652507|Ketamine|ketamine|mesh-list
56604427|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56604428|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56604429|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604430|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56604431|NCT02652507|Analgesics|analgesics|mesh-ancestor
56604432|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
56604433|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604434|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56604435|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56604436|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56604437|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
56604438|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604439|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604440|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56604441|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56604442|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
56604443|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
56604444|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55917250|NCT01270035|Adalimumab|adalimumab|mesh-list
56604479|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
56604480|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604481|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56604482|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
56604483|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56604502|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604504|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604505|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604506|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56604508|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56604509|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56604510|NCT05538247|Analgesics|analgesics|mesh-ancestor
56604511|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
56604512|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604513|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604514|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56604515|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604516|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
56604517|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
56604518|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56604519|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56604520|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604521|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604522|NCT03912363|Insulin|insulin|mesh-list
56604523|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56604524|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604525|NCT05740969|Fluorouracil|fluorouracil|mesh-list
56604526|NCT05740969|Imiquimod|imiquimod|mesh-list
56604527|NCT05740969|Melatonin|melatonin|mesh-list
56604528|NCT05740969|Antimetabolites|antimetabolites|mesh-ancestor
56604529|NCT05740969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604530|NCT05740969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56604531|NCT05740969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604532|NCT05740969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604533|NCT05740969|Immunologic Factors|immunologic factors|mesh-ancestor
56647085|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647086|NCT04186026|Glucagon|glucagon|mesh-list
56647087|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56647088|NCT04186026|Incretins|incretins|mesh-ancestor
56647089|NCT04186026|Hormones|hormones|mesh-ancestor
56647090|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647091|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647092|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56647093|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
56647094|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56647095|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
56501308|NCT00565682|Etoricoxib|etoricoxib|mesh-list
56604534|NCT05740969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604535|NCT05740969|Antioxidants|antioxidants|mesh-ancestor
56604536|NCT05740969|Protective Agents|protective agents|mesh-ancestor
56604537|NCT05740969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56604538|NCT05740969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56604539|NCT05740969|Interferon Inducers|interferon inducers|mesh-ancestor
56604540|NCT02568241|Interferons|interferons|mesh-list
56604564|NCT02647671|Antacids|antacids|mesh-ancestor
56604565|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604566|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56604567|NCT04578613|Rituximab|rituximab|mesh-list
56604568|NCT04578613|Chlorambucil|chlorambucil|mesh-list
56604569|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56604570|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604571|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
56604572|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604573|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604574|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56604575|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
56604576|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604577|NCT02647515|Ranibizumab|ranibizumab|mesh-list
56604578|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56604579|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56604580|NCT02647515|Growth Substances|growth substances|mesh-ancestor
56604581|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604582|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
56604583|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604584|NCT03818763|Factor VIII|factor viii|mesh-list
56604585|NCT03818763|Coagulants|coagulants|mesh-ancestor
56604586|NCT02647047|Acetaminophen|acetaminophen|mesh-list
56604587|NCT02647047|Ketorolac|ketorolac|mesh-list
56604588|NCT02647047|Sufentanil|sufentanil|mesh-list
56604589|NCT02647047|Ropivacaine|ropivacaine|mesh-list
56604590|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
56604591|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
55917396|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56604607|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56604608|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56604609|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
56604610|NCT00651651|Budesonide|budesonide|mesh-list
56604611|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
56604612|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56604613|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56604614|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
56604615|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604616|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604617|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56604618|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
56604619|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
56604620|NCT00651651|Hormones|hormones|mesh-ancestor
56604621|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604622|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56604623|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56604624|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56647096|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647097|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647098|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56647099|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
56647100|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
56647101|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56647102|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
56647103|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56647104|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647105|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56647106|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604625|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
56604626|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604627|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604628|NCT00709111|Maraviroc|maraviroc|mesh-list
56604629|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56604630|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56604631|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604632|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56604633|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56604634|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
56604635|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604636|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56604637|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
56604638|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56604639|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56604640|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56604641|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56604642|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604643|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
56604644|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604645|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604646|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56604647|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604648|NCT02646735|Fulvestrant|fulvestrant|mesh-list
56604649|NCT02646735|Exemestane|exemestane|mesh-list
56604667|NCT05741905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56604668|NCT05741905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56604669|NCT05741905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604670|NCT05741905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604671|NCT05741905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604672|NCT05741905|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56604673|NCT05741905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56604674|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56604675|NCT00651885|Treprostinil|treprostinil|mesh-list
56604676|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56604677|NCT02646657|Vedolizumab|vedolizumab|mesh-list
56604678|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56604679|NCT00652041|Thalidomide|thalidomide|mesh-list
56604680|NCT00652041|Bortezomib|bortezomib|mesh-list
56604681|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604682|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604683|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
56604684|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604685|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
56604686|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56604687|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604688|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56604689|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56604690|NCT00652041|Growth Substances|growth substances|mesh-ancestor
56604691|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
56604692|NCT02646111|Ribavirin|ribavirin|mesh-list
56604693|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
56647107|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56647108|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56647109|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647110|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
56647111|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56647112|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647113|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56647114|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647115|NCT00650819|Simvastatin|simvastatin|mesh-list
56647116|NCT00650819|Ezetimibe|ezetimibe|mesh-list
56647117|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56604694|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604695|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
56604696|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604697|NCT00652119|Paclitaxel|paclitaxel|mesh-list
56604698|NCT00652119|Bevacizumab|bevacizumab|mesh-list
56604699|NCT00652119|Carboplatin|carboplatin|mesh-list
56604700|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56604701|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604702|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
56604703|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
56604704|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
56604705|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604706|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56604727|NCT05740657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56604728|NCT05740657|Anesthetics, General|anesthetics, general|mesh-ancestor
56604729|NCT05740657|Anesthetics|anesthetics|mesh-ancestor
56604731|NCT02646267|Dabigatran|dabigatran|mesh-list
56604732|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
56604733|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
56604734|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56604735|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
56604736|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604737|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604738|NCT02646189|Interferons|interferons|mesh-list
56604739|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
56604740|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
56604741|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56604742|NCT02646189|REP 2139|rep 2139|mesh-list
56604743|NCT02646189|Thymalfasin|thymalfasin|mesh-list
56604744|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604745|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
56604746|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604747|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
56604748|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604749|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56604750|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
56604751|NCT03630081|Meropenem|meropenem|mesh-list
56604752|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56604753|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604754|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56604755|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56604756|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604757|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604758|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604759|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56604760|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56604761|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
56604762|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56604763|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56604764|NCT02645565|Prednisolone|prednisolone|mesh-list
56604765|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
55917572|NCT01395823|Vitamin D|vitamin d|mesh-list
56604779|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56604780|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
56647118|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56647119|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
56647120|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647121|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56647122|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56647123|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647124|NCT05662410|Aflibercept|aflibercept|mesh-list
56647125|NCT05662410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56647126|NCT05662410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56647127|NCT05662410|Growth Substances|growth substances|mesh-ancestor
56501498|NCT00574470|Infliximab|infliximab|mesh-list
56604781|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
56604782|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604783|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56604784|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
56604786|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604787|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56604788|NCT02645565|Protective Agents|protective agents|mesh-ancestor
56604789|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56604790|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
56604791|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56604792|NCT05460871|Pregabalin|pregabalin|mesh-list
56604793|NCT05460871|Analgesics|analgesics|mesh-ancestor
56604794|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
56604795|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604796|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604797|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
56604798|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56604799|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56604800|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604801|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56604802|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56604803|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56604804|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56604805|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56604806|NCT00699907|Flutamide|flutamide|mesh-list
56604807|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
56604808|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
56604809|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604810|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604811|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56604812|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604813|NCT00599313|Sunitinib|sunitinib|mesh-list
56604814|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604815|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56604816|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56604817|NCT00599313|Growth Substances|growth substances|mesh-ancestor
56604818|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604819|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
56604820|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56604821|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604822|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604823|NCT03159897|Doxorubicin|doxorubicin|mesh-list
56604824|NCT03159897|Bleomycin|bleomycin|mesh-list
56604825|NCT03159897|Dacarbazine|dacarbazine|mesh-list
56604826|NCT03159897|Vinblastine|vinblastine|mesh-list
56604827|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56604844|NCT05740345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604846|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56604847|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56604848|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56604849|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56647128|NCT05662410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647129|NCT05662410|Growth Inhibitors|growth inhibitors|mesh-ancestor
56647130|NCT05662410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647131|NCT03635489|Paclitaxel|paclitaxel|mesh-list
56647132|NCT03635489|Bevacizumab|bevacizumab|mesh-list
56647133|NCT03635489|Carboplatin|carboplatin|mesh-list
56647134|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56647135|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647136|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56647137|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56647138|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56647139|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647140|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56647141|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56647142|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56647143|NCT03635489|Growth Substances|growth substances|mesh-ancestor
56604850|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604851|NCT02567149|Cidofovir|cidofovir|mesh-list
56604852|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
56604853|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604854|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604855|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604856|NCT00707239|Imipenem|imipenem|mesh-list
56604857|NCT00707239|Tigecycline|tigecycline|mesh-list
56604858|NCT00707239|Cilastatin|cilastatin|mesh-list
56604859|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56604860|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604861|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56604862|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604863|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604864|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
56604865|NCT00968708|Alogliptin|alogliptin|mesh-list
56604866|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56604867|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604868|NCT00968708|Incretins|incretins|mesh-ancestor
56604869|NCT00968708|Hormones|hormones|mesh-ancestor
56604870|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604871|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56604872|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
56604873|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604874|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604875|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56604876|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
56604877|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604878|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
56604879|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604880|NCT05079841|Oxytocin|oxytocin|mesh-list
56353390|NCT00237523|Trace Elements|trace elements|mesh-ancestor
56604881|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
56604882|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56604883|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604884|NCT04062565|Treprostinil|treprostinil|mesh-list
56604905|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604906|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56604907|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56604908|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
56604909|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604910|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604911|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56647144|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647145|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
56647146|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56647147|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56647148|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647149|NCT02689362|Incretins|incretins|mesh-ancestor
56647150|NCT02689362|Hormones|hormones|mesh-ancestor
56647151|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647152|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56647153|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
56647154|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647155|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647156|NCT02687256|Heparin|heparin|mesh-list
56647157|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
56604912|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56604913|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
56604914|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56604915|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
56604916|NCT02863406|Dimercaprol|dimercaprol|mesh-list
56604917|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
56604918|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
56604919|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604920|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
56604921|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604922|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604923|NCT00629720|Alfuzosin|alfuzosin|mesh-list
56604924|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56604925|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56604926|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56604927|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
56604928|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604929|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604930|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604931|NCT00629720|Urological Agents|urological agents|mesh-ancestor
56604932|NCT00967616|Leucovorin|leucovorin|mesh-list
56604933|NCT00967616|Fluorouracil|fluorouracil|mesh-list
56604934|NCT00967616|Irinotecan|irinotecan|mesh-list
56604935|NCT00967616|Efatutazone|efatutazone|mesh-list
56604936|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
56604937|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
56604938|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604939|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56604940|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604964|NCT03107793|Ustekinumab|ustekinumab|mesh-list
56604965|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
56604966|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
56604967|NCT02640417|Vitamins|vitamins|mesh-ancestor
56604968|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
56604969|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604970|NCT02640495|Artesunate|artesunate|mesh-list
56604971|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
56604972|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56604973|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56604974|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604975|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604976|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
56604977|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
56604978|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56604979|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
56604980|NCT00653757|Leuprolide|leuprolide|mesh-list
56604981|NCT00653757|Goserelin|goserelin|mesh-list
56604982|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56604983|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
56647158|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56647159|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56647160|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647161|NCT00622206|Ritonavir|ritonavir|mesh-list
56647162|NCT00622206|Saquinavir|saquinavir|mesh-list
56647163|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56647164|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56647165|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
56647166|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604984|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56604985|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604986|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56604987|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604988|NCT00654225|Atorvastatin|atorvastatin|mesh-list
56604989|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56604990|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56604991|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56604992|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
56604993|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604994|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55917815|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56605012|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605013|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605014|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605015|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56605016|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56605017|NCT03909152|Anastrozole|anastrozole|mesh-list
56605018|NCT03909152|Onapristone|onapristone|mesh-list
56605019|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56605020|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605021|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56605022|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56605023|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605024|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605025|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56605026|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
56605027|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605028|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605029|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56605030|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
56605031|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56605032|NCT00654459|Policosanol|policosanol|mesh-list
56605033|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56605034|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56605035|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
56605036|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605037|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56605038|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56605039|NCT00654537|Atorvastatin|atorvastatin|mesh-list
56605040|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56605041|NCT00654537|Simvastatin|simvastatin|mesh-list
56605042|NCT00654537|Pravastatin|pravastatin|mesh-list
56605043|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56605044|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56605045|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
56605046|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605047|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56605048|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56605049|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605050|NCT03887702|Tenofovir|tenofovir|mesh-list
56605073|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56605074|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605075|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605076|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56605078|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
56647167|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647168|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56647169|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56647170|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
56647171|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647172|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56647173|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56647174|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
56647175|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56647176|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56647177|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647178|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
56647179|NCT03582293|Coagulants|coagulants|mesh-ancestor
56647180|NCT03574337|Neostigmine|neostigmine|mesh-list
56647181|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56647182|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647183|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605079|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605080|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56605081|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56605082|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56605083|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
56605084|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605085|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605087|NCT02638233|Ledipasvir|ledipasvir|mesh-list
56605088|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
56605089|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605090|NCT04285268|Rituximab|rituximab|mesh-list
56605091|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56605092|NCT04285268|Bortezomib|bortezomib|mesh-list
56605093|NCT04285268|Venetoclax|venetoclax|mesh-list
56605094|NCT04285268|Antibodies|antibodies|mesh-list
56605095|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
56605096|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56605097|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
56605098|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605099|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605100|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605101|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56605102|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605103|NCT01842399|Resveratrol|resveratrol|mesh-list
56605104|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
55917924|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
56605123|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605124|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56605125|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56605126|NCT02635893|Cycloserine|cycloserine|mesh-list
56605127|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56605128|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605129|NCT02635893|Renal Agents|renal agents|mesh-ancestor
56605130|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56605131|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
56605132|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56605133|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
56605134|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605135|NCT05729503|Lidocaine|lidocaine|mesh-list
56605136|NCT05729503|Anesthetics, Local|anesthetics, local|mesh-ancestor
56605137|NCT05729503|Anesthetics|anesthetics|mesh-ancestor
56073369|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56647184|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
56647185|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56647186|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647187|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56647188|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
56647189|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647190|NCT02689596|Oxytocin|oxytocin|mesh-list
56647191|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
56647192|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56647193|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647194|NCT04574856|Temozolomide|temozolomide|mesh-list
56647195|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56647196|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
56647197|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647198|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647199|NCT00423995|Loratadine|loratadine|mesh-list
56647200|NCT00423995|Montelukast|montelukast|mesh-list
56647201|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56647202|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
56647203|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56647204|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
56647205|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647206|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647207|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56605138|NCT05729503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605139|NCT05729503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605140|NCT05729503|Sensory System Agents|sensory system agents|mesh-ancestor
56605141|NCT05729503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605142|NCT05729503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56605143|NCT05729503|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56605144|NCT05729503|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56605145|NCT05729503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56605146|NCT05729503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605147|NCT02567773|Itraconazole|itraconazole|mesh-list
56605148|NCT02567773|GSK2881078|gsk2881078|mesh-list
56605149|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
56605150|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605151|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56605152|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56605153|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605154|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605155|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56605156|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
55917979|NCT04022239|Melphalan|melphalan|mesh-list
56605186|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56605187|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
56605188|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56605189|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887675|NCT05747326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647208|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56647209|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647210|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
56647211|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
56647212|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56647213|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56647214|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56647215|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
56647216|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
56647217|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56647218|NCT00380627|Etoricoxib|etoricoxib|mesh-list
56605190|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605191|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56605192|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56605193|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56605194|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56605195|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605196|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605197|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56605198|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56605199|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
56605200|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
56605233|NCT02861378|Phentolamine|phentolamine|mesh-list
56605234|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56605235|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56605236|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
56605237|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605238|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605239|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605240|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56605241|NCT05332561|Trastuzumab|trastuzumab|mesh-list
56605242|NCT05332561|Pertuzumab|pertuzumab|mesh-list
56605262|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605263|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605264|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56605265|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
56605266|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
56605267|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56605268|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56605269|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56605270|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
56605271|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605272|NCT04284722|Metformin|metformin|mesh-list
56605273|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56605274|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605275|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
56605276|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
56605277|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56605278|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56605279|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605280|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605281|NCT04283240|Urological Agents|urological agents|mesh-ancestor
56605282|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
56605283|NCT03588884|Vitamin D|vitamin d|mesh-list
56605284|NCT03588884|Calcifediol|calcifediol|mesh-list
56605285|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56605286|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605287|NCT03588884|Vitamins|vitamins|mesh-ancestor
56605288|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
56605289|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56605290|NCT03558152|Vedolizumab|vedolizumab|mesh-list
56605291|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56605292|NCT03557918|Tremelimumab|tremelimumab|mesh-list
56605293|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647219|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56647220|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56647221|NCT00380627|Analgesics|analgesics|mesh-ancestor
56647222|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
56647223|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647224|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647225|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647226|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56647227|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56647228|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56647229|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647230|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647231|NCT00212771|Olanzapine|olanzapine|mesh-list
56647232|NCT00212771|Asenapine|asenapine|mesh-list
56647233|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
56647234|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
56647235|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647236|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647237|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501923|NCT04590638|Epinephrine|epinephrine|mesh-list
56605294|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56605295|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56605296|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
56605297|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56605298|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
56605299|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56605300|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918116|NCT02991339|Hormones|hormones|mesh-ancestor
56605323|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
56605324|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56605325|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605326|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56605327|NCT00757588|Insulin|insulin|mesh-list
56605328|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56605329|NCT00757588|Saxagliptin|saxagliptin|mesh-list
56605330|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56605331|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605332|NCT00757588|Incretins|incretins|mesh-ancestor
56605333|NCT00757588|Hormones|hormones|mesh-ancestor
56605334|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605335|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56605336|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
56605337|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605338|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605339|NCT00917254|Enoxaparin|enoxaparin|mesh-list
56605340|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
56605341|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56605342|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56605343|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605344|NCT02599792|Ivacaftor|ivacaftor|mesh-list
56605345|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56605346|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56605347|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605348|NCT00705679|Tenofovir|tenofovir|mesh-list
56605349|NCT00705679|Emtricitabine|emtricitabine|mesh-list
56073370|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
56647238|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56647239|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56647240|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647241|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56647242|NCT00212771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56647243|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56647244|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56647245|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647246|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56647247|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
56647248|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56647249|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56647250|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56647251|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647252|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647253|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
56647254|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647255|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56647256|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56647257|NCT03829722|Paclitaxel|paclitaxel|mesh-list
56647258|NCT03829722|Carboplatin|carboplatin|mesh-list
56647259|NCT03829722|Nivolumab|nivolumab|mesh-list
56647260|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56647261|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647262|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
56605350|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56605351|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
56605373|NCT05674513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56605375|NCT00916942|Prilocaine|prilocaine|mesh-list
56605376|NCT00916942|Capsaicin|capsaicin|mesh-list
56605377|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
56605378|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
56605379|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605380|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605381|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
56605382|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605383|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56605384|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56605385|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56605386|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56605387|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605388|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
56605389|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
56605390|NCT00751114|Metformin|metformin|mesh-list
56605391|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
56605392|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56605393|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073371|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
56647263|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
56647264|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
56647265|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647266|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56647267|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56647268|NCT03822312|Tobramycin|tobramycin|mesh-list
56647269|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56647270|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647271|NCT03691493|Tamoxifen|tamoxifen|mesh-list
56647272|NCT03691493|Letrozole|letrozole|mesh-list
56605394|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605395|NCT00751114|Incretins|incretins|mesh-ancestor
56605396|NCT00751114|Hormones|hormones|mesh-ancestor
56605397|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605398|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56605399|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
56605400|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605401|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605402|NCT00960440|Tofacitinib|tofacitinib|mesh-list
56605403|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55918244|NCT01272609|Timolol|timolol|mesh-list
56605430|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605431|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605432|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56605434|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56605435|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56605436|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
56605437|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
56605438|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
56605439|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605440|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56605441|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605442|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605443|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56605444|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56605445|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56605446|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56605447|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605448|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605472|NCT04019782|Protective Agents|protective agents|mesh-ancestor
56605473|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605474|NCT02599480|Mirabegron|mirabegron|mesh-list
56605475|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56605476|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56605477|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56605478|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
56605479|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605480|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605481|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605482|NCT02599480|Urological Agents|urological agents|mesh-ancestor
56605483|NCT03245840|Budesonide|budesonide|mesh-list
56605484|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56605485|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56605486|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
56605487|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605488|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605489|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56605490|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
56605491|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
56605492|NCT03245840|Hormones|hormones|mesh-ancestor
56605493|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605494|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
56605495|NCT04091698|Ubiquinone|ubiquinone|mesh-list
56605496|NCT04091698|Vitamins|vitamins|mesh-ancestor
56647273|NCT03691493|Fulvestrant|fulvestrant|mesh-list
56647274|NCT03691493|Palbociclib|palbociclib|mesh-list
56647275|NCT03691493|Anastrozole|anastrozole|mesh-list
56647276|NCT03691493|Exemestane|exemestane|mesh-list
56647277|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647278|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56647279|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56647280|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647281|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647282|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56647283|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
56647284|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647285|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647286|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56647287|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56647288|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56647289|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56605497|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
56605498|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605499|NCT04281290|Bleomycin|bleomycin|mesh-list
56605500|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56605501|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605522|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605523|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605524|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56605525|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
56605526|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
56605527|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56605528|NCT02599168|Analgesics|analgesics|mesh-ancestor
56605529|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
56605530|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605531|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56605532|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56605533|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56605534|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
56605535|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605536|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605538|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605539|NCT01032629|Canagliflozin|canagliflozin|mesh-list
56605540|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56605541|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605542|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56605543|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605544|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56605545|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56605546|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56605547|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56605548|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56605549|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
56605550|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605551|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605552|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605553|NCT00749944|Varenicline|varenicline|mesh-list
56605617|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56605618|NCT00742924|Methotrexate|methotrexate|mesh-list
56605619|NCT00742924|Etoposide|etoposide|mesh-list
56647290|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56647291|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56647292|NCT02687178|Canrenone|canrenone|mesh-list
56647293|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56647294|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
56647295|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647296|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647297|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56647298|NCT02687178|Diuretics|diuretics|mesh-ancestor
56647299|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
56647300|NCT03711318|Buprenorphine|buprenorphine|mesh-list
56647301|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56605620|NCT00742924|Ifosfamide|ifosfamide|mesh-list
56605621|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
56605622|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
56605623|NCT00742924|Razoxane|razoxane|mesh-list
56605624|NCT00742924|Imidazole|imidazole|mesh-list
56605625|NCT00742924|Lenograstim|lenograstim|mesh-list
56605626|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
56605627|NCT00742924|Mesna|mesna|mesh-list
56605628|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605629|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56605630|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56605631|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56605632|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605633|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605634|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605635|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56605636|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
56605638|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56605639|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
56605640|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
56605687|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605688|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56605689|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56605690|NCT00745498|Growth Substances|growth substances|mesh-ancestor
56605691|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605692|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
56605693|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
56605694|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56605695|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605696|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
56605697|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605698|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
56605699|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605700|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605701|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56605702|NCT02596828|Sirolimus|sirolimus|mesh-list
56605703|NCT02596828|Irinotecan|irinotecan|mesh-list
56605704|NCT02596828|Temozolomide|temozolomide|mesh-list
56605705|NCT02596828|Dasatinib|dasatinib|mesh-list
56605706|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56605707|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56605708|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605709|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605710|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354224|NCT00242008|Rotigotine|rotigotine|mesh-list
56605711|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56605712|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
56605713|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56605714|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605715|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56605716|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
56647302|NCT03711318|Naloxone|naloxone|mesh-list
56647303|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56647304|NCT03711318|Narcotics|narcotics|mesh-ancestor
56647305|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647306|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647307|NCT03711318|Analgesics|analgesics|mesh-ancestor
56647308|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
56647309|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647310|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56647311|NCT03535116|Ketorolac|ketorolac|mesh-list
56647312|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56647313|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56647314|NCT03535116|Analgesics|analgesics|mesh-ancestor
56647315|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
56647316|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647317|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647318|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647319|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56647320|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56647321|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647322|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647323|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
56647324|NCT03704298|Fludarabine|fludarabine|mesh-list
56647325|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647326|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
56647327|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647328|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605717|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56605718|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
56605719|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605720|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56605721|NCT03896815|INCB054329|incb054329|mesh-list
56605722|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605723|NCT02598856|Naloxone|naloxone|mesh-list
56605724|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56605725|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605726|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
56605727|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605728|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
56605729|NCT05256901|Neostigmine|neostigmine|mesh-list
56605730|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56605731|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605732|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605733|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
56605734|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918607|NCT03591913|Misoprostol|misoprostol|mesh-list
56605786|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605787|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56605788|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647329|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56647330|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
56647331|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647332|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647333|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56647334|NCT02687100|Beclomethasone|beclomethasone|mesh-list
56647335|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647336|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
56647337|NCT02687100|Hormones|hormones|mesh-ancestor
56502263|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605790|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605791|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
56605792|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
56605793|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
56605794|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605795|NCT01023659|Bupropion|bupropion|mesh-list
56605796|NCT01023659|Varenicline|varenicline|mesh-list
56605797|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56605798|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
56605799|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56605800|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56605801|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56605802|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56605803|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605804|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
56605805|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605806|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605807|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56605808|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56605809|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605810|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56605811|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56605812|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
56605813|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
56605814|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56605815|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56605816|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605817|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
56605818|NCT00740116|Coagulants|coagulants|mesh-ancestor
56605819|NCT02567461|Aspirin|aspirin|mesh-list
56605820|NCT02567461|Edoxaban|edoxaban|mesh-list
56605821|NCT02567461|Clopidogrel|clopidogrel|mesh-list
56605822|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56605823|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56605824|NCT02567461|Analgesics|analgesics|mesh-ancestor
56605825|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
56605826|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605827|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605828|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56605829|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605830|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56605831|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56605832|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918645|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
56605844|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56605845|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
56605846|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
56605847|NCT00698581|Brivaracetam|brivaracetam|mesh-list
56605848|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
56605849|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
56605850|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
56605851|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56605852|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56605853|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605854|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801261|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647338|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647339|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647340|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56647341|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
56647342|NCT05662098|Hydroxyurea|hydroxyurea|mesh-list
56647343|NCT05662098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647344|NCT05662098|Antisickling Agents|antisickling agents|mesh-ancestor
56647345|NCT05662098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647346|NCT05662098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647347|NCT05662098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56647348|NCT02153645|Amantadine|amantadine|mesh-list
56647349|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56647350|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56647351|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
56647352|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647353|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
56605855|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605856|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605857|NCT01023581|Metformin|metformin|mesh-list
56605858|NCT01023581|Alogliptin|alogliptin|mesh-list
56605859|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56605860|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605861|NCT01023581|Incretins|incretins|mesh-ancestor
56605862|NCT01023581|Hormones|hormones|mesh-ancestor
56605863|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605864|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56605865|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
56605866|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605867|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605868|NCT05571787|Rabeprazole|rabeprazole|mesh-list
56605869|NCT05571787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56605870|NCT05571787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56605871|NCT05571787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56605872|NCT05571787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605873|NCT05571787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605874|NCT04063189|Clarithromycin|clarithromycin|mesh-list
56605875|NCT04063189|Dexamethasone|dexamethasone|mesh-list
56605876|NCT04063189|Lenalidomide|lenalidomide|mesh-list
56605877|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56605878|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
56605879|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
56605880|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605881|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605882|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56605883|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
56605884|NCT04063189|Hormones|hormones|mesh-ancestor
56605885|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605886|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56605887|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605888|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
56605889|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56605890|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56605891|NCT04063189|Growth Substances|growth substances|mesh-ancestor
56605892|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
56605893|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56605894|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605895|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56605896|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647354|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56647355|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647356|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647357|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56647358|NCT02153645|Analgesics|analgesics|mesh-ancestor
56647359|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
56647360|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647361|NCT02688738|Doxycycline|doxycycline|mesh-list
56647362|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56647363|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647364|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
56647365|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56647366|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56647367|NCT00639366|Trastuzumab|trastuzumab|mesh-list
56923717|NCT03595124|Axitinib|axitinib|mesh-list
56293369|NCT00085111|Growth Substances|growth substances|mesh-ancestor
56502384|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55918704|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56605935|NCT00734656|Dutasteride|dutasteride|mesh-list
56605936|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56605937|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605938|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605939|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605940|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56605941|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56605942|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605943|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605944|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
56605945|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605946|NCT04644289|Durvalumab|durvalumab|mesh-list
56605947|NCT04644289|Olaparib|olaparib|mesh-list
56605948|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56605949|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605950|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56605951|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605952|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605953|NCT02565979|Resveratrol|resveratrol|mesh-list
56605954|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
56605955|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605956|NCT02565979|Protective Agents|protective agents|mesh-ancestor
56605957|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605958|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605959|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56605960|NCT04062175|Azithromycin|azithromycin|mesh-list
56605961|NCT04062175|Cephalosporins|cephalosporins|mesh-list
56605962|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56605963|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605964|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
56605965|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56605966|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56605967|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56605968|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56605969|NCT04391569|Ganaxolone|ganaxolone|mesh-list
56605970|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
56605971|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605972|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605973|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605974|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
56647368|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56647369|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647370|NCT02686710|Propofol|propofol|mesh-list
56647371|NCT02686710|Sevoflurane|sevoflurane|mesh-list
56647372|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56647373|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647374|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647375|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56647376|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
56647377|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
56647378|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56647379|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56647380|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56647381|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
56647382|NCT01773083|Heparin|heparin|mesh-list
56647383|NCT01773083|Calcium heparin|calcium heparin|mesh-list
56647384|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
56647385|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56647386|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56605975|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
56605976|NCT05324917|Rituximab|rituximab|mesh-list
56605977|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56605978|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605979|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
56605980|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605981|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605982|NCT00739648|Levofloxacin|levofloxacin|mesh-list
55918795|NCT04126200|Growth Substances|growth substances|mesh-ancestor
56605996|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56605997|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605998|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605999|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606001|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56606002|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606003|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56606004|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606005|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56606006|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
56606007|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
56606008|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606009|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606011|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
56606012|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606013|NCT02871713|Morphine|morphine|mesh-list
56606014|NCT02871713|Ropivacaine|ropivacaine|mesh-list
56606015|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56606016|NCT02871713|Narcotics|narcotics|mesh-ancestor
56606017|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606018|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606020|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
56606021|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606022|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
56606023|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
56606024|NCT04342975|Niacinamide|niacinamide|mesh-list
56606025|NCT04342975|Niacin|niacin|mesh-list
56606026|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
56606027|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
56606028|NCT04342975|Vitamins|vitamins|mesh-ancestor
56606029|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
56606030|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647387|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647388|NCT02354898|Sorafenib|sorafenib|mesh-list
56647389|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647390|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56647391|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647392|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647393|NCT00110435|Atorvastatin|atorvastatin|mesh-list
56647394|NCT00110435|Simvastatin|simvastatin|mesh-list
56647395|NCT00110435|Ezetimibe|ezetimibe|mesh-list
56647396|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56647397|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56647398|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
56647399|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647400|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56647401|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56647402|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647403|NCT00093899|Simvastatin|simvastatin|mesh-list
56647404|NCT00093899|Ezetimibe|ezetimibe|mesh-list
56502500|NCT04582136|Sirolimus|sirolimus|mesh-list
56606031|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56606032|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
56606033|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606034|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56606035|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
56606036|NCT00734578|Guanfacine|guanfacine|mesh-list
56606037|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56606038|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56606039|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56606040|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56606041|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
56606042|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606043|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606044|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606045|NCT00637715|Alfuzosin|alfuzosin|mesh-list
56606058|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
56606059|NCT02593708|Paclitaxel|paclitaxel|mesh-list
56606060|NCT02593708|Trastuzumab|trastuzumab|mesh-list
56606061|NCT02593708|Pertuzumab|pertuzumab|mesh-list
56606062|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56606063|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606064|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606065|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56606066|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606067|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606068|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56606069|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
56606070|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56606071|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
56606072|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606073|NCT00696787|Pregabalin|pregabalin|mesh-list
56606074|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56606075|NCT00696787|Analgesics|analgesics|mesh-ancestor
56606076|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
56606077|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606078|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606079|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
56606080|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56647405|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56647406|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56647407|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
56647408|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647409|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56647410|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56647411|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647412|NCT00092807|Ezetimibe|ezetimibe|mesh-list
56647413|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56647414|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56647415|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
56647416|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647417|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56647418|NCT00092729|Naproxen|naproxen|mesh-list
56647419|NCT00092729|Etoricoxib|etoricoxib|mesh-list
56647420|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56647421|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56647422|NCT00092729|Analgesics|analgesics|mesh-ancestor
56647423|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
56606081|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56606082|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606083|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56606084|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56354599|NCT00067301|Citalopram|citalopram|mesh-list
56606085|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56606086|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606087|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56606088|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56606089|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56606090|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606091|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
56606092|NCT01012037|Linagliptin|linagliptin|mesh-list
56606093|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56606094|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606095|NCT01012037|Incretins|incretins|mesh-ancestor
56606096|NCT01012037|Hormones|hormones|mesh-ancestor
56606097|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606098|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56606099|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
56606100|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606101|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606102|NCT00630110|Docetaxel|docetaxel|mesh-list
56606103|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606104|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606105|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
55918974|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606167|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56606168|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606169|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56606170|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606171|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606172|NCT02595190|Gabapentin|gabapentin|mesh-list
56606173|NCT02595190|Tramadol|tramadol|mesh-list
56606174|NCT02595190|Analgesics|analgesics|mesh-ancestor
56606175|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
56647424|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647425|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647426|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647427|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56647428|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
56647429|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56647430|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647431|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647432|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56647433|NCT02686476|Empagliflozin|empagliflozin|mesh-list
56647434|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56647435|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647436|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56647437|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647438|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
56647439|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56647440|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606176|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606177|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606178|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
56606179|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56606180|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56606181|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606182|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56606183|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56606184|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56606185|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606186|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606187|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
56606204|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606205|NCT00733408|Paclitaxel|paclitaxel|mesh-list
56606206|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56606207|NCT00733408|Bevacizumab|bevacizumab|mesh-list
56606208|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56606209|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56606210|NCT00733408|Antibodies|antibodies|mesh-list
56606211|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
56606212|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56606213|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56606214|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606215|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606216|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56606217|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606218|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606219|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56606220|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56606221|NCT00733408|Growth Substances|growth substances|mesh-ancestor
56606222|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606223|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
56606224|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
56606225|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56606226|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606227|NCT04296383|Azithromycin|azithromycin|mesh-list
56606228|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56606229|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293450|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
56647452|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
56647453|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56647454|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647455|NCT00616382|Indomethacin|indomethacin|mesh-list
56647456|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
56647457|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56606230|NCT00576823|Alfuzosin|alfuzosin|mesh-list
56606231|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56606232|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56606233|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56606235|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606236|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606237|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606238|NCT00576823|Urological Agents|urological agents|mesh-ancestor
56606240|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56606241|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
56606242|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606243|NCT00962390|Equol|equol|mesh-list
56606244|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
56606245|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56606246|NCT00962390|Estrogens|estrogens|mesh-ancestor
56606247|NCT00962390|Hormones|hormones|mesh-ancestor
56606248|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606263|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
56606264|NCT03221257|Pirfenidone|pirfenidone|mesh-list
56606265|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56606266|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606267|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56606268|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
56606269|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56606270|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56606271|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606272|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606273|NCT03221257|Analgesics|analgesics|mesh-ancestor
56606274|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
56606275|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606276|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606277|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56606278|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56606279|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56606280|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56606281|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56606282|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56606283|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56606284|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56606285|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606286|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606287|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606288|NCT00960986|Analgesics|analgesics|mesh-ancestor
56606289|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
56606290|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606291|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
56606292|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56606293|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
56606294|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56606295|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647458|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647459|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647460|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56647461|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56647462|NCT00616382|Protective Agents|protective agents|mesh-ancestor
56647463|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647464|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
56647465|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56647466|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
56647467|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56647468|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56647469|NCT00616382|Analgesics|analgesics|mesh-ancestor
56647470|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
56647471|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647472|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56606296|NCT00958880|Yohimbine|yohimbine|mesh-list
56606297|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
56606298|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
56606299|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606300|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606301|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56606302|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56606303|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56606304|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
56354817|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
56606305|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606306|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606307|NCT00958880|Urological Agents|urological agents|mesh-ancestor
56606359|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606361|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56606362|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56606363|NCT02858804|Cytarabine|cytarabine|mesh-list
56606364|NCT02858804|Thalidomide|thalidomide|mesh-list
56606365|NCT02858804|Dexamethasone|dexamethasone|mesh-list
56606366|NCT02858804|Prednisone|prednisone|mesh-list
56606367|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
56606368|NCT02858804|Rituximab|rituximab|mesh-list
56606369|NCT02858804|Doxorubicin|doxorubicin|mesh-list
56606370|NCT02858804|Etoposide|etoposide|mesh-list
56606371|NCT02858804|Vincristine|vincristine|mesh-list
56606372|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56606373|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
56606374|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606375|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56606376|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56606377|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
56606378|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159350|NCT02862912|Analgesics|analgesics|mesh-ancestor
56606379|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606380|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56606381|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56606382|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56606383|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
56606384|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
56606385|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606386|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606387|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
56606388|NCT02858804|Hormones|hormones|mesh-ancestor
56606389|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606390|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56647473|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56647474|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
56647475|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
56647476|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56647477|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56647478|NCT01864746|Palbociclib|palbociclib|mesh-list
56647479|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647480|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56647481|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647482|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647483|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
56647484|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56647485|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
56647486|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56647487|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
56647488|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647489|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647490|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
56647491|NCT04212650|Losartan|losartan|mesh-list
56647492|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56647493|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56647494|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56647495|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56647496|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647497|NCT02574728|Sirolimus|sirolimus|mesh-list
56647498|NCT02574728|Celecoxib|celecoxib|mesh-list
56647499|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
56647500|NCT02574728|Etoposide|etoposide|mesh-list
56606391|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56606392|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56606393|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56606449|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56606450|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606451|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606453|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56606454|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606455|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
56606456|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606457|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56606459|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
56606460|NCT04295993|Norepinephrine|norepinephrine|mesh-list
56606461|NCT04295993|Methylene Blue|methylene blue|mesh-list
56606462|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56606463|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56606464|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
56606465|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606466|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606467|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647501|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647502|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
56647503|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647504|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56647505|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56647506|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
56647507|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647508|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647509|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56647510|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56647511|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56647512|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56606468|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
56606469|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
56606470|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919297|NCT01276587|Vitamin D|vitamin d|mesh-list
56606484|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56606485|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56606486|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56606487|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
56606488|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56606489|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606490|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606491|NCT00957944|Rotigotine|rotigotine|mesh-list
56606492|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
56606493|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
56606494|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606495|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606496|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606497|NCT02871323|Durvalumab|durvalumab|mesh-list
56606498|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
56606499|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56606500|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
56606501|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56606502|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606503|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
56606504|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606505|NCT04296149|Octreotide|octreotide|mesh-list
56606506|NCT04296149|Edotreotide|edotreotide|mesh-list
56606507|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606508|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56606509|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606510|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56606511|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606512|NCT01005875|Sorafenib|sorafenib|mesh-list
56606513|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606514|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56606515|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606516|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606517|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
56606518|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56606519|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606520|NCT02701088|Mitomycins|mitomycins|mesh-list
56606521|NCT02701088|Mitomycin|mitomycin|mesh-list
56606522|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56606523|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606524|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
56606525|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355044|NCT00099684|Ezetimibe|ezetimibe|mesh-list
56606526|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56606527|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606528|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
56647513|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647514|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56647515|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647516|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56647517|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
56647518|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56647519|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56647520|NCT02574728|Analgesics|analgesics|mesh-ancestor
56647521|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
56647522|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647523|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647524|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56647525|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56647526|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
56647527|NCT00617474|Hematinics|hematinics|mesh-ancestor
56647528|NCT00619034|Diclofenac|diclofenac|mesh-list
56647529|NCT00619034|Dorzolamide|dorzolamide|mesh-list
56647530|NCT00619034|Latanoprost|latanoprost|mesh-list
56647531|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56647532|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56647533|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56647534|NCT00619034|Analgesics|analgesics|mesh-ancestor
56606529|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56606530|NCT04279106|Listerine|listerine|mesh-list
56606531|NCT04279106|Fluorides|fluorides|mesh-list
56606532|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
56606533|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
55919349|NCT04025671|Naloxone|naloxone|mesh-list
56606554|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56606555|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56606556|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606557|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56606558|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606559|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606560|NCT02840227|Anesthetics|anesthetics|mesh-list
56606561|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606562|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606564|NCT02856854|Oxazepam|oxazepam|mesh-list
56606565|NCT02856854|Metyrapone|metyrapone|mesh-list
56606566|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
56606567|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
56606568|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606569|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606570|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
56606571|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606572|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56606573|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56606574|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56606575|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56606576|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606577|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
56606578|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606579|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
56606580|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606581|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56647535|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
56647536|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647537|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647538|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647539|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56647540|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56647541|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647542|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647543|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56647544|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56647545|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56647546|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56647547|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56647548|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56647549|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647550|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647551|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56647552|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56647553|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56647554|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56647555|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
56647556|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56647557|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647558|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56647559|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56647560|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
56606582|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56606583|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56606584|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56606585|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
56606586|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
56606587|NCT02857166|Antibodies|antibodies|mesh-list
55919408|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
56606598|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606599|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606601|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56606602|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56606603|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56606604|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56606605|NCT02563951|Granisetron|granisetron|mesh-list
56606606|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
56606607|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
56606608|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606609|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606610|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606611|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56647561|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56647562|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56647563|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
56647564|NCT01165632|Fluorides|fluorides|mesh-list
56647565|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
56647566|NCT01165632|Protective Agents|protective agents|mesh-ancestor
56647567|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647568|NCT00638742|Latanoprost|latanoprost|mesh-list
56647569|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56647570|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56647571|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56647572|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56647573|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56647574|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647575|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502996|NCT01140880|Emtricitabine|emtricitabine|mesh-list
56606612|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
56606613|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606614|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606615|NCT00953576|Ketoconazole|ketoconazole|mesh-list
56606616|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
56606618|NCT00953576|Dutasteride|dutasteride|mesh-list
56606619|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56606620|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606621|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56606622|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606623|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606624|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
56606625|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56606626|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56606627|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56606628|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56606629|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
56606630|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606631|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606632|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56606633|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56606634|NCT02100956|Oxytocin|oxytocin|mesh-list
56606635|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
56606636|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56606637|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606638|NCT02073968|Paclitaxel|paclitaxel|mesh-list
56606639|NCT02073968|Carboplatin|carboplatin|mesh-list
56606640|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56606641|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56606642|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606643|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606644|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
56606645|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606646|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606647|NCT01005329|Paclitaxel|paclitaxel|mesh-list
56606648|NCT01005329|Bevacizumab|bevacizumab|mesh-list
56606649|NCT01005329|Cisplatin|cisplatin|mesh-list
56606650|NCT01005329|Carboplatin|carboplatin|mesh-list
56606651|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55919462|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
56606679|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606680|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56647576|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
56647577|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647578|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56647579|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56647580|NCT02686242|Anesthetics|anesthetics|mesh-list
56647581|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647582|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647583|NCT05661786|Antiviral Agents|antiviral agents|mesh-list
56647584|NCT05661786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647585|NCT00639522|Paclitaxel|paclitaxel|mesh-list
56647586|NCT00639522|Capecitabine|capecitabine|mesh-list
56647587|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56647588|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647589|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
56647590|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
56503061|NCT00585741|Alovudine|alovudine|mesh-list
56606681|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56606682|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
56606683|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
56606684|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606685|NCT01005251|Lesogaberan|lesogaberan|mesh-list
56606686|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606687|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56606688|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
56606689|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
56606690|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606691|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606692|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606693|NCT03048578|Liraglutide|liraglutide|mesh-list
56606694|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56606695|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606696|NCT03048578|Incretins|incretins|mesh-ancestor
56606725|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
56606726|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606727|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606728|NCT02857712|Axitinib|axitinib|mesh-list
56606729|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606730|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56606731|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606732|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606733|NCT00696241|Olmesartan|olmesartan|mesh-list
56606734|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56606735|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56606736|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56606737|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56606738|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56606739|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606740|NCT02007044|Rituximab|rituximab|mesh-list
56606741|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56606742|NCT02007044|Antibodies|antibodies|mesh-list
56606743|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
56606744|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56606766|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56606767|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
56606768|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56606769|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56606770|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56606771|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56606772|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606773|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
56074046|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
56647591|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
56647592|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647593|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56647594|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
56647595|NCT00411138|Paclitaxel|paclitaxel|mesh-list
56647596|NCT00411138|Carboplatin|carboplatin|mesh-list
56647597|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56647598|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647599|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
56647600|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
56647601|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503112|NCT01139008|Azelaic acid|azelaic acid|mesh-list
56606774|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606775|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606776|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56606777|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56606778|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606780|NCT02563795|Bupivacaine|bupivacaine|mesh-list
56606781|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
56606782|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
56606783|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606784|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606785|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
56606786|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606787|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56606788|NCT02563795|Narcotics|narcotics|mesh-ancestor
56606789|NCT02563795|Analgesics|analgesics|mesh-ancestor
56606790|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56606791|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56606792|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
56606793|NCT04281680|Octreotide|octreotide|mesh-list
56606794|NCT04281680|Pasireotide|pasireotide|mesh-list
56606795|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606796|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56606797|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606798|NCT04281680|Hormones|hormones|mesh-ancestor
56606809|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
56606810|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606811|NCT04060459|Paclitaxel|paclitaxel|mesh-list
56606812|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56606813|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606814|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606815|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
56606816|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606817|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606818|NCT01007435|Methotrexate|methotrexate|mesh-list
56606819|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56606820|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
56606821|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56606822|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606823|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56606824|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
56606825|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606826|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606827|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
56606828|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606829|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56606830|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56606831|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
56606832|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56606833|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56606834|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
56606835|NCT00948896|Piperaquine|piperaquine|mesh-list
56606836|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
56606837|NCT00948896|Trimethoprim|trimethoprim|mesh-list
56647602|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647603|NCT02686086|Albuterol|albuterol|mesh-list
56647604|NCT02686086|Ipratropium|ipratropium|mesh-list
56647605|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56647606|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
56647607|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647608|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647609|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56647610|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
56647611|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
56647612|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56647613|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56647614|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56647615|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56647616|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
56647617|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606838|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56606839|NCT00948896|Artenimol|artenimol|mesh-list
56606840|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56606841|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
56606842|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
56606843|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56606844|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56606845|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56606846|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56606847|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606848|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606849|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56606850|NCT00948896|Renal Agents|renal agents|mesh-ancestor
56606851|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56606852|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56606853|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56606854|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56606855|NCT01004159|Irinotecan|irinotecan|mesh-list
56606856|NCT01004159|Cetuximab|cetuximab|mesh-list
56606857|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56606858|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56606859|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606860|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919677|NCT04146259|Vitamins|vitamins|mesh-ancestor
56606872|NCT00948506|Cidofovir|cidofovir|mesh-list
56606873|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
56606874|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56606875|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606876|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606877|NCT00689221|Temozolomide|temozolomide|mesh-list
56606878|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56606879|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
56606880|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606881|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606882|NCT04060771|Dexamethasone|dexamethasone|mesh-list
56606883|NCT04060771|Palonosetron|palonosetron|mesh-list
56606884|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56606885|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
56606886|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
56606887|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606888|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606889|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606890|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
56647618|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647619|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56647620|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
56647621|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
56647622|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56647623|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
56647624|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647625|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
56647626|NCT03460158|Protective Agents|protective agents|mesh-ancestor
56647627|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
56647628|NCT02697630|Entinostat|entinostat|mesh-list
56647629|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56647630|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647631|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56647632|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647633|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647634|NCT02685852|Exenatide|exenatide|mesh-list
56647635|NCT02685852|Acarbose|acarbose|mesh-list
56647636|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56647637|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647638|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56606891|NCT04060771|Hormones|hormones|mesh-ancestor
56606892|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606893|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56606894|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606895|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56606896|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56606897|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
56606898|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606899|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606900|NCT00744913|Nicotine|nicotine|mesh-list
56606901|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56606902|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
56606903|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606904|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606906|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56606907|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
56606908|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606909|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606910|NCT01875445|Inositol|inositol|mesh-list
56606911|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
56606912|NCT01875445|Vitamins|vitamins|mesh-ancestor
56606913|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
56606914|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606915|NCT00745069|Tapentadol|tapentadol|mesh-list
56606916|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56606917|NCT00745069|Narcotics|narcotics|mesh-ancestor
56606918|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606919|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606920|NCT00745069|Analgesics|analgesics|mesh-ancestor
56606921|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
56606922|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606923|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56606935|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56647639|NCT02685852|Incretins|incretins|mesh-ancestor
56647640|NCT02685852|Hormones|hormones|mesh-ancestor
56647641|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647642|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56647643|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647644|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647645|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56647646|NCT02697162|Octenidine|octenidine|mesh-list
56647647|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647648|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56503297|NCT00574964|Temozolomide|temozolomide|mesh-list
56606936|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606937|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606938|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56606939|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
56606940|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606941|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606942|NCT00948428|Imiquimod|imiquimod|mesh-list
56606943|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56606944|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
56606945|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606946|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606947|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
56606948|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
56606949|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56606950|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
56606951|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606952|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606953|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56606954|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
56606955|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56606956|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
56606957|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606958|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606959|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56606960|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
56606961|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
56606962|NCT00948194|Protective Agents|protective agents|mesh-ancestor
56606963|NCT00691483|Varenicline|varenicline|mesh-list
56606964|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56606965|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56606966|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
56606967|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606968|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606969|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606970|NCT00691093|Fesoterodine|fesoterodine|mesh-list
56606971|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56606972|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56606973|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
56606974|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606975|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606976|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606977|NCT00691093|Urological Agents|urological agents|mesh-ancestor
56606978|NCT03646825|Antioxidants|antioxidants|mesh-list
56606979|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606980|NCT03646825|Protective Agents|protective agents|mesh-ancestor
56606981|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606982|NCT00745225|Pioglitazone|pioglitazone|mesh-list
56606983|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56606984|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606985|NCT02856542|Betamethasone|betamethasone|mesh-list
56606986|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
56607000|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647649|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56647650|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647651|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
56647652|NCT00622674|Cetuximab|cetuximab|mesh-list
56647653|NCT00622674|Bortezomib|bortezomib|mesh-list
56647654|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56647655|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647656|NCT02687724|Golimumab|golimumab|mesh-list
56647657|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56647658|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647659|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647660|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
56607001|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607002|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
56607003|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607004|NCT04204382|Levofloxacin|levofloxacin|mesh-list
56607005|NCT04204382|Ofloxacin|ofloxacin|mesh-list
56607006|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56607007|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607008|NCT04204382|Renal Agents|renal agents|mesh-ancestor
56607009|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56607010|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56607011|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56607012|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607013|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607014|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607015|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56607016|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56607017|NCT02856230|Paclitaxel|paclitaxel|mesh-list
56607018|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56607019|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607020|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
56607021|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
56607022|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
56607023|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607024|NCT00631124|Drospirenone|drospirenone|mesh-list
56607025|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56607026|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56607027|NCT00631124|Estradiol|estradiol|mesh-list
56607028|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56607029|NCT00631124|Estrogens|estrogens|mesh-ancestor
56607030|NCT00631124|Hormones|hormones|mesh-ancestor
56607031|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607032|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607033|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56607034|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
56607035|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56607036|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56607037|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56607038|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
56607039|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56607040|NCT00631124|Diuretics|diuretics|mesh-ancestor
56607041|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
56607042|NCT02855684|Insulin|insulin|mesh-list
56607043|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56607044|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
56607045|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56607046|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607048|NCT01667744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55919888|NCT04144933|Analgesics|analgesics|mesh-ancestor
56607074|NCT00950690|Latanoprost|latanoprost|mesh-list
56607075|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56607076|NCT02855138|Isotretinoin|isotretinoin|mesh-list
56607077|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
56607078|NCT01471106|Dasatinib|dasatinib|mesh-list
56647661|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647662|NCT02687958|Everolimus|everolimus|mesh-list
56647663|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647664|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647665|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
56647666|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647667|NCT02685774|Metformin|metformin|mesh-list
56647668|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56647669|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647670|NCT00638976|Eptifibatide|eptifibatide|mesh-list
56647671|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56647672|NCT05661708|Chitosan|chitosan|mesh-list
56647673|NCT05661708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56647674|NCT05661708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56647675|NCT05661708|Antimetabolites|antimetabolites|mesh-ancestor
56607079|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607080|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56607081|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607082|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607083|NCT00694369|Acetaminophen|acetaminophen|mesh-list
56607084|NCT00694369|Ibuprofen|ibuprofen|mesh-list
56607085|NCT00694369|Etoricoxib|etoricoxib|mesh-list
56607086|NCT00694369|Codeine|codeine|mesh-list
56607087|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56607088|NCT00694369|Analgesics|analgesics|mesh-ancestor
56607089|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
56607090|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607091|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607092|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
56607093|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56607094|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56607095|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55919952|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
56607110|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56607112|NCT02563405|Nifedipine|nifedipine|mesh-list
56607113|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56607114|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56607115|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607116|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56607117|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607118|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
56607119|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
56607120|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56607121|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56607122|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56607123|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56607124|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56607125|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
56607126|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607127|NCT03412747|Adalimumab|adalimumab|mesh-list
56607128|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56607129|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56607131|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
56607132|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56607133|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56607134|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607135|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56607136|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607137|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56607138|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56607139|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647676|NCT05661708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647677|NCT05661708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56647678|NCT05661708|Chelating Agents|chelating agents|mesh-ancestor
56647679|NCT05661708|Sequestering Agents|sequestering agents|mesh-ancestor
56647680|NCT05661708|Hemostatics|hemostatics|mesh-ancestor
56647681|NCT05661708|Coagulants|coagulants|mesh-ancestor
56647682|NCT00639756|Allopurinol|allopurinol|mesh-list
56647683|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
56647684|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647685|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647686|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
56647687|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56607140|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56607141|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56607142|NCT00053677|Naltrexone|naltrexone|mesh-list
56607143|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56607144|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56607145|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607146|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
56607147|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607148|NCT00954512|Leucovorin|leucovorin|mesh-list
56607149|NCT00954512|Folic Acid|folic acid|mesh-list
56607150|NCT00954512|Gemcitabine|gemcitabine|mesh-list
56607151|NCT00954512|Carboplatin|carboplatin|mesh-list
56607152|NCT00954512|Trastuzumab|trastuzumab|mesh-list
56607153|NCT00954512|Irinotecan|irinotecan|mesh-list
56607154|NCT00954512|Cetuximab|cetuximab|mesh-list
56607155|NCT00954512|Everolimus|everolimus|mesh-list
56607156|NCT00954512|Epirubicin|epirubicin|mesh-list
56607170|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56607171|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56607172|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56607173|NCT00954512|Antidotes|antidotes|mesh-ancestor
56607174|NCT00954512|Protective Agents|protective agents|mesh-ancestor
56607175|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
56607176|NCT00954512|Vitamins|vitamins|mesh-ancestor
56607177|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
56607178|NCT00954512|Hematinics|hematinics|mesh-ancestor
56607179|NCT00691015|Cytarabine|cytarabine|mesh-list
56607180|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
56607181|NCT00691015|Melphalan|melphalan|mesh-list
56607182|NCT00691015|Busulfan|busulfan|mesh-list
56607183|NCT00691015|Carmustine|carmustine|mesh-list
56607184|NCT00691015|Rituximab|rituximab|mesh-list
56607185|NCT00691015|Fludarabine|fludarabine|mesh-list
56607186|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
56607187|NCT00691015|Etoposide|etoposide|mesh-list
56607188|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
56607189|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56607190|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607191|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
56607192|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607193|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56607194|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56607195|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
56607196|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607197|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607198|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56607199|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607200|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56607201|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
56607202|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56607203|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56607204|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56607205|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607206|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
56607207|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607208|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
56607209|NCT00950300|Docetaxel|docetaxel|mesh-list
56607210|NCT00950300|Fluorouracil|fluorouracil|mesh-list
56647688|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56647689|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
56647690|NCT00639756|Protective Agents|protective agents|mesh-ancestor
56647691|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647692|NCT00622752|Nicotine|nicotine|mesh-list
56647693|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56647694|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
56647695|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647696|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647697|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56647698|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56647699|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
56607211|NCT00950300|Trastuzumab|trastuzumab|mesh-list
56607212|NCT00950300|Epirubicin|epirubicin|mesh-list
56607213|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607214|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
56607215|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607216|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56607217|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56607218|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
56607219|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607220|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607255|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56607256|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607257|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607285|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56607286|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
56607287|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607288|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56607289|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
56607290|NCT00737464|Hematinics|hematinics|mesh-ancestor
56607291|NCT00729586|Tamoxifen|tamoxifen|mesh-list
56607292|NCT00729586|Sirolimus|sirolimus|mesh-list
56607293|NCT00729586|Megestrol|megestrol|mesh-list
56607294|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
56607295|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56607296|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607297|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56607298|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607299|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
56607300|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607301|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
56607302|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607303|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56607304|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
56607305|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607306|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56607307|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56607326|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56607327|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
56607328|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607329|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56607330|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56607331|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607332|NCT02593162|Ribavirin|ribavirin|mesh-list
56607333|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
56607334|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607335|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
56607336|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607337|NCT00686959|Paclitaxel|paclitaxel|mesh-list
56607338|NCT00686959|Etoposide|etoposide|mesh-list
56607339|NCT00686959|Vinorelbine|vinorelbine|mesh-list
56607340|NCT00686959|Carboplatin|carboplatin|mesh-list
56607341|NCT00686959|Pemetrexed|pemetrexed|mesh-list
56607342|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56647700|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56647701|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647702|NCT03451578|alpha-MSH|alpha-msh|mesh-list
56647703|NCT03451578|Hormones|hormones|mesh-ancestor
56647704|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647705|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647706|NCT02686008|Olaparib|olaparib|mesh-list
56647707|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56647708|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647709|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647710|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647711|NCT02685618|Iloprost|iloprost|mesh-list
56647712|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56647713|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
56647714|NCT00602472|Linagliptin|linagliptin|mesh-list
56647715|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56647716|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647717|NCT00602472|Incretins|incretins|mesh-ancestor
56647718|NCT00602472|Hormones|hormones|mesh-ancestor
56647719|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647720|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56647721|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
56647722|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647723|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159365|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
56607343|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607344|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
56607345|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
56607346|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
56607347|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607348|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56607349|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56607350|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607351|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56607352|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56607353|NCT04088110|Trastuzumab|trastuzumab|mesh-list
56607354|NCT04088110|Letrozole|letrozole|mesh-list
56607355|NCT04088110|Anastrozole|anastrozole|mesh-list
56607356|NCT04088110|Exemestane|exemestane|mesh-list
56607357|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56355866|NCT00253396|Heparin|heparin|mesh-list
56607358|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607359|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607360|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56607361|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607382|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607384|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
56607385|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607386|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56647724|NCT03384654|Cytarabine|cytarabine|mesh-list
56647725|NCT03384654|Prednisone|prednisone|mesh-list
56647726|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
56647727|NCT03384654|Doxorubicin|doxorubicin|mesh-list
56647728|NCT03384654|Methotrexate|methotrexate|mesh-list
56647729|NCT03384654|Vincristine|vincristine|mesh-list
56647730|NCT03384654|Asparaginase|asparaginase|mesh-list
56647731|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
56647732|NCT03384654|Daratumumab|daratumumab|mesh-list
56647733|NCT03384654|Pegaspargase|pegaspargase|mesh-list
56647734|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647735|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
56647736|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647737|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56647738|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56647739|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
56647740|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647741|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293761|NCT04762953|Vitamins|vitamins|mesh-ancestor
56647742|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56647743|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56607387|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
56607388|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56607389|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56607390|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56607391|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607392|NCT05311579|Niraparib|niraparib|mesh-list
56607393|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56607394|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607395|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607396|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607397|NCT00946088|Progesterone|progesterone|mesh-list
56607398|NCT00946088|Progestins|progestins|mesh-ancestor
56607399|NCT00946088|Hormones|hormones|mesh-ancestor
56607400|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607401|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607402|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
56607403|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56607404|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607405|NCT00736996|Pioglitazone|pioglitazone|mesh-list
56607406|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56607407|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607408|NCT00741949|Propofol|propofol|mesh-list
56607409|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56607410|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56607411|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607412|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56607467|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607468|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607470|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56607471|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
56607472|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
56607473|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607474|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
56607475|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607476|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
56607477|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647744|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56647746|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647747|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647748|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
56647749|NCT03384654|Hormones|hormones|mesh-ancestor
56647750|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647751|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56647752|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56647753|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
56647754|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56647755|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56647756|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
56647757|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
56607478|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
56607479|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56607480|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56607481|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607482|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56607483|NCT02854904|Analgesics|analgesics|mesh-ancestor
56607484|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
56607485|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607486|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56607487|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56607488|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56607489|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
55920357|NCT05109312|Ibuprofen|ibuprofen|mesh-list
56607514|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56607515|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
56607516|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607517|NCT00602342|Terbinafine|terbinafine|mesh-list
56607518|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
56607519|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607520|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607521|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607522|NCT00602498|Clarithromycin|clarithromycin|mesh-list
56607523|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56607524|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607525|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56607526|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607527|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607528|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56607529|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56607530|NCT00736450|Prednisone|prednisone|mesh-list
56607531|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
56607532|NCT00736450|Rituximab|rituximab|mesh-list
56607533|NCT00736450|Doxorubicin|doxorubicin|mesh-list
56607534|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56607535|NCT00736450|Vincristine|vincristine|mesh-list
56607536|NCT00736450|Oblimersen|oblimersen|mesh-list
56607537|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607538|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
56607539|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607540|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56607541|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56607542|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
56607557|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
56607558|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
56607559|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
56607560|NCT00686881|Interferons|interferons|mesh-list
56607561|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
56607562|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
56607563|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56647758|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56647759|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56647760|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
56647761|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503795|NCT00193050|Gemcitabine|gemcitabine|mesh-list
56607564|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607565|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
56607566|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607567|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
56607568|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607569|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56607570|NCT02857244|Modafinil|modafinil|mesh-list
56607571|NCT02857244|Donepezil|donepezil|mesh-list
56607572|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56607573|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56607574|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56607575|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607576|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607577|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607578|NCT02857244|Analgesics|analgesics|mesh-ancestor
56607579|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
56356087|NCT00069875|Gemcitabine|gemcitabine|mesh-list
56607580|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607581|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
56607582|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56607583|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
56607584|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56607585|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607586|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
56607587|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
56607588|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56607589|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56607590|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56607591|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56607592|NCT04273256|Inositol|inositol|mesh-list
56607593|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
56607594|NCT04273256|Vitamins|vitamins|mesh-ancestor
56607595|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
56607596|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607597|NCT00921661|Aflibercept|aflibercept|mesh-list
56607598|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56607599|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56607600|NCT00921661|Growth Substances|growth substances|mesh-ancestor
56607619|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607620|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
56607621|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56607622|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56607623|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56607624|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56607625|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56607626|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56607627|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
56607629|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56607630|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607631|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607632|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56607633|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607634|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607635|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56607636|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
56607637|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607638|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607639|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
56607640|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
56607641|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607642|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607643|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607644|NCT00735904|Gemcitabine|gemcitabine|mesh-list
56607645|NCT00735904|Axitinib|axitinib|mesh-list
56647762|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56647763|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
56647764|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
56647765|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
56647766|NCT02685462|Digoxin|digoxin|mesh-list
56647767|NCT02685462|Caffeine|caffeine|mesh-list
56647768|NCT02685462|Atorvastatin|atorvastatin|mesh-list
56647769|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56647770|NCT02685462|Simvastatin|simvastatin|mesh-list
56647771|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56647772|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56647773|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
56647774|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647775|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56647776|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56607646|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607647|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56607648|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
56607649|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607650|NCT00735904|Antiviral Agents|antiviral agents|mesh-ancestor
56607651|NCT00735904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607652|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607653|NCT00735904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356158|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56607654|NCT00735904|Immunologic Factors|immunologic factors|mesh-ancestor
55920516|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
56607690|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56607691|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56607692|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56607693|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56607694|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56607695|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56607696|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
56607726|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
56607727|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
56356236|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
56607728|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56607729|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56607730|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56607731|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56607732|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56607733|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56607734|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56607735|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56607736|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56607737|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
56607738|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56607739|NCT00918034|Talaporfin|talaporfin|mesh-list
56607740|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607741|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56607742|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56607743|NCT02593942|Remifentanil|remifentanil|mesh-list
56607744|NCT02593942|Propofol|propofol|mesh-list
56607745|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56607746|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56607813|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607815|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56607816|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56607817|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
56607818|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075129|NCT05647278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56647777|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647778|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56647779|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647780|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56647781|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56647782|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56647783|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
56647784|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56647785|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56647786|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56647787|NCT02685462|Protective Agents|protective agents|mesh-ancestor
56647788|NCT02685306|Paclitaxel|paclitaxel|mesh-list
56647789|NCT02685306|Taxane|taxane|mesh-list
56647790|NCT02685306|Bavituximab|bavituximab|mesh-list
56647791|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56647792|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647793|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
56647794|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
56647795|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
56647796|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647797|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56647798|NCT02680938|Oxytocin|oxytocin|mesh-list
56647799|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
56647800|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56647801|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647802|NCT05663892|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56647803|NCT05663892|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56607832|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56607833|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
56607834|NCT05381558|Hormones|hormones|mesh-ancestor
56607835|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607836|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607837|NCT04055233|Biguanides|biguanides|mesh-list
56607838|NCT04055233|Polihexanide|polihexanide|mesh-list
56607839|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607840|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
56607841|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56607842|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607843|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
56607844|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607845|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
56607846|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607847|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56607848|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56607849|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
56607850|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607851|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607852|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56607853|NCT04268966|Brincidofovir|brincidofovir|mesh-list
56647804|NCT05663892|Estradiol|estradiol|mesh-list
56647805|NCT05663892|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56647806|NCT05663892|Estrogens|estrogens|mesh-ancestor
56647807|NCT05663892|Hormones|hormones|mesh-ancestor
56647808|NCT05663892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647809|NCT05663892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647810|NCT05663892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56647811|NCT05663892|Contraceptive Agents|contraceptive agents|mesh-ancestor
56647812|NCT05663892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56647813|NCT05663892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56647814|NCT02685228|Gemcitabine|gemcitabine|mesh-list
56647815|NCT02685228|Decitabine|decitabine|mesh-list
56647816|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56647817|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
56647818|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647819|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647820|NCT02685228|Antiviral Agents|antiviral agents|mesh-ancestor
56647821|NCT02685228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647822|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647823|NCT02685228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647824|NCT02685228|Immunologic Factors|immunologic factors|mesh-ancestor
56647825|NCT02685228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647826|NCT00616460|Bivalirudin|bivalirudin|mesh-list
56647827|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
56647828|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56647829|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
56647830|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647831|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647832|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
56647833|NCT00616538|Fluticasone|fluticasone|mesh-list
56647835|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647836|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56647837|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
56647838|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647839|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647840|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56503965|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56607854|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
56607855|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647841|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
56647842|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
56647843|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56647844|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
56647845|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56647846|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56647847|NCT02680548|Prednisolone|prednisolone|mesh-list
56647848|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
56647849|NCT02680548|Bupivacaine|bupivacaine|mesh-list
56647850|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56647851|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
56647852|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
56647853|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
56647854|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647855|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647856|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
56647857|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647858|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56647859|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
56647860|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
56647861|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56607856|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
56607857|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56607858|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56607859|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607860|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56607861|NCT04269278|Analgesics|analgesics|mesh-ancestor
56607862|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
56607863|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607864|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56607865|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56607866|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56607867|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
56607868|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607869|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607870|NCT02853578|Budesonide|budesonide|mesh-list
56607871|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56607872|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56607873|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
56607874|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607875|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607876|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56607877|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
56607878|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
56607879|NCT02853578|Hormones|hormones|mesh-ancestor
55920732|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56607936|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607938|NCT00747097|Cetuximab|cetuximab|mesh-list
56607939|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56607940|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
56607941|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607942|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607943|NCT00747097|Antiviral Agents|antiviral agents|mesh-ancestor
56607944|NCT00747097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607945|NCT00747097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607946|NCT00747097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647862|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
56647863|NCT02680548|Hormones|hormones|mesh-ancestor
56647864|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56647865|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56647866|NCT02680548|Protective Agents|protective agents|mesh-ancestor
56647867|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56647868|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647869|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
56647870|NCT02680626|Ropivacaine|ropivacaine|mesh-list
56647871|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
56647872|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
56647873|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647874|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647875|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
56647876|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647877|NCT02680626|Analgesics|analgesics|mesh-ancestor
56647878|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56647879|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
56647880|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56647881|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56647882|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647883|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56607947|NCT00747097|Immunologic Factors|immunologic factors|mesh-ancestor
56607948|NCT00747097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607949|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607950|NCT00747331|Fenoldopam|fenoldopam|mesh-list
56607951|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56607952|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
56607953|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
56607954|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
56607955|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607956|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607957|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607958|NCT00747409|Insulin|insulin|mesh-list
56607959|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56607960|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
56607961|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
56607962|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
56607963|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56607964|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
56607965|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
56607966|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
56607967|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56607968|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607998|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56607999|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56608000|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608001|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56608002|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608003|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608005|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
56608006|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56647884|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
56647885|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56647886|NCT05663736|Glimepiride|glimepiride|mesh-list
56647887|NCT05663736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56647888|NCT05663736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56647889|NCT05663736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647890|NCT05663736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647891|NCT05663736|Immunologic Factors|immunologic factors|mesh-ancestor
56293904|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608007|NCT02851394|Narcotics|narcotics|mesh-ancestor
56608008|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608009|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608010|NCT02851394|Analgesics|analgesics|mesh-ancestor
56608011|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
56608036|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56608037|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
56608038|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
56608039|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
56608040|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608041|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
56608042|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608043|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608044|NCT00938366|Cladribine|cladribine|mesh-list
56608045|NCT00938366|Pantoprazole|pantoprazole|mesh-list
56608046|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56608047|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608048|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56608049|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608050|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608051|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608052|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608053|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
56608054|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608055|NCT00943592|Melphalan|melphalan|mesh-list
56608056|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
56608057|NCT00943592|Clofarabine|clofarabine|mesh-list
56608058|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56608059|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
56608060|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920931|NCT04405375|Hormones|hormones|mesh-ancestor
56608082|NCT00943124|Vitamins|vitamins|mesh-ancestor
56608083|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
56608084|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608085|NCT00492050|Valacyclovir|valacyclovir|mesh-list
56608086|NCT00492050|Rituximab|rituximab|mesh-list
56608087|NCT00492050|Bortezomib|bortezomib|mesh-list
56608088|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608089|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608090|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
56608091|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608092|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608093|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
56608094|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608095|NCT04019548|Cisplatin|cisplatin|mesh-list
56608096|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608097|NCT00940316|Irinotecan|irinotecan|mesh-list
56608098|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56608099|NCT00940316|Panitumumab|panitumumab|mesh-list
56608100|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56608101|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56608102|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608103|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608104|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608105|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56608106|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608107|NCT02850848|Entecavir|entecavir|mesh-list
56608108|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
56608109|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608110|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
56647892|NCT02685150|Omeprazole|omeprazole|mesh-list
56647894|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56647895|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56647896|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647897|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647898|NCT02682186|Ropivacaine|ropivacaine|mesh-list
56647899|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
56647900|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
56647901|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647902|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647903|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
56647904|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647905|NCT01832402|Fentanyl|fentanyl|mesh-list
56647906|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56647907|NCT01832402|Narcotics|narcotics|mesh-ancestor
56647908|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647909|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647910|NCT01832402|Analgesics|analgesics|mesh-ancestor
56608111|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
56608113|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56608114|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608115|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56608116|NCT05381168|Antacids|antacids|mesh-ancestor
55920978|NCT03029611|Paclitaxel|paclitaxel|mesh-list
56608125|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608126|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608127|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608128|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56608129|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608130|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608131|NCT00572455|Latanoprost|latanoprost|mesh-list
56608132|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56608133|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56608134|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56608135|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56608136|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
56608137|NCT00686335|Prednisone|prednisone|mesh-list
56608138|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608139|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
56608140|NCT00686335|Hormones|hormones|mesh-ancestor
56608141|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608142|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608143|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56608144|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608145|NCT00685945|Isosorbide|isosorbide|mesh-list
56608146|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56608147|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56608148|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
56608149|NCT00685945|Bradykinin|bradykinin|mesh-list
56608150|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56608151|NCT00685945|Kininogens|kininogens|mesh-list
56608152|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
56608153|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56608154|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56608155|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608156|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608157|NCT00685945|Urological Agents|urological agents|mesh-ancestor
56608158|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56608159|NCT00685945|Diuretics|diuretics|mesh-ancestor
56647911|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
56647912|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647913|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56647914|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56647915|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
56647916|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
56647917|NCT00619268|Interferons|interferons|mesh-list
56647918|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
56647919|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
56647920|NCT00619268|Sirolimus|sirolimus|mesh-list
56647921|NCT00619268|Bevacizumab|bevacizumab|mesh-list
56647922|NCT00619268|Sunitinib|sunitinib|mesh-list
56647923|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56647924|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647925|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56647926|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56647927|NCT00619268|Growth Substances|growth substances|mesh-ancestor
56647928|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647929|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
56647930|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
56647931|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647932|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
56647933|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56647934|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647935|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647936|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56647937|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56647938|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
56647939|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647940|NCT00619346|Pafuramidine|pafuramidine|mesh-list
56647941|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56647942|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56647943|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56647944|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647945|NCT03063944|Azacitidine|azacitidine|mesh-list
56647946|NCT03063944|Decitabine|decitabine|mesh-list
56608160|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
56608161|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608162|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56608163|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56608164|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
56608166|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
56608167|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647947|NCT03063944|Venetoclax|venetoclax|mesh-list
56647948|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56647949|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
56647950|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647951|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647952|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647953|NCT04182828|Lidocaine|lidocaine|mesh-list
56647954|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
56647955|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
56647956|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56647957|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647958|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
56647959|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56647960|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56647961|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56647962|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56608168|NCT00747487|Protective Agents|protective agents|mesh-ancestor
56608169|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608170|NCT00750217|Buprenorphine|buprenorphine|mesh-list
56608171|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56608172|NCT00750217|Narcotics|narcotics|mesh-ancestor
56608173|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608174|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608175|NCT00750217|Analgesics|analgesics|mesh-ancestor
56608176|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
56608177|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608178|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56608179|NCT00687739|Leuprolide|leuprolide|mesh-list
56608180|NCT00687739|Estradiol|estradiol|mesh-list
56608181|NCT00687739|Estrogens|estrogens|mesh-ancestor
56608182|NCT00687739|Hormones|hormones|mesh-ancestor
56608183|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608184|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608206|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608207|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
56608208|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56608209|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608210|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608211|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56608212|NCT00747721|Analgesics|analgesics|mesh-ancestor
56608213|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
56608214|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608215|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56608216|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56608217|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56608218|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
56608219|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608220|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608221|NCT01006889|Exenatide|exenatide|mesh-list
56608222|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56608223|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608224|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56608225|NCT01006889|Incretins|incretins|mesh-ancestor
56608226|NCT01006889|Hormones|hormones|mesh-ancestor
56608227|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608228|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
56608229|NCT02561767|Tacrolimus|tacrolimus|mesh-list
56608230|NCT02561767|Basiliximab|basiliximab|mesh-list
56608231|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56647963|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56647964|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647965|NCT00619424|Pemetrexed|pemetrexed|mesh-list
56647966|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56647967|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647968|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647969|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647970|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56647971|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56504331|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56608232|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
56608233|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608234|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56608235|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608236|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608237|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56608238|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608239|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56608240|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
56608241|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56608242|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608258|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608259|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608260|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56608261|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608262|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608263|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
56608264|NCT01001429|Propofol|propofol|mesh-list
56608265|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56608266|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608267|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608268|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56608269|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
56608270|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
56608271|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56608272|NCT01001429|Analgesics|analgesics|mesh-ancestor
56608273|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
56608274|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608275|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56608276|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56608277|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56608278|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
56608279|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608280|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608281|NCT01000961|Cysteamine|cysteamine|mesh-list
56608282|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56608283|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608284|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56608285|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56608286|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56608287|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56608288|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608289|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608290|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608291|NCT01000805|Analgesics|analgesics|mesh-ancestor
56608292|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
56608293|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608294|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
56608295|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56608296|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
56608297|NCT00684307|Vitamin K|vitamin k|mesh-list
56647972|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56647973|NCT00641004|Esomeprazole|esomeprazole|mesh-list
56647974|NCT00641004|Rebamipide|rebamipide|mesh-list
56647975|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56647976|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56647977|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56647978|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647979|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647980|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
56647981|NCT00641004|Protective Agents|protective agents|mesh-ancestor
56647982|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56647983|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
56647984|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56608298|NCT00684307|Warfarin|warfarin|mesh-list
56608299|NCT00684307|Vitamins|vitamins|mesh-ancestor
56608300|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
56608301|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608332|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608333|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56608334|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
56608335|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608336|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608337|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56608338|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
56608340|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608341|NCT00752479|Cyclosporine|cyclosporine|mesh-list
56608342|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
56608343|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
56608344|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56608345|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56608346|NCT00752479|Prednisolone|prednisolone|mesh-list
56608347|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
56608372|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608373|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
56608374|NCT00752479|Hormones|hormones|mesh-ancestor
56608375|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608376|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56608377|NCT00752479|Protective Agents|protective agents|mesh-ancestor
56608378|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56608379|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
56608380|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
56608381|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56608382|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56608383|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56608384|NCT00752635|Norgestimate|norgestimate|mesh-list
56608385|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56608386|NCT00752635|Estradiol|estradiol|mesh-list
56608387|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56608388|NCT00752635|Cyproterone|cyproterone|mesh-list
56608389|NCT00752635|Estrogens|estrogens|mesh-ancestor
56608390|NCT00752635|Hormones|hormones|mesh-ancestor
56608391|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608392|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608393|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56608394|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
56608395|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56608396|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56608397|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56608398|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56608399|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
56608423|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608424|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608425|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
55887676|NCT05747326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56647985|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56647986|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56647987|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56647988|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647989|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647990|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647991|NCT01009788|Temozolomide|temozolomide|mesh-list
56647992|NCT01009788|Veliparib|veliparib|mesh-list
56647993|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56647994|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
56647995|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56647996|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56647997|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56647998|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56647999|NCT04183608|Adalimumab|adalimumab|mesh-list
56648000|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56648001|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56648002|NCT00641082|Adefovir|adefovir|mesh-list
56648003|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56648004|NCT00641082|Clevudine|clevudine|mesh-list
56648005|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
56648006|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648007|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56648008|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56648009|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648010|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648011|NCT00641160|Vinorelbine|vinorelbine|mesh-list
56608426|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608427|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608428|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
56608429|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56608430|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56608431|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56608432|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
56608433|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608434|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56608435|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56608436|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608437|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608438|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56608439|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56608440|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
56608441|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
56608442|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56608443|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
56608444|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608445|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608446|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56648012|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56648013|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648014|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
56648015|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
56648016|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
56648017|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648018|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
56648019|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56648020|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
56648021|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648022|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
56648023|NCT02679924|Protective Agents|protective agents|mesh-ancestor
56648024|NCT01828112|Docetaxel|docetaxel|mesh-list
56648025|NCT01828112|Pemetrexed|pemetrexed|mesh-list
56648026|NCT01828112|Ceritinib|ceritinib|mesh-list
56648027|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648028|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
56648029|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
56648030|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
56648031|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648032|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648033|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56648034|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56648035|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56648036|NCT00618176|Lamivudine|lamivudine|mesh-list
56648037|NCT00618176|Zidovudine|zidovudine|mesh-list
56648038|NCT00618176|Nevirapine|nevirapine|mesh-list
56648039|NCT00618176|Didanosine|didanosine|mesh-list
56648040|NCT00618176|Stavudine|stavudine|mesh-list
56648041|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56648042|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56648043|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648044|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648046|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56504520|NCT00473382|Ranibizumab|ranibizumab|mesh-list
56608447|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
56608448|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56608449|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
55921338|NCT03156829|Hormones|hormones|mesh-ancestor
56608471|NCT00752947|Metronidazole|metronidazole|mesh-list
56608472|NCT00752947|Levofloxacin|levofloxacin|mesh-list
56608473|NCT00752947|Ofloxacin|ofloxacin|mesh-list
56608474|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56608475|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648047|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56648048|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56648049|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
56648050|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56648051|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56648052|NCT04211558|Ozanimod|ozanimod|mesh-list
56648053|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56648054|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648055|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56648056|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
56648057|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648058|NCT05048498|Azacitidine|azacitidine|mesh-list
56648059|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56648060|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
56648061|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648062|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648063|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648064|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56648065|NCT00901901|Sorafenib|sorafenib|mesh-list
56648066|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648067|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56648068|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648069|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648070|NCT00618254|Granisetron|granisetron|mesh-list
56648071|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
56648072|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
56648073|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648074|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648075|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56648076|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56608476|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56608477|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56608478|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608479|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608480|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608481|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56608482|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56608483|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56608484|NCT00752947|Renal Agents|renal agents|mesh-ancestor
56608485|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56608486|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56608487|NCT04614545|Phentermine|phentermine|mesh-list
56608488|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56648077|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
56648078|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648079|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648080|NCT04184466|Insulin|insulin|mesh-list
56648081|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56648082|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
56648083|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
56648084|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56648085|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56648086|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648087|NCT03620201|Atezolizumab|atezolizumab|mesh-list
56608489|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608490|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
56608491|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56608492|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
56608493|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
56608494|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608495|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
56608496|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608497|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608498|NCT01031381|Bevacizumab|bevacizumab|mesh-list
56608499|NCT01031381|Everolimus|everolimus|mesh-list
56608500|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608501|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608502|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55921372|NCT05119452|Adalimumab|adalimumab|mesh-list
56608522|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
56608523|NCT00753103|Prednisolone|prednisolone|mesh-list
56608524|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
56608525|NCT00753103|Azathioprine|azathioprine|mesh-list
56608526|NCT00753103|Infliximab|infliximab|mesh-list
56608527|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608528|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
56608529|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608530|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608531|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56608532|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
56608533|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608534|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608535|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56608536|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56608537|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56608538|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
56608539|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56608540|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608541|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608542|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608543|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
56608544|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
56608545|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608546|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608547|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
56608548|NCT00753103|Hormones|hormones|mesh-ancestor
56608549|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608550|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56608551|NCT00753103|Protective Agents|protective agents|mesh-ancestor
56608552|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56608553|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
56608554|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
56608555|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56608556|NCT00748891|Cediranib|cediranib|mesh-list
56608557|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608558|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56608584|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608585|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
56648088|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648089|NCT04201769|Dexamethasone|dexamethasone|mesh-list
56648090|NCT04201769|Palonosetron|palonosetron|mesh-list
56648091|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56648092|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
56648093|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
56648094|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648095|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648096|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608586|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56608587|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56608588|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608589|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608590|NCT00753571|Protective Agents|protective agents|mesh-ancestor
56608591|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608592|NCT00753727|Sunitinib|sunitinib|mesh-list
56608593|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608594|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56608595|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56608596|NCT00753727|Growth Substances|growth substances|mesh-ancestor
56608597|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608598|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
56608599|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56608600|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608601|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608602|NCT00755989|Morphine|morphine|mesh-list
56608603|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56608604|NCT00755989|Narcotics|narcotics|mesh-ancestor
56608605|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608606|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608607|NCT00755989|Analgesics|analgesics|mesh-ancestor
56608608|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
56608609|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921480|NCT05632627|Anticonvulsants|anticonvulsants|mesh-ancestor
56608643|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56608645|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
56608646|NCT00720382|Azelastine|azelastine|mesh-list
56608647|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608702|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608704|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
56608705|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56608706|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608708|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
56608709|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56608710|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
55921595|NCT01631292|Vitamins|vitamins|mesh-list
56608730|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608732|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
56608733|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
56608734|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56608735|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56608736|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56608737|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608738|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56608739|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56608740|NCT00756847|Paclitaxel|paclitaxel|mesh-list
56608741|NCT00756847|Carboplatin|carboplatin|mesh-list
56608742|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56608743|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608744|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
56608745|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
56608746|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
56608747|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608749|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56608750|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56608751|NCT04051567|Analgesics|analgesics|mesh-ancestor
56648097|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
56648098|NCT04201769|Hormones|hormones|mesh-ancestor
56648099|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56648100|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56648101|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648102|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56648103|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56648104|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
56648105|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648106|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648107|NCT05336825|Lidocaine|lidocaine|mesh-list
56648108|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
56648109|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
56648110|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648111|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648112|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
56648113|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648114|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56648115|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56648116|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56648117|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55916095|NCT04476966|Mirabegron|mirabegron|mesh-list
56648118|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608752|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
56608753|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608754|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608755|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608756|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608757|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56608758|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56608759|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608760|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56608761|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56608762|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608763|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
56608764|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
55921646|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
56608792|NCT00754351|Docetaxel|docetaxel|mesh-list
56608793|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608794|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608795|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56608796|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56608797|NCT00754351|Growth Substances|growth substances|mesh-ancestor
56608798|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608799|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
56608800|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56608801|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
56608802|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608803|NCT00754351|Antiviral Agents|antiviral agents|mesh-ancestor
56648119|NCT04748783|Listerine|listerine|mesh-list
56648120|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
56648121|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56648122|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56648123|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
56648124|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
56648125|NCT04748783|Protective Agents|protective agents|mesh-ancestor
56648126|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648127|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56608804|NCT00754351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608805|NCT00754351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608806|NCT00754351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608807|NCT00754351|Immunologic Factors|immunologic factors|mesh-ancestor
56608808|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
56608809|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
56608810|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
56608811|NCT00754429|Losartan|losartan|mesh-list
56608812|NCT00754429|Amlodipine|amlodipine|mesh-list
56608813|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56608814|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56608835|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56608836|NCT00725608|Narcotics|narcotics|mesh-ancestor
56608837|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608838|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608839|NCT00725608|Analgesics|analgesics|mesh-ancestor
56608840|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
56608841|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608842|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56608843|NCT00725452|Infliximab|infliximab|mesh-list
56608844|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
56608845|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608846|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608847|NCT00725296|Infliximab|infliximab|mesh-list
56608848|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
56608849|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608850|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608851|NCT00585052|Paclitaxel|paclitaxel|mesh-list
56608852|NCT00585052|Lovastatin|lovastatin|mesh-list
56608853|NCT00585052|L 647318|l 647318|mesh-list
56608854|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
56608855|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56608856|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608857|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
56608858|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
56608859|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
56608860|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608861|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56608862|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56608863|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
56608864|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56608865|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56608892|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56608893|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56608894|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56608895|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
56608896|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608897|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608898|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608899|NCT02590900|Acetaminophen|acetaminophen|mesh-list
56608900|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56608901|NCT02590900|Analgesics|analgesics|mesh-ancestor
56608902|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
56608903|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608904|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608905|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
56608906|NCT02591914|Bevacizumab|bevacizumab|mesh-list
56608907|NCT02591914|Ranibizumab|ranibizumab|mesh-list
56608908|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608909|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608910|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56648128|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648129|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
56504846|NCT00478179|Bupivacaine|bupivacaine|mesh-list
56608911|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56608912|NCT02591914|Growth Substances|growth substances|mesh-ancestor
56608913|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608914|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
56608916|NCT00723190|Analgesics|analgesics|mesh-ancestor
56608970|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56608971|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608973|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
56608974|NCT00741286|Aspirin|aspirin|mesh-list
56608975|NCT00741286|Cilostazol|cilostazol|mesh-list
56608976|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56608977|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56608978|NCT00741286|Analgesics|analgesics|mesh-ancestor
56608979|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
56608980|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608981|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608982|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608983|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608984|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56608985|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56608986|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608987|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56608988|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56608989|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608990|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
55921865|NCT01674283|Glucagon|glucagon|mesh-list
56609013|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56609014|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609015|NCT00716092|Incretins|incretins|mesh-ancestor
56609016|NCT00716092|Hormones|hormones|mesh-ancestor
56609017|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609018|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56609019|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
56609020|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609021|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609022|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
56609023|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609024|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609025|NCT02590510|Methotrexate|methotrexate|mesh-list
56609026|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56609027|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
56609028|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56609029|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609030|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56609031|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
56609032|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609033|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609034|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
56609035|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609036|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56609037|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609038|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
56609039|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56609040|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56609041|NCT00919204|Axitinib|axitinib|mesh-list
55921911|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
56609068|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
56609069|NCT00919282|Hematinics|hematinics|mesh-ancestor
56609070|NCT00679783|Olaparib|olaparib|mesh-list
56609071|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56609072|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609073|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609074|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609075|NCT05414305|Lidocaine|lidocaine|mesh-list
56609076|NCT05414305|Heparin|heparin|mesh-list
56609077|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
56609078|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
56609079|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609080|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609081|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
56648130|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
56648131|NCT02777580|Tenecteplase|tenecteplase|mesh-list
56648132|NCT02777580|Clopidogrel|clopidogrel|mesh-list
56648133|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56504908|NCT01132807|Procarbazine|procarbazine|mesh-list
56609082|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609083|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56609084|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56609085|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56609086|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56609087|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609088|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
56609089|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56609090|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56609091|NCT00757549|Cetuximab|cetuximab|mesh-list
56609092|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56609104|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
56609105|NCT00754819|Colchicine|colchicine|mesh-list
56609106|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
56609107|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56609108|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
56609109|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
56609110|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
56609111|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609112|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609113|NCT05684692|Siltuximab|siltuximab|mesh-list
56609114|NCT05684692|Erenumab|erenumab|mesh-list
56609115|NCT05684692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56609116|NCT05684692|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56609117|NCT05684692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609118|NCT05684692|Analgesics|analgesics|mesh-ancestor
56609119|NCT05684692|Sensory System Agents|sensory system agents|mesh-ancestor
56609120|NCT05684692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609121|NCT05684692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609122|NCT05684692|Immunologic Factors|immunologic factors|mesh-ancestor
56609123|NCT05684692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609124|NCT02589652|Interferons|interferons|mesh-list
56609125|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
56609126|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
56609127|NCT02589652|Entecavir|entecavir|mesh-list
56609128|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56609129|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609130|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
56609131|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609132|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
56609133|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609134|NCT05226598|Paclitaxel|paclitaxel|mesh-list
56609135|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56609136|NCT05226598|Carboplatin|carboplatin|mesh-list
56609137|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
56609138|NCT05226598|Pemetrexed|pemetrexed|mesh-list
56609139|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56609140|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609141|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
56609142|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
56609143|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
56609144|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609145|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609146|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609147|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56609148|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56609149|NCT00679627|Galantamine|galantamine|mesh-list
56609150|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56609151|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609152|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609153|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
56609154|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922015|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609206|NCT04084912|Hormones|hormones|mesh-ancestor
56609207|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609208|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55887677|NCT05747326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56648134|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56648135|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56648136|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56609209|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609210|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
56609211|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609212|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609213|NCT00755053|Clotrimazole|clotrimazole|mesh-list
56609214|NCT00755053|Miconazole|miconazole|mesh-list
56609215|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56609216|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609217|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
56609218|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56609219|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56609220|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609221|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609222|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56609223|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
56609224|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609225|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609226|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56609227|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56609228|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
56609229|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56609230|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56609231|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609232|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
56609233|NCT00755209|Coagulants|coagulants|mesh-ancestor
56609234|NCT02589340|Buspirone|buspirone|mesh-list
56609235|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56609236|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56609237|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609259|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56609260|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609261|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
56609262|NCT05340205|Coagulants|coagulants|mesh-ancestor
56609263|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56609264|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
56609265|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56609266|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56609268|NCT00713830|Lixisenatide|lixisenatide|mesh-list
56609269|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56609270|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609271|NCT05291221|Lidocaine|lidocaine|mesh-list
56609272|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
56609273|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
56609274|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
56609275|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609276|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609277|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
56609278|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609279|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56609280|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56609281|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56609282|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56609283|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609284|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56609285|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56609286|NCT05291221|Analgesics|analgesics|mesh-ancestor
56609287|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56609288|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56609289|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56609290|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
56609291|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609292|NCT05289193|Nivolumab|nivolumab|mesh-list
56609293|NCT05289193|Ipilimumab|ipilimumab|mesh-list
56609307|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56609308|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56609309|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887678|NCT05747326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56648137|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
56648138|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648139|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505065|NCT01087905|Nicotine|nicotine|mesh-list
56609310|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357810|NCT00268177|Xhance|xhance|mesh-list
56609311|NCT00681187|Lanreotide|lanreotide|mesh-list
56609312|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609313|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56609314|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
56609315|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56609316|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56609317|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56609318|NCT00680407|Silymarin|silymarin|mesh-list
56609319|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
56609320|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609321|NCT00680407|Protective Agents|protective agents|mesh-ancestor
56609322|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609323|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56609324|NCT04007809|Glucagon|glucagon|mesh-list
56609325|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56609326|NCT04007809|Hormones|hormones|mesh-ancestor
56609327|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609328|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609329|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
56609330|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609331|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609332|NCT05170009|Oseltamivir|oseltamivir|mesh-list
56609333|NCT05170009|Baloxavir|baloxavir|mesh-list
56609334|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
56609335|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609336|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609337|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609338|NCT04083664|Hepcidins|hepcidins|mesh-list
56609339|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609340|NCT05202730|Anesthetics|anesthetics|mesh-list
56609341|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
56609342|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609343|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609344|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
56609345|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609346|NCT00677365|Levofloxacin|levofloxacin|mesh-list
56609347|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56609348|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609349|NCT00677365|Renal Agents|renal agents|mesh-ancestor
56609350|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56609351|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56609352|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56609353|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609381|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609383|NCT05190094|Palbociclib|palbociclib|mesh-list
56609384|NCT05190094|Anastrozole|anastrozole|mesh-list
56609385|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56609386|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357884|NCT00102414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609387|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56609388|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609389|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609390|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56609391|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
56609392|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609393|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609394|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56609395|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56609396|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56609397|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
56609398|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55922282|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56609425|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56609426|NCT05007106|Gemcitabine|gemcitabine|mesh-list
56609427|NCT05007106|Docetaxel|docetaxel|mesh-list
56609428|NCT05007106|Bevacizumab|bevacizumab|mesh-list
56648140|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648141|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56648142|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56648143|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
56648144|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56648145|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648146|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648147|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56648148|NCT04628663|Analgesics|analgesics|mesh-ancestor
56648149|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
56648150|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648151|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56648152|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56648153|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56648154|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
56648155|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648156|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648157|NCT05663268|Infliximab|infliximab|mesh-list
56648158|NCT05663268|Dermatologic Agents|dermatologic agents|mesh-ancestor
56648159|NCT05663268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56648160|NCT05663268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56648161|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
56609429|NCT05007106|Carboplatin|carboplatin|mesh-list
56609430|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
56609431|NCT05007106|Fluorouracil|fluorouracil|mesh-list
56609432|NCT05007106|Capecitabine|capecitabine|mesh-list
56609433|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
56609434|NCT05007106|Lenvatinib|lenvatinib|mesh-list
56609435|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609436|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
56609437|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
56609438|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
56609439|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609440|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609441|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56609442|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56609443|NCT05007106|Growth Substances|growth substances|mesh-ancestor
56609444|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609445|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
56609446|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56609471|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609473|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609474|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609475|NCT04997980|Amiodarone|amiodarone|mesh-list
56609476|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56609477|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
56609478|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56609479|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56609480|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609481|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56609482|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56609483|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56648162|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56648163|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56648164|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
56648165|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648166|NCT00642096|Metoprolol|metoprolol|mesh-list
56648167|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56648168|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56648169|NCT00642096|Diuretics|diuretics|mesh-ancestor
56648170|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
56648171|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648172|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56648173|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56648174|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648175|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56648176|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
56648177|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
56648178|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609484|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609485|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56609486|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56609487|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56609488|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56609489|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
56609490|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609491|NCT04989946|Nivolumab|nivolumab|mesh-list
56609492|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609493|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609494|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55922390|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609517|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609518|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56609519|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56609520|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609521|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
56609522|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609523|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56609524|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609525|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609526|NCT02588716|Terlipressin|terlipressin|mesh-list
56609527|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56609528|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56609529|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56609530|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56609531|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56609532|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
56609533|NCT00761449|Lenalidomide|lenalidomide|mesh-list
56609534|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
56609535|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609536|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56609537|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56609538|NCT00761449|Growth Substances|growth substances|mesh-ancestor
56609539|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
56609540|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609541|NCT04968106|Doxorubicin|doxorubicin|mesh-list
56609542|NCT04968106|Ifosfamide|ifosfamide|mesh-list
56609543|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56609544|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648179|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56648180|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56648181|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56648182|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
56609545|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56609546|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56609547|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922440|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56609577|NCT04809766|Fludarabine|fludarabine|mesh-list
56609578|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609579|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
56609580|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609581|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56609582|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56609583|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
56609584|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609585|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609586|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56609587|NCT04809220|Dulaglutide|dulaglutide|mesh-list
56609589|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56609590|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
56609591|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56609592|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609593|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609594|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609595|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56609596|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609616|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609617|NCT00676195|Expectorants|expectorants|mesh-ancestor
56609618|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
56609619|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56609620|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
56609621|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609622|NCT00676195|Protective Agents|protective agents|mesh-ancestor
56609623|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609624|NCT00676195|Antidotes|antidotes|mesh-ancestor
56609625|NCT02558959|Capecitabine|capecitabine|mesh-list
56609626|NCT02558959|Irinotecan|irinotecan|mesh-list
56609627|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56609628|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
56609629|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609630|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609631|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56609632|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56609633|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609635|NCT04049539|Daunorubicin|daunorubicin|mesh-list
56609636|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56609637|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
56609638|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609639|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609640|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
56609641|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609642|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609643|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
56609644|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609645|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56609646|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56609647|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56609648|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609649|NCT05681650|Paclitaxel|paclitaxel|mesh-list
56609650|NCT05681650|Cyclophosphamide|cyclophosphamide|mesh-list
56609651|NCT05681650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56609652|NCT05681650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55922554|NCT00246129|Daclizumab|daclizumab|mesh-list
56609676|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56609677|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56609678|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609679|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609680|NCT04082962|Dexamethasone|dexamethasone|mesh-list
56609681|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56648183|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648184|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56648185|NCT02679456|Fluconazole|fluconazole|mesh-list
56648186|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
56505309|NCT04568265|Entecavir|entecavir|mesh-list
56609682|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
56609683|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
56609684|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609685|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609686|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56609687|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
56609689|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609690|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56609691|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609692|NCT02471833|Telmisartan|telmisartan|mesh-list
56609693|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56609694|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56609695|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56609696|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609697|NCT04895410|Dexamethasone|dexamethasone|mesh-list
56609698|NCT04895410|Daratumumab|daratumumab|mesh-list
56609699|NCT04895410|Pomalidomide|pomalidomide|mesh-list
56609700|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56609701|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
56609702|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
56609703|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609735|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56609736|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
56609737|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56609738|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609739|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
56609740|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
56609741|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
56609742|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609743|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56609744|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56609745|NCT02312245|Growth Substances|growth substances|mesh-ancestor
56609746|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609747|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
56609748|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
56609778|NCT04767061|Pindolol|pindolol|mesh-list
56609779|NCT04767061|Betaxolol|betaxolol|mesh-list
56609780|NCT04767061|Penbutolol|penbutolol|mesh-list
56609781|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56609782|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56609783|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
56609784|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609785|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609786|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609787|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56609788|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56609789|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
56609790|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
56609791|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
56609792|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609793|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56609794|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
56609795|NCT04767061|Protective Agents|protective agents|mesh-ancestor
56609796|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56609797|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55922697|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609823|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609824|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56609825|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56609826|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56609827|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609828|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56609829|NCT00759421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56609830|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56609831|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887679|NCT05747326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56648187|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
56505377|NCT00590408|Ubiquinone|ubiquinone|mesh-list
56609832|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609833|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609834|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
56609835|NCT04869358|Ofatumumab|ofatumumab|mesh-list
56609836|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609837|NCT00762775|Vitamin D|vitamin d|mesh-list
56358337|NCT00074399|Nevirapine|nevirapine|mesh-list
56609838|NCT00762775|Calcium|calcium|mesh-list
56609839|NCT00762775|Vitamins|vitamins|mesh-ancestor
56609840|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
56609841|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609842|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56609843|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56609844|NCT00763165|Triclosan|triclosan|mesh-list
56609845|NCT00763165|Fluorides|fluorides|mesh-list
56609868|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609869|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56609870|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
56609871|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56609872|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56609873|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
56609874|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609875|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
56609876|NCT00760045|Protective Agents|protective agents|mesh-ancestor
56609877|NCT05576350|Ethanol|ethanol|mesh-list
56609878|NCT05576350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56609879|NCT05576350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609880|NCT05576350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609881|NCT05576350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609882|NCT00678379|Lidocaine|lidocaine|mesh-list
56609883|NCT00678379|Clonidine|clonidine|mesh-list
56609884|NCT00678379|Bupivacaine|bupivacaine|mesh-list
56609885|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
56609886|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
56609887|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609888|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609889|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
56609890|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609891|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56609892|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56609893|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56609894|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56609895|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609934|NCT04115956|Dexamethasone|dexamethasone|mesh-list
56609935|NCT04115956|Melphalan|melphalan|mesh-list
56609956|NCT00678301|Vaccines|vaccines|mesh-list
56609957|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
56609958|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609959|NCT02586454|Morphine|morphine|mesh-list
56609960|NCT02586454|Ropivacaine|ropivacaine|mesh-list
56609961|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56609962|NCT02586454|Narcotics|narcotics|mesh-ancestor
56609963|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609964|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609965|NCT02586454|Analgesics|analgesics|mesh-ancestor
56609966|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
56609967|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609968|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
56609969|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
56609970|NCT00939770|Crizotinib|crizotinib|mesh-list
56609971|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609972|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56609973|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609974|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609975|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
56609976|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
56609977|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
56609978|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609979|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609980|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
56609981|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609982|NCT00939692|Topiramate|topiramate|mesh-list
56609983|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
56609984|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56609985|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648188|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648189|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56609986|NCT00920608|Methotrexate|methotrexate|mesh-list
56609987|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56609988|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
56609989|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56043676|NCT02768727|Xenon|xenon|mesh-list
56610017|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56610018|NCT04674514|Growth Substances|growth substances|mesh-ancestor
56610019|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
56610020|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56610021|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
56610023|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56610024|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56610025|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56610026|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
56610027|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56610028|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610029|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56610030|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56610031|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56610032|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56610033|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610034|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
56610035|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56610056|NCT00942968|Tinzaparin|tinzaparin|mesh-list
56610057|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56610058|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
56610059|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56610060|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56610061|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610062|NCT00942734|Everolimus|everolimus|mesh-list
56610063|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56610064|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610065|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358564|NCT00272116|Protective Agents|protective agents|mesh-ancestor
56610066|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
56610067|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610068|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56610069|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610070|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610072|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56610073|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56610074|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56610075|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56610076|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610077|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
56610078|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610079|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610080|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56610081|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610082|NCT00919984|Paclitaxel|paclitaxel|mesh-list
56610083|NCT00919984|Carboplatin|carboplatin|mesh-list
56610084|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56610085|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610086|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
56610087|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
56610088|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922986|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56610108|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
56610109|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610110|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56610111|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610112|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
56610113|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56610114|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56610116|NCT00603824|Lepirudin|lepirudin|mesh-list
56610117|NCT00603824|Fondaparinux|fondaparinux|mesh-list
56610118|NCT00603824|Argatroban|argatroban|mesh-list
56610119|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56610120|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
56610121|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56610122|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
56610123|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648190|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56294206|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
56610124|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610125|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
56610126|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56610127|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56610128|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56610129|NCT00677833|Azithromycin|azithromycin|mesh-list
56610130|NCT00677833|Chloroquine|chloroquine|mesh-list
56610131|NCT00677833|Lumefantrine|lumefantrine|mesh-list
56610132|NCT00677833|Artemether|artemether|mesh-list
56610133|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56610134|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56610135|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610136|NCT00677833|Amebicides|amebicides|mesh-ancestor
56610137|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56610138|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56610139|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
56610140|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56610141|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
56610142|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56610143|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56610166|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
56610167|NCT00942266|Vitamins|vitamins|mesh-ancestor
56610168|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
56610169|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56610170|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610171|NCT05382182|Androgens|androgens|mesh-list
56610172|NCT05382182|Hormones|hormones|mesh-ancestor
56610173|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610174|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610175|NCT04727242|Gemcitabine|gemcitabine|mesh-list
56610176|NCT04727242|Dacarbazine|dacarbazine|mesh-list
56610177|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56610178|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
56610179|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610180|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610181|NCT04727242|Antiviral Agents|antiviral agents|mesh-ancestor
56610182|NCT04727242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610183|NCT04727242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610184|NCT04727242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610185|NCT04727242|Immunologic Factors|immunologic factors|mesh-ancestor
56610186|NCT04727242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610187|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56610188|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
56610189|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
56610190|NCT04505878|Vitamins|vitamins|mesh-ancestor
56610191|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
56610192|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610193|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
56610194|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610195|NCT04505878|Protective Agents|protective agents|mesh-ancestor
56610196|NCT04079374|Etanercept|etanercept|mesh-list
56610197|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56610198|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56610199|NCT04079374|Analgesics|analgesics|mesh-ancestor
55923102|NCT05347381|Dexamethasone|dexamethasone|mesh-list
56610229|NCT02586610|Capecitabine|capecitabine|mesh-list
56610230|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56610231|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610232|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56610233|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
56610234|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610235|NCT00604682|Apremilast|apremilast|mesh-list
56610236|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56610237|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56610238|NCT00604682|Analgesics|analgesics|mesh-ancestor
56610239|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
56610240|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610241|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610242|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610243|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56610244|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56610245|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56648191|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648192|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648193|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56648194|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
56648195|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56648196|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648197|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56610246|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923150|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56610270|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56610271|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56610272|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
56610273|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610274|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56610275|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56610276|NCT04080388|Diuretics|diuretics|mesh-list
56610277|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
56610278|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610279|NCT04080622|Selenium|selenium|mesh-list
56610280|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
56610281|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610282|NCT04080622|Protective Agents|protective agents|mesh-ancestor
56610283|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610284|NCT04080622|Trace Elements|trace elements|mesh-ancestor
56610285|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
56610286|NCT04079140|Dinoprostone|dinoprostone|mesh-list
56610288|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56610289|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610290|NCT04707196|Fulvestrant|fulvestrant|mesh-list
56610291|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56610292|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56610293|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610294|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56610295|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56610296|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
56610320|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610321|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56610322|NCT00764413|Protective Agents|protective agents|mesh-ancestor
56610323|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56610324|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610326|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610327|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
56610328|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56610329|NCT00583102|Cytarabine|cytarabine|mesh-list
56610330|NCT00583102|Lovastatin|lovastatin|mesh-list
56610331|NCT00583102|L 647318|l 647318|mesh-list
56610332|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
56610333|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56610334|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
56610335|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610336|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610337|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
56610338|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610339|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610340|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
56610341|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610342|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56610343|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56610344|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56610345|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56610346|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923250|NCT03807297|Propofol|propofol|mesh-list
56610370|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56610371|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56610372|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
56610373|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648198|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56648199|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
56648200|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
56648201|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56648202|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56648203|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648204|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648205|NCT00640458|Urological Agents|urological agents|mesh-ancestor
56648206|NCT00909948|Fludarabine|fludarabine|mesh-list
56610374|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610375|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610376|NCT04204304|Isotretinoin|isotretinoin|mesh-list
56610377|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
56610378|NCT05380778|Anesthetics|anesthetics|mesh-list
56610379|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610380|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610381|NCT02852720|Anesthetics|anesthetics|mesh-list
56610382|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
56610383|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610384|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610385|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
56610386|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
56610387|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610388|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
56610389|NCT00941720|Busulfan|busulfan|mesh-list
56610390|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610391|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
56610392|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610393|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56610394|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56610395|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
56610396|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610397|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923307|NCT03809637|Pemetrexed|pemetrexed|mesh-list
56610427|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56610428|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56610429|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56610430|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
56610431|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
56610432|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
56610433|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
56610434|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610435|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610437|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56610438|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56610439|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56610440|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
56358954|NCT00277225|Abatacept|abatacept|mesh-list
56610441|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610443|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610480|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56610481|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56610482|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56610535|NCT02584738|Analgesics|analgesics|mesh-ancestor
56610536|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
56610537|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
56610538|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610539|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56610540|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56610541|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56610542|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610543|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56610544|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
56610545|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56610546|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56648207|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648208|NCT04650269|Emtricitabine|emtricitabine|mesh-list
56648209|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
56505723|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
56610547|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56610548|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
56610549|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56610550|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56610551|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56610552|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
56610553|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610554|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56610555|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
56610556|NCT00765271|Ritonavir|ritonavir|mesh-list
56610557|NCT00765271|Darunavir|darunavir|mesh-list
56610558|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
56610559|NCT00765271|Abacavir|abacavir|mesh-list
56610560|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56610561|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56610562|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
56610563|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610564|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610565|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56610566|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56610567|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
56610568|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610569|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56610599|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610600|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610601|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610602|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56610603|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
56610604|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610605|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
56610606|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56610607|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610608|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610609|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
56610610|NCT00764725|Methotrexate|methotrexate|mesh-list
56610611|NCT00764725|Infliximab|infliximab|mesh-list
56610612|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56610613|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
56610614|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55923516|NCT04762147|Fentanyl|fentanyl|mesh-list
56610645|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610646|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610648|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
56610649|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
56610650|NCT04077892|Hormones|hormones|mesh-ancestor
56610651|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610652|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56610653|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
56610654|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56610655|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56610656|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610683|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610684|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
56610685|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56610686|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610687|NCT05400148|Bupivacaine|bupivacaine|mesh-list
56610688|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
56610689|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
56610690|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610691|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610692|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
56610693|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610694|NCT00765427|Retinol acetate|retinol acetate|mesh-list
56610695|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56610696|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
56610697|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610698|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56610699|NCT00765427|Protective Agents|protective agents|mesh-ancestor
56648210|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648211|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56648212|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56648213|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648214|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648215|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56648216|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56648217|NCT02681562|Olaparib|olaparib|mesh-list
56505794|NCT03453164|Nivolumab|nivolumab|mesh-list
56610700|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610701|NCT02584582|Liraglutide|liraglutide|mesh-list
56610702|NCT02584582|Exenatide|exenatide|mesh-list
56610703|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56610704|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610722|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56610723|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56610724|NCT05293964|Palbociclib|palbociclib|mesh-list
56610725|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610726|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56610727|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610728|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610729|NCT00770497|Pioglitazone|pioglitazone|mesh-list
56610730|NCT00770497|Ramipril|ramipril|mesh-list
56610731|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56610732|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610733|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56610734|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
56610735|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610736|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610737|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56610738|NCT02581696|Irsogladine|irsogladine|mesh-list
56610739|NCT02581696|Lafutidine|lafutidine|mesh-list
56610740|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610741|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56610742|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56610743|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56610744|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
56610745|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
56610746|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610747|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610748|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610749|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56610750|NCT02581696|Protective Agents|protective agents|mesh-ancestor
56610751|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56610752|NCT00607958|Ritonavir|ritonavir|mesh-list
56610753|NCT00607958|Tipranavir|tipranavir|mesh-list
56610754|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56610755|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56610756|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
56610757|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610758|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610759|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56610760|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56610761|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
56610762|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923655|NCT04572828|Naproxen|naproxen|mesh-list
56610783|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610784|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56610785|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610786|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56610787|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
56610788|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610789|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
56610790|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610791|NCT00775255|Clarithromycin|clarithromycin|mesh-list
56610792|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56610793|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648218|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56648219|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648220|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648221|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648222|NCT00633035|Esomeprazole|esomeprazole|mesh-list
56610794|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56610795|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610796|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610797|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56610798|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56610800|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610801|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56610802|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610803|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610804|NCT00766285|Vaccines|vaccines|mesh-list
56610805|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
56610806|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610807|NCT04265456|Acetaminophen|acetaminophen|mesh-list
56610808|NCT04265456|Pregabalin|pregabalin|mesh-list
56610809|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56610810|NCT04265456|Analgesics|analgesics|mesh-ancestor
56610811|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
56610812|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610813|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610814|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
56610815|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
56610816|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56610817|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56610843|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
56610844|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
56610845|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
56610846|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
56610847|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610848|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610849|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56610850|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56610851|NCT04378426|Analgesics|analgesics|mesh-ancestor
56610852|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
56610853|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610854|NCT02581462|Trastuzumab|trastuzumab|mesh-list
56610855|NCT02581462|Pertuzumab|pertuzumab|mesh-list
56610856|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56610857|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610858|NCT00668863|Leucovorin|leucovorin|mesh-list
56610859|NCT00668863|Fluorouracil|fluorouracil|mesh-list
56610860|NCT00668863|Irinotecan|irinotecan|mesh-list
56610861|NCT00668863|Sunitinib|sunitinib|mesh-list
56610862|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
56610863|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
56610864|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610865|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56610866|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610867|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610868|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
55923772|NCT03451591|Isosorbide|isosorbide|mesh-list
56610894|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610895|NCT05379530|Anesthetics|anesthetics|mesh-list
56610896|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610897|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610898|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56610899|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56610900|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610901|NCT00766441|Incretins|incretins|mesh-ancestor
56610902|NCT00766441|Hormones|hormones|mesh-ancestor
56610903|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610904|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56610905|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
56610906|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610907|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610908|NCT05265806|Oxytocin|oxytocin|mesh-list
56648223|NCT00633035|Famotidine|famotidine|mesh-list
56648224|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56648225|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56648226|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56648227|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648228|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505945|NCT02486367|Clopidogrel|clopidogrel|mesh-list
56610909|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
56610910|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56610911|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610912|NCT00771043|Natalizumab|natalizumab|mesh-list
56610913|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
56610914|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610915|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
56610916|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56610917|NCT04267250|Estradiol|estradiol|mesh-list
56610918|NCT04267250|PF-06700841|pf-06700841|mesh-list
56610919|NCT04267250|Estrogens|estrogens|mesh-ancestor
56610920|NCT04267250|Hormones|hormones|mesh-ancestor
56622937|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610972|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56610973|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610974|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610975|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
56610976|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
56610977|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56610978|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
56610979|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
56610980|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56610981|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610982|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610983|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56610985|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
56610986|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610987|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56610988|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56610989|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56610990|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
56610991|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610992|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610993|NCT00605774|Epinephrine|epinephrine|mesh-list
56610994|NCT00605774|Racepinephrine|racepinephrine|mesh-list
56610995|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
56610996|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56610997|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56610998|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
56610999|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611000|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611001|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611002|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56611003|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56611004|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
56611005|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611006|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56611007|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
56611008|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
56611009|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
56611010|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56611011|NCT04264286|Esmolol|esmolol|mesh-list
56611012|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56611070|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56611071|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
56611072|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611073|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611074|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56611075|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56611076|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
56611077|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
56611078|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648229|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56648230|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
56648231|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
56611079|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611080|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
56611081|NCT04240054|Hormones|hormones|mesh-ancestor
56611082|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56611083|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56611084|NCT03830866|Carboplatin|carboplatin|mesh-list
56611085|NCT03830866|Durvalumab|durvalumab|mesh-list
56611086|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611087|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611089|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
56611090|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611091|NCT00668707|Protective Agents|protective agents|mesh-ancestor
56611092|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611093|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611094|NCT00766909|Cyclosporine|cyclosporine|mesh-list
56611095|NCT00766909|Tacrolimus|tacrolimus|mesh-list
56611096|NCT00766909|Cyclosporins|cyclosporins|mesh-list
56611097|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611098|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
56611099|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611100|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56611101|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611102|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611124|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
56611125|NCT04047628|Ofatumumab|ofatumumab|mesh-list
56611126|NCT04047628|Cladribine|cladribine|mesh-list
56611127|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
56611128|NCT04047628|Natalizumab|natalizumab|mesh-list
56611129|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611130|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611131|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
56611132|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611133|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611134|NCT00668317|Omeprazole|omeprazole|mesh-list
56611135|NCT00668317|Ranitidine|ranitidine|mesh-list
56611136|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56611137|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56611138|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611139|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56611140|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611141|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611142|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56611143|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
56611144|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
56611145|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611146|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611147|NCT00775879|Sevoflurane|sevoflurane|mesh-list
56611148|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56611149|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56611150|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
56611151|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
56611152|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611153|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611154|NCT00767221|Budesonide|budesonide|mesh-list
55924045|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
56611271|NCT03742414|Xhance|xhance|mesh-list
56611272|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56611273|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56611274|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
56611275|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611276|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611277|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56611278|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
56611279|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
56611280|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56611281|NCT03742102|Paclitaxel|paclitaxel|mesh-list
56611282|NCT03742102|Trastuzumab|trastuzumab|mesh-list
56611283|NCT03742102|Durvalumab|durvalumab|mesh-list
56611284|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56611285|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611286|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
56611287|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
56648232|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648233|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648234|NCT02511132|Gemcitabine|gemcitabine|mesh-list
56648235|NCT02511132|Docetaxel|docetaxel|mesh-list
56648236|NCT02511132|Irinotecan|irinotecan|mesh-list
56611288|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
56611314|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611315|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611316|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611318|NCT00767689|Pyridoxal|pyridoxal|mesh-list
56611319|NCT00767689|Pyridoxine|pyridoxine|mesh-list
56611320|NCT00767689|Vitamins|vitamins|mesh-ancestor
56611321|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
56611322|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611323|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
56611324|NCT00772057|Propranolol|propranolol|mesh-list
56611325|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56611326|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56611327|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
56611328|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611329|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611330|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611331|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56611332|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56611333|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
56611334|NCT00776347|Donepezil|donepezil|mesh-list
56611335|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56611336|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611397|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611399|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56611400|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56611401|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611402|NCT00772135|Urological Agents|urological agents|mesh-ancestor
56611403|NCT00776503|Vorinostat|vorinostat|mesh-list
56611404|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611429|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
56611430|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611431|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611432|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611433|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
56611434|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56611435|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56611436|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
56611437|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
56611438|NCT00669955|Amoxicillin|amoxicillin|mesh-list
56611439|NCT00669955|Metronidazole|metronidazole|mesh-list
56611440|NCT00669955|Clarithromycin|clarithromycin|mesh-list
56611441|NCT00669955|Tetracycline|tetracycline|mesh-list
56611442|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56611443|NCT00669955|Omeprazole|omeprazole|mesh-list
56611444|NCT00669955|Bismuth|bismuth|mesh-list
56611445|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56611446|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611447|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56611448|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56611449|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56611450|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611451|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56611452|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611453|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611454|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55924332|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
56611483|NCT05673928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611484|NCT05673928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56611485|NCT05673928|Tubulin Modulators|tubulin modulators|mesh-ancestor
56611486|NCT05673928|Antimitotic Agents|antimitotic agents|mesh-ancestor
56611487|NCT05673928|Mitosis Modulators|mitosis modulators|mesh-ancestor
56611488|NCT05673928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611489|NCT05673928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56611490|NCT05673928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359985|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
56611492|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56611493|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56648237|NCT02511132|Temozolomide|temozolomide|mesh-list
56648238|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56648239|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
56648240|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648241|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648242|NCT02511132|Antiviral Agents|antiviral agents|mesh-ancestor
56648243|NCT02511132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648244|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648245|NCT02511132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56648246|NCT02511132|Immunologic Factors|immunologic factors|mesh-ancestor
56648247|NCT02511132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648248|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
56506140|NCT02211222|Lenvatinib|lenvatinib|mesh-list
56611494|NCT03595150|Analgesics|analgesics|mesh-ancestor
56611495|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
56611496|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611497|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611498|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56611568|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611570|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611571|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56611572|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
56611573|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
56611574|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611606|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56611607|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56611608|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
56611609|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611610|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611611|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611612|NCT03866668|Esomeprazole|esomeprazole|mesh-list
56611613|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56611614|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611615|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56611616|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611646|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
56611647|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
56611648|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611649|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611650|NCT00768937|Sorafenib|sorafenib|mesh-list
56611651|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611652|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56611653|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611654|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611655|NCT04047745|Bupivacaine|bupivacaine|mesh-list
56611656|NCT04047745|Ropivacaine|ropivacaine|mesh-list
56611657|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
56611658|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
56611659|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611660|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924542|NCT00081289|Capecitabine|capecitabine|mesh-list
56611693|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611694|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56611695|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56611696|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611697|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611698|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611699|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56611700|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
56611701|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56611736|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56611737|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56648249|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
56648250|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
56648251|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56648252|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56648253|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56648254|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
56648255|NCT02678520|Goserelin|goserelin|mesh-list
56648256|NCT02678520|Bicalutamide|bicalutamide|mesh-list
56648257|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56648258|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648259|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56648260|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648261|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
56611738|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611739|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56611740|NCT02829502|Incretins|incretins|mesh-ancestor
56611741|NCT02829502|Hormones|hormones|mesh-ancestor
56611742|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56611743|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611744|NCT02635191|Amoxicillin|amoxicillin|mesh-list
56611745|NCT02635191|Metronidazole|metronidazole|mesh-list
56611746|NCT02635191|Clarithromycin|clarithromycin|mesh-list
56611783|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56611784|NCT00777673|Growth Substances|growth substances|mesh-ancestor
56611785|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56611817|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
56611818|NCT02579590|Desogestrel|desogestrel|mesh-list
56611819|NCT02579590|Etonogestrel|etonogestrel|mesh-list
56611820|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56611821|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56611822|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56611823|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
56611824|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56611825|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611826|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56611827|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56611828|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56611829|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56611830|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611865|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611866|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
56611867|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611868|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56612008|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
56612009|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612010|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56612011|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
56612012|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56612013|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56612014|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612015|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56612016|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
55924918|NCT05135286|Miotics|miotics|mesh-ancestor
56612047|NCT00669409|Tanezumab|tanezumab|mesh-list
56612048|NCT00669409|Analgesics|analgesics|mesh-ancestor
56612049|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
56612050|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612051|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612052|NCT00778141|Metformin|metformin|mesh-list
56612053|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56612054|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612055|NCT00774475|Clopidogrel|clopidogrel|mesh-list
56648262|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
56648263|NCT00642252|Fluorides|fluorides|mesh-list
56648264|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
56648265|NCT00642252|Protective Agents|protective agents|mesh-ancestor
56648266|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648267|NCT00642330|Ibuprofen|ibuprofen|mesh-list
56648268|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56648269|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56648270|NCT00642330|Analgesics|analgesics|mesh-ancestor
56648271|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
56648272|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648273|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648274|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56648275|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612056|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56612057|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56612058|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56612059|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56612060|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
56612061|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612062|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612063|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612064|NCT00669331|Mannitol|mannitol|mesh-list
56612065|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56612099|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56612100|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56612101|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
56612102|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56612103|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612104|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56612169|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56612170|NCT02556229|Growth Substances|growth substances|mesh-ancestor
56612171|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612172|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
56612173|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612174|NCT00929864|Adalimumab|adalimumab|mesh-list
56612175|NCT00929864|Abatacept|abatacept|mesh-list
56612176|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612177|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612178|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56612179|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612180|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612181|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56612182|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
56612183|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612184|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
56612185|NCT00597753|Hematinics|hematinics|mesh-ancestor
56612186|NCT04262804|Gemcitabine|gemcitabine|mesh-list
56612187|NCT04262804|Capecitabine|capecitabine|mesh-list
56612188|NCT04262804|Trastuzumab|trastuzumab|mesh-list
56612189|NCT04262804|Vinorelbine|vinorelbine|mesh-list
56612190|NCT04262804|Margetuximab|margetuximab|mesh-list
56612191|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56612217|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56612218|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612219|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612220|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56612221|NCT02633709|Itraconazole|itraconazole|mesh-list
56612222|NCT02633709|Risdiplam|risdiplam|mesh-list
56612223|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
56612224|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612225|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56648276|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56648277|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648278|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612226|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56612227|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612228|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612229|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56612230|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
56612231|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56612232|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612233|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56612234|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56612235|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612236|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
56612237|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
56612238|NCT04264988|Protective Agents|protective agents|mesh-ancestor
56612239|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612240|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56612330|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612332|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56612333|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56612334|NCT00790075|Risperidone|risperidone|mesh-list
56612335|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56612336|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
56612337|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612338|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612339|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612340|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56612341|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56612342|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612343|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612344|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56612345|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
56612346|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56612347|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56612348|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612349|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56612350|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
56612387|NCT00790387|Enoxaparin|enoxaparin|mesh-list
56612388|NCT00790387|Calcium heparin|calcium heparin|mesh-list
56612439|NCT00665353|Pioglitazone|pioglitazone|mesh-list
56612440|NCT00665353|Ribavirin|ribavirin|mesh-list
56612441|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
56612442|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612443|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
56612444|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612445|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56612446|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612447|NCT00785395|Oxytocin|oxytocin|mesh-list
56612448|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
56612449|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56612450|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612451|NCT00662571|Acamprosate|acamprosate|mesh-list
56612452|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56612453|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56612454|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612455|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56612456|NCT02555761|Alcaftadine|alcaftadine|mesh-list
56612457|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56612458|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56612459|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
56612460|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
56612461|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612462|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612463|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360961|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
56612464|NCT04155879|Colchicine|colchicine|mesh-list
56612465|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
55925340|NCT04383717|Levamisole|levamisole|mesh-list
56612497|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56648279|NCT02681796|Bupivacaine|bupivacaine|mesh-list
56648280|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
56648281|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
56648282|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56506407|NCT00478205|Donepezil|donepezil|mesh-list
56612498|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
56612499|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
56612500|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612501|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56612502|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56612503|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612504|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612505|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612506|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
56612507|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56612508|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
56612510|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
56612511|NCT00785473|Calcium|calcium|mesh-list
55925378|NCT00809055|Caffeine|caffeine|mesh-list
56612541|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612542|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612543|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56612544|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56612545|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
56612547|NCT00663195|Spironolactone|spironolactone|mesh-list
56612548|NCT00663195|Diuretics|diuretics|mesh-ancestor
56612549|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
56612550|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612551|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56612552|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56612553|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612554|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56612555|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
56612617|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612618|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612620|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56612686|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612687|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612688|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56612689|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
56612690|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
56612691|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56612692|NCT02631135|Analgesics|analgesics|mesh-ancestor
56612693|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
56612694|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612695|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55925555|NCT03361735|Goserelin|goserelin|mesh-list
56333942|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
56333943|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56333944|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56333945|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
56333946|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333947|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56333948|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
56333949|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
56333950|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333951|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333952|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
56333954|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56333955|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56333956|NCT00037115|Protective Agents|protective agents|mesh-ancestor
56333957|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56333958|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
56333959|NCT00037154|Urological Agents|urological agents|mesh-ancestor
56333960|NCT00064389|Albuterol|albuterol|mesh-list
56333961|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56333962|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
56333963|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333964|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333965|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56648283|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648284|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
56506498|NCT00475670|Taxane|taxane|mesh-list
56333966|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
56612754|NCT00879411|Telmisartan|telmisartan|mesh-list
56612755|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56612756|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56612757|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56612758|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612759|NCT00671151|Theophylline|theophylline|mesh-list
56612760|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56612761|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
56612762|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612763|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612764|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56612765|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
56612766|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56612767|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612768|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612769|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
56612770|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56612771|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56612772|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
56612773|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612774|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56612776|NCT00666757|Fluoxetine|fluoxetine|mesh-list
56612777|NCT00666757|Paroxetine|paroxetine|mesh-list
56612778|NCT00666757|Citalopram|citalopram|mesh-list
56612779|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56612780|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56612834|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612836|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612837|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
56612838|NCT00666679|Montelukast|montelukast|mesh-list
56612839|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56612840|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
56612841|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56612842|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
56612843|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56612844|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612845|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56612846|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56612847|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612848|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612849|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
56612850|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56612851|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56612852|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56612853|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56612854|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612855|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612856|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612857|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56612858|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56612859|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
56612860|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612861|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612862|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56612863|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56612865|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56612932|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56612933|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
56612934|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612935|NCT04293809|Bupivacaine|bupivacaine|mesh-list
56612936|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
56612937|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
56612938|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925850|NCT05602597|Rifampin|rifampin|mesh-list
56612971|NCT00998309|Azithromycin|azithromycin|mesh-list
56612972|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56648285|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648286|NCT02842931|Prednisone|prednisone|mesh-list
56648287|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
56612973|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612975|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56612976|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612977|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56612978|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612979|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
56612980|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56612981|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
56613000|NCT00672867|Adefovir|adefovir|mesh-list
56613001|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56613002|NCT00672867|Clevudine|clevudine|mesh-list
56613003|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
56613004|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613005|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56613006|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56613007|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613008|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613009|NCT00997373|Letrozole|letrozole|mesh-list
56613010|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613011|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56613012|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56613013|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613014|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613015|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56613016|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
56613017|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56613018|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613019|NCT04152759|Golimumab|golimumab|mesh-list
56613020|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56613021|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56613022|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613023|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
56613024|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613025|NCT00792025|Sunitinib|sunitinib|mesh-list
56613026|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613027|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56613028|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56613029|NCT00792025|Growth Substances|growth substances|mesh-ancestor
56613030|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613031|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
56613032|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56613033|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613034|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613035|NCT02870231|Liraglutide|liraglutide|mesh-list
56613070|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56613071|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56613072|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56613073|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
56613075|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
56613076|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
56613077|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925989|NCT04278703|Analgesics|analgesics|mesh-ancestor
56613107|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56613108|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56613109|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56613110|NCT00996593|Iodine|iodine|mesh-list
56613111|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
56613112|NCT00996593|Antibodies|antibodies|mesh-list
56613113|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
56613114|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
56613115|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613116|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56613117|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613118|NCT00996593|Trace Elements|trace elements|mesh-ancestor
56613119|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
56613120|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613157|NCT04047355|Propranolol|propranolol|mesh-list
56613158|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56613159|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56613284|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613285|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648288|NCT02842931|Doxorubicin|doxorubicin|mesh-list
56648289|NCT02842931|Etoposide|etoposide|mesh-list
56648290|NCT02842931|Vincristine|vincristine|mesh-list
56648291|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613287|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613288|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56613289|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56613290|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56613291|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55926206|NCT03379051|Venetoclax|venetoclax|mesh-list
56613318|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56613320|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613321|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613322|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613323|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613324|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56613325|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
56613326|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613327|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613328|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56613329|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
56613330|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
56613331|NCT04259684|Protective Agents|protective agents|mesh-ancestor
56613332|NCT00788515|Lormetazepam|lormetazepam|mesh-list
56613333|NCT00788515|Volinanserin|volinanserin|mesh-list
56613334|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56613335|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926244|NCT03674151|Povidone|povidone|mesh-list
56613363|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56613364|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
56613365|NCT00609752|Hormones|hormones|mesh-ancestor
56613366|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56613367|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613368|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56613369|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613370|NCT00662857|Insulin|insulin|mesh-list
56613371|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56613372|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56613373|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613374|NCT00878553|Zaleplon|zaleplon|mesh-list
56613375|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
56613376|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56613377|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613378|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613379|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
56613380|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
56613381|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613416|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613417|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56613418|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613419|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
56613420|NCT00929708|AZD-3199|azd-3199|mesh-list
56613421|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56613444|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613445|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56613446|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56613447|NCT04046653|Sulforaphane|sulforaphane|mesh-list
56613448|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56613449|NCT04046653|Protective Agents|protective agents|mesh-ancestor
56613450|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613451|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613453|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613454|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
56613455|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613456|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56613457|NCT00675207|Dorzolamide|dorzolamide|mesh-list
56613458|NCT00675207|Brinzolamide|brinzolamide|mesh-list
56613459|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56613460|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56613461|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56613462|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56613463|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
56648292|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
56648293|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648294|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56648295|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56648296|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
56648297|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648298|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648299|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56506687|NCT04554615|Insulin|insulin|mesh-list
56613464|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613465|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613466|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613467|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56613468|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613469|NCT00795223|Morphine|morphine|mesh-list
56613470|NCT00795223|Bupivacaine|bupivacaine|mesh-list
56613471|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
56613472|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
56613473|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926378|NCT00818805|Tranilast|tranilast|mesh-list
56613500|NCT00789763|Sorafenib|sorafenib|mesh-list
56613501|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56613502|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
56613503|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613504|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613505|NCT00789763|Antiviral Agents|antiviral agents|mesh-ancestor
56613506|NCT00789763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613507|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613508|NCT00789763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613509|NCT00789763|Immunologic Factors|immunologic factors|mesh-ancestor
56613510|NCT00789763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613511|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56613512|NCT02554357|Bupivacaine|bupivacaine|mesh-list
56613513|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
56613514|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
56613515|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613516|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613517|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
56613518|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613519|NCT00877929|Amlodipine|amlodipine|mesh-list
56613520|NCT00877929|Telmisartan|telmisartan|mesh-list
56613548|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613549|NCT04979780|Heparin|heparin|mesh-list
56613550|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56613551|NCT04979780|Tinzaparin|tinzaparin|mesh-list
56613552|NCT04979780|Dalteparin|dalteparin|mesh-list
56613553|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
56613554|NCT04979780|Anticoagulants|anticoagulants|mesh-list
56613555|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56613556|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56613557|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613558|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56613559|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
56613560|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56613561|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
56613562|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613563|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
56613564|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613565|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56613566|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613567|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613568|NCT00795613|Doxorubicin|doxorubicin|mesh-list
56613603|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56613604|NCT00800917|Growth Substances|growth substances|mesh-ancestor
56613605|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613606|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
56613607|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56648300|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56648301|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56648302|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56613608|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613609|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56613610|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
56613672|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56613673|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56362187|NCT00086892|Cetuximab|cetuximab|mesh-list
56613674|NCT00610142|Analgesics|analgesics|mesh-ancestor
56613675|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
56613676|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613677|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613678|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56613679|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56613680|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613681|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
56613682|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56613683|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613684|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613685|NCT04151823|Vitamin D|vitamin d|mesh-list
56613686|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
56613687|NCT04151823|Vitamins|vitamins|mesh-ancestor
56613688|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
55926584|NCT05236569|Coagulants|coagulants|mesh-ancestor
56613755|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56613756|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613757|NCT00795847|Diuretics|diuretics|mesh-ancestor
56613758|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
56613759|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613760|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56613761|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56613797|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613798|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613799|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613800|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
56613801|NCT00912171|Hormones|hormones|mesh-ancestor
56613802|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56613803|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55926707|NCT00827073|Lidocaine|lidocaine|mesh-list
56613832|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
56613833|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613834|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56613836|NCT00629135|Metronidazole|metronidazole|mesh-list
56613837|NCT00629135|Tazobactam|tazobactam|mesh-list
56613838|NCT00629135|Piperacillin|piperacillin|mesh-list
56613839|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56613840|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56613841|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613842|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56613843|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56613844|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613845|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613846|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613847|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55926747|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56613986|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
56613987|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613988|NCT02554045|Tadalafil|tadalafil|mesh-list
56613989|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
56614068|NCT00678327|Etoposide|etoposide|mesh-list
56614069|NCT00678327|Vincristine|vincristine|mesh-list
56614070|NCT00678327|Bleomycin|bleomycin|mesh-list
56614071|NCT00678327|Vinblastine|vinblastine|mesh-list
56614072|NCT00678327|Procarbazine|procarbazine|mesh-list
56614073|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56614074|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
56614075|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614076|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56614077|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56614078|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
56614079|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614080|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648303|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648304|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56648305|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56648306|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
56648307|NCT02842931|Hormones|hormones|mesh-ancestor
56614081|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56614082|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56614083|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56614084|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56614085|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614086|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56614087|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
56614140|NCT00609284|Cetuximab|cetuximab|mesh-list
56614141|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614142|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56614143|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56614144|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614145|NCT00930722|Quinapril|quinapril|mesh-list
56614146|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56614147|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
56614148|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614149|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614150|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56614151|NCT00610610|Paroxetine|paroxetine|mesh-list
56614152|NCT00610610|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56614153|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56614154|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56614155|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614156|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614157|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
56614158|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614159|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56614160|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
56614161|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56614162|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56614163|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56614164|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614165|NCT00912327|Cetuximab|cetuximab|mesh-list
56614166|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56614167|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614168|NCT04257812|Tazobactam|tazobactam|mesh-list
56614169|NCT04257812|Ceftolozane|ceftolozane|mesh-list
56614170|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56614283|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614284|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56614285|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614287|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
56614288|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614289|NCT00680277|Protective Agents|protective agents|mesh-ancestor
56614290|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614291|NCT00680355|Carotenoids|carotenoids|mesh-list
56614292|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
56622939|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56614324|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56614325|NCT00801853|Interleukin-4|interleukin-4|mesh-list
56614326|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56614327|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
56614328|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614329|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614330|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56614331|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56614332|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56614333|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
56614334|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56614335|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614355|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614356|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614357|NCT04899115|Vancomycin|vancomycin|mesh-list
56614358|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56648308|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56648309|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56648310|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
56614359|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614360|NCT00684957|Hormones|hormones|mesh-list
56614361|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614362|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614363|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
56614364|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56614365|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56614366|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
56614367|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614368|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56614369|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56614370|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614371|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614372|NCT00685269|Eszopiclone|eszopiclone|mesh-list
56614373|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56614374|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614375|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614376|NCT00794209|Fentanyl|fentanyl|mesh-list
56614377|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56614378|NCT00794209|Narcotics|narcotics|mesh-ancestor
56614379|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614380|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614381|NCT00794209|Analgesics|analgesics|mesh-ancestor
56614382|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
56614383|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614384|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56614385|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56614386|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
56614387|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
56614388|NCT00985985|Nicotine|nicotine|mesh-list
56614389|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56614424|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56614425|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
56614426|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927182|NCT03104634|Bromides|bromides|mesh-list
56614447|NCT00802009|Hormones|hormones|mesh-ancestor
56614448|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614449|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56614450|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614451|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
56614452|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
56614453|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614454|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
56614455|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
56614456|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56614457|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
56614458|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614459|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
56614460|NCT02868437|Protective Agents|protective agents|mesh-ancestor
56614461|NCT00802087|Acetaminophen|acetaminophen|mesh-list
56614462|NCT00802087|Hydrocodone|hydrocodone|mesh-list
56614463|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56614464|NCT00802087|Analgesics|analgesics|mesh-ancestor
56614465|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
56614466|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614467|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614468|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
56614469|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56614470|NCT00802087|Narcotics|narcotics|mesh-ancestor
56614471|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614472|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
56614473|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
56614474|NCT00923936|Bevacizumab|bevacizumab|mesh-list
56614475|NCT00923936|Doxorubicin|doxorubicin|mesh-list
56614476|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56614477|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56614478|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614479|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56614480|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56614481|NCT00923936|Growth Substances|growth substances|mesh-ancestor
56648311|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
56648312|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
56648313|NCT04183296|Propofol|propofol|mesh-list
56648314|NCT04183296|Sevoflurane|sevoflurane|mesh-list
56648315|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56506962|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614482|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614483|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
56614512|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56614514|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56614515|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614516|NCT00924950|Calcitriol|calcitriol|mesh-list
56614517|NCT00924950|Betamethasone|betamethasone|mesh-list
56614518|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56614519|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
56614520|NCT00924950|Hormones|hormones|mesh-ancestor
56614521|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614522|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614523|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56614524|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
56614525|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56614526|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56614527|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56614528|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614529|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56614530|NCT00924950|Vitamins|vitamins|mesh-ancestor
56614565|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
56614566|NCT00685971|Vitamin D|vitamin d|mesh-list
56614567|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56614568|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614642|NCT00686985|Carboplatin|carboplatin|mesh-list
56614643|NCT00686985|Docetaxel|docetaxel|mesh-list
56614644|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614645|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
56614646|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
56614647|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
56614648|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614649|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
56614650|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56614651|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614652|NCT02625753|Acetaminophen|acetaminophen|mesh-list
56614653|NCT02625753|Codeine|codeine|mesh-list
56614654|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56614655|NCT02625753|Analgesics|analgesics|mesh-ancestor
56614656|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
56614657|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614658|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614659|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
56614660|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56614661|NCT02625753|Narcotics|narcotics|mesh-ancestor
56614662|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614663|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
56614664|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
56614665|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
56614666|NCT00687843|Tegafur|tegafur|mesh-list
56614667|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56615042|NCT00696111|Progestins|progestins|mesh-ancestor
56615043|NCT00696111|Hormones|hormones|mesh-ancestor
56615044|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615045|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615046|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56615047|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
56615048|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56615049|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56615050|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615051|NCT02623569|Atenolol|atenolol|mesh-list
56615052|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56615053|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56615054|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
56615055|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
55927686|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
56648316|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648317|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648318|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56507036|NCT00556088|Paclitaxel|paclitaxel|mesh-list
56615171|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
56615172|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615173|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615175|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615366|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
56615367|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55927979|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56615432|NCT02619747|Antacids|antacids|mesh-ancestor
56615467|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615468|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
56615469|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615470|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
56615471|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56615472|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56615502|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
56615503|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615504|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615505|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56615506|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
56615507|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
56615508|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56615509|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
56615510|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615511|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615512|NCT02619201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56615513|NCT02619201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56615514|NCT02619201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615515|NCT02619201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56615516|NCT02619201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56615517|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56615518|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56615547|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56364073|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
56615548|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615549|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56615550|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615551|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615552|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56615553|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56615554|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
56615555|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615556|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56615557|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56615558|NCT02862977|Analgesics|analgesics|mesh-ancestor
56615559|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
56615560|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615561|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56615562|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615563|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56615564|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55928171|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56615638|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56615639|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56615640|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615641|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56615643|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
56615645|NCT02617485|Doxorubicin|doxorubicin|mesh-list
56615646|NCT02617485|Vincristine|vincristine|mesh-list
56615647|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615648|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
56615649|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615692|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615693|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
56615694|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
56364218|NCT00089154|Antibodies|antibodies|mesh-list
56615695|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
55928304|NCT01494506|Antidotes|antidotes|mesh-ancestor
56648319|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
56648320|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
56648321|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56648322|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56648323|NCT00642408|Micronutrients|micronutrients|mesh-list
56648324|NCT00642408|Trace Elements|trace elements|mesh-list
56648325|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648326|NCT02678598|Micafungin|micafungin|mesh-list
56648327|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
56648328|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648329|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
56648330|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56648331|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648332|NCT02678364|Vitamin D|vitamin d|mesh-list
56648333|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
56648334|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56648335|NCT02678364|Calcifediol|calcifediol|mesh-list
56615815|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56615816|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615817|NCT00803335|Estrogens|estrogens|mesh-list
56615818|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56615819|NCT00803335|Hormones|hormones|mesh-ancestor
56615820|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615821|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615822|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
56615823|NCT00656617|Cytarabine|cytarabine|mesh-list
56615954|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615955|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615956|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615958|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56615959|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56615960|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
56615961|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615962|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615963|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615964|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56615965|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56616029|NCT00806923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616030|NCT00806923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616031|NCT00806923|Immunologic Factors|immunologic factors|mesh-ancestor
56616033|NCT00698607|Everolimus|everolimus|mesh-list
56616065|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616067|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56616068|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
56616069|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56616070|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56616071|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616072|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364595|NCT00294853|Calcium|calcium|mesh-list
56616073|NCT00698763|Protective Agents|protective agents|mesh-ancestor
56616110|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56616111|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
56616112|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56616149|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
56616150|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616151|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616292|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
56616294|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616295|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648336|NCT02678364|Vitamins|vitamins|mesh-ancestor
56648337|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
56648338|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616296|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56616297|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616298|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
56616299|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
56616300|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928894|NCT03138720|Immunologic Factors|immunologic factors|mesh-ancestor
56616360|NCT00701337|Hormones|hormones|mesh-ancestor
56616361|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616362|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616363|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56616364|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
56616365|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56616420|NCT00654745|Diuretics|diuretics|mesh-ancestor
56616421|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
56616422|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56616423|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56616424|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56616425|NCT00809887|Micafungin|micafungin|mesh-list
56616426|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
56616427|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616459|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56616460|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56616461|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56616462|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616463|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56616465|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56616466|NCT02551549|Rezafungin|rezafungin|mesh-list
56616467|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
56616468|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616469|NCT00810121|Ketoprofen|ketoprofen|mesh-list
56616470|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56616471|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616525|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616526|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616527|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56616528|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616529|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
55929132|NCT00795522|Desloratadine|desloratadine|mesh-list
56616634|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616635|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
56616637|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616638|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
56616639|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616676|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616743|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159585|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
56616744|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616745|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616746|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616748|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56616883|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
56616884|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
56616885|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56616886|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
56616887|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56616888|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56616889|NCT00809029|Incretins|incretins|mesh-ancestor
56616890|NCT00809029|Hormones|hormones|mesh-ancestor
56616891|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616892|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616893|NCT00842829|Fentanyl|fentanyl|mesh-list
56617044|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
56617045|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
56617046|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56617047|NCT00815893|Analgesics|analgesics|mesh-ancestor
56617048|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
56617049|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617050|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56648339|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56294365|NCT00091312|Antidotes|antidotes|mesh-ancestor
56648340|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56648341|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
56507238|NCT01087151|Rituximab|rituximab|mesh-list
56617051|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56617052|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56617053|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
56617054|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617055|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617108|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617109|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617110|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56617111|NCT00811837|Narcotics|narcotics|mesh-ancestor
56617112|NCT00811837|Analgesics|analgesics|mesh-ancestor
56617113|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
56617114|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617116|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56617384|NCT00816283|Dasatinib|dasatinib|mesh-list
56617385|NCT00816283|Vorinostat|vorinostat|mesh-list
56617386|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617387|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56617388|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617389|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617390|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56617391|NCT00910910|Lenalidomide|lenalidomide|mesh-list
56617843|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619244|NCT02840526|Propofol|propofol|mesh-list
56619245|NCT02840526|Sevoflurane|sevoflurane|mesh-list
56619246|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
56619247|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
56619248|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619249|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619250|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
56619251|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619252|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56619253|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56619254|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
56619255|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56619256|NCT02840526|Narcotics|narcotics|mesh-ancestor
56619257|NCT02840526|Analgesics|analgesics|mesh-ancestor
56619258|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56619259|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56619260|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
56619261|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56619262|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56619263|NCT02342444|Enoxaparin|enoxaparin|mesh-list
56619264|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
56619265|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
56619266|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56619267|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56619268|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619269|NCT00825253|Insulin|insulin|mesh-list
56619270|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56619271|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
56619272|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
56619273|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56619274|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56619275|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619276|NCT00820885|Teduglutide|teduglutide|mesh-list
56619277|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619278|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56619279|NCT00820885|Protective Agents|protective agents|mesh-ancestor
56619280|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619281|NCT03845582|Vitamin A|vitamin a|mesh-list
56619282|NCT03845582|Retinol acetate|retinol acetate|mesh-list
56619283|NCT03845582|Vitamins|vitamins|mesh-ancestor
56619284|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
56619285|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619286|NCT03845582|Protective Agents|protective agents|mesh-ancestor
56619287|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56619288|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648342|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56648343|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56648344|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648345|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
56648346|NCT02678208|Coagulants|coagulants|mesh-ancestor
56648347|NCT05551182|Nicergoline|nicergoline|mesh-list
56648348|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56648349|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56648350|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
56507330|NCT04990037|Folfirinox|folfirinox|mesh-list
56619289|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56619290|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
56619291|NCT00820963|Temozolomide|temozolomide|mesh-list
56619292|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56619293|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
56622945|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56619334|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619335|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619337|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56619338|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56619339|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619340|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
56619341|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
56619342|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
56619343|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619344|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619345|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
56619346|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619347|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56619348|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619349|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56619350|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619351|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619352|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
56619353|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619354|NCT02838030|Aspirin|aspirin|mesh-list
56619355|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56619356|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56619357|NCT02838030|Analgesics|analgesics|mesh-ancestor
56619358|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
56619359|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619360|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619361|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56619362|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56619363|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56619364|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56619365|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619366|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56619367|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56619368|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619369|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
56619370|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
56619371|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56619372|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367911|NCT00320320|Irinotecan|irinotecan|mesh-list
56619373|NCT04044079|Misoprostol|misoprostol|mesh-list
56619709|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619710|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
56619711|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56619712|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
56619713|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619714|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56619715|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56619716|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619717|NCT02842580|Antidotes|antidotes|mesh-ancestor
56648351|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648352|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507376|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619718|NCT02842580|Protective Agents|protective agents|mesh-ancestor
56619719|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
56619720|NCT02842580|Vitamins|vitamins|mesh-ancestor
56619721|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
56619722|NCT00836277|Irinotecan|irinotecan|mesh-list
56619723|NCT00836277|Panitumumab|panitumumab|mesh-list
56619724|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56619725|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56002817|NCT02478320|Ilorasertib|ilorasertib|mesh-list
56620238|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56620239|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56620240|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620241|NCT04245774|Bupivacaine|bupivacaine|mesh-list
56620242|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
56620243|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
56620244|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
56620245|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620246|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620247|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
56620248|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620249|NCT04247646|Melatonin|melatonin|mesh-list
56620250|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
56620251|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620252|NCT04247646|Protective Agents|protective agents|mesh-ancestor
56620253|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620254|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620255|NCT05174832|Paclitaxel|paclitaxel|mesh-list
56620256|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
56620257|NCT05174832|Olaparib|olaparib|mesh-list
56620258|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56620259|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620260|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
56620261|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
56620262|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
56620263|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620264|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56620265|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56620266|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620267|NCT00900146|Metformin|metformin|mesh-list
56620268|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56620269|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620270|NCT00140972|Diclofenac|diclofenac|mesh-list
56620271|NCT00140972|Etoricoxib|etoricoxib|mesh-list
56620272|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56620273|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56620274|NCT00140972|Analgesics|analgesics|mesh-ancestor
56620275|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
56620276|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620277|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620278|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620279|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620280|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56620281|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620791|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620792|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620794|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56620795|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56620796|NCT02547025|Amoxicillin|amoxicillin|mesh-list
56620797|NCT02547025|Clarithromycin|clarithromycin|mesh-list
56620798|NCT02547025|Levofloxacin|levofloxacin|mesh-list
56620799|NCT02547025|Ofloxacin|ofloxacin|mesh-list
56620800|NCT02547025|Tetracycline|tetracycline|mesh-list
56620801|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56620802|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56620803|NCT02547025|Rabeprazole|rabeprazole|mesh-list
56620804|NCT02547025|Bismuth|bismuth|mesh-list
56620805|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621005|NCT05660694|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56621006|NCT05660694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56621007|NCT05660694|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56621008|NCT05660694|Vasodilator Agents|vasodilator agents|mesh-ancestor
56648353|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648354|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
56648355|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
56621009|NCT05660694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56621113|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
56621114|NCT02611635|Dabigatran|dabigatran|mesh-list
56621115|NCT02611635|Apixaban|apixaban|mesh-list
56621116|NCT02611635|Edoxaban|edoxaban|mesh-list
56621117|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
56621118|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56621119|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
56621120|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56621121|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
56621122|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621123|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621124|NCT02824926|Ketoconazole|ketoconazole|mesh-list
56621125|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
56621126|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621127|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56621128|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56621129|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621130|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621131|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56621132|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
56621133|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56621134|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621135|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56621225|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621226|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621227|NCT00633672|Esomeprazole|esomeprazole|mesh-list
56621228|NCT00633672|Ranitidine|ranitidine|mesh-list
56621229|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56621230|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56621231|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621232|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56621233|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621234|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621235|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56055007|NCT00832299|Vitamins|vitamins|mesh-ancestor
56621236|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
56621237|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
56621238|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621239|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621241|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56621242|NCT02547103|Mupirocin|mupirocin|mesh-list
56621243|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56621244|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621245|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
56621246|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621247|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56621248|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56621249|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621250|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621251|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56621252|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56621253|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621254|NCT00848809|Vancomycin|vancomycin|mesh-list
56621255|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56621256|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621257|NCT00834847|Pravastatin|pravastatin|mesh-list
56621258|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56621259|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56621260|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
56621261|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621262|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56621263|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56621264|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621265|NCT00841477|Vaccines|vaccines|mesh-list
56621266|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
56621267|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621268|NCT00834925|Diltiazem|diltiazem|mesh-list
56621269|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55887680|NCT03108300|Doxorubicin|doxorubicin|mesh-list
56648356|NCT02677584|Caffeine|caffeine|mesh-list
56648357|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
56648358|NCT02677584|Citric Acid|citric acid|mesh-list
56648359|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
56648360|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
56648361|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56648362|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
56648363|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
56621270|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56621271|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56004213|NCT01942694|Vitamin D|vitamin d|mesh-list
56621624|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56621625|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56621626|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56621627|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56370155|NCT00345826|Dasatinib|dasatinib|mesh-list
56621741|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56621742|NCT04519476|Growth Substances|growth substances|mesh-ancestor
56621743|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
56621744|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621745|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621746|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
56621747|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
56621748|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621888|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621889|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621890|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622134|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56622171|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
56622172|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622986|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622987|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622988|NCT00859807|Amodiaquine|amodiaquine|mesh-list
56622989|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
56622990|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56622991|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56622992|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622993|NCT00859885|Clopidogrel|clopidogrel|mesh-list
56622994|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622995|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622996|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56622997|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56622998|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56622999|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56623000|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
56623001|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623002|NCT02798874|Clopidogrel|clopidogrel|mesh-list
56623003|NCT02798874|Ticagrelor|ticagrelor|mesh-list
56623018|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56623020|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623021|NCT00959699|Interferons|interferons|mesh-list
56623022|NCT00959699|Ribavirin|ribavirin|mesh-list
56623023|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
56623024|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
56623025|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56623026|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623027|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
56623028|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623029|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
56623030|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623031|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
56623032|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623033|NCT02806128|Kallikreins|kallikreins|mesh-list
56623034|NCT02806128|Coagulants|coagulants|mesh-ancestor
56623035|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56623036|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
56623037|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56623038|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623039|NCT00860119|Alprazolam|alprazolam|mesh-list
56623040|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56623041|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648364|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648365|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56648366|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648367|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56507604|NCT04996823|Ipilimumab|ipilimumab|mesh-list
56623042|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623043|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56623044|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623045|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623046|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
56623047|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
56623048|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623049|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623050|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
56623051|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56623052|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56623053|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56623054|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
56623055|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623056|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623057|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623058|NCT02805738|Tenofovir|tenofovir|mesh-list
56623059|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
56623060|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623061|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56623062|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56623095|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623096|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623097|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56623098|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56623099|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
56623100|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623101|NCT00860275|Fluconazole|fluconazole|mesh-list
56623102|NCT00860275|Ketoconazole|ketoconazole|mesh-list
56623103|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
56623104|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623105|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56623134|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623135|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56623136|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56623138|NCT02802696|Furosemide|furosemide|mesh-list
56623139|NCT02802696|Diuretics|diuretics|mesh-ancestor
56623140|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
56623141|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623142|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56623143|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623144|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623146|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56623167|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623168|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56623169|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56623170|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623171|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623172|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
56623173|NCT00955721|Gemcitabine|gemcitabine|mesh-list
56623174|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
56623176|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56623177|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
56623178|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623179|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623180|NCT00955721|Antiviral Agents|antiviral agents|mesh-ancestor
56623181|NCT00955721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623182|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623183|NCT00955721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56623184|NCT00955721|Immunologic Factors|immunologic factors|mesh-ancestor
56623185|NCT00955721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623186|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56648368|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648369|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56507659|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56623187|NCT02802540|Nabilone|nabilone|mesh-list
56623188|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
56623189|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
56623190|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623191|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623192|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56623193|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56623194|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623195|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623196|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623197|NCT00865501|Spironolactone|spironolactone|mesh-list
56623198|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56623200|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623201|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623285|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
56623286|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
56623287|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159701|NCT03017508|Riluzole|riluzole|mesh-list
56623288|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623289|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
56623290|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623291|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56623292|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56623293|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56623294|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623295|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623296|NCT02939183|Dexamethasone|dexamethasone|mesh-list
56623297|NCT02939183|Pomalidomide|pomalidomide|mesh-list
56623298|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56623299|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
56623300|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
56623301|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623302|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623303|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56623304|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
56623305|NCT02939183|Hormones|hormones|mesh-ancestor
56623306|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623307|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56623308|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623309|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
56623310|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56623311|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56623312|NCT02939183|Growth Substances|growth substances|mesh-ancestor
56623313|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
56623314|NCT03074513|Bevacizumab|bevacizumab|mesh-list
56623315|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56623316|NCT03074513|Atezolizumab|atezolizumab|mesh-list
56623317|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
56623318|NCT03074513|Antibodies|antibodies|mesh-list
56623319|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
56623320|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56623376|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56623377|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623378|NCT00860977|Valacyclovir|valacyclovir|mesh-list
56623379|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
56623380|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623381|NCT00865891|Nifedipine|nifedipine|mesh-list
56623382|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56623383|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623384|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623385|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56623386|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623387|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
56623388|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
56623389|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56623390|NCT02797236|Vaccines|vaccines|mesh-list
56623391|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
56623420|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623421|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
56648370|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56648371|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
56648372|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648373|NCT05662956|Azacitidine|azacitidine|mesh-list
56648374|NCT05662956|Venetoclax|venetoclax|mesh-list
56623422|NCT02805426|Coagulants|coagulants|mesh-ancestor
56623423|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56623424|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
56623425|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56623426|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623427|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56623428|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56623429|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
56623430|NCT02801292|Ketamine|ketamine|mesh-list
56623431|NCT02801292|Analgesics|analgesics|mesh-ancestor
56623432|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
56623433|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623434|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623435|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56623436|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56623437|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
56623438|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
56623454|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
56623455|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623457|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
56623458|NCT03853044|Doxorubicin|doxorubicin|mesh-list
56623459|NCT03853044|Vincristine|vincristine|mesh-list
56623460|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56623461|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
56623462|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623463|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56623464|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56623465|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
56623466|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623467|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623468|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56623469|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56623470|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56623471|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56623472|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623473|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56623474|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
56623475|NCT03853044|Hormones|hormones|mesh-ancestor
56623476|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623477|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56623478|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56623479|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
56623480|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
56623481|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
56623482|NCT00870337|Everolimus|everolimus|mesh-list
56623483|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623484|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56623485|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
56623486|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623487|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56623488|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56623489|NCT00866437|Estropipate|estropipate|mesh-list
56623490|NCT00866437|Estradiol|estradiol|mesh-list
56623491|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56623492|NCT00866437|Estrone|estrone|mesh-list
56623493|NCT00866437|Progesterone|progesterone|mesh-list
56623494|NCT00866437|Estrogens|estrogens|mesh-ancestor
56623495|NCT00866437|Hormones|hormones|mesh-ancestor
56623496|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623497|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623530|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
56623531|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623532|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623533|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56623534|NCT02795754|Ritonavir|ritonavir|mesh-list
56623553|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623554|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648375|NCT05662956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56648376|NCT05662956|Antimetabolites|antimetabolites|mesh-ancestor
56648377|NCT05662956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648378|NCT05662956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648379|NCT05662956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648380|NCT02838173|Ropivacaine|ropivacaine|mesh-list
56623555|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
56623556|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623557|NCT00812487|Insulin|insulin|mesh-list
56623558|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56623559|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56623560|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623561|NCT04235868|Mitogens|mitogens|mesh-list
56623562|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
56623563|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623564|NCT03927378|Ketamine|ketamine|mesh-list
56623565|NCT03927378|Esketamine|esketamine|mesh-list
56623566|NCT03927378|Analgesics|analgesics|mesh-ancestor
56623567|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
56623568|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623569|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372125|NCT00131040|Aprotinin|aprotinin|mesh-list
56623570|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56623571|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56623572|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
56623573|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
56623574|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623575|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56623576|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56623577|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623578|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623579|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
56623580|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623581|NCT02800902|Atorvastatin|atorvastatin|mesh-list
56623582|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56623583|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56623584|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56623585|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
56623586|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623587|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56623588|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56623589|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623613|NCT04233996|Tazobactam|tazobactam|mesh-list
56623614|NCT04233996|Piperacillin|piperacillin|mesh-list
56623615|NCT04233996|Cefepime|cefepime|mesh-list
56623616|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56623617|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56623618|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623619|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56623620|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623621|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623622|NCT00812253|Insulin|insulin|mesh-list
56623623|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56623624|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56623625|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623626|NCT00870571|Amlodipine|amlodipine|mesh-list
56623627|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56623628|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56623629|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623630|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623631|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56623632|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623633|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
56623634|NCT05756439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56623635|NCT05756439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623636|NCT05756439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623637|NCT00616759|Propofol|propofol|mesh-list
56623638|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55887681|NCT03108300|Propranolol|propranolol|mesh-list
56648381|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
56648382|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
56507896|NCT04559048|Tacrolimus|tacrolimus|mesh-list
56623639|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623640|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623641|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56623678|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623679|NCT02796378|Vitamins|vitamins|mesh-ancestor
56623714|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
56623715|NCT00870961|Vitamin D|vitamin d|mesh-list
56623716|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56623717|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623718|NCT00870961|Vitamins|vitamins|mesh-ancestor
56623719|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
56623720|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56623721|NCT00811941|Nalmefene|nalmefene|mesh-list
56623722|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56623770|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56623771|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623772|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56623773|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56623774|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
56623776|NCT04234776|Aripiprazole|aripiprazole|mesh-list
56623777|NCT04234776|Citalopram|citalopram|mesh-list
56623778|NCT04234776|Analgesics|analgesics|mesh-ancestor
56623779|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
56623780|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623781|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623782|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56623783|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56623784|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
56623785|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
56623786|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623787|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56623788|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56623789|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176765|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
56623835|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56623836|NCT04040491|Growth Substances|growth substances|mesh-ancestor
56623837|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
56623838|NCT02794584|Sufentanil|sufentanil|mesh-list
56623839|NCT02794584|Dsuvia|dsuvia|mesh-list
56623840|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
56623841|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623842|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623843|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56623844|NCT02794584|Narcotics|narcotics|mesh-ancestor
56623845|NCT02794584|Analgesics|analgesics|mesh-ancestor
56623846|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
56623847|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623848|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56623849|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56623850|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
56623851|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56623852|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
56623853|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623854|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56623855|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623856|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623857|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623858|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56623859|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56623860|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623861|NCT00871507|Incretins|incretins|mesh-ancestor
56623862|NCT00871507|Hormones|hormones|mesh-ancestor
56623863|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623864|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56623865|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
56623866|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623867|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623868|NCT00865033|Metformin|metformin|mesh-list
56623869|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56623870|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623871|NCT05755737|Ondansetron|ondansetron|mesh-list
56372421|NCT00433459|Hormones|hormones|mesh-ancestor
56648383|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648384|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648385|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
56623872|NCT05755737|Antiemetics|antiemetics|mesh-ancestor
56623873|NCT05755737|Autonomic Agents|autonomic agents|mesh-ancestor
56623874|NCT05755737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623875|NCT05755737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623876|NCT05755737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56623877|NCT05755737|Antipruritics|antipruritics|mesh-ancestor
56623878|NCT05755737|Dermatologic Agents|dermatologic agents|mesh-ancestor
56623879|NCT05755737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56623880|NCT05755737|Serotonin Agents|serotonin agents|mesh-ancestor
56623913|NCT00872131|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56623914|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56623915|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623916|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623917|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623918|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
56623919|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623920|NCT04233294|Decitabine|decitabine|mesh-list
56623921|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56623922|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
56623923|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623976|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623977|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
56623978|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56623979|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56623980|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
56623981|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56623982|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56623983|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623984|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56623985|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56623986|NCT00617305|Ambrisentan|ambrisentan|mesh-list
56623987|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
56623988|NCT00617305|Tadalafil|tadalafil|mesh-list
56623989|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
56623990|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56623991|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56623992|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623993|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623994|NCT00617305|Urological Agents|urological agents|mesh-ancestor
56623995|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56623996|NCT02792712|Clopidogrel|clopidogrel|mesh-list
56623997|NCT02792712|Ticagrelor|ticagrelor|mesh-list
56623998|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56623999|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56624000|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56624001|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56624002|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
56624003|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624004|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624005|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624006|NCT02789202|Fluorides|fluorides|mesh-list
56624007|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
56624008|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
56624009|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
56624033|NCT02792946|Expectorants|expectorants|mesh-ancestor
56624034|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
56624035|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
56624036|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56624037|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56624038|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624039|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56624040|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56624041|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624042|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624043|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624044|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56624045|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
56648386|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648387|NCT00641472|Budesonide|budesonide|mesh-list
56624046|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56624047|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624048|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56624049|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56624050|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56624051|NCT05079789|Amiloride|amiloride|mesh-list
56624052|NCT05079789|Furosemide|furosemide|mesh-list
56624053|NCT05079789|Diuretics|diuretics|mesh-ancestor
56624054|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
56624055|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624056|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56624057|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56624058|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624059|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56624060|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56624078|NCT02609997|Hormones|hormones|mesh-ancestor
56624079|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56624080|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56624081|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624082|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
56624083|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
56624084|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624085|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
56624086|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
56624087|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56624088|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624089|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56624090|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
56624091|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
56624092|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624093|NCT04114500|Estradiol|estradiol|mesh-list
56624094|NCT04114500|Progesterone|progesterone|mesh-list
56624095|NCT04114500|Estrogens|estrogens|mesh-ancestor
56624096|NCT04114500|Hormones|hormones|mesh-ancestor
56624097|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56624098|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624099|NCT04114500|Progestins|progestins|mesh-ancestor
56624100|NCT05755659|Fosaprepitant|fosaprepitant|mesh-list
56624101|NCT05755659|Aprepitant|aprepitant|mesh-list
56624102|NCT05755659|Antiemetics|antiemetics|mesh-ancestor
56624103|NCT05755659|Autonomic Agents|autonomic agents|mesh-ancestor
56624104|NCT05755659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624105|NCT05755659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624106|NCT05755659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624107|NCT05755659|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56624108|NCT05755659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624109|NCT05755659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624110|NCT00913887|Diclofenac|diclofenac|mesh-list
56624111|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56624112|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56624113|NCT00913887|Analgesics|analgesics|mesh-ancestor
56624114|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
56624115|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624144|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56624145|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624146|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
56624147|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
56624148|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
56624149|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624150|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56624151|NCT05755581|Antineoplastic Agents|antineoplastic agents|mesh-list
56624152|NCT05755581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
56624153|NCT05017155|Mexiletine|mexiletine|mesh-list
56624154|NCT05017155|Lamotrigine|lamotrigine|mesh-list
56624155|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
56624156|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56624157|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56624158|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624159|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56648388|NCT00641472|Montelukast|montelukast|mesh-list
56648389|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624214|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
56624215|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
56624216|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
56624217|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56624218|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
56624219|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624220|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56624221|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624222|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56624223|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624225|NCT00877123|Vitamins|vitamins|mesh-ancestor
56624226|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
56624227|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624228|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56624229|NCT00873223|Liraglutide|liraglutide|mesh-list
56624230|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
56624231|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56624232|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624233|NCT00873223|Incretins|incretins|mesh-ancestor
56624234|NCT00873223|Hormones|hormones|mesh-ancestor
56624235|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56624236|NCT00873379|Melatonin|melatonin|mesh-list
56624237|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
56624238|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159718|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56624240|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372794|NCT00403806|Hormones|hormones|mesh-ancestor
56624241|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624242|NCT00868855|Bradykinin|bradykinin|mesh-list
56624243|NCT00868855|Kininogens|kininogens|mesh-list
56624244|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
56624245|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56624246|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
56624247|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624248|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624272|NCT00616603|Ropivacaine|ropivacaine|mesh-list
56624273|NCT00616603|BB 1101|bb 1101|mesh-list
56624274|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624275|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
56624276|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
56624277|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624278|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624279|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624280|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
56624281|NCT00616603|Hormones|hormones|mesh-ancestor
56624282|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56624283|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56624284|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624285|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
56624286|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624287|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624288|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
56624289|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
56624290|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624291|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
56624292|NCT00873535|Varenicline|varenicline|mesh-list
56624293|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56624294|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56624295|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
56624296|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624297|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624298|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624299|NCT02790996|Vancomycin|vancomycin|mesh-list
56624323|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
56624324|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
56624325|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624326|NCT02790450|Renal Agents|renal agents|mesh-ancestor
56624327|NCT02790528|Atorvastatin|atorvastatin|mesh-list
56624328|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56624329|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56624330|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
56624331|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648390|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56648391|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
56648392|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648393|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624332|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56624333|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56624334|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624335|NCT00953615|Thalidomide|thalidomide|mesh-list
56624336|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624337|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
56624338|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624339|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
56624340|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56624341|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624342|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56624343|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56624344|NCT00953615|Growth Substances|growth substances|mesh-ancestor
56624345|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
56624346|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624347|NCT00873769|Loxapine|loxapine|mesh-list
56624348|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56624349|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56624350|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624351|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624352|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56624353|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56624390|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56624391|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56372939|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56624410|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624411|NCT03870529|Protective Agents|protective agents|mesh-ancestor
56624412|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56624413|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624414|NCT03412266|Cytarabine|cytarabine|mesh-list
56624415|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
56624416|NCT03412266|Busulfan|busulfan|mesh-list
56624417|NCT03412266|Semustine|semustine|mesh-list
56624418|NCT03412266|Fludarabine|fludarabine|mesh-list
56624419|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56624420|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624421|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
56624422|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624423|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624424|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56624425|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
56624426|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624427|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624428|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56624429|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56624430|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
56624431|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
56624432|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624433|NCT04969887|Nivolumab|nivolumab|mesh-list
56624434|NCT04969887|Ipilimumab|ipilimumab|mesh-list
56624435|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56624436|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624437|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56624438|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624439|NCT00877591|Ritonavir|ritonavir|mesh-list
56624440|NCT00877591|Darunavir|darunavir|mesh-list
56624441|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
56624442|NCT00877591|Rifampin|rifampin|mesh-list
56624443|NCT00877591|Rifabutin|rifabutin|mesh-list
56624444|NCT00877591|Buprenorphine|buprenorphine|mesh-list
56624445|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56624446|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56624447|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
56624448|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624449|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624450|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56624451|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56624452|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
56624453|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648394|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56648395|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
56624468|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56624469|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56624470|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56624471|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56624472|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56624473|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56624474|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56624476|NCT04200222|Trace Elements|trace elements|mesh-ancestor
56624477|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
56624478|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624480|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
56624481|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56624482|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56624483|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
56624484|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
56624485|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624486|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624487|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624488|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56624489|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56624490|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624491|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56624492|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56624493|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56624494|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
56624495|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56624496|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56624497|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
56624498|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56624499|NCT04915365|Acetazolamide|acetazolamide|mesh-list
56624500|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
56624501|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56624502|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624503|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624504|NCT04915365|Diuretics|diuretics|mesh-ancestor
56624505|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
56624506|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624507|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
56624508|NCT02785146|Leucovorin|leucovorin|mesh-list
56624509|NCT02785146|Fluorouracil|fluorouracil|mesh-list
56624510|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
56624511|NCT02785146|Calcium|calcium|mesh-list
56624512|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
56624513|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56624535|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56624537|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
56624538|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624539|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624540|NCT05753865|Paclitaxel|paclitaxel|mesh-list
56624541|NCT05753865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56624542|NCT05753865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624543|NCT05753865|Tubulin Modulators|tubulin modulators|mesh-ancestor
56624544|NCT05753865|Antimitotic Agents|antimitotic agents|mesh-ancestor
56624545|NCT05753865|Mitosis Modulators|mitosis modulators|mesh-ancestor
56624546|NCT05753865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624547|NCT00869869|Melatonin|melatonin|mesh-list
56624548|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
56624549|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624550|NCT00869869|Protective Agents|protective agents|mesh-ancestor
56624551|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624552|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624553|NCT05753787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56624554|NCT05753787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56624555|NCT00874315|Cyclosporine|cyclosporine|mesh-list
56624556|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
56624557|NCT00874315|Fludarabine|fludarabine|mesh-list
56624558|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
56624559|NCT00874315|Busulfan|busulfan|mesh-list
56624560|NCT00874315|Tacrolimus|tacrolimus|mesh-list
56624561|NCT00874315|Cyclosporins|cyclosporins|mesh-list
56624562|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
56648396|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
56648397|NCT00641472|Hormones|hormones|mesh-ancestor
56508346|NCT01124422|Xhance|xhance|mesh-list
56624563|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56624564|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624565|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56624566|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
56624567|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624591|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624593|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624594|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624595|NCT00874393|Protective Agents|protective agents|mesh-ancestor
56624596|NCT04199364|Poractant alfa|poractant alfa|mesh-list
56624597|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56624598|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
56624599|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56624600|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56624601|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624602|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
56624603|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56624604|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624605|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
56624606|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56624607|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56624608|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56624609|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56624610|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624611|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
56624612|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624613|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624614|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56624615|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624616|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
56624617|NCT02784054|Melphalan|melphalan|mesh-list
56373177|NCT00135408|Hormones|hormones|mesh-ancestor
56624618|NCT02784054|Thiotepa|thiotepa|mesh-list
56624649|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56624650|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56624651|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624652|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56624653|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
56624654|NCT02066220|Lomustine|lomustine|mesh-list
56624655|NCT02066220|Cisplatin|cisplatin|mesh-list
56624656|NCT02066220|Carboplatin|carboplatin|mesh-list
56624657|NCT02066220|Vincristine|vincristine|mesh-list
56624658|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624659|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
56624660|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624661|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624662|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56624663|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
56624664|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159744|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
56624680|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624681|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624682|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624683|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
56624684|NCT00573391|Hormones|hormones|mesh-ancestor
56624685|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56624686|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56624687|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624688|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
56624689|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624690|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624691|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56624692|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
56624693|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56624694|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624695|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
56624696|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
56624697|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56624698|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648398|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56648399|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56624699|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56624700|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56624701|NCT00573391|Growth Substances|growth substances|mesh-ancestor
56624702|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
56624704|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624705|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
56624706|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
56624707|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624708|NCT00878371|Morphine|morphine|mesh-list
56624709|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56624710|NCT00878371|Narcotics|narcotics|mesh-ancestor
56624711|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624712|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624713|NCT00878371|Analgesics|analgesics|mesh-ancestor
56624714|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
56624715|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624716|NCT04230564|Azacitidine|azacitidine|mesh-list
56624717|NCT04230564|Venetoclax|venetoclax|mesh-list
56624718|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56624719|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
56624720|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624721|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624722|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624723|NCT04054635|Fluorides|fluorides|mesh-list
56624724|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
56624725|NCT04054635|Protective Agents|protective agents|mesh-ancestor
56624726|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624727|NCT00923299|Trastuzumab|trastuzumab|mesh-list
56624728|NCT00923299|Cetuximab|cetuximab|mesh-list
56624729|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56624747|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56624748|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624749|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
56624750|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624751|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56624752|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624753|NCT04029831|Ketamine|ketamine|mesh-list
56624754|NCT04029831|Propofol|propofol|mesh-list
56624755|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56624756|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624757|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624758|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56624759|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
56624760|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
56624761|NCT04029831|Analgesics|analgesics|mesh-ancestor
56624762|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
56624763|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624764|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56624765|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56624766|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56624767|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624768|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624769|NCT00878449|Etoposide|etoposide|mesh-list
56624770|NCT00878449|Navitoclax|navitoclax|mesh-list
56624771|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624772|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56624773|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56624774|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56624775|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624776|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624777|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
56624778|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56624779|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
56624780|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624781|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624782|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624784|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56624785|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624786|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624787|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
56648400|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
56648401|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56648402|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56648403|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648404|NCT00896051|Ritonavir|ritonavir|mesh-list
56648405|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56648406|NCT00896051|Tenofovir|tenofovir|mesh-list
56648407|NCT00896051|Etravirine|etravirine|mesh-list
56624788|NCT02932956|Fludarabine|fludarabine|mesh-list
56624815|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624816|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624817|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56624818|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
56624819|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
56624820|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624821|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624822|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
56624823|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624825|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
56624826|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624827|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56624828|NCT02783586|Bupivacaine|bupivacaine|mesh-list
56624829|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
56624830|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
56624831|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624832|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624833|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
56624834|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624835|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56624836|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56624837|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56624838|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624860|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
56624861|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
56624862|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
56624863|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624864|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624865|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624866|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56624867|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624868|NCT02608437|Ipilimumab|ipilimumab|mesh-list
56624869|NCT02608437|Guadecitabine|guadecitabine|mesh-list
56624870|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56624871|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624872|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56624873|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624874|NCT05753007|Cannabidiol|cannabidiol|mesh-list
56624875|NCT05753007|Anticonvulsants|anticonvulsants|mesh-ancestor
56624876|NCT04230330|Gemcitabine|gemcitabine|mesh-list
56624877|NCT04230330|Dexamethasone|dexamethasone|mesh-list
56624878|NCT04230330|Nivolumab|nivolumab|mesh-list
56624879|NCT04230330|Asparaginase|asparaginase|mesh-list
56624880|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624881|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
56624882|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
56624883|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624884|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624885|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624887|NCT04230330|Hormones|hormones|mesh-ancestor
56624888|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56624889|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56624890|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624891|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56624892|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
56624893|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624916|NCT05752929|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56624917|NCT05752929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56624918|NCT05752929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648408|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56648409|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56648410|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56648411|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
56624919|NCT00880477|Edetic Acid|edetic acid|mesh-list
56624920|NCT00880477|Vaccines|vaccines|mesh-list
56624921|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
56624922|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
56624923|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624924|NCT00880477|Antidotes|antidotes|mesh-ancestor
56624925|NCT00880477|Protective Agents|protective agents|mesh-ancestor
56624926|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
56624927|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
56624928|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624929|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56624930|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
56624931|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56624932|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56624933|NCT05293938|Cathartics|cathartics|mesh-ancestor
56624934|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624935|NCT00882739|Clopidogrel|clopidogrel|mesh-list
56624936|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56624937|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56624938|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56624939|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56624940|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
56624941|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624942|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624943|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624944|NCT02783040|Digoxin|digoxin|mesh-list
56624945|NCT02783040|Midazolam|midazolam|mesh-list
56624946|NCT02783040|BI 425809|bi 425809|mesh-list
56624947|NCT02783040|Omeprazole|omeprazole|mesh-list
56624948|NCT02783040|Warfarin|warfarin|mesh-list
56624949|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56624950|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56625006|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56625007|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625008|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625009|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56625010|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56625011|NCT00805935|Leuprolide|leuprolide|mesh-list
56625012|NCT00805935|Menotropins|menotropins|mesh-list
56625013|NCT00805935|Progesterone|progesterone|mesh-list
56625014|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56625015|NCT00805935|Progestins|progestins|mesh-ancestor
56625016|NCT00805935|Hormones|hormones|mesh-ancestor
56625017|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56625018|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625019|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56625020|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
56625021|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56625022|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56625023|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625024|NCT00878917|Dorzolamide|dorzolamide|mesh-list
56625025|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56625026|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56625045|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625046|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56625047|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56625048|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625049|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625050|NCT02783196|Liraglutide|liraglutide|mesh-list
56625051|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56625052|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625053|NCT02783196|Incretins|incretins|mesh-ancestor
56625054|NCT02783196|Hormones|hormones|mesh-ancestor
56625055|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56625056|NCT05188170|Niclosamide|niclosamide|mesh-list
56625057|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
56625058|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56625059|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
56648412|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625060|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56625061|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625062|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
56625063|NCT05180994|Infliximab|infliximab|mesh-list
56625064|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
56625065|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56625066|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625067|NCT02782338|Diclofenac|diclofenac|mesh-list
56625068|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56625069|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625070|NCT02782338|Analgesics|analgesics|mesh-ancestor
56625071|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
56625072|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625073|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625074|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56625075|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56373623|NCT00103103|Leucovorin|leucovorin|mesh-list
56625076|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56625077|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625078|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625079|NCT02782260|Dipyridamole|dipyridamole|mesh-list
56625080|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56625131|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625132|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56625133|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56625134|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
56625135|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625136|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625137|NCT00615199|Tofacitinib|tofacitinib|mesh-list
56625138|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56625139|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625140|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625141|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56625142|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56625143|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
56625144|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625145|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625146|NCT00880867|Poly ICLC|poly iclc|mesh-list
56625147|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
56625148|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
56625149|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625150|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56625151|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56625152|NCT02782182|Leucovorin|leucovorin|mesh-list
56625153|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
56625154|NCT02782182|Irinotecan|irinotecan|mesh-list
56625155|NCT02782182|Folfirinox|folfirinox|mesh-list
56625192|NCT00634686|Calcium|calcium|mesh-list
56625193|NCT00634686|Vitamins|vitamins|mesh-ancestor
56625194|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
56625195|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625196|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56625197|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56625198|NCT05340192|Octreotide|octreotide|mesh-list
56625199|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56625200|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56625201|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625202|NCT03955861|Adalimumab|adalimumab|mesh-list
56625203|NCT03955861|Etanercept|etanercept|mesh-list
56625204|NCT03955861|Golimumab|golimumab|mesh-list
56625205|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
56625206|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56625207|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625208|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56625209|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625210|NCT03955861|Analgesics|analgesics|mesh-ancestor
56625211|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
56625212|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625213|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625214|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56625215|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56625216|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
56625217|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56625218|NCT00881179|Clarithromycin|clarithromycin|mesh-list
56625219|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56648413|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648414|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56648415|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56625220|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625221|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56625222|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625279|NCT02937116|Immunologic Factors|immunologic factors|mesh-ancestor
56625280|NCT02937116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625281|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56625282|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56625283|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56625284|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56625285|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56625286|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56625287|NCT03927105|Nivolumab|nivolumab|mesh-list
56625288|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56625289|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625290|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56625291|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625292|NCT00613327|Oxybutynin|oxybutynin|mesh-list
56625293|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
56625294|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
56625295|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625296|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625297|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56373842|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
56625298|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56625299|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
56625300|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625301|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625302|NCT00613327|Urological Agents|urological agents|mesh-ancestor
56625303|NCT04273997|Metronidazole|metronidazole|mesh-list
56625304|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625305|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56625306|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56625307|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56625308|NCT05339802|Linezolid|linezolid|mesh-list
56625309|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56625310|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625399|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56625400|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625401|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
56625402|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56625403|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56625404|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56625405|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
56625406|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625407|NCT00630851|Donepezil|donepezil|mesh-list
56625408|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56625409|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625410|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625411|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
56625412|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625413|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625414|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
56625415|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
56625416|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625417|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56625418|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625419|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625420|NCT05156892|Tamoxifen|tamoxifen|mesh-list
56625421|NCT05156892|Itraconazole|itraconazole|mesh-list
56625422|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56625423|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
56625446|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625447|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625448|NCT02859077|Gemcitabine|gemcitabine|mesh-list
56625449|NCT02859077|Carboplatin|carboplatin|mesh-list
56625451|NCT02859077|Gefitinib|gefitinib|mesh-list
56625452|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625453|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56648416|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
56648417|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648418|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56648419|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56648420|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56625454|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
56625455|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625456|NCT02859077|Antiviral Agents|antiviral agents|mesh-ancestor
56625457|NCT02859077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625458|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625459|NCT02859077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56625460|NCT02859077|Immunologic Factors|immunologic factors|mesh-ancestor
56625461|NCT02859077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625462|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56625463|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56625464|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56625465|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56625466|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
56625467|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56625468|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56625469|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56625470|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625483|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625484|NCT03851835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56625485|NCT03851835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56625486|NCT03851835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625487|NCT03851835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56625488|NCT03851835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56625489|NCT00879385|Decitabine|decitabine|mesh-list
56625490|NCT00879385|Panitumumab|panitumumab|mesh-list
56625491|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56625492|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
56625493|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625494|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625495|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625496|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56625497|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
56625498|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56625499|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625500|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56625501|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56625502|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625503|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625504|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625505|NCT00953225|Vitamin D|vitamin d|mesh-list
56625506|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
56625507|NCT00953225|Vitamins|vitamins|mesh-ancestor
56625508|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
56625509|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625510|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56625511|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56625512|NCT03819231|Oxytocin|oxytocin|mesh-list
56625513|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
56625514|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56625515|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625516|NCT00613015|Guanfacine|guanfacine|mesh-list
56625517|NCT00613015|Modafinil|modafinil|mesh-list
56625518|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56625519|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625520|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56625521|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56625522|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56625523|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374078|NCT00104975|Melphalan|melphalan|mesh-list
56625524|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56625525|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56625526|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56625527|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56648422|NCT04250051|Cytarabine|cytarabine|mesh-list
56648423|NCT04250051|Fludarabine|fludarabine|mesh-list
56648424|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
56648425|NCT04250051|Ivosidenib|ivosidenib|mesh-list
56625528|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
56625529|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625530|NCT02779608|Docetaxel|docetaxel|mesh-list
56625531|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625532|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
56625533|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
56625592|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56625593|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56625594|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56625595|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56625596|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
56625597|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
56625598|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
56374141|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56625599|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
56625600|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625601|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625603|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
56625604|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
56625605|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625606|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625607|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
56625608|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625609|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56625610|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56625611|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56625612|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56625613|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625614|NCT00803595|Oseltamivir|oseltamivir|mesh-list
56625615|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
56625616|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625617|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625618|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625619|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
56625620|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56625621|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625622|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
56625623|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56625624|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625625|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
56625626|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
56625627|NCT04227990|Docetaxel|docetaxel|mesh-list
56625628|NCT04227990|Doxorubicin|doxorubicin|mesh-list
56625644|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625646|NCT02606409|Propofol|propofol|mesh-list
56625647|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56625648|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625649|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625650|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56625651|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
56625652|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
56625653|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625654|NCT02606409|Analgesics|analgesics|mesh-ancestor
56625655|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
56625656|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625657|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56625658|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56625659|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56625660|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
56625661|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625662|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625663|NCT00611767|Thiopental|thiopental|mesh-list
56625664|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
56625665|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56625666|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625667|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625668|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56625669|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
56625670|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
56625671|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
56648426|NCT04250051|Lenograstim|lenograstim|mesh-list
56648427|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648428|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56625672|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
56625673|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374216|NCT00135018|Celecoxib|celecoxib|mesh-list
56625674|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625675|NCT04967508|Ustekinumab|ustekinumab|mesh-list
56625676|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
56625677|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56625678|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56625679|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56625680|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56625681|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625682|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625683|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625684|NCT00803361|Analgesics|analgesics|mesh-ancestor
56625685|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
56625715|NCT04985604|Vitamins|vitamins|mesh-ancestor
56625716|NCT04985604|Micronutrients|micronutrients|mesh-ancestor
56625717|NCT04985604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625718|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
56625719|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56625720|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625721|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56625722|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56625723|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625724|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625725|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625726|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
56625727|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
56625728|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
56625729|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56625730|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56625731|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625732|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625750|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56625752|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56625753|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56625754|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56625755|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625756|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
56625757|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625758|NCT00953147|Ciclesonide|ciclesonide|mesh-list
56625759|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
56625760|NCT00953147|Hormones|hormones|mesh-ancestor
56625761|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56625762|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625763|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56625764|NCT05333744|Prednisone|prednisone|mesh-list
56625765|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56625766|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
56625767|NCT05333744|Hormones|hormones|mesh-ancestor
56625768|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56625769|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625770|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56625771|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625772|NCT04250246|Nivolumab|nivolumab|mesh-list
56625773|NCT04250246|Ipilimumab|ipilimumab|mesh-list
56625774|NCT04250246|Guadecitabine|guadecitabine|mesh-list
56625775|NCT04250246|Azacitidine|azacitidine|mesh-list
56625776|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56625777|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625778|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56625779|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625780|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56625781|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
56625782|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625783|NCT04273529|Thalidomide|thalidomide|mesh-list
56625784|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56625785|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
56625786|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648429|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
56648430|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648431|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56648432|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
56625787|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
56625788|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56625807|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625808|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56625809|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625810|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625812|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56625813|NCT00952523|Tretinoin|tretinoin|mesh-list
56625814|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56625815|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
56625816|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56625817|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625818|NCT00952523|Analgesics|analgesics|mesh-ancestor
56625819|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
56625820|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625821|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625822|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56625823|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625824|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625825|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
56625827|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56625829|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56625830|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625831|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56625832|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625833|NCT02857361|Ketamine|ketamine|mesh-list
56625834|NCT02857361|Analgesics|analgesics|mesh-ancestor
56625835|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
56625836|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625837|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625838|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56625839|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56625840|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
56625841|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
56625842|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625843|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56625844|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56625845|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625886|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56625887|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625888|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56625889|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625890|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625891|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56625892|NCT04204928|Pralsetinib|pralsetinib|mesh-list
56625893|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625894|NCT02834546|Sorafenib|sorafenib|mesh-list
56625895|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625896|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56059679|NCT05687721|Avelumab|avelumab|mesh-list
56625897|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625898|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625899|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56625900|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56625901|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
56625902|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625903|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56625905|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
56625906|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625907|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625908|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
56625909|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625926|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
56625927|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56625928|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56648433|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648434|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
56648435|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625929|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56625930|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
56625931|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625932|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625933|NCT02854787|Protective Agents|protective agents|mesh-ancestor
56625935|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56625936|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625937|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56625938|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625939|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625940|NCT05206110|Ketorolac|ketorolac|mesh-list
56625941|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56625942|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56625943|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625944|NCT05206110|Analgesics|analgesics|mesh-ancestor
56625945|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
56625946|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625947|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625948|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56625949|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625950|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56625951|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625952|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625953|NCT02777736|Methotrexate|methotrexate|mesh-list
56625954|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56625955|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
56625956|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56625957|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625958|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56625959|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
56625960|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625961|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625962|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
56625963|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625964|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56625965|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56625966|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
56625967|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56626030|NCT02836028|Talazoparib|talazoparib|mesh-list
56626031|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56626032|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
56626033|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626034|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626035|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56626036|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626037|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
56626038|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
56626039|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
56626040|NCT01778946|Nicotine|nicotine|mesh-list
56626041|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56626042|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
56626043|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626044|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626045|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56374595|NCT00436267|Fluorouracil|fluorouracil|mesh-list
56626046|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56626047|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
56626048|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626059|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626061|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56626062|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626063|NCT02833610|Denosumab|denosumab|mesh-list
56626064|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56626065|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626071|NCT04225728|Iron|iron|mesh-list
56626072|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56626073|NCT04225728|Teferrol|teferrol|mesh-list
56626074|NCT04225728|Trace Elements|trace elements|mesh-ancestor
56626075|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
56648436|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56648437|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648438|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56626076|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626077|NCT04225728|Hematinics|hematinics|mesh-ancestor
56626078|NCT02835716|Ustekinumab|ustekinumab|mesh-list
56626079|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
56626080|NCT04247984|Bevacizumab|bevacizumab|mesh-list
56626081|NCT04247984|Fluorouracil|fluorouracil|mesh-list
56626082|NCT04247984|Capecitabine|capecitabine|mesh-list
56626083|NCT04247984|Irinotecan|irinotecan|mesh-list
56626084|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56626085|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626086|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56626087|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56626088|NCT04247984|Growth Substances|growth substances|mesh-ancestor
56626089|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626090|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
56626091|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
56626092|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626093|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56626094|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56626095|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
56626096|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56626097|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56626098|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626099|NCT00948389|Dasatinib|dasatinib|mesh-list
56626100|NCT00948389|Lomustine|lomustine|mesh-list
56626101|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626102|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626103|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626104|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626105|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56626106|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
56626107|NCT02775318|Bupivacaine|bupivacaine|mesh-list
56626108|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
56626109|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
56626110|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626111|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626112|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
56626113|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626114|NCT00948155|Varenicline|varenicline|mesh-list
56626115|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56626116|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56626117|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
56626118|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176766|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56626130|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
56626131|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56626132|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56626133|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626134|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56626135|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626136|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56626137|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626138|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56626139|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56626140|NCT04910178|Protective Agents|protective agents|mesh-ancestor
56626141|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
56626142|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56626143|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
56626144|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56626145|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56626146|NCT02778594|Levodopa|levodopa|mesh-list
56626147|NCT02778594|Benserazide|benserazide|mesh-list
56626148|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56626149|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56626150|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
56626151|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626152|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626153|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626154|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626155|NCT02775006|Docetaxel|docetaxel|mesh-list
56648439|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56648440|NCT02673606|Estradiol|estradiol|mesh-list
56648441|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56648442|NCT02673606|Estrogens|estrogens|mesh-ancestor
56626156|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56626157|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626158|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
56626159|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
56626160|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
56626161|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626162|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626163|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626164|NCT04851834|Cisplatin|cisplatin|mesh-list
56626165|NCT04851834|Carboplatin|carboplatin|mesh-list
56626166|NCT04851834|Temozolomide|temozolomide|mesh-list
56626167|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626168|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56626169|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
56626170|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626171|NCT01880567|Rituximab|rituximab|mesh-list
56626172|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56626173|NCT01880567|Antibodies|antibodies|mesh-list
56626174|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
56626175|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56626176|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
56626177|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626178|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626179|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56626180|NCT02776722|Tagatose|tagatose|mesh-list
56626181|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56626182|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
56626203|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
56626204|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
56626205|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626206|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626207|NCT02772744|Ribavirin|ribavirin|mesh-list
56626208|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
56626209|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
56626210|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626211|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
56626212|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626213|NCT02774382|Vancomycin|vancomycin|mesh-list
56626214|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56626215|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626216|NCT02774460|Amlodipine|amlodipine|mesh-list
56626217|NCT02774460|Candesartan|candesartan|mesh-list
56626218|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
56626219|NCT02774460|Lisinopril|lisinopril|mesh-list
56626220|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56626221|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56626222|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56626223|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626224|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56626225|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626226|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
56626227|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56626228|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56626229|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56626230|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
56626231|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626232|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56626248|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56626249|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56626250|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56626251|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
56626252|NCT00611455|Ofatumumab|ofatumumab|mesh-list
56626253|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626254|NCT02767752|Gemcitabine|gemcitabine|mesh-list
56626255|NCT02767752|Capecitabine|capecitabine|mesh-list
56626256|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56626257|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
56626258|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626259|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648443|NCT02673606|Hormones|hormones|mesh-ancestor
56648444|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56648445|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648446|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56648447|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
56648448|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56626260|NCT02767752|Antiviral Agents|antiviral agents|mesh-ancestor
56626261|NCT02767752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626262|NCT02767752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626263|NCT02767752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56626264|NCT02767752|Immunologic Factors|immunologic factors|mesh-ancestor
56626265|NCT02767752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626266|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56626267|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
56626268|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626269|NCT02835404|Nedaplatin|nedaplatin|mesh-list
56626270|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626271|NCT00885781|SMOFlipid|smoflipid|mesh-list
56374824|NCT00106847|Infliximab|infliximab|mesh-list
56626272|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56626273|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56626274|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56626275|NCT02767674|Gemcitabine|gemcitabine|mesh-list
56626276|NCT02767674|Prednisone|prednisone|mesh-list
56626277|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
56626278|NCT02767674|Rituximab|rituximab|mesh-list
56626279|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
56626280|NCT02767674|Epirubicin|epirubicin|mesh-list
56626281|NCT02767674|Vindesine|vindesine|mesh-list
56626282|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56626283|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
56626284|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626285|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56626286|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56626287|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
56626288|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626289|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626290|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56626291|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56626292|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56626317|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56626318|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56626319|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56626320|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
56626321|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626322|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626323|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
56626324|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56626325|NCT00947531|Protective Agents|protective agents|mesh-ancestor
56626326|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626327|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
56626329|NCT00612313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56626330|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56626331|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56626332|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626333|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626334|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
56626335|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626336|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56626337|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
56626338|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56626339|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56626340|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56626341|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626378|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56626379|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626380|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
56626381|NCT02542813|Oxytocin|oxytocin|mesh-list
56648449|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56648450|NCT02675400|Methylphenidate|methylphenidate|mesh-list
56648451|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56648452|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56626382|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
56626383|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56626384|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626385|NCT02772120|Progesterone|progesterone|mesh-list
56626386|NCT02772120|Progestins|progestins|mesh-ancestor
56626387|NCT02772120|Hormones|hormones|mesh-ancestor
56626388|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56626389|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626390|NCT04248608|Morphine|morphine|mesh-list
56626391|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56626392|NCT04248608|Narcotics|narcotics|mesh-ancestor
56626393|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626394|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626395|NCT04248608|Analgesics|analgesics|mesh-ancestor
56626396|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
56626397|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626398|NCT04783194|Dexamethasone|dexamethasone|mesh-list
56626399|NCT04783194|Bupivacaine|bupivacaine|mesh-list
56626400|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626401|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
56626402|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
56626403|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626404|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626405|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56626406|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
56626407|NCT04783194|Hormones|hormones|mesh-ancestor
56626408|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060197|NCT01654861|Protective Agents|protective agents|mesh-ancestor
56626409|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56626410|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626411|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
56626412|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
56626413|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626414|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
56626415|NCT02854241|Liver Extracts|liver extracts|mesh-list
56626416|NCT02854241|Hematinics|hematinics|mesh-ancestor
56626417|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
56626418|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56626419|NCT02835170|Antibodies|antibodies|mesh-list
56626420|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
56374966|NCT00138177|Leucovorin|leucovorin|mesh-list
56626421|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626422|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
56626423|NCT02856425|Nintedanib|nintedanib|mesh-list
56626424|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56626426|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626427|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626428|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626438|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626439|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56626440|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56626442|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56626443|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56626444|NCT00611923|Flutamide|flutamide|mesh-list
56626445|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
56626446|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
56626447|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56626448|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626449|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56626450|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626451|NCT04246502|Capecitabine|capecitabine|mesh-list
56626452|NCT04246502|Trastuzumab|trastuzumab|mesh-list
56626453|NCT04246502|Pertuzumab|pertuzumab|mesh-list
56626454|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56626455|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
56626456|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626457|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075357|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
56648453|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648454|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56648455|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56648456|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56648457|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648458|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
56648459|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648460|NCT05501886|Fulvestrant|fulvestrant|mesh-list
56648461|NCT05501886|Palbociclib|palbociclib|mesh-list
56626458|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56626459|NCT02767362|Atorvastatin|atorvastatin|mesh-list
56626460|NCT02767362|Ezetimibe|ezetimibe|mesh-list
56626461|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56626462|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56626463|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
56626464|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626465|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56626466|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56626467|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626468|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
56626469|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56626470|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626471|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56626472|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56626473|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626474|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626475|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626476|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56626477|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56626478|NCT02541643|Elotuzumab|elotuzumab|mesh-list
56626479|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626480|NCT02696694|Progesterone|progesterone|mesh-list
56626481|NCT02696694|Progestins|progestins|mesh-ancestor
56626482|NCT02696694|Hormones|hormones|mesh-ancestor
56626483|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56626484|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626485|NCT04038073|Antibodies|antibodies|mesh-list
56626486|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
56626487|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
56626488|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626489|NCT04739592|Vitamin D|vitamin d|mesh-list
56626490|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
56626491|NCT04739592|Alendronate|alendronate|mesh-list
56626492|NCT04739592|Vitamins|vitamins|mesh-ancestor
56626493|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
56626494|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626527|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626529|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
56626530|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626531|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626532|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56626533|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
56626534|NCT00888901|Hormones|hormones|mesh-ancestor
56626535|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56626536|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56626701|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56626702|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
56626703|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
56626704|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626705|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56626706|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56626707|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626708|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626709|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
56626710|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56648462|NCT05501886|Gedatolisib|gedatolisib|mesh-list
56648463|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56648464|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648465|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56648466|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56648467|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
56648468|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56648469|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648470|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626711|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
56626712|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626713|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
56626714|NCT05278897|Protective Agents|protective agents|mesh-ancestor
56626715|NCT00889525|Cabergoline|cabergoline|mesh-list
56626815|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56626816|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
56626817|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56626818|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56626819|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
56626820|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56626821|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
56626822|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56626823|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56626824|NCT04243850|Empagliflozin|empagliflozin|mesh-list
56626825|NCT04243850|Caffeine|caffeine|mesh-list
56626826|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56626827|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626828|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56626829|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626830|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626831|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56626832|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56626833|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
56626834|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626835|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56626836|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56626837|NCT00892801|Everolimus|everolimus|mesh-list
56626838|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626839|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56626840|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
56626841|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626843|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626844|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626845|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626846|NCT00633542|Interferons|interferons|mesh-list
56626847|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
56626848|NCT00633542|Thalidomide|thalidomide|mesh-list
56626849|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626850|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
56626851|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626852|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
56626853|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626854|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56626855|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
56626856|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56626857|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56626858|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56626859|NCT00633542|Growth Substances|growth substances|mesh-ancestor
56626860|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
56626861|NCT02766036|Propolis|propolis|mesh-list
56626862|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626908|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626909|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56626910|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56648526|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56648527|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733164|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56555574|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555575|NCT00675649|Golimumab|golimumab|mesh-list
56555576|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56555577|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555578|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56555579|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
56555580|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555581|NCT01107912|Clopidogrel|clopidogrel|mesh-list
56555582|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56555583|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56555584|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56555585|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56555588|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555589|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555590|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555591|NCT00678145|Epinephrine|epinephrine|mesh-list
56555592|NCT00678145|Morphine|morphine|mesh-list
56555593|NCT00678145|Naloxone|naloxone|mesh-list
56555594|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555595|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56555596|NCT00678145|Narcotics|narcotics|mesh-ancestor
56555597|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555598|NCT00678145|Analgesics|analgesics|mesh-ancestor
56555599|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
56555600|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555601|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56555602|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56555603|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
56555604|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555605|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555606|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56555607|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56555608|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
56555609|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56555610|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
56555611|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
56555612|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
56555613|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56555614|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56555615|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
56555616|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
56555617|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
56555618|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555619|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555620|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
56555621|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555622|NCT02690506|Pregabalin|pregabalin|mesh-list
56555623|NCT02690506|Analgesics|analgesics|mesh-ancestor
56555624|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
56555625|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555626|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555627|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
56555628|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56555629|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56555630|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555631|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56555632|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56555633|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56555634|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555635|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56555636|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
56555637|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56555638|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555640|NCT04239586|Glipizide|glipizide|mesh-list
56555641|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56555642|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555643|NCT02628613|Paclitaxel|paclitaxel|mesh-list
56555644|NCT02628613|Vinorelbine|vinorelbine|mesh-list
56555645|NCT02628613|Epirubicin|epirubicin|mesh-list
56648528|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648529|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555646|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56555647|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555648|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
56555649|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555650|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
56555651|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555652|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56555653|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56555654|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56555655|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555656|NCT01100034|Etanercept|etanercept|mesh-list
56555657|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56555658|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56555659|NCT01100034|Analgesics|analgesics|mesh-ancestor
56555660|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
56555664|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555665|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555666|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56555667|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
56555668|NCT04148833|Paclitaxel|paclitaxel|mesh-list
56555669|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56555670|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555671|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
56555672|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555673|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
56555674|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555675|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56555676|NCT02821468|Acetaminophen|acetaminophen|mesh-list
56555677|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
56555678|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56555679|NCT02821468|Analgesics|analgesics|mesh-ancestor
56555680|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
56555681|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555682|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555683|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
56555684|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56555685|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555686|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555687|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56555688|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555689|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555690|NCT04964622|Ibuprofen|ibuprofen|mesh-list
56555691|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56555692|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56555693|NCT04964622|Analgesics|analgesics|mesh-ancestor
56555694|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
56555695|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555696|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555697|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555698|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555699|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56555700|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555701|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555702|NCT04769050|Docetaxel|docetaxel|mesh-list
56555703|NCT04769050|Capecitabine|capecitabine|mesh-list
56555704|NCT04769050|Trastuzumab|trastuzumab|mesh-list
56555705|NCT04769050|Pertuzumab|pertuzumab|mesh-list
56555706|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555707|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
56555708|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555709|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
56555710|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555711|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56555712|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
56555713|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56555715|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56555716|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
56555717|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56555718|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56648530|NCT04181346|Pregabalin|pregabalin|mesh-list
56648531|NCT04181346|Analgesics|analgesics|mesh-ancestor
56648532|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
56648533|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648534|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934910|NCT00964353|Warfarin|warfarin|mesh-list
56555719|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56555720|NCT02821390|Analgesics|analgesics|mesh-ancestor
56555721|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
56555722|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555723|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555724|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555725|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555726|NCT02821312|DA-8010|da-8010|mesh-list
56555727|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56555728|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56555729|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
56555730|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555731|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555732|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555734|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56555736|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555737|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555738|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56555739|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
56555740|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56555741|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
56555742|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555743|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555744|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56555745|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
56555746|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
56555747|NCT02821156|Protective Agents|protective agents|mesh-ancestor
56555748|NCT02820922|Anesthetics|anesthetics|mesh-list
56555749|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555750|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555751|NCT00633958|Alovudine|alovudine|mesh-list
56555752|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
56555753|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555754|NCT02820688|Bupivacaine|bupivacaine|mesh-list
56555755|NCT02820688|Prilocaine|prilocaine|mesh-list
56555756|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
56555757|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
56555758|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555759|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555760|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
56555761|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555762|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56555763|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56555764|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56555765|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56555766|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56555767|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56555768|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56555769|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56555770|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
56555771|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555772|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555773|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555774|NCT02818816|Laxatives|laxatives|mesh-ancestor
56555775|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555776|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
56555777|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
56555778|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56555779|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555780|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555781|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56304105|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56555782|NCT02820610|Analgesics|analgesics|mesh-ancestor
56648535|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
56648536|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56648537|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56555783|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
56555784|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555785|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56555786|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56555787|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56555788|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
56555789|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555790|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555791|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
56555792|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56555793|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
56555794|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56555795|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56555796|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56555797|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
56555798|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56555799|NCT04745728|Prednisone|prednisone|mesh-list
56555800|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
56555801|NCT04745728|Rituximab|rituximab|mesh-list
56555802|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56555803|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
56555804|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555805|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555807|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
56555808|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555809|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555810|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56555811|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56555812|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555813|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
56555814|NCT04745728|Hormones|hormones|mesh-ancestor
56555815|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555816|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56555817|NCT02818660|Cosyntropin|cosyntropin|mesh-list
56555818|NCT02818660|Hormones|hormones|mesh-ancestor
56555819|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555820|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555821|NCT01107444|Docetaxel|docetaxel|mesh-list
56555822|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555823|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
56555824|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555825|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
56555826|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555827|NCT04238806|Desflurane|desflurane|mesh-list
56555828|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56555829|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
56555830|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
56555831|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555832|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555833|NCT00876187|Naproxen|naproxen|mesh-list
56555834|NCT00876187|Tanezumab|tanezumab|mesh-list
56555835|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56555836|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56555837|NCT00876187|Analgesics|analgesics|mesh-ancestor
56555838|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
56555839|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555840|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555841|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555842|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555843|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
56555844|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56555845|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555846|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555847|NCT04238884|Voriconazole|voriconazole|mesh-list
56555848|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
56555849|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555850|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56555851|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56648538|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648539|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56555852|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555853|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555854|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56555855|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
56555856|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555857|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555858|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56555860|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
56555861|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
56555862|NCT01102374|Vitamins|vitamins|mesh-list
56555863|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
56555864|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555865|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56555866|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56555867|NCT05658640|Cytarabine|cytarabine|mesh-list
56555868|NCT05658640|Dexamethasone|dexamethasone|mesh-list
56555869|NCT05658640|Cyclophosphamide|cyclophosphamide|mesh-list
56555870|NCT05658640|Trametinib|trametinib|mesh-list
56555871|NCT05658640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56555872|NCT05658640|Immunologic Factors|immunologic factors|mesh-ancestor
56555873|NCT05658640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555874|NCT05658640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555875|NCT05658640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56555876|NCT05658640|Alkylating Agents|alkylating agents|mesh-ancestor
56555877|NCT05658640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555878|NCT05658640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555879|NCT05658640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56555880|NCT05658640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555882|NCT05658640|Autonomic Agents|autonomic agents|mesh-ancestor
56555883|NCT05658640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555884|NCT05658640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555885|NCT05658640|Glucocorticoids|glucocorticoids|mesh-ancestor
56555886|NCT05658640|Hormones|hormones|mesh-ancestor
56555887|NCT05658640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555888|NCT05658640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56555889|NCT05658640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56555890|NCT05658640|Antimetabolites|antimetabolites|mesh-ancestor
56555891|NCT05658640|Antiviral Agents|antiviral agents|mesh-ancestor
56555892|NCT05658640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555893|NCT05658640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56555894|NCT05658640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555895|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
56555896|NCT02818270|Albuterol|albuterol|mesh-list
56555897|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56555898|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
56555899|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555900|NCT02818270|Expectorants|expectorants|mesh-ancestor
56555901|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
56555902|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56555903|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
56555904|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555905|NCT02818270|Protective Agents|protective agents|mesh-ancestor
56555906|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555907|NCT02818270|Antidotes|antidotes|mesh-ancestor
56555908|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56555909|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
56555910|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555911|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56555912|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
56555913|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56555914|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56555915|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56555916|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56555917|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
56555918|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555919|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
56555920|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56555921|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555922|NCT02818348|Darunavir|darunavir|mesh-list
56555923|NCT02818348|Cobicistat|cobicistat|mesh-list
56648540|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56648541|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56648542|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555924|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56555925|NCT02818348|Etravirine|etravirine|mesh-list
56555926|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56555927|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56555928|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
56304269|NCT02971345|Iodine|iodine|mesh-list
56555929|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555930|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555931|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56555932|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56555933|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
56555934|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555935|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56555936|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56555937|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56555938|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56555939|NCT00634192|Tobramycin|tobramycin|mesh-list
56555940|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56555941|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555942|NCT00684463|Palonosetron|palonosetron|mesh-list
56555943|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
56555944|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
56555945|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555946|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555947|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555948|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56555949|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56555950|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
56555951|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555952|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555953|NCT00678457|Ondansetron|ondansetron|mesh-list
56555955|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
56555956|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
56555957|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555958|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555959|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555960|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
56555961|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
56555962|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56555963|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
56555964|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555965|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555966|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56555967|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56555968|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555969|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56555970|NCT00678457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56555971|NCT00678457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56555972|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56555973|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56555974|NCT00678613|Norfloxacin|norfloxacin|mesh-list
56555975|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56555976|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555977|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56555978|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56555979|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555980|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555981|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555982|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56555983|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56555984|NCT00678769|Sirolimus|sirolimus|mesh-list
56555985|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56555986|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56555987|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555988|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56555989|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555990|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
56555991|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56648543|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56648544|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56648545|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56555992|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
56555993|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555994|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56555995|NCT04146883|Cephalexin|cephalexin|mesh-list
56555996|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555997|NCT02817256|Vitamins|vitamins|mesh-list
56555998|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
56555999|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556000|NCT02817100|Itraconazole|itraconazole|mesh-list
56556001|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
56556002|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556003|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56556004|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56556005|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556006|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556007|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56556008|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
56556009|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556010|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556011|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56556013|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56556014|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556015|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56556016|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56556017|NCT00684853|Growth Substances|growth substances|mesh-ancestor
56556018|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556019|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
56556020|NCT02816476|Daratumumab|daratumumab|mesh-list
56556021|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556022|NCT04549792|Ustekinumab|ustekinumab|mesh-list
56556023|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
56556024|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
56556025|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56556026|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556027|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556036|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556038|NCT00685009|Progestins|progestins|mesh-ancestor
56556039|NCT00679237|Metformin|metformin|mesh-list
56556040|NCT00679237|Glimepiride|glimepiride|mesh-list
56556041|NCT00679237|Ezetimibe|ezetimibe|mesh-list
56556042|NCT00679237|Diuretics|diuretics|mesh-list
56556043|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56556044|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556045|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56556046|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56556047|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
56556048|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556049|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56556050|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56556051|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56556052|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
56556053|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
56556054|NCT00681733|Pioglitazone|pioglitazone|mesh-list
56556055|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
56556056|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56556057|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556058|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56556059|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556060|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556061|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56556062|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56556063|NCT00681733|Protective Agents|protective agents|mesh-ancestor
56556064|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
56556065|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56556066|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
56556067|NCT00679315|Alfuzosin|alfuzosin|mesh-list
56556068|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56556069|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56556070|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56648546|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648547|NCT00642798|Incretins|incretins|mesh-ancestor
56648548|NCT00642798|Hormones|hormones|mesh-ancestor
56556071|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
56556072|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556073|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556074|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556075|NCT00679315|Urological Agents|urological agents|mesh-ancestor
56556076|NCT05652400|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56556077|NCT05652400|Antiviral Agents|antiviral agents|mesh-ancestor
56556078|NCT05652400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556079|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56556080|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
56556081|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556083|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56556084|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
56556085|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556086|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556087|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556088|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56556089|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56556090|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556091|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56556092|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56556093|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
56556094|NCT04460248|Rituximab|rituximab|mesh-list
56556095|NCT04460248|Lenalidomide|lenalidomide|mesh-list
56556097|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56556099|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
56556100|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556101|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56556102|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56556103|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56556104|NCT04460248|Growth Substances|growth substances|mesh-ancestor
56556105|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
56556106|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56556107|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556108|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556109|NCT05658874|Methenamine|methenamine|mesh-list
56556110|NCT05658874|Methenamine hippurate|methenamine hippurate|mesh-list
56556111|NCT05658874|Methenamine mandelate|methenamine mandelate|mesh-list
56556112|NCT05658874|Gabapentin|gabapentin|mesh-list
56556113|NCT05658874|Amitriptyline|amitriptyline|mesh-list
56556114|NCT05658874|Mirabegron|mirabegron|mesh-list
56556115|NCT05658874|Oxybutynin|oxybutynin|mesh-list
56556116|NCT05658874|Estrogens|estrogens|mesh-list
56556117|NCT05658874|Analgesics|analgesics|mesh-ancestor
56556118|NCT05658874|Sensory System Agents|sensory system agents|mesh-ancestor
56556119|NCT05658874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556120|NCT05658874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556121|NCT05658874|Anticonvulsants|anticonvulsants|mesh-ancestor
56556122|NCT05658874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56556123|NCT05658874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56556124|NCT05658874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556125|NCT05658874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56556126|NCT05658874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56556127|NCT05658874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56556128|NCT05658874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556129|NCT05658874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556130|NCT05658874|Antimanic Agents|antimanic agents|mesh-ancestor
56556131|NCT05658874|Hormones|hormones|mesh-ancestor
56556132|NCT05658874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556133|NCT05658874|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56556134|NCT05658874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56556135|NCT05658874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56556136|NCT05658874|Adrenergic Agents|adrenergic agents|mesh-ancestor
56556137|NCT05658874|Urological Agents|urological agents|mesh-ancestor
56556138|NCT05658874|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56556139|NCT05658874|Antidepressive Agents|antidepressive agents|mesh-ancestor
56556140|NCT05658874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56556141|NCT05658874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56556142|NCT05658874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56648549|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56648550|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56556143|NCT05658874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56556144|NCT05658874|Parasympatholytics|parasympatholytics|mesh-ancestor
56556145|NCT05658874|Autonomic Agents|autonomic agents|mesh-ancestor
56556146|NCT05658874|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56556147|NCT05658874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56556148|NCT05658874|Cholinergic Agents|cholinergic agents|mesh-ancestor
56556149|NCT05658874|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56556150|NCT05658874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556151|NCT05658874|Renal Agents|renal agents|mesh-ancestor
56556152|NCT05658874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556153|NCT01106898|Paclitaxel|paclitaxel|mesh-list
56556154|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
56556155|NCT01106898|Trastuzumab|trastuzumab|mesh-list
56556156|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56556157|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556158|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
56556159|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
56556160|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
56556161|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556162|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56556163|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
56556164|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556165|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56556166|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56556167|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
56556168|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56129829|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56556171|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
56556172|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56556173|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56556174|NCT02627521|Ticagrelor|ticagrelor|mesh-list
56556175|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56556176|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56556177|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56556178|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56556179|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
56556180|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556181|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556182|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556183|NCT00681967|Gefitinib|gefitinib|mesh-list
56556184|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556185|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56556186|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556187|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556188|NCT04239118|Hemostatics|hemostatics|mesh-list
56556189|NCT04239118|Coagulants|coagulants|mesh-ancestor
56556190|NCT04139941|Antibodies|antibodies|mesh-list
56556191|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
56556192|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
56556193|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556194|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
56556195|NCT00875017|Sevelamer|sevelamer|mesh-list
56556196|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
56556197|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
56556198|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556199|NCT00679705|Atosiban|atosiban|mesh-list
56556200|NCT00679705|Ritodrine|ritodrine|mesh-list
56556201|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
56556202|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556203|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556204|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
56556205|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56556206|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
56556207|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
56556208|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556209|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56556210|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56556211|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56556212|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
56556213|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648551|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
56648552|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648553|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648554|NCT05364996|Dimercaprol|dimercaprol|mesh-list
56648555|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
55999604|NCT02773576|Risperidone|risperidone|mesh-list
56556214|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556215|NCT00685633|Bicalutamide|bicalutamide|mesh-list
56556216|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
56556217|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
56556218|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556219|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556220|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556221|NCT04371952|Doxycycline|doxycycline|mesh-list
56556222|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556223|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556224|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
56556225|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56556226|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56556228|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
56556229|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556230|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556231|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
56304576|NCT00037141|Ethanol|ethanol|mesh-list
56556232|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56556233|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56556234|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556235|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556236|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56556237|NCT04237246|Tacrolimus|tacrolimus|mesh-list
56556238|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56556239|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
56556240|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556241|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56556242|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556243|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556244|NCT00680095|Tavaborole|tavaborole|mesh-list
56556245|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
56556246|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556247|NCT02814058|Zolpidem|zolpidem|mesh-list
56556248|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56556249|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56556250|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556251|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556252|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56556253|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
56556254|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
56556255|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556256|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556257|NCT00680173|Interferons|interferons|mesh-list
56556258|NCT00680173|Ribavirin|ribavirin|mesh-list
56556259|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
56556260|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
56556261|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56556262|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556263|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
56556264|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556265|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
56556266|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556267|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
56556268|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556269|NCT00682279|Topotecan|topotecan|mesh-list
56556270|NCT00682279|Lapatinib|lapatinib|mesh-list
56556271|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56556272|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56556273|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556274|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556275|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556276|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56556277|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
56556278|NCT02811484|Exenatide|exenatide|mesh-list
56648556|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
56648557|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648558|NCT00643734|Azithromycin|azithromycin|mesh-list
56648559|NCT00643734|Levofloxacin|levofloxacin|mesh-list
56556279|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56556280|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556281|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56556282|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556283|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56556284|NCT02811484|Incretins|incretins|mesh-ancestor
56556285|NCT02811484|Hormones|hormones|mesh-ancestor
56556286|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556287|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
56556288|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556289|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556290|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56556291|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56556292|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556293|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556294|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556295|NCT00922597|Factor VIII|factor viii|mesh-list
56556296|NCT00922597|Coagulants|coagulants|mesh-ancestor
56556297|NCT00874939|Donepezil|donepezil|mesh-list
56556298|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56556299|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556300|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556301|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
56556302|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556303|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556304|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
56556305|NCT00634348|Aripiprazole|aripiprazole|mesh-list
56556306|NCT00634348|Ziprasidone|ziprasidone|mesh-list
56556307|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
56556308|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56556309|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56556310|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56556311|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556312|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556313|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
56556314|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
56556315|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556316|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556317|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56556318|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56556319|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
56556321|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56556322|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56556323|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56556324|NCT00680329|Timolol|timolol|mesh-list
56556325|NCT00680329|Travoprost|travoprost|mesh-list
56556326|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56556327|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56556328|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56556329|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56556330|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
56556331|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556332|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556333|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556334|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56556335|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56556336|NCT01185353|Methotrexate|methotrexate|mesh-list
56556337|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56556338|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
56556339|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56556340|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556341|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56556342|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
56556343|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556344|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556345|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
56648560|NCT00643734|Ofloxacin|ofloxacin|mesh-list
56648561|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556346|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556347|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56556348|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56556349|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
56556350|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56556351|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56556352|NCT02811016|Budesonide|budesonide|mesh-list
56556353|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56556354|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56556355|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
56556356|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556357|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556358|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56556359|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
56556360|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
56556361|NCT02811016|Hormones|hormones|mesh-ancestor
56556362|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556363|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
56556364|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56556365|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556366|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556367|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56556368|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56556369|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556370|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556371|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556372|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56556373|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
56556374|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56556375|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556376|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56556377|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56556378|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56556379|NCT04237480|Vitamin D|vitamin d|mesh-list
56556380|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
56556381|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
56556382|NCT04237480|Vitamins|vitamins|mesh-list
56556383|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
56556384|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556385|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56556386|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56556387|NCT02813356|Naloxegol|naloxegol|mesh-list
56556388|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56556389|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556390|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
56556391|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556392|NCT02810782|Morphine|morphine|mesh-list
56556394|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
56556395|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56556396|NCT02810782|Narcotics|narcotics|mesh-ancestor
56556397|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556398|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556399|NCT02810782|Analgesics|analgesics|mesh-ancestor
56556400|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
56556401|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556402|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
56556403|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56556404|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56556405|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56556406|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556407|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556408|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
56556409|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
56556410|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56556411|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56556412|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56556413|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
56556414|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
56556415|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56556416|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56556417|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56648562|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648563|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56648564|NCT00643734|Renal Agents|renal agents|mesh-ancestor
56556418|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56556419|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56556420|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
56556421|NCT02810548|Mitogens|mitogens|mesh-list
56556422|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
56556423|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556424|NCT01155869|Naltrexone|naltrexone|mesh-list
56556425|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56556426|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56556427|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556428|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
56556429|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556430|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
56556431|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56556432|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556433|NCT02625415|Vitamins|vitamins|mesh-list
56556434|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
56556435|NCT02625415|Pyridoxal|pyridoxal|mesh-list
56556436|NCT02625415|Pyridoxine|pyridoxine|mesh-list
56556437|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
56556438|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
56556439|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556440|NCT02809768|Itraconazole|itraconazole|mesh-list
56556441|NCT02809768|Fluconazole|fluconazole|mesh-list
56556442|NCT02809768|Rifampin|rifampin|mesh-list
56556443|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
56556444|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556445|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56556446|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56556447|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556448|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556449|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56556450|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
56556451|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556452|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556453|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56556454|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56556455|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
56556456|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556457|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
56556458|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56556459|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56556460|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56556461|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56556462|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56556463|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56556464|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56556465|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56556466|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56556471|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56556472|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556473|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556474|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
56556475|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
56556476|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
56556477|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556478|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
56556479|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
56556480|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56556481|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56556482|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
56556483|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
56556484|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556485|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556486|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56556487|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
56556488|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
56556489|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56556490|NCT00690781|Caseins|caseins|mesh-list
56648565|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56648566|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56648567|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999613|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56556491|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
56556492|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
56556493|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556494|NCT00682825|Anesthetics|anesthetics|mesh-list
56556495|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
56556496|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556497|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556498|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
56556499|NCT04187248|Asparaginase|asparaginase|mesh-list
56556500|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556501|NCT00912379|Chrysarobin|chrysarobin|mesh-list
56556502|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56556503|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56556504|NCT00912379|Analgesics|analgesics|mesh-ancestor
56556505|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
56556506|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556507|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556508|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56556509|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56556510|NCT02809378|Remifentanil|remifentanil|mesh-list
56556511|NCT02809378|Thiopental|thiopental|mesh-list
56556512|NCT02809378|Palonosetron|palonosetron|mesh-list
56556513|NCT02809378|Propofol|propofol|mesh-list
56556514|NCT02809378|Sevoflurane|sevoflurane|mesh-list
56556515|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56556516|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556517|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556518|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56556519|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
56556520|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
56556521|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56556522|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56556523|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56556524|NCT02809378|Narcotics|narcotics|mesh-ancestor
56556525|NCT02809378|Analgesics|analgesics|mesh-ancestor
56556526|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
56556527|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556528|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
56304859|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556529|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
56556530|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56556531|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56556532|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56556534|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556535|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556536|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
56556537|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
56556538|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
56556539|NCT00683059|Paclitaxel|paclitaxel|mesh-list
56556540|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56556541|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556542|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
56556545|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556547|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56556548|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56556549|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556550|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556551|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56556552|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56556553|NCT00683137|Analgesics|analgesics|mesh-ancestor
56556554|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
56556555|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556556|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556557|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56556558|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56556559|NCT02809456|Nicorandil|nicorandil|mesh-list
56556560|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56556561|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56648568|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556562|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
56556563|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
56556564|NCT02809456|Vitamins|vitamins|mesh-ancestor
56556565|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
56556566|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556567|NCT05576740|Contraceptive Agents|contraceptive agents|mesh-list
56556568|NCT05576740|Hormones|hormones|mesh-list
56556569|NCT05576740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556570|NCT05576740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556571|NCT05576740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56556572|NCT04139629|Antibodies|antibodies|mesh-list
56556573|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
56556574|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556575|NCT02813044|Anesthetics|anesthetics|mesh-list
56556576|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556577|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556578|NCT04236778|Vancomycin|vancomycin|mesh-list
56556579|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556580|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556581|NCT02812888|Propranolol|propranolol|mesh-list
56556582|NCT02812888|Methimazole|methimazole|mesh-list
56556583|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
56556584|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56556585|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56556586|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
56556587|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556588|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556589|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556590|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56556591|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56556592|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
56556593|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
56556594|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
56556595|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556596|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
56556597|NCT00687661|Diphosphonates|diphosphonates|mesh-list
56556598|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56556599|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556600|NCT00687817|Paclitaxel|paclitaxel|mesh-list
56556601|NCT00687817|Carboplatin|carboplatin|mesh-list
56556602|NCT00687817|Bavituximab|bavituximab|mesh-list
56556603|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56556604|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556605|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
56556606|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
56556607|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
56556608|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556609|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56556611|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56556612|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556613|NCT02625805|Methylphenidate|methylphenidate|mesh-list
56556614|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56130271|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556615|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556617|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56556618|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56556619|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556620|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
56556621|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556622|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
56556623|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56556624|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556625|NCT02880462|Sulforaphane|sulforaphane|mesh-list
56556626|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56556627|NCT02880462|Protective Agents|protective agents|mesh-ancestor
56556628|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556629|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556630|NCT00688363|Chrysarobin|chrysarobin|mesh-list
56556631|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56556632|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56556633|NCT00688363|Analgesics|analgesics|mesh-ancestor
56556634|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
56648569|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648570|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56648571|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56648573|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56648574|NCT04178148|Amikacin|amikacin|mesh-list
56556635|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556636|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556637|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56556638|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56556639|NCT02812654|Doxorubicin|doxorubicin|mesh-list
56556640|NCT02812654|Ifosfamide|ifosfamide|mesh-list
56556641|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56556642|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556643|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56556644|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56556645|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556646|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556647|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56556648|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
56556649|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
56556650|NCT02809066|Calcium|calcium|mesh-list
56556651|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56556652|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556653|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56556654|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
56556655|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556656|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56556657|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556658|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556659|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
56556660|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56556661|NCT02808676|Vitamin D|vitamin d|mesh-list
56556662|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
56556663|NCT02808676|Vitamins|vitamins|mesh-ancestor
56556664|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
56556665|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556666|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56556667|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56556668|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56556669|NCT00690937|Sevelamer|sevelamer|mesh-list
56556670|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
56556671|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
56556672|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556673|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56556674|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56556675|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
56556676|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56556678|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
56556679|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556680|NCT04999644|Nicotine|nicotine|mesh-list
56305003|NCT00015288|Naloxone|naloxone|mesh-list
56556681|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56556683|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556684|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556685|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56556686|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56556687|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
56556688|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556689|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556690|NCT00912457|Donepezil|donepezil|mesh-list
56556691|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56556692|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556693|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556694|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
56556695|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556696|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556697|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
56556698|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
56556699|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56648575|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56648576|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648577|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
56648578|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56648579|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56556700|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556701|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56556702|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556703|NCT02625103|Clozapine|clozapine|mesh-list
56556704|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56556705|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
56556706|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556707|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556708|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556709|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56556710|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56556711|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556712|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56556713|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
56556714|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
56556715|NCT01155479|Rasagiline|rasagiline|mesh-list
56556716|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56556717|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556718|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556719|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56556720|NCT01155479|Protective Agents|protective agents|mesh-ancestor
56556721|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556722|NCT02807272|Tipifarnib|tipifarnib|mesh-list
56556723|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556724|NCT02807194|Anesthetics|anesthetics|mesh-list
56556725|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556726|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556727|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56556728|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
56556729|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56556730|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56556731|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56556732|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556733|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556734|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
56556735|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56556736|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
56556737|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556738|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
56556739|NCT02625727|Protective Agents|protective agents|mesh-ancestor
56556740|NCT02807116|Rifampin|rifampin|mesh-list
56556741|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56556742|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
56556743|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556744|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556745|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
56556746|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56556747|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556748|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556749|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56556750|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56556751|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56556752|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56556753|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56556754|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56556755|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56556756|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
56556757|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556758|NCT05605366|Minocycline|minocycline|mesh-list
56556759|NCT05605366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556760|NCT05605366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556761|NCT01155167|Lidocaine|lidocaine|mesh-list
56556762|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
56556763|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
56556764|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
56648580|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56648581|NCT04178850|Folic Acid|folic acid|mesh-list
56648582|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
56648583|NCT04178850|Infliximab|infliximab|mesh-list
56648584|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
56648585|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56648586|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56648587|NCT04178850|Hematinics|hematinics|mesh-ancestor
56648588|NCT04178850|Vitamins|vitamins|mesh-ancestor
56648589|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
56648590|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648591|NCT02676336|Iodine|iodine|mesh-list
56648592|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
56556766|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556767|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
56556768|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556769|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56556770|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56556771|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56556772|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56556773|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556774|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
56556775|NCT05238155|Antimetabolites|antimetabolites|mesh-list
56556776|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556777|NCT01106586|Ritonavir|ritonavir|mesh-list
56556778|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56556779|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56556780|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56556781|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
56556782|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556783|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556784|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56556785|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56556786|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
56556787|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556788|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56556789|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56556790|NCT00683995|Fentanyl|fentanyl|mesh-list
56556791|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56556792|NCT00683995|Narcotics|narcotics|mesh-ancestor
56556793|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556794|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556795|NCT00683995|Analgesics|analgesics|mesh-ancestor
56556796|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
56556797|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556798|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56556799|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56556800|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
56556801|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
56556802|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56556803|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556804|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556805|NCT02884817|Listerine|listerine|mesh-list
56556806|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56556807|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556808|NCT02806804|Vaccines|vaccines|mesh-list
56556809|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
56556810|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556811|NCT02879292|Anesthetics|anesthetics|mesh-list
56556812|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556813|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556814|NCT02806648|Palbociclib|palbociclib|mesh-list
56556815|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556816|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56648593|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56648594|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648595|NCT02676336|Trace Elements|trace elements|mesh-ancestor
56556817|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556818|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556819|NCT00689845|Cytarabine|cytarabine|mesh-list
56556820|NCT00689845|Prednisone|prednisone|mesh-list
56556821|NCT00689845|Prednisolone|prednisolone|mesh-list
56556822|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
56556823|NCT00689845|Ifosfamide|ifosfamide|mesh-list
56556824|NCT00689845|Rituximab|rituximab|mesh-list
56556825|NCT00689845|Doxorubicin|doxorubicin|mesh-list
56556826|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56556827|NCT00689845|Methotrexate|methotrexate|mesh-list
56556828|NCT00689845|Etoposide|etoposide|mesh-list
56556829|NCT00689845|Vincristine|vincristine|mesh-list
56556830|NCT00689845|Bleomycin|bleomycin|mesh-list
56556831|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
56556832|NCT00689845|Vindesine|vindesine|mesh-list
56556833|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56556834|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
56556835|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556836|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56556837|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56556838|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
56130494|NCT03064854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556839|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556841|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56556842|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56556843|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56556844|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56556845|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56556846|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556847|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56556848|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
56556849|NCT00689845|Hormones|hormones|mesh-ancestor
56556850|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556851|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56556852|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56556853|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
56556854|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56556855|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56556856|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
56556857|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
56556858|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56556859|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56556860|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56556861|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
56556862|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556863|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
56556864|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
56556865|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
56556866|NCT00624767|Insulin|insulin|mesh-list
56556867|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56556868|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
56556869|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56556870|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556871|NCT02806492|Phenylephrine|phenylephrine|mesh-list
56556872|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
56556873|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56556874|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
56556875|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
56556876|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556877|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556878|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
56556879|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56556880|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
56556881|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
56556882|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56556883|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56556884|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56556885|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
56556886|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556887|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648596|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
56648597|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648598|NCT02672358|Trametinib|trametinib|mesh-list
56648599|NCT02672358|Dabrafenib|dabrafenib|mesh-list
56648600|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556888|NCT02806492|Protective Agents|protective agents|mesh-ancestor
56556889|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56556890|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
56556891|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56556892|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
56556893|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56556894|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556895|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56556896|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
56556897|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56556898|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56556899|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56556900|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
56556901|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556902|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556903|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56556904|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56556905|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56556906|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56556907|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56556908|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556910|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556911|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556913|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56556914|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
56556915|NCT02804776|Gefitinib|gefitinib|mesh-list
56556916|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556917|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56556918|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556919|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556920|NCT01154153|Loratadine|loratadine|mesh-list
56556921|NCT01154153|Triamcinolone|triamcinolone|mesh-list
56556922|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56556923|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56556924|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56556925|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56556926|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
56556927|NCT01154153|Hormones|hormones|mesh-ancestor
56556928|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556929|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556930|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56556931|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
56556932|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556933|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556934|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
56556935|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
56556936|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56556937|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56556938|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56556939|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
56556940|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
56556941|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556942|NCT00684229|Anesthetics|anesthetics|mesh-list
56556943|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556944|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556945|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
56556946|NCT00874237|Loxapine|loxapine|mesh-list
56556947|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56556948|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556949|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56556950|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56556951|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556952|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556953|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648601|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56648602|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999644|NCT05599828|Histamine Agents|histamine agents|mesh-ancestor
56556954|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556955|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56556956|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56556957|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556958|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56556959|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56556960|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
56556961|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56556962|NCT02805946|Posaconazole|posaconazole|mesh-list
56556963|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
56556964|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56556965|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56556966|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56556967|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56556968|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56556969|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56556970|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56556971|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556972|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56556973|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
56556974|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56556975|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556976|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
56556977|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
56556979|NCT02805868|Siltuximab|siltuximab|mesh-list
56556980|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56556981|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556982|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
56556983|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556984|NCT00684385|Gefitinib|gefitinib|mesh-list
56556985|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556986|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56556988|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56556989|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
56556990|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56556991|NCT02690038|Antibodies|antibodies|mesh-list
56556992|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
56556993|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56556994|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
56556995|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556996|NCT00691795|Clonidine|clonidine|mesh-list
56556997|NCT00691795|Fentanyl|fentanyl|mesh-list
56556998|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56556999|NCT00691795|Narcotics|narcotics|mesh-ancestor
56557000|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557001|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557002|NCT00691795|Analgesics|analgesics|mesh-ancestor
56557003|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
56557004|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557005|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56557006|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56557007|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
56557008|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
56557009|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56557010|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
56557011|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
56557012|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56557013|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56557014|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56557015|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
56557016|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557017|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557018|NCT02805556|Fostemsavir|fostemsavir|mesh-list
56557019|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56557020|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56557021|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
56557022|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557023|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56557024|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56557025|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648603|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648604|NCT02675868|Phenylephrine|phenylephrine|mesh-list
56648605|NCT02675868|Vasopressins|vasopressins|mesh-list
56557026|NCT04032964|Doxorubicin|doxorubicin|mesh-list
56557027|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56557028|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557029|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56557030|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56557031|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557032|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557033|NCT00694291|Sorafenib|sorafenib|mesh-list
56557034|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557035|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56557036|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557037|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557038|NCT01153763|Dabrafenib|dabrafenib|mesh-list
56557039|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557040|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56557041|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557042|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557043|NCT00691873|Omalizumab|omalizumab|mesh-list
56557044|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56557045|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56557046|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
56557047|NCT05538052|Lidocaine|lidocaine|mesh-list
56557048|NCT05538052|Tramadol|tramadol|mesh-list
56557049|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
56557050|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
56557051|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557052|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557053|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
56557054|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557055|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56557056|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56557057|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56557058|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56557059|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557060|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56557063|NCT00691951|Budesonide|budesonide|mesh-list
56557064|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
56557065|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56557066|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56557067|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
56557068|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557069|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557070|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56557071|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
56557072|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
56557073|NCT00691951|Hormones|hormones|mesh-ancestor
56557074|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56557075|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56557076|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56557077|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56557078|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
56557079|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557080|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557081|NCT04316351|Pemetrexed|pemetrexed|mesh-list
56557082|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557083|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557084|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557085|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56557086|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56557087|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
56557088|NCT02625337|Trametinib|trametinib|mesh-list
56557089|NCT02625337|Dabrafenib|dabrafenib|mesh-list
56557090|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557091|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557092|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56557093|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557094|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557095|NCT04236310|Trastuzumab|trastuzumab|mesh-list
56648606|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
56648607|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
56648608|NCT02675868|Norepinephrine|norepinephrine|mesh-list
56557096|NCT04236310|Anastrozole|anastrozole|mesh-list
56557097|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557098|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557099|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56557100|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56557101|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56557102|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557103|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557104|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56557105|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
56557106|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56557107|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557108|NCT02621515|Nivolumab|nivolumab|mesh-list
56557109|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557110|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557111|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56557112|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557113|NCT02803918|Metformin|metformin|mesh-list
56557114|NCT02803918|Lixisenatide|lixisenatide|mesh-list
56557115|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56557116|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557117|NCT02805010|Abatacept|abatacept|mesh-list
56557118|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56557119|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557120|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557121|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557122|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
56557123|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557124|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56557125|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
56557126|NCT02800408|Provitamins|provitamins|mesh-ancestor
56557127|NCT02800408|Vitamins|vitamins|mesh-ancestor
56557128|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
56557129|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557130|NCT00692263|Tramadol|tramadol|mesh-list
56557131|NCT00692263|Citalopram|citalopram|mesh-list
56557132|NCT00692263|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56557133|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56557135|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557136|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557137|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
56557138|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557139|NCT00692263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56557140|NCT00692263|Antidepressive Agents|antidepressive agents|mesh-ancestor
56557141|NCT00692263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56557142|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557143|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56557144|NCT00692263|Narcotics|narcotics|mesh-ancestor
56557145|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557146|NCT00692263|Analgesics|analgesics|mesh-ancestor
56557147|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
56557149|NCT02800486|Mannitol|mannitol|mesh-list
56557150|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557151|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557152|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56557153|NCT02800486|Diuretics|diuretics|mesh-ancestor
56557154|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
56557155|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557156|NCT00694759|Metformin|metformin|mesh-list
56557157|NCT00694759|Pioglitazone|pioglitazone|mesh-list
56557158|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56557159|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557160|NCT00694837|Nelfinavir|nelfinavir|mesh-list
56557161|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56557162|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56557163|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
56557164|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557165|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557166|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56557167|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56648609|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56648610|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
56648611|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
56557168|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
56557169|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557170|NCT02800252|Aspirin|aspirin|mesh-list
56557171|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56557172|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56557173|NCT02800252|Analgesics|analgesics|mesh-ancestor
56557174|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
56557175|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557176|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557177|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56557178|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56557179|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56557180|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56557181|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557182|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56557183|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56557184|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557186|NCT02621359|Doxycycline|doxycycline|mesh-list
56557187|NCT02621359|Levofloxacin|levofloxacin|mesh-list
56557188|NCT02621359|Ofloxacin|ofloxacin|mesh-list
56557189|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
56557190|NCT02621359|Omeprazole|omeprazole|mesh-list
56557191|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56557192|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56557193|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56557194|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557195|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557196|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56557197|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557198|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
56557199|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56557200|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56557201|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56557202|NCT02621359|Renal Agents|renal agents|mesh-ancestor
56557203|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56557204|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56557206|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56557207|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56557208|NCT01152437|Cetuximab|cetuximab|mesh-list
56557209|NCT01152437|Afatinib|afatinib|mesh-list
56557210|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557212|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56557213|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557214|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557215|NCT02800174|Clopidogrel|clopidogrel|mesh-list
56557216|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56557217|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557218|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557219|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56557220|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56557221|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56557222|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
56557223|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557224|NCT02800330|Esomeprazole|esomeprazole|mesh-list
56557225|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56557226|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56557227|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56557228|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557229|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557230|NCT02799862|Paclitaxel|paclitaxel|mesh-list
56557231|NCT02799862|Carboplatin|carboplatin|mesh-list
56557232|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56557233|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557234|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
56557235|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
56557236|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
56557237|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557238|NCT01151579|Albuterol|albuterol|mesh-list
56557239|NCT01151579|Ipratropium|ipratropium|mesh-list
56557240|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56648612|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648613|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648614|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
56557241|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
56557242|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557243|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557244|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56557245|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
56557246|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
56557247|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56557248|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56557249|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56557250|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56557251|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
56557252|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557253|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557254|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56557255|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
56557256|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
56557257|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56557258|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
56557259|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557260|NCT01097616|Suvorexant|suvorexant|mesh-list
56557262|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56557263|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557264|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557265|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56557266|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557267|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557268|NCT00695071|Itraconazole|itraconazole|mesh-list
56557269|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
56557270|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557271|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56557272|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56557273|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557274|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557275|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56557276|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
56557277|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56557278|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557279|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56557280|NCT02803216|Amoxicillin|amoxicillin|mesh-list
56557281|NCT02803216|Clarithromycin|clarithromycin|mesh-list
56557282|NCT02803216|Omeprazole|omeprazole|mesh-list
56557283|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56557286|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56557287|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56557288|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557289|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557290|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56557291|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56557292|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56557294|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
56557295|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557296|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
56557297|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56557298|NCT02799238|Temozolomide|temozolomide|mesh-list
56557299|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56557300|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
56557301|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557302|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557303|NCT02620813|Tretinoin|tretinoin|mesh-list
56557304|NCT02620813|Isotretinoin|isotretinoin|mesh-list
56557305|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
56557306|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557307|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
56557308|NCT00692731|Caffeine|caffeine|mesh-list
56557309|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56557310|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648615|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55936659|NCT04977960|Canrenone|canrenone|mesh-list
56557311|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56557312|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557313|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557314|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56557315|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56557316|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
56557317|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557318|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
56557319|NCT02624401|Ketamine|ketamine|mesh-list
56557320|NCT02624401|Propofol|propofol|mesh-list
56557321|NCT02624401|Sevoflurane|sevoflurane|mesh-list
56557322|NCT02624401|Esketamine|esketamine|mesh-list
56557323|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56557324|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557325|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557326|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56557327|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
56557328|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
56557329|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56557330|NCT02624401|Analgesics|analgesics|mesh-ancestor
56557331|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
56557332|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557333|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56557334|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56557335|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56557336|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
56557337|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557338|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557339|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56557340|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56557341|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56557342|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56557343|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56557344|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
56557345|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56557346|NCT02802748|Letrozole|letrozole|mesh-list
56557347|NCT02802748|Vinorelbine|vinorelbine|mesh-list
56557348|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557349|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56557350|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56557351|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557352|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557353|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56557354|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
56557355|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56557357|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56557358|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
56557359|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
56557360|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
56557362|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557363|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56557364|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
56557365|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557366|NCT05502250|Antiviral Agents|antiviral agents|mesh-ancestor
56557367|NCT05502250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557368|NCT05502250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557369|NCT05502250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557370|NCT05502250|Immunologic Factors|immunologic factors|mesh-ancestor
56557371|NCT05502250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557372|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
56557373|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56557374|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56557375|NCT02798068|Prednisolone|prednisolone|mesh-list
56557376|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
56557377|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56557378|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
56557379|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56557380|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
56557381|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
56557382|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557383|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648616|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
56648617|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
56648618|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56648619|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56648620|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56557384|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56557385|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
56557386|NCT02798068|Hormones|hormones|mesh-ancestor
56557387|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56557388|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56557389|NCT02798068|Protective Agents|protective agents|mesh-ancestor
56557390|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56557391|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557392|NCT00593827|Epothilones|epothilones|mesh-list
56557393|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
56557394|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
56557395|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
56557396|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557397|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557398|NCT04135885|Folic Acid|folic acid|mesh-list
56557399|NCT04135885|Hematinics|hematinics|mesh-ancestor
56557400|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
56557401|NCT04135885|Vitamins|vitamins|mesh-ancestor
56557402|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
56557403|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557404|NCT00693043|Lidocaine|lidocaine|mesh-list
56557405|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
56557406|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
56557407|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557408|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557409|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
56557410|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557411|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56557412|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56557413|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56557414|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56557415|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557416|NCT00695929|Simendan|simendan|mesh-list
56557417|NCT00695929|Milrinone|milrinone|mesh-list
56557418|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56557419|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
56557420|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56557421|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56557422|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557423|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557424|NCT00695929|Protective Agents|protective agents|mesh-ancestor
56557425|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557426|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56557427|NCT04235296|Mitogens|mitogens|mesh-list
56557428|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
56557429|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557430|NCT02620501|Lidocaine|lidocaine|mesh-list
56557432|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
56557433|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557434|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557435|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
56557436|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557437|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56557438|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56557439|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56557440|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56557441|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557442|NCT00693121|Amantadine|amantadine|mesh-list
56557443|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56557444|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56557445|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
56557446|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557447|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
56557448|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648621|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
56648622|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648623|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557449|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557450|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557451|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56557452|NCT00693121|Analgesics|analgesics|mesh-ancestor
56557453|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
56557454|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557455|NCT02620423|Leucovorin|leucovorin|mesh-list
56557456|NCT02620423|Gemcitabine|gemcitabine|mesh-list
56557457|NCT02620423|Fluorouracil|fluorouracil|mesh-list
56557458|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
56557459|NCT02620423|Irinotecan|irinotecan|mesh-list
56557460|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56557461|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
56557462|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557463|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557464|NCT02620423|Antiviral Agents|antiviral agents|mesh-ancestor
56557465|NCT02620423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557466|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557467|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557468|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
56557469|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557470|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557471|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56557472|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56557473|NCT02620423|Antidotes|antidotes|mesh-ancestor
56557474|NCT02620423|Protective Agents|protective agents|mesh-ancestor
56557475|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
56557476|NCT02620423|Vitamins|vitamins|mesh-ancestor
56557477|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
56557478|NCT00696007|Gemcitabine|gemcitabine|mesh-list
56557479|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557480|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56557481|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
56557482|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557483|NCT00696007|Antiviral Agents|antiviral agents|mesh-ancestor
56557484|NCT00696007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557485|NCT00696007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557486|NCT00696007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557487|NCT00696007|Immunologic Factors|immunologic factors|mesh-ancestor
56557488|NCT00696007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557489|NCT02624089|Ropivacaine|ropivacaine|mesh-list
56557490|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
56557491|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
56557492|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557493|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557494|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
56557495|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557497|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
56557498|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
56557499|NCT00693199|Amlodipine|amlodipine|mesh-list
56557500|NCT00693199|Prazosin|prazosin|mesh-list
56305839|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56557501|NCT00693199|Terazosin|terazosin|mesh-list
56557502|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56557503|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56557504|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56557505|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557507|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557508|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
56557509|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56557510|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56557511|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56557512|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
56557513|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557514|NCT00693199|Urological Agents|urological agents|mesh-ancestor
56557515|NCT02795884|Cisplatin|cisplatin|mesh-list
56557516|NCT02795884|Pemetrexed|pemetrexed|mesh-list
56557517|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56557518|NCT02795884|Vinorelbine|vinorelbine|mesh-list
56557519|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648624|NCT02675868|Protective Agents|protective agents|mesh-ancestor
56648625|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
56648626|NCT02675868|Coagulants|coagulants|mesh-ancestor
56648627|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56648628|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
56648629|NCT05279742|Valsartan|valsartan|mesh-list
56557520|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557521|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557522|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56557523|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56557524|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56557525|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56557526|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
56557527|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
56557528|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
56557529|NCT02795572|Vitamin D|vitamin d|mesh-list
56557530|NCT02795572|Vitamins|vitamins|mesh-list
56557531|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
56557532|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
56557533|NCT02795572|Pyridoxal|pyridoxal|mesh-list
56557534|NCT02795572|Pyridoxine|pyridoxine|mesh-list
56557535|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
56557536|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
56557537|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557538|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56557539|NCT05445778|Bevacizumab|bevacizumab|mesh-list
56557540|NCT05445778|Maytansine|maytansine|mesh-list
56557541|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557542|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557543|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56557544|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56557545|NCT05445778|Growth Substances|growth substances|mesh-ancestor
56557546|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557547|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
56557548|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56557549|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56557550|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56557551|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56557552|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557553|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
56557554|NCT02801188|Bupivacaine|bupivacaine|mesh-list
56557555|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
56257599|NCT01916174|Incretins|incretins|mesh-ancestor
56509510|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
56509511|NCT02213588|Antioxidants|antioxidants|mesh-list
56509512|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509513|NCT02213588|Protective Agents|protective agents|mesh-ancestor
56509514|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509515|NCT01642524|Dextrans|dextrans|mesh-list
56509516|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
56509517|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
56509518|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
56509519|NCT02213783|Imipenem|imipenem|mesh-list
56509520|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509521|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509522|NCT04552613|Carboplatin|carboplatin|mesh-list
56509523|NCT04552613|Pemetrexed|pemetrexed|mesh-list
56509524|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509525|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509526|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509527|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56509528|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56509529|NCT02213328|Tenofovir|tenofovir|mesh-list
56509530|NCT02213328|Emtricitabine|emtricitabine|mesh-list
56509531|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56509532|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
56509533|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509534|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56509536|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509537|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509538|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56509539|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56509540|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
56648630|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56648631|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56648632|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56648633|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56509541|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509542|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56509543|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509544|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509545|NCT02219490|Ribavirin|ribavirin|mesh-list
56509546|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
56509547|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509548|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
56509549|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509550|NCT01117051|Prucalopride|prucalopride|mesh-list
56509551|NCT01117051|Laxatives|laxatives|mesh-ancestor
56509552|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509553|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56509554|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56509555|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
56509556|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509557|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509558|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509559|NCT02211417|Evening primrose oil|evening primrose oil|mesh-list
56509560|NCT02211417|Mineral Oil|mineral oil|mesh-list
56509561|NCT02211417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56509562|NCT02211417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56509563|NCT02211417|Analgesics|analgesics|mesh-ancestor
56509564|NCT02211417|Sensory System Agents|sensory system agents|mesh-ancestor
56509565|NCT02211417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509566|NCT02211417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509567|NCT02211417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509568|NCT02211417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509569|NCT02211417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56509570|NCT02211417|Antimetabolites|antimetabolites|mesh-ancestor
56509571|NCT02211417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509572|NCT02211417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56509573|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
56509574|NCT02211417|Emollients|emollients|mesh-ancestor
56509575|NCT02279121|Taurolidine|taurolidine|mesh-list
56509576|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56509577|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509578|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56509579|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509580|NCT02218164|Interferons|interferons|mesh-list
56509581|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
56509582|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
56509583|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56509584|NCT02218164|Fluorouracil|fluorouracil|mesh-list
56509585|NCT02218164|Capecitabine|capecitabine|mesh-list
56509586|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
56509587|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509588|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56509589|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509590|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56509591|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
56509592|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509593|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
56509594|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509595|NCT04552067|Enoxaparin|enoxaparin|mesh-list
56509596|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
56509597|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56509598|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56509599|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509600|NCT01643187|Vitamins|vitamins|mesh-list
56509601|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
56509602|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509603|NCT01643265|Caseins|caseins|mesh-list
56509604|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
56509605|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
56509606|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648634|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648635|NCT02673840|Ketotifen|ketotifen|mesh-list
56648636|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
56648637|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
56648638|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56509607|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
56509608|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
56509609|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
56509611|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509612|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
56509613|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509614|NCT04551755|Doxycycline|doxycycline|mesh-list
56509615|NCT04551755|Ivermectin|ivermectin|mesh-list
56509616|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509617|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509618|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
56509619|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56509620|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56509621|NCT01643499|Leucovorin|leucovorin|mesh-list
56509622|NCT01643499|Fluorouracil|fluorouracil|mesh-list
56509623|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
56509624|NCT01643499|Irinotecan|irinotecan|mesh-list
56509625|NCT01643499|Calcium|calcium|mesh-list
56509626|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
56509627|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56509628|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509629|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
56509630|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509631|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56509632|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509633|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56509634|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
56509635|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56509636|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56509637|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509638|NCT01643499|Antidotes|antidotes|mesh-ancestor
56509639|NCT01643499|Protective Agents|protective agents|mesh-ancestor
56509640|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
56509641|NCT01643499|Vitamins|vitamins|mesh-ancestor
56509642|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
56509643|NCT01117012|Ivacaftor|ivacaftor|mesh-list
56509644|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56509645|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56509646|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509647|NCT01116739|Fluorides|fluorides|mesh-list
56509648|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
56509649|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
56509650|NCT01116739|Protective Agents|protective agents|mesh-ancestor
56509651|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509652|NCT01640496|Vitamin D|vitamin d|mesh-list
56509653|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
56509654|NCT01640496|Vitamins|vitamins|mesh-ancestor
56509655|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
56509656|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167826|NCT00005604|Aldesleukin|aldesleukin|mesh-list
56509657|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56509658|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56509659|NCT04551248|Vaccines|vaccines|mesh-list
56509660|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56509661|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
56509662|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509663|NCT01640535|Cetirizine|cetirizine|mesh-list
56509664|NCT01640535|Montelukast|montelukast|mesh-list
56509665|NCT01640535|Levocetirizine|levocetirizine|mesh-list
56509666|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56509667|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
56509668|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56509669|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
56509670|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509671|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509672|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56509673|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56509674|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648639|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
56648640|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
56648641|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509675|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56509676|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56509677|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
56509678|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
56509679|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509680|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56509681|NCT04550936|Isavuconazole|isavuconazole|mesh-list
56509682|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
56509683|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509684|NCT04550858|Rebamipide|rebamipide|mesh-list
56509685|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56509686|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509687|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
56509688|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509689|NCT04550858|Protective Agents|protective agents|mesh-ancestor
56509690|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509691|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509692|NCT01640574|Chloroquine|chloroquine|mesh-list
56509693|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56509694|NCT01640574|Piperaquine|piperaquine|mesh-list
56509695|NCT01640574|Artenimol|artenimol|mesh-list
56509696|NCT01640574|Artemisinins|artemisinins|mesh-list
56509697|NCT01640574|Amebicides|amebicides|mesh-ancestor
56509698|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56509699|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56509700|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509701|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
56509702|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509703|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56509704|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56509705|NCT01640574|Analgesics|analgesics|mesh-ancestor
56509706|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
56509707|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509708|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509709|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509710|NCT01640574|Filaricides|filaricides|mesh-ancestor
56509711|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
56509712|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
56509713|NCT01116427|Abatacept|abatacept|mesh-list
56509714|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56509715|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509716|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509717|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56509718|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
56509719|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509720|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509721|NCT04529226|Haloperidol|haloperidol|mesh-list
56509722|NCT04529226|Pimozide|pimozide|mesh-list
56509723|NCT04529226|Olanzapine|olanzapine|mesh-list
56509724|NCT04529226|Risperidone|risperidone|mesh-list
56509725|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
56509726|NCT04529226|Clozapine|clozapine|mesh-list
56509727|NCT04529226|Amisulpride|amisulpride|mesh-list
56509728|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56509729|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
56509730|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509731|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509732|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509733|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56509734|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56509735|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509736|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56509737|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56509738|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
56509739|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
56509740|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
56509741|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509742|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509743|NCT04529226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56509744|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56509745|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56509746|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56509747|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
56648642|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648643|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648644|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55999683|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56509748|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
56509749|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56509750|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
56509751|NCT04310683|Hormones|hormones|mesh-list
56509752|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509753|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509754|NCT04550702|Mirabegron|mirabegron|mesh-list
56509755|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56509756|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56509757|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56509758|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
56509759|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509760|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509761|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509762|NCT04550702|Urological Agents|urological agents|mesh-ancestor
56509763|NCT01116232|Sirolimus|sirolimus|mesh-list
56509764|NCT01116232|Rituximab|rituximab|mesh-list
56509765|NCT01116232|Tacrolimus|tacrolimus|mesh-list
56509766|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56509767|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56509768|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509769|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
56509770|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509771|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509772|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56509773|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56509774|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509775|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509776|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509777|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509778|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56509779|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
56509780|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56509781|NCT04550351|Vaccines|vaccines|mesh-list
56509782|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
56509783|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509784|NCT04550234|Allopurinol|allopurinol|mesh-list
56509785|NCT04550234|Verinurad|verinurad|mesh-list
56509786|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
56509787|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509788|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509789|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
56509790|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509791|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56509792|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
56509793|NCT04550234|Protective Agents|protective agents|mesh-ancestor
56509794|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509795|NCT01640691|Vaccines|vaccines|mesh-list
56509796|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
56509797|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509798|NCT04550585|Insulin|insulin|mesh-list
56509799|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56509800|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56509801|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509802|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
56509803|NCT01643889|Domperidone|domperidone|mesh-list
56509804|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509805|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509806|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56509807|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56509808|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509809|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509810|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509811|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509812|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
56509813|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
56509814|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648646|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56648647|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56509815|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509816|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56509817|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
56509818|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509819|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
56509820|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
56509822|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56509823|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509824|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56509825|NCT04550078|Antacids|antacids|mesh-ancestor
56509826|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509827|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509828|NCT01205035|Ranibizumab|ranibizumab|mesh-list
56509829|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56509830|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56509831|NCT01205035|Growth Substances|growth substances|mesh-ancestor
56509832|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509833|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
56509834|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509835|NCT04549844|Bupivacaine|bupivacaine|mesh-list
56509836|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
56509837|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
56509838|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509839|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509840|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
56509841|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509842|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56509843|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
56509844|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
56509845|NCT01204918|Riluzole|riluzole|mesh-list
56509846|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
56509847|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56509848|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56509849|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509850|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509851|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509852|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56509853|NCT01204918|Protective Agents|protective agents|mesh-ancestor
56509854|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
56509855|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56509856|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56509857|NCT04528797|Prednisolone|prednisolone|mesh-list
56509858|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
56509859|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56509860|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
56509861|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509862|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
56509863|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
56509864|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509865|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509866|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509867|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
56509868|NCT04528797|Hormones|hormones|mesh-ancestor
56509869|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509870|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56509871|NCT04528797|Protective Agents|protective agents|mesh-ancestor
56509872|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56509873|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509874|NCT00624481|Teriparatide|teriparatide|mesh-list
56509875|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56509876|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509877|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56509879|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
56509880|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56509881|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509882|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509883|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56509884|NCT04529187|Analgesics|analgesics|mesh-ancestor
56509885|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
56509886|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648648|NCT00644124|Growth Substances|growth substances|mesh-ancestor
56648649|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509887|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56509888|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56509889|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56509890|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
56509891|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509892|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509893|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56509894|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56509895|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56509896|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56509897|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56509898|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
56509899|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
56509900|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
56509901|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
56509902|NCT04549415|Metformin|metformin|mesh-list
56509903|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56509904|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509905|NCT02214368|Propofol|propofol|mesh-list
56509906|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56509907|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509908|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509909|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56509910|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
56509911|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
56509912|NCT01204294|Metformin|metformin|mesh-list
56509913|NCT01204294|Linagliptin|linagliptin|mesh-list
56509914|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56509915|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509916|NCT01204294|Incretins|incretins|mesh-ancestor
56509919|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56509920|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
56509921|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509922|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509923|NCT01182181|Anastrozole|anastrozole|mesh-list
56509924|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56509925|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509926|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56509927|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56509928|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509929|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509930|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56509931|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
56509932|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509933|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509934|NCT01181986|Exenatide|exenatide|mesh-list
56509935|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56509936|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509937|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56509938|NCT01181986|Incretins|incretins|mesh-ancestor
56509939|NCT01181986|Hormones|hormones|mesh-ancestor
56509940|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509941|NCT04315909|Vitamin E|vitamin e|mesh-list
56509942|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56509943|NCT04315909|Vitamins|vitamins|mesh-ancestor
56509944|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
56509945|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509946|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
56167837|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
56509947|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509948|NCT04315909|Protective Agents|protective agents|mesh-ancestor
56509949|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
56509950|NCT04315909|Coagulants|coagulants|mesh-ancestor
56509952|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
56509953|NCT01181167|Edoxaban|edoxaban|mesh-list
56509954|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
56509955|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56509956|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56509957|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509958|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56509959|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
56509960|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56509961|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
56648650|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
56648651|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509962|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509963|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
56509964|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56258048|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509965|NCT04548557|Antibodies|antibodies|mesh-list
56509966|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
56509967|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56509968|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
56509969|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509970|NCT01181128|Factor VIII|factor viii|mesh-list
56509971|NCT01181128|Coagulants|coagulants|mesh-ancestor
56509972|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56509973|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
56509974|NCT04548284|Hormones|hormones|mesh-ancestor
56509975|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509976|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509977|NCT04547894|TMC-310911|tmc-310911|mesh-list
56509978|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
56509979|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509980|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509981|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
56509982|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
56509983|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509984|NCT01644825|Paclitaxel|paclitaxel|mesh-list
56509985|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56509986|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509987|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
56509988|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
56509989|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56509991|NCT01644864|Ropivacaine|ropivacaine|mesh-list
56509992|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
56509993|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
56509994|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509995|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509996|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
56509997|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509998|NCT04547855|Temozolomide|temozolomide|mesh-list
56509999|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56510000|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
56510001|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510002|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510003|NCT01641510|Clopidogrel|clopidogrel|mesh-list
56510004|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56510005|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56510006|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56510007|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56510008|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56510009|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
56510010|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510011|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510012|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510013|NCT04547621|Temozolomide|temozolomide|mesh-list
56510014|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56510015|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
56510016|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510017|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510018|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56510019|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56510020|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510021|NCT04547348|Denosumab|denosumab|mesh-list
56510022|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56510023|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510024|NCT04547426|Nicotine|nicotine|mesh-list
56510025|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56510026|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
56510027|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510028|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510029|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56510030|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56510031|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
56111184|NCT01622088|Pramipexole|pramipexole|mesh-list
56648652|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
56648653|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
56648654|NCT02670954|Tramadol|tramadol|mesh-list
56648655|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56648656|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510032|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510033|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510034|NCT01641666|Ribavirin|ribavirin|mesh-list
56510035|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56510036|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
56510037|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
56510038|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510039|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
56510040|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258123|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56510041|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
56510042|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510044|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510045|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56510046|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510047|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510048|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
56510049|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56510050|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510051|NCT01645254|Antimalarials|antimalarials|mesh-list
56510052|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56510053|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56510054|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510055|NCT01181011|Amlodipine|amlodipine|mesh-list
56510056|NCT01181011|Telmisartan|telmisartan|mesh-list
56510057|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56510058|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56510059|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56510060|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56131762|NCT02535312|Pemetrexed|pemetrexed|mesh-list
56510062|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510063|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510064|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
56510065|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56510066|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56510067|NCT01641783|Paclitaxel|paclitaxel|mesh-list
56510068|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56510069|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56510070|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510071|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
56510072|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
56510073|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
56510074|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510075|NCT02214602|Doxorubicin|doxorubicin|mesh-list
56510076|NCT02214602|Epirubicin|epirubicin|mesh-list
56510077|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56510078|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510079|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56510080|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56510081|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510082|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510083|NCT01646580|Ciclopirox|ciclopirox|mesh-list
56510084|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
56510085|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510086|NCT04546802|Grazoprevir|grazoprevir|mesh-list
56510087|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56510088|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
56510089|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510090|NCT01580033|Vaccines|vaccines|mesh-list
56510091|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
56510092|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510093|NCT04546373|Niraparib|niraparib|mesh-list
56510094|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56510095|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510096|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510097|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648657|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648658|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56648659|NCT02670954|Analgesics|analgesics|mesh-ancestor
56648660|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
56648661|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510098|NCT01645410|Atorvastatin|atorvastatin|mesh-list
56510099|NCT01645410|Calcium|calcium|mesh-list
56510100|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510101|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510102|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56510103|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56510104|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
56510105|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510106|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56510107|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56510108|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510109|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
56510110|NCT04546334|Analgesics|analgesics|mesh-ancestor
56510111|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
56510112|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510113|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510114|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
56510115|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510116|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56510117|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
56510118|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56510119|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510120|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510121|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510122|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
56510123|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56510124|NCT02755272|Gemcitabine|gemcitabine|mesh-list
56510125|NCT02755272|Carboplatin|carboplatin|mesh-list
56510126|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
56510127|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510128|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56510129|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
56510130|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510131|NCT02755272|Antiviral Agents|antiviral agents|mesh-ancestor
56510132|NCT02755272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510133|NCT02755272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510134|NCT02755272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56510135|NCT02755272|Immunologic Factors|immunologic factors|mesh-ancestor
56510136|NCT02755272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510137|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56510138|NCT04546256|Fluticasone|fluticasone|mesh-list
56510140|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56510141|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56510142|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56510143|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56510144|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
56510145|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510146|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510147|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56510148|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
56510149|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
56510150|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56510151|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56510152|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56510153|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56510154|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
56510155|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510156|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510157|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
56510158|NCT04546256|Hormones|hormones|mesh-ancestor
56510159|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56510160|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
56510162|NCT01645449|Calcium|calcium|mesh-list
56111185|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
56648662|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56648663|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56648664|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56648665|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
56648666|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510163|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510164|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510165|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56510166|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56510167|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
56510168|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510169|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56510170|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56510171|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510172|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56510173|NCT01645800|Muramidase|muramidase|mesh-list
56510174|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510175|NCT02214680|Timolol|timolol|mesh-list
56510176|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56510177|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
56510178|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56510179|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56510180|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
56510181|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510182|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510183|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510184|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56510185|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56510186|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56510187|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56510188|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56510189|NCT02756208|Vaccines|vaccines|mesh-list
56510190|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
56510191|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510192|NCT04545788|Linezolid|linezolid|mesh-list
56510193|NCT04545788|Cycloserine|cycloserine|mesh-list
56510194|NCT04545788|Bedaquiline|bedaquiline|mesh-list
56510195|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56510196|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510197|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56510198|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510199|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510200|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56510201|NCT04545788|Renal Agents|renal agents|mesh-ancestor
56510202|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56510203|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
56510204|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
56510205|NCT02756013|Paclitaxel|paclitaxel|mesh-list
56510206|NCT02756013|Carboplatin|carboplatin|mesh-list
56510207|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56510210|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56510211|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
56510212|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510214|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
56510215|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56510216|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56510217|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510218|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510219|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56510220|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56510221|NCT04545710|Osimertinib|osimertinib|mesh-list
56510222|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510223|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56510224|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510225|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510226|NCT01646229|Polymyxins|polymyxins|mesh-list
56510227|NCT01646229|Polymyxin B|polymyxin b|mesh-list
56510228|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55999701|NCT01313416|Gemcitabine|gemcitabine|mesh-list
56510229|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510230|NCT01680081|Adenosine|adenosine|mesh-list
56510231|NCT01680081|Analgesics|analgesics|mesh-ancestor
56510232|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
56510233|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167850|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
56510234|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510235|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56510236|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
56510237|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56510238|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
56510239|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
56510240|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510241|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510242|NCT01646307|Atorvastatin|atorvastatin|mesh-list
56510243|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56510244|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56510245|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56510246|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
56510247|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510248|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56510249|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56510250|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510251|NCT04544969|Gemcitabine|gemcitabine|mesh-list
56510252|NCT04544969|Cisplatin|cisplatin|mesh-list
56510253|NCT04544969|Docetaxel|docetaxel|mesh-list
56510254|NCT04544969|Fluorouracil|fluorouracil|mesh-list
56510255|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510256|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56510257|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
56510258|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510259|NCT04544969|Antiviral Agents|antiviral agents|mesh-ancestor
56510260|NCT04544969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510261|NCT04544969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510262|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56510263|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
56510264|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510265|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
56510266|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
56510267|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
56510268|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56510269|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56510270|NCT04541732|Anesthetics|anesthetics|mesh-list
56510271|NCT04541732|Propofol|propofol|mesh-list
56510272|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510273|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510274|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56510275|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56510276|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
56510277|NCT01680471|Midazolam|midazolam|mesh-list
56510278|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56510279|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56510280|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510281|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510283|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56510284|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56510285|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56510286|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
56510287|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
56510288|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
56510289|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
56510290|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510291|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510292|NCT02279316|Vitamin D|vitamin d|mesh-list
56510293|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
56510294|NCT02279316|Vitamins|vitamins|mesh-ancestor
56510295|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
56510296|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510297|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56510298|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510299|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
56510300|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56510301|NCT04544228|Ketamine|ketamine|mesh-list
56510302|NCT04544228|Bupivacaine|bupivacaine|mesh-list
56510303|NCT04544228|Neostigmine|neostigmine|mesh-list
56510304|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
56648667|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648668|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56648669|NCT02670954|Narcotics|narcotics|mesh-ancestor
56510305|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
56510306|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510307|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510308|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
56510309|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510310|NCT04544228|Analgesics|analgesics|mesh-ancestor
56510311|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56510312|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56510313|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
56510314|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56510315|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56510316|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510317|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510318|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56510319|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510320|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
56510321|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56510322|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
56510323|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
56510324|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56510325|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
56510326|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510327|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56510328|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56510329|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
56510330|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510331|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510332|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56510333|NCT04542005|Albuterol|albuterol|mesh-list
56510334|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56510335|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
56510336|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510337|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510338|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56510339|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
56510340|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
56510341|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56510342|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56510343|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56510344|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56510345|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
56510346|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510347|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510348|NCT01646775|Fentanyl|fentanyl|mesh-list
56510349|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56510350|NCT01646775|Narcotics|narcotics|mesh-ancestor
56510351|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510352|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510353|NCT01646775|Analgesics|analgesics|mesh-ancestor
56510354|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
56510357|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56510358|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
56510359|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
56510360|NCT01646853|Fluorouracil|fluorouracil|mesh-list
56510361|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510362|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
56510363|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510364|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56510365|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56510366|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
56510367|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510368|NCT01647165|Dexamethasone|dexamethasone|mesh-list
56510369|NCT01647165|Lenalidomide|lenalidomide|mesh-list
56510370|NCT01647165|Bortezomib|bortezomib|mesh-list
56510371|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56510372|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
56510373|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
56510374|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510375|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648670|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56648671|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56648672|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56510376|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56510377|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
56510378|NCT01647165|Hormones|hormones|mesh-ancestor
56510379|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56510380|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56510381|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510382|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
56510383|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56510384|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56510385|NCT01647165|Growth Substances|growth substances|mesh-ancestor
56510386|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
56510388|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56510389|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
56510390|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510391|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56510392|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510393|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510394|NCT04543916|Irinotecan|irinotecan|mesh-list
56510395|NCT04543916|Venetoclax|venetoclax|mesh-list
56510396|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56510397|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56510398|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510399|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510400|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510401|NCT04541147|Dexamethasone|dexamethasone|mesh-list
56510402|NCT04541147|Analgesics|analgesics|mesh-list
56510403|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56510404|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
56510405|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
56510406|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510407|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510408|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56510409|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
56510410|NCT04541147|Hormones|hormones|mesh-ancestor
56510411|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56510412|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56510413|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510414|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
56258499|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
56510415|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
56510416|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56510417|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56510418|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510419|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
56510420|NCT04541303|Coagulants|coagulants|mesh-ancestor
56510421|NCT02214992|Telmisartan|telmisartan|mesh-list
56510422|NCT02214992|Ramipril|ramipril|mesh-list
56510423|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56510424|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56510425|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56510426|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510427|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56510431|NCT04528095|Amisulpride|amisulpride|mesh-list
56510432|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56510433|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
56510434|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510435|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510436|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510437|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56510438|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56510439|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510440|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56510441|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
56510442|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
56510443|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56510444|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
56510445|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56510446|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
56648673|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56648674|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648675|NCT00644904|Vitamin D|vitamin d|mesh-list
56648676|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
56648677|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
56510447|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
56510448|NCT04528056|Ambrisentan|ambrisentan|mesh-list
56510449|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510450|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56510451|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56510452|NCT04528056|Analgesics|analgesics|mesh-ancestor
56510453|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
56510454|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510455|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510456|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56510457|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56510458|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56510459|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56510461|NCT04543565|Pradefovir|pradefovir|mesh-list
56510462|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
56510463|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510464|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56510465|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56510466|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510467|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510468|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56510469|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56510470|NCT01647555|Cetuximab|cetuximab|mesh-list
56510471|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56510472|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510473|NCT04543370|Deflazacort|deflazacort|mesh-list
56510474|NCT04543370|Midazolam|midazolam|mesh-list
56510475|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56510476|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56510477|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510478|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510479|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56510480|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56510481|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56510482|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56510483|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
56510484|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
56510485|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
56510486|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
56510487|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510488|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510489|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56510490|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56510491|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
56510492|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
56510493|NCT01681563|Ofatumumab|ofatumumab|mesh-list
56510494|NCT01681563|Pentostatin|pentostatin|mesh-list
56510495|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56510496|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
56510497|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510498|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56510499|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56510500|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
56510501|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510502|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510503|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56510504|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56510505|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510506|NCT01681680|Metformin|metformin|mesh-list
56510507|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56510508|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510509|NCT01647633|Calcium|calcium|mesh-list
56510510|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510511|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510512|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56510513|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510514|NCT01647984|Vitamins|vitamins|mesh-list
56510515|NCT01647984|Vitamin E|vitamin e|mesh-list
55937895|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
55937896|NCT02075255|Benralizumab|benralizumab|mesh-list
55937897|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55937898|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
55937899|NCT03532217|Nivolumab|nivolumab|mesh-list
55937900|NCT03532217|Ipilimumab|ipilimumab|mesh-list
55937901|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937902|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937903|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55937905|NCT03529487|Phenylephrine|phenylephrine|mesh-list
56510516|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
56510517|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
56510518|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510519|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
56510520|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510521|NCT01647984|Protective Agents|protective agents|mesh-ancestor
56510522|NCT02215382|Atropine|atropine|mesh-list
56510523|NCT02215382|Neostigmine|neostigmine|mesh-list
56510524|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56510525|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56510526|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56510527|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
56510528|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510529|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510530|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56510531|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
56510532|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
56510533|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
56510534|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56510535|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56510536|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
56510537|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510538|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510539|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56510540|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510541|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56510542|NCT01682109|Valacyclovir|valacyclovir|mesh-list
56510543|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
56510544|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510545|NCT02215148|Tolvaptan|tolvaptan|mesh-list
56510546|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56510547|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510548|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
56510549|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510550|NCT01682343|Calcium|calcium|mesh-list
56510551|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510552|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510553|NCT01648257|Cabotegravir|cabotegravir|mesh-list
56510554|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56510555|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56510556|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510557|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510558|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56510559|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56510560|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
56510561|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510562|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
56510563|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56510564|NCT02215460|Azithromycin|azithromycin|mesh-list
56510565|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56510566|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510567|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
56510568|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
56510569|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56510570|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
56510571|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56510572|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56648678|NCT00644904|Vitamins|vitamins|mesh-list
56648679|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
56648680|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510573|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
56510574|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
56510575|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510576|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510577|NCT01648608|Exemestane|exemestane|mesh-list
56510578|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132291|NCT02323698|Caffeine|caffeine|mesh-list
56510580|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56510581|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510582|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510583|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56510584|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
56510585|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56510586|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510587|NCT02215538|Methylphenidate|methylphenidate|mesh-list
56510588|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56510589|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510590|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56510591|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56510592|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510593|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510594|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
56510596|NCT01682421|Dexamethasone|dexamethasone|mesh-list
56510597|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
56510598|NCT01682421|BB 1101|bb 1101|mesh-list
56510599|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510600|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510601|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56510602|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
56510603|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
56510604|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510605|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56510606|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
56510607|NCT01682421|Hormones|hormones|mesh-ancestor
56510608|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56510609|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56510610|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510611|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
56510612|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510613|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
56510614|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
56510615|NCT01682499|Calcium|calcium|mesh-list
56510616|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510617|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510618|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56510619|NCT01682499|Analgesics|analgesics|mesh-ancestor
56510620|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
56510621|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510622|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
56510623|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510624|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56510625|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
56510626|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56510627|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510628|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510629|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
56510630|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56510631|NCT04539977|Cisplatin|cisplatin|mesh-list
56510632|NCT04539977|Etoposide|etoposide|mesh-list
56510633|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
56510634|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510635|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56510636|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56510637|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56510638|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510639|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510640|NCT04540055|Anesthetics|anesthetics|mesh-list
56510641|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648681|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56648682|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510642|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510643|NCT01180660|Lidocaine|lidocaine|mesh-list
56510644|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
56510645|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
56510646|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510647|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510648|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
56510649|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510650|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56510651|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56510653|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510654|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510655|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56510656|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56510657|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510658|NCT01202227|Pregabalin|pregabalin|mesh-list
56510659|NCT01202227|Analgesics|analgesics|mesh-ancestor
56510660|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
56510661|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510662|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510663|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
56510664|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56510665|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510666|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167862|NCT00005634|Vorinostat|vorinostat|mesh-list
56510667|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510668|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56510669|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56510670|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510671|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56510672|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
56510673|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56510674|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510675|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510676|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
56510677|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510678|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510679|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
56510680|NCT04539314|Bupivacaine|bupivacaine|mesh-list
56510681|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
56510682|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
56510683|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510684|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510685|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
56510686|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510687|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56510688|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56510689|NCT04539314|Analgesics|analgesics|mesh-ancestor
56510690|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56510691|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56510692|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56510693|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
56510694|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510695|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510696|NCT01682772|Olaparib|olaparib|mesh-list
56510697|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56510698|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510699|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510700|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510701|NCT01649037|Terlipressin|terlipressin|mesh-list
56510702|NCT01649037|Epinephrine|epinephrine|mesh-list
56510703|NCT01649037|Racepinephrine|racepinephrine|mesh-list
56510704|NCT01649037|Norepinephrine|norepinephrine|mesh-list
56510705|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
56510706|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56510707|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56510708|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
56510709|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648683|NCT02670564|Busulfan|busulfan|mesh-list
56648684|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
56648685|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999716|NCT05499234|Meperidine|meperidine|mesh-list
56510710|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510711|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510712|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56510713|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56510714|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
56510715|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510716|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56510717|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
56510718|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
56510719|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
56510720|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56510721|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56510722|NCT04539119|Tenofovir|tenofovir|mesh-list
56510723|NCT04539119|Entecavir|entecavir|mesh-list
56510726|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56510727|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56510728|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510729|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510730|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56510731|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56510732|NCT02279511|Adenosine|adenosine|mesh-list
56510733|NCT02279511|Analgesics|analgesics|mesh-ancestor
56510734|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
56510735|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510736|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510737|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56510738|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
56510739|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56510740|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
56510741|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
56510742|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510743|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510744|NCT02279628|Morphine|morphine|mesh-list
56510745|NCT02279628|Ropivacaine|ropivacaine|mesh-list
56510746|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56510747|NCT02279628|Narcotics|narcotics|mesh-ancestor
56510748|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510749|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510750|NCT02279628|Analgesics|analgesics|mesh-ancestor
56510751|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
56510752|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510753|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
56510754|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
56510755|NCT04542629|Trace Elements|trace elements|mesh-list
56510756|NCT04542629|Rituximab|rituximab|mesh-list
56510757|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56510758|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510759|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
56510760|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510761|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56510762|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
56510763|NCT01683006|Rocuronium|rocuronium|mesh-list
56510764|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56510765|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56510766|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56510767|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510768|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510769|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56510770|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56510771|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56510772|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56510773|NCT02215733|Telmisartan|telmisartan|mesh-list
56510774|NCT02215733|Diuretics|diuretics|mesh-list
56510775|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56510776|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56510777|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56510778|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56111496|NCT02052960|Cisplatin|cisplatin|mesh-list
56648686|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56648687|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
56648688|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510779|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510780|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
56510781|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510782|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56510783|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
56510784|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510785|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
56510786|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
56510787|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56510788|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
56510789|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510790|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510791|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56510792|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
56510793|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
56510794|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56510795|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
56510796|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510798|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56510799|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56510800|NCT01179919|Oseltamivir|oseltamivir|mesh-list
56510801|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
56510802|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510803|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510804|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510805|NCT01201798|Prednisolone|prednisolone|mesh-list
56510806|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56510807|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
56510808|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56510809|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
56510810|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56510811|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
56510812|NCT01201798|Difluprednate|difluprednate|mesh-list
56510813|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56510814|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
56510815|NCT01201798|Hormones|hormones|mesh-ancestor
56510816|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56510817|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510818|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56510819|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510820|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
56510821|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
56510822|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510823|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56510824|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56510825|NCT01201798|Protective Agents|protective agents|mesh-ancestor
56510826|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56510827|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
56510828|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56510829|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56510830|NCT01201759|Analgesics|analgesics|mesh-ancestor
56510831|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
56510832|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510833|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510834|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56510835|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56510836|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56510837|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510838|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510839|NCT04532684|Pregabalin|pregabalin|mesh-list
56510840|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56510841|NCT04532684|Analgesics|analgesics|mesh-ancestor
56510842|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
56510843|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510844|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510845|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
56510846|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56510847|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888584|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
56648689|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56648690|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999724|NCT05499234|Narcotics|narcotics|mesh-ancestor
56510848|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510849|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56510850|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56510851|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56510852|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510853|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56510854|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56510855|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56510856|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510857|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
56510858|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
56510859|NCT01649466|Insulin|insulin|mesh-list
56510860|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56510861|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56510862|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510863|NCT01200589|Rituximab|rituximab|mesh-list
56510864|NCT01200589|Ofatumumab|ofatumumab|mesh-list
56510865|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56510866|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56510867|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510868|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
56510869|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510872|NCT01683552|Prednisone|prednisone|mesh-list
56510873|NCT01683552|Aprepitant|aprepitant|mesh-list
56510874|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56510875|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
56510876|NCT01683552|Hormones|hormones|mesh-ancestor
56510877|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56510878|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510879|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56510880|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510881|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
56510882|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
56510883|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510884|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56510885|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56510886|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510887|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510888|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56510889|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56510890|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56510891|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
56510892|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
56510893|NCT04532606|Anesthetics|anesthetics|mesh-list
56510894|NCT04532606|Propofol|propofol|mesh-list
56510895|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510896|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510897|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56510898|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56510899|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
56510900|NCT01649544|Amiodarone|amiodarone|mesh-list
56510901|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56510902|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
56510903|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56510904|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510905|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510906|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56510907|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56510908|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56510909|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510910|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56510911|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56510912|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56510913|NCT04528290|Ozanimod|ozanimod|mesh-list
56510914|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56510915|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648691|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56648692|NCT02672202|Pregabalin|pregabalin|mesh-list
56648693|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56648694|NCT02672202|Analgesics|analgesics|mesh-ancestor
56510916|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56510917|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
56510918|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510919|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
56510920|NCT01179334|Riociguat|riociguat|mesh-list
56510921|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
56510922|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56510923|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56510924|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510925|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510926|NCT01179334|Urological Agents|urological agents|mesh-ancestor
56510927|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
56510928|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56510929|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56510930|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
56510931|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510932|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510933|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
56510934|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56510935|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56510936|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510937|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
56510938|NCT01683747|Coagulants|coagulants|mesh-ancestor
56510939|NCT01178671|Mirtazapine|mirtazapine|mesh-list
56510940|NCT01178671|Sertraline|sertraline|mesh-list
56510941|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
56510943|NCT01178671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56510944|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56510945|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510946|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510947|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56510949|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56510950|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56510951|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
56510952|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
56510953|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56510954|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56510955|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56510956|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56510957|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56510958|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56510959|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
56510960|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56510961|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56510962|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56510963|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
56510964|NCT04532060|Nystatin|nystatin|mesh-list
56510965|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56510966|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
56510967|NCT04532060|Ionophores|ionophores|mesh-ancestor
56510968|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56510969|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510970|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56510971|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
56510972|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56510973|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56510974|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510975|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510976|NCT01649739|Urological Agents|urological agents|mesh-ancestor
56510977|NCT04532333|Heparin|heparin|mesh-list
56510978|NCT04532333|Bivalirudin|bivalirudin|mesh-list
56510979|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
56510980|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56510981|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56510982|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510983|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
56510984|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56648695|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
56648696|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999729|NCT01269034|Exenatide|exenatide|mesh-list
56510985|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
56510986|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510987|NCT01649895|Cycloserine|cycloserine|mesh-list
56510988|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56510989|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510990|NCT01649895|Renal Agents|renal agents|mesh-ancestor
56510991|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56510992|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
56510993|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56510994|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
56510995|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510996|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56510997|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
56510998|NCT01649505|Coagulants|coagulants|mesh-ancestor
56510999|NCT01178086|Rituximab|rituximab|mesh-list
56511000|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56511001|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511002|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
56511003|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511004|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56511005|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
56511006|NCT04531865|Rituximab|rituximab|mesh-list
56511007|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56511008|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511009|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
56511010|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511011|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56511012|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56511013|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56511014|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
56511016|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511017|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511018|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511019|NCT01643070|Capecitabine|capecitabine|mesh-list
56511020|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
56511021|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56511022|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
56511023|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511024|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511025|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
56511026|NCT01684059|Astringents|astringents|mesh-ancestor
56511027|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511028|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
56511029|NCT04531748|Toremifene|toremifene|mesh-list
56511030|NCT04531748|Melatonin|melatonin|mesh-list
56511031|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
56511032|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511033|NCT04531748|Protective Agents|protective agents|mesh-ancestor
56511034|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511035|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511036|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56511037|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511038|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56511039|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56511040|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
56511041|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511042|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56511043|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56511044|NCT01177813|Empagliflozin|empagliflozin|mesh-list
56511045|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511046|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511047|NCT01177813|Incretins|incretins|mesh-ancestor
56511048|NCT01177813|Hormones|hormones|mesh-ancestor
56511049|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511050|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56511051|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
56511052|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511053|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888585|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56648697|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648698|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
56511054|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56511055|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
56511056|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56511057|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511058|NCT04315831|Buprenorphine|buprenorphine|mesh-list
56511059|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56511060|NCT04315831|Narcotics|narcotics|mesh-ancestor
56511061|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511062|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511063|NCT04315831|Analgesics|analgesics|mesh-ancestor
56511064|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
56511065|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511066|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56511067|NCT02216045|Ribavirin|ribavirin|mesh-list
56511068|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56511069|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
56511070|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
56511071|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511072|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
56511073|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511074|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
56511075|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511076|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
56511077|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56511078|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56511079|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511080|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
56511081|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56511082|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56511083|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511084|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511085|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511086|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
56511087|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511089|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
56511090|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56511091|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511092|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56511093|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511094|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511095|NCT01684449|Gemcitabine|gemcitabine|mesh-list
56511097|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56511098|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
56511099|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511100|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511101|NCT01684449|Antiviral Agents|antiviral agents|mesh-ancestor
56511102|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511103|NCT01684449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511104|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56511105|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
56511106|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511107|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56511108|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56511109|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
56511110|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56511111|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
56511112|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
56511113|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511114|NCT01684683|Theophylline|theophylline|mesh-list
56511115|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56511116|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
56511117|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511118|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511119|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56511120|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
56511121|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56511122|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511123|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511124|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
56648699|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56648700|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56648701|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648702|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56648703|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56648704|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56648705|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648706|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56648707|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56648708|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56511125|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56511126|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56511127|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
56511128|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511129|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56511130|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
56511131|NCT01684800|Coagulants|coagulants|mesh-ancestor
56511132|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56511133|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
56511134|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511135|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
56511136|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56511137|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
56511138|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511139|NCT04531163|Expectorants|expectorants|mesh-ancestor
56511140|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
56511141|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56511142|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
56511143|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511144|NCT04531163|Protective Agents|protective agents|mesh-ancestor
56511145|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511146|NCT04531163|Antidotes|antidotes|mesh-ancestor
56511147|NCT01684995|Nicotine|nicotine|mesh-list
56511148|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56511149|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
56511150|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511151|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511152|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56511153|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56511154|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
56511156|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511157|NCT01685502|Acarbose|acarbose|mesh-list
56511158|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56511159|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511160|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511161|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511162|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511164|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56511166|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
56511167|NCT01200355|Posaconazole|posaconazole|mesh-list
56511168|NCT01200355|Micafungin|micafungin|mesh-list
56511169|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
56511170|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511171|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56511172|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56511173|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56511174|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56511175|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56511176|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511177|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511178|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56511179|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
56648709|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648710|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
55938655|NCT01144455|Gemcitabine|gemcitabine|mesh-list
56511180|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511181|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511182|NCT04527666|Anticoagulants|anticoagulants|mesh-list
56511183|NCT04530500|Androgens|androgens|mesh-list
56511184|NCT04530500|Hormones|hormones|mesh-ancestor
56511185|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511186|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511187|NCT01685658|Acetaminophen|acetaminophen|mesh-list
56511188|NCT01685658|Ketoprofen|ketoprofen|mesh-list
56511189|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56511190|NCT01685658|Analgesics|analgesics|mesh-ancestor
56511191|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
56511192|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511193|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511194|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
56511195|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56511196|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56511197|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56511198|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56511199|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511200|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511201|NCT04530578|Heparin|heparin|mesh-list
56511202|NCT04530578|Calcium heparin|calcium heparin|mesh-list
56511203|NCT04530578|Enoxaparin|enoxaparin|mesh-list
56511204|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56511205|NCT04530578|Tinzaparin|tinzaparin|mesh-list
56511206|NCT04530578|Dalteparin|dalteparin|mesh-list
56511207|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
56511208|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56511209|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56511210|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511211|NCT01685853|Bisacodyl|bisacodyl|mesh-list
56511212|NCT01685853|Cathartics|cathartics|mesh-ancestor
56511213|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511214|NCT01685853|Laxatives|laxatives|mesh-ancestor
56511215|NCT04530422|Azithromycin|azithromycin|mesh-list
56511216|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
56511217|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
56511218|NCT04530422|Oseltamivir|oseltamivir|mesh-list
56511219|NCT04530422|Ledipasvir|ledipasvir|mesh-list
56511220|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56511221|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511222|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
56511223|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56511224|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56511225|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511226|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511227|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56511228|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
56511229|NCT02887573|Mosapride|mosapride|mesh-list
56167892|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511230|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511231|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511232|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56511233|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
56511234|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259329|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511235|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511236|NCT01685892|Venetoclax|venetoclax|mesh-list
56511237|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
56511241|NCT02887534|Analgesics|analgesics|mesh-ancestor
56511242|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
56511243|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511244|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511245|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
56511246|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56511247|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56511248|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
56511249|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
56511250|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56511251|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56511252|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56511253|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
56648711|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
56648712|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
56648713|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56511254|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511255|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511256|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56511257|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56511258|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56511259|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511260|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511261|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56511262|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56511263|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56511264|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
56511265|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511266|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511267|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56511268|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56511269|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
56511270|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
56511271|NCT01685970|Cathartics|cathartics|mesh-ancestor
56511272|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511273|NCT04530617|Camostat|camostat|mesh-list
56511274|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
56511275|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511276|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511277|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56511278|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56511279|NCT01686009|Ketamine|ketamine|mesh-list
56511280|NCT01686009|Analgesics|analgesics|mesh-ancestor
56511281|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
56511282|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511283|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511284|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56511285|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56511286|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
56511287|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
56511288|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511289|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56511290|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56511291|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511292|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511293|NCT04536662|Dexamethasone|dexamethasone|mesh-list
56511294|NCT04536662|Prednisone|prednisone|mesh-list
56511295|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
56511296|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56511297|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
56511298|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
56511299|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511300|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511301|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511303|NCT04536662|Hormones|hormones|mesh-ancestor
56511304|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511305|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56511306|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511307|NCT01686321|Rituximab|rituximab|mesh-list
56511308|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56511309|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56511310|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511312|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259405|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56511314|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56511315|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
56511316|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511317|NCT01199731|Etravirine|etravirine|mesh-list
56511318|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56511319|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56511320|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511321|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511322|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
56511323|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648714|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
56648715|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
56511324|NCT01686555|Venetoclax|venetoclax|mesh-list
56511325|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511337|NCT01686711|Pioglitazone|pioglitazone|mesh-list
56511338|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511339|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511340|NCT01686789|Interferons|interferons|mesh-list
56511341|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
56511342|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
56511343|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56511344|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511345|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
56511346|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511347|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
56511348|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511349|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
56511350|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56511351|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
56511352|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511353|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511354|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56511355|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
56511356|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56511357|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
56511358|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511359|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511360|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56511361|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
56511362|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
56511363|NCT02217683|Protective Agents|protective agents|mesh-ancestor
56511364|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56511365|NCT02217722|Amoxicillin|amoxicillin|mesh-list
56511366|NCT02217722|Metronidazole|metronidazole|mesh-list
56511367|NCT02217722|Doxycycline|doxycycline|mesh-list
56511368|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511369|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56511370|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56511371|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
56511372|NCT02217839|Octreotide|octreotide|mesh-list
56511373|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511374|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56511375|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511376|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
56511377|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56511378|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
56511379|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
56511380|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511381|NCT02217956|Bevacizumab|bevacizumab|mesh-list
56511382|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56511383|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511384|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56511385|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56511386|NCT02217956|Growth Substances|growth substances|mesh-ancestor
56511387|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511388|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
56511389|NCT01687140|Cycloserine|cycloserine|mesh-list
56511390|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56511391|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511392|NCT01687140|Renal Agents|renal agents|mesh-ancestor
56511393|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56511394|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
56511395|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56511397|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511398|NCT04535960|Liraglutide|liraglutide|mesh-list
56511399|NCT04535960|Empagliflozin|empagliflozin|mesh-list
56511400|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511401|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511402|NCT04535960|Incretins|incretins|mesh-ancestor
56511404|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511405|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56511406|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511407|NCT04536428|Hemostatics|hemostatics|mesh-list
56511408|NCT04536428|Coagulants|coagulants|mesh-ancestor
56511409|NCT01687374|Hormones|hormones|mesh-list
56511410|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
56648716|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648717|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511411|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511412|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511413|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56511414|NCT04530188|Propofol|propofol|mesh-list
56511415|NCT04530188|Sevoflurane|sevoflurane|mesh-list
56511416|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56511417|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511418|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511419|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56511420|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
56511421|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
56511422|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56511423|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56511424|NCT01687491|Enoxaparin|enoxaparin|mesh-list
56511425|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
56511426|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56511427|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56511428|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511429|NCT04530227|Paclitaxel|paclitaxel|mesh-list
56511430|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56511431|NCT04530227|Pemetrexed|pemetrexed|mesh-list
56511432|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56511433|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511434|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
56511435|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
56511436|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
56511437|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511438|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511439|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56511440|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56511441|NCT01199263|Paclitaxel|paclitaxel|mesh-list
56511442|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56511443|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56511444|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511445|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
56511446|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
56511447|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
56511448|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511450|NCT02218034|Tazarotene|tazarotene|mesh-list
56511451|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56511452|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
56511453|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
56511454|NCT02218034|Vitamins|vitamins|mesh-ancestor
56511455|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
56511456|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511457|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
56511458|NCT01688154|Procyanidin|procyanidin|mesh-list
56511459|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
56511460|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511461|NCT01688154|Protective Agents|protective agents|mesh-ancestor
56511462|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511463|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56259553|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56511464|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56511465|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511466|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
56511467|NCT01688349|Hormones|hormones|mesh-ancestor
56511468|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511469|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511470|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
56511474|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
56511475|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56511476|NCT04535804|Aspirin|aspirin|mesh-list
56511477|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56511478|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56511479|NCT04535804|Analgesics|analgesics|mesh-ancestor
56511480|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
56511481|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511482|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511483|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56511484|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56648718|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56648719|NCT02671578|Analgesics|analgesics|mesh-ancestor
56648720|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
55999752|NCT05599126|GABA Modulators|gaba modulators|mesh-ancestor
56511485|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56511486|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56511487|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511488|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56511489|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56511490|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511491|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
56511492|NCT04529525|Ivermectin|ivermectin|mesh-list
56511493|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56511494|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511495|NCT02216409|Magrolimab|magrolimab|mesh-list
56511496|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56511497|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511498|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56511499|NCT05126121|Amoxicillin|amoxicillin|mesh-list
56511500|NCT05126121|Clarithromycin|clarithromycin|mesh-list
56511501|NCT05126121|Levofloxacin|levofloxacin|mesh-list
56511502|NCT05126121|Ofloxacin|ofloxacin|mesh-list
56511503|NCT05126121|Tetracycline|tetracycline|mesh-list
56511504|NCT05126121|Tinidazole|tinidazole|mesh-list
56511505|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56511506|NCT05126121|Furazolidone|furazolidone|mesh-list
56511507|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511508|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
56511509|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56511510|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511511|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511512|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56511513|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56511514|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56511515|NCT05126121|Renal Agents|renal agents|mesh-ancestor
56511516|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56511517|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56511518|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511519|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56511520|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56511521|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56511522|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56511523|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56511524|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56511525|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
56511527|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56511528|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511529|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511530|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56511531|NCT01199068|Efatutazone|efatutazone|mesh-list
56511532|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511533|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56511534|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511535|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511536|NCT04535700|Pioglitazone|pioglitazone|mesh-list
56511537|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511538|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511539|NCT01198873|Dronedarone|dronedarone|mesh-list
56511540|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56511541|NCT01198795|Citalopram|citalopram|mesh-list
56511542|NCT01198795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56511543|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56511544|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56511546|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511547|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
56511548|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511549|NCT01198795|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56511550|NCT01198795|Antidepressive Agents|antidepressive agents|mesh-ancestor
56511551|NCT01198795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56511552|NCT04918017|Esomeprazole|esomeprazole|mesh-list
56511553|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56511554|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55888586|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56648721|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648722|NCT00644982|Sertraline|sertraline|mesh-list
56511555|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511556|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511557|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511558|NCT02278913|Insulin|insulin|mesh-list
56511559|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
56511560|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56511561|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511562|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511563|NCT02216513|Deferoxamine|deferoxamine|mesh-list
56511564|NCT02216513|Siderophores|siderophores|mesh-ancestor
56511565|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56511566|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
56511567|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
56511568|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511569|NCT02218775|Aticaprant|aticaprant|mesh-list
56511570|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56511571|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511572|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
56511573|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511574|NCT02216552|Resveratrol|resveratrol|mesh-list
56511575|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
56511576|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511577|NCT02216552|Protective Agents|protective agents|mesh-ancestor
56511578|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511579|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511580|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56511581|NCT01198756|Vaccines|vaccines|mesh-list
56511582|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
56511583|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511584|NCT02216487|Irinotecan|irinotecan|mesh-list
56511585|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56511586|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56511587|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511588|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511589|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511590|NCT02218814|Bupivacaine|bupivacaine|mesh-list
56511591|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
56511592|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
56511593|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511594|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511595|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
56511596|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511597|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56511598|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56511599|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56511600|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511601|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
56511602|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56511603|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
56511604|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511605|NCT01198132|Vitamin D|vitamin d|mesh-list
56511606|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
56511607|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
56511608|NCT01198132|Vitamins|vitamins|mesh-list
56511609|NCT01198132|Interferons|interferons|mesh-list
56511610|NCT01198132|Interferon-beta|interferon-beta|mesh-list
56511611|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
56511612|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
56511613|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511614|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56511615|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56511616|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511617|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
56511618|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511619|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
56511623|NCT02219165|Antibodies|antibodies|mesh-list
56511624|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
56511625|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511626|NCT04534725|Interferons|interferons|mesh-list
56511627|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
56511628|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511629|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
55888587|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56648723|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56648724|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
56648725|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56648726|NCT00644982|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56648727|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56648728|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56648729|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648730|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648731|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
55999756|NCT05599126|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56511630|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511631|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
56511632|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511633|NCT04534478|Prednisone|prednisone|mesh-list
56511634|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56511635|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
56511636|NCT04534478|Hormones|hormones|mesh-ancestor
56511637|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511638|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511639|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56511640|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511641|NCT02216669|Imidazole|imidazole|mesh-list
56511642|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511643|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511644|NCT03772158|Cetirizine|cetirizine|mesh-list
56511645|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56511646|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56511647|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56511648|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
56511649|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
56511650|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511651|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511652|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511653|NCT01196416|Cisplatin|cisplatin|mesh-list
56511654|NCT01196416|Temozolomide|temozolomide|mesh-list
56511655|NCT01196416|Vinblastine|vinblastine|mesh-list
56511656|NCT01196416|R04929097|r04929097|mesh-list
56511657|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511658|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56511659|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
56511660|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511661|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56511662|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
56511663|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
56511664|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
56511665|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511666|NCT01196104|Insulin|insulin|mesh-list
56511667|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56511668|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
56511669|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
56511670|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511671|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511672|NCT04534322|Dexamethasone|dexamethasone|mesh-list
56511673|NCT04534322|Melphalan|melphalan|mesh-list
56511674|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56511675|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
56511676|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
56511677|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511678|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511679|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511680|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
56511681|NCT04534322|Hormones|hormones|mesh-ancestor
56511682|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511683|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56648732|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648733|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56511684|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511685|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56511686|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
56511687|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511688|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56511689|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56511690|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
56511691|NCT02219672|Ritonavir|ritonavir|mesh-list
56511692|NCT02219672|Lopinavir|lopinavir|mesh-list
56511693|NCT02219672|Tenofovir|tenofovir|mesh-list
56511696|NCT02219672|Triptolide|triptolide|mesh-list
56511697|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56511698|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56511699|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
56511700|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511701|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511702|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56511703|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56511704|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
56511705|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511706|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56511707|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56511708|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56511709|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56511710|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56511711|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56511712|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56511713|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511714|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56511715|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
56511716|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56511717|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56511718|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
56511719|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56511720|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
56511721|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511722|NCT03113955|Epirubicin|epirubicin|mesh-list
56511723|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56511724|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511725|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56511726|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56511727|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511728|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511729|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56511730|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511731|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511732|NCT04534452|Phenylephrine|phenylephrine|mesh-list
56511733|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
56511734|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56511735|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
56511736|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
56511737|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511738|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511739|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
56511740|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56511741|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
56511742|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
56511743|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56511744|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56511745|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56511746|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
56511747|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511748|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511749|NCT04534452|Protective Agents|protective agents|mesh-ancestor
56511750|NCT03016338|Niraparib|niraparib|mesh-list
56511751|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56511752|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511753|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648734|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56648735|NCT02670642|Esomeprazole|esomeprazole|mesh-list
56648736|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56648737|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511754|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511755|NCT02219789|Fulvestrant|fulvestrant|mesh-list
56511756|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56511757|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511758|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56511759|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56511760|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
56511761|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511762|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511763|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56511764|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56511767|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
56511768|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
56511769|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511770|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511771|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511772|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
56511773|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
56511774|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56511775|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
56511776|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511777|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511778|NCT04533867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56511779|NCT04533867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56511780|NCT04533867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511781|NCT04533867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56511782|NCT04533867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56511783|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56511784|NCT02219867|Ketamine|ketamine|mesh-list
56511785|NCT02219867|Analgesics|analgesics|mesh-ancestor
56511786|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
56511787|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511788|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511789|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56511790|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56511791|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
56511792|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
56511793|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511794|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56511795|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56511796|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511797|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511798|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
56511799|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56511800|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511801|NCT02219906|Resveratrol|resveratrol|mesh-list
56511802|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
56511803|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511804|NCT02219906|Protective Agents|protective agents|mesh-ancestor
56511805|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511806|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511807|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56511808|NCT04533243|Fentanyl|fentanyl|mesh-list
56511809|NCT04533243|Morphine|morphine|mesh-list
56511810|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56511811|NCT04533243|Narcotics|narcotics|mesh-ancestor
56511812|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511813|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511814|NCT04533243|Analgesics|analgesics|mesh-ancestor
56511815|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
56511816|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511817|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56511818|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56511819|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
56511821|NCT04533321|Afatinib|afatinib|mesh-list
56511822|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648738|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56648739|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648740|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648741|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56648742|NCT02670018|Metformin|metformin|mesh-list
56511823|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56511824|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511825|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511826|NCT01195831|Calcipotriene|calcipotriene|mesh-list
56511827|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
56511828|NCT01195675|Empagliflozin|empagliflozin|mesh-list
56511829|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
56511830|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56511831|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511832|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56511833|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56511834|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511835|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511836|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511837|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511838|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56133608|NCT00060528|Molgramostim|molgramostim|mesh-list
56511842|NCT04532931|Artesunate|artesunate|mesh-list
56259933|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56511843|NCT04532931|Favipiravir|favipiravir|mesh-list
56511844|NCT04532931|Amodiaquine|amodiaquine|mesh-list
56511845|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
56511846|NCT04532931|Pyronaridine|pyronaridine|mesh-list
56511847|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56511848|NCT04532931|Analgesics|analgesics|mesh-ancestor
56511849|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
56511850|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511851|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511852|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
56511853|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
56511854|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511855|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
56511856|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56511857|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56511858|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511859|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
56511860|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56511861|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
56511862|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56511863|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
56511864|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56511865|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56511866|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56511867|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56511868|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511869|NCT01195090|Pioglitazone|pioglitazone|mesh-list
56511870|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56511871|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511872|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511873|NCT01195090|Incretins|incretins|mesh-ancestor
56511875|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511876|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56511877|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
56511878|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511879|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511880|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
56511881|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56511882|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
56511883|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56511884|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511885|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56511886|NCT02213627|Menotropins|menotropins|mesh-list
56511887|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56511888|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
56511889|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56111497|NCT02052960|Fluorouracil|fluorouracil|mesh-list
56648743|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511890|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511891|NCT02216799|Insulin|insulin|mesh-list
56511892|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56511893|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
56511894|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511895|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511896|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
56511897|NCT02216877|Antacids|antacids|mesh-ancestor
56511898|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511899|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511900|NCT02214563|Vitamin D|vitamin d|mesh-list
56511901|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
56511902|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
56511903|NCT02214563|Vitamins|vitamins|mesh-list
56511904|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
56511905|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511906|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56511907|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56511908|NCT01194973|Eculizumab|eculizumab|mesh-list
56511909|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56511910|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56511911|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
56511912|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511913|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56511914|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
56511918|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56511919|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
56511920|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511921|NCT02216747|Prednisone|prednisone|mesh-list
56511922|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56511923|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
56511924|NCT02216747|Hormones|hormones|mesh-ancestor
56511925|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511926|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511927|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56511928|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511929|NCT02216786|Everolimus|everolimus|mesh-list
56511930|NCT02216786|Fulvestrant|fulvestrant|mesh-list
56511931|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511932|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56511933|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
56511934|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511935|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56511936|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56511937|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56511938|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
56511939|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511940|NCT02279147|Neostigmine|neostigmine|mesh-list
56511941|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56511942|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511943|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511944|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
56511945|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56511946|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511947|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56511948|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
56511949|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56511950|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
56511951|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56511952|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56511953|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511954|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
56511955|NCT02279186|Coagulants|coagulants|mesh-ancestor
56511956|NCT01177540|Decitabine|decitabine|mesh-list
56511957|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56511958|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
56511959|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167915|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
56511960|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511961|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511962|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56511963|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56511964|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939481|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
56511965|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56511966|NCT01177384|Glimepiride|glimepiride|mesh-list
56511967|NCT01177384|Acarbose|acarbose|mesh-list
56511968|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511969|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511970|NCT01177384|Incretins|incretins|mesh-ancestor
56511971|NCT01177384|Hormones|hormones|mesh-ancestor
56511972|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511973|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56511974|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
56511975|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511976|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511977|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56511978|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56511979|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
56511980|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56511981|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
56511982|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511983|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56511984|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56511986|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
56511987|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56511988|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511989|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56511990|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
56511991|NCT01194154|Hematinics|hematinics|mesh-ancestor
56260086|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511992|NCT01640210|Insulin|insulin|mesh-list
56511993|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511994|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56511995|NCT01640405|Bevacizumab|bevacizumab|mesh-list
56511996|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56511997|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511998|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56511999|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56512000|NCT01640405|Growth Substances|growth substances|mesh-ancestor
56512001|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512002|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
56512003|NCT01640444|Bevacizumab|bevacizumab|mesh-list
56512004|NCT01640444|Cetuximab|cetuximab|mesh-list
56512005|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56512006|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512007|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56512008|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56512009|NCT01640444|Growth Substances|growth substances|mesh-ancestor
56512010|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512011|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
56512012|NCT01642433|Prazosin|prazosin|mesh-list
56512013|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56512014|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56512015|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56512016|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56512017|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
56512018|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512019|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512020|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512021|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
56512022|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56512023|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
56512024|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56512025|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512026|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56512027|NCT01640639|Thalidomide|thalidomide|mesh-list
56512028|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56512029|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
56512030|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512031|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
56512032|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56512033|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512034|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56512035|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56512036|NCT01640639|Growth Substances|growth substances|mesh-ancestor
56648744|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648745|NCT02670096|Acetazolamide|acetazolamide|mesh-list
56648746|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
56512037|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
56512038|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512039|NCT01642667|Saruplase|saruplase|mesh-list
56512040|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56512041|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56512042|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512043|NCT01642745|Mannitol|mannitol|mesh-list
56512044|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
56512045|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56512046|NCT01642745|Diuretics|diuretics|mesh-ancestor
56512047|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
56512048|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512049|NCT01642745|Miotics|miotics|mesh-ancestor
56512050|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
56512051|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512052|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56512053|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56512054|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
56512055|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56512056|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56512059|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512060|NCT01640990|GW 328267|gw 328267|mesh-list
56512061|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56512062|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56512063|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
56512064|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
56512065|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512066|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512067|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512068|NCT01642862|Simvastatin|simvastatin|mesh-list
56512069|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56512070|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56512071|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
56512072|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512073|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56512074|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56512075|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512076|NCT01642940|Ticagrelor|ticagrelor|mesh-list
56512077|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56512078|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56512079|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56512080|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56512081|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56512082|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
56512083|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512084|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512085|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512086|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
56512087|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
56512088|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56512089|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56512090|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512091|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512092|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512093|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56512094|NCT01641224|Pinaverium|pinaverium|mesh-list
56512095|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56512096|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56512097|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512098|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56512099|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512101|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
56512102|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512103|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
56512104|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
56512105|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56512106|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56512107|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512108|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
56512109|NCT01643135|Coagulants|coagulants|mesh-ancestor
56512110|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
56512111|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56512112|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56512113|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512114|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56512115|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56512116|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512117|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512118|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
56512119|NCT01641341|Pancrelipase|pancrelipase|mesh-list
56512120|NCT01641341|Pancreatin|pancreatin|mesh-list
56512121|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56512122|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512123|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56512124|NCT01641419|Dexamethasone|dexamethasone|mesh-list
56512125|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
56512126|NCT01641419|BB 1101|bb 1101|mesh-list
56512127|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512128|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
56512129|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
56133906|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
56512130|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512131|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512132|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56512133|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
56512134|NCT01641419|Hormones|hormones|mesh-ancestor
56512135|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512136|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56512137|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512138|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
56512139|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512140|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512141|NCT01643252|Riboflavin|riboflavin|mesh-list
56512142|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56512143|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56512144|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
56512145|NCT01643252|Vitamins|vitamins|mesh-ancestor
56512146|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
56512147|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512148|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56512149|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
56512150|NCT01641458|Capecitabine|capecitabine|mesh-list
56512151|NCT01641458|Fluorouracil|fluorouracil|mesh-list
56512152|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56512153|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
56512154|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512155|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512156|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56512157|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
56512158|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512159|NCT01641536|Entecavir|entecavir|mesh-list
56512160|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
56512161|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512162|NCT01641575|Gemcitabine|gemcitabine|mesh-list
56512163|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512164|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56512165|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
56512166|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512167|NCT01641575|Antiviral Agents|antiviral agents|mesh-ancestor
56512168|NCT01641575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512169|NCT01641575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512170|NCT01641575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56512171|NCT01641575|Immunologic Factors|immunologic factors|mesh-ancestor
56512172|NCT01641575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512173|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
56512174|NCT01643447|Urinastatin|urinastatin|mesh-list
56512175|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56512176|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56512177|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
56512178|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512179|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512180|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512181|NCT01643603|Dasatinib|dasatinib|mesh-list
56512182|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512183|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56512184|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648747|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56648748|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648749|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648750|NCT02670096|Diuretics|diuretics|mesh-ancestor
56648751|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
56648752|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648753|NCT00645060|Antibodies|antibodies|mesh-list
56512185|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512186|NCT02279394|Dexamethasone|dexamethasone|mesh-list
56512187|NCT02279394|Lenalidomide|lenalidomide|mesh-list
56512188|NCT02279394|Elotuzumab|elotuzumab|mesh-list
56512189|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512190|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
56512191|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
56512192|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512193|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512194|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56512195|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
56512196|NCT02279394|Hormones|hormones|mesh-ancestor
56512197|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512198|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56512199|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512200|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
56512201|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56512202|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56512203|NCT02279394|Growth Substances|growth substances|mesh-ancestor
56512204|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
56512205|NCT02754011|Capecitabine|capecitabine|mesh-list
56512207|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
56512208|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512209|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512210|NCT02755844|Metformin|metformin|mesh-list
56512211|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
56512212|NCT02755844|Olaparib|olaparib|mesh-list
56512213|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56512214|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
56512215|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512216|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56512217|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56512218|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
56512219|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512221|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56512222|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56512223|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56512224|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512225|NCT02756897|Venetoclax|venetoclax|mesh-list
56512226|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512227|NCT01601106|Prednisolone|prednisolone|mesh-list
56512228|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512229|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
56512230|NCT01601106|Hormones|hormones|mesh-ancestor
56512231|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512232|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512233|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56512234|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512235|NCT02750540|Tenofovir|tenofovir|mesh-list
56512236|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
56512237|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512238|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56512239|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56512240|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512241|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512242|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56512243|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56512244|NCT01601184|Temozolomide|temozolomide|mesh-list
56512245|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56512246|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
56512247|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648754|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56648755|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
56648756|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512248|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512249|NCT01643759|Buprenorphine|buprenorphine|mesh-list
56512251|NCT01643759|Narcotics|narcotics|mesh-ancestor
56512252|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512253|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512254|NCT01643759|Analgesics|analgesics|mesh-ancestor
56512255|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
56512256|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512257|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56512258|NCT04488237|Vitamin D|vitamin d|mesh-list
56512259|NCT04488237|Vitamins|vitamins|mesh-ancestor
56512260|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
56512261|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512262|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56512263|NCT04528628|Norepinephrine|norepinephrine|mesh-list
56512264|NCT04528628|Serotonin|serotonin|mesh-list
56512265|NCT04528628|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56512266|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
56512267|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56512268|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56512269|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
56512270|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512271|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512272|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512273|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
56512274|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
56512275|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512276|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56512277|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56512278|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
56512279|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56512280|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56512282|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56512284|NCT01680107|Renal Agents|renal agents|mesh-ancestor
56512285|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56512286|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
56512287|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56512288|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
56512289|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512290|NCT01680146|Caseins|caseins|mesh-list
56512291|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
56512292|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
56512293|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512295|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56512296|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
56512297|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
56512298|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
56512299|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
56512300|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
56512301|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56512302|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512303|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56512304|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56512305|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56512306|NCT01680263|Analgesics|analgesics|mesh-ancestor
56512307|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
56512308|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512309|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512310|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56512311|NCT01601730|Dexetimide|dexetimide|mesh-list
56512312|NCT01601730|Modafinil|modafinil|mesh-list
56512313|NCT01601730|Citalopram|citalopram|mesh-list
56512314|NCT01601730|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56512315|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56512316|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56512317|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512318|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512319|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
56512320|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648757|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56648758|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56648759|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56648760|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
56512321|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56512322|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
56512323|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56512324|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56512325|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56512326|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
56512327|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
56512328|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512329|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56512330|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56512331|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
56512332|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56512333|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56512334|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56512335|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56512336|NCT01644071|Dexetimide|dexetimide|mesh-list
56512337|NCT01644071|Citalopram|citalopram|mesh-list
56512338|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56512339|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56512340|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
56512341|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
56512342|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512343|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512344|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56512345|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56512346|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
56512347|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512348|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512349|NCT01644071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56512350|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56512351|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56512352|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
56512353|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56512354|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
56512356|NCT01644110|Pomalidomide|pomalidomide|mesh-list
56512357|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
56512358|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512359|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56512360|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56512361|NCT01644110|Growth Substances|growth substances|mesh-ancestor
56512362|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
56512363|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512365|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56260462|NCT01941264|Artemether|artemether|mesh-list
56260468|NCT01941316|Irinotecan|irinotecan|mesh-list
56512366|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56512367|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512368|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56512369|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56512370|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
56512371|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512372|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56512373|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56512374|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56512375|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512376|NCT01602003|Incretins|incretins|mesh-ancestor
56512377|NCT01602003|Hormones|hormones|mesh-ancestor
56512378|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512379|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56512380|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
56512381|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512382|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512383|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56512384|NCT01193920|Vaccines|vaccines|mesh-list
56512385|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
56512386|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512387|NCT01644773|Dasatinib|dasatinib|mesh-list
56648761|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648762|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56648763|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56648764|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512388|NCT01644773|Crizotinib|crizotinib|mesh-list
56512389|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512390|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56512391|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512392|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512393|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
56512394|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
56512395|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56512396|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56512397|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512398|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512399|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512400|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56512402|NCT01681550|Hormones|hormones|mesh-ancestor
56512403|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512404|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512405|NCT01645085|Mannitol|mannitol|mesh-list
56512406|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56512407|NCT01645085|Diuretics|diuretics|mesh-ancestor
56512408|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
56512409|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512410|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
56512411|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512412|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
56512413|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512414|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512415|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56512416|NCT01602861|Spironolactone|spironolactone|mesh-list
56512417|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56512418|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
56512419|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512420|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512421|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56512422|NCT01602861|Diuretics|diuretics|mesh-ancestor
56512423|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
56512424|NCT01681667|Ibuprofen|ibuprofen|mesh-list
56512425|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56512426|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56512427|NCT01681667|Analgesics|analgesics|mesh-ancestor
56512429|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512430|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512431|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512432|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56512433|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56512434|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512435|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512436|NCT01600365|Ganciclovir|ganciclovir|mesh-list
56512437|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56512438|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
56512439|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56512440|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56512441|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
56512442|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512443|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56512444|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512445|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512447|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
56512448|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56512449|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56512450|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56512451|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512452|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512453|NCT01645241|Ganirelix|ganirelix|mesh-list
56512454|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
56648765|NCT00644670|Atorvastatin|atorvastatin|mesh-list
56648766|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56512455|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512456|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512457|NCT01602939|Cladribine|cladribine|mesh-list
56512458|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512459|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56512460|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
56512461|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512462|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56512463|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56512465|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512466|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512467|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512468|NCT01603134|Allopurinol|allopurinol|mesh-list
56512469|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
56512470|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512471|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512472|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
56512473|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56512474|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56512475|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
56512476|NCT01603134|Protective Agents|protective agents|mesh-ancestor
56512477|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512478|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56512479|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
56512480|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56512481|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56512482|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56512483|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512484|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512485|NCT01603212|Interferons|interferons|mesh-list
56512486|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
56512487|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
56512488|NCT01603212|Aldesleukin|aldesleukin|mesh-list
56512489|NCT01603212|Interleukin-2|interleukin-2|mesh-list
56512490|NCT01603212|Vemurafenib|vemurafenib|mesh-list
56512491|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512492|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
56512493|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512494|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
56512495|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512496|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56512497|NCT01603212|Analgesics|analgesics|mesh-ancestor
56512498|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
56512499|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512500|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56512501|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56134276|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
56512504|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512506|NCT01645748|Docetaxel|docetaxel|mesh-list
56512507|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512508|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
56512509|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
56512510|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
56512511|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512512|NCT02484924|Clopidogrel|clopidogrel|mesh-list
56512513|NCT02484924|Ticagrelor|ticagrelor|mesh-list
56512514|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56512515|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56512516|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56512517|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56512518|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
56512519|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512520|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512521|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512523|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56512524|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56512525|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56512526|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512527|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56512528|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648767|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56648768|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
56648769|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512529|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
56512530|NCT01607034|Pramipexole|pramipexole|mesh-list
56512531|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
56512532|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512533|NCT01607034|Protective Agents|protective agents|mesh-ancestor
56512534|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512535|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56512536|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56512537|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
56512539|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512540|NCT01603251|Ivermectin|ivermectin|mesh-list
56512541|NCT01603251|Lumefantrine|lumefantrine|mesh-list
56512542|NCT01603251|Artemether|artemether|mesh-list
56512543|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56512544|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56512545|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512546|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
56512547|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56512548|NCT01646294|Mirabegron|mirabegron|mesh-list
56512549|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56512550|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56512551|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56512552|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
56512553|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512554|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512555|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512556|NCT01646294|Urological Agents|urological agents|mesh-ancestor
56512557|NCT01603758|Ezetimibe|ezetimibe|mesh-list
56512558|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56512559|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56512560|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
56512561|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512562|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56512563|NCT01177228|Vedolizumab|vedolizumab|mesh-list
56512564|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56512565|NCT02279342|Febuxostat|febuxostat|mesh-list
56512566|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
56512567|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56512568|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56512569|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
56512570|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56512571|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512572|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
56512573|NCT01646567|Betamethasone|betamethasone|mesh-list
56512574|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
56512575|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56512576|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
56512581|NCT01646567|Hormones|hormones|mesh-ancestor
56512582|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512583|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512584|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56512585|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
56512586|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
56512587|NCT01681979|Fluticasone|fluticasone|mesh-list
56512588|NCT01681979|Xhance|xhance|mesh-list
56512589|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56512590|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512591|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56512592|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
56512593|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512594|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512595|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56512596|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
56512597|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
56512598|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56512599|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56512600|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56512601|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56512602|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
56512603|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111498|NCT02052960|Cetuximab|cetuximab|mesh-list
56648770|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55863886|NCT01727713|Aripiprazole|aripiprazole|mesh-list
56512604|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512606|NCT01646684|Hormones|hormones|mesh-ancestor
56512607|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512608|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512609|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
56512610|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56512611|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56512612|NCT01607580|Prednisolone|prednisolone|mesh-list
56512613|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
56512614|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56512615|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
56512616|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
56512617|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512618|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
56512619|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
56512620|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512621|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512622|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56512623|NCT01607580|Hormones|hormones|mesh-ancestor
56512624|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512625|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56512626|NCT01607580|Protective Agents|protective agents|mesh-ancestor
56512627|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56512628|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512629|NCT01604031|Lenalidomide|lenalidomide|mesh-list
56512630|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
56512631|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512632|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56512633|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56512634|NCT01604031|Growth Substances|growth substances|mesh-ancestor
56512635|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
56512636|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512637|NCT01647152|Ustekinumab|ustekinumab|mesh-list
56512638|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
56512639|NCT01604187|Fentanyl|fentanyl|mesh-list
56512640|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56512641|NCT01604187|Narcotics|narcotics|mesh-ancestor
56512642|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512643|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512644|NCT01604187|Analgesics|analgesics|mesh-ancestor
56512645|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
56512646|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512647|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56512648|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56134426|NCT01899690|Clindamycin|clindamycin|mesh-list
56512651|NCT01604382|Remifentanil|remifentanil|mesh-list
56512652|NCT01604382|Bupivacaine|bupivacaine|mesh-list
56512653|NCT01604382|Anesthetics|anesthetics|mesh-list
56512654|NCT01604382|Propofol|propofol|mesh-list
56512655|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
56512656|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512657|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512658|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
56512659|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512660|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56512661|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56512662|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
56512663|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56512664|NCT01604382|Narcotics|narcotics|mesh-ancestor
56512665|NCT01604382|Analgesics|analgesics|mesh-ancestor
56512666|NCT01682408|Mannitol|mannitol|mesh-list
56512667|NCT01682408|Ranitidine|ranitidine|mesh-list
56512668|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56512669|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56512671|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
56512672|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512673|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56512674|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56512675|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56512676|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
56512677|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
56512678|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512679|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512680|NCT01607970|Oxytocin|oxytocin|mesh-list
56648771|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56648772|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648773|NCT02669706|Pentamidine|pentamidine|mesh-list
56648774|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
56512681|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
56512682|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56512683|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512684|NCT01608009|Paclitaxel|paclitaxel|mesh-list
56512685|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56512686|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512687|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
56512688|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
56512689|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
56512690|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512691|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
56512692|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56512693|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512694|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
56512695|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56512696|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56512697|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56512698|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512699|NCT01608360|Lidocaine|lidocaine|mesh-list
56512700|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
56512701|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
56512702|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512703|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512704|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
56512705|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512706|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56512707|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56512708|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56512709|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56512710|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512711|NCT01647659|Trametinib|trametinib|mesh-list
56512712|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512713|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56512714|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512715|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512716|NCT01604811|Tamsulosin|tamsulosin|mesh-list
56512717|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
56512718|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56512719|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56512720|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56512721|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
56512722|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134496|NCT04083144|Varenicline|varenicline|mesh-list
56512723|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512724|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512725|NCT01604811|Urological Agents|urological agents|mesh-ancestor
56512726|NCT01683032|Methylphenidate|methylphenidate|mesh-list
56512727|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56512728|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512729|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56512730|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56512731|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56512732|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512733|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
56512734|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512735|NCT01604928|Mirabegron|mirabegron|mesh-list
56512736|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56512737|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56512738|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56512739|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56260834|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512740|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
56512741|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512742|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648775|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648776|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56648777|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56648778|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56648779|NCT00645138|Anesthetics|anesthetics|mesh-list
55999801|NCT05586620|Mitomycin|mitomycin|mesh-list
56512743|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512744|NCT01604928|Urological Agents|urological agents|mesh-ancestor
56512745|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56512746|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56512747|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
56512748|NCT01683149|Sorafenib|sorafenib|mesh-list
56512749|NCT01683149|Topotecan|topotecan|mesh-list
56512750|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
56512751|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512752|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56512753|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512754|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512755|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56512756|NCT01608555|Tobramycin|tobramycin|mesh-list
56512757|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56512758|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512759|NCT01605084|Ritonavir|ritonavir|mesh-list
56512760|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56512761|NCT01605084|Darunavir|darunavir|mesh-list
56512762|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56512763|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56512764|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
56512765|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512766|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512767|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56512768|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56512769|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
56512770|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512771|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56512772|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56512773|NCT01647893|Bivalirudin|bivalirudin|mesh-list
56512774|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
56512775|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56512776|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
56512777|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512778|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512779|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
56512780|NCT01648010|Mitomycins|mitomycins|mesh-list
56512781|NCT01648010|Mitomycin|mitomycin|mesh-list
56512782|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56512783|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512784|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
56512785|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512786|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56512787|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512788|NCT01605318|Irinotecan|irinotecan|mesh-list
56512789|NCT01605318|Labetuzumab|labetuzumab|mesh-list
56512790|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
56512791|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
56512792|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512793|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56512794|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56512795|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512796|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512799|NCT01608711|Gemcitabine|gemcitabine|mesh-list
56512800|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56512801|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
56512802|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512803|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512804|NCT01608711|Antiviral Agents|antiviral agents|mesh-ancestor
56512805|NCT01608711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512806|NCT01608711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512807|NCT01608711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56512808|NCT01608711|Immunologic Factors|immunologic factors|mesh-ancestor
56512809|NCT01608711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512810|NCT01605357|Mannitol|mannitol|mesh-list
56648780|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512811|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56512812|NCT01605357|Diuretics|diuretics|mesh-ancestor
56512813|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
56512814|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512815|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56512816|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56512817|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512818|NCT01608750|Folic Acid|folic acid|mesh-list
56512819|NCT01608750|Hematinics|hematinics|mesh-ancestor
56512820|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
56512821|NCT01608750|Vitamins|vitamins|mesh-ancestor
56512822|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
56512823|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512824|NCT01605513|Interferons|interferons|mesh-list
56512825|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512826|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
56512827|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512828|NCT04528277|Isoniazid|isoniazid|mesh-list
56512829|NCT04528277|Rifapentine|rifapentine|mesh-list
56512830|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
56512831|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56512832|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512833|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56512834|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56512835|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
56512836|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512837|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56512838|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56512840|NCT01683656|Niacin|niacin|mesh-list
56512841|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56512842|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
56512843|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512844|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56512845|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
56512846|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
56512847|NCT01683656|Vitamins|vitamins|mesh-ancestor
56512848|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
56512849|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512850|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56512851|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56512852|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512853|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
56512854|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56512855|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56512856|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56512857|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512858|NCT01608984|Sufentanil|sufentanil|mesh-list
56512859|NCT01608984|Isoflurane|isoflurane|mesh-list
56512860|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56512861|NCT01608984|Narcotics|narcotics|mesh-ancestor
56512862|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512863|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512864|NCT01608984|Analgesics|analgesics|mesh-ancestor
56512865|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
56512866|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512867|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56512868|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56512869|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
56512870|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
56512871|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56512872|NCT01648517|Gemcitabine|gemcitabine|mesh-list
56512873|NCT01648517|Carboplatin|carboplatin|mesh-list
56512874|NCT01648517|Docetaxel|docetaxel|mesh-list
56512875|NCT01648517|Vinorelbine|vinorelbine|mesh-list
56512876|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512877|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56512878|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
56512879|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512880|NCT01648517|Antiviral Agents|antiviral agents|mesh-ancestor
56512881|NCT01648517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512882|NCT01648517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512883|NCT01648517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56512884|NCT01648517|Immunologic Factors|immunologic factors|mesh-ancestor
56512885|NCT01648517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512886|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
56512887|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
56512888|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
56648781|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648782|NCT00895895|Donepezil|donepezil|mesh-list
56648783|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56648784|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512889|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56512891|NCT01609101|Trace Elements|trace elements|mesh-ancestor
56512892|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
56512893|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512894|NCT01648556|Prednisone|prednisone|mesh-list
56512895|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512896|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
56512897|NCT01648556|Hormones|hormones|mesh-ancestor
56512898|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56512899|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512900|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56512901|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512902|NCT01648595|Fentanyl|fentanyl|mesh-list
56512903|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56512904|NCT01648595|Narcotics|narcotics|mesh-ancestor
56512905|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512906|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512907|NCT01648595|Analgesics|analgesics|mesh-ancestor
56512908|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
56512909|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512910|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56512911|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56512912|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
56512913|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
56512914|NCT01648634|Nebivolol|nebivolol|mesh-list
56512915|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56512916|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
56512917|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56512918|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56512919|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56512920|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56512921|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512922|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512923|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512924|NCT01606059|Acetaminophen|acetaminophen|mesh-list
56512925|NCT01606059|Tramadol|tramadol|mesh-list
56512926|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56512927|NCT01606059|Analgesics|analgesics|mesh-ancestor
56512928|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
56512929|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512930|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512931|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
56512932|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56512933|NCT01606059|Narcotics|narcotics|mesh-ancestor
56512934|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512935|NCT01648712|Heparin|heparin|mesh-list
56512936|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
56512937|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56512938|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56512939|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512940|NCT01688544|Benzimidazole|benzimidazole|mesh-list
56512941|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
56512942|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56512943|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512944|NCT01688583|Fentanyl|fentanyl|mesh-list
56512945|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56512946|NCT01688583|Narcotics|narcotics|mesh-ancestor
56512947|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512948|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512949|NCT01688583|Analgesics|analgesics|mesh-ancestor
56512950|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
56512951|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512954|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
56512955|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
56512956|NCT01648829|Atorvastatin|atorvastatin|mesh-list
56512957|NCT01648829|Pitavastatin|pitavastatin|mesh-list
56512958|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56512959|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56512960|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
56512961|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648785|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648786|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
56648787|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648788|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512962|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56512963|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56512964|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512965|NCT01688700|Paclitaxel|paclitaxel|mesh-list
56512966|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
56512967|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56512968|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512969|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56512970|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56512971|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56512972|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512973|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56512974|NCT01684085|Lorazepam|lorazepam|mesh-list
56512975|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
56512976|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
56512977|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
56512978|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56512979|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512980|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56512981|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56512982|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56512983|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56512984|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56512985|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56512986|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
56512987|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
56512988|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512989|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512990|NCT05140512|Goserelin|goserelin|mesh-list
56512991|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56512992|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512993|NCT01684241|Vaccines|vaccines|mesh-list
56512994|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
56512995|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56512996|NCT01688934|Naproxen|naproxen|mesh-list
56512997|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56512998|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56512999|NCT01688934|Analgesics|analgesics|mesh-ancestor
56513000|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
56513001|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513002|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513003|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513004|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513005|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
56513006|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56513007|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513008|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513009|NCT01684319|Caseins|caseins|mesh-list
56513010|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
56513011|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
56513012|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513013|NCT02279576|Paclitaxel|paclitaxel|mesh-list
56513014|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56513015|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56513016|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513017|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
56513018|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
56513019|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56513020|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513021|NCT02279615|Tamsulosin|tamsulosin|mesh-list
56513022|NCT02279615|Mirabegron|mirabegron|mesh-list
56513023|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56513024|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56513025|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56513027|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513028|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648789|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
56648790|NCT00644748|Gabapentin|gabapentin|mesh-list
56648792|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
56513029|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513030|NCT02279615|Urological Agents|urological agents|mesh-ancestor
56513031|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56513032|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56513033|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56513034|NCT01689051|Glucagon|glucagon|mesh-list
56513035|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56513036|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56513037|NCT01689051|Hormones|hormones|mesh-ancestor
56513038|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513039|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513040|NCT01689051|Incretins|incretins|mesh-ancestor
56513041|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
56513042|NCT01689090|Citric Acid|citric acid|mesh-list
56513043|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
56513044|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56513045|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
56513046|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56513047|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
56513048|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
56513049|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513050|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56513051|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513052|NCT01689090|Analgesics|analgesics|mesh-ancestor
56513053|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
56513054|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513055|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513056|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513057|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513058|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513060|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56167942|NCT00354900|Aprotinin|aprotinin|mesh-list
56513061|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
56513062|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56513063|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513064|NCT01689285|Valacyclovir|valacyclovir|mesh-list
56513065|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
56513066|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513067|NCT01606527|Ibuprofen|ibuprofen|mesh-list
56513068|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56513069|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513070|NCT01606527|Analgesics|analgesics|mesh-ancestor
56513071|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
56513072|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513073|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513074|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513075|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513076|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56513077|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513078|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513079|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56513080|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56513081|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513082|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
56513083|NCT01609413|Antacids|antacids|mesh-ancestor
56513084|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513085|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56513086|NCT02279966|Vortioxetine|vortioxetine|mesh-list
56513087|NCT02279966|Paroxetine|paroxetine|mesh-list
56513088|NCT02279966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56513089|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56513090|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56513091|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513092|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513093|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
56513094|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513095|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56513096|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
56513097|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56648793|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648794|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648795|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
56513098|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56513101|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56513102|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56513103|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513104|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56513105|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56513106|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56513107|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56513108|NCT01684787|Ribavirin|ribavirin|mesh-list
56513109|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56513110|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
56513111|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
56513112|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513113|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
56513114|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513115|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
56513116|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513117|NCT01649258|Granisetron|granisetron|mesh-list
56513118|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
56513119|NCT01649258|Aprepitant|aprepitant|mesh-list
56513120|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
56513121|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
56513122|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513123|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513124|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56513125|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56513126|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
56513127|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513128|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513129|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56513131|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
56513132|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56513133|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513134|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
56513135|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
56513136|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513137|NCT01609491|Phenylephrine|phenylephrine|mesh-list
56513138|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
56513139|NCT01609491|Norepinephrine|norepinephrine|mesh-list
56513140|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56513141|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
56513142|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
56513143|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513144|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513145|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
56513146|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56513147|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
56513148|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
56513149|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56513150|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56513151|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56513152|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
56513153|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513154|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513155|NCT01609491|Protective Agents|protective agents|mesh-ancestor
56513156|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
56513157|NCT01606878|Doxorubicin|doxorubicin|mesh-list
56513158|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56513159|NCT01606878|Vincristine|vincristine|mesh-list
56513160|NCT01606878|Topotecan|topotecan|mesh-list
56513161|NCT01606878|Crizotinib|crizotinib|mesh-list
56513162|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
56513163|NCT01606878|Razoxane|razoxane|mesh-list
56513164|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56513165|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
56513166|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513167|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513168|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56513169|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
56513170|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648796|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56648797|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56648798|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648799|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56513171|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513172|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56513173|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56513182|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56513183|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56513184|NCT01606878|Protective Agents|protective agents|mesh-ancestor
56513186|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56513187|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513188|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
56513189|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513190|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513191|NCT01580163|Methadone|methadone|mesh-list
56513192|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56513193|NCT01580163|Narcotics|narcotics|mesh-ancestor
56513194|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513195|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513196|NCT01580163|Analgesics|analgesics|mesh-ancestor
56513197|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
56513198|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513199|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
56513200|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
56513201|NCT01609647|Clopidogrel|clopidogrel|mesh-list
56513202|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56513203|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56513204|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56513205|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56513206|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56513207|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
56513208|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513209|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513210|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513211|NCT01580202|Lamivudine|lamivudine|mesh-list
56513212|NCT01580202|Entecavir|entecavir|mesh-list
56513213|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56513214|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56513215|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513216|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513217|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
56513218|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513219|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56513220|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56513221|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
56513222|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56513223|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513224|NCT01609881|Ketorolac|ketorolac|mesh-list
56513225|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56513226|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513227|NCT01609881|Analgesics|analgesics|mesh-ancestor
56513228|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
56513229|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513230|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513231|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513232|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513233|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56513234|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513235|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513236|NCT01609959|Valsartan|valsartan|mesh-list
56513237|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56513238|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56513239|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56513241|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513242|NCT01609998|Vaccines|vaccines|mesh-list
56513243|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
56513244|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513245|NCT01606098|Bevacizumab|bevacizumab|mesh-list
56513246|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56648800|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56648801|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56648802|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648803|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513247|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513248|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56513249|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56513250|NCT01606098|Growth Substances|growth substances|mesh-ancestor
56513251|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513252|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
56513253|NCT01649921|Interferons|interferons|mesh-list
56513254|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
56513255|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513256|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
56513257|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513258|NCT01606566|Bleomycin|bleomycin|mesh-list
56513259|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56513260|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513261|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
56513262|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56513263|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513264|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513265|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513266|NCT01649999|Peficitinib|peficitinib|mesh-list
56513267|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513268|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513269|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56513270|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
56513271|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513272|NCT01604889|Ipilimumab|ipilimumab|mesh-list
56513273|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56513274|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513275|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56513276|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513277|NCT01685762|Metformin|metformin|mesh-list
56513278|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56167946|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56513279|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513280|NCT01602822|Ritonavir|ritonavir|mesh-list
56513281|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56513282|NCT01602822|Tenofovir|tenofovir|mesh-list
56513283|NCT01602822|Emtricitabine|emtricitabine|mesh-list
56513284|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56513285|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56513286|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56513287|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
56513288|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513289|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513290|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56513291|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56513292|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
56513293|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513294|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56513295|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56513296|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56513297|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56513298|NCT02273154|Buspirone|buspirone|mesh-list
56513299|NCT02273154|Paroxetine|paroxetine|mesh-list
56513300|NCT02273154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56513301|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56513302|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56513303|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513304|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513305|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
56513306|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513307|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56513308|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
56648804|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
56648805|NCT00910416|Remifentanil|remifentanil|mesh-list
56513309|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56513310|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56513311|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56513312|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513313|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56513314|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56513315|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513316|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56513317|NCT01602393|Flurbiprofen|flurbiprofen|mesh-list
56513318|NCT01602393|Analgesics|analgesics|mesh-ancestor
56513319|NCT01602393|Sensory System Agents|sensory system agents|mesh-ancestor
56513320|NCT01602393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513321|NCT01602393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513322|NCT01602393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56513323|NCT01602393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513324|NCT01602393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513325|NCT01602393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513326|NCT01602393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56513327|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513328|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513329|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
56513330|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56513331|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56513332|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513333|NCT02270034|Crizotinib|crizotinib|mesh-list
56513334|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513335|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56513336|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513337|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513338|NCT02273271|Alovudine|alovudine|mesh-list
56513339|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
56513340|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513341|NCT05140811|Azacitidine|azacitidine|mesh-list
56513342|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56513343|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
56513344|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513345|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513346|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513347|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
56513348|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56513349|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
56513350|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513351|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513352|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56513353|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
56513354|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513355|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513356|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56513357|NCT02270424|Fluticasone|fluticasone|mesh-list
56513358|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56513359|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56513360|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513361|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56513362|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
56513363|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513364|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513365|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56513366|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
56513367|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
56513368|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56513369|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56513370|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56513371|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56513372|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
56513373|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513374|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513375|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
56513376|NCT02270424|Hormones|hormones|mesh-ancestor
56513377|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56648806|NCT00910416|Propofol|propofol|mesh-list
56648807|NCT00910416|Sevoflurane|sevoflurane|mesh-list
56648808|NCT00910416|Atracurium|atracurium|mesh-list
56513378|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
56513379|NCT01686347|Ropivacaine|ropivacaine|mesh-list
56513380|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
56513381|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
56513382|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513384|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
56513385|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513386|NCT05140655|Fulvestrant|fulvestrant|mesh-list
56513387|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56513388|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513389|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56513390|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56513391|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
56513392|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513393|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513394|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
56513395|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56513396|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56513397|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56513398|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56513399|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513400|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513401|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513402|NCT01688570|Analgesics|analgesics|mesh-ancestor
56513403|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
56513404|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513405|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
56513406|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56513407|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
56513408|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
56513409|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
56513410|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56513411|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56513412|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
56513413|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
56513414|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56513415|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
55769539|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
56513417|NCT01686464|Valacyclovir|valacyclovir|mesh-list
56513418|NCT01686464|Prednisone|prednisone|mesh-list
56513419|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513420|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
56513421|NCT01686464|Hormones|hormones|mesh-ancestor
56513422|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513423|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513424|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56513425|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513426|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
56513427|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513428|NCT02270970|Belimumab|belimumab|mesh-list
56513429|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56513430|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
56513431|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513432|NCT01688648|Lidocaine|lidocaine|mesh-list
56513433|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
56513434|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
56513435|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
56513436|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513437|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513438|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
56513439|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513440|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56513441|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56513442|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56513443|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56513444|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513445|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56513446|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513447|NCT01688648|Analgesics|analgesics|mesh-ancestor
56513448|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56648809|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56648810|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999825|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56513449|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56513450|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56513451|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
56513452|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513453|NCT01686659|Chrysarobin|chrysarobin|mesh-list
56513454|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56513455|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513458|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513459|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513460|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513461|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513462|NCT02271126|Heparin|heparin|mesh-list
56513463|NCT02271126|Thromboplastin|thromboplastin|mesh-list
56513464|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
56513465|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56513466|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56513467|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513468|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
56513469|NCT02271126|Coagulants|coagulants|mesh-ancestor
56513470|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
56513471|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56513472|NCT02271165|Antibodies|antibodies|mesh-list
56513473|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
56513474|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513475|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
56513476|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56513477|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513478|NCT02271282|Toremifene|toremifene|mesh-list
56513479|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56513480|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513481|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56513482|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56513483|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
56513484|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513485|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513486|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56513488|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56513489|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56513490|NCT01688960|Growth Substances|growth substances|mesh-ancestor
56513491|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513492|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
56513493|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513495|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
56513496|NCT02271360|Calcium|calcium|mesh-list
56513497|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56513498|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513499|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56513500|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56513501|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
56513502|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
56513503|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513504|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513505|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
56513506|NCT02271360|Coagulants|coagulants|mesh-ancestor
56513507|NCT01687049|Red yeast rice|red yeast rice|mesh-list
56513508|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56513509|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56513510|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56513511|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
56513512|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513513|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513514|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56513515|NCT02271399|Aspirin|aspirin|mesh-list
56513516|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
56513517|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56513518|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513519|NCT02271399|Analgesics|analgesics|mesh-ancestor
56513520|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
56648811|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648812|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56648813|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
56648814|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
55999828|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56513521|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513522|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513523|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513524|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513525|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56513526|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56513527|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513528|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56513529|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56513530|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513532|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56513533|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
56513534|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56513535|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
56513536|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
56513537|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
56513538|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56513539|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56513540|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513541|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56513542|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56513543|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513544|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513545|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513546|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56513547|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
56513548|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56513549|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513550|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56513551|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56513552|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56513553|NCT01687127|Folic Acid|folic acid|mesh-list
56513554|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
56513555|NCT01687127|Calcium|calcium|mesh-list
56513556|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56513557|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513558|NCT01687127|Hematinics|hematinics|mesh-ancestor
56513559|NCT01687127|Vitamins|vitamins|mesh-ancestor
56513560|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
56513561|NCT02271555|Remifentanil|remifentanil|mesh-list
56513562|NCT02271555|Sevoflurane|sevoflurane|mesh-list
56513563|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56513564|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56513565|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
56261663|NCT02138617|Antidotes|antidotes|mesh-ancestor
56513567|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513568|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513569|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56513570|NCT02271555|Narcotics|narcotics|mesh-ancestor
56513571|NCT02271555|Analgesics|analgesics|mesh-ancestor
56513572|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
56513573|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513574|NCT01687205|Tenofovir|tenofovir|mesh-list
56513575|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
56513576|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513577|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56513578|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56513579|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513580|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513581|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56513582|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56513583|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
56513584|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56513585|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56513586|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648815|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56648816|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56513587|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56513588|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56513589|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513590|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513591|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513592|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56513593|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
56513594|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56513595|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513596|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56513597|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56513598|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56513599|NCT01689194|Cisplatin|cisplatin|mesh-list
56513600|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513601|NCT01687439|Vinorelbine|vinorelbine|mesh-list
56513602|NCT01687439|Endostar protein|endostar protein|mesh-list
56513603|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513604|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56513605|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
56513608|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513609|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56513610|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56513611|NCT01687439|Growth Substances|growth substances|mesh-ancestor
56513612|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513613|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
56513614|NCT01588704|Bevacizumab|bevacizumab|mesh-list
56513615|NCT01588704|Pemetrexed|pemetrexed|mesh-list
56513616|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56513617|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513618|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56513619|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56513620|NCT01588704|Growth Substances|growth substances|mesh-ancestor
56513621|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513622|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
56513623|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513624|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513625|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56513626|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56513627|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
56513628|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56513629|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513630|NCT01689311|Alprostadil|alprostadil|mesh-list
56513631|NCT01689311|Misoprostol|misoprostol|mesh-list
56513632|NCT01689311|Oxytocin|oxytocin|mesh-list
56513633|NCT01689311|Ergonovine|ergonovine|mesh-list
56513634|NCT01689311|Dinoprost|dinoprost|mesh-list
56513635|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
56513636|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
56513637|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56513638|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513639|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56513640|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
56513641|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56513643|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56513644|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
56513645|NCT01689311|Urological Agents|urological agents|mesh-ancestor
56513646|NCT01588782|Ketoconazole|ketoconazole|mesh-list
56513647|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
56513648|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513649|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56513650|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56513651|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513652|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513653|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56513654|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
56513655|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513656|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513657|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56513658|NCT02272101|Vitamin D|vitamin d|mesh-list
56513659|NCT02272101|Vitamins|vitamins|mesh-ancestor
56648817|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56648818|NCT00910416|Narcotics|narcotics|mesh-ancestor
56648819|NCT00910416|Analgesics|analgesics|mesh-ancestor
56648820|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
56648821|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513660|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
56513661|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513662|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56513663|NCT02278133|Cetuximab|cetuximab|mesh-list
56513664|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56513665|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513666|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
56513667|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56513668|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513669|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513670|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513671|NCT01687868|Analgesics|analgesics|mesh-ancestor
56513672|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
56513673|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513674|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56513675|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56513676|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56513677|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
56513678|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135456|NCT00353652|Diuretics|diuretics|mesh-ancestor
56513681|NCT01688024|Mitomycin|mitomycin|mesh-list
56513682|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56513683|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513684|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
56513685|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513686|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56513687|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513688|NCT01689623|Simeprevir|simeprevir|mesh-list
56513689|NCT01689623|Atorvastatin|atorvastatin|mesh-list
56513690|NCT01689623|Simvastatin|simvastatin|mesh-list
56513691|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56513692|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56513693|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
56513694|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513695|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56513696|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56513697|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513698|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
56513699|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513700|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
56513701|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
56513702|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56513703|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513704|NCT04055142|Cidofovir|cidofovir|mesh-list
56513705|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
56513706|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513707|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513708|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513709|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56513710|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56513712|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
56513713|NCT02272647|Estradiol|estradiol|mesh-list
56513714|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56513715|NCT02272647|Progesterone|progesterone|mesh-list
56513716|NCT02272647|Estrogens|estrogens|mesh-ancestor
56513717|NCT02272647|Hormones|hormones|mesh-ancestor
56513718|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513719|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513720|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56513721|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
56513722|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56513723|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56513724|NCT02272647|Progestins|progestins|mesh-ancestor
56513725|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56513726|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56648822|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56648823|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56648824|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56648825|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56513727|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56513728|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56513729|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56513730|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513731|NCT02272764|Itraconazole|itraconazole|mesh-list
56513732|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56513733|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
56513734|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513735|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56513736|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56513737|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513738|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513739|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56513740|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
56513741|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513742|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513743|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56513744|NCT01689896|Testosterone|testosterone|mesh-list
56513745|NCT01689896|Androgens|androgens|mesh-ancestor
56513746|NCT01689896|Hormones|hormones|mesh-ancestor
56513747|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513748|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513749|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
56513750|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56513752|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56513753|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513754|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56513755|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56513756|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
56513758|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56513759|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
56513760|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513761|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56513762|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513763|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513764|NCT05654064|Fentanyl|fentanyl|mesh-list
56513765|NCT05654064|Dexmedetomidine|dexmedetomidine|mesh-list
56513766|NCT05654064|Remifentanil|remifentanil|mesh-list
56513767|NCT05654064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56513768|NCT05654064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513769|NCT05654064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513770|NCT05654064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513771|NCT05654064|Analgesics|analgesics|mesh-ancestor
56513772|NCT05654064|Sensory System Agents|sensory system agents|mesh-ancestor
56513773|NCT05654064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513774|NCT05654064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56513775|NCT05654064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56513776|NCT05654064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56513777|NCT05654064|Adrenergic Agents|adrenergic agents|mesh-ancestor
56513778|NCT05654064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513779|NCT05654064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513780|NCT05654064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56513781|NCT05654064|Narcotics|narcotics|mesh-ancestor
56513782|NCT05654064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56513783|NCT05654064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56513784|NCT05654064|Anesthetics, General|anesthetics, general|mesh-ancestor
56513785|NCT05654064|Anesthetics|anesthetics|mesh-ancestor
56513786|NCT01687985|Laxatives|laxatives|mesh-list
56513787|NCT01687985|Cathartics|cathartics|mesh-list
56513788|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56513789|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
56513790|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56513791|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513792|NCT05653401|Diclofenac|diclofenac|mesh-list
56513793|NCT05653401|Lidocaine|lidocaine|mesh-list
56513794|NCT05653401|Magnesium Sulfate|magnesium sulfate|mesh-list
56648826|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56648827|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
56648828|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733165|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513795|NCT05653401|Anesthetics, Local|anesthetics, local|mesh-ancestor
56513796|NCT05653401|Anesthetics|anesthetics|mesh-ancestor
56513797|NCT05653401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513798|NCT05653401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513799|NCT05653401|Sensory System Agents|sensory system agents|mesh-ancestor
56513800|NCT05653401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513801|NCT05653401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56513802|NCT05653401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56513803|NCT05653401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56513804|NCT05653401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56513805|NCT05653401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513806|NCT05653401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56513807|NCT05653401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513808|NCT05653401|Analgesics|analgesics|mesh-ancestor
56513809|NCT05653401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513810|NCT05653401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513811|NCT05653401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56513812|NCT05653401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513813|NCT05653401|Anticonvulsants|anticonvulsants|mesh-ancestor
56513814|NCT05653401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56513815|NCT05653401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56513816|NCT05653401|Tocolytic Agents|tocolytic agents|mesh-ancestor
56513817|NCT05653401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56513818|NCT01685255|Tamoxifen|tamoxifen|mesh-list
56513819|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56513820|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
56513821|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513822|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513823|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56513824|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513825|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56513826|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56513827|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56513829|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513830|NCT02272998|Ponatinib|ponatinib|mesh-list
56513831|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513832|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56513833|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513834|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513835|NCT01683188|Vemurafenib|vemurafenib|mesh-list
56513836|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513837|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56513838|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513839|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513840|NCT01339923|Vaccines|vaccines|mesh-list
56513841|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
56513842|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513843|NCT04417088|Carboplatin|carboplatin|mesh-list
56513844|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513845|NCT01380093|Naltrexone|naltrexone|mesh-list
56513846|NCT01380093|Morphine|morphine|mesh-list
56513847|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56513848|NCT01380093|Narcotics|narcotics|mesh-ancestor
56513849|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513850|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513851|NCT01380093|Analgesics|analgesics|mesh-ancestor
56513852|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
56513853|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513854|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56513855|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56513856|NCT01379937|Vaccines|vaccines|mesh-list
56513857|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
56513858|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513859|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56513860|NCT03558854|Aspirin|aspirin|mesh-list
56111510|NCT02052414|Gabapentin|gabapentin|mesh-list
56648829|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648830|NCT02669238|Etonogestrel|etonogestrel|mesh-list
56733166|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56513861|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56513862|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56261959|NCT04755244|Azacitidine|azacitidine|mesh-list
56513864|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
56513865|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513866|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513867|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513868|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513869|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56513870|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56513871|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513872|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56513873|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56513874|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513875|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
56513876|NCT01335477|Nintedanib|nintedanib|mesh-list
56513877|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513878|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56513879|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513880|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513881|NCT03366272|Gemcitabine|gemcitabine|mesh-list
56513882|NCT03366272|Rituximab|rituximab|mesh-list
56513883|NCT03366272|Nivolumab|nivolumab|mesh-list
56513884|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
56513885|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56513886|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513887|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
56513888|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513889|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513890|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56513891|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
56513892|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513893|NCT03366272|Antiviral Agents|antiviral agents|mesh-ancestor
56513894|NCT03366272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56513895|NCT03366272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513896|NCT03366272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56513897|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56513898|NCT01371747|Losartan|losartan|mesh-list
56513899|NCT01371747|Spironolactone|spironolactone|mesh-list
56513902|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56513903|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56513904|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513905|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56513906|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
56513907|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513908|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513909|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56513910|NCT01371747|Diuretics|diuretics|mesh-ancestor
56513911|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
56513912|NCT01335399|Dexamethasone|dexamethasone|mesh-list
56513913|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
56513914|NCT01335399|Lenalidomide|lenalidomide|mesh-list
56513915|NCT01335399|Elotuzumab|elotuzumab|mesh-list
56513916|NCT01335399|BB 1101|bb 1101|mesh-list
56513917|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513918|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
56513919|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
56513920|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513921|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513922|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56513923|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
56513924|NCT01335399|Hormones|hormones|mesh-ancestor
56513925|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513926|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56513927|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513928|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
56513929|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513930|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648831|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56648832|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
56513931|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
56513932|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56513933|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56513934|NCT01335399|Growth Substances|growth substances|mesh-ancestor
56513935|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
56513936|NCT04825262|Tacrolimus|tacrolimus|mesh-list
56513938|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
56513939|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513940|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56513941|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513942|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513943|NCT01335009|Antibodies|antibodies|mesh-list
56513944|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56513945|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
56513946|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513947|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
56513948|NCT01332630|Dexamethasone|dexamethasone|mesh-list
56513949|NCT01332630|Ranitidine|ranitidine|mesh-list
56513950|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56513951|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513952|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
56513953|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
56513954|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513955|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513956|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56513957|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
56513958|NCT01332630|Hormones|hormones|mesh-ancestor
56513959|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513960|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56513961|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513962|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56513963|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56513964|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56513965|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
56513966|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
56513967|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
56513968|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56513969|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
56513970|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
56513971|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56513972|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135798|NCT00318708|Xhance|xhance|mesh-list
56513974|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56513975|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56513976|NCT01366209|Pirfenidone|pirfenidone|mesh-list
56513977|NCT01366209|Analgesics|analgesics|mesh-ancestor
56513978|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
56513979|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56513980|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513981|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56513982|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56513983|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56513984|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56513985|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513986|NCT01365507|Insulin|insulin|mesh-list
56513987|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
56513988|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56513989|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513990|NCT02995694|Estradiol|estradiol|mesh-list
56513991|NCT02995694|Estrogens|estrogens|mesh-ancestor
56513992|NCT02995694|Hormones|hormones|mesh-ancestor
56513993|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56513994|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513995|NCT01365468|Everolimus|everolimus|mesh-list
56513996|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56513997|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56513998|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
56513999|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514000|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
56514001|NCT04827836|Povidone|povidone|mesh-list
56514002|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56514003|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56514004|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
56648833|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56514005|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
56514006|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56514007|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514008|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
56514009|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56514010|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56514011|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56514012|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56514013|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514014|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
56514015|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514016|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514017|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56514018|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514019|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
56514020|NCT01332318|Promethazine|promethazine|mesh-list
56514021|NCT01332318|Gabapentin|gabapentin|mesh-list
56514022|NCT01332318|Analgesics|analgesics|mesh-ancestor
56514023|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
56514024|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514025|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514026|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
56514027|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56514028|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56514029|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514030|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514031|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56514032|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56514033|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514034|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514035|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
56514036|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56514037|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56514038|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
56514039|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
56514040|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
56514041|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
56514042|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56514043|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56514044|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
56514045|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
56514046|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56514047|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
56514048|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
56514051|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
56514052|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514053|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514054|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56514055|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
56514056|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
56514057|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56514058|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56514059|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56514060|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
56514061|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514062|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514064|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
56514065|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56514066|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56514067|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56514068|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514069|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514070|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514071|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56514072|NCT01331109|Analgesics|analgesics|mesh-ancestor
56514073|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
56514074|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514075|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
56514076|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514077|NCT01357161|Paclitaxel|paclitaxel|mesh-list
56514078|NCT01357161|Carboplatin|carboplatin|mesh-list
56514079|NCT01357161|Adavosertib|adavosertib|mesh-list
56112323|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
56648834|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648835|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56648836|NCT02669004|Morphine|morphine|mesh-list
56648837|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56514080|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56514081|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514082|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
56514083|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
56514084|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
56514085|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514086|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514087|NCT01351350|Paclitaxel|paclitaxel|mesh-list
56514088|NCT01351350|Trastuzumab|trastuzumab|mesh-list
56514089|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56514090|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514091|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
56514092|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
56514093|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
56514094|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514095|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56514096|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56514097|NCT02271503|Carbidopa|carbidopa|mesh-list
56514098|NCT02271503|Levodopa|levodopa|mesh-list
56514099|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56514100|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
56514101|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514102|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56514103|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56514104|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
56514105|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
56514106|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514107|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514108|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56514109|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514110|NCT01350804|Abatacept|abatacept|mesh-list
56514111|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56514112|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514113|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514114|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56514115|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
56514116|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514117|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56514118|NCT02270957|Abatacept|abatacept|mesh-list
56514119|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56514120|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514122|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56514123|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
56514124|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514125|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56514127|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56514128|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56514129|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514130|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514131|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514132|NCT01348542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56514133|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56514134|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56514135|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514136|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514137|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
56514138|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56514139|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
56514140|NCT01346592|Vaccines|vaccines|mesh-list
56514141|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
56167970|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
56514142|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514143|NCT01193335|Vaccines|vaccines|mesh-list
56514144|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56514145|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
56648838|NCT02669004|Narcotics|narcotics|mesh-ancestor
56648839|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942066|NCT04161599|Cathartics|cathartics|mesh-ancestor
56514146|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514147|NCT02893995|Treprostinil|treprostinil|mesh-list
56514148|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56514149|NCT01342887|Cyclosporine|cyclosporine|mesh-list
56514150|NCT01342887|Etoposide|etoposide|mesh-list
56514151|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
56514152|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
56514153|NCT01342887|Pravastatin|pravastatin|mesh-list
56514154|NCT01342887|Cyclosporins|cyclosporins|mesh-list
56514155|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56514156|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514157|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56514158|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56514159|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514160|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514161|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56514162|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
56514163|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514164|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
56514165|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514166|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
56514167|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56514168|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56514169|NCT01342887|Analgesics|analgesics|mesh-ancestor
56514170|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
56514171|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514172|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56514173|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56514174|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
56514175|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56514176|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56514177|NCT04445415|Antibodies|antibodies|mesh-list
56514178|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
56514179|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514180|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
56514181|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56514182|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514183|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56514184|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514185|NCT01340664|Metformin|metformin|mesh-list
56514186|NCT01340664|Canagliflozin|canagliflozin|mesh-list
56514187|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56514188|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514189|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56514190|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514191|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56514192|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56514193|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56514196|NCT01340625|Estradiol|estradiol|mesh-list
56514197|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56514198|NCT01340625|Estrogens|estrogens|mesh-ancestor
56514199|NCT01340625|Hormones|hormones|mesh-ancestor
56514200|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514201|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514202|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56514203|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
56514204|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56514205|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56514206|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56514207|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56514208|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56514209|NCT04823468|Cisplatin|cisplatin|mesh-list
56514210|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514211|NCT01340196|Tenofovir|tenofovir|mesh-list
56514212|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
56514213|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514214|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56514215|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56514216|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514217|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648840|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648841|NCT02669004|Analgesics|analgesics|mesh-ancestor
56648842|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
56648843|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648844|NCT00895661|Rituximab|rituximab|mesh-list
56648845|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56648846|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648847|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
56648848|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514218|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56514219|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56514220|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56514221|NCT02893332|Gefitinib|gefitinib|mesh-list
56514222|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514223|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56514224|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514225|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514226|NCT04328493|Chloroquine|chloroquine|mesh-list
56514227|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56514228|NCT04328493|Amebicides|amebicides|mesh-ancestor
56514229|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56514230|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56514231|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514232|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
56514233|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56514234|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56514235|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56514236|NCT04328493|Analgesics|analgesics|mesh-ancestor
56514237|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
56514238|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514239|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514240|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56514241|NCT04328493|Filaricides|filaricides|mesh-ancestor
56514242|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
56514243|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
56514245|NCT04396587|Oxycodone|oxycodone|mesh-list
56514246|NCT04396587|Hydromorphone|hydromorphone|mesh-list
56514247|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56514248|NCT04396587|Narcotics|narcotics|mesh-ancestor
56514249|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514250|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514251|NCT04396587|Analgesics|analgesics|mesh-ancestor
56514252|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
56514253|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514254|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56514255|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56514256|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
56514257|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
56514258|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
56514259|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
56514260|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514261|NCT01327599|Timolol|timolol|mesh-list
56514262|NCT01327599|Travoprost|travoprost|mesh-list
56514263|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56514264|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56514265|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56514266|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56514267|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
56514268|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514269|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136049|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
56514281|NCT02893371|Lamotrigine|lamotrigine|mesh-list
56514282|NCT02893371|Carbamazepine|carbamazepine|mesh-list
56514283|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
56514284|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56514285|NCT02893371|Valproic Acid|valproic acid|mesh-list
56514286|NCT02893371|Haloperidol|haloperidol|mesh-list
56514287|NCT02893371|Olanzapine|olanzapine|mesh-list
56514288|NCT02893371|Risperidone|risperidone|mesh-list
56514289|NCT02893371|Aripiprazole|aripiprazole|mesh-list
56648849|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56648850|NCT00645294|Adefovir|adefovir|mesh-list
55942251|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
56514290|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56514291|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56514293|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56514294|NCT02893371|Clozapine|clozapine|mesh-list
56514295|NCT02893371|Asenapine|asenapine|mesh-list
56514296|NCT02893371|Perphenazine|perphenazine|mesh-list
56514297|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
56514298|NCT02893371|Mirtazapine|mirtazapine|mesh-list
56514299|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
56514300|NCT02893371|Doxepin|doxepin|mesh-list
56514301|NCT02893371|Citalopram|citalopram|mesh-list
56514302|NCT02893371|Bupropion|bupropion|mesh-list
56514303|NCT02893371|Sertraline|sertraline|mesh-list
56514304|NCT02893371|Fluoxetine|fluoxetine|mesh-list
56514305|NCT02893371|Paroxetine|paroxetine|mesh-list
56514306|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56514307|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56514308|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56514309|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56514310|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
56514311|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514312|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262410|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56262411|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
56262412|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56262413|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262414|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56514313|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514314|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56514316|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514317|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514318|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56514319|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
56514320|NCT02893371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56514321|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56514322|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56514323|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56514324|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
56514325|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56514326|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
56514327|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514328|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
56514329|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56514330|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56514331|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56514332|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56514333|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514335|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56514336|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56514337|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56514338|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56514339|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56514340|NCT02893371|Analgesics|analgesics|mesh-ancestor
56514341|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
56514342|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
56514343|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
56514344|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56514345|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56514346|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56514347|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
56514348|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56514349|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
56514350|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
56514351|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56514352|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56514353|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56514354|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56514355|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56514356|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56514357|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56514358|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56648851|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56648852|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
56648853|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648854|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56648855|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56648856|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514359|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56514360|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
56514361|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56514362|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56514363|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56514364|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56514365|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56514366|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56514367|NCT05138978|Listerine|listerine|mesh-list
56514368|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
56514369|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
56514370|NCT05138978|Protective Agents|protective agents|mesh-ancestor
56514371|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514372|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56514373|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514374|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56514375|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56514376|NCT02893176|Macitentan|macitentan|mesh-list
56514377|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56514378|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56514379|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514380|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56514381|NCT01193218|Empagliflozin|empagliflozin|mesh-list
56514382|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56514383|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514384|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56514385|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514386|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56514387|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56514388|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514389|NCT04328805|Ibuprofen|ibuprofen|mesh-list
56514390|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56514391|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56514392|NCT04328805|Analgesics|analgesics|mesh-ancestor
56514393|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
56514394|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514395|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514396|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56514397|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56514398|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56514399|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514400|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514401|NCT04329000|Esomeprazole|esomeprazole|mesh-list
56514402|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56514403|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56514405|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514406|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514407|NCT01192399|Eculizumab|eculizumab|mesh-list
56514408|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56514409|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56514410|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
56514411|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514412|NCT04389294|Antibodies|antibodies|mesh-list
56514413|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
56514414|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514415|NCT01176916|Exemestane|exemestane|mesh-list
56514416|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514417|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56514418|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56648857|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648858|NCT02837003|Aspirin|aspirin|mesh-list
56648859|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56648860|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56514419|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514420|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514421|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56514422|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
56514423|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514424|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514425|NCT05382091|Naltrexone|naltrexone|mesh-list
56514426|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56514427|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56514428|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514429|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
56514430|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514431|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56514432|NCT02894268|Doxycycline|doxycycline|mesh-list
56514434|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56514435|NCT02894268|Esomeprazole|esomeprazole|mesh-list
56514436|NCT02894268|Bismuth|bismuth|mesh-list
56514437|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514438|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56514439|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56514440|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56514441|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514442|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514443|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
56514444|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56514445|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56514446|NCT02894268|Antacids|antacids|mesh-ancestor
56514447|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56514448|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56514449|NCT02894268|Renal Agents|renal agents|mesh-ancestor
56514450|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56514451|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56514452|NCT01600625|Minocycline|minocycline|mesh-list
56514453|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56514454|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514455|NCT01600742|Vorinostat|vorinostat|mesh-list
56514456|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514457|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56514458|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514459|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262563|NCT05356936|Vitamin K|vitamin k|mesh-list
56514461|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56514462|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56514463|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
56514464|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514465|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56514466|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56514467|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514468|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514469|NCT02893488|Lamivudine|lamivudine|mesh-list
56514470|NCT02893488|Dolutegravir|dolutegravir|mesh-list
56514471|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56514472|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56514473|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514474|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514475|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
56514476|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514477|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56514478|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56514479|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56514480|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56514481|NCT04328883|Aspirin|aspirin|mesh-list
56514482|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56514483|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56514484|NCT04328883|Analgesics|analgesics|mesh-ancestor
56514485|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
56514486|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648861|NCT02837003|Analgesics|analgesics|mesh-ancestor
56648862|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
56514487|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514488|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56514489|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56514490|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56514491|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56514492|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514493|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56514494|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56514495|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514496|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
56514497|NCT01600235|Phenylephrine|phenylephrine|mesh-list
56514498|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
56514499|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56514500|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
56514501|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
56514502|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514503|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514504|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
56514505|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56514506|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
56514507|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
56167979|NCT00355602|Rifaximin|rifaximin|mesh-list
56514508|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56514510|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56514511|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
56514512|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514513|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514514|NCT01600235|Protective Agents|protective agents|mesh-ancestor
56514515|NCT02893254|Adalimumab|adalimumab|mesh-list
56514516|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56514517|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56514518|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
56514519|NCT00592137|Calcium|calcium|mesh-list
56514520|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56514521|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514522|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56514523|NCT04455776|Propofol|propofol|mesh-list
56514524|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56514525|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514526|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514527|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56514528|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
56514529|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
56514530|NCT04135092|Aldesleukin|aldesleukin|mesh-list
56514531|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
56514532|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
56514533|NCT04135092|Fludarabine|fludarabine|mesh-list
56514534|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56514535|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
56514536|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514537|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56514538|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56514539|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
56514540|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514541|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514542|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56514543|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56514544|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56514545|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56514546|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
56514547|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514548|NCT00592215|Misoprostol|misoprostol|mesh-list
56514549|NCT00592215|Mifepristone|mifepristone|mesh-list
56514550|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56514551|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
56514552|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56514553|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514554|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56514555|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56514556|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
56514558|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56514559|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56514560|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56648863|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648864|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294886|NCT00006257|Paclitaxel|paclitaxel|mesh-list
56514561|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
56514562|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56514563|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56514564|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
56514565|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514566|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
56514567|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56514568|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56514569|NCT00592332|Alprazolam|alprazolam|mesh-list
56514570|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56514571|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514572|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514573|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56514574|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56514575|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514576|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
56514577|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
56514578|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514579|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514580|NCT04477382|Tretinoin|tretinoin|mesh-list
56514581|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514582|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
56514583|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56514584|NCT01600274|Dienogest|dienogest|mesh-list
56514585|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56514586|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56514587|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56514588|NCT01600274|Estradiol|estradiol|mesh-list
56514589|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56514590|NCT01600274|Nandrolone|nandrolone|mesh-list
56514591|NCT01600274|Estrogens|estrogens|mesh-ancestor
56514592|NCT01600274|Hormones|hormones|mesh-ancestor
56514593|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514594|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514595|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56514596|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
56514597|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56514598|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56514599|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56514600|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56514601|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56514602|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
56514603|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56514604|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514605|NCT01600274|Androgens|androgens|mesh-ancestor
56514606|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
56514607|NCT01176565|Nicardipine|nicardipine|mesh-list
56514608|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56514609|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56514610|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56514611|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514612|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56514613|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514614|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
56514615|NCT04374123|Antibodies|antibodies|mesh-list
56514616|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
56514617|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
56514618|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514619|NCT01113541|Ziprasidone|ziprasidone|mesh-list
56514620|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56514621|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
56514622|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514623|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514624|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514625|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56514626|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56514627|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514628|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514629|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56648865|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56648866|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56648867|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56514630|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
56514633|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
56514634|NCT00591708|Calcium|calcium|mesh-list
56514635|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
56514636|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56514637|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514638|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56514639|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
56514640|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56514641|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
56514642|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
56514643|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514644|NCT01176058|Fluconazole|fluconazole|mesh-list
56514645|NCT01176058|Anidulafungin|anidulafungin|mesh-list
56514646|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
56514647|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514648|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56514649|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56514650|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514651|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514652|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56514653|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
56514654|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514655|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514656|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56514657|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56514658|NCT02273765|Tenofovir|tenofovir|mesh-list
56514659|NCT02273765|Lamivudine|lamivudine|mesh-list
56514660|NCT02273765|Efavirenz|efavirenz|mesh-list
56514661|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
56514662|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
56514663|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514664|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56514665|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56514666|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514667|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514668|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56514669|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56514670|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56514671|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56514672|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56514673|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56514674|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56514675|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56514676|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56514677|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56514678|NCT01607333|Lamotrigine|lamotrigine|mesh-list
56514679|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
56514680|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56514681|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56262790|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56514682|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514683|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56514684|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514685|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56514686|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56514687|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514688|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514689|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56514691|NCT01601093|Cefoperazone|cefoperazone|mesh-list
56514692|NCT01601093|Sulperazone|sulperazone|mesh-list
56514693|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56514694|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514695|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56514696|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514697|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648868|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56648869|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514698|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56514699|NCT01601093|Renal Agents|renal agents|mesh-ancestor
56514700|NCT04367688|Tenofovir|tenofovir|mesh-list
56514701|NCT04367688|Emtricitabine|emtricitabine|mesh-list
56514702|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
56514705|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56514706|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514707|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514708|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56514709|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56514710|NCT02485418|Propofol|propofol|mesh-list
56514711|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56514712|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514713|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514714|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56514715|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
56514716|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
56514717|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
56514718|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56514719|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
56514720|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514721|NCT01175824|Insulin|insulin|mesh-list
56514722|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56514723|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
56514724|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
56514725|NCT01175824|Protamines|protamines|mesh-list
56514726|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56514727|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514728|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
56514729|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514730|NCT01175824|Coagulants|coagulants|mesh-ancestor
56514731|NCT01175707|Vancomycin|vancomycin|mesh-list
56514732|NCT01175707|Daptomycin|daptomycin|mesh-list
56514733|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56514734|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514735|NCT01112059|Doxycycline|doxycycline|mesh-list
56514736|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56514737|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514738|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
56514739|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56514740|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56514741|NCT01175668|Clonidine|clonidine|mesh-list
56514742|NCT01175668|Phenobarbital|phenobarbital|mesh-list
56514743|NCT01175668|Analgesics|analgesics|mesh-ancestor
56514744|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
56514745|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514746|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514747|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56514748|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
56514749|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
56514750|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56514751|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56514752|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56514753|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
56514754|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514755|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514756|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
56514757|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56514758|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514759|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56514760|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56514761|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
56514762|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
56514763|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56514764|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56514765|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56514766|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
56514767|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56514768|NCT01601327|Testosterone|testosterone|mesh-list
56514769|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
56514770|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
56514771|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56514772|NCT01601327|Androgens|androgens|mesh-ancestor
56514773|NCT01601327|Hormones|hormones|mesh-ancestor
56648870|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56648871|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56648872|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648873|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
56648874|NCT02668926|Amphetamine|amphetamine|mesh-list
56648875|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56648876|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
56648877|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56514774|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514775|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514776|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56514777|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514780|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
56514781|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
56514782|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56514783|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56514784|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514785|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56514786|NCT01607762|Olanzapine|olanzapine|mesh-list
56514787|NCT01607762|Risperidone|risperidone|mesh-list
56514788|NCT01607762|Aripiprazole|aripiprazole|mesh-list
56514789|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56514790|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56514791|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56514792|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
56514793|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514794|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514795|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514796|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56514797|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56514798|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514799|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514800|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56514801|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
56514802|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
56514803|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
56514804|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514805|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56514806|NCT01607762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56514807|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56514808|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56514809|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
56514810|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
56514811|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56514812|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56514813|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56514814|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56514815|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
56514816|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56514817|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
56514818|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514819|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
56514820|NCT04327947|Protective Agents|protective agents|mesh-ancestor
56514821|NCT01607879|Androgens|androgens|mesh-list
56514822|NCT01607879|Hormones|hormones|mesh-ancestor
56514823|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514824|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514825|NCT01607918|Amoxicillin|amoxicillin|mesh-list
56514826|NCT01607918|Metronidazole|metronidazole|mesh-list
56514827|NCT01607918|Clarithromycin|clarithromycin|mesh-list
56514828|NCT01607918|Lansoprazole|lansoprazole|mesh-list
56514829|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
56514830|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56514831|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514832|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56514833|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56514834|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56648878|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648879|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
55999890|NCT02556918|Insulin|insulin|mesh-list
56514835|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514836|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514837|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56514838|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56514839|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56514840|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56514841|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56514842|NCT01607996|Anesthetics|anesthetics|mesh-list
56514843|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514844|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514845|NCT01601561|Insulin|insulin|mesh-list
56514846|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56514847|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56514848|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514849|NCT01601795|Sevoflurane|sevoflurane|mesh-list
56514850|NCT01601795|Isoflurane|isoflurane|mesh-list
56514851|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56514855|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514856|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514857|NCT01601912|Dexetimide|dexetimide|mesh-list
56514858|NCT01601912|Citalopram|citalopram|mesh-list
56514859|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56514860|NCT01601912|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56514861|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56514862|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56514863|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514864|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514865|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
56514866|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514867|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56514868|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
56514869|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514870|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56514871|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56514872|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
56514873|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
56514874|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514875|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56514876|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56514877|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
56514878|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56514879|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
56514880|NCT01111825|Sirolimus|sirolimus|mesh-list
56514881|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56514882|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514883|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56514884|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514885|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
56514886|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56514887|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
56514888|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514889|NCT01175590|Besifloxacin|besifloxacin|mesh-list
56514890|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56514891|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514892|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56514893|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56514894|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514895|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514896|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514897|NCT01175473|Metformin|metformin|mesh-list
56514898|NCT01175473|Liraglutide|liraglutide|mesh-list
56514899|NCT01175473|Lixisenatide|lixisenatide|mesh-list
56514900|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56514901|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514902|NCT01175473|Incretins|incretins|mesh-ancestor
56514903|NCT01175473|Hormones|hormones|mesh-ancestor
56514904|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514905|NCT01111552|Aripiprazole|aripiprazole|mesh-list
56514906|NCT01111552|Citalopram|citalopram|mesh-list
56514907|NCT01111552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56648880|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
56648881|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648882|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
56648883|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648884|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514908|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56263018|NCT02238496|Sirolimus|sirolimus|mesh-list
56514909|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56514910|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514911|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514912|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
56514913|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514914|NCT01111552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56514915|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
56514916|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56514917|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56514918|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56514919|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56514920|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
56514921|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
56514922|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56514924|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56514926|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56514927|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56514928|NCT01602185|Memantine|memantine|mesh-list
56514929|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
56514930|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
56514931|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56514932|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56514933|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
56514934|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56514935|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514936|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514937|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56514938|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56514939|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
56514940|NCT01602302|Adalimumab|adalimumab|mesh-list
56514941|NCT01602302|Etanercept|etanercept|mesh-list
56514942|NCT01602302|Golimumab|golimumab|mesh-list
56514943|NCT01602302|Abatacept|abatacept|mesh-list
56514944|NCT01602302|Infliximab|infliximab|mesh-list
56514945|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
56514946|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56514947|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56514948|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
56514949|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56514950|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56514951|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56514952|NCT01602302|Analgesics|analgesics|mesh-ancestor
56514953|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
56514954|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56514955|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514956|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56514957|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
56514958|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56514959|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514960|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514961|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56514962|NCT02893722|Oxytocin|oxytocin|mesh-list
56514963|NCT02893722|Atosiban|atosiban|mesh-list
56514964|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
56514965|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56514966|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514967|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
56514968|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514969|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
56514970|NCT01608269|Lamivudine|lamivudine|mesh-list
56514971|NCT01608269|Abacavir|abacavir|mesh-list
56514972|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56112324|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648885|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
56648886|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56514973|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56514974|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56514975|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514976|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
56514977|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514978|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56514979|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56514980|NCT01608347|Folic Acid|folic acid|mesh-list
56514981|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
56514982|NCT01608347|Hematinics|hematinics|mesh-ancestor
56514983|NCT01608347|Vitamins|vitamins|mesh-ancestor
56514984|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
56514985|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514986|NCT04405284|Disinfectants|disinfectants|mesh-list
56514987|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514988|NCT01608464|Cisplatin|cisplatin|mesh-list
56514989|NCT01608464|Docetaxel|docetaxel|mesh-list
56514990|NCT01608464|Fluorouracil|fluorouracil|mesh-list
56514991|NCT01608464|Irinotecan|irinotecan|mesh-list
56514992|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514993|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
56514994|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
56514995|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
56514996|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514997|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
56514998|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515002|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56515003|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56515004|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515006|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56515007|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
56515008|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56515009|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56515010|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56515011|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
56515012|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56515013|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515014|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56515015|NCT01608698|Estrogens|estrogens|mesh-ancestor
56515016|NCT01608698|Hormones|hormones|mesh-ancestor
56515017|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515018|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56515019|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
56515020|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56515021|NCT01608698|Diuretics|diuretics|mesh-ancestor
56515022|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
56515023|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
56515024|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56515025|NCT04310254|Edetic Acid|edetic acid|mesh-list
56515026|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56515027|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
56515028|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
56515029|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56515030|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
56515031|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
56515032|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515033|NCT04310254|Antidotes|antidotes|mesh-ancestor
56515034|NCT04310254|Protective Agents|protective agents|mesh-ancestor
56515035|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515036|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56515037|NCT01603511|Charcoal|charcoal|mesh-list
56515038|NCT01603511|Antidotes|antidotes|mesh-ancestor
56515039|NCT01603511|Protective Agents|protective agents|mesh-ancestor
56515040|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515041|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56515042|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56515043|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515044|NCT01174186|Adalimumab|adalimumab|mesh-list
56515045|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56515046|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515047|NCT01609049|Ribavirin|ribavirin|mesh-list
56515048|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56515049|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
55888588|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648887|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56648888|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56515050|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515051|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
56515052|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515053|NCT01609088|Erythritol|erythritol|mesh-list
56515054|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
56515055|NCT01609127|Capecitabine|capecitabine|mesh-list
56515056|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515057|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
56515058|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515059|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515060|NCT01609166|Allopurinol|allopurinol|mesh-list
56515061|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
56515062|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515063|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515064|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
56515065|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515066|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56515067|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
56515068|NCT01609166|Protective Agents|protective agents|mesh-ancestor
56515069|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515070|NCT01609205|Adalimumab|adalimumab|mesh-list
56515071|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56515073|NCT01604057|Teriparatide|teriparatide|mesh-list
56515074|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56515075|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515076|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56515077|NCT00592566|Dexamethasone|dexamethasone|mesh-list
56515078|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56515079|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56515080|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
56515081|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
56515082|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515083|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515084|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56515085|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
56515086|NCT00592566|Hormones|hormones|mesh-ancestor
56515087|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515088|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56515089|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515090|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
56515091|NCT00592566|Coagulants|coagulants|mesh-ancestor
56515092|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56515093|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
56515094|NCT01111123|Halobetasol|halobetasol|mesh-list
56515095|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56515096|NCT01604330|Baclofen|baclofen|mesh-list
56515097|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56515098|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515099|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56515100|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515101|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56515102|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
56515103|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
56515104|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515105|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515106|NCT00622830|Darapladib|darapladib|mesh-list
56515107|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56515108|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515109|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515110|NCT01173679|Rituximab|rituximab|mesh-list
56515111|NCT01173679|Fludarabine|fludarabine|mesh-list
56515112|NCT01173679|Dasatinib|dasatinib|mesh-list
56515113|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56515114|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515115|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
56515116|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515117|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515118|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515119|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56515120|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515121|NCT02881528|Metformin|metformin|mesh-list
56515122|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56648889|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56648890|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
56648891|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56648892|NCT02668536|Protective Agents|protective agents|mesh-ancestor
56648893|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515123|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515124|NCT01609439|Vitamin D|vitamin d|mesh-list
56515125|NCT01609439|Vitamins|vitamins|mesh-ancestor
56515126|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
56515127|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515128|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56515129|NCT01110382|Amoxicillin|amoxicillin|mesh-list
56515130|NCT01110382|Meropenem|meropenem|mesh-list
56515131|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
56515132|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
56515133|NCT01110382|Doripenem|doripenem|mesh-list
56515134|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56515135|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56515136|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515137|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56515138|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515139|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515140|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
56515142|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
56515143|NCT00592917|Calcium|calcium|mesh-list
56515144|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56515145|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515146|NCT00592917|Vitamins|vitamins|mesh-ancestor
56515147|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
56515148|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56515152|NCT01609517|Bupivacaine|bupivacaine|mesh-list
56515153|NCT01609517|Anesthetics|anesthetics|mesh-list
56515154|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
56515155|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515156|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515157|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
56515158|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515159|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
56515160|NCT05265325|Hematinics|hematinics|mesh-ancestor
56515161|NCT00593151|Interferons|interferons|mesh-list
56515162|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
56515163|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
56515164|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56515165|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515166|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
56515167|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515168|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
56515169|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515170|NCT02489006|Olaparib|olaparib|mesh-list
56515171|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56515172|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515173|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515174|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515175|NCT01173601|Serotonin|serotonin|mesh-list
56515176|NCT01173601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56515177|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56515178|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
56515179|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515180|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515181|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515182|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56515183|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56515184|NCT01609673|Everolimus|everolimus|mesh-list
56515185|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515186|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515187|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
56515188|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515189|NCT01173055|Milnacipran|milnacipran|mesh-list
56515190|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
56515191|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56515192|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56648894|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56648895|NCT00645372|Risperidone|risperidone|mesh-list
56648896|NCT00645372|Ziprasidone|ziprasidone|mesh-list
55943234|NCT04390789|Calcium|calcium|mesh-list
56515193|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56515194|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515195|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515196|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515197|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56515198|NCT01173055|Analgesics|analgesics|mesh-ancestor
56515199|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
56515200|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515201|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
56515202|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56515203|NCT00593463|Cycloserine|cycloserine|mesh-list
56515204|NCT00593463|Verapamil|verapamil|mesh-list
56515205|NCT00593463|Diltiazem|diltiazem|mesh-list
56515206|NCT00593463|Isradipine|isradipine|mesh-list
56515207|NCT00593463|Nifedipine|nifedipine|mesh-list
56515208|NCT00593463|Gabapentin|gabapentin|mesh-list
56515209|NCT00593463|Naloxone|naloxone|mesh-list
56515210|NCT00593463|Analgesics|analgesics|mesh-ancestor
56515211|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
56515212|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515213|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515214|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
56515215|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56263315|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56515217|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515218|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56515219|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56515220|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56137008|NCT00504504|Dacarbazine|dacarbazine|mesh-list
56515223|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
56515224|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56515225|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56515226|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56515227|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56515228|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
56515229|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
56515230|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56515231|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56515232|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515233|NCT00593463|Renal Agents|renal agents|mesh-ancestor
56515234|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56515235|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
56515236|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56515237|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
56515238|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56515239|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56515240|NCT00593502|Oseltamivir|oseltamivir|mesh-list
56515241|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
56515242|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515243|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515244|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515246|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56515247|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56515248|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56515249|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
56515250|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515251|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56515252|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56515253|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515254|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56515255|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56515256|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56515257|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
56515258|NCT00593580|Vitamin D|vitamin d|mesh-list
56515259|NCT00593580|Alendronate|alendronate|mesh-list
56515260|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56515261|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515262|NCT00593580|Vitamins|vitamins|mesh-ancestor
56515263|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
56515264|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56648897|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56515265|NCT04327011|Flucytosine|flucytosine|mesh-list
56515266|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
56515267|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515268|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
56515269|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515270|NCT00593619|Iron|iron|mesh-list
56515271|NCT00593619|Dextrans|dextrans|mesh-list
56515272|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56515273|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
56515274|NCT00593619|Trace Elements|trace elements|mesh-ancestor
56515275|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
56515276|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515277|NCT00593619|Hematinics|hematinics|mesh-ancestor
56515278|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
56515279|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
56515280|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
56515281|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
56515282|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56515283|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515284|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515285|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56515286|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56515287|NCT00593658|Protective Agents|protective agents|mesh-ancestor
56515288|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515289|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
56263391|NCT01947790|Metformin|metformin|mesh-list
56515290|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56515291|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
56515292|NCT00593697|Docetaxel|docetaxel|mesh-list
56515293|NCT00593697|Trastuzumab|trastuzumab|mesh-list
56515294|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515296|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
56515297|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
56515298|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515299|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56515300|NCT01601522|Ranitidine|ranitidine|mesh-list
56515301|NCT01601522|Desloratadine|desloratadine|mesh-list
56515302|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
56515303|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56515304|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56515305|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
56515306|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515307|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515308|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515309|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56515310|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
56515311|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56515312|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56515313|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56515314|NCT00593853|Methylphenidate|methylphenidate|mesh-list
56515315|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56515316|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515317|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56515318|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56515319|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56515320|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515321|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
56515322|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515323|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56515324|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56515325|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
56515326|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515327|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56515328|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515329|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56515330|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515331|NCT00594087|Eszopiclone|eszopiclone|mesh-list
56515332|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56515333|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515334|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515335|NCT00594126|Imetelstat|imetelstat|mesh-list
56515336|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
56515337|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648898|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
56648899|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869136|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
56515338|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515339|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56515340|NCT01605344|Leucovorin|leucovorin|mesh-list
56515341|NCT01605344|Fluorouracil|fluorouracil|mesh-list
56515342|NCT01605344|Irinotecan|irinotecan|mesh-list
56515343|NCT01605344|Atorvastatin|atorvastatin|mesh-list
56515344|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
56515345|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515346|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515347|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515348|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515349|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
56515350|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515351|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56515352|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56515353|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515354|NCT01605344|Antidotes|antidotes|mesh-ancestor
56515355|NCT01605344|Protective Agents|protective agents|mesh-ancestor
56515356|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
56515357|NCT01605344|Vitamins|vitamins|mesh-ancestor
56515358|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
56515359|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56515360|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56515361|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56515362|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56515363|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
56515364|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56515365|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515366|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56515367|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56515368|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515369|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515370|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515372|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
56515373|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515374|NCT00592410|Insulin|insulin|mesh-list
56515375|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56515376|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56515377|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515378|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56515379|NCT04328064|Calcium|calcium|mesh-list
56515380|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56515381|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515382|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56515383|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56515384|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
56515385|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515386|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56515387|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56515388|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515389|NCT01605734|Sorafenib|sorafenib|mesh-list
56515390|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
56515391|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515392|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56515393|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515394|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515395|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56515396|NCT01605734|Estrogens|estrogens|mesh-ancestor
56515398|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515399|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515400|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56515401|NCT01605773|Glyburide|glyburide|mesh-list
56515402|NCT01605773|Repaglinide|repaglinide|mesh-list
56515403|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56515404|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515405|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
56515406|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56515407|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515408|NCT00594555|Cytarabine|cytarabine|mesh-list
56515409|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
55869219|NCT04375852|Autoantibodies|autoantibodies|mesh-list
55943492|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943493|NCT02196831|Tesamorelin|tesamorelin|mesh-list
55943494|NCT02196831|Growth Substances|growth substances|mesh-ancestor
55943495|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943496|NCT04944966|Lumefantrine|lumefantrine|mesh-list
55943497|NCT04944966|Artemether|artemether|mesh-list
55943499|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
56515410|NCT00594555|Cladribine|cladribine|mesh-list
56515411|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515412|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
56515413|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515414|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515415|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
56515416|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515417|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515418|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
56515419|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515420|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56515421|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515422|NCT01605929|Mepivacaine|mepivacaine|mesh-list
56515423|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
56515424|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
56515425|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515426|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515427|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
56515428|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515429|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
56515430|NCT02270606|Leucovorin|leucovorin|mesh-list
56515431|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
56515432|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56515433|NCT02270606|Fluorouracil|fluorouracil|mesh-list
56515434|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
56515435|NCT02270606|Calcium|calcium|mesh-list
56515436|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
56515437|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56515438|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515439|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56515440|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
56515441|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515442|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515443|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515446|NCT02270606|Antidotes|antidotes|mesh-ancestor
56515447|NCT02270606|Protective Agents|protective agents|mesh-ancestor
56515448|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
56515449|NCT02270606|Vitamins|vitamins|mesh-ancestor
56515450|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
56515451|NCT00594633|Donepezil|donepezil|mesh-list
56515452|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56515453|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515454|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515455|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
56515456|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515457|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515458|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
56515459|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56515460|NCT01605968|Laxatives|laxatives|mesh-ancestor
56515461|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56515462|NCT01606046|Anesthetics|anesthetics|mesh-list
56515463|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
56168000|NCT00355602|Renal Agents|renal agents|mesh-ancestor
56515464|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56515465|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
56515466|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515467|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515468|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
56515469|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515470|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56515471|NCT02892942|Cetrorelix|cetrorelix|mesh-list
56515472|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56515473|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
56648900|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648901|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943604|NCT04407390|Niacin|niacin|mesh-list
56515474|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56515475|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515476|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
56515477|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515478|NCT00594867|Aspirin|aspirin|mesh-list
56515479|NCT00594867|Acetaminophen|acetaminophen|mesh-list
56515480|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56515481|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56515482|NCT00594867|Analgesics|analgesics|mesh-ancestor
56515483|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
56515484|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515485|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515486|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56515487|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515488|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56515489|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56515490|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515491|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56515492|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56515493|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515494|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
56515495|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
56515496|NCT01606241|Vaccines|vaccines|mesh-list
56515497|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
56515498|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515499|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515500|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515501|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56515502|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
56515503|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515504|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515505|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56515506|NCT02270918|Apixaban|apixaban|mesh-list
56515507|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56515508|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
56515509|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56515510|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
56515511|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515512|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515513|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
56515514|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
56515515|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56515516|NCT00595140|Octreotide|octreotide|mesh-list
56515517|NCT00595140|Dopamine|dopamine|mesh-list
56515520|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
56515521|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56515522|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56515523|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515524|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56515525|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
56515526|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
56515527|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515528|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515529|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
56515530|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515531|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515532|NCT00595140|Protective Agents|protective agents|mesh-ancestor
56515533|NCT00595140|Hormones|hormones|mesh-ancestor
56515534|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515535|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56515536|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56515537|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
56515538|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56515539|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
56515540|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515541|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
56515542|NCT02271035|Protective Agents|protective agents|mesh-ancestor
56515543|NCT01606358|Carboplatin|carboplatin|mesh-list
56515544|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648902|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56515546|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
56515547|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
56515548|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56515549|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56515550|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515551|NCT02271191|Nicardipine|nicardipine|mesh-list
56515552|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56515553|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56515554|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56515555|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515556|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56515557|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515558|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
56515559|NCT00595374|Insulin|insulin|mesh-list
56515560|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56515561|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
56515562|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
56515563|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
56515564|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
56515565|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
56515566|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56515567|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515568|NCT00595569|Insulin|insulin|mesh-list
56515569|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56515570|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515571|NCT02271347|Brincidofovir|brincidofovir|mesh-list
56515572|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
56515573|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515574|NCT01172938|Thalidomide|thalidomide|mesh-list
56515575|NCT01172938|Apremilast|apremilast|mesh-list
56515576|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56515577|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56515578|NCT01172938|Analgesics|analgesics|mesh-ancestor
56515579|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
56515580|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515581|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515582|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56515583|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515584|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56515585|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56515586|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515587|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515588|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515589|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
56515590|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
56515591|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56515592|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137385|NCT00527592|Travoprost|travoprost|mesh-list
56515594|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56515595|NCT01172938|Growth Substances|growth substances|mesh-ancestor
56515596|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
56515597|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515598|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
56515599|NCT02271464|Bevacizumab|bevacizumab|mesh-list
56515600|NCT02271464|Capecitabine|capecitabine|mesh-list
56515601|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515602|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
56515603|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515604|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515605|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56515606|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
56515607|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515608|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515609|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56515610|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56515611|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56515612|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56515613|NCT02271464|Growth Substances|growth substances|mesh-ancestor
56515614|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
56515615|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515616|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
56515617|NCT04326894|Methotrexate|methotrexate|mesh-list
56515618|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56515619|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
56648903|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56648904|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56648905|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56515620|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56515621|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515622|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515623|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
56515624|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515625|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515626|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
56515627|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515628|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56515629|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515630|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
56515631|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515632|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56515633|NCT02271542|Propofol|propofol|mesh-list
56515634|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56515635|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515636|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515637|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56515638|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
56515639|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
56515640|NCT01109992|Regadenoson|regadenoson|mesh-list
56515641|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56515642|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56515643|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
56515644|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
56515645|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515646|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515647|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515648|NCT02892357|Omeprazole|omeprazole|mesh-list
56515649|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56515650|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56515651|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56515652|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515653|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515654|NCT01109524|Cetuximab|cetuximab|mesh-list
56515655|NCT01109524|Vinorelbine|vinorelbine|mesh-list
56515656|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515657|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56515658|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56515659|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
56515660|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
56515661|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
56515662|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515663|NCT01109173|Nepafenac|nepafenac|mesh-list
56515664|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56137455|NCT03117972|Bevacizumab|bevacizumab|mesh-list
56515667|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
56515668|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515669|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515670|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56515671|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515672|NCT02271971|Vitamin D|vitamin d|mesh-list
56515673|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
56515674|NCT02271971|Vitamins|vitamins|mesh-ancestor
56515675|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
56168010|NCT00356226|Clonidine|clonidine|mesh-list
56515676|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515677|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56515678|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56515679|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
56515680|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56515681|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56515682|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
56515683|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515684|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515685|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56515686|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
56515687|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
56113558|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
56648906|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56648907|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
56648908|NCT05074992|Ipilimumab|ipilimumab|mesh-list
56515688|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56515689|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
56515690|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515691|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515692|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56515693|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56515694|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56515695|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
56515696|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
56515697|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56515698|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
56515699|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515700|NCT01172275|Expectorants|expectorants|mesh-ancestor
56515701|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
56515702|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56515703|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
56515704|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515705|NCT01172275|Protective Agents|protective agents|mesh-ancestor
56515706|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515707|NCT01172275|Antidotes|antidotes|mesh-ancestor
56515708|NCT05034952|Acetaminophen|acetaminophen|mesh-list
56515709|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56515710|NCT05034952|Analgesics|analgesics|mesh-ancestor
56515711|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
56515712|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515713|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515714|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
56515715|NCT00596037|Hormones|hormones|mesh-list
56515716|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515717|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515718|NCT02273102|Tretinoin|tretinoin|mesh-list
56515719|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
56515720|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515721|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
56515722|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
56515723|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
56515724|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56515725|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56515726|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515727|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515728|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56515729|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56515730|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515731|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515732|NCT02272478|Decitabine|decitabine|mesh-list
56515733|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
56515734|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515735|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
56515736|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515737|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515739|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56515740|NCT02272517|Vortioxetine|vortioxetine|mesh-list
56515741|NCT02272517|Citalopram|citalopram|mesh-list
56515742|NCT02272517|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56515743|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56515744|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56515745|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515746|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515747|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
56515748|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515749|NCT02272517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56515750|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
56515751|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56515752|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56515753|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56515754|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515755|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56515756|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56515757|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56648909|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56648910|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943929|NCT04037241|Paclitaxel|paclitaxel|mesh-list
56515758|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56515759|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
56515760|NCT02272829|Narcotics|narcotics|mesh-ancestor
56515761|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515762|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515763|NCT02272829|Analgesics|analgesics|mesh-ancestor
56515764|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
56515765|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515766|NCT00596115|Pramipexole|pramipexole|mesh-list
56515767|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
56515768|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515769|NCT00596115|Protective Agents|protective agents|mesh-ancestor
56515770|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515771|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56515772|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56515773|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
56515774|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
56515775|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515776|NCT02272868|Rifaximin|rifaximin|mesh-list
56515777|NCT02272868|Omeprazole|omeprazole|mesh-list
56515778|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56515779|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56515780|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56515781|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56515782|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515783|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515784|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56515785|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515786|NCT02272868|Laxatives|laxatives|mesh-ancestor
56515787|NCT02273453|Oxazepam|oxazepam|mesh-list
56515788|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56515789|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515790|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515791|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56515792|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56515793|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56515794|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
56515795|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
56515796|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515797|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515798|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56515799|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56515800|NCT01108510|Cobicistat|cobicistat|mesh-list
56515801|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56515802|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56515803|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515804|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515805|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
56515806|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515807|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56515808|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56515809|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56515810|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56515813|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56515814|NCT02273258|Insulin|insulin|mesh-list
56515815|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56515816|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
56515817|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56515818|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515819|NCT05015686|Vaccines|vaccines|mesh-list
56515820|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
56515821|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515822|NCT04327245|Tagatose|tagatose|mesh-list
56515824|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
56515825|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
56515826|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515827|NCT04327401|Dexamethasone|dexamethasone|mesh-list
56515828|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56515829|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
56515830|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
56113560|NCT00281879|Busulfan|busulfan|mesh-list
56648911|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56648912|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648913|NCT00645918|Clopidogrel|clopidogrel|mesh-list
56648914|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56648915|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56648916|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56648917|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56648918|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
56648919|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56648920|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648921|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648922|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
56648923|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
56515831|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515832|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515833|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56515834|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
56515835|NCT04327401|Hormones|hormones|mesh-ancestor
56515836|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515837|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56515838|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515839|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
56515840|NCT01340027|Mirabegron|mirabegron|mesh-list
56515841|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56515842|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56515843|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
56515844|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515845|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515846|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515847|NCT01340027|Urological Agents|urological agents|mesh-ancestor
56515848|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56515849|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56515850|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56515851|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
56515852|NCT01107925|Clopidogrel|clopidogrel|mesh-list
56515853|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56515854|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56515855|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56515856|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56515857|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56515858|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
56515859|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515860|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515861|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515862|NCT04310293|Hormones|hormones|mesh-list
56515863|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515864|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515865|NCT01339559|Brivaracetam|brivaracetam|mesh-list
56515866|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
56515867|NCT01588847|Sufentanil|sufentanil|mesh-list
56515868|NCT01588847|Bupivacaine|bupivacaine|mesh-list
56515869|NCT01588847|Anesthetics|anesthetics|mesh-list
56515870|NCT01588847|Propofol|propofol|mesh-list
56515871|NCT01588847|Sevoflurane|sevoflurane|mesh-list
56515872|NCT01588847|Rocuronium|rocuronium|mesh-list
56515873|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
56515874|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56515875|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515876|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
56648924|NCT00646854|Doxorubicin|doxorubicin|mesh-list
56648925|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56648926|NCT00646854|Vincristine|vincristine|mesh-list
56515877|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515878|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56515879|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56515880|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
56515881|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56515882|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56515883|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56515884|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56515886|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56515887|NCT01588847|Narcotics|narcotics|mesh-ancestor
56515888|NCT01588847|Analgesics|analgesics|mesh-ancestor
56515889|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56515890|NCT00107900|Edoxaban|edoxaban|mesh-list
56515891|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56515892|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
56515893|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56515894|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
56515895|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515896|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515897|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
56515898|NCT00107315|Bevacizumab|bevacizumab|mesh-list
56515899|NCT00107315|Capecitabine|capecitabine|mesh-list
56515900|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56515901|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515902|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56515903|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56515904|NCT00107315|Growth Substances|growth substances|mesh-ancestor
56515905|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515906|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
56515907|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515908|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
56515909|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515910|NCT01335971|Sulforaphane|sulforaphane|mesh-list
56515911|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56515912|NCT01335971|Protective Agents|protective agents|mesh-ancestor
56515913|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515914|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515915|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
56515916|NCT00107276|Capecitabine|capecitabine|mesh-list
56515917|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515918|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
56515919|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515920|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515921|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56515922|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
56515923|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515924|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515925|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56515926|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56515927|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
56515929|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56515930|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56515931|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56515932|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
56515933|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515934|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515935|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56515936|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56515937|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
56515938|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56515939|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56515940|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56515941|NCT00107198|Prednisone|prednisone|mesh-list
56515942|NCT00107198|Cortisone|cortisone|mesh-list
56515943|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
56515944|NCT00107198|Doxorubicin|doxorubicin|mesh-list
56515945|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56515946|NCT00107198|Vincristine|vincristine|mesh-list
56515947|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515948|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
56515949|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648927|NCT00646854|Lenograstim|lenograstim|mesh-list
56648928|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515950|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515951|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56515952|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
56515953|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515954|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515955|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56515956|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56515957|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56515958|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56515959|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515960|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56515963|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56515964|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56515965|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56515966|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
56515967|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
56515968|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
56515970|NCT00107120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56515971|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56515972|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56515973|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515974|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515975|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
56515976|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515977|NCT00107120|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56515978|NCT00107120|Antidepressive Agents|antidepressive agents|mesh-ancestor
56515979|NCT00107120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56515980|NCT01335464|Nintedanib|nintedanib|mesh-list
56515981|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515982|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56515983|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515984|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515985|NCT00106184|Rituximab|rituximab|mesh-list
56515986|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56515987|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56515988|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
56515989|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515990|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515991|NCT00598923|Topiramate|topiramate|mesh-list
56515992|NCT00598923|Phenytoin|phenytoin|mesh-list
56515993|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
56515994|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56515995|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515996|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56515997|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56515998|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56515999|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516000|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56516001|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56516002|NCT02892318|Atezolizumab|atezolizumab|mesh-list
56516003|NCT02892318|Guadecitabine|guadecitabine|mesh-list
56516004|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516005|NCT01334918|Regadenoson|regadenoson|mesh-list
56516006|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56516007|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56516008|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56516009|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
56516010|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
56516011|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516012|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516013|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516014|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56516015|NCT00598962|Azithromycin|azithromycin|mesh-list
56516016|NCT00598962|Rifampin|rifampin|mesh-list
56516017|NCT00598962|Rifabutin|rifabutin|mesh-list
56516018|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56516019|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516020|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56516021|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
56648929|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
56648930|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944259|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
56516022|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
56516023|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56516024|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516025|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516026|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56516027|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56516028|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56516029|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56516030|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56516031|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56516032|NCT01332968|Prednisone|prednisone|mesh-list
56516035|NCT01332968|Rituximab|rituximab|mesh-list
56516036|NCT01332968|Doxorubicin|doxorubicin|mesh-list
56516037|NCT01332968|Vincristine|vincristine|mesh-list
56516038|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
56516039|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56516040|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
56516041|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516042|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56516043|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56516044|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
56516045|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516046|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516047|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56516048|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56516049|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56516050|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56516051|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56516052|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516053|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56516054|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
56516055|NCT01332968|Hormones|hormones|mesh-ancestor
56516056|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516057|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56516058|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56516059|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
56516060|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
56516061|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
56516062|NCT00599079|Azithromycin|azithromycin|mesh-list
56516063|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56516064|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516065|NCT00599235|Hydralazine|hydralazine|mesh-list
56516066|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
56516067|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
56516068|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56516069|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56516070|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516071|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516072|NCT00599235|Urological Agents|urological agents|mesh-ancestor
56516073|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56516074|NCT00599274|Interferons|interferons|mesh-list
56516075|NCT00599274|Interferon-beta|interferon-beta|mesh-list
56516076|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
56516077|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516078|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
56516079|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516080|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
56516081|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516082|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56516083|NCT01332227|Ritonavir|ritonavir|mesh-list
56516084|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56516085|NCT01332227|Tenofovir|tenofovir|mesh-list
56516086|NCT01332227|Emtricitabine|emtricitabine|mesh-list
56516087|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
56516088|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56516089|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56516090|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
56516091|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516092|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648931|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944344|NCT02455687|Hormones|hormones|mesh-ancestor
56516093|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56516094|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56516095|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
56516096|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516097|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56516098|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56516099|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56516100|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56516101|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56516102|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56516103|NCT01332149|Pregabalin|pregabalin|mesh-list
56516104|NCT01332149|Analgesics|analgesics|mesh-ancestor
56516105|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
56516106|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137905|NCT00605904|Yohimbine|yohimbine|mesh-list
56516108|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
56516109|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56516110|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516111|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516112|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56516113|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56516114|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56516115|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516116|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56264224|NCT01953172|Vitamins|vitamins|mesh-ancestor
56516117|NCT01326702|Rituximab|rituximab|mesh-list
56516118|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56516119|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56516120|NCT01326702|Veliparib|veliparib|mesh-list
56516121|NCT01326702|Antibodies|antibodies|mesh-list
56516122|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
56516123|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56516124|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
56516125|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516126|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516127|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56516128|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56516129|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
56516130|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516131|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56516132|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516133|NCT00599625|Pravastatin|pravastatin|mesh-list
56516134|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56516135|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56516136|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
56516137|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516138|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56516139|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56516140|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516141|NCT05650697|Cannabidiol|cannabidiol|mesh-list
56516142|NCT05650697|Anticonvulsants|anticonvulsants|mesh-ancestor
56516143|NCT05649878|Methylprednisolone|methylprednisolone|mesh-list
56516144|NCT05649878|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56516145|NCT05649878|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56516146|NCT05649878|Prednisolone|prednisolone|mesh-list
56516147|NCT05649878|Prednisolone acetate|prednisolone acetate|mesh-list
56516148|NCT05649878|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56516149|NCT05649878|Prednisolone phosphate|prednisolone phosphate|mesh-list
56516150|NCT05649878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56516151|NCT05649878|Antiemetics|antiemetics|mesh-ancestor
56516152|NCT05649878|Autonomic Agents|autonomic agents|mesh-ancestor
56516153|NCT05649878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516154|NCT05649878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516155|NCT05649878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56516156|NCT05649878|Glucocorticoids|glucocorticoids|mesh-ancestor
56516157|NCT05649878|Hormones|hormones|mesh-ancestor
56516158|NCT05649878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516159|NCT05649878|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56516160|NCT05649878|Protective Agents|protective agents|mesh-ancestor
56516161|NCT05649878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56516162|NCT05649878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516163|NCT01327703|Pancreatin|pancreatin|mesh-list
56648932|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56648933|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
56648934|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516164|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56516165|NCT01380080|Efavirenz|efavirenz|mesh-list
56516166|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56516167|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56516168|NCT01380080|Rifampin|rifampin|mesh-list
56516169|NCT01380080|Isoniazid|isoniazid|mesh-list
56516170|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
56516171|NCT01380080|Ethambutol|ethambutol|mesh-list
56516172|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
56516173|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56516174|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56516175|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516176|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516177|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
56516178|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516180|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56516181|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56516182|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55783088|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
56516183|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56516184|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56516185|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56516186|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56516187|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56516188|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
56516189|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56516190|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
56516191|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56516192|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56516193|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56516194|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56516195|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56516196|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
56516197|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56516198|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
56516199|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
56516200|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56516201|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56516202|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516203|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516204|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516205|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56516206|NCT01371851|Doxazosin|doxazosin|mesh-list
56516207|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56516208|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56516209|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56516210|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56516211|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
56516212|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516213|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516214|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516215|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56516216|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56516217|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56516218|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516219|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516220|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516221|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516222|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
56516223|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56516224|NCT04328870|Oxytocin|oxytocin|mesh-list
56516225|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516226|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
56516227|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56648935|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294956|NCT00095524|Aripiprazole|aripiprazole|mesh-list
56648936|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56648937|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56648938|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56648939|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56648940|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56648941|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56648942|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648943|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56648944|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
56648945|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
56648946|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
56648947|NCT04173858|Naloxegol|naloxegol|mesh-list
56648948|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56648949|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648950|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
56648951|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56648952|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
56648953|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56516228|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56516229|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56516230|NCT00591617|Narcotics|narcotics|mesh-ancestor
56516231|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516232|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516233|NCT00591617|Analgesics|analgesics|mesh-ancestor
56516234|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
56516235|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516236|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56516237|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
56516238|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56516239|NCT01357889|Incretins|incretins|mesh-ancestor
56516240|NCT01357889|Hormones|hormones|mesh-ancestor
56516241|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516242|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516243|NCT01357655|Dasatinib|dasatinib|mesh-list
56516244|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516245|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56516246|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516247|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516248|NCT01357616|Timolol|timolol|mesh-list
56516251|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56516252|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56516253|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56516255|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516256|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516257|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516258|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56516259|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56516260|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56516261|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516262|NCT01351025|Atorvastatin|atorvastatin|mesh-list
56516263|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56516264|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56648954|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648955|NCT00646932|Vitamins|vitamins|mesh-ancestor
56648956|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
56648957|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56648958|NCT00646152|Poly ICLC|poly iclc|mesh-list
56516265|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
56516266|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516267|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56516268|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56516269|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516270|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56516272|NCT01348763|Darunavir|darunavir|mesh-list
56516273|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56516274|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56516275|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516276|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516277|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
56516278|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516279|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56516280|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56516281|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56516282|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56516283|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56516284|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56516285|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56516286|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
56516287|NCT01346540|Nintedanib|nintedanib|mesh-list
56516288|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516289|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56516290|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516291|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516292|NCT01342913|Fluticasone|fluticasone|mesh-list
56516293|NCT01342913|Xhance|xhance|mesh-list
56516294|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56516295|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56516296|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56516297|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
56516298|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516299|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516300|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56516301|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
56516302|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
56516303|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56516304|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56516305|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56516306|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56516307|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
56516308|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516309|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516310|NCT01342796|Vaccines|vaccines|mesh-list
56516311|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
56516312|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516313|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
56516314|NCT01342640|Hematinics|hematinics|mesh-ancestor
56516315|NCT01342484|Linagliptin|linagliptin|mesh-list
56516316|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56516317|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516318|NCT01342484|Incretins|incretins|mesh-ancestor
56516319|NCT01342484|Hormones|hormones|mesh-ancestor
56516320|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516321|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56516324|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516325|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56516326|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56516327|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516328|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56516329|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56516330|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56648959|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
56648960|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
56648961|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516331|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516332|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
56516333|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516334|NCT01342367|Bicalutamide|bicalutamide|mesh-list
56516335|NCT01342367|Finasteride|finasteride|mesh-list
56516336|NCT01342367|Dutasteride|dutasteride|mesh-list
56516337|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
56516338|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
56516339|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516340|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516341|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516342|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56516343|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56516344|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516345|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516346|NCT01342367|Urological Agents|urological agents|mesh-ancestor
56516347|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56516349|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56516350|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56516351|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
56516352|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516353|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516354|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56516356|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56516357|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56516358|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56516359|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56516360|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
56516361|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516362|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516363|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516364|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56516365|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56516366|NCT01340768|Metformin|metformin|mesh-list
56516367|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56516368|NCT01340768|Glimepiride|glimepiride|mesh-list
56516369|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56516370|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516371|NCT01340768|Incretins|incretins|mesh-ancestor
56516372|NCT01340768|Hormones|hormones|mesh-ancestor
56516373|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516374|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56516375|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
56516376|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516377|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516378|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56516379|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56516380|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
56516381|NCT01340300|Metformin|metformin|mesh-list
56516382|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56516383|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516384|NCT01107535|Palivizumab|palivizumab|mesh-list
56516385|NCT01107535|Antibodies|antibodies|mesh-list
56516386|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56516387|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
56516388|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516389|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
56516390|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516391|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56516392|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516393|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
56516394|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56516395|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56516397|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516398|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516399|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
56516400|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516401|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648962|NCT00647166|Azathioprine|azathioprine|mesh-list
56648963|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
56648964|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648965|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56516402|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56516403|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516404|NCT00598338|Prucalopride|prucalopride|mesh-list
56516405|NCT00598338|Laxatives|laxatives|mesh-ancestor
56516406|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56516407|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56516408|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56516409|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
56516410|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264515|NCT01954784|Bortezomib|bortezomib|mesh-list
56516411|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516412|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516413|NCT00598572|Deferoxamine|deferoxamine|mesh-list
56516414|NCT00598572|Siderophores|siderophores|mesh-ancestor
56516415|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56516416|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
56516417|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
56516418|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516419|NCT00599820|Bevacizumab|bevacizumab|mesh-list
56516420|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56516421|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516422|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56516423|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56516424|NCT00599820|Growth Substances|growth substances|mesh-ancestor
56516425|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516426|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
56516427|NCT00599898|Nifedipine|nifedipine|mesh-list
56516428|NCT00599898|Atosiban|atosiban|mesh-list
56516429|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56516430|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516431|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516432|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56516433|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516434|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
56516435|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
56516436|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56516437|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
56516438|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516439|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
56516440|NCT00600054|Antibodies|antibodies|mesh-list
56516441|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56516442|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
56516443|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516444|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56516445|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516446|NCT00600210|Bevacizumab|bevacizumab|mesh-list
56516447|NCT00600210|Carboplatin|carboplatin|mesh-list
56516448|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56516449|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516450|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56516451|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56516452|NCT00600210|Growth Substances|growth substances|mesh-ancestor
56516453|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516454|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
56516455|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
56516456|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
56516457|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56516458|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56516459|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516460|NCT01326546|Entecavir|entecavir|mesh-list
56516461|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
56516462|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516463|NCT00600600|Tigecycline|tigecycline|mesh-list
56516464|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56516465|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516466|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56648966|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648967|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56648968|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
56648969|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648970|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56648971|NCT00647244|Tenofovir|tenofovir|mesh-list
56648972|NCT00647244|Abacavir|abacavir|mesh-list
56648973|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
56648974|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56648975|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56648976|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56648977|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648978|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56648979|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56648980|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56648981|NCT00895583|Sirolimus|sirolimus|mesh-list
56648982|NCT00895583|Tacrolimus|tacrolimus|mesh-list
56648983|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56648984|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
56648985|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56648986|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56648987|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648988|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516467|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516486|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516487|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516488|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56516489|NCT00623220|Analgesics|analgesics|mesh-ancestor
56516490|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
56516491|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516492|NCT00600912|SMOFlipid|smoflipid|mesh-list
56516493|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56516494|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56516495|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56516496|NCT00600990|Vestipitant|vestipitant|mesh-list
56516497|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56516498|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516499|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516500|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516501|NCT00601302|Amlodipine|amlodipine|mesh-list
56516502|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56516503|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56516504|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516505|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516506|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56516507|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516508|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
56516509|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
56516510|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
56516511|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56516512|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56648989|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56648990|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516513|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516514|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
56516515|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56516516|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516517|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516518|NCT00601614|Temozolomide|temozolomide|mesh-list
56516519|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56516520|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
56516521|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516522|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516525|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516526|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
56516527|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
56516528|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
56516529|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516530|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56516531|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56516532|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516533|NCT00602004|Losartan|losartan|mesh-list
56516534|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56516535|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56516536|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56516537|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56516538|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516539|NCT00602082|Capecitabine|capecitabine|mesh-list
56516540|NCT00602082|Streptozocin|streptozocin|mesh-list
56516541|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516542|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56516543|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
56516544|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516545|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56516546|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
56516547|NCT01171963|Vaccines|vaccines|mesh-list
56516548|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
56516549|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516550|NCT01171183|Carvedilol|carvedilol|mesh-list
56516551|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56516552|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56516553|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
56516554|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516555|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516556|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516557|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56516558|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
56516559|NCT01171183|Protective Agents|protective agents|mesh-ancestor
56516560|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56516561|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516562|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56516563|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
56516564|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56516565|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56516566|NCT01169779|Metformin|metformin|mesh-list
56516567|NCT01169779|Lixisenatide|lixisenatide|mesh-list
56516568|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56516569|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516570|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
56516571|NCT01169701|Everolimus|everolimus|mesh-list
56516572|NCT01169701|Tacrolimus|tacrolimus|mesh-list
56516573|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56516574|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
56516575|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516576|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56516577|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516578|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516579|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516580|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56516581|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56516582|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
56516583|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56648991|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56648992|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648993|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
56648994|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
56648995|NCT00646230|Fenretinide|fenretinide|mesh-list
56516584|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516585|NCT01167907|Ropivacaine|ropivacaine|mesh-list
56516586|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
56516587|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
56516588|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516589|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516590|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
56516591|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516592|NCT01115491|Bevacizumab|bevacizumab|mesh-list
56516593|NCT01115491|Temozolomide|temozolomide|mesh-list
56516594|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56516595|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516596|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56516598|NCT01115491|Growth Substances|growth substances|mesh-ancestor
56516599|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516600|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
56516601|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56516602|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
56516603|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516605|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56516606|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516607|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
56516608|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56516609|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56516610|NCT02881177|Oxytocin|oxytocin|mesh-list
56516611|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
56516612|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56516613|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516614|NCT02880787|Rocuronium|rocuronium|mesh-list
56516615|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56516616|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56516617|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56516618|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516619|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516620|NCT01106677|Metformin|metformin|mesh-list
56516621|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56516622|NCT01106677|Canagliflozin|canagliflozin|mesh-list
56516623|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56516624|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516625|NCT01106677|Incretins|incretins|mesh-ancestor
56516626|NCT01106677|Hormones|hormones|mesh-ancestor
56516627|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516628|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56516629|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
56516630|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516631|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516632|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56516633|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56516635|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56516636|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56516637|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516638|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
56516639|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
56516640|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56516641|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56516642|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516643|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516644|NCT04985929|Urological Agents|urological agents|mesh-ancestor
56516645|NCT04308343|Methotrexate|methotrexate|mesh-list
56516646|NCT04308343|Letrozole|letrozole|mesh-list
56516647|NCT04308343|Cetrorelix|cetrorelix|mesh-list
56516648|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56516649|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
56516650|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56648996|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56648997|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56516651|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516652|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56516653|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
56516654|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516655|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516656|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
56516657|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516658|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56516659|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56516660|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
56516661|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56516662|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56516663|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56516664|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56516665|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56516666|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
56516667|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516668|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56516669|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
56516670|NCT01099579|Ritonavir|ritonavir|mesh-list
56516671|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56516672|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56516673|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56516674|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
56516675|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516676|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516677|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56516678|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56516679|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
56516680|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516681|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56516682|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56516683|NCT01103713|Azithromycin|azithromycin|mesh-list
56516684|NCT01103713|Chloroquine|chloroquine|mesh-list
56516685|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56516686|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516687|NCT01103713|Amebicides|amebicides|mesh-ancestor
56516688|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56516689|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56516690|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
56516691|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56516692|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56516693|NCT01103245|Spironolactone|spironolactone|mesh-list
56516694|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56516695|NCT01103245|Diuretics|diuretics|mesh-ancestor
56516696|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
56516697|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516698|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56516699|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516700|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516701|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56516702|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
56516703|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516704|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56516706|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
56516707|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56516708|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516709|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516710|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56516711|NCT02878837|Analgesics|analgesics|mesh-ancestor
56516712|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
56516713|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516714|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56516715|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56516716|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56516717|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
56516718|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516719|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516720|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56648998|NCT00646230|Protective Agents|protective agents|mesh-ancestor
56648999|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649000|NCT04174872|Midazolam|midazolam|mesh-list
56649001|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
56649002|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55945159|NCT01894867|Antacids|antacids|mesh-ancestor
56516721|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56516722|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56516723|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56516724|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56516725|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
56516726|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
56516727|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
56516728|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
56516729|NCT02880007|Cisplatin|cisplatin|mesh-list
56516730|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516731|NCT04982029|Cannabidiol|cannabidiol|mesh-list
56516732|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
56516733|NCT02880085|Lidocaine|lidocaine|mesh-list
56516734|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
56516735|NCT02880085|Anesthetics|anesthetics|mesh-list
56516736|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516737|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516738|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
56516739|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516740|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56516741|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56516742|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56516743|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516744|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516745|NCT01098097|Ribavirin|ribavirin|mesh-list
56516746|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
56516755|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516756|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56516757|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
56516758|NCT04407572|Hematinics|hematinics|mesh-ancestor
56516759|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
56516760|NCT04328636|Analgesics|analgesics|mesh-ancestor
56516761|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
56516762|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516763|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516764|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
56516765|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516766|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56516767|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
56516768|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56516769|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516770|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516771|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56516772|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
56516773|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56516774|NCT02893826|Nimodipine|nimodipine|mesh-list
56516775|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56516776|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56516777|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516778|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516779|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56516780|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516781|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
56516782|NCT02893280|Aspirin|aspirin|mesh-list
56516783|NCT02893280|Enoxaparin|enoxaparin|mesh-list
56516784|NCT02893280|Streptokinase|streptokinase|mesh-list
56516785|NCT02893280|Clopidogrel|clopidogrel|mesh-list
56516786|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56516787|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56516788|NCT02893280|Analgesics|analgesics|mesh-ancestor
56516789|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
56516790|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516791|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516792|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56516793|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56649003|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649004|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649005|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56516794|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56516795|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56516796|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516797|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56516798|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56516799|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516800|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
56516801|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56516802|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56516803|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56516804|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
56516805|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516806|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
56516807|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56516808|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56516809|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
56516810|NCT04328480|Colchicine|colchicine|mesh-list
56516811|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
56516812|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56516813|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
56516814|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
56516816|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516817|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516818|NCT00592280|Pancrelipase|pancrelipase|mesh-list
56516819|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56516820|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56516821|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56516822|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
56516823|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516824|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56516825|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
56516826|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516827|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56516828|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
56516829|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516831|NCT00592670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56516832|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56516833|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516834|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516835|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516836|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
56516837|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516838|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56516839|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
56516840|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56516841|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56516842|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56516843|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516844|NCT04327232|Spironolactone|spironolactone|mesh-list
56516845|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56516846|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
56516847|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516848|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516849|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56516850|NCT04327232|Diuretics|diuretics|mesh-ancestor
56516851|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
56516852|NCT00593060|Sirolimus|sirolimus|mesh-list
56516853|NCT00593060|Cetuximab|cetuximab|mesh-list
56516854|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56516855|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516856|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56264962|NCT01957436|Hormones|hormones|mesh-ancestor
56516857|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516858|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56516859|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
56516860|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56516861|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
56649006|NCT04174872|Analgesics|analgesics|mesh-ancestor
56649007|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
56649008|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649009|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56649010|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56516862|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516863|NCT00593138|Methylphenidate|methylphenidate|mesh-list
56516864|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56516865|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56516866|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516867|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56516868|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56516869|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516870|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516871|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
56516872|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516873|NCT00593294|Drospirenone|drospirenone|mesh-list
56516874|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56516875|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516876|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56516877|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
56516878|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56516879|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56516880|NCT00593294|Diuretics|diuretics|mesh-ancestor
56516881|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
56516882|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56516883|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56516884|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56516886|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56516887|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56516888|NCT00593294|Estrogens|estrogens|mesh-ancestor
56516889|NCT00593294|Hormones|hormones|mesh-ancestor
56516890|NCT00593996|Vitamin D|vitamin d|mesh-list
56516891|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
56516892|NCT00593996|Vitamins|vitamins|mesh-ancestor
56516893|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
56516894|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516895|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56516896|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56516897|NCT00594542|Lidocaine|lidocaine|mesh-list
56168047|NCT00356850|Azithromycin|azithromycin|mesh-list
56516898|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
56516899|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
56516900|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516901|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516902|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
56516903|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516904|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56516905|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56516906|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56516907|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56516908|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516909|NCT00595322|Bevacizumab|bevacizumab|mesh-list
56516910|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56516911|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516912|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56516913|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56516914|NCT00595322|Growth Substances|growth substances|mesh-ancestor
56516915|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516916|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
56516917|NCT00596336|Imiquimod|imiquimod|mesh-list
56516918|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56516919|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
56516920|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516921|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516922|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
56516923|NCT00596414|Midazolam|midazolam|mesh-list
56516924|NCT00596414|Meperidine|meperidine|mesh-list
56649011|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56649012|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
56295029|NCT00095758|Aripiprazole|aripiprazole|mesh-list
56295103|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
56516925|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56516926|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56516927|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56516928|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516929|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56516930|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56516931|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56516932|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56516933|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
56516934|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
56516935|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
56516936|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
56516937|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56516938|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516939|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56516940|NCT00596414|Narcotics|narcotics|mesh-ancestor
56516941|NCT00596414|Analgesics|analgesics|mesh-ancestor
56516942|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
56516943|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56516944|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56516945|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516946|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56516947|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516948|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516950|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516951|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
56516952|NCT00622934|Hematinics|hematinics|mesh-ancestor
56516953|NCT00597662|Icodextrin|icodextrin|mesh-list
56516954|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
56516955|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56516956|NCT00598052|Citalopram|citalopram|mesh-list
56516957|NCT00598052|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56516958|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56516959|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55745510|NCT05714839|Dexamethasone|dexamethasone|mesh-list
56516962|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
56516963|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516964|NCT00598052|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56516965|NCT00598052|Antidepressive Agents|antidepressive agents|mesh-ancestor
56516966|NCT00598052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56516967|NCT04326296|Lenalidomide|lenalidomide|mesh-list
56516969|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56516970|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
56516971|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516972|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56516973|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56516974|NCT04326296|Growth Substances|growth substances|mesh-ancestor
56516975|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
56516976|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516977|NCT00598676|Sirolimus|sirolimus|mesh-list
56516978|NCT00598676|Everolimus|everolimus|mesh-list
56516979|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516980|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56516981|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
56516982|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516983|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56516984|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516985|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56516986|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
56516987|NCT00599222|Ranibizumab|ranibizumab|mesh-list
56516988|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56516989|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56516990|NCT00599222|Growth Substances|growth substances|mesh-ancestor
56516991|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516992|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56516993|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516994|NCT00599534|Montelukast|montelukast|mesh-list
56516995|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56516996|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
56516997|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56649013|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649014|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649015|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56649016|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56649017|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649018|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649019|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56649020|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
56649021|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
56649022|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
56649023|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
56649024|NCT02841137|Progesterone|progesterone|mesh-list
56649025|NCT02841137|Progestins|progestins|mesh-ancestor
56516998|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
56516999|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517000|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517001|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56517002|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56517003|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517004|NCT00600158|Lidocaine|lidocaine|mesh-list
56265107|NCT01958866|Analgesics|analgesics|mesh-ancestor
56517005|NCT00600158|Hydromorphone|hydromorphone|mesh-list
56517006|NCT00600158|Bupivacaine|bupivacaine|mesh-list
56517007|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
56517008|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
56517009|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517010|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517011|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
56517012|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517013|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56517014|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56517015|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56517016|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56517017|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517018|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56517019|NCT00600158|Narcotics|narcotics|mesh-ancestor
56517020|NCT00600158|Analgesics|analgesics|mesh-ancestor
56517021|NCT04325984|Dexamethasone|dexamethasone|mesh-list
56517022|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517023|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
56517024|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
56517025|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517026|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517027|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56517028|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
56517029|NCT04325984|Hormones|hormones|mesh-ancestor
56517030|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517031|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56517033|NCT00600548|Miltefosine|miltefosine|mesh-list
56517034|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56517035|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
56517036|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517037|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517038|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56517039|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56517041|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56517042|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
56517043|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
56517044|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56517045|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
56517046|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
56517047|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
56517048|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
56649026|NCT02841137|Hormones|hormones|mesh-ancestor
56649027|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945532|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
56517049|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56517050|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517052|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
56517053|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517054|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
56517055|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517056|NCT00601016|Imiquimod|imiquimod|mesh-list
56517057|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56517058|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
56517059|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517060|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517061|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
56517062|NCT00601328|Calcitriol|calcitriol|mesh-list
56517063|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56517064|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517065|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56517066|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56517067|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517068|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56517069|NCT00601328|Vitamins|vitamins|mesh-ancestor
56517070|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
56517071|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56517072|NCT00601562|Zidovudine|zidovudine|mesh-list
56517073|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
56517074|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517075|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56517076|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56517077|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517078|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
56517079|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517080|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56517081|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56517082|NCT00601874|Pilocarpine|pilocarpine|mesh-list
56517083|NCT00601874|Miotics|miotics|mesh-ancestor
56517084|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
56517085|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517086|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517087|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56517088|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56517089|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
56517090|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517091|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517092|NCT01326026|Insulin|insulin|mesh-list
56517093|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56517094|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
56517095|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56517096|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517097|NCT01097629|Suvorexant|suvorexant|mesh-list
56517098|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56517099|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56517100|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517101|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517102|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56517103|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517104|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517105|NCT04308031|Digoxin|digoxin|mesh-list
56517106|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56138952|NCT05526157|Glucagon|glucagon|mesh-list
56517107|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56517108|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517109|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517110|NCT04308031|Protective Agents|protective agents|mesh-ancestor
56517111|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517113|NCT01096849|Ofloxacin|ofloxacin|mesh-list
56517114|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56517115|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517116|NCT01096849|Renal Agents|renal agents|mesh-ancestor
56517117|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56517118|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56649028|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649029|NCT00645606|Rituximab|rituximab|mesh-list
56649030|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649031|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517119|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56517120|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517121|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517122|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517123|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56517124|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56517125|NCT01324388|Dulaglutide|dulaglutide|mesh-list
56517126|NCT01324388|Metoprolol|metoprolol|mesh-list
56517127|NCT01324388|Lisinopril|lisinopril|mesh-list
56517128|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56517129|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56517130|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
56517131|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
56517132|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517133|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517134|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56517135|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56517136|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56517137|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
56517138|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517139|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517140|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56517141|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
56517142|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517143|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56517144|NCT01324388|Protective Agents|protective agents|mesh-ancestor
56517145|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56517146|NCT02878681|Ranibizumab|ranibizumab|mesh-list
56517147|NCT02878681|Aflibercept|aflibercept|mesh-list
56517148|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56517149|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56517150|NCT02878681|Growth Substances|growth substances|mesh-ancestor
56517151|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517152|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
56517153|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517154|NCT01324310|Ketoconazole|ketoconazole|mesh-list
56517155|NCT01324310|Romidepsin|romidepsin|mesh-list
56517156|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
56517157|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517158|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56517159|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56517160|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517161|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517162|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56517163|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
56517164|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517165|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517166|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56517167|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56517168|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517169|NCT01102231|Cetuximab|cetuximab|mesh-list
56517170|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56517171|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517172|NCT01095835|Interferons|interferons|mesh-list
56517173|NCT01095835|Lamivudine|lamivudine|mesh-list
56517174|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56517175|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
56517176|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517177|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
56517178|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517179|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56517180|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56517182|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517183|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56517184|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56517185|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
56649032|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
56649033|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649034|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56649035|NCT02836847|Trastuzumab|trastuzumab|mesh-list
56649036|NCT02836847|Cetuximab|cetuximab|mesh-list
56649037|NCT02836847|Everolimus|everolimus|mesh-list
56649038|NCT02836847|Sorafenib|sorafenib|mesh-list
56649039|NCT02836847|Lapatinib|lapatinib|mesh-list
56649040|NCT02836847|Gefitinib|gefitinib|mesh-list
56649041|NCT02836847|Crizotinib|crizotinib|mesh-list
56000023|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56517186|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517187|NCT04908865|Belimumab|belimumab|mesh-list
56517188|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517189|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
56517190|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517191|NCT01324232|Quinidine|quinidine|mesh-list
56517192|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
56517193|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
56517194|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
56517195|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56517196|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56517197|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517198|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517199|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517200|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56517201|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56517202|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
56517203|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56517204|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
56517205|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56517206|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56517207|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517208|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517209|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56517210|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56517211|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
56517212|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56517213|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56517214|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56517215|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56517216|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56517217|NCT02878291|Vaccines|vaccines|mesh-list
56517218|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
56517219|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517220|NCT05645432|Pregnanolone|pregnanolone|mesh-list
56517221|NCT05645432|Brexanolone|brexanolone|mesh-list
56517222|NCT05645432|Anesthetics|anesthetics|mesh-ancestor
56517223|NCT05645432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517224|NCT05645432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517225|NCT05645432|Neurosteroids|neurosteroids|mesh-ancestor
56517226|NCT05645432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517227|NCT05645432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517228|NCT05645432|GABA Modulators|gaba modulators|mesh-ancestor
56517229|NCT05645432|GABA Agents|gaba agents|mesh-ancestor
56517230|NCT01323920|Methotrexate|methotrexate|mesh-list
56517231|NCT01323920|Bortezomib|bortezomib|mesh-list
56517232|NCT01323920|Tacrolimus|tacrolimus|mesh-list
56517233|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56517234|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
56517235|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56517236|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517237|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56517238|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
56517239|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517240|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517241|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
56517242|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649042|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649043|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517243|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56517244|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517245|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
56517246|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517247|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56517248|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56517249|NCT01093885|Ambrisentan|ambrisentan|mesh-list
56517250|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56517251|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56517252|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517253|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56517254|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517258|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56517259|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517260|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517261|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
56517262|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517263|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517264|NCT00598377|Cosyntropin|cosyntropin|mesh-list
56517265|NCT00598377|Hormones|hormones|mesh-ancestor
56517266|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517267|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517268|NCT00598533|Sirolimus|sirolimus|mesh-list
56517269|NCT00598533|Probucol|probucol|mesh-list
56517270|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56517271|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517272|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56517273|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517274|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
56517275|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517276|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
56517277|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517278|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56517279|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56517280|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
56517281|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517282|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56517283|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
56517284|NCT00598533|Protective Agents|protective agents|mesh-ancestor
56517285|NCT00598611|Loratadine|loratadine|mesh-list
56517286|NCT00598611|Desloratadine|desloratadine|mesh-list
56517287|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56517288|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
56517289|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517290|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517291|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517292|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56517293|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56517294|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
56517295|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
56517296|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
56517297|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
56517298|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56517299|NCT00599937|Tretinoin|tretinoin|mesh-list
56517300|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517301|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
56517302|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
56517303|NCT00600093|Amantadine|amantadine|mesh-list
56517304|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56265406|NCT01961219|Anesthetics|anesthetics|mesh-list
56517305|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56517306|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
56517307|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517308|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
56517309|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517310|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517311|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517312|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56517313|NCT00600093|Analgesics|analgesics|mesh-ancestor
56517314|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
56517315|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649044|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649045|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
56649046|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649047|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56517316|NCT00600249|Docetaxel|docetaxel|mesh-list
56517317|NCT00600249|Cetuximab|cetuximab|mesh-list
56517318|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517319|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
56517320|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
56517321|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
56517322|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517323|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56517324|NCT00600405|Ibuprofen|ibuprofen|mesh-list
56517325|NCT00600405|Oxycodone|oxycodone|mesh-list
56517326|NCT00600405|Tamsulosin|tamsulosin|mesh-list
56517327|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56517328|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56517332|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517333|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517334|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517335|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56517336|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517337|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517338|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56517339|NCT00600405|Narcotics|narcotics|mesh-ancestor
56517340|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517341|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56517342|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56517343|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56517344|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
56517345|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517346|NCT00600405|Urological Agents|urological agents|mesh-ancestor
56517347|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56517348|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56517349|NCT00600639|Prednisolone|prednisolone|mesh-list
56517350|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56517351|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
56517352|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56517353|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
56517354|NCT00600639|Albuterol|albuterol|mesh-list
56517355|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56517356|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
56517357|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517358|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
56517359|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517360|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
56517361|NCT00600639|Hormones|hormones|mesh-ancestor
56517362|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517363|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517364|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56517365|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517366|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
56517367|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
56517368|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517369|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56517370|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56517371|NCT00600639|Protective Agents|protective agents|mesh-ancestor
56517372|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56517373|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56517374|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
56517375|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
56517376|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56517377|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56517378|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56517379|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56517380|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
56517381|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517382|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517383|NCT00600873|Pramipexole|pramipexole|mesh-list
56517384|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
56517385|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649048|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649049|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649050|NCT02666040|Anesthetics|anesthetics|mesh-list
56649051|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649052|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649053|NCT00894413|Tadalafil|tadalafil|mesh-list
56649054|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
56649055|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56000036|NCT01147042|Interferons|interferons|mesh-list
56517386|NCT00600873|Protective Agents|protective agents|mesh-ancestor
56517387|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517388|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56517389|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56517390|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
56517391|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
56517392|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517393|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
56517394|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
56517395|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517396|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
56517397|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
56517398|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56517399|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517400|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517402|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56517403|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517404|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517406|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56517407|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56517408|NCT00601887|Analgesics|analgesics|mesh-ancestor
56517409|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
56517410|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517411|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517412|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517413|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517414|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56517415|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56517416|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517417|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517418|NCT01325493|Ketamine|ketamine|mesh-list
56517419|NCT01325493|Analgesics|analgesics|mesh-ancestor
56517420|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
56517421|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517422|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517423|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56517424|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56517425|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
56517426|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
56517427|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517428|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56517429|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56517430|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517431|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517432|NCT01325337|Bimatoprost|bimatoprost|mesh-list
56517433|NCT01325337|Minoxidil|minoxidil|mesh-list
56517434|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56517435|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56517436|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
56517437|NCT01324947|Pomalidomide|pomalidomide|mesh-list
56517438|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
56517439|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517440|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56517441|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56517442|NCT01324947|Growth Substances|growth substances|mesh-ancestor
56517443|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
56649056|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56649057|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000042|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
56517444|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517445|NCT01101841|Paroxetine|paroxetine|mesh-list
56517446|NCT01101841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56517447|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56517448|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56517449|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517450|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517451|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
56517452|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517453|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56517454|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
56517455|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56517456|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56517457|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56517458|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517459|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
56517460|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56517461|NCT02877511|Protective Agents|protective agents|mesh-ancestor
56517462|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517463|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
56517464|NCT01324323|Rifampin|rifampin|mesh-list
56517465|NCT01324323|Romidepsin|romidepsin|mesh-list
56168070|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
56517466|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56517467|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
56517468|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56517469|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517470|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
56517471|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56517472|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517474|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56517475|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56517476|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56517477|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56517478|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56517479|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56517480|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56517481|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517482|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56517483|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517484|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56517485|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517486|NCT02879227|Cisplatin|cisplatin|mesh-list
56517487|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
56517488|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517489|NCT01323582|Azithromycin|azithromycin|mesh-list
56517490|NCT01323582|Erythromycin|erythromycin|mesh-list
56517491|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
56517492|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56517493|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
56517494|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56517495|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517496|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56517497|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56517498|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517499|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517500|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
56517501|NCT05367765|HH-GV-678|hh-gv-678|mesh-list
56517502|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517503|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56517504|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517505|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517506|NCT01323621|Fluticasone|fluticasone|mesh-list
56517507|NCT01323621|Xhance|xhance|mesh-list
56517508|NCT01323621|Albuterol|albuterol|mesh-list
56517509|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56517510|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517511|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56517512|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
56649058|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649059|NCT00894413|Urological Agents|urological agents|mesh-ancestor
56649060|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56649061|NCT04250519|Eusol|eusol|mesh-list
56649062|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
56649063|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649064|NCT04172220|Midazolam|midazolam|mesh-list
56649065|NCT04172220|Anesthetics|anesthetics|mesh-list
56649066|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517513|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517514|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517515|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56517516|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
56517517|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
56517518|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56517519|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56517520|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56517521|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56517522|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
56517523|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517524|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517525|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
56517526|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56517527|NCT05645289|Alendronate|alendronate|mesh-list
56517528|NCT05645289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56517529|NCT05645289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517530|NCT01320033|Doxycycline|doxycycline|mesh-list
56517531|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56517532|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517533|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
56517534|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56517535|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56517536|NCT05644743|Gemcitabine|gemcitabine|mesh-list
56517537|NCT05644743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517538|NCT05644743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56517539|NCT05644743|Antimetabolites|antimetabolites|mesh-ancestor
56517540|NCT05644743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517541|NCT05644743|Antiviral Agents|antiviral agents|mesh-ancestor
56517542|NCT05644743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517543|NCT05644743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517544|NCT05644743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517545|NCT05644743|Immunologic Factors|immunologic factors|mesh-ancestor
56517549|NCT01317615|Everolimus|everolimus|mesh-list
56517550|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56517551|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517552|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
56517553|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
56517554|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
56517555|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517556|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517557|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
56517558|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517559|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
56517560|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56517561|NCT01078675|Calcium|calcium|mesh-list
56517562|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56517563|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517564|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56517565|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56517566|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56517567|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
56517568|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517569|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56517570|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56517571|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517572|NCT04926571|Dexamethasone|dexamethasone|mesh-list
56649067|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649068|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56649069|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56649070|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56649071|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649072|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649073|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55946175|NCT04392557|Alogliptin|alogliptin|mesh-list
56517573|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517574|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
56517575|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
56517576|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517577|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517578|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56517579|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
56517580|NCT04926571|Hormones|hormones|mesh-ancestor
56517581|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517582|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56517583|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517584|NCT01100437|Naltrexone|naltrexone|mesh-list
56517585|NCT01100437|Morphine|morphine|mesh-list
56517586|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56517587|NCT01100437|Narcotics|narcotics|mesh-ancestor
56517588|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517589|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517590|NCT01100437|Analgesics|analgesics|mesh-ancestor
56517591|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
56517592|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517593|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56517594|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56517595|NCT01322490|Molgramostim|molgramostim|mesh-list
56517596|NCT01322490|Sargramostim|sargramostim|mesh-list
56517597|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
56517598|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517599|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517600|NCT01314261|Interferons|interferons|mesh-list
56517601|NCT01314261|Ribavirin|ribavirin|mesh-list
56517602|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517603|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
56517604|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517605|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
56265705|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
56168078|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56517606|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517607|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56517608|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56517609|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517611|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56517612|NCT01321710|Analgesics|analgesics|mesh-ancestor
56517613|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
56517614|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517615|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517616|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
56517618|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
56517619|NCT01321008|Doxorubicin|doxorubicin|mesh-list
56517620|NCT01321008|Vincristine|vincristine|mesh-list
56139484|NCT04929223|Cetuximab|cetuximab|mesh-list
56517622|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
56517623|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517624|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517625|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56517626|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
56517627|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517628|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517629|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56517630|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56517631|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56517632|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56517633|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649074|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
56649075|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
56649076|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
56649077|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517634|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517635|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
56517636|NCT01321008|Hormones|hormones|mesh-ancestor
56517637|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517638|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56517639|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56517640|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56517641|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56517642|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56517643|NCT01323530|Capecitabine|capecitabine|mesh-list
56517644|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56517645|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
56517646|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517647|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517648|NCT01313637|Bromides|bromides|mesh-list
56517649|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
56517650|NCT01320722|Vitamin D|vitamin d|mesh-list
56517651|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
56517652|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
56517653|NCT01320722|Vitamins|vitamins|mesh-list
56517654|NCT01320722|Allopurinol|allopurinol|mesh-list
56517655|NCT01320722|Probenecid|probenecid|mesh-list
56517656|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
56517657|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517658|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56517659|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56517660|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
56517661|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517662|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517663|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
56517664|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517665|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56517666|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
56517667|NCT01320722|Protective Agents|protective agents|mesh-ancestor
56517668|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
56517669|NCT01320722|Renal Agents|renal agents|mesh-ancestor
56517670|NCT01313559|Everolimus|everolimus|mesh-list
56517671|NCT01313559|Pasireotide|pasireotide|mesh-list
56517672|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517673|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517674|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
56517675|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517676|NCT01313559|Hormones|hormones|mesh-ancestor
56517677|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517678|NCT05661279|Acetaminophen|acetaminophen|mesh-list
56517679|NCT05661279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56517680|NCT05661279|Analgesics|analgesics|mesh-ancestor
56517681|NCT05661279|Sensory System Agents|sensory system agents|mesh-ancestor
56265781|NCT01964170|Goserelin|goserelin|mesh-list
56517682|NCT05661279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517683|NCT05661279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517684|NCT05661279|Antipyretics|antipyretics|mesh-ancestor
56517685|NCT02890875|Ethanol|ethanol|mesh-list
56517686|NCT02890875|Heparin|heparin|mesh-list
56517687|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
56517688|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56517689|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56517690|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517691|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56517692|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517693|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517694|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517695|NCT01312467|Metformin|metformin|mesh-list
56517699|NCT01310127|Bromfenac|bromfenac|mesh-list
56517700|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56517701|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56517702|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56517703|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56517704|NCT01310127|Analgesics|analgesics|mesh-ancestor
56517705|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
56517706|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649078|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649079|NCT02665806|Fluticasone|fluticasone|mesh-list
56649080|NCT02665806|Ciclesonide|ciclesonide|mesh-list
56517707|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517708|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517709|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517710|NCT01318902|Dexamethasone|dexamethasone|mesh-list
56517711|NCT01318902|Ixazomib|ixazomib|mesh-list
56517712|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517713|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
56517714|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
56517715|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517716|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517717|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56517718|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
56517719|NCT01318902|Hormones|hormones|mesh-ancestor
56517720|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517721|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56517722|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517723|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
56517724|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517725|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517726|NCT01313858|Golimumab|golimumab|mesh-list
56517727|NCT01313858|Methotrexate|methotrexate|mesh-list
56517728|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56517729|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
56517730|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56517731|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517732|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56517733|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
56517734|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517735|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517736|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
56517737|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517738|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56517739|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517740|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
56517741|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517742|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56517743|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56517744|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517745|NCT01313780|Oxycodone|oxycodone|mesh-list
56517746|NCT01313780|Naloxone|naloxone|mesh-list
56517747|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56517748|NCT01313780|Narcotics|narcotics|mesh-ancestor
56168093|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56517749|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517750|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517752|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
56517753|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517754|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56517755|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56517756|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
56517757|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517759|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
56517760|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56517761|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
56517762|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56517763|NCT01170208|Insulin|insulin|mesh-list
56517764|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56517765|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517766|NCT02891018|Paclitaxel|paclitaxel|mesh-list
56517767|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56517768|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56517769|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517778|NCT01169038|Rifampin|rifampin|mesh-list
56517779|NCT01169038|Ethambutol|ethambutol|mesh-list
56517780|NCT01169038|Levofloxacin|levofloxacin|mesh-list
56517781|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56517782|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517783|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56517784|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
56517785|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
56649081|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56649082|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56649083|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
56649084|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517786|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56517787|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517788|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517789|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56517790|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56517791|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56517792|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56517793|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56517794|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56517795|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56517796|NCT01169038|Renal Agents|renal agents|mesh-ancestor
56517797|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56517798|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56517799|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517800|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56517801|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56517802|NCT00624754|Budesonide|budesonide|mesh-list
56517803|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
56517804|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517805|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56517806|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
56517807|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517808|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517809|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56517810|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
56517811|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
56517812|NCT00624754|Hormones|hormones|mesh-ancestor
56517813|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517814|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56517815|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56517816|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56517817|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
56168095|NCT00357240|Ritonavir|ritonavir|mesh-list
56517819|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517820|NCT01114828|Tolvaptan|tolvaptan|mesh-list
56517821|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56517822|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517823|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
56517824|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517825|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
56517826|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56517827|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56517828|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56517829|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56265966|NCT01964846|Curcumin|curcumin|mesh-list
56517830|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517831|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
56517832|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866583|NCT01889069|Prednisone|prednisone|mesh-list
56517839|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517840|NCT01114672|Vitamins|vitamins|mesh-ancestor
56517841|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
56517842|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56517843|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56517844|NCT01114516|Clindamycin|clindamycin|mesh-list
56517845|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
56517846|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
56517847|NCT01114516|Cefazolin|cefazolin|mesh-list
56517848|NCT01114516|Indomethacin|indomethacin|mesh-list
56517849|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517850|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56517851|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517852|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517853|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56517854|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56649085|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649086|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56649087|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
55946468|NCT04385940|Vitamin D|vitamin d|mesh-list
56517855|NCT01114516|Analgesics|analgesics|mesh-ancestor
56517856|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
56517857|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517858|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517859|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517860|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517861|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
56517862|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
56517863|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56517864|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56517865|NCT01313078|Asparaginase|asparaginase|mesh-list
56517866|NCT01313078|Pegaspargase|pegaspargase|mesh-list
56517867|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517868|NCT01114360|Melatonin|melatonin|mesh-list
56517869|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
56517870|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517871|NCT01114360|Protective Agents|protective agents|mesh-ancestor
56517872|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517873|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56517874|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56517875|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517876|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56517877|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517878|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517879|NCT01075321|Lenalidomide|lenalidomide|mesh-list
56517880|NCT01075321|Everolimus|everolimus|mesh-list
56517881|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
56517882|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517883|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56517884|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56517885|NCT01075321|Growth Substances|growth substances|mesh-ancestor
56517886|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
56517887|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517888|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517889|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56517890|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56517891|NCT01114204|Hematinics|hematinics|mesh-ancestor
56517892|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56517893|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56517894|NCT01075243|Acetaminophen|acetaminophen|mesh-list
56517895|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56517896|NCT01075243|Analgesics|analgesics|mesh-ancestor
56517897|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
56517898|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517899|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517900|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
56517901|NCT01078441|Dexamethasone|dexamethasone|mesh-list
56517902|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
56517903|NCT01078441|Doxorubicin|doxorubicin|mesh-list
56517906|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517907|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
56517908|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517909|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517910|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56517911|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
56517912|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517913|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517914|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56517915|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56517916|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
56517917|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
56517918|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517919|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56517920|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
56517921|NCT01078441|Hormones|hormones|mesh-ancestor
56517922|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56517923|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56517924|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56649088|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
56649089|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56649090|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
56649091|NCT02665806|Hormones|hormones|mesh-ancestor
56649092|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649093|NCT00646386|Adalimumab|adalimumab|mesh-list
56649094|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56649095|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56649096|NCT00647634|Alprazolam|alprazolam|mesh-list
56649097|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56649098|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649099|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649100|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56517925|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56517926|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56517927|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517928|NCT05644184|Vaccines|vaccines|mesh-list
56517929|NCT05644184|Immunologic Factors|immunologic factors|mesh-ancestor
56517930|NCT05644184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517931|NCT00626665|Tadalafil|tadalafil|mesh-list
56517932|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
56517933|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56517934|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56517935|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517936|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517937|NCT00626665|Urological Agents|urological agents|mesh-ancestor
56517938|NCT01090063|Ustekinumab|ustekinumab|mesh-list
56517939|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
56517940|NCT01306214|Empagliflozin|empagliflozin|mesh-list
56517941|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56517942|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517943|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56517944|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517945|NCT00623402|Interferons|interferons|mesh-list
56517946|NCT00623402|Sorafenib|sorafenib|mesh-list
56517947|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517948|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
56517949|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56517950|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56517951|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517952|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517953|NCT01077739|Leucovorin|leucovorin|mesh-list
56517954|NCT01077739|Bevacizumab|bevacizumab|mesh-list
56517955|NCT01077739|Fluorouracil|fluorouracil|mesh-list
56517956|NCT01077739|Capecitabine|capecitabine|mesh-list
56517957|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
56517958|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56517959|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517960|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56517961|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56517962|NCT01077739|Growth Substances|growth substances|mesh-ancestor
56517963|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517964|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
56517965|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
56517966|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517967|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56517968|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517969|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
56517970|NCT01077739|Antidotes|antidotes|mesh-ancestor
56517971|NCT01077739|Protective Agents|protective agents|mesh-ancestor
56517972|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
56517973|NCT01077739|Vitamins|vitamins|mesh-ancestor
56517974|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
56517975|NCT01306058|Sorafenib|sorafenib|mesh-list
56649101|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649102|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649103|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
56649104|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
55946624|NCT02043457|Hormones|hormones|mesh-list
56517976|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517977|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56517978|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517988|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517989|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517990|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56517991|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56517992|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56517993|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
56517994|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517995|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517996|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517997|NCT02877901|Urological Agents|urological agents|mesh-ancestor
56517998|NCT04306159|Anesthetics|anesthetics|mesh-list
56517999|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518000|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518001|NCT01305200|Calcium|calcium|mesh-list
56518002|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56518003|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518004|NCT01304498|Vaccines|vaccines|mesh-list
56518005|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
56518006|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518007|NCT01074931|Ritonavir|ritonavir|mesh-list
56518008|NCT01074931|Lopinavir|lopinavir|mesh-list
56518009|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56518010|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56518011|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
56518012|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518013|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518014|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56518015|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56518016|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
56518017|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518018|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56518019|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56518020|NCT04774159|Colchicine|colchicine|mesh-list
56518021|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
56518022|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56518023|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
56518024|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
56518025|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
56518026|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518027|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518028|NCT01303172|Gemcitabine|gemcitabine|mesh-list
56518029|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56518030|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
56518031|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518032|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518033|NCT01303172|Antiviral Agents|antiviral agents|mesh-ancestor
56518034|NCT01303172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518035|NCT01303172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518036|NCT01303172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56518037|NCT01303172|Immunologic Factors|immunologic factors|mesh-ancestor
56518038|NCT01303172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518039|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56518040|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56518041|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56518042|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
56518043|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518045|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518046|NCT01302938|Urological Agents|urological agents|mesh-ancestor
56518047|NCT01076647|Insulin|insulin|mesh-list
56518048|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56518049|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
56518050|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56518051|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518052|NCT04306081|Evolocumab|evolocumab|mesh-list
56649105|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649106|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649107|NCT04172064|Dobutamine|dobutamine|mesh-list
56518053|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56518054|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56518055|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
56266154|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
56518056|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518057|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56518058|NCT01074307|Bisoprolol|bisoprolol|mesh-list
56518059|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56518060|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
56518061|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
56518062|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518063|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518064|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56518065|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56518066|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56518067|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
56518068|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518069|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518070|NCT01076335|Docetaxel|docetaxel|mesh-list
56518071|NCT01076335|Leuprolide|leuprolide|mesh-list
56518072|NCT01076335|Goserelin|goserelin|mesh-list
56518073|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518074|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
56518075|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
56518076|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
56518077|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518078|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56518079|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
56518080|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56518081|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518082|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56518083|NCT01309737|Tofacitinib|tofacitinib|mesh-list
56518084|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56518085|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518086|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518087|NCT01074229|Ropivacaine|ropivacaine|mesh-list
56518088|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
56518089|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
56518090|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518091|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518092|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
56518093|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518094|NCT01106014|Selexipag|selexipag|mesh-list
56518095|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56518096|NCT01105936|Acetaminophen|acetaminophen|mesh-list
56518097|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56518098|NCT01105936|Analgesics|analgesics|mesh-ancestor
56518099|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
56518100|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518101|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518102|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
56518103|NCT01309659|Iron|iron|mesh-list
56518104|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56518105|NCT01309659|Trace Elements|trace elements|mesh-ancestor
56518106|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
56518107|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518108|NCT01309659|Hematinics|hematinics|mesh-ancestor
56518109|NCT04989166|Curcumin|curcumin|mesh-list
56518110|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56518111|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56518112|NCT04989166|Analgesics|analgesics|mesh-ancestor
56518113|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
56518114|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518115|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518116|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518117|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56518119|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518120|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518121|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
56518122|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56649108|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56649109|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
56649110|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
56649111|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649112|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518123|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518124|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518125|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56518126|NCT05320705|Analgesics|analgesics|mesh-ancestor
56518127|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
56518128|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518129|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56518130|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56518131|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56518132|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
56518133|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518134|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518136|NCT04746235|Venetoclax|venetoclax|mesh-list
56518137|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56518138|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
56518139|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518140|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518141|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518142|NCT01104766|Aripiprazole|aripiprazole|mesh-list
56518143|NCT01104766|Cariprazine|cariprazine|mesh-list
56518144|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
56518145|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56518146|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56518147|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56518148|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518149|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518150|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
56518151|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
56518152|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518153|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518154|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56518155|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56518156|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
56518157|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56518158|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56518159|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56518160|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56518161|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56518162|NCT02880280|Menotropins|menotropins|mesh-list
56518163|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56518164|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518165|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56518166|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
56518167|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
56518168|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56518169|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518170|NCT01104376|Efavirenz|efavirenz|mesh-list
56518171|NCT01104376|Voriconazole|voriconazole|mesh-list
56518172|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56518173|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56518174|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518175|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518176|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
56518177|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518178|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56518179|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56518180|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56518181|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56518182|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56518183|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56518184|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
56518185|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56518186|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56649113|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56649114|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56649115|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56649116|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
56649117|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649118|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649119|NCT04172064|Protective Agents|protective agents|mesh-ancestor
56649120|NCT00647712|Valproic Acid|valproic acid|mesh-list
56649121|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
56518187|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
56518188|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518190|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56518191|NCT02875873|Methamphetamine|methamphetamine|mesh-list
56518192|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
56518193|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56518194|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518195|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
56518196|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
56518197|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518198|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
56518199|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518200|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518201|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
56518202|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56518203|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56518204|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56518205|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56518206|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56518207|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56518209|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56518210|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56518211|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518212|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56518213|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56518214|NCT01072357|Growth Substances|growth substances|mesh-ancestor
56518215|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518216|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
56518217|NCT01072357|Laxatives|laxatives|mesh-ancestor
56518218|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56518219|NCT01072201|Triclosan|triclosan|mesh-list
56518220|NCT01072201|Fluorides|fluorides|mesh-list
56518221|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
56518222|NCT01072201|Protective Agents|protective agents|mesh-ancestor
56518223|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518224|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56518225|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518226|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56518227|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56518228|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
56518229|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518230|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56518231|NCT02893709|Omeprazole|omeprazole|mesh-list
56518232|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56518233|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56518234|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56518235|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518236|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518237|NCT04972396|Metformin|metformin|mesh-list
56518238|NCT04972396|Digoxin|digoxin|mesh-list
56518239|NCT04972396|Warfarin|warfarin|mesh-list
56518240|NCT04972396|Atorvastatin|atorvastatin|mesh-list
56518241|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
56518242|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56518243|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56518244|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518245|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56649122|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649123|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649124|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
56649125|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649126|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649127|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
56649128|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649129|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649130|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649131|NCT04173390|Pregabalin|pregabalin|mesh-list
56649132|NCT04173390|Analgesics|analgesics|mesh-ancestor
56649133|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
56518246|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56518247|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
56518248|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518249|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56518250|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56518251|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518252|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
56518253|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56518254|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
56518255|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56518256|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56518257|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56518258|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56518259|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56518260|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56518261|NCT04972396|Protective Agents|protective agents|mesh-ancestor
56518262|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56518263|NCT04972396|Estrogens|estrogens|mesh-ancestor
56518266|NCT01089361|Ketamine|ketamine|mesh-list
56518267|NCT01089361|Analgesics|analgesics|mesh-ancestor
56518268|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
56518269|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518270|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518271|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56518272|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56518273|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
56518274|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
56518275|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518276|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56518277|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56518278|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518279|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518280|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56518281|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56518282|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56518283|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56518284|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518285|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518286|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
56518287|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518288|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56518289|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56518290|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56518291|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56518292|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
56518293|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
56518294|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56518295|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518296|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
56518297|NCT02893553|Midodrine|midodrine|mesh-list
56649134|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649135|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518298|NCT02893553|Bromides|bromides|mesh-list
56518299|NCT02893553|Mirabegron|mirabegron|mesh-list
56518300|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56518301|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
56518302|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56518303|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56518304|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56518305|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
56518306|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518307|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518308|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518309|NCT02893553|Urological Agents|urological agents|mesh-ancestor
56518310|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
56518311|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
56518312|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518313|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56518314|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56518315|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56518316|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56518317|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518318|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
56518319|NCT01087489|Lidocaine|lidocaine|mesh-list
56518320|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
56518321|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
56518322|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518323|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518324|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
56518325|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518326|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56518327|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56518328|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56518329|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56518330|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518331|NCT04306627|Amlodipine|amlodipine|mesh-list
56518332|NCT04306627|Perindopril|perindopril|mesh-list
56518333|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56518334|NCT04306627|Atorvastatin|atorvastatin|mesh-list
56140232|NCT03884998|Nivolumab|nivolumab|mesh-list
56518336|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56518337|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
56518338|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518339|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56518340|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56518341|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518342|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56518343|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56518344|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56518345|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56518346|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518347|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
56518348|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56518349|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
56518350|NCT04306471|Evolocumab|evolocumab|mesh-list
56518351|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56518352|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56518353|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
56518354|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518355|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56518356|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56518358|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
56518359|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518360|NCT01082965|Donepezil|donepezil|mesh-list
56518361|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56518362|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518363|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518364|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
56518365|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518366|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518367|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
56649136|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
56649137|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56649138|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56649139|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649140|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56518368|NCT01102426|Dexamethasone|dexamethasone|mesh-list
56518369|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518370|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
56518371|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
56518372|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518373|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518374|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56518375|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
56518376|NCT01102426|Hormones|hormones|mesh-ancestor
56518377|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518378|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56518379|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518380|NCT04308850|Vitamin D|vitamin d|mesh-list
56518381|NCT04308850|Vitamins|vitamins|mesh-ancestor
56518382|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
56518383|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518384|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56518385|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56518386|NCT01101334|Efatutazone|efatutazone|mesh-list
56518387|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518388|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56518389|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518390|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518391|NCT01327547|Maraviroc|maraviroc|mesh-list
56518392|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56518393|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56518394|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518395|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56518396|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56518397|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
56518398|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518399|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56518400|NCT01308567|Prednisone|prednisone|mesh-list
56518401|NCT01308567|Docetaxel|docetaxel|mesh-list
56518402|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518403|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
56518404|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
56518405|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
56518406|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518407|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140303|NCT03617679|Rucaparib|rucaparib|mesh-list
56518410|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518411|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518412|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56518413|NCT04381091|Idebenone|idebenone|mesh-list
56518414|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
56518415|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518416|NCT04381091|Protective Agents|protective agents|mesh-ancestor
56518417|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518418|NCT00592241|Insulin|insulin|mesh-list
56518419|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56518420|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56518421|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518422|NCT02890719|Ribavirin|ribavirin|mesh-list
56518423|NCT02890719|Grazoprevir|grazoprevir|mesh-list
56518424|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
56518425|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518426|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
56518427|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266525|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518428|NCT04325061|Dexamethasone|dexamethasone|mesh-list
56518429|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
56518430|NCT04325061|BB 1101|bb 1101|mesh-list
56518431|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518432|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
56649141|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56649142|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649143|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649144|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56518433|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
56518434|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518435|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518436|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56518437|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
56518438|NCT04325061|Hormones|hormones|mesh-ancestor
56518439|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518440|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56518441|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518442|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
56518443|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518444|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518445|NCT01307319|Beclomethasone|beclomethasone|mesh-list
56518446|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518447|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
56518448|NCT01307319|Hormones|hormones|mesh-ancestor
56518449|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518450|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518451|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56518452|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
56518453|NCT04365725|Remdesivir|remdesivir|mesh-list
56518454|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
56518455|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518456|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
56518457|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518458|NCT01080391|Dexamethasone|dexamethasone|mesh-list
56518459|NCT01080391|Lenalidomide|lenalidomide|mesh-list
56518460|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518461|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
56518462|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
56518463|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518464|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518465|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56518466|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
56518468|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518469|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56518470|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518471|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
56518472|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56518473|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56518474|NCT01080391|Growth Substances|growth substances|mesh-ancestor
56518475|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
56518476|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56518477|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56518478|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56518479|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56518480|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518482|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518483|NCT01070329|Analgesics|analgesics|mesh-ancestor
56518484|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
56518485|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518486|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
56518487|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56518488|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
56518489|NCT04327427|Aspirin|aspirin|mesh-list
56518490|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56518491|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56518492|NCT04327427|Analgesics|analgesics|mesh-ancestor
56518493|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
56518494|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518495|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518496|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518497|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56518498|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56518499|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56649145|NCT04895202|Siponimod|siponimod|mesh-list
56649146|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56649147|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649148|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649149|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
56649150|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518500|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518501|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56518502|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56518503|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518504|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
56518505|NCT02875717|Aspirin|aspirin|mesh-list
56518506|NCT02875717|Heparin|heparin|mesh-list
56518507|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56518508|NCT02875717|Tinzaparin|tinzaparin|mesh-list
56518509|NCT02875717|Dalteparin|dalteparin|mesh-list
56518510|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
56518511|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56518512|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56518513|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518514|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56518515|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56518516|NCT02875717|Analgesics|analgesics|mesh-ancestor
56518517|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
56518518|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518519|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518520|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518521|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56518522|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56518523|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56518524|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518525|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
56518526|NCT04334837|Copper|copper|mesh-list
56518527|NCT04334837|Trace Elements|trace elements|mesh-ancestor
56518528|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
56518529|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518530|NCT00593099|Bupropion|bupropion|mesh-list
56518531|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56518532|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
56518533|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56518534|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56518535|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56518536|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56518537|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518538|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
56518539|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518540|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518541|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56518542|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56518543|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518544|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
56518545|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56518546|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518547|NCT00593255|Insulin|insulin|mesh-list
56518548|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56518549|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
56518550|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
56518551|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
56518552|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
56518553|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56518554|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518555|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
56518559|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56518560|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
56518561|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518562|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518563|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56518564|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56649151|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
56649152|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649153|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649154|NCT00647868|Testosterone|testosterone|mesh-list
56518565|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
56518566|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518567|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518568|NCT00594191|Simvastatin|simvastatin|mesh-list
56518569|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56518570|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56518571|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
56518572|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518573|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56518574|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56518575|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518576|NCT00594269|Risperidone|risperidone|mesh-list
56518577|NCT00594269|Citalopram|citalopram|mesh-list
56518578|NCT00594269|Sertraline|sertraline|mesh-list
56518579|NCT00594269|Paroxetine|paroxetine|mesh-list
56518580|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56518581|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
56518582|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518583|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518584|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518585|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56518586|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56518587|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518588|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56518589|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56518590|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
56518591|NCT00594269|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56518592|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56518593|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56518594|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56518595|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
56518596|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56518597|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56518598|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518599|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56518600|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
56518601|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518602|NCT04326959|Triamcinolone|triamcinolone|mesh-list
56518603|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56518604|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56518605|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56518606|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518607|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
56518608|NCT04326959|Hormones|hormones|mesh-ancestor
56518609|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518610|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518611|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56518612|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
56518613|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518614|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518615|NCT00594737|Memantine|memantine|mesh-list
56518616|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56518617|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56518618|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
56518619|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518620|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518621|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518622|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56518623|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56518624|NCT00595049|Bosentan|bosentan|mesh-list
56518625|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56518626|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56518629|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518630|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56518632|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649155|NCT00647868|Androgens|androgens|mesh-ancestor
56649156|NCT00647868|Hormones|hormones|mesh-ancestor
56649157|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649158|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518633|NCT00596063|Insulin|insulin|mesh-list
56518634|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56518635|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518636|NCT00596219|Celecoxib|celecoxib|mesh-list
56518637|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56518638|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56518639|NCT00596219|Analgesics|analgesics|mesh-ancestor
56518640|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
56518641|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518642|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518643|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518644|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56518645|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56518646|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56518647|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518648|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518649|NCT00596297|Bevacizumab|bevacizumab|mesh-list
56518650|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56518651|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518652|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56518653|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56518654|NCT00596297|Growth Substances|growth substances|mesh-ancestor
56518655|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518656|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
56518657|NCT00596375|Lidocaine|lidocaine|mesh-list
56518658|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
56518659|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
56518660|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518661|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518662|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
56518663|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518664|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56518665|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56518666|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56518667|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56518668|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518669|NCT00596531|Acamprosate|acamprosate|mesh-list
56518670|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56518671|NCT00596609|Morphine|morphine|mesh-list
56518672|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56518673|NCT00596609|Narcotics|narcotics|mesh-ancestor
56518674|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518675|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518676|NCT00596609|Analgesics|analgesics|mesh-ancestor
56518677|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
56518678|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518679|NCT04326803|Vaccines|vaccines|mesh-list
56518680|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
56518681|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518682|NCT00597233|Insulin|insulin|mesh-list
56518683|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56518684|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
56518685|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
56518686|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
56518687|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
56518688|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56518689|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518690|NCT01064401|Interferons|interferons|mesh-list
56518691|NCT01064401|Interferon-beta|interferon-beta|mesh-list
56518692|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
56518693|NCT01064401|Daclizumab|daclizumab|mesh-list
56518694|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518695|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
56518696|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518697|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
56518698|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518699|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56518700|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649159|NCT00647946|Tenofovir|tenofovir|mesh-list
56649160|NCT00647946|Abacavir|abacavir|mesh-list
56649161|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
56649162|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649163|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56649164|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56649165|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649166|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649167|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56649168|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56649169|NCT00648024|Anagrelide|anagrelide|mesh-list
56649170|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56649171|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56000133|NCT05479032|Amantadine|amantadine|mesh-list
56518701|NCT00597389|Propranolol|propranolol|mesh-list
56518702|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56518703|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56518704|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
56518705|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518706|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518707|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518708|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56518709|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56518710|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
56518711|NCT01306617|Ritonavir|ritonavir|mesh-list
56518712|NCT01306617|Ribavirin|ribavirin|mesh-list
56518713|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56518714|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56518715|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
56518716|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518717|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518718|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56518719|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56518720|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
56518721|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518722|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56518723|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56518724|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
56518725|NCT00597623|Adalimumab|adalimumab|mesh-list
56518726|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518727|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56518729|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518730|NCT00627133|Levetiracetam|levetiracetam|mesh-list
56518731|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
56518732|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
56518733|NCT00598013|Pioglitazone|pioglitazone|mesh-list
56518734|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56518735|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518736|NCT04303429|Capecitabine|capecitabine|mesh-list
56518737|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56518738|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
56518739|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518740|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518741|NCT00598091|Gemcitabine|gemcitabine|mesh-list
56518742|NCT00598091|Dasatinib|dasatinib|mesh-list
56518743|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56518744|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
56518745|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518746|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518747|NCT00598091|Antiviral Agents|antiviral agents|mesh-ancestor
56518748|NCT00598091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518749|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518750|NCT00598091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56518751|NCT00598091|Immunologic Factors|immunologic factors|mesh-ancestor
56649172|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649173|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56649174|NCT04685616|Doxorubicin|doxorubicin|mesh-list
56649175|NCT04685616|Bleomycin|bleomycin|mesh-list
56518752|NCT00598091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518753|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56518754|NCT00623415|Flupirtine|flupirtine|mesh-list
56518755|NCT00623415|Analgesics|analgesics|mesh-ancestor
56518756|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
56518757|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518758|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518759|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
56518760|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
56518761|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56518762|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56518763|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518764|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518765|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518766|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56518767|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
56518768|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518769|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
56518770|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56518771|NCT00598169|Dexamethasone|dexamethasone|mesh-list
56518772|NCT00598169|Rituximab|rituximab|mesh-list
56518773|NCT00598169|Carboplatin|carboplatin|mesh-list
56518774|NCT00598169|Etoposide|etoposide|mesh-list
56518775|NCT00598169|Bortezomib|bortezomib|mesh-list
56518776|NCT00598169|Ifosfamide|ifosfamide|mesh-list
56518777|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56518778|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518780|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518782|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518783|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
56518784|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
56518785|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518786|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56518787|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
56518788|NCT00598169|Hormones|hormones|mesh-ancestor
56518789|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518790|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56518791|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56518792|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56518793|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56518794|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518795|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518796|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56518797|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
56518798|NCT00598247|Paclitaxel|paclitaxel|mesh-list
56518799|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56518800|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56518801|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518802|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
56518803|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
56518804|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
56518805|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518806|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
56518807|NCT00598403|Cefditoren|cefditoren|mesh-list
56518808|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
56518809|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56518810|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518811|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56518812|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56518813|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518814|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518816|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56518817|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56518818|NCT00598637|Everolimus|everolimus|mesh-list
56518819|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518820|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56518821|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
56113561|NCT00281879|Carmustine|carmustine|mesh-list
56649176|NCT04685616|Dacarbazine|dacarbazine|mesh-list
56649177|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56649178|NCT04685616|Vinblastine|vinblastine|mesh-list
56649179|NCT04685616|Mitogens|mitogens|mesh-list
56649180|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56518822|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518823|NCT00598715|Sirolimus|sirolimus|mesh-list
56518824|NCT00598715|Paclitaxel|paclitaxel|mesh-list
56518825|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56518826|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518827|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
56518828|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
56518829|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
56518830|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518831|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56518832|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518833|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56518834|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
56518835|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56518836|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
56518837|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518838|NCT00598793|Insulin|insulin|mesh-list
56518839|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56518840|NCT00598793|Metformin|metformin|mesh-list
56518841|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
56518842|NCT00598793|Pioglitazone|pioglitazone|mesh-list
56518843|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
56518844|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
56518845|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56518846|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518847|NCT01326845|Deferasirox|deferasirox|mesh-list
56518848|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56518849|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
56518850|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
56518851|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518852|NCT01062763|Spironolactone|spironolactone|mesh-list
56518853|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56518855|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518856|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518858|NCT01062763|Diuretics|diuretics|mesh-ancestor
56518859|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
56518860|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
56518861|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56518862|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
56518863|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518864|NCT00599573|Ondansetron|ondansetron|mesh-list
56518865|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
56518866|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
56518867|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518868|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518869|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56518870|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
56518871|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
56518872|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56518873|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
56518874|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518875|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518876|NCT00599573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56518877|NCT00599573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56518878|NCT00599573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56518879|NCT00599573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56518880|NCT00599573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56518881|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56518882|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
56518883|NCT01048099|Trastuzumab|trastuzumab|mesh-list
56518885|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56518886|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518887|NCT00599807|Vitamin D|vitamin d|mesh-list
56518888|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
56518889|NCT00599807|Vitamins|vitamins|mesh-ancestor
56518890|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
56518891|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518892|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56649181|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649182|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56649183|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56649184|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518893|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56518894|NCT00599885|Valsartan|valsartan|mesh-list
56518895|NCT00599885|Telmisartan|telmisartan|mesh-list
56518896|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56518897|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56518898|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56518899|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518900|NCT01303965|Sirolimus|sirolimus|mesh-list
56518901|NCT01303965|Lenalidomide|lenalidomide|mesh-list
56518902|NCT01303965|Tacrolimus|tacrolimus|mesh-list
56518903|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56518904|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
56518905|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518906|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56518907|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518908|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518909|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56518910|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56518911|NCT01303965|Growth Substances|growth substances|mesh-ancestor
56518912|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
56518913|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518914|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56518915|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518916|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56518917|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
56518918|NCT00600041|Pantoprazole|pantoprazole|mesh-list
56518919|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56518920|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56518921|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56518922|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518923|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518924|NCT01045993|Analgesics|analgesics|mesh-list
56518925|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
56518926|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518927|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518928|NCT00600509|Levetiracetam|levetiracetam|mesh-list
56518940|NCT00600587|Carboplatin|carboplatin|mesh-list
56518941|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56518942|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518943|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56518944|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
56518945|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518946|NCT00600587|Antiviral Agents|antiviral agents|mesh-ancestor
56518947|NCT00600587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518948|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518949|NCT00600587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56518950|NCT00600587|Immunologic Factors|immunologic factors|mesh-ancestor
56518951|NCT00600587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518952|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56518953|NCT01045447|Insulin|insulin|mesh-list
56518954|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56518955|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
56518956|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
56518957|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56518959|NCT00623207|Atropine|atropine|mesh-list
56518960|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56518961|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56518962|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56518964|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518965|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518966|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56518967|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
56518968|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
56518969|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
56518970|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56518971|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56518972|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
56518973|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649185|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649186|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
56649187|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56518974|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518975|NCT00600977|Doxorubicin|doxorubicin|mesh-list
56518976|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56518977|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56518978|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518979|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56518980|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56518981|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518982|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518983|NCT04695847|Antibodies|antibodies|mesh-list
56518984|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
56518985|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
56518986|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56518987|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
56518988|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518989|NCT00601211|Pilocarpine|pilocarpine|mesh-list
56518990|NCT00601211|Miotics|miotics|mesh-ancestor
56518991|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
56518992|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56518993|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518994|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56518995|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56518996|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
56518997|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518999|NCT00601289|Temozolomide|temozolomide|mesh-list
56519000|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56519001|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
56519002|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519003|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519004|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56519005|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519006|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56519007|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519008|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519009|NCT00601991|Aflibercept|aflibercept|mesh-list
56519010|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
56519011|NCT00601991|Growth Substances|growth substances|mesh-ancestor
56519012|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519013|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56519014|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56519015|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
56519016|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519017|NCT01301391|Maleic acid|maleic acid|mesh-list
56519018|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519019|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519020|NCT04325633|Naproxen|naproxen|mesh-list
56519021|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56519022|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56519023|NCT04325633|Analgesics|analgesics|mesh-ancestor
56519024|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
56519025|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519026|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519027|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519028|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519029|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
56519030|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56519031|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519032|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519034|NCT05643651|Vitamin K|vitamin k|mesh-list
56519035|NCT05643651|Warfarin|warfarin|mesh-list
56519036|NCT05643651|Rivaroxaban|rivaroxaban|mesh-list
56519037|NCT05643651|Clopidogrel|clopidogrel|mesh-list
56519038|NCT05643651|Vitamins|vitamins|mesh-ancestor
56519039|NCT05643651|Micronutrients|micronutrients|mesh-ancestor
56519040|NCT05643651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519041|NCT05643651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56519042|NCT05643651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56519043|NCT05643651|Analgesics|analgesics|mesh-ancestor
56113562|NCT00281879|Methotrexate|methotrexate|mesh-list
56649188|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
56649189|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649190|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56649191|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
56649192|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
56649193|NCT02665416|Bevacizumab|bevacizumab|mesh-list
56519044|NCT05643651|Sensory System Agents|sensory system agents|mesh-ancestor
56519045|NCT05643651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519046|NCT05643651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519047|NCT05643651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519048|NCT05643651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56519049|NCT05643651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56519050|NCT05643651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519051|NCT05643651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56519052|NCT05643651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56519053|NCT05643651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519054|NCT05643651|Antipyretics|antipyretics|mesh-ancestor
56519055|NCT05643651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56519056|NCT05643651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56519057|NCT05643651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56519058|NCT05643651|Purinergic Agents|purinergic agents|mesh-ancestor
56519059|NCT05643651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519060|NCT05643651|Anticoagulants|anticoagulants|mesh-ancestor
56519061|NCT05643651|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56519062|NCT05643651|Antithrombins|antithrombins|mesh-ancestor
56519063|NCT05643651|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56519064|NCT05643651|Protease Inhibitors|protease inhibitors|mesh-ancestor
56519065|NCT05643651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56519066|NCT05643651|Hemostatics|hemostatics|mesh-ancestor
56519067|NCT05643651|Coagulants|coagulants|mesh-ancestor
56519068|NCT01061359|Epirubicin|epirubicin|mesh-list
56519069|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56519070|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519071|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56140969|NCT04386876|Ritonavir|ritonavir|mesh-list
56519075|NCT05643417|Bevacizumab|bevacizumab|mesh-list
56519076|NCT05643417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56519077|NCT05643417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519078|NCT05643417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56519079|NCT05643417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56519080|NCT05643417|Growth Substances|growth substances|mesh-ancestor
56519081|NCT05643417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519082|NCT05643417|Growth Inhibitors|growth inhibitors|mesh-ancestor
56519083|NCT04303741|Apatinib|apatinib|mesh-list
56519084|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519085|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56519086|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519087|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519088|NCT00626977|Clonidine|clonidine|mesh-list
56519089|NCT00626977|Ropivacaine|ropivacaine|mesh-list
56519090|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
56519091|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
56519092|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519093|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519094|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
56519095|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519096|NCT00626977|Analgesics|analgesics|mesh-ancestor
56519097|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56519098|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
56519099|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
56519100|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56519101|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56519102|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56519103|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
56519104|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519105|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519106|NCT04303819|Exenatide|exenatide|mesh-list
56267202|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56519108|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519109|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56649194|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649195|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649196|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56649197|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56649198|NCT02665416|Growth Substances|growth substances|mesh-ancestor
56649199|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649200|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
56649201|NCT00646620|Fluticasone|fluticasone|mesh-list
56649202|NCT00646620|Budesonide|budesonide|mesh-list
56649203|NCT00646620|Albuterol|albuterol|mesh-list
56649204|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
56519110|NCT04303819|Incretins|incretins|mesh-ancestor
56519112|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519113|NCT01301079|Ketamine|ketamine|mesh-list
56519114|NCT01301079|Analgesics|analgesics|mesh-ancestor
56519115|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
56519116|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519117|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519118|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56519119|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56519120|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
56519121|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
56519122|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519123|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56519124|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56519125|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519126|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519127|NCT05271721|Dexamethasone|dexamethasone|mesh-list
56519128|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
56519129|NCT05271721|BB 1101|bb 1101|mesh-list
56519130|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519131|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
56519132|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
56519133|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519134|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519135|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56519136|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
56519137|NCT05271721|Hormones|hormones|mesh-ancestor
56519138|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519139|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56519140|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519141|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
56519142|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519143|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519199|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56519200|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
56519201|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519202|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519203|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519204|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56519205|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56519206|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56519207|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519208|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519209|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56519210|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
56519211|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
56519212|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519213|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56519214|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56519215|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56519216|NCT01035463|Growth Substances|growth substances|mesh-ancestor
56519217|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
56649205|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56649206|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56649207|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56649208|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56649209|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56649210|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
56649211|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519218|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56519220|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56519221|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
56519222|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
56519223|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
56519224|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
56519225|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
56519226|NCT01300923|Acamprosate|acamprosate|mesh-list
56519227|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56519228|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
56519229|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
56519230|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519231|NCT02890173|Eplerenone|eplerenone|mesh-list
56519232|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56519233|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
56519234|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519235|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519236|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56519237|NCT02890173|Diuretics|diuretics|mesh-ancestor
56519238|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
56519239|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56519240|NCT01300455|Suvorexant|suvorexant|mesh-list
56519241|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56519242|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56519243|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519244|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519245|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56519246|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519247|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519248|NCT01101178|Oxycodone|oxycodone|mesh-list
56519249|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56519250|NCT01101178|Narcotics|narcotics|mesh-ancestor
56519251|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519252|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519253|NCT01101178|Analgesics|analgesics|mesh-ancestor
56519254|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
56519255|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519256|NCT05637645|Bupivacaine|bupivacaine|mesh-list
56519257|NCT05637645|Anesthetics, Local|anesthetics, local|mesh-ancestor
56519258|NCT05637645|Anesthetics|anesthetics|mesh-ancestor
56519259|NCT05637645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519260|NCT05637645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519261|NCT05637645|Sensory System Agents|sensory system agents|mesh-ancestor
56519262|NCT05637645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519263|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56519264|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56519265|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519266|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56519267|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56519268|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56519269|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519270|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
56519271|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519272|NCT02879110|Sulforaphane|sulforaphane|mesh-list
56519273|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56519274|NCT02879110|Protective Agents|protective agents|mesh-ancestor
56519275|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519276|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649212|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649213|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56649214|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
56649215|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
56649216|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56649217|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
56649218|NCT00646620|Hormones|hormones|mesh-ancestor
56649219|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649220|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56649221|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56649222|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56649223|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
56649224|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649225|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649226|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
56649227|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56649228|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
56649229|NCT00648180|Doxycycline|doxycycline|mesh-list
56649230|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649231|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649232|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
56649233|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56519277|NCT04207515|Anesthetics|anesthetics|mesh-list
56519278|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519279|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519280|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
56519281|NCT01100944|Doxorubicin|doxorubicin|mesh-list
56519282|NCT01100944|Belinostat|belinostat|mesh-list
56519283|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56519284|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
56519285|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519286|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519287|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56519288|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
56519289|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519290|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141189|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519293|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56519294|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56519295|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519296|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56519297|NCT01100320|Oxycodone|oxycodone|mesh-list
56519298|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56519299|NCT01100320|Narcotics|narcotics|mesh-ancestor
56519300|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519301|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519302|NCT01100320|Analgesics|analgesics|mesh-ancestor
56519303|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
56519304|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519305|NCT04309708|Nimodipine|nimodipine|mesh-list
56519306|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56519307|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56519308|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56649234|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56649235|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56649236|NCT02664168|Laxatives|laxatives|mesh-ancestor
56649237|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56649238|NCT00648492|Metformin|metformin|mesh-list
56519309|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519310|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56519311|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519312|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
56519313|NCT01100086|Oxycodone|oxycodone|mesh-list
56519314|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56519315|NCT01100086|Narcotics|narcotics|mesh-ancestor
56519316|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519317|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519318|NCT01100086|Analgesics|analgesics|mesh-ancestor
56519319|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
56519320|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519321|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56519322|NCT00626080|Insulin|insulin|mesh-list
56519323|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56519324|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
56519325|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
56519326|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
56519327|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
56519328|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56519329|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519331|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56519332|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
56519333|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56519334|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
56519335|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519336|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519338|NCT01035229|Everolimus|everolimus|mesh-list
56519339|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519340|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56519341|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
56519342|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519343|NCT01059799|Insulin|insulin|mesh-list
56519344|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56519345|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
56519346|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56519347|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519348|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56519349|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519350|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
56519351|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56519352|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56519353|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56519354|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519355|NCT01106092|Vaccines|vaccines|mesh-list
56519356|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
56519357|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519358|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
56519359|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56519360|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519361|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519362|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56519363|NCT04307290|Analgesics|analgesics|mesh-ancestor
56519364|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
56519365|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519366|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56519369|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
56519370|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519371|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519372|NCT01325207|Trastuzumab|trastuzumab|mesh-list
56519373|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56519374|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519375|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56519376|NCT01324349|Hemostatics|hemostatics|mesh-list
56519377|NCT01324349|Coagulants|coagulants|mesh-ancestor
56519378|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56519379|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
56649239|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56649240|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649241|NCT00648570|Dexetimide|dexetimide|mesh-list
56649242|NCT00648570|Citalopram|citalopram|mesh-list
56519380|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519381|NCT01095094|Ritonavir|ritonavir|mesh-list
56519382|NCT01095094|Lopinavir|lopinavir|mesh-list
56519383|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56519384|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56519385|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
56519386|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519387|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519388|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56519389|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56519390|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
56519391|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519392|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56519393|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56519394|NCT00623285|Pregabalin|pregabalin|mesh-list
56519395|NCT00623285|Analgesics|analgesics|mesh-ancestor
56519396|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
56519397|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519398|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519399|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
56519400|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56519401|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56168166|NCT00357864|Protective Agents|protective agents|mesh-ancestor
56519402|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519403|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56519404|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56519405|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56519406|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267511|NCT01975259|Glucagon|glucagon|mesh-list
56519407|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56519408|NCT01097044|Afamelanotide|afamelanotide|mesh-list
56519409|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
56519410|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
56519411|NCT01322009|Probenecid|probenecid|mesh-list
56519412|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56519413|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
56519414|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519415|NCT01322009|Expectorants|expectorants|mesh-ancestor
56519416|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
56519417|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56519418|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
56519419|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519420|NCT01322009|Protective Agents|protective agents|mesh-ancestor
56519421|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519422|NCT01322009|Antidotes|antidotes|mesh-ancestor
56519423|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
56519424|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
56519425|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519426|NCT01322009|Renal Agents|renal agents|mesh-ancestor
56519427|NCT01320683|Leucovorin|leucovorin|mesh-list
56519428|NCT01320683|Bevacizumab|bevacizumab|mesh-list
56519429|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56519430|NCT01320683|Fluorouracil|fluorouracil|mesh-list
56519431|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
56519432|NCT01320683|Irinotecan|irinotecan|mesh-list
56519433|NCT01320683|Antibodies|antibodies|mesh-list
56519434|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
56519435|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56519436|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
56519437|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519438|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56519439|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56519440|NCT01320683|Growth Substances|growth substances|mesh-ancestor
56141341|NCT04359966|Esomeprazole|esomeprazole|mesh-list
56519441|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519443|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
56519444|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
56519445|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519446|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56519447|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56519448|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56649243|NCT00648570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56649244|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56649245|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56649246|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649247|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649248|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
56649249|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649250|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56649251|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
56649252|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649253|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56649254|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56649255|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
56519449|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56519450|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519451|NCT01320683|Antidotes|antidotes|mesh-ancestor
56519452|NCT01320683|Protective Agents|protective agents|mesh-ancestor
56519453|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
56519454|NCT01320683|Vitamins|vitamins|mesh-ancestor
56519455|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
56519456|NCT01320293|Adalimumab|adalimumab|mesh-list
56519457|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519458|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519459|NCT01318811|Heparin|heparin|mesh-list
56519460|NCT01318811|Calcium heparin|calcium heparin|mesh-list
56519461|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
56519462|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56519463|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56519464|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519465|NCT05644769|Lisinopril|lisinopril|mesh-list
56519466|NCT05644769|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56519467|NCT05644769|Protease Inhibitors|protease inhibitors|mesh-ancestor
56519468|NCT05644769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519469|NCT05644769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519470|NCT05644769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56519471|NCT05644769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56519472|NCT05644769|Protective Agents|protective agents|mesh-ancestor
56519473|NCT05644769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519474|NCT05644691|Emollients|emollients|mesh-list
56519475|NCT05644691|Dermatologic Agents|dermatologic agents|mesh-ancestor
56519476|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56519477|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
56519478|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519479|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
56519480|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56519481|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56519482|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
56519483|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519484|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519485|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519486|NCT01093534|Urological Agents|urological agents|mesh-ancestor
56519488|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
56519489|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519490|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519491|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519492|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56519493|NCT01093222|Sorafenib|sorafenib|mesh-list
56519494|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519495|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56519496|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519497|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649256|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
56649257|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649258|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56649259|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56000220|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
56519498|NCT02878018|Hormones|hormones|mesh-list
56519499|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
56519500|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56519501|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56519502|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519503|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519504|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519505|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519506|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
56519507|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
56519508|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519509|NCT01313663|Pemetrexed|pemetrexed|mesh-list
56519510|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519511|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519512|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519513|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56519514|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56519515|NCT01092832|Voriconazole|voriconazole|mesh-list
56519518|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56519519|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56519520|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519521|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519522|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56519523|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
56519524|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519525|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519526|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56519527|NCT02878564|Praziquantel|praziquantel|mesh-list
56519528|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
56519529|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56519530|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519531|NCT04308070|Hemostatics|hemostatics|mesh-list
56519532|NCT04308070|Coagulants|coagulants|mesh-ancestor
56519533|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
56519534|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
56519535|NCT01313273|Lanreotide|lanreotide|mesh-list
56519536|NCT01313273|Androgens|androgens|mesh-list
56519537|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56519538|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56519539|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
56519540|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
56519541|NCT01313273|Hormones|hormones|mesh-ancestor
56519542|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519543|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519544|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
56519545|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519546|NCT01313273|Protective Agents|protective agents|mesh-ancestor
56519547|NCT01313273|Vitamins|vitamins|mesh-ancestor
56519549|NCT01313273|Estrogens|estrogens|mesh-ancestor
56519550|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56519551|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519552|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
56519553|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
56519554|NCT01091974|Modafinil|modafinil|mesh-list
56519555|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56519556|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519557|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56519558|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56519559|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56519560|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519561|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
56519562|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
56519563|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649260|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
56649261|NCT00648258|Naproxen|naproxen|mesh-list
56649262|NCT00648258|Valdecoxib|valdecoxib|mesh-list
56649263|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56649264|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56649265|NCT00648258|Analgesics|analgesics|mesh-ancestor
56649266|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
56000223|NCT02134912|Pemetrexed|pemetrexed|mesh-list
56519564|NCT01313117|Protective Agents|protective agents|mesh-ancestor
56519565|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519566|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
56519567|NCT01313117|Vitamins|vitamins|mesh-ancestor
56519568|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
56519569|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56519570|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
56519571|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56519572|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56519573|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56519574|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519575|NCT01312961|Fluticasone|fluticasone|mesh-list
56519576|NCT01312961|Xhance|xhance|mesh-list
56519577|NCT01312961|Albuterol|albuterol|mesh-list
56519578|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56519579|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56519580|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56519581|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519582|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56519583|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
56519584|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519585|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519586|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56519587|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
56519588|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
56519589|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56519601|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519602|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
56519603|NCT00626158|Gemcitabine|gemcitabine|mesh-list
56519604|NCT00626158|Capecitabine|capecitabine|mesh-list
56519605|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56519606|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
56519607|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519608|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519609|NCT00626158|Antiviral Agents|antiviral agents|mesh-ancestor
56519610|NCT00626158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519611|NCT00626158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519612|NCT00626158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56519613|NCT00626158|Immunologic Factors|immunologic factors|mesh-ancestor
56519614|NCT00626158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519615|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56519616|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56519617|NCT01310777|Brinzolamide|brinzolamide|mesh-list
56519618|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56519619|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56519620|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56519621|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56519622|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56519623|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
56519624|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519625|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519626|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519627|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56519628|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519630|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
56519631|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56519632|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519633|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
56519634|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519635|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56649267|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649268|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649269|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519636|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56519637|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519638|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519640|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56519641|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519642|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
56519643|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519644|NCT01308749|Oxytocin|oxytocin|mesh-list
56519645|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
56519646|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56519647|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519648|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56519649|NCT01307891|Paclitaxel|paclitaxel|mesh-list
56519650|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519651|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56519652|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
56519653|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
56519654|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
56519655|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519657|NCT05644301|Celecoxib|celecoxib|mesh-list
56519658|NCT05644301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56519659|NCT05644301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56519660|NCT05644301|Analgesics|analgesics|mesh-ancestor
56519661|NCT05644301|Sensory System Agents|sensory system agents|mesh-ancestor
56519662|NCT05644301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519663|NCT05644301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519664|NCT05644301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519665|NCT05644301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519666|NCT05644301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56519667|NCT05644301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56519668|NCT05644301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519669|NCT05644301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519670|NCT05644301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56519671|NCT05644301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519672|NCT02890745|Empagliflozin|empagliflozin|mesh-list
56519673|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56519674|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519675|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56519676|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519677|NCT01307579|Fluconazole|fluconazole|mesh-list
56519678|NCT01307579|Caspofungin|caspofungin|mesh-list
56519679|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
56519680|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519681|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56519682|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56519683|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168175|NCT00358020|Thalidomide|thalidomide|mesh-list
56519684|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519685|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56519686|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
56519687|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519688|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519689|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56519690|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56519691|NCT01057693|Pregabalin|pregabalin|mesh-list
56519692|NCT01057693|Analgesics|analgesics|mesh-ancestor
56519693|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
56519694|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519695|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519696|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
56519697|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56519698|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56519699|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519700|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56519701|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56649270|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56649271|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
56649272|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56649273|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649274|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649275|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56649276|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
56649277|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
56649278|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649279|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56649280|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649281|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649282|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
56649283|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649284|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56649285|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649286|NCT04650984|Doxorubicin|doxorubicin|mesh-list
56649287|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56649288|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649289|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56649290|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56519702|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56519703|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519704|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56519705|NCT04325009|Atorvastatin|atorvastatin|mesh-list
56519706|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56519707|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56519708|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
56519709|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519710|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56519711|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56519712|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519713|NCT01034137|Methotrexate|methotrexate|mesh-list
56519714|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56519715|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
56519716|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56519717|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519718|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56519719|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
56519720|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519721|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519722|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
56141631|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
56519725|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56519726|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
56519727|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519728|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56519729|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
56519730|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56519731|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
56519732|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649291|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649292|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519733|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56519734|NCT04655755|Decitabine|decitabine|mesh-list
56519735|NCT04655755|Venetoclax|venetoclax|mesh-list
56519736|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56519737|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
56519738|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519739|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519740|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519741|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56519742|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56519743|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56519744|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56519745|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519746|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519747|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519748|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
56519749|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56519750|NCT02875093|Cytarabine|cytarabine|mesh-list
56519751|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56519752|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
56519753|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519754|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519755|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
56519756|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519757|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56519758|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
56519759|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519760|NCT01033825|Ciclesonide|ciclesonide|mesh-list
56519761|NCT01033825|Dexamethasone|dexamethasone|mesh-list
56519762|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
56519763|NCT01033825|BB 1101|bb 1101|mesh-list
56519764|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519765|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
56519766|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
56519767|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519768|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519769|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56519770|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
56519771|NCT01033825|Hormones|hormones|mesh-ancestor
56519772|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519773|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56519774|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519775|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
56519776|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519777|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519778|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56519779|NCT01033747|Deferasirox|deferasirox|mesh-list
56267882|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
56519780|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56519781|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
56519782|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
56519783|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519784|NCT02875015|Lidocaine|lidocaine|mesh-list
56519785|NCT02875015|Bupivacaine|bupivacaine|mesh-list
56519786|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
56519787|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
56519788|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519789|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519790|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
56519791|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519792|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56519793|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56519794|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56519797|NCT01091428|Paclitaxel|paclitaxel|mesh-list
56519798|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56519799|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519800|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
56519801|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
56519802|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
55888589|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649293|NCT00648414|Fentanyl|fentanyl|mesh-list
56649294|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56649295|NCT00648414|Narcotics|narcotics|mesh-ancestor
56649296|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649297|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649298|NCT00648414|Analgesics|analgesics|mesh-ancestor
56649299|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
56649300|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649301|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56649302|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56649303|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
56649304|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
56649305|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
56649306|NCT04558866|Testosterone|testosterone|mesh-list
56649307|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
56649308|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
56649309|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56649310|NCT04558866|Androgens|androgens|mesh-ancestor
56649311|NCT04558866|Hormones|hormones|mesh-ancestor
56000233|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
56519803|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519804|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
56519805|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56519806|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519807|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519808|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56519809|NCT01096186|Carbidopa|carbidopa|mesh-list
56519810|NCT01096186|Levodopa|levodopa|mesh-list
56519811|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56519812|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
56519813|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519814|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56519815|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56519816|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
56519817|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
56519818|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519819|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519820|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56519821|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519822|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
56519823|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56519824|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56519825|NCT01049503|Fluorides|fluorides|mesh-list
56519826|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
56519827|NCT01049503|Protective Agents|protective agents|mesh-ancestor
56519828|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519829|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
56519830|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56519831|NCT04640779|Salicylates|salicylates|mesh-list
56519832|NCT04640779|Choline|choline|mesh-list
56519833|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
56519834|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56519835|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
56519836|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519837|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56519838|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56519839|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
56649312|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649313|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649314|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56649315|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649316|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
56649318|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
56649319|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56649320|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56649321|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649322|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649323|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
56649324|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
56649325|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56649326|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
56649327|NCT00648726|Azithromycin|azithromycin|mesh-list
56649328|NCT00648726|Erythromycin|erythromycin|mesh-list
56649329|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
56649330|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56649331|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
56649332|NCT00648726|Cefuroxime|cefuroxime|mesh-list
56649333|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
56649334|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649335|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649336|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56649337|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56519840|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56519841|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56519842|NCT04640779|Analgesics|analgesics|mesh-ancestor
56519843|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
56519844|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519845|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519846|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519847|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519848|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56519849|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519850|NCT04301557|Capecitabine|capecitabine|mesh-list
56519851|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
56519852|NCT04301557|Antibodies|antibodies|mesh-list
56519853|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
56267960|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
56519854|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519855|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56519856|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
56519857|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519858|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519859|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56519860|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519861|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
56519862|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56519863|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
56519864|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519865|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
56649338|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649339|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649340|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
56649341|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56649342|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649343|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649344|NCT00648804|Ondansetron|ondansetron|mesh-list
56649345|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
56649346|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
56519868|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56519870|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56519871|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519872|NCT01023217|Lamivudine|lamivudine|mesh-list
56519873|NCT01023217|Adefovir|adefovir|mesh-list
56519874|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56519875|NCT01023217|Entecavir|entecavir|mesh-list
56519876|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56519877|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56519878|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519879|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519880|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
56519881|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519882|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56519883|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56519884|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56519885|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56519886|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56519887|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56519888|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519889|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519890|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
56519891|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519892|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56519893|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56519894|NCT01023061|Prednisone|prednisone|mesh-list
56519895|NCT01023061|Leuprolide|leuprolide|mesh-list
56519896|NCT01023061|Goserelin|goserelin|mesh-list
56519897|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
56519898|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519899|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
56519900|NCT01023061|Hormones|hormones|mesh-ancestor
56519901|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519902|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519903|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56519904|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519905|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56519906|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
56519907|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56519908|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56519909|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519910|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519911|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
56519912|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56519913|NCT01027897|Doripenem|doripenem|mesh-list
56519914|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56519915|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519916|NCT01027351|Vaccines|vaccines|mesh-list
56519917|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
56519918|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519919|NCT05661045|Anesthetics|anesthetics|mesh-list
56519920|NCT05661045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519921|NCT05661045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519923|NCT01294683|Niacinamide|niacinamide|mesh-list
56519924|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
56519925|NCT01294683|Simvastatin|simvastatin|mesh-list
56519926|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56649347|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649348|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649349|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56649350|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
56649351|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
56649352|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56649353|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
56649354|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649355|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649356|NCT00648804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56649357|NCT00648804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649358|NCT00648804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649359|NCT00648804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649360|NCT00648804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56649361|NCT02664012|Menthol|menthol|mesh-list
56649362|NCT02664012|Nicotine|nicotine|mesh-list
56649363|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56649364|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
56649365|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649366|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649367|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56649368|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56649369|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
56649370|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649371|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649372|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
56649373|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
56649374|NCT00895037|Factor VIII|factor viii|mesh-list
56649375|NCT00895037|Coagulants|coagulants|mesh-ancestor
56649376|NCT04170504|Methotrexate|methotrexate|mesh-list
56649377|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56649378|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
56649379|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56649380|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649388|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649389|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
56649390|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56649391|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56295412|NCT00098878|Carboplatin|carboplatin|mesh-list
56649392|NCT04170270|Omeprazole|omeprazole|mesh-list
56649393|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56649394|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56649395|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56649396|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649397|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649398|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56649399|NCT00633347|Cetrorelix|cetrorelix|mesh-list
56649400|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56649401|NCT00633347|Hormones|hormones|mesh-ancestor
56649402|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649403|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649404|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56649405|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
55948946|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
56519927|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56519929|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519930|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56519931|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56519932|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519933|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
56519934|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
56519935|NCT01294683|Vitamins|vitamins|mesh-ancestor
56519936|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
56519937|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519938|NCT01294449|Cytarabine|cytarabine|mesh-list
56519939|NCT01294449|Dexamethasone|dexamethasone|mesh-list
56519942|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
56519943|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519944|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519945|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
56519946|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519947|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56519948|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
56519949|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519950|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56519951|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
56519952|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
56519953|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519954|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56519955|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
56519956|NCT01294449|Hormones|hormones|mesh-ancestor
56519957|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56519958|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56519959|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56519960|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
56519961|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56519962|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
56519963|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519964|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56649406|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56649407|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
56649408|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
56519965|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56519966|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56519967|NCT01293123|Tenofovir|tenofovir|mesh-list
56519968|NCT01293123|Emtricitabine|emtricitabine|mesh-list
56519969|NCT01293123|Efavirenz|efavirenz|mesh-list
56519970|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
56519971|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
56519972|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519973|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56519974|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56519975|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519976|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519977|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56519978|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56519979|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56519980|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56519981|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56519982|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56519983|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56519984|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56519985|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56519986|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56519987|NCT01292187|Calcitonin|calcitonin|mesh-list
56519988|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
56519989|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56519990|NCT01292187|Katacalcin|katacalcin|mesh-list
56519991|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56519992|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519993|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56519994|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
56519995|NCT01026493|Temozolomide|temozolomide|mesh-list
56519996|NCT01026493|Veliparib|veliparib|mesh-list
56519997|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56519998|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
56519999|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520000|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268108|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56520001|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56520002|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520003|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56520004|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56520005|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520006|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56520007|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56520008|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56520009|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520013|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520014|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56520015|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520016|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520018|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56520019|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
56520020|NCT01290315|Hematinics|hematinics|mesh-ancestor
56520021|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
56520022|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
56520023|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
56520024|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
56520025|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56520026|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56520027|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
56520028|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520029|NCT01021813|Suvorexant|suvorexant|mesh-list
56520030|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56520031|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56520032|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520033|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520034|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56649409|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56649410|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
56649411|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56649412|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56649413|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649414|NCT02838719|Dexamethasone|dexamethasone|mesh-list
56649415|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
56649416|NCT02838719|BB 1101|bb 1101|mesh-list
56649417|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56649418|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
56649419|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
56649420|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649421|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649422|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56649423|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
56649424|NCT02838719|Hormones|hormones|mesh-ancestor
56649425|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649426|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56649427|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649428|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
56649429|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649430|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649431|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56649432|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56520035|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520036|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520037|NCT01025635|Azelaic acid|azelaic acid|mesh-list
56520038|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520039|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
56520040|NCT01021423|Lenalidomide|lenalidomide|mesh-list
56520041|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
56520042|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520043|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56520044|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56520045|NCT01021423|Growth Substances|growth substances|mesh-ancestor
56520046|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
56520047|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520048|NCT01020877|Metronidazole|metronidazole|mesh-list
56520049|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520050|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56520051|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56520052|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56520053|NCT01020799|Citalopram|citalopram|mesh-list
56520054|NCT01020799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56520055|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56520056|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56520057|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520058|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520059|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
56649433|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649434|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56649435|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56520060|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520061|NCT01020799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56520062|NCT01020799|Antidepressive Agents|antidepressive agents|mesh-ancestor
56520063|NCT01020799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56520064|NCT02872597|Dexamethasone|dexamethasone|mesh-list
56520065|NCT02872597|Prednisone|prednisone|mesh-list
56520066|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
56520067|NCT02872597|Prednisolone|prednisolone|mesh-list
56520068|NCT02872597|Albuterol|albuterol|mesh-list
56520069|NCT02872597|Ipratropium|ipratropium|mesh-list
56520070|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520071|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
56520072|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
56520073|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520074|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520075|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56520076|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
56520077|NCT02872597|Hormones|hormones|mesh-ancestor
56520078|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520079|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56520080|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520081|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520082|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56520083|NCT02872597|Protective Agents|protective agents|mesh-ancestor
56141998|NCT05508594|Analgesics|analgesics|mesh-ancestor
56520085|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56520086|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520088|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56520089|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56520090|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56520091|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56520092|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
56520093|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520094|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56520095|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
56520096|NCT02873065|Amoxicillin|amoxicillin|mesh-list
56520097|NCT02873065|Clarithromycin|clarithromycin|mesh-list
56520098|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
56520099|NCT02873065|Bismuth|bismuth|mesh-list
56520100|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520101|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56520102|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520103|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56520104|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520105|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56520106|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56520107|NCT02873065|Antacids|antacids|mesh-ancestor
56520108|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56520109|NCT02873065|Diuretics|diuretics|mesh-ancestor
56520110|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
56520111|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520113|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520114|NCT00628225|Bupropion|bupropion|mesh-list
56520115|NCT00628225|Nicotine|nicotine|mesh-list
56520116|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56520117|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
56520118|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520119|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520120|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56520121|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56520122|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
56520123|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520124|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520125|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56520126|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
56520127|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56520128|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56520129|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55888590|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
56649436|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56649437|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649438|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
56649439|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649440|NCT00649194|Rabeprazole|rabeprazole|mesh-list
56649441|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56649442|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56649443|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56649444|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649445|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649446|NCT02659254|Sirolimus|sirolimus|mesh-list
56649447|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649448|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649449|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56649450|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649451|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
56649452|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649453|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
56649454|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649455|NCT02658864|Lafutidine|lafutidine|mesh-list
56649456|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56520130|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56520131|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
56520132|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56520133|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56520134|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520135|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
56520136|NCT01014013|Ertapenem|ertapenem|mesh-list
56520137|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56520138|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520139|NCT01013701|Fluticasone|fluticasone|mesh-list
56520140|NCT01013701|Xhance|xhance|mesh-list
56520141|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520142|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56520143|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
56520144|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520145|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520146|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56520147|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520148|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56520149|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56520150|NCT01020019|Lofexidine|lofexidine|mesh-list
56520151|NCT01020019|Dronabinol|dronabinol|mesh-list
56520152|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
56520153|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520154|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56520155|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520156|NCT01020019|Analgesics|analgesics|mesh-ancestor
56520157|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
56520158|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520159|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56520160|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56520161|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520162|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888591|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
56649457|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56649458|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56649459|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
56649460|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
56649461|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649462|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649463|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649464|NCT04249037|Tenofovir|tenofovir|mesh-list
56649465|NCT04249037|Emtricitabine|emtricitabine|mesh-list
56000341|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
56520164|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520165|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56520166|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56520167|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56520168|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56520169|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56520170|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
56520171|NCT00627835|Cisplatin|cisplatin|mesh-list
56520172|NCT00627835|Sorafenib|sorafenib|mesh-list
56520173|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520174|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56520175|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520176|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520177|NCT01019317|Cytarabine|cytarabine|mesh-list
56520178|NCT01019317|Fludarabine|fludarabine|mesh-list
56520179|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
56520180|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520181|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56520182|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
56520183|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520184|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168195|NCT00358410|Casopitant|casopitant|mesh-list
56520185|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
56520186|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520187|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
56520188|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520189|NCT02877238|Sevoflurane|sevoflurane|mesh-list
56520190|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
56520191|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520192|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520193|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56520194|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56520195|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
56520196|NCT01288911|Bicalutamide|bicalutamide|mesh-list
56520197|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
56520198|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
56520199|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520200|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520201|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520202|NCT01288443|Atorvastatin|atorvastatin|mesh-list
56520203|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56520204|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56520205|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56520206|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
56520207|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520208|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56520209|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56520210|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520211|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
56520212|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520213|NCT01288209|Ribavirin|ribavirin|mesh-list
56520214|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56520215|NCT01288209|Simeprevir|simeprevir|mesh-list
56520216|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
56520217|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649466|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56649467|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56649468|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
56520218|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
56520219|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520220|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
56520221|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520222|NCT01287195|Omeprazole|omeprazole|mesh-list
56520223|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
56520224|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56520225|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268334|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
56520226|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56520227|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520228|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520229|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
56520230|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520231|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56142145|NCT03030300|Metformin|metformin|mesh-list
56520234|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56520235|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520237|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56520238|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520239|NCT05572203|Caseins|caseins|mesh-list
56520240|NCT05572203|Chelating Agents|chelating agents|mesh-ancestor
56520241|NCT05572203|Sequestering Agents|sequestering agents|mesh-ancestor
56520242|NCT05572203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520243|NCT01285401|Interferons|interferons|mesh-list
56520244|NCT01285401|Interferon-beta|interferon-beta|mesh-list
56520245|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
56520246|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520247|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
56520248|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520249|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
56520250|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520251|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56520252|NCT01285323|Reslizumab|reslizumab|mesh-list
56520253|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56520254|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520255|NCT01284621|Empagliflozin|empagliflozin|mesh-list
56520256|NCT01284621|Ramipril|ramipril|mesh-list
56520257|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56520258|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
56520259|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520260|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520261|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56520262|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56520263|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56520264|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520266|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56520267|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
56520268|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520269|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
56520270|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56520271|NCT01281969|Antibodies|antibodies|mesh-list
56520272|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
56520273|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56520274|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
56520275|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520276|NCT01281813|Ritonavir|ritonavir|mesh-list
56520277|NCT01281813|Darunavir|darunavir|mesh-list
56520278|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56520279|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56520280|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
56520281|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520282|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520283|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56520284|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56520285|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
56520286|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520287|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56520288|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56520289|NCT01090414|Idelalisib|idelalisib|mesh-list
56520290|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649469|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649470|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56649471|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56649472|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649473|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649474|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56649475|NCT02835833|Bevacizumab|bevacizumab|mesh-list
56649476|NCT02835833|Nintedanib|nintedanib|mesh-list
56649477|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649478|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649479|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56649480|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56649481|NCT02835833|Growth Substances|growth substances|mesh-ancestor
56649482|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649483|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
56649484|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56649485|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733167|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56520291|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520292|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520293|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56520294|NCT01090102|Mesalamine|mesalamine|mesh-list
56520295|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56520296|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520297|NCT01090102|Analgesics|analgesics|mesh-ancestor
56520298|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
56520299|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520300|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520301|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520302|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56520303|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
56520304|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56520305|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520306|NCT01281189|Pramipexole|pramipexole|mesh-list
56520307|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
56520308|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520309|NCT01281189|Protective Agents|protective agents|mesh-ancestor
56520310|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520311|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56520312|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56520313|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
56520314|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
56520315|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520316|NCT04306666|Anesthetics|anesthetics|mesh-list
56520317|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520318|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520320|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56520321|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56520322|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
56520323|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520324|NCT01280721|Tolvaptan|tolvaptan|mesh-list
56520325|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56520326|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520327|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
56520328|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520329|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
56649486|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649487|NCT04171284|Docetaxel|docetaxel|mesh-list
56649488|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649489|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
56649490|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
56649491|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
56649492|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649493|NCT02838329|Ropivacaine|ropivacaine|mesh-list
56649494|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
56649495|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
56649496|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649497|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649498|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
56649499|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649500|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
56649501|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56649502|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56649503|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56649504|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56649505|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649506|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
56649507|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649508|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000365|NCT05478330|Flutamide|flutamide|mesh-list
56520330|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56520331|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
56520332|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520333|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56520334|NCT04306354|Oxytocin|oxytocin|mesh-list
56520335|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
56520336|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56520337|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520338|NCT04306276|Dienogest|dienogest|mesh-list
56520339|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56520340|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
56520341|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56520342|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520343|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56520344|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56520345|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56520346|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56520347|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
56520348|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520349|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56520350|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520351|NCT01078168|Acitretin|acitretin|mesh-list
56520352|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
56520353|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
56520354|NCT01086358|Naproxen|naproxen|mesh-list
56520355|NCT01086358|Sumatriptan|sumatriptan|mesh-list
56520356|NCT01086358|Naratriptan|naratriptan|mesh-list
56649509|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56649510|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649511|NCT02835521|Triamcinolone|triamcinolone|mesh-list
56649512|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56649513|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56649514|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56649515|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56649516|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
56649517|NCT02835521|Hormones|hormones|mesh-ancestor
56649518|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649519|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649520|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649521|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
56649522|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649523|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520357|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
56520358|NCT01086358|Rizatriptan|rizatriptan|mesh-list
56520359|NCT01086358|Eletriptan|eletriptan|mesh-list
56520360|NCT01086358|Almotriptan|almotriptan|mesh-list
56520361|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56520362|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520363|NCT01086358|Analgesics|analgesics|mesh-ancestor
56520364|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
56520365|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520366|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520367|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520368|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56520369|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
56520370|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56520371|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520372|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520373|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56520374|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56520375|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56520376|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
56268483|NCT01983449|Hormones|hormones|mesh-ancestor
56268552|NCT01983735|Niacin|niacin|mesh-list
56520377|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520378|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56520379|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
56520380|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520381|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
56520382|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56520383|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
56520385|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520386|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56520387|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520388|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
56520389|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56520390|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
56520391|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520392|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520393|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56520395|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56520396|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520397|NCT01081834|Incretins|incretins|mesh-ancestor
56520398|NCT01081834|Hormones|hormones|mesh-ancestor
56520399|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520400|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56520401|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
56649524|NCT00649272|Oxybutynin|oxybutynin|mesh-list
56649525|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
55949557|NCT04394975|Sunitinib|sunitinib|mesh-list
56520402|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520403|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520404|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56520406|NCT01079962|Bisoprolol|bisoprolol|mesh-list
56520407|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56520408|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56520409|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
56520410|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
56520411|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520412|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520413|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56520414|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56520415|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56520416|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
56520417|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520418|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520419|NCT01274637|Dalteparin|dalteparin|mesh-list
56520420|NCT01274637|Tinzaparin|tinzaparin|mesh-list
56520421|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56520422|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
56520423|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56520424|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56520425|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520426|NCT01079806|Entecavir|entecavir|mesh-list
56520427|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
56520428|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520429|NCT02876770|Melatonin|melatonin|mesh-list
56520430|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
56520431|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520432|NCT02876770|Protective Agents|protective agents|mesh-ancestor
56520433|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520434|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520435|NCT01077622|Ofatumumab|ofatumumab|mesh-list
56520436|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520437|NCT01313676|Fluticasone|fluticasone|mesh-list
56520439|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520440|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56520441|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
56520442|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520443|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520444|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56520445|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520446|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
56520447|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56520448|NCT00623376|Dronabinol|dronabinol|mesh-list
56520449|NCT00623376|Nabilone|nabilone|mesh-list
56520450|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
56520451|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
56520452|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520453|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520454|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56520455|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56520456|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56520457|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520458|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56520459|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
56520463|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56520464|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56520465|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520466|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520467|NCT00623376|Hormones|hormones|mesh-ancestor
56520468|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520469|NCT01313286|Globalagliatin|globalagliatin|mesh-list
56520470|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
56520471|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520472|NCT01313208|Etanercept|etanercept|mesh-list
56520473|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56520474|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520475|NCT01313208|Analgesics|analgesics|mesh-ancestor
56520476|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
56649526|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
56649527|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649528|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520477|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520478|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520479|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520480|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56520481|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56520482|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56520483|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
56520484|NCT01075984|Posaconazole|posaconazole|mesh-list
56520485|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
56520486|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520487|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56520488|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56520489|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56520490|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56520491|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56520492|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520493|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520494|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56520495|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
56520496|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520497|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520498|NCT01024231|Nivolumab|nivolumab|mesh-list
56520499|NCT01024231|Ipilimumab|ipilimumab|mesh-list
56520500|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56520501|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520502|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56520503|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520504|NCT04527991|Paclitaxel|paclitaxel|mesh-list
56520505|NCT04527991|Docetaxel|docetaxel|mesh-list
56520506|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56520507|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520508|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
56520509|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
56520510|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
56520511|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520512|NCT01012999|Sufentanil|sufentanil|mesh-list
56520513|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56520514|NCT01012999|Narcotics|narcotics|mesh-ancestor
56520515|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520516|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520517|NCT01012999|Analgesics|analgesics|mesh-ancestor
56520518|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
56520519|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520520|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56520521|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56520522|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
56520523|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
56520524|NCT00637663|Lamivudine|lamivudine|mesh-list
56520525|NCT00637663|Entecavir|entecavir|mesh-list
56520526|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56520527|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56520528|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520529|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520530|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
56520531|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520532|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56520535|NCT01016977|Clindamycin|clindamycin|mesh-list
56520536|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
56520537|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
56520538|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56520540|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56520541|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520542|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56520543|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520544|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520545|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
56520546|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
56520547|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
56520548|NCT01016977|Vitamins|vitamins|mesh-ancestor
56649529|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56649530|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56649531|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
55949719|NCT04836156|Docetaxel|docetaxel|mesh-list
56520549|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
56520550|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520551|NCT02871661|Amitriptyline|amitriptyline|mesh-list
56520552|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56520553|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
56520554|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56520555|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520556|NCT02871661|Analgesics|analgesics|mesh-ancestor
56520557|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
56520558|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520559|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520560|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56520561|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56520562|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56520563|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520564|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
56520565|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520566|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
56520567|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56520568|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
56520569|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520570|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520571|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56520572|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520573|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
56520574|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56520575|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
56520576|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520577|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520578|NCT00628459|Micronutrients|micronutrients|mesh-list
56520579|NCT00628459|Trace Elements|trace elements|mesh-list
56520580|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520581|NCT00627913|Anesthetics|anesthetics|mesh-list
56520582|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520583|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520584|NCT00627991|Valsartan|valsartan|mesh-list
56520585|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56520586|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56520587|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56520588|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520589|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
56520590|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56520591|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520592|NCT01006291|Insulin|insulin|mesh-list
56520593|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56520594|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
56520595|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
56520596|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56520597|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520598|NCT04296175|Paclitaxel|paclitaxel|mesh-list
56520599|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56520600|NCT04296175|Carboplatin|carboplatin|mesh-list
56520601|NCT04296175|Epirubicin|epirubicin|mesh-list
56268715|NCT01984567|Protective Agents|protective agents|mesh-ancestor
56520602|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56520603|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520604|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
56520605|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
56520606|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
56520609|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56520611|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520612|NCT04420195|Tacrolimus|tacrolimus|mesh-list
56520613|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56520614|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
56520615|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520616|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56520617|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888592|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649532|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649533|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649534|NCT00649272|Urological Agents|urological agents|mesh-ancestor
56520618|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520619|NCT02871349|Propranolol|propranolol|mesh-list
56520620|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56520621|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56520622|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
56520623|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520624|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520625|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520626|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56520627|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56520628|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
56520629|NCT04471987|Interleukin-12|interleukin-12|mesh-list
56520630|NCT04471987|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56520631|NCT04471987|Immunologic Factors|immunologic factors|mesh-ancestor
56520632|NCT04471987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520633|NCT04471987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56520634|NCT04471987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56520635|NCT04471987|Growth Substances|growth substances|mesh-ancestor
56520636|NCT04471987|Growth Inhibitors|growth inhibitors|mesh-ancestor
56520637|NCT04471987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520638|NCT01012609|Irinotecan|irinotecan|mesh-list
56520639|NCT01012609|Cetuximab|cetuximab|mesh-list
56520640|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56520641|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56520642|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520643|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520644|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520645|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56520646|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56520647|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
56520648|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520649|NCT01012219|Aspirin|aspirin|mesh-list
56520650|NCT01012219|Niacin|niacin|mesh-list
56520651|NCT01012219|Clopidogrel|clopidogrel|mesh-list
56520652|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56520653|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520654|NCT01012219|Analgesics|analgesics|mesh-ancestor
56520655|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
56520656|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520657|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520658|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520659|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56520660|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56520661|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56520662|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520663|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56520664|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56520665|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520666|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
56520667|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56520668|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56520669|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56520670|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
56520671|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520672|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56520673|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
56520674|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56520675|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
56520676|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
56520677|NCT01012219|Vitamins|vitamins|mesh-ancestor
56520678|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
56520681|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56520682|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
56520683|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520684|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520685|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520686|NCT01011673|Ketorolac|ketorolac|mesh-list
56520687|NCT01011673|Metoclopramide|metoclopramide|mesh-list
56113563|NCT00281879|Fludarabine|fludarabine|mesh-list
56649535|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
56649536|NCT02666898|Fludarabine|fludarabine|mesh-list
56649537|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
56649538|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649539|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
56520688|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56520689|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520690|NCT01011673|Analgesics|analgesics|mesh-ancestor
56520691|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
56520692|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520693|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520694|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520695|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56520696|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56520697|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520698|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520699|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
56520700|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
56520701|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56520702|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56520703|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56520704|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
56520705|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520706|NCT01311648|Factor VIII|factor viii|mesh-list
56520707|NCT01311648|Coagulants|coagulants|mesh-ancestor
56520708|NCT01011439|Maleic acid|maleic acid|mesh-list
56520709|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520710|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520711|NCT04406857|Capecitabine|capecitabine|mesh-list
56520712|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
56520713|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56520714|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
56520715|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520716|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520717|NCT01311024|Vaccines|vaccines|mesh-list
56520718|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
56520719|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520720|NCT02871193|Dexamethasone|dexamethasone|mesh-list
56520721|NCT02871193|Ropivacaine|ropivacaine|mesh-list
56520722|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520723|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
56520724|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
56520725|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520726|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520727|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56520728|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
56520729|NCT02871193|Hormones|hormones|mesh-ancestor
56520730|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520731|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56520732|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520733|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
56520735|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520736|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
56520737|NCT01310868|Carmustine|carmustine|mesh-list
56520738|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56520739|NCT01310868|Levulinic acid|levulinic acid|mesh-list
56520740|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56520741|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
56520742|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520743|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520744|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520745|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56520746|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
56520747|NCT01273155|Belinostat|belinostat|mesh-list
56520748|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520749|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56520750|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520751|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520752|NCT05657925|Ondansetron|ondansetron|mesh-list
56520753|NCT05657925|Antiemetics|antiemetics|mesh-ancestor
56520754|NCT05657925|Autonomic Agents|autonomic agents|mesh-ancestor
56520757|NCT05657925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56649540|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649541|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56649542|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56649543|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
56649544|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649545|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649546|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56649547|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649548|NCT00633425|Glimepiride|glimepiride|mesh-list
56649549|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56649550|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56649551|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649552|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000402|NCT01973062|Rituximab|rituximab|mesh-list
56520758|NCT05657925|Antipruritics|antipruritics|mesh-ancestor
56520759|NCT05657925|Dermatologic Agents|dermatologic agents|mesh-ancestor
56520760|NCT05657925|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56520761|NCT05657925|Serotonin Agents|serotonin agents|mesh-ancestor
56520762|NCT05657925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520763|NCT05657925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520764|NCT05657925|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56520765|NCT05657925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56520766|NCT05657925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520767|NCT05657925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56520768|NCT05657925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56520769|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
56520770|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56520771|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
56520772|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520773|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520774|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
56520776|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
56520777|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56520778|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56520779|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56520780|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
56520781|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520782|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520783|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520784|NCT02889549|Clopidogrel|clopidogrel|mesh-list
56520785|NCT02889549|Ticagrelor|ticagrelor|mesh-list
56520786|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56520787|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56520788|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56520789|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56520790|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
56520791|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520792|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520793|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520794|NCT01309386|Morphine|morphine|mesh-list
56520795|NCT01309386|Tapentadol|tapentadol|mesh-list
56520796|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56520797|NCT01309386|Narcotics|narcotics|mesh-ancestor
56520798|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520799|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520800|NCT01309386|Analgesics|analgesics|mesh-ancestor
56520801|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
56520802|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113564|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
56649553|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
56649554|NCT00648960|Clarithromycin|clarithromycin|mesh-list
56520803|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56520804|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56520805|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56520806|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520807|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
56520808|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520809|NCT04295317|Capecitabine|capecitabine|mesh-list
56520810|NCT04295317|Antibodies|antibodies|mesh-list
56520811|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
56520812|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
56520813|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520814|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56520815|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
56520816|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520817|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520818|NCT01266603|Aldesleukin|aldesleukin|mesh-list
56520819|NCT01266603|Interleukin-2|interleukin-2|mesh-list
56520820|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520821|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520822|NCT01266603|Analgesics|analgesics|mesh-ancestor
56520823|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
56520824|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520825|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520828|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
56520829|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520830|NCT04295551|Ritonavir|ritonavir|mesh-list
56520831|NCT04295551|Lopinavir|lopinavir|mesh-list
56520832|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56520833|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56520834|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
56520835|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520836|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520837|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56520838|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56520839|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
56520840|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520841|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56520842|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56520843|NCT01266291|Vigabatrin|vigabatrin|mesh-list
56520844|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
56520845|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520846|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520847|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
56520848|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520849|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520850|NCT01004263|Rizatriptan|rizatriptan|mesh-list
56520851|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56520852|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
56520853|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520854|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520855|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520856|NCT01265823|Adalimumab|adalimumab|mesh-list
56520857|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520858|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56520859|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56520860|NCT01004185|Mesalamine|mesalamine|mesh-list
56520861|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56520862|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520863|NCT01004185|Analgesics|analgesics|mesh-ancestor
56520864|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
56520865|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520866|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520867|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520868|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56520869|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
56520870|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56520871|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520872|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56520874|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56520875|NCT01264965|Acetaminophen|acetaminophen|mesh-list
56520876|NCT01264965|Oxycodone|oxycodone|mesh-list
56520877|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520878|NCT01264965|Analgesics|analgesics|mesh-ancestor
56520879|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
56520880|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520881|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520882|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
56520883|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56520884|NCT01264965|Narcotics|narcotics|mesh-ancestor
56520885|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520886|NCT01264887|Tapentadol|tapentadol|mesh-list
56520887|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56520888|NCT01264887|Narcotics|narcotics|mesh-ancestor
56520889|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520890|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520891|NCT01264887|Analgesics|analgesics|mesh-ancestor
56520892|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
56520893|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520894|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56520895|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56520896|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56520897|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520898|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
56520899|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520900|NCT01011283|Azacitidine|azacitidine|mesh-list
56142818|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56520902|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56520903|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
56520904|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520905|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520906|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520907|NCT01263483|Inositol|inositol|mesh-list
56520908|NCT01263483|Alogliptin|alogliptin|mesh-list
56520909|NCT01263483|Voglibose|voglibose|mesh-list
56520910|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56520911|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520912|NCT01263483|Incretins|incretins|mesh-ancestor
56520913|NCT01263483|Hormones|hormones|mesh-ancestor
56520914|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520915|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56520916|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
56520917|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520918|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520919|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56520920|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
56520921|NCT01263483|Vitamins|vitamins|mesh-ancestor
56520922|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
56520923|NCT01011049|Vaccines|vaccines|mesh-list
56520924|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
56520925|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520926|NCT01263093|Clopidogrel|clopidogrel|mesh-list
56520927|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56520928|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56168253|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
56520929|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56520930|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56520931|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
56520932|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520933|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520934|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520935|NCT01010971|Ciclesonide|ciclesonide|mesh-list
56520936|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
56520937|NCT01010971|Hormones|hormones|mesh-ancestor
56520938|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56520939|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520940|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56520941|NCT01306656|Vitamin D|vitamin d|mesh-list
56520942|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
56520943|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
56520944|NCT01306656|Vitamins|vitamins|mesh-list
56520945|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
56520946|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520947|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56520948|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56520949|NCT01003639|Aspirin|aspirin|mesh-list
56520950|NCT01003639|Acetaminophen|acetaminophen|mesh-list
56520951|NCT01003639|Ibuprofen|ibuprofen|mesh-list
56520952|NCT01003639|Naproxen|naproxen|mesh-list
56520953|NCT01003639|Acetazolamide|acetazolamide|mesh-list
56520954|NCT01003639|Codeine|codeine|mesh-list
56649555|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649556|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649557|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56649558|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789523|NCT04400695|Paclitaxel|paclitaxel|mesh-list
56520955|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56520956|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520957|NCT01003639|Analgesics|analgesics|mesh-ancestor
56520958|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
56520959|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520960|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520961|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56520962|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56520963|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56520964|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56520965|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520966|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56520967|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56520968|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56520969|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
56520970|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
56520971|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
56520972|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56520973|NCT01003639|Diuretics|diuretics|mesh-ancestor
56520977|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56520978|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
56520979|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
56520980|NCT01003249|Baclofen|baclofen|mesh-list
56520981|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56520982|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520983|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56520984|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520985|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56520986|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
56520987|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
56520988|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520989|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520990|NCT04297033|Lovastatin|lovastatin|mesh-list
56520991|NCT04297033|L 647318|l 647318|mesh-list
56520992|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
56520993|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56520994|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56520995|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
56520996|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520997|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56520998|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56520999|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521000|NCT04294537|Anesthetics|anesthetics|mesh-list
56521001|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521002|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521003|NCT04295629|Anesthetics|anesthetics|mesh-list
56521004|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521005|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521006|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
56521007|NCT01306032|Veliparib|veliparib|mesh-list
56521008|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521009|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
56521010|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521011|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521012|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56521013|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
56521014|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521015|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521016|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56521017|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56521018|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521019|NCT01263015|Lamivudine|lamivudine|mesh-list
56521020|NCT01263015|Abacavir|abacavir|mesh-list
56521021|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
56268990|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649559|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649560|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56521022|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56521023|NCT01263015|Dolutegravir|dolutegravir|mesh-list
56521024|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56521025|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56521026|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521027|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521028|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
56521029|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521030|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56521031|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56521032|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56521033|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56521034|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
56521035|NCT04322955|Nivolumab|nivolumab|mesh-list
56521036|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521037|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521038|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56521039|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521040|NCT04322175|Meloxicam|meloxicam|mesh-list
56521041|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56521042|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56521043|NCT04322175|Analgesics|analgesics|mesh-ancestor
56521044|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
56521045|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521048|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521049|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56521050|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56521051|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521052|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521053|NCT04321785|Caffeine|caffeine|mesh-list
56269170|NCT01987167|Hormones|hormones|mesh-ancestor
56521054|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56521055|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521056|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56521057|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521058|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521059|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56521060|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56521061|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
56521062|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521063|NCT01305408|Modafinil|modafinil|mesh-list
56521064|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56521065|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521066|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56521067|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56521068|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56521069|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521071|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56521072|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56521073|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56521074|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56521075|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521076|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
56521077|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521078|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521079|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56521080|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521081|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
56521082|NCT05576415|Varenicline|varenicline|mesh-list
56521083|NCT05576415|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56521084|NCT05576415|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56521085|NCT05576415|Cholinergic Agents|cholinergic agents|mesh-ancestor
56521086|NCT05576415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521087|NCT05576415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521088|NCT05576415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521089|NCT00624039|Pilocarpine|pilocarpine|mesh-list
56649561|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56649562|NCT04437329|Cisplatin|cisplatin|mesh-list
56649563|NCT04437329|Docetaxel|docetaxel|mesh-list
56649564|NCT04437329|Fluorouracil|fluorouracil|mesh-list
56649565|NCT04437329|Nedaplatin|nedaplatin|mesh-list
56649566|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649567|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
56521090|NCT00624039|Miotics|miotics|mesh-ancestor
56521091|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
56521092|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521093|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521094|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56521095|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56521096|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
56521097|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521098|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521099|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56521100|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521101|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
56521102|NCT01304706|Hormones|hormones|mesh-ancestor
56521103|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521104|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521105|NCT05661240|Docetaxel|docetaxel|mesh-list
56521106|NCT05661240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521107|NCT05661240|Tubulin Modulators|tubulin modulators|mesh-ancestor
56521108|NCT05661240|Antimitotic Agents|antimitotic agents|mesh-ancestor
56521109|NCT05661240|Mitosis Modulators|mitosis modulators|mesh-ancestor
56521110|NCT05661240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521111|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56521112|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521113|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521114|NCT05340465|Iron|iron|mesh-list
56521115|NCT05340465|Dextrans|dextrans|mesh-list
56521116|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
56521117|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56521118|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
56521119|NCT05340465|Trace Elements|trace elements|mesh-ancestor
56521120|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
56521121|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521123|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56521124|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56521125|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
56521126|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
56521127|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
56521128|NCT02889003|Pioglitazone|pioglitazone|mesh-list
56521129|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56521130|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521131|NCT01008553|Fentanyl|fentanyl|mesh-list
56521132|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56521133|NCT01008553|Narcotics|narcotics|mesh-ancestor
56521134|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521135|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521136|NCT01008553|Analgesics|analgesics|mesh-ancestor
56521137|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
56521138|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521139|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56521140|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56521141|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
56521142|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
56521143|NCT05226663|Fluorides|fluorides|mesh-list
56521144|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
56521145|NCT05226663|Protective Agents|protective agents|mesh-ancestor
56521146|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521147|NCT05141877|Anesthetics|anesthetics|mesh-list
56521148|NCT05141877|Propofol|propofol|mesh-list
56521149|NCT05141877|Sevoflurane|sevoflurane|mesh-list
56521150|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521151|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521152|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56521153|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56521154|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
56521155|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56649568|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
56649569|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
56000423|NCT00981370|Deferasirox|deferasirox|mesh-list
56521156|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56521157|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
56521158|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56521159|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521160|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
56521161|NCT04941105|Evolocumab|evolocumab|mesh-list
56521162|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56521163|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56521164|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
56521165|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521166|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56521167|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
56521168|NCT04901169|Giapreza|giapreza|mesh-list
56521169|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
56521170|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56521171|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56521172|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
56521173|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521174|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521175|NCT04479267|Prednisone|prednisone|mesh-list
56521176|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
56521177|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56521178|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56521179|NCT04479267|Prednisolone|prednisolone|mesh-list
56521180|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
56521181|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
56521182|NCT04479267|Cortisone|cortisone|mesh-list
56521183|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
56521184|NCT04479267|Rituximab|rituximab|mesh-list
56521185|NCT04479267|Doxorubicin|doxorubicin|mesh-list
56521186|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56521187|NCT04479267|Antibodies|antibodies|mesh-list
56521188|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
56521189|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56521190|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
56521191|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56521192|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
56521193|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521194|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
56521195|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521196|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521197|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56521198|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
56521199|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521200|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521201|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56521202|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521203|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56521204|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56521205|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56521206|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521207|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521208|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
56521209|NCT04479267|Hormones|hormones|mesh-ancestor
56521210|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521211|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56521212|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
56521213|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
56521214|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521215|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56521216|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56521217|NCT04479267|Protective Agents|protective agents|mesh-ancestor
56521218|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
56521219|NCT04439799|Testosterone|testosterone|mesh-list
56521220|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
56521221|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
56521222|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56521223|NCT04439799|Androgens|androgens|mesh-ancestor
56521224|NCT04439799|Hormones|hormones|mesh-ancestor
56521225|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521226|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521227|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56649570|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649571|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
56649572|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56649573|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649574|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
56521228|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521229|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
56521230|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56521231|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56521232|NCT04021017|Estradiol|estradiol|mesh-list
56521233|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56521234|NCT04021017|Estrogens|estrogens|mesh-ancestor
56521235|NCT04021017|Hormones|hormones|mesh-ancestor
56521236|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521237|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521238|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56521239|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
56521240|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56521241|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56521242|NCT03916185|Vaccines|vaccines|mesh-list
56521243|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
56521244|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521245|NCT03764553|Leucovorin|leucovorin|mesh-list
56521246|NCT03764553|Carboplatin|carboplatin|mesh-list
56521247|NCT03764553|Fluorouracil|fluorouracil|mesh-list
56521248|NCT03764553|Capecitabine|capecitabine|mesh-list
56521249|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
56521250|NCT03764553|Irinotecan|irinotecan|mesh-list
56521251|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521252|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
56521253|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521254|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56521255|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521256|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
56168313|NCT00361452|Epinephrine|epinephrine|mesh-list
56521257|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521259|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56521260|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521261|NCT03764553|Antidotes|antidotes|mesh-ancestor
56521262|NCT03764553|Protective Agents|protective agents|mesh-ancestor
56521263|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
56521264|NCT03764553|Vitamins|vitamins|mesh-ancestor
56521265|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
56521266|NCT04320225|Dexamethasone|dexamethasone|mesh-list
56521267|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521268|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
56521269|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
56521270|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521271|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143188|NCT00589056|Nelfinavir|nelfinavir|mesh-list
56521273|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
56521275|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521276|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56521277|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521278|NCT03221751|Prazosin|prazosin|mesh-list
56521279|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56521280|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56521281|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56521282|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56521283|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
56521284|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521285|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521286|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521287|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
56521288|NCT03219177|Narcotics|narcotics|mesh-ancestor
56521289|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521290|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521291|NCT03219177|Analgesics|analgesics|mesh-ancestor
56521292|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
56521293|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521294|NCT01302834|Cetuximab|cetuximab|mesh-list
56113565|NCT00281879|Etoposide|etoposide|mesh-list
56649575|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649576|NCT02834507|Levodopa|levodopa|mesh-list
56649577|NCT02834507|Carbidopa|carbidopa|mesh-list
56649578|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56649579|NCT02834507|Entacapone|entacapone|mesh-list
56649580|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56521295|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521296|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521297|NCT03048825|Colchicine|colchicine|mesh-list
56521298|NCT03048825|Spironolactone|spironolactone|mesh-list
56521299|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
56521300|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521301|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
56521302|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
56521303|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56521304|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521305|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521306|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56521307|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
56521308|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521309|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521310|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56521311|NCT03048825|Diuretics|diuretics|mesh-ancestor
56521312|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
56521313|NCT02866071|Ketamine|ketamine|mesh-list
56521314|NCT02866071|Analgesics|analgesics|mesh-ancestor
56521315|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
56521316|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521317|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521318|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56521319|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56521320|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
56521321|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
56521322|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521323|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56521324|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56521325|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521326|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521328|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56521329|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56521330|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521331|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521332|NCT05507775|Protective Agents|protective agents|mesh-ancestor
56521333|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521334|NCT02890602|Prednisolone|prednisolone|mesh-list
56521335|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
56521336|NCT02890602|Vincristine|vincristine|mesh-list
56521337|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
56521338|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521339|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
56521340|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521341|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521342|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56521343|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
56521344|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521346|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56521347|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56521348|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
56521349|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
56521350|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
56521351|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521352|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
56521353|NCT02890602|Hormones|hormones|mesh-ancestor
56521354|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521355|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56521356|NCT02890602|Hematinics|hematinics|mesh-ancestor
56521357|NCT01259115|Ketoconazole|ketoconazole|mesh-list
56521358|NCT01259115|Buprenorphine|buprenorphine|mesh-list
56521359|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56521360|NCT01259115|Narcotics|narcotics|mesh-ancestor
56649581|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56649582|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
56649583|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649584|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649585|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521361|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521362|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521363|NCT01259115|Analgesics|analgesics|mesh-ancestor
56521364|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
56521365|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521366|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56521367|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
56521368|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521369|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56521370|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56521371|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521372|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521373|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56521374|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
56521375|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521376|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56521377|NCT01302054|Fesoterodine|fesoterodine|mesh-list
56521378|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56521379|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56521380|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
56521381|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521382|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521383|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521384|NCT01302054|Urological Agents|urological agents|mesh-ancestor
56521385|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56521386|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521387|NCT01300572|Cyclosporine|cyclosporine|mesh-list
56521388|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
56521389|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56521390|NCT01300572|Fludarabine|fludarabine|mesh-list
56521391|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
56521392|NCT01300572|Antibodies|antibodies|mesh-list
56521393|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
56521394|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56521395|NCT01300572|Cyclosporins|cyclosporins|mesh-list
56521396|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
56521397|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521399|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56521400|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
56521401|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521402|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521403|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521404|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
56521405|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521406|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
56521407|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521408|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56521409|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56521410|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56521411|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
56521412|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56521413|NCT01077154|Denosumab|denosumab|mesh-list
56521414|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56521415|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521416|NCT01258101|Ribavirin|ribavirin|mesh-list
56521417|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56521418|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
56521419|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
56521421|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
56521422|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521423|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
56521424|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521426|NCT05640804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649586|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56649587|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649588|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55950869|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
56521427|NCT05640804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56521428|NCT05640804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521429|NCT05640804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521430|NCT00623688|Imidacloprid|imidacloprid|mesh-list
56521431|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
56521432|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521433|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521434|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521435|NCT01300260|Dulaglutide|dulaglutide|mesh-list
56521436|NCT01300260|Glucagon|glucagon|mesh-list
56521437|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56521438|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56521439|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521440|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56521441|NCT01300260|Hormones|hormones|mesh-ancestor
56521442|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521443|NCT01300260|Incretins|incretins|mesh-ancestor
56521444|NCT01256385|Sirolimus|sirolimus|mesh-list
56521445|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56521446|NCT01256385|Cetuximab|cetuximab|mesh-list
56521447|NCT01256385|Antibodies|antibodies|mesh-list
56521448|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
56521449|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56521450|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
56521451|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521452|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521453|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56521454|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521455|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56521456|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
56521457|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521458|NCT00637182|Anastrozole|anastrozole|mesh-list
56521459|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56521460|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521461|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56521462|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56521463|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521464|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521465|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56521466|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
56168326|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
56521467|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521468|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521469|NCT01298778|Acetaminophen|acetaminophen|mesh-list
56521470|NCT01298778|Morphine|morphine|mesh-list
56521471|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56521472|NCT01298778|Analgesics|analgesics|mesh-ancestor
56521473|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
56521474|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521475|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521476|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
56521477|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56521478|NCT01298778|Narcotics|narcotics|mesh-ancestor
56521479|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521480|NCT01298700|Bimatoprost|bimatoprost|mesh-list
56521481|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56521482|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56521483|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56521484|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56521485|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56521486|NCT01297920|Brinzolamide|brinzolamide|mesh-list
56521487|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56521488|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56521489|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56521490|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56521491|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56521492|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
56115282|NCT00002447|Saquinavir|saquinavir|mesh-list
56649589|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
56649590|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
56649591|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56649592|NCT02831543|Mosapride|mosapride|mesh-list
56649593|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649594|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56521495|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521496|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56521497|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521498|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
56521499|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521500|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
56521501|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521502|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521503|NCT01297062|Exenatide|exenatide|mesh-list
56521504|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
56521505|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56521506|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521507|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56521508|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56521509|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521510|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521511|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521512|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521513|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56521514|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56521516|NCT01297062|Hormones|hormones|mesh-ancestor
56521517|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521518|NCT01296672|Finasteride|finasteride|mesh-list
56521519|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56521520|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56521521|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521522|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521523|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
56521524|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521525|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521526|NCT01296672|Urological Agents|urological agents|mesh-ancestor
56521527|NCT01254669|Vaccines|vaccines|mesh-list
56521528|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
56521529|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521530|NCT04324476|Bevacizumab|bevacizumab|mesh-list
56521531|NCT04324476|Capecitabine|capecitabine|mesh-list
56521532|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
56521533|NCT04324476|Irinotecan|irinotecan|mesh-list
56521534|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521535|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521536|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56168333|NCT00361686|Tramadol|tramadol|mesh-list
56521537|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56521538|NCT04324476|Growth Substances|growth substances|mesh-ancestor
56521539|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521540|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
56521541|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56521542|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
56521543|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521544|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56521545|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56521546|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521548|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521549|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521550|NCT01254045|Oxytocin|oxytocin|mesh-list
56521551|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
56521552|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56521553|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521554|NCT01075282|Metformin|metformin|mesh-list
56521555|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
56521556|NCT01075282|Glimepiride|glimepiride|mesh-list
56521557|NCT01075282|Dulaglutide|dulaglutide|mesh-list
56521558|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56649595|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56649596|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
56649597|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649598|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649599|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56649600|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
56649601|NCT02667054|Anesthetics|anesthetics|mesh-list
56649602|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
56649603|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649604|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649605|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
56649606|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649607|NCT02662296|Idelalisib|idelalisib|mesh-list
56649608|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649609|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649610|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649611|NCT02662374|Nystatin|nystatin|mesh-list
56649612|NCT02662374|Calcium|calcium|mesh-list
56649613|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56295635|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
56521559|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521560|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56521561|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521562|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
56521563|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
56521564|NCT04324086|Calcium|calcium|mesh-list
56521565|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56521566|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521568|NCT01295034|Vitamin D|vitamin d|mesh-list
56521569|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
56521570|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
56521571|NCT01295034|Vitamins|vitamins|mesh-list
56521572|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
56521573|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521574|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56521575|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56521576|NCT01253421|Amisulpride|amisulpride|mesh-list
56521577|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56521578|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56521579|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521580|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521581|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56521582|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56521583|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
56521584|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521585|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521586|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56521587|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
56521588|NCT01077076|Omeprazole|omeprazole|mesh-list
56521589|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56521590|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56521591|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56521592|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56521593|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115283|NCT00002447|Efavirenz|efavirenz|mesh-list
56649614|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951119|NCT00074815|Citalopram|citalopram|mesh-list
56521594|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521595|NCT02876224|Bevacizumab|bevacizumab|mesh-list
56521596|NCT02876224|Atezolizumab|atezolizumab|mesh-list
56521597|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521598|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521599|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56521600|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56521601|NCT02876224|Growth Substances|growth substances|mesh-ancestor
56521602|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521603|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
56521604|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
56521605|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56521606|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56521607|NCT01253265|Ixekizumab|ixekizumab|mesh-list
56521608|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
56521609|NCT01293006|Suvorexant|suvorexant|mesh-list
56521610|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56521611|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56521612|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521613|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521614|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56521615|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521616|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521617|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
56521618|NCT01253187|Drospirenone|drospirenone|mesh-list
56521619|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56521620|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
56521621|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521622|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521623|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56521624|NCT01253187|Diuretics|diuretics|mesh-ancestor
56521625|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
56521626|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
56521627|NCT01253187|Vitamins|vitamins|mesh-ancestor
56521628|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
56521629|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
56521630|NCT01252953|Anacetrapib|anacetrapib|mesh-list
56521631|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56521632|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56521633|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
56521634|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521635|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56521636|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521637|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56521638|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521639|NCT01252563|Amlodipine|amlodipine|mesh-list
56521640|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56521642|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56521643|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521644|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56521645|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521646|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
56521647|NCT01292226|Cyclosporine|cyclosporine|mesh-list
56521648|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
56521649|NCT01292226|Antibodies|antibodies|mesh-list
56521650|NCT01292226|Cyclosporins|cyclosporins|mesh-list
56521651|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
56521652|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521653|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521654|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521655|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521656|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
56521657|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521658|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
56521659|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521660|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56521661|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56521662|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521663|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56521664|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
56521665|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649615|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649616|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649617|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
56649618|NCT02662374|Ionophores|ionophores|mesh-ancestor
56649619|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56521667|NCT01075048|Cetuximab|cetuximab|mesh-list
56521668|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56521669|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56521670|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521671|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521672|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521673|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521674|NCT01252251|Everolimus|everolimus|mesh-list
56521675|NCT01252251|Pasireotide|pasireotide|mesh-list
56521676|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521677|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521678|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
56521679|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521680|NCT01252251|Hormones|hormones|mesh-ancestor
56521681|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521682|NCT02888301|Clofarabine|clofarabine|mesh-list
56521683|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56521684|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
56521685|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521686|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521687|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
56521688|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
56521689|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56521690|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56521691|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521692|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521693|NCT00624273|Urological Agents|urological agents|mesh-ancestor
56521694|NCT04305964|Silicon|silicon|mesh-list
56521695|NCT04305964|Trace Elements|trace elements|mesh-ancestor
56521696|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
56521697|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521698|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
56521699|NCT04306042|Nivolumab|nivolumab|mesh-list
56521700|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521701|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521702|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56521703|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521704|NCT01074502|Apremilast|apremilast|mesh-list
56521705|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56521706|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56521707|NCT01074502|Analgesics|analgesics|mesh-ancestor
56521708|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
56521709|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521710|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521711|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521712|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521713|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56521714|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56521716|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521717|NCT01251861|Bicalutamide|bicalutamide|mesh-list
56521718|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
56521719|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
56521720|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521721|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521722|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521723|NCT02890368|Interferons|interferons|mesh-list
56521724|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56521725|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56521726|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
56521727|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521728|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
56521729|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521730|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56269849|NCT01992588|Insulin|insulin|mesh-list
56649620|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649621|NCT05334251|Anesthetics|anesthetics|mesh-list
56733168|NCT00400946|Leucovorin|leucovorin|mesh-list
56521731|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
56521732|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521733|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521734|NCT04303312|Benzydamine|benzydamine|mesh-list
56521735|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521736|NCT01285908|Norepinephrine|norepinephrine|mesh-list
56521737|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56521738|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56521739|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
56521740|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521741|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521742|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521743|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
56521744|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
56521745|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521746|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56521747|NCT01074268|Insulin|insulin|mesh-list
56521748|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56521749|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
56521750|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
56521751|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56521752|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521753|NCT01074190|Fentanyl|fentanyl|mesh-list
56521754|NCT01074190|Bupivacaine|bupivacaine|mesh-list
56521755|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
56521756|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
56168339|NCT00361686|Analgesics|analgesics|mesh-ancestor
56521757|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521758|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521759|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
56521760|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521761|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56521762|NCT01074190|Narcotics|narcotics|mesh-ancestor
56521763|NCT01074190|Analgesics|analgesics|mesh-ancestor
56521764|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56521765|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56521766|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
56521767|NCT01073566|Insulin|insulin|mesh-list
56521768|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56521769|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56521770|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521771|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
56521772|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56521773|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
56521774|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521775|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521776|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56521777|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
56521778|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
56521779|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56521780|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
56521781|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521782|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521783|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
56521784|NCT01045096|Lansoprazole|lansoprazole|mesh-list
56521785|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56521786|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56521787|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56521788|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521789|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521791|NCT02876146|Benzimidazole|benzimidazole|mesh-list
56521792|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
56521793|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56521794|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521795|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
56521796|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56521797|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56521798|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
56521799|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
56521800|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
56521801|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649622|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649623|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649624|NCT00649350|Metformin|metformin|mesh-list
56521802|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521803|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56521804|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
56521805|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521806|NCT02875756|Ivermectin|ivermectin|mesh-list
56521807|NCT02875756|Selamectin|selamectin|mesh-list
56269929|NCT01993251|Melatonin|melatonin|mesh-list
56521808|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56521809|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521811|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56521812|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56521813|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56521814|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
56521815|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521816|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521817|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521818|NCT04305028|Aspirin|aspirin|mesh-list
56521819|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
56521820|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56521821|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56521822|NCT04305028|Analgesics|analgesics|mesh-ancestor
56521823|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
56521824|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521825|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521826|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521827|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521828|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56521829|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56521830|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521831|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56521832|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56521833|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521834|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
56521835|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56521836|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
56521837|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56521838|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
56521839|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
56521840|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
56521841|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
56521842|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521843|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521844|NCT01283334|Carboplatin|carboplatin|mesh-list
56521845|NCT01283334|Cetuximab|cetuximab|mesh-list
56521846|NCT01283334|Everolimus|everolimus|mesh-list
56521847|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521848|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521849|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56521850|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
56521851|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521852|NCT04304716|Anesthetics|anesthetics|mesh-list
56521853|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521854|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521855|NCT01282476|Rituximab|rituximab|mesh-list
56521856|NCT01282476|Panobinostat|panobinostat|mesh-list
56521857|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521858|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521859|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
56521860|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521861|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521862|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56521863|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521866|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56521868|NCT02889822|Urological Agents|urological agents|mesh-ancestor
56521869|NCT01282164|Insulin|insulin|mesh-list
56521870|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56521871|NCT01282164|Glucagon|glucagon|mesh-list
56521872|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56521873|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56521874|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649625|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56649626|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649627|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
56649628|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56649629|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649630|NCT00649506|Renal Agents|renal agents|mesh-ancestor
56649631|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649632|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56649633|NCT00649038|Benazepril|benazepril|mesh-list
56649634|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56649635|NCT00649038|Diuretics|diuretics|mesh-ancestor
56649636|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
56649637|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733169|NCT00400946|Cytarabine|cytarabine|mesh-list
56521875|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56521876|NCT01282164|Hormones|hormones|mesh-ancestor
56521877|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521878|NCT01282164|Incretins|incretins|mesh-ancestor
56521879|NCT01250379|Bevacizumab|bevacizumab|mesh-list
56521880|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521881|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521882|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56521883|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56521884|NCT01250379|Growth Substances|growth substances|mesh-ancestor
56521885|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521886|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
56521887|NCT01072630|Modafinil|modafinil|mesh-list
56521888|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56521889|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521890|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56521891|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56521892|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56521893|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521894|NCT04302532|Ubiquinone|ubiquinone|mesh-list
56521895|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
56521896|NCT04302532|Clomiphene|clomiphene|mesh-list
56521897|NCT04302532|Enclomiphene|enclomiphene|mesh-list
56521898|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
56521899|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56521900|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
56168343|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521901|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521902|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521903|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56521904|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
56521905|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56521906|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56521907|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56521908|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
56521909|NCT04302532|Vitamins|vitamins|mesh-ancestor
56521910|NCT01281306|Valsartan|valsartan|mesh-list
56521911|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56521912|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56521913|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56521914|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56521915|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521916|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
56521917|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56521918|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521919|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56521920|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649638|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56649639|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56649640|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521921|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
56521922|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521923|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56521924|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521925|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521926|NCT01250145|Teriparatide|teriparatide|mesh-list
56521927|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56521928|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521929|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56521930|NCT04319601|Rituximab|rituximab|mesh-list
56521931|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56521932|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521935|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56521937|NCT04640896|Bupivacaine|bupivacaine|mesh-list
56521938|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
56521939|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
56521940|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521941|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521942|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
56521943|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521944|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56521945|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56521946|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56521947|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56521948|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521949|NCT01273818|Gentamicins|gentamicins|mesh-list
56521950|NCT01273818|Cefazolin|cefazolin|mesh-list
56521951|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56521952|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56521953|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56521954|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270073|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
56521955|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521956|NCT01037218|Udenafil|udenafil|mesh-list
56521957|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56521958|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56521959|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521960|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521961|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56521962|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521963|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56521964|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521965|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521966|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
56521967|NCT01269918|Remifentanil|remifentanil|mesh-list
56521968|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56521969|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56521970|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521971|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56521972|NCT01269918|Analgesics|analgesics|mesh-ancestor
56521973|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
56521974|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521975|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56521976|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56521977|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56521978|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
56521979|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521980|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521981|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56521982|NCT01269918|Narcotics|narcotics|mesh-ancestor
56521983|NCT01036594|Ketoconazole|ketoconazole|mesh-list
56521984|NCT01036594|Dexamethasone|dexamethasone|mesh-list
56521985|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
56521986|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
56521987|NCT01036594|BB 1101|bb 1101|mesh-list
56521988|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521989|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
56649641|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56649642|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
56649643|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649644|NCT04169256|Bupivacaine|bupivacaine|mesh-list
56649645|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
56649646|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
56649647|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649648|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649649|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
56649650|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649651|NCT02658396|Bortezomib|bortezomib|mesh-list
56649652|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521990|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
56521991|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56521992|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521993|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56521994|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
56521995|NCT01036594|Hormones|hormones|mesh-ancestor
56521996|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56521997|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56521998|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521999|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
56522000|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522001|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522002|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
56522003|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522005|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56522006|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56522007|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
56522008|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56522009|NCT04301908|Interferons|interferons|mesh-list
56522010|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522011|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
56522012|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522013|NCT04304248|Paclitaxel|paclitaxel|mesh-list
56522014|NCT04304248|Carboplatin|carboplatin|mesh-list
56522015|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56522016|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56522017|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522018|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56522019|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56522020|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56522021|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522022|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56522023|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56522024|NCT01268046|Estradiol|estradiol|mesh-list
56522025|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56522026|NCT01268046|Estrogens|estrogens|mesh-list
56522027|NCT01268046|Hormones|hormones|mesh-ancestor
56522028|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56270148|NCT01995006|Dipyrone|dipyrone|mesh-list
56522029|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522030|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56522031|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
56522032|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56522033|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56522034|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
56522035|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56522036|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
56522037|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522038|NCT04732000|Expectorants|expectorants|mesh-ancestor
56522039|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
56522040|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56649653|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
56649654|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649655|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649656|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56522041|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
56522042|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522043|NCT04732000|Protective Agents|protective agents|mesh-ancestor
56522044|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522045|NCT04732000|Antidotes|antidotes|mesh-ancestor
56522046|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
56522047|NCT01267266|Saracatinib|saracatinib|mesh-list
56522048|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522049|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522050|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522051|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522052|NCT01034176|Levofloxacin|levofloxacin|mesh-list
56522054|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56522055|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522056|NCT01034176|Renal Agents|renal agents|mesh-ancestor
56522057|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56522058|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56522059|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56522060|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522061|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522062|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522063|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56522064|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56522065|NCT02889432|Melatonin|melatonin|mesh-list
56522066|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
56522067|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522068|NCT02889432|Protective Agents|protective agents|mesh-ancestor
56522069|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522070|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56522071|NCT01033942|Tenofovir|tenofovir|mesh-list
56522072|NCT01033942|Emtricitabine|emtricitabine|mesh-list
56522073|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
56522074|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522075|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56522076|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56522077|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522078|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522079|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56522080|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56522081|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
56522082|NCT01062256|Guaifenesin|guaifenesin|mesh-list
56522083|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56522084|NCT01062256|Expectorants|expectorants|mesh-ancestor
56522085|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
56522086|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56522087|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56522088|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
56522089|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522090|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522091|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522092|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
56522093|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56522094|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
56522095|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
56522096|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522097|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
56522098|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56522099|NCT01029886|Liraglutide|liraglutide|mesh-list
56522100|NCT01029886|Exenatide|exenatide|mesh-list
56522101|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56270222|NCT01995292|Anesthetics|anesthetics|mesh-list
56522102|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522103|NCT01029886|Incretins|incretins|mesh-ancestor
56522105|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56522106|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56522107|NCT01244061|Varenicline|varenicline|mesh-list
56649657|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56649658|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733170|NCT00400946|Dexamethasone|dexamethasone|mesh-list
56522108|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56522109|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56522110|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
56522111|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522112|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522113|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522114|NCT01243671|Adalimumab|adalimumab|mesh-list
56522115|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522116|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522117|NCT01240785|Metformin|metformin|mesh-list
56522118|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56522119|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522120|NCT01033240|Sorafenib|sorafenib|mesh-list
56522121|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522122|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56522123|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522124|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522125|NCT01032382|Gentamicins|gentamicins|mesh-list
56522126|NCT01032382|Paromomycin|paromomycin|mesh-list
56522127|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56522128|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522129|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56522130|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522131|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522132|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56522133|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56522134|NCT01029652|Triamcinolone|triamcinolone|mesh-list
56522135|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56522136|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56522137|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56522138|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56522139|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522140|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
56522141|NCT01029652|Hormones|hormones|mesh-ancestor
56522142|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56522143|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522144|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56522145|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
56522146|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522147|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522148|NCT01029340|Factor VIII|factor viii|mesh-list
56522149|NCT01029340|Coagulants|coagulants|mesh-ancestor
56522150|NCT01265550|Baclofen|baclofen|mesh-list
56522151|NCT01265550|Desipramine|desipramine|mesh-list
56522152|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56522153|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522157|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
56522158|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
56522159|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522160|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522161|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56522162|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
56522163|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522164|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522165|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56522166|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56522167|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522168|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
56522169|NCT01265394|Flutemetamol|flutemetamol|mesh-list
56522170|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56522171|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522172|NCT01029262|Lenalidomide|lenalidomide|mesh-list
56522173|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
56522174|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522175|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56522176|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56522177|NCT01029262|Growth Substances|growth substances|mesh-ancestor
56522178|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56522179|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522181|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56649659|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649660|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649661|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56649662|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56649663|NCT00894803|Eptifibatide|eptifibatide|mesh-list
56649664|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56649665|NCT00601458|Naproxen|naproxen|mesh-list
56649666|NCT00601458|Pregabalin|pregabalin|mesh-list
56649667|NCT00601458|Analgesics|analgesics|mesh-ancestor
56649668|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
56649669|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522182|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56522183|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
56522184|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522185|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522186|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522187|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
56522188|NCT01028014|Ephedrine|ephedrine|mesh-list
56522189|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
56522190|NCT01028014|Imipramine|imipramine|mesh-list
56522191|NCT01028014|Tamsulosin|tamsulosin|mesh-list
56522192|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
56522193|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56522194|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56522195|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56522196|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
56522197|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522198|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522199|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522200|NCT01028014|Urological Agents|urological agents|mesh-ancestor
56522201|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56522202|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56522203|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
56522204|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56522205|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
56522206|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522207|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56522208|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
56522209|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
56522210|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56522211|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56522212|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
56522213|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56522214|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
56522215|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522216|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56522217|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56522218|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56522219|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56522220|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56522221|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56522222|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522223|NCT01264770|Adalimumab|adalimumab|mesh-list
56522224|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522225|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522226|NCT02873650|Dabrafenib|dabrafenib|mesh-list
56522228|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56522229|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522230|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522231|NCT01302080|Sertraline|sertraline|mesh-list
56522232|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
56522233|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522234|NCT01302080|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56649670|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522235|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56522236|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522237|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522238|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522239|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
56522240|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522241|NCT01032070|Etoposide|etoposide|mesh-list
56522242|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56522243|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56522244|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522245|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56522246|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56522247|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522248|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522249|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56522250|NCT01237899|Eplerenone|eplerenone|mesh-list
56522251|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56270372|NCT01996306|Vitamins|vitamins|mesh-ancestor
56522252|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
56522253|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56522254|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522255|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56522256|NCT01237899|Diuretics|diuretics|mesh-ancestor
56522257|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
56522258|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56522259|NCT01263444|Timolol|timolol|mesh-list
56522260|NCT01263444|Bimatoprost|bimatoprost|mesh-list
56522261|NCT01263444|Travoprost|travoprost|mesh-list
56522262|NCT01263444|Latanoprost|latanoprost|mesh-list
56522263|NCT01263444|Brinzolamide|brinzolamide|mesh-list
56522264|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56522265|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56522266|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
56522267|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522268|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522269|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522270|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56522271|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56522272|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56522273|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56522274|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56522275|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522276|NCT01031836|Sifalimumab|sifalimumab|mesh-list
56522277|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56522278|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
56522279|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522280|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56522281|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56522282|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56522283|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522284|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522285|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522286|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522287|NCT01237587|Analgesics|analgesics|mesh-ancestor
56522288|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
56522289|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522290|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
56522291|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522292|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
56522293|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
56522294|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56522295|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522296|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56522297|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522298|NCT01031446|Paclitaxel|paclitaxel|mesh-list
56522299|NCT01031446|Everolimus|everolimus|mesh-list
56522300|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56522301|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522302|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
56522303|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
56522304|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
56649671|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
56649672|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56649673|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733171|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
56522305|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522306|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56522307|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
56522308|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522309|NCT01030900|Prednisone|prednisone|mesh-list
56522310|NCT01030900|Cyclophosphamide|cyclophosphamide|mesh-list
56522311|NCT01030900|Rituximab|rituximab|mesh-list
56522312|NCT01030900|Doxorubicin|doxorubicin|mesh-list
56522313|NCT01030900|Etoposide|etoposide|mesh-list
56522314|NCT01030900|Vincristine|vincristine|mesh-list
56522315|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
56522316|NCT01030900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56522317|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
56522318|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522319|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522320|NCT01030900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56522321|NCT01030900|Alkylating Agents|alkylating agents|mesh-ancestor
56522322|NCT01030900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522323|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522324|NCT01030900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56522325|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56522326|NCT01030900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56522327|NCT01030900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56522328|NCT01030900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56522329|NCT01030900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522330|NCT01030900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522331|NCT01030900|Glucocorticoids|glucocorticoids|mesh-ancestor
56522332|NCT01030900|Hormones|hormones|mesh-ancestor
56522333|NCT01030900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56522334|NCT01030900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56522335|NCT01030900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56522336|NCT01030900|Tubulin Modulators|tubulin modulators|mesh-ancestor
56522337|NCT01030900|Antimitotic Agents|antimitotic agents|mesh-ancestor
56522338|NCT01030900|Mitosis Modulators|mitosis modulators|mesh-ancestor
56522339|NCT01030822|Vaccines|vaccines|mesh-list
56522340|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56522341|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
56522342|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522343|NCT01026454|Valacyclovir|valacyclovir|mesh-list
56522344|NCT01026454|Acyclovir|acyclovir|mesh-list
56522345|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
56522346|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522347|NCT01026220|Prednisone|prednisone|mesh-list
56522348|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
56522349|NCT01026220|Ifosfamide|ifosfamide|mesh-list
56522350|NCT01026220|Doxorubicin|doxorubicin|mesh-list
56522351|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56522352|NCT01026220|Etoposide|etoposide|mesh-list
56522353|NCT01026220|Vincristine|vincristine|mesh-list
56522354|NCT01026220|Vinorelbine|vinorelbine|mesh-list
56522355|NCT01026220|Bleomycin|bleomycin|mesh-list
56522356|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
56522357|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56522358|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
56522359|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522360|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522361|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56522362|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
56168403|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56522363|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522364|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522365|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56522366|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56522367|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56522368|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56522369|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522370|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522371|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
56522372|NCT01026220|Hormones|hormones|mesh-ancestor
56268991|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649674|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649675|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56649676|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56522373|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56522374|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56522376|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
56522377|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
56522378|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
56522379|NCT01026142|Capecitabine|capecitabine|mesh-list
56522380|NCT01026142|Trastuzumab|trastuzumab|mesh-list
56522381|NCT01026142|Pertuzumab|pertuzumab|mesh-list
56522382|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56522383|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
56522384|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522385|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522386|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56522387|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
56522388|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56522389|NCT01030666|Doxycycline|doxycycline|mesh-list
56522390|NCT01030666|Ibuprofen|ibuprofen|mesh-list
56522391|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56522392|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56522393|NCT01030666|Analgesics|analgesics|mesh-ancestor
56522394|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
56522395|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522396|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522397|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522398|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522399|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56522400|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522401|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522402|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56270524|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
56522403|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522404|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
56522405|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
56522406|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56522407|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
56522408|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56522409|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56522410|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56522411|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
56522412|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522413|NCT04304014|Sulfalene|sulfalene|mesh-list
56522414|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522415|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56522416|NCT04304014|Renal Agents|renal agents|mesh-ancestor
56522417|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
56522418|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56522419|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56522420|NCT01058668|Cariprazine|cariprazine|mesh-list
56522421|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56522422|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56522423|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56522424|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522425|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522426|NCT00623558|Docetaxel|docetaxel|mesh-list
56522427|NCT00623558|Cetuximab|cetuximab|mesh-list
56522428|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522429|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
56522430|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
56522431|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
56522432|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522433|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56522434|NCT01301066|Pravastatin|pravastatin|mesh-list
56522435|NCT01301066|Pitavastatin|pitavastatin|mesh-list
56522436|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56522437|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56522438|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
56522439|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522440|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56522441|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56649677|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649678|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56522442|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522443|NCT01022398|Vitamin D|vitamin d|mesh-list
56522444|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
56522445|NCT01022398|Vitamins|vitamins|mesh-ancestor
56522446|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
56522447|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522448|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56522449|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56522454|NCT05642624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56522455|NCT05642624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56522456|NCT05642624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522457|NCT05642624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56522458|NCT05642624|Antifungal Agents|antifungal agents|mesh-ancestor
56522459|NCT05642624|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56522460|NCT05642624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56522461|NCT05027308|Teduglutide|teduglutide|mesh-list
56522462|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56522463|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56522464|NCT05027308|Protective Agents|protective agents|mesh-ancestor
56522465|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522466|NCT04324346|Paclitaxel|paclitaxel|mesh-list
56522467|NCT04324346|Docetaxel|docetaxel|mesh-list
56522468|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56522469|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522470|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
56522471|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
56522472|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
56522473|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522474|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
56522475|NCT02890238|Citric Acid|citric acid|mesh-list
56522476|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
56522477|NCT02890238|Clomiphene|clomiphene|mesh-list
56522478|NCT02890238|Enclomiphene|enclomiphene|mesh-list
56522479|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
56522480|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
56522481|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56522482|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
56522483|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
56522484|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522485|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
56522486|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56522487|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56522488|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522489|NCT02890238|Urological Agents|urological agents|mesh-ancestor
56522490|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56522491|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
56522492|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56522493|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522494|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56522495|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
56522496|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56522497|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56522498|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56522499|NCT00627796|Lanreotide|lanreotide|mesh-list
56522500|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522507|NCT01299896|Nicotine|nicotine|mesh-list
56522508|NCT01299896|Varenicline|varenicline|mesh-list
56522509|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56522510|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
56522511|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522512|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522513|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56522514|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56522515|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
56522516|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522517|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522518|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56522519|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
56522520|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522521|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56522522|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56522523|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56649679|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649680|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56649681|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56649682|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522524|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
56522525|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56522526|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56522527|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522528|NCT01299584|Remifentanil|remifentanil|mesh-list
56522540|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522541|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522542|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56522543|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
56522544|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522545|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522546|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56522547|NCT04323228|Antioxidants|antioxidants|mesh-list
56522548|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522549|NCT04323228|Protective Agents|protective agents|mesh-ancestor
56522550|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522552|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
56522553|NCT04322760|Bupivacaine|bupivacaine|mesh-list
56522554|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
56522555|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
56270673|NCT01998126|Nivolumab|nivolumab|mesh-list
56522556|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56522557|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522558|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
56522559|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522560|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56522561|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56522562|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56522563|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522564|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522565|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56522566|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56522567|NCT04322760|Analgesics|analgesics|mesh-ancestor
56522568|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56522569|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56522570|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56522571|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
56522572|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522573|NCT04322214|Cobicistat|cobicistat|mesh-list
56522574|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56522575|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56522576|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
56522577|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522578|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56522579|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56522580|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522581|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522582|NCT01057810|Ipilimumab|ipilimumab|mesh-list
56522583|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56522584|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522585|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56522586|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522587|NCT01262352|Ivacaftor|ivacaftor|mesh-list
56522588|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56522589|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56144526|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56522590|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522592|NCT01299272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56522593|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56522594|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
56522595|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522596|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522597|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649683|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56649684|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
56649685|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56649686|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522598|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56522599|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522600|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
56522601|NCT01299116|Etonogestrel|etonogestrel|mesh-list
56522602|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
56522603|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56522604|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522605|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56522606|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56522607|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56522608|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56522609|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
56522610|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522611|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522612|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522613|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56522614|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56522615|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56522616|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
56522617|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522618|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56522619|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56522620|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522621|NCT04321278|Azithromycin|azithromycin|mesh-list
56522622|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
56522623|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56522624|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522625|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
56522626|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56522627|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56522628|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522629|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522630|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522631|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
56522632|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56522633|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56522634|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
56522635|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522636|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56522637|NCT01260948|Donepezil|donepezil|mesh-list
56522638|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56522639|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522640|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522641|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
56522642|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522643|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522644|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
56522645|NCT01025284|Lenograstim|lenograstim|mesh-list
56168417|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56522646|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56522647|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
56522648|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522649|NCT02873026|Triamcinolone|triamcinolone|mesh-list
56522650|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56522651|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56522652|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56522653|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522654|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
56522655|NCT02873026|Hormones|hormones|mesh-ancestor
56522656|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56522657|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522658|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56522659|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
56522660|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745711|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
56522670|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649687|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
56649688|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56522672|NCT01298570|Leucovorin|leucovorin|mesh-list
56522673|NCT01298570|Fluorouracil|fluorouracil|mesh-list
56522674|NCT01298570|Irinotecan|irinotecan|mesh-list
56522675|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
56522676|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
56522677|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522678|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56522679|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522680|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56522681|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
56522682|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522683|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56522684|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56522685|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522686|NCT01298570|Antidotes|antidotes|mesh-ancestor
56522687|NCT01298570|Protective Agents|protective agents|mesh-ancestor
56522688|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
56522689|NCT01298570|Vitamins|vitamins|mesh-ancestor
56522690|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
56522691|NCT01259856|Aspirin|aspirin|mesh-list
56522692|NCT01259856|Interferons|interferons|mesh-list
56522693|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
56522694|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
56522695|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56522696|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
56522697|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522698|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
56522699|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522700|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56522701|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56522702|NCT01259856|Analgesics|analgesics|mesh-ancestor
56522703|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
56522704|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522705|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522706|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522707|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522708|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56522709|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56522710|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522711|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56522712|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56522713|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522714|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
56522715|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
56522716|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
56522717|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56522718|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56522719|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56522720|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56522721|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522723|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56522724|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
56522725|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522726|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522727|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56522739|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56522740|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522741|NCT05569044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56522742|NCT05525910|Ritonavir|ritonavir|mesh-list
56522743|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56522744|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56522745|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
56522746|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522747|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522748|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56522749|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56522750|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
56522751|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522752|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56522753|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56522754|NCT00624078|Antivenins|antivenins|mesh-list
56522755|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
56522756|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649689|NCT02660736|Incretins|incretins|mesh-ancestor
56649690|NCT02660736|Hormones|hormones|mesh-ancestor
56649691|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649692|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522757|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
56522758|NCT05286528|Dasatinib|dasatinib|mesh-list
56522759|NCT05286528|Ponatinib|ponatinib|mesh-list
56522760|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522761|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56522762|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522763|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522764|NCT04752696|Leucovorin|leucovorin|mesh-list
56522765|NCT04752696|Fluorouracil|fluorouracil|mesh-list
56522766|NCT04752696|Irinotecan|irinotecan|mesh-list
56522767|NCT04752696|Onvansertib|onvansertib|mesh-list
56522768|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
56522769|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522770|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56522771|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522772|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56522773|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
56522774|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522775|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56522776|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56522777|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522778|NCT04752696|Antidotes|antidotes|mesh-ancestor
56270902|NCT01999829|Caffeine|caffeine|mesh-list
56522779|NCT04752696|Protective Agents|protective agents|mesh-ancestor
56522780|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
56522781|NCT04752696|Vitamins|vitamins|mesh-ancestor
56522782|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
56522783|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56522784|NCT04554732|Mitogens|mitogens|mesh-list
56168427|NCT00364026|Darusentan|darusentan|mesh-list
56522785|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
56522786|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522788|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56522789|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522790|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56522791|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522813|NCT03181932|Vancomycin|vancomycin|mesh-list
56522814|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56522815|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522816|NCT02797470|Cytarabine|cytarabine|mesh-list
56522817|NCT02797470|Etoposide|etoposide|mesh-list
56522818|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
56522819|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
56522820|NCT02797470|Melphalan|melphalan|mesh-list
56522821|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
56522822|NCT02797470|Carmustine|carmustine|mesh-list
56522823|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56522824|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56522825|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522826|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56522827|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56522828|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522829|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522830|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56522831|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
56522832|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
56522833|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522834|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56522835|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
56522836|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522837|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56522838|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
56522839|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56522840|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
56522841|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
56522842|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56522843|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56522844|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56522845|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
56522846|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56649693|NCT00649584|Gemcitabine|gemcitabine|mesh-list
56649694|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56649695|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56649696|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
56522847|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
56522849|NCT02583672|Expectorants|expectorants|mesh-ancestor
56522850|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
56522851|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56270976|NCT02000388|Ketorolac|ketorolac|mesh-list
56522852|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
56522853|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522854|NCT02583672|Protective Agents|protective agents|mesh-ancestor
56522856|NCT02583672|Antidotes|antidotes|mesh-ancestor
56522857|NCT02888730|Tobramycin|tobramycin|mesh-list
56522858|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56522859|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522860|NCT01696734|Domperidone|domperidone|mesh-list
56522861|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
56522862|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
56522863|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522864|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522865|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56522866|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56522867|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
56522868|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522869|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522870|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56522871|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56522872|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56522873|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522874|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522875|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522876|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522877|NCT01598298|Analgesics|analgesics|mesh-ancestor
56522878|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
56522879|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522880|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
56522881|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522882|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
56522883|NCT02888652|Clopidogrel|clopidogrel|mesh-list
56522884|NCT02888652|Ticagrelor|ticagrelor|mesh-list
56522885|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56522886|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56522887|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56522888|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56522889|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
56522890|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522891|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522892|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522893|NCT01235949|Acetaminophen|acetaminophen|mesh-list
56522894|NCT01235949|Ibuprofen|ibuprofen|mesh-list
56522895|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56522896|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56522897|NCT01235949|Analgesics|analgesics|mesh-ancestor
56522898|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
56522899|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522900|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522901|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522902|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522903|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56522904|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522905|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522906|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
56522907|NCT00691158|Pramlintide|pramlintide|mesh-list
56522908|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
56522909|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56522910|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522911|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
56522912|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56522913|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
56522914|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649697|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649698|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649699|NCT00649584|Antiviral Agents|antiviral agents|mesh-ancestor
56649700|NCT00649584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649701|NCT00649584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649702|NCT00649584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789634|NCT04900415|Vitamin A|vitamin a|mesh-list
56522915|NCT01235793|Temozolomide|temozolomide|mesh-list
56522916|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56522917|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
56522918|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522919|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522920|NCT05601648|Psilocybin|psilocybin|mesh-list
56522921|NCT05601648|Hallucinogens|hallucinogens|mesh-ancestor
56522922|NCT05601648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522923|NCT05601648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522924|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56522925|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
56522926|NCT01235715|Coagulants|coagulants|mesh-ancestor
56522927|NCT01235403|Lacosamide|lacosamide|mesh-list
56522928|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
56522929|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56271048|NCT02001012|Amebicides|amebicides|mesh-ancestor
56522931|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522932|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522933|NCT01024036|Siltuximab|siltuximab|mesh-list
56522934|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522935|NCT01234467|Rituximab|rituximab|mesh-list
56522936|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56522937|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56522938|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522939|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
56522940|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522941|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522942|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56522943|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
56522944|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522945|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
56522946|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56522947|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56522948|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56522949|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56522950|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522951|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
56522952|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522953|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522954|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56522955|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522956|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56522957|NCT01233687|Rilotumumab|rilotumumab|mesh-list
56522958|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522959|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56522960|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522961|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522962|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56522963|NCT01233609|Valproic Acid|valproic acid|mesh-list
56522964|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
56522965|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522966|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522967|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
56522968|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522969|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522970|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
56522971|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56522972|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56522973|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522974|NCT01232283|Apremilast|apremilast|mesh-list
56268992|NCT01986283|Oxycodone|oxycodone|mesh-list
56649703|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
56649704|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649705|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56522975|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56522976|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56522977|NCT01232283|Analgesics|analgesics|mesh-ancestor
56522978|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
56522979|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522980|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522981|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56522982|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56522983|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56522984|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56522985|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522986|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522987|NCT01232127|Ritonavir|ritonavir|mesh-list
56522988|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56522989|NCT01232127|Tenofovir|tenofovir|mesh-list
56522990|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56522991|NCT01232127|Famotidine|famotidine|mesh-list
56522992|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56522993|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56522994|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
56522995|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522997|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56522998|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56522999|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
56523000|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523001|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56523002|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56523003|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56523004|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56523005|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56523006|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56523007|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
56523008|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
56523009|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523010|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523011|NCT01258608|Sorafenib|sorafenib|mesh-list
56523012|NCT01258608|Mapatumumab|mapatumumab|mesh-list
56523013|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523014|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56523015|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523016|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523017|NCT01231659|Everolimus|everolimus|mesh-list
56523018|NCT01231659|Letrozole|letrozole|mesh-list
56523019|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523020|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56523021|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
56523022|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523023|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56523024|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56523025|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523026|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523027|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56523028|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
56523029|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523030|NCT02875288|Bupivacaine|bupivacaine|mesh-list
56523031|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
56523032|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
56523033|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523034|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523035|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
56523036|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523037|NCT01054222|Fesoterodine|fesoterodine|mesh-list
56523038|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56523039|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56523040|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
56523041|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523042|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523043|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649706|NCT02141282|Venetoclax|venetoclax|mesh-list
56649707|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649708|NCT02657616|Vitamin K|vitamin k|mesh-list
56523044|NCT01054222|Urological Agents|urological agents|mesh-ancestor
56523045|NCT01052428|Metoprolol|metoprolol|mesh-list
56523046|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56523047|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56523048|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
56523049|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
56523050|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523051|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523052|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56523053|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56523054|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56523055|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
56523056|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523057|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523058|NCT01052272|Allopurinol|allopurinol|mesh-list
56523059|NCT01052272|Candesartan|candesartan|mesh-list
56523060|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
56523061|NCT01052272|Ramipril|ramipril|mesh-list
56523062|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56523063|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56523064|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56523065|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523067|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523068|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
56523090|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56523092|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523093|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523094|NCT01231581|Antiviral Agents|antiviral agents|mesh-ancestor
56523095|NCT01231581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523096|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523097|NCT01231581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56523098|NCT01231581|Immunologic Factors|immunologic factors|mesh-ancestor
56523099|NCT01231581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523100|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56523101|NCT01050634|Exemestane|exemestane|mesh-list
56523102|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523103|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56523104|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56523105|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523106|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523107|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56523108|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
56523109|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523110|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523111|NCT01020526|Pregabalin|pregabalin|mesh-list
56523112|NCT01020526|Analgesics|analgesics|mesh-ancestor
56523113|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
56523114|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523115|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523116|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
56523117|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56523118|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56523119|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523120|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56523121|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56523122|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56523123|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523124|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56523134|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56523135|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56523136|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523137|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
56523138|NCT01256658|Lumefantrine|lumefantrine|mesh-list
56523139|NCT01256658|Artemether|artemether|mesh-list
56523140|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56523141|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
56523142|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56523143|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56523144|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649709|NCT02657616|Anticoagulants|anticoagulants|mesh-list
56649710|NCT02657616|Vitamins|vitamins|mesh-ancestor
56649711|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
56649712|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649713|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56649714|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56649715|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649716|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
56649717|NCT02657616|Coagulants|coagulants|mesh-ancestor
56649718|NCT05288777|Capecitabine|capecitabine|mesh-list
56649719|NCT05288777|Trastuzumab|trastuzumab|mesh-list
56649720|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56649721|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56649722|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
56649723|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649724|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523145|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56523146|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
56523147|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
56523148|NCT01256190|Coagulants|coagulants|mesh-ancestor
56523149|NCT02888574|Oxytocin|oxytocin|mesh-list
56523150|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
56271272|NCT02001948|Analgesics|analgesics|mesh-ancestor
56523151|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56523152|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523153|NCT01231503|Vaccines|vaccines|mesh-list
56523154|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
56523155|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523156|NCT01228071|Testosterone|testosterone|mesh-list
56523157|NCT01228071|Androgens|androgens|mesh-ancestor
56523158|NCT01228071|Hormones|hormones|mesh-ancestor
56523159|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523160|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523161|NCT04319289|Vitamin D|vitamin d|mesh-list
56523162|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
56523163|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
56523164|NCT04319289|Vitamins|vitamins|mesh-list
56523165|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
56523166|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523167|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56523168|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56523169|NCT01008475|Irinotecan|irinotecan|mesh-list
56523170|NCT01008475|Cetuximab|cetuximab|mesh-list
56523171|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56523172|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56523173|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523174|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523175|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523176|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56523177|NCT01226745|Ceralifimod|ceralifimod|mesh-list
56523178|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56523179|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523180|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56523181|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
56523182|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523183|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56523184|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56523185|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56523186|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56523187|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649725|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649726|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
56649727|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
56523188|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523189|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523190|NCT01226511|Analgesics|analgesics|mesh-ancestor
56523191|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
56523192|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523193|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
56523194|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56523195|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
56523196|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
56523197|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523198|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523200|NCT01001377|Panitumumab|panitumumab|mesh-list
56523201|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56523202|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523203|NCT01225887|Nintedanib|nintedanib|mesh-list
56523204|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168453|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
56523205|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56523206|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523207|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523209|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56523210|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523211|NCT01296698|Nicotine|nicotine|mesh-list
56523212|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56523213|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
56523214|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523215|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523216|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56523217|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56523218|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
56523219|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523220|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523221|NCT01001221|Gemcitabine|gemcitabine|mesh-list
56523222|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56523223|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
56523224|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523225|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523226|NCT01001221|Antiviral Agents|antiviral agents|mesh-ancestor
56523227|NCT01001221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523228|NCT01001221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523229|NCT01001221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56523230|NCT01001221|Immunologic Factors|immunologic factors|mesh-ancestor
56523231|NCT01001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523232|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56523233|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
56523234|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56523235|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56523236|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56523237|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
56523238|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56523239|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523240|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56523241|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56523242|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56523243|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56523244|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523245|NCT04373317|Pimavanserin|pimavanserin|mesh-list
56523246|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56523247|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
56523248|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56523249|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56523250|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56523251|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523252|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523253|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56523254|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56523255|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56523256|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56649728|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
56649729|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
56649730|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56523257|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
56523258|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523259|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523260|NCT01002547|Vitamins|vitamins|mesh-list
56523261|NCT01002547|Vitamin E|vitamin e|mesh-list
56523262|NCT01002547|Tocopherols|tocopherols|mesh-list
56523263|NCT01002547|Tocotrienols|tocotrienols|mesh-list
56523272|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
56523273|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523274|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56523275|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523276|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523277|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
56523278|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523279|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523280|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56523281|NCT04325659|Lofexidine|lofexidine|mesh-list
56523282|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56523283|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56523284|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523285|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
56523286|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523287|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56523288|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56523289|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56523290|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
56523291|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523292|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523293|NCT04313881|Azacitidine|azacitidine|mesh-list
56523294|NCT04313881|Magrolimab|magrolimab|mesh-list
56523295|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56523296|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
56523297|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523298|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523299|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523300|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56523301|NCT01007149|Omalizumab|omalizumab|mesh-list
56523302|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56523303|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56523304|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
56523305|NCT04433767|Nicotine|nicotine|mesh-list
56523306|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56523307|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
56523308|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523309|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523310|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56523311|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56523312|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
56523313|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523314|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523315|NCT00998335|Insulin|insulin|mesh-list
56523316|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56523317|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
56523318|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
56523319|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56523320|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
56523321|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523322|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523323|NCT02871505|Penicillins|penicillins|mesh-list
56523324|NCT02871505|Penicillin G|penicillin g|mesh-list
56523325|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56523326|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
56523327|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56523328|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523339|NCT01006603|Saxagliptin|saxagliptin|mesh-list
56523340|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56523341|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523342|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523343|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649731|NCT02657694|Ledipasvir|ledipasvir|mesh-list
56649732|NCT02657694|Velpatasvir|velpatasvir|mesh-list
56649733|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
56649734|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649735|NCT02657460|Cisplatin|cisplatin|mesh-list
56523344|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
56523345|NCT01006603|Incretins|incretins|mesh-ancestor
56523346|NCT01006603|Hormones|hormones|mesh-ancestor
56523347|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523348|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56523349|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
56523350|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523351|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523352|NCT00997321|Ketamine|ketamine|mesh-list
56523353|NCT00997321|Propofol|propofol|mesh-list
56523354|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56523355|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523356|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523357|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56523358|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
56523359|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
56523360|NCT00997321|Analgesics|analgesics|mesh-ancestor
56523361|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
56523362|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523363|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56523364|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56523365|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56523366|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523367|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523368|NCT01294592|Tamsulosin|tamsulosin|mesh-list
56523369|NCT01294592|Dutasteride|dutasteride|mesh-list
56523370|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56523371|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56523372|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56523373|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
56523374|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523375|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523376|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523377|NCT01294592|Urological Agents|urological agents|mesh-ancestor
56523378|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56523379|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56523380|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523381|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
56523382|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523383|NCT00997243|Azacitidine|azacitidine|mesh-list
56523384|NCT00997243|Lintuzumab|lintuzumab|mesh-list
56523385|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56523386|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
56523387|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523388|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523389|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523390|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56523391|NCT02869321|Fentanyl|fentanyl|mesh-list
56523392|NCT02869321|Morphine|morphine|mesh-list
56523402|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
56523403|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
56523404|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
56523405|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56523406|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523407|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523408|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523409|NCT01294358|Gemcitabine|gemcitabine|mesh-list
56523410|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56523411|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
56523412|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523413|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523414|NCT01294358|Antiviral Agents|antiviral agents|mesh-ancestor
56523415|NCT01294358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523416|NCT01294358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523417|NCT01294358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56649736|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649737|NCT00649896|Estradiol|estradiol|mesh-list
56649738|NCT00649896|Estrogens|estrogens|mesh-ancestor
56649739|NCT00649896|Hormones|hormones|mesh-ancestor
56733172|NCT00400946|Prednisolone|prednisolone|mesh-list
56523418|NCT01294358|Immunologic Factors|immunologic factors|mesh-ancestor
56523419|NCT01294358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523420|NCT01224639|Vaccines|vaccines|mesh-list
56523421|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
56523422|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523423|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
56523424|NCT01293968|Promethazine|promethazine|mesh-list
56523425|NCT01293968|Ibuprofen|ibuprofen|mesh-list
56523426|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56523427|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56523428|NCT01293968|Analgesics|analgesics|mesh-ancestor
56523429|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
56523430|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523431|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523432|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56523433|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56523434|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56523435|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523436|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523437|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56523438|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56523439|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523440|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
56523441|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
56523442|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
56523443|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
56523444|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56523445|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56523446|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
56523447|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
56523448|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271575|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
56523449|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56523450|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
56523451|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
56523452|NCT01293032|Tamoxifen|tamoxifen|mesh-list
56523453|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56523454|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523455|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56523456|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
56523468|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56523469|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
56523470|NCT01223937|Coagulants|coagulants|mesh-ancestor
56523471|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56523472|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
56523473|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523474|NCT01223235|Bevacizumab|bevacizumab|mesh-list
56523475|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56523476|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523477|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56523478|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56523479|NCT01223235|Growth Substances|growth substances|mesh-ancestor
56523480|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523481|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
56523482|NCT00993967|Idebenone|idebenone|mesh-list
56523483|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
56523484|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523485|NCT00993967|Protective Agents|protective agents|mesh-ancestor
56523486|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523487|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
56523488|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56523489|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
56523490|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523491|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523492|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56523493|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
56523494|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
56523495|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56523496|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
56649740|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649741|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649742|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
56523497|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523498|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523499|NCT01221753|Carboplatin|carboplatin|mesh-list
56523500|NCT01221753|Docetaxel|docetaxel|mesh-list
56523501|NCT01221753|Fluorouracil|fluorouracil|mesh-list
56523502|NCT01221753|Cetuximab|cetuximab|mesh-list
56523503|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523504|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
56523505|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
56523506|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
56523507|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523508|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
56523509|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56523510|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56523511|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
56523512|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523513|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56523514|NCT02888223|Factor VIII|factor viii|mesh-list
56523515|NCT02888223|Coagulants|coagulants|mesh-ancestor
56523516|NCT01014988|Zanamivir|zanamivir|mesh-list
56523517|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
56523518|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523519|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523537|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56523538|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523539|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56523540|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523541|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
56523542|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56523543|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
56523544|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523545|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56523546|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523547|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523548|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
56523549|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56523550|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523551|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56523552|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
56523553|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56523554|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523555|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523556|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523557|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56523558|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56523559|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
56523560|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523561|NCT02869165|Estrogens|estrogens|mesh-list
56523562|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56523563|NCT02869165|Hormones|hormones|mesh-ancestor
56523564|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523565|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523566|NCT01219959|Icodextrin|icodextrin|mesh-list
56523567|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
56523568|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56523569|NCT00993421|Sibutramine|sibutramine|mesh-list
56523570|NCT00993421|Metoprolol|metoprolol|mesh-list
56523571|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56523572|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56523573|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
56523574|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
56523575|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523576|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523577|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56523578|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56523579|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56523580|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
56523581|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268993|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56649743|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649744|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649745|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56649746|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56649747|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649748|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649749|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649750|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56649751|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56649752|NCT04188158|Capecitabine|capecitabine|mesh-list
56649753|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
56523582|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523583|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
56523584|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56523585|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
56523586|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56523587|NCT01014208|Rituximab|rituximab|mesh-list
56523588|NCT01014208|Ofatumumab|ofatumumab|mesh-list
56523589|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56523590|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523591|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
56523592|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523593|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56523594|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
56523595|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56523596|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56523597|NCT04205578|Protective Agents|protective agents|mesh-ancestor
56523598|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523599|NCT00991939|Dexamethasone|dexamethasone|mesh-list
56523600|NCT00991939|Prednisone|prednisone|mesh-list
56523601|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56523602|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
56523603|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
56523604|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523605|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523606|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56523607|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
56523608|NCT00991939|Hormones|hormones|mesh-ancestor
56523609|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523610|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56523611|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523612|NCT02868385|Praziquantel|praziquantel|mesh-list
56523613|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
56523614|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56523615|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523616|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
56523617|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56523618|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
56523619|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523620|NCT00993265|Expectorants|expectorants|mesh-ancestor
56523621|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
56523622|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56523623|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
56523624|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523625|NCT00993265|Protective Agents|protective agents|mesh-ancestor
56523626|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523627|NCT00993265|Antidotes|antidotes|mesh-ancestor
56523628|NCT00993031|Ritonavir|ritonavir|mesh-list
56523629|NCT00993031|Lopinavir|lopinavir|mesh-list
56523630|NCT00993031|Lamivudine|lamivudine|mesh-list
56523631|NCT00993031|Zidovudine|zidovudine|mesh-list
56523632|NCT00993031|Efavirenz|efavirenz|mesh-list
56523633|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56523634|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56523635|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
56523636|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649754|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56649755|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
56649756|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649757|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523637|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523638|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56523639|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56523640|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
56523641|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523642|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56523643|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56523644|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56523645|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56523646|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
56523647|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56523648|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56523649|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56523650|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56523651|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56523652|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56523655|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523656|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523657|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56523658|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56523659|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56523660|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
56523661|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523662|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523663|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56523664|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56523665|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
56523666|NCT04291729|Interferons|interferons|mesh-list
56523667|NCT04291729|Ritonavir|ritonavir|mesh-list
56523668|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523669|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
56523670|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523671|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56523672|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56523673|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
56523674|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271801|NCT02005575|Bupivacaine|bupivacaine|mesh-list
56523675|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523676|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56523677|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56523678|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56523679|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56523681|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523682|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523683|NCT01018810|Interleukin-23|interleukin-23|mesh-list
56523684|NCT01018810|Antibodies|antibodies|mesh-list
56523685|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
56523686|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
56523687|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523688|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56523689|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56523690|NCT01018810|Growth Substances|growth substances|mesh-ancestor
56523691|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
56523692|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523693|NCT02867917|Psyllium|psyllium|mesh-list
56523694|NCT02867917|Cathartics|cathartics|mesh-ancestor
56523695|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56523696|NCT01018732|Lactitol|lactitol|mesh-list
56523697|NCT01018732|Cathartics|cathartics|mesh-ancestor
56523698|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56523699|NCT01218867|Aldesleukin|aldesleukin|mesh-list
56523700|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
56523701|NCT01218867|Fludarabine|fludarabine|mesh-list
56523702|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56523703|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
56523704|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649758|NCT02831231|Xanomeline|xanomeline|mesh-list
56649759|NCT02831231|Trospium chloride|trospium chloride|mesh-list
56649760|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
56649761|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
56649762|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733173|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
56523705|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56523706|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56523707|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
56523708|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523709|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523710|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56523711|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56523712|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56523713|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
56523714|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523715|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
56523716|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56523717|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56523718|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
56523719|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523720|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523721|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523722|NCT01018264|Urological Agents|urological agents|mesh-ancestor
56523723|NCT01018186|Fluticasone|fluticasone|mesh-list
56523724|NCT01018186|Xhance|xhance|mesh-list
56523725|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56523726|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56523727|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
56523741|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56523742|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56523743|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
56523744|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
56523745|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523746|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523747|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56523748|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
56271879|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
56523749|NCT04566328|Hormones|hormones|mesh-ancestor
56523750|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168503|NCT00366834|Dexamethasone|dexamethasone|mesh-list
56523751|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56523752|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523753|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
56523754|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523755|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523756|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
56523757|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56523758|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56523759|NCT04566328|Growth Substances|growth substances|mesh-ancestor
56523760|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
56523761|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
56523762|NCT00992407|Risperidone|risperidone|mesh-list
56523763|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56523764|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
56523765|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523766|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523767|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523768|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56523769|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56523770|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523771|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56523772|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56523773|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
56523774|NCT00986245|Ropinirole|ropinirole|mesh-list
56523775|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56523776|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56523777|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
56523778|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
56523779|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523780|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547629|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523781|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523782|NCT00989833|Budesonide|budesonide|mesh-list
56523783|NCT00989833|Terbutaline|terbutaline|mesh-list
56523784|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
56523785|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56523786|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56523787|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
56523788|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523789|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523790|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56523798|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
56523799|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523800|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523801|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
56523802|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
56523803|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56523804|NCT04292119|Crizotinib|crizotinib|mesh-list
56523805|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523806|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56523807|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523808|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523809|NCT01218477|Dasatinib|dasatinib|mesh-list
56523810|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523811|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56523812|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523813|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523814|NCT01218009|Albuterol|albuterol|mesh-list
56523815|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56523816|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
56523817|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523818|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523819|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56523820|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
56523821|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
56523822|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56523823|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56523824|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56523825|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56523826|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
56523828|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523829|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
56523830|NCT02868151|Vitamins|vitamins|mesh-ancestor
56523831|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
56523832|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523833|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
56523834|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523835|NCT02868151|Protective Agents|protective agents|mesh-ancestor
56523836|NCT01217307|Metformin|metformin|mesh-list
56523837|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523838|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523839|NCT02868073|Vaccines|vaccines|mesh-list
56523840|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
56523841|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523842|NCT01013740|Capecitabine|capecitabine|mesh-list
56523843|NCT01013740|Vinorelbine|vinorelbine|mesh-list
56523844|NCT01013740|Lapatinib|lapatinib|mesh-list
56523845|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56523846|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
56523847|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523848|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523849|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56523850|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
56523851|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
56523852|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
56523853|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56523854|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523855|NCT01217073|Metformin|metformin|mesh-list
56523856|NCT01217073|Pioglitazone|pioglitazone|mesh-list
56523857|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523858|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523859|NCT00985621|Oxycodone|oxycodone|mesh-list
56523860|NCT00985621|Tanezumab|tanezumab|mesh-list
56523863|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268994|NCT01986283|Narcotics|narcotics|mesh-ancestor
56523864|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523865|NCT00985621|Analgesics|analgesics|mesh-ancestor
56523866|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
56523867|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523868|NCT01215981|Vaccines|vaccines|mesh-list
56523869|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
56523870|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523871|NCT01215435|Insulin|insulin|mesh-list
56523872|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56523873|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
56523874|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
56523875|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56523876|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
56523877|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56523878|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
56523879|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523880|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523881|NCT01215357|Ecopipam|ecopipam|mesh-list
56523882|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56523883|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56523884|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523885|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523886|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56523887|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56523888|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
56523889|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523890|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523891|NCT01017874|Pemetrexed|pemetrexed|mesh-list
56523892|NCT01017874|Gefitinib|gefitinib|mesh-list
56523893|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523894|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523895|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523896|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56523897|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56523898|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56523899|NCT00627952|Amlodipine|amlodipine|mesh-list
56523900|NCT00627952|Manidipine|manidipine|mesh-list
56523901|NCT00627952|Delapril|delapril|mesh-list
56523902|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56523903|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56523904|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56523905|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523906|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56523907|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523908|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
56523909|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56523910|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
56523911|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523913|NCT01009840|Busulfan|busulfan|mesh-list
56523914|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523915|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
56523916|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523917|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56523918|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
56523919|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523920|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56523921|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56523922|NCT04420936|Benzocaine|benzocaine|mesh-list
56523923|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
56523924|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
56523925|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523926|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523927|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
56523928|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523929|NCT04542148|Insulin|insulin|mesh-list
56523930|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56523931|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
56523932|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
56523933|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523934|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523935|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
56523956|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
56523957|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56523958|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523959|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649763|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649764|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56649765|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56649766|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
56649767|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649768|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649769|NCT02831231|Urological Agents|urological agents|mesh-ancestor
56649770|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56649771|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649772|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56649773|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56649774|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
56523960|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
56523961|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523962|NCT02867293|Anesthetics|anesthetics|mesh-list
56523963|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523964|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523965|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
56523966|NCT01005316|Prednisone|prednisone|mesh-list
56523967|NCT01005316|Tacrolimus|tacrolimus|mesh-list
56523968|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
56523969|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56523970|NCT01005316|Antibodies|antibodies|mesh-list
56523971|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
56523972|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56523973|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56523974|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
56523975|NCT01005316|Hormones|hormones|mesh-ancestor
56523976|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523977|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523978|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56523979|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523980|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56523981|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
56523982|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56523983|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523984|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523985|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56523986|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56523987|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
56523988|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56523989|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523990|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56524017|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524018|NCT01004614|Amlodipine|amlodipine|mesh-list
56524019|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56524020|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56524021|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524022|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524023|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56524024|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524025|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
56524026|NCT04119037|Morphine|morphine|mesh-list
56524027|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56524028|NCT04119037|Narcotics|narcotics|mesh-ancestor
56524029|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524030|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524031|NCT04119037|Analgesics|analgesics|mesh-ancestor
56524032|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
56524033|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524034|NCT04297462|Oseltamivir|oseltamivir|mesh-list
56524035|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
56524036|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524037|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649775|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649776|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649777|NCT05237141|Etonogestrel|etonogestrel|mesh-list
56524038|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524039|NCT00981409|Heparin|heparin|mesh-list
56524040|NCT00981409|Calcium heparin|calcium heparin|mesh-list
56524041|NCT00981409|PENTA|penta|mesh-list
56524061|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56524062|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
56524063|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524064|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524065|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56524066|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56524067|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
56524068|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524069|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524070|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
56524071|NCT00628732|Topotecan|topotecan|mesh-list
56524072|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56524073|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
56524074|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524075|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524076|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56524077|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
56524078|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524079|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524080|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56524081|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56524082|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56524083|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524084|NCT04401748|Azacitidine|azacitidine|mesh-list
56524085|NCT04401748|Venetoclax|venetoclax|mesh-list
56524086|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56524087|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
56524088|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524089|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524090|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524091|NCT04131829|Fluoxetine|fluoxetine|mesh-list
56524092|NCT04131829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56524093|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56524094|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524095|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524096|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524097|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
56524098|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524100|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
56524101|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56524102|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56524103|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56524104|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524105|NCT04205344|Bupivacaine|bupivacaine|mesh-list
56524106|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
56524107|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
56524108|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524109|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524110|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
56524111|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524112|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56524113|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56524114|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56524115|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
56524116|NCT00978757|Ketamine|ketamine|mesh-list
56524117|NCT00978757|Analgesics|analgesics|mesh-ancestor
56524118|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
56524119|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168513|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56524120|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524121|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56524122|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56524124|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
56524125|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649778|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56649779|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
56649780|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56649781|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649782|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56524126|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56524127|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56524129|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524130|NCT01214421|Tolvaptan|tolvaptan|mesh-list
56524131|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56524132|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524133|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
56524134|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524135|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
56524136|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
56524137|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524138|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
56524139|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524140|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524141|NCT02866903|Bevacizumab|bevacizumab|mesh-list
56524142|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
56524143|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524144|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524145|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56524146|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56524147|NCT02866903|Growth Substances|growth substances|mesh-ancestor
56524148|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524149|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
56524150|NCT04289467|Fenfluramine|fenfluramine|mesh-list
56524151|NCT04289467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56524152|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56524153|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524154|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524155|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524156|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
56524157|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524158|NCT03945019|Infliximab|infliximab|mesh-list
56524159|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
56524160|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56524161|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524162|NCT01003990|Ritonavir|ritonavir|mesh-list
56524163|NCT01003990|Lopinavir|lopinavir|mesh-list
56524164|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56524165|NCT01003990|Tenofovir|tenofovir|mesh-list
56524166|NCT01003990|Emtricitabine|emtricitabine|mesh-list
56524167|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56524168|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56524169|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
56524170|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524171|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524172|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56524198|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56524199|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56524200|NCT00628810|Growth Substances|growth substances|mesh-ancestor
56524201|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524202|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
56524203|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56524204|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
56524205|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524206|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56524207|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56524208|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
56524209|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56524210|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56524211|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524212|NCT00628810|Antidotes|antidotes|mesh-ancestor
56524213|NCT00628810|Protective Agents|protective agents|mesh-ancestor
56524214|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
56649783|NCT00649740|Topiramate|topiramate|mesh-list
56649784|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
56649785|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56649786|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524215|NCT00628810|Vitamins|vitamins|mesh-ancestor
56524216|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
56524217|NCT00975481|Alprazolam|alprazolam|mesh-list
56524218|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56524219|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524220|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524221|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56524222|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56524223|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56524224|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
56524225|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
56524240|NCT04290013|Coagulants|coagulants|mesh-ancestor
56524241|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56524242|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56524243|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56524244|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
56524245|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56524246|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524247|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56524248|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56524249|NCT04288999|Capecitabine|capecitabine|mesh-list
56524250|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56524251|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
56524252|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524253|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524254|NCT01213173|Metoprolol|metoprolol|mesh-list
56524255|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56524256|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56524257|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
56524258|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
56524259|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524260|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524261|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56524262|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56524263|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56524264|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
56524265|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524266|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524267|NCT04095715|Hemostatics|hemostatics|mesh-list
56524268|NCT04095715|Coagulants|coagulants|mesh-ancestor
56524269|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
56524270|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524271|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
56524272|NCT02866435|Protective Agents|protective agents|mesh-ancestor
56524273|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56524274|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56524275|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524276|NCT00973765|Renal Agents|renal agents|mesh-ancestor
56524277|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56524278|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
56524279|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56524280|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56524282|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56524283|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56524284|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524285|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
56524300|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524301|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
56524302|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56524303|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56524304|NCT04288765|Growth Substances|growth substances|mesh-ancestor
56524305|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
56524306|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56524307|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
56524308|NCT02863861|Ketamine|ketamine|mesh-list
56524309|NCT02863861|Propofol|propofol|mesh-list
56524310|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56524311|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524312|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649787|NCT04209920|Chromium|chromium|mesh-list
56649788|NCT04209920|Nickel|nickel|mesh-list
56649789|NCT04209920|Trace Elements|trace elements|mesh-ancestor
55954212|NCT00048737|Rituximab|rituximab|mesh-list
56524313|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56524314|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
56524315|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
56524316|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56524317|NCT02863861|Analgesics|analgesics|mesh-ancestor
56524318|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
56524319|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524320|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56524321|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56524322|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56524323|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
56524324|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524325|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524326|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56524327|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56524328|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56524329|NCT05406765|Bupivacaine|bupivacaine|mesh-list
56524330|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
56524331|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
56524332|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524333|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524334|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
56524335|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524336|NCT03846505|Oxytocin|oxytocin|mesh-list
56524337|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
56524338|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56524339|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524340|NCT01011556|Teriparatide|teriparatide|mesh-list
56524341|NCT01011556|Hormones|hormones|mesh-list
56524342|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
56524343|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56524344|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524345|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56524346|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56524375|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56524376|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524377|NCT04287361|Clonazepam|clonazepam|mesh-list
56524378|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
56524379|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
56524380|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
56524381|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524382|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524383|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524384|NCT00624429|Budesonide|budesonide|mesh-list
56524385|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56524386|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56524387|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
56524388|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524389|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524390|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56524391|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
56524405|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56524407|NCT04287205|Progestins|progestins|mesh-ancestor
56524408|NCT04287205|Hormones|hormones|mesh-ancestor
56168522|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
56524409|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56524410|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524411|NCT00628576|Heparin|heparin|mesh-list
56524412|NCT00628576|Calcium heparin|calcium heparin|mesh-list
56524413|NCT00628576|Tinzaparin|tinzaparin|mesh-list
56524414|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56524415|NCT00628576|Dalteparin|dalteparin|mesh-list
56524416|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
56524417|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56524418|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56524419|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524420|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
56524421|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524422|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649790|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
56649791|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649792|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
55954286|NCT00048893|Metronidazole|metronidazole|mesh-list
56524423|NCT04370548|Clindamycin|clindamycin|mesh-list
56524424|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
56524425|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
56524426|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56524427|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524428|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56524429|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524430|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524432|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56524433|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56524434|NCT01208181|Analgesics|analgesics|mesh-ancestor
56524435|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
56524436|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524437|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524438|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56524439|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524440|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56524441|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56524442|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524443|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524444|NCT01208103|Bevacizumab|bevacizumab|mesh-list
56524445|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56524446|NCT01208103|Capecitabine|capecitabine|mesh-list
56524447|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
56524448|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
56524449|NCT01208103|Antibodies|antibodies|mesh-list
56524450|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
56524451|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56524452|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
56524455|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56524456|NCT01208103|Growth Substances|growth substances|mesh-ancestor
56524457|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524458|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
56524459|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
56524460|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56524461|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
56524462|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524463|NCT01206777|Rituximab|rituximab|mesh-list
56524464|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524465|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524466|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
56524467|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524468|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524469|NCT01001494|Bromides|bromides|mesh-list
56524470|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
56524471|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56524472|NCT01205685|Letrozole|letrozole|mesh-list
56524473|NCT01205685|Goserelin|goserelin|mesh-list
56524474|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524475|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56524476|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524477|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524478|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56524479|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56524480|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56524481|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
56168523|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
56524482|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56524483|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524484|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56524485|NCT01205529|Procainamide|procainamide|mesh-list
56524486|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56524487|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56524488|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56524489|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524490|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524491|NCT04294966|Dronabinol|dronabinol|mesh-list
56649793|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56649794|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56649795|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954379|NCT02092181|Mirabegron|mirabegron|mesh-list
56524492|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
56524493|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524494|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56524495|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56524496|NCT04294966|Analgesics|analgesics|mesh-ancestor
56524497|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
56524498|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524499|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56524500|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56524501|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524502|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524504|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56524505|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
56524506|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56524507|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56524508|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56524509|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524510|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524511|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
56524512|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524513|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524514|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56524515|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524516|NCT04294732|Bupivacaine|bupivacaine|mesh-list
56524517|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
56524518|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
56524519|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524520|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524521|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
56524522|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524523|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
56524541|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56524542|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56524544|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
56524545|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524546|NCT01202955|Tolcapone|tolcapone|mesh-list
56524547|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56524548|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56524549|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56524550|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524551|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524553|NCT01202877|Midostaurin|midostaurin|mesh-list
56524554|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56524555|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
56524556|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524557|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524558|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524559|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56524560|NCT01202409|Panitumumab|panitumumab|mesh-list
56524561|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524562|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524563|NCT01202175|Nebivolol|nebivolol|mesh-list
56524564|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56524565|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
56524566|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56524567|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56524568|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56524569|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
56524570|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524571|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524572|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524573|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56524575|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649796|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56649797|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649798|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56649799|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
56649800|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56649801|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649802|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649803|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56649804|NCT02660658|Analgesics|analgesics|mesh-ancestor
56649805|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
56524576|NCT01201785|Aspirin|aspirin|mesh-list
56524577|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56524578|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56524579|NCT01201785|Analgesics|analgesics|mesh-ancestor
56524603|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524605|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
56524606|NCT01199055|Paclitaxel|paclitaxel|mesh-list
56524607|NCT01199055|Carboplatin|carboplatin|mesh-list
56524608|NCT01199055|Efatutazone|efatutazone|mesh-list
56524609|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56524610|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524611|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
56524612|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
56524613|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
56524614|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524615|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
56524616|NCT01198587|Astringents|astringents|mesh-ancestor
56524617|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524618|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
56524619|NCT01198509|Vancomycin|vancomycin|mesh-list
56524620|NCT01198509|Doxycycline|doxycycline|mesh-list
56524621|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56524622|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524623|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
56524624|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56524625|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56524626|NCT01198275|Amiodarone|amiodarone|mesh-list
56524627|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56524628|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
56524629|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56524630|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524631|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524638|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56524640|NCT01197417|Analgesics|analgesics|mesh-ancestor
56524641|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
56524642|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524643|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524644|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
56524645|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524646|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56524647|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
56524648|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56524649|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524650|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524651|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56524652|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
56524653|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56524654|NCT00977431|Temozolomide|temozolomide|mesh-list
56524655|NCT00977431|Afatinib|afatinib|mesh-list
56524656|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56524657|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
56524658|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524659|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649806|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649807|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56000651|NCT01701622|Febuxostat|febuxostat|mesh-list
56524660|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56524661|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524662|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
56524663|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56524664|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56524665|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56524666|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524667|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524668|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
56524669|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524670|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524671|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56524672|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524673|NCT02864095|Epinephrine|epinephrine|mesh-list
56524674|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
56524675|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56524676|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56524677|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524678|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
56524679|NCT02864095|Coagulants|coagulants|mesh-ancestor
56524680|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56524681|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56524682|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
56524683|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524684|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524685|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56524686|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56524687|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
56524688|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524689|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56524690|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
56524691|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
56524692|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
56524693|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56524694|NCT03933163|Resveratrol|resveratrol|mesh-list
56524695|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
56524696|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524709|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524710|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56524712|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56524713|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524714|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56524715|NCT04288219|Nifedipine|nifedipine|mesh-list
56524716|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56524717|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524718|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524719|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56524720|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524721|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
56524722|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
56524723|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56524724|NCT04064359|Antibodies|antibodies|mesh-list
56524725|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
56524726|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
56524727|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524728|NCT00974233|Rituximab|rituximab|mesh-list
56524729|NCT00974233|Lenalidomide|lenalidomide|mesh-list
56524730|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56524731|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524732|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524733|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
56524734|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524735|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524736|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56524737|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56524738|NCT00974233|Growth Substances|growth substances|mesh-ancestor
56524739|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
56524740|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56649808|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56649809|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56524741|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
56524742|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524743|NCT00972595|Ondansetron|ondansetron|mesh-list
56524744|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
56524745|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
56524746|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524747|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524748|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56524749|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
56524750|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
56524751|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56524752|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
56524753|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524754|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524755|NCT00972595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56524756|NCT00972595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56524757|NCT00972595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524758|NCT00972595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56524759|NCT00972595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56524768|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524769|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524770|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
56524771|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56524772|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56524773|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524774|NCT00972283|Insulin|insulin|mesh-list
56524775|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56524776|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
56524777|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
56524778|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56524779|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524780|NCT01194219|Apremilast|apremilast|mesh-list
56524781|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56524782|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56524783|NCT01194219|Analgesics|analgesics|mesh-ancestor
56524784|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
56524785|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524786|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524787|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56524788|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524789|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56524790|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56524791|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524792|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524793|NCT05366049|Acetaminophen|acetaminophen|mesh-list
56524794|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56524795|NCT05366049|Analgesics|analgesics|mesh-ancestor
56524796|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
56524797|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524798|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524799|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
56524800|NCT00969709|Milnacipran|milnacipran|mesh-list
56524801|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
56524802|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56524803|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56524804|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524805|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524806|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524807|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524808|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
56524809|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56524810|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56524811|NCT00969709|Analgesics|analgesics|mesh-ancestor
56524812|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
56524813|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524814|NCT01193517|Capecitabine|capecitabine|mesh-list
56524815|NCT01193517|Azacitidine|azacitidine|mesh-list
56524817|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
56524818|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56524819|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
56524820|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000654|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
56524821|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524822|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524823|NCT02863705|Timolol|timolol|mesh-list
56524824|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56524825|NCT02863705|Bimatoprost|bimatoprost|mesh-list
56524826|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56524827|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56524828|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56524840|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
56524841|NCT01193283|Cyclosporins|cyclosporins|mesh-list
56524842|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56524843|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
56524844|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524845|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524846|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56524847|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
56524848|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524849|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524850|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56524851|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524852|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
56524853|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524854|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
56524855|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56524856|NCT02863471|Gemcitabine|gemcitabine|mesh-list
56524857|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56524858|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
56524859|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524860|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524861|NCT02863471|Antiviral Agents|antiviral agents|mesh-ancestor
56524862|NCT02863471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524863|NCT02863471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524864|NCT02863471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56524865|NCT02863471|Immunologic Factors|immunologic factors|mesh-ancestor
56524866|NCT02863471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524867|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56524868|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56524869|NCT01193127|Mydriatics|mydriatics|mesh-list
56524870|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
56524871|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524872|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524873|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56524874|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524875|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56524876|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524877|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524878|NCT01192191|Fluticasone|fluticasone|mesh-list
56524879|NCT01192191|Xhance|xhance|mesh-list
56524880|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56524881|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56524882|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
56524883|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524884|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524885|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56524886|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
56524887|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
56524888|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56524889|NCT01307267|Rituximab|rituximab|mesh-list
56524890|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56524891|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
56524905|NCT01191801|Cytarabine|cytarabine|mesh-list
56524906|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56524907|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
56524908|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524909|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524910|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
56524911|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524912|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56524914|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524915|NCT01306643|Idelalisib|idelalisib|mesh-list
56524916|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524917|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524918|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524919|NCT05656833|Cysteamine|cysteamine|mesh-list
56524920|NCT05656833|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56649810|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
56649811|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649812|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649813|NCT02660502|Insulin|insulin|mesh-list
56649814|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56524921|NCT05656833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524922|NCT01306331|Nonoxynol|nonoxynol|mesh-list
56524923|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56524924|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56524925|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524926|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56524927|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
56524928|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56524929|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56524930|NCT00624663|Rivastigmine|rivastigmine|mesh-list
56524931|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56524932|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524933|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524934|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
56524935|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524936|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524937|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56524938|NCT00624663|Protective Agents|protective agents|mesh-ancestor
56524939|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
56524940|NCT02890823|Vitamin D|vitamin d|mesh-list
56524941|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56273076|NCT04886154|Vaccines|vaccines|mesh-list
56524942|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524943|NCT02890823|Vitamins|vitamins|mesh-ancestor
56524944|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
56524945|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56524946|NCT02887443|Midazolam|midazolam|mesh-list
56524947|NCT02887443|Idebenone|idebenone|mesh-list
56524948|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56524949|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56524950|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56524951|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524952|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56524953|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56524954|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56524970|NCT05655273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56524971|NCT05655273|Immunologic Factors|immunologic factors|mesh-ancestor
56524972|NCT05655273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524973|NCT05655273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56524974|NCT05655273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524975|NCT05655273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524976|NCT01305941|Trastuzumab|trastuzumab|mesh-list
56524978|NCT01305941|Vinorelbine|vinorelbine|mesh-list
56524979|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524980|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524981|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56524982|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
56524983|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524984|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56524985|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
56524986|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
56524987|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
56524988|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524989|NCT05658549|Acetylcysteine|acetylcysteine|mesh-list
56524990|NCT05658549|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56524991|NCT05658549|Antiviral Agents|antiviral agents|mesh-ancestor
56524992|NCT05658549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524993|NCT05658549|Expectorants|expectorants|mesh-ancestor
56524994|NCT05658549|Respiratory System Agents|respiratory system agents|mesh-ancestor
56524995|NCT05658549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56524996|NCT05658549|Antioxidants|antioxidants|mesh-ancestor
56524997|NCT05658549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524998|NCT05658549|Protective Agents|protective agents|mesh-ancestor
56524999|NCT05658549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525000|NCT05658549|Antidotes|antidotes|mesh-ancestor
56649815|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
56649816|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56649817|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649818|NCT02660346|Vancomycin|vancomycin|mesh-list
56525001|NCT02887365|Tegafur|tegafur|mesh-list
56525002|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56525003|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
56525004|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525005|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525006|NCT05658159|Vitamin D|vitamin d|mesh-list
56525007|NCT05658159|Ergocalciferols|ergocalciferols|mesh-list
56525008|NCT05658159|Cholecalciferol|cholecalciferol|mesh-list
56525009|NCT05658159|Vitamins|vitamins|mesh-list
56525010|NCT05658159|Micronutrients|micronutrients|mesh-ancestor
56525011|NCT05658159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525012|NCT05658159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56525013|NCT05658159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56525014|NCT01305239|Exemestane|exemestane|mesh-list
56525015|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525023|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525025|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
56525026|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56525027|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56525028|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56525029|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525030|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525031|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56525032|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
56525033|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525034|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525035|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56525036|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56525037|NCT01304693|Ranibizumab|ranibizumab|mesh-list
56525038|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56525039|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56525040|NCT01304693|Growth Substances|growth substances|mesh-ancestor
56525041|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525042|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
56525043|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525044|NCT01304147|Ketamine|ketamine|mesh-list
56525045|NCT01304147|Analgesics|analgesics|mesh-ancestor
56525046|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
56525047|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525048|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525049|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56525050|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56525051|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
56525052|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
56525053|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525054|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56525055|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56525056|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525057|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525059|NCT05661227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56525060|NCT05661227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525061|NCT05661227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525062|NCT05661227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56525063|NCT05661227|Analgesics|analgesics|mesh-ancestor
56525064|NCT05661227|Sensory System Agents|sensory system agents|mesh-ancestor
56525065|NCT05661227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525066|NCT05661227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56525067|NCT05661227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56525068|NCT05661227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56525069|NCT05661227|Adrenergic Agents|adrenergic agents|mesh-ancestor
56525070|NCT05661227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525071|NCT05661227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525072|NCT01303445|Omeprazole|omeprazole|mesh-list
56525073|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56525074|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56649819|NCT02660346|Daptomycin|daptomycin|mesh-list
56649820|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56649821|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56525075|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56525076|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56525077|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525078|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525079|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56525080|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56525101|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56525102|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525103|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56525104|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525105|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525106|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56525107|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56525108|NCT01187901|Analgesics|analgesics|mesh-ancestor
56525109|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
56525110|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525111|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525112|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56525113|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56525114|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56525116|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56525117|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
56525118|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56525119|NCT01301729|Paclitaxel|paclitaxel|mesh-list
56525120|NCT01301729|Docetaxel|docetaxel|mesh-list
56525121|NCT01301729|Trastuzumab|trastuzumab|mesh-list
56525122|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56525123|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525124|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
56525125|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
56525126|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
56525127|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525128|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525129|NCT05643677|Irinotecan|irinotecan|mesh-list
56525130|NCT05643677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56525131|NCT05643677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56525132|NCT05643677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525143|NCT01301027|Pioglitazone|pioglitazone|mesh-list
56525144|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56525145|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525146|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56525147|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56525148|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56525149|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56525150|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525151|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525152|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525153|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56525154|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
56525155|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56525156|NCT01185171|Gefitinib|gefitinib|mesh-list
56525157|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525158|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56525159|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525160|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525161|NCT05641883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56525162|NCT02886897|Antibodies|antibodies|mesh-list
56525163|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
56525164|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525165|NCT05641649|Valproic Acid|valproic acid|mesh-list
56525166|NCT05641649|Anticonvulsants|anticonvulsants|mesh-ancestor
56525167|NCT05641649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525168|NCT05641649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525169|NCT05641649|GABA Agents|gaba agents|mesh-ancestor
56525170|NCT05641649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525171|NCT05641649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525172|NCT05641649|Antimanic Agents|antimanic agents|mesh-ancestor
56525173|NCT05641649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649822|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649823|NCT04937738|Leucovorin|leucovorin|mesh-list
56649824|NCT04937738|Docetaxel|docetaxel|mesh-list
56525174|NCT05641649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525175|NCT05641649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56525176|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56525177|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
56525178|NCT01184859|Coagulants|coagulants|mesh-ancestor
56525179|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56525180|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
56525181|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525182|NCT02890511|Paclitaxel|paclitaxel|mesh-list
56525183|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56525184|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525185|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
56525186|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
56525187|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
56525188|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525189|NCT01184079|Vaccines|vaccines|mesh-list
56525190|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
56525191|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525192|NCT05333289|Vaccines|vaccines|mesh-list
56525193|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
56525194|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525195|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56525196|NCT01289990|Empagliflozin|empagliflozin|mesh-list
56525197|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56525210|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
56525211|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525212|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56525213|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525214|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56525215|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56525216|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56525217|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525218|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56525219|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525220|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
56525221|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56525223|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
56525224|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525225|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
56525226|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525227|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56525228|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56525229|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
56525230|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525231|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525232|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56525233|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525234|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
56525235|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56525236|NCT02890277|Chitosan|chitosan|mesh-list
56525237|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56525238|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56525239|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
56525240|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525241|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56525242|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
56525243|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
56525244|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
56525245|NCT02890277|Coagulants|coagulants|mesh-ancestor
56525246|NCT01289678|Interleukin-2|interleukin-2|mesh-list
56525247|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525248|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56525249|NCT01289678|Analgesics|analgesics|mesh-ancestor
56525250|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
56525251|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525252|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525253|NCT02890082|Tamoxifen|tamoxifen|mesh-list
56525254|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56525255|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
56525256|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649825|NCT04937738|Fluorouracil|fluorouracil|mesh-list
56649826|NCT04937738|Capecitabine|capecitabine|mesh-list
56649827|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
56649828|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649829|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
56649830|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
56649831|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
56649832|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649833|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
56649834|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56649835|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525270|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525271|NCT01183065|Folic Acid|folic acid|mesh-list
56525272|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
56525273|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
56525274|NCT01183065|Vitamins|vitamins|mesh-ancestor
56525275|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
56525276|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525277|NCT01183065|Hematinics|hematinics|mesh-ancestor
56525278|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
56525279|NCT01182441|Warfarin|warfarin|mesh-list
56525280|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
56525281|NCT01182285|Valproic Acid|valproic acid|mesh-list
56525282|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
56525283|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525284|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525285|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
56525286|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525287|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525288|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
56525289|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56525290|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525291|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56525292|NCT04315935|Fentanyl|fentanyl|mesh-list
56525293|NCT04315935|Butorphanol|butorphanol|mesh-list
56525294|NCT04315935|Propofol|propofol|mesh-list
56525295|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56525296|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525297|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525298|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56525299|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
56525300|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
56525301|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56525302|NCT04315935|Narcotics|narcotics|mesh-ancestor
56525303|NCT04315935|Analgesics|analgesics|mesh-ancestor
56525304|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
56525305|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525306|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56525307|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
56525308|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
56525309|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56525310|NCT01182207|Drospirenone|drospirenone|mesh-list
56525311|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56273451|NCT04200911|Sirolimus|sirolimus|mesh-list
56525312|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56525313|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56525314|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56525315|NCT01182207|Estradiol|estradiol|mesh-list
56525316|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56525317|NCT01182207|Estrogens|estrogens|mesh-ancestor
56525318|NCT01182207|Hormones|hormones|mesh-ancestor
56525319|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525331|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
56525332|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56525333|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56525334|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
56525335|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525336|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649836|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
56525337|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56525338|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
56525339|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56525340|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56525341|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56525342|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
56525343|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525344|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525346|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
56525347|NCT01181271|Busulfan|busulfan|mesh-list
56525348|NCT01181271|Methotrexate|methotrexate|mesh-list
56525349|NCT01181271|Fludarabine|fludarabine|mesh-list
56525350|NCT01181271|Etoposide|etoposide|mesh-list
56525351|NCT01181271|Tacrolimus|tacrolimus|mesh-list
56525352|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525353|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
56525354|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525355|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56525356|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56525357|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
56525358|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525359|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525360|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56525361|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56525362|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
56525363|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56525364|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56525365|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
56525366|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
56525367|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525368|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56525369|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56525370|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56525371|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56525372|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56525373|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56525374|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56525375|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56525376|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56525377|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
56525378|NCT00624741|Pergolide|pergolide|mesh-list
56525379|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
56525380|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
56525381|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525382|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525383|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525403|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
56525404|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525405|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56525406|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56525407|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525408|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
56525409|NCT04286035|Bupivacaine|bupivacaine|mesh-list
56525410|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
56525411|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
56525412|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525413|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525414|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
56525415|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525416|NCT05194111|Valsartan|valsartan|mesh-list
56525417|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56525418|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525419|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56525420|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56525421|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525422|NCT00629473|Dexamethasone|dexamethasone|mesh-list
56525423|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56525424|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56525425|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
56525426|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
56525427|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525428|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649837|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649838|NCT04937738|Antidotes|antidotes|mesh-ancestor
56649839|NCT04937738|Protective Agents|protective agents|mesh-ancestor
55955337|NCT01686165|Rituximab|rituximab|mesh-list
56525429|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56525430|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
56525431|NCT00629473|Hormones|hormones|mesh-ancestor
56525432|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525433|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56525434|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525435|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
56525436|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525437|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525438|NCT04046107|Cemiplimab|cemiplimab|mesh-list
56525440|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525441|NCT04286503|Ritonavir|ritonavir|mesh-list
56525442|NCT04286503|Lopinavir|lopinavir|mesh-list
56525443|NCT04286503|Chloroquine|chloroquine|mesh-list
56525444|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56525445|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56525446|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56525447|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
56525448|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525449|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525450|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56525451|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56525452|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
56525453|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56525454|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56525455|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56525456|NCT04286503|Amebicides|amebicides|mesh-ancestor
56525457|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56525458|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56525459|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
56525460|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56525461|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56525462|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56273605|NCT03933215|Cladribine|cladribine|mesh-list
56525463|NCT04286503|Analgesics|analgesics|mesh-ancestor
56525464|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
56525465|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525466|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525467|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56525468|NCT04286503|Filaricides|filaricides|mesh-ancestor
56525469|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
56525470|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
56525471|NCT03792841|Etanercept|etanercept|mesh-list
56525472|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
56525473|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56525474|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525475|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525476|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56525477|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56525478|NCT03792841|Analgesics|analgesics|mesh-ancestor
56525479|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
56525480|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525481|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525482|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56525483|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56525484|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56525485|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525486|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
56525487|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525488|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
56525489|NCT00968617|Hematinics|hematinics|mesh-ancestor
56525490|NCT00968539|Vaccines|vaccines|mesh-list
56525491|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
56525492|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525493|NCT00976573|Paclitaxel|paclitaxel|mesh-list
56525494|NCT00976573|Bevacizumab|bevacizumab|mesh-list
56525495|NCT00976573|Carboplatin|carboplatin|mesh-list
56525496|NCT00976573|Everolimus|everolimus|mesh-list
56525497|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56525498|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547630|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649840|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
56525499|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
56525500|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
56525501|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
56525502|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525503|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525504|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56525505|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56525506|NCT00976573|Growth Substances|growth substances|mesh-ancestor
56525507|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525508|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
56525509|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525510|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
56525511|NCT03661723|Bevacizumab|bevacizumab|mesh-list
56525512|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
56525513|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525524|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56525525|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525526|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
56525527|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525528|NCT02865733|Treprostinil|treprostinil|mesh-list
56525529|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525530|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
56525531|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56525532|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56525533|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525534|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56525535|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525536|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525537|NCT00976495|Diuretics|diuretics|mesh-ancestor
56525538|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
56525539|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56525540|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56525541|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
56525542|NCT00630019|Levofloxacin|levofloxacin|mesh-list
56525544|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56525545|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56525546|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56525547|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56525548|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56525549|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56525550|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56525551|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525552|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525553|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525554|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56525555|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
56525556|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56525557|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525558|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56525559|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56525560|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56525561|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56525562|NCT00630019|Renal Agents|renal agents|mesh-ancestor
56525563|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56525564|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56525566|NCT00998296|Afatinib|afatinib|mesh-list
56525567|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525568|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56525569|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525570|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525571|NCT01178073|Ambrisentan|ambrisentan|mesh-list
56525572|NCT01178073|Tadalafil|tadalafil|mesh-list
56525573|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
56525574|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56525575|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56525576|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525586|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525587|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525588|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649841|NCT04937738|Vitamins|vitamins|mesh-ancestor
56649842|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
56649843|NCT00620438|Efavirenz|efavirenz|mesh-list
56649844|NCT00620438|Nevirapine|nevirapine|mesh-list
56649845|NCT00620438|Rifampin|rifampin|mesh-list
56649846|NCT00620438|Lumefantrine|lumefantrine|mesh-list
56649847|NCT00620438|Artemether|artemether|mesh-list
56649848|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56649849|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56525589|NCT01177293|Amlodipine|amlodipine|mesh-list
56525590|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525591|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56525592|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56525593|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525594|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56525595|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525596|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
56525597|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
56525598|NCT02886429|Bupivacaine|bupivacaine|mesh-list
56525599|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
56525600|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
56525601|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525602|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525603|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
56525604|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525605|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56525606|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56525607|NCT02886429|Analgesics|analgesics|mesh-ancestor
56525608|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56525609|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56525610|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56525611|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
56168576|NCT00368238|Aspirin|aspirin|mesh-list
56525612|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525613|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525615|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56525616|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56525617|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525618|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525619|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56525620|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56525621|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56525622|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
56525623|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525624|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525625|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56525626|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56525627|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
56525628|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
56525629|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56525630|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
56525631|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
56525632|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525633|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525634|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56525635|NCT02886351|Analgesics|analgesics|mesh-ancestor
56525636|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
56525637|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525638|NCT00976027|Vaccines|vaccines|mesh-list
56525639|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
56525640|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525641|NCT01298765|Buprenorphine|buprenorphine|mesh-list
56525642|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56525643|NCT01298765|Narcotics|narcotics|mesh-ancestor
56525644|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525645|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525646|NCT01298765|Analgesics|analgesics|mesh-ancestor
56525647|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
56115484|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
56649850|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56649851|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000690|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56525648|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525649|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56525650|NCT04296214|Azacitidine|azacitidine|mesh-list
56525651|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56525652|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
56525653|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525654|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525655|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525656|NCT04296370|Apatinib|apatinib|mesh-list
56525657|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525658|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56525659|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525660|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525661|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
56525662|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
56525663|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525664|NCT00997438|Protective Agents|protective agents|mesh-ancestor
56525665|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525666|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
56525667|NCT00997438|Vitamins|vitamins|mesh-ancestor
56525668|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
56525669|NCT00997126|Alfentanil|alfentanil|mesh-list
56525670|NCT00997126|Propofol|propofol|mesh-list
56525671|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56525672|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525673|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525674|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56525675|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
56525676|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
56525677|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56525678|NCT00997126|Narcotics|narcotics|mesh-ancestor
56525679|NCT00997126|Analgesics|analgesics|mesh-ancestor
56525680|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
56525681|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525682|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56525683|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56525684|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56525685|NCT04433494|Tamoxifen|tamoxifen|mesh-list
56525686|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56525687|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
56525688|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525689|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525690|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56525691|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525692|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56525693|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56525694|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56525696|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525697|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525698|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525699|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56525700|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56525701|NCT02862691|Acetaminophen|acetaminophen|mesh-list
56525702|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56525703|NCT02862691|Oxycodone|oxycodone|mesh-list
56525704|NCT02862691|Analgesics|analgesics|mesh-list
56525705|NCT02862691|Bupivacaine|bupivacaine|mesh-list
56525706|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
56525707|NCT02862691|Anesthetics|anesthetics|mesh-list
56525708|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525709|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525710|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
56525711|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525712|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56525713|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
56525714|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56525715|NCT02862691|Narcotics|narcotics|mesh-ancestor
56525716|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56525717|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56649852|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649853|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
56649854|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649855|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56649856|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56649857|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56649858|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56649859|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56649860|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56649861|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56649862|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
56649863|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56649864|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
56649865|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56649866|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56525718|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56525719|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
56525720|NCT00965341|Testosterone|testosterone|mesh-list
56525721|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
56525722|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
56525723|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56525724|NCT00965341|Androgens|androgens|mesh-ancestor
56525725|NCT00965341|Hormones|hormones|mesh-ancestor
56525726|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525727|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525728|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56525729|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525730|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
56525731|NCT01175811|Insulin|insulin|mesh-list
56525732|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56525733|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
56525734|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
56525735|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
56525736|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
56525737|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
56525738|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56525739|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525740|NCT00965263|Cocaine|cocaine|mesh-list
56525741|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
56525742|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
56525743|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525744|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525745|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
56525746|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525747|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56525748|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56525749|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56525750|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56525751|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525752|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
56525753|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525754|NCT02886195|Pemetrexed|pemetrexed|mesh-list
56525755|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56525756|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525757|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525758|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649867|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56649868|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56525759|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56525760|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56525761|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56525763|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525764|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525765|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56525766|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525767|NCT02862769|Lidocaine|lidocaine|mesh-list
56525768|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
56525769|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
56525770|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525771|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525772|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
56525773|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525774|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56525775|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56525776|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56525777|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56525778|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525779|NCT00965185|Atorvastatin|atorvastatin|mesh-list
56525780|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56525781|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56525782|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
56525783|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525784|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56525785|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56525786|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525787|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56525788|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525789|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56525790|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525791|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525792|NCT01298531|Etanercept|etanercept|mesh-list
56525793|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56525794|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56525796|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
56525797|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525798|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525799|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56525800|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56525801|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56525802|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525803|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
56525804|NCT02862145|Dexamethasone|dexamethasone|mesh-list
56525805|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56525806|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
56525807|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
56525808|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525809|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525810|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56525811|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
56525812|NCT02862145|Hormones|hormones|mesh-ancestor
56525813|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525814|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56525815|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525816|NCT01174173|Ranolazine|ranolazine|mesh-list
56525817|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56525818|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56525819|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525820|NCT00964795|Aflibercept|aflibercept|mesh-list
56525821|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56525822|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56525823|NCT00964795|Growth Substances|growth substances|mesh-ancestor
56525824|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525825|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
56525826|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525827|NCT01173471|Niacinamide|niacinamide|mesh-list
56525828|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
56525829|NCT01173471|Vitamins|vitamins|mesh-ancestor
56649869|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56649870|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
56649871|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56525830|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
55783571|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
56525831|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525832|NCT01172847|Oseltamivir|oseltamivir|mesh-list
56525833|NCT01172847|Rimantadine|rimantadine|mesh-list
56525834|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
56525835|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56525836|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525837|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525838|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56525840|NCT00966355|Terlipressin|terlipressin|mesh-list
56525841|NCT00966355|Somatostatin|somatostatin|mesh-list
56525842|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56525843|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56525844|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525845|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525846|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56525847|NCT00966355|Hormones|hormones|mesh-ancestor
56525848|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525849|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525850|NCT01172535|Ritonavir|ritonavir|mesh-list
56525851|NCT01172535|Lopinavir|lopinavir|mesh-list
56525852|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56525853|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56525854|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
56525855|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525856|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525857|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56525858|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56525859|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
56525860|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56525861|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56525862|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56525863|NCT05160493|Pregabalin|pregabalin|mesh-list
56525864|NCT05160493|Ketamine|ketamine|mesh-list
56525865|NCT05160493|Esketamine|esketamine|mesh-list
56525866|NCT05160493|Analgesics|analgesics|mesh-ancestor
56525867|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
56525868|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525869|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525870|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56525871|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56525872|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
56525874|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525875|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56525876|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56525877|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525878|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525879|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
56525880|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56525881|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56525882|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56525883|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56525884|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56525885|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56525886|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
56525887|NCT00966277|Dalteparin|dalteparin|mesh-list
56525888|NCT00966277|Tinzaparin|tinzaparin|mesh-list
56525889|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56525890|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
56525891|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56525892|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56525893|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525894|NCT04324307|Gemcitabine|gemcitabine|mesh-list
56525895|NCT04324307|Paclitaxel|paclitaxel|mesh-list
56525896|NCT04324307|Fluorouracil|fluorouracil|mesh-list
56525897|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
56525898|NCT04324307|Irinotecan|irinotecan|mesh-list
56525899|NCT04324307|Folfirinox|folfirinox|mesh-list
56525900|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56525901|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649872|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56649873|NCT00891839|Rituximab|rituximab|mesh-list
56649874|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56649875|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649876|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649877|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
56649878|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955892|NCT00096161|Cyclosporine|cyclosporine|mesh-list
56525902|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
56525903|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
56525904|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
56168581|NCT00368238|Analgesics|analgesics|mesh-ancestor
56525905|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525906|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56525907|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
56525908|NCT04324307|Antiviral Agents|antiviral agents|mesh-ancestor
56525909|NCT04324307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56525910|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525911|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525912|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
56525913|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525914|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56525915|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56525916|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56525917|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56525918|NCT01297517|Brinzolamide|brinzolamide|mesh-list
56525919|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56525920|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525921|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56525922|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56525923|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56525924|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
56525925|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525926|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525927|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525928|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56525929|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525930|NCT01296347|Ketamine|ketamine|mesh-list
56525931|NCT01296347|Analgesics|analgesics|mesh-ancestor
56525932|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
56525933|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525934|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525935|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56525936|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56525937|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
56525938|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
56525939|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525940|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56525941|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56525942|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525955|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
56525956|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
56525957|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56525958|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
56525959|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56525960|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525961|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
56525962|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56525963|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56525964|NCT01294553|Metformin|metformin|mesh-list
56525965|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
56525966|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56525967|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525968|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56525970|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525971|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525972|NCT01294397|Denosumab|denosumab|mesh-list
56649879|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56649880|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56525973|NCT01294397|Etanercept|etanercept|mesh-list
56525974|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56525975|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56525976|NCT01294397|Analgesics|analgesics|mesh-ancestor
56525977|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
56525978|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525979|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525980|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56525981|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56525982|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56525983|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525984|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
56525985|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56274137|NCT01163357|Sirolimus|sirolimus|mesh-list
56525987|NCT05605535|Carboplatin|carboplatin|mesh-list
56525988|NCT05605535|Oregovomab|oregovomab|mesh-list
56525989|NCT05605535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56525990|NCT05605535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525991|NCT05605535|Tubulin Modulators|tubulin modulators|mesh-ancestor
56525992|NCT05605535|Antimitotic Agents|antimitotic agents|mesh-ancestor
56525993|NCT05605535|Mitosis Modulators|mitosis modulators|mesh-ancestor
56525994|NCT05605535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525995|NCT05605535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525996|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56525997|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56525998|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525999|NCT01293539|Melphalan|melphalan|mesh-list
56526000|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56526001|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
56526002|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526003|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526004|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56526005|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526006|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
56526019|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56526021|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526022|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526023|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526024|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526025|NCT00630175|Zolpidem|zolpidem|mesh-list
56526026|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56526027|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56526028|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526029|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526030|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56526031|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
56526032|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
56526033|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526034|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526035|NCT00965575|Melatonin|melatonin|mesh-list
56526036|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
56526037|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526038|NCT00965575|Protective Agents|protective agents|mesh-ancestor
56526039|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526040|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526041|NCT00965497|Citalopram|citalopram|mesh-list
56526042|NCT00965497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56526043|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56526044|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526045|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526046|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526047|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
56526048|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526049|NCT00965497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56526050|NCT00965497|Antidepressive Agents|antidepressive agents|mesh-ancestor
56526051|NCT00965497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56526052|NCT00963937|Sumatriptan|sumatriptan|mesh-list
56526053|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56649881|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
56000720|NCT01602016|Antidotes|antidotes|mesh-ancestor
56526054|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56526055|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56526056|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
56526057|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526058|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526059|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526061|NCT01170663|Ramucirumab|ramucirumab|mesh-list
56526062|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56526063|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526064|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
56526065|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
56526066|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
56526067|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526068|NCT04315155|Nivolumab|nivolumab|mesh-list
56526069|NCT04315155|Ipilimumab|ipilimumab|mesh-list
56526072|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526073|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56526074|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526075|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56526076|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526077|NCT01170273|Vitamin D|vitamin d|mesh-list
56526078|NCT01170273|Vitamins|vitamins|mesh-ancestor
56526079|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
56526080|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526081|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56526082|NCT01170039|Lubiprostone|lubiprostone|mesh-list
56526083|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56526084|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526085|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526086|NCT01169337|Lenalidomide|lenalidomide|mesh-list
56526087|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
56526088|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526089|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56526090|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56526091|NCT01169337|Growth Substances|growth substances|mesh-ancestor
56526092|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
56526093|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526094|NCT01286558|Amlodipine|amlodipine|mesh-list
56526096|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56526097|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56526098|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526099|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526100|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526101|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526102|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
56526103|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56526104|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56526105|NCT01169103|Hormones|hormones|mesh-list
56526106|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526107|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526108|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
56526109|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56526110|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56526111|NCT01286168|Eusol|eusol|mesh-list
56526112|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56526113|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56526114|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526115|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
56526116|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
56526117|NCT05582096|Tirzepatide|tirzepatide|mesh-list
56526118|NCT05582096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56526119|NCT05582096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526120|NCT05582096|Incretins|incretins|mesh-ancestor
56526121|NCT05582096|Hormones|hormones|mesh-ancestor
56526122|NCT05582096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526123|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56526124|NCT02889692|Gefitinib|gefitinib|mesh-list
56526125|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526126|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56526127|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115741|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
56649882|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649883|NCT00600756|Risperidone|risperidone|mesh-list
56526128|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526129|NCT05569382|Verapamil|verapamil|mesh-list
56526130|NCT05569382|Bisoprolol|bisoprolol|mesh-list
56526131|NCT05569382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56526132|NCT05569382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56274293|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
56526133|NCT05569382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526134|NCT05569382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526135|NCT05569382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526136|NCT05569382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526137|NCT05569382|Vasodilator Agents|vasodilator agents|mesh-ancestor
56526138|NCT05569382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56526139|NCT05569382|Sympatholytics|sympatholytics|mesh-ancestor
56526140|NCT05569382|Autonomic Agents|autonomic agents|mesh-ancestor
56526141|NCT05569382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526158|NCT01285310|Analgesics|analgesics|mesh-ancestor
56526159|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
56526160|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526161|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526162|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56526163|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56526164|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56526165|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56526167|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526168|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526169|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
56526170|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
56526171|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56526172|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526173|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56526174|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56526175|NCT01285310|Growth Substances|growth substances|mesh-ancestor
56526176|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
56526177|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526178|NCT01254630|Vaccines|vaccines|mesh-list
56526179|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
56526180|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526181|NCT01253304|Dulaglutide|dulaglutide|mesh-list
56526182|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56526183|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526184|NCT04319484|Lenvatinib|lenvatinib|mesh-list
56526185|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526186|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56526187|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526188|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526189|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56526190|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
56526191|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526192|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56526193|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
56526194|NCT00624312|Hematinics|hematinics|mesh-ancestor
56526195|NCT01250418|Ketamine|ketamine|mesh-list
56526196|NCT01250418|Analgesics|analgesics|mesh-ancestor
56526197|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
56526198|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526199|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526200|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56526201|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56526202|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
56526203|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
56526212|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526213|NCT05494398|Expectorants|expectorants|mesh-ancestor
56526214|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
56526215|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56526216|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
56526217|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526218|NCT05494398|Protective Agents|protective agents|mesh-ancestor
56526219|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526220|NCT05494398|Antidotes|antidotes|mesh-ancestor
56526221|NCT05491356|Plasminogen|plasminogen|mesh-list
56526222|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56649884|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56649885|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56649886|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
56649887|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526223|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56526224|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56526225|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526226|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
56526228|NCT01292603|Fludarabine|fludarabine|mesh-list
56526229|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526230|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
56526231|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526232|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56526233|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56526234|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
56526235|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526236|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526237|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56526238|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526239|NCT01292057|Aripiprazole|aripiprazole|mesh-list
56526240|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
56526241|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56526242|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56526243|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56526244|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526245|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526246|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
56526247|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
56526248|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526249|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526250|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56526251|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56526252|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
56526253|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56526254|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56526255|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56526256|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56526257|NCT01290887|Reslizumab|reslizumab|mesh-list
56526258|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56526259|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
56526260|NCT01290731|Interferons|interferons|mesh-list
56526261|NCT01290731|Ribavirin|ribavirin|mesh-list
56526262|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56526263|NCT01290731|Simeprevir|simeprevir|mesh-list
56526264|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526265|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
56526266|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526267|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
56526268|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526269|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
56526287|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
56526288|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526289|NCT02890199|Lidocaine|lidocaine|mesh-list
56526290|NCT02890199|Bupivacaine|bupivacaine|mesh-list
56526291|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
56526292|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
56526293|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526294|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526295|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
56526296|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526297|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56526298|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56526299|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56526300|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526301|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526302|NCT01289639|Pioglitazone|pioglitazone|mesh-list
56526303|NCT01289639|Fenofibrate|fenofibrate|mesh-list
56526304|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56526305|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526306|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56649888|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000729|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56526307|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
56526308|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526309|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56526310|NCT01288937|Milnacipran|milnacipran|mesh-list
56526311|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
56526312|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56526313|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56526314|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526315|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526316|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526317|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526318|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56526319|NCT01288937|Analgesics|analgesics|mesh-ancestor
56526320|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
56526321|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526322|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
56526323|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56526324|NCT01288469|Atorvastatin|atorvastatin|mesh-list
56526325|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56526336|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56526337|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56526338|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526339|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526340|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526341|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526343|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
56526344|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526345|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
56526346|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56526347|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
56526348|NCT01287221|Riboflavin|riboflavin|mesh-list
56526349|NCT01287221|Rifampin|rifampin|mesh-list
56526350|NCT01287221|Vitamins|vitamins|mesh-ancestor
56526351|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
56526352|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526353|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
56526354|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56526355|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
56526356|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56526357|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526358|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
56526359|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56526360|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526361|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526362|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56526363|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56526364|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56526365|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56526366|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56526367|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56526368|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56526369|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
56526370|NCT05660213|Bevacizumab|bevacizumab|mesh-list
56526371|NCT05660213|Atezolizumab|atezolizumab|mesh-list
56526372|NCT05660213|Apatinib|apatinib|mesh-list
56526373|NCT05660213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526374|NCT05660213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526375|NCT05660213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56526376|NCT05660213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56526377|NCT05660213|Growth Substances|growth substances|mesh-ancestor
56526378|NCT05660213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526379|NCT05660213|Growth Inhibitors|growth inhibitors|mesh-ancestor
56526380|NCT05660213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56526381|NCT05660213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526382|NCT05660213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526383|NCT01167153|Amlodipine|amlodipine|mesh-list
56526384|NCT01167153|Valsartan|valsartan|mesh-list
56526385|NCT01167153|Nifedipine|nifedipine|mesh-list
56649889|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649890|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56526386|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56526387|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56526407|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
56526408|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526409|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526410|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
56526411|NCT02885727|Durvalumab|durvalumab|mesh-list
56526412|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526413|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526414|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56526415|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
56526416|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526418|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56526419|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526420|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56526421|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56526422|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56526423|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526424|NCT01165281|Oxycodone|oxycodone|mesh-list
56526425|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56526426|NCT01165281|Narcotics|narcotics|mesh-ancestor
56526427|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274594|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
56526428|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526429|NCT01165281|Analgesics|analgesics|mesh-ancestor
56526430|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
56526431|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526432|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56526433|NCT02860897|Estrogens|estrogens|mesh-ancestor
56526434|NCT02860897|Hormones|hormones|mesh-ancestor
56526435|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526436|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526437|NCT02860819|Gemcitabine|gemcitabine|mesh-list
56526438|NCT02860819|Carboplatin|carboplatin|mesh-list
56526439|NCT02860819|Veliparib|veliparib|mesh-list
56526440|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526441|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56526453|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
56526455|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56526456|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
56526457|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
56526458|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526459|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526460|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56526461|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
56526462|NCT04284007|Hormones|hormones|mesh-ancestor
56526463|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526464|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56526465|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526466|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
56526467|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526468|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526469|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
56526470|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
56526471|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526472|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
56526473|NCT02965963|Dopamine|dopamine|mesh-list
56526474|NCT02965963|Metoclopramide|metoclopramide|mesh-list
56526475|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
56526476|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
56526477|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526478|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526479|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56526480|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56526481|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56526482|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
56526483|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526484|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526485|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56526486|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
56649891|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649892|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526487|NCT02965963|Protective Agents|protective agents|mesh-ancestor
56526488|NCT01165203|Vaccines|vaccines|mesh-list
56526489|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
56526490|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526492|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56526493|NCT00960661|Metformin|metformin|mesh-list
56526494|NCT00960661|Exenatide|exenatide|mesh-list
56526495|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
56526496|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56526497|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526498|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56526499|NCT00960661|Incretins|incretins|mesh-ancestor
56526500|NCT00960661|Hormones|hormones|mesh-ancestor
56274669|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
56526501|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526502|NCT00960193|Colchicine|colchicine|mesh-list
56526503|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
56526504|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56526505|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
56526506|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
56526507|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
56526509|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526510|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
56526511|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
56526512|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526513|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526514|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56526515|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56526516|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
56526517|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526518|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526519|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56526520|NCT00959647|Bevacizumab|bevacizumab|mesh-list
56526521|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526522|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526523|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56526524|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56526525|NCT00959647|Growth Substances|growth substances|mesh-ancestor
56526526|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526527|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
56526528|NCT00957853|Cetuximab|cetuximab|mesh-list
56526529|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526530|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526531|NCT02725567|Ivacaftor|ivacaftor|mesh-list
56526532|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56526533|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526534|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526535|NCT02859571|Oxytocin|oxytocin|mesh-list
56526536|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
56526537|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56526538|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526539|NCT00956839|Vitamin D|vitamin d|mesh-list
56526540|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
56526541|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
56526542|NCT00956839|Vitamins|vitamins|mesh-list
56526543|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
56526544|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526545|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56526546|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526547|NCT00956293|Cyclosporine|cyclosporine|mesh-list
56526548|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
56526549|NCT00956293|Everolimus|everolimus|mesh-list
56526550|NCT00956293|Cyclosporins|cyclosporins|mesh-list
56526551|NCT00956293|Basiliximab|basiliximab|mesh-list
56526552|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526553|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526554|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526555|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
56526556|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526557|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
56526558|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526559|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
56526560|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115742|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
56649893|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649894|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56649895|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
55956577|NCT00272311|Analgesics|analgesics|mesh-ancestor
56526561|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56526562|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526563|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56526564|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56526565|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
56526566|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56526567|NCT04282291|Morphine|morphine|mesh-list
56526568|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56526569|NCT04282291|Narcotics|narcotics|mesh-ancestor
56526570|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526571|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526572|NCT04282291|Analgesics|analgesics|mesh-ancestor
56526573|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
56526574|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526575|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56526576|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56526577|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56526578|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56274747|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
56526579|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526581|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526583|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56526584|NCT02869009|Aspirin|aspirin|mesh-list
56526585|NCT02869009|Clopidogrel|clopidogrel|mesh-list
56526586|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56526587|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56526588|NCT02869009|Analgesics|analgesics|mesh-ancestor
56526589|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
56526590|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526591|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526592|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56526593|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56526594|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56526595|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56526596|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526597|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56526598|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56526599|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526600|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
56526601|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56526602|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56526603|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56526604|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
56526605|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526606|NCT01164579|Methotrexate|methotrexate|mesh-list
56526607|NCT01164579|Tofacitinib|tofacitinib|mesh-list
56526608|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56526609|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
56526610|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56526611|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526612|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56526613|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
56526614|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526615|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526616|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
56526617|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526618|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56526619|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526620|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
56526621|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56526622|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56526623|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56526624|NCT02859259|Fostemsavir|fostemsavir|mesh-list
56526625|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56526626|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56526627|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
56526628|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000737|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
56526629|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56526630|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56526631|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526632|NCT02530489|Paclitaxel|paclitaxel|mesh-list
56526633|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56526634|NCT02530489|Atezolizumab|atezolizumab|mesh-list
56526635|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56526636|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56526637|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526638|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56526639|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56526640|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56526641|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526642|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
56526643|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526644|NCT02857777|Esketamine|esketamine|mesh-list
56526645|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
56526646|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56526647|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
56526648|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526649|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526650|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
56526651|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
55745943|NCT05061147|Azacitidine|azacitidine|mesh-list
56526670|NCT02445391|Carboplatin|carboplatin|mesh-list
56526671|NCT02445391|Capecitabine|capecitabine|mesh-list
56526672|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526673|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56526674|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
56526675|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526676|NCT01246986|Sorafenib|sorafenib|mesh-list
56526677|NCT01246986|Ramucirumab|ramucirumab|mesh-list
56526678|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526679|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56526680|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526681|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526682|NCT01164501|Empagliflozin|empagliflozin|mesh-list
56526683|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56526684|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526685|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56526686|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526687|NCT01163721|Ranolazine|ranolazine|mesh-list
56526688|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56526689|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526690|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526691|NCT03150511|Tesamorelin|tesamorelin|mesh-list
56526692|NCT03150511|Growth Substances|growth substances|mesh-ancestor
56526693|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526694|NCT00958243|Vaccines|vaccines|mesh-list
56526695|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
56526696|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526697|NCT01241760|Interferons|interferons|mesh-list
56526698|NCT01241760|Ribavirin|ribavirin|mesh-list
56526699|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
56526700|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
56526701|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56526702|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526703|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
56526704|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526705|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
56526706|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526707|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
56526708|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526709|NCT04280263|Caffeine|caffeine|mesh-list
55760648|NCT04857177|Ranibizumab|ranibizumab|mesh-list
56526728|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526729|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56526730|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56526731|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
56526732|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526733|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56526734|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56526735|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56649896|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
56649897|NCT04126070|Docetaxel|docetaxel|mesh-list
56649898|NCT04126070|Nivolumab|nivolumab|mesh-list
56649899|NCT04126070|Leuprolide|leuprolide|mesh-list
56649900|NCT04126070|Goserelin|goserelin|mesh-list
56649901|NCT04126070|Androgens|androgens|mesh-list
56649902|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56649903|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
56649904|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
56526736|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56526737|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56526738|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56526739|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56526740|NCT00953329|Alefacept|alefacept|mesh-list
56526741|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
56526742|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
56526743|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526744|NCT02857153|Urapidil|urapidil|mesh-list
56526745|NCT02857153|Phenylephrine|phenylephrine|mesh-list
56526746|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
56526747|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56526748|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
56526749|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
56526750|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526751|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526752|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
56526753|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56526754|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
56526755|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
56526756|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56526757|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56526758|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56526759|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
56526760|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526761|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526762|NCT02857153|Protective Agents|protective agents|mesh-ancestor
56526763|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56526764|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
56526765|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56526766|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
56526784|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526785|NCT02338609|Everolimus|everolimus|mesh-list
56526786|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526787|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526788|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
56526789|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526790|NCT00955279|Golimumab|golimumab|mesh-list
56526791|NCT00955279|Ustekinumab|ustekinumab|mesh-list
56526792|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
56526793|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56526794|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56526795|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526796|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
56526797|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526798|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56526799|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
56526800|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56526801|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526802|NCT02857309|Hormones|hormones|mesh-ancestor
56526803|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526804|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526805|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
56526806|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56526807|NCT02857309|Diuretics|diuretics|mesh-ancestor
56526808|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
56526809|NCT04261231|Anesthetics|anesthetics|mesh-list
56526810|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526811|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526812|NCT02857465|Dexamethasone|dexamethasone|mesh-list
56649905|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
56649906|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649907|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56649908|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56649909|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56649910|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
56649911|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56649912|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649913|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56649914|NCT04126070|Hormones|hormones|mesh-ancestor
56000746|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
56526813|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
56526814|NCT02857465|Sufentanil|sufentanil|mesh-list
56526816|NCT02857465|Ropivacaine|ropivacaine|mesh-list
56526817|NCT02857465|BB 1101|bb 1101|mesh-list
56526818|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56526819|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
56526820|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
56526821|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526822|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526823|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56526824|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
56526825|NCT02857465|Hormones|hormones|mesh-ancestor
56526834|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526835|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
56526836|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56526837|NCT02857465|Narcotics|narcotics|mesh-ancestor
56526838|NCT02857465|Analgesics|analgesics|mesh-ancestor
56526839|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56526840|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56526841|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
56526842|NCT04260139|Metronidazole|metronidazole|mesh-list
56526844|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56526845|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56526846|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56526847|NCT04206618|Denosumab|denosumab|mesh-list
56526848|NCT04206618|Teriparatide|teriparatide|mesh-list
56526849|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56526850|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526851|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526852|NCT01239732|Paclitaxel|paclitaxel|mesh-list
56526853|NCT01239732|Bevacizumab|bevacizumab|mesh-list
56526854|NCT01239732|Carboplatin|carboplatin|mesh-list
56526855|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56526856|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526857|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
56526858|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
56526859|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
56526860|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526861|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526862|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56526863|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56526864|NCT01239732|Growth Substances|growth substances|mesh-ancestor
56526865|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526866|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
56526867|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56526868|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56526869|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56526870|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56526871|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56526872|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
56526873|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526874|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526875|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649915|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649916|NCT04865042|Gabapentin|gabapentin|mesh-list
56649917|NCT04865042|Analgesics|analgesics|mesh-ancestor
56649918|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
56649919|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649920|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649921|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
56649922|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56649923|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56649924|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649925|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56649926|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56649927|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56649928|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649929|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649930|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
56649931|NCT04245371|Lidocaine|lidocaine|mesh-list
56649932|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
56649933|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
56000760|NCT03414684|Nivolumab|nivolumab|mesh-list
56526876|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56526877|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56275042|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
56526878|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526879|NCT00947011|Incretins|incretins|mesh-ancestor
56526880|NCT00947011|Hormones|hormones|mesh-ancestor
56526881|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526882|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56526883|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
56526884|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526885|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526886|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
56526887|NCT02856685|Analgesics|analgesics|mesh-ancestor
56526888|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
56526889|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526890|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526914|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
56526915|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
56526916|NCT02860663|Vitamins|vitamins|mesh-list
56526917|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
56526918|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526919|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56526920|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526921|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
56526922|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526923|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526924|NCT01239342|Everolimus|everolimus|mesh-list
56526925|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526926|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526927|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
56526928|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526929|NCT00946309|Sulforaphane|sulforaphane|mesh-list
56526930|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56526931|NCT00946309|Protective Agents|protective agents|mesh-ancestor
56115743|NCT00002531|Thioguanine|thioguanine|mesh-list
56649934|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649935|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956962|NCT01748643|Rocuronium|rocuronium|mesh-list
56526932|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526933|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526934|NCT02853799|Insulin|insulin|mesh-list
56526935|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56526936|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526937|NCT01236534|Lubiprostone|lubiprostone|mesh-list
56526938|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56526939|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526940|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526941|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
56526942|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745953|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
56526943|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
56526944|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526945|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56526946|NCT01235442|Etanercept|etanercept|mesh-list
56526947|NCT01235442|Clobetasol|clobetasol|mesh-list
56526948|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56526949|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56526950|NCT01235442|Analgesics|analgesics|mesh-ancestor
56526951|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
56526952|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526953|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526954|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56526956|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56526957|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526958|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
56526959|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
56526960|NCT01235442|Hormones|hormones|mesh-ancestor
56526961|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526962|NCT01163253|Tofacitinib|tofacitinib|mesh-list
56526963|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56526964|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526965|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526966|NCT01162863|Lubiprostone|lubiprostone|mesh-list
56526967|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56526968|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526969|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526970|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
56526971|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56526972|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
56526973|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56526974|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526975|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56526976|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
56526977|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56526978|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
56526979|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526980|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526981|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56526982|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
56526983|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
56526984|NCT05304039|Protective Agents|protective agents|mesh-ancestor
56526986|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
56526987|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
56526988|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526989|NCT01162239|Varenicline|varenicline|mesh-list
56526990|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56526991|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56526992|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
56526993|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526994|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526995|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526996|NCT01161537|Ivacaftor|ivacaftor|mesh-list
56526997|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56526998|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526999|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527000|NCT04314297|Durvalumab|durvalumab|mesh-list
56649936|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
56527001|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527002|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527003|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
56527004|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56527005|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
56527006|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527007|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
56527008|NCT04124133|Protective Agents|protective agents|mesh-ancestor
56527009|NCT01233258|Factor VIII|factor viii|mesh-list
56527010|NCT01233258|Coagulants|coagulants|mesh-ancestor
56527011|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
56527012|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56527013|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
56527014|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527015|NCT01232790|Expectorants|expectorants|mesh-ancestor
56527016|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56527017|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56527018|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
56527019|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527020|NCT01232790|Protective Agents|protective agents|mesh-ancestor
56527021|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527023|NCT01232556|Gemcitabine|gemcitabine|mesh-list
56527024|NCT01232556|Rituximab|rituximab|mesh-list
56527025|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56527026|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56527027|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527028|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527029|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
56527030|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527031|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56527032|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56527033|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
56527034|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527035|NCT01232556|Antiviral Agents|antiviral agents|mesh-ancestor
56527036|NCT01232556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527037|NCT01232556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527038|NCT01232556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56527039|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56527040|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
56527041|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56527043|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527044|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56527045|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527046|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527048|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
56527049|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527050|NCT01160289|Tadalafil|tadalafil|mesh-list
56527051|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
56527052|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56527053|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56527054|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527055|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527056|NCT01160289|Urological Agents|urological agents|mesh-ancestor
56527057|NCT01159665|Plasminogen|plasminogen|mesh-list
56527058|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
56527059|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56527060|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56527061|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527062|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56527063|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
56527064|NCT01158261|Coagulants|coagulants|mesh-ancestor
56527065|NCT01157169|Buprenorphine|buprenorphine|mesh-list
56527066|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56527067|NCT01157169|Narcotics|narcotics|mesh-ancestor
56527068|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56527069|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527070|NCT01157169|Analgesics|analgesics|mesh-ancestor
56527071|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
56527072|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527073|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56527074|NCT04313907|Clonazepam|clonazepam|mesh-list
56527075|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
56527076|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
56527077|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
56527078|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649937|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649938|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56527079|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527080|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527081|NCT01231620|Oseltamivir|oseltamivir|mesh-list
56527082|NCT01231620|Zanamivir|zanamivir|mesh-list
56527083|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
56527084|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527085|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527086|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527087|NCT01809691|Bicalutamide|bicalutamide|mesh-list
56527088|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
56527089|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
56527090|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527091|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527092|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527093|NCT01231464|Fluticasone|fluticasone|mesh-list
56527094|NCT01231464|Xhance|xhance|mesh-list
56527095|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56527096|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56527097|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
56527098|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527099|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527100|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56527101|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
56527102|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
56527103|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56527104|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56527105|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
56527106|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56527107|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
56527108|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527109|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
56527110|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56527111|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56527112|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56527113|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527114|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527115|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
56527116|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527117|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527118|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56527119|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527120|NCT01155531|Sertraline|sertraline|mesh-list
56527121|NCT01155531|Telenzepine|telenzepine|mesh-list
56527122|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
56527123|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56527124|NCT01155531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56527125|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56527126|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527127|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527128|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527129|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
56527130|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527131|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
56527132|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
56527133|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527134|NCT01155219|Latanoprost|latanoprost|mesh-list
56527135|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56527136|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56527137|NCT01098955|Varenicline|varenicline|mesh-list
56527138|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56527139|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56527140|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
56527141|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527142|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527143|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527144|NCT00631033|Metformin|metformin|mesh-list
56527145|NCT00631033|Diazoxide|diazoxide|mesh-list
56527146|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56527147|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527148|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56527149|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
56649939|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56649940|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56649941|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527150|NCT01155063|Exemestane|exemestane|mesh-list
56527151|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527152|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56527153|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56527154|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527155|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527156|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56527157|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
56527158|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527159|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527160|NCT03040999|Cisplatin|cisplatin|mesh-list
56527161|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
56527162|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527163|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527164|NCT01154673|Ritonavir|ritonavir|mesh-list
56527165|NCT01154673|Lopinavir|lopinavir|mesh-list
56527166|NCT01154673|Tenofovir|tenofovir|mesh-list
56527167|NCT01154673|Emtricitabine|emtricitabine|mesh-list
56527168|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
56527169|NCT01154673|Maraviroc|maraviroc|mesh-list
56527170|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56527171|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56527172|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
56527173|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527174|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527175|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56527176|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56527177|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
56527178|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527179|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56275343|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
56527180|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56527181|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56527182|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56527184|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56527185|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56527186|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56527187|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56527188|NCT02884713|Doxycycline|doxycycline|mesh-list
56527189|NCT02884713|Levofloxacin|levofloxacin|mesh-list
56527190|NCT02884713|Ofloxacin|ofloxacin|mesh-list
56527191|NCT02884713|Esomeprazole|esomeprazole|mesh-list
56527192|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56527193|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56527194|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56527195|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527196|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527197|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56527198|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527199|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
56527200|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56527201|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56527202|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56527203|NCT02884713|Renal Agents|renal agents|mesh-ancestor
56527204|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56527205|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56527206|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527207|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56527208|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56527209|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
56527210|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56527211|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56527212|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56527213|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
56527214|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527215|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527216|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527217|NCT01228734|Leucovorin|leucovorin|mesh-list
56527218|NCT01228734|Folic Acid|folic acid|mesh-list
56649942|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649943|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
56649944|NCT02657148|Etonogestrel|etonogestrel|mesh-list
56527219|NCT01228734|Fluorouracil|fluorouracil|mesh-list
56527220|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
56527221|NCT01228734|Cetuximab|cetuximab|mesh-list
56527222|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
56527223|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
56527224|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527225|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56527226|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527227|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56527228|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
56527229|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527230|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527231|NCT01228734|Antidotes|antidotes|mesh-ancestor
56527232|NCT01228734|Protective Agents|protective agents|mesh-ancestor
56527233|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
56527234|NCT01228734|Vitamins|vitamins|mesh-ancestor
56527235|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
56527236|NCT01228734|Hematinics|hematinics|mesh-ancestor
56527237|NCT01153971|Rituximab|rituximab|mesh-list
56527238|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527239|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527240|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
56527241|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527242|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56527243|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56527244|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
56527245|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527246|NCT00951379|Pioglitazone|pioglitazone|mesh-list
56527247|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56527248|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527250|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56527252|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56527253|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527254|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527255|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
56527256|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527257|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527258|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56527259|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527260|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
56527261|NCT01153425|Teriparatide|teriparatide|mesh-list
56527262|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56527263|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527264|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56527265|NCT01153269|Ritonavir|ritonavir|mesh-list
56527266|NCT01153269|Lopinavir|lopinavir|mesh-list
56527267|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56527268|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56527269|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
56527270|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527271|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527272|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56527273|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56527274|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
56527275|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527276|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56527277|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56527278|NCT02884635|Methotrexate|methotrexate|mesh-list
56527279|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56527280|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
56527281|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56527282|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527283|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56527284|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
56527285|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527286|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527287|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
56527288|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649945|NCT02657148|Desogestrel|desogestrel|mesh-list
56649946|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56649947|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649948|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56649949|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56649950|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56649951|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56649952|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56649953|NCT02657148|Progestins|progestins|mesh-ancestor
56649954|NCT02657148|Hormones|hormones|mesh-ancestor
56649955|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56649956|NCT04247087|Vitamin K|vitamin k|mesh-list
56649957|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
56649958|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56649959|NCT04247087|Vitamins|vitamins|mesh-ancestor
56649960|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
56649961|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649962|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56649963|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56649964|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649965|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
56649966|NCT04247087|Coagulants|coagulants|mesh-ancestor
56649967|NCT00649116|Metoprolol|metoprolol|mesh-list
56527289|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56527290|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56527291|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
56527292|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56527293|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56527294|NCT02884479|Docetaxel|docetaxel|mesh-list
56527295|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527296|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
56527297|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
56527298|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
56527299|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527300|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
56527301|NCT01152021|Propofol|propofol|mesh-list
56527302|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56527303|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56527304|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527305|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56527306|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
56527307|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
56527308|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56527309|NCT01152021|Analgesics|analgesics|mesh-ancestor
56527310|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
56527311|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527312|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56527313|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56527314|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56527315|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
56527316|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527317|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527318|NCT01151085|Voriconazole|voriconazole|mesh-list
56649968|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56649969|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56649970|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
56649971|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
56649972|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56649973|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649974|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56649975|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56649976|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56649977|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
56649978|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56649979|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56649980|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
56649981|NCT04459416|Narcotics|narcotics|mesh-ancestor
56000810|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
56527319|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
56527320|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527321|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56527322|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56527323|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527324|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527325|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56527326|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
56527327|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527328|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527329|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56527330|NCT01149369|Aprepitant|aprepitant|mesh-list
56527331|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
56527332|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
56168764|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
56527333|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527334|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527335|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56527336|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56527337|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527338|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527339|NCT01740427|Letrozole|letrozole|mesh-list
56527340|NCT01740427|Palbociclib|palbociclib|mesh-list
56527341|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527342|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56527343|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56527344|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527345|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527346|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56527347|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
56527348|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527349|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527350|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56527351|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
56527352|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56527353|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56527354|NCT00879931|Prednisolone|prednisolone|mesh-list
56527355|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
56527356|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56527357|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
56527358|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56527359|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
56527360|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
56649982|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649983|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56649984|NCT04459416|Analgesics|analgesics|mesh-ancestor
56649985|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
56527361|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527362|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527363|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56527364|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
56527365|NCT00879931|Hormones|hormones|mesh-ancestor
56527366|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527367|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56527368|NCT00879931|Protective Agents|protective agents|mesh-ancestor
56527369|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56527370|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527371|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56527372|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
56527373|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56527374|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
56527375|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527376|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
56527377|NCT00739141|Thiotepa|thiotepa|mesh-list
56527378|NCT00739141|Fludarabine|fludarabine|mesh-list
56527379|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56527380|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
56527381|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527382|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56527383|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56527384|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
56527385|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527386|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527387|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56527388|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56527389|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56527390|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527391|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56527392|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56527393|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527394|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527395|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
56527396|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527397|NCT01735825|Paclitaxel|paclitaxel|mesh-list
55783782|NCT03111511|Betadex|betadex|mesh-list
56527398|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56527399|NCT01735825|Everolimus|everolimus|mesh-list
56527400|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56527401|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527402|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
56527403|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
56527404|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56527405|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527406|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56527407|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
56527408|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527409|NCT01148511|Ranibizumab|ranibizumab|mesh-list
56527410|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56527411|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56527412|NCT01148511|Growth Substances|growth substances|mesh-ancestor
56527413|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527414|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
56527415|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527416|NCT02860117|Ketamine|ketamine|mesh-list
56527417|NCT02860117|Analgesics|analgesics|mesh-ancestor
56527418|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
56527419|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527420|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527421|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56527422|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56527423|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
56527424|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
56527425|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56649986|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527426|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56527427|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56527428|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527429|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527430|NCT02853253|SMOFlipid|smoflipid|mesh-list
56527431|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56527432|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56527433|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56527434|NCT04269187|Theophylline|theophylline|mesh-list
56527435|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56527436|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
56527437|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527438|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527439|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56527440|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
56527441|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56527442|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527443|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527444|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
56527445|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56527446|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56527447|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
56527448|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527449|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
56527450|NCT04269109|Narcotics|narcotics|mesh-ancestor
56527451|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56527452|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527453|NCT04269109|Analgesics|analgesics|mesh-ancestor
56527454|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
56527455|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527456|NCT01661881|Cytarabine|cytarabine|mesh-list
56527457|NCT01661881|Rituximab|rituximab|mesh-list
56527458|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56527459|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527460|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527461|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
56527462|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527463|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56527464|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56527465|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
56527466|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527467|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
56527468|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527469|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56527470|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56527471|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
56527472|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
56527473|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527475|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56527476|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56527477|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275649|NCT02018289|Triclosan|triclosan|mesh-list
56527478|NCT04268563|Incretins|incretins|mesh-ancestor
56527479|NCT04268563|Hormones|hormones|mesh-ancestor
56527480|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527481|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56527482|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
56527483|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527484|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527485|NCT01225146|Ranibizumab|ranibizumab|mesh-list
56527486|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56168818|NCT00373464|Etoricoxib|etoricoxib|mesh-list
56527488|NCT01225146|Growth Substances|growth substances|mesh-ancestor
56527489|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527490|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
56527491|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527492|NCT01223196|Pioglitazone|pioglitazone|mesh-list
56527493|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56527494|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527495|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56527496|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527497|NCT00950911|Denosumab|denosumab|mesh-list
56649987|NCT02652234|Endostar protein|endostar protein|mesh-list
56649988|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55957726|NCT04209114|Nivolumab|nivolumab|mesh-list
56527498|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56527499|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527500|NCT02855515|Anesthetics|anesthetics|mesh-list
56527501|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56527502|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527503|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56527504|NCT04206228|Hematinics|hematinics|mesh-ancestor
56527505|NCT01218594|Endostatins|endostatins|mesh-list
56527506|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56527507|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56527508|NCT01218594|Growth Substances|growth substances|mesh-ancestor
56527509|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527510|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56527511|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527512|NCT01610557|Bevacizumab|bevacizumab|mesh-list
56527513|NCT01610557|Ranibizumab|ranibizumab|mesh-list
56527514|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527515|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527516|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56527517|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56527518|NCT01610557|Growth Substances|growth substances|mesh-ancestor
56527519|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527520|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
56527521|NCT00943735|Fesoterodine|fesoterodine|mesh-list
56527522|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56527523|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56527524|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
56527525|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527526|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527527|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527528|NCT00943735|Urological Agents|urological agents|mesh-ancestor
56527529|NCT00489307|Dexamethasone|dexamethasone|mesh-list
56527530|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56527531|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
56527532|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
56527533|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527534|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527535|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56527536|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
56527538|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527539|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56527540|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527541|NCT00943111|Eliglustat|eliglustat|mesh-list
56527542|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527543|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527545|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56527546|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
56527547|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56527548|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527549|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56527550|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56527551|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
56527552|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
56527553|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56527554|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
56527555|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527556|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56527557|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
56527559|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
56527560|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527561|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527562|NCT01147107|Efavirenz|efavirenz|mesh-list
56527563|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
56527564|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56527565|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56527566|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527567|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527568|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
56527569|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56649989|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56296005|NCT00102310|Z 338|z 338|mesh-list
56527570|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56527571|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56527572|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56527573|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56527574|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56527575|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56527576|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56527577|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56527578|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56527579|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56527580|NCT01146951|Rufinamide|rufinamide|mesh-list
56527581|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
56527582|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56527583|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56527584|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527585|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527586|NCT01146873|Ritonavir|ritonavir|mesh-list
56527587|NCT01146873|Lopinavir|lopinavir|mesh-list
56527588|NCT01146873|Abacavir|abacavir|mesh-list
56527589|NCT01146873|Stavudine|stavudine|mesh-list
56527590|NCT01146873|Efavirenz|efavirenz|mesh-list
56527591|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56527592|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56527593|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
56527594|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527595|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527596|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56527597|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56527598|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
56527599|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527600|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56527601|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56168879|NCT00376272|Valsartan|valsartan|mesh-list
56527602|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56527603|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56527604|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56527605|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56527606|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56527607|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56527608|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56527609|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
56527610|NCT01146795|Paclitaxel|paclitaxel|mesh-list
56527611|NCT01146795|Bevacizumab|bevacizumab|mesh-list
56527612|NCT01146795|Carboplatin|carboplatin|mesh-list
56527613|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56527614|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527615|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
56527616|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
56527617|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
56527618|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527619|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527620|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56527621|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56527622|NCT01146795|Growth Substances|growth substances|mesh-ancestor
56527623|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527624|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
56527625|NCT01146561|Tanezumab|tanezumab|mesh-list
56527626|NCT01146561|Analgesics|analgesics|mesh-ancestor
56527627|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
56527628|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527629|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527630|NCT00942175|Esomeprazole|esomeprazole|mesh-list
56527631|NCT00942175|Omeprazole|omeprazole|mesh-list
56527632|NCT00942175|Lansoprazole|lansoprazole|mesh-list
56527633|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
56527634|NCT00942175|Clopidogrel|clopidogrel|mesh-list
56527635|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56527636|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56527637|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56527638|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56527639|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
56649996|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56649997|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957872|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
56527640|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527641|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527642|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527643|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56527644|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56527645|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56527646|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527647|NCT01145625|Minoxidil|minoxidil|mesh-list
56527648|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56527649|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
56527650|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
56527651|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527652|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527653|NCT01489813|Genistein|genistein|mesh-list
56527654|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56527655|NCT01489813|Protective Agents|protective agents|mesh-ancestor
56527656|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527657|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527658|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56527659|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527660|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527661|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
56527662|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56527663|NCT01489813|Estrogens|estrogens|mesh-ancestor
56527664|NCT01489813|Hormones|hormones|mesh-ancestor
56527665|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527666|NCT02852083|Pioglitazone|pioglitazone|mesh-list
56527667|NCT02852083|Clarithromycin|clarithromycin|mesh-list
56527668|NCT02852083|Nivolumab|nivolumab|mesh-list
56527669|NCT02852083|Treosulfan|treosulfan|mesh-list
56527670|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56527671|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168884|NCT00376428|Gentamicins|gentamicins|mesh-list
56527672|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56527673|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527674|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56527675|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527676|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56527677|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527678|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56527679|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527680|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56527681|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56527682|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56527683|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
56527685|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56527686|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
56527687|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527688|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527689|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56527690|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
56527691|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56527692|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56527693|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527694|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56527695|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
56527696|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56527697|NCT00602407|Protective Agents|protective agents|mesh-ancestor
56527698|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56527699|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56527700|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527701|NCT00950599|Saxagliptin|saxagliptin|mesh-list
56527703|NCT00950599|Hormones|hormones|mesh-ancestor
56527704|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527705|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527706|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56527707|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
56527708|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56649998|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56649999|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56650000|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56000832|NCT00678574|Fluoxetine|fluoxetine|mesh-list
56527709|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527710|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56527711|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56527712|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
56527713|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56527714|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56527715|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56527716|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
56527717|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56527718|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527719|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56527720|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56527721|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56527722|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56527723|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527724|NCT01143051|Epinephrine|epinephrine|mesh-list
56527725|NCT01143051|Racepinephrine|racepinephrine|mesh-list
56527726|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
56527727|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56527728|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56527729|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
56527730|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527731|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527732|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527733|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56527734|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56527735|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
56527736|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527737|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56527738|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
56527739|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
56527740|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
56168890|NCT00376584|Niacin|niacin|mesh-list
56527741|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56527743|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56527744|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56527745|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56527746|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
56527747|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527748|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527749|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56527750|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
56527751|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
56527752|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
56527753|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56527754|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56527755|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
56527756|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527757|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527758|NCT01142193|Topiramate|topiramate|mesh-list
56527759|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
56527760|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56527761|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527762|NCT01139775|Pemetrexed|pemetrexed|mesh-list
56527763|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527764|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527765|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527766|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56527767|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56527768|NCT01283516|Ceritinib|ceritinib|mesh-list
56527769|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527770|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56527771|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527772|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527773|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56527774|NCT05367063|Canagliflozin|canagliflozin|mesh-list
56527775|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56527776|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650001|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650002|NCT00649974|Valacyclovir|valacyclovir|mesh-list
56527778|NCT05367063|Hormones|hormones|mesh-ancestor
56527779|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527780|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56527781|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
56527782|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527783|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527784|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56527785|NCT01283282|Clopidogrel|clopidogrel|mesh-list
56527786|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56527787|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56527788|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56527789|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56527790|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
56527791|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527792|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527793|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527794|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56527795|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56527796|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56527797|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527798|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527799|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527800|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527801|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56527802|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
56527803|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56527804|NCT00941863|Sorafenib|sorafenib|mesh-list
56527805|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527806|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56527807|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527808|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527810|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56527811|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
56527812|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527813|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527814|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56527815|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
56527816|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56527817|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56527818|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527819|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56527820|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
56527821|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56527822|NCT00602173|Protective Agents|protective agents|mesh-ancestor
56527823|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56527824|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56527825|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527826|NCT02852239|Dabrafenib|dabrafenib|mesh-list
56527827|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527828|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56527829|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527830|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527831|NCT01282424|Idelalisib|idelalisib|mesh-list
56527832|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527833|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527834|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527835|NCT00602251|Terbinafine|terbinafine|mesh-list
56527836|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
56527837|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527838|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527839|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527840|NCT01281956|Naluzotan|naluzotan|mesh-list
56527841|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56527842|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56527843|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
56527844|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650003|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
56650004|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958107|NCT01813149|Analgesics|analgesics|mesh-ancestor
56527845|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527846|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527848|NCT01279850|Analgesics|analgesics|mesh-ancestor
56527849|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
56527850|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527851|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527852|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
56527853|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56527854|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527855|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527856|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56527857|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56527858|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56527859|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56527860|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56527861|NCT00604357|Sirolimus|sirolimus|mesh-list
56527862|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56527863|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56527864|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56527865|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527866|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
56527867|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56527868|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
56527869|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527870|NCT00602719|Zolpidem|zolpidem|mesh-list
56527871|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56527872|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56527873|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56527874|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527875|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56527876|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
56527877|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
56168900|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
56527878|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527879|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527880|NCT00604435|Docetaxel|docetaxel|mesh-list
56527881|NCT00604435|Epirubicin|epirubicin|mesh-list
56527882|NCT00604435|Endostatins|endostatins|mesh-list
56527883|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527884|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
56527885|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
56527886|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
56527887|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527888|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56527889|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56527890|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56527891|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527892|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56527893|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56527894|NCT00604435|Growth Substances|growth substances|mesh-ancestor
56527895|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527896|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
56527897|NCT01136967|Lenvatinib|lenvatinib|mesh-list
56527898|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527899|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56527900|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527901|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527902|NCT01218516|Paclitaxel|paclitaxel|mesh-list
56527903|NCT01218516|Carboplatin|carboplatin|mesh-list
56527904|NCT01218516|Pemetrexed|pemetrexed|mesh-list
56527905|NCT01218516|Farletuzumab|farletuzumab|mesh-list
56527906|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56527907|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527908|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
56527909|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
56527910|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
56527911|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527912|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527913|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56115744|NCT00002531|Vindesine|vindesine|mesh-list
56650005|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56650006|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650007|NCT00620594|Dactolisib|dactolisib|mesh-list
56650008|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958184|NCT01465178|Vitamins|vitamins|mesh-ancestor
56527914|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56527915|NCT00938431|Lacosamide|lacosamide|mesh-list
56527916|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
56527917|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56527918|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56276107|NCT02021123|Anidulafungin|anidulafungin|mesh-list
56527919|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527920|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527921|NCT05381389|Bupivacaine|bupivacaine|mesh-list
56527922|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
56527923|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
56527924|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56527925|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527926|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
56527927|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527928|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
56527929|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
56527930|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
56527931|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56527932|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56527933|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
56527934|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
56527935|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527936|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527937|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527938|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56527939|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
56527940|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56527942|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56527943|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
56527944|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56527945|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527946|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56527947|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527948|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56527949|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56527950|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56527951|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
56527952|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527953|NCT05379283|Lidocaine|lidocaine|mesh-list
56527954|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
56527955|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
56527956|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56527957|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527958|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
56527959|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56527960|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56527961|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56527962|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56527963|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56527964|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527965|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56527966|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
56527967|NCT01218438|Antibodies|antibodies|mesh-list
56527968|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
56527969|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56527970|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56527971|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
56527972|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
56527973|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527974|NCT00605995|Simvastatin|simvastatin|mesh-list
56527975|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56527976|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56527977|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
56527978|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650009|NCT02655822|Atezolizumab|atezolizumab|mesh-list
56527979|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56527980|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56527981|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527982|NCT00604591|Tolcapone|tolcapone|mesh-list
56527983|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56527984|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56527985|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56527986|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56527987|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527989|NCT02691156|Bilirubin|bilirubin|mesh-list
56527990|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
56527991|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527992|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
56527993|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56527994|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527996|NCT02691156|Protective Agents|protective agents|mesh-ancestor
56527997|NCT00603031|Glucagon|glucagon|mesh-list
56527998|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56527999|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528000|NCT00603031|Hormones|hormones|mesh-ancestor
56528001|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528002|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528003|NCT00603031|Incretins|incretins|mesh-ancestor
56528004|NCT05379049|Adalimumab|adalimumab|mesh-list
56528005|NCT05379049|Etanercept|etanercept|mesh-list
56528006|NCT05379049|Infliximab|infliximab|mesh-list
56528007|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528008|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56528009|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
56528010|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528011|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56528012|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56528013|NCT05379049|Analgesics|analgesics|mesh-ancestor
56528014|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
56528015|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528016|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528017|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528018|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
56528019|NCT02851459|Vaccines|vaccines|mesh-list
56528020|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
56528021|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528022|NCT00603343|Propiverine|propiverine|mesh-list
56528023|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
56528024|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
56528025|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528026|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528027|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56528028|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56528029|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
56528030|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528031|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528032|NCT00603343|Urological Agents|urological agents|mesh-ancestor
56528033|NCT01277510|Cinacalcet|cinacalcet|mesh-list
56528034|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56528035|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528036|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56528037|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
56528038|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528039|NCT00937495|Bortezomib|bortezomib|mesh-list
56528040|NCT00937495|Vorinostat|vorinostat|mesh-list
56528041|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528042|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56528043|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528044|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528045|NCT05550662|Xenon|xenon|mesh-list
56528046|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56528047|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
56528048|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
56528049|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528050|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528051|NCT04265833|Calcium|calcium|mesh-list
56528052|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56528053|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528054|NCT02851303|Morphine|morphine|mesh-list
56528055|NCT02851303|Methadone|methadone|mesh-list
56528056|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56528057|NCT02851303|Narcotics|narcotics|mesh-ancestor
56528058|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528059|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528060|NCT02851303|Analgesics|analgesics|mesh-ancestor
56528061|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
56528062|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528063|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
56528064|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
56528065|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56528066|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
56528067|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56528068|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56528069|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56528070|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528071|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528072|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56528073|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56528074|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56528075|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528076|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528077|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
56528078|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528079|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56528080|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56528081|NCT05378503|Topiramate|topiramate|mesh-list
56528082|NCT05378503|Phentermine|phentermine|mesh-list
56528083|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
56528084|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56528085|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528086|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56528087|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
56528088|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56528089|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
56528090|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
56528091|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528092|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
56528093|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528094|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528095|NCT05378191|Vaccines|vaccines|mesh-list
56528096|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
56528097|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528098|NCT00605137|Insulin|insulin|mesh-list
56528099|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56528100|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
56528101|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
56528102|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
56528103|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
56528104|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56528105|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528106|NCT00606775|Carvedilol|carvedilol|mesh-list
56528107|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56528108|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56528109|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
56528110|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528111|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528112|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168947|NCT00377988|Norgestimate|norgestimate|mesh-list
56528113|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56528114|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
56528115|NCT00606775|Protective Agents|protective agents|mesh-ancestor
56528116|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56528117|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528118|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56528119|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
56528120|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56528121|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56528122|NCT00605371|Lamotrigine|lamotrigine|mesh-list
56528123|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
56528124|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56528125|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528126|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528127|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56650010|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650011|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56528128|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528129|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56528130|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56528131|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528132|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56528133|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56528135|NCT04267549|Apatinib|apatinib|mesh-list
56528136|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56528137|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528138|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
56528139|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
56528140|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56528141|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528142|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56528143|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528144|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56528145|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56528147|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56528148|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528149|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
56528150|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56528151|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56528152|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
56528153|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56528154|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56528155|NCT00934843|Prednisolone|prednisolone|mesh-list
56528156|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
56528157|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56528158|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
56528159|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
56528160|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528161|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
56528162|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
56528163|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528164|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528165|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528167|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528168|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56528169|NCT00934843|Protective Agents|protective agents|mesh-ancestor
56528170|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56528171|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528172|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
56528173|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
56528174|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
56528175|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56528176|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56528177|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528178|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528179|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528180|NCT04267237|Atezolizumab|atezolizumab|mesh-list
56528181|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528182|NCT00605683|Cabergoline|cabergoline|mesh-list
56528183|NCT00605683|Pramipexole|pramipexole|mesh-list
56528184|NCT00605683|Ropinirole|ropinirole|mesh-list
56528185|NCT00605683|Bromocriptine|bromocriptine|mesh-list
56528186|NCT00605683|Lisuride|lisuride|mesh-list
56528187|NCT00605683|Apomorphine|apomorphine|mesh-list
56528188|NCT00605683|Pergolide|pergolide|mesh-list
56528189|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56528190|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56528191|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
56528192|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
56528193|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528194|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528195|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528196|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
56528197|NCT00605683|Protective Agents|protective agents|mesh-ancestor
56528198|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
56528199|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528200|NCT00605683|Emetics|emetics|mesh-ancestor
56528201|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
56528202|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650012|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56528203|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528204|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56528205|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
56528206|NCT01266902|Rilpivirine|rilpivirine|mesh-list
56528207|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56528208|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56528209|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528210|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528211|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
56528212|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528213|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56528214|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56528215|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
56528216|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56528217|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56528218|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
56276403|NCT02023021|Gemcitabine|gemcitabine|mesh-list
56528219|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
56528220|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528221|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528222|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
56528223|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528224|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56528225|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
56528226|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528227|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56528228|NCT05382481|Dalteparin|dalteparin|mesh-list
56528229|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
56528230|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56528231|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56528232|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528233|NCT01266590|Digoxin|digoxin|mesh-list
56528234|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56528235|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56528236|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528237|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528238|NCT01266590|Protective Agents|protective agents|mesh-ancestor
56528239|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528240|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56528241|NCT01265498|Cathartics|cathartics|mesh-ancestor
56528242|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528243|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
56528244|NCT00607711|Ifosfamide|ifosfamide|mesh-list
56528245|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56528246|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
56528247|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528248|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528249|NCT01263782|Bevacizumab|bevacizumab|mesh-list
56528250|NCT01263782|Carboplatin|carboplatin|mesh-list
56528251|NCT01263782|Pemetrexed|pemetrexed|mesh-list
56528252|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56528253|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528254|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56168965|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
56528255|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56528256|NCT01263782|Growth Substances|growth substances|mesh-ancestor
56528257|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528258|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
56528259|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528260|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528261|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56528262|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56528263|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
56528264|NCT01263704|Rituximab|rituximab|mesh-list
56528265|NCT01263704|Fludarabine|fludarabine|mesh-list
56528266|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528267|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
56528268|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528269|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56528270|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56528271|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
56528272|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528273|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528274|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56650013|NCT00650442|Estradiol|estradiol|mesh-list
56650014|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56650015|NCT00650442|Estrogens|estrogens|mesh-ancestor
56650016|NCT00650442|Hormones|hormones|mesh-ancestor
56650017|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650018|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650019|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56000846|NCT01475500|Dimercaprol|dimercaprol|mesh-list
56528275|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56528276|NCT01263470|Alogliptin|alogliptin|mesh-list
56528277|NCT01263470|Voglibose|voglibose|mesh-list
56528278|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56528279|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528280|NCT01263470|Incretins|incretins|mesh-ancestor
56528281|NCT01263470|Hormones|hormones|mesh-ancestor
56528282|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528283|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56528284|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
56528285|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528286|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528287|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56528288|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56528289|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
56528290|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528291|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528292|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
56528293|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
56528294|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528295|NCT04322240|Protective Agents|protective agents|mesh-ancestor
56528296|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528297|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
56528299|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
56528300|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56528301|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
56528302|NCT01262456|Coagulants|coagulants|mesh-ancestor
56528303|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56528304|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
56528305|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528306|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
56528307|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528308|NCT04321850|Zinc|zinc|mesh-list
56528309|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
56528310|NCT04321850|Trace Elements|trace elements|mesh-ancestor
56528311|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
56528312|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528313|NCT04321850|Astringents|astringents|mesh-ancestor
56528314|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
56528315|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
56528317|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
56528318|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56528319|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56528320|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528321|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528322|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528323|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56528324|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
56528325|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
56528326|NCT00932893|Docetaxel|docetaxel|mesh-list
56528327|NCT00932893|Pemetrexed|pemetrexed|mesh-list
56528328|NCT00932893|Crizotinib|crizotinib|mesh-list
56528329|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528330|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
56528331|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
56528332|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
56528333|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528334|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528335|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56528336|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56528337|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56650020|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
56650021|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56650022|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56650023|NCT00890825|Docetaxel|docetaxel|mesh-list
56528338|NCT04321070|Clindamycin|clindamycin|mesh-list
56528339|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
56528340|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
56528341|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56528342|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528343|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56528344|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528345|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528346|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
56528347|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528348|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56528349|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56528350|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56528351|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528352|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528353|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528354|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528355|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56528356|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
56528357|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56528358|NCT00939523|Lapatinib|lapatinib|mesh-list
56528359|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528360|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56528361|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528362|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528363|NCT01260584|Clopidogrel|clopidogrel|mesh-list
56528364|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56528365|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56528366|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56528367|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56528368|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56528369|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
56528370|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528371|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528372|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528373|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
56528374|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56528375|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528377|NCT04262635|Cetuximab|cetuximab|mesh-list
56528378|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56528379|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
56528380|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528381|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528382|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56528383|NCT00608101|Dexamethasone|dexamethasone|mesh-list
56528384|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
56528385|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528386|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
56528387|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
56528388|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528389|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528390|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528391|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
56528392|NCT00608101|Hormones|hormones|mesh-ancestor
56528393|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528394|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56528395|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528396|NCT04264039|Fludarabine|fludarabine|mesh-list
56528397|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
56528398|NCT04264039|Melphalan|melphalan|mesh-list
56528399|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528400|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528401|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528402|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
56528403|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650024|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650025|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
56650026|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
56650027|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56650028|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650029|NCT04760132|Vaccines|vaccines|mesh-list
56650030|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
56528404|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56528405|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56528406|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
56528407|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56528408|NCT00608179|Glimepiride|glimepiride|mesh-list
56528409|NCT00608179|Glyburide|glyburide|mesh-list
56528410|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56528411|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56528412|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528413|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528414|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
56528415|NCT00608335|Micafungin|micafungin|mesh-list
56528416|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
56528417|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528418|NCT00927589|Carboplatin|carboplatin|mesh-list
56528419|NCT00927589|Docetaxel|docetaxel|mesh-list
56528420|NCT00927589|Trastuzumab|trastuzumab|mesh-list
56528421|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528422|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
56528423|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
56528424|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
56528425|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528426|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56528427|NCT00932113|Folic Acid|folic acid|mesh-list
56528428|NCT00932113|Adalimumab|adalimumab|mesh-list
56528429|NCT00932113|Methotrexate|methotrexate|mesh-list
56528430|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56528431|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
56528432|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56528433|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528434|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56528435|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
56169002|NCT00378456|Hematinics|hematinics|mesh-ancestor
56528436|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528437|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528438|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
56528439|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528440|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56528441|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528442|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
56276629|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
56528443|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56528444|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56528445|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528446|NCT00932113|Hematinics|hematinics|mesh-ancestor
56528447|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
56528448|NCT00932113|Vitamins|vitamins|mesh-ancestor
56528449|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
56528450|NCT00931801|Tenofovir|tenofovir|mesh-list
56528451|NCT00931801|Emtricitabine|emtricitabine|mesh-list
56528452|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
56528453|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56528454|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
56528455|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528456|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56528457|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56528458|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528459|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528460|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56528461|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56528462|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56528463|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56528464|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56650031|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650032|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
56528465|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56528466|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
56528467|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56528468|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
56528469|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56528470|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56528471|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56528472|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528473|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528474|NCT05025397|Propofol|propofol|mesh-list
56528475|NCT05025397|Sevoflurane|sevoflurane|mesh-list
56528476|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56528477|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528478|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528479|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56528480|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
56528481|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
56528482|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56528483|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56528484|NCT00608803|Doxorubicin|doxorubicin|mesh-list
56528485|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56528486|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528487|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56528488|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56528489|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528490|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528491|NCT00931255|Sirolimus|sirolimus|mesh-list
56528492|NCT00931255|Tacrolimus|tacrolimus|mesh-list
56528493|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528494|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
56528495|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528496|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56528497|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528498|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528499|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56528500|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528501|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56528502|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528503|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
56528504|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56528505|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
56528506|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56528507|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56528508|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56169015|NCT00378690|Leuprolide|leuprolide|mesh-list
56528509|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528510|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528511|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
56528512|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56528513|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528514|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
56528515|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56528516|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528517|NCT00609817|Dexamethasone|dexamethasone|mesh-list
56528518|NCT00609817|Bortezomib|bortezomib|mesh-list
56276700|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
56528519|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528520|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
56528522|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528523|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528524|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528525|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
56528526|NCT00609817|Hormones|hormones|mesh-ancestor
56528527|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528528|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56528529|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528530|NCT00929695|Prednisone|prednisone|mesh-list
56528531|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
56528532|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56528533|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56528534|NCT00929695|Prednisolone|prednisolone|mesh-list
56528535|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
56115745|NCT00002531|Teniposide|teniposide|mesh-list
56650033|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56650034|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528536|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56528537|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
56528538|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528539|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
56528540|NCT00929695|Hormones|hormones|mesh-ancestor
56528541|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528542|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528543|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56528544|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528545|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
56528546|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
56528547|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528548|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528549|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56528550|NCT00929695|Protective Agents|protective agents|mesh-ancestor
56528551|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
56528552|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56528553|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528554|NCT04261465|Paclitaxel|paclitaxel|mesh-list
56528555|NCT04261465|Carboplatin|carboplatin|mesh-list
56528556|NCT04261465|Olaparib|olaparib|mesh-list
56528557|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56528558|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528559|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
56528560|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
56528561|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
56528562|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528563|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56528564|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528565|NCT04260607|Ketamine|ketamine|mesh-list
56528566|NCT04260607|Analgesics|analgesics|mesh-ancestor
56528567|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
56528568|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528569|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528570|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56528571|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56528572|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
56528573|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
56528574|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528575|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56528576|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56528577|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528578|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528579|NCT00927355|Pioglitazone|pioglitazone|mesh-list
56528580|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56169016|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56528581|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528582|NCT00923845|Sirolimus|sirolimus|mesh-list
56528583|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
56528584|NCT00923845|Pentostatin|pentostatin|mesh-list
56528585|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528586|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
56528587|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528588|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56528589|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56528590|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
56528591|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528592|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276805|NCT02025023|Hormones|hormones|mesh-ancestor
56528593|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56528594|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56528595|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528596|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56528597|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
56528598|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56528599|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528600|NCT05052541|Dronabinol|dronabinol|mesh-list
56528601|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
56528602|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528603|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56528604|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56528605|NCT05052541|Analgesics|analgesics|mesh-ancestor
56650035|NCT00649818|Lorazepam|lorazepam|mesh-list
56650036|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
56650037|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
56528606|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
56528607|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528608|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56528609|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56528610|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528611|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528612|NCT05052541|Hormones|hormones|mesh-ancestor
56528613|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528614|NCT04260685|Lidocaine|lidocaine|mesh-list
56528615|NCT04260685|Esmolol|esmolol|mesh-list
56528616|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
56528617|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
56528618|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528619|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528620|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
56528621|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528622|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56528623|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56528624|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56528625|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528626|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528627|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56528628|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56528629|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56528630|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
56528631|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528632|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
56528633|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56528634|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
56528635|NCT05013463|Indapamide|indapamide|mesh-list
56528636|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
56528637|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56528638|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56528639|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528640|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528641|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528642|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56528643|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56528644|NCT05013463|Diuretics|diuretics|mesh-ancestor
56528645|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
56528646|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528647|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56528648|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528650|NCT00922987|Analgesics|analgesics|mesh-ancestor
56528651|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
56528652|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528653|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528654|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
56528655|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56528656|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528657|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528658|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56528659|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56528660|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56528661|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528662|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56528663|NCT00610909|Paroxetine|paroxetine|mesh-list
56528664|NCT00610909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56528665|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56528666|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528667|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528668|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528669|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
56528670|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528671|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56528672|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
56528673|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56650038|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
56000864|NCT00542542|Ropivacaine|ropivacaine|mesh-list
56528674|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56528675|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56528676|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528677|NCT00927901|Maleic acid|maleic acid|mesh-list
56528678|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528679|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528680|NCT04255771|Gemcitabine|gemcitabine|mesh-list
56528681|NCT04255771|Cisplatin|cisplatin|mesh-list
56528682|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528683|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56528684|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
56528685|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528686|NCT04255771|Antiviral Agents|antiviral agents|mesh-ancestor
56528687|NCT04255771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528688|NCT04255771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528689|NCT04255771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528690|NCT04255771|Immunologic Factors|immunologic factors|mesh-ancestor
56528691|NCT04255771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528692|NCT01218204|Atorvastatin|atorvastatin|mesh-list
56528693|NCT01218204|Ezetimibe|ezetimibe|mesh-list
56528694|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56528695|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56528696|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
56528697|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528698|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56528699|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56528700|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528701|NCT00926575|Beclomethasone|beclomethasone|mesh-list
56528702|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528703|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
56528704|NCT00926575|Hormones|hormones|mesh-ancestor
56528705|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528706|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528707|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56528708|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
56528709|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56528710|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56528711|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528712|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528713|NCT01217892|Metformin|metformin|mesh-list
56528714|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
56528715|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56528716|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528717|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56528718|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528719|NCT01217814|Leucovorin|leucovorin|mesh-list
56528720|NCT01217814|Folic Acid|folic acid|mesh-list
56528721|NCT01217814|Golimumab|golimumab|mesh-list
56528722|NCT01217814|Methotrexate|methotrexate|mesh-list
56528723|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
56528724|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56528725|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
56528726|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56528727|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528728|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56528729|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
56528730|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528731|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528732|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
56528733|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528734|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56528735|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528736|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
56528737|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56528738|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56528739|NCT01217814|Antidotes|antidotes|mesh-ancestor
56528741|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
56528742|NCT01217814|Vitamins|vitamins|mesh-ancestor
56528744|NCT01217814|Hematinics|hematinics|mesh-ancestor
56528745|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56528746|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528747|NCT01217190|Ondansetron|ondansetron|mesh-list
56650039|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650040|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650041|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528748|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
56528749|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
56528750|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528751|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528752|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528753|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
56528754|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
56528755|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56528756|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
56528757|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528758|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528759|NCT01217190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56528760|NCT01217190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56528761|NCT01217190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56528762|NCT01217190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56528763|NCT01217190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56528764|NCT01136733|Everolimus|everolimus|mesh-list
56528765|NCT01136733|Lenvatinib|lenvatinib|mesh-list
56528766|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528767|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56528768|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
56528769|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528770|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56528771|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528772|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528773|NCT05178693|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56528774|NCT05178693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56528775|NCT05178693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528776|NCT01136655|Budesonide|budesonide|mesh-list
56528777|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
56528778|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56528779|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528780|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56528781|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
56528782|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528783|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528784|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56528785|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
56528786|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
56528787|NCT01136655|Hormones|hormones|mesh-ancestor
56528788|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528789|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56528790|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56528791|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56528792|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
56528793|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528794|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528795|NCT01135017|Dronedarone|dronedarone|mesh-list
56528796|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56528797|NCT01134705|Beclomethasone|beclomethasone|mesh-list
56528798|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56528799|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
56528800|NCT01134705|Hormones|hormones|mesh-ancestor
56528801|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528802|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528803|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56528804|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
56528805|NCT01134627|Minocycline|minocycline|mesh-list
56528806|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56528807|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528808|NCT01134393|Amlodipine|amlodipine|mesh-list
56528809|NCT01134393|Telmisartan|telmisartan|mesh-list
56528810|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56528811|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56528812|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56528813|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528814|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650042|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56650043|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959157|NCT02989623|Copper|copper|mesh-list
56528815|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56277003|NCT02026310|Metformin|metformin|mesh-list
56528816|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528817|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
56528818|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56528819|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56528820|NCT05331469|Insulin|insulin|mesh-list
56528821|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56528822|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528823|NCT00922441|Valsartan|valsartan|mesh-list
56528824|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56528825|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56528826|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56528827|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528828|NCT01217112|Cannabidiol|cannabidiol|mesh-list
56528829|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
56528830|NCT01216332|Vaccines|vaccines|mesh-list
56528831|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
56528832|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528833|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56528834|NCT00922207|Entecavir|entecavir|mesh-list
56528835|NCT00922207|Adefovir|adefovir|mesh-list
56528836|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
56528837|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528838|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56528839|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56528840|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528841|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528842|NCT01134315|Calcitriol|calcitriol|mesh-list
56528843|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56528844|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528845|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56528846|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528847|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528848|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56528849|NCT01134315|Vitamins|vitamins|mesh-ancestor
56528850|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
56528851|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56528852|NCT01216176|Anastrozole|anastrozole|mesh-list
56528853|NCT01216176|Saracatinib|saracatinib|mesh-list
56528854|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56528855|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528856|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56528857|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56528858|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528859|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528860|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56528861|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
56528862|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56528863|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528864|NCT01133847|Guanfacine|guanfacine|mesh-list
56528865|NCT01133847|Methylphenidate|methylphenidate|mesh-list
56528866|NCT01133847|Amphetamine|amphetamine|mesh-list
56528867|NCT01133847|Adderall|adderall|mesh-list
56528868|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56528869|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56528870|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528871|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56528872|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56528873|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528874|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528875|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
56528876|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528877|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56528878|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
56528879|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
56528880|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
56528881|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650044|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56650045|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55789921|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
56528882|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56528883|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56528884|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56528885|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56528886|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
56528887|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56277069|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528889|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
56528890|NCT01133379|Protective Agents|protective agents|mesh-ancestor
56528891|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528892|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56528893|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56528894|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56528895|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
56528896|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528897|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56528898|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56528899|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528900|NCT05154669|Nicotine|nicotine|mesh-list
56528901|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56528902|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
56528903|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56528904|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528905|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56528906|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56528907|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
56528908|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528909|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528910|NCT00637455|Fexofenadine|fexofenadine|mesh-list
56528911|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56528912|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56528913|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56528914|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
56528915|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
56528916|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528917|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528918|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528919|NCT00919711|Denosumab|denosumab|mesh-list
56528920|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
56528921|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56528922|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528923|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56528924|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56528925|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528926|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56528927|NCT01131585|Ranibizumab|ranibizumab|mesh-list
56528928|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56528929|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56528930|NCT01131585|Growth Substances|growth substances|mesh-ancestor
56528931|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528932|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
56528933|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528934|NCT01131507|Pancrelipase|pancrelipase|mesh-list
56528935|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56528936|NCT00919633|Interferons|interferons|mesh-list
56528937|NCT00919633|Ribavirin|ribavirin|mesh-list
56528938|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
56528939|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
56528940|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56528941|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528942|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528943|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
56528944|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528945|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
56528946|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528947|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
56528948|NCT05139225|Daratumumab|daratumumab|mesh-list
56528949|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528950|NCT00926029|Listerine|listerine|mesh-list
56528951|NCT00926029|Triclosan|triclosan|mesh-list
56650046|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56650047|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
56650048|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
56650049|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650050|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528952|NCT00926029|Fluorides|fluorides|mesh-list
56528953|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
56528954|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
56528955|NCT00926029|Protective Agents|protective agents|mesh-ancestor
56528956|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528957|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56528958|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528959|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56528960|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56528961|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
56528962|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528964|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
56528965|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56528966|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56528967|NCT04254913|Edaravone|edaravone|mesh-list
56528968|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56528969|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
56528970|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528971|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56528972|NCT04254913|Protective Agents|protective agents|mesh-ancestor
56528973|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528974|NCT01130493|Levodopa|levodopa|mesh-list
56528975|NCT01130493|Carbidopa|carbidopa|mesh-list
56528976|NCT01130493|Entacapone|entacapone|mesh-list
56528977|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56528978|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56528979|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56528980|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
56528981|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56528982|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528983|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56528984|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56528985|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56528986|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56528987|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56528988|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
56528989|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
56528990|NCT01130337|Capecitabine|capecitabine|mesh-list
56528991|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
56528992|NCT01130337|Trastuzumab|trastuzumab|mesh-list
56528993|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56528994|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
56528995|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56528996|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56528997|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56528998|NCT04901689|Leronlimab|leronlimab|mesh-list
56528999|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56529000|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56529001|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529002|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56529003|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56529004|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
56529005|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529006|NCT04252963|Streptokinase|streptokinase|mesh-list
56529007|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56529008|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56529009|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529010|NCT04258657|Paclitaxel|paclitaxel|mesh-list
56529011|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56529012|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529013|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
56529014|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
56529015|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
56529016|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650056|NCT04246697|Acetaminophen|acetaminophen|mesh-list
56650057|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56529017|NCT01130103|Paroxetine|paroxetine|mesh-list
56529018|NCT01130103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56529019|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56529020|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56529021|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529022|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529023|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
56529024|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529025|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56529026|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
56529027|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56529028|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56529029|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56529030|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529031|NCT04254523|Morphine|morphine|mesh-list
56529032|NCT04254523|Bupivacaine|bupivacaine|mesh-list
56529033|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
56529034|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
56529035|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56529036|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169069|NCT00381030|Carvedilol|carvedilol|mesh-list
56529038|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529039|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56529040|NCT04254523|Narcotics|narcotics|mesh-ancestor
56529041|NCT04254523|Analgesics|analgesics|mesh-ancestor
56529042|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56529043|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
56529044|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56529045|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56529046|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56529047|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
56529048|NCT00625209|Protein C|protein c|mesh-list
56529049|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529050|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
56529051|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56529052|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56529053|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529054|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529055|NCT04254601|Erythromycin|erythromycin|mesh-list
56529056|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
56529057|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56529058|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
56529059|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56529060|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529061|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56529062|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56529063|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529064|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529065|NCT01129557|Valsartan|valsartan|mesh-list
56529066|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56529067|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56529068|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56529069|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529070|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
56529071|NCT04254679|Analgesics|analgesics|mesh-list
56529072|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56529073|NCT04254679|Narcotics|narcotics|mesh-ancestor
56529074|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56529075|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529076|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
56529077|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529078|NCT01129011|Naproxen|naproxen|mesh-list
56529079|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56529080|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529081|NCT01129011|Analgesics|analgesics|mesh-ancestor
56529082|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
56529083|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529084|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529085|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529086|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529087|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
56650058|NCT04246697|Morphine|morphine|mesh-list
56650059|NCT04246697|Oxycodone|oxycodone|mesh-list
56650060|NCT04246697|Gabapentin|gabapentin|mesh-list
56650061|NCT04246697|Bupivacaine|bupivacaine|mesh-list
56650062|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
56296081|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
56650063|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
55959463|NCT00289211|Complement C1s|complement c1s|mesh-list
56529088|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56529089|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529090|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529091|NCT04252885|Ritonavir|ritonavir|mesh-list
56529092|NCT04252885|Lopinavir|lopinavir|mesh-list
56529093|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56529094|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56529095|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
56529096|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529097|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529098|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56529099|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56529100|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
56529101|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529102|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56529103|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56529104|NCT04258423|Everolimus|everolimus|mesh-list
56529105|NCT04258423|Tacrolimus|tacrolimus|mesh-list
56529106|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56529107|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
56529108|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529109|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56529110|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277297|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
56529111|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529112|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529113|NCT04962841|Metformin|metformin|mesh-list
56529114|NCT04962841|Amlodipine|amlodipine|mesh-list
56529115|NCT04962841|Ramipril|ramipril|mesh-list
56529116|NCT04962841|Nebivolol|nebivolol|mesh-list
56529117|NCT04962841|Rivastigmine|rivastigmine|mesh-list
56529118|NCT04962841|Sertraline|sertraline|mesh-list
56529119|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56529120|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529121|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56529122|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56529123|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56529124|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529125|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56529126|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
56529127|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
56529128|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56529129|NCT04962841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56529130|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56529131|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529132|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
56529133|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56529134|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
56529135|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529136|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56529137|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56529138|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56529139|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
56529140|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56529141|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
56529142|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56529143|NCT04962841|Protective Agents|protective agents|mesh-ancestor
56529144|NCT00919867|Guanfacine|guanfacine|mesh-list
56529145|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56529146|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56529147|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529148|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56529149|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56650064|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56650065|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213236|NCT02420821|Bevacizumab|bevacizumab|mesh-list
56529150|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56529151|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529152|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
56529153|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529154|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56529155|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56529156|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56529157|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56529158|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
56529159|NCT04252261|Sulforaphane|sulforaphane|mesh-list
56529160|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56529161|NCT04252261|Protective Agents|protective agents|mesh-ancestor
56529162|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529163|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529164|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
56529165|NCT05069935|Fludarabine|fludarabine|mesh-list
56529166|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56529167|NCT05069935|Antibodies|antibodies|mesh-list
56529168|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
56529169|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56529170|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56529171|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
56529172|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529173|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529174|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56529175|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
56529176|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529177|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529178|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56529179|NCT04251871|Interferons|interferons|mesh-list
56529180|NCT04251871|Ritonavir|ritonavir|mesh-list
56529181|NCT04251871|Lopinavir|lopinavir|mesh-list
56529182|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
56529183|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56529185|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
56529186|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529187|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56529188|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56529189|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
56529190|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529191|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529192|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56529193|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56529194|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56529195|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56529196|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
56529197|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529198|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56529199|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56529200|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529201|NCT01128621|Incretins|incretins|mesh-ancestor
56529202|NCT01128621|Hormones|hormones|mesh-ancestor
56529203|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56529204|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56529205|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
56529206|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529207|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529208|NCT00918463|Dasatinib|dasatinib|mesh-list
56529209|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529210|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56529211|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529212|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529213|NCT05330065|Bevacizumab|bevacizumab|mesh-list
56529214|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56529215|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529216|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56529217|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56529218|NCT05330065|Growth Substances|growth substances|mesh-ancestor
55959597|NCT05748561|Hormones|hormones|mesh-ancestor
56529219|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529220|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
56529221|NCT01128543|Vinorelbine|vinorelbine|mesh-list
56529222|NCT01128543|Lapatinib|lapatinib|mesh-list
56529223|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56529224|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529225|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
56529226|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
56529227|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
56529228|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529229|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56529230|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529231|NCT01128387|Panitumumab|panitumumab|mesh-list
56529232|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56529233|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529234|NCT01214850|Vaccines|vaccines|mesh-list
56529235|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
56529236|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529237|NCT01128153|Saxagliptin|saxagliptin|mesh-list
56529238|NCT01128153|Incretins|incretins|mesh-ancestor
56529239|NCT01128153|Hormones|hormones|mesh-ancestor
56529240|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56529241|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529242|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56529243|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
56529244|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529245|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529246|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56529247|NCT00925015|Irinotecan|irinotecan|mesh-list
56529248|NCT00925015|Cetuximab|cetuximab|mesh-list
56529249|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56529250|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56529251|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56529252|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529253|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529254|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529255|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56529256|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
56529257|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529259|NCT01127763|Everolimus|everolimus|mesh-list
56277447|NCT02028923|Analgesics|analgesics|mesh-ancestor
56529260|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529261|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56529262|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
56529263|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529264|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56529265|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56529266|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529267|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56529268|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56529269|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56529270|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529271|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
56529272|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529273|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
56529274|NCT00924781|Hematinics|hematinics|mesh-ancestor
56529275|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
56529276|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529277|NCT01214616|Vinorelbine|vinorelbine|mesh-list
56529278|NCT01214616|Afatinib|afatinib|mesh-list
56529279|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56529280|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529281|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
56529282|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
56529283|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
56529284|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529285|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56529286|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529287|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56529288|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
56529289|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56529290|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56529291|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56115746|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
56650066|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
56650067|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650068|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56529292|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56529293|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529294|NCT01213524|Nicotine|nicotine|mesh-list
56529295|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56529296|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
56529297|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529298|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529299|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56529300|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56529301|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
56529302|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529303|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529304|NCT01212588|Mifepristone|mifepristone|mesh-list
56529305|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56529306|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
56529307|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56529308|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529309|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56529310|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56529311|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56529312|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
56529313|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56529314|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56529315|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
56529316|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56529317|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
56529318|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56529319|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56529320|NCT00918385|Dasatinib|dasatinib|mesh-list
56529321|NCT00918385|Nilutamide|nilutamide|mesh-list
56529322|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529323|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56529324|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529325|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529326|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
56529327|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
56529328|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56529329|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529330|NCT00637819|Leflunomide|leflunomide|mesh-list
56529331|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529332|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529334|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
56529335|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529336|NCT00631501|Doxycycline|doxycycline|mesh-list
56529337|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56529338|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529339|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
56529340|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56529341|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56529342|NCT04746547|Dolutegravir|dolutegravir|mesh-list
56529343|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56529344|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56529345|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529346|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529347|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56529348|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56529349|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
56529350|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529351|NCT04782037|Calcium|calcium|mesh-list
56529352|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56529353|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529354|NCT00924469|Prednisone|prednisone|mesh-list
56529355|NCT00924469|Leuprolide|leuprolide|mesh-list
56529356|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529357|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
56529358|NCT00924469|Hormones|hormones|mesh-ancestor
56529359|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56115951|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650069|NCT04246697|Narcotics|narcotics|mesh-ancestor
56650070|NCT04246697|Analgesics|analgesics|mesh-ancestor
55959800|NCT00248807|Enalapril|enalapril|mesh-list
56529360|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529361|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56529362|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529363|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56529364|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
56169113|NCT00381732|Urological Agents|urological agents|mesh-ancestor
56529365|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56529366|NCT00631579|Rasburicase|rasburicase|mesh-list
56529367|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
56529368|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529369|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56529371|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56529372|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56529373|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529374|NCT00916357|Insulin|insulin|mesh-list
56529375|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56529376|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
56529377|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56529378|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529379|NCT00916279|Paclitaxel|paclitaxel|mesh-list
56529380|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56529381|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529382|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
56529383|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
56529384|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
56529385|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529386|NCT01209078|Linezolid|linezolid|mesh-list
56529387|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56529388|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529389|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56529390|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529391|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529392|NCT04318158|Fentanyl|fentanyl|mesh-list
56529393|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
56529394|NCT04318158|Bupivacaine|bupivacaine|mesh-list
56529395|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
56529396|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
56529397|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56529398|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529399|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
56529400|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529401|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56529402|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529403|NCT04318158|Analgesics|analgesics|mesh-ancestor
56529404|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56529405|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56529406|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56529407|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56529408|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529409|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529411|NCT04318158|Narcotics|narcotics|mesh-ancestor
56529412|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56529413|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56529414|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
56529415|NCT01207596|Hydromorphone|hydromorphone|mesh-list
56529416|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56529417|NCT01207596|Narcotics|narcotics|mesh-ancestor
56529418|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56529419|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529420|NCT01207596|Analgesics|analgesics|mesh-ancestor
56529421|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
56529422|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529423|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
56529424|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56529425|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56529426|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56529427|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529428|NCT04203043|Pycnogenols|pycnogenols|mesh-list
56529429|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56529431|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529432|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
56650071|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
56650072|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56650073|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56529433|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529434|NCT04203043|Protective Agents|protective agents|mesh-ancestor
56529435|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56529436|NCT04435015|Camostat|camostat|mesh-list
56529437|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
56529438|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529439|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529440|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56529441|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56529442|NCT00631813|Prucalopride|prucalopride|mesh-list
56529443|NCT00631813|Laxatives|laxatives|mesh-ancestor
56529444|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56529445|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56529446|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56529447|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
56529448|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529449|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529450|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529451|NCT04404049|UB-421|ub-421|mesh-list
56529452|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56529453|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
56529454|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529455|NCT04636255|Calcium|calcium|mesh-list
56529456|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56529457|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529458|NCT04911517|Capecitabine|capecitabine|mesh-list
56529459|NCT04911517|Antibodies|antibodies|mesh-list
56529460|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56529461|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
56529462|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529463|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56529464|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
56529465|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529466|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529467|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
56529468|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56529469|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529470|NCT00637897|Paclitaxel|paclitaxel|mesh-list
56529471|NCT00637897|Docetaxel|docetaxel|mesh-list
56529472|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56529473|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56529474|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529475|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
56529476|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
56529477|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
56529478|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529479|NCT03992443|Reteplase|reteplase|mesh-list
56529480|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56529481|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56529482|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529483|NCT04329949|Paclitaxel|paclitaxel|mesh-list
56529485|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529486|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
56529487|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
56529488|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
56529489|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529490|NCT04597099|Flutamide|flutamide|mesh-list
56529491|NCT04597099|Estradiol|estradiol|mesh-list
56529492|NCT04597099|Progesterone|progesterone|mesh-list
56529493|NCT04597099|Estrogens|estrogens|mesh-ancestor
56529494|NCT04597099|Hormones|hormones|mesh-ancestor
56529495|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56529496|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529497|NCT04597099|Progestins|progestins|mesh-ancestor
56529498|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
56529499|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
56169127|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529500|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56529501|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529502|NCT04816513|Ustekinumab|ustekinumab|mesh-list
56529503|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
56650074|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56650075|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56650076|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56650077|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650078|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650079|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
56650080|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56650081|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
56650082|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56650083|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650084|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650085|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56650086|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650087|NCT02830139|Capecitabine|capecitabine|mesh-list
56650088|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
56650089|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650090|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56650091|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
56529504|NCT04203511|Paclitaxel|paclitaxel|mesh-list
56529505|NCT04203511|Etoposide|etoposide|mesh-list
56529506|NCT04203511|Carboplatin|carboplatin|mesh-list
56529507|NCT04203511|Pemetrexed|pemetrexed|mesh-list
56529508|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56529509|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529510|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
56529511|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
56529512|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
56529513|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529514|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56529515|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56529516|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529517|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56529518|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56529519|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
56529520|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56529521|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56529522|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529523|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
56529524|NCT03690037|Coagulants|coagulants|mesh-ancestor
56529525|NCT00910273|Etanercept|etanercept|mesh-list
56529526|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56529527|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529528|NCT00910273|Analgesics|analgesics|mesh-ancestor
56529529|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
56529530|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529531|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529532|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529533|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529534|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56529535|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56529536|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
56529537|NCT04156087|Gemcitabine|gemcitabine|mesh-list
56529538|NCT04156087|Durvalumab|durvalumab|mesh-list
56529539|NCT04156087|Tremelimumab|tremelimumab|mesh-list
56529540|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56529541|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
56529542|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529543|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650092|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529544|NCT04156087|Antiviral Agents|antiviral agents|mesh-ancestor
56529545|NCT04156087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529546|NCT04156087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529547|NCT04156087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56529548|NCT04156087|Immunologic Factors|immunologic factors|mesh-ancestor
56529549|NCT04156087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529550|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56529551|NCT00910039|Sunitinib|sunitinib|mesh-list
56529552|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529553|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56529554|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56529555|NCT00910039|Growth Substances|growth substances|mesh-ancestor
56529556|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529557|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
56529558|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56529559|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529560|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529561|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
56529562|NCT00909181|Oxybutynin|oxybutynin|mesh-list
56529563|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
56529564|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
56529565|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529566|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529567|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56529568|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56529569|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
56529570|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529571|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529572|NCT00909181|Urological Agents|urological agents|mesh-ancestor
56529573|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56529574|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529575|NCT00909181|Renal Agents|renal agents|mesh-ancestor
56529576|NCT05579665|Hyaluronic Acid|hyaluronic acid|mesh-list
56529577|NCT05579665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56529578|NCT05579665|Immunologic Factors|immunologic factors|mesh-ancestor
56529579|NCT05579665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529580|NCT05579665|Viscosupplements|viscosupplements|mesh-ancestor
56529581|NCT05579665|Protective Agents|protective agents|mesh-ancestor
56529582|NCT01286987|Talazoparib|talazoparib|mesh-list
56529583|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56529584|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529585|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529586|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529587|NCT01286753|Vemurafenib|vemurafenib|mesh-list
56529588|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529589|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56529590|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529591|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529592|NCT01284959|Risperidone|risperidone|mesh-list
56529593|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56529594|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56529595|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
56529596|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529597|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529598|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529599|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56529600|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56529601|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56529602|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56529603|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56529604|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
56529605|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56529606|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56529607|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
56529608|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56529609|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56529610|NCT01283009|Prednisolone|prednisolone|mesh-list
56529611|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
56529612|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56529613|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
56529614|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529615|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
56650093|NCT02833025|Thrombin|thrombin|mesh-list
56650094|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
56650095|NCT02833025|Coagulants|coagulants|mesh-ancestor
56650096|NCT02651610|Paclitaxel|paclitaxel|mesh-list
56650097|NCT02651610|Docetaxel|docetaxel|mesh-list
56650098|NCT02651610|Taxane|taxane|mesh-list
56650099|NCT02651610|Bavituximab|bavituximab|mesh-list
56529616|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
56529617|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529618|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529619|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56529620|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
56529621|NCT01283009|Hormones|hormones|mesh-ancestor
56529622|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56529623|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56529624|NCT01283009|Protective Agents|protective agents|mesh-ancestor
56529625|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56169156|NCT00383682|Mexiletine|mexiletine|mesh-list
56529626|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529627|NCT01282463|Docetaxel|docetaxel|mesh-list
56529628|NCT01282463|Ramucirumab|ramucirumab|mesh-list
56529629|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529630|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
56529631|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
56529632|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
56529633|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529634|NCT01281917|Sirolimus|sirolimus|mesh-list
56529636|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529637|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56529638|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529639|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56529640|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
56529641|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56529642|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
56529643|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529644|NCT01281839|Ribavirin|ribavirin|mesh-list
56529645|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56529646|NCT01281839|Simeprevir|simeprevir|mesh-list
56529647|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
56529648|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529649|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
56529650|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529651|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
56529652|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529653|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
56529654|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56529655|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56529656|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529657|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
56529658|NCT01280981|Coagulants|coagulants|mesh-ancestor
56529659|NCT02889653|Anticoagulants|anticoagulants|mesh-list
56529660|NCT01280591|Naproxen|naproxen|mesh-list
56529661|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56529662|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529663|NCT01280591|Analgesics|analgesics|mesh-ancestor
56529664|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
56529665|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529666|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529667|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529668|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529669|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
56529670|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56529671|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529672|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529673|NCT04323761|Remdesivir|remdesivir|mesh-list
56529674|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
56529675|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529676|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
56529677|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529678|NCT05566223|Aldesleukin|aldesleukin|mesh-list
56529679|NCT05566223|Cyclophosphamide|cyclophosphamide|mesh-list
56529680|NCT05566223|Pembrolizumab|pembrolizumab|mesh-list
56529681|NCT05566223|Fludarabine|fludarabine|mesh-list
56529682|NCT05566223|Interleukin-2|interleukin-2|mesh-list
56650100|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55960088|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
56529683|NCT05566223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56529684|NCT05566223|Immunologic Factors|immunologic factors|mesh-ancestor
56529685|NCT05566223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529686|NCT05566223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529687|NCT05566223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56529688|NCT05566223|Alkylating Agents|alkylating agents|mesh-ancestor
56529689|NCT05566223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529690|NCT05566223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529691|NCT05566223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56529692|NCT05566223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56529693|NCT05566223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529694|NCT05566223|Analgesics|analgesics|mesh-ancestor
56529695|NCT05566223|Sensory System Agents|sensory system agents|mesh-ancestor
56529696|NCT05566223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529697|NCT05566223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56529698|NCT05566223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56529699|NCT05566223|Antiviral Agents|antiviral agents|mesh-ancestor
56529700|NCT05566223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529701|NCT01271933|Pregabalin|pregabalin|mesh-list
56529702|NCT01271933|Analgesics|analgesics|mesh-ancestor
56529703|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
56529704|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529705|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529706|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
56529707|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56529708|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56529709|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529710|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56529711|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56529712|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56529713|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56529714|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56529716|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56529717|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
56529718|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56529719|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529720|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56529721|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529722|NCT01268891|Rasagiline|rasagiline|mesh-list
56529723|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56529724|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529725|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529726|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56529727|NCT01268891|Protective Agents|protective agents|mesh-ancestor
56529728|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529729|NCT04323527|Chloroquine|chloroquine|mesh-list
56529730|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56529731|NCT04323527|Amebicides|amebicides|mesh-ancestor
56529732|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56529733|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56529734|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529735|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
56529736|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529737|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56529738|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529739|NCT04323527|Analgesics|analgesics|mesh-ancestor
56529740|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
56529741|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529742|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529743|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529744|NCT04323527|Filaricides|filaricides|mesh-ancestor
56529745|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
56529746|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
56529747|NCT01267175|Insulin|insulin|mesh-list
56529748|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56529749|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529750|NCT02889497|Vaccines|vaccines|mesh-list
56529751|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
56529752|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529753|NCT01266317|Rituximab|rituximab|mesh-list
56529754|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56650101|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650102|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56529755|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529756|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
56529757|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529758|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529759|NCT01266161|Ibuprofen|ibuprofen|mesh-list
56529760|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56529761|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529762|NCT01266161|Analgesics|analgesics|mesh-ancestor
56529763|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
56529764|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529765|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529766|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529767|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529768|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56529769|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529770|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529771|NCT01265849|Indomethacin|indomethacin|mesh-list
56529772|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
56529773|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56529774|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
56529775|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529776|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529777|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56529778|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
56529779|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529780|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529781|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56529782|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56529783|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529785|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
56529786|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529787|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529788|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
56529790|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56529791|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56529793|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
56529794|NCT01265615|Vitamin D|vitamin d|mesh-list
56529795|NCT01265615|Calcitriol|calcitriol|mesh-list
56529796|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56529797|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529798|NCT01265615|Vitamins|vitamins|mesh-ancestor
56529799|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
56529800|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56529801|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56529802|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56529803|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529804|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56529805|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56529806|NCT01264679|Hematinics|hematinics|mesh-ancestor
56529807|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56529808|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56529809|NCT05542667|Fluorides|fluorides|mesh-list
56529810|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
56529811|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
56529812|NCT05542667|Protective Agents|protective agents|mesh-ancestor
56529813|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529814|NCT01263509|Inositol|inositol|mesh-list
56529815|NCT01263509|Alogliptin|alogliptin|mesh-list
56529816|NCT01263509|Voglibose|voglibose|mesh-list
56529817|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56529818|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529819|NCT01263509|Incretins|incretins|mesh-ancestor
56529820|NCT01263509|Hormones|hormones|mesh-ancestor
56529821|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56529822|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56529823|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
56529824|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529825|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529826|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56529827|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
56529828|NCT01263509|Vitamins|vitamins|mesh-ancestor
56650103|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56650104|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56650105|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529829|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
56529830|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
56529831|NCT01263197|Propranolol|propranolol|mesh-list
56529832|NCT01263197|Albuterol|albuterol|mesh-list
56529833|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56529834|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56529835|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
56529836|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529837|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529838|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529839|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56529840|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56529841|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
56529842|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56529843|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
56529844|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529845|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56529846|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
56529847|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
56529848|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56529849|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56529850|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56529851|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56529852|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56529853|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529854|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
56529856|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
56529857|NCT01262651|Nabiximols|nabiximols|mesh-list
56529858|NCT01262651|Analgesics|analgesics|mesh-ancestor
56529859|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
56529860|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529861|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529862|NCT05534087|Irinotecan|irinotecan|mesh-list
56529863|NCT05534087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56529864|NCT05534087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56529865|NCT05534087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529866|NCT05534087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529872|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
56529874|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56529875|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529876|NCT04321655|Analgesics|analgesics|mesh-ancestor
56529877|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
56529878|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529879|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529880|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529881|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529882|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56529883|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529884|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529885|NCT05529251|Carboplatin|carboplatin|mesh-list
56529886|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529887|NCT01261325|Brivaracetam|brivaracetam|mesh-list
56529888|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
56529889|NCT01260467|Memantine|memantine|mesh-list
56529890|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56529891|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56529892|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
56529893|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529894|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529895|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529896|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56529897|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56529898|NCT01260311|Fesoterodine|fesoterodine|mesh-list
56529899|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56529900|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56529901|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
56529902|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529903|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650106|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56650107|NCT04208594|Propranolol|propranolol|mesh-list
56650108|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56650109|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56650110|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
56650111|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650112|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213279|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529904|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529905|NCT01260311|Urological Agents|urological agents|mesh-ancestor
56529906|NCT00623987|Warfarin|warfarin|mesh-list
56529907|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
56529909|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529910|NCT05536037|Metformin|metformin|mesh-list
56529911|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56529912|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529913|NCT00624143|Voriconazole|voriconazole|mesh-list
56529914|NCT00624143|Amphotericin B|amphotericin b|mesh-list
56529915|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56529916|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
56529917|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56529918|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56529919|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56529920|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529921|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529922|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56529923|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
56529924|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56529925|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529926|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56529927|NCT00624143|Amebicides|amebicides|mesh-ancestor
56529928|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56529929|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56529930|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56529936|NCT05241275|Xenon|xenon|mesh-list
56529937|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56529938|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
56529939|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
56529940|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56529941|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529942|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
56529943|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56529944|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529945|NCT04650893|Dexamethasone|dexamethasone|mesh-list
56529946|NCT04650893|Ketorolac|ketorolac|mesh-list
56529947|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529948|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
56529949|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
56529950|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529951|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529952|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56529953|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
56529954|NCT04650893|Hormones|hormones|mesh-ancestor
56529955|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56529956|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56529957|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529958|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56529959|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529960|NCT04650893|Analgesics|analgesics|mesh-ancestor
56529961|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
56529962|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56529963|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56529964|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529965|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529966|NCT04540835|Calcium|calcium|mesh-list
56529967|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56650113|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650114|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56529968|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529969|NCT04005287|Pirenzepine|pirenzepine|mesh-list
56529970|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56529971|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56529972|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56529973|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56529974|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
56529975|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56529976|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529977|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529978|NCT04320173|Lidocaine|lidocaine|mesh-list
56529979|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
56529980|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
56529981|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56529982|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529983|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
56529984|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529985|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56529986|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56529987|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56529988|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56529989|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56529990|NCT03192215|Aspirin|aspirin|mesh-list
56529991|NCT03192215|Apixaban|apixaban|mesh-list
56529992|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56529993|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56529994|NCT03192215|Analgesics|analgesics|mesh-ancestor
56529995|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
56529996|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529997|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56529998|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56529999|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56530000|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56530001|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56530002|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530003|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56530004|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56530005|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530006|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
56530007|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56530008|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
56530009|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56530010|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
56530011|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
56278203|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56530012|NCT04321733|Amoxicillin|amoxicillin|mesh-list
56530013|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
56530014|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
56530015|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56530016|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530017|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530018|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56530019|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530020|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530021|NCT02029001|Everolimus|everolimus|mesh-list
56530022|NCT02029001|Sorafenib|sorafenib|mesh-list
56530023|NCT02029001|Durvalumab|durvalumab|mesh-list
56530024|NCT02029001|Olaparib|olaparib|mesh-list
56530025|NCT02029001|Lapatinib|lapatinib|mesh-list
56530026|NCT02029001|Tremelimumab|tremelimumab|mesh-list
56530027|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530028|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56530029|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
56530030|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530031|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56530032|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530033|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530034|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56530035|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56530036|NCT01613495|Octreotide|octreotide|mesh-list
56530037|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650115|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56650116|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
55960506|NCT04129619|Ether|ether|mesh-list
56530038|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56530039|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530040|NCT01321073|Treprostinil|treprostinil|mesh-list
56530041|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56530042|NCT00694733|Anastrozole|anastrozole|mesh-list
56530043|NCT00694733|Leuprolide|leuprolide|mesh-list
56530044|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
56530045|NCT00694733|Estradiol|estradiol|mesh-list
56530046|NCT00694733|Estrogens|estrogens|mesh-list
56530047|NCT00694733|Testosterone|testosterone|mesh-list
56530048|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
56530049|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
56530050|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56530051|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56530052|NCT00694733|Hormones|hormones|mesh-ancestor
56530053|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530054|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530055|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56530056|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56530057|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530058|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56530059|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530060|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530061|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56530062|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
56530063|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56530064|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
56530065|NCT00694733|Androgens|androgens|mesh-ancestor
56530066|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
56530067|NCT01259297|Amlodipine|amlodipine|mesh-list
56530068|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56530069|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56530070|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56530071|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530072|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530073|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56530074|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530075|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
56530076|NCT01259297|Diuretics|diuretics|mesh-ancestor
56530077|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
56530078|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56530079|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
56530080|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56530081|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
56530082|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530083|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530084|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56530085|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
56530086|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
56530087|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56530088|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
56530089|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530090|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530092|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
56530093|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530094|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56530095|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530096|NCT01126359|Lidocaine|lidocaine|mesh-list
56530097|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
56530098|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
56530099|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530100|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530101|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
56530102|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530103|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56530104|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56530105|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56169200|NCT00384540|Dobutamine|dobutamine|mesh-list
56530106|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530107|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650117|NCT04733144|Dexamethasone|dexamethasone|mesh-list
56650118|NCT04733144|Prednisolone|prednisolone|mesh-list
56650119|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650120|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
56530108|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
56530109|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56530110|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56530111|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56530112|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530113|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530114|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
56530115|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530116|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530117|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56530118|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530119|NCT01125813|Factor VIII|factor viii|mesh-list
56530120|NCT01125813|Coagulants|coagulants|mesh-ancestor
56530121|NCT04311645|Charcoal|charcoal|mesh-list
56530122|NCT04311645|Antidotes|antidotes|mesh-ancestor
56530123|NCT04311645|Protective Agents|protective agents|mesh-ancestor
56530124|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530125|NCT01257581|Tamoxifen|tamoxifen|mesh-list
56530126|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56530127|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
56530128|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530129|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530130|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56530131|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530132|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56530133|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56530134|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56530135|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
56530136|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56530137|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530138|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56530139|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
56530140|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56530141|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
56530142|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56530143|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530144|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56530145|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56530146|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530147|NCT00995488|Paclitaxel|paclitaxel|mesh-list
56530148|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56530149|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56530150|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530151|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
56530152|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
56530153|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
56530154|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530155|NCT04293172|Ticagrelor|ticagrelor|mesh-list
56530156|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56530157|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56530158|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56530159|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56530160|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
56530161|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530162|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530163|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530165|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56530166|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56530167|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56530168|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
56530169|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
56530170|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530171|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530172|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530173|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56650121|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
56650122|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650123|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530174|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56530175|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530176|NCT02869672|Vaccines|vaccines|mesh-list
56530177|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
56530178|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530179|NCT01125189|Interferons|interferons|mesh-list
56530180|NCT01125189|Ribavirin|ribavirin|mesh-list
56530181|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
56530182|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
56530183|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56530184|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530185|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
56530186|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530187|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
56530188|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530189|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
56530190|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530191|NCT01256567|Docetaxel|docetaxel|mesh-list
56530192|NCT01256567|Ramucirumab|ramucirumab|mesh-list
56530193|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530194|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
56530195|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
56530196|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
56530197|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530198|NCT00996736|Voriconazole|voriconazole|mesh-list
56530199|NCT00996736|Natamycin|natamycin|mesh-list
56530200|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
56530201|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530202|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56530203|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56530204|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530205|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530206|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56530207|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
56530208|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530209|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530210|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56530211|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56530212|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530213|NCT00996658|Linagliptin|linagliptin|mesh-list
56530214|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56530215|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530216|NCT00996658|Incretins|incretins|mesh-ancestor
56530217|NCT00996658|Hormones|hormones|mesh-ancestor
56530218|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530219|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56530220|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
56530221|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530222|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530223|NCT04310631|Ranibizumab|ranibizumab|mesh-list
56530224|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56530225|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56530226|NCT04310631|Growth Substances|growth substances|mesh-ancestor
56530227|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530228|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
56530229|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530230|NCT01256411|Amlodipine|amlodipine|mesh-list
56530231|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56530232|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56530233|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56530234|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56530235|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530236|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530237|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56530238|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530239|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
56530241|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
56650124|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650125|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
56650126|NCT04733144|Hormones|hormones|mesh-ancestor
56530242|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56530243|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56530244|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
56530245|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56530246|NCT00996580|Estradiol|estradiol|mesh-list
56530247|NCT00996580|Estrogens|estrogens|mesh-ancestor
56530248|NCT00996580|Hormones|hormones|mesh-ancestor
56530249|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530250|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530251|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56530252|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
56530253|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56530254|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56530255|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56530256|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56530257|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56530258|NCT01124175|Losartan|losartan|mesh-list
56530259|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56530260|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56530261|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56530262|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56530263|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530264|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56530265|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
56530266|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56530267|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56530268|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56530269|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530270|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530271|NCT02882451|Pinaverium|pinaverium|mesh-list
56530272|NCT02882451|Bromides|bromides|mesh-list
56530273|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530274|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530275|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
56530276|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56530277|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530278|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56530279|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
56530280|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
56530281|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530282|NCT00999544|Oxycodone|oxycodone|mesh-list
56530283|NCT00999544|Aprepitant|aprepitant|mesh-list
56530284|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
56530285|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56530286|NCT00999544|Narcotics|narcotics|mesh-ancestor
56530287|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530288|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530289|NCT00999544|Analgesics|analgesics|mesh-ancestor
56530290|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
56530291|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530292|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
56530293|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
56530294|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56530295|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56530296|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530297|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530298|NCT02869984|Ramosetron|ramosetron|mesh-list
56530299|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
56530300|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
56530301|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530302|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530303|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56530304|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56530305|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
56530306|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530307|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278501|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
56530309|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
56530310|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56650127|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650128|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56650129|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530311|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56530312|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530313|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530315|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
56530316|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56530317|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
56530318|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
56530319|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
56530320|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530321|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530322|NCT01255787|Vortioxetine|vortioxetine|mesh-list
56530323|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
56530324|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56530325|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56530326|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56530327|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530328|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530329|NCT01255787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56530330|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56530331|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530332|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530333|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530334|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
56530335|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56530336|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56530337|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56530338|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56530339|NCT01255163|Exenatide|exenatide|mesh-list
56530340|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56530341|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530342|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56530343|NCT01255163|Incretins|incretins|mesh-ancestor
56530344|NCT01255163|Hormones|hormones|mesh-ancestor
56530345|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530346|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
56530347|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
56530348|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530349|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56530350|NCT05588609|Abiraterone Acetate|abiraterone acetate|mesh-list
56530351|NCT05588609|Afatinib|afatinib|mesh-list
56530352|NCT05588609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530353|NCT05588609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56530354|NCT05588609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530355|NCT05588609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530356|NCT05588609|Hormone Antagonists|hormone antagonists|mesh-ancestor
56530357|NCT05588609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530358|NCT05588609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530359|NCT05588609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56530360|NCT05588609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56530361|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
56530362|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56530363|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530364|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
56530365|NCT01254305|Milnacipran|milnacipran|mesh-list
56530366|NCT01254305|Sertraline|sertraline|mesh-list
56530367|NCT01254305|Fluoxetine|fluoxetine|mesh-list
56530368|NCT01254305|Paroxetine|paroxetine|mesh-list
56530369|NCT01254305|Citalopram|citalopram|mesh-list
56530370|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
56530371|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
56530372|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56530373|NCT01254305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56530374|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56530375|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530376|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530377|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650130|NCT04724720|Famotidine|famotidine|mesh-list
56650131|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55960856|NCT02009449|Vitamins|vitamins|mesh-ancestor
56530378|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
56530379|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530380|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56530381|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56530382|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56530383|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530384|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530385|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56530386|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56530388|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
56530389|NCT01122927|Aripiprazole|aripiprazole|mesh-list
56530390|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
56530391|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56530392|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56530393|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56530394|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530395|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530396|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
56530397|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
56530398|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530399|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530400|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56530401|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56530402|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
56530403|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56530404|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56530405|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56530406|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56530407|NCT01254227|Deferasirox|deferasirox|mesh-list
56530408|NCT01254227|Deferoxamine|deferoxamine|mesh-list
56530409|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56530410|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
56530411|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
56530412|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530413|NCT01254227|Siderophores|siderophores|mesh-ancestor
56530414|NCT04311255|Anesthetics|anesthetics|mesh-list
56530415|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530416|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530417|NCT01122381|Ethosuximide|ethosuximide|mesh-list
56530418|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
56530419|NCT00996034|Nicotine|nicotine|mesh-list
56530420|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530421|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56530422|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
56530423|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530424|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56530425|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56530426|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
56530427|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530428|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530429|NCT01121991|Hormones|hormones|mesh-list
56530430|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530431|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530432|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56530433|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
56530434|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56530435|NCT04292236|Protective Agents|protective agents|mesh-ancestor
56530436|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530437|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530438|NCT01121913|Trazodone|trazodone|mesh-list
56530439|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56530440|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56530441|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530442|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169227|NCT00384696|Nicotine|nicotine|mesh-list
56530444|NCT01121913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56530445|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56530446|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56115952|NCT00002621|Interferons|interferons|mesh-list
56650132|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650133|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56530447|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530448|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530449|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
56530450|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56530451|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
56530452|NCT04310943|Paclitaxel|paclitaxel|mesh-list
56530453|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56530455|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
56530456|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
56530457|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
56530458|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530459|NCT02868814|Pregabalin|pregabalin|mesh-list
56530461|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
56530462|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530463|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530464|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
56530465|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56530466|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530467|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530468|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56530469|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56530470|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56530471|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530472|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56530473|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
56530474|NCT04292314|Deferoxamine|deferoxamine|mesh-list
56530475|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530476|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
56530477|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530478|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530479|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56530480|NCT04292314|Siderophores|siderophores|mesh-ancestor
56530481|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56530482|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
56530483|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
56530484|NCT01121757|Lenalidomide|lenalidomide|mesh-list
56530485|NCT01121757|Azacitidine|azacitidine|mesh-list
56530486|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
56530487|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530488|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56530489|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56530490|NCT01121757|Growth Substances|growth substances|mesh-ancestor
56530491|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
56530492|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530493|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56530494|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
56530495|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530496|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530497|NCT04319471|Capecitabine|capecitabine|mesh-list
56530498|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56530499|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
56530500|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530501|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530502|NCT02882217|Histamine|histamine|mesh-list
56530503|NCT02882217|Glutarimide|glutarimide|mesh-list
56530504|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
56530505|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
56530506|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530507|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530508|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530509|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56530510|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530512|NCT01253135|Emollients|emollients|mesh-ancestor
56530513|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
56530514|NCT00993616|Carboplatin|carboplatin|mesh-list
56530515|NCT00993616|Belinostat|belinostat|mesh-list
56530516|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530517|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56530518|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530519|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650134|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
56650135|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
56650136|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650137|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650138|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650139|NCT02833103|Pinaverium|pinaverium|mesh-list
56650140|NCT02833103|Bromides|bromides|mesh-list
56296154|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56650141|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
56650142|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56650143|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56650144|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530520|NCT01120899|Minocycline|minocycline|mesh-list
56530521|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530522|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530523|NCT01120275|R04929097|r04929097|mesh-list
56530524|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530525|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530526|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
56530527|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56530528|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530530|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
56530531|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530532|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530533|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530534|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530535|NCT01119963|Castor Oil|castor oil|mesh-list
56530536|NCT01119963|Progesterone|progesterone|mesh-list
56530537|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56530538|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56530539|NCT01119963|Progestins|progestins|mesh-ancestor
56530540|NCT01119963|Hormones|hormones|mesh-ancestor
56530541|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530542|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530543|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56530544|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
56530545|NCT01119963|Cathartics|cathartics|mesh-ancestor
56530546|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56530547|NCT01252667|Cyclosporine|cyclosporine|mesh-list
56530548|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
56530549|NCT01252667|Clofarabine|clofarabine|mesh-list
56530550|NCT01252667|Cyclosporins|cyclosporins|mesh-list
56530551|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530552|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530553|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56530554|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
56530555|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530556|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
56530557|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530558|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
56530559|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56530560|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56530561|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56530562|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530563|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56530564|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
56530565|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530566|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56530567|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
56530568|NCT02868580|Lamivudine|lamivudine|mesh-list
56530569|NCT02868580|Abacavir|abacavir|mesh-list
56530570|NCT02868580|Dolutegravir|dolutegravir|mesh-list
56530571|NCT02868580|Triumeq|triumeq|mesh-list
56530572|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56650145|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56530573|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56530574|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530575|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530576|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
56530577|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530578|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56530579|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56530580|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56530581|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56530582|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
56530583|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
56530584|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530585|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56530586|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530587|NCT01119105|Vancomycin|vancomycin|mesh-list
56530588|NCT01119105|Lefamulin|lefamulin|mesh-list
56530589|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530590|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530591|NCT01118949|Lacosamide|lacosamide|mesh-list
56530592|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
56530593|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56530594|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56530595|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530596|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530597|NCT01252355|Interferons|interferons|mesh-list
56530598|NCT01252355|Interferon-beta|interferon-beta|mesh-list
56530599|NCT01252355|Teriflunomide|teriflunomide|mesh-list
56530600|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530601|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
56530602|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530603|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
56530604|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530605|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56530606|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56530608|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
56530609|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530610|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56530611|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56530612|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56530613|NCT01118325|Clopidogrel|clopidogrel|mesh-list
56530614|NCT01118325|Ticagrelor|ticagrelor|mesh-list
56530615|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56530616|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56530617|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56530618|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56530619|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
56530620|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530621|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530622|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530623|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56530624|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56530625|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56530626|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56169258|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
56530627|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530628|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530629|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530630|NCT01117857|Analgesics|analgesics|mesh-ancestor
56530631|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
56530632|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530633|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
56530634|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56530635|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
56530636|NCT00991276|Pregabalin|pregabalin|mesh-list
56530637|NCT00991276|Pramipexole|pramipexole|mesh-list
56530638|NCT00991276|Analgesics|analgesics|mesh-ancestor
56530639|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
56530640|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530641|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530642|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
56530643|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56115953|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
56650146|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650147|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
56650148|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
56650149|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530644|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530645|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530646|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56530647|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56530648|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56530649|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530650|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56530651|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
56530652|NCT00991276|Protective Agents|protective agents|mesh-ancestor
56530653|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56530654|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56530655|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
56530656|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
56530657|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530658|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56530659|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56530660|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530661|NCT00990652|Temozolomide|temozolomide|mesh-list
56530662|NCT00990652|Bortezomib|bortezomib|mesh-list
56530663|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56530664|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
56530665|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530666|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530667|NCT02867878|Adenosine|adenosine|mesh-list
56530668|NCT02867878|Analgesics|analgesics|mesh-ancestor
56530669|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
56530670|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530671|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530672|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56530673|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
56530674|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56530675|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
56530676|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
56530677|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530678|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530679|NCT01207440|Ponatinib|ponatinib|mesh-list
56530680|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530681|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56530682|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530683|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530684|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56530685|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56530686|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56530687|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
56530688|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530689|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56530690|NCT00990106|Prazosin|prazosin|mesh-list
56530691|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56530692|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56530693|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56530694|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56530695|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
56530696|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530697|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530698|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530699|NCT02867566|Rituximab|rituximab|mesh-list
56530700|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56530701|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530702|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
56530703|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530704|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56530705|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56530706|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56530707|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
56530708|NCT02867800|Acetaminophen|acetaminophen|mesh-list
56530709|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
56650151|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
56650152|NCT02648490|Promethazine|promethazine|mesh-list
56650153|NCT02648490|Dexamethasone|dexamethasone|mesh-list
56650154|NCT02648490|Ondansetron|ondansetron|mesh-list
56650155|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650156|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
56650157|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
56650158|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650159|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530710|NCT02867800|Promethazine|promethazine|mesh-list
56530711|NCT02867800|Cyclosporine|cyclosporine|mesh-list
56530712|NCT02867800|Sirolimus|sirolimus|mesh-list
56530713|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
56530714|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
56530715|NCT02867800|Methotrexate|methotrexate|mesh-list
56530716|NCT02867800|Fludarabine|fludarabine|mesh-list
56530717|NCT02867800|Melphalan|melphalan|mesh-list
56530718|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
56530719|NCT02867800|Abatacept|abatacept|mesh-list
56530720|NCT02867800|Thiotepa|thiotepa|mesh-list
56530721|NCT02867800|Meperidine|meperidine|mesh-list
56530722|NCT02867800|Tacrolimus|tacrolimus|mesh-list
56530723|NCT02867800|Cyclosporins|cyclosporins|mesh-list
56530724|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
56530725|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56530726|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
56530728|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530729|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56530730|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
56530731|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530732|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530733|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
56530734|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530735|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56530736|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56530737|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
56530738|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56530739|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56530740|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56530741|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
56530742|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530743|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56530744|NCT02867800|Analgesics|analgesics|mesh-ancestor
56530745|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
56530746|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530747|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
56530748|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56530749|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56530750|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
56530751|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530752|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56530753|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
56530754|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
56530755|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56530756|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
56530757|NCT02867800|Hormones|hormones|mesh-ancestor
56530758|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530759|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56530760|NCT02867800|Protective Agents|protective agents|mesh-ancestor
56530761|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56530762|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
56530763|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56530764|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56530765|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56530766|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56530767|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56530768|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530769|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
56530770|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
56530771|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56530772|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
56650160|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650161|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
56530773|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
56530774|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530775|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56530776|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
56530777|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56530778|NCT02867800|Narcotics|narcotics|mesh-ancestor
56530779|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56530780|NCT00629200|Interferons|interferons|mesh-list
56530781|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
56530782|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
56530783|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56530784|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530785|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
56530786|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530787|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
56530788|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530789|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56530790|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56530791|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
56530792|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56530793|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
56530794|NCT02867176|Ketorolac|ketorolac|mesh-list
56530795|NCT02867176|Gabapentin|gabapentin|mesh-list
56530796|NCT02867176|Analgesics|analgesics|mesh-ancestor
56530797|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
56530798|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56530799|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530800|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
56530801|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56530802|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56530803|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530804|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56530805|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56530806|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56530807|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530808|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530809|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
56530810|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56530811|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56530812|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56530813|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56530814|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56530815|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530816|NCT00982228|Insulin|insulin|mesh-list
56530817|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56530818|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
56530819|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
56530820|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56530821|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530822|NCT02867956|Etoposide|etoposide|mesh-list
56530823|NCT02867956|Apatinib|apatinib|mesh-list
56530824|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56530825|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530826|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56530827|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56530828|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530829|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530830|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56279022|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
56530831|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
56530832|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56530833|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530834|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
56530835|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530836|NCT04291066|Expectorants|expectorants|mesh-ancestor
56530837|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
56530838|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56530839|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
56530840|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530841|NCT04291066|Protective Agents|protective agents|mesh-ancestor
56530842|NCT04291066|Antidotes|antidotes|mesh-ancestor
56530843|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
56530844|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
56530845|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530846|NCT04150042|Vitamins|vitamins|mesh-list
56650162|NCT02648490|Hormones|hormones|mesh-ancestor
56650163|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650164|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56650165|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650166|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56650167|NCT02648490|Analgesics|analgesics|mesh-ancestor
56650168|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
56650169|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
56650170|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
56530847|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
56530848|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
56530849|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
56530850|NCT04150042|Ethanol|ethanol|mesh-list
56530851|NCT04150042|Melphalan|melphalan|mesh-list
56530852|NCT04150042|Carmustine|carmustine|mesh-list
56530853|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
56530854|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530855|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56530856|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
56530857|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530858|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530859|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56530860|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56530861|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
56530862|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
56530863|NCT04150042|Protective Agents|protective agents|mesh-ancestor
56530864|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
56530865|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56530866|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530867|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56530868|NCT04150042|Hematinics|hematinics|mesh-ancestor
56530869|NCT01260194|Trastuzumab|trastuzumab|mesh-list
56530870|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56530871|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530872|NCT00629278|Tamoxifen|tamoxifen|mesh-list
56530873|NCT00629278|Docetaxel|docetaxel|mesh-list
56530874|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
56530875|NCT00629278|Doxorubicin|doxorubicin|mesh-list
56530876|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56530877|NCT00629278|Fluorouracil|fluorouracil|mesh-list
56530878|NCT00629278|Trastuzumab|trastuzumab|mesh-list
56530879|NCT00629278|Epirubicin|epirubicin|mesh-list
56530880|NCT00629278|Hormones|hormones|mesh-list
56530881|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56530882|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530883|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
56530884|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
56530885|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
56530886|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530887|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56530888|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
56530889|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530890|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56530891|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56530892|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
56530893|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56530894|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56530895|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56530896|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56530897|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530898|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
56530899|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56530900|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56530901|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530902|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56530903|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
56530904|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56530905|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56650171|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
56650172|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56650173|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
56650174|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213339|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56530906|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56530907|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56530908|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56530909|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
56530911|NCT04207112|Bedaquiline|bedaquiline|mesh-list
56530912|NCT04207112|Clofazimine|clofazimine|mesh-list
56530913|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530914|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530915|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56530916|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56530917|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530918|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530919|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530920|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56530921|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
56530925|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56530927|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56530928|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56530929|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56530930|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530931|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
56530932|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530933|NCT00624026|Memantine|memantine|mesh-list
56530934|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56530935|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56530936|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
56530937|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56530938|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530939|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530940|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56530941|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56530945|NCT05512910|Minocycline|minocycline|mesh-list
56530946|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530947|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530948|NCT02888990|Dasatinib|dasatinib|mesh-list
56530949|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530950|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56530951|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530952|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530953|NCT05383742|Rifampin|rifampin|mesh-list
56530954|NCT05383742|Isoniazid|isoniazid|mesh-list
56530955|NCT05383742|Linezolid|linezolid|mesh-list
56530956|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
56530957|NCT05383742|Ethambutol|ethambutol|mesh-list
56530958|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56530959|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
56530960|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56530961|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56530962|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
56530963|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56530964|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56530965|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530966|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56530967|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56530968|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56530969|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56530970|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56530971|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56530972|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56530973|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56530974|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
56530975|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56530976|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56530977|NCT05101928|Prednisone|prednisone|mesh-list
56650175|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650176|NCT02648490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56530978|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56530979|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
56530980|NCT05101928|Hormones|hormones|mesh-ancestor
56530981|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530982|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530983|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56530984|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56530986|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
56530987|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530988|NCT04654052|Clopidogrel|clopidogrel|mesh-list
56530989|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56530990|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56530991|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56530992|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56530993|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
56530994|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169356|NCT00423228|Donepezil|donepezil|mesh-list
56530995|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56530996|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56530997|NCT05625308|Folic Acid|folic acid|mesh-list
56530998|NCT05625308|Vitamin B 12|vitamin b 12|mesh-list
56530999|NCT05625308|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56531000|NCT05625308|Hyaluronic Acid|hyaluronic acid|mesh-list
56531001|NCT05625308|Vitamins|vitamins|mesh-ancestor
56531002|NCT05625308|Micronutrients|micronutrients|mesh-ancestor
56531003|NCT05625308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531004|NCT05625308|Hematinics|hematinics|mesh-ancestor
56531005|NCT05625308|Vitamin B Complex|vitamin b complex|mesh-ancestor
56531006|NCT05625308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56531007|NCT05625308|Immunologic Factors|immunologic factors|mesh-ancestor
56531008|NCT05625308|Viscosupplements|viscosupplements|mesh-ancestor
56531009|NCT05625308|Protective Agents|protective agents|mesh-ancestor
56531010|NCT05625308|Antioxidants|antioxidants|mesh-ancestor
56531011|NCT05625308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531012|NCT05625308|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56531013|NCT05625308|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56531014|NCT05625308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531015|NCT05625308|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56531016|NCT04291664|Prednisone|prednisone|mesh-list
56531017|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
56531018|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56531019|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
56531020|NCT04291664|Hormones|hormones|mesh-ancestor
56531021|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531022|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531023|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56531024|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531025|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56531026|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531027|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531028|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
56531029|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56531030|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
56531031|NCT04187469|Rifampin|rifampin|mesh-list
56531032|NCT04187469|Isoniazid|isoniazid|mesh-list
56531033|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
56531034|NCT04187469|Ethambutol|ethambutol|mesh-list
56531035|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56531036|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531037|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56531038|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56531039|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531040|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531041|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531042|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56531043|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
56531044|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
56531045|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56531046|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56531047|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56650177|NCT02648490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56650178|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56650179|NCT02648490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56650180|NCT02648490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56650181|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56650182|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56650183|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
56650184|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
56650185|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56650186|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
56650187|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
56650188|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56650189|NCT04965272|Cariprazine|cariprazine|mesh-list
56650190|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56650191|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56650192|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531048|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56531049|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56531050|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56531051|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56531052|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56531053|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56531054|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
56531055|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56531056|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
56279249|NCT00005925|Muscimol|muscimol|mesh-list
56531057|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56531058|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531060|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56531061|NCT01116687|R04929097|r04929097|mesh-list
56531062|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531063|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531064|NCT02867020|Prednisone|prednisone|mesh-list
56531065|NCT02867020|Goserelin|goserelin|mesh-list
56531066|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56531067|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
56531068|NCT02867020|Hormones|hormones|mesh-ancestor
56531069|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531070|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531071|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56531072|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531073|NCT03918278|Gemcitabine|gemcitabine|mesh-list
56531075|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56531076|NCT03918278|Carboplatin|carboplatin|mesh-list
56531077|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
56531078|NCT03918278|Pemetrexed|pemetrexed|mesh-list
56531079|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56531080|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531081|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
56531082|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
56531083|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
56531084|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531085|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56531086|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
56531087|NCT03918278|Antiviral Agents|antiviral agents|mesh-ancestor
56531088|NCT03918278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531089|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531090|NCT03918278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56531091|NCT03918278|Immunologic Factors|immunologic factors|mesh-ancestor
56531092|NCT03918278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115954|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
56650193|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650194|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56650195|NCT02648412|Ketamine|ketamine|mesh-list
56650196|NCT02648412|Analgesics|analgesics|mesh-ancestor
56531093|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56531094|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56531095|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56531096|NCT03817502|Cariprazine|cariprazine|mesh-list
56531097|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56531098|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56531099|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531100|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531101|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56531102|NCT04319978|Dexamethasone|dexamethasone|mesh-list
56531103|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
56531104|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56531105|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
56531106|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
56531107|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531108|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531109|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56531110|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
56531111|NCT04319978|Hormones|hormones|mesh-ancestor
56531112|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531113|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56531114|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531115|NCT01114737|Verapamil|verapamil|mesh-list
56531116|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56531117|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56531118|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531119|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531120|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56531121|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531122|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
56531123|NCT00624182|Gemcitabine|gemcitabine|mesh-list
56531124|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56531125|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
56531126|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531127|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531128|NCT00624182|Antiviral Agents|antiviral agents|mesh-ancestor
56531129|NCT00624182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531130|NCT00624182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279333|NCT00005949|Aldesleukin|aldesleukin|mesh-list
56531131|NCT00624182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56531133|NCT00624182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531134|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56531135|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531136|NCT00625677|Vaccines|vaccines|mesh-list
56531137|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
56169364|NCT01799616|Pamidronate|pamidronate|mesh-list
56531138|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531140|NCT00979576|Nintedanib|nintedanib|mesh-list
56531141|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531142|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531143|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531144|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56531145|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56531146|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56531147|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
56531148|NCT02867332|Interleukin-2|interleukin-2|mesh-list
56531149|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56531150|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
56531151|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531152|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56531153|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56531154|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
56531155|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531156|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531157|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56531158|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56531159|NCT02867332|Analgesics|analgesics|mesh-ancestor
56650197|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
56650198|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650199|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650200|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56650201|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56531160|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
56531161|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531162|NCT02702180|Molgramostim|molgramostim|mesh-list
56531163|NCT02702180|Sargramostim|sargramostim|mesh-list
56531164|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531165|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
56531166|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531167|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
56531168|NCT00980980|Mupirocin|mupirocin|mesh-list
56531169|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56531170|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531171|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
56531172|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56531173|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56531174|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531175|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531176|NCT04128748|Cytarabine|cytarabine|mesh-list
56531177|NCT04128748|Daunorubicin|daunorubicin|mesh-list
56531178|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56531179|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
56531180|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531181|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531182|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
56531183|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531184|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56531185|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
56531186|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531187|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56531188|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56531189|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56531190|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531191|NCT04116502|Interferons|interferons|mesh-list
56531192|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
56531193|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
56531194|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
56531195|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531196|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
56531197|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531198|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
56531199|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531200|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
56531201|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531202|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531203|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56531204|NCT04290442|Ropivacaine|ropivacaine|mesh-list
56531205|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
56531206|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
56531207|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531208|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531209|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
56531210|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531211|NCT02866786|Metformin|metformin|mesh-list
56531212|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
56531213|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56531214|NCT02866786|Estradiol|estradiol|mesh-list
56531215|NCT02866786|Cyproterone|cyproterone|mesh-list
56531216|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56531217|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531218|NCT02866786|Estrogens|estrogens|mesh-ancestor
56531219|NCT02866786|Hormones|hormones|mesh-ancestor
56531220|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531221|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56531222|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
56531223|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56531224|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56531225|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56650202|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
56650203|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
56650204|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56650205|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56650206|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56531227|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
56531228|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
56531229|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531230|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56531231|NCT00979654|Sifalimumab|sifalimumab|mesh-list
56531232|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
56531233|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531234|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56531235|NCT00978562|Hematinics|hematinics|mesh-ancestor
56531236|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56531237|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56531238|NCT04289974|Fulvestrant|fulvestrant|mesh-list
56531239|NCT04289974|Palbociclib|palbociclib|mesh-list
56531240|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56531241|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531242|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56531243|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56531244|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
56531245|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531246|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531247|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56531248|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531249|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531250|NCT02865616|Vancomycin|vancomycin|mesh-list
56531251|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56531252|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531253|NCT04084210|Nicotine|nicotine|mesh-list
56531254|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56531255|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
56531256|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531257|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531258|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56531259|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56531260|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
56531261|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531262|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531263|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
56531264|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
56531265|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531266|NCT02865460|Vitamins|vitamins|mesh-ancestor
56531267|NCT00946712|Paclitaxel|paclitaxel|mesh-list
56531268|NCT00946712|Bevacizumab|bevacizumab|mesh-list
56531269|NCT00946712|Carboplatin|carboplatin|mesh-list
56531270|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56531271|NCT00946712|Cetuximab|cetuximab|mesh-list
56531272|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56531273|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
56531274|NCT00946712|Antibodies|antibodies|mesh-list
56531275|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
56531276|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56531277|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
56531278|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56531279|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531280|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
56531281|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
56531282|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279473|NCT00005985|Etoposide|etoposide|mesh-list
56531283|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531285|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56531286|NCT00946712|Growth Substances|growth substances|mesh-ancestor
56531287|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531288|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
56531289|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
56531290|NCT01206816|Afatinib|afatinib|mesh-list
56531291|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531292|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56650207|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650208|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650209|NCT00650520|Bromocriptine|bromocriptine|mesh-list
56531293|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531294|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531295|NCT01259102|Buprenorphine|buprenorphine|mesh-list
56531296|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56531297|NCT01259102|Narcotics|narcotics|mesh-ancestor
56531298|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531299|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531301|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
56531302|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531303|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56531304|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
56531305|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
56531306|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531307|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
56531308|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56531309|NCT01259024|Estrogens|estrogens|mesh-ancestor
56531310|NCT01259024|Hormones|hormones|mesh-ancestor
56531311|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531312|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531313|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56531314|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531315|NCT04319900|Chloroquine|chloroquine|mesh-list
56531316|NCT04319900|Favipiravir|favipiravir|mesh-list
56531317|NCT04319900|Amebicides|amebicides|mesh-ancestor
56531318|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56531319|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56531320|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531321|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
56531322|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56531323|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
56531324|NCT01257698|Timolol|timolol|mesh-list
56531325|NCT01257698|Dorzolamide|dorzolamide|mesh-list
56531326|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56531327|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56531328|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56531329|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
56531330|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531331|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531332|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531333|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56531334|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56531335|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56531336|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531337|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56531338|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
56531339|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
56531340|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
56531341|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56531342|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56531343|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531344|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531345|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531346|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
56531347|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56531348|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
56531349|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531350|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531351|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56531352|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
56531353|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
56531354|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56531355|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
56531356|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531357|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531358|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56531359|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56531360|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
56531361|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650210|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56650211|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56650212|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
56531362|NCT01204710|Prednisone|prednisone|mesh-list
56531363|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
56531364|NCT01204710|Olaratumab|olaratumab|mesh-list
56531365|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56531366|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
56531367|NCT01204710|Hormones|hormones|mesh-ancestor
56531368|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531369|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531370|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56531371|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531372|NCT01204710|Analgesics|analgesics|mesh-ancestor
56531373|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
56531374|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531375|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56531376|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56531377|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531378|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531379|NCT01256450|Buprenorphine|buprenorphine|mesh-list
56531380|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56531381|NCT01256450|Narcotics|narcotics|mesh-ancestor
56531382|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531383|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531384|NCT01256450|Analgesics|analgesics|mesh-ancestor
56531385|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
56531386|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531387|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56531389|NCT01204398|Telmisartan|telmisartan|mesh-list
56531390|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56531391|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56531392|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56531393|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531394|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531395|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56531396|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531397|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
56531398|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56531399|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56531400|NCT01111851|Dexamethasone|dexamethasone|mesh-list
56531401|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
56531402|NCT01111851|Ondansetron|ondansetron|mesh-list
56531403|NCT01111851|Aprepitant|aprepitant|mesh-list
56531404|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
56531405|NCT01111851|BB 1101|bb 1101|mesh-list
56531406|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56531407|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
56531408|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
56531409|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531410|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531411|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56531412|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
56531413|NCT01111851|Hormones|hormones|mesh-ancestor
56531414|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531415|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56531416|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531417|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
56531418|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531419|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531420|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
56531421|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
56531422|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56531423|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
56531424|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531425|NCT01111851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56531426|NCT01111851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56531427|NCT01111851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531428|NCT01111851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56531429|NCT01111851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56531430|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56531431|NCT01256294|Tacrolimus|tacrolimus|mesh-list
56279629|NCT00006015|Leucovorin|leucovorin|mesh-list
56650213|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650214|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650215|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
56531432|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56531433|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
56531434|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531435|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56531436|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531437|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531438|NCT01256060|Oxytocin|oxytocin|mesh-list
56531439|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
56531440|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56531441|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531442|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
56531443|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
56531444|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56531445|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531446|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531447|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56531448|NCT01255904|Analgesics|analgesics|mesh-ancestor
56531449|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
56531450|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531451|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56531452|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56531453|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56531454|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
56531455|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531456|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531457|NCT01255670|Metronidazole|metronidazole|mesh-list
56531458|NCT01255670|Penicillins|penicillins|mesh-list
56531459|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531460|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56531461|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56531462|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56531463|NCT01203930|Rituximab|rituximab|mesh-list
56531464|NCT01203930|Idelalisib|idelalisib|mesh-list
56531465|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56531466|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531467|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
56531468|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531469|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56531470|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531471|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531472|NCT01254890|Azacitidine|azacitidine|mesh-list
56531473|NCT01254890|Sorafenib|sorafenib|mesh-list
56531474|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56531475|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
56531476|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531477|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531478|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531479|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56531480|NCT01203852|Metoprolol|metoprolol|mesh-list
56531481|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
56531482|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56531483|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56531484|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
56531485|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
56531486|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531487|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531488|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56531489|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56531490|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56531491|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
56531492|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531493|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531494|NCT01203852|Diuretics|diuretics|mesh-ancestor
56531495|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
56531496|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56531497|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531498|NCT01203072|Edoxaban|edoxaban|mesh-list
56531499|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56650216|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
56650217|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531500|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
56531501|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56531502|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
56531503|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531504|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531505|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
56531506|NCT01105377|Azacitidine|azacitidine|mesh-list
56531507|NCT01105377|Entinostat|entinostat|mesh-list
56531508|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56531509|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56531510|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
56531511|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531512|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531513|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531514|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56531515|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56531516|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56531517|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56531518|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56531519|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
56531520|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531521|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531522|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531524|NCT01111539|Citalopram|citalopram|mesh-list
56531525|NCT01111539|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56531526|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56531527|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531528|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531529|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531530|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
56531531|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531532|NCT01111539|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56531533|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
56531534|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56531535|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56531536|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56531537|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531538|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
56531539|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
56531540|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56531541|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56531542|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56531543|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56531544|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56531545|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56531546|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
56531547|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56531548|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531549|NCT02879955|Acarbose|acarbose|mesh-list
56531550|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56169452|NCT02996214|Paclitaxel|paclitaxel|mesh-list
56531551|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531552|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531553|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56531554|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531555|NCT02880033|Deferiprone|deferiprone|mesh-list
56531556|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56531557|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
56531558|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
56531559|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531560|NCT01111461|Lenvatinib|lenvatinib|mesh-list
56531561|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531562|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56531563|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531564|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531565|NCT00625911|Ketamine|ketamine|mesh-list
56531566|NCT00625911|Morphine|morphine|mesh-list
56531567|NCT00625911|Analgesics|analgesics|mesh-ancestor
56531568|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
56531569|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650218|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531570|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531571|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56531572|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56531573|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
56531574|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
56531575|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531576|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56531577|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56531578|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531579|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531580|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56531581|NCT00625911|Narcotics|narcotics|mesh-ancestor
56531582|NCT01111149|Bupropion|bupropion|mesh-list
56531583|NCT01111149|Varenicline|varenicline|mesh-list
56531584|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56531585|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
56531586|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56531587|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56531588|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56531589|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531590|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531591|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
56531592|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531593|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531594|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56531595|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56531604|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531605|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531606|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
56531607|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531608|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56531609|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56531610|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56531611|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56531612|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56531613|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56531622|NCT01254344|Metronidazole|metronidazole|mesh-list
56531623|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
56531624|NCT01254344|Ertapenem|ertapenem|mesh-list
56531625|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531626|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56531627|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56531628|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56531629|NCT05051007|Lidocaine|lidocaine|mesh-list
56531630|NCT05051007|Fentanyl|fentanyl|mesh-list
56531631|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
56531632|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
56531633|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531634|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531635|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
56531636|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531637|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56531638|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56531639|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56531640|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531641|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531642|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56531643|NCT05051007|Narcotics|narcotics|mesh-ancestor
56531644|NCT05051007|Analgesics|analgesics|mesh-ancestor
56531645|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56531646|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56531647|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
56531648|NCT01102803|Cycloserine|cycloserine|mesh-list
56531649|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56531650|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531651|NCT01102803|Renal Agents|renal agents|mesh-ancestor
56531652|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56531653|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
56531654|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56531656|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650220|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
56531657|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56531658|NCT01109979|Drospirenone|drospirenone|mesh-list
56531659|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56531660|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56531661|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
56531662|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56531663|NCT01109979|Estradiol|estradiol|mesh-list
56531664|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56531665|NCT01109979|Estrogens|estrogens|mesh-ancestor
56531666|NCT01109979|Hormones|hormones|mesh-ancestor
56531667|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531668|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531669|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56531670|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
56531671|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56531672|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56531673|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56531674|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56531675|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56531676|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56531677|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56531678|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531679|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56531680|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
56531681|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56531682|NCT01109979|Diuretics|diuretics|mesh-ancestor
56531683|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
56531684|NCT01102491|Ramosetron|ramosetron|mesh-list
56531685|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
56531686|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
56531687|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531688|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531689|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56531690|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56531691|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
56531692|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531693|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531694|NCT01108809|Telmisartan|telmisartan|mesh-list
56531695|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56531696|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56531697|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56531698|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531699|NCT01253408|Dronabinol|dronabinol|mesh-list
56531700|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
56531701|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531702|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56531703|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56531704|NCT01253408|Analgesics|analgesics|mesh-ancestor
56531705|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
56531706|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531707|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56531708|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56531709|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531710|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531711|NCT01253408|Hormones|hormones|mesh-ancestor
56531712|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531713|NCT05506982|Psilocybin|psilocybin|mesh-list
56531714|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
56531715|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531716|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56531717|NCT02879643|Vincristine|vincristine|mesh-list
56531718|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56531719|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531720|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
56531721|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
56531722|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
56531723|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531724|NCT02879721|Candesartan|candesartan|mesh-list
56531725|NCT02879721|Enalapril|enalapril|mesh-list
56531726|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56279970|NCT04803084|TEMPO|tempo|mesh-list
56531727|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56650221|NCT04244981|Coagulants|coagulants|mesh-ancestor
56650222|NCT00621218|Tretinoin|tretinoin|mesh-list
56650223|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650224|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
56650225|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
56531728|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56531729|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531730|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56531731|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
56531732|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531733|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
56531734|NCT01253174|Drospirenone|drospirenone|mesh-list
56531735|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56531736|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
56531737|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56531738|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531739|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56531740|NCT01253174|Diuretics|diuretics|mesh-ancestor
56531741|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
56531742|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
56531743|NCT01253174|Vitamins|vitamins|mesh-ancestor
56531744|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
56531746|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
56531747|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56531748|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56531749|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531750|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531751|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531752|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531753|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56531754|NCT01108731|Analgesics|analgesics|mesh-ancestor
56531755|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
56531756|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531757|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
56531758|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56531759|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
56531760|NCT04308525|Narcotics|narcotics|mesh-ancestor
56531761|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531762|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531763|NCT04308525|Analgesics|analgesics|mesh-ancestor
56531764|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
56531765|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531766|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56531767|NCT01108341|Ofatumumab|ofatumumab|mesh-list
56531768|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56531769|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
56531770|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531771|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531772|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
56531773|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
56531774|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56531775|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56531776|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56531777|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531778|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531779|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56531780|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56531781|NCT01252238|Amlodipine|amlodipine|mesh-list
56531782|NCT01252238|Valsartan|valsartan|mesh-list
56531783|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56531784|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56531785|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531786|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531787|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56531788|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531789|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
56531790|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56531791|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56650226|NCT02655276|Glycine|glycine|mesh-list
56650227|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
56650228|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650229|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531792|NCT01101321|Oxycodone|oxycodone|mesh-list
56531793|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56531794|NCT01101321|Narcotics|narcotics|mesh-ancestor
56531795|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531796|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531797|NCT01101321|Analgesics|analgesics|mesh-ancestor
56531798|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
56531799|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531800|NCT04309929|Analgesics|analgesics|mesh-list
56531801|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
56531802|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531803|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531804|NCT01101165|Oxycodone|oxycodone|mesh-list
56531813|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56531814|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56531815|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531816|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
56531817|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531818|NCT02879097|Paclitaxel|paclitaxel|mesh-list
56531819|NCT02879097|Carboplatin|carboplatin|mesh-list
56531820|NCT02879097|Bevacizumab|bevacizumab|mesh-list
56531821|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56531822|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531823|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
56531824|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
56531825|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
56531826|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531827|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56531828|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56531829|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56531830|NCT02879097|Growth Substances|growth substances|mesh-ancestor
56531831|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531832|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
56531841|NCT02878863|Peoniflorin|peoniflorin|mesh-list
56531842|NCT02878863|Silymarin|silymarin|mesh-list
56531843|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
56531844|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531845|NCT02878863|Protective Agents|protective agents|mesh-ancestor
56531846|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531847|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56531848|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56531849|NCT02878863|Analgesics|analgesics|mesh-ancestor
56531850|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
56531851|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531852|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56531853|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56531854|NCT02881125|Paclitaxel|paclitaxel|mesh-list
56531855|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56531856|NCT02881125|Nortriptyline|nortriptyline|mesh-list
56531857|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56531858|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531859|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
56531860|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
56531861|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
56531862|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531863|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56531864|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
56531865|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56531866|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56531867|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56531868|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531869|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
56169512|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
56531870|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531871|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531872|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56531873|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56531874|NCT01097577|Pregabalin|pregabalin|mesh-list
56650230|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650231|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
56213386|NCT01746173|Etoposide|etoposide|mesh-list
56531875|NCT01097577|Analgesics|analgesics|mesh-ancestor
56531876|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
56531877|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531878|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531879|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
56531880|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56531881|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531882|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531883|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56531884|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56531885|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56531886|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56531887|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56531888|NCT01097421|Pramipexole|pramipexole|mesh-list
56531889|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
56531890|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531891|NCT01097421|Protective Agents|protective agents|mesh-ancestor
56531892|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531893|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56531894|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56531895|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
56531896|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
56531897|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531898|NCT01251614|Adalimumab|adalimumab|mesh-list
56531899|NCT01251614|Methotrexate|methotrexate|mesh-list
56531900|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56531901|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
56531902|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56531903|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531904|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56531905|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
56531906|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531907|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56531908|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
56531909|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531910|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56531911|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56531912|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
56531913|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56531914|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56531915|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56531917|NCT01106625|Canagliflozin|canagliflozin|mesh-list
56531918|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56531919|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531920|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56531921|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531922|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
56531923|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56531924|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56531925|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56531926|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56531927|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531928|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
56531929|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531930|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531931|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56531932|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531933|NCT01251146|Atenolol|atenolol|mesh-list
56531934|NCT01251146|Bisoprolol|bisoprolol|mesh-list
56531935|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56531936|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56531937|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
56531938|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
56531939|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56531940|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531941|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56531942|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56531943|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56650232|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56650233|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
56650234|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56650235|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
56531944|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
56531945|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56531946|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56531947|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
56334925|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334927|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56334928|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56334929|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
56334930|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334931|NCT00067860|Hormones|hormones|mesh-list
56334932|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334933|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334934|NCT00071448|Insulin|insulin|mesh-list
56334935|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56334936|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
56334937|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
56334938|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56334939|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334940|NCT02599324|Paclitaxel|paclitaxel|mesh-list
56334941|NCT02599324|Docetaxel|docetaxel|mesh-list
56334942|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
56334943|NCT02599324|Cetuximab|cetuximab|mesh-list
56334944|NCT02599324|Everolimus|everolimus|mesh-list
56334945|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56334946|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956741|NCT02243007|Paclitaxel|paclitaxel|mesh-list
56334947|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334948|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334949|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334950|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334951|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56334952|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334953|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
56334954|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334956|NCT01331018|Prednisone|prednisone|mesh-list
56334957|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
56334958|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56334959|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56334960|NCT01331018|Prednisolone|prednisolone|mesh-list
56334962|NCT01331018|Cortisone|cortisone|mesh-list
56334963|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56334964|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
56334965|NCT01331018|Lenograstim|lenograstim|mesh-list
56334966|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56334967|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
56334968|NCT01331018|Hormones|hormones|mesh-ancestor
56334969|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334970|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334971|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56334972|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334973|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56334974|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
56334975|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
56334976|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
56334977|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334978|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56334979|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56334980|NCT01331018|Protective Agents|protective agents|mesh-ancestor
56334981|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56334982|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56334983|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
56334984|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334986|NCT00067899|Vitamin E|vitamin e|mesh-list
56334987|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
56334988|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334989|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
56334990|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334991|NCT00067899|Protective Agents|protective agents|mesh-ancestor
56334992|NCT00067938|Lamotrigine|lamotrigine|mesh-list
56334993|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
56334994|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56650236|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962567|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56334995|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56334996|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334997|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56334998|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334999|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56335000|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56335001|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335002|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335003|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56335005|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
56335006|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
56335007|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335008|NCT01809808|Hormones|hormones|mesh-list
56335009|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335010|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335011|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
56335012|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56335013|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56335014|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
56335015|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335016|NCT01406197|Progesterone|progesterone|mesh-list
56335017|NCT01406197|Progestins|progestins|mesh-ancestor
56335018|NCT01406197|Hormones|hormones|mesh-ancestor
56335019|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335020|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335021|NCT00038402|Paclitaxel|paclitaxel|mesh-list
56335022|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
56335023|NCT00038402|Fluorouracil|fluorouracil|mesh-list
56335024|NCT00038402|Trastuzumab|trastuzumab|mesh-list
55956808|NCT04790175|Tolvaptan|tolvaptan|mesh-list
56335025|NCT00038402|Epirubicin|epirubicin|mesh-list
56335026|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56335027|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335028|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
56335029|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
56335030|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
56335031|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335032|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335033|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
56335034|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335035|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335036|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56335037|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
56335038|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56335039|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
56335040|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56169547|NCT02991768|Budesonide|budesonide|mesh-list
56335041|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56335042|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56335043|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56335044|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56335045|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335047|NCT00144703|Tacrolimus|tacrolimus|mesh-list
56335048|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335049|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
56335050|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335051|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56335052|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335053|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335054|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56335055|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335056|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56335057|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335058|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
56335059|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
56335060|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56335061|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
56335062|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335063|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
56335064|NCT00144820|Protective Agents|protective agents|mesh-ancestor
56335065|NCT00071643|Citalopram|citalopram|mesh-list
56650237|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650238|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
56650239|NCT00651300|Parecoxib|parecoxib|mesh-list
56335066|NCT00071643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56335067|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56335068|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56335069|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335070|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56335071|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
56335072|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335073|NCT00071643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56335074|NCT00071643|Antidepressive Agents|antidepressive agents|mesh-ancestor
56335075|NCT00071643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335077|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335078|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56335079|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335080|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335081|NCT00038480|Ritonavir|ritonavir|mesh-list
56335082|NCT00038480|Lopinavir|lopinavir|mesh-list
56335083|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56335084|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56335085|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
56335086|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335087|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335088|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56335089|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56335090|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
56335091|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335092|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56335093|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56335094|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
56335095|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
56335096|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335097|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335098|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335099|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
56335100|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56335101|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335102|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335103|NCT00038519|Ritonavir|ritonavir|mesh-list
56335104|NCT00038519|Saquinavir|saquinavir|mesh-list
56335105|NCT00038519|Amprenavir|amprenavir|mesh-list
56335106|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56335107|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56335108|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
56335109|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335110|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335111|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56335112|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56335114|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335115|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56335116|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56335117|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56335118|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
56335119|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56335120|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56335121|NCT00202345|Hematinics|hematinics|mesh-ancestor
56335122|NCT02966847|Anesthetics|anesthetics|mesh-list
56335123|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335124|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335125|NCT00202423|Nabiximols|nabiximols|mesh-list
56335126|NCT00202423|Analgesics|analgesics|mesh-ancestor
56335127|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
56335128|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335129|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335130|NCT00202462|Testosterone|testosterone|mesh-list
56335131|NCT00202462|Androgens|androgens|mesh-ancestor
56335132|NCT00202462|Hormones|hormones|mesh-ancestor
56335133|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335134|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335135|NCT00038558|Doxorubicin|doxorubicin|mesh-list
56650240|NCT00651300|Valdecoxib|valdecoxib|mesh-list
56335136|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56335137|NCT00038558|Bleomycin|bleomycin|mesh-list
56335138|NCT00038558|Dacarbazine|dacarbazine|mesh-list
56335139|NCT00038558|Vinblastine|vinblastine|mesh-list
56335140|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56335141|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335142|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56335143|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56335144|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335145|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335146|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56335147|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
56335148|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56335149|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
56335150|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
56335151|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
56335153|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335154|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335155|NCT00202618|Amlodipine|amlodipine|mesh-list
56335156|NCT00202618|Valsartan|valsartan|mesh-list
56335157|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56335158|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56335159|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56335160|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335161|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56335162|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335163|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
56335164|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56335165|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56335166|NCT00202696|Nalmefene|nalmefene|mesh-list
56335167|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56335168|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335169|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
56335170|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335171|NCT00038636|Ritonavir|ritonavir|mesh-list
56335172|NCT00038636|Lopinavir|lopinavir|mesh-list
56335173|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56335174|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56335175|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
56335176|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335177|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335179|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56335180|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
56335181|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335182|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56335183|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56335184|NCT00202774|Fluorouracil|fluorouracil|mesh-list
56335185|NCT00202774|Capecitabine|capecitabine|mesh-list
56335186|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
56335187|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
56335188|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335189|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56335190|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335191|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335192|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
56335193|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335194|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
56335195|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56335197|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335198|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
56335199|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335200|NCT00202852|Infliximab|infliximab|mesh-list
56335201|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56335202|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56335203|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335204|NCT00202891|Sisomicin|sisomicin|mesh-list
56335205|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56335206|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335207|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56335208|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335209|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335210|NCT00202969|Cisplatin|cisplatin|mesh-list
56335211|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335212|NCT00203125|Rasagiline|rasagiline|mesh-list
56650241|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56650242|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56650243|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650244|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335213|NCT00203125|Tyramine|tyramine|mesh-list
56335214|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56335215|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335216|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335217|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56335218|NCT00203125|Protective Agents|protective agents|mesh-ancestor
56335219|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335220|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
56335221|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
56335222|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335223|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56335224|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56335225|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56335226|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
56335227|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56335228|NCT00203164|Rasagiline|rasagiline|mesh-list
56335229|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56335230|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335231|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335232|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56335233|NCT00203164|Protective Agents|protective agents|mesh-ancestor
56335234|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335235|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
56335236|NCT00203281|Tacrolimus|tacrolimus|mesh-list
56335237|NCT00203281|Daclizumab|daclizumab|mesh-list
56335238|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
56335239|NCT00203281|Antibodies|antibodies|mesh-list
56335240|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
56335241|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56335242|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56335243|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335244|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
56169576|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
56335245|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335246|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56335247|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957032|NCT05696886|Analgesics|analgesics|mesh-ancestor
56335248|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335249|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56335250|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335251|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56335252|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
56335253|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56335254|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335256|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56335257|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56335258|NCT00203320|Analgesics|analgesics|mesh-ancestor
56335259|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
56335260|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335261|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335262|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335263|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335264|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56335265|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335266|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
56335267|NCT00038792|Mitogens|mitogens|mesh-list
56335268|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
56335269|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335270|NCT00203359|Etanercept|etanercept|mesh-list
56335271|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56335272|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56335273|NCT00203359|Analgesics|analgesics|mesh-ancestor
56335274|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
56335275|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335276|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335277|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650245|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56650246|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56650247|NCT00651300|Analgesics|analgesics|mesh-ancestor
56335278|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335279|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56335280|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335281|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
56335282|NCT00410644|Hydromorphone|hydromorphone|mesh-list
56335283|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56335284|NCT00410644|Narcotics|narcotics|mesh-ancestor
56335285|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335286|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335287|NCT00410644|Analgesics|analgesics|mesh-ancestor
56335288|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
56335289|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335290|NCT00038831|Fludarabine|fludarabine|mesh-list
56335291|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
56335292|NCT00038831|Melphalan|melphalan|mesh-list
56335293|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
56335294|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56335295|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
56335296|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335297|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56335298|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
56335299|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335300|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991211|NCT00986401|Metformin|metformin|mesh-list
56335301|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
56335302|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335303|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56335304|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
56335305|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56335306|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56335307|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
56335308|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56335309|NCT00071955|Antibodies|antibodies|mesh-list
56335310|NCT00071955|Sargramostim|sargramostim|mesh-list
56335311|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56335312|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
56335313|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335314|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56335315|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
56335316|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56335317|NCT00203554|Protective Agents|protective agents|mesh-ancestor
56335318|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335319|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
56335320|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56335321|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335322|NCT00071994|Gefitinib|gefitinib|mesh-list
56335323|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335324|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56335325|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335326|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335328|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56335329|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
56335330|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56335331|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335332|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335333|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56335334|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56335335|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335336|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335337|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56335338|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
56335339|NCT00072033|Docetaxel|docetaxel|mesh-list
56335340|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335341|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
56335342|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
56335343|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
56335344|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335345|NCT00203905|Bevacizumab|bevacizumab|mesh-list
56335346|NCT00203905|Fluorouracil|fluorouracil|mesh-list
56335347|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
56335348|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56650248|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
56650249|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650250|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335349|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335350|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56335351|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56335352|NCT00203905|Growth Substances|growth substances|mesh-ancestor
56335353|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335354|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
56335355|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
56335356|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335357|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56335358|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335359|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
56335360|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
56335361|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335362|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56335363|NCT00072072|Celecoxib|celecoxib|mesh-list
56335364|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56335365|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335366|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56335367|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335368|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335369|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56335370|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56335371|NCT00072072|Analgesics|analgesics|mesh-ancestor
56335372|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
56335373|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335374|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335375|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335376|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335377|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56335378|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56335380|NCT00204022|Azathioprine|azathioprine|mesh-list
56335381|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56169582|NCT02999958|Protective Agents|protective agents|mesh-ancestor
56335382|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335383|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56335384|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
56335385|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56335386|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335387|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335388|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335389|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
56335390|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56335391|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335392|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
56335393|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335394|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335395|NCT00204061|Amisulpride|amisulpride|mesh-list
56335396|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56335397|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56335398|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335399|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335400|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335401|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56335402|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
56335403|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56335404|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335405|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56335406|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
56335407|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
56335408|NCT02966652|Testosterone|testosterone|mesh-list
56335409|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
56335410|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
56335411|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56335412|NCT02966652|Androgens|androgens|mesh-ancestor
56335413|NCT02966652|Hormones|hormones|mesh-ancestor
56335414|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335416|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56650251|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650252|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650253|NCT00790010|Bevacizumab|bevacizumab|mesh-list
56650254|NCT00790010|Ipilimumab|ipilimumab|mesh-list
55790064|NCT03257033|Gemcitabine|gemcitabine|mesh-list
56335417|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335418|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
56335419|NCT00039026|Exenatide|exenatide|mesh-list
56335420|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56335421|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335422|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56335423|NCT00039026|Incretins|incretins|mesh-ancestor
56335424|NCT00039026|Hormones|hormones|mesh-ancestor
56335425|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335426|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56335427|NCT00204256|Hematinics|hematinics|mesh-ancestor
56335428|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56335429|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335430|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
56335431|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56335432|NCT00204451|Estradiol|estradiol|mesh-list
56335433|NCT00204451|Estrogens|estrogens|mesh-ancestor
56335434|NCT00204451|Hormones|hormones|mesh-ancestor
56335435|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335436|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335437|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56335438|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
56335439|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56335440|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56335441|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56335442|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56335443|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56335444|NCT00204529|Interferons|interferons|mesh-list
56335445|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
56335446|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
56335447|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56335448|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335449|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
56335450|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335451|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
56335452|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335453|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
56335454|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56335455|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335456|NCT00204568|Doxorubicin|doxorubicin|mesh-list
56335457|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56335458|NCT00204568|Trofosfamide|trofosfamide|mesh-list
56335459|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56335460|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335461|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56335462|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56335463|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335464|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335465|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335466|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
56335467|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335468|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56335469|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
56335470|NCT00072150|Bortezomib|bortezomib|mesh-list
56335471|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335472|NCT00204646|Carboplatin|carboplatin|mesh-list
56335473|NCT00204646|Etoposide|etoposide|mesh-list
56335474|NCT00204646|Doxorubicin|doxorubicin|mesh-list
56335475|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56335476|NCT00204646|Ifosfamide|ifosfamide|mesh-list
56335477|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335478|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56335479|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56335480|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56335481|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335482|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335483|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56335484|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56650255|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56650256|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650257|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56335485|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
56335486|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56335487|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335488|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56335489|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335491|NCT00410878|Hydromorphone|hydromorphone|mesh-list
56335492|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56335493|NCT00410878|Narcotics|narcotics|mesh-ancestor
56335494|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335495|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335496|NCT00410878|Analgesics|analgesics|mesh-ancestor
56335497|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
56335498|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335499|NCT00410995|Naproxen|naproxen|mesh-list
56335500|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56335501|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56335502|NCT00410995|Analgesics|analgesics|mesh-ancestor
56335503|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
56335504|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335505|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335506|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335507|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335508|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
56335509|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56335510|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335511|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335512|NCT00039338|Cisplatin|cisplatin|mesh-list
56335513|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335514|NCT00072228|Gemcitabine|gemcitabine|mesh-list
56335515|NCT00072228|Soblidotin|soblidotin|mesh-list
56335516|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56335517|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
56335518|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335519|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335520|NCT00072228|Antiviral Agents|antiviral agents|mesh-ancestor
56335521|NCT00072228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335522|NCT00072228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335523|NCT00072228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335524|NCT00072228|Immunologic Factors|immunologic factors|mesh-ancestor
56335525|NCT00072228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335526|NCT00204919|Vitamin D|vitamin d|mesh-list
56335527|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
56335529|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
56335530|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335531|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56335532|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56335533|NCT00072267|Topotecan|topotecan|mesh-list
56335534|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56335535|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56335536|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56335537|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335538|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335539|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335540|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56335541|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
56335542|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335543|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56335544|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335545|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335546|NCT00072345|Thalidomide|thalidomide|mesh-list
56335547|NCT00072345|Temozolomide|temozolomide|mesh-list
56335548|NCT00072345|Lomustine|lomustine|mesh-list
56335549|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56335550|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
56335551|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335552|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335553|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335554|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
56335555|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650258|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56650259|NCT00790010|Growth Substances|growth substances|mesh-ancestor
56650260|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213408|NCT01746173|Hormones|hormones|mesh-ancestor
56335556|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
56335557|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56335558|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335559|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56335560|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56335561|NCT00072345|Growth Substances|growth substances|mesh-ancestor
56335562|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
56335563|NCT00039455|Trastuzumab|trastuzumab|mesh-list
56335564|NCT00039455|Alvocidib|alvocidib|mesh-list
56335566|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335567|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
56335568|NCT00039455|Growth Substances|growth substances|mesh-ancestor
56335569|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335570|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56335571|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335572|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335573|NCT00205231|Etanercept|etanercept|mesh-list
56335574|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56335575|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56335576|NCT00205231|Analgesics|analgesics|mesh-ancestor
56335577|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
56335578|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335579|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335580|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335581|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335582|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56335583|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335584|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
56335585|NCT00072462|Tamoxifen|tamoxifen|mesh-list
56335586|NCT00072462|Anastrozole|anastrozole|mesh-list
56335587|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335588|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56335589|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
56335590|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335591|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335592|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56335593|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335594|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56335595|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56335596|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56335597|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56335598|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56335599|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335600|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56335601|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
56335602|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335603|NCT00039494|Temozolomide|temozolomide|mesh-list
56335604|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56335605|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56335606|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
56335607|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335608|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335609|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56335610|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335611|NCT00205738|Olanzapine|olanzapine|mesh-list
56335612|NCT00205738|Risperidone|risperidone|mesh-list
56335613|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56335614|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
56335615|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56335616|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335617|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335618|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56335619|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56335620|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335621|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335622|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56650261|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
56650262|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56650263|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650264|NCT02828033|Rilonacept|rilonacept|mesh-list
56650265|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335623|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
56335624|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
56335625|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
56335626|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335627|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56335628|NCT00205738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56335629|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56335630|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56335631|NCT00205816|Tigecycline|tigecycline|mesh-list
56335632|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56335633|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335634|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56335635|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335636|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335640|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56335641|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56335642|NCT00072540|Analgesics|analgesics|mesh-ancestor
56335643|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
56335644|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335645|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335646|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335647|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335648|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56335649|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56335650|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335651|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
56335652|NCT00206050|Esomeprazole|esomeprazole|mesh-list
56335653|NCT00206050|Pantoprazole|pantoprazole|mesh-list
56335654|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56335655|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56335656|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56335657|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335658|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335659|NCT00206089|Ximelagatran|ximelagatran|mesh-list
56335660|NCT00206089|Melagatran|melagatran|mesh-list
56335661|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
56335662|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56335663|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
56335664|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335665|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335666|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
56335667|NCT00072579|Sargramostim|sargramostim|mesh-list
56335668|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
56335669|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335670|NCT04732247|Oxytocin|oxytocin|mesh-list
56335671|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
56169661|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
56335672|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56335673|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335674|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56335675|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
56335676|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335677|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56335678|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56335679|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335680|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335681|NCT00206167|Budesonide|budesonide|mesh-list
56335682|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
56335683|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335684|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56335685|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
56335686|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335687|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335688|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56335689|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
56650266|NCT00621998|Olanzapine|olanzapine|mesh-list
56650267|NCT00621998|Risperidone|risperidone|mesh-list
56335690|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
56335691|NCT00206167|Hormones|hormones|mesh-ancestor
56335692|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335693|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56335694|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56335695|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56335696|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
56335697|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56335698|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335699|NCT00039611|Leucovorin|leucovorin|mesh-list
55957496|NCT00122447|Aspirin|aspirin|mesh-list
56335700|NCT00039611|Fluorouracil|fluorouracil|mesh-list
56335702|NCT00039611|Calcium|calcium|mesh-list
56335703|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
56335704|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56335705|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335706|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
56335707|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335708|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56335709|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335711|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
56335712|NCT00039611|Antidotes|antidotes|mesh-ancestor
56335713|NCT00039611|Protective Agents|protective agents|mesh-ancestor
56335714|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
56335715|NCT00039611|Vitamins|vitamins|mesh-ancestor
56335716|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
56335717|NCT00068289|Bortezomib|bortezomib|mesh-list
56335718|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335719|NCT00039767|Lepirudin|lepirudin|mesh-list
56335720|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
56335721|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56335722|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
56335723|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335724|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335725|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
56335726|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56335727|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56335728|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
56335729|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335730|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56335731|NCT00072618|Protective Agents|protective agents|mesh-ancestor
56335732|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335733|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56335734|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335735|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335736|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56335737|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56335738|NCT00072618|Analgesics|analgesics|mesh-ancestor
56335739|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
56335740|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335741|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335742|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335743|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
56335744|NCT00039884|Hematinics|hematinics|mesh-ancestor
56335745|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
56335746|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56335747|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335748|NCT00399204|Metformin|metformin|mesh-list
56335749|NCT00399204|Pioglitazone|pioglitazone|mesh-list
56335750|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56335751|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335752|NCT00411034|Hydromorphone|hydromorphone|mesh-list
56335753|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56335754|NCT00411034|Narcotics|narcotics|mesh-ancestor
56335755|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335756|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335757|NCT00411034|Analgesics|analgesics|mesh-ancestor
56335758|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
56335759|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335760|NCT00411073|Darapladib|darapladib|mesh-list
56335761|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56335762|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335763|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335764|NCT00411190|Acetaminophen|acetaminophen|mesh-list
56650268|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56650269|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
56650270|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650271|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650272|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335765|NCT00411190|Ibuprofen|ibuprofen|mesh-list
56335766|NCT00411190|Atorvastatin|atorvastatin|mesh-list
56335767|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56335768|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56335769|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
56335770|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335771|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56335772|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56335773|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335774|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56335775|NCT00411190|Analgesics|analgesics|mesh-ancestor
56335776|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
55957572|NCT00183677|Citalopram|citalopram|mesh-list
56335777|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335778|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335779|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
56335780|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56335781|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335782|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335783|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56335784|NCT00411229|Capecitabine|capecitabine|mesh-list
56335785|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
56335790|NCT00411268|Hydromorphone|hydromorphone|mesh-list
56335791|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56335792|NCT00411268|Narcotics|narcotics|mesh-ancestor
56335793|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335794|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335795|NCT00411268|Analgesics|analgesics|mesh-ancestor
56335796|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
56335797|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335798|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56335799|NCT00039962|Thymalfasin|thymalfasin|mesh-list
56335800|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
56335801|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335802|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56335803|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
56335804|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335805|NCT00424333|Insulin|insulin|mesh-list
56335806|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56335807|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56335808|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335809|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56335810|NCT00206557|Estradiol|estradiol|mesh-list
56335811|NCT00206557|Estrogens|estrogens|mesh-ancestor
56335812|NCT00206557|Hormones|hormones|mesh-ancestor
56335813|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335814|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335815|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56335816|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
56335817|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56335818|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56335819|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56335820|NCT00068484|Bortezomib|bortezomib|mesh-list
56335821|NCT00068484|Topotecan|topotecan|mesh-list
56335822|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335823|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56335824|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56335825|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335826|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335827|NCT00206596|Sargramostim|sargramostim|mesh-list
56335828|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
56335829|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335830|NCT00206635|Interferons|interferons|mesh-list
56335831|NCT00206635|Interferon-beta|interferon-beta|mesh-list
56335832|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
56335833|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650273|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56650274|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56650275|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56650276|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335834|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
56335835|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335836|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
56335837|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335838|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56335839|NCT00206674|Sargramostim|sargramostim|mesh-list
56335840|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
56335841|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335842|NCT00206713|Sargramostim|sargramostim|mesh-list
56335843|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
56335844|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335845|NCT00040040|Bupropion|bupropion|mesh-list
56335846|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56335847|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
56335848|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335849|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56335850|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56335851|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56335852|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335853|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
56335854|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56335855|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335856|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56335859|NCT00068523|Cyclosporine|cyclosporine|mesh-list
56335860|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
56335861|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
56335862|NCT00068523|Fludarabine|fludarabine|mesh-list
56335863|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
56335864|NCT00068523|Cyclosporins|cyclosporins|mesh-list
56335865|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56335866|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335867|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
56335868|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335869|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335870|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56335871|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
56335872|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335873|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335874|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56335875|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56335876|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
56335877|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335878|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
56335879|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335880|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
56335881|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56335882|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56335883|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
56335884|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
56335885|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335886|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56335887|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
56335888|NCT00068523|Hormones|hormones|mesh-ancestor
56335889|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56335890|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56335891|NCT00068523|Protective Agents|protective agents|mesh-ancestor
56335892|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
56335893|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56335894|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56335895|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335896|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335897|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
56335898|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335899|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56335900|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56335901|NCT00206947|Ziprasidone|ziprasidone|mesh-list
56335902|NCT00206947|Donepezil|donepezil|mesh-list
56116315|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650277|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56650278|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
56650279|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
56650280|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
56650281|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650282|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650283|NCT00621998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56335903|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56335904|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335905|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335906|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
56335907|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56335908|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335909|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
56335910|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56335911|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
56335912|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56335913|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56335914|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335915|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335916|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56335917|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
56335919|NCT00068757|Trastuzumab|trastuzumab|mesh-list
56335920|NCT00068757|Lonafarnib|lonafarnib|mesh-list
56335921|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56335922|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335923|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
56335924|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
56335925|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
56335926|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335927|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56335928|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335930|NCT00206986|Analgesics|analgesics|mesh-ancestor
56335931|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
56335932|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56335934|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56335935|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
56335936|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
56335937|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56335938|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56335939|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56335940|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
56335941|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56335942|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335943|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56335944|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
56335945|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56335946|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56335947|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56335948|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56335949|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335950|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
56335951|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56335952|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56335953|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335954|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335955|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
56335956|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56335957|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56335958|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56335959|NCT00072852|Irinotecan|irinotecan|mesh-list
56335960|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56335961|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56335962|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335963|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335964|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335965|NCT00207532|Folic Acid|folic acid|mesh-list
56335966|NCT00207532|Hematinics|hematinics|mesh-ancestor
56335967|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
56650284|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55963606|NCT03940807|Estradiol|estradiol|mesh-list
56335968|NCT00207532|Vitamins|vitamins|mesh-ancestor
56335969|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
56335970|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335971|NCT00040391|Leucovorin|leucovorin|mesh-list
56335972|NCT00040391|Fluorouracil|fluorouracil|mesh-list
56335973|NCT00040391|Irinotecan|irinotecan|mesh-list
56335974|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
56335975|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335976|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56335977|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335978|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335979|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
56335980|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335981|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56335982|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56335983|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335984|NCT00040391|Antidotes|antidotes|mesh-ancestor
56335985|NCT00040391|Protective Agents|protective agents|mesh-ancestor
56335986|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
56335988|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
56335989|NCT00207688|Infliximab|infliximab|mesh-list
56335990|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
56335991|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56335992|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335993|NCT00207766|Infliximab|infliximab|mesh-list
56335994|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
56335995|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56335996|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56335997|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
56335998|NCT00040469|Busulfan|busulfan|mesh-list
56335999|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
56336000|NCT00040469|Phenytoin|phenytoin|mesh-list
56336001|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336002|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
56336003|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336004|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56336005|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56336006|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
56336007|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336008|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336009|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56336012|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56336013|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56336014|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336015|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56336016|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56336017|NCT00207844|Selenium|selenium|mesh-list
56336018|NCT00207844|Selenious Acid|selenious acid|mesh-list
56336019|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
56336020|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
56336021|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336022|NCT00207844|Protective Agents|protective agents|mesh-ancestor
56336023|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336024|NCT00207844|Trace Elements|trace elements|mesh-ancestor
56336025|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
56336026|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
56336027|NCT00072930|Prednisone|prednisone|mesh-list
56336028|NCT00072930|Docetaxel|docetaxel|mesh-list
56336029|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336030|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336031|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336032|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336033|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336034|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56336035|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
56336036|NCT00072930|Hormones|hormones|mesh-ancestor
56336037|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336038|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336039|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56336040|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56336041|NCT00411307|Hydromorphone|hydromorphone|mesh-list
56336042|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56336043|NCT00411307|Narcotics|narcotics|mesh-ancestor
56336044|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56650285|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56650286|NCT02655198|Fenfluramine|fenfluramine|mesh-list
56650287|NCT02655198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56650288|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56650289|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56650290|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650291|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650292|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
56296381|NCT00104845|Vaccines|vaccines|mesh-list
56336045|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336046|NCT00411307|Analgesics|analgesics|mesh-ancestor
56336047|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
56336048|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336050|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56336051|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336052|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56336053|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336054|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
56336055|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336056|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
56336057|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336058|NCT00424411|Insulin|insulin|mesh-list
56336059|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56336060|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336061|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336062|NCT00072969|Daclizumab|daclizumab|mesh-list
56336063|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336064|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
56336065|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336066|NCT00424606|Docetaxel|docetaxel|mesh-list
56336067|NCT00424606|Epirubicin|epirubicin|mesh-list
56336068|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336069|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336070|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336071|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336072|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336073|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56336074|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56336075|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56336076|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336077|NCT00208039|Calfactant|calfactant|mesh-list
56336078|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56336079|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
56336080|NCT02962921|Insulin|insulin|mesh-list
56336081|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56336082|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
56336083|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336084|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336085|NCT00040586|Interleukin-2|interleukin-2|mesh-list
56336090|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336091|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56336092|NCT00040586|Analgesics|analgesics|mesh-ancestor
56336093|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
56336094|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336095|NCT00208117|Sertraline|sertraline|mesh-list
56336096|NCT00208117|Simvastatin|simvastatin|mesh-list
56336097|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56336098|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56336099|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
56336100|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336101|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56336102|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56336103|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336104|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
56336105|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336106|NCT00208117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56336107|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56650293|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336108|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336109|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336110|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
56336111|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336112|NCT00208156|Mifepristone|mifepristone|mesh-list
56336113|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56336114|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
56336115|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56336116|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336117|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56336118|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56336119|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56336120|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
56336121|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56336122|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56336123|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
56336124|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336125|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
56336126|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56336127|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56336128|NCT00040625|Pemetrexed|pemetrexed|mesh-list
56336129|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336130|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336131|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336132|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56336133|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56336134|NCT00208195|Valproic Acid|valproic acid|mesh-list
56336135|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
56336136|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336137|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336138|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
56336139|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336140|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336141|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
56336142|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56336143|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336144|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336145|NCT00208234|Omalizumab|omalizumab|mesh-list
56336146|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56336147|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56336148|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56336149|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
56336150|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
56336151|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336152|NCT00208273|Letrozole|letrozole|mesh-list
56336153|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336154|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56336155|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56336156|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336159|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
56336160|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336161|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336163|NCT00208312|Regadenoson|regadenoson|mesh-list
56336164|NCT00208312|Analgesics|analgesics|mesh-ancestor
56336165|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
56336166|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336167|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336168|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56336169|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
56336170|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56336171|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
56336172|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
56336173|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336174|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336175|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56336176|NCT00040781|Gefitinib|gefitinib|mesh-list
56336177|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336178|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56336179|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336180|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336181|NCT00068952|Temozolomide|temozolomide|mesh-list
56650294|NCT00650052|Zonisamide|zonisamide|mesh-list
56650295|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
56650296|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56336182|NCT00068952|Carmustine|carmustine|mesh-list
56336183|NCT00068952|Lomustine|lomustine|mesh-list
56336184|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56336185|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
56336186|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336187|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336188|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
56336189|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336190|NCT00208546|Bevacizumab|bevacizumab|mesh-list
56336191|NCT00208546|Cetuximab|cetuximab|mesh-list
56336192|NCT00208546|Capecitabine|capecitabine|mesh-list
56336193|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
56336194|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56336195|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169748|NCT01273974|Vaccines|vaccines|mesh-list
56336196|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56336197|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56336198|NCT00208546|Growth Substances|growth substances|mesh-ancestor
56336199|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336200|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
56336201|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56336202|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
56336203|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336204|NCT00208585|Sertraline|sertraline|mesh-list
56336205|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
56336206|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336207|NCT00208585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56336208|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56336209|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336210|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336211|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336212|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
56336213|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336214|NCT00040859|Capecitabine|capecitabine|mesh-list
56336215|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
56336216|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56336217|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
56336218|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336219|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336220|NCT00208702|Sertraline|sertraline|mesh-list
56336221|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
56336222|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336223|NCT00208702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56336224|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56336225|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336226|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336228|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
56336229|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336230|NCT00208741|Tiagabine|tiagabine|mesh-list
56336231|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
55958052|NCT01811355|Mexiletine|mexiletine|mesh-list
56336232|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56336233|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56336234|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336235|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336237|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336238|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336239|NCT00399048|Hydromorphone|hydromorphone|mesh-list
56336240|NCT00399048|Oxycodone|oxycodone|mesh-list
56336241|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56336242|NCT00399048|Narcotics|narcotics|mesh-ancestor
56336243|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336244|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336245|NCT00399048|Analgesics|analgesics|mesh-ancestor
56336246|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
56336247|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336248|NCT00208819|Valproic Acid|valproic acid|mesh-list
56336249|NCT00208819|Olanzapine|olanzapine|mesh-list
56336250|NCT00208819|Risperidone|risperidone|mesh-list
56336251|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56336252|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56650297|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56650298|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336253|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
56336254|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336255|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336256|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336257|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56336258|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56336259|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336260|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336261|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56336262|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
56336263|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
56336264|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
56336265|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336266|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56336267|NCT00208819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56169749|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
56336268|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56336269|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336270|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
56336271|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
56336272|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336273|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
56336274|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
56336275|NCT00208858|Topiramate|topiramate|mesh-list
56336276|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
56336277|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336278|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336279|NCT00041015|Etoposide|etoposide|mesh-list
56336280|NCT00041015|Topotecan|topotecan|mesh-list
56336281|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336282|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56336283|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56336284|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56336285|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336286|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336287|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56336288|NCT00073047|Daclizumab|daclizumab|mesh-list
56336289|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336290|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
56336291|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336292|NCT00208897|Fluoxetine|fluoxetine|mesh-list
56336293|NCT00208897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56336294|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56336295|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336296|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336297|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336298|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
56336299|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336300|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56336303|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56336304|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56336305|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336306|NCT00208936|Fluorouracil|fluorouracil|mesh-list
56336307|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336308|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
56336309|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336310|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56336311|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336312|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
56336313|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336315|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336316|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
56336317|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336318|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
56336319|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56336320|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336321|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56336322|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56336323|NCT00209014|Growth Substances|growth substances|mesh-ancestor
56650299|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56650300|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650301|NCT00891527|Bevacizumab|bevacizumab|mesh-list
56650302|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
56336324|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
56336325|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336326|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
56336327|NCT00041054|Carboplatin|carboplatin|mesh-list
56336328|NCT00041054|Etoposide|etoposide|mesh-list
56336329|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336330|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56336331|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56336332|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56336333|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336334|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336335|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56336336|NCT00041054|Protective Agents|protective agents|mesh-ancestor
56336337|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336338|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56336339|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56336340|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56336341|NCT00041054|Analgesics|analgesics|mesh-ancestor
56336342|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
56336343|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336344|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56336345|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56336346|NCT00209209|Interferons|interferons|mesh-list
56336347|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
56336348|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
56336349|NCT00209209|Prednisone|prednisone|mesh-list
56336350|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
56336351|NCT00209209|Rituximab|rituximab|mesh-list
56336352|NCT00209209|Doxorubicin|doxorubicin|mesh-list
56336353|NCT00209209|Fludarabine|fludarabine|mesh-list
56336354|NCT00209209|Vincristine|vincristine|mesh-list
56336355|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336356|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
56336357|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336358|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56336359|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56336360|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
56336361|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336362|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336363|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56336364|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56336365|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56336366|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56336367|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56336368|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336369|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56336370|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
56336371|NCT00209209|Hormones|hormones|mesh-ancestor
56336372|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336373|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56336374|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
56336378|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336379|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
55958181|NCT01465178|Vitamin D|vitamin d|mesh-list
56336380|NCT00041093|Docetaxel|docetaxel|mesh-list
56336381|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336382|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336383|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336384|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336385|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336386|NCT00399087|Prednisone|prednisone|mesh-list
56336387|NCT00399087|Docetaxel|docetaxel|mesh-list
56336388|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336389|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336390|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336391|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336392|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336393|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56336394|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
56650303|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56650304|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336395|NCT00399087|Hormones|hormones|mesh-ancestor
56336396|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336397|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336398|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56336399|NCT00209482|Metformin|metformin|mesh-list
56336400|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336401|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336402|NCT00041171|Docetaxel|docetaxel|mesh-list
56336403|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336404|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336405|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336406|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336407|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336408|NCT00209521|Propofol|propofol|mesh-list
56336409|NCT00209521|Fospropofol|fospropofol|mesh-list
56336410|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56336411|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336412|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336413|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56336414|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
56336415|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
56336416|NCT00209599|Fospropofol|fospropofol|mesh-list
56336417|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56336418|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336419|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336420|NCT00209638|Irinotecan|irinotecan|mesh-list
56336421|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56336422|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56336423|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336424|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336425|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336426|NCT00399126|Paclitaxel|paclitaxel|mesh-list
56336427|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56336428|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336429|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336430|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336431|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336432|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336433|NCT00209677|Gemcitabine|gemcitabine|mesh-list
56336434|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56336435|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
56336436|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336437|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336438|NCT00209677|Antiviral Agents|antiviral agents|mesh-ancestor
56336439|NCT00209677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336440|NCT00209677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336441|NCT00209677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336443|NCT00209677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336444|NCT00209716|Cisplatin|cisplatin|mesh-list
56336445|NCT00209716|Docetaxel|docetaxel|mesh-list
56336446|NCT00209716|Fluorouracil|fluorouracil|mesh-list
56336447|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336449|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336450|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336451|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336452|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
56336453|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56336454|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336455|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
56336456|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958235|NCT02193191|Plerixafor|plerixafor|mesh-list
56336458|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
56336459|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336460|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
56336461|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336462|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
56336463|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
56336464|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56336465|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
56336466|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56336467|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56650305|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56650306|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56650307|NCT00891527|Growth Substances|growth substances|mesh-ancestor
55964096|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
56336468|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336469|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56336470|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336471|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336472|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56336473|NCT00209794|Renal Agents|renal agents|mesh-ancestor
56336474|NCT00209833|Cytarabine|cytarabine|mesh-list
56336475|NCT00209833|Fludarabine|fludarabine|mesh-list
56336476|NCT00209833|Etoposide|etoposide|mesh-list
56336477|NCT00209833|Idarubicin|idarubicin|mesh-list
56336478|NCT00209833|Daunorubicin|daunorubicin|mesh-list
56336479|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336480|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56336481|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
56336482|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336483|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336484|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
56336485|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336486|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56336487|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56336488|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56336489|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336490|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
56336491|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336492|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56336493|NCT00041210|Prednisone|prednisone|mesh-list
56336494|NCT00041210|Doxorubicin|doxorubicin|mesh-list
56336495|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56336496|NCT00041210|Bleomycin|bleomycin|mesh-list
56336497|NCT00041210|Etoposide|etoposide|mesh-list
56336498|NCT00041210|Vincristine|vincristine|mesh-list
56336499|NCT00041210|Dacarbazine|dacarbazine|mesh-list
56336500|NCT00041210|Vinblastine|vinblastine|mesh-list
56336501|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
56336502|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56336503|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336504|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56336505|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56336506|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336507|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336508|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56336509|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
56336510|NCT00041210|Hormones|hormones|mesh-ancestor
56336511|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336512|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336513|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56336514|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56336515|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336516|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336517|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336518|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56336519|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
56336520|NCT00209872|Lidocaine|lidocaine|mesh-list
56336521|NCT00209872|Ketamine|ketamine|mesh-list
56336522|NCT00209872|Gabapentin|gabapentin|mesh-list
56336523|NCT00209872|Esketamine|esketamine|mesh-list
56336524|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
56336526|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336527|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336528|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
56336529|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336530|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56336531|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56336532|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56336533|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336534|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336536|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56336537|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56650308|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650309|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
56336538|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
56336539|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56336540|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56336541|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336542|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
56336543|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56336544|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56336545|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336546|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
56336547|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
56336548|NCT00209950|Gaboxadol|gaboxadol|mesh-list
56336549|NCT00209950|Analgesics|analgesics|mesh-ancestor
56336550|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
56336551|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336552|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336553|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
56336554|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
56336555|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
56336556|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336557|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336558|NCT00209989|Tipifarnib|tipifarnib|mesh-list
56336559|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336560|NCT00210028|Tamoxifen|tamoxifen|mesh-list
56336561|NCT00210028|Tipifarnib|tipifarnib|mesh-list
56336562|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56336563|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
56336564|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336565|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336566|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56336567|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336568|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56336569|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56336570|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56336571|NCT00041288|Cyclosporine|cyclosporine|mesh-list
56336572|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
56336573|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
56336574|NCT00041288|Methotrexate|methotrexate|mesh-list
56336575|NCT00041288|Fludarabine|fludarabine|mesh-list
56336576|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
56336577|NCT00041288|Tacrolimus|tacrolimus|mesh-list
56336578|NCT00041288|Cyclosporins|cyclosporins|mesh-list
56336579|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336580|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
56336581|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336582|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56336583|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56336584|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
56336585|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336586|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336587|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56336588|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56336589|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
56336590|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56336591|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56336592|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
56336593|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
56336594|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336595|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56336596|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56336597|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56336598|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
56336599|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336601|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56336602|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
56336603|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56336604|NCT00073164|Valproic Acid|valproic acid|mesh-list
56336606|NCT00073164|Risperidone|risperidone|mesh-list
56336607|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56336608|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
56336609|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336610|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336611|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650310|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56650311|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650312|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650313|NCT04246229|Bilirubin|bilirubin|mesh-list
56650314|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
56650315|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650316|NCT04246229|Protective Agents|protective agents|mesh-ancestor
55964265|NCT03340675|Ifetroban|ifetroban|mesh-list
56336612|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56336613|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56336614|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336615|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336616|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56336617|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
56336619|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
56336620|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336621|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56336622|NCT00073164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56336623|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56336624|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336625|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
56336626|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336627|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
56336628|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
56336629|NCT00210301|Modafinil|modafinil|mesh-list
56336630|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56336631|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336632|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56336633|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56336634|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56336635|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336636|NCT00210340|Rituximab|rituximab|mesh-list
56336637|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56336638|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336639|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
56336640|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336641|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56336642|NCT00411541|Dexamethasone|dexamethasone|mesh-list
56336643|NCT00411541|Vincristine|vincristine|mesh-list
56336644|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56336645|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
56336646|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
56336647|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336648|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336649|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56336650|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
56336651|NCT00411541|Hormones|hormones|mesh-ancestor
56336652|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336653|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56336654|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336655|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56336656|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336657|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336658|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336659|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336660|NCT00210379|Rituximab|rituximab|mesh-list
56336661|NCT00210379|Methotrexate|methotrexate|mesh-list
56336662|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56336663|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336664|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
56336665|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336666|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56336667|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56336668|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
56336669|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56336670|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56650317|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650318|NCT03861078|Nicotine|nicotine|mesh-list
56650319|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56650320|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
56650321|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650322|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650323|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56650324|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56650325|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
56650326|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650327|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650328|NCT03845166|Atezolizumab|atezolizumab|mesh-list
56650329|NCT03845166|Avelumab|avelumab|mesh-list
56650330|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650331|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56650332|NCT02829359|Entecavir|entecavir|mesh-list
56650333|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
56650334|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650335|NCT02650752|Capecitabine|capecitabine|mesh-list
56650336|NCT02650752|Lapatinib|lapatinib|mesh-list
56650337|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56336671|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
56336672|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336673|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
56336675|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56336676|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336677|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56336678|NCT00041327|Interferons|interferons|mesh-list
56336679|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
56336680|NCT00041327|Lamivudine|lamivudine|mesh-list
56336681|NCT00041327|Zidovudine|zidovudine|mesh-list
56336682|NCT00041327|Prednisone|prednisone|mesh-list
56336683|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
56336684|NCT00041327|Doxorubicin|doxorubicin|mesh-list
56336686|NCT00041327|Etoposide|etoposide|mesh-list
56336687|NCT00041327|Vincristine|vincristine|mesh-list
56336688|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56336689|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
56336690|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336691|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56336692|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56336693|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
56336694|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336695|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336696|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56336697|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56336698|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56336699|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56336700|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336701|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56336702|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
56336703|NCT00041327|Hormones|hormones|mesh-ancestor
56336704|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336705|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56336706|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56336707|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
56336708|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650338|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
56650339|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650340|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964360|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
56336709|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336710|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336711|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336712|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56169833|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336713|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56336714|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56336715|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56336716|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
56336718|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336719|NCT00210496|Topiramate|topiramate|mesh-list
56336720|NCT00210496|Almotriptan|almotriptan|mesh-list
56336721|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
56336722|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336723|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336724|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56336725|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
56336726|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336727|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336728|NCT00210535|Topiramate|topiramate|mesh-list
56336729|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
56336730|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336731|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336732|NCT00210574|Topiramate|topiramate|mesh-list
56336733|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
56336734|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336735|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336736|NCT00210691|Risperidone|risperidone|mesh-list
56336737|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56336738|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
56336739|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336740|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336741|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336742|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56336743|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56336744|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336745|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336746|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56336747|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
56336748|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
56336749|NCT00210730|Hematinics|hematinics|mesh-ancestor
56336750|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56336751|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56336754|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336755|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336756|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56336757|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56336758|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
55958533|NCT01898507|Nicotine|nicotine|mesh-list
56336759|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336760|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336761|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56336762|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56336763|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
56336764|NCT00210808|Topiramate|topiramate|mesh-list
56336765|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
56336766|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336767|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336768|NCT00210847|Acetaminophen|acetaminophen|mesh-list
56336769|NCT00210847|Tramadol|tramadol|mesh-list
56336770|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56336771|NCT00210847|Analgesics|analgesics|mesh-ancestor
56336772|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
56169836|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
56336773|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336774|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336775|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
56336776|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56336777|NCT00210847|Narcotics|narcotics|mesh-ancestor
56116853|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650341|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56650342|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650343|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
56650344|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56213481|NCT03136731|Antibodies|antibodies|mesh-list
56336778|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336779|NCT00210886|Levofloxacin|levofloxacin|mesh-list
56336780|NCT00210886|Ofloxacin|ofloxacin|mesh-list
56336781|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56336782|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336783|NCT00210886|Renal Agents|renal agents|mesh-ancestor
56336784|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56336785|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56336786|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56336787|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336788|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336789|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336790|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56336791|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56336792|NCT00210925|Topiramate|topiramate|mesh-list
56336793|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
56336794|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336795|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336796|NCT00211003|Doripenem|doripenem|mesh-list
56336797|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56336798|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336799|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
56336800|NCT00211120|Hematinics|hematinics|mesh-ancestor
56336801|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
56336802|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336803|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
56336804|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336805|NCT00211315|Anecortave|anecortave|mesh-list
56336806|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56336807|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56336808|NCT00211315|Growth Substances|growth substances|mesh-ancestor
56336809|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336810|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
56336811|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336812|NCT00211354|Anecortave|anecortave|mesh-list
56336813|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56336814|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56336815|NCT00211354|Growth Substances|growth substances|mesh-ancestor
56336816|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336817|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
56336818|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336819|NCT00211393|Ketoconazole|ketoconazole|mesh-list
56336820|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
56336821|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336822|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56336823|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56336824|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336826|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56336827|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
56336828|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336829|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336830|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56336831|NCT00211432|Anecortave|anecortave|mesh-list
56336832|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56336833|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56336834|NCT00211432|Growth Substances|growth substances|mesh-ancestor
56336835|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169851|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56336837|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336838|NCT00211471|Anecortave|anecortave|mesh-list
56336839|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56336840|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56336841|NCT00211471|Growth Substances|growth substances|mesh-ancestor
56336842|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336843|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
56336844|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336845|NCT00211588|Galantamine|galantamine|mesh-list
56650345|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56650346|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
56650347|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56650348|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55964523|NCT00504751|Rituximab|rituximab|mesh-list
56336846|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56336847|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336848|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336849|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
56336850|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336851|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336852|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56336853|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
56336854|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336855|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
56336856|NCT00211705|Pravastatin|pravastatin|mesh-list
56336857|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56336858|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56336859|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
56336860|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336861|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56336862|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56336863|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336864|NCT00211744|Topiramate|topiramate|mesh-list
56336865|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
56336866|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336867|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336868|NCT00211939|Atorvastatin|atorvastatin|mesh-list
56336869|NCT00211939|Calcium|calcium|mesh-list
56336870|NCT00211939|Sevelamer|sevelamer|mesh-list
56336871|NCT00211939|Calcium acetate|calcium acetate|mesh-list
56336872|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56336873|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336874|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56336875|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56336876|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
56336877|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336878|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56336879|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56336880|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336881|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
56336882|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
56336883|NCT00211978|Calcium|calcium|mesh-list
56336884|NCT00211978|Calcium acetate|calcium acetate|mesh-list
56336885|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56336886|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336887|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
56336888|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
56336889|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336890|NCT00212017|Voglibose|voglibose|mesh-list
56336891|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336892|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336893|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56336895|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336896|NCT00212095|Ketoconazole|ketoconazole|mesh-list
56336897|NCT00212095|Docetaxel|docetaxel|mesh-list
56336898|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336901|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
56336902|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336903|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
56336904|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336905|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56336906|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56336907|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336908|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56336909|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
56336910|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336911|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336912|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56650349|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650350|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
56650351|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336914|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
56336915|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336916|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
56336917|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56336918|NCT00212212|Selenium|selenium|mesh-list
56336919|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
56336920|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336921|NCT00212212|Protective Agents|protective agents|mesh-ancestor
56336922|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336923|NCT00212212|Trace Elements|trace elements|mesh-ancestor
56336924|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
56336925|NCT00212290|Pioglitazone|pioglitazone|mesh-list
56336926|NCT00212290|Nateglinide|nateglinide|mesh-list
56336927|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336928|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336929|NCT00073203|Paroxetine|paroxetine|mesh-list
56336930|NCT00073203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56336931|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56336932|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56336933|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336934|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336935|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
56336936|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336937|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56336938|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
56336939|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336940|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56336941|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56336942|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336943|NCT00411736|Azithromycin|azithromycin|mesh-list
56336944|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56336945|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336946|NCT00212602|Aprepitant|aprepitant|mesh-list
56336947|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
56336948|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
56336949|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
56336950|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56336951|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336952|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56336953|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56336954|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336955|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336956|NCT00212680|Landiolol|landiolol|mesh-list
56336957|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56336958|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56336959|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
56336960|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336961|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336962|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336963|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56336964|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
56336965|NCT00212875|Hematinics|hematinics|mesh-ancestor
56336966|NCT00213070|Miglitol|miglitol|mesh-list
56336967|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336968|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336969|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336970|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336971|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56336973|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336974|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336975|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56336976|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336977|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56336978|NCT00213226|Dexamethasone|dexamethasone|mesh-list
56336979|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56336980|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
56336981|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
56336982|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958757|NCT00218465|Glycine|glycine|mesh-list
56336983|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336984|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56336985|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
56336986|NCT00213226|Hormones|hormones|mesh-ancestor
56336987|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56336988|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56336989|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56336990|NCT00213265|Vaccines|vaccines|mesh-list
56336991|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56336992|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
56336993|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336994|NCT00213538|Methotrexate|methotrexate|mesh-list
56336995|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56336996|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56336997|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
56336998|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56336999|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337000|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337001|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
56337002|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337003|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337004|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
56337005|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337006|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56337007|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56337008|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
56337009|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56337010|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56337011|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
56337012|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56337013|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56337014|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337015|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
56337016|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337017|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337018|NCT00213694|Celecoxib|celecoxib|mesh-list
56337019|NCT00213694|Docetaxel|docetaxel|mesh-list
56337020|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337021|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
56337022|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
56337023|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
56337024|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337025|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56337026|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56337028|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
56337029|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337030|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337031|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56337032|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56337033|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56337034|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56337035|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337036|NCT00214084|Allopurinol|allopurinol|mesh-list
56337037|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
56337038|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337039|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337040|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
56337041|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56337042|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56337043|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
56337044|NCT00214084|Protective Agents|protective agents|mesh-ancestor
56337048|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
56337049|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56337050|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56337051|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
56337052|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337053|NCT00214318|Metoprolol|metoprolol|mesh-list
56337054|NCT00214318|Carvedilol|carvedilol|mesh-list
56337055|NCT00214318|Terbutaline|terbutaline|mesh-list
56337056|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56337057|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56337058|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
56337059|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
56337060|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650352|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650353|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56650354|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
56650355|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
56650356|NCT02832713|Protective Agents|protective agents|mesh-ancestor
56213490|NCT02939573|Colchicine|colchicine|mesh-list
56337061|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337062|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56337063|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56337064|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56337065|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
56337066|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337067|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337068|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
56337069|NCT00214318|Protective Agents|protective agents|mesh-ancestor
56337070|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56337071|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56337072|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56337073|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
56337074|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56337075|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56337076|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56337077|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56337078|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
56337079|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
56337080|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
56337081|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56337082|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56337083|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56337084|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56337085|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56337086|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
56337087|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337088|NCT00214552|Rabeprazole|rabeprazole|mesh-list
56337089|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56337090|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56337091|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56337092|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337093|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337094|NCT00069459|Bupropion|bupropion|mesh-list
56337095|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55991229|NCT03078946|Midazolam|midazolam|mesh-list
56337096|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
56337097|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337098|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56337099|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56337100|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56337101|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337102|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
56337103|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337104|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337105|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56337106|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56337107|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337108|NCT00214630|Atorvastatin|atorvastatin|mesh-list
56337109|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56337110|NCT00214630|Calcium|calcium|mesh-list
56337111|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56337112|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337113|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56337114|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56337115|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
56337116|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337118|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56337119|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337120|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56337121|NCT00214825|Eplerenone|eplerenone|mesh-list
56116854|NCT04928261|Trastuzumab|trastuzumab|mesh-list
56650357|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56650358|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337122|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56337123|NCT00214825|Diuretics|diuretics|mesh-ancestor
56337124|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
56337125|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337126|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56337127|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56337128|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337129|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56337130|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
56337131|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56337132|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56337134|NCT00214864|Capecitabine|capecitabine|mesh-list
56337135|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337136|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
56337137|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
56337138|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
56337139|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337140|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337141|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
56337142|NCT00214942|Fentanyl|fentanyl|mesh-list
56337143|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56337145|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337146|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337147|NCT00214942|Analgesics|analgesics|mesh-ancestor
56337148|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
56337149|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337150|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56337151|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56337152|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
56337153|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
56337154|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56337155|NCT00069498|Mesalamine|mesalamine|mesh-list
56337156|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
56337157|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56337158|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337159|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56337160|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56337161|NCT00069498|Analgesics|analgesics|mesh-ancestor
56337162|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
56337163|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337164|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337165|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56337166|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56337167|NCT00214981|Modafinil|modafinil|mesh-list
56337168|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56337169|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337170|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56337171|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56337172|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56337173|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337174|NCT00397241|Timolol|timolol|mesh-list
56337175|NCT00397241|Dorzolamide|dorzolamide|mesh-list
56337176|NCT00397241|Latanoprost|latanoprost|mesh-list
56337177|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
56337178|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56337179|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56337180|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
56337181|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337182|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337183|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337184|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56337185|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56337186|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56337187|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56337188|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56337189|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337191|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56337192|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56337193|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337194|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337195|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337196|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56337197|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56337198|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
56337199|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337200|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337201|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56337202|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56337203|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
56337205|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56337206|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337207|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56337208|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56337209|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56337210|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337211|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56337212|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
56337213|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337214|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56337215|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56337216|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337217|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337218|NCT00041483|Anecortave|anecortave|mesh-list
56337219|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56337220|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56337221|NCT00041483|Growth Substances|growth substances|mesh-ancestor
56337222|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337223|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
56337224|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337225|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
56337226|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56337227|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
56337228|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337229|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337230|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56337231|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
56337232|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56337233|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56337234|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56337235|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56337236|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337237|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337238|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
56337239|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56337240|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
56337241|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337242|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337243|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56337244|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
56337245|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56337246|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56337247|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56337248|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
56337249|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337250|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337251|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
56337252|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56337253|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
56337254|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337255|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337256|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56337257|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
56337258|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56337259|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56337260|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56337264|NCT00215722|Cetuximab|cetuximab|mesh-list
56337265|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56337266|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337267|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56337268|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
56337269|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650359|NCT02832635|Temozolomide|temozolomide|mesh-list
56213496|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
56337270|NCT00215839|Ribavirin|ribavirin|mesh-list
56337271|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
56337272|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337273|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
56337274|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337275|NCT00215956|Topotecan|topotecan|mesh-list
56337276|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56337277|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56337278|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337279|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337280|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337281|NCT00215995|Cisplatin|cisplatin|mesh-list
56337282|NCT00215995|Irinotecan|irinotecan|mesh-list
56337283|NCT00215995|Gefitinib|gefitinib|mesh-list
56337284|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337285|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56337286|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56337287|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337288|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337289|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56337290|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
56337291|NCT00216034|Tegafur|tegafur|mesh-list
56337292|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337293|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
56337294|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337295|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337296|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56337297|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
56337298|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337299|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56337300|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
56337301|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337302|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
56337303|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56337304|NCT00216034|Protective Agents|protective agents|mesh-ancestor
56337305|NCT00216073|Capecitabine|capecitabine|mesh-list
56337306|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
56337307|NCT00216073|Trastuzumab|trastuzumab|mesh-list
56337308|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337309|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
56337310|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337311|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337312|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56337313|NCT00216112|Docetaxel|docetaxel|mesh-list
56337314|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
55991231|NCT03078946|Morphine|morphine|mesh-list
56337315|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337316|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
56337317|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
56337318|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
56337319|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337320|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56337321|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337322|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
56337323|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56337324|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337325|NCT00216190|Midazolam|midazolam|mesh-list
56337326|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
56337327|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56337328|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337329|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337330|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56337331|NCT00216190|Analgesics|analgesics|mesh-ancestor
56337332|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
56337334|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56337335|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56337336|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56337337|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
56337338|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337339|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337340|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56337341|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56650360|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56337342|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56337343|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337344|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56337345|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
56337346|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
56337347|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
56337348|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
56337349|NCT00216268|Ribavirin|ribavirin|mesh-list
56337350|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
56337351|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337352|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
56337353|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337354|NCT00216346|Amphotericin B|amphotericin b|mesh-list
56337355|NCT00216346|Paromomycin|paromomycin|mesh-list
56337356|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56337357|NCT00216346|Amebicides|amebicides|mesh-ancestor
56337358|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56337359|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56337360|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337361|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56337362|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
56337363|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
56337364|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56337365|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337366|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56337367|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56337368|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56337369|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56337370|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337371|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337372|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337373|NCT00216424|Capecitabine|capecitabine|mesh-list
56337374|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337375|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
56337376|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337377|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337378|NCT00216463|Mipomersen|mipomersen|mesh-list
56337379|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56337380|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56337381|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
56337382|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337383|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56337384|NCT00216502|Galantamine|galantamine|mesh-list
56337385|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56337386|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337387|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337388|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
56337389|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337390|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337391|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56337392|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
56337393|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337394|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
56337395|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
56337396|NCT00216541|Hematinics|hematinics|mesh-ancestor
56337397|NCT00216580|Risperidone|risperidone|mesh-list
56337398|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56337399|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
56337400|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337401|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337402|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337403|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56337404|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56337405|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337406|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337407|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56337425|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
56337426|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56337427|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959218|NCT04871061|Fentanyl|fentanyl|mesh-list
56337428|NCT00216658|Fentanyl|fentanyl|mesh-list
56337429|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56337430|NCT00216658|Narcotics|narcotics|mesh-ancestor
56337431|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337432|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650361|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
56650362|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965142|NCT02985554|Nivolumab|nivolumab|mesh-list
56337433|NCT00216658|Analgesics|analgesics|mesh-ancestor
56337434|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
56337435|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337436|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56337437|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56337438|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
56337439|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
56337440|NCT00216697|Bortezomib|bortezomib|mesh-list
56337441|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337442|NCT00216775|Interferons|interferons|mesh-list
56337443|NCT00216775|Ribavirin|ribavirin|mesh-list
56337444|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
56337445|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
56337446|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337447|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
56337448|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337449|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
56337450|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337451|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
56337452|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337453|NCT00041639|Labetuzumab|labetuzumab|mesh-list
56337454|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56337455|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337456|NCT00216892|Betamethasone|betamethasone|mesh-list
56337457|NCT00216892|Calcipotriene|calcipotriene|mesh-list
56337458|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56337459|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
56337460|NCT00216892|Hormones|hormones|mesh-ancestor
56337461|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56337462|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337463|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56337464|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
56337465|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
56337467|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56337468|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
56337469|NCT00217009|Furocoumarins|furocoumarins|mesh-list
56337473|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
56337474|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
56337475|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337476|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337477|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56337478|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56337479|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56337480|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56337481|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337482|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337483|NCT00217048|Urological Agents|urological agents|mesh-ancestor
56337484|NCT00217204|Pancrelipase|pancrelipase|mesh-list
56337485|NCT00217204|Pancreatin|pancreatin|mesh-list
56337486|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56337487|NCT00412126|Insulin|insulin|mesh-list
56337488|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56337489|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337490|NCT00412204|Bromides|bromides|mesh-list
56337491|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
56337492|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56337493|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
56337494|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337495|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337496|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56337497|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
56337498|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
56337499|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56337500|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
56337501|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337502|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337503|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
56337504|NCT00041678|Aripiprazole|aripiprazole|mesh-list
56337505|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
56337506|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337507|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56650363|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650364|NCT00650598|Diclofenac|diclofenac|mesh-list
56650365|NCT00650598|Valdecoxib|valdecoxib|mesh-list
55790151|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
56337508|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56337509|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337510|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337511|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
56337512|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
56337513|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337514|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337515|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56337516|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56337517|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
56337518|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56337519|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56337520|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56337521|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56337522|NCT00217243|Lidocaine|lidocaine|mesh-list
56337523|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
56337524|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
56337525|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337526|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337527|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
56337528|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337529|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56337530|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56337531|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56337532|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56337533|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337534|NCT00217282|Gemcitabine|gemcitabine|mesh-list
56337535|NCT00217282|Bevacizumab|bevacizumab|mesh-list
56337536|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
56337537|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56337538|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337539|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56337540|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56337541|NCT00217282|Growth Substances|growth substances|mesh-ancestor
56337544|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337545|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
56337546|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337547|NCT00217282|Antiviral Agents|antiviral agents|mesh-ancestor
56337548|NCT00217282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337549|NCT00217282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337550|NCT00217282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56337551|NCT00217282|Immunologic Factors|immunologic factors|mesh-ancestor
56337552|NCT00217477|Gemcitabine|gemcitabine|mesh-list
56337553|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337554|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
56337555|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337556|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337557|NCT00217477|Antiviral Agents|antiviral agents|mesh-ancestor
56337558|NCT00217477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337559|NCT00217477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337560|NCT00217477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56337561|NCT00217477|Immunologic Factors|immunologic factors|mesh-ancestor
56337562|NCT00217477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337563|NCT00217516|Selenium|selenium|mesh-list
56337564|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
56337565|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337566|NCT00217516|Protective Agents|protective agents|mesh-ancestor
56337567|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337568|NCT00217516|Trace Elements|trace elements|mesh-ancestor
56337569|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
56337570|NCT00217555|Gemcitabine|gemcitabine|mesh-list
56337571|NCT00217555|Topotecan|topotecan|mesh-list
56337572|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337573|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
56337574|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337575|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337576|NCT00217555|Antiviral Agents|antiviral agents|mesh-ancestor
56650366|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56650367|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56650368|NCT00650598|Analgesics|analgesics|mesh-ancestor
56650369|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
56650370|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337577|NCT00217555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337578|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959360|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56337579|NCT00217555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56337580|NCT00217555|Immunologic Factors|immunologic factors|mesh-ancestor
56337581|NCT00217555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337582|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56337583|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56337584|NCT00217711|Capecitabine|capecitabine|mesh-list
56337585|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
56337586|NCT00217711|Irinotecan|irinotecan|mesh-list
56337587|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337588|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
56337589|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337590|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337591|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56337592|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56337593|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337594|NCT00217789|Dimercaprol|dimercaprol|mesh-list
56337595|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
56337596|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
56337597|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337598|NCT00217828|Citalopram|citalopram|mesh-list
56337599|NCT00217828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56337600|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56337601|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56337602|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337603|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337604|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
56337605|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337606|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56337607|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
56337608|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337609|NCT00041990|Decitabine|decitabine|mesh-list
56337610|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337611|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
55991233|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169966|NCT00249444|Mirtazapine|mirtazapine|mesh-list
56337612|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337613|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337616|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
56337617|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56337618|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56337619|NCT00218101|Buprenorphine|buprenorphine|mesh-list
56337620|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56337621|NCT00218101|Narcotics|narcotics|mesh-ancestor
56337622|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337623|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337624|NCT00218101|Analgesics|analgesics|mesh-ancestor
56337625|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
56337626|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337627|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56337628|NCT00218140|Nicotine|nicotine|mesh-list
56337629|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56337630|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
56337631|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337632|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337633|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56337634|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56337635|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
56337636|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337637|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337638|NCT00042029|Aprepitant|aprepitant|mesh-list
56337639|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
56337640|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
56650371|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650372|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650373|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650374|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56650375|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650376|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650377|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56650378|NCT00620204|Atorvastatin|atorvastatin|mesh-list
56337641|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337642|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337643|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56337644|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56337645|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337646|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337647|NCT00218218|Nicotine|nicotine|mesh-list
56337648|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56337649|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
56337650|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337651|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959434|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337652|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56337653|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56337654|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
56337655|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337656|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337657|NCT00218374|Gabapentin|gabapentin|mesh-list
56337658|NCT00218374|Analgesics|analgesics|mesh-ancestor
56337659|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
56337660|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337661|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337662|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
56337663|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56337664|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56337665|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337666|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337667|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56337668|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56337669|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337670|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337671|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
56337672|NCT00218413|Vaccines|vaccines|mesh-list
56337673|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
56337674|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337675|NCT00042068|Meloxicam|meloxicam|mesh-list
56337676|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56337677|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56337678|NCT00042068|Analgesics|analgesics|mesh-ancestor
56337679|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
56337680|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337681|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337682|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56337683|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56337684|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56337685|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56337689|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56337690|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56337691|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337692|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
56337693|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337694|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56337695|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56337696|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56337697|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
56337698|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650379|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56337699|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337700|NCT00218569|Naltrexone|naltrexone|mesh-list
56337701|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56337702|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56337703|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337704|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
56337705|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337706|NCT00218608|Disulfiram|disulfiram|mesh-list
56337707|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56337708|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56337709|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337710|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337711|NCT00042146|Zolpidem|zolpidem|mesh-list
56337712|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56337713|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56337714|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337715|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337716|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56337717|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
56337718|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
56337719|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337720|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337721|NCT00412321|Siltuximab|siltuximab|mesh-list
56337722|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337723|NCT00219232|Rivastigmine|rivastigmine|mesh-list
56337724|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56337725|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337726|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337727|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
56337728|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337729|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337730|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56337731|NCT00219232|Protective Agents|protective agents|mesh-ancestor
56337732|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
56337733|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56337734|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337735|NCT00219310|Famciclovir|famciclovir|mesh-list
56337736|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
56337737|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337738|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56337739|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337740|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337741|NCT00219388|Simendan|simendan|mesh-list
56337742|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56337743|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
56169986|NCT00249288|Folic Acid|folic acid|mesh-list
56337744|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56337745|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56337746|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337747|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337748|NCT00219388|Protective Agents|protective agents|mesh-ancestor
56337749|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337750|NCT00219466|Zinc|zinc|mesh-list
56337751|NCT00219466|Tocopherols|tocopherols|mesh-list
56337752|NCT00219466|Vitamin E|vitamin e|mesh-list
56337753|NCT00219466|Tocotrienols|tocotrienols|mesh-list
56337754|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
56337755|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
56337756|NCT00219466|Trace Elements|trace elements|mesh-ancestor
56337757|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
56337758|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337761|NCT00219466|Protective Agents|protective agents|mesh-ancestor
56337762|NCT00219466|Vitamins|vitamins|mesh-ancestor
56337763|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
56337764|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
56337765|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56337766|NCT00042302|Paclitaxel|paclitaxel|mesh-list
56337767|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56337768|NCT00042302|Carboplatin|carboplatin|mesh-list
56337769|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56337770|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337771|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
56337772|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
56337773|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
56268995|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56650380|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56650381|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
56337774|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337775|NCT00219700|Ibuprofen|ibuprofen|mesh-list
56337776|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56337777|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56337778|NCT00219700|Analgesics|analgesics|mesh-ancestor
56337779|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
56337780|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337781|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337782|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56337783|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56337784|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56337785|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337786|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337787|NCT00219739|Interferons|interferons|mesh-list
56337788|NCT00219739|Cytarabine|cytarabine|mesh-list
56337789|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
56337790|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337791|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
56337792|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337793|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337794|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
56337795|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337796|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56337797|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
56337798|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337799|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56337800|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337801|NCT00219778|Mifepristone|mifepristone|mesh-list
56337802|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56337803|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
56337804|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56337805|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337806|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56337807|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56337808|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56337809|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
56337810|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56337811|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56337812|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
56337813|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56337814|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
56337815|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56337816|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56337818|NCT00219856|Desflurane|desflurane|mesh-list
56337819|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56337820|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337821|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337822|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56337823|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
56337824|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
56337825|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56337826|NCT00042458|Pramlintide|pramlintide|mesh-list
56337827|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56337828|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337829|NCT00219895|Ibuprofen|ibuprofen|mesh-list
56337830|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56337831|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56337832|NCT00219895|Analgesics|analgesics|mesh-ancestor
56337833|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
56337835|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337836|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56337837|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56337838|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56337839|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337840|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337841|NCT00077337|Romidepsin|romidepsin|mesh-list
56337842|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56337843|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337844|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56337845|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
56650382|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965602|NCT04192292|Gliclazide|gliclazide|mesh-list
56337846|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337847|NCT00219973|Bemiparin|bemiparin|mesh-list
56337848|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
56337849|NCT00220051|Capecitabine|capecitabine|mesh-list
56337850|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
56337851|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337852|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
56337853|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337854|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337855|NCT00077415|Gemcitabine|gemcitabine|mesh-list
56337856|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337857|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
56337858|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337859|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337860|NCT00077415|Antiviral Agents|antiviral agents|mesh-ancestor
56337861|NCT00077415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337862|NCT00077415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337863|NCT00077415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56337864|NCT00077415|Immunologic Factors|immunologic factors|mesh-ancestor
56337865|NCT00077415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337866|NCT00042536|Naltrexone|naltrexone|mesh-list
56337867|NCT00042536|Yohimbine|yohimbine|mesh-list
56337868|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56337869|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56337870|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337871|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
56337872|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337873|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
56337874|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
56337875|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56337876|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56337877|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56337878|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
56337879|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337880|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337881|NCT00042536|Urological Agents|urological agents|mesh-ancestor
56337882|NCT00220129|Capecitabine|capecitabine|mesh-list
56337883|NCT00220129|Epirubicin|epirubicin|mesh-list
56337884|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337885|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337886|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
56337887|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337888|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56337889|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56337890|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56337891|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337892|NCT00220168|Capecitabine|capecitabine|mesh-list
56337893|NCT00220168|Irinotecan|irinotecan|mesh-list
56337894|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56337895|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
56337896|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337897|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337898|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56337899|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56337900|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337901|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56337902|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56337903|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56337904|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56337905|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337906|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337915|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
56337916|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337917|NCT00077454|Temozolomide|temozolomide|mesh-list
56337918|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56337919|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56337920|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
56337921|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337922|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337923|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56650383|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56213518|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337924|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337925|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56337926|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56337927|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56337928|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56337929|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
56337930|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56337931|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337932|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56337933|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56337934|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56337935|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56337936|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56337937|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56337938|NCT00412555|Oseltamivir|oseltamivir|mesh-list
56337939|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
56337940|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337941|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337942|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337943|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
56337944|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56337946|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56337947|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337948|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56337949|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
56337950|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56337951|NCT00073593|Heparin|heparin|mesh-list
56337952|NCT00073593|Bivalirudin|bivalirudin|mesh-list
56337953|NCT00073593|Protamines|protamines|mesh-list
56337954|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
56337955|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56337956|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56337957|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337958|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
56337959|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56337960|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
56337961|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337962|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
56337963|NCT00073593|Coagulants|coagulants|mesh-ancestor
56337964|NCT00220480|Citalopram|citalopram|mesh-list
56337965|NCT00220480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56337966|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56337967|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56337968|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337969|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337970|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
56337971|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337972|NCT00220480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56337975|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
56337976|NCT00220675|Hematinics|hematinics|mesh-ancestor
56337977|NCT00042731|Lycopene|lycopene|mesh-list
56337978|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56337979|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
56337980|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337981|NCT00042731|Protective Agents|protective agents|mesh-ancestor
56337982|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337983|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56337984|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56337985|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56337986|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
56337987|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56337988|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56337989|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337990|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337991|NCT00077493|Antibodies|antibodies|mesh-list
56337992|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
56337993|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56337994|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
56337995|NCT00077493|Immunotoxins|immunotoxins|mesh-list
56337996|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
56650384|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56650385|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337997|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337998|NCT00220831|Vitamin E|vitamin e|mesh-list
56337999|NCT00220831|Vitamins|vitamins|mesh-ancestor
56338000|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
56338001|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338002|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
56338003|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338004|NCT00220831|Protective Agents|protective agents|mesh-ancestor
56338005|NCT00220909|Lansoprazole|lansoprazole|mesh-list
56338006|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
56338007|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56338008|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56338009|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56338010|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338011|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338012|NCT00220987|Insulin|insulin|mesh-list
56338013|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56338014|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56338015|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338016|NCT02966067|Anesthetics|anesthetics|mesh-list
56338017|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56338018|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56338019|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338020|NCT00221026|Methoxsalen|methoxsalen|mesh-list
56338021|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56338022|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
56338023|NCT00042809|Paclitaxel|paclitaxel|mesh-list
56338024|NCT00042809|Trastuzumab|trastuzumab|mesh-list
56338025|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56338026|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56338027|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338028|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
56338029|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
56338030|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
56338031|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338032|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56338033|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56338034|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338035|NCT00073710|Calcitriol|calcitriol|mesh-list
56338036|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56338037|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338038|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56338039|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338040|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338041|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56338042|NCT00073710|Vitamins|vitamins|mesh-ancestor
56338043|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
56338044|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56338045|NCT00042848|Modafinil|modafinil|mesh-list
56338046|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56338047|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338049|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56338050|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56338051|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338052|NCT00221260|Anesthetics|anesthetics|mesh-list
56338053|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56338054|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338056|NCT00402259|Omeprazole|omeprazole|mesh-list
56338057|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56338058|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56338059|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56338060|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338061|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338062|NCT02965677|Paclitaxel|paclitaxel|mesh-list
56338063|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56338064|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338065|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
56338066|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
56338067|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
56338068|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650386|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56650387|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650388|NCT02650596|Liraglutide|liraglutide|mesh-list
56650389|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56213521|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338069|NCT00402376|Carvedilol|carvedilol|mesh-list
56338070|NCT00402376|Perindopril|perindopril|mesh-list
56338071|NCT00402376|Pravastatin|pravastatin|mesh-list
56338072|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56338073|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56338074|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
56338075|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338076|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338077|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338078|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56338079|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
56338080|NCT00402376|Protective Agents|protective agents|mesh-ancestor
56338081|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56338082|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338083|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56338084|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
56338085|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56338086|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56338087|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56338088|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56338089|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
56338090|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56338091|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56338092|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338093|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56338094|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
56338095|NCT00042887|Mitomycins|mitomycins|mesh-list
56338096|NCT00042887|Mitomycin|mitomycin|mesh-list
56338097|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56338098|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959880|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56338099|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
56338100|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338101|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56338102|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338103|NCT00122746|Cisplatin|cisplatin|mesh-list
56338104|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338105|NCT00122785|Dexamethasone|dexamethasone|mesh-list
56338106|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56338107|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
56338108|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
56338109|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338110|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338111|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56338112|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
56338113|NCT00122785|Hormones|hormones|mesh-ancestor
56338114|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56338115|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56338116|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338117|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56338118|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56338119|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56338121|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338122|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338123|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338124|NCT00122824|Analgesics|analgesics|mesh-ancestor
56338125|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
56338126|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338127|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
56338129|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
56338130|NCT00077532|Ipilimumab|ipilimumab|mesh-list
56338131|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
56338132|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56338133|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650390|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650391|NCT02650596|Incretins|incretins|mesh-ancestor
56650392|NCT02650596|Hormones|hormones|mesh-ancestor
56650393|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650394|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56213525|NCT02876107|Paclitaxel|paclitaxel|mesh-list
56338134|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56338135|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338136|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56338137|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
56338138|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338139|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56338140|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56338141|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56338142|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338143|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338144|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338145|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338146|NCT00122863|Analgesics|analgesics|mesh-ancestor
56338147|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
56338148|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338149|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
56338150|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56338151|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
56338152|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56338153|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56338154|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338155|NCT00122941|Micronutrients|micronutrients|mesh-list
56338156|NCT00122941|Trace Elements|trace elements|mesh-list
56338157|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338158|NCT00077688|Paclitaxel|paclitaxel|mesh-list
56338159|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56338160|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338161|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
56338162|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
56338163|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
56338164|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338165|NCT00397319|Hormones|hormones|mesh-list
56338166|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56338167|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338168|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
56338169|NCT02965443|Saxagliptin|saxagliptin|mesh-list
55959956|NCT01393964|Dexamethasone|dexamethasone|mesh-list
56338170|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56338171|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338172|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56338173|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338174|NCT02965443|Incretins|incretins|mesh-ancestor
56338175|NCT02965443|Hormones|hormones|mesh-ancestor
56338176|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56338177|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56338178|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
56338179|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338180|NCT00042965|Gemcitabine|gemcitabine|mesh-list
56338181|NCT00042965|Capecitabine|capecitabine|mesh-list
56338182|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56338183|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
56338184|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338185|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338186|NCT00042965|Antiviral Agents|antiviral agents|mesh-ancestor
56338187|NCT00042965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338188|NCT00042965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338189|NCT00042965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338190|NCT00042965|Immunologic Factors|immunologic factors|mesh-ancestor
56338194|NCT00123175|Progestins|progestins|mesh-list
56338195|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56338196|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56650395|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650396|NCT02832089|Carvedilol|carvedilol|mesh-list
56650397|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56650398|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56338197|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56338198|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
56338199|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56338200|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338201|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56338202|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56338203|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56338204|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56338205|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338206|NCT00123175|Hormones|hormones|mesh-ancestor
56338207|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56338208|NCT00123253|Tesamorelin|tesamorelin|mesh-list
56338209|NCT00123253|Growth Substances|growth substances|mesh-ancestor
56338210|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338211|NCT00077727|Galantamine|galantamine|mesh-list
56338212|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56338213|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338214|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338215|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
56338216|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338217|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338218|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56338219|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
56338220|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338221|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
56338222|NCT00123292|Plasminogen|plasminogen|mesh-list
56338223|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
56338224|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56338225|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56338226|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338227|NCT00043004|Leucovorin|leucovorin|mesh-list
56338228|NCT00043004|Bevacizumab|bevacizumab|mesh-list
56338229|NCT00043004|Fluorouracil|fluorouracil|mesh-list
56338230|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
56338231|NCT00043004|Calcium|calcium|mesh-list
56338232|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
56338233|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56338234|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338235|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56338236|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56338237|NCT00043004|Growth Substances|growth substances|mesh-ancestor
56338238|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338239|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
56338240|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56338241|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
56338242|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338243|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56338244|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338245|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
56338246|NCT00043004|Antidotes|antidotes|mesh-ancestor
56338247|NCT00043004|Protective Agents|protective agents|mesh-ancestor
56338248|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
56338249|NCT00043004|Vitamins|vitamins|mesh-ancestor
56338250|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
56338251|NCT00123331|Cyclosporine|cyclosporine|mesh-list
56338252|NCT00123331|Sirolimus|sirolimus|mesh-list
56338253|NCT00123331|Cyclosporins|cyclosporins|mesh-list
56338254|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338255|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338256|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338257|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
56338258|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338259|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
56338260|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338261|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
56338262|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56338263|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56338266|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118166|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56650399|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
56213535|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56338268|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56338269|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338270|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56338271|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56338272|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56338273|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338274|NCT00043043|Celecoxib|celecoxib|mesh-list
56338275|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56338276|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56338277|NCT00043043|Analgesics|analgesics|mesh-ancestor
56338278|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
56338279|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338280|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338281|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56338282|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56338283|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56338284|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56338285|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338286|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338287|NCT00077805|Enoxaparin|enoxaparin|mesh-list
56338288|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
56338289|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
56338290|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56338291|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56338292|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338293|NCT00043082|Carboplatin|carboplatin|mesh-list
56338294|NCT00043082|Doxorubicin|doxorubicin|mesh-list
56338295|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56338296|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338297|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56338298|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56338299|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56338300|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338301|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338302|NCT00123877|Esorubicin|esorubicin|mesh-list
56338303|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56338304|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338305|NCT00123916|Benzonidazole|benzonidazole|mesh-list
56338306|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338307|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
56338308|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338309|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56338310|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56338311|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56338312|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338313|NCT00073827|Albuterol|albuterol|mesh-list
56338314|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56338315|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
56338316|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338317|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960103|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56338318|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56338319|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
56338320|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
56338321|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56170057|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56338322|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56338323|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56338324|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56338325|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
56338326|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338327|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338328|NCT02970539|Paclitaxel|paclitaxel|mesh-list
56338329|NCT02970539|Ramucirumab|ramucirumab|mesh-list
56338330|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56338331|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338332|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
56338333|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
56338335|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338336|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
56650400|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650401|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650402|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338338|NCT00124111|Methotrexate|methotrexate|mesh-list
56338339|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338340|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
56338341|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338342|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56338343|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56338344|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
56338345|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338346|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338347|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56338348|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
56338349|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56338350|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56338351|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
56338352|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56338353|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
56338354|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338355|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56338356|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56338357|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
56338358|NCT00124150|Analgesics|analgesics|mesh-ancestor
56338359|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
56338360|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338361|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338362|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
56338363|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56338364|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56338365|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
56338366|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56338367|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338368|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338369|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56338370|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
56338371|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56338372|NCT02958046|Domperidone|domperidone|mesh-list
56338373|NCT02958046|Lansoprazole|lansoprazole|mesh-list
56338374|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
56338375|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56338376|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56338377|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56338378|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338379|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338380|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
56338381|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
56338382|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338383|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338384|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56338385|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
56338386|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338387|NCT00073905|Gemcitabine|gemcitabine|mesh-list
56338388|NCT00073905|Capecitabine|capecitabine|mesh-list
56338389|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56338390|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
56338391|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338392|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960180|NCT01392560|Empagliflozin|empagliflozin|mesh-list
56338393|NCT00073905|Antiviral Agents|antiviral agents|mesh-ancestor
56338394|NCT00073905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338395|NCT00073905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338396|NCT00073905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338397|NCT00073905|Immunologic Factors|immunologic factors|mesh-ancestor
56338398|NCT00073905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338399|NCT00124267|Quinine|quinine|mesh-list
56338400|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
56338401|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56338402|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56338403|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338404|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56650403|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56338405|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338406|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56338409|NCT00124267|Analgesics|analgesics|mesh-ancestor
56338410|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
56338411|NCT00077844|Enoxaparin|enoxaparin|mesh-list
56338412|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
56338413|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
56338414|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56338415|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56338416|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338417|NCT00043121|Leucovorin|leucovorin|mesh-list
56338418|NCT00043121|Fluorouracil|fluorouracil|mesh-list
56338419|NCT00043121|Capecitabine|capecitabine|mesh-list
56338420|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
56338421|NCT00043121|Calcium|calcium|mesh-list
56338422|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
56338423|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56338424|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338425|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
56338426|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338427|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56338428|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338429|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338430|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
56338431|NCT00043121|Antidotes|antidotes|mesh-ancestor
56338432|NCT00043121|Protective Agents|protective agents|mesh-ancestor
56338433|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
56338434|NCT00043121|Vitamins|vitamins|mesh-ancestor
56338435|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
56338436|NCT00402415|Sirolimus|sirolimus|mesh-list
56338437|NCT00402415|Sunitinib|sunitinib|mesh-list
56338438|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56338439|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338440|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56338441|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338442|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
56338443|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338444|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
56338445|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338446|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56338447|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56338448|NCT00402415|Growth Substances|growth substances|mesh-ancestor
56338449|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
56338450|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56338451|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338452|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338453|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56338454|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56338455|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338456|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56338457|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56338458|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338459|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338460|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
56338461|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338462|NCT00124306|Amitriptyline|amitriptyline|mesh-list
56338463|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56338464|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
56338465|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56338466|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56338467|NCT00124306|Analgesics|analgesics|mesh-ancestor
56338468|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
55960255|NCT05266651|Tadalafil|tadalafil|mesh-list
56338469|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338470|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338471|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56338472|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56338473|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338474|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338475|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
56338476|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338477|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
56338478|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650404|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
56650405|NCT02832089|Protective Agents|protective agents|mesh-ancestor
56338480|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56338481|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338482|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56338483|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56338484|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56338485|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338487|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338488|NCT00124540|Misoprostol|misoprostol|mesh-list
56338489|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56338490|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
56338492|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338493|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56338494|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56338495|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
56338496|NCT00124696|Cocaethylene|cocaethylene|mesh-list
56338497|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56338498|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56338499|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338500|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338501|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
56338502|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338503|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338504|NCT00043277|Bivalirudin|bivalirudin|mesh-list
56338505|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
56338506|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56338507|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
56338508|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338509|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338510|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
56338511|NCT00074022|Docetaxel|docetaxel|mesh-list
56338512|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338513|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
56338514|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
56338515|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
56338516|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338517|NCT00124813|Thalidomide|thalidomide|mesh-list
56338518|NCT00124813|Idarubicin|idarubicin|mesh-list
56338519|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338520|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
56338521|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338522|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
56338523|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56338524|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338525|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56338526|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56338527|NCT00124813|Growth Substances|growth substances|mesh-ancestor
56338528|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
56338529|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338530|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56338531|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56338532|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56338533|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338534|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338535|NCT00124930|Olanzapine|olanzapine|mesh-list
56338536|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
56338537|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
56338538|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338539|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338540|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56338541|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56338542|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56338543|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56338544|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56338545|NCT00124930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56338546|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56338547|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338548|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338549|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338550|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
56338551|NCT00124969|Amlodipine|amlodipine|mesh-list
56650406|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56650407|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56650408|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56650409|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
56650410|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56650411|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56650412|NCT04247633|Palbociclib|palbociclib|mesh-list
56650413|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966356|NCT03674827|Vaccines|vaccines|mesh-list
56338552|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56338555|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338556|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56338557|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338558|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
56338559|NCT00043316|Interferons|interferons|mesh-list
56338560|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
56338562|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
56338563|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338564|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
56338565|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56338566|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338567|NCT00125008|Vaccines|vaccines|mesh-list
56338568|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
56338569|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338570|NCT00125047|Vaccines|vaccines|mesh-list
56338571|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
56338572|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338573|NCT00078000|Sunitinib|sunitinib|mesh-list
56338574|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338575|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56338576|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56338577|NCT00078000|Growth Substances|growth substances|mesh-ancestor
56338578|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338579|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
56338580|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56338581|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338582|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338583|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
56338584|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
56338585|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56338586|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56170097|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338587|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56338588|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338589|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338590|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
56338591|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338592|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338593|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56338594|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338595|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56338596|NCT00043355|Interferons|interferons|mesh-list
56338597|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
56338598|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338599|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
56338600|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338601|NCT00125398|Fospropofol|fospropofol|mesh-list
56338602|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56338603|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56338604|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338605|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
56338606|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56338607|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
56338608|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56338609|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
56338610|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650414|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56650415|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966429|NCT05293249|Hormones|hormones|mesh-ancestor
56338611|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338612|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
56338613|NCT00125437|Spironolactone|spironolactone|mesh-list
56338614|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56338615|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
55960403|NCT00330863|Olanzapine|olanzapine|mesh-list
56338616|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56338617|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338618|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56338619|NCT00125437|Diuretics|diuretics|mesh-ancestor
56338620|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
56338621|NCT00125554|Metyrapone|metyrapone|mesh-list
56338622|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
56338623|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338624|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338628|NCT00125671|Warfarin|warfarin|mesh-list
56338629|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
56338630|NCT00125827|Clofarabine|clofarabine|mesh-list
56338631|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56338632|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
56338633|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338634|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338636|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56338637|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56338638|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56338639|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338640|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56338641|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56338642|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56338643|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
56338644|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338645|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338646|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56338647|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56338648|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
56338649|NCT00125905|Bupropion|bupropion|mesh-list
56338650|NCT00125905|Nicotine|nicotine|mesh-list
56338651|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56338652|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
56338653|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338654|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338655|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56338656|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56338657|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
56338658|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338659|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338660|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56338661|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
56338662|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56338663|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56338664|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56338665|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338666|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
56338667|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56338668|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56338669|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338670|NCT00078117|Buprenorphine|buprenorphine|mesh-list
56338671|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56338672|NCT00078117|Narcotics|narcotics|mesh-ancestor
56338673|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56338674|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338675|NCT00078117|Analgesics|analgesics|mesh-ancestor
56338676|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
56338677|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338678|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56338679|NCT00125983|Ritonavir|ritonavir|mesh-list
56338680|NCT00125983|Lopinavir|lopinavir|mesh-list
56338681|NCT00125983|Norinyl|norinyl|mesh-list
56338682|NCT00125983|Ortho Evra|ortho evra|mesh-list
56338683|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56650416|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650417|NCT00891371|Lanreotide|lanreotide|mesh-list
56338684|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56338685|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
56338686|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338687|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338688|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56338689|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56338690|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
56338691|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338692|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56338693|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56338694|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56338695|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56338696|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56338697|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
56338700|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56338701|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56338702|NCT00126022|Tedisamil|tedisamil|mesh-list
56338703|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56338704|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56338705|NCT00126022|Protective Agents|protective agents|mesh-ancestor
56338706|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338707|NCT00402454|Rifampin|rifampin|mesh-list
56338708|NCT00402454|Isoniazid|isoniazid|mesh-list
56338709|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
56338710|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56338711|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
56338712|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56338713|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338714|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
56338715|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56338716|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338717|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338718|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56338719|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56338720|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56338721|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56338722|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56338723|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56338724|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56338725|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56338726|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
56338727|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56338729|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56338730|NCT00402493|Latanoprost|latanoprost|mesh-list
56338731|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56338732|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56338733|NCT00402493|Analgesics|analgesics|mesh-ancestor
56338734|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
56338735|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338736|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338737|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56338738|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56338739|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56338740|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338741|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338742|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56338743|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56338744|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56338745|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56338746|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56338747|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56338748|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
56338749|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338750|NCT00402532|Everolimus|everolimus|mesh-list
56338751|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338752|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338753|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
56338754|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338755|NCT00126061|Tedisamil|tedisamil|mesh-list
56338756|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56650418|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650419|NCT04324229|Liraglutide|liraglutide|mesh-list
56650420|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56650421|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650422|NCT04324229|Incretins|incretins|mesh-ancestor
56650423|NCT04324229|Hormones|hormones|mesh-ancestor
56650424|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650425|NCT04430894|Dexamethasone|dexamethasone|mesh-list
56650426|NCT04430894|Lenalidomide|lenalidomide|mesh-list
56650427|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650428|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
56650429|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
56650430|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650431|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338757|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56338758|NCT00126061|Protective Agents|protective agents|mesh-ancestor
56338759|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338760|NCT00043589|Donepezil|donepezil|mesh-list
56338761|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56338762|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338763|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338764|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
56338765|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338766|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338767|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
56338768|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
56338770|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338771|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
56338782|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56338783|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
56338784|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338786|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
56338787|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56338788|NCT00074100|Amonafide|amonafide|mesh-list
56338789|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338790|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
56338791|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338792|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834362|NCT01628393|Ozanimod|ozanimod|mesh-list
56338793|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338794|NCT00126256|Leucovorin|leucovorin|mesh-list
56338795|NCT00126256|Fluorouracil|fluorouracil|mesh-list
56338796|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
56338797|NCT00126256|Irinotecan|irinotecan|mesh-list
56338798|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
56338799|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338800|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56338801|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338802|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338803|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
56338804|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338805|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56338806|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56338807|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338808|NCT00126256|Antidotes|antidotes|mesh-ancestor
56338809|NCT00126256|Protective Agents|protective agents|mesh-ancestor
56338810|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
56338811|NCT00126256|Vitamins|vitamins|mesh-ancestor
56338812|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
56338813|NCT00043667|Daclizumab|daclizumab|mesh-list
56338814|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338815|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
56338816|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338817|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
56338818|NCT00074139|Docetaxel|docetaxel|mesh-list
56650432|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650433|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
56338819|NCT00074139|Doxorubicin|doxorubicin|mesh-list
56338820|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56338821|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338822|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
56338823|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338824|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56338825|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56338826|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
56338827|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338828|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338829|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56338830|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
56338831|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
56338832|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
56338833|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56338834|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56338835|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56338836|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338839|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
56338840|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56338841|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56338842|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56338843|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338844|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338845|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
56338846|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338847|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338848|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56338849|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56338850|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338851|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56338852|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338853|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338854|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338855|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56338857|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56338858|NCT00043706|Mitogens|mitogens|mesh-list
56338859|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
56338860|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338861|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
56338862|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338863|NCT00126451|Vorinostat|vorinostat|mesh-list
56338864|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338865|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56338866|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338867|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338868|NCT00126607|Trastuzumab|trastuzumab|mesh-list
56338869|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56338870|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338872|NCT00074178|Dexamethasone|dexamethasone|mesh-list
56338873|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
56338874|NCT00074178|Methotrexate|methotrexate|mesh-list
56338875|NCT00074178|Etoposide|etoposide|mesh-list
56338876|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
56338877|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56338878|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
56338879|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338880|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56338881|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56338882|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
56338883|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338884|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338885|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56338886|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56338887|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
56338888|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
56338889|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338890|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56338891|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
56338892|NCT00074178|Hormones|hormones|mesh-ancestor
56118638|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
56650434|NCT04430894|Hormones|hormones|mesh-ancestor
55966714|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56338893|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56338894|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56338895|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56338896|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
56338897|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56338898|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56338899|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
56338900|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56338901|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338902|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56338903|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56338904|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56338905|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56338906|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56338912|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
56338913|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338915|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56338916|NCT00126763|Narcotics|narcotics|mesh-ancestor
56338917|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56338918|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338919|NCT00126763|Analgesics|analgesics|mesh-ancestor
56338920|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
56338921|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338922|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56338923|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56338924|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
56338925|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
56338926|NCT00402571|Acetaminophen|acetaminophen|mesh-list
56338927|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56338928|NCT00402571|Analgesics|analgesics|mesh-ancestor
56338929|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
56338930|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338931|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338932|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
56338933|NCT00126880|Lamivudine|lamivudine|mesh-list
56338934|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56338935|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56338936|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338937|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338938|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
56338939|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338940|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56338941|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56338942|NCT02965911|Fenofibrate|fenofibrate|mesh-list
56338943|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56338944|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
56338945|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338946|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56338947|NCT00127075|Estradiol|estradiol|mesh-list
56338948|NCT00127075|Estrogens|estrogens|mesh-ancestor
56338949|NCT00127075|Hormones|hormones|mesh-ancestor
56338950|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56338951|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338952|NCT00127114|Amantadine|amantadine|mesh-list
56338953|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56338954|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56338955|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
56338956|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338957|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
56338958|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338959|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338960|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338961|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56338962|NCT00127114|Analgesics|analgesics|mesh-ancestor
56338963|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
56338964|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338965|NCT00043784|Enoxaparin|enoxaparin|mesh-list
56338966|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
56338967|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56338968|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56338969|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650435|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650436|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56650437|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338970|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56338971|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
56338972|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338973|NCT00399477|Levodopa|levodopa|mesh-list
56338974|NCT00399477|Pramipexole|pramipexole|mesh-list
56338975|NCT00399477|Rasagiline|rasagiline|mesh-list
56338976|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56338977|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56338978|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
56338979|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338982|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56338983|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56338984|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56338985|NCT00399477|Protective Agents|protective agents|mesh-ancestor
56338987|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
56338988|NCT00127270|Darifenacin|darifenacin|mesh-list
56338989|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56338990|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56338991|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
56338992|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338993|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338994|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338996|NCT00043823|Bevacizumab|bevacizumab|mesh-list
56338997|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56338998|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56338999|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339000|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56339001|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56339002|NCT00043823|Growth Substances|growth substances|mesh-ancestor
56170132|NCT03808818|Nicotine|nicotine|mesh-list
56339003|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339004|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
56339005|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56339006|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339007|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339008|NCT00074334|Immunotoxins|immunotoxins|mesh-list
56339009|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
56339010|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339011|NCT00127387|Etanercept|etanercept|mesh-list
56339012|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56339013|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56339014|NCT00127387|Analgesics|analgesics|mesh-ancestor
56339015|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
56339016|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339017|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339018|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56339019|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56339020|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56339021|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339022|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
56339023|NCT00043862|Topotecan|topotecan|mesh-list
56339024|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56339025|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56339026|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339027|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339028|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339029|NCT00127504|Azithromycin|azithromycin|mesh-list
56339030|NCT00127504|Rifampin|rifampin|mesh-list
56339031|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56339032|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339033|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56339034|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
56339035|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
56339036|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56339037|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339038|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339039|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56118639|NCT00003317|Paclitaxel|paclitaxel|mesh-list
56650438|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
56650439|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56339040|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56339041|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56339042|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56339043|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56339044|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56339045|NCT00043901|Lamotrigine|lamotrigine|mesh-list
56339046|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
56339047|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56339048|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56339049|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339059|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56339060|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
56339061|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339062|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
56339063|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339064|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339065|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339066|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56339067|NCT00127777|Analgesics|analgesics|mesh-ancestor
56339068|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
56339069|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339070|NCT00399633|Sumatriptan|sumatriptan|mesh-list
56339071|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56339072|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56339073|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56339074|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
56339075|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339076|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339077|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339078|NCT04726657|Insulin|insulin|mesh-list
56339079|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56339080|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
56339081|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
56339082|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
56339083|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56339084|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339085|NCT00402610|Rifampin|rifampin|mesh-list
56339086|NCT00402610|Isoniazid|isoniazid|mesh-list
56339087|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
56339088|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56339089|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
56339090|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56339091|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339092|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
56339093|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56339094|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339095|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339096|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56339097|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56339098|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56339099|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56339100|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56339101|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56339102|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56339103|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56339104|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
56339105|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56339106|NCT00402766|Dexamethasone|dexamethasone|mesh-list
56339107|NCT00402766|Cisplatin|cisplatin|mesh-list
56339108|NCT00402766|Pemetrexed|pemetrexed|mesh-list
56339109|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
56339110|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56339111|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
56339112|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
56339113|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339114|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339118|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339119|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56339120|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650440|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56650441|NCT04430894|Growth Substances|growth substances|mesh-ancestor
56650442|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
56339121|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339122|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339123|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56339124|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56339125|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56339126|NCT00127972|Lamivudine|lamivudine|mesh-list
56339127|NCT00127972|Efavirenz|efavirenz|mesh-list
56339128|NCT00127972|Nevirapine|nevirapine|mesh-list
56339129|NCT00127972|Stavudine|stavudine|mesh-list
56339130|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56339131|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56339132|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339133|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339134|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
56339135|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339136|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56339137|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56339138|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56339139|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56339140|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56339141|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56339142|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56339143|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56339144|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
56339145|NCT00043940|Bivalirudin|bivalirudin|mesh-list
56339146|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
56339147|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56339148|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
56339149|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339150|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339151|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
56339152|NCT04711434|Antibodies|antibodies|mesh-list
56339153|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
56339154|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339155|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
56339156|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56339157|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56339158|NCT00128245|Analgesics|analgesics|mesh-ancestor
56339159|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
56339160|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339161|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339162|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56339163|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56339164|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
56339165|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339166|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
56339167|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56339168|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339169|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339170|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56339171|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56339172|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56339173|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339174|NCT00044135|Clevudine|clevudine|mesh-list
56339175|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
56339176|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339177|NCT05561725|Dexamethasone|dexamethasone|mesh-list
56339178|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56339179|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
56339180|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
56339181|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339182|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339183|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56339184|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
56339185|NCT05561725|Hormones|hormones|mesh-ancestor
56339186|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339188|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339189|NCT00078195|Omalizumab|omalizumab|mesh-list
56339190|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
56650443|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
56650444|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339191|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
56339192|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56339193|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339194|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56339195|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56339196|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
56339197|NCT00044291|Toremifene|toremifene|mesh-list
56339198|NCT00044291|Letrozole|letrozole|mesh-list
56339199|NCT00044291|Hormones|hormones|mesh-list
56339200|NCT00044291|Atamestane|atamestane|mesh-list
56339201|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
56339202|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
56339203|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
56339204|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339205|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339206|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339207|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56339208|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56339209|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339210|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339211|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
56339212|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56339213|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55961007|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339214|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56339215|NCT00078234|Rituximab|rituximab|mesh-list
56339216|NCT00078234|Fludarabine|fludarabine|mesh-list
56339217|NCT00078234|Oblimersen|oblimersen|mesh-list
56339218|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56339219|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339220|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
56339221|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339222|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56339223|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
56339224|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339225|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339226|NCT00078351|Hylan|hylan|mesh-list
56339227|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
56339228|NCT00078351|Protective Agents|protective agents|mesh-ancestor
56339229|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339230|NCT00044447|Glimepiride|glimepiride|mesh-list
56339231|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56339232|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56339233|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339234|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339235|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
56339237|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
56339238|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56339239|NCT05519917|Afatinib|afatinib|mesh-list
56339240|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339241|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56339242|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339243|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339244|NCT00078390|S 3304|s 3304|mesh-list
56339245|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
56339246|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
56339247|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339248|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339249|NCT00044486|Posaconazole|posaconazole|mesh-list
56339250|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
56339251|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339252|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56339253|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56097809|NCT00002504|Interferons|interferons|mesh-list
56339254|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56339255|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56339256|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56339257|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339258|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339259|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56339260|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
56339263|NCT05497336|Cetuximab|cetuximab|mesh-list
56650445|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
56650446|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650447|NCT02829281|Triamcinolone|triamcinolone|mesh-list
56650448|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56650449|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56339264|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56339265|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339267|NCT00044525|IDN 5109|idn 5109|mesh-list
56339268|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339269|NCT05417425|Lidocaine|lidocaine|mesh-list
56339270|NCT05417425|Protective Agents|protective agents|mesh-list
56339271|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
56339272|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
56339273|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56339274|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339275|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
56339276|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339277|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56339278|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56339279|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56339280|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56339281|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339282|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
56339283|NCT00397475|Vitamin D|vitamin d|mesh-list
56339284|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56339285|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339286|NCT00397475|Vitamins|vitamins|mesh-ancestor
56339287|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
56339288|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56339289|NCT00074607|Gemcitabine|gemcitabine|mesh-list
56339290|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339291|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
56339292|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339293|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339294|NCT00074607|Antiviral Agents|antiviral agents|mesh-ancestor
56339295|NCT00074607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339296|NCT00074607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339297|NCT00074607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339298|NCT00074607|Immunologic Factors|immunologic factors|mesh-ancestor
56339299|NCT00074607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339300|NCT05323435|Vaccines|vaccines|mesh-list
56339301|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
56339302|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339303|NCT05305885|Pemetrexed|pemetrexed|mesh-list
56339304|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339305|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339306|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339307|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56339308|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56339310|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339311|NCT05284552|Tinzaparin|tinzaparin|mesh-list
56339312|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56339313|NCT05284552|Dalteparin|dalteparin|mesh-list
56339314|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
56339315|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56339316|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56339317|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339318|NCT05161468|Triamcinolone|triamcinolone|mesh-list
56339319|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56339320|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56339321|NCT05161468|Lidocaine|lidocaine|mesh-list
56339322|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
56339323|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
56339324|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56339325|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
56339326|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
56339327|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56339328|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339330|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339331|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56268996|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650450|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
56650451|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56650452|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56650453|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56650454|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56339332|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56339333|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56339334|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56339337|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56339338|NCT05161468|Hormones|hormones|mesh-ancestor
56339339|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339340|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339341|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
56339342|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339343|NCT00078546|Antibodies|antibodies|mesh-list
56339344|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56339345|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
56339346|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339347|NCT00044642|Lorazepam|lorazepam|mesh-list
56339348|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
56339349|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
56339350|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
56339351|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339352|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339353|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56339354|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56339355|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56339356|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56339357|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56339358|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56339359|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
56339360|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
56339361|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339362|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339363|NCT05084989|Vaccines|vaccines|mesh-list
56339364|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
56339365|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339367|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56339368|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
56339369|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339370|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339371|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339372|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56339373|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56339374|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56339375|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56339376|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56339377|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
56339378|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56339379|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56339380|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339381|NCT00044720|Sirolimus|sirolimus|mesh-list
56339383|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339384|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56339385|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339386|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
56339387|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339388|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
56339389|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339390|NCT04938466|Hormones|hormones|mesh-list
56339391|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339392|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339393|NCT00403000|Dutasteride|dutasteride|mesh-list
56339394|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56339395|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56339396|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339397|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339398|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
56268997|NCT01986283|Analgesics|analgesics|mesh-ancestor
56650455|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56650456|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650457|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
56339399|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339400|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339401|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
56339402|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56339403|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339404|NCT00403039|Ranibizumab|ranibizumab|mesh-list
56339405|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56339406|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56339407|NCT00403039|Growth Substances|growth substances|mesh-ancestor
56339408|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339414|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
56339415|NCT00078858|Cyclosporins|cyclosporins|mesh-list
56339416|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339417|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339418|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
56339419|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339420|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339421|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
56339422|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339423|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339424|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
56339425|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339426|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
56339427|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56339428|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56339429|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56339430|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56339431|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
56339432|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56339433|NCT00044759|Tazobactam|tazobactam|mesh-list
56339434|NCT00044759|Piperacillin|piperacillin|mesh-list
56339435|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56339436|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56339437|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339438|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56339439|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339440|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339442|NCT00044798|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56339443|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56339444|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56339445|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339446|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339447|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
56339448|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339449|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56339450|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
56339451|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56339452|NCT00074841|Azithromycin|azithromycin|mesh-list
56339453|NCT00074841|Chloroquine|chloroquine|mesh-list
56339454|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56339455|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
56339457|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56339458|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56339459|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339460|NCT00074841|Amebicides|amebicides|mesh-ancestor
56339461|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56339462|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56339463|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
56339464|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56339465|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56339466|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56339467|NCT00074841|Analgesics|analgesics|mesh-ancestor
56339468|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
56339469|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339470|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339471|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56339472|NCT00074841|Filaricides|filaricides|mesh-ancestor
56650458|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213582|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
56339473|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
56339474|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
56339475|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56339476|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339477|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339478|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56339479|NCT00074841|Renal Agents|renal agents|mesh-ancestor
56339480|NCT00078975|Gemcitabine|gemcitabine|mesh-list
56339481|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339485|NCT00078975|Antiviral Agents|antiviral agents|mesh-ancestor
56339486|NCT00078975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339487|NCT00078975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339488|NCT00078975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339489|NCT00078975|Immunologic Factors|immunologic factors|mesh-ancestor
56339490|NCT00078975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339491|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56339492|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
56339493|NCT00044837|Estradiol|estradiol|mesh-list
56339494|NCT00044837|Estrogens|estrogens|mesh-ancestor
56339495|NCT00044837|Hormones|hormones|mesh-ancestor
56339496|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339497|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339498|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56339499|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
56339500|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56339501|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56339502|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56339503|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56339504|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56339505|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56339506|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56339507|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339508|NCT04457557|Ropivacaine|ropivacaine|mesh-list
56339509|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
56339510|NCT04457557|Anesthetics|anesthetics|mesh-list
56339511|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56339512|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961314|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
56339513|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
56339514|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339515|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
56339516|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56339517|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
56339518|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56339519|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339520|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56339521|NCT00079014|Doxorubicin|doxorubicin|mesh-list
56339522|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56339523|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56339524|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339525|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56339526|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56339527|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339528|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339530|NCT04731740|Lenvatinib|lenvatinib|mesh-list
56339531|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56339532|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339533|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56339534|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339535|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339536|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
56339537|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56339538|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56339539|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
56339540|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339541|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339542|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339543|NCT04321408|Ziconotide|ziconotide|mesh-list
56339544|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56339545|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55967369|NCT03583424|Cytarabine|cytarabine|mesh-list
56170188|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56339546|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339547|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56339548|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339549|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56339552|NCT04321408|Analgesics|analgesics|mesh-ancestor
56339553|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
56339554|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339555|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56339556|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339557|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56339558|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339559|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339560|NCT04263298|Capecitabine|capecitabine|mesh-list
56339561|NCT04263298|Fulvestrant|fulvestrant|mesh-list
56339562|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339563|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
56339564|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339565|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339566|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56339567|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56339568|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56339569|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
56339570|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339571|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339572|NCT00044954|Cyclosporine|cyclosporine|mesh-list
56339573|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
56339574|NCT00044954|Fludarabine|fludarabine|mesh-list
56339575|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
56339576|NCT00044954|Cyclosporins|cyclosporins|mesh-list
56339577|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339578|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339579|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
56339580|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339581|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339582|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
56339583|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961391|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
56339584|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339585|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
56339586|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339587|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
56339588|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56339589|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56339590|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56339591|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56339592|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
56339593|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56339594|NCT00079092|Thalidomide|thalidomide|mesh-list
56339595|NCT00079092|Procarbazine|procarbazine|mesh-list
56339596|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339597|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
56339598|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339599|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
56339600|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56339601|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339602|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56339603|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56339604|NCT00079092|Growth Substances|growth substances|mesh-ancestor
56339605|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
56339606|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339607|NCT00044993|Docetaxel|docetaxel|mesh-list
56339608|NCT00044993|Doxorubicin|doxorubicin|mesh-list
56339609|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56339610|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339611|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56339612|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
56339613|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56170193|NCT04432584|Eculizumab|eculizumab|mesh-list
56339614|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339615|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56339616|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56339617|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56650459|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650460|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56339618|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339619|NCT04162210|Dexamethasone|dexamethasone|mesh-list
56339620|NCT04162210|Pomalidomide|pomalidomide|mesh-list
56339621|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56339625|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339626|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56339627|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
56339628|NCT04162210|Hormones|hormones|mesh-ancestor
56339629|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339630|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56339631|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339632|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
56339633|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56339634|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56339635|NCT04162210|Growth Substances|growth substances|mesh-ancestor
56339636|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
56339637|NCT00079131|Oblimersen|oblimersen|mesh-list
56339638|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339639|NCT00045149|Aldesleukin|aldesleukin|mesh-list
56339640|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339641|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56339642|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56339643|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
56339644|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339645|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
56339646|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339647|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56339648|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339649|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339650|NCT00403156|Ranibizumab|ranibizumab|mesh-list
56339651|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
56339652|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56339653|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56339654|NCT00403156|Growth Substances|growth substances|mesh-ancestor
56339655|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339656|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
56339657|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339658|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56339659|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339660|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339662|NCT00045227|Vaccines|vaccines|mesh-list
56339663|NCT00045227|Sargramostim|sargramostim|mesh-list
56339664|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
56339665|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339666|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339667|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
56339668|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
56339669|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
56339670|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339671|NCT00075075|Infliximab|infliximab|mesh-list
56339672|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
56339673|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56339674|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56339675|NCT04065451|Epinephrine|epinephrine|mesh-list
56339676|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56339677|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56339678|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
56339679|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339680|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339681|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339682|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56339683|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56339684|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
56339685|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339686|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56339687|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
56339688|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
56339689|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
56339690|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56339692|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56339693|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56339694|NCT00045266|Growth Substances|growth substances|mesh-ancestor
56650461|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
56650462|NCT02829281|Hormones|hormones|mesh-ancestor
56650463|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650464|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56650465|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
56650466|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650467|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56650468|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650469|NCT04210544|Caseins|caseins|mesh-list
56650470|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
56650471|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
56650472|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650473|NCT04168944|Lenvatinib|lenvatinib|mesh-list
56650474|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56650475|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339695|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339696|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
56339698|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56339699|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
56339700|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
56339701|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339703|NCT03948568|Letrozole|letrozole|mesh-list
56339704|NCT03948568|Anastrozole|anastrozole|mesh-list
56339705|NCT03948568|Exemestane|exemestane|mesh-list
56339706|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339707|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56339708|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56339709|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339710|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339711|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56339712|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
56339713|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339714|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339715|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56339716|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56339717|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56339718|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56339719|NCT03928366|Remifentanil|remifentanil|mesh-list
56339720|NCT03928366|Propofol|propofol|mesh-list
56339721|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56339722|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56339723|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339724|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56339725|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
56339726|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
56339727|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56339728|NCT03928366|Narcotics|narcotics|mesh-ancestor
56339729|NCT03928366|Analgesics|analgesics|mesh-ancestor
56339730|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
56339731|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339732|NCT00045422|Interferons|interferons|mesh-list
56339733|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
56339734|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
56339735|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339736|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
56339737|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339738|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
56339739|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339740|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56339741|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650476|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56650477|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339742|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339743|NCT00075192|Leuprolide|leuprolide|mesh-list
56339744|NCT00075192|Bicalutamide|bicalutamide|mesh-list
56339745|NCT00075192|Tremelimumab|tremelimumab|mesh-list
56339746|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56339747|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
56339748|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56339749|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339750|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56339751|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339752|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
56339753|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
56339754|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339755|NCT03739411|Temozolomide|temozolomide|mesh-list
56339756|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56339757|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
56339758|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339759|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339760|NCT00045461|Carboplatin|carboplatin|mesh-list
56339761|NCT00045461|Ifosfamide|ifosfamide|mesh-list
56339762|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339763|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56339764|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
56339765|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339766|NCT00075231|Ritonavir|ritonavir|mesh-list
56339767|NCT00075231|Lopinavir|lopinavir|mesh-list
56339768|NCT00075231|Lamivudine|lamivudine|mesh-list
56339769|NCT00075231|Zidovudine|zidovudine|mesh-list
56339770|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56339781|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56339782|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56339783|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56339784|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56339785|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
56339786|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56339787|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56339788|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56339789|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56339790|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56339792|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56339793|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
56339794|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339795|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339796|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56339797|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56339798|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
56339799|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339800|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339801|NCT00079170|Docetaxel|docetaxel|mesh-list
56339802|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339803|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
56339804|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
56339805|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
56339806|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339807|NCT00045500|Prednisone|prednisone|mesh-list
56339808|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56339809|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56339810|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
56339811|NCT00045500|Hormones|hormones|mesh-ancestor
56339812|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339813|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339814|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56339815|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339816|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56339817|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339818|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339819|NCT03560752|Vaccines|vaccines|mesh-list
56339820|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
56339821|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650478|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339822|NCT00045539|Leucovorin|leucovorin|mesh-list
56339823|NCT00045539|Methotrexate|methotrexate|mesh-list
56339824|NCT00045539|Thiotepa|thiotepa|mesh-list
56339825|NCT00045539|Calcium|calcium|mesh-list
56339827|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56170201|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339828|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339829|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56339830|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
56339831|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56339832|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339833|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
56339835|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339836|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
56339837|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339838|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56339839|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339840|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
56339841|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56339842|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56339843|NCT00045539|Antidotes|antidotes|mesh-ancestor
56339844|NCT00045539|Protective Agents|protective agents|mesh-ancestor
56339845|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
56339847|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
56339848|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56339849|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
56339850|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56339851|NCT00079248|Progesterone|progesterone|mesh-list
56339852|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56339853|NCT00079248|Estrogens|estrogens|mesh-list
56339854|NCT00079248|Progestins|progestins|mesh-ancestor
56339855|NCT00079248|Hormones|hormones|mesh-ancestor
56339856|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339857|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339858|NCT00045617|Etoposide|etoposide|mesh-list
56339859|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56339860|NCT00045617|Vaccines|vaccines|mesh-list
56339861|NCT00045617|Antibodies|antibodies|mesh-list
56339862|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
56339863|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56339864|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56339865|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
56339866|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339867|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339868|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56339869|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56339870|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56339871|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339872|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339873|NCT03442309|Fluorides|fluorides|mesh-list
56339874|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
56339875|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
56339876|NCT03442309|Protective Agents|protective agents|mesh-ancestor
56339877|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339878|NCT03399838|Midazolam|midazolam|mesh-list
56339879|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
56339880|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56339881|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56339882|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339883|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56339884|NCT03399838|Analgesics|analgesics|mesh-ancestor
56339885|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
56339886|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339887|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56339888|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56339889|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56339890|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
56339891|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339892|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339893|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56339894|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56339895|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56339896|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56339897|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56339898|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
56339899|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
56339901|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
56339902|NCT00079287|Gemcitabine|gemcitabine|mesh-list
56339903|NCT00079287|Paclitaxel|paclitaxel|mesh-list
56339904|NCT00079287|Vinorelbine|vinorelbine|mesh-list
56339905|NCT00079287|Docetaxel|docetaxel|mesh-list
56339906|NCT00079287|Carboplatin|carboplatin|mesh-list
56339907|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56339908|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339909|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
56339910|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
56339912|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339913|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339914|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
56339915|NCT00079287|Antiviral Agents|antiviral agents|mesh-ancestor
56339916|NCT00079287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339917|NCT00079287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339918|NCT00079287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339919|NCT00079287|Immunologic Factors|immunologic factors|mesh-ancestor
56339920|NCT00079287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339921|NCT00045695|Bortezomib|bortezomib|mesh-list
56339922|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339923|NCT00079365|Gemcitabine|gemcitabine|mesh-list
56339924|NCT00079365|Fluorouracil|fluorouracil|mesh-list
56339925|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339926|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
56339927|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339928|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339929|NCT00079365|Antiviral Agents|antiviral agents|mesh-ancestor
56339930|NCT00079365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339931|NCT00079365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339932|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339933|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
56339934|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339935|NCT02962414|Everolimus|everolimus|mesh-list
56339936|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339937|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56339938|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
56339939|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339940|NCT00045773|Sertraline|sertraline|mesh-list
56339941|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
56339942|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56339943|NCT00045773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56339944|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56339945|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56339946|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339947|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339948|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
56339949|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339950|NCT02839915|Leucovorin|leucovorin|mesh-list
56339951|NCT02839915|Folic Acid|folic acid|mesh-list
56339952|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
56339953|NCT02839915|Antidotes|antidotes|mesh-ancestor
56339954|NCT02839915|Protective Agents|protective agents|mesh-ancestor
56339955|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339956|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
56339957|NCT02839915|Vitamins|vitamins|mesh-ancestor
56339958|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
56339959|NCT02839915|Hematinics|hematinics|mesh-ancestor
56339960|NCT00045812|Ezetimibe|ezetimibe|mesh-list
56339961|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56339962|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56339963|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
56339964|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961767|NCT01794533|Lidocaine|lidocaine|mesh-list
56339965|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56339967|NCT00079443|Fludarabine|fludarabine|mesh-list
56339968|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
56339969|NCT00079443|Romidepsin|romidepsin|mesh-list
56339970|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56339971|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339972|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
56339973|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339974|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56339975|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339976|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
56339977|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339979|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56650479|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
56650480|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650481|NCT02697032|Bicalutamide|bicalutamide|mesh-list
56650482|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
56650483|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
56339980|NCT02599363|Paclitaxel|paclitaxel|mesh-list
56339981|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56339982|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339983|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
56339984|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
56339985|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
56339986|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339987|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56339988|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56339989|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56339990|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339991|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339992|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56339993|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56339994|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339995|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
56339996|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56339997|NCT00403429|Capecitabine|capecitabine|mesh-list
56339998|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56339999|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
56340000|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340001|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340002|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
56340003|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340004|NCT00079560|Dronabinol|dronabinol|mesh-list
56340005|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
56340006|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340007|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56340008|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56340009|NCT00079560|Analgesics|analgesics|mesh-ancestor
56340010|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
56340011|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340012|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56340013|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56340014|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340015|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340016|NCT00079560|Hormones|hormones|mesh-ancestor
56340017|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340018|NCT00046163|Midodrine|midodrine|mesh-list
56340019|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
56340020|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
56340021|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340022|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340023|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56340024|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56340025|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56340026|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56340027|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
56340028|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340029|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340030|NCT01409161|Vitamins|vitamins|mesh-list
56340031|NCT01409161|Vitamin A|vitamin a|mesh-list
56340032|NCT01409161|Tretinoin|tretinoin|mesh-list
56340033|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
56340034|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
56340035|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
56340036|NCT01409161|Calicheamicins|calicheamicins|mesh-list
56340037|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
56340038|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340039|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340040|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
56340041|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
56340043|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340044|NCT01409161|Protective Agents|protective agents|mesh-ancestor
56340045|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56733174|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56340046|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56340047|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340048|NCT00079638|Niacin|niacin|mesh-list
56340049|NCT00079638|Atorvastatin|atorvastatin|mesh-list
56340050|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56340051|NCT00079638|Simvastatin|simvastatin|mesh-list
56340052|NCT00079638|Ezetimibe|ezetimibe|mesh-list
56340053|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56340054|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56340055|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
56340056|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340057|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56340058|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56340059|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340060|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
56340061|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
56340063|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
56340064|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340065|NCT00046241|Bupropion|bupropion|mesh-list
56340067|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
56340068|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56340069|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56340070|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56340071|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56340072|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340073|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
56340074|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340075|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340076|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56340077|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56340078|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340079|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
56340080|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56340081|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340082|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
56340083|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56340084|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
56340085|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340086|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
56340087|NCT00130468|Protective Agents|protective agents|mesh-ancestor
56340088|NCT00130507|Capecitabine|capecitabine|mesh-list
56340089|NCT00130507|Trastuzumab|trastuzumab|mesh-list
56340090|NCT00130507|Vinorelbine|vinorelbine|mesh-list
56340091|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56340092|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
56340093|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340094|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340095|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56340096|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340097|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340098|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340099|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340100|NCT00130546|Sirolimus|sirolimus|mesh-list
56340101|NCT00130546|Paclitaxel|paclitaxel|mesh-list
56340102|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340103|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340104|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340105|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340106|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340107|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340108|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56340109|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340110|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340111|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
56340112|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340113|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
56340114|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340115|NCT00130585|Folic Acid|folic acid|mesh-list
56340116|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
56340117|NCT00130585|Hematinics|hematinics|mesh-ancestor
56340118|NCT00130585|Vitamins|vitamins|mesh-ancestor
56340119|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
56340120|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340121|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56340122|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56340123|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340125|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340126|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56340127|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340128|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340129|NCT00130819|Buprenorphine|buprenorphine|mesh-list
56340130|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56340131|NCT00130819|Narcotics|narcotics|mesh-ancestor
56340132|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56340133|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340134|NCT00130819|Analgesics|analgesics|mesh-ancestor
56340135|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
56340136|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340137|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56340138|NCT00130858|Carboplatin|carboplatin|mesh-list
56340139|NCT00130858|Topotecan|topotecan|mesh-list
56340140|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340141|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56340142|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56340143|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340144|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340145|NCT00130897|Sunitinib|sunitinib|mesh-list
56340146|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340147|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56340148|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56340149|NCT00130897|Growth Substances|growth substances|mesh-ancestor
56340150|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340151|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
56340152|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56340153|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340154|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340155|NCT00046319|Ambrisentan|ambrisentan|mesh-list
56340156|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56340157|NCT00079833|Esomeprazole|esomeprazole|mesh-list
56340158|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56340159|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56340160|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56340161|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340162|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340163|NCT00079872|Pemetrexed|pemetrexed|mesh-list
56340164|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340165|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340166|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340167|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56340168|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56340169|NCT00046358|Ibuprofen|ibuprofen|mesh-list
56340170|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56340171|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56340172|NCT00046358|Analgesics|analgesics|mesh-ancestor
56340173|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
56340174|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340175|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340176|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340177|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340178|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56340179|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340180|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340181|NCT00130936|Carboplatin|carboplatin|mesh-list
56340182|NCT00130936|Capecitabine|capecitabine|mesh-list
56340183|NCT00130936|Epirubicin|epirubicin|mesh-list
56340184|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340185|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56340186|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
56340187|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340188|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340189|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56340190|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56340191|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340192|NCT00130975|Candesartan|candesartan|mesh-list
56340193|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56340194|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56340195|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56340196|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733175|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56340197|NCT00131053|Cytarabine|cytarabine|mesh-list
56340198|NCT00131053|Dexamethasone|dexamethasone|mesh-list
56340199|NCT00131053|Prednisolone|prednisolone|mesh-list
56340200|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
56340201|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
56340202|NCT00131053|Methotrexate|methotrexate|mesh-list
56340203|NCT00131053|Vincristine|vincristine|mesh-list
56340204|NCT00131053|Asparaginase|asparaginase|mesh-list
56340205|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
56340206|NCT00131053|Pirarubicin|pirarubicin|mesh-list
56340207|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340208|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
56340209|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340210|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340211|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56340212|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
56340213|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340214|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340215|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56340216|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340218|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
56340219|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340220|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56340221|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
56340222|NCT00131053|Hormones|hormones|mesh-ancestor
56340223|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340224|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56340225|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56340226|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
56340227|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56340228|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56340229|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
56340230|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
56340231|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340232|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56340233|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56340234|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
56340235|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340236|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340237|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340238|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340239|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340240|NCT00079911|Valacyclovir|valacyclovir|mesh-list
56340241|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
56340242|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340243|NCT00397592|Hormones|hormones|mesh-list
56340244|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340245|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340246|NCT00131326|Hylan|hylan|mesh-list
56340247|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
56340248|NCT00131326|Protective Agents|protective agents|mesh-ancestor
56340249|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340250|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
56340251|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56340252|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56340253|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340254|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340255|NCT00131404|Hormones|hormones|mesh-ancestor
56340256|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340257|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340258|NCT00131443|Topiramate|topiramate|mesh-list
56340259|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
56340260|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56340261|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340262|NCT00079989|Tigecycline|tigecycline|mesh-list
56340263|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55962062|NCT01405820|Natalizumab|natalizumab|mesh-list
56340264|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340265|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56340266|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340267|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340268|NCT00131482|Thrombin|thrombin|mesh-list
56340269|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
56650484|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650485|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650486|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650487|NCT04409834|Heparin|heparin|mesh-list
56340270|NCT00131482|Coagulants|coagulants|mesh-ancestor
56340271|NCT00397709|Rifampin|rifampin|mesh-list
56340272|NCT00397709|Isoniazid|isoniazid|mesh-list
56340273|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56340274|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
56340275|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56340276|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340277|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
56340278|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56340279|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340280|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340281|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56340282|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56340283|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56340284|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56340285|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56340286|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56340289|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
56340290|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56340292|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
56340293|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340294|NCT00131521|Expectorants|expectorants|mesh-ancestor
56340295|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
56340296|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56340297|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
56340298|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340299|NCT00131521|Protective Agents|protective agents|mesh-ancestor
56340300|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340301|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
56340302|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340303|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56340304|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
56340305|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
56340306|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
56340307|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56340308|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
56340309|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56340310|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56340311|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340312|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56340313|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340314|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340315|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56340316|NCT00131716|Renal Agents|renal agents|mesh-ancestor
56340317|NCT00131755|Diazoxide|diazoxide|mesh-list
56340318|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56340319|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
56340320|NCT00080145|Risperidone|risperidone|mesh-list
56340321|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56340322|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
56340323|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340324|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340325|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340326|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56340327|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56340328|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56340329|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56340330|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56340331|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
56340333|NCT00403663|Morphine|morphine|mesh-list
56340334|NCT00403663|Bupivacaine|bupivacaine|mesh-list
56340335|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
56340336|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
56340337|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56340338|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340339|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
56340340|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650488|NCT04409834|Calcium heparin|calcium heparin|mesh-list
56650489|NCT04409834|Enoxaparin|enoxaparin|mesh-list
56650490|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
56340341|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56340342|NCT00403663|Narcotics|narcotics|mesh-ancestor
56340343|NCT00403663|Analgesics|analgesics|mesh-ancestor
56340344|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56340345|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56340346|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
56340347|NCT00403780|Pregabalin|pregabalin|mesh-list
56340348|NCT00403780|Analgesics|analgesics|mesh-ancestor
56340349|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
56340350|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340351|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340352|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
56340353|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56340354|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56340355|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340356|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56340357|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56340358|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56340359|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56340360|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56340361|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56340365|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56340366|NCT00403858|Lactulose|lactulose|mesh-list
56340367|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56340368|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56340369|NCT00403858|Laxatives|laxatives|mesh-ancestor
56340370|NCT00046553|Mifepristone|mifepristone|mesh-list
56340371|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56340372|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
56340373|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56340374|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340375|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56340376|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56340377|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56340378|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
56340379|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56340380|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56340381|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
56340382|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340383|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
56340384|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56340385|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56340386|NCT00131989|Sorafenib|sorafenib|mesh-list
56340387|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340388|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56340389|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340390|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340391|NCT00132067|Vorinostat|vorinostat|mesh-list
56340392|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340393|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56340394|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340395|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340396|NCT00132106|Phentolamine|phentolamine|mesh-list
56340397|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56340398|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56340399|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
56340400|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340401|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340402|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340403|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56340404|NCT00080340|Gefitinib|gefitinib|mesh-list
56340405|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340406|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56340407|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340408|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340409|NCT00132184|Vitamin D|vitamin d|mesh-list
56340410|NCT00132184|Vitamins|vitamins|mesh-ancestor
56340411|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
56340412|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650491|NCT04409834|Clopidogrel|clopidogrel|mesh-list
56340413|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56340414|NCT00132379|Docetaxel|docetaxel|mesh-list
56340415|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340416|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340417|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340418|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340419|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340420|NCT00132418|Etanercept|etanercept|mesh-list
56340421|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56340422|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56340423|NCT00132418|Analgesics|analgesics|mesh-ancestor
56340424|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
56340425|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340426|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340427|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340428|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340429|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56340430|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340431|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
56340433|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
56340434|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
56340435|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56340436|NCT00132535|Amebicides|amebicides|mesh-ancestor
56340437|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56340438|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56340439|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340440|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
56340441|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340442|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56340443|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340444|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340445|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56340446|NCT00132535|Renal Agents|renal agents|mesh-ancestor
56340448|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340449|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340450|NCT00132652|Lamivudine|lamivudine|mesh-list
56340451|NCT00132652|Telbivudine|telbivudine|mesh-list
56340452|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56340453|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56340454|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340455|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340456|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
56340457|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340458|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56340459|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56340460|NCT00046748|Omalizumab|omalizumab|mesh-list
56340461|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56340462|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56340463|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
56340464|NCT00132886|Tolvaptan|tolvaptan|mesh-list
56340465|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56340466|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340467|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
56340468|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340470|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340471|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340472|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340473|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340474|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340475|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340476|NCT00132925|Triamcinolone|triamcinolone|mesh-list
56340477|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340478|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
56340479|NCT00132925|Hormones|hormones|mesh-ancestor
56340480|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340481|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340482|NCT00133003|Abciximab|abciximab|mesh-list
56340483|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
56340484|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56340485|NCT00046787|Lurtotecan|lurtotecan|mesh-list
56340486|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340487|NCT00133042|Omalizumab|omalizumab|mesh-list
55962289|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340488|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56650492|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56650493|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56650494|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56650495|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56340489|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56340490|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
56340491|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
56340492|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56340493|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340494|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
56340495|NCT00133198|Pramipexole|pramipexole|mesh-list
56340496|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
56340497|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340498|NCT00133198|Protective Agents|protective agents|mesh-ancestor
56340499|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340500|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56340501|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56340502|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
56340503|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
56340504|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340505|NCT00046826|Thalidomide|thalidomide|mesh-list
56340507|NCT00046826|Estramustine|estramustine|mesh-list
56340508|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340509|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340510|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340511|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340514|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
56340515|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340516|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
56340517|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56340518|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340519|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56340520|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56340521|NCT00046826|Growth Substances|growth substances|mesh-ancestor
56340522|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
56340523|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56340524|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
56340525|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56340526|NCT00133237|Sirolimus|sirolimus|mesh-list
56340527|NCT00133237|Paclitaxel|paclitaxel|mesh-list
56340528|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340529|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340530|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340531|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340532|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340533|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340534|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56340535|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340536|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340537|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
56340538|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340539|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
56340540|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340541|NCT00399672|Interferons|interferons|mesh-list
56340542|NCT00399672|Ribavirin|ribavirin|mesh-list
56340543|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340544|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
56340545|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340546|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
56340547|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340548|NCT00133276|Citalopram|citalopram|mesh-list
56340549|NCT00133276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56340550|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56340551|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56340552|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340553|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340554|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
56340555|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340556|NCT00133276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56340557|NCT00133276|Antidepressive Agents|antidepressive agents|mesh-ancestor
56650496|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
56340558|NCT00133276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56340559|NCT00133315|Adalimumab|adalimumab|mesh-list
56340560|NCT00133315|Etanercept|etanercept|mesh-list
56340561|NCT00133315|Infliximab|infliximab|mesh-list
56340562|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340563|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962362|NCT01795235|Hormones|hormones|mesh-ancestor
56340564|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
56340565|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56340566|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56340567|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56340568|NCT00133315|Analgesics|analgesics|mesh-ancestor
56340569|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
56340570|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340571|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340572|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340573|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
56340574|NCT00080496|Imipenem|imipenem|mesh-list
56340575|NCT00080496|Tigecycline|tigecycline|mesh-list
56340576|NCT00080496|Cilastatin|cilastatin|mesh-list
56340577|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56340578|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340579|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56340580|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340581|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340582|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
56340583|NCT00133354|Anastrozole|anastrozole|mesh-list
56340585|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340587|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56340588|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340589|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56340590|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56340591|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340592|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340593|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56340594|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
56340595|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
56340596|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56340597|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340598|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340599|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56340600|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56340601|NCT00133393|Protective Agents|protective agents|mesh-ancestor
56340602|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340603|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
56340604|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56340605|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
56340606|NCT00046904|Etanercept|etanercept|mesh-list
56340607|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56340608|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56340609|NCT00046904|Analgesics|analgesics|mesh-ancestor
56340610|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
56340611|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340612|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340613|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340614|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340615|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56340616|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340617|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
56340618|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56340619|NCT00403897|Laxatives|laxatives|mesh-ancestor
56340620|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56340621|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56340622|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56340623|NCT00046943|Atrasentan|atrasentan|mesh-list
56340624|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340625|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56340626|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56340627|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340628|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56340629|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
56340630|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340631|NCT00080613|Exemestane|exemestane|mesh-list
56340632|NCT00080613|Hormones|hormones|mesh-list
56650497|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650498|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650499|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340633|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340634|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340635|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340636|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56340637|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56340638|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340639|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340640|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56340641|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
56340642|NCT00047021|Cytarabine|cytarabine|mesh-list
56340643|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
56340644|NCT00047021|Sargramostim|sargramostim|mesh-list
56340645|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56340646|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
56340647|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340648|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340649|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
56340650|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340651|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340652|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
56340653|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340654|NCT00047021|Analgesics|analgesics|mesh-ancestor
56340655|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
56340659|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340661|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
56340662|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
56340663|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56340664|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
56340665|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
56340666|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340667|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340668|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340669|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56340670|NCT00133744|Folic Acid|folic acid|mesh-list
56170266|NCT03198078|Aripiprazole|aripiprazole|mesh-list
56340671|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
56340672|NCT00133744|Vitamins|vitamins|mesh-ancestor
56340673|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
56340674|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340675|NCT00133744|Hematinics|hematinics|mesh-ancestor
56340676|NCT00080808|Phentolamine|phentolamine|mesh-list
56340677|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
56340678|NCT00080808|Alprostadil|alprostadil|mesh-list
56340679|NCT00080808|Papaverine|papaverine|mesh-list
56340680|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340681|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
56340682|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56340683|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56340684|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340685|NCT00080808|Urological Agents|urological agents|mesh-ancestor
56340686|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56340687|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56340688|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
56340689|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340690|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340691|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56340692|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56340693|NCT00047099|Tamoxifen|tamoxifen|mesh-list
56340694|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
56340695|NCT00047099|Docetaxel|docetaxel|mesh-list
56340696|NCT00047099|Fluorouracil|fluorouracil|mesh-list
56340697|NCT00047099|Epirubicin|epirubicin|mesh-list
56340698|NCT00047099|Goserelin|goserelin|mesh-list
56340699|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340700|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
56340701|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340702|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340703|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56340704|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
56340705|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650500|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
56650501|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56650502|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56340706|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340707|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56340708|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340709|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340710|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340711|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
56340712|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56340713|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340714|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56340715|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56340716|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340717|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56340718|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
56340719|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340720|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56340721|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56340722|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56340723|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56340725|NCT00133822|Sertraline|sertraline|mesh-list
56340726|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56340727|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
56340728|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340729|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340731|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56340732|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56340733|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56340734|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56340735|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56340736|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
56340737|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
56340738|NCT00133822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56340739|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56340740|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56340741|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
56340742|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56340743|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56340744|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340745|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
56340746|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340747|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340749|NCT00134095|Tegafur|tegafur|mesh-list
56340750|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56340751|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56340752|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340753|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340754|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340755|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56340756|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
56340757|NCT00047138|Dactinomycin|dactinomycin|mesh-list
56340758|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
56340759|NCT00047138|Carboplatin|carboplatin|mesh-list
56340760|NCT00047138|Doxorubicin|doxorubicin|mesh-list
56340761|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56340762|NCT00047138|Etoposide|etoposide|mesh-list
56340763|NCT00047138|Vincristine|vincristine|mesh-list
56340764|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340765|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
56340766|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340767|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340768|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56340769|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
56340770|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340771|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340772|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56340773|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340774|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56340775|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56340776|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968679|NCT00654511|Fentanyl|fentanyl|mesh-list
56340777|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340778|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340779|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340780|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340781|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56340782|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340783|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56340784|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56340785|NCT00080847|Prednisone|prednisone|mesh-list
56340786|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
56340787|NCT00080847|Rituximab|rituximab|mesh-list
56340788|NCT00080847|Doxorubicin|doxorubicin|mesh-list
56340789|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55962584|NCT00442507|Bevacizumab|bevacizumab|mesh-list
56340790|NCT00080847|Vincristine|vincristine|mesh-list
56340791|NCT00080847|Oblimersen|oblimersen|mesh-list
56340792|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340793|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
56340794|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340795|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340796|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56340797|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
56340798|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340799|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340800|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56340801|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56340802|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340803|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56340804|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56340805|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340806|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340807|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
56340809|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340810|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56340811|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340812|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340813|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340814|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340816|NCT00134173|Torcetrapib|torcetrapib|mesh-list
56340817|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56340818|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56340819|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
56170270|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56340820|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340822|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56340823|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340824|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
56340825|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340826|NCT00080886|Cytarabine|cytarabine|mesh-list
56340827|NCT00080886|Rituximab|rituximab|mesh-list
56340828|NCT00080886|Etoposide|etoposide|mesh-list
56340829|NCT00080886|Melphalan|melphalan|mesh-list
56340830|NCT00080886|Carmustine|carmustine|mesh-list
56340831|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56340832|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340833|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
56340834|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340835|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340836|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340837|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56340838|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56340839|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340840|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340841|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56340842|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
56340843|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
56340844|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340845|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340846|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56340847|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
56340848|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56340849|NCT00134212|Epinephrine|epinephrine|mesh-list
56340850|NCT00134212|Norepinephrine|norepinephrine|mesh-list
56340851|NCT00134212|Dopexamine|dopexamine|mesh-list
56340852|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56650503|NCT02647632|Ribavirin|ribavirin|mesh-list
56650504|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
56650505|NCT02647632|Grazoprevir|grazoprevir|mesh-list
56650506|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56650507|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
56650508|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650509|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
56650510|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650511|NCT00621452|Aldesleukin|aldesleukin|mesh-list
56650512|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
56650513|NCT00621452|Interleukin-2|interleukin-2|mesh-list
56650514|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56650515|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
56296546|NCT00106288|Micafungin|micafungin|mesh-list
56650516|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650517|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650518|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56650519|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
56650520|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340853|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56340854|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56340855|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56340856|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340857|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340858|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56340859|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56340860|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
56340861|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340862|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56340863|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
56340864|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
56340865|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
55962657|NCT00448201|Methotrexate|methotrexate|mesh-list
56340866|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56340867|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
56340868|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
56340869|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
56340870|NCT00134290|Metformin|metformin|mesh-list
56340871|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56340872|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340873|NCT00047216|Tipifarnib|tipifarnib|mesh-list
56340874|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340875|NCT00080925|Cytarabine|cytarabine|mesh-list
56340876|NCT00080925|Cyclosporine|cyclosporine|mesh-list
56340877|NCT00080925|Prednisone|prednisone|mesh-list
56340878|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
56340879|NCT00080925|Rituximab|rituximab|mesh-list
56340880|NCT00080925|Doxorubicin|doxorubicin|mesh-list
56340882|NCT00080925|Fludarabine|fludarabine|mesh-list
56340883|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
56340884|NCT00080925|Etoposide|etoposide|mesh-list
56340885|NCT00080925|Vincristine|vincristine|mesh-list
56340886|NCT00080925|Cyclosporins|cyclosporins|mesh-list
56340887|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340888|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
56340889|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340890|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340891|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56340892|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
56340893|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650521|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650522|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56650523|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56650524|NCT00621452|Analgesics|analgesics|mesh-ancestor
56650525|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
56650526|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650527|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56650528|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56650529|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
56650530|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650531|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
56650532|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
56650533|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56650534|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56650535|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650536|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650537|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650538|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650539|NCT00651612|Timolol|timolol|mesh-list
56650540|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56650541|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56340894|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340895|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56340896|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56340897|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340898|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56340899|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56340900|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340901|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340902|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
56340903|NCT00080925|Hormones|hormones|mesh-ancestor
56340904|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56340905|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56340906|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56340907|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
56340908|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340909|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
56340910|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340911|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340912|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340913|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340914|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
56340915|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
56340916|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56340917|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56340918|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56340919|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340920|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
56340921|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340922|NCT00047255|Carboplatin|carboplatin|mesh-list
56340923|NCT00047255|Docetaxel|docetaxel|mesh-list
56340924|NCT00047255|Trastuzumab|trastuzumab|mesh-list
56340925|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340926|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340927|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340928|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
56213645|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56340929|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340930|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56340931|NCT00134368|Etanercept|etanercept|mesh-list
56340932|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56340933|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56340934|NCT00134368|Analgesics|analgesics|mesh-ancestor
56340935|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
56340936|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340937|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340938|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340939|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340940|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56340941|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340942|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
56340943|NCT00134485|Atorvastatin|atorvastatin|mesh-list
56340944|NCT00134485|Torcetrapib|torcetrapib|mesh-list
56340945|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56340946|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56340947|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
56340948|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340949|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56340950|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56340951|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340952|NCT00047294|Thalidomide|thalidomide|mesh-list
56340953|NCT00047294|Celecoxib|celecoxib|mesh-list
56340954|NCT00047294|Temozolomide|temozolomide|mesh-list
56340955|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56340956|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
56340957|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340958|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340959|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56340960|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56340961|NCT00047294|Analgesics|analgesics|mesh-ancestor
56340962|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
56340963|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340964|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340965|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56340966|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56340967|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56340968|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56340970|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340971|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
56340972|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
56340973|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56340974|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340975|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56340976|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56340977|NCT00047294|Growth Substances|growth substances|mesh-ancestor
56340978|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
56340979|NCT00042822|Romidepsin|romidepsin|mesh-list
56340980|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56340981|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340982|NCT00134641|Gemcitabine|gemcitabine|mesh-list
56340983|NCT00134641|Vinorelbine|vinorelbine|mesh-list
56340984|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56340985|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
56340986|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340987|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340988|NCT00134641|Antiviral Agents|antiviral agents|mesh-ancestor
56340989|NCT00134641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56340990|NCT00134641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56340991|NCT00134641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340992|NCT00134641|Immunologic Factors|immunologic factors|mesh-ancestor
56340993|NCT00134641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340994|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56340995|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
56340996|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
56340997|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340998|NCT00134680|Trastuzumab|trastuzumab|mesh-list
56340999|NCT00134680|Letrozole|letrozole|mesh-list
56341000|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56341001|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341002|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56650542|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56650543|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56650544|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56650545|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
56650546|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650547|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650548|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650549|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56341003|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56341004|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341005|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341006|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56341007|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
56341008|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341009|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341010|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56341011|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56341012|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341013|NCT00081042|Paclitaxel|paclitaxel|mesh-list
56341014|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56341015|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56341016|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962815|NCT01421342|Bupropion|bupropion|mesh-list
56341017|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56341018|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
56341019|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56341020|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341021|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56341022|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341023|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56341024|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341025|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341026|NCT00134875|Buprenorphine|buprenorphine|mesh-list
56341027|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56341028|NCT00134875|Naloxone|naloxone|mesh-list
56341029|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56341032|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341033|NCT00134875|Analgesics|analgesics|mesh-ancestor
56341034|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
56341035|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341036|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56341037|NCT00134914|Buprenorphine|buprenorphine|mesh-list
56341038|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56341039|NCT00134914|Narcotics|narcotics|mesh-ancestor
56341040|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341041|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341042|NCT00134914|Analgesics|analgesics|mesh-ancestor
56341043|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
56341044|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341045|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56341046|NCT00134953|Rivastigmine|rivastigmine|mesh-list
56341047|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56341048|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341049|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341050|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
56341051|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341052|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341053|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56341054|NCT00134953|Protective Agents|protective agents|mesh-ancestor
56341055|NCT00042861|Leucovorin|leucovorin|mesh-list
56341056|NCT00042861|Fluorouracil|fluorouracil|mesh-list
56341057|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56341058|NCT00042861|Calcium|calcium|mesh-list
56341059|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
56341060|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55968997|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56341061|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341062|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
56341063|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341064|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56341065|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341066|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341067|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
56341068|NCT00042861|Antidotes|antidotes|mesh-ancestor
56341069|NCT00042861|Protective Agents|protective agents|mesh-ancestor
56341070|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
56341071|NCT00042861|Vitamins|vitamins|mesh-ancestor
56341072|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
56341073|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56341074|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341075|NCT00134992|Prednisolone|prednisolone|mesh-list
56341076|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56341077|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
56341078|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56341079|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
56341080|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56341081|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
56341082|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56341083|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
56341084|NCT00134992|Hormones|hormones|mesh-ancestor
56341085|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341086|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341087|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56341088|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341089|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
56341090|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
56341091|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341092|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341093|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56341094|NCT00134992|Protective Agents|protective agents|mesh-ancestor
56341095|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
56341096|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56341097|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341098|NCT00135187|Dexamethasone|dexamethasone|mesh-list
56341099|NCT00135187|Bortezomib|bortezomib|mesh-list
56341100|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56341101|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
56341102|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
56341103|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341104|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341107|NCT00135187|Hormones|hormones|mesh-ancestor
56341108|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341109|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56341110|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341111|NCT00145093|Chromium|chromium|mesh-list
56341112|NCT00145093|Trace Elements|trace elements|mesh-ancestor
56341113|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
56341114|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341116|NCT00047450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56341117|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56341118|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56341119|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341120|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341121|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
56341122|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341123|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56341124|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
56341125|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56341126|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
56341127|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341128|NCT00145171|Apomorphine|apomorphine|mesh-list
56341129|NCT00145171|Emetics|emetics|mesh-ancestor
56341130|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341131|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
56341132|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341133|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341134|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
56341135|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
56341136|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268998|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
56650550|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56650551|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56650552|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56650553|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56650554|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56650555|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56650556|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
56650557|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650558|NCT02831933|Valacyclovir|valacyclovir|mesh-list
56650559|NCT02831933|Nivolumab|nivolumab|mesh-list
56650560|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56650561|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650562|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56650563|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650564|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
56650565|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650566|NCT02650206|Liraglutide|liraglutide|mesh-list
56650567|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56341137|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341138|NCT00145210|Atenolol|atenolol|mesh-list
56341139|NCT00145210|Nebivolol|nebivolol|mesh-list
56341140|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56341141|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56341142|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
56341143|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
56341144|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341145|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341146|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56341147|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56341148|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56341149|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
56341150|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341151|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341152|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
56341153|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56341154|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56341155|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56341156|NCT00081276|Cisplatin|cisplatin|mesh-list
56341157|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341158|NCT00145405|Octreotide|octreotide|mesh-list
56341159|NCT00145405|Lanreotide|lanreotide|mesh-list
56341160|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341161|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56341162|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341163|NCT00145444|Olanzapine|olanzapine|mesh-list
56341164|NCT00145444|Ziprasidone|ziprasidone|mesh-list
56341165|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
56341166|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
56341167|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341168|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341169|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341170|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56341171|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56341172|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341173|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56341174|NCT00145444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56341175|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56650568|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650569|NCT02650206|Incretins|incretins|mesh-ancestor
56650570|NCT02650206|Hormones|hormones|mesh-ancestor
56650571|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650572|NCT05368766|Diuretics|diuretics|mesh-list
56650573|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
56650574|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650575|NCT00891293|Fenofibrate|fenofibrate|mesh-list
56341176|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56341177|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341178|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341181|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56341182|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
56341183|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
56341184|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
56341185|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56341186|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55841539|NCT04144582|Docetaxel|docetaxel|mesh-list
56341187|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341188|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341189|NCT00145483|Urological Agents|urological agents|mesh-ancestor
56341191|NCT00145522|Estradiol|estradiol|mesh-list
56341192|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
56341193|NCT00145522|Estrogens|estrogens|mesh-ancestor
56341194|NCT00145522|Hormones|hormones|mesh-ancestor
56341195|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341196|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341197|NCT00145522|Progestins|progestins|mesh-ancestor
56341198|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
56341199|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
56341200|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56341201|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56341202|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341203|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56341204|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
56341205|NCT00081315|Amifostine|amifostine|mesh-list
56341206|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56341207|NCT00081315|Protective Agents|protective agents|mesh-ancestor
56341208|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341209|NCT00145561|Ritonavir|ritonavir|mesh-list
56341210|NCT00145561|Saquinavir|saquinavir|mesh-list
56341211|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56341212|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56341213|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
56341214|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341215|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341216|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56341217|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56341218|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
56341219|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341220|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56341221|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56341222|NCT00145639|Carboplatin|carboplatin|mesh-list
56341223|NCT00145639|Doxorubicin|doxorubicin|mesh-list
56341224|NCT00145639|Ifosfamide|ifosfamide|mesh-list
56341225|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341226|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56341227|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56341228|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56341229|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341230|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341231|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56341232|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
56341233|NCT00047567|Zonisamide|zonisamide|mesh-list
56341234|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
56341235|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56341236|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56268999|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650576|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56650577|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
56341237|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341238|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56341239|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341240|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56341241|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
56341242|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341243|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
56341244|NCT00145990|Miotics|miotics|mesh-ancestor
55963035|NCT01796899|Brivaracetam|brivaracetam|mesh-list
56341245|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
56341246|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341247|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341248|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56341249|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56341250|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
56341251|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56341252|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56341253|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
56341256|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
56341257|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56341258|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
56341259|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341260|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341261|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
56341262|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341263|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
56341264|NCT00081471|Hematinics|hematinics|mesh-ancestor
56341265|NCT00047645|Interferons|interferons|mesh-list
56341266|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
56341267|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341268|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
56341269|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341271|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
56341272|NCT00146146|Dutasteride|dutasteride|mesh-list
56341273|NCT00146146|Testosterone|testosterone|mesh-list
56341274|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
56341275|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
56341276|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56341277|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341278|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56341279|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56341280|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341281|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341282|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56341283|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
56341284|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341285|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341286|NCT00146146|Androgens|androgens|mesh-ancestor
56341287|NCT00146146|Hormones|hormones|mesh-ancestor
56341288|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56341289|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
56341290|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56341291|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
56341292|NCT00146224|Hematinics|hematinics|mesh-ancestor
56341293|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
56341294|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341295|NCT00146341|Telmisartan|telmisartan|mesh-list
56341296|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56341297|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56341298|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56341299|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341300|NCT00146380|Lamivudine|lamivudine|mesh-list
56341301|NCT00146380|Zidovudine|zidovudine|mesh-list
56341302|NCT00146380|Nevirapine|nevirapine|mesh-list
56341303|NCT00146380|Nelfinavir|nelfinavir|mesh-list
56341304|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56341305|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56341306|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341307|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341308|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
56341309|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341310|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56650578|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213686|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56341311|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56341312|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
56341313|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56341314|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56341315|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56341316|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56341317|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
56341318|NCT00081588|Darunavir|darunavir|mesh-list
56341319|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56341320|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56341321|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
56341322|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341323|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341324|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56341325|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56341326|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
56341327|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341328|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56341332|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56341333|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341334|NCT00146497|Budesonide|budesonide|mesh-list
56341335|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56341336|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56341337|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56341338|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
56341339|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341340|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341341|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56341342|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
56341343|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
56341344|NCT00146497|Hormones|hormones|mesh-ancestor
56341345|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341346|NCT02957890|Vaccines|vaccines|mesh-list
56341347|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
56341348|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341349|NCT00146575|Sirolimus|sirolimus|mesh-list
56341350|NCT00146575|Paclitaxel|paclitaxel|mesh-list
56341351|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56341352|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341353|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
56341354|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
56341355|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
56341356|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341357|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56341358|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341359|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56341360|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
56341361|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341362|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
56341363|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341364|NCT00146614|Sirolimus|sirolimus|mesh-list
56341365|NCT00146614|Methotrexate|methotrexate|mesh-list
56341366|NCT00146614|Tacrolimus|tacrolimus|mesh-list
56341367|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56341368|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
56341369|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56341370|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341371|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56341372|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
56341373|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341374|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341375|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
56341376|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341377|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56341378|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341379|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
56341380|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56341381|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56341382|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56341383|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56341384|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650579|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56650580|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
55969389|NCT03779048|Phentermine|phentermine|mesh-list
56341385|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56341386|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
56341387|NCT00047762|Bevacizumab|bevacizumab|mesh-list
56341388|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56341389|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56341390|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341391|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56341392|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56341393|NCT00047762|Growth Substances|growth substances|mesh-ancestor
56341394|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341395|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
56341396|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56341397|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341398|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341399|NCT00042978|Carboplatin|carboplatin|mesh-list
56341400|NCT00042978|Etoposide|etoposide|mesh-list
56341401|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
56341402|NCT00042978|Oblimersen|oblimersen|mesh-list
56341405|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56341406|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56341407|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341408|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341410|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56341411|NCT00405730|Nepafenac|nepafenac|mesh-list
56341412|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56341413|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56341414|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56341415|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56341416|NCT00405730|Analgesics|analgesics|mesh-ancestor
56341417|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
56341418|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341419|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341420|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56341421|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56341422|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56341423|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341424|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341425|NCT00405769|Red yeast rice|red yeast rice|mesh-list
56341426|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56341427|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56341428|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56341429|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
56341430|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341431|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341432|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56341433|NCT00047801|Docetaxel|docetaxel|mesh-list
56341434|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341435|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
56341436|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
56341437|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
56341438|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341439|NCT00146731|Artesunate|artesunate|mesh-list
56341440|NCT00146731|Amodiaquine|amodiaquine|mesh-list
56341441|NCT00146731|Dapsone|dapsone|mesh-list
56341442|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
56341443|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
56341444|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56341445|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56341446|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341447|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341448|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
56341449|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
56341450|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56341451|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
56341452|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56341453|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341454|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341455|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
56341456|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56341457|NCT00047840|Docetaxel|docetaxel|mesh-list
56341458|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650581|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56650582|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
55969460|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56341459|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
56341460|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
56341461|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
56341462|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341463|NCT00146926|Lidocaine|lidocaine|mesh-list
56341464|NCT00146926|Ephedrine|ephedrine|mesh-list
56341465|NCT00146926|Ketamine|ketamine|mesh-list
56341466|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
56341467|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
56341468|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341469|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963258|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
56341470|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
56341471|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341472|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56341473|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56341474|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56341476|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341478|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56341479|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56341480|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
56341481|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56341482|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56341483|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341484|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56341486|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
56341487|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56341488|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
56341489|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
56341490|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56341491|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56341492|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56341493|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56341494|NCT00147121|Rituximab|rituximab|mesh-list
56341495|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56341496|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341497|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
56341498|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341499|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56341500|NCT00147160|Temozolomide|temozolomide|mesh-list
56341501|NCT00147160|Cisplatin|cisplatin|mesh-list
56341502|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56341503|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
56341504|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341505|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341506|NCT04732104|Lidocaine|lidocaine|mesh-list
56341507|NCT04732104|Xylometazoline|xylometazoline|mesh-list
56341508|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
56341509|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
56341510|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
56341511|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341512|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341513|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
56341514|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341515|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56341516|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56341517|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56341518|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56341519|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341520|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56341521|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
56341522|NCT00147355|Acetaminophen|acetaminophen|mesh-list
56341523|NCT00147355|Ibuprofen|ibuprofen|mesh-list
56341524|NCT00147355|Codeine|codeine|mesh-list
56341525|NCT00147355|Ondansetron|ondansetron|mesh-list
56341526|NCT00147355|Metoclopramide|metoclopramide|mesh-list
56341527|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56341528|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56341529|NCT00147355|Analgesics|analgesics|mesh-ancestor
56269000|NCT01986309|Lidocaine|lidocaine|mesh-list
56650583|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650584|NCT00889421|Apremilast|apremilast|mesh-list
56650585|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56650586|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56341530|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
56341531|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341532|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341533|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56341534|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56341535|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56341536|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341537|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341538|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
56341539|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
56341540|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
56341541|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341542|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
56341543|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
56341544|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56341545|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
56341546|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341547|NCT00147355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56341548|NCT00147355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56170296|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
56341549|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341552|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56341553|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56341554|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
56341555|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56341557|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
56341558|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
56341559|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
56341560|NCT00048152|Cyclosporine|cyclosporine|mesh-list
56341561|NCT00048152|Cyclosporins|cyclosporins|mesh-list
56341562|NCT00048152|Daclizumab|daclizumab|mesh-list
56341563|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56341564|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341565|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56341566|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
56341567|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56341568|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341569|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341570|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341571|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
56341572|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
56341573|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341574|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
56341575|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341576|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56341577|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56341578|NCT00147394|Risperidone|risperidone|mesh-list
56341579|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56341580|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
56341581|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341582|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341583|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341584|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56341585|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56341586|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341587|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56341588|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56341589|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
56341590|NCT04725682|Tacrolimus|tacrolimus|mesh-list
56341591|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341592|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
56341593|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341594|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56341595|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341596|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341597|NCT00147511|Linezolid|linezolid|mesh-list
56341598|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56341599|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650587|NCT00889421|Analgesics|analgesics|mesh-ancestor
56650588|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
56213693|NCT02467478|Linagliptin|linagliptin|mesh-list
56341600|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56341601|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341602|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341603|NCT00043095|Gemcitabine|gemcitabine|mesh-list
56341604|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56341605|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
56341606|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341607|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341608|NCT00043095|Antiviral Agents|antiviral agents|mesh-ancestor
56341609|NCT00043095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341610|NCT00043095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341611|NCT00043095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341612|NCT00043095|Immunologic Factors|immunologic factors|mesh-ancestor
56341613|NCT00043095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341614|NCT00048230|Bortezomib|bortezomib|mesh-list
56341615|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341616|NCT00147589|Eplerenone|eplerenone|mesh-list
56341617|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56341618|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
56341619|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341620|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341621|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55963466|NCT01397162|Xhance|xhance|mesh-list
56341622|NCT00147589|Diuretics|diuretics|mesh-ancestor
56341623|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
56341624|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56341625|NCT00397332|Alefacept|alefacept|mesh-list
56341628|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341629|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
56341630|NCT00147628|Citric Acid|citric acid|mesh-list
56341631|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
56341632|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
56341633|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56341634|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
56341635|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
56341636|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341637|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
56341638|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56341639|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56341640|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341641|NCT00147628|Urological Agents|urological agents|mesh-ancestor
56341642|NCT00147667|Erythromycin|erythromycin|mesh-list
56341643|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
56341644|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56341645|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
56341646|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56341647|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341648|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341649|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56341650|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341651|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341652|NCT00147784|Interferons|interferons|mesh-list
56341654|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341655|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
56341656|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341657|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
56341658|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341659|NCT00081744|Tigecycline|tigecycline|mesh-list
56341660|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56341661|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341662|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56341663|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341664|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341665|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
56341666|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56341667|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56341668|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341669|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
56341670|NCT00147862|Coagulants|coagulants|mesh-ancestor
56341671|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
56341672|NCT00147901|Fludarabine|fludarabine|mesh-list
56650589|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650590|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213696|NCT02467478|Incretins|incretins|mesh-ancestor
56341673|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
56341674|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341675|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
56341676|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341677|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56341678|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56341679|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
56341680|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341681|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341682|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56341683|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56341684|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
56341685|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56341686|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
56341687|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
56341688|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341689|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341690|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56341691|NCT02957851|Analgesics|analgesics|mesh-ancestor
56341692|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
56341693|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341694|NCT00147979|Heparin|heparin|mesh-list
56341695|NCT00147979|Calcium heparin|calcium heparin|mesh-list
56341697|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56341698|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56341699|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341700|NCT00148018|Dexamethasone|dexamethasone|mesh-list
56341705|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341706|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341707|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341709|NCT00148018|Hormones|hormones|mesh-ancestor
56341710|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341711|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56341712|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341713|NCT00081822|Cytarabine|cytarabine|mesh-list
56341714|NCT00081822|Clofarabine|clofarabine|mesh-list
56341715|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56341716|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
56341717|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341718|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341719|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
56341720|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341721|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341722|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
56341723|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341724|NCT00048425|Simendan|simendan|mesh-list
56341725|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56341726|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
56341727|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56341728|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56341729|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341730|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341731|NCT00048425|Protective Agents|protective agents|mesh-ancestor
56341732|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341733|NCT00148135|Gemcitabine|gemcitabine|mesh-list
56341734|NCT00148135|Carboplatin|carboplatin|mesh-list
56341735|NCT00148135|Capecitabine|capecitabine|mesh-list
56341736|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341737|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56341738|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
56341739|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341740|NCT00148135|Antiviral Agents|antiviral agents|mesh-ancestor
56341741|NCT00148135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341742|NCT00148135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341743|NCT00148135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341744|NCT00148135|Immunologic Factors|immunologic factors|mesh-ancestor
56341745|NCT00148135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341746|NCT00399711|Metformin|metformin|mesh-list
56341747|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
56650591|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650592|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56341748|NCT00399711|Repaglinide|repaglinide|mesh-list
56341749|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56341750|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341751|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
56341752|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56341753|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341754|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56341755|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
56341756|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56341757|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341758|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341759|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341760|NCT00148291|Docetaxel|docetaxel|mesh-list
56341761|NCT00148291|Vinorelbine|vinorelbine|mesh-list
56341762|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341763|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
56341764|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
56341765|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
56341766|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341767|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56341768|NCT00148330|Triamcinolone|triamcinolone|mesh-list
56341769|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56341770|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
56341771|NCT00148330|Hormones|hormones|mesh-ancestor
56341772|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341775|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56341776|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56341777|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56341778|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341779|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341781|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341782|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341783|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
56341784|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56341785|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341787|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56341788|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341789|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341790|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56341791|NCT00405847|Analgesics|analgesics|mesh-ancestor
56341792|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
56341793|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341794|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56341795|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56341796|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56341797|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
56341798|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341799|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341800|NCT00148408|Montelukast|montelukast|mesh-list
56341801|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56341802|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
56341803|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56341804|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
56341805|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341806|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341807|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56341808|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56341809|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341810|NCT00048503|Tipifarnib|tipifarnib|mesh-list
56341811|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341812|NCT00148447|Citalopram|citalopram|mesh-list
56341813|NCT00148447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56341814|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56341815|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56341816|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341817|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341818|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
56650593|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56650594|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56650595|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341819|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341820|NCT00148447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56341821|NCT00148447|Antidepressive Agents|antidepressive agents|mesh-ancestor
56341822|NCT00148447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56341823|NCT00043134|Decitabine|decitabine|mesh-list
56341824|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56341825|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
56341826|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341827|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341828|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341829|NCT00148564|Olanzapine|olanzapine|mesh-list
56341830|NCT00148564|Ziprasidone|ziprasidone|mesh-list
56341831|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
56341832|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
56341833|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341834|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341835|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341836|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56341837|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56341838|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341839|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56341840|NCT00148564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56341841|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56341842|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56341843|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341848|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
56341849|NCT00148603|Montelukast|montelukast|mesh-list
56341850|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56341851|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
56341852|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56341853|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
56341854|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56341855|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341856|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56341857|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56341858|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341859|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
56341860|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56341861|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341862|NCT00148681|Paclitaxel|paclitaxel|mesh-list
56341863|NCT00148681|Vinorelbine|vinorelbine|mesh-list
56341864|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
56341865|NCT00148681|Doxorubicin|doxorubicin|mesh-list
56341866|NCT00148681|Trastuzumab|trastuzumab|mesh-list
56341867|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56341868|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341869|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
56341870|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
56341871|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
56341872|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341873|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341874|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
56341875|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341876|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56341877|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56341878|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
56341879|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56341880|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56341881|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56341882|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56341883|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341884|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56341885|NCT00148720|Capecitabine|capecitabine|mesh-list
56341886|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56341887|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
56650596|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650598|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
56341888|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341889|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341890|NCT00148837|Interferons|interferons|mesh-list
56341891|NCT00148837|Ribavirin|ribavirin|mesh-list
56341892|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
56341893|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
56341894|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56341895|NCT00148837|Prazosin|prazosin|mesh-list
56341896|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341897|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
56341898|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341899|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
56341900|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341901|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
56341902|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341903|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56341904|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56341905|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56341906|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56170308|NCT02458014|Blinatumomab|blinatumomab|mesh-list
56341907|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
56341908|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341910|NCT00148876|Trastuzumab|trastuzumab|mesh-list
56341911|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56341912|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
56341913|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341914|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341916|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
56341917|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56341918|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341919|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56341920|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56341921|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56341922|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56341923|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341924|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341925|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341926|NCT00149110|Analgesics|analgesics|mesh-ancestor
56341927|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
56341928|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341929|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
56341930|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56341931|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
56341932|NCT00149149|Polaprezinc|polaprezinc|mesh-list
56341933|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56341934|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341935|NCT00149188|Lanreotide|lanreotide|mesh-list
56341936|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341937|NCT00048776|Cilostazol|cilostazol|mesh-list
56341938|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56341939|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
56341940|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341941|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341942|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56341943|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
56341944|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56341945|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56341946|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341947|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56341948|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
56341949|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56341950|NCT00048776|Protective Agents|protective agents|mesh-ancestor
56341951|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56341952|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56341953|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341954|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
56341955|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56341956|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341957|NCT00048854|Sertraline|sertraline|mesh-list
56341958|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
56650599|NCT02827643|Lamivudine|lamivudine|mesh-list
56650600|NCT02827643|Calcium|calcium|mesh-list
56341959|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56341960|NCT00048854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56341961|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56341962|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56341963|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341964|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341965|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
56341966|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341967|NCT00081978|Etravirine|etravirine|mesh-list
56341968|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56341969|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56341970|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341971|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341972|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
56341974|NCT00149539|Buprenorphine|buprenorphine|mesh-list
56341975|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56341976|NCT00149539|Naloxone|naloxone|mesh-list
56341977|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56341978|NCT00149539|Narcotics|narcotics|mesh-ancestor
56341979|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341980|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341981|NCT00149539|Analgesics|analgesics|mesh-ancestor
56341982|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
56341983|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56341984|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56341985|NCT00149578|Leucovorin|leucovorin|mesh-list
56341986|NCT00149578|Gemcitabine|gemcitabine|mesh-list
56341987|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
56342002|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
56342003|NCT00149617|Buspirone|buspirone|mesh-list
56342004|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56342005|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342006|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342007|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342008|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342009|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56342010|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
56342011|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342012|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342013|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
56342014|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
56342015|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342016|NCT00149656|Selenium|selenium|mesh-list
56342017|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
56342018|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342019|NCT00149656|Protective Agents|protective agents|mesh-ancestor
56342020|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342021|NCT00149656|Trace Elements|trace elements|mesh-ancestor
56342022|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
56342023|NCT00082095|Doxorubicin|doxorubicin|mesh-list
56342024|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56342025|NCT00082095|Capecitabine|capecitabine|mesh-list
56342026|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56342027|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342028|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56342029|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56342030|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342031|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342032|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56342033|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
56342034|NCT00149851|Tegaserod|tegaserod|mesh-list
56342035|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56342036|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
56342037|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342038|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342039|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342040|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
56342041|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56342042|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342043|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56342044|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
56342045|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56342046|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650601|NCT02827643|Vitamins|vitamins|mesh-ancestor
56650602|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
56650603|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650604|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56650605|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56650606|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56650607|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56650608|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650609|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650610|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
56650611|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650612|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56650613|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56650614|NCT02646774|Micafungin|micafungin|mesh-list
56650615|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
56650616|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650617|NCT02647086|Metoprolol|metoprolol|mesh-list
56650618|NCT02647086|Midazolam|midazolam|mesh-list
56650619|NCT02647086|Caffeine|caffeine|mesh-list
56650620|NCT02647086|Omeprazole|omeprazole|mesh-list
56650621|NCT02647086|Warfarin|warfarin|mesh-list
56650622|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56650623|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56650624|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213708|NCT02466243|Hormones|hormones|mesh-ancestor
56342047|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342048|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342049|NCT00049088|Bevacizumab|bevacizumab|mesh-list
56342050|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56342054|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56342055|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342056|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56342057|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56342058|NCT00049088|Growth Substances|growth substances|mesh-ancestor
56342059|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342060|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
56342061|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
56342062|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
56342063|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
56342064|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56342065|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342066|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
56342067|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56342068|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342069|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56342070|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
56342071|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56342072|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342074|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342076|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56342077|NCT04725448|Bevacizumab|bevacizumab|mesh-list
56650625|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650626|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56650627|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56650628|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56650629|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56650630|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
56650631|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
56650632|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
56650633|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
56650634|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342078|NCT04725448|Carboplatin|carboplatin|mesh-list
56342079|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56342080|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342081|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
56342082|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
56342083|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
56342084|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342085|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56342086|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56342087|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56342088|NCT04725448|Growth Substances|growth substances|mesh-ancestor
56342089|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342090|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
56342091|NCT00405925|Lamivudine|lamivudine|mesh-list
56342092|NCT00405925|Zidovudine|zidovudine|mesh-list
56342093|NCT00405925|Abacavir|abacavir|mesh-list
56342094|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56342095|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56342096|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342097|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342098|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
56342099|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342100|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56342101|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56342102|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
56342103|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56342104|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342105|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56342106|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342107|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342108|NCT00082212|Cetuximab|cetuximab|mesh-list
56342109|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56342110|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342111|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
56342112|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56342113|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342114|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56342115|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
56342116|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56342117|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342118|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342119|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342120|NCT00150046|Everolimus|everolimus|mesh-list
56342121|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342122|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342123|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
56342124|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342125|NCT00150085|Cyclosporine|cyclosporine|mesh-list
56342126|NCT00150085|Cyclosporins|cyclosporins|mesh-list
56342127|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342129|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342130|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
56342131|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342132|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
56342133|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342134|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
56342135|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650635|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650636|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
56342136|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56342139|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56342140|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56342141|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
56342142|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342143|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56342144|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56342145|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342146|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
56342147|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
56342150|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342151|NCT00049244|Capecitabine|capecitabine|mesh-list
56342152|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56342153|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
56342154|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342155|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342156|NCT00150124|Methimazole|methimazole|mesh-list
56342157|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
56342158|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
56342159|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56342160|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342161|NCT00049283|Docetaxel|docetaxel|mesh-list
56342162|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56342163|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342164|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
56342165|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
56342166|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
56342167|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342168|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56342169|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342170|NCT00150241|Varenicline|varenicline|mesh-list
56342171|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56342172|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56342173|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
56342174|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342175|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342176|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342177|NCT00150280|Ibuprofen|ibuprofen|mesh-list
56342178|NCT00150280|Celecoxib|celecoxib|mesh-list
56342179|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56342180|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56342181|NCT00150280|Analgesics|analgesics|mesh-ancestor
56342182|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
56342183|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342184|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342185|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56342186|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342187|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56342188|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342189|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342190|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56342191|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
56342192|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342193|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
56342194|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56342195|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56342196|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170321|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
56342197|NCT00150358|Urological Agents|urological agents|mesh-ancestor
56342198|NCT00049361|Thalidomide|thalidomide|mesh-list
56342199|NCT00049361|Temozolomide|temozolomide|mesh-list
56342200|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56342201|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
56342204|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342205|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
56342206|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342207|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
56342208|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56342209|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650637|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56650638|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56342210|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56342211|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56342212|NCT00049361|Growth Substances|growth substances|mesh-ancestor
56342213|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
56342215|NCT00150436|Analgesics|analgesics|mesh-ancestor
55964002|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
56342216|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
56342217|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342218|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342219|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
56342220|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56342221|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342222|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342223|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56342224|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56342225|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342226|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342227|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342229|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
56342230|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
56342231|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342232|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342233|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342234|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342235|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56342236|NCT00150553|Analgesics|analgesics|mesh-ancestor
56342237|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
56342238|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342239|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56342240|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342241|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342242|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56342243|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56342244|NCT00150631|Candesartan|candesartan|mesh-list
56342245|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56342246|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56342247|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56342248|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342249|NCT00082446|Vaccines|vaccines|mesh-list
56342250|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
56342251|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342252|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
56342253|NCT00049439|Lomustine|lomustine|mesh-list
56342254|NCT00049439|Etoposide|etoposide|mesh-list
56342255|NCT00049439|Procarbazine|procarbazine|mesh-list
56342256|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342257|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
56342258|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342259|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342260|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56342261|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
56342262|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342263|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342264|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56342265|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56342266|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56342267|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56342268|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342269|NCT00150670|Cisplatin|cisplatin|mesh-list
56342270|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342271|NCT00150709|Levetiracetam|levetiracetam|mesh-list
56342272|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
56342277|NCT00150787|Levetiracetam|levetiracetam|mesh-list
56342278|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
56342279|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
56342280|NCT00150826|Quinapril|quinapril|mesh-list
56342281|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56342282|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
56342283|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342284|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650639|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650640|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56650641|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56650642|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
56342285|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56342286|NCT00150865|Ropivacaine|ropivacaine|mesh-list
56342287|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
56342288|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
56342289|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342290|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342292|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342293|NCT00049556|Gefitinib|gefitinib|mesh-list
56342294|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342295|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56342296|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342297|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342298|NCT00150982|Alefacept|alefacept|mesh-list
56342299|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
56342300|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
56342301|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342302|NCT00049634|Cyclosporine|cyclosporine|mesh-list
56342303|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
56342304|NCT00049634|Busulfan|busulfan|mesh-list
56342305|NCT00049634|Methotrexate|methotrexate|mesh-list
56342306|NCT00049634|Cyclosporins|cyclosporins|mesh-list
56342307|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342308|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
56342309|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342310|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342311|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56342312|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
56342313|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342314|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342315|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56342316|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56342317|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
56342318|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56342319|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56342320|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
56342321|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
56342322|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342323|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56342324|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56342325|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
56342326|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342327|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56342328|NCT00151060|Paclitaxel|paclitaxel|mesh-list
56342329|NCT00151060|Etoposide|etoposide|mesh-list
56342330|NCT00151060|Estramustine|estramustine|mesh-list
56342331|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56342332|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342333|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
56342334|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
56342335|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
56342336|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342337|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56342338|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56342339|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342340|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56342341|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
56342342|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56342343|NCT00151138|Atenolol|atenolol|mesh-list
56342344|NCT00151138|Lisinopril|lisinopril|mesh-list
56342345|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56342346|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
56342347|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342348|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342350|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56342351|NCT00151138|Protective Agents|protective agents|mesh-ancestor
56342352|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342353|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56342354|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
56650643|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56650644|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650645|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56650646|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56650647|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56342355|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
56342356|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342357|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56342358|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56342359|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56342360|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
56342361|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342362|NCT00082485|Baclofen|baclofen|mesh-list
56342363|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56342364|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342365|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56342366|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342367|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56342368|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
56342369|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
56342370|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342371|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342372|NCT00151255|Cytarabine|cytarabine|mesh-list
56342373|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
56342374|NCT00151255|Idarubicin|idarubicin|mesh-list
56342375|NCT00151255|Tretinoin|tretinoin|mesh-list
56342376|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56342377|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
56342378|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342379|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342380|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
56342381|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342382|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342383|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
56342384|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342385|NCT00151255|Analgesics|analgesics|mesh-ancestor
56342386|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
56342387|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342388|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56342389|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56342390|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342391|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56342392|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
56342393|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
56342394|NCT00049751|Adalimumab|adalimumab|mesh-list
56342395|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56342396|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342397|NCT00151294|Dexetimide|dexetimide|mesh-list
56342398|NCT00151294|Citalopram|citalopram|mesh-list
56342399|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
56342400|NCT00151294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56342401|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56342402|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342403|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342404|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342405|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
56342406|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342407|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56342408|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342409|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56342410|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56342411|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
56342412|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
56342413|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342414|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56342415|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56342416|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
56342417|NCT00151450|Pregabalin|pregabalin|mesh-list
56342418|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56342419|NCT00151450|Analgesics|analgesics|mesh-ancestor
56342420|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
56650648|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
56650649|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
56650650|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650651|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56650652|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56650653|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56650654|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
56650655|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
56650656|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56650657|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56342421|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342422|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342426|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342427|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56342428|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56342429|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342430|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342431|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342432|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56342433|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56342434|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342435|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56342436|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
56342437|NCT00151489|Pregabalin|pregabalin|mesh-list
56342438|NCT00151489|Analgesics|analgesics|mesh-ancestor
56342439|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
56342440|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342441|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342442|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
56342443|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56342444|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342445|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342446|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56342447|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56342448|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342449|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342450|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342451|NCT00049790|Paclitaxel|paclitaxel|mesh-list
56342452|NCT00049790|Carboplatin|carboplatin|mesh-list
56342453|NCT00049790|Angiostatins|angiostatins|mesh-list
56342454|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56342455|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342456|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
56342457|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
56342458|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56342459|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342460|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56342461|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56342462|NCT00049790|Growth Substances|growth substances|mesh-ancestor
56342463|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342464|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
56342465|NCT00082524|Caspofungin|caspofungin|mesh-list
56342466|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
56342467|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342468|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342469|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342470|NCT00406003|Paroxetine|paroxetine|mesh-list
56342471|NCT00406003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56342472|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56342473|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342474|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342475|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650658|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56650659|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342476|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
56342477|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342478|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56342479|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
56342480|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342481|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56342482|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56342483|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342484|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
56342485|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56342486|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342487|NCT00406042|Prednisolone|prednisolone|mesh-list
56342488|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56342489|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
56342490|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56342491|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
56342493|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
56342494|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56342495|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
56342496|NCT00406042|Hormones|hormones|mesh-ancestor
56342497|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56342498|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342499|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56342500|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342501|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
56342502|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
56342503|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342504|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56342505|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56342506|NCT00406042|Protective Agents|protective agents|mesh-ancestor
56342507|NCT00082563|Azithromycin|azithromycin|mesh-list
56342508|NCT00082563|Chloroquine|chloroquine|mesh-list
56342509|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56342510|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56342511|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342512|NCT00082563|Amebicides|amebicides|mesh-ancestor
56342513|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56342514|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56342515|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
56342516|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342517|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56342518|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56342520|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
56342521|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342522|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342523|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56342524|NCT00082563|Filaricides|filaricides|mesh-ancestor
56342525|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
56342526|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
56342527|NCT00151528|Pregabalin|pregabalin|mesh-list
56342528|NCT00151528|Analgesics|analgesics|mesh-ancestor
56342529|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
56342530|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342531|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342532|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
56342533|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56342534|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342535|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342536|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56342537|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56342538|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342539|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342540|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342541|NCT00397787|Sunitinib|sunitinib|mesh-list
56342542|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342543|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56342544|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56342545|NCT00397787|Growth Substances|growth substances|mesh-ancestor
56342546|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342547|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
56650660|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650661|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
56650662|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342548|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56342549|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342550|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342551|NCT00082602|Galantamine|galantamine|mesh-list
56342552|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56342553|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342554|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342555|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
56342556|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342557|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342558|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56342559|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
56342560|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342561|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
56342563|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56342564|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56342565|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56342566|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
56342567|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342570|NCT00151567|Urological Agents|urological agents|mesh-ancestor
56342571|NCT00397826|Simvastatin|simvastatin|mesh-list
56342572|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56342573|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56342574|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
56342575|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342576|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56342577|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56342578|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342579|NCT00151684|Diazoxide|diazoxide|mesh-list
56342580|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56342581|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
56342582|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56342583|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56342584|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56342585|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
56342586|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342587|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56342588|NCT00151801|Interferons|interferons|mesh-list
56342589|NCT00151801|Interferon-beta|interferon-beta|mesh-list
56342590|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
56342591|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342593|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342594|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
56342595|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342596|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56342597|NCT04725253|Niacinamide|niacinamide|mesh-list
56342599|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
56342600|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
56342601|NCT04725253|Vitamins|vitamins|mesh-ancestor
56342602|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
56342603|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342604|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56342605|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
56342606|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342607|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56342608|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
56342609|NCT00082719|Interferons|interferons|mesh-list
56342610|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
56342611|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
56342612|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342613|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
56342614|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342615|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
56342616|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342617|NCT00151957|Methylphenidate|methylphenidate|mesh-list
56342618|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56342619|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342620|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56342621|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56650663|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650664|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56213758|NCT01657591|Vemurafenib|vemurafenib|mesh-list
56342622|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342623|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342624|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
56342625|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342626|NCT00049946|Risperidone|risperidone|mesh-list
56342627|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56342628|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
56342629|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342630|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342631|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342632|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56342633|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342634|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342635|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342636|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56342637|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
56342638|NCT00152035|Amphetamine|amphetamine|mesh-list
56342639|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
56342640|NCT00152035|Adderall|adderall|mesh-list
56342641|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56342644|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
56342645|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342646|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
56342647|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342648|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342649|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
56342650|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56342651|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56342652|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342653|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56342654|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
56342655|NCT00049985|Hematinics|hematinics|mesh-ancestor
56342656|NCT00082797|Leucovorin|leucovorin|mesh-list
56342657|NCT00082797|Methotrexate|methotrexate|mesh-list
56342658|NCT00082797|Calcium|calcium|mesh-list
56342659|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
56342660|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56342661|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342662|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56342663|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
56342664|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55964465|NCT03590912|Cetirizine|cetirizine|mesh-list
56342665|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56342667|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342668|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342669|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
56342670|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342671|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56342672|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342673|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
56342674|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342675|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56342677|NCT00082797|Protective Agents|protective agents|mesh-ancestor
56342678|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
56342679|NCT00082797|Vitamins|vitamins|mesh-ancestor
56342680|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
56342681|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
56342682|NCT00152191|Fluorouracil|fluorouracil|mesh-list
56342683|NCT00152191|Methotrexate|methotrexate|mesh-list
56342684|NCT00152191|Tegafur|tegafur|mesh-list
56342685|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342686|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
56342687|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342688|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342689|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56342690|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
56342691|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342692|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342693|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56342694|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
56650665|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650666|NCT00651768|Budesonide|budesonide|mesh-list
56650668|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56342695|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56342696|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56342697|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
56342698|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56342699|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
56342700|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342701|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56342702|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56342703|NCT00152230|Tegafur|tegafur|mesh-list
56342704|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56342705|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
56342706|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342707|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342708|NCT00152308|Sirolimus|sirolimus|mesh-list
56342709|NCT00152308|Ethanol|ethanol|mesh-list
56342710|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56342711|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342712|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56342713|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342714|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
56342715|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342716|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
56342719|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342720|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
56342721|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342722|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
56342723|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342724|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342726|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56342727|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342728|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
56342729|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342730|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342731|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
56342732|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342733|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
56342734|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342735|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342736|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
56342737|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56342738|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
55964548|NCT01013779|Carboplatin|carboplatin|mesh-list
56342739|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342740|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342741|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56342742|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
56342743|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56342745|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342746|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342747|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56342748|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
56342749|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
56342750|NCT00152542|Protective Agents|protective agents|mesh-ancestor
56342752|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56342753|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56342754|NCT00043680|Analgesics|analgesics|mesh-ancestor
56342755|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
56342756|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342757|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342758|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56342759|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342760|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56342761|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56342762|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342763|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342764|NCT00152581|Interferons|interferons|mesh-list
56342766|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
56342767|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
56650669|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650670|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56650671|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
56650672|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650673|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650674|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56650675|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
56650676|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
56650677|NCT00651768|Hormones|hormones|mesh-ancestor
56650678|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650679|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56213764|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56213765|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56213766|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213767|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
56213768|NCT01599468|Coagulants|coagulants|mesh-ancestor
56342768|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56342769|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342770|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
56342771|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342772|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
56342773|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342774|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
56342775|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342776|NCT00152620|Dexamethasone|dexamethasone|mesh-list
56342777|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
56342778|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56342779|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56342780|NCT00152620|Prednisolone|prednisolone|mesh-list
56342781|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
56342782|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56342783|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
56342784|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56342785|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
56342786|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
56342787|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342788|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342789|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56342790|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
56342791|NCT00152620|Hormones|hormones|mesh-ancestor
56342793|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56342794|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342795|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56342796|NCT00152620|Protective Agents|protective agents|mesh-ancestor
56342798|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342799|NCT04725214|Temozolomide|temozolomide|mesh-list
56342800|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56342801|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
56342802|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342803|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342804|NCT00152698|Irbesartan|irbesartan|mesh-list
56342805|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56342806|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56342807|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56342808|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342809|NCT00050180|Indinavir|indinavir|mesh-list
56342810|NCT00050180|Saquinavir|saquinavir|mesh-list
56342811|NCT00050180|Midazolam|midazolam|mesh-list
56650680|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56650681|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56650682|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
56650683|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342812|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56342813|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56342814|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342815|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342817|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342818|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342819|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56342820|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
56342821|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
56342822|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
56342823|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
56342824|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56342825|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342826|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56342827|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56342828|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
56342829|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342830|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56342831|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56342832|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
56342833|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342834|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56342835|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56342836|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
56342837|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342838|NCT00152815|Vitamin E|vitamin e|mesh-list
56342839|NCT00152815|Antioxidants|antioxidants|mesh-list
56342840|NCT00152815|Vitamins|vitamins|mesh-ancestor
56342841|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
56342842|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342843|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342844|NCT00152815|Protective Agents|protective agents|mesh-ancestor
56342845|NCT00043719|Vitamin D|vitamin d|mesh-list
56342846|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
56342847|NCT00043719|Calcium|calcium|mesh-list
56342848|NCT00043719|Vitamins|vitamins|mesh-ancestor
56342849|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
56342850|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342851|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56342852|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56342853|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
56342854|NCT00152854|Acetaminophen|acetaminophen|mesh-list
56342855|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56342856|NCT00152854|Analgesics|analgesics|mesh-ancestor
56342857|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
56170362|NCT05311722|Ketamine|ketamine|mesh-list
56342858|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342859|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342860|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
56342861|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
56342862|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56342863|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342864|NCT00152893|Chromium|chromium|mesh-list
56342866|NCT00152893|Trace Elements|trace elements|mesh-ancestor
56342867|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
56342868|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342869|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56342870|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
56342871|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342872|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56342873|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
56342874|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
56342876|NCT00152932|Dorzolamide|dorzolamide|mesh-list
56342877|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56342878|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56342879|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342880|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650684|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650685|NCT05660525|Nicotine|nicotine|mesh-list
56650686|NCT05660525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56342881|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
56342882|NCT00083031|Bevacizumab|bevacizumab|mesh-list
56342883|NCT00083031|Methotrexate|methotrexate|mesh-list
56342884|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342885|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
55964688|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
56342886|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342887|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56342888|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56342889|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
56342890|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342891|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342893|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56342894|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56342895|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56342896|NCT00083031|Growth Substances|growth substances|mesh-ancestor
56342897|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
56342898|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56342899|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
56342900|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56342901|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56342902|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
56342903|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
56342904|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342905|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56342906|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56342907|NCT00050336|Lonafarnib|lonafarnib|mesh-list
56342908|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342909|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342910|NCT00043758|Tolvaptan|tolvaptan|mesh-list
56342911|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56342912|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342913|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
56342914|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342915|NCT00050375|Oregovomab|oregovomab|mesh-list
56342916|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56342917|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342918|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56342919|NCT00153049|Telmisartan|telmisartan|mesh-list
56342920|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
56342921|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56342922|NCT00153049|Diuretics|diuretics|mesh-ancestor
56342923|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
56342924|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342925|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56342926|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342927|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342928|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56342930|NCT00153088|Telmisartan|telmisartan|mesh-list
56342931|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56342932|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56342933|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56342934|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342935|NCT00083070|Temozolomide|temozolomide|mesh-list
56342936|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56342937|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
56342938|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342940|NCT00050414|Dexamethasone|dexamethasone|mesh-list
56342941|NCT00050414|Trabectedin|trabectedin|mesh-list
56342942|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56342943|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
56342944|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
56342945|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342946|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342947|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56342948|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
56342949|NCT00050414|Hormones|hormones|mesh-ancestor
56650687|NCT05660525|Autonomic Agents|autonomic agents|mesh-ancestor
56650688|NCT05660525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650689|NCT05660525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650690|NCT05660525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56650691|NCT05660525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56650692|NCT05660525|Cholinergic Agents|cholinergic agents|mesh-ancestor
56650693|NCT05660525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650694|NCT05660525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650695|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56650696|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56650697|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56650698|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650699|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56650700|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
56342950|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56342951|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56342952|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342953|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56342954|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
56342955|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342956|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56342957|NCT00153127|Laxatives|laxatives|mesh-ancestor
56342958|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56342959|NCT00083109|Suramin|suramin|mesh-list
56342960|NCT00083109|Fluorouracil|fluorouracil|mesh-list
55964764|NCT00439673|Azacitidine|azacitidine|mesh-list
56342961|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
55991268|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
56342962|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342963|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56342964|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342965|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56342966|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
56342967|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342968|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
56342969|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
56342970|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56342971|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56342972|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56342973|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56342974|NCT00153244|Lamotrigine|lamotrigine|mesh-list
56342975|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
56342976|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56342977|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342978|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342979|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56342980|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342981|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56342982|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342983|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342984|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342985|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56342987|NCT00153283|Analgesics|analgesics|mesh-ancestor
56342988|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
56342989|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56342990|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342991|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
56650701|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56650702|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56650703|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56650704|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56650705|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56650706|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56650707|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56650708|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56650709|NCT04167306|Bupropion|bupropion|mesh-list
56650710|NCT04167306|Varenicline|varenicline|mesh-list
56650711|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56650712|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
56650713|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56650714|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56650715|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56650716|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56650717|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650718|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
56650719|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650720|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650721|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56650722|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56650723|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650724|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56650725|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56650726|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
56650727|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
56650728|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56650729|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56342992|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56342993|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56342994|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56342995|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56342996|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56342997|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56342998|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170364|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56342999|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343000|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
56343001|NCT00050531|Interferons|interferons|mesh-list
56343002|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
56343003|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
56650730|NCT04244591|Prednisolone|prednisolone|mesh-list
56650731|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
56650732|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56650733|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
56650734|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650735|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
56650736|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
56650737|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650738|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650739|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650740|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
56650741|NCT04244591|Hormones|hormones|mesh-ancestor
56650742|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650743|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56650744|NCT04244591|Protective Agents|protective agents|mesh-ancestor
56650745|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56650746|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650747|NCT02649582|Temozolomide|temozolomide|mesh-list
56650748|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56650749|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
56650750|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650751|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650752|NCT05660447|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56650753|NCT05660447|Lubricant Eye Drops|lubricant eye drops|mesh-list
56650754|NCT05660447|Glycerol|glycerol|mesh-list
56650755|NCT05660447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56650756|NCT05660447|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56650757|NCT05660447|Protective Agents|protective agents|mesh-ancestor
56650758|NCT05660447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650759|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
56650760|NCT04167696|Fludarabine|fludarabine|mesh-list
56650761|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
56650762|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56650763|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
56650764|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650765|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650766|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56650767|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
56650768|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650769|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650770|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56650771|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56650772|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
56650773|NCT02827487|Celecoxib|celecoxib|mesh-list
56650774|NCT02827487|Tramadol|tramadol|mesh-list
56650775|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56650776|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56650777|NCT02827487|Analgesics|analgesics|mesh-ancestor
56650778|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
56650779|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650780|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650781|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650782|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650783|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56650784|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56650785|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650786|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650787|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56650788|NCT02827487|Narcotics|narcotics|mesh-ancestor
56650789|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56650790|NCT04098666|Metformin|metformin|mesh-list
56650791|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56650792|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650793|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
56650794|NCT02649504|Dexamethasone|dexamethasone|mesh-list
56650795|NCT02649504|Rituximab|rituximab|mesh-list
56650796|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56343004|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56343005|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56343006|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
56343007|NCT00050531|Molgramostim|molgramostim|mesh-list
56343008|NCT00050531|Sargramostim|sargramostim|mesh-list
56343009|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343010|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
56343012|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
56343013|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343014|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56343015|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343016|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343017|NCT00083148|Capecitabine|capecitabine|mesh-list
56343018|NCT00083148|Irinotecan|irinotecan|mesh-list
56343019|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56650797|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650798|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
56650799|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650800|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650801|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650802|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
56650803|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
56650804|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650805|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650806|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
56650807|NCT02649504|Hormones|hormones|mesh-ancestor
56650808|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650809|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56650810|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56650811|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56296836|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547631|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56650812|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
56650813|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56650814|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650815|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650816|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650818|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56650819|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56650820|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
56213830|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56343020|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
56343021|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343022|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343023|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56343024|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56343025|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343026|NCT00153517|Metronidazole|metronidazole|mesh-list
56343027|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343028|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343029|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56343030|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56343031|NCT00153556|Vaccines|vaccines|mesh-list
56343032|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
56343033|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964848|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
56343034|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
56343035|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343036|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
56343037|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343038|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343039|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56343041|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
56650821|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733176|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56343042|NCT00153634|Meropenem|meropenem|mesh-list
56343043|NCT00153634|Tazobactam|tazobactam|mesh-list
56343044|NCT00153634|Piperacillin|piperacillin|mesh-list
56343045|NCT00153634|Tobramycin|tobramycin|mesh-list
56343046|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
56343047|NCT00153634|Amikacin|amikacin|mesh-list
56343048|NCT00153634|Ceftazidime|ceftazidime|mesh-list
56343049|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56343050|NCT00153634|Ticarcillin|ticarcillin|mesh-list
56343051|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
56343052|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343053|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343054|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56343055|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56343056|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343057|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343058|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343059|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56343060|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56343061|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56343062|NCT00050609|Tadalafil|tadalafil|mesh-list
56343063|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
56343064|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56343065|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56343066|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343067|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343068|NCT00050609|Urological Agents|urological agents|mesh-ancestor
56343069|NCT00153673|Celecoxib|celecoxib|mesh-list
56343070|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56343071|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56343072|NCT00153673|Analgesics|analgesics|mesh-ancestor
56343073|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
56343074|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343075|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343076|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56343077|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343078|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56343079|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56343080|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343081|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343082|NCT00050648|Cyclosporine|cyclosporine|mesh-list
56343083|NCT00050648|Cyclosporins|cyclosporins|mesh-list
56343084|NCT00050648|Daclizumab|daclizumab|mesh-list
56343085|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343087|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343088|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
56343089|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343090|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
56343091|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343092|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
56343093|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343094|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56343095|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
56343096|NCT00153868|Hematinics|hematinics|mesh-ancestor
56343097|NCT00153907|Capecitabine|capecitabine|mesh-list
56343098|NCT00153907|Vinorelbine|vinorelbine|mesh-list
56343099|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56343100|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
56343101|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343102|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343103|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56343104|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
56343105|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
56343106|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
56343107|NCT00050726|Interleukin-2|interleukin-2|mesh-list
56343108|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343109|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56343110|NCT00050726|Analgesics|analgesics|mesh-ancestor
56343111|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
56343112|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343113|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343114|NCT00153946|Edaravone|edaravone|mesh-list
56343115|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56650822|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650823|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650824|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56343116|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
56343117|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343118|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56343119|NCT00153946|Protective Agents|protective agents|mesh-ancestor
56343120|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343121|NCT00154024|Irbesartan|irbesartan|mesh-list
56343122|NCT00154024|Atorvastatin|atorvastatin|mesh-list
56343123|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56343124|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56343125|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
56343126|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343127|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56343128|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56343129|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343130|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56343131|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56343132|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56343133|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56343134|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
56343135|NCT00154141|Coagulants|coagulants|mesh-ancestor
56343136|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56343137|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56343138|NCT00154180|Estradiol|estradiol|mesh-list
56343139|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56343140|NCT00154180|Estrogens|estrogens|mesh-list
56343141|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56343142|NCT00154180|Progesterone|progesterone|mesh-list
56343143|NCT00154180|Hormones|hormones|mesh-ancestor
56343144|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56343145|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343146|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56343147|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
56343148|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56343149|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56343150|NCT00154180|Progestins|progestins|mesh-ancestor
56343151|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
56343152|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56343153|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56343154|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343155|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343156|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56343157|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56343158|NCT00154219|Analgesics|analgesics|mesh-ancestor
56343159|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
56343162|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56343163|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343164|NCT00043875|Lamotrigine|lamotrigine|mesh-list
56343165|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
56343166|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56343167|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56343168|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343169|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56343170|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343171|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56343172|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56343173|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56343174|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343175|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56343176|NCT00154258|Clozapine|clozapine|mesh-list
56343177|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56343178|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
56343179|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343180|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343181|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343182|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56343183|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56650825|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56343184|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965012|NCT04196426|Calcium|calcium|mesh-list
56343185|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343186|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
56343187|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
56343188|NCT00154336|Methotrexate|methotrexate|mesh-list
56343189|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
56343190|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56343191|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
56343192|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56343193|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343194|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56343195|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
56343196|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343197|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343198|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
56343199|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343200|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56343201|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343202|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
56343203|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343204|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56343205|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56343206|NCT00050804|Sertraline|sertraline|mesh-list
56343207|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
56343208|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343209|NCT00050804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56343210|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56343211|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56343212|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343213|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343214|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
56343215|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343216|NCT00043914|Lamotrigine|lamotrigine|mesh-list
56343217|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
56343218|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56343219|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170367|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56343220|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343221|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56343222|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343223|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56343224|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56343225|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56343226|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343227|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56343229|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56343233|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56343235|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
56343236|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343237|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
56343238|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
56343239|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
56343240|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343241|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343242|NCT04705909|Pitavastatin|pitavastatin|mesh-list
56343243|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56343244|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56343245|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56343246|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
56343247|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343248|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343249|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56343250|NCT00083304|Efaproxiral|efaproxiral|mesh-list
56343251|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
56343252|NCT00050843|Thalidomide|thalidomide|mesh-list
56343253|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343254|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
56343255|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343256|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
56343257|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56650826|NCT00650910|Lapatinib|lapatinib|mesh-list
56650827|NCT00650910|Digoxin|digoxin|mesh-list
56650828|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650829|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56343258|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965061|NCT04020380|Azithromycin|azithromycin|mesh-list
56343259|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343260|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343261|NCT00050843|Growth Substances|growth substances|mesh-ancestor
56343262|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343263|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343264|NCT00406237|Tigecycline|tigecycline|mesh-list
56343265|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343266|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343267|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56343268|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343269|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343270|NCT00406432|Paroxetine|paroxetine|mesh-list
56343271|NCT00406432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56343272|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56343273|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56343274|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343275|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343276|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
56343277|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343278|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56343279|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
56343280|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343281|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56343282|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56343283|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343284|NCT00083343|Caspofungin|caspofungin|mesh-list
56343285|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
56343286|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343287|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343288|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343289|NCT00406471|Ranibizumab|ranibizumab|mesh-list
56343290|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343291|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343292|NCT00406471|Growth Substances|growth substances|mesh-ancestor
56343293|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343294|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343295|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343296|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56343297|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56343298|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
56343299|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343303|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343304|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
56343305|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
56343306|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
56343307|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343309|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56343310|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343311|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
56343312|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343313|NCT00083460|Thalidomide|thalidomide|mesh-list
56343314|NCT00083460|Dexamethasone|dexamethasone|mesh-list
56343315|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56343316|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
56343317|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
56343318|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343319|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343320|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56343321|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
56343322|NCT00083460|Hormones|hormones|mesh-ancestor
56343323|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56343324|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56343325|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343326|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343327|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
56650830|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343328|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
56343329|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343330|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343331|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343332|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343333|NCT00083460|Growth Substances|growth substances|mesh-ancestor
56343334|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343336|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56343337|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343338|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
56343339|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
56343340|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
56343341|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343342|NCT00154804|Paclitaxel|paclitaxel|mesh-list
56343343|NCT00154804|Cisplatin|cisplatin|mesh-list
56343344|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56343345|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343346|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
56343347|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
56343348|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56343349|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343350|NCT00154843|Lycopene|lycopene|mesh-list
56343351|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56343352|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
56343353|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343354|NCT00154843|Protective Agents|protective agents|mesh-ancestor
56343355|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343356|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56343357|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56343358|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343359|NCT00043953|Ritonavir|ritonavir|mesh-list
56343360|NCT00043953|Lopinavir|lopinavir|mesh-list
56343361|NCT00043953|Saquinavir|saquinavir|mesh-list
56343362|NCT00043953|Lamivudine|lamivudine|mesh-list
56343363|NCT00043953|Zidovudine|zidovudine|mesh-list
56343364|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56343365|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56343366|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56343367|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
56343368|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343369|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343370|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56343371|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56343372|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
56343373|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343386|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343387|NCT00051077|Ribavirin|ribavirin|mesh-list
56343388|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56343389|NCT00051077|Adefovir|adefovir|mesh-list
56343390|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56343391|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
56343392|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343393|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
56343394|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343395|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56343396|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56343397|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343398|NCT00155233|Morphine|morphine|mesh-list
56343399|NCT00155233|Nalbuphine|nalbuphine|mesh-list
56343400|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56343401|NCT00155233|Narcotics|narcotics|mesh-ancestor
56343402|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56343403|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343404|NCT00155233|Analgesics|analgesics|mesh-ancestor
56343405|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
56343406|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343407|NCT00051116|Lenalidomide|lenalidomide|mesh-list
56343408|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
55965219|NCT04025372|Bicalutamide|bicalutamide|mesh-list
56343409|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343410|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343411|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343413|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343414|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650831|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650832|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56213842|NCT01599988|Caseins|caseins|mesh-list
56343415|NCT00155272|Thalidomide|thalidomide|mesh-list
56343416|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343417|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
56343418|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343419|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
56343420|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343421|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343422|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343423|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343424|NCT00155272|Growth Substances|growth substances|mesh-ancestor
56343425|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343426|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343427|NCT00155350|Pioglitazone|pioglitazone|mesh-list
56343428|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56343429|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343431|NCT00051155|Travoprost|travoprost|mesh-list
56343432|NCT00051155|Latanoprost|latanoprost|mesh-list
56343433|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56343434|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56343435|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
56343436|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343437|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343441|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56343442|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56343443|NCT00083538|Thalidomide|thalidomide|mesh-list
56343444|NCT00083538|Dexamethasone|dexamethasone|mesh-list
56343445|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
56343446|NCT00083538|Etoposide|etoposide|mesh-list
56343447|NCT00083538|Doxorubicin|doxorubicin|mesh-list
56343448|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56343449|NCT00083538|Cisplatin|cisplatin|mesh-list
56343450|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343451|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
56343452|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343453|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343454|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56343455|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
56343456|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343457|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343458|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56343459|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56343460|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
56343461|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
56343462|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343463|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56343464|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
56343465|NCT00083538|Hormones|hormones|mesh-ancestor
56343466|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56343467|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56343468|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56343469|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56343470|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56343471|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343472|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56343473|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
56343474|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343475|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343476|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343477|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343478|NCT00083538|Growth Substances|growth substances|mesh-ancestor
56343479|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343480|NCT00083577|Thalidomide|thalidomide|mesh-list
56343481|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343482|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
56343483|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343484|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
56343485|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343486|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343487|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343488|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56650833|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56650834|NCT00650910|Protective Agents|protective agents|mesh-ancestor
55971569|NCT00571493|Cytarabine|cytarabine|mesh-list
56343489|NCT00083577|Growth Substances|growth substances|mesh-ancestor
56343490|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343491|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343492|NCT00406744|Bevacizumab|bevacizumab|mesh-list
56343493|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56343494|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343495|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343496|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343497|NCT00406744|Growth Substances|growth substances|mesh-ancestor
56343498|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343499|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343500|NCT00399750|Bevacizumab|bevacizumab|mesh-list
56343501|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
56343502|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56343503|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343504|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343505|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343506|NCT00399750|Growth Substances|growth substances|mesh-ancestor
56343507|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343508|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343509|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
56343510|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343511|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343512|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
56343513|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343514|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56343515|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343516|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343517|NCT00156325|Citalopram|citalopram|mesh-list
56343518|NCT00156325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56343519|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56343520|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56343521|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343522|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343523|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
56343524|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343525|NCT00156325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56343526|NCT00156325|Antidepressive Agents|antidepressive agents|mesh-ancestor
56343527|NCT00156325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343528|NCT00156403|Amlodipine|amlodipine|mesh-list
56343529|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56343530|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56343531|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56343532|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343533|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56343534|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343535|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
56343536|NCT00051272|Bupropion|bupropion|mesh-list
56343537|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56343538|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
56343539|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343540|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56343541|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56343542|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56343543|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343544|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
56343545|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343546|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170399|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
56343547|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56343548|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56343550|NCT00044187|Sibutramine|sibutramine|mesh-list
56343551|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
56343552|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343553|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
56343554|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56343555|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
56650835|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650836|NCT02654730|Piperaquine|piperaquine|mesh-list
56650837|NCT02654730|Primaquine|primaquine|mesh-list
56343556|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56343557|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56343558|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343560|NCT00156520|Coagulants|coagulants|mesh-ancestor
56343561|NCT00083694|Thalidomide|thalidomide|mesh-list
56343562|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343563|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
56343564|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343565|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
56343566|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343567|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343568|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343569|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343570|NCT00083694|Growth Substances|growth substances|mesh-ancestor
56343571|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343572|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343573|NCT00051389|Fosinopril|fosinopril|mesh-list
56343574|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56343575|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
56343576|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343577|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343578|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56343579|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
56343580|NCT00156949|Hematinics|hematinics|mesh-ancestor
56343581|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
56343582|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56343583|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
56343584|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343585|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343586|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56343587|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56343588|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
56343589|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56343590|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
56343591|NCT00157066|Vitamin D|vitamin d|mesh-list
56343592|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56343593|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343594|NCT00157066|Vitamins|vitamins|mesh-ancestor
56343595|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
56343596|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56343597|NCT00157105|Factor VIII|factor viii|mesh-list
56343598|NCT00157105|Coagulants|coagulants|mesh-ancestor
56343599|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56343600|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
56343601|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343602|NCT00157261|Tenecteplase|tenecteplase|mesh-list
56343603|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56343604|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56343605|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343606|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
56343607|NCT00157300|Hematinics|hematinics|mesh-ancestor
56343608|NCT00157378|Haloperidol|haloperidol|mesh-list
56343609|NCT00157378|Risperidone|risperidone|mesh-list
56343610|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
56343611|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56343612|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
56343613|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343614|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343615|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343616|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56343617|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56343618|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56343619|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343620|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56343622|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
56343623|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
56343624|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343625|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56343626|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56343627|NCT00406861|Montelukast|montelukast|mesh-list
56343628|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56343629|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
56650838|NCT02654730|Artenimol|artenimol|mesh-list
56650839|NCT02654730|Artemisinins|artemisinins|mesh-list
56650840|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
56650841|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56650842|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56650843|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343630|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56343631|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
56343632|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56343633|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343634|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55991271|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
56343635|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56343636|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343638|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56343639|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
56343640|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343641|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343642|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56343643|NCT00398099|Ertapenem|ertapenem|mesh-list
56343644|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343645|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343646|NCT00406978|Thalidomide|thalidomide|mesh-list
56343647|NCT00406978|Prednisone|prednisone|mesh-list
56343648|NCT00406978|Melphalan|melphalan|mesh-list
56343649|NCT00406978|Defibrotide|defibrotide|mesh-list
56343650|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56343651|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
56343652|NCT00406978|Hormones|hormones|mesh-ancestor
56343653|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56343654|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343655|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56343656|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343657|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56343658|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
56343659|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343660|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56343663|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
56343664|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56343665|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343666|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343667|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343668|NCT00406978|Growth Substances|growth substances|mesh-ancestor
56343669|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343670|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56343671|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56343672|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56343673|NCT00157651|Warfarin|warfarin|mesh-list
56343674|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
56343675|NCT00044343|Lapatinib|lapatinib|mesh-list
56343676|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343677|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56343678|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343679|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343680|NCT00157690|Alendronate|alendronate|mesh-list
56343681|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56343682|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343683|NCT00051506|Carboplatin|carboplatin|mesh-list
56343684|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343685|NCT00157729|Pyridoxal|pyridoxal|mesh-list
56343686|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
56343687|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56343688|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
56343689|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343690|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343691|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
56343692|NCT00157729|Vitamins|vitamins|mesh-ancestor
56343693|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
56343694|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343695|NCT00051545|Seocalcitol|seocalcitol|mesh-list
56650844|NCT00888329|Aprepitant|aprepitant|mesh-list
56650845|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
56650846|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
56343696|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343697|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343698|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
56343699|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343700|NCT00157885|Artesunate|artesunate|mesh-list
56343701|NCT00157885|Amodiaquine|amodiaquine|mesh-list
56343702|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
56343703|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56343704|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56343705|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343706|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343707|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
56343708|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
56343709|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56343710|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
56343711|NCT00158002|Topiramate|topiramate|mesh-list
56343712|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
56343713|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56343714|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343715|NCT00158041|Amifostine|amifostine|mesh-list
56343716|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56343717|NCT00158041|Protective Agents|protective agents|mesh-ancestor
56343718|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343719|NCT00051584|Gemcitabine|gemcitabine|mesh-list
56343720|NCT00051584|Doxorubicin|doxorubicin|mesh-list
56343721|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
56343722|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56343723|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
56343724|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343725|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343726|NCT00051584|Antiviral Agents|antiviral agents|mesh-ancestor
56343727|NCT00051584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343728|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343729|NCT00051584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343730|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
56343731|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343732|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56343733|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56343734|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56343735|NCT00044382|Lenalidomide|lenalidomide|mesh-list
56343736|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
56343737|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343738|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56343739|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56343740|NCT00044382|Growth Substances|growth substances|mesh-ancestor
56343741|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
56343742|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343744|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56343745|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
56343746|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343747|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343748|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56343749|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56343750|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
56343751|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343752|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343753|NCT00051623|Infliximab|infliximab|mesh-list
56343754|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
56343755|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56343756|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343757|NCT00158236|Buprenorphine|buprenorphine|mesh-list
56343758|NCT00158236|Hydromorphone|hydromorphone|mesh-list
56343759|NCT00158236|Naloxone|naloxone|mesh-list
56343760|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56343761|NCT00158236|Narcotics|narcotics|mesh-ancestor
56343762|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56343763|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343764|NCT00158236|Analgesics|analgesics|mesh-ancestor
56343765|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
56343766|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343767|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56343768|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
56343769|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343770|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
56650847|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650848|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650849|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56733177|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
56343771|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343772|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343774|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56343775|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343776|NCT00158470|Lamivudine|lamivudine|mesh-list
56343777|NCT00158470|Efavirenz|efavirenz|mesh-list
56343778|NCT00158470|Didanosine|didanosine|mesh-list
56343779|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56343780|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56343781|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343782|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343783|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
56343784|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343785|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56343786|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56343787|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56343788|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56343789|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56343790|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56343791|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56343792|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56343793|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
56343794|NCT00158509|Valacyclovir|valacyclovir|mesh-list
56343795|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
56343796|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343797|NCT00158548|Artesunate|artesunate|mesh-list
56343798|NCT00158548|Chloroquine|chloroquine|mesh-list
56343799|NCT00158548|Primaquine|primaquine|mesh-list
56343800|NCT00158548|Amodiaquine|amodiaquine|mesh-list
56343801|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
56343802|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56343803|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56343804|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343805|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343806|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
56343807|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
56343808|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56343809|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
56343810|NCT00158548|Amebicides|amebicides|mesh-ancestor
56343811|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343812|NCT00158587|Primaquine|primaquine|mesh-list
56343813|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
56343814|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56343815|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56343816|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343817|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56343818|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
56343819|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343820|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56343821|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56343822|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343823|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343825|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343826|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56343827|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343828|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343829|NCT00158821|Tenofovir|tenofovir|mesh-list
56343830|NCT00158821|Lamivudine|lamivudine|mesh-list
56343831|NCT00158821|Efavirenz|efavirenz|mesh-list
56343832|NCT00158821|Stavudine|stavudine|mesh-list
56343833|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
56343834|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343835|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56343836|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56343837|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343838|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343839|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56343840|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56269001|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
56650850|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56650851|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733178|NCT00400946|Doxorubicin|doxorubicin|mesh-list
56343841|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56343842|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56343843|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56343844|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56343845|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56343846|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56343847|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
56343848|NCT05568147|Aspirin|aspirin|mesh-list
56343849|NCT05568147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56343850|NCT05568147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56343851|NCT05568147|Analgesics|analgesics|mesh-ancestor
56343852|NCT05568147|Sensory System Agents|sensory system agents|mesh-ancestor
56343853|NCT05568147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343854|NCT05568147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343855|NCT05568147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56343856|NCT05568147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343857|NCT05568147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56343858|NCT05568147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56343859|NCT05568147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343860|NCT05568147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56343861|NCT05568147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56343862|NCT05568147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965666|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56343863|NCT05568147|Antipyretics|antipyretics|mesh-ancestor
56343865|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56343866|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56343867|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56343868|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343869|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
56343870|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343871|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343872|NCT04724473|Tretinoin|tretinoin|mesh-list
56343873|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343874|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
56343875|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
56343876|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
56343877|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343878|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56343879|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343880|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343881|NCT00159094|Vinorelbine|vinorelbine|mesh-list
56343882|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56343883|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343884|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
56343885|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
56343886|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
56343887|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343888|NCT02965053|Sevelamer|sevelamer|mesh-list
56343890|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
56343891|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343892|NCT00159133|Lorazepam|lorazepam|mesh-list
56343893|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
56343894|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
56343895|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
56343896|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
56343897|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343898|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343899|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56343900|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56343901|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56343902|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56343903|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56343904|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343905|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
56343906|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
56343907|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343908|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343909|NCT00051974|Bortezomib|bortezomib|mesh-list
56650852|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650853|NCT00652002|Budesonide|budesonide|mesh-list
56650854|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
56650855|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650856|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56650857|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
56650858|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650859|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650860|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56650861|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
56650862|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
56650863|NCT00652002|Hormones|hormones|mesh-ancestor
56733179|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56343910|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343911|NCT00159211|Pioglitazone|pioglitazone|mesh-list
56343912|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56343913|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343914|NCT05567718|Anesthetics|anesthetics|mesh-list
56343915|NCT05567718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56343916|NCT05567718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343917|NCT00052013|Vatalanib|vatalanib|mesh-list
56343918|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56343919|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343920|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343921|NCT00159445|Gemcitabine|gemcitabine|mesh-list
56343922|NCT00159445|Capecitabine|capecitabine|mesh-list
56343923|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56343924|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
56343925|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343926|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343927|NCT00159445|Antiviral Agents|antiviral agents|mesh-ancestor
56343928|NCT00159445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343929|NCT00159445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343930|NCT00159445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343931|NCT00159445|Immunologic Factors|immunologic factors|mesh-ancestor
56343932|NCT00159445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343933|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
56343934|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56343935|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343936|NCT00159484|Celecoxib|celecoxib|mesh-list
56343937|NCT00159484|Epothilone B|epothilone b|mesh-list
56343938|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56343939|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56343940|NCT00159484|Analgesics|analgesics|mesh-ancestor
56343941|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
56343942|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343943|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343944|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56343945|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56343946|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56343947|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56343948|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56343949|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343950|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343951|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
56343952|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
56343953|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
56343954|NCT00052052|Interferons|interferons|mesh-list
56343955|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
56343956|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343957|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
56343958|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343960|NCT00044538|IDN 5109|idn 5109|mesh-list
56650864|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650865|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56343961|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343962|NCT00159679|Pregabalin|pregabalin|mesh-list
56343963|NCT00159679|Analgesics|analgesics|mesh-ancestor
56343964|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
56343965|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343983|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56343985|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56343986|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56343987|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56343988|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56343989|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343990|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
56343991|NCT00159757|Ziprasidone|ziprasidone|mesh-list
56343992|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56343993|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
56343994|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56343995|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343996|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343997|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56343998|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56343999|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56344000|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56344001|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56344002|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
56344003|NCT00159835|Atorvastatin|atorvastatin|mesh-list
56344004|NCT00159835|Simvastatin|simvastatin|mesh-list
56344005|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56344006|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56344007|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
56344008|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344009|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56344010|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56344011|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344012|NCT00052169|Docetaxel|docetaxel|mesh-list
56344013|NCT00052169|Gefitinib|gefitinib|mesh-list
55965815|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
56344015|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
56344016|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
56344017|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
56344018|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344019|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56344020|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344021|NCT00159952|Insulin|insulin|mesh-list
56344023|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344024|NCT00052208|Gefitinib|gefitinib|mesh-list
56344025|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344026|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56344027|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344028|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344029|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
56344030|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
56344031|NCT00407017|Ketorolac|ketorolac|mesh-list
56344032|NCT00407017|Nepafenac|nepafenac|mesh-list
56344033|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
56344034|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344035|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344036|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56344037|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56344038|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344039|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344040|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344041|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344042|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56344043|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56344044|NCT00407017|Analgesics|analgesics|mesh-ancestor
56344045|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
56344046|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56344047|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56344048|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56269002|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
56650866|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56650867|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56344049|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56344050|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56344051|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56344052|NCT00160030|Cisplatin|cisplatin|mesh-list
56344053|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344054|NCT00160069|Sagopilone|sagopilone|mesh-list
56344055|NCT00160069|Epothilones|epothilones|mesh-list
56344056|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344057|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
56344058|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
56344059|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
56344060|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344061|NCT00052286|Modafinil|modafinil|mesh-list
56344062|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56344063|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344064|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56344065|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56344066|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56344067|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344068|NCT00160186|Pancreatin|pancreatin|mesh-list
56344069|NCT00160186|Pancrelipase|pancrelipase|mesh-list
56344070|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344071|NCT05567484|Itraconazole|itraconazole|mesh-list
56344072|NCT05567484|Antifungal Agents|antifungal agents|mesh-ancestor
56344073|NCT05567484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344074|NCT05567484|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56344075|NCT05567484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56344076|NCT05567484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344077|NCT05567484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344078|NCT05567484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56344079|NCT05567484|Hormone Antagonists|hormone antagonists|mesh-ancestor
56344080|NCT05567484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344081|NCT05567484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344082|NCT05567484|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56344083|NCT00160264|Vitamin D|vitamin d|mesh-list
56344084|NCT00160264|Lactulose|lactulose|mesh-list
56344085|NCT00160264|Calcium|calcium|mesh-list
56344086|NCT00160264|Vitamins|vitamins|mesh-ancestor
56344087|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
56344088|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344089|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56344090|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56344091|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344092|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
56344093|NCT00160342|Estrogens|estrogens|mesh-list
56344094|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
56344095|NCT00160342|Estrone|estrone|mesh-list
56344096|NCT00160342|Testosterone|testosterone|mesh-list
56344097|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
56344098|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
56344099|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56344100|NCT00160342|Hormones|hormones|mesh-ancestor
56344101|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344102|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344103|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56344104|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344105|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
56344106|NCT00160342|Androgens|androgens|mesh-ancestor
56344107|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
56344108|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344109|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56344110|NCT00052403|Antibodies|antibodies|mesh-list
56344111|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
56344112|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56344113|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
56344114|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
56344115|NCT00052403|Mitogens|mitogens|mesh-list
56344116|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344117|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344118|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
56344119|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344120|NCT00160498|Lercanidipine|lercanidipine|mesh-list
56650868|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
56650869|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733180|NCT00400946|Methotrexate|methotrexate|mesh-list
56344121|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56344122|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56344123|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56344124|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344125|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56344126|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344127|NCT00160537|Levocetirizine|levocetirizine|mesh-list
56344128|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56344129|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56344130|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
56344131|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
56344132|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344133|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344134|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344135|NCT00160576|Levetiracetam|levetiracetam|mesh-list
56344136|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
56344137|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
56344138|NCT00160849|Lopinavir|lopinavir|mesh-list
56344139|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56344140|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56344141|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
56344142|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344143|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344144|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56344145|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56344146|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
56344147|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344148|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56344149|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56344150|NCT00160888|Nitroprusside|nitroprusside|mesh-list
56344151|NCT00160888|Acetylcholine|acetylcholine|mesh-list
56344152|NCT00160888|Bradykinin|bradykinin|mesh-list
56344153|NCT00160888|Kininogens|kininogens|mesh-list
56344154|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56344155|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
56344156|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56344157|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344158|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56344159|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
56344160|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344161|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344162|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56344163|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
56344164|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344165|NCT00160927|Nitroprusside|nitroprusside|mesh-list
56344166|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56344167|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
56344168|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56344169|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344170|NCT00160966|Cyclosporine|cyclosporine|mesh-list
56344171|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
56344172|NCT00160966|Everolimus|everolimus|mesh-list
56344176|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
56344177|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344178|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56344179|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344180|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344181|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
56344182|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344183|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
56344184|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56344185|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344186|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56344187|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56344188|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
56344189|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344191|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56344192|NCT00052559|Fluorouracil|fluorouracil|mesh-list
56344193|NCT00052559|Antibodies|antibodies|mesh-list
56344194|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
56650870|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650871|NCT02646540|Metolazone|metolazone|mesh-list
56650872|NCT02646540|Furosemide|furosemide|mesh-list
56650873|NCT02646540|Tolvaptan|tolvaptan|mesh-list
56650874|NCT02646540|Diuretics|diuretics|mesh-list
56650875|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
55972386|NCT00611897|Expectorants|expectorants|mesh-ancestor
56344195|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56344196|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344197|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56344198|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56344199|NCT00052559|Growth Substances|growth substances|mesh-ancestor
56344200|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344201|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
56344202|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
56344203|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
56344204|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344205|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56344206|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344207|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56344208|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56344209|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344210|NCT00044577|Tenofovir|tenofovir|mesh-list
56344211|NCT00044577|Lamivudine|lamivudine|mesh-list
56344212|NCT00044577|Abacavir|abacavir|mesh-list
56344213|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
56344214|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
56344215|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344216|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56344217|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56344218|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344219|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344220|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56344221|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56344222|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
56344223|NCT00161122|Vaccines|vaccines|mesh-list
56344224|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56344225|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
56344226|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344227|NCT00161200|Pantoprazole|pantoprazole|mesh-list
56344228|NCT00161200|Ranitidine|ranitidine|mesh-list
56344229|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56344230|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56344231|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344232|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56344233|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344234|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344235|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56344236|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
56344237|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
56344238|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344239|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966075|NCT00487721|Silymarin|silymarin|mesh-list
56344241|NCT00161239|Methotrexate|methotrexate|mesh-list
56344242|NCT00161239|Asparaginase|asparaginase|mesh-list
56344243|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56344244|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
56344245|NCT00161239|Hormones|hormones|mesh-ancestor
56344246|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344250|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56344251|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
56344252|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56344253|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56344254|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
56344255|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344256|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
56344257|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344258|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56344259|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344260|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
56344261|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56650876|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650877|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56344262|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56344263|NCT00161278|Paclitaxel|paclitaxel|mesh-list
56344264|NCT00161278|Carboplatin|carboplatin|mesh-list
56344265|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56344266|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344267|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
56344268|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
56344269|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
56344270|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344271|NCT00044616|Fluoxetine|fluoxetine|mesh-list
56344272|NCT00044616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56344273|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56344274|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56344275|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344276|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344277|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
56344278|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344279|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56344280|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
56344281|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56344282|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56344283|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56344284|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344285|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56344286|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
56344287|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344288|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56344289|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56344290|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56344291|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56344292|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344293|NCT00161434|Valacyclovir|valacyclovir|mesh-list
56344294|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
56344295|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344296|NCT00044694|Exenatide|exenatide|mesh-list
56344297|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56344298|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344299|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56344300|NCT00044694|Incretins|incretins|mesh-ancestor
56344301|NCT00044694|Hormones|hormones|mesh-ancestor
56344302|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344303|NCT00052754|Gefitinib|gefitinib|mesh-list
56344304|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344305|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56344306|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344307|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344308|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
56344309|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56344310|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344311|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
56344312|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56344313|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344314|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56344315|NCT00052832|Vitamins|vitamins|mesh-ancestor
55966122|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
56344316|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
56344319|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56344320|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
56344321|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56344322|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56344323|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
56344324|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344325|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344326|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
56344327|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56344328|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344329|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
56344330|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344331|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56650878|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733181|NCT00400946|Etoposide|etoposide|mesh-list
56344332|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344333|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344334|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56344335|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
56344336|NCT00161902|Coagulants|coagulants|mesh-ancestor
56344337|NCT00053027|Rituximab|rituximab|mesh-list
56344338|NCT00053027|Cladribine|cladribine|mesh-list
56344339|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56344340|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344341|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
56344342|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344343|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56344344|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344345|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56344346|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
56344347|NCT00161980|Coagulants|coagulants|mesh-ancestor
56344348|NCT00162019|Factor VIII|factor viii|mesh-list
56344349|NCT00162019|Coagulants|coagulants|mesh-ancestor
56344350|NCT00162214|Ketoconazole|ketoconazole|mesh-list
56344351|NCT00162214|Dasatinib|dasatinib|mesh-list
56344352|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344353|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56344354|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344355|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344356|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
56344357|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344358|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56344359|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56344360|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56344361|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
56344362|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344363|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344364|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56344365|NCT04731116|Cannabidiol|cannabidiol|mesh-list
56344366|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
56344367|NCT00407056|Difluprednate|difluprednate|mesh-list
56344368|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
56344369|NCT00407056|Hormones|hormones|mesh-ancestor
56344370|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344371|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344372|NCT00405457|Cyclosporine|cyclosporine|mesh-list
56344373|NCT00405457|Cyclosporins|cyclosporins|mesh-list
56344374|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344375|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344376|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344377|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
56344378|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344379|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
56344380|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344381|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
56344382|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56344383|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56344384|NCT00053105|Cytarabine|cytarabine|mesh-list
56344385|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
56344386|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56344387|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56344389|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
56344390|NCT00053105|Pixantrone|pixantrone|mesh-list
56344391|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56344394|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56344395|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
56344396|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344397|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
56344398|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344399|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344400|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
56344401|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344402|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56344403|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
56344404|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
56344405|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56344406|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344407|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
56650879|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650880|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56650881|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56213892|NCT01602874|Metronidazole|metronidazole|mesh-list
56344409|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344411|NCT00053105|Protective Agents|protective agents|mesh-ancestor
56344412|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56344413|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56344414|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56344415|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344416|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56344417|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56344418|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344419|NCT00162409|Folic Acid|folic acid|mesh-list
56344420|NCT00162409|Hematinics|hematinics|mesh-ancestor
56344421|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
56344422|NCT00162409|Vitamins|vitamins|mesh-ancestor
56344423|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
56344424|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344425|NCT00053144|Cytarabine|cytarabine|mesh-list
56344426|NCT00053144|Irinotecan|irinotecan|mesh-list
56344427|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56344428|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56344429|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344430|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344431|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344432|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56344433|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
56344434|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
56344435|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344436|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344437|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
56344438|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344439|NCT00162487|Albuterol|albuterol|mesh-list
56344440|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56344441|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
56344442|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56344443|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344444|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56344445|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
56344446|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
56344447|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56344448|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56344449|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56344450|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56344451|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
56344452|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344453|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344454|NCT00162526|Tocopherols|tocopherols|mesh-list
56344455|NCT00162526|Vitamin E|vitamin e|mesh-list
56344456|NCT00162526|Tocotrienols|tocotrienols|mesh-list
56344457|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
56344458|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
56344459|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344460|NCT00162526|Protective Agents|protective agents|mesh-ancestor
56344461|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344462|NCT00162526|Vitamins|vitamins|mesh-ancestor
56344463|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
56344464|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56344465|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56344466|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
56344471|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
56344472|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344473|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344474|NCT00162643|Ritonavir|ritonavir|mesh-list
56344475|NCT00162643|Lopinavir|lopinavir|mesh-list
56344476|NCT00162643|Lamivudine|lamivudine|mesh-list
56344477|NCT00162643|Zidovudine|zidovudine|mesh-list
56344478|NCT00162643|Efavirenz|efavirenz|mesh-list
56344479|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56344480|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56344481|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
56650882|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56650883|NCT00651066|Ritonavir|ritonavir|mesh-list
56650884|NCT00651066|Lopinavir|lopinavir|mesh-list
56650885|NCT00651066|Rifabutin|rifabutin|mesh-list
56650886|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56344482|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344483|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344484|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56344485|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56344486|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
56344487|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344488|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56344489|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56344490|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56344491|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56344492|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
56344493|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56344494|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56344495|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56344496|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56344497|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56344498|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56344499|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
56344500|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344501|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56344502|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56344503|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56344504|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56344505|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344506|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344507|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344508|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56344509|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
56344510|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56344511|NCT00162721|Doxorubicin|doxorubicin|mesh-list
56344512|NCT00162721|Ifosfamide|ifosfamide|mesh-list
56344513|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344514|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56344515|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56344516|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56344517|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344518|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344519|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56344520|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
56344521|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
56344522|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344523|NCT00162760|Thalidomide|thalidomide|mesh-list
56344524|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344525|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
56344526|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344527|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
56344528|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344529|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344530|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56344531|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56344532|NCT00162760|Growth Substances|growth substances|mesh-ancestor
56344533|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
56344534|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344535|NCT00162799|Triflusal|triflusal|mesh-list
56344536|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56344538|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56344541|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
56344542|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
56344543|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344544|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344545|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344546|NCT00162877|Esomeprazole|esomeprazole|mesh-list
56344547|NCT00162877|Rabeprazole|rabeprazole|mesh-list
56344548|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56213899|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56650887|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56650888|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
56650889|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650890|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650891|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56650892|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56650893|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
56650894|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56650895|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56650896|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56650897|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344549|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344550|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56344551|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344552|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344553|NCT00162916|Citalopram|citalopram|mesh-list
56344554|NCT00162916|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56344555|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56344556|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56344557|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344558|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344559|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
56344560|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344561|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56344562|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
56344563|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56344564|NCT00162955|Valsartan|valsartan|mesh-list
56344565|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56344566|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56344567|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56344568|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344569|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
56344570|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56344571|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344572|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
56344573|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56344574|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344575|NCT00163111|Amphotericin B|amphotericin b|mesh-list
56344576|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56344577|NCT00163111|Fluconazole|fluconazole|mesh-list
56344578|NCT00163111|Amebicides|amebicides|mesh-ancestor
56344579|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56344580|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56344581|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344582|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344583|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
56344584|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56344585|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56344586|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344587|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344588|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56344589|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
56344590|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344591|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344592|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56344593|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56344594|NCT00163150|Atorvastatin|atorvastatin|mesh-list
56344595|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56650898|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56650899|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
56650901|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56650902|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56650903|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56344596|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56344597|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
56344598|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344599|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56344600|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56344601|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344602|NCT00163267|Clopidogrel|clopidogrel|mesh-list
56344603|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56344604|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56344605|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56344606|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56344607|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
56344609|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344611|NCT00163306|Pantoprazole|pantoprazole|mesh-list
56344612|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55966421|NCT05293249|Prednisolone phosphate|prednisolone phosphate|mesh-list
56344613|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344614|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56344615|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344616|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344617|NCT00044889|Clofarabine|clofarabine|mesh-list
56344618|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56344619|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
56344620|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344621|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344622|NCT00163345|Ciclesonide|ciclesonide|mesh-list
56344623|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
56170464|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56344625|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344626|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344627|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56344628|NCT00163384|Ciclesonide|ciclesonide|mesh-list
56344629|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
56344631|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344632|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344633|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56344634|NCT00163423|Ciclesonide|ciclesonide|mesh-list
56344635|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
56344636|NCT00163423|Hormones|hormones|mesh-ancestor
56344637|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344638|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344639|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56344640|NCT04731038|Paclitaxel|paclitaxel|mesh-list
56344641|NCT04731038|Carboplatin|carboplatin|mesh-list
56344642|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56344643|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344644|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
56344645|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
56344646|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56344647|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344648|NCT00163462|Ciclesonide|ciclesonide|mesh-list
56344649|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
56344650|NCT00163462|Hormones|hormones|mesh-ancestor
56344651|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344652|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344653|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56344654|NCT00053300|Thalidomide|thalidomide|mesh-list
56344655|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344656|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
56344657|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344658|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
56344659|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344660|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733182|NCT00400946|Vincristine|vincristine|mesh-list
56733183|NCT00400946|Asparaginase|asparaginase|mesh-list
56733184|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
56344661|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56344662|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56344663|NCT00053300|Growth Substances|growth substances|mesh-ancestor
56344664|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
56344665|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344666|NCT00163501|Ciclesonide|ciclesonide|mesh-list
56344667|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
56344668|NCT00163501|Hormones|hormones|mesh-ancestor
56344669|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344670|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344671|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56344672|NCT00163540|Formaldehyde|formaldehyde|mesh-list
56344673|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
56344674|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344675|NCT00053339|Tamoxifen|tamoxifen|mesh-list
56344676|NCT00053339|Trastuzumab|trastuzumab|mesh-list
56344677|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56344678|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344679|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56344680|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
56344682|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344683|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56344684|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56344685|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56344686|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56344687|NCT00163618|Formaldehyde|formaldehyde|mesh-list
56344688|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
56344689|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344691|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56344692|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344694|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56344695|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344696|NCT02970383|Analgesics|analgesics|mesh-ancestor
56344697|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
56344698|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56344699|NCT05502900|Melatonin|melatonin|mesh-list
56344700|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
56344701|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344702|NCT05502900|Protective Agents|protective agents|mesh-ancestor
56344703|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344704|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56344705|NCT00163969|Ketamine|ketamine|mesh-list
56344706|NCT00163969|Analgesics|analgesics|mesh-ancestor
56344707|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
56344708|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56344709|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344710|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56344711|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56344712|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
56344713|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
56344714|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56344715|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56344716|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56344717|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344718|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344719|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
56344720|NCT00164008|Pamidronate|pamidronate|mesh-list
56344721|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56344722|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344723|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
56344724|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56344725|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
56344726|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
56344727|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56344728|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344729|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56344730|NCT00164047|Analgesics|analgesics|mesh-ancestor
56344731|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
56344732|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56344733|NCT00164086|Atorvastatin|atorvastatin|mesh-list
56650904|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56650905|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56650906|NCT02646072|Analgesics|analgesics|mesh-ancestor
56650907|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
56650908|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650909|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733185|NCT00400946|Pegaspargase|pegaspargase|mesh-list
56344734|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56344735|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56344736|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
56344737|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344738|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56344739|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56344740|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344741|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56344742|NCT00164125|Laxatives|laxatives|mesh-ancestor
56344743|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344744|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56344745|NCT00164164|Laxatives|laxatives|mesh-ancestor
56344746|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344747|NCT00164242|Galantamine|galantamine|mesh-list
56344748|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56344749|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344750|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344751|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
56344752|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344753|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344757|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
56344758|NCT00164281|Isoniazid|isoniazid|mesh-list
56344759|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
56344760|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344761|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344762|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56344763|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56344764|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
56344765|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344766|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56344767|NCT00044928|Tazobactam|tazobactam|mesh-list
56344768|NCT00044928|Piperacillin|piperacillin|mesh-list
56344769|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56344771|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344772|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56344773|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344774|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344775|NCT00164359|Artesunate|artesunate|mesh-list
56344776|NCT00164359|Amodiaquine|amodiaquine|mesh-list
56344777|NCT00164359|Dapsone|dapsone|mesh-list
56344778|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
56344779|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
56344780|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56344781|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56344782|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344783|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344784|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
56344785|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
56344786|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56344787|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
56344788|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56344789|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344790|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344791|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
56344792|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344793|NCT00053612|Vitamin A|vitamin a|mesh-list
56344794|NCT00053612|Vitamins|vitamins|mesh-ancestor
56344795|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
56344796|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344797|NCT00045006|Vorinostat|vorinostat|mesh-list
56344798|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344799|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56650910|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650911|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56344800|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344801|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344802|NCT00164710|Artesunate|artesunate|mesh-list
56344803|NCT00164710|Lumefantrine|lumefantrine|mesh-list
56344804|NCT00164710|Artemether|artemether|mesh-list
56344805|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
56344806|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
56344807|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56344808|NCT00164710|Amodiaquine|amodiaquine|mesh-list
56344809|NCT00164710|Dapsone|dapsone|mesh-list
56344810|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
56344811|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
56344812|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56344813|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56344814|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344815|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344816|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
56344817|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
56344818|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56344819|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
56344820|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56344821|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344822|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344823|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56344824|NCT00164710|Renal Agents|renal agents|mesh-ancestor
56344825|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
56344826|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344827|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56344828|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56344829|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344830|NCT00164749|Curcumin|curcumin|mesh-list
56344834|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
56344835|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56344836|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344837|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56344838|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56344839|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344840|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344841|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344842|NCT00164788|Esomeprazole|esomeprazole|mesh-list
56344843|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56170472|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56344844|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344845|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56344846|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344847|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344849|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
56344850|NCT00053768|Doxorubicin|doxorubicin|mesh-list
56344851|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56344852|NCT00053768|Etoposide|etoposide|mesh-list
56344853|NCT00053768|Vincristine|vincristine|mesh-list
56344854|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344855|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
56344856|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344857|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56344858|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56344859|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
56344860|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344861|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344862|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56344863|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56344864|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56344865|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56344866|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344867|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56344868|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
56344869|NCT00053768|Hormones|hormones|mesh-ancestor
56344870|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344871|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56344872|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56344873|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
56344874|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
56650912|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56344875|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
56344876|NCT00164866|Omeprazole|omeprazole|mesh-list
56344877|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56344878|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344879|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56344880|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344881|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344882|NCT00407212|Maleic acid|maleic acid|mesh-list
56344883|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344884|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344885|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
56344886|NCT00165139|Melphalan|melphalan|mesh-list
56344887|NCT00165139|Ifosfamide|ifosfamide|mesh-list
56344888|NCT00165139|Carboplatin|carboplatin|mesh-list
56344889|NCT00165139|Etoposide|etoposide|mesh-list
56344890|NCT00165139|Vincristine|vincristine|mesh-list
56344891|NCT00165139|Doxorubicin|doxorubicin|mesh-list
56344892|NCT00165139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56344893|NCT00165139|Lenograstim|lenograstim|mesh-list
56344894|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344895|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
56344896|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344897|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56344898|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56344899|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
56344900|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344901|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344902|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56344903|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56344904|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56344906|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344907|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
56344908|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
56344909|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
56344910|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56344911|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56344913|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
56344914|NCT00053807|Aldesleukin|aldesleukin|mesh-list
56344915|NCT00053807|Fluorouracil|fluorouracil|mesh-list
56344916|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
56344917|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344918|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56344920|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344921|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
56344922|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344924|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344925|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56344926|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56344927|NCT00165178|Leucovorin|leucovorin|mesh-list
56344928|NCT00165178|Cytarabine|cytarabine|mesh-list
56344929|NCT00165178|Dexamethasone|dexamethasone|mesh-list
56344930|NCT00165178|Prednisone|prednisone|mesh-list
56344931|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
56344932|NCT00165178|Doxorubicin|doxorubicin|mesh-list
56344933|NCT00165178|Methotrexate|methotrexate|mesh-list
56344934|NCT00165178|Vincristine|vincristine|mesh-list
56344935|NCT00165178|Asparaginase|asparaginase|mesh-list
56344936|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
56344937|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56344938|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
56344939|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
56344940|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56344941|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344942|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56344943|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
56344944|NCT00165178|Hormones|hormones|mesh-ancestor
56344945|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344946|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56344947|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344948|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56344949|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56344950|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56344951|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344952|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344953|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56650913|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650914|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650915|NCT05074355|Azacitidine|azacitidine|mesh-list
56650916|NCT05074355|Venetoclax|venetoclax|mesh-list
56650917|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56650918|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
56650919|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650920|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650921|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344954|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
56344955|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56344956|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56344957|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
56344958|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56344959|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56344960|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344961|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
56344962|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56344963|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56344964|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
56344965|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344966|NCT00165178|Antidotes|antidotes|mesh-ancestor
56344967|NCT00165178|Protective Agents|protective agents|mesh-ancestor
56344968|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
56344969|NCT00165178|Vitamins|vitamins|mesh-ancestor
56344970|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
56344971|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56344972|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
56344973|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
56344974|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
56344975|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56344976|NCT00165217|Thalidomide|thalidomide|mesh-list
56344977|NCT00165217|Capecitabine|capecitabine|mesh-list
56344978|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56344979|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
56344980|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344981|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344982|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344983|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
56344985|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
56344986|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56344987|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56344988|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56344989|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56344991|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
56344992|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
55966791|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
56344993|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344994|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
56344995|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56344996|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56344997|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344998|NCT00165295|Urological Agents|urological agents|mesh-ancestor
56345000|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56345001|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345002|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345003|NCT00165334|Cetuximab|cetuximab|mesh-list
56345004|NCT00165334|Vinorelbine|vinorelbine|mesh-list
56345005|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345006|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345007|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56345008|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345009|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345010|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345011|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345012|NCT00165373|Endostatins|endostatins|mesh-list
56650922|NCT02654106|Temozolomide|temozolomide|mesh-list
56650923|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56650924|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
56733186|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
56345013|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345014|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56345015|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56345016|NCT00165373|Growth Substances|growth substances|mesh-ancestor
56345017|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345018|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
56345019|NCT00165451|Thalidomide|thalidomide|mesh-list
56345020|NCT00165451|Celecoxib|celecoxib|mesh-list
56345021|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
56345022|NCT00165451|Etoposide|etoposide|mesh-list
56345023|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345024|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
56345025|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345026|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345027|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56345028|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
56345029|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345030|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345031|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56345032|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56345033|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56345034|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56345035|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345036|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56345037|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56345038|NCT00165451|Analgesics|analgesics|mesh-ancestor
56345039|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
56345040|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345041|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345042|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56345043|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56345044|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
56345045|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345046|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345047|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56345048|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56345049|NCT00165451|Growth Substances|growth substances|mesh-ancestor
56345050|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
56345051|NCT00165490|Irinotecan|irinotecan|mesh-list
56345052|NCT00165490|Cetuximab|cetuximab|mesh-list
56345053|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345054|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56345055|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56345056|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345057|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345059|NCT00165568|Bevacizumab|bevacizumab|mesh-list
56345060|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345061|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345062|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56345063|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56345064|NCT00165568|Growth Substances|growth substances|mesh-ancestor
56345065|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345066|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
56345068|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
56345069|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56345070|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
56345071|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56345072|NCT00045279|Interferons|interferons|mesh-list
56345073|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
56345074|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
56345075|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56345076|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345077|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
56345078|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345079|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
56345080|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345081|NCT00053963|Romidepsin|romidepsin|mesh-list
56345082|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56345083|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650925|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650926|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650927|NCT04243733|Pemetrexed|pemetrexed|mesh-list
56650928|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650929|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213929|NCT01605240|Ibuprofen|ibuprofen|mesh-list
56345084|NCT00165763|Donepezil|donepezil|mesh-list
56345085|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56345086|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345087|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345088|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
56345089|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345090|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345091|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
56345092|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56345093|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345094|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56345095|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345096|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345097|NCT00045318|Exatecan|exatecan|mesh-list
56345098|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56345099|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56345100|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345101|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345102|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345103|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56345104|NCT00054002|Trioxsalen|trioxsalen|mesh-list
56345105|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345106|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
56345107|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56345108|NCT00054041|Vaccines|vaccines|mesh-list
56345109|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
56345110|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345111|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
56345112|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56345113|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345114|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56345115|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
56345116|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345117|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345118|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345119|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345120|NCT00054197|Gemcitabine|gemcitabine|mesh-list
56345121|NCT00054197|Paclitaxel|paclitaxel|mesh-list
56345122|NCT00054197|Vinorelbine|vinorelbine|mesh-list
56345123|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56345124|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56345125|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345126|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345127|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345128|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345129|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345130|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345131|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
56345132|NCT00054197|Antiviral Agents|antiviral agents|mesh-ancestor
56345134|NCT00054197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345135|NCT00054197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345136|NCT00054197|Immunologic Factors|immunologic factors|mesh-ancestor
56345137|NCT00054197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345139|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345140|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
55966945|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345141|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345142|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56345143|NCT00166426|Protective Agents|protective agents|mesh-ancestor
56345144|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345145|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56345146|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345147|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650930|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650931|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56650932|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56345148|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56345149|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56345151|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
56345152|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345153|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345154|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345155|NCT00166465|Leucovorin|leucovorin|mesh-list
56345156|NCT00166465|Fluorouracil|fluorouracil|mesh-list
56345157|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
56345158|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
56345159|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345160|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345161|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345162|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345163|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
56345164|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345165|NCT00166465|Antidotes|antidotes|mesh-ancestor
56345166|NCT00166465|Protective Agents|protective agents|mesh-ancestor
56345167|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
56345168|NCT00166465|Vitamins|vitamins|mesh-ancestor
56345169|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
56345170|NCT00166621|Buspirone|buspirone|mesh-list
56345171|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56345172|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56345173|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56345174|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345175|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56345176|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56345177|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
56345178|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345179|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345180|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
56345181|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
56345182|NCT00054236|Fludarabine|fludarabine|mesh-list
56345183|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
56345184|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56345185|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345186|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
56345187|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345188|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345189|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56345190|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
56345191|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345192|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345193|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56345194|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345195|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
56345196|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345197|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
56345198|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
56345199|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345200|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56345201|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
56345202|NCT00054236|Hormones|hormones|mesh-ancestor
56345203|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56345204|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56345205|NCT00054236|Protective Agents|protective agents|mesh-ancestor
56345206|NCT00054392|Gemcitabine|gemcitabine|mesh-list
56345207|NCT00054392|Paclitaxel|paclitaxel|mesh-list
56345208|NCT00054392|Carboplatin|carboplatin|mesh-list
56345214|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345215|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967021|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
56345216|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
56345217|NCT00054392|Antiviral Agents|antiviral agents|mesh-ancestor
56345218|NCT00054392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345219|NCT00054392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345220|NCT00054392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345221|NCT00054392|Immunologic Factors|immunologic factors|mesh-ancestor
56345222|NCT00054392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345223|NCT00166816|Cyclosporine|cyclosporine|mesh-list
56345224|NCT00166816|Sirolimus|sirolimus|mesh-list
56345225|NCT00166816|Tacrolimus|tacrolimus|mesh-list
56345226|NCT00166816|Cyclosporins|cyclosporins|mesh-list
56345227|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345228|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
56345229|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345230|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56345231|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345232|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345233|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
56345234|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345235|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
56345236|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345237|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345238|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56345239|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345240|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
56345241|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56345242|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56345243|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345244|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
56345245|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
56345246|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
56345247|NCT00054431|Decitabine|decitabine|mesh-list
56345248|NCT00054431|Azacitidine|azacitidine|mesh-list
56345249|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345250|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56345251|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345252|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345253|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345254|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
56345255|NCT00054470|Trastuzumab|trastuzumab|mesh-list
56345256|NCT00054470|Tipifarnib|tipifarnib|mesh-list
56345257|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345258|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345259|NCT00054548|Paclitaxel|paclitaxel|mesh-list
56345260|NCT00054548|Oblimersen|oblimersen|mesh-list
56345261|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56345262|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345263|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345264|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345265|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345266|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345267|NCT00045513|Fludarabine|fludarabine|mesh-list
56345268|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
56345269|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56345270|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345271|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345272|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
56345273|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345274|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345275|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
56345276|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345277|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56345278|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345279|NCT00167401|Docetaxel|docetaxel|mesh-list
56345282|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345283|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345284|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345286|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56345287|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
56345288|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345289|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345290|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345291|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56345292|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56345293|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56345294|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56345295|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56345297|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
56345299|NCT00054587|Fluorouracil|fluorouracil|mesh-list
56345300|NCT00054587|Trastuzumab|trastuzumab|mesh-list
56345301|NCT00054587|Epirubicin|epirubicin|mesh-list
56345302|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345303|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
56650933|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
56650934|NCT03434366|Ketamine|ketamine|mesh-list
56650935|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56345304|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345305|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345306|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56345307|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
56345308|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345309|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345310|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56345311|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345312|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345313|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345314|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
56345315|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345316|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345317|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56345318|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56345319|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56345320|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345321|NCT00167518|Triamcinolone|triamcinolone|mesh-list
56345322|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345323|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
56345324|NCT00167518|Hormones|hormones|mesh-ancestor
56345325|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56345326|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345327|NCT00167557|Interferons|interferons|mesh-list
56345328|NCT00167557|Ribavirin|ribavirin|mesh-list
56345329|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345330|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
56345331|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345332|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
56345333|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345334|NCT00167674|Zidovudine|zidovudine|mesh-list
56345335|NCT00167674|Nevirapine|nevirapine|mesh-list
56345336|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
56345337|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345338|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56345339|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56345340|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345341|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
56345342|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345343|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56345344|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56345345|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56345346|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56345347|NCT00054626|Gemcitabine|gemcitabine|mesh-list
56345348|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345349|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345350|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
56345351|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345352|NCT00054626|Antiviral Agents|antiviral agents|mesh-ancestor
56345353|NCT00054626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345354|NCT00054626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345356|NCT00054626|Immunologic Factors|immunologic factors|mesh-ancestor
56345357|NCT00054626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345358|NCT00167713|Ibuprofen|ibuprofen|mesh-list
56345359|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56345360|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56345361|NCT00167713|Analgesics|analgesics|mesh-ancestor
56345363|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345364|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345365|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345366|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345367|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55967168|NCT03585140|Doxycycline|doxycycline|mesh-list
56345368|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345369|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345370|NCT00167791|Rituximab|rituximab|mesh-list
56345371|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345372|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345373|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
56118640|NCT00003317|Carboplatin|carboplatin|mesh-list
56650936|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56650937|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345374|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345375|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345376|NCT00045591|Celecoxib|celecoxib|mesh-list
56345377|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56345378|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56345379|NCT00045591|Analgesics|analgesics|mesh-ancestor
56345380|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
56345381|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345382|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345383|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345384|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345385|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56345386|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56345387|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345388|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345389|NCT00167908|Amifostine|amifostine|mesh-list
56345390|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56345391|NCT00167908|Protective Agents|protective agents|mesh-ancestor
56345392|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345393|NCT00167947|Cyclosporine|cyclosporine|mesh-list
56345394|NCT00167947|Sirolimus|sirolimus|mesh-list
56345395|NCT00167947|Cyclosporins|cyclosporins|mesh-list
56345396|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345397|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345398|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345399|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
56345400|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345401|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
56345402|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345403|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
56345404|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345405|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56345406|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345407|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56345408|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345409|NCT00167986|Vancomycin|vancomycin|mesh-list
56345410|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345411|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345412|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
56345413|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56345414|NCT00168025|Antibodies|antibodies|mesh-list
56345415|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
56345416|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345417|NCT00168181|Pilocarpine|pilocarpine|mesh-list
56345418|NCT00168181|Miotics|miotics|mesh-ancestor
56345419|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
56345420|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345421|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345422|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56345423|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56345424|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
56345425|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345426|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345427|NCT00407251|Epothilone B|epothilone b|mesh-list
56345428|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345429|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345432|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345433|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
56345434|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345435|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56345436|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345437|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345438|NCT00407290|Neostigmine|neostigmine|mesh-list
56345439|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56345440|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345441|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345442|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
56345443|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345444|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345445|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56345446|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
56650938|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56650939|NCT03434366|Analgesics|analgesics|mesh-ancestor
56650940|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
56345447|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345448|NCT00407407|Carboplatin|carboplatin|mesh-list
56345449|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56345450|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345451|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
56345452|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
56345453|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56345454|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56345455|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345456|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345457|NCT00407446|Urological Agents|urological agents|mesh-ancestor
56345458|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
56345459|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56345460|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56345461|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56345462|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56345463|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345464|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
56345465|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345466|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345467|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56345468|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345469|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
56345470|NCT00168493|Serotonin|serotonin|mesh-list
56345471|NCT00168493|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56345472|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56345473|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56345474|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
56345475|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345476|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345477|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345478|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56345479|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56345480|NCT00168532|Trimethoprim|trimethoprim|mesh-list
56345481|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56345482|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
56345483|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56345484|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345485|NCT00168532|Renal Agents|renal agents|mesh-ancestor
56345486|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
56345487|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56345488|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56345489|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56345490|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345491|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345492|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56345493|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56345494|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56345495|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345496|NCT00168610|Vitamin A|vitamin a|mesh-list
56345497|NCT00168610|Vitamins|vitamins|mesh-ancestor
56345498|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
56345499|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345500|NCT04731948|Vitamins|vitamins|mesh-list
56345501|NCT04731948|Folic Acid|folic acid|mesh-list
56345504|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
56345505|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
56345506|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345507|NCT04731948|Hematinics|hematinics|mesh-ancestor
56345508|NCT00168649|Vitamin A|vitamin a|mesh-list
56345509|NCT00168649|Vitamins|vitamins|mesh-ancestor
56345510|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
56345511|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345512|NCT00168688|Micronutrients|micronutrients|mesh-list
56345513|NCT00168688|Trace Elements|trace elements|mesh-list
56345514|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345515|NCT00168766|Interferons|interferons|mesh-list
56345516|NCT00168766|Interferon-beta|interferon-beta|mesh-list
56345517|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
56345518|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
56345519|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650941|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650942|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56650943|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56650944|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56345520|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
56345521|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345522|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345524|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
56345525|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345526|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345527|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56345528|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
56345529|NCT00168766|Hormones|hormones|mesh-ancestor
56345530|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56345531|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56345532|NCT00168766|Protective Agents|protective agents|mesh-ancestor
56345533|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
56345534|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56345535|NCT00168883|Paclitaxel|paclitaxel|mesh-list
56345536|NCT00168883|Vinorelbine|vinorelbine|mesh-list
56345537|NCT00168883|Carboplatin|carboplatin|mesh-list
56345538|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56345539|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345540|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345541|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345542|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345543|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345544|NCT04731909|Cisplatin|cisplatin|mesh-list
56345545|NCT04731909|Carboplatin|carboplatin|mesh-list
56345546|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345547|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56345548|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56345549|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
56345550|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345551|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345552|NCT00054938|Aspirin|aspirin|mesh-list
56345553|NCT00054938|Ramipril|ramipril|mesh-list
56345554|NCT00054938|Pravastatin|pravastatin|mesh-list
56345555|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345556|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56345557|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56345558|NCT00054938|Analgesics|analgesics|mesh-ancestor
56345559|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
56345560|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345561|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345562|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345563|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56345564|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56345565|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345566|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56345567|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56345568|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345569|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
56345570|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56345571|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
56345572|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56345573|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56345574|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56345575|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
56345576|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56345577|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56345578|NCT00169000|Docetaxel|docetaxel|mesh-list
56345581|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345582|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345583|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345584|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345585|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345586|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
56345587|NCT00045747|Fluorouracil|fluorouracil|mesh-list
56345588|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56345589|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
56650945|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
56650946|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650947|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345590|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345591|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345592|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345593|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345594|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
56345595|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345596|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56345597|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345598|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
56345600|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56345601|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
56345602|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345603|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345604|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345605|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56345606|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56345607|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56345608|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56345609|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
56345610|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
56345611|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
56345612|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
56345613|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345614|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56345615|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56345616|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
56345617|NCT00169078|Chloroquine|chloroquine|mesh-list
56345618|NCT00169078|Amebicides|amebicides|mesh-ancestor
56345619|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56345620|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56345621|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345622|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
56345623|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345624|NCT00054977|Fluorouracil|fluorouracil|mesh-list
56345625|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
56345626|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345627|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345628|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345629|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345630|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
56345631|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345632|NCT00169156|Prednisone|prednisone|mesh-list
56345633|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
56345634|NCT00169156|Rituximab|rituximab|mesh-list
56345635|NCT00169156|Doxorubicin|doxorubicin|mesh-list
56345636|NCT00169156|Vincristine|vincristine|mesh-list
56345637|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345638|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
56345639|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345640|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345641|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56345642|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
56345643|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345644|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345645|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56345646|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345647|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56345648|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56345649|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56345650|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345651|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345652|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
56345653|NCT00169156|Hormones|hormones|mesh-ancestor
56345655|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56345656|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56345657|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345658|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345659|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345660|NCT00169195|Gemcitabine|gemcitabine|mesh-list
56345661|NCT00169195|Rituximab|rituximab|mesh-list
56650948|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55974010|NCT03267680|Indomethacin|indomethacin|mesh-list
56345662|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
56345663|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345664|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345665|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
56345666|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345667|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345668|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967478|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
56345669|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
56345670|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345671|NCT00169195|Antiviral Agents|antiviral agents|mesh-ancestor
56345672|NCT00169195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345673|NCT00169195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345674|NCT00169195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345675|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56345676|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
56345677|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345679|NCT00169468|Bortezomib|bortezomib|mesh-list
56345680|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345681|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345682|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
56345683|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345684|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345685|NCT00169546|Fluticasone|fluticasone|mesh-list
56345686|NCT00169546|Xhance|xhance|mesh-list
56345687|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56345688|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345689|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56345690|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
56345691|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345692|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345693|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56345694|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
56345695|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
56345696|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56345697|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56345698|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56345699|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56345700|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56345701|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345702|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345703|NCT00398372|Rituximab|rituximab|mesh-list
56345704|NCT00398372|Epratuzumab|epratuzumab|mesh-list
56345705|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345706|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345707|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
56345708|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345709|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345710|NCT00169585|Levofloxacin|levofloxacin|mesh-list
56345711|NCT00169585|Ofloxacin|ofloxacin|mesh-list
56345712|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56345713|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345714|NCT00169585|Renal Agents|renal agents|mesh-ancestor
56345715|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345716|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56345717|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56345718|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345719|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345720|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345721|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56345722|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56345723|NCT00169624|Metformin|metformin|mesh-list
56345724|NCT00169624|Gliclazide|gliclazide|mesh-list
56345725|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56345726|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345727|NCT00407641|Heparin|heparin|mesh-list
56345731|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
56345732|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56345733|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56345734|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345735|NCT00407680|Valsartan|valsartan|mesh-list
56345736|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56650949|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56650950|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
56650951|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
56650952|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56650953|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56650954|NCT04167228|Ceftazidime|ceftazidime|mesh-list
56650955|NCT04167228|Avibactam|avibactam|mesh-list
56547632|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56733187|NCT00400946|Razoxane|razoxane|mesh-list
56345737|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56345738|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56345739|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345741|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
56345742|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56345743|NCT00055133|Paclitaxel|paclitaxel|mesh-list
56345744|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56345745|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345746|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345747|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345748|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345749|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345751|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345752|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345753|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56345754|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345755|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
56345756|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345757|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
56345758|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345759|NCT00055250|Gemcitabine|gemcitabine|mesh-list
56345760|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56345761|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
56345762|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345763|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345764|NCT00055250|Antiviral Agents|antiviral agents|mesh-ancestor
56345765|NCT00055250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345766|NCT00055250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345767|NCT00055250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345768|NCT00055250|Immunologic Factors|immunologic factors|mesh-ancestor
56345769|NCT00055250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345770|NCT00170209|Rifampin|rifampin|mesh-list
56345771|NCT00170209|Isoniazid|isoniazid|mesh-list
56345772|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56345773|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
56345774|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345775|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345776|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
56345777|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56345778|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345779|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345780|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56345781|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56345782|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56345783|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56345784|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56345785|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56345786|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56345787|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56345788|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
56345789|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56345790|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
56345791|NCT02964091|Ledipasvir|ledipasvir|mesh-list
56345792|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
56345793|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345794|NCT00170404|Vitamins|vitamins|mesh-list
56345795|NCT00170404|Folic Acid|folic acid|mesh-list
56345796|NCT00170404|Vitamin A|vitamin a|mesh-list
56650956|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
56650957|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56650958|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733188|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
56345797|NCT00170404|Thiamine|thiamine|mesh-list
56345798|NCT00170404|Selenium|selenium|mesh-list
56345799|NCT00170404|Micronutrients|micronutrients|mesh-list
56345800|NCT00170404|Trace Elements|trace elements|mesh-list
56345801|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345802|NCT00170404|Hematinics|hematinics|mesh-ancestor
56345803|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
56345805|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345807|NCT00055367|Natalizumab|natalizumab|mesh-list
56345808|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
56345809|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345810|NCT00170677|Topotecan|topotecan|mesh-list
56345811|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56345812|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56345813|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345814|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345815|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345817|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56345818|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56345819|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
56345820|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345821|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967621|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
56345822|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345823|NCT00170755|Urological Agents|urological agents|mesh-ancestor
56345824|NCT00170794|Everolimus|everolimus|mesh-list
56345825|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345826|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345827|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
56345828|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345829|NCT00170833|Everolimus|everolimus|mesh-list
56345830|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345831|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345832|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
56345833|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345834|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
56345835|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56345836|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56345837|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345838|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345839|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56345840|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56345841|NCT00170872|Analgesics|analgesics|mesh-ancestor
56345842|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
56345843|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56345844|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345845|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345846|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345847|NCT00170989|Valsartan|valsartan|mesh-list
56345848|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56345849|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56345850|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56345851|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56345852|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345853|NCT00170989|Diuretics|diuretics|mesh-ancestor
56345854|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
56345855|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345856|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56345857|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56345858|NCT00171028|Valsartan|valsartan|mesh-list
56345859|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56345860|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56345861|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56345862|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345863|NCT00055484|Zonisamide|zonisamide|mesh-list
56345864|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
56650959|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55974254|NCT05502146|Norepinephrine|norepinephrine|mesh-list
56345865|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56345866|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56345867|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345868|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56345869|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345870|NCT00171067|Valsartan|valsartan|mesh-list
56345871|NCT00171067|Lisinopril|lisinopril|mesh-list
56345872|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56345873|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56345874|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56345875|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345877|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
56345878|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345879|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56345880|NCT00171067|Protective Agents|protective agents|mesh-ancestor
56345881|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345882|NCT00171106|Valsartan|valsartan|mesh-list
56345883|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56345884|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56345885|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56345886|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345887|NCT00171145|Darifenacin|darifenacin|mesh-list
56345888|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56345889|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56345890|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
56345891|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345892|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345893|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345894|NCT00171145|Urological Agents|urological agents|mesh-ancestor
56345895|NCT00171184|Darifenacin|darifenacin|mesh-list
56345896|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56345897|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56345898|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
56345899|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345900|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345901|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345902|NCT00171184|Urological Agents|urological agents|mesh-ancestor
56345903|NCT00055523|Adalimumab|adalimumab|mesh-list
56345904|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56345905|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345906|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
56345907|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56345908|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345909|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56345910|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
56345911|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56345912|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345913|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345914|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345915|NCT00171418|Tegaserod|tegaserod|mesh-list
56345916|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56345917|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
56345918|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345919|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345920|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345921|NCT00171457|Tegaserod|tegaserod|mesh-list
56345922|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56345923|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
56345924|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56345925|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345926|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345927|NCT00055562|Lenalidomide|lenalidomide|mesh-list
56345928|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
56345929|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345930|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56345931|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56345932|NCT00055562|Growth Substances|growth substances|mesh-ancestor
56345933|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
56345934|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56650960|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650961|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650962|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
56213960|NCT01605279|Protective Agents|protective agents|mesh-ancestor
56345935|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
56345936|NCT04924374|Atezolizumab|atezolizumab|mesh-list
56345937|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56345938|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345939|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345940|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
56345941|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345942|NCT00171496|Cyclosporine|cyclosporine|mesh-list
56345943|NCT00171496|Tacrolimus|tacrolimus|mesh-list
56345945|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345946|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
56345947|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345948|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56345949|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345953|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
56345954|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345955|NCT00171535|Amlodipine|amlodipine|mesh-list
56345956|NCT00171535|Valsartan|valsartan|mesh-list
56345957|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56345958|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56345959|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56345960|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345961|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56345962|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345963|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
56345964|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56345965|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56345967|NCT00171574|Lisinopril|lisinopril|mesh-list
56345968|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56345969|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56345971|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345972|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56345973|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
56345974|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56345975|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56345976|NCT00171574|Protective Agents|protective agents|mesh-ancestor
56345977|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345978|NCT00171613|Octreotide|octreotide|mesh-list
56345979|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56345980|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56345981|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345982|NCT04920981|Atezolizumab|atezolizumab|mesh-list
56345983|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345984|NCT00055640|Prednisone|prednisone|mesh-list
56345985|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
56345986|NCT00055640|Rituximab|rituximab|mesh-list
56345987|NCT00055640|Doxorubicin|doxorubicin|mesh-list
56345988|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56345989|NCT00055640|Vincristine|vincristine|mesh-list
56345990|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345991|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
56345992|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345993|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56345994|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56345995|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
56345996|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345997|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345998|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56345999|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56346000|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56346001|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56346002|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56346003|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346004|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56346005|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
56346006|NCT00055640|Hormones|hormones|mesh-ancestor
56346007|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56650963|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56650964|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
56346008|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56346009|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56346010|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
56346011|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
56346012|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
56346013|NCT00171652|Diclofenac|diclofenac|mesh-list
56346014|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56346015|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56346016|NCT00171652|Analgesics|analgesics|mesh-ancestor
56346017|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
56346018|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852378|NCT00218062|Amphetamine|amphetamine|mesh-list
56346019|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346020|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56346021|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346023|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346024|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346026|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56346027|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56346028|NCT00171691|Analgesics|analgesics|mesh-ancestor
56346029|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
56346030|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346031|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346032|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56346033|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346034|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56346035|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346036|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346037|NCT00171769|Certoparin|certoparin|mesh-list
56346038|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
56346039|NCT00171808|Letrozole|letrozole|mesh-list
56346040|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346041|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56346042|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56346043|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346044|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346045|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56346046|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
56346047|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346048|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346049|NCT00171847|Trastuzumab|trastuzumab|mesh-list
56346050|NCT00171847|Letrozole|letrozole|mesh-list
56346051|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56346052|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346053|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56346054|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56346055|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346056|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346057|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56346058|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
56346059|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346060|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346061|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
56346062|NCT00055679|Fluorouracil|fluorouracil|mesh-list
56346063|NCT00055679|Epirubicin|epirubicin|mesh-list
56346064|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346065|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
56346066|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346067|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346068|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56346069|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
56346070|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346071|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346072|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56346073|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
56346074|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56346075|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56346076|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56346077|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56650965|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56733189|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56733190|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
56346078|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346079|NCT00171886|Octreotide|octreotide|mesh-list
56346080|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56346081|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56346082|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346083|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
56346084|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56346085|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346086|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
56346087|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56346088|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346089|NCT00055718|Silymarin|silymarin|mesh-list
56346091|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346092|NCT00055718|Protective Agents|protective agents|mesh-ancestor
56346093|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346094|NCT00055757|Gemcitabine|gemcitabine|mesh-list
56346095|NCT00055757|Tipifarnib|tipifarnib|mesh-list
56346098|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
56346099|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346100|NCT00055757|Antiviral Agents|antiviral agents|mesh-ancestor
56346101|NCT00055757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346102|NCT00055757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346103|NCT00055757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346104|NCT00055757|Immunologic Factors|immunologic factors|mesh-ancestor
56346105|NCT00055757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346107|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56346108|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56346109|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
56346110|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346111|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56346112|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56346113|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346114|NCT00055835|Gemcitabine|gemcitabine|mesh-list
56346115|NCT00055835|Paclitaxel|paclitaxel|mesh-list
56346116|NCT00055835|Carboplatin|carboplatin|mesh-list
55967923|NCT00582205|Paclitaxel|paclitaxel|mesh-list
56346117|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56346118|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346119|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
56346120|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
56346121|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
56346122|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346123|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56346124|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
56346125|NCT00055835|Antiviral Agents|antiviral agents|mesh-ancestor
56346126|NCT00055835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346127|NCT00055835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346128|NCT00055835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346129|NCT00055835|Immunologic Factors|immunologic factors|mesh-ancestor
56346130|NCT00055835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346131|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
56346132|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56346133|NCT04764162|Choline|choline|mesh-list
56346134|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
56346135|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56346136|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
56346137|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346138|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56346139|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56346140|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
56346141|NCT00055874|Interferons|interferons|mesh-list
56346142|NCT00055874|Cytarabine|cytarabine|mesh-list
56346143|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
56346144|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
56346145|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
56346146|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346147|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
56346148|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346149|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56346150|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
56346151|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733191|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974541|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
56346152|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346153|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
56346154|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346155|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56346156|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346157|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
56346158|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56346159|NCT00407719|Bevacizumab|bevacizumab|mesh-list
56346160|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56346161|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346162|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56346163|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56346164|NCT00407719|Growth Substances|growth substances|mesh-ancestor
56346165|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346166|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
56346167|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
56346168|NCT04732845|Fludarabine|fludarabine|mesh-list
56346169|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346175|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346177|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56346178|NCT00055913|Bevacizumab|bevacizumab|mesh-list
56346179|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56346180|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56346182|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
56346183|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56346184|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346185|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56346186|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56346187|NCT00055913|Growth Substances|growth substances|mesh-ancestor
56346188|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346189|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
56346190|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
56346191|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55968029|NCT00630253|Hormones|hormones|mesh-ancestor
56346192|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346193|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346194|NCT00045864|Aldesleukin|aldesleukin|mesh-list
56346195|NCT00045864|Rituximab|rituximab|mesh-list
56346196|NCT00045864|Interleukin-2|interleukin-2|mesh-list
56346197|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56346198|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346199|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
56346200|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346201|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346202|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56346203|NCT00045864|Analgesics|analgesics|mesh-ancestor
56346204|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
56346205|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346206|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56346207|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56346208|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
56346209|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346210|NCT00055952|Exatecan|exatecan|mesh-list
56346211|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56346212|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56346213|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346214|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346215|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346216|NCT00055991|Bexarotene|bexarotene|mesh-list
56346217|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346218|NCT04631484|Riboflavin|riboflavin|mesh-list
56346219|NCT04631484|Niacinamide|niacinamide|mesh-list
56346220|NCT04631484|Niacin|niacin|mesh-list
56346221|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
56346222|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
56346223|NCT04631484|Vitamins|vitamins|mesh-ancestor
56346224|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
56346225|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346226|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56346227|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56346228|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56346229|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
56170515|NCT03212820|Methamphetamine|methamphetamine|mesh-list
56118809|NCT00004361|Calcium|calcium|mesh-list
56650966|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
56346230|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346231|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56346232|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
56346234|NCT00056030|Fluorouracil|fluorouracil|mesh-list
56346235|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
56346236|NCT00056030|Cetuximab|cetuximab|mesh-list
56346237|NCT00056030|Calcium|calcium|mesh-list
56346238|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
56346239|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56346240|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346241|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
56346243|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56346244|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346245|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346246|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
56346248|NCT00056030|Protective Agents|protective agents|mesh-ancestor
56346249|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
56346250|NCT00056030|Vitamins|vitamins|mesh-ancestor
56346251|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
56346252|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56346253|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56346254|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56346255|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346256|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346257|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346258|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346259|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346260|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56346261|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
56346262|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346263|NCT00173875|Gefitinib|gefitinib|mesh-list
56346264|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346265|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56346266|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346267|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346268|NCT04605081|Naltrexone|naltrexone|mesh-list
56346269|NCT04605081|Bupropion|bupropion|mesh-list
56346270|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56346271|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56346272|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346273|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
56346274|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346275|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56346276|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
56346277|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346278|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56346279|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346280|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346281|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346282|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
56346283|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346284|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56346285|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56346286|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346287|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56346288|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56346289|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346290|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56346291|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346292|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346293|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346294|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
56346295|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346296|NCT00174226|Buspirone|buspirone|mesh-list
56346297|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55852829|NCT01732796|Ribavirin|ribavirin|mesh-list
56346298|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56346299|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346300|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346301|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346302|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
56346303|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346304|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346305|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56346306|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56346307|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346308|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346309|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56346314|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56346315|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56346316|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
56346317|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346318|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56346319|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56346320|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346321|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56346322|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56346323|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346324|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56346325|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346326|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
56346328|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346329|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56346330|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56346331|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346332|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346333|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56346334|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
56346335|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346336|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346337|NCT00174499|Nicotine|nicotine|mesh-list
56346338|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55968142|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56346339|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
56346340|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346341|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346342|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56346343|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56346344|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
56346345|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346346|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346347|NCT00174538|Codeine|codeine|mesh-list
56346348|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56346349|NCT00174538|Narcotics|narcotics|mesh-ancestor
56346350|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346351|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346352|NCT00174538|Analgesics|analgesics|mesh-ancestor
56346353|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
56346354|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346355|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
56346356|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
56346357|NCT00174577|Risperidone|risperidone|mesh-list
56346358|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56346359|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
56346360|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346361|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346362|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346363|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56346364|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56346365|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346366|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346367|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56346368|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
56346369|NCT00046137|Teriparatide|teriparatide|mesh-list
56346370|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56346371|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56346372|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346373|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56346374|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56650967|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56733192|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346375|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
56346376|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346377|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56346378|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56346380|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
56346381|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
56346382|NCT00056225|Pyridoxal|pyridoxal|mesh-list
56346383|NCT00056225|Pyridoxine|pyridoxine|mesh-list
56346384|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
56346385|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
56346386|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346387|NCT00174616|Capecitabine|capecitabine|mesh-list
56346388|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
56346389|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56346390|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
56346391|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346392|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346393|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
56346394|NCT00174655|Docetaxel|docetaxel|mesh-list
56346395|NCT00174655|Doxorubicin|doxorubicin|mesh-list
56346396|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56346397|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346398|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
56346399|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346400|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346401|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56346402|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
56346403|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346404|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346405|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56346406|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
56346407|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
56346408|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
56346409|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56346410|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56346411|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56346412|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346413|NCT00174694|Telithromycin|telithromycin|mesh-list
56346414|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56346415|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346416|NCT00174733|Ciclesonide|ciclesonide|mesh-list
56346417|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
56346419|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346420|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346421|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56346422|NCT00056264|Infliximab|infliximab|mesh-list
56346423|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
56346424|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56346425|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346426|NCT00174772|Cisplatin|cisplatin|mesh-list
56346427|NCT00174772|Docetaxel|docetaxel|mesh-list
56346428|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346429|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
56346430|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
56346431|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
56346432|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346433|NCT00174811|Telithromycin|telithromycin|mesh-list
56346434|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56346435|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346436|NCT02963779|Apremilast|apremilast|mesh-list
56346437|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56346438|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56346439|NCT02963779|Analgesics|analgesics|mesh-ancestor
56346440|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
56346441|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346442|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346443|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56346444|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346445|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56346446|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56346447|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346448|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650968|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974868|NCT00652847|Ezetimibe|ezetimibe|mesh-list
56346449|NCT00046176|Lamivudine|lamivudine|mesh-list
56346450|NCT00046176|Abacavir|abacavir|mesh-list
56346451|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
56346452|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56346453|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56346454|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346455|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346456|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
56346460|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
56346461|NCT00174928|Lansoprazole|lansoprazole|mesh-list
56346462|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
56346463|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56346464|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56346465|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56346466|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346467|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346468|NCT00175045|Lansoprazole|lansoprazole|mesh-list
56346469|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
56346470|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56346471|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56346472|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56346473|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346474|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346475|NCT00056381|Anidulafungin|anidulafungin|mesh-list
56346476|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
56346478|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56346479|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56346480|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56346481|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346482|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346483|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56346484|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346485|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346486|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
56346487|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346488|NCT00175357|Methadone|methadone|mesh-list
56346489|NCT00175357|Heroin|heroin|mesh-list
56346490|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56346491|NCT00175357|Narcotics|narcotics|mesh-ancestor
56346492|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346493|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346494|NCT00175357|Analgesics|analgesics|mesh-ancestor
56346495|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
56346496|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346497|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
56346498|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
56346499|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
56346500|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56346501|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346502|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
56346503|NCT00175396|Leuprolide|leuprolide|mesh-list
56346504|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
56346505|NCT00175396|Flutamide|flutamide|mesh-list
56346506|NCT00175396|Bicalutamide|bicalutamide|mesh-list
56346507|NCT00175396|Nilutamide|nilutamide|mesh-list
56346508|NCT00175396|Buserelin|buserelin|mesh-list
56346510|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56346511|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56346512|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
56346513|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56346514|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346515|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56346516|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346517|NCT00175396|Hormones|hormones|mesh-ancestor
56346518|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346519|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
56346520|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346521|NCT00175396|Protective Agents|protective agents|mesh-ancestor
56346522|NCT00175396|Vitamins|vitamins|mesh-ancestor
56346523|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
56346524|NCT00175396|Estrogens|estrogens|mesh-ancestor
56346525|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
56346526|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
56650969|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56650970|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650971|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
56650972|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56213972|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346527|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
56346528|NCT00056459|Vatalanib|vatalanib|mesh-list
56346529|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56346530|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346531|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346532|NCT00175435|Vaccines|vaccines|mesh-list
56346533|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
56346537|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346538|NCT00175591|Bupivacaine|bupivacaine|mesh-list
56346539|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
56346540|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
56346541|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346542|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346543|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
56346544|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346545|NCT00175630|Bupivacaine|bupivacaine|mesh-list
56346546|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
56346547|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
56346548|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346549|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346550|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
56346551|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346552|NCT00408031|Cycloserine|cycloserine|mesh-list
56346553|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56346554|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346555|NCT00408031|Renal Agents|renal agents|mesh-ancestor
56346556|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56346557|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
56346558|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56346559|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
56346560|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346561|NCT00175747|Budesonide|budesonide|mesh-list
56346562|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56346563|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56346564|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
56346565|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346566|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346567|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56346568|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
56346569|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
56346570|NCT00175747|Hormones|hormones|mesh-ancestor
56346571|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346572|NCT04493619|Carboplatin|carboplatin|mesh-list
56346573|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346574|NCT00056576|Zonisamide|zonisamide|mesh-list
56346575|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
56346576|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56346577|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346578|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346579|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56346580|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346581|NCT00175903|Carbamazepine|carbamazepine|mesh-list
56346582|NCT00175903|Levetiracetam|levetiracetam|mesh-list
56346583|NCT00175903|Valproic Acid|valproic acid|mesh-list
56346584|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
56346585|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
56346586|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346587|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346588|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
56346589|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346590|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346591|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
56346592|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56346593|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346594|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346595|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56650973|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346596|NCT00175903|Analgesics|analgesics|mesh-ancestor
56346597|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
56346598|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346599|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56346600|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346601|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56346602|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56346603|NCT00056654|Leuprolide|leuprolide|mesh-list
56346604|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56346605|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
56346606|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56346610|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
56346611|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
56346612|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
56346613|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56346614|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56346615|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346616|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346617|NCT00175981|Urological Agents|urological agents|mesh-ancestor
56346618|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56346619|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56346620|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346621|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346622|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346623|NCT00175981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56346624|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346625|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346626|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346627|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
56346628|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56346629|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
56346630|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56346631|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56346632|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56346633|NCT04420533|Mirabegron|mirabegron|mesh-list
56346634|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56346635|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56346636|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56346637|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
56346638|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346639|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346640|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346641|NCT04420533|Urological Agents|urological agents|mesh-ancestor
56346642|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
56346643|NCT00176020|Niacin|niacin|mesh-list
56346644|NCT00176020|Niacinamide|niacinamide|mesh-list
56346645|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
56346646|NCT00176020|Vitamins|vitamins|mesh-ancestor
56346647|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
56346648|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346649|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56346650|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
56346651|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346652|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56346653|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
56346654|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
56346655|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56346657|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
56346658|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56346659|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
56346660|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346661|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56346662|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56346663|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346664|NCT00176293|Dexamethasone|dexamethasone|mesh-list
56346665|NCT00176293|Doxorubicin|doxorubicin|mesh-list
56346666|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56346667|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
56346668|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
56346669|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346670|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346671|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56650974|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650975|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56346672|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
56346673|NCT00176293|Hormones|hormones|mesh-ancestor
56346674|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346675|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56346676|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346677|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56346678|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56346683|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346684|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56346685|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56346686|NCT00056693|Growth Substances|growth substances|mesh-ancestor
56346687|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346688|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
56346689|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56346690|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346691|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346692|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56346693|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56346694|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56346695|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
56346696|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346697|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56346698|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56346699|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346701|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56346702|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
56346703|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346704|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56346705|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346706|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346707|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346708|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
56346709|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346710|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346711|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56346712|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56346713|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346714|NCT00398450|Interferons|interferons|mesh-list
56346715|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
56346716|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
56346717|NCT00398450|Azacitidine|azacitidine|mesh-list
56346718|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346719|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
56346720|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346721|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56346722|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
56346723|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346724|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346725|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
56346726|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346727|NCT00046293|Abciximab|abciximab|mesh-list
56346728|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
56346729|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56346730|NCT00176527|Interferons|interferons|mesh-list
56346731|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
56346732|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
56346733|NCT00176527|Docetaxel|docetaxel|mesh-list
56346734|NCT00176527|Estramustine|estramustine|mesh-list
56346735|NCT00176527|Isotretinoin|isotretinoin|mesh-list
56346736|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346737|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
56346738|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
56346739|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
56346740|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346741|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
56346742|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346743|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
56346744|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346745|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
56119953|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650976|NCT02648958|Analgesics|analgesics|mesh-ancestor
56650977|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
56650978|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56650979|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56650980|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56650981|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56650982|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
56650983|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56650984|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650985|NCT00887549|Pemetrexed|pemetrexed|mesh-list
56650986|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346746|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56346747|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
56346748|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56346749|NCT00398489|Tamoxifen|tamoxifen|mesh-list
56346751|NCT00398489|Docetaxel|docetaxel|mesh-list
56346752|NCT00398489|Trastuzumab|trastuzumab|mesh-list
56346753|NCT00398489|Epirubicin|epirubicin|mesh-list
56346754|NCT00398489|Anastrozole|anastrozole|mesh-list
56346755|NCT00398489|Goserelin|goserelin|mesh-list
56346756|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346757|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
56346758|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346759|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346760|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56346761|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
56346762|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346763|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346764|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56346765|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56346766|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56346767|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56346768|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56346769|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56346770|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56346771|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56346772|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346773|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56346774|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
56346775|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346776|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56346777|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56346778|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56346779|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56346780|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56346781|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56346782|NCT00176761|Interleukin-2|interleukin-2|mesh-list
56346783|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346784|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56346785|NCT00176761|Analgesics|analgesics|mesh-ancestor
56346786|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
56346787|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346788|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346789|NCT00176995|Eflornithine|eflornithine|mesh-list
56346790|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346791|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56346792|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56346793|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55968594|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56346794|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346795|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56346796|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346797|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650987|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56650988|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346799|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
56346800|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
56346801|NCT00408148|Rimonabant|rimonabant|mesh-list
56346802|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56346803|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56346804|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56346805|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346806|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346807|NCT00408148|Hormones|hormones|mesh-ancestor
56346808|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56346809|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346810|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
56346811|NCT00397566|BMS-707035|bms-707035|mesh-list
56346812|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
56346813|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346814|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346815|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56346816|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56346817|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
56346818|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346819|NCT00177424|Sertraline|sertraline|mesh-list
56346820|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
56346821|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346822|NCT00177424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56346823|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346827|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
56346828|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346829|NCT00177580|Pravastatin|pravastatin|mesh-list
56346830|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56346831|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56346832|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
56346833|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346834|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56346835|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56346836|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346837|NCT04723342|Blinatumomab|blinatumomab|mesh-list
56346838|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346839|NCT00177619|Alendronate|alendronate|mesh-list
56346840|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56346841|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346842|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
56346843|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56346844|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346845|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346846|NCT00177853|Celecoxib|celecoxib|mesh-list
56346847|NCT00177853|Irinotecan|irinotecan|mesh-list
56346848|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56346849|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56346850|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346851|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346852|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346853|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56346854|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56346855|NCT00177853|Analgesics|analgesics|mesh-ancestor
56346856|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
56346857|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346858|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346859|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56346860|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346861|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56346862|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56346863|NCT00178048|Paroxetine|paroxetine|mesh-list
56346864|NCT00178048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56346865|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346866|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346867|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346869|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
56346870|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120362|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
56650989|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56650990|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56650991|NCT04243811|Anesthetics|anesthetics|mesh-list
56346871|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56346872|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
56346873|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346874|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56346875|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56346876|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346877|NCT00056966|Fludarabine|fludarabine|mesh-list
56346878|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
56346879|NCT00056966|Tacrolimus|tacrolimus|mesh-list
56346880|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346881|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346882|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346883|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
56346884|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346885|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56346886|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346887|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56346888|NCT00178828|Bupropion|bupropion|mesh-list
56346889|NCT00178828|Sertraline|sertraline|mesh-list
56346890|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56346891|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
56346892|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346893|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56346895|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346896|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346898|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346899|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346900|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56346901|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56346902|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346903|NCT00178828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56346904|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
56346905|NCT00408187|Cyclosporine|cyclosporine|mesh-list
56346906|NCT00408187|Cyclosporins|cyclosporins|mesh-list
56346907|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346908|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346909|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346910|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
56346911|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346912|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
56346913|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346914|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
56346915|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346916|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56346917|NCT00408226|Pemetrexed|pemetrexed|mesh-list
56346918|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346919|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346920|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346921|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56346922|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56346923|NCT02963896|Gentamicins|gentamicins|mesh-list
56346924|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56346925|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346926|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56346927|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170558|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
56346928|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346929|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
56346930|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56346931|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56346932|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56346933|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346934|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346935|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
56346936|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346937|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346938|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56650992|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213980|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
56346939|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346940|NCT00397722|Paroxetine|paroxetine|mesh-list
56346941|NCT00397722|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56346942|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346943|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346944|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346945|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346946|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
56346947|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346948|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56346949|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
56346950|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56346951|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56346952|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56346953|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346954|NCT00179023|Trimethaphan|trimethaphan|mesh-list
56346955|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
56346956|NCT00179023|Ephedrine|ephedrine|mesh-list
56346957|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
56346958|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56346959|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
56346960|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56346961|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346962|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56346963|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
56346978|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
56346979|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
56346980|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56346981|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
56346982|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346983|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346984|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56346985|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
56346986|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346987|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346988|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56346989|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56346990|NCT00179062|Olanzapine|olanzapine|mesh-list
56346991|NCT00179062|Risperidone|risperidone|mesh-list
56346992|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56346993|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
56346994|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346995|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346996|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346997|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56346998|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56346999|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56347000|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56347001|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56347002|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
56347003|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
56347004|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
56347005|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347006|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56347007|NCT00179062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56347008|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56347009|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347010|NCT04125927|Cysteamine|cysteamine|mesh-list
56347011|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56347012|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347013|NCT04723459|Ivermectin|ivermectin|mesh-list
56347014|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56347015|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347016|NCT00179257|Sertraline|sertraline|mesh-list
56347017|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
56347018|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56347019|NCT00179257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56347020|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56347021|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347022|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56650993|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347023|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347030|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347032|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56347033|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347034|NCT00057122|Rifampin|rifampin|mesh-list
56347035|NCT00057122|Rifapentine|rifapentine|mesh-list
56347036|NCT00057122|Isoniazid|isoniazid|mesh-list
56347037|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56347038|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
56347039|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56347040|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347041|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
56347042|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56347043|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347044|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347045|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56347046|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56347047|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56347048|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56347049|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56347050|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56347051|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56347052|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56347053|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
56347054|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56347055|NCT00179608|Lenalidomide|lenalidomide|mesh-list
56347056|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
56347057|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347058|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56347059|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56347060|NCT00179608|Growth Substances|growth substances|mesh-ancestor
56347061|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
56347062|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347063|NCT00179686|Lenalidomide|lenalidomide|mesh-list
56347064|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
56347065|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347066|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56347067|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56347068|NCT00179686|Growth Substances|growth substances|mesh-ancestor
56347069|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
56347070|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347072|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56347073|NCT00179725|Lenalidomide|lenalidomide|mesh-list
56347074|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56347075|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347076|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56347077|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56347078|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347079|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347080|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
56347081|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347082|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56347083|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56347084|NCT00179725|Growth Substances|growth substances|mesh-ancestor
56347085|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
56347086|NCT00179764|Busulfan|busulfan|mesh-list
56347087|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
56347088|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347090|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
56347091|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347092|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56347096|NCT00179881|Carboplatin|carboplatin|mesh-list
56347097|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347098|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347099|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
56347100|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347101|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
56347102|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56347103|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347104|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56347105|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56650994|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
56347106|NCT00179881|Growth Substances|growth substances|mesh-ancestor
56347107|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
56347108|NCT00179920|Carboplatin|carboplatin|mesh-list
56347109|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347110|NCT00180037|Ubiquinone|ubiquinone|mesh-list
56347111|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
56347112|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
56347113|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347114|NCT00180037|Vitamins|vitamins|mesh-ancestor
56347115|NCT00180076|Budesonide|budesonide|mesh-list
56347116|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56347117|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56347118|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
56347119|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347120|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347121|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56347122|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
56347123|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
56347124|NCT00180076|Hormones|hormones|mesh-ancestor
56347125|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56347126|NCT00180115|Cytarabine|cytarabine|mesh-list
56347127|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56347128|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
56347129|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347130|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347131|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
56347132|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347133|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347134|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
56347135|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347136|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56347137|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347138|NCT00180310|Paclitaxel|paclitaxel|mesh-list
56347139|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56347140|NCT00180310|Everolimus|everolimus|mesh-list
56347141|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56347142|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347143|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
56347144|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
56347145|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
56347146|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347147|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347148|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
56347149|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347150|NCT00057278|Gabapentin|gabapentin|mesh-list
56347151|NCT00057278|Analgesics|analgesics|mesh-ancestor
56347152|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
56347153|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347154|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347155|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
56347156|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56347157|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56347158|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56347159|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56347160|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56347161|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56347162|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347163|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347165|NCT04030026|Nalbuphine|nalbuphine|mesh-list
56347166|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56347167|NCT04030026|Narcotics|narcotics|mesh-ancestor
56347168|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56347169|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347170|NCT04030026|Analgesics|analgesics|mesh-ancestor
56347171|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
56347172|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347173|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
56347174|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
56347175|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56347176|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
56347177|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347178|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347179|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56347180|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
56347181|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56650995|NCT00638300|Calcium|calcium|mesh-list
56347182|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
56347183|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347184|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347185|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56347186|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
56347187|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
56347188|NCT00180622|Protective Agents|protective agents|mesh-ancestor
56347189|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
56347190|NCT00180895|Rituximab|rituximab|mesh-list
56347191|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347192|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347193|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
56347194|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347195|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56347196|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
56347197|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347198|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
56347199|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347200|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347201|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56347202|NCT04729491|Azithromycin|azithromycin|mesh-list
56347203|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
56347204|NCT04729491|Dutasteride|dutasteride|mesh-list
56347205|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56347206|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347207|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56347208|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56347209|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347210|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347211|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
56347212|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56347213|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347214|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56347216|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56347217|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347218|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
56347219|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347220|NCT00181012|Lidocaine|lidocaine|mesh-list
56347221|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
56347222|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
56347223|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56347224|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347225|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
56347226|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347227|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56347228|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56347229|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56347230|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347231|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347232|NCT00181246|Fentanyl|fentanyl|mesh-list
56347233|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56347234|NCT00181246|Narcotics|narcotics|mesh-ancestor
55969049|NCT00557193|Prednisolone|prednisolone|mesh-list
56347235|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56347236|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347237|NCT00181246|Analgesics|analgesics|mesh-ancestor
56347238|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
56347239|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347240|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56347242|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
56347243|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
56347244|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
56347246|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56347247|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347248|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347249|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56347250|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56347251|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347252|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
56347253|NCT00181597|Trilostane|trilostane|mesh-list
56347254|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120363|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
56650996|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56650997|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56650998|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56347255|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56347256|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
56347257|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56347258|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347259|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347260|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347261|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347262|NCT00181636|Galantamine|galantamine|mesh-list
56347263|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56347264|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347265|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347266|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
56347267|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347268|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347269|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56347270|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
56347271|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347272|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
56347273|NCT00181675|Galantamine|galantamine|mesh-list
56347274|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56347275|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347276|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347277|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
56347278|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347279|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347280|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56347281|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
56347282|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347283|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
56347284|NCT00181870|Carbamazepine|carbamazepine|mesh-list
56347285|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
56347286|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
56347287|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56347288|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56347289|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347290|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56347291|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56347293|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
56347294|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347295|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56347296|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347297|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347298|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56347299|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56347300|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56347301|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56347302|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56347303|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347304|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347305|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
56347306|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347307|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347308|NCT00181987|Methylphenidate|methylphenidate|mesh-list
56347309|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56347310|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347311|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56347312|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56347314|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347315|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
56347316|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347318|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
56347319|NCT00182143|Heparin|heparin|mesh-list
56347320|NCT00182143|Calcium heparin|calcium heparin|mesh-list
56347321|NCT00182143|Dalteparin|dalteparin|mesh-list
56347322|NCT00182143|Tinzaparin|tinzaparin|mesh-list
56347323|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56650999|NCT00887315|Cisplatin|cisplatin|mesh-list
56651000|NCT00887315|Docetaxel|docetaxel|mesh-list
56651001|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651002|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
56347324|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
56347325|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56347326|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56347327|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347328|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
56347329|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56347330|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56347331|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347332|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
56347333|NCT00182221|Coagulants|coagulants|mesh-ancestor
56347334|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56347335|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347336|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347338|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
56347339|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56347340|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
56347341|NCT00408655|Sirolimus|sirolimus|mesh-list
56347342|NCT00408655|Paclitaxel|paclitaxel|mesh-list
56347343|NCT00408655|Carboplatin|carboplatin|mesh-list
56347344|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56347345|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347346|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
56347347|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
56347348|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
56347349|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347350|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56347351|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347352|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56347353|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
56347354|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347355|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
56347356|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347357|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56347358|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
56347359|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
56347360|NCT00182455|Topiramate|topiramate|mesh-list
56347361|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
56347362|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56347363|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347364|NCT00182494|Metformin|metformin|mesh-list
56347365|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56347366|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347367|NCT00182533|Sertraline|sertraline|mesh-list
56347368|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
56347369|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56347370|NCT00182533|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56347371|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56347372|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347373|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347374|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347375|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
56347376|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347377|NCT00182572|Naltrexone|naltrexone|mesh-list
56347378|NCT00182572|Buprenorphine|buprenorphine|mesh-list
56347379|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56347380|NCT00182572|Narcotics|narcotics|mesh-ancestor
56347381|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56347382|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969207|NCT03749018|Antibodies|antibodies|mesh-list
56347383|NCT00182572|Analgesics|analgesics|mesh-ancestor
56347384|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
56347385|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347386|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56347387|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56347388|NCT00182611|Tegafur|tegafur|mesh-list
56347398|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347399|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
56347400|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347401|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56347402|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56651003|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
56651004|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56651005|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347403|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
56347404|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347405|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347406|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56347407|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56347408|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
56347409|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347410|NCT00182806|Gemcitabine|gemcitabine|mesh-list
56347411|NCT00182806|Irinotecan|irinotecan|mesh-list
56347412|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56347413|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
56347414|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347415|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347416|NCT00182806|Antiviral Agents|antiviral agents|mesh-ancestor
56347417|NCT00182806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347418|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347419|NCT00182806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347420|NCT00182806|Immunologic Factors|immunologic factors|mesh-ancestor
56347421|NCT00182806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347422|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56347423|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56347424|NCT00182845|Donepezil|donepezil|mesh-list
56347425|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56347426|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347427|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347428|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
56347429|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347430|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347431|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
56347432|NCT00182884|Donepezil|donepezil|mesh-list
56347433|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56347434|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347435|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347436|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
56347437|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347438|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347439|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
56347441|NCT00183001|Vitamins|vitamins|mesh-ancestor
56347442|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
56347443|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347444|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56347445|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56347446|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347447|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
56347448|NCT00183001|Coagulants|coagulants|mesh-ancestor
56347449|NCT00183040|Hormones|hormones|mesh-list
56347450|NCT00183040|Testosterone|testosterone|mesh-list
56347451|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56347452|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347453|NCT00183040|Androgens|androgens|mesh-ancestor
56347454|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
56347455|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347458|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56347459|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56347460|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56347461|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56347462|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347463|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
56347464|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
56347465|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347466|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347467|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56347468|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56347469|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
56347470|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56347471|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56347472|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56651006|NCT02645994|Anesthetics|anesthetics|mesh-list
56651007|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651008|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651009|NCT03170960|Atezolizumab|atezolizumab|mesh-list
56347473|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56347475|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
56347476|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347477|NCT00057512|Protective Agents|protective agents|mesh-ancestor
56347478|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347479|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56347480|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347481|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56347482|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56347483|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56347484|NCT00057512|Analgesics|analgesics|mesh-ancestor
56347485|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
56347486|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347487|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56347488|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56347489|NCT00183742|Docetaxel|docetaxel|mesh-list
56347490|NCT00183742|Doxorubicin|doxorubicin|mesh-list
56347491|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56347492|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347493|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
56347494|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
56347495|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
56347496|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347497|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56347498|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56347499|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56347500|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347501|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
56347502|NCT02965248|Leucovorin|leucovorin|mesh-list
56347503|NCT02965248|Capecitabine|capecitabine|mesh-list
56347504|NCT02965248|Raltitrexed|raltitrexed|mesh-list
56347505|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
56347506|NCT02965248|Calcium|calcium|mesh-list
56347507|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
56347508|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56347509|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347510|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56347511|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56347512|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
56347513|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347514|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347516|NCT02965248|Protective Agents|protective agents|mesh-ancestor
56347517|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
56347518|NCT02965248|Vitamins|vitamins|mesh-ancestor
56347519|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
56347520|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56347521|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347522|NCT00183820|Gemcitabine|gemcitabine|mesh-list
56347523|NCT00183820|Paclitaxel|paclitaxel|mesh-list
56347524|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
56347525|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56347526|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347527|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
56347528|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
56347529|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
56347530|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347531|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55969354|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56347535|NCT00183820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347536|NCT00183820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347537|NCT00183820|Immunologic Factors|immunologic factors|mesh-ancestor
56347538|NCT00183820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347540|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
56347541|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56347542|NCT02969720|Protective Agents|protective agents|mesh-ancestor
56347543|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347544|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
56347545|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56347546|NCT00183859|Irinotecan|irinotecan|mesh-list
56651010|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651011|NCT03014648|Atezolizumab|atezolizumab|mesh-list
56213998|NCT01608217|Analgesics|analgesics|mesh-ancestor
56347547|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56347548|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56347549|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347550|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347551|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347552|NCT00183898|Capecitabine|capecitabine|mesh-list
56347553|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
56347554|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56347555|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
56170596|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56347556|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347557|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347558|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56347559|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347560|NCT00183937|Docetaxel|docetaxel|mesh-list
56347561|NCT00183937|Bortezomib|bortezomib|mesh-list
56347562|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347563|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
56347564|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
56347565|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
56347566|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347567|NCT00408772|Bevacizumab|bevacizumab|mesh-list
56347568|NCT00408772|Capecitabine|capecitabine|mesh-list
56347569|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
56347570|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347571|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347572|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56347573|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56347574|NCT00408772|Growth Substances|growth substances|mesh-ancestor
56347575|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347576|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
56347577|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56347578|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
56347579|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347580|NCT00408850|Pioglitazone|pioglitazone|mesh-list
56347581|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56347582|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347583|NCT00183976|Rituximab|rituximab|mesh-list
56347584|NCT00183976|Doxorubicin|doxorubicin|mesh-list
56347585|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56347586|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347587|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347588|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
56347589|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347590|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56347591|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56347592|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56347593|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56347594|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347595|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347596|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
56347597|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347598|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347599|NCT00184015|Bevacizumab|bevacizumab|mesh-list
56347600|NCT00184015|Bortezomib|bortezomib|mesh-list
56347601|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347602|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347605|NCT00184015|Growth Substances|growth substances|mesh-ancestor
56347606|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347607|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
56347608|NCT00184171|Budesonide|budesonide|mesh-list
56347609|NCT00184171|Bismuth|bismuth|mesh-list
56347610|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56347611|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56347612|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
56347613|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347614|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347615|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56347616|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
56347617|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
56347618|NCT00184171|Hormones|hormones|mesh-ancestor
56651012|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651013|NCT02645058|Analgesics|analgesics|mesh-list
55976147|NCT00706121|Selenium|selenium|mesh-list
56347619|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56347620|NCT00184171|Antacids|antacids|mesh-ancestor
56347621|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347622|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56347623|NCT00057707|Modafinil|modafinil|mesh-list
56347624|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56347625|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347626|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55856390|NCT00555880|Midodrine|midodrine|mesh-list
56347627|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56347628|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56347629|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347630|NCT00184522|Esomeprazole|esomeprazole|mesh-list
56347631|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56347632|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56347633|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56347634|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347635|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347636|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
56347637|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
56347638|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56347639|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347640|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
56347641|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56347642|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347643|NCT00058097|Tipifarnib|tipifarnib|mesh-list
56347644|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347645|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
56347646|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347647|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56347648|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56347649|NCT03847311|Analgesics|analgesics|mesh-ancestor
56347650|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
56347651|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347652|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347653|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56347654|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56347655|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56347656|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56347657|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56347658|NCT00184795|Norethindrone|norethindrone|mesh-list
56347659|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
56347660|NCT00184795|Estradiol|estradiol|mesh-list
56347661|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56347662|NCT00184795|Estrogens|estrogens|mesh-ancestor
56347663|NCT00184795|Hormones|hormones|mesh-ancestor
56347664|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56347665|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347666|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56347667|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
56347668|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56347669|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56347670|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56347671|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56347672|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56347673|NCT00058253|Docetaxel|docetaxel|mesh-list
56347674|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347676|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
56347677|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
56347678|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347679|NCT00046800|Lurtotecan|lurtotecan|mesh-list
56347680|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347681|NCT00058292|Cytarabine|cytarabine|mesh-list
56347682|NCT00058292|Rituximab|rituximab|mesh-list
56347683|NCT00058292|Etoposide|etoposide|mesh-list
56347684|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
56347685|NCT00058292|Melphalan|melphalan|mesh-list
56347686|NCT00058292|Carmustine|carmustine|mesh-list
56347688|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347689|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347690|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
55976229|NCT03809455|Fentanyl|fentanyl|mesh-list
56347691|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347692|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56347693|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56347694|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56347695|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56347696|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347697|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347698|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56347699|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
56347700|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
56347701|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347702|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347703|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56347704|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56347705|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
56347706|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56347708|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
56347709|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347710|NCT03816774|Emollients|emollients|mesh-ancestor
56347711|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
56347712|NCT00184912|Caffeine|caffeine|mesh-list
56347713|NCT00184912|Annexin A5|annexin a5|mesh-list
56347714|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56347715|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347716|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56347717|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347718|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347719|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56347720|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56347721|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
56347722|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347723|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56347724|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56347725|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56347726|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
56347727|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347728|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56347729|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56347730|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347731|NCT00184990|Pimagedine|pimagedine|mesh-list
56347732|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347733|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347734|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
56347735|NCT00058331|Hematinics|hematinics|mesh-ancestor
56347736|NCT03815643|Avelumab|avelumab|mesh-list
56347737|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347738|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347739|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56347740|NCT00185068|Olmesartan|olmesartan|mesh-list
56347741|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56347742|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56347744|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
56347745|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347746|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56347747|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347748|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347749|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56347750|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56347751|NCT00185107|Simvastatin|simvastatin|mesh-list
56347756|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
56347757|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347758|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56347759|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56347760|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347761|NCT00058448|Docetaxel|docetaxel|mesh-list
56347762|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347763|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
56347764|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
56347765|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
56347766|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347767|NCT00185185|Atenolol|atenolol|mesh-list
56347768|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56651014|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651015|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
56347769|NCT00185185|Olmesartan|olmesartan|mesh-list
56347770|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56347771|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56347772|NCT00185185|Diuretics|diuretics|mesh-ancestor
56347773|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
56347774|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347775|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56347776|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347777|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347778|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56347779|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56347780|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56347781|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
56347782|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
56347783|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347784|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56347785|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56347786|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56347787|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
56347788|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347789|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56347790|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56347791|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56347792|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56347793|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
56347794|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56347795|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347796|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56347797|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56347798|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56347799|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56347800|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56347801|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56347802|NCT00185302|Entinostat|entinostat|mesh-list
56347803|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56347804|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347805|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347806|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347807|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
56347808|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347809|NCT02969681|Vitamins|vitamins|mesh-ancestor
56347810|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
56347811|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
56347812|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347813|NCT02969681|Protective Agents|protective agents|mesh-ancestor
56347814|NCT03784014|Durvalumab|durvalumab|mesh-list
56347816|NCT03784014|Lapatinib|lapatinib|mesh-list
56347817|NCT03784014|Palbociclib|palbociclib|mesh-list
56347818|NCT03784014|Trametinib|trametinib|mesh-list
56347819|NCT03784014|Dabrafenib|dabrafenib|mesh-list
56347820|NCT03784014|Ceritinib|ceritinib|mesh-list
56347821|NCT03784014|Futibatinib|futibatinib|mesh-list
56347822|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347823|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347826|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347827|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56347828|NCT00058487|Thalidomide|thalidomide|mesh-list
56347829|NCT00058487|Epirubicin|epirubicin|mesh-list
56347830|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56347831|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347832|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56347833|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56347834|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347835|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347836|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347837|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
56347838|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347839|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
56347840|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56651016|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651017|NCT02644980|Anesthetics|anesthetics|mesh-list
56651018|NCT02644980|Propofol|propofol|mesh-list
56651019|NCT02644980|Etomidate|etomidate|mesh-list
56651020|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651021|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651022|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56651023|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56651024|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
56651025|NCT04187456|Midazolam|midazolam|mesh-list
56651026|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56347841|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347842|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56347843|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56347844|NCT00058487|Growth Substances|growth substances|mesh-ancestor
56347845|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
56347846|NCT00185419|Desogestrel|desogestrel|mesh-list
56347847|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56347848|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347849|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56347850|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56347851|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56347852|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
56347853|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56347854|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56347855|NCT00185419|Progestins|progestins|mesh-ancestor
56347856|NCT00185419|Hormones|hormones|mesh-ancestor
56347857|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56347858|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56347859|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56347860|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56347861|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347862|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347863|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347864|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347865|NCT00185575|Analgesics|analgesics|mesh-ancestor
56347866|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
56347867|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347868|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
56347869|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56347870|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
56347871|NCT03731832|Dexamethasone|dexamethasone|mesh-list
56347872|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
56347873|NCT03731832|Pomalidomide|pomalidomide|mesh-list
56347874|NCT03731832|Ixazomib|ixazomib|mesh-list
56347875|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56347876|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
56347877|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347878|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56347879|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56347880|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
56347881|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347882|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347883|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56347884|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56347885|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
56347886|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
56347887|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347889|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
56347890|NCT03731832|Hormones|hormones|mesh-ancestor
56347891|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56347892|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56347893|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56347894|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56651027|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56651028|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547633|NCT04259008|Manganese|manganese|mesh-list
56547634|NCT04259008|Trace Elements|trace elements|mesh-ancestor
56347895|NCT03731832|Growth Substances|growth substances|mesh-ancestor
56347900|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56347901|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
56347902|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347903|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347904|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56347905|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
56347906|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
56347907|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
56347908|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56347909|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56347910|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56347911|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56347912|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
56347913|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347914|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347915|NCT00186082|Cefoxitin|cefoxitin|mesh-list
56347916|NCT00186082|Cefotetan|cefotetan|mesh-list
56347917|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56347918|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347919|NCT00186277|Docetaxel|docetaxel|mesh-list
56347920|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
56170611|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
56347921|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347922|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
56347923|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
56347924|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
56347925|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347926|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56347927|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
56347928|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347929|NCT03611595|Tretinoin|tretinoin|mesh-list
56347930|NCT03611595|Isotretinoin|isotretinoin|mesh-list
56347931|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347932|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
56347933|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
56347934|NCT00058682|Anidulafungin|anidulafungin|mesh-list
56347935|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
56347936|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347937|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56347938|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
56347939|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347940|NCT00186706|Selenium|selenium|mesh-list
56347941|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
56347942|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347943|NCT00186706|Protective Agents|protective agents|mesh-ancestor
56347944|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347945|NCT00186706|Trace Elements|trace elements|mesh-ancestor
56347946|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
56347947|NCT00409201|Reboxetine|reboxetine|mesh-list
56347948|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
56347949|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56347950|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56347951|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56347952|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347953|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347954|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
56347955|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347956|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347957|NCT00046878|Carmustine|carmustine|mesh-list
56347958|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56347959|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56347960|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
56347961|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347962|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347963|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347964|NCT00186745|Tinzaparin|tinzaparin|mesh-list
56347965|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56347966|NCT00186745|Dalteparin|dalteparin|mesh-list
56651029|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651030|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56651031|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651032|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56651033|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56347967|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
56347968|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56347972|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
56347973|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347974|NCT00186862|Interleukin-2|interleukin-2|mesh-list
56347975|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347976|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56347977|NCT00186862|Analgesics|analgesics|mesh-ancestor
56347978|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
56347979|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56347980|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347981|NCT03551964|Ticagrelor|ticagrelor|mesh-list
56347982|NCT03551964|Cangrelor|cangrelor|mesh-list
56347983|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56347984|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56347985|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56347987|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
56347988|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56347989|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347990|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347991|NCT00186940|Rasburicase|rasburicase|mesh-list
56347992|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
56347993|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56347994|NCT00186979|Cefixime|cefixime|mesh-list
56347995|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
56347996|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
56347997|NCT00186979|Irinotecan|irinotecan|mesh-list
56347999|NCT00186979|Gefitinib|gefitinib|mesh-list
56348000|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56348001|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56348002|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348003|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348004|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348005|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56348006|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56348007|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56348008|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56348009|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56348010|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56348011|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348012|NCT00187057|Cytarabine|cytarabine|mesh-list
56348013|NCT00187057|Dexamethasone|dexamethasone|mesh-list
56348014|NCT00187057|Prednisone|prednisone|mesh-list
56348015|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
56348016|NCT00187057|Doxorubicin|doxorubicin|mesh-list
56348017|NCT00187057|Methotrexate|methotrexate|mesh-list
56348018|NCT00187057|Etoposide|etoposide|mesh-list
56348019|NCT00187057|Vincristine|vincristine|mesh-list
56348020|NCT00187057|Daunorubicin|daunorubicin|mesh-list
56348021|NCT00187057|Asparaginase|asparaginase|mesh-list
56348022|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
56348023|NCT00187057|Vinblastine|vinblastine|mesh-list
56348024|NCT00187057|Procarbazine|procarbazine|mesh-list
56348025|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348026|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
56348027|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348028|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56348029|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56348030|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
56348031|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348032|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348033|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56348034|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56348035|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
56348036|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
56348037|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348038|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56348039|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
56348040|NCT00187057|Hormones|hormones|mesh-ancestor
56651034|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
56651035|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
56651036|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
56651037|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
56651038|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651039|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651040|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56651041|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
56651042|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
56651043|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56651044|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651045|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651046|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651047|NCT02687204|Enoxaparin|enoxaparin|mesh-list
56651048|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
56651049|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
56214018|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
56348041|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56348042|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56348043|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56348044|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56348045|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56348047|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56348049|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56348050|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348051|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
56348052|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
56348053|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56348054|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348055|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56348056|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
56348057|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348058|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
56348059|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56348060|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56348061|NCT00046917|Irinotecan|irinotecan|mesh-list
56348062|NCT00046917|Alvocidib|alvocidib|mesh-list
56348063|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348064|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56348065|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56348066|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348067|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348068|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
56348069|NCT00046917|Growth Substances|growth substances|mesh-ancestor
56348070|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348071|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56348072|NCT00187174|Everolimus|everolimus|mesh-list
56348073|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348074|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348075|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
56348076|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348077|NCT03538938|Nicotine|nicotine|mesh-list
56348078|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56348079|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
56348080|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348081|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348082|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56348083|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56348084|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
56651050|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56651051|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56348085|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348086|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348087|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
56348088|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56348089|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
56348090|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348091|NCT00187330|Expectorants|expectorants|mesh-ancestor
56348092|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
56348093|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56348094|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
56348095|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348096|NCT00187330|Protective Agents|protective agents|mesh-ancestor
56348097|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348098|NCT00187330|Antidotes|antidotes|mesh-ancestor
56348099|NCT00187408|Heparin|heparin|mesh-list
56348100|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56348101|NCT00187408|Tinzaparin|tinzaparin|mesh-list
56348102|NCT00187408|Dalteparin|dalteparin|mesh-list
56348103|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
56348104|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56348105|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56348106|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348107|NCT00187447|Indomethacin|indomethacin|mesh-list
56348108|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56348109|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56348110|NCT00187447|Analgesics|analgesics|mesh-ancestor
56348111|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
56348112|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348113|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348114|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56348115|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56348116|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
56348117|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
56348118|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56348119|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56348120|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348123|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56348124|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348126|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56348127|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56348129|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348130|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348131|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348132|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56348133|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56348134|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
56348135|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
56348136|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348137|NCT00187564|Protective Agents|protective agents|mesh-ancestor
55970026|NCT03510884|Niacin|niacin|mesh-list
56348139|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
56348140|NCT00187564|Vitamins|vitamins|mesh-ancestor
56348141|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
56348142|NCT00046995|Leucovorin|leucovorin|mesh-list
56348143|NCT00046995|Carboplatin|carboplatin|mesh-list
56348144|NCT00046995|Fluorouracil|fluorouracil|mesh-list
56348145|NCT00046995|Calcium|calcium|mesh-list
56348146|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
56348147|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348148|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56348149|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348150|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
56348151|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348152|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348153|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348154|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
56348155|NCT00046995|Antidotes|antidotes|mesh-ancestor
56348156|NCT00046995|Protective Agents|protective agents|mesh-ancestor
56348157|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
56348158|NCT00046995|Vitamins|vitamins|mesh-ancestor
56348159|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
56348160|NCT04723069|Metronidazole|metronidazole|mesh-list
56348161|NCT04723069|Doxycycline|doxycycline|mesh-list
56348162|NCT04723069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651052|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348163|NCT04723069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56348164|NCT04723069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56348165|NCT04723069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56348166|NCT04723069|Antimalarials|antimalarials|mesh-ancestor
56348167|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
56348168|NCT00058955|Triazolam|triazolam|mesh-list
56348169|NCT00058955|Pentobarbital|pentobarbital|mesh-list
56348170|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56348171|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56348172|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
56348173|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
56348174|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56348175|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348176|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56348177|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56348178|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56348179|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
56348180|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
56348181|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348182|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348183|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56348184|NCT00187759|Cephalexin|cephalexin|mesh-list
56348185|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56348186|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348187|NCT00187798|Metformin|metformin|mesh-list
56348188|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56348189|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348190|NCT00058994|Anecortave|anecortave|mesh-list
56348191|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56348192|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56348193|NCT00058994|Growth Substances|growth substances|mesh-ancestor
56348194|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348195|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
56348196|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348201|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348202|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
56348203|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348204|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56348205|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348206|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348207|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
56348208|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348209|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
56348210|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56348211|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56348212|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348213|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56348214|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
56348215|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56348216|NCT00187993|Hormones|hormones|mesh-list
56348217|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56348218|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348219|NCT00188071|Acetaminophen|acetaminophen|mesh-list
56348220|NCT00188071|Ketoprofen|ketoprofen|mesh-list
56348221|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56348222|NCT00188071|Analgesics|analgesics|mesh-ancestor
56170618|NCT01832922|Rituximab|rituximab|mesh-list
56348223|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
56348224|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348225|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348226|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
56348227|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56348228|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56348229|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56348230|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56348231|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348232|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348233|NCT00188227|Midazolam|midazolam|mesh-list
56348234|NCT00188227|Pirinitramide|pirinitramide|mesh-list
56348235|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56348236|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56348237|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56348238|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348239|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56651053|NCT00650208|Lamotrigine|lamotrigine|mesh-list
56651054|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
56651055|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56651056|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348240|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56348241|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56348242|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56348243|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
56348244|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
56348245|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
56348246|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
56348247|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348248|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348249|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56348250|NCT00188227|Narcotics|narcotics|mesh-ancestor
56348251|NCT00188227|Analgesics|analgesics|mesh-ancestor
56348252|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
56348253|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348254|NCT00188266|Fluorouracil|fluorouracil|mesh-list
56348255|NCT00188266|Cisplatin|cisplatin|mesh-list
56348256|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
56348257|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348258|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348259|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348260|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348261|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
56348262|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348263|NCT00047073|Sirolimus|sirolimus|mesh-list
56348264|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56348265|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348266|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56348267|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348268|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
56348269|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348273|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56348274|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56348275|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
56348276|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348277|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
56348278|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348279|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348280|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348281|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56348282|NCT00188383|Analgesics|analgesics|mesh-ancestor
56348283|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
56348284|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348286|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
56348287|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56348288|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348289|NCT00188617|Gefitinib|gefitinib|mesh-list
55970105|NCT00671528|Miconazole|miconazole|mesh-list
56348290|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348291|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56348292|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348293|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348294|NCT00047112|Fluorouracil|fluorouracil|mesh-list
56348295|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348296|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
56348297|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348298|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348299|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348300|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
56348301|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348302|NCT00409318|Etanercept|etanercept|mesh-list
56348303|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56348304|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56348305|NCT00409318|Analgesics|analgesics|mesh-ancestor
56348306|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
56348307|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348308|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348309|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56348310|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651057|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651058|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55976882|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
56348311|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56348312|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348313|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
56348314|NCT00409357|Alfuzosin|alfuzosin|mesh-list
56348315|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56348316|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56348317|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56348318|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348319|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348320|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348321|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348322|NCT00409357|Urological Agents|urological agents|mesh-ancestor
56348323|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56348324|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56348325|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348326|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348327|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348328|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
56348329|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348330|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
56348331|NCT00188773|Heparin|heparin|mesh-list
56348332|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56348333|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56348334|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
56348335|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56348336|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56348337|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348338|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
56348339|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348340|NCT00188773|Expectorants|expectorants|mesh-ancestor
56348343|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
56348344|NCT00188773|Protective Agents|protective agents|mesh-ancestor
56348345|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348346|NCT00188773|Antidotes|antidotes|mesh-ancestor
56348347|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56348348|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56348349|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56348350|NCT00188812|Donepezil|donepezil|mesh-list
56348351|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56348352|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348353|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348354|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
56348355|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348356|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348357|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
56348358|NCT02963194|Oxytocin|oxytocin|mesh-list
56348359|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
56348360|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56348361|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348362|NCT00059306|Aspirin|aspirin|mesh-list
56348363|NCT00059306|Clopidogrel|clopidogrel|mesh-list
56348364|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56348365|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56348366|NCT00059306|Analgesics|analgesics|mesh-ancestor
56348367|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
56348368|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348369|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348371|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56348372|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56348373|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56348374|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348375|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56348376|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56348377|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348378|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
56348379|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56348380|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56348381|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56651059|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651060|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56348382|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
56348383|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348384|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
56348385|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
56348386|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348387|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
56348388|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348389|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
56348390|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348391|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348392|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56348393|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
56348394|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56348395|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
56348396|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
56348397|NCT00189007|Allopurinol|allopurinol|mesh-list
56348398|NCT00189007|Mannitol|mannitol|mesh-list
56348399|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
56348400|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348401|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348402|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
56348403|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56348404|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56348405|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
56348406|NCT00189007|Protective Agents|protective agents|mesh-ancestor
56348407|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348408|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56348409|NCT00189007|Diuretics|diuretics|mesh-ancestor
56348410|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
56348411|NCT00399945|Tobramycin|tobramycin|mesh-list
56348412|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56348413|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348414|NCT00189085|Simvastatin|simvastatin|mesh-list
56348415|NCT00189085|Ezetimibe|ezetimibe|mesh-list
56348416|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56348420|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348422|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56348423|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348424|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56348425|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56348426|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
56348427|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348428|NCT00189163|Pioglitazone|pioglitazone|mesh-list
56348429|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56348430|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348431|NCT00189358|Tamoxifen|tamoxifen|mesh-list
56348432|NCT00189358|Gefitinib|gefitinib|mesh-list
56348433|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56348434|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
56348435|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56348436|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348437|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56348438|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348439|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56348440|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56348441|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56348442|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56348443|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348444|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348445|NCT00189397|Azathioprine|azathioprine|mesh-list
56348446|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
56348447|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348448|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348449|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348450|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348451|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
56348452|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348453|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56348454|NCT00189514|Pramlintide|pramlintide|mesh-list
56348455|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56348456|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651061|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651062|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651063|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56651064|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56651065|NCT02645370|Topiramate|topiramate|mesh-list
56651066|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
56348458|NCT00189553|Carboplatin|carboplatin|mesh-list
56348459|NCT00189553|Doxorubicin|doxorubicin|mesh-list
56348460|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56348461|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56348462|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348463|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
56348464|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
56348465|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
56348466|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348467|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56348468|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56348469|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56348470|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348471|NCT00189709|Fluconazole|fluconazole|mesh-list
56348472|NCT00189709|Micafungin|micafungin|mesh-list
56348473|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
56348474|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348475|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56348476|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56348477|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348478|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348479|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56348480|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
56348481|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56348482|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348483|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56348484|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56348485|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56348486|NCT00189748|Tacrolimus|tacrolimus|mesh-list
56348487|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348488|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
56348490|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56348491|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348492|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348493|NCT00189787|Tacrolimus|tacrolimus|mesh-list
56348494|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348495|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
56348496|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348497|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56348498|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348499|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348500|NCT00059462|Interleukin-2|interleukin-2|mesh-list
56348501|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348502|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56348503|NCT00059462|Analgesics|analgesics|mesh-ancestor
56348504|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
56348505|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348506|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348507|NCT00189826|Tacrolimus|tacrolimus|mesh-list
56348508|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348509|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
56348510|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348511|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56348512|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348513|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348515|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348516|NCT00189982|Factor VIII|factor viii|mesh-list
56348518|NCT00190021|Donepezil|donepezil|mesh-list
56348519|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56348520|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348521|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348522|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
56651067|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56651068|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651069|NCT00652392|Budesonide|budesonide|mesh-list
56651070|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
56651071|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651072|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56651073|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
56651074|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651075|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651076|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56651077|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
56651078|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
56348523|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348524|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348525|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
56348526|NCT00190060|Testosterone|testosterone|mesh-list
56348527|NCT00190060|Androgens|androgens|mesh-ancestor
56348528|NCT00190060|Hormones|hormones|mesh-ancestor
56348529|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56348530|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348531|NCT00047229|Doxorubicin|doxorubicin|mesh-list
56348532|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56348533|NCT00047229|Oblimersen|oblimersen|mesh-list
56348534|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56348535|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348536|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56348537|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56348538|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348539|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348540|NCT00190099|Dexamethasone|dexamethasone|mesh-list
56348541|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56348542|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
56348543|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
56348544|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348545|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348546|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56348547|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
56348548|NCT00190099|Hormones|hormones|mesh-ancestor
56348549|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56348550|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56348551|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348552|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
56348553|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56348554|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56348555|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
56348556|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348557|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56348558|NCT00047268|Cytarabine|cytarabine|mesh-list
56348559|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
56348560|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348561|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
56348562|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348563|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348564|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
56348566|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348567|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
56348568|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348569|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348570|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348571|NCT00190294|Misoprostol|misoprostol|mesh-list
56348572|NCT00190294|Mifepristone|mifepristone|mesh-list
56348573|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56348574|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
56651079|NCT00652392|Hormones|hormones|mesh-ancestor
56651080|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56651081|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56348575|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56348576|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348577|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56348578|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56348579|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
56348580|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56348581|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56348582|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56348583|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56348584|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
56348585|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56348586|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56348587|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
56348588|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56348589|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
56348590|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56348591|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56348593|NCT03238365|Tadalafil|tadalafil|mesh-list
56348594|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56348595|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348596|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56348597|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348598|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
56348599|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56348600|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56348601|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348602|NCT03238365|Urological Agents|urological agents|mesh-ancestor
56348603|NCT00059618|Carboplatin|carboplatin|mesh-list
56348604|NCT00059618|Bortezomib|bortezomib|mesh-list
56348605|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348606|NCT00190333|Citalopram|citalopram|mesh-list
56348607|NCT00190333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56348608|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348609|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348610|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348611|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348612|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
56348613|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348614|NCT00190333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56348615|NCT00190333|Antidepressive Agents|antidepressive agents|mesh-ancestor
56348616|NCT00190333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56348617|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56348618|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56348619|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348620|NCT00190411|Celiprolol|celiprolol|mesh-list
56348621|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56348622|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56348623|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
56348624|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
56348625|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348626|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348627|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
56348628|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56348629|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56348630|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56348631|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348632|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348633|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348634|NCT00047307|Gemcitabine|gemcitabine|mesh-list
56348635|NCT00047307|Alvocidib|alvocidib|mesh-list
56348636|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348637|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
56348642|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348643|NCT00047307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348644|NCT00047307|Immunologic Factors|immunologic factors|mesh-ancestor
56348645|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651082|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56348646|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
56348647|NCT00047307|Growth Substances|growth substances|mesh-ancestor
56348648|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56348649|NCT00190489|Docetaxel|docetaxel|mesh-list
56348650|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348651|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56348652|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56348653|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56348654|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348655|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56348656|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56348657|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348658|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348659|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348660|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348661|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348662|NCT00190567|Analgesics|analgesics|mesh-ancestor
56348663|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
56348664|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348665|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
56348666|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56348667|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
56348669|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
56348670|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56348671|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348672|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56348673|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56348674|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56348675|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348676|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348677|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348678|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348679|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348680|NCT00190606|Analgesics|analgesics|mesh-ancestor
56348681|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
56348682|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348683|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
56348684|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56348685|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
56348686|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56348687|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56348688|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348689|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348690|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348691|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348692|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348693|NCT00190645|Analgesics|analgesics|mesh-ancestor
56348694|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
56348695|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348696|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
56348697|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56348698|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
56348699|NCT00190762|Pemetrexed|pemetrexed|mesh-list
56348700|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348701|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348702|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348703|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56348704|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348705|NCT00190801|Pemetrexed|pemetrexed|mesh-list
56348706|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348709|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56348710|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348711|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56348712|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348713|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56348714|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348715|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348717|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348718|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120364|NCT01902966|Propranolol|propranolol|mesh-list
56651083|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56651084|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
56651085|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348719|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348720|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56348721|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348722|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56348723|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56348724|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348725|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348726|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348727|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348728|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348729|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348731|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348732|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348733|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348734|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56348735|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348736|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56348737|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56348738|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348739|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348740|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348741|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348742|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348743|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348744|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56348745|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56348746|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348747|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348748|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348749|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348750|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348751|NCT00190996|Analgesics|analgesics|mesh-ancestor
56348752|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
56348753|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348754|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
56348755|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56348756|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
56348757|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56348758|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56348759|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348760|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348761|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348762|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348763|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348764|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348765|NCT02922894|Trazodone|trazodone|mesh-list
56348766|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56348767|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56348768|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56348769|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348770|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56348771|NCT02922894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56348772|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348773|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348775|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348776|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
56348777|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56348778|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
56348779|NCT00191230|Gemcitabine|gemcitabine|mesh-list
56348780|NCT00191230|Carboplatin|carboplatin|mesh-list
56348781|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348782|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348783|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
56269003|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651086|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651087|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56348784|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348785|NCT00191230|Antiviral Agents|antiviral agents|mesh-ancestor
56348786|NCT00191230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348787|NCT00191230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348788|NCT00191230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348789|NCT00191230|Immunologic Factors|immunologic factors|mesh-ancestor
56348790|NCT00191230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348791|NCT00191347|Gemcitabine|gemcitabine|mesh-list
56348793|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348794|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
56348795|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348796|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348797|NCT00191347|Antiviral Agents|antiviral agents|mesh-ancestor
56348798|NCT00191347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348799|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348800|NCT00191347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348801|NCT00191347|Immunologic Factors|immunologic factors|mesh-ancestor
56348802|NCT00191347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348803|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56348804|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55970628|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56348806|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56348807|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56348808|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348809|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56348810|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56348811|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
56348812|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56348813|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56348814|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56348815|NCT00191464|Insulin|insulin|mesh-list
56348816|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56348817|NCT00191464|Metformin|metformin|mesh-list
56348818|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
56348819|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
56348820|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56348821|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348822|NCT04723030|Paclitaxel|paclitaxel|mesh-list
56348823|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56348824|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348825|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
56348826|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
56348827|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
56348828|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348829|NCT00191503|Gemcitabine|gemcitabine|mesh-list
56348830|NCT00191503|Pemetrexed|pemetrexed|mesh-list
56348831|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348832|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
56348833|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348834|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348835|NCT00191503|Antiviral Agents|antiviral agents|mesh-ancestor
56348836|NCT00191503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348837|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348838|NCT00191503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348839|NCT00191503|Immunologic Factors|immunologic factors|mesh-ancestor
56348840|NCT00191503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348841|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56348842|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348843|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56348844|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56348845|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348850|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348851|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56348852|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348853|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56348855|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348856|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
56348857|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56348858|NCT00191581|Insulin|insulin|mesh-list
56348859|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
56348860|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56348861|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
56348862|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56348863|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348864|NCT00191620|Gemcitabine|gemcitabine|mesh-list
56348865|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348866|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348867|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
56348868|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348869|NCT00191620|Antiviral Agents|antiviral agents|mesh-ancestor
56348870|NCT00191620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348871|NCT00191620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348872|NCT00191620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348873|NCT00191620|Immunologic Factors|immunologic factors|mesh-ancestor
56348874|NCT00191620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348875|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56348876|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56348877|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348878|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348879|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348880|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348881|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348882|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348883|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56348884|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56348885|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348886|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348887|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348888|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348889|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348890|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348892|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56348893|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56348894|NCT02470299|Analgesics|analgesics|mesh-ancestor
56348895|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
56348896|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348897|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348898|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56348899|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56348900|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56348901|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348902|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348903|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56348904|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56348905|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348906|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348907|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348908|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348909|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348910|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348911|NCT00191893|Teriparatide|teriparatide|mesh-list
56348913|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348914|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56348915|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56348916|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56348917|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56348918|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348919|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348920|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348921|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348922|NCT00191932|Analgesics|analgesics|mesh-ancestor
56348923|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
56348924|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56348925|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
56348926|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56348927|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
56348928|NCT00059813|Interferons|interferons|mesh-list
56348929|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
56348930|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
56651088|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977516|NCT01276223|Hormones|hormones|mesh-ancestor
56348931|NCT00059813|Oblimersen|oblimersen|mesh-list
56348932|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348933|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
56348934|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348935|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
56348936|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348937|NCT00191971|Gemcitabine|gemcitabine|mesh-list
56348938|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348939|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
56348940|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348941|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348942|NCT00191971|Antiviral Agents|antiviral agents|mesh-ancestor
56348943|NCT00191971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348944|NCT00191971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348945|NCT00191971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348946|NCT00191971|Immunologic Factors|immunologic factors|mesh-ancestor
56348947|NCT00191971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348948|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
56348949|NCT00047502|Lonafarnib|lonafarnib|mesh-list
56348950|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348951|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56348952|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348953|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348955|NCT00192049|Mitomycins|mitomycins|mesh-list
56348956|NCT00192049|Mitomycin|mitomycin|mesh-list
56348957|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348958|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
56348959|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348960|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348961|NCT00192049|Antiviral Agents|antiviral agents|mesh-ancestor
56348962|NCT00192049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348963|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348964|NCT00192049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348965|NCT00192049|Immunologic Factors|immunologic factors|mesh-ancestor
56348966|NCT00192049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348967|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56348968|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
56348969|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348970|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
56348971|NCT00192088|Pemetrexed|pemetrexed|mesh-list
56348972|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348973|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348974|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348975|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56348976|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56348977|NCT00059852|Gemcitabine|gemcitabine|mesh-list
56348978|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56348979|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56348980|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
56348981|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348982|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348983|NCT00059852|Antiviral Agents|antiviral agents|mesh-ancestor
56348984|NCT00059852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348985|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348994|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348995|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
56348996|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56348997|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56348998|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
56348999|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
56349000|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56349001|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56349002|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56349003|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
56349004|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349005|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349006|NCT02968901|Tadalafil|tadalafil|mesh-list
56349007|NCT02968901|Macitentan|macitentan|mesh-list
56349008|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
56349009|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56349010|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56349011|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651089|NCT02653638|Indomethacin|indomethacin|mesh-list
56651090|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55977606|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
56349012|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349013|NCT02968901|Urological Agents|urological agents|mesh-ancestor
56349014|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56349015|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56349016|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56349017|NCT00192595|Tenofovir|tenofovir|mesh-list
56349018|NCT00192595|Lamivudine|lamivudine|mesh-list
56349019|NCT00192595|Zidovudine|zidovudine|mesh-list
56349020|NCT00192595|Efavirenz|efavirenz|mesh-list
56349021|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
56349022|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349023|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56349024|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56349025|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349026|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349027|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56349028|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56349029|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
56349030|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56349031|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56349032|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56349033|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56349034|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56349035|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56349036|NCT00192634|Tenofovir|tenofovir|mesh-list
56349037|NCT00192634|Lamivudine|lamivudine|mesh-list
56349038|NCT00192634|Emtricitabine|emtricitabine|mesh-list
56349039|NCT00192634|Abacavir|abacavir|mesh-list
56349040|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
56349041|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349042|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56349043|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56349044|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349045|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349046|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56349047|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56349048|NCT00192673|Asparaginase|asparaginase|mesh-list
56349049|NCT00192673|Pegaspargase|pegaspargase|mesh-list
56349050|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349051|NCT00192712|Gemcitabine|gemcitabine|mesh-list
56349052|NCT00192712|Irinotecan|irinotecan|mesh-list
56349053|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56349055|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349056|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349057|NCT00192712|Antiviral Agents|antiviral agents|mesh-ancestor
56349058|NCT00192712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349059|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349060|NCT00192712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349061|NCT00192712|Immunologic Factors|immunologic factors|mesh-ancestor
56349062|NCT00192712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349063|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56349064|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56349065|NCT00047658|Interferons|interferons|mesh-list
56349066|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
56349067|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349068|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
56349069|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349071|NCT00193024|Epirubicin|epirubicin|mesh-list
56349072|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349073|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349074|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349075|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349076|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349077|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56349078|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56349079|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56349080|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349081|NCT00193102|Thalidomide|thalidomide|mesh-list
56349082|NCT00193102|Capecitabine|capecitabine|mesh-list
56349083|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56651091|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651092|NCT02653638|Analgesics|analgesics|mesh-ancestor
56349084|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
56170640|NCT01833312|Narcotics|narcotics|mesh-ancestor
56349085|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349086|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349087|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349088|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
56349089|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349090|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
56349091|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56349092|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349093|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56349094|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56349095|NCT00193102|Growth Substances|growth substances|mesh-ancestor
56349096|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
56349098|NCT00193141|Carboplatin|carboplatin|mesh-list
56349099|NCT00193141|Fluorouracil|fluorouracil|mesh-list
56349100|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56349101|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349102|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349103|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349104|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349105|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349106|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
56349107|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56349108|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349109|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
56349110|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349111|NCT00193297|Paclitaxel|paclitaxel|mesh-list
56349112|NCT00193297|Carboplatin|carboplatin|mesh-list
56349113|NCT00193297|Topotecan|topotecan|mesh-list
56349114|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56349115|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349116|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349117|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349118|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349119|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349120|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56349121|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56349122|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349123|NCT00193336|Gefitinib|gefitinib|mesh-list
56349124|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349125|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56349126|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349127|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349128|NCT00193531|Paclitaxel|paclitaxel|mesh-list
56349129|NCT00193531|Etoposide|etoposide|mesh-list
56349130|NCT00193531|Carboplatin|carboplatin|mesh-list
56349140|NCT00193570|Docetaxel|docetaxel|mesh-list
56349141|NCT00193570|Topotecan|topotecan|mesh-list
56349142|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349143|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349144|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349145|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349146|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349147|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56349149|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349150|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56349151|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349152|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56349153|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349154|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349155|NCT00409591|Ritonavir|ritonavir|mesh-list
56349156|NCT00409591|Lopinavir|lopinavir|mesh-list
56349157|NCT00409591|Zidovudine|zidovudine|mesh-list
56349158|NCT00409591|Nevirapine|nevirapine|mesh-list
56349159|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56349160|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56349161|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
56349162|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349163|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349164|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56349165|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56349166|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
56120625|NCT01869192|Docetaxel|docetaxel|mesh-list
56651093|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
56651094|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651095|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651096|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349167|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349168|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56349169|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56349170|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
56349171|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56349172|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56349173|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56349174|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56349175|NCT00409630|Fluticasone|fluticasone|mesh-list
56349176|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349177|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56349178|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
56349179|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349180|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349181|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56349182|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
56349183|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
56349184|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56349185|NCT00060125|Tipifarnib|tipifarnib|mesh-list
56349186|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349187|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
56349188|NCT00193648|Adalimumab|adalimumab|mesh-list
56349189|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349190|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56349191|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56349192|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349193|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56349194|NCT00193726|Estradiol|estradiol|mesh-list
56349195|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56349196|NCT00193726|Estrogens|estrogens|mesh-ancestor
56349197|NCT00193726|Hormones|hormones|mesh-ancestor
56349202|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56349203|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56349204|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56349205|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56349206|NCT00193882|Cisplatin|cisplatin|mesh-list
56349207|NCT00193882|Fluorouracil|fluorouracil|mesh-list
56349208|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349209|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
56349210|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170645|NCT01834014|Bevacizumab|bevacizumab|mesh-list
56349211|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56349212|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349213|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
56349214|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349215|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
56349216|NCT00060242|Combretastatin|combretastatin|mesh-list
56349217|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56349218|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349219|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349220|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349221|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349222|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349223|NCT00193921|Gemcitabine|gemcitabine|mesh-list
56349224|NCT00193921|Cisplatin|cisplatin|mesh-list
56349225|NCT00193921|Vinorelbine|vinorelbine|mesh-list
56349226|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349227|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56349228|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
56349229|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349230|NCT00193921|Antiviral Agents|antiviral agents|mesh-ancestor
56349231|NCT00193921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349232|NCT00193921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349233|NCT00193921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349234|NCT00193921|Immunologic Factors|immunologic factors|mesh-ancestor
56349235|NCT00193921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349236|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56349237|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
56651097|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651098|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
56651099|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
56214075|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56349238|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349239|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349240|NCT00194038|Aripiprazole|aripiprazole|mesh-list
56349241|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
56349242|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349243|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56349244|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56349245|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349246|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349247|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
56349248|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
56349249|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349250|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971091|NCT05220917|Incretins|incretins|mesh-ancestor
56349251|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56349252|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56349253|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
56349254|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56349255|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56349256|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56349257|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56349258|NCT00060359|Paclitaxel|paclitaxel|mesh-list
56349259|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56349260|NCT00060359|Carboplatin|carboplatin|mesh-list
56349261|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56349262|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56349263|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349264|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349265|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349273|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56349274|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
56349275|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170672|NCT01835184|Vemurafenib|vemurafenib|mesh-list
56349276|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349277|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
56349278|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349279|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56349280|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349281|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
56349282|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56349283|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56349284|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
56349285|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
56349286|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56349287|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
56349288|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349289|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349290|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56349291|NCT00194467|Valganciclovir|valganciclovir|mesh-list
56349292|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
56349293|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349294|NCT00060398|Dexamethasone|dexamethasone|mesh-list
56349295|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
56349296|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349297|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
56349298|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
56349299|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349300|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349301|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56349302|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
56349303|NCT00060398|Hormones|hormones|mesh-ancestor
56349304|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56349305|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56349306|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349307|NCT00060398|Hematinics|hematinics|mesh-ancestor
56349308|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
56349309|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56349310|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56349311|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56651100|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56651101|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56651102|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923718|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56651103|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651104|NCT02644590|Melatonin|melatonin|mesh-list
56651105|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
56651106|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651107|NCT02644590|Protective Agents|protective agents|mesh-ancestor
56349312|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56349313|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349314|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
56349315|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349316|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349317|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56349318|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349319|NCT00194740|Docetaxel|docetaxel|mesh-list
56349320|NCT00194740|Vinorelbine|vinorelbine|mesh-list
56349321|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349322|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349323|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349324|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349325|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349326|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56349327|NCT00194818|Mesalamine|mesalamine|mesh-list
55971158|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349328|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56349329|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56349330|NCT00194818|Analgesics|analgesics|mesh-ancestor
56349331|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
56349332|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349333|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349334|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349335|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56349336|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
56349337|NCT00194857|Hematinics|hematinics|mesh-ancestor
56349338|NCT00194935|Topotecan|topotecan|mesh-list
56349339|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56349340|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56349341|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349342|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349343|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349344|NCT00194974|Clonidine|clonidine|mesh-list
56349345|NCT00194974|Labetalol|labetalol|mesh-list
56349346|NCT00194974|Methyldopa|methyldopa|mesh-list
56349347|NCT00194974|Nifedipine|nifedipine|mesh-list
56349348|NCT00194974|Analgesics|analgesics|mesh-ancestor
56349349|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
56349350|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349351|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349352|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56349353|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
56349354|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
56349355|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56349356|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56349357|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56349358|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
56349359|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349360|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349361|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56349362|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56349363|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56349364|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
56349365|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
56349366|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56651108|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651109|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349367|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56349368|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56349370|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56349371|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56349372|NCT00195208|Pantoprazole|pantoprazole|mesh-list
56349373|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56349374|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56349375|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56349376|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349377|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349378|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56349379|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56349380|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56349381|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
56349382|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349383|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56349384|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56349385|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349386|NCT00195286|Tazobactam|tazobactam|mesh-list
56349387|NCT00195286|Piperacillin|piperacillin|mesh-list
56349388|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56349389|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56349390|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349391|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56349392|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349393|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349394|NCT00084201|Amoxicillin|amoxicillin|mesh-list
56349395|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56349396|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349397|NCT00195364|Etanercept|etanercept|mesh-list
56349398|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56349399|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56349400|NCT00195364|Analgesics|analgesics|mesh-ancestor
56349401|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
56349402|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349403|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349404|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349405|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56349406|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56349407|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349408|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
56349410|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56349411|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349412|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56349413|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349414|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
56349415|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349416|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
56349417|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349418|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
56349419|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56349420|NCT00195559|Estradiol|estradiol|mesh-list
56349421|NCT00195559|Estrogens|estrogens|mesh-ancestor
56349422|NCT00195559|Hormones|hormones|mesh-ancestor
56349423|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56349424|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349425|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56349426|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
56349427|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56349428|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56349429|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56349430|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56349431|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56349432|NCT00084240|Azithromycin|azithromycin|mesh-list
56349433|NCT00084240|Chloroquine|chloroquine|mesh-list
56349434|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56349435|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
56349436|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
56349437|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56349438|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56651110|NCT00910806|Nevirapine|nevirapine|mesh-list
56651111|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55790582|NCT03103009|Hormones|hormones|mesh-ancestor
56349439|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349440|NCT00084240|Amebicides|amebicides|mesh-ancestor
56349441|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56349442|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56349443|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
56349444|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56349445|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56349446|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56349447|NCT00084240|Analgesics|analgesics|mesh-ancestor
56349448|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
56349449|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349450|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349451|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349452|NCT00084240|Filaricides|filaricides|mesh-ancestor
56349453|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
56349454|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
56349455|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56349456|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349457|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349458|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56349459|NCT00084240|Renal Agents|renal agents|mesh-ancestor
56349460|NCT00195598|Paroxetine|paroxetine|mesh-list
56349461|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56349462|NCT00195598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56349463|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56349464|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56349465|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349466|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349467|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
56349468|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349469|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56349470|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
56349471|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349472|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56349473|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56349474|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349475|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56349476|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
56349477|NCT00195637|Antibodies|antibodies|mesh-list
56349478|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
56349479|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56349480|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56349481|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
56349483|NCT00195754|Valproic Acid|valproic acid|mesh-list
56349484|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
56349485|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349486|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349487|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
56349488|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349489|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349490|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
56349491|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56349492|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349493|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349494|NCT00195793|Atorvastatin|atorvastatin|mesh-list
56349495|NCT00195793|Ezetimibe|ezetimibe|mesh-list
56349496|NCT00195793|Fenofibrate|fenofibrate|mesh-list
56349497|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56349498|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56349499|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
56349500|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349501|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56349502|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56349503|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349504|NCT00195871|Cytarabine|cytarabine|mesh-list
56349505|NCT00195871|Prednisone|prednisone|mesh-list
56349506|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
56349507|NCT00195871|Methotrexate|methotrexate|mesh-list
56349508|NCT00195871|Etoposide|etoposide|mesh-list
56349509|NCT00195871|Vincristine|vincristine|mesh-list
56349510|NCT00195871|Daunorubicin|daunorubicin|mesh-list
56349511|NCT00195871|Asparaginase|asparaginase|mesh-list
56651112|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56651113|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651114|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651115|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
56349512|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349513|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
56349514|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349515|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56349516|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56349518|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349519|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349520|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56349521|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349522|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
56349523|NCT00195871|Hormones|hormones|mesh-ancestor
56349524|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56349525|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56349526|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56349527|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
56349528|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56349529|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56349530|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
56349531|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
56349532|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349533|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56349534|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56349535|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56349536|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56349537|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56349538|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349539|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349540|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349541|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
56349542|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349543|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56349544|NCT00195910|Morphine|morphine|mesh-list
56349545|NCT00195910|Hydromorphone|hydromorphone|mesh-list
56349546|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56349547|NCT00195910|Narcotics|narcotics|mesh-ancestor
56349548|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349549|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971387|NCT01950039|Betaine|betaine|mesh-list
56349550|NCT00195910|Analgesics|analgesics|mesh-ancestor
56349551|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
56349552|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349553|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
56349554|NCT00195988|Tacrolimus|tacrolimus|mesh-list
56349555|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349556|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
56349557|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349560|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349561|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56349562|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349563|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56349564|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
56349565|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56349566|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349568|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56349569|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56349570|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349571|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349572|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56349573|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56349574|NCT00060476|Analgesics|analgesics|mesh-ancestor
56349575|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
56349576|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349577|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349578|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651116|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651117|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56349579|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56349580|NCT00084279|Interferons|interferons|mesh-list
56349582|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
56349583|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
56349584|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
56349585|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349586|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
56349587|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349588|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
56349589|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349590|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
56349591|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349593|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56349594|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
56349595|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
56349596|NCT00196378|Hormones|hormones|mesh-ancestor
56349597|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56349598|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349599|NCT00196417|Heparin|heparin|mesh-list
56349600|NCT00196417|Certoparin|certoparin|mesh-list
56349601|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
56349602|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56349603|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56349604|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349605|NCT00060554|Heparin|heparin|mesh-list
56349606|NCT00060554|PENTA|penta|mesh-list
56349607|NCT00060554|Fondaparinux|fondaparinux|mesh-list
56349608|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
56349609|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56349610|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56349611|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349612|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56349613|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
56349614|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56349615|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
56349616|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349617|NCT00048087|Docetaxel|docetaxel|mesh-list
56349618|NCT00048087|Gefitinib|gefitinib|mesh-list
56349619|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349620|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349621|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349622|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349623|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349624|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56349625|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349626|NCT00196534|Thrombin|thrombin|mesh-list
56349627|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
55971453|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
56349628|NCT00196534|Coagulants|coagulants|mesh-ancestor
56349629|NCT00048126|Capecitabine|capecitabine|mesh-list
56349630|NCT00048126|Irinotecan|irinotecan|mesh-list
56349631|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56349632|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
56349633|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349634|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349635|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56349636|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56349637|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349638|NCT00196612|Emtricitabine|emtricitabine|mesh-list
56349639|NCT00196612|Efavirenz|efavirenz|mesh-list
56349640|NCT00196612|Didanosine|didanosine|mesh-list
56349641|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
56349642|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349643|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56349644|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56349645|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349646|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349647|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56349648|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56349649|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56349650|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56349651|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56349652|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56651118|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56651119|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56651120|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56349653|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56349654|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56349655|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
56349656|NCT00196690|Donepezil|donepezil|mesh-list
56349657|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56349658|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349659|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349660|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
56349661|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349662|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349663|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
56349664|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
56349665|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349666|NCT00084396|Letrozole|letrozole|mesh-list
56349667|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349668|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56349669|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56349670|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349671|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349672|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56349673|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
56349674|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56349675|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349676|NCT00196846|Goserelin|goserelin|mesh-list
56349677|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56349678|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349679|NCT00060632|Sirolimus|sirolimus|mesh-list
56349680|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56349681|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349682|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56349683|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349684|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
56349685|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56349686|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
56349687|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349688|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
56349689|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56349690|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
56349691|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349692|NCT00196885|Expectorants|expectorants|mesh-ancestor
56349693|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
56349694|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56349695|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
56349696|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349697|NCT00196885|Protective Agents|protective agents|mesh-ancestor
56349698|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349699|NCT00196885|Antidotes|antidotes|mesh-ancestor
56349700|NCT00048204|Paroxetine|paroxetine|mesh-list
56349701|NCT00048204|Vestipitant|vestipitant|mesh-list
56349702|NCT00048204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56349703|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56349704|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55971539|NCT00571259|Heparin|heparin|mesh-list
56349705|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349706|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349707|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
56349712|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56349713|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56349714|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349715|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56349716|NCT00197080|Ropinirole|ropinirole|mesh-list
56349717|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56349718|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56349719|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
56349720|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
56349721|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349722|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120626|NCT01869192|Capecitabine|capecitabine|mesh-list
56651121|NCT00652704|Doxycycline|doxycycline|mesh-list
56651122|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56349723|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349724|NCT00060671|Rituximab|rituximab|mesh-list
56349725|NCT00060671|Pixantrone|pixantrone|mesh-list
56349726|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56349727|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349728|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
56349729|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349730|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56349731|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56349732|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56349733|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349734|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349735|NCT00197197|Aplaviroc|aplaviroc|mesh-list
56349736|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56349737|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56349738|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349739|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56349740|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56349741|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
56349742|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349743|NCT00409903|Eprosartan|eprosartan|mesh-list
56349744|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56349745|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
56349746|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56349747|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349748|NCT00084435|Docetaxel|docetaxel|mesh-list
56349749|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349750|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349751|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349752|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349753|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349754|NCT00197353|Bupivacaine|bupivacaine|mesh-list
56349755|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
56349756|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
56349757|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349758|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349759|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
56349760|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349761|NCT02962999|Ketamine|ketamine|mesh-list
56349762|NCT02962999|Analgesics|analgesics|mesh-ancestor
56349763|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
56349764|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349765|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349766|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56349767|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56349768|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
56349769|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
56349770|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349771|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56349772|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56349773|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349774|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349775|NCT00084513|Trastuzumab|trastuzumab|mesh-list
56349776|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
56349781|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349784|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
56349785|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349786|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349787|NCT00197548|Folic Acid|folic acid|mesh-list
56349788|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
56349789|NCT00197548|Vitamins|vitamins|mesh-ancestor
56349790|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
56349791|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349792|NCT00197548|Hematinics|hematinics|mesh-ancestor
56349793|NCT00197587|Nevirapine|nevirapine|mesh-list
56349794|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56349795|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56349796|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349797|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349798|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
56651123|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651124|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
55790590|NCT03694249|Ifetroban|ifetroban|mesh-list
56349799|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349800|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56349801|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56349802|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56349803|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56349804|NCT00197743|Vitamin A|vitamin a|mesh-list
56349805|NCT00197743|Beta Carotene|beta carotene|mesh-list
56349806|NCT00197743|Carotenoids|carotenoids|mesh-list
56349807|NCT00197743|Vitamins|vitamins|mesh-ancestor
56349808|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
56349809|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349810|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
56349811|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349812|NCT00197743|Protective Agents|protective agents|mesh-ancestor
56349813|NCT00197743|Provitamins|provitamins|mesh-ancestor
56349814|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
56349815|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349816|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56349817|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349818|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349819|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56349820|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
56349821|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349822|NCT00084669|Zolpidem|zolpidem|mesh-list
56349823|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56349824|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56349825|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56349826|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56349827|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349828|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349829|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349830|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56349831|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
56349832|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349833|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56349834|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56349835|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349836|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56349837|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
56349838|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
56349839|NCT00060866|Propranolol|propranolol|mesh-list
56349840|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56349841|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56349842|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
56349843|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349844|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349845|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349847|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56349848|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
56349849|NCT00048360|Bupropion|bupropion|mesh-list
56349850|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56349851|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
56349852|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349853|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55785650|NCT05738161|Gemcitabine|gemcitabine|mesh-list
56349854|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56349855|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56349856|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349857|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
56349858|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349859|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349860|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56349861|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56349862|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349863|NCT00198055|Aripiprazole|aripiprazole|mesh-list
56349864|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
56349865|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349866|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56651125|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56651126|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56651127|NCT00652782|Rolofylline|rolofylline|mesh-list
56651128|NCT00652782|Diuretics|diuretics|mesh-ancestor
56349867|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56349868|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349869|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349870|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
56349871|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
56349872|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349873|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349874|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56349875|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56349876|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
56349877|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56349878|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56349879|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56349880|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56349881|NCT00198094|Alprazolam|alprazolam|mesh-list
56349882|NCT00198094|Sertraline|sertraline|mesh-list
56349883|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
56349884|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349885|NCT00198094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56349886|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56349887|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56349888|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349889|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349890|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
56349891|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349892|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56349893|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349894|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56349895|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56349896|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
56349897|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
56349899|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349900|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56349901|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56349902|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56349903|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349904|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349905|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56349906|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56349907|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56349908|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56349909|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349910|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349911|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349912|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56349913|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
56349914|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349915|NCT00084708|Calcitriol|calcitriol|mesh-list
56349916|NCT00084708|Dexamethasone|dexamethasone|mesh-list
56349919|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
56349920|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
56349921|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349922|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349923|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55971760|NCT01270087|Adalimumab|adalimumab|mesh-list
56349924|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
56349925|NCT00084708|Hormones|hormones|mesh-ancestor
56349926|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56349927|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56349928|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349929|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56349930|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349931|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349932|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56349933|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56651129|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
56651130|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651131|NCT00653562|Zolpidem|zolpidem|mesh-list
56651132|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56349934|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56349935|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56349936|NCT00084708|Vitamins|vitamins|mesh-ancestor
56349937|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
56349938|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56349939|NCT00198367|Cisplatin|cisplatin|mesh-list
56349940|NCT00198367|Carboplatin|carboplatin|mesh-list
56349941|NCT00198367|Vinorelbine|vinorelbine|mesh-list
56349942|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349943|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349944|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56349945|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349946|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349947|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349948|NCT00198445|Bromfenac|bromfenac|mesh-list
56349949|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56349950|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56349951|NCT00198445|Analgesics|analgesics|mesh-ancestor
56349952|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
56349953|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349954|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349955|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349957|NCT00048399|Fludarabine|fludarabine|mesh-list
56349958|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
56349959|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349960|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56349961|NCT00060905|Valproic Acid|valproic acid|mesh-list
56349962|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
56349963|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349964|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349965|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
56349966|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56349967|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349968|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
56349969|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56349970|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56349971|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349972|NCT00198523|Tobramycin|tobramycin|mesh-list
56349973|NCT00198523|Prednisolone|prednisolone|mesh-list
56349974|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56349975|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
56349976|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56349977|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
56349978|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56349979|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
56349980|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349981|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
56349982|NCT00198523|Hormones|hormones|mesh-ancestor
56349983|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56349984|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349985|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56349986|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349987|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
56349988|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
56349989|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349990|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56349998|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56349999|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350000|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350001|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56350002|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350003|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
56350004|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56350005|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56350006|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56350007|NCT00409942|Torsemide|torsemide|mesh-list
56350008|NCT00409942|Furosemide|furosemide|mesh-list
56350009|NCT00409942|Diuretics|diuretics|mesh-ancestor
56651133|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56651134|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651135|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651136|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56651137|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
56651138|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
56214100|NCT01610934|Hormones|hormones|mesh-ancestor
56350010|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
56350011|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350012|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56350013|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350014|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350015|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56350016|NCT00084786|Docetaxel|docetaxel|mesh-list
56350017|NCT00084786|Gefitinib|gefitinib|mesh-list
56350018|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350019|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
56350020|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
56350021|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
56350022|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350023|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56350024|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350025|NCT00409981|Paclitaxel|paclitaxel|mesh-list
56350026|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56350027|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350028|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
56350029|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
56350030|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
56350031|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350033|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56350034|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350035|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56350036|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350037|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350038|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56350039|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350040|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
56350041|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56350042|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350043|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
56350044|NCT00084825|Docetaxel|docetaxel|mesh-list
56350045|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
56350046|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350047|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
56350048|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
56350049|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56350050|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350051|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56350052|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350053|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56350054|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350055|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350056|NCT00199147|Cytarabine|cytarabine|mesh-list
56350057|NCT00199147|Fludarabine|fludarabine|mesh-list
56350058|NCT00199147|Etoposide|etoposide|mesh-list
56350059|NCT00199147|Idarubicin|idarubicin|mesh-list
56350060|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350065|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
56350066|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350067|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56350068|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56350069|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56350070|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350071|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
56350072|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350073|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56350074|NCT00199186|Cytarabine|cytarabine|mesh-list
56350075|NCT00199186|Dexamethasone|dexamethasone|mesh-list
56350076|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
56651139|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651140|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651141|NCT00887159|Cisplatin|cisplatin|mesh-list
56651142|NCT00887159|Etoposide|etoposide|mesh-list
56350077|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
56350078|NCT00199186|Methotrexate|methotrexate|mesh-list
56350079|NCT00199186|Vincristine|vincristine|mesh-list
56350080|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
56350081|NCT00199186|Idarubicin|idarubicin|mesh-list
56350082|NCT00199186|BB 1101|bb 1101|mesh-list
56350083|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350084|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
56350085|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350086|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350087|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56350088|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
56350089|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350090|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350091|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56350092|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56350093|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
56350094|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
56350095|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350096|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350097|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
56350098|NCT00199186|Hormones|hormones|mesh-ancestor
56350099|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56350100|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56350101|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
56350102|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350103|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56350104|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
56350105|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55991300|NCT04564755|Abrocitinib|abrocitinib|mesh-list
56350106|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56350107|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
56350108|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
56350109|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56350110|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56350111|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56350112|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
56350113|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
56350114|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
56350115|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
56350116|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350117|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56350118|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56350119|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56350120|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56350121|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
56350122|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56350123|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350124|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56350125|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56350126|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350127|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350128|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350129|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
56350130|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
56350132|NCT00061022|Protective Agents|protective agents|mesh-ancestor
56350133|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350134|NCT00199264|Albaconazole|albaconazole|mesh-list
56350135|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
56350136|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350137|NCT00199342|Ecromeximab|ecromeximab|mesh-list
56350138|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56350139|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350140|NCT00199420|Istradefylline|istradefylline|mesh-list
56350141|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56350142|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56350143|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56350144|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
56651143|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
56651144|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
56651145|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56651146|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350145|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350146|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350147|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350148|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
56350149|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56350150|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56350151|NCT00199576|Prednisolone|prednisolone|mesh-list
56350152|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
56350153|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56350154|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
56350155|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56350156|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
56350157|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
56350158|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350159|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350160|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350161|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
56350162|NCT00199576|Hormones|hormones|mesh-ancestor
56350163|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56350164|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56350165|NCT00199576|Protective Agents|protective agents|mesh-ancestor
56350166|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56350167|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350168|NCT00084942|Gemcitabine|gemcitabine|mesh-list
56350169|NCT00084942|Capecitabine|capecitabine|mesh-list
56350170|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56350171|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
56350172|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350173|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350174|NCT00084942|Antiviral Agents|antiviral agents|mesh-ancestor
56350175|NCT00084942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350176|NCT00084942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350177|NCT00084942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350178|NCT00084942|Immunologic Factors|immunologic factors|mesh-ancestor
56350179|NCT00084942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350180|NCT02968394|Omalizumab|omalizumab|mesh-list
56350181|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56350182|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56350183|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
56350184|NCT00199771|Dextrans|dextrans|mesh-list
56350185|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
56350186|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
56350187|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
56350188|NCT00084981|Decitabine|decitabine|mesh-list
56350189|NCT00084981|Azacitidine|azacitidine|mesh-list
56350190|NCT00084981|Valproic Acid|valproic acid|mesh-list
56350191|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56350192|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
56350193|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350194|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350195|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350196|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
56350197|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
56350198|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350199|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350200|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
56350201|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56350202|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350203|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350204|NCT00199966|Valproic Acid|valproic acid|mesh-list
56350205|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
56350208|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
56350209|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350210|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350211|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
56350212|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56350213|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350214|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350215|NCT00085020|Trastuzumab|trastuzumab|mesh-list
56120627|NCT01869192|Epirubicin|epirubicin|mesh-list
56651147|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56651148|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56651149|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56350217|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56350218|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350219|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56350220|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350221|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350222|NCT00410215|Bisacodyl|bisacodyl|mesh-list
56350223|NCT00410215|Cathartics|cathartics|mesh-ancestor
56350224|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350225|NCT00410215|Laxatives|laxatives|mesh-ancestor
56350226|NCT00410254|Midazolam|midazolam|mesh-list
56350227|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56350228|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56350229|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350230|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350231|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56350232|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56350233|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350234|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56350235|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
56350237|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
56350238|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
56350239|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350240|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350241|NCT00061178|Bevacizumab|bevacizumab|mesh-list
56350242|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56350243|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350244|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56350245|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56350246|NCT00061178|Growth Substances|growth substances|mesh-ancestor
56350247|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350248|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
56350249|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56350250|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350251|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56350252|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350253|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350254|NCT00200434|Nebivolol|nebivolol|mesh-list
56350255|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56350256|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
56350257|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56350258|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56350259|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56350260|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
56350261|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350262|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350263|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350264|NCT00200473|Nebivolol|nebivolol|mesh-list
56350265|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56350266|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
56350267|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56350268|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56350269|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56350270|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
56350271|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350272|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350273|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350274|NCT02962804|Nivolumab|nivolumab|mesh-list
56350275|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56350276|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350277|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56350278|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350279|NCT00048555|Galiximab|galiximab|mesh-list
56350284|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350285|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
56350286|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350287|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350288|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
56651150|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651151|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651152|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
56350289|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
56350290|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350291|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350292|NCT00200551|Cyclosporine|cyclosporine|mesh-list
56350293|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
56350294|NCT00200551|Cyclosporins|cyclosporins|mesh-list
56350295|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56350296|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350297|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350298|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350299|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
56350300|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350301|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
56350303|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
56350304|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350305|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56350306|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56350307|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350308|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56350309|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
56350310|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56350311|NCT00061256|Vitamin D|vitamin d|mesh-list
56350312|NCT00061256|Alendronate|alendronate|mesh-list
56350313|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
56350314|NCT00061256|Calcium|calcium|mesh-list
56350315|NCT00061256|Vitamins|vitamins|mesh-ancestor
56350316|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
56350317|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350318|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56350319|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56350320|NCT00061256|Antacids|antacids|mesh-ancestor
56350321|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350322|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350323|NCT00200590|Acetaminophen|acetaminophen|mesh-list
56350324|NCT00200590|Morphine|morphine|mesh-list
56350325|NCT00200590|Nalbuphine|nalbuphine|mesh-list
56350326|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56350327|NCT00200590|Narcotics|narcotics|mesh-ancestor
56350328|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350329|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350330|NCT00200590|Analgesics|analgesics|mesh-ancestor
56350331|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
56350332|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350333|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56350334|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
56350335|NCT00200629|Adenosine|adenosine|mesh-list
56350336|NCT00200629|Analgesics|analgesics|mesh-ancestor
56350337|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
56350338|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350339|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350340|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56350341|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
56350342|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56350343|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
56350344|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
56350345|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350346|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350348|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56350349|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350350|NCT00048594|Aprepitant|aprepitant|mesh-list
56350351|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
56350352|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
56350353|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350354|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350355|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350358|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350360|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
56350361|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56350362|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350363|NCT00201253|Dimercaprol|dimercaprol|mesh-list
56350364|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
56350365|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
56350366|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350367|NCT00201331|Leucovorin|leucovorin|mesh-list
56350368|NCT00201331|Antidotes|antidotes|mesh-ancestor
56350369|NCT00201331|Protective Agents|protective agents|mesh-ancestor
56350370|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350371|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
56350372|NCT00201331|Vitamins|vitamins|mesh-ancestor
56350373|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
56350374|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
55972204|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56350375|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350376|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56350377|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350378|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350380|NCT00201682|Rituximab|rituximab|mesh-list
56350381|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56350382|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350383|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
56350384|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350385|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350386|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56350387|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56350388|NCT00201682|Analgesics|analgesics|mesh-ancestor
56350389|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
56350390|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350391|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56350392|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350393|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350394|NCT00410371|Lamotrigine|lamotrigine|mesh-list
56350395|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
56350396|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56350397|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350398|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350399|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56350400|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350401|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56350402|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56350403|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350404|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350405|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56350406|NCT00410449|Tocopherols|tocopherols|mesh-list
56350407|NCT00410449|Vitamin E|vitamin e|mesh-list
56350408|NCT00410449|Tocotrienols|tocotrienols|mesh-list
56350409|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
56350410|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
56350411|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350412|NCT00410449|Protective Agents|protective agents|mesh-ancestor
56350413|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350414|NCT00410449|Vitamins|vitamins|mesh-ancestor
56350415|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
56350416|NCT00061451|Gemcitabine|gemcitabine|mesh-list
56350417|NCT00061451|Pemetrexed|pemetrexed|mesh-list
56350418|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56350419|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
56170732|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
56350420|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350421|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350423|NCT00061451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350424|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350425|NCT00061451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350426|NCT00061451|Immunologic Factors|immunologic factors|mesh-ancestor
56350427|NCT00061451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350428|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56350430|NCT00410527|Meropenem|meropenem|mesh-list
56350431|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56350432|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350433|NCT00048750|Micafungin|micafungin|mesh-list
56350434|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
56350435|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350436|NCT00221416|Aripiprazole|aripiprazole|mesh-list
56350437|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
56350438|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350439|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56350440|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56350441|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651153|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
56651154|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
56651155|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
56651156|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
56350442|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350443|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
56350444|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
56350445|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350446|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350447|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56350448|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56350449|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
56350450|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56350451|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56350452|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56350453|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56350454|NCT00221494|Pindolol|pindolol|mesh-list
56350455|NCT00221494|Citalopram|citalopram|mesh-list
56350456|NCT00221494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56350457|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56350458|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350459|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350460|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350461|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
56350462|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350463|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56350464|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
56350465|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350466|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56350467|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56350468|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
56350469|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56350470|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56350471|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
56350472|NCT00221611|Baclofen|baclofen|mesh-list
56350473|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56350474|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350475|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56350476|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350477|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56350478|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
56350479|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
56350480|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350481|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350482|NCT00221650|Ribavirin|ribavirin|mesh-list
56350483|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56350484|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
56350485|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350486|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
56350487|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350488|NCT00221689|Baclofen|baclofen|mesh-list
56350489|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56350490|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350491|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56350492|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350493|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56350495|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
56350496|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350497|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350498|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
56350499|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
56350500|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350501|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350502|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350505|NCT00412789|Epothilone B|epothilone b|mesh-list
56350506|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350507|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
56350508|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
56350509|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
56350510|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651157|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
56651158|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651159|NCT00650286|Modafinil|modafinil|mesh-list
56651160|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56350511|NCT00048828|Olanzapine|olanzapine|mesh-list
56350512|NCT00048828|Clozapine|clozapine|mesh-list
56350513|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
56350514|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
56350515|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350516|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350517|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350518|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56350519|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56350520|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350521|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350522|NCT00048828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56350523|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56350524|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350525|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350526|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350527|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
56350528|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56350530|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
56350531|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56350532|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56350533|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56350534|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56350535|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56350536|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56350537|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56350538|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
56350539|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350540|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350541|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350542|NCT00221845|Telmisartan|telmisartan|mesh-list
56350543|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56350544|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56350545|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56350546|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350547|NCT00085761|Capsaicin|capsaicin|mesh-list
56350548|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
56350549|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
56350550|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
56350551|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350552|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350553|NCT00221962|Aripiprazole|aripiprazole|mesh-list
56350554|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
56350555|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350556|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56350557|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56350558|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350559|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350560|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
56350561|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
56350562|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350563|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350564|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56350565|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56350567|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56350568|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56350569|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56350570|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56350571|NCT02968160|Telmisartan|telmisartan|mesh-list
56350572|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56350573|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56350574|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56350575|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
56350576|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350579|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121092|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56651161|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651162|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56214123|NCT01610999|Plerixafor|plerixafor|mesh-list
56350580|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56350581|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56350582|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56350583|NCT00222079|Esomeprazole|esomeprazole|mesh-list
56350584|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56350585|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350586|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56350587|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350588|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350589|NCT00222235|Cycloserine|cycloserine|mesh-list
56350590|NCT00222235|Glycine|glycine|mesh-list
56350591|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56350592|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350593|NCT00222235|Renal Agents|renal agents|mesh-ancestor
56350594|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56350595|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
56350596|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56350597|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
56350598|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350599|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
56350600|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350601|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350602|NCT00061646|Carboplatin|carboplatin|mesh-list
56350603|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350604|NCT00222469|Gemcitabine|gemcitabine|mesh-list
56350605|NCT00222469|Bevacizumab|bevacizumab|mesh-list
56350606|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
56350607|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56350608|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350609|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56350610|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56350611|NCT00222469|Growth Substances|growth substances|mesh-ancestor
56350612|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350613|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
56350614|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56350615|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
56350616|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350617|NCT00222469|Antiviral Agents|antiviral agents|mesh-ancestor
56350618|NCT00222469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350619|NCT00222469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350620|NCT00222469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350621|NCT00222469|Immunologic Factors|immunologic factors|mesh-ancestor
56350622|NCT00222547|Vitamin A|vitamin a|mesh-list
56350623|NCT00222547|Albendazole|albendazole|mesh-list
56350624|NCT00222547|Vitamins|vitamins|mesh-ancestor
56350625|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
56350626|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350627|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350628|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350629|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
56350630|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56350631|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350632|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
56350633|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56350634|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56350635|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
56350636|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
56350637|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
56350638|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
56350639|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350640|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56350641|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56350643|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56350644|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56350645|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
56350646|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
56350647|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350648|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350649|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56350650|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
56350651|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56651163|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56651164|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56350653|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350654|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350655|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56350656|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
56350657|NCT00222820|Citalopram|citalopram|mesh-list
56350658|NCT00222820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56350659|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56350660|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350661|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350662|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350663|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
56350664|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350665|NCT00222820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56350666|NCT00222820|Antidepressive Agents|antidepressive agents|mesh-ancestor
56350667|NCT00222820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350668|NCT00085332|Docetaxel|docetaxel|mesh-list
56350669|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350670|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
56350671|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
56350672|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
56350673|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972500|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
56350674|NCT00222976|Naproxen|naproxen|mesh-list
56350675|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56350676|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56350678|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
56350679|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350680|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350681|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56350682|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350683|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
56350684|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56350685|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350686|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350687|NCT00223015|Tacrolimus|tacrolimus|mesh-list
56350688|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350689|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
56350690|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350691|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56350692|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350693|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350694|NCT00061763|Deferasirox|deferasirox|mesh-list
56350695|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56350696|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
56350697|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
56350698|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350699|NCT00223054|Cyclosporine|cyclosporine|mesh-list
56350700|NCT00223054|Sirolimus|sirolimus|mesh-list
56350701|NCT00223054|Everolimus|everolimus|mesh-list
56350702|NCT00223054|Tacrolimus|tacrolimus|mesh-list
56350703|NCT00223054|Cyclosporins|cyclosporins|mesh-list
56350704|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350705|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
56350706|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350707|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56350708|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170742|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
56350709|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350710|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
56350711|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350712|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
56350713|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350714|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350715|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56350716|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56350717|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56350718|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
56350719|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350720|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56350721|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56733193|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56350722|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350723|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350725|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56350727|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
56350728|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350729|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350730|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350731|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56350732|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56350733|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350734|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350735|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56350736|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
56350737|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
56350738|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56350739|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
56350740|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350741|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56350742|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56350743|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56350744|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350745|NCT00223288|Citalopram|citalopram|mesh-list
56350746|NCT00223288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56350747|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55972583|NCT01271023|Insulin|insulin|mesh-list
56350748|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350749|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350750|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350751|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
56350752|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350753|NCT00223288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56350754|NCT00223288|Antidepressive Agents|antidepressive agents|mesh-ancestor
56350755|NCT00223288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350756|NCT00085449|Cyclosporine|cyclosporine|mesh-list
56350757|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
56350758|NCT00085449|Fludarabine|fludarabine|mesh-list
56350759|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
56350760|NCT00085449|Melphalan|melphalan|mesh-list
56350761|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
56350762|NCT00085449|Cyclosporins|cyclosporins|mesh-list
56350763|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350764|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56350765|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
56350766|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350767|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350768|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
56350769|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350770|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350771|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
56350772|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350773|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
56350774|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350775|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56350776|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56350777|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56350778|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
56350779|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56350780|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55991304|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
56350781|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
56350782|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56350783|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56350784|NCT00223561|Methylphenidate|methylphenidate|mesh-list
56350785|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56350786|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350787|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56350788|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56350789|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350790|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350791|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
56350792|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350793|NCT00223639|Topiramate|topiramate|mesh-list
56214129|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56350794|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
56350795|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56350796|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350797|NCT00223717|Aspirin|aspirin|mesh-list
56350809|NCT00223717|Captopril|captopril|mesh-list
56350810|NCT00223717|Nifedipine|nifedipine|mesh-list
56350811|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56350812|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
56350813|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
56350814|NCT00223717|Dipyridamole|dipyridamole|mesh-list
56350815|NCT00223717|Carbidopa|carbidopa|mesh-list
56350816|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56350817|NCT00223717|Tamsulosin|tamsulosin|mesh-list
56350818|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56350819|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56350820|NCT00223717|Analgesics|analgesics|mesh-ancestor
56350821|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
56350822|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350823|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350824|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56350825|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350826|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56350827|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56350828|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350829|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56350830|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56350831|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350832|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
56350833|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
56350834|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56350835|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56350836|NCT00223717|Urological Agents|urological agents|mesh-ancestor
56350837|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56350838|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56350839|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56350840|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56350841|NCT00223717|Diuretics|diuretics|mesh-ancestor
56350842|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
56350843|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56350844|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350845|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
56350846|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
56350847|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56350848|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56350849|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56350850|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
56350851|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350852|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56170750|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
56350853|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56350854|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56350855|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56350856|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56350857|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56350858|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56350859|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
56350860|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56350861|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56350862|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56350863|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
56350864|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56350865|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56350868|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56350869|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56350870|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56350871|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56350872|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
56350873|NCT00223717|Coagulants|coagulants|mesh-ancestor
56350874|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56350875|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56350876|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
56350877|NCT00061919|Thalidomide|thalidomide|mesh-list
56350878|NCT00061919|Carboplatin|carboplatin|mesh-list
56651165|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651166|NCT02640846|Simendan|simendan|mesh-list
56651167|NCT02640846|Milrinone|milrinone|mesh-list
56651168|NCT02640846|Norepinephrine|norepinephrine|mesh-list
56651169|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56350880|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
56350881|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350882|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56350883|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56350884|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56350885|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350886|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350887|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350888|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
56350889|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350890|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
56350891|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56350892|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350893|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56350894|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56350895|NCT00061919|Growth Substances|growth substances|mesh-ancestor
56350896|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
56350897|NCT00085527|Romidepsin|romidepsin|mesh-list
56350898|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56350899|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350900|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
56350901|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350902|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
56350903|NCT00224068|Hematinics|hematinics|mesh-ancestor
56350904|NCT00224146|Oxybutynin|oxybutynin|mesh-list
56350905|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
56350906|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
56350907|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350908|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350909|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56350910|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56350911|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
56350912|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350913|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350914|NCT00224146|Urological Agents|urological agents|mesh-ancestor
56350915|NCT00061997|Inositol|inositol|mesh-list
56350916|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
56350917|NCT00061997|Vitamins|vitamins|mesh-ancestor
56350918|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
56350919|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350920|NCT00224185|Dimercaprol|dimercaprol|mesh-list
56350921|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
56350922|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
56170753|NCT01839240|Cytarabine|cytarabine|mesh-list
56350923|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350925|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
56350926|NCT00062036|Fludarabine|fludarabine|mesh-list
56350927|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
56350928|NCT00062036|Interleukin-2|interleukin-2|mesh-list
56350929|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
56350930|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350931|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
56350932|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350933|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350934|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56350935|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
56350936|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350937|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350938|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56350939|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56350940|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
56350942|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56350943|NCT00062036|Analgesics|analgesics|mesh-ancestor
56350944|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
56350945|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350946|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56350947|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56651170|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56651171|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
56651172|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651173|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214134|NCT01611077|Candesartan|candesartan|mesh-list
56350948|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
56350949|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350950|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56350951|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56350952|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56350953|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56350954|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350955|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350956|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350957|NCT00224302|Analgesics|analgesics|mesh-ancestor
56350958|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
56350959|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350960|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
56350961|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56350962|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
56350963|NCT00062075|Romidepsin|romidepsin|mesh-list
56350964|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56350965|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350966|NCT00224419|Nicotine|nicotine|mesh-list
56350967|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56350968|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
56350969|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350970|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350971|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56350972|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56350973|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
56350974|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350975|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350976|NCT00224458|Efavirenz|efavirenz|mesh-list
56350977|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56350978|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56350979|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56350981|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350982|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
56350983|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56350984|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56350985|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56350986|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56350987|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56350988|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56350989|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56350990|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56350991|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56350992|NCT00062114|Rituximab|rituximab|mesh-list
56350993|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56350994|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350995|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
56350996|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56350997|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350998|NCT00095043|Gaboxadol|gaboxadol|mesh-list
56350999|NCT00095043|Analgesics|analgesics|mesh-ancestor
56351000|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
56351001|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351002|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351004|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
56351005|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
56351006|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351007|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351008|NCT00095082|Insulin|insulin|mesh-list
56351009|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56351010|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
56351011|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
56351012|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
56651174|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651175|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
56351013|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351014|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351015|NCT00062231|Amoxicillin|amoxicillin|mesh-list
56351020|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56351021|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56351022|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56351023|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351024|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56351025|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56351026|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351027|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351028|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351029|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56351030|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
56351031|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56351032|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351033|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56351034|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56351035|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56351036|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56351037|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56351038|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56351039|NCT00224692|Ketamine|ketamine|mesh-list
56351040|NCT00224692|Analgesics|analgesics|mesh-ancestor
56351041|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
56351042|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351043|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351044|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56351045|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56351046|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
56351047|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
56351048|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351049|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56351050|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56351051|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351052|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351053|NCT00224809|Aspirin|aspirin|mesh-list
56351054|NCT00224809|Spironolactone|spironolactone|mesh-list
56351055|NCT00224809|Clopidogrel|clopidogrel|mesh-list
56351056|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56351057|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56351058|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56351059|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56351060|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56351061|NCT00224809|Analgesics|analgesics|mesh-ancestor
56351062|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
56170762|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351063|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351064|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351065|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56351066|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56351067|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56351068|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56351069|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351070|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56351071|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56351072|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
56351073|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56351074|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56351075|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56351077|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351078|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56351079|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
56351080|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56351081|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56351082|NCT00224809|Diuretics|diuretics|mesh-ancestor
56351083|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
56651176|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
56547635|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
56351084|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
56351088|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351089|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56351090|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
56351091|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351092|NCT00062270|Antiviral Agents|antiviral agents|mesh-ancestor
56351093|NCT00062270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351094|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351095|NCT00062270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351096|NCT00062270|Immunologic Factors|immunologic factors|mesh-ancestor
56351097|NCT00062270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351098|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
56351099|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
56351100|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
56351101|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56351102|NCT00413023|Casopitant|casopitant|mesh-list
56351103|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
56351104|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
56351105|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351106|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351107|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56351108|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56351109|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351110|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351111|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
56351112|NCT00095277|Hematinics|hematinics|mesh-ancestor
56351113|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
56351114|NCT00413101|Hematinics|hematinics|mesh-ancestor
56351115|NCT00413179|Metformin|metformin|mesh-list
56351116|NCT00413179|Clomiphene|clomiphene|mesh-list
56351117|NCT00413179|Enclomiphene|enclomiphene|mesh-list
56351118|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
56351119|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351120|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351121|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56351122|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
56351123|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972967|NCT05688098|Amlodipine|amlodipine|mesh-list
56351124|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56351125|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
56351126|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56351127|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56351128|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56351129|NCT00413257|Nefopam|nefopam|mesh-list
56351130|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56351131|NCT00413257|Analgesics|analgesics|mesh-ancestor
56351132|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
56351133|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351134|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351135|NCT00095316|Caspofungin|caspofungin|mesh-list
56351136|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
56351137|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351138|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351139|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351141|NCT00225043|Epinephrine|epinephrine|mesh-list
56351142|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
56351143|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56351144|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56351145|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
56351146|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351147|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351148|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351149|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56351150|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56351151|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
56351152|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351153|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56351154|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
56351155|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
56351156|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
56351157|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56351158|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56351159|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
56651177|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651178|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56651179|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55979978|NCT00354627|Etravirine|etravirine|mesh-list
56351163|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351164|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351165|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351166|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
56351167|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56351168|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351169|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351170|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
56351171|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
56351172|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351173|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
56351174|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
56351175|NCT00225160|Vitamins|vitamins|mesh-ancestor
56351176|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
56351177|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351178|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
56351179|NCT00225238|Esomeprazole|esomeprazole|mesh-list
56351180|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56351181|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56351182|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56351183|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351184|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351185|NCT00062426|Leucovorin|leucovorin|mesh-list
56351186|NCT00062426|Bevacizumab|bevacizumab|mesh-list
56351187|NCT00062426|Fluorouracil|fluorouracil|mesh-list
56351188|NCT00062426|Capecitabine|capecitabine|mesh-list
56351189|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
56351190|NCT00062426|Calcium|calcium|mesh-list
56351191|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
56351192|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56351193|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351194|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56351195|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56351196|NCT00062426|Growth Substances|growth substances|mesh-ancestor
56351197|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351198|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
56351199|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56351200|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
56351201|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351202|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56351203|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351204|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
56351205|NCT00062426|Antidotes|antidotes|mesh-ancestor
56351206|NCT00062426|Protective Agents|protective agents|mesh-ancestor
56351207|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
56351208|NCT00062426|Vitamins|vitamins|mesh-ancestor
56351209|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
56351210|NCT00095433|Ranibizumab|ranibizumab|mesh-list
56351211|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56351212|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56351213|NCT00095433|Growth Substances|growth substances|mesh-ancestor
56351214|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351216|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351217|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
56351218|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351219|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351220|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56351221|NCT00225433|Ganirelix|ganirelix|mesh-list
56351222|NCT00225433|Hormones|hormones|mesh-ancestor
56351223|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56351224|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351225|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
56351226|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56351227|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351228|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351229|NCT02962258|Amlodipine|amlodipine|mesh-list
56351230|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56351231|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56351232|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56121094|NCT01793688|Sulbactam|sulbactam|mesh-list
56651180|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
56351233|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351234|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351236|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351237|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
56351238|NCT02962258|Diuretics|diuretics|mesh-ancestor
56351239|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
56351240|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56351241|NCT00225511|Milnacipran|milnacipran|mesh-list
56351242|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56351243|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
56351244|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56351245|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56351246|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351247|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351248|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351249|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351250|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56351251|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
56351252|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351253|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56351254|NCT00225511|Analgesics|analgesics|mesh-ancestor
56351255|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
56351256|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351257|NCT00095511|Aripiprazole|aripiprazole|mesh-list
56351258|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
56351259|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351260|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56351261|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56351262|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351263|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351264|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
56351265|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
56351266|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351267|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351268|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56351269|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56351270|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
56351271|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56351272|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56351273|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56351274|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56351275|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56351276|NCT00225589|Calcium|calcium|mesh-list
56351277|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56351278|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351279|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56351280|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56351282|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351283|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56351284|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56351285|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351286|NCT02967887|Fluorouracil|fluorouracil|mesh-list
56351287|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351288|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
56351289|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351290|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56351291|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351292|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
56351293|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351295|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56351296|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56351297|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56351298|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351299|NCT00225706|Ibuprofen|ibuprofen|mesh-list
56351300|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56351301|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56351302|NCT00225706|Analgesics|analgesics|mesh-ancestor
56351303|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
56351304|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651181|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56651182|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56351305|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351306|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56351309|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351310|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351312|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351313|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56351314|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351315|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351316|NCT00225862|Ropinirole|ropinirole|mesh-list
56351317|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56351318|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56351319|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
56351320|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
56351321|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351322|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351323|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351324|NCT00095706|Bevacizumab|bevacizumab|mesh-list
56351325|NCT00095706|Trastuzumab|trastuzumab|mesh-list
56351326|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56351327|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351328|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56351329|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56351330|NCT00095706|Growth Substances|growth substances|mesh-ancestor
56351331|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351332|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
56351333|NCT00225901|Mitogens|mitogens|mesh-list
56351334|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
56351335|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351336|NCT00225979|Octreotide|octreotide|mesh-list
56351337|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56351338|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56351339|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351340|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
56351341|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56351342|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
56351343|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56351344|NCT00095745|Aripiprazole|aripiprazole|mesh-list
56351345|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
56351346|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351347|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56351348|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56351349|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351350|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351351|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
56351353|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351354|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351355|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56351356|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56351358|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56351359|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56351360|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56351361|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56351362|NCT00226096|Metoprolol|metoprolol|mesh-list
56351363|NCT00226096|Clonidine|clonidine|mesh-list
56351364|NCT00226096|Nitroprusside|nitroprusside|mesh-list
56351365|NCT00226096|Hydralazine|hydralazine|mesh-list
56351366|NCT00226096|Labetalol|labetalol|mesh-list
56351367|NCT00226096|Nicardipine|nicardipine|mesh-list
56351368|NCT00226096|Phentolamine|phentolamine|mesh-list
56351369|NCT00226096|Urapidil|urapidil|mesh-list
56351370|NCT00226096|Enalaprilat|enalaprilat|mesh-list
56351371|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
56351372|NCT00226096|Esmolol|esmolol|mesh-list
56351373|NCT00226096|Glycerol|glycerol|mesh-list
56351374|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56351375|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56351376|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
56351377|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
56351378|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351379|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351380|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56351381|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56651183|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651184|NCT02640846|Protective Agents|protective agents|mesh-ancestor
56651185|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56651186|NCT02644044|Methotrexate|methotrexate|mesh-list
56214147|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
56351382|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56351383|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
56351384|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351387|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
56351388|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56351389|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56351390|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56351391|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
56351392|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56351393|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56351394|NCT00226096|Protective Agents|protective agents|mesh-ancestor
56351395|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
56351396|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56351397|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56351398|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56351399|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351400|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56351401|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56351402|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
56351403|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56351404|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
56351405|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351406|NCT00226135|Lamotrigine|lamotrigine|mesh-list
56351407|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351408|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351409|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56351410|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351411|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351412|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
56351413|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56351414|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351415|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56351416|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56351417|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56351418|NCT00400374|Celecoxib|celecoxib|mesh-list
56351419|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56351420|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351421|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55973252|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351422|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351423|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351424|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56351426|NCT00400374|Analgesics|analgesics|mesh-ancestor
56351427|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
56351428|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351429|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351430|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56351431|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56351432|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56351433|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56351434|NCT00226330|Pioglitazone|pioglitazone|mesh-list
56351435|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351436|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351437|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
56351438|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351439|NCT00226408|Interferons|interferons|mesh-list
56351440|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
56351441|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
56351442|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351443|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
56351444|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351445|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
56351446|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351447|NCT00226447|Interferons|interferons|mesh-list
56351448|NCT00226447|Lamivudine|lamivudine|mesh-list
56651187|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56351449|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351450|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
56351451|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351452|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56351453|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56351454|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351455|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351456|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56351470|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
56351471|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351472|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351473|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56351474|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56351475|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56351476|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351477|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
56351479|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
56351480|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351481|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56351482|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56351483|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351484|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351485|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
56351486|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
56351487|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351488|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351489|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56351490|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56351491|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
56351492|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56351493|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56351494|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56351495|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56351496|NCT00226564|Alfentanil|alfentanil|mesh-list
56351497|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56351498|NCT00226564|Narcotics|narcotics|mesh-ancestor
56351499|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351500|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351501|NCT00226564|Analgesics|analgesics|mesh-ancestor
56351502|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
56351503|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351504|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56351505|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
56351506|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
56351507|NCT00062699|Calcitriol|calcitriol|mesh-list
56351508|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56351509|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351510|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56351511|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351512|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351513|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56351514|NCT00062699|Vitamins|vitamins|mesh-ancestor
56351515|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
56351516|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56351517|NCT00226798|Capecitabine|capecitabine|mesh-list
56351518|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56351519|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
56351524|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56351525|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56351526|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
56351527|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351528|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351529|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351531|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56351532|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
56351533|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
56351534|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351535|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351536|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56351537|NCT00226837|Analgesics|analgesics|mesh-ancestor
56351538|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
56651188|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
56651189|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56651190|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351539|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351540|NCT00226915|Paclitaxel|paclitaxel|mesh-list
56351541|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56351542|NCT00226915|Carboplatin|carboplatin|mesh-list
56351543|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56351544|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351545|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
56351546|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
56351547|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
56351548|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351549|NCT00095862|Interferons|interferons|mesh-list
56351550|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
56351551|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
56351552|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351553|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
56351554|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351555|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56351556|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56351557|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
56351558|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351559|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351560|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56351561|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
56351562|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351563|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
56351564|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56351565|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351566|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56351567|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351568|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56351569|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351570|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351571|NCT00095901|Capecitabine|capecitabine|mesh-list
56351572|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56351573|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
56351574|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351576|NCT00227110|Pioglitazone|pioglitazone|mesh-list
56351577|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351578|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351579|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
56351580|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351581|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56351582|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
56351583|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351584|NCT00096057|Antibodies|antibodies|mesh-list
56351585|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56351586|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
56351587|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351588|NCT00227461|Levetiracetam|levetiracetam|mesh-list
56351589|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
56351590|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
56351591|NCT00227500|Pravastatin|pravastatin|mesh-list
56351595|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351596|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56351597|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56351598|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351599|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
56351600|NCT00096096|Tacrolimus|tacrolimus|mesh-list
56351601|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351602|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
56351603|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351604|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56351605|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351606|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351607|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56351608|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351609|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56351610|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
56651191|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56651192|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
56351611|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56351612|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351613|NCT04721899|Vitamin D|vitamin d|mesh-list
56351614|NCT04721899|Vitamins|vitamins|mesh-ancestor
56351615|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
56351616|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351617|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56351618|NCT00062972|Donepezil|donepezil|mesh-list
56351619|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56351620|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351621|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351622|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
56351623|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351624|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351625|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
56351626|NCT00227656|Interferons|interferons|mesh-list
56351627|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
56351628|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
56351629|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56351630|NCT00227656|Capecitabine|capecitabine|mesh-list
56351631|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56351632|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
56351633|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351634|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351636|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351637|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
56351638|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351639|NCT00227695|Rituximab|rituximab|mesh-list
56351640|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56351641|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351642|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
56351643|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351644|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56351645|NCT00227734|Capecitabine|capecitabine|mesh-list
56351646|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
56351647|NCT00227734|Cetuximab|cetuximab|mesh-list
56351648|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56351649|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
56351650|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351651|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351652|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56351653|NCT00063011|Calcium|calcium|mesh-list
56351654|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56351655|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351656|NCT00227773|Octreotide|octreotide|mesh-list
56351657|NCT00227773|Hormones|hormones|mesh-list
56351658|NCT00227773|Somatostatin|somatostatin|mesh-list
56351659|NCT00227773|Mitogens|mitogens|mesh-list
56351660|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56351661|NCT00227773|Vatalanib|vatalanib|mesh-list
56351662|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56351663|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351664|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
56351665|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351667|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56351668|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351669|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56351671|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56351672|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
56351673|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351674|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56351675|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56351676|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351677|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351678|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
56351679|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351680|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351681|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56351682|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56351683|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351684|NCT00096291|Paclitaxel|paclitaxel|mesh-list
56651193|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651194|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651195|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
56651196|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651197|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56351685|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56351686|NCT00096291|Doxorubicin|doxorubicin|mesh-list
56351687|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56351688|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56351689|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351690|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
56351691|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
56351692|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
56351693|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351694|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56170797|NCT01834248|Poly I-C|poly i-c|mesh-list
56351695|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56351697|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351698|NCT02967302|Triamcinolone|triamcinolone|mesh-list
56351699|NCT02967302|Morphine|morphine|mesh-list
56351700|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56351701|NCT02967302|Narcotics|narcotics|mesh-ancestor
56351702|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351703|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351704|NCT02967302|Analgesics|analgesics|mesh-ancestor
56351705|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
56351706|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351707|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56351708|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
56351709|NCT02967302|Hormones|hormones|mesh-ancestor
56351710|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56351711|NCT00096330|Folic Acid|folic acid|mesh-list
56351712|NCT00096330|Hematinics|hematinics|mesh-ancestor
56351713|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
56351714|NCT00096330|Vitamins|vitamins|mesh-ancestor
56351715|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
56351716|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351717|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
56351718|NCT02962492|Exenatide|exenatide|mesh-list
56351719|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56351720|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351721|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351722|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351723|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55973547|NCT00737737|Morphine|morphine|mesh-list
56351724|NCT02962492|Incretins|incretins|mesh-ancestor
56351725|NCT02962492|Hormones|hormones|mesh-ancestor
55991314|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351726|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56351728|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56351729|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
56351730|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56351731|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351732|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56351733|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351734|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56351735|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56351736|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56351737|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
56351742|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
56351743|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56351744|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351745|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56351746|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56351747|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351748|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351749|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
56351750|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351751|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
56651198|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56651199|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
55980547|NCT05446623|Analgesics|analgesics|mesh-ancestor
56351752|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
56351753|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351754|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
56351755|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56351756|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
56351757|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351758|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
56351759|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
56351760|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56351761|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351762|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351763|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
56351764|NCT00063089|Antibodies|antibodies|mesh-list
56351765|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
56351766|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56351767|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56351768|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
56170809|NCT01834248|Laxatives|laxatives|mesh-ancestor
56351769|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351770|NCT00228163|Teriflunomide|teriflunomide|mesh-list
56351771|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56351772|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56351773|NCT00228163|Analgesics|analgesics|mesh-ancestor
56351774|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
56351775|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351776|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351777|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56351778|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56351779|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351780|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
56351781|NCT00063128|Insulin|insulin|mesh-list
56351782|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56351783|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351784|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351785|NCT00075465|Docetaxel|docetaxel|mesh-list
56351786|NCT00075465|Epirubicin|epirubicin|mesh-list
56351787|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351788|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
56351789|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
56351790|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
56351791|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351792|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56351793|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56351794|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56351795|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351796|NCT00228319|Vitamins|vitamins|mesh-list
56351797|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
56351798|NCT00228319|Vitamin E|vitamin e|mesh-list
56351799|NCT00228319|Vitamin A|vitamin a|mesh-list
56351800|NCT00228319|Carboplatin|carboplatin|mesh-list
56351802|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351803|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351804|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
56351805|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351806|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
56351807|NCT00228319|Protective Agents|protective agents|mesh-ancestor
56351808|NCT00096525|Lenalidomide|lenalidomide|mesh-list
56351809|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
56351810|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351811|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56351812|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56351817|NCT00228358|Interleukin-2|interleukin-2|mesh-list
56351818|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
56351819|NCT00228358|Immunotoxins|immunotoxins|mesh-list
56351820|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351821|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
56351822|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351823|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56351824|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56351825|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
56351826|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351827|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351828|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56651200|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651201|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56651202|NCT00652860|Doxorubicin|doxorubicin|mesh-list
56651203|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56351829|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56351830|NCT00228358|Analgesics|analgesics|mesh-ancestor
56351831|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
56351832|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351833|NCT00228397|Sirolimus|sirolimus|mesh-list
56351834|NCT00228397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56351835|NCT00228397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351836|NCT00228397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56351837|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351838|NCT00228397|Antifungal Agents|antifungal agents|mesh-ancestor
56351839|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351840|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
56351841|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351842|NCT00075543|Docetaxel|docetaxel|mesh-list
56351843|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
56351844|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351845|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
56351846|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
56351847|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
56351848|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351849|NCT00228475|Budesonide|budesonide|mesh-list
56351850|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56351851|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56351852|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
56351853|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351854|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351855|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56351856|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
56351857|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
56351858|NCT00228475|Hormones|hormones|mesh-ancestor
56351859|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56351860|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56351861|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56351862|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56351863|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
56351864|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351865|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56351866|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56351867|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351868|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
56351869|NCT00228592|Antibodies|antibodies|mesh-list
56351870|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
56351871|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56351872|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56351873|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
56351874|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351875|NCT00075621|Melphalan|melphalan|mesh-list
56351876|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
56351877|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351878|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56351879|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
56351880|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351881|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351882|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56351883|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351885|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56351888|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351890|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
56351891|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
56351892|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56351893|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351894|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351895|NCT00228982|Vancomycin|vancomycin|mesh-list
56351896|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
56351897|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56351898|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56351899|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351900|NCT00229060|Doripenem|doripenem|mesh-list
56351901|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56651204|NCT00652860|Ifosfamide|ifosfamide|mesh-list
56651205|NCT00652860|Molgramostim|molgramostim|mesh-list
56651206|NCT00652860|Mitomycins|mitomycins|mesh-list
56651207|NCT00652860|Mitomycin|mitomycin|mesh-list
56651208|NCT00652860|Sargramostim|sargramostim|mesh-list
56651209|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351902|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351903|NCT00229138|Tacrolimus|tacrolimus|mesh-list
56351904|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56351905|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
56351906|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351907|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56351908|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351909|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351910|NCT00063323|Bupropion|bupropion|mesh-list
56351911|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56351912|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
56351913|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351914|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56351915|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56351916|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351917|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351918|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
56170813|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56351919|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351920|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351921|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56351922|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56351923|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351924|NCT00229216|Tinidazole|tinidazole|mesh-list
56351925|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
56351926|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351927|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56351928|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351929|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56351930|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56351931|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56351932|NCT02967653|Atorvastatin|atorvastatin|mesh-list
56351933|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56351934|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56351935|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
56351936|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351937|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56351938|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56351939|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351940|NCT00229333|Citalopram|citalopram|mesh-list
56351941|NCT00229333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56351942|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56351943|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351944|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351945|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351946|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
56351947|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351948|NCT00229333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56351949|NCT00229333|Antidepressive Agents|antidepressive agents|mesh-ancestor
55973777|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
56351950|NCT00229333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351951|NCT00229450|Estrogens|estrogens|mesh-list
56351953|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56351954|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351955|NCT00229528|Paroxetine|paroxetine|mesh-list
56351956|NCT00229528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56351959|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351960|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56351961|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
56351962|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351963|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56351964|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
56351965|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56651210|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56651211|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56214167|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
56351966|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56351967|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56351968|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351969|NCT00075699|Vincristine|vincristine|mesh-list
56351970|NCT00075699|Vinorelbine|vinorelbine|mesh-list
56351972|NCT00075699|Mitomycin|mitomycin|mesh-list
56351973|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351974|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56351975|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
56351976|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
56351977|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
56351978|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351979|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56351980|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
56351981|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56351982|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56351983|NCT00229567|Lidocaine|lidocaine|mesh-list
56351984|NCT00229567|Ketamine|ketamine|mesh-list
56351985|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
56351986|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
56351987|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56351988|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351989|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
56351990|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56351991|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56351992|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56351993|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56351994|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351995|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351996|NCT00229567|Analgesics|analgesics|mesh-ancestor
56351997|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56351998|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56351999|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
56352000|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56352001|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56352002|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352003|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56352004|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
56352005|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352006|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56352007|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56352008|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352009|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352010|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
56352011|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56352012|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352013|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56352014|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56352015|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352016|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352017|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352018|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56352019|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56352020|NCT00229684|Pioglitazone|pioglitazone|mesh-list
56352021|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56352022|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352023|NCT00096720|Levodopa|levodopa|mesh-list
56352024|NCT00096720|Pramipexole|pramipexole|mesh-list
56352025|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56352026|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56352027|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
56352033|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
56352034|NCT00413608|Clopidogrel|clopidogrel|mesh-list
56352035|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56352036|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56352037|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56352038|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56352039|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
56651212|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56651213|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352040|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352041|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352042|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352043|NCT00229918|Triamcinolone|triamcinolone|mesh-list
56352044|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56352045|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56352046|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56352047|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352048|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
56352049|NCT00229918|Hormones|hormones|mesh-ancestor
56352050|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352051|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352052|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352053|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
56352054|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352055|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352056|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56170816|NCT01836432|Leucovorin|leucovorin|mesh-list
56352057|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56352058|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56352059|NCT00229996|Leuprolide|leuprolide|mesh-list
56352060|NCT00229996|Norethindrone|norethindrone|mesh-list
56352061|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
56352062|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
56352063|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
56352064|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56352065|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
56352066|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56352067|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352068|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56352069|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352070|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56352071|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56352072|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56352073|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56352074|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
56352075|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
56352076|NCT00230035|Rituximab|rituximab|mesh-list
56352077|NCT00230035|Methotrexate|methotrexate|mesh-list
56352078|NCT00230035|Azathioprine|azathioprine|mesh-list
56352079|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
56352080|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56352081|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56352082|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
56352083|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56352084|NCT00230035|Leflunomide|leflunomide|mesh-list
56352085|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
56352086|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56352087|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56352088|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352089|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
56352090|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352091|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56352092|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56352093|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
56352094|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56352095|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56352096|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
56352098|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
56352100|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56352101|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56352102|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56352103|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56352104|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
56352105|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56352106|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352107|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352108|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
56352109|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
56352110|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352111|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56352112|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
56651214|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352113|NCT00230035|Hormones|hormones|mesh-ancestor
56352114|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352115|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56352116|NCT00230035|Protective Agents|protective agents|mesh-ancestor
56352117|NCT00063401|Paclitaxel|paclitaxel|mesh-list
56352118|NCT00063401|Carboplatin|carboplatin|mesh-list
56352119|NCT00063401|Cetuximab|cetuximab|mesh-list
56352120|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56352121|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352122|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
56352123|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
56352124|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
56352125|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352126|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56352127|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
56352128|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352129|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56352130|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
56352131|NCT00230464|Vildagliptin|vildagliptin|mesh-list
56352132|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56352133|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352134|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56352135|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
56352136|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352137|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352138|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
56352139|NCT00096915|Hematinics|hematinics|mesh-ancestor
56352140|NCT00230503|Adefovir|adefovir|mesh-list
56352141|NCT00230503|Pradefovir|pradefovir|mesh-list
56352142|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
56352143|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352144|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56352145|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56352146|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352147|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352148|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56352149|NCT00424723|Pemetrexed|pemetrexed|mesh-list
56352150|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352151|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352152|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352153|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56352154|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56352155|NCT00230542|Carboplatin|carboplatin|mesh-list
56352156|NCT00230542|Pemetrexed|pemetrexed|mesh-list
56352157|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352158|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352159|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352160|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56352161|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56352162|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
56352163|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56352164|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352165|NCT00097032|Risperidone|risperidone|mesh-list
56352166|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56352167|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56352168|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
56352169|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352170|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352174|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352175|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352176|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56352177|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
56352178|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
56352179|NCT02962336|Amlodipine|amlodipine|mesh-list
56352180|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56352181|NCT02962336|Olmesartan|olmesartan|mesh-list
56352182|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56352183|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56352184|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56352185|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56352186|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352187|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56651215|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56651216|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
56651217|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
56651218|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651219|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56352188|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352189|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
56352190|NCT02962336|Diuretics|diuretics|mesh-ancestor
56352191|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
56352192|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56352193|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56352194|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56352195|NCT00075738|Leucovorin|leucovorin|mesh-list
56352196|NCT00075738|Fluorouracil|fluorouracil|mesh-list
56352197|NCT00075738|Irinotecan|irinotecan|mesh-list
56352198|NCT00075738|Calcium|calcium|mesh-list
56352199|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
56352200|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352201|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56352202|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352203|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
56352204|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352205|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56352206|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352207|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
56352208|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56352209|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56352210|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352211|NCT00075738|Antidotes|antidotes|mesh-ancestor
56352212|NCT00075738|Protective Agents|protective agents|mesh-ancestor
56352213|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
56352214|NCT00075738|Vitamins|vitamins|mesh-ancestor
56352215|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
56352216|NCT00230698|Topiramate|topiramate|mesh-list
56352217|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
56352218|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56352219|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352220|NCT00230776|Pregabalin|pregabalin|mesh-list
56352221|NCT00230776|Analgesics|analgesics|mesh-ancestor
56352222|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
56352223|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352224|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352225|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
56352226|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56352227|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56352228|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352229|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56352230|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56352231|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56352232|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352233|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352234|NCT00075777|Valproic Acid|valproic acid|mesh-list
56352235|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
56352236|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352237|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352238|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
56352239|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352240|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352241|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
56352242|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56352243|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352244|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352245|NCT02967614|Timolol|timolol|mesh-list
56352249|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56352250|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
56352251|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352252|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352253|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352254|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56352255|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56651220|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
56651221|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56651222|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651223|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651224|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651225|NCT02536014|Analgesics|analgesics|mesh-ancestor
56651226|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
56651227|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651228|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56651229|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56651230|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56651231|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
56352256|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56352257|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56352258|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56352259|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56352260|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352261|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56352262|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56352264|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352265|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352266|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56352267|NCT00097071|Insulin|insulin|mesh-list
56352268|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56352269|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
56352270|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
56352271|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56352272|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352273|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
56352274|NCT02967380|Antidotes|antidotes|mesh-ancestor
56352275|NCT02967380|Protective Agents|protective agents|mesh-ancestor
56352276|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352277|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
56352278|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
56352279|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352280|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56352281|NCT00075855|Testosterone|testosterone|mesh-list
56352282|NCT00075855|Androgens|androgens|mesh-ancestor
56352283|NCT00075855|Hormones|hormones|mesh-ancestor
56352284|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352285|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352286|NCT00063596|Vitamin A|vitamin a|mesh-list
56352287|NCT00063596|Vitamins|vitamins|mesh-ancestor
56352288|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
56352289|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352290|NCT00231244|Sirolimus|sirolimus|mesh-list
56352291|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56352292|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352293|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56352294|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352295|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
56352296|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352297|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
56352298|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352299|NCT00231322|Praziquantel|praziquantel|mesh-list
56352300|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
56352301|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56352302|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352303|NCT00231517|Morphine|morphine|mesh-list
56352304|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56352305|NCT00231517|Narcotics|narcotics|mesh-ancestor
56352306|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352307|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352308|NCT00231517|Analgesics|analgesics|mesh-ancestor
56651232|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651233|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352309|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
56352310|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352311|NCT00075894|Alanosine|alanosine|mesh-list
56352312|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56352313|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352314|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
56352315|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
56352316|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352317|NCT00231556|Topiramate|topiramate|mesh-list
56352318|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
56352319|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56352320|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352322|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
56352323|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56352324|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352326|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
56352327|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56352328|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352329|NCT00231673|Topiramate|topiramate|mesh-list
56352330|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
56352331|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56352332|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352333|NCT00097188|Rituximab|rituximab|mesh-list
56352334|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56352335|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352336|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
56352337|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352338|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56352339|NCT00231829|Celecoxib|celecoxib|mesh-list
56352340|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56352341|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56352342|NCT00231829|Analgesics|analgesics|mesh-ancestor
56352343|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
56352344|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352345|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352346|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352347|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56352348|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56352349|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56352350|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352351|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352352|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
56352353|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352354|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56352355|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56352356|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352357|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352358|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
56352359|NCT00063713|Bortezomib|bortezomib|mesh-list
56352360|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352361|NCT00232024|Tegaserod|tegaserod|mesh-list
56352362|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56352363|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
56352364|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352365|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352366|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352367|NCT00232063|Cyclosporine|cyclosporine|mesh-list
56352368|NCT00232063|Cyclosporins|cyclosporins|mesh-list
56352369|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352370|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352371|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352372|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
56352373|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352374|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
56352375|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352376|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
56352377|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56352378|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56352379|NCT00232102|Tegaserod|tegaserod|mesh-list
56352380|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56352381|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
56651234|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
56651235|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56651236|NCT02653014|Hormones|hormones|mesh-ancestor
56651237|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56651238|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352382|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352383|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352384|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352385|NCT00097227|Paclitaxel|paclitaxel|mesh-list
56352386|NCT00097227|Carboplatin|carboplatin|mesh-list
56352387|NCT00097227|Cetuximab|cetuximab|mesh-list
56170870|NCT01720290|Metformin|metformin|mesh-list
56352388|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56352389|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352390|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
56352391|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
56352392|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
56352393|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352394|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56352398|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56352399|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56352400|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352401|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352403|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56352404|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352406|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352407|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56352408|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
56352409|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352410|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56352411|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56352412|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352413|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352414|NCT00232492|Ketamine|ketamine|mesh-list
56352415|NCT00232492|Analgesics|analgesics|mesh-ancestor
56352416|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
56352417|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352418|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352419|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56352420|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56352421|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
56352422|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
56352423|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352424|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56352425|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56352426|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352427|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352428|NCT00075972|Nicotine|nicotine|mesh-list
56352429|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56352430|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
56352431|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352432|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352433|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56352434|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56352435|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
56352436|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352437|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352438|NCT00063869|Etanercept|etanercept|mesh-list
56352439|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56352440|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56352441|NCT00063869|Analgesics|analgesics|mesh-ancestor
56352442|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
56352443|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352444|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352445|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352446|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56352447|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56352448|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56651239|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
56651240|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56651241|NCT02653014|Diuretics|diuretics|mesh-ancestor
56651242|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
56352449|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
56352451|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
56352452|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56352453|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
56352454|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352455|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56352456|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
56352457|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
56352458|NCT00232531|Vitamins|vitamins|mesh-ancestor
56352459|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
56352460|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352461|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56352462|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
56352463|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352464|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56352465|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56352466|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352467|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352468|NCT00097266|Haloperidol|haloperidol|mesh-list
56352474|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55974296|NCT04682847|Hematinics|hematinics|mesh-ancestor
56352475|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352476|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352477|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
56352478|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
56352479|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352480|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352481|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56352482|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56352483|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
56352484|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56352485|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56352486|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56352487|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56352488|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
56352489|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
56352490|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352491|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56352492|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56352493|NCT00063947|Gemcitabine|gemcitabine|mesh-list
56352494|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56352495|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56352496|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
56352497|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352498|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352499|NCT00063947|Antiviral Agents|antiviral agents|mesh-ancestor
56352500|NCT00063947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352501|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352502|NCT00063947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352503|NCT00063947|Immunologic Factors|immunologic factors|mesh-ancestor
56352504|NCT00063947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352505|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56352507|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352508|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56352509|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
56352510|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352511|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352512|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56352513|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
56352514|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
56352515|NCT00232648|Hormones|hormones|mesh-ancestor
56352516|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352517|NCT00232687|Aripiprazole|aripiprazole|mesh-list
56352518|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
56352519|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352520|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56352521|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56122001|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56352522|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352523|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352524|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
56352525|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
56352526|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352527|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352528|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56352529|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56352530|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
56170877|NCT01721382|Incretins|incretins|mesh-ancestor
56352531|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56352533|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56352534|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56352535|NCT00232765|Sirolimus|sirolimus|mesh-list
56352536|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56352537|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352538|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56352541|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352542|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
56352543|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352544|NCT02958566|Acetaminophen|acetaminophen|mesh-list
56352545|NCT02958566|Ketorolac|ketorolac|mesh-list
56352546|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56352547|NCT02958566|Lidocaine|lidocaine|mesh-list
56352548|NCT02958566|Fentanyl|fentanyl|mesh-list
56352549|NCT02958566|Ketamine|ketamine|mesh-list
56352550|NCT02958566|Morphine|morphine|mesh-list
56352551|NCT02958566|Gabapentin|gabapentin|mesh-list
56352552|NCT02958566|Tramadol|tramadol|mesh-list
56352555|NCT02958566|Hydromorphone|hydromorphone|mesh-list
56352556|NCT02958566|Orphenadrine|orphenadrine|mesh-list
56352557|NCT02958566|Bupivacaine|bupivacaine|mesh-list
56352558|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
56352559|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
56352560|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352561|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352562|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
56352563|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352564|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56352565|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56352566|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56352567|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56352568|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352569|NCT02958566|Analgesics|analgesics|mesh-ancestor
56352570|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56352571|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56352572|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
56352573|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56352574|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56352575|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352576|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56352577|NCT02958566|Narcotics|narcotics|mesh-ancestor
56352578|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56352579|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56352580|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
56352581|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
56352582|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56352583|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56352584|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352585|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
56352586|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56352587|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352588|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56352589|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56352590|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352591|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
56352592|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
56352593|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56352594|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56352595|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56352596|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56352597|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
56352598|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
56352599|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56352600|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56352601|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
56352602|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
56651243|NCT00886613|Vaccines|vaccines|mesh-list
56651244|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
56214200|NCT01611506|Capecitabine|capecitabine|mesh-list
56352603|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56352604|NCT00097344|Toremifene|toremifene|mesh-list
56352605|NCT00097344|Letrozole|letrozole|mesh-list
56352606|NCT00097344|Hormones|hormones|mesh-list
56352607|NCT00097344|Atamestane|atamestane|mesh-list
56352608|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
56352609|NCT00097344|Estrogens|estrogens|mesh-list
56352610|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
56352612|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352613|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352614|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352615|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56352616|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56352617|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352619|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
56352620|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56352621|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56352622|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56352623|NCT00232882|Atenolol|atenolol|mesh-list
56352624|NCT00232882|Candesartan|candesartan|mesh-list
56352625|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
56352626|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56352627|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56352628|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56352629|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56352630|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352631|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56352632|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
56352633|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
56352634|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352635|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352636|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56352637|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56352638|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56352639|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
56352640|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352641|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56352642|NCT00232882|Diuretics|diuretics|mesh-ancestor
56352643|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
56352644|NCT00064064|Gemcitabine|gemcitabine|mesh-list
56352645|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56352646|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
56352647|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352648|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352649|NCT00064064|Antiviral Agents|antiviral agents|mesh-ancestor
56352650|NCT00064064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352651|NCT00064064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352652|NCT00064064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352653|NCT00064064|Immunologic Factors|immunologic factors|mesh-ancestor
56352654|NCT00064064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352655|NCT00413686|Gemcitabine|gemcitabine|mesh-list
56352656|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56352658|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352659|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352660|NCT00413686|Antiviral Agents|antiviral agents|mesh-ancestor
56352661|NCT00413686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352662|NCT00413686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352663|NCT00413686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352664|NCT00413686|Immunologic Factors|immunologic factors|mesh-ancestor
56352665|NCT00413686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352666|NCT00233038|Ethanol|ethanol|mesh-list
56352667|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56352668|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352669|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56352670|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352671|NCT00097383|Epirubicin|epirubicin|mesh-list
56352672|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56352673|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352674|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56651245|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651246|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56651247|NCT00653016|Norelgestromin|norelgestromin|mesh-list
56352675|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56352676|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352677|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352678|NCT00233155|Capsaicin|capsaicin|mesh-list
56352679|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
56352680|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
56352681|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
56352682|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352683|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352684|NCT00064142|Halofuginone|halofuginone|mesh-list
56352685|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352686|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
56352687|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56352688|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56352689|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352690|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56352693|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56352694|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56352695|NCT00064142|Growth Substances|growth substances|mesh-ancestor
56352696|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352697|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
56352698|NCT00064181|Leucovorin|leucovorin|mesh-list
56352699|NCT00064181|Celecoxib|celecoxib|mesh-list
56352700|NCT00064181|Fluorouracil|fluorouracil|mesh-list
56352701|NCT00064181|Capecitabine|capecitabine|mesh-list
56352702|NCT00064181|Irinotecan|irinotecan|mesh-list
56352703|NCT00064181|Calcium|calcium|mesh-list
55974518|NCT03480971|Tempol|tempol|mesh-list
56352704|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
56352705|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56352706|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352707|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
56352708|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352709|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56352710|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352711|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352712|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
56352713|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56352714|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56352715|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352716|NCT00064181|Antidotes|antidotes|mesh-ancestor
56352717|NCT00064181|Protective Agents|protective agents|mesh-ancestor
56352718|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
56352719|NCT00064181|Vitamins|vitamins|mesh-ancestor
56352720|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
56352721|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56352722|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56352723|NCT00064181|Analgesics|analgesics|mesh-ancestor
56352724|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
56352725|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352726|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352727|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56352728|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56352729|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56352730|NCT00233545|Miltefosine|miltefosine|mesh-list
56352731|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
56352732|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352733|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352734|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56352735|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56352736|NCT00233584|Budesonide|budesonide|mesh-list
56352737|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352738|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56352739|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
56352740|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56352741|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352742|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56352743|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
56352744|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
56352745|NCT00233584|Hormones|hormones|mesh-ancestor
56352746|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352747|NCT00233623|Leucovorin|leucovorin|mesh-list
56352748|NCT00233623|Fluorouracil|fluorouracil|mesh-list
56651248|NCT00653016|Estradiol|estradiol|mesh-list
56651249|NCT00653016|Estrogens|estrogens|mesh-ancestor
56651250|NCT00653016|Hormones|hormones|mesh-ancestor
56651251|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56651252|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651253|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56352749|NCT00233623|Irinotecan|irinotecan|mesh-list
56352750|NCT00233623|Gefitinib|gefitinib|mesh-list
56352751|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
56352752|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352753|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56352754|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352755|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352756|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
56352757|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352758|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56352759|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56352760|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352761|NCT00233623|Antidotes|antidotes|mesh-ancestor
56352762|NCT00233623|Protective Agents|protective agents|mesh-ancestor
56352763|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
56352764|NCT00233623|Vitamins|vitamins|mesh-ancestor
56352765|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
56352769|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
56352770|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352771|NCT00064220|Soblidotin|soblidotin|mesh-list
56352772|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352773|NCT00233779|Sirolimus|sirolimus|mesh-list
56352774|NCT00233779|Heparin|heparin|mesh-list
56352775|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56352776|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352777|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56352778|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352779|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
56352780|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352781|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
56352782|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352783|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
56352784|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56352785|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56352786|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352787|NCT00233818|Sirolimus|sirolimus|mesh-list
56352788|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56352789|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352790|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56352791|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352792|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
56352793|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352794|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
56352795|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352796|NCT00076206|Sirolimus|sirolimus|mesh-list
56352797|NCT00076206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56352798|NCT00076206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352799|NCT00076206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56352800|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352801|NCT00076206|Antifungal Agents|antifungal agents|mesh-ancestor
56352802|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352803|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
56352804|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352805|NCT00233896|Beclomethasone|beclomethasone|mesh-list
56352806|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352807|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
56352808|NCT00233896|Hormones|hormones|mesh-ancestor
56352809|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352810|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352811|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56352812|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
56352813|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56352814|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
56352815|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651254|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
56651255|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56651256|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56651257|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56352816|NCT00233935|Protective Agents|protective agents|mesh-ancestor
56352817|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352818|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56352819|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56352820|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352821|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56352822|NCT00234091|Ritonavir|ritonavir|mesh-list
56352823|NCT00234091|Lopinavir|lopinavir|mesh-list
56352824|NCT00234091|Nelfinavir|nelfinavir|mesh-list
56352825|NCT00234091|Lamivudine|lamivudine|mesh-list
56352826|NCT00234091|Zidovudine|zidovudine|mesh-list
56352827|NCT00234091|Nevirapine|nevirapine|mesh-list
56352828|NCT00234091|Abacavir|abacavir|mesh-list
56352829|NCT00234091|Efavirenz|efavirenz|mesh-list
56352830|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56352831|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56352832|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
56352833|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352834|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352835|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56352836|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56352837|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
56352838|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352839|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56352840|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56352848|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56352849|NCT04721704|Amoxicillin|amoxicillin|mesh-list
56352850|NCT04721704|Metronidazole|metronidazole|mesh-list
56352851|NCT04721704|Clarithromycin|clarithromycin|mesh-list
56352852|NCT04721704|Omeprazole|omeprazole|mesh-list
56352853|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55974667|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352854|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352855|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56352856|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56352857|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56352858|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56352859|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56352860|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352861|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352862|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56352863|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56352864|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56352865|NCT00076284|Aplaviroc|aplaviroc|mesh-list
56352866|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56352867|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56352868|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352869|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56352870|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56352871|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
56352872|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352873|NCT00234403|Fulvestrant|fulvestrant|mesh-list
56352874|NCT00234403|Gefitinib|gefitinib|mesh-list
56352875|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56352876|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352877|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56352878|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56352879|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
56352880|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352881|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352882|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56352883|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352884|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352885|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
56352886|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56352887|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56352888|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
56352889|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651258|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56651259|NCT00886379|Vitamin D|vitamin d|mesh-list
56651260|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
56651261|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
56651262|NCT00886379|Vitamins|vitamins|mesh-list
56651263|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
56651264|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651265|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56651266|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56352890|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352891|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56352892|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
56352893|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56352894|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56352895|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56352896|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
56352897|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352898|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352899|NCT00234442|Gefitinib|gefitinib|mesh-list
56352900|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352901|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56352902|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352903|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352904|NCT00076323|Primaquine|primaquine|mesh-list
56352906|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56352907|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56352908|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352909|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
56352910|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56352911|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56352912|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352913|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
56352914|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
56352915|NCT00234637|Memantine|memantine|mesh-list
56352916|NCT00234637|Rivastigmine|rivastigmine|mesh-list
56352917|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56352918|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56352919|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
56352920|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352921|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352922|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352923|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56352924|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56352925|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56352926|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352927|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
56352928|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56352929|NCT00234637|Protective Agents|protective agents|mesh-ancestor
56352930|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56352931|NCT00234676|Estrogens|estrogens|mesh-ancestor
56352933|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56352934|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352935|NCT00076362|Octreotide|octreotide|mesh-list
56352936|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56352937|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56352938|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352939|NCT00234871|Verapamil|verapamil|mesh-list
56352940|NCT00234871|Amlodipine|amlodipine|mesh-list
56352941|NCT00234871|Benazepril|benazepril|mesh-list
56352942|NCT00234871|Trandolapril|trandolapril|mesh-list
56352943|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56352944|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56352945|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56352946|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352947|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56352948|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352949|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
56651267|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
56651268|NCT00633581|Vitamins|vitamins|mesh-ancestor
56651269|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
56651270|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651271|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
56651272|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352950|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56352951|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56352952|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
56352953|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352954|NCT00234910|Ritonavir|ritonavir|mesh-list
56352955|NCT00234910|Lopinavir|lopinavir|mesh-list
56352956|NCT00234910|Tenofovir|tenofovir|mesh-list
56352957|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56352958|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56352959|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
56352960|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352961|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352962|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56352963|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56352964|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
56352965|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352966|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56352967|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56352968|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56352969|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56352970|NCT00234949|Cephalexin|cephalexin|mesh-list
56352971|NCT00234949|Cefdinir|cefdinir|mesh-list
56352972|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56352973|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352974|NCT00234988|Sibutramine|sibutramine|mesh-list
56352975|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
56352976|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352977|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
56352978|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56352979|NCT00400491|Vitamin D|vitamin d|mesh-list
56352980|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
56352981|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
56352985|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56352986|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56352988|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56352989|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56352990|NCT00235144|Sirolimus|sirolimus|mesh-list
56352991|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56352992|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56352993|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56352994|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352995|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
56352996|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56352997|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
56352998|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352999|NCT00400530|Alendronate|alendronate|mesh-list
56353000|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353001|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56353002|NCT00064610|Bortezomib|bortezomib|mesh-list
56353003|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353004|NCT00235222|Stavudine|stavudine|mesh-list
56353005|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
56353006|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353007|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56353008|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56353009|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353010|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
56353011|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353012|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56353013|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56353014|NCT00235261|Dexamethasone|dexamethasone|mesh-list
56353015|NCT00235261|Pregabalin|pregabalin|mesh-list
56353016|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353017|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
56353018|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
56353019|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651273|NCT00633581|Protective Agents|protective agents|mesh-ancestor
56651274|NCT02825147|Dexamethasone|dexamethasone|mesh-list
56651275|NCT02825147|Methotrexate|methotrexate|mesh-list
56651276|NCT02825147|Etoposide|etoposide|mesh-list
56651277|NCT02825147|Pegaspargase|pegaspargase|mesh-list
56651278|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353020|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353021|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353022|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
56353023|NCT00235261|Hormones|hormones|mesh-ancestor
56353024|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353025|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56353026|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353027|NCT00235261|Analgesics|analgesics|mesh-ancestor
56353028|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
56353029|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
56353030|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56353031|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56353032|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353033|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56353034|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56353035|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56353036|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353037|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56353038|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
56353039|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56353040|NCT00235300|Basiliximab|basiliximab|mesh-list
56353041|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
56353042|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353043|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353044|NCT00064649|Finasteride|finasteride|mesh-list
56353045|NCT00064649|Alfuzosin|alfuzosin|mesh-list
56353046|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56353047|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56353048|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353049|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353050|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
56353051|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353052|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353053|NCT00064649|Urological Agents|urological agents|mesh-ancestor
56353057|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
56353058|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353059|NCT00097734|Ertapenem|ertapenem|mesh-list
56353060|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353061|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353062|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
56353063|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353064|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353065|NCT00235651|Amphotericin B|amphotericin b|mesh-list
56353066|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56353067|NCT00235651|Amebicides|amebicides|mesh-ancestor
56353068|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56353069|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56353070|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353071|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353072|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
56353073|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
56353074|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56353075|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353076|NCT00064766|Doxycycline|doxycycline|mesh-list
56353077|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353078|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353079|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
56353080|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56353081|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56353083|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56353084|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56353085|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353086|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
56353087|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353088|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56651279|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
56651280|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
56651281|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651282|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651283|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56651284|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
56651285|NCT02825147|Hormones|hormones|mesh-ancestor
56214225|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353089|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56353090|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56353091|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
56353092|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353093|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353094|NCT00235885|Adalimumab|adalimumab|mesh-list
56353095|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353096|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56353097|NCT04728750|Pancrelipase|pancrelipase|mesh-list
56353098|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353099|NCT00235963|Simvastatin|simvastatin|mesh-list
56353100|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56353101|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56353102|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
56353103|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353104|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56353105|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56353106|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353107|NCT00236002|Alendronate|alendronate|mesh-list
56353108|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56353109|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353110|NCT00414037|Eszopiclone|eszopiclone|mesh-list
56353111|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56353112|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353113|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353114|NCT00236275|Telbivudine|telbivudine|mesh-list
56353115|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
56353116|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353117|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56353118|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353119|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353120|NCT00236353|Risperidone|risperidone|mesh-list
56353121|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56353122|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
56353123|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353124|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353125|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353126|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56353129|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56353130|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56353131|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
56353132|NCT00236392|Rabeprazole|rabeprazole|mesh-list
56353133|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56353134|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353135|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56353136|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353137|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353138|NCT00236431|Galantamine|galantamine|mesh-list
56353139|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56353140|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353141|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353142|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
56353143|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353144|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353145|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56353146|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
56353147|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353148|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
56353149|NCT00097929|Vorinostat|vorinostat|mesh-list
56353150|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214232|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353151|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56353152|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353153|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353154|NCT00236470|Risperidone|risperidone|mesh-list
56353155|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56353156|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
56353157|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353158|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353159|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353160|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56353161|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56353162|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353163|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56353164|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56353166|NCT00236509|Topiramate|topiramate|mesh-list
56353167|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
56353168|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353169|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353170|NCT02962141|Paclitaxel|paclitaxel|mesh-list
56353171|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56353172|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353173|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
56353174|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
56353175|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
56353176|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353177|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
56353178|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353179|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56353180|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
56353181|NCT00236548|Risperidone|risperidone|mesh-list
56353182|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56353183|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
56353184|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353185|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353186|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353187|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56353188|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56353189|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353190|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56353191|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56353192|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
56353193|NCT00236587|Risperidone|risperidone|mesh-list
56353194|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56353195|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
56353196|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353197|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353198|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353199|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56353200|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56353202|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56353203|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56353204|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
56353206|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
56353207|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353208|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353209|NCT00236665|Topiramate|topiramate|mesh-list
56353210|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
56353211|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353212|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353213|NCT00399282|Vitamin E|vitamin e|mesh-list
56353214|NCT00399282|Vitamins|vitamins|mesh-ancestor
56353215|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
56353216|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353217|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
56353218|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353219|NCT00399282|Protective Agents|protective agents|mesh-ancestor
56353220|NCT00236704|Topiramate|topiramate|mesh-list
56353221|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
56353222|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353223|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353224|NCT00236743|Topiramate|topiramate|mesh-list
56353225|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
56353226|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353227|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353228|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56651286|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56651287|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56651288|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651289|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56651290|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
56353229|NCT00236782|Norelgestromin|norelgestromin|mesh-list
56353230|NCT00236782|Estradiol|estradiol|mesh-list
56353231|NCT00236782|Estrogens|estrogens|mesh-ancestor
56353232|NCT00236782|Hormones|hormones|mesh-ancestor
56353233|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353234|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353235|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56353236|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
56353237|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56353238|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56353239|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56353240|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56353242|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353243|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353244|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
56353245|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353246|NCT00236821|Levofloxacin|levofloxacin|mesh-list
56353247|NCT00236821|Ofloxacin|ofloxacin|mesh-list
56353248|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56353249|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353250|NCT00236821|Renal Agents|renal agents|mesh-ancestor
56353251|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353252|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56353253|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56353254|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353255|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353256|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353257|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56353258|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56353259|NCT00236860|Topiramate|topiramate|mesh-list
56353260|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
56353261|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353262|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353263|NCT00065117|Leucovorin|leucovorin|mesh-list
56353264|NCT00065117|Fluorouracil|fluorouracil|mesh-list
56353265|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
56353266|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
56353267|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353268|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56353269|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353270|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353271|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
56353272|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353273|NCT00065117|Antidotes|antidotes|mesh-ancestor
56353274|NCT00065117|Protective Agents|protective agents|mesh-ancestor
56353275|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
56353276|NCT00065117|Vitamins|vitamins|mesh-ancestor
56353277|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
56353278|NCT00237016|Doxycycline|doxycycline|mesh-list
56353280|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353281|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
56353282|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56353283|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56353284|NCT00237133|Letrozole|letrozole|mesh-list
56353285|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353286|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56353287|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56353288|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353289|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353290|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56353291|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
56353292|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353293|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353294|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
56651291|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56651292|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56651293|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
56651294|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651295|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
56651296|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651297|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56651298|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56651299|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
56651300|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651301|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56651302|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56651303|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56651304|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56651305|NCT02825225|Anesthetics|anesthetics|mesh-list
56651306|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651307|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353295|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353296|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56353297|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353298|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353299|NCT00237211|Letrozole|letrozole|mesh-list
56353300|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353301|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56353302|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56353303|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353304|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353305|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56353306|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
56353307|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353308|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353309|NCT00098007|Everolimus|everolimus|mesh-list
56353310|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353311|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353312|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
56353313|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353314|NCT00237250|Vildagliptin|vildagliptin|mesh-list
56353315|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353316|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353317|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56353318|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
56353319|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353320|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353321|NCT00237289|Topiramate|topiramate|mesh-list
56353322|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
56353323|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353324|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353325|NCT00237328|Heparin|heparin|mesh-list
56353326|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
56353327|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56353328|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56353329|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353330|NCT00237367|Rabeprazole|rabeprazole|mesh-list
56353331|NCT00237367|Pantoprazole|pantoprazole|mesh-list
56353332|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56353333|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56651308|NCT00637949|Rofecoxib|rofecoxib|mesh-list
56651309|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
56651310|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56651311|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56651312|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651313|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651314|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56651315|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651316|NCT00637949|Analgesics|analgesics|mesh-ancestor
56651317|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
56651318|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651319|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651320|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651321|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651322|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56651323|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
56651324|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56651325|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
56651326|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56353334|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56353335|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353336|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353337|NCT00098046|Famciclovir|famciclovir|mesh-list
56353338|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
56353339|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353340|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56353341|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353342|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353343|NCT00065273|Olanzapine|olanzapine|mesh-list
56353344|NCT00065273|Risperidone|risperidone|mesh-list
56353345|NCT00065273|Clozapine|clozapine|mesh-list
56353346|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56353347|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
56353348|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353349|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353350|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353351|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56353352|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56353357|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
56353358|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
56353359|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353360|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353361|NCT00065273|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56353362|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56353363|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56353364|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
56353365|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
56353366|NCT00237445|Azithromycin|azithromycin|mesh-list
56353367|NCT00237445|Telithromycin|telithromycin|mesh-list
56353368|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353369|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353370|NCT00237484|Interferons|interferons|mesh-list
56353371|NCT00237484|Ribavirin|ribavirin|mesh-list
56353372|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
56353373|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
56353374|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56353375|NCT00237484|Infliximab|infliximab|mesh-list
56651327|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651328|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56214267|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
56353376|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353377|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
56353378|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353379|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
56353380|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353381|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
56353382|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353383|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56353384|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353385|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975195|NCT00659165|Insulin|insulin|mesh-list
56353387|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
56353388|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56353389|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353391|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
56353392|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353393|NCT00098124|Milnacipran|milnacipran|mesh-list
56353394|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
56353395|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56353396|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56353397|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56353398|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353399|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353400|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353401|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56353402|NCT00098124|Analgesics|analgesics|mesh-ancestor
56353403|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
56353404|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353405|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
56353406|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56353407|NCT04710160|Calcium|calcium|mesh-list
56353408|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56353409|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353410|NCT00065351|Lenalidomide|lenalidomide|mesh-list
56353411|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
56353412|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353413|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56353414|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56353415|NCT00065351|Growth Substances|growth substances|mesh-ancestor
56353416|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
56353417|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353418|NCT04709770|Simethicone|simethicone|mesh-list
56353419|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353420|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
56353421|NCT04709770|Emollients|emollients|mesh-ancestor
56353422|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
56353423|NCT04709731|Ponatinib|ponatinib|mesh-list
56353424|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353425|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56353426|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353430|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56353431|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353432|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353433|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
56353434|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353435|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56353436|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56353437|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56353438|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56353439|NCT00076440|Leuprolide|leuprolide|mesh-list
56353440|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56353441|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
56353442|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56353443|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353444|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56353445|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353446|NCT00237874|Aripiprazole|aripiprazole|mesh-list
56353447|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
56353448|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56353449|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56353450|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56353451|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353452|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353453|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
56353454|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
56353455|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353456|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353457|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56353458|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56353459|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
56353460|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56353461|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56353462|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56353463|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56353465|NCT00237913|Risperidone|risperidone|mesh-list
56353466|NCT00237913|Aripiprazole|aripiprazole|mesh-list
56353467|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56353468|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56353469|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
56353470|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353471|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353472|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353473|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56353474|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56353475|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353476|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56353477|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56353478|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
56353479|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
56353480|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
56353481|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353482|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353483|NCT00237913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56353484|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56353485|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56353486|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
56353487|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
56353488|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56353489|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56353490|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56353491|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56353492|NCT00237952|Chelating Agents|chelating agents|mesh-list
56353493|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
56353494|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353495|NCT00098241|Everolimus|everolimus|mesh-list
56353496|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353497|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353500|NCT04721119|Anesthetics|anesthetics|mesh-list
56353501|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353502|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353503|NCT00238147|Carboplatin|carboplatin|mesh-list
56353505|NCT00238147|Capecitabine|capecitabine|mesh-list
56353506|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353507|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
56353508|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
56353509|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
56353510|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353511|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56353512|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
56353513|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
56353514|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
56353515|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56353516|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56353517|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353518|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56353519|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353520|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353522|NCT00238225|Ketoconazole|ketoconazole|mesh-list
56353523|NCT00238225|Dexamethasone|dexamethasone|mesh-list
56353524|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353525|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
56353526|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
56651329|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56651330|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353527|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353528|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353529|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353530|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
56353531|NCT00238225|Hormones|hormones|mesh-ancestor
56353532|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353533|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56353534|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353535|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
56353537|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55975333|NCT00242489|Diclofenac|diclofenac|mesh-list
56353538|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56353539|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353540|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353541|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56353542|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
56353543|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56353544|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56353545|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56353546|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56353547|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56353548|NCT00238225|Vitamins|vitamins|mesh-ancestor
56353549|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
56353550|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56353551|NCT00076518|Fenofibrate|fenofibrate|mesh-list
56353552|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56353553|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
56353554|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353555|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56353556|NCT00065546|Choline|choline|mesh-list
56353557|NCT00065546|Estrogens|estrogens|mesh-list
56353558|NCT00065546|Hormones|hormones|mesh-ancestor
56353559|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353560|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353561|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
56353562|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56353563|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
56353564|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353565|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353566|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56353567|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
56353568|NCT00098280|Eculizumab|eculizumab|mesh-list
56353569|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56353570|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353571|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
56353572|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353573|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56353575|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
56353576|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353577|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
56353578|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353579|NCT00238498|Vildagliptin|vildagliptin|mesh-list
56353580|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353581|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353582|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56353583|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
56353584|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353585|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353586|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56353587|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56353588|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56353589|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353590|NCT00098319|Folic Acid|folic acid|mesh-list
56353591|NCT00098319|Hematinics|hematinics|mesh-ancestor
56353592|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
56353593|NCT00098319|Vitamins|vitamins|mesh-ancestor
56353594|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
56353595|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353596|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
56353597|NCT00238732|Estrogens|estrogens|mesh-list
56122002|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651331|NCT05660135|Amlodipine|amlodipine|mesh-list
56651332|NCT05660135|Olmesartan|olmesartan|mesh-list
56651333|NCT05660135|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56651334|NCT05660135|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56651335|NCT05660135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56651336|NCT05660135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56651337|NCT05660135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56651338|NCT05660135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651339|NCT05660135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56651340|NCT05660135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353598|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56353599|NCT00238732|Hormones|hormones|mesh-ancestor
56353600|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353601|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353602|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56353603|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56353604|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
56353605|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56353606|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
56353607|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353608|NCT00238927|Fluticasone|fluticasone|mesh-list
56353610|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56353611|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
56353612|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353613|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353614|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56353615|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
56353616|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
56353617|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56353618|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
56353619|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
56353620|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353621|NCT00065624|Protective Agents|protective agents|mesh-ancestor
56353622|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353623|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
56353624|NCT00065624|Vitamins|vitamins|mesh-ancestor
56353625|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
56353626|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
56353627|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56353628|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353629|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56353630|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
56353631|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353632|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353633|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353634|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353635|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
56353636|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56353637|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353638|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56353639|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
56353640|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353641|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353642|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353643|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353644|NCT00098358|Zileuton|zileuton|mesh-list
56353645|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56353646|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56353647|NCT00098358|Analgesics|analgesics|mesh-ancestor
56353650|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353651|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353652|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56353653|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56651341|NCT05660135|Vasodilator Agents|vasodilator agents|mesh-ancestor
56651342|NCT05660135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56353654|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353655|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353656|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56353657|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
56353658|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353659|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
56353660|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56353661|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353662|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56353663|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
56353664|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353665|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353666|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353667|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353668|NCT00239161|Levofloxacin|levofloxacin|mesh-list
56353669|NCT00239161|Ofloxacin|ofloxacin|mesh-list
56353670|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56353671|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353672|NCT00239161|Renal Agents|renal agents|mesh-ancestor
56353673|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353674|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56353675|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56353676|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353677|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353678|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353679|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56353680|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56353681|NCT00239200|Lapatinib|lapatinib|mesh-list
56353683|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56353684|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353685|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353686|NCT02961829|Niacinamide|niacinamide|mesh-list
56353687|NCT02961829|Maraviroc|maraviroc|mesh-list
56353688|NCT02961829|Dolutegravir|dolutegravir|mesh-list
56353689|NCT02961829|Auranofin|auranofin|mesh-list
56353690|NCT02961829|Vaccines|vaccines|mesh-list
56353691|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56353692|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
56353693|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353694|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56353695|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56353696|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353697|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56353698|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56353699|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
56353700|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353701|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56353702|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56353703|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56353704|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353705|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
56353706|NCT02961829|Vitamins|vitamins|mesh-ancestor
56353707|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
56353708|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56353709|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
56353710|NCT00239239|Hematinics|hematinics|mesh-ancestor
56353711|NCT00414349|Analgesics|analgesics|mesh-list
56353712|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
56353713|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353714|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353715|NCT00065741|Silymarin|silymarin|mesh-list
56353716|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
56353717|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353718|NCT00065741|Protective Agents|protective agents|mesh-ancestor
56353719|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353720|NCT00098397|Romidepsin|romidepsin|mesh-list
56353721|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56353725|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
56353726|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353727|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
56353729|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56651343|NCT05660135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56651344|NCT05660135|Antimetabolites|antimetabolites|mesh-ancestor
55982499|NCT00338377|Mesna|mesna|mesh-list
56353730|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353731|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56353732|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353733|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
56353734|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353735|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56353736|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56353737|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
56353738|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56353739|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56353740|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56353741|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
56353742|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353743|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353745|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56353746|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56353747|NCT00239395|Analgesics|analgesics|mesh-ancestor
56353748|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
56353749|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353750|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353751|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353752|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56353753|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56353754|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56353755|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353756|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353757|NCT00076635|Interferons|interferons|mesh-list
56353758|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
56353759|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353760|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
56353761|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353762|NCT00239434|Bromides|bromides|mesh-list
56353763|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
56353764|NCT00239434|Ipratropium|ipratropium|mesh-list
56353765|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56353766|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
56353767|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353768|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353769|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56353770|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
56353771|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
56353772|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56353773|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
56353774|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353775|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353776|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
56353777|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56353778|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
56353779|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56353780|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
56353781|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353782|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353783|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56353784|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
56353785|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
56353786|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56353787|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
56353788|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353789|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353790|NCT00239512|Ibuprofen|ibuprofen|mesh-list
56353791|NCT00239512|Indomethacin|indomethacin|mesh-list
56353792|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56353793|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56353794|NCT00239512|Analgesics|analgesics|mesh-ancestor
56353810|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353811|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353812|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353813|NCT00239551|Lansoprazole|lansoprazole|mesh-list
56353814|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56651345|NCT05660135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56214285|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56353815|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353816|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56353817|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353818|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353819|NCT00239629|Teriparatide|teriparatide|mesh-list
56353820|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
56353821|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56353822|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353823|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56353824|NCT00098436|Temozolomide|temozolomide|mesh-list
56353825|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56353826|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
56353827|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353828|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353829|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56353830|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56353831|NCT00239707|Incretins|incretins|mesh-ancestor
56353832|NCT00239707|Hormones|hormones|mesh-ancestor
56353833|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353834|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353835|NCT00239746|Ibuprofen|ibuprofen|mesh-list
56353836|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56353837|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56353838|NCT00239746|Analgesics|analgesics|mesh-ancestor
56353839|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
56353840|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353841|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353842|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353843|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56353844|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56353845|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353846|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353847|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56353848|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56353849|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353850|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353852|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353853|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56353854|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56353855|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353856|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353857|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
56353858|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353859|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56353860|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56353861|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353862|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353863|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
56353864|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353865|NCT00239980|Dalteparin|dalteparin|mesh-list
56353866|NCT00239980|Tinzaparin|tinzaparin|mesh-list
56353867|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56353868|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
56353869|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56353870|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56353871|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353872|NCT00240019|Furosemide|furosemide|mesh-list
56353873|NCT00240019|Diuretics|diuretics|mesh-ancestor
56353874|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
56353875|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353876|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56353877|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56353878|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353879|NCT00240058|Phenylephrine|phenylephrine|mesh-list
56353880|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
56353881|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
56353882|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56651346|NCT05660135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56651347|NCT05660135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651348|NCT05660135|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56214286|NCT01612273|Analgesics|analgesics|mesh-ancestor
56353883|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
56353884|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
56353885|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353886|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353887|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
56353888|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56353889|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
56353890|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
56353891|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56353892|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56353893|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56353894|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
56353895|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353896|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353897|NCT00240058|Protective Agents|protective agents|mesh-ancestor
56353898|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56353899|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56353900|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56353901|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
56353902|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56353903|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
56353905|NCT00098553|Everolimus|everolimus|mesh-list
56353906|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353907|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353908|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
56353909|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353911|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353912|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353913|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56353914|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353915|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
56353916|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56353917|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
56353918|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353919|NCT00240253|Pramlintide|pramlintide|mesh-list
56353920|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353921|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353922|NCT00065936|Naltrexone|naltrexone|mesh-list
56353923|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56353924|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56353925|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353929|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56353930|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56353931|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
56353932|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353933|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56353934|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56353935|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353936|NCT00240409|Pramipexole|pramipexole|mesh-list
56353937|NCT00240409|Bromocriptine|bromocriptine|mesh-list
56353938|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
56353939|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353940|NCT00240409|Protective Agents|protective agents|mesh-ancestor
56353942|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56353943|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56353944|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
56353945|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
56353946|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353947|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
56353948|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56353949|NCT00240448|Valsartan|valsartan|mesh-list
56353950|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56353951|NCT00240448|Telmisartan|telmisartan|mesh-list
56353952|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56353953|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56353954|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56651349|NCT05660135|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56651350|NCT00599196|Rotigotine|rotigotine|mesh-list
56353955|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353956|NCT00240448|Diuretics|diuretics|mesh-ancestor
56353957|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
56353958|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353959|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56353960|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56353961|NCT00098631|Lapatinib|lapatinib|mesh-list
56353962|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353963|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56353964|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353965|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353966|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
56353967|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353968|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353969|NCT00076791|Tenofovir|tenofovir|mesh-list
56353970|NCT00076791|Emtricitabine|emtricitabine|mesh-list
56353971|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56353972|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
56353973|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353974|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56353975|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56353976|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353977|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353978|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56353979|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56353980|NCT00240682|Cetuximab|cetuximab|mesh-list
56353981|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56353982|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353983|NCT00240721|Topiramate|topiramate|mesh-list
56353984|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
56353985|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56353986|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353987|NCT00240760|Memantine|memantine|mesh-list
56353988|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56353989|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56353990|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
56353991|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56353992|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353993|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353994|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56353995|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56353996|NCT00066092|Lenograstim|lenograstim|mesh-list
56353997|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56354001|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354002|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56354003|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56354004|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354005|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354006|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56354007|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
56354008|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354009|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354010|NCT00240799|Acetaminophen|acetaminophen|mesh-list
56170975|NCT01724814|Insulin|insulin|mesh-list
56354011|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56354012|NCT00240799|Analgesics|analgesics|mesh-ancestor
56354013|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
56354014|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354015|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354016|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
56354017|NCT00240838|Acetaminophen|acetaminophen|mesh-list
56354018|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56354019|NCT00240838|Analgesics|analgesics|mesh-ancestor
56354020|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
56354021|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354022|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354023|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
56354024|NCT02965404|Vaccines|vaccines|mesh-list
56354025|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
56354026|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354027|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
56651351|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
56354028|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354029|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354030|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56354031|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
56354032|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56354033|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354034|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354035|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354036|NCT00241072|Valsartan|valsartan|mesh-list
56354037|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56354038|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56354039|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56354040|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354041|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
56354042|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56354043|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354044|NCT00241150|Valsartan|valsartan|mesh-list
56354045|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56354046|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56354047|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56354048|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354049|NCT00076869|Amphotericin B|amphotericin b|mesh-list
56354050|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56354051|NCT00076869|Caspofungin|caspofungin|mesh-list
56354052|NCT00076869|Amebicides|amebicides|mesh-ancestor
56354053|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56354054|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56354055|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354056|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56354057|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
56354058|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354059|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354060|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
56354061|NCT00066248|Megestrol|megestrol|mesh-list
56354062|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
56354063|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56354064|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56354065|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56354066|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
56354067|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56354068|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354069|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56354070|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56354071|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56354073|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
56354074|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56354075|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
56354076|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
56354077|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354078|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56354079|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
56354080|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
56354081|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354082|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354083|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56354085|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56354086|NCT00241189|Sirolimus|sirolimus|mesh-list
56354087|NCT00241189|Methotrexate|methotrexate|mesh-list
56354088|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56354089|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
56354090|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56354091|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354092|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56354093|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
56354094|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354095|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354096|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
56354097|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354098|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56354099|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354100|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
56354101|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651352|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
56651353|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651354|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354102|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56354103|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56354104|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354105|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354106|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
56354107|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
56354108|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354109|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56354110|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354111|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354112|NCT00241345|Valganciclovir|valganciclovir|mesh-list
56354113|NCT00241345|Ganciclovir|ganciclovir|mesh-list
56354114|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56354115|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
56354116|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354117|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56354118|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354119|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354120|NCT00241423|Exenatide|exenatide|mesh-list
56354121|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56354122|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354123|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56354124|NCT00241423|Incretins|incretins|mesh-ancestor
56354125|NCT00241423|Hormones|hormones|mesh-ancestor
56354126|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354128|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56354129|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354130|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56354131|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354132|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354133|NCT00076986|Carmustine|carmustine|mesh-list
56354134|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56354135|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
56354136|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354137|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354138|NCT00241540|Esomeprazole|esomeprazole|mesh-list
56354139|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56354140|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354141|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56354142|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354143|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354149|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
56354150|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170985|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
56354152|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56354153|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56354154|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354155|NCT00098982|Leucovorin|leucovorin|mesh-list
56354156|NCT00098982|Fluorouracil|fluorouracil|mesh-list
56354157|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
56354158|NCT00098982|Bortezomib|bortezomib|mesh-list
56354159|NCT00098982|Calcium|calcium|mesh-list
56354160|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
56354161|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56354162|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354163|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
56354164|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354165|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56354166|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354167|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354168|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
56354169|NCT00098982|Antidotes|antidotes|mesh-ancestor
56354170|NCT00098982|Protective Agents|protective agents|mesh-ancestor
56354171|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
56354172|NCT00098982|Vitamins|vitamins|mesh-ancestor
56354173|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
56354174|NCT00241618|Interferons|interferons|mesh-list
56354175|NCT00241618|Ribavirin|ribavirin|mesh-list
56354176|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
56354177|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
56651355|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651356|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
56651357|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56354178|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354179|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
56354180|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354181|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
56354182|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354183|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
56354184|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354185|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
56354186|NCT00066482|Cisplatin|cisplatin|mesh-list
56354187|NCT00066482|Etoposide|etoposide|mesh-list
56354188|NCT00066482|Bleomycin|bleomycin|mesh-list
56354189|NCT00066482|Lenograstim|lenograstim|mesh-list
56354190|NCT00066482|Mesna|mesna|mesh-list
56354191|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354192|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
56354193|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354194|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56354195|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56354196|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
56354197|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354198|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354199|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56354200|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56354201|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56354202|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56354204|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56354205|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354206|NCT00066482|Protective Agents|protective agents|mesh-ancestor
56354207|NCT00099060|Lapatinib|lapatinib|mesh-list
56354208|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354209|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56354210|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354211|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354212|NCT00066599|Voriconazole|voriconazole|mesh-list
56354213|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
56354214|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354215|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56354216|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56354217|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354218|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354229|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354231|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56354232|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
56354233|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
56354234|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56354235|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354236|NCT02962024|Morphine|morphine|mesh-list
56354237|NCT02962024|Bupivacaine|bupivacaine|mesh-list
56354238|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
56354239|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
56354240|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354241|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354242|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
56354243|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354244|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56354245|NCT02962024|Narcotics|narcotics|mesh-ancestor
56354246|NCT02962024|Analgesics|analgesics|mesh-ancestor
56354247|NCT00066638|Romidepsin|romidepsin|mesh-list
56354248|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354249|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354250|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
56354251|NCT00242203|Docetaxel|docetaxel|mesh-list
56354252|NCT00242203|Trastuzumab|trastuzumab|mesh-list
56354253|NCT00242203|Epirubicin|epirubicin|mesh-list
56354254|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354255|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
56354256|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
56354257|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
56354258|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122761|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
56651358|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651359|NCT02824601|Calcium|calcium|mesh-list
56651360|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56651361|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651362|NCT02643732|Methylphenidate|methylphenidate|mesh-list
56354259|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56354260|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354261|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56354262|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56354263|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354264|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56354265|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354266|NCT00077025|Gefitinib|gefitinib|mesh-list
56354267|NCT00077025|Anastrozole|anastrozole|mesh-list
56354268|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354269|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56354270|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354271|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354272|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56354273|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56354274|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56354275|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56354276|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
56354277|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354278|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354280|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56354281|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56354282|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
56354283|NCT00066716|Celecoxib|celecoxib|mesh-list
56354284|NCT00066716|Paclitaxel|paclitaxel|mesh-list
56354285|NCT00066716|Carboplatin|carboplatin|mesh-list
56354288|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
56354289|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
56354290|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
56354291|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354292|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56354293|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56354294|NCT00066716|Analgesics|analgesics|mesh-ancestor
56354295|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
56354296|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354297|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354298|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56354299|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56354300|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56354301|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56354302|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354304|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56354305|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
56354306|NCT00077103|Combretastatin|combretastatin|mesh-list
56354307|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354308|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354309|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56354310|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56354311|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354312|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354313|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56354314|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
56354315|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
56354316|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
56354317|NCT00242437|Thrombin|thrombin|mesh-list
56354318|NCT00242437|Hemostatics|hemostatics|mesh-list
56354319|NCT00242437|Coagulants|coagulants|mesh-ancestor
56354320|NCT00066794|Cytarabine|cytarabine|mesh-list
56354321|NCT00066794|Cyclosporine|cyclosporine|mesh-list
56354322|NCT00066794|Daunorubicin|daunorubicin|mesh-list
56354323|NCT00066794|Cyclosporins|cyclosporins|mesh-list
56354324|NCT00066794|Sargramostim|sargramostim|mesh-list
56354325|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56354326|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
56354327|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651363|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56651364|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651365|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56354328|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354329|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
56354330|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354331|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354332|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
56354333|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354334|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354335|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
56354336|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
56354337|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56354338|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56354339|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354340|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56354341|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56354342|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
56354343|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56354344|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354345|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
56354346|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56354347|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354348|NCT00242749|Gefitinib|gefitinib|mesh-list
56354349|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354350|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56354351|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354352|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354354|NCT00242788|Gefitinib|gefitinib|mesh-list
56354355|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56354356|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
56354357|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354358|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354359|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56354360|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354361|NCT00066872|Imiquimod|imiquimod|mesh-list
56354376|NCT00243100|Gemcitabine|gemcitabine|mesh-list
56354377|NCT00243100|Vorinostat|vorinostat|mesh-list
56354378|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56354379|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
56354380|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354381|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354382|NCT00243100|Antiviral Agents|antiviral agents|mesh-ancestor
56354383|NCT00243100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354384|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354385|NCT00243100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354386|NCT00243100|Immunologic Factors|immunologic factors|mesh-ancestor
56354387|NCT00243100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354388|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56354389|NCT00099216|Rivastigmine|rivastigmine|mesh-list
56354390|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56354391|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354392|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354393|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
56354394|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354395|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354396|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56354397|NCT00099216|Protective Agents|protective agents|mesh-ancestor
56354398|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
56354399|NCT00066989|Antibodies|antibodies|mesh-list
56354400|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
56354401|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56354402|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56354403|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
56354404|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354405|NCT00243178|Clopidogrel|clopidogrel|mesh-list
56354406|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56354407|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56354408|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56354409|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56354410|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
56354411|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651366|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56651367|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56651368|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651369|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
56651370|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651371|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
56651372|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56651373|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651374|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651375|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651376|NCT04876937|Analgesics|analgesics|mesh-ancestor
56651377|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
56651378|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651379|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56651380|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56651381|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56354412|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354413|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354414|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
56354415|NCT00243256|Vitamin D|vitamin d|mesh-list
56354416|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56354417|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354418|NCT00243256|Vitamins|vitamins|mesh-ancestor
56354419|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
56354420|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56354421|NCT00243646|Bicalutamide|bicalutamide|mesh-list
56354424|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
56354425|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
56354426|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354427|NCT00099333|Exenatide|exenatide|mesh-list
56354428|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56354429|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354430|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56354431|NCT00099333|Incretins|incretins|mesh-ancestor
56354432|NCT00099333|Hormones|hormones|mesh-ancestor
56354433|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354434|NCT00243724|Esomeprazole|esomeprazole|mesh-list
56354435|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56354436|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354437|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56354438|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354439|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354440|NCT00243880|Lovastatin|lovastatin|mesh-list
56354441|NCT00243880|L 647318|l 647318|mesh-list
56354442|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
55785941|NCT01700569|Leucovorin|leucovorin|mesh-list
56354443|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56354444|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56354445|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
56354446|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354447|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56354448|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56354449|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354450|NCT00244075|Hormones|hormones|mesh-list
56354451|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354452|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354453|NCT00244153|Dexamethasone|dexamethasone|mesh-list
56651382|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
56651383|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651384|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651385|NCT05660993|Nivolumab|nivolumab|mesh-list
56651386|NCT05660993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56651387|NCT05660993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651388|NCT05660993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56651389|NCT05660993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651390|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56651391|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56651392|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
56651393|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
56651394|NCT04241705|Lumefantrine|lumefantrine|mesh-list
56651395|NCT04241705|Artemether|artemether|mesh-list
56651396|NCT04241705|Primaquine|primaquine|mesh-list
56651397|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56547636|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354454|NCT00244153|Morphine|morphine|mesh-list
56354455|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56354456|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
56354457|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
56354458|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354459|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354460|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354461|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
56354462|NCT00244153|Hormones|hormones|mesh-ancestor
56354463|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354464|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56354465|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354466|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56354467|NCT00244153|Narcotics|narcotics|mesh-ancestor
56354468|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354469|NCT00244153|Analgesics|analgesics|mesh-ancestor
56354470|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
56354471|NCT02967029|Remifentanil|remifentanil|mesh-list
56354472|NCT02967029|Esmolol|esmolol|mesh-list
56354473|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56354474|NCT02967029|Narcotics|narcotics|mesh-ancestor
56354475|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354476|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354477|NCT02967029|Analgesics|analgesics|mesh-ancestor
56354478|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
56354479|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354480|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56354481|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56354482|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56354483|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
56354484|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354485|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354486|NCT00244192|Infliximab|infliximab|mesh-list
56354487|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
56354488|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354489|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56354490|NCT00077181|Cytarabine|cytarabine|mesh-list
56354491|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56354492|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
56354493|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651399|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56651400|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56651401|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651402|NCT04243109|Dexamethasone|dexamethasone|mesh-list
56354496|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354497|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354498|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
56354499|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354500|NCT00244309|Tamsulosin|tamsulosin|mesh-list
56354501|NCT00244309|Dutasteride|dutasteride|mesh-list
56354502|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56354503|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56354504|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56354505|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
56354506|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354507|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354508|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354509|NCT00244309|Urological Agents|urological agents|mesh-ancestor
56354510|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56354511|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56354513|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
56354514|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354515|NCT00244348|Fluorouracil|fluorouracil|mesh-list
56354516|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
56354517|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
56354518|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354519|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56354520|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354521|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354522|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
56354523|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354524|NCT00077220|Paclitaxel|paclitaxel|mesh-list
56354525|NCT00077220|Carboplatin|carboplatin|mesh-list
56354526|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56354527|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354528|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
56354529|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
56354530|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
56354531|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354532|NCT00244426|Aspirin|aspirin|mesh-list
56354533|NCT00244426|Indobufen|indobufen|mesh-list
56354534|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56354535|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56354536|NCT00244426|Analgesics|analgesics|mesh-ancestor
56354537|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
56354538|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354539|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354540|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56354541|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56354542|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56354543|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56354544|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354545|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56354546|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56354547|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354548|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
56354549|NCT00398957|Naltrexone|naltrexone|mesh-list
56354550|NCT00398957|Hydromorphone|hydromorphone|mesh-list
56354551|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
56354552|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56354553|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354554|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
56354555|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354556|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56354557|NCT00398957|Narcotics|narcotics|mesh-ancestor
56354558|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354559|NCT00398957|Analgesics|analgesics|mesh-ancestor
56354560|NCT00099450|INS 50589|ins 50589|mesh-list
56354561|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56354562|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56354563|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
56354564|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651403|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
56651404|NCT04243109|Pomalidomide|pomalidomide|mesh-list
56651405|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56651406|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
56354565|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354566|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354567|NCT00244504|Moxonidine|moxonidine|mesh-list
56354570|NCT00099489|Interferon-beta|interferon-beta|mesh-list
56354571|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
56354572|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354573|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
56354574|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354575|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
56354576|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354577|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56354579|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
56354580|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171003|NCT01725204|Dasatinib|dasatinib|mesh-list
56354581|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354582|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
56354583|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354584|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354585|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
56354586|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56354587|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354588|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56354589|NCT00244738|Castor Oil|castor oil|mesh-list
56354590|NCT00244738|Cathartics|cathartics|mesh-ancestor
56354591|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354592|NCT00077259|Epothilones|epothilones|mesh-list
56354593|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
56354594|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
56354595|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
56354596|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
56354597|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354598|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354600|NCT00067301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56354601|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56354602|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56354603|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354604|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354605|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
56354606|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354607|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56354608|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
56354609|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56354610|NCT00244972|Sorafenib|sorafenib|mesh-list
56354611|NCT00244972|Tipifarnib|tipifarnib|mesh-list
56354612|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354613|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56354614|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354615|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354616|NCT00245089|Dactinomycin|dactinomycin|mesh-list
56354617|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
56354618|NCT00245089|Vincristine|vincristine|mesh-list
56354619|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354620|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
56354621|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354622|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56354623|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56354624|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
56354625|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354626|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354627|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56354628|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56354629|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
56354630|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
56354631|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
56354632|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56354633|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354634|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354635|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56651407|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651408|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651409|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56354636|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354637|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56354638|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
56354639|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56354640|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354641|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
56354642|NCT00245206|Olanzapine|olanzapine|mesh-list
56354646|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
56354647|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354648|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354649|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354650|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56354651|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56354652|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354653|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56354654|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56354655|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
56354657|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
56354658|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354659|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354660|NCT00245206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56354661|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56354662|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56354663|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
56354664|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
56354666|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56354667|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56354668|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56354669|NCT00245245|Factor VIII|factor viii|mesh-list
56354670|NCT00245245|Coagulants|coagulants|mesh-ancestor
56354671|NCT00077298|Bevacizumab|bevacizumab|mesh-list
56354672|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56354673|NCT00077298|Cetuximab|cetuximab|mesh-list
56354674|NCT00077298|Irinotecan|irinotecan|mesh-list
56354675|NCT00077298|Antibodies|antibodies|mesh-list
56354676|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
56354677|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56354678|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354679|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56354680|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56354681|NCT00077298|Growth Substances|growth substances|mesh-ancestor
56354682|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354683|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
56354684|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
56354685|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56354686|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56354687|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354688|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354689|NCT00245401|Sirolimus|sirolimus|mesh-list
56354690|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56354691|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354692|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354693|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354694|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
56354695|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354696|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
56354697|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354698|NCT00245440|Azithromycin|azithromycin|mesh-list
56354699|NCT00245440|Telithromycin|telithromycin|mesh-list
56354700|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56354701|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354702|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56354703|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56354704|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
56354705|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354706|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354707|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56354708|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
56354709|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
56354710|NCT00400608|Hormones|hormones|mesh-ancestor
56651410|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
56651411|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651412|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651413|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56354711|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354712|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
56354713|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
56354714|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
56354715|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56354716|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56354717|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354718|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354720|NCT00245674|Amisulpride|amisulpride|mesh-list
56354721|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56354722|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56354723|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354724|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354725|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56354726|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56354727|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
55785958|NCT05090761|Bupivacaine|bupivacaine|mesh-list
56354729|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354730|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56354731|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
56354732|NCT00245713|Levetiracetam|levetiracetam|mesh-list
56354733|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
56354734|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
56354735|NCT00067457|Alosetron|alosetron|mesh-list
56354736|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354737|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56354738|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
56354739|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354740|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354741|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354742|NCT00102843|Folic Acid|folic acid|mesh-list
56354743|NCT00102843|Betaine|betaine|mesh-list
56354744|NCT00102843|Hematinics|hematinics|mesh-ancestor
56354745|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
56354746|NCT00102843|Vitamins|vitamins|mesh-ancestor
56354747|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
56354748|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354749|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354750|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
56354751|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56354752|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
56354753|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354754|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56354755|NCT00245791|Levofloxacin|levofloxacin|mesh-list
56354756|NCT00245791|Ofloxacin|ofloxacin|mesh-list
56354757|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56354758|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354759|NCT00245791|Renal Agents|renal agents|mesh-ancestor
56354760|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56354761|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56354762|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56354763|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354764|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354765|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354766|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56354767|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56354768|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
56354769|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354770|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354771|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56354772|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
56354773|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56354774|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354775|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354776|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354777|NCT00245908|Azithromycin|azithromycin|mesh-list
56651414|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651415|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
56651416|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
56651417|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651418|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214354|NCT01612832|Pregabalin|pregabalin|mesh-list
56354778|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56354779|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354780|NCT00067496|Modafinil|modafinil|mesh-list
56354781|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56354782|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354783|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56354784|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56354785|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56354786|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354787|NCT00400725|Clobetasol|clobetasol|mesh-list
56354788|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56354789|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
56354790|NCT00400725|Hormones|hormones|mesh-ancestor
56354791|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354793|NCT00246064|Infliximab|infliximab|mesh-list
56354794|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
56354795|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354796|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56354797|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
56354798|NCT00246103|Fluorouracil|fluorouracil|mesh-list
56354799|NCT00246103|Epirubicin|epirubicin|mesh-list
56354800|NCT00246103|Valproic Acid|valproic acid|mesh-list
56354801|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56354803|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354804|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56354805|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56354806|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
56354807|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354808|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354809|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56354810|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
56354811|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56354812|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56354813|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55976622|NCT00716963|Fluticasone|fluticasone|mesh-list
56354814|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56354815|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354816|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
56354818|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354819|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
56354820|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56354821|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354822|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56354823|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
56354824|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56354825|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56354826|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56354827|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56354828|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354829|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
56354830|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354831|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354832|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56354833|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354834|NCT00067535|Cocaine|cocaine|mesh-list
56354835|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
56354836|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
56354837|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354838|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354839|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
56354840|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354841|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56354842|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56354843|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56651419|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
56651420|NCT04243109|Hormones|hormones|mesh-ancestor
56651421|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354844|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56354845|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354846|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
56354847|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354848|NCT00102882|Fluticasone|fluticasone|mesh-list
56354849|NCT00102882|Xhance|xhance|mesh-list
56354850|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56354851|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56354852|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56354853|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56354854|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
56354855|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354856|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354857|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56354858|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
56354859|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
56354860|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56354861|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56354862|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56354863|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56354864|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
56354865|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171018|NCT01725672|Metformin|metformin|mesh-list
56354876|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56354877|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354878|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
56354879|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354881|NCT00424801|Valsartan|valsartan|mesh-list
56354882|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56354883|NCT00424801|Doxazosin|doxazosin|mesh-list
56354884|NCT00424801|Lercanidipine|lercanidipine|mesh-list
56354885|NCT00424801|Pindolol|pindolol|mesh-list
56354886|NCT00424801|Moxonidine|moxonidine|mesh-list
56354887|NCT00424801|Amiloride|amiloride|mesh-list
56354888|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56354889|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56354890|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56354891|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354892|NCT00424801|Diuretics|diuretics|mesh-ancestor
56354893|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
56354894|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354895|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56354896|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56354897|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56354898|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56354899|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56354900|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56354901|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56354902|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56354903|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56354904|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
56354905|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354906|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56354907|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
56354908|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
56354909|NCT00424801|Vitamins|vitamins|mesh-ancestor
56354910|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
56354911|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56354912|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56354913|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56354914|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56354915|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
56354916|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
56354917|NCT00246298|Hematinics|hematinics|mesh-ancestor
56354918|NCT00246415|Memantine|memantine|mesh-list
56354919|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56354920|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56354921|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
56354922|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123071|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56651422|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56651423|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55983642|NCT01839955|Quinacrine|quinacrine|mesh-list
56354923|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354924|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354925|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56354926|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56354927|NCT00246532|Morphine|morphine|mesh-list
56354928|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56354933|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
56354934|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354935|NCT00246610|Nelfinavir|nelfinavir|mesh-list
56354936|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56354937|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56354938|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
56354939|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354940|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354941|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56354942|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56354943|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
56354944|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354945|NCT00246688|Sagopilone|sagopilone|mesh-list
56354946|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354947|NCT04728516|Amoxicillin|amoxicillin|mesh-list
56354948|NCT04728516|Pantoprazole|pantoprazole|mesh-list
56354950|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354951|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56354952|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56354953|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56354954|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354955|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354956|NCT00400998|Fluticasone|fluticasone|mesh-list
56354957|NCT00400998|Xhance|xhance|mesh-list
56354958|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56354959|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56354960|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
56354961|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56354962|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354963|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56354964|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
56354965|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
56354966|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56354967|NCT00247078|Antivenins|antivenins|mesh-list
56354968|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
56354969|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354970|NCT00247117|Metformin|metformin|mesh-list
56354971|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56354972|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354973|NCT00099606|Dasatinib|dasatinib|mesh-list
56354974|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354975|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56354976|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354977|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354978|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
56354979|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56354980|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
56354981|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354982|NCT00247507|Expectorants|expectorants|mesh-ancestor
56354983|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
56354984|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56354985|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
56354986|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354987|NCT00247507|Protective Agents|protective agents|mesh-ancestor
56354988|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354989|NCT00247507|Antidotes|antidotes|mesh-ancestor
56354990|NCT00247585|Ethanol|ethanol|mesh-list
56354991|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56354992|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56354993|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354994|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354995|NCT00099645|Mifepristone|mifepristone|mesh-list
56354996|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56354997|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
56354998|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56651424|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56651425|NCT04243109|Growth Substances|growth substances|mesh-ancestor
56651426|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
56651427|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
56651428|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56651429|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
56651430|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354999|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355000|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56355001|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56355002|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56355007|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355008|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
56355009|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56355010|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56355011|NCT00247663|Letrozole|letrozole|mesh-list
56355012|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355013|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56355014|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56355015|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355016|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355017|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56355018|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
56355019|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355020|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355022|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
56355023|NCT01349660|Bevacizumab|bevacizumab|mesh-list
56355024|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355025|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355026|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56355027|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56355028|NCT01349660|Growth Substances|growth substances|mesh-ancestor
56355029|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355030|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
56355031|NCT00247741|Lidocaine|lidocaine|mesh-list
56355032|NCT00247741|Carticaine|carticaine|mesh-list
56355033|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
56355034|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
56355035|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355036|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355037|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
56355038|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355039|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56355040|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56355041|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56355042|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355043|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355045|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56355046|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56355047|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
56355048|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355049|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56355050|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56355051|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355052|NCT00248053|Curcumin|curcumin|mesh-list
56355053|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56355054|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56355055|NCT00248053|Analgesics|analgesics|mesh-ancestor
56355056|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
56355057|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355058|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355059|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56355060|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56355061|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355062|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123072|NCT01554618|Incretins|incretins|mesh-ancestor
56651431|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
56651432|NCT04165902|Protective Agents|protective agents|mesh-ancestor
56651433|NCT04861181|Niraparib|niraparib|mesh-list
56651434|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56651435|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355063|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355064|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56355065|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56355066|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355067|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56355068|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56355069|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355070|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355071|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
56355074|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56355075|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56355076|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355078|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56355079|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
56355080|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355081|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56355082|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56355083|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355084|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355085|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
56355086|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355087|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355088|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56355089|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56355090|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355091|NCT00248248|Doxorubicin|doxorubicin|mesh-list
56355092|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56355093|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56355094|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355095|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56355096|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56355097|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355098|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355099|NCT00248443|Dimercaprol|dimercaprol|mesh-list
56355100|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
56355101|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
56355102|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355103|NCT00248482|Cisplatin|cisplatin|mesh-list
56355104|NCT00248482|Irinotecan|irinotecan|mesh-list
56355105|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
56355106|NCT00248482|Camptothecin|camptothecin|mesh-list
56355107|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355108|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56355109|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56355110|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355111|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355112|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56355113|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56355114|NCT00103233|Trastuzumab|trastuzumab|mesh-list
56355115|NCT00103233|Vinorelbine|vinorelbine|mesh-list
56355116|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355117|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355118|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56355119|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
56355120|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
56355121|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
56355122|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355123|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
56355124|NCT00248716|Hematinics|hematinics|mesh-ancestor
56355125|NCT00067925|Calcium|calcium|mesh-list
56355126|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56355127|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651436|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651437|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355128|NCT00103272|Bortezomib|bortezomib|mesh-list
56355129|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355130|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56355131|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56355132|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
56355133|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355134|NCT00249106|Vaccines|vaccines|mesh-list
56355135|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
56355136|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355137|NCT00068042|Octreotide|octreotide|mesh-list
56355138|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56355139|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56355140|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355141|NCT00249145|Risperidone|risperidone|mesh-list
56355142|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56355143|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
56355144|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355159|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
56355160|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56355161|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355162|NCT00068081|Capsaicin|capsaicin|mesh-list
56355163|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
56355164|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
56355165|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
56355166|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355167|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355168|NCT00249223|Risperidone|risperidone|mesh-list
56355169|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56355170|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
56355171|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355172|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355173|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355174|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56355175|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56355176|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355177|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355178|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56355179|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
56355180|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56355181|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355182|NCT02967224|Insulin|insulin|mesh-list
56355183|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56355184|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
56355185|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
56355187|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
56355188|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
56355189|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56355190|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355191|NCT00099918|Vildagliptin|vildagliptin|mesh-list
56355192|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56355193|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355194|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56355195|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
56355196|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355197|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355198|NCT00249574|Buprenorphine|buprenorphine|mesh-list
56355199|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56355200|NCT00249574|Naloxone|naloxone|mesh-list
56355201|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56355202|NCT00249574|Narcotics|narcotics|mesh-ancestor
56355203|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355206|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
56355207|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355208|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56355209|NCT00249691|Topiramate|topiramate|mesh-list
56355210|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
56355211|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56355212|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355213|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
56355214|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
56355215|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56355216|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56651438|NCT00603512|Tofacitinib|tofacitinib|mesh-list
56651439|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56651440|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651441|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651442|NCT04167774|Paclitaxel|paclitaxel|mesh-list
56355217|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355218|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355219|NCT00249730|Urological Agents|urological agents|mesh-ancestor
56355220|NCT00249847|Paroxetine|paroxetine|mesh-list
56355221|NCT00249847|Estrogens|estrogens|mesh-list
56355222|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56355223|NCT00249847|Hormones|hormones|mesh-ancestor
56355224|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355225|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355226|NCT00249847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56355227|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56355228|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355229|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355230|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355232|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56355233|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
56355234|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355235|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56355236|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56355237|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355238|NCT00249886|Citalopram|citalopram|mesh-list
56355239|NCT00249886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56355240|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56355241|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355242|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355244|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
56355245|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355246|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56355247|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
56355248|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355249|NCT00249964|Paclitaxel|paclitaxel|mesh-list
56355250|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56355251|NCT00249964|Carboplatin|carboplatin|mesh-list
56355252|NCT00249964|Temozolomide|temozolomide|mesh-list
56355253|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56355254|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355255|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
56355256|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
56355257|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
56355258|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355259|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56355260|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
56355262|NCT00068276|Vitamin D|vitamin d|mesh-list
56355263|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56355264|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355265|NCT00068276|Vitamins|vitamins|mesh-ancestor
56355266|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
56355267|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56355268|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
56355269|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
56355270|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355271|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56355272|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355273|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355274|NCT00068315|Rituximab|rituximab|mesh-list
56355275|NCT00068315|Fludarabine|fludarabine|mesh-list
56355276|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
56355277|NCT00068315|Bortezomib|bortezomib|mesh-list
56355278|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355283|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56355284|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
56355285|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355286|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56651443|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56651444|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56651445|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355287|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
56355288|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56355289|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355290|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355291|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
56355292|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355293|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355294|NCT00250120|Camptothecin|camptothecin|mesh-list
56355295|NCT00250120|Rubitecan|rubitecan|mesh-list
56355296|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56355297|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355298|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56355299|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56355300|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355301|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355302|NCT04720573|Neostigmine|neostigmine|mesh-list
56355303|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56355304|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355305|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355306|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
56355307|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355308|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355309|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56355310|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
56355311|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355312|NCT00103545|Abagovomab|abagovomab|mesh-list
56355313|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355314|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355315|NCT00068432|Gemcitabine|gemcitabine|mesh-list
56355316|NCT00068432|Celecoxib|celecoxib|mesh-list
56355317|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56355319|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355320|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355321|NCT00068432|Antiviral Agents|antiviral agents|mesh-ancestor
56355322|NCT00068432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355323|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355324|NCT00068432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56355325|NCT00068432|Immunologic Factors|immunologic factors|mesh-ancestor
56355326|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355327|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56355328|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56355329|NCT00068432|Analgesics|analgesics|mesh-ancestor
56355330|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
56355331|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355332|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56355333|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56355334|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56355335|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56355336|NCT00250237|Haloperidol|haloperidol|mesh-list
56355337|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
56355338|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
56355339|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
56355340|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355341|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355342|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56355343|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56355344|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56355345|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355346|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355347|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56355348|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
56355349|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355351|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56355352|NCT00099957|Vildagliptin|vildagliptin|mesh-list
56355353|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56355354|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355355|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56355356|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
56651446|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
56651447|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
56651448|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
55984047|NCT01727401|PENTA|penta|mesh-list
56355357|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355358|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355359|NCT00250315|Dobutamine|dobutamine|mesh-list
56355360|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56355361|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
56355362|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
56355363|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355364|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355365|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56355366|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56355367|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56355368|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
56355369|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355370|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355371|NCT00250315|Protective Agents|protective agents|mesh-ancestor
56355372|NCT00068471|Anidulafungin|anidulafungin|mesh-list
56355373|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
56355374|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355375|NCT00250354|Risperidone|risperidone|mesh-list
56355376|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56355377|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
56355378|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355379|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355380|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355381|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56355382|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56355383|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355384|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355385|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56355386|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
56355387|NCT00250393|Istradefylline|istradefylline|mesh-list
56355388|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56355389|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56355390|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56355391|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
56355392|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355393|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355394|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355395|NCT02961634|Ciclopirox|ciclopirox|mesh-list
56355396|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
56355397|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355398|NCT02966717|Rituximab|rituximab|mesh-list
56355399|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355400|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355401|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
56355402|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355403|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56355404|NCT00099996|Ezetimibe|ezetimibe|mesh-list
56355405|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55977227|NCT01274039|Acetazolamide|acetazolamide|mesh-list
56355406|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56355407|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
56355408|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355409|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56355410|NCT00250744|Gabapentin|gabapentin|mesh-list
56355411|NCT00250744|Aprepitant|aprepitant|mesh-list
56355412|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
56355413|NCT00250744|Analgesics|analgesics|mesh-ancestor
56355414|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
56355415|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355416|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355417|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
56355418|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56355419|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56355420|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355421|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355422|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56355425|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651449|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651450|NCT02640300|Clozapine|clozapine|mesh-list
56355426|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
56355427|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
56355428|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
56355429|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56355430|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56355431|NCT00103623|Abarelix|abarelix|mesh-list
56355432|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
56355433|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355434|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355435|NCT00250861|Aldesleukin|aldesleukin|mesh-list
56355436|NCT00250861|Rituximab|rituximab|mesh-list
56355437|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355438|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355439|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
56355440|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355441|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56355443|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56355444|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
56355445|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355446|NCT00068549|Gemcitabine|gemcitabine|mesh-list
56355447|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355448|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56355449|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
56355450|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355451|NCT00068549|Antiviral Agents|antiviral agents|mesh-ancestor
56355452|NCT00068549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355453|NCT00068549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355454|NCT00068549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56355455|NCT00068549|Immunologic Factors|immunologic factors|mesh-ancestor
56355456|NCT00068549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355457|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
56355458|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355459|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56355460|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56355461|NCT04720183|Analgesics|analgesics|mesh-ancestor
56355462|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
56355463|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355464|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355465|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56355466|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56355467|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56355469|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355470|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355471|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56355472|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56355473|NCT00250978|Growth Substances|growth substances|mesh-ancestor
56355474|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355475|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
56355476|NCT00068666|Temozolomide|temozolomide|mesh-list
56355477|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56355478|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
56355479|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355480|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355481|NCT00103701|Dasatinib|dasatinib|mesh-list
56355482|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355483|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56355484|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355485|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355486|NCT00251017|Vancomycin|vancomycin|mesh-list
56355487|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56355488|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355489|NCT00251056|Mannitol|mannitol|mesh-list
56355490|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56355491|NCT00251056|Diuretics|diuretics|mesh-ancestor
56355492|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
56355493|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355494|NCT00251095|Paclitaxel|paclitaxel|mesh-list
56355495|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56355496|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355497|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
56355502|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56651451|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56651452|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
56355503|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
56355504|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355505|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355506|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56355507|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56355508|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
56355509|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355510|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355511|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
56355512|NCT00068744|Fluorouracil|fluorouracil|mesh-list
56355513|NCT00068744|Mitomycins|mitomycins|mesh-list
56355514|NCT00068744|Mitomycin|mitomycin|mesh-list
56355515|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355516|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
55785993|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355517|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355518|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56355519|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56355520|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
56355521|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355522|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56355523|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
56355524|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56355525|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355526|NCT00100113|Vanoxerine|vanoxerine|mesh-list
56355527|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56355528|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56355529|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355530|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355531|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
56355532|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355533|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355534|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
56355535|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355536|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56355537|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355538|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355539|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
56355540|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355541|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
56355542|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355543|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355544|NCT00251407|Docetaxel|docetaxel|mesh-list
56355545|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355546|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
56355547|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
56355548|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
56355549|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355550|NCT02966522|Thalidomide|thalidomide|mesh-list
56355551|NCT02966522|Dexamethasone|dexamethasone|mesh-list
56355552|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56355553|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
56355554|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
56355555|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355556|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355557|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56355558|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
56355559|NCT02966522|Hormones|hormones|mesh-ancestor
56355560|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355561|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56355562|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355563|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56355564|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
56355565|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
56355566|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56355583|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355584|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
56355585|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355586|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355587|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56651453|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651454|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651455|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651456|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56651457|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651458|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171051|NCT01726920|Naproxen|naproxen|mesh-list
56355588|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56355589|NCT00068861|Metformin|metformin|mesh-list
56355590|NCT00068861|Clomiphene|clomiphene|mesh-list
56355591|NCT00068861|Enclomiphene|enclomiphene|mesh-list
56355592|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
56355593|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56355594|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355595|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56355596|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
56355597|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355598|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56355599|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
56355600|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56355601|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56355602|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56355603|NCT00251602|Propranolol|propranolol|mesh-list
56355604|NCT00251602|Atropine|atropine|mesh-list
56355605|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56355606|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56355607|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
56355608|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355609|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355610|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355611|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56355612|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56355613|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
56355614|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56355615|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56355616|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
56355617|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355618|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56355619|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
56355621|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
56355622|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56355623|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56355624|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
56355625|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
56355626|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56355628|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
56355629|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355631|NCT00103818|Analgesics|analgesics|mesh-ancestor
56355632|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
56355633|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355634|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355635|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
56355636|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
56355637|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
56355638|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355639|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355640|NCT00251680|Atorvastatin|atorvastatin|mesh-list
56355641|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56355642|NCT00251680|Simvastatin|simvastatin|mesh-list
56355643|NCT00251680|Fenofibrate|fenofibrate|mesh-list
56355644|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56355645|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56355646|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
56355647|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355648|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56355649|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56355650|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355651|NCT00251797|Thalidomide|thalidomide|mesh-list
56355652|NCT00251797|Irinotecan|irinotecan|mesh-list
56651459|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56651460|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
56651461|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
56651462|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
56355653|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56355654|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56355655|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355656|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355657|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355658|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56355659|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
56355660|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355661|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
56355662|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56355663|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355664|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56355665|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56355666|NCT00251797|Growth Substances|growth substances|mesh-ancestor
56355667|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
56355669|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56355670|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56355671|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56355672|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355673|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355674|NCT00100269|Antioxidants|antioxidants|mesh-list
56355675|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355676|NCT00100269|Protective Agents|protective agents|mesh-ancestor
56355677|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355678|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
56355679|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
56355680|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56355681|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
56355682|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56355683|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56355684|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355685|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56355686|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355687|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355688|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56355689|NCT00399074|Renal Agents|renal agents|mesh-ancestor
56355690|NCT00100308|Heparin|heparin|mesh-list
56355691|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
56355692|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56355693|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56355694|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355695|NCT00251953|Metformin|metformin|mesh-list
56355696|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56355697|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355698|NCT00251992|Esomeprazole|esomeprazole|mesh-list
56355699|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56355700|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56355701|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56355702|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355705|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56355706|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355707|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55977520|NCT00784225|Vitamins|vitamins|mesh-list
56355709|NCT00103935|Hormones|hormones|mesh-ancestor
56355710|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355711|NCT00399152|Sunitinib|sunitinib|mesh-list
56355712|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355713|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56355714|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56355715|NCT00399152|Growth Substances|growth substances|mesh-ancestor
56355716|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355717|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
56355718|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56355719|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355720|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355721|NCT00104013|Xaliproden|xaliproden|mesh-list
56355722|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56355723|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56651463|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56651464|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
56651465|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651466|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
56651467|NCT02640144|Protective Agents|protective agents|mesh-ancestor
56651468|NCT02643186|Misoprostol|misoprostol|mesh-list
56214400|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56355724|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
56355725|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355726|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355727|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355728|NCT04719715|Antibodies|antibodies|mesh-list
56355729|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
56355730|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355731|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56355732|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
56355733|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355734|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56355735|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56355736|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355737|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355738|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
56355739|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355740|NCT00252304|Astringents|astringents|mesh-ancestor
56355741|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
56355742|NCT00252343|Amibegron|amibegron|mesh-list
56355743|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56355744|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56355745|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
56355746|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355747|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355748|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355749|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
56355750|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
56355751|NCT00252655|Sirolimus|sirolimus|mesh-list
56355752|NCT00252655|Tacrolimus|tacrolimus|mesh-list
56355753|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56355754|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
56355755|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355756|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56355757|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355758|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355759|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56355760|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355761|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56355762|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355763|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
56355765|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355766|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56355767|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355768|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355769|NCT00069251|Bupropion|bupropion|mesh-list
56355770|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56355771|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
56355772|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355773|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56355774|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56355789|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56355790|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355791|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355792|NCT00252928|Troclosene|troclosene|mesh-list
56355793|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
56355794|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355795|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
56355796|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
56355797|NCT00253123|Risperidone|risperidone|mesh-list
56355798|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56355799|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
56355800|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651469|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56651470|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
56651471|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56297502|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
56651472|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651473|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56651474|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56171062|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56355801|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355802|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355803|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56355804|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56355805|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355806|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355807|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56355808|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
56355809|NCT00253162|Risperidone|risperidone|mesh-list
56355810|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56355811|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
56355812|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355813|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355814|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355815|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56355816|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56355817|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355818|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355819|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56355820|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
56355821|NCT00253201|Galantamine|galantamine|mesh-list
56355822|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56355823|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355824|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355825|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
56355826|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355827|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355828|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56355829|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
56355830|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355831|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
56355832|NCT00253318|Dexamethasone|dexamethasone|mesh-list
56355833|NCT00253318|Docetaxel|docetaxel|mesh-list
56355841|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
56355842|NCT00253318|Hormones|hormones|mesh-ancestor
56355843|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355844|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56355845|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355846|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
56355847|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
56355848|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
56355849|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355850|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56355851|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
56355852|NCT00100464|Paroxetine|paroxetine|mesh-list
56355853|NCT00100464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56355854|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56355855|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355856|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355857|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355858|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
56355859|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355860|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56355861|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
56355862|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355863|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56355864|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56355865|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651475|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
56651476|NCT02652312|Diclofenac|diclofenac|mesh-list
56651477|NCT02652312|Fentanyl|fentanyl|mesh-list
56651478|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
56651479|NCT02652312|Ondansetron|ondansetron|mesh-list
56651480|NCT02652312|Propofol|propofol|mesh-list
56355867|NCT00253396|Enoxaparin|enoxaparin|mesh-list
56355868|NCT00253396|Calcium heparin|calcium heparin|mesh-list
56355869|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
56355870|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56355871|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56355872|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355873|NCT00253474|Interferons|interferons|mesh-list
56355874|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
56355875|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
56355876|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56355877|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355878|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
56355879|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355880|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
56355881|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355882|NCT00253552|Cyclosporine|cyclosporine|mesh-list
56355883|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
56355884|NCT00253552|Busulfan|busulfan|mesh-list
56355885|NCT00253552|Methotrexate|methotrexate|mesh-list
56355886|NCT00253552|Etoposide|etoposide|mesh-list
56355887|NCT00253552|Cyclosporins|cyclosporins|mesh-list
56355888|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56355889|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
56355890|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355891|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56355892|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56355893|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
56355894|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355895|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355896|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56355897|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56355898|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
56355899|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56355900|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56355901|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
56355902|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
56355903|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355914|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56355916|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
56355917|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
56355918|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355919|NCT04719481|Pravastatin|pravastatin|mesh-list
56355920|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56355921|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56355922|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
56355923|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355924|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56355925|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56355926|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355927|NCT00253903|SR 46349B|sr 46349b|mesh-list
56355928|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56355929|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56355930|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355931|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56355932|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56355933|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
56355934|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355935|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355937|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
56355938|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
56355939|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
56355940|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355941|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355942|NCT00254020|Citalopram|citalopram|mesh-list
56355943|NCT00254020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56355944|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56651481|NCT02652312|Desflurane|desflurane|mesh-list
56651482|NCT02652312|Atracurium|atracurium|mesh-list
56651483|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56651484|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651485|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651486|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56355945|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355946|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355947|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355948|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
56355949|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355950|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56355951|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
56355952|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355953|NCT00254137|Capecitabine|capecitabine|mesh-list
56355954|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
56355955|NCT00254137|Irinotecan|irinotecan|mesh-list
56355956|NCT00254137|Cetuximab|cetuximab|mesh-list
56355957|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56355958|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
56355959|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355960|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355961|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56355962|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56355963|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355964|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355965|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
56355966|NCT00104169|Hematinics|hematinics|mesh-ancestor
56355967|NCT00415090|Nevirapine|nevirapine|mesh-list
56355968|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56355979|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56355980|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56355981|NCT00254254|Exenatide|exenatide|mesh-list
56355982|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56355983|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355984|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56355985|NCT00254254|Incretins|incretins|mesh-ancestor
56355986|NCT00254254|Hormones|hormones|mesh-ancestor
56355987|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355988|NCT00254371|Androgens|androgens|mesh-list
56355989|NCT00254371|Hormones|hormones|mesh-ancestor
56355990|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56355991|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355992|NCT00254449|Capsaicin|capsaicin|mesh-list
56355993|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
56355994|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
56355995|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
56355996|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355997|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355998|NCT00104286|Troxacitabine|troxacitabine|mesh-list
56355999|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356000|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56356001|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56356002|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
56356003|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356004|NCT00254800|Exenatide|exenatide|mesh-list
56356005|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56356006|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56356007|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
56356008|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55977823|NCT00766753|Vaccines|vaccines|mesh-list
56356009|NCT00254800|Estradiol|estradiol|mesh-list
56356010|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56356011|NCT00254800|Estrogens|estrogens|mesh-ancestor
56356012|NCT00254800|Hormones|hormones|mesh-ancestor
56356013|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356014|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356015|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56356016|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
56356017|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56356018|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56651487|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
56651488|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
56651489|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651490|NCT02652312|Analgesics|analgesics|mesh-ancestor
56651491|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
56214420|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56356019|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56356020|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56356021|NCT00254800|Incretins|incretins|mesh-ancestor
56356022|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56356023|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56356024|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56356025|NCT00104403|Dexamethasone|dexamethasone|mesh-list
56356026|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
56356027|NCT00104403|Ondansetron|ondansetron|mesh-list
56356028|NCT00104403|Casopitant|casopitant|mesh-list
56356029|NCT00104403|BB 1101|bb 1101|mesh-list
56356030|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56356031|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
56356032|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
56356033|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356040|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356042|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356043|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356044|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
56356045|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
56356046|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56356047|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
56356048|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356049|NCT00104403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56356050|NCT00104403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56356051|NCT00104403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56356052|NCT00104403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56356053|NCT00104403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56356054|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56356055|NCT00069836|Metformin|metformin|mesh-list
56356056|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
56356057|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56356058|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356059|NCT00254878|Methylphenidate|methylphenidate|mesh-list
56356060|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56356061|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356062|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56356063|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56356064|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56356065|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356067|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356068|NCT00254917|Vaccines|vaccines|mesh-list
56356069|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
56356070|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356071|NCT00254956|Ciclesonide|ciclesonide|mesh-list
56356072|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
56356073|NCT00254956|Hormones|hormones|mesh-ancestor
56356074|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356075|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356076|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56356077|NCT00255073|Baclofen|baclofen|mesh-list
56356078|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56356079|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356080|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56356081|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356082|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56356083|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
56356084|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
56356085|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356086|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356088|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356089|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356090|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
56356091|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356092|NCT00069875|Antiviral Agents|antiviral agents|mesh-ancestor
56651492|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651493|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56651494|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56651495|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56651496|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
56651497|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651498|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651499|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56651500|NCT02652312|Narcotics|narcotics|mesh-ancestor
56651501|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56356093|NCT00069875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356094|NCT00069875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356095|NCT00069875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356096|NCT00069875|Immunologic Factors|immunologic factors|mesh-ancestor
56356097|NCT00069875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356098|NCT00255268|Goserelin|goserelin|mesh-list
56356099|NCT00255268|Bicalutamide|bicalutamide|mesh-list
56356100|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356101|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356102|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
56356120|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56356121|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56356122|NCT00069992|Fludarabine|fludarabine|mesh-list
56356123|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
56356124|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356125|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56356126|NCT00255463|Gefitinib|gefitinib|mesh-list
56356127|NCT00255463|Anastrozole|anastrozole|mesh-list
56356128|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356129|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56356130|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356131|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356132|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356133|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56356134|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56356135|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56356136|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
56356137|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356138|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356140|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56356141|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56356142|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
56356143|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
56356144|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356145|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356146|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56356147|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56356148|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56356149|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
56356150|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356151|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356152|NCT00255541|Glyburide|glyburide|mesh-list
56356153|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56356154|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356155|NCT00255658|Sirolimus|sirolimus|mesh-list
56356156|NCT00255658|Sorafenib|sorafenib|mesh-list
56356157|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356159|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356160|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356169|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
56356170|NCT00070148|Oxandrolone|oxandrolone|mesh-list
56356171|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56356172|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56356173|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56651502|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
56651503|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
56651504|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56651505|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
56356174|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
56356175|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56356176|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356177|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56356178|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56356179|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356180|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356181|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
56356182|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56356183|NCT00070148|Androgens|androgens|mesh-ancestor
56356184|NCT00070148|Hormones|hormones|mesh-ancestor
56356185|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356186|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
56356187|NCT00100581|Interferons|interferons|mesh-list
56356188|NCT00100581|Ritonavir|ritonavir|mesh-list
56356189|NCT00100581|Tenofovir|tenofovir|mesh-list
56356190|NCT00100581|Ribavirin|ribavirin|mesh-list
56356191|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
56356192|NCT00100581|Lamivudine|lamivudine|mesh-list
56356193|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
56356194|NCT00100581|Efavirenz|efavirenz|mesh-list
56356195|NCT00100581|Lopinavir|lopinavir|mesh-list
56356196|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56356197|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356198|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
56356199|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356200|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56356201|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56356202|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
56356203|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356204|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356205|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56356206|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56356207|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56356208|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56356209|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56356210|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56356211|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
56356212|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
56356213|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356214|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56356215|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56356216|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56356217|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56356218|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56356220|NCT00070187|Cytarabine|cytarabine|mesh-list
56356221|NCT00070187|Aldesleukin|aldesleukin|mesh-list
56356222|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
56356223|NCT00070187|Cyclosporine|cyclosporine|mesh-list
56356224|NCT00070187|Etoposide|etoposide|mesh-list
56356225|NCT00070187|Melphalan|melphalan|mesh-list
56356226|NCT00070187|Interleukin-2|interleukin-2|mesh-list
56356227|NCT00070187|Carmustine|carmustine|mesh-list
56356228|NCT00070187|Cyclosporins|cyclosporins|mesh-list
56356229|NCT00070187|Lenograstim|lenograstim|mesh-list
56356230|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56356245|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
56356246|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56356247|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56356248|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56356249|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
56356250|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56356251|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56356252|NCT00070187|Analgesics|analgesics|mesh-ancestor
56356253|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
56356254|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356255|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56356256|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56356257|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56356258|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
56356259|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56651506|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56651507|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56651508|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
56651509|NCT02652312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56651510|NCT02652312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56356260|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
56356261|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56356262|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356263|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56356264|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356265|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356266|NCT00415285|Docetaxel|docetaxel|mesh-list
56356267|NCT00415285|Capecitabine|capecitabine|mesh-list
56356268|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356269|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
56356270|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
56356271|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
56356272|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356273|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356274|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
56356275|NCT00256009|Misoprostol|misoprostol|mesh-list
56356276|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56356277|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
56356278|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56356279|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356280|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56356281|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56356282|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
56356283|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
56356284|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56356285|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356286|NCT00070265|Capecitabine|capecitabine|mesh-list
56356287|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
56356288|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356289|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
56356290|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356291|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356292|NCT00104598|Bupropion|bupropion|mesh-list
56356301|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356302|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356303|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56356304|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56356305|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356306|NCT00256321|Celecoxib|celecoxib|mesh-list
56356307|NCT00256321|Capecitabine|capecitabine|mesh-list
56356308|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
56356309|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356310|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
56356311|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356312|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356313|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56356314|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56356315|NCT00256321|Analgesics|analgesics|mesh-ancestor
56356316|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
56356317|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356318|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356319|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56356320|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56356321|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56356322|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56356323|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356324|NCT00070304|Gemcitabine|gemcitabine|mesh-list
56356325|NCT00070304|Vinorelbine|vinorelbine|mesh-list
56356326|NCT00070304|Lenograstim|lenograstim|mesh-list
56356327|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356328|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
56356329|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356330|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356331|NCT00070304|Antiviral Agents|antiviral agents|mesh-ancestor
56356332|NCT00070304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356333|NCT00070304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651511|NCT02652312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56651512|NCT02652312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56214437|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356334|NCT00070304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356335|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
56356336|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356337|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56356338|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56356339|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
56356340|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
56356341|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
56356342|NCT00100737|Rituximab|rituximab|mesh-list
56356343|NCT00100737|Interleukin-2|interleukin-2|mesh-list
56356344|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56356345|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356346|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
56356347|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356348|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56356349|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56356350|NCT00100737|Analgesics|analgesics|mesh-ancestor
56356351|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
56356352|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356353|NCT00070343|Dacarbazine|dacarbazine|mesh-list
56356354|NCT00070343|Oblimersen|oblimersen|mesh-list
56356355|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56356356|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
56356357|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356368|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
56356369|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356370|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356371|NCT00256711|Vinorelbine|vinorelbine|mesh-list
56356372|NCT00256711|Gefitinib|gefitinib|mesh-list
56356373|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56356374|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356375|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
56356376|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
56356377|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
56356378|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356379|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56356380|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356381|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
56356382|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
56356383|NCT00070382|Hematinics|hematinics|mesh-ancestor
56356384|NCT04709380|Sorafenib|sorafenib|mesh-list
56356385|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356386|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56356387|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356388|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356389|NCT00256828|Lamivudine|lamivudine|mesh-list
56356390|NCT00256828|Efavirenz|efavirenz|mesh-list
56356391|NCT00256828|Didanosine|didanosine|mesh-list
56356392|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56356393|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56356394|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356395|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356396|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
56356397|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356398|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56356399|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56356400|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56356401|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56356402|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56356403|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56356404|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56356405|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56356406|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
56356407|NCT00100776|Olanzapine|olanzapine|mesh-list
56356408|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
56356409|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
56356410|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356411|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356412|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56651513|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56651514|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651515|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651516|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56651517|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651518|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56356413|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56356414|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56356415|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56356416|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56356417|NCT00100776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56356418|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56356419|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56356420|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356421|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356422|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
56356423|NCT04709185|Dexamethasone|dexamethasone|mesh-list
56356433|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356434|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356435|NCT00070538|Cytarabine|cytarabine|mesh-list
56356436|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356437|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
56356438|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356439|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356440|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
56356441|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356442|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356443|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
56356444|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356445|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56356446|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56356447|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56356448|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56356449|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356450|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56356451|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56356452|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56356453|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
56356454|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356455|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356456|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55978283|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
56356457|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56356458|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
56356459|NCT00257062|Levofloxacin|levofloxacin|mesh-list
56356460|NCT00257062|Ofloxacin|ofloxacin|mesh-list
56356461|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56356462|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356463|NCT00257062|Renal Agents|renal agents|mesh-ancestor
56356464|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56356465|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56356466|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56356467|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356468|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356469|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356470|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56356471|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56356472|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56356473|NCT00100854|Fulvestrant|fulvestrant|mesh-list
56356474|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356475|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56356476|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356477|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356478|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356479|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56356480|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56356481|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
56214445|NCT01613092|Cefazolin|cefazolin|mesh-list
56356482|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356483|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356484|NCT00257140|Levofloxacin|levofloxacin|mesh-list
56356485|NCT00257140|Ofloxacin|ofloxacin|mesh-list
56356486|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56356496|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56356497|NCT00257257|Rimonabant|rimonabant|mesh-list
56356498|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56356499|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56356500|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56356501|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356502|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356503|NCT00257257|Hormones|hormones|mesh-ancestor
56356504|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356505|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356506|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
56356507|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
56356508|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56356509|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356510|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56356511|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56356512|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356513|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356514|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356515|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356516|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56356517|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
56356518|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356519|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56356520|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
56356521|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
56356522|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56356523|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
56356524|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356525|NCT00257491|Telmisartan|telmisartan|mesh-list
56356526|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56356527|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56356528|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55978375|NCT00248495|Pemetrexed|pemetrexed|mesh-list
56356529|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356530|NCT00104793|Carboplatin|carboplatin|mesh-list
56356531|NCT00104793|Irinotecan|irinotecan|mesh-list
56356532|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356533|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56356534|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56356535|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356536|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356537|NCT00070655|Vitamin K|vitamin k|mesh-list
56356538|NCT00070655|Warfarin|warfarin|mesh-list
56356539|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
56356540|NCT00070655|Idraparinux|idraparinux|mesh-list
56356541|NCT00070655|Vitamins|vitamins|mesh-ancestor
56356542|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
56356543|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356544|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
56356545|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56356546|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56356547|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356548|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
56356549|NCT00070655|Coagulants|coagulants|mesh-ancestor
56356550|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56356564|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56356565|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
56356566|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
56356567|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356568|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356569|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356570|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
56356571|NCT00100893|Procyanidin|procyanidin|mesh-list
56356573|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356574|NCT00100893|Protective Agents|protective agents|mesh-ancestor
56356575|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356576|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56651519|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56651520|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56651521|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56651522|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56651523|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56651524|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
56651525|NCT04165512|Triamcinolone|triamcinolone|mesh-list
56651526|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56356577|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56356578|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356579|NCT00257803|Oxytocin|oxytocin|mesh-list
56356580|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
56356581|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56356582|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356583|NCT00401115|Sirolimus|sirolimus|mesh-list
56356584|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56356585|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356586|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56356587|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356588|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
56356589|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356590|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
56356591|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356592|NCT00257959|Amiodarone|amiodarone|mesh-list
56356593|NCT00257959|Sotalol|sotalol|mesh-list
56356594|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56356595|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56356596|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
56356597|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356598|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356599|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356600|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56356601|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
56356602|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56356603|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56356604|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56356605|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56356606|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56356607|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356608|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56356609|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56356610|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56356611|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
56356612|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
56356622|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356623|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356624|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356625|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
56356626|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
56356627|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56356628|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356629|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56356630|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56356631|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56356632|NCT00258115|Analgesics|analgesics|mesh-ancestor
56356633|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
56356634|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356635|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356636|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56356637|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56356638|NCT00258193|Linaclotide|linaclotide|mesh-list
56356639|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56356640|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
56356641|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356642|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56356644|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
56651527|NCT04165512|Bupivacaine|bupivacaine|mesh-list
56214454|NCT01613105|Acarbose|acarbose|mesh-list
56356645|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356646|NCT00258232|Celecoxib|celecoxib|mesh-list
56356647|NCT00258232|Capecitabine|capecitabine|mesh-list
56356648|NCT00258232|Irinotecan|irinotecan|mesh-list
56356649|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356650|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
56356651|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356652|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356653|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56356654|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56356655|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356656|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56356657|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56356659|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
56356660|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356661|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356662|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56356663|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56356664|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56356665|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56356666|NCT00258271|Cytarabine|cytarabine|mesh-list
56356667|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
56356668|NCT00258271|Cladribine|cladribine|mesh-list
56356669|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356670|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
56356671|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356672|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356673|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
56356674|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356675|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356676|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
56356677|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356678|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56356679|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978509|NCT01979445|Clopidogrel|clopidogrel|mesh-list
56356691|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356692|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356694|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
56356695|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356696|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56356697|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356698|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356699|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56356700|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356701|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56356702|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
56356703|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356704|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
56356705|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356706|NCT00258622|Lidocaine|lidocaine|mesh-list
56356707|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
56356708|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
56356709|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56356710|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356711|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
56356712|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356713|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56356714|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56356715|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56356716|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56356717|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356719|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56356720|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56356721|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56356722|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356723|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56356724|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56356725|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56356726|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56356727|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
56356728|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
56651528|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
56651529|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
56651530|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651531|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356729|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
56356730|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
56356731|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356732|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356734|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356735|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56356736|NCT00415324|Cisplatin|cisplatin|mesh-list
56356737|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356738|NCT00258739|Gemcitabine|gemcitabine|mesh-list
56356739|NCT00258739|Carboplatin|carboplatin|mesh-list
56356740|NCT00258739|Docetaxel|docetaxel|mesh-list
56356741|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356742|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356743|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
56356744|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356749|NCT00258739|Immunologic Factors|immunologic factors|mesh-ancestor
56356750|NCT00258739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356751|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
56356752|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
56356753|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
56356754|NCT00104949|Trastuzumab|trastuzumab|mesh-list
56356755|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56356756|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356757|NCT00101127|Gemcitabine|gemcitabine|mesh-list
56356758|NCT00101127|Docetaxel|docetaxel|mesh-list
56356759|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356760|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
56356761|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356762|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356763|NCT00101127|Antiviral Agents|antiviral agents|mesh-ancestor
56356764|NCT00101127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356765|NCT00101127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356766|NCT00101127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356767|NCT00101127|Immunologic Factors|immunologic factors|mesh-ancestor
56356768|NCT00101127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356769|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
56356770|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
56356771|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
56356772|NCT00259051|Omeprazole|omeprazole|mesh-list
56356773|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56356774|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56356775|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56356776|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356777|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356778|NCT00259129|Sorafenib|sorafenib|mesh-list
56356779|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356780|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56356781|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356782|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356783|NCT00259168|Nateglinide|nateglinide|mesh-list
56356784|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56356785|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356786|NCT00071084|Zanolimumab|zanolimumab|mesh-list
56171122|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
56356787|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56356788|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356789|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
56356790|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356791|NCT00104988|Thalidomide|thalidomide|mesh-list
56356792|NCT00104988|Temozolomide|temozolomide|mesh-list
56356793|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56356794|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
56356795|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356796|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356797|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356798|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
56356799|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356800|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
56651532|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
56651533|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651534|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651535|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
56651536|NCT04165512|Hormones|hormones|mesh-ancestor
56651537|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56651538|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356801|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56356802|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356803|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56356804|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56356805|NCT00104988|Growth Substances|growth substances|mesh-ancestor
56356806|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
56356807|NCT00415402|Vitamin D|vitamin d|mesh-list
56356808|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
56356809|NCT00415402|Vitamins|vitamins|mesh-ancestor
56356810|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
56356811|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356812|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56356813|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56356814|NCT00259402|Fluorouracil|fluorouracil|mesh-list
56356815|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
56356816|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356819|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356820|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356822|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356823|NCT00259441|Simvastatin|simvastatin|mesh-list
56356824|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56356825|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56356826|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
56356827|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356828|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56356829|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56356830|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356831|NCT00071201|Adefovir|adefovir|mesh-list
56356832|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56356833|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
56356834|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356835|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56356836|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56356837|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356838|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356839|NCT00259636|Zonisamide|zonisamide|mesh-list
56356840|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
56356841|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56356842|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56356843|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356844|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56356845|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356846|NCT00259675|Gemcitabine|gemcitabine|mesh-list
56356847|NCT00259675|Carboplatin|carboplatin|mesh-list
56356848|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356849|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356850|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
56356851|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356852|NCT00259675|Antiviral Agents|antiviral agents|mesh-ancestor
56356853|NCT00259675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356854|NCT00259675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356855|NCT00259675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356856|NCT00259675|Immunologic Factors|immunologic factors|mesh-ancestor
56356857|NCT00259675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356858|NCT00105105|Mifepristone|mifepristone|mesh-list
56356859|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56356860|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
56356861|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56356862|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123073|NCT01554618|Hormones|hormones|mesh-ancestor
56651539|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
56214465|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
56356863|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56356864|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56356865|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56356866|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
56356867|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56356868|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56356869|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
56356870|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356871|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
56356872|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56356873|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56356875|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56356877|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356878|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356879|NCT00259792|Budesonide|budesonide|mesh-list
56356880|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
56356881|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56356882|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56356883|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
56356884|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356885|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356886|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56356887|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
56356890|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356891|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56356892|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56356893|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56356894|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
56356895|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356896|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356897|NCT00105144|Caspofungin|caspofungin|mesh-list
56356898|NCT00105144|Micafungin|micafungin|mesh-list
56356899|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
56356900|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356901|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356902|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356903|NCT00259870|Olanzapine|olanzapine|mesh-list
56356904|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
56356905|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
56356906|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356907|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356908|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56356909|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56356910|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56356911|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56356912|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56356913|NCT00259870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56356914|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56356915|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56356916|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356917|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356918|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
56356919|NCT00071279|Idraparinux|idraparinux|mesh-list
56356920|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56356921|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
56356922|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56356923|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
56356924|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356925|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356926|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
56356928|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356929|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56356930|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356931|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356932|NCT00260026|Docetaxel|docetaxel|mesh-list
56356933|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356934|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
56356935|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
56651544|NCT02642874|Methocarbamol|methocarbamol|mesh-list
56651545|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
56356936|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
56356937|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356938|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
56356939|NCT00260143|Testosterone|testosterone|mesh-list
56356940|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
56356941|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
56356942|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56356943|NCT00260143|Androgens|androgens|mesh-ancestor
56356944|NCT00260143|Hormones|hormones|mesh-ancestor
56356945|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356946|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356947|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356948|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356949|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
56356950|NCT00260260|Oxycodone|oxycodone|mesh-list
56356951|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56356952|NCT00260260|Narcotics|narcotics|mesh-ancestor
56356953|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56356954|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356955|NCT00260260|Analgesics|analgesics|mesh-ancestor
56356956|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
56356957|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356958|NCT00105300|Adalimumab|adalimumab|mesh-list
56356959|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56356960|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56356961|NCT00260416|Abciximab|abciximab|mesh-list
56356962|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
56356965|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
56356966|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356967|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
56356968|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
56356969|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
56356970|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356971|NCT00424086|Vaccines|vaccines|mesh-list
56356972|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
56356973|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356974|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
56356975|NCT00101205|Etoposide|etoposide|mesh-list
56356976|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
56356977|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356978|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56356979|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56356980|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55978810|NCT03381183|Durvalumab|durvalumab|mesh-list
56356981|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356982|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356983|NCT00261079|Fexofenadine|fexofenadine|mesh-list
56356984|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56356985|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56356986|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56356987|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
56356988|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
56356989|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356990|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356991|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356993|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56356994|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356995|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
56356996|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356997|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56356998|NCT00071747|Lamotrigine|lamotrigine|mesh-list
56356999|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
56357000|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56357001|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56357002|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357003|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56357004|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357005|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56357006|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651546|NCT02642874|Calcium|calcium|mesh-list
56651547|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56547637|NCT04258930|Calcium|calcium|mesh-list
56651548|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651549|NCT02642874|Antacids|antacids|mesh-ancestor
56651550|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651551|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56651552|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56651553|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56651554|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651556|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
56357007|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56357008|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56357009|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56357010|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
56357011|NCT00261313|Hematinics|hematinics|mesh-ancestor
56357012|NCT00261352|Metformin|metformin|mesh-list
56357013|NCT00261352|Fenofibrate|fenofibrate|mesh-list
56357014|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56357015|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357016|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56357017|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
56357018|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357019|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56357020|NCT00261391|Marimastat|marimastat|mesh-list
56357021|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357022|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357024|NCT00071942|Vaccines|vaccines|mesh-list
56357025|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
56357026|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357027|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357028|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56357029|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56357030|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56357031|NCT00261469|Topiramate|topiramate|mesh-list
56357032|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
56357033|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56357034|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357035|NCT00261508|Risperidone|risperidone|mesh-list
56357036|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56357037|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
56357040|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357041|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56357042|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56357043|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56357044|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56357045|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56357046|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
56357047|NCT00261547|Rituximab|rituximab|mesh-list
56357048|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56357049|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357050|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
56357051|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357052|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357053|NCT00261586|Aspirin|aspirin|mesh-list
56357054|NCT00261586|Acetaminophen|acetaminophen|mesh-list
56357055|NCT00261586|Ibuprofen|ibuprofen|mesh-list
56357056|NCT00261586|Celecoxib|celecoxib|mesh-list
56357057|NCT00261586|Naproxen|naproxen|mesh-list
56357058|NCT00261586|Rofecoxib|rofecoxib|mesh-list
56357059|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56357060|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56357061|NCT00261586|Analgesics|analgesics|mesh-ancestor
56357062|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
56357063|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357064|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357065|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651557|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651558|NCT00653874|Protective Agents|protective agents|mesh-ancestor
56651559|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651560|NCT04224701|Vaccines|vaccines|mesh-list
56651561|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
56651562|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651563|NCT00653952|Paclitaxel|paclitaxel|mesh-list
56651564|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56651565|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651566|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
56651567|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
56651568|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
56214483|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
56357066|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357067|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56357068|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56357069|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357070|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56357071|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56357072|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357073|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
56357074|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56357075|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
56357076|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
56357077|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56357078|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357079|NCT00261625|Alendronate|alendronate|mesh-list
56357080|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56357081|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357082|NCT00261703|Cisplatin|cisplatin|mesh-list
56357083|NCT00261703|Docetaxel|docetaxel|mesh-list
56357084|NCT00261703|Fluorouracil|fluorouracil|mesh-list
56357085|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357086|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
56357087|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
56357088|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
56357089|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357090|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
56357091|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357092|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357093|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
56357094|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357095|NCT00261742|Penicillins|penicillins|mesh-list
56357096|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56357097|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357098|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
56357100|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
56357101|NCT00261820|Sirolimus|sirolimus|mesh-list
56357102|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
56357103|NCT00261820|Prednisolone|prednisolone|mesh-list
56357104|NCT00261820|Tacrolimus|tacrolimus|mesh-list
56357105|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357106|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
56357107|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357108|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56357109|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357110|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357111|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56357112|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357113|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56357115|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56357116|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357117|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
56357118|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651569|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651570|NCT00650364|Midodrine|midodrine|mesh-list
56651571|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
56357119|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
56357120|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
56357121|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357122|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56357123|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
56357125|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56357126|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56357127|NCT00261820|Protective Agents|protective agents|mesh-ancestor
56357128|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56357129|NCT00072098|Interleukin-12|interleukin-12|mesh-list
56357130|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56357131|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
56357132|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978954|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357133|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56357134|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56357136|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
56357137|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357138|NCT00261937|Furosemide|furosemide|mesh-list
56357139|NCT00261937|Diuretics|diuretics|mesh-ancestor
56357140|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
56357141|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357142|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56357143|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56357144|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357145|NCT00105495|Deferiprone|deferiprone|mesh-list
56357146|NCT00105495|Deferoxamine|deferoxamine|mesh-list
56357147|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56357148|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
56357149|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
56357150|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357151|NCT00105495|Siderophores|siderophores|mesh-ancestor
56357152|NCT00261976|Infliximab|infliximab|mesh-list
56357153|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
56357154|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56357155|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357156|NCT00072137|Metronidazole|metronidazole|mesh-list
56357157|NCT00072137|Molgramostim|molgramostim|mesh-list
56357158|NCT00072137|Vaccines|vaccines|mesh-list
56357159|NCT00072137|Sargramostim|sargramostim|mesh-list
56357160|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
56357161|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357162|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357163|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357164|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56357165|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56357166|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56357167|NCT00262015|Vaccines|vaccines|mesh-list
56357168|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
56357169|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357170|NCT00262054|Heparin|heparin|mesh-list
56357171|NCT00262054|Calcium heparin|calcium heparin|mesh-list
56357172|NCT00262054|Bivalirudin|bivalirudin|mesh-list
56357173|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
56357174|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56357175|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56357176|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357178|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56357179|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
56357180|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357181|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
56357182|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56357183|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357184|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56357185|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
56357186|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56357187|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357188|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357189|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357190|NCT00262210|Prednisolone|prednisolone|mesh-list
56357205|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56651572|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
56651573|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651574|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651575|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56214498|NCT01613547|Amoxicillin|amoxicillin|mesh-list
56357207|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979025|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56357208|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
56357209|NCT00262210|Hormones|hormones|mesh-ancestor
56357210|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56357211|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56357212|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56357213|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56357214|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56357216|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
56357217|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357218|NCT00262327|Endostatins|endostatins|mesh-list
56357219|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357220|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56357221|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56357222|NCT00262327|Growth Substances|growth substances|mesh-ancestor
56357223|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357224|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
56357225|NCT02966288|Ibuprofen|ibuprofen|mesh-list
56357226|NCT02966288|Ketorolac|ketorolac|mesh-list
56357227|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56357228|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56357229|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56357230|NCT02966288|Analgesics|analgesics|mesh-ancestor
56357231|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
56357232|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357233|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357234|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56357235|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357236|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56357237|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357238|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357239|NCT00262405|Prednisone|prednisone|mesh-list
56357240|NCT00262405|Zileuton|zileuton|mesh-list
56357241|NCT00262405|Azathioprine|azathioprine|mesh-list
56357242|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56357243|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
56357244|NCT00262405|Hormones|hormones|mesh-ancestor
56357245|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56357246|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357247|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56357248|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357252|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357253|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
56357254|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357255|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56357256|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56357257|NCT00262405|Analgesics|analgesics|mesh-ancestor
56357258|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
56357259|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357260|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56357261|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357262|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56357263|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
56357264|NCT00262483|Ribavirin|ribavirin|mesh-list
56357265|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56357266|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
56357267|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357268|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
56357269|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357270|NCT00262561|Aspirin|aspirin|mesh-list
56357271|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56357272|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56357273|NCT00262561|Analgesics|analgesics|mesh-ancestor
56357274|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
56651576|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56651577|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56651578|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56651579|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
56357275|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357276|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357277|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56357278|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357279|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56357280|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56357281|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357282|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56171155|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56357283|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56357284|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357285|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
56357286|NCT00072215|Paclitaxel|paclitaxel|mesh-list
56357287|NCT00072215|Vinblastine|vinblastine|mesh-list
56357288|NCT00072215|Ifosfamide|ifosfamide|mesh-list
56357289|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56357290|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357291|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
56357292|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
56357293|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
56357294|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357295|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56357296|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
56357297|NCT00262795|Fludarabine|fludarabine|mesh-list
56357298|NCT00262795|Chlorambucil|chlorambucil|mesh-list
56357299|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357300|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357301|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56357302|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
56357303|NCT00072332|Cisplatin|cisplatin|mesh-list
56357304|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357305|NCT00263029|Capecitabine|capecitabine|mesh-list
56357306|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
56357307|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357308|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
56357309|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357310|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357311|NCT00263068|Rotigotine|rotigotine|mesh-list
56357312|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
56357313|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
56357314|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357315|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357316|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357317|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56357318|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56357319|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56357324|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56357325|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
56357326|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357327|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357328|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56357329|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56357330|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
56357331|NCT00263185|Vitamin D|vitamin d|mesh-list
56357332|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
56357333|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
56357334|NCT00263185|Vitamins|vitamins|mesh-list
56357335|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
56357336|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
56357337|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357338|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56357339|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56357340|NCT00263185|Antacids|antacids|mesh-ancestor
56357341|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357342|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56357343|NCT00263263|Sirolimus|sirolimus|mesh-list
56357344|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56124223|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
56651580|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651581|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357345|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357346|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56357347|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357348|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
56357349|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357350|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
56357351|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357352|NCT00101673|Vildagliptin|vildagliptin|mesh-list
56357353|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56357354|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357355|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56357356|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
56171156|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56357357|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979172|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357358|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357359|NCT00263302|Dexamethasone|dexamethasone|mesh-list
56357360|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56357361|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
56357362|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
56357363|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357364|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357365|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56357366|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
56357367|NCT00263302|Hormones|hormones|mesh-ancestor
56357368|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56357369|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56357370|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357371|NCT00263458|Buprenorphine|buprenorphine|mesh-list
56357372|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56357373|NCT00263458|Narcotics|narcotics|mesh-ancestor
56357374|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56357375|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357376|NCT00263458|Analgesics|analgesics|mesh-ancestor
56357377|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
56357378|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357379|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56357380|NCT00101712|Vildagliptin|vildagliptin|mesh-list
56357381|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56357382|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357383|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56357384|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
56357385|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357386|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357387|NCT00072527|Carboplatin|carboplatin|mesh-list
56357388|NCT00072527|Irinotecan|irinotecan|mesh-list
56357390|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357391|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56357392|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56357393|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357394|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357395|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56357396|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56357398|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
56357399|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56357400|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357401|NCT00263965|Metformin|metformin|mesh-list
56357402|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56357403|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357404|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
56357405|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56357406|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357407|NCT00072683|Tolvaptan|tolvaptan|mesh-list
56357408|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56357409|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357410|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
56357411|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357412|NCT00101790|Pamidronate|pamidronate|mesh-list
56357413|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56651582|NCT04909697|Sivelestat|sivelestat|mesh-list
56651583|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56651584|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
56357414|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357415|NCT00264277|Vitamin K|vitamin k|mesh-list
56357416|NCT00264277|Anticoagulants|anticoagulants|mesh-list
56357417|NCT00264277|Vitamins|vitamins|mesh-ancestor
56357418|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
56357419|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357420|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56357421|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56357422|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357423|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
56357424|NCT00264277|Coagulants|coagulants|mesh-ancestor
56357425|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56357426|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357427|NCT04709029|Dexamethasone|dexamethasone|mesh-list
56357428|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
56357429|NCT04709029|BB 1101|bb 1101|mesh-list
56357430|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56357431|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
56357432|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
56357433|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357434|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979249|NCT02665117|Cathartics|cathartics|mesh-ancestor
56357435|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56357438|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56357439|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56357440|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357441|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
56357442|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357443|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357444|NCT00072722|Pomalidomide|pomalidomide|mesh-list
56357445|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
56357446|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357447|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56357448|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56357449|NCT00072722|Growth Substances|growth substances|mesh-ancestor
56357450|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
56357451|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357452|NCT00264355|Cyclosporine|cyclosporine|mesh-list
56357453|NCT00264355|Cyclosporins|cyclosporins|mesh-list
56357454|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357455|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357456|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357457|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
56357458|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357459|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
56357460|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357461|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
56357462|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357463|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56357464|NCT00264472|Eniluracil|eniluracil|mesh-list
56357465|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357469|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357470|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
56357471|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357472|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357473|NCT00072839|Teduglutide|teduglutide|mesh-list
56357474|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56357475|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56357476|NCT00072839|Protective Agents|protective agents|mesh-ancestor
56357477|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357478|NCT00264628|Casopitant|casopitant|mesh-list
56357479|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
56357480|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
56357481|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357482|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357483|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56357484|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56357485|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357486|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357487|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
56357488|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56651585|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651586|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651587|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
56651588|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
56357489|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357490|NCT00265018|Doxorubicin|doxorubicin|mesh-list
56357491|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56357492|NCT00265018|Bleomycin|bleomycin|mesh-list
56357493|NCT00265018|Vinblastine|vinblastine|mesh-list
56357494|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56357495|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357496|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56357497|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56357498|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357499|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357500|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56357501|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56357502|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56357503|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56357504|NCT00265135|Siltuximab|siltuximab|mesh-list
56357505|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357506|NCT00106197|Bupropion|bupropion|mesh-list
56357507|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56357508|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
56357509|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56357510|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56357511|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56357512|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56357513|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357514|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
56357515|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357516|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357517|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56357518|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56357519|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357520|NCT00265252|Alendronate|alendronate|mesh-list
56357521|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56357522|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357524|NCT00265291|Desipramine|desipramine|mesh-list
56357525|NCT00265291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56357526|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56357527|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56357528|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357529|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357530|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
56357531|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357532|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56357533|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
56357534|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56357535|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55871607|NCT03373851|Dsuvia|dsuvia|mesh-list
56357538|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56357539|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56357540|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
56357542|NCT00265408|Warfarin|warfarin|mesh-list
56357543|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56357544|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56357545|NCT00265408|Analgesics|analgesics|mesh-ancestor
56357546|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
56357547|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357548|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357549|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56357550|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357551|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56357552|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56357553|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357554|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56357555|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56357556|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651589|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56651590|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651591|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56651592|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56651593|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651594|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651595|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651596|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56651597|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56651598|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
56214518|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
56357557|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
56357558|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
56357559|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
56357560|NCT00265486|Hematinics|hematinics|mesh-ancestor
56357561|NCT00265642|Irbesartan|irbesartan|mesh-list
56357562|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56357563|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56357564|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56357565|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357566|NCT00265876|Gemcitabine|gemcitabine|mesh-list
56357567|NCT00265876|Saracatinib|saracatinib|mesh-list
56357568|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357569|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
56357570|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357571|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357572|NCT00265876|Antiviral Agents|antiviral agents|mesh-ancestor
56357573|NCT00265876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357574|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357576|NCT00265876|Immunologic Factors|immunologic factors|mesh-ancestor
56357577|NCT00265876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357578|NCT00265915|Rituximab|rituximab|mesh-list
56357579|NCT00265915|Sargramostim|sargramostim|mesh-list
56357580|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56357581|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357582|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
56357583|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357584|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357585|NCT00265993|Enoxaparin|enoxaparin|mesh-list
56357586|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
56357587|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56357588|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56357589|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357590|NCT00266149|Lamotrigine|lamotrigine|mesh-list
56357591|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
56357592|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56357593|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56357594|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357595|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56357596|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357597|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56357598|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56357599|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56357600|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56357601|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56357602|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56357603|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56357604|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
56357605|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357606|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56357607|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56357608|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357611|NCT00415831|Entacapone|entacapone|mesh-list
56651599|NCT00654108|Protective Agents|protective agents|mesh-ancestor
56651600|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651601|NCT00654108|Vitamins|vitamins|mesh-ancestor
56651602|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
56651603|NCT02639598|Topiramate|topiramate|mesh-list
56651604|NCT02639598|Flunarizine|flunarizine|mesh-list
56357612|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56357613|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56357614|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56357615|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
56357616|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357617|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357618|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357619|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56357620|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357621|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56357622|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56357623|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
56357624|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
56357625|NCT00102141|Drospirenone|drospirenone|mesh-list
56357626|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56357627|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56357628|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56357629|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56357630|NCT00102141|Estradiol|estradiol|mesh-list
56357631|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56357632|NCT00102141|Estrogens|estrogens|mesh-ancestor
56357633|NCT00102141|Hormones|hormones|mesh-ancestor
56357634|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56357635|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357636|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56357637|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
56357638|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56357639|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56357640|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56357641|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
56357642|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56357643|NCT00102141|Diuretics|diuretics|mesh-ancestor
56357644|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
56357645|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56357646|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56357647|NCT00266344|Gaboxadol|gaboxadol|mesh-list
56357648|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357649|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357650|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357651|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357652|NCT00266344|Analgesics|analgesics|mesh-ancestor
56357653|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
56357654|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
56357655|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
56357656|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
56357657|NCT00266539|Fentanyl|fentanyl|mesh-list
56357658|NCT00266539|Morphine|morphine|mesh-list
56357659|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56357660|NCT00266539|Narcotics|narcotics|mesh-ancestor
56357661|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56357662|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357663|NCT00266539|Analgesics|analgesics|mesh-ancestor
56357664|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
56357665|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357666|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56357667|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56357668|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
56357669|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
56357670|NCT00266578|Fluticasone|fluticasone|mesh-list
56357671|NCT00266578|Xhance|xhance|mesh-list
56357672|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56357673|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56357674|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
56357675|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357676|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651605|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
56651606|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56651607|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651608|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56651609|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56651610|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651611|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56651612|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56651613|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
56651614|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
56651615|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986178|NCT02790515|Sirolimus|sirolimus|mesh-list
56357677|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56357678|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
56357679|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
56357680|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56357681|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
56357682|NCT00266617|Hematinics|hematinics|mesh-ancestor
56357683|NCT00102219|Doxorubicin|doxorubicin|mesh-list
56357684|NCT00102219|Pemetrexed|pemetrexed|mesh-list
56357693|NCT01349569|Lenalidomide|lenalidomide|mesh-list
56357694|NCT01349569|Vaccines|vaccines|mesh-list
56357695|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
56357696|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357697|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56357698|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56357699|NCT01349569|Growth Substances|growth substances|mesh-ancestor
56357700|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
56357701|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357702|NCT00267163|Donepezil|donepezil|mesh-list
56357703|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56357704|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357705|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357706|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
56357707|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357708|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357709|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
56357710|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
56357711|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
56357712|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56357713|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
56357714|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357715|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357716|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357717|NCT00073385|Docetaxel|docetaxel|mesh-list
56357718|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357719|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
56357720|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
56357721|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
56357722|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357723|NCT00102258|Hormones|hormones|mesh-list
56357724|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56357725|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357726|NCT00267514|Sevelamer|sevelamer|mesh-list
56357727|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
56357728|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
56357729|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357730|NCT00267553|Toremifene|toremifene|mesh-list
56357731|NCT00267553|Letrozole|letrozole|mesh-list
56357732|NCT00267553|Atamestane|atamestane|mesh-list
56357733|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357734|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56357735|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56357736|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124226|NCT01470144|Tezosentan|tezosentan|mesh-list
56651616|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
56651617|NCT04907279|Aripiprazole|aripiprazole|mesh-list
56651618|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
56651619|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56214540|NCT01613807|Insulin|insulin|mesh-list
56357737|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357738|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56357739|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
56357740|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56357741|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357742|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56357743|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56357744|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56357745|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56357746|NCT00106548|Methotrexate|methotrexate|mesh-list
56357747|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56357748|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
56357749|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56357753|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357754|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357755|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
56357756|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357757|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56357758|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357759|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
56357760|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357761|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56357762|NCT00267709|Visilizumab|visilizumab|mesh-list
56357763|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
56357764|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357765|NCT00267826|Rituximab|rituximab|mesh-list
56357766|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56357767|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357768|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
56357769|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357770|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357771|NCT00425620|Amphotericin B|amphotericin b|mesh-list
56357772|NCT00425620|Amebicides|amebicides|mesh-ancestor
56357773|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56357774|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56357775|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357776|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56357777|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
56357778|NCT00106587|Paclitaxel|paclitaxel|mesh-list
56357779|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56357780|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357781|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56357782|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56357783|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
56357784|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357785|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56357786|NCT00267943|Telmisartan|telmisartan|mesh-list
56357787|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56357788|NCT00267943|Diuretics|diuretics|mesh-ancestor
56357789|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
56357790|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357791|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56357792|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56357793|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357794|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56357795|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56357796|NCT04711265|Vaccines|vaccines|mesh-list
56357798|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357799|NCT00268138|Fluorides|fluorides|mesh-list
56357800|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
56357801|NCT00268138|Protective Agents|protective agents|mesh-ancestor
56357802|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357803|NCT00102375|Topotecan|topotecan|mesh-list
56357804|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56357805|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56651620|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56651621|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56214544|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
56357806|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357807|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357808|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357809|NCT00268177|Fluticasone|fluticasone|mesh-list
56357811|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56357812|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56357813|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56357814|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
56357815|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357816|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357817|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56357818|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
56357819|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
56357820|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56357821|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56357822|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56357823|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56357826|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357827|NCT00268216|Fluticasone|fluticasone|mesh-list
56357829|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56357830|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56357831|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56357832|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
56357833|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357834|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357835|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56357836|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
56357837|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
56357838|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56357839|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56357840|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56357841|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56357842|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
56357843|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991364|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56357844|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357845|NCT00073580|Hirudins|hirudins|mesh-list
56357846|NCT00073580|Anticoagulants|anticoagulants|mesh-list
56357847|NCT00073580|Bivalirudin|bivalirudin|mesh-list
56357848|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
56357849|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56357850|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
56357851|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357852|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357853|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56357854|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56357855|NCT00073658|Risperidone|risperidone|mesh-list
56357856|NCT00073658|Citalopram|citalopram|mesh-list
56357857|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56357858|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
56357859|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357860|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357861|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357862|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56357863|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56357864|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56357865|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56357866|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56357867|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
56357868|NCT00073658|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56357869|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56171166|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
56357870|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56357871|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56357872|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
56357874|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56357875|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357876|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56357877|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651622|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651623|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651624|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
56651625|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
56651626|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651627|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651628|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56651629|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56651630|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
56214545|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56357878|NCT00102414|Gemcitabine|gemcitabine|mesh-list
56357879|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357880|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
56357881|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357882|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357883|NCT00102414|Antiviral Agents|antiviral agents|mesh-ancestor
55979705|NCT00767507|Cangrelor|cangrelor|mesh-list
56357885|NCT00102414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357886|NCT00102414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357887|NCT00102414|Immunologic Factors|immunologic factors|mesh-ancestor
56357888|NCT00102414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357889|NCT00268333|Leucovorin|leucovorin|mesh-list
56357890|NCT00268333|Fluorouracil|fluorouracil|mesh-list
56357891|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
56357892|NCT00268333|Calcium|calcium|mesh-list
56357893|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
56357894|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56357895|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357896|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
56357898|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357899|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357900|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357901|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
56357902|NCT00268333|Antidotes|antidotes|mesh-ancestor
56357903|NCT00268333|Protective Agents|protective agents|mesh-ancestor
56357904|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
56357905|NCT00268333|Vitamins|vitamins|mesh-ancestor
56357906|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
56357907|NCT00073697|Dexetimide|dexetimide|mesh-list
56357908|NCT00073697|Citalopram|citalopram|mesh-list
56357909|NCT00073697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56357910|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56357911|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56357912|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357913|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357914|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
56357915|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357916|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56357917|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
56357918|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56357919|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56357920|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56357921|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
56357922|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
56357923|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357924|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56357925|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56357926|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
56357927|NCT00268372|Docetaxel|docetaxel|mesh-list
56357928|NCT00268372|Fluorouracil|fluorouracil|mesh-list
56357929|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357930|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
56357931|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
56357932|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
56357933|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357934|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
56651631|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56651632|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56651633|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56651634|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56651635|NCT02642718|Ketorolac|ketorolac|mesh-list
56357935|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357936|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357937|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
56357938|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357939|NCT00268411|Gemcitabine|gemcitabine|mesh-list
56357940|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
56357941|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357942|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
56357943|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357944|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357945|NCT00268411|Antiviral Agents|antiviral agents|mesh-ancestor
56357946|NCT00268411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357947|NCT00268411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357948|NCT00268411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357949|NCT00268411|Immunologic Factors|immunologic factors|mesh-ancestor
56357950|NCT00268411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357951|NCT00073736|Cytarabine|cytarabine|mesh-list
56357952|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357953|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
56357954|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357955|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357956|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
56357957|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357958|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357959|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
56357960|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357961|NCT00268489|Bevacizumab|bevacizumab|mesh-list
56357962|NCT00268489|Pemetrexed|pemetrexed|mesh-list
56357963|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56357964|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357965|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56357966|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56357967|NCT00268489|Growth Substances|growth substances|mesh-ancestor
56357968|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357969|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
56357970|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357973|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56357974|NCT00268528|Methotrexate|methotrexate|mesh-list
56357975|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
56357976|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56357977|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
56357978|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56357979|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357980|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357981|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
56357982|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357983|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357984|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
56357985|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357986|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56357987|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357988|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
56357989|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357990|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56357991|NCT00073814|Albuterol|albuterol|mesh-list
56357992|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56357993|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
56357994|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56357995|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357996|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56357997|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
56357998|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
56357999|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56358000|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55903293|NCT01580969|Bevacizumab|bevacizumab|mesh-list
56651636|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56651637|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55986487|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
56358001|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56358002|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56358003|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
56358004|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358005|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358006|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
56358007|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56358008|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358009|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358010|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56358011|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56358012|NCT00102453|Protective Agents|protective agents|mesh-ancestor
56358013|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358014|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
56358015|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56358016|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
56358017|NCT00268567|Prednisone|prednisone|mesh-list
56358018|NCT00268567|Leflunomide|leflunomide|mesh-list
56358019|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56358020|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
56358021|NCT00268567|Hormones|hormones|mesh-ancestor
56358022|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358023|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358024|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56358025|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358026|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358027|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358028|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358029|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
56358030|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
56358031|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56358032|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979854|NCT02368431|Zonisamide|zonisamide|mesh-list
56358033|NCT00268684|Temozolomide|temozolomide|mesh-list
56358034|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56358035|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56358036|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
56358037|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358038|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358039|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56358040|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358043|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56358044|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
56358045|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358046|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358047|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56358048|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
56358049|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
56358050|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56358051|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
56358052|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358053|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358054|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
56358055|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
56358056|NCT00073931|Sargramostim|sargramostim|mesh-list
56358057|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
56358058|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358059|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358060|NCT00268723|Albuterol|albuterol|mesh-list
56358061|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56358062|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
56358063|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358064|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358065|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56358066|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
56358067|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
56358068|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56358069|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56651638|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651639|NCT02642718|Analgesics|analgesics|mesh-ancestor
56651640|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
56651641|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358070|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56358071|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56358072|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
56358073|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358074|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358076|NCT00268840|Docetaxel|docetaxel|mesh-list
56358077|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56358078|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
56358079|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358080|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358081|NCT00268840|Antiviral Agents|antiviral agents|mesh-ancestor
56358082|NCT00268840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358083|NCT00268840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171171|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
56358084|NCT00268840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358085|NCT00268840|Immunologic Factors|immunologic factors|mesh-ancestor
56358086|NCT00268840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358087|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
56358088|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
56358089|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
56358090|NCT00268879|Renzapride|renzapride|mesh-list
56358091|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56358092|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
56358093|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358094|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358095|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358096|NCT00268918|Docetaxel|docetaxel|mesh-list
56358097|NCT00268918|Vatalanib|vatalanib|mesh-list
56358098|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358099|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
56358100|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
56358101|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
56358102|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358103|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56358104|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358105|NCT00268957|Sevelamer|sevelamer|mesh-list
56358106|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
56358107|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
56358108|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358110|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56358111|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56358112|NCT00073970|Analgesics|analgesics|mesh-ancestor
56358113|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
56358114|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872122|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358116|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56358118|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56358119|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56358120|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358121|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358122|NCT00102492|Casopitant|casopitant|mesh-list
56358123|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
56358124|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
56358125|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358126|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358128|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56358129|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358130|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358131|NCT00269035|Risperidone|risperidone|mesh-list
56358132|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56358133|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
56358134|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358135|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358136|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358137|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56358138|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55903662|NCT00121251|Immunologic Factors|immunologic factors|mesh-ancestor
56651642|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651643|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214567|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
56358139|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56358140|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56358141|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56358142|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
56358143|NCT00074009|Bortezomib|bortezomib|mesh-list
56358144|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358145|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
56358146|NCT00269386|Clarithromycin|clarithromycin|mesh-list
56358147|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56358148|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358149|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56358150|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358151|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358152|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55991524|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
56358153|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56358154|NCT00074087|Doxorubicin|doxorubicin|mesh-list
56358155|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56358156|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56358157|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358158|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56358159|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56358160|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358161|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358162|NCT00269542|Iron|iron|mesh-list
56358163|NCT00269542|Folic Acid|folic acid|mesh-list
56358164|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
56358165|NCT00269542|Trace Elements|trace elements|mesh-ancestor
56358166|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
55991602|NCT03158116|Aztreonam|aztreonam|mesh-list
56358167|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358168|NCT00269542|Hematinics|hematinics|mesh-ancestor
56358169|NCT00269542|Vitamins|vitamins|mesh-ancestor
56358170|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56358171|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56358172|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56358173|NCT00269620|Etonogestrel|etonogestrel|mesh-list
56358174|NCT00269620|NuvaRing|nuvaring|mesh-list
56358175|NCT00269620|Norelgestromin|norelgestromin|mesh-list
56358176|NCT00269620|Ortho Evra|ortho evra|mesh-list
56358177|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
56358178|NCT00269620|Estradiol|estradiol|mesh-list
56358179|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56358180|NCT00269620|Estrogens|estrogens|mesh-ancestor
56358181|NCT00269620|Hormones|hormones|mesh-ancestor
56358182|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358183|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358184|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56358185|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56358186|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56358187|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55749569|NCT04500743|Leuprolide|leuprolide|mesh-list
56358197|NCT00074204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358198|NCT00074204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358199|NCT00074204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358200|NCT00074204|Immunologic Factors|immunologic factors|mesh-ancestor
56358201|NCT00074204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358202|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
56358203|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992008|NCT00421863|Amlodipine|amlodipine|mesh-list
56358204|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
56358205|NCT00416143|Prednisone|prednisone|mesh-list
56358206|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56358207|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
56358208|NCT00416143|Hormones|hormones|mesh-ancestor
56358209|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358210|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358211|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56358212|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358213|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
56358214|NCT00416221|Citalopram|citalopram|mesh-list
56358215|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56358216|NCT00416221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56651644|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651645|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56358217|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56358218|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56358219|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358220|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358221|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
56358222|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358223|NCT00416221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56358224|NCT00269737|Fentanyl|fentanyl|mesh-list
56358225|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56358226|NCT00269737|Narcotics|narcotics|mesh-ancestor
55992191|NCT03410446|Ketamine|ketamine|mesh-list
56358227|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56358228|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358230|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
56358231|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358232|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56358233|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56358234|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
56358235|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
56358236|NCT00269776|Methylphenidate|methylphenidate|mesh-list
56358237|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56358238|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358239|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55992336|NCT03574779|Paclitaxel|paclitaxel|mesh-list
56358240|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55992392|NCT00635102|Cycloserine|cycloserine|mesh-list
56358241|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56358242|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358243|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
56358244|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358245|NCT00269815|Methylphenidate|methylphenidate|mesh-list
56358246|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56358247|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358248|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56358249|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56358250|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56358261|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358262|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
56358263|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358264|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56358265|NCT00269893|Abciximab|abciximab|mesh-list
56358266|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
56358267|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56358268|NCT00074321|Capecitabine|capecitabine|mesh-list
56358269|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
56358270|NCT00074321|Irinotecan|irinotecan|mesh-list
56358271|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56358272|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
56171184|NCT01048788|Tolvaptan|tolvaptan|mesh-list
56171198|NCT01044498|Norinyl|norinyl|mesh-list
56358273|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358274|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358275|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56358276|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56358277|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358278|NCT00102609|Dexamethasone|dexamethasone|mesh-list
56358279|NCT00102609|Doxorubicin|doxorubicin|mesh-list
56358280|NCT00102609|Trabectedin|trabectedin|mesh-list
56358281|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56358282|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
56358283|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
56358284|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358285|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358286|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358287|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
56358288|NCT00102609|Hormones|hormones|mesh-ancestor
56358289|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358290|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56358291|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358292|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56358293|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56651646|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651647|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651648|NCT02642484|Gabapentin|gabapentin|mesh-list
56651649|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
56358294|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56358295|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358296|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358297|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56358298|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
56358299|NCT00269932|Levofloxacin|levofloxacin|mesh-list
56358300|NCT00269932|Ofloxacin|ofloxacin|mesh-list
56358301|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56358302|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358303|NCT00269932|Renal Agents|renal agents|mesh-ancestor
56358305|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56358306|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56358307|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358308|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358309|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358310|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56358311|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56358312|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
56358313|NCT00269971|Hematinics|hematinics|mesh-ancestor
56358314|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
56358315|NCT00270010|Hematinics|hematinics|mesh-ancestor
56358316|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
55992787|NCT00633152|Linezolid|linezolid|mesh-list
56358317|NCT00270049|Hematinics|hematinics|mesh-ancestor
56358318|NCT00107016|Letrozole|letrozole|mesh-list
56358328|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358329|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358330|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
56358331|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
56358332|NCT00270088|Hematinics|hematinics|mesh-ancestor
56358333|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
56358334|NCT00270127|Hematinics|hematinics|mesh-ancestor
56358335|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
56358336|NCT00270166|Hematinics|hematinics|mesh-ancestor
56358338|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56358339|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56358340|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358341|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358342|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
55993071|NCT03445390|Acetaminophen|acetaminophen|mesh-list
56358343|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358344|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55993124|NCT05593627|Antacids|antacids|mesh-ancestor
56358345|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56358346|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56358347|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56358348|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
56358349|NCT00270283|Hematinics|hematinics|mesh-ancestor
56358350|NCT00270322|Fentanyl|fentanyl|mesh-list
56358351|NCT00270322|Morphine|morphine|mesh-list
56358352|NCT00270322|Bupivacaine|bupivacaine|mesh-list
56358353|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56358354|NCT00270322|Narcotics|narcotics|mesh-ancestor
56358355|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56358356|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358357|NCT00270322|Analgesics|analgesics|mesh-ancestor
56358358|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
56358359|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358360|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56358361|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56358362|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
56358363|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
56358364|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
56358365|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56358366|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
56358367|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358368|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
56358369|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
56358370|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
56358371|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56358372|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651650|NCT02642484|Calcium|calcium|mesh-list
56651651|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56651652|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651653|NCT02642484|Analgesics|analgesics|mesh-ancestor
56358373|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
56358374|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358375|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56358376|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
56358377|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358378|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56358379|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358380|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
56358381|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
56358382|NCT00270478|Hematinics|hematinics|mesh-ancestor
56358383|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358384|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
56358385|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358388|NCT00270517|Telithromycin|telithromycin|mesh-list
56358389|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56358390|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358391|NCT00270556|Tenofovir|tenofovir|mesh-list
56358392|NCT00270556|Abacavir|abacavir|mesh-list
56358393|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
56358394|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358395|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56358396|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56358397|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358398|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358399|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56358400|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56358401|NCT00074438|Rituximab|rituximab|mesh-list
56358402|NCT00074438|Methotrexate|methotrexate|mesh-list
56358403|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56358404|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358405|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
56358406|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358407|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56358408|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56358409|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
56358410|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56358411|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55993516|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
56358413|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358414|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
56358415|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358416|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56358417|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358418|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56358420|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56358421|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358422|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56358423|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
56358424|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358425|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
56358426|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56358427|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56358428|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358429|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56358430|NCT04730375|Analgesics|analgesics|mesh-ancestor
56358431|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
56358432|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993585|NCT03241030|Ibuprofen|ibuprofen|mesh-list
56358433|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56358434|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56358436|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
56358437|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358438|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358439|NCT00270907|Gemcitabine|gemcitabine|mesh-list
56358440|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56358441|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56358442|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
55903965|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56651654|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
56651655|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651656|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
56651657|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56358443|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358444|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358445|NCT00270907|Antiviral Agents|antiviral agents|mesh-ancestor
56358446|NCT00270907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358447|NCT00270907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358448|NCT00270907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358449|NCT00270907|Immunologic Factors|immunologic factors|mesh-ancestor
56358450|NCT00270907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358451|NCT00271063|Annamycin|annamycin|mesh-list
56358452|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56358453|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358455|NCT00107523|Idarubicin|idarubicin|mesh-list
56358456|NCT00107523|Pravastatin|pravastatin|mesh-list
56358457|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56358458|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
55872464|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358462|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358463|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358464|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
56358465|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358466|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56358467|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56358468|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56358469|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358470|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56358471|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56358472|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56171226|NCT01042158|Urological Agents|urological agents|mesh-ancestor
56358473|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56358475|NCT00416377|Doxorubicin|doxorubicin|mesh-list
56358476|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56358477|NCT00416377|Bleomycin|bleomycin|mesh-list
56358478|NCT00416377|Vincristine|vincristine|mesh-list
56358479|NCT00416377|Dacarbazine|dacarbazine|mesh-list
56358480|NCT00416377|Vinblastine|vinblastine|mesh-list
56358481|NCT00416377|Procarbazine|procarbazine|mesh-list
56358482|NCT00416377|Chlorambucil|chlorambucil|mesh-list
56358483|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56358484|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358485|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56358486|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55980313|NCT04345445|Prednisolone|prednisolone|mesh-list
56358487|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358488|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358489|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56358490|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
56358491|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
56358492|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
56358493|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56358494|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
56358495|NCT00416377|Hormones|hormones|mesh-ancestor
56358496|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358497|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358498|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56358499|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56358500|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
56358501|NCT02965859|Adefovir|adefovir|mesh-list
56358502|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56358503|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
56358504|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358505|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55993875|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56358506|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56358507|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358508|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358509|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
56358510|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56358511|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651658|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651659|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651660|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56651661|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56358512|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993939|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
56358513|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56358515|NCT00271336|Protective Agents|protective agents|mesh-ancestor
56358516|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358517|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
56358518|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56358519|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
56358520|NCT00271414|Fentanyl|fentanyl|mesh-list
56358521|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56358522|NCT00271414|Narcotics|narcotics|mesh-ancestor
56358523|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56358524|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358525|NCT00271414|Analgesics|analgesics|mesh-ancestor
56358526|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
56358527|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358528|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56358531|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
56358532|NCT00271453|Fentanyl|fentanyl|mesh-list
56358533|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56358534|NCT00271453|Narcotics|narcotics|mesh-ancestor
56358535|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56358536|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358537|NCT00271453|Analgesics|analgesics|mesh-ancestor
56358538|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
56358539|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358540|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56358541|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56358542|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
56358543|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
56358545|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358546|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56358547|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56358548|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358549|NCT00271804|Bortezomib|bortezomib|mesh-list
56358550|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358551|NCT00107601|Insulin|insulin|mesh-list
56358552|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55994132|NCT03281200|Nintedanib|nintedanib|mesh-list
56358553|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358554|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
56358555|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56358556|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358557|NCT00272116|Vitamins|vitamins|mesh-list
56358558|NCT00272116|Vitamin A|vitamin a|mesh-list
56358559|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
56358560|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
56358561|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358562|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
56358563|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358565|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56358566|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358567|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
56358568|NCT00272428|Vitamin E|vitamin e|mesh-list
56358569|NCT00272428|Beta Carotene|beta carotene|mesh-list
56358570|NCT00272428|Selenium|selenium|mesh-list
56358571|NCT00272428|Carotenoids|carotenoids|mesh-list
56358572|NCT00272428|Vitamins|vitamins|mesh-ancestor
56358573|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
56358574|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358575|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
56358576|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358577|NCT00272428|Protective Agents|protective agents|mesh-ancestor
56358578|NCT00272428|Trace Elements|trace elements|mesh-ancestor
56358579|NCT00272428|Provitamins|provitamins|mesh-ancestor
56358580|NCT00272467|Omeprazole|omeprazole|mesh-list
56358581|NCT00272467|Rebamipide|rebamipide|mesh-list
56358582|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56358583|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358584|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56651662|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56651663|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358585|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358586|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358587|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
56358588|NCT00272467|Protective Agents|protective agents|mesh-ancestor
56358589|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358591|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56358592|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
56358593|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358594|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358595|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358596|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56358597|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56358598|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56358599|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56358600|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56358601|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
56358602|NCT00272701|Esomeprazole|esomeprazole|mesh-list
56358603|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56358604|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358605|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56358606|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872609|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56358608|NCT00272740|Fulvestrant|fulvestrant|mesh-list
56358609|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56358610|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358611|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56358612|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56358613|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
56358614|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358615|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358616|NCT00074750|Molgramostim|molgramostim|mesh-list
56358617|NCT00074750|Sargramostim|sargramostim|mesh-list
56171237|NCT03409458|Avelumab|avelumab|mesh-list
56358618|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
56358619|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358620|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358621|NCT00416533|Prednisone|prednisone|mesh-list
56358622|NCT00416533|Docetaxel|docetaxel|mesh-list
56358623|NCT00416533|Doxorubicin|doxorubicin|mesh-list
56358624|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56358625|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358626|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
56358627|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
56358628|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
56358629|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358630|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56358631|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56358632|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56358633|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358634|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994503|NCT04354961|Paclitaxel|paclitaxel|mesh-list
56358635|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
56358636|NCT00416533|Hormones|hormones|mesh-ancestor
56358637|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358638|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358639|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56358640|NCT00107796|Modafinil|modafinil|mesh-list
56358641|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56358642|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358643|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56358644|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56358645|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56358646|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358647|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
56358648|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358649|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
56358650|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56358651|NCT00272896|Protective Agents|protective agents|mesh-ancestor
56358652|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358654|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56651664|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651665|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
56651666|NCT02642484|Antacids|antacids|mesh-ancestor
56651667|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214587|NCT01613963|Cyclosporins|cyclosporins|mesh-list
56358655|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
56358656|NCT00272935|Hormones|hormones|mesh-ancestor
56358657|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358658|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358659|NCT00273013|Montelukast|montelukast|mesh-list
55994625|NCT03398278|Oxycodone|oxycodone|mesh-list
56358660|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56358661|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
56358662|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56358663|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
56358664|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358665|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358666|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56358667|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56358668|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358669|NCT00107835|Lidocaine|lidocaine|mesh-list
56358670|NCT00107835|Tetracaine|tetracaine|mesh-list
56358671|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
56358672|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
56358673|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56358674|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358675|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
55872680|NCT04399395|Naltrexone|naltrexone|mesh-list
56358677|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56358678|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56358679|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56358680|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56358681|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358683|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56358684|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
56358685|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56358686|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358687|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56358688|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358689|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
56358690|NCT00074828|Enoxaparin|enoxaparin|mesh-list
56358691|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
56358692|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56358693|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56358694|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994841|NCT04744623|Hormones|hormones|mesh-ancestor
56358695|NCT00273247|Interferons|interferons|mesh-list
56358696|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
56358697|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
56358698|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358699|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
56358700|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358701|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
56358702|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358703|NCT00273442|Timolol|timolol|mesh-list
56358704|NCT00273442|Dorzolamide|dorzolamide|mesh-list
56358705|NCT00273442|Maleic acid|maleic acid|mesh-list
56358706|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358707|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358708|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56358709|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56358710|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56358711|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358712|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358713|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56358714|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55994949|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
56358715|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56358716|NCT00401427|Trastuzumab|trastuzumab|mesh-list
56358717|NCT00401427|Vinorelbine|vinorelbine|mesh-list
56651668|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
56651669|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56651670|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651671|NCT04185350|Exenatide|exenatide|mesh-list
56651672|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56358718|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56358719|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358720|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56358721|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
56358722|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
56358723|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
56358724|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358725|NCT00273481|Timolol|timolol|mesh-list
56358726|NCT00273481|Dorzolamide|dorzolamide|mesh-list
56358727|NCT00273481|Latanoprost|latanoprost|mesh-list
56358728|NCT00273481|Maleic acid|maleic acid|mesh-list
56358729|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358730|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358731|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56358732|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56358733|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
56358734|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995012|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56358735|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358736|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56358737|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56358738|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56358739|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56358740|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55995067|NCT03013075|Analgesics|analgesics|mesh-ancestor
56358742|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56358743|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358744|NCT00273559|Prednisone|prednisone|mesh-list
56358745|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56358746|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
56358747|NCT00273559|Hormones|hormones|mesh-ancestor
56358748|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995149|NCT03605914|Acetaminophen|acetaminophen|mesh-list
56358750|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56358751|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358753|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56358754|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358755|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
56358756|NCT00273871|Cyclosporine|cyclosporine|mesh-list
56358758|NCT00273871|Cyclosporins|cyclosporins|mesh-list
56358759|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358760|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
56358761|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358762|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56358763|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358764|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358765|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
56358766|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358767|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
56358768|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56358769|NCT00273949|Lactulose|lactulose|mesh-list
56358770|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358771|NCT00273988|Nevirapine|nevirapine|mesh-list
56358772|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56358773|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56358774|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358775|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358776|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
55995261|NCT04900038|Lamivudine|lamivudine|mesh-list
56358777|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358778|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56358779|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56358780|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56358781|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56358782|NCT00274027|Bromides|bromides|mesh-list
56358783|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
56651673|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651674|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56651675|NCT04185350|Incretins|incretins|mesh-ancestor
56651676|NCT04185350|Hormones|hormones|mesh-ancestor
56358784|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56358785|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
56358786|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358787|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358788|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56358789|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
56358790|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
56358791|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56358792|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
56358793|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358794|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358795|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
56358796|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56358797|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56358798|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358799|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358800|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
56358801|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358802|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358803|NCT00274066|Fenoterol|fenoterol|mesh-list
56358804|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
56358805|NCT00274066|Ipratropium|ipratropium|mesh-list
56358806|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56358807|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
56358808|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358809|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358810|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56358811|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
56358812|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
56358813|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56358814|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
56358815|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358816|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358817|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
56358818|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
56358819|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56358820|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56358821|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56358830|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56358831|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56358832|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56358833|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358835|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56358836|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56358837|NCT00108186|Analgesics|analgesics|mesh-ancestor
56358838|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
56358839|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358840|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358841|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56358842|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56358843|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56358844|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56358845|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358846|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358847|NCT00274339|Lansoprazole|lansoprazole|mesh-list
56358848|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56358849|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358850|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56358851|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995713|NCT01041781|Analgesics|analgesics|mesh-ancestor
56358852|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358853|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56358854|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
56358855|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358856|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56358857|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651677|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56651678|NCT00653172|Streptogramin A|streptogramin a|mesh-list
56651679|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55987324|NCT03409367|Emollients|emollients|mesh-list
56358858|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56358859|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995774|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358860|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358861|NCT00274417|Dutasteride|dutasteride|mesh-list
56358862|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56358863|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56358864|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358865|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358866|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
55995838|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
56358867|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358868|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358870|NCT00274495|Ribavirin|ribavirin|mesh-list
56358871|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56358872|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
56358873|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995911|NCT00957359|Vitamins|vitamins|mesh-ancestor
56358874|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
56358875|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358876|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56358877|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358878|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
56358879|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56358880|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56358881|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
55872903|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
56358886|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
56358887|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56358888|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
56358889|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358890|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358891|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56358892|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56358893|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56358894|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
56358895|NCT00274573|Bromides|bromides|mesh-list
56358896|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
56358897|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56358898|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
56358899|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358900|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358901|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56358902|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
56358903|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
56358904|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56358905|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
56358906|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358907|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358908|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
56358909|NCT00274612|Telmisartan|telmisartan|mesh-list
56358910|NCT00274612|Ramipril|ramipril|mesh-list
55996183|NCT01167829|Testosterone|testosterone|mesh-list
56358911|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56358912|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56358913|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56358914|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358915|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56358916|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
56358917|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358918|NCT00075374|Docetaxel|docetaxel|mesh-list
56358919|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358920|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
56358921|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
56358922|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
56358923|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651680|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651681|NCT02639520|Fosfomycin|fosfomycin|mesh-list
56651682|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55987397|NCT03402295|Bortezomib|bortezomib|mesh-list
56358924|NCT00274690|Casopitant|casopitant|mesh-list
56358925|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
56358926|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
56358927|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358928|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358929|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56358930|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56358931|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358932|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358933|NCT00274807|Cytarabine|cytarabine|mesh-list
56358934|NCT00274807|Etoposide|etoposide|mesh-list
56358935|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
56358936|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56358937|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358938|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56358939|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56358940|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358941|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358942|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56358944|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
56358945|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56358946|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358947|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
56358948|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358950|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
56358951|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358952|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
56358955|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56358956|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358957|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358958|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56358959|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
56358960|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358961|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56358963|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56358964|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
56358965|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358966|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358967|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56358968|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
56358969|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
56358970|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56358971|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
56358972|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358973|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358975|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56358976|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56358977|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56358978|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56358979|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
56358980|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358981|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358982|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358983|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
56358984|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358986|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56358987|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358988|NCT00277498|Timolol|timolol|mesh-list
56358989|NCT00277498|Latanoprost|latanoprost|mesh-list
56358990|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56358991|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56358992|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
56358993|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358994|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358995|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358996|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56651683|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651684|NCT02822729|Timolol|timolol|mesh-list
56651685|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56651686|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56651687|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56358997|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56358998|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56358999|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56359000|NCT00108498|Mirtazapine|mirtazapine|mesh-list
56359001|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
56359002|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359003|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56359004|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
56359005|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
56359006|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359007|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359008|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359009|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56359010|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56359011|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359012|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56359013|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56359014|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56359015|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
56359016|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56359017|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56359018|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
55996820|NCT01181323|Vaccines|vaccines|mesh-list
56359019|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56359020|NCT00277537|Mannitol|mannitol|mesh-list
56359021|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56359022|NCT00277537|Diuretics|diuretics|mesh-ancestor
56359023|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
56359024|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359025|NCT00075452|Gemcitabine|gemcitabine|mesh-list
56359029|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359030|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359032|NCT00075452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359033|NCT00075452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359034|NCT00075452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359035|NCT00075452|Immunologic Factors|immunologic factors|mesh-ancestor
56359036|NCT00075452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359038|NCT00108537|Nicotine|nicotine|mesh-list
56359039|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56359040|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
56359041|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359042|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359043|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56359044|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56359045|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
56359046|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359047|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359048|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56359049|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
56359050|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55997013|NCT05607446|Montelukast|montelukast|mesh-list
56359051|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56359052|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56359053|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359054|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
56359055|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56359056|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56359057|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359058|NCT00277654|Risperidone|risperidone|mesh-list
56359059|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56359060|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
56359061|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359062|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359063|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651688|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56651689|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
56651690|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359064|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56359065|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56359066|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359067|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359068|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56359069|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
56359070|NCT00277693|Spironolactone|spironolactone|mesh-list
56359071|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56359072|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
56359073|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997217|NCT00955253|Guanfacine|guanfacine|mesh-list
56359074|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359075|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56359076|NCT00277693|Diuretics|diuretics|mesh-ancestor
56359077|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
56359078|NCT00108576|Valproic Acid|valproic acid|mesh-list
56359079|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
56359080|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359081|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359082|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
56359083|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359084|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359086|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56359087|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359088|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359089|NCT00075491|Fenretinide|fenretinide|mesh-list
56359090|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359091|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56359092|NCT00075491|Protective Agents|protective agents|mesh-ancestor
56359093|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359094|NCT00108615|Metformin|metformin|mesh-list
56359095|NCT00108615|Pioglitazone|pioglitazone|mesh-list
56359099|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56359100|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
56359101|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359102|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359103|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56359104|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
55997344|NCT02337530|Carboplatin|carboplatin|mesh-list
56359105|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56359106|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
56359107|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359108|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359109|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56359110|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
56359111|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
56359112|NCT00278083|Protective Agents|protective agents|mesh-ancestor
56359114|NCT00278122|Sargramostim|sargramostim|mesh-list
56359115|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56359116|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359117|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
56359118|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
56359119|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
56359120|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359121|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
56359122|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359123|NCT00075647|Sirolimus|sirolimus|mesh-list
55997549|NCT03827876|Vitamins|vitamins|mesh-ancestor
56359124|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56359125|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359126|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56359127|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359128|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
56359129|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359130|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
56359131|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359132|NCT00278278|Prednisone|prednisone|mesh-list
56359133|NCT00278278|Methotrexate|methotrexate|mesh-list
56359134|NCT00278278|Etoposide|etoposide|mesh-list
56359135|NCT00278278|Vincristine|vincristine|mesh-list
56359136|NCT00278278|Ifosfamide|ifosfamide|mesh-list
56359137|NCT00278278|Lomustine|lomustine|mesh-list
56651691|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651692|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651693|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56651694|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56359138|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359139|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56359140|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
56359141|NCT00278278|Hormones|hormones|mesh-ancestor
56359142|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56359143|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359144|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56359145|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56359146|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
56359147|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56359148|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359149|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
56359150|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359151|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
56359152|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359153|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56359154|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359155|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
56359156|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56359157|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56359158|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56359159|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56359160|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56359161|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
55997655|NCT01022567|Ertapenem|ertapenem|mesh-list
56359162|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
56359163|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
56359164|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56359165|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
56359167|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56359173|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359174|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56359175|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56359176|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
56359177|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
56359179|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56359180|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359181|NCT00075686|Gemcitabine|gemcitabine|mesh-list
56359182|NCT00075686|Cetuximab|cetuximab|mesh-list
56359183|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359184|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
56359185|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359186|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359187|NCT00075686|Antiviral Agents|antiviral agents|mesh-ancestor
56359188|NCT00075686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359189|NCT00075686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359190|NCT00075686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359191|NCT00075686|Immunologic Factors|immunologic factors|mesh-ancestor
56359192|NCT00075686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359193|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56359194|NCT00278824|Fentanyl|fentanyl|mesh-list
56359195|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56359196|NCT00278824|Narcotics|narcotics|mesh-ancestor
56359197|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359198|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359199|NCT00278824|Analgesics|analgesics|mesh-ancestor
56359200|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
56359201|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359202|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56359203|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56359204|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
56359205|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
56359206|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56359207|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
56359209|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56359210|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651695|NCT02642250|Metronidazole|metronidazole|mesh-list
56651696|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651697|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56297742|NCT00007826|Vaccines|vaccines|mesh-list
56359211|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359212|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359213|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
56359214|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56359215|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
56359216|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359217|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359218|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56359219|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
56359220|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
56359221|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56359222|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
56359223|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359224|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359226|NCT00108849|Estrogens|estrogens|mesh-ancestor
56359227|NCT00108849|Hormones|hormones|mesh-ancestor
56359228|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56359229|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359230|NCT00279253|Clonidine|clonidine|mesh-list
56359231|NCT00279253|Analgesics|analgesics|mesh-ancestor
56359232|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
56359233|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359234|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359235|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55997897|NCT02972294|Iron|iron|mesh-list
56359236|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
56359237|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
56359238|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56359239|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56359240|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56359244|NCT00109044|Citalopram|citalopram|mesh-list
56359245|NCT00109044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56359246|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56359247|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359248|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171265|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
56359249|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359250|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
55997947|NCT03825068|Anesthetics|anesthetics|mesh-list
56359251|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359252|NCT00109044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56359253|NCT00109044|Antidepressive Agents|antidepressive agents|mesh-ancestor
56359254|NCT00109044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359255|NCT00279448|Tamoxifen|tamoxifen|mesh-list
56359256|NCT00279448|Exemestane|exemestane|mesh-list
56359257|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56359258|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
56359259|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56359260|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359261|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56359262|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359263|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56359264|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56359265|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56359266|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56359267|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56359268|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359269|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359270|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
56359271|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
56359272|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359273|NCT00075959|Protective Agents|protective agents|mesh-ancestor
56359274|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359275|NCT00279487|Gabapentin|gabapentin|mesh-list
56359276|NCT00279487|Analgesics|analgesics|mesh-ancestor
56359277|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
55904658|NCT01582243|Vildagliptin|vildagliptin|mesh-list
56651698|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56651699|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56651700|NCT00653250|Celecoxib|celecoxib|mesh-list
56651701|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56359278|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359279|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359280|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
56359281|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56359282|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56359283|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359285|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56359286|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56359287|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359288|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359289|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
56359290|NCT00279565|Interferons|interferons|mesh-list
56359291|NCT00279565|Ribavirin|ribavirin|mesh-list
56359292|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
56359293|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
56359294|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56359295|NCT00279565|Buprenorphine|buprenorphine|mesh-list
56359296|NCT00279565|Methadone|methadone|mesh-list
56359297|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359298|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
56359299|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359300|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
56359301|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359302|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
56359303|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359304|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56359305|NCT00279565|Narcotics|narcotics|mesh-ancestor
56359306|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359307|NCT00279565|Analgesics|analgesics|mesh-ancestor
55998191|NCT05504694|Ofatumumab|ofatumumab|mesh-list
56359308|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
56359309|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359315|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359317|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359319|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56359320|NCT00109161|Daclizumab|daclizumab|mesh-list
56359321|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
56359322|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359323|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359324|NCT00279760|Abatacept|abatacept|mesh-list
56359325|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56359326|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359327|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359328|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359329|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
56359330|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359331|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56359332|NCT00109200|Omalizumab|omalizumab|mesh-list
56359333|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56359334|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56359335|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
56359336|NCT00416728|Valsartan|valsartan|mesh-list
56359337|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56359338|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56359339|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56359340|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359341|NCT00416767|Leucovorin|leucovorin|mesh-list
56359342|NCT00416767|Fluorouracil|fluorouracil|mesh-list
56359343|NCT00416767|Irinotecan|irinotecan|mesh-list
56359344|NCT00416767|Calcium|calcium|mesh-list
56359345|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
56359346|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56359347|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359348|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
56359349|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359350|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359351|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359352|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56651702|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651703|NCT00653250|Analgesics|analgesics|mesh-ancestor
56359353|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
56359354|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56359355|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56359356|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359357|NCT00416767|Antidotes|antidotes|mesh-ancestor
56359358|NCT00416767|Protective Agents|protective agents|mesh-ancestor
56359359|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
56359360|NCT00416767|Vitamins|vitamins|mesh-ancestor
56359361|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
56359362|NCT00076115|Risperidone|risperidone|mesh-list
56359363|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56359364|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
56359365|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359366|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359367|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359368|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56359369|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56359370|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998616|NCT04281420|Niacin|niacin|mesh-list
56359371|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359372|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56359373|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
56359374|NCT00109239|Bevacizumab|bevacizumab|mesh-list
56359375|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56359376|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359377|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56359378|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56359379|NCT00109239|Growth Substances|growth substances|mesh-ancestor
56359380|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359381|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
56359382|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56359383|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56359385|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359387|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359388|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56359390|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
56359391|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359392|NCT00280267|Testosterone|testosterone|mesh-list
56359393|NCT00280267|Androgens|androgens|mesh-ancestor
56359394|NCT00280267|Hormones|hormones|mesh-ancestor
56359395|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56359396|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359397|NCT00076232|Acyclovir|acyclovir|mesh-list
56359398|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
56359400|NCT00280423|Casopitant|casopitant|mesh-list
56359401|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
56359402|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
56359403|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359404|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359405|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56359406|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56359407|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359408|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359409|NCT00109356|AQ4N|aq4n|mesh-list
56359410|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359411|NCT00280462|Nifedipine|nifedipine|mesh-list
56359412|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55998701|NCT02861300|Capecitabine|capecitabine|mesh-list
56359413|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359414|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359415|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56359416|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359417|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
56359418|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
56359419|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56359420|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56359421|NCT00280501|Sulpiride|sulpiride|mesh-list
56359422|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
56359423|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359424|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56359425|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56359426|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904659|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56651704|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
56651705|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359427|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359428|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56359429|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
56359430|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359431|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359432|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56359434|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56359435|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55998816|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
56359436|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56359437|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56359438|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359439|NCT00280540|Diuretics|diuretics|mesh-ancestor
56359440|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
56359441|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359442|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56359443|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359444|NCT00076349|Rituximab|rituximab|mesh-list
56359445|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56359446|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56359447|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359448|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
56359449|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359450|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56359451|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56359452|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
56359453|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359454|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
56359455|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359456|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56359461|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359462|NCT00280696|Levetiracetam|levetiracetam|mesh-list
56359463|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
56359464|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
56359465|NCT00076388|Docetaxel|docetaxel|mesh-list
56359466|NCT00076388|Gefitinib|gefitinib|mesh-list
56359467|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359468|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
56359469|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
56359470|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
56359471|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998945|NCT00378118|Antibodies|antibodies|mesh-list
56359472|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56359473|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359474|NCT00280774|Memantine|memantine|mesh-list
56359475|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56359476|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56359477|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
56359478|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359479|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359480|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359481|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56359482|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56359483|NCT00109551|Folic Acid|folic acid|mesh-list
56359484|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
56359485|NCT00109551|Hematinics|hematinics|mesh-ancestor
56359486|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
56359487|NCT00109551|Vitamins|vitamins|mesh-ancestor
56359488|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
56359489|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359490|NCT00109551|Astringents|astringents|mesh-ancestor
56359491|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
56359492|NCT00280930|Letrozole|letrozole|mesh-list
56359493|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359494|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56359495|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56359496|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359497|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359498|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56359499|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
56269004|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651706|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651707|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651708|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651709|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56359500|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56359501|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359502|NCT04730297|Acetaminophen|acetaminophen|mesh-list
56359503|NCT04730297|Ibuprofen|ibuprofen|mesh-list
56359504|NCT04730297|Codeine|codeine|mesh-list
56359505|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56359507|NCT04730297|Analgesics|analgesics|mesh-ancestor
56359508|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
56359509|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359510|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359511|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56359512|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56359513|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56359514|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359515|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359517|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56359518|NCT04730297|Narcotics|narcotics|mesh-ancestor
55999114|NCT00377806|Diclofenac|diclofenac|mesh-list
56359519|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359520|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
56359521|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
56359522|NCT00280969|Efavirenz|efavirenz|mesh-list
56359523|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56359524|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56359525|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56359526|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359527|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359528|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
55999233|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359531|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56359532|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56359533|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56359534|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56359535|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56359536|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56359537|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56359538|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
56359539|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56359540|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56359541|NCT00281008|Mipomersen|mipomersen|mesh-list
55999370|NCT05489796|Ketorolac|ketorolac|mesh-list
56359542|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56359543|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56359544|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
56359545|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359546|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56359547|NCT00281125|Pemetrexed|pemetrexed|mesh-list
56359548|NCT00281125|Vatalanib|vatalanib|mesh-list
56359549|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359550|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359551|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999442|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999443|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999444|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55726698|NCT01601626|Isoniazid|isoniazid|mesh-list
56359552|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56359553|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56359554|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56359555|NCT00109746|Chromium|chromium|mesh-list
56359556|NCT00109746|Picolinic acid|picolinic acid|mesh-list
56359557|NCT00109746|Trace Elements|trace elements|mesh-ancestor
56359558|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
56359559|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359560|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56359561|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
56359562|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
56269005|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
56651710|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56651711|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988031|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56359563|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359564|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
56359565|NCT00399269|Hematinics|hematinics|mesh-ancestor
56359566|NCT00281281|Vancomycin|vancomycin|mesh-list
56359567|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56359568|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359569|NCT00109785|Idoxuridine|idoxuridine|mesh-list
56359570|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56359571|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56359572|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359573|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
56359574|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999510|NCT04139304|Prednisone|prednisone|mesh-list
56359575|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56359576|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359577|NCT00281476|Simvastatin|simvastatin|mesh-list
56359578|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56359579|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56359580|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
56359581|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359582|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56359583|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56359584|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359585|NCT00416923|Rituximab|rituximab|mesh-list
56359586|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56359587|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359588|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
56359589|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359590|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56359591|NCT00416962|Oseltamivir|oseltamivir|mesh-list
56359592|NCT00416962|Amantadine|amantadine|mesh-list
56359593|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
56359594|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359595|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359596|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359598|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56359599|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
56359600|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359601|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359602|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56359604|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
56359605|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359606|NCT00109824|Decitabine|decitabine|mesh-list
56359607|NCT00109824|Azacitidine|azacitidine|mesh-list
56359608|NCT00109824|Valproic Acid|valproic acid|mesh-list
56359609|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359610|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
55999695|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359611|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359612|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359614|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
56359615|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
56359616|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359617|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359618|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
56359619|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56359620|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359621|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359622|NCT00281515|Lonafarnib|lonafarnib|mesh-list
56359623|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359624|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359625|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
56359626|NCT00109941|Mitogens|mitogens|mesh-list
56359627|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
56359628|NCT00109941|Narcotics|narcotics|mesh-ancestor
56359629|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359630|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359631|NCT00109941|Analgesics|analgesics|mesh-ancestor
56359632|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
56359633|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359634|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
56651712|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651713|NCT00638534|Telithromycin|telithromycin|mesh-list
56359635|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359636|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359637|NCT00281593|Telmisartan|telmisartan|mesh-list
56359638|NCT00281593|Ramipril|ramipril|mesh-list
56359639|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56359640|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56359641|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56359642|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359643|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56359644|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
56359645|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359646|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
56359647|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56359648|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56359649|NCT00281710|Prednisolone|prednisolone|mesh-list
56359650|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
56359651|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56359652|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
56359653|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56359654|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
56359655|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
56359656|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359657|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359658|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56359659|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
56359660|NCT00281710|Hormones|hormones|mesh-ancestor
56359661|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56359662|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56359663|NCT00281710|Protective Agents|protective agents|mesh-ancestor
56359664|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56359665|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359666|NCT00076544|Ziconotide|ziconotide|mesh-list
56359667|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56359668|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359669|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873676|NCT00637377|Growth Substances|growth substances|mesh-ancestor
56359672|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56359673|NCT00076544|Protective Agents|protective agents|mesh-ancestor
56359674|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56359675|NCT00076544|Analgesics|analgesics|mesh-ancestor
56359676|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
56359677|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359678|NCT00281788|Paclitaxel|paclitaxel|mesh-list
56359679|NCT00281788|Carboplatin|carboplatin|mesh-list
56359680|NCT00281788|Capecitabine|capecitabine|mesh-list
56359681|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56359682|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359683|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
56359684|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
56359685|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
56359686|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359687|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359689|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56359690|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359691|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56359692|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359693|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359694|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
56359695|NCT00281905|Carboplatin|carboplatin|mesh-list
56359696|NCT00281905|Methotrexate|methotrexate|mesh-list
56359697|NCT00281905|Vincristine|vincristine|mesh-list
56359698|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359699|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
56359700|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359701|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56359702|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56359703|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
56359704|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359705|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359706|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56651714|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56651715|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651716|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56359707|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56359708|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
56359709|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56359710|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359711|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
56359712|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
56359713|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359714|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56359715|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56359716|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56359717|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
56359718|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
56359719|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
56359720|NCT00110058|Interferons|interferons|mesh-list
56359721|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
56359722|NCT00110058|Cyclosporine|cyclosporine|mesh-list
56359723|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
56359724|NCT00110058|Fludarabine|fludarabine|mesh-list
56359725|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
56359726|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
56359727|NCT00110058|Cyclosporins|cyclosporins|mesh-list
56359728|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359729|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359730|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
56359731|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359732|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359733|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
56359734|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359735|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
56359736|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359737|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359738|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
56359739|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
56359740|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56359741|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56359742|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56359743|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56359747|NCT00281944|Leucovorin|leucovorin|mesh-list
56359748|NCT00281944|Fluorouracil|fluorouracil|mesh-list
56359749|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
56359750|NCT00281944|Calcium|calcium|mesh-list
56359751|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
56359752|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56359753|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359754|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
56359755|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359756|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359757|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359758|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359759|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
56359760|NCT00281944|Antidotes|antidotes|mesh-ancestor
55981582|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
56359761|NCT00281944|Protective Agents|protective agents|mesh-ancestor
56359762|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
56359764|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
56359766|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
56359767|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
56359768|NCT00281983|Busulfan|busulfan|mesh-list
56359769|NCT00281983|Rituximab|rituximab|mesh-list
56359770|NCT00281983|Methotrexate|methotrexate|mesh-list
56359771|NCT00281983|Fludarabine|fludarabine|mesh-list
56359772|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
56359773|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
56359774|NCT00281983|Cyclosporins|cyclosporins|mesh-list
56359775|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56359776|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359777|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
56359778|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359779|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56359780|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56359781|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
56359782|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905732|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651717|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56651718|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56359783|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359784|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56000356|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
56359785|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56359786|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56359787|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
56359788|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56359789|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359790|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
56359791|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
56359792|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359793|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56359794|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56359795|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
56359796|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359797|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56359798|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56359799|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56000499|NCT01890694|Tolvaptan|tolvaptan|mesh-list
56359800|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
56359801|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56359803|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
56359804|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359805|NCT00282061|Protective Agents|protective agents|mesh-ancestor
56359806|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359807|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359808|NCT00282100|Gefitinib|gefitinib|mesh-list
56359809|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359810|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56359811|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359812|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000619|NCT00843310|Melphalan|melphalan|mesh-list
56359813|NCT00282139|Aripiprazole|aripiprazole|mesh-list
56359814|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
56359815|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359816|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56359824|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56171289|NCT03403140|Etanercept|etanercept|mesh-list
56359825|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56359826|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
56359827|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56359828|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56359829|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56359830|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56359831|NCT00110253|Lidocaine|lidocaine|mesh-list
56359832|NCT00110253|Tetracaine|tetracaine|mesh-list
56359833|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
56359834|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
56359835|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359836|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359837|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
55981659|NCT00823043|Timolol|timolol|mesh-list
56359838|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359839|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56359840|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56359841|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56359842|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359843|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359844|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56359845|NCT00282178|Candesartan|candesartan|mesh-list
56359846|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56359847|NCT00282178|Diuretics|diuretics|mesh-ancestor
56359848|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
56359849|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359850|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56359851|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359852|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359853|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56359854|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56359856|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56651719|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651720|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214636|NCT01614132|Cisplatin|cisplatin|mesh-list
56359857|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359858|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56359859|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359860|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
56359861|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56359862|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
56359863|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359864|NCT00282451|Insulin|insulin|mesh-list
56359865|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56359866|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
56359867|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
56359868|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56359869|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
56359870|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56359871|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359872|NCT00282607|Udenafil|udenafil|mesh-list
56359873|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56359874|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56359875|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359876|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359877|NCT00282724|Liarozole|liarozole|mesh-list
56359878|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
56359879|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
56000930|NCT05476380|Paclitaxel|paclitaxel|mesh-list
55873889|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359884|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359885|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56359886|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359888|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56359889|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56359890|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56359891|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359892|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359893|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
56359894|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359895|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001054|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56359897|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359899|NCT00282997|Analgesics|analgesics|mesh-ancestor
56359900|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
56359901|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56359902|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359903|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
56359904|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56359905|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359906|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359907|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56359908|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56359909|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56359910|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359911|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359913|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56359914|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56359915|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56359916|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359917|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
56359918|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56359919|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359920|NCT00283114|Lintuzumab|lintuzumab|mesh-list
56359921|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56359922|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359923|NCT00076856|Temozolomide|temozolomide|mesh-list
56359924|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56359925|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
56359926|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359927|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651721|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56651722|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56651723|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651724|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
56359928|NCT00283192|Sertraline|sertraline|mesh-list
56359929|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
56359930|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56359931|NCT00283192|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56359932|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56359933|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56359934|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001477|NCT02344472|Paclitaxel|paclitaxel|mesh-list
56359935|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359936|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
56359937|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359938|NCT00283309|Riluzole|riluzole|mesh-list
56359939|NCT00283309|Memantine|memantine|mesh-list
56359940|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56359941|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56359942|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
56359943|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359944|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359945|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873956|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56359954|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56359955|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359956|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56359957|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
56359958|NCT00283465|Hematinics|hematinics|mesh-ancestor
56359959|NCT00283543|Temozolomide|temozolomide|mesh-list
56359961|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56359962|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
56359963|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359964|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359965|NCT00283621|Doxorubicin|doxorubicin|mesh-list
56359966|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56359967|NCT00283621|Ifosfamide|ifosfamide|mesh-list
56359968|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
56359969|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56359970|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359971|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56359972|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56359974|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359975|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56359976|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
56359977|NCT00283621|Hematinics|hematinics|mesh-ancestor
56359978|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
56359979|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
56359980|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
56359981|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56359982|NCT00283660|Protective Agents|protective agents|mesh-ancestor
56359983|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359984|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
56359986|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359987|NCT00283699|Albendazole|albendazole|mesh-list
56359988|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
56359989|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56359990|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359991|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
56359992|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56359993|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56359994|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
56359995|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
56359996|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
56359997|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359998|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359999|NCT00283777|Chromium|chromium|mesh-list
56360000|NCT00283777|Picolinic acid|picolinic acid|mesh-list
56360001|NCT00283777|Trace Elements|trace elements|mesh-ancestor
56360002|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
56651725|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651726|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
56651727|NCT02638896|Celecoxib|celecoxib|mesh-list
56651728|NCT02638896|Etanercept|etanercept|mesh-list
56651729|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56651730|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651731|NCT02638896|Analgesics|analgesics|mesh-ancestor
56651732|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
56651733|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651734|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651735|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651736|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651737|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56651738|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56651739|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214642|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
56360003|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360004|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56360005|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
56360006|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
56360007|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360008|NCT00110448|Aspirin|aspirin|mesh-list
56360009|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56360010|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56360011|NCT00110448|Analgesics|analgesics|mesh-ancestor
56360012|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
56360013|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360014|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360015|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56360016|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56360022|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360024|NCT00284206|Risperidone|risperidone|mesh-list
56360025|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56360026|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
56360027|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360028|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360029|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360030|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56360031|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56360032|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360033|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360034|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56360035|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
56360036|NCT00077129|Paclitaxel|paclitaxel|mesh-list
56360037|NCT00077129|Carboplatin|carboplatin|mesh-list
56360038|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56360039|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360040|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
56360041|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
56360042|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
56360043|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360044|NCT00284323|Adenosine|adenosine|mesh-list
56360045|NCT00284323|Analgesics|analgesics|mesh-ancestor
56360046|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
56360047|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360048|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360049|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56360050|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
56360051|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56360052|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
56651740|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651741|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56651742|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56651743|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
56651744|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651745|NCT00653406|Risperidone|risperidone|mesh-list
56651746|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56651747|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
56360053|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
56360054|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360055|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360057|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56360058|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360059|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
56360060|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
56360061|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
56360062|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360063|NCT00077168|Tamoxifen|tamoxifen|mesh-list
56360064|NCT00077168|Anastrozole|anastrozole|mesh-list
56360065|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360066|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56360067|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
56360068|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360069|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360070|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56360071|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360072|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56360073|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56360074|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56360075|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56360076|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56360077|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360078|NCT00110604|Folic Acid|folic acid|mesh-list
56360079|NCT00110604|Hematinics|hematinics|mesh-ancestor
56360080|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
56360081|NCT00110604|Vitamins|vitamins|mesh-ancestor
56360082|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
56360083|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360084|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56360085|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360095|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360096|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
56360097|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360098|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56360099|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56360100|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56360101|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360102|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
56360103|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56360104|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56360105|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56360106|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56360107|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360108|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56360109|NCT00284947|Prednisone|prednisone|mesh-list
56360110|NCT00284947|Prednisolone|prednisolone|mesh-list
56360111|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
56360112|NCT00284947|Basiliximab|basiliximab|mesh-list
56360113|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56360114|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
56360115|NCT00284947|Hormones|hormones|mesh-ancestor
56360116|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360117|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360118|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56360119|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360120|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
56651748|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651749|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651750|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651751|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56651752|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651753|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651754|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56651755|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56651756|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
56651757|NCT00638612|Valacyclovir|valacyclovir|mesh-list
56651758|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
56651759|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651760|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
56651761|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56651762|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651763|NCT04239755|Doxycycline|doxycycline|mesh-list
56360121|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
56360122|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360123|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56360124|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56360125|NCT00284947|Protective Agents|protective agents|mesh-ancestor
56360126|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360127|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
56360128|NCT00110682|Imiquimod|imiquimod|mesh-list
56360129|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56360130|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
56360131|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360132|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360133|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
56360134|NCT00077246|Paclitaxel|paclitaxel|mesh-list
56360135|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56360136|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56360137|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360138|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
56360139|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
56360140|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
56360141|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360142|NCT00110721|Fluorouracil|fluorouracil|mesh-list
56360143|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
56360144|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360145|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56360146|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360147|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360148|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
56360149|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360150|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
55874163|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360158|NCT00110760|Tetracaine|tetracaine|mesh-list
56360159|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
56360160|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
56360161|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360162|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360163|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
56360164|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360165|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56360166|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56360167|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56360168|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56360169|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651764|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56651765|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651766|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
56651767|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56214679|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
56360170|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
56360171|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56360172|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360173|NCT00285181|Simvastatin|simvastatin|mesh-list
56360174|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56360175|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56360176|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
56360177|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360178|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56360179|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56360180|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360181|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
56360182|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56360183|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360184|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360185|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56360186|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56360187|NCT00285298|Protective Agents|protective agents|mesh-ancestor
56360188|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360189|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
56360190|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56360191|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
56360192|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56360193|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
56360194|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360195|NCT00285376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56360196|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56360197|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56360198|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360199|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360200|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
56360201|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360202|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56360203|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56360204|NCT00077363|Capecitabine|capecitabine|mesh-list
56360205|NCT00077363|Tipifarnib|tipifarnib|mesh-list
56360206|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55982031|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
56360207|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
56360208|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360209|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360210|NCT00285415|Carboplatin|carboplatin|mesh-list
56360211|NCT00285415|Docetaxel|docetaxel|mesh-list
56360212|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360213|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
56360214|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
56360215|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
56360216|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360220|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56360221|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56360222|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
56360223|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
56360224|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360225|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360226|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360227|NCT00077402|Fenretinide|fenretinide|mesh-list
56360228|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360229|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56360230|NCT00077402|Protective Agents|protective agents|mesh-ancestor
56360231|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360232|NCT00285766|Selegiline|selegiline|mesh-list
56360233|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
56360234|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360235|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56360236|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56651768|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56651769|NCT04185194|Lidocaine|lidocaine|mesh-list
56651770|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
56651771|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
56297831|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
56651772|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651773|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651774|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
56651775|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214685|NCT01614236|Pregabalin|pregabalin|mesh-list
56360237|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56360238|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360239|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360240|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56360241|NCT00285766|Protective Agents|protective agents|mesh-ancestor
56360242|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360243|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
56360244|NCT00285805|Amiloride|amiloride|mesh-list
56360245|NCT00285805|Furosemide|furosemide|mesh-list
56360246|NCT00285805|Diuretics|diuretics|mesh-ancestor
56360247|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
56360248|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360249|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56360250|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56360251|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360252|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56360253|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56360254|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56360255|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56360256|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56360257|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56360258|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56360259|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360261|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360262|NCT00285883|Saquinavir|saquinavir|mesh-list
56360263|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56360264|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56360265|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
56360266|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360267|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360268|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56360269|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56360270|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
56360271|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360272|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56360273|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56360274|NCT00110877|Darunavir|darunavir|mesh-list
56360275|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56360276|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56360277|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
56360278|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360279|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360280|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56360281|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56360282|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
56360283|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360284|NCT00077519|Tipifarnib|tipifarnib|mesh-list
56360285|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360286|NCT00286117|Tamoxifen|tamoxifen|mesh-list
56360287|NCT00286117|Anastrozole|anastrozole|mesh-list
56360288|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56360289|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
55874300|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360292|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56360293|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360294|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56651776|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56651777|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56651778|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56360295|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56360296|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56360297|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56360298|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56360299|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360300|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360301|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56360302|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56360303|NCT00077558|Fludarabine|fludarabine|mesh-list
56360304|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
56360305|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360306|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56360307|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
56360308|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360309|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360310|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
56360311|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360313|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56360314|NCT00286273|Tinzaparin|tinzaparin|mesh-list
56360315|NCT00286273|Dalteparin|dalteparin|mesh-list
56360316|NCT00286273|Nadroparin|nadroparin|mesh-list
56360317|NCT00286273|Citric Acid|citric acid|mesh-list
56360318|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
56360319|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
56360320|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56360321|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
56360322|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
56360323|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360324|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56360325|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56360326|NCT00286312|Atorvastatin|atorvastatin|mesh-list
56360327|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56360328|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56360329|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
56360330|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360331|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56171298|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56360332|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56360333|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360334|NCT00286351|Goserelin|goserelin|mesh-list
56360335|NCT00286351|Anastrozole|anastrozole|mesh-list
56360336|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56360337|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360338|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56360339|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56360340|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360341|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360342|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56360343|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
56360344|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360345|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360346|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
56360347|NCT00110955|Hematinics|hematinics|mesh-ancestor
56360349|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56360350|NCT00286585|Anesthetics|anesthetics|mesh-list
56360351|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56360352|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360353|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360354|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
56360355|NCT00111072|Dexamethasone|dexamethasone|mesh-list
56360356|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56360357|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
56360358|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
56360359|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360360|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360364|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360365|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56360366|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651779|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56651780|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651781|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
55988832|NCT00934375|Donepezil|donepezil|mesh-list
56360367|NCT00286624|Cyclosporine|cyclosporine|mesh-list
56360368|NCT00286624|Everolimus|everolimus|mesh-list
56360369|NCT00286624|Cyclosporins|cyclosporins|mesh-list
56360370|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56360371|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360372|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360373|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360374|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
56360375|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360376|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
56360377|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360378|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
56360379|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56360380|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56360381|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360382|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
56360383|NCT00077597|Hematinics|hematinics|mesh-ancestor
56360384|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
56360385|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56360386|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360387|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56360388|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
56360389|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56360390|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360391|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56360392|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56360393|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56360394|NCT00111111|Etanercept|etanercept|mesh-list
56360395|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56360396|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56360397|NCT00111111|Analgesics|analgesics|mesh-ancestor
56360398|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
56360399|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360400|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360401|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56360402|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56360403|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56360404|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360405|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
56360406|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56360407|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56360408|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56360409|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360410|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360411|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360412|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56360413|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56360414|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
56360415|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360416|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360417|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56360418|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56360419|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
56360420|NCT00111150|Tenofovir|tenofovir|mesh-list
56360421|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
56360422|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360423|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56360424|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56360425|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360426|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360427|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56360428|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56360429|NCT00417430|Fulvestrant|fulvestrant|mesh-list
56360430|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56360431|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360432|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56360436|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651782|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56651783|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56651784|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56651785|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56214699|NCT01614301|Pioglitazone|pioglitazone|mesh-list
56360439|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
56360440|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56360441|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56360442|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360443|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56360444|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56360445|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56360446|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360447|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360448|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360449|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56360450|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56360451|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
56360452|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360453|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360454|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56360455|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56360456|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
56360457|NCT00077792|Enoxaparin|enoxaparin|mesh-list
56360458|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
56360459|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
56360460|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56360461|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56360462|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360463|NCT00111267|Vitamins|vitamins|mesh-list
56360464|NCT00111267|Folic Acid|folic acid|mesh-list
56360465|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
56360466|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
56360467|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
56360468|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
56360469|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360470|NCT00111267|Hematinics|hematinics|mesh-ancestor
56360471|NCT00286936|Zolpidem|zolpidem|mesh-list
56360472|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56360473|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56360474|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360475|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360476|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56360477|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
56360478|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
56360479|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360480|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360481|NCT00111306|Epratuzumab|epratuzumab|mesh-list
56360482|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56360483|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360484|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
56360485|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
56360486|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360487|NCT00287170|Calcitriol|calcitriol|mesh-list
56360488|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
56360489|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56360490|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360491|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56360492|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56360493|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360494|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56360495|NCT00287170|Vitamins|vitamins|mesh-ancestor
56360496|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
56360497|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56360498|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
56360499|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56360500|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360501|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360502|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
56360503|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56360504|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651786|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651787|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
56651788|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214701|NCT01614301|Etoricoxib|etoricoxib|mesh-list
56360506|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56360507|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
55982337|NCT00841087|Insulin|insulin|mesh-list
56360508|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56360509|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56360510|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360511|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56360512|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56360513|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56360514|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360515|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56360516|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56360517|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56360518|NCT00077948|Metoprolol|metoprolol|mesh-list
56360519|NCT00077948|Enoximone|enoximone|mesh-list
56360520|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56360521|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56360522|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
56360523|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
56360524|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360525|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360526|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56360527|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56360528|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56360529|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
56360530|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360531|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360532|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56360533|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
56360534|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56360535|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56360536|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360537|NCT00077948|Protective Agents|protective agents|mesh-ancestor
56360538|NCT00111345|Daunorubicin|daunorubicin|mesh-list
56360539|NCT00111345|Idarubicin|idarubicin|mesh-list
56360540|NCT00111345|Cladribine|cladribine|mesh-list
56360541|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56360542|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360543|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56360544|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56360545|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360546|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360547|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360548|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
56360549|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360550|NCT00287326|Clonidine|clonidine|mesh-list
56360551|NCT00287326|Morphine|morphine|mesh-list
56360552|NCT00287326|Bupivacaine|bupivacaine|mesh-list
56360553|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
56360554|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
56360555|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360556|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360557|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
56360558|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360559|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56360560|NCT00287326|Narcotics|narcotics|mesh-ancestor
56360561|NCT00287326|Analgesics|analgesics|mesh-ancestor
56360562|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56360563|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
56360564|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
56360565|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56360566|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56360567|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56360568|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
56360569|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360570|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360571|NCT00287443|Hormones|hormones|mesh-list
56651789|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651790|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56651791|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651792|NCT04239833|Gefitinib|gefitinib|mesh-list
56651793|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360572|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360573|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360574|NCT00077987|Sunitinib|sunitinib|mesh-list
56360575|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360576|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56360577|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56360580|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
56360581|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56360582|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360583|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360585|NCT00287521|Latanoprost|latanoprost|mesh-list
56360586|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360587|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56360588|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56360589|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
56360590|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360591|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360592|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56360593|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56360594|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56360595|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56360596|NCT00287560|Propofol|propofol|mesh-list
56360597|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56360598|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360599|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360600|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56360601|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
56360602|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
56360603|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
56360604|NCT00111462|Hematinics|hematinics|mesh-ancestor
56360605|NCT00287677|Hormones|hormones|mesh-list
56360606|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360607|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360608|NCT00287794|Diazepam|diazepam|mesh-list
56360609|NCT00287794|Melatonin|melatonin|mesh-list
56360610|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
56360611|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360612|NCT00287794|Protective Agents|protective agents|mesh-ancestor
56360613|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360614|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360615|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56360616|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
56360617|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
56360618|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
56360619|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360620|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56360621|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56360622|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56360623|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56360624|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56360625|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56360626|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360627|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56360628|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
56360629|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
56360630|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
56360631|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
56360632|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360633|NCT00287911|Topotecan|topotecan|mesh-list
56360634|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360635|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56360636|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56360637|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360638|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360639|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
56360640|NCT00287950|Carboplatin|carboplatin|mesh-list
56651794|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56651795|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214709|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360641|NCT00287950|Etoposide|etoposide|mesh-list
56360642|NCT00287950|Vincristine|vincristine|mesh-list
56360643|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360644|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
56360645|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360646|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56360647|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56360648|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
56360649|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360650|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360651|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55874666|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
56360657|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
56360658|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
56360659|NCT00288028|Bortezomib|bortezomib|mesh-list
56360660|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360661|NCT00111540|Exenatide|exenatide|mesh-list
56360662|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56360663|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360664|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56360665|NCT00111540|Incretins|incretins|mesh-ancestor
56360666|NCT00111540|Hormones|hormones|mesh-ancestor
56360667|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360668|NCT00288184|Allopurinol|allopurinol|mesh-list
56360669|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
56360670|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360671|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360672|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
56360673|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56360674|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56360675|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
56360676|NCT00288184|Protective Agents|protective agents|mesh-ancestor
56360677|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360678|NCT00288223|Telithromycin|telithromycin|mesh-list
56360679|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56360680|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360681|NCT00288262|Melatonin|melatonin|mesh-list
56360682|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
56360683|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360684|NCT00288262|Protective Agents|protective agents|mesh-ancestor
56360685|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360686|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360687|NCT00288379|Budesonide|budesonide|mesh-list
56360688|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
56360689|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56360690|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56360691|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
56360692|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360693|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360694|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56360695|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
56360696|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
56360697|NCT00288379|Hormones|hormones|mesh-ancestor
56360698|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360699|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56360700|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56360701|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56360702|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
56360703|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360704|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360705|NCT00078182|Tenofovir|tenofovir|mesh-list
56360706|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
56360707|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360708|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56360709|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56360710|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360711|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360712|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56360713|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56360714|NCT00111618|Vadimezan|vadimezan|mesh-list
56651796|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651797|NCT03513770|Ketorolac|ketorolac|mesh-list
56651798|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56651799|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56651800|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651801|NCT03513770|Analgesics|analgesics|mesh-ancestor
56651802|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
56651803|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651804|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651805|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651806|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56651807|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56651808|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651809|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651810|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
56651811|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
56651812|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651813|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56651814|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651815|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
56651816|NCT02823977|Ketamine|ketamine|mesh-list
56651817|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56360715|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360716|NCT00399425|Heparin|heparin|mesh-list
56360717|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56360718|NCT00399425|Tinzaparin|tinzaparin|mesh-list
56360719|NCT00399425|Dalteparin|dalteparin|mesh-list
56360720|NCT00399425|Bemiparin|bemiparin|mesh-list
56360721|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
56360722|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56360723|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56360728|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56360730|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
56360731|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360732|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
56360733|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360734|NCT00399464|Alfuzosin|alfuzosin|mesh-list
56360735|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56360736|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56360737|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56360739|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360740|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360741|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360742|NCT00399464|Urological Agents|urological agents|mesh-ancestor
56360743|NCT00288652|Reboxetine|reboxetine|mesh-list
56360744|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
56360745|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360746|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56360747|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56360748|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56360749|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360750|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
56651818|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651819|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651820|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651821|NCT02823977|Analgesics|analgesics|mesh-ancestor
56651822|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
56651823|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360751|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360752|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360753|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56360754|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
56360755|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360756|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
56360757|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
56360758|NCT00288769|Vitamins|vitamins|mesh-ancestor
56360759|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
56360760|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360761|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
56360762|NCT00288769|Hematinics|hematinics|mesh-ancestor
56360763|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
56360764|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56360765|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56360766|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360767|NCT00289042|Enoxaparin|enoxaparin|mesh-list
56360768|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
56360769|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56360770|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56360771|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360772|NCT00111891|Niacin|niacin|mesh-list
56360773|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56360774|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
56360775|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360776|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56360777|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
56360778|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
56360779|NCT00111891|Vitamins|vitamins|mesh-ancestor
56360780|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
56360781|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360782|NCT00289354|Chromium|chromium|mesh-list
56360783|NCT00289354|Biotin|biotin|mesh-list
56360784|NCT00289354|Picolinic acid|picolinic acid|mesh-list
56360785|NCT00289354|Trace Elements|trace elements|mesh-ancestor
56360786|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
56360787|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360788|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
56360789|NCT00289354|Vitamins|vitamins|mesh-ancestor
56360790|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56360791|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
56360792|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
56360793|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360794|NCT00289510|Vaccines|vaccines|mesh-list
56360795|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
56360801|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360802|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360803|NCT00289627|Ipilimumab|ipilimumab|mesh-list
56360804|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56360805|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360806|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56360807|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360808|NCT00401661|Alfuzosin|alfuzosin|mesh-list
55982637|NCT02726620|Isoproterenol|isoproterenol|mesh-list
56360809|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56360810|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56360811|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56360812|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
56360813|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360814|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360815|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360816|NCT00401661|Urological Agents|urological agents|mesh-ancestor
56360817|NCT00289861|Risperidone|risperidone|mesh-list
56651824|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56651825|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56651826|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56651827|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
56651828|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651829|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651830|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56651831|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56651832|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
56651833|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
56360818|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56360819|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
56360820|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360821|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360822|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360823|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56360824|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56360825|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56360826|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360827|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56360828|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
56360829|NCT00290017|Pemetrexed|pemetrexed|mesh-list
56360830|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360831|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360832|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360833|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56360834|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56360835|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
56360836|NCT00112008|Hematinics|hematinics|mesh-ancestor
56360837|NCT00112086|Paclitaxel|paclitaxel|mesh-list
56360838|NCT00112086|Carboplatin|carboplatin|mesh-list
56360839|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56360840|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360841|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
56360842|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
56360843|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
56171315|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56360844|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360845|NCT00290173|Ritodrine|ritodrine|mesh-list
56360846|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
56360847|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
56360848|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360849|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360850|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
56360851|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56360852|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56360853|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56360854|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56360855|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
56360856|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360857|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360858|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
56360859|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360860|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56360861|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360862|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360863|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56360866|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360867|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360868|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360869|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56360870|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56360871|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
56651834|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56651835|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56651836|NCT00680511|Methamphetamine|methamphetamine|mesh-list
55989334|NCT05685225|Naltrexone|naltrexone|mesh-list
56360872|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56360873|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56360875|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
56360876|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56360877|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
56360878|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56360879|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
56360880|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
56360881|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360882|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360883|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56360884|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
56360886|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360887|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56360888|NCT00290602|Protective Agents|protective agents|mesh-ancestor
56360889|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56360890|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360891|NCT00290641|Cyclosporine|cyclosporine|mesh-list
56360892|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
56360893|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
56360894|NCT00290641|Fludarabine|fludarabine|mesh-list
56360895|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
56360896|NCT00290641|Cyclosporins|cyclosporins|mesh-list
56360897|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360898|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
56360899|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360900|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56360901|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56360902|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
56360903|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360904|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360905|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56360906|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56360907|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
56360908|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360909|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
56360910|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360911|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
56360912|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56360913|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56360914|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56360915|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
56360916|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56360918|NCT00290680|Bortezomib|bortezomib|mesh-list
56360919|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360920|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56360921|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56360922|NCT00290680|Analgesics|analgesics|mesh-ancestor
56360923|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
56360924|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360925|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360926|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56360927|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56360928|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56360929|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56360930|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360931|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360932|NCT02960815|Imiquimod|imiquimod|mesh-list
56360933|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56360934|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
56360935|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360936|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360937|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
56360938|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56360943|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360944|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56360945|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56651837|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56360946|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360947|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360948|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56360950|NCT00290836|Aprotinin|aprotinin|mesh-list
56360951|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
56360952|NCT00290836|Coagulants|coagulants|mesh-ancestor
56360953|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56360954|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56360955|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
56360956|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360957|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360958|NCT04729556|Chitosan|chitosan|mesh-list
56360959|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56360960|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56360962|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360963|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56360964|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
56360965|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
56360966|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
56360967|NCT04729556|Coagulants|coagulants|mesh-ancestor
56360968|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56360969|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
56360970|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360971|NCT00290914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56360972|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56360973|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56360974|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360975|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56360976|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
56360977|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360978|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56360979|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56360980|NCT00290992|Rasburicase|rasburicase|mesh-list
56360981|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
56360982|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56360983|NCT00291109|Letrozole|letrozole|mesh-list
56360984|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360985|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56360986|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56360987|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360988|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360989|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56360990|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
56360991|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360992|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360993|NCT00291148|Pregabalin|pregabalin|mesh-list
56360994|NCT00291148|Paroxetine|paroxetine|mesh-list
56360995|NCT00291148|Analgesics|analgesics|mesh-ancestor
56360996|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
56360997|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56360998|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360999|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
56361000|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56361001|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56361002|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361003|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56361004|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56361005|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56361006|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56361007|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56361008|NCT00291148|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56361009|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56361012|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56361013|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
56361014|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56361015|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56361016|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361017|NCT00291382|Fluticasone|fluticasone|mesh-list
56361018|NCT00291382|Xhance|xhance|mesh-list
56361019|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56651838|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651839|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
56651840|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
56361020|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56361021|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56361022|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
56361023|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361024|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361025|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56361026|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
56361027|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56361028|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56361029|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56361030|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55982870|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56361031|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56361032|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
56361033|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361034|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361035|NCT00112476|Sirolimus|sirolimus|mesh-list
56361036|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
56361037|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56361038|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361039|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56361040|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361041|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
56361042|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361043|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
56361044|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361045|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56361046|NCT00291538|Bortezomib|bortezomib|mesh-list
56361047|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361048|NCT00291616|Interferons|interferons|mesh-list
56361049|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
56361050|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
56361051|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56361052|NCT00291616|Thymalfasin|thymalfasin|mesh-list
56361053|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361054|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
56361055|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361056|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
56361057|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361058|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56361059|NCT00078572|Capecitabine|capecitabine|mesh-list
56361060|NCT00078572|Lapatinib|lapatinib|mesh-list
56361061|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361062|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
56361063|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361064|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361065|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56361066|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361067|NCT00291733|Levetiracetam|levetiracetam|mesh-list
56361068|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
56361069|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
56361071|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56361072|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361073|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56361074|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56361075|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56361076|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361077|NCT00291772|Pramlintide|pramlintide|mesh-list
56361078|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56361079|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361080|NCT00078611|Natalizumab|natalizumab|mesh-list
56361081|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
56361082|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361083|NCT00291811|Plerixafor|plerixafor|mesh-list
56361084|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56361087|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361088|NCT00291850|Paclitaxel|paclitaxel|mesh-list
56361089|NCT00291850|Cisplatin|cisplatin|mesh-list
56361090|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56361091|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361092|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
56651841|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651842|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
56651843|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547638|NCT04258930|Calcium acetate|calcium acetate|mesh-list
56651844|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651846|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56651847|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56651848|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56651849|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56651850|NCT00654576|Olanzapine|olanzapine|mesh-list
56651851|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
56361093|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
56361094|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
56361095|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361096|NCT00112554|Cytarabine|cytarabine|mesh-list
56361097|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361098|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
56361099|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361100|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361101|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
56361102|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361103|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361104|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
56361105|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361106|NCT04718311|Tacrolimus|tacrolimus|mesh-list
56361107|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361108|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
56361109|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361110|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56361111|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361112|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361114|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361115|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
56361116|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361117|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
56361118|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361119|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56361120|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361121|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361122|NCT00078845|Amifostine|amifostine|mesh-list
56361123|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56361124|NCT00078845|Protective Agents|protective agents|mesh-ancestor
56361125|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361126|NCT00275314|Valganciclovir|valganciclovir|mesh-list
56361127|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
56361128|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361129|NCT00275275|Pramipexole|pramipexole|mesh-list
56361130|NCT00275275|Ropinirole|ropinirole|mesh-list
56361131|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
56361132|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361133|NCT00275275|Protective Agents|protective agents|mesh-ancestor
56361134|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361135|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56361136|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56361137|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
56361138|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
56361139|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361141|NCT00112710|Carboplatin|carboplatin|mesh-list
56361142|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361143|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361144|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
56361145|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361146|NCT00112710|Antiviral Agents|antiviral agents|mesh-ancestor
56361147|NCT00112710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651852|NCT00654576|Risperidone|risperidone|mesh-list
56651853|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56651854|NCT00654576|Clozapine|clozapine|mesh-list
56651855|NCT00654576|Sulpiride|sulpiride|mesh-list
56651856|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56361148|NCT00112710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361149|NCT00112710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361150|NCT00112710|Immunologic Factors|immunologic factors|mesh-ancestor
56361151|NCT00112710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361152|NCT00275236|Rotigotine|rotigotine|mesh-list
56361153|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
56361154|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
56361155|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361156|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361157|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361158|NCT00275197|Sertraline|sertraline|mesh-list
56361159|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
56361160|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56361164|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361166|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
56361167|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361168|NCT00275119|Gemcitabine|gemcitabine|mesh-list
56361169|NCT00275119|Fluorouracil|fluorouracil|mesh-list
56361170|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
56361171|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361172|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
56361173|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361174|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361175|NCT00275119|Antiviral Agents|antiviral agents|mesh-ancestor
56361176|NCT00275119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361177|NCT00275119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361178|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361179|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
56361180|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361181|NCT00275080|Decitabine|decitabine|mesh-list
55983018|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
56361182|NCT00275080|Azacitidine|azacitidine|mesh-list
56361183|NCT00275080|Vorinostat|vorinostat|mesh-list
56361184|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361185|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
56361186|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361187|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361188|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361189|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56361191|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361192|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
56361193|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361194|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361195|NCT00078962|Antiviral Agents|antiviral agents|mesh-ancestor
56361196|NCT00078962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361197|NCT00078962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361198|NCT00078962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361199|NCT00078962|Immunologic Factors|immunologic factors|mesh-ancestor
56361200|NCT00078962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361201|NCT00275041|Irinotecan|irinotecan|mesh-list
56361202|NCT00275041|Cetuximab|cetuximab|mesh-list
56361203|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56361204|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56361205|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361206|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361207|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361208|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56361209|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56361210|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
56361211|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56361212|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
56361213|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361214|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361216|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
56361217|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361218|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651857|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
56651858|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651859|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651860|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651861|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56651862|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651863|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651864|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56651865|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56651866|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
56651867|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
56651868|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
56651869|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361219|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56361220|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56361221|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361222|NCT00102765|Fluticasone|fluticasone|mesh-list
56361223|NCT00102765|Xhance|xhance|mesh-list
56361224|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56361225|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56361226|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56361227|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56361228|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
56361229|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361230|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875276|NCT01200160|Niacin|niacin|mesh-list
56361235|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56361236|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56361237|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56361238|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
56361239|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361240|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361241|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
56361242|NCT00102765|Hormones|hormones|mesh-ancestor
56165334|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361243|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361244|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
56361245|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
56361246|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56361247|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361248|NCT00079079|Gemcitabine|gemcitabine|mesh-list
56361249|NCT00079079|Carboplatin|carboplatin|mesh-list
56361250|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361251|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361252|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
56361253|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361254|NCT00079079|Antiviral Agents|antiviral agents|mesh-ancestor
56361255|NCT00079079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361256|NCT00079079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361257|NCT00079079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361258|NCT00079079|Immunologic Factors|immunologic factors|mesh-ancestor
56361259|NCT00079079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361260|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
56361261|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56361262|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
56361263|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361264|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361265|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56361266|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
56361267|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56361268|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56361269|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56651870|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56651871|NCT00654576|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56651872|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56651873|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56651874|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
56651875|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
56651876|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
56651877|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56214785|NCT01614964|Artemether|artemether|mesh-list
56361270|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
56361271|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361272|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361273|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56361274|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
56361275|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56361276|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
56361277|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361278|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56361279|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56361280|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56361281|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56361282|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361284|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56361285|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56361286|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
56361287|NCT00119301|Leucovorin|leucovorin|mesh-list
56361288|NCT00119301|Trimetrexate|trimetrexate|mesh-list
56361289|NCT00119301|Methotrexate|methotrexate|mesh-list
56361290|NCT00119301|Calcium|calcium|mesh-list
56361291|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
56361292|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56361293|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361294|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56361295|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
56361296|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56361297|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361298|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
56361299|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361300|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361306|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361307|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56361308|NCT00119301|Antidotes|antidotes|mesh-ancestor
56361309|NCT00119301|Protective Agents|protective agents|mesh-ancestor
56361310|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
56361311|NCT00119301|Vitamins|vitamins|mesh-ancestor
56361312|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
56361313|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
56361314|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361315|NCT00079118|Docetaxel|docetaxel|mesh-list
56361316|NCT00079118|Irinotecan|irinotecan|mesh-list
56361317|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361318|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56361319|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56361320|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56361321|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361322|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56361323|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56361324|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361326|NCT00130195|Dexamethasone|dexamethasone|mesh-list
56361327|NCT00130195|Prednisolone|prednisolone|mesh-list
56361328|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
56361329|NCT00130195|Methotrexate|methotrexate|mesh-list
56361330|NCT00130195|Vincristine|vincristine|mesh-list
56361331|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
56361332|NCT00130195|Daunorubicin|daunorubicin|mesh-list
56361333|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361334|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
56361335|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651878|NCT00622622|Gemcitabine|gemcitabine|mesh-list
56651879|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56651880|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
56651881|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651882|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651883|NCT00622622|Antiviral Agents|antiviral agents|mesh-ancestor
56651884|NCT00622622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651885|NCT00622622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651886|NCT00622622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361336|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361337|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56361338|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
56361339|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361340|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361341|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56361342|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56361343|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
56361344|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
56361345|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361346|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56361347|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
56361348|NCT00130195|Hormones|hormones|mesh-ancestor
56361349|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361350|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56361351|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56361352|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
56361353|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56361354|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361355|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
56361356|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
56361357|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361358|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56361359|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56361361|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361362|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56361363|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
56361364|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
56361365|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
56361366|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56361367|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56361368|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56361369|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56361370|NCT00394303|Insulin|insulin|mesh-list
56361371|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56361372|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361373|NCT00119340|Cyclosporine|cyclosporine|mesh-list
56361374|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
56361375|NCT00119340|Fludarabine|fludarabine|mesh-list
56361381|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361383|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
56361384|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361385|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361386|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
56361387|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361388|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
56361389|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361390|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56361391|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56361392|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56361393|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
56361394|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56361396|NCT00130156|Bunazosin|bunazosin|mesh-list
56361397|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56361398|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56361399|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56651887|NCT00622622|Immunologic Factors|immunologic factors|mesh-ancestor
56651888|NCT00622622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651889|NCT00598650|Donepezil|donepezil|mesh-list
56651890|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56651891|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361400|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56361401|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
56361402|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361403|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361404|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361405|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
56361406|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
56361407|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56361408|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56361409|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361410|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56361411|NCT00079157|Sargramostim|sargramostim|mesh-list
56361412|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
56361413|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
56361414|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361415|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56361416|NCT00130000|Eculizumab|eculizumab|mesh-list
56361417|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56361418|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361419|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
56361420|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361421|NCT00079235|Sirolimus|sirolimus|mesh-list
56361422|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56361423|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361424|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56361425|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361426|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
56361427|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361428|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
56361429|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361430|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
56361431|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361432|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56361433|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
56361434|NCT00129805|Aspirin|aspirin|mesh-list
56361435|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
56361436|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56361437|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56361438|NCT00129805|Analgesics|analgesics|mesh-ancestor
56361439|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
56361440|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361441|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361442|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56361443|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361444|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56361445|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55875453|NCT01157416|Cycloserine|cycloserine|mesh-list
56361454|NCT00129727|Paclitaxel|paclitaxel|mesh-list
56361455|NCT00129727|Bevacizumab|bevacizumab|mesh-list
56361456|NCT00129727|Carboplatin|carboplatin|mesh-list
56361457|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56361458|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361459|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
56361460|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
56361461|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
56361462|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361463|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56361464|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56361465|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56361466|NCT00129727|Growth Substances|growth substances|mesh-ancestor
56361467|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361468|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
56361469|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
56361470|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361471|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56361472|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651892|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651893|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
56651894|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651895|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214801|NCT01615055|Fluoxetine|fluoxetine|mesh-list
56361473|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361474|NCT00129688|Amikacin|amikacin|mesh-list
56361475|NCT00129688|Cloxacillin|cloxacillin|mesh-list
56361476|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56361477|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361478|NCT00079352|Gemcitabine|gemcitabine|mesh-list
56361479|NCT00079352|Irinotecan|irinotecan|mesh-list
56361480|NCT00079352|Alvocidib|alvocidib|mesh-list
56361481|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361482|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
56361483|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361484|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361485|NCT00079352|Antiviral Agents|antiviral agents|mesh-ancestor
56361486|NCT00079352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361487|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361488|NCT00079352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361489|NCT00079352|Immunologic Factors|immunologic factors|mesh-ancestor
56361490|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361491|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56361492|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56361493|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
56361494|NCT00079352|Growth Substances|growth substances|mesh-ancestor
56361495|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56361496|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
56361497|NCT00119496|Beclomethasone|beclomethasone|mesh-list
56361498|NCT00119496|Theophylline|theophylline|mesh-list
56361499|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361500|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361501|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56361502|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361503|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56361504|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
56361505|NCT00119496|Hormones|hormones|mesh-ancestor
56361506|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361507|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56361508|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
56361509|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56361510|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
56361511|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875521|NCT01158820|Narcotics|narcotics|mesh-ancestor
56361513|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
56361514|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56361515|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56361516|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
56361517|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361518|NCT00298285|Enoxaparin|enoxaparin|mesh-list
56361519|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
56361520|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56361521|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56361522|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361523|NCT00298324|Cyclosporine|cyclosporine|mesh-list
56361524|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
56361525|NCT00298324|Prednisone|prednisone|mesh-list
56361526|NCT00298324|Cyclosporins|cyclosporins|mesh-list
56361527|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56361528|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
56361529|NCT00298324|Hormones|hormones|mesh-ancestor
56361530|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361531|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361532|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56361533|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361534|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361535|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361536|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361537|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
56361538|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
56651896|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
56651897|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56651898|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56651899|NCT04150731|Estradiol|estradiol|mesh-list
55989981|NCT01008319|Clomiphene|clomiphene|mesh-list
56361539|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361540|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
56361541|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361542|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56001733|NCT03252600|Hormones|hormones|mesh-ancestor
56361543|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56361544|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56361545|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
56361546|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56361547|NCT00079430|Paclitaxel|paclitaxel|mesh-list
56361548|NCT00079430|Bevacizumab|bevacizumab|mesh-list
56361549|NCT00079430|Carboplatin|carboplatin|mesh-list
56361550|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56361551|NCT00079430|Antibodies|antibodies|mesh-list
56361552|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
56361553|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56361554|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56361555|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361556|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
56361557|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
56361558|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
56361559|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361560|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56361561|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56361562|NCT00079430|Growth Substances|growth substances|mesh-ancestor
56361563|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361564|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
56361565|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
56361566|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
56361567|NCT00298597|Hematinics|hematinics|mesh-ancestor
56361568|NCT00298636|Adenosine|adenosine|mesh-list
56361569|NCT00298636|Analgesics|analgesics|mesh-ancestor
56361570|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
56361571|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361572|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361573|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56361574|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
56361575|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56361576|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
56361577|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
56361578|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361579|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361580|NCT00086112|Risperidone|risperidone|mesh-list
56361581|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56361582|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
56361583|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361584|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361585|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361590|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56361591|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
56361593|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56361594|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
56361595|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56361596|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56361597|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56361598|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56361599|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361600|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
56361601|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361602|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361603|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56361604|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56361605|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361606|NCT00298675|Irinotecan|irinotecan|mesh-list
56361607|NCT00298675|Iniparib|iniparib|mesh-list
56361608|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56361609|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56651900|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56651901|NCT04150731|Estrogens|estrogens|mesh-ancestor
56651902|NCT04150731|Hormones|hormones|mesh-ancestor
56651903|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361610|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361611|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361612|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361613|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56361614|NCT00298714|Losartan|losartan|mesh-list
56361615|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56361616|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56361617|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56361618|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56361619|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361621|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
56361622|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56361623|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
56361624|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361625|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361626|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
56361627|NCT00298870|Isoniazid|isoniazid|mesh-list
56361628|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
56361629|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56361630|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361631|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56361632|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56361633|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
56361634|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361635|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56361636|NCT00298909|Niacin|niacin|mesh-list
56361637|NCT00298909|Niacinamide|niacinamide|mesh-list
56361638|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
56361639|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56361640|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
56361641|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361642|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56361643|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
56361644|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
56361645|NCT00298909|Vitamins|vitamins|mesh-ancestor
56361646|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
56361647|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361648|NCT00299026|Paclitaxel|paclitaxel|mesh-list
56361649|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56361650|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361651|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
56361652|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
56361653|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
56361654|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361656|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56361657|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56361658|NCT00299065|Analgesics|analgesics|mesh-ancestor
56361661|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361662|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56361663|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361664|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56361665|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361666|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361667|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56361668|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
56361669|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361670|NCT00079586|Heparin|heparin|mesh-list
56361671|NCT00079586|Bivalirudin|bivalirudin|mesh-list
56361672|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
56361673|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56361674|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56361675|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361676|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
56361677|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56361678|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
56361679|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651904|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651905|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56651906|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
56651907|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56361680|NCT00418132|Thalidomide|thalidomide|mesh-list
56361681|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361682|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
56361683|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361684|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
56361685|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56361686|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361687|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56361688|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56361689|NCT00418132|Growth Substances|growth substances|mesh-ancestor
56361690|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
56361691|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361693|NCT00119613|Hematinics|hematinics|mesh-ancestor
56361694|NCT00299377|Abciximab|abciximab|mesh-list
56361695|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
56361696|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56361697|NCT00299455|Amoxicillin|amoxicillin|mesh-list
56361698|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
56361699|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
56361700|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56361701|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56361702|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361703|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56361704|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361705|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361706|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
56361707|NCT00086268|Carboplatin|carboplatin|mesh-list
56361708|NCT00086268|Docetaxel|docetaxel|mesh-list
56361709|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361710|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
56361711|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
56361712|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
56361713|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361714|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56361715|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361716|NCT00299572|Alendronate|alendronate|mesh-list
56361717|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56361718|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361719|NCT00299611|Levetiracetam|levetiracetam|mesh-list
56361720|NCT00299611|Sertraline|sertraline|mesh-list
56361721|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
56361722|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56361723|NCT00299611|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56361724|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56361725|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56361726|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361727|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361728|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
56361729|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361730|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
56361731|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
56361732|NCT00299650|Cisatracurium|cisatracurium|mesh-list
56361734|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56361735|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56361736|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361737|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361738|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56361739|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56361740|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56361741|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
56361742|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361743|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361745|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56361746|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56361747|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361748|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651908|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56651909|NCT04763135|Mirtazapine|mirtazapine|mesh-list
56651910|NCT04763135|Citalopram|citalopram|mesh-list
56651911|NCT04763135|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56651912|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56651913|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56651914|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651915|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651916|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
56361749|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361750|NCT00299845|Lansoprazole|lansoprazole|mesh-list
56361751|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
56361752|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56361753|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56361754|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56361755|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361756|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361757|NCT00299884|Atorvastatin|atorvastatin|mesh-list
56361758|NCT00299884|Ezetimibe|ezetimibe|mesh-list
56361759|NCT00299884|Fenofibrate|fenofibrate|mesh-list
56361760|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56361761|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56361762|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
56361763|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361764|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56361765|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56361766|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361767|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56361768|NCT00119652|Paroxetine|paroxetine|mesh-list
56361769|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
56361770|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56361771|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56361772|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56361773|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56361774|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361775|NCT00119652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56361776|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56361777|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56361778|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361779|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361780|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
56361781|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56361782|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56361783|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56361784|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361785|NCT00299923|Ribavirin|ribavirin|mesh-list
56361786|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56361787|NCT00299923|Amantadine|amantadine|mesh-list
56361788|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
56361789|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361790|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
56361791|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361792|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56361793|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56361794|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
56361795|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361796|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361797|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56361798|NCT00299923|Analgesics|analgesics|mesh-ancestor
56361799|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
56361800|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361801|NCT00299962|Interferons|interferons|mesh-list
56361802|NCT00299962|Interferon-beta|interferon-beta|mesh-list
56361803|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361804|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
56361805|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651917|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651918|NCT04763135|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56651919|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
56651920|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56361806|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
55875805|NCT01213576|Ivermectin|ivermectin|mesh-list
56361811|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
56361812|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361813|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361814|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56361815|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56361816|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56361817|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56361818|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56361819|NCT00418171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56361820|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56361821|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56361822|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361823|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361824|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
56361825|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56361826|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56361827|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
56361828|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56361829|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
56361830|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361831|NCT00300040|Chrysarobin|chrysarobin|mesh-list
56361832|NCT00300040|HBOC 201|hboc 201|mesh-list
56361833|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56361834|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56361835|NCT00300040|Analgesics|analgesics|mesh-ancestor
56361836|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
56361837|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361838|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361839|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56361840|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361841|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
56361843|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
56361844|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361845|NCT00300079|Brinzolamide|brinzolamide|mesh-list
56361846|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56361847|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361848|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361849|NCT00300118|Budesonide|budesonide|mesh-list
56361850|NCT00300118|Mesalamine|mesalamine|mesh-list
56361851|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56361852|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56361853|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
56361854|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361855|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361856|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56361857|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
56361858|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
56361859|NCT00300118|Hormones|hormones|mesh-ancestor
56361860|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361861|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56361862|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56361863|NCT00300118|Analgesics|analgesics|mesh-ancestor
56361864|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
56361865|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361866|NCT00119730|Rituximab|rituximab|mesh-list
56361867|NCT00119730|Fludarabine|fludarabine|mesh-list
56361868|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
56361869|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56361870|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361871|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
56361872|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361873|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361874|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361875|NCT00119730|Analgesics|analgesics|mesh-ancestor
56651921|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56651922|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
56651923|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
56361876|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
56361877|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361878|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56361879|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56361882|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
56361883|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56361884|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56361885|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361886|NCT00119769|Hormones|hormones|mesh-list
56361887|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361888|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361889|NCT00300313|Citalopram|citalopram|mesh-list
56361890|NCT00300313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56361891|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56361892|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56361893|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361894|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361895|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
56361896|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361897|NCT00300313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56361898|NCT00300313|Antidepressive Agents|antidepressive agents|mesh-ancestor
56361899|NCT00300313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56361900|NCT00399659|Tegaserod|tegaserod|mesh-list
56361901|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56361902|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
56361903|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361904|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361905|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361906|NCT00300352|Folic Acid|folic acid|mesh-list
56361907|NCT00300352|Hematinics|hematinics|mesh-ancestor
56361908|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
56361909|NCT00300352|Vitamins|vitamins|mesh-ancestor
56361910|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
56361911|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361912|NCT00300508|Anastrozole|anastrozole|mesh-list
56361913|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56361914|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361915|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56361916|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56361917|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361918|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361919|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56361920|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
56361921|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361922|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361923|NCT00086463|Iloprost|iloprost|mesh-list
56361924|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56361925|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
56361926|NCT00079976|Tigecycline|tigecycline|mesh-list
56361927|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56361928|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361929|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56361930|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361931|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361932|NCT00300586|Gemcitabine|gemcitabine|mesh-list
56361933|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56361934|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361935|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
56361936|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361937|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361938|NCT00300586|Antiviral Agents|antiviral agents|mesh-ancestor
56361939|NCT00300586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361940|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361941|NCT00300586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361942|NCT00300586|Immunologic Factors|immunologic factors|mesh-ancestor
56361943|NCT00300586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361944|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56361945|NCT00086541|Interferons|interferons|mesh-list
56651924|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56651925|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56651926|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214833|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
56361946|NCT00086541|Ribavirin|ribavirin|mesh-list
56361947|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
56361948|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361949|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
56361950|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361951|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
56361952|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361955|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361957|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56361958|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361959|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
56361960|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983852|NCT02506114|Ipilimumab|ipilimumab|mesh-list
56361961|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56361962|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
56361963|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
56361964|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
56361965|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56361966|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56361967|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361968|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361969|NCT04718233|Urological Agents|urological agents|mesh-ancestor
56361970|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
56361971|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56361972|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56361973|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361974|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
56361975|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361976|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361977|NCT00300937|Ubiquinone|ubiquinone|mesh-list
56361978|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
56361979|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
56361980|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361981|NCT00300937|Vitamins|vitamins|mesh-ancestor
56361982|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
56361983|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56361984|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
56361985|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361986|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361987|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56361988|NCT00418249|Protective Agents|protective agents|mesh-ancestor
56361989|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56361990|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56361991|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361992|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361993|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
56361994|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56361995|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
56361996|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
56361997|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56361998|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
56361999|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56362000|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56362001|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362002|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56362003|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362004|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362005|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56362006|NCT00301054|Renal Agents|renal agents|mesh-ancestor
56362007|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
56362008|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362009|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56362010|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362011|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362012|NCT00301171|Fluticasone|fluticasone|mesh-list
56362013|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651927|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56651928|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56362014|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56362015|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
56171350|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56362016|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362017|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362018|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56362019|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
56362020|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
56362021|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56362028|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
56362029|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362031|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
56362032|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56362033|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56362034|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55983922|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
56362035|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56362036|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362037|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
56362038|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
56362039|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362040|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362041|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56362042|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56362043|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
56362044|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56362045|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56362046|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56362047|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56362048|NCT00301405|Thalidomide|thalidomide|mesh-list
56362049|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362050|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
56362051|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362052|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
56362053|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362054|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362055|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56362056|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56362057|NCT00301405|Growth Substances|growth substances|mesh-ancestor
56362058|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
56362059|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362061|NCT00301483|HBOC 201|hboc 201|mesh-list
56362062|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56362063|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56362064|NCT00301483|Analgesics|analgesics|mesh-ancestor
56362065|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
56362066|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362067|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362068|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56362069|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362070|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
56362071|NCT00301522|Paclitaxel|paclitaxel|mesh-list
56362072|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56362073|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362074|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
56362075|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
56362076|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
56362077|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362078|NCT00080405|Bortezomib|bortezomib|mesh-list
56362079|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362080|NCT00292123|Methadone|methadone|mesh-list
56362081|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56362082|NCT00292123|Narcotics|narcotics|mesh-ancestor
56362083|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56362084|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362085|NCT00292123|Analgesics|analgesics|mesh-ancestor
56362086|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
56362087|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362088|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
56362089|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
56651929|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56651930|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
56651931|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56362090|NCT00080444|Dexamethasone|dexamethasone|mesh-list
56362091|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
56362095|NCT00080444|BB 1101|bb 1101|mesh-list
56362096|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56362097|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
56362098|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
56362099|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362100|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362101|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56362102|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
56362103|NCT00080444|Hormones|hormones|mesh-ancestor
56362104|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362105|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56362106|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362107|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
56362108|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362109|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983997|NCT05532306|Ribavirin|ribavirin|mesh-list
56362110|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
56362111|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
56362112|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56362113|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
56362114|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362115|NCT00080444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56362116|NCT00080444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56362117|NCT00080444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56362118|NCT00080444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56362119|NCT00080444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56362120|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56362121|NCT00086736|Eflornithine|eflornithine|mesh-list
56362122|NCT00086736|Bicalutamide|bicalutamide|mesh-list
56362123|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
56362124|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
56362125|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362126|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362127|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362128|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56362129|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56362130|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56362131|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362132|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56362133|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362134|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362136|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56362137|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56362138|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
56362139|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362140|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56362141|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56362142|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362143|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56362144|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56362145|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56362146|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56362147|NCT00080522|Ritonavir|ritonavir|mesh-list
56362148|NCT00080522|Lopinavir|lopinavir|mesh-list
56362149|NCT00080522|Lamivudine|lamivudine|mesh-list
56362150|NCT00080522|Zidovudine|zidovudine|mesh-list
56362151|NCT00080522|Didanosine|didanosine|mesh-list
56362152|NCT00080522|Stavudine|stavudine|mesh-list
56362153|NCT00080522|Efavirenz|efavirenz|mesh-list
56362154|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56362155|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56362156|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
56362157|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362158|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362159|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56362160|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56362161|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
56362162|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651932|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56651933|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56651934|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
56362163|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56362164|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56362165|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56362168|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56362169|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56362170|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56362171|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56362172|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56362173|NCT00086775|Rituximab|rituximab|mesh-list
56362174|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
56362175|NCT00086775|Fludarabine|fludarabine|mesh-list
56362176|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
56362177|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362178|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362179|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
56362180|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362181|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362182|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362183|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
56362184|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362185|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362186|NCT00086892|Carboplatin|carboplatin|mesh-list
56362188|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362189|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362190|NCT00292708|Cefmetazole|cefmetazole|mesh-list
56362191|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362192|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362193|NCT00086931|Capecitabine|capecitabine|mesh-list
56362194|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
56362195|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362196|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
56362197|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362198|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362199|NCT00292747|Ibuprofen|ibuprofen|mesh-list
56362200|NCT00292747|Drotaverin|drotaverin|mesh-list
56362201|NCT00292747|Papaverine|papaverine|mesh-list
56362202|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56362203|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56362204|NCT00292747|Analgesics|analgesics|mesh-ancestor
56362205|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
56362206|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362207|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362208|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56362209|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362210|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56362211|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362212|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362213|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
56362214|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
56362215|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
56362216|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56362217|NCT00292747|Urological Agents|urological agents|mesh-ancestor
56362218|NCT00120003|Candesartan|candesartan|mesh-list
56362219|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
56362220|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56362221|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56362222|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56362223|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362224|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
56362226|NCT00201721|Pentostatin|pentostatin|mesh-list
56362227|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362228|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
56362229|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362230|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362231|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56362232|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
56362233|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905739|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
56651935|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56651936|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651937|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362234|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362235|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56362236|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362237|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56362238|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362240|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
56362252|NCT00086970|Ifosfamide|ifosfamide|mesh-list
56362253|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56362254|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56362255|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
56362256|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362257|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362258|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362259|NCT00201955|Rebamipide|rebamipide|mesh-list
56362260|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56362261|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56362262|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
56362263|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362264|NCT00201955|Protective Agents|protective agents|mesh-ancestor
56362265|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362266|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362267|NCT00080795|Gemcitabine|gemcitabine|mesh-list
56362268|NCT00080795|Doxorubicin|doxorubicin|mesh-list
56362269|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56362270|NCT00080795|Ifosfamide|ifosfamide|mesh-list
56362271|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362272|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362273|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
56362274|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362275|NCT00080795|Antiviral Agents|antiviral agents|mesh-ancestor
56362276|NCT00080795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362277|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362278|NCT00080795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362279|NCT00080795|Immunologic Factors|immunologic factors|mesh-ancestor
56362280|NCT00080795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362281|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56362282|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56362283|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56362284|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56362285|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
56362286|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56362287|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56362288|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
56362289|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362291|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362292|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56362293|NCT00201994|Tolvaptan|tolvaptan|mesh-list
56362294|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56362295|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362296|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
56362297|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362298|NCT00120120|Lenalidomide|lenalidomide|mesh-list
56362299|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
56362300|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362301|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56362302|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56362303|NCT00120120|Growth Substances|growth substances|mesh-ancestor
56362304|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
56362305|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362314|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
56362315|NCT00202189|Hormones|hormones|mesh-ancestor
56362316|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362317|NCT00202228|Riboflavin|riboflavin|mesh-list
56362318|NCT00202228|Thiamine|thiamine|mesh-list
56362319|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
56362320|NCT00202228|Vitamins|vitamins|mesh-ancestor
56362321|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
56362322|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651938|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56651940|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
55990753|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
56362323|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56362324|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56362325|NCT00087009|Rituximab|rituximab|mesh-list
56362326|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362327|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362328|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
56362329|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362330|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362331|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
56362332|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362333|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362334|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56362335|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55984222|NCT02311920|Nivolumab|nivolumab|mesh-list
56362336|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362337|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362338|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362339|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
56362340|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
56362341|NCT00306358|Vitamins|vitamins|mesh-ancestor
56362342|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
56362343|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362344|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
56362345|NCT00306358|Hematinics|hematinics|mesh-ancestor
56362346|NCT00306397|Sirolimus|sirolimus|mesh-list
56362347|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362348|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362349|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56362350|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362351|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
56362352|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362353|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
56362354|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362355|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56362356|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
56362357|NCT00418600|Vitamins|vitamins|mesh-ancestor
56362359|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362360|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56362361|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56362362|NCT00087048|Topotecan|topotecan|mesh-list
56362363|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56362364|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56362365|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362366|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362367|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362368|NCT00080951|Leucovorin|leucovorin|mesh-list
56362369|NCT00080951|Fluorouracil|fluorouracil|mesh-list
56362370|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
56362371|NCT00080951|Irinotecan|irinotecan|mesh-list
56362372|NCT00080951|Calcium|calcium|mesh-list
56362373|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
56362374|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55876380|NCT01872611|Analgesics|analgesics|mesh-ancestor
56362377|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362378|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362379|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362380|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362382|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56362383|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56362384|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362385|NCT00080951|Antidotes|antidotes|mesh-ancestor
56362387|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
56362388|NCT00080951|Vitamins|vitamins|mesh-ancestor
56362389|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
56362390|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
56362391|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56362392|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362393|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56362394|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
56362395|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362396|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362397|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651941|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651942|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56651943|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56651944|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56651945|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
56651946|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56651947|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651948|NCT04249076|Clobetasol|clobetasol|mesh-list
56362398|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362399|NCT00301639|Methylphenidate|methylphenidate|mesh-list
56362400|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56362401|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362402|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56362403|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56362404|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56362405|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362406|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
56362407|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362408|NCT00087087|Pemetrexed|pemetrexed|mesh-list
56362409|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362410|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362411|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362412|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56362413|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56362414|NCT00301795|Rituximab|rituximab|mesh-list
56362415|NCT00301795|Oblimersen|oblimersen|mesh-list
56362416|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362417|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362418|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
56362419|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362420|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362421|NCT00080990|Leucovorin|leucovorin|mesh-list
56362422|NCT00080990|Fluorouracil|fluorouracil|mesh-list
56362423|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
56362424|NCT00080990|Alvocidib|alvocidib|mesh-list
56362425|NCT00080990|Calcium|calcium|mesh-list
56362426|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
56362427|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56362428|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362429|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
56362430|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362431|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362432|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362433|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362434|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
56362436|NCT00080990|Protective Agents|protective agents|mesh-ancestor
56362437|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
56362438|NCT00080990|Vitamins|vitamins|mesh-ancestor
56362439|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
56362440|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
56362441|NCT00080990|Growth Substances|growth substances|mesh-ancestor
56362442|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56362443|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362444|NCT00301912|Methotrexate|methotrexate|mesh-list
56362445|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
56362446|NCT00301912|Fludarabine|fludarabine|mesh-list
56362447|NCT00301912|Busulfan|busulfan|mesh-list
56362448|NCT00301912|Tacrolimus|tacrolimus|mesh-list
56362449|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56362450|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
56362463|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56362464|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56362465|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
56362466|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56362467|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56362468|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
56362469|NCT00301951|Fludarabine|fludarabine|mesh-list
56651949|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56651950|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
56651951|NCT04249076|Hormones|hormones|mesh-ancestor
56214853|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56362470|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
56362471|NCT00301951|Busulfan|busulfan|mesh-list
56362472|NCT00301951|Tacrolimus|tacrolimus|mesh-list
56362473|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56362474|NCT00301951|Sargramostim|sargramostim|mesh-list
56362475|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362476|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362477|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
56362478|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362479|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362480|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
56362481|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362482|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56362483|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362484|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56362485|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56362486|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
56362487|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362488|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362489|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
56362490|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56362491|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56362492|NCT00301990|Aldesleukin|aldesleukin|mesh-list
56362493|NCT00301990|Bevacizumab|bevacizumab|mesh-list
56362494|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362495|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362496|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56362497|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56362498|NCT00301990|Growth Substances|growth substances|mesh-ancestor
56362499|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362500|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
56362501|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56362502|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56362503|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
56362504|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362505|NCT00120198|Rituximab|rituximab|mesh-list
56362506|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362507|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362508|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
56362509|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362510|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362511|NCT00302224|Ketoconazole|ketoconazole|mesh-list
56362512|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
56362513|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362515|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56362516|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362517|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362518|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56362519|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
56362520|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362521|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362522|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56362523|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
56362524|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362525|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362527|NCT00087165|Docetaxel|docetaxel|mesh-list
56362528|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362529|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
56362530|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
56362531|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
56362532|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362533|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56362534|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
56362535|NCT00087165|Hormones|hormones|mesh-ancestor
56362536|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362537|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362538|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56651952|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56651953|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651954|NCT00681135|Olaflur|olaflur|mesh-list
55718274|NCT03117933|Cediranib|cediranib|mesh-list
56362539|NCT00302341|Trimethoprim|trimethoprim|mesh-list
56362540|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56362541|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
56362542|NCT00302341|Pafuramidine|pafuramidine|mesh-list
56362543|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362544|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362545|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56362546|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362547|NCT00302341|Renal Agents|renal agents|mesh-ancestor
56362548|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
56362549|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56362550|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56362551|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56362552|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56362553|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56362554|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56362555|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362556|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56362557|NCT00302419|Streptokinase|streptokinase|mesh-list
56362558|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56362559|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56362560|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362561|NCT00302497|Basiliximab|basiliximab|mesh-list
56362562|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362563|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
56362564|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362565|NCT00081107|Epothilones|epothilones|mesh-list
56362566|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
56362567|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56362568|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56362569|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56362570|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362571|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362572|NCT00302536|Tacrolimus|tacrolimus|mesh-list
56362573|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362574|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
56362575|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362576|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56362577|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362578|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362579|NCT00081224|Celecoxib|celecoxib|mesh-list
56362580|NCT00081224|Capecitabine|capecitabine|mesh-list
56362581|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362582|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
56362583|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362584|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876573|NCT03434340|Dexamethasone|dexamethasone|mesh-list
56362586|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56362587|NCT00081224|Analgesics|analgesics|mesh-ancestor
56362588|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
56362589|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362590|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362591|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56362592|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362593|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56362594|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56362595|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362596|NCT00120237|Misoprostol|misoprostol|mesh-list
56362597|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56362598|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
56362599|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56362600|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362601|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56362602|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56362603|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
56362604|NCT00081302|Paclitaxel|paclitaxel|mesh-list
56362605|NCT00081302|Carboplatin|carboplatin|mesh-list
56362606|NCT00081302|Cetuximab|cetuximab|mesh-list
56651955|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
56651956|NCT00681135|Protective Agents|protective agents|mesh-ancestor
56362607|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56362608|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362609|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
56362610|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
56362611|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
56362612|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362613|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362614|NCT00302653|Rasburicase|rasburicase|mesh-list
56362615|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
56362616|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362617|NCT00418288|Glucagon|glucagon|mesh-list
56362618|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56362619|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56362620|NCT00418288|Hormones|hormones|mesh-ancestor
56362621|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362622|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362623|NCT00418288|Incretins|incretins|mesh-ancestor
56362624|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56362625|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362626|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56362627|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362628|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362629|NCT00087282|Irinotecan|irinotecan|mesh-list
56362630|NCT00087282|Alvocidib|alvocidib|mesh-list
56362631|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56362632|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56362633|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362634|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362635|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362636|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
56362637|NCT00087282|Growth Substances|growth substances|mesh-ancestor
56362638|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362639|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56362640|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56362641|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56362642|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362643|NCT00418366|Incretins|incretins|mesh-ancestor
56362644|NCT00418366|Hormones|hormones|mesh-ancestor
56362645|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362646|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56362647|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
56362648|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362649|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362650|NCT00120315|Esomeprazole|esomeprazole|mesh-list
56362651|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56362652|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56362653|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56362654|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362655|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362656|NCT00081380|Valproic Acid|valproic acid|mesh-list
56362657|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56362658|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
56362662|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56362663|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362664|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362665|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362666|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
56362667|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
56362668|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
56362669|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362670|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
56362671|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56362672|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56362673|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362674|NCT00302692|Metoprolol|metoprolol|mesh-list
56362675|NCT00302692|Esmolol|esmolol|mesh-list
56362676|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56362677|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56362678|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
56362680|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362681|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651957|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651958|NCT02821559|Bevacizumab|bevacizumab|mesh-list
56651959|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
56651960|NCT02821559|Raltitrexed|raltitrexed|mesh-list
56651961|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56651962|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651963|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56362682|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56362683|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56362684|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56362685|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
56362686|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362687|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362688|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56362689|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
56362690|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56362691|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56362692|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56362693|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56362694|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362695|NCT00081536|Capecitabine|capecitabine|mesh-list
56362696|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362697|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
56362698|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362699|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362700|NCT00303004|Bosentan|bosentan|mesh-list
56362701|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
56362702|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
56362703|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56362704|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56362705|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362706|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362707|NCT00303004|Urological Agents|urological agents|mesh-ancestor
56362708|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56362709|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56362710|NCT00081575|Levofloxacin|levofloxacin|mesh-list
56362711|NCT00081575|Ofloxacin|ofloxacin|mesh-list
56362712|NCT00081575|Tigecycline|tigecycline|mesh-list
56362713|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56362714|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362715|NCT00081575|Renal Agents|renal agents|mesh-ancestor
56362716|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362717|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56362718|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56362719|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362720|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362721|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362722|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56362723|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56362724|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56362725|NCT00087399|Gabapentin|gabapentin|mesh-list
56362726|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
56362727|NCT00087399|Analgesics|analgesics|mesh-ancestor
56362728|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
56362729|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362730|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362731|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
56362732|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55876724|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56362737|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56362738|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362739|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362740|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
56362741|NCT00081614|Bevacizumab|bevacizumab|mesh-list
56362742|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56362743|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362744|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56651964|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56651965|NCT02821559|Growth Substances|growth substances|mesh-ancestor
56362745|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56362746|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56362747|NCT00081614|Growth Substances|growth substances|mesh-ancestor
56362748|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362749|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
56362750|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56362751|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362752|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362754|NCT00303277|Pravastatin|pravastatin|mesh-list
56362755|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56362756|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56362757|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
56362758|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362759|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56362760|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56362761|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362762|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56362763|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362764|NCT00303433|Memantine|memantine|mesh-list
56362765|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56362766|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56362767|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
56362768|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362769|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362770|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362771|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56362772|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56362773|NCT00303550|Linezolid|linezolid|mesh-list
56362774|NCT00303550|Iclaprim|iclaprim|mesh-list
56362775|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362776|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362777|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56362778|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362779|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362780|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56362781|NCT00120354|Lamivudine|lamivudine|mesh-list
56362782|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56362783|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56362784|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362785|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362786|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
56362787|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362788|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56362789|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56362790|NCT00399698|Risperidone|risperidone|mesh-list
56362791|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56362792|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
56362793|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362794|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362795|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362796|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56362797|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56362798|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56362799|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56362800|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56362801|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
56362802|NCT00303589|Lactams|lactams|mesh-list
56362803|NCT00303589|beta-Lactams|beta-lactams|mesh-list
56362804|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362808|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56362809|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56362810|NCT00081848|Analgesics|analgesics|mesh-ancestor
56362811|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
56362812|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362813|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362814|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56362815|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362816|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56362817|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56362818|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651966|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651967|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
56651968|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56651969|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
56651970|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651971|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56651972|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56651973|NCT00681213|Sirolimus|sirolimus|mesh-list
56651974|NCT00681213|Tacrolimus|tacrolimus|mesh-list
56651975|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56651976|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
56651977|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651978|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56651979|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214865|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56362819|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362820|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362821|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362822|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56362823|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56362824|NCT00120432|Phenylephrine|phenylephrine|mesh-list
56362825|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
56362826|NCT00120432|Tropicamide|tropicamide|mesh-list
56362827|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56362828|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
56362829|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
56362830|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362831|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362832|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
56362833|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56362834|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
56362835|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
56362836|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56362837|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56362838|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56362839|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
56362840|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56362841|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362842|NCT00120432|Protective Agents|protective agents|mesh-ancestor
56362843|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56362844|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56362845|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
56362846|NCT00303745|Capecitabine|capecitabine|mesh-list
56362847|NCT00303745|Irinotecan|irinotecan|mesh-list
56362848|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362849|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
56362850|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362851|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362852|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56362853|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56362854|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362855|NCT00303784|Goserelin|goserelin|mesh-list
56362856|NCT00303784|Estradiol|estradiol|mesh-list
56362857|NCT00303784|Estrogens|estrogens|mesh-ancestor
56362858|NCT00303784|Hormones|hormones|mesh-ancestor
56362859|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362860|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362861|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56362862|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362863|NCT00081887|Clofarabine|clofarabine|mesh-list
56362865|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
56651980|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56651981|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56651982|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56651983|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56651984|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362866|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362867|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362868|NCT00303940|Carboplatin|carboplatin|mesh-list
56362869|NCT00303940|Temozolomide|temozolomide|mesh-list
56362870|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362871|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56362872|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
56362873|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362874|NCT00304018|Prednisone|prednisone|mesh-list
56362875|NCT00304018|Fludarabine|fludarabine|mesh-list
56362876|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
56362877|NCT00304018|Etoposide|etoposide|mesh-list
56362878|NCT00304018|Busulfan|busulfan|mesh-list
56362879|NCT00304018|Tacrolimus|tacrolimus|mesh-list
56362880|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56362881|NCT00304018|Sargramostim|sargramostim|mesh-list
55876867|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
56362886|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362887|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56362888|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362889|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362890|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
56362891|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362892|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362893|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
56362894|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56362895|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56362896|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56362897|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362898|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56362899|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
56362900|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56362901|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56362902|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
56362903|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362904|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56362905|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362906|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362908|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
56362909|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362910|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362911|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
56362912|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362913|NCT00304135|Antiviral Agents|antiviral agents|mesh-ancestor
56362914|NCT00304135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362915|NCT00304135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362916|NCT00304135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362917|NCT00304135|Immunologic Factors|immunologic factors|mesh-ancestor
56362918|NCT00304135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362919|NCT00304213|Testosterone|testosterone|mesh-list
56362920|NCT00304213|Androgens|androgens|mesh-ancestor
56362921|NCT00304213|Hormones|hormones|mesh-ancestor
56362922|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362923|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362924|NCT00304252|Interferons|interferons|mesh-list
56362925|NCT00304252|Interferon-beta|interferon-beta|mesh-list
56362926|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
56362927|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362928|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
56362929|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362930|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
56362931|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362932|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56362933|NCT00120471|Tenofovir|tenofovir|mesh-list
56362934|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
56651985|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
56651986|NCT02638506|Fentanyl|fentanyl|mesh-list
56651987|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56651988|NCT02638506|Narcotics|narcotics|mesh-ancestor
56651989|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56651990|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56651991|NCT02638506|Analgesics|analgesics|mesh-ancestor
56214871|NCT01615393|Ribavirin|ribavirin|mesh-list
56362935|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362936|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56362937|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56362938|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362939|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362941|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56362942|NCT00082043|Dutasteride|dutasteride|mesh-list
56362943|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56362944|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56362945|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362946|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362947|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
56362948|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362949|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362950|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
56362951|NCT00304291|Analgesics|analgesics|mesh-ancestor
56362955|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124631|NCT04044222|Ifosfamide|ifosfamide|mesh-list
56362956|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56362957|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56362958|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362959|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362960|NCT00304369|Metronidazole|metronidazole|mesh-list
56362961|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362962|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56362963|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56362964|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56362965|NCT00082082|Thymalfasin|thymalfasin|mesh-list
56362966|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56362967|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
56362968|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362969|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
56362970|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56362971|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362972|NCT00087711|Gemcitabine|gemcitabine|mesh-list
56362973|NCT00087711|Pemetrexed|pemetrexed|mesh-list
56362974|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362975|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362976|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
56362977|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362978|NCT00087711|Antiviral Agents|antiviral agents|mesh-ancestor
56362979|NCT00087711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362980|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362981|NCT00087711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362982|NCT00087711|Immunologic Factors|immunologic factors|mesh-ancestor
56362983|NCT00087711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362984|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56362985|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56362986|NCT00304642|Dapivirine|dapivirine|mesh-list
56362987|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56362988|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56362989|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
56362990|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362991|NCT00304681|Methylphenidate|methylphenidate|mesh-list
56362992|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56362993|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362994|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56362995|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56362996|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269006|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651992|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
56651993|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56651994|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56651995|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56651996|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
56651997|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
56651998|NCT04745975|Gemcitabine|gemcitabine|mesh-list
56651999|NCT04745975|Paclitaxel|paclitaxel|mesh-list
56652000|NCT04745975|Vinorelbine|vinorelbine|mesh-list
56652001|NCT04745975|Capecitabine|capecitabine|mesh-list
56652002|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56214874|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
56362997|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362998|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
56362999|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363000|NCT00304720|Tacrolimus|tacrolimus|mesh-list
56363001|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363002|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
56363003|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363004|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56363005|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363006|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363007|NCT00082199|Aripiprazole|aripiprazole|mesh-list
56363008|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
56363009|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363010|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56363011|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55984883|NCT03910972|Vaccines|vaccines|mesh-list
56363012|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56363013|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363014|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
56363015|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
56363016|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363017|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363018|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56363019|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56363020|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
55877009|NCT01928511|Tenofovir|tenofovir|mesh-list
56363022|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56363023|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56363024|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56363025|NCT00120510|Lamivudine|lamivudine|mesh-list
56363026|NCT00120510|Zidovudine|zidovudine|mesh-list
56363027|NCT00120510|Efavirenz|efavirenz|mesh-list
56363028|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56363029|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56363030|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56363031|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363032|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363033|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
56363034|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363035|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56363036|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56363037|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
56363038|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56363039|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56363040|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56363041|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56363042|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56363043|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56363044|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56363045|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
56363046|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363047|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56652003|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652004|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
56652005|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
56652006|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
56214883|NCT01615601|Ritonavir|ritonavir|mesh-list
56363048|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56363049|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56363050|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363052|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
56363053|NCT00304993|Fenofibrate|fenofibrate|mesh-list
56363054|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56363055|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363056|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56363057|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
56363058|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363059|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56363060|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
56363061|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
56363062|NCT00304993|Vitamins|vitamins|mesh-ancestor
56363063|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
56363064|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
56363065|NCT00082277|Anastrozole|anastrozole|mesh-list
56363066|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56363067|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363068|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56363069|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56363070|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363071|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363072|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56363073|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
56363074|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363075|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363076|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56363077|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56363078|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56363079|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56363080|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
56363081|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
56363082|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363083|NCT00082316|Capsaicin|capsaicin|mesh-list
56363084|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
56363085|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
56363086|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
56363087|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363088|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363089|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56363090|NCT00305383|Taribavirin|taribavirin|mesh-list
56363091|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
56363092|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363093|NCT00305422|Risperidone|risperidone|mesh-list
56363094|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56363098|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363100|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56363101|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56363102|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56363103|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363104|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56363105|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
56363106|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
56363107|NCT00305461|Ciclesonide|ciclesonide|mesh-list
56363108|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
56363109|NCT00305461|Hormones|hormones|mesh-ancestor
56363110|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363111|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363112|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56363113|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56363114|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56363115|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56363116|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56363117|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
56363118|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652007|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652008|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56652009|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
56652010|NCT04745975|Antiviral Agents|antiviral agents|mesh-ancestor
56652011|NCT04745975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766123|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
56363119|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363120|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56363121|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56363122|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
56363123|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363124|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56363125|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56363126|NCT00305500|Citalopram|citalopram|mesh-list
56363127|NCT00305500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56363128|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56363129|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56363130|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363131|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363132|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
56363133|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363134|NCT00305500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56363135|NCT00305500|Antidepressive Agents|antidepressive agents|mesh-ancestor
56363136|NCT00305500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363137|NCT00305539|Adalimumab|adalimumab|mesh-list
56363138|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56363139|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56363140|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
56363141|NCT00305734|Gemcitabine|gemcitabine|mesh-list
56363142|NCT00305734|Bortezomib|bortezomib|mesh-list
56363143|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56363144|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
56363145|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363146|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363147|NCT00305734|Antiviral Agents|antiviral agents|mesh-ancestor
56363148|NCT00305734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363149|NCT00305734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363150|NCT00305734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363151|NCT00305734|Immunologic Factors|immunologic factors|mesh-ancestor
56363152|NCT00305734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363153|NCT00082472|Docetaxel|docetaxel|mesh-list
56363154|NCT00082472|Doxorubicin|doxorubicin|mesh-list
56363155|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56363156|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363157|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56363158|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56363159|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56363160|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363161|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56363162|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56363163|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56363164|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363165|NCT00087867|Bortezomib|bortezomib|mesh-list
56363167|NCT00305812|Dexamethasone|dexamethasone|mesh-list
56363168|NCT00305812|Lenalidomide|lenalidomide|mesh-list
56363169|NCT00305812|Melphalan|melphalan|mesh-list
56363170|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56363171|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
56363172|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
56363173|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363174|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363175|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363176|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
56363177|NCT00305812|Hormones|hormones|mesh-ancestor
56124633|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363178|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363179|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56363180|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363181|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
56652012|NCT04745975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652013|NCT04745975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652014|NCT04745975|Immunologic Factors|immunologic factors|mesh-ancestor
56652015|NCT04745975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652016|NCT04150107|Insulin|insulin|mesh-list
56652017|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56652018|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56652019|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652020|NCT02638428|Cytarabine|cytarabine|mesh-list
56652021|NCT02638428|Carboplatin|carboplatin|mesh-list
56652022|NCT02638428|Trastuzumab|trastuzumab|mesh-list
56652023|NCT02638428|Fludarabine|fludarabine|mesh-list
56652024|NCT02638428|Etoposide|etoposide|mesh-list
56363182|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56363183|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56363184|NCT00305812|Growth Substances|growth substances|mesh-ancestor
56363185|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
56363186|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56363187|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
56363188|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363189|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56363190|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363191|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56363192|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56363193|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
56363194|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363195|NCT00306046|Diphosphonates|diphosphonates|mesh-list
56363196|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56363197|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363198|NCT00306124|Levodopa|levodopa|mesh-list
56363199|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56363200|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56363201|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
56363202|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363203|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363204|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363205|NCT00082589|Eplerenone|eplerenone|mesh-list
56363206|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56363207|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
56363208|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363209|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363210|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56363211|NCT00082589|Diuretics|diuretics|mesh-ancestor
56363212|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
56363213|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56363214|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56363215|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56363216|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56363217|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
56363218|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363219|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363220|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363221|NCT00313924|Urological Agents|urological agents|mesh-ancestor
56363222|NCT00306475|Valproic Acid|valproic acid|mesh-list
56363223|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
56363224|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363225|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363226|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
56363227|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363228|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363229|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
56363230|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56363231|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652025|NCT02638428|Everolimus|everolimus|mesh-list
56652026|NCT02638428|Sorafenib|sorafenib|mesh-list
56652027|NCT02638428|Dasatinib|dasatinib|mesh-list
56652028|NCT02638428|Ifosfamide|ifosfamide|mesh-list
56652029|NCT02638428|Axitinib|axitinib|mesh-list
56652030|NCT02638428|Vemurafenib|vemurafenib|mesh-list
56652031|NCT02638428|Crizotinib|crizotinib|mesh-list
56652032|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652033|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56652034|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56652035|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
56652036|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652037|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652038|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
56652039|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652040|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56652041|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56652042|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56652043|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214900|NCT01615614|Rifabutin|rifabutin|mesh-list
56363232|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363233|NCT00082667|Gefitinib|gefitinib|mesh-list
56363234|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363235|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56363236|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363237|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363241|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363243|NCT00082784|Bortezomib|bortezomib|mesh-list
56363244|NCT00082784|Alvocidib|alvocidib|mesh-list
56363245|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363246|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
56363247|NCT00082784|Growth Substances|growth substances|mesh-ancestor
56363248|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363249|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56363250|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171392|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56363251|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363252|NCT00306826|Pioglitazone|pioglitazone|mesh-list
56363253|NCT00306826|Simvastatin|simvastatin|mesh-list
56363254|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56363255|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56363256|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
56363257|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363258|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56363259|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56363260|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363261|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56363262|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363263|NCT00082823|Aflibercept|aflibercept|mesh-list
56363264|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56363265|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56363266|NCT00082823|Growth Substances|growth substances|mesh-ancestor
56363267|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363268|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
56363269|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363270|NCT00087945|Lamivudine|lamivudine|mesh-list
56363271|NCT00087945|Zidovudine|zidovudine|mesh-list
56363272|NCT00087945|Abacavir|abacavir|mesh-list
56652044|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
56652045|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652046|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56652047|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56363273|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
56363274|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56363275|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56363276|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363277|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363278|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
56363279|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363280|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56363281|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56363282|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
56363283|NCT00082862|Gemcitabine|gemcitabine|mesh-list
56363284|NCT00082862|Interferons|interferons|mesh-list
56363285|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
56363286|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363287|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56363288|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
56363289|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363290|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
56363291|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363292|NCT00082862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363293|NCT00082862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363294|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
56363295|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363296|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56363297|NCT00307099|Meropenem|meropenem|mesh-list
56363298|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363299|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
56363300|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363301|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56363302|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
56363303|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
56363304|NCT00307177|Vaccines|vaccines|mesh-list
56363305|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
56363306|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363307|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
56363308|NCT00120705|Hematinics|hematinics|mesh-ancestor
56363309|NCT00307255|Gemcitabine|gemcitabine|mesh-list
56363310|NCT00307255|Paclitaxel|paclitaxel|mesh-list
56363311|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55985168|NCT03338920|Sumatriptan|sumatriptan|mesh-list
56363314|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
56363315|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
56363316|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
56363317|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363318|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56363319|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
56363320|NCT00307255|Antiviral Agents|antiviral agents|mesh-ancestor
56363321|NCT00307255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363322|NCT00307255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363323|NCT00307255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363324|NCT00307255|Immunologic Factors|immunologic factors|mesh-ancestor
56363325|NCT00307255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363327|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363328|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363329|NCT00307450|Levetiracetam|levetiracetam|mesh-list
56363330|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
56363331|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
56363332|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56363333|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
56363334|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363335|NCT00120744|Ondansetron|ondansetron|mesh-list
56363336|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
56363337|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
56363338|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363339|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363340|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363341|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
56363342|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56363343|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56652048|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
56652049|NCT01003964|Gemcitabine|gemcitabine|mesh-list
56652050|NCT01003964|Cisplatin|cisplatin|mesh-list
56652051|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652052|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56652053|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
56652054|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363344|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
56363345|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363346|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363347|NCT00120744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56363348|NCT00120744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56363349|NCT00120744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56363350|NCT00120744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363351|NCT00120744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56363352|NCT00083057|Paclitaxel|paclitaxel|mesh-list
56363353|NCT00083057|Gefitinib|gefitinib|mesh-list
56363354|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56363355|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363356|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
56363357|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56363358|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56363359|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363360|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56363361|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363362|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
56363363|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56363364|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56363365|NCT00307606|Prednisolone|prednisolone|mesh-list
56363366|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
56363367|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56363368|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
56363369|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56363370|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
56363371|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
56363372|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363373|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363374|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363375|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
56363376|NCT00307606|Hormones|hormones|mesh-ancestor
56363377|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363378|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56363379|NCT00307606|Protective Agents|protective agents|mesh-ancestor
56363380|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56363381|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363382|NCT00083096|Temozolomide|temozolomide|mesh-list
56363383|NCT00083096|Lonafarnib|lonafarnib|mesh-list
56363384|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56363387|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363388|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363389|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
56363390|NCT00307645|Prednisone|prednisone|mesh-list
56363391|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
56363392|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
56363393|NCT00307645|Azathioprine|azathioprine|mesh-list
56363394|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363395|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
56363396|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363397|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56363398|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56363399|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
56171396|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
56363400|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363401|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363402|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56363403|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56363404|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
56363405|NCT00307645|Hormones|hormones|mesh-ancestor
56363406|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56652055|NCT01003964|Antiviral Agents|antiviral agents|mesh-ancestor
56652056|NCT01003964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652057|NCT01003964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652058|NCT01003964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652059|NCT01003964|Immunologic Factors|immunologic factors|mesh-ancestor
56652060|NCT01003964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652061|NCT05659823|Fentanyl|fentanyl|mesh-list
56363407|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56363408|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56363409|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56363410|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
56363411|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56363412|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363413|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363414|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
56363415|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
56363416|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363417|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363418|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56363419|NCT00307645|Protective Agents|protective agents|mesh-ancestor
56363420|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
56363421|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56363422|NCT00120783|Ritonavir|ritonavir|mesh-list
56363423|NCT00120783|Indinavir|indinavir|mesh-list
56363424|NCT00120783|Lamivudine|lamivudine|mesh-list
56363425|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56363426|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56363427|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
56363428|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363429|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363430|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56363431|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56363432|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
56363433|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363434|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56363435|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56363436|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56363437|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56363438|NCT00307723|Gemcitabine|gemcitabine|mesh-list
56363439|NCT00307723|Bevacizumab|bevacizumab|mesh-list
56363440|NCT00307723|Fluorouracil|fluorouracil|mesh-list
56363441|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
56363442|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56363443|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363444|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56363445|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56363446|NCT00307723|Growth Substances|growth substances|mesh-ancestor
56363447|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363448|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
56363449|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56363450|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
56363451|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363452|NCT00307723|Antiviral Agents|antiviral agents|mesh-ancestor
56363453|NCT00307723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363454|NCT00307723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363455|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363456|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
56363463|NCT00120822|Hematinics|hematinics|mesh-ancestor
56363464|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
56363465|NCT00120822|Vitamins|vitamins|mesh-ancestor
56363466|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
56363467|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363468|NCT00083213|Aflibercept|aflibercept|mesh-list
56363469|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56363470|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56363471|NCT00083213|Growth Substances|growth substances|mesh-ancestor
56363472|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363473|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
56363474|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363476|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
56652062|NCT05659823|Morphine|morphine|mesh-list
56652063|NCT05659823|Bupivacaine|bupivacaine|mesh-list
56652064|NCT05659823|Anesthetics, Local|anesthetics, local|mesh-ancestor
56652065|NCT05659823|Anesthetics|anesthetics|mesh-ancestor
56652066|NCT05659823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652067|NCT05659823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652068|NCT05659823|Sensory System Agents|sensory system agents|mesh-ancestor
56652069|NCT05659823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652070|NCT05659823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56652071|NCT05659823|Narcotics|narcotics|mesh-ancestor
56363477|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
56363478|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363479|NCT00307996|Vitamins|vitamins|mesh-ancestor
56363480|NCT00083252|Cisplatin|cisplatin|mesh-list
56363481|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363482|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
56363483|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56363484|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363485|NCT00418678|Nabilone|nabilone|mesh-list
56363486|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
56363487|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
56363488|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363489|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363490|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363491|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56363492|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56363493|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56363494|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363495|NCT00120861|Interferons|interferons|mesh-list
56363496|NCT00120861|Ribavirin|ribavirin|mesh-list
56363497|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363498|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
56363499|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363500|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
56363501|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363502|NCT05446142|Rabeprazole|rabeprazole|mesh-list
56363503|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56363504|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363505|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56363506|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363507|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363508|NCT00308191|Bromides|bromides|mesh-list
56363509|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
56363510|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
56363511|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56363512|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
56363513|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363514|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363515|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56363516|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
56363517|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56363518|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56363519|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56363520|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
56363521|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363522|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363523|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
56363524|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56363525|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
56363526|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
56363527|NCT00308269|Folic Acid|folic acid|mesh-list
56363528|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
56363529|NCT00308269|Hematinics|hematinics|mesh-ancestor
56363531|NCT00308269|Vitamins|vitamins|mesh-ancestor
56363532|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
56363533|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363534|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363535|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
56363536|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
56652072|NCT05659823|Analgesics|analgesics|mesh-ancestor
56652073|NCT05659823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56652074|NCT05659823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56652075|NCT05659823|Anesthetics, General|anesthetics, general|mesh-ancestor
56652076|NCT02502786|Antibodies|antibodies|mesh-list
56652077|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
56363537|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
56363538|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363539|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
56363540|NCT00308425|Valsartan|valsartan|mesh-list
56363541|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56363542|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363543|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56363544|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
56363545|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56363546|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363547|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363548|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363549|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56363550|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56363551|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56363552|NCT00308503|SR 46349B|sr 46349b|mesh-list
56363553|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56363555|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363556|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56363557|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56363558|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
56363559|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363560|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363561|NCT00308542|Dexamethasone|dexamethasone|mesh-list
56363562|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56363563|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
56363564|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
56363565|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363566|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363567|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363568|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
56363569|NCT00308542|Hormones|hormones|mesh-ancestor
56363570|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363571|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56363572|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363573|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
56363574|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56363575|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363576|NCT00083408|Pamidronate|pamidronate|mesh-list
56363577|NCT00083408|Thalidomide|thalidomide|mesh-list
56363578|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363579|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
56363580|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363581|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
56363582|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56363583|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363584|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56363585|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56363586|NCT00083408|Growth Substances|growth substances|mesh-ancestor
56363587|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
56363588|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363589|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56363590|NCT00308971|Vitamin E|vitamin e|mesh-list
56363591|NCT00308971|Tocopherols|tocopherols|mesh-list
56363592|NCT00308971|Tocotrienols|tocotrienols|mesh-list
56363593|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
56363594|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
56363595|NCT00308971|Vitamins|vitamins|mesh-ancestor
56363596|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
56363597|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363598|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
56363599|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363600|NCT00308971|Protective Agents|protective agents|mesh-ancestor
56363601|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
56363602|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
56652078|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652079|NCT02823743|Aspirin|aspirin|mesh-list
56363603|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363604|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56363605|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
56363606|NCT00309049|Epothilones|epothilones|mesh-list
56363609|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
56363610|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363611|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363612|NCT00309088|Tacrolimus|tacrolimus|mesh-list
56363613|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363614|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
56363615|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363616|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56363617|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363618|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363619|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
56363620|NCT00083486|Hematinics|hematinics|mesh-ancestor
56363621|NCT00120978|Fluticasone|fluticasone|mesh-list
56363622|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56363623|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
56363624|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363625|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363626|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56363627|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
56363628|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56363629|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56363630|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56363631|NCT00309205|Dapivirine|dapivirine|mesh-list
56363632|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56363633|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56363634|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
56363635|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363636|NCT00309283|Somatostatin|somatostatin|mesh-list
56363637|NCT00309283|Hormones|hormones|mesh-ancestor
56363638|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363639|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363640|NCT00083525|Capecitabine|capecitabine|mesh-list
56363641|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56363642|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
56363643|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363644|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363645|NCT00309322|Phentolamine|phentolamine|mesh-list
56363646|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56363647|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56363648|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
56363649|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363650|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363651|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363652|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56363653|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56363654|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56363655|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56363656|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56363657|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363658|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363659|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363660|NCT04727502|Analgesics|analgesics|mesh-ancestor
56363661|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
56363662|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363663|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
56363664|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363665|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
56363666|NCT00309361|Phentolamine|phentolamine|mesh-list
56363667|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56363668|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56363669|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
56363670|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363671|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363672|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363673|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56363674|NCT00088491|Olanzapine|olanzapine|mesh-list
56363675|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
56652080|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56652081|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56652082|NCT02823743|Analgesics|analgesics|mesh-ancestor
56652083|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
56652084|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652085|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652086|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652087|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652088|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56652089|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56652090|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652091|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56652092|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56652093|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652094|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
56652095|NCT00654888|Mitomycins|mitomycins|mesh-list
56652096|NCT00654888|Mitomycin|mitomycin|mesh-list
56652097|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56652098|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652099|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
56363676|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
56363677|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363678|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363679|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363680|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56363681|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56363682|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56363683|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363684|NCT00088491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56363685|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56363686|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56363687|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363688|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363689|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
56363690|NCT00309478|Tamoxifen|tamoxifen|mesh-list
55985545|NCT05720559|Vitamins|vitamins|mesh-ancestor
56363691|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
56363692|NCT00309478|Fluorouracil|fluorouracil|mesh-list
56363693|NCT00309478|Methotrexate|methotrexate|mesh-list
56363694|NCT00309478|Goserelin|goserelin|mesh-list
56363695|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363696|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
56363697|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363698|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56363699|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56363700|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
56363701|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363702|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363703|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56363704|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
56363705|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56363706|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56363707|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
56363708|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56652100|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652101|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56363709|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56363710|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363711|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56363712|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56363713|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56363714|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
56363715|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363716|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56363717|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56363718|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56363719|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56363721|NCT00309517|Edrecolomab|edrecolomab|mesh-list
56363722|NCT00309517|Antidotes|antidotes|mesh-ancestor
56363723|NCT00309517|Protective Agents|protective agents|mesh-ancestor
56363724|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363725|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
56363726|NCT00309517|Vitamins|vitamins|mesh-ancestor
56363727|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
56363728|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56363729|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
56363730|NCT00121017|Ritonavir|ritonavir|mesh-list
56363731|NCT00121017|Lopinavir|lopinavir|mesh-list
56363732|NCT00121017|Tenofovir|tenofovir|mesh-list
56363733|NCT00121017|Emtricitabine|emtricitabine|mesh-list
56363734|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56363735|NCT00121017|Efavirenz|efavirenz|mesh-list
56363736|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56363737|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56363738|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
56363739|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363740|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363741|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56363742|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56363743|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
56363744|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363745|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56363746|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56363747|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56363748|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56363749|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56363750|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56363751|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56363752|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56363755|NCT00309556|Capecitabine|capecitabine|mesh-list
56363756|NCT00309556|Trastuzumab|trastuzumab|mesh-list
56363757|NCT00309556|Epirubicin|epirubicin|mesh-list
56363758|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363759|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56363760|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56363761|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56363762|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363763|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56363764|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
56363765|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56363766|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56363767|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56363768|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56363769|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363770|NCT00402207|Fluticasone|fluticasone|mesh-list
56363771|NCT00402207|Beclomethasone|beclomethasone|mesh-list
56363772|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56363773|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56363774|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
56363775|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363776|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363777|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56363778|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
56363779|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
56363780|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56652102|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652103|NCT05299203|Verapamil|verapamil|mesh-list
56652104|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56652105|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56363781|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
56363782|NCT00402207|Hormones|hormones|mesh-ancestor
56363783|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363784|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56363785|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
56363786|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363787|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363788|NCT00309634|Vaccines|vaccines|mesh-list
56363789|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
56363790|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363791|NCT00309673|Lidocaine|lidocaine|mesh-list
56363792|NCT00309673|Prilocaine|prilocaine|mesh-list
56363793|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56363794|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
56363795|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
56363796|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56363797|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363798|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
56363799|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363800|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56363801|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56363802|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56363803|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56363804|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363805|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56363806|NCT00309712|Simvastatin|simvastatin|mesh-list
56363807|NCT00309712|Fenofibrate|fenofibrate|mesh-list
56363808|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56363809|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56363810|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
56363811|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363812|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56363813|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56363814|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363815|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56363816|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56363817|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
56363818|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
56363819|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56363820|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56363821|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363822|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363823|NCT00309790|Urological Agents|urological agents|mesh-ancestor
56363824|NCT00418873|Risperidone|risperidone|mesh-list
56363825|NCT00418873|Zotepine|zotepine|mesh-list
56363826|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56363830|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363832|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56363833|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56363834|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363835|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56363836|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
56363837|NCT00088608|Pasireotide|pasireotide|mesh-list
56363838|NCT00088608|Hormones|hormones|mesh-ancestor
56363839|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363840|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363841|NCT00310024|Bortezomib|bortezomib|mesh-list
56363842|NCT00310024|Vorinostat|vorinostat|mesh-list
56363843|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363844|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56363845|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363846|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363847|NCT00310141|Nicotine|nicotine|mesh-list
56363848|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56363849|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
56363850|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908822|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
56652106|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652107|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652108|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56652109|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652110|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
56363851|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363852|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56363853|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56363854|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
56363855|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363856|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363858|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
56363859|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
56363860|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
56363861|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363862|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363863|NCT00083681|Thalidomide|thalidomide|mesh-list
56363864|NCT00083681|Dexamethasone|dexamethasone|mesh-list
56363865|NCT00083681|Etoposide|etoposide|mesh-list
56363866|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
56363867|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56363868|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
56363869|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
56363870|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363871|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363872|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363873|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
56363874|NCT00083681|Hormones|hormones|mesh-ancestor
56363875|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363876|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56363877|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363878|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56363879|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56363880|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56363881|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363882|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363883|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56363884|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
56363885|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56363886|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56363887|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
56363888|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56363889|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
56363890|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56363891|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363892|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56363893|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56363894|NCT00083681|Growth Substances|growth substances|mesh-ancestor
56363895|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
56363896|NCT00121095|Docetaxel|docetaxel|mesh-list
56363897|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
56363898|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363901|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
56363902|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363903|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56363904|NCT00121095|Analgesics|analgesics|mesh-ancestor
56363905|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
56363906|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363907|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363908|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
56363909|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56363910|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363911|NCT00310336|Interferons|interferons|mesh-list
56363912|NCT00310336|Ribavirin|ribavirin|mesh-list
56363913|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
56363914|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
56363915|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56363916|NCT00310336|Betaine|betaine|mesh-list
56363918|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
56652111|NCT02638584|Rabeprazole|rabeprazole|mesh-list
56652112|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56652113|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214947|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
56363919|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363920|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
56363921|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363922|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
56363923|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363924|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56124641|NCT01390428|Grazoprevir|grazoprevir|mesh-list
56363926|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56363927|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56363928|NCT05568602|Dexamethasone|dexamethasone|mesh-list
56363929|NCT05568602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56363930|NCT05568602|Antiemetics|antiemetics|mesh-ancestor
56363931|NCT05568602|Autonomic Agents|autonomic agents|mesh-ancestor
56363932|NCT05568602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363933|NCT05568602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363934|NCT05568602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363935|NCT05568602|Glucocorticoids|glucocorticoids|mesh-ancestor
56363936|NCT05568602|Hormones|hormones|mesh-ancestor
56363937|NCT05568602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363938|NCT05568602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56363939|NCT05568602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363940|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56363941|NCT00310531|Estradiol|estradiol|mesh-list
56363942|NCT00310531|Estrogens|estrogens|mesh-ancestor
56363943|NCT00310531|Hormones|hormones|mesh-ancestor
56363944|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56363945|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363946|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56363947|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
56363948|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56363949|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56363950|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56363951|NCT00310765|Pregabalin|pregabalin|mesh-list
56363952|NCT00310765|Gabapentin|gabapentin|mesh-list
56363953|NCT00310765|Analgesics|analgesics|mesh-ancestor
56363954|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
56363955|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56363956|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363957|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
56363958|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56363959|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56363960|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363961|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56363962|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56363963|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56363964|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56363965|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56363966|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56363967|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56363968|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363969|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
56363970|NCT00310843|Nevirapine|nevirapine|mesh-list
56363971|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56363972|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56363973|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363975|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
56363976|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56363977|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56363978|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56363979|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56363980|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56363981|NCT00310921|Misoprostol|misoprostol|mesh-list
56363982|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56363983|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
56363984|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56363985|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363986|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56652114|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56652115|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652116|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363987|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363988|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
56363989|NCT05568212|Durvalumab|durvalumab|mesh-list
56363990|NCT05568212|Olaparib|olaparib|mesh-list
56363991|NCT05568212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56363992|NCT05568212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363993|NCT05568212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56363994|NCT05568212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363995|NCT05568212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363996|NCT00121329|Lidocaine|lidocaine|mesh-list
56363997|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
56363998|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
56363999|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364001|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
56364002|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364003|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56364004|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56364005|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56364006|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56364007|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364008|NCT00311038|Landiolol|landiolol|mesh-list
56171452|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364009|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56364010|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56364011|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
56364012|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364013|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364014|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364015|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56364016|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
56364017|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56364018|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364019|NCT00311116|Vitamin E|vitamin e|mesh-list
56364020|NCT00311116|Vitamins|vitamins|mesh-ancestor
56364021|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
56364022|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364023|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
56364024|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364025|NCT00311116|Protective Agents|protective agents|mesh-ancestor
56364026|NCT00088959|Celecoxib|celecoxib|mesh-list
56364027|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56364028|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364029|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56364030|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364031|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364032|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56364033|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56364034|NCT00088959|Analgesics|analgesics|mesh-ancestor
56364035|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
56364036|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364037|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364038|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364039|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56364040|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56364041|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56364042|NCT05568017|Edotreotide|edotreotide|mesh-list
56364043|NCT05568017|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56364044|NCT05568017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364045|NCT00311389|Timolol|timolol|mesh-list
56364049|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56364050|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364051|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56364052|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56364053|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
56364054|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364055|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364056|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56652117|NCT04208516|Dexamethasone|dexamethasone|mesh-list
56652118|NCT04208516|Lidocaine|lidocaine|mesh-list
56652119|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
56652120|NCT04208516|Ropivacaine|ropivacaine|mesh-list
56652121|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364057|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56364058|NCT00088998|Bevacizumab|bevacizumab|mesh-list
56364059|NCT00088998|Docetaxel|docetaxel|mesh-list
56364060|NCT00088998|Capecitabine|capecitabine|mesh-list
56364061|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56364062|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364063|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56364064|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56364065|NCT00088998|Growth Substances|growth substances|mesh-ancestor
56364066|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364067|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
56364068|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
56364069|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
56364070|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
56364071|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364072|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56364074|NCT00311467|Interferons|interferons|mesh-list
56364075|NCT00311467|Capecitabine|capecitabine|mesh-list
56364076|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56364077|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
56364078|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364079|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364080|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
56364081|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364082|NCT00311545|Siltuximab|siltuximab|mesh-list
56364083|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364084|NCT00089037|Sirolimus|sirolimus|mesh-list
56364085|NCT00089037|Methotrexate|methotrexate|mesh-list
56364086|NCT00089037|Tacrolimus|tacrolimus|mesh-list
56364087|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56364088|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
56364089|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56364090|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364091|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56364092|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
56364093|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364094|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364095|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
56364096|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364097|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56364098|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364099|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
56364100|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56364101|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56364102|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56364103|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56364104|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364105|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56364106|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
56364107|NCT00311740|Valsartan|valsartan|mesh-list
56364108|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56364109|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56364110|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56364111|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56364112|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364113|NCT00311740|Diuretics|diuretics|mesh-ancestor
56364114|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
56364115|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364116|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56364117|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56364118|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
55878106|NCT01358266|Sirolimus|sirolimus|mesh-list
56364120|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364121|NCT00121407|Verteporfin|verteporfin|mesh-list
56364122|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56364123|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
56364125|NCT00311857|Temozolomide|temozolomide|mesh-list
55908823|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
56652122|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
56652123|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
56652124|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652125|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364126|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56364127|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364128|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56364129|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
56364130|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364131|NCT00311896|Bemiparin|bemiparin|mesh-list
56364132|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
56364133|NCT00121446|Enoxaparin|enoxaparin|mesh-list
56364134|NCT00121446|Tenecteplase|tenecteplase|mesh-list
56364135|NCT00121446|Clopidogrel|clopidogrel|mesh-list
56364136|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56364137|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56364138|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56364139|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56364140|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
56364141|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364142|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364143|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364144|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
56364145|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56364146|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56364147|NCT00311974|Dihydralazine|dihydralazine|mesh-list
56364148|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56364149|NCT00312013|Nadroparin|nadroparin|mesh-list
56364150|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
56364151|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56364152|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56364153|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364154|NCT00121524|Atropine|atropine|mesh-list
56364155|NCT00121524|Amiodarone|amiodarone|mesh-list
56364156|NCT00121524|Epinephrine|epinephrine|mesh-list
56364157|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56364158|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56364159|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
56364160|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364161|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364162|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364163|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56364164|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56364165|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
56364166|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364167|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56364168|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
56364169|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
56364170|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
56364171|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56364172|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56364173|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56364174|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
56364175|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56364176|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56364177|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
56364178|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
56364179|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56364180|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56364181|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56364182|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56364183|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56364184|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364185|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56364186|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56364187|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56364188|NCT00312130|Vildagliptin|vildagliptin|mesh-list
56364189|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56364190|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364191|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56364192|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
56652126|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56652127|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
56652128|NCT04208516|Hormones|hormones|mesh-ancestor
56652129|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364196|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
56364197|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56364198|NCT00089115|Antibodies|antibodies|mesh-list
56364199|NCT00089115|Sargramostim|sargramostim|mesh-list
56364200|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56364201|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56364202|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364203|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
56364204|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364205|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56364206|NCT00312325|Prednisolone|prednisolone|mesh-list
56364207|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364208|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
56364209|NCT00312325|Hormones|hormones|mesh-ancestor
56364210|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364211|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364212|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56364213|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364214|NCT05567471|Vaccines|vaccines|mesh-list
56364215|NCT05567471|Immunologic Factors|immunologic factors|mesh-ancestor
56364216|NCT05567471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364217|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56364219|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
56364220|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56364221|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
56364222|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364223|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364224|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
56364225|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
56364226|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
56364227|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56364228|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364229|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
56364230|NCT00312481|Protective Agents|protective agents|mesh-ancestor
56364231|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364232|NCT00312481|Vitamins|vitamins|mesh-ancestor
56364233|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
56364234|NCT00312481|Cathartics|cathartics|mesh-ancestor
56364235|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56364236|NCT00312481|Laxatives|laxatives|mesh-ancestor
56364237|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
56364238|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56364239|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56364240|NCT00312520|Prednisolone|prednisolone|mesh-list
56364241|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
56364242|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56364243|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
56364244|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364245|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
56364246|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
56364247|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364248|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364249|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56364250|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
56364251|NCT00312520|Hormones|hormones|mesh-ancestor
56364252|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364253|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56364254|NCT00312520|Protective Agents|protective agents|mesh-ancestor
56364255|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56364256|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364257|NCT00089193|Sargramostim|sargramostim|mesh-list
56364258|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
56364259|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
56364260|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364261|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56364262|NCT00293098|Deferiprone|deferiprone|mesh-list
56364263|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56364264|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
56364265|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
56652130|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56652131|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652132|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
56652133|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
56652134|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767337|NCT02061280|Xhance|xhance|mesh-list
56364266|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364267|NCT00293176|Donepezil|donepezil|mesh-list
56364268|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56364270|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364271|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
56364272|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364273|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364274|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
56364275|NCT05567315|Anesthetics|anesthetics|mesh-list
56364276|NCT05567315|Anesthetics, Local|anesthetics, local|mesh-list
56364277|NCT05567315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364278|NCT05567315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364279|NCT05567315|Sensory System Agents|sensory system agents|mesh-ancestor
56364280|NCT05567315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364281|NCT00121563|Thalidomide|thalidomide|mesh-list
56364282|NCT00121563|Ibuprofen|ibuprofen|mesh-list
56364283|NCT00121563|Diazepam|diazepam|mesh-list
56364284|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56364285|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56364286|NCT00121563|Analgesics|analgesics|mesh-ancestor
56364287|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
56364288|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364289|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364290|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364291|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56364292|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56364293|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364294|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364295|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364296|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
56364297|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
56364298|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56364299|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364300|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56364301|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56364302|NCT00121563|Growth Substances|growth substances|mesh-ancestor
56364303|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
56364304|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364305|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56364307|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
56364308|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
56364309|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56364310|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56364311|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364312|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56364313|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56364314|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56364315|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56364316|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56364317|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56364318|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
56364319|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
56364320|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
56364321|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
56364322|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364323|NCT00293332|Bevacizumab|bevacizumab|mesh-list
56364324|NCT00293332|Carboplatin|carboplatin|mesh-list
56364325|NCT00293332|Docetaxel|docetaxel|mesh-list
56364326|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56364327|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364328|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56364329|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56364330|NCT00293332|Growth Substances|growth substances|mesh-ancestor
56364331|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364332|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56652135|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
56652136|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56364333|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
56364334|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
56364335|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
56364336|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364337|NCT00293371|Prednisone|prednisone|mesh-list
56364338|NCT00293371|Docetaxel|docetaxel|mesh-list
56364339|NCT00293371|Vatalanib|vatalanib|mesh-list
56364340|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364341|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
56364342|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
56364343|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
56364344|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364346|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
56364347|NCT00293371|Hormones|hormones|mesh-ancestor
56364348|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364349|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364350|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56364351|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56364352|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364353|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
56364354|NCT00293410|Clofarabine|clofarabine|mesh-list
56364355|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364356|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
56364357|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364358|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56364359|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56364360|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
56364361|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364362|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364363|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56364364|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56364365|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
56364366|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
56364367|NCT00121602|Hematinics|hematinics|mesh-ancestor
56364368|NCT00293527|Interferons|interferons|mesh-list
56364369|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
56364370|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
56364371|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364373|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364374|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
56364375|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364376|NCT04711161|Paclitaxel|paclitaxel|mesh-list
56364377|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56364378|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364379|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
56364380|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
56364381|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
56364382|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364383|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
56364384|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
56364385|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
56364386|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364387|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364388|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56364389|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56364390|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
56364391|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
56364392|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364393|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364394|NCT00293761|Travoprost|travoprost|mesh-list
56364395|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56364396|NCT00293800|Timolol|timolol|mesh-list
56364397|NCT00293800|Travoprost|travoprost|mesh-list
56364398|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56364400|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56364401|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56364402|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56364403|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
56364404|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364405|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908824|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
56652137|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56364406|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364407|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56364408|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56364409|NCT00423969|Galantamine|galantamine|mesh-list
56364410|NCT00423969|Citalopram|citalopram|mesh-list
56364411|NCT00423969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56364412|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56364413|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56364414|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364415|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364416|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
56364417|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364418|NCT00423969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56364421|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
56364422|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364423|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
56364424|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56364425|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364426|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56364427|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
56364428|NCT00293839|Oxybutynin|oxybutynin|mesh-list
56364429|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
56364430|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
56364431|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364432|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364433|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56364434|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56364435|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
56364436|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364437|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364438|NCT00293839|Urological Agents|urological agents|mesh-ancestor
56364439|NCT00293917|Tacrolimus|tacrolimus|mesh-list
56364440|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364441|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
56364442|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364443|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56364444|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364445|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364447|NCT05567081|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56364448|NCT05567081|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56364449|NCT05567081|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56364450|NCT05567081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364451|NCT05567081|Glucocorticoids|glucocorticoids|mesh-ancestor
56364452|NCT05567081|Hormones|hormones|mesh-ancestor
56364453|NCT05567081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364454|NCT05567081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364455|NCT05567081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364456|NCT05567081|Immunologic Factors|immunologic factors|mesh-ancestor
56364457|NCT05567081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364458|NCT05567081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364459|NCT04710927|Fluorides|fluorides|mesh-list
56364460|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
56364461|NCT04710927|Protective Agents|protective agents|mesh-ancestor
56364462|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364463|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
56364464|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364465|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
56364466|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364467|NCT00417898|Aspirin|aspirin|mesh-list
56364468|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56364469|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56364470|NCT00417898|Analgesics|analgesics|mesh-ancestor
56364471|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
56364472|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364473|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364474|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364475|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56364476|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56364477|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56364478|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908825|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
56652138|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56652139|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652140|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652141|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56652142|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56652143|NCT04208516|Analgesics|analgesics|mesh-ancestor
56652144|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56547639|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
56652145|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56652146|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56214968|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
56364479|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56364480|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56364481|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364482|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
56364483|NCT00294190|Topotecan|topotecan|mesh-list
56364484|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56364485|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56364486|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364487|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364488|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364489|NCT02960503|Azithromycin|azithromycin|mesh-list
56364490|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56364491|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364492|NCT04706091|Suvorexant|suvorexant|mesh-list
55878482|NCT01849289|Insulin|insulin|mesh-list
56364495|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364496|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364497|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56364498|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364499|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364500|NCT00294385|Gemcitabine|gemcitabine|mesh-list
56364501|NCT00294385|Docetaxel|docetaxel|mesh-list
56364502|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56364503|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
56364504|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364505|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364506|NCT00294385|Antiviral Agents|antiviral agents|mesh-ancestor
56364507|NCT00294385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364508|NCT00294385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364509|NCT00294385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364510|NCT00294385|Immunologic Factors|immunologic factors|mesh-ancestor
56364511|NCT00294385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364512|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
56364513|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
56364514|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
56364515|NCT00294463|Tibolone|tibolone|mesh-list
56364516|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56364517|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56364518|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56364519|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
56364520|NCT00294463|Estradiol|estradiol|mesh-list
56364521|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56364522|NCT00294463|Progesterone|progesterone|mesh-list
56364523|NCT00294463|Estrogens|estrogens|mesh-ancestor
56364524|NCT00294463|Hormones|hormones|mesh-ancestor
56364525|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364526|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364527|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56364528|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
56364529|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56364530|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56364531|NCT00294463|Progestins|progestins|mesh-ancestor
56364532|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
56652147|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
56652148|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652150|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
56652151|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
56652152|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652153|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652154|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
56364533|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
56364534|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56364535|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56364536|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364537|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56364538|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
56364539|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56364540|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56364541|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56364542|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56364543|NCT00294502|Minocycline|minocycline|mesh-list
56364544|NCT00294502|Gentamicins|gentamicins|mesh-list
56364545|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364546|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56364547|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364548|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56364549|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364550|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56364551|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
56364552|NCT00089349|Methotrexate|methotrexate|mesh-list
56364553|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
56364554|NCT00089349|Antibodies|antibodies|mesh-list
56364555|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
56364556|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56364557|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
56364558|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364559|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364560|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56364561|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
56364562|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56364563|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56364564|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
56364565|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364567|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364568|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56364569|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364570|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56364571|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56364572|NCT00294580|Maloprim|maloprim|mesh-list
56364573|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
56364574|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56364575|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56364576|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364577|NCT00294619|Hormones|hormones|mesh-list
56364578|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364579|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364580|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56364581|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364582|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56364583|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364584|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364585|NCT00294775|Candesartan|candesartan|mesh-list
56364586|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56364587|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56364588|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56364589|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364590|NCT00121680|Lenvatinib|lenvatinib|mesh-list
56364591|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364592|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55986456|NCT04380857|Hormones|hormones|mesh-ancestor
56364593|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652155|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652156|NCT02820935|Itraconazole|itraconazole|mesh-list
56652157|NCT02820935|Rifampin|rifampin|mesh-list
56652158|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
56652159|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652160|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56652161|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56652162|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652163|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652164|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56652165|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
56652166|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56652167|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214979|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
56364594|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364596|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56364597|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364598|NCT00294892|Nevirapine|nevirapine|mesh-list
56364608|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56364609|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56364610|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
56364611|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
56364612|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56364613|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364614|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364615|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56364616|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56364617|NCT00294892|Analgesics|analgesics|mesh-ancestor
56364618|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
56364619|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364620|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56364621|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56364622|NCT00089427|Temozolomide|temozolomide|mesh-list
56364623|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56364624|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
56364625|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364626|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364627|NCT00294931|Bevacizumab|bevacizumab|mesh-list
56364628|NCT00294931|Carboplatin|carboplatin|mesh-list
56364629|NCT00294931|Irinotecan|irinotecan|mesh-list
56364630|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56364631|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364632|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56364633|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56364634|NCT00294931|Growth Substances|growth substances|mesh-ancestor
56364635|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364636|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
56364637|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56364638|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56364639|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364640|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364650|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
56364651|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56364652|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
56364653|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364654|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364655|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652168|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56652169|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56652170|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
55767725|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56364660|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56364661|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56364662|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364663|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364664|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364665|NCT00295282|Antibodies|antibodies|mesh-list
56364666|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56364667|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
56364668|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364670|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364671|NCT00089622|Levodopa|levodopa|mesh-list
56364672|NCT00089622|Lisuride|lisuride|mesh-list
56364673|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56364674|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56364675|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
56364676|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364677|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364678|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364679|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56364680|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
56364681|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
56364682|NCT00295555|Doxazosin|doxazosin|mesh-list
56364683|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56364684|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56364685|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56364686|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56364687|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
56364688|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364689|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364690|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364691|NCT00295594|Tacrolimus|tacrolimus|mesh-list
56364692|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364693|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
56364694|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364695|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56364696|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364697|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364698|NCT00121875|Hormones|hormones|mesh-list
56364699|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364700|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364701|NCT00295672|Vinorelbine|vinorelbine|mesh-list
56364702|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56364703|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364704|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
56364705|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
56364706|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
56364707|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364708|NCT00295789|Paclitaxel|paclitaxel|mesh-list
56364709|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56364710|NCT00295789|Carboplatin|carboplatin|mesh-list
56364711|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56364712|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364713|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
56364714|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
56364715|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
56364716|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364717|NCT00089700|Ibalizumab|ibalizumab|mesh-list
56364718|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56364719|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56364720|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
56364721|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364722|NCT04718584|Antibodies|antibodies|mesh-list
56364723|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56364724|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
56364725|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364726|NCT00417937|Azelaic acid|azelaic acid|mesh-list
56364727|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652171|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56652172|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
56652173|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56652174|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56652175|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56652176|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56652177|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56652178|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56214996|NCT01616186|Growth Substances|growth substances|mesh-ancestor
56364728|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
56364730|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
56364731|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
56364732|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
56364733|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364734|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
56364735|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364736|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56364737|NCT00295945|Fentanyl|fentanyl|mesh-list
56364738|NCT00295945|Hydromorphone|hydromorphone|mesh-list
56364739|NCT00295945|Ropivacaine|ropivacaine|mesh-list
56364740|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
56364741|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
56364742|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364743|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364744|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
56364745|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364746|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56364747|NCT00295945|Narcotics|narcotics|mesh-ancestor
56364748|NCT00295945|Analgesics|analgesics|mesh-ancestor
56364749|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56364750|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56364751|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
56364752|NCT00121914|Ethanol|ethanol|mesh-list
56364753|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56364754|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364755|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364756|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364757|NCT00295984|Nicotine|nicotine|mesh-list
56364758|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56364759|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
56364760|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364761|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364762|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56364763|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56364764|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
56364765|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364766|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364767|NCT00296023|Methotrexate|methotrexate|mesh-list
56364768|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
56364769|NCT00296023|Fludarabine|fludarabine|mesh-list
56364770|NCT00296023|Busulfan|busulfan|mesh-list
56364771|NCT00296023|Tacrolimus|tacrolimus|mesh-list
56364772|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56364773|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56364774|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
56364775|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56364776|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364777|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56364778|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
56364779|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364780|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364781|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
56364782|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364783|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56364784|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364785|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
56652179|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56652180|NCT02626845|Rituximab|rituximab|mesh-list
56652181|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56652182|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652183|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
56364786|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56364787|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56364788|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56364789|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
56364790|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56364791|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56364792|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
56364793|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56364794|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364795|NCT00296062|Bevacizumab|bevacizumab|mesh-list
56364796|NCT00296062|Capecitabine|capecitabine|mesh-list
56364797|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
56364798|NCT00296062|Irinotecan|irinotecan|mesh-list
56364799|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56364800|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364802|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56364803|NCT00296062|Growth Substances|growth substances|mesh-ancestor
56364804|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364805|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
56364806|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56364808|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364809|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56364810|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56364811|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364812|NCT00296179|Zolpidem|zolpidem|mesh-list
56364813|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56364814|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56364815|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364816|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364817|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56364818|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
56364820|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364821|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364822|NCT00296218|Irbesartan|irbesartan|mesh-list
56364823|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56364824|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56364825|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56364826|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364827|NCT00089856|Prednisone|prednisone|mesh-list
56364828|NCT00089856|Docetaxel|docetaxel|mesh-list
56364829|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364830|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
56364831|NCT00089856|Hormones|hormones|mesh-ancestor
56364832|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364833|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364834|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56364835|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364836|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
56364837|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
56364838|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
56364839|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364840|NCT00296257|Rimacalib|rimacalib|mesh-list
56364841|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56364842|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364843|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364844|NCT00296530|Fluticasone|fluticasone|mesh-list
56364845|NCT00296530|Xhance|xhance|mesh-list
56364846|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56364847|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56364848|NCT00296530|Montelukast|montelukast|mesh-list
56364849|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364850|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56364851|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
56364852|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652184|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652185|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652186|NCT02821247|Aflibercept|aflibercept|mesh-list
56652187|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56652188|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56652189|NCT02821247|Growth Substances|growth substances|mesh-ancestor
56652190|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652191|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
56652192|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652193|NCT00681525|Atorvastatin|atorvastatin|mesh-list
56652194|NCT00681525|Ezetimibe|ezetimibe|mesh-list
56652195|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
56652196|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56652197|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56364853|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364854|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56364855|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
56364856|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
56364857|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56364858|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56364859|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56364860|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56364861|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
56364862|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364863|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364864|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56364865|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
56364866|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56364867|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56364868|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56364869|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
56364870|NCT00296530|Hormones|hormones|mesh-ancestor
56364871|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
56364872|NCT00090012|Olanzapine|olanzapine|mesh-list
56364873|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56364874|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
56364875|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
56364876|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364877|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364878|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56364879|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56364880|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56364883|NCT00090012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56364884|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56364885|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56364886|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364887|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364888|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
56364889|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
56364890|NCT00296608|Leucovorin|leucovorin|mesh-list
56364891|NCT00296608|Fluorouracil|fluorouracil|mesh-list
56364892|NCT00296608|Calcium|calcium|mesh-list
56364893|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
56364894|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56364895|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364896|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
56364897|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364898|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56364899|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364900|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56364901|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
56364902|NCT00296608|Antidotes|antidotes|mesh-ancestor
56652198|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
56652199|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652200|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56652201|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56364903|NCT00296608|Protective Agents|protective agents|mesh-ancestor
56364904|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
56364905|NCT00296608|Vitamins|vitamins|mesh-ancestor
56364906|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
56364907|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
56364908|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
56364909|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56364910|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364911|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56364912|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56364913|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56364914|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364915|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
56364916|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364917|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
56364918|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56364919|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56364920|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364921|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56364922|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56364923|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364924|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56364925|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
56364926|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56364927|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56364928|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56364929|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364930|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364931|NCT00296803|Clopidogrel|clopidogrel|mesh-list
56364932|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56364933|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56364934|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56364935|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56364936|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
56364937|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364938|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364939|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364940|NCT00090090|Elsamicin A|elsamicin a|mesh-list
56364941|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56364942|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56364943|NCT00296959|Topiramate|topiramate|mesh-list
56364944|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
56364945|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56364946|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364947|NCT00297076|Aplaviroc|aplaviroc|mesh-list
56364948|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56364949|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56364950|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364951|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56364952|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56364957|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56364958|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364959|NCT00297388|Risperidone|risperidone|mesh-list
56364960|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56364961|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
56364962|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364963|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364964|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364965|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56364966|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56364967|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364968|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56364969|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56364970|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
56364972|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56652202|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652203|NCT00681603|Bevacizumab|bevacizumab|mesh-list
56364973|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
56364974|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56364975|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364976|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56364977|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56364978|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
56364979|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364980|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364981|NCT00297505|Citalopram|citalopram|mesh-list
56364982|NCT00297505|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56364983|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56364984|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56364985|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364986|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56364987|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
56364988|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364989|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56364990|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
56364991|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56364992|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
56364993|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
56364994|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56364995|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56364996|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364997|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364998|NCT00297544|Urological Agents|urological agents|mesh-ancestor
56364999|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
56365000|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56365001|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365002|NCT00297661|Sirolimus|sirolimus|mesh-list
56365003|NCT00297661|Paclitaxel|paclitaxel|mesh-list
56365004|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56365005|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365006|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
56365007|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
56365008|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
56365009|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365010|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56365011|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365012|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56365014|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365015|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
56365016|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365017|NCT00090207|Ondansetron|ondansetron|mesh-list
56365018|NCT00090207|Aprepitant|aprepitant|mesh-list
56365019|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
56365020|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
56365021|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365022|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365023|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56365024|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
56365025|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
56365026|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56365029|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365030|NCT00090207|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56365031|NCT00090207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56365032|NCT00090207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56365033|NCT00090207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56365034|NCT00090207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56365035|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56365036|NCT00297739|Risperidone|risperidone|mesh-list
56365037|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56365038|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
56365039|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001743|NCT02749526|Tegafur|tegafur|mesh-list
56365040|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986899|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
56365042|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56365043|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56365044|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56365045|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56652204|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56652205|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652206|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56652207|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56652208|NCT00681603|Growth Substances|growth substances|mesh-ancestor
56652209|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365046|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56365047|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
56365048|NCT00090246|Ondansetron|ondansetron|mesh-list
56365049|NCT00090246|Aprepitant|aprepitant|mesh-list
56365050|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
56365051|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
56365052|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365053|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365054|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56365055|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
56365056|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
56365057|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56365058|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
56365059|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365060|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365061|NCT00090246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56365062|NCT00090246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56365063|NCT00090246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56365064|NCT00090246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56365065|NCT00090246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56365066|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56365067|NCT00297817|Vaccines|vaccines|mesh-list
56365068|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
56365069|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365070|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56365071|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
56365072|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56365073|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56365074|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56365075|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56365076|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365077|NCT05319353|Maribavir|maribavir|mesh-list
56365078|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
56365079|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365080|NCT00122226|Ritonavir|ritonavir|mesh-list
56365081|NCT00122226|Lopinavir|lopinavir|mesh-list
56365082|NCT00122226|Lamivudine|lamivudine|mesh-list
56365083|NCT00122226|Zidovudine|zidovudine|mesh-list
56365084|NCT00122226|Nevirapine|nevirapine|mesh-list
56365085|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56365086|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56365087|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
56365088|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365089|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365090|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56365091|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56365092|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
56365093|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365094|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56365095|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56365096|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56365097|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56365098|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
56365099|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56365100|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56365103|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365104|NCT00298012|Methotrexate|methotrexate|mesh-list
56365105|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56365106|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
56365107|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56365108|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365109|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56365110|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
55909268|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
56652210|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
56652211|NCT04239443|Apatinib|apatinib|mesh-list
56652212|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56652213|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652214|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56652215|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365111|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365112|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365113|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
56365115|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56365116|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986975|NCT01839149|Oxytocin|oxytocin|mesh-list
56365117|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
56365118|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56365119|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56365120|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
56365121|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56365122|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
56365123|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365124|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56365125|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365126|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
56365127|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365128|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
56365129|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56365130|NCT00298168|Protective Agents|protective agents|mesh-ancestor
56365131|NCT00122304|Eculizumab|eculizumab|mesh-list
56365132|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56365133|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365134|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
56365135|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365136|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
56365137|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56365138|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56365139|NCT00322543|Analgesics|analgesics|mesh-ancestor
56365140|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
56365141|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365142|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365143|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365144|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56365145|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
56365146|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365147|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
56365148|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56365149|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365150|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365151|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
56365152|NCT00313963|Analgesics|analgesics|mesh-ancestor
56365153|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
56365154|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171578|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
56365155|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365156|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
56365157|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56365158|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56365159|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
56365160|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56365161|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56365162|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365163|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56365164|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
56365165|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56365166|NCT00122343|Sirolimus|sirolimus|mesh-list
56365167|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56365168|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365169|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56365170|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365171|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
56365172|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768241|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
56365174|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365176|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
56365177|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
56365178|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365179|NCT00314158|Timolol|timolol|mesh-list
56365180|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56365181|NCT00314158|Brinzolamide|brinzolamide|mesh-list
56365182|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56365183|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56365184|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56365185|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56365186|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365187|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365188|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365189|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56365190|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56365191|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56365192|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365194|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
56365195|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365196|NCT00322660|Epinephrine|epinephrine|mesh-list
56365197|NCT00322660|Racepinephrine|racepinephrine|mesh-list
56365198|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
56365199|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56365200|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56365201|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
56365202|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365203|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365204|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365205|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56365206|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56365207|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
56365208|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365209|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56365210|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
56365211|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
56365212|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
56365213|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56365214|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56365215|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
56365216|NCT00322699|Trioxsalen|trioxsalen|mesh-list
56365217|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365218|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
56365219|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56365220|NCT00322972|Azithromycin|azithromycin|mesh-list
56365221|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56365222|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365223|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
56365224|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
56365225|NCT00323011|Leucovorin|leucovorin|mesh-list
56365226|NCT00323011|Folic Acid|folic acid|mesh-list
56365227|NCT00323011|Bevacizumab|bevacizumab|mesh-list
56365228|NCT00323011|Fluorouracil|fluorouracil|mesh-list
56365229|NCT00323011|Irinotecan|irinotecan|mesh-list
56365230|NCT00323011|Dalteparin|dalteparin|mesh-list
56365231|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
56365232|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56365233|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365234|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56365235|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56365236|NCT00323011|Growth Substances|growth substances|mesh-ancestor
56365237|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365238|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
56365239|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
56365240|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365241|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56365242|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365243|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
56365244|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56365245|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56365246|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365247|NCT00323011|Antidotes|antidotes|mesh-ancestor
56365248|NCT00323011|Protective Agents|protective agents|mesh-ancestor
56365249|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
56365250|NCT00323011|Vitamins|vitamins|mesh-ancestor
56365255|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56652216|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652217|NCT04200599|Oxytocin|oxytocin|mesh-list
56652218|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
56298336|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652219|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56652220|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365256|NCT04729101|Lansoprazole|lansoprazole|mesh-list
56365257|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
56365258|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56365259|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56365260|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56365261|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365262|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365263|NCT00323206|Interleukin-12|interleukin-12|mesh-list
56365264|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56365265|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
56365266|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365267|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56365268|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56365269|NCT00323206|Growth Substances|growth substances|mesh-ancestor
56365270|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
56365271|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365272|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
56365275|NCT04717531|Epirubicin|epirubicin|mesh-list
56365276|NCT04717531|Pertuzumab|pertuzumab|mesh-list
56365277|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365278|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
56365279|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365280|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56365281|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56365282|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
56365283|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365284|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365285|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56365286|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
56365287|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
56365288|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
56365289|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56365290|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56365291|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56365292|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56365293|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365294|NCT00323323|Prednisone|prednisone|mesh-list
56365295|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
56365296|NCT00323323|Doxorubicin|doxorubicin|mesh-list
56365297|NCT00323323|Vincristine|vincristine|mesh-list
56365298|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
56365299|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365300|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
56365301|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365302|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56365303|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56365304|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
56365305|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365306|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365307|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55786485|NCT02229149|Paclitaxel|paclitaxel|mesh-list
56365308|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56365309|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56365310|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56365311|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365312|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365313|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
56365314|NCT00323323|Hormones|hormones|mesh-ancestor
56365315|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56365316|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56365317|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56365318|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
56365319|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
56652221|NCT02820077|Hemostatics|hemostatics|mesh-list
56652222|NCT02820077|Coagulants|coagulants|mesh-ancestor
56652223|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
56652224|NCT00681993|Carboplatin|carboplatin|mesh-list
56652225|NCT00681993|Docetaxel|docetaxel|mesh-list
56652226|NCT00681993|Trastuzumab|trastuzumab|mesh-list
56652227|NCT00681993|Doxorubicin|doxorubicin|mesh-list
56652228|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56365320|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
56365321|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56365322|NCT00122499|Tadalafil|tadalafil|mesh-list
56365323|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
56365324|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56365326|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365327|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365328|NCT00122499|Urological Agents|urological agents|mesh-ancestor
56365329|NCT05047718|Vaccines|vaccines|mesh-list
56365330|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
56365331|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365332|NCT00312598|Aripiprazole|aripiprazole|mesh-list
56365333|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
56365334|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56365335|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56365336|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56365337|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56365338|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365339|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
56365340|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
56365341|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365342|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365343|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56365344|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56365345|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
56365346|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56365347|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56365348|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56365349|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56365350|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56365351|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56365352|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56365353|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
56365354|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365355|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365356|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56365357|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56365358|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
56365359|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365361|NCT00312871|Hematinics|hematinics|mesh-ancestor
56365362|NCT00090675|Gefitinib|gefitinib|mesh-list
56365363|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365364|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56365365|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365366|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365367|NCT00312988|Gemcitabine|gemcitabine|mesh-list
56365368|NCT00312988|Topotecan|topotecan|mesh-list
56365369|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56365370|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
56365371|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365372|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365373|NCT00312988|Antiviral Agents|antiviral agents|mesh-ancestor
56365374|NCT00312988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365375|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365376|NCT00312988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365377|NCT00312988|Immunologic Factors|immunologic factors|mesh-ancestor
56365378|NCT00312988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365379|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56365380|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56365381|NCT00122538|Lamivudine|lamivudine|mesh-list
56365382|NCT00122538|Efavirenz|efavirenz|mesh-list
56365383|NCT00122538|Didanosine|didanosine|mesh-list
56365384|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56652229|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652230|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
56652231|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215038|NCT01616615|Analgesics|analgesics|mesh-ancestor
56365385|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56365386|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365387|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365388|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
56365389|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365390|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56365391|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56365392|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56365393|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56365394|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56365395|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56365396|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56365397|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56365398|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
56365401|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
56365402|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365403|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365404|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56365405|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56365406|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
56365407|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365408|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365409|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
56365410|NCT00313183|Pramlintide|pramlintide|mesh-list
56365411|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56365412|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365413|NCT00122577|Ritonavir|ritonavir|mesh-list
56365414|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56365415|NCT00122577|Tenofovir|tenofovir|mesh-list
56365416|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56365417|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56365418|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
56365419|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365420|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365421|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56365422|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56365423|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
56365424|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365425|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56365426|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56365427|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56365428|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56365429|NCT00313261|Clevudine|clevudine|mesh-list
56365430|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
56365431|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365432|NCT00425074|Aspirin|aspirin|mesh-list
56365433|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
56365434|NCT00425074|Salicylates|salicylates|mesh-list
56365435|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365436|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
56365437|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
56365438|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
56365439|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56365440|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56365441|NCT00425074|Analgesics|analgesics|mesh-ancestor
56365442|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
56365443|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365444|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365445|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365446|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56365447|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56365448|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365449|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365450|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56365451|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56365452|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56652232|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652233|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56652234|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
56215039|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
56365453|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
56365455|NCT00425152|Levamisole|levamisole|mesh-list
56365456|NCT00425152|Fluorouracil|fluorouracil|mesh-list
56365457|NCT00425152|Calcium|calcium|mesh-list
56365458|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
56365459|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56365460|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365461|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
56365462|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365463|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56365464|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365465|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365466|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
56365467|NCT00425152|Antidotes|antidotes|mesh-ancestor
56365468|NCT00425152|Protective Agents|protective agents|mesh-ancestor
56365469|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
56365470|NCT00425152|Vitamins|vitamins|mesh-ancestor
56365471|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
56365472|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56365473|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
56365474|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
55879443|NCT04447092|Vitamins|vitamins|mesh-ancestor
56365480|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365481|NCT00122616|Ribavirin|ribavirin|mesh-list
56365482|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56365483|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56365484|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
56365485|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365486|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
56365487|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365488|NCT04984070|Metformin|metformin|mesh-list
56365489|NCT04984070|Drospirenone|drospirenone|mesh-list
56365490|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
56365491|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56365492|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
56365493|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56365494|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56365495|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56365496|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365497|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55987346|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56365498|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56365499|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56365500|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56365501|NCT04984070|Estrogens|estrogens|mesh-ancestor
56365502|NCT04984070|Hormones|hormones|mesh-ancestor
56365503|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56365504|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56365505|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
56365506|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56365507|NCT04984070|Diuretics|diuretics|mesh-ancestor
56365508|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
56365509|NCT00314509|Ciclesonide|ciclesonide|mesh-list
56365510|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
56365511|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56365512|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
56365513|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365514|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365515|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56365516|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
56171595|NCT02246244|Citalopram|citalopram|mesh-list
56365517|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56365518|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56365519|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56365520|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
56365521|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365522|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365523|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
56365524|NCT00314509|Hormones|hormones|mesh-ancestor
56652235|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652236|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652237|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56652238|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56652239|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
56652240|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56365525|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56365526|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56365527|NCT00314548|Epoprostenol|epoprostenol|mesh-list
56365528|NCT00314548|Alprostadil|alprostadil|mesh-list
56365529|NCT00314548|Tezosentan|tezosentan|mesh-list
56365530|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56365531|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
56365532|NCT00314548|Urological Agents|urological agents|mesh-ancestor
56365533|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56365534|NCT00314626|Lamivudine|lamivudine|mesh-list
56365535|NCT00314626|Efavirenz|efavirenz|mesh-list
56365536|NCT00314626|Abacavir|abacavir|mesh-list
56365537|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56365538|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56365539|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365540|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365541|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
56365542|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365543|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56365544|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56365547|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56365548|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56365549|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56365550|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56365551|NCT00314665|Thalidomide|thalidomide|mesh-list
56365552|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365553|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
56365554|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365555|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
56365556|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56365557|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365558|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56365559|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56365560|NCT00314665|Growth Substances|growth substances|mesh-ancestor
56365561|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
56365562|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365563|NCT00314704|Dopamine|dopamine|mesh-list
56365564|NCT00314704|Norepinephrine|norepinephrine|mesh-list
56365565|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56365566|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56365567|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
56365568|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365569|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365570|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365571|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
56365572|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
56365573|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365574|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56365575|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56365576|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
56365577|NCT00314704|Protective Agents|protective agents|mesh-ancestor
56365578|NCT00090909|Gemcitabine|gemcitabine|mesh-list
56365579|NCT00090909|Dexamethasone|dexamethasone|mesh-list
56365580|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365581|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
56365582|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
56365583|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365584|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365585|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56365586|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
56365587|NCT00090909|Hormones|hormones|mesh-ancestor
56365588|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56365589|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55909269|NCT02338518|Etoposide|etoposide|mesh-list
56652241|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56365591|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56365592|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
56365593|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365594|NCT00090909|Antiviral Agents|antiviral agents|mesh-ancestor
56365595|NCT00090909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365596|NCT00090909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365597|NCT00090909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365598|NCT00090909|Immunologic Factors|immunologic factors|mesh-ancestor
56365599|NCT04943627|Gemcitabine|gemcitabine|mesh-list
56365600|NCT04943627|Irinotecan|irinotecan|mesh-list
56365601|NCT04943627|Pemetrexed|pemetrexed|mesh-list
56365602|NCT04943627|Topotecan|topotecan|mesh-list
56365603|NCT04943627|Vinorelbine|vinorelbine|mesh-list
56365604|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56365605|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
56365606|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365607|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365608|NCT04943627|Antiviral Agents|antiviral agents|mesh-ancestor
56365609|NCT04943627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365610|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365611|NCT04943627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365612|NCT04943627|Immunologic Factors|immunologic factors|mesh-ancestor
56365613|NCT04943627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365614|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56365615|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56365616|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56365617|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56365618|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56365624|NCT00314743|Aprepitant|aprepitant|mesh-list
56365625|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365626|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
56365627|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
56365628|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365629|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365630|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56365631|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
56365632|NCT00314743|Hormones|hormones|mesh-ancestor
56365633|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56365634|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56365635|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365636|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
56365637|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
56365638|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56365639|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
56365640|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365641|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365642|NCT00314743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56365643|NCT00314743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56365644|NCT00314743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56365645|NCT00314743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56365646|NCT00314743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56365647|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56365648|NCT00314782|Docetaxel|docetaxel|mesh-list
56365649|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365650|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
56365651|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
56365652|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
56365653|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365654|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56365655|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56365656|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
56365657|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56365658|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365659|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365660|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
56365661|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365662|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56365663|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56365664|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56365665|NCT00314821|Ropinirole|ropinirole|mesh-list
56365666|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56365667|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56365668|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
56652242|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56652243|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56652244|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56652245|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652246|NCT02819999|Etoposide|etoposide|mesh-list
56652247|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652248|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56365669|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
56365670|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365671|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365672|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365673|NCT00314860|Ropinirole|ropinirole|mesh-list
56365674|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56365675|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56365676|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
56365677|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
56365678|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365679|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365680|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365681|NCT04928339|Bupivacaine|bupivacaine|mesh-list
56365682|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
56365683|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
56365684|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56365685|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365686|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
56365687|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365688|NCT00091104|Aldesleukin|aldesleukin|mesh-list
56365689|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
56365692|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
56365693|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365694|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
56365695|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365696|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56365697|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56365698|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
56365699|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365700|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365701|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56365702|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56365703|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
56365704|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56365705|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56365706|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56365707|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
56365708|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365709|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
56365710|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
56365711|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365712|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
56365713|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365714|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365715|NCT00313456|Satraplatin|satraplatin|mesh-list
56365716|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365718|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
56365719|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365720|NCT00313534|Protective Agents|protective agents|mesh-ancestor
56365721|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365722|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56365723|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365724|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56365725|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55987570|NCT01727531|Analgesics|analgesics|mesh-ancestor
56365726|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56365727|NCT00313534|Analgesics|analgesics|mesh-ancestor
56365728|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
56365729|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365730|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365731|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652249|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56652250|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56652251|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652252|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652253|NCT04173494|Danazol|danazol|mesh-list
56215049|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365732|NCT04786574|Tolvaptan|tolvaptan|mesh-list
56365733|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56365734|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365735|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
56365736|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365737|NCT00313690|Docetaxel|docetaxel|mesh-list
56365738|NCT00313690|Bortezomib|bortezomib|mesh-list
56365739|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365740|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56365741|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56365742|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56365743|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365744|NCT00313885|SR 46349B|sr 46349b|mesh-list
56365745|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56365746|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56365747|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365748|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56365749|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56365750|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
56365751|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365752|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365753|NCT00091143|Fludarabine|fludarabine|mesh-list
56365754|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
56365755|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
56365756|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56365757|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365758|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56365759|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
56365760|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365761|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365764|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56365765|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
56365766|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365767|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
56365768|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365769|NCT04635280|Pancrelipase|pancrelipase|mesh-list
56365770|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56365771|NCT00122733|Loxapine|loxapine|mesh-list
56365772|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56365773|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56365774|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56365775|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365776|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56365777|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56365778|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
56365779|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365780|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365781|NCT04432012|Dexamethasone|dexamethasone|mesh-list
56365782|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
56365783|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56365784|NCT04432012|BB 1101|bb 1101|mesh-list
56365785|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365786|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
56365787|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
56365788|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365789|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365790|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56365791|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
56365792|NCT04432012|Hormones|hormones|mesh-ancestor
56165335|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365793|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56365794|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56365795|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652254|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
56652255|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56652256|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
56652257|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56652258|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652259|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56652260|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652261|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652262|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56652263|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56652264|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56652265|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652266|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652267|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652268|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215060|NCT01616732|Testosterone|testosterone|mesh-list
56365796|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
56365797|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365798|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365799|NCT00091299|Warfarin|warfarin|mesh-list
56365800|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
56365801|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56365802|NCT04607603|Cannabidiol|cannabidiol|mesh-list
56365803|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
56365804|NCT00122772|Cisplatin|cisplatin|mesh-list
56365805|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365806|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
56365807|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56365808|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
56365809|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365810|NCT00122811|Perindopril|perindopril|mesh-list
56365811|NCT00122811|Indapamide|indapamide|mesh-list
56365812|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56365813|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
56365814|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365815|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365816|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56365817|NCT00122811|Diuretics|diuretics|mesh-ancestor
56365818|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
56365819|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365820|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56365821|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56365822|NCT04551170|Theophylline|theophylline|mesh-list
56365823|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56365824|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
56365825|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365826|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365827|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56365828|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
56365829|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56365830|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365831|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652269|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
56652270|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56652271|NCT00875979|Trastuzumab|trastuzumab|mesh-list
56652272|NCT00875979|Pertuzumab|pertuzumab|mesh-list
56652273|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56365832|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
56365833|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55750790|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
56365835|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
56365836|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365837|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56365838|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56365839|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56365840|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56365841|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56365842|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365843|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365844|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365845|NCT00122850|Analgesics|analgesics|mesh-ancestor
56365846|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
56365847|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365848|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
56365849|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56365850|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
56365851|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56365859|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365860|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
56365861|NCT04542278|Hormones|hormones|mesh-ancestor
56365862|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56365863|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365864|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56365865|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365866|NCT03975439|Chrysarobin|chrysarobin|mesh-list
56365867|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56365868|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56365869|NCT03975439|Analgesics|analgesics|mesh-ancestor
56365870|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
56365871|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365872|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365873|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365874|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56365876|NCT00091377|Cisplatin|cisplatin|mesh-list
56365877|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56365878|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56365880|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
56365881|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
56365882|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365883|NCT03897868|Losartan|losartan|mesh-list
56365884|NCT03897868|Amlodipine|amlodipine|mesh-list
56365885|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56365886|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56365887|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56365888|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365889|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56365890|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365891|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
56365892|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56365893|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56365894|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56365895|NCT03878524|Vitamins|vitamins|mesh-list
56365896|NCT03878524|Leucovorin|leucovorin|mesh-list
56365897|NCT03878524|Vitamin A|vitamin a|mesh-list
56365898|NCT03878524|Sirolimus|sirolimus|mesh-list
56365899|NCT03878524|Celecoxib|celecoxib|mesh-list
56365900|NCT03878524|Paclitaxel|paclitaxel|mesh-list
56365901|NCT03878524|Maytansine|maytansine|mesh-list
56365902|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56365903|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56365904|NCT03878524|Bevacizumab|bevacizumab|mesh-list
56365905|NCT03878524|Carboplatin|carboplatin|mesh-list
56365906|NCT03878524|Doxorubicin|doxorubicin|mesh-list
56652274|NCT00875979|Maytansine|maytansine|mesh-list
56652275|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56652276|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652277|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56365907|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56365908|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
56365909|NCT03878524|Fluorouracil|fluorouracil|mesh-list
56365910|NCT03878524|Capecitabine|capecitabine|mesh-list
56365911|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
56365912|NCT03878524|Nivolumab|nivolumab|mesh-list
56365913|NCT03878524|Trastuzumab|trastuzumab|mesh-list
56365914|NCT03878524|Everolimus|everolimus|mesh-list
56365915|NCT03878524|Bortezomib|bortezomib|mesh-list
56365916|NCT03878524|Ipilimumab|ipilimumab|mesh-list
56365917|NCT03878524|Sorafenib|sorafenib|mesh-list
56365918|NCT03878524|Durvalumab|durvalumab|mesh-list
56365924|NCT03878524|Lenvatinib|lenvatinib|mesh-list
56365925|NCT03878524|Palbociclib|palbociclib|mesh-list
56365926|NCT03878524|Pertuzumab|pertuzumab|mesh-list
56365927|NCT03878524|Vorinostat|vorinostat|mesh-list
56365928|NCT03878524|Trametinib|trametinib|mesh-list
56365929|NCT03878524|Tretinoin|tretinoin|mesh-list
56365930|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
56365931|NCT03878524|Bicalutamide|bicalutamide|mesh-list
56365932|NCT03878524|Afatinib|afatinib|mesh-list
56365933|NCT03878524|Vemurafenib|vemurafenib|mesh-list
56365934|NCT03878524|Dabrafenib|dabrafenib|mesh-list
56365935|NCT03878524|Panobinostat|panobinostat|mesh-list
56365936|NCT03878524|Ponatinib|ponatinib|mesh-list
56365937|NCT03878524|Idelalisib|idelalisib|mesh-list
56365938|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56365939|NCT03878524|Losartan|losartan|mesh-list
56365940|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
56365941|NCT03878524|Antibodies|antibodies|mesh-list
56365942|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
56365943|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56365944|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56365945|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
56365946|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
56365947|NCT03878524|Entrectinib|entrectinib|mesh-list
56365948|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
56365949|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165336|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
56365951|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
56365952|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
56365953|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
56365954|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56365955|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56365956|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56365957|NCT03878524|Growth Substances|growth substances|mesh-ancestor
56365958|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365959|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
56365960|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
56365961|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
56365962|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56365963|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56365964|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56365965|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56365966|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
56365967|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56365968|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56365969|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56365970|NCT03878524|Antidotes|antidotes|mesh-ancestor
56365971|NCT03878524|Protective Agents|protective agents|mesh-ancestor
56365972|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
56365973|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56365974|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56365975|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365976|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
56365977|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56365978|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56365979|NCT03878524|Analgesics|analgesics|mesh-ancestor
56365980|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
56365981|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56365982|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56365983|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56365984|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56365985|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56652278|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56652279|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56652280|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56215079|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56365986|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56365987|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56365988|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56365989|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56365990|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56365991|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56365992|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
56365993|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
56365994|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
56365995|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56365998|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56365999|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56366001|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
56366002|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
56366003|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366004|NCT00122889|Protective Agents|protective agents|mesh-ancestor
56366005|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366006|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56366007|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366008|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56366009|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366010|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366011|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56366012|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
56366013|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56366014|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56366015|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56366016|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
56366017|NCT04729868|Bupivacaine|bupivacaine|mesh-list
56366018|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
56366019|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
56366020|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
56366021|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56366022|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366023|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
56366024|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366025|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56366026|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366027|NCT04729868|Analgesics|analgesics|mesh-ancestor
56366028|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56366029|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56366030|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56366031|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
56366032|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366033|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366034|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
56366035|NCT03715972|Acetazolamide|acetazolamide|mesh-list
56366036|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366037|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
56366038|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366039|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366040|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56366041|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
56366042|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56366043|NCT03715972|Diuretics|diuretics|mesh-ancestor
56366044|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
56366045|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366046|NCT00419887|Vildagliptin|vildagliptin|mesh-list
56366047|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56366048|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366049|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56366050|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
56366051|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366052|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366053|NCT03690544|Apremilast|apremilast|mesh-list
56366054|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56652281|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652282|NCT02818751|Citalopram|citalopram|mesh-list
56652283|NCT02818751|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56652284|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56215082|NCT01616927|Lanreotide|lanreotide|mesh-list
56366055|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366056|NCT03690544|Analgesics|analgesics|mesh-ancestor
56366057|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
56366058|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366059|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366060|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366061|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366062|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56366063|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56366064|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366065|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366066|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
56366067|NCT00314977|Docetaxel|docetaxel|mesh-list
56366073|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366074|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56366075|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
56366076|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366077|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366078|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56366079|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
56366080|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
56366081|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
56366082|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56366083|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56366084|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56366085|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366086|NCT00315016|Eplerenone|eplerenone|mesh-list
56366087|NCT00315016|Fosinopril|fosinopril|mesh-list
56366088|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56366089|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
56366090|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366091|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366092|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56366093|NCT00315016|Diuretics|diuretics|mesh-ancestor
56366094|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
56366095|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56366096|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56366097|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
56366098|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366099|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366100|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
56366101|NCT00419068|Vitamin D|vitamin d|mesh-list
56366102|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56366103|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366104|NCT00419068|Vitamins|vitamins|mesh-ancestor
56366105|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
56366106|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56366107|NCT00419146|Vitamins|vitamins|mesh-list
56366108|NCT00419146|Vitamin E|vitamin e|mesh-list
56366109|NCT00419146|Tocopherols|tocopherols|mesh-list
56366110|NCT00419146|Tocotrienols|tocotrienols|mesh-list
56366111|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
56366112|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56366113|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
56366114|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366115|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
56366116|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366117|NCT00419146|Protective Agents|protective agents|mesh-ancestor
56366118|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56366119|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56366120|NCT02965196|Dexamethasone|dexamethasone|mesh-list
56366121|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366122|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
56366123|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
56366124|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652285|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652286|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652287|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652288|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
56366125|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366126|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56366127|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
56366128|NCT02965196|Hormones|hormones|mesh-ancestor
56366129|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366130|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56366131|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366132|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
56366133|NCT00091611|Fludarabine|fludarabine|mesh-list
56366134|NCT00091611|Interleukin-2|interleukin-2|mesh-list
56366135|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366136|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
56366137|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366138|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366139|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56366141|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366142|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366143|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56366144|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366145|NCT00091611|Analgesics|analgesics|mesh-ancestor
56366146|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
56366147|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366148|NCT00123201|Dronabinol|dronabinol|mesh-list
56366149|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
56366150|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366151|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56366152|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366153|NCT00123201|Analgesics|analgesics|mesh-ancestor
56366154|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
56366155|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366156|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56366157|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56366158|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366159|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366160|NCT00123201|Hormones|hormones|mesh-ancestor
56366161|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366162|NCT03031483|Clarithromycin|clarithromycin|mesh-list
56366163|NCT03031483|Lenalidomide|lenalidomide|mesh-list
56366164|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
56366165|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366166|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56366167|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56366168|NCT03031483|Growth Substances|growth substances|mesh-ancestor
56366169|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
56366170|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366171|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56366172|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366173|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56366174|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366175|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366176|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56366177|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56366178|NCT00091650|Olanzapine|olanzapine|mesh-list
56366179|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
56366180|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
56366181|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366182|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366183|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56366184|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56366185|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56366186|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56366187|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56366188|NCT00091650|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56366189|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56366190|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652289|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652290|NCT02818751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56215089|NCT01616966|Propofol|propofol|mesh-list
56366191|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366192|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366193|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
56366194|NCT02645149|Trametinib|trametinib|mesh-list
56366195|NCT02645149|Ceritinib|ceritinib|mesh-list
56366196|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366197|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56366198|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366199|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366200|NCT01808599|Rituximab|rituximab|mesh-list
56366201|NCT01808599|Chlorambucil|chlorambucil|mesh-list
56366202|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56366203|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366204|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
56366205|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366206|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366207|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56366208|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
56366209|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366210|NCT01691833|Vitamin D|vitamin d|mesh-list
56366211|NCT01691833|Vitamins|vitamins|mesh-ancestor
56366213|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366214|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56366215|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56366216|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
56366217|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
56366218|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
56366219|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56366220|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56366221|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366222|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56366223|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56366224|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56366225|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56366226|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56366227|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56366228|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366229|NCT03972488|Octreotide|octreotide|mesh-list
56366230|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56366231|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56366232|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56366233|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366234|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56366235|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366236|NCT00123279|Plasminogen|plasminogen|mesh-list
56366237|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56366238|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56366239|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366240|NCT00091806|Panitumumab|panitumumab|mesh-list
56366241|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56366242|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366243|NCT00123318|Cisplatin|cisplatin|mesh-list
56366244|NCT00123318|Fluorouracil|fluorouracil|mesh-list
56366245|NCT00123318|Epirubicin|epirubicin|mesh-list
56366246|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366247|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
56366248|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366249|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56366250|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366251|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
56366252|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366253|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56366254|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56366255|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56366256|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366257|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
56366258|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
56366259|NCT00327535|Hematinics|hematinics|mesh-ancestor
56652291|NCT02818751|Antidepressive Agents|antidepressive agents|mesh-ancestor
56652292|NCT02818751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56652293|NCT04238975|Vaccines|vaccines|mesh-list
56652294|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
56652295|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652296|NCT00602420|Naproxen|naproxen|mesh-list
56652297|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56652298|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56652299|NCT00602420|Analgesics|analgesics|mesh-ancestor
56652300|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
56652301|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652302|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366260|NCT00327691|Atorvastatin|atorvastatin|mesh-list
56366261|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56366262|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56366263|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
56366264|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366265|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56366266|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56366267|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366268|NCT03913832|Sirolimus|sirolimus|mesh-list
56366269|NCT03913832|Paclitaxel|paclitaxel|mesh-list
56366270|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56366271|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366272|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
56366273|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
56366274|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
56366275|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366276|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56366277|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366278|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56366279|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
56366280|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366281|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
56366282|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366283|NCT00327730|Eperisone|eperisone|mesh-list
56366284|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
56366285|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56366287|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366288|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56366289|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366290|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56366291|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56366292|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366293|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
56366294|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
56366295|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
56366297|NCT04716868|Psyllium|psyllium|mesh-list
56366298|NCT04716868|Cathartics|cathartics|mesh-ancestor
56366299|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56366300|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366301|NCT00327769|Fulvestrant|fulvestrant|mesh-list
56366302|NCT00327769|Anastrozole|anastrozole|mesh-list
56366303|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56366304|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366305|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56366306|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56366307|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
56366308|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366309|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366310|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56366311|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56366312|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652303|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652304|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652305|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
56652306|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56652307|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366313|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366314|NCT00092001|Sunitinib|sunitinib|mesh-list
56366315|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366316|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56366317|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56366318|NCT00092001|Growth Substances|growth substances|mesh-ancestor
56366319|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366320|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
56366321|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56366322|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366323|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366325|NCT03883919|Leucovorin|leucovorin|mesh-list
56366326|NCT03883919|Fluorouracil|fluorouracil|mesh-list
56366327|NCT03883919|Irinotecan|irinotecan|mesh-list
56366328|NCT03883919|Vitamins|vitamins|mesh-ancestor
56366329|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
56366330|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366331|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56366332|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
56366333|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366334|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56366335|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366336|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366337|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
56366338|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56366339|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56366340|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366341|NCT03883919|Antidotes|antidotes|mesh-ancestor
56366342|NCT03883919|Protective Agents|protective agents|mesh-ancestor
56366343|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
56366344|NCT00327808|Budesonide|budesonide|mesh-list
56366345|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366346|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56366347|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
56366348|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366349|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366350|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56366351|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
56366352|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
56366353|NCT00327808|Hormones|hormones|mesh-ancestor
56366354|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366355|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
56366356|NCT00092079|Vitamin D|vitamin d|mesh-list
56366357|NCT00092079|Alendronate|alendronate|mesh-list
56366358|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56366359|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366360|NCT00092079|Vitamins|vitamins|mesh-ancestor
56366363|NCT00327847|Vitamin D|vitamin d|mesh-list
56366364|NCT00327847|Vitamins|vitamins|mesh-ancestor
56366365|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
56366366|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366367|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56366368|NCT00327925|Antibodies|antibodies|mesh-list
56366369|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
56366370|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366371|NCT03709550|Decitabine|decitabine|mesh-list
56366372|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56366373|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
56366374|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366375|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366376|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366377|NCT00315211|Docetaxel|docetaxel|mesh-list
56366378|NCT00315211|Topotecan|topotecan|mesh-list
56366379|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366380|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
56366381|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
56366382|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
55909270|NCT02338518|Epirubicin|epirubicin|mesh-list
56652308|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652309|NCT04635605|Methylene Blue|methylene blue|mesh-list
56366383|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366384|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56366385|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56366386|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366387|NCT00315367|Donepezil|donepezil|mesh-list
56366388|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56366389|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366390|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171625|NCT02247414|Aspirin|aspirin|mesh-list
56366391|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
56366392|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366393|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366394|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
56366395|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
56366396|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
56366397|NCT00315484|Hematinics|hematinics|mesh-ancestor
56366398|NCT03646175|Choline|choline|mesh-list
56366399|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
56366400|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56366401|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
56366402|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366403|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56366404|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56366405|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
55988252|NCT00920075|Alendronate|alendronate|mesh-list
56366406|NCT00315523|Levocetirizine|levocetirizine|mesh-list
56366407|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56366408|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56366409|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
56366410|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
56366411|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366412|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366413|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366414|NCT00092196|Aprepitant|aprepitant|mesh-list
56366415|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
56366416|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
56366417|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366418|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366419|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56366420|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56366421|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366422|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366423|NCT00315601|Azithromycin|azithromycin|mesh-list
56366424|NCT00315601|Telithromycin|telithromycin|mesh-list
56366425|NCT00315601|Dimercaprol|dimercaprol|mesh-list
56366426|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56366427|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366428|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
56366429|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
56366430|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366431|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
56366432|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56366433|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880375|NCT01557322|Etanercept|etanercept|mesh-list
56366434|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366436|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56366437|NCT00315679|Protective Agents|protective agents|mesh-ancestor
56366438|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366439|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
56366440|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56366441|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
56366442|NCT00092274|Ofatumumab|ofatumumab|mesh-list
56366443|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366444|NCT00315835|Buprenorphine|buprenorphine|mesh-list
56366445|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56366446|NCT00315835|Narcotics|narcotics|mesh-ancestor
56366447|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56366448|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366449|NCT00315835|Analgesics|analgesics|mesh-ancestor
56366450|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
56366451|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366452|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56652310|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652311|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652312|NCT02688374|Nicotine|nicotine|mesh-list
56652313|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56652314|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
56366453|NCT00315874|Buprenorphine|buprenorphine|mesh-list
56366454|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56366455|NCT00315874|Narcotics|narcotics|mesh-ancestor
56366456|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56366457|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366458|NCT00315874|Analgesics|analgesics|mesh-ancestor
56366459|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
56366460|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366461|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56366462|NCT00315913|Propranolol|propranolol|mesh-list
56366463|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56171628|NCT02247414|Tinzaparin|tinzaparin|mesh-list
56366465|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
56366466|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366467|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366468|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366469|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56366470|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56366471|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
56366472|NCT00092313|Acetaminophen|acetaminophen|mesh-list
56366473|NCT00092313|Rofecoxib|rofecoxib|mesh-list
56366474|NCT00092313|Oxycodone|oxycodone|mesh-list
56366475|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366476|NCT00092313|Analgesics|analgesics|mesh-ancestor
56366477|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
56366478|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366479|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366480|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
56366481|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56366482|NCT00092313|Narcotics|narcotics|mesh-ancestor
56366483|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56366484|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56366485|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56366486|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366487|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366488|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56366489|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366491|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
56366492|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366493|NCT00316030|Bexarotene|bexarotene|mesh-list
56366494|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366495|NCT00123552|Artesunate|artesunate|mesh-list
56366496|NCT00123552|Lumefantrine|lumefantrine|mesh-list
56366497|NCT00123552|Artemether|artemether|mesh-list
56366498|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
56366499|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
56366500|NCT00123552|Amodiaquine|amodiaquine|mesh-list
56366501|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56366502|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
56366503|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56366504|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56366505|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366506|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366507|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
56366508|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
56366509|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56366510|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
56366511|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56366514|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56366515|NCT00123552|Renal Agents|renal agents|mesh-ancestor
56366516|NCT03352427|Everolimus|everolimus|mesh-list
56366517|NCT03352427|Dasatinib|dasatinib|mesh-list
56366518|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366519|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366520|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
56366521|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366522|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56366523|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652315|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215111|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
56366524|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366525|NCT00316420|Gemcitabine|gemcitabine|mesh-list
56366526|NCT00316420|Capecitabine|capecitabine|mesh-list
56366527|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56366528|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
56366529|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366530|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366531|NCT00316420|Antiviral Agents|antiviral agents|mesh-ancestor
56366532|NCT00316420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366533|NCT00316420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366534|NCT00316420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366535|NCT00316420|Immunologic Factors|immunologic factors|mesh-ancestor
56366536|NCT00316420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366537|NCT00092352|Celecoxib|celecoxib|mesh-list
56366538|NCT00092352|Rofecoxib|rofecoxib|mesh-list
56366539|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56366540|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366541|NCT00092352|Analgesics|analgesics|mesh-ancestor
56366542|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
56366543|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366544|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366545|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366546|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366547|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56366548|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56366550|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366551|NCT00316498|Miglustat|miglustat|mesh-list
56366552|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366553|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366554|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56366555|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56366556|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
56366557|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366558|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56366559|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56366560|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366561|NCT03319901|Venetoclax|venetoclax|mesh-list
56366562|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366563|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
56366564|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
56366565|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56366566|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366567|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
56366568|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366569|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366570|NCT00092391|Vaccines|vaccines|mesh-list
56366571|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
56366572|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366573|NCT00316849|Sirolimus|sirolimus|mesh-list
56366574|NCT00316849|Temozolomide|temozolomide|mesh-list
56366575|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56366576|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
56366577|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366578|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366579|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56366580|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366581|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56366582|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
56366583|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366584|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
56366585|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366587|NCT03272477|Paclitaxel|paclitaxel|mesh-list
56366588|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56366589|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
56366590|NCT03272477|Trastuzumab|trastuzumab|mesh-list
56366591|NCT03272477|Letrozole|letrozole|mesh-list
56366592|NCT03272477|Epirubicin|epirubicin|mesh-list
56366593|NCT03272477|Anastrozole|anastrozole|mesh-list
56366594|NCT03272477|Pertuzumab|pertuzumab|mesh-list
56366595|NCT03272477|Exemestane|exemestane|mesh-list
56366596|NCT03272477|Goserelin|goserelin|mesh-list
56366597|NCT03272477|Leuprolide|leuprolide|mesh-list
56366598|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56366599|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652316|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652317|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56652318|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56652319|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
56366600|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
56366601|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
56366602|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
56366603|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366604|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366605|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
56366606|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366607|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366608|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56366609|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
56366610|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56366611|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56366612|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56366613|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56366614|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366615|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56366616|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
56366617|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366618|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56366619|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56366620|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56366621|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56366622|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56001751|NCT02749526|Growth Substances|growth substances|mesh-ancestor
56366623|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56366624|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56366625|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56366626|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
56366627|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56366628|NCT02959957|Cefotaxime|cefotaxime|mesh-list
56366629|NCT02959957|Cefoxitin|cefoxitin|mesh-list
56366630|NCT02959957|Temocillin|temocillin|mesh-list
56366631|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56366632|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366633|NCT00316927|Aspirin|aspirin|mesh-list
56366634|NCT00316927|Dexamethasone|dexamethasone|mesh-list
56366635|NCT00316927|Fosfestrol|fosfestrol|mesh-list
56366636|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
56366637|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366638|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
56366639|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
56366640|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366641|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366642|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56366643|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
56366644|NCT00316927|Hormones|hormones|mesh-ancestor
56366645|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366646|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56366647|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366648|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56366649|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366650|NCT00316927|Analgesics|analgesics|mesh-ancestor
56366651|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
56366652|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366653|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56366654|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56366655|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366656|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56366657|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56366658|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366659|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
56366660|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56366661|NCT00316927|Estrogens|estrogens|mesh-ancestor
56366663|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56366664|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56366665|NCT00123669|Progestins|progestins|mesh-ancestor
56366666|NCT00123669|Hormones|hormones|mesh-ancestor
55909730|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
56652320|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652321|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366667|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366668|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366669|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56366671|NCT00317200|Paclitaxel|paclitaxel|mesh-list
56366672|NCT00317200|Bevacizumab|bevacizumab|mesh-list
56366673|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56366674|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366675|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56366676|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56366677|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56366678|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366679|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56366680|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56366681|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56366682|NCT00317200|Growth Substances|growth substances|mesh-ancestor
56366683|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366684|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
56366685|NCT02960035|Etanercept|etanercept|mesh-list
56366686|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56366687|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366688|NCT02960035|Analgesics|analgesics|mesh-ancestor
56366689|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
56366690|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366691|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366692|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366693|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366694|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56366695|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366696|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
56366697|NCT00317434|Lapatinib|lapatinib|mesh-list
56366698|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366699|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56366700|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366701|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366702|NCT00328120|Fulvestrant|fulvestrant|mesh-list
56366703|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56366704|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366705|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56366706|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56366707|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
56366708|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366709|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366710|NCT00328393|Pioglitazone|pioglitazone|mesh-list
56366711|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56366712|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366713|NCT00328432|Celecoxib|celecoxib|mesh-list
56366714|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56366715|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55988543|NCT03490825|Melatonin|melatonin|mesh-list
56366716|NCT00328432|Analgesics|analgesics|mesh-ancestor
56366717|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
56366718|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366719|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366720|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366721|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366722|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56366723|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56366724|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366725|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366726|NCT02571725|Olaparib|olaparib|mesh-list
56366727|NCT02571725|Tremelimumab|tremelimumab|mesh-list
56366728|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56366729|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366730|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366731|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366732|NCT00328549|Interferons|interferons|mesh-list
56366733|NCT00328549|Ribavirin|ribavirin|mesh-list
56366734|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366735|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
56652322|NCT02819375|Ketamine|ketamine|mesh-list
56652323|NCT02819375|Remifentanil|remifentanil|mesh-list
56366738|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366739|NCT00092508|Mesalamine|mesalamine|mesh-list
56171655|NCT02247648|Analgesics|analgesics|mesh-ancestor
56366740|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56366741|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366742|NCT00092508|Analgesics|analgesics|mesh-ancestor
56366743|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
56366744|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366745|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366746|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366747|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366748|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56366749|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
56366750|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56366751|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56366752|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56366753|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56366754|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366755|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
56366756|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366757|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56366758|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366759|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366760|NCT00420082|Cetirizine|cetirizine|mesh-list
56366761|NCT00420082|Fexofenadine|fexofenadine|mesh-list
56366762|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56366763|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56366764|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56366765|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
56366766|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
56366767|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366768|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366769|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366770|NCT01821833|Paclitaxel|paclitaxel|mesh-list
56366771|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56366772|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366773|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
56366774|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
56366775|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
56366776|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366777|NCT00328900|Atropine|atropine|mesh-list
56366778|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56366779|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56366780|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56366781|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
56366782|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366783|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366784|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56366785|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
56366786|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
56366787|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
56366788|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56366789|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55988635|NCT02933320|Rituximab|rituximab|mesh-list
56366790|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
56366791|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366792|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366793|NCT00328939|Enoxaparin|enoxaparin|mesh-list
56366795|NCT00328939|Fondaparinux|fondaparinux|mesh-list
56366796|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
56366797|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56366798|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56366799|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366800|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56366801|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
56366802|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56366803|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
56366804|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366805|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56366806|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
56366807|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56366808|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56652324|NCT02819375|Propofol|propofol|mesh-list
56652325|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56652326|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652327|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652328|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56652329|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
56366811|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366812|NCT00329095|Bimatoprost|bimatoprost|mesh-list
56366814|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
56366815|NCT00329095|Latanoprost|latanoprost|mesh-list
56366816|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56366817|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56366818|NCT00329134|Quinine|quinine|mesh-list
56366819|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
56366820|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56366821|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56366822|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366823|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56366824|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366825|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56366826|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366827|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366828|NCT00329134|Analgesics|analgesics|mesh-ancestor
56366829|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
56366830|NCT00329173|Atorvastatin|atorvastatin|mesh-list
56366831|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56366832|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56366833|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56366834|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
56366835|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366836|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56366837|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56366838|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366839|NCT00123825|Gemcitabine|gemcitabine|mesh-list
56366840|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366841|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56366842|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
56366843|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366844|NCT00123825|Antiviral Agents|antiviral agents|mesh-ancestor
56366845|NCT00123825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366846|NCT00123825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366847|NCT00123825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366848|NCT00123825|Immunologic Factors|immunologic factors|mesh-ancestor
56366849|NCT00123825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366850|NCT00329329|Capecitabine|capecitabine|mesh-list
56366851|NCT00329329|Satraplatin|satraplatin|mesh-list
56366852|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56366853|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
56366854|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366855|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366856|NCT00329368|Folic Acid|folic acid|mesh-list
56366857|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
56366858|NCT00329368|Interferons|interferons|mesh-list
56366859|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
56366860|NCT00329368|Interleukin-2|interleukin-2|mesh-list
56366861|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56366862|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988704|NCT02935738|Hormones|hormones|mesh-ancestor
56366863|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
56366864|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366865|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
56366866|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366868|NCT00329368|Analgesics|analgesics|mesh-ancestor
56366869|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
56366870|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366871|NCT00329368|Hematinics|hematinics|mesh-ancestor
56366872|NCT00329368|Vitamins|vitamins|mesh-ancestor
56366873|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
56366874|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56366875|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56366876|NCT00329446|Citalopram|citalopram|mesh-list
56366877|NCT00329446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56652330|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
56652331|NCT02819375|Analgesics|analgesics|mesh-ancestor
56652332|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
56652333|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652334|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56652335|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56652336|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56652337|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366878|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56366879|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56366880|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366881|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366882|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
56366883|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366887|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56366888|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56366889|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56366890|NCT00092937|Busulfan|busulfan|mesh-list
56366891|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
56366892|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366893|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366894|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
56366895|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366896|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56366897|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366898|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56366899|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56366900|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56366901|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
56366902|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
56366903|NCT04716751|Paclitaxel|paclitaxel|mesh-list
56366904|NCT04716751|Carboplatin|carboplatin|mesh-list
56366905|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56366906|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366907|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
56366908|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
56366909|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
56366910|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366911|NCT00123903|Metoprolol|metoprolol|mesh-list
56366912|NCT00123903|Carvedilol|carvedilol|mesh-list
56366913|NCT00123903|Lisinopril|lisinopril|mesh-list
56366914|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56366915|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56366916|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
56366917|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
56366918|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366919|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366920|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56366921|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56366922|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56366923|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
56366924|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56366925|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366926|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
56366927|NCT00123903|Protective Agents|protective agents|mesh-ancestor
56366928|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56366929|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56366930|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56366931|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
56366932|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56366933|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56366934|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56366935|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
56366936|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366937|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56652338|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652339|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56652340|NCT02819375|Narcotics|narcotics|mesh-ancestor
56652341|NCT02818985|Dexamethasone|dexamethasone|mesh-list
56652342|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
56652343|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652344|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
56652345|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
56652346|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366938|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
56366939|NCT00329680|Antioxidants|antioxidants|mesh-list
56366940|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366941|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366942|NCT00329680|Protective Agents|protective agents|mesh-ancestor
56366943|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56366944|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56366945|NCT00329680|Analgesics|analgesics|mesh-ancestor
56366946|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
56366947|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56366948|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56366949|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56366950|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56366951|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
56366952|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56366953|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56366954|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56366956|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56366957|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
56366958|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366959|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56366960|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56366961|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366962|NCT00329914|Progesterone|progesterone|mesh-list
56366963|NCT00329914|Progestins|progestins|mesh-ancestor
56366964|NCT00329914|Hormones|hormones|mesh-ancestor
56366965|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56366966|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366967|NCT00092976|Factor VIII|factor viii|mesh-list
56366968|NCT00092976|Coagulants|coagulants|mesh-ancestor
56366969|NCT00083876|Thalidomide|thalidomide|mesh-list
56366970|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366971|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
56366972|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366973|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
56366974|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56366975|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366976|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56366977|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56366978|NCT00083876|Growth Substances|growth substances|mesh-ancestor
56366979|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
56366980|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366981|NCT00330148|Eflornithine|eflornithine|mesh-list
56366982|NCT00330148|Nifurtimox|nifurtimox|mesh-list
56366983|NCT00330148|Melarsoprol|melarsoprol|mesh-list
56366984|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366985|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56366986|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56366987|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56366988|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366989|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56366990|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366991|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366992|NCT00093093|Interferons|interferons|mesh-list
56366993|NCT00093093|Ribavirin|ribavirin|mesh-list
56366994|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
56366995|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
56366996|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56366997|NCT00093093|Taribavirin|taribavirin|mesh-list
56652347|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652348|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56652349|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
56652350|NCT02818985|Hormones|hormones|mesh-ancestor
56652351|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56652352|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56652353|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652354|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56652355|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652356|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56652357|NCT02818985|Analgesics|analgesics|mesh-ancestor
56652358|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
56652359|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56652360|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56652361|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56652362|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
56652363|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56923719|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652364|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366998|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56366999|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
56367000|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367001|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
56367002|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367003|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
56367004|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367005|NCT00330304|Isoniazid|isoniazid|mesh-list
56367006|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56367007|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
56367008|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56367009|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367010|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56367011|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56367012|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
56367013|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367014|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56367015|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56367016|NCT00330304|Renal Agents|renal agents|mesh-ancestor
56367017|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
56367018|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56367019|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56367020|NCT00330499|Cisplatin|cisplatin|mesh-list
56367021|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367022|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56367023|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
56367024|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56367025|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56367026|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55786565|NCT04982549|Paclitaxel|paclitaxel|mesh-list
56367027|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56367028|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367029|NCT00330577|Timolol|timolol|mesh-list
56367032|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652365|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
56652366|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56652367|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652369|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56367033|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56367034|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56367035|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
56367036|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367037|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367038|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56367039|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56367040|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56367041|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56367042|NCT00083993|Sirolimus|sirolimus|mesh-list
56367043|NCT00083993|Letrozole|letrozole|mesh-list
56367044|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367045|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56367046|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56367047|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367048|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367049|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56367050|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
56367051|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56367052|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367053|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56367054|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367055|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56367056|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
56367057|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367058|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
56367059|NCT00323791|Gemcitabine|gemcitabine|mesh-list
56367060|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
56367061|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367062|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
56367063|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367064|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367065|NCT00323791|Antiviral Agents|antiviral agents|mesh-ancestor
56367066|NCT00323791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367067|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367068|NCT00323791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367069|NCT00323791|Immunologic Factors|immunologic factors|mesh-ancestor
56367070|NCT00323791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367071|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56367072|NCT00323830|Capecitabine|capecitabine|mesh-list
56367073|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367074|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367075|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
56367076|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367077|NCT00317512|Chrysarobin|chrysarobin|mesh-list
56367078|NCT00317512|HBOC 201|hboc 201|mesh-list
56367079|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56367080|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56367081|NCT00317512|Analgesics|analgesics|mesh-ancestor
56367082|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
56367083|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367084|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367085|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367086|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367087|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
56367088|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56367089|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
56367090|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55988920|NCT00935311|Acetaminophen|acetaminophen|mesh-list
56367091|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56367092|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56367093|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56367094|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367095|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56367096|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
56367097|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367098|NCT00323947|Methylphenidate|methylphenidate|mesh-list
56652370|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652371|NCT00639938|Nevirapine|nevirapine|mesh-list
56652372|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
56652373|NCT00639938|Antibodies|antibodies|mesh-list
56652374|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
56652375|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56652376|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56652377|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
56652378|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652379|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56652380|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56652381|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652382|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652383|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
56652384|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652385|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56652386|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56652387|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56652388|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56652389|NCT05648201|Raltegravir Potassium|raltegravir potassium|mesh-list
56367099|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56367100|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367101|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56367103|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367104|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367105|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
56367106|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367107|NCT00323986|Azithromycin|azithromycin|mesh-list
56367108|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56367109|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367110|NCT00324025|Efungumab|efungumab|mesh-list
56367111|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
56367112|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367113|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56367114|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
56367115|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56367116|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
56367117|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367118|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367119|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56367120|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
56367121|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56367122|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
56367123|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367124|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367125|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56367126|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
56367127|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
56367128|NCT00317629|Protective Agents|protective agents|mesh-ancestor
56367129|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56367130|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56367131|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367132|NCT00093249|Clevidipine|clevidipine|mesh-list
56367133|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56367134|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652390|NCT05648201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56652391|NCT05648201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56652392|NCT05648201|Antiviral Agents|antiviral agents|mesh-ancestor
56652393|NCT05648201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367135|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367136|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56367137|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367138|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
56367139|NCT00124098|Hematinics|hematinics|mesh-ancestor
56367140|NCT00324142|Tinidazole|tinidazole|mesh-list
56367141|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
56367142|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367143|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56367144|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367145|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56367147|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56367148|NCT00324298|Etoposide|etoposide|mesh-list
56367149|NCT00324298|Bleomycin|bleomycin|mesh-list
56367150|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367151|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56367152|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56367153|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56367154|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367155|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367156|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56367157|NCT00124137|Diuretics|diuretics|mesh-list
56367158|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
56367159|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367160|NCT00324376|Sevelamer|sevelamer|mesh-list
56367161|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
56367162|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
56367163|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367164|NCT00084227|Azithromycin|azithromycin|mesh-list
56367165|NCT00084227|Chloroquine|chloroquine|mesh-list
56367166|NCT00084227|Atovaquone|atovaquone|mesh-list
56367167|NCT00084227|Proguanil|proguanil|mesh-list
56367168|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56367169|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56367170|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367171|NCT00084227|Amebicides|amebicides|mesh-ancestor
56367172|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56367173|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56367174|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
56367175|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367176|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367177|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367181|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56367182|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367183|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367185|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
56367186|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367187|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56367188|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
56367189|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56367190|NCT00317785|Cyclosporine|cyclosporine|mesh-list
56367191|NCT00317785|Sirolimus|sirolimus|mesh-list
56367192|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
56367193|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
56367194|NCT00317785|Methotrexate|methotrexate|mesh-list
56367195|NCT00317785|Tacrolimus|tacrolimus|mesh-list
56367196|NCT00317785|Cyclosporins|cyclosporins|mesh-list
56367197|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367198|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
56367199|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367200|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367201|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56367202|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
56367203|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367204|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367205|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56367206|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56367207|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
56652394|NCT05648201|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56652395|NCT05648201|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55770322|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
56367208|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56367209|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367210|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
56367211|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56367212|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367213|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56367214|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56367215|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56367216|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
56367217|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367218|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56367219|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56367220|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
56367221|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56367223|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56367224|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
56367225|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56367226|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56367227|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56367228|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367229|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367230|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
56367231|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367232|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367233|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56367234|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56367235|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367236|NCT00324454|Levetiracetam|levetiracetam|mesh-list
56367237|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
56367238|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
56367239|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
56367240|NCT00317902|Hematinics|hematinics|mesh-ancestor
56367241|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56367242|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56367243|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56367244|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367245|NCT00324571|Calcium|calcium|mesh-list
56367246|NCT00324571|Sevelamer|sevelamer|mesh-list
56367247|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56367248|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367249|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
55881174|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
56367253|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56367254|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367255|NCT00324610|Capecitabine|capecitabine|mesh-list
56367256|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367257|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
56367258|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367259|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367261|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
56367262|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56367263|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56367264|NCT00093366|Analgesics|analgesics|mesh-ancestor
56367265|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
56367266|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367267|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367268|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367269|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367270|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56367271|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367272|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
56367273|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367274|NCT00324688|Tenofovir|tenofovir|mesh-list
56367275|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
56367276|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367277|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56367278|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56367279|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367280|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652396|NCT05648201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652397|NCT05648201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652398|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
56652399|NCT04456439|Promethazine|promethazine|mesh-list
56652400|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
56652401|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
56215159|NCT01617226|Azacitidine|azacitidine|mesh-list
56367281|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56367282|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56367283|NCT00324727|Melphalan|melphalan|mesh-list
56367284|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56367285|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
56367286|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367287|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367288|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56367289|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367290|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
56367291|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367292|NCT00324766|Simendan|simendan|mesh-list
56367293|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56367294|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
56367295|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56367296|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56367297|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367298|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367299|NCT00324766|Protective Agents|protective agents|mesh-ancestor
56367300|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367301|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
56367302|NCT00084578|Celecoxib|celecoxib|mesh-list
56367303|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56367304|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56367305|NCT00084578|Analgesics|analgesics|mesh-ancestor
56367306|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
56367307|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367308|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367309|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367310|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367311|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56367312|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56367313|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367314|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367315|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56367316|NCT00318175|Bosentan|bosentan|mesh-list
56367317|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56367318|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56367319|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367320|NCT00093444|Doxorubicin|doxorubicin|mesh-list
56367321|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56367322|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56367324|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56367325|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56367326|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367327|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367328|NCT00325000|Amitriptyline|amitriptyline|mesh-list
56367329|NCT00325000|Sertraline|sertraline|mesh-list
56367330|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
56367331|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56367332|NCT00325000|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56367333|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56367334|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367335|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367336|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367337|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
56367338|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367339|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56367340|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56367341|NCT00325000|Analgesics|analgesics|mesh-ancestor
56367342|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
56652402|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652403|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56652404|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56367343|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367344|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56367345|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
56367346|NCT00318448|Zolpidem|zolpidem|mesh-list
56367347|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56367348|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56367349|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56367350|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367351|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56367352|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
56367353|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
56367354|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367355|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367356|NCT00325117|Vildagliptin|vildagliptin|mesh-list
56367357|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56367358|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367359|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56367360|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
56367361|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367362|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367363|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
56367364|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
56367365|NCT00084695|Melphalan|melphalan|mesh-list
56367366|NCT00084695|Busulfan|busulfan|mesh-list
56367367|NCT00084695|Fludarabine|fludarabine|mesh-list
56367368|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
56367369|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56367370|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367371|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
56367372|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367373|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367374|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56367375|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
56367376|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367377|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367378|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56367379|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367380|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
56367381|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367382|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
56367383|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
56367384|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367385|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56367386|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
56367388|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56367389|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56367390|NCT00084695|Protective Agents|protective agents|mesh-ancestor
56367391|NCT00325351|Carboplatin|carboplatin|mesh-list
55989214|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56367392|NCT00325351|Sagopilone|sagopilone|mesh-list
56367393|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367394|NCT00093483|Cytarabine|cytarabine|mesh-list
56367395|NCT00093483|Idarubicin|idarubicin|mesh-list
56367396|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
56367398|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
56367399|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367400|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367401|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
56367402|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367403|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367404|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
56367405|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367406|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56367407|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56367408|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56367409|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367410|NCT00084734|Docetaxel|docetaxel|mesh-list
56367411|NCT00084734|Capecitabine|capecitabine|mesh-list
56367412|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367413|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56652405|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652406|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652407|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
56652408|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
56367414|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56367415|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56367416|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367417|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367418|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
56367419|NCT00325390|Clopidogrel|clopidogrel|mesh-list
56367420|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56367421|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56367422|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56367423|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56367424|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
56367425|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367426|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367427|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367428|NCT00325429|Vildagliptin|vildagliptin|mesh-list
56367429|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56367430|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367431|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56367432|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
56367433|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367434|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367435|NCT00093522|Fludarabine|fludarabine|mesh-list
56367436|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
56367437|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56367438|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367439|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367440|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
56367441|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367442|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367443|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
56367444|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367445|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56367446|NCT00084773|Fluorouracil|fluorouracil|mesh-list
56367447|NCT00084773|Cetuximab|cetuximab|mesh-list
56367448|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
56367449|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367450|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367451|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367452|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367453|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
56367454|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367455|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56367456|NCT00325546|Rimonabant|rimonabant|mesh-list
56367457|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56367458|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56367459|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56367460|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367461|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367462|NCT00325546|Hormones|hormones|mesh-ancestor
56367463|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56367464|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989289|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
56367465|NCT00084812|Safingol|safingol|mesh-list
56367466|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881398|NCT03630666|Hormones|hormones|mesh-list
56367471|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
56367472|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
56367473|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56367474|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367475|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
56367476|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367477|NCT00318760|Clonidine|clonidine|mesh-list
56367478|NCT00318760|Analgesics|analgesics|mesh-ancestor
56367479|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
56367480|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652409|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
56652410|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652411|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
56652412|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
56367481|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367482|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56367483|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
56367484|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
56367485|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56367486|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56367487|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56367488|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
56367489|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367490|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367491|NCT00093561|Lycopene|lycopene|mesh-list
56367492|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367493|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
56367494|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367495|NCT00093561|Protective Agents|protective agents|mesh-ancestor
56367496|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367497|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56367498|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56367499|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367500|NCT00084890|Carboplatin|carboplatin|mesh-list
56367501|NCT00084890|Docetaxel|docetaxel|mesh-list
56367502|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367503|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56367504|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56367505|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56367506|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367507|NCT00318838|Azimilide|azimilide|mesh-list
56367508|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56367509|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56367510|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367511|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367512|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56367513|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367514|NCT00085124|Cytarabine|cytarabine|mesh-list
56367515|NCT00085124|Daunorubicin|daunorubicin|mesh-list
56367516|NCT00085124|Oblimersen|oblimersen|mesh-list
56367517|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367518|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
56367519|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367520|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367521|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
56367522|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367523|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367524|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
56367525|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367526|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56367527|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56367528|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56367529|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367530|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
56367531|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56367532|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367533|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367534|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56367535|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367536|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56367540|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56367541|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367543|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
56367544|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367545|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
56367546|NCT00318955|Propofol|propofol|mesh-list
56367547|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56367548|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56367549|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652413|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56652414|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56652415|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
56367550|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56367551|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
56367552|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
56367553|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56367554|NCT00318955|Analgesics|analgesics|mesh-ancestor
56367555|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
56367556|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367557|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56367558|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56367559|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56367560|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
56367561|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367562|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367563|NCT00325936|Cilnidipine|cilnidipine|mesh-list
56367564|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56367565|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367566|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367567|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56367568|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367569|NCT00318994|Meropenem|meropenem|mesh-list
56367570|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56367571|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367572|NCT00093600|Cytarabine|cytarabine|mesh-list
56367573|NCT00093600|Daunorubicin|daunorubicin|mesh-list
56367574|NCT00093600|Midostaurin|midostaurin|mesh-list
56367575|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367576|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
56367577|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367578|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367579|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
56367580|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367581|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367582|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
56367583|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367584|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56367585|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56367586|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56367587|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367588|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56367589|NCT00319033|Bosentan|bosentan|mesh-list
56367590|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56367591|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56171695|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
56367592|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367594|NCT00085163|Celecoxib|celecoxib|mesh-list
56367595|NCT00085163|Fluorouracil|fluorouracil|mesh-list
56367596|NCT00085163|Calcium|calcium|mesh-list
56367597|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
56367598|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56367599|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367600|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
56367601|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367602|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367603|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367604|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367605|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
56367606|NCT00085163|Antidotes|antidotes|mesh-ancestor
56367607|NCT00085163|Protective Agents|protective agents|mesh-ancestor
56367608|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
56367609|NCT00085163|Vitamins|vitamins|mesh-ancestor
56367610|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
56367612|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56367613|NCT00085163|Analgesics|analgesics|mesh-ancestor
55989439|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
56367614|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
56367615|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367616|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367617|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367618|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55913730|NCT00574587|Doxorubicin|doxorubicin|mesh-list
56652416|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
56652417|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652418|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367619|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56367620|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367621|NCT00319072|Hormones|hormones|mesh-list
56367622|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56367623|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367624|NCT00093639|Everolimus|everolimus|mesh-list
56367625|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
56367626|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367627|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367628|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
56367629|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367630|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56367631|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367632|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367633|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
56367634|NCT00319150|Hematinics|hematinics|mesh-ancestor
56367635|NCT00326053|Budesonide|budesonide|mesh-list
56367636|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
56367637|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367638|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56367639|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
56367640|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367641|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367642|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56367643|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
56367644|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
56367645|NCT00326053|Hormones|hormones|mesh-ancestor
56367646|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56367647|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56367648|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56367649|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56367650|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
56367651|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367652|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367653|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
56367654|NCT00400088|Paroxetine|paroxetine|mesh-list
56367655|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
56367656|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56367657|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367658|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367659|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
56367660|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56367661|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56367662|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367663|NCT00400088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56367664|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56367665|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367666|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367667|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
56367668|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56367669|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56367670|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56367671|NCT00326092|Timolol|timolol|mesh-list
56367672|NCT00326092|Brinzolamide|brinzolamide|mesh-list
56367673|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56367674|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56367675|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
56367676|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367677|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367678|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367679|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56367680|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56367681|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56367685|NCT00319189|Nateglinide|nateglinide|mesh-list
56367686|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56367687|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367688|NCT00319267|Bosentan|bosentan|mesh-list
56652419|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56652420|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
56652421|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
56652422|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
56652423|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367689|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56367690|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56367691|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367692|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56367693|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367694|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56367695|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367696|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367697|NCT00326248|Casopitant|casopitant|mesh-list
56367698|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
56367699|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
56367700|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367701|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367702|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56367703|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56367704|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367705|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367706|NCT00319306|Budesonide|budesonide|mesh-list
56367707|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
56367708|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56367709|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367710|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56367711|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
56367712|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367713|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367714|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56367715|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
56367716|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
56367717|NCT00319306|Hormones|hormones|mesh-ancestor
56367718|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56367719|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56367720|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56367721|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56367722|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
56367723|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367724|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367726|NCT00085358|Docetaxel|docetaxel|mesh-list
56367727|NCT00085358|Bevacizumab|bevacizumab|mesh-list
56367728|NCT00085358|Carboplatin|carboplatin|mesh-list
56367729|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56367730|NCT00085358|Antibodies|antibodies|mesh-list
56367731|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
56367732|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56367733|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56367734|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367736|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56367737|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56367738|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367739|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56367740|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56367741|NCT00085358|Growth Substances|growth substances|mesh-ancestor
56367742|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367743|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
56367744|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
56367745|NCT00093678|Celecoxib|celecoxib|mesh-list
56367746|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56367747|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56367748|NCT00093678|Analgesics|analgesics|mesh-ancestor
56367749|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
56367750|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367751|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367752|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367753|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367754|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56652424|NCT02815319|Dexamethasone|dexamethasone|mesh-list
56652425|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652426|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
56652427|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
56652428|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881680|NCT03061539|Nivolumab|nivolumab|mesh-list
56367758|NCT00319345|Mannitol|mannitol|mesh-list
56367759|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56367760|NCT00319345|Diuretics|diuretics|mesh-ancestor
56367761|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
56367762|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367763|NCT00419536|Panobinostat|panobinostat|mesh-list
56367764|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367765|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56367766|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367767|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367768|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56367769|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56367770|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56367771|NCT00326404|Desogestrel|desogestrel|mesh-list
56367772|NCT00326404|Estradiol|estradiol|mesh-list
56367773|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56367774|NCT00326404|Estrogens|estrogens|mesh-ancestor
56367775|NCT00326404|Hormones|hormones|mesh-ancestor
56367776|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56367777|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367778|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56367779|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
56367780|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56367781|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56367782|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56367783|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56367784|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56367785|NCT00326404|Progestins|progestins|mesh-ancestor
56367786|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
56367787|NCT00093834|Doxorubicin|doxorubicin|mesh-list
56367788|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56367789|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56367790|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
56367791|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367792|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367793|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56367794|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
56367795|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367796|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367797|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56367798|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56367799|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56367800|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56367801|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367802|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
56367803|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367804|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56367805|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367806|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367807|NCT00319618|Docetaxel|docetaxel|mesh-list
56367808|NCT00319618|Gefitinib|gefitinib|mesh-list
56367809|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367810|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
56367811|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
56367812|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
56367813|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367814|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56367815|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367816|NCT00124332|Rimonabant|rimonabant|mesh-list
56367817|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56367818|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56367819|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56367820|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367821|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367822|NCT00124332|Hormones|hormones|mesh-ancestor
55913731|NCT00574587|Trastuzumab|trastuzumab|mesh-list
56652429|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652430|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56652431|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
56367823|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56367824|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367825|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56367828|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56367829|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367830|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367831|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
56367832|NCT00400335|Testosterone|testosterone|mesh-list
56367833|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
56367834|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
56367835|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56367837|NCT00400335|Androgens|androgens|mesh-ancestor
56367838|NCT00400335|Hormones|hormones|mesh-ancestor
56367839|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56367840|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367841|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56367842|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367843|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
56367844|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56367845|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56367846|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367847|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367848|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
56367849|NCT00319852|Vaccines|vaccines|mesh-list
56367850|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
56367851|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367852|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
56367853|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
56367854|NCT00326833|Vitamins|vitamins|mesh-ancestor
56367855|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
56367856|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367857|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
56367858|NCT00326833|Hematinics|hematinics|mesh-ancestor
56367859|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56367860|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56367861|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56367862|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56367863|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367864|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56367865|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56367866|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56367867|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
56367868|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367869|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367870|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56367871|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56367872|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
56367874|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56367875|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
56367876|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
56367877|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56367878|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367879|NCT00320047|Baclofen|baclofen|mesh-list
56367880|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56367881|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367883|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367884|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56367885|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
56367886|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
56367887|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367888|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367889|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
56367890|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367891|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56367892|NCT00085826|Protective Agents|protective agents|mesh-ancestor
56367893|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367894|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56367895|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652432|NCT02815319|Hormones|hormones|mesh-ancestor
56652433|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56652434|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56652435|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652436|NCT02815475|Curcumin|curcumin|mesh-list
56298488|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
56652437|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56652438|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56652440|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
56652441|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367896|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367897|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56367898|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56367899|NCT00085826|Analgesics|analgesics|mesh-ancestor
56367900|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
55881823|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367905|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56367906|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367907|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
56367908|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56367909|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367910|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367912|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56367913|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56367914|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367915|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367916|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367917|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
56367918|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56367919|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56367920|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367921|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
56367922|NCT00327106|Coagulants|coagulants|mesh-ancestor
56367923|NCT00320359|Cisplatin|cisplatin|mesh-list
56367924|NCT00320359|Etoposide|etoposide|mesh-list
56367925|NCT00320359|Topotecan|topotecan|mesh-list
56367926|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367927|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56367928|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56367929|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56367930|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367931|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367932|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56367933|NCT00093912|Nitroprusside|nitroprusside|mesh-list
56367934|NCT00093912|Clevidipine|clevidipine|mesh-list
56367935|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56367936|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
56367937|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56367938|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367939|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56367940|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367941|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56367942|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367944|NCT00327145|Valsartan|valsartan|mesh-list
56367945|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56367946|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56367947|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56367948|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56367949|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367950|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56367951|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652442|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652443|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367952|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
56367953|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56367954|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56367955|NCT00327145|Diuretics|diuretics|mesh-ancestor
56367956|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
56367957|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56367958|NCT00085943|Ritonavir|ritonavir|mesh-list
56367959|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
56367960|NCT00085943|Lamivudine|lamivudine|mesh-list
56367961|NCT00085943|Abacavir|abacavir|mesh-list
56367962|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56367963|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56367964|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
56367965|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367966|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367967|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56367968|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56367969|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
56367970|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56367971|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56367972|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56367976|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
56367977|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56367978|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56367979|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367981|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56367982|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989864|NCT05285943|Hormones|hormones|mesh-ancestor
56367983|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
56367984|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56367985|NCT00093951|Protective Agents|protective agents|mesh-ancestor
56367986|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367987|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
56367988|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
56367989|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367990|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367991|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
56367992|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
56367993|NCT00320476|Bortezomib|bortezomib|mesh-list
56367994|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367995|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
56367996|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367997|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56367998|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367999|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368000|NCT00093990|Tipifarnib|tipifarnib|mesh-list
56368001|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368002|NCT00327379|Aprotinin|aprotinin|mesh-list
56368003|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
56368004|NCT00327379|Coagulants|coagulants|mesh-ancestor
56368005|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56368006|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56368007|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
56368008|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368009|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368010|NCT00327418|Atorvastatin|atorvastatin|mesh-list
56368011|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56368012|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56368013|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
56368014|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368015|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56368016|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56368017|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368018|NCT00094029|Sunitinib|sunitinib|mesh-list
56368019|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368020|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56368021|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56368022|NCT00094029|Growth Substances|growth substances|mesh-ancestor
56368023|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368024|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
56368025|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56652444|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652445|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652446|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652447|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368026|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368027|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368029|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56368030|NCT00086099|Protective Agents|protective agents|mesh-ancestor
56368031|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368032|NCT00320632|Desipramine|desipramine|mesh-list
56368033|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56368034|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
56368035|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368036|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368037|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368038|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56368039|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368040|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56368041|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
56368042|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368043|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368052|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368053|NCT00086177|Progesterone|progesterone|mesh-list
56368054|NCT00086177|Progestins|progestins|mesh-ancestor
56368055|NCT00086177|Hormones|hormones|mesh-ancestor
55989894|NCT02245789|Propofol|propofol|mesh-list
56368056|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56368057|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368058|NCT05458765|Tenofovir|tenofovir|mesh-list
56368059|NCT05458765|Emtricitabine|emtricitabine|mesh-list
56368060|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56368061|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56368062|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
56368063|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368064|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56368065|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56368066|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368067|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368068|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56368069|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56368070|NCT00094146|Octreotide|octreotide|mesh-list
56368071|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56368072|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56368073|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368074|NCT00086255|Tiagabine|tiagabine|mesh-list
56368075|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
56368076|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56368077|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368078|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56368079|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368080|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
56368081|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368082|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368083|NCT00321178|Clarithromycin|clarithromycin|mesh-list
56368084|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368085|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368086|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56368087|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368088|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368089|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56368090|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56368091|NCT00124527|Capecitabine|capecitabine|mesh-list
56368092|NCT00124527|Irofulven|irofulven|mesh-list
56368093|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56368094|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
56368095|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368096|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652448|NCT00640796|Aldesleukin|aldesleukin|mesh-list
56652449|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
56368097|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56368098|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
56368100|NCT00086294|Pimavanserin|pimavanserin|mesh-list
56368101|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56368102|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56368103|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
56368104|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368105|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368106|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368107|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56368108|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56368109|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56368117|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368118|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368119|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
56368120|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368121|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
56368122|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368124|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368125|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
56368126|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
56368127|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
56368128|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368129|NCT05458180|Prednisone|prednisone|mesh-list
56368130|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
56368131|NCT05458180|Etoposide|etoposide|mesh-list
56368132|NCT05458180|Vincristine|vincristine|mesh-list
56368133|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
56368134|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368135|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
56368136|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368137|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368138|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56368139|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
56368140|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368141|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368142|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56368143|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56368144|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
56368145|NCT05458180|Hormones|hormones|mesh-ancestor
56368146|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56368147|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56368148|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56368149|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56368150|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368151|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368152|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
56368153|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
56368154|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
56368155|NCT05458180|Analgesics|analgesics|mesh-ancestor
56368156|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
56368157|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368158|NCT00419653|Haloperidol|haloperidol|mesh-list
56368159|NCT00419653|Olanzapine|olanzapine|mesh-list
56368160|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
56368161|NCT00419653|Amisulpride|amisulpride|mesh-list
56368162|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
56368164|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368165|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368166|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56368167|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56368168|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56368169|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56368170|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368171|NCT00419653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56368172|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368173|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56001765|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
56368174|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368175|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368176|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
56368177|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56652450|NCT00640796|Fludarabine|fludarabine|mesh-list
56652451|NCT00640796|Interleukin-2|interleukin-2|mesh-list
56652452|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368178|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
56368183|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56368185|NCT00094341|Analgesics|analgesics|mesh-ancestor
56368186|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
56368187|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368188|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368189|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56368190|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368191|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56368192|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368193|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
56368194|NCT00086489|Tremelimumab|tremelimumab|mesh-list
56368195|NCT00086489|Ipilimumab|ipilimumab|mesh-list
56368196|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368197|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56368198|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56368199|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368200|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
56368201|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368202|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
56368203|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368204|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368205|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56368206|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
56368207|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368208|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368209|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56368210|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56368211|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56368212|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
56368213|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368214|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56368215|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56368216|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56368217|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368218|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56368219|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368220|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56368221|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368222|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368223|NCT00321490|Analgesics|analgesics|mesh-ancestor
56368224|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
56368225|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368226|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
56368227|NCT00086528|XL647|xl647|mesh-list
56368228|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368229|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56368230|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368231|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368232|NCT05457829|Doxorubicin|doxorubicin|mesh-list
56368233|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56368235|NCT05457829|Vincristine|vincristine|mesh-list
56368236|NCT05457829|Temozolomide|temozolomide|mesh-list
56368237|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368238|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368239|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56368240|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368241|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368242|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368243|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56368244|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56368245|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
56368247|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
56368248|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56368249|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
56368250|NCT05457751|Rocuronium|rocuronium|mesh-list
56368253|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56368254|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652453|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
56652454|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652455|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652456|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56652457|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
56368255|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368257|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56368258|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56368259|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
56368260|NCT00124566|Prednisone|prednisone|mesh-list
56368261|NCT00124566|Capecitabine|capecitabine|mesh-list
56368262|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
56368263|NCT00124566|Irofulven|irofulven|mesh-list
56368264|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56368265|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
56368266|NCT00124566|Hormones|hormones|mesh-ancestor
56368267|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56368268|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368269|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56368270|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368271|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56368272|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
56368273|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368274|NCT00124566|Analgesics|analgesics|mesh-ancestor
56368275|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
56368276|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368277|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56368278|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368279|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368280|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56368281|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
56368282|NCT00321724|Cediranib|cediranib|mesh-list
56368283|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368284|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368285|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368286|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56368287|NCT00086645|Dexetimide|dexetimide|mesh-list
56368288|NCT00086645|Citalopram|citalopram|mesh-list
56368289|NCT00086645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56368290|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368291|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56368292|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368293|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368294|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
56368295|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368296|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56368297|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
56368298|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368299|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56368300|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56368301|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
56368302|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
56368303|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368304|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56368305|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56368306|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
56368307|NCT00321802|Simvastatin|simvastatin|mesh-list
56368308|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56368309|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56368310|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
56368311|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368312|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56368313|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56368314|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368315|NCT00124605|Pamidronate|pamidronate|mesh-list
56368316|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
56368317|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368318|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56368319|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652458|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652459|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652460|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56652461|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56652462|NCT00640796|Analgesics|analgesics|mesh-ancestor
55771442|NCT04372433|Venetoclax|venetoclax|mesh-list
56368320|NCT05457361|Azacitidine|azacitidine|mesh-list
56368321|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
55882248|NCT03368274|Hormones|hormones|mesh-ancestor
56368324|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368325|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368326|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368327|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56368328|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56368329|NCT00086801|Gemcitabine|gemcitabine|mesh-list
56368330|NCT00086801|Doxorubicin|doxorubicin|mesh-list
56368331|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56368332|NCT00086801|Vinblastine|vinblastine|mesh-list
56368333|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56368334|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56368335|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
56368336|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368337|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368338|NCT00086801|Antiviral Agents|antiviral agents|mesh-ancestor
56368339|NCT00086801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368340|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368341|NCT00086801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368342|NCT00086801|Immunologic Factors|immunologic factors|mesh-ancestor
56368343|NCT00086801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368344|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368345|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56368346|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368347|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56368348|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56368349|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
56368350|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
56368351|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
56368352|NCT05456113|Cannabidiol|cannabidiol|mesh-list
56368353|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
55990196|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56368355|NCT00124644|Etoposide|etoposide|mesh-list
56368356|NCT00124644|Daunorubicin|daunorubicin|mesh-list
56368357|NCT00124644|Tipifarnib|tipifarnib|mesh-list
56368358|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56368359|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56368360|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368361|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56368362|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368363|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368364|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56368365|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
56368366|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
56368367|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368368|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368369|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
56368370|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368371|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368372|NCT00086840|Sirolimus|sirolimus|mesh-list
56368373|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368374|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368375|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368376|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368377|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
56368378|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368379|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
56368380|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368381|NCT00124683|Bupropion|bupropion|mesh-list
56368382|NCT00124683|Nicotine|nicotine|mesh-list
56368383|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56368385|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368386|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652463|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
56652464|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652465|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56652466|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56652467|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
56368387|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56368388|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56368389|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
56368390|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368391|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368392|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56368393|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
56368394|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368395|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55882321|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56368404|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368405|NCT00086879|Temozolomide|temozolomide|mesh-list
56368406|NCT00086879|Carmustine|carmustine|mesh-list
56368407|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56368408|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56368409|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
56368410|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368411|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368412|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56368413|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368414|NCT00124722|Bromides|bromides|mesh-list
56368415|NCT00124722|Rocuronium|rocuronium|mesh-list
56368416|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
56368417|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56368418|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56368419|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56368420|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368421|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368422|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
56368423|NCT00322036|Analgesics|analgesics|mesh-ancestor
56368424|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
56368425|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368426|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368427|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56368428|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56368430|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368431|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56368432|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368433|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368434|NCT00094614|Atropine|atropine|mesh-list
56368435|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56368436|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56368437|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56368438|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
56368439|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368440|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368441|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56368442|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
56368443|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
56368444|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
56368445|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56368446|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56368447|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
56368448|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368449|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368450|NCT00087035|Docetaxel|docetaxel|mesh-list
56368451|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56368452|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368453|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
56368454|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
56368455|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
56368456|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368457|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56368458|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368460|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56652468|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652469|NCT02687984|Risperidone|risperidone|mesh-list
56652470|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56652471|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
55771576|NCT02359643|Aspirin|aspirin|mesh-list
56368461|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368462|NCT00322114|Lycopene|lycopene|mesh-list
56368463|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56368467|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368468|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56368469|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56368470|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368471|NCT00087074|Sirolimus|sirolimus|mesh-list
56368472|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368473|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368474|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368475|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368476|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
56368477|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368478|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
56368479|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368480|NCT00332176|Ribavirin|ribavirin|mesh-list
56368481|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56368482|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
56368483|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368484|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
56368485|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368486|NCT00087113|Pemetrexed|pemetrexed|mesh-list
56368487|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368488|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368489|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368490|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56368491|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56368492|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56368493|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368494|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
56368495|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56368496|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56368497|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56368498|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368499|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368500|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56368501|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368502|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368503|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368504|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368505|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56368506|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
56368507|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56368508|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368509|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56368510|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56368511|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56368512|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
56368513|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56368514|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
56368515|NCT05222932|Avelumab|avelumab|mesh-list
56368516|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56368517|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368518|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
56368519|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56368520|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56368521|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56368522|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56368523|NCT00094692|Atropine|atropine|mesh-list
56368524|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56368525|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56368526|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56368527|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
56368528|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368529|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652472|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652473|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652474|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652475|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55771637|NCT02356913|Nicotine|nicotine|mesh-list
56368530|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56368531|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
56368532|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
56368533|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
56368534|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56368537|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368538|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368539|NCT05181007|Valproic Acid|valproic acid|mesh-list
56368540|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
56368541|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368542|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368543|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
56368544|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368545|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368546|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
56368547|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56368548|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56368549|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368550|NCT00124839|Naltrexone|naltrexone|mesh-list
56368551|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56368552|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56368553|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368554|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
56368555|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368556|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56368557|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368558|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56368559|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368560|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368561|NCT05126836|Cilostazol|cilostazol|mesh-list
56368562|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56368563|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
56368564|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368565|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368566|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56368567|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
56368568|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56368569|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56368570|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368571|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56368572|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
56368573|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56368574|NCT05126836|Protective Agents|protective agents|mesh-ancestor
56368575|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56368576|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56368577|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368578|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56368580|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56368581|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56368582|NCT04960930|Minocycline|minocycline|mesh-list
56368583|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368584|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368585|NCT00419692|Ropinirole|ropinirole|mesh-list
56368586|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56368587|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56368588|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
56368589|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
56368590|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368591|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368592|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368593|NCT00419731|Naltrexone|naltrexone|mesh-list
56368594|NCT00419731|Bupropion|bupropion|mesh-list
56368595|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56171734|NCT02249364|Propofol|propofol|mesh-list
56368596|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56652476|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56652477|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652478|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368597|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368598|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
56368599|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368600|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56368601|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
56368602|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368603|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56368604|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368605|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56368606|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368609|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56368610|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56368611|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368612|NCT00419848|Azithromycin|azithromycin|mesh-list
56368613|NCT00419848|Doxycycline|doxycycline|mesh-list
56368614|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368615|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368616|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
56368617|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56368618|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56368619|NCT00094848|Mapatumumab|mapatumumab|mesh-list
56368620|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368621|NCT00087425|Rituximab|rituximab|mesh-list
56368622|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
56368623|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56368624|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368625|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
56368626|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368627|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368628|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56368629|NCT00330655|Memantine|memantine|mesh-list
56368630|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56368631|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56368632|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
56368633|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368634|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368635|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368636|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56368637|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56368638|NCT00330772|Aspirin|aspirin|mesh-list
56368639|NCT00330772|Clopidogrel|clopidogrel|mesh-list
56368640|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56368641|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56368642|NCT00330772|Analgesics|analgesics|mesh-ancestor
56368643|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
56368644|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368645|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368646|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56368647|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368648|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56368649|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56368650|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368651|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56368652|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56368653|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368654|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
56368655|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56368656|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56368657|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56368658|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
56368659|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368660|NCT00094926|Risperidone|risperidone|mesh-list
56368661|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56368662|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
56368663|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368664|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368665|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652479|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56652480|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
56652481|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56652482|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56652483|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
56368666|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56368667|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56368668|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56368670|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56368671|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
56368672|NCT00087464|Tenofovir|tenofovir|mesh-list
56368673|NCT00087464|Emtricitabine|emtricitabine|mesh-list
56368674|NCT00087464|Nevirapine|nevirapine|mesh-list
56368675|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
56368676|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368677|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56368678|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56368679|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368680|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368681|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56368683|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56368684|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56368686|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56368687|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56368688|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
56368689|NCT00331084|Dexamethasone|dexamethasone|mesh-list
56368690|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
56368691|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56368692|NCT00331084|BB 1101|bb 1101|mesh-list
56368693|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56368694|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
56368695|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
56368696|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368697|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368698|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56368699|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
56368700|NCT00331084|Hormones|hormones|mesh-ancestor
56368701|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56368702|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56368703|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368704|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
56368705|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368706|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368707|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368708|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56368709|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368710|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56368711|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
56368712|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56368713|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56368714|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56368715|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56368716|NCT00420355|Ritonavir|ritonavir|mesh-list
56368717|NCT00420355|Lopinavir|lopinavir|mesh-list
56368718|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56368719|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56368720|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56368721|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
56368722|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368723|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368724|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56368725|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56368726|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
56368727|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368728|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56368729|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56368731|NCT00331123|Androgens|androgens|mesh-ancestor
56368732|NCT00331123|Hormones|hormones|mesh-ancestor
56368733|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56368734|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368735|NCT00087542|Pimavanserin|pimavanserin|mesh-list
56652484|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652485|NCT02684786|Lidocaine|lidocaine|mesh-list
56652486|NCT02684786|Reserpine|reserpine|mesh-list
56368736|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56368737|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56368738|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56368739|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56368740|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56368741|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368742|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368743|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56368744|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56368745|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
56368746|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368747|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368748|NCT00331240|Timolol|timolol|mesh-list
56368749|NCT00331240|Travoprost|travoprost|mesh-list
56368750|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
56368751|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56368752|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56368753|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
56368754|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368755|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368758|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56368759|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56368760|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56368761|NCT00124956|Doxorubicin|doxorubicin|mesh-list
56368762|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368763|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368764|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56368765|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368766|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368767|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368768|NCT00087581|Cyclosporine|cyclosporine|mesh-list
56368769|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
56368770|NCT00087581|Tacrolimus|tacrolimus|mesh-list
56368771|NCT00087581|Cyclosporins|cyclosporins|mesh-list
56368772|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368773|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
56368774|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368775|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56368776|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368777|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368778|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
56368779|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368780|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
56368781|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368782|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368783|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368784|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56368785|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
56368786|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368787|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
56368788|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368789|NCT00331435|Verteporfin|verteporfin|mesh-list
56368790|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56368791|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
56368792|NCT00331513|Vorinostat|vorinostat|mesh-list
56368793|NCT00331513|Idarubicin|idarubicin|mesh-list
56368794|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368795|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56368796|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368797|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368798|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368799|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56368800|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368801|NCT00087620|Capecitabine|capecitabine|mesh-list
55990645|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368802|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56368803|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
56368804|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368805|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368806|NCT00124995|Terbutaline|terbutaline|mesh-list
56652487|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
56652488|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
56652489|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652490|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652491|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
56652492|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652493|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56652494|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56652495|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56652496|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652497|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652498|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56652499|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56652500|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56652501|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215226|NCT01617694|Analgesics|analgesics|mesh-ancestor
56368807|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56368808|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
56368809|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368810|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368811|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56368812|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
56368813|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
56368814|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
56368815|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56368816|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56368817|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56368818|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56368819|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
56368820|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368821|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368822|NCT00331708|Artesunate|artesunate|mesh-list
56368823|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
56368824|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
56368825|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56368826|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
56368827|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56368828|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56368830|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368831|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
56368832|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
56368833|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56368834|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
56368835|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56368836|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368837|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368838|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56368839|NCT00331708|Renal Agents|renal agents|mesh-ancestor
56368840|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
56368841|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
56368842|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56368843|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
56368844|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368845|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368846|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368847|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
56368848|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56368849|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652502|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56652503|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56652504|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
56652505|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652506|NCT02683070|Tramadol|tramadol|mesh-list
56652507|NCT02683070|Ropivacaine|ropivacaine|mesh-list
56652508|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
56368850|NCT00331786|Aspirin|aspirin|mesh-list
56368851|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
56368852|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
56368853|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56368854|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56368855|NCT00331786|Analgesics|analgesics|mesh-ancestor
56368856|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
56368857|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368858|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368859|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56368860|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56368861|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56368862|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56368863|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368864|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56368865|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56368866|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368867|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
56368868|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56368869|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
56368870|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56368871|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
56368872|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56368873|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
56368874|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368875|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56368876|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
56368877|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
56368878|NCT00331786|Protective Agents|protective agents|mesh-ancestor
56368879|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56368880|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
56368881|NCT00331825|Olanzapine|olanzapine|mesh-list
56368882|NCT00331825|Risperidone|risperidone|mesh-list
56368883|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56368884|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
56368885|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368886|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368887|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368888|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56368889|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56368890|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56368891|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368892|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56368893|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
56368894|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
56368895|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
56368896|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56368897|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56368898|NCT00331825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56368899|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368900|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56368901|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
56368902|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56368903|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368908|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368909|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368910|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56368911|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56368912|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368913|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56368914|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652509|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
56652510|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652511|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368915|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368916|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368917|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56368918|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
56368919|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368920|NCT00331981|Amisulpride|amisulpride|mesh-list
56368921|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56368922|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56368923|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56368924|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368925|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368926|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56368927|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
56368928|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368929|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368930|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56368931|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
56368932|NCT00126633|Gemcitabine|gemcitabine|mesh-list
56368933|NCT00126633|Bevacizumab|bevacizumab|mesh-list
56368934|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56368935|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368936|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56368937|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56368938|NCT00126633|Growth Substances|growth substances|mesh-ancestor
56368939|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368940|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
56368941|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56368942|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
56368943|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368944|NCT00126633|Antiviral Agents|antiviral agents|mesh-ancestor
56368945|NCT00126633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368946|NCT00126633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368947|NCT00126633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56368948|NCT00126633|Immunologic Factors|immunologic factors|mesh-ancestor
56368949|NCT00332020|Enoxaparin|enoxaparin|mesh-list
55990793|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56368951|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56368952|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
56368953|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56368954|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
56368955|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368956|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368957|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
56368958|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56368959|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56368960|NCT02965274|Fluoxetine|fluoxetine|mesh-list
56368961|NCT02965274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56368962|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368963|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56368964|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368965|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368966|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
56368967|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368968|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56368969|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
56368970|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368971|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56368998|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
56368999|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369000|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56369001|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56369002|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
56369003|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
56369004|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56369005|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56369006|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369007|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
56652512|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
56298562|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
56652513|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652514|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56652515|NCT02683070|Narcotics|narcotics|mesh-ancestor
56652516|NCT02683070|Analgesics|analgesics|mesh-ancestor
56652517|NCT02685176|Charcoal|charcoal|mesh-list
56652518|NCT02685176|Antidotes|antidotes|mesh-ancestor
56652519|NCT02685176|Protective Agents|protective agents|mesh-ancestor
56652520|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652521|NCT03199040|Durvalumab|durvalumab|mesh-list
56652522|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56652523|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652524|NCT05664074|Ketorolac|ketorolac|mesh-list
56652525|NCT05664074|Indomethacin|indomethacin|mesh-list
56652526|NCT05664074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56652527|NCT05664074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56652528|NCT05664074|Analgesics|analgesics|mesh-ancestor
56652529|NCT05664074|Sensory System Agents|sensory system agents|mesh-ancestor
56652530|NCT05664074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652531|NCT05664074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652532|NCT05664074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652533|NCT05664074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652534|NCT05664074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56652535|NCT05664074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652536|NCT05664074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652537|NCT05664074|Gout Suppressants|gout suppressants|mesh-ancestor
56652538|NCT05664074|Tocolytic Agents|tocolytic agents|mesh-ancestor
56652539|NCT05664074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56652540|NCT00634205|Doxorubicin|doxorubicin|mesh-list
56652541|NCT00634205|Valproic Acid|valproic acid|mesh-list
56652542|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56652543|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652544|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56369008|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369009|NCT00087815|Dexamethasone|dexamethasone|mesh-list
56369010|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369011|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
56369012|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
56369013|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369014|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369015|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369016|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
56652545|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56652546|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652547|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652548|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
56652549|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
56652550|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652551|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652552|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
56652553|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56652554|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652555|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56652556|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
56652557|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56652558|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652559|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56652560|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56652561|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215278|NCT01617811|Anesthetics|anesthetics|mesh-list
56369017|NCT00087815|Hormones|hormones|mesh-ancestor
56369018|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369019|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56369024|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369026|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369027|NCT04715620|Niraparib|niraparib|mesh-list
56369028|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56369029|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369030|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369031|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369032|NCT00125229|Mannitol|mannitol|mesh-list
56369033|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56369034|NCT00125229|Diuretics|diuretics|mesh-ancestor
56369035|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
56369036|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369037|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
56369038|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
56369039|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
56369040|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56369041|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56369042|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369043|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56369044|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369045|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369046|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56369047|NCT00126906|Renal Agents|renal agents|mesh-ancestor
56369048|NCT00088049|Olanzapine|olanzapine|mesh-list
56369049|NCT00088049|Aripiprazole|aripiprazole|mesh-list
56369050|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
56369051|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
56369052|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369053|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369054|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369055|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56369056|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56369057|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369058|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56369059|NCT00088049|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56369060|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56652562|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652563|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652564|NCT02818049|Dimercaprol|dimercaprol|mesh-list
55791607|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
56369061|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56165337|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369062|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369063|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369064|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
56369065|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
56369066|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
56369067|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
56369068|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56369069|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56369070|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56369071|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56369072|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56369073|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56369074|NCT00088088|Paclitaxel|paclitaxel|mesh-list
56369075|NCT00088088|Carboplatin|carboplatin|mesh-list
56369076|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56369077|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369078|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
56369079|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
56369080|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56369081|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369082|NCT00125307|Tacrolimus|tacrolimus|mesh-list
56369083|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369084|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
56369085|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369086|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56369087|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369088|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369089|NCT00127023|Vaccines|vaccines|mesh-list
56369090|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
56369091|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369095|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
56369096|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369097|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56369098|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56369099|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56369100|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56369101|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56369102|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369103|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56369104|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369106|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56369107|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56369108|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
56369109|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369110|NCT00333034|Etanercept|etanercept|mesh-list
56369111|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56369112|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56369113|NCT00333034|Analgesics|analgesics|mesh-ancestor
56369114|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
56369115|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369116|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369117|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369118|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369119|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369120|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369121|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
56369122|NCT00088478|Olanzapine|olanzapine|mesh-list
56369123|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
56369124|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
56369125|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369126|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369127|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369128|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56369129|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56652565|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
56652566|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
56652567|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652568|NCT02684708|Prednisone|prednisone|mesh-list
56652569|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
56369130|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369131|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56369132|NCT00088478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56369133|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56369134|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56369135|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369136|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369137|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
56369138|NCT00125346|Tobramycin|tobramycin|mesh-list
56369139|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56369140|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369141|NCT00333112|Tamsulosin|tamsulosin|mesh-list
56369142|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
56369143|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56369144|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56369145|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56369146|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
56369147|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369148|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369149|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369150|NCT00333112|Urological Agents|urological agents|mesh-ancestor
56369151|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56369152|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56369153|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
56369154|NCT00333151|Metformin|metformin|mesh-list
56369155|NCT00333151|Liraglutide|liraglutide|mesh-list
56369156|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
56369157|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56369158|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369159|NCT00333151|Incretins|incretins|mesh-ancestor
56369160|NCT00333151|Hormones|hormones|mesh-ancestor
56369161|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369162|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56369167|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56369168|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369169|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56369170|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56369171|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56369172|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369174|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369175|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56369176|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369177|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369178|NCT00333307|Methocarbamol|methocarbamol|mesh-list
56369179|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56369180|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369181|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56369182|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369183|NCT00125424|Midazolam|midazolam|mesh-list
56369184|NCT00125424|Fospropofol|fospropofol|mesh-list
56369185|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56369186|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56369187|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369188|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369189|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56369190|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56369191|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56369192|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56369193|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
56369194|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
56369195|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
56369196|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
56369197|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369198|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369199|NCT00333346|Tramadol|tramadol|mesh-list
56652570|NCT02684708|Dacarbazine|dacarbazine|mesh-list
56652571|NCT02684708|Vincristine|vincristine|mesh-list
56652572|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652573|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
55772272|NCT02344511|Oxacillin|oxacillin|mesh-list
56369200|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56369201|NCT00333346|Narcotics|narcotics|mesh-ancestor
56369202|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369203|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369204|NCT00333346|Analgesics|analgesics|mesh-ancestor
56369205|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
56369206|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369207|NCT00333385|Ceftazidime|ceftazidime|mesh-list
56369208|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56369209|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369210|NCT00127257|Diazepam|diazepam|mesh-list
56369211|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56369213|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
56369214|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
56369215|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369216|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369217|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369218|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56369219|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369220|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56369221|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56369222|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56369223|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56369224|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56369225|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56369226|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
56369227|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
56369228|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
56369229|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
56369230|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369231|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369232|NCT00333424|Vaccines|vaccines|mesh-list
56369233|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
56369234|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369235|NCT00125463|Candesartan|candesartan|mesh-list
56369236|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
56369239|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56369240|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369241|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56369242|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369243|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56369244|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369245|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369247|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56369248|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
56369249|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56369251|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369252|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369253|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56369254|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56369255|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369256|NCT00421096|Gemcitabine|gemcitabine|mesh-list
56369257|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369258|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56369259|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
56369260|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369261|NCT00421096|Antiviral Agents|antiviral agents|mesh-ancestor
56369262|NCT00421096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369263|NCT00421096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369264|NCT00421096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369265|NCT00421096|Immunologic Factors|immunologic factors|mesh-ancestor
56369266|NCT00421096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369267|NCT00089063|Sargramostim|sargramostim|mesh-list
56369268|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56369269|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
56369270|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
56215302|NCT01618006|Aspirin|aspirin|mesh-list
56369271|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369272|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56369273|NCT00333931|Phenytoin|phenytoin|mesh-list
56369274|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
56369275|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56369276|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56369277|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56369278|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369279|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56369280|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56369281|NCT00334048|Ropinirole|ropinirole|mesh-list
56369282|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56369283|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56369284|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
56369286|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369287|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369288|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369289|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56369290|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56369291|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
56369292|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56369293|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56369294|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56369295|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369296|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369297|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56369298|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56369299|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
56369300|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369301|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171770|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
56369302|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56369303|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56369304|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
56369305|NCT00089219|Sargramostim|sargramostim|mesh-list
56369306|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
56369308|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369309|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56369311|NCT00334321|Carboplatin|carboplatin|mesh-list
56369312|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56369313|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369314|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
56369315|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
56369316|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
56369317|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369318|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
56369319|NCT00334360|Buspirone|buspirone|mesh-list
56369320|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56369321|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369322|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369323|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56369324|NCT00334360|Analgesics|analgesics|mesh-ancestor
56369325|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
56369326|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369327|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56369328|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56369329|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56369330|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
56369331|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369332|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369333|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56369334|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56369335|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56369336|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56369337|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
56369338|NCT00334399|Miglitol|miglitol|mesh-list
56369339|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369340|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369341|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56369342|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369343|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56369344|NCT00334438|Rituximab|rituximab|mesh-list
56652574|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652575|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55772427|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369345|NCT00334438|Bortezomib|bortezomib|mesh-list
56369346|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56369347|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56369348|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369349|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
56369350|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369351|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369352|NCT00334477|Tadalafil|tadalafil|mesh-list
56369353|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
56369354|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56369355|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56369356|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369357|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369358|NCT00334477|Urological Agents|urological agents|mesh-ancestor
56369360|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56369361|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369362|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369363|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56369364|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56369365|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56369366|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
56369367|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
56369368|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171776|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
56369369|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369370|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56369371|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56369372|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369373|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
56369374|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369376|NCT00089258|Antibodies|antibodies|mesh-list
56369377|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56369378|NCT00089258|Sargramostim|sargramostim|mesh-list
56369379|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
56369380|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369381|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
56369385|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
56369386|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369387|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369389|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369390|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369391|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369392|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56369393|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56369394|NCT00334672|Cyclosporine|cyclosporine|mesh-list
56369395|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
56369396|NCT00334672|Dexamethasone|dexamethasone|mesh-list
56369397|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
56369398|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56369399|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56369400|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56369401|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
56369402|NCT00334672|Busulfan|busulfan|mesh-list
56369403|NCT00334672|Methotrexate|methotrexate|mesh-list
56369404|NCT00334672|Etoposide|etoposide|mesh-list
56369405|NCT00334672|Cyclosporins|cyclosporins|mesh-list
56369406|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56369407|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369408|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
56369409|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369410|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369411|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56369412|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
56369413|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369414|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369415|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56369416|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369417|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
56369418|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
56369419|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652576|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55772505|NCT02437825|Octreotide|octreotide|mesh-list
56369420|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369421|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
56369422|NCT00334672|Hormones|hormones|mesh-ancestor
56369423|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369424|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56369425|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56369426|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
56369427|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56369428|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56369429|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
56369430|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
56369431|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369432|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56165338|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
56369433|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56369434|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56369435|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56369436|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56369437|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
56369438|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369439|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56369440|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56369441|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56369442|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
56369443|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56369445|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
56369447|NCT00089453|Fludarabine|fludarabine|mesh-list
56369448|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369449|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
56369450|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369451|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369452|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56369453|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
56369454|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369460|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369461|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369462|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
56369463|NCT00089453|Hormones|hormones|mesh-ancestor
56369464|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369465|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56369466|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
56369467|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56369468|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56369469|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369470|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55991317|NCT00375622|Tamoxifen|tamoxifen|mesh-list
56369471|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56369472|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
56369473|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369474|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
56369475|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
56369476|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
56369477|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56369478|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56369479|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369480|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369481|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369482|NCT00334789|Vitamin A|vitamin a|mesh-list
56369483|NCT00334789|Tretinoin|tretinoin|mesh-list
56369484|NCT00334789|Belinostat|belinostat|mesh-list
56369485|NCT00334789|Isotretinoin|isotretinoin|mesh-list
56369486|NCT00334789|Vitamins|vitamins|mesh-ancestor
56369487|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
56369488|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369489|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369490|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
56369491|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
56369492|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369493|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56369494|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652577|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
56215306|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
56369495|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
56369496|NCT00334867|Ifosfamide|ifosfamide|mesh-list
56369497|NCT00334867|Doxorubicin|doxorubicin|mesh-list
56369498|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56369499|NCT00334867|Etoposide|etoposide|mesh-list
56369500|NCT00334867|Vincristine|vincristine|mesh-list
56369501|NCT00334867|Topotecan|topotecan|mesh-list
56369502|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
56369503|NCT00334867|Razoxane|razoxane|mesh-list
56369504|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369505|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
56369506|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369507|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165339|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369508|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56369509|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
56369510|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369511|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369512|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56369513|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56369514|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56369515|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56369516|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369517|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56369518|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
56369519|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
56369520|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
56369521|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56369522|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56369523|NCT00334867|Protective Agents|protective agents|mesh-ancestor
56369524|NCT04715152|Dexamethasone|dexamethasone|mesh-list
56369525|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
56369531|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369532|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369533|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369534|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
56369535|NCT04715152|Hormones|hormones|mesh-ancestor
56369536|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369537|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56369538|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369539|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
56369540|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369541|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369542|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
56369543|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
56369544|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369545|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
56369546|NCT00334906|Memantine|memantine|mesh-list
56369547|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56369548|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56369549|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
56369550|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369551|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369552|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369553|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56369554|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56369555|NCT00089570|Terlipressin|terlipressin|mesh-list
56369556|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56369557|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56369558|NCT00342862|Alefacept|alefacept|mesh-list
56369559|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
56369560|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
56369561|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369562|NCT00089687|Vanoxerine|vanoxerine|mesh-list
56369563|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56369564|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56369565|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56369566|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369567|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
56369568|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369569|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369570|NCT00127764|Dexamethasone|dexamethasone|mesh-list
56652578|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652579|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652580|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56652581|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652582|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
56652583|NCT02684708|Hormones|hormones|mesh-ancestor
56652584|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56652585|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56652586|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56652587|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56298643|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
56652588|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56652589|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56652590|NCT02817503|Folic Acid|folic acid|mesh-list
56652591|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
56652592|NCT02817503|Amlodipine|amlodipine|mesh-list
56652593|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56652594|NCT02817503|Enalapril|enalapril|mesh-list
56652595|NCT02817503|Enalaprilat|enalaprilat|mesh-list
56215310|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369571|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369572|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
56369573|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
56369574|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369575|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369576|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369577|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
56369578|NCT00127764|Hormones|hormones|mesh-ancestor
56369579|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369580|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56369581|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369582|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
56369583|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369584|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
56369585|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369586|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369587|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56369588|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
56369589|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369590|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369591|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56369592|NCT00343096|Lorazepam|lorazepam|mesh-list
56369593|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
56369594|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
56369595|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
56369596|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369597|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369601|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56369602|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56369603|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56369604|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
56369605|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
56369606|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369607|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369608|NCT00335179|Imiquimod|imiquimod|mesh-list
56369609|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56369610|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
56652596|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56652597|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56369611|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369612|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369613|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
56369614|NCT00089765|Ranibizumab|ranibizumab|mesh-list
56369615|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56369616|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56369617|NCT00089765|Growth Substances|growth substances|mesh-ancestor
56369618|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369619|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
56369620|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369621|NCT00343135|Amoxicillin|amoxicillin|mesh-list
56369622|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
56369623|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
56369624|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56369625|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56369626|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369627|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56369628|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369629|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369630|NCT00343174|Ancrod|ancrod|mesh-list
56369631|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
56369632|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56369633|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56369634|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369635|NCT00343369|Cytarabine|cytarabine|mesh-list
56369636|NCT00343369|Dexamethasone|dexamethasone|mesh-list
56369637|NCT00343369|Prednisolone|prednisolone|mesh-list
56369638|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
56369639|NCT00343369|Doxorubicin|doxorubicin|mesh-list
56369640|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56369641|NCT00343369|Methotrexate|methotrexate|mesh-list
56369642|NCT00343369|Vincristine|vincristine|mesh-list
56369643|NCT00343369|Daunorubicin|daunorubicin|mesh-list
56369644|NCT00343369|Asparaginase|asparaginase|mesh-list
56369645|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
56369646|NCT00343369|Pegaspargase|pegaspargase|mesh-list
56369647|NCT00343369|Thioguanine|thioguanine|mesh-list
56369648|NCT00343369|Teniposide|teniposide|mesh-list
56369649|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369650|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
56369651|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369652|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369653|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56369654|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
56369655|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369656|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369657|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56369658|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369659|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
56369660|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
56369661|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369662|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369663|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
56369664|NCT00343369|Hormones|hormones|mesh-ancestor
56369665|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369666|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56369667|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56369668|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56369669|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56369670|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369671|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56369674|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56369676|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
56369677|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56369678|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56369679|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
56369680|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369681|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56369682|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
56369683|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
56369684|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
56369685|NCT00343408|Leucovorin|leucovorin|mesh-list
56369686|NCT00343408|Gemcitabine|gemcitabine|mesh-list
56369687|NCT00343408|Fluorouracil|fluorouracil|mesh-list
56652598|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652599|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215328|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
56369688|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
56369689|NCT00343408|Cediranib|cediranib|mesh-list
56369690|NCT00343408|Calcium|calcium|mesh-list
56369691|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
56369692|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369693|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56369694|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
56369695|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369696|NCT00343408|Antiviral Agents|antiviral agents|mesh-ancestor
56369697|NCT00343408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369698|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369699|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369700|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
56369701|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369702|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56369703|NCT00343408|Antidotes|antidotes|mesh-ancestor
56369704|NCT00343408|Protective Agents|protective agents|mesh-ancestor
56369705|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
56369706|NCT00343408|Vitamins|vitamins|mesh-ancestor
56369707|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
56369708|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56369709|NCT02958111|Capecitabine|capecitabine|mesh-list
56369710|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56369711|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
56369712|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369713|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369714|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
56369715|NCT00343447|Rituximab|rituximab|mesh-list
56369716|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369717|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
56369718|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369719|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369720|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56369721|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
56369722|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369723|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369724|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56369725|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56369726|NCT00343486|Solabegron|solabegron|mesh-list
56369727|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56369728|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56369729|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56369730|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
56369731|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369732|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369733|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369735|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369736|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
56369737|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369738|NCT00343525|Bavituximab|bavituximab|mesh-list
56369739|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56369740|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369741|NCT00127881|Zanolimumab|zanolimumab|mesh-list
56369742|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56369743|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369744|NCT00343720|Bortezomib|bortezomib|mesh-list
56369745|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369746|NCT00343759|Lapatinib|lapatinib|mesh-list
56369751|NCT00127920|Bevacizumab|bevacizumab|mesh-list
56369752|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56369753|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369754|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56369755|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56369756|NCT00127920|Growth Substances|growth substances|mesh-ancestor
56369757|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369758|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
56369759|NCT00343798|Cyclosporine|cyclosporine|mesh-list
56369760|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
56369761|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
56369762|NCT00343798|Fludarabine|fludarabine|mesh-list
56652600|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56652601|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652602|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
56652603|NCT02817503|Diuretics|diuretics|mesh-ancestor
56369763|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
56369764|NCT00343798|Cyclosporins|cyclosporins|mesh-list
56369765|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369766|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
56369767|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369768|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369769|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56369770|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
56369771|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369772|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369773|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56369774|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56369775|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
56369776|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369777|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
56369778|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369779|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
56369780|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56369781|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56369782|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56369783|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
56369784|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56369785|NCT00343876|Aspirin|aspirin|mesh-list
56369786|NCT00343876|Clopidogrel|clopidogrel|mesh-list
56369787|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56369788|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56369789|NCT00343876|Analgesics|analgesics|mesh-ancestor
56369790|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
56369791|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369792|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369793|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369794|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369795|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56369796|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56369797|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369798|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56369799|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56369800|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369801|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
56369802|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56369803|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56369804|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56369805|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
56369806|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369807|NCT00402636|Sirolimus|sirolimus|mesh-list
56369808|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56369809|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369810|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56369811|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369812|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
56369813|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56369814|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
56369815|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369817|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56369820|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369821|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369822|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
56369823|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56369824|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369825|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369826|NCT00344227|Ranibizumab|ranibizumab|mesh-list
56369827|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56369828|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56369829|NCT00344227|Growth Substances|growth substances|mesh-ancestor
56369830|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369831|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
56652604|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
56652605|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56652606|NCT02817503|Hematinics|hematinics|mesh-ancestor
56652607|NCT02817503|Vitamins|vitamins|mesh-ancestor
56369832|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369833|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56369834|NCT00344383|Norgestimate|norgestimate|mesh-list
56369835|NCT00344383|Estradiol|estradiol|mesh-list
56369836|NCT00344383|Estrogens|estrogens|mesh-ancestor
56369837|NCT00344383|Hormones|hormones|mesh-ancestor
56369838|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369839|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369840|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56369841|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
56369842|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56369843|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56369844|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56369845|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56369846|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56369847|NCT00344422|Dexamethasone|dexamethasone|mesh-list
56369848|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
56369849|NCT00344422|Doxorubicin|doxorubicin|mesh-list
55991695|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
56369850|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56369851|NCT00344422|Vincristine|vincristine|mesh-list
56369852|NCT00344422|BB 1101|bb 1101|mesh-list
56369853|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369855|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
56369856|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369857|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369858|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369859|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
56369860|NCT00344422|Hormones|hormones|mesh-ancestor
56369861|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369862|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56369863|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369864|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
56369865|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369866|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369867|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56369868|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56369869|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56369870|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56369871|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
56369872|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
56369873|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
56369874|NCT00090038|Rituximab|rituximab|mesh-list
56369875|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56369876|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369878|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369879|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369880|NCT00402792|Acetaminophen|acetaminophen|mesh-list
56369881|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56369882|NCT00402792|Hydrocodone|hydrocodone|mesh-list
56369883|NCT00402792|Oxycodone|oxycodone|mesh-list
56369884|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56369885|NCT00402792|Analgesics|analgesics|mesh-ancestor
56369886|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
56369887|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56369888|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369889|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
56369890|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56369891|NCT00402792|Narcotics|narcotics|mesh-ancestor
56369892|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369896|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369897|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369898|NCT00127959|Tenofovir|tenofovir|mesh-list
56369899|NCT00127959|Zidovudine|zidovudine|mesh-list
56369900|NCT00127959|Emtricitabine|emtricitabine|mesh-list
56369901|NCT00127959|Efavirenz|efavirenz|mesh-list
56369902|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
56369903|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369904|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56369905|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56652608|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
56652609|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56652610|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
56652611|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652612|NCT02814461|Axitinib|axitinib|mesh-list
56652613|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369906|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369907|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369908|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56369909|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56369910|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
56369911|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56369912|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56369913|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56369914|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56369915|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56369916|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56369917|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56369918|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56369919|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
56369920|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369921|NCT00344539|Antacids|antacids|mesh-ancestor
56369922|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369923|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369924|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56369925|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56369926|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369927|NCT00344617|Bevacizumab|bevacizumab|mesh-list
56369928|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56369929|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369930|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56369931|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56369932|NCT00344617|Growth Substances|growth substances|mesh-ancestor
56369933|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369934|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
56369936|NCT00127998|Chloroquine|chloroquine|mesh-list
56369937|NCT00127998|Lumefantrine|lumefantrine|mesh-list
56369938|NCT00127998|Artemether|artemether|mesh-list
56369939|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
56369940|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
56369941|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56369942|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56369943|NCT00127998|Amodiaquine|amodiaquine|mesh-list
56369945|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
56369946|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56369947|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56369948|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56369949|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369950|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
56369951|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
56369952|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56369953|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
56369954|NCT00127998|Amebicides|amebicides|mesh-ancestor
56369955|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56369956|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56369957|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369958|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369959|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56369960|NCT00127998|Renal Agents|renal agents|mesh-ancestor
56369961|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
56369962|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56369963|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56369964|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369967|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369968|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369969|NCT00344695|Bupropion|bupropion|mesh-list
56369970|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56652614|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56652615|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652616|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652617|NCT00875667|Fludarabine|fludarabine|mesh-list
56652618|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
56369971|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
56369972|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56369973|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56369974|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56369975|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56369976|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369977|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
56369978|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56369979|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369980|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56369981|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56369982|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369983|NCT00128037|Mitomycins|mitomycins|mesh-list
56369984|NCT00128037|Mitomycin|mitomycin|mesh-list
56369985|NCT00128037|Vindesine|vindesine|mesh-list
56369986|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369987|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56369988|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
56369989|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369990|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56369991|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369992|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56369993|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
56369994|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
56369995|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
56369996|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56369997|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369998|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369999|NCT00344812|Buprenorphine|buprenorphine|mesh-list
56370000|NCT00344812|Methadone|methadone|mesh-list
56370001|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56370002|NCT00344812|Narcotics|narcotics|mesh-ancestor
56370003|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370004|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370005|NCT00344812|Analgesics|analgesics|mesh-ancestor
56370006|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
56370007|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370008|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56370009|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
56370010|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
56370011|NCT00344851|Metformin|metformin|mesh-list
56370012|NCT00344851|Exenatide|exenatide|mesh-list
56370013|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56370014|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370015|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56370016|NCT00344851|Incretins|incretins|mesh-ancestor
56370017|NCT00344851|Hormones|hormones|mesh-ancestor
56370018|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56370019|NCT00090155|Ondansetron|ondansetron|mesh-list
56370020|NCT00090155|Aprepitant|aprepitant|mesh-list
56370021|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
56370022|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
56370023|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370024|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370025|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56370026|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
56370027|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
56370028|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56370029|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
56370030|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370031|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370032|NCT00090155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56370033|NCT00090155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370034|NCT00090155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370035|NCT00090155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56652619|NCT00875667|Lenalidomide|lenalidomide|mesh-list
56652620|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652621|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56370036|NCT00090155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56370037|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56370038|NCT00335413|Spironolactone|spironolactone|mesh-list
56370040|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
56370041|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56370042|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370043|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56370044|NCT00335413|Diuretics|diuretics|mesh-ancestor
56370045|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
56370046|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
56370047|NCT00090194|Antibodies|antibodies|mesh-list
56370048|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
56370049|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56370050|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56370051|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
56370052|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370053|NCT00345163|Bevacizumab|bevacizumab|mesh-list
56370054|NCT00345163|Irinotecan|irinotecan|mesh-list
56370055|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370056|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370057|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56370058|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56370059|NCT00345163|Growth Substances|growth substances|mesh-ancestor
56370060|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370061|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
56370062|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56370063|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56370064|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370065|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370066|NCT00345202|Atorvastatin|atorvastatin|mesh-list
56370067|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56370068|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56370069|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
56370070|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370071|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56370072|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56370073|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370074|NCT00335647|Fluphenazine|fluphenazine|mesh-list
56370075|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
56370076|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
56370077|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56370078|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370079|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370080|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370081|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370082|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56370083|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
56370084|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370085|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370086|NCT00128154|Chromium|chromium|mesh-list
56370087|NCT00128154|Picolinic acid|picolinic acid|mesh-list
56370088|NCT00128154|Trace Elements|trace elements|mesh-ancestor
56370089|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
56370090|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370091|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56370092|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
56370093|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
56370094|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370095|NCT00335686|Lopinavir|lopinavir|mesh-list
56370096|NCT00335686|Nevirapine|nevirapine|mesh-list
56370097|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56370098|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56370099|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
56370100|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370101|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370102|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56370103|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56370104|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
56370105|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370106|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56652622|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
56652623|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652624|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652625|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
56652626|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652627|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56652628|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56370107|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56370108|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56370109|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56370110|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55884050|NCT02510976|Prucalopride|prucalopride|mesh-list
56370120|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370121|NCT00090272|Ertapenem|ertapenem|mesh-list
56370122|NCT00090272|Cefotetan|cefotetan|mesh-list
56370123|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56370124|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370125|NCT00345787|Buprenorphine|buprenorphine|mesh-list
56370126|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56370127|NCT00345787|Narcotics|narcotics|mesh-ancestor
56370128|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370129|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370130|NCT00345787|Analgesics|analgesics|mesh-ancestor
56370131|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
56370132|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370133|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56370134|NCT00128271|Bavituximab|bavituximab|mesh-list
56370135|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370136|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370137|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56370138|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
56370139|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370140|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56370141|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370142|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370143|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370144|NCT02959762|Vitamins|vitamins|mesh-list
56370145|NCT02959762|Vitamin K|vitamin k|mesh-list
56370146|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
56370147|NCT02959762|Vitamin MK 7|vitamin mk 7|mesh-list
56370148|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
56370149|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991998|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
56370150|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56370151|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56370152|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370153|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
56370154|NCT02959762|Coagulants|coagulants|mesh-ancestor
56370156|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370157|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56370158|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370159|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370160|NCT00345982|Sertindole|sertindole|mesh-list
56370161|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56370162|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370163|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370164|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370165|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370166|NCT00346099|Capecitabine|capecitabine|mesh-list
56370167|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
56370168|NCT00346099|Panitumumab|panitumumab|mesh-list
56370169|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56370170|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
56370171|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370172|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370173|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370174|NCT00125736|Rabeprazole|rabeprazole|mesh-list
56370175|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56652629|NCT00875667|Growth Substances|growth substances|mesh-ancestor
56652630|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
56652631|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56652632|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56370176|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56370177|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56370178|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370179|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370184|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
56370185|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370186|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370187|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56370188|NCT00346294|Etanercept|etanercept|mesh-list
56370189|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56370190|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56370191|NCT00346294|Analgesics|analgesics|mesh-ancestor
56370192|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
56370193|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370194|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370195|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56370196|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370197|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56370198|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56370199|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
56370200|NCT00346489|Fluorouracil|fluorouracil|mesh-list
56370201|NCT00346489|Mitomycins|mitomycins|mesh-list
56370202|NCT00346489|Mitomycin|mitomycin|mesh-list
56370203|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
56370204|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370205|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56370206|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370207|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56370208|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
56370209|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370210|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56370211|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
56370212|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56370213|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370214|NCT00125814|Interferons|interferons|mesh-list
56370215|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
56370216|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
56370217|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370218|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
56370219|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370220|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
56370221|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370222|NCT00346567|Tenofovir|tenofovir|mesh-list
56370223|NCT00346567|Lamivudine|lamivudine|mesh-list
56370224|NCT00346567|Zidovudine|zidovudine|mesh-list
56370225|NCT00346567|Emtricitabine|emtricitabine|mesh-list
56370226|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56370227|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56370228|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
56370229|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370230|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56370231|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56370232|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370233|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370234|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56370235|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56370236|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
56370237|NCT00090623|Ranibizumab|ranibizumab|mesh-list
56370238|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56370239|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56370240|NCT00090623|Growth Substances|growth substances|mesh-ancestor
56370241|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370242|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
56370243|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370244|NCT02957994|Tenofovir|tenofovir|mesh-list
56370245|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
56370246|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370247|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56652633|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652634|NCT02811341|Scopolamine|scopolamine|mesh-list
56652635|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56370248|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56370249|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370250|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370253|NCT00346645|Bortezomib|bortezomib|mesh-list
56370254|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370255|NCT00346684|Rituximab|rituximab|mesh-list
56370256|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370257|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370259|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370260|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370261|NCT04728932|Simendan|simendan|mesh-list
56370262|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56370263|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
56370264|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56370265|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56370266|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370267|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370268|NCT04728932|Protective Agents|protective agents|mesh-ancestor
56370269|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370270|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56370271|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56370272|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56370273|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56370274|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370275|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370276|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370277|NCT00125892|Analgesics|analgesics|mesh-ancestor
56370278|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
56370279|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370280|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
56370281|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370282|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
56370283|NCT00346801|Celecoxib|celecoxib|mesh-list
56370284|NCT00346801|Cisplatin|cisplatin|mesh-list
56370285|NCT00346801|Irinotecan|irinotecan|mesh-list
56370286|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370287|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56370288|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56370289|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370290|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370291|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56370292|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56370293|NCT00346801|Analgesics|analgesics|mesh-ancestor
56370294|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
56370295|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370296|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370297|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56370298|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370299|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56370300|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56370301|NCT00346840|Misoprostol|misoprostol|mesh-list
56370302|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56370304|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56370305|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370307|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56370308|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
56370310|NCT00346879|Fondaparinux|fondaparinux|mesh-list
56370311|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56370312|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
56370313|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56370314|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
56370315|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370316|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370317|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
56370318|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56370319|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56370320|NCT00126009|Amisulpride|amisulpride|mesh-list
56652636|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56652637|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
56652638|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
56652639|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652640|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215356|NCT01618448|Tolvaptan|tolvaptan|mesh-list
56370321|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56370322|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370323|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370324|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370325|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370326|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56370330|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56370331|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
56370332|NCT00346918|Sirolimus|sirolimus|mesh-list
56370333|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56370334|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370335|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56370336|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370337|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
56370338|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56370339|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
56370340|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370341|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
56370342|NCT00346957|Anecortave|anecortave|mesh-list
56370343|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56370344|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56370345|NCT00346957|Growth Substances|growth substances|mesh-ancestor
56370346|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370347|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
56370348|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370349|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56370350|NCT00346996|Insulin|insulin|mesh-list
56370351|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56370352|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
56370353|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
56370354|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
56370355|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
56370356|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56370357|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370358|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
56370359|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370360|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
56370361|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370362|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370363|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56370364|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56370365|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56370366|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56370367|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56370368|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56370369|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
56370370|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370371|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370372|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370373|NCT00347113|Albendazole|albendazole|mesh-list
56370374|NCT00347113|Praziquantel|praziquantel|mesh-list
56370375|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
56370376|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56370377|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370378|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
56370379|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56370380|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56370381|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
56370382|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
56370383|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
56370384|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370385|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370386|NCT00347152|Valproic Acid|valproic acid|mesh-list
56370387|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
56370388|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652641|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56652642|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
56652643|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56652644|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
56652645|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773447|NCT02440243|Vaccines|vaccines|mesh-list
56370389|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370390|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
56370391|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370392|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370393|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
56370394|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370395|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370396|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370398|NCT00090896|Antibodies|antibodies|mesh-list
56370399|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56370400|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
56370405|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370406|NCT00402558|Aldesleukin|aldesleukin|mesh-list
56370407|NCT00402558|Methotrexate|methotrexate|mesh-list
56370408|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
56370409|NCT00402558|Fludarabine|fludarabine|mesh-list
56370410|NCT00402558|Busulfan|busulfan|mesh-list
56370411|NCT00402558|Interleukin-2|interleukin-2|mesh-list
56370412|NCT00402558|Tacrolimus|tacrolimus|mesh-list
56370413|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
56370414|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56370415|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56370416|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
56370417|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56370418|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370419|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56370420|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
56370421|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370422|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370423|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
56370424|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370425|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56370426|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56370427|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
56370428|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370429|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56370430|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
56370431|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370432|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56370433|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
56370434|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56370435|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56370436|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56370437|NCT00402558|Analgesics|analgesics|mesh-ancestor
56370438|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
56370439|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370440|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56370441|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56370442|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
56370443|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370444|NCT00347386|Astringents|astringents|mesh-ancestor
56370445|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
56370446|NCT00347425|Olanzapine|olanzapine|mesh-list
56370447|NCT00347425|Risperidone|risperidone|mesh-list
56370448|NCT00347425|Aripiprazole|aripiprazole|mesh-list
56370449|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56370450|NCT00347425|Ziprasidone|ziprasidone|mesh-list
56370451|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56370452|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
56370453|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370454|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370455|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370456|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56370457|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370458|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370459|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56652646|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652647|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56215361|NCT01618474|Docetaxel|docetaxel|mesh-list
56370460|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56370461|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
56370462|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
56370463|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
56370464|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370465|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56370466|NCT00347425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56370467|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56370468|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56370469|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
56370470|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
56370471|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56370472|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56370485|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
56370486|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
56370487|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370488|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370489|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
56370490|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370491|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370492|NCT00126087|Protective Agents|protective agents|mesh-ancestor
56370493|NCT00347503|Ketorolac|ketorolac|mesh-list
56370494|NCT00347503|Bromfenac|bromfenac|mesh-list
56370495|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56370496|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56370497|NCT00347503|Analgesics|analgesics|mesh-ancestor
56370498|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
56370499|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370500|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370501|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56370502|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370503|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56370504|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370505|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370506|NCT00347542|Vitamin D|vitamin d|mesh-list
56370507|NCT00347542|Vitamins|vitamins|mesh-ancestor
56370508|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
56370509|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370510|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56370511|NCT00091052|Sargramostim|sargramostim|mesh-list
56370512|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
56370513|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370514|NCT00347581|Methamphetamine|methamphetamine|mesh-list
56370515|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56370516|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370517|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
56370518|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
56370519|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370520|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
56370521|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370522|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370523|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
56370524|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56370525|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56370526|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56370527|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56370528|NCT00421252|Clopidogrel|clopidogrel|mesh-list
56370529|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56370530|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56370531|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56370532|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56370533|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
56370544|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56370545|NCT04705402|Diuretics|diuretics|mesh-ancestor
56370546|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
56370547|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370548|NCT00091130|Vaccines|vaccines|mesh-list
56370549|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
56652648|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
56652649|NCT00682383|Docetaxel|docetaxel|mesh-list
56652650|NCT00682383|Etoposide|etoposide|mesh-list
56652651|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652652|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
56652653|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
56652654|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
56652655|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652656|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56652657|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56652658|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56652659|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652660|NCT04237493|Insulin|insulin|mesh-list
56652661|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56652662|NCT04237493|Metformin|metformin|mesh-list
56298716|NCT02706873|Methotrexate|methotrexate|mesh-list
56652663|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
56652665|NCT04237493|Vildagliptin|vildagliptin|mesh-list
56370550|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370551|NCT00126243|Rituximab|rituximab|mesh-list
56370552|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370553|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370554|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
56370555|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370556|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370557|NCT00426439|Chloroquine|chloroquine|mesh-list
56370558|NCT00426439|Lumefantrine|lumefantrine|mesh-list
56370559|NCT00426439|Artemether|artemether|mesh-list
56370560|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56370561|NCT00426439|Amebicides|amebicides|mesh-ancestor
56370562|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56370563|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56370564|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370565|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
56370566|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370567|NCT00426478|Amlodipine|amlodipine|mesh-list
56370568|NCT00426478|Valsartan|valsartan|mesh-list
56370569|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56370570|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56370571|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56370572|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56370573|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370574|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56370575|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370576|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
56370577|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56370578|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56370579|NCT00426478|Diuretics|diuretics|mesh-ancestor
56370580|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
56370581|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56370582|NCT04705519|Paclitaxel|paclitaxel|mesh-list
56370583|NCT04705519|Bevacizumab|bevacizumab|mesh-list
56370584|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56370585|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370586|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
56370587|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
56370588|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
56370589|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370590|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370591|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56652666|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56652667|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652668|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56652669|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652670|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
56652671|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56652672|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
56652673|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652674|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652675|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
56652676|NCT00683319|Carboplatin|carboplatin|mesh-list
56370592|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56370594|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370595|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
56370596|NCT00126282|Cycloserine|cycloserine|mesh-list
56370597|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56370598|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370599|NCT00126282|Renal Agents|renal agents|mesh-ancestor
56370600|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56370602|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56370603|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
56370604|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370605|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
56370606|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370607|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56370608|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370609|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370610|NCT00126321|Cladribine|cladribine|mesh-list
56370611|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370612|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56370613|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
56370614|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370615|NCT00426595|Omeprazole|omeprazole|mesh-list
56370616|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56370617|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56370618|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56370619|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370620|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370621|NCT00426673|Brivaracetam|brivaracetam|mesh-list
56370622|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
56370623|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
56370624|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56370625|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
56370626|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370627|NCT00091247|Tetracycline|tetracycline|mesh-list
56370628|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56370629|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370630|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56370631|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370632|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370633|NCT00126360|Anastrozole|anastrozole|mesh-list
56370634|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56370635|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370636|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56370637|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56370638|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370639|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370640|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56370641|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
56370642|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56370643|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370644|NCT01058863|Albuterol|albuterol|mesh-list
56370645|NCT01058863|Procaterol|procaterol|mesh-list
56652677|NCT00683319|Methotrexate|methotrexate|mesh-list
56652678|NCT00683319|Vincristine|vincristine|mesh-list
56652679|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652680|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
56652681|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652682|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652683|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56652684|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
56652685|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652686|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652687|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56652688|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56652689|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
56652690|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56652691|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56652692|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
56652693|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
56652694|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652695|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56215369|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
56370646|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56370647|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
56370648|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370649|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370650|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56370651|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
56370652|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
56370653|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56370654|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56370655|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56370656|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56370657|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
56370658|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370659|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370660|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
56370661|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56370662|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56370663|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
56171831|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
56370664|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370665|NCT00126399|Doxycycline|doxycycline|mesh-list
56370666|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56370667|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370668|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
56370669|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56370670|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56370671|NCT01058395|Minocycline|minocycline|mesh-list
56370672|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56370673|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370676|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370677|NCT00091325|Protective Agents|protective agents|mesh-ancestor
56370678|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370679|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56370680|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56370681|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652696|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56652697|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56652698|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
56652699|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
56652700|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
56652701|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56652702|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56652703|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56652704|NCT02810483|Topiramate|topiramate|mesh-list
56652705|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
56652706|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56652707|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652708|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
56652709|NCT00683865|Ofloxacin|ofloxacin|mesh-list
56652710|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56652711|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56652712|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652713|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56652714|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56652715|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215372|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56370682|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56370685|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56370686|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
56370687|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56370688|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56370689|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370690|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56370691|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56370692|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
56370693|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56370694|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
56370695|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370697|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370698|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370699|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56370700|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370701|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56370702|NCT01058005|Interferons|interferons|mesh-list
56370703|NCT01058005|Interferon-beta|interferon-beta|mesh-list
56370704|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
56370705|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
56370706|NCT01058005|Natalizumab|natalizumab|mesh-list
56370707|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
56370708|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370709|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
56370710|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370711|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
56370712|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370713|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56370714|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56370715|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370716|NCT00091559|Vorinostat|vorinostat|mesh-list
56370717|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652716|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652717|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652718|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56652719|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
56652720|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56652721|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652722|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56652723|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56652724|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56652725|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56652726|NCT00683865|Renal Agents|renal agents|mesh-ancestor
56652727|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56652728|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56652729|NCT02813369|Naloxegol|naloxegol|mesh-list
56370718|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56370719|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370720|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370721|NCT00426829|Bevacizumab|bevacizumab|mesh-list
56370722|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370723|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370724|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56370725|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56370726|NCT00426829|Growth Substances|growth substances|mesh-ancestor
56370727|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370728|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
56370729|NCT00426946|Reboxetine|reboxetine|mesh-list
56370730|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
56370731|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370732|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56370733|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56370734|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56370735|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370736|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
56370737|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370738|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370739|NCT00091598|Ambrisentan|ambrisentan|mesh-list
56370740|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56370741|NCT00426985|Ketoprofen|ketoprofen|mesh-list
56370742|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56370743|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56370744|NCT00426985|Analgesics|analgesics|mesh-ancestor
56370745|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
56370746|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370747|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370756|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370757|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56370758|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370759|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56370760|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56370761|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370762|NCT03929718|Spironolactone|spironolactone|mesh-list
56370763|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56370764|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
56370765|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56370766|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370767|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56370768|NCT03929718|Diuretics|diuretics|mesh-ancestor
56652730|NCT02813369|Laxatives|laxatives|mesh-list
56652731|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56652732|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652733|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
56652734|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652735|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56652736|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
56652737|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
56652738|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56652739|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652740|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652741|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
56652742|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56215381|NCT01618591|Azithromycin|azithromycin|mesh-list
56370769|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
56370770|NCT01056523|Cytarabine|cytarabine|mesh-list
56370771|NCT01056523|Ribavirin|ribavirin|mesh-list
56370772|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56370773|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
56370774|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370775|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370776|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
56370777|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370778|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56370779|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
56370780|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370781|NCT00091715|Bosentan|bosentan|mesh-list
56370782|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56370783|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56370784|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370785|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
56370786|NCT00427492|Antacids|antacids|mesh-ancestor
56370787|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370788|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56370789|NCT00427570|Fluorouracil|fluorouracil|mesh-list
56370790|NCT00427570|Vincristine|vincristine|mesh-list
56370791|NCT00427570|Semustine|semustine|mesh-list
56370792|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
56370793|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
56370794|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370795|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56370796|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370797|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56370798|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
56370799|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370800|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56370801|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
56370802|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
56370803|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
56370804|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56370805|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56370806|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
56370807|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56370808|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56370809|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370810|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
56370811|NCT00091910|Hematinics|hematinics|mesh-ancestor
56370812|NCT00427882|Alfuzosin|alfuzosin|mesh-list
56370813|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55884761|NCT00708162|Elvitegravir|elvitegravir|mesh-list
56370825|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370826|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652743|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652744|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652745|NCT05633147|Clarithromycin|clarithromycin|mesh-list
56652746|NCT05633147|Midazolam|midazolam|mesh-list
56652747|NCT05633147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56652748|NCT05633147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56652749|NCT05633147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652750|NCT05633147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652751|NCT05633147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56652752|NCT05633147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56652753|NCT05633147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56652754|NCT05633147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56652755|NCT05633147|Anesthetics, General|anesthetics, general|mesh-ancestor
56652756|NCT05633147|Anesthetics|anesthetics|mesh-ancestor
56652757|NCT05633147|GABA Modulators|gaba modulators|mesh-ancestor
56652758|NCT05633147|GABA Agents|gaba agents|mesh-ancestor
56370827|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56370828|NCT04704622|Analgesics|analgesics|mesh-ancestor
56370829|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
56370830|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370831|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56370832|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56370833|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56370834|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
56370835|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370836|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370837|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56370838|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56370839|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
56370840|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
56370841|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56370842|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56370843|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56370844|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56370845|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370846|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370847|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
56370848|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
56370849|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56370850|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370851|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56370852|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370853|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370854|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
56370855|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370856|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370857|NCT00092183|Ondansetron|ondansetron|mesh-list
56370858|NCT00092183|Aprepitant|aprepitant|mesh-list
56370859|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
56370860|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
56370861|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370862|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370863|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56370864|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
56370865|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
56370866|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56370867|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
56370868|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370869|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370870|NCT00092183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56652759|NCT05633147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652760|NCT05633147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652761|NCT05633147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56652762|NCT05633147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652763|NCT05633147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56652764|NCT05633147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652765|NCT05633147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56652766|NCT05633147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56652767|NCT02813135|Carboplatin|carboplatin|mesh-list
56652768|NCT02813135|Nivolumab|nivolumab|mesh-list
56652769|NCT02813135|Irinotecan|irinotecan|mesh-list
56652770|NCT02813135|Temozolomide|temozolomide|mesh-list
56652771|NCT02813135|Topotecan|topotecan|mesh-list
56370871|NCT00092183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370872|NCT00092183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370873|NCT00092183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370874|NCT00092183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56370875|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56370876|NCT00428272|Interferons|interferons|mesh-list
56370877|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
56370885|NCT01580254|Latanoprost|latanoprost|mesh-list
56370886|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56370887|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56370888|NCT00428311|Metformin|metformin|mesh-list
56370889|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
56370890|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56370891|NCT00428311|Estradiol|estradiol|mesh-list
56370892|NCT00428311|Cyproterone|cyproterone|mesh-list
56370893|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56370894|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370895|NCT00428311|Estrogens|estrogens|mesh-ancestor
56370896|NCT00428311|Hormones|hormones|mesh-ancestor
56370897|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56370898|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56370899|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
56370900|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56370901|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56370902|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56370903|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56370904|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
56370905|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
56370906|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370907|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56370908|NCT00092300|Valdecoxib|valdecoxib|mesh-list
56370909|NCT00092300|Rofecoxib|rofecoxib|mesh-list
56370910|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56370911|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56370912|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370913|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370914|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56370915|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56370916|NCT00092300|Analgesics|analgesics|mesh-ancestor
56370917|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
56370918|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370919|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370920|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56370921|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370922|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56370923|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
56370924|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56370925|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56370926|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56370927|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56370928|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652772|NCT02813135|Olaparib|olaparib|mesh-list
56652773|NCT02813135|Adavosertib|adavosertib|mesh-list
56652774|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652775|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56652776|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56370929|NCT00428428|Isoproterenol|isoproterenol|mesh-list
56370930|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56370931|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56370932|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
56370933|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370934|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370935|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370936|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56370937|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
56370938|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370939|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56370940|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
56370941|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56370942|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
56370943|NCT00428428|Protective Agents|protective agents|mesh-ancestor
56370945|NCT00092339|Rofecoxib|rofecoxib|mesh-list
55884896|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
56370954|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370955|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370956|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56370957|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370958|NCT00428545|Bevacizumab|bevacizumab|mesh-list
56370959|NCT00428545|Bortezomib|bortezomib|mesh-list
56370960|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370961|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370962|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56370963|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56370964|NCT00428545|Growth Substances|growth substances|mesh-ancestor
56370965|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370966|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
56370967|NCT00092378|Diclofenac|diclofenac|mesh-list
56370968|NCT00092378|Rofecoxib|rofecoxib|mesh-list
56370969|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56370970|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56370971|NCT00092378|Analgesics|analgesics|mesh-ancestor
56370972|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
56370973|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370974|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370975|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56370976|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370977|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56370978|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370979|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370980|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56370981|NCT00092846|Lovastatin|lovastatin|mesh-list
55992833|NCT01929512|Metformin|metformin|mesh-list
56370982|NCT00092846|L 647318|l 647318|mesh-list
56370983|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
56370984|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56370985|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56370986|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
56370987|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370988|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56370989|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56370990|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370991|NCT00092924|Mapatumumab|mapatumumab|mesh-list
56370992|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370993|NCT03705507|Dexamethasone|dexamethasone|mesh-list
56370994|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56370995|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
56370996|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
56370997|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370998|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370999|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371000|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
56371001|NCT03705507|Hormones|hormones|mesh-ancestor
56269007|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56652777|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652778|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56652779|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56652780|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652781|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56652782|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
56652783|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56652784|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
56652785|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56652786|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56652787|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56652788|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652789|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652790|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
56652791|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652792|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652793|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56652794|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652795|NCT02809781|Etanercept|etanercept|mesh-list
56652796|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56652797|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56652798|NCT02809781|Analgesics|analgesics|mesh-ancestor
56371002|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371003|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56371004|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371005|NCT00093002|Fulvestrant|fulvestrant|mesh-list
56371006|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56371007|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371008|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56371009|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56371010|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
56371013|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56371014|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371015|NCT00093158|Anticoagulants|anticoagulants|mesh-list
56371016|NCT00093158|Bivalirudin|bivalirudin|mesh-list
56371017|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
56371018|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56371019|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
56371020|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371021|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371022|NCT03501498|Loperamide|loperamide|mesh-list
56371023|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
56371024|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371025|NCT05561049|Thalidomide|thalidomide|mesh-list
56371026|NCT05561049|Dexamethasone|dexamethasone|mesh-list
56371027|NCT05561049|Bortezomib|bortezomib|mesh-list
56371028|NCT05561049|Daratumumab|daratumumab|mesh-list
56371029|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56371030|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
56371031|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
56371032|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652799|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
56652800|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652801|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652802|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652803|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56652804|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56652805|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652806|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
56652807|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
56652808|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56652809|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652810|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652811|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56652812|NCT02809937|Analgesics|analgesics|mesh-ancestor
56652813|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
56652814|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652815|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56652816|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56652817|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56371033|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371034|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371035|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
56371036|NCT05561049|Hormones|hormones|mesh-ancestor
56371037|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371038|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56371039|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371040|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371041|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
56371042|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
56371043|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56371044|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371045|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56371046|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56371047|NCT05561049|Growth Substances|growth substances|mesh-ancestor
56371048|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
56371049|NCT00424034|Ambrisentan|ambrisentan|mesh-list
56371050|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56371051|NCT05561010|Bupivacaine|bupivacaine|mesh-list
56371052|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
56371053|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
56371054|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371055|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371056|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
56371057|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371058|NCT03448107|Fluorides|fluorides|mesh-list
56371060|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
56371061|NCT03448107|Protective Agents|protective agents|mesh-ancestor
56371062|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371063|NCT00093314|Ofatumumab|ofatumumab|mesh-list
56371064|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371065|NCT00093353|Cefixime|cefixime|mesh-list
56371066|NCT00093353|Irinotecan|irinotecan|mesh-list
56371067|NCT00093353|Temozolomide|temozolomide|mesh-list
56371068|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56371069|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56371070|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914043|NCT04066725|Aspirin|aspirin|mesh-list
56652818|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
56652819|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652820|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652821|NCT02812979|Albuterol|albuterol|mesh-list
56652822|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56652823|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
56652824|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652825|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652826|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56652827|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
56652828|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
56652829|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56652830|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56652831|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56652832|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56652833|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
56652834|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652835|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652836|NCT02809469|Apixaban|apixaban|mesh-list
56652837|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56652838|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
56215433|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
56371071|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371072|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371073|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56371074|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
56371075|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56371076|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371077|NCT00093509|Doxorubicin|doxorubicin|mesh-list
56371078|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56371079|NCT00093509|Ifosfamide|ifosfamide|mesh-list
56371080|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
56371082|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56371083|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371084|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56371085|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55885029|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371094|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
56371095|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371097|NCT05549895|Bupivacaine|bupivacaine|mesh-list
56371098|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56371099|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
56371100|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
56371101|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371102|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371103|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371104|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
56371105|NCT05549895|Hormones|hormones|mesh-ancestor
56371106|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371107|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56371108|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371109|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
56371110|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
56652839|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56652840|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
56652841|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652842|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652843|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
56652844|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
56652845|NCT02809079|Prednisone|prednisone|mesh-list
56652846|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652847|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
56652848|NCT02809079|Hormones|hormones|mesh-ancestor
56652849|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56652850|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652851|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56652852|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371111|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371112|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
56371113|NCT00093587|Cyclosporine|cyclosporine|mesh-list
56371114|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
56371115|NCT00093587|Busulfan|busulfan|mesh-list
56371116|NCT00093587|Cyclosporins|cyclosporins|mesh-list
56371117|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56371118|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371119|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
56371120|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371121|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56371122|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56371123|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
56371124|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371125|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371126|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56371127|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371128|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
56371129|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371130|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
56371131|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56371132|NCT00093626|Sorafenib|sorafenib|mesh-list
56371133|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371134|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371135|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371136|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371137|NCT05543109|Fentanyl|fentanyl|mesh-list
56371138|NCT05543109|Narcotics|narcotics|mesh-list
56371139|NCT05543109|Propofol|propofol|mesh-list
56371140|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56371141|NCT05543109|Ropivacaine|ropivacaine|mesh-list
56371142|NCT05543109|Anesthetics|anesthetics|mesh-list
56371143|NCT05543109|Sevoflurane|sevoflurane|mesh-list
56371144|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
56371145|NCT05543109|Rocuronium|rocuronium|mesh-list
56371146|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56371147|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786710|NCT04305145|Prednisone|prednisone|mesh-list
56371148|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371149|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
56371150|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
56371151|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371152|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56371153|NCT05543109|Analgesics|analgesics|mesh-ancestor
56371154|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55885100|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371164|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371165|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371166|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
56652853|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56652854|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55774255|NCT02423083|Guanabenz|guanabenz|mesh-list
56371167|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371168|NCT00093704|Ganciclovir|ganciclovir|mesh-list
56371169|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56371171|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371172|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
56371173|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371174|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56371175|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371176|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371177|NCT01055314|Dactinomycin|dactinomycin|mesh-list
56371178|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
56371179|NCT01055314|Temozolomide|temozolomide|mesh-list
56371180|NCT01055314|Ifosfamide|ifosfamide|mesh-list
56371181|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
56371182|NCT01055314|Doxorubicin|doxorubicin|mesh-list
56371183|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56371184|NCT01055314|Irinotecan|irinotecan|mesh-list
56371185|NCT01055314|Etoposide|etoposide|mesh-list
56371186|NCT01055314|Vincristine|vincristine|mesh-list
56371187|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
56371188|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
56371189|NCT01055314|Camptothecin|camptothecin|mesh-list
56371190|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56371191|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371192|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
56371193|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371194|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56371195|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56371196|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
56371197|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371198|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371199|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56371200|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56371201|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56371202|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56371203|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371204|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56371205|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55993052|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371206|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
56371207|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
56371208|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
56371209|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
56371210|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
56371211|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56371212|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371213|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56371214|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56371215|NCT00093743|Cyclosporine|cyclosporine|mesh-list
56371216|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
56371217|NCT00093743|Fludarabine|fludarabine|mesh-list
56371218|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
56371219|NCT00093743|Cyclosporins|cyclosporins|mesh-list
56371220|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371235|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
56371236|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56371237|NCT00400322|Valganciclovir|valganciclovir|mesh-list
56371238|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
56371239|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371240|NCT00093860|Propranolol|propranolol|mesh-list
56371241|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56371242|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56371243|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
56371244|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371245|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371246|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371247|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56371248|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56371249|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
56371250|NCT00402909|Nateglinide|nateglinide|mesh-list
56371251|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56371252|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652855|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
56652856|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56652857|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652858|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652859|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652860|NCT02812199|Lidocaine|lidocaine|mesh-list
56652861|NCT02812199|Epinephrine|epinephrine|mesh-list
56652862|NCT02812199|Racepinephrine|racepinephrine|mesh-list
56652863|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
56652864|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
56652865|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
56652866|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56652867|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652868|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
56652869|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652870|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56652871|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56652872|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56652873|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652874|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652875|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56652876|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56652877|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
56371253|NCT02823366|Fenofibrate|fenofibrate|mesh-list
56371254|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56371255|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
56371256|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371257|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56371258|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
56371259|NCT00093977|Hematinics|hematinics|mesh-ancestor
56371260|NCT00094289|Disulfiram|disulfiram|mesh-list
56371261|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56371262|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56371263|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371264|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371265|NCT00094367|Lamivudine|lamivudine|mesh-list
56371266|NCT00094367|Abacavir|abacavir|mesh-list
56371267|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56371268|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56371269|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371270|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371271|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
56371272|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371273|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56371274|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56371275|NCT00094406|Dimercaprol|dimercaprol|mesh-list
56371276|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
56371277|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
56371278|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
56371279|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371280|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
56652878|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652879|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56652880|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56652881|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
56652882|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56652883|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
56652884|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
56652885|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
56652886|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56652887|NCT02812043|Amorolfine|amorolfine|mesh-list
56652888|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
56652889|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652890|NCT02808767|Ticagrelor|ticagrelor|mesh-list
56371281|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
56371282|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885237|NCT02491320|Letrozole|letrozole|mesh-list
56371291|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56371292|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56371293|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
56371294|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371295|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371296|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56371297|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56371298|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
56371299|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371300|NCT00428701|Esomeprazole|esomeprazole|mesh-list
56371301|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56371302|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371303|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56371304|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371305|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371306|NCT00428818|Doxycycline|doxycycline|mesh-list
56371307|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56371308|NCT00428818|Trimethoprim|trimethoprim|mesh-list
56371309|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
56371310|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56371311|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371312|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
56371313|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56371314|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56371315|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56371316|NCT00428818|Renal Agents|renal agents|mesh-ancestor
56371317|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56371318|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371319|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371320|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56371321|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56371322|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56371323|NCT00094640|Olanzapine|olanzapine|mesh-list
56371324|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
56371325|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
56371326|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371327|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371328|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371329|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56371330|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56371331|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371332|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56371333|NCT00094640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56371334|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56371335|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56371336|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371337|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371338|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
56652891|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56652892|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56652893|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56652894|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56652895|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56652896|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
56652897|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652898|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652899|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652900|NCT02812355|Heparin|heparin|mesh-list
56652901|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
56652902|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56652903|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56652904|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652905|NCT02811731|Amlodipine|amlodipine|mesh-list
56652906|NCT02811731|Candesartan|candesartan|mesh-list
56652907|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56652908|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56652909|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652910|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652911|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56652912|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215499|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
56371339|NCT02415309|Melatonin|melatonin|mesh-list
56371340|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
56371341|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371342|NCT02415309|Protective Agents|protective agents|mesh-ancestor
56371343|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371344|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371345|NCT05393817|Caffeine|caffeine|mesh-list
56371346|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
56371347|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371357|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56371358|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371359|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56371360|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371361|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
56371362|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371363|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
56371364|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371365|NCT00095069|Gaboxadol|gaboxadol|mesh-list
56371366|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371367|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371368|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371369|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371370|NCT00095069|Analgesics|analgesics|mesh-ancestor
56371371|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
56371372|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
56652913|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
56652914|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56652915|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56652916|NCT02811809|Leuprolide|leuprolide|mesh-list
56652917|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56652918|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
56652919|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56652920|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652921|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56652922|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652923|NCT05569421|Budesonide|budesonide|mesh-list
56652924|NCT05569421|Formoterol Fumarate|formoterol fumarate|mesh-list
56652925|NCT05569421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56652926|NCT05569421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56652927|NCT05569421|Autonomic Agents|autonomic agents|mesh-ancestor
56652928|NCT05569421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56652929|NCT05569421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652930|NCT05569421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56652931|NCT05569421|Respiratory System Agents|respiratory system agents|mesh-ancestor
56652932|NCT05569421|Glucocorticoids|glucocorticoids|mesh-ancestor
56652933|NCT05569421|Hormones|hormones|mesh-ancestor
56371373|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
56371374|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
56371375|NCT00403533|Atorvastatin|atorvastatin|mesh-list
56371376|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56371377|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56371378|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
56371379|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371380|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56371381|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56371382|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371383|NCT00095186|Lactoferrin|lactoferrin|mesh-list
56371384|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371385|NCT00095225|Bevacizumab|bevacizumab|mesh-list
56371386|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56371387|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56371388|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371389|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56371390|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56371391|NCT00095225|Growth Substances|growth substances|mesh-ancestor
56371392|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371393|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
56371394|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371395|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371396|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371397|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
56371398|NCT00095264|Hematinics|hematinics|mesh-ancestor
56371399|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
56371400|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
56371401|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371402|NCT00403611|Praziquantel|praziquantel|mesh-list
56371403|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
56371404|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56371405|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371406|NCT00428896|Gefitinib|gefitinib|mesh-list
56652934|NCT05569421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56652935|NCT05569421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56652936|NCT05569421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56652937|NCT05569421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56652938|NCT05569421|Adrenergic Agents|adrenergic agents|mesh-ancestor
56652939|NCT05569421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652940|NCT05569421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652941|NCT02808611|Propranolol|propranolol|mesh-list
56652942|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56652943|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56652944|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
56371407|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371408|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371409|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371410|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371411|NCT01990911|Diuretics|diuretics|mesh-list
56371412|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
56371413|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371425|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371426|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56371427|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56371428|NCT00095459|Growth Substances|growth substances|mesh-ancestor
56371429|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371430|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
56371431|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371432|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371433|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371434|NCT00429208|Nicotine|nicotine|mesh-list
56371435|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56371436|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
56371437|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371438|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371439|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56371440|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56371441|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
56371442|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371443|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371444|NCT00429247|Trastuzumab|trastuzumab|mesh-list
56371445|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56371446|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371447|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
56371448|NCT00095654|Ramipril|ramipril|mesh-list
56371449|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56371450|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371451|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56371452|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
56371453|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371454|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371455|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56371456|NCT00095693|Sorafenib|sorafenib|mesh-list
56371457|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56371458|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371459|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371460|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371461|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371462|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56371464|NCT01054573|Ribavirin|ribavirin|mesh-list
56371465|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371466|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
56371467|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371468|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
55914253|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56652945|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652946|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652947|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652948|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56652949|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56652950|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
56652951|NCT02808533|Topiramate|topiramate|mesh-list
56652952|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
56652953|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56652954|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652955|NCT02811497|Azacitidine|azacitidine|mesh-list
56652956|NCT02811497|Durvalumab|durvalumab|mesh-list
56652957|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56652958|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
56652959|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299022|NCT00121303|Cytarabine|cytarabine|mesh-list
56652960|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652961|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652962|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56652963|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56652964|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56652965|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56215547|NCT01619176|Analgesics|analgesics|mesh-ancestor
56371469|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371470|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
56371471|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371472|NCT00429442|Simvastatin|simvastatin|mesh-list
56371473|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56371474|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56371475|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
56371476|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371477|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55885422|NCT03328494|Paclitaxel|paclitaxel|mesh-list
56371481|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56371483|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371484|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
56371485|NCT00429520|Protective Agents|protective agents|mesh-ancestor
56371486|NCT00429559|Gemcitabine|gemcitabine|mesh-list
56371487|NCT00429559|Topotecan|topotecan|mesh-list
56371488|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371489|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
56371490|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371492|NCT00429559|Antiviral Agents|antiviral agents|mesh-ancestor
56371493|NCT00429559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371494|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371495|NCT00429559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371496|NCT00429559|Immunologic Factors|immunologic factors|mesh-ancestor
56371497|NCT00429559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371498|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56371499|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56371500|NCT00095810|Aripiprazole|aripiprazole|mesh-list
56371501|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
56652966|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652967|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652968|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
56652969|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56652970|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652971|NCT02807909|Itraconazole|itraconazole|mesh-list
56652972|NCT02807909|Diltiazem|diltiazem|mesh-list
56652973|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
56652974|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56652975|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56652976|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56652977|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652978|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652979|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56652980|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
56652981|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56652982|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56652983|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56652984|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56652985|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56652986|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56652987|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56652988|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
56652989|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
56652990|NCT02808065|Tacrolimus|tacrolimus|mesh-list
56652991|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56652992|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
56652993|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215572|NCT01619527|Darunavir|darunavir|mesh-list
56371502|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56371503|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56371504|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56371505|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371506|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371507|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
56371508|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
56371509|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371510|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371511|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56371512|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56371513|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
56371514|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56652994|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56652995|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56652996|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56652997|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56652998|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56652999|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56653000|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
56653001|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56653002|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653003|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56653004|NCT00602030|Entinostat|entinostat|mesh-list
56653005|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653006|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56653007|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371515|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56371516|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56371517|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56371518|NCT05234112|Acetic Acid|acetic acid|mesh-list
56371519|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56371520|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371521|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
56371522|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56371523|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371524|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56371525|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371526|NCT00095888|Gemcitabine|gemcitabine|mesh-list
56371527|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371528|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
56371529|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371530|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371531|NCT00095888|Antiviral Agents|antiviral agents|mesh-ancestor
56371532|NCT00095888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371533|NCT00095888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371534|NCT00095888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371535|NCT00095888|Immunologic Factors|immunologic factors|mesh-ancestor
56371536|NCT00095888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371537|NCT00429676|Haloperidol|haloperidol|mesh-list
56371538|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
56371539|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
56371540|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
56371541|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371542|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371543|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371544|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56371545|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56371546|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371547|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56371548|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56371549|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
56171911|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
56371559|NCT00095927|Amifostine|amifostine|mesh-list
56371560|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56371561|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371562|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
56371563|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
56371564|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
56371565|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371566|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56371567|NCT00095927|Protective Agents|protective agents|mesh-ancestor
56371568|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653008|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653009|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56653010|NCT02804711|Vaccines|vaccines|mesh-list
56653011|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
56653012|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653013|NCT00640094|Melatonin|melatonin|mesh-list
56653014|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
56653015|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653016|NCT00640094|Protective Agents|protective agents|mesh-ancestor
56653017|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653018|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653019|NCT04183634|Rotigotine|rotigotine|mesh-list
56653020|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
56653021|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
56653022|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653023|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653024|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653025|NCT02804633|Acetaminophen|acetaminophen|mesh-list
56653026|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56653027|NCT02804633|Analgesics|analgesics|mesh-ancestor
56653062|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56653063|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653064|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653065|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653066|NCT02682758|Xenon|xenon|mesh-list
56653067|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56653068|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
56653069|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
56653070|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653071|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653072|NCT02682524|Aceclofenac|aceclofenac|mesh-list
56653073|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56653074|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56653075|NCT02682524|Analgesics|analgesics|mesh-ancestor
56653076|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
56215666|NCT01619813|Hormones|hormones|mesh-ancestor
56371569|NCT00429754|Aprepitant|aprepitant|mesh-list
56371570|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
56371571|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
56371572|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371573|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371574|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371575|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56371576|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371577|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371578|NCT05232084|Fentanyl|fentanyl|mesh-list
56371579|NCT05232084|Bupivacaine|bupivacaine|mesh-list
56371580|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
56371581|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
56371582|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371583|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371584|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
56371585|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371586|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56371587|NCT05232084|Narcotics|narcotics|mesh-ancestor
56371588|NCT05232084|Analgesics|analgesics|mesh-ancestor
56371589|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56371590|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56371591|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
56371592|NCT00429832|Promethazine|promethazine|mesh-list
56371593|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
56371594|NCT00429832|Ondansetron|ondansetron|mesh-list
56371595|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
56371596|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
56371597|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371598|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371599|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371600|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
56371601|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
56371602|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56371603|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
56371604|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371605|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371606|NCT00429832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56371607|NCT00429832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56371608|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371609|NCT00429832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56371610|NCT00429832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56371611|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56371612|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
56371613|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
56653077|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653078|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653079|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653080|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56653081|NCT04183556|Naproxen|naproxen|mesh-list
56653082|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56653083|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56653084|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56653085|NCT04183556|Analgesics|analgesics|mesh-ancestor
56653086|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
56653087|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653088|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653089|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56653090|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
56653091|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56653092|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653093|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653094|NCT00640952|Acamprosate|acamprosate|mesh-list
56653095|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56653096|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
56653097|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56653098|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653099|NCT02807051|Clarithromycin|clarithromycin|mesh-list
56653100|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56653101|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653102|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56371614|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56371615|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55885565|NCT01726738|Dabrafenib|dabrafenib|mesh-list
56371621|NCT00429871|Capecitabine|capecitabine|mesh-list
56371622|NCT00429871|Epirubicin|epirubicin|mesh-list
56371623|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371624|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
56371625|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
56371626|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
56371627|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371628|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371629|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
56371630|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56371631|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56371632|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56371633|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371634|NCT00095966|Gemcitabine|gemcitabine|mesh-list
56371635|NCT00095966|Sorafenib|sorafenib|mesh-list
56371636|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371637|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
56371638|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371639|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371640|NCT00095966|Antiviral Agents|antiviral agents|mesh-ancestor
56653103|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653104|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653105|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56653106|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55774674|NCT01990300|Alogliptin|alogliptin|mesh-list
56371641|NCT00095966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371642|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371643|NCT00095966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371644|NCT00095966|Immunologic Factors|immunologic factors|mesh-ancestor
56371645|NCT00095966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371646|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371647|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
56371648|NCT01803594|Niacin|niacin|mesh-list
56371649|NCT01803594|Niacinamide|niacinamide|mesh-list
56371650|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
56371651|NCT01803594|Vitamins|vitamins|mesh-ancestor
56371652|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
56371653|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371654|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56371655|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
56371656|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371657|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56371658|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
56371659|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
56371660|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371661|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371662|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371663|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371664|NCT00096005|Bortezomib|bortezomib|mesh-list
56371665|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371666|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
56371667|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371668|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
56371669|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371670|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56371671|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56371672|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
56371673|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371674|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371675|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56371676|NCT00430144|Belotecan|belotecan|mesh-list
56371677|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56371678|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56371679|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371680|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371681|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371682|NCT00430261|Sunitinib|sunitinib|mesh-list
56371683|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371684|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56371685|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56371686|NCT00430261|Growth Substances|growth substances|mesh-ancestor
56371687|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371701|NCT01726452|Leucovorin|leucovorin|mesh-list
56371702|NCT01726452|Paclitaxel|paclitaxel|mesh-list
56371703|NCT01726452|Docetaxel|docetaxel|mesh-list
56371704|NCT01726452|Carboplatin|carboplatin|mesh-list
56371705|NCT01726452|Fluorouracil|fluorouracil|mesh-list
56371706|NCT01726452|Capecitabine|capecitabine|mesh-list
56371707|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
56371708|NCT01726452|Epirubicin|epirubicin|mesh-list
56371709|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56371710|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371711|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
56371712|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
56371713|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
56371714|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371715|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
56371716|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371717|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371718|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
56371719|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653107|NCT02684084|Dexamethasone|dexamethasone|mesh-list
56653108|NCT02684084|Ranibizumab|ranibizumab|mesh-list
56653109|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653110|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
56653111|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
56653112|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653113|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653114|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56653115|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
56653116|NCT02684084|Hormones|hormones|mesh-ancestor
56653117|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653118|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56653119|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653120|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56653121|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56653122|NCT02684084|Growth Substances|growth substances|mesh-ancestor
56653123|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
56653124|NCT02684318|Olaparib|olaparib|mesh-list
56653125|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56653126|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653127|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371720|NCT01726452|Antidotes|antidotes|mesh-ancestor
56371721|NCT01726452|Protective Agents|protective agents|mesh-ancestor
56371722|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
56371723|NCT01726452|Vitamins|vitamins|mesh-ancestor
56371724|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
56371725|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56371726|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56371727|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56371728|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371729|NCT00096317|Ketoconazole|ketoconazole|mesh-list
56371730|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
56371731|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371732|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56371733|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56371734|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371735|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371736|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56371737|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
56371738|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371739|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371740|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55993577|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
56371741|NCT00096395|Gemcitabine|gemcitabine|mesh-list
56371742|NCT00096395|Sorafenib|sorafenib|mesh-list
56371743|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371744|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
56371745|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371746|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371747|NCT00096395|Antiviral Agents|antiviral agents|mesh-ancestor
55885705|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
56371751|NCT00096395|Immunologic Factors|immunologic factors|mesh-ancestor
56371752|NCT00096395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653128|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653129|NCT02806817|Bevacizumab|bevacizumab|mesh-list
56653130|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653131|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653132|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56653133|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56653134|NCT02806817|Growth Substances|growth substances|mesh-ancestor
56653135|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653136|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
56653137|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56653138|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56653139|NCT04182854|Diuretics|diuretics|mesh-ancestor
56653140|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
56653141|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653142|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56653143|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56653144|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653145|NCT02680808|Olorofim|olorofim|mesh-list
56653146|NCT02680808|Midazolam|midazolam|mesh-list
56653147|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56371753|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371754|NCT00096434|Sorafenib|sorafenib|mesh-list
56371755|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371756|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371757|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371758|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371759|NCT00096473|Donepezil|donepezil|mesh-list
56371760|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56371761|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371762|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371763|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
56371764|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371765|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371767|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
56371768|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56371769|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371771|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371772|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371773|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371774|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371775|NCT00096551|Metronidazole|metronidazole|mesh-list
56371776|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371777|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56371778|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56371779|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56371780|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
56371781|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56371782|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56371783|NCT00130572|Analgesics|analgesics|mesh-ancestor
56371784|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
56371785|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371786|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371787|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653148|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56653149|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653150|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653151|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56653152|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56653153|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56653154|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56653155|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
56653156|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
56653157|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
56653158|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
56653159|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653160|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653161|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
56653162|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653163|NCT05663684|Proxymetacaine|proxymetacaine|mesh-list
56653164|NCT05663684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56653165|NCT05663684|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56653166|NCT05663684|Anesthetics, Local|anesthetics, local|mesh-ancestor
56653167|NCT05663684|Anesthetics|anesthetics|mesh-ancestor
56653168|NCT05663684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653169|NCT05663684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653170|NCT05663684|Sensory System Agents|sensory system agents|mesh-ancestor
56653171|NCT05663684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653172|NCT04004819|Rituximab|rituximab|mesh-list
56653173|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653174|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371788|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56371789|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
56371790|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371791|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
56371792|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56371793|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371794|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371795|NCT00096629|Vaccines|vaccines|mesh-list
56371796|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
56371797|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371798|NCT00430651|Carboplatin|carboplatin|mesh-list
56371799|NCT00430651|Docetaxel|docetaxel|mesh-list
56371800|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371801|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
56371802|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
56371803|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
56371804|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371805|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
56371806|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
56371807|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56371808|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56371809|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653175|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
56653176|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653177|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56653178|NCT00641654|Interferons|interferons|mesh-list
56653179|NCT00641654|Ribavirin|ribavirin|mesh-list
56653180|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
56653181|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
56653182|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56653183|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653184|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
56653185|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653186|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
56653187|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653188|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
56653189|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371810|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371811|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371812|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56371813|NCT00096668|Paclitaxel|paclitaxel|mesh-list
56371814|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56371815|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371816|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
56371817|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
56371818|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
56371819|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371820|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55885756|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371840|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371841|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
56371842|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371843|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56371844|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56371845|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371846|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371847|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56371848|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56371849|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371850|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
56371851|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371852|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56371853|NCT05102409|Lifitegrast|lifitegrast|mesh-list
56371854|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56371855|NCT01053247|Tacrolimus|tacrolimus|mesh-list
56371856|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371857|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
56371858|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371859|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56371860|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371861|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371862|NCT00096863|Haloperidol|haloperidol|mesh-list
56371863|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
56371864|NCT00096863|Ziprasidone|ziprasidone|mesh-list
56371865|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
56371866|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
56371867|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371868|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371869|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371870|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56371871|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56371872|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371873|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56653190|NCT02826434|Durvalumab|durvalumab|mesh-list
56653191|NCT02826434|Poly ICLC|poly iclc|mesh-list
56653192|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653193|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653194|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
56653195|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
56653196|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653197|NCT00549601|Rivastigmine|rivastigmine|mesh-list
56653198|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56653199|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653200|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653201|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
56653202|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653203|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653204|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56653205|NCT00549601|Protective Agents|protective agents|mesh-ancestor
56653206|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56653207|NCT02806349|Cathartics|cathartics|mesh-ancestor
56653208|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56653209|NCT04184492|Insulin|insulin|mesh-list
56653210|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56653211|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
56653212|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
56215766|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56371874|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56371875|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
56371876|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371877|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371878|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56371883|NCT01052779|Hematinics|hematinics|mesh-ancestor
56371884|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56371885|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56371886|NCT00130767|Finasteride|finasteride|mesh-list
56371887|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56371888|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56371889|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371890|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371891|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
56171949|NCT00550836|Immunologic Factors|immunologic factors|mesh-ancestor
56371892|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371893|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371894|NCT00130767|Urological Agents|urological agents|mesh-ancestor
56371895|NCT00431080|Paclitaxel|paclitaxel|mesh-list
56371896|NCT00431080|Docetaxel|docetaxel|mesh-list
56371897|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
56371898|NCT00431080|Epirubicin|epirubicin|mesh-list
56371899|NCT00431080|Fluorouracil|fluorouracil|mesh-list
56371900|NCT00431080|Lenograstim|lenograstim|mesh-list
56371901|NCT00431080|Mitogens|mitogens|mesh-list
56371902|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56371903|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371904|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
56371905|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
56653213|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56653214|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
56653215|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56653216|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
56653217|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56653218|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653219|NCT02806115|Acetic Acid|acetic acid|mesh-list
56653220|NCT02806115|Retinol acetate|retinol acetate|mesh-list
56653221|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56653222|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371906|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
56371907|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371908|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371909|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
56371910|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371911|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56371912|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56371913|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
56371914|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56371915|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56371916|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56371917|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56371918|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371920|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371921|NCT00431080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56371922|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
56371923|NCT00431119|Azathioprine|azathioprine|mesh-list
56371924|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56371925|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371926|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56371927|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
56371928|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56371929|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371930|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371931|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371932|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
56371933|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371934|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371935|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
56371936|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371937|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56371938|NCT00097019|Bevacizumab|bevacizumab|mesh-list
56371939|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56371940|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371941|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56371942|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56371943|NCT00097019|Growth Substances|growth substances|mesh-ancestor
56371944|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371945|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
56371946|NCT00431197|Ketoconazole|ketoconazole|mesh-list
56371947|NCT00431197|Testosterone|testosterone|mesh-list
56371948|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
56371949|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371950|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56371957|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371958|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56371959|NCT00431197|Androgens|androgens|mesh-ancestor
56371960|NCT00431197|Hormones|hormones|mesh-ancestor
56371961|NCT00431236|Dexamethasone|dexamethasone|mesh-list
56371962|NCT00431236|Ondansetron|ondansetron|mesh-list
56371963|NCT00431236|Casopitant|casopitant|mesh-list
56371964|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56371965|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
56371966|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
55914254|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653223|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56653224|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
56653225|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653226|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56653227|NCT02806115|Protective Agents|protective agents|mesh-ancestor
56653228|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653229|NCT02682134|Dexamethasone|dexamethasone|mesh-list
56653230|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
56653231|NCT02682134|Lidocaine|lidocaine|mesh-list
56653232|NCT02682134|BB 1101|bb 1101|mesh-list
56653233|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653234|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
56653235|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
56653236|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653237|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653238|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56653239|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
56653240|NCT02682134|Hormones|hormones|mesh-ancestor
56653241|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653242|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56653243|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653244|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
56653245|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653246|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653247|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
56653248|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
56653249|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371967|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56371968|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371969|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56371970|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
56371971|NCT00431236|Hormones|hormones|mesh-ancestor
56371972|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371973|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56371974|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371975|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
56371976|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
56371977|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56371978|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
56371979|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371980|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371981|NCT00431236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56371982|NCT00431236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56371983|NCT00431236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56371984|NCT00431236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56371985|NCT00431236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56371986|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56371987|NCT00431275|Tremelimumab|tremelimumab|mesh-list
56653250|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
56653251|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56653252|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56653253|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56653254|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56653255|NCT04236323|Remifentanil|remifentanil|mesh-list
56653256|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56653257|NCT04236323|Narcotics|narcotics|mesh-ancestor
56299316|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
56653258|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653259|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653260|NCT04236323|Analgesics|analgesics|mesh-ancestor
56653261|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
56653262|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653263|NCT04206163|Edotreotide|edotreotide|mesh-list
56653264|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56371988|NCT00431275|Ipilimumab|ipilimumab|mesh-list
56371989|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371990|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56371991|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56371992|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371993|NCT00431353|Valganciclovir|valganciclovir|mesh-list
56371994|NCT00431353|Ganciclovir|ganciclovir|mesh-list
56371995|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56371996|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
56371997|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371998|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56371999|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372000|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372001|NCT00130845|Octreotide|octreotide|mesh-list
56372002|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372003|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56372004|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372005|NCT00431392|Atropine|atropine|mesh-list
56372006|NCT00431392|Propranolol|propranolol|mesh-list
56372007|NCT00431392|Phenylephrine|phenylephrine|mesh-list
56372008|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
56372009|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56372010|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56372011|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
56372012|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
56372013|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372014|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372015|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
56372016|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56372029|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56372030|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
56372031|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56372032|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56372033|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
56372034|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56372035|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56372036|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56372037|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
56372038|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372039|NCT00130884|Simendan|simendan|mesh-list
56372040|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56372041|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
56372042|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56372043|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56372044|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653265|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653266|NCT00909974|Micronutrients|micronutrients|mesh-list
56653267|NCT00909974|Trace Elements|trace elements|mesh-list
56653268|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653269|NCT05300347|Adenosine|adenosine|mesh-list
56653270|NCT05300347|Analgesics|analgesics|mesh-ancestor
56653271|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
56653272|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653273|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653274|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56653275|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
56653276|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56653277|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
56653278|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
56653279|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653280|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653281|NCT04011241|Itraconazole|itraconazole|mesh-list
56653282|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
56653283|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653284|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56653285|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56653286|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653287|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653288|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56653289|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
56653290|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653291|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653292|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56653293|NCT00956059|Prednisone|prednisone|mesh-list
56653294|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372045|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372046|NCT00130884|Protective Agents|protective agents|mesh-ancestor
56372047|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372048|NCT01052662|Memantine|memantine|mesh-list
56372049|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56372050|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56372051|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
56372052|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372053|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372054|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372055|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55914548|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56653295|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
56653296|NCT00956059|Hormones|hormones|mesh-ancestor
56653297|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653298|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653299|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56653300|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653301|NCT04010929|Pemetrexed|pemetrexed|mesh-list
56653302|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653303|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653304|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653305|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56653306|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56653307|NCT00956215|Aprepitant|aprepitant|mesh-list
56653308|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
56653309|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
56372056|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56372057|NCT00097214|Carboplatin|carboplatin|mesh-list
56372058|NCT00097214|Cetuximab|cetuximab|mesh-list
56372059|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372060|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56372061|NCT05049057|Erenumab|erenumab|mesh-list
56372062|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56372063|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372064|NCT05049057|Analgesics|analgesics|mesh-ancestor
56372065|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
56372066|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372067|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372068|NCT04703803|Lidocaine|lidocaine|mesh-list
56372069|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
56372070|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
56372071|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56372072|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372073|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
56372074|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372075|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56372076|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56372077|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56372079|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372080|NCT00431665|Heparin|heparin|mesh-list
56372081|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56372082|NCT00431665|Somatostatin|somatostatin|mesh-list
56372083|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56372084|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372085|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
56372086|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56372087|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56372088|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372089|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56372090|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56372091|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56372092|NCT00431665|Hormones|hormones|mesh-ancestor
56372093|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372094|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372095|NCT05001828|Azacitidine|azacitidine|mesh-list
56372096|NCT05001828|Venetoclax|venetoclax|mesh-list
56372097|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56372098|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
56372099|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372100|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653310|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
56653311|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653312|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653313|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56653314|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56653315|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653316|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653317|NCT00640640|Bevacizumab|bevacizumab|mesh-list
56653318|NCT00640640|Ranibizumab|ranibizumab|mesh-list
56653319|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653320|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653321|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56653322|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56653323|NCT00640640|Growth Substances|growth substances|mesh-ancestor
56653324|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653325|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
56653326|NCT00641030|Melphalan|melphalan|mesh-list
56653327|NCT00641030|Clofarabine|clofarabine|mesh-list
56653328|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56653329|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
56653330|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653331|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653332|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56653333|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56653334|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
56653335|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653336|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56653337|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
56653339|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
56653340|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56653341|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56653342|NCT03973177|Prednisolone|prednisolone|mesh-list
56653343|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
56653344|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56653345|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
56653346|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653348|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
56653349|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653350|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653351|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56653352|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
56653353|NCT03973177|Hormones|hormones|mesh-ancestor
56653354|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653355|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56653356|NCT03973177|Protective Agents|protective agents|mesh-ancestor
56653357|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56653358|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653359|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56653360|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653361|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
56653362|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56653363|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56653364|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
56653365|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56653366|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653367|NCT00961909|Metformin|metformin|mesh-list
56653368|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56372101|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372102|NCT04703608|Ivermectin|ivermectin|mesh-list
56372103|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56372104|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372105|NCT04727073|Spironolactone|spironolactone|mesh-list
56372106|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56372107|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
56372108|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372109|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372110|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56372111|NCT04727073|Diuretics|diuretics|mesh-ancestor
56372112|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
56372113|NCT00432016|Zidovudine|zidovudine|mesh-list
56372114|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
56372115|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372116|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56372117|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56372118|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372119|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
56372120|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372121|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56372122|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56372123|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
56372124|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56372126|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
56372127|NCT00131040|Coagulants|coagulants|mesh-ancestor
56372128|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56372129|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56372130|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
56372131|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165340|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56372132|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372133|NCT00400478|Rituximab|rituximab|mesh-list
55915156|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56653369|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653370|NCT04115189|Sunitinib|sunitinib|mesh-list
56653371|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653372|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56653373|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56653374|NCT04115189|Growth Substances|growth substances|mesh-ancestor
56653375|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653376|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
56653377|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56653378|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653379|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653380|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
56653381|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56653382|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653383|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
56653384|NCT02678234|Acetaminophen|acetaminophen|mesh-list
56653385|NCT02678234|Phenylephrine|phenylephrine|mesh-list
56653386|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
56653387|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653388|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56653389|NCT02678234|Analgesics|analgesics|mesh-ancestor
56653390|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
56653391|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653392|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
56653393|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653394|NCT02678234|Protective Agents|protective agents|mesh-ancestor
56653395|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56653396|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
56653397|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
56653398|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
56653399|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56653400|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
56372134|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56372135|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372136|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
56372137|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372138|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372139|NCT01052038|Dexamethasone|dexamethasone|mesh-list
56372140|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
56372141|NCT01052038|BB 1101|bb 1101|mesh-list
56372142|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372143|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
56372144|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
56372145|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915435|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
56653401|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
56653402|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56653403|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56653404|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56653405|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
56653406|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653407|NCT00601640|Eflornithine|eflornithine|mesh-list
56372146|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372147|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372148|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
56372149|NCT01052038|Hormones|hormones|mesh-ancestor
56372150|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372151|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56372160|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56372161|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372162|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
56372163|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372164|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372165|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56372166|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372167|NCT04711044|Menthol|menthol|mesh-list
56372168|NCT04711044|Histamine|histamine|mesh-list
56372169|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
56372170|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
56372171|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
56372172|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
56372173|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372174|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372175|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372176|NCT01051960|Ambrisentan|ambrisentan|mesh-list
56372177|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56372178|NCT00432367|Artesunate|artesunate|mesh-list
56372179|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
56372180|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
56372181|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56372182|NCT00432367|Amodiaquine|amodiaquine|mesh-list
56372183|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
56372184|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56372185|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56372186|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372187|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372188|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
56372189|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
56372190|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56372191|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
56372192|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56372193|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372194|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372195|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56372196|NCT00432367|Renal Agents|renal agents|mesh-ancestor
56372197|NCT00097760|Natalizumab|natalizumab|mesh-list
56372198|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
56372199|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372200|NCT00432406|Etanercept|etanercept|mesh-list
56372201|NCT00432406|Infliximab|infliximab|mesh-list
56372202|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
56372203|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372204|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372205|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56372206|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56372207|NCT00432406|Analgesics|analgesics|mesh-ancestor
56372208|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
56372209|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372210|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372211|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372212|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372213|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
56372214|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
56372215|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56653408|NCT00601640|Diclofenac|diclofenac|mesh-list
56653409|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56653410|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56653411|NCT00601640|Analgesics|analgesics|mesh-ancestor
56653412|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
56653413|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653414|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653415|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653416|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56653417|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56653418|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215946|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56215947|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56215948|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372216|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372217|NCT02957656|Vaccines|vaccines|mesh-list
56372218|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
56372224|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
56372225|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372226|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372227|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56372228|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56372229|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
56372230|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372231|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56372232|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56372233|NCT01051921|Interferons|interferons|mesh-list
56372234|NCT01051921|Ribavirin|ribavirin|mesh-list
56372235|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372236|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
56372237|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372238|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
56372239|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372240|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56372241|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56372242|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56372243|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56372244|NCT00432757|Ketotifen|ketotifen|mesh-list
56372245|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
56372246|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
56372247|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56372248|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
56372249|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
56372250|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372251|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372252|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372253|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56372254|NCT00432796|Dalteparin|dalteparin|mesh-list
56372255|NCT00432796|Tinzaparin|tinzaparin|mesh-list
56372256|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56372257|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
56372258|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56372259|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56372260|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372261|NCT00097877|Insulin|insulin|mesh-list
56372262|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56372263|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
56372264|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
56372265|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
56372266|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56372267|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653419|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653420|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653421|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56653422|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56653423|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56653424|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653425|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56653426|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
56653427|NCT02805725|Trabectedin|trabectedin|mesh-list
56653428|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372268|NCT00097916|Memantine|memantine|mesh-list
56372269|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56372270|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56372271|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
56372272|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372273|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372274|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372275|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56372276|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56372277|NCT00433069|Pioglitazone|pioglitazone|mesh-list
56372278|NCT00433069|Interferons|interferons|mesh-list
56372279|NCT00433069|Ribavirin|ribavirin|mesh-list
56372280|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
56372281|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
56372282|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372283|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
56372284|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372285|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
56372286|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372287|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
56372288|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372289|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55886239|NCT02488902|Tafenoquine|tafenoquine|mesh-list
56372292|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372293|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372294|NCT00403026|Bevacizumab|bevacizumab|mesh-list
56372295|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56372296|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372297|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56372298|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56372299|NCT00403026|Growth Substances|growth substances|mesh-ancestor
56372300|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372301|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
56372302|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
56372303|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372304|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56171993|NCT00556374|Denosumab|denosumab|mesh-list
56372305|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372306|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372307|NCT00098033|Clofarabine|clofarabine|mesh-list
56372308|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56372309|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
56372310|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372311|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372312|NCT00403065|Dexamethasone|dexamethasone|mesh-list
56372313|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372314|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
56372315|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
56372316|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372317|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372318|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372319|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
56372320|NCT00403065|Hormones|hormones|mesh-ancestor
56372321|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372322|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56653429|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
56653430|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653431|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56653432|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56653433|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
56215958|NCT01621620|Yohimbine|yohimbine|mesh-list
56372323|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372324|NCT00098111|Azathioprine|azathioprine|mesh-list
56372325|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
56372326|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372327|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56372328|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372329|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372330|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
56372331|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372332|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372333|NCT04702906|Trimetazidine|trimetazidine|mesh-list
56372334|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
56372335|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
56372336|NCT00131313|Rituximab|rituximab|mesh-list
56372337|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372338|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
56372339|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372340|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372341|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56372342|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
56372343|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994173|NCT01079143|Cyclosporine|cyclosporine|mesh-list
56372344|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372345|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56372346|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56372347|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
56372348|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56372349|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372350|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56372351|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
56372352|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56372353|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372354|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372355|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372356|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
56372358|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56372359|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
56372360|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56372361|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
56372370|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56372372|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
56372373|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
56372374|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372375|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372376|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56372377|NCT00433225|Protective Agents|protective agents|mesh-ancestor
56372378|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56372379|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56372380|NCT00433225|Analgesics|analgesics|mesh-ancestor
56372381|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
56372382|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372383|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56372384|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372385|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372386|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56372387|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372388|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56372389|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56372390|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56372391|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56372392|NCT00433342|Floxacillin|floxacillin|mesh-list
56372393|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56372394|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653434|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653435|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653436|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56653437|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
56653438|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56653439|NCT03549715|Durvalumab|durvalumab|mesh-list
56653440|NCT03549715|Tremelimumab|tremelimumab|mesh-list
56653441|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653442|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653443|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
56653444|NCT02803385|Anesthetics|anesthetics|mesh-list
56653445|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
56653446|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215970|NCT01621698|Fentanyl|fentanyl|mesh-list
56372395|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
56372396|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56372397|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56372398|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372399|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372400|NCT00131391|Hormones|hormones|mesh-ancestor
56372401|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372402|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372403|NCT00433459|Prednisone|prednisone|mesh-list
56372404|NCT00433459|Prednisolone|prednisolone|mesh-list
56372405|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
56372406|NCT00433459|Dacarbazine|dacarbazine|mesh-list
56372407|NCT00433459|Vincristine|vincristine|mesh-list
56372408|NCT00433459|Procarbazine|procarbazine|mesh-list
56372409|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56372410|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372411|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
56372412|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372413|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372414|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56372415|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
56372416|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372417|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372418|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56372419|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372420|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
56372422|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372423|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56372424|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56372425|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
56372426|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
56372427|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
56172003|NCT03028350|Ifetroban|ifetroban|mesh-list
56372438|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372440|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56372441|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
56372442|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56372443|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56372444|NCT00433576|Resveratrol|resveratrol|mesh-list
56372445|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
56372446|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372447|NCT00433576|Protective Agents|protective agents|mesh-ancestor
56372448|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372449|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915921|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
56653447|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653448|NCT02803385|Narcotics|narcotics|mesh-ancestor
56653449|NCT02803385|Analgesics|analgesics|mesh-ancestor
56653450|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
56653451|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653452|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56653453|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56653454|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653455|NCT00642434|Metoprolol|metoprolol|mesh-list
56653456|NCT00642434|Carvedilol|carvedilol|mesh-list
56653457|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56653458|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56653459|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
56653460|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
56653461|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653462|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653463|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56372450|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56372451|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
56372452|NCT00433615|Hematinics|hematinics|mesh-ancestor
56372453|NCT00098384|Rifaximin|rifaximin|mesh-list
56372454|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56372455|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372456|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372457|NCT00433732|Naproxen|naproxen|mesh-list
56372458|NCT00433732|Sumatriptan|sumatriptan|mesh-list
56372459|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56372460|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56372461|NCT00433732|Analgesics|analgesics|mesh-ancestor
56372462|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
56372463|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372464|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372465|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372466|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372467|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
56372468|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56372469|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372470|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372471|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56372472|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56372473|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56372474|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
56372475|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372476|NCT00098423|Cytarabine|cytarabine|mesh-list
56372477|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56372478|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
56372479|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372480|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372481|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
56372482|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372483|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372484|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
56372485|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372486|NCT01050790|Lenalidomide|lenalidomide|mesh-list
56372487|NCT01050790|Azacitidine|azacitidine|mesh-list
56372488|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
56372489|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372490|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56372491|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56653464|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56653465|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56653466|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
56653467|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653468|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653469|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
56653470|NCT00642434|Protective Agents|protective agents|mesh-ancestor
56653471|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56653472|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56653473|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56653474|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
56653475|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56653476|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56653477|NCT05352373|Calcium|calcium|mesh-list
56653478|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56653479|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653480|NCT02677532|Acetaminophen|acetaminophen|mesh-list
56653481|NCT02677532|Sufentanil|sufentanil|mesh-list
56653482|NCT02677532|Morphine|morphine|mesh-list
56299538|NCT00018850|Nicotine|nicotine|mesh-list
56653483|NCT02677532|Dsuvia|dsuvia|mesh-list
56653484|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
56653485|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56653486|NCT02677532|Narcotics|narcotics|mesh-ancestor
56653487|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653488|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653489|NCT02677532|Analgesics|analgesics|mesh-ancestor
56653490|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
56653491|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653492|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56653493|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
56653494|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56653495|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56653496|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
56372493|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
56372494|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372495|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56372507|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56372508|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56372510|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372511|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
56372512|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56372513|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56653497|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
56653498|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
56653499|NCT00641810|Caffeine|caffeine|mesh-list
56653500|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56653501|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653502|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56653503|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653504|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653505|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56216018|NCT01621893|Calcium|calcium|mesh-list
56372514|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372515|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372516|NCT00433927|Antidotes|antidotes|mesh-ancestor
56372517|NCT00433927|Protective Agents|protective agents|mesh-ancestor
56372518|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
56372519|NCT00433927|Vitamins|vitamins|mesh-ancestor
56372520|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
56372521|NCT00433927|Hematinics|hematinics|mesh-ancestor
56372522|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
56372523|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56372524|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56372525|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372526|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372527|NCT00131430|Hormones|hormones|mesh-ancestor
56372528|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372529|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372530|NCT00098462|Sirolimus|sirolimus|mesh-list
56372531|NCT00098462|Gefitinib|gefitinib|mesh-list
56372532|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56372533|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372534|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56372535|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372536|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
56372537|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372538|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
56372539|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372540|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56372541|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372542|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372543|NCT00098501|Sirolimus|sirolimus|mesh-list
56372544|NCT00098501|EKB 569|ekb 569|mesh-list
56372545|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56372546|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372547|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56372548|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372549|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
56372550|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372551|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
56372552|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372553|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56372554|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372555|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372556|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
56372557|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56372558|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
56372559|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372560|NCT00434005|Expectorants|expectorants|mesh-ancestor
56172094|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
56372569|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56372571|NCT00434044|Analgesics|analgesics|mesh-ancestor
56372572|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
56372573|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372574|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653506|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56653507|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
56653508|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653509|NCT02802995|Thrombin|thrombin|mesh-list
56653510|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
56653511|NCT02802995|Coagulants|coagulants|mesh-ancestor
56653512|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56653513|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
56372575|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372576|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372577|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372578|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372579|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
56372580|NCT00434083|Naproxen|naproxen|mesh-list
56372581|NCT00434083|Sumatriptan|sumatriptan|mesh-list
56372582|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56372583|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56372584|NCT00434083|Analgesics|analgesics|mesh-ancestor
56372585|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
56372586|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372587|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372588|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372589|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372590|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
56372591|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56372592|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372593|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372594|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56372595|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56372596|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56372597|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
56372598|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372599|NCT00098540|Sorafenib|sorafenib|mesh-list
56372600|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372601|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56372602|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372603|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372604|NCT00098579|Doxorubicin|doxorubicin|mesh-list
56372605|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56372606|NCT00098579|Alvocidib|alvocidib|mesh-list
56372607|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56372608|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372609|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56372610|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56372611|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372612|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372613|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
56372614|NCT00098579|Growth Substances|growth substances|mesh-ancestor
56372615|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372616|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56372617|NCT00098618|Interferons|interferons|mesh-list
56372618|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
56372619|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
56372620|NCT00098618|Sorafenib|sorafenib|mesh-list
56372621|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372622|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
56372623|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372624|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56372625|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372626|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372627|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
55886568|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
56372631|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372633|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
56372634|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372635|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
56372636|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56372637|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372638|NCT01059448|Brodalumab|brodalumab|mesh-list
56372639|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
56653514|NCT00910052|Coagulants|coagulants|mesh-ancestor
56653515|NCT02677376|Listerine|listerine|mesh-list
56653516|NCT02677376|Fluorides|fluorides|mesh-list
56653517|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
56653518|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
56653519|NCT02677376|Protective Agents|protective agents|mesh-ancestor
56653520|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653521|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56653522|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653523|NCT02800889|Pixantrone|pixantrone|mesh-list
56653524|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56653525|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56653526|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653527|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653528|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653529|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
56653530|NCT02803073|Testosterone|testosterone|mesh-list
56653531|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
56653532|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
56653533|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56653534|NCT02803073|Androgens|androgens|mesh-ancestor
56653535|NCT02803073|Hormones|hormones|mesh-ancestor
56653536|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653537|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653538|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56372640|NCT00098891|Entinostat|entinostat|mesh-list
56372641|NCT00098891|Isotretinoin|isotretinoin|mesh-list
56372642|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56372643|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
56372644|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372645|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372646|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372647|NCT00098969|Resveratrol|resveratrol|mesh-list
56372648|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
56372649|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372650|NCT00098969|Protective Agents|protective agents|mesh-ancestor
56372651|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372652|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372653|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56372654|NCT00099008|Genistein|genistein|mesh-list
56372655|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56372656|NCT00099008|Protective Agents|protective agents|mesh-ancestor
56372657|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372658|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372659|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56372660|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372661|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372662|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
56372663|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56372664|NCT00099008|Estrogens|estrogens|mesh-ancestor
56372665|NCT00099008|Hormones|hormones|mesh-ancestor
55916135|NCT03768414|Antiviral Agents|antiviral agents|mesh-ancestor
56653539|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653540|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
56653541|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
56653542|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56653543|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
56653544|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653545|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653546|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56653547|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
56653548|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56653549|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
56653550|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653551|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653552|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56653553|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
56653554|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
56372666|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372667|NCT00434239|Lenalidomide|lenalidomide|mesh-list
56372668|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
56372669|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372670|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56372671|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56372672|NCT00434239|Growth Substances|growth substances|mesh-ancestor
56372673|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
56372674|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372675|NCT01057147|Rebamipide|rebamipide|mesh-list
56372676|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56372677|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56372678|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56372679|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372680|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
56372681|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372682|NCT01057147|Protective Agents|protective agents|mesh-ancestor
56372683|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372684|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372685|NCT00099125|Irinotecan|irinotecan|mesh-list
56372686|NCT00099125|Temozolomide|temozolomide|mesh-list
56372687|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56372688|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56372689|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372690|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372691|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372692|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56372693|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
56372694|NCT00131703|Chloroquine|chloroquine|mesh-list
56372695|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
56372696|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
56372697|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56372698|NCT00131703|Amodiaquine|amodiaquine|mesh-list
56372703|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
56372704|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372705|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56372707|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372708|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56372709|NCT00131703|Renal Agents|renal agents|mesh-ancestor
56372710|NCT01051414|Asunaprevir|asunaprevir|mesh-list
56372711|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
56372712|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916439|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
56653555|NCT00922532|Protective Agents|protective agents|mesh-ancestor
56653556|NCT05662904|Gemtuzumab|gemtuzumab|mesh-list
56653557|NCT05662904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653558|NCT05662904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653559|NCT00642512|Dronabinol|dronabinol|mesh-list
56653560|NCT00642512|Ondansetron|ondansetron|mesh-list
56653561|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
56653562|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
56653563|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653564|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653565|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56653566|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
56653567|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
56653568|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56653569|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
56653570|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653571|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653572|NCT00642512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56372713|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372714|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
56372715|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56372716|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372717|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56372718|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56372719|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56372720|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
56372721|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372722|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372723|NCT00099164|Progestins|progestins|mesh-ancestor
56372724|NCT00099164|Hormones|hormones|mesh-ancestor
56372725|NCT00131742|Lamivudine|lamivudine|mesh-list
56372726|NCT00131742|Telbivudine|telbivudine|mesh-list
56372727|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56372728|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56372729|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372730|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372731|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
56372732|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372733|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56372734|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56372735|NCT04621149|Lactoferrin|lactoferrin|mesh-list
56372736|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
56372738|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56372739|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372740|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56372741|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
56372742|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
56372743|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372744|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372745|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372746|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372747|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
56372748|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
56372749|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
56372750|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
56372751|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56372752|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372753|NCT00099242|Rivastigmine|rivastigmine|mesh-list
56653573|NCT00642512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56653574|NCT00642512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653575|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56653576|NCT00642512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56653577|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
56653578|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56653579|NCT00642512|Analgesics|analgesics|mesh-ancestor
56653580|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
56653581|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56653582|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56653583|NCT00642512|Hormones|hormones|mesh-ancestor
56653584|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653585|NCT02802683|Phenylephrine|phenylephrine|mesh-list
56653586|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
56653587|NCT02802683|Bupivacaine|bupivacaine|mesh-list
56653588|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
56653589|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
56653590|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
56653591|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653592|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653593|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
56653594|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653595|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56653596|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
56653597|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
56653598|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
56653599|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56653600|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
56653601|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
56653602|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56653603|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56653604|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56372754|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56372755|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372756|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372757|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
56372758|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372759|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372760|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56372761|NCT00099242|Protective Agents|protective agents|mesh-ancestor
56372762|NCT00099320|Exenatide|exenatide|mesh-list
56372763|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56372764|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372765|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56653605|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
56653606|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653607|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653608|NCT02802683|Protective Agents|protective agents|mesh-ancestor
56653609|NCT00641264|Omeprazole|omeprazole|mesh-list
56653610|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56653611|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56653612|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56653613|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653614|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653615|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
56653616|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56653617|NCT05484167|Testosterone|testosterone|mesh-list
56653618|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
56653619|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
56653620|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56653621|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653622|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
56653623|NCT05484167|Hormones|hormones|mesh-ancestor
56653624|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653625|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653626|NCT05484167|Androgens|androgens|mesh-ancestor
56216098|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
56372766|NCT00099320|Incretins|incretins|mesh-ancestor
56372767|NCT00099320|Hormones|hormones|mesh-ancestor
56372768|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372769|NCT00403650|Iloprost|iloprost|mesh-list
56372770|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56372771|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
56372772|NCT00403728|Cyclosporine|cyclosporine|mesh-list
56372783|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56372784|NCT00403806|Dexamethasone|dexamethasone|mesh-list
56372785|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
56372786|NCT00403806|BB 1101|bb 1101|mesh-list
56372787|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372788|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
56372789|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
56372790|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372791|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994627|NCT03398278|Narcotics|narcotics|mesh-ancestor
56372792|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372793|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
56372795|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372796|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56372797|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372798|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
56372799|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372800|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372801|NCT00400556|Lenograstim|lenograstim|mesh-list
56372802|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56372803|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
56372804|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372805|NCT00400595|Mupirocin|mupirocin|mesh-list
56653627|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56653628|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
56653629|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653630|NCT04180982|Febuxostat|febuxostat|mesh-list
56653631|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
56653632|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56653633|NCT02802605|Bemiparin|bemiparin|mesh-list
56653634|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
56653635|NCT02800265|Sulforaphane|sulforaphane|mesh-list
56653636|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56653637|NCT02800265|Protective Agents|protective agents|mesh-ancestor
56653638|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653639|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653641|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653642|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56653643|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56653644|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653645|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653646|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56216113|NCT01622504|Naloxone|naloxone|mesh-list
56372806|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56372807|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372808|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56372809|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372810|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372811|NCT00099554|Etanercept|etanercept|mesh-list
56372812|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56372813|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56372814|NCT00099554|Analgesics|analgesics|mesh-ancestor
56372815|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
56372816|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372817|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372818|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372819|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172131|NCT05444556|Protective Agents|protective agents|mesh-ancestor
56372820|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56372821|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372822|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
56372823|NCT00132054|Irinotecan|irinotecan|mesh-list
56372824|NCT00132054|Amrubicin|amrubicin|mesh-list
56372825|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56372826|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56372827|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372828|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372829|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372830|NCT00099710|Curcumin|curcumin|mesh-list
56372831|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56372832|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56372833|NCT00099710|Analgesics|analgesics|mesh-ancestor
56372834|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
56372835|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372836|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372844|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372846|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
56372847|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653647|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
56653648|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653649|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653650|NCT02802215|Folic Acid|folic acid|mesh-list
56653651|NCT02802215|Metformin|metformin|mesh-list
56653652|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56653653|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653654|NCT02802215|Hematinics|hematinics|mesh-ancestor
56372848|NCT00132093|Eplerenone|eplerenone|mesh-list
56372849|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56372850|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
56372851|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372852|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372853|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56372854|NCT00132093|Diuretics|diuretics|mesh-ancestor
56372855|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
56372856|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56372857|NCT00099788|Ranolazine|ranolazine|mesh-list
56372858|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56372859|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56372860|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372861|NCT00099866|Metformin|metformin|mesh-list
56372862|NCT00099866|Vildagliptin|vildagliptin|mesh-list
56372863|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56372864|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994704|NCT02516241|Antiviral Agents|antiviral agents|mesh-ancestor
56372865|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56372867|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372868|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372869|NCT00099905|Vildagliptin|vildagliptin|mesh-list
56372870|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56372871|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372872|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56372873|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
56372874|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372875|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372876|NCT00132210|Interferons|interferons|mesh-list
56372877|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372878|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
56372879|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372880|NCT00099944|Glimepiride|glimepiride|mesh-list
56372881|NCT00099944|Vildagliptin|vildagliptin|mesh-list
56372882|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56372883|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56372884|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372885|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372886|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
56372887|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56372888|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56372889|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372890|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372891|NCT04352166|Buprenorphine|buprenorphine|mesh-list
56372892|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56372893|NCT04352166|Narcotics|narcotics|mesh-ancestor
56372894|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56372895|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372896|NCT04352166|Analgesics|analgesics|mesh-ancestor
56372897|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
56172272|NCT05768191|Insulin|insulin|mesh-list
56372898|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372899|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56372900|NCT04333914|Avdoralimab|avdoralimab|mesh-list
56372909|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56372910|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372911|NCT00100139|Paclitaxel|paclitaxel|mesh-list
56372912|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56372913|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56653655|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
56653656|NCT02802215|Vitamins|vitamins|mesh-ancestor
56653657|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
56653658|NCT02799797|Sufentanil|sufentanil|mesh-list
56653659|NCT02799797|Dsuvia|dsuvia|mesh-list
56653660|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56653661|NCT02799797|Narcotics|narcotics|mesh-ancestor
56653662|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653663|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653664|NCT02799797|Analgesics|analgesics|mesh-ancestor
56653665|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
56653666|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775942|NCT04517357|Apatinib|apatinib|mesh-list
56372914|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372915|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
56372916|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
56372917|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
56372918|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372919|NCT00100412|Phenylephrine|phenylephrine|mesh-list
56372920|NCT00100412|Dobutamine|dobutamine|mesh-list
56372921|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
56372922|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56372923|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
56372924|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
56372925|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372926|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372927|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
56372928|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56372929|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
56372930|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
56372931|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56372932|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56372933|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56372934|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
56372935|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372936|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372937|NCT00100412|Protective Agents|protective agents|mesh-ancestor
56372938|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56372940|NCT04244058|Amantadine|amantadine|mesh-list
56372941|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56372942|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56372943|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
56372944|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372945|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
56372946|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372947|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372948|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372949|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56372950|NCT04244058|Analgesics|analgesics|mesh-ancestor
56372951|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
56372952|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56372954|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56372955|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
56372956|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372957|NCT00100568|Lamivudine|lamivudine|mesh-list
56372958|NCT00100568|Zidovudine|zidovudine|mesh-list
56372959|NCT00100568|Efavirenz|efavirenz|mesh-list
56372960|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56372961|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56372962|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56372963|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372964|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372965|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
56372966|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372967|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56372968|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56653667|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56653668|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56653669|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
56653670|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
56653671|NCT05663372|Eplerenone|eplerenone|mesh-list
56653672|NCT05663372|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56653673|NCT05663372|Hormone Antagonists|hormone antagonists|mesh-ancestor
56653674|NCT05663372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653675|NCT05663372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653676|NCT05663372|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56653677|NCT05663372|Diuretics|diuretics|mesh-ancestor
56653678|NCT05663372|Natriuretic Agents|natriuretic agents|mesh-ancestor
56653679|NCT05663372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56372969|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
56372978|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
56372979|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
56372980|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56372981|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56372982|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372983|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372984|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
56372985|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
56372986|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56372987|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
56372988|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56372989|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372990|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372991|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56372992|NCT00132561|Renal Agents|renal agents|mesh-ancestor
56372993|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56372994|NCT04728581|Mirtazapine|mirtazapine|mesh-list
56372995|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
56372996|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56372997|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56372998|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56372999|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56373000|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373001|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56373002|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
56373003|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
56373004|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373005|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373006|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56373007|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56373008|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56373009|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56373010|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
56373011|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56373012|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56373013|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
56373014|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56373015|NCT04728659|Desogestrel|desogestrel|mesh-list
56373016|NCT04728659|Ganirelix|ganirelix|mesh-list
56373017|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56373018|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56373019|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56373020|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
56373021|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56373022|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373023|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56373024|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56172311|NCT05767827|Lidocaine|lidocaine|mesh-list
56653680|NCT02802137|Timolol|timolol|mesh-list
56653681|NCT02802137|Dorzolamide|dorzolamide|mesh-list
56373026|NCT04728659|Hormones|hormones|mesh-ancestor
56373027|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56373028|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
56373029|NCT00132600|Bacitracin|bacitracin|mesh-list
56373030|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56373031|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373032|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56373033|NCT00132639|Docetaxel|docetaxel|mesh-list
56373034|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373035|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
56373046|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373047|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373048|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56373049|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56373050|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373051|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373052|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373053|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
56373054|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373055|NCT00100646|Ritonavir|ritonavir|mesh-list
56373056|NCT00100646|Lopinavir|lopinavir|mesh-list
56373057|NCT00100646|Lamivudine|lamivudine|mesh-list
56373058|NCT00100646|Stavudine|stavudine|mesh-list
56373059|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56373060|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56373061|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
56373062|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373063|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373064|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56373065|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56373066|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
56373067|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373068|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56373069|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56373070|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56373071|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56373072|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
56373073|NCT00100685|Volociximab|volociximab|mesh-list
56373074|NCT00100685|Antibodies|antibodies|mesh-list
56373075|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56373076|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
56373077|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373078|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56373079|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56373080|NCT00100685|Growth Substances|growth substances|mesh-ancestor
56373081|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
56373082|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373083|NCT00132756|Estramustine|estramustine|mesh-list
56373084|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56373085|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
56373086|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373087|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373088|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56373090|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
56373091|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373092|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56373093|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56373094|NCT00100880|Growth Substances|growth substances|mesh-ancestor
56373095|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
56373096|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373097|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
56373098|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56373099|NCT00100958|Protective Agents|protective agents|mesh-ancestor
56373100|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373101|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373102|NCT00101075|Capecitabine|capecitabine|mesh-list
56373114|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373115|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373116|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56373117|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
56373118|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56373119|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653682|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56653683|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56653684|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
56653685|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653686|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653687|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653688|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56653689|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56653690|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56653691|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653692|NCT04033562|Lidocaine|lidocaine|mesh-list
56653693|NCT04033562|Bupivacaine|bupivacaine|mesh-list
56653694|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
56653695|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
56653696|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653697|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653698|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
56373121|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
56373122|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
56373123|NCT00101114|Sorafenib|sorafenib|mesh-list
56373124|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373125|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
56373126|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373127|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56373128|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373129|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373130|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
56373131|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373132|NCT00101153|Cytarabine|cytarabine|mesh-list
56373133|NCT00101153|Daunorubicin|daunorubicin|mesh-list
56373134|NCT00101153|Tipifarnib|tipifarnib|mesh-list
56373135|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56373136|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
56373137|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373138|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373139|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
56373140|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373141|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56373142|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
56373143|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373144|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56373145|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56373146|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56373147|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373148|NCT00132951|Azithromycin|azithromycin|mesh-list
56373149|NCT00132951|Telithromycin|telithromycin|mesh-list
56373150|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56373151|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373152|NCT00400790|Propofol|propofol|mesh-list
56373153|NCT00400790|Desflurane|desflurane|mesh-list
56373154|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56373155|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56373156|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373157|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56373158|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
56373159|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
56001809|NCT02530034|Antibodies|antibodies|mesh-list
56373160|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56373161|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56653699|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653700|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56653701|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56653702|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56653703|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56653704|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653705|NCT04032834|Budesonide|budesonide|mesh-list
56653706|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653707|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56653708|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
56653709|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653710|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653711|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56299772|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
56653712|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
56653713|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
56653714|NCT04032834|Hormones|hormones|mesh-ancestor
56653715|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653716|NCT02817191|Tobramycin|tobramycin|mesh-list
56653717|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56653718|NCT02817191|Dexamethasone|dexamethasone|mesh-list
56653719|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
56653720|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56653721|NCT02817191|BB 1101|bb 1101|mesh-list
56373162|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373164|NCT00135408|Ipilimumab|ipilimumab|mesh-list
56373165|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56373166|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373167|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56373182|NCT00101231|Growth Substances|growth substances|mesh-ancestor
56373183|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373184|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56373185|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373186|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373187|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
56373188|NCT00101270|Irinotecan|irinotecan|mesh-list
56373189|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373190|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56373191|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56373192|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373193|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373194|NCT00101309|Aldesleukin|aldesleukin|mesh-list
56373195|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373196|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56373197|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56373198|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
56373199|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373200|NCT00101348|Bevacizumab|bevacizumab|mesh-list
56373201|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56373202|NCT00101348|Cetuximab|cetuximab|mesh-list
56653722|NCT02817191|Dipivefrin|dipivefrin|mesh-list
56653723|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653724|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
56653725|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
56653726|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653727|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653728|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56653729|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
56653730|NCT02817191|Hormones|hormones|mesh-ancestor
56653731|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653732|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56653733|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653734|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
56653735|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776205|NCT03168997|Memantine|memantine|mesh-list
56373203|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56373204|NCT00101348|Antibodies|antibodies|mesh-list
56373205|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
56373206|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56373207|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373208|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56373209|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56373210|NCT00101348|Growth Substances|growth substances|mesh-ancestor
56373211|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373212|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
56373213|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
56373214|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56373215|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373216|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373217|NCT00101426|Ranirestat|ranirestat|mesh-list
56373218|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373219|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373220|NCT00135525|Paroxetine|paroxetine|mesh-list
56373221|NCT00135525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56373222|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56373223|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56373224|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373225|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373226|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
56373227|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887165|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
56373231|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56373232|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56373233|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373234|NCT00133185|Losartan|losartan|mesh-list
56373235|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56373236|NCT00133185|Telmisartan|telmisartan|mesh-list
56373237|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56373238|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56373239|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55995088|NCT01122901|R04929097|r04929097|mesh-list
56373240|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56373241|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373242|NCT00133185|Diuretics|diuretics|mesh-ancestor
56373243|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
56373244|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373245|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56373246|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56373247|NCT00135603|Amoxicillin|amoxicillin|mesh-list
56373248|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
56373249|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
56653736|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653737|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56653738|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56653739|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653740|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56653741|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
56653742|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653743|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
56653744|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653745|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653746|NCT05656508|Vaccines|vaccines|mesh-list
56653747|NCT05656508|Immunologic Factors|immunologic factors|mesh-ancestor
56653748|NCT05656508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653749|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
56373250|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56373251|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56373252|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373253|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56373254|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373255|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373256|NCT00133224|Prednisone|prednisone|mesh-list
56373257|NCT00133224|Docetaxel|docetaxel|mesh-list
56373258|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373259|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
56373260|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
56373261|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
56373262|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373263|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56373264|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
56373265|NCT00133224|Hormones|hormones|mesh-ancestor
56373266|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56373267|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373268|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56373269|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
56373270|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56373271|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373272|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56373273|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
56373274|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56373275|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373276|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373277|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373278|NCT00135681|Nedocromil|nedocromil|mesh-list
56373279|NCT00135681|Budesonide|budesonide|mesh-list
56373280|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56373281|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56373282|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
56172338|NCT05767827|Autonomic Agents|autonomic agents|mesh-ancestor
56373283|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373284|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373285|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56373286|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
56373287|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
56373289|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56373290|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56373291|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
56373292|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56373293|NCT00135720|Etanercept|etanercept|mesh-list
56373294|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56373295|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56653750|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
56653751|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56653752|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56653753|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653754|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
56653755|NCT05474027|Coagulants|coagulants|mesh-ancestor
56653756|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
56653757|NCT00546871|Antibodies|antibodies|mesh-list
56653758|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
56653759|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56653760|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56653761|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
56653762|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653763|NCT00642824|Bevacizumab|bevacizumab|mesh-list
56653764|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653765|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653766|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56653767|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56653768|NCT00642824|Growth Substances|growth substances|mesh-ancestor
56653769|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653770|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
56653771|NCT02679014|Petesicatib|petesicatib|mesh-list
56653772|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216199|NCT01623206|Coagulants|coagulants|mesh-ancestor
56373296|NCT00135720|Analgesics|analgesics|mesh-ancestor
56373297|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
56373299|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373300|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56373301|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56373302|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56373303|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56373304|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
56373305|NCT00101894|Panitumumab|panitumumab|mesh-list
56373306|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
56373307|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56373308|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373309|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56373310|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373311|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373312|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
56373313|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373314|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373316|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56373317|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56373318|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373319|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
56373320|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373321|NCT00133341|Parthenolide|parthenolide|mesh-list
56373322|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56373323|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56373324|NCT00133341|Analgesics|analgesics|mesh-ancestor
56373325|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
56653773|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653774|NCT02801357|Lofexidine|lofexidine|mesh-list
56653775|NCT02801357|Buprenorphine|buprenorphine|mesh-list
56653776|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56653777|NCT02801357|Narcotics|narcotics|mesh-ancestor
56653778|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653779|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653780|NCT02801357|Analgesics|analgesics|mesh-ancestor
56653781|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
56653782|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373326|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373327|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373328|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56373329|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56373330|NCT00135837|Verteporfin|verteporfin|mesh-list
56373331|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56373332|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
56373333|NCT00133380|Atorvastatin|atorvastatin|mesh-list
56373334|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56373335|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56373336|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
56373337|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373338|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56373339|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56373340|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373341|NCT00102167|Gaboxadol|gaboxadol|mesh-list
56373342|NCT00102167|Analgesics|analgesics|mesh-ancestor
56373343|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
56373344|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373345|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373346|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
56373347|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
56373348|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
56373349|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373350|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373351|NCT00135876|Dalteparin|dalteparin|mesh-list
56373352|NCT00135876|Tinzaparin|tinzaparin|mesh-list
56373353|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56373354|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
56373355|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56373356|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56373357|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373359|NCT00102206|Lopinavir|lopinavir|mesh-list
56373360|NCT00102206|Saquinavir|saquinavir|mesh-list
56373361|NCT00102206|Tenofovir|tenofovir|mesh-list
56373362|NCT00102206|Lamivudine|lamivudine|mesh-list
56373363|NCT00102206|Zidovudine|zidovudine|mesh-list
56373364|NCT00102206|Emtricitabine|emtricitabine|mesh-list
56373365|NCT00102206|Abacavir|abacavir|mesh-list
56373366|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56373367|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56373368|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
56373369|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373370|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373371|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56373372|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56373373|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
56373374|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373376|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56373377|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56373378|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56373379|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
56373380|NCT00102284|Levodopa|levodopa|mesh-list
56373381|NCT00102284|Modafinil|modafinil|mesh-list
56373382|NCT00102284|Rivastigmine|rivastigmine|mesh-list
56373383|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56373384|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56373386|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653783|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56653784|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56653785|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56653786|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56653787|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56653788|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
56653789|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653790|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653792|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
56653793|NCT02676674|Vitamins|vitamins|mesh-ancestor
56653794|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
56653795|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653796|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56653797|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56653798|NCT00962299|Beclomethasone|beclomethasone|mesh-list
56653799|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653800|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
56653801|NCT00962299|Hormones|hormones|mesh-ancestor
56653802|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653803|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373387|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373388|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373389|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56373390|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56373391|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56373392|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56373393|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56373395|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
56373396|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56373397|NCT00102284|Protective Agents|protective agents|mesh-ancestor
56373398|NCT00403962|Paroxetine|paroxetine|mesh-list
56373399|NCT00403962|Vestipitant|vestipitant|mesh-list
56373400|NCT00403962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56373401|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56373402|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56373403|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373404|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373405|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
56373406|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373407|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56373408|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
56373409|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373410|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56373411|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56373412|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373413|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56373414|NCT00102479|Aripiprazole|aripiprazole|mesh-list
56373415|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
56373416|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373417|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56373418|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56373419|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653804|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56653805|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
56653806|NCT02679092|Misoprostol|misoprostol|mesh-list
56653807|NCT02679092|Mifepristone|mifepristone|mesh-list
56653808|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56653809|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
56653810|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56653811|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653812|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56653813|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56653814|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
56653815|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56653816|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56653817|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56653818|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56653819|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
56653820|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56653821|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56653822|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
56653823|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653824|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
56653825|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56653826|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56653827|NCT00642122|Budesonide|budesonide|mesh-list
56653828|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653829|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56653830|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
56653831|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653832|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373420|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373421|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
56373422|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
56373423|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373424|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373425|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56373426|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56373427|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
56373428|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56373429|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56373430|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56373431|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56373432|NCT00135954|Prednisolone|prednisolone|mesh-list
56373433|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
56653833|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56653834|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
56653835|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
56653836|NCT00642122|Hormones|hormones|mesh-ancestor
56653837|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56653838|NCT02817113|Fluorouracil|fluorouracil|mesh-list
56653839|NCT02817113|Cetuximab|cetuximab|mesh-list
56653840|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
56653841|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653842|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56653843|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653844|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56653845|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
56653846|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653847|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653848|NCT02801201|Midazolam|midazolam|mesh-list
56653849|NCT02801201|Bupivacaine|bupivacaine|mesh-list
56653850|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
56653851|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
56653852|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653853|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653854|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
56653855|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653856|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56653857|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56653858|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56653859|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56653860|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56653861|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56653862|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
56653863|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
56653864|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
56653865|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653866|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653867|NCT04182932|Vaccines|vaccines|mesh-list
56373434|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56373435|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
56373436|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373437|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55916440|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
56653868|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
56653869|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653870|NCT03951805|Insulin|insulin|mesh-list
56653871|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56653872|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
56653873|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56653874|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653875|NCT02681198|Lofexidine|lofexidine|mesh-list
56653876|NCT02681198|Paroxetine|paroxetine|mesh-list
56653877|NCT02681198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56653878|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56653879|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56653880|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653881|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653882|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
56653883|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653884|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56653885|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
56653886|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56653887|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56653888|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56653889|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653890|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56653891|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56653892|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
56653893|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653894|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56653895|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56653896|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56653897|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
56653898|NCT05597306|Venetoclax|venetoclax|mesh-list
56653899|NCT05597306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653900|NCT00962533|Telbivudine|telbivudine|mesh-list
56653901|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
56653902|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653903|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56216312|NCT01624025|Epirubicin|epirubicin|mesh-list
56653904|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653905|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653906|NCT00642980|Clindamycin|clindamycin|mesh-list
56653907|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
56653908|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
56653909|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56653910|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653911|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56653912|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653913|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653914|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
56216344|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
56373438|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56373439|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
56373440|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373441|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373442|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56373443|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56373444|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
56373446|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56373447|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56373448|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
56373458|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373459|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56373460|NCT00102635|Protective Agents|protective agents|mesh-ancestor
56373461|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373462|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995312|NCT00952133|Hormones|hormones|mesh-ancestor
56373463|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373464|NCT00133419|Vitamins|vitamins|mesh-list
56373465|NCT00133419|Vitamin A|vitamin a|mesh-list
56373466|NCT00133419|Zinc|zinc|mesh-list
56373467|NCT00133419|Trace Elements|trace elements|mesh-list
56373468|NCT00133419|Micronutrients|micronutrients|mesh-list
56373469|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
56373470|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373471|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
56373472|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373473|NCT00133419|Protective Agents|protective agents|mesh-ancestor
56373474|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56373475|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373476|NCT00102674|Cangrelor|cangrelor|mesh-list
56373477|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56373478|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56373479|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56373480|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56373481|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
56373482|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373483|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373484|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373485|NCT00135993|Rotigotine|rotigotine|mesh-list
56373486|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
56373487|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
56373488|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373489|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373490|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373491|NCT00102713|Valproic Acid|valproic acid|mesh-list
56373492|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
56373493|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373494|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373495|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
56373496|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56653915|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653916|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
56653917|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56653918|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56653919|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653920|NCT02798159|Urological Agents|urological agents|mesh-ancestor
56653921|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
56653922|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56653923|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653924|NCT02678780|Lenvatinib|lenvatinib|mesh-list
56653925|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653926|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56653927|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373497|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373498|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
56373499|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56373500|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56373501|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373502|NCT00133458|Albendazole|albendazole|mesh-list
56373503|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
56373504|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56172425|NCT05767632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56373505|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373506|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
56373507|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56373508|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56373509|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
56373510|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
56373511|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
56373512|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373513|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373514|NCT00102752|Gemcitabine|gemcitabine|mesh-list
56373517|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373519|NCT00102752|Antiviral Agents|antiviral agents|mesh-ancestor
56373520|NCT00102752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373521|NCT00102752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373522|NCT00102752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56373523|NCT00102752|Immunologic Factors|immunologic factors|mesh-ancestor
56373524|NCT00102752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373525|NCT00102830|Trebananib|trebananib|mesh-list
56373526|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56373527|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56373528|NCT00102830|Growth Substances|growth substances|mesh-ancestor
56373529|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373530|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
56373531|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373533|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
56373534|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373535|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373536|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
56373537|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373538|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373539|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
56373540|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56373541|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56373542|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373543|NCT00136188|Folic Acid|folic acid|mesh-list
56373544|NCT00136188|Hematinics|hematinics|mesh-ancestor
56373545|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
56373546|NCT00136188|Vitamins|vitamins|mesh-ancestor
56373547|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
56373548|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373549|NCT00102869|Levodopa|levodopa|mesh-list
56653928|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653929|NCT00963001|Treprostinil|treprostinil|mesh-list
56653930|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56653931|NCT00643136|Pregabalin|pregabalin|mesh-list
56653932|NCT00643136|Analgesics|analgesics|mesh-ancestor
56653933|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
56373550|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56373551|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56373552|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
56373553|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373554|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373555|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373556|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
56373557|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56373558|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373559|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
56373560|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373561|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56373562|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373563|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373564|NCT00136266|Vitamin D|vitamin d|mesh-list
56373565|NCT00136266|Vitamins|vitamins|mesh-list
56373566|NCT00136266|Vitamin A|vitamin a|mesh-list
56373567|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
56373568|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
56373569|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373570|NCT00136266|Trace Elements|trace elements|mesh-ancestor
56373571|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56373572|NCT00102947|Daptomycin|daptomycin|mesh-list
56172433|NCT05767515|Vitamins|vitamins|mesh-ancestor
56373574|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373575|NCT00136344|Levofloxacin|levofloxacin|mesh-list
56373576|NCT00136344|Ofloxacin|ofloxacin|mesh-list
56373577|NCT00136344|Cefuroxime|cefuroxime|mesh-list
56373578|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
56373579|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56373580|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373581|NCT00136344|Renal Agents|renal agents|mesh-ancestor
56373582|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56373583|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56373584|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56373585|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373586|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373587|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373588|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56373589|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56373600|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373601|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56373602|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56373603|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56373605|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56373606|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56373607|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56373608|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373610|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373611|NCT00136383|Analgesics|analgesics|mesh-ancestor
56373612|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
56373613|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373614|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
56373615|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373616|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
56373617|NCT00136383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56373618|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
56373619|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56373620|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56373621|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56373622|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373624|NCT00103103|Fluorouracil|fluorouracil|mesh-list
56373625|NCT00103103|Bortezomib|bortezomib|mesh-list
56653934|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56653935|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653936|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
56300001|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
56653941|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56653942|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56653943|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56653944|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56653945|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56653946|NCT01563367|Hematinics|hematinics|mesh-ancestor
56653947|NCT00963313|Adalimumab|adalimumab|mesh-list
56653948|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56653949|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56653950|NCT02797145|Digoxin|digoxin|mesh-list
56653951|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56653952|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56653953|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653954|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653955|NCT02797145|Protective Agents|protective agents|mesh-ancestor
56373626|NCT00103103|Calcium|calcium|mesh-list
56373627|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
56373628|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56373629|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373630|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
56373631|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373632|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56373633|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373634|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56373635|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
56373636|NCT00103103|Antidotes|antidotes|mesh-ancestor
56373637|NCT00103103|Protective Agents|protective agents|mesh-ancestor
56373638|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
56373639|NCT00103103|Vitamins|vitamins|mesh-ancestor
56373640|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
56373641|NCT00133692|Atenolol|atenolol|mesh-list
56373642|NCT00133692|Verapamil|verapamil|mesh-list
56373643|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56373644|NCT00133692|Trandolapril|trandolapril|mesh-list
56373645|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56373646|NCT00133692|Diuretics|diuretics|mesh-ancestor
56373647|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
56373648|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373649|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56373650|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56373651|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373652|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56373653|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
56373654|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
56373655|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373656|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56373666|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373667|NCT00133731|Heparin|heparin|mesh-list
56373668|NCT00133731|Calcium heparin|calcium heparin|mesh-list
56373669|NCT00133731|Otamixaban|otamixaban|mesh-list
56373670|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
56373671|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56373672|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56373673|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373674|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56653956|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653957|NCT02690129|Progesterone|progesterone|mesh-list
56653958|NCT02690129|Progestins|progestins|mesh-ancestor
56653959|NCT02690129|Hormones|hormones|mesh-ancestor
56653960|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56373675|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
56373676|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56373677|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
56373678|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373679|NCT00103298|Leucovorin|leucovorin|mesh-list
56373680|NCT00103298|Fluorouracil|fluorouracil|mesh-list
56373681|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
56373682|NCT00103298|Melphalan|melphalan|mesh-list
56373683|NCT00103298|Calcium|calcium|mesh-list
56373684|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
56373685|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56373686|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373687|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
56373688|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373689|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56373690|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373691|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56373692|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
56373693|NCT00103298|Antidotes|antidotes|mesh-ancestor
56373694|NCT00103298|Protective Agents|protective agents|mesh-ancestor
56373695|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
56373696|NCT00103298|Vitamins|vitamins|mesh-ancestor
56373698|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56373699|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
56373700|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56373701|NCT00136461|Tretinoin|tretinoin|mesh-list
56373702|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
56373703|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373704|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
56373705|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
56373706|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56373707|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
56373708|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373709|NCT00133770|Pantoprazole|pantoprazole|mesh-list
56373710|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56373711|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56373712|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56373713|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373714|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373715|NCT00133848|Retapamulin|retapamulin|mesh-list
56373716|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56373717|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373718|NCT00133887|Sirolimus|sirolimus|mesh-list
56373719|NCT00133887|Cyclosporine|cyclosporine|mesh-list
56373720|NCT00133887|Tacrolimus|tacrolimus|mesh-list
56373721|NCT00133887|Cyclosporins|cyclosporins|mesh-list
56373722|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56373723|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
56373724|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373725|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56373727|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373728|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56373729|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373730|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56373731|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373732|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
56373733|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
56373734|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56373735|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
56373736|NCT00136539|Doxorubicin|doxorubicin|mesh-list
56373737|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56373738|NCT00136539|Trastuzumab|trastuzumab|mesh-list
56373739|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56373740|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
56373741|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373742|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56373743|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56373744|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
55916577|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
56653961|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56653962|NCT00883116|Paclitaxel|paclitaxel|mesh-list
56653963|NCT00883116|Doxorubicin|doxorubicin|mesh-list
56653964|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56653965|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56653966|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653967|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
56653968|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
56653969|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
56653970|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653971|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56653972|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56653973|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56653974|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653975|NCT02139397|Eflornithine|eflornithine|mesh-list
56653976|NCT02139397|Bortezomib|bortezomib|mesh-list
55776732|NCT04959175|Sirolimus|sirolimus|mesh-list
56373745|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373746|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373747|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56373748|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56373749|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56373750|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56373751|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373752|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56373753|NCT00103571|Olanzapine|olanzapine|mesh-list
56373754|NCT00103571|Aripiprazole|aripiprazole|mesh-list
56373755|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
56373756|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
56373757|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373758|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373759|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56373760|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56373761|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56373762|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56373763|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373764|NCT00103571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56373765|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56373766|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56373767|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995607|NCT01008059|Analgesics|analgesics|mesh-ancestor
56373768|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373769|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
56373770|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
56373771|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
56373772|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
56373773|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56373774|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56373775|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56373776|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56373777|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56373778|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56373779|NCT00136578|Carboplatin|carboplatin|mesh-list
56373780|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373782|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56373783|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56373784|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
56373785|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916578|NCT00713583|Levodopa|levodopa|mesh-list
56653977|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653978|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56653979|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56653980|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56653981|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653982|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56653983|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373786|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373787|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373788|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
56373789|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56373790|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56373791|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56373792|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373793|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56373794|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56373795|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373796|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
56373797|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
56373811|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
56373812|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56373813|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56373814|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56373815|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373816|NCT00103805|Levodopa|levodopa|mesh-list
56373817|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56373818|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56373819|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
56373820|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373821|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373822|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373823|NCT00404040|Lactulose|lactulose|mesh-list
56373824|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56373825|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56373826|NCT00404040|Laxatives|laxatives|mesh-ancestor
56373827|NCT00103922|Cilomilast|cilomilast|mesh-list
56373828|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56373829|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56373830|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373831|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373832|NCT00134160|Amlodipine|amlodipine|mesh-list
56373833|NCT00134160|Olmesartan|olmesartan|mesh-list
56373835|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
56373836|NCT00134160|Calcium|calcium|mesh-list
56373837|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56373838|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373839|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56373840|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56373841|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373843|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56373844|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56373845|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56373846|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56373847|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373848|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
56373849|NCT00134199|Sibutramine|sibutramine|mesh-list
56373850|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
56373851|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373852|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
56373853|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56373854|NCT04729088|Isosorbide|isosorbide|mesh-list
56373855|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56373856|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56373857|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56373858|NCT04729088|Diuretics|diuretics|mesh-ancestor
56373859|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
56373860|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373864|NCT00136734|Methylphenidate|methylphenidate|mesh-list
55916579|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56653984|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653985|NCT02795429|Spartalizumab|spartalizumab|mesh-list
56653986|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56653987|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56653988|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56653989|NCT00643292|Amoxicillin|amoxicillin|mesh-list
56653990|NCT00643292|Azithromycin|azithromycin|mesh-list
56653991|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
56653992|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
56653993|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56653994|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56653995|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56653996|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56653997|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56653998|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654004|NCT02797067|Indomethacin|indomethacin|mesh-list
56654005|NCT02797067|Glycerol|glycerol|mesh-list
56654006|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56654007|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654008|NCT02797067|Analgesics|analgesics|mesh-ancestor
56654009|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
56654010|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654011|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216370|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
56373865|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56373866|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373867|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56373868|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56373869|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56373870|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373871|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
56373872|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373874|NCT00136773|Benazepril|benazepril|mesh-list
56373875|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56373876|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56373877|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56373878|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373879|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56373880|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373881|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
56373882|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56373883|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
56373884|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373885|NCT00136851|Amlodipine|amlodipine|mesh-list
56373886|NCT00136851|Benazepril|benazepril|mesh-list
56373887|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56373888|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56373889|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56654012|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56654013|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56216392|NCT01624337|Piperaquine|piperaquine|mesh-list
56373890|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373891|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56373892|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373893|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
56373894|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56373895|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
56373896|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373897|NCT00104273|Rasagiline|rasagiline|mesh-list
56373898|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56373899|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373900|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373901|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56373902|NCT00104273|Protective Agents|protective agents|mesh-ancestor
56373903|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373904|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56373905|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56373906|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373907|NCT00134355|Vatalanib|vatalanib|mesh-list
56373908|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56373909|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373910|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373911|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56373912|NCT00104429|Aplaviroc|aplaviroc|mesh-list
56373913|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56373914|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56373916|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373917|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
56373918|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373919|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56373920|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56373921|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56373922|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56373923|NCT00136968|Voriconazole|voriconazole|mesh-list
56373924|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
56373925|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373926|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56373927|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56373928|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887873|NCT03311178|Dobutamine|dobutamine|mesh-list
56373937|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56373938|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56373939|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
56373940|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373941|NCT00137007|Azithromycin|azithromycin|mesh-list
56373942|NCT00137007|Ampicillin|ampicillin|mesh-list
56373943|NCT00137007|Sulbactam|sulbactam|mesh-list
56373944|NCT00137007|Sultamicillin|sultamicillin|mesh-list
56373945|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56373946|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373947|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56373948|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373949|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373950|NCT00137085|Ketamine|ketamine|mesh-list
56373951|NCT00137085|Analgesics|analgesics|mesh-ancestor
56373952|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
56373953|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373954|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373955|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56373956|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56373957|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
56373958|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
56373959|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56373960|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56373961|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56373962|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373963|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373964|NCT00104546|Vitamin K|vitamin k|mesh-list
56373965|NCT00104546|Vitamins|vitamins|mesh-ancestor
56373966|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
56654014|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
56654015|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
56654016|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56654017|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56654018|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654019|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654020|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56654021|NCT02797067|Protective Agents|protective agents|mesh-ancestor
56654022|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
56654023|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56373967|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373968|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56373969|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56373970|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373971|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
56373972|NCT00104546|Coagulants|coagulants|mesh-ancestor
56373973|NCT00134394|Etanercept|etanercept|mesh-list
56373974|NCT00134394|Tacrolimus|tacrolimus|mesh-list
56373975|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56373976|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
56373977|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373978|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56373979|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373980|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373981|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56373982|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56373984|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
56373985|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373986|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56373988|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56373989|NCT00104624|Docetaxel|docetaxel|mesh-list
56373990|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373991|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
56373992|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
56373993|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
56373994|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373995|NCT00104663|Quinacrine|quinacrine|mesh-list
56373996|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
56374000|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374002|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56374003|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
56374004|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374005|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374006|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374007|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56374008|NCT00104741|Flutamide|flutamide|mesh-list
56374009|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
56374010|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56374011|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
56374012|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56374013|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374014|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56374015|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56374016|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374017|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
56374018|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
56374019|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374020|NCT00134511|Atorvastatin|atorvastatin|mesh-list
56374021|NCT00134511|Torcetrapib|torcetrapib|mesh-list
56374022|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56374023|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56374024|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
56374025|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374026|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55916929|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56654024|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654025|NCT00963703|Rituximab|rituximab|mesh-list
56654026|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56654027|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374027|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56374028|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374029|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
56374030|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56374031|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
56374032|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374033|NCT00134550|Atorvastatin|atorvastatin|mesh-list
56374034|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56374035|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56374036|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
56374037|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374038|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56374039|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56374040|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374041|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
56374042|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56374043|NCT00104819|Antibodies|antibodies|mesh-list
56374044|NCT00104819|Sargramostim|sargramostim|mesh-list
56374045|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56374046|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
56374047|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374048|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
56374049|NCT00137202|Promethazine|promethazine|mesh-list
56374050|NCT00137202|Ondansetron|ondansetron|mesh-list
56374051|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
56374052|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
56374053|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374054|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374055|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56374056|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
56374057|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
56374058|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56374059|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
56374060|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374061|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374062|NCT00137202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56374063|NCT00137202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56374064|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56374065|NCT00137202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56374066|NCT00137202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56374067|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56374068|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56374089|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56374090|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374091|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56374092|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
56374093|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56374094|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56374095|NCT00137358|Amifostine|amifostine|mesh-list
56374096|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56374097|NCT00137358|Protective Agents|protective agents|mesh-ancestor
56374098|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374099|NCT00134667|Verteporfin|verteporfin|mesh-list
56374100|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56374101|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
56374102|NCT00134706|Carboplatin|carboplatin|mesh-list
56374103|NCT00134706|Docetaxel|docetaxel|mesh-list
56374104|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374105|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
56374106|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
56374107|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
56374108|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374109|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56374110|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56374111|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56374112|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
56374113|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374114|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654028|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
56654029|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654030|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654031|NCT00655122|Dalteparin|dalteparin|mesh-list
56654032|NCT00655122|Tinzaparin|tinzaparin|mesh-list
56654033|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56654034|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
56654035|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56374115|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374116|NCT00137397|Urological Agents|urological agents|mesh-ancestor
56374117|NCT00134745|Estradiol|estradiol|mesh-list
56374118|NCT00134745|Estrogens|estrogens|mesh-ancestor
56374119|NCT00134745|Hormones|hormones|mesh-ancestor
56374120|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374121|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374122|NCT00105209|Aspirin|aspirin|mesh-list
56374123|NCT00105209|Clopidogrel|clopidogrel|mesh-list
56374124|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56374125|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56374126|NCT00105209|Analgesics|analgesics|mesh-ancestor
56374127|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
55888072|NCT03307512|Insulin|insulin|mesh-list
56374130|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56374131|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56374132|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56374133|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56374134|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374135|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56374136|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56374137|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374138|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
56374139|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56374140|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56374142|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
56374143|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374144|NCT00105287|Fentanyl|fentanyl|mesh-list
56374145|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56374146|NCT00105287|Narcotics|narcotics|mesh-ancestor
56374147|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56374148|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374149|NCT00105287|Analgesics|analgesics|mesh-ancestor
56374150|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
56374151|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374152|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56374153|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56374154|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
56374155|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
56374156|NCT00137514|Chloroquine|chloroquine|mesh-list
56374157|NCT00137514|Amodiaquine|amodiaquine|mesh-list
56374158|NCT00137514|Amebicides|amebicides|mesh-ancestor
56374159|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56374160|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56374161|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374162|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
56374163|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56374164|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56374165|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56374166|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56374167|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56374168|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374169|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56374170|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56374171|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56374172|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
56374173|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374174|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374175|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56374176|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56374177|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
56374179|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
56654036|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56654037|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654038|NCT02638116|Omeprazole|omeprazole|mesh-list
56654039|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56654040|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56654041|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56654042|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654043|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654044|NCT04164264|Propofol|propofol|mesh-list
56654045|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56216401|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374180|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56374181|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
56374182|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56374183|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56374184|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374185|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56374186|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374187|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374188|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56374189|NCT00137553|Renal Agents|renal agents|mesh-ancestor
56374190|NCT00105404|Triamcinolone|triamcinolone|mesh-list
56374191|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56374192|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56374193|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56374194|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56374195|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
56374196|NCT00105404|Hormones|hormones|mesh-ancestor
56374197|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374198|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374199|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374200|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
56374201|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888121|NCT05726916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374213|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
56374214|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374215|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374217|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56374218|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56374219|NCT00135018|Analgesics|analgesics|mesh-ancestor
56374220|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
56374221|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374222|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374223|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56374224|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56374225|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56374226|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56374227|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374228|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374229|NCT00137709|Lamotrigine|lamotrigine|mesh-list
56374230|NCT00137709|Valproic Acid|valproic acid|mesh-list
56374231|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
56374232|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56374233|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56374234|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374235|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56374236|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374237|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56374238|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56374239|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56374240|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56374241|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56654046|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654047|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216411|NCT01624493|Gemcitabine|gemcitabine|mesh-list
56374242|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374243|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
56374244|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374245|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
56374246|NCT01054144|Dexamethasone|dexamethasone|mesh-list
56374247|NCT01054144|Prednisone|prednisone|mesh-list
56374248|NCT01054144|Lenalidomide|lenalidomide|mesh-list
56374249|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56374250|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
56374251|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
56374252|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374253|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374254|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56374255|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
56374256|NCT01054144|Hormones|hormones|mesh-ancestor
56374257|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374258|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56374259|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374260|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
56374261|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56374262|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56374263|NCT01054144|Growth Substances|growth substances|mesh-ancestor
55888197|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
56374266|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56374268|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374269|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374270|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56374271|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56374272|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
56374273|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374274|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374275|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
56374276|NCT00137787|Cefepime|cefepime|mesh-list
56374277|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56374279|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56374280|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56374281|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374282|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374283|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374284|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56374285|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56374286|NCT04702048|Aflibercept|aflibercept|mesh-list
56374287|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56374288|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56374289|NCT04702048|Growth Substances|growth substances|mesh-ancestor
56374290|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374291|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
56374292|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374293|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
56374294|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374295|NCT00135057|Insulin|insulin|mesh-list
56374296|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56374297|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
56374298|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
56374299|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56374300|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374301|NCT00434668|Cisplatin|cisplatin|mesh-list
56374302|NCT00434668|Docetaxel|docetaxel|mesh-list
56374303|NCT00434668|Vinorelbine|vinorelbine|mesh-list
56374304|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374305|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
56374306|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
56374307|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
56374308|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374309|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56374310|NCT00434746|Fezakinumab|fezakinumab|mesh-list
56374311|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
56374312|NCT00137826|Bevacizumab|bevacizumab|mesh-list
56374313|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56374314|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56374315|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654048|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56654049|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
56654050|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
56654051|NCT02795039|Fulvestrant|fulvestrant|mesh-list
56654052|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56654053|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654054|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56654055|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56654056|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
56654057|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654058|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654059|NCT02796833|SMOFlipid|smoflipid|mesh-list
56654060|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56654061|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56654062|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56654063|NCT04009603|Metformin|metformin|mesh-list
56654064|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56654065|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654066|NCT02635230|Aspirin|aspirin|mesh-list
56654067|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56654068|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654069|NCT02635230|Analgesics|analgesics|mesh-ancestor
56654070|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
56654071|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654072|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654073|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56654074|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56374316|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56374317|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56374318|NCT00137826|Growth Substances|growth substances|mesh-ancestor
56374319|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374320|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
56374321|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56374322|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374323|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374324|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
56374325|NCT00434824|Testosterone|testosterone|mesh-list
56374326|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
56374327|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
56374328|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56374329|NCT00434824|Androgens|androgens|mesh-ancestor
56374330|NCT00434824|Hormones|hormones|mesh-ancestor
56374331|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374332|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374333|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56374334|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374335|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
56654075|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56654076|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56374336|NCT00105950|Lapatinib|lapatinib|mesh-list
56374337|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374338|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56374343|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56374344|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56374345|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56374346|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374347|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
56374348|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374349|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374350|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56374351|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374353|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374354|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
56374355|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374356|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374357|NCT00135096|Insulin|insulin|mesh-list
56374358|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56374359|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
56374360|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
56374361|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56374362|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374363|NCT00435058|Timolol|timolol|mesh-list
56374364|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56374365|NCT00435058|Travoprost|travoprost|mesh-list
56374366|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374367|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56374368|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56374369|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
56374370|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374371|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374372|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56374373|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56374374|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56374375|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56374376|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56374378|NCT00435175|Estrogens|estrogens|mesh-ancestor
56374379|NCT00435175|Hormones|hormones|mesh-ancestor
56374380|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374381|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374382|NCT00135135|Carboplatin|carboplatin|mesh-list
56374383|NCT00135135|Doxorubicin|doxorubicin|mesh-list
56374384|NCT00135135|Irinotecan|irinotecan|mesh-list
56374385|NCT00135135|Etoposide|etoposide|mesh-list
56374386|NCT00135135|Melphalan|melphalan|mesh-list
56374387|NCT00135135|Topotecan|topotecan|mesh-list
56374388|NCT00135135|Gefitinib|gefitinib|mesh-list
56374389|NCT00135135|Tretinoin|tretinoin|mesh-list
56374390|NCT00135135|Isotretinoin|isotretinoin|mesh-list
56374391|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374392|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56374393|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56374394|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56374395|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374396|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374397|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56374398|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56374399|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56374400|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
56374401|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56374402|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374403|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
56374404|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374405|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56374406|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
56374407|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
56374408|NCT00435292|Naproxen|naproxen|mesh-list
56374409|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56374410|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56374418|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56374419|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051871|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56654077|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654078|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56654079|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56654080|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374420|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374422|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56374423|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56374424|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56374425|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374426|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56374427|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374428|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
56374429|NCT00435448|Lonidamine|lonidamine|mesh-list
56374430|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374431|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56374432|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374433|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56374434|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
56374435|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56374436|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56374437|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56374438|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56374439|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374440|NCT00435760|Bromides|bromides|mesh-list
56374441|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
56374442|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56374443|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
56374444|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374445|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374446|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56374447|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
56374448|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
56374449|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56374450|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
56374451|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374452|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374453|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
56374454|NCT00435799|Riboflavin|riboflavin|mesh-list
56374455|NCT00435799|Dextrans|dextrans|mesh-list
56374456|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56374457|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
56374458|NCT00435799|Vitamins|vitamins|mesh-ancestor
56374459|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
56374460|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374461|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56374462|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
56374463|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56374464|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
56374465|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
56374466|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
56374467|NCT00142467|Gemcitabine|gemcitabine|mesh-list
56374468|NCT00142467|Bevacizumab|bevacizumab|mesh-list
56374469|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
56374470|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56374471|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374472|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56374473|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56374474|NCT00142467|Growth Substances|growth substances|mesh-ancestor
56374475|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374476|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
56374477|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374478|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
55888401|NCT02720484|Nivolumab|nivolumab|mesh-list
56374486|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56374487|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374488|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
56374489|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374490|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56374492|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
56374493|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56654081|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
56654082|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56654083|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
56654084|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
56654085|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56374494|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56374495|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56374496|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374497|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374498|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374499|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56374500|NCT00436033|Analgesics|analgesics|mesh-ancestor
56374501|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
56374502|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374504|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56374505|NCT00436072|Irinotecan|irinotecan|mesh-list
56374506|NCT00436072|Cetuximab|cetuximab|mesh-list
56374507|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56374508|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56374509|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374510|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374511|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374512|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56374513|NCT03275857|Cisplatin|cisplatin|mesh-list
56374514|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374515|NCT03279289|Leucovorin|leucovorin|mesh-list
56374516|NCT03279289|Folic Acid|folic acid|mesh-list
56374517|NCT03279289|Fluorouracil|fluorouracil|mesh-list
56374518|NCT03279289|Irinotecan|irinotecan|mesh-list
56374519|NCT03279289|Aflibercept|aflibercept|mesh-list
56374520|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
56374521|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
56374522|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374523|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374524|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374525|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374526|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
56374527|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374528|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56374529|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56374530|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374531|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56374532|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56374533|NCT03279289|Growth Substances|growth substances|mesh-ancestor
56374534|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
56374535|NCT03279289|Antidotes|antidotes|mesh-ancestor
56374536|NCT03279289|Protective Agents|protective agents|mesh-ancestor
56374537|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
56374538|NCT03279289|Vitamins|vitamins|mesh-ancestor
56374539|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
56374540|NCT03279289|Hematinics|hematinics|mesh-ancestor
56374541|NCT03276052|Bromides|bromides|mesh-list
56374542|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
56374543|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
56374544|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56374545|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
56374546|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56374547|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
56374548|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888467|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374549|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374551|NCT04702360|Ivacaftor|ivacaftor|mesh-list
56374552|NCT04702360|Elexacaftor|elexacaftor|mesh-list
56374553|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56374554|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56374555|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374556|NCT04702204|Denosumab|denosumab|mesh-list
56374557|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56374558|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374559|NCT00138060|Fluorouracil|fluorouracil|mesh-list
56374560|NCT00138060|Irinotecan|irinotecan|mesh-list
56374561|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
56374562|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654086|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
56654087|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56654088|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
56654089|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56654090|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654091|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56654092|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56654093|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654094|NCT04009525|Cyclosporine|cyclosporine|mesh-list
56654095|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
56654096|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
56654097|NCT04009525|Busulfan|busulfan|mesh-list
56374563|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374564|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374565|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374566|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
56374567|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374568|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56374569|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56374570|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374571|NCT04702009|Antibodies|antibodies|mesh-list
56374572|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56374573|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
56374574|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374575|NCT00142545|Apomorphine|apomorphine|mesh-list
56374576|NCT00142545|Emetics|emetics|mesh-ancestor
56374577|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374578|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
56374579|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374580|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56374581|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
56374582|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
56374583|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374584|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374585|NCT00106262|Irinotecan|irinotecan|mesh-list
56374586|NCT00106262|Bortezomib|bortezomib|mesh-list
56374587|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56374588|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55996431|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
56374589|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172557|NCT05757557|Antioxidants|antioxidants|mesh-ancestor
56374590|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374591|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374592|NCT00106301|Romidepsin|romidepsin|mesh-list
56374593|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56374594|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374596|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
56374597|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374598|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374599|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374600|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374601|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
56374602|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374603|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
56374604|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56374605|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374606|NCT00138099|Dalteparin|dalteparin|mesh-list
56374607|NCT00138099|Tinzaparin|tinzaparin|mesh-list
56374608|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56374609|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
56374610|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56374611|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56374612|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374613|NCT00106379|Tenofovir|tenofovir|mesh-list
56374614|NCT00106379|Emtricitabine|emtricitabine|mesh-list
56654098|NCT04009525|Methotrexate|methotrexate|mesh-list
56654099|NCT04009525|Fludarabine|fludarabine|mesh-list
56654100|NCT04009525|Tacrolimus|tacrolimus|mesh-list
56654101|NCT04009525|Cyclosporins|cyclosporins|mesh-list
56654102|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
56654103|NCT04009525|Basiliximab|basiliximab|mesh-list
56654104|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654105|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
55777560|NCT02893241|Cafedrine|cafedrine|mesh-list
56374615|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56374616|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
56374617|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374618|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56374619|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56374620|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374621|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374631|NCT00436423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374632|NCT00436423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374633|NCT00436423|Immunologic Factors|immunologic factors|mesh-ancestor
56374634|NCT00436423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374635|NCT00436579|Sorafenib|sorafenib|mesh-list
56374636|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374637|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56374638|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374639|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374640|NCT00436657|Cisplatin|cisplatin|mesh-list
56374641|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374642|NCT00106418|Romidepsin|romidepsin|mesh-list
56374643|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56374644|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374645|NCT00436930|Sargramostim|sargramostim|mesh-list
56374646|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
56374647|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374648|NCT00437008|Benphothiamine|benphothiamine|mesh-list
56374649|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56374650|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
56374651|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374652|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
56374653|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
56374654|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374655|NCT00437086|Bortezomib|bortezomib|mesh-list
56374656|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374657|NCT00437164|Insulin|insulin|mesh-list
56374658|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56374659|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56374660|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374661|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56374662|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56374663|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
56374664|NCT00106496|Tacrolimus|tacrolimus|mesh-list
56374665|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374666|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
56374667|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374668|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56374669|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374670|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374672|NCT00437359|Anastrozole|anastrozole|mesh-list
56374673|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374674|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56374675|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374676|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56374677|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56374678|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374679|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56374680|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
56374681|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374682|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374683|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56654106|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654107|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654108|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55777670|NCT04752527|Decitabine|decitabine|mesh-list
56374684|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56374685|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56374686|NCT00437476|Ribavirin|ribavirin|mesh-list
56374687|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55888621|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56374692|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374693|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56374694|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374695|NCT00437554|Glimepiride|glimepiride|mesh-list
56374696|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56374697|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56374698|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374699|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374700|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
56374701|NCT00437632|Caffeine|caffeine|mesh-list
56374702|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56374703|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374704|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56374705|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374706|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374707|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56374708|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56374709|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
56374710|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374711|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
56374712|NCT00437671|Antibodies|antibodies|mesh-list
56374713|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
56374714|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56374715|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56374716|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
56374717|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374718|NCT00106613|Romidepsin|romidepsin|mesh-list
56374719|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56374720|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374721|NCT00401180|Docetaxel|docetaxel|mesh-list
56374722|NCT00401180|Temozolomide|temozolomide|mesh-list
56374723|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374724|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
56374725|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
56374726|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
56374727|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374728|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56374729|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
56374730|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
56374731|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56374732|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374733|NCT00401219|Estrogens|estrogens|mesh-list
56374734|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56374735|NCT00401219|Progestins|progestins|mesh-list
56374736|NCT00401219|Hormones|hormones|mesh-ancestor
56374737|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374738|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374739|NCT04701463|Calcium|calcium|mesh-list
56374740|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56374741|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374742|NCT00438139|Dronabinol|dronabinol|mesh-list
56374743|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
56374745|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56374746|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56374747|NCT00438139|Analgesics|analgesics|mesh-ancestor
56374748|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
56374749|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374750|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56374751|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56374752|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374753|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374754|NCT00438139|Hormones|hormones|mesh-ancestor
56051872|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
56654109|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
56654110|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654111|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654112|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56654113|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56654114|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
56654115|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56654116|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56654117|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
56654118|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
56654119|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374755|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374756|NCT00438178|Obatoclax|obatoclax|mesh-list
56374757|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374758|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374764|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56374765|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374766|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56374767|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374768|NCT00438217|Hormones|hormones|mesh-ancestor
56374769|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374770|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
56374771|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56374772|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
56374773|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56374774|NCT00106691|Toremifene|toremifene|mesh-list
56374775|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56374776|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374777|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56374778|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56374779|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
56374780|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374781|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374782|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56374783|NCT03279757|Lidocaine|lidocaine|mesh-list
56374784|NCT03279757|Epinephrine|epinephrine|mesh-list
56374785|NCT03279757|Racepinephrine|racepinephrine|mesh-list
56374786|NCT03279757|Tetracaine|tetracaine|mesh-list
56374787|NCT03279757|Carticaine|carticaine|mesh-list
56374788|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
56374789|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
56374790|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
56374791|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56374792|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374793|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
56374794|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374795|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56374796|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56374797|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56374798|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56374799|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374800|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56374801|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56374802|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
56374803|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374804|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56374805|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56374806|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
56374807|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56374808|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
56374809|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
56654120|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56654121|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56654122|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56654123|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
56654124|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654125|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56654126|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56654127|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
56654128|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56654129|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
56654130|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56654131|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
56654132|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654133|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654134|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56216470|NCT01625156|Sirolimus|sirolimus|mesh-list
56374810|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
56374811|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56374812|NCT00438568|Insulin|insulin|mesh-list
56374813|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56374814|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56374815|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996655|NCT00982280|Analgesics|analgesics|mesh-ancestor
56374816|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
56374817|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56374818|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56374819|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56374820|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
56374821|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374822|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374823|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374825|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
56374826|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55888752|NCT01886872|Antibodies|antibodies|mesh-list
56374829|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
56374830|NCT00106886|Pyridoxal|pyridoxal|mesh-list
56374831|NCT00106886|Pyridoxine|pyridoxine|mesh-list
56374832|NCT00106886|Vitamins|vitamins|mesh-ancestor
56374833|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
56374834|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374835|NCT00106886|Hematinics|hematinics|mesh-ancestor
56374836|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
56374837|NCT00438841|Thalidomide|thalidomide|mesh-list
56374838|NCT00438841|Dexamethasone|dexamethasone|mesh-list
56374839|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
56374840|NCT00438841|Bortezomib|bortezomib|mesh-list
56374841|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374842|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
56374843|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374844|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56374845|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56374846|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
56374847|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374848|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374849|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56374850|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56374851|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
56374852|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
56374853|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172587|NCT05751343|Atezolizumab|atezolizumab|mesh-list
56654135|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
56654136|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56654137|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
56654138|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654139|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654140|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56654141|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
56654142|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
56654143|NCT04032366|Protective Agents|protective agents|mesh-ancestor
56654144|NCT02537600|Vemurafenib|vemurafenib|mesh-list
56654145|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654146|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56654147|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654148|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654149|NCT00684099|Docetaxel|docetaxel|mesh-list
56654150|NCT00684099|Pemetrexed|pemetrexed|mesh-list
56654151|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654152|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
56654153|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
56654154|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
56216484|NCT01625260|Antiviral Agents|antiviral agents|mesh-ancestor
56374854|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56374855|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
56374856|NCT00438841|Hormones|hormones|mesh-ancestor
56374857|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56374858|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56374859|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
56374860|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56374861|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374862|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56374863|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56374864|NCT00438841|Growth Substances|growth substances|mesh-ancestor
56374865|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
56374866|NCT00438958|Lenograstim|lenograstim|mesh-list
56374867|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56374868|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
56374869|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374870|NCT00107003|Lapatinib|lapatinib|mesh-list
56374871|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374872|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56374873|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374874|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374875|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56374876|NCT00107081|Amoxicillin|amoxicillin|mesh-list
56374877|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
56374878|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374879|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56374880|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56374881|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374882|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374883|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374884|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56374885|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56374886|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56654155|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654156|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777842|NCT02969837|Hormones|hormones|mesh-ancestor
56374887|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56374888|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56374889|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
56374890|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374891|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374892|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374893|NCT00439192|Urological Agents|urological agents|mesh-ancestor
56374894|NCT00439426|Capecitabine|capecitabine|mesh-list
56374895|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
56374896|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374897|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
56374898|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374899|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374900|NCT00138138|Methylphenidate|methylphenidate|mesh-list
56172595|NCT05702853|Cyclophosphamide|cyclophosphamide|mesh-list
56374919|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
56374921|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56374922|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
56374923|NCT00107237|Everolimus|everolimus|mesh-list
56374924|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374925|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374926|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
56374927|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374928|NCT00439699|Memantine|memantine|mesh-list
56374929|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56374930|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56374931|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
56374932|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374933|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374934|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374935|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56374936|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56374937|NCT00439855|Heparin|heparin|mesh-list
56374938|NCT00439855|Enoxaparin|enoxaparin|mesh-list
56374939|NCT00439855|Calcium heparin|calcium heparin|mesh-list
56374940|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
56374941|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56374942|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56374943|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374944|NCT00107354|Cytarabine|cytarabine|mesh-list
56374945|NCT00107354|Aldesleukin|aldesleukin|mesh-list
56374946|NCT00107354|Etoposide|etoposide|mesh-list
56374947|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
56374948|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56374949|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374950|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56374951|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56374952|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374953|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374954|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374955|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
56374967|NCT00138177|Fluorouracil|fluorouracil|mesh-list
56374968|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
56374969|NCT00138177|Vorinostat|vorinostat|mesh-list
56374970|NCT00138177|Calcium|calcium|mesh-list
56374971|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
56374972|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56374973|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374974|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
56374975|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374976|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374977|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374978|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374979|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
56374980|NCT00138177|Antidotes|antidotes|mesh-ancestor
56374981|NCT00138177|Protective Agents|protective agents|mesh-ancestor
56374982|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
56374983|NCT00138177|Vitamins|vitamins|mesh-ancestor
56374984|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
56374985|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56374986|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654157|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56374987|NCT03279601|Capecitabine|capecitabine|mesh-list
56374988|NCT03279601|Temozolomide|temozolomide|mesh-list
56374989|NCT03279601|Dacarbazine|dacarbazine|mesh-list
56374990|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374991|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
56374992|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374993|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374994|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56374995|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
56374996|NCT00107393|Capecitabine|capecitabine|mesh-list
56374997|NCT00107393|Trastuzumab|trastuzumab|mesh-list
56374998|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374999|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
56375000|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375001|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375002|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56375003|NCT00138216|Irinotecan|irinotecan|mesh-list
56375004|NCT00138216|Vincristine|vincristine|mesh-list
56375005|NCT00138216|Temozolomide|temozolomide|mesh-list
56375006|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56375007|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56375008|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375009|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375010|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375011|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56375012|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
56375013|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
56375014|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
56375015|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56375016|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
56375017|NCT00105586|Citalopram|citalopram|mesh-list
56375018|NCT00105586|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56375019|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56375020|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375021|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375022|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375035|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56375036|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56375037|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
56375038|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56375039|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375040|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56375041|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375042|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56375043|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56375044|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375045|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375046|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375047|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56375048|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56375049|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56375050|NCT00440128|Docetaxel|docetaxel|mesh-list
56375051|NCT00440128|Casopitant|casopitant|mesh-list
56375052|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375053|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
56375054|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
56375055|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
56375056|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375057|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
56375058|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
56375059|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375060|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375061|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56375062|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56375063|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375064|NCT00440167|Gemcitabine|gemcitabine|mesh-list
56375065|NCT00440167|Capecitabine|capecitabine|mesh-list
56375066|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56375067|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56375068|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
56375069|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051873|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
56654158|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56654159|NCT04159896|Nivolumab|nivolumab|mesh-list
56654160|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56375070|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375071|NCT00440167|Antiviral Agents|antiviral agents|mesh-ancestor
56375072|NCT00440167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375073|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375074|NCT00440167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56375075|NCT00440167|Immunologic Factors|immunologic factors|mesh-ancestor
56375076|NCT00440167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375077|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56375078|NCT00107471|Topotecan|topotecan|mesh-list
56375079|NCT00107471|Lenograstim|lenograstim|mesh-list
56375080|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56375081|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
56375082|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375083|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56375084|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56375085|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889021|NCT03945448|Fluconazole|fluconazole|mesh-list
56375089|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56375091|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
56375092|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375093|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375094|NCT02957266|Gemcitabine|gemcitabine|mesh-list
56375095|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375096|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56375097|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
56375098|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375099|NCT02957266|Antiviral Agents|antiviral agents|mesh-ancestor
56375100|NCT02957266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375101|NCT02957266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375102|NCT02957266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56375103|NCT02957266|Immunologic Factors|immunologic factors|mesh-ancestor
56172635|NCT05647681|Antipyretics|antipyretics|mesh-ancestor
56375104|NCT02957266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375106|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56375107|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375108|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
56375109|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375110|NCT00404196|Calcipotriene|calcipotriene|mesh-list
56375111|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
56375112|NCT00107510|Carboplatin|carboplatin|mesh-list
56375113|NCT00107510|Docetaxel|docetaxel|mesh-list
56375114|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375115|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
56375116|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
56375117|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
56375118|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375119|NCT00440245|Albuterol|albuterol|mesh-list
56375120|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56375121|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
56375122|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375123|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375124|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56375125|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
56375126|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
56375127|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56375128|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56375129|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56375130|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56375131|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
56375132|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375133|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375134|NCT00440284|Insulin|insulin|mesh-list
56375135|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56375136|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375137|NCT00142779|Fluoxetine|fluoxetine|mesh-list
56375138|NCT00142779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56375139|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56375140|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375141|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654161|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300228|NCT00388700|Leucovorin|leucovorin|mesh-list
56654162|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56654163|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654165|NCT02635074|Idarubicin|idarubicin|mesh-list
56654166|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56654167|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
56654168|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654169|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654170|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
56654171|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654172|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654173|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
56654174|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654175|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56654176|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56654177|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56375142|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375143|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
56375144|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375145|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56375146|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
56375147|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375148|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56375149|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56375150|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375151|NCT00440323|Zolpidem|zolpidem|mesh-list
56375152|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56375153|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56375154|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55889083|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375157|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
56375158|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
56375159|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375160|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375161|NCT00440440|Testosterone|testosterone|mesh-list
56375162|NCT00440440|Androgens|androgens|mesh-ancestor
56375163|NCT00440440|Hormones|hormones|mesh-ancestor
56375164|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375165|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375166|NCT00142896|Morphine|morphine|mesh-list
56375167|NCT00142896|Tramadol|tramadol|mesh-list
56375168|NCT00142896|Naloxone|naloxone|mesh-list
56375169|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56375170|NCT00142896|Narcotics|narcotics|mesh-ancestor
56375171|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375172|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375174|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
56375175|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375176|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56375177|NCT00440479|Bortezomib|bortezomib|mesh-list
56375178|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375179|NCT00440635|Bortezomib|bortezomib|mesh-list
56375180|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375181|NCT00440674|Paclitaxel|paclitaxel|mesh-list
56375182|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56375183|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654178|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654179|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
56654180|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56654181|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654182|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654183|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654184|NCT02537366|Analgesics|analgesics|mesh-ancestor
56654185|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
56654186|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654187|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56654188|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56654189|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56375184|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
56375185|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
56375186|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
56375187|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375188|NCT00440713|Aripiprazole|aripiprazole|mesh-list
56375189|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
56375190|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55997039|NCT04558502|Amoxicillin|amoxicillin|mesh-list
56375191|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56375192|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56375193|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375194|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375195|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
56375196|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
56375197|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375198|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375199|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56375200|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56375201|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
56375202|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56375203|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56375204|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56375205|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56375206|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
56375207|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56375208|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
56375209|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375210|NCT00440869|Expectorants|expectorants|mesh-ancestor
56375211|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
56375212|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56375213|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
56375214|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375215|NCT00440869|Protective Agents|protective agents|mesh-ancestor
56375216|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375217|NCT00440869|Antidotes|antidotes|mesh-ancestor
56375218|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
56375219|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56375220|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375222|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56375223|NCT00441298|Tenofovir|tenofovir|mesh-list
56375224|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
56375225|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375226|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56375227|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56375228|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375229|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375243|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56375244|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56375245|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56375246|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56654190|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
56654191|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654192|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172637|NCT05644145|Immunologic Factors|immunologic factors|mesh-ancestor
56375247|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375248|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
56375249|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375250|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375251|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56375252|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375254|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
56375255|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
56375256|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375257|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375258|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
56375259|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375260|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56375261|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56375262|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56375263|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55997116|NCT04550546|Nystatin|nystatin|mesh-list
56375264|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375265|NCT00441649|Methylphenidate|methylphenidate|mesh-list
56375266|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56375267|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375268|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56375269|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56375270|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375271|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375272|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
56375273|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375275|NCT00107822|Tetracaine|tetracaine|mesh-list
56375276|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
56375277|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
56375278|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375279|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375280|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
56375281|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375282|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56375283|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56375284|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56375285|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375286|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375287|NCT03279328|Petrolatum|petrolatum|mesh-list
56375288|NCT03279328|Emollients|emollients|mesh-ancestor
56375289|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
56375302|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56375303|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375304|NCT03279133|Ledipasvir|ledipasvir|mesh-list
56375305|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
56375306|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375307|NCT00108017|Timolol|timolol|mesh-list
56375308|NCT00108017|Dorzolamide|dorzolamide|mesh-list
56375309|NCT00108017|Maleic acid|maleic acid|mesh-list
56375310|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375311|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375312|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56375313|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56375314|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
56375315|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375316|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375317|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56375318|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56375319|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56375320|NCT00441922|Docetaxel|docetaxel|mesh-list
56375321|NCT00441922|Vinorelbine|vinorelbine|mesh-list
56375322|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375323|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
56375324|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
56375325|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
56654193|NCT00690417|Vitamin D|vitamin d|mesh-list
56654194|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
56654195|NCT00690417|Vitamins|vitamins|mesh-ancestor
56654196|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
56654197|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654198|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56216535|NCT01625572|Morphine|morphine|mesh-list
56375326|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375327|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56375328|NCT00441961|Methotrexate|methotrexate|mesh-list
56375329|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56375330|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
56375331|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56375332|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375333|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56375334|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
56375335|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375336|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375337|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
56375338|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375339|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56375340|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56375341|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
56375342|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375343|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56375345|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56375346|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375347|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56375348|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56375349|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375350|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375351|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375352|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56375353|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56375374|NCT00108095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56375375|NCT03278938|Bupropion|bupropion|mesh-list
56375376|NCT03278938|Citalopram|citalopram|mesh-list
56375377|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56375378|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
56375379|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375380|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56375381|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56375382|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375383|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375384|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
56375385|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375386|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375387|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56375388|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56375389|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375390|NCT03278938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56375391|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
56375392|NCT03278860|Oxytocin|oxytocin|mesh-list
56375393|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
56375394|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56375395|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375396|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56375397|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56375398|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
56375399|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56375400|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56375401|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
56375402|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375403|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375404|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375405|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56654199|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56654200|NCT05434559|Insulin|insulin|mesh-list
56654201|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56654202|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654203|NCT00546637|Fesoterodine|fesoterodine|mesh-list
56654204|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56654205|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56654206|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
56654207|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654208|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654209|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375406|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56375407|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55997266|NCT00966641|Naproxen|naproxen|mesh-list
56375409|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889356|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
56375419|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56375421|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375422|NCT00442741|Epothilone B|epothilone b|mesh-list
56375423|NCT00442741|Epothilones|epothilones|mesh-list
56375424|NCT00442741|Omeprazole|omeprazole|mesh-list
56375425|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56375426|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56375427|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56375428|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375429|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375430|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375431|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
56375432|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
56375433|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
56375434|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
56375435|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56375436|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56375437|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56375438|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
56375439|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375440|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375441|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375442|NCT00404586|Fluticasone|fluticasone|mesh-list
56375443|NCT00404586|Xhance|xhance|mesh-list
56375444|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375445|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56375446|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
56375447|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375448|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375449|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56375450|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
56375451|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
56375452|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56375453|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56375454|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
56375455|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56375456|NCT00442819|Protective Agents|protective agents|mesh-ancestor
56375457|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375458|NCT00108251|Eplerenone|eplerenone|mesh-list
56375459|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56375460|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
56375461|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375462|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375463|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56375464|NCT00108251|Diuretics|diuretics|mesh-ancestor
56375465|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
56654210|NCT00546637|Urological Agents|urological agents|mesh-ancestor
56654211|NCT00690885|Interferons|interferons|mesh-list
56654212|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
56654213|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
56654214|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56375466|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56375468|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
56375469|NCT00443170|Midazolam|midazolam|mesh-list
56375470|NCT00443170|Caffeine|caffeine|mesh-list
56375471|NCT00443170|Omeprazole|omeprazole|mesh-list
56375472|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56375473|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56375474|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375475|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889413|NCT03004833|Nivolumab|nivolumab|mesh-list
56375480|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
56375481|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
56375482|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
56375483|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
56375484|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375485|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375486|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56375487|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56375489|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56375490|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56375491|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
56375492|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56375493|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56375494|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56375495|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56375496|NCT00443170|Analgesics|analgesics|mesh-ancestor
56375497|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
56375498|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375499|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56375500|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56375501|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375502|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375503|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56375504|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56375505|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
56375506|NCT00138567|Vildagliptin|vildagliptin|mesh-list
56375507|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56375508|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375509|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56375510|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
56375511|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375512|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375513|NCT00108368|Olanzapine|olanzapine|mesh-list
56375514|NCT00108368|Risperidone|risperidone|mesh-list
56375515|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56375516|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
56375517|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375518|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375519|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375520|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56375521|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56375522|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375523|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375524|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56375525|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
56375526|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
56375527|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
56375528|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375529|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56375530|NCT00108368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56375531|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56375532|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375533|NCT00108446|Lidocaine|lidocaine|mesh-list
56375534|NCT00108446|Fentanyl|fentanyl|mesh-list
56375535|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
56375536|NCT00108446|Naloxone|naloxone|mesh-list
56375537|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
56375538|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
55916930|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
56654215|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778471|NCT03165253|Amoxicillin|amoxicillin|mesh-list
56375539|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375540|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375541|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
56375542|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375543|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56375544|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56375545|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56375546|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375547|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375570|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375571|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375572|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56375573|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
56375574|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56375575|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56375576|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56375577|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
56375578|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375579|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375580|NCT00443521|Triamcinolone|triamcinolone|mesh-list
56375581|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56375582|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56375583|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56375584|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375585|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
56375586|NCT00443521|Hormones|hormones|mesh-ancestor
56375587|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375588|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375589|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56375590|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
56375591|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375592|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375593|NCT03278431|Albendazole|albendazole|mesh-list
56375594|NCT03278431|Mebendazole|mebendazole|mesh-list
56375595|NCT03278431|Piperazine|piperazine|mesh-list
56375596|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
56375597|NCT03278431|Pyrantel|pyrantel|mesh-list
56375598|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
56375599|NCT03278431|Oxantel|oxantel|mesh-list
56375600|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
56375601|NCT03278431|DMP 777|dmp 777|mesh-list
56375614|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375615|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56375616|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56375617|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56375618|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375619|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375621|NCT04726332|Fulvestrant|fulvestrant|mesh-list
56375622|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375623|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
56375624|NCT04726332|Hormones|hormones|mesh-ancestor
56375625|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375626|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375627|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56375628|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375629|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56375630|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56375631|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
56375632|NCT00108563|Citalopram|citalopram|mesh-list
55997486|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
56375633|NCT00108563|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56375634|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56375635|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375636|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375637|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375638|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
56375639|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172760|NCT05586802|Testosterone|testosterone|mesh-list
56375640|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56375641|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
56654216|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
56654217|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654218|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
56375642|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375644|NCT00443716|Hormones|hormones|mesh-ancestor
56375645|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375646|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375647|NCT00443794|Aspirin|aspirin|mesh-list
56375648|NCT00443794|Atenolol|atenolol|mesh-list
56375649|NCT00443794|Ramipril|ramipril|mesh-list
56375650|NCT00443794|Simvastatin|simvastatin|mesh-list
56375651|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56375652|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56375653|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56375654|NCT00443794|Analgesics|analgesics|mesh-ancestor
56375655|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
56375656|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375657|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375658|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375659|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375660|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56375661|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55889605|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56375668|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56375670|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56375671|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56375672|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56375673|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
56375674|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56375675|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56375676|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
56375677|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
56375678|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56375679|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56375680|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56375681|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
56375682|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375683|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375684|NCT00443794|Diuretics|diuretics|mesh-ancestor
56375685|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
56375686|NCT00108602|Acetazolamide|acetazolamide|mesh-list
56375687|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
56375688|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56375689|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375690|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375692|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
56375693|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375694|NCT03278314|Ivacaftor|ivacaftor|mesh-list
56375695|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56375696|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375697|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375698|NCT00443950|Etanercept|etanercept|mesh-list
56375699|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56375700|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56375701|NCT00443950|Analgesics|analgesics|mesh-ancestor
56375702|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
56375703|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375704|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375705|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375706|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375707|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56375708|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56375709|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
56375710|NCT00444184|Timolol|timolol|mesh-list
56375711|NCT00444184|Travoprost|travoprost|mesh-list
56172771|NCT05586802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56375712|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56375713|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56375714|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
56375715|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375716|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375717|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654219|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654220|NCT04138719|Paclitaxel|paclitaxel|mesh-list
56375718|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56375719|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56375720|NCT00444223|Fluorides|fluorides|mesh-list
56375721|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
56375722|NCT00444223|Protective Agents|protective agents|mesh-ancestor
56375723|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375724|NCT00138801|Doxycycline|doxycycline|mesh-list
56375725|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
56375726|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56375727|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375728|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
55889672|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
56375730|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56375732|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56375733|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56375734|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
56375735|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375736|NCT00451360|Diacetylrhein|diacetylrhein|mesh-list
56375737|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375738|NCT00451399|Metformin|metformin|mesh-list
56375739|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56375740|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375741|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
56375742|NCT00108797|Coagulants|coagulants|mesh-ancestor
56375743|NCT04698772|Ketamine|ketamine|mesh-list
56375744|NCT04698772|Morphine|morphine|mesh-list
56375745|NCT04698772|Analgesics|analgesics|mesh-ancestor
56375746|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
56375747|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375748|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375749|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56375750|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56375751|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
56375752|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
56375753|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375754|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56375755|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56375756|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375757|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375758|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56375759|NCT04698772|Narcotics|narcotics|mesh-ancestor
56375760|NCT00451594|Dexamethasone|dexamethasone|mesh-list
56375761|NCT00451594|Prednisolone|prednisolone|mesh-list
56375762|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375763|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
56375764|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
56375765|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375766|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375767|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56375768|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
56375769|NCT00451594|Hormones|hormones|mesh-ancestor
56375770|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375771|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56375772|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375773|NCT00139035|Cyclosporine|cyclosporine|mesh-list
56375774|NCT00139035|Cyclosporins|cyclosporins|mesh-list
56375775|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375776|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375777|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56375778|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
56375779|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375780|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
56375781|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375782|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
56375783|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375784|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56375786|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56375787|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56375788|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
56375789|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375790|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375791|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
56375792|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
56375793|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654221|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56654222|NCT04138719|Carboplatin|carboplatin|mesh-list
56654223|NCT04138719|Epirubicin|epirubicin|mesh-list
56654224|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56654225|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216559|NCT01625793|Interferons|interferons|mesh-list
56375794|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375795|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
56375796|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56375797|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
56375798|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375799|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375800|NCT00451711|Amphotericin B|amphotericin b|mesh-list
56375801|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56375802|NCT00451711|Amebicides|amebicides|mesh-ancestor
56375803|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56375804|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56375812|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56375813|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56375814|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375815|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375816|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
56375817|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375818|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375820|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375821|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
56375822|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
56375823|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375824|NCT00451828|Simvastatin|simvastatin|mesh-list
56375825|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56172786|NCT05581823|Carbamazepine|carbamazepine|mesh-list
56375826|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56375828|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375829|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56375830|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56375831|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375832|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
56375833|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56375835|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56375836|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
56375837|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56375838|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375839|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375840|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375841|NCT00143091|Sertraline|sertraline|mesh-list
56375842|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
56375843|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375844|NCT00143091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56375845|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56375846|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375847|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375848|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375849|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
56375850|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375851|NCT00451984|Interleukin-2|interleukin-2|mesh-list
56375852|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375853|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56375854|NCT00451984|Analgesics|analgesics|mesh-ancestor
56375855|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
56375856|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375857|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375858|NCT00452062|Dexamethasone|dexamethasone|mesh-list
56375860|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
56375861|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
56375862|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375863|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375864|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56375865|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
56375866|NCT00452062|Hormones|hormones|mesh-ancestor
56654226|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
56654227|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
56654228|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
56654229|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654230|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56654231|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56654232|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56654233|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654234|NCT02790203|Celecoxib|celecoxib|mesh-list
56300306|NCT00022165|Protective Agents|protective agents|mesh-ancestor
56654235|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56375867|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375868|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56375869|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375870|NCT00108992|Diclofenac|diclofenac|mesh-list
56375871|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56375872|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56375873|NCT00108992|Analgesics|analgesics|mesh-ancestor
55889813|NCT01951768|Gentamicins|gentamicins|mesh-list
56375876|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375877|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375878|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375879|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56375880|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375881|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375883|NCT00143130|Analgesics|analgesics|mesh-ancestor
56375884|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
56375885|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375886|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375887|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
56375888|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56375889|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56375890|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375891|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56375892|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56375893|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56375894|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375895|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375896|NCT00109070|Bevacizumab|bevacizumab|mesh-list
56375897|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56375898|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375899|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56375900|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56375901|NCT00109070|Growth Substances|growth substances|mesh-ancestor
56375902|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375903|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
56375904|NCT00452218|Sorafenib|sorafenib|mesh-list
56375905|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375906|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56375907|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375908|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375910|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56375911|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56375912|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375913|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375914|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56375915|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56375916|NCT00143169|Analgesics|analgesics|mesh-ancestor
56375917|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
56375918|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917103|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
56654236|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654237|NCT02790203|Analgesics|analgesics|mesh-ancestor
56654238|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
56654239|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654240|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654241|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375919|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375920|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375921|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375922|NCT00109109|Vorinostat|vorinostat|mesh-list
56375923|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375924|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56375925|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375926|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375927|NCT03275116|Bromides|bromides|mesh-list
56375928|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
56375929|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
56375930|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56375931|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
56375932|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375933|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375934|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56375935|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
56375936|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56375937|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56375938|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56375939|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
56375940|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375941|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375942|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
56375943|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56375944|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
56375956|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375958|NCT00452569|Dexamethasone|dexamethasone|mesh-list
56375959|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375960|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
56375961|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
56375962|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375963|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375964|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56375965|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
56375966|NCT00452569|Hormones|hormones|mesh-ancestor
56375967|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375968|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56375969|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375970|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56375971|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
56375972|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
56375973|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56375974|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375975|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56375976|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56375977|NCT00452569|Growth Substances|growth substances|mesh-ancestor
56375978|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
56375979|NCT00143286|Varenicline|varenicline|mesh-list
56375980|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56375981|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56375982|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
56375983|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375984|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375985|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375986|NCT00109187|Omalizumab|omalizumab|mesh-list
56375987|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56375988|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56375989|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
56375990|NCT00452608|Atorvastatin|atorvastatin|mesh-list
56375991|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56375992|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56375993|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
56654242|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654243|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56654244|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56654245|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778873|NCT04310995|Nicorandil|nicorandil|mesh-list
56375994|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375995|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56375996|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56375997|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375998|NCT00109226|Bevacizumab|bevacizumab|mesh-list
56375999|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56376000|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376001|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56376002|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56376010|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376011|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376012|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376013|NCT00452725|Hormones|hormones|mesh-list
56172825|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376014|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376015|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376016|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56376017|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376018|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56376019|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376020|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376022|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56376023|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56376024|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
56376025|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376026|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376027|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376028|NCT00452881|Gemcitabine|gemcitabine|mesh-list
56376029|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
56376030|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376031|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56376032|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
56376033|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376034|NCT00452881|Antiviral Agents|antiviral agents|mesh-ancestor
56376035|NCT00452881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376036|NCT00452881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376037|NCT00452881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376038|NCT00452881|Immunologic Factors|immunologic factors|mesh-ancestor
56376039|NCT00452881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376040|NCT00452920|Docetaxel|docetaxel|mesh-list
56376041|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376042|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
56376043|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
56376044|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
56376045|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376046|NCT00143442|Reboxetine|reboxetine|mesh-list
56376047|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
56376048|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56376049|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56376050|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56376051|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56376052|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376053|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56376054|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376055|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376057|NCT00109382|Clopidogrel|clopidogrel|mesh-list
56376058|NCT00109382|Simvastatin|simvastatin|mesh-list
56376059|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56376060|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56376061|NCT00109382|Analgesics|analgesics|mesh-ancestor
56376062|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
56376063|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654246|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654247|NCT02816567|Sufentanil|sufentanil|mesh-list
56654248|NCT02816567|Propofol|propofol|mesh-list
56654249|NCT02816567|Cisatracurium|cisatracurium|mesh-list
56376064|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376065|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376066|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56376067|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56376068|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56376069|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376080|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56376081|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
56376082|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56376083|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56376085|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56376086|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376087|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
56376088|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
56376089|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
56376090|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376091|NCT00453115|Gemcitabine|gemcitabine|mesh-list
56376092|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
56376093|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56376094|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
56376095|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376096|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376097|NCT00453115|Antiviral Agents|antiviral agents|mesh-ancestor
56376098|NCT00453115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376099|NCT00453115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376100|NCT00453115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376101|NCT00453115|Immunologic Factors|immunologic factors|mesh-ancestor
56376102|NCT00453115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376103|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56376104|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56376105|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56376106|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
56376107|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376108|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376109|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376110|NCT00143481|Urological Agents|urological agents|mesh-ancestor
56376111|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56376112|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56376113|NCT00453232|Etoposide|etoposide|mesh-list
56376114|NCT00453232|Bleomycin|bleomycin|mesh-list
56376115|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376116|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56376117|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56376118|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56376119|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376120|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376121|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56376122|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
56376123|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56376125|NCT00143520|Pioglitazone|pioglitazone|mesh-list
56376126|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56376127|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376128|NCT00143559|Antibodies|antibodies|mesh-list
56376129|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
56376130|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376131|NCT00453778|Fluticasone|fluticasone|mesh-list
56376132|NCT00453778|Xhance|xhance|mesh-list
56376133|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376144|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56376145|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56376146|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376148|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
56376149|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
56376150|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
56376151|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56376152|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
56376153|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56654250|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56654251|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654252|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376154|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56376155|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376156|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56376157|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376158|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376159|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56376161|NCT00454168|Sargramostim|sargramostim|mesh-list
56376162|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
56376163|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376164|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
56376165|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56376166|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
56376167|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376168|NCT03274765|Estradiol|estradiol|mesh-list
56376169|NCT03274765|Estrogens|estrogens|mesh-ancestor
56376170|NCT03274765|Hormones|hormones|mesh-ancestor
56376171|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376172|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376173|NCT00454402|Alfuzosin|alfuzosin|mesh-list
56376174|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56376175|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56376176|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56376177|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56376178|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376179|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376180|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376181|NCT00454402|Urological Agents|urological agents|mesh-ancestor
56376182|NCT00143676|Atorvastatin|atorvastatin|mesh-list
56376183|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56376184|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56376185|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
56376186|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376187|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56376188|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56376189|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376190|NCT00454480|Cytarabine|cytarabine|mesh-list
56376191|NCT00454480|Fludarabine|fludarabine|mesh-list
56376192|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
56376193|NCT00454480|Azacitidine|azacitidine|mesh-list
56376194|NCT00454480|Melphalan|melphalan|mesh-list
56376195|NCT00454480|Busulfan|busulfan|mesh-list
56376196|NCT00454480|Daunorubicin|daunorubicin|mesh-list
56376197|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
56376198|NCT00454480|Clofarabine|clofarabine|mesh-list
56376199|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
56376200|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
56376201|NCT00454480|Tipifarnib|tipifarnib|mesh-list
56376212|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56376213|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
56172852|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
56376214|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56376215|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56376216|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56376217|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56376218|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56376219|NCT00110006|Prednisone|prednisone|mesh-list
56376220|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
56376221|NCT00110006|Rituximab|rituximab|mesh-list
56376222|NCT00110006|Doxorubicin|doxorubicin|mesh-list
56376223|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56376224|NCT00110006|Vincristine|vincristine|mesh-list
56376225|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56376226|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376227|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
56376228|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376229|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56376230|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56376231|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
56376232|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376233|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654253|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56654254|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
56654255|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
56654256|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56654257|NCT02816567|Narcotics|narcotics|mesh-ancestor
56654258|NCT02816567|Analgesics|analgesics|mesh-ancestor
56654259|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
56654260|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654261|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56216590|NCT01625936|Growth Substances|growth substances|mesh-ancestor
56376234|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56376235|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56376236|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56376237|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56376238|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56376239|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376240|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376241|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
56376242|NCT00110006|Hormones|hormones|mesh-ancestor
56376243|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376244|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56376245|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56376246|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
56376247|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
56376248|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
56376249|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56376250|NCT00454519|Mitomycins|mitomycins|mesh-list
56376251|NCT00454519|Mitomycin|mitomycin|mesh-list
56376252|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376253|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56376254|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
56376255|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376256|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56376257|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376258|NCT00454558|Riociguat|riociguat|mesh-list
56376259|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
56376260|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376261|NCT00112749|Infliximab|infliximab|mesh-list
56376262|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
56376263|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376264|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56376265|NCT00110045|Caspofungin|caspofungin|mesh-list
56376276|NCT00454714|Urological Agents|urological agents|mesh-ancestor
56376278|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
56376279|NCT00143715|Vitamins|vitamins|mesh-ancestor
56376280|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
56376281|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376282|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56376283|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56376284|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376285|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
56376286|NCT00143715|Coagulants|coagulants|mesh-ancestor
56376287|NCT00454831|Chitosan|chitosan|mesh-list
56376288|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56376289|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56376290|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
56376291|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376292|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56376293|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
56376294|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
56376295|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
56376296|NCT00454831|Coagulants|coagulants|mesh-ancestor
56376297|NCT00110123|Fotemustine|fotemustine|mesh-list
56376298|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376299|NCT00455026|Remifentanil|remifentanil|mesh-list
56376300|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56376301|NCT00455026|Narcotics|narcotics|mesh-ancestor
56376302|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654262|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56654263|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56654264|NCT00657774|Prednisone|prednisone|mesh-list
56654265|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376303|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376304|NCT00455026|Analgesics|analgesics|mesh-ancestor
56376305|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
56376306|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376308|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56376309|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376310|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
56376311|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376312|NCT00110162|Hormones|hormones|mesh-list
56376313|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
56376314|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376315|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376316|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
56376317|NCT02273713|Paclitaxel|paclitaxel|mesh-list
56376318|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56376319|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376320|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
56376321|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
56376322|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
56376323|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376324|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56376325|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
56376326|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376327|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56376328|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56376329|NCT02273791|Clomiphene|clomiphene|mesh-list
56376330|NCT02273791|Enclomiphene|enclomiphene|mesh-list
56376331|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
56376341|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56376343|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
56376344|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56376345|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
56376346|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56376347|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56376348|NCT00110240|Vildagliptin|vildagliptin|mesh-list
56376349|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56376350|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376351|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56376352|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
56376353|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376354|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376356|NCT00455416|Allicin|allicin|mesh-list
56376357|NCT00455416|Resveratrol|resveratrol|mesh-list
56376358|NCT00455416|Quercetin|quercetin|mesh-list
56376359|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
56376360|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376361|NCT00455416|Protective Agents|protective agents|mesh-ancestor
56376362|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376363|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376364|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56376365|NCT00455416|Trace Elements|trace elements|mesh-ancestor
56376366|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
56376367|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376368|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56376369|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
56376370|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56376371|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56376372|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56376373|NCT00143871|Rituximab|rituximab|mesh-list
56376374|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56376375|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376376|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
56376377|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376378|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56376379|NCT00455572|Vinorelbine|vinorelbine|mesh-list
56376380|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998238|NCT03821714|Vitamins|vitamins|mesh-list
56376381|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56654266|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
56654267|NCT00657774|Hormones|hormones|mesh-ancestor
56654268|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654269|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654270|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56654271|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654272|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
56376382|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
56376383|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
56376384|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
56376385|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376386|NCT00401492|Gemcitabine|gemcitabine|mesh-list
56376387|NCT00401492|Vinorelbine|vinorelbine|mesh-list
56376388|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376389|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56376390|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
56376391|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376392|NCT00401492|Antiviral Agents|antiviral agents|mesh-ancestor
56376393|NCT00401492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376394|NCT00401492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376395|NCT00401492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376396|NCT00401492|Immunologic Factors|immunologic factors|mesh-ancestor
56376397|NCT00401492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376407|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56376408|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56376409|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376410|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376411|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376412|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56376413|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376414|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56376416|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56376417|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
56376418|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56376419|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376420|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56376421|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56376422|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56376423|NCT00110474|Acetaminophen|acetaminophen|mesh-list
56376424|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56376425|NCT00110474|Analgesics|analgesics|mesh-ancestor
56376426|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
56376427|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376428|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376429|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
56376430|NCT00113100|Ethanol|ethanol|mesh-list
56376431|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56376432|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56376433|NCT00113100|Estradiol|estradiol|mesh-list
56376434|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56376435|NCT00113100|Estrogens|estrogens|mesh-ancestor
56376436|NCT00113100|Hormones|hormones|mesh-ancestor
56376437|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376438|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376439|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56376440|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
56376441|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56376442|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56376443|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56376444|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376445|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56376446|NCT00143949|Losartan|losartan|mesh-list
56376447|NCT00143949|Enalapril|enalapril|mesh-list
56376448|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56376449|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56376450|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56376451|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56654273|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
56654274|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654275|NCT02789969|Fentanyl|fentanyl|mesh-list
56654276|NCT02789969|Hydromorphone|hydromorphone|mesh-list
56376452|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376453|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56376454|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
56376455|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376456|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
56376457|NCT00456235|Cyclosporine|cyclosporine|mesh-list
56376458|NCT00456235|Tacrolimus|tacrolimus|mesh-list
56376459|NCT00456235|Cyclosporins|cyclosporins|mesh-list
56376460|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376461|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
56376462|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376463|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56376464|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376472|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
56376473|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
56376474|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56376475|NCT00456313|Fluticasone|fluticasone|mesh-list
56376476|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56376477|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56376478|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
56376479|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376480|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376481|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56376482|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
56376483|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
56376484|NCT00456313|Hormones|hormones|mesh-ancestor
56376485|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376486|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
56376487|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376488|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
56376489|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56376490|NCT00110630|Nicotine|nicotine|mesh-list
56376491|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56376492|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
56376493|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376494|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376495|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56376496|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56376497|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
56376498|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376499|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376500|NCT00456430|Citalopram|citalopram|mesh-list
56376501|NCT00456430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56376502|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56376503|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56376504|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376505|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376506|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
56376507|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376508|NCT00456430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56376509|NCT00456430|Antidepressive Agents|antidepressive agents|mesh-ancestor
56376510|NCT00456430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56376511|NCT00456586|Istradefylline|istradefylline|mesh-list
56376512|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56376513|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56376514|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56376515|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
56376516|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376517|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376518|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376519|NCT00110669|Prednisone|prednisone|mesh-list
56376520|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376521|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
56376522|NCT00110669|Hormones|hormones|mesh-ancestor
56376523|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376524|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917104|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
56654277|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56654278|NCT02789969|Narcotics|narcotics|mesh-ancestor
56654279|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654280|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376525|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56376526|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376527|NCT00113256|Rubitecan|rubitecan|mesh-list
56376528|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376529|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56376539|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56376540|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
56376541|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56376542|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56376543|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56376544|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56376545|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376546|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
56376547|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376548|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376549|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56376550|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56376551|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376553|NCT00456898|Paroxetine|paroxetine|mesh-list
56376554|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56376555|NCT00456898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56376556|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56376557|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56376558|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376559|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376560|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
56376561|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376562|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56376563|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
56376564|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56376565|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56376566|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56376567|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376568|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56376569|NCT00456898|Narcotics|narcotics|mesh-ancestor
56376570|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56376571|NCT00456898|Analgesics|analgesics|mesh-ancestor
56376572|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
56376573|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376574|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
56376575|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
56376576|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56376577|NCT03274102|Vaccines|vaccines|mesh-list
56376578|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
56376579|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376580|NCT00110747|Lidocaine|lidocaine|mesh-list
56376581|NCT00110747|Tetracaine|tetracaine|mesh-list
56376582|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
56376583|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
56376584|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56376585|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376586|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
56376587|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376588|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56376589|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56376590|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55890539|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
56376605|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
56376606|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56376607|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56376608|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56376609|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56376610|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376611|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654281|NCT02789969|Analgesics|analgesics|mesh-ancestor
56654282|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
56654283|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654284|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56654285|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56376612|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56376613|NCT00456976|Protective Agents|protective agents|mesh-ancestor
56376614|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376615|NCT00144066|Gefitinib|gefitinib|mesh-list
56376616|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376617|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56376618|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376619|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376620|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
56376621|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
56376622|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56376623|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376624|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376625|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
56376626|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56376627|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56376628|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376629|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
56376630|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56376631|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376632|NCT00457405|Dipyridamole|dipyridamole|mesh-list
56376633|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56376634|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376635|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376636|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56376637|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
56376638|NCT00457483|Valsartan|valsartan|mesh-list
56376639|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56376640|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56376641|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56001844|NCT00000196|Naltrexone|naltrexone|mesh-list
56376642|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56376643|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376644|NCT00457483|Diuretics|diuretics|mesh-ancestor
56376645|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
56376646|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376647|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56376648|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56376660|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376662|NCT00457678|Hormones|hormones|mesh-ancestor
56376663|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376664|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56376665|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376666|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56376667|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56376668|NCT00457678|Growth Substances|growth substances|mesh-ancestor
56376669|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
56376670|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56376671|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
56376672|NCT00457717|Atropine|atropine|mesh-list
56376673|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56376674|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56376675|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56376676|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
56376677|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376678|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376679|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56376680|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
56376681|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
56376682|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
56376683|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56376684|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56376685|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
56376686|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654286|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
56654287|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
55779477|NCT03126617|Elotuzumab|elotuzumab|mesh-list
56376687|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376688|NCT00110903|Etanercept|etanercept|mesh-list
56376689|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56376690|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56376691|NCT00110903|Analgesics|analgesics|mesh-ancestor
56376692|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
56376693|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376694|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376695|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376696|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56376697|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376698|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376699|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
56376700|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
56376701|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
56376702|NCT00144144|Giapreza|giapreza|mesh-list
56376703|NCT00144144|Calcium|calcium|mesh-list
56376704|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
56376705|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56376706|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56376707|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376708|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56376709|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56376710|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
56376711|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376712|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376713|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56376722|NCT00144183|Zidovudine|zidovudine|mesh-list
56376723|NCT00144183|Nevirapine|nevirapine|mesh-list
56376724|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
56376725|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376726|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56376727|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56376728|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376729|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
56376730|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376731|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56376732|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56376733|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56376734|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56376735|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56376736|NCT00465751|Cathartics|cathartics|mesh-ancestor
56376737|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376738|NCT00110981|Etanercept|etanercept|mesh-list
56376739|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56376740|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56376741|NCT00110981|Analgesics|analgesics|mesh-ancestor
56376742|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
56376743|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376744|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376745|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376746|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56376747|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376748|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376749|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
56376750|NCT00465907|Paclitaxel|paclitaxel|mesh-list
56376751|NCT00465907|Carboplatin|carboplatin|mesh-list
56376752|NCT00465907|Irinotecan|irinotecan|mesh-list
56376753|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56376754|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376755|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
56376756|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
56376757|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
56376758|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376759|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56376760|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56376761|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376762|NCT00113685|Dextrans|dextrans|mesh-list
56376763|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56376764|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
56376765|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
56654288|NCT00657852|Pamidronate|pamidronate|mesh-list
56654289|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56376766|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
56376767|NCT00111020|Sorafenib|sorafenib|mesh-list
56376768|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376769|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56376770|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376771|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376772|NCT00466063|Deferasirox|deferasirox|mesh-list
56376773|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56376774|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
56376775|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
56376776|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376777|NCT00466102|Everolimus|everolimus|mesh-list
56376778|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376779|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376780|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
55890725|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376789|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56376790|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376791|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376792|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
56376793|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376795|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56376796|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56376797|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56376798|NCT00466219|Interferons|interferons|mesh-list
56376799|NCT00466219|Ribavirin|ribavirin|mesh-list
56376800|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
56376801|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
56376802|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56376803|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376804|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
56376805|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376806|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
56376807|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376808|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
56376809|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376810|NCT00144261|Nevirapine|nevirapine|mesh-list
56376811|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56376812|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56376813|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376814|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376815|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
56376816|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376817|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56376818|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56376819|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56376820|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56376821|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56376822|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
56376823|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376824|NCT00144378|Irinotecan|irinotecan|mesh-list
56376825|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56376826|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55998696|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56376827|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376828|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376829|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376830|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
56376831|NCT00111098|Hematinics|hematinics|mesh-ancestor
56376832|NCT00347698|Bevacizumab|bevacizumab|mesh-list
56376833|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56376834|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376835|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56376836|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56376837|NCT00347698|Growth Substances|growth substances|mesh-ancestor
56376838|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376839|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
56376840|NCT00347737|Teriparatide|teriparatide|mesh-list
56376841|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56376842|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376843|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56654290|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654291|NCT00691275|Ondansetron|ondansetron|mesh-list
56654292|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
56654293|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
56376844|NCT00347815|Buprenorphine|buprenorphine|mesh-list
56376845|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56376855|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
56376856|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376857|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56376858|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376859|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
56376860|NCT00111137|Hematinics|hematinics|mesh-ancestor
56376861|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56376862|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56376863|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
56376864|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56376865|NCT00347854|Laxatives|laxatives|mesh-ancestor
56376866|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376868|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56376869|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376870|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
56376871|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376872|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56376873|NCT00113958|Cinacalcet|cinacalcet|mesh-list
56376874|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56376875|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376876|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56376877|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
56376878|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376879|NCT00348010|Tramadol|tramadol|mesh-list
56376880|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56376881|NCT00348010|Narcotics|narcotics|mesh-ancestor
56376882|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56376883|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376884|NCT00348010|Analgesics|analgesics|mesh-ancestor
56376885|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
56376886|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376887|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
56376888|NCT00144417|Rifampin|rifampin|mesh-list
56376889|NCT00144417|Isoniazid|isoniazid|mesh-list
56376890|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
56376891|NCT00144417|Ethambutol|ethambutol|mesh-list
56376892|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56376893|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376894|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56376895|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56376896|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376897|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376898|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376899|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56376900|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
56376901|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
56376902|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56376903|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56376904|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56376905|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56376906|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56376907|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56376908|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56376909|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56376910|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56376911|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
56376912|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56376925|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
56376926|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376927|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376928|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
56376929|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56376930|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56376931|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
56376932|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917308|NCT04089150|Gemcitabine|gemcitabine|mesh-list
56654294|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654295|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376933|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376934|NCT00348244|Prednisolone|prednisolone|mesh-list
56376935|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56376936|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
56376937|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56376938|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
56376939|NCT00348244|Ketorolac|ketorolac|mesh-list
56001846|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56376940|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56376941|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
56376942|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376943|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
56376944|NCT00348244|Hormones|hormones|mesh-ancestor
56376945|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376946|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376947|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56376948|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376949|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
56376950|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
56376951|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376952|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376953|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56376954|NCT00348244|Protective Agents|protective agents|mesh-ancestor
56376955|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56376956|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56376957|NCT00348244|Analgesics|analgesics|mesh-ancestor
56376958|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
56376959|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56376960|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56376961|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376962|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376963|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56376964|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
56376965|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56376966|NCT00348361|Fluticasone|fluticasone|mesh-list
56376968|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376969|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56376970|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
56376971|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376972|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376973|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56376974|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
56376981|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56376982|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56376983|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56376984|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56376985|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56376986|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
56376987|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376988|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376989|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376990|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56376991|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376992|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
56376993|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56376994|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
56376995|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56376996|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376998|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
56376999|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
56377000|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56377001|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56377002|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377003|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56377004|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56377005|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
56377006|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56377007|NCT00348517|Laxatives|laxatives|mesh-ancestor
56377008|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56377009|NCT00348634|Tegaserod|tegaserod|mesh-list
56654296|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56654297|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
56377010|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56377011|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
56377012|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377013|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377014|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377015|NCT00348712|Insulin|insulin|mesh-list
56377016|NCT00348712|Metformin|metformin|mesh-list
56377017|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
56377019|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56377020|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377021|NCT02964689|Pemetrexed|pemetrexed|mesh-list
56377022|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377023|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377024|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377025|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56377026|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56377027|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
56377028|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
56377029|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56377030|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56377031|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377032|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377033|NCT04715113|Urological Agents|urological agents|mesh-ancestor
56377034|NCT00348985|Bortezomib|bortezomib|mesh-list
56377035|NCT00348985|Belinostat|belinostat|mesh-list
56377036|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377037|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56377038|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377039|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377040|NCT00349024|Povidone|povidone|mesh-list
56377041|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
56377042|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56377043|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
56377044|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377045|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
56377046|NCT00349024|Protective Agents|protective agents|mesh-ancestor
56377047|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
56377048|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
56377050|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56377064|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
56377066|NCT00421369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56377067|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56377068|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377069|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377070|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377071|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
56377072|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377073|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56377074|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
56377075|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56377076|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377077|NCT00421447|Anastrozole|anastrozole|mesh-list
56377078|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56377079|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377080|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56377081|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56377082|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377083|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377084|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56377085|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
56377086|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56377087|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377088|NCT04729140|Doxycycline|doxycycline|mesh-list
56377089|NCT04729140|Ivermectin|ivermectin|mesh-list
56377090|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56377091|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377092|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
56377093|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56377094|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56377095|NCT00349219|Gemcitabine|gemcitabine|mesh-list
56377096|NCT00349219|Cisplatin|cisplatin|mesh-list
56654298|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
56654299|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56654300|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
56654301|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654302|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377097|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56377098|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377099|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377100|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
56377101|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377102|NCT00349219|Antiviral Agents|antiviral agents|mesh-ancestor
56377103|NCT00349219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377104|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377105|NCT00349219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377106|NCT00349219|Immunologic Factors|immunologic factors|mesh-ancestor
56377107|NCT00349219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377108|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56377109|NCT00111449|Etanercept|etanercept|mesh-list
56377110|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56377111|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55998998|NCT01458236|Beraprost|beraprost|mesh-list
56377128|NCT00349375|Simvastatin|simvastatin|mesh-list
56377129|NCT00349375|Fenofibrate|fenofibrate|mesh-list
56377130|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56377131|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56377132|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
56377133|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377134|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56377135|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56377136|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377137|NCT00349453|Deferiprone|deferiprone|mesh-list
56377138|NCT00349453|Deferoxamine|deferoxamine|mesh-list
56377139|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56377140|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
56377141|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
56377142|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377143|NCT00349453|Siderophores|siderophores|mesh-ancestor
56377144|NCT00349492|Cisplatin|cisplatin|mesh-list
56377145|NCT00349492|Irinotecan|irinotecan|mesh-list
56377146|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377147|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56377148|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56377149|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377150|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377151|NCT00349531|Pramipexole|pramipexole|mesh-list
56377152|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
56377153|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377154|NCT00349531|Protective Agents|protective agents|mesh-ancestor
56377155|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377156|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56377157|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56377158|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
56377159|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
56377160|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377161|NCT00111566|Eptifibatide|eptifibatide|mesh-list
56377162|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56377163|NCT00404703|Bevacizumab|bevacizumab|mesh-list
56377164|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56377165|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377166|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56377167|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56377168|NCT00404703|Growth Substances|growth substances|mesh-ancestor
56377169|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377170|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
56377172|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
56377174|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
56377175|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377176|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
56377177|NCT00111644|Lactams|lactams|mesh-list
56377178|NCT00111644|beta-Lactams|beta-lactams|mesh-list
56377179|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56654303|NCT00691275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56654304|NCT00691275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56654305|NCT00691275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377180|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377181|NCT00350038|Irbesartan|irbesartan|mesh-list
56377182|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
56377183|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56377184|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56377185|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56377186|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377187|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56377188|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
56377189|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56377190|NCT00350077|Vitamins|vitamins|mesh-list
56377191|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
56377192|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
56377193|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377194|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
56377195|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377196|NCT00350077|Protective Agents|protective agents|mesh-ancestor
56377197|NCT00114153|Carboplatin|carboplatin|mesh-list
56377198|NCT00114153|Capecitabine|capecitabine|mesh-list
56377199|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377200|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377201|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
56377202|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377203|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
56377204|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
56377205|NCT00350116|Vitamins|vitamins|mesh-ancestor
56377206|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
56377207|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377208|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
56377209|NCT00350116|Hematinics|hematinics|mesh-ancestor
56377210|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
56377211|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56377212|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56377213|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377214|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377215|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56377216|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56377217|NCT00350155|Analgesics|analgesics|mesh-ancestor
56377218|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
56377219|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377220|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377221|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56377222|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377223|NCT00404781|Aspirin|aspirin|mesh-list
56377224|NCT00404781|Cilostazol|cilostazol|mesh-list
56377225|NCT00404781|Clopidogrel|clopidogrel|mesh-list
56377226|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56377227|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56377228|NCT00404781|Analgesics|analgesics|mesh-ancestor
56377229|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
56377230|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377231|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377232|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56377233|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377234|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56377235|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56377236|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377237|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56377238|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56377239|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377240|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
56377241|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56377242|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56377243|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56377244|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
56377245|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377246|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56377258|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654306|NCT00691275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56654307|NCT00691275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56654308|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
56654309|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56654310|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654311|NCT04138251|Empagliflozin|empagliflozin|mesh-list
56377259|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377260|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56377261|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56377262|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
56377263|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173011|NCT05249634|Testosterone|testosterone|mesh-list
56377264|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377265|NCT00114192|Thalidomide|thalidomide|mesh-list
56377266|NCT00114192|Docetaxel|docetaxel|mesh-list
56377267|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377268|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
56377269|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
56377270|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
56377271|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377272|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377273|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
56377274|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377275|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
56377276|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56377277|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377278|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56377279|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56377280|NCT00114192|Growth Substances|growth substances|mesh-ancestor
56377281|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
56377283|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56377284|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
56377285|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
56377286|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377287|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377288|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56377289|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56377290|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56377291|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377292|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377293|NCT00350467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56377294|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56377295|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377296|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377297|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377298|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
56377299|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56377300|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56377301|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56377302|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56377303|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
56377304|NCT00350662|Deferiprone|deferiprone|mesh-list
56377305|NCT00350662|Deferoxamine|deferoxamine|mesh-list
56377306|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56377307|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
56377308|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
56377309|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377310|NCT00350662|Siderophores|siderophores|mesh-ancestor
56377311|NCT00350818|Azacitidine|azacitidine|mesh-list
56377314|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377315|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377316|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377317|NCT00350857|Carbamazepine|carbamazepine|mesh-list
56377318|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
56377319|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
56377320|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56377321|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377322|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377323|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377324|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654312|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56216627|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56377326|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
56377327|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377328|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56377329|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377330|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377331|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56377332|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56377333|NCT00111956|Etanercept|etanercept|mesh-list
56377334|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56173014|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56377335|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56377336|NCT00111956|Analgesics|analgesics|mesh-ancestor
56377337|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
56377338|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377339|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377340|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56377341|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377342|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56377343|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377344|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
56377345|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
56377347|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377348|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56377349|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56377350|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377351|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377352|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56377353|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
56377354|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56377355|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377356|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56377357|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
56377358|NCT00111995|Hematinics|hematinics|mesh-ancestor
56377359|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
56377360|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56377361|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56377362|NCT00351052|Analgesics|analgesics|mesh-ancestor
56377363|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
56377364|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377365|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377366|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56377367|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377368|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
56377369|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377370|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
56377371|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56377372|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377373|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377374|NCT00401609|Gemcitabine|gemcitabine|mesh-list
56377375|NCT00401609|Carboplatin|carboplatin|mesh-list
56377385|NCT00401609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377386|NCT00401609|Immunologic Factors|immunologic factors|mesh-ancestor
56377387|NCT00401609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377388|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56377389|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56377390|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56377391|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
56377392|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
56377393|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
56377394|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
56377395|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56377396|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377397|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377398|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56377399|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377400|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56377401|NCT00351130|Amlodipine|amlodipine|mesh-list
56377402|NCT00351130|Valsartan|valsartan|mesh-list
56654313|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654314|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56654315|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654316|NCT00655512|Clobetasol|clobetasol|mesh-list
56654317|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
56377403|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56377404|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56377405|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56173018|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377406|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377407|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56377408|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377409|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
56377410|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56377411|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56377412|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56377413|NCT00351169|Citalopram|citalopram|mesh-list
56377414|NCT00351169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56377415|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56377416|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377417|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377418|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377419|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
56377420|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377421|NCT00351169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56377422|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
56377423|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377424|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56377425|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56377426|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377427|NCT00401648|Brivaracetam|brivaracetam|mesh-list
56377428|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
56377429|NCT00351286|Simvastatin|simvastatin|mesh-list
56377430|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56377431|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56377432|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
56377433|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377434|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56377435|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56377436|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891400|NCT05439694|Coagulants|coagulants|mesh-ancestor
56377446|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
56377447|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56377448|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377449|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377450|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
56377451|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377452|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377453|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56377454|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377455|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56377456|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377457|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
56377458|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377459|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56377460|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56377462|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
56377463|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377464|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56377465|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
56377466|NCT00112034|Hormones|hormones|mesh-ancestor
56377467|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56377468|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56377469|NCT00112034|Protective Agents|protective agents|mesh-ancestor
56173019|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
56377470|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56377471|NCT00114387|Tocopherols|tocopherols|mesh-list
56377472|NCT00114387|Vitamin E|vitamin e|mesh-list
56654318|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56654319|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
56654320|NCT00655512|Hormones|hormones|mesh-ancestor
56654321|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56377473|NCT00114387|Tocotrienols|tocotrienols|mesh-list
56377474|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
56377475|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
56377476|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377477|NCT00114387|Protective Agents|protective agents|mesh-ancestor
56377478|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377479|NCT00114387|Vitamins|vitamins|mesh-ancestor
56377480|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
56377481|NCT00351364|Montelukast|montelukast|mesh-list
56377482|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56377483|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
56377484|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56377485|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
56377486|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56377487|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377488|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56377489|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56377490|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377491|NCT00351403|Ribavirin|ribavirin|mesh-list
56377492|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56377493|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
56377494|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377495|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
56377496|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377497|NCT05595096|Anesthetics|anesthetics|mesh-list
56377498|NCT05595096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377499|NCT05595096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377500|NCT00351637|Methadone|methadone|mesh-list
56377501|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56377519|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
56377521|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56377522|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377523|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56377524|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
56173029|NCT05199714|Pramlintide|pramlintide|mesh-list
56377525|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377526|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377527|NCT00351871|Ribavirin|ribavirin|mesh-list
56377528|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56377529|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
56377530|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377531|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
56377532|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377533|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56377534|NCT00351910|Amitriptyline|amitriptyline|mesh-list
56377535|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56377536|NCT00351910|Citalopram|citalopram|mesh-list
56377537|NCT00351910|Bupropion|bupropion|mesh-list
56377538|NCT00351910|Fluoxetine|fluoxetine|mesh-list
56377539|NCT00351910|Paroxetine|paroxetine|mesh-list
56377540|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56377541|NCT00351910|Sertraline|sertraline|mesh-list
56377542|NCT00351910|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56377543|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56377544|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377545|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377546|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377547|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
56377548|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377549|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56377550|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
56377551|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377552|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377553|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56377554|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
56377555|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55917309|NCT04089150|Paclitaxel|paclitaxel|mesh-list
56654322|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654323|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56654324|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654325|NCT00655512|Analgesics|analgesics|mesh-ancestor
56654326|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
56216637|NCT01626560|Vancomycin|vancomycin|mesh-list
56377556|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56377557|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891516|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
56377561|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56377562|NCT00351910|Analgesics|analgesics|mesh-ancestor
56377563|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
56377564|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56377565|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56377566|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56377567|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
56377568|NCT00112346|Gemcitabine|gemcitabine|mesh-list
56377570|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377571|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
56377572|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377573|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377574|NCT00112346|Antiviral Agents|antiviral agents|mesh-ancestor
56377575|NCT00112346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377576|NCT00112346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377577|NCT00112346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377578|NCT00112346|Immunologic Factors|immunologic factors|mesh-ancestor
56377579|NCT00112346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377580|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56377581|NCT00352144|Eszopiclone|eszopiclone|mesh-list
56377582|NCT00352144|Zopiclone|zopiclone|mesh-list
56377583|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56377584|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377585|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377586|NCT00352183|Simvastatin|simvastatin|mesh-list
56377587|NCT00352183|Fenofibrate|fenofibrate|mesh-list
56377588|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56377589|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56377590|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
56377591|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377592|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56377593|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56377594|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377595|NCT00112619|Topotecan|topotecan|mesh-list
56377596|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56377597|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56377598|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377599|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377600|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377601|NCT00352261|Esomeprazole|esomeprazole|mesh-list
56377602|NCT00352261|Lansoprazole|lansoprazole|mesh-list
56377603|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
56377604|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56377605|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56377606|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56377607|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377608|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377609|NCT00352300|Paclitaxel|paclitaxel|mesh-list
56377610|NCT00352300|Carboplatin|carboplatin|mesh-list
56377611|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56377612|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377613|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
56377614|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
56377615|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
56377616|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377617|NCT00112658|Leucovorin|leucovorin|mesh-list
56377618|NCT00112658|Gemcitabine|gemcitabine|mesh-list
56377619|NCT00112658|Fluorouracil|fluorouracil|mesh-list
56377620|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
56377621|NCT00112658|Irinotecan|irinotecan|mesh-list
56377622|NCT00112658|Calcium|calcium|mesh-list
56377623|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
56654327|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654328|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654329|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
56377624|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377625|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
56377626|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377627|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377628|NCT00112658|Antiviral Agents|antiviral agents|mesh-ancestor
56377629|NCT00112658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377630|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377641|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
56377642|NCT00352339|Aripiprazole|aripiprazole|mesh-list
56377643|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
56377644|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377645|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56377646|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56377647|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377648|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377649|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
56377650|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
56377651|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377652|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377653|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56377654|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56377655|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
56377656|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56377657|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56377658|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56377659|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56377660|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
56377661|NCT00352378|Docetaxel|docetaxel|mesh-list
56377662|NCT00352378|Doxorubicin|doxorubicin|mesh-list
56377663|NCT00352378|Capecitabine|capecitabine|mesh-list
56377664|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377665|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
56377666|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377667|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377668|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56377669|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
56377670|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377671|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377672|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56377673|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
56377674|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
56377675|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
56377676|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56377677|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56377678|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56377679|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377680|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377681|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
56377682|NCT00352495|Carboplatin|carboplatin|mesh-list
56377683|NCT00352495|Vinblastine|vinblastine|mesh-list
56377684|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377685|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56377686|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
56377687|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
56377688|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
56377689|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377690|NCT00112697|Docetaxel|docetaxel|mesh-list
56377691|NCT00112697|Fluorouracil|fluorouracil|mesh-list
56377692|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377693|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
56377694|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
56377695|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
56377696|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377699|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377700|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
56377701|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377702|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
56377703|NCT02959606|Clopidogrel|clopidogrel|mesh-list
56377704|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55917310|NCT04089150|Fluorouracil|fluorouracil|mesh-list
56654330|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654331|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
56654332|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55780485|NCT02378389|Docetaxel|docetaxel|mesh-list
56377705|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56377706|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56377707|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56377708|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
56377709|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377710|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377711|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377712|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56377713|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56377714|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56377715|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
56377716|NCT00352651|Pregabalin|pregabalin|mesh-list
56377717|NCT00352651|Analgesics|analgesics|mesh-ancestor
56377718|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
56377719|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377720|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377721|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
56377722|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56377723|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377724|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377725|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56377726|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56377727|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56377728|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377730|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
56377731|NCT00112775|Dasatinib|dasatinib|mesh-list
56377732|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377733|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56377734|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377735|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377737|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377738|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377739|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56377740|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56377741|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377742|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377743|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377744|NCT00352768|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56377745|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56377746|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377747|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377748|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
56377749|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56377750|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
56377751|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56377752|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56377753|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56377754|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56377755|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56377756|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56377757|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56377758|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56377759|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
56377760|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377761|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377762|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377763|NCT00112853|Etoposide|etoposide|mesh-list
56377764|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
56377765|NCT00112853|Tipifarnib|tipifarnib|mesh-list
56377766|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56377767|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377768|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56377780|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56377781|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56654333|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654334|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654335|NCT00644306|Thalidomide|thalidomide|mesh-list
56654336|NCT00644306|Prednisone|prednisone|mesh-list
56654337|NCT00644306|Melphalan|melphalan|mesh-list
56654338|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56377782|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56377783|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377784|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377785|NCT00353041|Lidocaine|lidocaine|mesh-list
56377786|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
56377787|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
56377788|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377789|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377790|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
56377791|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377792|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56377793|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56377794|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56377795|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377796|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377797|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
56377798|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56377799|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377800|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377801|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56377802|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377803|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56377804|NCT00112892|Selenium|selenium|mesh-list
56377805|NCT00112892|Irinotecan|irinotecan|mesh-list
56377806|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56377807|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56377808|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377809|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377810|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377811|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
56377812|NCT00112892|Protective Agents|protective agents|mesh-ancestor
56377813|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377814|NCT00112892|Trace Elements|trace elements|mesh-ancestor
56377815|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
56377816|NCT00112931|Rituximab|rituximab|mesh-list
56377817|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56377818|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377819|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
56377820|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377821|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377822|NCT00353665|Riluzole|riluzole|mesh-list
56377823|NCT00353665|Memantine|memantine|mesh-list
56377824|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56377825|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56377826|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
56377827|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377828|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377829|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377830|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56377844|NCT05594784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377845|NCT05594784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56377846|NCT05594784|Tubulin Modulators|tubulin modulators|mesh-ancestor
56377847|NCT05594784|Antimitotic Agents|antimitotic agents|mesh-ancestor
56377848|NCT05594784|Mitosis Modulators|mitosis modulators|mesh-ancestor
56377849|NCT05594784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377850|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
56377851|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56377852|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377853|NCT00353743|Metronidazole|metronidazole|mesh-list
56377854|NCT00353743|Doxycycline|doxycycline|mesh-list
56377855|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377856|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56654339|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
56654340|NCT00644306|Hormones|hormones|mesh-ancestor
56654341|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216655|NCT01626911|Heparin|heparin|mesh-list
56377857|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56377858|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56377859|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
56377860|NCT05594745|Lifitegrast|lifitegrast|mesh-list
56377861|NCT05594745|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56377862|NCT05594745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56377863|NCT00113165|Lamotrigine|lamotrigine|mesh-list
56377864|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
56377865|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56377866|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377867|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377868|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56377869|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377870|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56377871|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56377872|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377873|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377874|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56173123|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
56173125|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
56377875|NCT00354094|Reboxetine|reboxetine|mesh-list
56377876|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
56377877|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377878|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56377879|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56377880|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377881|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377882|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
56377883|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377884|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377885|NCT00114816|Docetaxel|docetaxel|mesh-list
56377886|NCT00114816|Capecitabine|capecitabine|mesh-list
56377887|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377888|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
56377889|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
56377890|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
56377903|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
56377904|NCT00354523|Dacarbazine|dacarbazine|mesh-list
56377905|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377906|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
56377907|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377908|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377909|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56377910|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377911|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56377912|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
56377913|NCT00114933|Ritonavir|ritonavir|mesh-list
56377914|NCT00114933|Lopinavir|lopinavir|mesh-list
56377915|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56377916|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56377917|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
56377918|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377919|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377920|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56377921|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56377922|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
56377923|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377924|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56377925|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56377926|NCT00113282|Interleukin-2|interleukin-2|mesh-list
56377927|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377928|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56377929|NCT00113282|Analgesics|analgesics|mesh-ancestor
56377930|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
56377931|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377932|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377933|NCT00425932|Rituximab|rituximab|mesh-list
56377934|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56654342|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654343|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56654344|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654345|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56654346|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
56216657|NCT01626911|Tinzaparin|tinzaparin|mesh-list
56377935|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377936|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
56377937|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377938|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377939|NCT00426010|Caffeine|caffeine|mesh-list
56377940|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56377941|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377942|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56377943|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377944|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377945|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56377946|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56377947|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
56377948|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377949|NCT00115011|Citalopram|citalopram|mesh-list
56377950|NCT00115011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56377951|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56173170|NCT05019638|Ketorolac|ketorolac|mesh-list
55891953|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
56377965|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56377966|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56377967|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56377968|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377969|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377970|NCT00113594|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56377971|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56377972|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377973|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377974|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377975|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
56377977|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377978|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377979|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
56377980|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377981|NCT05594433|Lenograstim|lenograstim|mesh-list
56377982|NCT05594433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56377983|NCT05594433|Immunologic Factors|immunologic factors|mesh-ancestor
56377984|NCT05594433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377985|NCT00115089|Beclomethasone|beclomethasone|mesh-list
56377986|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56377987|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
56377988|NCT00115089|Hormones|hormones|mesh-ancestor
56377989|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56377990|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377991|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56377992|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
56377993|NCT00115128|Lenograstim|lenograstim|mesh-list
56377994|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56377995|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
56377996|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377997|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
56377998|NCT00115167|Hematinics|hematinics|mesh-ancestor
56377999|NCT00115245|Adefovir|adefovir|mesh-list
56378000|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56378001|NCT00115245|Telbivudine|telbivudine|mesh-list
56378003|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378004|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56378005|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56378006|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378007|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378008|NCT01059526|Ecallantide|ecallantide|mesh-list
56378009|NCT01059526|Analgesics|analgesics|mesh-ancestor
56378010|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
56654347|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216663|NCT01627041|Cytarabine|cytarabine|mesh-list
56378011|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378012|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378013|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56378014|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56378018|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56378020|NCT00444340|Analgesics|analgesics|mesh-ancestor
56378021|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
56378022|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378023|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999906|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
56378024|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378025|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56378026|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56378027|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378028|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
56378029|NCT00444379|Ritonavir|ritonavir|mesh-list
56378030|NCT00444379|Lopinavir|lopinavir|mesh-list
56378031|NCT00444379|Tenofovir|tenofovir|mesh-list
56378032|NCT00444379|Emtricitabine|emtricitabine|mesh-list
56378033|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56378034|NCT00444379|Efavirenz|efavirenz|mesh-list
56378035|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56378036|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56378037|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
56378038|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173238|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
56173239|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173240|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173241|NCT04806386|Psyllium|psyllium|mesh-list
56173242|NCT04806386|Cathartics|cathartics|mesh-ancestor
56173243|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56173253|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
56173254|NCT04804072|Narcotics|narcotics|mesh-ancestor
56173255|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56173256|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173257|NCT04804072|Analgesics|analgesics|mesh-ancestor
56378039|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378041|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56378042|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
56378043|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378044|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56378045|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56378046|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56378047|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56378048|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56378049|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56378050|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56378051|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56378052|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56378053|NCT00444418|Naltrexone|naltrexone|mesh-list
56378054|NCT00444418|Naloxone|naloxone|mesh-list
56378055|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56378056|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56378057|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378058|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
56378059|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378061|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56378062|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378063|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56378064|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56378065|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56378066|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378067|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
56378068|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378069|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
56378070|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
56378071|NCT00444613|Vitamins|vitamins|mesh-ancestor
56378072|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
56378073|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378074|NCT00444652|Enoxaparin|enoxaparin|mesh-list
56654348|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55780837|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
56378075|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
56378076|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56378088|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378089|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56378090|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
56378092|NCT00113828|Cyclosporins|cyclosporins|mesh-list
56378093|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378094|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378095|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378096|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
56378097|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378098|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
56378099|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378100|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
56378101|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56378102|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56378103|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
56378104|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56378105|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56378106|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56378107|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56378108|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378109|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
56378110|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378111|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378112|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56378113|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378114|NCT05594121|Buprenorphine|buprenorphine|mesh-list
56378115|NCT05594121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56378116|NCT05594121|Narcotics|narcotics|mesh-ancestor
56378117|NCT05594121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378118|NCT05594121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378119|NCT05594121|Analgesics|analgesics|mesh-ancestor
56378120|NCT05594121|Sensory System Agents|sensory system agents|mesh-ancestor
56378121|NCT05594121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378122|NCT05594121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56378123|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56378124|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56378125|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56378126|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56378127|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378128|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378129|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378130|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56378131|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
56378132|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56378133|NCT00445042|Sorafenib|sorafenib|mesh-list
56378134|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378135|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56378136|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378137|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378138|NCT00445081|Cyclosporine|cyclosporine|mesh-list
56378148|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378149|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378150|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378151|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
56378152|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
56378153|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378154|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
56378155|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56378156|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56378157|NCT00113906|Melatonin|melatonin|mesh-list
56378158|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
56378159|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378160|NCT00113906|Protective Agents|protective agents|mesh-ancestor
56378161|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378162|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378163|NCT05594082|Trastuzumab|trastuzumab|mesh-list
56378164|NCT05594082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56654349|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654350|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
56654351|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
56654352|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56654353|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654354|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56378165|NCT05594082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378166|NCT00113945|Cinacalcet|cinacalcet|mesh-list
56378167|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56378168|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378169|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56378170|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
56378171|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378172|NCT00445159|Treprostinil|treprostinil|mesh-list
56378173|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56378174|NCT00445276|Diacetylrhein|diacetylrhein|mesh-list
56378175|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378176|NCT00113984|Metronidazole|metronidazole|mesh-list
56378177|NCT00113984|Ipilimumab|ipilimumab|mesh-list
56378178|NCT00113984|Sargramostim|sargramostim|mesh-list
56378179|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
56378180|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378181|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378182|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56378183|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56378184|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378185|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378186|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56378187|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56378188|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56378189|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
56378190|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56378191|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56378192|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378193|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378194|NCT00114023|Imiquimod|imiquimod|mesh-list
56378195|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56378196|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
56378197|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378198|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378199|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
56378200|NCT00445861|Docetaxel|docetaxel|mesh-list
56378201|NCT00445861|Cetuximab|cetuximab|mesh-list
56378202|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378221|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
56378222|NCT00445900|Hormones|hormones|mesh-ancestor
56378223|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378224|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56378225|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
56378226|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56378227|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378228|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56378229|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56378230|NCT00445900|Growth Substances|growth substances|mesh-ancestor
56378231|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
56378232|NCT00115479|Insulin|insulin|mesh-list
56378233|NCT00115479|Benzocaine|benzocaine|mesh-list
56378234|NCT00115479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56378235|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378236|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
56378237|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
56378238|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378239|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
56378240|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378241|NCT00446017|Milrinone|milrinone|mesh-list
56378242|NCT00446017|Epinephrine|epinephrine|mesh-list
56378243|NCT00446017|Racepinephrine|racepinephrine|mesh-list
56378244|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
56378245|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56654355|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56654356|NCT00644306|Growth Substances|growth substances|mesh-ancestor
56654357|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
56654358|NCT02634528|Insulin|insulin|mesh-list
56378246|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56378247|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
56378248|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378249|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378250|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378251|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56378252|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56378253|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
56378254|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378255|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56378256|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
56378257|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
56378258|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
56378259|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56378260|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56378261|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56378262|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
56378278|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56378279|NCT00446212|Propofol|propofol|mesh-list
56378280|NCT00446212|Desflurane|desflurane|mesh-list
56378281|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56378282|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378283|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378284|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56378285|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
56378286|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
56378287|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56378288|NCT00446329|Cinacalcet|cinacalcet|mesh-list
56378289|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56378290|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378291|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56378292|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
56378293|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378294|NCT00446368|Everolimus|everolimus|mesh-list
56378295|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378296|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378297|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
56378298|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378299|NCT00401765|Docetaxel|docetaxel|mesh-list
56378300|NCT00401765|Siltuximab|siltuximab|mesh-list
56378301|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378302|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
56378303|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
56378304|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
56378305|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378306|NCT00115518|Cetuximab|cetuximab|mesh-list
56378307|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56378308|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378309|NCT00446524|Amlodipine|amlodipine|mesh-list
56378310|NCT00446524|Valsartan|valsartan|mesh-list
56378311|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56378312|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56378313|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56378314|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378315|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56378316|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378317|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
56378318|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56378319|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56378320|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
56000217|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
56378321|NCT00446602|Hematinics|hematinics|mesh-ancestor
56378337|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378338|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56378339|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56378340|NCT00114179|Growth Substances|growth substances|mesh-ancestor
56378341|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654359|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56654360|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
56378342|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
56378343|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
56378344|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56378345|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
56378346|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378347|NCT00114179|Antiviral Agents|antiviral agents|mesh-ancestor
56378348|NCT00114179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378349|NCT00114179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378350|NCT00114179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378351|NCT00446680|Mannitol|mannitol|mesh-list
56378352|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56378353|NCT00446680|Diuretics|diuretics|mesh-ancestor
56378354|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
56378355|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378356|NCT00114257|Decitabine|decitabine|mesh-list
56378357|NCT00114257|Romidepsin|romidepsin|mesh-list
56378358|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56378359|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
56378360|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378361|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378362|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378363|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56378364|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56378365|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56378366|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378367|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378368|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
56378369|NCT00404937|Hormones|hormones|mesh-ancestor
56378370|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378371|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378372|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56378373|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56378374|NCT00446836|Paclitaxel|paclitaxel|mesh-list
56378375|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56378376|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56378377|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378378|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
56378379|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
56378380|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
56378381|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378382|NCT00114374|Citalopram|citalopram|mesh-list
56378383|NCT00114374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56378392|NCT00114374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56378393|NCT00446953|Betamethasone|betamethasone|mesh-list
56378394|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378395|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
56378396|NCT00446953|Hormones|hormones|mesh-ancestor
56173341|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56378397|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378398|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378399|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56378400|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
56378401|NCT00447031|Triamcinolone|triamcinolone|mesh-list
56378402|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56378403|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56378404|NCT00447031|Bevacizumab|bevacizumab|mesh-list
56378405|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56378406|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56378407|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378408|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56378409|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56378410|NCT00447031|Growth Substances|growth substances|mesh-ancestor
56378411|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378412|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
56378413|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378414|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
56378415|NCT00447031|Hormones|hormones|mesh-ancestor
56378416|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378417|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378418|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
56378419|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654361|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
56654362|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
55781201|NCT03965741|Dabigatran|dabigatran|mesh-list
56378420|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378421|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56378422|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56378423|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56378424|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
56378425|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378426|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378427|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56378428|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56378429|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
56378430|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378431|NCT00115635|Gemcitabine|gemcitabine|mesh-list
56378432|NCT00115635|Docetaxel|docetaxel|mesh-list
56378433|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56378434|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
56378435|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378436|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378437|NCT00115635|Antiviral Agents|antiviral agents|mesh-ancestor
56378438|NCT00115635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378439|NCT00115635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378440|NCT00115635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378441|NCT00115635|Immunologic Factors|immunologic factors|mesh-ancestor
56378442|NCT00115635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378443|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
56378444|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
56378445|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
56378446|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
56378447|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56378462|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56378463|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
56378464|NCT00447577|Hormones|hormones|mesh-ancestor
56378465|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56173358|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56378466|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56378467|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378468|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56378469|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378470|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56378471|NCT05569512|Fludarabine|fludarabine|mesh-list
56378473|NCT05569512|Clofarabine|clofarabine|mesh-list
56378474|NCT05569512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378475|NCT05569512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56378476|NCT05569512|Antimetabolites|antimetabolites|mesh-ancestor
56378477|NCT05569512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378478|NCT05569512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378479|NCT05569512|Immunologic Factors|immunologic factors|mesh-ancestor
56378480|NCT05569512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378481|NCT05569512|Alkylating Agents|alkylating agents|mesh-ancestor
56378482|NCT05569512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56378483|NCT05569512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56378484|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56378485|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56378487|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
56378488|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378489|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56378490|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56378491|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378492|NCT00114569|Lorazepam|lorazepam|mesh-list
56378493|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
56378494|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
56378495|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
56378496|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378497|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378498|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56378499|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56378500|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378501|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56378502|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56378503|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56378504|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
56654363|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56654364|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654365|NCT02816411|Caseins|caseins|mesh-list
56654366|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
56654367|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
56654368|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378505|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
56378506|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378507|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378508|NCT05564598|Valganciclovir|valganciclovir|mesh-list
56378509|NCT05564598|Ganciclovir|ganciclovir|mesh-list
56378519|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378520|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56378521|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378522|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378523|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
56378524|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378525|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56378526|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56378527|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378528|NCT00447967|Antidotes|antidotes|mesh-ancestor
56378529|NCT00447967|Protective Agents|protective agents|mesh-ancestor
56378530|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
56378531|NCT00447967|Vitamins|vitamins|mesh-ancestor
56378532|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
56378533|NCT00401856|Eplerenone|eplerenone|mesh-list
56378534|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56378535|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
56378536|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378537|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378538|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56378539|NCT00401856|Diuretics|diuretics|mesh-ancestor
56378541|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56378542|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56378543|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378544|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56378545|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378546|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378547|NCT00448396|Epothilone B|epothilone b|mesh-list
56378548|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378549|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
56378550|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
56378551|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
56378552|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378553|NCT00114686|Valproic Acid|valproic acid|mesh-list
56378554|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56378555|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
56378556|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56378557|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56378558|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56378559|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378560|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378561|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378562|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378563|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
56378564|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
56378565|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
56378566|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378568|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56378569|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56378570|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378571|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378572|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56378573|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56378574|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56378575|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56378576|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
56378577|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
56378578|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
56654369|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
56654370|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
55783578|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
56378579|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
56378580|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378594|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56378595|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
56378596|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378597|NCT00448786|Niacinamide|niacinamide|mesh-list
56378598|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
56378600|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56378601|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378602|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378603|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
56378604|NCT00448786|Vitamins|vitamins|mesh-ancestor
56378605|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
56378606|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378607|NCT00114803|Calcitonin|calcitonin|mesh-list
56378608|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
56378609|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56378610|NCT00114803|Katacalcin|katacalcin|mesh-list
56378611|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56378612|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378613|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56378614|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
56378615|NCT00448825|Topiramate|topiramate|mesh-list
56378616|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
56378617|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56378618|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378619|NCT00448903|Bemiparin|bemiparin|mesh-list
56378620|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
56378621|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
56378622|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56378623|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378624|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
56378625|NCT00402012|Pioglitazone|pioglitazone|mesh-list
56378626|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56378627|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378629|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56378630|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001877|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
56378631|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
56378632|NCT03276325|Dexamethasone|dexamethasone|mesh-list
56378633|NCT03276325|Nalbuphine|nalbuphine|mesh-list
56378634|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378635|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
56378636|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
56378637|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378638|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378639|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56378640|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
56378641|NCT03276325|Hormones|hormones|mesh-ancestor
56378642|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378643|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56378663|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56378664|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378665|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378666|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56378667|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56378668|NCT00115752|Analgesics|analgesics|mesh-ancestor
56378669|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
56378670|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378671|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378672|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378673|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56378674|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
56378675|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
56378676|NCT00449137|Leucovorin|leucovorin|mesh-list
56378677|NCT00449137|Fluorouracil|fluorouracil|mesh-list
56378678|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
56378679|NCT00449137|Calcium|calcium|mesh-list
56378680|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
56378681|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56378682|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378683|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
55917311|NCT04089150|Capecitabine|capecitabine|mesh-list
56654371|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
56654372|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56654373|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56654374|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378684|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378685|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56378686|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378687|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378688|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
56378689|NCT00449137|Antidotes|antidotes|mesh-ancestor
56378690|NCT00449137|Protective Agents|protective agents|mesh-ancestor
56378691|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
56378692|NCT00449137|Vitamins|vitamins|mesh-ancestor
56378693|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
56378694|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
56378695|NCT00449254|Estrone|estrone|mesh-list
56378696|NCT00449254|Estrogens|estrogens|mesh-ancestor
56378697|NCT00449254|Hormones|hormones|mesh-ancestor
56378698|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378699|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378700|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56378701|NCT00449410|Atorvastatin|atorvastatin|mesh-list
56378702|NCT00449410|Ezetimibe|ezetimibe|mesh-list
55892734|NCT03296358|Hormones|hormones|mesh-ancestor
56378711|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
56378712|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
56378713|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378714|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378715|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
56378716|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378717|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56378718|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56378719|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56378720|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56378721|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378722|NCT00115115|Dopamine|dopamine|mesh-list
56378723|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56378724|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
56378725|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
56378726|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378727|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378728|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
56378729|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378730|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378731|NCT00115115|Protective Agents|protective agents|mesh-ancestor
56378732|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
56378733|NCT00449488|Hematinics|hematinics|mesh-ancestor
56378734|NCT00115830|Atorvastatin|atorvastatin|mesh-list
56378735|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56378736|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56378737|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56378738|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
56378739|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378740|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56378741|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56378742|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378743|NCT00115154|Imiquimod|imiquimod|mesh-list
56378744|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56378745|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
56378746|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378747|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378748|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
56378749|NCT00449527|Budesonide|budesonide|mesh-list
56378750|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
56378751|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378752|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56378753|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
56378754|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378755|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378756|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56378757|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
56378758|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
56378759|NCT00449527|Hormones|hormones|mesh-ancestor
56654375|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654376|NCT00655590|Urological Agents|urological agents|mesh-ancestor
56378760|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378761|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56378762|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56378763|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56378764|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
56378765|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378766|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378767|NCT00449683|Terazosin|terazosin|mesh-list
56378768|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55892781|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56378788|NCT00449839|Insulin|insulin|mesh-list
56378789|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56378790|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
56378791|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
56378792|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56378793|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56378794|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378795|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56378796|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56378797|NCT00450229|Protective Agents|protective agents|mesh-ancestor
56378798|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378799|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378800|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56378801|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56378802|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56378803|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
56378804|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378805|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56378806|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56378807|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378808|NCT00450307|Antibodies|antibodies|mesh-list
56378809|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56378810|NCT00450307|Sargramostim|sargramostim|mesh-list
56378811|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
56378812|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378813|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
56378814|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56378815|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378817|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56378818|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56378819|NCT00450736|Analgesics|analgesics|mesh-ancestor
56378820|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
56378821|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378822|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378823|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378824|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56378825|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56378826|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56378841|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56378842|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56378843|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56378844|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378845|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378846|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56378847|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
56378848|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
56378849|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56378850|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56378851|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56378853|NCT00450853|Granisetron|granisetron|mesh-list
56378854|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
56378855|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
56378856|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378857|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378858|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56378859|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56378860|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
56378861|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917312|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
56654377|NCT02794025|Esmolol|esmolol|mesh-list
56654378|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56654379|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56654380|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56654381|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
56378862|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378863|NCT00450892|Docetaxel|docetaxel|mesh-list
56378864|NCT00450892|Trastuzumab|trastuzumab|mesh-list
56378865|NCT00450892|Lapatinib|lapatinib|mesh-list
56378866|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378867|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
56378868|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
56378869|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
56378870|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378871|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56378872|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56378873|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378874|NCT00115310|Capsaicin|capsaicin|mesh-list
56378875|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
56378876|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
56378877|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
56378878|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378879|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378880|NCT00115908|Ribavirin|ribavirin|mesh-list
56378881|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56378882|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
56378883|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378884|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
56378885|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378886|NCT00458185|Etanercept|etanercept|mesh-list
56378887|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56378888|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56378889|NCT00458185|Analgesics|analgesics|mesh-ancestor
56378897|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
56378898|NCT00458263|Hormones|hormones|mesh-list
56378899|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378900|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378901|NCT00458419|Naloxone|naloxone|mesh-list
56378902|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56378903|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378904|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
56378905|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378906|NCT00458458|Leuprolide|leuprolide|mesh-list
56378907|NCT00458458|Norethindrone|norethindrone|mesh-list
56378908|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
56378909|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56378910|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
56378911|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56378912|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378913|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56378914|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378915|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56378916|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56378917|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56378918|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
56378919|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56378920|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56378921|NCT00458614|Lansoprazole|lansoprazole|mesh-list
56378922|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
56378923|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56378924|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56378925|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56378926|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000809|NCT05482464|Caseins|caseins|mesh-list
56378927|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378929|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56378930|NCT00458731|Cediranib|cediranib|mesh-list
56378931|NCT00458731|Antibodies|antibodies|mesh-list
56378932|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
56378933|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56378934|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654382|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654383|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654384|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654385|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
56654386|NCT00546481|Hematinics|hematinics|mesh-ancestor
56378935|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56378936|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56378937|NCT00458731|Growth Substances|growth substances|mesh-ancestor
56378938|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378939|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
56378940|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
56378941|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378942|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378943|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56378944|NCT03274024|Mitomycins|mitomycins|mesh-list
56378945|NCT03274024|Mitomycin|mitomycin|mesh-list
56378946|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56378947|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378948|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
56378949|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378950|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56378951|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378952|NCT00115947|Terlipressin|terlipressin|mesh-list
56378953|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56378954|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56378955|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
56378956|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378957|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56378965|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378967|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378968|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378969|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
56378970|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56378971|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56378972|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56378973|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378974|NCT00115622|Fluticasone|fluticasone|mesh-list
56378975|NCT00115622|Xhance|xhance|mesh-list
56378976|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378977|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56378978|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
56378979|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378980|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378981|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56378982|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
56378983|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56378984|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56378985|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
56378986|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378987|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
56378988|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56378989|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378990|NCT04728321|Lenvatinib|lenvatinib|mesh-list
56378991|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378992|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56378993|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378994|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378995|NCT00459901|Capecitabine|capecitabine|mesh-list
56378996|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56378997|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56378998|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
56378999|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379000|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379001|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56379002|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379003|NCT00401804|Dexamethasone|dexamethasone|mesh-list
56379004|NCT00401804|Doxorubicin|doxorubicin|mesh-list
56379005|NCT00401804|Bortezomib|bortezomib|mesh-list
56379006|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300460|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300533|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379007|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
56379008|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
56379009|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379010|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379011|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379012|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
56379013|NCT00401804|Hormones|hormones|mesh-ancestor
56379014|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379015|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56379016|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379017|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56379018|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56379019|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56379020|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379021|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379022|NCT00459940|Pioglitazone|pioglitazone|mesh-list
56379023|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379025|NCT00460057|Alendronate|alendronate|mesh-list
56379026|NCT00460057|Diphosphonates|diphosphonates|mesh-list
56379027|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56379028|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379029|NCT00401921|Minocycline|minocycline|mesh-list
56379030|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56379031|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379032|NCT00460174|Gemcitabine|gemcitabine|mesh-list
56379033|NCT00460174|Bevacizumab|bevacizumab|mesh-list
56379034|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56379035|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379036|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56379037|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56379038|NCT00460174|Growth Substances|growth substances|mesh-ancestor
56379039|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379040|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
56379041|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56379042|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
56379043|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379044|NCT00460174|Antiviral Agents|antiviral agents|mesh-ancestor
56379045|NCT00460174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379046|NCT00460174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379047|NCT00460174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379048|NCT00460174|Immunologic Factors|immunologic factors|mesh-ancestor
56379049|NCT00460213|Valsartan|valsartan|mesh-list
56379050|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56379051|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56379052|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56379053|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379054|NCT00460252|Insulin|insulin|mesh-list
56379055|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379056|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379057|NCT00115817|Atorvastatin|atorvastatin|mesh-list
56379058|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56379059|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56379060|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
56379061|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379062|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56379063|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56379064|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379065|NCT00460369|Artesunate|artesunate|mesh-list
56379066|NCT00460369|Lumefantrine|lumefantrine|mesh-list
56379067|NCT00460369|Artemether|artemether|mesh-list
56379068|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
56379069|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
56379070|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56379071|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56379072|NCT00460369|Amodiaquine|amodiaquine|mesh-list
56379073|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
56379074|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56379075|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56379076|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379077|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379078|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
56379079|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
56654387|NCT02789813|Valproic Acid|valproic acid|mesh-list
56654388|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
56654389|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654390|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654391|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
56654392|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654393|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379080|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56379081|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
56379082|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56379084|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379085|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56379086|NCT00460369|Renal Agents|renal agents|mesh-ancestor
56379087|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
56379088|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56379089|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379090|NCT00460486|Formaldehyde|formaldehyde|mesh-list
56379091|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
56379092|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379093|NCT00460642|Cetrorelix|cetrorelix|mesh-list
56379094|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56379095|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
56379096|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56379097|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379098|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
56379099|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379103|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379104|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
56379105|NCT00460759|Rifapentine|rifapentine|mesh-list
56379106|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56379107|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379108|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56379109|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56379110|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379111|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379112|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379113|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56379114|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
56379115|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
56379116|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
56379117|NCT00460837|Cathartics|cathartics|mesh-ancestor
56379118|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379119|NCT00460876|Topotecan|topotecan|mesh-list
56379120|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56379121|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56379122|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379123|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379124|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379125|NCT00460915|Amlodipine|amlodipine|mesh-list
56379126|NCT00460915|Lacidipine|lacidipine|mesh-list
56379127|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56379128|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56379129|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56379130|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379131|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56379132|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379133|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
56379134|NCT00460954|Levodopa|levodopa|mesh-list
56379135|NCT00460954|Carbidopa|carbidopa|mesh-list
56379136|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56379137|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56379138|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56379139|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
56379140|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379141|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379142|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379143|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56654394|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
56379144|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379145|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56379146|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
56379147|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
56379148|NCT00461149|Octreotide|octreotide|mesh-list
56379149|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379150|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56379151|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379152|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
56379153|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379154|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379155|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56379156|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
56379157|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
56379158|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379159|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56379160|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56379161|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379162|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56379163|NCT00461344|Docetaxel|docetaxel|mesh-list
56379164|NCT00461344|Doxorubicin|doxorubicin|mesh-list
56379165|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379166|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
56379167|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
56379168|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
56379169|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379170|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56379171|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56379172|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56379173|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379175|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
56379176|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56379177|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379178|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56379179|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379180|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379181|NCT03273595|Paclitaxel|paclitaxel|mesh-list
56379182|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
56379183|NCT03273595|Trastuzumab|trastuzumab|mesh-list
56379184|NCT03273595|Epirubicin|epirubicin|mesh-list
56379185|NCT03273595|Lapatinib|lapatinib|mesh-list
56379186|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56379187|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379188|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
56379189|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
56379190|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
56379191|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379192|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379193|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
56379194|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379195|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56379196|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56379197|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
56379198|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56379199|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56379200|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56379201|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56379202|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56379203|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379204|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56379206|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
56379207|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
56379208|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56379209|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379210|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
56379211|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379212|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56379213|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56379214|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56379215|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56379216|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379217|NCT04728308|Bupivacaine|bupivacaine|mesh-list
56379218|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
56379219|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
56654395|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56654396|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654397|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56654398|NCT02632578|Vaccines|vaccines|mesh-list
56379220|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56379221|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379222|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
56379223|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379224|NCT00461422|Ganirelix|ganirelix|mesh-list
56379225|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
56379226|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379228|NCT04697992|Vitamins|vitamins|mesh-list
56379229|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
56379230|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
56379231|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
56379232|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379233|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56379234|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56379235|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379236|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
56379237|NCT04697992|Coagulants|coagulants|mesh-ancestor
56379238|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
56379239|NCT04697992|Protective Agents|protective agents|mesh-ancestor
56379240|NCT05483634|Estrogens|estrogens|mesh-list
56379241|NCT05483634|Hormones|hormones|mesh-ancestor
56379242|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379243|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379244|NCT00461578|Artesunate|artesunate|mesh-list
56379245|NCT00461578|Dapsone|dapsone|mesh-list
56379246|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
56379247|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
56379248|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56379249|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55893255|NCT03289182|Rituximab|rituximab|mesh-list
56379251|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379253|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
56379254|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56379255|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
56379256|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56379257|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379258|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379259|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
56379260|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56379261|NCT00461617|Mitiglinide|mitiglinide|mesh-list
56379262|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379263|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379264|NCT00116064|Lorazepam|lorazepam|mesh-list
56379265|NCT00116064|Paraldehyde|paraldehyde|mesh-list
56379266|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
56379267|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
56379268|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
56379269|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379270|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379271|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379272|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56379273|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56379274|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56379275|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56379276|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56379277|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
56379278|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
56379279|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379280|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379281|NCT04728035|Irinotecan|irinotecan|mesh-list
56379282|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56379283|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56379284|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379285|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379286|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379287|NCT00461890|Naltrexone|naltrexone|mesh-list
56379288|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56379289|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56379290|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379291|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
56654399|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
56654400|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654401|NCT00964171|Efavirenz|efavirenz|mesh-list
56654402|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56654403|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56654404|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216710|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56379292|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379293|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56379294|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56379295|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379296|NCT00461968|Simvastatin|simvastatin|mesh-list
56379297|NCT00461968|Ezetimibe|ezetimibe|mesh-list
56379298|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56379299|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56379300|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
56379301|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001199|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56379302|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56379303|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56379304|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379305|NCT00116103|Tacrolimus|tacrolimus|mesh-list
56379306|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379307|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
56379308|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379309|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56379310|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379311|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379312|NCT02956252|Anesthetics|anesthetics|mesh-list
56379313|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56379314|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379315|NCT00462358|Filanesib|filanesib|mesh-list
56379316|NCT00462358|Lenograstim|lenograstim|mesh-list
56379317|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56379318|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
56379319|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379320|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56379321|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56379322|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379326|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56379327|NCT00116181|Analgesics|analgesics|mesh-ancestor
56379328|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
56379329|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379330|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379331|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379332|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56379333|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379334|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379335|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
56379336|NCT00462397|Paclitaxel|paclitaxel|mesh-list
56379337|NCT00462397|Carboplatin|carboplatin|mesh-list
56379338|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56379339|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379340|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
56379341|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
56379342|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
56379343|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379344|NCT00462475|Hormones|hormones|mesh-list
56379345|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379346|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379347|NCT00462553|Gemcitabine|gemcitabine|mesh-list
56379348|NCT00462553|Sunitinib|sunitinib|mesh-list
56379349|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56379350|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
56379351|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173559|NCT04382898|Cemiplimab|cemiplimab|mesh-list
56379352|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654405|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654406|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
56654407|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654408|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56654409|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56654410|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56379353|NCT00462553|Antiviral Agents|antiviral agents|mesh-ancestor
56379354|NCT00462553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379355|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379356|NCT00462553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379357|NCT00462553|Immunologic Factors|immunologic factors|mesh-ancestor
56379358|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379359|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56379360|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56379361|NCT00462553|Growth Substances|growth substances|mesh-ancestor
56379362|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
56379363|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56379364|NCT00462592|Budesonide|budesonide|mesh-list
56379365|NCT00462592|Montelukast|montelukast|mesh-list
56379366|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379367|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56379368|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
56379369|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379370|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379371|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56379372|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
56379373|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
56379374|NCT00462592|Hormones|hormones|mesh-ancestor
56379375|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379376|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56379377|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
56379378|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56379379|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56379380|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379382|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379383|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379384|NCT00462631|Paclitaxel|paclitaxel|mesh-list
56379385|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56379386|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56379387|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379388|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
56379389|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
56379390|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
56379391|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379392|NCT00462787|Dexamethasone|dexamethasone|mesh-list
56379393|NCT00462787|Topotecan|topotecan|mesh-list
56379394|NCT00462787|Vinorelbine|vinorelbine|mesh-list
56379399|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
56379400|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379401|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379402|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379403|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
56379405|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379406|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56379407|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379408|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
56379409|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56379410|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56379411|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379412|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379413|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56379414|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
56379415|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
56379416|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
56379417|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56379418|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
56654411|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56654412|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56654413|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56654414|NCT04016246|Propofol|propofol|mesh-list
56379419|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56379420|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379421|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56379422|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
56379423|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56379424|NCT00463021|Vitamins|vitamins|mesh-ancestor
56379425|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
56379426|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379427|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56379428|NCT00116259|Aripiprazole|aripiprazole|mesh-list
56379429|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
56379430|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56379431|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56379432|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56379433|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56379434|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379435|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
56379436|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
56379437|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379438|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379439|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56379440|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56379441|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
56379442|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56379443|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56379444|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56379445|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56379446|NCT00116324|Montelukast|montelukast|mesh-list
56379447|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56379448|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
56379449|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56379450|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
56379451|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379452|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379453|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56001887|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56379454|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56379455|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379456|NCT00116402|Fluticasone|fluticasone|mesh-list
56379457|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56379458|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379459|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56379460|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
56173585|NCT04330638|Siltuximab|siltuximab|mesh-list
56379461|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379462|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379465|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
56379466|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56379467|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56379468|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56379469|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56379470|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56379471|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379472|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379473|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56379474|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56379475|NCT00463762|Sulbactam|sulbactam|mesh-list
56379476|NCT00463762|Cefoperazone|cefoperazone|mesh-list
56379477|NCT00463762|Sulperazone|sulperazone|mesh-list
56379478|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56379479|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379480|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56379481|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379482|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379483|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56379484|NCT00463762|Renal Agents|renal agents|mesh-ancestor
56379485|NCT00116480|Misoprostol|misoprostol|mesh-list
56379486|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56379487|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
56379488|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56379489|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379490|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56379491|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379492|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
56379493|NCT00463879|Galantamine|galantamine|mesh-list
56379494|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56379495|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379496|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379497|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
56379498|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379499|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379500|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56379501|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
56379502|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379503|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
56379504|NCT00463918|Varenicline|varenicline|mesh-list
56379505|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56379506|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56379507|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
56379508|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379509|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379510|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379511|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
56379512|NCT00463957|Tadalafil|tadalafil|mesh-list
56379513|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
56379514|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56379515|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56379516|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379517|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379518|NCT00463957|Urological Agents|urological agents|mesh-ancestor
56379520|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56379521|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379522|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
56379523|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379524|NCT00464191|Citalopram|citalopram|mesh-list
56379525|NCT00464191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56001422|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
56379526|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56379527|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56379528|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379529|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379530|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
56379531|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379532|NCT00464191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56379533|NCT00464191|Antidepressive Agents|antidepressive agents|mesh-ancestor
56379534|NCT00464191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56379536|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56379537|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56379540|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56379541|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379542|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56379543|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56379544|NCT00464347|Growth Substances|growth substances|mesh-ancestor
56379545|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379546|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
56379547|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379548|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
56379549|NCT00464347|Hormones|hormones|mesh-ancestor
56379550|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379551|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379552|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
56379553|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379554|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379555|NCT00116493|Folic Acid|folic acid|mesh-list
56379556|NCT00116493|Mebendazole|mebendazole|mesh-list
56379557|NCT00116493|Piperazine|piperazine|mesh-list
56379558|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
56379559|NCT00116493|DMP 777|dmp 777|mesh-list
56379560|NCT00116493|Hematinics|hematinics|mesh-ancestor
56379561|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
56654415|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56654416|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654417|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654418|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56654419|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
56654420|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
56654421|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56654422|NCT04178876|Ethanol|ethanol|mesh-list
56654423|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56654424|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654425|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654426|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654427|NCT02789579|Levofloxacin|levofloxacin|mesh-list
56379562|NCT00116493|Vitamins|vitamins|mesh-ancestor
56379563|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
56379564|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379565|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
56379566|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
56379567|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56379568|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379569|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
56379570|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
56379571|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
56379572|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379573|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379574|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379575|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56379577|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56379578|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56379579|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
56379580|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379581|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56379582|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56379583|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379584|NCT00116532|Citalopram|citalopram|mesh-list
56379585|NCT00116532|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56379586|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56379587|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56379588|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379589|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379590|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
56379591|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379592|NCT00116532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56379593|NCT00116532|Antidepressive Agents|antidepressive agents|mesh-ancestor
56379594|NCT00116532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56379595|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
56379596|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379597|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379598|NCT00464893|Catumaxomab|catumaxomab|mesh-list
56379599|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56379600|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379601|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
56379602|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379603|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
56379604|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379605|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
56379606|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56379607|NCT00464932|Protective Agents|protective agents|mesh-ancestor
56379608|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379609|NCT00464971|Estradiol|estradiol|mesh-list
56379610|NCT00464971|Estrogens|estrogens|mesh-ancestor
56379611|NCT00464971|Hormones|hormones|mesh-ancestor
56379612|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379617|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56379618|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56379619|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
56173645|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
56379620|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379622|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56379623|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379624|NCT00465205|Valacyclovir|valacyclovir|mesh-list
56379625|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
56379626|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379627|NCT00465244|Levetiracetam|levetiracetam|mesh-list
56379628|NCT00465244|Lorazepam|lorazepam|mesh-list
56379629|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
56379630|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
56379631|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
56379632|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
56379633|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379634|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379635|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379636|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56379637|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56379638|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56379639|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56379640|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56379641|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
56379642|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
56379643|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379644|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379645|NCT00465283|Donepezil|donepezil|mesh-list
56379646|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56379647|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379648|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379649|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
56379650|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379651|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379652|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
56379653|NCT03272425|Allopurinol|allopurinol|mesh-list
56379654|NCT03272425|Lesinurad|lesinurad|mesh-list
56379655|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
56379656|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379657|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379658|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
56379659|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56379660|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56379661|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
56379662|NCT03272425|Protective Agents|protective agents|mesh-ancestor
56379663|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379664|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
56379665|NCT03272425|Renal Agents|renal agents|mesh-ancestor
56379666|NCT00116948|Cimetidine|cimetidine|mesh-list
56379667|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56379668|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379669|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56379670|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
56379671|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
56379672|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379673|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379674|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379675|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56001574|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56379676|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56379677|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379678|NCT03272503|Pimozide|pimozide|mesh-list
56379679|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56379680|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56379681|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56379682|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379683|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56379684|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56379685|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
56379688|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56379689|NCT00465439|Lidocaine|lidocaine|mesh-list
56379690|NCT00465439|Epinephrine|epinephrine|mesh-list
56379691|NCT00465439|Racepinephrine|racepinephrine|mesh-list
56379692|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
55866014|NCT01910519|Vaccines|vaccines|mesh-list
56379694|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
56654428|NCT02789579|Ofloxacin|ofloxacin|mesh-list
56654429|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
56654430|NCT02789579|Cefuroxime|cefuroxime|mesh-list
56379695|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56379696|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379697|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
56379698|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379699|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56379700|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56379701|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56379702|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56379703|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379704|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56379705|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56379706|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
56379707|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379708|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56379709|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56379710|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
56379711|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56379712|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
56379713|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
56379714|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
56379715|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56379716|NCT00116727|Etanercept|etanercept|mesh-list
56379717|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56379718|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56379719|NCT00116727|Analgesics|analgesics|mesh-ancestor
56379720|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
56379721|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379722|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379723|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379724|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56379725|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379726|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379727|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
56379728|NCT00473551|Sirolimus|sirolimus|mesh-list
56379729|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
56379730|NCT00473551|Rituximab|rituximab|mesh-list
56379731|NCT00473551|Fludarabine|fludarabine|mesh-list
56379732|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
56379733|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379734|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
56379735|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379736|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56379737|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56379738|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
56379739|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379740|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379741|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56379742|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56379743|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56379744|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
56379745|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379746|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56379747|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56379748|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
56379749|NCT00473707|Oxytocin|oxytocin|mesh-list
56379750|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
56379751|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56173666|NCT04131309|Dexamethasone|dexamethasone|mesh-list
56379752|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379754|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56379755|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
56379756|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379757|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
56379758|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
55893798|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56379769|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379770|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56379771|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56379772|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56379773|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051874|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654431|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
56654432|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56654433|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654434|NCT02789579|Renal Agents|renal agents|mesh-ancestor
56379774|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379775|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56379776|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379777|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56379778|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
56379779|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
56379780|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56379781|NCT00474019|Esomeprazole|esomeprazole|mesh-list
56379782|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56379783|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379784|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56379785|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379786|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379787|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
56379788|NCT00117065|Hematinics|hematinics|mesh-ancestor
56379789|NCT00474136|Diclofenac|diclofenac|mesh-list
56379790|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56379791|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56379792|NCT00474136|Analgesics|analgesics|mesh-ancestor
56379793|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
56379794|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379795|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379796|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379797|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56379798|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56379799|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379800|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379801|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
56379802|NCT00117104|Hematinics|hematinics|mesh-ancestor
56379803|NCT03270709|Vitamin D|vitamin d|mesh-list
56379804|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
56379805|NCT03270709|Vitamins|vitamins|mesh-ancestor
56379806|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
56379807|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379808|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56379809|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56379810|NCT03270553|Metformin|metformin|mesh-list
56379811|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379812|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379813|NCT00117182|Budesonide|budesonide|mesh-list
56379814|NCT00117182|Mannitol|mannitol|mesh-list
56379815|NCT00117182|Bromides|bromides|mesh-list
56379816|NCT00117182|Albuterol|albuterol|mesh-list
56379817|NCT00117182|Ipratropium|ipratropium|mesh-list
56379818|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379819|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56379820|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
56379821|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379822|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379823|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56379824|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
56379825|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
56379837|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56379838|NCT00117182|Diuretics|diuretics|mesh-ancestor
56379839|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
56379840|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56379841|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
56379842|NCT00116922|Metformin|metformin|mesh-list
56379843|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
56379844|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379845|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379846|NCT00116961|Dexamethasone|dexamethasone|mesh-list
56379847|NCT00116961|Bortezomib|bortezomib|mesh-list
56379848|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379849|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
56379850|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
56379851|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379852|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379853|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379854|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
56379855|NCT00116961|Hormones|hormones|mesh-ancestor
56654435|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56654436|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56654437|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56654438|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379856|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379857|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56379858|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379859|NCT00474721|Acetaminophen|acetaminophen|mesh-list
56379860|NCT00474721|Ibuprofen|ibuprofen|mesh-list
56379861|NCT00474721|Codeine|codeine|mesh-list
56379862|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56379863|NCT00474721|Analgesics|analgesics|mesh-ancestor
56379864|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
56379865|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379866|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379867|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
56379868|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56379869|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379870|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56379871|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56379872|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379873|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379874|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56379875|NCT00474721|Narcotics|narcotics|mesh-ancestor
56379876|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56379877|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
56379878|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
56379879|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
56379880|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56379881|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56379882|NCT00117260|Estradiol|estradiol|mesh-list
56379883|NCT00117260|Estrogens|estrogens|mesh-ancestor
56379884|NCT00117260|Hormones|hormones|mesh-ancestor
56379885|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379886|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379887|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56379888|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
56379889|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56379890|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55893936|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
56379895|NCT00474838|Metformin|metformin|mesh-list
56379896|NCT00474838|Glimepiride|glimepiride|mesh-list
56379897|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56379898|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379899|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56379900|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379901|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
56379902|NCT00474916|KRN 5500|krn 5500|mesh-list
56379903|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379904|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56379906|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379908|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56379909|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
56379910|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379911|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
56379912|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379913|NCT00117299|Vatalanib|vatalanib|mesh-list
56379914|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56379915|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379916|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379917|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
56379918|NCT00117000|Testosterone|testosterone|mesh-list
56379919|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
56379920|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
56379921|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56379922|NCT00117000|Androgens|androgens|mesh-ancestor
56379923|NCT00117000|Hormones|hormones|mesh-ancestor
56379924|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379925|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379926|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56379927|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654439|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654440|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654441|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56379928|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
56379929|NCT02956408|Vitamin D|vitamin d|mesh-list
56379930|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
56379931|NCT02956408|Vitamins|vitamins|mesh-ancestor
56379932|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
56379933|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379934|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56379935|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56379936|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
56379937|NCT00475189|Norinyl|norinyl|mesh-list
56379938|NCT00475189|Mestranol|mestranol|mesh-list
56379939|NCT00475189|Norethindrone|norethindrone|mesh-list
56379940|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56379941|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56379942|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56379943|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
56379944|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56379945|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379946|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56379947|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56379948|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
56379949|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56379950|NCT00475189|Estrogens|estrogens|mesh-ancestor
56379951|NCT00475189|Hormones|hormones|mesh-ancestor
56379952|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379953|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
56379954|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56379955|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56379956|NCT00117377|Analgesics|analgesics|mesh-ancestor
56379957|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
56379958|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379959|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379960|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379961|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56379962|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
56379966|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379967|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379968|NCT02964195|Rifaximin|rifaximin|mesh-list
56379969|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56379970|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379971|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56379972|NCT00475462|Metoprolol|metoprolol|mesh-list
56379973|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56379974|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56379975|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
56379976|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
56379977|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379978|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001893|NCT00000208|Analgesics|analgesics|mesh-ancestor
56379979|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56379980|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56379982|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
56379983|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379984|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379985|NCT00475618|Fluorides|fluorides|mesh-list
56379986|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
56379987|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
56379988|NCT00475618|Protective Agents|protective agents|mesh-ancestor
56379989|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379990|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
56379991|NCT00117039|Hematinics|hematinics|mesh-ancestor
56379992|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56379993|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56379994|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56379995|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56379996|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654442|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56654443|NCT04233203|Insulin|insulin|mesh-list
56654444|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56654445|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56379997|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379998|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379999|NCT00475696|Analgesics|analgesics|mesh-ancestor
56380000|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
56380001|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380002|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
56380003|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380004|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
56380005|NCT00117455|Lenograstim|lenograstim|mesh-list
56380006|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56380007|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
56380008|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380009|NCT03270007|Vinorelbine|vinorelbine|mesh-list
56380010|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56380011|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380012|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
56380013|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
56380014|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
56380015|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380016|NCT00475813|Fluticasone|fluticasone|mesh-list
56380017|NCT00475813|Xhance|xhance|mesh-list
56380018|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
56380019|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380020|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56380021|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
56380022|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380023|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380024|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56380025|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
56380026|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
56380027|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56380028|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56380029|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56380030|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56380031|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
56380032|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380033|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380034|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
56380038|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380039|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
56380040|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380041|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
56380042|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56380043|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56380044|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380045|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
56380046|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
56380047|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56380048|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56380049|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56380050|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56380051|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380052|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380053|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380055|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
56380056|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380057|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
56380058|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380059|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
56380060|NCT00476164|Rituximab|rituximab|mesh-list
56380061|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56380062|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380063|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
56380064|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380065|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56380066|NCT00402077|Pramlintide|pramlintide|mesh-list
56380067|NCT00402077|Phentermine|phentermine|mesh-list
56654446|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654447|NCT00959101|Metformin|metformin|mesh-list
56654448|NCT00959101|Repaglinide|repaglinide|mesh-list
56380068|NCT00402077|Sibutramine|sibutramine|mesh-list
56380069|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56380070|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380071|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56380072|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
56380073|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56380074|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
56380075|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
56380076|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380077|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
56380078|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380079|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380080|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
56380081|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380082|NCT00476359|Lopinavir|lopinavir|mesh-list
56380083|NCT00476359|Saquinavir|saquinavir|mesh-list
56380084|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56380085|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56380086|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
56380087|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380088|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380089|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56380090|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56380091|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
56380092|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380093|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56380094|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56380095|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
56380096|NCT00117117|Hematinics|hematinics|mesh-ancestor
56380097|NCT00476437|Insulin|insulin|mesh-list
56380098|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56380099|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
56380100|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
56380101|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56380102|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380103|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56380104|NCT00117494|Pravastatin|pravastatin|mesh-list
56380105|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56380106|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56380108|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380109|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56380110|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56380111|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380112|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
56380113|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380115|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
56380116|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
56380117|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380118|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
56380119|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380120|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380121|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
56380122|NCT00117234|Hematinics|hematinics|mesh-ancestor
56380123|NCT00117611|Omalizumab|omalizumab|mesh-list
56380124|NCT00117611|Antibodies|antibodies|mesh-list
56380125|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
56380126|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380127|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56380128|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56380130|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56380131|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56380132|NCT04727684|Cetrorelix|cetrorelix|mesh-list
56380133|NCT04727684|Menotropins|menotropins|mesh-list
56380134|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
56380135|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56380136|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
56380137|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56380138|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380139|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56380140|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56380141|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654449|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56654450|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654451|NCT04233359|Anesthetics|anesthetics|mesh-list
56380142|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56380143|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
56380144|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
56380145|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380146|NCT03277261|Teriflunomide|teriflunomide|mesh-list
56380147|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56380148|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56380149|NCT03277261|Analgesics|analgesics|mesh-ancestor
56380150|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
56380151|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380152|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380153|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380154|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56380155|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56380156|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
56380157|NCT02273947|BMS-955176|bms-955176|mesh-list
56380158|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56380159|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56380160|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
56380161|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380162|NCT05367336|Fentanyl|fentanyl|mesh-list
56380163|NCT05367336|Morphine|morphine|mesh-list
56380164|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56380165|NCT05367336|Narcotics|narcotics|mesh-ancestor
56380166|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380167|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380168|NCT05367336|Analgesics|analgesics|mesh-ancestor
56380169|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
56380170|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380171|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56173707|NCT04091217|Bevacizumab|bevacizumab|mesh-list
56380172|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56380173|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
56380174|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
56380175|NCT00476515|Rituximab|rituximab|mesh-list
56380176|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56380177|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380178|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
56380179|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380180|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56380181|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
56380182|NCT00117689|Tacrolimus|tacrolimus|mesh-list
56380183|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
56380184|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56380185|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55894207|NCT03265782|Acetaminophen|acetaminophen|mesh-list
56380190|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380192|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380193|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56380194|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
56380195|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56380196|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380197|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
56380198|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56380199|NCT00117273|Estradiol|estradiol|mesh-list
56380200|NCT00117273|Estrogens|estrogens|mesh-ancestor
56380201|NCT00117273|Hormones|hormones|mesh-ancestor
56380202|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380203|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380204|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56380205|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
56380206|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56380207|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56380208|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56380210|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56380211|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56380212|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56380213|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56380214|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
56380215|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380216|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56654452|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
56654453|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654454|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654455|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
56380218|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56380219|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56380220|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380221|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380222|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
56380223|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380224|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56380225|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56380226|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56380227|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56380228|NCT00117767|Terbinafine|terbinafine|mesh-list
56380229|NCT00117767|Griseofulvin|griseofulvin|mesh-list
56380230|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
56380231|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380232|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380233|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380234|NCT03277066|Diclofenac|diclofenac|mesh-list
56380235|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56380236|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56380237|NCT03277066|Analgesics|analgesics|mesh-ancestor
56380238|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
56380239|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380240|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380241|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380242|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173719|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380243|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56380244|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380245|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380246|NCT00117351|Bortezomib|bortezomib|mesh-list
56380247|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380248|NCT00118196|Azacitidine|azacitidine|mesh-list
56380249|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
56380250|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56380251|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
56380252|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380253|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380254|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380255|NCT00118235|Bevacizumab|bevacizumab|mesh-list
56380260|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56380261|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380262|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56380263|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56380264|NCT00118235|Growth Substances|growth substances|mesh-ancestor
56380265|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380266|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
56380267|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
56380268|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56380269|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56380270|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380271|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380272|NCT00118313|Imiquimod|imiquimod|mesh-list
56380273|NCT00118313|Sargramostim|sargramostim|mesh-list
56380274|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
56380275|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56380276|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
56380277|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380278|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380279|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56380280|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
56380281|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56380282|NCT00118313|Protective Agents|protective agents|mesh-ancestor
56380283|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56380285|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380286|NCT03271021|Minocycline|minocycline|mesh-list
56380287|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917313|NCT04089150|Irinotecan|irinotecan|mesh-list
56654456|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654457|NCT00964327|Darunavir|darunavir|mesh-list
56654458|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56654459|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56654460|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
56654461|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654462|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654463|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56654464|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56654465|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
56216762|NCT01627262|Mesalamine|mesalamine|mesh-list
56380288|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380289|NCT02273986|Digoxin|digoxin|mesh-list
56380290|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56380291|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56380292|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380293|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380294|NCT02273986|Protective Agents|protective agents|mesh-ancestor
56380295|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380296|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
56380297|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56380298|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56380299|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380300|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56380301|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380302|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56380303|NCT00476983|Ritonavir|ritonavir|mesh-list
56380304|NCT00476983|Saquinavir|saquinavir|mesh-list
56380305|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56380306|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56380307|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56380308|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
56380309|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380310|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380311|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56380312|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56380313|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
56380314|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380315|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56380316|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56380317|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56380318|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56380319|NCT00477061|Morphine|morphine|mesh-list
56380320|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56380321|NCT00477061|Narcotics|narcotics|mesh-ancestor
56380322|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380323|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380324|NCT00477061|Analgesics|analgesics|mesh-ancestor
56380325|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
56380326|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380327|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
56380343|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380344|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380345|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56380346|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
56380347|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380348|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
56380349|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380350|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
56380351|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56380352|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56380353|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
56380354|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56654466|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654468|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
56654469|NCT05252546|Bentonite|bentonite|mesh-list
56654470|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56654471|NCT05252546|Antidotes|antidotes|mesh-ancestor
56654472|NCT05252546|Protective Agents|protective agents|mesh-ancestor
56216770|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56002256|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56380355|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56380356|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56380357|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56380358|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380359|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
56380360|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380361|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380362|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56380363|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380364|NCT05330871|Vaccines|vaccines|mesh-list
56380365|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
56380366|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380367|NCT00477880|Cetuximab|cetuximab|mesh-list
56380368|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56380369|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380370|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56380371|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380372|NCT00477997|Hormones|hormones|mesh-list
56380373|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380374|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380375|NCT00478075|Bortezomib|bortezomib|mesh-list
56380376|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
56380377|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380378|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56380379|NCT00478075|Analgesics|analgesics|mesh-ancestor
56380380|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
56380381|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380382|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380383|NCT00478114|Sorafenib|sorafenib|mesh-list
56380384|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380385|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55894440|NCT02089113|Hormones|hormones|mesh-ancestor
56380387|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380389|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56380390|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380391|NCT00478504|Letrozole|letrozole|mesh-list
56380392|NCT00478504|Clomiphene|clomiphene|mesh-list
56380393|NCT00478504|Enclomiphene|enclomiphene|mesh-list
56380394|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
56380395|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380396|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380397|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56380398|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56380399|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380400|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56380401|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
56380402|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380403|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380404|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56380405|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
56380406|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56380407|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56380408|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56380409|NCT00117468|Progesterone|progesterone|mesh-list
56380410|NCT00117468|Progestins|progestins|mesh-ancestor
56380411|NCT00117468|Hormones|hormones|mesh-ancestor
56380412|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380413|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380414|NCT03271879|Empagliflozin|empagliflozin|mesh-list
56380415|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55917457|NCT00159432|Capecitabine|capecitabine|mesh-list
56654473|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654474|NCT00644384|Acitretin|acitretin|mesh-list
56654475|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
56654476|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
56654477|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
56380416|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380417|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56380418|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380419|NCT00478543|Furosemide|furosemide|mesh-list
56380420|NCT00478543|Diuretics|diuretics|mesh-ancestor
56380421|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
56380422|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001897|NCT00001930|Amantadine|amantadine|mesh-list
56380423|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56380424|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56380425|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380426|NCT00118937|Metformin|metformin|mesh-list
56380427|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56002329|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56380428|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380429|NCT00478621|Vaccines|vaccines|mesh-list
56380430|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
56380431|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380432|NCT00478660|Adalimumab|adalimumab|mesh-list
56380433|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380434|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56380435|NCT00478699|Gemcitabine|gemcitabine|mesh-list
56380436|NCT00478699|Cisplatin|cisplatin|mesh-list
56380437|NCT00478699|Docetaxel|docetaxel|mesh-list
56380438|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380439|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56380440|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
56380441|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380442|NCT00478699|Antiviral Agents|antiviral agents|mesh-ancestor
56380443|NCT00478699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380444|NCT00478699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380445|NCT00478699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56380446|NCT00478699|Immunologic Factors|immunologic factors|mesh-ancestor
56380447|NCT00478699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380448|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
56380449|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
56380450|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
56380451|NCT00118976|Lisinopril|lisinopril|mesh-list
56380452|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56380453|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
56380454|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380455|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380456|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56380459|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380461|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
56380462|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56380463|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
56380464|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380465|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380466|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380467|NCT00478816|Vaccines|vaccines|mesh-list
56380468|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
56380469|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380470|NCT00478855|Piperacillin|piperacillin|mesh-list
56380471|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56380472|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56380473|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380474|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56380475|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380476|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380477|NCT00117546|Methyldopa|methyldopa|mesh-list
56380478|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56380479|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
56380480|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
56380481|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380482|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654478|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56654479|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56654480|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
56380483|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56380484|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56380485|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56380486|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56380487|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380488|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380489|NCT00479206|Artesunate|artesunate|mesh-list
56380490|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
56380491|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56380492|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56380493|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380494|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380495|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
56380496|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
56380497|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56380498|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
56380499|NCT00119132|Artesunate|artesunate|mesh-list
56380500|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
56380501|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
56380502|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56380503|NCT00119132|Amodiaquine|amodiaquine|mesh-list
56380504|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
56380505|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56380506|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56380507|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380508|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380509|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
56380510|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
56380511|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56380512|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
56380513|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56380514|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380515|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380516|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56380517|NCT00119132|Renal Agents|renal agents|mesh-ancestor
56380518|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56380519|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
56380520|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380521|NCT00479362|Aspirin|aspirin|mesh-list
56380522|NCT00479362|Warfarin|warfarin|mesh-list
56380523|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56380524|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56380525|NCT00479362|Analgesics|analgesics|mesh-ancestor
56380526|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
56380527|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380528|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380529|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380530|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56380533|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380534|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56380536|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380537|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
56380538|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
56380539|NCT00119171|Capecitabine|capecitabine|mesh-list
56380540|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56380541|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
56380542|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380543|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380544|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
56380545|NCT00117624|Hematinics|hematinics|mesh-ancestor
56380546|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
56380547|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
56380548|NCT00479479|Vitamins|vitamins|mesh-ancestor
56380549|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
56380550|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380551|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
56380552|NCT00479479|Hematinics|hematinics|mesh-ancestor
56380553|NCT00119210|Bupropion|bupropion|mesh-list
56380554|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56380555|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
56380556|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380557|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56654481|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
56654482|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654483|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654484|NCT02815865|Oxytocin|oxytocin|mesh-list
56654485|NCT02815865|Dinoprostone|dinoprostone|mesh-list
56654486|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
56654487|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56380558|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56380559|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56380560|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380561|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
56380562|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380563|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380564|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56380565|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56380566|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380567|NCT00117663|Hormones|hormones|mesh-list
56380568|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001900|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
56380569|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380571|NCT00479752|Cetuximab|cetuximab|mesh-list
56380572|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380573|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56380574|NCT00119249|Sorafenib|sorafenib|mesh-list
56380575|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380576|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56380577|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380578|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380579|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
56380580|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
56380581|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380582|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
56380583|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56380584|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56380585|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380586|NCT00479908|Urological Agents|urological agents|mesh-ancestor
56380587|NCT00479986|Pioglitazone|pioglitazone|mesh-list
56380588|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56380589|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380591|NCT00480064|Lomustine|lomustine|mesh-list
56380592|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56380593|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
56380594|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380595|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380596|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
56380597|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380598|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56380599|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
56380600|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380601|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56380602|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
56380603|NCT00480103|Mineral Oil|mineral oil|mesh-list
56380605|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
56380607|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56380608|NCT00480142|Narcotics|narcotics|mesh-ancestor
56380609|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380610|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380611|NCT00480142|Analgesics|analgesics|mesh-ancestor
56380612|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
56380613|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380614|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
56380615|NCT00119483|Testosterone|testosterone|mesh-list
56380616|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
56380617|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
56380618|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56380619|NCT00119483|Androgens|androgens|mesh-ancestor
56380620|NCT00119483|Hormones|hormones|mesh-ancestor
56380621|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654488|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654489|NCT02673866|Pregabalin|pregabalin|mesh-list
56654490|NCT02673866|DS-1971a|ds-1971a|mesh-list
56654491|NCT02673866|Analgesics|analgesics|mesh-ancestor
56654492|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
56654493|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654494|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654495|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
56654496|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56654497|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56380622|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380623|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56380624|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380625|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
56380626|NCT00480181|Nabilone|nabilone|mesh-list
56380627|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
56380628|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
56380629|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380630|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380631|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56380632|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56380633|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56380634|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380635|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380636|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
56380637|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56380638|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56380639|NCT00480298|Prednisolone|prednisolone|mesh-list
56380640|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
56380641|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56380642|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
56380643|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380644|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
56380645|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
56380646|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380647|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380648|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56380649|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
56380650|NCT00480298|Hormones|hormones|mesh-ancestor
56380651|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380652|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56380653|NCT00480298|Protective Agents|protective agents|mesh-ancestor
56380654|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56380655|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380656|NCT00480376|Gentamicins|gentamicins|mesh-list
56380657|NCT00480376|Ofloxacin|ofloxacin|mesh-list
56380658|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56380659|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380660|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56380661|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380662|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380663|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56380664|NCT00480376|Renal Agents|renal agents|mesh-ancestor
56380665|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56380666|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56380667|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380668|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56380669|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56380670|NCT00117702|Everolimus|everolimus|mesh-list
56380671|NCT00117702|Tacrolimus|tacrolimus|mesh-list
56380672|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56380673|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
56380674|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380675|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56380676|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380677|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654498|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654499|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56654500|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56380678|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380681|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380683|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
56380684|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
56380685|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380686|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380687|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380688|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56380689|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56380690|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380691|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380692|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56380693|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
56380694|NCT00480610|Tacrolimus|tacrolimus|mesh-list
56380695|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56380696|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
56380697|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380698|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56380699|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380700|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380701|NCT00480649|Fluticasone|fluticasone|mesh-list
56380702|NCT00480649|Xhance|xhance|mesh-list
56380703|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56380704|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380705|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56380706|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
56380707|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380708|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380709|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56380710|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
56380711|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
56380712|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56380713|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56380714|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56380715|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56380716|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
56380717|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380718|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380719|NCT00119639|Sorafenib|sorafenib|mesh-list
56380720|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380721|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56380722|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380723|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380724|NCT00480844|Risperidone|risperidone|mesh-list
56380725|NCT00480844|Sertindole|sertindole|mesh-list
56380726|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56380727|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
56380728|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380729|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380730|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380731|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56380732|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56380733|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380734|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380735|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56380736|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
56380737|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56380738|NCT00480883|Allopurinol|allopurinol|mesh-list
56380739|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
56380740|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380741|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380742|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
56380743|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56380744|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56380745|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
56380746|NCT00480883|Protective Agents|protective agents|mesh-ancestor
56380747|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380748|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56654501|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56654502|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654503|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56654504|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56380749|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56380750|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380751|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56380752|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
56380755|NCT05236998|Incretins|incretins|mesh-ancestor
56380757|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380758|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56380759|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
56380760|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380761|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380762|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56380763|NCT01240096|Mirtazapine|mirtazapine|mesh-list
56380764|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
56380765|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380766|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56380767|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
56380768|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
56380769|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380770|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380771|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380772|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56380773|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56380774|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380775|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56380776|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56380777|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56380778|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
56380779|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56380780|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56380781|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
56380782|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56380783|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56380784|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56380785|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56380786|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380787|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380788|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380789|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56380790|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56380791|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
56380792|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380793|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380794|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56380795|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56380796|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
56380797|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56380798|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380799|NCT01240252|Insulin|insulin|mesh-list
56380800|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56380801|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56380802|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380803|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
56380804|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56380805|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380806|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380807|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56380808|NCT05233605|Analgesics|analgesics|mesh-ancestor
56380809|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
56380810|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380811|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56380812|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56380813|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56380814|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
56380815|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654505|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56654506|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56654507|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
56654508|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56654509|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654510|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
56380816|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380817|NCT00117780|Insulin|insulin|mesh-list
56380818|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56380819|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
56380820|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
56380821|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56380822|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380823|NCT01240408|Lenvatinib|lenvatinib|mesh-list
56380824|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380825|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56380827|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380828|NCT00481273|Azacitidine|azacitidine|mesh-list
56380829|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56380830|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
56380831|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380832|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380833|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380834|NCT00481312|Midazolam|midazolam|mesh-list
56380835|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
56380836|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56380837|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380838|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380839|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56380840|NCT00481312|Analgesics|analgesics|mesh-ancestor
56380841|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
56380842|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380843|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56380844|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56380845|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56380846|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
56380847|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380848|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380849|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56380850|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56380851|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56380852|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380853|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56380855|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
56380856|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
56380857|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
56380858|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
56380859|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56380860|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380861|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
56380862|NCT00119990|Icodextrin|icodextrin|mesh-list
56380863|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56380864|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
56380865|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
56380866|NCT00481624|Hematinics|hematinics|mesh-ancestor
56380867|NCT00117897|Lenograstim|lenograstim|mesh-list
56380868|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56380869|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
56380870|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380871|NCT00481663|Metformin|metformin|mesh-list
56380872|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56380873|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56380874|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380875|NCT00481663|Incretins|incretins|mesh-ancestor
56380876|NCT00481663|Hormones|hormones|mesh-ancestor
56380877|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380878|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56380879|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
56380880|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380881|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380882|NCT00481702|Metronidazole|metronidazole|mesh-list
56654511|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56654512|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56654513|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380884|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380885|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56380886|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56380887|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56380888|NCT00481741|Hemostatics|hemostatics|mesh-list
56380889|NCT00481741|Coagulants|coagulants|mesh-ancestor
56380890|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
56380891|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
56380892|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56380893|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56380894|NCT00481819|Prednisolone|prednisolone|mesh-list
56380895|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
56380896|NCT00481819|Tacrolimus|tacrolimus|mesh-list
56380897|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56380898|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
56380899|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56380900|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
56380901|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380902|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56380910|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380911|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380912|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
56380913|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
56380914|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380915|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56380916|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
56380917|NCT00481819|Hormones|hormones|mesh-ancestor
56380918|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380919|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56380920|NCT00481819|Protective Agents|protective agents|mesh-ancestor
56380921|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56380922|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56380923|NCT02958059|Cefoxitin|cefoxitin|mesh-list
56380924|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56380925|NCT00481975|Rimonabant|rimonabant|mesh-list
56380926|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56380927|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56380928|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56380929|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380930|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380932|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380933|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380934|NCT00482209|Misoprostol|misoprostol|mesh-list
56380935|NCT00482209|Mifepristone|mifepristone|mesh-list
56380936|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56380937|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
56380938|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56380939|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380940|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56380941|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56380942|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
56380943|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56380944|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56380945|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56380946|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56380947|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
56380948|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56380949|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56380950|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
56380951|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56380952|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
56380953|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56380954|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56380955|NCT00117936|Mitogens|mitogens|mesh-list
56380956|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
56002864|NCT00000412|Calcitriol|calcitriol|mesh-list
56380957|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380958|NCT00482248|Omalizumab|omalizumab|mesh-list
56380959|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56654514|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654515|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654516|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56216801|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380960|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56380961|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
56380962|NCT00120185|Interleukin-2|interleukin-2|mesh-list
56380963|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380964|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56380965|NCT00120185|Analgesics|analgesics|mesh-ancestor
56380966|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
56380967|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895021|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
56380970|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380971|NCT00117975|Galiximab|galiximab|mesh-list
56380972|NCT00117975|Rituximab|rituximab|mesh-list
56380973|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56380974|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380975|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
56380976|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380977|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56380978|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380979|NCT00482521|Pomalidomide|pomalidomide|mesh-list
56380980|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
56380981|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380982|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56380983|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56380984|NCT00482521|Growth Substances|growth substances|mesh-ancestor
56380985|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
56380986|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380987|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
56380988|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56380989|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56380990|NCT00120302|Analgesics|analgesics|mesh-ancestor
56380991|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
56380992|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56380993|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380994|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56380995|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56380996|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
56380997|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56380998|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
56380999|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56381000|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381001|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381003|NCT00482716|Dextrans|dextrans|mesh-list
56381004|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
56381005|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56381006|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
56381007|NCT00482716|Trace Elements|trace elements|mesh-ancestor
56381008|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
56381009|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381010|NCT00482716|Hematinics|hematinics|mesh-ancestor
56381011|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
56381012|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
56381013|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
56381014|NCT00482755|Sunitinib|sunitinib|mesh-list
56381015|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381016|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56381017|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56381018|NCT00482755|Growth Substances|growth substances|mesh-ancestor
56381019|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381020|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
56381021|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56381022|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381023|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381024|NCT00120341|Analgesics|analgesics|mesh-list
56381025|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
56381026|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381027|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381028|NCT00482989|Sifalimumab|sifalimumab|mesh-list
56381029|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
56654517|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56654518|NCT02793323|Anesthetics|anesthetics|mesh-list
56654519|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56381030|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381031|NCT00120380|Iloprost|iloprost|mesh-list
56381032|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56381033|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
56381034|NCT00483028|Donepezil|donepezil|mesh-list
56381035|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56381036|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381037|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381038|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
56381039|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381040|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381041|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
56381042|NCT00118014|Sertraline|sertraline|mesh-list
56381043|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
56381044|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56381045|NCT00118014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56381046|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56381047|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381048|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381049|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381050|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
56381051|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381052|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
56381053|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56381054|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381055|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56381056|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
56381057|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56381058|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381059|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381060|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381061|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
56381062|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
56381063|NCT05176470|Fludarabine|fludarabine|mesh-list
56381064|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56381065|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
56381066|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381067|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381068|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56381069|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
56381070|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381071|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381072|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56381073|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56381074|NCT01241032|Udenafil|udenafil|mesh-list
56381075|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56381076|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56381077|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381078|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381079|NCT00483067|Cytarabine|cytarabine|mesh-list
56381080|NCT00483067|Cladribine|cladribine|mesh-list
56381081|NCT00483067|Lenograstim|lenograstim|mesh-list
56381082|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56381083|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
56381084|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381085|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381086|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
56381087|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381088|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56381089|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
56381090|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381091|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56381092|NCT00483106|Methylphenidate|methylphenidate|mesh-list
56381093|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56381094|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381095|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56381096|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56654520|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654521|NCT00964639|Ropivacaine|ropivacaine|mesh-list
56654522|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
56654523|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
56654524|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654525|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654526|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
56381097|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381098|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381099|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
56381100|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381101|NCT00118170|Sorafenib|sorafenib|mesh-list
56381102|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381103|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56381104|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381105|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381106|NCT00120497|Hormones|hormones|mesh-list
56003004|NCT00001318|Interferons|interferons|mesh-list
56381107|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56381108|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381109|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56381110|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56381111|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56381112|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
56381113|NCT00483301|Sorafenib|sorafenib|mesh-list
56381114|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56381117|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381118|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381119|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56381120|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381121|NCT00120536|Vildagliptin|vildagliptin|mesh-list
56381122|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381123|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381124|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56381125|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
56381126|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381127|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381128|NCT00483730|Actovegin|actovegin|mesh-list
56381129|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56381130|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381131|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56381132|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56381133|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
56381134|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381135|NCT00483730|Protective Agents|protective agents|mesh-ancestor
56381136|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56381137|NCT00118326|Lenograstim|lenograstim|mesh-list
56381138|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56381139|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
56381140|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381141|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
56381142|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381143|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381144|NCT00405171|Nevirapine|nevirapine|mesh-list
56381145|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56381146|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56381147|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381148|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381149|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
56381150|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381151|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56381152|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56381153|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56381154|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56381155|NCT00483886|Prucalopride|prucalopride|mesh-list
56381156|NCT00483886|Laxatives|laxatives|mesh-ancestor
56381157|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56654527|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654528|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56654529|NCT00880620|Carbidopa|carbidopa|mesh-list
56654530|NCT00880620|Levodopa|levodopa|mesh-list
56654531|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56654532|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
56381158|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56381159|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56381160|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
56381161|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381162|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381163|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381164|NCT00483964|Olanzapine|olanzapine|mesh-list
56381165|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
56381166|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
56381167|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381168|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381169|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56381170|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56381171|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56381172|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56381173|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56381174|NCT00483964|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56381175|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56381176|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381177|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381178|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56003084|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
56381179|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
56381180|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
56381181|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56381182|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56381183|NCT00484003|Analgesics|analgesics|mesh-ancestor
56381184|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
56381185|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381186|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381187|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381188|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381189|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
56381190|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56381191|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
56381192|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56381193|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381194|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381196|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56381197|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381198|NCT01241110|Renal Agents|renal agents|mesh-ancestor
56381199|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56381200|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56381201|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56381202|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381203|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381204|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381205|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56381206|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56381207|NCT00120653|Metoclopramide|metoclopramide|mesh-list
56381208|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
56381209|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
56381210|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381211|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381212|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56381213|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56381214|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56381215|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
56381216|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381217|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381218|NCT00484120|Diclofenac|diclofenac|mesh-list
56381219|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56654533|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300608|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
56654534|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56654535|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56654536|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
56654537|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
56654538|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784023|NCT05002361|Hormones|hormones|mesh-ancestor
56381220|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56381221|NCT00484120|Analgesics|analgesics|mesh-ancestor
56381222|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
56381223|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381224|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381225|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381226|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381227|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56381228|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381229|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381230|NCT00484237|Etanercept|etanercept|mesh-list
56381231|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56381232|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56381234|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
56381235|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381236|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381237|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381238|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381239|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56381240|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56381241|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
56381242|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
56381243|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
56381244|NCT00120692|Hematinics|hematinics|mesh-ancestor
56381245|NCT00484432|Doxorubicin|doxorubicin|mesh-list
56381246|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56381247|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381248|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56381249|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56381250|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381251|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381252|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
56381253|NCT00484510|Vitamins|vitamins|mesh-ancestor
56381254|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
56381255|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381256|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
56381257|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381258|NCT00484510|Protective Agents|protective agents|mesh-ancestor
56381260|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
56381261|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381263|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56381264|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381265|NCT00120731|Diuretics|diuretics|mesh-ancestor
56381266|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
56381267|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381268|NCT00120731|Expectorants|expectorants|mesh-ancestor
56381269|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
56381270|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
56381271|NCT00484744|Acetaminophen|acetaminophen|mesh-list
56381272|NCT00484744|Ibuprofen|ibuprofen|mesh-list
56381273|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56381274|NCT00484744|Analgesics|analgesics|mesh-ancestor
56381275|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
56381276|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381277|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381278|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
56381279|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56381280|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381281|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381282|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56381283|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654539|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654540|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56654541|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654542|NCT00959335|Bicalutamide|bicalutamide|mesh-list
56654543|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
56381284|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381285|NCT00484822|Heparin|heparin|mesh-list
56381286|NCT00484822|Calcium heparin|calcium heparin|mesh-list
56381287|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
56381288|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56381289|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56381290|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381291|NCT00405210|Docetaxel|docetaxel|mesh-list
56381292|NCT00405210|Sorafenib|sorafenib|mesh-list
56381293|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381294|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
56381295|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
56381296|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
56381297|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381298|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56381299|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381300|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
56381301|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
56381302|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56381303|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
56381304|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56381305|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56381306|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381307|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56381308|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381309|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381310|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56381312|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56381313|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
56381314|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56381315|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56381316|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381317|NCT05062356|Ketorolac|ketorolac|mesh-list
56381318|NCT05062356|Epinephrine|epinephrine|mesh-list
56381319|NCT05062356|Bupivacaine|bupivacaine|mesh-list
56381320|NCT05062356|Prilocaine|prilocaine|mesh-list
56381321|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56381322|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
56381323|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
56173830|NCT03786783|Vitamin A|vitamin a|mesh-list
56381324|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56381325|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381326|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
56381327|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381328|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56381329|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56003237|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
56381331|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381332|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381333|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56381334|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56381335|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
56381336|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56381340|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56381341|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56381342|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56381343|NCT05062356|Analgesics|analgesics|mesh-ancestor
56381344|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381345|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381346|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56381347|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381348|NCT01241383|Bosentan|bosentan|mesh-list
56381349|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56381350|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56381351|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654544|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
56654545|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654546|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654547|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654548|NCT00644618|Gemcitabine|gemcitabine|mesh-list
56654549|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56654550|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
56381352|NCT00485056|Pioglitazone|pioglitazone|mesh-list
56381353|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381354|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381355|NCT00120887|Atorvastatin|atorvastatin|mesh-list
56381356|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56381357|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56381358|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
56381359|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381360|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56381361|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56381362|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381363|NCT01241422|Montelukast|montelukast|mesh-list
56381364|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56381365|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56381366|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56381367|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
56381368|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56381369|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381370|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56381371|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56381372|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381373|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
56381374|NCT00118638|Hematinics|hematinics|mesh-ancestor
56381375|NCT00485368|Perindopril|perindopril|mesh-list
56381376|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56381377|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
56381378|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381379|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381380|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56381381|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56381382|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56381383|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56173845|NCT03786783|Tretinoin|tretinoin|mesh-list
56381384|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381385|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381386|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
56381387|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381388|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381390|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381391|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56381392|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381393|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381394|NCT05058612|Midodrine|midodrine|mesh-list
56381395|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
56381396|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
56381397|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381398|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381399|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56381400|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56003307|NCT00001498|Leucovorin|leucovorin|mesh-list
56381401|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56381402|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56381403|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
56381404|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381405|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381408|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
56381409|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654551|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654552|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654553|NCT00644618|Antiviral Agents|antiviral agents|mesh-ancestor
56654554|NCT00644618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654555|NCT00644618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654556|NCT00644618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654557|NCT00644618|Immunologic Factors|immunologic factors|mesh-ancestor
56654558|NCT00644618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654559|NCT03967847|Ketorolac|ketorolac|mesh-list
56654560|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56381410|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381411|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56381412|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
56381413|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56381414|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56381415|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56381416|NCT05058417|Empagliflozin|empagliflozin|mesh-list
56381417|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56381418|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381419|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381420|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381421|NCT02274337|Abivertinib|abivertinib|mesh-list
56381422|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56381423|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381424|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381425|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56381426|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381427|NCT00485680|Olanzapine|olanzapine|mesh-list
56381428|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
56381429|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
56381430|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
56381431|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381432|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381433|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56381434|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56381435|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56381436|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56381437|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56381438|NCT00485680|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56381439|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56381440|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381441|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381442|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381443|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
56381444|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
56381445|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381446|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
56381447|NCT00118794|Lumefantrine|lumefantrine|mesh-list
56381448|NCT00118794|Artemether|artemether|mesh-list
56381449|NCT00118794|Dapsone|dapsone|mesh-list
56381450|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
56381451|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56381452|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
56381453|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56381454|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56381455|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381456|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56381457|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381458|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381459|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
56381460|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56381461|NCT01241773|Efavirenz|efavirenz|mesh-list
56381462|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
56381463|NCT01241773|Simeprevir|simeprevir|mesh-list
56654561|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654562|NCT03967847|Analgesics|analgesics|mesh-ancestor
56654563|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
56654564|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654565|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654566|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381464|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56381465|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56381466|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381467|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381468|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
56381469|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381470|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56381471|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56381472|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56381473|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56381474|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56381475|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56381476|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56381477|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56381480|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
56381481|NCT00121277|Capecitabine|capecitabine|mesh-list
56381482|NCT00121277|Vorinostat|vorinostat|mesh-list
56381483|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56381484|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
56381485|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173894|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
56381486|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381487|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56381488|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381489|NCT00485797|Methylphenidate|methylphenidate|mesh-list
56381490|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56381491|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381492|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56381493|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56381494|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381495|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381496|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
56381497|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381498|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56381499|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56381500|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56381501|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381502|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381503|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
56381504|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381505|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381506|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
56381507|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56381508|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56381509|NCT00121316|Analgesics|analgesics|mesh-ancestor
56381510|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
56381511|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381512|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381513|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381514|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381515|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
56381516|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56381517|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
56381518|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56381519|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381520|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381521|NCT00118950|Metformin|metformin|mesh-list
56381522|NCT00118950|Repaglinide|repaglinide|mesh-list
56381523|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381524|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654567|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654568|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56654569|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654570|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654571|NCT05259943|Psilocybin|psilocybin|mesh-list
56654572|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
56654573|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381525|NCT00486187|Metformin|metformin|mesh-list
56381526|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
56381527|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381528|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381529|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
56381530|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56381531|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381532|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
56381533|NCT00486343|Zileuton|zileuton|mesh-list
56381534|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56381535|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56381536|NCT00486343|Analgesics|analgesics|mesh-ancestor
56381537|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
56381538|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381539|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173908|NCT03639935|Nivolumab|nivolumab|mesh-list
56381540|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381541|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381542|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56381543|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381544|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381545|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56003454|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381546|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
56381550|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56381552|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
56381553|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381554|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381555|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381556|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
56381557|NCT00486421|Hormones|hormones|mesh-ancestor
56381558|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56381559|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56381560|NCT00486460|Gemcitabine|gemcitabine|mesh-list
56381561|NCT00486460|Curcumin|curcumin|mesh-list
56381562|NCT00486460|Celecoxib|celecoxib|mesh-list
56381563|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56381564|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
56381565|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381566|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381567|NCT00486460|Antiviral Agents|antiviral agents|mesh-ancestor
56381568|NCT00486460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381569|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381570|NCT00486460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56381571|NCT00486460|Immunologic Factors|immunologic factors|mesh-ancestor
56381572|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381573|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56381574|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56381575|NCT00486460|Analgesics|analgesics|mesh-ancestor
56381576|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
56381577|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381578|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381579|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381580|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56381581|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56381582|NCT00121511|Fluorouracil|fluorouracil|mesh-list
56381583|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
56381584|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381585|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56381586|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381587|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654574|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56381588|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
56381589|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381590|NCT00486694|Artesunate|artesunate|mesh-list
56381591|NCT00486694|Chloroquine|chloroquine|mesh-list
56381592|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
56381593|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
56381594|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56381595|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
56381596|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56381597|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56381598|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381599|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381600|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
56381601|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
56381602|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56381603|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
56381604|NCT00486694|Amebicides|amebicides|mesh-ancestor
56381605|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381606|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56381607|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381608|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381609|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56381610|NCT00486694|Renal Agents|renal agents|mesh-ancestor
56381611|NCT00486772|Calcium|calcium|mesh-list
56381612|NCT00486772|Sevelamer|sevelamer|mesh-list
56381613|NCT00486772|Calcium acetate|calcium acetate|mesh-list
56381614|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56381615|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381616|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
56381617|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
56381618|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381619|NCT00121550|Clarithromycin|clarithromycin|mesh-list
56381620|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56381624|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381625|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56381626|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56381628|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56381629|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381630|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56381631|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381632|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381633|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56381634|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56381635|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
56381636|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381638|NCT01242202|Voglibose|voglibose|mesh-list
56381639|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
56381640|NCT01242202|Miglitol|miglitol|mesh-list
56381641|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
56381642|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381643|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381644|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381645|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381646|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56381647|NCT00119145|Artesunate|artesunate|mesh-list
56381648|NCT00119145|Amodiaquine|amodiaquine|mesh-list
56381649|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56381650|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
56381651|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56381652|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56381653|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381654|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381655|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
56381656|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
56381657|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56381658|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
56381659|NCT00119184|Anesthetics|anesthetics|mesh-list
56001922|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
56381660|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56381661|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381662|NCT00487123|Valsartan|valsartan|mesh-list
56381663|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56381664|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56381665|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56654575|NCT03747419|Avelumab|avelumab|mesh-list
56654576|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56654577|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654578|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
56654579|NCT04175990|Progestins|progestins|mesh-ancestor
56654580|NCT04175990|Hormones|hormones|mesh-ancestor
56216843|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56381666|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56381667|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381668|NCT00487123|Diuretics|diuretics|mesh-ancestor
56381669|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
56381670|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381671|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56381672|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381673|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
56381674|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56381675|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56381676|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56381677|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381678|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381679|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
56381680|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381681|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381682|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56381683|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381684|NCT00487591|Simvastatin|simvastatin|mesh-list
56381685|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56381686|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56381687|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
56381688|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381689|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55895749|NCT00061893|Etoposide|etoposide|mesh-list
56381699|NCT00488137|Laxatives|laxatives|mesh-ancestor
56381700|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56381701|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56381702|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56381703|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
56381704|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381705|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381706|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381707|NCT00488176|Cetirizine|cetirizine|mesh-list
56381708|NCT00488176|Montelukast|montelukast|mesh-list
56381709|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56381710|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
56381711|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56381712|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
56381713|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56381714|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381715|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56381716|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56381717|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381718|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56381719|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56381720|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56381721|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
56381722|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
56381723|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381724|NCT00488215|Prucalopride|prucalopride|mesh-list
56381725|NCT00488215|Laxatives|laxatives|mesh-ancestor
56381726|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56381727|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56381728|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56381729|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
56381730|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381731|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381732|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381733|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
56654581|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654582|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654583|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56654584|NCT00959569|Esmolol|esmolol|mesh-list
56654585|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56654586|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
56654587|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216847|NCT01627639|Acetazolamide|acetazolamide|mesh-list
56381734|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56381735|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381736|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381738|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56381739|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56381740|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56381741|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
56381742|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381743|NCT04930887|Bupivacaine|bupivacaine|mesh-list
56381744|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
56381745|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
56381746|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56381747|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381748|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
56381749|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381750|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
56381751|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381752|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381753|NCT00488566|Lamotrigine|lamotrigine|mesh-list
56381754|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
56381755|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56381756|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381757|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381758|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56381759|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381762|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56381763|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56381764|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56381765|NCT00488605|Leucovorin|leucovorin|mesh-list
56381766|NCT00488605|Prednisone|prednisone|mesh-list
56381767|NCT00488605|Methotrexate|methotrexate|mesh-list
56381768|NCT00488605|Vinblastine|vinblastine|mesh-list
56381769|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
56381770|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381771|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
56381772|NCT00488605|Hormones|hormones|mesh-ancestor
56381773|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56381774|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381775|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56381776|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381777|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56381778|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
56381779|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56381780|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56381781|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
56381782|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381783|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
56381784|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381785|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56381786|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56381787|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
56381788|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381789|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56381790|NCT00488605|Antidotes|antidotes|mesh-ancestor
56381791|NCT00488605|Protective Agents|protective agents|mesh-ancestor
56381792|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
56381793|NCT00488605|Vitamins|vitamins|mesh-ancestor
56381794|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
56654588|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654589|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654590|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56654591|NCT00881868|Clobetasol|clobetasol|mesh-list
56654592|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56381795|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56381796|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
56381797|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
56381798|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
56381799|NCT00488722|Goserelin|goserelin|mesh-list
56381800|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56381801|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381802|NCT00488761|Tigecycline|tigecycline|mesh-list
56381803|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56381804|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381805|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56381806|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381807|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381809|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56381810|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381811|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56381812|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
56381813|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56381814|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381815|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381816|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381817|NCT00145236|Nebivolol|nebivolol|mesh-list
56381818|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56381819|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
56381820|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56381821|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56381822|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56381823|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
56381824|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381825|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381826|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381827|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
56381828|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56381829|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895892|NCT02359006|Tetracycline|tetracycline|mesh-list
56381834|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56381835|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381836|NCT00488995|Tremelimumab|tremelimumab|mesh-list
56381837|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381838|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
56381839|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
56381840|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56381841|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56003762|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
56381842|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381843|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381844|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381845|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381846|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56381847|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56381848|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56381849|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381850|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381851|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381852|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381853|NCT00489073|Analgesics|analgesics|mesh-ancestor
56381854|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
56381855|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381856|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
56381857|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56381858|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
56381859|NCT00489151|Lamivudine|lamivudine|mesh-list
56381860|NCT00489151|Adefovir|adefovir|mesh-list
56654593|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
56654594|NCT00881868|Hormones|hormones|mesh-ancestor
56654595|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654596|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654597|NCT04176068|Calcium|calcium|mesh-list
55793107|NCT05018923|Bismuth|bismuth|mesh-list
56381861|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56381862|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56381863|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56381864|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381865|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381866|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
56381867|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381868|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56381869|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56381870|NCT00145314|Leucovorin|leucovorin|mesh-list
56381871|NCT00145314|Folic Acid|folic acid|mesh-list
56381872|NCT00145314|Fluorouracil|fluorouracil|mesh-list
56381873|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
56381874|NCT00145314|Cetuximab|cetuximab|mesh-list
56381875|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
56381876|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
56381877|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381878|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56381879|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381880|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56381881|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
56381882|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381883|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56381884|NCT00145314|Antidotes|antidotes|mesh-ancestor
56381885|NCT00145314|Protective Agents|protective agents|mesh-ancestor
56381886|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
56381887|NCT00145314|Vitamins|vitamins|mesh-ancestor
56381888|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
56381889|NCT00145314|Hematinics|hematinics|mesh-ancestor
56381890|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
56381891|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381892|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381893|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
56381894|NCT00489229|Ramipril|ramipril|mesh-list
56381895|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381896|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381897|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56381898|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
56381899|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381900|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381904|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381905|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
56381906|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381908|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381909|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56381910|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
56381911|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381912|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
56381913|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
56381914|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381915|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381916|NCT01242904|Icodextrin|icodextrin|mesh-list
56381917|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
56381918|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56381919|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
56381920|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56381921|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381922|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56381923|NCT00121979|Racivir|racivir|mesh-list
56381924|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56381925|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381926|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381927|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
56381928|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381929|NCT00489658|Eflornithine|eflornithine|mesh-list
56381930|NCT00489658|Nifurtimox|nifurtimox|mesh-list
56654598|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56654599|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654600|NCT00959725|Infliximab|infliximab|mesh-list
56654601|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
56654602|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56216862|NCT01627678|Antacids|antacids|mesh-ancestor
56381931|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381932|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56381933|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56381934|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56381935|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381936|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56381937|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381938|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381939|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
56381940|NCT00122018|Fenoldopam|fenoldopam|mesh-list
56381941|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56381942|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
56381943|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381944|NCT00122018|Expectorants|expectorants|mesh-ancestor
56381945|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
56381946|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56381947|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
56381948|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381949|NCT00122018|Protective Agents|protective agents|mesh-ancestor
56381950|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381951|NCT00122018|Antidotes|antidotes|mesh-ancestor
56381952|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56381953|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
56381954|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
56381955|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
56381956|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381957|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56381958|NCT00489775|Paroxetine|paroxetine|mesh-list
56381959|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56381960|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56381961|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56381962|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381963|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56381964|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381965|NCT00489775|Analgesics|analgesics|mesh-ancestor
56381966|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
56381967|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56381968|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
56381969|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56381971|NCT00489775|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56381972|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
56381973|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56381974|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56381978|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381980|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56381981|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381982|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56381983|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56381984|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56381985|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381986|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
56381987|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56381988|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
56381989|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56381990|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381991|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56381992|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56381994|NCT01243060|Zolpidem|zolpidem|mesh-list
56381995|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56381996|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56381997|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654603|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56381998|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381999|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56382000|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
56382001|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
56382002|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382003|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382004|NCT00490204|Cetirizine|cetirizine|mesh-list
56382005|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56382006|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56382007|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56382008|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
56382009|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
56382010|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382011|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382012|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382013|NCT00122096|Valdecoxib|valdecoxib|mesh-list
56382014|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56382015|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56382016|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382017|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382018|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56382019|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56382020|NCT00122096|Analgesics|analgesics|mesh-ancestor
56382021|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
56382022|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382023|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382024|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56382025|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56382026|NCT00490243|Budesonide|budesonide|mesh-list
56382027|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
56382028|NCT00490243|Montelukast|montelukast|mesh-list
56382029|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56382030|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56382031|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
56382032|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382033|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382034|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56382035|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
56382036|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
56382037|NCT00490243|Hormones|hormones|mesh-ancestor
56382038|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56382039|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56382040|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56382042|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
56382043|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382044|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382045|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56382047|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56382048|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56382049|NCT00490360|Gemcitabine|gemcitabine|mesh-list
56382050|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382051|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56382052|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
56382053|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382054|NCT00490360|Antiviral Agents|antiviral agents|mesh-ancestor
56382055|NCT00490360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382056|NCT00490360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382057|NCT00490360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382058|NCT00490360|Immunologic Factors|immunologic factors|mesh-ancestor
56382059|NCT00490360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382060|NCT00490399|Gemcitabine|gemcitabine|mesh-list
56382061|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382062|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56382063|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
56382064|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382065|NCT00490399|Antiviral Agents|antiviral agents|mesh-ancestor
56382066|NCT00490399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382067|NCT00490399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382068|NCT00490399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382069|NCT00490399|Immunologic Factors|immunologic factors|mesh-ancestor
56382070|NCT00490399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382071|NCT04844385|Paclitaxel|paclitaxel|mesh-list
56654604|NCT02789189|Gemcitabine|gemcitabine|mesh-list
56654605|NCT02789189|Nedaplatin|nedaplatin|mesh-list
56654606|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56654607|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
56654608|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654609|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654610|NCT02789189|Antiviral Agents|antiviral agents|mesh-ancestor
56382072|NCT04844385|Capecitabine|capecitabine|mesh-list
56382073|NCT04844385|Nedaplatin|nedaplatin|mesh-list
56382074|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56382075|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382076|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
56382077|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
56382078|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
56382079|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382080|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56382081|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
56382082|NCT00490633|Ethanol|ethanol|mesh-list
56382083|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
56382084|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56382085|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382086|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382087|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382088|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
56382089|NCT00490711|Gemcitabine|gemcitabine|mesh-list
56382090|NCT00490711|Paclitaxel|paclitaxel|mesh-list
56382091|NCT00490711|Carboplatin|carboplatin|mesh-list
56382092|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56382093|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382094|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
56382095|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
56382096|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
56382097|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382098|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56382099|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
56382100|NCT00490711|Antiviral Agents|antiviral agents|mesh-ancestor
56382101|NCT00490711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382102|NCT00490711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382103|NCT00490711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382104|NCT00490711|Immunologic Factors|immunologic factors|mesh-ancestor
56382105|NCT00490711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382106|NCT00122291|Capecitabine|capecitabine|mesh-list
56382107|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56382108|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
56382109|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382110|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382111|NCT00490789|Sirolimus|sirolimus|mesh-list
56126565|NCT03580980|Narcotics|narcotics|mesh-ancestor
56382112|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56382113|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382114|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56382115|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382116|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
56382117|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382118|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
56382119|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382121|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56382122|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56382123|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56382124|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56382125|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
56382126|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
56382127|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382129|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
56382130|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382131|NCT00490867|Protective Agents|protective agents|mesh-ancestor
56382132|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382133|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
56382134|NCT00490867|Vitamins|vitamins|mesh-ancestor
56654611|NCT02789189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654612|NCT02789189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654613|NCT02789189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654614|NCT02789189|Immunologic Factors|immunologic factors|mesh-ancestor
56654615|NCT02789189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654616|NCT04233515|Anticoagulants|anticoagulants|mesh-list
56654617|NCT04234607|Carboplatin|carboplatin|mesh-list
56654618|NCT04234607|Etoposide|etoposide|mesh-list
56654619|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654620|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56654621|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56654622|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56654623|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654624|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654625|NCT03955471|Niraparib|niraparib|mesh-list
56382135|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
56382136|NCT00122330|Eculizumab|eculizumab|mesh-list
56382137|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56382138|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382139|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
56382140|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382141|NCT00490906|Interferons|interferons|mesh-list
56382142|NCT00490906|Interferon-beta|interferon-beta|mesh-list
56382143|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
56382144|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
56382145|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
56382146|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
56382147|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382148|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
56382149|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382150|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
56382151|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382152|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56382153|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382154|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56382155|NCT00122486|Tenofovir|tenofovir|mesh-list
56382156|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
56382157|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382158|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56382159|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56382160|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382161|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382162|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56382163|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56382164|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
56382165|NCT00491413|Hematinics|hematinics|mesh-ancestor
56382166|NCT00145665|Telbivudine|telbivudine|mesh-list
56382167|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
56382168|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382169|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56382170|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382171|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382172|NCT00491725|Metformin|metformin|mesh-list
56382173|NCT00491725|Repaglinide|repaglinide|mesh-list
56382174|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173945|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56382175|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382176|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
56382177|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
56382178|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56382179|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56382181|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382182|NCT00491803|Urological Agents|urological agents|mesh-ancestor
56654626|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56654627|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654628|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654629|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654630|NCT02637726|Remifentanil|remifentanil|mesh-list
56654631|NCT02637726|Propofol|propofol|mesh-list
56654632|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56654633|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216885|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
56382184|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
56382185|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56382186|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56382187|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
56382188|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382189|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382190|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56382191|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56382192|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
56382193|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382194|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56382195|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56382196|NCT00491920|Vitamin D|vitamin d|mesh-list
56382198|NCT00491920|Vitamins|vitamins|mesh-ancestor
56382199|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
56382200|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382201|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56382202|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56382203|NCT00491998|Entacapone|entacapone|mesh-list
56382204|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56382205|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56382206|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56382207|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382208|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382209|NCT00492037|Conivaptan|conivaptan|mesh-list
56382210|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56382211|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382212|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
56382213|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382214|NCT00402272|Everolimus|everolimus|mesh-list
56382215|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382216|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382217|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
56382218|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382219|NCT00492388|Ketamine|ketamine|mesh-list
56382220|NCT00492388|Analgesics|analgesics|mesh-ancestor
56382221|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
56382222|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382223|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382224|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56382226|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
56382227|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
56382228|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382229|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56382230|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56382231|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382232|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382233|NCT01243528|Vitamin D|vitamin d|mesh-list
56382234|NCT01243528|Vitamins|vitamins|mesh-ancestor
56382235|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
56382236|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382237|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56382238|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
56382239|NCT00492427|Hematinics|hematinics|mesh-ancestor
56382240|NCT00492466|Interferons|interferons|mesh-list
56382241|NCT00492466|Interferon-beta|interferon-beta|mesh-list
56382242|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
56654634|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654635|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56654636|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
56654637|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
56654638|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56654639|NCT02637726|Narcotics|narcotics|mesh-ancestor
56654640|NCT02637726|Analgesics|analgesics|mesh-ancestor
56654641|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
56654642|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654643|NCT04161768|Norfloxacin|norfloxacin|mesh-list
56654644|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56654645|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654646|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56654647|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56654648|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654649|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654650|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654651|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56654652|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56654653|NCT05300282|Gemcitabine|gemcitabine|mesh-list
56654654|NCT05300282|Atezolizumab|atezolizumab|mesh-list
56654655|NCT05300282|Vinorelbine|vinorelbine|mesh-list
56654656|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56654657|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56654658|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
56654659|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654660|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382243|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
56382244|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382245|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
56382246|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382247|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56382248|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
56382249|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
56382250|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382251|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382252|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56382254|NCT00492466|Hormones|hormones|mesh-ancestor
56382255|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56382256|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56382257|NCT00492466|Protective Agents|protective agents|mesh-ancestor
56382258|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
56382259|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56382260|NCT00492505|Tamoxifen|tamoxifen|mesh-list
56382261|NCT00492505|Sorafenib|sorafenib|mesh-list
56382262|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382263|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382264|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56654661|NCT05300282|Antiviral Agents|antiviral agents|mesh-ancestor
56654662|NCT05300282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654663|NCT05300282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654664|NCT05300282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654665|NCT05300282|Immunologic Factors|immunologic factors|mesh-ancestor
56654666|NCT05300282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654667|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56654668|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
56654669|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
56654670|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
56654671|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56654672|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
56654673|NCT02793011|Dexamethasone|dexamethasone|mesh-list
56654674|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56654675|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
56654676|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
56382265|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382266|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56382267|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
56382268|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56382269|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382270|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56382271|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56382272|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56382277|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382278|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56382279|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173988|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56382280|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382282|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56382283|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382286|NCT00402350|Fentanyl|fentanyl|mesh-list
56382287|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56382288|NCT00402350|Narcotics|narcotics|mesh-ancestor
56382289|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382290|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382291|NCT00402350|Analgesics|analgesics|mesh-ancestor
56382292|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
56382293|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382294|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56382295|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56382296|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
56382297|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
56382298|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
56382299|NCT00122720|Hematinics|hematinics|mesh-ancestor
56382300|NCT00492934|Menotropins|menotropins|mesh-list
56382301|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56382302|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
56382303|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56382304|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382305|NCT02274454|Oxytocin|oxytocin|mesh-list
56382306|NCT02274454|Calcium|calcium|mesh-list
56382307|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56382308|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382309|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
56382310|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56382311|NCT04760730|Vaccines|vaccines|mesh-list
56382312|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
56382313|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382314|NCT00122759|Ketamine|ketamine|mesh-list
56654677|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654678|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654679|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56382315|NCT00122759|Analgesics|analgesics|mesh-ancestor
56382316|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
56382317|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382318|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382319|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56382320|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56382321|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
56382322|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
56382323|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382324|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56382325|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56382326|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382327|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382328|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
56382330|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382331|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56382332|NCT00493129|Analgesics|analgesics|mesh-ancestor
56382333|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
56382334|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382335|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382336|NCT00126542|Bevacizumab|bevacizumab|mesh-list
56382337|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56382338|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56382339|NCT00126542|Antibodies|antibodies|mesh-list
56382340|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
56382341|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56382342|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382343|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56382344|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56382345|NCT00126542|Growth Substances|growth substances|mesh-ancestor
56382346|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382349|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56382350|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382351|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382352|NCT00493324|Alefacept|alefacept|mesh-list
56382353|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56382354|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
56382355|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382356|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
56382357|NCT01243801|Ketamine|ketamine|mesh-list
56382358|NCT01243801|Analgesics|analgesics|mesh-ancestor
56382359|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
56382360|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382361|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382362|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56382363|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56382364|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
56382365|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
56382366|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382367|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56382368|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56382369|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382370|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382371|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56382372|NCT00126620|Sorafenib|sorafenib|mesh-list
56382373|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382374|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56382375|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382376|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382377|NCT00493363|Artesunate|artesunate|mesh-list
56382378|NCT00493363|Mefloquine|mefloquine|mesh-list
56382379|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
56382380|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56382381|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56382382|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382383|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382384|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
56382385|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
56654680|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
56654681|NCT02793011|Hormones|hormones|mesh-ancestor
56654682|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654683|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56654684|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382386|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56382387|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
56382388|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
56382389|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56382390|NCT00126698|Trimethoprim|trimethoprim|mesh-list
56382391|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
56382392|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56382393|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382394|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56382395|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56382396|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382397|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382398|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382399|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56382400|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56382401|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56382402|NCT00126698|Renal Agents|renal agents|mesh-ancestor
56382403|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
56382404|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56382405|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56382406|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56382407|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56382408|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56382409|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
56382410|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56382411|NCT00493402|Estrogens|estrogens|mesh-ancestor
56382412|NCT00493402|Hormones|hormones|mesh-ancestor
56382413|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56382414|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382415|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56382416|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382417|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
56382418|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
56382419|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56382421|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382422|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382423|NCT00145938|Urological Agents|urological agents|mesh-ancestor
56382424|NCT00493480|Propranolol|propranolol|mesh-list
56382425|NCT00493480|Carvedilol|carvedilol|mesh-list
56382426|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56382427|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56382429|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382430|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382431|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382432|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56382433|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56382434|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
56382435|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
56382436|NCT00493480|Protective Agents|protective agents|mesh-ancestor
56382437|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56382438|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56382439|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56382440|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56382441|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56382442|NCT01243996|Ibuprofen|ibuprofen|mesh-list
56382443|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56382444|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56382445|NCT01243996|Analgesics|analgesics|mesh-ancestor
56382446|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
56382447|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382448|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382449|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56382450|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654685|NCT00965107|Thiopental|thiopental|mesh-list
56654686|NCT00965107|Propofol|propofol|mesh-list
56654687|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56654688|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654689|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654690|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56654691|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
56654692|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
56382451|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56382452|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382453|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382454|NCT01244113|Propofol|propofol|mesh-list
56382455|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56382456|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382457|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382458|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56382459|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
56382460|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
56382461|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
56382462|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56382463|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56382464|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382465|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382466|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
56382467|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382468|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56382469|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56382470|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
56382471|NCT00493987|Testosterone|testosterone|mesh-list
56382472|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
56382473|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
56382474|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56382475|NCT00493987|Dutasteride|dutasteride|mesh-list
56382476|NCT00493987|Androgens|androgens|mesh-ancestor
56382477|NCT00493987|Hormones|hormones|mesh-ancestor
56382478|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56382479|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382480|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56382481|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382482|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
56382483|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56382484|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56382485|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382486|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382487|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
56382488|NCT00494104|Vitamin D|vitamin d|mesh-list
56382489|NCT00494104|Vitamins|vitamins|mesh-ancestor
56382490|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
56382491|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382492|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56382493|NCT00405366|Sorafenib|sorafenib|mesh-list
56382495|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56382497|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382498|NCT00494338|Docetaxel|docetaxel|mesh-list
56382499|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382500|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
56382501|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
56382502|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
56382503|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382504|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56382505|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56382506|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56382507|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56382508|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382509|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382510|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382511|NCT00494377|Analgesics|analgesics|mesh-ancestor
56654693|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
56654694|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
56654695|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
56654696|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654697|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382512|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
56382513|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382514|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
56382515|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56382516|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
56382517|NCT00146016|Amantadine|amantadine|mesh-list
56382518|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56004449|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382519|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56382520|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
56382521|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382522|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
56382523|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382524|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382525|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382526|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56382527|NCT00146016|Analgesics|analgesics|mesh-ancestor
56382528|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
56382529|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382530|NCT00126971|Dapsone|dapsone|mesh-list
56382531|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
56382532|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382533|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
56382534|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56382535|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56382536|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56382537|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382538|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382539|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
56382540|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56382541|NCT01244230|Fexofenadine|fexofenadine|mesh-list
56382542|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56382543|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56382544|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56382545|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
56382546|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
56382547|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382548|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382549|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382550|NCT01244269|Methylphenidate|methylphenidate|mesh-list
56382551|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56382552|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382553|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56382554|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56382555|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56382556|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382557|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
56382558|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382559|NCT00127010|Vaccines|vaccines|mesh-list
56382560|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
56382561|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382562|NCT00494533|Treprostinil|treprostinil|mesh-list
56382563|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56382564|NCT00494572|Montelukast|montelukast|mesh-list
56382566|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
56382567|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56382568|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
56382569|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56382570|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382571|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56382572|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56382573|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382575|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56654698|NCT02788877|Aflibercept|aflibercept|mesh-list
56654699|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56654700|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56654701|NCT02788877|Growth Substances|growth substances|mesh-ancestor
56382576|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382577|NCT00127049|Gemcitabine|gemcitabine|mesh-list
56382578|NCT00127049|Ifosfamide|ifosfamide|mesh-list
56382579|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382580|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56382581|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
56382582|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382583|NCT00127049|Antiviral Agents|antiviral agents|mesh-ancestor
56382584|NCT00127049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382585|NCT00127049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382586|NCT00127049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382587|NCT00127049|Immunologic Factors|immunologic factors|mesh-ancestor
56382588|NCT00127049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382589|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56382590|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
56382591|NCT00494884|Vildagliptin|vildagliptin|mesh-list
56382592|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56382593|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382594|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56382595|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
56382596|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382597|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382598|NCT00127088|Docetaxel|docetaxel|mesh-list
56382599|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382600|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
56382601|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
56382602|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56382603|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382604|NCT02957877|Heparin|heparin|mesh-list
56382605|NCT02957877|Calcium heparin|calcium heparin|mesh-list
56382606|NCT02957877|Nadroparin|nadroparin|mesh-list
56382607|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
56382608|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56382609|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56382610|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382611|NCT01244581|Amoxicillin|amoxicillin|mesh-list
56382612|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
56382613|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
56382614|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56382615|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56382616|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382617|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56382618|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382619|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382620|NCT01244659|Tacrolimus|tacrolimus|mesh-list
56382621|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382622|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
56382623|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382624|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56382625|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382626|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382627|NCT01244698|Clindamycin|clindamycin|mesh-list
56382628|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
56382629|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
56382630|NCT01244698|Cefazolin|cefazolin|mesh-list
56382631|NCT01244698|Cefadroxil|cefadroxil|mesh-list
56382632|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56382633|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382634|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56382635|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382636|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896708|NCT02376010|Warfarin|warfarin|mesh-list
56382639|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
56382640|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382641|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382642|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382643|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56382644|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56654702|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654703|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
56654704|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654705|NCT00959881|Donepezil|donepezil|mesh-list
56654706|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56382645|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382646|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56382647|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56382648|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
56382649|NCT00495313|Metronidazole|metronidazole|mesh-list
56382650|NCT00495313|Doxycycline|doxycycline|mesh-list
56382651|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382652|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56382653|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56382654|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56382655|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
56382656|NCT00495352|Bupropion|bupropion|mesh-list
56382657|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56382658|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
56382659|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56382660|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56382661|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56382662|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56382663|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382664|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
56382665|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382666|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004602|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382667|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56382668|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56382669|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382670|NCT00495547|Azacitidine|azacitidine|mesh-list
56382671|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
56382672|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56382673|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
56382674|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382675|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382676|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382677|NCT00495547|Hematinics|hematinics|mesh-ancestor
56382679|NCT00495781|Trace Elements|trace elements|mesh-ancestor
56382680|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
56382681|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382682|NCT00405405|Bevacizumab|bevacizumab|mesh-list
56382683|NCT00405405|Cisplatin|cisplatin|mesh-list
56382684|NCT00405405|Docetaxel|docetaxel|mesh-list
56382685|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56382686|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56382687|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382688|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56382689|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56382690|NCT00405405|Growth Substances|growth substances|mesh-ancestor
56382691|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382692|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
56382693|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
56382694|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
56382695|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
56382696|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382697|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56382698|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382700|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56382701|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382702|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56382703|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382704|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
56382705|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382706|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
56382707|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382708|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56382709|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
56382710|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654707|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654708|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654709|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
56654710|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382726|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
56382727|NCT00496444|Azacitidine|azacitidine|mesh-list
56382728|NCT00496444|Valproic Acid|valproic acid|mesh-list
56382729|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56382730|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
56382731|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382732|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382733|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382734|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
56382735|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
56382736|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382737|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382738|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
56382739|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56382740|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382741|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56382742|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
56382743|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382744|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
56382745|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56382746|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
56382747|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
56382748|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382749|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382750|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56382751|NCT00146250|Analgesics|analgesics|mesh-ancestor
56382752|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
56382753|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382755|NCT00496600|Epothilone B|epothilone b|mesh-list
56382756|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382757|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382758|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
56382759|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382760|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
56382761|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
56382762|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
56382763|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382764|NCT00127595|Gemcitabine|gemcitabine|mesh-list
56382765|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
56382766|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56382767|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
56382768|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382773|NCT00127595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382774|NCT00127595|Immunologic Factors|immunologic factors|mesh-ancestor
56382775|NCT00127595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382777|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56382778|NCT04665765|Carboplatin|carboplatin|mesh-list
56382780|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
56382781|NCT04665765|Ifosfamide|ifosfamide|mesh-list
56382782|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
56382783|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
56382784|NCT04665765|Antibodies|antibodies|mesh-list
56382785|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
56382786|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56382787|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
56382788|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
56382789|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382790|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382791|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56382792|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56382793|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56382794|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56382795|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382796|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382797|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56382798|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
56382799|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
56382800|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
56654711|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654712|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
56654713|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
56382801|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
56382802|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
56382803|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
56382804|NCT00497029|Fluorides|fluorides|mesh-list
56382805|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
56382806|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
56382807|NCT00497029|Protective Agents|protective agents|mesh-ancestor
56382808|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382809|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
56382810|NCT00497107|Leucovorin|leucovorin|mesh-list
56382811|NCT00497107|Calcium|calcium|mesh-list
56382812|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
56382813|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56382814|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382815|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56382816|NCT00497107|Antidotes|antidotes|mesh-ancestor
56382817|NCT00497107|Protective Agents|protective agents|mesh-ancestor
56382818|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
56382819|NCT00497107|Vitamins|vitamins|mesh-ancestor
56382820|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
56382821|NCT00146289|Telmisartan|telmisartan|mesh-list
56382822|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56382823|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56382824|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56382825|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382826|NCT01244932|Bupivacaine|bupivacaine|mesh-list
56382827|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
56382828|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
56382829|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382830|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382831|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
56382832|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382833|NCT01244971|Acarbose|acarbose|mesh-list
56382834|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56382835|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382836|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382838|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382839|NCT04599894|Pregabalin|pregabalin|mesh-list
56382840|NCT04599894|Analgesics|analgesics|mesh-ancestor
56382841|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
56382842|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382843|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382851|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382853|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56382854|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382855|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56382856|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382857|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382858|NCT04726982|Acetazolamide|acetazolamide|mesh-list
56382859|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
56382860|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56382861|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382862|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382863|NCT04726982|Diuretics|diuretics|mesh-ancestor
56382864|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
56382865|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382866|NCT00497341|Cefuroxime|cefuroxime|mesh-list
56382867|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
56382868|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56382869|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382870|NCT00127829|Gefitinib|gefitinib|mesh-list
56382871|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382872|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56382873|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382874|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382875|NCT00497458|Testosterone|testosterone|mesh-list
56382876|NCT00497458|Androgens|androgens|mesh-ancestor
56382877|NCT00497458|Hormones|hormones|mesh-ancestor
56382878|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654714|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654715|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654716|NCT03651011|Aflibercept|aflibercept|mesh-list
56382879|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382880|NCT00497497|Bevacizumab|bevacizumab|mesh-list
56382881|NCT00497497|Cetuximab|cetuximab|mesh-list
56382882|NCT00497497|Irinotecan|irinotecan|mesh-list
56382883|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56382884|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382885|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56382886|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56382887|NCT00497497|Growth Substances|growth substances|mesh-ancestor
56382888|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382889|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
56382890|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56382891|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56382892|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382893|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382894|NCT00127868|Selenium|selenium|mesh-list
56382896|NCT00127868|Ciclopirox|ciclopirox|mesh-list
56382897|NCT00127868|Griseofulvin|griseofulvin|mesh-list
56382898|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
56382899|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
56382900|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382901|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56382902|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56382903|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382904|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382905|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56382906|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
56382907|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56382908|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382909|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56382915|NCT00497536|Insulin|insulin|mesh-list
56382916|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56382917|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
56382918|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
56382919|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56382920|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56382921|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382922|NCT00497614|Adalimumab|adalimumab|mesh-list
56382923|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56382924|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56382925|NCT00127907|Vasopressins|vasopressins|mesh-list
56382926|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
56382927|NCT00127907|Epinephrine|epinephrine|mesh-list
56382928|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56382929|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56382930|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
56382931|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56382932|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382933|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382934|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56382935|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56382936|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
56382937|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56382938|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56382939|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
56382940|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
56382941|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
56382942|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56382943|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
56382944|NCT00127907|Coagulants|coagulants|mesh-ancestor
56382945|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56382946|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
56382947|NCT00497809|Lenograstim|lenograstim|mesh-list
56382948|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56382949|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
56382950|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382951|NCT00146484|Insulin|insulin|mesh-list
56382952|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56382953|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382954|NCT00402584|Sibutramine|sibutramine|mesh-list
56654717|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56654718|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56654719|NCT03651011|Growth Substances|growth substances|mesh-ancestor
56654720|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654721|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
56382955|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
56382956|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56382957|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
56382958|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56382959|NCT00498004|Risperidone|risperidone|mesh-list
56382960|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56382961|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56382962|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
56382963|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174134|NCT02811133|Inositol|inositol|mesh-list
56382964|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382965|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382966|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56382967|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56382968|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56382969|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56382970|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56382971|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
56382972|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
56382973|NCT00146523|Mifepristone|mifepristone|mesh-list
56382974|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56382975|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
56382976|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56382977|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382978|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56382979|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56382980|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56382981|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
56382982|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56382983|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56382995|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56382996|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382997|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56382998|NCT04520490|Incretins|incretins|mesh-ancestor
56382999|NCT04520490|Hormones|hormones|mesh-ancestor
56383000|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383001|NCT00402662|Everolimus|everolimus|mesh-list
56383002|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
56383003|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383004|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383005|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
56383006|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383007|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383008|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383009|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383010|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
56383011|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
56383012|NCT00498316|Melphalan|melphalan|mesh-list
56383013|NCT00498316|Busulfan|busulfan|mesh-list
56383014|NCT00498316|Rituximab|rituximab|mesh-list
56383015|NCT00498316|Fludarabine|fludarabine|mesh-list
56383016|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
56383017|NCT00498316|Clofarabine|clofarabine|mesh-list
56383018|NCT00498316|Tacrolimus|tacrolimus|mesh-list
56383019|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
56383020|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56383021|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383022|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
56383023|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383024|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383025|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56383026|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
56383027|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383028|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383029|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56383030|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56654722|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654723|NCT00880542|Sorafenib|sorafenib|mesh-list
56654724|NCT00880542|Ifosfamide|ifosfamide|mesh-list
56654725|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654726|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55819559|NCT01993329|Mesna|mesna|mesh-list
56383031|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56383032|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
56383033|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383034|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56383035|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383036|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56174155|NCT02689778|Pirfenidone|pirfenidone|mesh-list
56383037|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56383038|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
56383039|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56383040|NCT00146562|Paclitaxel|paclitaxel|mesh-list
56383041|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
56383042|NCT00146562|Doxorubicin|doxorubicin|mesh-list
56383043|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
56383044|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56383045|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383046|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
56383047|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
56383048|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
56383049|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383050|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383053|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383054|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56383055|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
56383056|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56383057|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56383058|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383059|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383060|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383061|NCT00146562|Hematinics|hematinics|mesh-ancestor
56383062|NCT01245166|Metformin|metformin|mesh-list
56383063|NCT01245166|Acarbose|acarbose|mesh-list
56383064|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56383065|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383066|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56383067|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383068|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383069|NCT00146601|Fulvestrant|fulvestrant|mesh-list
56383070|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56383071|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383072|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56383073|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56383074|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
56383075|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383076|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383077|NCT00498589|Methotrexate|methotrexate|mesh-list
56383078|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56383079|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
56383080|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56383081|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383082|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56383083|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
56383084|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383085|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383086|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
56383087|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383088|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56383089|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383090|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
56383091|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174166|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56383092|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56383093|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
56383094|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56654727|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654728|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654729|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56654730|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
56654731|NCT00960037|Vitamin D|vitamin d|mesh-list
56383095|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
56383096|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56383097|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383098|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56383099|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56383100|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56383101|NCT00498901|Letrozole|letrozole|mesh-list
56383102|NCT00498901|Leuprolide|leuprolide|mesh-list
56383103|NCT00498901|Goserelin|goserelin|mesh-list
56383104|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383105|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56383106|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56383107|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383108|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383109|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56383110|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
56383111|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001945|NCT00000226|Analgesics|analgesics|mesh-ancestor
56383112|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383113|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56383114|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
56383115|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56383116|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56383117|NCT00498979|Interferons|interferons|mesh-list
56383118|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
56383119|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
56383120|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56383121|NCT00498979|Dacarbazine|dacarbazine|mesh-list
56383125|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383126|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
56383127|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383128|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56383129|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
56383130|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383131|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56383132|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56383133|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56383134|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56383135|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56383136|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56383137|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
56383138|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56383139|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
56383141|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383142|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383143|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383144|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383145|NCT01245244|Morphine|morphine|mesh-list
56383146|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56383147|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56383148|NCT01245244|Narcotics|narcotics|mesh-ancestor
56383149|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56383150|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383151|NCT01245244|Analgesics|analgesics|mesh-ancestor
56383152|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
56383153|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383154|NCT00405717|Atorvastatin|atorvastatin|mesh-list
56383155|NCT00405717|Pravastatin|pravastatin|mesh-list
56383156|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56383157|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56383158|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
56383159|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383160|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56383161|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56654732|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
56654733|NCT00960037|Vitamins|vitamins|mesh-ancestor
56654734|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
56383162|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383164|NCT00499018|Prednisone|prednisone|mesh-list
56383165|NCT00499018|Rituximab|rituximab|mesh-list
56383166|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
56383167|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
56383168|NCT00499018|Vincristine|vincristine|mesh-list
56383169|NCT00499018|Doxorubicin|doxorubicin|mesh-list
56383170|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56383171|NCT00499018|Lenograstim|lenograstim|mesh-list
56383172|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56383173|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383174|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
56383175|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383176|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383177|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383178|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
56383179|NCT00499018|Hormones|hormones|mesh-ancestor
56383180|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383181|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56383182|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56383183|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
56383184|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383185|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
56383186|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383187|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383188|NCT00499018|Analgesics|analgesics|mesh-ancestor
56383189|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
56383190|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383191|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383192|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383193|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383194|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56383195|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
56383198|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56383199|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56383200|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56383201|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56383202|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56383204|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56383205|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
56383206|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56383207|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
56383208|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56383209|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
56383210|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383211|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
56383212|NCT00127985|Hormones|hormones|mesh-ancestor
56383213|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383214|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383215|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56383216|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383217|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
56383218|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
56383219|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383220|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56383221|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56383222|NCT00127985|Protective Agents|protective agents|mesh-ancestor
56383223|NCT00424164|Tamoxifen|tamoxifen|mesh-list
56383224|NCT00424164|Lapatinib|lapatinib|mesh-list
56383225|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383226|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56383227|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
56383228|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383229|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383230|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56383231|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383232|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56383233|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56383234|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56383235|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56654735|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819793|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56383236|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383237|NCT00499135|Alovudine|alovudine|mesh-list
56383238|NCT00499135|Sunitinib|sunitinib|mesh-list
56383239|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383240|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56383241|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56383242|NCT00499135|Growth Substances|growth substances|mesh-ancestor
56383243|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383244|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
56383245|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383246|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383247|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383248|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
56383249|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383250|NCT01245361|Infliximab|infliximab|mesh-list
56383251|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
56383252|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56383253|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383254|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
56383255|NCT00424203|Doxorubicin|doxorubicin|mesh-list
56383256|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56383257|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383258|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
56383259|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383260|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383261|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56383262|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
56383263|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383264|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383265|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56383266|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56383267|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383277|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383278|NCT01245556|Ipilimumab|ipilimumab|mesh-list
56383279|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56383280|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383281|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56383282|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383283|NCT00499525|Paclitaxel|paclitaxel|mesh-list
56383284|NCT00499525|Sorafenib|sorafenib|mesh-list
56383285|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56383286|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383287|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
56383288|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
56383289|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
56174187|NCT02659384|Analgesics|analgesics|mesh-ancestor
56383290|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383291|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383292|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383294|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56383295|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383296|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383297|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383298|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383299|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383300|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383301|NCT00499720|Aztreonam|aztreonam|mesh-list
56383302|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56383303|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383304|NCT05562518|Estrogens|estrogens|mesh-list
56383305|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56383306|NCT05562518|Hormones|hormones|mesh-ancestor
56383307|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383308|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383309|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56383310|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
56383311|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56383312|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
56383313|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56383314|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56383315|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
56654736|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56654737|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56654738|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56654739|NCT04161690|Ropivacaine|ropivacaine|mesh-list
56216977|NCT01628666|Vancomycin|vancomycin|mesh-list
56383316|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383317|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383318|NCT00499876|Mefloquine|mefloquine|mesh-list
56383319|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
56383320|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56383321|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56383322|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383323|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
56383324|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
56383325|NCT00146718|Amodiaquine|amodiaquine|mesh-list
56383326|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
56383327|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56383328|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56383329|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383330|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56383331|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383332|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383333|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56383334|NCT00146718|Renal Agents|renal agents|mesh-ancestor
56383344|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56383345|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56383346|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56383347|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005286|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
56383348|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56383349|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56383350|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56383351|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56383352|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
56383353|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
56383354|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
56383355|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
56383356|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383357|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383358|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56383359|NCT00500344|Ranibizumab|ranibizumab|mesh-list
56383360|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56383361|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56383362|NCT00500344|Growth Substances|growth substances|mesh-ancestor
56383363|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383364|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
56383365|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383366|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56383367|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
56383368|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383369|NCT01245868|Lidocaine|lidocaine|mesh-list
56383370|NCT01245868|Bupivacaine|bupivacaine|mesh-list
56383371|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
56383372|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
56383373|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56383374|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383375|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
56383376|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383377|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56383378|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56383379|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56383380|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56383381|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383382|NCT00500422|Gemcitabine|gemcitabine|mesh-list
56383383|NCT00500422|Doxorubicin|doxorubicin|mesh-list
56383384|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56383385|NCT00500422|Bortezomib|bortezomib|mesh-list
56383386|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56383387|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
56383388|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917458|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
56654740|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
56654741|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
56654742|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820046|NCT01785472|Olmesartan|olmesartan|mesh-list
56383389|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383390|NCT00500422|Antiviral Agents|antiviral agents|mesh-ancestor
56383391|NCT00500422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383392|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383393|NCT00500422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383394|NCT00500422|Immunologic Factors|immunologic factors|mesh-ancestor
56383395|NCT00500422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383396|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56383397|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383398|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383399|NCT01245946|Doxycycline|doxycycline|mesh-list
56383400|NCT01245946|Adapalene|adapalene|mesh-list
56383401|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56383402|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383405|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56383406|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56383407|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56383408|NCT01245946|Analgesics|analgesics|mesh-ancestor
56383409|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
56383410|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383411|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383412|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383413|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383414|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56383416|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
56383417|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383418|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
56383419|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383420|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383421|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005373|NCT01156597|Pioglitazone|pioglitazone|mesh-list
56174206|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
56383422|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383423|NCT00501124|Clevudine|clevudine|mesh-list
56383424|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
56383425|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383426|NCT00501241|ATI 7505|ati 7505|mesh-list
56383427|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56383428|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56383429|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
56383430|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383431|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383432|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383433|NCT01246180|Diclofenac|diclofenac|mesh-list
56383434|NCT01246180|Amiloride|amiloride|mesh-list
56383435|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56383436|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56383437|NCT01246180|Analgesics|analgesics|mesh-ancestor
56383438|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
56383439|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383440|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383441|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383442|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383443|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56383444|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383445|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383446|NCT01246180|Diuretics|diuretics|mesh-ancestor
56383447|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
56383448|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56383449|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56383450|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56383451|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56383452|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56383453|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
56383454|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56383455|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
56383456|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383457|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
56654743|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654744|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
56216983|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56383458|NCT05561972|Protective Agents|protective agents|mesh-ancestor
56383459|NCT02274610|Docetaxel|docetaxel|mesh-list
56383460|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383461|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56383462|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56383463|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56383464|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383465|NCT00501397|Ketoconazole|ketoconazole|mesh-list
56383466|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
56383467|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383468|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56383469|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56383470|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383471|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383472|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56383473|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
55897525|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56383483|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383484|NCT00501748|Rituximab|rituximab|mesh-list
56383485|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56383486|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383487|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
56383488|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383489|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383491|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56383492|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383493|NCT00147264|Telmisartan|telmisartan|mesh-list
56383494|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56383495|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56383496|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56383497|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383498|NCT00501904|Metformin|metformin|mesh-list
56383499|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56383500|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383501|NCT00501982|Poractant alfa|poractant alfa|mesh-list
56383502|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56383503|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
56383511|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
56383512|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56383513|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56383514|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383515|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56383516|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56383517|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
56383518|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383519|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383520|NCT00502060|Cediranib|cediranib|mesh-list
56383521|NCT00502060|Gefitinib|gefitinib|mesh-list
56383522|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383523|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383524|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383525|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383526|NCT00502099|Interferons|interferons|mesh-list
56383527|NCT00502099|Ribavirin|ribavirin|mesh-list
56383528|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
56383529|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
56383530|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56383531|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56383532|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383533|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
56383534|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383535|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
56383536|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383537|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
56383538|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383539|NCT00502138|Pramlintide|pramlintide|mesh-list
56383540|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
56383541|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56383542|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654745|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654746|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56654747|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56383543|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
56383544|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56383545|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
55897601|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
56383546|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383548|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
56383549|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383550|NCT00502411|Doxorubicin|doxorubicin|mesh-list
56383551|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56383552|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56383553|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383554|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383555|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383556|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383557|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383558|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56383559|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56383560|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56383561|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383563|NCT00147381|Tacrolimus|tacrolimus|mesh-list
56383564|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383565|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
56383566|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383567|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56383568|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383569|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383570|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56383571|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383573|NCT00502567|Docetaxel|docetaxel|mesh-list
56383574|NCT00502567|Fluorouracil|fluorouracil|mesh-list
56383575|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
56383576|NCT00502567|Irinotecan|irinotecan|mesh-list
56383577|NCT00502567|Pemetrexed|pemetrexed|mesh-list
56383578|NCT00502567|Cetuximab|cetuximab|mesh-list
56383579|NCT00502567|Cediranib|cediranib|mesh-list
56383580|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383581|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
56383582|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
56383583|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
56383584|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383585|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
56383586|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56383587|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383588|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
56383589|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383590|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56383591|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383592|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383593|NCT00502567|Antidotes|antidotes|mesh-ancestor
56383594|NCT00502567|Protective Agents|protective agents|mesh-ancestor
56383595|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
56383596|NCT00502567|Vitamins|vitamins|mesh-ancestor
56383597|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
56383598|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56383599|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56383600|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56383601|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383602|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
56383603|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
56383604|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
56383605|NCT00502684|Etodolac|etodolac|mesh-list
56383606|NCT00502684|Propranolol|propranolol|mesh-list
56383607|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56383608|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56383609|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
56383610|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383611|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383612|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383613|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56654748|NCT04161690|Analgesics|analgesics|mesh-ancestor
56654749|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55820368|NCT01607476|Corticosterone|corticosterone|mesh-list
56383614|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56383615|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
56383616|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56383617|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56383619|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
56383620|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383621|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383622|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383623|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56383626|NCT00502762|Topotecan|topotecan|mesh-list
56383627|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56383628|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383629|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383630|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383631|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383632|NCT00502879|Etanercept|etanercept|mesh-list
56383633|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56001968|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
56383634|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56383635|NCT00502879|Analgesics|analgesics|mesh-ancestor
56383636|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
56383637|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383638|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383639|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383640|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383641|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56383642|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383643|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
56383644|NCT00503152|Valsartan|valsartan|mesh-list
56383645|NCT00503152|Benazepril|benazepril|mesh-list
56383646|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56383647|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56383648|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56383649|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383650|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56383651|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
56383652|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383653|NCT00503347|Bavituximab|bavituximab|mesh-list
56383654|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56383655|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383656|NCT00503386|Palonosetron|palonosetron|mesh-list
56383657|NCT00503386|Granisetron|granisetron|mesh-list
56383658|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
56383659|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
56383660|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383661|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383662|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56383663|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56383664|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56383665|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
56383666|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383667|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383668|NCT00503503|Etanercept|etanercept|mesh-list
56383669|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56383670|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56383671|NCT00503503|Analgesics|analgesics|mesh-ancestor
56383672|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
56383673|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383674|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383675|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383676|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383677|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56383678|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383679|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
56383680|NCT00503542|Metronidazole|metronidazole|mesh-list
56383681|NCT00503542|Clindamycin|clindamycin|mesh-list
56383682|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
56383683|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
56383684|NCT00503542|Fluconazole|fluconazole|mesh-list
56383685|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654750|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654751|NCT05194969|Petrolatum|petrolatum|mesh-list
56654752|NCT05194969|Emollients|emollients|mesh-ancestor
56654753|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
56383686|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56383687|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56383688|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56383689|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56383690|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383691|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383692|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
56383693|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56383694|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56383695|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56383697|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383699|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56383700|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56383701|NCT00147615|Eplerenone|eplerenone|mesh-list
56383702|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56383703|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
56383704|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383705|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383706|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56383707|NCT00147615|Diuretics|diuretics|mesh-ancestor
56383708|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
56383709|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56383710|NCT05561036|Doxorubicin|doxorubicin|mesh-list
56383711|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56383712|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383713|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383714|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383715|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383716|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383717|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
56383718|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56383719|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56383720|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
56005662|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383721|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383722|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56383723|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56383724|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383725|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383726|NCT00147654|Tamsulosin|tamsulosin|mesh-list
56383727|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56383728|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56383729|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56383730|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56383731|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
56383732|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383733|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383734|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383735|NCT00147654|Urological Agents|urological agents|mesh-ancestor
56383736|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56383737|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56383738|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
56383739|NCT01246921|Fluticasone|fluticasone|mesh-list
56383740|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383741|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56383742|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
56383743|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383744|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383745|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56383746|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
56383747|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
56383748|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56383749|NCT04696939|Carboplatin|carboplatin|mesh-list
56383750|NCT04696939|Etoposide|etoposide|mesh-list
56383751|NCT04696939|Atezolizumab|atezolizumab|mesh-list
56383752|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918293|NCT01409915|Sargramostim|sargramostim|mesh-list
56654754|NCT00885534|Temozolomide|temozolomide|mesh-list
56654755|NCT00885534|Vinblastine|vinblastine|mesh-list
56654756|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654757|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56654758|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
56383753|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56383754|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383755|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383756|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383757|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383758|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56383759|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56383760|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56383761|NCT05560919|Protective Agents|protective agents|mesh-ancestor
56383762|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383763|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56383764|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
56383765|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383776|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383777|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383778|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56383779|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383780|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
56383782|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
56383783|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383784|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383785|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56383786|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56383787|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
56383788|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56383789|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56383790|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
56383791|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383792|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383793|NCT04063163|Carboplatin|carboplatin|mesh-list
56383794|NCT04063163|Etoposide|etoposide|mesh-list
56383795|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383796|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56383797|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383798|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383799|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383800|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383801|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56383803|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56383804|NCT01247077|Selenium|selenium|mesh-list
56383805|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
56383806|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383807|NCT01247077|Protective Agents|protective agents|mesh-ancestor
56383808|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383809|NCT01247077|Trace Elements|trace elements|mesh-ancestor
56383810|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
56383811|NCT03990467|Tazobactam|tazobactam|mesh-list
56383812|NCT03990467|Piperacillin|piperacillin|mesh-list
56383813|NCT03990467|Amikacin|amikacin|mesh-list
56383814|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56383815|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383816|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56383817|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383818|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383819|NCT01247311|Vitamin D|vitamin d|mesh-list
56383820|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
56383821|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
56383822|NCT01247311|Vitamins|vitamins|mesh-list
56383823|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
56383824|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174273|NCT02296229|Androgens|androgens|mesh-list
56383825|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56383826|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56383827|NCT00147771|Imiquimod|imiquimod|mesh-list
56383828|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56383829|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
56654759|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654760|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56300842|NCT00023998|Antidotes|antidotes|mesh-ancestor
56654761|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
56654762|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
56654763|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
56654764|NCT05277038|Clonidine|clonidine|mesh-list
56654765|NCT05277038|Zopiclone|zopiclone|mesh-list
56654766|NCT05277038|Analgesics|analgesics|mesh-ancestor
56654767|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
56654768|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383830|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383831|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897887|NCT05681260|Cytarabine|cytarabine|mesh-list
56383834|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56383836|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383837|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383838|NCT03981146|Nivolumab|nivolumab|mesh-list
56383839|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56383840|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383841|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56383842|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383843|NCT01247857|Ropivacaine|ropivacaine|mesh-list
56383844|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
56383845|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
56383846|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56383847|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383848|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
56383849|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383850|NCT04331730|Aflibercept|aflibercept|mesh-list
56383851|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56383852|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56383853|NCT04331730|Growth Substances|growth substances|mesh-ancestor
56383854|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383855|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
56383856|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383858|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56383859|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
56383860|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56383861|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383862|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56383863|NCT00503971|Vorinostat|vorinostat|mesh-list
56383864|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383865|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383866|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383867|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383868|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56383869|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56383870|NCT02274961|Pantoprazole|pantoprazole|mesh-list
56383871|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56383872|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56383873|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56383874|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383875|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383876|NCT02275039|Gemcitabine|gemcitabine|mesh-list
56383877|NCT02275039|Vaccines|vaccines|mesh-list
56383878|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
56383879|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383880|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56383881|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
56383882|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383883|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383884|NCT02275039|Antiviral Agents|antiviral agents|mesh-ancestor
56654769|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654770|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56654771|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
56654772|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
56383885|NCT02275039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383886|NCT02275039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383887|NCT02275039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383888|NCT04263051|Nivolumab|nivolumab|mesh-list
56383889|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56383891|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56383892|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383893|NCT01248403|Paclitaxel|paclitaxel|mesh-list
56383894|NCT01248403|Everolimus|everolimus|mesh-list
56383895|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56383896|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383897|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
56383898|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
56383899|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
56383900|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383901|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383902|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
56383903|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383904|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
56383905|NCT01248442|Vitamin D|vitamin d|mesh-list
56383909|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
56383910|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56383911|NCT01248481|Acarbose|acarbose|mesh-list
56383912|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56383913|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383914|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383915|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56383916|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383917|NCT01249339|Lobeline|lobeline|mesh-list
56383918|NCT01249339|Nicotine|nicotine|mesh-list
56383919|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56383920|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
56383921|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383922|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383923|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56383924|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56383925|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
56383926|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56383927|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383928|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
56383929|NCT03809429|Cetrorelix|cetrorelix|mesh-list
56383930|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56383931|NCT03809429|Hormones|hormones|mesh-ancestor
56383932|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383933|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383934|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56383935|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
56383936|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56383937|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
56383938|NCT00504127|Naproxen|naproxen|mesh-list
56383939|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56383940|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56383941|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56383942|NCT00504127|Analgesics|analgesics|mesh-ancestor
56383943|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
56383944|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383945|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383946|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383947|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56383948|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
56383949|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56383950|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383951|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383952|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56383953|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56383954|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56383955|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56654773|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56654774|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56654775|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56654776|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
56383956|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383957|NCT04085250|Nivolumab|nivolumab|mesh-list
56383958|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56383959|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383960|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56383961|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383962|NCT01249690|Thalidomide|thalidomide|mesh-list
56383963|NCT01249690|Dexamethasone|dexamethasone|mesh-list
56383964|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
56383965|NCT01249690|Bortezomib|bortezomib|mesh-list
56383966|NCT01249690|Pirarubicin|pirarubicin|mesh-list
56383967|NCT01249690|Doxorubicin|doxorubicin|mesh-list
56383968|NCT01249690|BB 1101|bb 1101|mesh-list
56383969|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56383970|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
56383971|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
56383972|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56383973|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383974|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56383975|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
56383976|NCT01249690|Hormones|hormones|mesh-ancestor
56383977|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383979|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383981|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383982|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383983|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56383984|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
56383985|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
56383986|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56383987|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56383988|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56383989|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56383990|NCT01249690|Growth Substances|growth substances|mesh-ancestor
56383991|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
56383992|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56383993|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56383994|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383995|NCT03712826|Ustekinumab|ustekinumab|mesh-list
56383996|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
56383997|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
56383998|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56383999|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56384000|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384001|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
56384002|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
56384003|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
56384004|NCT00504244|Azathioprine|azathioprine|mesh-list
56384005|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
56165341|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56384006|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384007|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56384008|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384009|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384010|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
56384011|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384012|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384013|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56384014|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56384015|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
56384016|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56384017|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384018|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384020|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56384021|NCT00405444|Narcotics|narcotics|mesh-ancestor
56384022|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56384023|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384024|NCT00405444|Analgesics|analgesics|mesh-ancestor
55918294|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
56654777|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654778|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384025|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
56384026|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384027|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56384028|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56384029|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
56384030|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
56384031|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56384033|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56384034|NCT00504283|Narcotics|narcotics|mesh-ancestor
56384035|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56384036|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384037|NCT00504283|Analgesics|analgesics|mesh-ancestor
56384038|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
56384039|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384040|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56384041|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56384042|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56384043|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384044|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56384045|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384046|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384047|NCT00504400|Ranibizumab|ranibizumab|mesh-list
56384048|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56384049|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56384050|NCT00504400|Growth Substances|growth substances|mesh-ancestor
56384051|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384065|NCT04054830|Analgesics|analgesics|mesh-ancestor
56384066|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
56384067|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384068|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384069|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56384070|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384071|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56384072|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384073|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384074|NCT03622775|Daratumumab|daratumumab|mesh-list
56384075|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384076|NCT01249651|Esomeprazole|esomeprazole|mesh-list
56384078|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56384079|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56001972|NCT00000988|Stavudine|stavudine|mesh-list
56384080|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384081|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384082|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
56384083|NCT03999723|Vitamins|vitamins|mesh-ancestor
56384084|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
56384085|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384086|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
56384087|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384088|NCT03999723|Protective Agents|protective agents|mesh-ancestor
56384089|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
56384090|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56384091|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56384092|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56384093|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56384094|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384095|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
56384096|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56384097|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384098|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56384099|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384100|NCT00403325|Ranibizumab|ranibizumab|mesh-list
56384101|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56384102|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56384103|NCT00403325|Growth Substances|growth substances|mesh-ancestor
56384104|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384105|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
56384106|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384107|NCT04725747|Midazolam|midazolam|mesh-list
56384108|NCT04725747|Ketamine|ketamine|mesh-list
56654779|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56654780|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654781|NCT00960349|Cisplatin|cisplatin|mesh-list
56384109|NCT04725747|Analgesics|analgesics|mesh-ancestor
56384110|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
56384111|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384112|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898173|NCT02446002|Lofexidine|lofexidine|mesh-list
56384119|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56384120|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56384121|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384122|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56384123|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56384124|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56384125|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56384126|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56384127|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
56384128|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
56384129|NCT03546686|Nivolumab|nivolumab|mesh-list
56384130|NCT03546686|Ipilimumab|ipilimumab|mesh-list
56384131|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56384132|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384133|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56384134|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384135|NCT04725942|Posaconazole|posaconazole|mesh-list
56384136|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
56384137|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384138|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56384139|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56384140|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56384141|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56384142|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56384143|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384144|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384145|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56384146|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
56384147|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384148|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384150|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
56384151|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56384152|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56384153|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384154|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56384155|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384156|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56384157|NCT03890952|Bevacizumab|bevacizumab|mesh-list
56384159|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56384160|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56384161|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384162|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56384163|NCT03890952|Growth Substances|growth substances|mesh-ancestor
56384164|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384165|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
56384166|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56384167|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384168|NCT03868722|Venetoclax|venetoclax|mesh-list
56006166|NCT00002620|Cobalt|cobalt|mesh-list
56384169|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
56384170|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384171|NCT03761511|Niacinamide|niacinamide|mesh-list
56384172|NCT03761511|Niacin|niacin|mesh-list
56384173|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
56384174|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
56384175|NCT03761511|Vitamins|vitamins|mesh-ancestor
56384176|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
56384177|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384178|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56384179|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
56384180|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898245|NCT02444364|Incretins|incretins|mesh-ancestor
56384191|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56384193|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
56654782|NCT00960349|Capecitabine|capecitabine|mesh-list
56654783|NCT00960349|Cediranib|cediranib|mesh-list
56654784|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654785|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56654786|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
56654787|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384194|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384195|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384196|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56384197|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384198|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56384199|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56384200|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384201|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56384202|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56384203|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384204|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
56384205|NCT02736422|Xenon|xenon|mesh-list
56384206|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56384207|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
56384208|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
56384209|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56384210|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384211|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
56384212|NCT03721497|Testosterone|testosterone|mesh-list
56384213|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
56384214|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
56384215|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56384216|NCT03721497|Androgens|androgens|mesh-ancestor
56384217|NCT03721497|Hormones|hormones|mesh-ancestor
56384218|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384219|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384220|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56384221|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384222|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
56384223|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
56384224|NCT03682029|Vitamins|vitamins|mesh-ancestor
56384225|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
56384226|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384227|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
56165342|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
56384228|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384229|NCT03682029|Protective Agents|protective agents|mesh-ancestor
56384230|NCT00139230|Leucovorin|leucovorin|mesh-list
56384231|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
56384232|NCT00139230|Fluorouracil|fluorouracil|mesh-list
56384233|NCT00139230|Docetaxel|docetaxel|mesh-list
56384234|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384235|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
56384236|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384237|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56384238|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384239|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
56384240|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384241|NCT00139230|Antidotes|antidotes|mesh-ancestor
56384242|NCT00139230|Protective Agents|protective agents|mesh-ancestor
56384243|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
56384244|NCT00139230|Vitamins|vitamins|mesh-ancestor
56384245|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
56384246|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
56384247|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
56384250|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384251|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56384252|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56384253|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384254|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56384255|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56384256|NCT03648996|Allopurinol|allopurinol|mesh-list
56384257|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
56384258|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384259|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654788|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56654789|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654790|NCT05375903|Imiquimod|imiquimod|mesh-list
56654791|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56654792|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56654793|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
56654794|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654795|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654796|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
56654797|NCT02670434|Pitavastatin|pitavastatin|mesh-list
56654798|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56654799|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56654800|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56654801|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
56654802|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654803|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654804|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56654805|NCT00965653|Folic Acid|folic acid|mesh-list
56654806|NCT00965653|Methotrexate|methotrexate|mesh-list
56654807|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56654808|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
56654809|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56654810|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654811|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56654812|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
56654813|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654814|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654815|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
56654816|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654817|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56654818|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56654819|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
56384260|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
56384261|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384262|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56384263|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
56384264|NCT03648996|Protective Agents|protective agents|mesh-ancestor
56384265|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384267|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56384268|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384269|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
56384270|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654820|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654821|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56654822|NCT00965653|Hematinics|hematinics|mesh-ancestor
56654823|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
56654824|NCT00965653|Vitamins|vitamins|mesh-ancestor
56384271|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384273|NCT00139269|Fluorouracil|fluorouracil|mesh-list
56384274|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384275|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
56384276|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
56384277|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
56384278|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384279|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
56384280|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56384281|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384282|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
56384283|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384284|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
56384285|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384286|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
56384287|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384288|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384289|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56384290|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
56384291|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384292|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384293|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56384294|NCT00403364|Amoxicillin|amoxicillin|mesh-list
56384295|NCT00403364|Clarithromycin|clarithromycin|mesh-list
56384296|NCT00403364|Tinidazole|tinidazole|mesh-list
56384297|NCT00403364|Pantoprazole|pantoprazole|mesh-list
56384298|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56384299|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384300|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56384301|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384302|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001973|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
56384303|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56384304|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56384305|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56384306|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56384307|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56384308|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
56384309|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56384310|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56384311|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56384312|NCT00403442|Bevacizumab|bevacizumab|mesh-list
56384313|NCT00403442|Verteporfin|verteporfin|mesh-list
56384314|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56384315|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384316|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56384317|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56384318|NCT00403442|Growth Substances|growth substances|mesh-ancestor
56384319|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384320|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
56384333|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
56384334|NCT00402974|Vitamin K|vitamin k|mesh-list
56384335|NCT00402974|Vitamin MK 7|vitamin mk 7|mesh-list
56384336|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56384337|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56384338|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384339|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
56384340|NCT00402974|Coagulants|coagulants|mesh-ancestor
56384341|NCT00402974|Vitamins|vitamins|mesh-ancestor
56384342|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
56128750|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56384343|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384344|NCT01731236|Aspirin|aspirin|mesh-list
56384345|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56384346|NCT01731236|Vancomycin|vancomycin|mesh-list
56384347|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
56384348|NCT01731236|Neomycin|neomycin|mesh-list
56384349|NCT01731236|Choline|choline|mesh-list
55888740|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56654825|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
56654826|NCT00644696|Cefixime|cefixime|mesh-list
56654827|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
56654828|NCT00644696|Irinotecan|irinotecan|mesh-list
56654829|NCT00644696|Bortezomib|bortezomib|mesh-list
56654830|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56654831|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56654832|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384350|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56384351|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56384352|NCT01731236|Analgesics|analgesics|mesh-ancestor
56384353|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
56384354|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384355|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384356|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56384357|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384358|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56384359|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56384360|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384361|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56384362|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56384363|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384364|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
56384365|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384366|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56384367|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56384368|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384369|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56384370|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56384371|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
56384372|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56384373|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
56384374|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56384375|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56384376|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
56384377|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56384378|NCT03510078|Insulin|insulin|mesh-list
56384379|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56384380|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384381|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
56384382|NCT00139581|Tacrolimus|tacrolimus|mesh-list
56384383|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56384384|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56384385|NCT00139581|Analgesics|analgesics|mesh-ancestor
56384386|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
56384387|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384388|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384389|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56384390|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384391|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
56384392|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384393|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
56384401|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384402|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56384403|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384404|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384405|NCT00130481|Atorvastatin|atorvastatin|mesh-list
56384406|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56384407|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56384408|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
56384409|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384410|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56384411|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56384412|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384413|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56384415|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56384416|NCT00139698|Diuretics|diuretics|mesh-ancestor
56384417|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
56384418|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654833|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654834|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821872|NCT02909335|Prednisolone|prednisolone|mesh-list
56384419|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56384420|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56384421|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384422|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56384423|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56384424|NCT00130676|Mifepristone|mifepristone|mesh-list
56384425|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56384426|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
56384427|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56384428|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384429|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56384430|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56384431|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56384432|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
56384433|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56384434|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56384435|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
56384436|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384437|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
56384438|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56384439|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56384440|NCT00404274|Casopitant|casopitant|mesh-list
56384441|NCT00404274|Warfarin|warfarin|mesh-list
56384442|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
56384443|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
56384444|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
56384445|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384446|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384447|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56384448|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56384449|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56384450|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384451|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
56384452|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
56384453|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384454|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384455|NCT00130871|Simendan|simendan|mesh-list
56384456|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56384457|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
56384462|NCT00130871|Protective Agents|protective agents|mesh-ancestor
56384463|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384464|NCT00130910|Albendazole|albendazole|mesh-list
56384465|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
56384466|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56384467|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384468|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
56384469|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56384470|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56384471|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
56384472|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
56384473|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
56384474|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384475|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384476|NCT03226821|Tesamorelin|tesamorelin|mesh-list
56384477|NCT03226821|Growth Substances|growth substances|mesh-ancestor
56384478|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384479|NCT00139815|Enoxaparin|enoxaparin|mesh-list
56384480|NCT00139815|PENTA|penta|mesh-list
56384481|NCT00139815|Fondaparinux|fondaparinux|mesh-list
56384482|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
56384483|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56384484|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56384485|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384486|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56384487|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
56384488|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56384489|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
56384490|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384491|NCT00131027|Cytarabine|cytarabine|mesh-list
56654835|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56654836|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300913|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
56654837|NCT00960739|Topotecan|topotecan|mesh-list
56654838|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56654839|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56654840|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56384492|NCT00131027|Dexamethasone|dexamethasone|mesh-list
56384493|NCT00131027|Prednisolone|prednisolone|mesh-list
56384494|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
56384495|NCT00131027|Doxorubicin|doxorubicin|mesh-list
56384496|NCT00131027|Methotrexate|methotrexate|mesh-list
56384497|NCT00131027|Etoposide|etoposide|mesh-list
56384498|NCT00131027|Vincristine|vincristine|mesh-list
56384499|NCT00131027|Daunorubicin|daunorubicin|mesh-list
56384500|NCT00131027|Asparaginase|asparaginase|mesh-list
56384501|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
56384502|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384503|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
56384504|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384505|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384506|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56384507|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
56384508|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384509|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384510|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56384511|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56384512|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
56384513|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
56384514|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384515|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56384516|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
56384517|NCT00131027|Hormones|hormones|mesh-ancestor
56384518|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384519|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56384520|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56384521|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56384522|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56384523|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384524|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56384525|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
56384526|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56384527|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56384528|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
56384529|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
56384530|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56384532|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56384534|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384535|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
56384536|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
56384537|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
56384538|NCT00139854|Alprazolam|alprazolam|mesh-list
56384539|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56384540|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56384541|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384542|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56384543|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56384544|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56384545|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
56384546|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
56384547|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56384548|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384549|NCT00131144|Octreotide|octreotide|mesh-list
56384550|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56384551|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56384552|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384553|NCT00139893|Metoclopramide|metoclopramide|mesh-list
56384554|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
56384555|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
56384556|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384557|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654841|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654842|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654843|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654844|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56654845|NCT00659022|Bevacizumab|bevacizumab|mesh-list
56654846|NCT00659022|Capecitabine|capecitabine|mesh-list
56654847|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
56217064|NCT01629368|Carbamazepine|carbamazepine|mesh-list
56384558|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56384559|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56384560|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56384561|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
56384563|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384564|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
56384565|NCT00131183|Androgens|androgens|mesh-ancestor
56384566|NCT00131183|Hormones|hormones|mesh-ancestor
56384567|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384568|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384569|NCT03186456|Aspirin|aspirin|mesh-list
56384570|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56384571|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56384572|NCT03186456|Analgesics|analgesics|mesh-ancestor
56384573|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
56384574|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384575|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384576|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56384577|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384578|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56384579|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56384580|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384581|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56384582|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56384583|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384584|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
56384585|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
56384586|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56384587|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
56384588|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384589|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384590|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56384591|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
56384592|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56384593|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56384594|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56384595|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
56384596|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56384597|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384598|NCT00131261|Dexamethasone|dexamethasone|mesh-list
56384599|NCT00131261|Belinostat|belinostat|mesh-list
56384600|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56384601|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
56384602|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
56384603|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898654|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56384604|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384606|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
56384607|NCT00131261|Hormones|hormones|mesh-ancestor
56384608|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384609|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56384610|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384611|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56384612|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384613|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384614|NCT03184935|Decitabine|decitabine|mesh-list
56384615|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56384616|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
55919463|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
56654848|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56654849|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654850|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56654851|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56654852|NCT00659022|Growth Substances|growth substances|mesh-ancestor
56654853|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217072|NCT01629368|Analgesics|analgesics|mesh-ancestor
56384617|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384618|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384619|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384621|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
56384622|NCT00131300|Protective Agents|protective agents|mesh-ancestor
56384623|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006573|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
56384624|NCT00131339|Cycloserine|cycloserine|mesh-list
56384625|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56384626|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384627|NCT00131339|Renal Agents|renal agents|mesh-ancestor
56384628|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56384629|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
56384630|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56384631|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
56384632|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384633|NCT00139971|Gemcitabine|gemcitabine|mesh-list
56384634|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56384635|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
56384636|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384637|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384638|NCT00139971|Antiviral Agents|antiviral agents|mesh-ancestor
56384639|NCT00139971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384640|NCT00139971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384641|NCT00139971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384642|NCT00139971|Immunologic Factors|immunologic factors|mesh-ancestor
56384643|NCT00139971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384644|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
56384645|NCT00140010|Hematinics|hematinics|mesh-ancestor
56384646|NCT00131495|Testosterone|testosterone|mesh-list
56384647|NCT00131495|Androgens|androgens|mesh-ancestor
56384648|NCT00131495|Hormones|hormones|mesh-ancestor
56384649|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384650|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384651|NCT04726631|Insulin|insulin|mesh-list
56384652|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56384653|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
56384654|NCT04726631|Protamines|protamines|mesh-list
56384655|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56384656|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384657|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
56384658|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384659|NCT04726631|Coagulants|coagulants|mesh-ancestor
56384660|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
56384661|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384662|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
56384663|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384664|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384665|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56384666|NCT03117309|Nivolumab|nivolumab|mesh-list
56384667|NCT03117309|Ipilimumab|ipilimumab|mesh-list
56384668|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56384669|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384670|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56384671|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384672|NCT00140166|Pyridoxine|pyridoxine|mesh-list
56384673|NCT00140166|Niacinamide|niacinamide|mesh-list
56384674|NCT00140166|Niacin|niacin|mesh-list
56384675|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
56384676|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
56384677|NCT00140166|Vitamins|vitamins|mesh-ancestor
56384678|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
55898732|NCT03132532|Paclitaxel|paclitaxel|mesh-list
56654854|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
56654855|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56654856|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
56654857|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654858|NCT02788643|Dimercaprol|dimercaprol|mesh-list
56384682|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384683|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56384684|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
56384685|NCT03095274|Durvalumab|durvalumab|mesh-list
56384687|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56384688|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384690|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
56384691|NCT00131768|Protective Agents|protective agents|mesh-ancestor
56384692|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384693|NCT01248949|Paclitaxel|paclitaxel|mesh-list
56384694|NCT01248949|Bevacizumab|bevacizumab|mesh-list
56384695|NCT01248949|Carboplatin|carboplatin|mesh-list
56384696|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56384697|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384698|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
56384699|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
56384700|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
56384701|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384702|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56384703|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56384704|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56384705|NCT01248949|Growth Substances|growth substances|mesh-ancestor
56384706|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384707|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
56384709|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384710|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384711|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
56384712|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56384713|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
56384714|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384715|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
56384716|NCT04696666|Protective Agents|protective agents|mesh-ancestor
56384717|NCT01248793|Golimumab|golimumab|mesh-list
56384718|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56384719|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56384720|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56384721|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384722|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
56384723|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384724|NCT01248715|Oseltamivir|oseltamivir|mesh-list
56384725|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
56384726|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384727|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384728|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384729|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56384730|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56384731|NCT01248364|Empagliflozin|empagliflozin|mesh-list
56384732|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56384733|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384734|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56384735|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384736|NCT00140361|Artesunate|artesunate|mesh-list
56384737|NCT00140361|Lumefantrine|lumefantrine|mesh-list
56384738|NCT00140361|Artemether|artemether|mesh-list
56384739|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
56384740|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
56384741|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56384742|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
56384743|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56384744|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56384745|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384746|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384747|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
56384748|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
56384749|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56384750|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
56654859|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
56654860|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
56654861|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654862|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
56654863|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56384751|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56384752|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384753|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384757|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56384758|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
56384759|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384760|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56384761|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384762|NCT00131963|Paclitaxel|paclitaxel|mesh-list
56384763|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
56384764|NCT00131963|Doxorubicin|doxorubicin|mesh-list
56384765|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56384766|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384767|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
56384768|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
56384769|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
56384770|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384771|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384772|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
56384773|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384774|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384775|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56384776|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
56384777|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56384778|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56384779|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56384780|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56384781|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384782|NCT00132119|Nalmefene|nalmefene|mesh-list
56384783|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56384784|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384785|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
56384786|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384787|NCT00132158|Irinotecan|irinotecan|mesh-list
56384788|NCT00132158|Gefitinib|gefitinib|mesh-list
56384789|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56384790|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56384791|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384792|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384793|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384794|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56384795|NCT00140478|Mifepristone|mifepristone|mesh-list
56384796|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56384797|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
56384798|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56384799|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384800|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56384801|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56384802|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56384803|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
56384804|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56384805|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56384806|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
56384807|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384808|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
56384809|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56384810|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56384811|NCT00140517|Chloroquine|chloroquine|mesh-list
56384812|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
56384813|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
56384814|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56384815|NCT00140517|Amebicides|amebicides|mesh-ancestor
56384816|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56654864|NCT04175522|Antibodies|antibodies|mesh-list
56654865|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
56654866|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
56654867|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654868|NCT00960817|Aspirin|aspirin|mesh-list
56384817|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56384818|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384819|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
56384820|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384821|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56384822|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384823|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384824|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56384826|NCT00132236|Nicotine|nicotine|mesh-list
56384835|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384836|NCT00132275|Amoxicillin|amoxicillin|mesh-list
56384837|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
56384838|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
56384839|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56384840|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384841|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56384842|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384843|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384844|NCT01246999|Vaccines|vaccines|mesh-list
56384845|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
56384846|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384847|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
56384848|NCT00140595|Rituximab|rituximab|mesh-list
56384849|NCT00140595|Doxorubicin|doxorubicin|mesh-list
56384850|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56384851|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
56006805|NCT04330300|Metolazone|metolazone|mesh-list
56384852|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384853|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384854|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56384855|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
56384856|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384857|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384858|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56384859|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56384860|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56384861|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56384862|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56384863|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384864|NCT04696783|Esomeprazole|esomeprazole|mesh-list
56384865|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56384866|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56384867|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56384868|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384869|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384870|NCT00132431|Cinacalcet|cinacalcet|mesh-list
56384871|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56384872|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384873|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56384874|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
56384875|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384876|NCT00140712|Ropinirole|ropinirole|mesh-list
56384877|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56384878|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56384879|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
56384880|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
56384881|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56384882|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384883|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384884|NCT00132548|Artesunate|artesunate|mesh-list
56384885|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
56384886|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
56384887|NCT00132548|Amodiaquine|amodiaquine|mesh-list
56384888|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56384889|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
56384890|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56384891|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56654869|NCT00960817|Dipyridamole|dipyridamole|mesh-list
56654870|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56654871|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654872|NCT00960817|Analgesics|analgesics|mesh-ancestor
56654873|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
56654874|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654875|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654876|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56654877|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56384892|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384893|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384894|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
56384898|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56384899|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384900|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384901|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56384904|NCT02333370|Letrozole|letrozole|mesh-list
56384905|NCT02333370|Fulvestrant|fulvestrant|mesh-list
56384906|NCT02333370|Goserelin|goserelin|mesh-list
56384907|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384908|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56384909|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56384910|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384911|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384912|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56384913|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
56384914|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384915|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384916|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56384917|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56384918|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56384919|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56384920|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56384921|NCT00140751|Ritonavir|ritonavir|mesh-list
56384922|NCT00140751|Lopinavir|lopinavir|mesh-list
56384923|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56384924|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56384925|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
56006883|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
56384926|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384927|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384929|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56384930|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
56384931|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56384932|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56384933|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56384934|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56384935|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
56384936|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56384937|NCT00132587|Protective Agents|protective agents|mesh-ancestor
56384938|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384939|NCT00140790|Valsartan|valsartan|mesh-list
56384940|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56384941|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56384942|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56384943|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384944|NCT02266329|Prazosin|prazosin|mesh-list
56384945|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56384946|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56384947|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56384948|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56384949|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
56384950|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888741|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56654878|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56654879|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56217090|NCT01629446|Lofexidine|lofexidine|mesh-list
56384951|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384952|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384953|NCT01245673|Lenalidomide|lenalidomide|mesh-list
56384954|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56384955|NCT01245673|Poly ICLC|poly iclc|mesh-list
56384956|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
56384957|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384959|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56384960|NCT01245673|Growth Substances|growth substances|mesh-ancestor
56384961|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56384962|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384963|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
56384964|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
56384965|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56384966|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56384967|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384971|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56384972|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
56384974|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384975|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56384976|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
56384977|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56384978|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56384979|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384980|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56384981|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
56384982|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56384983|NCT00132743|Protective Agents|protective agents|mesh-ancestor
56384984|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56384985|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56384986|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384987|NCT00132821|Bupropion|bupropion|mesh-list
56384988|NCT00132821|Nicotine|nicotine|mesh-list
56384989|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56384990|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
56384991|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384992|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384993|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56384994|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56384995|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
56384996|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56384997|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384998|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56384999|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
56385000|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385001|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56385002|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56385003|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56385004|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
56385005|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56385006|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56385007|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385008|NCT00132860|Azithromycin|azithromycin|mesh-list
56385009|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56385010|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385011|NCT01244815|Asenapine|asenapine|mesh-list
56385012|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56385013|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56385014|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385015|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385016|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385017|NCT00132899|Methotrexate|methotrexate|mesh-list
56385018|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56385019|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
56385020|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56385021|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385022|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56385023|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
56654880|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654881|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56654882|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56385024|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385025|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385026|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
56385027|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385028|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56385029|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385030|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
56385031|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385032|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56385033|NCT00140868|Phenobarbital|phenobarbital|mesh-list
56385034|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
56385035|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56385036|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385037|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385038|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56385039|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56385040|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385045|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56385046|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56385047|NCT00132938|Telithromycin|telithromycin|mesh-list
56385048|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56385049|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385050|NCT01894308|Testosterone|testosterone|mesh-list
56385051|NCT01894308|Androgens|androgens|mesh-ancestor
56385052|NCT01894308|Hormones|hormones|mesh-ancestor
56385053|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385054|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385055|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
56385056|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
56385057|NCT02955706|Vitamins|vitamins|mesh-ancestor
56385058|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
56385059|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385060|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
56385061|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56385062|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
56385063|NCT01244425|Coagulants|coagulants|mesh-ancestor
56385064|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56385065|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56385066|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385067|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56385068|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56385069|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56385070|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385071|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
56385072|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385073|NCT01154439|Cytarabine|cytarabine|mesh-list
56385074|NCT01154439|Etoposide|etoposide|mesh-list
56385075|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
56385076|NCT01154439|Idarubicin|idarubicin|mesh-list
56385077|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
56385078|NCT01154439|Everolimus|everolimus|mesh-list
56385079|NCT01154439|Ifosfamide|ifosfamide|mesh-list
56385080|NCT01154439|Carboplatin|carboplatin|mesh-list
56385081|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56385082|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385083|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56385084|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56385085|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385086|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385087|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56385088|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
56385089|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
56385090|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385091|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385092|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
56385093|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385094|NCT01154439|Analgesics|analgesics|mesh-ancestor
56385095|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
55888742|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654883|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654884|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
56654885|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56654886|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
56654887|NCT00965809|Dronabinol|dronabinol|mesh-list
56385096|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385097|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56385098|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56385099|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
56385100|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
56385102|NCT00133172|Tacrolimus|tacrolimus|mesh-list
56385103|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56385104|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
56385105|NCT00133172|Hormones|hormones|mesh-ancestor
56385106|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385107|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385108|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56385109|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385110|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385111|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
56385112|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56385113|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385115|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56385116|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56385117|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
56385118|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56385119|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385120|NCT00141141|Atorvastatin|atorvastatin|mesh-list
56385121|NCT00141141|Simvastatin|simvastatin|mesh-list
56385122|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56385123|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56385124|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
56385125|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385126|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56385127|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56385128|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385129|NCT00133250|Heparin|heparin|mesh-list
56385130|NCT00133250|Calcium heparin|calcium heparin|mesh-list
56385131|NCT00133250|Abciximab|abciximab|mesh-list
56385132|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
56385133|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56385134|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56385135|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385136|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56385137|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
56385138|NCT00144495|Hematinics|hematinics|mesh-ancestor
56385139|NCT00133328|Valsartan|valsartan|mesh-list
56385140|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56385141|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56385142|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56385143|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385144|NCT00133367|Sirolimus|sirolimus|mesh-list
56385145|NCT00133367|Fludarabine|fludarabine|mesh-list
56385146|NCT00133367|Melphalan|melphalan|mesh-list
56385147|NCT00133367|Tacrolimus|tacrolimus|mesh-list
56385148|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
56385149|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56385150|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385151|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385152|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385153|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
56385154|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385155|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56385156|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385157|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56385158|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385159|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56385160|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
56385161|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56385162|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
56385163|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56385165|NCT00141258|Analgesics|analgesics|mesh-ancestor
56654888|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
56654889|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385166|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
56385167|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385168|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385169|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
56385170|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56385171|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56385172|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385173|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56385174|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56385175|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56385176|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385177|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385179|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56385180|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
56385181|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385182|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385183|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56385184|NCT00403910|Diuretics|diuretics|mesh-ancestor
56385185|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
56385186|NCT00141336|Pregabalin|pregabalin|mesh-list
56385187|NCT00141336|Analgesics|analgesics|mesh-ancestor
56385188|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
56385191|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
56385192|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56385193|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56385194|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385195|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56385196|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56385197|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56385198|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385199|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385200|NCT00133406|Vitamin A|vitamin a|mesh-list
56385201|NCT00133406|Glycine|glycine|mesh-list
56385202|NCT00133406|Vitamins|vitamins|mesh-ancestor
56385203|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
56385204|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385205|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385206|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
56385207|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385208|NCT00133445|Vaccines|vaccines|mesh-list
56385209|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
56385210|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385211|NCT00141375|Pregabalin|pregabalin|mesh-list
56385212|NCT00141375|Analgesics|analgesics|mesh-ancestor
56385213|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
56385214|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385215|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385216|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
56385217|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56385218|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56385219|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385220|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56385221|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56385222|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56385223|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385224|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385225|NCT00133523|Vaccines|vaccines|mesh-list
56385226|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
56385227|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385228|NCT00133562|Glycine|glycine|mesh-list
56385229|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
56385230|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385231|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385232|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385233|NCT00404391|Acetaminophen|acetaminophen|mesh-list
56174426|NCT01750567|Metformin|metformin|mesh-list
56385234|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56385235|NCT00404391|Hydrocodone|hydrocodone|mesh-list
56385236|NCT00404391|Oxycodone|oxycodone|mesh-list
56654890|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56654891|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654892|NCT00965809|Analgesics|analgesics|mesh-ancestor
56654893|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
56654894|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217100|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385237|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56385238|NCT00404391|Analgesics|analgesics|mesh-ancestor
56385239|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
56385240|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385241|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385242|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
56385243|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56385244|NCT00404391|Narcotics|narcotics|mesh-ancestor
56385245|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385246|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
56385247|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
56385248|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56385249|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56385250|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385251|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
56385252|NCT00144807|Rituximab|rituximab|mesh-list
56385253|NCT00144807|Doxorubicin|doxorubicin|mesh-list
56385254|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385255|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
56385256|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385257|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385258|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56385259|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
56385260|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385263|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56385264|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56385265|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56385266|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56385267|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385268|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
56385269|NCT00133640|Vitamin D|vitamin d|mesh-list
56385270|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56385271|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385272|NCT00133640|Vitamins|vitamins|mesh-ancestor
56385273|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
56385274|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56385275|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56385276|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385277|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56385278|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385279|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385280|NCT00404508|Hydralazine|hydralazine|mesh-list
56385281|NCT00404508|Valproic Acid|valproic acid|mesh-list
56385282|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
56385283|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385284|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385285|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
56385286|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385287|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385288|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
56385289|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56385290|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385291|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385292|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56385293|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
56385294|NCT00133757|Bupropion|bupropion|mesh-list
56385295|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56385296|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
56385297|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385298|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56007263|NCT01059929|Narcotics|narcotics|mesh-ancestor
56385299|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56385300|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56654895|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56654896|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56654897|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654898|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654899|NCT00965809|Hormones|hormones|mesh-ancestor
56385301|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385302|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
56385303|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385304|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385305|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56385306|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56385307|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385309|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56385310|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
56385311|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385312|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385313|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56385314|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
56385315|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
56385316|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56385317|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56385318|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56385319|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56385320|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
56385321|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385322|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385323|NCT00133796|Trastuzumab|trastuzumab|mesh-list
56385324|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56385325|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385326|NCT00133874|Retapamulin|retapamulin|mesh-list
56385327|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56385328|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385329|NCT00141414|Pregabalin|pregabalin|mesh-list
56385330|NCT00141414|Analgesics|analgesics|mesh-ancestor
56385331|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
56385332|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385335|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56385336|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56385337|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385338|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56385339|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56385340|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56385341|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385343|NCT00145002|Lenograstim|lenograstim|mesh-list
56385344|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56385345|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
56385346|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385347|NCT00134030|Interferons|interferons|mesh-list
56385348|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
56385349|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
56385350|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56385351|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56385352|NCT00134030|Cisplatin|cisplatin|mesh-list
56385353|NCT00134030|Doxorubicin|doxorubicin|mesh-list
56385354|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56385355|NCT00134030|Methotrexate|methotrexate|mesh-list
56385356|NCT00134030|Etoposide|etoposide|mesh-list
56385357|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
56385358|NCT00134030|Ifosfamide|ifosfamide|mesh-list
56385359|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
56385360|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
56385361|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385362|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56385363|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56385364|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56385365|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385366|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385367|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56385368|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
56654900|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654901|NCT00885378|Metformin|metformin|mesh-list
56654902|NCT00885378|Saxagliptin|saxagliptin|mesh-list
56654903|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56129793|NCT02914158|Tamoxifen|tamoxifen|mesh-list
56385369|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56385370|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385371|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56385372|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
56385373|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
56385374|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56385375|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385376|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
56385377|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385378|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56385379|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56385380|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
56385381|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385382|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56385383|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
56385384|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
56385385|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
56385386|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
56385387|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
56385388|NCT00141492|Testosterone|testosterone|mesh-list
56385389|NCT00141492|Androgens|androgens|mesh-ancestor
56385390|NCT00141492|Hormones|hormones|mesh-ancestor
56385391|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385392|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385393|NCT00141531|Apaziquone|apaziquone|mesh-list
56385394|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385395|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56385396|NCT00134069|Cetuximab|cetuximab|mesh-list
56385397|NCT00134069|Irinotecan|irinotecan|mesh-list
56385398|NCT00134069|Sorafenib|sorafenib|mesh-list
56385399|NCT00134069|Antibodies|antibodies|mesh-list
56385400|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
56385401|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56385402|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
56385403|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385404|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385405|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56385406|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56385407|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899464|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56385410|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
56385411|NCT00141570|Estrogens|estrogens|mesh-list
56385412|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
56385413|NCT00141570|Testosterone|testosterone|mesh-list
56385414|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
56385415|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
56385416|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56385417|NCT00141570|Hormones|hormones|mesh-ancestor
56385418|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385419|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385420|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56385421|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385423|NCT00141570|Androgens|androgens|mesh-ancestor
56385424|NCT00134147|Insulin|insulin|mesh-list
56385425|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56385426|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385427|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
56385428|NCT00403988|Vinorelbine|vinorelbine|mesh-list
56385429|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385430|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56385431|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
56385432|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
56385433|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
56385434|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385435|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
56385436|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385437|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56385438|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
56385439|NCT00141648|Prednisolone|prednisolone|mesh-list
56654904|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654905|NCT00885378|Incretins|incretins|mesh-ancestor
56654906|NCT00885378|Hormones|hormones|mesh-ancestor
55784696|NCT03227263|Bevacizumab|bevacizumab|mesh-list
56385440|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
56385441|NCT00141648|Doxorubicin|doxorubicin|mesh-list
56385442|NCT00141648|Vincristine|vincristine|mesh-list
56385443|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385444|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
56385445|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385446|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385447|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56385448|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
56385449|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385450|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385451|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56385452|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56385453|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56385454|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56385455|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385456|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56385457|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
56385458|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
56385459|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
56385460|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56385461|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
56385462|NCT00141648|Hormones|hormones|mesh-ancestor
56385463|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385464|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56385465|NCT00134420|Clonidine|clonidine|mesh-list
56385466|NCT00134420|Mitogens|mitogens|mesh-list
56385467|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385468|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
56385469|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385470|NCT00134420|Analgesics|analgesics|mesh-ancestor
56385471|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
56385472|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385473|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56385474|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
56385475|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
56385476|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56385477|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56385478|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56385479|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
56385480|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385481|NCT00141804|Sirolimus|sirolimus|mesh-list
56385484|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56385485|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385486|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
56001980|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56385487|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385488|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
56385489|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385490|NCT00134498|Atorvastatin|atorvastatin|mesh-list
56385491|NCT00134498|Torcetrapib|torcetrapib|mesh-list
56385492|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56385493|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56385494|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
56385495|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385496|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56385497|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56385498|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385499|NCT00141843|Factor VIII|factor viii|mesh-list
56385500|NCT00141843|Coagulants|coagulants|mesh-ancestor
56385501|NCT00141882|Memantine|memantine|mesh-list
56385502|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56385503|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56385504|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
56385505|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385506|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385507|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385508|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56385509|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56217114|NCT01629511|Antiviral Agents|antiviral agents|mesh-ancestor
56385510|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56385511|NCT00152295|Estrogens|estrogens|mesh-ancestor
56385512|NCT00152295|Hormones|hormones|mesh-ancestor
56385513|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385514|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385515|NCT00152373|Levetiracetam|levetiracetam|mesh-list
56385516|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
56385517|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
56385518|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56385519|NCT00134654|Estrogens|estrogens|mesh-ancestor
56385520|NCT00134654|Hormones|hormones|mesh-ancestor
56385521|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385522|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385523|NCT00141960|Famotidine|famotidine|mesh-list
56385524|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56385525|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56385526|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56385527|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
56385528|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
56385529|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385530|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385531|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385532|NCT00134693|Prednisolone|prednisolone|mesh-list
56385533|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56385534|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
56385535|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56385536|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
56385537|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56385538|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
56385539|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56385540|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
56385541|NCT00134693|Hormones|hormones|mesh-ancestor
56385542|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385543|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385544|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56385545|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385546|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
56385547|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
56385548|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385549|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56385550|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56385551|NCT00134693|Protective Agents|protective agents|mesh-ancestor
56385552|NCT00152412|Levocetirizine|levocetirizine|mesh-list
56385553|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56385556|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
56385557|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385558|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385559|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385560|NCT00142038|Docetaxel|docetaxel|mesh-list
56385562|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385563|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
56385564|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
56385565|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56385566|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385567|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56385568|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
56385569|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
56385570|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56385571|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56385572|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56385573|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56385574|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385575|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
56385576|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385577|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385578|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56385579|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385580|NCT02964455|Docetaxel|docetaxel|mesh-list
56385581|NCT02964455|Nedaplatin|nedaplatin|mesh-list
56385582|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385583|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
56385584|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
56385585|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
56654907|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56654908|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56654909|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
56654910|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300989|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654911|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654913|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56654914|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
56654915|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
56385586|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385587|NCT00142155|Rituximab|rituximab|mesh-list
56385588|NCT00142155|Antibodies|antibodies|mesh-list
56385589|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56385590|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
56385591|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385592|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56385593|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385594|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385595|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
56385596|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385597|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
56385598|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385599|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385600|NCT00134888|Buprenorphine|buprenorphine|mesh-list
56385601|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56385603|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56385604|NCT00134888|Narcotics|narcotics|mesh-ancestor
56385605|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385606|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385607|NCT00134888|Analgesics|analgesics|mesh-ancestor
56385608|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
56385609|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385610|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56385611|NCT00134966|Levodopa|levodopa|mesh-list
56385612|NCT00134966|Carbidopa|carbidopa|mesh-list
56385613|NCT00134966|Entacapone|entacapone|mesh-list
56385614|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56385615|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56385616|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
56385617|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385618|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385619|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385620|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56385621|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385622|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56385623|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
56385624|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385625|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56385626|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385627|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385628|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
56385631|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385632|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385633|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385635|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56385636|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385637|NCT04725357|Meloxicam|meloxicam|mesh-list
56385638|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56385639|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56385640|NCT04725357|Analgesics|analgesics|mesh-ancestor
56385641|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
56385642|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385643|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654916|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56654917|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654918|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824299|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
56385644|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56385645|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385646|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56385647|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56385648|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385649|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385650|NCT00135122|Prednisolone|prednisolone|mesh-list
56385651|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56385652|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
56385653|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56385654|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
56385655|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56385656|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
56385657|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56385658|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
56385659|NCT00135122|Hormones|hormones|mesh-ancestor
56385660|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385661|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385662|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56385663|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385664|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
56385665|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
56385666|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385667|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56385668|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56385669|NCT00135122|Protective Agents|protective agents|mesh-ancestor
56385670|NCT00142350|Fluorouracil|fluorouracil|mesh-list
56385671|NCT00142350|Irinotecan|irinotecan|mesh-list
56385672|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385673|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
56385674|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385675|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56385676|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385677|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
56385678|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385679|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56385680|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56385681|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385682|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
56385683|NCT00135317|Hematinics|hematinics|mesh-ancestor
56385684|NCT00152646|Clopidogrel|clopidogrel|mesh-list
56385685|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56385686|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56385687|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56385688|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56385689|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
56385690|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385691|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385692|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385693|NCT00135434|Ritonavir|ritonavir|mesh-list
56385694|NCT00135434|Lopinavir|lopinavir|mesh-list
56385695|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56385696|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56385697|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56385698|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
56385699|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385700|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385701|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56385706|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56385708|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56385709|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56385710|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56385711|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385712|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
56385713|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
56385714|NCT00142428|Cetuximab|cetuximab|mesh-list
56385715|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56654919|NCT04095494|Analgesics|analgesics|mesh-ancestor
56654920|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
55824362|NCT02260388|Mexiletine|mexiletine|mesh-list
56385716|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385717|NCT00135551|Benidipine|benidipine|mesh-list
56385718|NCT00135551|Diuretics|diuretics|mesh-list
56385719|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56385720|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56385721|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56385722|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
56385723|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385724|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385725|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56385726|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56385727|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
56385728|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385729|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56385730|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56385731|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
56385732|NCT00152724|Aspirin|aspirin|mesh-list
56385733|NCT00152724|Celecoxib|celecoxib|mesh-list
56385734|NCT00152724|Indomethacin|indomethacin|mesh-list
56385735|NCT00152724|Nitroprusside|nitroprusside|mesh-list
56385736|NCT00152724|Acetylcholine|acetylcholine|mesh-list
56385737|NCT00152724|Capsaicin|capsaicin|mesh-list
56385738|NCT00152724|Clopidogrel|clopidogrel|mesh-list
56385739|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56385740|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56385741|NCT00152724|Analgesics|analgesics|mesh-ancestor
56385742|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
56385743|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385744|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385745|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56385746|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385747|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56385748|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56385749|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385750|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56007719|NCT00002896|Cobalt|cobalt|mesh-list
56385751|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56385752|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385753|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
56385754|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56385755|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56385756|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56385757|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
56385758|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385759|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56385760|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
56385761|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
56385762|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
56385763|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
56001992|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56385764|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56385765|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56385766|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
56385767|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56385768|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56385769|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
56385770|NCT00135668|Nitroprusside|nitroprusside|mesh-list
56385771|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56385773|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56385774|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385776|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
56385777|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385778|NCT00135746|Nicotine|nicotine|mesh-list
56385779|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56385780|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
56385781|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385782|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385783|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56385784|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56385785|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
56385786|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888743|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
56654921|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654922|NCT02537210|Mesalamine|mesalamine|mesh-list
56654923|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56654924|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654925|NCT02537210|Analgesics|analgesics|mesh-ancestor
56654926|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
56654927|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385787|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385788|NCT00135785|Bupropion|bupropion|mesh-list
56385789|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56385790|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
56385791|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385792|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56385793|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56385794|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56174530|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385795|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385797|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385798|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385799|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56385800|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56385801|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385802|NCT00159081|Haloperidol|haloperidol|mesh-list
56385803|NCT00159081|Risperidone|risperidone|mesh-list
56385804|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
56385805|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56385806|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
56385807|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385808|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385809|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385810|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56385811|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56385812|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385813|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385814|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56385815|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
56385816|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
56385817|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
56385818|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385819|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56385820|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56385821|NCT00152841|Vitamin E|vitamin e|mesh-list
56385822|NCT00152841|Vitamins|vitamins|mesh-ancestor
56385823|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
56385824|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007789|NCT00002902|Irinotecan|irinotecan|mesh-list
56385825|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
56385826|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385827|NCT00152841|Protective Agents|protective agents|mesh-ancestor
56385828|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
56385829|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56385830|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56385831|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385832|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56385833|NCT00159159|Cyclosporine|cyclosporine|mesh-list
56385834|NCT00159159|Cyclosporins|cyclosporins|mesh-list
56385835|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385836|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385837|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385838|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
56385839|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385840|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
56385841|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385842|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
56385843|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899915|NCT00113217|Bevacizumab|bevacizumab|mesh-list
56385847|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56385848|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
56654928|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654929|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56654930|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654931|NCT01563289|Ibuprofen|ibuprofen|mesh-list
56217133|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
56385849|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
56385850|NCT00135863|Tinzaparin|tinzaparin|mesh-list
56385851|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56385852|NCT00135863|Dalteparin|dalteparin|mesh-list
56385853|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
56385854|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56385855|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56385856|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385857|NCT00135902|Progesterone|progesterone|mesh-list
56385858|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56385859|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56385860|NCT00135902|Progestins|progestins|mesh-ancestor
56385861|NCT00135902|Hormones|hormones|mesh-ancestor
56385862|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56385863|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385864|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56385865|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
56385866|NCT00135941|Insulin|insulin|mesh-list
56385867|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56385868|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
56385869|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
56385870|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56385871|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385872|NCT00152919|Meloxicam|meloxicam|mesh-list
56385873|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56385874|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56385875|NCT00152919|Analgesics|analgesics|mesh-ancestor
56385876|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
56385877|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385878|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385879|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56385880|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56385881|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56385882|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56385883|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385884|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385885|NCT00406146|Artesunate|artesunate|mesh-list
56385886|NCT00406146|Lumefantrine|lumefantrine|mesh-list
56385887|NCT00406146|Artemether|artemether|mesh-list
56385888|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56385889|NCT00406146|Amodiaquine|amodiaquine|mesh-list
56385890|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
56385891|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56385892|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56385893|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385894|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385895|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
56385896|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
56385897|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56385898|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
56385899|NCT00136058|Alendronate|alendronate|mesh-list
56385901|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56385902|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385903|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56385904|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56385905|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385906|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56385907|NCT00152958|Pramipexole|pramipexole|mesh-list
56385908|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
56385909|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385910|NCT00152958|Protective Agents|protective agents|mesh-ancestor
56385911|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385912|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56385913|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56385914|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
56385915|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
56385916|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654932|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56654933|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56654934|NCT01563289|Analgesics|analgesics|mesh-ancestor
56654935|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
56654936|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654937|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654938|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56654939|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56654940|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56217145|NCT01629680|Moxaverine|moxaverine|mesh-list
56385917|NCT00136175|Gemcitabine|gemcitabine|mesh-list
56385918|NCT00136175|Paclitaxel|paclitaxel|mesh-list
56385919|NCT00136175|Carboplatin|carboplatin|mesh-list
56385920|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56385928|NCT00136175|Antiviral Agents|antiviral agents|mesh-ancestor
56385929|NCT00136175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385930|NCT00136175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385931|NCT00136175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385932|NCT00136175|Immunologic Factors|immunologic factors|mesh-ancestor
56385933|NCT00136175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385934|NCT00152997|Pramipexole|pramipexole|mesh-list
56385935|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
56385936|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385937|NCT00152997|Protective Agents|protective agents|mesh-ancestor
56385938|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385939|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56385940|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56385941|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
56385942|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
56385943|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385945|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56385946|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385947|NCT00153075|Fenoterol|fenoterol|mesh-list
56385948|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
56385949|NCT00153075|Ipratropium|ipratropium|mesh-list
56385950|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56385951|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
56385952|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385953|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385954|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56385955|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
56385956|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
56385957|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
56385958|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56385959|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56385960|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56385961|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56385962|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
56385963|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385964|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385965|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56385966|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
56385967|NCT00159471|Gemcitabine|gemcitabine|mesh-list
56385968|NCT00159471|Capecitabine|capecitabine|mesh-list
56385969|NCT00159471|Docetaxel|docetaxel|mesh-list
56385970|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56385971|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
56385972|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385973|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385975|NCT00159471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385976|NCT00159471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56385977|NCT00159471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56385978|NCT00159471|Immunologic Factors|immunologic factors|mesh-ancestor
56385979|NCT00159471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385980|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
56385981|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
56654941|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654942|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385982|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
56385983|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
56385984|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56385985|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385986|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
56385987|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
56385988|NCT00159510|Methylene Blue|methylene blue|mesh-list
56385989|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56385990|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
56385998|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56385999|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56386000|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
56386001|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
56386002|NCT00159510|Protective Agents|protective agents|mesh-ancestor
56386003|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386004|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
56386005|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386006|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56386007|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386008|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386009|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56386010|NCT00153114|Laxatives|laxatives|mesh-ancestor
56386011|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56386012|NCT00136448|Cytarabine|cytarabine|mesh-list
56386013|NCT00136448|Interleukin-2|interleukin-2|mesh-list
56386014|NCT00136448|Daunorubicin|daunorubicin|mesh-list
56386015|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56386016|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
56386017|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386018|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386019|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
56386020|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386021|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56386022|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
56386023|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386024|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386025|NCT00136448|Analgesics|analgesics|mesh-ancestor
56386026|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
56386027|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386028|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56386029|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56386030|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56386031|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386032|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56386033|NCT00153153|Laxatives|laxatives|mesh-ancestor
56386034|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56386035|NCT00136487|Celecoxib|celecoxib|mesh-list
56386036|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386037|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386038|NCT00136487|Analgesics|analgesics|mesh-ancestor
56386039|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
56386040|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386041|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386042|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386043|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386044|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56386045|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56386046|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386047|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386048|NCT00153192|Dronabinol|dronabinol|mesh-list
56386049|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
56386050|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386051|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56386052|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386053|NCT00153192|Analgesics|analgesics|mesh-ancestor
56386054|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
56386055|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386056|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55900132|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
56386063|NCT00136526|Fosfestrol|fosfestrol|mesh-list
56386064|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
56386065|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654943|NCT00960973|Menatetrenone|menatetrenone|mesh-list
56654944|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
56654945|NCT00960973|Coagulants|coagulants|mesh-ancestor
56654946|NCT04099849|Zinc|zinc|mesh-list
56654947|NCT04099849|Trace Elements|trace elements|mesh-ancestor
56654948|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
56654949|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654950|NCT00659100|Gabapentin|gabapentin|mesh-list
56654951|NCT00659100|Analgesics|analgesics|mesh-ancestor
56217150|NCT01629732|Ribavirin|ribavirin|mesh-list
56386066|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
56386067|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
56386068|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
56386069|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386070|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56386071|NCT00136526|Estrogens|estrogens|mesh-ancestor
56386072|NCT00136526|Hormones|hormones|mesh-ancestor
56386073|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386074|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386075|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56386076|NCT00136565|Prednisone|prednisone|mesh-list
56386077|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
56386078|NCT00136565|Doxorubicin|doxorubicin|mesh-list
56386079|NCT00136565|Bortezomib|bortezomib|mesh-list
56386080|NCT00136565|Bleomycin|bleomycin|mesh-list
56386081|NCT00136565|Vindesine|vindesine|mesh-list
56386082|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56386083|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
56386084|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386085|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386086|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56386087|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
56386088|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386089|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386090|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56386091|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56386092|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56386093|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56386094|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386095|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386096|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
56386097|NCT00136565|Hormones|hormones|mesh-ancestor
56386098|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386099|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56386100|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56386101|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
56386102|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
56386103|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
56386104|NCT00159627|Rolofylline|rolofylline|mesh-list
56386105|NCT00159627|Diuretics|diuretics|mesh-ancestor
56386106|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
56386107|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386108|NCT00159666|Pregabalin|pregabalin|mesh-list
56386109|NCT00159666|Analgesics|analgesics|mesh-ancestor
56386110|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
56386111|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002029|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386112|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386113|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
56386114|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56386115|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56386116|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386117|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56386118|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56386119|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56386120|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56386121|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56386122|NCT00153270|Valproic Acid|valproic acid|mesh-list
56386123|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
56654952|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
56654953|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56654954|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654955|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
56654956|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56654957|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56654958|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56386124|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900200|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
56386141|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386142|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56386144|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56386145|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56386146|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56386147|NCT00136994|Ziprasidone|ziprasidone|mesh-list
56386148|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56386149|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
56386150|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386151|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386152|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386153|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56386154|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56386155|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56386156|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56386157|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56386158|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
56386159|NCT00137033|Celecoxib|celecoxib|mesh-list
56386160|NCT00137033|Naproxen|naproxen|mesh-list
56386161|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386162|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386163|NCT00137033|Analgesics|analgesics|mesh-ancestor
56386164|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
56386165|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386166|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386167|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386168|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386169|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56386170|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56386171|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386172|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386173|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
56386174|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
56165343|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386175|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386176|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
56386177|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56386178|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56386179|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386180|NCT00137072|Urological Agents|urological agents|mesh-ancestor
56386181|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
56174597|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
56386183|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386184|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
56386185|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386186|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
56386187|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56386188|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56386189|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386190|NCT00159900|Urological Agents|urological agents|mesh-ancestor
56386191|NCT00159978|Alovudine|alovudine|mesh-list
56386192|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
56386193|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386194|NCT00137345|Sirolimus|sirolimus|mesh-list
56386195|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56386196|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386197|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56654959|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56654960|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56654961|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56654962|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654963|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654964|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
55825486|NCT04192136|Niacin|niacin|mesh-list
56386198|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386199|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
56386200|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56386201|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
56386202|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386203|NCT00137462|Atorvastatin|atorvastatin|mesh-list
56386204|NCT00137462|Torcetrapib|torcetrapib|mesh-list
56386205|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56386206|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56386207|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
56386208|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386209|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56386210|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56386211|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386212|NCT00153543|Vaccines|vaccines|mesh-list
56386213|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56386214|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
56386215|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386216|NCT00137501|Nifedipine|nifedipine|mesh-list
56386217|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56386218|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56386219|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386220|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56386221|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386222|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
56386223|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
56386224|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56386225|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56386226|NCT00153660|Celecoxib|celecoxib|mesh-list
56386227|NCT00153660|Naproxen|naproxen|mesh-list
56386228|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56165344|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
56386229|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386230|NCT00153660|Analgesics|analgesics|mesh-ancestor
56386231|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
56386232|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386233|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386234|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386235|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386236|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56386237|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56386238|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386239|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386240|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
56386241|NCT00137657|Trimethoprim|trimethoprim|mesh-list
56386242|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56386243|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
56386244|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56386245|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386246|NCT00137657|Renal Agents|renal agents|mesh-ancestor
56386247|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
56386248|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56386249|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56386250|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56386251|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386252|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386253|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56386260|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386262|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56386263|NCT00137735|Gabapentin|gabapentin|mesh-list
56654965|NCT00659178|Doxorubicin|doxorubicin|mesh-list
56654966|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56654967|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56654968|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56654969|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56654970|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56654971|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56654972|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654973|NCT02792621|Acipimox|acipimox|mesh-list
56654974|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56654975|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
56654976|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654977|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56654978|NCT04009759|Ketamine|ketamine|mesh-list
56386264|NCT00137735|Analgesics|analgesics|mesh-ancestor
56386265|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
56386266|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386267|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386268|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
56386269|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56386270|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56386271|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56386272|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56386273|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56386274|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56386275|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386276|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386277|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
56386279|NCT00137774|Temozolomide|temozolomide|mesh-list
56386280|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56386281|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386282|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56386283|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56386284|NCT00137774|Growth Substances|growth substances|mesh-ancestor
56386285|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386286|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
56386287|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56386288|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
56386289|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386290|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56386291|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56386292|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56386293|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
56386294|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386295|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386296|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56386297|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56386298|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
56386299|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386300|NCT00137813|Bevacizumab|bevacizumab|mesh-list
56386301|NCT00137813|Docetaxel|docetaxel|mesh-list
56386302|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56386303|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386304|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56386305|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56386306|NCT00137813|Growth Substances|growth substances|mesh-ancestor
56386307|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386308|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
56386309|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
56386310|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
56654979|NCT04009759|Morphine|morphine|mesh-list
56654980|NCT04009759|Analgesics|analgesics|mesh-ancestor
56654981|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
56654982|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301061|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56386311|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
56386312|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386313|NCT00137852|Celecoxib|celecoxib|mesh-list
56386314|NCT00137852|Irinotecan|irinotecan|mesh-list
56386315|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386316|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56386317|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56386318|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386319|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386320|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386321|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386322|NCT00137852|Analgesics|analgesics|mesh-ancestor
56386325|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386326|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386327|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386328|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56386329|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56386331|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386332|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386333|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56386334|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56386335|NCT00153933|Lenalidomide|lenalidomide|mesh-list
56386336|NCT00153933|Bortezomib|bortezomib|mesh-list
56386337|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
56386338|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386339|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56386340|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56386341|NCT00153933|Growth Substances|growth substances|mesh-ancestor
56386342|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
56386343|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386344|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
56386345|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386346|NCT00153972|Levodopa|levodopa|mesh-list
56386347|NCT00153972|Cabergoline|cabergoline|mesh-list
56386348|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56008318|NCT00003418|Exemestane|exemestane|mesh-list
56386349|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56386350|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
56386351|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386352|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386353|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386354|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
56386356|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56386357|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386358|NCT00404183|Acetaminophen|acetaminophen|mesh-list
56386359|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56386360|NCT00404183|Hydrocodone|hydrocodone|mesh-list
56386361|NCT00404183|Oxycodone|oxycodone|mesh-list
56386362|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386363|NCT00404183|Analgesics|analgesics|mesh-ancestor
56386364|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
56386365|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386366|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386367|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
56386368|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56386369|NCT00404183|Narcotics|narcotics|mesh-ancestor
56386370|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56386371|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
56386372|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
56386373|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386374|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386375|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386376|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
56386377|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56386378|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386379|NCT00404222|Acetaminophen|acetaminophen|mesh-list
56654983|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56654984|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56654985|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56654986|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
56654987|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
56654988|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217171|NCT01630018|Belotecan|belotecan|mesh-list
56386380|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56386381|NCT00404222|Hydrocodone|hydrocodone|mesh-list
56386383|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386384|NCT00404222|Analgesics|analgesics|mesh-ancestor
56386385|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
56386386|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386387|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386388|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
56386389|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56386390|NCT00404222|Narcotics|narcotics|mesh-ancestor
56386391|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56386392|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
56386393|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
56386394|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386395|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386396|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386397|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
56386402|NCT00138242|Carboplatin|carboplatin|mesh-list
56386404|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386405|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
56386406|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
56386407|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
56386408|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386409|NCT00154050|Candesartan|candesartan|mesh-list
56386410|NCT00154050|Quinapril|quinapril|mesh-list
56386411|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56386412|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56386413|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56386414|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386415|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56386416|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
56386417|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386418|NCT00154089|Masoprocol|masoprocol|mesh-list
56386419|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
56386420|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386421|NCT00154089|Protective Agents|protective agents|mesh-ancestor
56386422|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386423|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56386424|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386425|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56386426|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386427|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386429|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
56386430|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386431|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386432|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386433|NCT00138359|Niclosamide|niclosamide|mesh-list
56386434|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
56386435|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56386436|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
56386437|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56386438|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386439|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
56386440|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
56386441|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386442|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
56386443|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
56386444|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
56386445|NCT00154167|Phentolamine|phentolamine|mesh-list
56386446|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56386447|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56386448|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
56654989|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56654990|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56654991|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56654992|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56654993|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56654994|NCT04009759|Narcotics|narcotics|mesh-ancestor
56386449|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165345|NCT00002838|Fludarabine|fludarabine|mesh-list
56386450|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386451|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386452|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56386453|NCT00138515|Vildagliptin|vildagliptin|mesh-list
56386454|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56386455|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386456|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56386457|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
56386458|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386459|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386460|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
56386461|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56386462|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386463|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56386464|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
56386465|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56386466|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386467|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900560|NCT00240981|Hormones|hormones|mesh-ancestor
56386476|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386478|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56386479|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386480|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56386481|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
56386482|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386483|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386484|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
56386485|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56386486|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386487|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56386488|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
56386489|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56386490|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386491|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386492|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386493|NCT00138632|Vatalanib|vatalanib|mesh-list
56386494|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56386495|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386496|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386497|NCT00160875|Irinotecan|irinotecan|mesh-list
56386498|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386499|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56386500|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56386501|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386502|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386504|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386505|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56386506|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56386507|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386508|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386509|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56386510|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
56386511|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386512|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386513|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
56386514|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
56386515|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56654995|NCT00645086|Clarithromycin|clarithromycin|mesh-list
56654996|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56654997|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56654998|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56654999|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386516|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56386517|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56174650|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
56386518|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386519|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56386520|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56386521|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
56386523|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56386524|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386525|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56386526|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386527|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56386528|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
56386529|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
56386530|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56386533|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386534|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56386535|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56386537|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56386538|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56386539|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56386540|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386541|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
56386542|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386543|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386544|NCT00154401|Liraglutide|liraglutide|mesh-list
56386545|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56386546|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386547|NCT00154401|Incretins|incretins|mesh-ancestor
56386548|NCT00154401|Hormones|hormones|mesh-ancestor
56386549|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386550|NCT00138944|Eplerenone|eplerenone|mesh-list
56386551|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56386552|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
56386553|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386554|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386555|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56386556|NCT00138944|Diuretics|diuretics|mesh-ancestor
56386557|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
56386558|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56386559|NCT00161070|Aspirin|aspirin|mesh-list
56386560|NCT00161070|Dipyridamole|dipyridamole|mesh-list
56386561|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386562|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386563|NCT00161070|Analgesics|analgesics|mesh-ancestor
56386564|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
56386565|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386566|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386567|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386568|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386569|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56386570|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56386571|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386572|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56386573|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56386574|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386575|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
56386576|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56386577|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
56386578|NCT00138983|Vitamin D|vitamin d|mesh-list
56386579|NCT00138983|Alendronate|alendronate|mesh-list
56386580|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
56655000|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655001|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56655002|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56386581|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56386582|NCT00138983|Vitamins|vitamins|mesh-ancestor
56386583|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
56386584|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386585|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56386586|NCT01243177|Lacosamide|lacosamide|mesh-list
56386587|NCT01243177|Carbamazepine|carbamazepine|mesh-list
56386588|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
56386589|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56386590|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56386591|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56386592|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386593|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
56386594|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56386595|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56386596|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386597|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56386598|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386599|NCT01243177|Analgesics|analgesics|mesh-ancestor
56386600|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
55900698|NCT03183492|Vaccines|vaccines|mesh-list
56386603|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56386605|NCT00154440|Metronidazole|metronidazole|mesh-list
56386606|NCT00154440|Clarithromycin|clarithromycin|mesh-list
56386607|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56386608|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56386609|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386610|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56386611|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56386612|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56386613|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386614|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386615|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56386616|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56386617|NCT00139061|Atorvastatin|atorvastatin|mesh-list
56386618|NCT00139061|Torcetrapib|torcetrapib|mesh-list
56386619|NCT00139061|Fenofibrate|fenofibrate|mesh-list
56386620|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56386621|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56386622|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
56386623|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386624|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56386625|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56386626|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386627|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
56386628|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56386629|NCT04705584|Cyclosporine|cyclosporine|mesh-list
56386630|NCT04705584|Prednisolone|prednisolone|mesh-list
56386631|NCT04705584|Cyclosporins|cyclosporins|mesh-list
56386632|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386633|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386634|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56386635|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
56386636|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386637|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
56386638|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386639|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
56386640|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386641|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56386642|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386643|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
56386644|NCT04705584|Hormones|hormones|mesh-ancestor
56386645|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386646|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56002073|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
56386648|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
56386649|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56386650|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
56655003|NCT05238649|Vaccines|vaccines|mesh-list
56655004|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
56655005|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655006|NCT02792153|Estradiol|estradiol|mesh-list
56655007|NCT02792153|Estrogens|estrogens|mesh-ancestor
56655008|NCT02792153|Hormones|hormones|mesh-ancestor
56655009|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55793403|NCT05505825|Chiauranib|chiauranib|mesh-list
56386651|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386652|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386653|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56386654|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
56386655|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56386656|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
56386657|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386658|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386659|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56386660|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
56386661|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
56386662|NCT00139217|Protective Agents|protective agents|mesh-ancestor
56386663|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
56386664|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56386665|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
56386666|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56386667|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386668|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56386669|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56386670|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56386671|NCT00139256|Betamethasone|betamethasone|mesh-list
56386672|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386675|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386677|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56386678|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
56386679|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
56386680|NCT00161304|Testosterone|testosterone|mesh-list
56386681|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
56386682|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
56386683|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56386684|NCT00161304|Androgens|androgens|mesh-ancestor
56386685|NCT00161304|Hormones|hormones|mesh-ancestor
56386686|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386687|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386688|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56386689|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386690|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
56386691|NCT01242748|Goserelin|goserelin|mesh-list
56386692|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56386693|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386694|NCT00139373|Donepezil|donepezil|mesh-list
56386695|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56386696|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386697|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386698|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
56386699|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386700|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386701|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
56386702|NCT00161421|Leuprolide|leuprolide|mesh-list
56386703|NCT00161421|Testosterone|testosterone|mesh-list
56386704|NCT00161421|Dutasteride|dutasteride|mesh-list
56386705|NCT00161421|Androgens|androgens|mesh-ancestor
56386706|NCT00161421|Hormones|hormones|mesh-ancestor
56386707|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386708|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386709|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56386710|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386711|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56386712|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
56386713|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56655010|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655011|NCT00644540|Vaccines|vaccines|mesh-list
56655012|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
56655013|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655014|NCT02669732|Firuglipel|firuglipel|mesh-list
56655015|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56386714|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56386715|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56386716|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386717|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386718|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
56386719|NCT00139568|Tegaserod|tegaserod|mesh-list
56386720|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56008690|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56386721|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
56386722|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386723|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386724|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386725|NCT00139646|Diclofenac|diclofenac|mesh-list
56386727|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386728|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386729|NCT00139646|Analgesics|analgesics|mesh-ancestor
56386730|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
56386731|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386732|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386733|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386734|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386735|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56386736|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386737|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386738|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56386739|NCT00406302|Docetaxel|docetaxel|mesh-list
56386740|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
56386741|NCT00406302|Cetuximab|cetuximab|mesh-list
56386742|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386743|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
56386744|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
56386745|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
56386747|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56386748|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56386750|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
56386751|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56386752|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386753|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56386754|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56386755|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56386756|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56386757|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386758|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56386759|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56386760|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56386761|NCT00406341|Difluprednate|difluprednate|mesh-list
56386762|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
56386763|NCT00406341|Hormones|hormones|mesh-ancestor
56386764|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386765|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386766|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56386767|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56386768|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56386769|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
56386770|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386771|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386772|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386773|NCT00139724|Urological Agents|urological agents|mesh-ancestor
56386774|NCT00161577|Ketorolac|ketorolac|mesh-list
56386775|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386776|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386777|NCT00161577|Analgesics|analgesics|mesh-ancestor
56386778|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
56655016|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655017|NCT05003245|Ranibizumab|ranibizumab|mesh-list
56655018|NCT05003245|Antibodies|antibodies|mesh-list
56655019|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56655020|NCT05003245|Mitogens|mitogens|mesh-list
56386779|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386780|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386781|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386782|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386783|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56386784|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386785|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386786|NCT00404261|Fluticasone|fluticasone|mesh-list
56386787|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56386788|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56386789|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386790|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56386791|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
56386792|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386793|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386794|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56386795|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
56386796|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
56386797|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56386798|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56386799|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56386800|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56386801|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
56386802|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386803|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386804|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
56386805|NCT00404261|Hormones|hormones|mesh-ancestor
56386806|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386807|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
56386808|NCT00406380|Bevacizumab|bevacizumab|mesh-list
56386809|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56386810|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386811|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56386812|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56386813|NCT00406380|Growth Substances|growth substances|mesh-ancestor
56386814|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386815|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
56386824|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
56386825|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56386826|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386827|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56386828|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
56386829|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386830|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386831|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
56386832|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386833|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56386834|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56386835|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
56386836|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386837|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56386838|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56386839|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56386840|NCT00161655|Analgesics|analgesics|mesh-ancestor
56386841|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
56386842|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386843|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56386844|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56386845|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56386846|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
56386847|NCT00161733|Coagulants|coagulants|mesh-ancestor
56386848|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56386849|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56386850|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
55919632|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
56655021|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
56655022|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
56655023|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655024|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
56386851|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386852|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386853|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56386854|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56386855|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
56386856|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386857|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56386858|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56386859|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
56386861|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386862|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386863|NCT04724187|Misoprostol|misoprostol|mesh-list
56386864|NCT04724187|Oxytocin|oxytocin|mesh-list
56386865|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
56386866|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56386867|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386868|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56386869|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
56386870|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56386871|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56386872|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
56386873|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56386874|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
56386875|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56386876|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
56386877|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386878|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386879|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
56386880|NCT04724226|Apatinib|apatinib|mesh-list
56386881|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386882|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56386883|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386887|NCT04724343|Cetrorelix|cetrorelix|mesh-list
56386888|NCT04724343|Menotropins|menotropins|mesh-list
56386889|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
56386890|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56386891|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
56386892|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56386893|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386894|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56386895|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56386896|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386897|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56386898|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
56386899|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
56386900|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386901|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
56386902|NCT00140075|Epirubicin|epirubicin|mesh-list
56386904|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56386905|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
56386906|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386907|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386908|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56386909|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
56386910|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386911|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386912|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56386913|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56386914|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56386915|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56386916|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386917|NCT00140114|Misoprostol|misoprostol|mesh-list
56386918|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56386919|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
56386920|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56386921|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655025|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655026|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56655027|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56217203|NCT01630096|Laxatives|laxatives|mesh-ancestor
56386922|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56386923|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56386924|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
56386925|NCT00140153|Testosterone|testosterone|mesh-list
56386926|NCT00140153|Androgens|androgens|mesh-ancestor
56386927|NCT00140153|Hormones|hormones|mesh-ancestor
56386928|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386929|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386930|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
56386931|NCT00140309|Rifampin|rifampin|mesh-list
56386932|NCT00140309|Isoniazid|isoniazid|mesh-list
56386933|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
56386934|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56386935|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174677|NCT01385228|Prednisone|prednisone|mesh-list
56386937|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56386938|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386939|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386940|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386941|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56386942|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
56386943|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
56386944|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56386945|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56386946|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56386947|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56386948|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56386949|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56386950|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56386951|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56386952|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56386953|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
56386954|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56386956|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
56386961|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386962|NCT01241734|Lenalidomide|lenalidomide|mesh-list
56386963|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
56386964|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386965|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56386966|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56386967|NCT01241734|Growth Substances|growth substances|mesh-ancestor
56386968|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
56386969|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386970|NCT00504634|Bortezomib|bortezomib|mesh-list
56386971|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56386972|NCT00140465|Clopidogrel|clopidogrel|mesh-list
56386973|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56386974|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56386975|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56386976|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56386977|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
56386978|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386979|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386980|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386981|NCT00504673|Insulin|insulin|mesh-list
56386982|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56386983|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
56386984|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
56386985|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
56386986|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
56386987|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
56386988|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56386989|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386990|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
56386991|NCT01247701|Busulfan|busulfan|mesh-list
56386992|NCT01247701|Fludarabine|fludarabine|mesh-list
56386993|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655028|NCT05003245|Growth Substances|growth substances|mesh-ancestor
56655029|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
56655030|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655031|NCT05367089|Fluconazole|fluconazole|mesh-list
56655032|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
56655033|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217205|NCT01630148|Bemiparin|bemiparin|mesh-list
56386994|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
56386995|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386996|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386997|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56386998|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
56386999|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387000|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387001|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56387002|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
56387003|NCT00140543|Sirolimus|sirolimus|mesh-list
56387004|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56387005|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387006|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56387007|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
56387008|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56387009|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387010|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387011|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387012|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
56387013|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387014|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
56387015|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387017|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
56387018|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56387019|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
56387020|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387021|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387022|NCT00154791|Antiviral Agents|antiviral agents|mesh-ancestor
56387023|NCT00154791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387024|NCT00154791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387025|NCT00154791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387026|NCT00154791|Immunologic Factors|immunologic factors|mesh-ancestor
56387027|NCT00154791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387028|NCT00140582|Rituximab|rituximab|mesh-list
56387029|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387038|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
56387039|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387040|NCT00140660|Rituximab|rituximab|mesh-list
56387041|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387042|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387043|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
56387044|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387045|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56387046|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
56387047|NCT00162006|Antibodies|antibodies|mesh-list
56387048|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
56387049|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56387050|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56387051|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
56387052|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387053|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56387054|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56387055|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387056|NCT02964572|Empagliflozin|empagliflozin|mesh-list
56387057|NCT02964572|Glimepiride|glimepiride|mesh-list
56387058|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56387059|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387060|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56387061|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387062|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56387063|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655034|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56655035|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56655036|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655037|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655038|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56655039|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
56655040|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655041|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655042|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56655043|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56387064|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
56387065|NCT00162201|Abatacept|abatacept|mesh-list
56387066|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56387067|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387068|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387069|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387070|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
56165346|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
56387071|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387072|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56387073|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56387074|NCT01248247|Sorafenib|sorafenib|mesh-list
56387075|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387076|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56387077|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387078|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387079|NCT00140894|Rofecoxib|rofecoxib|mesh-list
56387080|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387081|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387082|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387083|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56387084|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56387085|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387086|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56387087|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56387088|NCT00140894|Analgesics|analgesics|mesh-ancestor
56387089|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
56387090|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56387091|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009067|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56387092|NCT00155064|Losartan|losartan|mesh-list
56387093|NCT00155064|Captopril|captopril|mesh-list
56387094|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56387097|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56387098|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387099|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56387100|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
56387101|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387102|NCT02483260|Ribavirin|ribavirin|mesh-list
56387103|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
56387104|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387105|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
56387106|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387107|NCT00140933|Diclofenac|diclofenac|mesh-list
56387108|NCT00140933|Rofecoxib|rofecoxib|mesh-list
56387109|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56387110|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56387111|NCT00140933|Analgesics|analgesics|mesh-ancestor
56387112|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
56387113|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387114|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655044|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
56655045|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56655046|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56655047|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56655048|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56655049|NCT02791919|Cytarabine|cytarabine|mesh-list
56655050|NCT02791919|Fludarabine|fludarabine|mesh-list
56655051|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
56655052|NCT02791919|Lenograstim|lenograstim|mesh-list
56655053|NCT02791919|Adavosertib|adavosertib|mesh-list
56655054|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655055|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655056|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
56655057|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655058|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655059|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
56655060|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655061|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
56655062|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655063|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56655064|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655065|NCT00966121|Propranolol|propranolol|mesh-list
56655066|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56655067|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56655068|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
56655069|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655070|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655092|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655093|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
56655094|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655095|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56655096|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655097|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
56655098|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56655099|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56655100|NCT04176224|Edaravone|edaravone|mesh-list
56655101|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56387115|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56387116|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56387117|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56387118|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387119|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387120|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56387121|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56387122|NCT04515628|Branebrutinib|branebrutinib|mesh-list
56387123|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56387124|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56387125|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
56387126|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387127|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56387128|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56387129|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387130|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56387131|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56387132|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56387133|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
56387134|NCT04510051|Fludarabine|fludarabine|mesh-list
56387135|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387136|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
56387137|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387138|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56387139|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56387140|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
56387141|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387142|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387143|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56387144|NCT00141011|Ancrod|ancrod|mesh-list
56387145|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
56387146|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56387147|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56387148|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387149|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
56387150|NCT00504946|Vitamin D|vitamin d|mesh-list
56387151|NCT00504946|Prednisone|prednisone|mesh-list
56387152|NCT00504946|Budesonide|budesonide|mesh-list
56387153|NCT00504946|Montelukast|montelukast|mesh-list
56387154|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56387155|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
56387156|NCT00504946|Hormones|hormones|mesh-ancestor
56387157|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387158|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387159|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56387160|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387161|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56387162|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
56387163|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56387164|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
56387165|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56387166|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56387171|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56387173|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
56387174|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56655102|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
56655103|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655104|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56655105|NCT04176224|Protective Agents|protective agents|mesh-ancestor
56655106|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655107|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
56655108|NCT04158102|Bupivacaine|bupivacaine|mesh-list
56655109|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
56655110|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
56655111|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655112|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655113|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
56655114|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655115|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56655116|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
56655117|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655118|NCT04966663|Gemcitabine|gemcitabine|mesh-list
56655119|NCT04966663|Carboplatin|carboplatin|mesh-list
56655120|NCT04966663|Nivolumab|nivolumab|mesh-list
56387175|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56387176|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56387177|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387178|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56387179|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56387180|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387181|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387182|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
56387183|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387184|NCT04511416|Metformin|metformin|mesh-list
56387185|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56387186|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387187|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56387188|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56387189|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
56387190|NCT00407082|Hormones|hormones|mesh-ancestor
56387191|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387192|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387194|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56387195|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
56387196|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387197|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387198|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387199|NCT00407121|Bevacizumab|bevacizumab|mesh-list
56387200|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387201|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387202|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56387203|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56387204|NCT00407121|Growth Substances|growth substances|mesh-ancestor
56387205|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387206|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
56387207|NCT00141167|Varenicline|varenicline|mesh-list
56387208|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56387209|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56387210|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
56387211|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655121|NCT04966663|Pemetrexed|pemetrexed|mesh-list
56655122|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655123|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655124|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
56655125|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387212|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387213|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387215|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56387216|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56387217|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
56387218|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387219|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387220|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387221|NCT00141245|Pregabalin|pregabalin|mesh-list
56387222|NCT00141245|Analgesics|analgesics|mesh-ancestor
56387223|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
56387224|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387225|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387226|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
56387227|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56387228|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387229|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387230|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56387231|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56387232|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56387233|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387234|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56387235|NCT00141362|Pregabalin|pregabalin|mesh-list
56387238|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387239|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387240|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
56387241|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56387242|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387243|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387244|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56387245|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56387246|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56387247|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387248|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56387249|NCT00155259|Docetaxel|docetaxel|mesh-list
56387250|NCT00155259|Capecitabine|capecitabine|mesh-list
56387251|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387252|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
56387253|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
56387254|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
56387255|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387256|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56387257|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
56387258|NCT04518124|Propranolol|propranolol|mesh-list
56387259|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56387260|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56387261|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
56387262|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387263|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387264|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387265|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56387266|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56387267|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
56387268|NCT00141401|Pregabalin|pregabalin|mesh-list
56387269|NCT00141401|Analgesics|analgesics|mesh-ancestor
56387270|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
56387271|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387272|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387273|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
56387274|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56387275|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387276|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655126|NCT04966663|Antiviral Agents|antiviral agents|mesh-ancestor
56655127|NCT04966663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655128|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655129|NCT04966663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655130|NCT04966663|Immunologic Factors|immunologic factors|mesh-ancestor
56655131|NCT04966663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655132|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56655133|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56387277|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56387278|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56387279|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56387280|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387281|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56387282|NCT00505102|Everolimus|everolimus|mesh-list
56387283|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387284|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387285|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
56387286|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387287|NCT00404378|Ketoconazole|ketoconazole|mesh-list
56387288|NCT00404378|Casopitant|casopitant|mesh-list
56387289|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
56387290|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387291|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56387292|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56387293|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387294|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387295|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56387296|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
56387297|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387298|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387299|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56387300|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
56387301|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
56387302|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387303|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387304|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55901413|NCT02414256|Anesthetics|anesthetics|mesh-list
56387310|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56387311|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
56387314|NCT00162318|Gefitinib|gefitinib|mesh-list
56387315|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387316|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387317|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56387318|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387319|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387320|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
56387321|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56387322|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56387323|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56387324|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387325|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387326|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
56387327|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387328|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387329|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56387330|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387331|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56387332|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387333|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56387334|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56387335|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387336|NCT00404456|Melatonin|melatonin|mesh-list
56387337|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
56387338|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387339|NCT00404456|Protective Agents|protective agents|mesh-ancestor
56655134|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56655135|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56655136|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56655137|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56655138|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655139|NCT00961363|Incretins|incretins|mesh-ancestor
56655140|NCT00961363|Hormones|hormones|mesh-ancestor
56655141|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655142|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56387340|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387341|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387342|NCT00404534|Amoxicillin|amoxicillin|mesh-list
56387343|NCT00404534|Clarithromycin|clarithromycin|mesh-list
56387344|NCT00404534|Omeprazole|omeprazole|mesh-list
56387345|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56387346|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387347|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56387348|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387349|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56387350|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387351|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387352|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56387353|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56387354|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56387355|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
56387356|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56387357|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56387358|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387360|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56387361|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
56387362|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387363|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387364|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56387365|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
56387366|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
56387367|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56387368|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56387369|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56387370|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56387371|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
56387372|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387373|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387374|NCT00162435|Warfarin|warfarin|mesh-list
56387378|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387379|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56387380|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56387381|NCT04518982|Growth Substances|growth substances|mesh-ancestor
56387382|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
56387383|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387384|NCT00155376|Morphine|morphine|mesh-list
56387385|NCT00155376|Glucagon|glucagon|mesh-list
56387386|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56387387|NCT00155376|Narcotics|narcotics|mesh-ancestor
56387388|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387389|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387390|NCT00155376|Analgesics|analgesics|mesh-ancestor
56387391|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
56387392|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387393|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387394|NCT00155376|Hormones|hormones|mesh-ancestor
56387395|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387396|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
56387397|NCT00141557|Estrogens|estrogens|mesh-list
56387398|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
56387399|NCT00141557|Estrone|estrone|mesh-list
56387400|NCT00141557|Testosterone|testosterone|mesh-list
56655143|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
56655144|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655145|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655146|NCT02633202|Cisplatin|cisplatin|mesh-list
56387401|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
56387402|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
56387403|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56387404|NCT00141557|Hormones|hormones|mesh-ancestor
56387405|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387406|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387407|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56387408|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387409|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
56387410|NCT00141557|Androgens|androgens|mesh-ancestor
56387411|NCT00162474|Phenytoin|phenytoin|mesh-list
56387412|NCT00162474|Warfarin|warfarin|mesh-list
56387413|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
56387414|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
56387415|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56387416|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56387417|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002124|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56387418|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387419|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56387420|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56387421|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
56387422|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387423|NCT00505336|Eplerenone|eplerenone|mesh-list
56387424|NCT00505336|Atorvastatin|atorvastatin|mesh-list
56387425|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56387426|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56387427|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
56387428|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387429|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56387430|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56387431|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387432|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56387433|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
56387434|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387435|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387436|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56387437|NCT00505336|Diuretics|diuretics|mesh-ancestor
56387438|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
56387439|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56387440|NCT04518202|Lidocaine|lidocaine|mesh-list
56387441|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
56387442|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
56387443|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387444|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387445|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
56387446|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387450|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387451|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387453|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
56387454|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
56387455|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387456|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387457|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
56387458|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387459|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56009449|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
56387460|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56387461|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56387462|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387463|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387464|NCT00141596|Amiloride|amiloride|mesh-list
56387465|NCT00141596|Furosemide|furosemide|mesh-list
56387466|NCT00141596|Diuretics|diuretics|mesh-ancestor
56387467|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
56655147|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655148|NCT00645242|Fluconazole|fluconazole|mesh-list
56655149|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
56655150|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655151|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56655152|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56387468|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387469|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56387470|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387471|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387472|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56387473|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56387474|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56387475|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56387476|NCT02275663|Cytarabine|cytarabine|mesh-list
56387477|NCT02275663|Fludarabine|fludarabine|mesh-list
56387478|NCT02275663|Azacitidine|azacitidine|mesh-list
56387479|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387480|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56387481|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
56387482|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387483|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387484|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
56387485|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387486|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
56387487|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387488|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387489|NCT02275702|Dexamethasone|dexamethasone|mesh-list
56387490|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56387491|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
56387492|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
56387493|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387494|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387495|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387496|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
56387497|NCT02275702|Hormones|hormones|mesh-ancestor
56387498|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387499|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56387500|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387501|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
56387502|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56387503|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56387504|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387505|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
56387506|NCT04518163|Coagulants|coagulants|mesh-ancestor
56387507|NCT04517227|Durvalumab|durvalumab|mesh-list
56387508|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387509|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387510|NCT00141713|Etanercept|etanercept|mesh-list
56387511|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56387512|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56387513|NCT00141713|Analgesics|analgesics|mesh-ancestor
56387514|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
55901634|NCT02440204|Remifentanil|remifentanil|mesh-list
56387515|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387516|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387517|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56387518|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56387519|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387520|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387521|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
56387522|NCT04517188|Iodine|iodine|mesh-list
56387523|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
56387524|NCT04517188|Povidone|povidone|mesh-list
56387525|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56387526|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387527|NCT04517188|Trace Elements|trace elements|mesh-ancestor
56387528|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
56387529|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655153|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655154|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655155|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56655156|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
56655157|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655158|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655159|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56655160|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56387530|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
56387531|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
56387532|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
56387533|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56387534|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009524|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
56387535|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387536|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56387537|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56387539|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387540|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
56387541|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56387542|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
56387543|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
56387544|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387545|NCT04516681|Vitamins|vitamins|mesh-ancestor
56387546|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
56387547|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
56387548|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387549|NCT04516681|Protective Agents|protective agents|mesh-ancestor
56387550|NCT00141791|Etanercept|etanercept|mesh-list
56387551|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56387552|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56387553|NCT00141791|Analgesics|analgesics|mesh-ancestor
56387554|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
56387555|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387556|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387557|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56387558|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56387559|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387560|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387561|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
56387562|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
56387563|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56387564|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387565|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387566|NCT00162591|Remifentanil|remifentanil|mesh-list
56387567|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56387568|NCT00162591|Narcotics|narcotics|mesh-ancestor
56387569|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387570|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387571|NCT00162591|Analgesics|analgesics|mesh-ancestor
56387572|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
56387573|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387575|NCT00505492|Cisplatin|cisplatin|mesh-list
56387576|NCT00505492|Carboplatin|carboplatin|mesh-list
56387577|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56387578|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387579|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
56387580|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
56387581|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
56387582|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387583|NCT00141830|Methotrexate|methotrexate|mesh-list
56387584|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56387585|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
56387586|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56655161|NCT00659568|Metformin|metformin|mesh-list
56655162|NCT00659568|Sirolimus|sirolimus|mesh-list
56655163|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56655164|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655165|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56655166|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655167|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56655168|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655169|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
56655170|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655171|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
56387587|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387588|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56387589|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
56387590|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387591|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387596|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
56387597|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56387598|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56387599|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
56387600|NCT04516174|Ropivacaine|ropivacaine|mesh-list
56387601|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56387602|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387603|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387604|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56387605|NCT04516174|Analgesics|analgesics|mesh-ancestor
56387606|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
56387607|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174746|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
56387608|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56387609|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56387610|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56387611|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
56387612|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387613|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387614|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
56387615|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
56387616|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
56387617|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387618|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387619|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
56387621|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56387622|NCT00505531|Narcotics|narcotics|mesh-ancestor
56387623|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387624|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387625|NCT00505531|Analgesics|analgesics|mesh-ancestor
56387626|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
56387627|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387628|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56387629|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56387630|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
56387631|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
56387632|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
56387633|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
56387634|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387635|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56387636|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
56387637|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
56387638|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387639|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387640|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56387642|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56387643|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56387644|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56387645|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
56655172|NCT00961753|Ibuprofen|ibuprofen|mesh-list
56655173|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56655174|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56655175|NCT00961753|Analgesics|analgesics|mesh-ancestor
56655176|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
56655177|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655178|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655179|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56655180|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56655181|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56655182|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655183|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655184|NCT04232813|Estradiol|estradiol|mesh-list
56655185|NCT04232813|Estrogens|estrogens|mesh-ancestor
56655186|NCT04232813|Hormones|hormones|mesh-ancestor
56217337|NCT01631136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387646|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387647|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387648|NCT00141908|Progestins|progestins|mesh-ancestor
56387649|NCT00141908|Hormones|hormones|mesh-ancestor
56387650|NCT00141908|Cathartics|cathartics|mesh-ancestor
56387651|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387652|NCT00162669|Bevacizumab|bevacizumab|mesh-list
56387653|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387654|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387655|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56387656|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56387657|NCT00162669|Growth Substances|growth substances|mesh-ancestor
56387658|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387659|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
56387660|NCT00141947|Bexarotene|bexarotene|mesh-list
56387661|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387662|NCT04514770|Misoprostol|misoprostol|mesh-list
56387663|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56387664|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
56387669|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
56387671|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
56387672|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
56387673|NCT00141986|Vitamins|vitamins|mesh-list
56387674|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
56387675|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387676|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56387677|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56387678|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
56387679|NCT04514731|Analgesics|analgesics|mesh-ancestor
56387680|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
56387681|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387682|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387683|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
56387684|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387685|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56387686|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
56387687|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56387688|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387689|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387690|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56387691|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
56387692|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56387694|NCT04514419|Trastuzumab|trastuzumab|mesh-list
56387695|NCT04514419|Pertuzumab|pertuzumab|mesh-list
56655187|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655188|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655189|NCT00659958|Zonisamide|zonisamide|mesh-list
56655190|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
56655191|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56655192|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56655193|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655194|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217353|NCT01631305|Antacids|antacids|mesh-ancestor
56387696|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387697|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
56387698|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
56387699|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
56387700|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387701|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387702|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
56387703|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
56387704|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56387705|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56387706|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387707|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387708|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56387709|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56387710|NCT02275897|Methamphetamine|methamphetamine|mesh-list
56387711|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56387712|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387713|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
56387714|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
56387715|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387716|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
56387717|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387718|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387719|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
56387720|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56387721|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56387722|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387723|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56387725|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
56387726|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
56387727|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56387728|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
56387729|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
56387730|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387731|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387732|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387733|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
56387734|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55901861|NCT02410746|Morphine|morphine|mesh-list
56387738|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
56387739|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56387740|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387741|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387742|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56387743|NCT00505804|Analgesics|analgesics|mesh-ancestor
56387744|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
56387745|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387746|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56387747|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56387748|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56387749|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
56387750|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919633|NCT04146493|Heparin|heparin|mesh-list
56655195|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655196|NCT00644774|Azithromycin|azithromycin|mesh-list
56655197|NCT00644774|Cefdinir|cefdinir|mesh-list
56655198|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56655199|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655200|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
56655201|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56655202|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655203|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
56655204|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56655205|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
56655206|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655207|NCT00910442|Expectorants|expectorants|mesh-ancestor
56655208|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56655209|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56655210|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
56655211|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655212|NCT00910442|Protective Agents|protective agents|mesh-ancestor
56655213|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655214|NCT00910442|Antidotes|antidotes|mesh-ancestor
56655215|NCT00660036|Etoposide|etoposide|mesh-list
56655216|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
56655217|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
56655218|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56655219|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655220|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56655221|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56655222|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217362|NCT01631357|Antiviral Agents|antiviral agents|mesh-ancestor
56387751|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387752|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
56387753|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
56387754|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387755|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56387756|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56009750|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
56387757|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56387758|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56387759|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
56387760|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56387761|NCT00505843|Levodopa|levodopa|mesh-list
56387762|NCT00505843|Carbidopa|carbidopa|mesh-list
56387763|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56387764|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56387765|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
56387766|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387767|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387768|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888744|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56655223|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655224|NCT00660036|Analgesics|analgesics|mesh-ancestor
56655225|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
56655226|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655227|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655228|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56655229|NCT02791373|Gemcitabine|gemcitabine|mesh-list
56655230|NCT02791373|Vinorelbine|vinorelbine|mesh-list
55832489|NCT02094937|Xhance|xhance|mesh-list
56387769|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56387770|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387771|NCT00505882|Pramlintide|pramlintide|mesh-list
56387772|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56387773|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387774|NCT00142337|Zidovudine|zidovudine|mesh-list
56387775|NCT00142337|Didanosine|didanosine|mesh-list
56387776|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
56387777|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387778|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56387779|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56387780|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387781|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
56387782|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387783|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56387784|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56387785|NCT00162864|Montelukast|montelukast|mesh-list
56387786|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56387787|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
56387788|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56387789|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
56387790|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387791|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387792|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56387793|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56387794|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387795|NCT04512313|Rocuronium|rocuronium|mesh-list
56387796|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56387797|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56387798|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56387799|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387800|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387801|NCT00142493|Midazolam|midazolam|mesh-list
56387802|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
56387803|NCT00142493|Thiopental|thiopental|mesh-list
56387804|NCT00142493|Propofol|propofol|mesh-list
56387805|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56387806|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387812|NCT00142493|Analgesics|analgesics|mesh-ancestor
56387813|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
56387814|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387815|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56387816|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56387817|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56387818|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
56387819|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387820|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387821|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56387822|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56387823|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56387824|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56387825|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
56387826|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
56387827|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
56387828|NCT04511923|Heparin|heparin|mesh-list
56387829|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
56387830|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56655231|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655232|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
56655233|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655234|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655235|NCT02791373|Antiviral Agents|antiviral agents|mesh-ancestor
56655236|NCT02791373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655237|NCT02791373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655238|NCT02791373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655239|NCT02791373|Immunologic Factors|immunologic factors|mesh-ancestor
56655240|NCT02791373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655241|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56387831|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56387832|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387833|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
56387834|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56387835|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
56387836|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56387837|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
56387838|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387839|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387840|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
56387842|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56387843|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56387844|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56387845|NCT00142571|Gemcitabine|gemcitabine|mesh-list
56387846|NCT00142571|Docetaxel|docetaxel|mesh-list
56387847|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56387848|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
56387849|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387850|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387851|NCT00142571|Antiviral Agents|antiviral agents|mesh-ancestor
56387852|NCT00142571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387853|NCT00142571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387854|NCT00142571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387855|NCT00142571|Immunologic Factors|immunologic factors|mesh-ancestor
56387856|NCT00142571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387857|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
56387858|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
56387859|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
56387860|NCT00142610|Vitamins|vitamins|mesh-list
56387861|NCT00142610|Vitamin E|vitamin e|mesh-list
56387862|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
56387863|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387864|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
56387865|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387866|NCT00142610|Protective Agents|protective agents|mesh-ancestor
56387867|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
56387868|NCT04510870|Hematinics|hematinics|mesh-ancestor
56387869|NCT00406575|Methocarbamol|methocarbamol|mesh-list
56387870|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56387871|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387872|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56387873|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387874|NCT02275975|Fluconazole|fluconazole|mesh-list
56387875|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
56387876|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387877|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56387878|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56387879|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387881|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56387882|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
56387883|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919634|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
56655242|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
56655243|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
56655244|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
56655245|NCT03102047|Durvalumab|durvalumab|mesh-list
56655246|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56655247|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655248|NCT00966745|Milrinone|milrinone|mesh-list
56655249|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56655250|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56655251|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
56655252|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56655253|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56655254|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655255|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655256|NCT00966745|Protective Agents|protective agents|mesh-ancestor
56655257|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655258|NCT02669030|Suvorexant|suvorexant|mesh-list
56655259|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56655260|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56655261|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387884|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387885|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56387886|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56387887|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
56387888|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56387889|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
56387890|NCT00142727|Methadone|methadone|mesh-list
56387891|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
56387892|NCT00142727|Narcotics|narcotics|mesh-ancestor
56387893|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387894|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387895|NCT00142727|Analgesics|analgesics|mesh-ancestor
56387896|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
56387897|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387898|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
56387899|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
56387900|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
56387901|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56387902|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56387903|NCT00506194|Gliclazide|gliclazide|mesh-list
56387904|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56387905|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387906|NCT00404573|Cariprazine|cariprazine|mesh-list
56387907|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56387908|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56387909|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387910|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387911|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56387913|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56387914|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387915|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56387916|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
56387917|NCT00506311|Coagulants|coagulants|mesh-ancestor
56387918|NCT04519645|Lacosamide|lacosamide|mesh-list
56387919|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
55919635|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56655262|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655263|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56655264|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655265|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655266|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56655267|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56655268|NCT02668796|Estradiol|estradiol|mesh-list
56655269|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56387920|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56387921|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56387922|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387923|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387924|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56387925|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387926|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387927|NCT00142844|Naltrexone|naltrexone|mesh-list
56387928|NCT00142844|Disulfiram|disulfiram|mesh-list
56387929|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56387930|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56387931|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387932|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
56387933|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387934|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56387935|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387936|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387937|NCT04510207|Vaccines|vaccines|mesh-list
56387938|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
56387939|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387940|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56387941|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56387942|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
56387943|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56387944|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387945|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56387946|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56387947|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56387948|NCT00142883|Pregabalin|pregabalin|mesh-list
56387949|NCT00142883|Analgesics|analgesics|mesh-ancestor
56387950|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
56387951|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902070|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56387954|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56387955|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387956|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387957|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56387958|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56387959|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56387960|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387961|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56387963|NCT04512430|Carboplatin|carboplatin|mesh-list
56387964|NCT04512430|Pemetrexed|pemetrexed|mesh-list
56387965|NCT04512430|Atezolizumab|atezolizumab|mesh-list
56387966|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387967|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387968|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56387969|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56387970|NCT04512430|Growth Substances|growth substances|mesh-ancestor
56387971|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387972|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
56387973|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387974|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387975|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56387976|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56655270|NCT02668796|Estrogens|estrogens|mesh-ancestor
56655271|NCT02668796|Hormones|hormones|mesh-ancestor
56655272|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655273|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655274|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56655275|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
56387977|NCT04517851|Elotuzumab|elotuzumab|mesh-list
56387978|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387979|NCT04515238|Venetoclax|venetoclax|mesh-list
56387980|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56387981|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
56387982|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
56387983|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387984|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56387985|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
56387986|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387987|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56387988|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56387989|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387990|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56387991|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56387992|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56387993|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56387994|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387995|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
56387996|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387997|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387998|NCT00163254|Abciximab|abciximab|mesh-list
56387999|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
56388000|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56388001|NCT00143000|Ribavirin|ribavirin|mesh-list
56388002|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56388003|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
56388004|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388005|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
56388006|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388007|NCT04514029|Dexamethasone|dexamethasone|mesh-list
56388008|NCT04514029|Simvastatin|simvastatin|mesh-list
56388009|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56388010|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
56388011|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
56388012|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388013|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388014|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56388015|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
56388016|NCT04514029|Hormones|hormones|mesh-ancestor
56388017|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388018|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56388019|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388020|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56388021|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56388022|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
55902144|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56388024|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56388025|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56388026|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388027|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56388028|NCT02590393|Nicotine|nicotine|mesh-list
56388029|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56388030|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
56388031|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388032|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388033|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56388034|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56388035|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
56388036|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388037|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388038|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
56388039|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56655276|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56655277|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56388040|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
56388041|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388042|NCT00506506|Expectorants|expectorants|mesh-ancestor
56388043|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
56388044|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56388045|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
56388046|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388047|NCT00506506|Protective Agents|protective agents|mesh-ancestor
56388048|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388049|NCT00506506|Antidotes|antidotes|mesh-ancestor
56388050|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
56388051|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56388052|NCT00163332|Ciclesonide|ciclesonide|mesh-list
56388053|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
56388054|NCT00163332|Hormones|hormones|mesh-ancestor
56388055|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388056|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388057|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56388058|NCT00163371|Ciclesonide|ciclesonide|mesh-list
56388059|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
56388060|NCT00163371|Hormones|hormones|mesh-ancestor
56388061|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174796|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56388062|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388063|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56388064|NCT00143156|Pregabalin|pregabalin|mesh-list
56388065|NCT00143156|Analgesics|analgesics|mesh-ancestor
56388066|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
56388067|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388068|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388069|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
56388070|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56388071|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56388072|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388073|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56388074|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56388075|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56388076|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56388077|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56388078|NCT00163410|Ciclesonide|ciclesonide|mesh-list
56388079|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
56388080|NCT00163410|Hormones|hormones|mesh-ancestor
56388081|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388082|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388083|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56388084|NCT00143195|Amlodipine|amlodipine|mesh-list
56388085|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56388086|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56388087|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56388088|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388089|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56388090|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388091|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
56388092|NCT00163449|Ciclesonide|ciclesonide|mesh-list
56388093|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
56388094|NCT00163449|Hormones|hormones|mesh-ancestor
56388097|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56388098|NCT00143234|Amlodipine|amlodipine|mesh-list
56388099|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56388100|NCT00143234|Atorvastatin|atorvastatin|mesh-list
56388101|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56388102|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56388103|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
56388104|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388105|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56388106|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56388107|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388108|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56388109|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56388110|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56655278|NCT00645320|Ziprasidone|ziprasidone|mesh-list
56655279|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56655280|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
56301367|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655281|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655282|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655283|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655284|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56655285|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56655286|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655287|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56655288|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56655289|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
56655290|NCT03938857|Fentanyl|fentanyl|mesh-list
56217444|NCT01631513|Tapentadol|tapentadol|mesh-list
56388111|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56388112|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388113|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
56388114|NCT00163488|Ciclesonide|ciclesonide|mesh-list
56388115|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
56388116|NCT00163488|Hormones|hormones|mesh-ancestor
56388117|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388118|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388119|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56388120|NCT00143351|Ziprasidone|ziprasidone|mesh-list
56388121|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56388122|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
56388123|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388124|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388125|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388126|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56388127|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56388128|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56388129|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56388130|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56388131|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
56388132|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56388133|NCT00163605|Thrombin|thrombin|mesh-list
56388134|NCT00163605|Calcium|calcium|mesh-list
56388135|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56388136|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388137|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
56388138|NCT00163605|Coagulants|coagulants|mesh-ancestor
56388139|NCT02598583|Ravulizumab|ravulizumab|mesh-list
56388140|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56388141|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388142|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
56388143|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388144|NCT00143429|Latanoprost|latanoprost|mesh-list
56388145|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56388146|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56388147|NCT02598895|Carboplatin|carboplatin|mesh-list
56388148|NCT02598895|Docetaxel|docetaxel|mesh-list
56388149|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388150|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
56388151|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
56388152|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
56388153|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388154|NCT05147272|Gemcitabine|gemcitabine|mesh-list
56388155|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388156|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
55919973|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56655291|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
56655292|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56655293|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655294|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655295|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56655296|NCT03938857|Analgesics|analgesics|mesh-ancestor
56655297|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
56655298|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655299|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56655300|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56655301|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56655302|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
56655303|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655304|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655305|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56655306|NCT03938857|Narcotics|narcotics|mesh-ancestor
56655307|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56655308|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56388157|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388158|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388159|NCT05147272|Antiviral Agents|antiviral agents|mesh-ancestor
56388160|NCT05147272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388161|NCT05147272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388162|NCT05147272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388163|NCT05147272|Immunologic Factors|immunologic factors|mesh-ancestor
56388164|NCT05147272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388165|NCT00143546|Defibrotide|defibrotide|mesh-list
56388166|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56388172|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
56388173|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388174|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388175|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388176|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388177|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
56388178|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388179|NCT00155883|Antidotes|antidotes|mesh-ancestor
56388180|NCT00155883|Protective Agents|protective agents|mesh-ancestor
56388181|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
56388183|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
56388184|NCT00506545|Rolapitant|rolapitant|mesh-list
56388185|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56388186|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388187|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388188|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388189|NCT05143723|Hormones|hormones|mesh-list
56388190|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388191|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388192|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
56388193|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56388194|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388196|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
56388197|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56388198|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388199|NCT05142904|Trace Elements|trace elements|mesh-ancestor
56388200|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
56655309|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
56655310|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
56655311|NCT04160598|Fentanyl|fentanyl|mesh-list
56655312|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56655313|NCT04160598|Narcotics|narcotics|mesh-ancestor
56655314|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655315|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655316|NCT04160598|Analgesics|analgesics|mesh-ancestor
56655317|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
56217478|NCT01631669|Celecoxib|celecoxib|mesh-list
56388201|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388202|NCT05142865|Carboplatin|carboplatin|mesh-list
56388203|NCT05142865|Etoposide|etoposide|mesh-list
56388204|NCT05142865|Apatinib|apatinib|mesh-list
56388205|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388206|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010207|NCT00003340|Topotecan|topotecan|mesh-list
56388207|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56388208|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56388209|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388210|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388211|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56388213|NCT00143702|Thiamine|thiamine|mesh-list
56388214|NCT00143702|Abacavir|abacavir|mesh-list
56388215|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56388216|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56388217|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388218|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388219|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
56388220|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388221|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56388222|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56388223|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
56388224|NCT00143702|Vitamins|vitamins|mesh-ancestor
56388225|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
56388226|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388227|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56388228|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
56388229|NCT00156078|Pregabalin|pregabalin|mesh-list
56388230|NCT00156078|Analgesics|analgesics|mesh-ancestor
56388231|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
56388232|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388233|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388234|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
56388235|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56388236|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56388237|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388246|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
56388247|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388248|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174854|NCT01386372|Tolvaptan|tolvaptan|mesh-list
56388249|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56388250|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56388251|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388252|NCT00143741|Atorvastatin|atorvastatin|mesh-list
56388253|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56388254|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56388255|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
56388256|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388257|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56388258|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56388259|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388260|NCT00143780|Vaccines|vaccines|mesh-list
56388261|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
56388262|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388263|NCT02276365|Pioglitazone|pioglitazone|mesh-list
56388264|NCT02276365|Empagliflozin|empagliflozin|mesh-list
56388265|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56655318|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655319|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56655320|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56655321|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
56655322|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
56655323|NCT00967837|Insulin|insulin|mesh-list
56655324|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56388266|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388267|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56388268|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388269|NCT05145634|Anticoagulants|anticoagulants|mesh-list
56388270|NCT00143975|Cytarabine|cytarabine|mesh-list
56388271|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
56388272|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
56388273|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388274|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
56388275|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388276|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388277|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
56388278|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388279|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388280|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
56388281|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388282|NCT00143975|Analgesics|analgesics|mesh-ancestor
56388283|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
56388284|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388285|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56388286|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56388287|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388288|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56388289|NCT00156312|Docetaxel|docetaxel|mesh-list
56388290|NCT00156312|Capecitabine|capecitabine|mesh-list
56388291|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388292|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
56388293|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
56388294|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
56388295|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388296|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388297|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
56388298|NCT00506701|Tadalafil|tadalafil|mesh-list
56388299|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
56388300|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56388301|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56388302|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388303|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388311|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56388313|NCT00144053|Paclitaxel|paclitaxel|mesh-list
56388314|NCT00144053|Vindesine|vindesine|mesh-list
56388315|NCT00144053|Carboplatin|carboplatin|mesh-list
56388316|NCT00144053|Irinotecan|irinotecan|mesh-list
56388317|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56388318|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388319|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
56388320|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
56388321|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
56388322|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388323|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56388324|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56388325|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388326|NCT05147194|Trimetazidine|trimetazidine|mesh-list
56388327|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
56388328|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
56388329|NCT00144131|Hematinics|hematinics|mesh-ancestor
56388330|NCT00144209|Levodopa|levodopa|mesh-list
56388331|NCT00144209|Pramipexole|pramipexole|mesh-list
56388332|NCT00144209|Benserazide|benserazide|mesh-list
56388333|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56388334|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56388335|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
56388336|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388337|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655325|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56655326|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655327|NCT02668016|Atorvastatin|atorvastatin|mesh-list
56655328|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56655329|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56655330|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56655331|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
56655332|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655333|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56655334|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655335|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
56655336|NCT03012971|Morphine|morphine|mesh-list
56655337|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56655338|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655339|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655340|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56655341|NCT03012971|Analgesics|analgesics|mesh-ancestor
56655342|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
56655343|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655344|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56655345|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56655346|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56655347|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
56388338|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388339|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
56388340|NCT00144209|Protective Agents|protective agents|mesh-ancestor
56388341|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
56388342|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388343|NCT05149378|Azacitidine|azacitidine|mesh-list
56388344|NCT05149378|Venetoclax|venetoclax|mesh-list
56388345|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388346|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
56388347|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388348|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388349|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388350|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
56388351|NCT05149339|Vitamin D|vitamin d|mesh-list
56388352|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56388353|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388354|NCT05149339|Vitamins|vitamins|mesh-ancestor
56388355|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
56388356|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56388357|NCT00144248|Nevirapine|nevirapine|mesh-list
56388358|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56388359|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56388360|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388361|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388362|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
56388363|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388364|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56388365|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56655348|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655349|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655350|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56655351|NCT03012971|Narcotics|narcotics|mesh-ancestor
56655352|NCT00966901|Nicotine|nicotine|mesh-list
56655353|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56655354|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
56655355|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655356|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655357|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56655358|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56655359|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
56655360|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655361|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655362|NCT02668172|Pasireotide|pasireotide|mesh-list
56388366|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56388367|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56388368|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56388369|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
56388370|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388371|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388379|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388380|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56388381|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56388382|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
56388383|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388384|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56388385|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56388387|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
56388388|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56388389|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
56388390|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388391|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388392|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56388393|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
56388394|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
56388395|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56388396|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
56388397|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388398|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388399|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
56388401|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
56388402|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56388403|NCT02954692|Meglitinide|meglitinide|mesh-list
56388404|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
56388405|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56388406|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388407|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388408|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388409|NCT00506935|Vigabatrin|vigabatrin|mesh-list
56388410|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
56388411|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388412|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388413|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
56388414|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388415|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388416|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56388417|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
56388418|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655363|NCT02668172|Hormones|hormones|mesh-ancestor
56655364|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655365|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655366|NCT00660270|Gemcitabine|gemcitabine|mesh-list
56655367|NCT00660270|Interferons|interferons|mesh-list
56655368|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
56655369|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56655370|NCT00660270|Fluorouracil|fluorouracil|mesh-list
56217524|NCT01632007|Incretins|incretins|mesh-ancestor
56388419|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
56388420|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56388421|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56388422|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
56388423|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
56388424|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56388425|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388426|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56388427|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388428|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
56388429|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56388430|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
56388431|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388432|NCT00507052|Expectorants|expectorants|mesh-ancestor
56388433|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
56388434|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56388435|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
56388436|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388438|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388439|NCT00507052|Antidotes|antidotes|mesh-ancestor
56388440|NCT00507091|Leucovorin|leucovorin|mesh-list
56388441|NCT00507091|Fluorouracil|fluorouracil|mesh-list
56388442|NCT00507091|Irinotecan|irinotecan|mesh-list
56388443|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
56388446|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388447|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388448|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
56388449|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388450|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56388451|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55716731|NCT02227901|Temozolomide|temozolomide|mesh-list
56388452|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388453|NCT00507091|Antidotes|antidotes|mesh-ancestor
56388454|NCT00507091|Protective Agents|protective agents|mesh-ancestor
56388455|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
56388456|NCT00507091|Vitamins|vitamins|mesh-ancestor
56388457|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
56388458|NCT05148910|Copper|copper|mesh-list
56388459|NCT05148910|Trace Elements|trace elements|mesh-ancestor
56388460|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
56388461|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388462|NCT00148083|Risperidone|risperidone|mesh-list
56388463|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56388464|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
56388465|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388466|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388467|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388468|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56388469|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56388470|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56388471|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56388472|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56388473|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
56388474|NCT05148715|Tacrolimus|tacrolimus|mesh-list
56388475|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388476|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
56388477|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388478|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56388479|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388480|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388481|NCT05148442|Azacitidine|azacitidine|mesh-list
56388482|NCT05148442|Decitabine|decitabine|mesh-list
56655371|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834493|NCT02115113|Everolimus|everolimus|mesh-list
56388483|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388484|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
56388485|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388486|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388487|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388488|NCT05148403|Glyburide|glyburide|mesh-list
56388489|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56388490|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388491|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
56388492|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56388493|NCT05148169|Sulforaphane|sulforaphane|mesh-list
56388494|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56388495|NCT05148169|Protective Agents|protective agents|mesh-ancestor
56388496|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388497|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388498|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
56388499|NCT00144482|Hematinics|hematinics|mesh-ancestor
56388500|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
56388501|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56388502|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56388503|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
56388504|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388505|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56388506|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
56388507|NCT05146687|Bevacizumab|bevacizumab|mesh-list
56388508|NCT05146687|Ranibizumab|ranibizumab|mesh-list
56388509|NCT05146687|Aflibercept|aflibercept|mesh-list
56010502|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
56388510|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56388511|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388512|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56388513|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56388514|NCT05146687|Growth Substances|growth substances|mesh-ancestor
56388515|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388516|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
56388518|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56388527|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56388528|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56388529|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56388539|NCT05148637|Lidocaine|lidocaine|mesh-list
56388540|NCT05148637|Fentanyl|fentanyl|mesh-list
56388541|NCT05148637|Anesthetics|anesthetics|mesh-list
56388542|NCT05148637|Sevoflurane|sevoflurane|mesh-list
56388543|NCT05148637|Desflurane|desflurane|mesh-list
56388544|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
56388545|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56388546|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388547|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
56388548|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388549|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56388550|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56388551|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56388552|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56388553|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388554|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56388555|NCT05148637|Narcotics|narcotics|mesh-ancestor
56388556|NCT05148637|Analgesics|analgesics|mesh-ancestor
56388557|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56174986|NCT01386996|Budesonide|budesonide|mesh-list
56388558|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56388559|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
56388560|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56388561|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56388562|NCT00148278|Dobutamine|dobutamine|mesh-list
56388563|NCT00148278|Epinephrine|epinephrine|mesh-list
56388564|NCT00148278|Norepinephrine|norepinephrine|mesh-list
56388565|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56388566|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56388567|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
56388568|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388569|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388570|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388571|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56388572|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56655372|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655373|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
56655374|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655375|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
56655376|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655377|NCT00660270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655378|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655379|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
56655380|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655381|NCT04032132|Curcumin|curcumin|mesh-list
56655382|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56655383|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56655384|NCT04032132|Analgesics|analgesics|mesh-ancestor
56655385|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
56655386|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655387|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655388|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56655389|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56655390|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388573|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
56388574|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388575|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56388576|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
56388577|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
56388578|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
56388579|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56388580|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56388581|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56388582|NCT00148278|Protective Agents|protective agents|mesh-ancestor
56388583|NCT05594849|Budesonide|budesonide|mesh-list
56388584|NCT05594849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56388585|NCT05594849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56388586|NCT05594849|Autonomic Agents|autonomic agents|mesh-ancestor
56010576|NCT00004072|Carmustine|carmustine|mesh-list
56388587|NCT05594849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388588|NCT05594849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388589|NCT05594849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56388590|NCT05594849|Respiratory System Agents|respiratory system agents|mesh-ancestor
56388591|NCT05594849|Glucocorticoids|glucocorticoids|mesh-ancestor
56388593|NCT05594849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388595|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56388596|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388598|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56388599|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
56388600|NCT00507286|Urological Agents|urological agents|mesh-ancestor
56388601|NCT05143762|Acetaminophen|acetaminophen|mesh-list
56388602|NCT05143762|Dexamethasone|dexamethasone|mesh-list
56388604|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
56388605|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
56388606|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388607|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388608|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56388609|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
56388610|NCT05143762|Hormones|hormones|mesh-ancestor
56388611|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388612|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56655391|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655392|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655393|NCT00967057|Dexamethasone|dexamethasone|mesh-list
56655394|NCT00967057|Methotrexate|methotrexate|mesh-list
56655395|NCT00967057|Vincristine|vincristine|mesh-list
56655396|NCT00967057|Asparaginase|asparaginase|mesh-list
56655397|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
56655398|NCT00967057|Idarubicin|idarubicin|mesh-list
56655399|NCT00967057|Pegaspargase|pegaspargase|mesh-list
56655400|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56388613|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388614|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56388615|NCT05143762|Analgesics|analgesics|mesh-ancestor
56388616|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
56388617|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
56388618|NCT00148356|Paclitaxel|paclitaxel|mesh-list
56388619|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56388620|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388621|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
56388622|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
56388623|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
56388624|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388625|NCT00424281|PENTA|penta|mesh-list
56388626|NCT00424281|Fondaparinux|fondaparinux|mesh-list
56388627|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56388628|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
56388629|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56388630|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
56388631|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388632|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388633|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
56388634|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56388635|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56388636|NCT00148395|Gemcitabine|gemcitabine|mesh-list
56388637|NCT00148395|Carboplatin|carboplatin|mesh-list
56388638|NCT00148395|Ifosfamide|ifosfamide|mesh-list
56388639|NCT00148395|Mitomycins|mitomycins|mesh-list
56388640|NCT00148395|Mitomycin|mitomycin|mesh-list
56388641|NCT00148395|Vinorelbine|vinorelbine|mesh-list
56388642|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388643|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388644|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
56388645|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388646|NCT00148395|Antiviral Agents|antiviral agents|mesh-ancestor
56388647|NCT00148395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388648|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388649|NCT00148395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388650|NCT00148395|Immunologic Factors|immunologic factors|mesh-ancestor
56388651|NCT00148395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388652|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56388653|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
56388654|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56388655|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56388656|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56388657|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
56388658|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
56388659|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
56388660|NCT05594615|Midazolam|midazolam|mesh-list
56388661|NCT05594615|Caffeine|caffeine|mesh-list
56388662|NCT05594615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56388663|NCT05594615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56388664|NCT05594615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56388665|NCT05594615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56388666|NCT05594615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388667|NCT05594615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56388668|NCT05594615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56388681|NCT05594615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56388682|NCT05594615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388683|NCT05594615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56655401|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
56655402|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
56388684|NCT05594615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56388685|NCT05594615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56388686|NCT05594615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56388687|NCT05594615|Purinergic Agents|purinergic agents|mesh-ancestor
56388688|NCT02276677|Oxytocin|oxytocin|mesh-list
56388689|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
56388690|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56388691|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388692|NCT05141344|Melatonin|melatonin|mesh-list
56388693|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
56388694|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388695|NCT05141344|Protective Agents|protective agents|mesh-ancestor
56388696|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388697|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56388698|NCT00156858|Busulfan|busulfan|mesh-list
56388699|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
56388700|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388701|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388702|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
56388703|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388704|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56388705|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388706|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56388707|NCT03451825|Avelumab|avelumab|mesh-list
56388708|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56388709|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56388710|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388711|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
56388712|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388713|NCT00156897|Orlistat|orlistat|mesh-list
56388714|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388715|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388716|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56388717|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56388718|NCT03459859|Cytarabine|cytarabine|mesh-list
56388719|NCT03459859|Pevonedistat|pevonedistat|mesh-list
56388720|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388721|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
56388722|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388723|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388724|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
56388725|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388726|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388727|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
56388728|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388729|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388730|NCT05594459|Analgesics|analgesics|mesh-list
56010731|NCT00004108|Exatecan|exatecan|mesh-list
56388740|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388742|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388743|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388744|NCT05594381|Oxaliplatin|oxaliplatin|mesh-list
56388745|NCT05594381|Tegafur|tegafur|mesh-list
56388746|NCT05594381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388747|NCT05594381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388748|NCT05594381|Antimetabolites|antimetabolites|mesh-ancestor
56388749|NCT05594381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388750|NCT00148473|Misoprostol|misoprostol|mesh-list
56388751|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56388752|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
56388753|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56388754|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388755|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56388756|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56388758|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
56388759|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56388760|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56388761|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56388762|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56388763|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56388764|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655403|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655404|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655405|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56655406|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
56655407|NCT00967057|Hormones|hormones|mesh-ancestor
56217556|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388765|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
56388766|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388767|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388768|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56388769|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388770|NCT05594342|Dobutamine|dobutamine|mesh-list
56388771|NCT05594342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56388772|NCT05594342|Sympathomimetics|sympathomimetics|mesh-ancestor
56388773|NCT05594342|Autonomic Agents|autonomic agents|mesh-ancestor
56388774|NCT05594342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388775|NCT05594342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388776|NCT05594342|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56388777|NCT05594342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56388778|NCT05594342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56388779|NCT05594342|Adrenergic Agents|adrenergic agents|mesh-ancestor
56388780|NCT05594342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388781|NCT05594342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388782|NCT05594342|Protective Agents|protective agents|mesh-ancestor
56388783|NCT00157053|Factor VIII|factor viii|mesh-list
56388784|NCT00157053|Coagulants|coagulants|mesh-ancestor
56388785|NCT00507793|Cyclosporine|cyclosporine|mesh-list
56388786|NCT00507793|Sirolimus|sirolimus|mesh-list
56388787|NCT00507793|Cyclosporins|cyclosporins|mesh-list
56388788|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388789|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388790|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388791|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
56388792|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388793|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
56388794|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388795|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
56388796|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56388797|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56388798|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56388802|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56388803|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56388804|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56388805|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
56388807|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56388808|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56388809|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56388810|NCT00507832|Analgesics|analgesics|mesh-ancestor
56388811|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
56388812|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388813|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002159|NCT01226719|Antidotes|antidotes|mesh-ancestor
56388814|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56388815|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
56388816|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388817|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
56388818|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56388819|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388820|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388821|NCT00507949|Megestrol|megestrol|mesh-list
56388822|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
56388823|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56388824|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56388825|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56388826|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
56388827|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56388828|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388829|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56388830|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55919974|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
56655408|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655409|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56655410|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655411|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56655412|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
56655413|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56655414|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655415|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
56655416|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655417|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
56655418|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655419|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56655420|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655421|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
56655422|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217561|NCT01632514|Vitamins|vitamins|mesh-ancestor
56388831|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56388832|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388833|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
56388834|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56388835|NCT00148551|Triamcinolone|triamcinolone|mesh-list
56388836|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56388837|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56388838|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56388839|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56388840|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
56388841|NCT00148551|Hormones|hormones|mesh-ancestor
56175063|NCT01387568|Lidocaine|lidocaine|mesh-list
56175065|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
56388842|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388843|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388844|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388845|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
56388846|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388847|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388848|NCT05594186|Tranexamic Acid|tranexamic acid|mesh-list
56388849|NCT05594186|Contraceptive Agents|contraceptive agents|mesh-list
56388850|NCT05594186|Levonorgestrel|levonorgestrel|mesh-list
56388851|NCT05594186|Contraceptives, Oral|contraceptives, oral|mesh-list
56388852|NCT05594186|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56388853|NCT05594186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56388854|NCT05594186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56388855|NCT05594186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388856|NCT05594186|Hemostatics|hemostatics|mesh-ancestor
56388857|NCT05594186|Coagulants|coagulants|mesh-ancestor
56388858|NCT05594186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56388859|NCT05594186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388860|NCT05594186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56388861|NCT05594186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56388862|NCT05594186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56388863|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56388864|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
56388865|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56388866|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56388867|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
56388868|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888745|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56655423|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56655424|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56655425|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
56655426|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56655427|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56655428|NCT00967057|Analgesics|analgesics|mesh-ancestor
56655429|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
56655430|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56655431|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56655432|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56655433|NCT02633514|Etoposide|etoposide|mesh-list
56655434|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388869|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388871|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56388872|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56388873|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
56388874|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388875|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388876|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388877|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56388878|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56388879|NCT02954068|Oxytocin|oxytocin|mesh-list
56388880|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
56388881|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56388882|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388883|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56388884|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
56388885|NCT00157131|Coagulants|coagulants|mesh-ancestor
56388886|NCT02954029|Hemostatics|hemostatics|mesh-list
56388887|NCT02954029|Coagulants|coagulants|mesh-ancestor
56388888|NCT00508456|Temozolomide|temozolomide|mesh-list
56388889|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56388891|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388892|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388893|NCT00508495|Acetaminophen|acetaminophen|mesh-list
56388894|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56388895|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56388896|NCT00508495|Analgesics|analgesics|mesh-ancestor
56388897|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
56388898|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388899|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388900|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
56388901|NCT00508690|Metronidazole|metronidazole|mesh-list
56388902|NCT00508690|Kanamycin|kanamycin|mesh-list
56388903|NCT00508690|Cefmetazole|cefmetazole|mesh-list
56388904|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388905|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56388907|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56388908|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56388909|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388910|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388911|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56388912|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388913|NCT05591144|Prednisone|prednisone|mesh-list
56388914|NCT05591144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56388915|NCT05591144|Glucocorticoids|glucocorticoids|mesh-ancestor
56388916|NCT05591144|Hormones|hormones|mesh-ancestor
56388917|NCT05591144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388918|NCT05591144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388919|NCT05591144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56388920|NCT05591144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388921|NCT02953522|Folic Acid|folic acid|mesh-list
56388922|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
56388923|NCT02953522|Hematinics|hematinics|mesh-ancestor
56655435|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56655436|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56655437|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56655438|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655439|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388924|NCT02953522|Vitamins|vitamins|mesh-ancestor
56388925|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
56388926|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388927|NCT00148746|Cyclosporine|cyclosporine|mesh-list
56388928|NCT00148746|Prednisolone|prednisolone|mesh-list
56388929|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
56388930|NCT00148746|Prednicarbate|prednicarbate|mesh-list
56388931|NCT00148746|Tacrolimus|tacrolimus|mesh-list
56388932|NCT00148746|Cyclosporins|cyclosporins|mesh-list
56388933|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56388934|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
56388935|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388936|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56388937|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388938|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388939|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
56388940|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388941|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
56388942|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56388943|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56388944|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
56388945|NCT00148746|Hormones|hormones|mesh-ancestor
56388946|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388947|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56388951|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56388952|NCT00148746|Analgesics|analgesics|mesh-ancestor
56388953|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
56388954|NCT00148785|Ritonavir|ritonavir|mesh-list
56388955|NCT00148785|Indinavir|indinavir|mesh-list
56388956|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
56388957|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56388958|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56388959|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
56388960|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388961|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388962|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56388963|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56388964|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
56388965|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388966|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56388967|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56388968|NCT00148824|Vaccines|vaccines|mesh-list
56388969|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56388970|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
56388971|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388972|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
56388973|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
56388974|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56388975|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388976|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56388977|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56388978|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175095|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
56388979|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388980|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388981|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56388982|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56388983|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56388985|NCT00466609|Clomipramine|clomipramine|mesh-list
56388986|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
56388987|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56388988|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56388989|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56388990|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56388991|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388992|NCT00466609|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56655440|NCT00656214|Lycopene|lycopene|mesh-list
56655441|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56655442|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
56388993|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56388994|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56388995|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388996|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388997|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
56388998|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56388999|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56389000|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56389001|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389002|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56389003|NCT00157326|Tadalafil|tadalafil|mesh-list
56389004|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
56389005|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56389006|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56389007|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389008|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389009|NCT00157326|Urological Agents|urological agents|mesh-ancestor
56389010|NCT00466843|Prednisone|prednisone|mesh-list
56389011|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56389012|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389013|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
56389014|NCT00466843|Hormones|hormones|mesh-ancestor
56389015|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56389016|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389017|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56389023|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
56389024|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
56389025|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
56389026|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56389027|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389028|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
56389029|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389030|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
56389031|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389032|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
56389033|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389034|NCT00466999|Misoprostol|misoprostol|mesh-list
56389035|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56389036|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
56389037|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56389038|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389039|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56389040|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389041|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
56389042|NCT00467116|Gemcitabine|gemcitabine|mesh-list
56389043|NCT00467116|Cetuximab|cetuximab|mesh-list
56389044|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56389045|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
56389046|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389047|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389048|NCT00467116|Antiviral Agents|antiviral agents|mesh-ancestor
56389049|NCT00467116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389050|NCT00467116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389051|NCT00467116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56389052|NCT00467116|Immunologic Factors|immunologic factors|mesh-ancestor
56389053|NCT00467116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389054|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56389055|NCT00157482|Simvastatin|simvastatin|mesh-list
56389056|NCT00157482|Ezetimibe|ezetimibe|mesh-list
56389057|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56389058|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56389059|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
56389060|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389061|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56389062|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56389063|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389064|NCT00467194|Sirolimus|sirolimus|mesh-list
56389065|NCT00467194|Bevacizumab|bevacizumab|mesh-list
56389066|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56655443|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655444|NCT00656214|Protective Agents|protective agents|mesh-ancestor
55836955|NCT01946438|Vaccines|vaccines|mesh-list
56389067|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389068|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56389069|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56389070|NCT00467194|Growth Substances|growth substances|mesh-ancestor
56389071|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389072|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
56389073|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56389074|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389075|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56389076|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
56389077|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56389078|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
56389079|NCT00148902|Docetaxel|docetaxel|mesh-list
56389080|NCT00148902|Lapatinib|lapatinib|mesh-list
56389081|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389082|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
56389083|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
56389084|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
56389085|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389086|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56389087|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389088|NCT05507645|Saruplase|saruplase|mesh-list
56389089|NCT05507645|Anticoagulants|anticoagulants|mesh-list
56389090|NCT05507645|Clopidogrel|clopidogrel|mesh-list
56389094|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389096|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56389097|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56389098|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56389099|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
56389100|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389101|NCT03271918|Cabergoline|cabergoline|mesh-list
56389102|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56389103|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56389104|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
56389105|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
56389106|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389107|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389108|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389109|NCT00467467|Alfuzosin|alfuzosin|mesh-list
56389110|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56389111|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56389112|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56389113|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
56389114|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389115|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389116|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389119|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
56389120|NCT00406887|Hormones|hormones|mesh-ancestor
56389121|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56389122|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389124|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56389125|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
56389126|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389127|NCT00467545|Telbivudine|telbivudine|mesh-list
56389128|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
56389129|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389130|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56389131|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389132|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389133|NCT00467662|Acyclovir|acyclovir|mesh-list
56389134|NCT00467662|Docosanol|docosanol|mesh-list
56389135|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
56389136|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389137|NCT05497310|Tretinoin|tretinoin|mesh-list
56389138|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
56389139|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389140|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
56389141|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
56389142|NCT00467935|Ranibizumab|ranibizumab|mesh-list
55919998|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
56655445|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655446|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56655447|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56655448|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655449|NCT02790671|Firuglipel|firuglipel|mesh-list
56389143|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56389144|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56389145|NCT00467935|Growth Substances|growth substances|mesh-ancestor
56389146|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389147|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
56389148|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389149|NCT00149019|Antibodies|antibodies|mesh-list
56389150|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56389151|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
56389152|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389153|NCT00468091|Atropine|atropine|mesh-list
56389154|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56389155|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56389156|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56389157|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
56389158|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389159|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389160|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56389161|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
56389162|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
56389163|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
56389164|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56389167|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389168|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389170|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56389171|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
56389172|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
56389173|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
56389174|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
56389175|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56389176|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389177|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
56389178|NCT00149058|Hematinics|hematinics|mesh-ancestor
56389179|NCT00468520|Oxytocin|oxytocin|mesh-list
56389180|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
56389181|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56389182|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389183|NCT03271450|Warfarin|warfarin|mesh-list
56389184|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
56389185|NCT03271450|Dabigatran|dabigatran|mesh-list
56389186|NCT03271450|Apixaban|apixaban|mesh-list
56389187|NCT03271450|Edoxaban|edoxaban|mesh-list
56389188|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
56389189|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56389190|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
56389191|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56389192|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
56175104|NCT01388049|Antibodies|antibodies|mesh-list
56011177|NCT05774964|Cetuximab|cetuximab|mesh-list
56389194|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389195|NCT00468754|Insulin|insulin|mesh-list
56389196|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56389197|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389198|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56389199|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56389200|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389201|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
56389202|NCT00468871|Hormones|hormones|mesh-ancestor
56389203|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56389204|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389205|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
56389206|NCT00468988|Travoprost|travoprost|mesh-list
56389207|NCT00468988|Latanoprost|latanoprost|mesh-list
56389208|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56389209|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56389210|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56389211|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
56389212|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389213|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56655450|NCT02790671|Itraconazole|itraconazole|mesh-list
56655451|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
56655452|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655453|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56655454|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56655455|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655456|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655457|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56655458|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
56655459|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655460|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655461|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56655462|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56655463|NCT02668094|Lidocaine|lidocaine|mesh-list
56655464|NCT02668094|Pregabalin|pregabalin|mesh-list
56389214|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389215|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389216|NCT00469261|Doxycycline|doxycycline|mesh-list
56389217|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56389218|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389219|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
56389220|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56389221|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56389222|NCT00469300|Acyclovir|acyclovir|mesh-list
56389223|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
56389224|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389225|NCT04697641|Amoxicillin|amoxicillin|mesh-list
56389226|NCT04697641|Clarithromycin|clarithromycin|mesh-list
56389227|NCT04697641|Pantoprazole|pantoprazole|mesh-list
56389229|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56389230|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389231|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56389232|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389233|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389234|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56389235|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56389236|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56389237|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389238|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56389239|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56389240|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
56389241|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389255|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56389256|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56389257|NCT00149253|Analgesics|analgesics|mesh-ancestor
56389258|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
56389259|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389260|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389261|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56389262|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56389263|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56389264|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389265|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389266|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56389267|NCT00469690|Bromfenac|bromfenac|mesh-list
56011253|NCT05773950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389268|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56389269|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56655465|NCT02668094|Propofol|propofol|mesh-list
56655466|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
56655467|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
56389271|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
56389272|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389273|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389274|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389275|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56389276|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56389277|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389278|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389280|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56389281|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56389282|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
56389283|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389284|NCT00469885|Nicotine|nicotine|mesh-list
56389285|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56389286|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
56389287|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389288|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389289|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56389290|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56389291|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
56389292|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389293|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389294|NCT00469924|Caffeine|caffeine|mesh-list
56389295|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56389296|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389297|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56389298|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389299|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389300|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56389301|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56389302|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
56389303|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389314|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56389315|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389316|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
56389317|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389319|NCT00470041|Zidovudine|zidovudine|mesh-list
56389320|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
56389321|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56389322|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56389323|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389324|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389325|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389326|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56389327|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56389328|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
56389329|NCT00157716|Pyridoxal|pyridoxal|mesh-list
56389330|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
56389331|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
56389332|NCT00157716|Vitamins|vitamins|mesh-ancestor
56389333|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
56389334|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389335|NCT00470197|Cytarabine|cytarabine|mesh-list
56389336|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
56389337|NCT00470197|Alvocidib|alvocidib|mesh-list
56389338|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56389339|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
56389340|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389341|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389342|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
56389343|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389344|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717612|NCT02342769|Dolutegravir|dolutegravir|mesh-list
56389345|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
56389346|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389347|NCT00470197|Analgesics|analgesics|mesh-ancestor
56389349|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389350|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56389351|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56389352|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655468|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655469|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655470|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
56389353|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
56389354|NCT00470197|Growth Substances|growth substances|mesh-ancestor
56389355|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56389356|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
56389357|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56389358|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56389359|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389360|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389361|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389363|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
56389364|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
56389365|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389366|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389367|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389368|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56389369|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56389370|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56389371|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56389382|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56175132|NCT01388088|Diuretics|diuretics|mesh-ancestor
56389383|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389384|NCT00470353|Vitamins|vitamins|mesh-ancestor
56389385|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
56389386|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56389387|NCT00470353|Antacids|antacids|mesh-ancestor
56389388|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389389|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389390|NCT05391893|Diltiazem|diltiazem|mesh-list
56389391|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56389392|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56389393|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56389394|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389395|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56389396|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389397|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
56389398|NCT00470509|Adalimumab|adalimumab|mesh-list
56389399|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389400|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56389401|NCT05378906|Darunavir|darunavir|mesh-list
56389402|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56389403|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56389404|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
56389405|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389406|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389407|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56389408|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56389409|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
56389410|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389411|NCT00470665|Sirolimus|sirolimus|mesh-list
56389412|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56389413|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389414|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56389415|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389416|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
56389417|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56389418|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
56389419|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389420|NCT00470743|Ibuprofen|ibuprofen|mesh-list
56389421|NCT00470743|Indomethacin|indomethacin|mesh-list
56011403|NCT05463341|Fentanyl|fentanyl|mesh-list
56389422|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56389424|NCT00470743|Analgesics|analgesics|mesh-ancestor
56389425|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
56389426|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389427|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389428|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389429|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56389430|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56655471|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655472|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56655473|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56655474|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56655475|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56655476|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655477|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56655478|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56655479|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
56655480|NCT02668094|Analgesics|analgesics|mesh-ancestor
56655481|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
56655482|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56655483|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217623|NCT01633099|Decitabine|decitabine|mesh-list
56389431|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389432|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389433|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
56389434|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
56389435|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56389436|NCT00470821|Melatonin|melatonin|mesh-list
56389440|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389441|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56389443|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389444|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
56389445|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
56389446|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389447|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389448|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389449|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
56389450|NCT00335920|Hormones|hormones|mesh-ancestor
56389451|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56389452|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56389453|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389454|NCT00335998|Cisplatin|cisplatin|mesh-list
56389455|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389456|NCT00470977|Ranibizumab|ranibizumab|mesh-list
56389457|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56389458|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56389459|NCT00470977|Growth Substances|growth substances|mesh-ancestor
56389460|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389461|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
56389462|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389464|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56389465|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
56389466|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
56389467|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389468|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389469|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56389470|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56389471|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56389472|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
56389473|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389474|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389475|NCT05350592|Protective Agents|protective agents|mesh-ancestor
56389476|NCT00471055|Capsaicin|capsaicin|mesh-list
56389477|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
56389478|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
56389479|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
56389480|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389481|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655484|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56655485|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56655486|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56655487|NCT00967135|Pregabalin|pregabalin|mesh-list
56655488|NCT00967135|Analgesics|analgesics|mesh-ancestor
56655489|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
56655490|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655491|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655492|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
56655493|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56655494|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56655495|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655496|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56655497|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56655498|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56655499|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655500|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56655501|NCT02666768|Interferons|interferons|mesh-list
56655502|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
56655503|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655504|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
56389482|NCT00471094|Lansoprazole|lansoprazole|mesh-list
56389483|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
56389484|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56389485|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389486|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56389487|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389488|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389489|NCT00157872|Naproxen|naproxen|mesh-list
56389490|NCT00157872|Rofecoxib|rofecoxib|mesh-list
56389491|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56389492|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56389493|NCT00157872|Analgesics|analgesics|mesh-ancestor
56389494|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
56389495|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389496|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389497|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389498|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56389499|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
56389500|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56389501|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389502|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389503|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56389505|NCT03271255|Apatinib|apatinib|mesh-list
56389506|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56389507|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389508|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56389509|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56389511|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389512|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
56389513|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56389514|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389515|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655505|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301604|NCT00027547|Cytarabine|cytarabine|mesh-list
56655507|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56655508|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56655509|NCT00967213|Growth Substances|growth substances|mesh-ancestor
56655510|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655511|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
56655512|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389517|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56389518|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389519|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
56389520|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
56389521|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
56389522|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389523|NCT00336154|Tetracycline|tetracycline|mesh-list
56389524|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56389525|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389526|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56389527|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389528|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389529|NCT00158028|Risperidone|risperidone|mesh-list
56389530|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56389531|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
56389532|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389533|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389534|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389535|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56389536|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56389537|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56389538|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56389539|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56389540|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
56389541|NCT00471406|Verteporfin|verteporfin|mesh-list
56389542|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56389543|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
56389544|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
56389545|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389546|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
56389547|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389548|NCT00471484|Interferons|interferons|mesh-list
56389549|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
56389550|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
56389551|NCT00471484|Doxorubicin|doxorubicin|mesh-list
56389552|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56389553|NCT00471484|Fluorouracil|fluorouracil|mesh-list
56389554|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
56389555|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56389556|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389557|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56389558|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56389559|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389560|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389561|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
56389562|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56389563|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56389564|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
56389565|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389566|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
56389567|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389568|NCT00471523|Metformin|metformin|mesh-list
56389569|NCT00471523|Clomiphene|clomiphene|mesh-list
56389570|NCT00471523|Enclomiphene|enclomiphene|mesh-list
56389571|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
56389572|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56389573|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389574|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56389575|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
56389576|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920356|NCT05109312|Acetaminophen|acetaminophen|mesh-list
56655513|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
56655514|NCT04160676|Thiamine|thiamine|mesh-list
56655515|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
56655516|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56655517|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
56655518|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655519|NCT04160676|Protective Agents|protective agents|mesh-ancestor
56389577|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56389578|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
56389579|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56389580|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56389581|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56389582|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56389583|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56389584|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
56389586|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389590|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389591|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389592|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
56389593|NCT00471640|Hormones|hormones|mesh-ancestor
56389594|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56389595|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56389596|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389597|NCT00471679|Ethanol|ethanol|mesh-list
56389598|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56389599|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389600|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56389601|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389602|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56389603|NCT00149604|Estrogens|estrogens|mesh-list
56389604|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56389605|NCT00149604|Hormones|hormones|mesh-ancestor
56389606|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56389607|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389608|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56389609|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
56389610|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56389611|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56389612|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56389613|NCT05281406|Carboplatin|carboplatin|mesh-list
56389614|NCT05281406|Pemetrexed|pemetrexed|mesh-list
56389615|NCT05281406|Osimertinib|osimertinib|mesh-list
56389616|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389617|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389618|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389619|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56389620|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56389621|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56389622|NCT00471952|Caffeine|caffeine|mesh-list
56389623|NCT00471952|Rizatriptan|rizatriptan|mesh-list
56389624|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56389625|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389626|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56389627|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389628|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389629|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56389630|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56389631|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
56389632|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389633|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56389634|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
56389635|NCT00471991|Dienogest|dienogest|mesh-list
56389636|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56389637|NCT00471991|Estradiol|estradiol|mesh-list
56389638|NCT00471991|Estrogens|estrogens|mesh-ancestor
56389639|NCT00471991|Hormones|hormones|mesh-ancestor
56389640|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56389641|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655520|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655521|NCT04160676|Vitamins|vitamins|mesh-ancestor
56389642|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56389643|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
56389644|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56389645|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56389646|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56389648|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56389649|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
56389650|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56389651|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389652|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56389653|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56389654|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
56389656|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56389657|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389658|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
56389659|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56389662|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56389663|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389664|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
56389665|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389666|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389667|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56389668|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389669|NCT00472225|Rituximab|rituximab|mesh-list
56389670|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56389671|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389672|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
56389673|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389674|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56389675|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
56389676|NCT00336466|Hematinics|hematinics|mesh-ancestor
56389677|NCT00472381|Insulin|insulin|mesh-list
56389678|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56389679|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389680|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56389681|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56389682|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
56389683|NCT00336739|Cinacalcet|cinacalcet|mesh-list
56389684|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56389685|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389686|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56389687|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
56389688|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56389689|NCT00424151|Rituximab|rituximab|mesh-list
56389690|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56389691|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389692|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
56389693|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389694|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56389695|NCT00472810|Mitomycins|mitomycins|mesh-list
56389696|NCT00472810|Mitomycin|mitomycin|mesh-list
56389697|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56389698|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389699|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
56389700|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389701|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56389702|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389703|NCT00337051|Propofol|propofol|mesh-list
56389704|NCT00337051|Sevoflurane|sevoflurane|mesh-list
56389705|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56389706|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56389707|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389708|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56389709|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
56389710|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
56389711|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56389712|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56389713|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56389714|NCT00472927|Estrogens|estrogens|mesh-ancestor
56389715|NCT00472927|Hormones|hormones|mesh-ancestor
56389716|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655522|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
56655523|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
56655524|NCT00660426|Gemcitabine|gemcitabine|mesh-list
56655525|NCT00660426|Capecitabine|capecitabine|mesh-list
56655526|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
56655527|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655528|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
56655529|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389717|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389718|NCT00337090|Mirabegron|mirabegron|mesh-list
55717992|NCT03148509|Bupropion|bupropion|mesh-list
56389719|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56389720|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56389721|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56389722|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
56389723|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389724|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389725|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389726|NCT00337090|Urological Agents|urological agents|mesh-ancestor
56389727|NCT05262452|Folfirinox|folfirinox|mesh-list
56389728|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389729|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
56389730|NCT00337246|Rituximab|rituximab|mesh-list
56389731|NCT00337246|Fludarabine|fludarabine|mesh-list
56389732|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
56175213|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56389736|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389737|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56389738|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56389739|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
56389740|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389741|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389742|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56389743|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56389744|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56389745|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
56389746|NCT00337246|Analgesics|analgesics|mesh-ancestor
56389747|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
56389748|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389749|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56389750|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56389751|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389753|NCT00158301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56389754|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56389755|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56389756|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389757|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389758|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
56389759|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389760|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56389761|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
56389762|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56389763|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56389764|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56389765|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389766|NCT00473005|Capecitabine|capecitabine|mesh-list
56389767|NCT00473005|Everolimus|everolimus|mesh-list
56389768|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56389769|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
56389770|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389771|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389772|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56389773|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
56389774|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389775|NCT00149877|Tegaserod|tegaserod|mesh-list
56389776|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56389777|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
56655530|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655531|NCT00660426|Antiviral Agents|antiviral agents|mesh-ancestor
56655532|NCT00660426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655533|NCT00660426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655534|NCT00660426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655535|NCT00660426|Immunologic Factors|immunologic factors|mesh-ancestor
56655536|NCT00660426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655537|NCT00967291|Ifosfamide|ifosfamide|mesh-list
56655538|NCT00967291|Mitomycins|mitomycins|mesh-list
56655539|NCT00967291|Mitomycin|mitomycin|mesh-list
56655540|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56655541|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
56389778|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389779|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389780|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389781|NCT00473239|Vitamin D|vitamin d|mesh-list
56389782|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
56389783|NCT00473239|Vitamins|vitamins|mesh-ancestor
56389784|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
56389785|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389786|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56389787|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56389788|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
56389789|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56389790|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389791|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56389792|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
56389793|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56389794|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389795|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389796|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389797|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
56389798|NCT00337441|Hematinics|hematinics|mesh-ancestor
56389799|NCT05183048|Panitumumab|panitumumab|mesh-list
56389800|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56389801|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389802|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
56389803|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56389805|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
56389806|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56389807|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56389808|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
56389809|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389810|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389811|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389812|NCT00337558|Urological Agents|urological agents|mesh-ancestor
56389813|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56389814|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56389815|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56389816|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389817|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
56389818|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56389819|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
56389821|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56389822|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56389823|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389824|NCT00158457|Tenofovir|tenofovir|mesh-list
56389825|NCT00158457|Emtricitabine|emtricitabine|mesh-list
56389826|NCT00158457|Efavirenz|efavirenz|mesh-list
56389827|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
56389828|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389829|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56389830|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56389831|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389832|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655542|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655543|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389833|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56389834|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56389835|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56389836|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56389837|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56389838|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56389839|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56389840|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56389841|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56389842|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56389843|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56389844|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
56389845|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389846|NCT00509158|Antacids|antacids|mesh-ancestor
56389847|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389848|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389849|NCT00405080|Rifampin|rifampin|mesh-list
56389850|NCT00405080|Casopitant|casopitant|mesh-list
56389851|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56389852|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
56389853|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56389854|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389855|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
56389856|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56389857|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389858|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389859|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56389860|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56389861|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56389862|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56389863|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56389864|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56389866|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
56389867|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389868|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389869|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389870|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56389871|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389872|NCT00158496|Interferons|interferons|mesh-list
56389873|NCT00158496|Ribavirin|ribavirin|mesh-list
56389874|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
56389875|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
56389876|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56389877|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389879|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389880|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
56389881|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389882|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
56389883|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389884|NCT00337792|Fentanyl|fentanyl|mesh-list
56389885|NCT00337792|Midazolam|midazolam|mesh-list
56389886|NCT00337792|Oxycodone|oxycodone|mesh-list
56389887|NCT00337792|Lorazepam|lorazepam|mesh-list
56389888|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56389889|NCT00337792|Narcotics|narcotics|mesh-ancestor
56389890|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56389891|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389892|NCT00337792|Analgesics|analgesics|mesh-ancestor
56389893|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
56389894|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389895|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56389896|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56389897|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
56389898|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
56389899|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56389900|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56389901|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56389902|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56389903|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
56389904|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
56389905|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655544|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56655545|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56655546|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655547|NCT00645398|Pregabalin|pregabalin|mesh-list
56655548|NCT00645398|Analgesics|analgesics|mesh-ancestor
56389906|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389908|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
56389909|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
56389910|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389911|NCT00509353|Irinotecan|irinotecan|mesh-list
56389912|NCT00509353|Vincristine|vincristine|mesh-list
56389913|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56389914|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56389915|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56389916|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389917|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389918|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389919|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56389920|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
56389921|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
56389922|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
56389923|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56389924|NCT00405119|Esomeprazole|esomeprazole|mesh-list
56389925|NCT00405119|Ranitidine|ranitidine|mesh-list
56389926|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56389927|NCT00405119|Loxtidine|loxtidine|mesh-list
56389928|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56389929|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56389930|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56389931|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389932|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389933|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56389934|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
56389935|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
56389936|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389937|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389938|NCT04715737|Vasopressins|vasopressins|mesh-list
56389939|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
56389940|NCT04715737|Oxytocin|oxytocin|mesh-list
56389941|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
56389942|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56389943|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389944|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
56389945|NCT04715737|Coagulants|coagulants|mesh-ancestor
56389946|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56389947|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56389948|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
56389949|NCT00509431|Sirolimus|sirolimus|mesh-list
56389950|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56389951|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389952|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56389953|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389954|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389955|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56389956|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389960|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
56389961|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389962|NCT00509470|Amlodipine|amlodipine|mesh-list
56389963|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56389964|NCT00509470|Telmisartan|telmisartan|mesh-list
56389965|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56389966|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56389967|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56389968|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389969|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56389970|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389971|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
56389972|NCT00509470|Diuretics|diuretics|mesh-ancestor
56389973|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
56389974|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56389975|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56389976|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56655549|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
56655550|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655551|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655552|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
56655553|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56655554|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56655555|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655556|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56655557|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56655558|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56655559|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655560|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56655561|NCT00884832|Clonidine|clonidine|mesh-list
56655562|NCT00884832|Analgesics|analgesics|mesh-ancestor
56655563|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
56217689|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
56389977|NCT00405158|Acetaminophen|acetaminophen|mesh-list
56389978|NCT00405158|Antipyretics|antipyretics|mesh-list
56389979|NCT00405158|Penicillins|penicillins|mesh-list
56389980|NCT00405158|Floxacillin|floxacillin|mesh-list
56389981|NCT00405158|Cefadroxil|cefadroxil|mesh-list
56389982|NCT00405158|Oxytocin|oxytocin|mesh-list
56389983|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
56389984|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56389985|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389986|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56389987|NCT00405158|Analgesics|analgesics|mesh-ancestor
56389988|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
56389989|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389990|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56389991|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389992|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
56389993|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389994|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56389995|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56389996|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389997|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
56389998|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56389999|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
56390000|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56390001|NCT00150111|Rituximab|rituximab|mesh-list
56390002|NCT00150111|Methimazole|methimazole|mesh-list
56390003|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56390004|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390005|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
56390006|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390007|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390008|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
56390009|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
56390010|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56390011|NCT02953210|Dexamethasone|dexamethasone|mesh-list
56390012|NCT02953210|Ketorolac|ketorolac|mesh-list
56390013|NCT02953210|Lidocaine|lidocaine|mesh-list
56390014|NCT02953210|Clonidine|clonidine|mesh-list
56390015|NCT02953210|Fentanyl|fentanyl|mesh-list
56390016|NCT02953210|Midazolam|midazolam|mesh-list
56390017|NCT02953210|Ketamine|ketamine|mesh-list
56390018|NCT02953210|Ondansetron|ondansetron|mesh-list
56390019|NCT02953210|Bupivacaine|bupivacaine|mesh-list
56390020|NCT02953210|Propofol|propofol|mesh-list
56390021|NCT02953210|Isoflurane|isoflurane|mesh-list
56390022|NCT02953210|Ranitidine|ranitidine|mesh-list
56390023|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56655564|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655565|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655566|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56655567|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
56655568|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
56655569|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56655570|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56655571|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56655572|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
56655573|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655574|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655575|NCT00660582|Leucovorin|leucovorin|mesh-list
56655576|NCT00660582|Folic Acid|folic acid|mesh-list
56655577|NCT00660582|Fluorouracil|fluorouracil|mesh-list
56655578|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
56655579|NCT00660582|Cetuximab|cetuximab|mesh-list
56655580|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
56655581|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
56655582|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655583|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655584|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655585|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655586|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
56655587|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655588|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56655589|NCT00660582|Antidotes|antidotes|mesh-ancestor
56655590|NCT00660582|Protective Agents|protective agents|mesh-ancestor
56655591|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
56655592|NCT00660582|Vitamins|vitamins|mesh-ancestor
56655593|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
56655594|NCT00660582|Hematinics|hematinics|mesh-ancestor
56655595|NCT00646802|Progesterone|progesterone|mesh-list
56655596|NCT00646802|Progestins|progestins|mesh-ancestor
56655597|NCT00646802|Hormones|hormones|mesh-ancestor
56217700|NCT01633762|Gentamicins|gentamicins|mesh-list
56012008|NCT04737187|Trifluridine|trifluridine|mesh-list
56390024|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56390025|NCT02953210|Rocuronium|rocuronium|mesh-list
56390026|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56390027|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
56390029|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390030|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390031|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56390032|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
56655598|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655599|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655600|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56655601|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56655602|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
56655603|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
56655604|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56655605|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
56655606|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655607|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655608|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655609|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655610|NCT03568097|Avelumab|avelumab|mesh-list
56655611|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56655612|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655613|NCT00657228|Heparin|heparin|mesh-list
56655614|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
56655615|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56655616|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56655617|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655618|NCT02666534|Lidocaine|lidocaine|mesh-list
56655619|NCT02666534|Prilocaine|prilocaine|mesh-list
56390033|NCT02953210|Hormones|hormones|mesh-ancestor
56390037|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
56390038|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
56390039|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56390040|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
56390041|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56390042|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56390043|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56390044|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390045|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390046|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56390047|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56390048|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
56390049|NCT02953210|Analgesics|analgesics|mesh-ancestor
56390050|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56390051|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56390052|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56390053|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390054|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56390055|NCT02953210|Narcotics|narcotics|mesh-ancestor
56390056|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56390057|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56390058|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56390059|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56390060|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
56390061|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
56390062|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
56390063|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
56390064|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56390065|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
56655620|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56655621|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56655622|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56655623|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
56655624|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
56655625|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655626|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655627|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
56390066|NCT02953210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56390067|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56390068|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56390069|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390070|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56390071|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390072|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56390073|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56390074|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56390075|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56390076|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
56390077|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56390078|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56390079|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56390080|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
56390081|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56390082|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56390083|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56390084|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
56390085|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
56390086|NCT00509743|Diclofenac|diclofenac|mesh-list
56390087|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56390088|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56390089|NCT00509743|Analgesics|analgesics|mesh-ancestor
56390090|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
56390091|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390092|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390093|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56390094|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390095|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56390096|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390097|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390098|NCT00509860|Irinotecan|irinotecan|mesh-list
56390099|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56390100|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56390101|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390102|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390103|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390111|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
56390112|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
56390113|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390114|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390115|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
56390116|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56390117|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
56390118|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
56390119|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56390120|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56390121|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56390122|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
56390123|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390124|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390125|NCT02958215|Protective Agents|protective agents|mesh-ancestor
56390126|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
56390127|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
56390128|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56390129|NCT00158574|Dapsone|dapsone|mesh-list
56390130|NCT00158574|Mefloquine|mefloquine|mesh-list
56390131|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
56655628|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655629|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56655630|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56655631|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56655632|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56655633|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655634|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56655635|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
56655636|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56655637|NCT02787473|Docetaxel|docetaxel|mesh-list
56655638|NCT02787473|Pemetrexed|pemetrexed|mesh-list
56655639|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655640|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
56655641|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
56655642|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
56655643|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655644|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655645|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56655646|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56655647|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
56655648|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56655649|NCT00967603|Sunitinib|sunitinib|mesh-list
56655650|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655651|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56655652|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56655653|NCT00967603|Growth Substances|growth substances|mesh-ancestor
56655654|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655655|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
56655656|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56655657|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655658|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655659|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
56217773|NCT01634295|Vitamins|vitamins|mesh-ancestor
56390132|NCT00158574|Proguanil|proguanil|mesh-list
56390133|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
56390134|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56390135|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56390136|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390137|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56390138|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390139|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920358|NCT05109312|Bupivacaine|bupivacaine|mesh-list
56655660|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56655661|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56655662|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655663|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
56655664|NCT00657384|Coagulants|coagulants|mesh-ancestor
56655665|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
55840380|NCT01853228|Cytarabine|cytarabine|mesh-list
56390140|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56390141|NCT00158574|Renal Agents|renal agents|mesh-ancestor
56390142|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
56390143|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56390144|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
56390145|NCT05071313|Vaccines|vaccines|mesh-list
56390146|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
56390147|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390148|NCT00338221|Glycine|glycine|mesh-list
56390149|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
56390150|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390151|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390152|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390153|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
56390154|NCT00338299|Hematinics|hematinics|mesh-ancestor
56390155|NCT00510016|Clonidine|clonidine|mesh-list
56390156|NCT00510016|Analgesics|analgesics|mesh-ancestor
56390157|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
56390158|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390159|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390160|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56390161|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
56390162|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
56390163|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56390164|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56390165|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56390166|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
56390167|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390168|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390169|NCT00150228|Varenicline|varenicline|mesh-list
56390170|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56390171|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56390172|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
56390173|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390174|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390176|NCT00338338|Amlodipine|amlodipine|mesh-list
56390177|NCT00338338|Lacidipine|lacidipine|mesh-list
56390180|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390181|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390182|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56390183|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390184|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
56390186|NCT00338416|Hematinics|hematinics|mesh-ancestor
56390187|NCT00338494|Clofarabine|clofarabine|mesh-list
56390188|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390189|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
56390190|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390191|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390192|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56390193|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56390194|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56390195|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390196|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390197|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56390198|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390199|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390200|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
56390201|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390202|NCT00158652|Carboplatin|carboplatin|mesh-list
56390203|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390204|NCT00338650|Adalimumab|adalimumab|mesh-list
56390205|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56655666|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655667|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56655668|NCT00646880|Propiverine|propiverine|mesh-list
56655669|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56655670|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56655671|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
56655672|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655673|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655674|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655675|NCT00646880|Urological Agents|urological agents|mesh-ancestor
56655676|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
56655677|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
55840442|NCT04605393|Analgesics|analgesics|mesh-ancestor
56390206|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390207|NCT00158691|Amifostine|amifostine|mesh-list
56390208|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56390209|NCT00158691|Protective Agents|protective agents|mesh-ancestor
56390210|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390211|NCT00338767|Fluoxetine|fluoxetine|mesh-list
56390212|NCT00338767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56390213|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56390214|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390215|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390216|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390217|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
56390218|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390219|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56390220|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
56390221|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56390222|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56390223|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56390224|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390225|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
56390226|NCT00339001|Hematinics|hematinics|mesh-ancestor
56390227|NCT00150306|Sertraline|sertraline|mesh-list
56175353|NCT01389414|Antiviral Agents|antiviral agents|mesh-ancestor
56390228|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
56390229|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56390230|NCT00150306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56390231|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56390232|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390233|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390234|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390235|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
56390236|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390237|NCT00510172|Epoprostenol|epoprostenol|mesh-list
56390238|NCT00510172|Tezosentan|tezosentan|mesh-list
56390239|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56390240|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56390241|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
56390242|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
56390243|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
56390244|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56390245|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56390246|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390247|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390251|NCT00150384|Atorvastatin|atorvastatin|mesh-list
56390252|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56390253|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56390254|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
56390255|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655678|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655679|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
56655680|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
56655681|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56655682|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
56655683|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655684|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655685|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56655686|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
56655687|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655688|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655689|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56655690|NCT00968461|Protective Agents|protective agents|mesh-ancestor
56655691|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655692|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655693|NCT04157010|Methotrexate|methotrexate|mesh-list
56655694|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56655695|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
56390256|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56390257|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56390258|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390259|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56390260|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56390261|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390262|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56390263|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390264|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
56390265|NCT00425191|Gemcitabine|gemcitabine|mesh-list
56390267|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390268|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390269|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
56390270|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390271|NCT00425191|Antiviral Agents|antiviral agents|mesh-ancestor
56390272|NCT00425191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390273|NCT00425191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390274|NCT00425191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390275|NCT00425191|Immunologic Factors|immunologic factors|mesh-ancestor
56390276|NCT00425191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390277|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
56390278|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
56390279|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
56390280|NCT00339118|Doxorubicin|doxorubicin|mesh-list
56390281|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
56390282|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56390283|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390284|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56390285|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56390286|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390287|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390288|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390289|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
56390290|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390291|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390292|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56390293|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
56390294|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56655696|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56655697|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655698|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655699|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
56655700|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655701|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390295|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56390296|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390298|NCT00339196|Tretinoin|tretinoin|mesh-list
56390299|NCT00339196|Valproic Acid|valproic acid|mesh-list
56390300|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390301|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
56390302|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390303|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390304|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390305|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
56390306|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
56390307|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
56390308|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
56390309|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390310|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390311|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
56390312|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56390313|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56390314|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56390315|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56390316|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
56390317|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390318|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56390319|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56390320|NCT00510211|Olanzapine|olanzapine|mesh-list
56390321|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
56390322|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
56390323|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390326|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56390327|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56390328|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56390329|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56390330|NCT00510211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56390331|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56390332|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390333|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390334|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390335|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
56390336|NCT00150423|Pregabalin|pregabalin|mesh-list
56390337|NCT00150423|Analgesics|analgesics|mesh-ancestor
56390338|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
56390339|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390340|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390341|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
56390342|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56390343|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56175380|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
56390344|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390345|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56390346|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56390347|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56390348|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56390349|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56390350|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
56390351|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56390352|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56390353|NCT04988282|Prednisolone|prednisolone|mesh-list
56390354|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
56390355|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56390356|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
56390357|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56390358|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
56390359|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
56390360|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390361|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390362|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56390363|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
56390364|NCT04988282|Hormones|hormones|mesh-ancestor
56390365|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56390366|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56390367|NCT04988282|Protective Agents|protective agents|mesh-ancestor
56390368|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56390369|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390370|NCT00510250|Sorafenib|sorafenib|mesh-list
56390371|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390372|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390373|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390374|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390375|NCT04981067|Ropivacaine|ropivacaine|mesh-list
56390376|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
56390377|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
56390378|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56390379|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390380|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
56390381|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390382|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
56390383|NCT00510367|Doxorubicin|doxorubicin|mesh-list
56390384|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56390385|NCT00510367|Fluorouracil|fluorouracil|mesh-list
56390386|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390387|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
56390388|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390389|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390390|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56390391|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
56390392|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390393|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390394|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56390396|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56390397|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56390399|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
56390400|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390401|NCT00158847|Fluticasone|fluticasone|mesh-list
56390402|NCT00158847|Xhance|xhance|mesh-list
56390403|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56390404|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56390405|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56390406|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
56390407|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390408|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390409|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56390410|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
56390411|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
56390412|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56390413|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56390414|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56390415|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56390416|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
56390417|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390418|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390419|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56390420|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390421|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390422|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390423|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390424|NCT00158886|Topotecan|topotecan|mesh-list
56390425|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56390426|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56390427|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390428|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390429|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390430|NCT00510406|Tamsulosin|tamsulosin|mesh-list
56390431|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
56390432|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56390433|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56655702|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
56655703|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655704|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56655705|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655706|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
56655707|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217836|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56390434|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56390435|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
56390436|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390437|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390438|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390439|NCT00510406|Urological Agents|urological agents|mesh-ancestor
56390440|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56390441|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56390442|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
56390443|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
56390444|NCT00165555|Antidotes|antidotes|mesh-ancestor
56390445|NCT00165555|Protective Agents|protective agents|mesh-ancestor
56390446|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390447|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
56390448|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390449|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
56390450|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56390451|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390452|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
56390453|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
56390454|NCT00150579|Amphetamine|amphetamine|mesh-list
56390455|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
56390456|NCT00150579|Adderall|adderall|mesh-list
56390457|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56390458|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390459|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
56390460|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
56390461|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390462|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
56390463|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390464|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390465|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
56390466|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56390467|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56390468|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390471|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56390472|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390473|NCT00510445|Imetelstat|imetelstat|mesh-list
56390474|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
56390475|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390476|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390477|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390479|NCT00150657|Bevacizumab|bevacizumab|mesh-list
56390480|NCT00150657|Carboplatin|carboplatin|mesh-list
56390481|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56390482|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390483|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56390484|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56390485|NCT00150657|Growth Substances|growth substances|mesh-ancestor
56390486|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390487|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
56390488|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390489|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
56390490|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390491|NCT00150657|Antiviral Agents|antiviral agents|mesh-ancestor
56390492|NCT00150657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390493|NCT00150657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390494|NCT00150657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390495|NCT00150657|Immunologic Factors|immunologic factors|mesh-ancestor
56390496|NCT00511771|Tegaserod|tegaserod|mesh-list
56390497|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56390498|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
56655708|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56655709|NCT02632032|Insulin|insulin|mesh-list
56655710|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56655711|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56655712|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655713|NCT00973609|Folic Acid|folic acid|mesh-list
56655714|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
56655715|NCT00973609|Bevacizumab|bevacizumab|mesh-list
56655716|NCT00973609|Fluorouracil|fluorouracil|mesh-list
56655717|NCT00973609|Capecitabine|capecitabine|mesh-list
56655718|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56655719|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390499|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390500|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390501|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390502|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56390503|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390504|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56390505|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390506|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390507|NCT00511849|Paclitaxel|paclitaxel|mesh-list
56390508|NCT00511849|Carboplatin|carboplatin|mesh-list
56390509|NCT00511849|Sunitinib|sunitinib|mesh-list
56390510|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56390511|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390512|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
56390513|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
56390514|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
56390515|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390516|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56175427|NCT01389544|Narcotics|narcotics|mesh-ancestor
56390517|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56390519|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390520|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
56390521|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390522|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390523|NCT00510640|Sunitinib|sunitinib|mesh-list
56390524|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390525|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56390526|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56390527|NCT00510640|Growth Substances|growth substances|mesh-ancestor
56390528|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390529|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
56390530|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390531|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390532|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390533|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
56390534|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56390535|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390536|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390537|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56390538|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390539|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56390540|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
56390541|NCT00165633|Menatetrenone|menatetrenone|mesh-list
56390546|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390548|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
56390549|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390550|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56390551|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390552|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56390553|NCT00510913|Tacrolimus|tacrolimus|mesh-list
56655720|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56655721|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56655722|NCT00973609|Growth Substances|growth substances|mesh-ancestor
56655723|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655724|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
56655725|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
56655726|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655727|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655728|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655729|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
56655730|NCT00973609|Hematinics|hematinics|mesh-ancestor
56655731|NCT00973609|Vitamins|vitamins|mesh-ancestor
56655732|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
56301824|NCT00027937|Aldesleukin|aldesleukin|mesh-list
56655733|NCT02537054|Aflibercept|aflibercept|mesh-list
56655734|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56655735|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56655736|NCT02537054|Growth Substances|growth substances|mesh-ancestor
56655737|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655738|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
56217852|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56390554|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390555|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
56390556|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390557|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56390558|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390559|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390560|NCT00150735|Levetiracetam|levetiracetam|mesh-list
56390561|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
56390562|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
56390563|NCT04695925|Carboplatin|carboplatin|mesh-list
56390564|NCT04695925|Pemetrexed|pemetrexed|mesh-list
56390565|NCT04695925|Osimertinib|osimertinib|mesh-list
56390566|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390567|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390568|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390569|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56390570|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56390571|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390572|NCT00511069|Bortezomib|bortezomib|mesh-list
56390573|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390574|NCT00165750|Donepezil|donepezil|mesh-list
56390575|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56390576|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390577|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390578|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
56390579|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390580|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390581|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
56390582|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
56390583|NCT00511225|Vitamin D|vitamin d|mesh-list
56390584|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56390585|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390586|NCT00511225|Vitamins|vitamins|mesh-ancestor
56390587|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
56655739|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655740|NCT00973687|Dexamethasone|dexamethasone|mesh-list
56655741|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56655742|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
56655743|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
56655744|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655745|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655746|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56655747|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
56655748|NCT00973687|Hormones|hormones|mesh-ancestor
56655749|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56390588|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56390589|NCT00150774|Levetiracetam|levetiracetam|mesh-list
56390590|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
56390591|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
56390592|NCT04864067|Leucovorin|leucovorin|mesh-list
56390594|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
56390595|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390596|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
56390597|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390598|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390599|NCT04864067|Antidotes|antidotes|mesh-ancestor
56390600|NCT04864067|Protective Agents|protective agents|mesh-ancestor
56390601|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390602|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
56390603|NCT04864067|Vitamins|vitamins|mesh-ancestor
56390604|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
56390605|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
56390606|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390607|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390608|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390609|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390610|NCT00165828|Zonisamide|zonisamide|mesh-list
56390611|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
56390612|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56390613|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390614|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390615|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56390616|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390621|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390622|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390623|NCT00511498|Urological Agents|urological agents|mesh-ancestor
56390627|NCT00511576|Mocetinostat|mocetinostat|mesh-list
56390628|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390629|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
56390630|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
56390631|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56390632|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390633|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56390634|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390635|NCT00511654|Midazolam|midazolam|mesh-list
56390636|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56390637|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56390638|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56390639|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390640|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56390641|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56390642|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56390643|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56390644|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
56390645|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
56390646|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
56390647|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
56390648|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888746|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56655750|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56655751|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655752|NCT02785757|Thrombin|thrombin|mesh-list
56655753|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
56655754|NCT02785757|Coagulants|coagulants|mesh-ancestor
56655755|NCT00645554|Galantamine|galantamine|mesh-list
56390649|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390650|NCT04799249|Gemcitabine|gemcitabine|mesh-list
56390651|NCT04799249|Carboplatin|carboplatin|mesh-list
56390652|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390653|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390654|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
56390655|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390656|NCT04799249|Antiviral Agents|antiviral agents|mesh-ancestor
56390657|NCT04799249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390658|NCT04799249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390659|NCT04799249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390660|NCT04799249|Immunologic Factors|immunologic factors|mesh-ancestor
56390661|NCT04799249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390662|NCT00150852|Vancomycin|vancomycin|mesh-list
56390663|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56390664|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390665|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
56390666|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56390667|NCT02952235|Protective Agents|protective agents|mesh-ancestor
56390668|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390669|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
56390670|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56390671|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390672|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56390673|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390674|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390675|NCT02951806|Fentanyl|fentanyl|mesh-list
56390676|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56390677|NCT02951806|Narcotics|narcotics|mesh-ancestor
56390678|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56390679|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390680|NCT02951806|Analgesics|analgesics|mesh-ancestor
56390681|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
56390682|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390683|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56390684|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56390685|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
56390686|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
56390687|NCT00512980|Gemcitabine|gemcitabine|mesh-list
56390688|NCT00512980|Prednisone|prednisone|mesh-list
56390689|NCT00512980|Doxorubicin|doxorubicin|mesh-list
56390690|NCT00512980|Vinblastine|vinblastine|mesh-list
56390697|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390698|NCT00512980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390699|NCT00512980|Immunologic Factors|immunologic factors|mesh-ancestor
56390700|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390701|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56390702|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56390703|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56390704|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56390706|NCT00512980|Hormones|hormones|mesh-ancestor
56390707|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56390708|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56390709|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56390710|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
56390711|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
56390712|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
56390713|NCT00150891|Cyclosporine|cyclosporine|mesh-list
56390714|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
56390715|NCT00150891|Azathioprine|azathioprine|mesh-list
56390716|NCT00150891|Tacrolimus|tacrolimus|mesh-list
56390717|NCT00150891|Cyclosporins|cyclosporins|mesh-list
56390718|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390719|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
56390720|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390721|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56655756|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56655757|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655758|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655759|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
56655760|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655761|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655762|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56655763|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
56655764|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655765|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
56655766|NCT02785601|Trazodone|trazodone|mesh-list
56655767|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56655768|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56655769|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655770|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655771|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56655772|NCT02785601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56655773|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56655774|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56655775|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655776|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655777|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
56655778|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56655779|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
56655780|NCT05299567|Azithromycin|azithromycin|mesh-list
56655781|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56390722|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390723|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390724|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
56390725|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390726|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
56390727|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390728|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56390729|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390730|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56390731|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
56390732|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56390733|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
56390734|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390735|NCT00513058|Vinorelbine|vinorelbine|mesh-list
56390736|NCT00513058|Lapatinib|lapatinib|mesh-list
56390737|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56390738|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390739|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
56390740|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
56390741|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
56390742|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655782|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655783|NCT00660894|Leucovorin|leucovorin|mesh-list
56655784|NCT00660894|Tegafur|tegafur|mesh-list
56655785|NCT00660894|Calcium|calcium|mesh-list
56655786|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
56655787|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56655788|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655789|NCT00660894|Antidotes|antidotes|mesh-ancestor
56655790|NCT00660894|Protective Agents|protective agents|mesh-ancestor
56655791|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
56655792|NCT00660894|Vitamins|vitamins|mesh-ancestor
56655793|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
56655794|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655795|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
55841460|NCT04023292|Tamoxifen|tamoxifen|mesh-list
56390743|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390744|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390745|NCT02951962|Amlodipine|amlodipine|mesh-list
56390746|NCT02951962|Telmisartan|telmisartan|mesh-list
56390747|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56390748|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56390749|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56390750|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56390751|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390752|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390753|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56390754|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390755|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
56390756|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56390757|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56390758|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
56390759|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56390760|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56390761|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390764|NCT00513253|Lapatinib|lapatinib|mesh-list
56390765|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390766|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390767|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390768|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390769|NCT00513487|Fluticasone|fluticasone|mesh-list
56390770|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
56390771|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56390772|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56390773|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
56390774|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390775|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390776|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56012765|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56390777|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
56390779|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56390780|NCT00513487|Miotics|miotics|mesh-ancestor
56390781|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56390782|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56390783|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56390784|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56390785|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
56390786|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390787|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390788|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
56390789|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56390790|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
56390791|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390792|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655796|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655797|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655798|NCT00660972|Tenofovir|tenofovir|mesh-list
56655799|NCT00660972|Emtricitabine|emtricitabine|mesh-list
56655800|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
56655801|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56655802|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
56390793|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56390794|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
56390795|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
56390796|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56390797|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
56390798|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390799|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390800|NCT00403949|Azelaic acid|azelaic acid|mesh-list
56390801|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390802|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
56390803|NCT00513643|Insulin|insulin|mesh-list
56390804|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56390805|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
56390806|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56390807|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390808|NCT00151008|Bexarotene|bexarotene|mesh-list
56390809|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390810|NCT00513877|Bortezomib|bortezomib|mesh-list
56390811|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390812|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
56390813|NCT04695613|Analgesics|analgesics|mesh-ancestor
56390814|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
56175452|NCT01389713|Clomiphene|clomiphene|mesh-list
56390815|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390816|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390817|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
56390818|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56390819|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56390820|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
56390821|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56390822|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390823|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390824|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56390825|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
56390826|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56390827|NCT00151047|Docetaxel|docetaxel|mesh-list
56390828|NCT00151047|Capecitabine|capecitabine|mesh-list
56390829|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390830|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
56390831|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
56390832|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
56390833|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390843|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
56390844|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390845|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390846|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56390847|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
56390848|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390849|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390850|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56390851|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56390852|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56390853|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56390854|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390855|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56390856|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
56390857|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
56390858|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
56390859|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56390860|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
56390861|NCT00513955|Hormones|hormones|mesh-ancestor
56655803|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56655804|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56655805|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56655806|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655807|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655808|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56655809|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55841613|NCT04140136|Vitamin E|vitamin e|mesh-list
56390862|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56390863|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56390864|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
56390865|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
56390866|NCT00514072|Vaccines|vaccines|mesh-list
56390867|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
56390868|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
56390869|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390870|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56390871|NCT00514111|Interferons|interferons|mesh-list
56390872|NCT00514111|Ribavirin|ribavirin|mesh-list
56390873|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390874|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
56390875|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390876|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
56390877|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390878|NCT00151086|Vinorelbine|vinorelbine|mesh-list
56390879|NCT00151086|Estramustine|estramustine|mesh-list
56390880|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56390881|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390882|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
56390883|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
56390884|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
56390885|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390886|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56390887|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
56390888|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56390889|NCT00514228|Sunitinib|sunitinib|mesh-list
56390890|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390891|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56390892|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56390893|NCT00514228|Growth Substances|growth substances|mesh-ancestor
56390894|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390895|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
56390896|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390897|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390898|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390899|NCT04720781|Esomeprazole|esomeprazole|mesh-list
56390900|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56390901|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56390904|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390906|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390907|NCT00514618|Misoprostol|misoprostol|mesh-list
56390908|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56390909|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
56390910|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56390911|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390912|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56390913|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56390914|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
56390915|NCT00514657|Mitogens|mitogens|mesh-list
56390916|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
56390917|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390918|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56390919|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56390920|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56390922|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56390923|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655810|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56655811|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56655812|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
56655813|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56655814|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56655815|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
56655816|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655817|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390924|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
56390925|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56390926|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390927|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012922|NCT00004924|Paclitaxel|paclitaxel|mesh-list
56390928|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56390929|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56390930|NCT02951299|Protective Agents|protective agents|mesh-ancestor
56390931|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390932|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
56390933|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56390934|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
56390935|NCT00514891|Vitamin A|vitamin a|mesh-list
56390936|NCT00514891|Vitamins|vitamins|mesh-ancestor
56390937|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
56390938|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390939|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
56390940|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390941|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56390942|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390943|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390944|NCT02950948|Progesterone|progesterone|mesh-list
56390945|NCT02950948|Progestins|progestins|mesh-ancestor
56390946|NCT02950948|Hormones|hormones|mesh-ancestor
56390947|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56390948|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390949|NCT00515320|Fluoxetine|fluoxetine|mesh-list
56390950|NCT00515320|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56390951|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56390952|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56390953|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390954|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56390955|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
56390956|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390957|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56390958|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
56390959|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56390960|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56390961|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56390962|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390963|NCT00515359|Propofol|propofol|mesh-list
56390964|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56390965|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56390966|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390967|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56390968|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
56390969|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
56390970|NCT00515554|Rituximab|rituximab|mesh-list
56390971|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56390972|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390973|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
56390979|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56390980|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
56390981|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
56390982|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56390983|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390984|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56390985|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
56390986|NCT00151203|Hormones|hormones|mesh-ancestor
56655818|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655819|NCT02667470|Urological Agents|urological agents|mesh-ancestor
56655821|NCT05327699|Analgesics|analgesics|mesh-ancestor
56655822|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
56655823|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655824|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655825|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56655826|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56655827|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
56655828|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
56655829|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217941|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56390987|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56390988|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56390989|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390990|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
56390991|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56390992|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56390993|NCT00151203|Growth Substances|growth substances|mesh-ancestor
56390994|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
56390995|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56390996|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390997|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56390998|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390999|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391000|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56391001|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56391003|NCT04620200|Ipilimumab|ipilimumab|mesh-list
56391004|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
56391005|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56391006|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391007|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56391008|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391009|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391010|NCT00515593|Hormones|hormones|mesh-list
56391011|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
56391012|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56391013|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391014|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56391015|NCT00515788|Cytarabine|cytarabine|mesh-list
56391016|NCT00515788|Temozolomide|temozolomide|mesh-list
56391017|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56391018|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
56391019|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391020|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391021|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
56391022|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391023|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391024|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
56391025|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391026|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56391027|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
56391028|NCT02950870|Ritonavir|ritonavir|mesh-list
56391029|NCT02950870|Ribavirin|ribavirin|mesh-list
56391030|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56391031|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56391032|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
56391033|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391034|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391035|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56655830|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56655831|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56655832|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655833|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391036|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56391037|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
56391038|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391039|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56391040|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56391041|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
56391042|NCT00515866|Gemcitabine|gemcitabine|mesh-list
56391043|NCT00515866|Olaparib|olaparib|mesh-list
56391044|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56391046|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
56391047|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391048|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391049|NCT00515866|Antiviral Agents|antiviral agents|mesh-ancestor
56391050|NCT00515866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391051|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391052|NCT00515866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391053|NCT00515866|Immunologic Factors|immunologic factors|mesh-ancestor
56391054|NCT00515866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391056|NCT00515905|Sevoflurane|sevoflurane|mesh-list
56391057|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56391058|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391059|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391060|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56391061|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
56391062|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
56391063|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56391064|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56391065|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
56391066|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56391068|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56391069|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391070|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391071|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
56391072|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391073|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391074|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56013072|NCT00004186|Carboplatin|carboplatin|mesh-list
56391075|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391076|NCT00151242|Cytarabine|cytarabine|mesh-list
56391077|NCT00151242|Etoposide|etoposide|mesh-list
56391078|NCT00151242|Idarubicin|idarubicin|mesh-list
56391079|NCT00151242|Tretinoin|tretinoin|mesh-list
56391080|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56391081|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391082|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56391083|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56391084|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391085|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391086|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56391087|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
56391088|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
56391089|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391090|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391091|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
56391092|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391093|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56391094|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
56391095|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
56391096|NCT00516100|Pemetrexed|pemetrexed|mesh-list
56391097|NCT00516100|Bortezomib|bortezomib|mesh-list
56391098|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391099|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391100|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391101|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56391102|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56391103|NCT00166413|Thalidomide|thalidomide|mesh-list
56655834|NCT05050136|Volixibat|volixibat|mesh-list
56655835|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56655836|NCT04157478|Temozolomide|temozolomide|mesh-list
56655837|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56391104|NCT00166413|Lenalidomide|lenalidomide|mesh-list
56391105|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391106|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
56391107|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391108|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
56391109|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56391110|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391111|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56391112|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56391113|NCT00166413|Growth Substances|growth substances|mesh-ancestor
56391114|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
56391115|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391116|NCT02950441|Niacinamide|niacinamide|mesh-list
56391117|NCT02950441|Niacin|niacin|mesh-list
56391118|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
56391119|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
56391125|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391127|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
56391128|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
56391129|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56391130|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391131|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
56391132|NCT02950168|Edoxaban|edoxaban|mesh-list
56391133|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56391134|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
56391135|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56391136|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
56391137|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391138|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391139|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
56391140|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
56391141|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391142|NCT00166491|Insulin|insulin|mesh-list
56391143|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56391144|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391145|NCT04505189|Psilocybin|psilocybin|mesh-list
56391146|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
56391147|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391148|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56391149|NCT00508885|Niacinamide|niacinamide|mesh-list
56391150|NCT00508885|Niacin|niacin|mesh-list
56391151|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
56391152|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
56391153|NCT00508885|Vitamins|vitamins|mesh-ancestor
56391154|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
56391155|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391156|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56391157|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
56391158|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391159|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56391160|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
56391162|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56391163|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56391164|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56391165|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56391166|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
56391167|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391168|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391169|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391170|NCT00516802|Olaparib|olaparib|mesh-list
56391171|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56391172|NCT00516802|Dacarbazine|dacarbazine|mesh-list
56391173|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391174|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391175|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391176|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56391177|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
56391178|NCT02949895|Etoposide|etoposide|mesh-list
56391179|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888747|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
56655838|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
56655839|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655840|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655841|NCT00647192|Eplerenone|eplerenone|mesh-list
56655842|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56655843|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
56217956|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391180|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56391181|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56391182|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56391183|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391184|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391185|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
56391186|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56391187|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391188|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
56391189|NCT00516841|Volociximab|volociximab|mesh-list
56391190|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56391191|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56391196|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
56391197|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56391198|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391199|NCT04694677|Misoprostol|misoprostol|mesh-list
56391200|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
56391201|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56391202|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56391203|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391204|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
56391205|NCT04694677|Coagulants|coagulants|mesh-ancestor
56391206|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56391207|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
56391208|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56391209|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391210|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56391211|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56391212|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
56391213|NCT00516958|Levofloxacin|levofloxacin|mesh-list
56391214|NCT00516958|Ofloxacin|ofloxacin|mesh-list
56391215|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56391216|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56391217|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391218|NCT00516958|Renal Agents|renal agents|mesh-ancestor
56391219|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56391220|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56391221|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56391223|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391224|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391225|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56391226|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56391227|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
56391228|NCT00517114|Rabeprazole|rabeprazole|mesh-list
56391229|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56391230|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56391231|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56391232|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391233|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391234|NCT00517270|Rabeprazole|rabeprazole|mesh-list
56391235|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56391236|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56391237|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56391238|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391239|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391240|NCT00517309|Vaccines|vaccines|mesh-list
56391241|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
56391242|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391243|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56391244|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
56655844|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56655845|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655846|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56655847|NCT00647192|Diuretics|diuretics|mesh-ancestor
56655848|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
56655849|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56655850|NCT00661206|Clopidogrel|clopidogrel|mesh-list
56655851|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56655852|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56655853|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56655854|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56655855|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
56655856|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655857|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655858|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655859|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
56655860|NCT05276960|Vitamin D|vitamin d|mesh-list
56655861|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56391245|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56391246|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56391247|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56391248|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391249|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391250|NCT00517426|Acetazolamide|acetazolamide|mesh-list
56391251|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
56391252|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56391253|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391254|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391255|NCT00517426|Diuretics|diuretics|mesh-ancestor
56391256|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
56391257|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391258|NCT00517504|Methylphenidate|methylphenidate|mesh-list
56391259|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56391260|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391261|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56391262|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56391263|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391267|NCT00517582|Icatibant|icatibant|mesh-list
56391268|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56391269|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56391270|NCT00517582|Analgesics|analgesics|mesh-ancestor
56391271|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
56391272|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391273|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391274|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56391275|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391276|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56391277|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56391278|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391279|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56391280|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391281|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
56391282|NCT00517621|Paclitaxel|paclitaxel|mesh-list
56655862|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655863|NCT05276960|Vitamins|vitamins|mesh-ancestor
56655864|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
56655865|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56655866|NCT02787317|Heparin|heparin|mesh-list
56655867|NCT02787317|Bivalirudin|bivalirudin|mesh-list
56655868|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
56655869|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56655870|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56391283|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56391284|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391285|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
56391286|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
56391287|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
56391288|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391289|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55719563|NCT03493087|Coagulants|coagulants|mesh-ancestor
56391290|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56391291|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391292|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391293|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
56391294|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391295|NCT00151515|Minoxidil|minoxidil|mesh-list
56391296|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56391297|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
56391298|NCT00166686|Clonidine|clonidine|mesh-list
56391299|NCT00166686|Analgesics|analgesics|mesh-ancestor
56391300|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
56391301|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391302|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391303|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56391305|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
56391306|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56391307|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56391308|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56391309|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
56391310|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391311|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391312|NCT02949778|Ropivacaine|ropivacaine|mesh-list
56391313|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
56391314|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
56391315|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391316|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391317|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
56391318|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391319|NCT00518245|Enoxaparin|enoxaparin|mesh-list
56391320|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
56391321|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56391322|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56391323|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391324|NCT02957903|Ropivacaine|ropivacaine|mesh-list
56391325|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
56391326|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
56391327|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391328|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391329|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
56391330|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391331|NCT00518479|Amlodipine|amlodipine|mesh-list
56391332|NCT00518479|Valsartan|valsartan|mesh-list
56391333|NCT00518479|Moxonidine|moxonidine|mesh-list
56391334|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
56391339|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56391340|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391341|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
56391342|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56391343|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56391344|NCT00518479|Diuretics|diuretics|mesh-ancestor
56655871|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655872|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
56655873|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56655874|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
56655875|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655876|NCT00645632|Doxorubicin|doxorubicin|mesh-list
56655877|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56655878|NCT00645632|Methotrexate|methotrexate|mesh-list
56655879|NCT00645632|Ifosfamide|ifosfamide|mesh-list
56655880|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655881|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56655882|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56655883|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56655884|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655885|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655886|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56655887|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
56391345|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
56391346|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56391347|NCT00166725|Octreotide|octreotide|mesh-list
56391348|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56391349|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56391350|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391351|NCT00518635|Insulin|insulin|mesh-list
56391352|NCT00518635|Hormones|hormones|mesh-list
56391353|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56391354|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391355|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56391356|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
56391357|NCT00151632|Tacrolimus|tacrolimus|mesh-list
56391358|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391359|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
56391360|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391361|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56391362|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391363|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391364|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56391365|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391366|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56391367|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
56391368|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56391369|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391370|NCT02949232|Prednisolone|prednisolone|mesh-list
56391371|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56391372|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
56391373|NCT02949232|Hormones|hormones|mesh-ancestor
56391374|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013370|NCT00004252|Fluorouracil|fluorouracil|mesh-list
56391375|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391376|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56391377|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391379|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56391380|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56391381|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
56391382|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
56391383|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391384|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218002|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
56655888|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56655889|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655890|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56655891|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
56655892|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
56655893|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56655894|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56655895|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
56655896|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56655897|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56655898|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56655899|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
56655900|NCT04156464|Lorazepam|lorazepam|mesh-list
56655901|NCT04156464|Phenobarbital|phenobarbital|mesh-list
56655902|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
56655903|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
56655904|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
56655905|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655906|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655907|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56655908|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56655909|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655910|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55794184|NCT04785755|Etilefrine|etilefrine|mesh-list
56391385|NCT00518947|Verapamil|verapamil|mesh-list
56391386|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
56391387|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
56391388|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56391389|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391390|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391391|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
56391392|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56391393|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391394|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391395|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56391396|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56391397|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391398|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56391399|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
56391400|NCT02949466|Triamcinolone|triamcinolone|mesh-list
56391401|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
56391402|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56391403|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
56391410|NCT02949466|Protective Agents|protective agents|mesh-ancestor
56391411|NCT00151710|Pioglitazone|pioglitazone|mesh-list
56391412|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56391413|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391414|NCT00519181|Valproic Acid|valproic acid|mesh-list
56391415|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
56391416|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655911|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56655912|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56655913|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
56655914|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
56655915|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655916|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655917|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56655918|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56655919|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56655920|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56655921|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56655922|NCT02607215|Vinorelbine|vinorelbine|mesh-list
56655923|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56655924|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655925|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
56655926|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
56655927|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
56655928|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655929|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
56655930|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56655931|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56655932|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655933|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
56655934|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655935|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655936|NCT00968929|Streptokinase|streptokinase|mesh-list
56655937|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56655938|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56218015|NCT01635686|Etanercept|etanercept|mesh-list
56391417|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391418|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
56391419|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391420|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391421|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
56391422|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56391423|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391424|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56391425|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
56391426|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56391427|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391428|NCT02949310|Nefopam|nefopam|mesh-list
56391429|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56391430|NCT02949310|Analgesics|analgesics|mesh-ancestor
56391431|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
56655939|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655940|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56655941|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
56655942|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56655943|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56655944|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655945|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391432|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391433|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391434|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
56391435|NCT02949349|Prednisolone|prednisolone|mesh-list
56391436|NCT02949349|Azathioprine|azathioprine|mesh-list
56391437|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56391438|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391439|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56391440|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
56391441|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56391442|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391443|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391444|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391445|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56391446|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
56391447|NCT02949349|Hormones|hormones|mesh-ancestor
56391448|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56391449|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391450|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56391451|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
56391452|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56391453|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391454|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
56391455|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391456|NCT00166842|Cyclosporine|cyclosporine|mesh-list
56391457|NCT00166842|Sirolimus|sirolimus|mesh-list
56391458|NCT00166842|Tacrolimus|tacrolimus|mesh-list
56391459|NCT00166842|Cyclosporins|cyclosporins|mesh-list
56391460|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391461|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
56391462|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391463|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56391464|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391465|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391466|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
56391467|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391468|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
56391469|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391470|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56391471|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56391472|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391473|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56391478|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56391479|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56391481|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391482|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391483|NCT00519259|Lobeline|lobeline|mesh-list
56391484|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56391485|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
56391486|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391487|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391488|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56391489|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56391490|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
56391491|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391492|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391493|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
56391494|NCT00519298|Donepezil|donepezil|mesh-list
56655946|NCT00661596|Urological Agents|urological agents|mesh-ancestor
56655947|NCT04996004|Doxorubicin|doxorubicin|mesh-list
56655948|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56655949|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655950|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56655951|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56655952|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655953|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655954|NCT00969085|Curcumin|curcumin|mesh-list
56302049|NCT00012207|Vincristine|vincristine|mesh-list
56655955|NCT00969085|Turmeric extract|turmeric extract|mesh-list
56655956|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56655957|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56655958|NCT00969085|Analgesics|analgesics|mesh-ancestor
56391495|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56391496|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391497|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391498|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
56391499|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391500|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391501|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
56391502|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
56391503|NCT00519337|Vitamins|vitamins|mesh-ancestor
56391504|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
56391505|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391506|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
56391507|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391508|NCT00519337|Protective Agents|protective agents|mesh-ancestor
56391509|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56391510|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56391511|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56391512|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
56391513|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391514|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56391515|NCT00166881|Docetaxel|docetaxel|mesh-list
56391517|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391518|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
56391519|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
56391520|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
56391521|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391522|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56391523|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56391524|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391525|NCT02948998|Spironolactone|spironolactone|mesh-list
56391526|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56391528|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56391529|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391530|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56391531|NCT02948998|Diuretics|diuretics|mesh-ancestor
56391532|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
56391533|NCT00519688|Thalidomide|thalidomide|mesh-list
56391534|NCT00519688|Tegafur|tegafur|mesh-list
56391535|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391536|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
56391537|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391538|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
56391539|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56391540|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391541|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56391542|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56391543|NCT00519688|Growth Substances|growth substances|mesh-ancestor
56655959|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
56655960|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655961|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655962|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56655963|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56655964|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655965|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56655966|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655967|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
56655968|NCT00969085|Protective Agents|protective agents|mesh-ancestor
56655969|NCT00974155|Dexetimide|dexetimide|mesh-list
56655970|NCT00974155|Citalopram|citalopram|mesh-list
56655971|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56655972|NCT00974155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56655973|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56655974|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391544|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
56391545|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391547|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
56391548|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391549|NCT02948920|Ephedrine|ephedrine|mesh-list
56391550|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56391551|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391552|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
56391553|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
56391554|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391555|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56391556|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
56391557|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391558|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391559|NCT00151827|Losartan|losartan|mesh-list
56391560|NCT00151827|Olmesartan|olmesartan|mesh-list
56391561|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56391562|NCT00151827|Furosemide|furosemide|mesh-list
56391563|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56391564|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56391565|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56391566|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56391567|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391568|NCT00151827|Diuretics|diuretics|mesh-ancestor
56391569|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
56391570|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391571|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56391572|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391573|NCT00519805|Dalteparin|dalteparin|mesh-list
56391574|NCT00519805|Tinzaparin|tinzaparin|mesh-list
56391575|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56391576|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
56391577|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56391578|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56391579|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391580|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
56391581|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56391582|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391583|NCT04457180|Repaglinide|repaglinide|mesh-list
56391584|NCT04457180|Apatinib|apatinib|mesh-list
56391585|NCT04457180|Bupropion|bupropion|mesh-list
56391586|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56655975|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56655976|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56655977|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
56655978|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391587|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56391588|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391589|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391590|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56391591|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
56391592|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56391593|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56391594|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56391595|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391596|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
56391597|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391598|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391599|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56391600|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56391601|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56391603|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56391605|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391606|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56391607|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
56391608|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
56391609|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
56391610|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391611|NCT00151944|Mesalamine|mesalamine|mesh-list
56391612|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56391613|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56391614|NCT00151944|Analgesics|analgesics|mesh-ancestor
56391615|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
56391616|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391617|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391618|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56391619|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391624|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391626|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56391627|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56391628|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391629|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56391630|NCT00520507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56391631|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56391632|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391633|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391634|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391635|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
56391636|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
56391637|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391638|NCT00151983|Methylphenidate|methylphenidate|mesh-list
56391639|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56391640|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391641|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56391642|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56391643|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391644|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391645|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
56391646|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391647|NCT00520585|Atorvastatin|atorvastatin|mesh-list
56391648|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56391649|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56391650|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
56391651|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391652|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56391653|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56391654|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391655|NCT00152022|Amphetamine|amphetamine|mesh-list
56655979|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56655980|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
56655981|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56655982|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56655983|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56655984|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
56655985|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
56655986|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56655987|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56655988|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56655989|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
56655990|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56655991|NCT00879996|Buprenorphine|buprenorphine|mesh-list
56391656|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
56391657|NCT00152022|Adderall|adderall|mesh-list
56391658|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56391659|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391660|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
56391661|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
56391662|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391663|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
56391664|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391665|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391666|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
56391667|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56391668|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56391669|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391670|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56391671|NCT00520819|Antioxidants|antioxidants|mesh-list
56391672|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391673|NCT00520819|Protective Agents|protective agents|mesh-ancestor
56391674|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391675|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
56391676|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56391677|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56391678|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
56391679|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391680|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56391681|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56391682|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175484|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391683|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391684|NCT00521092|Sunitinib|sunitinib|mesh-list
56391685|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391686|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56391687|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56391692|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391693|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391694|NCT00521131|Levocetirizine|levocetirizine|mesh-list
56391695|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56391696|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56391697|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
56391698|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
56391699|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391700|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391701|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391702|NCT04694092|Landiolol|landiolol|mesh-list
56391703|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56391704|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56391705|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
56655992|NCT00879996|Methadone|methadone|mesh-list
56655993|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56655994|NCT00879996|Naloxone|naloxone|mesh-list
56655995|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56655996|NCT00879996|Narcotics|narcotics|mesh-ancestor
56655997|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56655998|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56655999|NCT00879996|Analgesics|analgesics|mesh-ancestor
56656000|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
56656001|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656002|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56656003|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
56656004|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
56656005|NCT00969163|Testosterone|testosterone|mesh-list
56656006|NCT00969163|Androgens|androgens|mesh-ancestor
56656007|NCT00969163|Hormones|hormones|mesh-ancestor
56656008|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656009|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656010|NCT00873093|Leucovorin|leucovorin|mesh-list
56656011|NCT00873093|Cytarabine|cytarabine|mesh-list
56656012|NCT00873093|Prednisone|prednisone|mesh-list
56656013|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
56656014|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56656015|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56391706|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391707|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391708|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391709|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56391710|NCT00521170|Levocetirizine|levocetirizine|mesh-list
56391711|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56391712|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56391713|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
56391714|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
56391715|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391716|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391717|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391718|NCT00521248|Morphine|morphine|mesh-list
56391719|NCT00521248|Buprenorphine|buprenorphine|mesh-list
56391720|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56391721|NCT00521248|Narcotics|narcotics|mesh-ancestor
56391722|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391723|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391724|NCT00521248|Analgesics|analgesics|mesh-ancestor
56391725|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
56391726|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391727|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56391728|NCT00167154|Risperidone|risperidone|mesh-list
56391729|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56391730|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
56391731|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391732|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391733|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391734|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56656016|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56656017|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
56656018|NCT00873093|Doxorubicin|doxorubicin|mesh-list
56656019|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56656020|NCT00873093|Methotrexate|methotrexate|mesh-list
56656021|NCT00873093|Etoposide|etoposide|mesh-list
56656022|NCT00873093|Vincristine|vincristine|mesh-list
56656023|NCT00873093|Bortezomib|bortezomib|mesh-list
56656024|NCT00873093|Asparaginase|asparaginase|mesh-list
56656025|NCT00873093|Pegaspargase|pegaspargase|mesh-list
56656026|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
56656027|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
56656028|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656029|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
56656030|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302129|NCT00028678|Dalteparin|dalteparin|mesh-list
56656031|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656032|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56656034|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656035|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656036|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56656037|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56656038|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56656039|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56656040|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656041|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656042|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
56656043|NCT00873093|Hormones|hormones|mesh-ancestor
56656044|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656045|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56656046|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56656047|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
56656048|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56656049|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56656050|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
56656051|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
56218115|NCT01636037|Levodopa|levodopa|mesh-list
56391735|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56391736|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391737|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56656052|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56656053|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56656054|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56656055|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
56656056|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656057|NCT00873093|Antidotes|antidotes|mesh-ancestor
56656058|NCT00873093|Protective Agents|protective agents|mesh-ancestor
56656059|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
56656060|NCT00873093|Vitamins|vitamins|mesh-ancestor
56656061|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
56656062|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
56656063|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
56656064|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
56656065|NCT00969319|Factor VIII|factor viii|mesh-list
56656066|NCT00969319|Coagulants|coagulants|mesh-ancestor
56656067|NCT02784899|Iloprost|iloprost|mesh-list
56391738|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56391740|NCT00521482|Thalidomide|thalidomide|mesh-list
56391741|NCT00521482|Temozolomide|temozolomide|mesh-list
56391742|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56391743|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
56391744|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391745|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391746|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391747|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
56391748|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391749|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
56391750|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56391751|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391752|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56391753|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56391754|NCT00521482|Growth Substances|growth substances|mesh-ancestor
56391755|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
56391756|NCT00521521|Docetaxel|docetaxel|mesh-list
56391757|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391758|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
56391762|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
56391763|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56391764|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391765|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
56391766|NCT00521950|Azathioprine|azathioprine|mesh-list
56391767|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
56391768|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391769|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56391770|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391771|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391772|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
56391773|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391774|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56391775|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391776|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391777|NCT00522184|Etanercept|etanercept|mesh-list
56391778|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56391779|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56391780|NCT00522184|Analgesics|analgesics|mesh-ancestor
56391781|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
56391782|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391783|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391784|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56391785|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391786|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56391787|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656068|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56656069|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
56656070|NCT00974389|Bevacizumab|bevacizumab|mesh-list
56656071|NCT00974389|Tegafur|tegafur|mesh-list
56656072|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56656073|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656074|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56656075|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56656076|NCT00974389|Growth Substances|growth substances|mesh-ancestor
56656077|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656078|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
56656079|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56656080|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
56656081|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656082|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56656083|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56656084|NCT00969397|Growth Substances|growth substances|mesh-ancestor
56656085|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656086|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
56656087|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656088|NCT00647660|Nadolol|nadolol|mesh-list
56656089|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
56656090|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56656091|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56656092|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
56218141|NCT01636128|Analgesics|analgesics|mesh-ancestor
56391788|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
56391789|NCT03458923|Diclofenac|diclofenac|mesh-list
56391790|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56391791|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56391792|NCT03458923|Ranibizumab|ranibizumab|mesh-list
56391793|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
56391794|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56391795|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56391796|NCT03458923|Growth Substances|growth substances|mesh-ancestor
56391797|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391798|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
56391799|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391800|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391801|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56391802|NCT03458923|Analgesics|analgesics|mesh-ancestor
56391803|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
56391804|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391805|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391806|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56391807|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391808|NCT04186013|Atezolizumab|atezolizumab|mesh-list
56391809|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391810|NCT00152139|Antibodies|antibodies|mesh-list
56656093|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656094|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656095|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656096|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56656097|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56656098|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
56656099|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
56656100|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656101|NCT00647660|Diuretics|diuretics|mesh-ancestor
56656102|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
56656103|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56656104|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56656105|NCT00634595|Paclitaxel|paclitaxel|mesh-list
56656106|NCT00634595|Cisplatin|cisplatin|mesh-list
56302276|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656107|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56656108|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656109|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
56656110|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
56656111|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
56656112|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656113|NCT00647738|Baclofen|baclofen|mesh-list
56656114|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56656115|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656116|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56656117|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656118|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56656119|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
56656120|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
56656121|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656122|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391811|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
56391812|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391813|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56391814|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56391815|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391816|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
56391817|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56391818|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56391819|NCT00167232|Naltrexone|naltrexone|mesh-list
56391820|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56391821|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56656123|NCT04008511|Capecitabine|capecitabine|mesh-list
56656124|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
56656125|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56656126|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
56656127|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656128|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656129|NCT00979537|Nisoldipine|nisoldipine|mesh-list
56656130|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56656131|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56391822|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391823|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
56391824|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391825|NCT04168112|Dexamethasone|dexamethasone|mesh-list
56391826|NCT04168112|Prednisolone|prednisolone|mesh-list
56391827|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56391828|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
56391829|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56391830|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
56391833|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56391834|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
56391835|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
56391836|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391837|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391838|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56391839|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
56391841|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56391842|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56391843|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391844|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56391845|NCT04168112|Protective Agents|protective agents|mesh-ancestor
56391846|NCT00522886|Cetuximab|cetuximab|mesh-list
56391847|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56391848|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391849|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
56391850|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
56391851|NCT04083560|Hematinics|hematinics|mesh-ancestor
56391852|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
56391853|NCT04083560|Vitamins|vitamins|mesh-ancestor
56391854|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
56391855|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391856|NCT00511966|Rabeprazole|rabeprazole|mesh-list
56391857|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56391858|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56391859|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56391860|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391861|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391862|NCT00152178|Tamoxifen|tamoxifen|mesh-list
56391863|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
56391864|NCT00152178|Fluorouracil|fluorouracil|mesh-list
56391865|NCT00152178|Methotrexate|methotrexate|mesh-list
56391866|NCT00152178|Tegafur|tegafur|mesh-list
56391867|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391868|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
56391869|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391870|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391871|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56391872|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
56391873|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391874|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391875|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56391876|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
56391877|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56391878|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56391879|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
56391880|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56391881|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56391882|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391883|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56656132|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56656133|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656134|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56656135|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656136|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
56656137|NCT00692055|Naproxen|naproxen|mesh-list
56656138|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56656139|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56656140|NCT00692055|Analgesics|analgesics|mesh-ancestor
56656141|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
56218176|NCT01636323|Nicotine|nicotine|mesh-list
56391884|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56391885|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56391886|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165347|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391887|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56391888|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56391889|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56391890|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56391891|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56391893|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56013904|NCT00004486|Fluoxetine|fluoxetine|mesh-list
56391894|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56391895|NCT00523120|Analgesics|analgesics|mesh-ancestor
56391896|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
56391897|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391898|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391899|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56391900|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391901|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56391902|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391905|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
56391906|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391907|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
56391908|NCT04693897|Mirabegron|mirabegron|mesh-list
56391909|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56391910|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56391911|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
56391912|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391913|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391914|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391915|NCT04693897|Urological Agents|urological agents|mesh-ancestor
56391916|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56391917|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56391918|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56391919|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
56391920|NCT00424242|Pemetrexed|pemetrexed|mesh-list
56391921|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391922|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391923|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391924|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56391925|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56391926|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
56391927|NCT04726553|Antimalarials|antimalarials|mesh-list
56391928|NCT04726553|Methotrexate|methotrexate|mesh-list
56391929|NCT04726553|Azathioprine|azathioprine|mesh-list
56391930|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56391931|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
56391932|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56391933|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391934|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56391935|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
56656142|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656143|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656144|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656145|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656146|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
56656147|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56656148|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656149|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656150|NCT04033250|Bisacodyl|bisacodyl|mesh-list
56656151|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
56656152|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
56656153|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
56656154|NCT04033250|Citric Acid|citric acid|mesh-list
56656155|NCT04033250|Cathartics|cathartics|mesh-ancestor
56656156|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56656157|NCT04033250|Laxatives|laxatives|mesh-ancestor
56656158|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
56656159|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56656160|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
56391936|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391937|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391938|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
56391939|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391940|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56391941|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391942|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
56391943|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391944|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56391945|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56391946|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56391947|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
56391948|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56391949|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56391950|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56391951|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56391952|NCT02947945|Reslizumab|reslizumab|mesh-list
56391953|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56391954|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
56391955|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
56391956|NCT02948101|Antibodies|antibodies|mesh-list
56391957|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56391958|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391959|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
56391960|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391961|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391962|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56391963|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
56391964|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391965|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391966|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56391968|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
56391969|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
56391970|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56391971|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391972|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
56391973|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391974|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56391975|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56656161|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
56656162|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656163|NCT04033250|Antacids|antacids|mesh-ancestor
56391978|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391980|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
56391981|NCT02951728|Rituximab|rituximab|mesh-list
56391982|NCT02951728|Doxorubicin|doxorubicin|mesh-list
56391983|NCT02951728|Vincristine|vincristine|mesh-list
56391984|NCT02951728|Decitabine|decitabine|mesh-list
56391985|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56391986|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
56391987|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391988|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56391989|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56391990|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
56391991|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391992|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391993|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56391994|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56391995|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56391996|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56391997|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56391998|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391999|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392000|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
56392001|NCT02951728|Hormones|hormones|mesh-ancestor
56392002|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392003|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56392004|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56392005|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
56392006|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
56392007|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
56392008|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56392009|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
56392010|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56392011|NCT04726046|Cefotetan|cefotetan|mesh-list
56392012|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392013|NCT00523354|Infliximab|infliximab|mesh-list
56392014|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
56392015|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56392016|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392017|NCT00523393|Insulin|insulin|mesh-list
56392018|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56392019|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56392020|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392021|NCT00523432|Sirolimus|sirolimus|mesh-list
56392022|NCT00523432|Topotecan|topotecan|mesh-list
56392023|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56392024|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56392025|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392026|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392027|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392028|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56392029|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392030|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56392031|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
56392032|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56392033|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
56392035|NCT00512044|Anesthetics|anesthetics|mesh-list
56392036|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392037|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392038|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56392039|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56392040|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392041|NCT00523666|Galantamine|galantamine|mesh-list
56392042|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56392043|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392044|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392045|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
56392046|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392047|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392048|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56656164|NCT02624973|Tamoxifen|tamoxifen|mesh-list
56656165|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
56656166|NCT02624973|Docetaxel|docetaxel|mesh-list
56656167|NCT02624973|Trastuzumab|trastuzumab|mesh-list
56656168|NCT02624973|Letrozole|letrozole|mesh-list
56656169|NCT02624973|Epirubicin|epirubicin|mesh-list
56656170|NCT02624973|Olaparib|olaparib|mesh-list
56656171|NCT02624973|Palbociclib|palbociclib|mesh-list
56656172|NCT02624973|Pertuzumab|pertuzumab|mesh-list
56656173|NCT02624973|Goserelin|goserelin|mesh-list
56656174|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656175|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
56656176|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656177|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656178|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56656179|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
56656180|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656181|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656182|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56656183|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
56656184|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
56656185|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
56656186|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56656187|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56656188|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56656189|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656190|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56656191|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
56656192|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656193|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56392049|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
56392052|NCT00167583|Interferons|interferons|mesh-list
56392053|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
56392054|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
56392055|NCT00167583|Cyclosporine|cyclosporine|mesh-list
56392056|NCT00167583|Cyclosporins|cyclosporins|mesh-list
56392057|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392058|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
56392059|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392060|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392061|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392062|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56392063|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
56392064|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392065|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
56392066|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56392067|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392068|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56392069|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56656194|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56656195|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56656196|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56656197|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56656198|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56656199|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56656200|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56656201|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56656202|NCT00647816|Propranolol|propranolol|mesh-list
56656203|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55794380|NCT02594735|Abatacept|abatacept|mesh-list
56392070|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392071|NCT00172809|Interferons|interferons|mesh-list
56392072|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
56392073|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
56392074|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56392075|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392076|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
56392077|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392078|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
56392079|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392080|NCT04696120|Apixaban|apixaban|mesh-list
56392081|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56392082|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
56392083|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56392084|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
56392085|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392086|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392087|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
56392088|NCT00512395|Fentanyl|fentanyl|mesh-list
56392089|NCT00512395|Ropivacaine|ropivacaine|mesh-list
56392090|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56392091|NCT00512395|Narcotics|narcotics|mesh-ancestor
56392092|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392093|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392094|NCT00512395|Analgesics|analgesics|mesh-ancestor
56392095|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
56392096|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392097|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56392098|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56392099|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
56392100|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
56392101|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
56392102|NCT00512473|Hormones|hormones|mesh-list
56392103|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392104|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392105|NCT00524095|Fluticasone|fluticasone|mesh-list
56392106|NCT00524095|Xhance|xhance|mesh-list
56392107|NCT00524095|Azithromycin|azithromycin|mesh-list
56392108|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392109|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56392110|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
56392111|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392112|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392113|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56392114|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
56392115|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
56392116|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56392117|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56392118|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392119|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56392120|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56392121|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56392122|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56392123|NCT00512668|Sirolimus|sirolimus|mesh-list
56656204|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56656205|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
56656206|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656207|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392124|NCT00512668|Leuprolide|leuprolide|mesh-list
56392125|NCT00512668|Goserelin|goserelin|mesh-list
56392127|NCT00512668|Bicalutamide|bicalutamide|mesh-list
56392131|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56392132|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392133|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56392134|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392135|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56392136|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392137|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56392138|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
56392139|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56392140|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
56392141|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
56392142|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
56392143|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392144|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
56392145|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
56392146|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56392147|NCT00167739|Quinine|quinine|mesh-list
56392148|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
56392149|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56392150|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56392151|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392152|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56392153|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392154|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392155|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56392156|NCT00167739|Renal Agents|renal agents|mesh-ancestor
56392157|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56392158|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392159|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56392160|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392161|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56392162|NCT00167739|Analgesics|analgesics|mesh-ancestor
56392163|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
56392164|NCT00524251|Esomeprazole|esomeprazole|mesh-list
56392165|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56392166|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56392167|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56392168|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392169|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392170|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
56392171|NCT00512824|Calcium|calcium|mesh-list
56392172|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56392173|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392174|NCT00512824|Antacids|antacids|mesh-ancestor
56392175|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392176|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56392177|NCT00512863|Adalimumab|adalimumab|mesh-list
56392178|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392179|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392180|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
56392181|NCT00524407|Hematinics|hematinics|mesh-ancestor
56392182|NCT00525889|Sirolimus|sirolimus|mesh-list
56392183|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56392184|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392185|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56392186|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392187|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
56392188|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175508|NCT01390012|Dexamethasone|dexamethasone|mesh-list
56392190|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392192|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392193|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56392194|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56392195|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920359|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
56656208|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656209|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56656210|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56656211|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
56656212|NCT05182931|Trametinib|trametinib|mesh-list
56656213|NCT05182931|Dabrafenib|dabrafenib|mesh-list
56656214|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656215|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56656216|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656217|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656218|NCT00647894|Alprazolam|alprazolam|mesh-list
56656219|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56656220|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656221|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656222|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56656223|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56656224|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56656225|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
56656226|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
56656227|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656228|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656229|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
56656230|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
56656231|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56656232|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56656233|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656234|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656235|NCT02782559|Urological Agents|urological agents|mesh-ancestor
56392196|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392197|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
56392198|NCT03879122|Docetaxel|docetaxel|mesh-list
56392199|NCT03879122|Nivolumab|nivolumab|mesh-list
56392200|NCT03879122|Ipilimumab|ipilimumab|mesh-list
56392201|NCT03879122|Androgens|androgens|mesh-list
56014196|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
56392204|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
56392205|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
56392206|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392207|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56392208|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56392210|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392211|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392212|NCT00525928|Varenicline|varenicline|mesh-list
56392213|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56392214|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56392215|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
56392216|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656236|NCT00647972|Olanzapine|olanzapine|mesh-list
56656237|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
56656238|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
56656239|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656240|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656241|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56656242|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56656243|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56218272|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392217|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392218|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392219|NCT00167817|Aripiprazole|aripiprazole|mesh-list
56392220|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
56392221|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56392222|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56392223|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56392224|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392225|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392226|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
56392227|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
56392228|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392229|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392230|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56392231|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56392232|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
56392233|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56392234|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56392235|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56392236|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56392237|NCT02947711|Diltiazem|diltiazem|mesh-list
56392238|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56392239|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56392240|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56392241|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392242|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56392243|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392244|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
56392245|NCT03845348|Ketoconazole|ketoconazole|mesh-list
56392246|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
56392247|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392248|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56392249|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56392250|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392251|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392252|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56392253|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
56392254|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392255|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392256|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56392257|NCT04723563|Heparin|heparin|mesh-list
56392258|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
56392259|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56175509|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
56392260|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56392261|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392262|NCT00525967|Acetaminophen|acetaminophen|mesh-list
56392263|NCT00525967|Methadone|methadone|mesh-list
56392264|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56392265|NCT00525967|Analgesics|analgesics|mesh-ancestor
56392266|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
56392267|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392268|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392269|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
56392270|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56392271|NCT00525967|Narcotics|narcotics|mesh-ancestor
56656244|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656245|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55844881|NCT04348006|Lenalidomide|lenalidomide|mesh-list
56392272|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392274|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
56392275|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56392276|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56392277|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56392278|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56392279|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392280|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392281|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392282|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56392283|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
56392284|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56392285|NCT00526006|Esomeprazole|esomeprazole|mesh-list
56392286|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56392287|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56392288|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56392289|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392290|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392291|NCT03681275|Tofacitinib|tofacitinib|mesh-list
56392292|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56392293|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392294|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392295|NCT02946814|Listerine|listerine|mesh-list
56392296|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
56392297|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56392298|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392299|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
56392300|NCT02946814|Protective Agents|protective agents|mesh-ancestor
56392301|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392302|NCT00524836|Levocetirizine|levocetirizine|mesh-list
56392303|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56392304|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56392305|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
56392306|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
56392307|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392308|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392309|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392310|NCT00524875|Bevacizumab|bevacizumab|mesh-list
56392311|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56392312|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392313|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56392314|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56392315|NCT00524875|Growth Substances|growth substances|mesh-ancestor
56392316|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392317|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
56392318|NCT00524914|Apomorphine|apomorphine|mesh-list
56392319|NCT00524914|Emetics|emetics|mesh-ancestor
56392320|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392321|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
56392322|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392323|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56392324|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
56392325|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
56392326|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392327|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392328|NCT02957864|Tenofovir|tenofovir|mesh-list
56392329|NCT02957864|Abacavir|abacavir|mesh-list
56392330|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
56392331|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392332|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56392333|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56392334|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392335|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392337|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56392339|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56392340|NCT00168012|Antibodies|antibodies|mesh-list
56392341|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
56656246|NCT00647972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56656247|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56656248|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56656249|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656250|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656251|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
56656252|NCT02782403|Axitinib|axitinib|mesh-list
56392342|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392343|NCT03632369|Xenon|xenon|mesh-list
56392344|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56392345|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
56392346|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
56392349|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
56392350|NCT03585452|Propofol|propofol|mesh-list
56392351|NCT03585452|Anesthetics|anesthetics|mesh-ancestor
56392352|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392353|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392354|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56392355|NCT03585452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56392356|NCT03585452|Anesthetics, General|anesthetics, general|mesh-ancestor
56392357|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56392358|NCT03585452|Analgesics|analgesics|mesh-ancestor
56392359|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
56392360|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392361|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56392362|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56392363|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56392364|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
56392365|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392366|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392367|NCT02947672|Dexamethasone|dexamethasone|mesh-list
56392368|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392369|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
56392370|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
56392371|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392372|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392373|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56392374|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
56392375|NCT02947672|Hormones|hormones|mesh-ancestor
56392376|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392377|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56392378|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392379|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56392380|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56392381|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56392382|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392383|NCT02946268|Ropivacaine|ropivacaine|mesh-list
56392384|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
56392385|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
56392386|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392387|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392388|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
56392389|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392390|NCT00168051|Factor VIII|factor viii|mesh-list
56392391|NCT00168051|Coagulants|coagulants|mesh-ancestor
56392392|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
56392393|NCT00526318|Melphalan|melphalan|mesh-list
56392394|NCT00526318|Ifosfamide|ifosfamide|mesh-list
56392395|NCT00526318|Dacarbazine|dacarbazine|mesh-list
56392396|NCT00526318|Carboplatin|carboplatin|mesh-list
56392397|NCT00526318|Doxorubicin|doxorubicin|mesh-list
56392398|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56392399|NCT00526318|Etoposide|etoposide|mesh-list
56392400|NCT00526318|Vincristine|vincristine|mesh-list
56392401|NCT00526318|Topotecan|topotecan|mesh-list
56392402|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
56392403|NCT00526318|Vindesine|vindesine|mesh-list
56392404|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56392405|NCT00526318|Isotretinoin|isotretinoin|mesh-list
56392406|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656253|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656254|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56656255|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656256|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656257|NCT00646178|Adalimumab|adalimumab|mesh-list
56656258|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656259|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656260|NCT02624817|Glyburide|glyburide|mesh-list
56656261|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56656262|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656263|NCT02664116|Ketorolac|ketorolac|mesh-list
56656264|NCT02664116|Diclofenac|diclofenac|mesh-list
56656265|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56218288|NCT01636700|Narcotics|narcotics|mesh-ancestor
56392407|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
56392408|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392409|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392410|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56392411|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
56392412|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392413|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392414|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56392415|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56392416|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56392417|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56392418|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392419|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56392420|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
56392423|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56392424|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
56392425|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56392426|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
56392427|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56392428|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56392429|NCT04693312|Prednisolone|prednisolone|mesh-list
56392430|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
56392431|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56392432|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
56392433|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392434|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
56392435|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
56392436|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392437|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392438|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56392439|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
56392440|NCT04693312|Hormones|hormones|mesh-ancestor
56392441|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392442|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56392443|NCT04693312|Protective Agents|protective agents|mesh-ancestor
56392444|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56392445|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392446|NCT00168090|Factor VIII|factor viii|mesh-list
56392447|NCT00168090|Coagulants|coagulants|mesh-ancestor
56392448|NCT00525382|Levocetirizine|levocetirizine|mesh-list
56392449|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56392450|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56392451|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
56392452|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
56392453|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392454|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392455|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392456|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
56656266|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56656267|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56656268|NCT02664116|Analgesics|analgesics|mesh-ancestor
56656269|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
56656270|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656271|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656272|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656273|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656274|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56656275|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656276|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656277|NCT00545077|Bevacizumab|bevacizumab|mesh-list
56392457|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56392458|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392459|NCT00168168|Lenograstim|lenograstim|mesh-list
56392460|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56392461|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
56392462|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392463|NCT03225755|Hormones|hormones|mesh-list
56392464|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392465|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392466|NCT00525577|Probucol|probucol|mesh-list
56392467|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56392468|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56392469|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
56392470|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392471|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56392472|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
56392473|NCT00525577|Protective Agents|protective agents|mesh-ancestor
56392474|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392475|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56392476|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56392477|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
56392478|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56392479|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56392480|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
56392481|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392482|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
56392483|NCT03186755|Protective Agents|protective agents|mesh-ancestor
56392484|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56392485|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56392486|NCT03186755|Analgesics|analgesics|mesh-ancestor
56392487|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
56392488|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392489|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392490|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392491|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56392492|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56392493|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56392494|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
56392498|NCT00525616|Rituximab|rituximab|mesh-list
56392499|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56392500|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392501|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
56392502|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392503|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392504|NCT00525694|Cocaine|cocaine|mesh-list
56392505|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
56392506|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
56392507|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392508|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392509|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
56656278|NCT00545077|Letrozole|letrozole|mesh-list
56656279|NCT00545077|Fulvestrant|fulvestrant|mesh-list
56656280|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56656281|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656282|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56656283|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56656284|NCT00545077|Growth Substances|growth substances|mesh-ancestor
56656285|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656286|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
56656287|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56656288|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56656289|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656290|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656291|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56656292|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
56656293|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656294|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56392510|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392511|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56392512|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56392513|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56392514|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56392515|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392516|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
56392517|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392518|NCT02947243|Morphine|morphine|mesh-list
56392519|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56392520|NCT02947243|Narcotics|narcotics|mesh-ancestor
56392521|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392522|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392523|NCT02947243|Analgesics|analgesics|mesh-ancestor
56392524|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
56392525|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392526|NCT02946970|Quinine|quinine|mesh-list
56392527|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
56392528|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56392529|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56392530|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392531|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56392532|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392533|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56392534|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392535|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56392536|NCT02946970|Analgesics|analgesics|mesh-ancestor
56392537|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
56392538|NCT00527020|Nicotine|nicotine|mesh-list
56392539|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56392540|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
56392541|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392542|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392543|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56392544|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56392545|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
56392546|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392547|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392548|NCT00407277|Nicotine|nicotine|mesh-list
56656295|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56656296|NCT00692601|Capsaicin|capsaicin|mesh-list
56656297|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
56656298|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
56656299|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
56656300|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656301|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656302|NCT02785055|Hydromorphone|hydromorphone|mesh-list
56656303|NCT02785055|Bupivacaine|bupivacaine|mesh-list
56656304|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
56656305|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
56656306|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656307|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656308|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
56656309|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656310|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56656311|NCT02785055|Narcotics|narcotics|mesh-ancestor
56656312|NCT02785055|Analgesics|analgesics|mesh-ancestor
56656313|NCT02624661|Glycerol|glycerol|mesh-list
56392549|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56392550|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
56392551|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392552|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392553|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56392554|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56392555|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
56392556|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392557|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392558|NCT03176498|Aspirin|aspirin|mesh-list
56392559|NCT03176498|Atorvastatin|atorvastatin|mesh-list
56392560|NCT03176498|Calcium|calcium|mesh-list
56165348|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
56392561|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56392562|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392563|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56392564|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56392565|NCT03176498|Analgesics|analgesics|mesh-ancestor
56392571|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56392572|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392573|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56392574|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56392575|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392576|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
56392577|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56392578|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56392579|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
56392580|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56392581|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56392582|NCT00527059|Simendan|simendan|mesh-list
56392583|NCT00527059|Spironolactone|spironolactone|mesh-list
56392584|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56392585|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56392586|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
56392587|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392588|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392589|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56392590|NCT00527059|Diuretics|diuretics|mesh-ancestor
56656314|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56656315|NCT02624661|Protective Agents|protective agents|mesh-ancestor
56656316|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656317|NCT00648050|Verapamil|verapamil|mesh-list
56656318|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56656319|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56656320|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56656321|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656322|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56656323|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656324|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
56656325|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
56656326|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56656327|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656328|NCT02624505|Albuterol|albuterol|mesh-list
56656329|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56656371|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656372|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56656373|NCT02784821|Gentamicins|gentamicins|mesh-list
56656374|NCT02784821|Ampicillin|ampicillin|mesh-list
56656375|NCT02784821|Cefotaxime|cefotaxime|mesh-list
56656376|NCT02784821|Cefoxitin|cefoxitin|mesh-list
56656377|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56656378|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656379|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
56656380|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56656381|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656382|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656383|NCT00693069|Clopidogrel|clopidogrel|mesh-list
56656384|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56656385|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56656386|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56656387|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56656388|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
56656389|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656390|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656391|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656392|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56392591|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
56392592|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56392593|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
56392594|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392595|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392596|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56392597|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
56392598|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56392599|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56392600|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392601|NCT00527059|Protective Agents|protective agents|mesh-ancestor
56392602|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
56392603|NCT03156452|Prednisolone|prednisolone|mesh-list
56392604|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56392605|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392606|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56392607|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
56392608|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56392609|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392610|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392611|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392612|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392613|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
56392614|NCT03156452|Hormones|hormones|mesh-ancestor
56392615|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392616|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392617|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56392618|NCT04692844|Propranolol|propranolol|mesh-list
56392619|NCT04692844|Primidone|primidone|mesh-list
56656393|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56656394|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656395|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56656396|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56656397|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
56656398|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656399|NCT00974935|Antacids|antacids|mesh-ancestor
56656400|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656401|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56656402|NCT00665808|Insulin|insulin|mesh-list
56656403|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56656404|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
56656405|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
56656406|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
56656407|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
56656408|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56656409|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656410|NCT04230083|Dienogest|dienogest|mesh-list
56656411|NCT04230083|Nandrolone|nandrolone|mesh-list
56656412|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56656413|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
56656414|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56392620|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56392621|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56392622|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
56392623|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392624|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392625|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392626|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56392627|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56392628|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
56392629|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
56392630|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
56392631|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
56392632|NCT00525772|Ciclesonide|ciclesonide|mesh-list
56392633|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
56392635|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392638|NCT02945956|Entecavir|entecavir|mesh-list
56392639|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
56392640|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392641|NCT03122639|Atorvastatin|atorvastatin|mesh-list
56392642|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56392643|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56392644|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
56392645|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392646|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56392647|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56392648|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392649|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
56392650|NCT00527137|Hematinics|hematinics|mesh-ancestor
56392651|NCT02945839|Topiramate|topiramate|mesh-list
56392652|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
56392653|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56392654|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392655|NCT02957786|Varenicline|varenicline|mesh-list
56656415|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656416|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56656417|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56656418|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56656419|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56656420|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
56656421|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656422|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56656423|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656424|NCT04230083|Androgens|androgens|mesh-ancestor
56656425|NCT04230083|Hormones|hormones|mesh-ancestor
56656426|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
56656427|NCT00645866|Docetaxel|docetaxel|mesh-list
56656428|NCT00645866|Capecitabine|capecitabine|mesh-list
56656429|NCT00645866|Epirubicin|epirubicin|mesh-list
56656430|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656431|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
56392656|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56392657|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56392658|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
56392659|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392660|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392661|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392662|NCT00407394|Amoxicillin|amoxicillin|mesh-list
56392663|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56392664|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392665|NCT03109964|Hemostatics|hemostatics|mesh-list
56392666|NCT03109964|Surgiflo|surgiflo|mesh-list
56392667|NCT03109964|Coagulants|coagulants|mesh-ancestor
56392668|NCT00407433|Gemcitabine|gemcitabine|mesh-list
56392669|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
56392670|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56392671|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
56392672|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392673|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392674|NCT00407433|Antiviral Agents|antiviral agents|mesh-ancestor
56392675|NCT00407433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392676|NCT00407433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392677|NCT00407433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56392678|NCT00407433|Immunologic Factors|immunologic factors|mesh-ancestor
56392679|NCT00407433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392680|NCT00516412|Everolimus|everolimus|mesh-list
56392681|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392682|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56392683|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
56392684|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392685|NCT03058835|Tenofovir|tenofovir|mesh-list
56392686|NCT03058835|Emtricitabine|emtricitabine|mesh-list
56392687|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
56392688|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392689|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56392690|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56392691|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392692|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392693|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56392694|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56392695|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56392696|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
56392697|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56392698|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
56656432|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
56656433|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
56656434|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656435|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56656436|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
56656437|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56656438|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56656439|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56656440|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656441|NCT05221151|Pregabalin|pregabalin|mesh-list
56656442|NCT05221151|Ondansetron|ondansetron|mesh-list
56656443|NCT05221151|Melatonin|melatonin|mesh-list
56656444|NCT05221151|Analgesics|analgesics|mesh-ancestor
56656445|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
56656446|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656447|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656448|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
56656449|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56656450|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56656451|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218423|NCT01637454|Terlipressin|terlipressin|mesh-list
56392699|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56392700|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392701|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56175518|NCT01390012|Hormones|hormones|mesh-ancestor
56392702|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56392703|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392704|NCT00516607|Temozolomide|temozolomide|mesh-list
56392705|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56392706|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
56392707|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392708|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392709|NCT00173667|Nifedipine|nifedipine|mesh-list
56392714|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392715|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
56392716|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
56392717|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56392718|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56392719|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56392720|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
56392721|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392722|NCT03016871|Carboplatin|carboplatin|mesh-list
56392724|NCT03016871|Etoposide|etoposide|mesh-list
56392725|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
56392726|NCT03016871|Ifosfamide|ifosfamide|mesh-list
56392727|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
56392728|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
56392729|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392730|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56392731|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56392732|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392733|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56392734|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56656452|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56656453|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56656454|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56656455|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656456|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56656457|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
56656458|NCT05221151|Protective Agents|protective agents|mesh-ancestor
56656459|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
56656460|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
56656461|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56656462|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
56218452|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
56392735|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56392736|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392737|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56392738|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
56392739|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
56392740|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
56392741|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
56392742|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
56392743|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
56392744|NCT03458689|Analgesics|analgesics|mesh-list
56392745|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
56392746|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392747|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392748|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
56392749|NCT00527215|Hematinics|hematinics|mesh-ancestor
56392750|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
56392751|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56392752|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56392753|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56392754|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56392755|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392756|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
56392757|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392758|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392759|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56392760|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392761|NCT02945644|Trazodone|trazodone|mesh-list
56392762|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56392763|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56392764|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392765|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392766|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56392767|NCT02945644|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56392768|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56392769|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56392770|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392771|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392772|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
56392773|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56137272|NCT00553410|Letrozole|letrozole|mesh-list
56392774|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
56392776|NCT02460887|Cisplatin|cisplatin|mesh-list
56392777|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392778|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56392779|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
56392789|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392790|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
56392791|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
56392792|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392793|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392794|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56392795|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
56392796|NCT02945527|Hormones|hormones|mesh-ancestor
56656463|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
56656464|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56656465|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
56656466|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656467|NCT05221151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56656468|NCT04008043|Acetaminophen|acetaminophen|mesh-list
56656469|NCT04008043|Dexamethasone|dexamethasone|mesh-list
56656470|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56656471|NCT04008043|Hydrocodone|hydrocodone|mesh-list
56656472|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656473|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
56392797|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392798|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56392799|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392800|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
56392801|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56392803|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392804|NCT02945527|Diuretics|diuretics|mesh-ancestor
56392805|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
56392806|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56392807|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56392808|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56392809|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56392810|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56392811|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
56392812|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392813|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392814|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392815|NCT02448095|Ponatinib|ponatinib|mesh-list
56392816|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392817|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56392818|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392819|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392820|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
56392821|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56392822|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56392823|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56392824|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56392825|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392826|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
56392827|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392828|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392829|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56392830|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392831|NCT00529594|Etoricoxib|etoricoxib|mesh-list
56392832|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56392833|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56392834|NCT00529594|Analgesics|analgesics|mesh-ancestor
56392835|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
56392836|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392837|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392838|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392839|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392840|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56392841|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56392842|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392843|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392844|NCT00173862|Gemcitabine|gemcitabine|mesh-list
56392845|NCT00173862|Ifosfamide|ifosfamide|mesh-list
56392846|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56392848|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392850|NCT00173862|Antiviral Agents|antiviral agents|mesh-ancestor
56392851|NCT00173862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656474|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
56656475|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656476|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656477|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56656478|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
56656479|NCT04008043|Hormones|hormones|mesh-ancestor
56656480|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656481|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56656482|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656483|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56656484|NCT04008043|Analgesics|analgesics|mesh-ancestor
56656485|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
56656486|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
56656487|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56656488|NCT04008043|Narcotics|narcotics|mesh-ancestor
56218463|NCT01637558|Nevirapine|nevirapine|mesh-list
56392852|NCT00173862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392853|NCT00173862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56392854|NCT00173862|Immunologic Factors|immunologic factors|mesh-ancestor
56392855|NCT00173862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392856|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56392857|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
56392859|NCT00529750|Irbesartan|irbesartan|mesh-list
56392860|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56392861|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56392862|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56392863|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392864|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56392865|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
56392866|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
56392867|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392868|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392869|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56392870|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56392871|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56392872|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
56392873|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392874|NCT00529867|Lumefantrine|lumefantrine|mesh-list
56392875|NCT00529867|Artemether|artemether|mesh-list
56392876|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56392877|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
56392878|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56392879|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56392880|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392881|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
56392882|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56392883|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56392884|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56392885|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56392886|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392887|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
56392888|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392889|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392890|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56392891|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392892|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
56392893|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56392894|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56392895|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56656489|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656490|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
56656491|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
56656492|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56656493|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656495|NCT02783183|Analgesics|analgesics|mesh-ancestor
56656496|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
56656497|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656498|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656499|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
56656500|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56392896|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56392897|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392898|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
56392899|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392900|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392901|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56392902|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392903|NCT00527449|Carboplatin|carboplatin|mesh-list
56392904|NCT00527449|Docetaxel|docetaxel|mesh-list
56392905|NCT00527449|Epirubicin|epirubicin|mesh-list
56392906|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392907|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
56392908|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
56392909|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
56392910|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392911|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56392912|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56392913|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56392914|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392915|NCT00168519|Nitroprusside|nitroprusside|mesh-list
56392916|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56392917|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
56392918|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56392919|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392921|NCT04692376|Cyclosporins|cyclosporins|mesh-list
56392922|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
56392923|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392924|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392925|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56392926|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
56392927|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392928|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
56392929|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392930|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
56392931|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392932|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56392934|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56392935|NCT00527683|Vigabatrin|vigabatrin|mesh-list
56392936|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
56392937|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392938|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392939|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
56392940|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392941|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392942|NCT00173901|Ceftazidime|ceftazidime|mesh-list
56392943|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56392944|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392945|NCT00527761|Cisplatin|cisplatin|mesh-list
56392946|NCT00527761|Docetaxel|docetaxel|mesh-list
56392947|NCT00527761|Temozolomide|temozolomide|mesh-list
56392948|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392950|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
56656501|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56656502|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656503|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56656504|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56656505|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56218482|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56392951|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
56392952|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392953|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56392954|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
56392955|NCT00527800|Lumefantrine|lumefantrine|mesh-list
56392956|NCT00527800|Artemether|artemether|mesh-list
56392957|NCT00527800|Piperaquine|piperaquine|mesh-list
56392958|NCT00527800|Trimethoprim|trimethoprim|mesh-list
56392959|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56392960|NCT00527800|Artenimol|artenimol|mesh-list
56392961|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56392962|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
56392963|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
56392964|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56392965|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56392966|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392967|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56392968|NCT00527800|Renal Agents|renal agents|mesh-ancestor
56392969|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56392970|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392971|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392972|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56392973|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56392974|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56392975|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56392976|NCT02945293|Oxycodone|oxycodone|mesh-list
56392977|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56392978|NCT02945293|Narcotics|narcotics|mesh-ancestor
56392979|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392980|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392981|NCT02945293|Analgesics|analgesics|mesh-ancestor
56392982|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
56392983|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392984|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
56392985|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56392986|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392987|NCT02945215|Rituximab|rituximab|mesh-list
56392988|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56392989|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392990|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
56392991|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392992|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392993|NCT00144677|Sirolimus|sirolimus|mesh-list
56392994|NCT00144677|Tacrolimus|tacrolimus|mesh-list
56392995|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56392996|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
56392997|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393002|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393003|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56393004|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393005|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
56393006|NCT00531076|Bevacizumab|bevacizumab|mesh-list
56393007|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56393009|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56393010|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56393011|NCT00531076|Growth Substances|growth substances|mesh-ancestor
56393012|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393013|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
56393014|NCT00531115|Cetuximab|cetuximab|mesh-list
56393015|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56393016|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393017|NCT00144716|Insect Repellents|insect repellents|mesh-list
56656506|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656507|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56656508|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
56656509|NCT00693381|Prednisone|prednisone|mesh-list
56656510|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
56656511|NCT00693381|Tacrolimus|tacrolimus|mesh-list
56656512|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656513|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
56656514|NCT00693381|Hormones|hormones|mesh-ancestor
56656515|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656516|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656517|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56656518|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656519|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656520|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
56656521|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56656522|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218486|NCT01637636|Rifampin|rifampin|mesh-list
56393018|NCT00144716|Protective Agents|protective agents|mesh-ancestor
56393019|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393020|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
56393021|NCT00531193|SCH 442416|sch 442416|mesh-list
56393022|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56393023|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56393025|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
56393026|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393027|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393028|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393029|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
56393030|NCT00144755|Hematinics|hematinics|mesh-ancestor
56393031|NCT00531271|Docetaxel|docetaxel|mesh-list
56393032|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393033|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
56393034|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
56393035|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
56393036|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393037|NCT00531310|Fludarabine|fludarabine|mesh-list
56393038|NCT00531310|Busulfan|busulfan|mesh-list
56393039|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393040|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393041|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56393042|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
56393043|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393044|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
56393045|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56393046|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56393047|NCT00407862|Losartan|losartan|mesh-list
56393048|NCT00407862|Telmisartan|telmisartan|mesh-list
56393049|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56393050|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56393051|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56393052|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56393053|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393054|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
56393055|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
56393056|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56656523|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656524|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56656525|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56656526|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
56656527|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56656528|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656529|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
56656530|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
56656531|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656532|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56656533|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56656534|NCT00693381|Protective Agents|protective agents|mesh-ancestor
56656535|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
56656536|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
56656537|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656538|NCT00693615|Vaccines|vaccines|mesh-list
56656539|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
56656540|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656541|NCT02663960|Citric Acid|citric acid|mesh-list
56656542|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
56656543|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
56656544|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56656545|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
56656546|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
56656547|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656548|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
56656549|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56656550|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656551|NCT00693849|Citalopram|citalopram|mesh-list
56656552|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56656553|NCT00693849|Sertraline|sertraline|mesh-list
56302650|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393057|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56393058|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393059|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393060|NCT00527995|Urological Agents|urological agents|mesh-ancestor
56393061|NCT00144833|Ritonavir|ritonavir|mesh-list
56393062|NCT00144833|Lopinavir|lopinavir|mesh-list
56393063|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
56393064|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56393065|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56393066|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
56393067|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393068|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393079|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
56656554|NCT00693849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56656555|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56656556|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56656557|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656558|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656559|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
56656560|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656561|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56656562|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
56656563|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56656564|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56656566|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656567|NCT00648362|Glimepiride|glimepiride|mesh-list
56656568|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56656569|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56656570|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656571|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656572|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
56656573|NCT00648440|Midodrine|midodrine|mesh-list
56656574|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
56656575|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
56656576|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656577|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656578|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56393080|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56124654|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
56393081|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393082|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393083|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56393084|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393085|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56393086|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56393087|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393088|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56393089|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56393091|NCT02945020|Odalasvir|odalasvir|mesh-list
56393092|NCT02945020|Dabigatran|dabigatran|mesh-list
56393093|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
56393094|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56393095|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
56393096|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393097|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393098|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
56393099|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
56393100|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393102|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56393103|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393104|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56656579|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56656580|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56656581|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56656582|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
56656583|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656584|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656585|NCT00694005|Sirolimus|sirolimus|mesh-list
56656586|NCT00694005|Paclitaxel|paclitaxel|mesh-list
56656587|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56656588|NCT00694005|Everolimus|everolimus|mesh-list
56218526|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56393105|NCT00528151|Curcumin|curcumin|mesh-list
56393106|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56393107|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56393108|NCT00528151|Analgesics|analgesics|mesh-ancestor
56393109|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
56393110|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393111|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393112|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56393113|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56393114|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393115|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393116|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393117|NCT00144911|Fluticasone|fluticasone|mesh-list
56393118|NCT00144911|Xhance|xhance|mesh-list
56393119|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56393120|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56393121|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56393122|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
56393123|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393124|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393125|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56393126|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
56393127|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
56393128|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56393129|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56393130|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56393131|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56393132|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
56393133|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393140|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56393142|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56393143|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393144|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56393146|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
56393147|NCT02944981|Gabapentin|gabapentin|mesh-list
56393148|NCT02944981|Analgesics|analgesics|mesh-ancestor
56393149|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
56393150|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393151|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393152|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
56393153|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56393154|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56393155|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393156|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56393157|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56393158|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56393159|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393160|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393161|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
56393162|NCT00168636|Vitamin A|vitamin a|mesh-list
56393163|NCT00168636|Vitamins|vitamins|mesh-ancestor
56393164|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
56393165|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656589|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56656590|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656591|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56656592|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56656593|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
56656594|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656595|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656596|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
56656597|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656598|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56656599|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656600|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56656601|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
56393166|NCT00144989|Cisplatin|cisplatin|mesh-list
56393167|NCT00144989|Irinotecan|irinotecan|mesh-list
56393168|NCT00144989|Etoposide|etoposide|mesh-list
56393169|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393170|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56393171|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56393172|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393173|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393174|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56393175|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56393177|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
56393178|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
56393179|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393180|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393181|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
56393182|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393183|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56393184|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56393185|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56393186|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393187|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393188|NCT00528619|Carboplatin|carboplatin|mesh-list
56393189|NCT00528619|Pemetrexed|pemetrexed|mesh-list
56393190|NCT00528619|Sunitinib|sunitinib|mesh-list
56393191|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393192|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393193|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393194|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56393195|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56393196|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56393197|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56393198|NCT00528619|Growth Substances|growth substances|mesh-ancestor
56393199|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393200|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
56393201|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56393202|NCT00168714|Interferons|interferons|mesh-list
56393203|NCT00168714|Interferon-beta|interferon-beta|mesh-list
56393210|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56393211|NCT00528658|Acetaminophen|acetaminophen|mesh-list
56393212|NCT00528658|Ibuprofen|ibuprofen|mesh-list
56393213|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56393214|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56393215|NCT00528658|Analgesics|analgesics|mesh-ancestor
56393216|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
56393217|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137704|NCT05161806|Growth Substances|growth substances|mesh-ancestor
56393218|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393219|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656602|NCT00975325|Yohimbine|yohimbine|mesh-list
56656603|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
56393220|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56393221|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56393222|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393223|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393224|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
56393225|NCT00145028|Carboplatin|carboplatin|mesh-list
56393226|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393227|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
56393228|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56393229|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393230|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
56393231|NCT00168753|Alefacept|alefacept|mesh-list
56393232|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
56393233|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
56393234|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393235|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
56393236|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56393237|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56393238|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
56393239|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393240|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56393241|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56393242|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393243|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393244|NCT00531349|Propofol|propofol|mesh-list
56393245|NCT00531349|Sevoflurane|sevoflurane|mesh-list
56393246|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
56393247|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393248|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393250|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56393251|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
56393252|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56393253|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56393254|NCT00531466|Tolperisone|tolperisone|mesh-list
56393255|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56393256|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393257|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56393258|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393259|NCT00168792|Tenecteplase|tenecteplase|mesh-list
56393260|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56393261|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56393262|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393263|NCT00531544|Sunitinib|sunitinib|mesh-list
56393264|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393265|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56393266|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56393267|NCT00531544|Growth Substances|growth substances|mesh-ancestor
56393268|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393269|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
56393270|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56393271|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393272|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393273|NCT00145106|Minocycline|minocycline|mesh-list
56393274|NCT00145106|Tazarotene|tazarotene|mesh-list
56393276|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393277|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56393278|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
56393280|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
56393281|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
56393282|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393283|NCT02944357|Gemcitabine|gemcitabine|mesh-list
56393284|NCT02944357|Cisplatin|cisplatin|mesh-list
56393285|NCT02944357|Vaccines|vaccines|mesh-list
56393286|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393287|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56393288|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
56393289|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393290|NCT02944357|Antiviral Agents|antiviral agents|mesh-ancestor
56393291|NCT02944357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393292|NCT02944357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393293|NCT02944357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56393294|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
56393295|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393296|NCT02944396|Paclitaxel|paclitaxel|mesh-list
56656604|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
56656605|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656606|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656607|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56656608|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56656609|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56656610|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
56656611|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656612|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656613|NCT00975325|Urological Agents|urological agents|mesh-ancestor
56656614|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56656615|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656616|NCT00648518|Metformin|metformin|mesh-list
56656617|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56656618|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656619|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
56656620|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
56656621|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56656622|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56656623|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656624|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656625|NCT00648596|Urological Agents|urological agents|mesh-ancestor
56656626|NCT03921151|Mirtazapine|mirtazapine|mesh-list
56393297|NCT02944396|Carboplatin|carboplatin|mesh-list
56393298|NCT02944396|Nivolumab|nivolumab|mesh-list
56393299|NCT02944396|Pemetrexed|pemetrexed|mesh-list
56393300|NCT02944396|Veliparib|veliparib|mesh-list
56393301|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56393302|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393303|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
56393304|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
56393305|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
56393306|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393307|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56393308|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56393309|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393310|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56393311|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56393312|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56393313|NCT00174174|Modafinil|modafinil|mesh-list
56393314|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56393315|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393316|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56393317|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56393318|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56393319|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393320|NCT00530101|Doxorubicin|doxorubicin|mesh-list
56393321|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56393322|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656627|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
56656628|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56656629|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56656630|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
56302802|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
56656631|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
56656632|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656633|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656634|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656635|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56656636|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56656637|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656638|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56656639|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56656640|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56393323|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56393324|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56393325|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393326|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393327|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56393328|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
56393329|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393330|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
56393331|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56393333|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393334|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56393335|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
56393336|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56393337|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56393338|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393339|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393340|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56393341|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56393342|NCT00145301|Analgesics|analgesics|mesh-ancestor
56393343|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
56393344|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393345|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393346|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56393347|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56393348|NCT00168870|Gemcitabine|gemcitabine|mesh-list
56393352|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393353|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393354|NCT00168870|Antiviral Agents|antiviral agents|mesh-ancestor
56393355|NCT00168870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393356|NCT00168870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393357|NCT00168870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56393358|NCT00168870|Immunologic Factors|immunologic factors|mesh-ancestor
56393359|NCT00168870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393360|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56393361|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
56393362|NCT02944201|Carvedilol|carvedilol|mesh-list
56393363|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56393364|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56393365|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
56393366|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393367|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656641|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
56656642|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56656643|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56656644|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
56656645|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56656646|NCT04570436|Diazepam|diazepam|mesh-list
56656647|NCT04570436|Gabapentin|gabapentin|mesh-list
56656648|NCT04570436|Analgesics|analgesics|mesh-ancestor
56656649|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
56656650|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656651|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656652|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
56656653|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56656654|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56656655|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393368|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393369|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56393370|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
56393371|NCT02944201|Protective Agents|protective agents|mesh-ancestor
56393372|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56393373|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393374|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56393375|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
56393376|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56393377|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56393378|NCT00145340|Pioglitazone|pioglitazone|mesh-list
56393379|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56393380|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393381|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
56393382|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56393383|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56393384|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393386|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
56393387|NCT00145379|Metformin|metformin|mesh-list
56393388|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56393389|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393390|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
56393391|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
56393392|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56393393|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56393394|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393395|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56393396|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393397|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393398|NCT00530413|Phenobarbital|phenobarbital|mesh-list
56393399|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
56393400|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56393401|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393402|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393403|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56393404|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56393405|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393406|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393407|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
56393408|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
56393409|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56393410|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56393411|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56393412|NCT00174330|Amlodipine|amlodipine|mesh-list
56393413|NCT00174330|Atorvastatin|atorvastatin|mesh-list
56656656|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56656657|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56656658|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56656659|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218603|NCT01638182|Coagulants|coagulants|mesh-ancestor
56393414|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56393415|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56393416|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
56393417|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393418|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56393419|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56393420|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393423|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393424|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56393425|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393427|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
56393428|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
56393429|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393430|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
56393431|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393432|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393433|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56393434|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56393435|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56393436|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393437|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393438|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393439|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393440|NCT00531895|Analgesics|analgesics|mesh-ancestor
56393441|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
56393442|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393443|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
56393444|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56393445|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
56393446|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
56393447|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56393448|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393449|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
56393450|NCT00169026|Clozapine|clozapine|mesh-list
56393451|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56393452|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002188|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56393453|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393454|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56393455|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56393456|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
56393457|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393458|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393459|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
56393460|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
56393461|NCT00145613|Antibodies|antibodies|mesh-list
56393462|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
56393463|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393464|NCT00531973|Doxorubicin|doxorubicin|mesh-list
56393465|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56393466|NCT00531973|Epirubicin|epirubicin|mesh-list
56393467|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56393468|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393469|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56393470|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56393471|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393472|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393473|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56393474|NCT00145652|Hematinics|hematinics|mesh-ancestor
56393475|NCT00174486|Tadalafil|tadalafil|mesh-list
56393476|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
56393477|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56393478|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56393479|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656660|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656661|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
56656662|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56656663|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
56656664|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
56656665|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56656666|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56656667|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56656668|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56656669|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56656670|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
56656671|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
56656672|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
56656673|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
56656674|NCT05195645|Abatacept|abatacept|mesh-list
56656675|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56656676|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656677|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656678|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656679|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
56656680|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656681|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656682|NCT04171388|Micronutrients|micronutrients|mesh-list
56656683|NCT04171388|Trace Elements|trace elements|mesh-list
56656684|NCT04171388|Azithromycin|azithromycin|mesh-list
56656685|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56656686|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656687|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656688|NCT05341193|Gemcitabine|gemcitabine|mesh-list
56656689|NCT05341193|Bevacizumab|bevacizumab|mesh-list
56656690|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56656691|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656692|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56656693|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56656694|NCT05341193|Growth Substances|growth substances|mesh-ancestor
56656695|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656696|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
56393480|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393481|NCT00174486|Urological Agents|urological agents|mesh-ancestor
56656697|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56656698|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
56656699|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656700|NCT05341193|Antiviral Agents|antiviral agents|mesh-ancestor
56656701|NCT05341193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656702|NCT05341193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656703|NCT05341193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656704|NCT05341193|Immunologic Factors|immunologic factors|mesh-ancestor
56656705|NCT04229459|Nivolumab|nivolumab|mesh-list
56656706|NCT04229459|Cetuximab|cetuximab|mesh-list
56656707|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393482|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
56393483|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
56393484|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56393485|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56393486|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393487|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393488|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56393489|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56393490|NCT05319340|Anticoagulants|anticoagulants|mesh-list
56393494|NCT05319301|Protective Agents|protective agents|mesh-ancestor
56393495|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393496|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393497|NCT00169065|Olanzapine|olanzapine|mesh-list
56393498|NCT00169065|Clozapine|clozapine|mesh-list
56393499|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
56393500|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
56393501|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393502|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393503|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56393504|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56393505|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56175538|NCT01390324|Naproxen|naproxen|mesh-list
56393506|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393508|NCT00169065|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56393509|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56393510|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393511|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393512|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393513|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
56393514|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56393515|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
56393516|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
56393517|NCT00145730|Ibuprofen|ibuprofen|mesh-list
56393518|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56393519|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56393520|NCT00145730|Analgesics|analgesics|mesh-ancestor
56393521|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
56393522|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393523|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393524|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56393525|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56393526|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56393527|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393528|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393529|NCT00169143|Rituximab|rituximab|mesh-list
56393530|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56393531|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393532|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
56393533|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393534|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56393535|NCT02942680|Aspirin|aspirin|mesh-list
56393536|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56393537|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56393538|NCT02942680|Analgesics|analgesics|mesh-ancestor
56656708|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56656709|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56656710|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656711|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
56656712|NCT05165225|Docetaxel|docetaxel|mesh-list
56656713|NCT05165225|Epirubicin|epirubicin|mesh-list
56656714|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656715|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
56656716|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656717|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656718|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56393539|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
56393540|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393541|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393542|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56393543|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56393544|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56393545|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56393546|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393547|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56393548|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56393549|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393550|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
56393551|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
56393552|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393553|NCT02276911|Ibuprofen|ibuprofen|mesh-list
56393554|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56393555|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56393556|NCT02276911|Analgesics|analgesics|mesh-ancestor
56393557|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
56393558|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393559|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393560|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56393561|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56393562|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56393568|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393569|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
56393570|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393571|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
56393572|NCT00169182|Niacin|niacin|mesh-list
56393573|NCT00169182|Docetaxel|docetaxel|mesh-list
56393574|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393575|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
56393576|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
56393577|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
56393578|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393579|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
56393581|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
56393582|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393583|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56393584|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
56393585|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56393586|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
56393587|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
56393588|NCT02944825|Trimethoprim|trimethoprim|mesh-list
56393589|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
56393590|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56393591|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393592|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56393593|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56393594|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393595|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393596|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920360|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
56656719|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
56656720|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656721|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656722|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56656723|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
56656724|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
56656725|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
56656726|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56656727|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56656728|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56656729|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656730|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
56656731|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56656732|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656733|NCT00980239|Bevacizumab|bevacizumab|mesh-list
56656734|NCT00980239|Cetuximab|cetuximab|mesh-list
56656735|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
56656736|NCT00980239|Irinotecan|irinotecan|mesh-list
56656737|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56656738|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656739|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56656740|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56656741|NCT00980239|Growth Substances|growth substances|mesh-ancestor
56656742|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656743|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
56656744|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56656745|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56656746|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656747|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656748|NCT02665832|Amlodipine|amlodipine|mesh-list
56656749|NCT02665832|Olmesartan|olmesartan|mesh-list
56656750|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56656751|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56218634|NCT01638273|Pregabalin|pregabalin|mesh-list
56393597|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56393598|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56393599|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56393600|NCT02944825|Renal Agents|renal agents|mesh-ancestor
56393601|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
56393602|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56393603|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56393604|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56393605|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56656752|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56656753|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56656754|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656755|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56656756|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656757|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
56656758|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56656759|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56393606|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56393608|NCT02942758|Azacitidine|azacitidine|mesh-list
56393609|NCT02942758|Tretinoin|tretinoin|mesh-list
56393610|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56393611|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
56393612|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393613|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393614|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393615|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56393616|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393617|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
56393618|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
56393619|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
56015582|NCT00265850|Leucovorin|leucovorin|mesh-list
56393620|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393621|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56393622|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56393623|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
56393624|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56393625|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56393626|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56393627|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393628|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393629|NCT02942563|Capecitabine|capecitabine|mesh-list
56393630|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
56393631|NCT02942563|Irinotecan|irinotecan|mesh-list
56393632|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56393633|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
56393634|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393637|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56393638|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393639|NCT00145925|Gliclazide|gliclazide|mesh-list
56393640|NCT00145925|Perindopril|perindopril|mesh-list
56393641|NCT00145925|Indapamide|indapamide|mesh-list
56393642|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
56393643|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56393644|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
56393645|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393646|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393647|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56393648|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56393649|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393650|NCT00145925|Diuretics|diuretics|mesh-ancestor
56393651|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
56175542|NCT01390324|Analgesics|analgesics|mesh-ancestor
56393652|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56393653|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393654|NCT00169221|Gefitinib|gefitinib|mesh-list
56393655|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393656|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56393657|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393658|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393659|NCT00529360|Clofarabine|clofarabine|mesh-list
56393660|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56393661|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
56393662|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393663|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656760|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
56656761|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56656762|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56656763|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393664|NCT00174642|Insulin|insulin|mesh-list
56393665|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56393666|NCT00174642|Metformin|metformin|mesh-list
56393667|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
56393668|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
56393669|NCT00174642|Secretagogues|secretagogues|mesh-list
56393670|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56393671|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393672|NCT05318248|Clonidine|clonidine|mesh-list
56393673|NCT05318248|Analgesics|analgesics|mesh-ancestor
56393674|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
56393675|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393676|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393677|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56393678|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
56393679|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
56393680|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56393681|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56393682|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56393683|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
56393684|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393685|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393686|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
56393687|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56393688|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393689|NCT03458416|Cannabidiol|cannabidiol|mesh-list
56393690|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
56393691|NCT00146042|Erythromycin|erythromycin|mesh-list
56393692|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
56393693|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56393694|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
56015656|NCT01087931|Bupivacaine|bupivacaine|mesh-list
56393695|NCT00146042|Docetaxel|docetaxel|mesh-list
56393696|NCT00146042|Trastuzumab|trastuzumab|mesh-list
56393697|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393698|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56393699|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
56393700|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56393701|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393702|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56393703|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56393704|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393705|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56393706|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56393707|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393711|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56393712|NCT00169299|Hormones|hormones|mesh-ancestor
56393713|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56393714|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393715|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56393716|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56393717|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56393718|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
56393719|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56393720|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56393721|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56393722|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56393723|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56393724|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393725|NCT02942602|Atorvastatin|atorvastatin|mesh-list
56393727|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
56393728|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56393729|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56393730|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
56393731|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393732|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56393733|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56656764|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56656765|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56656766|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
56656767|NCT02781467|Fludarabine|fludarabine|mesh-list
56656768|NCT02781467|Interleukin-2|interleukin-2|mesh-list
56656769|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656770|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
56656771|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656772|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656773|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56656774|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
56218674|NCT01638442|Tosedostat|tosedostat|mesh-list
56393734|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393735|NCT02942329|Apatinib|apatinib|mesh-list
56393736|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393737|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56393738|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393739|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393740|NCT00174720|Ciclesonide|ciclesonide|mesh-list
56393741|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
56393742|NCT00174720|Hormones|hormones|mesh-ancestor
56393743|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56393744|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393745|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56393746|NCT05318794|Doxorubicin|doxorubicin|mesh-list
56393747|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393748|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56393749|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56393750|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56393751|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393752|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393753|NCT02942212|Nicotine|nicotine|mesh-list
56393754|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56393755|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
56393756|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393757|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393758|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56393759|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56393760|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
56393761|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393762|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393763|NCT00146120|Etoposide|etoposide|mesh-list
56393764|NCT00146120|Idarubicin|idarubicin|mesh-list
56393765|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56393766|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393767|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56393768|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56393769|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393770|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393771|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56393772|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
56393773|NCT00146159|Analgesics|analgesics|mesh-ancestor
56393774|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
56393775|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393776|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393777|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393778|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56393779|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56393783|NCT02276989|Quinine|quinine|mesh-list
56393784|NCT02276989|Acetazolamide|acetazolamide|mesh-list
56393785|NCT02276989|Vitamins|vitamins|mesh-ancestor
56393786|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
56393787|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393788|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
56656775|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656776|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656777|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56656778|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56302874|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
56656779|NCT02781467|Analgesics|analgesics|mesh-ancestor
56656780|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
56656781|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656783|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56656784|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656785|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56656786|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656787|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656788|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56656789|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56656790|NCT00970567|Insulin|insulin|mesh-list
56218687|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
56393789|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56393790|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
56393791|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
56393792|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56393793|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393794|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393795|NCT02276989|Diuretics|diuretics|mesh-ancestor
56393796|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
56393797|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
56393798|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56393799|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56393800|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393801|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56393802|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56393803|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393804|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56393805|NCT02276989|Analgesics|analgesics|mesh-ancestor
56393806|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
56393807|NCT00174759|Clopidogrel|clopidogrel|mesh-list
56393808|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56393809|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56393810|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56393811|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56393812|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
56393813|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393814|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393815|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393817|NCT02940925|Fluorouracil|fluorouracil|mesh-list
56393818|NCT02940925|Capecitabine|capecitabine|mesh-list
56393819|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393820|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
56393821|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393822|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56393823|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56393824|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
56393825|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393826|NCT00146237|Phenytoin|phenytoin|mesh-list
56393827|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
56393828|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56656791|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56656792|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656793|NCT05341817|Letrozole|letrozole|mesh-list
56656794|NCT05341817|Mifepristone|mifepristone|mesh-list
56656795|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656796|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56656797|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56656798|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656799|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656800|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56656801|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
56656802|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656803|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656804|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56656805|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
56656806|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56656807|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56656808|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56656809|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56656810|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
56656811|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56656812|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56656813|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
56656814|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56656815|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56656816|NCT02663570|Melatonin|melatonin|mesh-list
56656817|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
56656818|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393829|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56393830|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56393831|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393832|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56393833|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56393834|NCT02277067|Misoprostol|misoprostol|mesh-list
56393835|NCT02277067|Carbetocin|carbetocin|mesh-list
56393836|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56393837|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
56393838|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56393839|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393840|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56393841|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56393842|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
56393843|NCT00146276|Gemcitabine|gemcitabine|mesh-list
56393844|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56656819|NCT02663570|Protective Agents|protective agents|mesh-ancestor
56656820|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656821|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656822|NCT00980473|Timolol|timolol|mesh-list
56656823|NCT00980473|Travoprost|travoprost|mesh-list
56656824|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56656825|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56656826|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
56656827|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656828|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656829|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656830|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56656831|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56656832|NCT02784743|Ivermectin|ivermectin|mesh-list
56656833|NCT02784743|Albendazole|albendazole|mesh-list
56656834|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56393845|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
56393846|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393847|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393848|NCT00146276|Antiviral Agents|antiviral agents|mesh-ancestor
56393849|NCT00146276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393850|NCT00146276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393851|NCT00146276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56393852|NCT00146276|Immunologic Factors|immunologic factors|mesh-ancestor
56393855|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56393856|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56393857|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
56393858|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393859|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393860|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393861|NCT00174798|Urological Agents|urological agents|mesh-ancestor
56393863|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56393864|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393865|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56393866|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393867|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393868|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56393869|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56393870|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
56393871|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393872|NCT00169416|Valacyclovir|valacyclovir|mesh-list
56393873|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
56393874|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393875|NCT00174876|Aripiprazole|aripiprazole|mesh-list
56393876|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
56393877|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56393878|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56393879|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56393880|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393881|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393882|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
56393883|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
56393884|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393885|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393886|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56393887|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56393888|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
56393889|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56656835|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656836|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
56656837|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
56656838|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56656839|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56656840|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
56656841|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
56656842|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
56656843|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656844|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656845|NCT05341583|Ensartinib|ensartinib|mesh-list
56656846|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218747|NCT01638780|Resveratrol|resveratrol|mesh-list
56393890|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56393891|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56393892|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56393894|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
56393895|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
56393896|NCT00174993|Pioglitazone|pioglitazone|mesh-list
56393897|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56393898|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393899|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56393900|NCT02940379|Metoprolol|metoprolol|mesh-list
56393901|NCT02940379|Midazolam|midazolam|mesh-list
56393902|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56393903|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56393904|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393905|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393906|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56393907|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56393908|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56393909|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56393910|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
56393911|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
56393912|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
56393913|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
56393914|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56393915|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393916|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56393917|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56015885|NCT02923128|Sufentanil|sufentanil|mesh-list
56393918|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
56393919|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
56393920|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393921|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56393922|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56393923|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56393938|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56393939|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56393940|NCT02940535|Menotropins|menotropins|mesh-list
56393941|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
56393942|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56393943|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
56393944|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56393945|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393946|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56393947|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56393948|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393949|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56393950|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
56393951|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
56393952|NCT00146588|Capecitabine|capecitabine|mesh-list
56393953|NCT00146588|Epirubicin|epirubicin|mesh-list
56393954|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56656847|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56656848|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656849|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656850|NCT00980551|Carboplatin|carboplatin|mesh-list
56656851|NCT00980551|Vincristine|vincristine|mesh-list
56656852|NCT00980551|Topotecan|topotecan|mesh-list
56656853|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656854|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56656855|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
56656856|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
56656857|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
56393955|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
56393956|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393957|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56393958|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56393959|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
56393960|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393961|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393962|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56393963|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56393964|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
56393965|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56393966|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56393967|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56393968|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393969|NCT00175032|Aspirin|aspirin|mesh-list
56393970|NCT00175032|Celecoxib|celecoxib|mesh-list
56393971|NCT00175032|Naproxen|naproxen|mesh-list
56393972|NCT00175032|Lansoprazole|lansoprazole|mesh-list
56393973|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
56393974|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56393975|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56393976|NCT00175032|Analgesics|analgesics|mesh-ancestor
56393977|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
56393978|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56393979|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393980|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56393981|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56393982|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56393983|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56393984|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393985|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56393997|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56393998|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56393999|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56394000|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394001|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56394002|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394003|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394004|NCT00169533|Lapatinib|lapatinib|mesh-list
56394005|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394006|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56394007|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394008|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394009|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56394010|NCT05085808|Trazodone|trazodone|mesh-list
56394011|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
56394012|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56394013|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56394014|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56394015|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394016|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394017|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56394018|NCT05085808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56656858|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656859|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56394019|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56394020|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56394021|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394022|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394023|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
56394024|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56394025|NCT00424229|Lenalidomide|lenalidomide|mesh-list
56394026|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
56394027|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394028|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56394029|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56394030|NCT00424229|Growth Substances|growth substances|mesh-ancestor
56394031|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
56394032|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394033|NCT02944123|Clopidogrel|clopidogrel|mesh-list
56394034|NCT02944123|Ticagrelor|ticagrelor|mesh-list
56394035|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56394036|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56394037|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56394038|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56394039|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56394040|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
56394041|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394042|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394043|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394044|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
56394045|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56394046|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56394047|NCT02944045|Prednisolone|prednisolone|mesh-list
56394048|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
56394049|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56394050|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
56394051|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394061|NCT02944045|Protective Agents|protective agents|mesh-ancestor
56394062|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56394063|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394064|NCT00169572|Dexamethasone|dexamethasone|mesh-list
56394065|NCT00169572|Ondansetron|ondansetron|mesh-list
56394066|NCT00169572|Aprepitant|aprepitant|mesh-list
56394067|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
56394068|NCT00169572|Casopitant|casopitant|mesh-list
56394070|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
56394071|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
56394072|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394073|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394074|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394075|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
56394076|NCT00169572|Hormones|hormones|mesh-ancestor
56394077|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394078|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56394079|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394080|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
56394081|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
56394082|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56394083|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
56394084|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394085|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394086|NCT00169572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56394087|NCT00169572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56394088|NCT00169572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394089|NCT00169572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56394090|NCT00169572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56394091|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56394092|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
56394093|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
56394094|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56394095|NCT00146783|Amodiaquine|amodiaquine|mesh-list
56394096|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
56394097|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56394098|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55920722|NCT05702359|Cholecalciferol|cholecalciferol|mesh-list
56656860|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56656861|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656862|NCT02660060|Pramipexole|pramipexole|mesh-list
56656863|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
56656864|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656865|NCT02660060|Protective Agents|protective agents|mesh-ancestor
56656866|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656867|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56656868|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56656869|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
56656870|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
56656871|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656872|NCT04008979|Aspirin|aspirin|mesh-list
56656873|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56656874|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56394099|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394100|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56394101|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394102|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394103|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56394104|NCT00146783|Renal Agents|renal agents|mesh-ancestor
56394105|NCT00169611|Methylphenidate|methylphenidate|mesh-list
56394106|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56394107|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394108|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56394109|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56394110|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56165349|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394111|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394113|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394114|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
56394115|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56394116|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
56394117|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
56394118|NCT02943655|Progesterone|progesterone|mesh-list
56394130|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56394131|NCT02943655|Analgesics|analgesics|mesh-ancestor
56394132|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
56394133|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394134|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394135|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56394136|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56394137|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394138|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394139|NCT02943655|Progestins|progestins|mesh-ancestor
56394140|NCT02943655|Hormones|hormones|mesh-ancestor
56175572|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
56394141|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394142|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
56394143|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56394144|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
56394145|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394146|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
56394147|NCT05085067|Protective Agents|protective agents|mesh-ancestor
56394148|NCT00175227|Furosemide|furosemide|mesh-list
56394149|NCT00175227|Mannitol|mannitol|mesh-list
56394150|NCT00175227|Diuretics|diuretics|mesh-ancestor
56394151|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
56394152|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920723|NCT05702359|Vitamins|vitamins|mesh-list
56656875|NCT04008979|Analgesics|analgesics|mesh-ancestor
56656876|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
56656877|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394153|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56394154|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56394155|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394156|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56394157|NCT02940262|Edetic Acid|edetic acid|mesh-list
56394158|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56394159|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
56394160|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
56394161|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394162|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
56394163|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56394164|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56394165|NCT00146900|Citalopram|citalopram|mesh-list
56394166|NCT00146900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56394167|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56394168|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56394169|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394170|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394171|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
56394172|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394173|NCT00146900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56394174|NCT00146900|Antidepressive Agents|antidepressive agents|mesh-ancestor
56394175|NCT00146900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56394176|NCT02939482|Triamcinolone|triamcinolone|mesh-list
56394177|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56394180|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394181|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
55722490|NCT05209490|Iodine|iodine|mesh-list
56394183|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394184|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394185|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56394186|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
56394187|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394188|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394189|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
56394190|NCT00175266|Infliximab|infliximab|mesh-list
56394191|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
56394192|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394193|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56394194|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56394195|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394196|NCT05013892|Memantine|memantine|mesh-list
56394197|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56394198|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56394199|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
56394200|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394201|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394202|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394203|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56394204|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56394205|NCT02939248|Morphine|morphine|mesh-list
56394206|NCT02939248|Naloxone|naloxone|mesh-list
56394207|NCT02939248|Ticagrelor|ticagrelor|mesh-list
56394208|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56394209|NCT02939248|Narcotics|narcotics|mesh-ancestor
56394210|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394211|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394213|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
56394214|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394215|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56394216|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56394217|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56394218|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56394219|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
56394220|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394221|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394222|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56394223|NCT02938975|Permethrin|permethrin|mesh-list
56656878|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656879|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656880|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56656881|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56656882|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56218784|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56394224|NCT02938975|Insect Repellents|insect repellents|mesh-list
56394225|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394226|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394227|NCT02938975|Protective Agents|protective agents|mesh-ancestor
56394228|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394229|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
56394230|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56394231|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394232|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
56394233|NCT00175305|Octreotide|octreotide|mesh-list
56394234|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394235|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56394236|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394237|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
56394238|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
56394239|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394240|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56394241|NCT00407589|Besifloxacin|besifloxacin|mesh-list
56394242|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56394243|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394244|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56394245|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56394246|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394247|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394248|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394249|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56394250|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56394254|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394255|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394256|NCT02938468|Dexamethasone|dexamethasone|mesh-list
56394257|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394258|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
56394259|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
56394260|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394261|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394262|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394263|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
56394264|NCT02938468|Hormones|hormones|mesh-ancestor
56394265|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394266|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56394267|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394268|NCT02938507|Solabegron|solabegron|mesh-list
56394269|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56394270|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56394271|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56394272|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
56394273|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394274|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394275|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394276|NCT04836910|Metformin|metformin|mesh-list
56394277|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
56394278|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
56394279|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56394280|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56394281|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394282|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56394283|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56394285|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56394286|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
56394287|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394288|NCT00147524|Quinapril|quinapril|mesh-list
56016246|NCT01447849|Lubiprostone|lubiprostone|mesh-list
56656883|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656884|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56656885|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56656886|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394289|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56394291|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394292|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394293|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56394294|NCT00147563|Eplerenone|eplerenone|mesh-list
56394295|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56394296|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
56394297|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394298|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394299|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56394300|NCT00147563|Diuretics|diuretics|mesh-ancestor
56394301|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
56394302|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56394303|NCT02938273|Cetuximab|cetuximab|mesh-list
56394304|NCT02938273|Avelumab|avelumab|mesh-list
56394305|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56394306|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394307|NCT00147602|Atorvastatin|atorvastatin|mesh-list
56394308|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56394309|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56394310|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
56394311|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394312|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56394313|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56394314|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394315|NCT02941744|Nivolumab|nivolumab|mesh-list
56394316|NCT02941744|Ipilimumab|ipilimumab|mesh-list
56394317|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56394318|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394319|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56394320|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394324|NCT02941510|Budesonide|budesonide|mesh-list
56394325|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394326|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56394327|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
56394328|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394329|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394330|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56394331|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
56394332|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
56394333|NCT02941510|Hormones|hormones|mesh-ancestor
56394334|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394335|NCT00147680|Paclitaxel|paclitaxel|mesh-list
56394336|NCT00147680|Carboplatin|carboplatin|mesh-list
56394337|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56394338|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394339|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
56394340|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
56394341|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
56394342|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394343|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56394344|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56394345|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394346|NCT02940184|Incretins|incretins|mesh-ancestor
56394347|NCT02940184|Hormones|hormones|mesh-ancestor
56394348|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394349|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56394350|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
56394351|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394352|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394353|NCT03458143|Ketamine|ketamine|mesh-list
56394354|NCT03458143|Remifentanil|remifentanil|mesh-list
56394355|NCT03458143|Analgesics|analgesics|mesh-ancestor
56394356|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
55920724|NCT05702359|Micronutrients|micronutrients|mesh-ancestor
56656887|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
56656888|NCT05263583|Bromides|bromides|mesh-list
56656889|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
56656890|NCT00970879|Mefloquine|mefloquine|mesh-list
56656891|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56656892|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
56656893|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55849992|NCT01483599|Adalimumab|adalimumab|mesh-list
56394357|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394358|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394359|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56394360|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56394361|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
56394362|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
56394363|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394364|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56394365|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56394367|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394368|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56394369|NCT03458143|Narcotics|narcotics|mesh-ancestor
56394370|NCT02941315|Captopril|captopril|mesh-list
56394371|NCT02941315|Spironolactone|spironolactone|mesh-list
56394372|NCT02941315|Furosemide|furosemide|mesh-list
56394373|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56394374|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56394375|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
56394376|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394377|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394378|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56394379|NCT02941315|Diuretics|diuretics|mesh-ancestor
56394380|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
56394381|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56394382|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
56394383|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394384|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394385|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56394386|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
56394387|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394388|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56394389|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56394390|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56394391|NCT02941198|Copper|copper|mesh-list
56394392|NCT02941198|Trace Elements|trace elements|mesh-ancestor
56394393|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
56394396|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56394397|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56394398|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
56394399|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394400|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56394401|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
56394402|NCT05273671|Nalbuphine|nalbuphine|mesh-list
56394403|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56394404|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394405|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394406|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56394408|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
56394409|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394410|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56394411|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56394412|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56394413|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
56394414|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394415|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394416|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56394417|NCT05273671|Narcotics|narcotics|mesh-ancestor
56394418|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56394419|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56656894|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56656895|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656896|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56656897|NCT00970879|Renal Agents|renal agents|mesh-ancestor
56656898|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56656899|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
56656900|NCT05340803|Midazolam|midazolam|mesh-list
56656901|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
56656902|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56656903|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394420|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56394421|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
56394422|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394423|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56394424|NCT02931526|Tigecycline|tigecycline|mesh-list
56394425|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56394426|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394427|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56394428|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394429|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394430|NCT00169845|Tocopherols|tocopherols|mesh-list
56394431|NCT00169845|Vitamin E|vitamin e|mesh-list
56394432|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
56394433|NCT00169845|Beta Carotene|beta carotene|mesh-list
56394434|NCT00169845|Carotenoids|carotenoids|mesh-list
56394435|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
56016395|NCT05156060|Ketamine|ketamine|mesh-list
56394436|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394437|NCT00169845|Protective Agents|protective agents|mesh-ancestor
56394438|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394439|NCT00169845|Vitamins|vitamins|mesh-ancestor
56394440|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
56394441|NCT00169845|Provitamins|provitamins|mesh-ancestor
56394442|NCT00147836|Insulin|insulin|mesh-list
56394443|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56394444|NCT00147836|Metformin|metformin|mesh-list
56394445|NCT00147836|Gliclazide|gliclazide|mesh-list
56394446|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
56394447|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
56394448|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
56394449|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56394450|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394451|NCT02931136|Huperzine A|huperzine a|mesh-list
56394452|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56394453|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394454|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394455|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
56394456|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394457|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394458|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56394459|NCT02931136|Protective Agents|protective agents|mesh-ancestor
56394460|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56394461|NCT02931175|Hormones|hormones|mesh-ancestor
56394462|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394463|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394464|NCT00147875|Gemcitabine|gemcitabine|mesh-list
56394465|NCT00147875|Prednisone|prednisone|mesh-list
56394466|NCT00147875|Doxorubicin|doxorubicin|mesh-list
56394467|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56394468|NCT00147875|Vinblastine|vinblastine|mesh-list
56394471|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394472|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394473|NCT00147875|Antiviral Agents|antiviral agents|mesh-ancestor
56394474|NCT00147875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394475|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394476|NCT00147875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56394477|NCT00147875|Immunologic Factors|immunologic factors|mesh-ancestor
56394478|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656904|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656905|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56656906|NCT05340803|Analgesics|analgesics|mesh-ancestor
56656907|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
56656908|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656909|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56656910|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56656911|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56656912|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
56394479|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56394480|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56394481|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56394482|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394484|NCT00147875|Hormones|hormones|mesh-ancestor
56394485|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394486|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56394487|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56394488|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
56394489|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
56394490|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
56394491|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
56394492|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56394493|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394494|NCT00147914|Amoxicillin|amoxicillin|mesh-list
56394495|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
56394496|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
56394497|NCT00147914|Cefdinir|cefdinir|mesh-list
56394498|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56394499|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56394500|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394501|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56394502|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394503|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394504|NCT00147953|Rituximab|rituximab|mesh-list
56394505|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56394506|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394507|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
56394508|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394509|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56394510|NCT02930551|Lidocaine|lidocaine|mesh-list
56394511|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
56394512|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
56394513|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394514|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394515|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
56394516|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394517|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56394518|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56394519|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56394520|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56394521|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394522|NCT00175617|Minoxidil|minoxidil|mesh-list
56394523|NCT00175617|Spironolactone|spironolactone|mesh-list
56394524|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56394525|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
56394526|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394527|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394528|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56394529|NCT00175617|Diuretics|diuretics|mesh-ancestor
56394530|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
56394531|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56394532|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
56394533|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
56394534|NCT02930707|Bupivacaine|bupivacaine|mesh-list
56394535|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
56656913|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656914|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656915|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56656916|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56394536|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
56394537|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394538|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394539|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
56394540|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394541|NCT02930707|Analgesics|analgesics|mesh-ancestor
56394545|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56394546|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394547|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56394548|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
56394549|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56394550|NCT00148031|Interferons|interferons|mesh-list
56394551|NCT00148031|Ribavirin|ribavirin|mesh-list
56394552|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394553|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
56394554|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394555|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
56394556|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394557|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
56394559|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
56394560|NCT02930434|Vitamins|vitamins|mesh-ancestor
56394561|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
56394562|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394563|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56175594|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394564|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56394565|NCT00148070|Erythromycin|erythromycin|mesh-list
56394566|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
56394567|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56394568|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
56394569|NCT00148070|Docetaxel|docetaxel|mesh-list
56394570|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394571|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
56394572|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
56394573|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
56394574|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394575|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56394576|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394577|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394578|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56394579|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394580|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56394581|NCT00175695|Protein C|protein c|mesh-list
56394582|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
56394583|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56394584|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56394585|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394586|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394587|NCT02930317|Factor VIII|factor viii|mesh-list
56394588|NCT02930317|Coagulants|coagulants|mesh-ancestor
56394589|NCT00148148|Amphotericin B|amphotericin b|mesh-list
56394590|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56394591|NCT00148148|Caspofungin|caspofungin|mesh-list
56394592|NCT00148148|Amebicides|amebicides|mesh-ancestor
56394593|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56394594|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56394595|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394596|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56394597|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
56394598|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394599|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394600|NCT00170001|Esomeprazole|esomeprazole|mesh-list
56394601|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56394602|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394603|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56394604|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394605|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394606|NCT00148265|Triamcinolone|triamcinolone|mesh-list
56656917|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56656918|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56656919|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56656920|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
56656921|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
56656922|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
56656923|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
56656924|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56656925|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
56656926|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56656927|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56656928|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56303024|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
56656929|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
56656930|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56656931|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
56656932|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56656933|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656934|NCT04033172|Fulvestrant|fulvestrant|mesh-list
56656935|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56656936|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656937|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56656938|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56656939|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
56656940|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656941|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656942|NCT00980707|Fluticasone|fluticasone|mesh-list
56656943|NCT00980707|Xhance|xhance|mesh-list
56656944|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56656945|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56656946|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
56218816|NCT01639027|Drotaverin|drotaverin|mesh-list
56394607|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394608|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
56394609|NCT00148265|Hormones|hormones|mesh-ancestor
56394610|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394611|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394612|NCT02929693|Gefitinib|gefitinib|mesh-list
56394613|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394614|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56394615|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394616|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394618|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56656947|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656948|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656949|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56656950|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
56656951|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
56656952|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56656953|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
56656954|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56656955|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656956|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656957|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56656958|NCT05340725|Analgesics|analgesics|mesh-ancestor
56656959|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
56656960|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656961|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56656962|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56656963|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56656964|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
56656965|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656966|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656967|NCT00970957|Bevacizumab|bevacizumab|mesh-list
56656968|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56656969|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56656970|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56656971|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56656972|NCT00970957|Growth Substances|growth substances|mesh-ancestor
56656973|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656974|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
56656975|NCT00976105|Zolpidem|zolpidem|mesh-list
56656976|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56656977|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56656978|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56656979|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218847|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
56394619|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56394620|NCT00175734|Analgesics|analgesics|mesh-ancestor
56394621|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
56394622|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56656980|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56656981|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
56656982|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
56656983|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56656984|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656985|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56656986|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56656987|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56656988|NCT00976261|Incretins|incretins|mesh-ancestor
56656989|NCT00976261|Hormones|hormones|mesh-ancestor
56656990|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56656991|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56394623|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394624|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394625|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56394626|NCT00148382|Cetilistat|cetilistat|mesh-list
56394627|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394628|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394629|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56394630|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56394631|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
56394632|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
56394633|NCT00148421|Hematinics|hematinics|mesh-ancestor
56394634|NCT02929888|Aspirin|aspirin|mesh-list
56394635|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56394636|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56394637|NCT02929888|Analgesics|analgesics|mesh-ancestor
56394638|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
56394639|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394640|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394641|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394643|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56394644|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56394645|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394646|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56394647|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56394648|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394649|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
56394650|NCT04689412|Resveratrol|resveratrol|mesh-list
56394651|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
56394652|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394653|NCT04689412|Protective Agents|protective agents|mesh-ancestor
56394654|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394655|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394656|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56394657|NCT00148460|Tenecteplase|tenecteplase|mesh-list
56394658|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56394659|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56394660|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394661|NCT00170196|Prednisone|prednisone|mesh-list
56016629|NCT04042142|Glucagon|glucagon|mesh-list
56394662|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394664|NCT00170196|Hormones|hormones|mesh-ancestor
56394665|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394666|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394667|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56394668|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394669|NCT02929459|Vitamins|vitamins|mesh-list
56394670|NCT02929459|Riboflavin|riboflavin|mesh-list
56394671|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
56394672|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
56394673|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921102|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
56656992|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
56656993|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656994|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56656995|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
56656996|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
56394674|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56394675|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
56394676|NCT02929576|Paclitaxel|paclitaxel|mesh-list
56394677|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56394678|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394679|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
56394680|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
56394681|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56394682|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394683|NCT00175812|Tretinoin|tretinoin|mesh-list
56394684|NCT00175812|Theophylline|theophylline|mesh-list
56394685|NCT00175812|Valproic Acid|valproic acid|mesh-list
56394686|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394687|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
56394688|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
56394689|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
56394690|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394691|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394697|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394698|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56394699|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56394700|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
56394701|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394702|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56394703|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
56394704|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56394705|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
56394706|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56394707|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56394708|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
56394709|NCT00148499|Benzocaine|benzocaine|mesh-list
56394710|NCT00148499|Ambroxol|ambroxol|mesh-list
56394711|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
56394712|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
56394713|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394714|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394715|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
56394716|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394717|NCT00148499|Expectorants|expectorants|mesh-ancestor
56394718|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
56394719|NCT04283578|Oxytocin|oxytocin|mesh-list
56394720|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
56394721|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56394722|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394723|NCT03457597|Pioglitazone|pioglitazone|mesh-list
56394724|NCT03457597|Tolbutamide|tolbutamide|mesh-list
56394725|NCT03457597|Metoprolol|metoprolol|mesh-list
56394726|NCT03457597|Midazolam|midazolam|mesh-list
56394727|NCT03457597|Omeprazole|omeprazole|mesh-list
56394728|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56394729|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56394730|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394731|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394732|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56394733|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56394734|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56394735|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56394736|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
56394737|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
56394738|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
56394739|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
56394740|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394741|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394742|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56394743|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56394744|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394745|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56394746|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56656997|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56656998|NCT00976651|Menotropins|menotropins|mesh-list
56656999|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56657000|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
56657001|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56303102|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657002|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657003|NCT00971581|Ketoprofen|ketoprofen|mesh-list
56657004|NCT00971581|Omeprazole|omeprazole|mesh-list
56657005|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56657006|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657007|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56657008|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657009|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657010|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56657011|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56657012|NCT00971581|Analgesics|analgesics|mesh-ancestor
56394747|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56394748|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56394749|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
56394750|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
56394751|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394752|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56394753|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56394754|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56394755|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
56394756|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56394757|NCT02929147|Morphine|morphine|mesh-list
56394758|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56394759|NCT02929147|Narcotics|narcotics|mesh-ancestor
56394760|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394761|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394762|NCT02929147|Analgesics|analgesics|mesh-ancestor
56394763|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
56394764|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394768|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56394769|NCT00175890|Levetiracetam|levetiracetam|mesh-list
56394770|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
56394771|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
56394772|NCT00148616|Memantine|memantine|mesh-list
56394773|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56394774|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56394775|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
56394776|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394777|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394778|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394779|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56394780|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56394782|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
56394784|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56394785|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394786|NCT02928679|Incretins|incretins|mesh-ancestor
56394787|NCT02928679|Hormones|hormones|mesh-ancestor
56394788|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394789|NCT02928601|Ondansetron|ondansetron|mesh-list
56394790|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
56394791|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
56394792|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394793|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657013|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
56657014|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657015|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394794|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394795|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
56394796|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
56394797|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56394798|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
56394799|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394800|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394801|NCT02928601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56394802|NCT02928601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56394803|NCT02928601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394804|NCT02928601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56394805|NCT02928601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56394806|NCT02928328|Lidocaine|lidocaine|mesh-list
56394807|NCT02928328|Lorazepam|lorazepam|mesh-list
56394808|NCT02928328|Capsaicin|capsaicin|mesh-list
56394809|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
56394810|NCT02928328|Butyric Acid|butyric acid|mesh-list
56394811|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
56394812|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
56394813|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394814|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394815|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
56394816|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394817|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56394818|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56394819|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56394820|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56394821|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394822|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
56394823|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
56394824|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
56394825|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
56394826|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
56394827|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394828|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56394829|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56394830|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56394831|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56394832|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
56394833|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
56394834|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394835|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
56394836|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
56394837|NCT00148694|Cisplatin|cisplatin|mesh-list
56394838|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394839|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56394840|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394856|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
56394857|NCT00148850|Pioglitazone|pioglitazone|mesh-list
56394858|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56394859|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394861|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394862|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56394863|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56394864|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56394865|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
56394866|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394867|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394868|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394869|NCT02926885|Liver Extracts|liver extracts|mesh-list
56394870|NCT02926885|Hematinics|hematinics|mesh-ancestor
56394871|NCT02926846|Vancomycin|vancomycin|mesh-list
56394872|NCT02926846|Gentamicins|gentamicins|mesh-list
56394873|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56394874|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394875|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56394876|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394877|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394878|NCT02926183|Gemcitabine|gemcitabine|mesh-list
56394879|NCT02926183|Paclitaxel|paclitaxel|mesh-list
56394880|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56657016|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56657017|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56657018|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56657019|NCT05340413|Olaparib|olaparib|mesh-list
56657020|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56657021|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657022|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394881|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394882|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
56394883|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
56394884|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
56394885|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394886|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56394887|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
56394888|NCT02926183|Antiviral Agents|antiviral agents|mesh-ancestor
56394889|NCT02926183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394890|NCT02926183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016858|NCT02101190|Opicapone|opicapone|mesh-list
56394891|NCT02926183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56394892|NCT02926183|Immunologic Factors|immunologic factors|mesh-ancestor
56394893|NCT02926183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394894|NCT02925832|Bupivacaine|bupivacaine|mesh-list
56394895|NCT02925832|Ropivacaine|ropivacaine|mesh-list
56394896|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
56394897|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
56394898|NCT02925832|Anesthetics|anesthetics|mesh-list
56394899|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394900|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394901|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
56394902|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394903|NCT00170430|Fluconazole|fluconazole|mesh-list
56394924|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394925|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56394926|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56394927|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56394928|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394929|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56394930|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56394931|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56394932|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
56394933|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394934|NCT00170469|Antacids|antacids|mesh-ancestor
56394935|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394936|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394937|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
56394938|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394939|NCT00149162|Aldesleukin|aldesleukin|mesh-list
56394940|NCT00149162|Interleukin-2|interleukin-2|mesh-list
56394941|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394942|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56394943|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56394944|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
56394945|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394946|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56394947|NCT00149162|Analgesics|analgesics|mesh-ancestor
56394948|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
56394949|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394950|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394951|NCT00170547|Vaccines|vaccines|mesh-list
56394952|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
56394953|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394954|NCT00149201|Fluorouracil|fluorouracil|mesh-list
56394968|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
56394969|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56394970|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56394971|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56394972|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56394973|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657023|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657024|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56394974|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
56394975|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394976|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394977|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56394978|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394979|NCT02925247|Anticoagulants|anticoagulants|mesh-list
56394980|NCT00170664|Paclitaxel|paclitaxel|mesh-list
56394981|NCT00170664|Carboplatin|carboplatin|mesh-list
56394982|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56394983|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394984|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
56394985|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
56394986|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
56394987|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394988|NCT04725617|Varenicline|varenicline|mesh-list
56394989|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56394990|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56394991|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
56394992|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394993|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394994|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394995|NCT03539614|Prazosin|prazosin|mesh-list
56394996|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56394997|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56394998|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56394999|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56395000|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
56395001|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395002|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395003|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395004|NCT00170742|Octreotide|octreotide|mesh-list
56395005|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56395006|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56395007|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395009|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
56395010|NCT02917525|Vitamins|vitamins|mesh-ancestor
56395011|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
56395012|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395013|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56395015|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395017|NCT02917525|Coagulants|coagulants|mesh-ancestor
56395018|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
56395019|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56395020|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56395021|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395022|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395023|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56395024|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56395025|NCT00170781|Analgesics|analgesics|mesh-ancestor
56395026|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
56395027|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395028|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395029|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56395030|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395031|NCT00170820|Everolimus|everolimus|mesh-list
56395032|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395033|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56395034|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
56395035|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395036|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
56395037|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56395038|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395039|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395040|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56395041|NCT02917018|Analgesics|analgesics|mesh-ancestor
56395042|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
56395043|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395044|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56395045|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56395046|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56657025|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657026|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657027|NCT00971659|Insulin|insulin|mesh-list
56657028|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56657029|NCT00971659|Metformin|metformin|mesh-list
56657030|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
56657031|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56657032|NCT00971659|Exenatide|exenatide|mesh-list
56657033|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56657034|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657035|NCT00971659|Incretins|incretins|mesh-ancestor
56657036|NCT00971659|Hormones|hormones|mesh-ancestor
56657037|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657038|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56657039|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
56657040|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395047|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
56395048|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395049|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395050|NCT00170859|Everolimus|everolimus|mesh-list
56395051|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395052|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56395053|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
56395054|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395055|NCT02917057|Exenatide|exenatide|mesh-list
56395056|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56395057|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395058|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56395059|NCT02917057|Incretins|incretins|mesh-ancestor
56395060|NCT02917057|Hormones|hormones|mesh-ancestor
56395061|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395062|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
56395063|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56395064|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
56395065|NCT02916940|Hormones|hormones|mesh-ancestor
56395066|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395067|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395068|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
56395069|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56395070|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56395071|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395072|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395073|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56395074|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56395075|NCT00170898|Analgesics|analgesics|mesh-ancestor
56395076|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
56395077|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395079|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56395080|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395081|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56395082|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395083|NCT02916511|Paclitaxel|paclitaxel|mesh-list
56395084|NCT02916511|Carboplatin|carboplatin|mesh-list
56395085|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56395089|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
56395090|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395092|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56395093|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56657041|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657042|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56657043|NCT00648986|Tazarotene|tazarotene|mesh-list
56657044|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
56657045|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
56657046|NCT00971815|Dexetimide|dexetimide|mesh-list
56657047|NCT00971815|Citalopram|citalopram|mesh-list
56657048|NCT00971815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56657049|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56218937|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56395094|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56395095|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56395096|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395097|NCT00170937|Diuretics|diuretics|mesh-ancestor
56395098|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
56395099|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395100|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56395101|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56395102|NCT02916238|Fluoxetine|fluoxetine|mesh-list
56395103|NCT02916238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56395104|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56395105|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56395106|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395107|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395108|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
56395109|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395110|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56395111|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
56395112|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56395113|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56395114|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56395115|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395116|NCT00149708|Hormones|hormones|mesh-list
56103344|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
56395117|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395118|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395119|NCT00163761|Gemcitabine|gemcitabine|mesh-list
56395120|NCT00163761|Vinorelbine|vinorelbine|mesh-list
56395121|NCT00163761|Ifosfamide|ifosfamide|mesh-list
56395122|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56395123|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
56395124|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395125|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395126|NCT00163761|Antiviral Agents|antiviral agents|mesh-ancestor
56395127|NCT00163761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395128|NCT00163761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395129|NCT00163761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56395130|NCT00163761|Immunologic Factors|immunologic factors|mesh-ancestor
56395131|NCT00163761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395132|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56395133|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
56395134|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
56395135|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
56395136|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56395137|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
56395138|NCT02916160|Valsartan|valsartan|mesh-list
56395139|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56395140|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56395141|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56395142|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56395143|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395144|NCT02916121|Folic Acid|folic acid|mesh-list
56395145|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
56657050|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657051|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657052|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657053|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
56657054|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657055|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56657056|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
56395146|NCT02916121|Vitamins|vitamins|mesh-ancestor
56395147|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
56395148|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395149|NCT02916121|Hematinics|hematinics|mesh-ancestor
56395153|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56395154|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56395155|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56395156|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395165|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56395166|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
56395167|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56395168|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395169|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395170|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395171|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
56395172|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56395173|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395174|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56395175|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
56395176|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56395177|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395178|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395179|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395180|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
56395181|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56395182|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56395183|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395184|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56395185|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56395186|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395187|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395188|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175655|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56395189|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56395191|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56395192|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395193|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56395194|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56395195|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56395197|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56395198|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56395199|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56395200|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56395201|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395202|NCT00171015|Diuretics|diuretics|mesh-ancestor
56395203|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
56395204|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395205|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56395206|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56395207|NCT05786677|Serotonin|serotonin|mesh-list
56395208|NCT05786677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56395209|NCT05786677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56395210|NCT05786677|Serotonin Agents|serotonin agents|mesh-ancestor
56395211|NCT05786677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395212|NCT05786677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395213|NCT05786677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657057|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657058|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56657059|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56657060|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
56657061|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
56395214|NCT05786677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56395215|NCT05786677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56395218|NCT05786612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56395219|NCT05786612|Laxatives|laxatives|mesh-ancestor
56395220|NCT05786612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56395240|NCT05786443|Empagliflozin|empagliflozin|mesh-list
56395241|NCT05786443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56395242|NCT05786443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395243|NCT05786443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56395244|NCT05786443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395245|NCT05786430|Carboplatin|carboplatin|mesh-list
56395246|NCT05786430|Pemetrexed|pemetrexed|mesh-list
56395247|NCT05786430|Lazertinib|lazertinib|mesh-list
56395248|NCT05786430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395249|NCT05786430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395250|NCT05786430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395251|NCT05786430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56395252|NCT05786430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56395253|NCT05786430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56395254|NCT05786417|Calcium Channel Blockers|calcium channel blockers|mesh-list
56395255|NCT05786417|Calcium|calcium|mesh-list
56395256|NCT05786417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56395257|NCT05786417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56395258|NCT05786417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395259|NCT05786417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56395260|NCT05786417|Adrenergic Agents|adrenergic agents|mesh-ancestor
56395261|NCT05786417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395262|NCT05786417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395263|NCT05786417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56395264|NCT05786378|Anesthetics|anesthetics|mesh-list
56395265|NCT05786378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395266|NCT05786378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395268|NCT05786365|Analgesics|analgesics|mesh-ancestor
56395269|NCT05786365|Sensory System Agents|sensory system agents|mesh-ancestor
56395270|NCT05786365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395271|NCT05786365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395272|NCT05786365|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56395273|NCT05786365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56395274|NCT05786365|Anesthetics, General|anesthetics, general|mesh-ancestor
56395275|NCT05786365|Anesthetics|anesthetics|mesh-ancestor
56395276|NCT05786365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395277|NCT05786365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56395278|NCT05786365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56395279|NCT05786365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395280|NCT05786365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395281|NCT05786339|Irbesartan|irbesartan|mesh-list
56395282|NCT05786339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56395283|NCT05786339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56395284|NCT05786339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56395285|NCT05786339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395286|NCT05786066|Ketamine|ketamine|mesh-list
56395287|NCT05786066|Analgesics|analgesics|mesh-ancestor
56395288|NCT05786066|Sensory System Agents|sensory system agents|mesh-ancestor
56395289|NCT05786066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395290|NCT05786066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395291|NCT05786066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56395292|NCT05786066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56395293|NCT05786066|Anesthetics, General|anesthetics, general|mesh-ancestor
56395294|NCT05786066|Anesthetics|anesthetics|mesh-ancestor
56395335|NCT05785689|Dexmedetomidine|dexmedetomidine|mesh-list
56395337|NCT05785689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395338|NCT05785689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395339|NCT05785689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56657062|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657063|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56657064|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56657065|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
56657066|NCT00981487|Ondansetron|ondansetron|mesh-list
56657067|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
56657068|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
56395340|NCT05785689|Analgesics|analgesics|mesh-ancestor
56395341|NCT05785689|Sensory System Agents|sensory system agents|mesh-ancestor
56395342|NCT05785689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395343|NCT05785689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56395344|NCT05785689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56395345|NCT05785689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56395346|NCT05785689|Adrenergic Agents|adrenergic agents|mesh-ancestor
56395347|NCT05785689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395348|NCT05785689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395349|NCT05785585|Vitamin B 12|vitamin b 12|mesh-list
56395350|NCT05785585|Hydroxocobalamin|hydroxocobalamin|mesh-list
56395351|NCT05785585|Vitamin B Complex|vitamin b complex|mesh-ancestor
56395352|NCT05785585|Vitamins|vitamins|mesh-ancestor
56395353|NCT05785585|Micronutrients|micronutrients|mesh-ancestor
56395354|NCT05785585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395355|NCT05785585|Hematinics|hematinics|mesh-ancestor
56395356|NCT05785442|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56395357|NCT05785442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395358|NCT05785429|Colchicine|colchicine|mesh-list
56395359|NCT05785429|Gout Suppressants|gout suppressants|mesh-ancestor
56395360|NCT05785429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395361|NCT05785429|Tubulin Modulators|tubulin modulators|mesh-ancestor
56395362|NCT05785429|Antimitotic Agents|antimitotic agents|mesh-ancestor
56395363|NCT05785429|Mitosis Modulators|mitosis modulators|mesh-ancestor
56395364|NCT05785429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395365|NCT05785429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395366|NCT05785377|Bupivacaine|bupivacaine|mesh-list
56395367|NCT05785377|Neostigmine|neostigmine|mesh-list
56395368|NCT05785377|Anesthetics, Local|anesthetics, local|mesh-ancestor
56395369|NCT05785377|Anesthetics|anesthetics|mesh-ancestor
56395370|NCT05785377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395371|NCT05785377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395372|NCT05785377|Sensory System Agents|sensory system agents|mesh-ancestor
56395373|NCT05785377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395374|NCT05785377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56395376|NCT05785377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395377|NCT05785377|Cholinergic Agents|cholinergic agents|mesh-ancestor
56395378|NCT05785377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395379|NCT05785377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56395380|NCT05785377|Autonomic Agents|autonomic agents|mesh-ancestor
56395381|NCT05785325|Bevacizumab|bevacizumab|mesh-list
56395382|NCT05785325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56395383|NCT05785325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395384|NCT05785325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56395385|NCT05785325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56395386|NCT05785325|Growth Substances|growth substances|mesh-ancestor
56395387|NCT05785325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395388|NCT05785325|Growth Inhibitors|growth inhibitors|mesh-ancestor
56395389|NCT05785234|Sufentanil|sufentanil|mesh-list
56395390|NCT05785234|Remifentanil|remifentanil|mesh-list
56395391|NCT05785234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56395392|NCT05785234|Narcotics|narcotics|mesh-ancestor
56395393|NCT05785234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395394|NCT05785234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395395|NCT05785234|Analgesics|analgesics|mesh-ancestor
56395396|NCT05785234|Sensory System Agents|sensory system agents|mesh-ancestor
56395397|NCT05785234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395398|NCT05785234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56395399|NCT05785234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56395400|NCT05785234|Anesthetics, General|anesthetics, general|mesh-ancestor
56395401|NCT05785234|Anesthetics|anesthetics|mesh-ancestor
56395402|NCT05785208|Osimertinib|osimertinib|mesh-list
56395403|NCT05785208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657069|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657070|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657071|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657072|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
56657073|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
56657074|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56657075|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
56547640|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56657076|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657077|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657078|NCT00981487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56657079|NCT00981487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56657080|NCT00981487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395404|NCT05785208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56395405|NCT05785208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395406|NCT05785208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395407|NCT05785195|Nitric Oxide|nitric oxide|mesh-list
56395408|NCT05785195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56395410|NCT05785195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395411|NCT05785195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395412|NCT05785195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56395416|NCT05785195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395417|NCT05785195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395418|NCT05785195|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56395419|NCT05785195|Vasodilator Agents|vasodilator agents|mesh-ancestor
56395420|NCT05785195|Gasotransmitters|gasotransmitters|mesh-ancestor
56395421|NCT05785195|Protective Agents|protective agents|mesh-ancestor
56395422|NCT05785065|Mycophenolic Acid|mycophenolic acid|mesh-list
56395423|NCT05785065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56395424|NCT05785065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395425|NCT05785065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56395426|NCT05785065|Antitubercular Agents|antitubercular agents|mesh-ancestor
56395427|NCT05785065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56395428|NCT05785065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395429|NCT05785065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395430|NCT05785065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395431|NCT05785026|Menthol|menthol|mesh-list
56395432|NCT05785026|Antipruritics|antipruritics|mesh-ancestor
56395433|NCT05785026|Dermatologic Agents|dermatologic agents|mesh-ancestor
56395434|NCT05784987|Rituximab|rituximab|mesh-list
56395435|NCT05784987|Etoposide|etoposide|mesh-list
56395436|NCT05784987|Lenalidomide|lenalidomide|mesh-list
56395438|NCT05784987|Ifosfamide|ifosfamide|mesh-list
56395439|NCT05784987|Isophosphamide mustard|isophosphamide mustard|mesh-list
56395440|NCT05784987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56395441|NCT05784987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395442|NCT05784987|Immunologic Factors|immunologic factors|mesh-ancestor
56395443|NCT05784987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395444|NCT05784987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395445|NCT05784987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56395446|NCT05784987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56395447|NCT05784987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56395448|NCT05784987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395449|NCT05784987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395450|NCT05784987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56395451|NCT05784987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56395452|NCT05784987|Growth Substances|growth substances|mesh-ancestor
56395453|NCT05784987|Growth Inhibitors|growth inhibitors|mesh-ancestor
56395454|NCT05784987|Analgesics|analgesics|mesh-ancestor
56395455|NCT05784987|Sensory System Agents|sensory system agents|mesh-ancestor
56657081|NCT00981487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657082|NCT00981487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56657083|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56657084|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56657085|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657086|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
56657087|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56657088|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56657089|NCT00971893|Prednisolone|prednisolone|mesh-list
56657090|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
56657091|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56657092|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
56657093|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56657094|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
56657095|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
56395456|NCT05784987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395457|NCT05784987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56395458|NCT05784987|Alkylating Agents|alkylating agents|mesh-ancestor
56395459|NCT05784870|Ferrous succinate|ferrous succinate|mesh-list
56395460|NCT05784870|Hematinics|hematinics|mesh-ancestor
56395461|NCT05784844|Meropenem|meropenem|mesh-list
56395462|NCT05784844|Micafungin|micafungin|mesh-list
56395463|NCT05784844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56395464|NCT05784844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395465|NCT05784844|Antifungal Agents|antifungal agents|mesh-ancestor
56395466|NCT05784753|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
56395467|NCT05784753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395468|NCT05784753|Immunologic Factors|immunologic factors|mesh-ancestor
56395469|NCT05784753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395473|NCT05784571|Insulin|insulin|mesh-list
56395474|NCT05784571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56395475|NCT05784571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395476|NCT05784519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56395477|NCT05784519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56395478|NCT05784467|Methamphetamine|methamphetamine|mesh-list
56395479|NCT05784467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56017441|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395480|NCT05784467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395481|NCT05784467|Sympathomimetics|sympathomimetics|mesh-ancestor
56395482|NCT05784467|Autonomic Agents|autonomic agents|mesh-ancestor
56395483|NCT05784467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395484|NCT05784467|Dopamine Agents|dopamine agents|mesh-ancestor
56395485|NCT05784467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395486|NCT05784467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395487|NCT05784467|Adrenergic Agents|adrenergic agents|mesh-ancestor
56395488|NCT05784467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56395501|NCT05784246|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56395502|NCT05784246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56395503|NCT05782894|Remifentanil|remifentanil|mesh-list
56395504|NCT05782894|Propofol|propofol|mesh-list
56395505|NCT05782894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56395506|NCT05782894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395507|NCT05782894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395508|NCT05782894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56395518|NCT05782712|Sensory System Agents|sensory system agents|mesh-ancestor
56395519|NCT05782712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395520|NCT05782712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395521|NCT05782712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56395522|NCT05782712|Vasodilator Agents|vasodilator agents|mesh-ancestor
56395523|NCT05782712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56395524|NCT05782712|Purinergic Agonists|purinergic agonists|mesh-ancestor
56395525|NCT05782712|Purinergic Agents|purinergic agents|mesh-ancestor
56657096|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657097|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657098|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657099|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
56395526|NCT05782712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395527|NCT05782712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395530|NCT05781516|Prednisolone|prednisolone|mesh-list
56395531|NCT05781516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56395532|NCT05781516|Glucocorticoids|glucocorticoids|mesh-ancestor
56395533|NCT05781516|Hormones|hormones|mesh-ancestor
56395534|NCT05781516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395535|NCT05781516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395536|NCT05781516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56395537|NCT05781516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395538|NCT05781321|Temozolomide|temozolomide|mesh-list
56395539|NCT05781321|Levodopa|levodopa|mesh-list
56395540|NCT05781321|Fluorides|fluorides|mesh-list
56395541|NCT05781321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56395542|NCT05781321|Alkylating Agents|alkylating agents|mesh-ancestor
56395543|NCT05781321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395544|NCT05781321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395545|NCT05781321|Cariostatic Agents|cariostatic agents|mesh-ancestor
56395546|NCT05781321|Protective Agents|protective agents|mesh-ancestor
56395547|NCT05781321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395548|NCT05781321|Dopamine Agents|dopamine agents|mesh-ancestor
56395549|NCT05781321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395550|NCT05781321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56395551|NCT05781321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56395552|NCT05780437|Remdesivir|remdesivir|mesh-list
56395553|NCT05780437|Antimetabolites|antimetabolites|mesh-ancestor
56395554|NCT05780437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395555|NCT05780437|Antiviral Agents|antiviral agents|mesh-ancestor
56395556|NCT05780437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395557|NCT05780424|Remdesivir|remdesivir|mesh-list
56395558|NCT05780424|Antimetabolites|antimetabolites|mesh-ancestor
56395559|NCT05780424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395560|NCT05780424|Antiviral Agents|antiviral agents|mesh-ancestor
56395561|NCT05780424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395565|NCT05779007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56395566|NCT05779007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395567|NCT05779007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395569|NCT05779007|Sensory System Agents|sensory system agents|mesh-ancestor
56395570|NCT05779007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395571|NCT05779007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395572|NCT05779007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56395573|NCT05779007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56395574|NCT05779007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56395575|NCT05779007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395576|NCT05778266|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56395577|NCT05778266|Laxatives|laxatives|mesh-ancestor
56395578|NCT05778266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56395586|NCT05777135|Propofol|propofol|mesh-list
56395587|NCT05777135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56395588|NCT05777135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395589|NCT05777135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395590|NCT05777135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56395591|NCT05777135|Anesthetics, General|anesthetics, general|mesh-ancestor
56395592|NCT05777135|Anesthetics|anesthetics|mesh-ancestor
56395593|NCT05774405|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56395594|NCT05774405|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56395595|NCT05774405|Estradiol|estradiol|mesh-list
56395596|NCT05774405|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56395597|NCT05774405|Estrogens|estrogens|mesh-ancestor
56395598|NCT05774405|Hormones|hormones|mesh-ancestor
56395599|NCT05774405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395600|NCT05774405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395601|NCT05774405|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56395602|NCT05774405|Contraceptive Agents|contraceptive agents|mesh-ancestor
56395603|NCT05774405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56395604|NCT05774405|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56657100|NCT00971893|Hormones|hormones|mesh-ancestor
56657101|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657102|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56657103|NCT00971893|Protective Agents|protective agents|mesh-ancestor
56657104|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56657105|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657106|NCT05101187|Amphotericin B|amphotericin b|mesh-list
56657107|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56395605|NCT05773066|Lidocaine|lidocaine|mesh-list
56395606|NCT05773066|Anesthetics, Local|anesthetics, local|mesh-ancestor
56395607|NCT05773066|Anesthetics|anesthetics|mesh-ancestor
56395608|NCT05773066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56395609|NCT05773066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395610|NCT05773066|Sensory System Agents|sensory system agents|mesh-ancestor
56395611|NCT05773066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395612|NCT05773066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56395613|NCT05773066|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56395614|NCT05773066|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56395615|NCT05773066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56395616|NCT05773066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395617|NCT05766683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56395618|NCT05766683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56395619|NCT05766683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56395620|NCT05766683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395621|NCT05766683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395622|NCT05766683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56395623|NCT05766683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56395624|NCT05766683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395625|NCT05766683|Cholinergic Agents|cholinergic agents|mesh-ancestor
56395626|NCT05766683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395627|NCT05764941|Vinorelbine|vinorelbine|mesh-list
56395628|NCT05764941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56395629|NCT05764941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395630|NCT05764941|Tubulin Modulators|tubulin modulators|mesh-ancestor
56395631|NCT05764941|Antimitotic Agents|antimitotic agents|mesh-ancestor
56395632|NCT05764941|Mitosis Modulators|mitosis modulators|mesh-ancestor
56395633|NCT05764941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395634|NCT05757869|Apixaban|apixaban|mesh-list
56395635|NCT05757869|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56395636|NCT05757869|Antithrombins|antithrombins|mesh-ancestor
56395637|NCT05757869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56395638|NCT05757869|Protease Inhibitors|protease inhibitors|mesh-ancestor
56395639|NCT05757869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395645|NCT05746559|Ravulizumab|ravulizumab|mesh-list
56395646|NCT05746559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56395647|NCT05746559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56395648|NCT05746559|Immunologic Factors|immunologic factors|mesh-ancestor
56395649|NCT05746559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395650|NCT05734105|Sunitinib|sunitinib|mesh-list
56395651|NCT05734105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395652|NCT05734105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56395653|NCT05734105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56395654|NCT05734105|Growth Substances|growth substances|mesh-ancestor
56395655|NCT05734105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395656|NCT05734105|Growth Inhibitors|growth inhibitors|mesh-ancestor
56395657|NCT05734105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56395658|NCT05734105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395659|NCT05734105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395689|NCT05700422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395690|NCT05700422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395692|NCT05691712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56395693|NCT05691712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395694|NCT05691712|Incretins|incretins|mesh-ancestor
56395695|NCT05691712|Hormones|hormones|mesh-ancestor
56395696|NCT05691712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657108|NCT05101187|Olorofim|olorofim|mesh-list
56657109|NCT05101187|Amebicides|amebicides|mesh-ancestor
56657110|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56657111|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56657112|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657113|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56657114|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
56657115|NCT02665208|Nicotine|nicotine|mesh-list
56657116|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56657117|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
56657118|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657119|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657120|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56657121|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56657122|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
56657123|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657124|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657125|NCT00977353|Citalopram|citalopram|mesh-list
56657126|NCT00977353|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56657127|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56657128|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657129|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657130|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017667|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
56395714|NCT05662332|Insulin|insulin|mesh-list
56395715|NCT05662332|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56395716|NCT05662332|Insulin Glargine|insulin glargine|mesh-list
56395717|NCT05662332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56395718|NCT05662332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395731|NCT05652205|Linaclotide|linaclotide|mesh-list
56395732|NCT05652205|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56395733|NCT05652205|Enzyme Activators|enzyme activators|mesh-ancestor
56395734|NCT05652205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395735|NCT05652205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56395736|NCT05650879|Trastuzumab|trastuzumab|mesh-list
56395737|NCT05650879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56395738|NCT05650879|Maytansine|maytansine|mesh-list
56395739|NCT05650879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56395740|NCT05650879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395741|NCT05650879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56395742|NCT05650879|Tubulin Modulators|tubulin modulators|mesh-ancestor
56395743|NCT05650879|Antimitotic Agents|antimitotic agents|mesh-ancestor
56395744|NCT05650879|Mitosis Modulators|mitosis modulators|mesh-ancestor
56395745|NCT05650879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395750|NCT05635110|Rifampin|rifampin|mesh-list
56395751|NCT05635110|Omeprazole|omeprazole|mesh-list
56395752|NCT05635110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56395753|NCT05635110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56395754|NCT05635110|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56395755|NCT05635110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395756|NCT05635110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395757|NCT05635110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56395758|NCT05635110|Antitubercular Agents|antitubercular agents|mesh-ancestor
56657131|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
56657132|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657133|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56657134|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
56657135|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657136|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56657137|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657138|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56657139|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657140|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657141|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
56657142|NCT04170530|Irinotecan|irinotecan|mesh-list
56657143|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657144|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56657145|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56657146|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657147|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657148|NCT02617017|Buspirone|buspirone|mesh-list
56395759|NCT05635110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56395760|NCT05635110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395761|NCT05635110|Leprostatic Agents|leprostatic agents|mesh-ancestor
56395762|NCT05635110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56395763|NCT05635110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56395764|NCT05635110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56395765|NCT05635110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56395766|NCT05635110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56395767|NCT05635110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56395768|NCT05635110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56395769|NCT05634577|Pembrolizumab|pembrolizumab|mesh-list
56395770|NCT05634577|Mitotane|mitotane|mesh-list
56395773|NCT05634577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56395774|NCT05634369|Gemcitabine|gemcitabine|mesh-list
56395775|NCT05634369|Dexamethasone|dexamethasone|mesh-list
56395776|NCT05634369|Docetaxel|docetaxel|mesh-list
56395777|NCT05634369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56395778|NCT05634369|Antiemetics|antiemetics|mesh-ancestor
56395779|NCT05634369|Autonomic Agents|autonomic agents|mesh-ancestor
56395780|NCT05634369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395781|NCT05634369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395782|NCT05634369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56017743|NCT01159067|Deferasirox|deferasirox|mesh-list
56395783|NCT05634369|Glucocorticoids|glucocorticoids|mesh-ancestor
56395784|NCT05634369|Hormones|hormones|mesh-ancestor
56395785|NCT05634369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395786|NCT05634369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56395787|NCT05634369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395788|NCT05634369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395789|NCT05634369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395790|NCT05634369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56395791|NCT05634369|Antimetabolites|antimetabolites|mesh-ancestor
56395792|NCT05634369|Antiviral Agents|antiviral agents|mesh-ancestor
56395793|NCT05634369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395794|NCT05634369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56395795|NCT05634369|Immunologic Factors|immunologic factors|mesh-ancestor
56395796|NCT05634369|Tubulin Modulators|tubulin modulators|mesh-ancestor
56395797|NCT05634369|Antimitotic Agents|antimitotic agents|mesh-ancestor
56657149|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56657150|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56657151|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657152|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657153|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657154|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56657155|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
56395798|NCT05634369|Mitosis Modulators|mitosis modulators|mesh-ancestor
56395807|NCT05622201|Rituximab|rituximab|mesh-list
56395808|NCT05622201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56395810|NCT05622201|Immunologic Factors|immunologic factors|mesh-ancestor
56395811|NCT05622201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395812|NCT05622201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395813|NCT05616260|Acetazolamide|acetazolamide|mesh-list
56395814|NCT05616260|Anticonvulsants|anticonvulsants|mesh-ancestor
56395815|NCT05616260|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56395816|NCT05616260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175679|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
56395918|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56395919|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56395920|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
56395922|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
56395923|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395924|NCT05541276|Protective Agents|protective agents|mesh-ancestor
56395925|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395926|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017897|NCT00343460|Hormones|hormones|mesh-ancestor
56395937|NCT05536804|Tirzepatide|tirzepatide|mesh-list
56395938|NCT05536804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56395939|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395940|NCT05536804|Incretins|incretins|mesh-ancestor
56395941|NCT05536804|Hormones|hormones|mesh-ancestor
56395942|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395943|NCT05535764|Interferons|interferons|mesh-list
56395944|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
56395945|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
56395946|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56395947|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395948|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
56395949|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395950|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
56395951|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395952|NCT05520567|Azacitidine|azacitidine|mesh-list
56395953|NCT05520567|Venetoclax|venetoclax|mesh-list
56395954|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56395955|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
56395956|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395957|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395958|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56395959|NCT05519085|Dexamethasone|dexamethasone|mesh-list
56395960|NCT05519085|Bortezomib|bortezomib|mesh-list
56395961|NCT05519085|Pomalidomide|pomalidomide|mesh-list
56395962|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56395963|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
56395964|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
56395970|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395971|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56395972|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395973|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
56395974|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56395975|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56395976|NCT05519085|Growth Substances|growth substances|mesh-ancestor
56395977|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
56395978|NCT05514054|Tamoxifen|tamoxifen|mesh-list
56395979|NCT05514054|Letrozole|letrozole|mesh-list
56395980|NCT05514054|Anastrozole|anastrozole|mesh-list
56395981|NCT05514054|Exemestane|exemestane|mesh-list
56395982|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395983|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56395984|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56395985|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657156|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657157|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657158|NCT02616861|Praliciguat|praliciguat|mesh-list
56395986|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395987|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56395988|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
56395989|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56395990|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395991|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56395992|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56395993|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56395994|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56395995|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56395996|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56395997|NCT05463744|Insulin|insulin|mesh-list
56395998|NCT05463744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56395999|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56396000|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396001|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
56396002|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56396003|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56396004|NCT05462730|Prednisolone|prednisolone|mesh-list
56396005|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
56396006|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56396007|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
56396008|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56396009|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
56396010|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
56396011|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396012|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396013|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56396014|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
56396015|NCT05462730|Hormones|hormones|mesh-ancestor
56396016|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396017|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56396018|NCT05462730|Protective Agents|protective agents|mesh-ancestor
56396019|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56396020|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396021|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
56396022|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56396023|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
56396024|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56396025|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396026|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56396027|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56396028|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56396029|NCT05440786|Irinotecan|irinotecan|mesh-list
56396030|NCT05440786|Temozolomide|temozolomide|mesh-list
56396031|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56396032|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56396033|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396034|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396045|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396046|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56396048|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
56396049|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
56396050|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396052|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396053|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56396054|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396055|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396063|NCT05405114|Decitabine|decitabine|mesh-list
56396064|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
56396065|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
56396066|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56396067|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
56396068|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396069|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396070|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396071|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
56657159|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56657160|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
56657161|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396072|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56396137|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56396138|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
56396139|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56396140|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56396141|NCT05357989|Phenserine|phenserine|mesh-list
56396142|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56396143|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396144|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396145|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
56396146|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396147|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396148|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
56396149|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56396150|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396151|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56396152|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56396153|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396154|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396155|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396156|NCT05352815|Insulin|insulin|mesh-list
56396157|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56396158|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396176|NCT05334017|Cocaine|cocaine|mesh-list
56396177|NCT05334017|Xylometazoline|xylometazoline|mesh-list
56396178|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
56396179|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
56396180|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56396181|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396182|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
56396183|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396184|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56396185|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56396186|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56396187|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56396188|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396189|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
56396190|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396191|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
56396192|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
56396193|NCT05327595|Midazolam|midazolam|mesh-list
56396194|NCT05327595|Atorvastatin|atorvastatin|mesh-list
56396195|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56396196|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56396197|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56396198|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396199|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56396200|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56396201|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56396202|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56396208|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396209|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56396210|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56396211|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
56396212|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56396213|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56396214|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396215|NCT05319639|Leucovorin|leucovorin|mesh-list
56396216|NCT05319639|Paclitaxel|paclitaxel|mesh-list
56396217|NCT05319639|Fluorouracil|fluorouracil|mesh-list
56396218|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
56396219|NCT05319639|Irinotecan|irinotecan|mesh-list
56396220|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
56396221|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56396222|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396223|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
56396224|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
56396225|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
55921923|NCT03855007|Methotrexate|methotrexate|mesh-list
56657162|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657163|NCT00981721|Cediranib|cediranib|mesh-list
56657164|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657165|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56657166|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219048|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56396226|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396227|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
56396228|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56396229|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396230|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
56396231|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396232|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56396233|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56396234|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396235|NCT05319639|Antidotes|antidotes|mesh-ancestor
56396236|NCT05319639|Protective Agents|protective agents|mesh-ancestor
56396237|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
56396238|NCT05319639|Vitamins|vitamins|mesh-ancestor
56396239|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
56396240|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56396241|NCT05308446|Nivolumab|nivolumab|mesh-list
56018201|NCT00315302|Atropine|atropine|mesh-list
56396242|NCT05308446|Cetuximab|cetuximab|mesh-list
56396243|NCT05308446|Antibodies|antibodies|mesh-list
56396244|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
56396245|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56396246|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
56396247|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396248|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396249|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56396250|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396251|NCT05292339|Triamcinolone|triamcinolone|mesh-list
56396252|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56396253|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56396254|NCT05292339|Ketorolac|ketorolac|mesh-list
56396255|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56396256|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56396257|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56396258|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
56396259|NCT05292339|Hormones|hormones|mesh-ancestor
56396260|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396261|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002226|NCT01147627|Protamines|protamines|mesh-list
56396267|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56396268|NCT05292339|Analgesics|analgesics|mesh-ancestor
56396269|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
56396270|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396271|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56396272|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56396273|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
56396274|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
56396275|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56396276|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
56396277|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396278|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
56396279|NCT05291650|Protective Agents|protective agents|mesh-ancestor
56396280|NCT05291650|Hormones|hormones|mesh-ancestor
56396286|NCT05288166|Hormones|hormones|mesh-ancestor
56396287|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396288|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396289|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56396290|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396296|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56396297|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56396298|NCT05275400|Insulin|insulin|mesh-list
56396299|NCT05275400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56396300|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56396301|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396302|NCT05266469|Ofatumumab|ofatumumab|mesh-list
56396303|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
56396304|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657167|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657168|NCT04133337|Apatinib|apatinib|mesh-list
56657169|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657170|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56657171|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219053|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56396305|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
56396306|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396307|NCT05266027|Nalbuphine|nalbuphine|mesh-list
56396308|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56396309|NCT05266027|Narcotics|narcotics|mesh-ancestor
56396310|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56396311|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396312|NCT05266027|Analgesics|analgesics|mesh-ancestor
56396313|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
56396314|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396315|NCT05257408|Paclitaxel|paclitaxel|mesh-list
56396316|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56396317|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56396318|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396319|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56396320|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56396321|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56396322|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396326|NCT05186974|Carboplatin|carboplatin|mesh-list
56396327|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
56396328|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396329|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396330|NCT05176483|Nivolumab|nivolumab|mesh-list
56396331|NCT05176483|Ipilimumab|ipilimumab|mesh-list
56396332|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396333|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396334|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56396335|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724592|NCT00152009|Guanfacine|guanfacine|mesh-list
56396337|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56396338|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396339|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56396340|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56396341|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
56396342|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396343|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396344|NCT05160922|Crizotinib|crizotinib|mesh-list
56396345|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396346|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56396347|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396348|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396349|NCT05159427|Glipizide|glipizide|mesh-list
56396350|NCT05159427|Rifaximin|rifaximin|mesh-list
56396351|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56396352|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396353|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56396354|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56396355|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396356|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
56396357|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56396358|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
56396359|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396364|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396365|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56396366|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396367|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396368|NCT05151744|Ranibizumab|ranibizumab|mesh-list
56396369|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56396370|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56396371|NCT05151744|Growth Substances|growth substances|mesh-ancestor
56396372|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396373|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
56396374|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657172|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657173|NCT04133259|Tenofovir|tenofovir|mesh-list
56657174|NCT04133259|Entecavir|entecavir|mesh-list
56657175|NCT04133259|Antibodies|antibodies|mesh-list
56396375|NCT05151731|Ranibizumab|ranibizumab|mesh-list
56396376|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56396377|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56396378|NCT05151731|Growth Substances|growth substances|mesh-ancestor
56396379|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396380|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
56396381|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396382|NCT05131386|Trabectedin|trabectedin|mesh-list
56396383|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56396384|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
56396385|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396386|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396387|NCT05129332|Vitamin E|vitamin e|mesh-list
56396388|NCT05129332|Vitamins|vitamins|mesh-ancestor
56396389|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
56396390|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396391|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
56396392|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396393|NCT05129332|Protective Agents|protective agents|mesh-ancestor
56396395|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
56396396|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56396397|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56396398|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
56396399|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396400|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396401|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56396402|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
56396403|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
56396404|NCT05111262|Hormones|hormones|mesh-ancestor
56396405|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396406|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56396407|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56396408|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56396409|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
56396410|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396411|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396412|NCT05094128|Upadacitinib|upadacitinib|mesh-list
56396413|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56396414|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56396415|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396416|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396417|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56396418|NCT05092958|Avelumab|avelumab|mesh-list
56396419|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56396420|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396421|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396422|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
56396423|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396424|NCT05091242|Clonidine|clonidine|mesh-list
56396425|NCT05091242|Analgesics|analgesics|mesh-ancestor
56396426|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
56396427|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396428|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396429|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56396430|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
56396432|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56396433|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56396434|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56396435|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
56396436|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396437|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396438|NCT05089734|Docetaxel|docetaxel|mesh-list
56396439|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396440|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56396441|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56396442|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56396443|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657176|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56657177|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
56657178|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657179|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
56657180|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657181|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56657182|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56657183|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657184|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219063|NCT01643941|Vaccines|vaccines|mesh-list
56396444|NCT05063552|Bevacizumab|bevacizumab|mesh-list
56396445|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56396446|NCT05063552|Cetuximab|cetuximab|mesh-list
56396447|NCT05063552|Cisplatin|cisplatin|mesh-list
56396448|NCT05063552|Carboplatin|carboplatin|mesh-list
56396449|NCT05063552|Docetaxel|docetaxel|mesh-list
56396450|NCT05063552|Atezolizumab|atezolizumab|mesh-list
56396451|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
56396452|NCT05063552|Antibodies|antibodies|mesh-list
56396453|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
56396454|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56396455|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
56396456|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396457|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56396458|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56396459|NCT05063552|Growth Substances|growth substances|mesh-ancestor
56396460|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396461|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
56396462|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
56396463|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
56396464|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
56396465|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
56396466|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396467|NCT05059522|Pemetrexed|pemetrexed|mesh-list
56396468|NCT05059522|Avelumab|avelumab|mesh-list
56396469|NCT05059522|Axitinib|axitinib|mesh-list
56396470|NCT05059522|Talazoparib|talazoparib|mesh-list
56396471|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396472|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396473|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396474|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56396475|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56396476|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396477|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56396478|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56396479|NCT05028140|Pioglitazone|pioglitazone|mesh-list
56396480|NCT05028140|Empagliflozin|empagliflozin|mesh-list
56396481|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56396482|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396483|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56396484|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396485|NCT05027516|Azithromycin|azithromycin|mesh-list
56396486|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
56396487|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56396488|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396489|NCT05013229|Insulin|insulin|mesh-list
56396490|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56396491|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
56396492|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
56396493|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56396494|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396495|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
56396496|NCT05000216|Methotrexate|methotrexate|mesh-list
56396497|NCT05000216|Vaccines|vaccines|mesh-list
56396498|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56396499|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
56396500|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657185|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56657186|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56657187|NCT02616315|Naltrexone|naltrexone|mesh-list
56657188|NCT02616315|Bupropion|bupropion|mesh-list
56657189|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56657190|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56657191|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657192|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
56657193|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219066|NCT01643980|Progesterone|progesterone|mesh-list
56396501|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56396502|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
56396503|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56396504|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56396505|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
56396506|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396511|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56396512|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56396513|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56396514|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56396515|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
56396516|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56396517|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396518|NCT04992013|Niraparib|niraparib|mesh-list
56396519|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56396520|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396521|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396522|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396523|NCT04989816|Trastuzumab|trastuzumab|mesh-list
56396524|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396525|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396526|NCT04975308|Fulvestrant|fulvestrant|mesh-list
56396527|NCT04975308|Exemestane|exemestane|mesh-list
56396528|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56396529|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396530|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56396531|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56396532|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
56396533|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396534|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396535|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56396536|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56396537|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396538|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396539|NCT04969263|Vaccines|vaccines|mesh-list
56396540|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
56396541|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396542|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56396543|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56018503|NCT02528214|Prednisone|prednisone|mesh-list
56396545|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
56396546|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56396547|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
56396548|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396549|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
56396550|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396551|NCT04933630|Norepinephrine|norepinephrine|mesh-list
56396552|NCT04933630|Serotonin|serotonin|mesh-list
56396553|NCT04933630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56396554|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56396555|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56396556|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
56396557|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396558|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396559|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657194|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56396560|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
56396561|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
56396570|NCT04923841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56396571|NCT04923841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56396572|NCT04923841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56396573|NCT04923841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56396575|NCT04923841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396576|NCT04923841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396577|NCT04923841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56396578|NCT04923841|Respiratory System Agents|respiratory system agents|mesh-ancestor
56396579|NCT04923841|Mydriatics|mydriatics|mesh-ancestor
56396580|NCT04923841|Parasympatholytics|parasympatholytics|mesh-ancestor
56396581|NCT04923841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56396582|NCT04923841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56396583|NCT04923841|Cholinergic Agents|cholinergic agents|mesh-ancestor
56396584|NCT04923841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396585|NCT04923841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396594|NCT04908202|BMS-986165|bms-986165|mesh-list
56396611|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56396612|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56396613|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56396614|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56396615|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
56396616|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56396617|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396618|NCT04892017|Trametinib|trametinib|mesh-list
56396619|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396620|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56396621|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396622|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396633|NCT04880863|Docetaxel|docetaxel|mesh-list
56396634|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
56396635|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396636|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
56396637|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
56396638|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
56396639|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396640|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396641|NCT04861987|Capecitabine|capecitabine|mesh-list
56396642|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56396643|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
56396644|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396645|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396646|NCT04848480|Insulin|insulin|mesh-list
56396647|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56396648|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
56396649|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56396650|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396651|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
56175698|NCT01391156|Minoxidil|minoxidil|mesh-list
56396653|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
56396654|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56396655|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
56396656|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396657|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396658|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
56396659|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56396660|NCT04836429|Trioxsalen|trioxsalen|mesh-list
56396661|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396662|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
56396663|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56396685|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396686|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396687|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56396688|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396690|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
56396691|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396692|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56396693|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56396694|NCT04792502|Growth Substances|growth substances|mesh-ancestor
56396695|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
56396696|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396697|NCT04784715|Trastuzumab|trastuzumab|mesh-list
56657195|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
56657196|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657197|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56657198|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56657199|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657200|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657201|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
56657202|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657203|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56657204|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56657205|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657206|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
56396698|NCT04784715|Pertuzumab|pertuzumab|mesh-list
56396699|NCT04784715|Taxane|taxane|mesh-list
56396700|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396701|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396702|NCT04777422|Defibrotide|defibrotide|mesh-list
56396703|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56396704|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56396705|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396706|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56396707|NCT04775953|Vancomycin|vancomycin|mesh-list
56396708|NCT04775953|Cefazolin|cefazolin|mesh-list
56396709|NCT04775953|Daptomycin|daptomycin|mesh-list
56396710|NCT04775953|Dalbavancin|dalbavancin|mesh-list
56396711|NCT04775953|Oxacillin|oxacillin|mesh-list
56396712|NCT04775953|Nafcillin|nafcillin|mesh-list
56396713|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56396714|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396715|NCT04766021|Mirabegron|mirabegron|mesh-list
56396716|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56396717|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56396718|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56396719|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
56396720|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396721|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396722|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396723|NCT04766021|Urological Agents|urological agents|mesh-ancestor
56396724|NCT04761198|Nivolumab|nivolumab|mesh-list
56396725|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396726|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396727|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56175701|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
56396728|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396729|NCT04759586|Prednisone|prednisone|mesh-list
56396730|NCT04759586|Prednisolone|prednisolone|mesh-list
56396731|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56396732|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
56396733|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56396734|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
56396735|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
56396736|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56396737|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56396738|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56396739|NCT04759586|Cortisone|cortisone|mesh-list
56396740|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
56396741|NCT04759586|Rituximab|rituximab|mesh-list
56396742|NCT04759586|Doxorubicin|doxorubicin|mesh-list
56396743|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56396744|NCT04759586|Nivolumab|nivolumab|mesh-list
56396745|NCT04759586|Etoposide|etoposide|mesh-list
56396746|NCT04759586|Vincristine|vincristine|mesh-list
56396747|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
56396748|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56396749|NCT04759586|Antibodies|antibodies|mesh-list
56657207|NCT02779283|Leucovorin|leucovorin|mesh-list
56657208|NCT02779283|Folic Acid|folic acid|mesh-list
56657209|NCT02779283|Cytarabine|cytarabine|mesh-list
56657210|NCT02779283|Dexamethasone|dexamethasone|mesh-list
56657211|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
56657212|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56657213|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56657214|NCT02779283|Prednisolone|prednisolone|mesh-list
56657215|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
56657216|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
56657217|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
56657218|NCT02779283|Rituximab|rituximab|mesh-list
56657219|NCT02779283|Doxorubicin|doxorubicin|mesh-list
56657220|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56657221|NCT02779283|Methotrexate|methotrexate|mesh-list
56657222|NCT02779283|Vincristine|vincristine|mesh-list
56657223|NCT02779283|Sorafenib|sorafenib|mesh-list
56657224|NCT02779283|Sunitinib|sunitinib|mesh-list
56657225|NCT02779283|Dasatinib|dasatinib|mesh-list
56303326|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657226|NCT02779283|Idarubicin|idarubicin|mesh-list
56657227|NCT02779283|Ponatinib|ponatinib|mesh-list
56657228|NCT02779283|Idelalisib|idelalisib|mesh-list
56657229|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56657230|NCT02779283|Antibodies|antibodies|mesh-list
56657231|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
56657232|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56657233|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56657234|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
56657235|NCT02779283|BB 1101|bb 1101|mesh-list
56657236|NCT02779283|Calcium|calcium|mesh-list
56657237|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
56396750|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
56396751|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56396752|NCT04759586|Lenograstim|lenograstim|mesh-list
56396753|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56396754|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
56396758|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56396759|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56396760|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
56396761|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396762|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396763|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56396764|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56396765|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56396766|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56396767|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396768|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56396769|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
56396770|NCT04759586|Hormones|hormones|mesh-ancestor
56396771|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396772|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56396773|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56657238|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56657239|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
56657240|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657241|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56657242|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56657243|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
56657244|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657245|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657246|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56657247|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56657248|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
56657249|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
56657250|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657251|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657252|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
56657253|NCT02779283|Hormones|hormones|mesh-ancestor
56657254|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657255|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56657256|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56657257|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56396774|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56396775|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56396776|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
56396777|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
56396778|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
56396779|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
56396780|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
56396781|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396782|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56396783|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56396784|NCT04759586|Protective Agents|protective agents|mesh-ancestor
56396785|NCT04751370|Nivolumab|nivolumab|mesh-list
56396786|NCT04751370|Ipilimumab|ipilimumab|mesh-list
56396787|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396788|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396789|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56396790|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396791|NCT04748276|Norepinephrine|norepinephrine|mesh-list
56396792|NCT04748276|Serotonin|serotonin|mesh-list
56396793|NCT04748276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56396794|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56396795|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56396796|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
56396797|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396798|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396799|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396800|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
56396801|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
56396802|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396803|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56396804|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56396805|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
56396806|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55922669|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
56657258|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56657259|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657260|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56657261|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56657262|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56657263|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
56657264|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56219127|NCT01648218|Insulin|insulin|mesh-list
56219128|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56219129|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
56219130|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
56219131|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
56219132|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
56396807|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56396808|NCT04686305|Carboplatin|carboplatin|mesh-list
56396809|NCT04686305|Trastuzumab|trastuzumab|mesh-list
56396810|NCT04686305|Pemetrexed|pemetrexed|mesh-list
56396811|NCT04686305|Durvalumab|durvalumab|mesh-list
56396812|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396813|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396814|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396815|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396816|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56396817|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56396818|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56396819|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396820|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
56396821|NCT04673617|Rituximab|rituximab|mesh-list
56396822|NCT04673617|Fludarabine|fludarabine|mesh-list
56396823|NCT04673617|Interleukin-2|interleukin-2|mesh-list
56396824|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396825|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
56396826|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396831|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396832|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56396833|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396834|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56396835|NCT04673617|Analgesics|analgesics|mesh-ancestor
56396836|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
56396837|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396846|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
56396847|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396848|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396849|NCT04633252|Prednisone|prednisone|mesh-list
56396850|NCT04633252|Docetaxel|docetaxel|mesh-list
56396851|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396852|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
56396853|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
56396854|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
56396855|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396856|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56396857|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
56396858|NCT04633252|Hormones|hormones|mesh-ancestor
56396859|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396860|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396861|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56396862|NCT04610658|Nivolumab|nivolumab|mesh-list
56396863|NCT04610658|Ipilimumab|ipilimumab|mesh-list
56396864|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396865|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396866|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56396867|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396868|NCT04597437|Zanamivir|zanamivir|mesh-list
56657265|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56657266|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
56657267|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
56657268|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56657269|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56657270|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
56657271|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657272|NCT02779283|Antidotes|antidotes|mesh-ancestor
56657273|NCT02779283|Protective Agents|protective agents|mesh-ancestor
56657274|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
56657275|NCT02779283|Vitamins|vitamins|mesh-ancestor
56657276|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
56657277|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56657278|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
56657279|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
56657280|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
56657281|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56219138|NCT01648218|Coagulants|coagulants|mesh-ancestor
56396869|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
56396870|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396871|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396872|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396873|NCT04595994|Gemcitabine|gemcitabine|mesh-list
56396874|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56396875|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
56396876|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396877|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396879|NCT04595994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396880|NCT04595994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396881|NCT04595994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396882|NCT04595994|Immunologic Factors|immunologic factors|mesh-ancestor
56396883|NCT04595994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396884|NCT04587791|Cannabidiol|cannabidiol|mesh-list
56396885|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
56396886|NCT04586426|Daratumumab|daratumumab|mesh-list
56396887|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396888|NCT04579224|Gemcitabine|gemcitabine|mesh-list
56396889|NCT04579224|Paclitaxel|paclitaxel|mesh-list
56396890|NCT04579224|Docetaxel|docetaxel|mesh-list
56396891|NCT04579224|Halichondrin B|halichondrin b|mesh-list
56396892|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56396893|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56396894|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396895|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
56396896|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
56396897|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
56396898|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396899|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56396900|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
56396901|NCT04579224|Antiviral Agents|antiviral agents|mesh-ancestor
56396902|NCT04579224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396903|NCT04579224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396904|NCT04579224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396905|NCT04579224|Immunologic Factors|immunologic factors|mesh-ancestor
56396906|NCT04579224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396911|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56396912|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396913|NCT04561375|Analgesics|analgesics|mesh-ancestor
56396914|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
56396915|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657282|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56657283|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56657284|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56657285|NCT02779283|Growth Substances|growth substances|mesh-ancestor
56657286|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
56657287|NCT02779283|Hematinics|hematinics|mesh-ancestor
56657288|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
56657289|NCT02616003|Liraglutide|liraglutide|mesh-list
56657290|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56396916|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56396917|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56396918|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
56396919|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
56396920|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
56396921|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56396922|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
56396923|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396924|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396925|NCT04532918|Cyclosporine|cyclosporine|mesh-list
56396926|NCT04532918|Rifampin|rifampin|mesh-list
56396927|NCT04532918|Allopurinol|allopurinol|mesh-list
56396928|NCT04532918|Verinurad|verinurad|mesh-list
56396929|NCT04532918|Cyclosporins|cyclosporins|mesh-list
56396930|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396931|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396932|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396933|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
56396934|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396935|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
56396936|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396937|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
56396938|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56396939|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56396940|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56396941|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
56396942|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56396943|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
56396944|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56396945|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56396946|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56396947|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56396948|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56396949|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56396950|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56396951|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
56396952|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
56396953|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56396954|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
56396955|NCT04532918|Protective Agents|protective agents|mesh-ancestor
56396956|NCT04513925|Atezolizumab|atezolizumab|mesh-list
56396958|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396959|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396960|NCT04511247|Sirolimus|sirolimus|mesh-list
56396961|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56396962|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56396963|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56396964|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396965|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
56396966|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396967|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
56396968|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396969|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
56396970|NCT04510428|Antibodies|antibodies|mesh-list
56396971|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
56396972|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56396973|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56396974|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
56396975|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396976|NCT04483466|Methotrexate|methotrexate|mesh-list
56657291|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657292|NCT02616003|Incretins|incretins|mesh-ancestor
56657293|NCT02616003|Hormones|hormones|mesh-ancestor
56657294|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657295|NCT02661152|Nimorazole|nimorazole|mesh-list
56657296|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56657297|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56657298|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56657299|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657300|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
56657301|NCT00697671|Etoposide|etoposide|mesh-list
56657302|NCT00697671|Interleukin-2|interleukin-2|mesh-list
56303421|NCT00033748|Antibodies|antibodies|mesh-list
56657303|NCT00697671|Clofarabine|clofarabine|mesh-list
56657304|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56657305|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
56657306|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657307|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56657308|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56657309|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
56657310|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657311|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396977|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56396978|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
56396979|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56396980|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396981|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56396987|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56396988|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396989|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
56396990|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56396991|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56396992|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56396993|NCT04466475|Melphalan|melphalan|mesh-list
56396994|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
56396995|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56396996|NCT04466475|Daratumumab|daratumumab|mesh-list
56396997|NCT04466475|Antibodies|antibodies|mesh-list
56396998|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
56396999|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56397000|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
56397001|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397002|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397003|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56397005|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397006|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56397007|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397008|NCT04396574|Lasmiditan|lasmiditan|mesh-list
56397009|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56397010|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
56397011|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56397012|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397013|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397014|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
56397015|NCT04387084|Nivolumab|nivolumab|mesh-list
56657312|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56657313|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56657314|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56657315|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56657316|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657317|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56657318|NCT00697671|Analgesics|analgesics|mesh-ancestor
56657319|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
56657320|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657321|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56657322|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
56657323|NCT03922945|Topiramate|topiramate|mesh-list
56657324|NCT03922945|Phentermine|phentermine|mesh-list
56657325|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
56657326|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56657327|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657328|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56657329|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
56657330|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56657331|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
56657332|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
56657333|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657334|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
56657335|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657336|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657337|NCT04973345|Terbutaline|terbutaline|mesh-list
56657338|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56657339|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
56657340|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56397016|NCT04387084|Durvalumab|durvalumab|mesh-list
56397017|NCT04387084|Avelumab|avelumab|mesh-list
56397018|NCT04387084|Cemiplimab|cemiplimab|mesh-list
56397019|NCT04387084|Atezolizumab|atezolizumab|mesh-list
56397025|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56397026|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397027|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
56397028|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397044|NCT04347798|Chloroquine|chloroquine|mesh-list
56397045|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
56397046|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56397047|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56397048|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397049|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397050|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397051|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397052|NCT04347798|Amebicides|amebicides|mesh-ancestor
56397058|NCT04335669|Paclitaxel|paclitaxel|mesh-list
56657341|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657342|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56657343|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
56657344|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
56657345|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
56657346|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56657347|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56657348|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56657349|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56219209|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
56397059|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56397060|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
56397061|NCT04335669|Carboplatin|carboplatin|mesh-list
56397062|NCT04335669|Pembrolizumab|pembrolizumab|mesh-list
56397063|NCT04335669|Capecitabine|capecitabine|mesh-list
56397064|NCT04335669|Epirubicin|epirubicin|mesh-list
56397065|NCT04335669|Taxane|taxane|mesh-list
56397066|NCT04335669|Antimetabolites|antimetabolites|mesh-list
56397067|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56397068|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397069|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56397070|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56397071|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56397072|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397073|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397074|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
56397075|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397076|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397077|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56019036|NCT05286008|Hormones|hormones|mesh-ancestor
56397078|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
56397079|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56397084|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56397085|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397087|NCT04334759|Carboplatin|carboplatin|mesh-list
56397089|NCT04334759|Pemetrexed|pemetrexed|mesh-list
56397090|NCT04334759|Ipilimumab|ipilimumab|mesh-list
56397091|NCT04334759|Durvalumab|durvalumab|mesh-list
56397092|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397093|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397094|NCT04334759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56397095|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397096|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397097|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56397098|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56397099|NCT04332367|Paclitaxel|paclitaxel|mesh-list
56397100|NCT04332367|Carboplatin|carboplatin|mesh-list
56397101|NCT04332367|Ramucirumab|ramucirumab|mesh-list
56397102|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56397103|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397104|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
56397105|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
56397106|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
56397107|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397108|NCT04310176|Bevacizumab|bevacizumab|mesh-list
56397109|NCT04310176|Fluorouracil|fluorouracil|mesh-list
56397110|NCT04310176|Capecitabine|capecitabine|mesh-list
56397111|NCT04310176|Valproic Acid|valproic acid|mesh-list
56397112|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397113|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397114|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56397115|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56397116|NCT04310176|Growth Substances|growth substances|mesh-ancestor
56397117|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397118|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
56397119|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
56397120|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923116|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
56657350|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
56657351|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657352|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397121|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56397122|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397123|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
56397124|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
56397125|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397126|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
56141361|NCT04359966|Antacids|antacids|mesh-ancestor
56397128|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
56397129|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56397130|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56397131|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56397132|NCT04298983|Androgens|androgens|mesh-list
56397133|NCT04298983|Hormones|hormones|mesh-ancestor
56397134|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397135|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397136|NCT04267939|Niraparib|niraparib|mesh-list
56397137|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56397138|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397139|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397140|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397166|NCT04255433|Tirzepatide|tirzepatide|mesh-list
56397167|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56397168|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397169|NCT04255433|Incretins|incretins|mesh-ancestor
56397170|NCT04255433|Hormones|hormones|mesh-ancestor
56397171|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397173|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
56397174|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397175|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56397176|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56397177|NCT04246086|Growth Substances|growth substances|mesh-ancestor
56397194|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56397195|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56397196|NCT04232553|Analgesics|analgesics|mesh-ancestor
56397197|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
56397198|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56397199|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397200|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56397201|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397202|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56397203|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56397204|NCT04223856|Gemcitabine|gemcitabine|mesh-list
56397205|NCT04223856|Carboplatin|carboplatin|mesh-list
56397206|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
56397207|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397208|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56397209|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
56397210|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397211|NCT04223856|Antiviral Agents|antiviral agents|mesh-ancestor
56397212|NCT04223856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397213|NCT04223856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397214|NCT04223856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397215|NCT04223856|Immunologic Factors|immunologic factors|mesh-ancestor
56397216|NCT04223856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397217|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397223|NCT04209595|Rucaparib|rucaparib|mesh-list
56397224|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56397225|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397226|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397227|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397244|NCT04187833|Talazoparib|talazoparib|mesh-list
56397245|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397246|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397247|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56397248|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397249|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56397250|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397262|NCT04173585|Bortezomib|bortezomib|mesh-list
56657353|NCT05236985|Oxytocin|oxytocin|mesh-list
56657354|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
56657355|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56657356|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657357|NCT03922477|Atezolizumab|atezolizumab|mesh-list
56657358|NCT03922477|Magrolimab|magrolimab|mesh-list
56657359|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657360|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56657361|NCT05227391|Letrozole|letrozole|mesh-list
56657362|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56657363|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56657364|NCT05227391|Estradiol|estradiol|mesh-list
56657365|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56657366|NCT05227391|Estrogens|estrogens|mesh-ancestor
56657367|NCT05227391|Hormones|hormones|mesh-ancestor
56657368|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657369|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657370|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56657371|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
56397263|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
56397264|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397265|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397266|NCT04172987|Tirzepatide|tirzepatide|mesh-list
56397267|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56397268|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397269|NCT04172987|Incretins|incretins|mesh-ancestor
56397290|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56397291|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397292|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397293|NCT04128501|Azacitidine|azacitidine|mesh-list
56397294|NCT04128501|Venetoclax|venetoclax|mesh-list
56397295|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56397296|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
56397297|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397298|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397299|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397300|NCT04127786|Vaccines|vaccines|mesh-list
56397301|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
56397302|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019248|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397339|NCT04084951|Nivolumab|nivolumab|mesh-list
56397340|NCT04084951|Ipilimumab|ipilimumab|mesh-list
56397341|NCT04084951|Atezolizumab|atezolizumab|mesh-list
56397342|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397343|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397344|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56397345|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397346|NCT04082780|Rifamycins|rifamycins|mesh-list
56397347|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
56397348|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56397349|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397350|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397351|NCT04077463|Carboplatin|carboplatin|mesh-list
56397352|NCT04077463|Pemetrexed|pemetrexed|mesh-list
56397353|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56397354|NCT04077463|Lazertinib|lazertinib|mesh-list
56397355|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397356|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397357|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657372|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56657373|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56657374|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657375|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56657376|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56657377|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657378|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657379|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56657381|NCT00978211|Octreotide|octreotide|mesh-list
56657382|NCT00978211|Somatostatin|somatostatin|mesh-list
56657383|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657384|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56657385|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657386|NCT00978211|Hormones|hormones|mesh-ancestor
56657387|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219235|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
56397358|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56397360|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56397361|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397366|NCT04049331|Testosterone|testosterone|mesh-list
56397367|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
56397368|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
56397369|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56397370|NCT04049331|Androgens|androgens|mesh-ancestor
56397371|NCT04049331|Hormones|hormones|mesh-ancestor
56397372|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397373|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397374|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56397375|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397376|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
56397377|NCT04033055|Ropivacaine|ropivacaine|mesh-list
56397378|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
56397379|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
56397380|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56397381|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397382|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
56397383|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56397391|NCT04015596|Naproxen|naproxen|mesh-list
56397392|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56397393|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56397394|NCT04015596|Analgesics|analgesics|mesh-ancestor
56397395|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
56397396|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56397397|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397398|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56397399|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397400|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
56397401|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56397402|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397403|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397404|NCT03990571|Avelumab|avelumab|mesh-list
56397405|NCT03990571|Axitinib|axitinib|mesh-list
56397406|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56397407|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397408|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397409|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56397410|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923419|NCT05008536|Fludarabine|fludarabine|mesh-list
56657388|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657389|NCT00867165|Ezetimibe|ezetimibe|mesh-list
56657390|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56657391|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56657392|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
56657393|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657394|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56657395|NCT00981955|Caffeine|caffeine|mesh-list
56657396|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56657397|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657398|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56657399|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657400|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657401|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56397411|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397412|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
56397413|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397414|NCT03985722|Trabectedin|trabectedin|mesh-list
56397415|NCT03985722|Olaratumab|olaratumab|mesh-list
56397416|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56397417|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
56397418|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397419|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397420|NCT03969212|Baloxavir|baloxavir|mesh-list
56397421|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
56397422|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397423|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397424|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397425|NCT03954327|Tenofovir|tenofovir|mesh-list
56397426|NCT03954327|Emtricitabine|emtricitabine|mesh-list
56397427|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
56397428|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
56397429|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397430|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56397431|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56397432|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397433|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397434|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56397435|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56397436|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56397437|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56397438|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
56397439|NCT03914625|Leucovorin|leucovorin|mesh-list
56397440|NCT03914625|Folic Acid|folic acid|mesh-list
56397441|NCT03914625|Cytarabine|cytarabine|mesh-list
56397442|NCT03914625|Dexamethasone|dexamethasone|mesh-list
56397446|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56397448|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56397449|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
56397450|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
56397451|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56397452|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56397453|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56397454|NCT03914625|Cortisone|cortisone|mesh-list
56397455|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
56397457|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56397458|NCT03914625|Methotrexate|methotrexate|mesh-list
56397459|NCT03914625|Vincristine|vincristine|mesh-list
56397460|NCT03914625|Asparaginase|asparaginase|mesh-list
56397461|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
56397462|NCT03914625|Pegaspargase|pegaspargase|mesh-list
56397463|NCT03914625|Thioguanine|thioguanine|mesh-list
56657402|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56657403|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
56657404|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657405|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56657406|NCT00972829|Ezetimibe|ezetimibe|mesh-list
56657407|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56657408|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56657409|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
56657410|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657411|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56657412|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56657413|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657414|NCT05037617|Oxytocin|oxytocin|mesh-list
56657415|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
56657416|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56657417|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657418|NCT00972907|Nifedipine|nifedipine|mesh-list
56657419|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56657420|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56219265|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397464|NCT03914625|Blinatumomab|blinatumomab|mesh-list
56397465|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56397466|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
56397467|NCT03914625|Antibodies|antibodies|mesh-list
56397468|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
56397469|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56397470|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56397471|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56397472|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
56397473|NCT03914625|BB 1101|bb 1101|mesh-list
56397474|NCT03914625|Calcium|calcium|mesh-list
56397475|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
56397476|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
56397477|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397478|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
56397479|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397480|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397481|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56397482|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
56397483|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397484|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397485|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56397486|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56397487|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
56397488|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
56397489|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56397490|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56397491|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
56397492|NCT03914625|Hormones|hormones|mesh-ancestor
56397493|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397494|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56397495|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
56397496|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397497|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56397498|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56397499|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56397500|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56657421|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657422|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56657423|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657424|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
56657425|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
56657426|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56657427|NCT02436707|Gemcitabine|gemcitabine|mesh-list
56657428|NCT02436707|Dexamethasone|dexamethasone|mesh-list
56657429|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
56657430|NCT02436707|Rituximab|rituximab|mesh-list
56657431|NCT02436707|Etoposide|etoposide|mesh-list
56657432|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56657433|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
56657434|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657435|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56657436|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56657437|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
56657438|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397501|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56397502|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56397503|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
56397504|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56397505|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56397506|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
56397507|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
56397508|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56397509|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56397510|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
56397511|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397512|NCT03914625|Antidotes|antidotes|mesh-ancestor
56397513|NCT03914625|Protective Agents|protective agents|mesh-ancestor
56397514|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
56397515|NCT03914625|Vitamins|vitamins|mesh-ancestor
56397516|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
56397517|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56397518|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
56397519|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
56397603|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
56397604|NCT03737955|Calicheamicins|calicheamicins|mesh-list
56397605|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397606|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397607|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56397608|NCT03736720|Leucovorin|leucovorin|mesh-list
56397609|NCT03736720|Fluorouracil|fluorouracil|mesh-list
56397610|NCT03736720|Irinotecan|irinotecan|mesh-list
56397611|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
56397612|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397613|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56397614|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397615|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397616|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
56397617|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397618|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56397619|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56397620|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397621|NCT03736720|Antidotes|antidotes|mesh-ancestor
56397622|NCT03736720|Protective Agents|protective agents|mesh-ancestor
56657439|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657440|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56657441|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56657442|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56657443|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
56657444|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
56657445|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657446|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657447|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
56657448|NCT02436707|Hormones|hormones|mesh-ancestor
56657449|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397623|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
56397624|NCT03736720|Vitamins|vitamins|mesh-ancestor
56397625|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
56397642|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56397644|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56397645|NCT03718234|Hormones|hormones|mesh-ancestor
56397646|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397647|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397648|NCT03706365|Prednisone|prednisone|mesh-list
56397649|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
56397650|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56397651|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
56397652|NCT03706365|Hormones|hormones|mesh-ancestor
56397653|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397654|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397655|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56397656|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397657|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56397658|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397659|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397660|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
56397661|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56397692|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56397694|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56397695|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56397696|NCT03490344|Lenalidomide|lenalidomide|mesh-list
56397697|NCT03490344|Daratumumab|daratumumab|mesh-list
56397698|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
56397699|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397700|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56397701|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56397702|NCT03490344|Growth Substances|growth substances|mesh-ancestor
56397703|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
56397704|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397705|NCT03473756|Atezolizumab|atezolizumab|mesh-list
56397706|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397707|NCT03460379|Citalopram|citalopram|mesh-list
56397708|NCT03460379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56397709|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56397710|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56397711|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397712|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56397713|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
56397714|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397715|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56397716|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
56397717|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56397718|NCT03460366|Enalapril|enalapril|mesh-list
56397719|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56397720|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
56397721|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397722|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657450|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56657451|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56657452|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
56657453|NCT02436707|Antiviral Agents|antiviral agents|mesh-ancestor
56657454|NCT02436707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657455|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657456|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56657457|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56657458|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56657459|NCT04008433|Lidocaine|lidocaine|mesh-list
56657460|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
56657461|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
56657462|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657463|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219311|NCT01650740|Analgesics|analgesics|mesh-ancestor
56397723|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56397724|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
56397725|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56397726|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397727|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56397728|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56397729|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56397730|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397731|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
56397732|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56397733|NCT03460327|Candesartan|candesartan|mesh-list
56397734|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56397735|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56397736|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56397737|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397738|NCT03460314|Buprenorphine|buprenorphine|mesh-list
56397739|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56397740|NCT03460314|Narcotics|narcotics|mesh-ancestor
56397741|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56397742|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397744|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
56397745|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56397746|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56397747|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56397748|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56397749|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56397750|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56397759|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56397760|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56397761|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397763|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397764|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397765|NCT03446001|Methylene Blue|methylene blue|mesh-list
56397766|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397767|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397768|NCT03440879|Goserelin|goserelin|mesh-list
56397769|NCT03440879|Androgens|androgens|mesh-list
56397770|NCT03440879|Hormones|hormones|mesh-ancestor
56397771|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397772|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397773|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56397774|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397775|NCT03433755|Evolocumab|evolocumab|mesh-list
56657464|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
56657465|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657466|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56657467|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56219320|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
56397776|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56397777|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56397779|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397780|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56397781|NCT03412877|Aldesleukin|aldesleukin|mesh-list
56397782|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
56397783|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
56397784|NCT03412877|Fludarabine|fludarabine|mesh-list
56397785|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397786|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
56397787|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397788|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397789|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56397790|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
56397791|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397792|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397793|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56397794|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397795|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56397796|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56397797|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
56397798|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397799|NCT03406507|Ravulizumab|ravulizumab|mesh-list
56397800|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56397801|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397802|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
56397803|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397809|NCT03288545|Gemcitabine|gemcitabine|mesh-list
56397810|NCT03288545|Carboplatin|carboplatin|mesh-list
56397811|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
56397812|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397813|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56397814|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
56397815|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397816|NCT03288545|Antiviral Agents|antiviral agents|mesh-ancestor
56397817|NCT03288545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397818|NCT03288545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397819|NCT03288545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397820|NCT03288545|Immunologic Factors|immunologic factors|mesh-ancestor
56397821|NCT03288545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397824|NCT03283150|Remifentanil|remifentanil|mesh-list
56397825|NCT03283150|Propofol|propofol|mesh-list
56397826|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56397827|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56397828|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397829|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56397830|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
56397831|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
56397832|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56397833|NCT03283150|Analgesics|analgesics|mesh-ancestor
56397834|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
56397835|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56397836|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56397837|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56397838|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56397840|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56397841|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397842|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56397843|NCT03283150|Narcotics|narcotics|mesh-ancestor
56397844|NCT03277924|Doxorubicin|doxorubicin|mesh-list
56397845|NCT03277924|Methotrexate|methotrexate|mesh-list
56397846|NCT03277924|Nivolumab|nivolumab|mesh-list
56397847|NCT03277924|Sunitinib|sunitinib|mesh-list
56397848|NCT03277924|Epirubicin|epirubicin|mesh-list
56397849|NCT03277924|Ifosfamide|ifosfamide|mesh-list
56397850|NCT03277924|Dacarbazine|dacarbazine|mesh-list
56397851|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657468|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56657469|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657470|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657471|NCT04132479|Amoxicillin|amoxicillin|mesh-list
56657472|NCT04132479|Clarithromycin|clarithromycin|mesh-list
56657473|NCT04132479|Tinidazole|tinidazole|mesh-list
56657474|NCT04132479|Rabeprazole|rabeprazole|mesh-list
56657475|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56657476|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657477|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56657478|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657479|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657480|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56657481|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56657482|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56657483|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657484|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56657485|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
56657486|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56657487|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56397852|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56397853|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56397854|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56397855|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397856|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397857|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56397858|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
56397859|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56397860|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397861|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56397862|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
56397863|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
56397864|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56397865|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397866|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
56397867|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397868|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56397869|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397870|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56397871|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56397872|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56397873|NCT03277924|Growth Substances|growth substances|mesh-ancestor
56397874|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
56397875|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56397876|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56397877|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
56397879|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397880|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397881|NCT03239340|Osimertinib|osimertinib|mesh-list
56397882|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397883|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56397884|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657488|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56657489|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
56657490|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56657491|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56657492|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657493|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
56657494|NCT04905901|Coagulants|coagulants|mesh-ancestor
56657495|NCT00972985|Lorazepam|lorazepam|mesh-list
56657496|NCT00972985|Methylphenidate|methylphenidate|mesh-list
56657497|NCT00972985|Modafinil|modafinil|mesh-list
56657498|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56657499|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657500|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56657501|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56657502|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657503|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657504|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
56657505|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657506|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56657507|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55795375|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
56397885|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397886|NCT03219268|Margetuximab|margetuximab|mesh-list
56397887|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397888|NCT03212274|Olaparib|olaparib|mesh-list
56397889|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56397890|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397891|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397892|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397893|NCT03201965|Dexamethasone|dexamethasone|mesh-list
56397894|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
56397895|NCT03201965|Bortezomib|bortezomib|mesh-list
56397912|NCT03201965|Hormones|hormones|mesh-ancestor
56397913|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397914|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56397916|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56397917|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397918|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
56397919|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56397920|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
56397921|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397922|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397923|NCT03127215|Olaparib|olaparib|mesh-list
56397924|NCT03127215|Trabectedin|trabectedin|mesh-list
56397925|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56397926|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397927|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397928|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397929|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56397930|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
56397931|NCT03110744|Palbociclib|palbociclib|mesh-list
56397932|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923420|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
56657508|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56657509|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
56657510|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
56657511|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
56397933|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56397934|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397935|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397936|NCT03056040|Eculizumab|eculizumab|mesh-list
56397937|NCT03056040|Ravulizumab|ravulizumab|mesh-list
56397938|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56397939|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397940|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
56397941|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397955|NCT02968810|Simvastatin|simvastatin|mesh-list
56397956|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56397957|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56397958|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
56397959|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397960|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56397961|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56397962|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397963|NCT02933255|Nivolumab|nivolumab|mesh-list
56397964|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397965|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397966|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56397967|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397968|NCT02927249|Aspirin|aspirin|mesh-list
56397974|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397975|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56397976|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397977|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56397978|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56397979|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397980|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56397981|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56397982|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397983|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
56397984|NCT02924038|Poly ICLC|poly iclc|mesh-list
56397985|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
56397986|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
56397987|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397988|NCT02873962|Bevacizumab|bevacizumab|mesh-list
56397989|NCT02873962|Nivolumab|nivolumab|mesh-list
56397990|NCT02873962|Rucaparib|rucaparib|mesh-list
56397991|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397992|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397993|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56397994|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56397995|NCT02873962|Growth Substances|growth substances|mesh-ancestor
56397996|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397997|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
56397998|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56397999|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398000|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56398001|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398002|NCT02830724|Aldesleukin|aldesleukin|mesh-list
56398003|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
56398004|NCT02830724|Fludarabine|fludarabine|mesh-list
56398005|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56398006|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
56398007|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398008|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56398009|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56398010|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
56398011|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398012|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398013|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56398014|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56398015|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56398016|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
56398017|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657512|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657513|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657514|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56657515|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398018|NCT02726581|Dexamethasone|dexamethasone|mesh-list
56398019|NCT02726581|Nivolumab|nivolumab|mesh-list
56398020|NCT02726581|Pomalidomide|pomalidomide|mesh-list
56398021|NCT02726581|Elotuzumab|elotuzumab|mesh-list
56398022|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398023|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
56398024|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
56398025|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398026|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398027|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398028|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
56398029|NCT02726581|Hormones|hormones|mesh-ancestor
56398030|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398031|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56398032|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398033|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56398034|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56398035|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398036|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
56398037|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56398038|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56398039|NCT02726581|Growth Substances|growth substances|mesh-ancestor
56398048|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398049|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
56398050|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398051|NCT02567435|Sirolimus|sirolimus|mesh-list
56398052|NCT02567435|Dactinomycin|dactinomycin|mesh-list
56398053|NCT02567435|Cactinomycin|cactinomycin|mesh-list
56398054|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
56398055|NCT02567435|Irinotecan|irinotecan|mesh-list
56398056|NCT02567435|Vincristine|vincristine|mesh-list
56398057|NCT02567435|Vinorelbine|vinorelbine|mesh-list
56398058|NCT02567435|Camptothecin|camptothecin|mesh-list
56398059|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56398060|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
56398061|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398062|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56398063|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56398064|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
56398065|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398066|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398067|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56398068|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56398069|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56398070|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398071|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56398072|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
56398073|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
56398074|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
56398075|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56398076|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398077|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56398079|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56398080|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56398081|NCT02535832|Pioglitazone|pioglitazone|mesh-list
56398082|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56398083|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398084|NCT02491632|Dexamethasone|dexamethasone|mesh-list
56398085|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
56398086|NCT02491632|Ichthammol|ichthammol|mesh-list
56398087|NCT02491632|BB 1101|bb 1101|mesh-list
56398088|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398089|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
56398090|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
56398091|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398092|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398093|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398094|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
56398095|NCT02491632|Hormones|hormones|mesh-ancestor
56657516|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56657517|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56657518|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657519|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
56657520|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
56657521|NCT00867087|Rituximab|rituximab|mesh-list
56219360|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
56398096|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398097|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56398098|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398099|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
56398100|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398101|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398102|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
56398103|NCT02428985|Riociguat|riociguat|mesh-list
56398104|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
56398105|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398106|NCT02425904|Clofarabine|clofarabine|mesh-list
56398107|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56398108|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
56398119|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
56398121|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398122|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398123|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56398124|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398125|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
56398126|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
56398127|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398128|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398129|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56398130|NCT02406209|Protective Agents|protective agents|mesh-ancestor
56398139|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56398140|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398141|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
56398142|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398143|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56398144|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56398146|NCT02296125|Osimertinib|osimertinib|mesh-list
56398147|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398148|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56398149|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398150|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398151|NCT02295722|Gemcitabine|gemcitabine|mesh-list
56398152|NCT02295722|Melphalan|melphalan|mesh-list
56398153|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56398154|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
56398155|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398156|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398157|NCT02295722|Antiviral Agents|antiviral agents|mesh-ancestor
56398158|NCT02295722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398159|NCT02295722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398160|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56398161|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
56398162|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398163|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56398164|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
56398165|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56398166|NCT02282059|Sunitinib|sunitinib|mesh-list
56398167|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398168|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56398169|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56398170|NCT02282059|Growth Substances|growth substances|mesh-ancestor
56398171|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398172|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
56398173|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56398174|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398175|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398176|NCT02242942|Venetoclax|venetoclax|mesh-list
56398177|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
56657522|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56657523|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56657524|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657525|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
56657526|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657527|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303628|NCT00396487|Irinotecan|irinotecan|mesh-list
56657528|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56657529|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56657530|NCT02778425|Somatostatin|somatostatin|mesh-list
56657531|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56657532|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
56657533|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657534|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398178|NCT02242942|Chlorambucil|chlorambucil|mesh-list
56398179|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398180|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56398181|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56398276|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56398277|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
56398278|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398279|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398280|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56398281|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
56398282|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
56398283|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56398284|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56398285|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56398289|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398292|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56398293|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398294|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
56398295|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398296|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56398297|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56398298|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
56398299|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398300|NCT01711554|Vitamin A|vitamin a|mesh-list
56398301|NCT01711554|Lenalidomide|lenalidomide|mesh-list
55726588|NCT02446418|Xhance|xhance|mesh-list
56398303|NCT01711554|Dinutuximab|dinutuximab|mesh-list
56398304|NCT01711554|Isotretinoin|isotretinoin|mesh-list
56398305|NCT01711554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56398306|NCT01711554|Vitamins|vitamins|mesh-ancestor
56398307|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
56398308|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398309|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
56398310|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56398311|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56398312|NCT01711554|Growth Substances|growth substances|mesh-ancestor
56398313|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
56398314|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398315|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
56398316|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
56398317|NCT01708941|Interferons|interferons|mesh-list
56398318|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
56398319|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
56398320|NCT01708941|Ipilimumab|ipilimumab|mesh-list
56398321|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398322|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
56398323|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398324|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56398325|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56398326|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398327|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
56398328|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398330|NCT01631617|Cephalexin|cephalexin|mesh-list
56398331|NCT01631617|Trimethoprim|trimethoprim|mesh-list
56398332|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
56398333|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56398334|NCT01631617|Eusol|eusol|mesh-list
56398335|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56398336|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398337|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
56398338|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56398339|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56398340|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56398341|NCT01631617|Renal Agents|renal agents|mesh-ancestor
56398342|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56398343|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398344|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398345|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56398346|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56398347|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56398348|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
56398349|NCT01575860|Lenalidomide|lenalidomide|mesh-list
56398350|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
56398351|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398352|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56398353|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56398354|NCT01575860|Growth Substances|growth substances|mesh-ancestor
56398355|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
56398356|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398357|NCT01445509|Bevacizumab|bevacizumab|mesh-list
56398358|NCT01445509|Dasatinib|dasatinib|mesh-list
56398359|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56398360|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398361|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56398375|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
56398376|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398377|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56398378|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56002236|NCT02548962|Dexamethasone|dexamethasone|mesh-list
56398379|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56398381|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398382|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398383|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
56398384|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56398385|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56398386|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
56398387|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398388|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56398389|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56398390|NCT01416831|Interleukin-2|interleukin-2|mesh-list
56398391|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398392|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56398393|NCT01416831|Analgesics|analgesics|mesh-ancestor
56175752|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
56398394|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
56398395|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398396|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398397|NCT01386385|Paclitaxel|paclitaxel|mesh-list
56398398|NCT01386385|Carboplatin|carboplatin|mesh-list
56398399|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56398400|NCT01386385|Veliparib|veliparib|mesh-list
56398401|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56398402|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398403|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
56398404|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
56398405|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
56398406|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398407|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56398408|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398409|NCT01364051|Cediranib|cediranib|mesh-list
56398410|NCT01364051|Maleic acid|maleic acid|mesh-list
56398411|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398412|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398413|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657535|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657537|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657538|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
56657539|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56657540|NCT04228757|Estrogens|estrogens|mesh-ancestor
56657541|NCT04228757|Hormones|hormones|mesh-ancestor
56657542|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657543|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398414|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56398415|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56398416|NCT01345175|Metronidazole|metronidazole|mesh-list
56398417|NCT01345175|Rifaximin|rifaximin|mesh-list
56398418|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56398419|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398420|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
56398421|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56398422|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56398423|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398447|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398448|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56398449|NCT01303341|Sorafenib|sorafenib|mesh-list
56398450|NCT01303341|Riluzole|riluzole|mesh-list
56398451|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398452|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56398453|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002237|NCT02548962|Pomalidomide|pomalidomide|mesh-list
56398454|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398455|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
56398456|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56398457|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56398458|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398459|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398460|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56398461|NCT01303341|Protective Agents|protective agents|mesh-ancestor
56398462|NCT01065454|Riociguat|riociguat|mesh-list
56398463|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
56398464|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398465|NCT01064648|Cisplatin|cisplatin|mesh-list
56398466|NCT01064648|Pemetrexed|pemetrexed|mesh-list
56398467|NCT01064648|Cediranib|cediranib|mesh-list
56398468|NCT01064648|Maleic acid|maleic acid|mesh-list
56398469|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398470|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398471|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398472|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56398473|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56398474|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56398480|NCT00878163|Gemcitabine|gemcitabine|mesh-list
56398481|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56398482|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56398483|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
56398484|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398485|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398486|NCT00878163|Antiviral Agents|antiviral agents|mesh-ancestor
56398487|NCT00878163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56398488|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398489|NCT00878163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56398490|NCT00878163|Immunologic Factors|immunologic factors|mesh-ancestor
56398491|NCT00878163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398492|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56398493|NCT00635700|Ziprasidone|ziprasidone|mesh-list
56398494|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56398495|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
56398496|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398497|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398498|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657544|NCT04227431|Insulin|insulin|mesh-list
56657545|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56657546|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398499|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56398500|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56398501|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398502|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56398503|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56398504|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
56398505|NCT00582075|Temozolomide|temozolomide|mesh-list
56398506|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56398515|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398516|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56398517|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
56398518|NCT00542451|Paclitaxel|paclitaxel|mesh-list
56398519|NCT00542451|Trastuzumab|trastuzumab|mesh-list
56398520|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56398521|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398522|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
56398523|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
56398524|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
56398525|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398526|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56398527|NCT00392353|Azacitidine|azacitidine|mesh-list
56398528|NCT00392353|Vorinostat|vorinostat|mesh-list
56398529|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56398530|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
56398531|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398532|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398533|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398534|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56398535|NCT00382070|Letrozole|letrozole|mesh-list
56398536|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398537|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56398538|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56398539|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398540|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398541|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56398542|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
56398543|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398544|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398545|NCT00326456|Paclitaxel|paclitaxel|mesh-list
56398546|NCT00326456|Carboplatin|carboplatin|mesh-list
56398547|NCT00326456|Doxorubicin|doxorubicin|mesh-list
56398548|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56398549|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56398550|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398551|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
56398552|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
56398553|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
56398554|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398555|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56398556|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56398557|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56398558|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398559|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
56398560|NCT00097474|Melatonin|melatonin|mesh-list
56398561|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398562|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
56398563|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398564|NCT00097474|Protective Agents|protective agents|mesh-ancestor
56398565|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398566|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398567|NCT00065676|Quercetin|quercetin|mesh-list
56398568|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
56398569|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398570|NCT00065676|Protective Agents|protective agents|mesh-ancestor
56398571|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021210|NCT04216524|Cytarabine|cytarabine|mesh-list
56021651|NCT00452426|Narcotics|narcotics|mesh-ancestor
56022097|NCT03243890|Vitamin D|vitamin d|mesh-list
56022175|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022476|NCT02129426|Analgesics|analgesics|mesh-ancestor
56657547|NCT04227041|Capecitabine|capecitabine|mesh-list
56657548|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56657549|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
56022922|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
56023299|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002245|NCT02548962|Hormones|hormones|mesh-ancestor
56023522|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
56023898|NCT02248051|CXA-10|cxa-10|mesh-list
56024416|NCT00595790|Vaccines|vaccines|mesh-list
56024493|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024874|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
56025025|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025170|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
56025398|NCT00708110|Dolutegravir|dolutegravir|mesh-list
56026374|NCT00756548|Laxatives|laxatives|mesh-ancestor
56026817|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56026964|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56027117|NCT01338857|Sorafenib|sorafenib|mesh-list
56027270|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
56027591|NCT01269047|Exenatide|exenatide|mesh-list
56027637|NCT01321541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027711|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027788|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027894|NCT04645550|Aspirin|aspirin|mesh-list
56028240|NCT01362959|Nicotine|nicotine|mesh-list
56028543|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56028693|NCT02252432|Ketamine|ketamine|mesh-list
56028768|NCT01495481|Adenosine|adenosine|mesh-list
56028842|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56029369|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
56029523|NCT00885638|Incretins|incretins|mesh-ancestor
56030202|NCT03215264|Entinostat|entinostat|mesh-list
56030267|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
56030344|NCT00904826|Eculizumab|eculizumab|mesh-list
56030416|NCT01832870|Ipilimumab|ipilimumab|mesh-list
56030643|NCT01834898|Oxycodone|oxycodone|mesh-list
56030718|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
56030868|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56031026|NCT02498418|Rifaximin|rifaximin|mesh-list
56031189|NCT01568255|Vitamin D|vitamin d|mesh-list
56031395|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
56031771|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56031920|NCT01725230|Simvastatin|simvastatin|mesh-list
56032150|NCT03406286|Tolvaptan|tolvaptan|mesh-list
56032894|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
56033199|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
56034178|NCT01620593|Metformin|metformin|mesh-list
56034774|NCT01680653|Hormones|hormones|mesh-ancestor
56035269|NCT02249585|Iodine|iodine|mesh-list
56035376|NCT02447250|Albuterol|albuterol|mesh-list
56036056|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
56036129|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56036365|NCT00585195|Itraconazole|itraconazole|mesh-list
56036429|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56036658|NCT01103414|Pioglitazone|pioglitazone|mesh-list
56037183|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037259|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
56037333|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037706|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
56038149|NCT05159193|Carboplatin|carboplatin|mesh-list
56038449|NCT03069963|Antacids|antacids|mesh-ancestor
56038594|NCT01292252|Teriparatide|teriparatide|mesh-list
56038751|NCT03901469|Talazoparib|talazoparib|mesh-list
56038827|NCT01231412|Sirolimus|sirolimus|mesh-list
56038986|NCT01303406|Idebenone|idebenone|mesh-list
56039582|NCT01311674|Vaccines|vaccines|mesh-list
56040249|NCT01766219|Vitamins|vitamins|mesh-ancestor
56040555|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56040782|NCT01785095|Hormones|hormones|mesh-list
56041307|NCT01404260|Gemcitabine|gemcitabine|mesh-list
56041604|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56042288|NCT05737121|Anesthetics|anesthetics|mesh-ancestor
56042890|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56043039|NCT02375724|Bromides|bromides|mesh-list
56043115|NCT03033303|Isotretinoin|isotretinoin|mesh-list
56043341|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56043414|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
56044536|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044611|NCT02346240|Analgesics|analgesics|mesh-ancestor
56044698|NCT04334967|Vitamins|vitamins|mesh-ancestor
56044831|NCT04826133|Vitamins|vitamins|mesh-ancestor
56045062|NCT02785185|Clobetasol|clobetasol|mesh-list
56045363|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
56045588|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045761|NCT01536938|Calcitriol|calcitriol|mesh-list
56046117|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
56046203|NCT05408585|Anesthetics|anesthetics|mesh-list
56657550|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657551|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657552|NCT05074823|Ketamine|ketamine|mesh-list
56657553|NCT05074823|Analgesics|analgesics|mesh-ancestor
56657554|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
56657555|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657556|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657557|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56657558|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56657559|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
56657560|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
56657561|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657562|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56657563|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56657564|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657565|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657566|NCT04226963|Ketamine|ketamine|mesh-list
56046417|NCT02860845|Miconazole|miconazole|mesh-list
56046720|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56047168|NCT02143466|Durvalumab|durvalumab|mesh-list
56047391|NCT05257460|Insulin|insulin|mesh-list
56048153|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56048980|NCT02683265|Methylphenidate|methylphenidate|mesh-list
56049283|NCT01658241|Panobinostat|panobinostat|mesh-list
56049576|NCT02249546|Antidotes|antidotes|mesh-ancestor
56049897|NCT03226899|Colchicine|colchicine|mesh-list
56049956|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
56050477|NCT02311907|Paclitaxel|paclitaxel|mesh-list
56050704|NCT02406443|Hormones|hormones|mesh-ancestor
56050805|NCT02037893|Antipyrine|antipyrine|mesh-list
56051392|NCT02383043|Cocaine|cocaine|mesh-list
56051749|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051974|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053106|NCT00557492|Gemcitabine|gemcitabine|mesh-list
56053409|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
56053568|NCT03879603|Antacids|antacids|mesh-ancestor
56053710|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
56053794|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
56053939|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
56054392|NCT01280643|Antidotes|antidotes|mesh-ancestor
56055218|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
56055600|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056071|NCT01807611|Melphalan|melphalan|mesh-list
56056696|NCT00000897|Zidovudine|zidovudine|mesh-list
56056976|NCT00001023|Azithromycin|azithromycin|mesh-list
56057067|NCT00001995|Rifabutin|rifabutin|mesh-list
56057202|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
56057583|NCT00359567|Granisetron|granisetron|mesh-list
56057960|NCT00002187|Fomivirsen|fomivirsen|mesh-list
56058034|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058415|NCT04862585|Hormones|hormones|mesh-ancestor
56058794|NCT00002565|Cytarabine|cytarabine|mesh-list
56058876|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
56058955|NCT00002589|Aldesleukin|aldesleukin|mesh-list
56059030|NCT05752305|Hormones|hormones|mesh-ancestor
56059102|NCT00002643|Etoposide|etoposide|mesh-list
56059185|NCT02249299|Nabiximols|nabiximols|mesh-list
56059405|NCT05751681|Hormones|hormones|mesh-ancestor
56059495|NCT00002757|Hormones|hormones|mesh-ancestor
56059783|NCT01635439|Dinoprostone|dinoprostone|mesh-list
56059934|NCT01641445|Topiramate|topiramate|mesh-list
56060157|NCT03740165|Docetaxel|docetaxel|mesh-list
56060532|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
56060687|NCT04713189|Fentanyl|fentanyl|mesh-list
56060914|NCT01950260|Hormones|hormones|mesh-list
56061202|NCT00000669|Didanosine|didanosine|mesh-list
56061804|NCT03340727|Caffeine|caffeine|mesh-list
56061961|NCT01708603|Brodalumab|brodalumab|mesh-list
56062705|NCT04726969|Ivermectin|ivermectin|mesh-list
56657567|NCT04226963|Analgesics|analgesics|mesh-ancestor
56657568|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
56657569|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657570|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657571|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56657572|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56657573|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
56657574|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
56657575|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657576|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56657577|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56657578|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657579|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657580|NCT00545233|Pioglitazone|pioglitazone|mesh-list
56657581|NCT00545233|Ribavirin|ribavirin|mesh-list
56657582|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56657583|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
56657584|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657585|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
56657586|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657587|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56657588|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657589|NCT02778971|Flutemetamol|flutemetamol|mesh-list
56657590|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56219401|NCT01651390|Paclitaxel|paclitaxel|mesh-list
56062854|NCT03083405|Opipramol|opipramol|mesh-list
56063007|NCT02877303|Vincristine|vincristine|mesh-list
56063087|NCT00002967|Tamoxifen|tamoxifen|mesh-list
56063467|NCT03965923|Dapivirine|dapivirine|mesh-list
56063695|NCT05635903|Diazepam|diazepam|mesh-list
56063772|NCT01754623|Gemcitabine|gemcitabine|mesh-list
56064371|NCT01734889|Nitisinone|nitisinone|mesh-list
56064529|NCT02525549|Adapalene|adapalene|mesh-list
56064750|NCT05324995|Celecoxib|celecoxib|mesh-list
56065047|NCT04953325|Vaccines|vaccines|mesh-list
56065279|NCT02561897|Warfarin|warfarin|mesh-list
56065570|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066245|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
56066472|NCT02264353|Donepezil|donepezil|mesh-list
56066550|NCT00367445|Insulin|insulin|mesh-list
55793940|NCT04462315|Cobalt|cobalt|mesh-list
56067595|NCT02265744|Antibodies|antibodies|mesh-list
56067901|NCT04408625|Hormones|hormones|mesh-ancestor
56068504|NCT04021121|Linezolid|linezolid|mesh-list
56068593|NCT00370019|Estradiol|estradiol|mesh-list
56068881|NCT05732701|Oxymetazoline|oxymetazoline|mesh-list
56069023|NCT05725135|Anesthetics, General|anesthetics, general|mesh-ancestor
56069473|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
56070084|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
56070611|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56071061|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56071203|NCT01979276|Dexamethasone|dexamethasone|mesh-list
56071432|NCT02034019|Hormones|hormones|mesh-ancestor
56072104|NCT02371850|Nicotine|nicotine|mesh-list
56072472|NCT02065687|Metformin|metformin|mesh-list
56072772|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
56072926|NCT05638880|Valsartan|valsartan|mesh-list
56657591|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657592|NCT02393248|Gemcitabine|gemcitabine|mesh-list
56657593|NCT02393248|Docetaxel|docetaxel|mesh-list
56657594|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
56657595|NCT02393248|Trastuzumab|trastuzumab|mesh-list
56657596|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657597|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56657598|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
56657599|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657600|NCT02393248|Antiviral Agents|antiviral agents|mesh-ancestor
56657601|NCT02393248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657602|NCT02393248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657603|NCT02393248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56657604|NCT02393248|Immunologic Factors|immunologic factors|mesh-ancestor
56657605|NCT02393248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657606|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56657607|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56657608|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56657609|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56657610|NCT00601484|Tanezumab|tanezumab|mesh-list
56657611|NCT00601484|Analgesics|analgesics|mesh-ancestor
56657612|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
56073751|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
56073900|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146268|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
56146269|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146270|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56146271|NCT02406222|Dexamethasone|dexamethasone|mesh-list
56146272|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
56146273|NCT02406222|Pomalidomide|pomalidomide|mesh-list
56146274|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146275|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
56146276|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146277|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146278|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146279|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
56146280|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146281|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146282|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56146283|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146284|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
56146285|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
56146286|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146287|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146288|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
56146289|NCT02406222|Hormones|hormones|mesh-ancestor
56146290|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146291|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56146292|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56146293|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56146294|NCT02406222|Growth Substances|growth substances|mesh-ancestor
56146295|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56146296|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
56146297|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55923668|NCT05134350|Omeprazole|omeprazole|mesh-list
56657613|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657614|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657615|NCT00978601|Analgesics|analgesics|mesh-list
56657616|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
56657617|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657618|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657619|NCT00883896|Fezakinumab|fezakinumab|mesh-list
56657620|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
56657621|NCT02778191|Carboplatin|carboplatin|mesh-list
56657622|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657623|NCT05170685|Nivolumab|nivolumab|mesh-list
56657624|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56657625|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657626|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56657627|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657628|NCT02778893|Thalidomide|thalidomide|mesh-list
56657629|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56657630|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
56657631|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657632|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
56657633|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56657634|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657635|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56657636|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56657637|NCT02778893|Growth Substances|growth substances|mesh-ancestor
56657638|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
56657639|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657640|NCT03920293|Ravulizumab|ravulizumab|mesh-list
56657641|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56657642|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56657643|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
56657646|NCT02671864|Incretins|incretins|mesh-list
56657656|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56657657|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56657658|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
56657659|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56657660|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56657661|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56657662|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56657663|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657664|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56657665|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56657666|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657667|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657668|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657669|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56657670|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
56657671|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56657672|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657673|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56657674|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56146298|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146299|NCT01022190|Etoricoxib|etoricoxib|mesh-list
56146300|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56146301|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56146302|NCT01022190|Analgesics|analgesics|mesh-ancestor
56146303|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
56146304|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146305|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146306|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146307|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146308|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56146309|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56146310|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146311|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146312|NCT01024686|Vaccines|vaccines|mesh-list
56146313|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
56146314|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146315|NCT01027806|Montelukast|montelukast|mesh-list
56146316|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56146317|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
56146318|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56146319|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
56146320|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146321|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146322|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56146323|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56146324|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146325|NCT01028820|Aripiprazole|aripiprazole|mesh-list
56146326|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
56146327|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56146328|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56146329|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56657675|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56657676|NCT02660840|Flupenthixol|flupenthixol|mesh-list
56657677|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
56657678|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56657679|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56657680|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657681|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657682|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657683|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56657684|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
56657685|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657686|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657687|NCT02777801|Entecavir|entecavir|mesh-list
56657688|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
56657689|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657690|NCT00649064|Ziprasidone|ziprasidone|mesh-list
56657691|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56146330|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56146331|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146332|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
56146333|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
56146334|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146335|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146336|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56146337|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56146340|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56146341|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56146342|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56146343|NCT01029054|Dexamethasone|dexamethasone|mesh-list
56146344|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
56146345|NCT01029054|Lenalidomide|lenalidomide|mesh-list
56146346|NCT01029054|BB 1101|bb 1101|mesh-list
56146347|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146348|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
56146349|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
56146350|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146351|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146352|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146353|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
56146354|NCT01029054|Hormones|hormones|mesh-ancestor
56146355|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146356|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56146357|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146358|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
56146359|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146360|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146361|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
56146362|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56146363|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56146364|NCT01029054|Growth Substances|growth substances|mesh-ancestor
56146365|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
56146366|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
56142952|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
56146367|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56146368|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56146369|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146370|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
56146371|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657692|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
56657693|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657694|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657695|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657696|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56657697|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56657698|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657699|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657700|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56657701|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
56657702|NCT04132713|Capecitabine|capecitabine|mesh-list
56657703|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56657704|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
56657705|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657706|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657707|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
56657708|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56657709|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657710|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657711|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56657712|NCT04007341|Analgesics|analgesics|mesh-ancestor
56657713|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
56657714|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146372|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146374|NCT05593458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146375|NCT05592678|Donepezil|donepezil|mesh-list
56146376|NCT05592678|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56146377|NCT05592678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146378|NCT05592678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146379|NCT05592678|Cholinergic Agents|cholinergic agents|mesh-ancestor
56146380|NCT05592678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146381|NCT05592678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146382|NCT05592678|Nootropic Agents|nootropic agents|mesh-ancestor
56146383|NCT05461404|Emollients|emollients|mesh-list
56146384|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146385|NCT05402826|Vitamin E|vitamin e|mesh-list
56146386|NCT05402826|Vitamins|vitamins|mesh-ancestor
56146387|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
56146388|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146389|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
56146390|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146391|NCT05402826|Protective Agents|protective agents|mesh-ancestor
56146392|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
56146393|NCT05385042|Thiamine|thiamine|mesh-list
56146394|NCT05385042|Vitamins|vitamins|mesh-ancestor
56146395|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
56146396|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146397|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
56146398|NCT05306028|Metformin|metformin|mesh-list
56146399|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56146400|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146401|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
55923669|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56657715|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56657716|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56657717|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56657718|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
56657719|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657720|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657721|NCT02656082|Etanercept|etanercept|mesh-list
56657722|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56657723|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56657724|NCT02656082|Analgesics|analgesics|mesh-ancestor
56146402|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56146403|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146404|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56146405|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146406|NCT04780932|Macitentan|macitentan|mesh-list
56146407|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56146408|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56146409|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727098|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
56146410|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56146411|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
56146414|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146416|NCT04410042|Coagulants|coagulants|mesh-ancestor
56146417|NCT04316910|Anesthetics|anesthetics|mesh-list
56146418|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
56146419|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56146420|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146421|NCT04308330|Vorinostat|vorinostat|mesh-list
56146422|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146423|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56146424|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146425|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146426|NCT04150458|Choline|choline|mesh-list
56146427|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
56146428|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56146429|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
56146430|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146431|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146432|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56146433|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
56146434|NCT03869268|Aspirin|aspirin|mesh-list
56146435|NCT03869268|Ticagrelor|ticagrelor|mesh-list
56146436|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56146437|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56146438|NCT03869268|Analgesics|analgesics|mesh-ancestor
56175763|NCT01391598|Lidocaine|lidocaine|mesh-list
56146439|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
56146440|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146441|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146442|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146443|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146444|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56146445|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56146446|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146447|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56146448|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56146449|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146450|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
56146451|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56146452|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56146453|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56146454|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
56657725|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
56657726|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657727|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657728|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56657729|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146455|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146456|NCT03680508|Antibodies|antibodies|mesh-list
56146457|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
56146458|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
56146459|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146460|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
56146461|NCT01842672|Clofarabine|clofarabine|mesh-list
56146462|NCT01842672|Analgesics|analgesics|mesh-ancestor
56146463|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
56146464|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146465|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146466|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146467|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56146468|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56146469|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146470|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146471|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56146472|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
56146473|NCT01034592|Lenalidomide|lenalidomide|mesh-list
56146474|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
56146475|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146476|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56146477|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56146478|NCT01034592|Growth Substances|growth substances|mesh-ancestor
56146479|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
56146480|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146481|NCT01037790|Palbociclib|palbociclib|mesh-list
56146482|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146483|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56146487|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56146489|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56146490|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
56074134|NCT02979223|Vitamins|vitamins|mesh-ancestor
56146491|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146492|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146493|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56146494|NCT01043640|Cyclosporine|cyclosporine|mesh-list
56146495|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
56146496|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
56146497|NCT01043640|Busulfan|busulfan|mesh-list
56146498|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
56146499|NCT01043640|Cyclosporins|cyclosporins|mesh-list
56146500|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146501|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
56146502|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146503|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146504|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146505|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
56146506|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146507|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146508|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56146509|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146510|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
56146512|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146513|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56146514|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56146515|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56146516|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
56146517|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56146518|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56146519|NCT01044264|Clindamycin|clindamycin|mesh-list
56146520|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
56146521|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
56146522|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56146523|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56146524|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657730|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657731|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146525|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56146526|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146527|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146528|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146529|NCT01044966|Temozolomide|temozolomide|mesh-list
56146530|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146531|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
56146532|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146533|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146534|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
56146535|NCT01045122|Propofol|propofol|mesh-list
56146536|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56146537|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56146538|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146539|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56146540|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
56146541|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
56146542|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56146543|NCT01045122|Analgesics|analgesics|mesh-ancestor
56146544|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
56146545|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146546|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56146547|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56146548|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56146549|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
56146550|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146551|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146552|NCT01050582|Risperidone|risperidone|mesh-list
56146553|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
56146554|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56146555|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
56146556|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146558|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146560|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56146561|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56146562|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56146564|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56146565|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
56146566|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56146567|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56146568|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56146569|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56146570|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146571|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56146572|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56146573|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56146574|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146575|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
56146576|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146577|NCT01051596|Temozolomide|temozolomide|mesh-list
56146578|NCT01051596|Veliparib|veliparib|mesh-list
56146579|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146580|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
56146581|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146582|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146583|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56146584|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146585|NCT01053000|Tazarotene|tazarotene|mesh-list
56146586|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146587|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
56146588|NCT01053078|Naltrexone|naltrexone|mesh-list
56146589|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56146590|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56146591|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146592|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
56146593|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146594|NCT01053156|Minocycline|minocycline|mesh-list
56146595|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56146596|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657732|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
56657733|NCT04132635|Mitogens|mitogens|mesh-list
56657734|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
56657735|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657736|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56657737|NCT03335488|Glycerol|glycerol|mesh-list
56657738|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56657739|NCT03335488|Protective Agents|protective agents|mesh-ancestor
56657740|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657741|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657742|NCT02623504|Carbamazepine|carbamazepine|mesh-list
56657743|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
56657744|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
56657745|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56146597|NCT01053312|Flutemetamol|flutemetamol|mesh-list
56146598|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56146599|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146600|NCT01054404|Furosemide|furosemide|mesh-list
56146601|NCT01054404|Diuretics|diuretics|mesh-ancestor
56146602|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
56146603|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146604|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56146605|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56146606|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146607|NCT01055184|Vaccines|vaccines|mesh-list
56146608|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
56146609|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146610|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
56146611|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
56146612|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56146613|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56146614|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146615|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146616|NCT01060020|Urological Agents|urological agents|mesh-ancestor
56146617|NCT01060098|Adalimumab|adalimumab|mesh-list
56146618|NCT01060098|Etanercept|etanercept|mesh-list
56146619|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146620|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146621|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56146622|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56146623|NCT01060098|Analgesics|analgesics|mesh-ancestor
56146624|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
56146625|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146626|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146627|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146628|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146632|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56146634|NCT01061034|Analgesics|analgesics|mesh-ancestor
56146635|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
56146636|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146637|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146638|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146639|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146640|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56146641|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56146642|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146643|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56146644|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56146645|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146646|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
56146647|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56146648|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657746|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657747|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657748|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56657749|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56657750|NCT02623504|Analgesics|analgesics|mesh-ancestor
56657751|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
56146649|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56146650|NCT01065558|Ecopipam|ecopipam|mesh-list
56146651|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56146652|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56146653|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56146654|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146655|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56146656|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56146657|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
56146658|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146659|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146660|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
56146661|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56146662|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
56146663|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146664|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
56146665|NCT01066026|Protective Agents|protective agents|mesh-ancestor
56146666|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
56146667|NCT01072188|Calcium|calcium|mesh-list
56146668|NCT01072188|Fluorides|fluorides|mesh-list
56146669|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56146670|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146671|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
56146672|NCT01072188|Protective Agents|protective agents|mesh-ancestor
56146673|NCT01072188|Antacids|antacids|mesh-ancestor
56146674|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146675|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146676|NCT01083732|Dabigatran|dabigatran|mesh-list
56146677|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
56146678|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56146679|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
56146680|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146681|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146682|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
56146683|NCT01084278|Colchicine|colchicine|mesh-list
56146684|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
56146685|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146686|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
56146687|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
56146688|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
56146689|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146690|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146691|NCT01085760|Metronidazole|metronidazole|mesh-list
56146692|NCT01085760|Vancomycin|vancomycin|mesh-list
56146693|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56146694|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56146695|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56146696|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56146697|NCT01090752|Metformin|metformin|mesh-list
56146698|NCT01090752|Pioglitazone|pioglitazone|mesh-list
56146699|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56146700|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146701|NCT01093794|Metformin|metformin|mesh-list
56146704|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146705|NCT01093794|Incretins|incretins|mesh-ancestor
56146706|NCT01093794|Hormones|hormones|mesh-ancestor
56146707|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146708|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56146709|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
56146710|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146711|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146712|NCT01094106|Ropivacaine|ropivacaine|mesh-list
56146713|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
56146714|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
56146715|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547641|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657752|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657753|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56657754|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657755|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657756|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56657757|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56657758|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
56657759|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56657760|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
56657761|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657762|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
56657763|NCT02777723|Protective Agents|protective agents|mesh-ancestor
56657764|NCT00601250|Linagliptin|linagliptin|mesh-list
56657765|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56657766|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657767|NCT00601250|Incretins|incretins|mesh-ancestor
56657768|NCT00601250|Hormones|hormones|mesh-ancestor
56657769|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657770|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56657771|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
56146716|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146717|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
56146718|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146719|NCT01094574|Propranolol|propranolol|mesh-list
56146720|NCT01094574|Alfentanil|alfentanil|mesh-list
56146721|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56146722|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56146723|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
56146724|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146725|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146726|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146727|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56146728|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56146729|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
56146730|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56146731|NCT01094574|Narcotics|narcotics|mesh-ancestor
56146732|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56146733|NCT01094574|Analgesics|analgesics|mesh-ancestor
56146734|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
56146735|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146736|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56146737|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
56146738|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
56146739|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56146740|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56146741|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146742|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
56146743|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146744|NCT01096290|Lubiprostone|lubiprostone|mesh-list
56146745|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56146746|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657772|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657773|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657774|NCT04226885|Fentanyl|fentanyl|mesh-list
56657775|NCT04226885|Midazolam|midazolam|mesh-list
56657776|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
56657777|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56657778|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657779|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146747|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146748|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56146749|NCT01096680|Modafinil|modafinil|mesh-list
56146750|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56146751|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146752|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56146753|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56146754|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56146755|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146756|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
56146757|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146758|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56146759|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56146760|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56146761|NCT01096992|Rituximab|rituximab|mesh-list
56146762|NCT01096992|Fludarabine|fludarabine|mesh-list
56146763|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
56146764|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56146765|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56146766|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146767|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
56146768|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146769|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146770|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56146771|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
56146772|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727479|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
56146777|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56146778|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146779|NCT01097460|Trastuzumab|trastuzumab|mesh-list
56146780|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56146781|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146782|NCT01098318|Sertraline|sertraline|mesh-list
56146783|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
56146784|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56146785|NCT01098318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56146786|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56146787|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56146788|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074430|NCT03441269|Ibuprofen|ibuprofen|mesh-list
56146789|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146790|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
56146791|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146793|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146794|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56146795|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
56146796|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146797|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146798|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56146799|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
56146800|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
56146802|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146803|NCT01100268|Methylphenidate|methylphenidate|mesh-list
56146804|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56146805|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146806|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56657780|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56657781|NCT04226885|Analgesics|analgesics|mesh-ancestor
56657782|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
56657783|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657784|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56657785|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56657786|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56657787|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
56657788|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657789|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657790|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56657791|NCT04226885|Narcotics|narcotics|mesh-ancestor
56657792|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56657793|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56657794|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
56657795|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
56657796|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56657797|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56657798|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56219607|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
56146807|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56146808|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56146809|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146810|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
56146811|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146812|NCT01101750|Vaccines|vaccines|mesh-list
56146813|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
56146814|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146815|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
56146816|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
56146817|NCT01102218|Hematinics|hematinics|mesh-ancestor
56146818|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56146819|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146820|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146821|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56146822|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56146823|NCT01102218|Protective Agents|protective agents|mesh-ancestor
56146824|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146825|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
56146826|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56146827|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
56146828|NCT01103934|Vitamin D|vitamin d|mesh-list
56146829|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
56146830|NCT01103934|Fluticasone|fluticasone|mesh-list
56146831|NCT01103934|Xhance|xhance|mesh-list
56146832|NCT01103934|Vitamins|vitamins|mesh-ancestor
56146833|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
56146834|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146835|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56146836|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146837|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56146838|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
56146839|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146840|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56146841|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
56146842|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146843|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56657799|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
56657800|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
56657801|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56657802|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
56657803|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56657804|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56657805|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657806|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657807|NCT02777411|Vaccines|vaccines|mesh-list
56657808|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
56657809|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657810|NCT02777489|Perindopril|perindopril|mesh-list
56657811|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56657812|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
56657813|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657814|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146847|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56146848|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56146849|NCT01105650|Prednisolone|prednisolone|mesh-list
56146850|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
56146851|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
56146852|NCT01105650|Fludarabine|fludarabine|mesh-list
56146853|NCT01105650|Interleukin-2|interleukin-2|mesh-list
56146854|NCT01105650|Cyclosporins|cyclosporins|mesh-list
56146855|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56146856|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
56146857|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146858|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
56146859|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146860|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146861|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146862|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
56146863|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146864|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146865|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56146866|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146867|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
56146868|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56146869|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146870|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56143460|NCT00648648|Gemcitabine|gemcitabine|mesh-list
56146871|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146873|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
56146874|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146875|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146876|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
56146877|NCT01105650|Hormones|hormones|mesh-ancestor
56146878|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146879|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56146880|NCT01105650|Protective Agents|protective agents|mesh-ancestor
56146881|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56146882|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56146883|NCT01105650|Analgesics|analgesics|mesh-ancestor
56146884|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
56146885|NCT01110876|Temozolomide|temozolomide|mesh-list
56146886|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56146887|NCT01110876|Vorinostat|vorinostat|mesh-list
56146888|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146889|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
56657815|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56657816|NCT02660762|Cytarabine|cytarabine|mesh-list
56657817|NCT02660762|Dexamethasone|dexamethasone|mesh-list
56657818|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
56657819|NCT02660762|Prednisone|prednisone|mesh-list
56657820|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
56657821|NCT02660762|Methotrexate|methotrexate|mesh-list
56657822|NCT02660762|Etoposide|etoposide|mesh-list
56657823|NCT02660762|Vincristine|vincristine|mesh-list
56657824|NCT02660762|Daunorubicin|daunorubicin|mesh-list
56657825|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
56657826|NCT02660762|Pegaspargase|pegaspargase|mesh-list
56657827|NCT02660762|Thioguanine|thioguanine|mesh-list
56146890|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146891|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146892|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56146893|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146894|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56146895|NCT01112358|Cetrorelix|cetrorelix|mesh-list
56146896|NCT01112358|Progesterone|progesterone|mesh-list
56146897|NCT01112358|Progestins|progestins|mesh-ancestor
56146898|NCT01112358|Hormones|hormones|mesh-ancestor
56146899|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146900|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146901|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56146902|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
56146903|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56146904|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
56146905|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56146906|NCT01112670|Atorvastatin|atorvastatin|mesh-list
56146907|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56146908|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56146909|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
56146910|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146911|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56146912|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56146913|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146914|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56146915|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146916|NCT01112670|Incretins|incretins|mesh-ancestor
56146922|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56146923|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56146925|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146926|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
56146927|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146928|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56146929|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
56146930|NCT01119222|Promethazine|promethazine|mesh-list
56146931|NCT01119222|Morphine|morphine|mesh-list
56146932|NCT01119222|Gabapentin|gabapentin|mesh-list
56146933|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56146934|NCT01119222|Narcotics|narcotics|mesh-ancestor
56146935|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56146936|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146937|NCT01119222|Analgesics|analgesics|mesh-ancestor
56146938|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
56146939|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146940|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
56146941|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56146942|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56146943|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56146944|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56146945|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56146946|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146947|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146948|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
56146949|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56146950|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56657829|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56657830|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
56657831|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657832|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56657833|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56657834|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
56657835|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657836|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657837|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56657838|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56657839|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
56657840|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
56657841|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657842|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657843|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
56657844|NCT02660762|Hormones|hormones|mesh-ancestor
56219648|NCT01652378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56146951|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
56146952|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
56146953|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
56146954|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
56146955|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146956|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56146957|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
56146958|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
56146959|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56146960|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
56146961|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146962|NCT01120236|Leuprolide|leuprolide|mesh-list
56146963|NCT01120236|Goserelin|goserelin|mesh-list
56146964|NCT01120236|Bicalutamide|bicalutamide|mesh-list
56146965|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56146966|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56146967|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
56146968|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56146969|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146970|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56146971|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146972|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
56146973|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
56146974|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146975|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
56146976|NCT01120704|Nicotine|nicotine|mesh-list
56146977|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56146978|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
56146979|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146980|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146981|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56146982|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56146983|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
56146984|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146985|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146986|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56146987|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
56146992|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56146993|NCT05307042|Vasopressins|vasopressins|mesh-list
56146994|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
56146995|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56146996|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
56146997|NCT05307042|Coagulants|coagulants|mesh-ancestor
56657845|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657846|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56657847|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
56657848|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657849|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56657850|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
56657851|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56657852|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219663|NCT01652417|Hormones|hormones|mesh-ancestor
56146998|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56146999|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56147000|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
56147001|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147002|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
56147003|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56147004|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147005|NCT04974138|Folic Acid|folic acid|mesh-list
56147006|NCT04974138|Amlodipine|amlodipine|mesh-list
56147007|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56147008|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56147009|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56147010|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147011|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56147012|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147013|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
56147014|NCT04974138|Hematinics|hematinics|mesh-ancestor
56147015|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
56147016|NCT04974138|Vitamins|vitamins|mesh-ancestor
56147017|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
56147018|NCT04973982|Tacrolimus|tacrolimus|mesh-list
56147019|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147020|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
56147021|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147022|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56147023|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147024|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147025|NCT04944654|Emtricitabine|emtricitabine|mesh-list
56147026|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
56147027|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147028|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56147029|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56147030|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147031|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147032|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56147033|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56147034|NCT04187352|Cisplatin|cisplatin|mesh-list
56147035|NCT04187352|Fluorouracil|fluorouracil|mesh-list
56147036|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147037|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
56147038|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147039|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56147040|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147041|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
56147042|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147043|NCT04142892|Onapristone|onapristone|mesh-list
56147044|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147045|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56147046|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
56147047|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56147048|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147049|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
56147050|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147051|NCT03697356|Dexamethasone|dexamethasone|mesh-list
56147052|NCT03697356|Rituximab|rituximab|mesh-list
56147053|NCT03697356|Lenalidomide|lenalidomide|mesh-list
56657853|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
56657854|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
56657855|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56147054|NCT03697356|Bortezomib|bortezomib|mesh-list
56147055|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56147056|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147057|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
56147058|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147059|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56147065|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
56147066|NCT03697356|Hormones|hormones|mesh-ancestor
56147067|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147068|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56147069|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56147070|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56002268|NCT02743598|Incretins|incretins|mesh-ancestor
56147071|NCT03697356|Growth Substances|growth substances|mesh-ancestor
56147072|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
56147073|NCT03616782|Ixazomib|ixazomib|mesh-list
56147074|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147075|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
56147076|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147077|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147078|NCT02410512|Atezolizumab|atezolizumab|mesh-list
56147079|NCT02410512|Antibodies|antibodies|mesh-list
56147080|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
56147081|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56147082|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
56147083|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147084|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147085|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56147086|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56147087|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56147088|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56147089|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147090|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
56147091|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147092|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147093|NCT01128192|Pasireotide|pasireotide|mesh-list
56147094|NCT01128192|Hormones|hormones|mesh-ancestor
56147095|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147096|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147097|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
56147098|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56147099|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147100|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147101|NCT01128972|Listerine|listerine|mesh-list
56147102|NCT01128972|Fluorides|fluorides|mesh-list
56147103|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
56147104|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
56147105|NCT01128972|Protective Agents|protective agents|mesh-ancestor
56147106|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147107|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56147108|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147109|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
56147110|NCT01129206|Docetaxel|docetaxel|mesh-list
56147111|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56147112|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147113|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56147114|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56147115|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56147116|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147117|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56147118|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
56147119|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
56147120|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147121|NCT01129440|Fluorides|fluorides|mesh-list
56147122|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
56147123|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
56147124|NCT01129440|Protective Agents|protective agents|mesh-ancestor
56147125|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147126|NCT01130844|Mesalamine|mesalamine|mesh-list
56147127|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56147128|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56657856|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56657857|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56657858|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56657859|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56657860|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
56657861|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657862|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
56657863|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
56657864|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
56147129|NCT01130844|Analgesics|analgesics|mesh-ancestor
56147130|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
56147134|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56147135|NCT01134198|Mifepristone|mifepristone|mesh-list
56147136|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56147137|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
56147138|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56147139|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147140|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56147141|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56147142|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56147144|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56147145|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56147146|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
56147147|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147148|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
56147149|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56147150|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56147151|NCT01134510|Complement C1s|complement c1s|mesh-list
56147152|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56147153|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56147154|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
56147155|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147156|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56147157|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147158|NCT01135368|Lansoprazole|lansoprazole|mesh-list
56147159|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
56147160|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56147161|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56147162|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56147163|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147164|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147165|NCT01136226|Leuprolide|leuprolide|mesh-list
56147166|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56147167|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
56147168|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56147169|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147170|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56147171|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147172|NCT01137396|Modafinil|modafinil|mesh-list
56147173|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56147174|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147175|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56147176|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56147177|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56147178|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147179|NCT01139190|Naproxen|naproxen|mesh-list
56147180|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56147181|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56147182|NCT01139190|Analgesics|analgesics|mesh-ancestor
56147183|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
56147184|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147185|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147186|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147187|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56657865|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56657866|NCT04006873|Ivacaftor|ivacaftor|mesh-list
56657867|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56657868|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657869|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657870|NCT02660684|Cyclosporine|cyclosporine|mesh-list
56657871|NCT02660684|Methotrexate|methotrexate|mesh-list
56657872|NCT02660684|Tacrolimus|tacrolimus|mesh-list
56657873|NCT02660684|Cyclosporins|cyclosporins|mesh-list
56657874|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56657875|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
56657876|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55795699|NCT04426097|Iodine|iodine|mesh-list
56147188|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
56147189|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56147190|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147191|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147192|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
56147193|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147194|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56147195|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147196|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147197|NCT01142310|Lamotrigine|lamotrigine|mesh-list
56147198|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
56147199|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56147200|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56147201|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147202|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56147203|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147205|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56147206|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147207|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56147208|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56147209|NCT01144338|Exenatide|exenatide|mesh-list
56147210|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56147211|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147212|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56147213|NCT01144338|Incretins|incretins|mesh-ancestor
56147214|NCT01144338|Hormones|hormones|mesh-ancestor
56147215|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147216|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56147217|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
56147218|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56147219|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56147220|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56147221|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56147222|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
56147223|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147224|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147225|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147226|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56147227|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56147228|NCT01146600|Clarithromycin|clarithromycin|mesh-list
56147229|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56147230|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147231|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56147232|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147233|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147234|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56147235|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56147236|NCT01146834|Plerixafor|plerixafor|mesh-list
56657877|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657878|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56657879|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
56657880|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657881|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657882|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
56657883|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657884|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56147237|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
56147238|NCT01146834|Bortezomib|bortezomib|mesh-list
56147239|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147240|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
56074888|NCT03501979|Tucatinib|tucatinib|mesh-list
56147241|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147242|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56147243|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56147244|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
56147245|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147246|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147247|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56147248|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56147249|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56147250|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
56147251|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147253|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56147254|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56147255|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
56147256|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147257|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56147258|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147259|NCT01149876|Tretinoin|tretinoin|mesh-list
56147260|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147261|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
56147262|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
56147263|NCT01150500|Sirolimus|sirolimus|mesh-list
56147264|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56147265|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147266|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56147267|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147268|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
56147269|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147270|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
56147271|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147272|NCT01151046|Exemestane|exemestane|mesh-list
56147273|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147274|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56147277|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147278|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56147279|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
56147280|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147281|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147282|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
56147283|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56147284|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
56147285|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147286|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
56147287|NCT01151436|Protective Agents|protective agents|mesh-ancestor
56147288|NCT01153620|Polihexanide|polihexanide|mesh-list
56147289|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
56147290|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147291|NCT01163214|Ropivacaine|ropivacaine|mesh-list
56147292|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
56147293|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
56147294|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147295|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147296|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
56147297|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657885|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56657886|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
56657887|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56657888|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56657889|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56657890|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
56657891|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56657892|NCT00982891|Morphine|morphine|mesh-list
56657893|NCT00982891|Hydromorphone|hydromorphone|mesh-list
56147298|NCT01163604|Argatroban|argatroban|mesh-list
56147299|NCT01163604|Clopidogrel|clopidogrel|mesh-list
56147300|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147301|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147302|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56147303|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147304|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56147305|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56147306|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56147307|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
56147308|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147309|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
56147310|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56147311|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
56147312|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
56147313|NCT01168674|Ziprasidone|ziprasidone|mesh-list
56147314|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56147315|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
56147316|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147317|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147318|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147319|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56147320|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56147321|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147322|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56147323|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56147324|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
56147325|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
56147326|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
56147327|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56147328|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56147329|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147330|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147331|NCT01168908|Urological Agents|urological agents|mesh-ancestor
56147332|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56147333|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56147334|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
56147335|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56147336|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56147337|NCT01170390|Estradiol|estradiol|mesh-list
56147338|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56147339|NCT01170390|Estrogens|estrogens|mesh-ancestor
56147340|NCT01170390|Hormones|hormones|mesh-ancestor
56147341|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147342|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147343|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56147344|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
56147345|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56147346|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56147349|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56147350|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56147351|NCT01171794|Ibuprofen|ibuprofen|mesh-list
56147352|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56147353|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56147354|NCT01171794|Analgesics|analgesics|mesh-ancestor
56147355|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
56147356|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657894|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56657895|NCT00982891|Narcotics|narcotics|mesh-ancestor
56657896|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657897|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657898|NCT00982891|Analgesics|analgesics|mesh-ancestor
56657899|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
56657900|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657901|NCT02615223|Bicalutamide|bicalutamide|mesh-list
56657902|NCT02615223|Hormones|hormones|mesh-list
56657903|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56657904|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56657905|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657907|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
56657908|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657909|NCT04132557|Methylphenidate|methylphenidate|mesh-list
56657910|NCT04132557|Amphetamine|amphetamine|mesh-list
56657911|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56657912|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
56657913|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56219701|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56147357|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147358|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147359|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56147360|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56147361|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147362|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147363|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
56147364|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
56147365|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56147366|NCT01172418|Daclizumab|daclizumab|mesh-list
56147367|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
56147368|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147369|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147370|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56147371|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147372|NCT01175148|Atorvastatin|atorvastatin|mesh-list
56147373|NCT01175148|Calcium|calcium|mesh-list
56147374|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56147375|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147376|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56147377|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56147378|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
56147379|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175787|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147380|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56147381|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56147382|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147384|NCT01177098|Bimatoprost|bimatoprost|mesh-list
56147385|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56147386|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56147387|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56147388|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56075036|NCT03450083|Benralizumab|benralizumab|mesh-list
56147389|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
56147390|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657914|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56657915|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657916|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56657917|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56657918|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56657919|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657920|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
56657921|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657922|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56657923|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
56657924|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
56657925|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
56657926|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147391|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147392|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147393|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56147394|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56147395|NCT01177956|Fluorouracil|fluorouracil|mesh-list
56147396|NCT01177956|Cetuximab|cetuximab|mesh-list
56147397|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147398|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
56147399|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147400|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56147401|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147402|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
56147403|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147404|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56147405|NCT01183650|Tadalafil|tadalafil|mesh-list
56147406|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
56147407|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56147408|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56147409|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147410|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147411|NCT01183650|Urological Agents|urological agents|mesh-ancestor
56147412|NCT01184898|Cytarabine|cytarabine|mesh-list
56147413|NCT01184898|Sirolimus|sirolimus|mesh-list
56147414|NCT01184898|Etoposide|etoposide|mesh-list
56147415|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
56147416|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
56147417|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56147418|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147420|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56147421|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147422|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147423|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56147424|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
56147425|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
56147426|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147427|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147428|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
56147429|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147430|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56147431|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56147432|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
56147433|NCT01184898|Analgesics|analgesics|mesh-ancestor
56147434|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
56147435|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147436|NCT01188876|Folic Acid|folic acid|mesh-list
56147437|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
56147438|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
56657927|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
56657928|NCT00978913|Vaccines|vaccines|mesh-list
56657929|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
56657930|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657931|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56657932|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56657933|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56657934|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
56147439|NCT01188876|Carboplatin|carboplatin|mesh-list
56147440|NCT01188876|Vitamins|vitamins|mesh-ancestor
56147441|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
56147442|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147443|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147444|NCT01188876|Hematinics|hematinics|mesh-ancestor
56147445|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
56147446|NCT01193868|R04929097|r04929097|mesh-list
56147447|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147448|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147449|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
56147450|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56175791|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
56147451|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147452|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147453|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56147454|NCT01195116|Analgesics|analgesics|mesh-ancestor
56147455|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
56147456|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147457|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56147458|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56147459|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56147460|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
56147461|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147462|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147463|NCT01197612|Budesonide|budesonide|mesh-list
56147464|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147465|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56147466|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
56147467|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147468|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147469|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56147470|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
56147471|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
56147472|NCT01197612|Hormones|hormones|mesh-ancestor
56147473|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147474|NCT01198158|Bevacizumab|bevacizumab|mesh-list
56147475|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56147476|NCT01198158|Everolimus|everolimus|mesh-list
56147477|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
56147478|NCT01198158|Antibodies|antibodies|mesh-list
56147479|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
56147480|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56147481|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
56147482|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147483|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56147484|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56147485|NCT01198158|Growth Substances|growth substances|mesh-ancestor
56147486|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147487|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
56147488|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
56147489|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147490|NCT01202994|Flutemetamol|flutemetamol|mesh-list
56147491|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56147492|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147495|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147496|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
56147497|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56147498|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147499|NCT01206660|Desoximetasone|desoximetasone|mesh-list
56657935|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657936|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657937|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56657938|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
56657939|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56657940|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657941|NCT02778659|Zolpidem|zolpidem|mesh-list
56657942|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56657943|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56147500|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147501|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
56147502|NCT01206660|Hormones|hormones|mesh-ancestor
56147503|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147504|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147505|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56147506|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
56147507|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56147508|NCT01207908|Mecasermin|mecasermin|mesh-list
56147509|NCT01207908|Growth Substances|growth substances|mesh-ancestor
56147510|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147511|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
56147512|NCT01208922|Rifamycins|rifamycins|mesh-list
56147513|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
56147514|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56147515|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147516|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56147517|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56147518|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147519|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147520|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147521|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56147522|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56147523|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56175795|NCT01392014|Primaquine|primaquine|mesh-list
56147524|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
56147525|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147526|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
56147527|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56147529|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56147530|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147531|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
56147532|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147534|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56147535|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56147536|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147537|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56147538|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56147539|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56147540|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
56147541|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147542|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147543|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56147545|NCT01215318|Trace Elements|trace elements|mesh-ancestor
56147546|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
56147547|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147548|NCT01215786|Timolol|timolol|mesh-list
56147549|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56147550|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56147551|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56147552|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56147553|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
56147554|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147555|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147556|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147557|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56657944|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657945|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657946|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56657947|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
56657948|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
56657949|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56657950|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657951|NCT04072900|Imiquimod|imiquimod|mesh-list
56657952|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56657953|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
56657954|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657955|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657956|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
56657957|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56657958|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56657959|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
56657960|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657961|NCT00984763|Antacids|antacids|mesh-ancestor
56657962|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147558|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56147559|NCT01216410|Phenylephrine|phenylephrine|mesh-list
56147560|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
56147561|NCT01216410|Ondansetron|ondansetron|mesh-list
56147562|NCT01216410|Metoclopramide|metoclopramide|mesh-list
56147563|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
56147564|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
56147565|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147566|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147567|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56147568|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
56147571|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
56147572|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147573|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147574|NCT01216410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56147575|NCT01216410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56147576|NCT01216410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147577|NCT01216410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56147578|NCT01216410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56147579|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56147580|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
56147581|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
56147582|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56147583|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
56147584|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
56147585|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56147586|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56147587|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56147588|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
56147589|NCT01216410|Protective Agents|protective agents|mesh-ancestor
55728298|NCT05235256|Lidocaine|lidocaine|mesh-list
56147590|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56147591|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56147592|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
56147593|NCT01218048|Carboplatin|carboplatin|mesh-list
56147594|NCT01218048|Cetuximab|cetuximab|mesh-list
56147595|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147596|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56657963|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56657964|NCT02578108|Lidocaine|lidocaine|mesh-list
56657965|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
56657966|NCT02578108|Anesthetics|anesthetics|mesh-list
56657967|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56657968|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56657969|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
56657970|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56657971|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56657972|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56657973|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56657974|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56304087|NCT00000752|Hormones|hormones|mesh-ancestor
56657975|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657976|NCT02776163|Docetaxel|docetaxel|mesh-list
56657977|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56657978|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
56657979|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
56657980|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
56657981|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657982|NCT05325346|Argatroban|argatroban|mesh-list
56657983|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
56657984|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56657985|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
56657986|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657987|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56657988|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
56657989|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56657990|NCT00984997|Etoposide|etoposide|mesh-list
56657991|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219765|NCT01652820|Antiviral Agents|antiviral agents|mesh-ancestor
56147597|NCT01218984|Naltrexone|naltrexone|mesh-list
56147598|NCT01218984|Hydromorphone|hydromorphone|mesh-list
56147599|NCT01218984|Naloxone|naloxone|mesh-list
56147600|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56175796|NCT01392014|Piperaquine|piperaquine|mesh-list
56147601|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56147602|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147603|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
56147604|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147605|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56147606|NCT01218984|Narcotics|narcotics|mesh-ancestor
56147607|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147608|NCT01218984|Analgesics|analgesics|mesh-ancestor
56147609|NCT01222260|Dexamethasone|dexamethasone|mesh-list
56657992|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56657993|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56657994|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56657995|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56657996|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147610|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56147611|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147612|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
56147613|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
56147614|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147615|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147616|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56147617|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
56147618|NCT01222260|Hormones|hormones|mesh-ancestor
56147619|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147620|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56147621|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147622|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56147623|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
56147624|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147625|NCT01222572|Etoposide|etoposide|mesh-list
56147626|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147627|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56147628|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56147629|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56147630|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147631|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147632|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56147633|NCT01222884|Hematinics|hematinics|mesh-ancestor
56147634|NCT01223352|Bosentan|bosentan|mesh-list
56147635|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56147636|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56147637|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147638|NCT01224210|Ambrisentan|ambrisentan|mesh-list
56147639|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56147640|NCT01224678|Vitamin D|vitamin d|mesh-list
56147641|NCT01224678|Vitamins|vitamins|mesh-ancestor
56147643|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147644|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56147646|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
56147647|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56147648|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56147649|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56147650|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147651|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147652|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147653|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56147654|NCT01225068|Analgesics|analgesics|mesh-ancestor
56147655|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
56147656|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147657|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
56147658|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56147659|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
56147660|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56147661|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56147662|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56147663|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56147664|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147665|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
56147666|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861962|NCT05701995|BMS-986165|bms-986165|mesh-list
56147667|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147668|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56147669|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147670|NCT01231230|Fluticasone|fluticasone|mesh-list
56147671|NCT01231230|Xhance|xhance|mesh-list
56147672|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56147673|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56147674|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147675|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56147676|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
56147677|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147678|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147679|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56147680|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
56147681|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
56147682|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56147683|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56147684|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56147685|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56147686|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
56147687|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147688|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147689|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
56147690|NCT01231230|Hormones|hormones|mesh-ancestor
56147691|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147692|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
56147693|NCT01232946|Insulin|insulin|mesh-list
56147694|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56147695|NCT01232946|Liraglutide|liraglutide|mesh-list
56147696|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
56147697|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56147698|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147699|NCT01232946|Incretins|incretins|mesh-ancestor
56147700|NCT01232946|Hormones|hormones|mesh-ancestor
56147701|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147702|NCT01235910|Cyclosporine|cyclosporine|mesh-list
56147703|NCT01235910|Cyclosporins|cyclosporins|mesh-list
56147704|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147705|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147706|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147707|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
56147708|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147709|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
56147710|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147711|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56147712|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56147713|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56147714|NCT01236378|Sirolimus|sirolimus|mesh-list
56147721|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
56147722|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147723|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
56147724|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
56147725|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
56147726|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56147727|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147728|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56147729|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56147730|NCT01238640|Nicotine|nicotine|mesh-list
56147731|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56147732|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
56147733|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147734|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147735|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56147736|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56147737|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
56147738|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147739|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147740|NCT01244724|Citalopram|citalopram|mesh-list
56147741|NCT01244724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56658026|NCT00973219|Interferons|interferons|mesh-list
56658027|NCT00973219|Tenofovir|tenofovir|mesh-list
56658028|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
56658029|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
56658030|NCT00973219|Adefovir|adefovir|mesh-list
56147742|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56147743|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56147744|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147745|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147747|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147748|NCT01244724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56147749|NCT01244724|Antidepressive Agents|antidepressive agents|mesh-ancestor
56147750|NCT01244724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56147751|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56147752|NCT01247220|Ranibizumab|ranibizumab|mesh-list
56147753|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56147754|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56147755|NCT01247220|Growth Substances|growth substances|mesh-ancestor
56147756|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147757|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
56147758|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147759|NCT01249872|Morphine|morphine|mesh-list
56147760|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
56147761|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56147762|NCT01249872|Narcotics|narcotics|mesh-ancestor
56147763|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147764|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147765|NCT01249872|Analgesics|analgesics|mesh-ancestor
56147766|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
56147767|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147768|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
56147769|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
56147770|NCT01250184|Lidocaine|lidocaine|mesh-list
56147771|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
56147772|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
56147773|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147774|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147775|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
56147776|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147777|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56147778|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56147779|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56147780|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56147781|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147782|NCT01250730|Crizotinib|crizotinib|mesh-list
56147783|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147795|NCT01253460|Rituximab|rituximab|mesh-list
56147796|NCT01253460|Sapacitabine|sapacitabine|mesh-list
56147797|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147798|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
56147799|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147800|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56147801|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56147802|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
56165351|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56658031|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56658032|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56658033|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658034|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
56658035|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658036|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56658037|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56658038|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658039|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658040|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56658041|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56658042|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
56658043|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658044|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
56658045|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56658046|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658047|NCT04973891|Metformin|metformin|mesh-list
56658048|NCT04973891|Canagliflozin|canagliflozin|mesh-list
56658049|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56658050|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304173|NCT00035581|Poly I-C|poly i-c|mesh-list
56547642|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
56658051|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56219830|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56147803|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147804|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147805|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56147806|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56147807|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
56147808|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
56147809|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56147810|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56147811|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147812|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147813|NCT01254396|Urological Agents|urological agents|mesh-ancestor
56147814|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56147815|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
56147816|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
56147817|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147820|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56147821|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56147822|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
56147823|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147824|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56147825|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56147826|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147827|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147828|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56658052|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658054|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
56658055|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658056|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
56658057|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
56658058|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
56658059|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147829|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56147830|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
56147831|NCT01262118|Tofacitinib|tofacitinib|mesh-list
56147832|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56147833|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147834|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147835|NCT01263132|Thiamine|thiamine|mesh-list
56147836|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
56147837|NCT01263132|Gabapentin|gabapentin|mesh-list
56147838|NCT01263132|Analgesics|analgesics|mesh-ancestor
56147839|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
56147840|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147841|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147842|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
56147843|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56147844|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56147845|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56147846|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56147849|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147850|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147852|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
56147853|NCT01263132|Vitamins|vitamins|mesh-ancestor
56147854|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
56147855|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56147856|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
56147857|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56147858|NCT01270542|Bevacizumab|bevacizumab|mesh-list
56147859|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56147860|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147861|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56147862|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56147863|NCT01270542|Growth Substances|growth substances|mesh-ancestor
56147864|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147865|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
56147866|NCT01271244|Citalopram|citalopram|mesh-list
56147867|NCT01271244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56147868|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56147869|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56147870|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147871|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147872|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
56147873|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147874|NCT01271244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56147875|NCT01271244|Antidepressive Agents|antidepressive agents|mesh-ancestor
56147876|NCT01271244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56147877|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
56147878|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56147879|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
56147880|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56147881|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147882|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56147883|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56147884|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56147885|NCT01275300|Aspirin|aspirin|mesh-list
56147886|NCT01275300|Niacin|niacin|mesh-list
56147887|NCT01275300|Niacinamide|niacinamide|mesh-list
56147888|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
56175803|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
56147889|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56147891|NCT01275300|Analgesics|analgesics|mesh-ancestor
56147892|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
56658060|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658061|NCT00983125|Clonidine|clonidine|mesh-list
56658062|NCT00983125|Analgesics|analgesics|mesh-ancestor
56219862|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147893|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147894|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147895|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147896|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56147897|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56147898|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56147899|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147900|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56147901|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56147902|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147903|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
56147904|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56147905|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
56147906|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56147907|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
56147908|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
56147909|NCT01275300|Vitamins|vitamins|mesh-ancestor
56147910|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
56147911|NCT01276314|Prednisolone|prednisolone|mesh-list
56147912|NCT01276314|Etanercept|etanercept|mesh-list
56147913|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147914|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
56147915|NCT01276314|Hormones|hormones|mesh-ancestor
56147916|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147917|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147918|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55757530|NCT03254849|Empagliflozin|empagliflozin|mesh-list
56147920|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147921|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56147922|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56147923|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56147925|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
56147926|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56147927|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147928|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
56147929|NCT01280058|Paclitaxel|paclitaxel|mesh-list
56147930|NCT01280058|Carboplatin|carboplatin|mesh-list
56147931|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56147932|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56147933|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147934|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
56147935|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
56147936|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
56147937|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147938|NCT01280604|Fenofibrate|fenofibrate|mesh-list
56147939|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56147940|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
56147941|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147942|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56147943|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56147944|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56147945|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56147946|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147947|NCT01285050|Tenofovir|tenofovir|mesh-list
56147948|NCT01285050|Emtricitabine|emtricitabine|mesh-list
56147949|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
56147950|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56147952|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147953|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56147954|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56147955|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147956|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147957|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56147958|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56147959|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56147960|NCT01286454|Fesoterodine|fesoterodine|mesh-list
56147961|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56147962|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56658063|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
56658064|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658065|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658066|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56658067|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
56658068|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
56658069|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56658070|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56658071|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56658072|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
56658073|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219864|NCT01653457|Memantine|memantine|mesh-list
56147963|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
56147964|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56147965|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147966|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147967|NCT01286454|Urological Agents|urological agents|mesh-ancestor
56147968|NCT01287078|Cyclosporine|cyclosporine|mesh-list
56147969|NCT01287078|Cyclosporins|cyclosporins|mesh-list
56147970|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147971|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147972|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147973|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
56147974|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147975|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
56147976|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147977|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
56147978|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56147979|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56147980|NCT01291056|Clomiphene|clomiphene|mesh-list
56147981|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56147982|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
56147983|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56147984|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147985|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56147986|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
56147987|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56147988|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56147989|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56147991|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56147992|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147994|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147996|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56147997|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
56147998|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
56147999|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56148000|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56148001|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56148002|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148003|NCT01294098|Bupivacaine|bupivacaine|mesh-list
56148004|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
56148005|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
56148006|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148007|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148008|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
56148009|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148010|NCT01295112|Dexamethasone|dexamethasone|mesh-list
56148011|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
56148012|NCT01295112|Bevacizumab|bevacizumab|mesh-list
56148013|NCT01295112|BB 1101|bb 1101|mesh-list
56148014|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658074|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658075|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
56658076|NCT00988039|Lopinavir|lopinavir|mesh-list
56658077|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56658078|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56658079|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
56658080|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658081|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56658082|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56658083|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658084|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658085|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56658086|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56658087|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
56148015|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148016|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56148017|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56148018|NCT01295112|Growth Substances|growth substances|mesh-ancestor
56148019|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148020|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
56175822|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
56148021|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148023|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
56148024|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148025|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56148026|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
56148027|NCT01295112|Hormones|hormones|mesh-ancestor
56148028|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148029|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56148030|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
56148031|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148032|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148033|NCT01301742|Empagliflozin|empagliflozin|mesh-list
56148034|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
56148035|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56148036|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148037|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56148038|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148039|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56148040|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
56148041|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56148042|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56148043|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56148044|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148045|NCT01304082|Lidocaine|lidocaine|mesh-list
56148046|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
56148047|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
56148048|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148049|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148050|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
56148051|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148052|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56148053|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56148054|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56148055|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56148056|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148058|NCT01304238|Lepirudin|lepirudin|mesh-list
56148059|NCT01304238|Danaparoid|danaparoid|mesh-list
56148060|NCT01304238|Fondaparinux|fondaparinux|mesh-list
56148061|NCT01304238|Argatroban|argatroban|mesh-list
56658088|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56658089|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56658090|NCT04855513|Metformin|metformin|mesh-list
56658091|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56658092|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658093|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
56658094|NCT02775773|Oxytocin|oxytocin|mesh-list
56658095|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
56658096|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56658097|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658098|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56658099|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56658100|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658101|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
56148062|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56148063|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
56148064|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56148065|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
56148066|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148067|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148069|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56148070|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56148071|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56148072|NCT01305252|Treprostinil|treprostinil|mesh-list
56148073|NCT01305252|Tadalafil|tadalafil|mesh-list
56148074|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
56148075|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56148076|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56148077|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148078|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148079|NCT01305252|Urological Agents|urological agents|mesh-ancestor
56148080|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56148081|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
56148082|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56148083|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56148084|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56148085|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56148086|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148087|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
56148088|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148089|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148090|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56148091|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148092|NCT01308294|Vaccines|vaccines|mesh-list
56148093|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56148094|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
56148095|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148096|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56148097|NCT01308840|Gemcitabine|gemcitabine|mesh-list
56148098|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
56148099|NCT01308840|Panitumumab|panitumumab|mesh-list
56148100|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56148101|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
56148102|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148103|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148104|NCT01308840|Antiviral Agents|antiviral agents|mesh-ancestor
56148105|NCT01308840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148106|NCT01308840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148107|NCT01308840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56148108|NCT01308840|Immunologic Factors|immunologic factors|mesh-ancestor
56148109|NCT01308840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658102|NCT02775773|Coagulants|coagulants|mesh-ancestor
56658103|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56658104|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
56658105|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56658106|NCT00988195|Doxorubicin|doxorubicin|mesh-list
56658107|NCT00988195|BCT-100|bct-100|mesh-list
56658108|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56658109|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658110|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56658111|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56658112|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658113|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658114|NCT00634985|Eletriptan|eletriptan|mesh-list
56658115|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56658116|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
56658117|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658118|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658119|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658120|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
56658121|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56658122|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56547643|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
56658123|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
56304309|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658124|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658125|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658126|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658127|NCT00985387|Urological Agents|urological agents|mesh-ancestor
56658128|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
56658129|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56658130|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
56148110|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56148111|NCT01311102|Lidocaine|lidocaine|mesh-list
56148112|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
56148113|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
56148114|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148115|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148116|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
56148117|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148118|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56148119|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56148120|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56148121|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56658131|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658132|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
56658133|NCT02776943|Protective Agents|protective agents|mesh-ancestor
56658134|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
56658135|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
56658136|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56148122|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148123|NCT01312038|Simethicone|simethicone|mesh-list
56148124|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
56148125|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148126|NCT01312038|Emollients|emollients|mesh-ancestor
56148127|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148128|NCT01312272|Oxytocin|oxytocin|mesh-list
56148129|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
56148130|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148131|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148132|NCT01312818|Dexamethasone|dexamethasone|mesh-list
56148133|NCT01312818|Methotrexate|methotrexate|mesh-list
56148134|NCT01312818|Bortezomib|bortezomib|mesh-list
56148135|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
56148136|NCT01312818|Vorinostat|vorinostat|mesh-list
56148137|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148138|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
56148139|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
56148140|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148141|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148145|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148147|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148148|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56148149|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
56148150|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148151|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56148152|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
56148153|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148154|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148155|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148156|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56148157|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56148158|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
56148159|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148160|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56148161|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56148162|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56148163|NCT01313520|Infliximab|infliximab|mesh-list
56148164|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148165|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56148166|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148167|NCT01315002|Nicotine|nicotine|mesh-list
56148168|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56148169|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
56148170|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148171|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148172|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56148173|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56148174|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
56148175|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148176|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148178|NCT01315158|Midazolam|midazolam|mesh-list
56148179|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
56148180|NCT01315158|Propofol|propofol|mesh-list
56148181|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56148182|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148183|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148184|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56148185|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
56148186|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
56148187|NCT01315158|Narcotics|narcotics|mesh-ancestor
56148188|NCT01315158|Analgesics|analgesics|mesh-ancestor
56148189|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
56148190|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148191|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56658137|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56658138|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658139|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658140|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658141|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56658142|NCT04654351|Icatibant|icatibant|mesh-list
56658143|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56658144|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56658145|NCT04654351|Analgesics|analgesics|mesh-ancestor
56658146|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
56658147|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658148|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658149|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56658150|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56658151|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56658152|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56658153|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658154|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56658155|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56148192|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56148193|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56148194|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56148195|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
56148196|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
56148197|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148198|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148199|NCT01318278|Dopamine|dopamine|mesh-list
56148200|NCT01318278|Vasopressins|vasopressins|mesh-list
56148201|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
56148202|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148203|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
56148204|NCT01318278|Coagulants|coagulants|mesh-ancestor
56148205|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56148206|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56148207|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
56148208|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56148209|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
56148210|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
56148211|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148212|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
56148213|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148214|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148215|NCT01318278|Protective Agents|protective agents|mesh-ancestor
56148219|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148220|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
56148221|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56148222|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56148223|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56148224|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148225|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148226|NCT01321554|Lenvatinib|lenvatinib|mesh-list
56148227|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148228|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56148229|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888748|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658156|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
56658157|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
56658158|NCT00582556|Leuprolide|leuprolide|mesh-list
56658159|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56658160|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658161|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56658162|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
56658163|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56658164|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56658165|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658166|NCT02776397|Vitamin E|vitamin e|mesh-list
56658167|NCT02776397|Tocopherols|tocopherols|mesh-list
56658168|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
56658169|NCT02776397|Vitamins|vitamins|mesh-ancestor
56658170|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
56658171|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658172|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
56658173|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658174|NCT02776397|Protective Agents|protective agents|mesh-ancestor
56658175|NCT00985777|Vitamin E|vitamin e|mesh-list
56658176|NCT00985777|Tocopherols|tocopherols|mesh-list
56658177|NCT00985777|Tocotrienols|tocotrienols|mesh-list
56658178|NCT00985777|Vitamins|vitamins|mesh-ancestor
56148230|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148232|NCT01324128|Sevelamer|sevelamer|mesh-list
56148233|NCT01324128|Trace Elements|trace elements|mesh-ancestor
56148234|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
56148235|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148236|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
56148237|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
56148238|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148239|NCT01328184|Empagliflozin|empagliflozin|mesh-list
56148240|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
56148241|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56148242|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56148243|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56148244|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56148245|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
56148246|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148247|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148248|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56148249|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56148250|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56148251|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56148252|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148253|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56148254|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56148255|NCT01328184|Estrogens|estrogens|mesh-ancestor
56148257|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148258|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56148259|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56148260|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56148261|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56658179|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
56658180|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658181|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
56658182|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658183|NCT00985777|Protective Agents|protective agents|mesh-ancestor
56658184|NCT01563601|Carboplatin|carboplatin|mesh-list
56658185|NCT01563601|Etoposide|etoposide|mesh-list
56658186|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
56658187|NCT01563601|Obatoclax|obatoclax|mesh-list
56658188|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658189|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56658190|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56658191|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56658192|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219974|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56219975|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
55795991|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55863438|NCT05574712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863439|NCT05574712|Hormone Antagonists|hormone antagonists|mesh-ancestor
55863440|NCT05574712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863441|NCT05574712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55863442|NCT01783015|Etanercept|etanercept|mesh-list
55863443|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55863478|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55863479|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55863480|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55863481|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863482|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55863582|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56148262|NCT01328964|Fluticasone|fluticasone|mesh-list
56148263|NCT01328964|Xhance|xhance|mesh-list
56148264|NCT01328964|Budesonide|budesonide|mesh-list
56148265|NCT01328964|Montelukast|montelukast|mesh-list
56148266|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148267|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56148268|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
56148269|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148270|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148271|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56148272|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
56148273|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148274|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56148275|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
56148276|NCT01328964|Hormones|hormones|mesh-ancestor
56658193|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658194|NCT00988507|Artesunate|artesunate|mesh-list
56658195|NCT00988507|Ferroquine|ferroquine|mesh-list
56658196|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
56658197|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56658198|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56658199|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658200|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658201|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
56658202|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
56658203|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56658204|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
56658205|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
56658206|NCT03131908|GSK2636771|gsk2636771|mesh-list
56658207|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658208|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658209|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56219976|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219977|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219978|NCT01654211|Ritonavir|ritonavir|mesh-list
56219979|NCT01654211|Lactams|lactams|mesh-list
56219980|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56219981|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56219982|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
56219983|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219984|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219985|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56219986|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56219987|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
56219988|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795993|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56148277|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148278|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56148279|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
56148280|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56148281|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56148282|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148283|NCT01330134|Lidocaine|lidocaine|mesh-list
56148284|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
56148285|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
56148286|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148287|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148289|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658210|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658211|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658212|NCT00985855|Etoposide|etoposide|mesh-list
56658213|NCT00985855|Cetuximab|cetuximab|mesh-list
56658214|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658215|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56658216|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56658217|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56658218|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219989|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55796008|NCT05700617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55785679|NCT05737693|Anesthetics, General|anesthetics, general|mesh-ancestor
55785680|NCT05737693|Anesthetics|anesthetics|mesh-ancestor
55785681|NCT05737693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785682|NCT05737693|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55785683|NCT05737693|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55785684|NCT05737693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148290|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56148291|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56148292|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56148293|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56148294|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148295|NCT01330290|Rotigotine|rotigotine|mesh-list
56148296|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
56148297|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
56148298|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148299|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148300|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148301|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56148302|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
56148303|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56148304|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56148305|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56148306|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148307|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148308|NCT01331694|Fluticasone|fluticasone|mesh-list
56148309|NCT01331694|Bromides|bromides|mesh-list
56148310|NCT01331694|Albuterol|albuterol|mesh-list
56148311|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
56148312|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56148313|NCT01331694|Ipratropium|ipratropium|mesh-list
56148314|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56175832|NCT01392209|Bevacizumab|bevacizumab|mesh-list
56148315|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148316|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56148317|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
56148318|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148319|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148320|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56148321|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
56148322|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148323|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56148324|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
56148325|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56148326|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
56148327|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148328|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658219|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658220|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658221|NCT04226105|Insulin|insulin|mesh-list
56658222|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56658223|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
56658224|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
56658225|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56658226|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56219990|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56219991|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56219992|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
56219993|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56219994|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56219995|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219996|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56219997|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796010|NCT05700617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148329|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56148330|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56148331|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56148332|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
56148334|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
56148335|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148336|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
56148337|NCT01331694|Hormones|hormones|mesh-ancestor
56148338|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148339|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
56148340|NCT01333098|Mifepristone|mifepristone|mesh-list
56148341|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56148342|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
56148343|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148344|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148345|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56148346|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56148347|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56148348|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
56148349|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56148350|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56148351|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
56148352|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148353|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
56148354|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56148355|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56148356|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
56148357|NCT01333488|Analgesics|analgesics|mesh-ancestor
56148358|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
56148359|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148360|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148364|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
56148365|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56148366|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56148367|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148368|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56658227|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56658228|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658229|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
56658230|NCT03092518|Mitomycins|mitomycins|mesh-list
56658231|NCT03092518|Mitomycin|mitomycin|mesh-list
56658232|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658233|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56658234|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
56658235|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658236|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56658237|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658238|NCT03092518|Antidotes|antidotes|mesh-ancestor
56658239|NCT03092518|Protective Agents|protective agents|mesh-ancestor
56658240|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658241|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
56658242|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
56219998|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219999|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56220000|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
56220001|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220002|NCT01654497|HU 211|hu 211|mesh-list
56220003|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56220004|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
56220005|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
56220006|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220007|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220008|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220009|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55796018|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56148369|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
56148370|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148371|NCT01335204|Bavituximab|bavituximab|mesh-list
56148372|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56148373|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148374|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56148375|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
56148376|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56148377|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148378|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56148379|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
56148380|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56148381|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148382|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148383|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148384|NCT01337700|Milnacipran|milnacipran|mesh-list
56658243|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56658244|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658245|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
56658246|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
56658247|NCT02776865|Lidocaine|lidocaine|mesh-list
56658248|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
56658249|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
56658250|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658251|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220010|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56220011|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220012|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220013|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56220014|NCT01654497|Protective Agents|protective agents|mesh-ancestor
56220015|NCT01654562|Simvastatin|simvastatin|mesh-list
56220016|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56220017|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56148386|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56148387|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56148388|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56148389|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148390|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148391|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148392|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56148393|NCT01337700|Analgesics|analgesics|mesh-ancestor
56148394|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
56148395|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148396|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
56148397|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56148398|NCT01339260|Dexamethasone|dexamethasone|mesh-list
56148399|NCT01339260|Palonosetron|palonosetron|mesh-list
56148400|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148401|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
56148402|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
56148403|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148404|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148405|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56148406|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
56148407|NCT01339260|Hormones|hormones|mesh-ancestor
56148408|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658252|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
56658253|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658254|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56658255|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56658256|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56658257|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56148409|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56148410|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148411|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56148412|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56148413|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
56148414|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148415|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148416|NCT01340586|Apixaban|apixaban|mesh-list
56148417|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56148418|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
56148419|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56148420|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
56148421|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148422|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148423|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
56148424|NCT01342770|Pioglitazone|pioglitazone|mesh-list
56148425|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56148426|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148427|NCT01343004|Teriparatide|teriparatide|mesh-list
56148428|NCT01343004|Abaloparatide|abaloparatide|mesh-list
56148429|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56148430|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148431|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56148434|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56148435|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148436|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56148437|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
56148438|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148439|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148440|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56148441|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
56148442|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148443|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56148444|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56148445|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56148446|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56148447|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
56148448|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175836|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56148449|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148450|NCT01351740|Ritonavir|ritonavir|mesh-list
56148451|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56148452|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56148453|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56148454|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
56148455|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148456|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148457|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56148458|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56148459|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
56148460|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148461|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56148462|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56148463|NCT01353144|Aspirin|aspirin|mesh-list
56148464|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56148465|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56148466|NCT01353144|Analgesics|analgesics|mesh-ancestor
56148467|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
56148468|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148469|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148470|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56658258|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658259|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56658260|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
56148471|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148472|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56148473|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56148474|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148475|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56148476|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56148477|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148478|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
56148479|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
56148480|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56148481|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56148482|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148483|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
56148484|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148485|NCT01363050|Ketorolac|ketorolac|mesh-list
56148486|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56148487|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56148488|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56148489|NCT01363050|Analgesics|analgesics|mesh-ancestor
56148490|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
56148491|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148492|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148493|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148494|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148495|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56148496|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148497|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148498|NCT01363128|Cytarabine|cytarabine|mesh-list
56148499|NCT01363128|Dexamethasone|dexamethasone|mesh-list
56148500|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
56148501|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
56148502|NCT01363128|Doxorubicin|doxorubicin|mesh-list
56148503|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56148504|NCT01363128|Methotrexate|methotrexate|mesh-list
56148505|NCT01363128|Vincristine|vincristine|mesh-list
56148509|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56148511|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148512|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148513|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56148514|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
56148515|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148516|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148517|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56148518|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148519|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
56148520|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
56148521|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148522|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56148523|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
56148524|NCT01363128|Hormones|hormones|mesh-ancestor
56148525|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148526|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56148527|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56148528|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56148529|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56148530|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148531|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56148532|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
56148533|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148534|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56148535|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
56148536|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148537|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56148538|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56148539|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
56148540|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148541|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56148542|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
55729256|NCT03514667|Curcumin|curcumin|mesh-list
56658261|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658262|NCT00542269|Amlodipine|amlodipine|mesh-list
56658263|NCT00542269|Ramipril|ramipril|mesh-list
56658264|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56658265|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56658266|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56658267|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658268|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56658269|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658270|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
56658271|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56658272|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
56304383|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56658273|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658275|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56658276|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56658277|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658278|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658279|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56658280|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56658281|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56658282|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56658283|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
56658284|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
56658285|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
56658286|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
56658287|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658288|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658289|NCT00542191|Paclitaxel|paclitaxel|mesh-list
56658290|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
56658291|NCT00542191|Carboplatin|carboplatin|mesh-list
56148543|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
56148544|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
56148545|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
56148547|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56148548|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56148549|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56148550|NCT01365624|Analgesics|analgesics|mesh-ancestor
56148551|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
56148552|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148553|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148554|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148555|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148556|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56658292|NCT00542191|Doxorubicin|doxorubicin|mesh-list
56658293|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56658294|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658295|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
56658296|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
56658297|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
56658298|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658299|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56658300|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
56658301|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658302|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56658303|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56658304|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
56658305|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56658306|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56658307|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56658308|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56658309|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658310|NCT00600938|Deferasirox|deferasirox|mesh-list
56658311|NCT00600938|Deferoxamine|deferoxamine|mesh-list
56658312|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56658313|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
56658314|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
56658315|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658316|NCT00600938|Siderophores|siderophores|mesh-ancestor
56658317|NCT03061474|Niacinamide|niacinamide|mesh-list
56148557|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148558|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148559|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
56148560|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56148561|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56148562|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148563|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
56148564|NCT01370460|Coagulants|coagulants|mesh-ancestor
56148565|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
56148566|NCT01371786|Ciclesonide|ciclesonide|mesh-list
56148567|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148568|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148569|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56148570|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
56148571|NCT01371786|Hormones|hormones|mesh-ancestor
56148572|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148573|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148574|NCT01375140|Prednisone|prednisone|mesh-list
56148575|NCT01375140|Lenalidomide|lenalidomide|mesh-list
56148576|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148577|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
56148578|NCT01375140|Hormones|hormones|mesh-ancestor
56148580|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888749|NCT01886872|Rituximab|rituximab|mesh-list
56658318|NCT03061474|Niacin|niacin|mesh-list
56658319|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
56658320|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
56658321|NCT03061474|Vitamins|vitamins|mesh-ancestor
56658322|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
56658323|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148581|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56148582|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148583|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
56148584|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56148585|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56148586|NCT01375140|Growth Substances|growth substances|mesh-ancestor
56148587|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
56148588|NCT01377636|Isoproterenol|isoproterenol|mesh-list
56148589|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56148590|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56148591|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
56148592|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148593|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148594|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148595|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56148596|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
56148597|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148598|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56148599|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
56148600|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56148601|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
56148602|NCT01377636|Protective Agents|protective agents|mesh-ancestor
56148604|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56148605|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
56148606|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148607|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148608|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148609|NCT01379664|Sevoflurane|sevoflurane|mesh-list
56148610|NCT01379664|Isoflurane|isoflurane|mesh-list
56148611|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56148612|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56148613|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
56148614|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
56148615|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148616|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148617|NCT01380366|Hormones|hormones|mesh-list
56148618|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148619|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148620|NCT01387464|Bromfenac|bromfenac|mesh-list
56148621|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56148622|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56148623|NCT01387464|Analgesics|analgesics|mesh-ancestor
56148624|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
56148625|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148626|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148627|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148628|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148629|NCT01388946|Ropivacaine|ropivacaine|mesh-list
56148630|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
56148631|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
56148632|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148633|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148634|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
56148635|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148636|NCT01390818|Niacinamide|niacinamide|mesh-list
56148637|NCT01390818|Sirolimus|sirolimus|mesh-list
56148638|NCT01390818|Elafin|elafin|mesh-list
56148639|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
56148640|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148641|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148642|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
56148643|NCT01390818|Vitamins|vitamins|mesh-ancestor
56148644|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
56148645|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148646|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56658324|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56658325|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
56658326|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658327|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56148647|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148648|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56148649|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148650|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
56148651|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56148657|NCT01393392|Methadone|methadone|mesh-list
56148658|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56148659|NCT01393392|Narcotics|narcotics|mesh-ancestor
56148660|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148661|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148662|NCT01393392|Analgesics|analgesics|mesh-ancestor
56148663|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
56148664|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148665|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
56148666|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
56148667|NCT01393704|Vasopressins|vasopressins|mesh-list
56148668|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
56148669|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
56148670|NCT01393704|Coagulants|coagulants|mesh-ancestor
56148671|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56148672|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56148673|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
56148674|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148675|NCT01399008|Colchicine|colchicine|mesh-list
56148676|NCT01399008|Allopurinol|allopurinol|mesh-list
56148677|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
56148678|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148679|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56148680|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56148681|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56148682|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148683|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148684|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
56148685|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148686|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56148687|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
56148688|NCT01399008|Protective Agents|protective agents|mesh-ancestor
56148689|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148690|NCT01399866|Cycloserine|cycloserine|mesh-list
56148691|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56148692|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148693|NCT01399866|Renal Agents|renal agents|mesh-ancestor
56148694|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56148695|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
56148696|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56148697|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
56148698|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148699|NCT01402050|Dinoprostone|dinoprostone|mesh-list
56148700|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
56148701|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148702|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148703|NCT01403376|Interferons|interferons|mesh-list
56148704|NCT01403376|Interferon-beta|interferon-beta|mesh-list
56148705|NCT01403376|Teriflunomide|teriflunomide|mesh-list
56148706|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
56148707|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148708|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
56148709|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148710|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56148711|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56148712|NCT01403376|Analgesics|analgesics|mesh-ancestor
56148713|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
56148714|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148715|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148716|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148717|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148718|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56148719|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
56148720|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56148721|NCT01404936|Interferons|interferons|mesh-list
56658328|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
56658329|NCT00988663|Memantine|memantine|mesh-list
56658330|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56658331|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56658332|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
56658333|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658334|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658335|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658336|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56658337|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56658338|NCT03006172|Metformin|metformin|mesh-list
56658339|NCT03006172|Trastuzumab|trastuzumab|mesh-list
56658340|NCT03006172|Pertuzumab|pertuzumab|mesh-list
56658341|NCT03006172|Letrozole|letrozole|mesh-list
56658342|NCT03006172|Fulvestrant|fulvestrant|mesh-list
56658343|NCT03006172|Palbociclib|palbociclib|mesh-list
56658344|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56304457|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56658345|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658346|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658347|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658348|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56658349|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56658350|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658351|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148722|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
56148723|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
56148724|NCT01404936|Doxorubicin|doxorubicin|mesh-list
56148725|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56148730|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148731|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56148732|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56148733|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148734|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148735|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
56076386|NCT04832100|Imipramine|imipramine|mesh-list
56148736|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148737|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
56148738|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148739|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56148740|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
56148741|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56148742|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
56148743|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
56148744|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
56148745|NCT01410084|Vitamin D|vitamin d|mesh-list
56148746|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
56148747|NCT01410084|Vitamins|vitamins|mesh-list
56148748|NCT01410084|Vitamin E|vitamin e|mesh-list
56148749|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
56148750|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148751|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56148752|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56658352|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56658353|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
56658354|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658355|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56658356|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56658357|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56658358|NCT04072198|Leucovorin|leucovorin|mesh-list
56658359|NCT04072198|Bevacizumab|bevacizumab|mesh-list
56658360|NCT04072198|Nivolumab|nivolumab|mesh-list
56658361|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
56658362|NCT04072198|Irinotecan|irinotecan|mesh-list
56658363|NCT04072198|Fluorouracil|fluorouracil|mesh-list
56658364|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658365|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658366|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56658367|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56658368|NCT04072198|Growth Substances|growth substances|mesh-ancestor
56658369|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658370|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
56658371|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56658372|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658373|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56658374|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56220114|NCT01655095|Prucalopride|prucalopride|mesh-list
56148754|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148755|NCT01410084|Protective Agents|protective agents|mesh-ancestor
56148756|NCT01413516|Varenicline|varenicline|mesh-list
56148757|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56148758|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56148759|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
56148760|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148761|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148762|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148763|NCT01413750|Paclitaxel|paclitaxel|mesh-list
56148764|NCT01413750|Carboplatin|carboplatin|mesh-list
56148765|NCT01413750|Vorinostat|vorinostat|mesh-list
56148766|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56148767|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148768|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
56148769|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
56148770|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
56148771|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148772|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56148773|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148774|NCT01417026|Oxytocin|oxytocin|mesh-list
56148775|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
56148776|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148777|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148778|NCT01420146|Trastuzumab|trastuzumab|mesh-list
56148779|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658375|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658376|NCT04072198|Antidotes|antidotes|mesh-ancestor
56658377|NCT04072198|Protective Agents|protective agents|mesh-ancestor
56658378|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
56658379|NCT04072198|Vitamins|vitamins|mesh-ancestor
56658380|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
56658381|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
56658382|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56658383|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56658384|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
56658385|NCT02772419|Benralizumab|benralizumab|mesh-list
56148780|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148781|NCT01421472|Paclitaxel|paclitaxel|mesh-list
56148782|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56148783|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148784|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56148785|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56148786|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56148787|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148788|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56148789|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56148790|NCT01428336|Cosyntropin|cosyntropin|mesh-list
56148791|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
56148792|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148793|NCT01428336|Hormones|hormones|mesh-ancestor
56148794|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148795|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148796|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148797|NCT01429272|Aspirin|aspirin|mesh-list
56148798|NCT01429272|Minocycline|minocycline|mesh-list
56148800|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56148801|NCT01429272|Analgesics|analgesics|mesh-ancestor
56148802|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
56148803|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148804|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148805|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148806|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148807|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56148808|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56148809|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148810|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56148811|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56148812|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148813|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
56148814|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56148815|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148817|NCT01429350|Plasminogen|plasminogen|mesh-list
56148818|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56148819|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56148820|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148821|NCT01432236|Pregabalin|pregabalin|mesh-list
56148822|NCT01432236|Analgesics|analgesics|mesh-ancestor
56148823|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
56148824|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148825|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148826|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
56148827|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56148828|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56148829|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148830|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56148831|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56148832|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56148833|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148834|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56148835|NCT01434186|Metformin|metformin|mesh-list
56148836|NCT01434186|Saxagliptin|saxagliptin|mesh-list
56658386|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56658387|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
56658388|NCT00543439|Factor VIII|factor viii|mesh-list
56658389|NCT00543439|Coagulants|coagulants|mesh-ancestor
56658390|NCT02772497|Aflibercept|aflibercept|mesh-list
56658391|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56658392|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56148837|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56148838|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148839|NCT01434186|Incretins|incretins|mesh-ancestor
56148840|NCT01434186|Hormones|hormones|mesh-ancestor
56148841|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56148842|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56148843|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
56148844|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148845|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148846|NCT01434342|Nicotine|nicotine|mesh-list
56148847|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56148848|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
56148849|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148850|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148851|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56148852|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56148853|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
56148854|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148855|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148856|NCT01435824|Amoxicillin|amoxicillin|mesh-list
56148857|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56148858|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148859|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
56148860|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56148861|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
56148862|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56148863|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
56148864|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148865|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148866|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
56148867|NCT01438710|Tacrolimus|tacrolimus|mesh-list
56148868|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56148869|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
56148870|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148871|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56148872|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148874|NCT01443546|Leuprolide|leuprolide|mesh-list
56148875|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56148876|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
56148877|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148878|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148879|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56148880|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148881|NCT01444716|Ofatumumab|ofatumumab|mesh-list
56148882|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56148883|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148884|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
56148885|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148886|NCT01445028|Isotretinoin|isotretinoin|mesh-list
56148887|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148888|NCT01452126|Ropivacaine|ropivacaine|mesh-list
56148889|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
56148890|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
56148891|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148892|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148893|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
56148894|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56148895|NCT01457430|Icatibant|icatibant|mesh-list
56148896|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56148897|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56148898|NCT01457430|Analgesics|analgesics|mesh-ancestor
56148899|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
56148900|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658393|NCT02772497|Growth Substances|growth substances|mesh-ancestor
56658394|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658395|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
56658396|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658397|NCT00582166|Rituximab|rituximab|mesh-list
56658398|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56658399|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658400|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658401|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
56658402|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658403|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56658404|NCT02775539|Mirabegron|mirabegron|mesh-list
56658405|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56658406|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56658407|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56658408|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
56658409|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658410|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658411|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658412|NCT02775539|Urological Agents|urological agents|mesh-ancestor
56658413|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
56658414|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
56658415|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658416|NCT04666961|Tamoxifen|tamoxifen|mesh-list
56658417|NCT04666961|Anastrozole|anastrozole|mesh-list
56658418|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56658419|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
56658420|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658421|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148901|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148902|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56148903|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56148904|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56148905|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56148906|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148907|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56148908|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56148909|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
56148910|NCT01458990|Omeprazole|omeprazole|mesh-list
56148911|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56148912|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56148913|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56148914|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148915|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148916|NCT01460940|Lenalidomide|lenalidomide|mesh-list
56658422|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56658423|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658424|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56658425|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56658426|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56658427|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56658428|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56658429|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658430|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658431|NCT04006639|Analgesics|analgesics|mesh-list
56658432|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
56658433|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658434|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658435|NCT00601172|Dexamethasone|dexamethasone|mesh-list
56658436|NCT00601172|Ondansetron|ondansetron|mesh-list
56658437|NCT00601172|Casopitant|casopitant|mesh-list
56658438|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56658439|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
56658440|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
56658441|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658442|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148917|NCT01460940|Panobinostat|panobinostat|mesh-list
56148918|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56148919|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
56148920|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148921|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56148922|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56148923|NCT01460940|Growth Substances|growth substances|mesh-ancestor
56148924|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
56148925|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148926|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148927|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148928|NCT01462812|Sumatriptan|sumatriptan|mesh-list
56148929|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56148930|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56148931|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56148932|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
56148933|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56148934|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148935|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148936|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56148937|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
56148938|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56148939|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56148940|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56148941|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
56148942|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148943|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148944|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56148949|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56148950|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
56148951|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56148952|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
56658443|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56658444|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
56658445|NCT00601172|Hormones|hormones|mesh-ancestor
56658446|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220191|NCT01655316|Verapamil|verapamil|mesh-list
56148953|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56148954|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148955|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56148956|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56148957|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56148958|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
56148959|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56148960|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56148961|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148962|NCT01468584|Ribavirin|ribavirin|mesh-list
56148963|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56148964|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
56148965|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148966|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
56148967|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148969|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
56148970|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
56148971|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148972|NCT01474122|Macitentan|macitentan|mesh-list
56148973|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56148974|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56148975|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148976|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56148977|NCT01474200|Furosemide|furosemide|mesh-list
56148978|NCT01474200|Diuretics|diuretics|mesh-list
56148979|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56148980|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
56148981|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148982|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56148983|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148984|NCT01474590|Doxycycline|doxycycline|mesh-list
56148985|NCT01474590|Isotretinoin|isotretinoin|mesh-list
56148986|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56148987|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56148988|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
56148989|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56148990|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56148991|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
56148992|NCT01477320|Pantoprazole|pantoprazole|mesh-list
56148993|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56148994|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56148995|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56148996|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56148997|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148998|NCT01478256|Erythromycin|erythromycin|mesh-list
56148999|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
56149000|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56149001|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
56149002|NCT01478256|Besifloxacin|besifloxacin|mesh-list
56149003|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56149004|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149005|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56149006|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56149007|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149008|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149009|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56149010|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56149011|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149012|NCT01479270|Epinephrine|epinephrine|mesh-list
56149013|NCT01479270|Ropivacaine|ropivacaine|mesh-list
56149014|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
56149015|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
56149018|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
56149019|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658447|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56658448|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658449|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
56658450|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
56658451|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56658452|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
56658453|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658454|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658455|NCT00601172|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56658456|NCT00601172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56658457|NCT00601172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658458|NCT00601172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56149020|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56149021|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56149022|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149023|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149024|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149025|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56149026|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56149027|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
56149028|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56149029|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149030|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
56149031|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
56149032|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56149033|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
56149034|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
56149035|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149036|NCT01483560|Metformin|metformin|mesh-list
56149037|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56149038|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149039|NCT01484340|Nicotine|nicotine|mesh-list
56149040|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56149041|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
56149042|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149043|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149044|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56149045|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56149046|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
56149047|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149048|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149049|NCT01485588|Immunoconjugates|immunoconjugates|mesh-list
56149050|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
56149051|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149052|NCT01488318|Cetuximab|cetuximab|mesh-list
56149053|NCT01488318|Dasatinib|dasatinib|mesh-list
56149054|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56149055|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149056|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56149057|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149058|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149059|NCT01495572|Aldesleukin|aldesleukin|mesh-list
56149060|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
56149061|NCT01495572|Fludarabine|fludarabine|mesh-list
56149062|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56149063|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
56149064|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149065|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56149066|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56149067|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
56149068|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149069|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149070|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56658459|NCT00601172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56658460|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56149071|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56149072|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56149073|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
56149074|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149075|NCT01504854|Resveratrol|resveratrol|mesh-list
56149076|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
56149077|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149078|NCT01504854|Protective Agents|protective agents|mesh-ancestor
56149079|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149080|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149081|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56149082|NCT01508832|Lidocaine|lidocaine|mesh-list
56149083|NCT01508832|Bupivacaine|bupivacaine|mesh-list
56149084|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
56149085|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
56149086|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149087|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149088|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
56149091|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56149092|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56149093|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149094|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149096|NCT01511640|Analgesics|analgesics|mesh-ancestor
56149097|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
56149098|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149099|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149100|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
56149101|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56149102|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149103|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149104|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56149105|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56149106|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56149107|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149108|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56076759|NCT05289804|Lidocaine|lidocaine|mesh-list
56149109|NCT01513122|Ritonavir|ritonavir|mesh-list
56149110|NCT01513122|Lopinavir|lopinavir|mesh-list
56149111|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
56149112|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56149113|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56149114|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
56149115|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149116|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149117|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56149118|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56149119|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
56149120|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149121|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56149122|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56149123|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56149124|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56149125|NCT01513902|Tofacitinib|tofacitinib|mesh-list
56149126|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56149127|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149128|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149129|NCT01515540|Lidocaine|lidocaine|mesh-list
56149130|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
56149131|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
56149132|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149133|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149134|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
56149135|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149136|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56149137|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56149138|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56149139|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149140|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149141|NCT01519284|Levodopa|levodopa|mesh-list
56658461|NCT02772107|Temozolomide|temozolomide|mesh-list
56658462|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56658463|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
56220206|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149142|NCT01519284|Carbidopa|carbidopa|mesh-list
56149143|NCT01519284|Opicapone|opicapone|mesh-list
56149144|NCT01519284|Entacapone|entacapone|mesh-list
56149145|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56149146|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56149147|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
56149148|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149149|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149150|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149151|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56149152|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149153|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56149154|NCT01520454|Heparin|heparin|mesh-list
56149155|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56149156|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
56149157|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56149158|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56149190|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
56149191|NCT01523496|Calcifediol|calcifediol|mesh-list
56149192|NCT01523496|Vitamins|vitamins|mesh-list
56149193|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
56149194|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149195|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56149196|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56149197|NCT01526538|Cycloserine|cycloserine|mesh-list
56149198|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56149199|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149200|NCT01526538|Renal Agents|renal agents|mesh-ancestor
56149201|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56149202|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
56149205|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149207|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56149208|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
56149209|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149210|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149211|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56149212|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149214|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
56149215|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149216|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149217|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56149218|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
56149219|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
56149220|NCT01529502|Protective Agents|protective agents|mesh-ancestor
56149221|NCT01532700|Ofatumumab|ofatumumab|mesh-list
56149222|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149223|NCT01533948|Axitinib|axitinib|mesh-list
56149224|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149225|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56149226|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149227|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149228|NCT01534416|Bupivacaine|bupivacaine|mesh-list
56149229|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
56149230|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
56149231|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149232|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149233|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
56149234|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149235|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
56149236|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56149237|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149238|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149239|NCT01535976|Ketamine|ketamine|mesh-list
56149240|NCT01535976|Analgesics|analgesics|mesh-ancestor
56149241|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
56149242|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149243|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658464|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658465|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658466|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56658467|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
56658468|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56658469|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56658470|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56658471|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658472|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658473|NCT00988897|Leucovorin|leucovorin|mesh-list
56658474|NCT00988897|Bevacizumab|bevacizumab|mesh-list
56149244|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56149245|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56149246|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
56149248|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149249|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56149250|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56149251|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149252|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149253|NCT01536366|Repaglinide|repaglinide|mesh-list
56149254|NCT01536366|Opicapone|opicapone|mesh-list
56149255|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56149256|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149257|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56149258|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149259|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149260|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56149261|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56149262|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
56149263|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56149264|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
56149265|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149266|NCT01537926|Expectorants|expectorants|mesh-ancestor
56149267|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149268|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56149269|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
56149270|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149271|NCT01537926|Protective Agents|protective agents|mesh-ancestor
56149272|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149273|NCT01537926|Antidotes|antidotes|mesh-ancestor
56149274|NCT01538862|Lenograstim|lenograstim|mesh-list
56149275|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56149276|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
56165352|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
56149287|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56149288|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56149289|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56149290|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56149291|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149292|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149293|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149294|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149295|NCT01542684|Azacitidine|azacitidine|mesh-list
56149296|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56149297|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
56149298|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149299|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149300|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149301|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
56149302|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
56149303|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149304|NCT01543074|Protective Agents|protective agents|mesh-ancestor
55924003|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658475|NCT00988897|Fluorouracil|fluorouracil|mesh-list
56658476|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
56658477|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658478|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658479|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56658480|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56658481|NCT00988897|Growth Substances|growth substances|mesh-ancestor
56658482|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658483|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
56658484|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
56658485|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220218|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149305|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149306|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56149307|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149308|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56149309|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149310|NCT01545336|Anastrozole|anastrozole|mesh-list
56149311|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56149312|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149313|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56149314|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56149315|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149316|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149317|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56149318|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
56149319|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56149320|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149321|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
56149322|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56149323|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
56149324|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149325|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149326|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
56149327|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56149328|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
56149329|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149330|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149331|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56149332|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149333|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56149334|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56149335|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56149336|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149337|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149338|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149339|NCT01553058|Adalimumab|adalimumab|mesh-list
56149342|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56149343|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149345|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
56149346|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
56149347|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149348|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149349|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
56149350|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149351|NCT01558128|Amiodarone|amiodarone|mesh-list
56149352|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56149353|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
56149354|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56149355|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55924005|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
56658486|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56658487|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56658488|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
56658489|NCT00988897|Antidotes|antidotes|mesh-ancestor
56658490|NCT00988897|Protective Agents|protective agents|mesh-ancestor
56658491|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
56658492|NCT00988897|Vitamins|vitamins|mesh-ancestor
56658493|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
56658494|NCT01697566|Metformin|metformin|mesh-list
56658495|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56658496|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658497|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
56658498|NCT02775227|Pasireotide|pasireotide|mesh-list
56658499|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56658500|NCT02775227|Hormones|hormones|mesh-ancestor
56658501|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658502|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658503|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
56149356|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149357|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56149358|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56149359|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56149360|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149361|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56149362|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56149363|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56149364|NCT01559064|Lidocaine|lidocaine|mesh-list
56149365|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
56149366|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
56149367|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
56149368|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149369|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149370|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
56149371|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149372|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56149373|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56149374|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56149375|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149376|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149377|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56149378|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
56149379|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
56149380|NCT01559064|Protective Agents|protective agents|mesh-ancestor
56149381|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56149382|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
56149383|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56149384|NCT01559922|Protective Agents|protective agents|mesh-ancestor
56149385|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175874|NCT01392430|Renal Agents|renal agents|mesh-ancestor
56149386|NCT01560624|Treprostinil|treprostinil|mesh-list
56149387|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56149388|NCT01562886|Rilpivirine|rilpivirine|mesh-list
56149389|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56149390|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56149391|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149392|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149393|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
56658504|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658505|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658506|NCT00984217|Panitumumab|panitumumab|mesh-list
56658507|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658508|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149394|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149395|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56149396|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56149397|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56149398|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149399|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149400|NCT01564914|Bevacizumab|bevacizumab|mesh-list
56149401|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56149402|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149403|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56149404|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56149405|NCT01564914|Growth Substances|growth substances|mesh-ancestor
56149406|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149407|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
56149409|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56149410|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149413|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56149414|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56149415|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56149416|NCT01565616|Fludarabine|fludarabine|mesh-list
56149417|NCT01565616|Busulfan|busulfan|mesh-list
56149418|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
56149419|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56149420|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149421|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149422|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56149423|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
56149424|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149425|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
56149426|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56149427|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56149428|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56149429|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56149430|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56149431|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149432|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149433|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56149434|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56149435|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56149436|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56149437|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149438|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149439|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149440|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56149441|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56149442|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
56149443|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56149444|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56149445|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
56149446|NCT01569126|Fluoxetine|fluoxetine|mesh-list
56149447|NCT01569126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56149448|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56149449|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149450|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149451|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149452|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
56149453|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149454|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56149455|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
56149456|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56175876|NCT01392534|Telmisartan|telmisartan|mesh-list
56149457|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56658509|NCT00989053|Citalopram|citalopram|mesh-list
56658510|NCT00989053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56658511|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56658512|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56658513|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658514|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658515|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
56658516|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658517|NCT00989053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56658518|NCT00989053|Antidepressive Agents|antidepressive agents|mesh-ancestor
56658519|NCT00989053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56658520|NCT04614493|Temozolomide|temozolomide|mesh-list
56658521|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56658522|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
56149458|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56149459|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149460|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56149461|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56149462|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149464|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
56149465|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56149466|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149467|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149468|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56149469|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56149470|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56149472|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
56149473|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149474|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149475|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56149476|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56149477|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56149478|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149479|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
56149480|NCT01580592|Omalizumab|omalizumab|mesh-list
56149483|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56149484|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149485|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
56149486|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149487|NCT01588158|Acetaminophen|acetaminophen|mesh-list
56149488|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56149489|NCT01588158|Hydrocodone|hydrocodone|mesh-list
56149490|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56149491|NCT01588158|Analgesics|analgesics|mesh-ancestor
56149492|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
56149493|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149494|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149495|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
56149496|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56149497|NCT01588158|Narcotics|narcotics|mesh-ancestor
56149498|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149499|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
56149500|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149501|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56149502|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56149503|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56149504|NCT01588470|Pioglitazone|pioglitazone|mesh-list
56149505|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56658523|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658524|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658525|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
56658526|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658527|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658528|NCT04033094|Morphine|morphine|mesh-list
56658529|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56149506|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149507|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
56149508|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56149509|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56149510|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56149511|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149512|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149513|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
56149514|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149515|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149516|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56149517|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149518|NCT05565924|Biguanides|biguanides|mesh-list
56149519|NCT05565924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56149520|NCT05565924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149521|NCT05565222|Meropenem|meropenem|mesh-list
56149522|NCT05565222|Tazobactam|tazobactam|mesh-list
56149523|NCT05565222|Piperacillin|piperacillin|mesh-list
56149524|NCT05565222|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56149525|NCT05565222|Temocillin|temocillin|mesh-list
56149526|NCT05565222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56149527|NCT05565222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149528|NCT05565222|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56149529|NCT05565222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149530|NCT05565222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149531|NCT05564832|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56149532|NCT05564832|Pilocarpine|pilocarpine|mesh-list
56149533|NCT05564832|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56149534|NCT05564832|Miotics|miotics|mesh-ancestor
56149535|NCT05564832|Autonomic Agents|autonomic agents|mesh-ancestor
56149536|NCT05564832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149537|NCT05564832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149538|NCT05564832|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56149539|NCT05564832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56149540|NCT05564832|Cholinergic Agents|cholinergic agents|mesh-ancestor
56149541|NCT05564832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149542|NCT05564832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149543|NCT05564442|Benzocaine|benzocaine|mesh-list
56149544|NCT05564442|Anesthetics, Local|anesthetics, local|mesh-ancestor
56149545|NCT05564442|Anesthetics|anesthetics|mesh-ancestor
56149546|NCT05564442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149547|NCT05564442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149548|NCT05564442|Sensory System Agents|sensory system agents|mesh-ancestor
56149549|NCT05564442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149550|NCT05493540|Ibuprofen|ibuprofen|mesh-list
56149551|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56149552|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56077210|NCT05363514|Naltrexone|naltrexone|mesh-list
56149553|NCT05493540|Analgesics|analgesics|mesh-ancestor
56149554|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
56149555|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149556|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149557|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56149558|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56149559|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56149560|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149561|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149562|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56149563|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56149564|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56149565|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56658530|NCT04033094|Narcotics|narcotics|mesh-ancestor
56658531|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56220257|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56149566|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56149567|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56149568|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56149569|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149570|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149571|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149572|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149573|NCT05672784|Acetaminophen|acetaminophen|mesh-list
56149575|NCT05672784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56149576|NCT05672784|Analgesics|analgesics|mesh-ancestor
56149577|NCT05672784|Sensory System Agents|sensory system agents|mesh-ancestor
56149578|NCT05672784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149579|NCT05672784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149580|NCT05672784|Antipyretics|antipyretics|mesh-ancestor
56149581|NCT05672784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56149582|NCT05672784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56149583|NCT05672784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56149584|NCT05672784|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56149585|NCT05672784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56149586|NCT05672784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149587|NCT05672784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149588|NCT05672472|Sivelestat|sivelestat|mesh-list
56149589|NCT05672472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56149590|NCT05672472|Protease Inhibitors|protease inhibitors|mesh-ancestor
56149591|NCT05672472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149592|NCT05672472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149593|NCT05672394|Lidocaine|lidocaine|mesh-list
56149594|NCT05672394|Epinephrine|epinephrine|mesh-list
56149595|NCT05672394|Bupivacaine|bupivacaine|mesh-list
56149596|NCT05672394|Anesthetics, Local|anesthetics, local|mesh-ancestor
56149597|NCT05672394|Anesthetics|anesthetics|mesh-ancestor
56149598|NCT05672394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149599|NCT05672394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149600|NCT05672394|Sensory System Agents|sensory system agents|mesh-ancestor
56149601|NCT05672394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149602|NCT05672394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56149603|NCT05672394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56149604|NCT05672394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56149605|NCT05672394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149606|NCT05672394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149607|NCT05672394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56149608|NCT05672394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56149609|NCT05672394|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149610|NCT05672394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149611|NCT05672394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56149612|NCT05672394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56149613|NCT05672394|Autonomic Agents|autonomic agents|mesh-ancestor
56149614|NCT05672394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56149615|NCT05672394|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149616|NCT05672394|Mydriatics|mydriatics|mesh-ancestor
56149617|NCT05672394|Sympathomimetics|sympathomimetics|mesh-ancestor
56149618|NCT05672394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56149619|NCT05607342|SR 142801|sr 142801|mesh-list
56149620|NCT05607342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56149621|NCT05607342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56149622|NCT05607342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149623|NCT05607342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149624|NCT05607342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56149625|NCT05562492|Insulin|insulin|mesh-list
56149626|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56149627|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149632|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56149633|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149634|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149635|NCT05326464|Tofacitinib|tofacitinib|mesh-list
56149636|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56149637|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149638|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658532|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658533|NCT04033094|Analgesics|analgesics|mesh-ancestor
56658534|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
56658535|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658536|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
56658537|NCT04073758|Remifentanil|remifentanil|mesh-list
56220258|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56149639|NCT04887792|Acetazolamide|acetazolamide|mesh-list
56149640|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
56149641|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56149642|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149643|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149644|NCT04887792|Diuretics|diuretics|mesh-ancestor
56149645|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
56149646|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149647|NCT04518228|Ritonavir|ritonavir|mesh-list
56149648|NCT04518228|Lopinavir|lopinavir|mesh-list
56149649|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56149650|NCT04518228|Darunavir|darunavir|mesh-list
56149651|NCT04518228|Tenofovir|tenofovir|mesh-list
56149652|NCT04518228|Dolutegravir|dolutegravir|mesh-list
56149653|NCT04518228|Cobicistat|cobicistat|mesh-list
56149654|NCT04518228|Cabotegravir|cabotegravir|mesh-list
56149655|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56149656|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56149657|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
56149658|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149659|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149660|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56149661|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56149662|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
56149663|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149664|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56149665|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56149666|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56149667|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56149668|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56149669|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56149670|NCT03729258|Amantadine|amantadine|mesh-list
56149671|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56149672|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56149673|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
56149674|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175882|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56149675|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
56149676|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149677|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149678|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149679|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56149680|NCT03729258|Analgesics|analgesics|mesh-ancestor
56149681|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
56149682|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149683|NCT03355170|Domperidone|domperidone|mesh-list
56149684|NCT03355170|Lansoprazole|lansoprazole|mesh-list
56149685|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
56149686|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56149687|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56149688|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56149689|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149690|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149691|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
56149692|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
56149693|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149694|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149695|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56149696|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
56149697|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149698|NCT03009240|Decitabine|decitabine|mesh-list
56149699|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56149700|NCT03009240|Pevonedistat|pevonedistat|mesh-list
56149701|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56658538|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56658539|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658540|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658541|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56658542|NCT04073758|Analgesics|analgesics|mesh-ancestor
56658543|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
56220263|NCT01655758|Dorzolamide|dorzolamide|mesh-list
56149703|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149705|NCT02760498|Cemiplimab|cemiplimab|mesh-list
56149706|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56149707|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149708|NCT02538666|Nivolumab|nivolumab|mesh-list
56149709|NCT02538666|Ipilimumab|ipilimumab|mesh-list
56149710|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56149711|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149712|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56149713|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149714|NCT02407236|Ustekinumab|ustekinumab|mesh-list
56149715|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
56149716|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
56149717|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56149718|NCT05120076|Dexamethasone|dexamethasone|mesh-list
56149719|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
56149720|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56149721|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
56149722|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
56149723|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149724|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149725|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56149726|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
56149727|NCT05120076|Hormones|hormones|mesh-ancestor
56149728|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56149729|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56149730|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149731|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56149732|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56149733|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56149734|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149735|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149736|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149737|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149738|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149739|NCT05094804|Docetaxel|docetaxel|mesh-list
56149740|NCT05094804|Cemiplimab|cemiplimab|mesh-list
56149741|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149742|NCT05094804|Tubulin Modulators|tubulin modulators|mesh-ancestor
56149743|NCT05094804|Antimitotic Agents|antimitotic agents|mesh-ancestor
56149744|NCT05094804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56149745|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149746|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56149747|NCT04992312|Glucagon|glucagon|mesh-list
56149748|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56149749|NCT04992312|Hormones|hormones|mesh-ancestor
56149750|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56149751|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149752|NCT04873596|Midazolam|midazolam|mesh-list
56149753|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
56149754|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56149755|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149756|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149757|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56149758|NCT04873596|Analgesics|analgesics|mesh-ancestor
56149759|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
56149760|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149761|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56149762|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56149763|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56658544|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658545|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56658546|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56658547|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56658548|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56658549|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149764|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149765|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149766|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149767|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56149768|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56149769|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56149770|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56149771|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56149772|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
56149773|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
56149774|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
56149779|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56077435|NCT03496662|Paclitaxel|paclitaxel|mesh-list
56149780|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149781|NCT04666272|Trametinib|trametinib|mesh-list
56149782|NCT04666272|Dabrafenib|dabrafenib|mesh-list
56149783|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149784|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56149785|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149786|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149787|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
56149788|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
56149789|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56149790|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149791|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149792|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56149793|NCT04508166|Analgesics|analgesics|mesh-ancestor
56149794|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
56149795|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149796|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56149797|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56149798|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56149799|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149800|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149801|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149802|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56149803|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56149804|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
56149805|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
56149806|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
56149807|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56149808|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149809|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56149810|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56149811|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149812|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149813|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149814|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56149815|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56149816|NCT04175964|Metformin|metformin|mesh-list
56149817|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56149818|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149819|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
56149820|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
56149821|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
56149822|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149823|NCT03624270|Protective Agents|protective agents|mesh-ancestor
56149824|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149825|NCT03624270|Vitamins|vitamins|mesh-ancestor
56149826|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
56149827|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149828|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55924334|NCT04079192|Umirolimus|umirolimus|mesh-list
56658550|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658551|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56658552|NCT04073758|Narcotics|narcotics|mesh-ancestor
56658553|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
56658554|NCT02660606|Narcotics|narcotics|mesh-ancestor
56658555|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658556|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658557|NCT02660606|Analgesics|analgesics|mesh-ancestor
56149829|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56149830|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149831|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149832|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149833|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149834|NCT03455088|Fluoxetine|fluoxetine|mesh-list
56149835|NCT03455088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56149836|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56149837|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149838|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149839|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149840|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
56149841|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149842|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56149843|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
56149846|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56149847|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149848|NCT03355560|Nivolumab|nivolumab|mesh-list
56149849|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56149850|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149851|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56149852|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149853|NCT01600170|Atorvastatin|atorvastatin|mesh-list
56149854|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56149855|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56149856|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
56149857|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149858|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56149859|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56149860|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149861|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
56149862|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56149863|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149864|NCT01605942|Dexamethasone|dexamethasone|mesh-list
56149865|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56149866|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
56149867|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
56149868|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149869|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149870|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56149871|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
56149872|NCT01605942|Hormones|hormones|mesh-ancestor
56149873|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56149874|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56149875|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149876|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
56149877|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56149878|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56149879|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56149880|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56149881|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149882|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
56149883|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149884|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149885|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56149886|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658558|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
56658559|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658560|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
56658561|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56658562|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
56658563|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658564|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658565|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56658566|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
56658567|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56658568|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
56658569|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658570|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658571|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56658572|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
56658573|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
56658574|NCT00582010|Protective Agents|protective agents|mesh-ancestor
56658575|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
56658576|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56658577|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56658578|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56658579|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56658580|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658581|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
56658582|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658583|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658584|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56658585|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658586|NCT00649922|Adalimumab|adalimumab|mesh-list
56658587|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56658588|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56658589|NCT00986557|Ganciclovir|ganciclovir|mesh-list
56658590|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56149887|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56175886|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56149888|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56149889|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149890|NCT01610154|Incretins|incretins|mesh-ancestor
56149891|NCT01610154|Hormones|hormones|mesh-ancestor
56149892|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56149893|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56658591|NCT00986557|Foscarnet|foscarnet|mesh-list
56658592|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56658593|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
56658594|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658595|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658596|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
56658597|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658598|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56149894|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
56149895|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149896|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149897|NCT01611948|Aprepitant|aprepitant|mesh-list
56149898|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
56149899|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
56149900|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149901|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149902|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56149903|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56149904|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149905|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149906|NCT01612884|Clopidogrel|clopidogrel|mesh-list
56149907|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56149908|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56149909|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56149910|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56149911|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56149912|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
56149913|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149914|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149915|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149916|NCT01614210|Tamoxifen|tamoxifen|mesh-list
56149917|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56149918|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
56149919|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56149920|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149921|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56149922|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077591|NCT05716867|Cystatins|cystatins|mesh-list
56149923|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56149924|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56149925|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56149926|NCT01616082|Phentermine|phentermine|mesh-list
56149927|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56149928|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149929|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
56149930|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56149931|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
56149932|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
56149933|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149934|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149935|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149936|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149937|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
56149938|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56149939|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
56149940|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56149942|NCT01619982|Cefazolin|cefazolin|mesh-list
56149943|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56149944|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149945|NCT01620216|Sorafenib|sorafenib|mesh-list
56149946|NCT01620216|Sunitinib|sunitinib|mesh-list
56149947|NCT01620216|Dasatinib|dasatinib|mesh-list
56149948|NCT01620216|Ponatinib|ponatinib|mesh-list
56149949|NCT01620216|Idelalisib|idelalisib|mesh-list
56149950|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
56149951|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56149952|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56658599|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658600|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658601|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56658602|NCT00910754|Prednisone|prednisone|mesh-list
56658603|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
56658604|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56658605|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
56658606|NCT00910754|Hormones|hormones|mesh-ancestor
56149953|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149954|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149955|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56149956|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56149957|NCT01620216|Growth Substances|growth substances|mesh-ancestor
56149958|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149959|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
56175890|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
56149960|NCT01621230|Fentanyl|fentanyl|mesh-list
56149961|NCT01621230|Bupivacaine|bupivacaine|mesh-list
56149962|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
56149963|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
56149964|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149965|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149966|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
56149967|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149968|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56149969|NCT01621230|Narcotics|narcotics|mesh-ancestor
56149970|NCT01621230|Analgesics|analgesics|mesh-ancestor
56149971|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56149972|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56149973|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
56149974|NCT01621776|Insulin|insulin|mesh-list
56149975|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56149976|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
56149977|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
56149978|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
56149979|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56149980|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149981|NCT01631682|Propranolol|propranolol|mesh-list
56149982|NCT01631682|Oxytocin|oxytocin|mesh-list
56149983|NCT01631682|Mifepristone|mifepristone|mesh-list
56149984|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
56149985|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56149986|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149987|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56149988|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56149989|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
56149991|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149993|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56149995|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56149996|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
56149997|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56149998|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56149999|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56150000|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
56150001|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56150002|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56150003|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
56150004|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150005|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
56150006|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56150007|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56150008|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
56150009|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56150010|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56150011|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56150012|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56150013|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150014|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
56658607|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658608|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658609|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56658610|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220324|NCT01655966|Vitamins|vitamins|mesh-ancestor
56150015|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150016|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150017|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56150018|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150019|NCT01636206|Lifitegrast|lifitegrast|mesh-list
56150020|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56150021|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56150022|NCT01639872|Risperidone|risperidone|mesh-list
56150023|NCT01639872|Clozapine|clozapine|mesh-list
56150024|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56150025|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
56150026|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150027|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150028|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150029|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56150030|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56150031|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150032|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56150033|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56175892|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56150034|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
56150035|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
56150036|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
56150037|NCT01640340|Dexamethasone|dexamethasone|mesh-list
56150038|NCT01640340|Ondansetron|ondansetron|mesh-list
56150039|NCT01640340|Aprepitant|aprepitant|mesh-list
56150040|NCT01640340|Palonosetron|palonosetron|mesh-list
56150041|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56150042|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
56150043|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
56150044|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150045|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150046|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56150047|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
56150048|NCT01640340|Hormones|hormones|mesh-ancestor
56150049|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150050|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56150051|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150052|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
56150053|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
56150054|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56150055|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
56150056|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150057|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150058|NCT01640340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56150059|NCT01640340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56150060|NCT01640340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150061|NCT01640340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56150062|NCT01640340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56150068|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150069|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
56150070|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150071|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
56150072|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150073|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56150074|NCT01643382|Insulin|insulin|mesh-list
56150075|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56150076|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56150077|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150078|NCT01643616|Midazolam|midazolam|mesh-list
56150079|NCT01643616|Ropivacaine|ropivacaine|mesh-list
56150080|NCT01643616|Prilocaine|prilocaine|mesh-list
56150081|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
56150082|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
56150083|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150084|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924335|NCT04079192|Paclitaxel|paclitaxel|mesh-list
56658611|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56658612|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658613|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658614|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
56658615|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56658616|NCT00649376|Fexofenadine|fexofenadine|mesh-list
56658617|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56658618|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56150085|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
56150086|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150087|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56150088|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56150089|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56150090|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56150091|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56150092|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56150093|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
56150094|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
56150096|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150097|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150098|NCT01644396|Adalimumab|adalimumab|mesh-list
56150099|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56150100|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56150101|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
56150102|NCT01645098|Ketamine|ketamine|mesh-list
56150103|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56150104|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150105|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150106|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56150107|NCT01645098|Analgesics|analgesics|mesh-ancestor
56150108|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
56150109|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150110|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56150111|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56150112|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56150113|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
56150114|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150115|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150116|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56150117|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56150118|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
56150119|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
56150120|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56150121|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56150122|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
56150123|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
56150124|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56150125|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56150126|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150127|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
56150128|NCT01651806|Coagulants|coagulants|mesh-ancestor
56150129|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
56150130|NCT01652040|Testosterone|testosterone|mesh-list
56150131|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
56150132|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
56150133|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56150136|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150137|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150138|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56150139|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150140|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
56150142|NCT01652976|Fluorouracil|fluorouracil|mesh-list
56150143|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
56150144|NCT01652976|Dasatinib|dasatinib|mesh-list
56150145|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
56150146|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658619|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56658620|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
56658621|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
56658622|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658623|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658624|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150147|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56150148|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150149|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150150|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
56150151|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150152|NCT01652976|Antidotes|antidotes|mesh-ancestor
56150153|NCT01652976|Protective Agents|protective agents|mesh-ancestor
56150154|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
56150155|NCT01652976|Vitamins|vitamins|mesh-ancestor
56150156|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
56150157|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56150158|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150159|NCT01656252|Cytarabine|cytarabine|mesh-list
56150160|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56150161|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
56150162|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150163|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150164|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
56150165|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150166|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150167|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
56150168|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150170|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150171|NCT01661946|Bevacizumab|bevacizumab|mesh-list
56150172|NCT01661946|Ranibizumab|ranibizumab|mesh-list
56150173|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56150174|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150175|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56150176|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56150177|NCT01661946|Growth Substances|growth substances|mesh-ancestor
56150178|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150179|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
56150180|NCT01663272|Gemcitabine|gemcitabine|mesh-list
56150181|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56150182|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
56150183|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150184|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150185|NCT01663272|Antiviral Agents|antiviral agents|mesh-ancestor
56150186|NCT01663272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150187|NCT01663272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150188|NCT01663272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150189|NCT01663272|Immunologic Factors|immunologic factors|mesh-ancestor
56150190|NCT01663272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150191|NCT01667796|Vitamin D|vitamin d|mesh-list
56150192|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
56150193|NCT01667796|Vitamins|vitamins|mesh-ancestor
56150194|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
56150195|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150196|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56150197|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56150198|NCT01668030|Bacitracin|bacitracin|mesh-list
56150199|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56150200|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150201|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56150202|NCT01669434|Ramipril|ramipril|mesh-list
56150203|NCT01669434|Enalapril|enalapril|mesh-list
56150204|NCT01669434|Enalaprilat|enalaprilat|mesh-list
56150205|NCT01669434|Lisinopril|lisinopril|mesh-list
56150206|NCT01669434|Perindopril|perindopril|mesh-list
56150207|NCT01669434|Benazepril|benazepril|mesh-list
56150208|NCT01669434|Captopril|captopril|mesh-list
56150209|NCT01669434|Quinapril|quinapril|mesh-list
56150210|NCT01669434|Trandolapril|trandolapril|mesh-list
56150211|NCT01669434|Fosinopril|fosinopril|mesh-list
56150212|NCT01669434|Moexipril|moexipril|mesh-list
56150216|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658625|NCT02340676|Interleukin-2|interleukin-2|mesh-list
56658626|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658627|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56658628|NCT02340676|Analgesics|analgesics|mesh-ancestor
56658629|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
56658630|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658631|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658632|NCT00781612|Paclitaxel|paclitaxel|mesh-list
56658633|NCT00781612|Maytansine|maytansine|mesh-list
56658634|NCT00781612|Docetaxel|docetaxel|mesh-list
56658635|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56658636|NCT00781612|Trastuzumab|trastuzumab|mesh-list
56658637|NCT00781612|Atezolizumab|atezolizumab|mesh-list
56658638|NCT00781612|Pertuzumab|pertuzumab|mesh-list
56658639|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56658640|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658641|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
56658642|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56658643|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56658644|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150217|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56150218|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56150219|NCT01669434|Protective Agents|protective agents|mesh-ancestor
56150220|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150222|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56150223|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56150224|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56150225|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150226|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56150227|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
56150228|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56150229|NCT01680900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56150230|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56150231|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56150232|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150233|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150234|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
56150235|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150236|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56150237|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56150238|NCT01682538|Nitisinone|nitisinone|mesh-list
56150239|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150240|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150241|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56150242|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
56150243|NCT01684020|Coagulants|coagulants|mesh-ancestor
56150244|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
56150245|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56150246|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
56150247|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150248|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150249|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56150250|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56150251|NCT01689324|Vaccines|vaccines|mesh-list
56150252|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
56150253|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658645|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658646|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56658647|NCT00649454|Metformin|metformin|mesh-list
56658648|NCT00649454|Glipizide|glipizide|mesh-list
56658649|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56658650|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658651|NCT03920215|Varenicline|varenicline|mesh-list
56658652|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56658653|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56658654|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
56658655|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220362|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
56150254|NCT01692756|Triamcinolone|triamcinolone|mesh-list
56150255|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56150256|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56150257|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56150258|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56150259|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56150260|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
56150261|NCT01692756|Hormones|hormones|mesh-ancestor
56150262|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150263|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150264|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150265|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
56150266|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150267|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150268|NCT01695330|Bortezomib|bortezomib|mesh-list
56150269|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150270|NCT01701102|Fentanyl|fentanyl|mesh-list
56150271|NCT01701102|Mepivacaine|mepivacaine|mesh-list
56150272|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56150273|NCT01701102|Narcotics|narcotics|mesh-ancestor
56150274|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150275|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150276|NCT01701102|Analgesics|analgesics|mesh-ancestor
56150277|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
56150278|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150279|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56150280|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56150281|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
56150282|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
56150283|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
56150284|NCT01701414|Bupivacaine|bupivacaine|mesh-list
56150287|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150288|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150290|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150291|NCT01706952|Epinephrine|epinephrine|mesh-list
56150292|NCT01706952|Racepinephrine|racepinephrine|mesh-list
56150293|NCT01706952|Cocaine|cocaine|mesh-list
56150294|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56150295|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
56150296|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56150297|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56150298|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
56150299|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150300|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150301|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150302|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56150303|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56150304|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
56150305|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150306|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56150307|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
56150308|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
56150309|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
56150310|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56658656|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658657|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658658|NCT02655770|Liraglutide|liraglutide|mesh-list
56658659|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56658660|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658661|NCT02655770|Incretins|incretins|mesh-ancestor
56658662|NCT02655770|Hormones|hormones|mesh-ancestor
56658663|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658664|NCT00986713|Amphotericin B|amphotericin b|mesh-list
56658665|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56658666|NCT00986713|Amebicides|amebicides|mesh-ancestor
56658667|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56658668|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56658669|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658670|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56658671|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
56658672|NCT02651870|Amlodipine|amlodipine|mesh-list
56658673|NCT02651870|Candesartan|candesartan|mesh-list
56658674|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56658675|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56658676|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56658677|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658678|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56658679|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658680|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
56658681|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56658682|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56658683|NCT02766803|Resveratrol|resveratrol|mesh-list
56658684|NCT02766803|Simvastatin|simvastatin|mesh-list
56658685|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56150311|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
56150312|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
56150313|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150314|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
56150315|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56150316|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56150317|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56150318|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
56150319|NCT01707420|Gabapentin|gabapentin|mesh-list
56150320|NCT01707420|Analgesics|analgesics|mesh-ancestor
56150321|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
56150322|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150323|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150324|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
56658686|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56658687|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
56658688|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658689|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56658690|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56658691|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658692|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
56658693|NCT02766803|Protective Agents|protective agents|mesh-ancestor
56658694|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658695|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56658696|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
56658697|NCT00650468|Prednisone|prednisone|mesh-list
56658698|NCT00650468|Tacrolimus|tacrolimus|mesh-list
56658699|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56658700|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
56658701|NCT00650468|Hormones|hormones|mesh-ancestor
56658702|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658703|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658704|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56658705|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658706|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56658707|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
56658708|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56658709|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150325|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56150326|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56150327|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150328|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56150329|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56150330|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56150331|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150332|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150333|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
56150334|NCT01708122|Fentanyl|fentanyl|mesh-list
56150335|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56150336|NCT01708122|Narcotics|narcotics|mesh-ancestor
56150337|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150338|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150339|NCT01708122|Analgesics|analgesics|mesh-ancestor
56150340|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
56150341|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150342|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56150343|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56150344|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
56150345|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
56150346|NCT01708278|Folic Acid|folic acid|mesh-list
56150347|NCT01708278|Quercetin|quercetin|mesh-list
56150348|NCT01708278|Hematinics|hematinics|mesh-ancestor
56150349|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
56150350|NCT01708278|Vitamins|vitamins|mesh-ancestor
56150351|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
56150352|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658710|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658711|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56658712|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56658713|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
56658714|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56658715|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150353|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
56150354|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150355|NCT01708278|Protective Agents|protective agents|mesh-ancestor
56150356|NCT01708590|Brodalumab|brodalumab|mesh-list
56150357|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56150358|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
56150359|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
56150362|NCT05711082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56150363|NCT05711082|Sympathomimetics|sympathomimetics|mesh-ancestor
56150364|NCT05711082|Autonomic Agents|autonomic agents|mesh-ancestor
56150365|NCT05711082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150366|NCT05711082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150367|NCT05711082|Dopamine Agents|dopamine agents|mesh-ancestor
56150368|NCT05711082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150369|NCT05711082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150370|NCT05711082|Protective Agents|protective agents|mesh-ancestor
56150372|NCT05710146|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56150373|NCT05710146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56150374|NCT05710146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150375|NCT05710146|Hemostatics|hemostatics|mesh-ancestor
56150376|NCT05710146|Coagulants|coagulants|mesh-ancestor
56150377|NCT05709444|Angiotensin II|angiotensin ii|mesh-list
56150378|NCT05709444|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56150379|NCT05709444|alpha-MSH|alpha-msh|mesh-list
56150380|NCT05709444|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56150381|NCT05709444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56150382|NCT05709444|Protease Inhibitors|protease inhibitors|mesh-ancestor
56150383|NCT05709444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150384|NCT05709444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150385|NCT05709444|Hormones|hormones|mesh-ancestor
56175922|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
56150386|NCT05709444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150387|NCT05709444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150388|NCT05700630|Vorinostat|vorinostat|mesh-list
56150389|NCT05700630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150390|NCT05700630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56150391|NCT05700630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150392|NCT05700630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150393|NCT05683548|Interferons|interferons|mesh-list
56150394|NCT05683548|Tenofovir|tenofovir|mesh-list
56150395|NCT05683548|Interferon-alpha|interferon-alpha|mesh-list
56150396|NCT05683548|Interferon alpha-2|interferon alpha-2|mesh-list
56150397|NCT05683548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56150398|NCT05683548|REP 2139|rep 2139|mesh-list
56150399|NCT05683548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150400|NCT05683548|Antiviral Agents|antiviral agents|mesh-ancestor
56150401|NCT05683548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150402|NCT05683548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56150403|NCT05683548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56150404|NCT05683548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150405|NCT05683548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150406|NCT05683548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56150407|NCT05683548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56150408|NCT05683548|Immunologic Factors|immunologic factors|mesh-ancestor
56150409|NCT05683548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150410|NCT05661942|Calcium|calcium|mesh-list
56150411|NCT05661942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56150412|NCT05661942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150413|NCT05636436|Vaccines|vaccines|mesh-list
56150414|NCT05636436|Immunologic Factors|immunologic factors|mesh-ancestor
56150415|NCT05636436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150416|NCT05613426|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56150417|NCT05613426|Evolocumab|evolocumab|mesh-list
56658716|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
56658717|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658718|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56658719|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658720|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658721|NCT04006483|Fluorides|fluorides|mesh-list
56658722|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
56304838|NCT00000959|Pyridoxine|pyridoxine|mesh-list
56658723|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
56658724|NCT04006483|Protective Agents|protective agents|mesh-ancestor
56658725|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658727|NCT02651792|Ketamine|ketamine|mesh-list
56658728|NCT02651792|Propofol|propofol|mesh-list
56658729|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56658730|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658731|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658732|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56658733|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
56658734|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
56658735|NCT02651792|Analgesics|analgesics|mesh-ancestor
56658736|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
56658737|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658738|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56658739|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56150418|NCT05613426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56150419|NCT05613426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56150420|NCT05613426|Antimetabolites|antimetabolites|mesh-ancestor
56150421|NCT05613426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150422|NCT05613426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56150423|NCT05613426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56150424|NCT05613426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150425|NCT05601492|Thalidomide|thalidomide|mesh-list
56150426|NCT05601492|Apremilast|apremilast|mesh-list
56150427|NCT05601492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56150428|NCT05601492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56150429|NCT05601492|Analgesics|analgesics|mesh-ancestor
56150430|NCT05601492|Sensory System Agents|sensory system agents|mesh-ancestor
56150431|NCT05601492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150432|NCT05601492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150433|NCT05601492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56150434|NCT05601492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56150435|NCT05601492|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56150436|NCT05601492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56150437|NCT05601492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150438|NCT05601492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150439|NCT05601492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150440|NCT05601492|Immunologic Factors|immunologic factors|mesh-ancestor
56150441|NCT05601492|Leprostatic Agents|leprostatic agents|mesh-ancestor
56150442|NCT05601492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56150443|NCT05601492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150444|NCT05601492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56658740|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56658741|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658742|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658743|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56658744|NCT02651792|Narcotics|narcotics|mesh-ancestor
56658745|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56658746|NCT04754815|Paclitaxel|paclitaxel|mesh-list
56658747|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56658748|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
56658749|NCT04754815|Pemetrexed|pemetrexed|mesh-list
56658750|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56658751|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658752|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
56658753|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
56658754|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
56658755|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658756|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658757|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658758|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56658759|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56658760|NCT00649532|Ondansetron|ondansetron|mesh-list
56658761|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
56150445|NCT05601492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56150446|NCT05601492|Growth Substances|growth substances|mesh-ancestor
56150447|NCT05601492|Growth Inhibitors|growth inhibitors|mesh-ancestor
56150448|NCT05601492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150450|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
56150451|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150452|NCT05463354|Vaccines|vaccines|mesh-list
56150453|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
56150454|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150455|NCT05416320|Calcipotriene|calcipotriene|mesh-list
56150456|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
56078108|NCT04871191|Rituximab|rituximab|mesh-list
56150465|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
56150466|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56150467|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
56150468|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150469|NCT05340504|Expectorants|expectorants|mesh-ancestor
56150470|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
56150471|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56150472|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
56150473|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150474|NCT05340504|Protective Agents|protective agents|mesh-ancestor
56150475|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150476|NCT05340504|Antidotes|antidotes|mesh-ancestor
56150477|NCT05338320|Fentanyl|fentanyl|mesh-list
56150478|NCT05338320|Morphine|morphine|mesh-list
56150479|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
56150480|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150481|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150482|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56150483|NCT05338320|Narcotics|narcotics|mesh-ancestor
56150484|NCT05338320|Analgesics|analgesics|mesh-ancestor
56150485|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
56658762|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
56658763|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658764|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658765|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56658766|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
56658767|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
56220464|NCT01656616|Antidotes|antidotes|mesh-list
56150486|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150487|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56150488|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56150489|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
56150490|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56150491|NCT05330130|Hormones|hormones|mesh-ancestor
56150492|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150493|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150494|NCT05293548|Vaccines|vaccines|mesh-list
56150495|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
56150496|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150497|NCT05157360|Vitamins|vitamins|mesh-list
56150498|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
56150499|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
56150500|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150501|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56150502|NCT05136066|Peppermint oil|peppermint oil|mesh-list
56150503|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
56150504|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
56150505|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150506|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150507|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56150508|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
56150509|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
56150510|NCT04676802|Narcotics|narcotics|mesh-ancestor
56150511|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150512|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150513|NCT04676802|Analgesics|analgesics|mesh-ancestor
56150514|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
56150515|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150516|NCT04278768|Azacitidine|azacitidine|mesh-list
56150517|NCT04278768|Venetoclax|venetoclax|mesh-list
56150518|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56150520|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150521|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150522|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150524|NCT04068948|Meperidine|meperidine|mesh-list
56150525|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
56150526|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56150527|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56150528|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150529|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150530|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56150531|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56150532|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56175935|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
56150533|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56078185|NCT02976727|Vitamin D|vitamin d|mesh-list
56150534|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
56150535|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
56150536|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
56150537|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
56150538|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150539|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150540|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56150541|NCT04068948|Narcotics|narcotics|mesh-ancestor
56150542|NCT04068948|Analgesics|analgesics|mesh-ancestor
56150543|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
56150544|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150545|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
56150546|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
56150547|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56150548|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
56150549|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
56658768|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56658769|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
56658770|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220465|NCT01656616|Protective Agents|protective agents|mesh-ancestor
56150551|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56150552|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150553|NCT03517722|Ustekinumab|ustekinumab|mesh-list
56150554|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
56150555|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56150556|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56150557|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150558|NCT01309074|Pregabalin|pregabalin|mesh-list
56150559|NCT01309074|Sertraline|sertraline|mesh-list
56150560|NCT01309074|Analgesics|analgesics|mesh-ancestor
56150561|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
56150562|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150563|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150564|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
56150565|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56150566|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56150567|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150568|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56150569|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56150570|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56150571|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150572|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56150573|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
56150574|NCT01309074|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56150575|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56150576|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150577|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
56150578|NCT01074294|Brexpiprazole|brexpiprazole|mesh-list
56150579|NCT01074294|Serotonin Agents|serotonin agents|mesh-ancestor
56150580|NCT01074294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150581|NCT01074294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150582|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150583|NCT01074294|Dopamine Agonists|dopamine agonists|mesh-ancestor
56150584|NCT01074294|Dopamine Agents|dopamine agents|mesh-ancestor
56150585|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
56150586|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150587|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150588|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56150589|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56150590|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56150591|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
56150592|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150595|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150597|NCT00577278|Rituximab|rituximab|mesh-list
56150598|NCT00577278|Fludarabine|fludarabine|mesh-list
56150599|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
56150600|NCT00577278|Melphalan|melphalan|mesh-list
56150601|NCT00577278|Tacrolimus|tacrolimus|mesh-list
56150602|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56150603|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56150604|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150605|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
56150606|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150607|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56150608|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56150609|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
56150610|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150611|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150612|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56150613|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150614|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56150615|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150616|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56150617|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
56150618|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56150619|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
56150620|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56658771|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658772|NCT00649532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56658773|NCT00649532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56220467|NCT01656642|Atezolizumab|atezolizumab|mesh-list
56150621|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
56150622|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
56150623|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
56150624|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
56150625|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56150626|NCT01721226|Narcotics|narcotics|mesh-ancestor
56150627|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150628|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150629|NCT01721226|Analgesics|analgesics|mesh-ancestor
56150630|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
56150631|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150632|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
56150633|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56150634|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150635|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150636|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56150637|NCT01721460|Analgesics|analgesics|mesh-ancestor
56150638|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
56150639|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150640|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56150641|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56150642|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56150643|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
56150644|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150645|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150646|NCT01722318|Plecanatide|plecanatide|mesh-list
56150647|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56150648|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
56150649|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150650|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56150651|NCT01723722|Methadone|methadone|mesh-list
56150652|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56150653|NCT01723722|Narcotics|narcotics|mesh-ancestor
56150654|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150655|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150656|NCT01723722|Analgesics|analgesics|mesh-ancestor
56150657|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
56150658|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150659|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
56150660|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
56150661|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
56150662|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56150663|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56150664|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150667|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
56150668|NCT01729338|Lenalidomide|lenalidomide|mesh-list
56150669|NCT01729338|Bortezomib|bortezomib|mesh-list
56150670|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150671|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
56150672|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150673|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56150674|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56150675|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
56150676|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150677|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150678|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56150679|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56150680|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56150681|NCT01729338|Growth Substances|growth substances|mesh-ancestor
56150682|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
56150683|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
56150684|NCT01729494|Prednisone|prednisone|mesh-list
56150685|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
56150686|NCT01729494|Abatacept|abatacept|mesh-list
56150687|NCT01729494|Tacrolimus|tacrolimus|mesh-list
56150688|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
56150689|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56150690|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56658774|NCT00649532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658775|NCT00649532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56658776|NCT00649532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56150691|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
56150692|NCT01729494|Hormones|hormones|mesh-ancestor
56150693|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150694|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150695|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56150696|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150697|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150698|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
56150699|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56150700|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150701|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150702|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56150703|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56150704|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
56150705|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56150706|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150707|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56150708|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56150709|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56150710|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
56150711|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150712|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
56150713|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56150714|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150715|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56150716|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56150717|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150718|NCT05316168|Dexamethasone|dexamethasone|mesh-list
56150719|NCT05316168|Bupivacaine|bupivacaine|mesh-list
56150720|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56150721|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
56150722|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
56150723|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150724|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150725|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56150726|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
56150727|NCT05316168|Hormones|hormones|mesh-ancestor
56150728|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150729|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56150730|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150731|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
56150732|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
56150733|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150734|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
56150735|NCT05315388|Vitamins|vitamins|mesh-list
56150736|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
56150737|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150739|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56150740|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150744|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150746|NCT04724772|Coagulants|coagulants|mesh-ancestor
56150747|NCT04196868|Metformin|metformin|mesh-list
56150748|NCT04196868|Methotrexate|methotrexate|mesh-list
56150749|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56150750|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150751|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56150752|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
56150753|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56150754|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56150755|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
56150756|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150757|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150758|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
56150759|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150760|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56150761|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150762|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
56150763|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56658777|NCT02655614|Midazolam|midazolam|mesh-list
56658778|NCT02655614|Caffeine|caffeine|mesh-list
56658779|NCT02655614|Rabeprazole|rabeprazole|mesh-list
56658780|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56150764|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56150765|NCT04007874|Vitamin E|vitamin e|mesh-list
56150766|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
56150767|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56150768|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56150769|NCT04007874|Vitamins|vitamins|mesh-ancestor
56150770|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
56150771|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150772|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
56150773|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150774|NCT04007874|Protective Agents|protective agents|mesh-ancestor
56150775|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56150776|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
56150777|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56150778|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56150779|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56150780|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56150781|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56150782|NCT04007874|Estrogens|estrogens|mesh-ancestor
56150783|NCT04007874|Hormones|hormones|mesh-ancestor
56150784|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150785|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56150786|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
56150787|NCT03878472|Apatinib|apatinib|mesh-list
56150788|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150789|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56150790|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150791|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150792|NCT03781752|Methylphenidate|methylphenidate|mesh-list
56150793|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56150794|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150795|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56150796|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56150797|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56150798|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150799|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
56150800|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150801|NCT03162510|Paclitaxel|paclitaxel|mesh-list
56150802|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56150803|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
56150804|NCT03162510|Tegafur|tegafur|mesh-list
56150805|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56150807|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
56150808|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
56150809|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
56150810|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150811|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56150812|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
56150818|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56150819|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56150820|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150821|NCT02394132|Imiquimod|imiquimod|mesh-list
56150822|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56150823|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
56150824|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150825|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150826|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
56150827|NCT00700596|Salvinorin A|salvinorin a|mesh-list
56150828|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
56150829|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150830|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56150831|NCT01733472|Remifentanil|remifentanil|mesh-list
56150832|NCT01733472|Propofol|propofol|mesh-list
56150833|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56150834|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56150835|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150836|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56150837|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
56658781|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56658782|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658783|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658784|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56658785|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56658786|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56658787|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56658788|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
56150838|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
56150839|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56150840|NCT01733472|Narcotics|narcotics|mesh-ancestor
56150841|NCT01733472|Analgesics|analgesics|mesh-ancestor
56150842|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
56150843|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150844|NCT01736358|Ketorolac|ketorolac|mesh-list
56150845|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56150846|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56150847|NCT01736358|Analgesics|analgesics|mesh-ancestor
56150848|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
56150849|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150850|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150851|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56150852|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56150853|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56150854|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150855|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150856|NCT01740258|Bevacizumab|bevacizumab|mesh-list
56150857|NCT01740258|Temozolomide|temozolomide|mesh-list
56150858|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56150859|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150860|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56150861|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56150862|NCT01740258|Growth Substances|growth substances|mesh-ancestor
56150863|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150864|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
56150865|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56150866|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
56150867|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150868|NCT01740414|Ibudilast|ibudilast|mesh-list
56150869|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56150870|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
56150871|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150872|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150873|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56150874|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
56150875|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56150876|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175969|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
56150877|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150878|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56150879|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
56150881|NCT01740726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56150882|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56150891|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56150892|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56150893|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150894|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56150895|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56150896|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150897|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56150898|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150899|NCT01744704|Mitogens|mitogens|mesh-list
56150900|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
56658789|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
56658790|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
56658791|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
56658792|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658793|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658794|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56658795|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56658796|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658797|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56658798|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56658799|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
56658801|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220481|NCT01656720|Methoxamine|methoxamine|mesh-list
56150901|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150902|NCT01746264|Vitamin D|vitamin d|mesh-list
56150903|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
56150904|NCT01746264|Vitamins|vitamins|mesh-ancestor
56150905|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
56150906|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150907|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56150908|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56150909|NCT01746420|Becaplermin|becaplermin|mesh-list
56150910|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
56150911|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56150912|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56150913|NCT01746420|Growth Substances|growth substances|mesh-ancestor
56150914|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150916|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56150917|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56150918|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
56150919|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150920|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150921|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150922|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56150923|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56150924|NCT01750086|Denosumab|denosumab|mesh-list
56150925|NCT01750086|Alendronate|alendronate|mesh-list
56150926|NCT01750086|Teriparatide|teriparatide|mesh-list
56150927|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56150928|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150929|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56150930|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
56150931|NCT01750398|Leuprolide|leuprolide|mesh-list
56150932|NCT01750398|Goserelin|goserelin|mesh-list
56150933|NCT01750398|Testosterone|testosterone|mesh-list
56150934|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
56150935|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
56150936|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56150937|NCT01750398|Androgens|androgens|mesh-ancestor
56150938|NCT01750398|Hormones|hormones|mesh-ancestor
56150939|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150940|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150941|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56150942|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150943|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
56150944|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56175971|NCT01392898|Liraglutide|liraglutide|mesh-list
56150946|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56150947|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
56150949|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56150950|NCT01752426|Protective Agents|protective agents|mesh-ancestor
56150951|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658802|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56658803|NCT02772029|Apatinib|apatinib|mesh-list
56658804|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658805|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56658806|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658807|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658808|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
56658809|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
56658810|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56658811|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56658812|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150953|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56150954|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150955|NCT01753362|Incretins|incretins|mesh-ancestor
56150956|NCT01753362|Hormones|hormones|mesh-ancestor
56150957|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150958|NCT01758432|Apixaban|apixaban|mesh-list
56150959|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56150960|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
56150961|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56150962|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
56150963|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150964|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150965|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
56150966|NCT01758588|Interferons|interferons|mesh-list
56150967|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
56150968|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56150969|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150970|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
56150971|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56150972|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
56150973|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150974|NCT01759602|Complement C1s|complement c1s|mesh-list
56150975|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56150976|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56150977|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
56150978|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150979|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56150980|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56150981|NCT01760304|Budesonide|budesonide|mesh-list
56150982|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
56150983|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56150984|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56150985|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
56150986|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56150987|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150988|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56150989|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
56150990|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
56150992|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56150993|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56150994|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56150995|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56150996|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
56150997|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150998|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150999|NCT01763346|Metformin|metformin|mesh-list
56151000|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56151001|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151002|NCT01766076|Atorvastatin|atorvastatin|mesh-list
56151003|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56151004|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56151005|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
55888750|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56658813|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658814|NCT02766725|Urological Agents|urological agents|mesh-ancestor
56658815|NCT02658422|Montelukast|montelukast|mesh-list
56658816|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56658817|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56658818|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56658819|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
56658820|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658821|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658822|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56658823|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56220501|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
56151006|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151007|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56151008|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56151009|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151010|NCT01766466|Ticagrelor|ticagrelor|mesh-list
56151011|NCT01766466|Cangrelor|cangrelor|mesh-list
56151012|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56151013|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56151014|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56151015|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56151016|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
56151017|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151018|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151019|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151020|NCT01767792|Bevacizumab|bevacizumab|mesh-list
56151021|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
56151026|NCT01767792|Growth Substances|growth substances|mesh-ancestor
56151027|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151028|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
56151029|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
56151030|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56151031|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
56151032|NCT01769586|Promethazine|promethazine|mesh-list
56151033|NCT01769586|Midazolam|midazolam|mesh-list
56151034|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56151035|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56151036|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151037|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151038|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56151039|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56151040|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56151041|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56151042|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
56151043|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
56151044|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
56151045|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
56151046|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151047|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151048|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56151049|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
56151050|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
56151051|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151052|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
56151053|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
56151054|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56151055|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56151056|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
56151057|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
56151058|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56658824|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658825|NCT02771795|Trastuzumab|trastuzumab|mesh-list
56658826|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658827|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658828|NCT02655536|Bevacizumab|bevacizumab|mesh-list
56658829|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56658830|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658831|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658832|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56658833|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56658834|NCT02655536|Growth Substances|growth substances|mesh-ancestor
56658835|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658836|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
56658837|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56658838|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658839|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658840|NCT02766647|Lenograstim|lenograstim|mesh-list
56658841|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56658842|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
56658843|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658844|NCT02651636|Folic Acid|folic acid|mesh-list
56658845|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
56658846|NCT02651636|Inositol|inositol|mesh-list
56658847|NCT02651636|Hematinics|hematinics|mesh-ancestor
56658848|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
56658849|NCT02651636|Vitamins|vitamins|mesh-ancestor
56658850|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
56220521|NCT01656980|Carmustine|carmustine|mesh-list
56151059|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
56151060|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
56151061|NCT01773954|Aflibercept|aflibercept|mesh-list
56151062|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56151063|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56151064|NCT01773954|Growth Substances|growth substances|mesh-ancestor
56151065|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151066|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
56151067|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151069|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56151070|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151071|NCT01783236|Acetaminophen|acetaminophen|mesh-list
56151072|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56151073|NCT01783236|Analgesics|analgesics|mesh-ancestor
56151074|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
56151075|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151076|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151077|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
56151078|NCT01783470|Mirabegron|mirabegron|mesh-list
56151079|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
56151080|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
56151081|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56658851|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658852|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
56658853|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658854|NCT02651636|Protective Agents|protective agents|mesh-ancestor
56658855|NCT02774993|Doxycycline|doxycycline|mesh-list
56658856|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56658857|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658858|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
56658859|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56658860|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56658861|NCT02774837|Tenofovir|tenofovir|mesh-list
56658862|NCT02774837|Telbivudine|telbivudine|mesh-list
56151082|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56151083|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151084|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151085|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175985|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151086|NCT01783470|Urological Agents|urological agents|mesh-ancestor
56151087|NCT01783860|Azithromycin|azithromycin|mesh-list
56151088|NCT01783860|Doxycycline|doxycycline|mesh-list
56151089|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56151090|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151091|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
56151092|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56151093|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56151094|NCT01785186|Pyridoxine|pyridoxine|mesh-list
56151097|NCT01785186|Isoniazid|isoniazid|mesh-list
56151098|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
56151099|NCT01785186|Ethambutol|ethambutol|mesh-list
56151100|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56151101|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151102|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56151103|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56151104|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151105|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151106|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151107|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151108|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56151109|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
56151110|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
56151111|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56151112|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56151113|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56151114|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56151115|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56151116|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56151117|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56151118|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56151119|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56151121|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56151122|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
56151123|NCT01785186|Vitamins|vitamins|mesh-ancestor
56151124|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
56151125|NCT01785810|Maraviroc|maraviroc|mesh-list
56151126|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56151127|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56151128|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151129|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56151130|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56151131|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
56151132|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151133|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56151134|NCT01786902|Hormones|hormones|mesh-list
56151135|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658863|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
56658864|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658865|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56658866|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56658867|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220545|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56151136|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151137|NCT01787916|Liraglutide|liraglutide|mesh-list
56151138|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56151139|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151140|NCT01787916|Incretins|incretins|mesh-ancestor
56151141|NCT01787916|Hormones|hormones|mesh-ancestor
56151142|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56151143|NCT01790490|Ketamine|ketamine|mesh-list
56151144|NCT01790490|Lorazepam|lorazepam|mesh-list
56151145|NCT01790490|Analgesics|analgesics|mesh-ancestor
56151146|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
56151147|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151148|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151149|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56151150|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56151151|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
56151152|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
56151153|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151154|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56175992|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
56151155|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56151156|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151157|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151158|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
56151159|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
56151160|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
56151161|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56151162|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56151163|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56151164|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56151165|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56151166|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
56151167|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
56151168|NCT01791972|Albuterol|albuterol|mesh-list
56151169|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56151171|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151172|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151173|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56151174|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
56151175|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
56151176|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56151177|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56151178|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56151179|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56151180|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
56151181|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151182|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151183|NCT01794702|Cytarabine|cytarabine|mesh-list
56151184|NCT01794702|Decitabine|decitabine|mesh-list
56151185|NCT01794702|Clofarabine|clofarabine|mesh-list
56151186|NCT01794702|Idarubicin|idarubicin|mesh-list
56151187|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56151188|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
56151189|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151190|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151191|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
56151192|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151193|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56151194|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
56151195|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151196|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151197|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56151198|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56151199|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56658868|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658869|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56658870|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56658871|NCT02658188|Gabapentin|gabapentin|mesh-list
56151200|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
56151201|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151202|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56151203|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151204|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151205|NCT01797822|Dexamethasone|dexamethasone|mesh-list
56151206|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
56151207|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56151208|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
56151209|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
56151210|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151211|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151212|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56151213|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
56078869|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
56151214|NCT01797822|Hormones|hormones|mesh-ancestor
56151215|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56151216|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56151217|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151218|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56151219|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56151220|NCT01809054|Aspirin|aspirin|mesh-list
56151221|NCT01809054|Fondaparinux|fondaparinux|mesh-list
56151222|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56151223|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56175993|NCT01393080|Cisplatin|cisplatin|mesh-list
56151224|NCT01809054|Analgesics|analgesics|mesh-ancestor
56151225|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
56151226|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151227|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151228|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56151229|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56151230|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56151231|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56151232|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151233|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56151234|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56151235|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151236|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
56151237|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56151238|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
56151239|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56151240|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
56151241|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
56151242|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
56151244|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
56151245|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151246|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151247|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56151248|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
56151249|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
56151250|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56151251|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
56151252|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151253|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151254|NCT01811940|Topiramate|topiramate|mesh-list
56151255|NCT01811940|Adderall|adderall|mesh-list
56151256|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
56151257|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56151258|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151259|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56151260|NCT01813734|Ponatinib|ponatinib|mesh-list
56151261|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151262|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56151263|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151264|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151265|NCT01818414|Vitamins|vitamins|mesh-list
56151266|NCT01818414|Folic Acid|folic acid|mesh-list
56658872|NCT02658188|Analgesics|analgesics|mesh-ancestor
56658873|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
56304986|NCT00015249|Analgesics|analgesics|mesh-ancestor
56151267|NCT01818414|Misoprostol|misoprostol|mesh-list
56151268|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
56151269|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151270|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56151272|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56151273|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56151274|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56151275|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
56151276|NCT01818414|Hematinics|hematinics|mesh-ancestor
56151277|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
56151278|NCT01820754|Paclitaxel|paclitaxel|mesh-list
56151279|NCT01820754|Carboplatin|carboplatin|mesh-list
56151280|NCT01820754|Ipilimumab|ipilimumab|mesh-list
56151281|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56151282|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151283|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
56151284|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
56151285|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
56151286|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151287|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56151288|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56151289|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56151290|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56151291|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56151292|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151293|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151294|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56151295|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56151296|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56151297|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56151298|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
56151299|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151300|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151301|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56151302|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56151303|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
56151304|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56151305|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56151306|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
56151307|NCT01822548|Metformin|metformin|mesh-list
56151308|NCT01822548|Vildagliptin|vildagliptin|mesh-list
56151309|NCT01822548|Glyburide|glyburide|mesh-list
56151310|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56151311|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151312|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56151313|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
56151314|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151315|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151316|NCT01825122|Nadolol|nadolol|mesh-list
56151317|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56151318|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56151321|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151322|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151323|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56151324|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56151325|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
56151326|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
56151327|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151328|NCT01825512|Deferasirox|deferasirox|mesh-list
56151329|NCT01825512|Deferiprone|deferiprone|mesh-list
56151330|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56151331|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
56151332|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
56151333|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151334|NCT01827462|Vaccines|vaccines|mesh-list
56151335|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
56151336|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151337|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
56151338|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151339|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56658876|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
56658877|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56658878|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56658879|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151340|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151341|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151342|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
56151343|NCT01828476|Navitoclax|navitoclax|mesh-list
56151344|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
56151345|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56151346|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56151347|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151348|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151349|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151350|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56151351|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151352|NCT01828554|Capecitabine|capecitabine|mesh-list
56151353|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56151354|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
56151355|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151356|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151357|NCT01833546|Gemcitabine|gemcitabine|mesh-list
56151358|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56151359|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
56151360|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151361|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151362|NCT01833546|Antiviral Agents|antiviral agents|mesh-ancestor
56151363|NCT01833546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151364|NCT01833546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151365|NCT01833546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56151366|NCT01833546|Immunologic Factors|immunologic factors|mesh-ancestor
56151367|NCT01833546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151369|NCT01834404|Phentermine|phentermine|mesh-list
56151370|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
56151371|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56151372|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151373|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56176000|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
56151374|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
56151375|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56151376|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
56151377|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
56151378|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151379|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
56151380|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151381|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151382|NCT01835262|Ketamine|ketamine|mesh-list
56151383|NCT01835262|Morphine|morphine|mesh-list
56151384|NCT01835262|Analgesics|analgesics|mesh-ancestor
56151385|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
56151386|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151387|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151388|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56151389|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56151390|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
56151391|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
56151392|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151396|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151397|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56151398|NCT01835262|Narcotics|narcotics|mesh-ancestor
56151399|NCT01835496|Deferiprone|deferiprone|mesh-list
56151400|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56151401|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
56151402|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
56151403|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151404|NCT01842594|Sirolimus|sirolimus|mesh-list
56151405|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
56151406|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56151407|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151408|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56151409|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151410|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
56658880|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56658881|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56658882|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56658883|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658884|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658885|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
56658886|NCT02771717|Budesonide|budesonide|mesh-list
56658887|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56658888|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56658889|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
56658890|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658891|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658892|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56658893|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
56658894|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
56658895|NCT02771717|Hormones|hormones|mesh-ancestor
56658896|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56658897|NCT02655380|Ketamine|ketamine|mesh-list
56658898|NCT02655380|Remifentanil|remifentanil|mesh-list
56658899|NCT02655380|Analgesics|analgesics|mesh-ancestor
56151411|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56151412|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
56151413|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151414|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
56151415|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56151416|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56151417|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151418|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151419|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56151420|NCT01843920|Trimethoprim|trimethoprim|mesh-list
56151421|NCT01843920|Polymyxins|polymyxins|mesh-list
56151422|NCT01843920|Polymyxin B|polymyxin b|mesh-list
56151423|NCT01843920|Prednisolone|prednisolone|mesh-list
56151424|NCT01843920|Timolol|timolol|mesh-list
56151425|NCT01843920|Dorzolamide|dorzolamide|mesh-list
56151426|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56151427|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
56151428|NCT01843920|Hormones|hormones|mesh-ancestor
56151429|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56151430|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151431|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56151432|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151433|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56151434|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56151435|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
56151436|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151437|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151438|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56151439|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56151440|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56079096|NCT00003327|Paclitaxel|paclitaxel|mesh-list
56151441|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151442|NCT01843920|Renal Agents|renal agents|mesh-ancestor
56151443|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
56151444|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56151445|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56658900|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
56658901|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56658902|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658903|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56658904|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56658905|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
56658906|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
56658907|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56220575|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56151446|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56151447|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151448|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56151449|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56151450|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56151451|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56151452|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56151453|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56151454|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56151455|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56151456|NCT01844388|Laxatives|laxatives|mesh-ancestor
56151457|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56151458|NCT01845636|Atropine|atropine|mesh-list
56151459|NCT01845636|Donepezil|donepezil|mesh-list
56151460|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56151461|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56151462|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56151463|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151464|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151469|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56151470|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56151471|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56151473|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151474|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56151475|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
56151476|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
56151477|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
56151478|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56151479|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56151480|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
56151481|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151482|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56151483|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151484|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151485|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
56151486|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56151487|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151488|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56151489|NCT01846728|Estrogens|estrogens|mesh-list
56151490|NCT01846728|Hormones|hormones|mesh-ancestor
56151491|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56151492|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151493|NCT01848054|Buprenorphine|buprenorphine|mesh-list
56151494|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56151495|NCT01848054|Naloxone|naloxone|mesh-list
56151497|NCT01848054|Narcotics|narcotics|mesh-ancestor
56151498|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151499|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151500|NCT01848054|Analgesics|analgesics|mesh-ancestor
56151501|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
56151502|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151503|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56151504|NCT01849068|Ezetimibe|ezetimibe|mesh-list
56151505|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56151506|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56151507|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
56658908|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56658909|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56658910|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658911|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658912|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56658913|NCT02655380|Narcotics|narcotics|mesh-ancestor
56658914|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
56658915|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56151508|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151509|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56151510|NCT01849692|Ranibizumab|ranibizumab|mesh-list
56151511|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56151512|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56151513|NCT01849692|Growth Substances|growth substances|mesh-ancestor
56151514|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151515|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
56151516|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151517|NCT01849770|Mexiletine|mexiletine|mesh-list
56151518|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56176003|NCT01393145|Xhance|xhance|mesh-list
56151519|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56151520|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56151521|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56151522|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151523|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
56151524|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56151525|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56151526|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151528|NCT01850394|Coagulants|coagulants|mesh-ancestor
56151529|NCT01852344|Methylphenidate|methylphenidate|mesh-list
56151530|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56151531|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151532|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56151533|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56151534|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56151537|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151539|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56151540|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56151541|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151542|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
56151543|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151544|NCT01858428|Paclitaxel|paclitaxel|mesh-list
56151545|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56151546|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151547|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
56151548|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
56151549|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
56151550|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151551|NCT01861002|Cytarabine|cytarabine|mesh-list
56151552|NCT01861002|Methotrexate|methotrexate|mesh-list
56151553|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
56151554|NCT01861002|Azacitidine|azacitidine|mesh-list
56151555|NCT01861002|Fludarabine|fludarabine|mesh-list
56151556|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56151557|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
56151558|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56151559|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151560|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56151561|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
56151562|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151563|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151564|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
56151565|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151566|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56658916|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
56658917|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658918|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56658919|NCT00987103|Tacrolimus|tacrolimus|mesh-list
56658920|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56151567|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56151568|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
56151569|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56151570|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56151571|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
56151572|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151574|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56151575|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
56151576|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151577|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151578|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
56151579|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151580|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56151581|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
56151582|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151583|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56151584|NCT01875510|SMOFlipid|smoflipid|mesh-list
56151585|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56151586|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56151587|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56151588|NCT01876212|Dasatinib|dasatinib|mesh-list
56151589|NCT01876212|Vaccines|vaccines|mesh-list
56079253|NCT03576001|Testosterone|testosterone|mesh-list
56151590|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
56151591|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151593|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56151594|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151595|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151596|NCT01876992|Metformin|metformin|mesh-list
56151597|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56151598|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151599|NCT01877538|Donepezil|donepezil|mesh-list
56151600|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56151601|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151602|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151603|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
56151604|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151605|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151606|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
56151607|NCT01878006|Morphine|morphine|mesh-list
56151608|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56151615|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56151616|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
56151617|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56151618|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56151619|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56151620|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151621|NCT05328102|Lenalidomide|lenalidomide|mesh-list
56151622|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
56151623|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151624|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56151625|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56151626|NCT05328102|Growth Substances|growth substances|mesh-ancestor
56151627|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
56151628|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151629|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
56151630|NCT05327088|Nalbuphine|nalbuphine|mesh-list
56151631|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56151632|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151633|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151634|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56151635|NCT05327088|Analgesics|analgesics|mesh-ancestor
56151636|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
56151637|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151638|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55924561|NCT00081289|Hematinics|hematinics|mesh-ancestor
56658921|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
56658922|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658923|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56658924|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56658925|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658926|NCT02655458|Lenalidomide|lenalidomide|mesh-list
56658927|NCT02655458|Elotuzumab|elotuzumab|mesh-list
56658928|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
56658929|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658930|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56658931|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56658932|NCT02655458|Growth Substances|growth substances|mesh-ancestor
56658933|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
56658934|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658935|NCT04006093|Apixaban|apixaban|mesh-list
56658936|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56658937|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
56658938|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56658939|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
56658940|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151639|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56151640|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56151641|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
56151642|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732358|NCT00846430|Celecoxib|celecoxib|mesh-list
56151643|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151645|NCT05327088|Narcotics|narcotics|mesh-ancestor
56151646|NCT05290194|Capecitabine|capecitabine|mesh-list
56151647|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56151648|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56151649|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
56151650|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151651|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151652|NCT05228574|Amiloride|amiloride|mesh-list
56151653|NCT05228574|Diuretics|diuretics|mesh-ancestor
56151654|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
56151655|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151656|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56151657|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56151658|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56151659|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151660|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56151661|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56151662|NCT04986072|Nitroprusside|nitroprusside|mesh-list
56151663|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56151664|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
56151665|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56151666|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151667|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56151669|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151670|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56151671|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151672|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56151673|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
56151674|NCT04103034|Coagulants|coagulants|mesh-ancestor
56658941|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658942|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
56658943|NCT02766257|Anesthetics|anesthetics|mesh-list
56658944|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658945|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305061|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
56658964|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56658965|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
56658966|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
56658967|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56658968|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56658969|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56658970|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658971|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658972|NCT00662220|Ribavirin|ribavirin|mesh-list
56658973|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56658974|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
56658975|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
56658976|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658977|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
56658978|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56658979|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
56658980|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658981|NCT02575924|Imidacloprid|imidacloprid|mesh-list
56658982|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
56151675|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56151676|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
56151677|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151682|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
56151683|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151684|NCT03222570|Serotonin|serotonin|mesh-list
56151685|NCT03222570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56151686|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56151687|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
56151688|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151689|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151690|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151691|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56151692|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56151693|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
56151694|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151695|NCT02766582|Paclitaxel|paclitaxel|mesh-list
56151696|NCT02766582|Carboplatin|carboplatin|mesh-list
56151697|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
56151698|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56151699|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151700|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56151701|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56151702|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56151703|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658983|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56658984|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56658985|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658986|NCT02651168|Aflibercept|aflibercept|mesh-list
56658987|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56658988|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56658989|NCT02651168|Growth Substances|growth substances|mesh-ancestor
56658990|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658991|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
56658992|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658993|NCT04073602|Trastuzumab|trastuzumab|mesh-list
56220631|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151704|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56151705|NCT01643460|Ethanol|ethanol|mesh-list
56151706|NCT01643460|Paclitaxel|paclitaxel|mesh-list
56151707|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56151708|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56151709|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151710|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
56151711|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
56151712|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
56151713|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151714|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56151715|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151716|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732435|NCT02217982|Emollients|emollients|mesh-ancestor
56151717|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151718|NCT00954876|Capecitabine|capecitabine|mesh-list
56151719|NCT00954876|Cetuximab|cetuximab|mesh-list
56151720|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56151721|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
56151722|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151723|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151724|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56151725|NCT05748366|Analgesics|analgesics|mesh-list
56151726|NCT05748366|Sensory System Agents|sensory system agents|mesh-ancestor
56176020|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151727|NCT05748366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151728|NCT05748366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151729|NCT05747352|Insulin|insulin|mesh-list
56151730|NCT05747352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56151731|NCT05747352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151732|NCT05714670|Curcumin|curcumin|mesh-list
56151733|NCT05714670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56151734|NCT05714670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56151735|NCT05714670|Analgesics|analgesics|mesh-ancestor
56151736|NCT05714670|Sensory System Agents|sensory system agents|mesh-ancestor
56151737|NCT05714670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151738|NCT05714670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151739|NCT05714670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56151740|NCT05714670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56151741|NCT05714670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151742|NCT05714670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151743|NCT05714670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151744|NCT05712018|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56151745|NCT05712018|Plasma Substitutes|plasma substitutes|mesh-ancestor
56151746|NCT05712018|Blood Substitutes|blood substitutes|mesh-ancestor
56151755|NCT05505630|Midazolam|midazolam|mesh-list
56151756|NCT05505630|Ketamine|ketamine|mesh-list
56151757|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
56151758|NCT05505630|Anesthetics|anesthetics|mesh-list
56151759|NCT05505630|Analgesics|analgesics|mesh-ancestor
56151760|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
56658994|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56658995|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56658996|NCT00650000|Modafinil|modafinil|mesh-list
56658997|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56658998|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56658999|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56659000|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56659001|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56659002|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151761|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151762|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151763|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56151764|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
56151765|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151766|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56151767|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56151768|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151769|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151770|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56151771|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56151772|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56151773|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56151774|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56151775|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
56151776|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
56151777|NCT05472948|Capecitabine|capecitabine|mesh-list
56151778|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56151779|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
56151780|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151781|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151782|NCT05450562|Cemiplimab|cemiplimab|mesh-list
56151783|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56151784|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151785|NCT05215470|Nivolumab|nivolumab|mesh-list
56151786|NCT05215470|Ipilimumab|ipilimumab|mesh-list
56151787|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56151788|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151789|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55732510|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56151790|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151791|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56151792|NCT05206500|Amoxicillin|amoxicillin|mesh-list
56151793|NCT05206500|Metronidazole|metronidazole|mesh-list
56151794|NCT05206500|Clindamycin|clindamycin|mesh-list
56151795|NCT05206500|Linezolid|linezolid|mesh-list
56151796|NCT05206500|Tetracycline|tetracycline|mesh-list
56151797|NCT05206500|Penicillins|penicillins|mesh-list
56151798|NCT05206500|Ampicillin|ampicillin|mesh-list
56151799|NCT05206500|Fosfomycin|fosfomycin|mesh-list
56151800|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
56151801|NCT05206500|Cephalosporins|cephalosporins|mesh-list
56151802|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
56151803|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151804|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56151805|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56151806|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56151807|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151808|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151809|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56151810|NCT05206500|Renal Agents|renal agents|mesh-ancestor
56151811|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56151812|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56151813|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56151824|NCT05163522|Anesthetics, General|anesthetics, general|mesh-ancestor
56151825|NCT05163522|Anesthetics|anesthetics|mesh-ancestor
56151826|NCT05163522|GABA Modulators|gaba modulators|mesh-ancestor
56659003|NCT02630862|Aspirin|aspirin|mesh-list
56659004|NCT02630862|Dipyridamole|dipyridamole|mesh-list
56659005|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56659006|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659007|NCT02630862|Analgesics|analgesics|mesh-ancestor
56659008|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
56659009|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659010|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659011|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56659012|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659013|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56659014|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56659015|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659016|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56659017|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56659018|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659019|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
56151827|NCT05163522|GABA Agents|gaba agents|mesh-ancestor
56151828|NCT05163522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151829|NCT05163522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151830|NCT05151588|Docetaxel|docetaxel|mesh-list
56151831|NCT05151588|Fluorouracil|fluorouracil|mesh-list
56151832|NCT05151588|Cisplatin|cisplatin|mesh-list
56151833|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151834|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
56151835|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
56151836|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
56151837|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151838|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
56151839|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56151840|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56151841|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
56151842|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151843|NCT04963296|Acetaminophen|acetaminophen|mesh-list
56151844|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
56151845|NCT04963296|Promethazine|promethazine|mesh-list
56151846|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
56151847|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
56151848|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56151849|NCT04963296|Analgesics|analgesics|mesh-ancestor
56151850|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
56151851|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151852|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151853|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
56151854|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56151855|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
56151856|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
56151857|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56151858|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
56151859|NCT04963296|Hormones|hormones|mesh-ancestor
56151860|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56151861|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56151862|NCT04963296|Protective Agents|protective agents|mesh-ancestor
56151863|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151864|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56151865|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56151866|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56176026|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
56151867|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659020|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56305135|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
56659021|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
56659022|NCT02536430|Ketorolac|ketorolac|mesh-list
56659023|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56659024|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56659025|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659026|NCT02536430|Analgesics|analgesics|mesh-ancestor
56659027|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
56151868|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
56151869|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
56151870|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56151871|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
56151872|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
56151873|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151874|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151875|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56151876|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
56151877|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
56151879|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
56151880|NCT04886232|Lidocaine|lidocaine|mesh-list
56151911|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
56151912|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
56151913|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151914|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56151915|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56176037|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
56151945|NCT04470804|Cyclosporine|cyclosporine|mesh-list
56151946|NCT04470804|Sirolimus|sirolimus|mesh-list
56151947|NCT04470804|Cyclosporins|cyclosporins|mesh-list
56151948|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56151949|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151950|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56151951|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
56151953|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
56151954|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56151955|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
56151956|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56151957|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56151958|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56151959|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56151960|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151961|NCT04418466|Risperidone|risperidone|mesh-list
56151962|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56151963|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
56151964|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151965|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151966|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151967|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56151968|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56151969|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151970|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56151971|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56151972|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
56151974|NCT04360044|Cannabidiol|cannabidiol|mesh-list
56151975|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
56151976|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
56151977|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151978|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56151979|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56151980|NCT04360044|Analgesics|analgesics|mesh-ancestor
56151981|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
56151982|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151983|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56151984|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56151985|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151986|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888751|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56659028|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659029|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659030|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56659031|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659032|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56659033|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220672|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
56151988|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56151989|NCT04337814|Ibuprofen|ibuprofen|mesh-list
56151990|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56151991|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56151992|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56151993|NCT04337814|Analgesics|analgesics|mesh-ancestor
56151994|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
56151995|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151996|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151997|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56151998|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56151999|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56152000|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152001|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152002|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
56152003|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
56152004|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152005|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56152006|NCT04336332|Azithromycin|azithromycin|mesh-list
56152007|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
56152008|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56176038|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
56152009|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152010|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
56152011|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56152012|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56152013|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152014|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152015|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152016|NCT04318548|Vaccines|vaccines|mesh-list
56152017|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
56152018|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152019|NCT04230408|Paclitaxel|paclitaxel|mesh-list
56152020|NCT04230408|Carboplatin|carboplatin|mesh-list
56152021|NCT04230408|Durvalumab|durvalumab|mesh-list
56152022|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56152023|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152024|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56152025|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56152029|NCT04205838|Vidarabine|vidarabine|mesh-list
56152030|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
56152031|NCT04205838|Fludarabine|fludarabine|mesh-list
56152032|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
56152033|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56152034|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56152035|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
56152036|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152037|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152038|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56152039|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
56152040|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152041|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152042|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56152043|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56152044|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
56152045|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
56152046|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152047|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
56152048|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152049|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56152050|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659034|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659035|NCT02631174|Antithrombins|antithrombins|mesh-list
56659036|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
56152051|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152052|NCT03064542|Carbimazole|carbimazole|mesh-list
56152053|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
56152054|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
56152055|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152056|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152057|NCT02718066|Nivolumab|nivolumab|mesh-list
56152058|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152059|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152060|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56152061|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152062|NCT02004522|Ofatumumab|ofatumumab|mesh-list
56152063|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152064|NCT02000622|Olaparib|olaparib|mesh-list
56152065|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56152066|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152067|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152068|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152069|NCT01724346|Chlorambucil|chlorambucil|mesh-list
56152070|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56152071|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
56152072|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152073|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152074|NCT01472562|Rituximab|rituximab|mesh-list
56152075|NCT01472562|Lenalidomide|lenalidomide|mesh-list
56152076|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152077|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152078|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
56152079|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152080|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152081|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56152082|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56152083|NCT01472562|Growth Substances|growth substances|mesh-ancestor
56152084|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
56152085|NCT01430442|Sumatriptan|sumatriptan|mesh-list
56152086|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56152087|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56152088|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56152089|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
56152090|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152091|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152092|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152093|NCT01420926|Bortezomib|bortezomib|mesh-list
56152094|NCT01420926|Decitabine|decitabine|mesh-list
56152095|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152099|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152101|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56152102|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152103|NCT01887132|Donepezil|donepezil|mesh-list
56152104|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56152105|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152106|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152107|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
56152108|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152109|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152110|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
56152111|NCT01887990|Ketamine|ketamine|mesh-list
56152112|NCT01887990|Analgesics|analgesics|mesh-ancestor
56152113|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
56152114|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152115|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152116|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56152117|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56152118|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
56152120|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152121|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56152122|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56659037|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56659038|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
56659039|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659040|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659041|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
56659042|NCT04686929|Abatacept|abatacept|mesh-list
56152123|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152124|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152125|NCT01890642|Lidocaine|lidocaine|mesh-list
56152126|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
56152127|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
56152128|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152129|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152130|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
56152131|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152132|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56152133|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56152134|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56152135|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56152136|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152137|NCT01891968|Bortezomib|bortezomib|mesh-list
56152138|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152139|NCT01901250|Fluorides|fluorides|mesh-list
56152140|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
56152141|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
56152142|NCT01901250|Protective Agents|protective agents|mesh-ancestor
56152143|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152144|NCT01904526|Guanfacine|guanfacine|mesh-list
56152145|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56152146|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56152147|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56152148|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56152149|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56152150|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152151|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152152|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152153|NCT01906866|Melatonin|melatonin|mesh-list
56152154|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
56152155|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152156|NCT01906866|Protective Agents|protective agents|mesh-ancestor
56152157|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152158|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152159|NCT01907334|Fluticasone|fluticasone|mesh-list
56152161|NCT01907334|Albuterol|albuterol|mesh-list
56152162|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56152163|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56152164|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
56152165|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56152166|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56152167|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
56152176|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56152177|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
56152178|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152179|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152180|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
56152181|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56152182|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
56152184|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152185|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
56152186|NCT01907334|Miotics|miotics|mesh-ancestor
56152187|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56152188|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56152189|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56152190|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56152191|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
56152192|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
56152193|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
56152194|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
56152195|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659043|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56659044|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659045|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659046|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56152196|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152197|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
56152198|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152199|NCT01908972|Prednisolone|prednisolone|mesh-list
56152200|NCT01908972|Propranolol|propranolol|mesh-list
56152201|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56152202|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
56152203|NCT01908972|Hormones|hormones|mesh-ancestor
56152204|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152205|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152206|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56152207|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152208|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56152209|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56152210|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
56152211|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152212|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152213|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56152214|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56152215|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
56152216|NCT01910064|Adapalene|adapalene|mesh-list
56152217|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56152218|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
56152219|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56152220|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56152221|NCT01910064|Analgesics|analgesics|mesh-ancestor
56152222|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
56152223|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152224|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152225|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56152226|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152227|NCT01912716|Indomethacin|indomethacin|mesh-list
56152228|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56152229|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56152230|NCT01912716|Analgesics|analgesics|mesh-ancestor
56152231|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
56152232|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152237|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
56152238|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56152239|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56152240|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152241|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152242|NCT01920282|Nebivolol|nebivolol|mesh-list
56152243|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56152244|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
56152245|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56152246|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56152247|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56152248|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
56152249|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152250|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152251|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152252|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
56152253|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56152254|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
56152255|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56152256|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56152257|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152258|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56152259|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152260|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56152261|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152262|NCT01929642|Sirolimus|sirolimus|mesh-list
56152263|NCT01929642|Everolimus|everolimus|mesh-list
56152264|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659047|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
56659048|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659049|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659050|NCT02765633|Cangrelor|cangrelor|mesh-list
56152265|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56152267|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152268|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56152269|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152270|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56152271|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
56152272|NCT01932060|Oxytocin|oxytocin|mesh-list
56152273|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
56152274|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56152275|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152276|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
56152277|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56152278|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
56152279|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152280|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56152281|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56152282|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
56152283|NCT01933776|Vaccines|vaccines|mesh-list
56152284|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
56152285|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152286|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56152287|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
56152288|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56152289|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56152290|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
56152291|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152292|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152293|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56152294|NCT01937598|Liraglutide|liraglutide|mesh-list
56176053|NCT01393340|Omalizumab|omalizumab|mesh-list
56152295|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56152296|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152297|NCT01937598|Incretins|incretins|mesh-ancestor
56152298|NCT01937598|Hormones|hormones|mesh-ancestor
56152299|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152300|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56152301|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
56152302|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152303|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152306|NCT01942668|Estradiol|estradiol|mesh-list
56152307|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56152308|NCT01942668|Progesterone|progesterone|mesh-list
56152309|NCT01942668|Estrogens|estrogens|mesh-ancestor
56152310|NCT01942668|Hormones|hormones|mesh-ancestor
56152311|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152312|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152313|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56152314|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
56152315|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56152316|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56152318|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
56152319|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
56152320|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56152321|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56152322|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152323|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152324|NCT01948518|Urological Agents|urological agents|mesh-ancestor
56152325|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
56152326|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56152327|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152328|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56152329|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152330|NCT01949844|Regadenoson|regadenoson|mesh-list
56152331|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56152332|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56152333|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
56659051|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56659052|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56659053|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56659054|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56659055|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
56659056|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659057|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659058|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659059|NCT00581776|Dexamethasone|dexamethasone|mesh-list
56659060|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
56659061|NCT00581776|Rituximab|rituximab|mesh-list
56659062|NCT00581776|Doxorubicin|doxorubicin|mesh-list
56659063|NCT00581776|Vincristine|vincristine|mesh-list
56659064|NCT00581776|Bortezomib|bortezomib|mesh-list
56659065|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56659066|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
56659067|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659068|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659069|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56659070|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
56220691|NCT01657812|Analgesics|analgesics|mesh-ancestor
56152334|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
56152335|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152336|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152337|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152338|NCT01951950|Nicardipine|nicardipine|mesh-list
56152339|NCT01951950|Esmolol|esmolol|mesh-list
56152340|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56152341|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56152342|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56152343|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
56152344|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152345|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152346|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152347|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56152348|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56152349|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56152350|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56152351|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
56152353|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56152354|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56152355|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56152356|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56152357|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
56152358|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152359|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152360|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152361|NCT01955382|Artesunate|artesunate|mesh-list
56152362|NCT01955382|Amodiaquine|amodiaquine|mesh-list
56152363|NCT01955382|Charcoal|charcoal|mesh-list
56152364|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
56152365|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56152366|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56659071|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659072|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659073|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56659074|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56659075|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56659076|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
56659077|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
56659078|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659079|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56659080|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
56152367|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152368|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152369|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
56152370|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
56152371|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56152372|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
56152373|NCT01955382|Antidotes|antidotes|mesh-ancestor
56152374|NCT01955382|Protective Agents|protective agents|mesh-ancestor
56152375|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152377|NCT01957410|Analgesics|analgesics|mesh-ancestor
56152378|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
56152381|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56152382|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56152383|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
56152385|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152386|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56152387|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56152388|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152389|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152390|NCT01958112|Trametinib|trametinib|mesh-list
56152391|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152392|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56152393|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152394|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152395|NCT05740098|Nicotine|nicotine|mesh-list
56152396|NCT05740098|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56152397|NCT05740098|Autonomic Agents|autonomic agents|mesh-ancestor
56152398|NCT05740098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152399|NCT05740098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152400|NCT05740098|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56152401|NCT05740098|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56152402|NCT05740098|Cholinergic Agents|cholinergic agents|mesh-ancestor
56152403|NCT05740098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152404|NCT05740098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152405|NCT05739786|Vitamin D|vitamin d|mesh-list
56152406|NCT05739786|Cholecalciferol|cholecalciferol|mesh-list
56152407|NCT05739786|Vitamins|vitamins|mesh-ancestor
56152408|NCT05739786|Micronutrients|micronutrients|mesh-ancestor
56152409|NCT05739786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152410|NCT05739786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56152411|NCT05739786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56152412|NCT05739630|Cytarabine|cytarabine|mesh-list
56152413|NCT05739630|Cyclophosphamide|cyclophosphamide|mesh-list
56152414|NCT05739630|Busulfan|busulfan|mesh-list
56152416|NCT05739630|Mitoxantrone|mitoxantrone|mesh-list
56152417|NCT05739630|Tacrolimus|tacrolimus|mesh-list
56152418|NCT05739630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56152419|NCT05739630|Immunologic Factors|immunologic factors|mesh-ancestor
56152420|NCT05739630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152421|NCT05739630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152422|NCT05739630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56152423|NCT05739630|Alkylating Agents|alkylating agents|mesh-ancestor
56152424|NCT05739630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152425|NCT05739630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152426|NCT05739630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56659081|NCT00581776|Hormones|hormones|mesh-ancestor
56659082|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659083|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56659084|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56659085|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56659086|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56659087|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659088|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56659089|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
56152427|NCT05739630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56152428|NCT05739630|Antimetabolites|antimetabolites|mesh-ancestor
56152429|NCT05739630|Antiviral Agents|antiviral agents|mesh-ancestor
56152430|NCT05739630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152431|NCT05739630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56152432|NCT05739630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152433|NCT05739630|Analgesics|analgesics|mesh-ancestor
56152434|NCT05739630|Sensory System Agents|sensory system agents|mesh-ancestor
56152435|NCT05739630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152436|NCT05739630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56152437|NCT05739630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56152438|NCT05739474|Vaccines|vaccines|mesh-list
56152439|NCT05739474|Immunologic Factors|immunologic factors|mesh-ancestor
56152440|NCT05739474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152441|NCT05739006|Pembrolizumab|pembrolizumab|mesh-list
56152442|NCT05739006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152443|NCT05739006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152445|NCT05738616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152446|NCT05738616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56152447|NCT05738616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152448|NCT05738616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152449|NCT05738460|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56152450|NCT05738460|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56152451|NCT05738460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152452|NCT05738460|Antitubercular Agents|antitubercular agents|mesh-ancestor
56152453|NCT05738382|Cetrorelix|cetrorelix|mesh-list
56152454|NCT05738382|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56152455|NCT05738382|Fertility Agents|fertility agents|mesh-ancestor
56152456|NCT05738382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56152457|NCT05738382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152458|NCT05738382|Hormone Antagonists|hormone antagonists|mesh-ancestor
56152459|NCT05738382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152460|NCT05737680|Hydroxychloroquine|hydroxychloroquine|mesh-list
56152461|NCT05737680|Colchicine|colchicine|mesh-list
56152462|NCT05737680|Antimalarials|antimalarials|mesh-ancestor
56152463|NCT05737680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56152464|NCT05737680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56152465|NCT05737680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152466|NCT05737680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152467|NCT05737680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152468|NCT05737680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152469|NCT05737680|Gout Suppressants|gout suppressants|mesh-ancestor
56152470|NCT05737680|Tubulin Modulators|tubulin modulators|mesh-ancestor
56152471|NCT05737680|Antimitotic Agents|antimitotic agents|mesh-ancestor
56152472|NCT05737680|Mitosis Modulators|mitosis modulators|mesh-ancestor
56152473|NCT05737680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152474|NCT05736198|Dexmedetomidine|dexmedetomidine|mesh-list
56152475|NCT05736198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56152476|NCT05736198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152477|NCT05736198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152478|NCT05736198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56152479|NCT05736198|Analgesics|analgesics|mesh-ancestor
56152480|NCT05736198|Sensory System Agents|sensory system agents|mesh-ancestor
56152481|NCT05736198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152482|NCT05736198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56152483|NCT05736198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56659090|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
56659091|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
56659092|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56659093|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56659094|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
56659095|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56659096|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56659097|NCT00662454|Estradiol|estradiol|mesh-list
56659098|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56659099|NCT00662454|Estrogens|estrogens|mesh-ancestor
56659100|NCT00662454|Hormones|hormones|mesh-ancestor
56659101|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659102|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659103|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56659104|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
56152484|NCT05736198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56152485|NCT05736198|Adrenergic Agents|adrenergic agents|mesh-ancestor
56152486|NCT05736198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152487|NCT05736198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152488|NCT05735028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56080167|NCT00004095|Gemcitabine|gemcitabine|mesh-list
56152489|NCT05735028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152490|NCT05735028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152491|NCT05733624|Cyclosporine|cyclosporine|mesh-list
56152492|NCT05733624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56152493|NCT05733624|Cyclosporins|cyclosporins|mesh-list
56152494|NCT05733624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152495|NCT05733624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152496|NCT05733624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56152497|NCT05733624|Immunologic Factors|immunologic factors|mesh-ancestor
56152498|NCT05733624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152499|NCT05733624|Antifungal Agents|antifungal agents|mesh-ancestor
56152500|NCT05733624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152501|NCT05733624|Dermatologic Agents|dermatologic agents|mesh-ancestor
56152502|NCT05733624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152503|NCT05733624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56152504|NCT05733624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56152505|NCT05725200|Gemcitabine|gemcitabine|mesh-list
56152506|NCT05725200|Methotrexate|methotrexate|mesh-list
56152507|NCT05725200|Pembrolizumab|pembrolizumab|mesh-list
56152508|NCT05725200|Trastuzumab|trastuzumab|mesh-list
56152509|NCT05725200|Cetuximab|cetuximab|mesh-list
56152510|NCT05725200|Everolimus|everolimus|mesh-list
56152511|NCT05725200|Venetoclax|venetoclax|mesh-list
56152512|NCT05725200|Dasatinib|dasatinib|mesh-list
56152513|NCT05725200|Palbociclib|palbociclib|mesh-list
56152514|NCT05725200|Panobinostat|panobinostat|mesh-list
56152515|NCT05725200|Crizotinib|crizotinib|mesh-list
56176061|NCT01393548|Ephedrine|ephedrine|mesh-list
56152517|NCT05725200|Idelalisib|idelalisib|mesh-list
56152518|NCT05725200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56152519|NCT05725200|Antimetabolites|antimetabolites|mesh-ancestor
56152520|NCT05725200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152521|NCT05725200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152522|NCT05725200|Antiviral Agents|antiviral agents|mesh-ancestor
56152523|NCT05725200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152524|NCT05725200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152525|NCT05725200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56152526|NCT05725200|Immunologic Factors|immunologic factors|mesh-ancestor
56152527|NCT05725200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152528|NCT05725200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152529|NCT05725200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56659105|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56659106|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56152533|NCT05725200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56152534|NCT05725200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152535|NCT05725200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56152536|NCT05725200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56152537|NCT05725200|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56152538|NCT05725200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56152539|NCT05721144|Nitric Oxide|nitric oxide|mesh-list
56152540|NCT05721144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56152541|NCT05721144|Autonomic Agents|autonomic agents|mesh-ancestor
56152542|NCT05721144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152543|NCT05721144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152544|NCT05721144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56152545|NCT05721144|Respiratory System Agents|respiratory system agents|mesh-ancestor
56152546|NCT05721144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56152547|NCT05721144|Antioxidants|antioxidants|mesh-ancestor
56152548|NCT05721144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152549|NCT05721144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152550|NCT05721144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56152551|NCT05721144|Vasodilator Agents|vasodilator agents|mesh-ancestor
56152552|NCT05721144|Gasotransmitters|gasotransmitters|mesh-ancestor
56152553|NCT05721144|Protective Agents|protective agents|mesh-ancestor
56152554|NCT05685732|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56152555|NCT05685732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56152556|NCT05685732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152557|NCT05685732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56152558|NCT05685732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56152559|NCT05685732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56152560|NCT05685732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152561|NCT05685732|Dopamine Agents|dopamine agents|mesh-ancestor
56152562|NCT05685732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152563|NCT05665140|Dexamethasone|dexamethasone|mesh-list
56152564|NCT05665140|Lenalidomide|lenalidomide|mesh-list
56152566|NCT05665140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56152567|NCT05665140|Antiemetics|antiemetics|mesh-ancestor
56152568|NCT05665140|Autonomic Agents|autonomic agents|mesh-ancestor
56152569|NCT05665140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152570|NCT05665140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152571|NCT05665140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56152572|NCT05665140|Glucocorticoids|glucocorticoids|mesh-ancestor
56152573|NCT05665140|Hormones|hormones|mesh-ancestor
56152574|NCT05665140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152575|NCT05665140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56152576|NCT05665140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152577|NCT05665140|Immunologic Factors|immunologic factors|mesh-ancestor
56152578|NCT05665140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56152579|NCT05665140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56152580|NCT05665140|Growth Substances|growth substances|mesh-ancestor
56152581|NCT05665140|Growth Inhibitors|growth inhibitors|mesh-ancestor
56152582|NCT05664750|Immunoglobulins|immunoglobulins|mesh-list
56152583|NCT05664750|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56152584|NCT05664750|Antibodies|antibodies|mesh-list
56152585|NCT05664750|Immunologic Factors|immunologic factors|mesh-ancestor
56152586|NCT05664750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152588|NCT05650008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152589|NCT05650008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152590|NCT05574894|Hormones|hormones|mesh-list
56152591|NCT05574894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152592|NCT05574894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152593|NCT05567952|Ritonavir|ritonavir|mesh-list
56152594|NCT05567952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56152595|NCT05567952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56152596|NCT05567952|Protease Inhibitors|protease inhibitors|mesh-ancestor
56152597|NCT05567952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152598|NCT05567952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152599|NCT05567952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56152600|NCT05567952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56152601|NCT05567952|Antiviral Agents|antiviral agents|mesh-ancestor
56152604|NCT05567952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56152605|NCT05530278|Midazolam|midazolam|mesh-list
56659107|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56659108|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56659109|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56659110|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56659111|NCT04156152|Listerine|listerine|mesh-list
56659112|NCT04156152|Fluorides|fluorides|mesh-list
56659113|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
56659114|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
56659115|NCT04156152|Protective Agents|protective agents|mesh-ancestor
56659116|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659117|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56659118|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659119|NCT00662610|Naproxen|naproxen|mesh-list
56659120|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56659121|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56659122|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659123|NCT00662610|Analgesics|analgesics|mesh-ancestor
56659124|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
56152606|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56152607|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56152608|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152609|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152610|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56152611|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56152612|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56152613|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56152614|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
56152615|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
56152616|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
56152617|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
56152618|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152619|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152620|NCT05459298|Vitamin D|vitamin d|mesh-list
56152621|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
56152622|NCT05459298|Vitamins|vitamins|mesh-ancestor
56152623|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
56152624|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152625|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56152626|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56152627|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
56152628|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56152629|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
56152630|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152631|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
56152632|NCT05436288|Protective Agents|protective agents|mesh-ancestor
56152633|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
56152634|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152635|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152636|NCT05374512|Paclitaxel|paclitaxel|mesh-list
56152637|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56152638|NCT05374512|Carboplatin|carboplatin|mesh-list
56152639|NCT05374512|Capecitabine|capecitabine|mesh-list
56080313|NCT00005025|Ganciclovir|ganciclovir|mesh-list
56152640|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56152641|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152642|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
56152643|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
56152644|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
56152645|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659125|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659126|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659127|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56659128|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659129|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
56152646|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56152647|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
56152648|NCT05312268|Rasburicase|rasburicase|mesh-list
56152649|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
56152650|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152651|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
56152652|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56152653|NCT05245734|Antibodies|antibodies|mesh-list
56152654|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
56152655|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56152656|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
56152657|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152658|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
56152659|NCT05242692|Ketamine|ketamine|mesh-list
56152660|NCT05242692|Esketamine|esketamine|mesh-list
56152661|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56152662|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152663|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152664|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56152665|NCT05242692|Analgesics|analgesics|mesh-ancestor
56152666|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
56152667|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152668|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56152669|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56152670|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56152671|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
56152672|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152673|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152674|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56152675|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56152676|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
56152678|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56152679|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56152680|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
56152681|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56152682|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
56152683|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
56152684|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152685|NCT05087940|Diuretics|diuretics|mesh-list
56152686|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56152687|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
56152688|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152689|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56152690|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152691|NCT04975152|Cemiplimab|cemiplimab|mesh-list
56152692|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152693|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152694|NCT04964934|Letrozole|letrozole|mesh-list
56152695|NCT04964934|Palbociclib|palbociclib|mesh-list
56152696|NCT04964934|Anastrozole|anastrozole|mesh-list
56152697|NCT04964934|Hormones|hormones|mesh-list
56152698|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56152699|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152700|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152701|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152702|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56152703|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56152704|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152705|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152706|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56152707|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
56152708|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56152709|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56152710|NCT04922658|Vinorelbine|vinorelbine|mesh-list
56659130|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56659131|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659132|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659133|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56659134|NCT04225325|Dolutegravir|dolutegravir|mesh-list
56659135|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56659136|NCT04225325|Emtricitabine|emtricitabine|mesh-list
56659137|NCT04225325|Darunavir|darunavir|mesh-list
56152711|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56152712|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152713|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
56152714|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
56152715|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
56152716|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152717|NCT04883346|Liraglutide|liraglutide|mesh-list
56152718|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56152719|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152720|NCT04883346|Incretins|incretins|mesh-ancestor
56152721|NCT04883346|Hormones|hormones|mesh-ancestor
56152722|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152723|NCT04767594|Palbociclib|palbociclib|mesh-list
56152724|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152725|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56152726|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152727|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152728|NCT04764942|Dexamethasone|dexamethasone|mesh-list
56152729|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
56152730|NCT04764942|Pomalidomide|pomalidomide|mesh-list
56152731|NCT04764942|Ichthammol|ichthammol|mesh-list
56152732|NCT04764942|BB 1101|bb 1101|mesh-list
56152733|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56152734|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
56152736|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152737|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152738|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56152739|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
56152740|NCT04764942|Hormones|hormones|mesh-ancestor
56152741|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152742|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56152743|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152744|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
56152745|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152746|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152747|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
56152748|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56152749|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56152750|NCT04764942|Growth Substances|growth substances|mesh-ancestor
56152755|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56152756|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
56152757|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152758|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56152761|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56152762|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
56152763|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152764|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152765|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56152766|NCT04676646|Diuretics|diuretics|mesh-ancestor
56152767|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
56152768|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
56152769|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
56152770|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
56152771|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56152772|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56152773|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
56152774|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
56152775|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924562|NCT01478594|Bevacizumab|bevacizumab|mesh-list
56659138|NCT04225325|Cobicistat|cobicistat|mesh-list
56659139|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56659140|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56659141|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659142|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659143|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56659144|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56659145|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
56659146|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659147|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56659148|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56659149|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56659150|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56659151|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
56659152|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56659153|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56659154|NCT00649610|Diclofenac|diclofenac|mesh-list
56659155|NCT00649610|Valdecoxib|valdecoxib|mesh-list
56659156|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56659157|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56152776|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152777|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56152778|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
56152779|NCT04544436|Hormones|hormones|mesh-ancestor
56152780|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152781|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56152782|NCT04544436|Protective Agents|protective agents|mesh-ancestor
56152783|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
56152784|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
56152785|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152786|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152787|NCT04543188|Midazolam|midazolam|mesh-list
56152788|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56152789|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56152790|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152791|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152792|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56152793|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56152794|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56152795|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56152796|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
56152797|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
56152798|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
56152799|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
56152800|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152801|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152802|NCT04538742|Paclitaxel|paclitaxel|mesh-list
56152803|NCT04538742|Trastuzumab|trastuzumab|mesh-list
56152804|NCT04538742|Durvalumab|durvalumab|mesh-list
56152805|NCT04538742|Pertuzumab|pertuzumab|mesh-list
56152806|NCT04538742|Tucatinib|tucatinib|mesh-list
56152807|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56152808|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152809|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
56152810|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
56659158|NCT00649610|Analgesics|analgesics|mesh-ancestor
56659159|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
56659160|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220787|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56152811|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
56152812|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152813|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152814|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56152815|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152816|NCT04438902|Osimertinib|osimertinib|mesh-list
56152817|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152818|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56152819|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152820|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152821|NCT04346394|Yohimbine|yohimbine|mesh-list
56152822|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
56152823|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
56152825|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152826|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56152828|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56152829|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
56152830|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152831|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152832|NCT04346394|Urological Agents|urological agents|mesh-ancestor
56152833|NCT04329390|Anticoagulants|anticoagulants|mesh-list
56152834|NCT04282668|Tretinoin|tretinoin|mesh-list
56152835|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152836|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
56152837|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
56152838|NCT04275180|Argatroban|argatroban|mesh-list
56152839|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
56152840|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56152841|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
56152842|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152843|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152844|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
56152845|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56152846|NCT04177602|Trifluridine|trifluridine|mesh-list
56152847|NCT04177602|Capecitabine|capecitabine|mesh-list
56152848|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56152849|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
56152850|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152851|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152852|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
56152853|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152854|NCT04158258|Bevacizumab|bevacizumab|mesh-list
56152855|NCT04158258|Trastuzumab|trastuzumab|mesh-list
56152856|NCT04158258|Pertuzumab|pertuzumab|mesh-list
56152857|NCT04158258|Capecitabine|capecitabine|mesh-list
56152858|NCT04158258|Atezolizumab|atezolizumab|mesh-list
56152859|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152860|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152861|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56152862|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56152863|NCT04158258|Growth Substances|growth substances|mesh-ancestor
56152864|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152865|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
56152866|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56152867|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
56152868|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152869|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
56152870|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56152871|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56152872|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152873|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
56152874|NCT03868956|Coagulants|coagulants|mesh-ancestor
56152875|NCT03847428|Bevacizumab|bevacizumab|mesh-list
56152876|NCT03847428|Durvalumab|durvalumab|mesh-list
56152877|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152878|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152879|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56152880|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56659161|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659162|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56659163|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659164|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56659165|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659166|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659167|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56659168|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56659169|NCT02655146|Progesterone|progesterone|mesh-list
56305288|NCT00015951|Analgesics|analgesics|mesh-ancestor
56305364|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659171|NCT02655146|Progestins|progestins|mesh-ancestor
56152881|NCT03847428|Growth Substances|growth substances|mesh-ancestor
56152882|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152883|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
56152884|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
56152885|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56152886|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152887|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56152888|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152889|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152890|NCT03616236|Buprenorphine|buprenorphine|mesh-list
56152891|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56152892|NCT03616236|Naloxone|naloxone|mesh-list
56152893|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56152894|NCT03616236|Narcotics|narcotics|mesh-ancestor
56152895|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56152896|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152897|NCT03616236|Analgesics|analgesics|mesh-ancestor
56152899|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152900|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56152901|NCT03551730|Enoxaparin|enoxaparin|mesh-list
56152902|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
56152903|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
56152904|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56152905|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56152906|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152907|NCT03522246|Nivolumab|nivolumab|mesh-list
56152908|NCT03522246|Rucaparib|rucaparib|mesh-list
56152909|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152910|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152911|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56152912|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152913|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56152914|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152915|NCT03464292|Capsaicin|capsaicin|mesh-list
56152916|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
56152917|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
56152918|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
56152919|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152920|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152921|NCT03462342|Olaparib|olaparib|mesh-list
56152922|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56152923|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152924|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152925|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152926|NCT03366480|Paclitaxel|paclitaxel|mesh-list
56152927|NCT03366480|Carboplatin|carboplatin|mesh-list
56152928|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56152929|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152930|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
56152931|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
56152932|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
55924844|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56659172|NCT02655146|Hormones|hormones|mesh-ancestor
56659173|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659174|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659175|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
56659176|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56659177|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
56659178|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56659179|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56659180|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56659181|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659182|NCT02655146|Estrogens|estrogens|mesh-ancestor
56659183|NCT02774525|Ethanol|ethanol|mesh-list
56659184|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56659185|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659186|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659187|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659188|NCT04167566|Artemisinins|artemisinins|mesh-list
56659189|NCT04167566|Artemisinin|artemisinin|mesh-list
56152933|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152934|NCT03128034|Cyclosporine|cyclosporine|mesh-list
56152935|NCT03128034|Sirolimus|sirolimus|mesh-list
56152936|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
56152937|NCT03128034|Fludarabine|fludarabine|mesh-list
56152938|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
56152939|NCT03128034|Cyclosporins|cyclosporins|mesh-list
56152940|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152941|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56152942|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
56152943|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152944|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56152945|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
56152946|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152947|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56152948|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
56152949|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152950|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56152951|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152952|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56152953|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56152954|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56152955|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
56152956|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56152957|NCT03024996|Atezolizumab|atezolizumab|mesh-list
56152958|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152959|NCT02867124|Naltrexone|naltrexone|mesh-list
56152960|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56152961|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56152962|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152963|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
56152964|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152965|NCT02723994|Leucovorin|leucovorin|mesh-list
56152966|NCT02723994|Cytarabine|cytarabine|mesh-list
56152967|NCT02723994|Dexamethasone|dexamethasone|mesh-list
56152968|NCT02723994|Prednisone|prednisone|mesh-list
56152969|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
56152970|NCT02723994|Doxorubicin|doxorubicin|mesh-list
56152971|NCT02723994|Methotrexate|methotrexate|mesh-list
56152972|NCT02723994|Vincristine|vincristine|mesh-list
56152973|NCT02723994|Asparaginase|asparaginase|mesh-list
56659190|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
56659191|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56659192|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56659193|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659194|NCT00650624|Valdecoxib|valdecoxib|mesh-list
56659195|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56659196|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56659197|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659198|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220824|NCT01658202|Nicotine|nicotine|mesh-list
56152974|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
56152975|NCT02723994|Pegaspargase|pegaspargase|mesh-list
56152976|NCT02723994|Thioguanine|thioguanine|mesh-list
56152977|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
56152978|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56152979|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
56152980|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152981|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152982|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56152983|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
56152984|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152985|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56152986|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56152987|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56152988|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
56152990|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152991|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56152992|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
56152994|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56152995|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56152996|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56152997|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56152998|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56152999|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153000|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56153001|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
56153002|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56153003|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56153004|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
56153005|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
56153006|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56153007|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56153008|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
56153009|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153010|NCT02723994|Antidotes|antidotes|mesh-ancestor
56153011|NCT02723994|Protective Agents|protective agents|mesh-ancestor
56153012|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
56153013|NCT02723994|Vitamins|vitamins|mesh-ancestor
56153014|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
56153015|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56153016|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080689|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56153017|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
56153018|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
56153019|NCT02534376|Simvastatin|simvastatin|mesh-list
56153020|NCT02534376|Ezetimibe|ezetimibe|mesh-list
56153022|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56153023|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
56153024|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153025|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56153026|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56153027|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153028|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
56153029|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56153030|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56153031|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56153032|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176077|NCT01393548|Protective Agents|protective agents|mesh-ancestor
56153033|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153034|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
56153035|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153036|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153037|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56153038|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153039|NCT02065596|Fludarabine|fludarabine|mesh-list
56153040|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
56153041|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153042|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56153043|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
56153044|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153045|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56153046|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
56153047|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153048|NCT02058420|Tocotrienols|tocotrienols|mesh-list
56153049|NCT02058420|Vitamin E|vitamin e|mesh-list
56153050|NCT02058420|Tocopherols|tocopherols|mesh-list
56153052|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153053|NCT02058420|Protective Agents|protective agents|mesh-ancestor
56153054|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153055|NCT02058420|Vitamins|vitamins|mesh-ancestor
56153056|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
56153057|NCT02043678|Prednisone|prednisone|mesh-list
56153058|NCT02043678|Prednisolone|prednisolone|mesh-list
56153059|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56153060|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153061|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
56153062|NCT02043678|Hormones|hormones|mesh-ancestor
56153063|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153064|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153065|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56153066|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153067|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
56153068|NCT01976286|Salicylates|salicylates|mesh-list
56153069|NCT01976286|Glycolic acid|glycolic acid|mesh-list
56153070|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153071|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
56153072|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
56153073|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
56153074|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56153075|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153076|NCT01976286|Analgesics|analgesics|mesh-ancestor
56153077|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
56153078|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153079|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153080|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153081|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56153082|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56153083|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153084|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153085|NCT01858740|Methotrexate|methotrexate|mesh-list
56153086|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
56153087|NCT01858740|Fludarabine|fludarabine|mesh-list
56153088|NCT01858740|Thiotepa|thiotepa|mesh-list
56153089|NCT01858740|Tacrolimus|tacrolimus|mesh-list
56153090|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56153091|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
56153092|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56153093|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153094|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56153095|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
56153096|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153097|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153098|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
56153099|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153100|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56153101|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56153102|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
56153103|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56153104|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56153105|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56153106|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56659199|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56659200|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659201|NCT00650624|Analgesics|analgesics|mesh-ancestor
56659202|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
56659203|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659204|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659205|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56659206|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56153107|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
56153108|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56153109|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
56153110|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56153111|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56153112|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56153113|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153114|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153115|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
56153116|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153117|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153118|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56153119|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153120|NCT01239030|Methylphenidate|methylphenidate|mesh-list
56153121|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56153122|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153123|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56153124|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56153125|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153126|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153127|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
56153128|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153129|NCT01086540|Acetaminophen|acetaminophen|mesh-list
56153130|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
56153131|NCT01086540|Promethazine|promethazine|mesh-list
56153132|NCT01086540|Prednisone|prednisone|mesh-list
56153133|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
56153134|NCT01086540|Rituximab|rituximab|mesh-list
56153135|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56153136|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153137|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
56153138|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153139|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56153140|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153141|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
56153142|NCT01086540|Hormones|hormones|mesh-ancestor
56153143|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153144|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56153145|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153146|NCT01086540|Analgesics|analgesics|mesh-ancestor
56153147|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
56153148|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153149|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
56153150|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
56153151|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
56153152|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56153153|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56153154|NCT01086540|Protective Agents|protective agents|mesh-ancestor
56153155|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56153156|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56153157|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153158|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153159|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
56153160|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56153161|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
56153162|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
56153163|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153164|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659207|NCT00666354|Methotrexate|methotrexate|mesh-list
56659208|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56659209|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
56659210|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56659211|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220834|NCT01658215|Nicotine|nicotine|mesh-list
56153165|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56153166|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
56153167|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
56153168|NCT01962870|Vasopressins|vasopressins|mesh-list
56153169|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
56153170|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
56153171|NCT01962870|Coagulants|coagulants|mesh-ancestor
56153172|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56153173|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56153174|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
56153175|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153176|NCT01965366|Dexamethasone|dexamethasone|mesh-list
56153177|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153178|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
56153179|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
56153180|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153181|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153182|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56153183|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
56153185|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153186|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56153187|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153188|NCT01965756|Metformin|metformin|mesh-list
56153189|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56153190|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153191|NCT01967862|Listerine|listerine|mesh-list
56153192|NCT01967862|Fluorides|fluorides|mesh-list
56153193|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
56153194|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
56153195|NCT01967862|Protective Agents|protective agents|mesh-ancestor
56153196|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153197|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56153198|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153199|NCT01976988|Heparin|heparin|mesh-list
56153200|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
56153201|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56153202|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56153203|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153221|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
56153222|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153223|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153224|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56153225|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
56153226|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56153227|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56153228|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56153229|NCT01987752|Timolol|timolol|mesh-list
56153230|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56153231|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56153232|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
56153233|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56153234|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153235|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56153236|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56153237|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
56153238|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153239|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153240|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56153241|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56153242|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56080918|NCT00004467|Expectorants|expectorants|mesh-ancestor
56153243|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56153244|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56153245|NCT01988922|Ketamine|ketamine|mesh-list
56659212|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56659213|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
56659214|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153247|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
56153248|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153249|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153250|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56153251|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56153253|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
56153254|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153255|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56153256|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56153257|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153258|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153259|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
56153260|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56153261|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56153262|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
56153288|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
56153289|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56153290|NCT01999920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56153291|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56153292|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153293|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153294|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153295|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
56153296|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153297|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56153298|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56153300|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56153301|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153302|NCT02002650|Analgesics|analgesics|mesh-ancestor
56153303|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
56153304|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153305|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153306|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153307|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56153308|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
56153309|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
56153310|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56153311|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56153312|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153313|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153314|NCT02004132|Testosterone|testosterone|mesh-list
56153315|NCT02004132|Androgens|androgens|mesh-ancestor
56153316|NCT02004132|Hormones|hormones|mesh-ancestor
56153317|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153318|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153319|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
56153320|NCT02004366|Linagliptin|linagliptin|mesh-list
56153321|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56176085|NCT01393574|Melatonin|melatonin|mesh-list
56153322|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153323|NCT02004366|Incretins|incretins|mesh-ancestor
56153324|NCT02004366|Hormones|hormones|mesh-ancestor
56153325|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153326|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56153327|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
56153328|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153329|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153330|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
56153331|NCT02004990|Povidone|povidone|mesh-list
56153332|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
56153333|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
56153334|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56153335|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153336|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
56153337|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56153338|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659215|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659216|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
56659217|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659218|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56659219|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56659220|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
56659221|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659222|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56659223|NCT02774291|Aldesleukin|aldesleukin|mesh-list
56659224|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
56659225|NCT02774291|Fludarabine|fludarabine|mesh-list
56659226|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
56659227|NCT02774291|Interleukin-2|interleukin-2|mesh-list
56153339|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153340|NCT02011464|Bupivacaine|bupivacaine|mesh-list
56153341|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153342|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
56153343|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153344|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153345|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
56153346|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153347|NCT02020278|Tolvaptan|tolvaptan|mesh-list
56153348|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56153349|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153350|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
56153351|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153352|NCT02024646|Brodalumab|brodalumab|mesh-list
56153353|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56153354|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
56153355|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
56153356|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153357|NCT02024724|Dexamethasone|dexamethasone|mesh-list
56153358|NCT02024724|Triamcinolone|triamcinolone|mesh-list
56153359|NCT02024724|Bupivacaine|bupivacaine|mesh-list
56153360|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153361|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
56153362|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
56153363|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153364|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153366|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
56153367|NCT02024724|Hormones|hormones|mesh-ancestor
56153368|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153369|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56153370|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153371|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153372|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
56153373|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153374|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
56153375|NCT02025426|Phenylephrine|phenylephrine|mesh-list
56153376|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
56153377|NCT02025426|Ephedrine|ephedrine|mesh-list
56153378|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56153379|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
56153380|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
56153381|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153382|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153383|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
56153389|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56153390|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
56153391|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153392|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153393|NCT02025426|Protective Agents|protective agents|mesh-ancestor
56176089|NCT01393574|Protective Agents|protective agents|mesh-ancestor
56153394|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56153395|NCT02028780|Dabigatran|dabigatran|mesh-list
56659228|NCT02774291|Lenograstim|lenograstim|mesh-list
56659229|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56659230|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
56659231|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659232|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659233|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56659234|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
56659235|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659236|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659237|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56659238|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56659239|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
56659240|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56659241|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659242|NCT02774291|Analgesics|analgesics|mesh-ancestor
56659243|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
56659244|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659245|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56659246|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56659247|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
56659248|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659249|NCT02536352|Vitamins|vitamins|mesh-list
56153396|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
56153397|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56153398|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
56153399|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153400|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153401|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
56153402|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
56153403|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56153404|NCT02029872|Mupirocin|mupirocin|mesh-list
56153405|NCT02029872|Calcium|calcium|mesh-list
56153406|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56153407|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153408|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56153409|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153410|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
56153411|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
56153412|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56153413|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56153414|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153415|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153416|NCT02030574|Gemcitabine|gemcitabine|mesh-list
56153417|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153418|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56153419|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
56153420|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153421|NCT02030574|Antiviral Agents|antiviral agents|mesh-ancestor
56153422|NCT02030574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153423|NCT02030574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153424|NCT02030574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56153425|NCT02030574|Immunologic Factors|immunologic factors|mesh-ancestor
56153426|NCT02030574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153427|NCT02032212|Nicotine|nicotine|mesh-list
56659250|NCT02536352|Fluorides|fluorides|mesh-list
56659251|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
56659252|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659253|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
56659254|NCT02536352|Protective Agents|protective agents|mesh-ancestor
56659255|NCT02773979|Chloroquine|chloroquine|mesh-list
56659256|NCT02773979|Amebicides|amebicides|mesh-ancestor
56659257|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56659258|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56659259|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659260|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
56659261|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659262|NCT00662844|Vitamin D|vitamin d|mesh-list
56659263|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
56659264|NCT00662844|Vitamins|vitamins|mesh-ancestor
56659265|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
56659266|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659267|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56659268|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56659269|NCT02650544|Mirtazapine|mirtazapine|mesh-list
56659270|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
56659271|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56659272|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56659273|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
56659274|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
56659275|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153428|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56153429|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
56153430|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153431|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153432|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56153433|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56153434|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
56153435|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153436|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153437|NCT02032758|Propranolol|propranolol|mesh-list
56153438|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56153439|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56153440|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56153441|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153442|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153443|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153444|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56153445|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56153446|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
56153447|NCT02036424|Dexamethasone|dexamethasone|mesh-list
56153448|NCT02036424|Bevacizumab|bevacizumab|mesh-list
56153449|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56153450|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153451|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56153452|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56153454|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659276|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659277|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659278|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56659279|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56659280|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659281|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56659282|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56659283|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56659284|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
56659285|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56659286|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56659287|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
56659288|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56659289|NCT02650388|Chrysarobin|chrysarobin|mesh-list
56659290|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56659291|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659292|NCT02650388|Analgesics|analgesics|mesh-ancestor
56659293|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
56659294|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659295|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659296|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56659297|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659298|NCT00883740|Pregabalin|pregabalin|mesh-list
56659299|NCT00883740|Analgesics|analgesics|mesh-ancestor
56659300|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
56659301|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659302|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659303|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
56659304|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56659305|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659306|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659307|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56153455|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
56153456|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153457|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
56153458|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
56153459|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153460|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56659308|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56659309|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56153461|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
56153462|NCT02036424|Hormones|hormones|mesh-ancestor
56153463|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153464|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56153465|NCT02044380|Afatinib|afatinib|mesh-list
56153466|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153467|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56153468|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153469|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153470|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
56153471|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56153472|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56153473|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
56153474|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153475|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153476|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153477|NCT02047032|Urological Agents|urological agents|mesh-ancestor
56153479|NCT02047500|Paclitaxel|paclitaxel|mesh-list
56153480|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56153481|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153482|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
56153483|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
56153484|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
56153485|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153486|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56153487|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
56153488|NCT02047500|Antiviral Agents|antiviral agents|mesh-ancestor
56153489|NCT02047500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153490|NCT02047500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153491|NCT02047500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56153492|NCT02047500|Immunologic Factors|immunologic factors|mesh-ancestor
56153493|NCT02047500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153494|NCT02054754|HU 211|hu 211|mesh-list
56153495|NCT02054754|Dronabinol|dronabinol|mesh-list
56153496|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56153497|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
56153498|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
56153499|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153500|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153501|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56153502|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56153503|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56153504|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153505|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153506|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56153507|NCT02054754|Protective Agents|protective agents|mesh-ancestor
56153508|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
56153509|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56153510|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153511|NCT02054754|Analgesics|analgesics|mesh-ancestor
56153512|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
56153513|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56153514|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56153515|NCT02054754|Hormones|hormones|mesh-ancestor
56153516|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153517|NCT02057640|Dexamethasone|dexamethasone|mesh-list
56153518|NCT02057640|Ixazomib|ixazomib|mesh-list
56153519|NCT02057640|Panobinostat|panobinostat|mesh-list
56153520|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153521|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
56153522|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
56153523|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153524|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153525|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56153526|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
56153527|NCT02057640|Hormones|hormones|mesh-ancestor
56153535|NCT02059902|Lidocaine|lidocaine|mesh-list
56153536|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153537|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
56153538|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153539|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659310|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659311|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56659312|NCT04183712|Gemcitabine|gemcitabine|mesh-list
56659313|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
56659314|NCT04183712|Afatinib|afatinib|mesh-list
56659315|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56659316|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
56659317|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659318|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659319|NCT04183712|Antiviral Agents|antiviral agents|mesh-ancestor
56659320|NCT04183712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659321|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153540|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
56153541|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153542|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56153543|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56153545|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153546|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153547|NCT02061384|Calcitriol|calcitriol|mesh-list
56153548|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56153549|NCT02061384|Tretinoin|tretinoin|mesh-list
56153550|NCT02061384|Isotretinoin|isotretinoin|mesh-list
56153551|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153552|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
56153553|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
56153554|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56153555|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153556|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56153557|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153558|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153559|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56153560|NCT02061384|Vitamins|vitamins|mesh-ancestor
56153561|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
56153562|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56153563|NCT02061774|Acetaminophen|acetaminophen|mesh-list
56153564|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153565|NCT02061774|Analgesics|analgesics|mesh-ancestor
56153566|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
56153567|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153568|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153569|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
56153570|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
56153571|NCT02062710|Promethazine|promethazine|mesh-list
56153572|NCT02062710|Phenylephrine|phenylephrine|mesh-list
56153573|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
56153574|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
56153575|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56153576|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
56153577|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
56153578|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153579|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153580|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
56153581|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56153582|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
56153583|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
56153584|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56153585|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56153586|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56153587|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
56153588|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153589|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153590|NCT02062710|Protective Agents|protective agents|mesh-ancestor
56153591|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56153592|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56659322|NCT04183712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56659323|NCT04183712|Immunologic Factors|immunologic factors|mesh-ancestor
56659324|NCT04183712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659325|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56659326|NCT02773199|Bupivacaine|bupivacaine|mesh-list
56659327|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153593|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153594|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153596|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
56153597|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
56153598|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56153599|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56153600|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
56153601|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
56153602|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56153603|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
56153604|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56153605|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
56153606|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56153607|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56153608|NCT02064582|Leuprolide|leuprolide|mesh-list
56153609|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56153610|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
56176097|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153611|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56153612|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153613|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56153614|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153615|NCT02069184|Acetaminophen|acetaminophen|mesh-list
56153616|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153617|NCT02069184|Analgesics|analgesics|mesh-ancestor
56153618|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
56153619|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153620|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153622|NCT02134314|Complement C1s|complement c1s|mesh-list
56153623|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56153624|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56153625|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
56153626|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153627|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56153628|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56153629|NCT02135016|Lidocaine|lidocaine|mesh-list
56153630|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153631|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
56153632|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153633|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153634|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
56153635|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153636|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56153637|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56153638|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56153639|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153640|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153641|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
56153642|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56153643|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56153644|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
56153645|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153646|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153647|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153648|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
56153649|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
56153650|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153651|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
56153652|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56153653|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
56153654|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
56153655|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56153656|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
56659328|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
56659329|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659330|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659331|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
56659332|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659333|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
56659334|NCT02654834|Anesthetics|anesthetics|mesh-list
56659335|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659336|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659337|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56659338|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
56659339|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659340|NCT02654834|Analgesics|analgesics|mesh-ancestor
56659341|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
56659342|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659344|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
56659345|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
56659346|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659347|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659348|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
56659349|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659350|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56220942|NCT01659047|Idelalisib|idelalisib|mesh-list
56153657|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
56153658|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153659|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153660|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153661|NCT02139540|Analgesics|analgesics|mesh-ancestor
56153662|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
56153663|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153665|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153666|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
56153667|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153668|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153669|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
56153674|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153675|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153676|NCT02149524|Trastuzumab|trastuzumab|mesh-list
56153677|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56153678|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153679|NCT02154048|Dexamethasone|dexamethasone|mesh-list
56153680|NCT02154048|Ropivacaine|ropivacaine|mesh-list
56153681|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153682|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
56153683|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
56153684|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153685|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153686|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56153687|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
56153688|NCT02154048|Hormones|hormones|mesh-ancestor
56153689|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153690|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56659351|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56659352|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56659353|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659354|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659355|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56659356|NCT02765009|Furosemide|furosemide|mesh-list
56659357|NCT02765009|Bumetanide|bumetanide|mesh-list
56659358|NCT02765009|Diuretics|diuretics|mesh-list
56659359|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56659360|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
56659361|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659362|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56659363|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659364|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659365|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56659366|NCT02649920|Dinoprostone|dinoprostone|mesh-list
56081371|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153691|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153692|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153693|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
56153694|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153695|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
56153696|NCT02156154|Acetaminophen|acetaminophen|mesh-list
56153697|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153698|NCT02156154|Analgesics|analgesics|mesh-ancestor
56153699|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
56153700|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153701|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153702|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
56153703|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
56153704|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56153705|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153706|NCT02159976|Amoxicillin|amoxicillin|mesh-list
56153707|NCT02159976|Metronidazole|metronidazole|mesh-list
56153708|NCT02159976|Clarithromycin|clarithromycin|mesh-list
56153709|NCT02159976|Tetracycline|tetracycline|mesh-list
56153710|NCT02159976|Pantoprazole|pantoprazole|mesh-list
56153711|NCT02159976|Bismuth|bismuth|mesh-list
56153712|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56153713|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153714|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56153715|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56153716|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56153717|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153718|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153719|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56153720|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56153721|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56153722|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56153723|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56153724|NCT02159976|Antacids|antacids|mesh-ancestor
56153725|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
56153726|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56153727|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56153728|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56153729|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153730|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153731|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
56659367|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
56659368|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56659369|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659370|NCT00649688|Metoprolol|metoprolol|mesh-list
56659371|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56659372|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56659373|NCT00649688|Diuretics|diuretics|mesh-ancestor
56659374|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
56659375|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659376|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56659377|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659378|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153732|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153733|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153734|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56153735|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153737|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56153738|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153739|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56153740|NCT02160990|Incretins|incretins|mesh-ancestor
56153745|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56153746|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56153747|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56153748|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
56153749|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153750|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153751|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153752|NCT02170662|Bimatoprost|bimatoprost|mesh-list
56153753|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56153754|NCT02173392|Brodalumab|brodalumab|mesh-list
56153755|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
56153756|NCT02178540|Tobramycin|tobramycin|mesh-list
56153757|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56153759|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
56153760|NCT02178696|Citalopram|citalopram|mesh-list
56153761|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56153762|NCT02178696|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56153763|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56153764|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153765|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153766|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153767|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
56153768|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153769|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56153770|NCT02179788|Metformin|metformin|mesh-list
56153771|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56153772|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153773|NCT02180100|Fluconazole|fluconazole|mesh-list
56153774|NCT02180100|Terconazole|terconazole|mesh-list
56153775|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
56153776|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153777|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56153778|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56153779|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153780|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153781|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56153782|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
56153783|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153784|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153785|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55924845|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56659379|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56659380|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
56659381|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
56659382|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659383|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56659384|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56659385|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56659386|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
56153786|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56153787|NCT02181426|Ketorolac|ketorolac|mesh-list
56153788|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56153789|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153790|NCT02181426|Analgesics|analgesics|mesh-ancestor
56153791|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
56153792|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153793|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153794|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153795|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56153796|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56153797|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153798|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153799|NCT02192814|Lacosamide|lacosamide|mesh-list
56153800|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
56153801|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56153802|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56153803|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153804|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153805|NCT02195232|Quercetin|quercetin|mesh-list
56153806|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
56153807|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153808|NCT02195232|Protective Agents|protective agents|mesh-ancestor
56153809|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153811|NCT02196168|Adavosertib|adavosertib|mesh-list
56153813|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153814|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153815|NCT02201394|Aspirin|aspirin|mesh-list
56153816|NCT02201394|Ticagrelor|ticagrelor|mesh-list
56153817|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56153818|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56153819|NCT02201394|Analgesics|analgesics|mesh-ancestor
56153820|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
56153821|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153822|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153823|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56153824|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56153825|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56153826|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56153827|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153828|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56153829|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56153830|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153831|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
56153832|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56153833|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56153834|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56153835|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
56153836|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153837|NCT02203578|Romidepsin|romidepsin|mesh-list
56153838|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56153839|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153841|NCT02206776|Ketamine|ketamine|mesh-list
56153842|NCT02206776|Analgesics|analgesics|mesh-ancestor
56153843|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
56153844|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153845|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924846|NCT01678963|Squalamine|squalamine|mesh-list
56659387|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659388|NCT00667056|Tacrolimus|tacrolimus|mesh-list
56659389|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56659390|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
56659391|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659392|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56305517|NCT00001181|Testolactone|testolactone|mesh-list
56659394|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659395|NCT02764619|Spironolactone|spironolactone|mesh-list
56659396|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56659397|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
56659398|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659399|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659400|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56659401|NCT02764619|Diuretics|diuretics|mesh-ancestor
56659402|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
56659403|NCT04032210|Zinc|zinc|mesh-list
56659404|NCT04032210|Fluorides|fluorides|mesh-list
56659405|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
56659406|NCT04032210|Protective Agents|protective agents|mesh-ancestor
56659407|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659408|NCT04032210|Trace Elements|trace elements|mesh-ancestor
56659409|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
56659410|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
56659411|NCT04223219|Fentanyl|fentanyl|mesh-list
56659412|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
56659413|NCT04223219|Ketamine|ketamine|mesh-list
56659414|NCT04223219|Propofol|propofol|mesh-list
56659415|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56659416|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659417|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659418|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56659419|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
56659420|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
56659421|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659422|NCT04223219|Analgesics|analgesics|mesh-ancestor
56659423|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
56659427|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56659428|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
56659429|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659430|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659431|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56659432|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56659433|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56659434|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56659435|NCT04223219|Narcotics|narcotics|mesh-ancestor
56659436|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56659437|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56659438|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
56221036|NCT01659359|Lidocaine|lidocaine|mesh-list
56153846|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56153847|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56153848|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
56153849|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
56153850|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153851|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56153852|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56153853|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153854|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153855|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56153856|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56153857|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56153858|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56153859|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56153860|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
56153861|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
56153862|NCT02209272|Lidocaine|lidocaine|mesh-list
56153863|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
56153864|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
56153865|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
56153866|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153867|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153868|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
56153869|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153870|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56153871|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56153872|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56153873|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153874|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153875|NCT02214420|Ribavirin|ribavirin|mesh-list
56153876|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
56153877|NCT02214420|Simeprevir|simeprevir|mesh-list
56153878|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
56153879|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153880|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
55734620|NCT04818749|BB 1101|bb 1101|mesh-list
56153882|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
56153883|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153884|NCT02215200|Lenograstim|lenograstim|mesh-list
56153885|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
56153886|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56153887|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56153890|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56153892|NCT02218320|Dolutegravir|dolutegravir|mesh-list
56153893|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56153894|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56153895|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
56153896|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153897|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56153898|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56153899|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659439|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56659440|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659441|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56659442|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
56659443|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56659444|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
56659445|NCT02631252|Etoposide|etoposide|mesh-list
56659446|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
56659447|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56659448|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221048|NCT01659372|Naproxen|naproxen|mesh-list
56153900|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153901|NCT02222610|Ranibizumab|ranibizumab|mesh-list
56153902|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56153903|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56153904|NCT02222610|Growth Substances|growth substances|mesh-ancestor
56153905|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153906|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
56153907|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153908|NCT02223702|Amoxicillin|amoxicillin|mesh-list
56153909|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
56153910|NCT02223702|Metronidazole|metronidazole|mesh-list
56153911|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56153912|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153913|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081595|NCT04829799|Ketorolac|ketorolac|mesh-list
56153914|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56153915|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153916|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153917|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153918|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56153919|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56153920|NCT02225106|Methylphenidate|methylphenidate|mesh-list
56153921|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56153922|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153923|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56153924|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56153925|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56153926|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153927|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
56153928|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153929|NCT02233296|Lasmiditan|lasmiditan|mesh-list
56153930|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56153931|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
56153932|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153933|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153934|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153935|NCT02233998|Listerine|listerine|mesh-list
56153936|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
56153937|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56153938|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56153939|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
56153940|NCT02233998|Protective Agents|protective agents|mesh-ancestor
56153941|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153942|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
56153943|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
56153944|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153945|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
56153946|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153947|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153948|NCT02239380|Lorazepam|lorazepam|mesh-list
56153949|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
56153950|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
56153951|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
55924948|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
56659449|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56659450|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56659451|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659452|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659453|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
56659454|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56659455|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56659456|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659457|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659458|NCT02631252|Analgesics|analgesics|mesh-ancestor
56659459|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
56659460|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659461|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659462|NCT02631408|Vancomycin|vancomycin|mesh-list
56659463|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56659464|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659465|NCT02630394|Azithromycin|azithromycin|mesh-list
56659466|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56659467|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659468|NCT04629443|Azacitidine|azacitidine|mesh-list
56659469|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56659470|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
56659471|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659472|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659473|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659474|NCT02771405|Ribavirin|ribavirin|mesh-list
56659475|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
56659476|NCT02771405|Simeprevir|simeprevir|mesh-list
56659477|NCT02771405|Ledipasvir|ledipasvir|mesh-list
56659478|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
56153952|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153953|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153954|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56153955|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56153956|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153957|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56153958|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56153959|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56153965|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56153966|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
56153967|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153968|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153969|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56153970|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56153971|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
56153972|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153973|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153974|NCT02241486|Fentanyl|fentanyl|mesh-list
56659479|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659480|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
56659481|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659482|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
56659483|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659484|NCT00667758|Cetrorelix|cetrorelix|mesh-list
56659485|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56659486|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
56659487|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56659488|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659489|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
56659490|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659491|NCT00542815|Sevelamer|sevelamer|mesh-list
56659492|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
56659493|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
56659494|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659495|NCT02762591|Pimavanserin|pimavanserin|mesh-list
56659496|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56659497|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56659498|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56153975|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56153976|NCT02241486|Narcotics|narcotics|mesh-ancestor
56153977|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56153978|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153979|NCT02241486|Analgesics|analgesics|mesh-ancestor
56153980|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
56153981|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153982|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56153983|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56153984|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
56153985|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
56153986|NCT02244918|Nicotine|nicotine|mesh-list
56153987|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56153988|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
56153989|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153990|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153991|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56153992|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56153993|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
56153994|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153995|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153996|NCT02250612|Timolol|timolol|mesh-list
56153997|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153998|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56153999|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56154000|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
56154001|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154002|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154003|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56154004|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56154005|NCT02251236|Tenofovir|tenofovir|mesh-list
56154006|NCT02251236|Emtricitabine|emtricitabine|mesh-list
56154007|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56154008|NCT02251236|Cobicistat|cobicistat|mesh-list
56659499|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56659500|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659501|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659502|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56154009|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56154010|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56154011|NCT02251236|Elvitegravir|elvitegravir|mesh-list
56154012|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
56154013|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154014|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56154015|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56154016|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154017|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154018|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56154019|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56154020|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56154021|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56154022|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56154023|NCT02251938|Sirolimus|sirolimus|mesh-list
56154024|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56154025|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154026|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56154027|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154028|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
56154029|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154030|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
56154033|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56154034|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
56154035|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154036|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154037|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154038|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
56154039|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
56154040|NCT02260440|Azacitidine|azacitidine|mesh-list
56154041|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56154042|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154043|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56154044|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
56154045|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154046|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154047|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
56154048|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56154049|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154050|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154051|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56154052|NCT02267538|Analgesics|analgesics|mesh-ancestor
56154053|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
56154054|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154055|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56154056|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56154057|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56154058|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
56154059|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154060|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154061|NCT02267772|Acetaminophen|acetaminophen|mesh-list
56154062|NCT02267772|Morphine|morphine|mesh-list
56081753|NCT02974387|Hormones|hormones|mesh-ancestor
56154063|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56154065|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154066|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154067|NCT02267772|Analgesics|analgesics|mesh-ancestor
56154068|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
56154069|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154070|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56154071|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
56154072|NCT02271906|Afatinib|afatinib|mesh-list
56154073|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154074|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56154075|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659503|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56659504|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56154076|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154077|NCT02274870|Bupivacaine|bupivacaine|mesh-list
56154078|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
56154079|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
56154080|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154081|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154082|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
56154083|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154084|NCT02276274|Alogliptin|alogliptin|mesh-list
56154085|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56154086|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154087|NCT02276274|Incretins|incretins|mesh-ancestor
56154088|NCT02276274|Hormones|hormones|mesh-ancestor
56154089|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56154090|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56154091|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
56154092|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154093|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154094|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56154095|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
56154096|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56154097|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55734825|NCT03446599|Vitamins|vitamins|mesh-ancestor
56154098|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56154099|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154100|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
56154101|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56154107|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154108|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56154109|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56154110|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
56154111|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154112|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154113|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56154114|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56154115|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56154116|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
56154117|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
56154118|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154119|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56154120|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
56154121|NCT02282514|Hormones|hormones|mesh-ancestor
56176110|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154122|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56154123|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56154124|NCT02282514|Protective Agents|protective agents|mesh-ancestor
56154125|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56154127|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
56154128|NCT02282904|Busulfan|busulfan|mesh-list
56154129|NCT02282904|Fludarabine|fludarabine|mesh-list
56154130|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154131|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
56154132|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154133|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56154134|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56154135|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
56154136|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154137|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154138|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56154139|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56154140|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154141|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56154142|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
56154143|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56154144|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
56154145|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56154146|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56154147|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659505|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
56659506|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659507|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659508|NCT02696369|Lidocaine|lidocaine|mesh-list
56659509|NCT02696369|Epinephrine|epinephrine|mesh-list
56659510|NCT02696369|Racepinephrine|racepinephrine|mesh-list
56659511|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
56659512|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
56659513|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
56659514|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659515|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659516|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
56659517|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659518|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55797125|NCT05678933|Prednisone|prednisone|mesh-list
56154148|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154149|NCT02284386|Bupivacaine|bupivacaine|mesh-list
56154150|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
56154151|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
56154152|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154153|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154154|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
56154155|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154156|NCT02284464|Prednisone|prednisone|mesh-list
56154157|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56154158|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
56154159|NCT02284464|Hormones|hormones|mesh-ancestor
56154160|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56154161|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154162|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56154163|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154164|NCT02284854|Carbamazepine|carbamazepine|mesh-list
56154165|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56154166|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
56154167|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
56154168|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56154169|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154170|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154172|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56154175|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154176|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56154177|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56154178|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154179|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56154180|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56154181|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56154183|NCT02285634|Phenylephrine|phenylephrine|mesh-list
56154184|NCT02285634|Epinephrine|epinephrine|mesh-list
56154185|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
56154186|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
56154187|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
56154188|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154189|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154190|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
56154191|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154192|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56154193|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56154194|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56154195|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659519|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56659520|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56659521|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659522|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659523|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56659524|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56659525|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
56659526|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659527|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56659528|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56659529|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
56154196|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154197|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56154198|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56154199|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56154200|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154201|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56154202|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56154203|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
56154204|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56154205|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
56154206|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
56154207|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
56154208|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56154209|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56154210|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
56154211|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56154212|NCT02285634|Protective Agents|protective agents|mesh-ancestor
56154213|NCT02286726|Cytarabine|cytarabine|mesh-list
56154214|NCT02286726|Daunorubicin|daunorubicin|mesh-list
56154215|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56154216|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
56154217|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154218|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154219|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
56154220|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154221|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154222|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
56154223|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154224|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56154225|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56154226|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56154227|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154228|NCT02287350|Diclofenac|diclofenac|mesh-list
56154229|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56154230|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56154231|NCT02287350|Analgesics|analgesics|mesh-ancestor
56154232|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
56154233|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154234|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154235|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56154236|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56154237|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56154238|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154239|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154240|NCT02288364|Lidocaine|lidocaine|mesh-list
56154241|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
56154242|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
56154243|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154244|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154248|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56154249|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56659530|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56659531|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
56659532|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
56659533|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
56659534|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56659535|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56659536|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659537|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659538|NCT02636088|Cetuximab|cetuximab|mesh-list
56659539|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56659540|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659541|NCT02630160|Epinephrine|epinephrine|mesh-list
56659542|NCT02630160|Bupivacaine|bupivacaine|mesh-list
56659543|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
56659544|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
56659545|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221131|NCT01659892|Montelukast|montelukast|mesh-list
56154250|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56154251|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154252|NCT02289222|Dexamethasone|dexamethasone|mesh-list
56154253|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
56154254|NCT02289222|Pomalidomide|pomalidomide|mesh-list
56154255|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56154256|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
56154257|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
56154258|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154259|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154260|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56154261|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
56154262|NCT02289222|Hormones|hormones|mesh-ancestor
56154263|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56154264|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56154265|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154266|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56154267|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
56154268|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56154269|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56154270|NCT02289222|Growth Substances|growth substances|mesh-ancestor
56154271|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56154272|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
56154273|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56154274|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
56154275|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154276|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154277|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56154278|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
56154279|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56154280|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56154281|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56154282|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
56154283|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154284|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154285|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
56154286|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
56154287|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154288|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56154289|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154290|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56659546|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659547|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
56221142|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56154291|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56154292|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56154293|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154294|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154295|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56154296|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56154297|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154298|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
56154299|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154301|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56154302|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56154303|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
56154304|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56154305|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154306|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
56154307|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
56154308|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154309|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154311|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56154312|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154313|NCT02303184|Aflibercept|aflibercept|mesh-list
56154314|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56154315|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56154325|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
56154326|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56154327|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
56154328|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154329|NCT02307318|Hemostatics|hemostatics|mesh-list
56154330|NCT02307318|Coagulants|coagulants|mesh-ancestor
56154331|NCT02312622|Irinotecan|irinotecan|mesh-list
56154332|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
56154333|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56154334|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56154335|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154336|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154337|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176116|NCT01393782|Giapreza|giapreza|mesh-list
56154338|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56154339|NCT02314104|Ropivacaine|ropivacaine|mesh-list
56154340|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
56154341|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
56154342|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154343|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154344|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
56154345|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154346|NCT02321748|Montelukast|montelukast|mesh-list
56154347|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56154348|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
56154349|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56154350|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
56154351|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56154352|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154353|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56154354|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56154355|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154356|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56154357|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56154358|NCT02330094|Gabapentin|gabapentin|mesh-list
56154359|NCT02330094|Analgesics|analgesics|mesh-ancestor
56154360|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
56154361|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154362|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154363|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
56154364|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56154365|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56154366|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154367|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56659548|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659549|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56659550|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56154368|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56154369|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56154370|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154371|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154372|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
56154373|NCT02330172|Neostigmine|neostigmine|mesh-list
56154374|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56154375|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154376|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154377|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
56154378|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154379|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154391|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56154392|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56154394|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154395|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154396|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
56154397|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154398|NCT02340156|Temozolomide|temozolomide|mesh-list
56154399|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56154400|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
56154401|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154402|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154403|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
56154404|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
56154405|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56154406|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56154407|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56154408|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154409|NCT02351700|Ibuprofen|ibuprofen|mesh-list
56154410|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56154411|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56154412|NCT02351700|Analgesics|analgesics|mesh-ancestor
56154413|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
56154414|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154415|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154416|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56154417|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56154418|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56154419|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154420|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154421|NCT02353806|Amlodipine|amlodipine|mesh-list
56154422|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56154423|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56154424|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56154425|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154426|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56154427|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154428|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
56082123|NCT02919787|Fluorouracil|fluorouracil|mesh-list
56154429|NCT02354352|Eplerenone|eplerenone|mesh-list
56154430|NCT02354352|Spironolactone|spironolactone|mesh-list
56154431|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56154432|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
56154433|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56154434|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154435|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56154436|NCT02354352|Diuretics|diuretics|mesh-ancestor
56154437|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
56154438|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56154439|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
56154440|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154441|NCT02357706|Acetaminophen|acetaminophen|mesh-list
56154466|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154468|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56659551|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
56659552|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659553|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659554|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56659555|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56659556|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
56659557|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56659558|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
56659559|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
56154469|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
56154470|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56154471|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56154472|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56154473|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56154474|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154475|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
56154476|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154477|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154478|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56176120|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
56154479|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56154480|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154481|NCT02374164|Febuxostat|febuxostat|mesh-list
56154482|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
56154483|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56154484|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
56154485|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56154486|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56154487|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154488|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
56154489|NCT02374398|Coagulants|coagulants|mesh-ancestor
56154490|NCT02377752|Doxorubicin|doxorubicin|mesh-list
56154491|NCT02377752|Olaratumab|olaratumab|mesh-list
56154492|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56154496|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154497|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154498|NCT02379858|Alvimopan|alvimopan|mesh-list
56154499|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56154500|NCT02384070|Aspirin|aspirin|mesh-list
56154501|NCT02384070|Bivalirudin|bivalirudin|mesh-list
56154502|NCT02384070|Clopidogrel|clopidogrel|mesh-list
56154503|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56154504|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56154505|NCT02384070|Analgesics|analgesics|mesh-ancestor
56154506|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
56154507|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154508|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154509|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56154510|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56154511|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56154512|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56154513|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154514|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56154515|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56154516|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154517|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
56154518|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56154519|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56154520|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56154521|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
56154522|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154523|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
56154524|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56154525|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
56154526|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
56154527|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56659560|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
56659561|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56659562|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
56659563|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56659564|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56659565|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221155|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
56154528|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56154529|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56154530|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56154531|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56154532|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
56154533|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154534|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154535|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154536|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
56154537|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
56154538|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
56154540|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56154541|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154542|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
56154543|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
56176123|NCT01393795|Capsaicin|capsaicin|mesh-list
56154544|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
56154545|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56154546|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
56154547|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
56154548|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154549|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154550|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56154551|NCT02391714|Analgesics|analgesics|mesh-ancestor
56154552|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
56154553|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154554|NCT02395692|Temozolomide|temozolomide|mesh-list
56154555|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56154556|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
56154557|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154558|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154559|NCT02397954|Ranibizumab|ranibizumab|mesh-list
56154560|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56154561|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56154562|NCT02397954|Growth Substances|growth substances|mesh-ancestor
56154563|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154564|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
56154577|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56154578|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
56154579|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56154580|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154581|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56154582|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56154583|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
56154585|NCT02413320|Docetaxel|docetaxel|mesh-list
56154586|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
56154587|NCT02413320|Carboplatin|carboplatin|mesh-list
56154588|NCT02413320|Doxorubicin|doxorubicin|mesh-list
56154589|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56154590|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154591|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
56154592|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
56154593|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
56154594|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154595|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154596|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
56154597|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154598|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56154599|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56154600|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
56154601|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55925053|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659566|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56659567|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56154602|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56154603|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56154604|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56154605|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154606|NCT05718882|Lenvatinib|lenvatinib|mesh-list
56154607|NCT05718882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154608|NCT05718882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56154609|NCT05718882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735345|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
56154610|NCT05718882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154611|NCT05718492|Leucovorin|leucovorin|mesh-list
56154612|NCT05718492|Fluorouracil|fluorouracil|mesh-list
56154613|NCT05718492|Oxaliplatin|oxaliplatin|mesh-list
56154614|NCT05718492|Antimetabolites|antimetabolites|mesh-ancestor
56154615|NCT05718492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154616|NCT05718492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56154617|NCT05718492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154618|NCT05718492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154619|NCT05718492|Immunologic Factors|immunologic factors|mesh-ancestor
56154620|NCT05718492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154621|NCT05718492|Antidotes|antidotes|mesh-ancestor
56154622|NCT05718492|Protective Agents|protective agents|mesh-ancestor
56154623|NCT05718492|Vitamin B Complex|vitamin b complex|mesh-ancestor
56154624|NCT05718492|Vitamins|vitamins|mesh-ancestor
56154625|NCT05718492|Micronutrients|micronutrients|mesh-ancestor
56154626|NCT05718024|Dexmedetomidine|dexmedetomidine|mesh-list
56154628|NCT05718024|Propofol|propofol|mesh-list
56154629|NCT05718024|Esketamine|esketamine|mesh-list
56154630|NCT05718024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56154631|NCT05718024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154632|NCT05718024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154633|NCT05718024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56154634|NCT05718024|Anesthetics, General|anesthetics, general|mesh-ancestor
56154635|NCT05718024|Anesthetics|anesthetics|mesh-ancestor
56154636|NCT05718024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56154637|NCT05718024|Analgesics|analgesics|mesh-ancestor
56154638|NCT05718024|Sensory System Agents|sensory system agents|mesh-ancestor
56154639|NCT05718024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154640|NCT05718024|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56154641|NCT05718024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56154642|NCT05718024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56154643|NCT05718024|Adrenergic Agents|adrenergic agents|mesh-ancestor
56154644|NCT05718024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154645|NCT05718024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154646|NCT05718024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56154647|NCT05718024|Narcotics|narcotics|mesh-ancestor
56154648|NCT05718024|Antidepressive Agents|antidepressive agents|mesh-ancestor
56154649|NCT05718024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56154650|NCT05717790|Gemcitabine|gemcitabine|mesh-list
56154651|NCT05717790|Nimotuzumab|nimotuzumab|mesh-list
56154652|NCT05717790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154653|NCT05717790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56154654|NCT05717790|Antimetabolites|antimetabolites|mesh-ancestor
56154655|NCT05717790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154656|NCT05717790|Antiviral Agents|antiviral agents|mesh-ancestor
56154657|NCT05717790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154658|NCT05717790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154659|NCT05717790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154660|NCT05717790|Immunologic Factors|immunologic factors|mesh-ancestor
56154661|NCT05717790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154662|NCT05717790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56154663|NCT05679258|Daratumumab|daratumumab|mesh-list
56154664|NCT05679258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56154665|NCT05679258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154666|NCT05679258|Immunologic Factors|immunologic factors|mesh-ancestor
56154667|NCT05679258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154668|NCT05602272|Anesthetics|anesthetics|mesh-list
56154669|NCT05602272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154670|NCT05602272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154671|NCT05589792|Acetazolamide|acetazolamide|mesh-list
56154672|NCT05589792|Anticonvulsants|anticonvulsants|mesh-ancestor
56154673|NCT05589792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56154674|NCT05589792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659568|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659569|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659570|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659571|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56659572|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
56659573|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56659574|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659575|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56659576|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56659577|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56659578|NCT00542425|Teriparatide|teriparatide|mesh-list
56659579|NCT00542425|Abaloparatide|abaloparatide|mesh-list
56659580|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
56659581|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56659582|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659583|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56659584|NCT00668538|Miconazole|miconazole|mesh-list
56659585|NCT00668538|Clotrimazole|clotrimazole|mesh-list
56659586|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
56221160|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154675|NCT05589792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154676|NCT05589792|Diuretics|diuretics|mesh-ancestor
56154677|NCT05589792|Natriuretic Agents|natriuretic agents|mesh-ancestor
56154678|NCT05589792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154679|NCT05543694|Bupivacaine|bupivacaine|mesh-list
56154680|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
56154681|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
56154682|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154683|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154684|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
56154685|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154686|NCT05495568|Adalimumab|adalimumab|mesh-list
56154687|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56154688|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56154689|NCT05359068|Valsartan|valsartan|mesh-list
56154690|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56154691|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56154692|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56154693|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154694|NCT05358834|Melatonin|melatonin|mesh-list
56154695|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
56154696|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154697|NCT05358834|Protective Agents|protective agents|mesh-ancestor
56154698|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154699|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154700|NCT05317806|Metformin|metformin|mesh-list
56154701|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56154719|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
56154720|NCT05105256|Hormones|hormones|mesh-ancestor
56154721|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56154722|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154723|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56659587|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659588|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56659589|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56659590|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659591|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659592|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56659593|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
56659594|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659595|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659596|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56221182|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
56154724|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154725|NCT04967196|Nivolumab|nivolumab|mesh-list
56154726|NCT04967196|Ipilimumab|ipilimumab|mesh-list
56154727|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56154728|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154729|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56154730|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154731|NCT04916886|Vaccines|vaccines|mesh-list
56154732|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
56154733|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154734|NCT04907682|Ribavirin|ribavirin|mesh-list
56154735|NCT04907682|Favipiravir|favipiravir|mesh-list
56154736|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
56154737|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154738|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
56154739|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154740|NCT04840992|Vaccines|vaccines|mesh-list
56154741|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
56154742|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154743|NCT04793022|Anesthetics|anesthetics|mesh-list
56154744|NCT04793022|Propofol|propofol|mesh-list
56154745|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154746|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154747|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56154748|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56154749|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
56154750|NCT04776018|Daratumumab|daratumumab|mesh-list
56154751|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154752|NCT04750902|Listerine|listerine|mesh-list
56154753|NCT04750902|Fluorides|fluorides|mesh-list
56154754|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
56154755|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
56154756|NCT04750902|Protective Agents|protective agents|mesh-ancestor
56154757|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154758|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56154759|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154760|NCT04711824|Gemcitabine|gemcitabine|mesh-list
56154764|NCT04711824|Carboplatin|carboplatin|mesh-list
56154765|NCT04711824|Capecitabine|capecitabine|mesh-list
56154766|NCT04711824|Durvalumab|durvalumab|mesh-list
56154767|NCT04711824|Olaparib|olaparib|mesh-list
56154768|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56154769|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154770|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
56154771|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
56154772|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
56154773|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154774|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56154775|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
56154776|NCT04711824|Antiviral Agents|antiviral agents|mesh-ancestor
56154777|NCT04711824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154778|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154779|NCT04711824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56659597|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56659598|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56154780|NCT04711824|Immunologic Factors|immunologic factors|mesh-ancestor
56154781|NCT04711824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154782|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56154783|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56154784|NCT04621500|Vitamin D|vitamin d|mesh-list
56154785|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
56154786|NCT04621500|Vitamins|vitamins|mesh-ancestor
56154787|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
56154788|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154789|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56154790|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56154791|NCT04567524|Risperidone|risperidone|mesh-list
56154792|NCT04567524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56154793|NCT04567524|Serotonin Agents|serotonin agents|mesh-ancestor
56154794|NCT04567524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154795|NCT04567524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154796|NCT04567524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154797|NCT04567524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56154798|NCT04567524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56154799|NCT04567524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154800|NCT04567524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56154801|NCT04567524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56154802|NCT04567524|Dopamine Agents|dopamine agents|mesh-ancestor
56154803|NCT04547790|Psyllium|psyllium|mesh-list
56154804|NCT04547790|Cathartics|cathartics|mesh-ancestor
56154805|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082513|NCT02513498|Ixazomib|ixazomib|mesh-list
56154806|NCT04481412|Cetirizine|cetirizine|mesh-list
56154807|NCT04481412|Ethanol|ethanol|mesh-list
56154808|NCT04481412|Minoxidil|minoxidil|mesh-list
56154809|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56154810|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154811|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154812|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154813|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56154814|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56154815|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56154816|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
56154817|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
56154818|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154819|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154820|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56154821|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
56154822|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
56154823|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56154824|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154825|NCT04317300|Varenicline|varenicline|mesh-list
56154826|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56154827|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56154828|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
56154829|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154830|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154831|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154832|NCT04143204|Insulin|insulin|mesh-list
56154833|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55735566|NCT03645603|Analgesics|analgesics|mesh-ancestor
56154842|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56154843|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56154844|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56154846|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56154847|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
56154848|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56154849|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
56154850|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154851|NCT03252522|Micronutrients|micronutrients|mesh-list
56154852|NCT03252522|Trace Elements|trace elements|mesh-list
56154853|NCT03252522|Antioxidants|antioxidants|mesh-list
56154854|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154855|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154856|NCT03252522|Protective Agents|protective agents|mesh-ancestor
56154857|NCT03191370|Anesthetics|anesthetics|mesh-list
56154858|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
56659599|NCT00668616|Paclitaxel|paclitaxel|mesh-list
56659600|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56659601|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
56659602|NCT00668616|Epirubicin|epirubicin|mesh-list
56659603|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56659604|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659605|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
56659606|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
56659607|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
56154859|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154860|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154861|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
56154862|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154863|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
56154864|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56154865|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154866|NCT03149874|Vaccines|vaccines|mesh-list
56154867|NCT03149874|Immunologic Factors|immunologic factors|mesh-ancestor
56154868|NCT03149874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154869|NCT02834052|Poly I-C|poly i-c|mesh-list
56154870|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
56154871|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56154872|NCT02834052|Poly ICLC|poly iclc|mesh-list
56154873|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56154874|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154875|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
56154876|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
56154877|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154878|NCT02834052|Laxatives|laxatives|mesh-ancestor
56154879|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56154880|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
56154881|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154882|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
56154883|NCT02828358|Leucovorin|leucovorin|mesh-list
56154884|NCT02828358|Folic Acid|folic acid|mesh-list
56154885|NCT02828358|Cytarabine|cytarabine|mesh-list
56154886|NCT02828358|Dexamethasone|dexamethasone|mesh-list
56154887|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
56154888|NCT02828358|Prednisolone|prednisolone|mesh-list
56154889|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56154890|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
56154891|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56154892|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
56154893|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
56154894|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56154895|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56154896|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56154897|NCT02828358|Cortisone|cortisone|mesh-list
56154898|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
56154899|NCT02828358|Methotrexate|methotrexate|mesh-list
56154900|NCT02828358|Vincristine|vincristine|mesh-list
56154901|NCT02828358|Azacitidine|azacitidine|mesh-list
56154902|NCT02828358|Daunorubicin|daunorubicin|mesh-list
56154903|NCT02828358|Asparaginase|asparaginase|mesh-list
56154904|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
56154905|NCT02828358|Pegaspargase|pegaspargase|mesh-list
56154906|NCT02828358|Thioguanine|thioguanine|mesh-list
56154907|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56154908|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
56154909|NCT02828358|BB 1101|bb 1101|mesh-list
56154910|NCT02828358|Calcium|calcium|mesh-list
56154912|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
56154913|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154914|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
56154915|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154917|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56154918|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
56154919|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154922|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56154923|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
56154924|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
56154925|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659608|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659609|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56659610|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
56659611|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221202|NCT01660373|Tirofiban|tirofiban|mesh-list
56154926|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56154927|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
56154929|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56154930|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56154931|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
56154932|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56154933|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56154934|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56154935|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56154936|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
56154937|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56154938|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56154939|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
56154940|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
56154941|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56154942|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56154943|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
56154944|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154945|NCT02828358|Antidotes|antidotes|mesh-ancestor
56154946|NCT02828358|Protective Agents|protective agents|mesh-ancestor
56154947|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
56154948|NCT02828358|Vitamins|vitamins|mesh-ancestor
56154949|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
56154950|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56154951|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56154952|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56154953|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56154954|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56154955|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56154956|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56154957|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56154958|NCT02828358|Hematinics|hematinics|mesh-ancestor
56154959|NCT02768532|Vedolizumab|vedolizumab|mesh-list
56154960|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56154961|NCT02756364|Fulvestrant|fulvestrant|mesh-list
56154962|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56154963|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154964|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56154965|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56082668|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
56154966|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
56154967|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176149|NCT01394094|Calcium|calcium|mesh-list
56154968|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154970|NCT02519322|Ipilimumab|ipilimumab|mesh-list
56154971|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
56154972|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
56154973|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56154974|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154975|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56154976|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154977|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
56154978|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154979|NCT02460042|Paclitaxel|paclitaxel|mesh-list
56154980|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56154981|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154982|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56154983|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
56154984|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56154985|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154986|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
56154987|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
56154988|NCT02272842|Vitamins|vitamins|mesh-ancestor
56154989|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
56154990|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659612|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659613|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56659614|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
56154992|NCT02272842|Hematinics|hematinics|mesh-ancestor
56154993|NCT01955460|Aldesleukin|aldesleukin|mesh-list
56154995|NCT01955460|Fludarabine|fludarabine|mesh-list
56154996|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
56154997|NCT01955460|Interleukin-2|interleukin-2|mesh-list
56154998|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154999|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
56155000|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155001|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155002|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56155003|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
56155004|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155005|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155006|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56155007|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155008|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
56155009|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155010|NCT01955460|Analgesics|analgesics|mesh-ancestor
56155011|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
56155012|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155013|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56155014|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56155015|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
56155016|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155017|NCT01869114|Sirolimus|sirolimus|mesh-list
56155018|NCT01869114|Azacitidine|azacitidine|mesh-list
56155019|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155020|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
56155021|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155022|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155023|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155024|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56155025|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155026|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56155027|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
56155028|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155029|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
56155030|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155031|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
56155032|NCT01176006|Busulfan|busulfan|mesh-list
56155033|NCT01176006|Fludarabine|fludarabine|mesh-list
56155034|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
56155035|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155036|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
56155037|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155038|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155039|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56155040|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
56155041|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155042|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155043|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56155044|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155045|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
56155046|NCT05723562|Dostarlimab-gxly|dostarlimab-gxly|mesh-list
56155047|NCT05723562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155048|NCT05722782|Acetaminophen|acetaminophen|mesh-list
56155049|NCT05722782|Piroxicam|piroxicam|mesh-list
56155050|NCT05722782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155051|NCT05722782|Analgesics|analgesics|mesh-ancestor
56155052|NCT05722782|Sensory System Agents|sensory system agents|mesh-ancestor
56155053|NCT05722782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155054|NCT05722782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155055|NCT05722782|Antipyretics|antipyretics|mesh-ancestor
56155056|NCT05722782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56155057|NCT05722782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56155058|NCT05722782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155059|NCT05722782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56155060|NCT05722782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155061|NCT05722782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155062|NCT05722548|Indomethacin|indomethacin|mesh-list
56659615|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56305745|NCT00038584|Lonafarnib|lonafarnib|mesh-list
56659616|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56659617|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56659618|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56155063|NCT05722548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56155064|NCT05722548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155065|NCT05722548|Analgesics|analgesics|mesh-ancestor
56155066|NCT05722548|Sensory System Agents|sensory system agents|mesh-ancestor
56155067|NCT05722548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155068|NCT05722548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155073|NCT05722548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56155074|NCT05722548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56155075|NCT05722548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155076|NCT05722548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155077|NCT05722002|Acetaminophen|acetaminophen|mesh-list
56155078|NCT05722002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155079|NCT05722002|Analgesics|analgesics|mesh-ancestor
56155080|NCT05722002|Sensory System Agents|sensory system agents|mesh-ancestor
56155081|NCT05722002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155082|NCT05722002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155083|NCT05722002|Antipyretics|antipyretics|mesh-ancestor
56155084|NCT05721846|Nivolumab|nivolumab|mesh-list
56155085|NCT05721846|Ipilimumab|ipilimumab|mesh-list
56155086|NCT05721846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155087|NCT05721846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155088|NCT05721846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56155089|NCT05721846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155090|NCT05721456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56155091|NCT05721456|Immunologic Factors|immunologic factors|mesh-ancestor
56155092|NCT05721456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155093|NCT05721300|Interferons|interferons|mesh-list
56155094|NCT05721300|Tenofovir|tenofovir|mesh-list
56155095|NCT05721300|Entecavir|entecavir|mesh-list
56155096|NCT05721300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155097|NCT05721300|Antiviral Agents|antiviral agents|mesh-ancestor
56155098|NCT05721300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155099|NCT05721300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56155100|NCT05721300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56155101|NCT05721300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155102|NCT05721300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155103|NCT05721300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56155104|NCT05721300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56155105|NCT05720988|Azacitidine|azacitidine|mesh-list
56155106|NCT05720988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155107|NCT05720988|Antimetabolites|antimetabolites|mesh-ancestor
56155108|NCT05720988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155109|NCT05720988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155110|NCT05720988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155111|NCT05720442|Mosapride|mosapride|mesh-list
56176168|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56155112|NCT05720442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155113|NCT05720442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56155114|NCT05720442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56155116|NCT05720442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155117|NCT05720442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155118|NCT05719818|Diphosphonates|diphosphonates|mesh-list
56155119|NCT05719818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56155120|NCT05719818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155121|NCT05719506|Dexmedetomidine|dexmedetomidine|mesh-list
56155122|NCT05719506|Ketamine|ketamine|mesh-list
56155123|NCT05719506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56155124|NCT05719506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155125|NCT05719506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155126|NCT05719506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155127|NCT05719506|Analgesics|analgesics|mesh-ancestor
56155128|NCT05719506|Sensory System Agents|sensory system agents|mesh-ancestor
56155129|NCT05719506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155130|NCT05719506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56659619|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659620|NCT02763761|Prednisone|prednisone|mesh-list
56659621|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
56659622|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56659623|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56659624|NCT02763761|Prednisolone|prednisolone|mesh-list
56659625|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
56659626|NCT02763761|Infliximab|infliximab|mesh-list
56659627|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56659628|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
56659629|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56155131|NCT05719506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56155132|NCT05719506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56155133|NCT05719506|Adrenergic Agents|adrenergic agents|mesh-ancestor
56155134|NCT05719506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155135|NCT05719506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155136|NCT05719506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56155137|NCT05719506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56155138|NCT05719506|Anesthetics, General|anesthetics, general|mesh-ancestor
56155140|NCT05719506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56155141|NCT05719506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56155142|NCT05717166|Hormones|hormones|mesh-list
56155143|NCT05717166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56155144|NCT05717166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155145|NCT05716932|Ranibizumab|ranibizumab|mesh-list
56155146|NCT05716932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56155147|NCT05716932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56155148|NCT05716932|Growth Substances|growth substances|mesh-ancestor
56155149|NCT05716932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155150|NCT05716932|Growth Inhibitors|growth inhibitors|mesh-ancestor
56155151|NCT05716932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155152|NCT05716854|Moxifloxacin|moxifloxacin|mesh-list
56155153|NCT05716854|Clarithromycin|clarithromycin|mesh-list
56155154|NCT05716854|Cobicistat|cobicistat|mesh-list
56155155|NCT05716854|Pimozide|pimozide|mesh-list
56155156|NCT05716854|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56155157|NCT05716854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56155158|NCT05716854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155159|NCT05716854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56155160|NCT05716854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56155161|NCT05716854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155162|NCT05716854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155163|NCT05716854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155164|NCT05716854|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56155165|NCT05716854|Contraceptive Agents|contraceptive agents|mesh-ancestor
56155166|NCT05716854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56155167|NCT05716854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155168|NCT05716854|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56155169|NCT05716854|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56155170|NCT05716854|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56155171|NCT05716854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56155172|NCT05716854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56155173|NCT05716854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56155174|NCT05716854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56155175|NCT05716854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56155176|NCT05716854|Antiviral Agents|antiviral agents|mesh-ancestor
56155177|NCT05716854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56155178|NCT05716854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56155179|NCT05716854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155180|NCT05716854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56155181|NCT05716854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56155182|NCT05716854|Dopamine Agents|dopamine agents|mesh-ancestor
56155184|NCT05716854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56155185|NCT05715840|Paclitaxel|paclitaxel|mesh-list
56155186|NCT05715840|Bevacizumab|bevacizumab|mesh-list
56659630|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
56659631|NCT02763761|Hormones|hormones|mesh-ancestor
56659632|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659633|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659634|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56659635|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659636|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
56659637|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
56659638|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659639|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56659640|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56659641|NCT02763761|Protective Agents|protective agents|mesh-ancestor
56659642|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
56659643|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155187|NCT05715840|Carboplatin|carboplatin|mesh-list
56155188|NCT05715840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56155189|NCT05715840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155190|NCT05715840|Tubulin Modulators|tubulin modulators|mesh-ancestor
56155191|NCT05715840|Antimitotic Agents|antimitotic agents|mesh-ancestor
56155192|NCT05715840|Mitosis Modulators|mitosis modulators|mesh-ancestor
56155193|NCT05715840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155194|NCT05715840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155195|NCT05715840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56155196|NCT05715840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56155197|NCT05715840|Growth Substances|growth substances|mesh-ancestor
56155198|NCT05715840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155199|NCT05715840|Growth Inhibitors|growth inhibitors|mesh-ancestor
56155200|NCT05713734|Thrombin|thrombin|mesh-list
56155201|NCT05713734|Hemostatics|hemostatics|mesh-ancestor
56155202|NCT05713734|Coagulants|coagulants|mesh-ancestor
56155203|NCT05698758|Dexmedetomidine|dexmedetomidine|mesh-list
56155204|NCT05698758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56155205|NCT05698758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155206|NCT05698758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155207|NCT05698758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155208|NCT05698758|Analgesics|analgesics|mesh-ancestor
56155209|NCT05698758|Sensory System Agents|sensory system agents|mesh-ancestor
56155210|NCT05698758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155211|NCT05698758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56155212|NCT05698758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56155213|NCT05698758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56155214|NCT05698758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56155215|NCT05698758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155216|NCT05698758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155217|NCT05683392|Insulin|insulin|mesh-list
56155218|NCT05683392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56155219|NCT05683392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155220|NCT05676294|Olanzapine|olanzapine|mesh-list
56155221|NCT05676294|Antiemetics|antiemetics|mesh-ancestor
56155222|NCT05676294|Autonomic Agents|autonomic agents|mesh-ancestor
56155223|NCT05676294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155224|NCT05676294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155225|NCT05676294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56155226|NCT05676294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56155227|NCT05676294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56155228|NCT05676294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155229|NCT05676294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56155230|NCT05676294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56155231|NCT05676294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56155232|NCT05676294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925396|NCT05689021|Niraparib|niraparib|mesh-list
56659644|NCT04155918|Allopurinol|allopurinol|mesh-list
56659645|NCT04155918|Febuxostat|febuxostat|mesh-list
56659646|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
56659647|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659648|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659649|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
56659650|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659651|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56659652|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
56659653|NCT04155918|Protective Agents|protective agents|mesh-ancestor
56155233|NCT05676294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155234|NCT05676294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155235|NCT05676294|Serotonin Agents|serotonin agents|mesh-ancestor
56155236|NCT05665062|Cyclophosphamide|cyclophosphamide|mesh-list
56155237|NCT05665062|Fludarabine|fludarabine|mesh-list
56155238|NCT05665062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155239|NCT05665062|Immunologic Factors|immunologic factors|mesh-ancestor
56155240|NCT05665062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155241|NCT05665062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155242|NCT05665062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56155243|NCT05665062|Alkylating Agents|alkylating agents|mesh-ancestor
56155244|NCT05665062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155245|NCT05665062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155246|NCT05665062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56155247|NCT05618808|Enoxaparin|enoxaparin|mesh-list
56155248|NCT05618808|Anticoagulants|anticoagulants|mesh-ancestor
56155249|NCT05618808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56155250|NCT05618808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56155251|NCT05618808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155252|NCT05612490|Furosemide|furosemide|mesh-list
56155253|NCT05612490|Diuretics|diuretics|mesh-ancestor
56155254|NCT05612490|Natriuretic Agents|natriuretic agents|mesh-ancestor
56155255|NCT05612490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155256|NCT05612490|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56155257|NCT05612490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56155258|NCT05612490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155259|NCT05600322|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56155260|NCT05600322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56155261|NCT05600322|Dermatologic Agents|dermatologic agents|mesh-ancestor
56155262|NCT05579730|Ketotifen|ketotifen|mesh-list
56155263|NCT05579730|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56155264|NCT05579730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56155265|NCT05579730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56155266|NCT05579730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56155267|NCT05579730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56155268|NCT05579730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56155270|NCT05579730|Adrenergic Agents|adrenergic agents|mesh-ancestor
56155271|NCT05579730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155272|NCT05579730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155273|NCT05579730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155274|NCT05579730|Antipruritics|antipruritics|mesh-ancestor
56155275|NCT05579730|Dermatologic Agents|dermatologic agents|mesh-ancestor
56155276|NCT05579730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56155277|NCT05579730|Histamine Antagonists|histamine antagonists|mesh-ancestor
56155278|NCT05579730|Histamine Agents|histamine agents|mesh-ancestor
56155279|NCT05579730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56155280|NCT05570292|Folic Acid|folic acid|mesh-list
56155281|NCT05570292|Domperidone|domperidone|mesh-list
56155282|NCT05570292|Hematinics|hematinics|mesh-ancestor
56155283|NCT05570292|Vitamin B Complex|vitamin b complex|mesh-ancestor
56155284|NCT05570292|Vitamins|vitamins|mesh-ancestor
56155285|NCT05570292|Micronutrients|micronutrients|mesh-ancestor
56155286|NCT05570292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155287|NCT05570292|Antiemetics|antiemetics|mesh-ancestor
56155288|NCT05570292|Autonomic Agents|autonomic agents|mesh-ancestor
56155289|NCT05570292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155291|NCT05570292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56659654|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659655|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56659656|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56659657|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
56659658|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659659|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56155292|NCT05570292|Dopamine Agents|dopamine agents|mesh-ancestor
56155293|NCT05570292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155301|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
56155302|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
56155303|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56155304|NCT05557812|Protective Agents|protective agents|mesh-ancestor
56155305|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155306|NCT05557812|Hematinics|hematinics|mesh-ancestor
56155307|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155308|NCT05549466|Gemcitabine|gemcitabine|mesh-list
56155309|NCT05549466|Capecitabine|capecitabine|mesh-list
56155311|NCT05549466|Apatinib|apatinib|mesh-list
56155312|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155313|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
56155314|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155315|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155316|NCT05549466|Antiviral Agents|antiviral agents|mesh-ancestor
56155317|NCT05549466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155318|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155319|NCT05549466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155320|NCT05549466|Immunologic Factors|immunologic factors|mesh-ancestor
56155321|NCT05549466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155322|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
56155323|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
56155324|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
56155325|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56155326|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
56155327|NCT05436678|Celecoxib|celecoxib|mesh-list
56155328|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56155329|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155330|NCT05436678|Analgesics|analgesics|mesh-ancestor
56155331|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
56155332|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155333|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155334|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56155335|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155336|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56155337|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56155338|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155339|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155340|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56155341|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155342|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56155343|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56155344|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155345|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56155346|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56155348|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56155349|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155350|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56155351|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155352|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
56155353|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155354|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
56155355|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155356|NCT05413122|Nicotine|nicotine|mesh-list
56155357|NCT05413122|Varenicline|varenicline|mesh-list
56155358|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56155359|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
56155360|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155361|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155362|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56155363|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56659660|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56659661|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
56659662|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
56659663|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659664|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155365|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155366|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155367|NCT05352282|Fentanyl|fentanyl|mesh-list
56155368|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56155369|NCT05352282|Narcotics|narcotics|mesh-ancestor
56155370|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155371|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155372|NCT05352282|Analgesics|analgesics|mesh-ancestor
56155373|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
56155374|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155375|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56155376|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56155377|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
56155378|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
56155379|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
56155380|NCT05322330|Fludarabine|fludarabine|mesh-list
56155381|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155382|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
56155383|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155384|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155385|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56155386|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
56155387|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155388|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155389|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56155390|NCT05312892|Amlodipine|amlodipine|mesh-list
56155391|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
56155392|NCT05312892|Moxonidine|moxonidine|mesh-list
56155393|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56155394|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56155395|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155396|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56155397|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155398|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
56155399|NCT05309616|Ixekizumab|ixekizumab|mesh-list
56155400|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
56155401|NCT05307198|Capecitabine|capecitabine|mesh-list
56155402|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
56155403|NCT05307198|Antibodies|antibodies|mesh-list
56155404|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56155405|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
56155406|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155407|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155408|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
56155409|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155410|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155412|NCT05281614|Vedolizumab|vedolizumab|mesh-list
56155413|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56155414|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155415|NCT05281614|Analgesics|analgesics|mesh-ancestor
56155416|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
56155417|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083113|NCT05272202|Propofol|propofol|mesh-list
56155418|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155419|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56155420|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155421|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56155422|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155423|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
56155424|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
56155425|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
56155426|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
56155427|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56155428|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56659665|NCT00541099|Bevacizumab|bevacizumab|mesh-list
56659666|NCT00541099|Docetaxel|docetaxel|mesh-list
56155429|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155430|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155431|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155432|NCT05251038|Leucovorin|leucovorin|mesh-list
56155433|NCT05251038|Gemcitabine|gemcitabine|mesh-list
56155434|NCT05251038|Paclitaxel|paclitaxel|mesh-list
56155435|NCT05251038|Fluorouracil|fluorouracil|mesh-list
56155436|NCT05251038|Irinotecan|irinotecan|mesh-list
56155437|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56155438|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155446|NCT05251038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155447|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155448|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155449|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
56155450|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155451|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56155452|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56155453|NCT05251038|Antidotes|antidotes|mesh-ancestor
56155454|NCT05251038|Protective Agents|protective agents|mesh-ancestor
56155455|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
56155456|NCT05251038|Vitamins|vitamins|mesh-ancestor
56155457|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
56155458|NCT05217498|Istradefylline|istradefylline|mesh-list
56155459|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56155460|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56155461|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56155462|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
56155463|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155464|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155465|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155466|NCT05206266|Turmeric extract|turmeric extract|mesh-list
56155467|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
56155468|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155469|NCT05206266|Protective Agents|protective agents|mesh-ancestor
56155470|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155471|NCT05205486|Cefazolin|cefazolin|mesh-list
56155472|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56155473|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155474|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
56155475|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
56155476|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155477|NCT05091372|Lenalidomide|lenalidomide|mesh-list
56155478|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
56155479|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155480|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56155482|NCT05091372|Growth Substances|growth substances|mesh-ancestor
56155483|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
56155484|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155485|NCT05042700|Melatonin|melatonin|mesh-list
56155486|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
56155487|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155488|NCT05042700|Protective Agents|protective agents|mesh-ancestor
56155489|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155490|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155491|NCT05027646|Granisetron|granisetron|mesh-list
56155492|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
56155493|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
56155494|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155495|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155496|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56155497|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56155498|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
56155499|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155500|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155501|NCT05005728|Carboplatin|carboplatin|mesh-list
56155502|NCT05005728|Docetaxel|docetaxel|mesh-list
56155503|NCT05005728|Olaparib|olaparib|mesh-list
56155504|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155505|NCT05005728|Tubulin Modulators|tubulin modulators|mesh-ancestor
56155506|NCT05005728|Antimitotic Agents|antimitotic agents|mesh-ancestor
56155507|NCT05005728|Mitosis Modulators|mitosis modulators|mesh-ancestor
56155508|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155511|NCT04988646|Acyclovir|acyclovir|mesh-list
56659667|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56659668|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659669|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56155512|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
56155513|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155514|NCT04972110|Olaparib|olaparib|mesh-list
56155515|NCT04972110|Niraparib|niraparib|mesh-list
56155516|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56155517|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155518|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155519|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155520|NCT04951206|Clobetasol|clobetasol|mesh-list
56155521|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56155522|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
56155523|NCT04951206|Hormones|hormones|mesh-ancestor
56155524|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56155525|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155526|NCT04924062|Gemcitabine|gemcitabine|mesh-list
56155527|NCT04924062|Cisplatin|cisplatin|mesh-list
56155528|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
56155529|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155530|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155531|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
56155532|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155533|NCT04924062|Antiviral Agents|antiviral agents|mesh-ancestor
56155534|NCT04924062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155535|NCT04924062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155536|NCT04924062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155537|NCT04924062|Immunologic Factors|immunologic factors|mesh-ancestor
56155538|NCT04924062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155539|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155540|NCT04911660|Empagliflozin|empagliflozin|mesh-list
56155541|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56155542|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155543|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56155544|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155545|NCT04876638|Minocycline|minocycline|mesh-list
56155546|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56155547|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155548|NCT04876248|Lenalidomide|lenalidomide|mesh-list
56155549|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
56155550|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155551|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56155552|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56155553|NCT04876248|Growth Substances|growth substances|mesh-ancestor
56155554|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
56155555|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155556|NCT04754334|Insulin|insulin|mesh-list
56155557|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56155558|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155559|NCT04748796|Landiolol|landiolol|mesh-list
56155560|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56155561|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56155562|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
56155563|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155564|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155565|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155566|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56155567|NCT04677816|Vitamin D|vitamin d|mesh-list
56155568|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
56083257|NCT02254278|Cisplatin|cisplatin|mesh-list
56155569|NCT04677816|Vitamins|vitamins|mesh-ancestor
56155570|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
56155571|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155572|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56155573|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56155574|NCT04676334|Rucaparib|rucaparib|mesh-list
56155575|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56155576|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155577|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155578|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155579|NCT04661358|Fenofibrate|fenofibrate|mesh-list
56659670|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56659671|NCT00541099|Growth Substances|growth substances|mesh-ancestor
56659672|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659673|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
56659674|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
56659675|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
56659676|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
56221252|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
56221253|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
56221254|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
56155580|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56155581|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
56155583|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56155586|NCT04625946|Metformin|metformin|mesh-list
56155587|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56155588|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155589|NCT04599816|Simendan|simendan|mesh-list
56155590|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56155591|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
56155592|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56155593|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56155594|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155595|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155596|NCT04599816|Protective Agents|protective agents|mesh-ancestor
56155597|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155598|NCT04579380|Trastuzumab|trastuzumab|mesh-list
56155599|NCT04579380|Fulvestrant|fulvestrant|mesh-list
56155601|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155602|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155603|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56155604|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56155605|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56155606|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
56155607|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56155608|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155609|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56155610|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155611|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155612|NCT04546230|Anesthetics|anesthetics|mesh-list
56155613|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155614|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155615|NCT04534218|Aspirin|aspirin|mesh-list
56155616|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
56155617|NCT04534218|Capecitabine|capecitabine|mesh-list
56155618|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155619|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
56155620|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155621|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155622|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56155623|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
56155624|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155625|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155626|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56155627|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155629|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56155630|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155631|NCT04534218|Analgesics|analgesics|mesh-ancestor
56155632|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
56155633|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155634|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56155635|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56155636|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56155637|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56155638|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56659677|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659678|NCT00580606|Glycerol|glycerol|mesh-list
56659679|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56659680|NCT00580606|Protective Agents|protective agents|mesh-ancestor
56659681|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659682|NCT05711641|Lidocaine|lidocaine|mesh-list
56659683|NCT05711641|Anesthetics, Local|anesthetics, local|mesh-ancestor
56659684|NCT05711641|Anesthetics|anesthetics|mesh-ancestor
56659685|NCT05711641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659686|NCT05711641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659687|NCT05711641|Sensory System Agents|sensory system agents|mesh-ancestor
56659688|NCT05711641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659689|NCT05711641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56659690|NCT05711641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56659691|NCT05711641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56659692|NCT05711641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659693|NCT05711641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659694|NCT02575768|Adenosine|adenosine|mesh-list
56659695|NCT02575768|Analgesics|analgesics|mesh-ancestor
56659696|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
56155639|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155640|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
56155641|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56155642|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155643|NCT04525014|Irinotecan|irinotecan|mesh-list
56155644|NCT04525014|Temozolomide|temozolomide|mesh-list
56155645|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56155646|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56155647|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155648|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155649|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155650|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56155651|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
56155653|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
56155654|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56155655|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155656|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155657|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56155658|NCT04509414|Analgesics|analgesics|mesh-ancestor
56155666|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155667|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56155668|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56155669|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56155670|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56155671|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56155672|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
56155673|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
56155674|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
56155675|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
56155676|NCT04480554|Naltrexone|naltrexone|mesh-list
56155677|NCT04480554|Buprenorphine|buprenorphine|mesh-list
56155678|NCT04480554|Methadone|methadone|mesh-list
56155679|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56155680|NCT04480554|Naloxone|naloxone|mesh-list
56155681|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56659697|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659698|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659699|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56659700|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
56659701|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56659702|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
56659703|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
56659704|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221278|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
56155682|NCT04480554|Narcotics|narcotics|mesh-ancestor
56155683|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155684|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155685|NCT04480554|Analgesics|analgesics|mesh-ancestor
56155686|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
56155687|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155688|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56155689|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56155690|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
56155691|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
56155692|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
56155693|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56155694|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56155695|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
56155696|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155697|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155698|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155699|NCT04437108|Urological Agents|urological agents|mesh-ancestor
56155700|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
56155701|NCT04416984|Fludarabine|fludarabine|mesh-list
56155702|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155703|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
56155704|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155705|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155706|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56155707|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
56155708|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155709|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155710|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56155711|NCT04320342|Beclomethasone|beclomethasone|mesh-list
56155712|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
56155713|NCT04320342|Bromides|bromides|mesh-list
56155714|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
56155715|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56155716|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
56083412|NCT02473783|Sertraline|sertraline|mesh-list
56155717|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155718|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155719|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56155720|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
56155721|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56155722|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56155723|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56155724|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
56155725|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155732|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56155733|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56155734|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56155735|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
56155736|NCT04307550|Ethanol|ethanol|mesh-list
56155737|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56155738|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155739|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155740|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155741|NCT04218240|Lofexidine|lofexidine|mesh-list
56155742|NCT04218240|Pregabalin|pregabalin|mesh-list
56155743|NCT04218240|Analgesics|analgesics|mesh-ancestor
56155744|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
56659705|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659706|NCT00987493|Rituximab|rituximab|mesh-list
56659707|NCT00987493|Lenalidomide|lenalidomide|mesh-list
56659708|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56659709|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56659710|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659711|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
56659712|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659713|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659714|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56659715|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56659716|NCT00987493|Growth Substances|growth substances|mesh-ancestor
56659717|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
56659718|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56659719|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
56659720|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659721|NCT02579356|Telmisartan|telmisartan|mesh-list
56659722|NCT02579356|Atorvastatin|atorvastatin|mesh-list
56221288|NCT01660750|Hormones|hormones|mesh-ancestor
56155745|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155746|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155747|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
56155748|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56155749|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56155750|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155751|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56155752|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56155753|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56155754|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155755|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56155756|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56155757|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56155758|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56155759|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56155760|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56155761|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
56155762|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155763|NCT04164732|Valsartan|valsartan|mesh-list
56155764|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56155765|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56155766|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56155767|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56155768|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155769|NCT04134000|Atezolizumab|atezolizumab|mesh-list
56213181|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155770|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155771|NCT04095858|Methotrexate|methotrexate|mesh-list
56155772|NCT04095858|Tacrolimus|tacrolimus|mesh-list
56155773|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56155774|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
56155775|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56155776|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155777|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155778|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
56659723|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56659724|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56659725|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
56659726|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659727|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56659728|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56659729|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659730|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56659731|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56221298|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221299|NCT01660867|Dexamethasone|dexamethasone|mesh-list
56221300|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221301|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
56221302|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
56155779|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155780|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155781|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
56155782|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155783|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56155784|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155785|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
56155786|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155787|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56155788|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56155789|NCT04052568|Psilocybin|psilocybin|mesh-list
56155790|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
56155791|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155800|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155801|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
56155802|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155803|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56155804|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56155805|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56155806|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56155807|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155809|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155810|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56155811|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56155812|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56155813|NCT03873402|Nivolumab|nivolumab|mesh-list
56155814|NCT03873402|Ipilimumab|ipilimumab|mesh-list
56155815|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155816|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155817|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56155818|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155819|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
56155820|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155821|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155822|NCT03813030|Lidocaine|lidocaine|mesh-list
56155823|NCT03813030|Prilocaine|prilocaine|mesh-list
56155824|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
56155825|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
56155826|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155827|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155828|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
56155829|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155830|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56155831|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56659732|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56659733|NCT03914170|Cetuximab|cetuximab|mesh-list
56659734|NCT03914170|Folfirinox|folfirinox|mesh-list
56659735|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56659736|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659737|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
56659738|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56659739|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659740|NCT02577250|Ketamine|ketamine|mesh-list
56659741|NCT02577250|Analgesics|analgesics|mesh-ancestor
56659742|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
56659743|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659744|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659745|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56659746|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56659747|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
56659748|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
56659749|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659750|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56659751|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56659752|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659753|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659754|NCT00668850|Insulin|insulin|mesh-list
56659755|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56659756|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56221307|NCT01660867|Hormones|hormones|mesh-ancestor
56155832|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56155833|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56155834|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155835|NCT03778944|Dopamine|dopamine|mesh-list
56155836|NCT03778944|Mannitol|mannitol|mesh-list
56155837|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56155838|NCT03778944|Diuretics|diuretics|mesh-ancestor
56155839|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
56155840|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155841|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56155842|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
56155843|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
56155844|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155845|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
56155846|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155847|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155848|NCT03778944|Protective Agents|protective agents|mesh-ancestor
56155849|NCT03660930|Sirolimus|sirolimus|mesh-list
56155850|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56155851|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155852|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56155853|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155854|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
56155855|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155856|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
56659757|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659758|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
56659759|NCT02762123|Digoxin|digoxin|mesh-list
56659760|NCT02762123|Midazolam|midazolam|mesh-list
56659761|NCT02762123|Omeprazole|omeprazole|mesh-list
56659762|NCT02762123|Montelukast|montelukast|mesh-list
56659763|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56659764|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56659765|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56305891|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
56659766|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659767|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56659768|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56659769|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56659770|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56659771|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
56659772|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
56659773|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
56659774|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
56659775|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221330|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221331|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155857|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155858|NCT03653052|Durvalumab|durvalumab|mesh-list
56155859|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155860|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155861|NCT03640728|Tenofovir|tenofovir|mesh-list
56155862|NCT03640728|Entecavir|entecavir|mesh-list
56155863|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
56155865|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56155866|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56155867|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155868|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155870|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56155871|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
56155872|NCT03606174|Nivolumab|nivolumab|mesh-list
56155873|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155874|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155875|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56155876|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155877|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
56155878|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155879|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155880|NCT03535272|Bismuth|bismuth|mesh-list
56155881|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56155882|NCT03535272|Antacids|antacids|mesh-ancestor
56155883|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155884|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56155885|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
56155886|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56155887|NCT03534180|Venetoclax|venetoclax|mesh-list
56155888|NCT03534180|Romidepsin|romidepsin|mesh-list
56155889|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155890|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155891|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56155892|NCT03529110|Trastuzumab|trastuzumab|mesh-list
56659776|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659777|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56659778|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56659779|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56659780|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659781|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56659782|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
56659783|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56659784|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
56659785|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659786|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56221348|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
56155893|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56155894|NCT03529110|Maytansine|maytansine|mesh-list
56155895|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155896|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155897|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56155898|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56155899|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56155900|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56155901|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155902|NCT03515304|Evolocumab|evolocumab|mesh-list
56155903|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56155904|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56155905|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
56155906|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155907|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56155908|NCT03502746|Nivolumab|nivolumab|mesh-list
56155909|NCT03502746|Ramucirumab|ramucirumab|mesh-list
56155910|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155911|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155912|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56155913|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155914|NCT03436368|Anesthetics|anesthetics|mesh-list
56155915|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155916|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155917|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56155918|NCT03393780|Hormones|hormones|mesh-ancestor
56155919|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56155921|NCT03367572|Dexamethasone|dexamethasone|mesh-list
56155922|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
56155923|NCT03367572|Olanzapine|olanzapine|mesh-list
56155924|NCT03367572|Palonosetron|palonosetron|mesh-list
56155925|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
56155926|NCT03367572|Ichthammol|ichthammol|mesh-list
56155927|NCT03367572|BB 1101|bb 1101|mesh-list
56155928|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56155929|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
56155930|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
56155931|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155932|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155933|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56155934|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
56155935|NCT03367572|Hormones|hormones|mesh-ancestor
56155936|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56155937|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56155938|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155939|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56155940|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56155944|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56155945|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659787|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56659788|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56659789|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56659790|NCT02762123|Protective Agents|protective agents|mesh-ancestor
56659791|NCT02762123|Analgesics|analgesics|mesh-ancestor
56659792|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
56659793|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659794|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56659795|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659796|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56659797|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659798|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56659799|NCT04153734|Paclitaxel|paclitaxel|mesh-list
56659800|NCT04153734|Carboplatin|carboplatin|mesh-list
56155946|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155947|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155948|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
56155949|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
56155950|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155951|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56155952|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56155953|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
56155954|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56155955|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
56155956|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
56155957|NCT03321630|Lenvatinib|lenvatinib|mesh-list
56155958|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155959|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155960|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56155961|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155962|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155963|NCT03317496|Gemcitabine|gemcitabine|mesh-list
56155964|NCT03317496|Cisplatin|cisplatin|mesh-list
56155965|NCT03317496|Carboplatin|carboplatin|mesh-list
56155966|NCT03317496|Pemetrexed|pemetrexed|mesh-list
56155967|NCT03317496|Avelumab|avelumab|mesh-list
56155968|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56155969|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155970|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155971|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
56155972|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155973|NCT03317496|Antiviral Agents|antiviral agents|mesh-ancestor
56155974|NCT03317496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155975|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155976|NCT03317496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56155977|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
56155978|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155979|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56155980|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56155981|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155982|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56155983|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155984|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155985|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56155986|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
56155987|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
56155988|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176198|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56155989|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155990|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56155991|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
56659801|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
56659802|NCT04153734|Pemetrexed|pemetrexed|mesh-list
56155992|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
56155993|NCT03212742|Temozolomide|temozolomide|mesh-list
56155994|NCT03212742|Olaparib|olaparib|mesh-list
56155995|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56155996|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
56155997|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155998|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155999|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56156000|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156001|NCT03202758|Durvalumab|durvalumab|mesh-list
56156002|NCT03202758|Tremelimumab|tremelimumab|mesh-list
56156003|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56156004|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156005|NCT03122262|Tenofovir|tenofovir|mesh-list
56156006|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56156007|NCT03122262|Dolutegravir|dolutegravir|mesh-list
56156008|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56156016|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56156017|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56156018|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56156019|NCT03051282|Enalapril|enalapril|mesh-list
56156020|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56156021|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
56156022|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156023|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156024|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56156025|NCT03042546|Calcium|calcium|mesh-list
56156026|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56156027|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156028|NCT02772588|Leuprolide|leuprolide|mesh-list
56156029|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56156030|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
56156031|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56156032|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156033|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56156034|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156035|NCT02748564|Aldesleukin|aldesleukin|mesh-list
56156036|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
56156037|NCT02748564|Interleukin-2|interleukin-2|mesh-list
56156038|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56156039|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156040|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56156041|NCT02748564|Analgesics|analgesics|mesh-ancestor
56156042|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
56156043|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156044|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156045|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56156046|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56156047|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
56156048|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156049|NCT02734602|Ketamine|ketamine|mesh-list
56156050|NCT02734602|Analgesics|analgesics|mesh-ancestor
56156051|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
56156052|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156053|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156054|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56156055|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56156056|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
56156057|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
56176203|NCT01394406|Ketamine|ketamine|mesh-list
56156058|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156059|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56156060|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56156061|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156062|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156063|NCT02663622|Methotrexate|methotrexate|mesh-list
56156064|NCT02663622|Tacrolimus|tacrolimus|mesh-list
56156065|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56156066|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
56156067|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56156068|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925506|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659803|NCT04153734|Cisplatin|cisplatin|mesh-list
56659804|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56659805|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659806|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56659807|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56221375|NCT01661322|Aspirin|aspirin|mesh-list
56156069|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56156070|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
56156071|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156072|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156073|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56156076|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156077|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
56156078|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56156079|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56156080|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56156081|NCT02486718|Gemcitabine|gemcitabine|mesh-list
56156082|NCT02486718|Docetaxel|docetaxel|mesh-list
56156083|NCT02486718|Pemetrexed|pemetrexed|mesh-list
56156084|NCT02486718|Atezolizumab|atezolizumab|mesh-list
56156085|NCT02486718|Vinorelbine|vinorelbine|mesh-list
56156086|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156087|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56156088|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
56156089|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156090|NCT02486718|Antiviral Agents|antiviral agents|mesh-ancestor
56156091|NCT02486718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156092|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156093|NCT02486718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156095|NCT02486718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156096|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
56156097|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
56156098|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
56156099|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56156100|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56156101|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56156102|NCT02420652|Aspirin|aspirin|mesh-list
56156103|NCT02420652|Metformin|metformin|mesh-list
56156104|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56156105|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156106|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56156107|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56156108|NCT02420652|Analgesics|analgesics|mesh-ancestor
56156109|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
56156110|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156111|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56156112|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56156113|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56156114|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56156115|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156116|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56156117|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56156118|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156119|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
56156120|NCT02257242|Rituximab|rituximab|mesh-list
56156121|NCT02257242|Vincristine|vincristine|mesh-list
56156122|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56156123|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56156124|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156125|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
56156126|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156127|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56156128|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56156129|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
56156130|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
56156131|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
56156147|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156148|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56156149|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156150|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
56659808|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56659809|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659810|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56659811|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659812|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56659813|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56659814|NCT04073680|Canagliflozin|canagliflozin|mesh-list
56659815|NCT04073680|Serabelisib|serabelisib|mesh-list
56659816|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56156151|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56156152|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156153|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
56156154|NCT02037048|Antidotes|antidotes|mesh-ancestor
56156155|NCT02037048|Protective Agents|protective agents|mesh-ancestor
56156156|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
56156157|NCT02037048|Vitamins|vitamins|mesh-ancestor
56156158|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
56156159|NCT02034630|Busulfan|busulfan|mesh-list
56156160|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
56156161|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156162|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156163|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
56156172|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156188|NCT01856478|Methotrexate|methotrexate|mesh-list
56156189|NCT01856478|Afatinib|afatinib|mesh-list
56156190|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56156191|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
56156192|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56156193|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156194|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56156195|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
56156196|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156197|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156198|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56156199|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156200|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56156201|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156202|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
56156203|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56156204|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56156205|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56156206|NCT01768338|Ofatumumab|ofatumumab|mesh-list
56156207|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156208|NCT01659606|Cyclosporine|cyclosporine|mesh-list
56156209|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
56156210|NCT01659606|Fludarabine|fludarabine|mesh-list
56156211|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
56156212|NCT01659606|Tacrolimus|tacrolimus|mesh-list
56156213|NCT01659606|Cyclosporins|cyclosporins|mesh-list
56156214|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156215|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156216|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156217|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
56156218|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156219|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56156220|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156221|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
56156222|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156223|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
56156224|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56156225|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56156226|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56156227|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
56156228|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56156229|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56156230|NCT00819546|Everolimus|everolimus|mesh-list
56156231|NCT00819546|Midostaurin|midostaurin|mesh-list
56659817|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659818|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56659819|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659820|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659821|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
56659822|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56659823|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
56659824|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659825|NCT02761577|Expectorants|expectorants|mesh-ancestor
56156232|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156233|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156234|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
56156235|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156236|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56156237|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156238|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156239|NCT00777036|Dasatinib|dasatinib|mesh-list
56156240|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156241|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56156242|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083928|NCT02587117|Lycopene|lycopene|mesh-list
56156243|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156245|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
56156246|NCT00596154|Busulfan|busulfan|mesh-list
56156247|NCT00596154|Thiotepa|thiotepa|mesh-list
56156248|NCT00596154|Rituximab|rituximab|mesh-list
56156249|NCT00596154|Methotrexate|methotrexate|mesh-list
56156250|NCT00596154|Vincristine|vincristine|mesh-list
56156251|NCT00596154|Procarbazine|procarbazine|mesh-list
56156252|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156253|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
56156254|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156255|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56156256|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56156257|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
56156258|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156259|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156260|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56156261|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56156262|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56156263|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
56156264|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56156265|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56156266|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
56156267|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
56156268|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156269|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56156270|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56156271|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56156272|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
56156273|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
56156274|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
56156275|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156276|NCT00281658|Paclitaxel|paclitaxel|mesh-list
56156277|NCT00281658|Lapatinib|lapatinib|mesh-list
56156278|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56156279|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156280|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
56156281|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
56156283|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156284|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56156285|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156286|NCT02417844|Tamsulosin|tamsulosin|mesh-list
56156287|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56156288|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56156289|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56156290|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
56659826|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
56659827|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56659828|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
56221396|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156291|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156292|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156293|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156294|NCT02417844|Urological Agents|urological agents|mesh-ancestor
56156295|NCT02418312|Famotidine|famotidine|mesh-list
56156296|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
56156297|NCT02418312|Histamine|histamine|mesh-list
56156298|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56156299|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56156300|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
56156301|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
56156302|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156303|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156304|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156305|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
56156306|NCT02421354|Nivolumab|nivolumab|mesh-list
56156307|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56156308|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156309|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56156310|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156311|NCT02422290|Ketamine|ketamine|mesh-list
56156312|NCT02422290|Analgesics|analgesics|mesh-ancestor
56156313|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
56156314|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156315|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156316|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56156317|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56156320|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156321|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56156322|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56156323|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156324|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156325|NCT02430090|Fentanyl|fentanyl|mesh-list
56156326|NCT02430090|Sufentanil|sufentanil|mesh-list
56156327|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
56156328|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56156329|NCT02430090|Narcotics|narcotics|mesh-ancestor
56156330|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156331|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156332|NCT02430090|Analgesics|analgesics|mesh-ancestor
56156333|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
56156334|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156335|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56156336|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56156337|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
56156338|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
56156339|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
56156340|NCT02431572|Vaccines|vaccines|mesh-list
56156341|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
56156342|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156344|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
56156345|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56156346|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56156347|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156348|NCT02437344|Naltrexone|naltrexone|mesh-list
56156349|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56156350|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56156351|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156352|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
56156353|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156354|NCT02440308|Bombesin|bombesin|mesh-list
56156355|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156356|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156357|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156358|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
56156359|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56156360|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56156362|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56659829|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659830|NCT02761577|Protective Agents|protective agents|mesh-ancestor
56659831|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659832|NCT02761577|Antidotes|antidotes|mesh-ancestor
56659833|NCT00579982|Lamotrigine|lamotrigine|mesh-list
56659834|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
56659835|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56659836|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659837|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659838|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56659839|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305966|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659841|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56659842|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659843|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56156363|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56156364|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56156365|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156366|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156367|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56156368|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56156369|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56156370|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156371|NCT02452866|Secnidazole|secnidazole|mesh-list
56156372|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56156373|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56156374|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156375|NCT02462148|Dexamethasone|dexamethasone|mesh-list
56156376|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
56156377|NCT02462148|Epinephrine|epinephrine|mesh-list
56156378|NCT02462148|Bupivacaine|bupivacaine|mesh-list
56156379|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56156380|NCT02462148|BB 1101|bb 1101|mesh-list
56156381|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56156382|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
56156383|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
56156384|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156385|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156386|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56156387|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
56156388|NCT02462148|Hormones|hormones|mesh-ancestor
56156389|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56156390|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56156391|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156392|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
56156394|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156395|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
56156396|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
56156397|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156398|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
56156399|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56156400|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56156401|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
56156402|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156403|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56156404|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56156405|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56659844|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56659845|NCT00596466|Pregabalin|pregabalin|mesh-list
56659846|NCT00596466|Analgesics|analgesics|mesh-ancestor
56659847|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
56659848|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659849|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659850|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
56659851|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56659852|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56659853|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659854|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56659855|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56659856|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56659857|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659858|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56659859|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56659860|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56659861|NCT04071574|Cetrorelix|cetrorelix|mesh-list
56659862|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56659863|NCT04071574|Hormones|hormones|mesh-ancestor
56156406|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
56156407|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
56156408|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
56156409|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56156410|NCT02462382|Ropivacaine|ropivacaine|mesh-list
56156411|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
56156412|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
56156413|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156414|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156415|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
56156416|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156417|NCT02464176|Dexamethasone|dexamethasone|mesh-list
56156418|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
56156419|NCT02464176|Epinephrine|epinephrine|mesh-list
56156420|NCT02464176|Bupivacaine|bupivacaine|mesh-list
56156421|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56156422|NCT02464176|BB 1101|bb 1101|mesh-list
56156423|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56156424|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
56156425|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
56156426|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156427|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156428|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56156429|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
56156430|NCT02464176|Hormones|hormones|mesh-ancestor
56156431|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56156432|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56156433|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156434|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
56156435|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156436|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156437|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
56156438|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
56156439|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156440|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
56156441|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56659864|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659865|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659866|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
56659867|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56659868|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
56156442|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56156443|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
56156444|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156445|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56156446|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56156447|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56156448|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
56156449|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
56156450|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
56156451|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56156452|NCT02468700|Dexamethasone|dexamethasone|mesh-list
56156453|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56156454|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
56156455|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
56156456|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156457|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156458|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56156459|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
56156460|NCT02468700|Hormones|hormones|mesh-ancestor
56156461|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56156462|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56156463|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156464|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
56156465|NCT02472522|Ropivacaine|ropivacaine|mesh-list
56156466|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
56156469|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156470|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56156472|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
56156473|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156474|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56156475|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56156477|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156478|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156479|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
56156480|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
56156481|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56156482|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
56156483|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156484|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
56156485|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
56156486|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156487|NCT02484222|Fentanyl|fentanyl|mesh-list
56156488|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56156489|NCT02484222|Narcotics|narcotics|mesh-ancestor
56156490|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156491|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156492|NCT02484222|Analgesics|analgesics|mesh-ancestor
56156493|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
56156494|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156495|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56156496|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56156497|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
56156499|NCT02486016|Fentanyl|fentanyl|mesh-list
56156500|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56156501|NCT02486016|Narcotics|narcotics|mesh-ancestor
56156502|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156503|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156504|NCT02486016|Analgesics|analgesics|mesh-ancestor
56156505|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
56156506|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156507|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56156508|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56156509|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
56659869|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56659870|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56156510|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
56156511|NCT02486328|Midazolam|midazolam|mesh-list
56156512|NCT02486328|Meperidine|meperidine|mesh-list
56156513|NCT02486328|Remifentanil|remifentanil|mesh-list
56156514|NCT02486328|Propofol|propofol|mesh-list
56156515|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56156516|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156517|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156518|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56156519|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
56156520|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
56156521|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56156522|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56156523|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56156524|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56156525|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
56156526|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
56156527|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156528|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156529|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56156530|NCT02486328|Narcotics|narcotics|mesh-ancestor
56156531|NCT02486328|Analgesics|analgesics|mesh-ancestor
56156532|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
56156533|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156534|NCT02491788|Suvorexant|suvorexant|mesh-list
56156535|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56156536|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56156537|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156538|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156539|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56156540|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156541|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156543|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156544|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56156545|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156546|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156547|NCT02492802|Posaconazole|posaconazole|mesh-list
56156548|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
56156549|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156550|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56156551|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56156552|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56156553|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56156554|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56156555|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156556|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156557|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56156558|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
56156559|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56156560|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156561|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
56156562|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56156563|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156564|NCT02500602|Doxazosin|doxazosin|mesh-list
56156565|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56156566|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56156567|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56156568|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56156569|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
56156570|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156571|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156572|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156573|NCT02500836|Cocaine|cocaine|mesh-list
56156574|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56156575|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
56156576|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
56156577|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156578|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156579|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
56156580|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659871|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56659872|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659873|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56156581|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56156582|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56156583|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56156584|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56156585|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156586|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
56156587|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156588|NCT02508636|Leuprolide|leuprolide|mesh-list
56156589|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56156590|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
56156591|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56156592|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156593|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56156594|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156595|NCT02513940|Ibutilide|ibutilide|mesh-list
56156596|NCT02513940|Testosterone|testosterone|mesh-list
56156597|NCT02513940|Progesterone|progesterone|mesh-list
56156598|NCT02513940|Androgens|androgens|mesh-ancestor
56156599|NCT02513940|Hormones|hormones|mesh-ancestor
56156600|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56156601|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156602|NCT02513940|Progestins|progestins|mesh-ancestor
56156603|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56156604|NCT02515890|Midazolam|midazolam|mesh-list
56156605|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
56156606|NCT02515890|Ketamine|ketamine|mesh-list
56156607|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56156608|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156609|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156610|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56156611|NCT02515890|Analgesics|analgesics|mesh-ancestor
56156612|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
56156613|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156616|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56156617|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
56156618|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156619|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156620|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56156621|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56156622|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
56156623|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
56156624|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56156625|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56156626|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56156627|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56156628|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56156629|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56156630|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
56156631|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
56156632|NCT02517996|Lidocaine|lidocaine|mesh-list
56156633|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
56156634|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
56156635|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156636|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156637|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
56156638|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156639|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56156640|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56156641|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56156642|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176220|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156643|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156644|NCT02525718|Dexamethasone|dexamethasone|mesh-list
56156645|NCT02525718|Epinephrine|epinephrine|mesh-list
56156646|NCT02525718|Bupivacaine|bupivacaine|mesh-list
56156647|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56156648|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
56156649|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
56156650|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925606|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
56659874|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
56659875|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
56659876|NCT02763059|Acetaminophen|acetaminophen|mesh-list
56659877|NCT02763059|Dexamethasone|dexamethasone|mesh-list
56156651|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156652|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56156653|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
56156654|NCT02525718|Hormones|hormones|mesh-ancestor
56156655|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56156656|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56156657|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156658|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
56156659|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
56156660|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156661|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
56156662|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56156663|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56156664|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
56156665|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156666|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156667|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56156668|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56156669|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56156670|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
56156671|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
56156672|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
56156673|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56156674|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
56156675|NCT02527512|Povidone|povidone|mesh-list
56156676|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
56156677|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
56156678|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56156679|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156680|NCT02529072|Nivolumab|nivolumab|mesh-list
56156681|NCT02529072|Vaccines|vaccines|mesh-list
56156682|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
56156683|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156684|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56156687|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156688|NCT02530476|Sorafenib|sorafenib|mesh-list
56156689|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156690|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56156691|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156692|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156693|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
56156694|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56156695|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56156696|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156697|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
56156698|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
56156699|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56156700|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56156701|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156702|NCT02536248|Incretins|incretins|mesh-ancestor
56156703|NCT02536248|Hormones|hormones|mesh-ancestor
56156704|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56156705|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56156706|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
56156707|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156708|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156709|NCT02538042|Nicotine|nicotine|mesh-list
56156710|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56156711|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
56156712|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156713|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156714|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56156715|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56156716|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
56156717|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156718|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156721|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
56156722|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659878|NCT02763059|Ibuprofen|ibuprofen|mesh-list
56659879|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56659880|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
56659881|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
56659882|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659883|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659884|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56659885|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
56659886|NCT02763059|Hormones|hormones|mesh-ancestor
56659887|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56659888|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56659889|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659890|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56659891|NCT02763059|Analgesics|analgesics|mesh-ancestor
56659892|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
56659893|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
56659894|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56659895|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56659896|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56659897|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659898|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659899|NCT04222517|Hemostatics|hemostatics|mesh-list
56156723|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
56156724|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56156725|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
56156726|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
56156727|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56156728|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56156729|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156730|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
56156731|NCT02540226|Coagulants|coagulants|mesh-ancestor
56156732|NCT02541864|Amoxicillin|amoxicillin|mesh-list
56156733|NCT02541864|Metronidazole|metronidazole|mesh-list
56156734|NCT02541864|Clarithromycin|clarithromycin|mesh-list
56156735|NCT02541864|Tetracycline|tetracycline|mesh-list
56156736|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56156737|NCT02541864|Pantoprazole|pantoprazole|mesh-list
56156738|NCT02541864|Bismuth|bismuth|mesh-list
56156739|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56156740|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156741|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56156742|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56156743|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56156744|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156745|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156746|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56156747|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56156748|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56156749|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56156750|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56156751|NCT02541864|Antacids|antacids|mesh-ancestor
56156752|NCT02542410|Cabergoline|cabergoline|mesh-list
56156753|NCT02542410|Norethindrone|norethindrone|mesh-list
56156754|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
56659900|NCT04222517|Coagulants|coagulants|mesh-ancestor
56659901|NCT00671112|Everolimus|everolimus|mesh-list
56659902|NCT00671112|Bortezomib|bortezomib|mesh-list
56659903|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659904|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156755|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56156756|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56156757|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56156758|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
56156759|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56156760|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156763|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56156764|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56156765|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
56156766|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
56156767|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156768|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156769|NCT02544984|Azithromycin|azithromycin|mesh-list
56156770|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56156771|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156773|NCT02547012|Levofloxacin|levofloxacin|mesh-list
56156774|NCT02547012|Ofloxacin|ofloxacin|mesh-list
56156775|NCT02547012|Tetracycline|tetracycline|mesh-list
56156776|NCT02547012|Esomeprazole|esomeprazole|mesh-list
56156777|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56156778|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156779|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56156780|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56156781|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56156782|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156783|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156784|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56156785|NCT02547012|Renal Agents|renal agents|mesh-ancestor
56156786|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56156787|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56156788|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156789|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56156790|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55737514|NCT03179605|Clobetasol|clobetasol|mesh-list
56156792|NCT02548728|Oxytocin|oxytocin|mesh-list
56156793|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
56156794|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56156795|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156796|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
56156797|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56156798|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56156799|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56156800|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
56156801|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156802|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156803|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156804|NCT02560038|Gemcitabine|gemcitabine|mesh-list
56156806|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56156807|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156808|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
56156809|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
56156810|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56156811|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156812|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56156813|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
56156814|NCT02560038|Antiviral Agents|antiviral agents|mesh-ancestor
56156815|NCT02560038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156816|NCT02560038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156817|NCT02560038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156818|NCT02560038|Immunologic Factors|immunologic factors|mesh-ancestor
56156819|NCT02560038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156820|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56156821|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56156822|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
56156823|NCT02561130|Metformin|metformin|mesh-list
56156824|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
56156825|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
56659905|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
56659906|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659907|NCT04857385|Hemostatics|hemostatics|mesh-list
56659908|NCT04857385|Coagulants|coagulants|mesh-ancestor
56156826|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56156827|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156828|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56156829|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156830|NCT02562066|Amifampridine|amifampridine|mesh-list
56156831|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56156832|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156833|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156834|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56156835|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56156846|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56156847|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
56156848|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156849|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56156850|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
56156851|NCT02563860|Lovastatin|lovastatin|mesh-list
56156852|NCT02563860|L 647318|l 647318|mesh-list
56156853|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
56156854|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56156855|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56156856|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
56156857|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156858|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56156859|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56156860|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156861|NCT02568852|Anesthetics|anesthetics|mesh-list
56156862|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156863|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156864|NCT02570022|Bupivacaine|bupivacaine|mesh-list
56156865|NCT02570022|Ropivacaine|ropivacaine|mesh-list
56156866|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
56156867|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
56156868|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156869|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156870|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
56156871|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156872|NCT02572752|Nintedanib|nintedanib|mesh-list
56156873|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156874|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56156875|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156876|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156877|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
56156878|NCT02577042|Atorvastatin|atorvastatin|mesh-list
56156879|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56156880|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56156881|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
56156882|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156883|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56156884|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56156885|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156886|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56156887|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56156888|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
56156889|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156890|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56156891|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56156892|NCT02582970|Bevacizumab|bevacizumab|mesh-list
56156893|NCT02582970|Fluorouracil|fluorouracil|mesh-list
56156894|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
56156895|NCT02582970|Irinotecan|irinotecan|mesh-list
56156896|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56156897|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156898|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56156899|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56156900|NCT02582970|Growth Substances|growth substances|mesh-ancestor
56156905|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56156906|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56659909|NCT00664014|Tolvaptan|tolvaptan|mesh-list
56659910|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56659911|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659912|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
56659913|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659914|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
56659915|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56659916|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659918|NCT02696915|Bupivacaine|bupivacaine|mesh-list
56659919|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
56659920|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
56659921|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659922|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659923|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
56659924|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659925|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56659926|NCT02696915|Narcotics|narcotics|mesh-ancestor
56659927|NCT02696915|Analgesics|analgesics|mesh-ancestor
56659928|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56156907|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
56156908|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56156909|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56156910|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156911|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
56156912|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
56156913|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156914|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
56156915|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56156916|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56156917|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56156918|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56156919|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156920|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
56156921|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156922|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156923|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56156924|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156925|NCT05249556|Ganaxolone|ganaxolone|mesh-list
56156926|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
56156927|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56156928|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156929|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156930|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
56156931|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
56156932|NCT05248152|Acetaminophen|acetaminophen|mesh-list
56156933|NCT05248152|Ibuprofen|ibuprofen|mesh-list
56156934|NCT05248152|Pregabalin|pregabalin|mesh-list
56156935|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56156936|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56156937|NCT05248152|Analgesics|analgesics|mesh-ancestor
56156938|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
56156939|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156940|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156941|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56156942|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56156943|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56659929|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56659930|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
56659931|NCT00911664|Vitamin D|vitamin d|mesh-list
56659932|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
56659933|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
56659934|NCT00911664|Vitamins|vitamins|mesh-list
56659935|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
56659936|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221486|NCT01661985|Doxycycline|doxycycline|mesh-list
56156944|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156945|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156946|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
56156947|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56156948|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56156949|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56156950|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56156951|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56156952|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156953|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56156954|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
56156955|NCT05247684|Paclitaxel|paclitaxel|mesh-list
56156956|NCT05247684|Carboplatin|carboplatin|mesh-list
56156957|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56156958|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156959|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
56156960|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
56156961|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
56156962|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156963|NCT05184348|Acitretin|acitretin|mesh-list
56156964|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
56156965|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
56156966|NCT05132166|Sirolimus|sirolimus|mesh-list
56156967|NCT05132166|Everolimus|everolimus|mesh-list
56156968|NCT05132166|Vedolizumab|vedolizumab|mesh-list
56156969|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56156970|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156971|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56156972|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
56156976|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56156977|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
56156978|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56156979|NCT04808466|Paclitaxel|paclitaxel|mesh-list
56156980|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56156981|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156982|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
56156983|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
56156984|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
56156985|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156986|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56156987|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56156988|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
56156989|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156990|NCT03907176|Acetaminophen|acetaminophen|mesh-list
56156991|NCT03907176|Ibuprofen|ibuprofen|mesh-list
56156992|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56156993|NCT03907176|Analgesics|analgesics|mesh-ancestor
56156994|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
56156995|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56156996|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156997|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
56156998|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56156999|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56157000|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56157001|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56157002|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157003|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157004|NCT03675672|Misoprostol|misoprostol|mesh-list
56157005|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56157006|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
56659937|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56659938|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56659939|NCT04821817|Rocuronium|rocuronium|mesh-list
56659940|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56659941|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56659942|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56659943|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56659944|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659945|NCT00664170|Docetaxel|docetaxel|mesh-list
56659946|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659947|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
56157007|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56157008|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157009|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56157010|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157011|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
56157012|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
56157013|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56157014|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
56157015|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157017|NCT02108496|Protective Agents|protective agents|mesh-ancestor
56157019|NCT02056236|Levetiracetam|levetiracetam|mesh-list
56157020|NCT02056236|Valproic Acid|valproic acid|mesh-list
56157021|NCT02056236|Lorazepam|lorazepam|mesh-list
56157022|NCT02056236|Thiopental|thiopental|mesh-list
56157023|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
56157024|NCT02056236|Propofol|propofol|mesh-list
56157025|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56157026|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157027|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157028|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56157029|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
56157030|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
56157031|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56157032|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56157033|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56157034|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56157035|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
56157036|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
56157037|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157038|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157039|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
56157040|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157041|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
56157042|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
56157043|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
56157044|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157045|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157046|NCT01962246|Capecitabine|capecitabine|mesh-list
56157047|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
56157048|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56157049|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
56157057|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157058|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
56157059|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56157065|NCT04945122|Atorvastatin|atorvastatin|mesh-list
56157066|NCT04945122|Pitavastatin|pitavastatin|mesh-list
56157067|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56157068|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56157069|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
56157070|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157071|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56084759|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
56157072|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56157073|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157074|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56659948|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
56659949|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
56659950|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659951|NCT02758067|Risperidone|risperidone|mesh-list
56659952|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
56659953|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56659954|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
56659955|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659956|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659957|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659958|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56659959|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56659960|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659961|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56157075|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56157076|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157077|NCT04227366|Methotrexate|methotrexate|mesh-list
56157078|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56157079|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
56157080|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56157081|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157082|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56157083|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
56157084|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157085|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157086|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
56157087|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157088|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56157089|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56157091|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56157092|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56157095|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56157096|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
56157097|NCT03560466|Hormones|hormones|mesh-ancestor
56157098|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157099|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157100|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56157101|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157102|NCT03376698|Colchicine|colchicine|mesh-list
56157103|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
56157104|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56157105|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
56157106|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
56157107|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
56157108|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157109|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157110|NCT03295734|Losartan|losartan|mesh-list
56157111|NCT03295734|Perindopril|perindopril|mesh-list
56157112|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56157113|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56157114|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56157115|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56157116|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157117|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56157118|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
56157119|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157120|NCT03246750|Cisplatin|cisplatin|mesh-list
56157121|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157122|NCT02595684|Tadalafil|tadalafil|mesh-list
56659962|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56157124|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56157125|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56157127|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157128|NCT02595684|Urological Agents|urological agents|mesh-ancestor
56157129|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
56157130|NCT02604810|Antibodies|antibodies|mesh-list
56157131|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
56157132|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56157133|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56157134|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
56157135|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
56157136|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157137|NCT02607618|Vancomycin|vancomycin|mesh-list
56157138|NCT02607618|Iclaprim|iclaprim|mesh-list
56157139|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56157140|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157141|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56157142|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157143|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157144|NCT05732064|Dexmedetomidine|dexmedetomidine|mesh-list
56157145|NCT05732064|Esketamine|esketamine|mesh-list
56084840|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
56157146|NCT05732064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56157147|NCT05732064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157148|NCT05732064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157149|NCT05732064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56157150|NCT05732064|Analgesics|analgesics|mesh-ancestor
56157151|NCT05732064|Sensory System Agents|sensory system agents|mesh-ancestor
56157152|NCT05732064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157153|NCT05732064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56157154|NCT05732064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56157155|NCT05732064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56157156|NCT05732064|Adrenergic Agents|adrenergic agents|mesh-ancestor
56157157|NCT05732064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157158|NCT05732064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157159|NCT05732064|Antidepressive Agents|antidepressive agents|mesh-ancestor
56157160|NCT05732064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56157161|NCT05731986|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
56157162|NCT05731986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55737901|NCT03419767|Melatonin|melatonin|mesh-list
56157164|NCT05731986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157165|NCT05731752|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56157166|NCT05731752|Immunologic Factors|immunologic factors|mesh-ancestor
56157167|NCT05731752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157168|NCT05731596|Ubiquinone|ubiquinone|mesh-list
56157169|NCT05731596|Coenzyme Q10|coenzyme q10|mesh-list
56157170|NCT05731596|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56157171|NCT05731596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56157172|NCT05731596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56157173|NCT05731596|Antimetabolites|antimetabolites|mesh-ancestor
56157174|NCT05731596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157175|NCT05731596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56157176|NCT05731596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56157177|NCT05731596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157178|NCT05731596|Micronutrients|micronutrients|mesh-ancestor
56157179|NCT05731596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157180|NCT05731596|Vitamins|vitamins|mesh-ancestor
56157181|NCT05731518|Irinotecan|irinotecan|mesh-list
56157182|NCT05731518|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56157183|NCT05731518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56157184|NCT05731518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157185|NCT05731518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157186|NCT05731518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157187|NCT05730816|Magnesium Sulfate|magnesium sulfate|mesh-list
56157188|NCT05730816|Analgesics|analgesics|mesh-ancestor
56157189|NCT05730816|Sensory System Agents|sensory system agents|mesh-ancestor
56157190|NCT05730816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157191|NCT05730816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157192|NCT05730816|Anesthetics|anesthetics|mesh-ancestor
56157193|NCT05730816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157194|NCT05730816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56157195|NCT05730816|Anticonvulsants|anticonvulsants|mesh-ancestor
56157205|NCT05730738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659963|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
56659964|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
56659965|NCT00664248|Clindamycin|clindamycin|mesh-list
56659966|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
56659967|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
56659968|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56659969|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56659970|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56659971|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56659972|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56659973|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659974|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
56659975|NCT00579670|Ziprasidone|ziprasidone|mesh-list
56659976|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56659977|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
56659978|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56659979|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56659980|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659981|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56659982|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56659983|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56659984|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56157206|NCT05730660|Quercetin|quercetin|mesh-list
56157207|NCT05730660|Antioxidants|antioxidants|mesh-ancestor
56157208|NCT05730660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157209|NCT05730660|Protective Agents|protective agents|mesh-ancestor
56157210|NCT05730660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157211|NCT05697276|Lidocaine|lidocaine|mesh-list
56157212|NCT05697276|Bupivacaine|bupivacaine|mesh-list
56157213|NCT05697276|Anesthetics, Local|anesthetics, local|mesh-ancestor
56157214|NCT05697276|Anesthetics|anesthetics|mesh-ancestor
56157215|NCT05697276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157216|NCT05697276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157217|NCT05697276|Sensory System Agents|sensory system agents|mesh-ancestor
56157218|NCT05697276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084921|NCT04159519|Budesonide|budesonide|mesh-list
56157219|NCT05697276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56157220|NCT05697276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56157221|NCT05697276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56157222|NCT05697276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56157223|NCT05697276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157224|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
56157225|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56157226|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157227|NCT05419674|Amoxicillin|amoxicillin|mesh-list
56157228|NCT05419674|Clarithromycin|clarithromycin|mesh-list
56157229|NCT05419674|Rabeprazole|rabeprazole|mesh-list
56157230|NCT05419674|Bismuth|bismuth|mesh-list
56157231|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56157232|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157233|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56157234|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176230|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56157237|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56659985|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56659986|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
56659987|NCT00669786|Menotropins|menotropins|mesh-list
56659988|NCT00669786|Hormones|hormones|mesh-list
56659989|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56659990|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157238|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56157239|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157240|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56157241|NCT05419674|Antacids|antacids|mesh-ancestor
56157242|NCT05386524|Bevacizumab|bevacizumab|mesh-list
56157243|NCT05386524|Doxorubicin|doxorubicin|mesh-list
56157244|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56157245|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56157246|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157247|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56157248|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56157249|NCT05386524|Growth Substances|growth substances|mesh-ancestor
56157250|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157251|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
56157252|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56157253|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56157254|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56157255|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157256|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157259|NCT04965714|Nivolumab|nivolumab|mesh-list
56157260|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56157261|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157263|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157265|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56157266|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56157267|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
56157268|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157269|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157270|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56157271|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
56157272|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
56157273|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
56157274|NCT04787562|Imipenem|imipenem|mesh-list
56157275|NCT04787562|Cilastatin|cilastatin|mesh-list
56157276|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56157277|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157278|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
56157279|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157280|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157281|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
56157282|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
56157283|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157284|NCT04708782|Treprostinil|treprostinil|mesh-list
56157285|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56157286|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
56157287|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
56157288|NCT04355130|Vitamins|vitamins|mesh-ancestor
56157289|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
56157290|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157291|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
56157292|NCT04355130|Hematinics|hematinics|mesh-ancestor
56084990|NCT00367471|Trastuzumab|trastuzumab|mesh-list
56157293|NCT04266912|Avelumab|avelumab|mesh-list
56157294|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56157295|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56157296|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157297|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
56157298|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157299|NCT04107168|Bevacizumab|bevacizumab|mesh-list
56157300|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
56157301|NCT04107168|Nivolumab|nivolumab|mesh-list
56157302|NCT04107168|Ipilimumab|ipilimumab|mesh-list
56157303|NCT04107168|Durvalumab|durvalumab|mesh-list
56157304|NCT04107168|Atezolizumab|atezolizumab|mesh-list
56157305|NCT04107168|Tremelimumab|tremelimumab|mesh-list
56157306|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56306208|NCT00041275|Megestrol|megestrol|mesh-list
56659991|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56659992|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56659993|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
56659994|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56659995|NCT02760953|Epirubicin|epirubicin|mesh-list
56157307|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157308|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56157309|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56157310|NCT04107168|Growth Substances|growth substances|mesh-ancestor
56157313|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56157314|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157315|NCT03958344|Prednisolone|prednisolone|mesh-list
56157316|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56157317|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
56157318|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56157319|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
56157320|NCT03958344|Triamcinolone|triamcinolone|mesh-list
56157321|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56157322|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
56157323|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56157324|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
56157325|NCT03958344|Hormones|hormones|mesh-ancestor
56157326|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157327|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157328|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56157329|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157330|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
56157331|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
56157332|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157333|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157334|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56157335|NCT03958344|Protective Agents|protective agents|mesh-ancestor
56157336|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
56157337|NCT02960646|Melphalan|melphalan|mesh-list
56157338|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
56157339|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56157343|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56157344|NCT02960646|Tacrolimus|tacrolimus|mesh-list
56157345|NCT02960646|Antibodies|antibodies|mesh-list
56157346|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
56157347|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56157348|NCT02960646|Lenograstim|lenograstim|mesh-list
56157349|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56157350|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
56157351|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157352|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56157353|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56157354|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
56157355|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157356|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157357|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56157358|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56157359|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
56157360|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56157361|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157362|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56157363|NCT02517684|Prednisolone|prednisolone|mesh-list
56157364|NCT02517684|Azathioprine|azathioprine|mesh-list
56157365|NCT02517684|Infliximab|infliximab|mesh-list
56157366|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56157367|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
56157368|NCT02517684|Hormones|hormones|mesh-ancestor
56157369|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157370|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085066|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
56157371|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56157372|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157373|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157374|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
56157375|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56157376|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
56659996|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56659997|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56659998|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56659999|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56660000|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660001|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660002|NCT02630004|Melatonin|melatonin|mesh-list
56660003|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
56221550|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
56157377|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157378|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56157379|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56157380|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
56157381|NCT01448616|Tenofovir|tenofovir|mesh-list
56157382|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
56157383|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157384|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56157385|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56157386|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157387|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157389|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56157390|NCT00074412|Nevirapine|nevirapine|mesh-list
56157391|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56157392|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56157393|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157394|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157395|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
56157396|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157397|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56157398|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56157399|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56157400|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56157401|NCT02618772|Midazolam|midazolam|mesh-list
56157402|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56157403|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56157404|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157405|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157406|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56157407|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56157408|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56157409|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56157410|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
56157411|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
56157412|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
56157413|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
56157415|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157416|NCT02620878|Pancrelipase|pancrelipase|mesh-list
56157417|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157418|NCT02624700|Pemetrexed|pemetrexed|mesh-list
56157419|NCT02624700|Sorafenib|sorafenib|mesh-list
56157420|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157421|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157422|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157423|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56157424|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56157425|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56157426|NCT02631954|Voriconazole|voriconazole|mesh-list
56157427|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
56157428|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157429|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56157430|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56157431|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157432|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157433|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56157434|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
56660004|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660005|NCT02630004|Protective Agents|protective agents|mesh-ancestor
56660006|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660007|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660008|NCT00129922|Paclitaxel|paclitaxel|mesh-list
56660009|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
56157435|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157436|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157437|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56157438|NCT02632812|Naproxen|naproxen|mesh-list
56157439|NCT02632812|Rebamipide|rebamipide|mesh-list
56157440|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56157441|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56157442|NCT02632812|Analgesics|analgesics|mesh-ancestor
56157443|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
56157444|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157445|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157446|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56157447|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56157448|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
56157449|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56157450|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157451|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157452|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56157453|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157454|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
56157455|NCT02632812|Protective Agents|protective agents|mesh-ancestor
56157456|NCT02634684|Amphetamine|amphetamine|mesh-list
56157457|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
56157458|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56157459|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157460|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
56157461|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
56157462|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157463|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
56157464|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157465|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157466|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
56157467|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56157468|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56157469|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56157470|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56157471|NCT02635542|Cisatracurium|cisatracurium|mesh-list
56157472|NCT02635542|Succinylcholine|succinylcholine|mesh-list
56157473|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56157474|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56157475|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157476|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157477|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56157478|NCT05585658|Epoetin Alfa|epoetin alfa|mesh-list
56157479|NCT05585658|Hematinics|hematinics|mesh-ancestor
56157480|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
56157481|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
56157482|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157483|NCT05510856|Lacosamide|lacosamide|mesh-list
56157484|NCT05510856|Gabapentin|gabapentin|mesh-list
56157485|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56157486|NCT05510856|Analgesics|analgesics|mesh-ancestor
56157489|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157491|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56157492|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56157493|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157494|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56157495|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56157496|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56157497|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157498|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660010|NCT00129922|Fluorouracil|fluorouracil|mesh-list
56660011|NCT00129922|Epirubicin|epirubicin|mesh-list
56660012|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56660013|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660014|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
56660015|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
56660016|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
56660017|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660018|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660019|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
56660020|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660021|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660022|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56660023|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
56660024|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56660025|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
56660026|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56660027|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56660028|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56660029|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56157499|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
56157500|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56157501|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56157502|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56157503|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
56157504|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
56157505|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56157506|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56157507|NCT05403138|Daratumumab|daratumumab|mesh-list
56157508|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157509|NCT05281770|Erenumab|erenumab|mesh-list
56157510|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56157511|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157512|NCT05281770|Analgesics|analgesics|mesh-ancestor
56157513|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
56157514|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157515|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157516|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
56157517|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56085215|NCT02169414|Opicapone|opicapone|mesh-list
56157518|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157519|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157520|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56157521|NCT05225610|Analgesics|analgesics|mesh-ancestor
56157522|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
56157523|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157524|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56157525|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56157526|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56157527|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
56157528|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157529|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660030|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660031|NCT03909295|Valsartan|valsartan|mesh-list
56660032|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56157531|NCT05150652|Letrozole|letrozole|mesh-list
56157532|NCT05150652|Anastrozole|anastrozole|mesh-list
56157534|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157535|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56157536|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56157537|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157538|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157539|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56157540|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
56157541|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157542|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157543|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56157544|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56157545|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56157546|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56157547|NCT04511052|Carotenoids|carotenoids|mesh-list
56157548|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
56157549|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157550|NCT04511052|Protective Agents|protective agents|mesh-ancestor
56157551|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157552|NCT03693846|Nivolumab|nivolumab|mesh-list
56157553|NCT03693846|Ipilimumab|ipilimumab|mesh-list
56157554|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56157555|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157556|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56157564|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
56157565|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157566|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56157567|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56157568|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157569|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157570|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56157571|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56157572|NCT03441048|Cytarabine|cytarabine|mesh-list
56157573|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
56157574|NCT03441048|Cladribine|cladribine|mesh-list
56157575|NCT03441048|Lintuzumab|lintuzumab|mesh-list
56157576|NCT03441048|Lenograstim|lenograstim|mesh-list
56157577|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56157578|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
56157579|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157580|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157581|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
56157582|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157583|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56157584|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
56157585|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157586|NCT03441048|Analgesics|analgesics|mesh-ancestor
56157587|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
56157588|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157589|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56157590|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56157591|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157592|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56157593|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56157594|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
56157595|NCT02828592|Fludarabine|fludarabine|mesh-list
56157596|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
56157597|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56157598|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
56157599|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157600|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56157601|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56157602|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
56157603|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157604|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157605|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56157607|NCT02369406|Zidovudine|zidovudine|mesh-list
56157608|NCT02369406|Nevirapine|nevirapine|mesh-list
56660033|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56660034|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56660035|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56660036|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660037|NCT04153968|Retinol acetate|retinol acetate|mesh-list
56660038|NCT04153968|Protective Agents|protective agents|mesh-ancestor
56660039|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157609|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56157610|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56157611|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157612|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157613|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
56157614|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157615|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56157616|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56157617|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
56157618|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56157619|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56157620|NCT02649192|Vitamin D|vitamin d|mesh-list
56157621|NCT02649192|Vitamin A|vitamin a|mesh-list
56157622|NCT02649192|Vitamins|vitamins|mesh-ancestor
56157623|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
56157624|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157625|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56157635|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
56157636|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157637|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157638|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157639|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
56157640|NCT02652390|Hormones|hormones|mesh-ancestor
56157641|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157642|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56157643|NCT02652390|Protective Agents|protective agents|mesh-ancestor
56157644|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56157645|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157646|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
56157647|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
56157648|NCT02653560|Citric Acid|citric acid|mesh-list
56157649|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
56157650|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
56157651|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56157652|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
56157653|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
56157654|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157655|NCT02653560|Diuretics|diuretics|mesh-ancestor
56157656|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
56157657|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157658|NCT02653560|Expectorants|expectorants|mesh-ancestor
56157659|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
56157660|NCT02653560|Cathartics|cathartics|mesh-ancestor
56157661|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157662|NCT02653872|Itraconazole|itraconazole|mesh-list
56157663|NCT02653872|Verapamil|verapamil|mesh-list
56157664|NCT02653872|Diltiazem|diltiazem|mesh-list
56157665|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
56085368|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
56157666|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157667|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56157668|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56157669|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157670|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157671|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56157672|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
56157673|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157674|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157675|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56176237|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
56660040|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56660041|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
56660042|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56660043|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660044|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
56660045|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56660046|NCT00671424|Furosemide|furosemide|mesh-list
56660047|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56660048|NCT00671424|Diuretics|diuretics|mesh-ancestor
56660049|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
56660050|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660051|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56660052|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56660053|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660054|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56660055|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56660056|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56660057|NCT00599924|Leucovorin|leucovorin|mesh-list
56660058|NCT00599924|Sunitinib|sunitinib|mesh-list
56660059|NCT00599924|Fluorouracil|fluorouracil|mesh-list
56157676|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56157677|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56157678|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56157679|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56157680|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
56157681|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56157682|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
56157683|NCT02655354|Promethazine|promethazine|mesh-list
56157684|NCT02655354|Prazosin|prazosin|mesh-list
56157685|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56157686|NCT02655354|Mirtazapine|mirtazapine|mesh-list
56157687|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
56157688|NCT02655354|Trazodone|trazodone|mesh-list
56157689|NCT02655354|Sertraline|sertraline|mesh-list
56157690|NCT02655354|Fluoxetine|fluoxetine|mesh-list
56157691|NCT02655354|Paroxetine|paroxetine|mesh-list
56157692|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56157693|NCT02655354|Citalopram|citalopram|mesh-list
56157695|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56157696|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56157697|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157699|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157700|NCT02655354|Analgesics|analgesics|mesh-ancestor
56157701|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
56157702|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157703|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
56157704|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56157705|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
56157706|NCT02655354|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56157707|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
56157708|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56157709|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56157710|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56157711|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157712|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
56157713|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56660060|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
56660061|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660062|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56660063|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56660064|NCT00599924|Growth Substances|growth substances|mesh-ancestor
56660065|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660066|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
56660067|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56660068|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660069|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660070|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
56660071|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56157714|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56157715|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157716|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
56157717|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
56157718|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
56157719|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157720|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56157721|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
56157722|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
56157723|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56157724|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
56157725|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
56157726|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56157727|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56157728|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56157729|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56157730|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56157731|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
56157732|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56157733|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56157734|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56157735|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56157736|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56157737|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56157738|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56157739|NCT02657928|Letrozole|letrozole|mesh-list
56157740|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157741|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56157742|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56157743|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157744|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157745|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56157746|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
56157747|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157748|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157749|NCT02658240|Epinephrine|epinephrine|mesh-list
56157750|NCT02658240|Ropivacaine|ropivacaine|mesh-list
56157751|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
56157752|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
56157753|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157754|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157755|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
56157756|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157757|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56157758|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56157759|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
56157760|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157761|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925994|NCT02647788|Codeine|codeine|mesh-list
56660072|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660073|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
56660074|NCT00599924|Antidotes|antidotes|mesh-ancestor
56660075|NCT00599924|Protective Agents|protective agents|mesh-ancestor
56660076|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
56660077|NCT00599924|Vitamins|vitamins|mesh-ancestor
56660078|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
56660079|NCT02757209|Fluticasone|fluticasone|mesh-list
56660080|NCT02757209|Xhance|xhance|mesh-list
56660081|NCT02757209|Budesonide|budesonide|mesh-list
56660082|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
56660083|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56660084|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56660085|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660086|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56660087|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
56660088|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157762|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56157763|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56157773|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
56157774|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56157775|NCT02665260|Cantharidin|cantharidin|mesh-list
56157776|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157777|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157778|NCT02665728|Laxatives|laxatives|mesh-list
56157779|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157780|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
56157781|NCT02666352|Ruzasvir|ruzasvir|mesh-list
56157782|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
56157783|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157784|NCT02673138|Canagliflozin|canagliflozin|mesh-list
56157785|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56157786|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157787|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56157788|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157789|NCT02673372|Ketamine|ketamine|mesh-list
56157790|NCT02673372|Morphine|morphine|mesh-list
56157791|NCT02673372|Analgesics|analgesics|mesh-ancestor
56157792|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
56157793|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157794|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157795|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56157796|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56157797|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
56157798|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
56157799|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157800|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56157801|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56157802|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157803|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157804|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56157805|NCT02673372|Narcotics|narcotics|mesh-ancestor
56157806|NCT02682498|Bupivacaine|bupivacaine|mesh-list
56157807|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
56157808|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
56157809|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157810|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157811|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
56157812|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157813|NCT02684136|Suvorexant|suvorexant|mesh-list
56157814|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56660089|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660090|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56660091|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
56660092|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
56660093|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56660094|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
56660095|NCT02757209|Hormones|hormones|mesh-ancestor
56660096|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660097|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56660098|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56660099|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56221650|NCT01663077|Clozapine|clozapine|mesh-list
56157815|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56157816|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157817|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157818|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56157819|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157820|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157822|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157823|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56157824|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157825|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157826|NCT02695446|Minocycline|minocycline|mesh-list
56157827|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56157828|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157829|NCT02698566|Ranibizumab|ranibizumab|mesh-list
56157830|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56157831|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56157837|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
56157838|NCT02701062|Dabigatran|dabigatran|mesh-list
56157839|NCT02701062|Apixaban|apixaban|mesh-list
56157840|NCT02701062|Anticoagulants|anticoagulants|mesh-list
56157841|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56157842|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
56157843|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56157844|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
56157845|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157846|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157847|NCT02704104|Hemostatics|hemostatics|mesh-list
56157848|NCT02704104|Coagulants|coagulants|mesh-ancestor
56157849|NCT02705352|Fluorouracil|fluorouracil|mesh-list
56157850|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
56157851|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157852|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56157853|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157854|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56157855|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
56157856|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157857|NCT02708238|Simethicone|simethicone|mesh-list
56157858|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
56157859|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157860|NCT02708238|Emollients|emollients|mesh-ancestor
56157861|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
56157862|NCT02709018|Losartan|losartan|mesh-list
56157863|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56157864|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56157865|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56157866|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56157867|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157868|NCT02713230|Bupivacaine|bupivacaine|mesh-list
56157869|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
56157870|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
55926090|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
56660100|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
56660101|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56660102|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660103|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
56660104|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660105|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
56660106|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56660107|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660108|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56660109|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56660110|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660111|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660112|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660113|NCT05338801|Menthol|menthol|mesh-list
56660114|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
56660115|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
56660116|NCT02757287|Desogestrel|desogestrel|mesh-list
56660117|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56660118|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56660119|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56660120|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
56660121|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56660122|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660123|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56660124|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56660125|NCT02757287|Progestins|progestins|mesh-ancestor
56660126|NCT02757287|Hormones|hormones|mesh-ancestor
56660127|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660128|NCT02649686|Trastuzumab|trastuzumab|mesh-list
56660129|NCT02649686|Durvalumab|durvalumab|mesh-list
56221656|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56157871|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157872|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157873|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
56157874|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157875|NCT02713698|Propofol|propofol|mesh-list
56157876|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56157877|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157878|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157879|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56157880|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
56157881|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
56157882|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56157883|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56660130|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56660131|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660132|NCT04729621|Denosumab|denosumab|mesh-list
56660133|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56660134|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660135|NCT02757365|Aspirin|aspirin|mesh-list
56660136|NCT02757365|Levofloxacin|levofloxacin|mesh-list
56660137|NCT02757365|Ofloxacin|ofloxacin|mesh-list
56660138|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56660139|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56157884|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56157885|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56157886|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157887|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157888|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157889|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56157890|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
56157891|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56157892|NCT02716818|Dexamethasone|dexamethasone|mesh-list
56157893|NCT02716818|Prednisone|prednisone|mesh-list
56157894|NCT02716818|Prednisolone|prednisolone|mesh-list
56157895|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
56157896|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56176243|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
56157898|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56157899|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
56157900|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56157901|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
56157902|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
56157905|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157906|NCT02716818|Hormones|hormones|mesh-ancestor
56157907|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157908|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56157909|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157910|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
56157911|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56157912|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157913|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56157914|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56157915|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157916|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157917|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157918|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56157919|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56157920|NCT02726178|Ibuprofen|ibuprofen|mesh-list
56157921|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56157922|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56157923|NCT02726178|Analgesics|analgesics|mesh-ancestor
56157924|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
56157925|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157926|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157927|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56157928|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56157929|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56157930|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157931|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157932|NCT02733588|Glucagon|glucagon|mesh-list
56157933|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56157934|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56157935|NCT02733588|Hormones|hormones|mesh-ancestor
56157936|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157937|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157938|NCT02733588|Incretins|incretins|mesh-ancestor
56157939|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
56660140|NCT02757365|Analgesics|analgesics|mesh-ancestor
56660141|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
56660142|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660143|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660144|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660145|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660146|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56660147|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56660148|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660149|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56660150|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56660151|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660152|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
56221692|NCT01663961|Digoxin|digoxin|mesh-list
56157940|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157941|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56157942|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157943|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157944|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
56157945|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56157946|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157947|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56157948|NCT05445024|Sufentanil|sufentanil|mesh-list
56157949|NCT05445024|Nalbuphine|nalbuphine|mesh-list
56157950|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56157951|NCT05445024|Narcotics|narcotics|mesh-ancestor
56157952|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157953|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157954|NCT05445024|Analgesics|analgesics|mesh-ancestor
56157955|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
56157956|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157957|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56157958|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56157959|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
56157960|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
56157961|NCT05444088|Bevacizumab|bevacizumab|mesh-list
56157962|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56157963|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157964|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56157965|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56157967|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157968|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
56157969|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
56157970|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56157971|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56157972|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157973|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56157976|NCT05443932|Diuretics|diuretics|mesh-ancestor
56157977|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
56157978|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56157979|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56157980|NCT05443308|Acetazolamide|acetazolamide|mesh-list
56157981|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
56157982|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56157983|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002962|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
56157984|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157985|NCT05443308|Diuretics|diuretics|mesh-ancestor
56003127|NCT01151761|Gemcitabine|gemcitabine|mesh-list
56157986|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
55926754|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
56660153|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56660154|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660155|NCT02757365|Renal Agents|renal agents|mesh-ancestor
56660156|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56660157|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56660158|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56157987|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157988|NCT05442996|Antibodies|antibodies|mesh-list
56157990|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56157991|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
56157992|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157993|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
56157994|NCT05439564|Morphine|morphine|mesh-list
56157995|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56157996|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56157997|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157998|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56157999|NCT05439564|Analgesics|analgesics|mesh-ancestor
56158000|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
56158001|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158002|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56158003|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56158004|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56158005|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
56158006|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158007|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158008|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56158009|NCT05439564|Narcotics|narcotics|mesh-ancestor
56158010|NCT05429814|Menthol|menthol|mesh-list
56158011|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
56158012|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
56158013|NCT05423340|Nicotine|nicotine|mesh-list
56158014|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56158015|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
56158016|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158017|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158018|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56158019|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56158020|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
56158021|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158022|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158023|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56158024|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158025|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158026|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56158027|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
56158028|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56158029|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158030|NCT05266404|Incretins|incretins|mesh-ancestor
56158031|NCT05266404|Hormones|hormones|mesh-ancestor
56158032|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158033|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56158034|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
56158035|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158036|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158037|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56158038|NCT05122494|Capecitabine|capecitabine|mesh-list
56158039|NCT05122494|Lapatinib|lapatinib|mesh-list
56158040|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56158042|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158043|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158044|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56158047|NCT05063604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56158048|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56158049|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56158050|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660159|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660160|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56158051|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158053|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003805|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56158054|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56158055|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
56158056|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56158057|NCT04978428|Cannabidiol|cannabidiol|mesh-list
56158058|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
56158060|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56158061|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158062|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158063|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56158064|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
56158065|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
56158066|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
56158067|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56158068|NCT04780464|Prednisone|prednisone|mesh-list
56158069|NCT04780464|Prednisolone|prednisolone|mesh-list
56158071|NCT04780464|Doxorubicin|doxorubicin|mesh-list
56158072|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56158073|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158074|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
56158075|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158076|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56158077|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56158078|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
56158079|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158080|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158081|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56158082|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56158083|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56004537|NCT01897454|Irinotecan|irinotecan|mesh-list
56158085|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158086|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158087|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
56158088|NCT04780464|Hormones|hormones|mesh-ancestor
56165353|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158089|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56004913|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
56158090|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56158091|NCT04521348|Antibodies|antibodies|mesh-list
56158092|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
56158093|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
56004990|NCT05750992|Narcotics|narcotics|mesh-ancestor
56158094|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158095|NCT04495608|Fluconazole|fluconazole|mesh-list
56158096|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
56005058|NCT00002494|Ifosfamide|ifosfamide|mesh-list
56158097|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158098|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56158099|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56158100|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732569|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
56158101|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158102|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56158103|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165354|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005726|NCT04868708|Paclitaxel|paclitaxel|mesh-list
56158104|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158105|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158106|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55733228|NCT02429258|Metformin|metformin|mesh-list
56158107|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56158108|NCT04356690|Etoposide|etoposide|mesh-list
56158109|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006249|NCT00002656|NSC 366140|nsc 366140|mesh-list
56158111|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56158112|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006342|NCT00002692|Leucovorin|leucovorin|mesh-list
56158113|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660161|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56660162|NCT05321251|Insulin|insulin|mesh-list
56006398|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56158114|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158115|NCT04238754|Cannabidiol|cannabidiol|mesh-list
56158116|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56158117|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
56158118|NCT04017468|Vancomycin|vancomycin|mesh-list
56158119|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56158120|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158121|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
56158122|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56158123|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158124|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158125|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56158127|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
56007093|NCT01057277|Everolimus|everolimus|mesh-list
56007147|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56158128|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007221|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
56158129|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56158130|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56158131|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56007379|NCT04104178|Clindamycin|clindamycin|mesh-list
56158132|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
56158133|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158134|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158135|NCT03668340|Adavosertib|adavosertib|mesh-list
56158136|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158137|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158138|NCT03586284|Valganciclovir|valganciclovir|mesh-list
56158139|NCT03586284|Ganciclovir|ganciclovir|mesh-list
56007821|NCT00002914|Piritrexim|piritrexim|mesh-list
56158140|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56158141|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
56158142|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158143|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56158144|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158145|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158146|NCT03567642|Etoposide|etoposide|mesh-list
56158147|NCT03567642|Osimertinib|osimertinib|mesh-list
56008110|NCT00003388|Methotrexate|methotrexate|mesh-list
56158148|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56158149|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008273|NCT00002974|Etoposide|etoposide|mesh-list
56158150|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56158151|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56158152|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158153|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158154|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56158155|NCT03190668|Cefazolin|cefazolin|mesh-list
56158156|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
56158157|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56158158|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158159|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56158160|NCT02952534|Rucaparib|rucaparib|mesh-list
56158161|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56158162|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158163|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158164|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158165|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
56158166|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56158167|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158168|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158169|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56158170|NCT02409810|Analgesics|analgesics|mesh-ancestor
56158171|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
56158172|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158173|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56158174|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56158175|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56158176|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
56158179|NCT01871766|Dactinomycin|dactinomycin|mesh-list
56660163|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56660164|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660165|NCT02649530|LGK974|lgk974|mesh-list
56660166|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660167|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158180|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
56158181|NCT01871766|Ifosfamide|ifosfamide|mesh-list
56158182|NCT01871766|Bevacizumab|bevacizumab|mesh-list
56158183|NCT01871766|Doxorubicin|doxorubicin|mesh-list
56158184|NCT01871766|Irinotecan|irinotecan|mesh-list
56158185|NCT01871766|Etoposide|etoposide|mesh-list
56158186|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
56158187|NCT01871766|Vincristine|vincristine|mesh-list
56158188|NCT01871766|Sorafenib|sorafenib|mesh-list
56158189|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
56158190|NCT01871766|Razoxane|razoxane|mesh-list
56158191|NCT01871766|Mitogens|mitogens|mesh-list
56158192|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158193|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
56158194|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158195|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56158196|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56158197|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
56158198|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158199|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158200|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56158201|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158202|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56158203|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56158204|NCT01871766|Growth Substances|growth substances|mesh-ancestor
56158205|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
56158206|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56008669|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
56158211|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56158212|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
56158213|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
56158214|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
56158215|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56158216|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56158217|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158218|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56158219|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56158220|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56158221|NCT01871766|Protective Agents|protective agents|mesh-ancestor
56158227|NCT05452434|Mirabegron|mirabegron|mesh-list
56158228|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56158229|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56158230|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56158231|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
56158232|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158233|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158234|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158235|NCT05452434|Urological Agents|urological agents|mesh-ancestor
56158236|NCT05450484|Durvalumab|durvalumab|mesh-list
56158237|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158238|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158239|NCT05450328|Epoprostenol|epoprostenol|mesh-list
56158240|NCT05450328|Milrinone|milrinone|mesh-list
56158241|NCT05450328|Tezosentan|tezosentan|mesh-list
56158242|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56158243|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56158244|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
56158245|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56158246|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56158247|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158248|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158249|NCT05450328|Protective Agents|protective agents|mesh-ancestor
56158250|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158252|NCT05449548|Lenalidomide|lenalidomide|mesh-list
56158253|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
56158254|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158255|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56660168|NCT02575534|Procainamide|procainamide|mesh-list
56660169|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56660170|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56660171|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56660172|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56660173|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660174|NCT05669989|Dexamethasone|dexamethasone|mesh-list
56660175|NCT05669989|Lenalidomide|lenalidomide|mesh-list
56660176|NCT05669989|Pomalidomide|pomalidomide|mesh-list
56660177|NCT05669989|Cemiplimab|cemiplimab|mesh-list
56660178|NCT05669989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660179|NCT05669989|Antiemetics|antiemetics|mesh-ancestor
56660180|NCT05669989|Autonomic Agents|autonomic agents|mesh-ancestor
56660181|NCT05669989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660182|NCT05669989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660183|NCT05669989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660184|NCT05669989|Glucocorticoids|glucocorticoids|mesh-ancestor
56660185|NCT05669989|Hormones|hormones|mesh-ancestor
56660186|NCT05669989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660187|NCT05669989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56660188|NCT05669989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660189|NCT05669989|Immunologic Factors|immunologic factors|mesh-ancestor
56660190|NCT05669989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56660191|NCT05669989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56660192|NCT05669989|Growth Substances|growth substances|mesh-ancestor
56660193|NCT05669989|Growth Inhibitors|growth inhibitors|mesh-ancestor
56660194|NCT05669989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56660195|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
56660196|NCT02757443|Anesthetics|anesthetics|mesh-list
56660197|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660198|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660199|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56660200|NCT02757443|Protective Agents|protective agents|mesh-ancestor
56660201|NCT04071262|Prednisolone|prednisolone|mesh-list
56660202|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
56660204|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
56660207|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660208|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56660209|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660210|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56660211|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158256|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56158257|NCT05449548|Growth Substances|growth substances|mesh-ancestor
56158258|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
56158259|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158260|NCT05448924|Hormones|hormones|mesh-list
56158262|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085968|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
56158264|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56008748|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
56158265|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56158266|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158267|NCT05447364|Pregabalin|pregabalin|mesh-list
56158268|NCT05447364|Analgesics|analgesics|mesh-ancestor
56008964|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009041|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009195|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56009347|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56158269|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
56158270|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009497|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158271|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009645|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56009719|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
56009873|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56158273|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56158274|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56158275|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158276|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56158277|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56158278|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56158279|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158280|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56158281|NCT05442684|Vaccines|vaccines|mesh-list
56158282|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
56010398|NCT00004066|Gemcitabine|gemcitabine|mesh-list
56158283|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158284|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
56010537|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56158286|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56158287|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56158288|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
56158289|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
56010914|NCT05776875|Growth Substances|growth substances|mesh-ancestor
56158290|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158291|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158292|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56158293|NCT05430750|Analgesics|analgesics|mesh-ancestor
56158294|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
56158295|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158296|NCT05418036|Sotalol|sotalol|mesh-list
56158297|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56158298|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56158299|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
56158300|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158301|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011202|NCT05774951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56011203|NCT05774951|Hormone Antagonists|hormone antagonists|mesh-ancestor
56011204|NCT05774951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011210|NCT05774899|Venetoclax|venetoclax|mesh-list
56158305|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
56158306|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158308|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158309|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011285|NCT05757791|Empagliflozin|empagliflozin|mesh-list
56660212|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660213|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
56660214|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56660215|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
56660216|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56660217|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
56660218|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660219|NCT04154982|Expectorants|expectorants|mesh-ancestor
56660220|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
56660221|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56660222|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
56221761|NCT01664650|Estrogens|estrogens|mesh-ancestor
56011286|NCT05757791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56011287|NCT05757791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011288|NCT05757791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56011289|NCT05757791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011290|NCT05738694|Axitinib|axitinib|mesh-list
56011293|NCT05738694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158318|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56158319|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56158320|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158321|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56158323|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56158324|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56158325|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158326|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158327|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158328|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56158329|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
56158330|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56158331|NCT04964466|Becaplermin|becaplermin|mesh-list
56158333|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56158334|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56158335|NCT04964466|Growth Substances|growth substances|mesh-ancestor
56158336|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158337|NCT04727424|Budesonide|budesonide|mesh-list
56158338|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
56011857|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56011858|NCT04895566|Antibodies|antibodies|mesh-list
56011859|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
56158339|NCT04727424|Fluoxetine|fluoxetine|mesh-list
56158340|NCT04727424|Maleic acid|maleic acid|mesh-list
56158341|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158342|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56158343|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
56158344|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158345|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158346|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56158347|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
56158348|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
56158349|NCT04727424|Hormones|hormones|mesh-ancestor
56011932|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56011995|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
56011996|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
56011997|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011998|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56011999|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012000|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012001|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012009|NCT04737187|Bevacizumab|bevacizumab|mesh-list
56158350|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158351|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926920|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56660223|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660224|NCT04154982|Protective Agents|protective agents|mesh-ancestor
56660225|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660226|NCT04154982|Antidotes|antidotes|mesh-ancestor
56660227|NCT04154748|Omeprazole|omeprazole|mesh-list
56660228|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56660229|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660230|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56660231|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158352|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158353|NCT04727424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56158354|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56158355|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56158356|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158357|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
56158358|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56158359|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
56158360|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56012146|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158361|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56158362|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56158363|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56158364|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56158365|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176257|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158366|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56158367|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56158369|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
56158370|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56158371|NCT04522206|Oxycodone|oxycodone|mesh-list
56158372|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56158373|NCT04522206|Narcotics|narcotics|mesh-ancestor
56012522|NCT03298087|Leuprolide|leuprolide|mesh-list
56158374|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158375|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158376|NCT04522206|Analgesics|analgesics|mesh-ancestor
56158377|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
56158378|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012734|NCT00603109|Rimonabant|rimonabant|mesh-list
56158380|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56158383|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56158384|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158385|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158386|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
56158387|NCT04505592|Tenecteplase|tenecteplase|mesh-list
56158388|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56158389|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56158390|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158391|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
56158392|NCT04477200|Temozolomide|temozolomide|mesh-list
56158393|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56158394|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158395|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56158396|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
56013245|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
56158397|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56158398|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158399|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158400|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158401|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56158402|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
56158403|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
56158404|NCT04415892|Capsaicin|capsaicin|mesh-list
56158405|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
56158406|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
56158407|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
56660232|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660233|NCT02657096|Hybenx|hybenx|mesh-list
56660234|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
56660235|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
56660236|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660237|NCT02536742|Fulvestrant|fulvestrant|mesh-list
56660238|NCT02536742|Palbociclib|palbociclib|mesh-list
56660239|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56660240|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660241|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56660242|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56660243|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
56660244|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660245|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660246|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56660247|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660248|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660249|NCT00670410|Fludarabine|fludarabine|mesh-list
56660250|NCT00670410|Busulfan|busulfan|mesh-list
56660251|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
56660252|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660253|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660254|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660255|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
56660256|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660257|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
56660258|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56660259|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56660260|NCT02756663|Dexamethasone|dexamethasone|mesh-list
56660261|NCT02756663|Panobinostat|panobinostat|mesh-list
56660262|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660263|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
56660264|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
56660265|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221780|NCT01664728|Hormones|hormones|mesh-ancestor
56158408|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158409|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158410|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56158412|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56660266|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660267|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660268|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
56660269|NCT02756663|Hormones|hormones|mesh-ancestor
56660270|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660271|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56660272|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660273|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56660274|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660275|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158413|NCT04415892|Protective Agents|protective agents|mesh-ancestor
56158414|NCT04316676|Regadenoson|regadenoson|mesh-list
56158415|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56158416|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56158417|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
56158418|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
56158419|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158420|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158421|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158423|NCT04176354|Palbociclib|palbociclib|mesh-list
56158424|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56158425|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014443|NCT01311895|Hydromorphone|hydromorphone|mesh-list
56158426|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56158427|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165356|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165357|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
56158428|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158429|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56158430|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165358|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
56158431|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56014965|NCT01899170|Carfentanil|carfentanil|mesh-list
56158432|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158433|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56158434|NCT04173780|Atropine|atropine|mesh-list
56158435|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56158436|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56015261|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56015346|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
56158437|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56158438|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
56158439|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158440|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158442|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
56158443|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
56158444|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
56158445|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56158446|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56158447|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
56158448|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016291|NCT01474213|Narcotics|narcotics|mesh-ancestor
56016419|NCT00210470|Zinc|zinc|mesh-list
56158461|NCT04128540|Fentanyl|fentanyl|mesh-list
56158462|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56158464|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158465|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016660|NCT01139801|Misoprostol|misoprostol|mesh-list
56158467|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
56158468|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158469|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56158470|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56158471|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
56158473|NCT04104438|Everolimus|everolimus|mesh-list
56660276|NCT02654678|Enalapril|enalapril|mesh-list
56660277|NCT02654678|Enalaprilat|enalaprilat|mesh-list
56660278|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56660279|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
56660280|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660281|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660282|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56660283|NCT05288023|Azithromycin|azithromycin|mesh-list
56660284|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56660285|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660286|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56660287|NCT00670566|Irbesartan|irbesartan|mesh-list
56660288|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56660289|NCT00670566|Diuretics|diuretics|mesh-ancestor
56306424|NCT00017628|Prednisolone|prednisolone|mesh-list
56660290|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
56660291|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660292|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56660293|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56221824|NCT01665079|Propofol|propofol|mesh-list
56158474|NCT04104438|Basiliximab|basiliximab|mesh-list
56158475|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158476|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158477|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
56158478|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158479|NCT03913104|Mifepristone|mifepristone|mesh-list
56158480|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56158481|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
56158482|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56158483|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158484|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56158485|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56158486|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56158487|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
56165359|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176268|NCT01394640|Vaccines|vaccines|mesh-list
56158488|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56158489|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56158490|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
56158491|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158492|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
56158493|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56158494|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56158495|NCT03745950|Olaparib|olaparib|mesh-list
56158496|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56158497|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165360|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
56158498|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158499|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158501|NCT03737604|Ropivacaine|ropivacaine|mesh-list
56158502|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
56158503|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
56017586|NCT01791608|Trace Elements|trace elements|mesh-ancestor
56158504|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158505|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660294|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660295|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56158506|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
56158507|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158508|NCT03703206|Anesthetics|anesthetics|mesh-list
56158509|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
56158520|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56158521|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158523|NCT03269136|Dexamethasone|dexamethasone|mesh-list
56018329|NCT05339022|Coal Tar|coal tar|mesh-list
56158524|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
56158525|NCT03269136|Lenalidomide|lenalidomide|mesh-list
56158526|NCT03269136|Pomalidomide|pomalidomide|mesh-list
56158527|NCT03269136|Antibodies|antibodies|mesh-list
56158528|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
56158529|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56158530|NCT03269136|BB 1101|bb 1101|mesh-list
56158531|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
56158532|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158533|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158534|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
56158535|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
56158536|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158537|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56158538|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
56158539|NCT03269136|Hormones|hormones|mesh-ancestor
56158540|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158541|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56158542|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158543|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
56158544|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158545|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158546|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56158547|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56158548|NCT03269136|Growth Substances|growth substances|mesh-ancestor
56158549|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
56158550|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158551|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
56158552|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56158553|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158554|NCT03260712|Gemcitabine|gemcitabine|mesh-list
56158555|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
56158556|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158557|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56158558|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
56158559|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158560|NCT03260712|Antiviral Agents|antiviral agents|mesh-ancestor
56158561|NCT03260712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158562|NCT03260712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158563|NCT03260712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158564|NCT03260712|Immunologic Factors|immunologic factors|mesh-ancestor
56158565|NCT03260712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018527|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
56158566|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158568|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56158569|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56158570|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158571|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158572|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158573|NCT03040596|Fluticasone|fluticasone|mesh-list
56158574|NCT03040596|Xhance|xhance|mesh-list
56158575|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158576|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56158577|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
56158585|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56158586|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56158587|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158588|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158589|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56158590|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56158591|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56018777|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
56158592|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56660296|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56660297|NCT02629848|Paclitaxel|paclitaxel|mesh-list
56660298|NCT02629848|Carboplatin|carboplatin|mesh-list
56660299|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
56018863|NCT04750382|Gemcitabine|gemcitabine|mesh-list
56158593|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
56158594|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
56018929|NCT00402194|Losartan|losartan|mesh-list
56158595|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
56158596|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
56158597|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165361|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158598|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158600|NCT02905578|Gemcitabine|gemcitabine|mesh-list
56158601|NCT02905578|Paclitaxel|paclitaxel|mesh-list
56158602|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56158603|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158604|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
56158605|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
56158606|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56158607|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158608|NCT02905578|Vitamins|vitamins|mesh-ancestor
56158609|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
56019509|NCT05288400|Amlodipine|amlodipine|mesh-list
56158610|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165362|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56019658|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
56158611|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56158612|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
56158613|NCT02905578|Antiviral Agents|antiviral agents|mesh-ancestor
56019809|NCT04241640|Nefopam|nefopam|mesh-list
56158614|NCT02905578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158615|NCT02905578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158616|NCT02905578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158617|NCT02905578|Immunologic Factors|immunologic factors|mesh-ancestor
56158618|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
56158619|NCT02905578|Protective Agents|protective agents|mesh-ancestor
56158620|NCT00783510|Adalimumab|adalimumab|mesh-list
56158621|NCT00783510|Methotrexate|methotrexate|mesh-list
56158622|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56019961|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
56158623|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
56158624|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56158625|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158626|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56158627|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
56158628|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158629|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158630|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
56158631|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158632|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56158633|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158634|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
56158635|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56158636|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56158637|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158638|NCT00677586|Liver Extracts|liver extracts|mesh-list
56158639|NCT00677586|Hematinics|hematinics|mesh-ancestor
56158641|NCT05453448|Entecavir|entecavir|mesh-list
56158656|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158657|NCT05354466|Neostigmine|neostigmine|mesh-list
56158658|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56158659|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158660|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158661|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
56020131|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
56158662|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020204|NCT00471068|Timolol|timolol|mesh-list
56158663|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158664|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56158665|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
56158666|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158668|NCT04978584|Cortisone|cortisone|mesh-list
56158669|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
56158670|NCT04978584|Rituximab|rituximab|mesh-list
56158671|NCT04978584|Doxorubicin|doxorubicin|mesh-list
56660300|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56660301|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660302|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
56660303|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
56660304|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
56660305|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660306|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56660307|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660308|NCT03912337|Erenumab|erenumab|mesh-list
56660309|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56221846|NCT01665222|Morphine|morphine|mesh-list
56158672|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56158674|NCT04978584|Lenalidomide|lenalidomide|mesh-list
56158675|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
56158676|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56158677|NCT04978584|Antibodies|antibodies|mesh-list
56158678|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
56158679|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56020661|NCT03007927|Dexamethasone|dexamethasone|mesh-list
56158680|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158681|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
56020719|NCT00496808|Trastuzumab|trastuzumab|mesh-list
56020787|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
56158682|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158683|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56158684|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56158685|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
56158686|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158687|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158688|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56158689|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56158690|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56020862|NCT05029596|Calcium heparin|calcium heparin|mesh-list
56158691|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56158692|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158693|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158694|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
56158695|NCT04978584|Hormones|hormones|mesh-ancestor
56158696|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158697|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56158711|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158714|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158715|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158716|NCT04095624|Analgesics|analgesics|mesh-ancestor
56158717|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
56158718|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158719|NCT03745716|Azacitidine|azacitidine|mesh-list
56021440|NCT05009862|Aspirin|aspirin|mesh-list
56158720|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56158721|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
56158722|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158723|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158724|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158725|NCT03341676|Dexamethasone|dexamethasone|mesh-list
56021808|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
56158726|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158728|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
56158729|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158730|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158731|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56158732|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
56158733|NCT03341676|Hormones|hormones|mesh-ancestor
56158734|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660310|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660311|NCT03912337|Analgesics|analgesics|mesh-ancestor
56660312|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
56660313|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660314|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660315|NCT00650156|Adalimumab|adalimumab|mesh-list
56660316|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660317|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660318|NCT02576782|Dexamethasone|dexamethasone|mesh-list
56660319|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
56660320|NCT02576782|Bupivacaine|bupivacaine|mesh-list
56660321|NCT02576782|BB 1101|bb 1101|mesh-list
56660322|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660323|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
56660324|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
56221857|NCT01665235|Atorvastatin|atorvastatin|mesh-list
56158735|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56158736|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158737|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
56158738|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158739|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158740|NCT03121716|Gemcitabine|gemcitabine|mesh-list
56158741|NCT03121716|Cisplatin|cisplatin|mesh-list
56158742|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56158743|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
56158744|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158745|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158746|NCT03121716|Antiviral Agents|antiviral agents|mesh-ancestor
56158747|NCT03121716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158748|NCT03121716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158749|NCT03121716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158750|NCT03121716|Immunologic Factors|immunologic factors|mesh-ancestor
56022033|NCT01511809|Ritonavir|ritonavir|mesh-list
56158751|NCT03121716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158752|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
56158753|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
56158754|NCT02714634|Methotrexate|methotrexate|mesh-list
56158755|NCT02714634|Leflunomide|leflunomide|mesh-list
56158756|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56158757|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
56165364|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
56158762|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158763|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158764|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
56158765|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158766|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56158767|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56158768|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
56158769|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022847|NCT00579878|Analgesics|analgesics|mesh-ancestor
56022906|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56158770|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56158771|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
56158772|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56023132|NCT00586196|Donepezil|donepezil|mesh-list
56158773|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56158774|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023506|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
56158775|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56158776|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56158777|NCT02714634|Analgesics|analgesics|mesh-ancestor
56158778|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
55750936|NCT04467957|Xenon|xenon|mesh-list
55926921|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
56660325|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660326|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660327|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660328|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
56660329|NCT02576782|Hormones|hormones|mesh-ancestor
56660330|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660331|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56660332|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660333|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
56660334|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660335|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660336|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
56660337|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
56660338|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158779|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158780|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158781|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023871|NCT03006445|Renal Agents|renal agents|mesh-ancestor
56158782|NCT02708394|Olanzapine|olanzapine|mesh-list
56158783|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
56158784|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
56158785|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158786|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158787|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56158788|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56158789|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56158790|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158791|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56158792|NCT02708394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56024459|NCT01790282|Progestins|progestins|mesh-ancestor
56158793|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56024612|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
56158794|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56158795|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158796|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158797|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
56158799|NCT01682616|Venetoclax|venetoclax|mesh-list
56158800|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158801|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158802|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
56158803|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158804|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56158805|NCT00553800|Bevacizumab|bevacizumab|mesh-list
56158806|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56158807|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158808|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158809|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56158810|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56158811|NCT00553800|Growth Substances|growth substances|mesh-ancestor
56158812|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158813|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
56025047|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
56158814|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56158815|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158816|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158817|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
56158818|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158819|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158824|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660339|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
56660340|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56660341|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660342|NCT02577094|Fludarabine|fludarabine|mesh-list
56660343|NCT02577094|Busulfan|busulfan|mesh-list
56660344|NCT02577094|Epratuzumab|epratuzumab|mesh-list
56158825|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158826|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56158827|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56158829|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158830|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158832|NCT02747628|Protective Agents|protective agents|mesh-ancestor
56158833|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158834|NCT02754570|Pilocarpine|pilocarpine|mesh-list
56158835|NCT02754570|Miotics|miotics|mesh-ancestor
56158836|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
56158837|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158838|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158839|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56158840|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56158841|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
56158843|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158844|NCT02765256|Promethazine|promethazine|mesh-list
56158845|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
56158846|NCT02765256|Vancomycin|vancomycin|mesh-list
56158847|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
56158848|NCT02765256|Neomycin|neomycin|mesh-list
56158849|NCT02765256|Fluconazole|fluconazole|mesh-list
56158850|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56158851|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56158852|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158853|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56158854|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56158855|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158856|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158857|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158858|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56158859|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56158860|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
56158861|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56158862|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56158863|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
56158864|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158865|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158866|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56158867|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56158868|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
56158869|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
56158870|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56158871|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
56158872|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
56158873|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158874|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56158875|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56158876|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56158877|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158878|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
56158879|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
56158880|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
56158881|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158882|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
56158884|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56158885|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56158886|NCT02765256|Laxatives|laxatives|mesh-ancestor
56025703|NCT00731588|Biotin|biotin|mesh-list
56158887|NCT02767128|Citric Acid|citric acid|mesh-list
56158888|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
56158889|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
56158890|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56158891|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
56158892|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
55927112|NCT00839319|Hormones|hormones|mesh-ancestor
56660345|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
56660346|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660347|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660348|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660349|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
56660350|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660351|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
56660352|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56660353|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56158893|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158894|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56158895|NCT02769702|Hormones|hormones|mesh-ancestor
56158898|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56158899|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158900|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56158901|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158902|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158903|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
56158904|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
56158905|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158906|NCT02773758|Fluorides|fluorides|mesh-list
56158907|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
56158908|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
56158909|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
56158910|NCT02773758|Protective Agents|protective agents|mesh-ancestor
56158911|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158912|NCT02774226|Vitamins|vitamins|mesh-list
56158913|NCT02774226|Vitamin E|vitamin e|mesh-list
56158915|NCT02774226|Antioxidants|antioxidants|mesh-list
56158916|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
56158917|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158918|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158919|NCT02774226|Protective Agents|protective agents|mesh-ancestor
56158920|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
56158922|NCT02775240|Digoxin|digoxin|mesh-list
56158923|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
56158924|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56158925|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56158926|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158927|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158929|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158930|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
56158931|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
56158932|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56158933|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56158934|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158935|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
56158936|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158937|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
56158938|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158939|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
56158940|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56158941|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56158942|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56158943|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158945|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56158946|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158947|NCT05349396|Eszopiclone|eszopiclone|mesh-list
56158948|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56158949|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158950|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158951|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
56158953|NCT05348148|Phenylephrine|phenylephrine|mesh-list
56158954|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
56158955|NCT05348148|Levocetirizine|levocetirizine|mesh-list
56158956|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660354|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56660355|NCT00649844|Ziprasidone|ziprasidone|mesh-list
56660356|NCT00649844|Clozapine|clozapine|mesh-list
56660357|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56660358|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
56660359|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56660360|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660361|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660362|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56660363|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56306500|NCT00042796|Decitabine|decitabine|mesh-list
56660364|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660365|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56660366|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56660367|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
56660368|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
56660369|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
56660370|NCT03912259|Emollients|emollients|mesh-list
56660371|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
56660372|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
56660373|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
56221901|NCT01665378|Vitamins|vitamins|mesh-ancestor
56158957|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
56158958|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56158959|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56158960|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56158961|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
56158962|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
56158963|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158964|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158965|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026342|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
56158967|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56158968|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
56158969|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
56158970|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
56158971|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158972|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
56158973|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56158975|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56158976|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
56158977|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56158978|NCT05348148|Protective Agents|protective agents|mesh-ancestor
56158979|NCT05257590|Nivolumab|nivolumab|mesh-list
56158980|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158981|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158982|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56158983|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158984|NCT05456022|Doxorubicin|doxorubicin|mesh-list
56158985|NCT05456022|Quercetin|quercetin|mesh-list
56158986|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56158987|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158988|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56158989|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56158990|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158991|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660374|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56660375|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56660376|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660377|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
56660378|NCT02656472|Coagulants|coagulants|mesh-ancestor
56660379|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56660380|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
56660381|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56660382|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56660383|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660384|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660385|NCT00665340|Urological Agents|urological agents|mesh-ancestor
56660386|NCT00665418|Sevoflurane|sevoflurane|mesh-list
56660387|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56660388|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56660389|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
56660390|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
56660391|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221921|NCT01665417|Docetaxel|docetaxel|mesh-list
56158992|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
56158993|NCT05456022|Protective Agents|protective agents|mesh-ancestor
56176293|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
56158994|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158995|NCT05453916|Rifaximin|rifaximin|mesh-list
56158996|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
56158997|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56158998|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158999|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56159000|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56159001|NCT05273814|Bevacizumab|bevacizumab|mesh-list
56159002|NCT05273814|Pemetrexed|pemetrexed|mesh-list
56159003|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56159004|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56026468|NCT03809702|Pregabalin|pregabalin|mesh-list
56026584|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
56159005|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159006|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56159007|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56159008|NCT05273814|Growth Substances|growth substances|mesh-ancestor
56159009|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159010|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
56159011|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159012|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159013|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56159014|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56159015|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
56159016|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56159017|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159018|NCT04784208|Hormones|hormones|mesh-list
56159019|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026729|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
56026798|NCT01216241|Daptomycin|daptomycin|mesh-list
56159020|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159021|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
56159022|NCT04741620|Capsaicin|capsaicin|mesh-list
56159023|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
56159024|NCT04741620|Citric Acid|citric acid|mesh-list
56159025|NCT04741620|Piperine|piperine|mesh-list
56159026|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
56660392|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660393|NCT04058990|Paclitaxel|paclitaxel|mesh-list
56660394|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56660395|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56027161|NCT01339247|Paroxetine|paroxetine|mesh-list
56159027|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
56159028|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
56159029|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159030|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159031|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
56159032|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56159034|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
56027676|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56159035|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159036|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56159037|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159038|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56159039|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159040|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56159041|NCT04741620|Protective Agents|protective agents|mesh-ancestor
56159042|NCT04024878|Nivolumab|nivolumab|mesh-list
56159043|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56159044|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159045|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56159046|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159048|NCT03845010|Sotalol|sotalol|mesh-list
56159049|NCT03845010|Flecainide|flecainide|mesh-list
56159050|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56028268|NCT01279187|Teriparatide|teriparatide|mesh-list
56159051|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56028368|NCT01365611|Xhance|xhance|mesh-list
56159052|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56028413|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56159053|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159054|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56159055|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159057|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56159058|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56159059|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
56159060|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159061|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
56159062|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
56159063|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028633|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159064|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56028702|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
56159065|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56159067|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
56159068|NCT03568890|Apixaban|apixaban|mesh-list
56159069|NCT03568890|Edoxaban|edoxaban|mesh-list
56159070|NCT03568890|Dabigatran|dabigatran|mesh-list
56159071|NCT03568890|Clopidogrel|clopidogrel|mesh-list
56159072|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56029074|NCT02513160|Albuterol|albuterol|mesh-list
56159073|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56159074|NCT03568890|Analgesics|analgesics|mesh-ancestor
56159075|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
56029222|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
56159076|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029466|NCT00882206|Cytarabine|cytarabine|mesh-list
56029524|NCT00885638|Hormones|hormones|mesh-ancestor
56029600|NCT00887510|Diuretics|diuretics|mesh-ancestor
56159077|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029759|NCT04979520|Brodalumab|brodalumab|mesh-list
56029825|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56159078|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159079|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159080|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56159081|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56159082|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159083|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56159084|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56660396|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660397|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
56660398|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
56660399|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
56660400|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660401|NCT00595920|Vaccines|vaccines|mesh-list
56660402|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
56660403|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660404|NCT02654288|Gemcitabine|gemcitabine|mesh-list
56660405|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56660406|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
56660407|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660408|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660409|NCT02654288|Antiviral Agents|antiviral agents|mesh-ancestor
56660410|NCT02654288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660411|NCT02654288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660412|NCT02654288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660413|NCT02654288|Immunologic Factors|immunologic factors|mesh-ancestor
56660414|NCT02654288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660415|NCT02649140|Acetic Acid|acetic acid|mesh-list
56660416|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56660417|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660418|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56660419|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
56660420|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56159085|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159086|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
56030339|NCT01532141|Protective Agents|protective agents|mesh-ancestor
56159087|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56159088|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56159089|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56159090|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
56159091|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159092|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56159093|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
56159094|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56159095|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
56159096|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
56159097|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
56159098|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56159099|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56159100|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56159101|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56159102|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159103|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
56159104|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159105|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159106|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56159107|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159108|NCT02529930|Vaccines|vaccines|mesh-list
56660421|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56660422|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660423|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660424|NCT00665496|Urological Agents|urological agents|mesh-ancestor
56660425|NCT02653898|Artesunate|artesunate|mesh-list
56660426|NCT02653898|Piperaquine|piperaquine|mesh-list
56660427|NCT02653898|Primaquine|primaquine|mesh-list
56660428|NCT02653898|Artenimol|artenimol|mesh-list
56660429|NCT02653898|Mefloquine|mefloquine|mesh-list
56660430|NCT02653898|Permethrin|permethrin|mesh-list
56660431|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
56660432|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56660433|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56660434|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660435|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660436|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
56660437|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
56660438|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56660439|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
56660440|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660441|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660443|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56159109|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
56159111|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
56159113|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159114|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
56159115|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56159116|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
56159117|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159118|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159119|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56031516|NCT01723670|Analgesics|analgesics|mesh-ancestor
56159120|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
56159121|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56159122|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
56031672|NCT03001349|Octreotide|octreotide|mesh-list
56159123|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031812|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
56159124|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031958|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
56159125|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56159126|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
56159127|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
56159128|NCT05101746|Protective Agents|protective agents|mesh-ancestor
56159129|NCT04763226|Furosemide|furosemide|mesh-list
56159130|NCT04763226|Diuretics|diuretics|mesh-ancestor
56159131|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
56159132|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032325|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159133|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56032475|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
56032545|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159134|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56159135|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159136|NCT04549428|Atezolizumab|atezolizumab|mesh-list
56159137|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159138|NCT04527900|Paclitaxel|paclitaxel|mesh-list
56660444|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
56660445|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660446|NCT02629536|Expectorants|expectorants|mesh-ancestor
56660447|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
56660448|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56159140|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56159141|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033146|NCT02244710|Clopidogrel|clopidogrel|mesh-list
56159143|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
56033292|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
56159144|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
56159145|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159146|NCT04340856|Bisacodyl|bisacodyl|mesh-list
56159147|NCT04340856|Laxatives|laxatives|mesh-list
56159148|NCT04340856|Cathartics|cathartics|mesh-ancestor
56159149|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56159150|NCT04040790|Phenylephrine|phenylephrine|mesh-list
56159151|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
56159152|NCT04040790|Tropicamide|tropicamide|mesh-list
56159154|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
56159155|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
56159156|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159157|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033815|NCT04641104|Thiamine|thiamine|mesh-list
56159158|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
56159159|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56159161|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56034029|NCT01703507|Ipilimumab|ipilimumab|mesh-list
56159162|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56159163|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56159164|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56159165|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
56086822|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
56159166|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159167|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159168|NCT04040790|Protective Agents|protective agents|mesh-ancestor
56159169|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56159170|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56159171|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
56159172|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
56159174|NCT03797196|Tacrolimus|tacrolimus|mesh-list
56159175|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56159176|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
56159177|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159178|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56159192|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56159193|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56159195|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56159197|NCT03556800|Hormones|hormones|mesh-ancestor
56034174|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56159198|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159199|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159200|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56159201|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
56159202|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56159203|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56159204|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
56159205|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56159206|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159207|NCT01785420|Trastuzumab|trastuzumab|mesh-list
56159208|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56159209|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034377|NCT01663259|Cetuximab|cetuximab|mesh-list
56159210|NCT01685814|Lenalidomide|lenalidomide|mesh-list
56159211|NCT01685814|Bortezomib|bortezomib|mesh-list
56159212|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
56159213|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159214|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56159215|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56159216|NCT01685814|Growth Substances|growth substances|mesh-ancestor
56159217|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
56159218|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159219|NCT00800514|Amantadine|amantadine|mesh-list
56660449|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
56660450|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660451|NCT02629536|Protective Agents|protective agents|mesh-ancestor
56660452|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660453|NCT02629536|Antidotes|antidotes|mesh-ancestor
56660454|NCT04071106|Betamethasone|betamethasone|mesh-list
56660455|NCT04071106|Calcipotriene|calcipotriene|mesh-list
56660456|NCT04071106|Petrolatum|petrolatum|mesh-list
56660457|NCT04071106|Turmeric extract|turmeric extract|mesh-list
56660458|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660459|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
56660460|NCT04071106|Hormones|hormones|mesh-ancestor
56660461|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660462|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660463|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56660464|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
56660465|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56660466|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
56660467|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660468|NCT04071106|Protective Agents|protective agents|mesh-ancestor
56660469|NCT04071106|Emollients|emollients|mesh-ancestor
56660470|NCT00670722|Insulin|insulin|mesh-list
56660471|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56159220|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56159221|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56159222|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
56159223|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159224|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
56159225|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159226|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159227|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159228|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56159230|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
56159231|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159232|NCT02780622|Oseltamivir|oseltamivir|mesh-list
56159233|NCT02780622|Warfarin|warfarin|mesh-list
56159234|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
56159235|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
56159236|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159237|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159238|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159269|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56036115|NCT02452476|Poractant alfa|poractant alfa|mesh-list
56159270|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036342|NCT01044212|Psyllium|psyllium|mesh-list
56159280|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56159281|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
56159282|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159284|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56159285|NCT02820324|Narcotics|narcotics|mesh-ancestor
56159286|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037376|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56159287|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159288|NCT02820324|Analgesics|analgesics|mesh-ancestor
56660472|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
56660473|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
56660474|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56660475|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
56660476|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
56660477|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56660478|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56660479|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660480|NCT02648906|Choline|choline|mesh-list
56037596|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
56159289|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
56159290|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159291|NCT02821338|Lamotrigine|lamotrigine|mesh-list
56037818|NCT01154192|Hormones|hormones|mesh-ancestor
56159292|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
56159293|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56159294|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56159295|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159296|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56038111|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159297|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159298|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56159299|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56159300|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159301|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56159302|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56159303|NCT02835846|Estrogens|estrogens|mesh-list
56159304|NCT02835846|Hormones|hormones|mesh-ancestor
56159305|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159306|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159307|NCT02844582|Prednisone|prednisone|mesh-list
56159308|NCT02844582|Cortisone|cortisone|mesh-list
56159309|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159310|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
56159311|NCT02844582|Hormones|hormones|mesh-ancestor
56159312|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159313|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159314|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56159315|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159316|NCT02845752|Bromides|bromides|mesh-list
56159317|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
56086969|NCT05450497|Propofol|propofol|mesh-list
56159318|NCT02845752|Olodaterol|olodaterol|mesh-list
56159319|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56159320|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
56159321|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159322|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159323|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56159328|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038749|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56159329|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159330|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
56159331|NCT02849184|Suvorexant|suvorexant|mesh-list
56159332|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56159333|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56159334|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159335|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159336|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56159337|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159338|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159339|NCT02862912|Fentanyl|fentanyl|mesh-list
56159340|NCT02862912|Bupivacaine|bupivacaine|mesh-list
56159341|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
56159342|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
56159343|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
55927228|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56660481|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
56660482|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56660483|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
56660484|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660485|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660486|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56660487|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
56660488|NCT00670878|Gemcitabine|gemcitabine|mesh-list
56660489|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56660490|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
56660491|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660492|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660493|NCT00670878|Antiviral Agents|antiviral agents|mesh-ancestor
56660494|NCT00670878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159344|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039494|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
56039573|NCT05099055|Analgesics|analgesics|mesh-ancestor
56159345|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159346|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
56039797|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
56039867|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
56159347|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159348|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56159349|NCT02862912|Narcotics|narcotics|mesh-ancestor
56159351|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56159352|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56159353|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
56159354|NCT02864706|Cyclosporine|cyclosporine|mesh-list
56040084|NCT01355588|Analgesics|analgesics|mesh-ancestor
56040150|NCT02625207|Maraviroc|maraviroc|mesh-list
56159355|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
56159356|NCT02864706|Everolimus|everolimus|mesh-list
56159357|NCT02864706|Cyclosporins|cyclosporins|mesh-list
56159358|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040297|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040374|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56159359|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159360|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56159361|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
56159362|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040677|NCT02865473|Pilocarpine|pilocarpine|mesh-list
56159363|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
56159364|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040978|NCT00367419|Erythromycin|erythromycin|mesh-list
56159366|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159367|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56041131|NCT01332578|Vitamins|vitamins|mesh-ancestor
56159368|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041271|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159369|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56159370|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56041417|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
56041568|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56159371|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
56041641|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
56159372|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56159373|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56159374|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56159375|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041861|NCT01416584|Methadone|methadone|mesh-list
56159376|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
56159377|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159378|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
56660495|NCT00670878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660496|NCT00670878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660497|NCT00670878|Immunologic Factors|immunologic factors|mesh-ancestor
56660498|NCT00670878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660499|NCT02760095|Vitamin A|vitamin a|mesh-list
56660500|NCT02760095|Acetic Acid|acetic acid|mesh-list
56660501|NCT02760095|Retinol acetate|retinol acetate|mesh-list
56660502|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
56660503|NCT02760095|Vitamins|vitamins|mesh-ancestor
56660504|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
56660505|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660506|NCT02760095|Protective Agents|protective agents|mesh-ancestor
56660507|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56660508|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660509|NCT02760095|Astringents|astringents|mesh-ancestor
56222036|NCT01666236|Hormones|hormones|mesh-ancestor
56159379|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56042088|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
56159381|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56042238|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
56159382|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56159383|NCT02880228|Dexamethasone|dexamethasone|mesh-list
56159384|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
56159385|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
56159387|NCT02880228|Ichthammol|ichthammol|mesh-list
56159388|NCT02880228|BB 1101|bb 1101|mesh-list
56159389|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159390|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
56159391|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
56087040|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56159392|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159393|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159394|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56159396|NCT02880228|Hormones|hormones|mesh-ancestor
56159397|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56042902|NCT01868633|Hormones|hormones|mesh-ancestor
56159398|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56042975|NCT03024437|Entinostat|entinostat|mesh-list
56043049|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56159399|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159400|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56159401|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
56043284|NCT05451147|Metformin|metformin|mesh-list
56159402|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56159403|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56159404|NCT02880228|Growth Substances|growth substances|mesh-ancestor
56159405|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
56159406|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
56159407|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159408|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159409|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56159410|NCT02880852|Belimumab|belimumab|mesh-list
56159411|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56159412|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
56159413|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159414|NCT02881008|Entecavir|entecavir|mesh-list
56159415|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
56159416|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159417|NCT02887404|Analgesics|analgesics|mesh-list
56159418|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
56159419|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159420|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159421|NCT02889510|Liraglutide|liraglutide|mesh-list
56159422|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56043777|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
56660510|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
56660511|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56660512|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
56660513|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306646|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
56660514|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660515|NCT04418167|Dabrafenib|dabrafenib|mesh-list
56660516|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660517|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56660518|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660519|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660520|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
56660521|NCT02576626|Albuterol|albuterol|mesh-list
56159423|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159424|NCT02889510|Incretins|incretins|mesh-ancestor
56159425|NCT02889510|Hormones|hormones|mesh-ancestor
56044009|NCT05523323|Lenvatinib|lenvatinib|mesh-list
56159426|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159427|NCT02902770|Ketorolac|ketorolac|mesh-list
56159428|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56159429|NCT02902770|Lidocaine|lidocaine|mesh-list
56159430|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
56159431|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
56044220|NCT01502306|Nicotine|nicotine|mesh-list
56159432|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159433|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159434|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
56044367|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56159435|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159436|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56044438|NCT05132439|Metformin|metformin|mesh-list
56159437|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56159438|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56159439|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56159440|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159441|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56159442|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56159443|NCT02902770|Analgesics|analgesics|mesh-ancestor
56159444|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159445|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56044584|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
56159448|NCT02907918|Trastuzumab|trastuzumab|mesh-list
56159449|NCT02907918|Letrozole|letrozole|mesh-list
56159450|NCT02907918|Palbociclib|palbociclib|mesh-list
56044876|NCT04771299|Cariprazine|cariprazine|mesh-list
56159452|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56045094|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159453|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159454|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56159455|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56045182|NCT00373581|Cocaine|cocaine|mesh-list
56159456|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159457|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159458|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56159459|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
56045394|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
56159460|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159461|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159462|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56159463|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56159464|NCT02908620|Anesthetics|anesthetics|mesh-list
56159465|NCT02908620|Tetracaine|tetracaine|mesh-list
56159466|NCT02908620|Benzocaine|benzocaine|mesh-list
56045688|NCT02903121|Tamoxifen|tamoxifen|mesh-list
56660522|NCT02576626|Ipratropium|ipratropium|mesh-list
56660523|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56660524|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
56660525|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159467|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159468|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045910|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
56159469|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
56159470|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
56159471|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159472|NCT02911818|Liraglutide|liraglutide|mesh-list
56045984|NCT01595282|Ibuprofen|ibuprofen|mesh-list
56046060|NCT03006380|Oxytocin|oxytocin|mesh-list
56159475|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159476|NCT02911818|Incretins|incretins|mesh-ancestor
56159478|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159479|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56159480|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
56159481|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56159482|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
56159483|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
56159484|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159485|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
56159486|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159487|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159488|NCT02912364|Carbamazepine|carbamazepine|mesh-list
56159489|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56159490|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
56159491|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
56159492|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56159493|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159494|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159495|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56159496|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56159497|NCT02912364|Analgesics|analgesics|mesh-ancestor
56159498|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
56159499|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159500|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56159501|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56046582|NCT03028467|Hematinics|hematinics|mesh-ancestor
56159502|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159503|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56046726|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
56159504|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56159505|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56159506|NCT02913924|Clonazepam|clonazepam|mesh-list
56159507|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
56159508|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
56159509|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
56159510|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159511|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159512|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159513|NCT02917122|Sertraline|sertraline|mesh-list
56159514|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
56159515|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56159516|NCT02917122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56159517|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56159518|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56159519|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774265|NCT02423863|Nivolumab|nivolumab|mesh-list
56159521|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
56047155|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
56159522|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159523|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
56047379|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
56159524|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56159525|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56159526|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159527|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
56159528|NCT02922582|Coagulants|coagulants|mesh-ancestor
56159529|NCT02925858|Ketamine|ketamine|mesh-list
56159530|NCT02925858|Analgesics|analgesics|mesh-ancestor
56660526|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660527|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56660528|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
56660529|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
56159531|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
56159532|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047679|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
56159533|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159534|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56159535|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56159536|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
56159537|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
56159538|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159539|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56159540|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56048343|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
56048420|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
56159541|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048568|NCT01642238|Aspirin|aspirin|mesh-list
56159542|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159543|NCT02933034|Manganese|manganese|mesh-list
56159544|NCT02933034|Trace Elements|trace elements|mesh-ancestor
56159545|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
56159546|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159547|NCT02937168|Reslizumab|reslizumab|mesh-list
56159548|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56159549|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56159550|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048858|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048951|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
56159551|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56049010|NCT03000309|Apremilast|apremilast|mesh-list
56159552|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
56159553|NCT02937558|Glucagon|glucagon|mesh-list
56159554|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56159555|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56159556|NCT02937558|Hormones|hormones|mesh-ancestor
56165366|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159557|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159558|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159559|NCT02937558|Incretins|incretins|mesh-ancestor
56159560|NCT02938494|Tazarotene|tazarotene|mesh-list
56159561|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
56159562|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
56159563|NCT02941692|Oxytocin|oxytocin|mesh-list
56159564|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
56159565|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56159566|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159567|NCT02953860|Fulvestrant|fulvestrant|mesh-list
56159568|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56159569|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159570|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56159571|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56159572|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165367|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56049518|NCT05066061|Analgesics|analgesics|mesh-list
56159573|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56049600|NCT01684748|Olmesartan|olmesartan|mesh-list
56159574|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159575|NCT02956044|Metformin|metformin|mesh-list
56159576|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56159580|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159581|NCT02956044|Incretins|incretins|mesh-ancestor
56050201|NCT01971593|Eplerenone|eplerenone|mesh-list
56165368|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
56159583|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159584|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56159586|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159587|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159588|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56159589|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56159590|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
56660530|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56660531|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56159591|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
56159592|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56159593|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56159595|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
56159596|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56051080|NCT01749956|Leucovorin|leucovorin|mesh-list
56159597|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
56051153|NCT03711188|Nivolumab|nivolumab|mesh-list
56159598|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
56159599|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56051367|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159600|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159602|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
56159603|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159604|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159605|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56159606|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
56159607|NCT02956122|Hormones|hormones|mesh-ancestor
56051662|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
56165369|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051756|NCT04296695|Tenofovir|tenofovir|mesh-list
56165370|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165371|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165372|NCT00002868|Interferons|interferons|mesh-list
56165373|NCT00002868|Cytarabine|cytarabine|mesh-list
56159608|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159609|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56159611|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56165374|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
56159612|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159613|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165375|NCT00002868|Etoposide|etoposide|mesh-list
56159614|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159615|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56159616|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56159617|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
56159619|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
56159620|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56159621|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56159622|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
56165376|NCT00002868|Idarubicin|idarubicin|mesh-list
56165377|NCT00002868|Busulfan|busulfan|mesh-list
56159623|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053074|NCT05692154|Histamine Agents|histamine agents|mesh-ancestor
56053151|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
56159625|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
56053297|NCT03920865|Risdiplam|risdiplam|mesh-list
56159626|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56159627|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
56159628|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56159629|NCT02968134|Posaconazole|posaconazole|mesh-list
56159630|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
56159631|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159632|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56159633|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56159634|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56159635|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56165378|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
56053662|NCT02281838|Labetalol|labetalol|mesh-list
56159636|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56159637|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053893|NCT04004481|Morphine|morphine|mesh-list
56159638|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053974|NCT02988440|Sorafenib|sorafenib|mesh-list
56159640|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
56159641|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054192|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
56159642|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159643|NCT02968368|Ferric maltol|ferric maltol|mesh-list
56159645|NCT02968914|Benralizumab|benralizumab|mesh-list
56159646|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56159647|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
56159648|NCT02970162|Amifampridine|amifampridine|mesh-list
56159649|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56660532|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56660533|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56660534|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
56159650|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159651|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159652|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56159653|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054488|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
56159654|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159655|NCT02970552|Progesterone|progesterone|mesh-list
56159656|NCT02970552|Progestins|progestins|mesh-ancestor
56159657|NCT02970552|Hormones|hormones|mesh-ancestor
56054784|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56165379|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56054955|NCT03734601|Tacrolimus|tacrolimus|mesh-list
56165380|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159658|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159659|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159660|NCT02978508|Permethrin|permethrin|mesh-list
56159661|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159662|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159663|NCT02988882|Dexamethasone|dexamethasone|mesh-list
56055312|NCT02101853|Leucovorin|leucovorin|mesh-list
56159664|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159666|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
56159667|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159668|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159669|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56159671|NCT02988882|Hormones|hormones|mesh-ancestor
56159672|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159673|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56056049|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56159674|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159675|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
56159676|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
56159677|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56159678|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159679|NCT03009162|Lasmiditan|lasmiditan|mesh-list
56159680|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56159681|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
56159682|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159683|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159684|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159685|NCT03009396|Clarithromycin|clarithromycin|mesh-list
56159686|NCT03009396|Rifabutin|rifabutin|mesh-list
56159687|NCT03009396|Clofazimine|clofazimine|mesh-list
56159688|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56159689|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159690|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56087341|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159691|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159692|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159693|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56159694|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56159695|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56159696|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
56159697|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159698|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
56159700|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159702|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
56057024|NCT00001989|Zidovudine|zidovudine|mesh-list
56159703|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56159705|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56057322|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56159706|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159707|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159708|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56159709|NCT03017508|Protective Agents|protective agents|mesh-ancestor
56159711|NCT03020004|Ribavirin|ribavirin|mesh-list
56159712|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56159713|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56660535|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56660536|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660537|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56660538|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56660539|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56660540|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
56660541|NCT00877890|Exenatide|exenatide|mesh-list
56660542|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56660543|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660544|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56660545|NCT00877890|Incretins|incretins|mesh-ancestor
56660546|NCT00877890|Hormones|hormones|mesh-ancestor
56660547|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660548|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
56660549|NCT04221971|Fludarabine|fludarabine|mesh-list
56660550|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660551|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
56660552|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660553|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660554|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56222072|NCT01666431|Lapatinib|lapatinib|mesh-list
56057701|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
56159714|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56159715|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
56159716|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159717|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159719|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56159720|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
56159721|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159722|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56159723|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56159724|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
56159725|NCT03020082|Ritonavir|ritonavir|mesh-list
56159726|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56159727|NCT03020082|Ribavirin|ribavirin|mesh-list
56159728|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56159729|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56159730|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
56159731|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159732|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159733|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56159734|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56159735|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
56159736|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159737|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56159738|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56159739|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
56159740|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
56159741|NCT03026556|Apixaban|apixaban|mesh-list
56159742|NCT03026556|Dabigatran|dabigatran|mesh-list
56159743|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56058345|NCT00002475|Vaccines|vaccines|mesh-list
56159745|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56159746|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
56159747|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660555|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
56660556|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660557|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660558|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56660559|NCT02644694|Dexamethasone|dexamethasone|mesh-list
56660560|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56660561|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56660562|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660563|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
56660564|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
56660565|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660566|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058497|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
56159748|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159749|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
56159750|NCT03035760|Oxfendazole|oxfendazole|mesh-list
56159751|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
56159752|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56159753|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159754|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
56159755|NCT03036384|Sufentanil|sufentanil|mesh-list
56159756|NCT03036384|Morphine|morphine|mesh-list
56159757|NCT03036384|Prilocaine|prilocaine|mesh-list
56159758|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56159759|NCT03036384|Narcotics|narcotics|mesh-ancestor
56159760|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159761|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159762|NCT03036384|Analgesics|analgesics|mesh-ancestor
56159763|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
56159764|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159765|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56159766|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56159767|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
56159768|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
56159769|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
56159772|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
56159773|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159774|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159775|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159776|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56159777|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
56159778|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
56176315|NCT01394770|Amlodipine|amlodipine|mesh-list
56159779|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159780|NCT03044418|Propofol|propofol|mesh-list
56159781|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
56059232|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159782|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059306|NCT00002715|Doxorubicin|doxorubicin|mesh-list
56159783|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159784|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56059387|NCT01625455|Aprepitant|aprepitant|mesh-list
56159785|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56159786|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
56159787|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56159789|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
56159790|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159791|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
56159792|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059899|NCT00382083|Acetaminophen|acetaminophen|mesh-list
56159793|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060047|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56159795|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660567|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660568|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
56660569|NCT02644694|Hormones|hormones|mesh-ancestor
56660570|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660571|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56660572|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660573|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56660574|NCT02653742|Ketorolac|ketorolac|mesh-list
56660575|NCT02653742|Fentanyl|fentanyl|mesh-list
56660576|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56660577|NCT02653742|Narcotics|narcotics|mesh-ancestor
56660578|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660579|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660580|NCT02653742|Analgesics|analgesics|mesh-ancestor
56660581|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
56660582|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660583|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56660584|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56660585|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
56660586|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
56222098|NCT01666587|Protective Agents|protective agents|mesh-ancestor
56060198|NCT01934582|Treprostinil|treprostinil|mesh-list
56060199|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56060200|NCT05735834|Rituximab|rituximab|mesh-list
56060201|NCT05735834|Zanubrutinib|zanubrutinib|mesh-list
56159796|NCT03057366|Paclitaxel|paclitaxel|mesh-list
56159797|NCT03057366|Docetaxel|docetaxel|mesh-list
56159798|NCT03057366|Carboplatin|carboplatin|mesh-list
56159799|NCT03057366|Pevonedistat|pevonedistat|mesh-list
56159800|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56159801|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060450|NCT00000327|Heroin|heroin|mesh-list
56159802|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
56159803|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
56159804|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
56159805|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159806|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159807|NCT03060486|Hybenx|hybenx|mesh-list
56159808|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
56159809|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
56159810|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060563|NCT01943864|Trametinib|trametinib|mesh-list
56159811|NCT03061812|Dexamethasone|dexamethasone|mesh-list
56159812|NCT03061812|Topotecan|topotecan|mesh-list
56159813|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159814|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
56159815|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
56159816|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159817|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159818|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56159819|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
56159821|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060844|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159822|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56159823|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159824|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56159825|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56159826|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660587|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56660588|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56660589|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660590|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660591|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56660592|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660593|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660594|NCT02755259|Acetazolamide|acetazolamide|mesh-list
56660595|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
56660596|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56660597|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660598|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159827|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159828|NCT03070470|Ritonavir|ritonavir|mesh-list
56159829|NCT03070470|Lopinavir|lopinavir|mesh-list
56159830|NCT03070470|Chloroquine|chloroquine|mesh-list
56159831|NCT03070470|Verapamil|verapamil|mesh-list
56159832|NCT03070470|Dofetilide|dofetilide|mesh-list
56159833|NCT03070470|Diltiazem|diltiazem|mesh-list
56159834|NCT03070470|Ranolazine|ranolazine|mesh-list
56159835|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56159836|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56159837|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
56159838|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159839|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159840|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56159841|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56159842|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
56087492|NCT05454085|Bisphenol A|bisphenol a|mesh-list
56159843|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159844|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56159845|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56159846|NCT03070470|Amebicides|amebicides|mesh-ancestor
56159847|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56159848|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56159849|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
56159850|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159853|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56159854|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56159855|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56159856|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
56159857|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56159858|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56159859|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56159860|NCT03070548|Talazoparib|talazoparib|mesh-list
56159861|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56159862|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159863|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159864|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159865|NCT03080142|Bupivacaine|bupivacaine|mesh-list
56159866|NCT03080142|Ropivacaine|ropivacaine|mesh-list
56159867|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
56159868|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
56159869|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159870|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159871|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
56159872|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159874|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56159875|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56159876|NCT03088800|Analgesics|analgesics|mesh-ancestor
56159877|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
56159878|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928172|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
56660599|NCT02755259|Diuretics|diuretics|mesh-ancestor
56660600|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
56660601|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660602|NCT02575222|Nivolumab|nivolumab|mesh-list
56660603|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56660604|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660605|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56660606|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660607|NCT00680394|Misoprostol|misoprostol|mesh-list
56660608|NCT00680394|Mifepristone|mifepristone|mesh-list
56660609|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56660610|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
56660611|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56660612|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660613|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56660614|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660615|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
56660616|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56660617|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56660618|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56660619|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56660620|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
56660621|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56660622|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56222139|NCT01666691|CKD732|ckd732|mesh-list
56159879|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159880|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159881|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159882|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56159883|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159884|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159885|NCT03096444|Lidocaine|lidocaine|mesh-list
56159886|NCT03096444|Ketamine|ketamine|mesh-list
56159887|NCT03096444|Amitriptyline|amitriptyline|mesh-list
56159888|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
56159889|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
56159890|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061077|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159891|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159892|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
56159893|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159894|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56159895|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56159896|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56159897|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56159898|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159899|NCT03096444|Analgesics|analgesics|mesh-ancestor
56159900|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56660623|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
56660624|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660625|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
56660626|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56660627|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56660628|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
56660629|NCT04724044|Clarithromycin|clarithromycin|mesh-list
56660630|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
56660631|NCT04724044|Lactams|lactams|mesh-list
56660632|NCT04724044|beta-Lactams|beta-lactams|mesh-list
56660633|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56660634|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56660635|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660636|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56660637|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56660638|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660639|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660640|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159901|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56159902|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
56159903|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56159904|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56159905|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159906|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56061358|NCT03438773|Tacrolimus|tacrolimus|mesh-list
56159907|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
56159909|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56061507|NCT04675983|Fluorouracil|fluorouracil|mesh-list
56159910|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56159911|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56159912|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
56159913|NCT03107754|Lidocaine|lidocaine|mesh-list
56159914|NCT03107754|Anesthetics|anesthetics|mesh-list
56159915|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
56159916|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159917|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159918|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
56061717|NCT05738564|Autonomic Agents|autonomic agents|mesh-ancestor
56061790|NCT02974439|Amlodipine|amlodipine|mesh-list
56159919|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159922|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56159923|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062166|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
56159924|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159925|NCT03124758|Chrysarobin|chrysarobin|mesh-list
56159926|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56159928|NCT03124758|Analgesics|analgesics|mesh-ancestor
56159929|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
56159930|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159931|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159932|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159933|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159934|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
56159935|NCT03148236|Vitamins|vitamins|mesh-ancestor
56159936|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
56159937|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660641|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56660642|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
56660643|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56222173|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56159938|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
56159939|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159940|NCT03148236|Protective Agents|protective agents|mesh-ancestor
56159941|NCT03174366|Denosumab|denosumab|mesh-list
56159942|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56159943|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159945|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56159946|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56159947|NCT03177798|Analgesics|analgesics|mesh-ancestor
56159948|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
56062593|NCT03836066|Bevacizumab|bevacizumab|mesh-list
56159949|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159950|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159951|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159952|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159953|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56159954|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56165381|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56159955|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062800|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159956|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56159957|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56159958|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
56159959|NCT05093790|Aspirin|aspirin|mesh-list
56159961|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56063029|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
56159962|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56159963|NCT05093790|Analgesics|analgesics|mesh-ancestor
56159964|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
56063113|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
56159965|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159966|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063261|NCT00003039|Alvocidib|alvocidib|mesh-list
56159967|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159968|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159969|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56159970|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56159971|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159972|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56159973|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56159976|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56159977|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56159978|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56159979|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
56159980|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159981|NCT05010954|Lansoprazole|lansoprazole|mesh-list
56159982|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
56159983|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56159984|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56159985|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56159986|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165382|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56159987|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159989|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56159990|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159993|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159994|NCT05405478|Omalizumab|omalizumab|mesh-list
56159995|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56159996|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56159997|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
56159998|NCT05262738|Misoprostol|misoprostol|mesh-list
56159999|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56160000|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
56160001|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56160003|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56064953|NCT02430389|Narcotics|narcotics|mesh-ancestor
56660644|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660645|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56660646|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56660647|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56660648|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56660649|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56660650|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56660651|NCT02768519|OTS167|ots167|mesh-list
56660652|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56660653|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660654|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660655|NCT03530696|Palbociclib|palbociclib|mesh-list
56660656|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660657|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56222181|NCT01667263|Tretinoin|tretinoin|mesh-list
56160004|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56160005|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
56160006|NCT05011188|Antibodies|antibodies|mesh-list
56160007|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
56065186|NCT02505269|Imidazole|imidazole|mesh-list
56160008|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
56160009|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
56160010|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065330|NCT04563923|Avdoralimab|avdoralimab|mesh-list
56160011|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56065402|NCT00558025|Pramipexole|pramipexole|mesh-list
56160012|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160013|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56065545|NCT02289690|Etoposide|etoposide|mesh-list
56160015|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160016|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
56160017|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56065692|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
56160018|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56160019|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160020|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56160021|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56160022|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
56160023|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56160024|NCT04263792|Trimethoprim|trimethoprim|mesh-list
56160025|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56160026|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160027|NCT04263792|Renal Agents|renal agents|mesh-ancestor
56160028|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
56066128|NCT02617667|Cyclosporine|cyclosporine|mesh-list
56160030|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56066209|NCT04665037|Posaconazole|posaconazole|mesh-list
56160031|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56066436|NCT05688215|Leucovorin|leucovorin|mesh-list
56066500|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160033|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160034|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56160035|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56160036|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56160038|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56160039|NCT03872700|Narcotics|narcotics|mesh-ancestor
56160040|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066872|NCT05588297|Bevacizumab|bevacizumab|mesh-list
56160041|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160042|NCT03872700|Analgesics|analgesics|mesh-ancestor
56160043|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
56160044|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660658|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660659|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660660|NCT00671814|Linezolid|linezolid|mesh-list
56160045|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56160046|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56160047|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
56160048|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
56160049|NCT03137160|Ixekizumab|ixekizumab|mesh-list
56067022|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
56160050|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
56067168|NCT04931693|Acetaminophen|acetaminophen|mesh-list
56160052|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160053|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56160054|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160055|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160056|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
56160057|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56160058|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56160059|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56160060|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56160061|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160063|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160064|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160065|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56160066|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160067|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
56160068|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56160069|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160070|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56160071|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
56160072|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56160073|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160074|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160075|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160077|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
56160078|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
56160079|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160080|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160081|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
56160082|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160083|NCT04131192|Gemcitabine|gemcitabine|mesh-list
56160084|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56160085|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
56160086|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160087|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160088|NCT04131192|Antiviral Agents|antiviral agents|mesh-ancestor
56067616|NCT00085735|Lomustine|lomustine|mesh-list
56160089|NCT04131192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160090|NCT04131192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160091|NCT04131192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56160092|NCT04131192|Immunologic Factors|immunologic factors|mesh-ancestor
56160093|NCT04131192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160094|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
56160095|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56160096|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160097|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
56160099|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56160100|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
56160101|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160102|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
56160103|NCT03883074|Protective Agents|protective agents|mesh-ancestor
56160104|NCT03883074|Antacids|antacids|mesh-ancestor
56160105|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160106|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56160107|NCT03670836|Misoprostol|misoprostol|mesh-list
56067864|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
56160108|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56160109|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
56160110|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56160111|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160112|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56160113|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660661|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56660662|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660663|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56660664|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160114|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
56160115|NCT03607656|Docetaxel|docetaxel|mesh-list
56160116|NCT03607656|Capecitabine|capecitabine|mesh-list
56160117|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
56068307|NCT01897285|Laxatives|laxatives|mesh-ancestor
56160118|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160119|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
56160120|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
56160121|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
56160122|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160123|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56160125|NCT03598842|Metronidazole|metronidazole|mesh-list
56160126|NCT03598842|Ivermectin|ivermectin|mesh-list
56160128|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
56160129|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160130|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56160131|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56160132|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
56160133|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
56160134|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56160135|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
56160138|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160139|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160141|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56160142|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160143|NCT02651844|Mifepristone|mifepristone|mesh-list
56160144|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56160145|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
56160146|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56069038|NCT05738317|Growth Inhibitors|growth inhibitors|mesh-ancestor
56160147|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160148|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56160149|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56160150|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56160151|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
56160152|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56160153|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56160154|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
56160155|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56160156|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
56160157|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56160158|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56160160|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
56160161|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160162|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56160163|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56160164|NCT01463670|Growth Substances|growth substances|mesh-ancestor
56160165|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
56160167|NCT00151398|Donepezil|donepezil|mesh-list
56160168|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56160169|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069331|NCT05306587|Daratumumab|daratumumab|mesh-list
56069402|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160170|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160171|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
56160172|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160173|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160174|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
56160176|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56160177|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160178|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56160179|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160180|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56160181|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56160182|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
56160184|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660665|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660666|NCT02627430|Talazoparib|talazoparib|mesh-list
56660667|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56660668|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222196|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070224|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56160185|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160186|NCT03202134|Narcotics|narcotics|mesh-ancestor
56160187|NCT03202134|Analgesics|analgesics|mesh-ancestor
56160188|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
56160189|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160190|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56160191|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
56160192|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56160193|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56160194|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56160195|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160196|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160197|NCT03218592|Tenofovir|tenofovir|mesh-list
56160198|NCT03218592|Emtricitabine|emtricitabine|mesh-list
56160199|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56160200|NCT03218592|Maraviroc|maraviroc|mesh-list
56160201|NCT03218592|Dolutegravir|dolutegravir|mesh-list
56160202|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
56160203|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160204|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56160205|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56160206|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160210|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56160211|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56160212|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56160213|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56160214|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56160215|NCT03219294|Bromides|bromides|mesh-list
56160216|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
56160217|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
56160218|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56160219|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56160220|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56160221|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160222|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160223|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56160224|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56160225|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
56160226|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160227|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160228|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
56160229|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56160230|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160232|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56160233|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56160234|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56160235|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160236|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160237|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56160238|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56160239|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56160240|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56160241|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160242|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160243|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160245|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56160246|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56160247|NCT03239106|Analgesics|analgesics|mesh-ancestor
56160248|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
56071200|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
56160249|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071276|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660669|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660670|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660671|NCT02759393|Lansoprazole|lansoprazole|mesh-list
56660672|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
56660673|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56660674|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660675|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56160250|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160251|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56160252|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56160253|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56160254|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56160255|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160256|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160257|NCT03257202|Clindamycin|clindamycin|mesh-list
56160258|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
56160259|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
56160260|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56160261|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56160262|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160263|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56160264|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160265|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160266|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160267|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56160268|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
56160269|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160270|NCT03278886|Naltrexone|naltrexone|mesh-list
56160271|NCT03278886|Nalmefene|nalmefene|mesh-list
56160272|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56071494|NCT02396732|Aspirin|aspirin|mesh-list
56160273|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56160274|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160275|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
56160277|NCT03285984|Listerine|listerine|mesh-list
56160278|NCT03285984|Fluorides|fluorides|mesh-list
56160279|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
56160280|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
56160281|NCT03285984|Protective Agents|protective agents|mesh-ancestor
56160282|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160283|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56160284|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160285|NCT03287310|Albuterol|albuterol|mesh-list
56160286|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56160287|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
56160288|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160289|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160290|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56160291|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
56160292|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
56160293|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56160294|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56160295|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56160296|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56160297|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160298|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160299|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160300|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56160302|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56071890|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56160303|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160304|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160305|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56160306|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56160307|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160308|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
56160309|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160310|NCT03315780|Dulaglutide|dulaglutide|mesh-list
56660676|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660677|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660679|NCT02758925|Rituximab|rituximab|mesh-list
56660680|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56160311|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56160312|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160313|NCT03334734|Isoniazid|isoniazid|mesh-list
56160314|NCT03334734|Macozinone|macozinone|mesh-list
56160315|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
56160316|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56160317|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160318|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56160319|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56160320|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
56160321|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160322|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56160323|NCT03336450|Midazolam|midazolam|mesh-list
56160324|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56160325|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56160326|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160327|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160328|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56160329|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56160330|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56160331|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56160332|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
56160333|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
56160334|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
56160335|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
56160336|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072079|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56160337|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160338|NCT03340350|Minocycline|minocycline|mesh-list
56160339|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56160340|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160341|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
56160342|NCT03341910|Tazarotene|tazarotene|mesh-list
56160344|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
56160345|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
56160346|NCT03341910|Vitamins|vitamins|mesh-ancestor
56160347|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
56160348|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160349|NCT03343080|Lidocaine|lidocaine|mesh-list
56160350|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
56160351|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
56160355|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160356|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56160357|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56160358|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56160359|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56160360|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160362|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56160364|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
56160365|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072227|NCT02062801|Ephedrine|ephedrine|mesh-list
56160366|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160367|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56160368|NCT03375294|Analgesics|analgesics|mesh-ancestor
56160369|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
56160370|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160371|NCT03379506|Grazoprevir|grazoprevir|mesh-list
56160372|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
56160373|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160374|NCT03395808|Tramadol|tramadol|mesh-list
56160375|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56160376|NCT03395808|Narcotics|narcotics|mesh-ancestor
56160377|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160378|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160379|NCT03395808|Analgesics|analgesics|mesh-ancestor
56160380|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
56160381|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160382|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
56160383|NCT03395886|Remifentanil|remifentanil|mesh-list
56660681|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56660682|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660683|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
56660684|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160384|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56160385|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160386|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160387|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56160388|NCT03395886|Analgesics|analgesics|mesh-ancestor
56160389|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
56160390|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160391|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56160392|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56160393|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56160394|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160395|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160396|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160397|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56160398|NCT03395886|Narcotics|narcotics|mesh-ancestor
56160399|NCT03426228|Progesterone|progesterone|mesh-list
56160400|NCT03426228|Estrogens|estrogens|mesh-list
56160401|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160402|NCT03426228|Hormones|hormones|mesh-ancestor
56160403|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56160404|NCT03426228|Progestins|progestins|mesh-ancestor
56160405|NCT03430050|Progesterone|progesterone|mesh-list
56160406|NCT03430050|Progestins|progestins|mesh-ancestor
56160407|NCT03430050|Hormones|hormones|mesh-ancestor
56160408|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56160409|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160410|NCT03440424|Lemborexant|lemborexant|mesh-list
56160411|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56160412|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160413|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160414|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56160415|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56160416|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160417|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160419|NCT03448068|Analgesics|analgesics|mesh-ancestor
56160420|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
56160421|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160422|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160425|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
56160427|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160428|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56160429|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56160430|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160431|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160433|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
56160434|NCT03453060|Coagulants|coagulants|mesh-ancestor
56160435|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
56160436|NCT03459612|Promethazine|promethazine|mesh-list
56160438|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56160439|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56160440|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160441|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160442|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
56160443|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
56160444|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
56160445|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160446|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
56160447|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
56160448|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56160449|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56160450|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
56160451|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
56160452|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160453|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160454|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56660685|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660686|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56660687|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
56222213|NCT01667523|Capsaicin|capsaicin|mesh-list
56160455|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
56160456|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160457|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56160458|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
56160459|NCT03463512|Racecadotril|racecadotril|mesh-list
56160460|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
56160461|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56160462|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
56160463|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160464|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160465|NCT03473184|Diacetylrhein|diacetylrhein|mesh-list
56160466|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56160468|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160469|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56160470|NCT03496974|Antibodies|antibodies|mesh-list
56160471|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
56160472|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56160473|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
56160474|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160475|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160476|NCT03503292|Ondansetron|ondansetron|mesh-list
56160477|NCT03503292|Granisetron|granisetron|mesh-list
56160478|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
56160479|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
56160480|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160481|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160482|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56160483|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
56160484|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160485|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56160486|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
56073061|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
56160487|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160488|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160489|NCT03503292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56160490|NCT03503292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56160491|NCT03503292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160492|NCT03503292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56160493|NCT03503292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56160494|NCT03506724|Labetalol|labetalol|mesh-list
56160495|NCT03506724|Nifedipine|nifedipine|mesh-list
56160496|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56160497|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56160498|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160499|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56073505|NCT03216356|Cycloserine|cycloserine|mesh-list
56160501|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
56073599|NCT00357188|Ritonavir|ritonavir|mesh-list
56160502|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
56160503|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56073724|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56073947|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56160504|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56160505|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56160506|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160507|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160508|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56160509|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
56160510|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
56160511|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160512|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56160513|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56160514|NCT03509766|Histamine|histamine|mesh-list
56160515|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
56160516|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
56160517|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074250|NCT00003387|Paclitaxel|paclitaxel|mesh-list
56074314|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074389|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
56160518|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660688|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660689|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
56660690|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660691|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660692|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56660693|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
56660694|NCT00676260|Pioglitazone|pioglitazone|mesh-list
56160519|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160520|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
56160522|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160523|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
56160524|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160525|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
56160526|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
56160527|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
56160528|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160529|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56160530|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56160531|NCT03541356|Carbidopa|carbidopa|mesh-list
56160532|NCT03541356|Levodopa|levodopa|mesh-list
56160533|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56160534|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56160535|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56160536|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
56160537|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074686|NCT00003255|Topotecan|topotecan|mesh-list
56160538|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160539|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074820|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56074894|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56160540|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56160541|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160542|NCT03541980|Acetaminophen|acetaminophen|mesh-list
56160543|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56160544|NCT03541980|Analgesics|analgesics|mesh-ancestor
56160545|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
56160546|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160547|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160548|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
56160549|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
56160550|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56160551|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160553|NCT03572478|Rucaparib|rucaparib|mesh-list
56160554|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56160555|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160556|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56160557|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075781|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56160558|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56075863|NCT04329494|Leucovorin|leucovorin|mesh-list
56160559|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160561|NCT03574818|Necitumumab|necitumumab|mesh-list
56076088|NCT03524339|Tamsulosin|tamsulosin|mesh-list
56076154|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
56160562|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160563|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56160565|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160566|NCT03574818|Antiviral Agents|antiviral agents|mesh-ancestor
56160567|NCT03574818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160569|NCT03574818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56160570|NCT03574818|Immunologic Factors|immunologic factors|mesh-ancestor
56160571|NCT03574818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160572|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56160574|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56160575|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160576|NCT03610464|Amphetamine|amphetamine|mesh-list
56160577|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56160578|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660695|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56660696|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660697|NCT00652652|Furosemide|furosemide|mesh-list
56660698|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56660699|NCT00652652|Diuretics|diuretics|mesh-ancestor
56660700|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
56660701|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660702|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56660703|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56660704|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160579|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
56160580|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
56160581|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160582|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
56160583|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160584|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160585|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160586|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56160587|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56160588|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56160589|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56160591|NCT03615534|Fenofibrate|fenofibrate|mesh-list
56160592|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56160593|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
56160594|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160595|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56160596|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
56160597|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
56076812|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
56076813|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076814|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56076815|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56076816|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56076817|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076818|NCT04474470|Cetuximab|cetuximab|mesh-list
56160598|NCT03615534|Vitamins|vitamins|mesh-ancestor
56160599|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
56077017|NCT05112601|Nivolumab|nivolumab|mesh-list
56176344|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
56160600|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077083|NCT04195698|Upadacitinib|upadacitinib|mesh-list
56077155|NCT03504410|Analgesics|analgesics|mesh-ancestor
56160602|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
56160603|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
56160604|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160605|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160606|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
56160607|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160608|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56077525|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
56160609|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56077618|NCT03140670|Rucaparib|rucaparib|mesh-list
56160610|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56160611|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56160612|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160614|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56160615|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160616|NCT03655080|Paclitaxel|paclitaxel|mesh-list
56160617|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56160618|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56160619|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160620|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
56160621|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
56160622|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
56660705|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
56660706|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56660707|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077961|NCT05648916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56160623|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160625|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56160626|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
56160627|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160629|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56160630|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56160631|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
56160632|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160633|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160634|NCT03704376|Clonidine|clonidine|mesh-list
56160635|NCT03704376|Ropivacaine|ropivacaine|mesh-list
56078257|NCT00361933|Valganciclovir|valganciclovir|mesh-list
56160636|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
56160637|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
56160638|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078412|NCT03822637|Expectorants|expectorants|mesh-ancestor
56160639|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160640|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
56160641|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160643|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55805891|NCT02489903|Taxane|taxane|mesh-list
56160644|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
56160645|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
56160646|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56160647|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56160648|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56078922|NCT00383487|Vitamins|vitamins|mesh-ancestor
56078990|NCT00003297|Analgesics|analgesics|mesh-ancestor
56160649|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160650|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56079139|NCT00003345|Irinotecan|irinotecan|mesh-list
56079150|NCT00002835|Leucovorin|leucovorin|mesh-list
56160651|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160652|NCT03716076|Carbetocin|carbetocin|mesh-list
56160653|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
56160654|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56160655|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160656|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
56160657|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
56160658|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160659|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
56160660|NCT03889158|Vaccines|vaccines|mesh-list
56160661|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
56160662|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160663|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
56160664|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079353|NCT00002865|Vitamins|vitamins|mesh-ancestor
56160665|NCT03889158|Protective Agents|protective agents|mesh-ancestor
56160666|NCT03889158|Vitamins|vitamins|mesh-ancestor
56079430|NCT04342351|Valsartan|valsartan|mesh-list
56160667|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
56160668|NCT04138758|Bromides|bromides|mesh-list
56160669|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
56160670|NCT04138758|Olodaterol|olodaterol|mesh-list
56160671|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56160672|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
56160673|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160674|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160675|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56160676|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
56160677|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
56160678|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56160679|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
56160680|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160681|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160682|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
56160684|NCT04323852|Vitamins|vitamins|mesh-ancestor
56160685|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
56160686|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160687|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56080474|NCT00003711|Irinotecan|irinotecan|mesh-list
56080546|NCT00003723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660708|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56660709|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56660710|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56660711|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660712|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
56660713|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56660714|NCT02644616|Torsemide|torsemide|mesh-list
56660715|NCT02644616|Tolvaptan|tolvaptan|mesh-list
56222236|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160689|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56160690|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
56160691|NCT04420572|Hormones|hormones|mesh-ancestor
56080696|NCT00004323|Methotrexate|methotrexate|mesh-list
56160692|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56160693|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160694|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56160695|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
56160697|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
56160698|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
56160699|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56160700|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
56160701|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56160702|NCT04335552|Azithromycin|azithromycin|mesh-list
56160703|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
56160704|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56160705|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160706|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
56160707|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56160708|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56160709|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160710|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160711|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56160712|NCT04284930|Bupivacaine|bupivacaine|mesh-list
56160714|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
56160715|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160716|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160717|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
56160718|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160719|NCT04267770|Insulin|insulin|mesh-list
56160720|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56160721|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56160722|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160723|NCT04204200|Vitamins|vitamins|mesh-list
56160724|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
56160725|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
56160726|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160727|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
56160728|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160729|NCT04204200|Protective Agents|protective agents|mesh-ancestor
56160730|NCT04179474|Erenumab|erenumab|mesh-list
56160731|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56081281|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
56160732|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160734|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
56160735|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160736|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160737|NCT04175262|Sunitinib|sunitinib|mesh-list
56160738|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160739|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56160740|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56160741|NCT04175262|Growth Substances|growth substances|mesh-ancestor
56160742|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160743|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56160744|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56160745|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160746|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660716|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56660717|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660718|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
56660719|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660720|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56660721|NCT02644616|Diuretics|diuretics|mesh-ancestor
56660722|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56660723|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56660724|NCT02648048|Pirfenidone|pirfenidone|mesh-list
56660725|NCT02648048|Analgesics|analgesics|mesh-ancestor
56660726|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
56660727|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660728|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160747|NCT04150224|Macozinone|macozinone|mesh-list
56160748|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
56160749|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56160750|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160751|NCT04112160|Ketorolac|ketorolac|mesh-list
56160752|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56160753|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56160754|NCT04112160|Analgesics|analgesics|mesh-ancestor
56160755|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
56160756|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160757|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160758|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56160759|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56160760|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56160761|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160762|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160763|NCT04102956|Kallikreins|kallikreins|mesh-list
56160764|NCT04102956|Coagulants|coagulants|mesh-ancestor
56160765|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56160766|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
56160767|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56160768|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160769|NCT04053270|Afamelanotide|afamelanotide|mesh-list
56160770|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160771|NCT03976752|Tenofovir|tenofovir|mesh-list
56160772|NCT03976752|Emtricitabine|emtricitabine|mesh-list
56160775|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56160776|NCT03976752|Elvitegravir|elvitegravir|mesh-list
56160777|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
56160778|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160779|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56160780|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56081454|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
56160781|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160782|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160784|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56081661|NCT01761877|Analgesics|analgesics|mesh-ancestor
56081737|NCT00588523|Temozolomide|temozolomide|mesh-list
56160785|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56160786|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56160788|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
56160789|NCT03962634|Tetracaine|tetracaine|mesh-list
56160790|NCT03962634|Carticaine|carticaine|mesh-list
56160791|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
56160792|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
56160793|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160794|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660729|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56660730|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56660731|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660732|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660733|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660734|NCT00676416|Propofol|propofol|mesh-list
56660735|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56660736|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660737|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160795|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
56160796|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082331|NCT02464657|Prednisolone|prednisolone|mesh-list
56082405|NCT02436668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56160797|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56160798|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56160799|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160800|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160801|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160803|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
56160804|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
56160805|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56160806|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
56082861|NCT05371574|Clonidine|clonidine|mesh-list
56160808|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160809|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
56160810|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160811|NCT03933618|Anastrozole|anastrozole|mesh-list
56160812|NCT03933618|Clomiphene|clomiphene|mesh-list
56160813|NCT03933618|Enclomiphene|enclomiphene|mesh-list
56160814|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
56083214|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56160815|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083361|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
56160816|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56160817|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160818|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56160819|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56160820|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160821|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56160822|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
56160823|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56160824|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160825|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56160826|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
56160827|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56160828|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56160829|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56160831|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
56083564|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56160832|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160833|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56083789|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56160834|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083940|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56160835|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56160836|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
56160837|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160840|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56160841|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
56160842|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56160843|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56160844|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160846|NCT03856164|Coagulants|coagulants|mesh-ancestor
56160847|NCT03849690|Esomeprazole|esomeprazole|mesh-list
56160848|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56660738|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56660739|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
56660741|NCT00651326|Docetaxel|docetaxel|mesh-list
56660742|NCT00651326|Leuprolide|leuprolide|mesh-list
56660743|NCT00651326|Goserelin|goserelin|mesh-list
56660744|NCT00651326|Bicalutamide|bicalutamide|mesh-list
56160849|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56160850|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56160851|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160852|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160853|NCT03822078|Denosumab|denosumab|mesh-list
56084229|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
56160854|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56160855|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160856|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
56160857|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56160858|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55811706|NCT02237157|Gemcitabine|gemcitabine|mesh-list
56160859|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160860|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
56160862|NCT03812328|Enoxaparin|enoxaparin|mesh-list
56160863|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
56160864|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56160865|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56084761|NCT04741165|Lenvatinib|lenvatinib|mesh-list
56160866|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160867|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
56160868|NCT03805386|Narcotics|narcotics|mesh-ancestor
56160869|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084901|NCT04979377|Hormones|hormones|mesh-list
56084973|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
56160870|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160871|NCT03805386|Analgesics|analgesics|mesh-ancestor
56085059|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
55812308|NCT02384395|Lamivudine|lamivudine|mesh-list
56160872|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
56160873|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160875|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56160876|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085425|NCT00367874|Analgesics|analgesics|mesh-ancestor
56085504|NCT02152670|Raclopride|raclopride|mesh-list
56085575|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56160877|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160878|NCT03796182|Metformin|metformin|mesh-list
56160879|NCT03796182|Abrocitinib|abrocitinib|mesh-list
56160880|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56160881|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085730|NCT05587231|Hormones|hormones|mesh-ancestor
56160883|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160884|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160885|NCT03730116|Bisoprolol|bisoprolol|mesh-list
56160886|NCT03730116|Perindopril|perindopril|mesh-list
56160887|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56160888|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
56160889|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
56160890|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160891|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160892|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56160893|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56160894|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56160895|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160896|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160897|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160898|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56160899|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
56160900|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160901|NCT03370536|Ibutilide|ibutilide|mesh-list
56160902|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56160903|NCT03161964|Propranolol|propranolol|mesh-list
56160904|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56160908|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160909|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660745|NCT00651326|Flutamide|flutamide|mesh-list
56660746|NCT00651326|Buserelin|buserelin|mesh-list
56660747|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660748|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56660749|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56660750|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56160911|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56160912|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
56160913|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
56085832|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56085917|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
56160914|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56160915|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56160916|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56086074|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56160917|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56086149|NCT02731820|Vitamin D|vitamin d|mesh-list
56160918|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160920|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160921|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160922|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56160923|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160924|NCT03042780|Folfirinox|folfirinox|mesh-list
56160925|NCT03042780|Lenograstim|lenograstim|mesh-list
56160926|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56160927|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
56176374|NCT01395069|Ketorolac|ketorolac|mesh-list
56160928|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160929|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160931|NCT02985840|Ondansetron|ondansetron|mesh-list
56160932|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56160933|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
56160934|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
56086591|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
56160935|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086739|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160936|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160937|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56160938|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
56160939|NCT02985840|Hormones|hormones|mesh-ancestor
56165384|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160940|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56160941|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56160942|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160943|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
56160944|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
56160945|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56160946|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
56160947|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087032|NCT05449483|Paclitaxel|paclitaxel|mesh-list
56165385|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
56160948|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160950|NCT02985840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56160951|NCT02985840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56087329|NCT04046575|Paclitaxel|paclitaxel|mesh-list
56160953|NCT02985840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56160954|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
56160955|NCT02974686|Everolimus|everolimus|mesh-list
56160956|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160957|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56160958|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
56160959|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160960|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56160961|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56160962|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
56160963|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56160964|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56160965|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160966|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087683|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56087835|NCT02740543|Fluticasone|fluticasone|mesh-list
56160968|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56660751|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660752|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56660753|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
56660754|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56660755|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660756|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56660757|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
56660758|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
56160970|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087997|NCT05032183|Mesna|mesna|mesh-list
56160971|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160972|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56160973|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
56160974|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
56160975|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56088200|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
56160976|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56160978|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56160979|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160980|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160981|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160982|NCT02774148|Acetaminophen|acetaminophen|mesh-list
56160983|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56088568|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56160985|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
56160986|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160987|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160988|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
56160989|NCT02744352|Ropivacaine|ropivacaine|mesh-list
56160990|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
56160992|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160993|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160994|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
56088937|NCT01163383|Iodine|iodine|mesh-list
56160995|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160996|NCT02587650|Ceritinib|ceritinib|mesh-list
56160997|NCT02587650|Entrectinib|entrectinib|mesh-list
56160998|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160999|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56161000|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165386|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161001|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161002|NCT02514252|Fentanyl|fentanyl|mesh-list
56161003|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56161004|NCT02514252|Narcotics|narcotics|mesh-ancestor
56089367|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
56089520|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
56161005|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161006|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161007|NCT02514252|Analgesics|analgesics|mesh-ancestor
56161008|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
56161010|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56161011|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56089898|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
56161012|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
56090125|NCT02832115|Lidocaine|lidocaine|mesh-list
56161014|NCT02434146|Phenylephrine|phenylephrine|mesh-list
56161015|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
56161016|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56161017|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
56161018|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
56161019|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161020|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161021|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
56090411|NCT03121820|Memantine|memantine|mesh-list
56161022|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56161023|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
56161024|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
56660759|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660760|NCT04150536|Lidocaine|lidocaine|mesh-list
56660761|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
56660762|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
56660763|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660764|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161025|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56161026|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56161027|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56161028|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
56090706|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161029|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090777|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
56090852|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56161030|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161031|NCT02434146|Protective Agents|protective agents|mesh-ancestor
56161032|NCT02382588|Ganciclovir|ganciclovir|mesh-list
56161033|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
56161034|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161035|NCT02345460|Leucovorin|leucovorin|mesh-list
56161036|NCT02345460|Fluorouracil|fluorouracil|mesh-list
56161037|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
56161038|NCT02345460|Irinotecan|irinotecan|mesh-list
56161042|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161043|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
56161044|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161045|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56161046|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161047|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56161048|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
56161049|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56161050|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56161051|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161053|NCT02345460|Protective Agents|protective agents|mesh-ancestor
56161054|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
56161055|NCT02345460|Vitamins|vitamins|mesh-ancestor
56161056|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
56161057|NCT02345772|Docetaxel|docetaxel|mesh-list
56161058|NCT02345772|Trastuzumab|trastuzumab|mesh-list
56161059|NCT02345772|Fulvestrant|fulvestrant|mesh-list
56161060|NCT02345772|Pertuzumab|pertuzumab|mesh-list
56161061|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161062|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
56161063|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
56161064|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
56161065|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161066|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56161067|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56091569|NCT05406050|Vitamins|vitamins|mesh-ancestor
56091644|NCT04874545|Propofol|propofol|mesh-list
56161068|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56161069|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56161070|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
56161071|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56091869|NCT03220958|Promethazine|promethazine|mesh-list
56161072|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161074|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56161075|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161076|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
56161077|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
56161078|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
56161079|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161080|NCT02140788|Metformin|metformin|mesh-list
56092308|NCT03383588|Bupivacaine|bupivacaine|mesh-list
56161081|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56161082|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161083|NCT02133534|Atorvastatin|atorvastatin|mesh-list
56161084|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56161085|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56161086|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
56660765|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
56660766|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660767|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56660768|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56660769|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56660770|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56660771|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660772|NCT05167123|Calcium|calcium|mesh-list
56222283|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56161087|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161088|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56161089|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56161090|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161091|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56161092|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56161093|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161094|NCT02015910|Incretins|incretins|mesh-ancestor
56161096|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56092607|NCT00377078|Lactoferrin|lactoferrin|mesh-list
56161097|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56161098|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
56161099|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161100|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161101|NCT01980342|Efavirenz|efavirenz|mesh-list
56161102|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56161103|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56161104|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161105|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161106|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
56161107|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161108|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56161110|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56161111|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56161112|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56161113|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56161114|NCT01881984|Glycerol|glycerol|mesh-list
56161115|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56161116|NCT01881984|Protective Agents|protective agents|mesh-ancestor
56161117|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161118|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
56161119|NCT01878786|Everolimus|everolimus|mesh-list
56161120|NCT01878786|Tacrolimus|tacrolimus|mesh-list
56093042|NCT00377780|Docetaxel|docetaxel|mesh-list
56161121|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56093184|NCT03840278|Pancreatin|pancreatin|mesh-list
56161122|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
56161123|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161124|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56161125|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161126|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161127|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161128|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56093547|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56161129|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56161130|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
56161131|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56161132|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161133|NCT01851174|Gemcitabine|gemcitabine|mesh-list
56161134|NCT01851174|Paclitaxel|paclitaxel|mesh-list
56161135|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56161136|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161137|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
56161138|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
56660773|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56660774|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660775|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56660776|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
56660777|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660778|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
56660779|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56660780|NCT02576314|Ledipasvir|ledipasvir|mesh-list
56660781|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
56660782|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660783|NCT00650234|Metformin|metformin|mesh-list
56660784|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56660785|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660786|NCT00680940|Paclitaxel|paclitaxel|mesh-list
56161139|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
56161140|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161141|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56161142|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
56161143|NCT01851174|Antiviral Agents|antiviral agents|mesh-ancestor
56161144|NCT01851174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161145|NCT01851174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161146|NCT01851174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56161147|NCT01851174|Immunologic Factors|immunologic factors|mesh-ancestor
56161148|NCT01851174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161149|NCT01846182|Pregabalin|pregabalin|mesh-list
56161150|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56161151|NCT01846182|Analgesics|analgesics|mesh-ancestor
56161152|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
56161153|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094122|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56161154|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161155|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
56161156|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56161157|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56165387|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56161158|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161159|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56161160|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56161161|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56094567|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
56161162|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161164|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56094939|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
56161165|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56161166|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161167|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
56161168|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
56161169|NCT01800162|Methotrexate|methotrexate|mesh-list
56161170|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56161171|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
56161172|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56161173|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161174|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56161175|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
56161190|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
56096341|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
56161191|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161192|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56161193|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56161194|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660787|NCT00680940|Cisplatin|cisplatin|mesh-list
56161195|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56161196|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56161197|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56161198|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161199|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
56161200|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161201|NCT01717482|Metformin|metformin|mesh-list
56161202|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56161203|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161204|NCT01702896|Interleukin-2|interleukin-2|mesh-list
56161205|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161206|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56161207|NCT01702896|Analgesics|analgesics|mesh-ancestor
56161208|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
56096698|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096775|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
56161209|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161210|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097072|NCT00002234|Lamivudine|lamivudine|mesh-list
56097216|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097291|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
56097591|NCT05701436|Leucovorin|leucovorin|mesh-list
56161224|NCT01683864|Cisplatin|cisplatin|mesh-list
56161225|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097819|NCT02360059|Metformin|metformin|mesh-list
56161226|NCT01608906|Heparin|heparin|mesh-list
56161227|NCT01608906|Calcium heparin|calcium heparin|mesh-list
56161228|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
56161229|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56161230|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56161231|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161232|NCT01602198|Rivastigmine|rivastigmine|mesh-list
56161233|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55825212|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56161234|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098177|NCT02239627|Analgesics|analgesics|mesh-ancestor
56161235|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161236|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
56161237|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161238|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161239|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56161240|NCT01602198|Protective Agents|protective agents|mesh-ancestor
56176399|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
56161244|NCT01527942|Acetaminophen|acetaminophen|mesh-list
56161245|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56161246|NCT01527942|Analgesics|analgesics|mesh-ancestor
56098398|NCT01402531|Bevacizumab|bevacizumab|mesh-list
56161247|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
56161248|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098466|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098614|NCT00002738|Antidotes|antidotes|mesh-ancestor
56161249|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161250|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
56161251|NCT01507584|Bimatoprost|bimatoprost|mesh-list
56161252|NCT01507584|Brinzolamide|brinzolamide|mesh-list
56161253|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56161254|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56161255|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161256|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161257|NCT01483872|Tigecycline|tigecycline|mesh-list
56161259|NCT01483872|Calcium heparin|calcium heparin|mesh-list
56161260|NCT01483872|Anticoagulants|anticoagulants|mesh-list
56161261|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161263|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56161264|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56161265|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161266|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56161267|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161268|NCT01385280|Exemestane|exemestane|mesh-list
56161269|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56161270|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56161271|NCT01385280|Estradiol|estradiol|mesh-list
56161272|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56161274|NCT01385280|Hormones|hormones|mesh-ancestor
56165389|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56161275|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660788|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56660789|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660790|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
56660791|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
56660792|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
56660793|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161276|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161277|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56161278|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
56161279|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56161280|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56161281|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161282|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56161283|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56161284|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161285|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161286|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56161287|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
56161288|NCT01350258|Fludarabine|fludarabine|mesh-list
56161289|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
56161290|NCT01350258|Melphalan|melphalan|mesh-list
56161291|NCT01350258|Thiotepa|thiotepa|mesh-list
56161293|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56161294|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
56161295|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161296|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56161297|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
56165390|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
56161298|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100092|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
56161299|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56100170|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
56161300|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
56161301|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56161302|NCT01302444|Tadalafil|tadalafil|mesh-list
56161303|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
56161304|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56100325|NCT00000811|Atovaquone|atovaquone|mesh-list
56161305|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56161306|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165391|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165392|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
56161307|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161308|NCT01302444|Urological Agents|urological agents|mesh-ancestor
56161309|NCT01292070|Histamine|histamine|mesh-list
56161311|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
56161312|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161313|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161314|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161315|NCT01284504|Celecoxib|celecoxib|mesh-list
56161316|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56161317|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56161318|NCT01284504|Analgesics|analgesics|mesh-ancestor
56161319|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
56161320|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161321|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100908|NCT00002972|Paclitaxel|paclitaxel|mesh-list
56161322|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56161323|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56100969|NCT00001009|Dextrans|dextrans|mesh-list
56161324|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56161325|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56101200|NCT00002317|Leucovorin|leucovorin|mesh-list
56161326|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161327|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161328|NCT01183416|Tretinoin|tretinoin|mesh-list
56161329|NCT01183416|Isotretinoin|isotretinoin|mesh-list
56161330|NCT01183416|Antibodies|antibodies|mesh-list
56161331|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56660794|NCT03472885|Eculizumab|eculizumab|mesh-list
56660795|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56660796|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56161332|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
56161333|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161334|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161335|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
56161336|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
56161337|NCT01169610|Varenicline|varenicline|mesh-list
56161338|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56161339|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56161340|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
56161341|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161342|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161343|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161345|NCT01166724|Tacrolimus|tacrolimus|mesh-list
56161346|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56161347|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
56161348|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161349|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56161350|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161351|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161352|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56161353|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161354|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56161355|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161356|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
56161357|NCT01151904|Timolol|timolol|mesh-list
56161358|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56161359|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56161360|NCT01151904|Latanoprost|latanoprost|mesh-list
56161361|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56161362|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56161363|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56161364|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
56161365|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161366|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161367|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161368|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56161369|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56161370|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56161371|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56161372|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56161373|NCT01115244|Dapsone|dapsone|mesh-list
56161374|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161375|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
56161376|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56161377|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56161378|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56161379|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161380|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161381|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
56161382|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56161385|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56161386|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161387|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161388|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56161389|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
56161390|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
56161391|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56161392|NCT00986310|Fluoxetine|fluoxetine|mesh-list
56101411|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161393|NCT00986310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56161394|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56101435|NCT00001999|Antibodies|antibodies|mesh-list
56161395|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56161396|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161397|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161398|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
56161399|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101585|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
56165393|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56660797|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
56660798|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660799|NCT02644304|Cabergoline|cabergoline|mesh-list
56660800|NCT02644304|Clomiphene|clomiphene|mesh-list
56660801|NCT02644304|Enclomiphene|enclomiphene|mesh-list
56161400|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56161401|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
56161402|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56161403|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56161404|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56161405|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161406|NCT00907218|Varenicline|varenicline|mesh-list
56102035|NCT00002185|Nelfinavir|nelfinavir|mesh-list
56161407|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56161408|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56161409|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
56161411|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102397|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56161412|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161413|NCT00903396|Palonosetron|palonosetron|mesh-list
56176440|NCT01395420|Avibactam|avibactam|mesh-list
56161415|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
56161416|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102697|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
56161417|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161418|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56102855|NCT05751265|Paclitaxel|paclitaxel|mesh-list
56161419|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56161420|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56161422|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161423|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161425|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56161426|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56161427|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161428|NCT00875394|Incretins|incretins|mesh-ancestor
56161430|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103290|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
56161431|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56161432|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
56161433|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161434|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161435|NCT00832572|Ranolazine|ranolazine|mesh-list
56103517|NCT05664061|Fluticasone|fluticasone|mesh-list
56161436|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56103671|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
56161437|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56103822|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165394|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165395|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56165396|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
56104196|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
56161438|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161439|NCT00811590|Everolimus|everolimus|mesh-list
56161440|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161441|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56161442|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
56161443|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161447|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
56161448|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56161449|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56161450|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56104644|NCT05557591|Cemiplimab|cemiplimab|mesh-list
56161451|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56161452|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161453|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
56161454|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56104871|NCT00004838|Succimer|succimer|mesh-list
56161455|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161456|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56161457|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56660802|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
56660803|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660804|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56660805|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
56161458|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832191|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
56161459|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56161460|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56161461|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
56161463|NCT00738972|Simvastatin|simvastatin|mesh-list
56161464|NCT00738972|Ezetimibe|ezetimibe|mesh-list
56161465|NCT00738972|Pravastatin|pravastatin|mesh-list
56161466|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56161467|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56161468|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
56161469|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161470|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56161471|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56161472|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161473|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56161474|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56161475|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56105988|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
56161477|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56161478|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161479|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
56161480|NCT00704496|Ephedrine|ephedrine|mesh-list
56161481|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55833465|NCT02110706|Rituximab|rituximab|mesh-list
56161483|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161484|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106587|NCT00385970|Vitamins|vitamins|mesh-ancestor
56106666|NCT04568876|Palmidrol|palmidrol|mesh-list
56106733|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
56161485|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56161486|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
56161487|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
56161488|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56161489|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56161490|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
56161491|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
56161492|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161493|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161495|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
56161496|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106887|NCT04173403|Ezetimibe|ezetimibe|mesh-list
56161497|NCT00692094|Protective Agents|protective agents|mesh-ancestor
56107036|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
56107186|NCT00002941|Etoposide|etoposide|mesh-list
56161498|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161499|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161502|NCT00676026|Progesterone|progesterone|mesh-list
56107345|NCT00002989|Melphalan|melphalan|mesh-list
56161503|NCT00676026|Progestins|progestins|mesh-ancestor
56161504|NCT00676026|Hormones|hormones|mesh-ancestor
56161505|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56161506|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161507|NCT00676026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56161508|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56161509|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56161510|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161513|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56161515|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56161516|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56161517|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56161518|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161519|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56161520|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56161521|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161522|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56108081|NCT00002881|Leuprolide|leuprolide|mesh-list
56660806|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56660807|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660808|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56660809|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
56660810|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56161524|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
56161525|NCT00656916|Fluticasone|fluticasone|mesh-list
56161526|NCT00656916|Xhance|xhance|mesh-list
56161527|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56161528|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56161529|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
56161530|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161531|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161532|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56161533|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
56161534|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
56161535|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56161536|NCT00619242|Sorafenib|sorafenib|mesh-list
56161537|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161538|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56161539|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108827|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
56161540|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161541|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56161542|NCT00601848|Trioxsalen|trioxsalen|mesh-list
56161543|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161544|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
56161545|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56161546|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
56161547|NCT00586716|Antibodies|antibodies|mesh-list
56161548|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
56161549|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56109360|NCT00003925|Vitamins|vitamins|mesh-ancestor
56161551|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
56109422|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56161552|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161553|NCT00571194|Pravastatin|pravastatin|mesh-list
56161554|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56109574|NCT00004885|Antidotes|antidotes|mesh-ancestor
56161555|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56161556|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
56109802|NCT00005017|Ritonavir|ritonavir|mesh-list
56176473|NCT01395602|Cabergoline|cabergoline|mesh-list
56161557|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161558|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56161559|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56161560|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161561|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56161562|NCT00570258|Fulvestrant|fulvestrant|mesh-list
56161563|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161564|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56161566|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161567|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56161568|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56161569|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56161570|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
56161571|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56161572|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110846|NCT02070744|Ivacaftor|ivacaftor|mesh-list
56161574|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161575|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
56161576|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110986|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
56165397|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56161577|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161579|NCT00577356|Docetaxel|docetaxel|mesh-list
56161580|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111429|NCT02034552|Prednisone|prednisone|mesh-list
56161581|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
56161582|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
56660811|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56660812|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56660813|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56306943|NCT00044668|Incretins|incretins|mesh-ancestor
56660814|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56660815|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
56660816|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
56660817|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56660818|NCT04703075|Rifapentine|rifapentine|mesh-list
56660819|NCT04703075|Rifampin|rifampin|mesh-list
56660820|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56660821|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
56660822|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56660823|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161583|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165399|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
56161584|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111723|NCT01990560|Mifepristone|mifepristone|mesh-list
56161586|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161587|NCT05599230|Ivacaftor|ivacaftor|mesh-list
56161588|NCT05599230|Elexacaftor|elexacaftor|mesh-list
56161589|NCT05599230|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56161590|NCT05599230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56161591|NCT05599230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161592|NCT05524584|Fulvestrant|fulvestrant|mesh-list
56161593|NCT05524584|Anastrozole|anastrozole|mesh-list
56161594|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56161595|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161596|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56161597|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56161598|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
56161599|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56161600|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161601|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56161602|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56161603|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161604|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161605|NCT05403762|Protective Agents|protective agents|mesh-list
56112528|NCT03855059|Dexamethasone|dexamethasone|mesh-list
56161606|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161608|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56161609|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161610|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56161611|NCT05001048|Phenylephrine|phenylephrine|mesh-list
56161612|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
56161613|NCT05001048|Synephrine|synephrine|mesh-list
56161614|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56161615|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
56161616|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
56161617|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161618|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161619|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
56161620|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56112883|NCT03792191|Narcotics|narcotics|mesh-ancestor
56161621|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
56161622|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
56161623|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56161624|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56161625|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56161626|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56161627|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113249|NCT00608465|Eplerenone|eplerenone|mesh-list
56660824|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
56660825|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56660826|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660827|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660828|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56660829|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56660830|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56660831|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56660832|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56660833|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56660834|NCT04302025|Atezolizumab|atezolizumab|mesh-list
56660835|NCT04302025|Vemurafenib|vemurafenib|mesh-list
56660836|NCT04302025|Pralsetinib|pralsetinib|mesh-list
56660837|NCT04302025|Entrectinib|entrectinib|mesh-list
56660838|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660839|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56113329|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
56113401|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113554|NCT00281879|Cytarabine|cytarabine|mesh-list
56161628|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161629|NCT05001048|Protective Agents|protective agents|mesh-ancestor
56161630|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56161631|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
56161632|NCT04954638|Eusol|eusol|mesh-list
56161633|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
56161634|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161635|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
56161636|NCT04810572|Silymarin|silymarin|mesh-list
56161637|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
56114092|NCT03055247|Ibuprofen|ibuprofen|mesh-list
56161638|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161639|NCT04810572|Protective Agents|protective agents|mesh-ancestor
56161640|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161641|NCT04575090|Simvastatin|simvastatin|mesh-list
56161642|NCT04575090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56161643|NCT04575090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56161644|NCT04575090|Antimetabolites|antimetabolites|mesh-ancestor
56161650|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
56161651|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161652|NCT04043520|Estradiol|estradiol|mesh-list
56161653|NCT04043520|Estrogens|estrogens|mesh-list
56114663|NCT00000659|Zidovudine|zidovudine|mesh-list
56161654|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56161655|NCT04043520|Hormones|hormones|mesh-ancestor
56161656|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56161657|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161659|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56161660|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
56161661|NCT03472872|Acetaminophen|acetaminophen|mesh-list
56161662|NCT03472872|Ketorolac|ketorolac|mesh-list
56161663|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56115326|NCT00002471|Cytarabine|cytarabine|mesh-list
56161664|NCT03472872|Analgesics|analgesics|mesh-ancestor
56161665|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
56161666|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161667|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161668|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
56115502|NCT00002171|Nelfinavir|nelfinavir|mesh-list
56161669|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56161670|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56161671|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660840|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660841|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161672|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56161673|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161674|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161675|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56161676|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
56161677|NCT03461406|Coagulants|coagulants|mesh-ancestor
56161678|NCT03301038|Rifampin|rifampin|mesh-list
56115855|NCT00002567|Etoposide|etoposide|mesh-list
56161679|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56161680|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
56115992|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
56161681|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56161682|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161683|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
56116145|NCT05750459|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56161684|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56161685|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161686|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161687|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56161688|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56161689|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56161690|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56161691|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56161692|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56161694|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56161695|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
56161696|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161697|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161698|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161699|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56161700|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56161701|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161702|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56116440|NCT05545319|Ritonavir|ritonavir|mesh-list
56161704|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
56116657|NCT05015621|Irinotecan|irinotecan|mesh-list
56117035|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161706|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161707|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56117256|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
56165400|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56161709|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161710|NCT00558870|Morphine|morphine|mesh-list
56161711|NCT00558870|Methadone|methadone|mesh-list
56161713|NCT00558870|Narcotics|narcotics|mesh-ancestor
56161714|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161715|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161717|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
56161718|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161719|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
56161720|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
56161721|NCT00548886|Epinephrine|epinephrine|mesh-list
56161722|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56161723|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56161724|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56161725|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161726|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161727|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161729|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56161730|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
56161731|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161732|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56161733|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
56161734|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
56161735|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
56161736|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56161738|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161739|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56161740|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928581|NCT03221400|Protective Agents|protective agents|mesh-ancestor
56660842|NCT00681174|Acetaminophen|acetaminophen|mesh-list
56660843|NCT00681174|Morphine|morphine|mesh-list
56660844|NCT00681174|Remifentanil|remifentanil|mesh-list
56660845|NCT00681174|Oxycodone|oxycodone|mesh-list
56161741|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161742|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
56161743|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161744|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56161745|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161746|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161747|NCT00506064|Melatonin|melatonin|mesh-list
56161748|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
56161749|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161750|NCT00506064|Protective Agents|protective agents|mesh-ancestor
56161751|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161752|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161753|NCT00503880|Cytarabine|cytarabine|mesh-list
56161754|NCT00503880|Clofarabine|clofarabine|mesh-list
56118130|NCT00003215|Analgesics|analgesics|mesh-ancestor
56161755|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118205|NCT00003605|Rituximab|rituximab|mesh-list
56161756|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
56165401|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161757|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161758|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161759|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
56161760|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161762|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
56161763|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161764|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
56161765|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161766|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56161767|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56161768|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
56161769|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161770|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56161771|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161772|NCT00145704|Vitamin D|vitamin d|mesh-list
56161773|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
56161774|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
56161775|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
56161776|NCT00145704|Diphosphonates|diphosphonates|mesh-list
56161777|NCT00145704|Vitamins|vitamins|mesh-list
56161778|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
56161779|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119320|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
56161780|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56161781|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56119615|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56161784|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161785|NCT00108342|Nicotine|nicotine|mesh-list
56161786|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56119836|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
56161789|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161790|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56161791|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56161792|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
56089442|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
56161793|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161794|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161795|NCT00090870|Interferons|interferons|mesh-list
56161796|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
56161797|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
56161798|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56161799|NCT00090870|Thalidomide|thalidomide|mesh-list
56161800|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161801|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
56161802|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161803|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
56161804|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161805|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56161806|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
56161807|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56161808|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55928582|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
56660846|NCT00681174|Propofol|propofol|mesh-list
56660847|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56660848|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660849|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161809|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56161810|NCT00090870|Growth Substances|growth substances|mesh-ancestor
56161811|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
56161813|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56161814|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
56161815|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
56161816|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161817|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161818|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56161819|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56161820|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56161821|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
56161822|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161823|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120256|NCT01907100|Cisplatin|cisplatin|mesh-list
56161824|NCT00074724|Protective Agents|protective agents|mesh-ancestor
56161826|NCT00058188|Vitamin D|vitamin d|mesh-list
56161827|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
56161828|NCT00058188|Calcium|calcium|mesh-list
56161829|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56161830|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161832|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
56161833|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56161834|NCT00003726|Lepirudin|lepirudin|mesh-list
56161835|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
56161836|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56161837|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
56161838|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120913|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
56161839|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161840|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
56161842|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56161843|NCT02595996|Propranolol|propranolol|mesh-list
56161844|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56161846|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56121353|NCT01769508|Lapatinib|lapatinib|mesh-list
56161847|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161848|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161849|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161850|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56161851|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56161852|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
56161853|NCT04422210|Carboplatin|carboplatin|mesh-list
56161855|NCT04422210|Atezolizumab|atezolizumab|mesh-list
56161856|NCT04422210|Venetoclax|venetoclax|mesh-list
56161857|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161862|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161864|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56161865|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
56161866|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
56161867|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161868|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161869|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56161870|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56161871|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56161872|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
56161873|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161874|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161876|NCT00000138|Prednisolone|prednisolone|mesh-list
56161877|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56161878|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
56161879|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56161880|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
56161881|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56161882|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
56122147|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
56161883|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56161884|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
56660850|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56660851|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
56660852|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
56660853|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56660854|NCT00681174|Narcotics|narcotics|mesh-ancestor
56660855|NCT00681174|Analgesics|analgesics|mesh-ancestor
56660856|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
56660857|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660858|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56660859|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
56660860|NCT02758769|Abatacept|abatacept|mesh-list
56660861|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56161886|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56161887|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161888|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56161889|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161891|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
56122514|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56161892|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122587|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161893|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56161894|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56161895|NCT00000138|Protective Agents|protective agents|mesh-ancestor
56161896|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
56161897|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161898|NCT00000174|Rivastigmine|rivastigmine|mesh-list
56161899|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56161900|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161901|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161902|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
56161903|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161904|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123024|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56161905|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56161906|NCT00000174|Protective Agents|protective agents|mesh-ancestor
56161907|NCT00000192|Lamotrigine|lamotrigine|mesh-list
56161908|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
56161909|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56123241|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56161910|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56161911|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123461|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
56161912|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56161913|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161914|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56161915|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56161916|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161917|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56161918|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56161919|NCT00000198|Piracetam|piracetam|mesh-list
56161920|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56161921|NCT00000198|Protective Agents|protective agents|mesh-ancestor
56161924|NCT00000204|Buprenorphine|buprenorphine|mesh-list
56161925|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56161926|NCT00000204|Narcotics|narcotics|mesh-ancestor
56161927|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161928|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161929|NCT00000204|Analgesics|analgesics|mesh-ancestor
56161930|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
56161931|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161934|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56161935|NCT00000210|Narcotics|narcotics|mesh-ancestor
56123886|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56161936|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660862|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660863|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660864|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660865|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
56660866|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660867|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660868|NCT04150146|Rebamipide|rebamipide|mesh-list
56660869|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56660870|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56660871|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
56161937|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161938|NCT00000210|Analgesics|analgesics|mesh-ancestor
56124040|NCT01449630|Celecoxib|celecoxib|mesh-list
56161939|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
56161940|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161941|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56161942|NCT00000222|Buprenorphine|buprenorphine|mesh-list
56161943|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56161944|NCT00000222|Narcotics|narcotics|mesh-ancestor
56161945|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161946|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161947|NCT00000222|Analgesics|analgesics|mesh-ancestor
56161948|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
56161949|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161950|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56161951|NCT00000228|Buprenorphine|buprenorphine|mesh-list
56161952|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56161953|NCT00000228|Narcotics|narcotics|mesh-ancestor
56124181|NCT01445886|Vitamins|vitamins|mesh-ancestor
56124244|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
56161954|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161955|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161957|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
56161958|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161959|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56161960|NCT00000234|Buprenorphine|buprenorphine|mesh-list
56161961|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56161962|NCT00000234|Narcotics|narcotics|mesh-ancestor
56161963|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161964|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161965|NCT00000234|Analgesics|analgesics|mesh-ancestor
56161966|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
56161967|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161968|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56161969|NCT00000240|Buprenorphine|buprenorphine|mesh-list
56161970|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56161971|NCT00000240|Narcotics|narcotics|mesh-ancestor
56161972|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161973|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161974|NCT00000240|Analgesics|analgesics|mesh-ancestor
56161975|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
56161976|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56161977|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56161978|NCT00000246|Flumazenil|flumazenil|mesh-list
56161979|NCT00000246|Antidotes|antidotes|mesh-ancestor
56161980|NCT00000246|Protective Agents|protective agents|mesh-ancestor
56161981|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161982|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
56161983|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
56161984|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161985|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161986|NCT00000264|Ethanol|ethanol|mesh-list
56161987|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
56161988|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56161989|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56161990|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56161991|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660872|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660873|NCT04150146|Protective Agents|protective agents|mesh-ancestor
56660874|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660875|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660876|NCT00652730|Buspirone|buspirone|mesh-list
56660877|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56660878|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56660879|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660880|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660881|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56660882|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56660883|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
56660884|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56161992|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56161993|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
56161994|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
56161995|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56161996|NCT00000264|Analgesics|analgesics|mesh-ancestor
56161998|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162000|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
56162001|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
56162002|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56162003|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162004|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
56162005|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162006|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56162007|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56162008|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56162009|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162010|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162011|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
56162012|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162013|NCT00000276|Bupropion|bupropion|mesh-list
56162014|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56162015|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
56162016|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56162017|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56162018|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56162019|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162020|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162021|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
56162022|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162023|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162024|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56162025|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162026|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162027|NCT00000282|Pemoline|pemoline|mesh-list
56162028|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56162029|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162030|NCT00000294|Carvedilol|carvedilol|mesh-list
56162031|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56162032|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56162033|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
56162034|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162035|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162036|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162037|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56162039|NCT00000294|Protective Agents|protective agents|mesh-ancestor
56162040|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56660885|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660886|NCT00652808|Naproxen|naproxen|mesh-list
56660887|NCT00652808|Valdecoxib|valdecoxib|mesh-list
56222387|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56162041|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162042|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56162043|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
56162044|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56162045|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56162046|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
56162047|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56162048|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162049|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56162050|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56162051|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162052|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162053|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
56162054|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162055|NCT00000318|Buprenorphine|buprenorphine|mesh-list
56162056|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56162057|NCT00000318|Narcotics|narcotics|mesh-ancestor
56162058|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56162059|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162060|NCT00000318|Analgesics|analgesics|mesh-ancestor
56162061|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
56162062|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162063|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56162064|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
56162065|NCT00000330|Narcotics|narcotics|mesh-ancestor
56162066|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56162067|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162068|NCT00000330|Analgesics|analgesics|mesh-ancestor
56162069|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
56162070|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162071|NCT00000336|Selegiline|selegiline|mesh-list
56162072|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
56162073|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56162074|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56162075|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56162076|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56162077|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162078|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162079|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56162080|NCT00000336|Protective Agents|protective agents|mesh-ancestor
56162081|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162082|NCT00000342|Risperidone|risperidone|mesh-list
56162083|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56162084|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
56162085|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162086|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162087|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162088|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56162089|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56162090|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56162091|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56162092|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56162093|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
56089749|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56162095|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
56162096|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
56162097|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162098|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162099|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162100|NCT00000354|Lofexidine|lofexidine|mesh-list
56162101|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56162102|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56162103|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162104|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
56162105|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660888|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56660889|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56660890|NCT00652808|Analgesics|analgesics|mesh-ancestor
56660891|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
56660892|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660893|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660894|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56660895|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660896|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
56660897|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56660898|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660899|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660900|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56162106|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56162107|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56162108|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56162110|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162111|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162112|NCT00000372|Cycloserine|cycloserine|mesh-list
56162113|NCT00000372|Clozapine|clozapine|mesh-list
56162114|NCT00000372|Glycine|glycine|mesh-list
56162115|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56162116|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162117|NCT00000372|Renal Agents|renal agents|mesh-ancestor
56162118|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56162119|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
56162120|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162121|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
56162122|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162123|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56162124|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
56162125|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162126|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162127|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56162128|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56162129|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56162130|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56162131|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
56162132|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
56162133|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
56162134|NCT00000384|Sertraline|sertraline|mesh-list
56162135|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
56162136|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56162137|NCT00000384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56162138|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56162139|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162140|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162141|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162143|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162144|NCT00000390|Imipramine|imipramine|mesh-list
56162146|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
56162148|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56162149|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56162150|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162151|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162152|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
56162153|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162154|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162155|NCT00000402|Calcium|calcium|mesh-list
55928583|NCT03221400|Vitamins|vitamins|mesh-ancestor
56660901|NCT00635531|Alprazolam|alprazolam|mesh-list
56660902|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56660903|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660904|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660905|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56660906|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56660907|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56660908|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
56660909|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
56660910|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56660911|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660912|NCT02535156|Risperidone|risperidone|mesh-list
56660913|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56660914|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
56660915|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56660916|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660917|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660918|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56660919|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56660920|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660921|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56660922|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56660923|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
56660924|NCT03417895|Apatinib|apatinib|mesh-list
56660925|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660926|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56660927|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660928|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660929|NCT05299164|Gemcitabine|gemcitabine|mesh-list
56660930|NCT05299164|Rituximab|rituximab|mesh-list
56660931|NCT05299164|Vinorelbine|vinorelbine|mesh-list
56660932|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
56660933|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56660934|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660935|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
56660936|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222404|NCT01668901|Aspirin|aspirin|mesh-list
56162156|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56660937|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56660938|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56660939|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
56660940|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660941|NCT05299164|Antiviral Agents|antiviral agents|mesh-ancestor
56660942|NCT05299164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660943|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660944|NCT05299164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660945|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56660946|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
56660947|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
56660948|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
56660949|NCT05299164|Analgesics|analgesics|mesh-ancestor
56660950|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
56162157|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162158|NCT00000438|Naltrexone|naltrexone|mesh-list
56162159|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56162160|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56162161|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162162|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
56162163|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162164|NCT00000444|Nicotine|nicotine|mesh-list
56162165|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56162166|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
56162167|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162168|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162169|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56162170|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56162171|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
56162172|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162173|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162174|NCT00000450|Naltrexone|naltrexone|mesh-list
56162175|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56162176|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56162177|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162178|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
56162179|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162180|NCT00000510|Aspirin|aspirin|mesh-list
56162181|NCT00000510|Dipyridamole|dipyridamole|mesh-list
56162182|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56162183|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56162184|NCT00000510|Analgesics|analgesics|mesh-ancestor
56162185|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
56162186|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162187|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162188|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56162189|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56162190|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56162191|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56162192|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162193|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56162194|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56162195|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162196|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
56162197|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56162198|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
56162199|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56162200|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
56162201|NCT00000600|Vitamins|vitamins|mesh-list
56162202|NCT00000600|Vitamin E|vitamin e|mesh-list
56162203|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
56162204|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660951|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660952|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56660953|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56660954|NCT01563835|Fentanyl|fentanyl|mesh-list
56660955|NCT01563835|Bupivacaine|bupivacaine|mesh-list
56660956|NCT01563835|Citric Acid|citric acid|mesh-list
56660957|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
56660958|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
56660959|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
56660960|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56660961|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660962|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
56660963|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56660964|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56660965|NCT01563835|Narcotics|narcotics|mesh-ancestor
56660966|NCT01563835|Analgesics|analgesics|mesh-ancestor
56162205|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
56162206|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162207|NCT00000600|Protective Agents|protective agents|mesh-ancestor
56162208|NCT00000636|Pyridoxine|pyridoxine|mesh-list
56162209|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
56162210|NCT00000636|Rifampin|rifampin|mesh-list
56162211|NCT00000636|Isoniazid|isoniazid|mesh-list
56162212|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
56162213|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56162214|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
56162215|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162216|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162217|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
56162218|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162223|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56162224|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56162225|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56162226|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56162227|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56162228|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56162229|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
56162230|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56162231|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
56162232|NCT00000636|Vitamins|vitamins|mesh-ancestor
56162233|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
56162234|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162235|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
56162236|NCT00000648|Penicillins|penicillins|mesh-list
56162237|NCT00000648|Penicillin G|penicillin g|mesh-list
56162238|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56162239|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
56162240|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162241|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162242|NCT00000654|Fialuridine|fialuridine|mesh-list
56162243|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
56162244|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162245|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162246|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162247|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162248|NCT00000660|Etoposide|etoposide|mesh-list
56162249|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56162250|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162251|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56162252|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56162253|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162254|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307171|NCT00045799|Omeprazole|omeprazole|mesh-list
56660967|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56660968|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56660969|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
56660970|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
56162255|NCT00000702|Zidovudine|zidovudine|mesh-list
56162256|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
56162257|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162258|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162259|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162260|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162261|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
56162262|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162263|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162264|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162265|NCT00000714|Leucovorin|leucovorin|mesh-list
56162266|NCT00000714|Trimetrexate|trimetrexate|mesh-list
56162267|NCT00000714|Calcium|calcium|mesh-list
56162268|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
56162269|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56162270|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162271|NCT00000714|Antidotes|antidotes|mesh-ancestor
56162272|NCT00000714|Protective Agents|protective agents|mesh-ancestor
56162273|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
56162274|NCT00000714|Vitamins|vitamins|mesh-ancestor
56162275|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
56162276|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
56162277|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162278|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56162279|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
56162280|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162281|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162282|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56162283|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162284|NCT00000732|Zidovudine|zidovudine|mesh-list
56162285|NCT00000732|Trimethoprim|trimethoprim|mesh-list
56162286|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
56162287|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56162288|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
56162289|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162291|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162293|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
56162294|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162295|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162296|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162297|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56162298|NCT00000732|Renal Agents|renal agents|mesh-ancestor
56162299|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
56162300|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56162301|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56162302|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56162303|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56162304|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56162305|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162306|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162307|NCT00000738|Zidovudine|zidovudine|mesh-list
56162308|NCT00000738|Nimodipine|nimodipine|mesh-list
56162309|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
56162310|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162311|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162312|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162313|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162314|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
56162315|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162316|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162317|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162318|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56089974|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
56162319|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56162320|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162321|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56162322|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660971|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56660972|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
56660973|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
56660974|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162323|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
56162324|NCT00000750|Zidovudine|zidovudine|mesh-list
56162325|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
56162326|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162327|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162328|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162329|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162330|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
56162331|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162332|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162333|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162334|NCT00000804|Indinavir|indinavir|mesh-list
56162335|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56162336|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56162337|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
56162338|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162339|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162340|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162341|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162342|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
56162343|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162346|NCT00000810|Delavirdine|delavirdine|mesh-list
56162347|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
56162348|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162349|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162350|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162351|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162352|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
56162353|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162354|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162355|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162356|NCT00000834|Lamivudine|lamivudine|mesh-list
56162357|NCT00000834|Zidovudine|zidovudine|mesh-list
56162358|NCT00000834|Methotrexate|methotrexate|mesh-list
56162359|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56162360|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
56162361|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56162362|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162363|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56162364|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
56162370|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56162371|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
56162372|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56162373|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162374|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162375|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
56162376|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162377|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162378|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162379|NCT00000864|Zidovudine|zidovudine|mesh-list
56162380|NCT00000864|Abacavir|abacavir|mesh-list
56162381|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
56162382|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162383|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162384|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162385|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162386|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
56162387|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162388|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162389|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162390|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
56162391|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
56162392|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162393|NCT00000894|Ganciclovir|ganciclovir|mesh-list
56162394|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56162395|NCT00000894|Cidofovir|cidofovir|mesh-list
56162396|NCT00000894|Probenecid|probenecid|mesh-list
56162397|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
56162398|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56660975|NCT02768207|Vemurafenib|vemurafenib|mesh-list
56660976|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660977|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56660978|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660979|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56660980|NCT02653196|Cyclosporine|cyclosporine|mesh-list
56660981|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
56660982|NCT02653196|Fludarabine|fludarabine|mesh-list
56660983|NCT02653196|Etoposide|etoposide|mesh-list
56660984|NCT02653196|Melphalan|melphalan|mesh-list
56660985|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
56660986|NCT02653196|Thiotepa|thiotepa|mesh-list
56660987|NCT02653196|Tacrolimus|tacrolimus|mesh-list
56660988|NCT02653196|Cyclosporins|cyclosporins|mesh-list
56660989|NCT02653196|Mitogens|mitogens|mesh-list
56660990|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56660991|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162399|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162400|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162401|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162402|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
56162403|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
56162404|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56162405|NCT00000894|Renal Agents|renal agents|mesh-ancestor
56162406|NCT00000912|Efavirenz|efavirenz|mesh-list
56162407|NCT00000912|Abacavir|abacavir|mesh-list
56162408|NCT00000912|Adefovir|adefovir|mesh-list
56162409|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56162410|NCT00000912|Nelfinavir|nelfinavir|mesh-list
56162411|NCT00000912|Indinavir|indinavir|mesh-list
56162412|NCT00000912|Saquinavir|saquinavir|mesh-list
56162413|NCT00000912|Amprenavir|amprenavir|mesh-list
56162414|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162415|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162416|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162417|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162418|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
56162419|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162420|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56162421|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162422|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56162423|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56162424|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56162425|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56162426|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162427|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162428|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56162429|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56162430|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
56162431|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56162432|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56162433|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
56162434|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162435|NCT00000918|Ritonavir|ritonavir|mesh-list
56162436|NCT00000918|Indinavir|indinavir|mesh-list
56162442|NCT00000918|Stavudine|stavudine|mesh-list
56162443|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56162444|NCT00000918|Efavirenz|efavirenz|mesh-list
56162445|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56162446|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56162447|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
56162448|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928584|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
56660992|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56660993|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
56660994|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56660995|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56660996|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56660997|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56162449|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162450|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162451|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162452|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
56162453|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162454|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56162455|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162456|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162457|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162458|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
56162459|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56162460|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56162461|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56162462|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56162463|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56162464|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56162465|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
56162466|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162467|NCT00000924|Ritonavir|ritonavir|mesh-list
56162468|NCT00000924|Nelfinavir|nelfinavir|mesh-list
56162469|NCT00000924|Nevirapine|nevirapine|mesh-list
56162470|NCT00000924|Didanosine|didanosine|mesh-list
56162471|NCT00000924|Stavudine|stavudine|mesh-list
56162472|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56162473|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56162474|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
56162475|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162476|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162477|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162478|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162479|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
56162480|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162481|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56162482|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162483|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162484|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162485|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56162486|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56162487|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
56162488|NCT00000936|Cyclosporine|cyclosporine|mesh-list
56162490|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162491|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162492|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56162493|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
56162494|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162495|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
56162496|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162497|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
56162498|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56162499|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56162500|NCT00000942|Nevirapine|nevirapine|mesh-list
56162501|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162502|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162503|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162504|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162505|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
56162506|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162507|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162508|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162509|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56162511|NCT00000948|Aldesleukin|aldesleukin|mesh-list
56660998|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56660999|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56661000|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
56661001|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661002|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
56661003|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661004|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56222492|NCT01669226|Taxane|taxane|mesh-list
56162512|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162513|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162514|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162515|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
56162516|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162517|NCT00000954|Didanosine|didanosine|mesh-list
56162518|NCT00000954|Zalcitabine|zalcitabine|mesh-list
56162519|NCT00000954|Doxorubicin|doxorubicin|mesh-list
56162520|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56162521|NCT00000954|Bleomycin|bleomycin|mesh-list
56162522|NCT00000954|Vincristine|vincristine|mesh-list
56162523|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56162524|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162525|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56162526|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56162527|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162528|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162529|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56162530|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
56162531|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
56162532|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
56162533|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
56162534|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162535|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162536|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
56162537|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162538|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162539|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162540|NCT00000960|Zidovudine|zidovudine|mesh-list
56162541|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
56162542|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162543|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162544|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162545|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162546|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
56162547|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162548|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56090202|NCT00374881|Cathartics|cathartics|mesh-ancestor
56162549|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162550|NCT00000990|Zidovudine|zidovudine|mesh-list
56162551|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
56162552|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162553|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162554|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162555|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162556|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
56162557|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162558|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162559|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162560|NCT00000996|Doxorubicin|doxorubicin|mesh-list
56162561|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56162562|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56162563|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162564|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56176688|NCT01396707|Capecitabine|capecitabine|mesh-list
56162565|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56162567|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162568|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56162569|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56162570|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
56162571|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162572|NCT00001044|Antacids|antacids|mesh-ancestor
56661005|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56661006|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
56162573|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162574|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56162575|NCT00001062|Ganciclovir|ganciclovir|mesh-list
56162576|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56162577|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
56162578|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162579|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162580|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162581|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162582|NCT00001068|Lamivudine|lamivudine|mesh-list
56162583|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162586|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162588|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162589|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162590|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162591|NCT00001080|Lamivudine|lamivudine|mesh-list
56162592|NCT00001080|Vaccines|vaccines|mesh-list
56162593|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56162594|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
56162595|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162596|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162597|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162598|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162599|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162600|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
56162601|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162602|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162603|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162604|NCT00001104|Zidovudine|zidovudine|mesh-list
56162605|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
56162606|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162607|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162608|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162609|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162610|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
56162611|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162612|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162613|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162614|NCT00001110|Dimercaprol|dimercaprol|mesh-list
56162615|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
56162616|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
56162617|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162618|NCT00001122|Efavirenz|efavirenz|mesh-list
56162619|NCT00001122|Didanosine|didanosine|mesh-list
56162620|NCT00001122|Stavudine|stavudine|mesh-list
56162621|NCT00001122|Nelfinavir|nelfinavir|mesh-list
56162622|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162623|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162624|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162625|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162627|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162628|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56162629|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162630|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56162631|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56162632|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56162633|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56162634|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56162635|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56162636|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
56162637|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162638|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162639|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
56162640|NCT00001128|Azithromycin|azithromycin|mesh-list
56162641|NCT00001128|Paromomycin|paromomycin|mesh-list
56162642|NCT00001128|Interleukin-12|interleukin-12|mesh-list
56162643|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162644|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162645|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56661007|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661008|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56162646|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
56162647|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162648|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56162649|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56162650|NCT00001128|Growth Substances|growth substances|mesh-ancestor
56162651|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
56162652|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162653|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56162654|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56162655|NCT00001296|Interferons|interferons|mesh-list
56162656|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
56162657|NCT00001296|Melphalan|melphalan|mesh-list
56162659|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
56162660|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162661|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56162662|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
56162663|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162664|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56162665|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56162666|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
56162667|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162668|NCT00001422|Fludarabine|fludarabine|mesh-list
56162669|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162670|NCT00001428|Fluorouracil|fluorouracil|mesh-list
56162671|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
56162672|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162673|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56162674|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162675|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56162676|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
56162677|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162678|NCT00001440|Interleukin-2|interleukin-2|mesh-list
56162679|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162680|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56162681|NCT00001440|Analgesics|analgesics|mesh-ancestor
56162682|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
56162683|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162684|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162685|NCT00001446|Thalidomide|thalidomide|mesh-list
56162686|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56162687|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
56162688|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162689|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
56162690|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162691|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162692|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56162693|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56162694|NCT00001446|Growth Substances|growth substances|mesh-ancestor
56162695|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
56162696|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162697|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
56162698|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56162699|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
56162700|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162701|NCT00001626|Cyclosporine|cyclosporine|mesh-list
56162703|NCT00001626|Cyclosporins|cyclosporins|mesh-list
56162704|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56162705|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56162706|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
56162707|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162708|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56162709|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56162710|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
56162711|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162712|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162713|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56162714|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162715|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
56162716|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162717|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
56162718|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56162719|NCT00001680|Thalidomide|thalidomide|mesh-list
56661009|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
56661010|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56661011|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
56661012|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56661013|NCT05135845|Spartalizumab|spartalizumab|mesh-list
56661014|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56661015|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661016|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661017|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
56661018|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56661019|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661020|NCT00677118|Cisplatin|cisplatin|mesh-list
56661021|NCT00677118|Fluorouracil|fluorouracil|mesh-list
56661022|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661023|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
56661024|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661025|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56661026|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56162720|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56162721|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
56162722|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162723|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
56162724|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162725|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162726|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56162727|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56162728|NCT00001680|Growth Substances|growth substances|mesh-ancestor
56162729|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
56162730|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162732|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56162735|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
56162736|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162737|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162738|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56162739|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56162740|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56162741|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162742|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162743|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
56162744|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
56162745|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56162746|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
56162747|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162748|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162749|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56162750|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
56162751|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56162752|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
56162753|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162754|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162755|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56162756|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
56162757|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
56162758|NCT00001716|Protective Agents|protective agents|mesh-ancestor
56162759|NCT00001812|Nystatin|nystatin|mesh-list
55928585|NCT03221400|Hematinics|hematinics|mesh-ancestor
56661027|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
56661028|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661029|NCT02644226|Sevoflurane|sevoflurane|mesh-list
56661030|NCT02644226|Desflurane|desflurane|mesh-list
56661031|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56661032|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56661033|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
56661034|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
56661035|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56162760|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162761|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162762|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
56162763|NCT00001812|Ionophores|ionophores|mesh-ancestor
56162764|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162765|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162766|NCT00001842|Dexamethasone|dexamethasone|mesh-list
56162767|NCT00001842|Lenograstim|lenograstim|mesh-list
56162768|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56162769|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
56162770|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
56162771|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56162772|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162773|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56162774|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
56162775|NCT00001842|Hormones|hormones|mesh-ancestor
56162776|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56162777|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56162778|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162779|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56162780|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
56162781|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56162782|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56162783|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
56162784|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56162785|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162786|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56162787|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56162788|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56162789|NCT00001854|Ribavirin|ribavirin|mesh-list
56162790|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
56162791|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162792|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
56162793|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162795|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56162796|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56162797|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162798|NCT00001890|Estrogens|estrogens|mesh-list
56162799|NCT00001890|Hormones|hormones|mesh-ancestor
56162800|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56162801|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162802|NCT00001944|Vinorelbine|vinorelbine|mesh-list
56162803|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56162804|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162805|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
56162807|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
56162808|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162809|NCT00001968|Ritonavir|ritonavir|mesh-list
56162810|NCT00001968|Amprenavir|amprenavir|mesh-list
56162811|NCT00001968|Lamivudine|lamivudine|mesh-list
56162812|NCT00001968|Abacavir|abacavir|mesh-list
56162813|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56162814|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56162815|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
56162816|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162817|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162818|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56661036|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661037|NCT02753855|Telavancin|telavancin|mesh-list
56661038|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661039|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661040|NCT04166383|Nivolumab|nivolumab|mesh-list
56661041|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56222529|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
56162819|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162820|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
56162821|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162822|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56162823|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162824|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162825|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162826|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56162827|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
56162828|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162829|NCT00001998|Nystatin|nystatin|mesh-list
56162830|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162831|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162832|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
56162833|NCT00001998|Ionophores|ionophores|mesh-ancestor
56162834|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162835|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162836|NCT00002010|Fluconazole|fluconazole|mesh-list
56162837|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
56162838|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162839|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56162840|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162841|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162842|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162843|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56162844|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
56162845|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56162846|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162847|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56162848|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56162849|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
56162850|NCT00002022|Hematinics|hematinics|mesh-ancestor
56162851|NCT00002028|Didanosine|didanosine|mesh-list
56162852|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
56162853|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162854|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162855|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162856|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162857|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
56162858|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162859|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162860|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162861|NCT00002034|Zidovudine|zidovudine|mesh-list
56162862|NCT00002034|Ganciclovir|ganciclovir|mesh-list
56162863|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56162864|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
56162865|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162866|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162867|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162868|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162869|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
56162870|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162871|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162872|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162873|NCT00002040|Fluconazole|fluconazole|mesh-list
56162874|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
56162875|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162876|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56162877|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162878|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222534|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
56162881|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
56162882|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56162883|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162884|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56162885|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56162886|NCT00002046|Zidovudine|zidovudine|mesh-list
56162887|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
56162888|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162889|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162890|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162891|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162892|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
56162893|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162894|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162895|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162896|NCT00002052|Amoxicillin|amoxicillin|mesh-list
56162897|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
56162898|NCT00002052|Ampicillin|ampicillin|mesh-list
56162899|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162900|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162901|NCT00002058|Clofazimine|clofazimine|mesh-list
56162902|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56162903|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
56162904|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162905|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162906|NCT00002064|Clindamycin|clindamycin|mesh-list
56162907|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
56162908|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
56162909|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
56162910|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162911|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162912|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56162913|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162914|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162915|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
56162916|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56162917|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56162918|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56162919|NCT00002070|Ganciclovir|ganciclovir|mesh-list
56162920|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56162921|NCT00002070|Sargramostim|sargramostim|mesh-list
56162922|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
56162923|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162924|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
56162925|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162926|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162927|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162928|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162929|NCT00002076|Fluconazole|fluconazole|mesh-list
56162930|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
56162931|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162932|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56162933|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162934|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162935|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162936|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56162937|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
56162938|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56162940|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56162941|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56162942|NCT00002082|Azithromycin|azithromycin|mesh-list
56162943|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162944|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162945|NCT00002094|Atevirdine|atevirdine|mesh-list
56162946|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162947|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162948|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162949|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162950|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
56162951|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162952|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
56162953|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
56661042|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661043|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56661044|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661045|NCT02758691|Insulin|insulin|mesh-list
56661046|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56661047|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661048|NCT00714376|Docetaxel|docetaxel|mesh-list
56661049|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661050|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
56661051|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
56162954|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56162955|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56162956|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162957|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
56162958|NCT00002106|Ranitidine|ranitidine|mesh-list
56162959|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56162960|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56162961|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56162962|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56162963|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
56162964|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
56162965|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56162966|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162967|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162968|NCT00002112|Fluconazole|fluconazole|mesh-list
56162969|NCT00002112|Nystatin|nystatin|mesh-list
56162970|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
56162971|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162972|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56162973|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56162974|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162975|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162976|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56162977|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
56162978|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56162979|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56162980|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56162981|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56162982|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56162983|NCT00002112|Ionophores|ionophores|mesh-ancestor
56162984|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56162985|NCT00002118|Zalcitabine|zalcitabine|mesh-list
56162986|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
56162987|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162988|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162989|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162990|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162991|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
56162992|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56162993|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56162994|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56162995|NCT00002124|Lamivudine|lamivudine|mesh-list
56162996|NCT00002124|Zidovudine|zidovudine|mesh-list
56162997|NCT00002124|Delavirdine|delavirdine|mesh-list
56162998|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162999|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163000|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163001|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163002|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
56163003|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163004|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163005|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163006|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
56163007|NCT00002130|Vesnarinone|vesnarinone|mesh-list
56163008|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56661052|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
56661053|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163009|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
56163010|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163012|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
56163013|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163014|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56163015|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56163016|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163017|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163018|NCT00002130|Protective Agents|protective agents|mesh-ancestor
56163019|NCT00002142|Cidofovir|cidofovir|mesh-list
56163020|NCT00002142|Probenecid|probenecid|mesh-list
56163021|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
56163022|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
56163023|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56163024|NCT00002142|Renal Agents|renal agents|mesh-ancestor
56163025|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
56163026|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163027|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163034|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163035|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
56163036|NCT00002154|Selegiline|selegiline|mesh-list
56163037|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
56163038|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56163039|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56163040|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56163041|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56163042|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163043|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163044|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56163045|NCT00002154|Protective Agents|protective agents|mesh-ancestor
56163046|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163047|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
56163048|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
56163049|NCT00002154|Vitamins|vitamins|mesh-ancestor
56163050|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
56163051|NCT00002160|Ziconotide|ziconotide|mesh-list
56163052|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56163053|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56163054|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163055|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56163056|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163057|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56163058|NCT00002160|Protective Agents|protective agents|mesh-ancestor
56163059|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56163060|NCT00002160|Analgesics|analgesics|mesh-ancestor
56163061|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
56163062|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56163063|NCT00002166|Nevirapine|nevirapine|mesh-list
56163064|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163065|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163066|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163067|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163068|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
56163069|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163070|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163071|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163072|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56163074|NCT00002178|Ritonavir|ritonavir|mesh-list
56163075|NCT00002178|Nelfinavir|nelfinavir|mesh-list
56163076|NCT00002178|Saquinavir|saquinavir|mesh-list
56163077|NCT00002178|Delavirdine|delavirdine|mesh-list
56163078|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163079|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163080|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163081|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163082|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163083|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163084|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163085|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
56163086|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163087|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56163088|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56661054|NCT04068766|Bupivacaine|bupivacaine|mesh-list
56661055|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
56661056|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
56661057|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56163089|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163090|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163091|NCT00002184|Lamivudine|lamivudine|mesh-list
56163092|NCT00002184|Zidovudine|zidovudine|mesh-list
56163093|NCT00002184|Stavudine|stavudine|mesh-list
56163094|NCT00002184|Adefovir|adefovir|mesh-list
56163095|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56163096|NCT00002184|Nelfinavir|nelfinavir|mesh-list
56163097|NCT00002184|Saquinavir|saquinavir|mesh-list
56163098|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163103|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163104|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163105|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163106|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
56163107|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163108|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163109|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163110|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56163111|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56163113|NCT00002190|Zidovudine|zidovudine|mesh-list
56163114|NCT00002190|Saquinavir|saquinavir|mesh-list
56163115|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163116|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163117|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163118|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163119|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
56163120|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163121|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163122|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163123|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
56163124|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163125|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163126|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163127|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56163128|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56163129|NCT00002202|Indinavir|indinavir|mesh-list
56163130|NCT00002202|Amprenavir|amprenavir|mesh-list
56163131|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163132|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163133|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163134|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163135|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163136|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163137|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163138|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
56163139|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163140|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56163141|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
56163142|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56163143|NCT00002208|Lamivudine|lamivudine|mesh-list
56163144|NCT00002208|Zidovudine|zidovudine|mesh-list
56163145|NCT00002208|Stavudine|stavudine|mesh-list
56163146|NCT00002208|Indinavir|indinavir|mesh-list
56163147|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163148|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163149|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163150|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163151|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
56163152|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163153|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163154|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163155|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
56163156|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163157|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163158|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163159|NCT00002214|Capravirine|capravirine|mesh-list
56163160|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163161|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163162|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163163|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661058|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661059|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
56222549|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
56163164|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
56163166|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163167|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163168|NCT00002220|Efavirenz|efavirenz|mesh-list
56163169|NCT00002220|Adefovir|adefovir|mesh-list
56163170|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56163171|NCT00002220|Indinavir|indinavir|mesh-list
56163172|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163174|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163175|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163177|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163178|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56163179|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56163180|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56163181|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56163182|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56163183|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56163184|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163185|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163186|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163187|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163188|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163189|NCT00002226|Semaxinib|semaxinib|mesh-list
56163190|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56163191|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56163192|NCT00002226|Growth Substances|growth substances|mesh-ancestor
56163193|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163194|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
56163195|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163196|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56163197|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163198|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163199|NCT00002238|Interferons|interferons|mesh-list
56163200|NCT00002238|Zidovudine|zidovudine|mesh-list
56163201|NCT00002238|Interferon-beta|interferon-beta|mesh-list
56163202|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
56163203|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163204|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
56163205|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163206|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
56163207|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163208|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163209|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163210|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163211|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163212|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163213|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
56163214|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163215|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56163216|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
56163217|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
56163218|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163219|NCT00002256|Zalcitabine|zalcitabine|mesh-list
56163220|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
56163221|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163222|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163223|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163224|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163225|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
56163226|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163227|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163228|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163229|NCT00002274|Didanosine|didanosine|mesh-list
56163230|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
56163231|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163232|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163233|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163234|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163235|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
56661060|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661061|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56661062|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56163236|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163237|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163238|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163239|NCT00002280|Didanosine|didanosine|mesh-list
56163240|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
56163241|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163242|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163243|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163244|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163247|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163248|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163250|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
56163251|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163252|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163253|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163254|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163255|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
56163256|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163257|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163258|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163259|NCT00002292|Pentamidine|pentamidine|mesh-list
56163260|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
56163261|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163262|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56163263|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56163264|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56163265|NCT00002298|Ribavirin|ribavirin|mesh-list
56163266|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
56163267|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163268|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
56163269|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163270|NCT00002304|Fluconazole|fluconazole|mesh-list
56163271|NCT00002304|Ketoconazole|ketoconazole|mesh-list
56163272|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
56163273|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163274|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56163275|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56163276|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163277|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163278|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56163279|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
56163280|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56163281|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163282|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56163283|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56163284|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56163285|NCT00002316|Amphotericin B|amphotericin b|mesh-list
56163286|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56163287|NCT00002316|Amebicides|amebicides|mesh-ancestor
56163288|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56163289|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56163290|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163291|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56163292|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
56163293|NCT00002322|Zidovudine|zidovudine|mesh-list
56163294|NCT00002322|Atevirdine|atevirdine|mesh-list
56163295|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
56163296|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163297|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163298|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163299|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163300|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
56163301|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163302|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163303|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163304|NCT00002328|Azithromycin|azithromycin|mesh-list
56163305|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56163306|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163307|NCT00002334|Zidovudine|zidovudine|mesh-list
56661063|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661064|NCT04725695|Lidocaine|lidocaine|mesh-list
56222555|NCT01669499|Hormones|hormones|mesh-ancestor
56163308|NCT00002334|Zalcitabine|zalcitabine|mesh-list
56163309|NCT00002334|Saquinavir|saquinavir|mesh-list
56163310|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
56163311|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163312|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163313|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163314|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163315|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
56163316|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163317|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163318|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163322|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56163323|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56163324|NCT00002340|Atovaquone|atovaquone|mesh-list
56163325|NCT00002340|Pentamidine|pentamidine|mesh-list
56163326|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163327|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
56163328|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56163329|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56163330|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163331|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163332|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
56163333|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56163334|NCT00002346|Adefovir|adefovir|mesh-list
56163335|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56163336|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
56163337|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163338|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163339|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163340|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163341|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163342|NCT00002352|Lobucavir|lobucavir|mesh-list
56163343|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163344|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163345|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163346|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163347|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
56163348|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163349|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163350|NCT00002358|Sorivudine|sorivudine|mesh-list
56163351|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
56163352|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163353|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163354|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163355|NCT00002364|Abacavir|abacavir|mesh-list
56163356|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163357|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163358|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163359|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163360|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
56163361|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163362|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163363|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163364|NCT00002370|Itraconazole|itraconazole|mesh-list
56163365|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
56163366|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163367|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56163368|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56163369|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163370|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163371|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56163372|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
56091027|NCT04736420|Warfarin|warfarin|mesh-list
56163373|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56163374|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163375|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56163377|NCT00002376|Zidovudine|zidovudine|mesh-list
56163378|NCT00002376|Didanosine|didanosine|mesh-list
56163379|NCT00002376|Stavudine|stavudine|mesh-list
56163380|NCT00002376|Indinavir|indinavir|mesh-list
56661065|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
56661066|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
56661067|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56163381|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163382|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163383|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163384|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163385|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
56163386|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163387|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163388|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163389|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
56163390|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163394|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163395|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163396|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163397|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163398|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163399|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163400|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163401|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
56163402|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163403|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56163404|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56163405|NCT00002388|Abacavir|abacavir|mesh-list
56163406|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163407|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163408|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163409|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163410|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
56163411|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163412|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163413|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163414|NCT00002394|Terbinafine|terbinafine|mesh-list
56163415|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
56163416|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163417|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163418|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163419|NCT00002400|Lamivudine|lamivudine|mesh-list
56163420|NCT00002400|Zidovudine|zidovudine|mesh-list
56163421|NCT00002400|Delavirdine|delavirdine|mesh-list
56163422|NCT00002400|Indinavir|indinavir|mesh-list
56163423|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163424|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163425|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163426|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163427|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
56163428|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163429|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163430|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163431|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
56163432|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163433|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163434|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163435|NCT00002406|Indinavir|indinavir|mesh-list
56163436|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163437|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163438|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163439|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163440|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163441|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163442|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163443|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
56163444|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163445|NCT00002412|Didanosine|didanosine|mesh-list
56163446|NCT00002412|Stavudine|stavudine|mesh-list
56091103|NCT05267054|Rituximab|rituximab|mesh-list
56163447|NCT00002412|Emivirine|emivirine|mesh-list
56163448|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
56163449|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163450|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
56163451|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163452|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661068|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661069|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
56661070|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661071|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56661072|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56661073|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56661074|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56661075|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661076|NCT04151472|Ubiquinone|ubiquinone|mesh-list
56661077|NCT04151472|Idebenone|idebenone|mesh-list
56661078|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
56661079|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661080|NCT04151472|Protective Agents|protective agents|mesh-ancestor
56661081|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661082|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
56661083|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
56661084|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56661085|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
56661086|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661087|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661088|NCT04070794|Metformin|metformin|mesh-list
56661089|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56661090|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661091|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
56661092|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56661093|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56661094|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661095|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
56661096|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56163453|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163454|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
56163455|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163456|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
56163457|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163458|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163459|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163460|NCT00002418|Nevirapine|nevirapine|mesh-list
56163461|NCT00002418|Didanosine|didanosine|mesh-list
56163462|NCT00002418|Stavudine|stavudine|mesh-list
56163463|NCT00002418|Emivirine|emivirine|mesh-list
56146202|NCT01018056|Riluzole|riluzole|mesh-list
56163464|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
56163468|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163469|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
56163470|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163471|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163472|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56661097|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
56661098|NCT00677664|Mannitol|mannitol|mesh-list
56661099|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
56661100|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56661101|NCT00677664|Diuretics|diuretics|mesh-ancestor
56661102|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
56661103|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661104|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56661105|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
56661106|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56661107|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661108|NCT02572492|Dexamethasone|dexamethasone|mesh-list
56661109|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
56661110|NCT02572492|Melphalan|melphalan|mesh-list
56661111|NCT02572492|BB 1101|bb 1101|mesh-list
56661112|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56661113|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
56661114|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
56661115|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661116|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661117|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222591|NCT01669967|Promethazine|promethazine|mesh-list
56163473|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56163474|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56163475|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163476|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
56163477|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
56163478|NCT00002424|Lamivudine|lamivudine|mesh-list
56163479|NCT00002424|Stavudine|stavudine|mesh-list
56163480|NCT00002424|Indinavir|indinavir|mesh-list
56163481|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163482|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163483|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163484|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163485|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
56163486|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163487|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163488|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163489|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
56163490|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163491|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163492|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163494|NCT00002430|Stavudine|stavudine|mesh-list
56163495|NCT00002430|Nelfinavir|nelfinavir|mesh-list
56163496|NCT00002430|Indinavir|indinavir|mesh-list
56163497|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55902857|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163498|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163499|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163500|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163501|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
56163503|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163504|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163505|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163506|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163507|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163508|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
56163509|NCT00002436|Lamivudine|lamivudine|mesh-list
56163510|NCT00002436|Zidovudine|zidovudine|mesh-list
56661118|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
56307244|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
56661119|NCT02572492|Hormones|hormones|mesh-ancestor
56661120|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661121|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56661122|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661123|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
56661124|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661125|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661126|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56661127|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
56163511|NCT00002436|Zalcitabine|zalcitabine|mesh-list
56163512|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55903162|NCT02085148|Irinotecan|irinotecan|mesh-list
55903224|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
56163513|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163514|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163515|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163516|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
56163517|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163518|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163519|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163520|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
56163521|NCT00002442|Lamivudine|lamivudine|mesh-list
56163522|NCT00002442|Stavudine|stavudine|mesh-list
56163523|NCT00002442|Nelfinavir|nelfinavir|mesh-list
56163524|NCT00002442|Indinavir|indinavir|mesh-list
56091175|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
56163525|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163526|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163527|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176770|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56163528|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163529|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
56163530|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163531|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56163532|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163533|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163534|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163535|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163536|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
56163538|NCT00002448|Saquinavir|saquinavir|mesh-list
56163539|NCT00002448|Efavirenz|efavirenz|mesh-list
56163541|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163542|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163543|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163544|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163545|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55904092|NCT03417388|Aspirin|aspirin|mesh-list
56163546|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56163547|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
56163548|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163549|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56163550|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56163551|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163552|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163553|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56163554|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56163555|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56163556|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56163557|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56163558|NCT00002460|Tamoxifen|tamoxifen|mesh-list
56163559|NCT00002460|Goserelin|goserelin|mesh-list
56163560|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56661128|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56661129|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56661130|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
56661131|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
56661132|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56661133|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661134|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
56661135|NCT00672282|Bicalutamide|bicalutamide|mesh-list
56661136|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
56661137|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
56661138|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56163561|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
56163562|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56163563|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163564|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56163565|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163566|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56163567|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56163568|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56163569|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
56163570|NCT00002466|Ifosfamide|ifosfamide|mesh-list
56163571|NCT00002466|Doxorubicin|doxorubicin|mesh-list
56163572|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56163573|NCT00002466|Etoposide|etoposide|mesh-list
56163574|NCT00002466|Vincristine|vincristine|mesh-list
56163575|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56163576|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
56163577|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163578|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56163579|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163580|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
56163581|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163582|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163583|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56163584|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56163585|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163586|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56163587|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163588|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55904587|NCT01582945|Ketamine|ketamine|mesh-list
56163589|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
56163590|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
56163591|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
56163592|NCT00002472|Etoposide|etoposide|mesh-list
56163593|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163594|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163595|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163596|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56163597|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163598|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163600|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163601|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163602|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163603|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56163604|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163605|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163606|NCT00002490|Mitomycins|mitomycins|mesh-list
56163607|NCT00002490|Mitomycin|mitomycin|mesh-list
56163610|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163611|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
55904935|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56163612|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002212|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
56661139|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661140|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163613|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163614|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163615|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56163616|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
56163617|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163619|NCT00002496|Fluorouracil|fluorouracil|mesh-list
56163620|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163621|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
56163622|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163623|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56163624|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905013|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
56163625|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
56163626|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163627|NCT00002496|Trace Elements|trace elements|mesh-ancestor
56163628|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
56163629|NCT00002502|Cytarabine|cytarabine|mesh-list
56163630|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
56163631|NCT00002502|Busulfan|busulfan|mesh-list
56163632|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905152|NCT03163914|Phenylephrine|phenylephrine|mesh-list
56163633|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
56163634|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163635|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56163636|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163637|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
56163638|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163639|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163640|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56163641|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56163642|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
56163643|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
56163644|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163645|NCT00002508|Carboplatin|carboplatin|mesh-list
56163646|NCT00002508|Etoposide|etoposide|mesh-list
56163647|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163648|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163649|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163650|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56163651|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163652|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163654|NCT00002514|Cytarabine|cytarabine|mesh-list
56163655|NCT00002514|Dexamethasone|dexamethasone|mesh-list
56163656|NCT00002514|Prednisone|prednisone|mesh-list
56163657|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
56163658|NCT00002514|Methotrexate|methotrexate|mesh-list
56163659|NCT00002514|Etoposide|etoposide|mesh-list
56163660|NCT00002514|Vincristine|vincristine|mesh-list
56163661|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
56163662|NCT00002514|Daunorubicin|daunorubicin|mesh-list
56163663|NCT00002514|Asparaginase|asparaginase|mesh-list
56163664|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
56163665|NCT00002514|Thioguanine|thioguanine|mesh-list
56163666|NCT00002514|Sargramostim|sargramostim|mesh-list
56163668|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56163669|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
56163670|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163671|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56163672|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163673|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
56163674|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163675|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163676|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56163677|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56163678|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
56163679|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
56163680|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56163681|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56163682|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
56163685|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56163686|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56163688|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56163689|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56661141|NCT02753309|Sirolimus|sirolimus|mesh-list
56661142|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661143|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661144|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56163690|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
56163691|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
56163692|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163693|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55905557|NCT00264381|Dalteparin|dalteparin|mesh-list
56163694|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55905624|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
56163695|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163696|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163698|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
56163699|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163700|NCT00002514|Antidotes|antidotes|mesh-ancestor
56163701|NCT00002514|Protective Agents|protective agents|mesh-ancestor
56163702|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
56163703|NCT00002514|Vitamins|vitamins|mesh-ancestor
56163704|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
55905986|NCT01790529|Metronidazole|metronidazole|mesh-list
56163706|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
56163707|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
56163708|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55906131|NCT02985593|KHK4083|khk4083|mesh-list
56163709|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56163711|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56163712|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
56163713|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56163714|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163715|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56163716|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56163717|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
56163718|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56163719|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163721|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56163722|NCT00002526|Ifosfamide|ifosfamide|mesh-list
56163723|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56163724|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163725|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163726|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56163727|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163728|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163729|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163730|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
56163731|NCT00002532|Leucovorin|leucovorin|mesh-list
56163732|NCT00002532|Cytarabine|cytarabine|mesh-list
56163734|NCT00002532|Prednisolone|prednisolone|mesh-list
56163735|NCT00002532|Methotrexate|methotrexate|mesh-list
56163736|NCT00002532|Etoposide|etoposide|mesh-list
56163737|NCT00002532|Daunorubicin|daunorubicin|mesh-list
56163738|NCT00002532|Asparaginase|asparaginase|mesh-list
56163739|NCT00002532|Ifosfamide|ifosfamide|mesh-list
56163740|NCT00002532|Idarubicin|idarubicin|mesh-list
56163741|NCT00002532|Vindesine|vindesine|mesh-list
56163742|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
56163743|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56163744|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
56163745|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
56163746|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56163747|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163748|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907001|NCT01000467|Probucol|probucol|mesh-list
56163749|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
56163750|NCT00002532|Hormones|hormones|mesh-ancestor
56165402|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163751|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56163752|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56163753|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163754|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56163755|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
56163756|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56163759|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163760|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
56163761|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661145|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661146|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
56661147|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56661148|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
56661149|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661150|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56661151|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56661152|NCT04147728|Growth Substances|growth substances|mesh-ancestor
56661153|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661154|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
56661155|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661156|NCT04544189|Fulvestrant|fulvestrant|mesh-list
56163762|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56163763|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56163764|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
56163765|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56163766|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163767|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163768|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163769|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56163770|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
56163771|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163772|NCT00002532|Antidotes|antidotes|mesh-ancestor
56163773|NCT00002532|Protective Agents|protective agents|mesh-ancestor
56163774|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
56163775|NCT00002532|Vitamins|vitamins|mesh-ancestor
56163776|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
56163777|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55907202|NCT02660580|Adalimumab|adalimumab|mesh-list
56163778|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163779|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
56163780|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
56163781|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
56163782|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
56163784|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
56163785|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163786|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
56163787|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
56163788|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
56163789|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163790|NCT00002544|Analgesics|analgesics|mesh-ancestor
56163791|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
56163792|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907790|NCT01493531|Lesinurad|lesinurad|mesh-list
56163793|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163794|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163795|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56163796|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163797|NCT00002550|Etoposide|etoposide|mesh-list
56163798|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163799|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163800|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163801|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56163802|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163803|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163804|NCT00002556|Interferons|interferons|mesh-list
56163805|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
56163806|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
56163807|NCT00002556|Prednisone|prednisone|mesh-list
56163808|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
56163809|NCT00002556|Melphalan|melphalan|mesh-list
56163810|NCT00002556|Carmustine|carmustine|mesh-list
56163811|NCT00002556|Vincristine|vincristine|mesh-list
56163812|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56163813|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
55907914|NCT02361528|Sargramostim|sargramostim|mesh-list
56661157|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56661158|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661159|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56661160|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56661161|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
56661162|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661163|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163815|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56163816|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163817|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
56163818|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163819|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163820|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56163821|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56163823|NCT00002556|Hormones|hormones|mesh-ancestor
56163824|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56163825|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56163826|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
56163827|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163828|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163829|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56163830|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56163831|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56163833|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163834|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908307|NCT00322335|PENTA|penta|mesh-list
56163835|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
56163836|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
56163837|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
56163838|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163839|NCT00002568|Paclitaxel|paclitaxel|mesh-list
56163840|NCT00002568|Cisplatin|cisplatin|mesh-list
56163841|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163842|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163843|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
56163844|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
56163845|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
56163846|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163847|NCT00002574|Interferons|interferons|mesh-list
56163848|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
56163849|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
56163850|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163851|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
56163852|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163853|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
56163854|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163855|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163856|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56163857|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163858|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163859|NCT00002580|Tamoxifen|tamoxifen|mesh-list
55908340|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
56163860|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
56163861|NCT00002580|Fluorouracil|fluorouracil|mesh-list
56163862|NCT00002580|Methotrexate|methotrexate|mesh-list
56163864|NCT00002580|Goserelin|goserelin|mesh-list
56163865|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56163866|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
56163867|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163868|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908461|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56163869|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163871|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163872|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908675|NCT02350218|Urological Agents|urological agents|mesh-ancestor
56163873|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56661164|NCT04330690|Artesunate|artesunate|mesh-list
56661165|NCT04330690|Dexamethasone|dexamethasone|mesh-list
56661166|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
56163875|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56163876|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56163877|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
56163878|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56163879|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
56163880|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163881|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56163882|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163883|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56163884|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
56163885|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56163886|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56163887|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56163888|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56163889|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56163890|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56163891|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
56163892|NCT00002586|Vitamin E|vitamin e|mesh-list
56163893|NCT00002586|Tocopherols|tocopherols|mesh-list
56163894|NCT00002586|Tocotrienols|tocotrienols|mesh-list
56163895|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
56163896|NCT00002586|Tretinoin|tretinoin|mesh-list
56163897|NCT00002586|Isotretinoin|isotretinoin|mesh-list
56163898|NCT00002586|Vitamins|vitamins|mesh-ancestor
56163899|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
56163900|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163901|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
56163902|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908883|NCT03146052|Emollients|emollients|mesh-ancestor
56163903|NCT00002586|Protective Agents|protective agents|mesh-ancestor
56163904|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163905|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
56091566|NCT05406050|Vitamin D|vitamin d|mesh-list
56163911|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163912|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56163913|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163914|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
56163915|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163916|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163917|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56163918|NCT00002598|Interferons|interferons|mesh-list
56163919|NCT00002598|Cytarabine|cytarabine|mesh-list
56163920|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
56163921|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
56163922|NCT00002598|Methotrexate|methotrexate|mesh-list
56163923|NCT00002598|Etoposide|etoposide|mesh-list
55909090|NCT02337036|Tacrolimus|tacrolimus|mesh-list
55909167|NCT02331576|Fentanyl|fentanyl|mesh-list
56163924|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
56163925|NCT00002598|Sargramostim|sargramostim|mesh-list
56163926|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56163927|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
56163928|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163929|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56163930|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163931|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
56163932|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163933|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163934|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56163935|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56163936|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
56163937|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56163938|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56163939|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
56163940|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
56163941|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163942|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56176813|NCT05268627|Liraglutide|liraglutide|mesh-list
56163943|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163944|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163945|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163946|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56661167|NCT04330690|Infliximab|infliximab|mesh-list
56661168|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56661169|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
56661170|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
56661171|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661172|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661173|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56661174|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
56661175|NCT04330690|Hormones|hormones|mesh-ancestor
56661176|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661177|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56661178|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661179|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56661180|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661181|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661182|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222658|NCT01670812|Rituximab|rituximab|mesh-list
56163947|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
56163948|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163949|NCT00002598|Analgesics|analgesics|mesh-ancestor
56163950|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
56163951|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56163952|NCT00002604|Carmustine|carmustine|mesh-list
56163953|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56163954|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163955|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
56163956|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163957|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163958|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163959|NCT00002610|Dactinomycin|dactinomycin|mesh-list
56163960|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
56163961|NCT00002610|Carboplatin|carboplatin|mesh-list
56163962|NCT00002610|Doxorubicin|doxorubicin|mesh-list
56163963|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56163964|NCT00002610|Etoposide|etoposide|mesh-list
56163965|NCT00002610|Vincristine|vincristine|mesh-list
56163966|NCT00002610|Lenograstim|lenograstim|mesh-list
56163967|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56163968|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
56163969|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909498|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
56163970|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56163971|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163972|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
56163973|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163974|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56163976|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56163977|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56163978|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56163979|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163980|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56163981|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56163982|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56163983|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56163984|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56163985|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56163986|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163987|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56163988|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56661183|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661184|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
56661185|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56661186|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56661187|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661188|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
56661189|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
56661190|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56661191|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
56661192|NCT03083041|Apatinib|apatinib|mesh-list
56661193|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661194|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56661195|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661196|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661197|NCT00672360|Folic Acid|folic acid|mesh-list
56661198|NCT00672360|Hematinics|hematinics|mesh-ancestor
56661199|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
56661200|NCT00672360|Vitamins|vitamins|mesh-ancestor
56661201|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
56661202|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661203|NCT02628522|Lidocaine|lidocaine|mesh-list
56661204|NCT02628522|Epinephrine|epinephrine|mesh-list
56163990|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
56163991|NCT00002616|Thiotepa|thiotepa|mesh-list
56163992|NCT00002616|Carboplatin|carboplatin|mesh-list
56163993|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56163994|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
55910152|NCT01487161|FX006|fx006|mesh-list
56163995|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56163996|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910271|NCT01484873|Incretins|incretins|mesh-ancestor
55910347|NCT00439335|Vaccines|vaccines|mesh-list
56163997|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56163998|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
56163999|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164000|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164002|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56164003|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56164004|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
56164005|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164006|NCT00002628|Paclitaxel|paclitaxel|mesh-list
56164007|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
56164008|NCT00002628|Carboplatin|carboplatin|mesh-list
56164009|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164010|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164011|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
56164012|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
56164013|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
56164014|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164015|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164016|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
56164017|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164018|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910857|NCT01506193|Vaccines|vaccines|mesh-list
56164019|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164020|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
56164021|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56164022|NCT00002634|Cobalt|cobalt|mesh-list
56164023|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
56661205|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
56661206|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
56661207|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661208|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661209|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
56661210|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661211|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56661212|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56661213|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56222684|NCT01672359|Choline|choline|mesh-list
56164025|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56164026|NCT00002634|Etoposide|etoposide|mesh-list
56164027|NCT00002634|Vincristine|vincristine|mesh-list
56164028|NCT00002634|Antibodies|antibodies|mesh-list
56164029|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56164030|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164031|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
56164032|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911294|NCT00464685|Hormones|hormones|mesh-ancestor
56164033|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164034|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164035|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
55911358|NCT01690520|Thiotepa|thiotepa|mesh-list
56164036|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164037|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164038|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56164039|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56164040|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55911656|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56164041|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164042|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911804|NCT04082767|Midazolam|midazolam|mesh-list
56164043|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164044|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
56164046|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
56164050|NCT00002646|Fenretinide|fenretinide|mesh-list
56164051|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56164052|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
56164053|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164054|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164055|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56164056|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164057|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56164058|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56164059|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56164060|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56164061|NCT00002646|Protective Agents|protective agents|mesh-ancestor
56164062|NCT00002652|Suramin|suramin|mesh-list
56091707|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56164063|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
56164064|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
56164065|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56164066|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164067|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164068|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56164069|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56164070|NCT00002658|Cytarabine|cytarabine|mesh-list
56164071|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
56164072|NCT00002658|Etoposide|etoposide|mesh-list
56164073|NCT00002658|Daunorubicin|daunorubicin|mesh-list
56164074|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
56164075|NCT00002658|Idarubicin|idarubicin|mesh-list
56164076|NCT00002658|Tretinoin|tretinoin|mesh-list
56164077|NCT00002658|Thioguanine|thioguanine|mesh-list
56164078|NCT00002658|Amsacrine|amsacrine|mesh-list
56164079|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164080|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
56164081|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661214|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56661215|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661216|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56661217|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56164082|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164083|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164084|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
56164085|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176817|NCT05268627|Hormones|hormones|mesh-ancestor
56164086|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164087|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55912972|NCT00497055|Aripiprazole|aripiprazole|mesh-list
56164088|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164089|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56164090|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164091|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913182|NCT02130063|Trace Elements|trace elements|mesh-ancestor
55913331|NCT00527475|Ranibizumab|ranibizumab|mesh-list
56164092|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56164093|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
56164094|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
56164095|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913636|NCT05065671|Tolcapone|tolcapone|mesh-list
55913704|NCT04514211|Propofol|propofol|mesh-list
56164097|NCT00002658|Analgesics|analgesics|mesh-ancestor
56164098|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
55913852|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164099|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164100|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
55913946|NCT01569464|Rotigotine|rotigotine|mesh-list
56164101|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
56164103|NCT00002664|Edrecolomab|edrecolomab|mesh-list
56164104|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
56164105|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164106|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56164107|NCT00002670|Cobalt|cobalt|mesh-list
56164108|NCT00002670|Trace Elements|trace elements|mesh-ancestor
56164109|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
56164110|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164111|NCT00002676|Cobalt|cobalt|mesh-list
56164112|NCT00002676|Cytarabine|cytarabine|mesh-list
56164113|NCT00002676|Dexamethasone|dexamethasone|mesh-list
56164114|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
56164117|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56164118|NCT00002676|Methotrexate|methotrexate|mesh-list
56164120|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164121|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
56164124|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164125|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
56164126|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164127|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164128|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56164129|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56164130|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
56164131|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
56164132|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164133|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56164134|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
56164136|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164137|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56091782|NCT02185014|Adalimumab|adalimumab|mesh-list
55915166|NCT01436201|Dulaglutide|dulaglutide|mesh-list
56164138|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56164139|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56164140|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164141|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164142|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56164143|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
56164144|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56164145|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56164146|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
56164147|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
56164148|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56661218|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
56661219|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661220|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56661221|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56661222|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
56661223|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56661224|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
56661225|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
56661226|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
56661227|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56661228|NCT02572336|Plasminogen|plasminogen|mesh-list
56164149|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56164150|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
56164151|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915521|NCT04497155|Norepinephrine|norepinephrine|mesh-list
56164152|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164153|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
56164154|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
56164155|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
55915688|NCT04797312|Sufentanil|sufentanil|mesh-list
56164156|NCT00002676|Trace Elements|trace elements|mesh-ancestor
55915749|NCT03142542|Udenafil|udenafil|mesh-list
56164157|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
56164159|NCT00002682|Metronidazole|metronidazole|mesh-list
56164160|NCT00002682|Clarithromycin|clarithromycin|mesh-list
56164161|NCT00002682|Tetracycline|tetracycline|mesh-list
56164162|NCT00002682|Omeprazole|omeprazole|mesh-list
56164163|NCT00002682|Bismuth|bismuth|mesh-list
56164164|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
55916110|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164165|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56164166|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164167|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56164168|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56164169|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55916265|NCT00665457|Analgesics|analgesics|mesh-ancestor
56164170|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56164171|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56164172|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164173|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916424|NCT04655586|Heparin|heparin|mesh-list
56164174|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56164175|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55916637|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
56164176|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56164178|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
56164179|NCT00002688|Cyclosporine|cyclosporine|mesh-list
56164180|NCT00002688|Etoposide|etoposide|mesh-list
56164181|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
56164182|NCT00002688|Cyclosporins|cyclosporins|mesh-list
55916931|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56164183|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164184|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917079|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56164185|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56164186|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164187|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164188|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917376|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
56164191|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164192|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
56164193|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164194|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
56164195|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917674|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164196|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56164198|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
56002213|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661229|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56661230|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56164199|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164201|NCT00002700|Cytarabine|cytarabine|mesh-list
56164202|NCT00002700|Dexamethasone|dexamethasone|mesh-list
56164203|NCT00002700|Prednisone|prednisone|mesh-list
56164204|NCT00002700|Prednisolone|prednisolone|mesh-list
56164205|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
56164206|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56164207|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56164208|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56164209|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
56164210|NCT00002700|Doxorubicin|doxorubicin|mesh-list
56164211|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56164212|NCT00002700|Methotrexate|methotrexate|mesh-list
56164213|NCT00002700|Vincristine|vincristine|mesh-list
56164214|NCT00002700|Daunorubicin|daunorubicin|mesh-list
56164215|NCT00002700|Asparaginase|asparaginase|mesh-list
56164216|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
56091865|NCT02157948|Denosumab|denosumab|mesh-list
56164218|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
56164219|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164220|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
55917977|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
56164221|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164222|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164223|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164224|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
56164225|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164226|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164227|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56164228|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56164229|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
56164230|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
55918631|NCT04198129|Sultamicillin|sultamicillin|mesh-list
56164231|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164232|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56164233|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
56164234|NCT00002700|Hormones|hormones|mesh-ancestor
56164235|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164236|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56164237|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56164238|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56164239|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164240|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164241|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55919088|NCT01272219|Hormones|hormones|mesh-ancestor
56164242|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
56164243|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56164244|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56164245|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
56164246|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
55919363|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56164247|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55919439|NCT00735969|Ribavirin|ribavirin|mesh-list
56164248|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56164250|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164251|NCT00002700|Antidotes|antidotes|mesh-ancestor
56164252|NCT00002700|Protective Agents|protective agents|mesh-ancestor
56164253|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
56164254|NCT00002700|Vitamins|vitamins|mesh-ancestor
56164255|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
56164256|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164257|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56164258|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56164259|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56164260|NCT00002700|Analgesics|analgesics|mesh-ancestor
56164265|NCT00002718|Thiotepa|thiotepa|mesh-list
56164266|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56164267|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164268|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
56164269|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164270|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164271|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164272|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
55919735|NCT04024813|Seladelpar|seladelpar|mesh-list
56164273|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661231|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56661232|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661233|NCT02750969|Lidocaine|lidocaine|mesh-list
56661234|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
56661235|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
56661236|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661237|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661238|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
56661239|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661240|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56661241|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56661242|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56661243|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56661244|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164274|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919886|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56164276|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56164277|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
56164278|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
56164279|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164280|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56164281|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
56164282|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
55920255|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920256|NCT02658084|Trastuzumab|trastuzumab|mesh-list
55920257|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55920258|NCT02658084|Vinorelbine|vinorelbine|mesh-list
55920259|NCT02658084|Maytansine|maytansine|mesh-list
55920260|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164283|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164284|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920641|NCT05040126|Linezolid|linezolid|mesh-list
56164286|NCT00002718|Hormones|hormones|mesh-ancestor
56164287|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164288|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56164289|NCT00002718|Protective Agents|protective agents|mesh-ancestor
56164290|NCT00002730|Melphalan|melphalan|mesh-list
56164291|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
56164292|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164293|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
56164294|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164295|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164296|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56164297|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164298|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
56164299|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164300|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
56164301|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56164302|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921143|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55921293|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56164303|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56164304|NCT00002730|Protective Agents|protective agents|mesh-ancestor
56164306|NCT00002742|Nystatin|nystatin|mesh-list
55921444|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
56164307|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56164308|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56164309|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
56164310|NCT00002742|Amebicides|amebicides|mesh-ancestor
56164311|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56661245|NCT04067011|Doxycycline|doxycycline|mesh-list
56661246|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
56661247|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661248|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222719|NCT01675115|Analgesics|analgesics|mesh-ancestor
56164312|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56164313|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164314|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55921741|NCT03153163|Trastuzumab|trastuzumab|mesh-list
56164315|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
56164317|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55921883|NCT01923649|Lanreotide|lanreotide|mesh-list
56164318|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164319|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56164320|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56164322|NCT00002748|Vaccines|vaccines|mesh-list
55922181|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56164323|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164324|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56164327|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164328|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164329|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
56164331|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56164332|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
56164333|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164334|NCT00002760|Ketoconazole|ketoconazole|mesh-list
56164335|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
56164336|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56164337|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56164338|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55922410|NCT02651220|Analgesics|analgesics|mesh-ancestor
56164339|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
56164340|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56164341|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
56164342|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922553|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
56164343|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56164344|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56164345|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922699|NCT03696199|Anesthetics|anesthetics|mesh-list
56176823|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
56164346|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922773|NCT03600649|Topotecan|topotecan|mesh-list
56164347|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56164348|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165403|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55923005|NCT00243867|Paclitaxel|paclitaxel|mesh-list
56164349|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164350|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164351|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56164352|NCT00002772|Tamoxifen|tamoxifen|mesh-list
56164353|NCT00002772|Paclitaxel|paclitaxel|mesh-list
56164354|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
56164355|NCT00002772|Carboplatin|carboplatin|mesh-list
56164356|NCT00002772|Doxorubicin|doxorubicin|mesh-list
56164357|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56164358|NCT00002772|Thiotepa|thiotepa|mesh-list
56164359|NCT00002772|Carmustine|carmustine|mesh-list
56164360|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164361|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164362|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
56164363|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
56164364|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
56164365|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923286|NCT03458221|Itraconazole|itraconazole|mesh-list
56164366|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164367|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
56164368|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164369|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164370|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164371|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
56165404|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164372|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56661249|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
56661250|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56661251|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56164373|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56164374|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56164375|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164376|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164377|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56164378|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
56164379|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164380|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56164381|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56164382|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56164383|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56164384|NCT00002778|Sargramostim|sargramostim|mesh-list
56164385|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
56164386|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164388|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
56164389|NCT00002784|Doxorubicin|doxorubicin|mesh-list
56164390|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56164392|NCT00002784|Methotrexate|methotrexate|mesh-list
56164393|NCT00002784|Epirubicin|epirubicin|mesh-list
56164394|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164395|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
56164396|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164397|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924234|NCT05742789|Anesthetics|anesthetics|mesh-ancestor
56164398|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55924462|NCT03803787|Hormones|hormones|mesh-ancestor
55924608|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924682|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56164400|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924829|NCT01019616|Paclitaxel|paclitaxel|mesh-list
56164401|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164402|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56164403|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56164404|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55925060|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164405|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164406|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164407|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
56164408|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56164409|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55925354|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
56164411|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56164413|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55925567|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164414|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56164415|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56164416|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
55925864|NCT05602597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55925937|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56164417|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164418|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55926158|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
56164419|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56164420|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56164421|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56164424|NCT00002790|Methotrexate|methotrexate|mesh-list
56164425|NCT00002790|Cyclosporins|cyclosporins|mesh-list
55926520|NCT00819507|Fluocinonide|fluocinonide|mesh-list
56164426|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55926603|NCT00857961|Hormones|hormones|mesh-ancestor
56164427|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
55926744|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
55926821|NCT04399525|Cetirizine|cetirizine|mesh-list
56164428|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56164429|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164430|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56164431|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
56164432|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164433|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164434|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
56164435|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927117|NCT03212989|Vorinostat|vorinostat|mesh-list
56164436|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56164437|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164438|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
56164439|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164440|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56164441|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
55927405|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56164442|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927556|NCT02854488|Ipilimumab|ipilimumab|mesh-list
56164443|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55927708|NCT01391663|Alogliptin|alogliptin|mesh-list
56164444|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56164445|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55927853|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
56164446|NCT05752110|Ketamine|ketamine|mesh-list
56164447|NCT05752110|Analgesics|analgesics|mesh-ancestor
56164448|NCT05752110|Sensory System Agents|sensory system agents|mesh-ancestor
55928072|NCT04375033|Analgesics|analgesics|mesh-ancestor
56164449|NCT05752110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164450|NCT05752110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164452|NCT05752110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56164453|NCT05752110|Anesthetics, General|anesthetics, general|mesh-ancestor
56164454|NCT05752110|Anesthetics|anesthetics|mesh-ancestor
56164455|NCT05752110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56164456|NCT05752110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56164457|NCT05752110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56164458|NCT05752110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56164459|NCT05752110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164461|NCT05751876|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56164462|NCT05751876|Contraceptive Agents|contraceptive agents|mesh-ancestor
55928437|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
56164463|NCT05751876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55928509|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
56164464|NCT05751876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164465|NCT05751876|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56164466|NCT05751876|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56164467|NCT05751876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56164468|NCT05751876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56164469|NCT05751876|Hormone Antagonists|hormone antagonists|mesh-ancestor
56164470|NCT05751876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164471|NCT05751876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56164472|NCT05751876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164473|NCT05751252|Ganirelix|ganirelix|mesh-list
55928954|NCT03024515|Analgesics|analgesics|mesh-ancestor
55929100|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
56164474|NCT05751252|Hormone Antagonists|hormone antagonists|mesh-ancestor
55929174|NCT00216671|Risperidone|risperidone|mesh-list
56164475|NCT05751252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164476|NCT05751252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164477|NCT05750628|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56164478|NCT05750628|Antimalarials|antimalarials|mesh-ancestor
56164479|NCT05750628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56164480|NCT05750628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56164481|NCT05750628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164482|NCT05749926|Vaccines|vaccines|mesh-list
56164483|NCT05749926|Immunologic Factors|immunologic factors|mesh-ancestor
56164484|NCT05749926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164485|NCT05749614|Lidocaine|lidocaine|mesh-list
56164486|NCT05749614|Anesthetics, Local|anesthetics, local|mesh-ancestor
56164487|NCT05749614|Anesthetics|anesthetics|mesh-ancestor
56164488|NCT05749614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56164489|NCT05749614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164490|NCT05749614|Sensory System Agents|sensory system agents|mesh-ancestor
55929764|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56164491|NCT05749614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164492|NCT05749614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56164493|NCT05749614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55930013|NCT05045274|Hormones|hormones|mesh-ancestor
56164494|NCT05749614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55930073|NCT00635089|Reslizumab|reslizumab|mesh-list
55930135|NCT00634543|Narcotics|narcotics|mesh-ancestor
56164495|NCT05749614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56661252|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55798692|NCT01653327|Ketamine|ketamine|mesh-list
55930209|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56164496|NCT05749614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164497|NCT05749380|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55930354|NCT05033574|Hormones|hormones|mesh-list
56164498|NCT05749380|Antifungal Agents|antifungal agents|mesh-ancestor
55930501|NCT00632827|Doxorubicin|doxorubicin|mesh-list
56164499|NCT05749380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164500|NCT05749380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55930582|NCT01044459|Bromides|bromides|mesh-list
56164501|NCT05749380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56164502|NCT05748990|Insulin|insulin|mesh-list
56164504|NCT05748990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56164505|NCT05748990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164506|NCT05748834|Doxorubicin|doxorubicin|mesh-list
56164507|NCT05748834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56164508|NCT05748834|Tucatinib|tucatinib|mesh-list
56164509|NCT05748834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56164510|NCT05748834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164511|NCT05748834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56164512|NCT05748834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164513|NCT05748834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164519|NCT05746806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092154|NCT03478982|Alprazolam|alprazolam|mesh-list
56164520|NCT05729568|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56164521|NCT05729568|Antiviral Agents|antiviral agents|mesh-ancestor
56164522|NCT05729568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164523|NCT05709990|Vitamin D|vitamin d|mesh-list
56164524|NCT05709990|Cholecalciferol|cholecalciferol|mesh-list
56164526|NCT05709990|Vitamins|vitamins|mesh-ancestor
56164527|NCT05709990|Micronutrients|micronutrients|mesh-ancestor
55931536|NCT04195139|Nivolumab|nivolumab|mesh-list
56164528|NCT05709990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164536|NCT05709990|Urological Agents|urological agents|mesh-ancestor
56164537|NCT05677698|Peppermint oil|peppermint oil|mesh-list
56164538|NCT05677698|Antiemetics|antiemetics|mesh-ancestor
56164539|NCT05677698|Autonomic Agents|autonomic agents|mesh-ancestor
56164540|NCT05677698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164541|NCT05677698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164542|NCT05677698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56164543|NCT05677698|Parasympatholytics|parasympatholytics|mesh-ancestor
56164545|NCT05660850|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56164546|NCT05660850|Diuretics|diuretics|mesh-ancestor
56164547|NCT05660850|Natriuretic Agents|natriuretic agents|mesh-ancestor
56164548|NCT05660850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164564|NCT05588388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164565|NCT05588388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164566|NCT05588388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56164567|NCT05588388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55932317|NCT04364139|Amlodipine|amlodipine|mesh-list
56164569|NCT05588388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932390|NCT04999176|Enoxaparin|enoxaparin|mesh-list
56164570|NCT05588388|Growth Inhibitors|growth inhibitors|mesh-ancestor
56164571|NCT05552196|Carbamazepine|carbamazepine|mesh-list
56164572|NCT05552196|Ponesimod|ponesimod|mesh-list
56176879|NCT04604353|Calcium|calcium|mesh-list
56164573|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
56164574|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
55932720|NCT03072264|Fluoxetine|fluoxetine|mesh-list
55932761|NCT04406051|Norepinephrine|norepinephrine|mesh-list
55932839|NCT04990830|Heparin|heparin|mesh-list
56164576|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932919|NCT04360317|Docetaxel|docetaxel|mesh-list
56164577|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164578|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55933061|NCT05580887|Paclitaxel|paclitaxel|mesh-list
55933062|NCT05580887|Cyclophosphamide|cyclophosphamide|mesh-list
55933063|NCT05580887|Carboplatin|carboplatin|mesh-list
55933064|NCT05580887|Doxorubicin|doxorubicin|mesh-list
55933065|NCT05580887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55933066|NCT05580887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933067|NCT05580887|Tubulin Modulators|tubulin modulators|mesh-ancestor
55933068|NCT05580887|Antimitotic Agents|antimitotic agents|mesh-ancestor
55933069|NCT05580887|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933071|NCT05580887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164579|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56164580|NCT05552196|Analgesics|analgesics|mesh-ancestor
55933138|NCT04143581|Empagliflozin|empagliflozin|mesh-list
55933213|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
56164581|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
56661253|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56661254|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222724|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164582|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164583|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56164584|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55933431|NCT03032367|Bedaquiline|bedaquiline|mesh-list
56164585|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164586|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55933514|NCT03587129|Apatinib|apatinib|mesh-list
55933575|NCT03585101|Grazoprevir|grazoprevir|mesh-list
55933726|NCT03581903|Vaccines|vaccines|mesh-list
55933797|NCT05104866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164587|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56164588|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55934179|NCT01674257|Fluorides|fluorides|mesh-list
56164591|NCT05543850|Pancrelipase|pancrelipase|mesh-list
56164592|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55934248|NCT01675895|Lidocaine|lidocaine|mesh-list
56164593|NCT05516628|Bevacizumab|bevacizumab|mesh-list
56164594|NCT05516628|Atezolizumab|atezolizumab|mesh-list
56092242|NCT02213094|Vitamins|vitamins|mesh-list
56164595|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164596|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164597|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55934457|NCT00962871|Tenofovir|tenofovir|mesh-list
56164598|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56164599|NCT05516628|Growth Substances|growth substances|mesh-ancestor
55934539|NCT02631876|Paclitaxel|paclitaxel|mesh-list
56164600|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164601|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
56164602|NCT05497674|Rifampin|rifampin|mesh-list
56164603|NCT05497674|Probenecid|probenecid|mesh-list
55934685|NCT03864419|Etoposide|etoposide|mesh-list
55934759|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164604|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56164605|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
55934855|NCT03814109|Niacin|niacin|mesh-list
56164607|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164608|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
56164609|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56164610|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164611|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164612|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56164613|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56164614|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56164615|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56164616|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56164617|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56164618|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
56164619|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
56164620|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164621|NCT05497674|Renal Agents|renal agents|mesh-ancestor
56164622|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
55934905|NCT03019809|Plerixafor|plerixafor|mesh-list
56164623|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164624|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164625|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
55935114|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
56164626|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56164627|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935263|NCT03738917|Bromides|bromides|mesh-list
55935350|NCT00977769|Oxytocin|oxytocin|mesh-list
56164628|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56164629|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164630|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164631|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164632|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164633|NCT05458674|Trastuzumab|trastuzumab|mesh-list
56164634|NCT05458674|Tucatinib|tucatinib|mesh-list
56164635|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164636|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164637|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56164638|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164639|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661255|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661256|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661257|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56661258|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56661259|NCT04109729|Nivolumab|nivolumab|mesh-list
56661260|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56661261|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661262|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56661263|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661264|NCT04044859|Pembrolizumab|pembrolizumab|mesh-list
56661265|NCT04044859|Nivolumab|nivolumab|mesh-list
56661266|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56661267|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661268|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56661269|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661271|NCT00719056|Lactams|lactams|mesh-list
56661272|NCT00719056|Cephalosporins|cephalosporins|mesh-list
56661273|NCT00719056|Teicoplanin|teicoplanin|mesh-list
56661274|NCT00719056|beta-Lactams|beta-lactams|mesh-list
56661275|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661276|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661277|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56661278|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56661279|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661280|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661281|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661282|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56661283|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56164660|NCT05427162|Tezosentan|tezosentan|mesh-list
55936742|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
56164661|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56164662|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56164663|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
56164665|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56164666|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164667|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56164668|NCT05391828|Cimetidine|cimetidine|mesh-list
55937175|NCT03568643|Amoxicillin|amoxicillin|mesh-list
56092304|NCT03581084|Antidotes|antidotes|mesh-ancestor
55937248|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164670|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56164671|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56164672|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
56164683|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164684|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
56661284|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56661285|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56661286|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
56661287|NCT03475004|Bevacizumab|bevacizumab|mesh-list
56661288|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
56661289|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56661290|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661291|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56661292|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56661293|NCT03475004|Growth Substances|growth substances|mesh-ancestor
56222754|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
56164685|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164686|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56164687|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
56164688|NCT05360628|Protective Agents|protective agents|mesh-ancestor
56164689|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164690|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
55937490|NCT01045551|Apremilast|apremilast|mesh-list
56164691|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937673|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937744|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56164692|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56164693|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164694|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164695|NCT05321940|Interferons|interferons|mesh-list
56164696|NCT05321940|Vaccines|vaccines|mesh-list
56164697|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
56164698|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164699|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164700|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
56164701|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164702|NCT05312112|Venetoclax|venetoclax|mesh-list
56164703|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164704|NCT05311176|Paclitaxel|paclitaxel|mesh-list
56164705|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
56164706|NCT05311176|Ramucirumab|ramucirumab|mesh-list
56164707|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164708|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164709|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
56164710|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
56164711|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
56164712|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164713|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164714|NCT05309928|Amoxicillin|amoxicillin|mesh-list
56164715|NCT05309928|Probenecid|probenecid|mesh-list
56164716|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56164717|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164718|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
56164719|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
56164720|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164721|NCT05309928|Renal Agents|renal agents|mesh-ancestor
56164722|NCT05296278|Lenvatinib|lenvatinib|mesh-list
56164723|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164724|NCT05296278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56164725|NCT05296278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164726|NCT05296278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164727|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
56164728|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56164729|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56164730|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164731|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56164732|NCT05271552|Analgesics|analgesics|mesh-ancestor
56164733|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
56164734|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164737|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56164738|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
56661294|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661295|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
56661296|NCT02695745|Celecoxib|celecoxib|mesh-list
56661297|NCT02695745|Capsaicin|capsaicin|mesh-list
56222764|NCT01677039|Ethanol|ethanol|mesh-list
56164739|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56164740|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164741|NCT05242458|Ustekinumab|ustekinumab|mesh-list
56164742|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
56164744|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56164745|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55938086|NCT01195779|Vaccines|vaccines|mesh-list
55938087|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
55938088|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938089|NCT02405585|Leucovorin|leucovorin|mesh-list
55938090|NCT02405585|Gemcitabine|gemcitabine|mesh-list
55938091|NCT02405585|Fluorouracil|fluorouracil|mesh-list
55938232|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56164746|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164747|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56164748|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164749|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
55938452|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56164750|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56164751|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164753|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164754|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164756|NCT05162976|Azacitidine|azacitidine|mesh-list
56164757|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164758|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938606|NCT00083915|Thalidomide|thalidomide|mesh-list
56164759|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56164760|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164761|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56164763|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164765|NCT05161338|Progesterone|progesterone|mesh-list
56164766|NCT05161338|Estrogens|estrogens|mesh-ancestor
56164767|NCT05161338|Hormones|hormones|mesh-ancestor
56164768|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164769|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164770|NCT05161338|Progestins|progestins|mesh-ancestor
56164771|NCT05083182|Ustekinumab|ustekinumab|mesh-list
56164782|NCT05043090|Growth Substances|growth substances|mesh-ancestor
56164783|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164784|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
56164785|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56164786|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164787|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164788|NCT04919382|Temozolomide|temozolomide|mesh-list
56164789|NCT04919382|Atezolizumab|atezolizumab|mesh-list
56164790|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56164791|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164792|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
56164793|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164794|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164795|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
56164796|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164799|NCT04836780|Dexamethasone|dexamethasone|mesh-list
56164800|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56164801|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
56164802|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
56164803|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164804|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164805|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56164806|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
56164808|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939229|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
56164809|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56164810|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939518|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
55939667|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
56661298|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56661299|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56661300|NCT02695745|Analgesics|analgesics|mesh-ancestor
55939814|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
56164819|NCT04800822|Cetuximab|cetuximab|mesh-list
55939973|NCT02915783|Everolimus|everolimus|mesh-list
56164822|NCT04759248|Trastuzumab|trastuzumab|mesh-list
56164823|NCT04759248|Atezolizumab|atezolizumab|mesh-list
56164824|NCT04759248|Vinorelbine|vinorelbine|mesh-list
55940255|NCT01920919|Hormones|hormones|mesh-ancestor
56164825|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164826|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940627|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
56164827|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164828|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56164829|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56164830|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56164831|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164832|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
56164833|NCT04740294|Analgesics|analgesics|mesh-ancestor
56164834|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
56164835|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164836|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164837|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
56164838|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56164839|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56164840|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
56164841|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56164842|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56164843|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164844|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56164845|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
56164846|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56164847|NCT04705818|Durvalumab|durvalumab|mesh-list
56164848|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164849|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164850|NCT04677972|Ebselen|ebselen|mesh-list
56164851|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56164852|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56164853|NCT04677972|Analgesics|analgesics|mesh-ancestor
56164854|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
56164855|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164856|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164857|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56164858|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164859|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56164860|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56164861|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
56164862|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164863|NCT04677972|Protective Agents|protective agents|mesh-ancestor
56164864|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56164865|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164866|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56164867|NCT04610736|Temozolomide|temozolomide|mesh-list
56164868|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56164869|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
56164870|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164871|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164873|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
56164874|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
56164875|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941574|NCT01920737|Leucovorin|leucovorin|mesh-list
56164877|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
56164878|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56164879|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56164880|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56164881|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56164882|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55941636|NCT01302483|Lidocaine|lidocaine|mesh-list
56164883|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164884|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56164885|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
56661301|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
56661302|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661303|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661304|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56661305|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661306|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56661307|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56661308|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661309|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661310|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
56661311|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
56661312|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56661313|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56222770|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55941934|NCT01927835|Vaccines|vaccines|mesh-list
56164886|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55942001|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56164896|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56164897|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56164898|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164900|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
55942815|NCT01346397|Tacrolimus|tacrolimus|mesh-list
56164901|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164902|NCT04521114|Leronlimab|leronlimab|mesh-list
56164903|NCT04521114|HIV Antibodies|hiv antibodies|mesh-list
56144629|NCT00803010|Sirolimus|sirolimus|mesh-list
56164904|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56164905|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55943053|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
56164906|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164907|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56164908|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56164909|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
56164910|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56164912|NCT04521114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164913|NCT04519164|Eplerenone|eplerenone|mesh-list
56164914|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
55943490|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943563|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
56164915|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56164916|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
56164917|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55943707|NCT02635555|Protective Agents|protective agents|mesh-ancestor
56164918|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943853|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56164919|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56164920|NCT04519164|Diuretics|diuretics|mesh-ancestor
56164921|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
56164922|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56164923|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56164924|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55944301|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944372|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56164925|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164927|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164928|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164930|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944743|NCT04883736|Tretinoin|tretinoin|mesh-list
56164931|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56661314|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56661315|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56661316|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56661317|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661318|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661319|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661320|NCT00990067|Analgesics|analgesics|mesh-ancestor
56661321|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
56661322|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661323|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
56661324|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56661325|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
56661326|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
56661327|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
56661328|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56661329|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
56661330|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
56164932|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164933|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945183|NCT03074045|Estradiol|estradiol|mesh-list
56164954|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55945914|NCT01895881|Estradiol|estradiol|mesh-list
55946058|NCT03589014|Propranolol|propranolol|mesh-list
55946173|NCT04392557|Metformin|metformin|mesh-list
56092615|NCT04495712|Diuretics|diuretics|mesh-ancestor
56164972|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
56164973|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
56164974|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946946|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
56164975|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164976|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
55947019|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56164977|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947206|NCT04866498|Analgesics|analgesics|mesh-list
56164981|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
55947243|NCT01895569|Hormones|hormones|mesh-ancestor
56164982|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56164983|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164984|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56164985|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164986|NCT04016142|Paclitaxel|paclitaxel|mesh-list
56164987|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56164988|NCT04016142|Carboplatin|carboplatin|mesh-list
56164989|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56164990|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164991|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
56164992|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
55947395|NCT01459133|Insulin|insulin|mesh-list
56164993|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
56164994|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164995|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
56164996|NCT03978624|Entinostat|entinostat|mesh-list
55947610|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
55947687|NCT02856893|Gefitinib|gefitinib|mesh-list
56164997|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56164999|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56165000|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888757|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165001|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165002|NCT03946800|Durvalumab|durvalumab|mesh-list
55947829|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165003|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55947981|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56165004|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165005|NCT03927690|Ranibizumab|ranibizumab|mesh-list
56165006|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56165007|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56165008|NCT03927690|Growth Substances|growth substances|mesh-ancestor
56165009|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165010|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
56165011|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948359|NCT04374474|Budesonide|budesonide|mesh-list
56165012|NCT03915678|Atezolizumab|atezolizumab|mesh-list
56165014|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165015|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
56165016|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165018|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
56165019|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
56165020|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165021|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56165022|NCT03874338|Colchicine|colchicine|mesh-list
56165026|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165027|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
55948730|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
56165028|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165029|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165030|NCT03846570|Beclomethasone|beclomethasone|mesh-list
56165031|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
56165032|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56165033|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
55948868|NCT02596685|Nicotine|nicotine|mesh-list
55948939|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
56165034|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165035|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165036|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56165037|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
56165038|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56165039|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56165040|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56165041|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
56165042|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165043|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165044|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949384|NCT04832880|Remdesivir|remdesivir|mesh-list
56165045|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
56165046|NCT03846570|Hormones|hormones|mesh-ancestor
55949600|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165405|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165047|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56165048|NCT03838848|Carboplatin|carboplatin|mesh-list
56165049|NCT03838848|Pemetrexed|pemetrexed|mesh-list
56165050|NCT03838848|Antibodies|antibodies|mesh-list
56165051|NCT03838848|Immunoglobulins|immunoglobulins|mesh-list
56165052|NCT03838848|Immunologic Factors|immunologic factors|mesh-ancestor
56165053|NCT03838848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165054|NCT03838848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165055|NCT03838848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165056|NCT03838848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165057|NCT03838848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55950057|NCT01189643|Bevacizumab|bevacizumab|mesh-list
56165058|NCT03838848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56165059|NCT03787602|Avelumab|avelumab|mesh-list
56165060|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56165061|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165062|NCT03782376|Ustekinumab|ustekinumab|mesh-list
56165063|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
56165064|NCT03745170|Capecitabine|capecitabine|mesh-list
56165065|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
56165066|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165067|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
56165068|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165406|NCT00002892|Interferons|interferons|mesh-list
56165069|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165071|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661331|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56661332|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
56661333|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661334|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
56165072|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165073|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165074|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165075|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165076|NCT03701490|Progesterone|progesterone|mesh-list
56165077|NCT03701490|Progestins|progestins|mesh-ancestor
56165078|NCT03701490|Hormones|hormones|mesh-ancestor
56165079|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56165407|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
56165080|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165081|NCT03691974|Fasinumab|fasinumab|mesh-list
55951011|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56165082|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56165083|NCT03691974|Analgesics|analgesics|mesh-ancestor
56165084|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
55951094|NCT00074269|Melphalan|melphalan|mesh-list
56165085|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951157|NCT00075829|Thalidomide|thalidomide|mesh-list
56165089|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
56165090|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56165091|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165092|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
56165093|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56165094|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165095|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165096|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56165097|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56165098|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56165099|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56165100|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56165101|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56165103|NCT03652428|Paclitaxel|paclitaxel|mesh-list
56165104|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165105|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165106|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165107|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165108|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165109|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165110|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165111|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
56165112|NCT03652428|Antiviral Agents|antiviral agents|mesh-ancestor
56165113|NCT03652428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165114|NCT03652428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165115|NCT03652428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951743|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
56165116|NCT03652428|Immunologic Factors|immunologic factors|mesh-ancestor
56165117|NCT03652428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165118|NCT03580044|Aztreonam|aztreonam|mesh-list
56165119|NCT03580044|Avibactam|avibactam|mesh-list
56165120|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56165121|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165122|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55952034|NCT04802928|Isoniazid|isoniazid|mesh-list
56165124|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165125|NCT03459222|Nivolumab|nivolumab|mesh-list
56165126|NCT03459222|Ipilimumab|ipilimumab|mesh-list
56165127|NCT03459222|Linrodostat|linrodostat|mesh-list
56165128|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56165129|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165130|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56165131|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165132|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165133|NCT03351348|Bupivacaine|bupivacaine|mesh-list
56165134|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
56165135|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
56165136|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56165137|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888758|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661335|NCT00719290|Protective Agents|protective agents|mesh-ancestor
56661336|NCT00635921|Ziprasidone|ziprasidone|mesh-list
56661337|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56661338|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
56661339|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661340|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661341|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661342|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56661344|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661345|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56661346|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56661347|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
56661348|NCT04166006|Interleukin-2|interleukin-2|mesh-list
56661349|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661350|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56661351|NCT04166006|Analgesics|analgesics|mesh-ancestor
56661352|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
56165138|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
56165139|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165140|NCT03237780|Atezolizumab|atezolizumab|mesh-list
56165141|NCT03237780|Halichondrin B|halichondrin b|mesh-list
56165142|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56165143|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165144|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
56165145|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165146|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165147|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165148|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165149|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165150|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
56165151|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56165152|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165153|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56165154|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56165155|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165159|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56165160|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165161|NCT02795988|Fluorouracil|fluorouracil|mesh-list
56165162|NCT02795988|Capecitabine|capecitabine|mesh-list
56165163|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
55952817|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
55952818|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952819|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952820|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952821|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
55952822|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55952895|NCT00081263|Celecoxib|celecoxib|mesh-list
55952896|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
55952897|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55952898|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56165165|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
56165166|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953054|NCT00086723|Captopril|captopril|mesh-list
56165167|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165168|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165169|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
56165170|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165171|NCT02782104|Esketamine|esketamine|mesh-list
56661353|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661354|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661355|NCT04069858|Entecavir|entecavir|mesh-list
56661356|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
56165172|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
56165173|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56165174|NCT02743494|Nivolumab|nivolumab|mesh-list
56165175|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56165176|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165177|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56165178|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165180|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56165181|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56165182|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56165183|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165184|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56165185|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56165186|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
56165187|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953564|NCT00095875|Docetaxel|docetaxel|mesh-list
56165188|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165189|NCT01394016|Fulvestrant|fulvestrant|mesh-list
55953700|NCT02440581|Alendronate|alendronate|mesh-list
56165190|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56165191|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165192|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56165193|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55953948|NCT05556720|Vaccines|vaccines|mesh-list
56165194|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165195|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56165196|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165197|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
56165198|NCT01096368|Cisplatin|cisplatin|mesh-list
56165199|NCT01096368|Carboplatin|carboplatin|mesh-list
56165200|NCT01096368|Etoposide|etoposide|mesh-list
55954062|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
55954140|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
56165201|NCT01096368|Vincristine|vincristine|mesh-list
56165203|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
56165204|NCT01096368|Lenograstim|lenograstim|mesh-list
56165205|NCT01096368|Mesna|mesna|mesh-list
56165206|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165207|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
56165208|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165209|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954508|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
55954582|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165210|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165211|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
56165408|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165214|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165215|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165216|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55954948|NCT00227617|Vitamins|vitamins|mesh-ancestor
56165409|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
55955098|NCT01678443|Antibodies|antibodies|mesh-list
56165217|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165219|NCT01096368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56165220|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165221|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165222|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165223|NCT01096368|Protective Agents|protective agents|mesh-ancestor
56165224|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
56165225|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56165226|NCT00978822|Clevidipine|clevidipine|mesh-list
56165227|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56165228|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56165229|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165230|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56165231|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165232|NCT00577200|Midazolam|midazolam|mesh-list
56165233|NCT00577200|Sufentanil|sufentanil|mesh-list
56165234|NCT00577200|Propofol|propofol|mesh-list
56165235|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56661357|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661358|NCT03958045|Nivolumab|nivolumab|mesh-list
56661359|NCT03958045|Rucaparib|rucaparib|mesh-list
56661360|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56661361|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955231|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56165236|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56165237|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165238|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56165239|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
56165241|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56165242|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56165243|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56165244|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56165245|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
56165246|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
56165247|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165248|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165249|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56165251|NCT00577200|Analgesics|analgesics|mesh-ancestor
56165252|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
56165253|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165254|NCT00002796|Interferons|interferons|mesh-list
56165255|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
56165256|NCT00002796|Indomethacin|indomethacin|mesh-list
56165257|NCT00002796|Fluorouracil|fluorouracil|mesh-list
56165258|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56165259|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
56165260|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165261|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165262|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165263|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165264|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
56165265|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165266|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
56165267|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165268|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56165269|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56165270|NCT00002796|Analgesics|analgesics|mesh-ancestor
56165271|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
56165272|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165273|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56165274|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165275|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
56165276|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
56165277|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56165278|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56165279|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165280|NCT00002802|Cobalt|cobalt|mesh-list
56165281|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
56165282|NCT00002802|Melphalan|melphalan|mesh-list
56165284|NCT00002802|Dacarbazine|dacarbazine|mesh-list
56165285|NCT00002802|Carboplatin|carboplatin|mesh-list
56165286|NCT00002802|Doxorubicin|doxorubicin|mesh-list
56165288|NCT00002802|Etoposide|etoposide|mesh-list
56165289|NCT00002802|Vincristine|vincristine|mesh-list
56165290|NCT00002802|Vindesine|vindesine|mesh-list
56165291|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165292|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
55956310|NCT04638517|Danazol|danazol|mesh-list
56165293|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165294|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165295|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165296|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
56165297|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956533|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
56165298|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165299|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165300|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56165301|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56165302|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165303|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165304|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56661362|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56661363|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661364|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56661365|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661366|NCT00710086|Remifentanil|remifentanil|mesh-list
56661367|NCT00710086|Hydromorphone|hydromorphone|mesh-list
56661368|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56661369|NCT00710086|Narcotics|narcotics|mesh-ancestor
56661370|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661371|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661372|NCT00710086|Analgesics|analgesics|mesh-ancestor
56661373|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
56661374|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661375|NCT00652886|Oxandrolone|oxandrolone|mesh-list
56661376|NCT00652886|Androgens|androgens|mesh-ancestor
56661377|NCT00652886|Hormones|hormones|mesh-ancestor
56661378|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661379|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661380|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
56661381|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
56661382|NCT00539305|Testosterone|testosterone|mesh-list
56661383|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
56661384|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
56165305|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165306|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165307|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165309|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
56165312|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165313|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957426|NCT05609682|Gabapentin|gabapentin|mesh-list
56165314|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165315|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165316|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165317|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957577|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957649|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
56334016|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334017|NCT00064857|Protective Agents|protective agents|mesh-ancestor
56334019|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
56334020|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56334021|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56334022|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334023|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334024|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
56334025|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334026|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56334027|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56334028|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56334029|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56334030|NCT04730622|Mitogens|mitogens|mesh-list
56334031|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
55888759|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56661385|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56661386|NCT00539305|Androgens|androgens|mesh-ancestor
56661387|NCT00539305|Hormones|hormones|mesh-ancestor
56334032|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334033|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56334034|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56334035|NCT00064974|Lenalidomide|lenalidomide|mesh-list
56334036|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
56334037|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334038|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56334039|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56334040|NCT00064974|Growth Substances|growth substances|mesh-ancestor
56334042|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334043|NCT00037817|Celecoxib|celecoxib|mesh-list
56334044|NCT00037817|Decitabine|decitabine|mesh-list
56334045|NCT00037817|Romidepsin|romidepsin|mesh-list
56334046|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56334047|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56334048|NCT00037817|Analgesics|analgesics|mesh-ancestor
56334049|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
56334050|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334051|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334052|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56334053|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56334054|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56334055|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56334056|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334057|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334058|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334065|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
56334067|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
56334068|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56334069|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334071|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56334072|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56334073|NCT00065169|Analgesics|analgesics|mesh-ancestor
56334074|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
56334075|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334076|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334077|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56334078|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56334079|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56334080|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56334081|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334082|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334084|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334085|NCT00038051|Lintuzumab|lintuzumab|mesh-list
55958632|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334086|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56334087|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334088|NCT00038090|Thalidomide|thalidomide|mesh-list
56334089|NCT00038090|Dexamethasone|dexamethasone|mesh-list
56334090|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56334091|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
56334092|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
56334093|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958997|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
55959073|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334094|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334095|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56334096|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
56334097|NCT00038090|Hormones|hormones|mesh-ancestor
56334098|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55959150|NCT04446871|Methylene Blue|methylene blue|mesh-list
56334099|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56334100|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959293|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
56334101|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334102|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
56334103|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
56334104|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56334105|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661388|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661389|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334106|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56334107|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56334108|NCT00038090|Growth Substances|growth substances|mesh-ancestor
55959585|NCT05748561|Prednisolone|prednisolone|mesh-list
56334109|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
56334110|NCT00065325|Fulvestrant|fulvestrant|mesh-list
56334111|NCT00065325|Exemestane|exemestane|mesh-list
56334112|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56334113|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334114|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56334116|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165318|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56165319|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55960185|NCT00342355|Ritonavir|ritonavir|mesh-list
56165320|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165321|NCT00002826|Paclitaxel|paclitaxel|mesh-list
56334117|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334118|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334119|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56334120|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56334121|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960335|NCT05266261|Vitamins|vitamins|mesh-ancestor
56334124|NCT00038168|Estramustine|estramustine|mesh-list
56334125|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55960628|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
56334126|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960768|NCT02107339|Methadone|methadone|mesh-list
56334127|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334128|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334129|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334130|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961156|NCT03873805|Vidarabine|vidarabine|mesh-list
56334131|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56334132|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
55961296|NCT00558519|Daunorubicin|daunorubicin|mesh-list
56334133|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56334134|NCT00398658|Clindamycin|clindamycin|mesh-list
55961378|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
55961449|NCT02660411|Propofol|propofol|mesh-list
56334135|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
56334136|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
56334137|NCT00398658|Gentamicins|gentamicins|mesh-list
56334138|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55961662|NCT00365599|Tamoxifen|tamoxifen|mesh-list
56334139|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334140|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56334141|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334142|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334143|NCT00038207|Vincristine|vincristine|mesh-list
56334144|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56334145|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334146|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334147|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334148|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334149|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334150|NCT00398697|Gemcitabine|gemcitabine|mesh-list
56334151|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334152|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
55961982|NCT03855371|Decitabine|decitabine|mesh-list
56334153|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334154|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334156|NCT00398697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962100|NCT00426283|Xhance|xhance|mesh-list
56334157|NCT00398697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334158|NCT00398697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334159|NCT00398697|Immunologic Factors|immunologic factors|mesh-ancestor
56334160|NCT00398697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334161|NCT00038246|Thalidomide|thalidomide|mesh-list
56334162|NCT00038246|Paclitaxel|paclitaxel|mesh-list
56334163|NCT00038246|Estramustine|estramustine|mesh-list
56334164|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55962469|NCT00455689|Leuprolide|leuprolide|mesh-list
56334166|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
56661390|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56661391|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661392|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
56661393|NCT02643914|Nicotine|nicotine|mesh-list
56661394|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56661395|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
56661396|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661397|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661398|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56661399|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56661400|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
56661401|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661402|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661403|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
56661404|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56661405|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334167|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334168|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334169|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334170|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334171|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
56334172|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334173|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
56334174|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56334175|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334176|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56334177|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56334178|NCT00038246|Growth Substances|growth substances|mesh-ancestor
56334179|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962823|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
56334180|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56334181|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
56334182|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962968|NCT00453895|Sunitinib|sunitinib|mesh-list
56334183|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56334184|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334185|NCT00398814|Sorafenib|sorafenib|mesh-list
55963042|NCT00477451|Alprazolam|alprazolam|mesh-list
56334186|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165322|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55963409|NCT01397552|Dexamethasone|dexamethasone|mesh-list
56334191|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56334192|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56334193|NCT00065559|Analgesics|analgesics|mesh-ancestor
56334194|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
55963704|NCT00425477|Sargramostim|sargramostim|mesh-list
56334195|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334196|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334197|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56334198|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56334199|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56334200|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56334201|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888760|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
56661406|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56661407|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56661408|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
56222871|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56334202|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963967|NCT01796093|Digoxin|digoxin|mesh-list
56334203|NCT00065637|Teriparatide|teriparatide|mesh-list
56165323|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964148|NCT00490477|Polymyxins|polymyxins|mesh-list
56165324|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334204|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56334205|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334206|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56334207|NCT00396578|Vancomycin|vancomycin|mesh-list
56334208|NCT00396578|Gentamicins|gentamicins|mesh-list
56334209|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56334210|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334211|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56334212|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334213|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334214|NCT00398853|Chromium|chromium|mesh-list
56334215|NCT00398853|Picolinic acid|picolinic acid|mesh-list
56334217|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
56334218|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334219|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56334220|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
56334221|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
56334222|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334223|NCT05433896|Dasatinib|dasatinib|mesh-list
56334224|NCT05433896|Omeprazole|omeprazole|mesh-list
56334225|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56334226|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56334227|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56334228|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334229|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334230|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334231|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56334232|NCT00069888|Docetaxel|docetaxel|mesh-list
56334233|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334234|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334235|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334236|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334237|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334238|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56334239|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
56334240|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55965333|NCT04193930|Letrozole|letrozole|mesh-list
55965457|NCT05533567|Dsuvia|dsuvia|mesh-list
56334241|NCT00069927|Methylphenidate|methylphenidate|mesh-list
56334242|NCT00069927|Amphetamine|amphetamine|mesh-list
56334243|NCT00069927|Adderall|adderall|mesh-list
56334244|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
55965620|NCT04176835|Oxytocin|oxytocin|mesh-list
56334245|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55965697|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
56165325|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334246|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334247|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56334248|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56334251|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
55966063|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
56334252|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334253|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
56334254|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
56334255|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334256|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
56334257|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56334258|NCT00069966|Cytarabine|cytarabine|mesh-list
56334259|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
56334260|NCT00069966|Rituximab|rituximab|mesh-list
56334261|NCT00069966|Pixantrone|pixantrone|mesh-list
56334262|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56334263|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956058|NCT02240589|Memantine|memantine|mesh-list
56334264|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
56165326|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
56661409|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661410|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
56661411|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56334265|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334266|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56334267|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334268|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
55966582|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
55966649|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56334269|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334270|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
56334271|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334272|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334273|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966879|NCT05605899|Hormones|hormones|mesh-ancestor
56334274|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
56334275|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
56334276|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334277|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56334278|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
56334279|NCT00069966|Hormones|hormones|mesh-ancestor
56334280|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55967244|NCT00502853|Rituximab|rituximab|mesh-list
56334282|NCT00069966|Protective Agents|protective agents|mesh-ancestor
55967389|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
56334284|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56334285|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334286|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
56334287|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56334288|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334289|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
56334290|NCT00065949|Analgesics|analgesics|mesh-ancestor
56334291|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
56334292|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967536|NCT00619723|Choline|choline|mesh-list
56334293|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967605|NCT00506597|Asparaginase|asparaginase|mesh-list
56334295|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56334296|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56334297|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
56334298|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55967827|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
56334299|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56165410|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968043|NCT00584701|Risperidone|risperidone|mesh-list
56165411|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
55968196|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56334300|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334301|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56334302|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
56334303|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56334304|NCT00066027|Doxycycline|doxycycline|mesh-list
56334305|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56334306|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334307|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
56334308|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56334309|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56334310|NCT00396734|Topiramate|topiramate|mesh-list
56334317|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56334318|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56334319|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334320|NCT00070083|Prednisone|prednisone|mesh-list
56334321|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
56334322|NCT00070083|Rituximab|rituximab|mesh-list
56334323|NCT00070083|Doxorubicin|doxorubicin|mesh-list
56334324|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56334325|NCT00070083|Vincristine|vincristine|mesh-list
56334326|NCT00070083|Oblimersen|oblimersen|mesh-list
56334327|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334328|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
56334329|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334330|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56334331|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56334332|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
56661412|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661413|NCT05359939|Choline|choline|mesh-list
56661414|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
56661415|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56661416|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
56661417|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661418|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56334333|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334334|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334335|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56334336|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56334337|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55968762|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334338|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56334339|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56334340|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334341|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56334342|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
56334343|NCT00070083|Hormones|hormones|mesh-ancestor
55968911|NCT03161132|Olaparib|olaparib|mesh-list
56165327|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334344|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334345|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56165328|NCT00002832|Cyclosporine|cyclosporine|mesh-list
56334346|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56334347|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334348|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334349|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334351|NCT00070122|Bevacizumab|bevacizumab|mesh-list
56334352|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56334353|NCT00070122|Fluorouracil|fluorouracil|mesh-list
56334354|NCT00070122|Capecitabine|capecitabine|mesh-list
56334356|NCT00070122|Antibodies|antibodies|mesh-list
56334357|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
56334358|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56334359|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
56334360|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334361|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56334362|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56334363|NCT00070122|Growth Substances|growth substances|mesh-ancestor
56334364|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334365|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
56334366|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
56334367|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
56165329|NCT00002832|Decitabine|decitabine|mesh-list
55969574|NCT00681265|Glycerol|glycerol|mesh-list
56334368|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334369|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334370|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334371|NCT00070122|Antidotes|antidotes|mesh-ancestor
56334372|NCT00070122|Protective Agents|protective agents|mesh-ancestor
56334373|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
56334375|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
56334376|NCT00070161|Donepezil|donepezil|mesh-list
56334377|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56334378|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334379|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334380|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
56334381|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970011|NCT03511976|Amphetamine|amphetamine|mesh-list
56334382|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334384|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
56334386|NCT00070200|Doxorubicin|doxorubicin|mesh-list
56334387|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56334388|NCT00070200|Etoposide|etoposide|mesh-list
56334389|NCT00070200|Vincristine|vincristine|mesh-list
56334390|NCT00070200|Topotecan|topotecan|mesh-list
56334391|NCT00070200|Isotretinoin|isotretinoin|mesh-list
56165330|NCT00002832|Cyclosporins|cyclosporins|mesh-list
56334393|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
56334394|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661419|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56661420|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
56661421|NCT00990223|Eplerenone|eplerenone|mesh-list
56661422|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56661423|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
56661424|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661425|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661426|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56661427|NCT00990223|Diuretics|diuretics|mesh-ancestor
56661428|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
56661429|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56661430|NCT00715780|Insulin|insulin|mesh-list
56661431|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56661432|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
56661433|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
56661434|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56661435|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
56661436|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
56222888|NCT01680198|Vitamin D|vitamin d|mesh-list
56334395|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56334396|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56334397|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
56334398|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334399|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334400|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56334401|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56334402|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56334403|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56334404|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334405|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55970684|NCT03086720|Eusol|eusol|mesh-list
56334407|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334408|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334409|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56334410|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
56334412|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970880|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
56334413|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56334414|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334415|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334416|NCT00070239|Alvocidib|alvocidib|mesh-list
55956210|NCT05535738|Xhance|xhance|mesh-list
56334417|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56334418|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56334419|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334420|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334421|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334422|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
56334423|NCT00070239|Growth Substances|growth substances|mesh-ancestor
55970961|NCT02987985|Narcotics|narcotics|mesh-ancestor
56334424|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56334425|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334426|NCT00070278|Gemcitabine|gemcitabine|mesh-list
56334428|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
56334429|NCT00070278|Epirubicin|epirubicin|mesh-list
56334430|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56334431|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334432|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
56661437|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
56661438|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
56661439|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
55971321|NCT03467750|Ketorolac|ketorolac|mesh-list
56334433|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334434|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334435|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334436|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334437|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
56334438|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334439|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56334440|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56334441|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
56334442|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55971457|NCT01892709|Hydromorphone|hydromorphone|mesh-list
56334443|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334444|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
56334445|NCT00070278|Antiviral Agents|antiviral agents|mesh-ancestor
55971612|NCT00572117|Topiramate|topiramate|mesh-list
56334446|NCT00070278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334447|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334448|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56334449|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56334450|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56334451|NCT00066378|Gefitinib|gefitinib|mesh-list
56334452|NCT00066378|Anastrozole|anastrozole|mesh-list
56334454|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56334455|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334456|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334457|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56334458|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56334459|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56334460|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56334461|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165331|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
56334462|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334463|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334464|NCT00066417|Cyclosporine|cyclosporine|mesh-list
56334465|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
56334466|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
56334467|NCT00066417|Thiotepa|thiotepa|mesh-list
56334468|NCT00066417|Fludarabine|fludarabine|mesh-list
56334469|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
56334470|NCT00066417|Cyclosporins|cyclosporins|mesh-list
56334471|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334472|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
56334473|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334474|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56334475|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56334476|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
56165332|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165333|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165412|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334477|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334478|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334479|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56334480|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334481|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
56334482|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334483|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
56334484|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334485|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
56334486|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56334487|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56334489|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
56334490|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334491|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56334492|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
55956273|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
56334493|NCT00066417|Hormones|hormones|mesh-ancestor
56334494|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334495|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56334496|NCT00066417|Protective Agents|protective agents|mesh-ancestor
56334497|NCT00066456|Docetaxel|docetaxel|mesh-list
56661440|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56661441|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661442|NCT02652884|Betamethasone|betamethasone|mesh-list
56661443|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
56222901|NCT05596968|Sorafenib|sorafenib|mesh-list
56334498|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334499|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334500|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334501|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334502|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334503|NCT00070434|Leucovorin|leucovorin|mesh-list
56334504|NCT00070434|Pyridoxine|pyridoxine|mesh-list
56334505|NCT00070434|Fluorouracil|fluorouracil|mesh-list
56334506|NCT00070434|Capecitabine|capecitabine|mesh-list
56334507|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
56165413|NCT00002898|Dactinomycin|dactinomycin|mesh-list
56334510|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334511|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
56165414|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
56334512|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334513|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334514|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334515|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334517|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56334518|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56334519|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334520|NCT00070434|Antidotes|antidotes|mesh-ancestor
56334521|NCT00070434|Protective Agents|protective agents|mesh-ancestor
56334522|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
56334523|NCT00070434|Vitamins|vitamins|mesh-ancestor
56334524|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
56334525|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
56334528|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334529|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334530|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
56334531|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56334532|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56334533|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334534|NCT00070473|Pemetrexed|pemetrexed|mesh-list
56334535|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334536|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165415|NCT00002898|Ifosfamide|ifosfamide|mesh-list
56334537|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334538|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56334539|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56334541|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56334542|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56334543|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334544|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334545|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334547|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334549|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974310|NCT03793439|Hormones|hormones|mesh-ancestor
56334550|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334551|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
56334552|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334553|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334554|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
56334555|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334556|NCT00070629|Paclitaxel|paclitaxel|mesh-list
56334557|NCT00070629|Docetaxel|docetaxel|mesh-list
56334558|NCT00070629|Cisplatin|cisplatin|mesh-list
56334559|NCT00070629|Carboplatin|carboplatin|mesh-list
56334560|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56334561|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334562|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334563|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334564|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334565|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334567|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334568|NCT05184920|Nicotine|nicotine|mesh-list
56334569|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56334570|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
56222902|NCT05596968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956365|NCT01665768|Rituximab|rituximab|mesh-list
56334571|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165416|NCT00002898|Carboplatin|carboplatin|mesh-list
55975104|NCT01967433|Promethazine|promethazine|mesh-list
56334572|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334573|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55975181|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
56334574|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56334575|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
56334577|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334578|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
56334580|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56334581|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334582|NCT02958501|Vitamins|vitamins|mesh-ancestor
56334583|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
55975769|NCT00667589|Fluocinonide|fluocinonide|mesh-list
56334584|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56334585|NCT00066651|Immunotoxins|immunotoxins|mesh-list
56334586|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
56334587|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334588|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
56334589|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
56334590|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334591|NCT00398892|Protective Agents|protective agents|mesh-ancestor
56334592|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334593|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
56334594|NCT00398892|Vitamins|vitamins|mesh-ancestor
56334595|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
56334596|NCT05019794|Infigratinib|infigratinib|mesh-list
56334597|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334598|NCT00066768|Gemcitabine|gemcitabine|mesh-list
56334599|NCT00066768|Suramin|suramin|mesh-list
56165419|NCT00002898|Epirubicin|epirubicin|mesh-list
56165420|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334603|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334604|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334605|NCT00066768|Antiviral Agents|antiviral agents|mesh-ancestor
56334606|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334607|NCT00066768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334608|NCT00066768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334609|NCT00066768|Immunologic Factors|immunologic factors|mesh-ancestor
56334610|NCT00066768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334611|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334612|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334613|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334614|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
56334615|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
56334616|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56334617|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56334619|NCT00066846|Leucovorin|leucovorin|mesh-list
56334620|NCT00066846|Bevacizumab|bevacizumab|mesh-list
56334621|NCT00066846|Fluorouracil|fluorouracil|mesh-list
56334622|NCT00066846|Calcium|calcium|mesh-list
56334623|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
56334624|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56334625|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334626|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56334627|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56334628|NCT00066846|Growth Substances|growth substances|mesh-ancestor
56334629|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334630|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
56165421|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
56334631|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56334632|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
56334633|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334634|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334635|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334636|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
56334637|NCT00066846|Antidotes|antidotes|mesh-ancestor
56334638|NCT00066846|Protective Agents|protective agents|mesh-ancestor
56334639|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
56334641|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
56334642|NCT00066885|Calcitriol|calcitriol|mesh-list
56334643|NCT00066885|Docetaxel|docetaxel|mesh-list
56334644|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334645|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
55978951|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
56661444|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56661445|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
56334648|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979171|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334649|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56334650|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334651|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55979327|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
56334652|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55979470|NCT02153983|Colchicine|colchicine|mesh-list
55979692|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
56334653|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56334655|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
56334656|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56334657|NCT04941521|Exenatide|exenatide|mesh-list
56334658|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55979917|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
56334659|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334660|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56334661|NCT04941521|Incretins|incretins|mesh-ancestor
56334662|NCT04941521|Hormones|hormones|mesh-ancestor
56093072|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
56165423|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165424|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56334663|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334664|NCT02966457|Colistin|colistin|mesh-list
56334665|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56334666|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334667|NCT00067041|Treprostinil|treprostinil|mesh-list
56334668|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55980436|NCT04818489|Colchicine|colchicine|mesh-list
56334670|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
56334672|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56334673|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334674|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
56334675|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334676|NCT04732598|Paclitaxel|paclitaxel|mesh-list
56334677|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56334678|NCT04732598|Bevacizumab|bevacizumab|mesh-list
56334679|NCT04732598|Atezolizumab|atezolizumab|mesh-list
56334680|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56334681|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334683|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
56334684|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334685|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334686|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56334687|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56334688|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56334689|NCT04732598|Growth Substances|growth substances|mesh-ancestor
56334690|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334691|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
56334692|NCT00067080|Deferasirox|deferasirox|mesh-list
56334693|NCT00067080|Deferoxamine|deferoxamine|mesh-list
56334694|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56334695|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
56334696|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
56334697|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334698|NCT00067080|Siderophores|siderophores|mesh-ancestor
56334699|NCT00396851|Metformin|metformin|mesh-list
56334700|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56334701|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334702|NCT00067119|Dipyridamole|dipyridamole|mesh-list
56334703|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56334704|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980707|NCT04340505|Hormones|hormones|mesh-ancestor
56334705|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56334706|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334707|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56334708|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
56334710|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56334711|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334712|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
56334713|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
55981213|NCT00849251|Hormones|hormones|mesh-ancestor
56661446|NCT02652884|Hormones|hormones|mesh-ancestor
56661447|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661448|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334715|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165425|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
55981359|NCT05635786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55981433|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
56334716|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56334717|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56334718|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
56334719|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
56334720|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334721|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56334722|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
56334724|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
56334725|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
56334726|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56334727|NCT00399165|Dutasteride|dutasteride|mesh-list
56334728|NCT00399165|Androgens|androgens|mesh-ancestor
56334729|NCT00399165|Hormones|hormones|mesh-ancestor
55982020|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56334730|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334731|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334732|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56334733|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334735|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56334736|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56334737|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334738|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334739|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
56334740|NCT00067158|Nicotine|nicotine|mesh-list
55982535|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
56334743|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56334744|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334745|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56334746|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55982920|NCT05444218|Amoxicillin|amoxicillin|mesh-list
56334747|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
56334748|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334749|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983451|NCT01954966|Progesterone|progesterone|mesh-list
56334750|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
56334751|NCT04245722|Rituximab|rituximab|mesh-list
56334752|NCT04245722|Fludarabine|fludarabine|mesh-list
56334753|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
56334754|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334755|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
56334756|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334757|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983727|NCT05031520|Metoprolol|metoprolol|mesh-list
56334758|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56334759|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
55983802|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
55983877|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
55984030|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
56334760|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334761|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334762|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56334763|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56334764|NCT04231643|Dronabinol|dronabinol|mesh-list
56334765|NCT04231643|Cannabidiol|cannabidiol|mesh-list
56334766|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
56334767|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334768|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56334769|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56334770|NCT04231643|Analgesics|analgesics|mesh-ancestor
55984259|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
56334771|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
56334772|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984393|NCT04476628|Budesonide|budesonide|mesh-list
56334773|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55984467|NCT00915655|Ritonavir|ritonavir|mesh-list
56661449|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56661450|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
56661451|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56661452|NCT00990301|Moexipril|moexipril|mesh-list
56661453|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56661454|NCT00990301|Diuretics|diuretics|mesh-ancestor
56334774|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56334775|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334776|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334777|NCT04231643|Hormones|hormones|mesh-ancestor
56334778|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334779|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
56334780|NCT00071097|Darunavir|darunavir|mesh-list
56334781|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55984876|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334782|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56334783|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
56334784|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334785|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334786|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56334787|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56334788|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
56334789|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334790|NCT00067353|Fluorides|fluorides|mesh-list
56334791|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
56334792|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
56334793|NCT00067353|Protective Agents|protective agents|mesh-ancestor
56334794|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334795|NCT00071136|Gemcitabine|gemcitabine|mesh-list
56334796|NCT00071136|Pemetrexed|pemetrexed|mesh-list
56334797|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334798|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
56334799|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334800|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985395|NCT02756572|Analgesics|analgesics|mesh-ancestor
56334802|NCT00071136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334803|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334804|NCT00071136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56334808|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56334809|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
56334810|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55985843|NCT01040689|Olodaterol|olodaterol|mesh-list
56334811|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
56334812|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56334813|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
56334814|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334815|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334816|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
56334817|NCT00067431|Valproic Acid|valproic acid|mesh-list
56334818|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
56334819|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334820|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334821|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
56334822|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334823|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334824|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
56334825|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56334826|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56334827|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56334828|NCT00067509|Progesterone|progesterone|mesh-list
56334830|NCT00067509|Progestins|progestins|mesh-ancestor
56334831|NCT00067509|Hormones|hormones|mesh-ancestor
56334832|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334833|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334835|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56334836|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56334837|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
56177035|NCT01175356|Etoposide|etoposide|mesh-list
56334838|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986126|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56661455|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
56661456|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661457|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56334839|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986272|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56334840|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56334841|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
55986346|NCT01831505|Hormones|hormones|mesh-ancestor
56334842|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
56334843|NCT01349673|Hormones|hormones|mesh-ancestor
56334844|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56334845|NCT00071253|Valproic Acid|valproic acid|mesh-list
56334846|NCT00071253|Olanzapine|olanzapine|mesh-list
56334847|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
56334848|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
56334849|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986786|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334850|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334851|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56334852|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56334853|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56334854|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56334855|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55987008|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
56334856|NCT00071253|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55987236|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
56334857|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56334858|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987455|NCT00909545|Isradipine|isradipine|mesh-list
56334859|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334860|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334861|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
56334862|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
56334863|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334864|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
56334865|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
56334866|NCT00067548|EKB 569|ekb 569|mesh-list
56334867|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334868|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56334869|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987891|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
56334884|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56334885|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988554|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334886|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334887|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177110|NCT05274113|Dexamethasone|dexamethasone|mesh-list
56334888|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55988771|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
56334889|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
56334890|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
56334891|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56334892|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56334893|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56334894|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56334895|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55989073|NCT03016741|Prednisone|prednisone|mesh-list
55989135|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55989136|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55989138|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55989139|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
56334896|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55989512|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
56334897|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56334898|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56334899|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56334900|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
55989739|NCT02959125|Micronutrients|micronutrients|mesh-list
55989811|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
55989885|NCT03029455|Ivacaftor|ivacaftor|mesh-list
56334901|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56334902|NCT00071331|Tolvaptan|tolvaptan|mesh-list
56002214|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
56661458|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56661459|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661460|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56334903|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55990130|NCT04361513|Hormones|hormones|mesh-ancestor
56334904|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334905|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
56334906|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334907|NCT02544815|Digoxin|digoxin|mesh-list
55990330|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334908|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56334909|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56334910|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334911|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334912|NCT02544815|Protective Agents|protective agents|mesh-ancestor
56334913|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334914|NCT00067626|Chromium|chromium|mesh-list
56334916|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
56334917|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334921|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56334922|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56334923|NCT00067743|Growth Substances|growth substances|mesh-ancestor
56334924|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
56167821|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167822|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167823|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56167824|NCT00005598|Protective Agents|protective agents|mesh-ancestor
56167825|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167827|NCT00005604|Interleukin-2|interleukin-2|mesh-list
56167828|NCT00005604|Interleukin-12|interleukin-12|mesh-list
56167829|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167830|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56167831|NCT00005604|Analgesics|analgesics|mesh-ancestor
56167832|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
56167833|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167834|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167835|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56167836|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56167838|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167839|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56167840|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
56167841|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56167842|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56167843|NCT00005604|Growth Substances|growth substances|mesh-ancestor
56167844|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
56167845|NCT00005610|Sargramostim|sargramostim|mesh-list
56167846|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
56167847|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167848|NCT00005616|Antibodies|antibodies|mesh-list
56167849|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56167851|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167852|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
56095478|NCT00000188|Selegiline|selegiline|mesh-list
56167853|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167854|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
55766497|NCT03176537|Hormones|hormones|mesh-ancestor
56167855|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167856|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55766633|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766634|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167857|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56167858|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
56167859|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167860|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167861|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56167863|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167864|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56167865|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167866|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167867|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56661461|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
56661462|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661463|NCT00715858|Doxycycline|doxycycline|mesh-list
56661464|NCT00715858|Rifampin|rifampin|mesh-list
56661465|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661466|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661467|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
56661468|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56661469|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56661470|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56661471|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
56661472|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
56661473|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56661474|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661475|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661476|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56661477|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56167868|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56167869|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167870|NCT00005646|Paclitaxel|paclitaxel|mesh-list
56167871|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56167872|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167874|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167875|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
55782968|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
56167876|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167877|NCT00005652|Rituximab|rituximab|mesh-list
56167878|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56167879|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167880|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
56167881|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167882|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167883|NCT00005658|Glycine|glycine|mesh-list
56167884|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
56167885|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167889|NCT00005796|Lomustine|lomustine|mesh-list
56167890|NCT00005796|Procarbazine|procarbazine|mesh-list
56167891|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55767318|NCT05504967|Hormones|hormones|mesh-ancestor
56167893|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
56167894|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167895|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167896|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167897|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56167898|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
56167899|NCT00005802|Cytarabine|cytarabine|mesh-list
56167900|NCT00005802|Aldesleukin|aldesleukin|mesh-list
56167901|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
56167902|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56167903|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56167904|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56167905|NCT00005802|Methotrexate|methotrexate|mesh-list
56167906|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
56167907|NCT00005802|Fludarabine|fludarabine|mesh-list
56167908|NCT00005802|Etoposide|etoposide|mesh-list
55767831|NCT02402465|Xhance|xhance|mesh-list
56167909|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
56167910|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56167911|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
56167912|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56661478|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56661479|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56661480|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56661481|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56661482|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
56661483|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56661484|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167913|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167914|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167916|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167917|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768177|NCT04480775|Hormones|hormones|mesh-ancestor
56167918|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
56167919|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768249|NCT02398487|Nicotine|nicotine|mesh-list
55783010|NCT02337127|Lamivudine|lamivudine|mesh-list
56167920|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56167921|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167922|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
56167923|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167924|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56167925|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56167926|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56167927|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56167928|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
56167929|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768597|NCT04275375|Anesthetics|anesthetics|mesh-list
56167930|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167931|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56167932|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56167933|NCT00005802|Analgesics|analgesics|mesh-ancestor
56167934|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
55768817|NCT02394197|Primaquine|primaquine|mesh-list
56167935|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167936|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
55789064|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
55769036|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
56167937|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56167938|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
56167940|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167941|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56167943|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
55783026|NCT05007587|Lenvatinib|lenvatinib|mesh-list
56167944|NCT00354900|Coagulants|coagulants|mesh-ancestor
55769256|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
56167945|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55769325|NCT05428215|Estradiol|estradiol|mesh-list
56167947|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
56167948|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769540|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55769541|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769542|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55769543|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769544|NCT05169437|Niraparib|niraparib|mesh-list
55769546|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167950|NCT00355290|Vitamin K|vitamin k|mesh-list
56167951|NCT00355290|Vitamins|vitamins|mesh-ancestor
56167952|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
56167953|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167954|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56167955|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56167956|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167957|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
56167958|NCT00355290|Coagulants|coagulants|mesh-ancestor
56167959|NCT00355446|Bimatoprost|bimatoprost|mesh-list
56167960|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56167962|NCT00355524|Darunavir|darunavir|mesh-list
56167963|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56167964|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56167965|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
56167966|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661485|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
56661486|NCT04696445|Morphine|morphine|mesh-list
56661487|NCT04696445|Oxycodone|oxycodone|mesh-list
56661488|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56661489|NCT04696445|Narcotics|narcotics|mesh-ancestor
56661490|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307619|NCT00047749|Analgesics|analgesics|mesh-ancestor
56661491|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661492|NCT04696445|Analgesics|analgesics|mesh-ancestor
56661493|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
56661494|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661495|NCT05360953|Clonidine|clonidine|mesh-list
56661496|NCT05360953|Doxazosin|doxazosin|mesh-list
56661497|NCT05360953|Analgesics|analgesics|mesh-ancestor
56661498|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
56661499|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661500|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661501|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56661502|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
56661503|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
56661504|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56661505|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56661506|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56661507|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
56661508|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661509|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661510|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55783039|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56167967|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167968|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56167969|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55770281|NCT02383121|Midodrine|midodrine|mesh-list
56167971|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167972|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55770342|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
56167973|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56167974|NCT00355602|Metronidazole|metronidazole|mesh-list
56167975|NCT00355602|Vancomycin|vancomycin|mesh-list
56167976|NCT00355602|Clarithromycin|clarithromycin|mesh-list
56167977|NCT00355602|Doxycycline|doxycycline|mesh-list
56167978|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
56167980|NCT00355602|Cefuroxime|cefuroxime|mesh-list
56167981|NCT00355602|Neomycin|neomycin|mesh-list
56167982|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56167983|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56167984|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167985|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56167986|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56167987|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56167988|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56661511|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56661512|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56661513|NCT02647424|Letrozole|letrozole|mesh-list
56661514|NCT02647424|Clomiphene|clomiphene|mesh-list
56661515|NCT02647424|Enclomiphene|enclomiphene|mesh-list
56661516|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
55771000|NCT03603509|Vaccines|vaccines|mesh-list
56167989|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783057|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
56167990|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167991|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56167992|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56167993|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
56167994|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56167995|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55783062|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
55771274|NCT02362529|Celecoxib|celecoxib|mesh-list
56167996|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167997|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56167998|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56167999|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56168001|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56168002|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56168003|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55783069|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168004|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56168005|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56168006|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168007|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
56168008|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168009|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168011|NCT00356226|Analgesics|analgesics|mesh-ancestor
56168012|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
56168013|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771831|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168014|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168015|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56168016|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
56168017|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
56168018|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56168019|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56168021|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
56168022|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168023|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168024|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56168025|NCT00356460|Antibodies|antibodies|mesh-list
56168026|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
56168027|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56168028|NCT00356460|Mitogens|mitogens|mesh-list
55783093|NCT03078725|Metformin|metformin|mesh-list
56168029|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
56168030|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168031|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168032|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
56168033|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168034|NCT00356616|Tenofovir|tenofovir|mesh-list
56168035|NCT00356616|Abacavir|abacavir|mesh-list
56168036|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
56168037|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168038|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56168039|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56168040|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168041|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168042|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56168043|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56168044|NCT00356772|Azithromycin|azithromycin|mesh-list
55772737|NCT02709655|Fluoxetine|fluoxetine|mesh-list
56168045|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56168046|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168048|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661517|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661518|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56661519|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56661520|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661521|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661522|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56661523|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
56661524|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661525|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661526|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56661527|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
56661528|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56661529|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56661530|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56661531|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
56661532|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56661533|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661534|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168049|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168050|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
56168051|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168052|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
56168053|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168054|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55783114|NCT05014685|Rabeprazole|rabeprazole|mesh-list
56168055|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56168056|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
56168057|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168058|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168059|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56168061|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
55783126|NCT05014685|Diuretics|diuretics|mesh-ancestor
56168062|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56168063|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56168064|NCT00357084|Prednisolone|prednisolone|mesh-list
56168065|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
56168066|NCT00357084|Methotrexate|methotrexate|mesh-list
56168067|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56168068|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
56168069|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56168071|NCT00357084|Hormones|hormones|mesh-ancestor
56168072|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168073|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168074|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56168075|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168076|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56168077|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
56168079|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56168080|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
56168081|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168082|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
56168083|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168084|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56661535|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661536|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56661537|NCT02574754|Warfarin|warfarin|mesh-list
56661538|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
56661539|NCT00719602|Ritonavir|ritonavir|mesh-list
56661540|NCT00719602|Lopinavir|lopinavir|mesh-list
56661541|NCT00719602|Lamivudine|lamivudine|mesh-list
56661542|NCT00719602|Zidovudine|zidovudine|mesh-list
56661543|NCT00719602|Nevirapine|nevirapine|mesh-list
56661544|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56661545|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56661546|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
56661547|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661548|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661549|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56661550|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56661551|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
56661552|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661553|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56661554|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56661555|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56661556|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56661557|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
56661558|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56661559|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56661560|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56661561|NCT02652650|Norethindrone|norethindrone|mesh-list
56661562|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
56661563|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56661564|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56661565|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56307700|NCT00048646|Hormones|hormones|mesh-ancestor
56661567|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56222992|NCT05596214|Curcumin|curcumin|mesh-list
56168085|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168086|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
56168087|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56168088|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56168090|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
56168091|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168092|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56168094|NCT00357084|Protective Agents|protective agents|mesh-ancestor
56168096|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56168100|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
56661568|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661569|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56661570|NCT02652650|Estrogens|estrogens|mesh-ancestor
56661571|NCT02652650|Hormones|hormones|mesh-ancestor
56661572|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661573|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56168101|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168102|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168103|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56168104|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56168105|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
56168106|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168107|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56168108|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55783156|NCT04762459|Pemetrexed|pemetrexed|mesh-list
56168109|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56168110|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56168111|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56168112|NCT00357318|Bevacizumab|bevacizumab|mesh-list
56168113|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56168114|NCT00357318|Sunitinib|sunitinib|mesh-list
56168115|NCT00357318|Antibodies|antibodies|mesh-list
56168116|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
56168117|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56168118|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168119|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56168120|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55783168|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
56168121|NCT00357318|Growth Substances|growth substances|mesh-ancestor
56168122|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168123|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
56168124|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
56168125|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56168126|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168127|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168128|NCT00357474|Ethanol|ethanol|mesh-list
56168129|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56168130|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168131|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168132|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168133|NCT00357630|Gemcitabine|gemcitabine|mesh-list
56168134|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56168135|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
56168136|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168137|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168138|NCT00357630|Antiviral Agents|antiviral agents|mesh-ancestor
56168139|NCT00357630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168140|NCT00357630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168141|NCT00357630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168142|NCT00357630|Immunologic Factors|immunologic factors|mesh-ancestor
56168143|NCT00357630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168144|NCT00357708|Decitabine|decitabine|mesh-list
56168145|NCT00357708|Azacitidine|azacitidine|mesh-list
56168146|NCT00357708|Vorinostat|vorinostat|mesh-list
56168147|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56168148|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
56168149|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783181|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
56168150|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168151|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168152|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56168153|NCT00357864|Carbachol|carbachol|mesh-list
56168154|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56168155|NCT00357864|Miotics|miotics|mesh-ancestor
56168156|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
55783185|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56168157|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168158|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168159|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56661574|NCT02643602|Theophylline|theophylline|mesh-list
56661575|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56661576|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
56661577|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168160|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
56168161|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783191|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168162|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168163|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56168164|NCT00357864|Analgesics|analgesics|mesh-ancestor
56168165|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
56168171|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168172|NCT00357942|Analgesics|analgesics|mesh-ancestor
56168173|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
55775422|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55775423|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775424|NCT03174457|Micafungin|micafungin|mesh-list
55775425|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
55775426|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775430|NCT02409433|Lacosamide|lacosamide|mesh-list
56168174|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168176|NCT00358020|Bortezomib|bortezomib|mesh-list
56168177|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168178|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168179|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
56168180|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168181|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
56168182|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56168183|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168184|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56168185|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56168186|NCT00358020|Growth Substances|growth substances|mesh-ancestor
56168187|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
56168188|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
56168189|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56168190|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56168191|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168192|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56168193|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783213|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56168194|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56168196|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
56168197|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
56168198|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168199|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783218|NCT02345707|Cabotegravir|cabotegravir|mesh-list
56168200|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56168201|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56168202|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168203|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168204|NCT00358488|Albuterol|albuterol|mesh-list
56168205|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56168206|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56168207|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
56168208|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168209|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168210|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56168211|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
56168212|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56168213|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55776214|NCT03171727|Heparin|heparin|mesh-list
56168214|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56168215|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
56168216|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168217|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168218|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
56168219|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56168220|NCT00358566|Gemcitabine|gemcitabine|mesh-list
56168221|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56168222|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
55888851|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56223031|NCT05596071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56223032|NCT05596071|Anesthetics, General|anesthetics, general|mesh-ancestor
55789079|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661578|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661579|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56661580|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
56661581|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56661582|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661583|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661584|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
56661585|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56661586|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56661587|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
56661588|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661589|NCT00710320|Anesthetics|anesthetics|mesh-list
56168223|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168224|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168225|NCT00358566|Antiviral Agents|antiviral agents|mesh-ancestor
56168226|NCT00358566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168227|NCT00358566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168228|NCT00358566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168229|NCT00358566|Immunologic Factors|immunologic factors|mesh-ancestor
56168230|NCT00358566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168231|NCT00359112|Metformin|metformin|mesh-list
56168234|NCT00359190|Lapatinib|lapatinib|mesh-list
56168235|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168236|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56168237|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168238|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168239|NCT00359658|Cyclosporine|cyclosporine|mesh-list
55783245|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
56168240|NCT00359658|Prednisolone|prednisolone|mesh-list
56168241|NCT00359658|Cyclosporins|cyclosporins|mesh-list
55783248|NCT03081923|Durvalumab|durvalumab|mesh-list
55776427|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776428|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
55776429|NCT04719065|Analgesics|analgesics|mesh-ancestor
55776430|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
55776431|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776432|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776433|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776434|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56168242|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168243|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168244|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168245|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
56168246|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168247|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
56168248|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168249|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
56168250|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661590|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661591|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661592|NCT00716170|Glucagon|glucagon|mesh-list
56661593|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56661594|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56223043|NCT05595447|Pembrolizumab|pembrolizumab|mesh-list
56168251|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56168252|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55776556|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168254|NCT00359658|Hormones|hormones|mesh-ancestor
56168255|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168256|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56168257|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168258|NCT00359814|Cyclosporine|cyclosporine|mesh-list
56168259|NCT00359814|Cyclosporins|cyclosporins|mesh-list
56177328|NCT05250141|Levodopa|levodopa|mesh-list
56168260|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168261|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168262|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168263|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
56168264|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168265|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
56168266|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168267|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
56168268|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56168269|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56168270|NCT00359892|Obatoclax|obatoclax|mesh-list
56168271|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783264|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56168272|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168273|NCT00359970|Azithromycin|azithromycin|mesh-list
56168274|NCT00359970|Loperamide|loperamide|mesh-list
56168275|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
56168276|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56168277|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168278|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56168279|NCT00360048|Oxytocin|oxytocin|mesh-list
56168280|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
56168281|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56168282|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168283|NCT00360438|Rasburicase|rasburicase|mesh-list
56168284|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
56168285|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56168286|NCT00360594|Acamprosate|acamprosate|mesh-list
56168287|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56168288|NCT00360750|Cytarabine|cytarabine|mesh-list
56168289|NCT00360750|Carboplatin|carboplatin|mesh-list
56168290|NCT00360750|Etoposide|etoposide|mesh-list
56168291|NCT00360750|Vincristine|vincristine|mesh-list
56168292|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168293|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56168294|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56168298|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56168299|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
56168300|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
56168301|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168302|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168303|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
56168304|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168305|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
56168306|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
56168307|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
56168309|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56168310|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
56168311|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56168312|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168314|NCT00361452|Albuterol|albuterol|mesh-list
56168315|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56168316|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56168317|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
56168318|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888852|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661595|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56661596|NCT00716170|Hormones|hormones|mesh-ancestor
56661597|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661598|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661599|NCT00716170|Incretins|incretins|mesh-ancestor
56661600|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
56661601|NCT02652806|Hematinics|hematinics|mesh-ancestor
56661602|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
56661603|NCT04529135|Remifentanil|remifentanil|mesh-list
56661604|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56168319|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168320|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776917|NCT05109299|Fluorides|fluorides|mesh-list
56168321|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56168322|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56168323|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
56168324|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168325|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56168327|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
56168328|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
56168329|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56168330|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
56168331|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56168332|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56168334|NCT00361686|Remifentanil|remifentanil|mesh-list
56168335|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56168336|NCT00361686|Narcotics|narcotics|mesh-ancestor
56168337|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168338|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168340|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
56168341|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168342|NCT00361920|Prednisone|prednisone|mesh-list
56168344|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
56168345|NCT00361920|Hormones|hormones|mesh-ancestor
56168346|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168347|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783337|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168348|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56168349|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168350|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
56168351|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56168352|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168353|NCT00361998|Renal Agents|renal agents|mesh-ancestor
56168354|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56168355|NCT00362310|Indinavir|indinavir|mesh-list
56168356|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56168357|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56168358|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
56168359|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168360|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168361|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56168362|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56168363|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
56168364|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168365|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56168366|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
56168367|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168368|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56168369|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56168370|NCT00362700|Clevudine|clevudine|mesh-list
56168374|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56177371|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
56168375|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168376|NCT00362934|Atorvastatin|atorvastatin|mesh-list
56168377|NCT00362934|Simvastatin|simvastatin|mesh-list
56168378|NCT00362934|Fenofibrate|fenofibrate|mesh-list
56168379|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56168380|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56661605|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661606|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661607|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56661608|NCT04529135|Analgesics|analgesics|mesh-ancestor
56661609|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
56661610|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661611|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56661612|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56223058|NCT05557253|Anesthetics|anesthetics|mesh-list
56168381|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
56168382|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168383|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56168384|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56168385|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168386|NCT00363090|Prednisone|prednisone|mesh-list
56168388|NCT00363090|Doxorubicin|doxorubicin|mesh-list
56168389|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56168390|NCT00363090|Vincristine|vincristine|mesh-list
56168391|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
56168392|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168393|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
56168394|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168395|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56168396|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56168397|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
56168398|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168399|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168400|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56168401|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56168402|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55783390|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168404|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168405|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56168406|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
56168407|NCT00363090|Hormones|hormones|mesh-ancestor
56168408|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777924|NCT05744635|Tacrolimus|tacrolimus|mesh-list
56177380|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168409|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56168410|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56168411|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
56168412|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
56168413|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
56168414|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56168416|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
56168418|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56168419|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168420|NCT00363948|Incretins|incretins|mesh-ancestor
56168421|NCT00363948|Hormones|hormones|mesh-ancestor
56168422|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168423|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56168424|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
56168425|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168426|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168428|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55783409|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56168429|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168430|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
56168431|NCT00364260|Hematinics|hematinics|mesh-ancestor
56168432|NCT00364572|Etanercept|etanercept|mesh-list
56168433|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55778322|NCT03115099|Incretins|incretins|mesh-ancestor
56168434|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56168435|NCT00364572|Analgesics|analgesics|mesh-ancestor
56168436|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
56661613|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56661614|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
56661615|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661616|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661617|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56661618|NCT04529135|Narcotics|narcotics|mesh-ancestor
56661619|NCT04154956|Docetaxel|docetaxel|mesh-list
56661620|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661621|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
56661622|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
56661623|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
56661624|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661625|NCT02647190|Asparaginase|asparaginase|mesh-list
56661626|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661627|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56661628|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
56661629|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661630|NCT04217447|Aspirin|aspirin|mesh-list
56661631|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56223063|NCT05539924|Gabapentin|gabapentin|mesh-list
56223064|NCT05539924|Vitamins|vitamins|mesh-ancestor
56168437|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783424|NCT05178823|Fluorides|fluorides|mesh-list
56168438|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168439|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56168440|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56168441|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56168445|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
56168446|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
56168447|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
56168448|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168449|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168450|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55783436|NCT03105115|Fentanyl|fentanyl|mesh-list
56168451|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56168452|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55778653|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
56168455|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168456|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56168457|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56168458|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168459|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56168460|NCT00365040|Mitomycins|mitomycins|mesh-list
56168461|NCT00365040|Mitomycin|mitomycin|mesh-list
56168462|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56168463|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168464|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
56168465|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168466|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56168467|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168468|NCT00365586|Ketoprofen|ketoprofen|mesh-list
56168469|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56168470|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56168471|NCT00365586|Analgesics|analgesics|mesh-ancestor
56168472|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
56002215|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
56661632|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56661633|NCT04217447|Analgesics|analgesics|mesh-ancestor
56661634|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
56661635|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661636|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661637|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56661638|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661639|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56661640|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56661641|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661642|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56661643|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56661644|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661645|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
56661646|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
56661647|NCT04165850|Celecoxib|celecoxib|mesh-list
56661648|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56661649|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56661650|NCT04165850|Analgesics|analgesics|mesh-ancestor
56661651|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
56661652|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661653|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661654|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56661655|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661656|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56661657|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56661658|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661659|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661660|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661661|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661675|NCT02647268|Analgesics|analgesics|mesh-ancestor
56661676|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
56661677|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661678|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
56661679|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661680|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56661681|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
56661682|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56661683|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56661684|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661685|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56661686|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
56661687|NCT04218149|Bupivacaine|bupivacaine|mesh-list
56661688|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
56661689|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
56223127|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56168473|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168474|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168475|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56168477|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56168478|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168479|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168480|NCT00365742|Simvastatin|simvastatin|mesh-list
56168481|NCT00365742|Red yeast rice|red yeast rice|mesh-list
56168482|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56168483|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56168484|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
56168485|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168486|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55783469|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56168487|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56168488|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168489|NCT00365820|Tegaserod|tegaserod|mesh-list
56168490|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56168491|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
56168492|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168493|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168494|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168495|NCT00365898|Hydromorphone|hydromorphone|mesh-list
56168496|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56168497|NCT00365898|Narcotics|narcotics|mesh-ancestor
56168498|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168499|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168500|NCT00365898|Analgesics|analgesics|mesh-ancestor
56168501|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
56168502|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168504|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
56168505|NCT00366834|Ondansetron|ondansetron|mesh-list
56168506|NCT00366834|Casopitant|casopitant|mesh-list
56168507|NCT00366834|BB 1101|bb 1101|mesh-list
56168508|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779299|NCT02388373|Xhance|xhance|mesh-list
56168509|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
56168510|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
56168511|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168512|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168514|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
56168515|NCT00366834|Hormones|hormones|mesh-ancestor
55779576|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
56168518|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661690|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661691|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168519|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
56168520|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168521|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168524|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56168525|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
56168526|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168527|NCT00366834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56168528|NCT00366834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56168529|NCT00366834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168530|NCT00366834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56168531|NCT00366834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55780007|NCT02642159|Niacin|niacin|mesh-list
56168532|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56168533|NCT00367068|Baclofen|baclofen|mesh-list
56168534|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55783520|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56168535|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168536|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55780138|NCT03377023|Nivolumab|nivolumab|mesh-list
56168537|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780277|NCT05482789|Incretins|incretins|mesh-ancestor
56168538|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55780360|NCT02389231|Interleukin-2|interleukin-2|mesh-list
56168539|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
56168540|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
55783529|NCT02338687|Calcium|calcium|mesh-list
56168541|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168542|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168543|NCT00367302|Buprenorphine|buprenorphine|mesh-list
56168544|NCT00367302|Methadone|methadone|mesh-list
56168545|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56168546|NCT00367302|Narcotics|narcotics|mesh-ancestor
56168547|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168548|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168549|NCT00367302|Analgesics|analgesics|mesh-ancestor
56168550|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
56168551|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783532|NCT02332135|Vitamin D|vitamin d|mesh-list
56168552|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56168553|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
56168554|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
56168556|NCT00367536|Estrogens|estrogens|mesh-list
56168557|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56168558|NCT00367536|Hormones|hormones|mesh-ancestor
56168559|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168560|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168561|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56168562|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56168563|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
56168564|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56168565|NCT00367614|Pantoprazole|pantoprazole|mesh-list
56168566|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56168567|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56168568|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56168569|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168570|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168571|NCT00368160|Eszopiclone|eszopiclone|mesh-list
56168572|NCT00368160|Zopiclone|zopiclone|mesh-list
55783548|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
55780798|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
56168573|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56168574|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168575|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168577|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
56168578|NCT00368238|Clopidogrel|clopidogrel|mesh-list
56168579|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55783569|NCT02638259|GP2015|gp2015|mesh-list
56168580|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56168582|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
56168583|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168584|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168587|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56002661|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
56661692|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
56661693|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661694|NCT04032860|Tenofovir|tenofovir|mesh-list
56661695|NCT04032860|Entecavir|entecavir|mesh-list
56661696|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
56661697|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661698|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56661699|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56661700|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661701|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661702|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56168588|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56168589|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168590|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56168591|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56168592|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783574|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56168594|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56168595|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56168596|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56168597|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
56168598|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168599|NCT00368238|Hematinics|hematinics|mesh-ancestor
56168600|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
56168601|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56168602|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168603|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
56168604|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56168605|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56168606|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56168607|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
56168608|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168609|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168610|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168611|NCT00368706|Urological Agents|urological agents|mesh-ancestor
56168612|NCT00368862|Memantine|memantine|mesh-list
56168613|NCT00368862|Citalopram|citalopram|mesh-list
56168614|NCT00368862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55783606|NCT02331823|Ethambutol|ethambutol|mesh-list
56168615|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56168616|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56168617|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168618|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168619|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
56168620|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168621|NCT00368862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56168622|NCT00368862|Antidepressive Agents|antidepressive agents|mesh-ancestor
56168623|NCT00368862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56168624|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56168625|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56168626|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
56168627|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56168628|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56168629|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56168630|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56168631|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56168632|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
56168633|NCT00369096|Bemiparin|bemiparin|mesh-list
56168634|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
56168635|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
56168637|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168638|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
56168639|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56003866|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56661703|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56661704|NCT00716248|Bucillamine|bucillamine|mesh-list
56661705|NCT00716248|Methotrexate|methotrexate|mesh-list
56661706|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56661707|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
56661708|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56661709|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661710|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56661711|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
56661712|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307844|NCT05640791|Durvalumab|durvalumab|mesh-list
56307920|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661713|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661714|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
56661715|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168640|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168641|NCT00369408|Naltrexone|naltrexone|mesh-list
56168642|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56168643|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56168644|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168645|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
56168646|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168647|NCT00369798|Rolipram|rolipram|mesh-list
56168648|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
56168649|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56168650|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56168651|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56168652|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168653|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168654|NCT00369954|Gemcitabine|gemcitabine|mesh-list
56168655|NCT00369954|Carboplatin|carboplatin|mesh-list
56168656|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168660|NCT00369954|Antiviral Agents|antiviral agents|mesh-ancestor
56168661|NCT00369954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168662|NCT00369954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168663|NCT00369954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168664|NCT00369954|Immunologic Factors|immunologic factors|mesh-ancestor
56168665|NCT00369954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168666|NCT00370188|Topiramate|topiramate|mesh-list
56168667|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
56168668|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56168669|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168670|NCT00370266|Triamcinolone|triamcinolone|mesh-list
55783659|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
56168671|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56168672|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
56168673|NCT00370266|Hormones|hormones|mesh-ancestor
56168674|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168675|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168676|NCT00370422|Triamcinolone|triamcinolone|mesh-list
56168677|NCT00370422|Bevacizumab|bevacizumab|mesh-list
56168678|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56168679|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168680|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56168681|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56168682|NCT00370422|Growth Substances|growth substances|mesh-ancestor
56168683|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168684|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
56168685|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56168686|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
56168687|NCT00370422|Hormones|hormones|mesh-ancestor
56661716|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56661717|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168688|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168689|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56168690|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
56168691|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56168692|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56168693|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56168694|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168695|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168696|NCT00370656|Pregabalin|pregabalin|mesh-list
56168697|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56168698|NCT00370656|Amitriptyline|amitriptyline|mesh-list
56168699|NCT00370656|Analgesics|analgesics|mesh-ancestor
56177576|NCT05052528|Antibodies|antibodies|mesh-list
56168700|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
56168701|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168702|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168703|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
56168704|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56168705|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56168706|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168707|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56168708|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56168709|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55783700|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
56168710|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168711|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782277|NCT03093545|Antibodies|antibodies|mesh-list
56168712|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56168713|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56168714|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168715|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
56168716|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
56168717|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56168718|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56168719|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56168720|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
56168721|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
56168722|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56168723|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56168724|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56168728|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168729|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168730|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56168731|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168732|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
56168733|NCT00370968|Astringents|astringents|mesh-ancestor
56168734|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168735|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
56168736|NCT00371124|Atropine|atropine|mesh-list
56168737|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56168738|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56168739|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56168740|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56168741|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56168742|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
56168743|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168744|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168745|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56168746|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
56168747|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
56168748|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
56168749|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56168750|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56168751|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
56168752|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168753|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168754|NCT00371592|Acyclovir|acyclovir|mesh-list
56168755|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
56168756|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168757|NCT00371904|Rituximab|rituximab|mesh-list
56003867|NCT02427620|Methotrexate|methotrexate|mesh-list
56661718|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
56661719|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661720|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56661721|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56661722|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56661723|NCT00716248|Analgesics|analgesics|mesh-ancestor
56661724|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
56661725|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661726|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56661727|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
56168758|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56168759|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168760|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
56168761|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168762|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56168763|NCT00372138|Thrombin|thrombin|mesh-list
56168765|NCT00372138|Coagulants|coagulants|mesh-ancestor
56168766|NCT00372216|Clopidogrel|clopidogrel|mesh-list
56168767|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56168768|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56168769|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56168770|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56168771|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
56168772|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168773|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168774|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168775|NCT00372294|Clindamycin|clindamycin|mesh-list
56168776|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
56168777|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
56168778|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
56168779|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
56168780|NCT00372294|Dexamethasone|dexamethasone|mesh-list
56168781|NCT00372294|Prednisolone|prednisolone|mesh-list
56168782|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56168783|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
56168784|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
56168785|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168786|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168787|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56168788|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
56168789|NCT00372294|Hormones|hormones|mesh-ancestor
56168790|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168791|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56168792|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168793|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56168794|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168795|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56168796|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168797|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168803|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
56168804|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56168805|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56168806|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168807|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56168808|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168809|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56168810|NCT00372762|Furosemide|furosemide|mesh-list
56168811|NCT00372762|Bumetanide|bumetanide|mesh-list
56168812|NCT00372762|Diuretics|diuretics|mesh-ancestor
56168813|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
56168814|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168815|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55783804|NCT03111511|Hormones|hormones|mesh-ancestor
56168816|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56661728|NCT00716248|Protective Agents|protective agents|mesh-ancestor
56661729|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
56661730|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56661731|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
56661732|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56661733|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
56661734|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661735|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661736|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
56661737|NCT02642900|Nystatin|nystatin|mesh-list
56661738|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661739|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661740|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
56661741|NCT02642900|Ionophores|ionophores|mesh-ancestor
56661742|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56661743|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661744|NCT02652728|Enalapril|enalapril|mesh-list
56661745|NCT02652728|Enalaprilat|enalaprilat|mesh-list
56661746|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56661747|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
56661748|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661749|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661750|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56661751|NCT00720148|Bortezomib|bortezomib|mesh-list
56661752|NCT00720148|Sunitinib|sunitinib|mesh-list
56661753|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661754|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56168817|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168819|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56168820|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56168821|NCT00373464|Analgesics|analgesics|mesh-ancestor
56168822|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
56168823|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168824|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168825|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56168826|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56168827|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56168828|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56168829|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168830|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168831|NCT00373542|Ropinirole|ropinirole|mesh-list
56168832|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56168833|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56168834|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
56096453|NCT00000542|Amlodipine|amlodipine|mesh-list
56168835|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
56168836|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168837|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661755|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56661756|NCT00720148|Growth Substances|growth substances|mesh-ancestor
56661757|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661758|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
56223206|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56168838|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168839|NCT00373620|Paclitaxel|paclitaxel|mesh-list
56168840|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56168841|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168842|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
56168843|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
56168844|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
56168845|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168846|NCT00373776|Miltefosine|miltefosine|mesh-list
56168847|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
56168848|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168849|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168850|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56168851|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56168852|NCT00374478|Scopolamine|scopolamine|mesh-list
56168853|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56168854|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56168855|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
56168856|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
56168857|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168858|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168859|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56168860|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
56168861|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56168862|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
56168863|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168864|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168865|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56168866|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
56168871|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
56168872|NCT00375258|Coagulants|coagulants|mesh-ancestor
56168873|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
56168874|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56168875|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168876|NCT00376038|Metformin|metformin|mesh-list
56168877|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56168878|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168880|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56168881|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56168882|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56168883|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168885|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56168886|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168887|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56168888|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168889|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168891|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56168892|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
56168893|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168894|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56168895|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
56168896|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
56168897|NCT00376584|Vitamins|vitamins|mesh-ancestor
55783893|NCT05075863|Letrozole|letrozole|mesh-list
56168899|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168901|NCT00376662|Hormones|hormones|mesh-list
56168902|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168903|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168904|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56168905|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
56168906|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56168907|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168908|NCT00376818|Hormones|hormones|mesh-list
56168909|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56661759|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56661760|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661761|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661762|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
56661763|NCT00710788|Calcium|calcium|mesh-list
56661764|NCT00710788|Sevelamer|sevelamer|mesh-list
56661765|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56661766|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661767|NCT00710788|Antacids|antacids|mesh-ancestor
56661768|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661769|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56661770|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
56661771|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
56661772|NCT03530189|Insulin|insulin|mesh-list
56661773|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56661774|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661775|NCT02646800|Micafungin|micafungin|mesh-list
56661776|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
56661777|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661778|NCT02749409|Parecoxib|parecoxib|mesh-list
56661779|NCT02749409|Morphine|morphine|mesh-list
56661780|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56661781|NCT02749409|Narcotics|narcotics|mesh-ancestor
56661782|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661783|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661784|NCT02749409|Analgesics|analgesics|mesh-ancestor
56661785|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
56661786|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168910|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168912|NCT00377052|Bortezomib|bortezomib|mesh-list
56168913|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56168914|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
56168915|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168916|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168917|NCT00377052|Antiviral Agents|antiviral agents|mesh-ancestor
56168918|NCT00377052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168919|NCT00377052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168920|NCT00377052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168921|NCT00377052|Immunologic Factors|immunologic factors|mesh-ancestor
56168922|NCT00377052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168923|NCT00377442|Simvastatin|simvastatin|mesh-list
56168924|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56168925|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56168926|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
56168927|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168928|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56168929|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56168930|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661787|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56661788|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56661789|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661790|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661791|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56661792|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56661793|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56661794|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661796|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56661797|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56661798|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
56661799|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168931|NCT00377910|Lidocaine|lidocaine|mesh-list
56168932|NCT00377910|Polidocanol|polidocanol|mesh-list
56168933|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
56168934|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
56168935|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168936|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168937|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
56168938|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168939|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56168940|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56168948|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
56168949|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56168950|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168951|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56168952|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56168953|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56168954|NCT00378066|Bevacizumab|bevacizumab|mesh-list
56168955|NCT00378066|Capecitabine|capecitabine|mesh-list
56168956|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
56168957|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56168958|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56168959|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56168960|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56168961|NCT00378066|Growth Substances|growth substances|mesh-ancestor
56168962|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168963|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
55801487|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56168964|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56168966|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168967|NCT00378144|Acetaminophen|acetaminophen|mesh-list
56168968|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
56168969|NCT00378144|Ephedrine|ephedrine|mesh-list
55783965|NCT02329795|Temozolomide|temozolomide|mesh-list
56168970|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56168971|NCT00378144|Analgesics|analgesics|mesh-ancestor
56168972|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
56168973|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56168974|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168975|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
56168976|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56168977|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
56168978|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56168979|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
56168980|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
56168981|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56096602|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
56168982|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56168983|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
56168984|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
56661800|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56661801|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56661802|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661803|NCT03449459|Amikacin|amikacin|mesh-list
56661804|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661805|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661806|NCT00653120|Propranolol|propranolol|mesh-list
56661807|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56661808|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56661809|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
56661810|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661811|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661812|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661813|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56661814|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56661815|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
56661816|NCT00678132|Gemcitabine|gemcitabine|mesh-list
56661817|NCT00678132|Olaparib|olaparib|mesh-list
56168985|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56168986|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168987|NCT00378456|Vitamins|vitamins|mesh-list
56168988|NCT00378456|Leucovorin|leucovorin|mesh-list
56168989|NCT00378456|Folic Acid|folic acid|mesh-list
56168990|NCT00378456|Vitamin A|vitamin a|mesh-list
56168991|NCT00378456|Zinc|zinc|mesh-list
56168992|NCT00378456|Selenium|selenium|mesh-list
56168993|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
56168994|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
56168995|NCT00378456|Antioxidants|antioxidants|mesh-list
56168996|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
56168997|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168998|NCT00378456|Trace Elements|trace elements|mesh-ancestor
56168999|NCT00378456|Antidotes|antidotes|mesh-ancestor
56169000|NCT00378456|Protective Agents|protective agents|mesh-ancestor
56169001|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
56169003|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169004|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56169005|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169006|NCT00378612|Sirolimus|sirolimus|mesh-list
56169007|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56169008|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169009|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56169010|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169011|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
56169012|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56169013|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
56169019|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169020|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56169022|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56169023|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
56169024|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169025|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56169026|NCT00379158|Micronutrients|micronutrients|mesh-list
56169027|NCT00379158|Trace Elements|trace elements|mesh-list
56169028|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169029|NCT00379626|Hormones|hormones|mesh-list
55784015|NCT05002361|Dexamethasone|dexamethasone|mesh-list
56169030|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169031|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169032|NCT00380406|Leuprolide|leuprolide|mesh-list
56661818|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661819|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56661820|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
56661821|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661822|NCT00678132|Antiviral Agents|antiviral agents|mesh-ancestor
56661823|NCT00678132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661824|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661825|NCT00678132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56661826|NCT00678132|Immunologic Factors|immunologic factors|mesh-ancestor
56661827|NCT00678132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661828|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56661829|NCT02789345|Osimertinib|osimertinib|mesh-list
56661830|NCT02789345|Ramucirumab|ramucirumab|mesh-list
56661831|NCT02789345|Necitumumab|necitumumab|mesh-list
56169033|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56169034|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
56169035|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56169036|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169037|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56169038|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784027|NCT02329405|Rifampin|rifampin|mesh-list
56169039|NCT00380484|Budesonide|budesonide|mesh-list
56169040|NCT00380484|Montelukast|montelukast|mesh-list
56169041|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56169042|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56169043|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
56169044|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169045|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169046|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56169047|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169048|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
56169049|NCT00380484|Hormones|hormones|mesh-ancestor
56169050|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169051|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56169052|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
56169053|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56169054|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56169055|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169056|NCT00380640|Trimethoprim|trimethoprim|mesh-list
56169057|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56096692|NCT00002156|Ganciclovir|ganciclovir|mesh-list
56169058|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169059|NCT00380640|Renal Agents|renal agents|mesh-ancestor
56169060|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
56169061|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56169062|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56169063|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56169064|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169065|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169066|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56169067|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56177731|NCT04760912|Bromides|bromides|mesh-list
56169068|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56169070|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56169071|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56169072|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
56169073|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784058|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56169074|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169075|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661832|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661833|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56661834|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661835|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169076|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56169077|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
56169078|NCT00381030|Protective Agents|protective agents|mesh-ancestor
56169079|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56169080|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56169083|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56169085|NCT00381264|Nabilone|nabilone|mesh-list
56169086|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
56169087|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
56169088|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169089|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169090|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169091|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56169092|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56169093|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169094|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56169095|NCT00381342|Exenatide|exenatide|mesh-list
56169096|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56169097|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169098|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56169099|NCT00381342|Incretins|incretins|mesh-ancestor
56169100|NCT00381342|Hormones|hormones|mesh-ancestor
56169101|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169102|NCT00381654|MP 412|mp 412|mesh-list
56169103|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169104|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56169105|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169106|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169107|NCT00381732|Tadalafil|tadalafil|mesh-list
56169108|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
56169109|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56169110|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56169111|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169112|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784087|NCT04654429|Ondansetron|ondansetron|mesh-list
56169114|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
56169115|NCT00382044|Hematinics|hematinics|mesh-ancestor
55814977|NCT05060627|Hormones|hormones|mesh-ancestor
56169116|NCT00382356|Dutasteride|dutasteride|mesh-list
56169117|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56169118|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56169119|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169120|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169121|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
56169122|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169123|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169124|NCT00382668|Dasatinib|dasatinib|mesh-list
56169125|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169128|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169129|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56169130|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56169131|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
56169132|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169134|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169135|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169136|NCT00383136|Tirofiban|tirofiban|mesh-list
56169137|NCT00383136|Abciximab|abciximab|mesh-list
56169138|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
56169139|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56169140|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56169141|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56169142|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169143|NCT00383214|Epratuzumab|epratuzumab|mesh-list
56169144|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56169145|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169146|NCT00383370|Aflibercept|aflibercept|mesh-list
56661836|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56661837|NCT02772965|Methotrexate|methotrexate|mesh-list
56661838|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56661839|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
56661840|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56661841|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661842|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56661843|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
56661844|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661845|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661846|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
56661847|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169147|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56169148|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56169149|NCT00383370|Growth Substances|growth substances|mesh-ancestor
56169150|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169151|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56169152|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169153|NCT00383526|Vaccines|vaccines|mesh-list
56169154|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
56169157|NCT00383682|Morphine|morphine|mesh-list
56169158|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56169159|NCT00383682|Narcotics|narcotics|mesh-ancestor
56169160|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169161|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169162|NCT00383682|Analgesics|analgesics|mesh-ancestor
56169163|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
56169164|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169165|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56169166|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56169167|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56169168|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56169169|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169170|NCT00383916|Pantoprazole|pantoprazole|mesh-list
56169171|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56169172|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169173|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56169174|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177761|NCT04706767|Analgesics|analgesics|mesh-ancestor
56169175|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169177|NCT00383994|Sargramostim|sargramostim|mesh-list
56169178|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56169179|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169180|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
56169181|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169182|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56169183|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
56169184|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56169185|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56169186|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
56169187|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169188|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169189|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56169190|NCT00384306|Prednisolone|prednisolone|mesh-list
56169191|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56169192|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
56169193|NCT00384306|Hormones|hormones|mesh-ancestor
56169194|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169195|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169196|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56661848|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56661849|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56661850|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
56661851|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661852|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56661853|NCT00681720|Flumazenil|flumazenil|mesh-list
56661854|NCT00681720|Antidotes|antidotes|mesh-ancestor
56661855|NCT00681720|Protective Agents|protective agents|mesh-ancestor
56661856|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661857|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
56661858|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
56661859|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223289|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
56169197|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169198|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
56169199|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56169201|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56169202|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
56169203|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
56169204|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169205|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169206|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56169207|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56169208|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56169209|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
56169210|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784208|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56169211|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169212|NCT00384540|Protective Agents|protective agents|mesh-ancestor
56169213|NCT00384618|Vitamin E|vitamin e|mesh-list
56169214|NCT00384618|Pravastatin|pravastatin|mesh-list
56169215|NCT00384618|Vitamins|vitamins|mesh-ancestor
56169216|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
56169217|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169218|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
56169219|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169220|NCT00384618|Protective Agents|protective agents|mesh-ancestor
56169221|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56169222|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56169223|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
56169224|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56169225|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56169237|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56169238|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56169240|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55784244|NCT03072485|Metformin|metformin|mesh-list
56169241|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56169242|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
56169243|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169244|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169245|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56169246|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169248|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56169249|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
56169250|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169251|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56169252|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
56169253|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169254|NCT00385710|Valproic Acid|valproic acid|mesh-list
56169255|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
56169256|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169257|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169259|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56661860|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661861|NCT00650312|Metformin|metformin|mesh-list
56661862|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56661863|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661864|NCT00538681|Pemetrexed|pemetrexed|mesh-list
56661865|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661866|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661867|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661868|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56661869|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56661870|NCT00650390|Adalimumab|adalimumab|mesh-list
56661871|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56661872|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56661873|NCT00681876|Bevacizumab|bevacizumab|mesh-list
56661874|NCT00681876|Cetuximab|cetuximab|mesh-list
56661875|NCT00681876|Irinotecan|irinotecan|mesh-list
56661876|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56661877|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661878|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56661879|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56661880|NCT00681876|Growth Substances|growth substances|mesh-ancestor
56661881|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661882|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
56661883|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56661884|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56661885|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223299|NCT05350696|Narcotics|narcotics|mesh-ancestor
56169260|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169261|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
56169262|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56169263|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169264|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56169265|NCT00386178|Vitamin E|vitamin e|mesh-list
56169266|NCT00386178|Tocopherols|tocopherols|mesh-list
56169267|NCT00386178|Tocotrienols|tocotrienols|mesh-list
56169268|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
56169269|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
56169270|NCT00386178|Vitamins|vitamins|mesh-ancestor
56169271|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
56169272|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169273|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
56169274|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169275|NCT00386178|Protective Agents|protective agents|mesh-ancestor
56169276|NCT00421824|Capecitabine|capecitabine|mesh-list
56169277|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
56169278|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56169279|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
56169280|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169281|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169282|NCT00421980|Etanercept|etanercept|mesh-list
56661886|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661887|NCT05359627|Polymyxins|polymyxins|mesh-list
56661888|NCT05359627|Polymyxin B|polymyxin b|mesh-list
56661889|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661890|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661891|NCT03927989|Nicotine|nicotine|mesh-list
56661892|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56661893|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
56661894|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661895|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661896|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56169283|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56169284|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56169285|NCT00421980|Analgesics|analgesics|mesh-ancestor
56169286|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
56169287|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169288|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169289|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56169290|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56169291|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169298|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56169299|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169300|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169301|NCT00422526|Progesterone|progesterone|mesh-list
56169302|NCT00422526|Progestins|progestins|mesh-ancestor
56169303|NCT00422526|Hormones|hormones|mesh-ancestor
56169304|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169305|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169306|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
56169307|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56169308|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56169309|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
56169310|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784277|NCT03111433|Ubiquinone|ubiquinone|mesh-list
56169311|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169312|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56169313|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169314|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
56169315|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56169316|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
56169317|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169318|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169319|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56169320|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56169321|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56169322|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
56169324|NCT00422682|Paclitaxel|paclitaxel|mesh-list
56169325|NCT00422682|Carboplatin|carboplatin|mesh-list
56169326|NCT00422682|Temozolomide|temozolomide|mesh-list
56169327|NCT00422682|Topotecan|topotecan|mesh-list
56169328|NCT00422682|Iniparib|iniparib|mesh-list
56169329|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56169330|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169331|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
56169332|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
56169333|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
55784331|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
56169334|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169335|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56169336|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
56169337|NCT00422682|Antiviral Agents|antiviral agents|mesh-ancestor
56169338|NCT00422682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169339|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169340|NCT00422682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56169341|NCT00422682|Immunologic Factors|immunologic factors|mesh-ancestor
56661897|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56661898|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
56661899|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169342|NCT00422682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169343|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56169344|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
55784346|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
56169345|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56169346|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56169347|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56169348|NCT00422994|Ropinirole|ropinirole|mesh-list
56169349|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56169350|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56169351|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
56169352|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
56169353|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169354|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169355|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169357|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55820278|NCT01765582|Leucovorin|leucovorin|mesh-list
56169358|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169359|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169361|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169362|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169363|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
55784371|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169365|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56169366|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169367|NCT01799850|Pioglitazone|pioglitazone|mesh-list
56169368|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56169369|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169370|NCT01792050|Paclitaxel|paclitaxel|mesh-list
56169371|NCT01792050|Docetaxel|docetaxel|mesh-list
56169372|NCT01792050|Tryptophan|tryptophan|mesh-list
56169373|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56169374|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169375|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
56169376|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
56169377|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
56169378|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169379|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56169380|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
56169381|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56169382|NCT01790100|Ribavirin|ribavirin|mesh-list
56169383|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
56169384|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169385|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
56169386|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169387|NCT01799460|Cyclosporine|cyclosporine|mesh-list
56169388|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
56169389|NCT01799460|Tacrolimus|tacrolimus|mesh-list
56169390|NCT01799460|Cyclosporins|cyclosporins|mesh-list
56169391|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56169392|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
56169393|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
56169394|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169395|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56169396|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56169397|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
56169398|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169399|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169400|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56169401|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56169402|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169403|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
56169404|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169405|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
56169406|NCT01799460|Hormones|hormones|mesh-ancestor
56169407|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169408|NCT02999724|Gabapentin|gabapentin|mesh-list
56169409|NCT02999724|Analgesics|analgesics|mesh-ancestor
56169410|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
56169411|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56661900|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661901|NCT02226367|Prazosin|prazosin|mesh-list
56661902|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56661903|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56661904|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56661905|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56661906|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
56661907|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223326|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169412|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169413|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
56169414|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56169415|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56169416|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169417|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56169418|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56169419|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55784424|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
56169420|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169421|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169422|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
56169423|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56169424|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56169425|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169426|NCT02998242|Apatinib|apatinib|mesh-list
56169427|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169428|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56169429|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169430|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169431|NCT02998398|Infliximab|infliximab|mesh-list
56169432|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
56169433|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169437|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56169439|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169440|NCT02996916|Amlodipine|amlodipine|mesh-list
56169441|NCT02996916|Olmesartan|olmesartan|mesh-list
56169442|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56169443|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56169444|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56169445|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169446|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56169447|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169448|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
56169449|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56169450|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56169451|NCT02996214|Gemcitabine|gemcitabine|mesh-list
56169453|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56169454|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169455|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
56169456|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
56169457|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
56169458|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169459|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56169460|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
56169461|NCT02996214|Antiviral Agents|antiviral agents|mesh-ancestor
56169462|NCT02996214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169463|NCT02996214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169464|NCT02996214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56169465|NCT02996214|Immunologic Factors|immunologic factors|mesh-ancestor
56169466|NCT02996214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169467|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
56169468|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56169469|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56661908|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661909|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661910|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56661911|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
56661912|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661913|NCT02159989|Aflibercept|aflibercept|mesh-list
56661914|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
56661915|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56661916|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56661917|NCT02159989|Growth Substances|growth substances|mesh-ancestor
56661918|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661919|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
56661920|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661921|NCT02628132|Paclitaxel|paclitaxel|mesh-list
56661922|NCT02628132|Durvalumab|durvalumab|mesh-list
56661923|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56661924|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661925|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
56661926|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
56661927|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
56169470|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169471|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56169472|NCT02996058|Analgesics|analgesics|mesh-ancestor
56169473|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
56169474|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169475|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56169476|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56169477|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56169478|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
56169479|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169480|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169481|NCT02995512|Colchicine|colchicine|mesh-list
56169482|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
56169483|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56169484|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
55821460|NCT03939637|Antibodies|antibodies|mesh-list
56169485|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
56169486|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
56169487|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169488|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169489|NCT02994888|Cetuximab|cetuximab|mesh-list
56169490|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56169491|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169492|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
56169493|NCT02993718|Propofol|propofol|mesh-list
56169494|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56169495|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169496|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169497|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56169498|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
56169499|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
56169500|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56169501|NCT02993718|Analgesics|analgesics|mesh-ancestor
56169504|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56169505|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56661928|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661929|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56661930|NCT02695355|Methylphenidate|methylphenidate|mesh-list
56661931|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56661932|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661933|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56661934|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56169506|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56169507|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
56169508|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169509|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169511|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
56169514|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56169515|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56169516|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
56169517|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169518|NCT02993094|Carboplatin|carboplatin|mesh-list
56169520|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169521|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
56169522|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169523|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169524|NCT02992938|Acetazolamide|acetazolamide|mesh-list
56169525|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
56169526|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56169527|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169528|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169529|NCT02992938|Diuretics|diuretics|mesh-ancestor
56169530|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
56169531|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169532|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56169533|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
56169534|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169535|NCT02992548|Pravastatin|pravastatin|mesh-list
56169536|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56169537|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56169538|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
56169539|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169540|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56169541|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56169542|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169543|NCT02992392|Dextrans|dextrans|mesh-list
56169544|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
56169545|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
55822293|NCT01939197|Ritonavir|ritonavir|mesh-list
56169546|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
56169548|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56169549|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56169550|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
56169551|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169552|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169553|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56169554|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169555|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
56169556|NCT02991768|Hormones|hormones|mesh-ancestor
56169557|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169558|NCT02991612|Rifaximin|rifaximin|mesh-list
56169559|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56169560|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169561|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169562|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
56169563|NCT02990286|Rituximab|rituximab|mesh-list
56169564|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56169565|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169566|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
56169567|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661935|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56923720|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56661936|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661937|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
56661938|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169568|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56169569|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56169570|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56169571|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
55822728|NCT04630821|Eusol|eusol|mesh-list
56169572|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56169573|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169574|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169575|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169577|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
56169580|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55784582|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
56169581|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169583|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169584|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
56169585|NCT02999958|Vitamins|vitamins|mesh-ancestor
56169586|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
56169587|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
56169588|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
56169589|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169590|NCT02999958|Expectorants|expectorants|mesh-ancestor
56169591|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169592|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56169593|NCT02999958|Antidotes|antidotes|mesh-ancestor
56169594|NCT02995746|Dexamethasone|dexamethasone|mesh-list
56169595|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56169596|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
56169597|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
56169598|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784599|NCT04989257|Clopidogrel|clopidogrel|mesh-list
56169599|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169600|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169601|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
56169602|NCT02995746|Hormones|hormones|mesh-ancestor
56169603|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169604|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56169605|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169606|NCT02990364|Lidocaine|lidocaine|mesh-list
56169607|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
56169608|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56169609|NCT02990364|Anesthetics|anesthetics|mesh-list
56169610|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169611|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169612|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
56169613|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169614|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56169615|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56169616|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56169617|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56169618|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169619|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56169620|NCT01270074|Azithromycin|azithromycin|mesh-list
56169621|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56169622|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169623|NCT01270308|Lansoprazole|lansoprazole|mesh-list
56169624|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
56169625|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56169626|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169627|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56169628|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169629|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169630|NCT01270386|Apatinib|apatinib|mesh-list
56169631|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169632|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56169633|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661939|NCT02573038|Aflibercept|aflibercept|mesh-list
56661940|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56661941|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56661942|NCT02573038|Growth Substances|growth substances|mesh-ancestor
56661943|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661944|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
56661945|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661946|NCT02159755|Palbociclib|palbociclib|mesh-list
56661947|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661948|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55784610|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
56169634|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169635|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
56169636|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56169637|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56169638|NCT01270932|Dexamethasone|dexamethasone|mesh-list
56169639|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
56169640|NCT01270932|Lenalidomide|lenalidomide|mesh-list
56169641|NCT01270932|BB 1101|bb 1101|mesh-list
56169642|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56169643|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
56169644|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
56169645|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169646|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169647|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784642|NCT04985435|Analgesics|analgesics|mesh-ancestor
56169648|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
56169649|NCT01270932|Hormones|hormones|mesh-ancestor
56169650|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169664|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169665|NCT01271088|Expectorants|expectorants|mesh-ancestor
56169666|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169667|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56169668|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
56169669|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169670|NCT01271088|Protective Agents|protective agents|mesh-ancestor
56169671|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169672|NCT01271088|Antidotes|antidotes|mesh-ancestor
56169674|NCT01271166|Bevacizumab|bevacizumab|mesh-list
56169675|NCT01271166|Fluorouracil|fluorouracil|mesh-list
56169676|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
56169677|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
56169678|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56169679|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784681|NCT04753957|Hormones|hormones|mesh-ancestor
56169680|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56169681|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56169682|NCT01271166|Growth Substances|growth substances|mesh-ancestor
56169683|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169684|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
56169685|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
56169686|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169687|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56169688|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56169689|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
56169690|NCT01271166|Antidotes|antidotes|mesh-ancestor
56169691|NCT01271166|Protective Agents|protective agents|mesh-ancestor
56169692|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
56169693|NCT01271166|Vitamins|vitamins|mesh-ancestor
56169694|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
56169695|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56169696|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169697|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56169698|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
56169699|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
56169700|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169701|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169702|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56661949|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661950|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661951|NCT01822015|Cytarabine|cytarabine|mesh-list
56661952|NCT01822015|Sirolimus|sirolimus|mesh-list
56661953|NCT01822015|Idarubicin|idarubicin|mesh-list
56661954|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56661955|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
56661956|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661957|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661958|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
56661959|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56661960|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56661961|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
56661962|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56661963|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56661964|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56661965|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
56661966|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56661967|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56661968|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661969|NCT00990535|Octreotide|octreotide|mesh-list
56661970|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56661971|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56661972|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661973|NCT05590897|Anti-Infective Agents|anti-infective agents|mesh-list
56661974|NCT05590897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56169703|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169704|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56169705|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56169706|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56169707|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
56169708|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169709|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169710|NCT01272258|Leronlimab|leronlimab|mesh-list
56169720|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56169721|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56169722|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56169723|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169724|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
56169725|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169726|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169727|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56169728|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169729|NCT01273506|Tapentadol|tapentadol|mesh-list
56169730|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56169731|NCT01273506|Narcotics|narcotics|mesh-ancestor
56169732|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169733|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169734|NCT01273506|Analgesics|analgesics|mesh-ancestor
56661975|NCT00720304|Docetaxel|docetaxel|mesh-list
56661976|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56661977|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56661978|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
56661979|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
56661980|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
56661981|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661982|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56661983|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661984|NCT05590585|Emollients|emollients|mesh-list
56661985|NCT05590585|Dermatologic Agents|dermatologic agents|mesh-ancestor
56661986|NCT03864406|Darunavir|darunavir|mesh-list
56661987|NCT03864406|Cobicistat|cobicistat|mesh-list
56169735|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
56169736|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169737|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56169738|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56169739|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56169740|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169741|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
56169742|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169743|NCT01273662|Axitinib|axitinib|mesh-list
56169744|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169745|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56169746|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784740|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
55784754|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56169747|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169750|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169751|NCT01274130|Metformin|metformin|mesh-list
56169752|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56169753|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169754|NCT01276080|Donepezil|donepezil|mesh-list
56169755|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56169756|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169757|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169758|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
56169759|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169760|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169761|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
56169762|NCT01276548|Carboplatin|carboplatin|mesh-list
56169763|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169764|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
56169765|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
56169766|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56169767|NCT01276704|Estrogens|estrogens|mesh-ancestor
56169768|NCT01276704|Hormones|hormones|mesh-ancestor
56169769|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169770|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169771|NCT01277172|Rituximab|rituximab|mesh-list
56169772|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56169773|NCT01277172|Antibodies|antibodies|mesh-list
56169774|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
56169775|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56169781|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56169782|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56169783|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
56169784|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169785|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
56169786|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56169787|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56169788|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56169789|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56169790|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661988|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56661989|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
56661990|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56661991|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
56661992|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56661993|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
56661994|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56661995|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223413|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
56223415|NCT04925960|Epalrestat|epalrestat|mesh-list
56169791|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
56169792|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169793|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169794|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56169795|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169796|NCT01279434|Vitamins|vitamins|mesh-list
56169797|NCT01279434|Vitamin E|vitamin e|mesh-list
56169798|NCT01279434|Tocopherols|tocopherols|mesh-list
56169799|NCT01279434|Tocotrienols|tocotrienols|mesh-list
56169800|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
56169801|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
56169802|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169803|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
55784811|NCT05635955|Anesthetics|anesthetics|mesh-ancestor
56169804|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169805|NCT01279434|Protective Agents|protective agents|mesh-ancestor
56169806|NCT01279512|Metformin|metformin|mesh-list
56169807|NCT01279512|Acarbose|acarbose|mesh-list
56169808|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56169809|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169810|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56169811|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169812|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169813|NCT01279668|Montelukast|montelukast|mesh-list
56169814|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56169815|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169816|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56169817|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
56169818|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169819|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169820|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56169821|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56169822|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169823|NCT01279902|Rituximab|rituximab|mesh-list
56169824|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56169825|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169826|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
56169827|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169828|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56169829|NCT01278342|Octreotide|octreotide|mesh-list
56169830|NCT01278342|Cabergoline|cabergoline|mesh-list
56169831|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169832|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56169834|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56169835|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56169837|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
56169838|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169839|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169840|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169841|NCT01277718|Rabeprazole|rabeprazole|mesh-list
56169842|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56169843|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169844|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56169845|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177843|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
56169846|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56661996|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
56661997|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56661998|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56169852|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56169853|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
56169854|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169855|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56169856|NCT01275222|Everolimus|everolimus|mesh-list
56169857|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
56169858|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169859|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56169860|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
56169861|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784866|NCT03013933|Cyclosporine|cyclosporine|mesh-list
56169862|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56169863|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169864|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169865|NCT01275144|Lorazepam|lorazepam|mesh-list
56169866|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
56169867|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
56169868|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
56169869|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169870|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169871|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56169872|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56169873|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169874|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56169875|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56169876|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56169877|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
56169878|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
56169879|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169880|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169881|NCT01272180|Vaccines|vaccines|mesh-list
56169882|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
56169883|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169884|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
56169885|NCT01271010|Rituximab|rituximab|mesh-list
56169886|NCT01271010|Fludarabine|fludarabine|mesh-list
56169887|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56169888|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
56169889|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169890|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56169891|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56169892|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
55784894|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56169893|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169894|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169895|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56169896|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56169897|NCT01270620|Propofol|propofol|mesh-list
56169898|NCT01270620|Desflurane|desflurane|mesh-list
56169899|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56169900|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169901|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169902|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56169903|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
56169904|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
56169905|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56169906|NCT01270464|Reslizumab|reslizumab|mesh-list
56169907|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56169908|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169909|NCT01279590|Atorvastatin|atorvastatin|mesh-list
56169910|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56169911|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56169912|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
56169913|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169914|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56169915|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56169916|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169917|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56169921|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169922|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
56003868|NCT02427620|Vincristine|vincristine|mesh-list
56661999|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56662000|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56662001|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
56662002|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662003|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56662004|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56662005|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
56662006|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
56662007|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
56662008|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662009|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169923|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169925|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169926|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
56169927|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
56169928|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169929|NCT01270152|Protective Agents|protective agents|mesh-ancestor
56169930|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169931|NCT01270152|Vitamins|vitamins|mesh-ancestor
56169932|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
56169933|NCT01274988|Methadone|methadone|mesh-list
56169934|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56169935|NCT01274988|Narcotics|narcotics|mesh-ancestor
56169936|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169937|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169938|NCT01274988|Analgesics|analgesics|mesh-ancestor
56169939|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
56169940|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169941|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
56169942|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
56169943|NCT01278498|Citalopram|citalopram|mesh-list
56169944|NCT01278498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56169945|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55827555|NCT05341349|Ipilimumab|ipilimumab|mesh-list
56169946|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56169947|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169948|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169949|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
56169950|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169951|NCT01278498|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56169952|NCT01278498|Antidepressive Agents|antidepressive agents|mesh-ancestor
56169953|NCT01278498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56169954|NCT01279980|Anesthetics|anesthetics|mesh-list
56169955|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
56169956|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169957|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169958|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
56169959|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169960|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56097583|NCT00002432|Foscarnet|foscarnet|mesh-list
56169961|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56169962|NCT00249834|Hormones|hormones|mesh-ancestor
55784974|NCT05086081|Ticagrelor|ticagrelor|mesh-list
56169963|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56169964|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169965|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56169967|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
56169968|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56169969|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56169970|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
56169971|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
56169972|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169973|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662010|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
56662011|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662012|NCT00990691|Desipramine|desipramine|mesh-list
56662013|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56662014|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
56662015|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56169974|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169975|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56169976|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56169977|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56169978|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56169979|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56169980|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56169981|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
56169982|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56169983|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56169984|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
56169985|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56169987|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
56169988|NCT00249288|Hematinics|hematinics|mesh-ancestor
56169991|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169993|NCT00247962|Etanercept|etanercept|mesh-list
56169994|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56169995|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56169996|NCT00247962|Analgesics|analgesics|mesh-ancestor
56169997|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
56169998|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169999|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170000|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170001|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170002|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55785008|NCT03138499|Nivolumab|nivolumab|mesh-list
56170003|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170004|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
56170005|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170006|NCT00247416|Gemcitabine|gemcitabine|mesh-list
56170007|NCT00247416|Dexamethasone|dexamethasone|mesh-list
56170008|NCT00247416|Carboplatin|carboplatin|mesh-list
56170009|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170010|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
56170011|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
56170012|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832027|NCT01490086|RP5063|rp5063|mesh-list
56170013|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170014|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56170015|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
56170016|NCT00247416|Hormones|hormones|mesh-ancestor
56170017|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170018|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56170019|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170020|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170021|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
56170022|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170023|NCT00247416|Antiviral Agents|antiviral agents|mesh-ancestor
56170024|NCT00247416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170025|NCT00247416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170026|NCT00247416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170027|NCT00247416|Immunologic Factors|immunologic factors|mesh-ancestor
56170028|NCT00246012|Dacarbazine|dacarbazine|mesh-list
56170029|NCT00246012|Intetumumab|intetumumab|mesh-list
56170030|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56170031|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
55785025|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56177885|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
56170032|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170033|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170034|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56170036|NCT00245856|Tinzaparin|tinzaparin|mesh-list
56170037|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56662016|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662017|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223437|NCT04818216|Niacin|niacin|mesh-list
56170038|NCT00245856|Warfarin|warfarin|mesh-list
56170039|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
56170040|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56170041|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56170042|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170043|NCT00242580|Triamcinolone|triamcinolone|mesh-list
56170044|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56170045|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56170046|NCT00242580|Verteporfin|verteporfin|mesh-list
56170047|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56170048|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170049|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
56170050|NCT00242580|Hormones|hormones|mesh-ancestor
56170051|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170052|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170053|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170054|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
56170055|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785065|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56170056|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170058|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
56170059|NCT00241644|Vaccines|vaccines|mesh-list
56170060|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
56170063|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56170064|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56170065|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170066|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170067|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
56170068|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170069|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170070|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56170071|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170072|NCT03804840|Dronabinol|dronabinol|mesh-list
56170073|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
55785071|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56170074|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170075|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56170076|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56170077|NCT03804840|Analgesics|analgesics|mesh-ancestor
56170078|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
56170079|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177900|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
56170080|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56170081|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56170082|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170083|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170085|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170086|NCT03804372|Tenofovir|tenofovir|mesh-list
56170087|NCT03804372|Rituximab|rituximab|mesh-list
56170088|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56170089|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170090|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
56170091|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170092|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170093|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
56170094|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170095|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56170096|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56170098|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170099|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56170100|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56170101|NCT03803124|Tolvaptan|tolvaptan|mesh-list
56170102|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56170103|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170104|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
56170105|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170106|NCT03802032|Lidocaine|lidocaine|mesh-list
56662018|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56662019|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56662020|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56662021|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
56662022|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662023|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662024|NCT00678522|Atorvastatin|atorvastatin|mesh-list
56662025|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56662026|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56662027|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
56662028|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662029|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56662030|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56223448|NCT04810793|Amoxicillin|amoxicillin|mesh-list
56170107|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
56170108|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
56170109|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170110|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170111|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
56170112|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170113|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56170114|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56170115|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56170116|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170117|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170118|NCT03801252|Azithromycin|azithromycin|mesh-list
56170120|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56170121|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170122|NCT03800550|Clarithromycin|clarithromycin|mesh-list
56170123|NCT03800550|Bedaquiline|bedaquiline|mesh-list
56170124|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56170125|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170126|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56170127|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785137|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56170128|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170129|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56170130|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56170135|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170136|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170137|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56170138|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56170139|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
56170140|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170141|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170142|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56170143|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
56170144|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170145|NCT05743764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56170146|NCT05743764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56170147|NCT05742750|Apatinib|apatinib|mesh-list
56170151|NCT05742750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170153|NCT05740332|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56170154|NCT05740332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170155|NCT05740332|Disinfectants|disinfectants|mesh-ancestor
56170156|NCT05558124|Cytarabine|cytarabine|mesh-list
56170157|NCT05558124|Daunorubicin|daunorubicin|mesh-list
56662031|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662032|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
56662033|NCT04391855|Tramadol|tramadol|mesh-list
56662034|NCT04391855|Ropivacaine|ropivacaine|mesh-list
56662035|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56662036|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662037|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662038|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56662039|NCT04391855|Analgesics|analgesics|mesh-ancestor
56662040|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
56662041|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662042|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56662043|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56662044|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56662045|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
56662046|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662047|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662048|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
56662049|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
56662050|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56662051|NCT04391855|Narcotics|narcotics|mesh-ancestor
56662052|NCT00716950|Losartan|losartan|mesh-list
56662053|NCT00716950|Valsartan|valsartan|mesh-list
56662054|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56662055|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56662056|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56662057|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662058|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56662059|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56662060|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56662061|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56170158|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
55785154|NCT02985619|Bevacizumab|bevacizumab|mesh-list
56170159|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170160|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
56170161|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170162|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170163|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
56170164|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170165|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170166|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
56170167|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170168|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56170169|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56662062|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56662063|NCT00678756|Ketoconazole|ketoconazole|mesh-list
56662064|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
56662065|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662066|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56662067|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56662068|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662069|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662070|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56662071|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
56170170|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56170171|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170172|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56170173|NCT05481684|Progesterone|progesterone|mesh-list
56170174|NCT05481684|Progestins|progestins|mesh-ancestor
56170175|NCT05481684|Hormones|hormones|mesh-ancestor
56170176|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170177|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170178|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56170179|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56170180|NCT05338398|Benzydamine|benzydamine|mesh-list
56170181|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785199|NCT01884259|Fluorouracil|fluorouracil|mesh-list
55785200|NCT01884259|Cetuximab|cetuximab|mesh-list
56170186|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56170187|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837111|NCT02029235|Analgesics|analgesics|mesh-ancestor
56170189|NCT04581408|Ivacaftor|ivacaftor|mesh-list
56170190|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56170191|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170192|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170194|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56170195|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170196|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
56170197|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170198|NCT04295772|Islatravir|islatravir|mesh-list
56170199|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
56170200|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170202|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170203|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56170204|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56170205|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56170206|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
56170207|NCT04209660|Lenvatinib|lenvatinib|mesh-list
55785215|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56170208|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56170209|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170227|NCT03467256|Dexamethasone|dexamethasone|mesh-list
56170228|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
56170229|NCT03467256|Fludarabine|fludarabine|mesh-list
56170230|NCT03467256|Etoposide|etoposide|mesh-list
56170231|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170232|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
56170233|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170234|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170235|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56170236|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
56170237|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170238|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170239|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55785239|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
56170240|NCT03467256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170241|NCT03467256|Antiemetics|antiemetics|mesh-ancestor
56170242|NCT03467256|Autonomic Agents|autonomic agents|mesh-ancestor
56170243|NCT03467256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662072|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662073|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662074|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56662075|NCT02748395|Triamcinolone|triamcinolone|mesh-list
56662076|NCT02748395|Lidocaine|lidocaine|mesh-list
56662077|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
56662078|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
56662079|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662080|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662081|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
56662082|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662083|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56662084|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56662085|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56662086|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56662087|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662089|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
56662090|NCT02748395|Hormones|hormones|mesh-ancestor
56662091|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662092|NCT02629224|Gabapentin|gabapentin|mesh-list
56662093|NCT02629224|Analgesics|analgesics|mesh-ancestor
56662094|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
56662095|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662096|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662097|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
56662098|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56662099|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56662100|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662101|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662102|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56662103|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56662104|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662111|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
56662112|NCT04069234|Clopidogrel|clopidogrel|mesh-list
56662113|NCT04069234|Ticagrelor|ticagrelor|mesh-list
56662114|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56662115|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56662116|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56170244|NCT03467256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56170245|NCT03467256|Glucocorticoids|glucocorticoids|mesh-ancestor
56170246|NCT03467256|Hormones|hormones|mesh-ancestor
56170247|NCT03467256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785240|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
56170248|NCT03467256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56170249|NCT03467256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170250|NCT03467256|Antimetabolites|antimetabolites|mesh-ancestor
56170251|NCT03467256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56170252|NCT03467256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56170253|NCT03467256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56170254|NCT03467256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170255|NCT03467256|Antiviral Agents|antiviral agents|mesh-ancestor
56170256|NCT03467256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170257|NCT03265080|Pembrolizumab|pembrolizumab|mesh-list
56170259|NCT03265080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170267|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
56170268|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
56170269|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56170271|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56170272|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170273|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170274|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
56170275|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
55785272|NCT01305889|Sertraline|sertraline|mesh-list
56170276|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170277|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177941|NCT04186663|Protective Agents|protective agents|mesh-ancestor
56170278|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56170279|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56170280|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
56170281|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56170282|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55785279|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170283|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56170284|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56170285|NCT03017820|Iodine|iodine|mesh-list
56170287|NCT03017820|Interferon-beta|interferon-beta|mesh-list
56170288|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
56170289|NCT03017820|Nivolumab|nivolumab|mesh-list
56170290|NCT03017820|Ipilimumab|ipilimumab|mesh-list
56170292|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
56170293|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170294|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170295|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55842165|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56170297|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170298|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170299|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56170300|NCT03017820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842654|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170301|NCT03017820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56170302|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
56170303|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170304|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56170305|NCT03017820|Trace Elements|trace elements|mesh-ancestor
56170306|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
56170307|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56170309|NCT02458014|Antibodies|antibodies|mesh-list
56170310|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
56170311|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56170312|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
56170313|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56662117|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56662118|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
56662119|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662120|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662121|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662122|NCT04374773|Dronabinol|dronabinol|mesh-list
56223538|NCT04463368|Nivolumab|nivolumab|mesh-list
56170314|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
56170315|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170316|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170317|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170318|NCT02017704|Leucovorin|leucovorin|mesh-list
56170319|NCT02017704|Fluorouracil|fluorouracil|mesh-list
56170320|NCT02017704|Capecitabine|capecitabine|mesh-list
56170322|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
55785311|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56170323|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170324|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170325|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170326|NCT02017704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844046|NCT02402920|Etoposide|etoposide|mesh-list
56170327|NCT02017704|Immunologic Factors|immunologic factors|mesh-ancestor
55785315|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
56170328|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170329|NCT02017704|Antidotes|antidotes|mesh-ancestor
56170330|NCT02017704|Protective Agents|protective agents|mesh-ancestor
56170331|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
56170332|NCT02017704|Vitamins|vitamins|mesh-ancestor
55785316|NCT05431283|Tofacitinib|tofacitinib|mesh-list
56170333|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
55785320|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
56170353|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170354|NCT05313282|Apatinib|apatinib|mesh-list
56170355|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170356|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56170357|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170358|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170359|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
56170360|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56170361|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
56170363|NCT05311722|Tramadol|tramadol|mesh-list
56170365|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170366|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785332|NCT03630835|Annexin A5|annexin a5|mesh-list
56170368|NCT05311722|Analgesics|analgesics|mesh-ancestor
56170369|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
56170370|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170371|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56170372|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56170373|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56170374|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
56170375|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170376|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170377|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56170378|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56170379|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
56170380|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
56170381|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56170382|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56170383|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56170387|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56170389|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56170390|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170391|NCT03215940|Dronabinol|dronabinol|mesh-list
56170392|NCT03215940|Cannabidiol|cannabidiol|mesh-list
56170393|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
56170394|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
55785355|NCT04537897|Midazolam|midazolam|mesh-list
56170395|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170396|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662123|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
56662124|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662125|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662126|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56662127|NCT04374773|Analgesics|analgesics|mesh-ancestor
56170397|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56170398|NCT03215940|Analgesics|analgesics|mesh-ancestor
56170400|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170401|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56170402|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56170403|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170404|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170405|NCT03215940|Hormones|hormones|mesh-ancestor
56170406|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170407|NCT03219528|Rifaximin|rifaximin|mesh-list
56170408|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56170409|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170410|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56170411|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56170412|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170413|NCT03218514|Dalteparin|dalteparin|mesh-list
56170414|NCT03218514|Tinzaparin|tinzaparin|mesh-list
56170415|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56170416|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
56170417|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56170418|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56170419|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170420|NCT03218124|Remifentanil|remifentanil|mesh-list
56170421|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56170422|NCT03218124|Narcotics|narcotics|mesh-ancestor
55785384|NCT05090449|Diuretics|diuretics|mesh-ancestor
56170423|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170424|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170425|NCT03218124|Analgesics|analgesics|mesh-ancestor
56170426|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
56170427|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170428|NCT03217734|Adalimumab|adalimumab|mesh-list
56170429|NCT03217734|Methotrexate|methotrexate|mesh-list
56170430|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56170431|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
56170432|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56170433|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170434|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170435|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
56170436|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170437|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170438|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
56170439|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170440|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56170441|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170442|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
56170443|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170444|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56170445|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170446|NCT03216876|Ursolic acid|ursolic acid|mesh-list
56170447|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170448|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55847783|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
56170449|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170450|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56170451|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170452|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170453|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56170454|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56170456|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
56170457|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170458|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170459|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170460|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170461|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56662128|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
56662129|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662130|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56662131|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56223548|NCT04450407|Insulin|insulin|mesh-list
56170462|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170465|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56170466|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56170467|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170468|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170469|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
56170470|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785431|NCT05730413|Adrenergic Agents|adrenergic agents|mesh-ancestor
56170471|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170473|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170474|NCT03216564|Vitamin D|vitamin d|mesh-list
56170475|NCT03216564|Calcitriol|calcitriol|mesh-list
56170476|NCT03216564|Vitamins|vitamins|mesh-ancestor
55850368|NCT00412594|Cladribine|cladribine|mesh-list
56170477|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
56170478|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785438|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56170479|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56170480|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56170481|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56170482|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55785444|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56170483|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170484|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56170485|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56170486|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56170487|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
56170488|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56170489|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170491|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
56170492|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785450|NCT04132817|Ipilimumab|ipilimumab|mesh-list
56170493|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170494|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
56170495|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
56170496|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170497|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
56170498|NCT03214770|Calcium|calcium|mesh-list
56170499|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55785459|NCT04118387|Acetazolamide|acetazolamide|mesh-list
56170500|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170501|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56170502|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56170503|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56170504|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56170505|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170506|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
56170507|NCT03213444|Fluorouracil|fluorouracil|mesh-list
56170508|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170509|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
56170510|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785471|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
56170511|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170512|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170513|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
56170514|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170516|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56170517|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170518|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
56170519|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
56170520|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170521|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
55785480|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
56170522|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662132|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662133|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662134|NCT04374773|Hormones|hormones|mesh-ancestor
56662135|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662136|NCT00720538|Thalidomide|thalidomide|mesh-list
56662137|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56662138|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
56662139|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662140|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
56662141|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56662142|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662143|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56170523|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170526|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56170527|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170528|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56170529|NCT03211728|Pregabalin|pregabalin|mesh-list
56170530|NCT03211728|Analgesics|analgesics|mesh-ancestor
56170531|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
56170532|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170533|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170534|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
56170535|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56170536|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170537|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170538|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56170539|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56170540|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56170541|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170542|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56170543|NCT03211572|Tamoxifen|tamoxifen|mesh-list
56170544|NCT03211572|Anastrozole|anastrozole|mesh-list
56170545|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56170546|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
56170547|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170548|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170549|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56170550|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170551|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56170552|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56170553|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56170554|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56170555|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56170556|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170557|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170559|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56170560|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
56170561|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170562|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
56170563|NCT03211650|Protective Agents|protective agents|mesh-ancestor
56170564|NCT03211104|Curcumin|curcumin|mesh-list
55785516|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56170565|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56170566|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56170567|NCT03211104|Analgesics|analgesics|mesh-ancestor
56170568|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
56170569|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170570|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170571|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170572|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56662144|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56662145|NCT00720538|Growth Substances|growth substances|mesh-ancestor
56662146|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
56662147|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662148|NCT00678990|Heparin|heparin|mesh-list
56662149|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
56662150|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56662151|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56170573|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170574|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170575|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170576|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56170577|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56170578|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56170579|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
56170580|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56170581|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170582|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56170583|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56170584|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56170585|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56170586|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56170587|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56170588|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56170589|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56170590|NCT03210324|Mifepristone|mifepristone|mesh-list
56170591|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56170595|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56170597|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56170598|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
56170599|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56170600|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56170601|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
56170602|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170603|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
56170604|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55856241|NCT01445535|Hormones|hormones|mesh-ancestor
56170605|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56170606|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
56170607|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
56170608|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56170609|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170610|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170612|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55857310|NCT01396005|Methadone|methadone|mesh-list
56170613|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170614|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170615|NCT01831674|Metformin|metformin|mesh-list
56170616|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56170617|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170619|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56170620|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56170621|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170622|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
55858522|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
56170623|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170624|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170625|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56170626|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
56098278|NCT00002618|Antidotes|antidotes|mesh-ancestor
56170627|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170628|NCT01833312|Meperidine|meperidine|mesh-list
56170629|NCT01833312|Buspirone|buspirone|mesh-list
56170630|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56170631|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56662152|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662153|NCT00679068|Bosentan|bosentan|mesh-list
56662154|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56662155|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56662156|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662157|NCT00679146|Ketoprofen|ketoprofen|mesh-list
56662158|NCT00679146|Colchicine|colchicine|mesh-list
56223568|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785585|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
56170632|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170633|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170634|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56170635|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56170636|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
56170637|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860166|NCT00705874|Antidotes|antidotes|mesh-ancestor
56170638|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170639|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56170641|NCT01833312|Analgesics|analgesics|mesh-ancestor
56170642|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
56170643|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170644|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56170646|NCT01834014|Cetuximab|cetuximab|mesh-list
56170647|NCT01834014|Fluorouracil|fluorouracil|mesh-list
56170648|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
56170649|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56170650|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170651|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56170652|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56170653|NCT01834014|Growth Substances|growth substances|mesh-ancestor
56170654|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178005|NCT03954743|Vaccines|vaccines|mesh-list
56170655|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
56170656|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
56170657|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170658|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170659|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170660|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
56170661|NCT01834170|Gemcitabine|gemcitabine|mesh-list
56170664|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170665|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170666|NCT01834170|Antiviral Agents|antiviral agents|mesh-ancestor
56170667|NCT01834170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170668|NCT01834170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170669|NCT01834170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170670|NCT01834170|Immunologic Factors|immunologic factors|mesh-ancestor
56170671|NCT01834170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170673|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170674|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56170675|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170676|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170677|NCT01835340|Anesthetics|anesthetics|mesh-list
56170679|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170680|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170681|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56170682|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56170683|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
56170684|NCT01836120|Docetaxel|docetaxel|mesh-list
56170685|NCT01836120|Raltitrexed|raltitrexed|mesh-list
56170686|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170687|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
56170688|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
56170689|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
56170690|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170691|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170692|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
56662159|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56662160|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56662161|NCT00679146|Analgesics|analgesics|mesh-ancestor
56662162|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
56662163|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662164|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662165|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56662166|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56662167|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56662168|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223575|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56170693|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56170694|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170695|NCT01836822|Dimercaprol|dimercaprol|mesh-list
56170696|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
56170697|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
55785651|NCT05738161|Cisplatin|cisplatin|mesh-list
56170698|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170699|NCT01836900|Hemostatics|hemostatics|mesh-list
56170700|NCT01836900|Coagulants|coagulants|mesh-ancestor
56170701|NCT01837992|Primaquine|primaquine|mesh-list
56170702|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
56170703|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56170704|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56170705|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170706|NCT01838460|Lobeline|lobeline|mesh-list
56170707|NCT01838460|Nicotine|nicotine|mesh-list
56170708|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56170709|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
56170710|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170711|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170712|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56170713|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56170715|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863040|NCT03809260|Metformin|metformin|mesh-list
56170716|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170717|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
56170718|NCT01838538|Paclitaxel|paclitaxel|mesh-list
56170719|NCT01838538|Bevacizumab|bevacizumab|mesh-list
56170720|NCT01838538|Carboplatin|carboplatin|mesh-list
56170721|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56170722|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170723|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
56170724|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
56170725|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
56170726|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170727|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56170728|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56170729|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56170730|NCT01838538|Growth Substances|growth substances|mesh-ancestor
56170731|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170733|NCT01838772|Interferons|interferons|mesh-list
56170734|NCT01838772|Ribavirin|ribavirin|mesh-list
56170735|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170736|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
56170737|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170743|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170744|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785691|NCT05737693|GABA Modulators|gaba modulators|mesh-ancestor
56170745|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
56170746|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170747|NCT01839084|Isoflurane|isoflurane|mesh-list
56170748|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56170749|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
56170751|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785698|NCT05737303|Paclitaxel|paclitaxel|mesh-list
56662169|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662170|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
56662171|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
56662172|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
56662173|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
56662174|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662175|NCT00679224|Ambrisentan|ambrisentan|mesh-list
56662176|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56662178|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56662179|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
56662180|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662181|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662182|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56662183|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
56662184|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
56662185|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56662186|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56662187|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56662188|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
56662189|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662190|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662191|NCT00594516|Tapentadol|tapentadol|mesh-list
56662192|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56662193|NCT00594516|Narcotics|narcotics|mesh-ancestor
56170752|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170754|NCT01839240|Azacitidine|azacitidine|mesh-list
56170755|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
56170756|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170757|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
56170758|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170759|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170760|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
56170761|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170763|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
56170764|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170765|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170766|NCT01839240|Analgesics|analgesics|mesh-ancestor
56170767|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
56170768|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170769|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56170770|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56170771|NCT01839552|Fentanyl|fentanyl|mesh-list
56170772|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56170773|NCT01839552|Narcotics|narcotics|mesh-ancestor
55785719|NCT05188313|Pertuzumab|pertuzumab|mesh-list
56170774|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170775|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170776|NCT01839552|Analgesics|analgesics|mesh-ancestor
56170777|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
56170778|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170779|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56662194|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223609|NCT04068246|Metformin|metformin|mesh-list
56170780|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56170781|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
56170782|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
56170783|NCT01839630|Sorafenib|sorafenib|mesh-list
56170784|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170785|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56170786|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170787|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170788|NCT01839864|Chrysarobin|chrysarobin|mesh-list
56170789|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56170790|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56170791|NCT01839864|Analgesics|analgesics|mesh-ancestor
56170792|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
56170793|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170794|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170795|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170796|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170798|NCT01834248|Decitabine|decitabine|mesh-list
56170799|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56170800|NCT01834248|Poly ICLC|poly iclc|mesh-list
56170801|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170802|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
56170803|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170804|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170805|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170806|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
56170807|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
56170808|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170810|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56170811|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
56170812|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170820|NCT01836432|Fluorouracil|fluorouracil|mesh-list
56170821|NCT01836432|Capecitabine|capecitabine|mesh-list
56170822|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
56170823|NCT01836432|Irinotecan|irinotecan|mesh-list
56170824|NCT01836432|Folfirinox|folfirinox|mesh-list
56170825|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56170826|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170827|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
56170828|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
56170829|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
56170830|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170831|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170832|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
56170833|NCT01836432|Antiviral Agents|antiviral agents|mesh-ancestor
55785778|NCT02382445|Anesthetics|anesthetics|mesh-list
56170834|NCT01836432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170835|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170836|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170837|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
56170838|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178128|NCT03704285|Propofol|propofol|mesh-list
56170839|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56170840|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56170841|NCT01836432|Antidotes|antidotes|mesh-ancestor
56170842|NCT01836432|Protective Agents|protective agents|mesh-ancestor
56170843|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
56170844|NCT01836432|Vitamins|vitamins|mesh-ancestor
56170845|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
56170846|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56170847|NCT01720056|Verapamil|verapamil|mesh-list
56170848|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170849|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
56170850|NCT01720056|Hormones|hormones|mesh-ancestor
56170851|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170852|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170853|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170854|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
56170855|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170856|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56170857|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56170858|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170859|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56662195|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662196|NCT00594516|Analgesics|analgesics|mesh-ancestor
56662197|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
56662198|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662199|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56662200|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56170860|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
56170861|NCT01720212|Mirabegron|mirabegron|mesh-list
56170862|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56170863|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56170864|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56170865|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56170866|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170867|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170868|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170869|NCT01720212|Urological Agents|urological agents|mesh-ancestor
56170871|NCT01720290|Repaglinide|repaglinide|mesh-list
56170872|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56170873|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170874|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56170875|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56170876|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170878|NCT01721382|Hormones|hormones|mesh-ancestor
56170879|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170880|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56170881|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
56170882|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170883|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170884|NCT01721616|Azithromycin|azithromycin|mesh-list
56170885|NCT01721616|Cefazolin|cefazolin|mesh-list
56170886|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56170890|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56170891|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170892|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56170893|NCT01722396|Vitamin D|vitamin d|mesh-list
56170894|NCT01722396|Vitamins|vitamins|mesh-ancestor
56170895|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
56178144|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
56170896|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170897|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56170898|NCT01722630|Dopamine|dopamine|mesh-list
56170899|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56170900|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
56170901|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
56170902|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170903|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170904|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
55785827|NCT05091775|Mesalamine|mesalamine|mesh-list
56170905|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170906|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170907|NCT01722630|Protective Agents|protective agents|mesh-ancestor
56170908|NCT01722942|Amiodarone|amiodarone|mesh-list
56170909|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56170910|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
56170911|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56170912|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170913|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170914|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56170915|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56170916|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56170917|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170918|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56170919|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56170920|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56170921|NCT01723800|Carboplatin|carboplatin|mesh-list
56170922|NCT01723800|Pemetrexed|pemetrexed|mesh-list
56170923|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170924|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662201|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56662202|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170925|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170926|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56170927|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56170928|NCT01724190|Vitamin D|vitamin d|mesh-list
56170929|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
56170930|NCT01724190|Vitamins|vitamins|mesh-ancestor
56170931|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
56170932|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170933|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56170934|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56170935|NCT01724268|Prednisolone|prednisolone|mesh-list
56170936|NCT01724268|Methotrexate|methotrexate|mesh-list
56170937|NCT01724268|Methamphetamine|methamphetamine|mesh-list
56170938|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56170939|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
56170940|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56170941|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170942|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170943|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
56170944|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170945|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56170946|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
55785887|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56170947|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170948|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56170949|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170950|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
56170951|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170952|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56170953|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56170954|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
56170955|NCT01724268|Hormones|hormones|mesh-ancestor
56170956|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56170959|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56170960|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56170962|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
56170963|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170964|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
56170965|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56170966|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56170967|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170968|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56170971|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170972|NCT01724424|Protective Agents|protective agents|mesh-ancestor
56170973|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170974|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170976|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56170977|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170978|NCT01725048|Mirtazapine|mirtazapine|mesh-list
56170979|NCT01725048|Citalopram|citalopram|mesh-list
56170980|NCT01725048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56170981|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56170982|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56170983|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170984|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56170986|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170987|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56170988|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
56170989|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56170990|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56170991|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
56170992|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
56170993|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56170994|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56170995|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56170996|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56170997|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56662203|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
56662204|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662205|NCT00682500|Calfactant|calfactant|mesh-list
56662206|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56662207|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56662208|NCT00538291|Capecitabine|capecitabine|mesh-list
56662209|NCT00538291|Cetuximab|cetuximab|mesh-list
56170998|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56170999|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56171000|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56171001|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56171002|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56171004|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171005|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56171006|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171007|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171008|NCT01725360|Montelukast|montelukast|mesh-list
56171009|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56171010|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
56171011|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56171012|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
56171013|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56171014|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171015|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56171016|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56171017|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171019|NCT01725672|Glimepiride|glimepiride|mesh-list
56171020|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56171021|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171022|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56171023|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171024|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
56171025|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56171026|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56171027|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171028|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
56171029|NCT01726530|Fentanyl|fentanyl|mesh-list
56171030|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56171031|NCT01726530|Narcotics|narcotics|mesh-ancestor
56171033|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171034|NCT01726530|Analgesics|analgesics|mesh-ancestor
56171035|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
56171036|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171037|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56171038|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56171039|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
56171040|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
56171041|NCT01726686|Ropivacaine|ropivacaine|mesh-list
56171042|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
56171043|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
56171044|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171045|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171046|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
56171047|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171048|NCT01726764|Metformin|metformin|mesh-list
56171049|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56171050|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171052|NCT01726920|Naratriptan|naratriptan|mesh-list
56171053|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56171054|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56171055|NCT01726920|Analgesics|analgesics|mesh-ancestor
56171056|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
56171057|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171058|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171059|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171060|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171061|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
56171063|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786006|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662210|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56662211|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
56662212|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662213|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662214|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56662215|NCT00682578|Artesunate|artesunate|mesh-list
56662216|NCT00682578|Chloroquine|chloroquine|mesh-list
56662217|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
56662218|NCT00682578|Piperaquine|piperaquine|mesh-list
56662219|NCT00682578|Artenimol|artenimol|mesh-list
56662220|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
56662221|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56662222|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56662223|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662224|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662225|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
56171064|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171065|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56171066|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56171067|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56171068|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
56171069|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171070|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55786008|NCT04533841|Propranolol|propranolol|mesh-list
56171071|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56171072|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171073|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
56171074|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56171075|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171076|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
56171077|NCT01728480|Cisplatin|cisplatin|mesh-list
56171078|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171079|NCT01728948|Sorafenib|sorafenib|mesh-list
56171080|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098723|NCT04713787|Albendazole|albendazole|mesh-list
56171081|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56171082|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171083|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171084|NCT01729104|Rituximab|rituximab|mesh-list
56171085|NCT01729104|Lenalidomide|lenalidomide|mesh-list
56171086|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56171087|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171088|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
56171089|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171090|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171091|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56171092|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56171093|NCT01729104|Growth Substances|growth substances|mesh-ancestor
56171094|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
56171095|NCT01729260|Mebendazole|mebendazole|mesh-list
56171096|NCT01729260|Piperazine|piperazine|mesh-list
56171097|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
56171098|NCT01729260|DMP 777|dmp 777|mesh-list
56171099|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
56171100|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
56171101|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56171102|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171103|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
56171104|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
56171106|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786050|NCT03063359|Narcotics|narcotics|mesh-ancestor
56171108|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171109|NCT01729806|Rituximab|rituximab|mesh-list
56662226|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
56662227|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56662228|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
56662229|NCT00682578|Amebicides|amebicides|mesh-ancestor
56171110|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56171111|NCT01729806|Ipilimumab|ipilimumab|mesh-list
56171112|NCT01729806|Antibodies|antibodies|mesh-list
56171113|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
56171114|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56171115|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
55786054|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
56171116|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171117|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171118|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171119|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56171120|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171121|NCT01720836|Poly ICLC|poly iclc|mesh-list
56171123|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
56171124|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171125|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
56171126|NCT01724658|Testosterone|testosterone|mesh-list
56171127|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
56171128|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
56171129|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56171130|NCT01724658|Androgens|androgens|mesh-ancestor
56171131|NCT01724658|Hormones|hormones|mesh-ancestor
56171132|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56171133|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171134|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56171135|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171136|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
56171137|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
56171138|NCT01049334|Analgesics|analgesics|mesh-ancestor
56171139|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
56171140|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171141|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171142|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56171143|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56171144|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171145|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171146|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56171147|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171148|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171149|NCT01048944|Bupropion|bupropion|mesh-list
56171150|NCT01048944|Nicotine|nicotine|mesh-list
56171151|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56171152|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
55786089|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
56171153|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171154|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171157|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
56171158|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171159|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171160|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56171161|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
56171162|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56171163|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56171164|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56171165|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56171167|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56171168|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56171169|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171170|NCT01048866|Acetaminophen|acetaminophen|mesh-list
56171172|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56171173|NCT01048866|Analgesics|analgesics|mesh-ancestor
56171174|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
56171175|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171176|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171177|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
56171178|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56662230|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56662231|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56662232|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662233|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662234|NCT00594906|Teriparatide|teriparatide|mesh-list
56662235|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56662236|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662237|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56662238|NCT02745431|Oxytocin|oxytocin|mesh-list
56662239|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
56662240|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56662241|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662242|NCT00682656|Azithromycin|azithromycin|mesh-list
56662243|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56662244|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56662245|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662246|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56662247|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56662248|NCT05590117|Leucovorin|leucovorin|mesh-list
56662249|NCT05590117|Fluorouracil|fluorouracil|mesh-list
56662250|NCT05590117|Oxaliplatin|oxaliplatin|mesh-list
56662251|NCT05590117|Pentoxifylline|pentoxifylline|mesh-list
56662252|NCT05590117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662253|NCT05590117|Antimetabolites|antimetabolites|mesh-ancestor
56662254|NCT05590117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171179|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171180|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171181|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56171182|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171183|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171185|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56171186|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171187|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
56171188|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171189|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56171190|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56171191|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56171193|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
56171194|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171195|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171196|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171197|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171199|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56171200|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56171201|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56171202|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
56171203|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56171204|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003869|NCT02427620|Daunorubicin|daunorubicin|mesh-list
56662255|NCT05590117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56223665|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
56171205|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56171206|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56171207|NCT01042938|Curcumin|curcumin|mesh-list
55786120|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
56171208|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56171209|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56171210|NCT01042938|Analgesics|analgesics|mesh-ancestor
56171211|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
56171212|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171213|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171214|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171215|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171216|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171217|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171218|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171219|NCT01042158|Ambrisentan|ambrisentan|mesh-list
56171220|NCT01042158|Tadalafil|tadalafil|mesh-list
56171221|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
56171222|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56171223|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56171224|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171225|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171227|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56171228|NCT01047540|Pritelivir|pritelivir|mesh-list
56171229|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
56171230|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171231|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171232|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171233|NCT03405870|SMOFlipid|smoflipid|mesh-list
56171234|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56171235|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56171236|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56178177|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
56171238|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56171239|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171240|NCT03409068|Anesthetics|anesthetics|mesh-list
56171241|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171242|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171243|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
56171244|NCT03408054|Oxytocin|oxytocin|mesh-list
56171245|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
56171246|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56171247|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171248|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
56171249|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
56171250|NCT03407976|Apatinib|apatinib|mesh-list
56171251|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56171252|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171259|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55786191|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55786192|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
56171260|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171261|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
56171262|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56171263|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56171264|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171266|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171267|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171268|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
56171269|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56171270|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56171271|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171272|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56171273|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56171274|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171275|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171276|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171277|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56171278|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
56171279|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56662256|NCT05590117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662257|NCT05590117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56662258|NCT05590117|Immunologic Factors|immunologic factors|mesh-ancestor
56662259|NCT05590117|Antidotes|antidotes|mesh-ancestor
56662260|NCT05590117|Protective Agents|protective agents|mesh-ancestor
56662261|NCT05590117|Vitamin B Complex|vitamin b complex|mesh-ancestor
56662262|NCT05590117|Vitamins|vitamins|mesh-ancestor
56662263|NCT05590117|Micronutrients|micronutrients|mesh-ancestor
56171280|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786211|NCT01117441|Prednisone|prednisone|mesh-list
56171281|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56171282|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56171283|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56171284|NCT03403452|Apatinib|apatinib|mesh-list
56171285|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171286|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56171287|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786218|NCT01117441|Etoposide|etoposide|mesh-list
56171288|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789076|NCT03053219|Abivertinib|abivertinib|mesh-list
56171290|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55786227|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
56171291|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56171292|NCT03403140|Analgesics|analgesics|mesh-ancestor
56171293|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
56171294|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171295|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171296|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171297|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171299|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171300|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
56171301|NCT03402984|Z 338|z 338|mesh-list
56171302|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56098954|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
56171303|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171304|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171305|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
56171306|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171307|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171308|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56171309|NCT03402438|Fulacimstat|fulacimstat|mesh-list
56171310|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171311|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171313|NCT03402204|Simvastatin|simvastatin|mesh-list
56171314|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56171316|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
56171320|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786249|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
56171321|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56171322|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
56171323|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171324|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56171325|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171326|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56171327|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171328|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
56171329|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56171330|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56171331|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
56171332|NCT03402048|Gemcitabine|gemcitabine|mesh-list
56171333|NCT03402048|Carboplatin|carboplatin|mesh-list
56171334|NCT03402048|Docetaxel|docetaxel|mesh-list
56171335|NCT03402048|Pemetrexed|pemetrexed|mesh-list
56171336|NCT03402048|Vinorelbine|vinorelbine|mesh-list
56171337|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171338|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56171339|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
56171340|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171341|NCT03402048|Antiviral Agents|antiviral agents|mesh-ancestor
56171342|NCT03402048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171343|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662264|NCT05590117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56662265|NCT05590117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662266|NCT05590117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56662267|NCT05590117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56662268|NCT05590117|Vasodilator Agents|vasodilator agents|mesh-ancestor
56662269|NCT05590117|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56662270|NCT05590117|Antioxidants|antioxidants|mesh-ancestor
56662271|NCT00636311|Gemcitabine|gemcitabine|mesh-list
56662272|NCT00636311|Bortezomib|bortezomib|mesh-list
56662273|NCT00636311|Vinorelbine|vinorelbine|mesh-list
56662274|NCT00636311|Ifosfamide|ifosfamide|mesh-list
56171344|NCT03402048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171345|NCT03402048|Immunologic Factors|immunologic factors|mesh-ancestor
55786270|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
56171346|NCT03402048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171347|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
56171348|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
56171349|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
56171351|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56171352|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56171353|NCT03401502|Ranolazine|ranolazine|mesh-list
56171354|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56171355|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56171356|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171357|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
56171358|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56171359|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
56171360|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
56171361|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171362|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171363|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171364|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56171365|NCT03401346|Analgesics|analgesics|mesh-ancestor
56171366|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
56171367|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171368|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
56171369|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56171370|NCT03401268|Antibodies|antibodies|mesh-list
56171371|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
56171372|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171373|NCT03400722|Clomiphene|clomiphene|mesh-list
56171374|NCT03400722|Hormones|hormones|mesh-list
56171375|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56171376|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171377|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56171378|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
56171379|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56171380|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
56171381|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56171382|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56171383|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56171384|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
56171385|NCT03400254|Gedatolisib|gedatolisib|mesh-list
56171386|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
56171387|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56171391|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171394|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
56171395|NCT03400020|Vitamins|vitamins|mesh-ancestor
55786309|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
56171397|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171398|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
56171399|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171400|NCT03400020|Protective Agents|protective agents|mesh-ancestor
56171401|NCT00012012|Amifostine|amifostine|mesh-list
56171402|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56171403|NCT00012012|Protective Agents|protective agents|mesh-ancestor
56662275|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56662276|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
56662277|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662278|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662279|NCT00636311|Antiviral Agents|antiviral agents|mesh-ancestor
56662280|NCT00636311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662281|NCT00636311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662282|NCT00636311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56662283|NCT00636311|Immunologic Factors|immunologic factors|mesh-ancestor
56662284|NCT00636311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662285|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56662286|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
56662287|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
56662288|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
56662289|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56662290|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
56662291|NCT03874715|Insulin|insulin|mesh-list
56171404|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171405|NCT02240160|Nabiximols|nabiximols|mesh-list
56171406|NCT02240160|Analgesics|analgesics|mesh-ancestor
56171407|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
56171408|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171409|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171410|NCT02240238|Gemcitabine|gemcitabine|mesh-list
56171411|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56171412|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
56171413|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171414|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171415|NCT02240238|Antiviral Agents|antiviral agents|mesh-ancestor
56171416|NCT02240238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171417|NCT02240238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171418|NCT02240238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171419|NCT02240238|Immunologic Factors|immunologic factors|mesh-ancestor
56171420|NCT02240238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171421|NCT02241096|Lidocaine|lidocaine|mesh-list
56171422|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
56171423|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
56171424|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171425|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171426|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
56171427|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178210|NCT03522584|Tremelimumab|tremelimumab|mesh-list
56171428|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56171429|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56171430|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56171431|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56171432|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171433|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56171434|NCT02241174|Eusol|eusol|mesh-list
56171435|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
56171436|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171437|NCT02241564|Sirolimus|sirolimus|mesh-list
56171438|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56171439|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171440|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171441|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56171442|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171443|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56662292|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56662293|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
56662294|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
56662295|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
56662296|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56662297|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56662298|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662299|NCT00679458|Buprenorphine|buprenorphine|mesh-list
56662300|NCT00679458|Naloxone|naloxone|mesh-list
56662301|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56662302|NCT00679458|Narcotics|narcotics|mesh-ancestor
56662303|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662304|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662305|NCT00679458|Analgesics|analgesics|mesh-ancestor
56662306|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
56662307|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662308|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56662309|NCT04216511|Autoantibodies|autoantibodies|mesh-list
56662310|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
56662311|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662312|NCT02747537|Irinotecan|irinotecan|mesh-list
56662313|NCT02747537|Sorafenib|sorafenib|mesh-list
56662314|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56662315|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56662316|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662317|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223697|NCT03749174|Anesthetics|anesthetics|mesh-list
56171444|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171445|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
56171446|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171447|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
56171448|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171449|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
56171450|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56171451|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
56099102|NCT01583647|Vitamins|vitamins|mesh-ancestor
56171453|NCT02241876|Expectorants|expectorants|mesh-ancestor
56171454|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
56171455|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56171457|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171458|NCT02241876|Protective Agents|protective agents|mesh-ancestor
56171459|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786363|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56171463|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
56171464|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56171465|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
56171466|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171467|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171468|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56171469|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
56662318|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662319|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56662320|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
56662321|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56662322|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56662323|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662324|NCT02747381|Vitamins|vitamins|mesh-ancestor
56662325|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
56662326|NCT00673218|Omalizumab|omalizumab|mesh-list
56662327|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56662328|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56662329|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
56662330|NCT00673296|Bevacizumab|bevacizumab|mesh-list
56171470|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
56171471|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56171472|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
56171473|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171474|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171475|NCT02242344|Telmisartan|telmisartan|mesh-list
56171476|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56171477|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56171478|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56171479|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171480|NCT02242656|Opium|opium|mesh-list
56171481|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56171482|NCT02242656|Narcotics|narcotics|mesh-ancestor
56171483|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786378|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
56171484|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171486|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
56171487|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171488|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
56171489|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56171490|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
56171491|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
56171492|NCT02242812|Metoprolol|metoprolol|mesh-list
56171493|NCT02242812|Telmisartan|telmisartan|mesh-list
56171494|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56171495|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56171496|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56171497|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171498|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56171499|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
55786389|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55786390|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56171500|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
56171501|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171502|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171503|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56171504|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56171505|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56171506|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
56171507|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171508|NCT02243124|Dexamethasone|dexamethasone|mesh-list
56171509|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171510|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
56171511|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
56171512|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171513|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171514|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56171515|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
56171516|NCT02243124|Hormones|hormones|mesh-ancestor
56171517|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662331|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56662332|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662333|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56662334|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56662335|NCT00673296|Growth Substances|growth substances|mesh-ancestor
56662336|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662337|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
56662338|NCT04216355|Azacitidine|azacitidine|mesh-list
56662339|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56662340|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
56662341|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662342|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662343|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662344|NCT00683124|Losartan|losartan|mesh-list
56662345|NCT00683124|Nebivolol|nebivolol|mesh-list
56662346|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56662347|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56662348|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56662349|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56662350|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662351|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
56662352|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56662353|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56662354|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56662355|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
56662356|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662357|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662358|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
56662359|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56223730|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171518|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56171519|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171520|NCT02243436|Cytarabine|cytarabine|mesh-list
56171521|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
56171522|NCT02243436|Etoposide|etoposide|mesh-list
55786414|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
56171523|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56171524|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171525|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56171526|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56171539|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
56171540|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171541|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56662360|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662361|NCT00683202|Aspirin|aspirin|mesh-list
56662362|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56662363|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56662364|NCT00683202|Analgesics|analgesics|mesh-ancestor
56662365|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
56662366|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662367|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662368|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56662369|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56662370|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56662371|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56662372|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662373|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56223763|NCT03571308|Hormones|hormones|mesh-ancestor
56171542|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
56171543|NCT02243436|Hormones|hormones|mesh-ancestor
56171544|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56171545|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56171546|NCT02243436|Protective Agents|protective agents|mesh-ancestor
56171547|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56171548|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
56171549|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56171550|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
56171551|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
56171552|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171553|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171554|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56171555|NCT02243826|Analgesics|analgesics|mesh-ancestor
55786450|NCT01916824|Analgesics|analgesics|mesh-ancestor
56171556|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
56171557|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171558|NCT02244216|Fenoterol|fenoterol|mesh-list
56171559|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56171560|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
56171561|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171562|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171563|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56171564|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
55786460|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56171565|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
56171566|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
56171567|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56171568|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56171569|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56171570|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56171571|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
56171572|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171573|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171574|NCT02244294|Tamsulosin|tamsulosin|mesh-list
55786473|NCT01936870|Fesoterodine|fesoterodine|mesh-list
56171575|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56171576|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56171577|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56171579|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786480|NCT01936870|Urological Agents|urological agents|mesh-ancestor
56171580|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171587|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662374|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56662375|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662376|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
56662377|NCT00679536|Fludarabine|fludarabine|mesh-list
56662378|NCT00679536|Busulfan|busulfan|mesh-list
56662379|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
56662380|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662381|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662382|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171588|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171589|NCT02244528|Urological Agents|urological agents|mesh-ancestor
56171590|NCT02245464|Telmisartan|telmisartan|mesh-list
56171591|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55786493|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
56171592|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56171593|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56171594|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786498|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
56171596|NCT02246244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56171597|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56171598|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55786502|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171599|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099251|NCT05467514|Hormones|hormones|mesh-ancestor
56171600|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171601|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
56171602|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171603|NCT02246244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56171604|NCT02246244|Antidepressive Agents|antidepressive agents|mesh-ancestor
56171605|NCT02246244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56171606|NCT02246712|Tramadol|tramadol|mesh-list
56171607|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56171608|NCT02246712|Narcotics|narcotics|mesh-ancestor
56171609|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171610|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171611|NCT02246712|Analgesics|analgesics|mesh-ancestor
56171612|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
56171613|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171614|NCT02246868|Factor VIII|factor viii|mesh-list
56171615|NCT02246868|Coagulants|coagulants|mesh-ancestor
56171616|NCT02247258|Azathioprine|azathioprine|mesh-list
56171617|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
56171618|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171619|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56171620|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171621|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171622|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
56171623|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171624|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171627|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56171629|NCT02247414|Dalteparin|dalteparin|mesh-list
56171630|NCT02247414|Dipyridamole|dipyridamole|mesh-list
56171631|NCT02247414|Warfarin|warfarin|mesh-list
56171632|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56171633|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56171634|NCT02247414|Analgesics|analgesics|mesh-ancestor
56171635|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
56171636|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171637|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171638|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171639|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171640|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56171641|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56171642|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171643|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56171644|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56662383|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
56662384|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662385|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
56662386|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56662387|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56662388|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
56662389|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56662390|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662391|NCT00537979|Vitamins|vitamins|mesh-ancestor
56662392|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
56662393|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56662394|NCT00679614|Acetaminophen|acetaminophen|mesh-list
56662395|NCT00679614|Tramadol|tramadol|mesh-list
56662396|NCT00679614|Naloxone|naloxone|mesh-list
56662397|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56662398|NCT00679614|Analgesics|analgesics|mesh-ancestor
56662399|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
56662400|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662401|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662402|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
56662403|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56662404|NCT00679614|Narcotics|narcotics|mesh-ancestor
56662405|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662406|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56662407|NCT02744417|Bupropion|bupropion|mesh-list
56662408|NCT02744417|Nicotine|nicotine|mesh-list
56662409|NCT02744417|Varenicline|varenicline|mesh-list
56662410|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56662411|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
56662412|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662413|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662414|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56662427|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56662428|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662429|NCT02629146|Fentanyl|fentanyl|mesh-list
56662430|NCT02629146|Midazolam|midazolam|mesh-list
56662431|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56662432|NCT02629146|Narcotics|narcotics|mesh-ancestor
56662433|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171645|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171646|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
56171647|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
56171648|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56171653|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171654|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171656|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
56171657|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171658|NCT02248428|Clarithromycin|clarithromycin|mesh-list
56171659|NCT02248428|Thalidomide|thalidomide|mesh-list
56171660|NCT02248428|Dexamethasone|dexamethasone|mesh-list
56171661|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
56171662|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171663|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
55786555|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
56171664|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171665|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56171666|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56171667|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
56171668|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786563|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
56171669|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171670|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56171671|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171672|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
56171673|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
56171674|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171675|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56171676|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
56171677|NCT02248428|Hormones|hormones|mesh-ancestor
55786570|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213170|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171678|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56171679|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56171680|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56171681|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171682|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56171683|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786572|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
56171684|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56171685|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56171686|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
56171687|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56171688|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56171689|NCT02248428|Growth Substances|growth substances|mesh-ancestor
56171690|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
56171691|NCT02248506|Clotrimazole|clotrimazole|mesh-list
56171692|NCT02248506|Miconazole|miconazole|mesh-list
56171693|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56171694|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171696|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56171697|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56171698|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171699|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171700|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56171701|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
56213171|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171702|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56171703|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171704|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56662434|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662435|NCT02629146|Analgesics|analgesics|mesh-ancestor
56171705|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56171706|NCT02248896|Telmisartan|telmisartan|mesh-list
56171707|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
56171708|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56171709|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56171710|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56171711|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56171712|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171713|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
56171714|NCT02249130|Ritonavir|ritonavir|mesh-list
56171720|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56171721|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56171722|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
56171723|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171724|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171726|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56171727|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
56171728|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171729|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56171730|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56171731|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56171732|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56171733|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
56171735|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56171736|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213172|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
56171737|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171738|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56171739|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
56171740|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
56171741|NCT02249442|Ritonavir|ritonavir|mesh-list
56171742|NCT02249442|Tipranavir|tipranavir|mesh-list
56171743|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56171744|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56171745|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
56171746|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786630|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56171747|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171748|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56171749|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56171750|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
56171751|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171752|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56171753|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56171755|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56171756|NCT02244762|Narcotics|narcotics|mesh-ancestor
55786640|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
56171757|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178225|NCT03410355|Cortisone|cortisone|mesh-list
56171758|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171759|NCT02244762|Analgesics|analgesics|mesh-ancestor
56171760|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
56171761|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171762|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
56171763|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
56171764|NCT02242734|Hydrocodone|hydrocodone|mesh-list
56171765|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56171766|NCT02242734|Narcotics|narcotics|mesh-ancestor
56171767|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171768|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171769|NCT02242734|Analgesics|analgesics|mesh-ancestor
56171771|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171772|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
56171773|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
56171774|NCT02244606|Fluconazole|fluconazole|mesh-list
56171775|NCT02244606|Micafungin|micafungin|mesh-list
56171777|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
56171778|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171779|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56171780|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56171781|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662436|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
56662437|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662438|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56662439|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56662440|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
56662441|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
56662442|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56662443|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56662444|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56662445|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662446|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
56662447|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
56662448|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662449|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662450|NCT02744339|Riociguat|riociguat|mesh-list
56662451|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
56662452|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662453|NCT00991159|Bococizumab|bococizumab|mesh-list
56662454|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56662455|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56662456|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
56662457|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662458|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56662459|NCT00679770|Tavaborole|tavaborole|mesh-list
56662460|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
56662461|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662462|NCT02744495|Betamethasone|betamethasone|mesh-list
56662463|NCT02744495|Droperidol|droperidol|mesh-list
56662464|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56662465|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
56662466|NCT02744495|Hormones|hormones|mesh-ancestor
56171782|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171783|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56171784|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
56171785|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786667|NCT04389775|Incretins|incretins|mesh-ancestor
56171794|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171796|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56171797|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
56171798|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171799|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786678|NCT02102789|Leucovorin|leucovorin|mesh-list
56171800|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56171801|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
56171802|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662467|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662468|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662469|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56662470|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
56662471|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56662472|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
56662473|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
56662474|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662475|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56662476|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56662477|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56662478|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662479|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662480|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56662481|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56662482|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
56662483|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662484|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662485|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56662486|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56662487|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
56662488|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662489|NCT00683436|Adipiplon|adipiplon|mesh-list
56662490|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171803|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56171804|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56171805|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56171806|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
56171807|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56171808|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56171809|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171810|NCT02243358|Gemcitabine|gemcitabine|mesh-list
56171811|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56171812|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
56171813|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171814|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171815|NCT02243358|Antiviral Agents|antiviral agents|mesh-ancestor
56171816|NCT02243358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171817|NCT02243358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178228|NCT03399617|Trace Elements|trace elements|mesh-list
56171818|NCT02243358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171819|NCT02243358|Immunologic Factors|immunologic factors|mesh-ancestor
56171820|NCT02243358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171821|NCT00559962|Atorvastatin|atorvastatin|mesh-list
56171822|NCT00559962|Ezetimibe|ezetimibe|mesh-list
56171823|NCT00559962|Fenofibrate|fenofibrate|mesh-list
56171824|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56099479|NCT00879619|Sunitinib|sunitinib|mesh-list
56171825|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56662491|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662492|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
56662493|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
56662494|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662495|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662496|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56662497|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56662498|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662499|NCT00989443|Cidofovir|cidofovir|mesh-list
56662500|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
56662501|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662502|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662503|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662504|NCT00683514|Cisplatin|cisplatin|mesh-list
56662505|NCT00683514|Vinorelbine|vinorelbine|mesh-list
56662506|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662507|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56662508|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
56662509|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
56662510|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
56662511|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662512|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
56662513|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171826|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
56171827|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171828|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56171829|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56171830|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171832|NCT00559104|Carmustine|carmustine|mesh-list
56171833|NCT00559104|Etoposide|etoposide|mesh-list
56171834|NCT00559104|Lenograstim|lenograstim|mesh-list
56171835|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171837|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171838|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786700|NCT02102789|Protective Agents|protective agents|mesh-ancestor
56171839|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56171840|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
56171841|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171842|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171843|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56171844|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56171845|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56171846|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56171847|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171852|NCT00558636|Sorafenib|sorafenib|mesh-list
56171853|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56171854|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171855|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
56171856|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
56171857|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
56171858|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662514|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
56662515|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662516|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56662517|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56662518|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
56662519|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662520|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662521|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56662522|NCT05629325|Buspirone|buspirone|mesh-list
56662523|NCT05629325|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56662524|NCT05629325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56662525|NCT05629325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662526|NCT05629325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662527|NCT05629325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662528|NCT05629325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56662529|NCT05629325|Serotonin Agents|serotonin agents|mesh-ancestor
56662530|NCT05629325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662531|NCT05629325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662532|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
56662533|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56662534|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
56662535|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662536|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
56662537|NCT02629380|Protective Agents|protective agents|mesh-ancestor
56662538|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
56662539|NCT02743247|Tacrolimus|tacrolimus|mesh-list
56662540|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308754|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662541|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
56662542|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171859|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56171860|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171861|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
56171862|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171863|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
56171864|NCT00558558|Hormones|hormones|mesh-ancestor
56171865|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56171866|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171867|NCT00557622|Paroxetine|paroxetine|mesh-list
56171868|NCT00557622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56171869|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56171870|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56171871|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662543|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56662544|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662545|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662546|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56662547|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662548|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56662549|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
56662550|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56662551|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662552|NCT00680160|Tavaborole|tavaborole|mesh-list
56662553|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
56662554|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662555|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
56662556|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56662557|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171872|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171873|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
56171874|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171875|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56171876|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
56171877|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56171878|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56171879|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56171880|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171881|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
56171882|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56171883|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
56171884|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171885|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171886|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56171887|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
56171888|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56171889|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56171890|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56171891|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
56171892|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171893|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171894|NCT00557310|Teriparatide|teriparatide|mesh-list
56171895|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55786717|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56171896|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171897|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56171899|NCT00555438|Fondaparinux|fondaparinux|mesh-list
56171900|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56171901|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
56171902|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56171903|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
56171904|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171905|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171906|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
56171907|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55786730|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56171908|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56171909|NCT00553644|Lenalidomide|lenalidomide|mesh-list
56171910|NCT00553644|Bortezomib|bortezomib|mesh-list
56171912|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171913|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56171914|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56171915|NCT00553644|Growth Substances|growth substances|mesh-ancestor
56662558|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
56662559|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56662560|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
56662561|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56662562|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
56662563|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662564|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662565|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
56662566|NCT00537823|Leucovorin|leucovorin|mesh-list
56662567|NCT00537823|Bevacizumab|bevacizumab|mesh-list
56662568|NCT00537823|Cetuximab|cetuximab|mesh-list
56662569|NCT00537823|Fluorouracil|fluorouracil|mesh-list
56662570|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
56662571|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56662572|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662573|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56662574|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56662575|NCT00537823|Growth Substances|growth substances|mesh-ancestor
56662576|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662577|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
56662578|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
56662579|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662580|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56171916|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
56171917|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171918|NCT00552240|Ritonavir|ritonavir|mesh-list
56171924|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56171925|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
56171926|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171927|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171928|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56171929|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56171930|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
56171931|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171932|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56171933|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56171934|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56171935|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56171936|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56171937|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56171939|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56171940|NCT00550836|Panitumumab|panitumumab|mesh-list
56171941|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56171942|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
56171943|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171944|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171945|NCT00550836|Antiviral Agents|antiviral agents|mesh-ancestor
56171946|NCT00550836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171947|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171948|NCT00550836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55786769|NCT03945721|Niraparib|niraparib|mesh-list
56171950|NCT00550836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662581|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56662582|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
56662583|NCT00537823|Antidotes|antidotes|mesh-ancestor
56662584|NCT00537823|Protective Agents|protective agents|mesh-ancestor
56662585|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
56662586|NCT00537823|Vitamins|vitamins|mesh-ancestor
56662587|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
56662588|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
56662589|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
56662590|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662591|NCT04139928|Cathartics|cathartics|mesh-ancestor
56171951|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56171952|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56171953|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
56171954|NCT00550680|Hematinics|hematinics|mesh-ancestor
56171955|NCT00556920|Carvedilol|carvedilol|mesh-list
56171956|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56171957|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56171958|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
55786782|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56171960|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171961|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171962|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56171963|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
56171964|NCT00556920|Protective Agents|protective agents|mesh-ancestor
56171965|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56171966|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55786791|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
56171967|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56171968|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
56171969|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56171970|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56171971|NCT00552708|Lisinopril|lisinopril|mesh-list
56171972|NCT00552708|Carvedilol|carvedilol|mesh-list
56099632|NCT05048719|Dulaglutide|dulaglutide|mesh-list
56171973|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56171975|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171976|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171977|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56171978|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56171979|NCT00552708|Protective Agents|protective agents|mesh-ancestor
56171980|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171981|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56171982|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56171983|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
56171984|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56171986|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56171987|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56171988|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56171991|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56171994|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56171995|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56171996|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171997|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56171998|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171999|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172000|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56172001|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
56172002|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56172004|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56172005|NCT03029676|Fentanyl|fentanyl|mesh-list
56172006|NCT03029676|Midazolam|midazolam|mesh-list
56172007|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
56172008|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662592|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56662593|NCT04139928|Antacids|antacids|mesh-ancestor
56662594|NCT05589025|Eugenol|eugenol|mesh-list
56662595|NCT05589025|Zinc Oxide|zinc oxide|mesh-list
56662596|NCT05589025|Dermatologic Agents|dermatologic agents|mesh-ancestor
56662597|NCT05589025|Sunscreening Agents|sunscreening agents|mesh-ancestor
56662598|NCT05589025|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56662599|NCT05589025|Protective Agents|protective agents|mesh-ancestor
56172009|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172010|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56172011|NCT03029676|Narcotics|narcotics|mesh-ancestor
56172012|NCT03029676|Analgesics|analgesics|mesh-ancestor
56172013|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
56172014|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172015|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56172016|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56172017|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
56172018|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56172019|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56172020|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56172021|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56172022|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
56172023|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
56172024|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172025|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172026|NCT04270344|Valsartan|valsartan|mesh-list
56172027|NCT04270344|Pitavastatin|pitavastatin|mesh-list
56172028|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56172029|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56172030|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56172031|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172032|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56172033|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56172034|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56172035|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
56172036|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172037|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56172039|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56172040|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172041|NCT04271202|Analgesics|analgesics|mesh-ancestor
56172042|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
56172043|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172044|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172045|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
56172046|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56172047|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172049|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
56172050|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
56172051|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172052|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172053|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
56172054|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172055|NCT03839550|Apatinib|apatinib|mesh-list
56172056|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172057|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56172058|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172059|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172060|NCT03839160|Morphine|morphine|mesh-list
56172061|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56172067|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172068|NCT03838926|Trichostatin A|trichostatin a|mesh-list
56172069|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
56172070|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56172071|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56172072|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172073|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172074|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56172075|NCT03834012|Beclomethasone|beclomethasone|mesh-list
56662600|NCT05589025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662601|NCT05589025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662602|NCT02742233|Saxagliptin|saxagliptin|mesh-list
56662603|NCT02742233|Incretins|incretins|mesh-ancestor
56662604|NCT02742233|Hormones|hormones|mesh-ancestor
56662605|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662606|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662607|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56662608|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
56662609|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662610|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662611|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56662612|NCT00673608|Deferasirox|deferasirox|mesh-list
56662613|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56662614|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
56662615|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
56662616|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662617|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
56223993|NCT02931890|Paclitaxel|paclitaxel|mesh-list
56172076|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56172077|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
56172078|NCT03834012|Hormones|hormones|mesh-ancestor
56172079|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56172080|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172081|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56172082|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
56172083|NCT03833466|Metformin|metformin|mesh-list
56172084|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56172085|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172086|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56172087|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56172088|NCT03830034|Iron|iron|mesh-list
56172089|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
56172090|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
56172091|NCT03830034|Trace Elements|trace elements|mesh-ancestor
56172092|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
56172093|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178247|NCT03359239|Poly ICLC|poly iclc|mesh-list
56172095|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
56172096|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172097|NCT03838068|Anesthetics|anesthetics|mesh-list
56172098|NCT03838068|Procaine|procaine|mesh-list
56172099|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
56172100|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172101|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172102|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
56172103|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172104|NCT05440734|Melatonin|melatonin|mesh-list
56172105|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
56172106|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172107|NCT05440734|Protective Agents|protective agents|mesh-ancestor
56172108|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172109|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172110|NCT05447208|Hormones|hormones|mesh-list
56172111|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56004030|NCT04756622|Antidotes|antidotes|mesh-ancestor
56662618|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
56662619|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56662620|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56662621|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662622|NCT02742467|Amlodipine|amlodipine|mesh-list
56662623|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56662624|NCT02742467|Perindopril|perindopril|mesh-list
56662625|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56662626|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56224005|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
56172112|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172113|NCT05444556|Repaglinide|repaglinide|mesh-list
56172114|NCT05444556|Quinidine|quinidine|mesh-list
56172115|NCT05444556|Digoxin|digoxin|mesh-list
56172116|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
56172117|NCT05444556|Omeprazole|omeprazole|mesh-list
56172118|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56172119|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56172120|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56172121|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
56172122|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172123|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56172124|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56172125|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172126|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56172127|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56172128|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56172129|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56172130|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55786948|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56172132|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172135|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56172136|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56172137|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172138|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56172139|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56172140|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56172141|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
56178253|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172142|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
56172143|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56172144|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56172145|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56172146|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56172147|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56172148|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
56172149|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56172150|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55786965|NCT05101291|Bupivacaine|bupivacaine|mesh-list
56172151|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56172152|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56172153|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56172154|NCT05445804|Cannabidiol|cannabidiol|mesh-list
56172155|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
56172156|NCT05440578|Bevacizumab|bevacizumab|mesh-list
56172157|NCT05440578|Olaparib|olaparib|mesh-list
56172158|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56172159|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172160|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56172161|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56172162|NCT05440578|Growth Substances|growth substances|mesh-ancestor
56172163|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172164|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
56172165|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56172166|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004031|NCT00002344|Azithromycin|azithromycin|mesh-list
56662627|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56662628|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662629|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56662630|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662631|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
56662632|NCT02742467|Diuretics|diuretics|mesh-ancestor
56662633|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
56662634|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56662635|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56662636|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
56662637|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662638|NCT00684216|Tamoxifen|tamoxifen|mesh-list
56662639|NCT00684216|Capecitabine|capecitabine|mesh-list
56662640|NCT00684216|Letrozole|letrozole|mesh-list
56662641|NCT00684216|Anastrozole|anastrozole|mesh-list
56662642|NCT00684216|Exemestane|exemestane|mesh-list
56662643|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56662644|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
56224014|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
56172167|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172168|NCT01689558|Endostatins|endostatins|mesh-list
56172169|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172170|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56172171|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56172172|NCT01689558|Growth Substances|growth substances|mesh-ancestor
56172173|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172174|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
56172175|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
56172176|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56172177|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172178|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
56172179|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56172180|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172181|NCT01689870|Ipilimumab|ipilimumab|mesh-list
56172182|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56172183|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172184|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56172185|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172186|NCT05768854|Diphosphonates|diphosphonates|mesh-list
56172187|NCT05768854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56172188|NCT05768854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172189|NCT05768711|Venetoclax|venetoclax|mesh-list
56172190|NCT05768711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172192|NCT05768542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56172193|NCT05768542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56099866|NCT00000199|Piracetam|piracetam|mesh-list
56172195|NCT05768542|Autonomic Agents|autonomic agents|mesh-ancestor
56172196|NCT05768542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172197|NCT05768542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172198|NCT05768542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56172199|NCT05768542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56172200|NCT05768542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56172201|NCT05768542|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172202|NCT05768542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662645|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662646|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662647|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56662648|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56662649|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662650|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56662651|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
56172219|NCT05768360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56172220|NCT05768360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56172221|NCT05768360|Antimetabolites|antimetabolites|mesh-ancestor
56172222|NCT05768360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172223|NCT05768360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56172224|NCT05768360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56172225|NCT05768360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172226|NCT05768360|Diuretics|diuretics|mesh-ancestor
56172227|NCT05768360|Natriuretic Agents|natriuretic agents|mesh-ancestor
56172228|NCT05768360|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56172229|NCT05768360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56172230|NCT05768360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56172231|NCT05768360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56172232|NCT05768360|Protective Agents|protective agents|mesh-ancestor
56172233|NCT05768334|Lubiprostone|lubiprostone|mesh-list
56172234|NCT05768334|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56172235|NCT05768334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56172236|NCT05768334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172237|NCT05768243|Hyaluronic Acid|hyaluronic acid|mesh-list
56172238|NCT05768243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56172239|NCT05768243|Immunologic Factors|immunologic factors|mesh-ancestor
56172240|NCT05768243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172241|NCT05768243|Viscosupplements|viscosupplements|mesh-ancestor
56172242|NCT05768243|Protective Agents|protective agents|mesh-ancestor
56172243|NCT05768230|Simendan|simendan|mesh-list
56172244|NCT05768230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56172245|NCT05768230|Vasodilator Agents|vasodilator agents|mesh-ancestor
56172246|NCT05768230|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56172247|NCT05768230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56172248|NCT05768230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172249|NCT05768230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172250|NCT05768230|Protective Agents|protective agents|mesh-ancestor
56172251|NCT05768230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172252|NCT05768204|Prednisolone|prednisolone|mesh-list
56172253|NCT05768204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56172254|NCT05768204|Methylprednisolone|methylprednisolone|mesh-list
56178281|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172255|NCT05768204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56172256|NCT05768204|Prednisolone acetate|prednisolone acetate|mesh-list
56172257|NCT05768204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56172258|NCT05768204|Prednisolone phosphate|prednisolone phosphate|mesh-list
56172259|NCT05768204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56172260|NCT05768204|Glucocorticoids|glucocorticoids|mesh-ancestor
56172267|NCT05768204|Autonomic Agents|autonomic agents|mesh-ancestor
56172268|NCT05768204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172269|NCT05768204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56172270|NCT05768204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56172271|NCT05768204|Protective Agents|protective agents|mesh-ancestor
56172273|NCT05768191|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56172274|NCT05768191|Isophane Insulin, Human|isophane insulin, human|mesh-list
56172275|NCT05768191|Insulin, Isophane|insulin, isophane|mesh-list
56172276|NCT05768191|Isophane insulin, beef|isophane insulin, beef|mesh-list
56172277|NCT05768191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56172278|NCT05768191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172284|NCT05768139|Fulvestrant|fulvestrant|mesh-list
56172285|NCT05768139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56172286|NCT05768139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172287|NCT05768139|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56172288|NCT05768139|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56172289|NCT05768139|Hormone Antagonists|hormone antagonists|mesh-ancestor
56004569|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
56662652|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662653|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662654|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56662655|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56662656|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56662657|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56662658|NCT00684450|Protamines|protamines|mesh-list
56662659|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
56224036|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
56172290|NCT05768139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56172291|NCT05768139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172292|NCT05768126|Rivastigmine|rivastigmine|mesh-list
56172293|NCT05768126|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56172294|NCT05768126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172295|NCT05768126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172296|NCT05768126|Cholinergic Agents|cholinergic agents|mesh-ancestor
56172297|NCT05768126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172298|NCT05768126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172299|NCT05768126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56172300|NCT05768126|Protective Agents|protective agents|mesh-ancestor
56172301|NCT05767944|Anesthetics|anesthetics|mesh-list
56172302|NCT05767944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172303|NCT05767944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172304|NCT05767892|Carboplatin|carboplatin|mesh-list
56172305|NCT05767892|Pemetrexed|pemetrexed|mesh-list
56172306|NCT05767892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172307|NCT05767892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172308|NCT05767892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172309|NCT05767892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55787132|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56172310|NCT05767892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56172312|NCT05767827|Epinephrine|epinephrine|mesh-list
56172313|NCT05767827|Racepinephrine|racepinephrine|mesh-list
56172314|NCT05767827|Dexmedetomidine|dexmedetomidine|mesh-list
56172315|NCT05767827|Ropivacaine|ropivacaine|mesh-list
56172316|NCT05767827|Epinephryl borate|epinephryl borate|mesh-list
56172317|NCT05767827|Anesthetics, Local|anesthetics, local|mesh-ancestor
56172318|NCT05767827|Anesthetics|anesthetics|mesh-ancestor
56172319|NCT05767827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172320|NCT05767827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172321|NCT05767827|Sensory System Agents|sensory system agents|mesh-ancestor
56172322|NCT05767827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172323|NCT05767827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56172324|NCT05767827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55787154|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56172325|NCT05767827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56172326|NCT05767827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56172327|NCT05767827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172328|NCT05767827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56172329|NCT05767827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172330|NCT05767827|Analgesics|analgesics|mesh-ancestor
56172331|NCT05767827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56172332|NCT05767827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56172333|NCT05767827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56172334|NCT05767827|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172337|NCT05767827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56172339|NCT05767827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56172340|NCT05767827|Respiratory System Agents|respiratory system agents|mesh-ancestor
56172341|NCT05767827|Mydriatics|mydriatics|mesh-ancestor
56172342|NCT05767827|Sympathomimetics|sympathomimetics|mesh-ancestor
56172343|NCT05767827|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56172344|NCT05767749|Lidocaine|lidocaine|mesh-list
56172345|NCT05767749|Epinephrine|epinephrine|mesh-list
56172346|NCT05767749|Racepinephrine|racepinephrine|mesh-list
56662660|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662661|NCT00684450|Coagulants|coagulants|mesh-ancestor
56662662|NCT00684528|Metformin|metformin|mesh-list
56662663|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56662664|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662665|NCT00684606|Oxytocin|oxytocin|mesh-list
56662666|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
56662667|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56662668|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662669|NCT00684372|Leflunomide|leflunomide|mesh-list
56662670|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662671|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662672|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56662673|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
56662674|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662675|NCT01505569|Etoposide|etoposide|mesh-list
56662676|NCT01505569|Carboplatin|carboplatin|mesh-list
56662677|NCT01505569|Melphalan|melphalan|mesh-list
56662678|NCT01505569|Busulfan|busulfan|mesh-list
56662679|NCT01505569|Ifosfamide|ifosfamide|mesh-list
56662680|NCT01505569|Thiotepa|thiotepa|mesh-list
56662681|NCT01505569|Lenograstim|lenograstim|mesh-list
56662682|NCT01505569|Mesna|mesna|mesh-list
56662683|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56662684|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662685|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172347|NCT05767749|Bupivacaine|bupivacaine|mesh-list
56172348|NCT05767749|Ropivacaine|ropivacaine|mesh-list
56172349|NCT05767749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56172350|NCT05767749|Epinephryl borate|epinephryl borate|mesh-list
56172351|NCT05767749|Anesthetics, Local|anesthetics, local|mesh-ancestor
56172352|NCT05767749|Anesthetics|anesthetics|mesh-ancestor
56172353|NCT05767749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172354|NCT05767749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172355|NCT05767749|Sensory System Agents|sensory system agents|mesh-ancestor
56172356|NCT05767749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172357|NCT05767749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56172358|NCT05767749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56172359|NCT05767749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56172360|NCT05767749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56172361|NCT05767749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172362|NCT05767749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56172363|NCT05767749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56172364|NCT05767749|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172365|NCT05767749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172366|NCT05767749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56172367|NCT05767749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56172368|NCT05767749|Autonomic Agents|autonomic agents|mesh-ancestor
56172369|NCT05767749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56172370|NCT05767749|Respiratory System Agents|respiratory system agents|mesh-ancestor
56172371|NCT05767749|Mydriatics|mydriatics|mesh-ancestor
56172372|NCT05767749|Sympathomimetics|sympathomimetics|mesh-ancestor
56662686|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56662687|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56662688|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662689|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56172373|NCT05767749|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56172374|NCT05767736|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56172375|NCT05767736|Dermatologic Agents|dermatologic agents|mesh-ancestor
56178306|NCT03276533|Analgesics|analgesics|mesh-ancestor
56172376|NCT05767736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56172377|NCT05767736|Immunologic Factors|immunologic factors|mesh-ancestor
56172378|NCT05767736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172379|NCT05767723|Aspirin|aspirin|mesh-list
56172380|NCT05767723|Ticagrelor|ticagrelor|mesh-list
56172381|NCT05767723|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56172382|NCT05767723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56172383|NCT05767723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56172384|NCT05767723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56172385|NCT05767723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56172386|NCT05767723|Purinergic Agents|purinergic agents|mesh-ancestor
56172387|NCT05767723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172388|NCT05767723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172389|NCT05767723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172390|NCT05767723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56172391|NCT05767723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172392|NCT05767723|Analgesics|analgesics|mesh-ancestor
56172393|NCT05767723|Sensory System Agents|sensory system agents|mesh-ancestor
56172394|NCT05767723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172395|NCT05767723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56172396|NCT05767723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172397|NCT05767723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56172398|NCT05767723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56172399|NCT05767723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56172400|NCT05767723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172401|NCT05767723|Antipyretics|antipyretics|mesh-ancestor
56172402|NCT05767684|Nivolumab|nivolumab|mesh-list
56172403|NCT05767684|Lenvatinib|lenvatinib|mesh-list
56172404|NCT05767684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56172405|NCT05767684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172406|NCT05767684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56172407|NCT05767684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172413|NCT05767671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172415|NCT05767632|Mirabegron|mirabegron|mesh-list
56172416|NCT05767632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56172417|NCT05767632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56172418|NCT05767632|Cholinergic Agents|cholinergic agents|mesh-ancestor
56172419|NCT05767632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172420|NCT05767632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172421|NCT05767632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172422|NCT05767632|Urological Agents|urological agents|mesh-ancestor
56172423|NCT05767632|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56172424|NCT05767632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56172426|NCT05767632|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172427|NCT05767515|Inositol|inositol|mesh-list
56172428|NCT05767515|Acetylcarnitine|acetylcarnitine|mesh-list
56172429|NCT05767515|Metformin|metformin|mesh-list
56172430|NCT05767515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56172431|NCT05767515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172432|NCT05767515|Vitamin B Complex|vitamin b complex|mesh-ancestor
56172434|NCT05767515|Micronutrients|micronutrients|mesh-ancestor
56172435|NCT05767515|Nootropic Agents|nootropic agents|mesh-ancestor
56172436|NCT05767359|Cyclophosphamide|cyclophosphamide|mesh-list
56172437|NCT05767359|Fludarabine|fludarabine|mesh-list
56172438|NCT05767359|Fludarabine phosphate|fludarabine phosphate|mesh-list
56172439|NCT05767359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56172440|NCT05767359|Immunologic Factors|immunologic factors|mesh-ancestor
56172441|NCT05767359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172442|NCT05767359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172443|NCT05767359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56172444|NCT05767359|Alkylating Agents|alkylating agents|mesh-ancestor
56172445|NCT05767359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172446|NCT05767359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662690|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
56662691|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56662692|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56662693|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
56662694|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662695|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56662696|NCT01505569|Protective Agents|protective agents|mesh-ancestor
56662697|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56662698|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56662699|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662700|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
56662701|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56662702|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662703|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56662704|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56662705|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
56662706|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662707|NCT00991627|Atropine|atropine|mesh-list
56662708|NCT00991627|Ephedrine|ephedrine|mesh-list
56662709|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
56662710|NCT00991627|Morphine|morphine|mesh-list
56662711|NCT00991627|Bupivacaine|bupivacaine|mesh-list
56662712|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
56662713|NCT00991627|Anesthetics|anesthetics|mesh-list
56662714|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662715|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662716|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
56662717|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662718|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56172447|NCT05767359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56172448|NCT05767359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56172449|NCT05767359|Antimetabolites|antimetabolites|mesh-ancestor
56172450|NCT05767346|Metoprolol|metoprolol|mesh-list
56172451|NCT05767346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56172452|NCT05767346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56172453|NCT05767346|Sympatholytics|sympatholytics|mesh-ancestor
56172454|NCT05767346|Autonomic Agents|autonomic agents|mesh-ancestor
56172455|NCT05767346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172456|NCT05767346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172457|NCT05767346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56172458|NCT05767346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56172459|NCT05767346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56172460|NCT05767346|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172461|NCT05767346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172462|NCT05767346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172463|NCT05767255|Insulin|insulin|mesh-list
56172464|NCT05767255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56662719|NCT00991627|Narcotics|narcotics|mesh-ancestor
56662720|NCT00991627|Analgesics|analgesics|mesh-ancestor
56662721|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56662722|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56662723|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56662724|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
56662725|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56662726|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
56662727|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
56662728|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
56662729|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56662730|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56662731|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
56662732|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662733|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662734|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56662735|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
56662736|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56662737|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
56662738|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
56172465|NCT05767255|Insulin Glargine|insulin glargine|mesh-list
56172466|NCT05767255|Insulin Aspart|insulin aspart|mesh-list
56172467|NCT05767255|Liraglutide|liraglutide|mesh-list
56172468|NCT05767255|Xultophy|xultophy|mesh-list
56172469|NCT05767255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56172470|NCT05767255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172471|NCT05767255|Incretins|incretins|mesh-ancestor
56172472|NCT05767255|Hormones|hormones|mesh-ancestor
56172473|NCT05767255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56172474|NCT05767229|Carvedilol|carvedilol|mesh-list
56172475|NCT05767229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56172476|NCT05767229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56172477|NCT05767229|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172478|NCT05767229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172479|NCT05767229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172480|NCT05767229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172486|NCT05767229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56172487|NCT05767229|Vasodilator Agents|vasodilator agents|mesh-ancestor
56172488|NCT05767229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56172489|NCT05767229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56100182|NCT00000325|Hormones|hormones|mesh-ancestor
56172511|NCT05767060|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56172512|NCT05767060|Immunologic Factors|immunologic factors|mesh-ancestor
56172513|NCT05767060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172514|NCT05767047|Apremilast|apremilast|mesh-list
56172515|NCT05767047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56172516|NCT05767047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172517|NCT05767047|Analgesics|analgesics|mesh-ancestor
56172518|NCT05767047|Sensory System Agents|sensory system agents|mesh-ancestor
56172519|NCT05767047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172520|NCT05767047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172521|NCT05767047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56172522|NCT05767047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172523|NCT05767047|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56172524|NCT05767047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56172525|NCT05767047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662739|NCT03562871|Carboplatin|carboplatin|mesh-list
56662740|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
56172526|NCT05767047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172527|NCT05767034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56172528|NCT05767034|Immunologic Factors|immunologic factors|mesh-ancestor
56172529|NCT05767034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172530|NCT05767021|Mirikizumab|mirikizumab|mesh-list
56172531|NCT05767021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56172532|NCT05767021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172533|NCT05767021|Analgesics|analgesics|mesh-ancestor
56172534|NCT05767021|Sensory System Agents|sensory system agents|mesh-ancestor
56172535|NCT05767021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172536|NCT05767021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172537|NCT05767021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56172538|NCT05767021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172539|NCT05767021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56172540|NCT05767021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56172541|NCT05765513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56172542|NCT05764733|Diphosphonates|diphosphonates|mesh-list
56172543|NCT05764733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56172544|NCT05764733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172545|NCT05761431|Octreotide|octreotide|mesh-list
56172546|NCT05761431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56172547|NCT05761431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56172548|NCT05761431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172549|NCT05757557|Nitric Oxide|nitric oxide|mesh-list
56172550|NCT05757557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56172551|NCT05757557|Autonomic Agents|autonomic agents|mesh-ancestor
55787387|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56172552|NCT05757557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172553|NCT05757557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172554|NCT05757557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56172555|NCT05757557|Respiratory System Agents|respiratory system agents|mesh-ancestor
56172556|NCT05757557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56172558|NCT05757557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172559|NCT05757557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172560|NCT05757557|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56172561|NCT05757557|Vasodilator Agents|vasodilator agents|mesh-ancestor
56172562|NCT05757557|Gasotransmitters|gasotransmitters|mesh-ancestor
56172563|NCT05757557|Protective Agents|protective agents|mesh-ancestor
56172564|NCT05755789|Cefoxitin|cefoxitin|mesh-list
56172565|NCT05755789|Cefotaxime|cefotaxime|mesh-list
56172566|NCT05755789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56172567|NCT05755789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56172568|NCT05754073|Oxytocin|oxytocin|mesh-list
56100237|NCT04099303|Vaccines|vaccines|mesh-list
56172570|NCT05754073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56178330|NCT03191240|Vasopressins|vasopressins|mesh-list
56172573|NCT05753267|Fenofibrate|fenofibrate|mesh-list
56172574|NCT05753267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56172575|NCT05753267|Antimetabolites|antimetabolites|mesh-ancestor
55787400|NCT02625623|Paclitaxel|paclitaxel|mesh-list
56172576|NCT05753267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172577|NCT05753267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56172578|NCT05753267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56172579|NCT05753267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172580|NCT05753267|Analgesics|analgesics|mesh-ancestor
56172581|NCT05753267|Sensory System Agents|sensory system agents|mesh-ancestor
56172582|NCT05753267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172583|NCT05753267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172584|NCT05753267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56172585|NCT05753267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172586|NCT05751343|Bevacizumab|bevacizumab|mesh-list
56172588|NCT05751343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56172589|NCT05751343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172590|NCT05751343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56172591|NCT05751343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56172592|NCT05751343|Growth Substances|growth substances|mesh-ancestor
56172593|NCT05751343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172594|NCT05751343|Growth Inhibitors|growth inhibitors|mesh-ancestor
56172596|NCT05702853|Fludarabine|fludarabine|mesh-list
56172597|NCT05702853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56172598|NCT05702853|Immunologic Factors|immunologic factors|mesh-ancestor
56172599|NCT05702853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172600|NCT05702853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56662741|NCT03562871|Pemetrexed|pemetrexed|mesh-list
56662742|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662743|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56662744|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787429|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172601|NCT05702853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56172602|NCT05702853|Alkylating Agents|alkylating agents|mesh-ancestor
56172603|NCT05702853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172604|NCT05702853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172605|NCT05702853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56172606|NCT05678348|Pyrimethamine|pyrimethamine|mesh-list
56172607|NCT05678348|Antimalarials|antimalarials|mesh-ancestor
56172608|NCT05678348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56172609|NCT05678348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56172610|NCT05678348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56172611|NCT05678348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56172612|NCT05678348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172613|NCT05678348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172614|NCT05664217|Antithrombin III|antithrombin iii|mesh-list
56172615|NCT05664217|Antithrombins|antithrombins|mesh-list
56172616|NCT05664217|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56172617|NCT05664217|Protease Inhibitors|protease inhibitors|mesh-ancestor
56172619|NCT05664217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172620|NCT05664217|Anticoagulants|anticoagulants|mesh-ancestor
56172621|NCT05654818|Vitamin D|vitamin d|mesh-list
56172622|NCT05654818|Vitamins|vitamins|mesh-ancestor
56172623|NCT05654818|Micronutrients|micronutrients|mesh-ancestor
56172624|NCT05654818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172625|NCT05654818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56172626|NCT05653050|Insulin|insulin|mesh-list
56172627|NCT05653050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56172628|NCT05653050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172629|NCT05647681|Acetaminophen|acetaminophen|mesh-list
56172630|NCT05647681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172631|NCT05647681|Analgesics|analgesics|mesh-ancestor
56172632|NCT05647681|Sensory System Agents|sensory system agents|mesh-ancestor
56172633|NCT05647681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787460|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787461|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787462|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55787463|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787464|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172634|NCT05647681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172636|NCT05644145|Vaccines|vaccines|mesh-list
56172638|NCT05644145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172639|NCT05643560|Factor VIII|factor viii|mesh-list
56172640|NCT05643560|Coagulants|coagulants|mesh-ancestor
56172641|NCT05642416|Ropivacaine|ropivacaine|mesh-list
56100311|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
56172644|NCT05642416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172645|NCT05642416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172646|NCT05642416|Sensory System Agents|sensory system agents|mesh-ancestor
56172647|NCT05642416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172648|NCT05631028|Dexmedetomidine|dexmedetomidine|mesh-list
56172649|NCT05631028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56172650|NCT05631028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172651|NCT05631028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172652|NCT05631028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172653|NCT05631028|Analgesics|analgesics|mesh-ancestor
56172654|NCT05631028|Sensory System Agents|sensory system agents|mesh-ancestor
56172655|NCT05631028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172656|NCT05631028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56172657|NCT05631028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56172658|NCT05631028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56172659|NCT05631028|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172660|NCT05631028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172661|NCT05631028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172662|NCT05630976|Isavuconazole|isavuconazole|mesh-list
56172663|NCT05630976|Antifungal Agents|antifungal agents|mesh-ancestor
56172664|NCT05630976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56172666|NCT05621616|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56662745|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662746|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56662747|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56662748|NCT00690222|Mydriatics|mydriatics|mesh-list
56662749|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
56662750|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662751|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172667|NCT05621616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56172668|NCT05621616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56172669|NCT05621616|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172670|NCT05621616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172671|NCT05621616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172672|NCT05621616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172673|NCT05621616|Urological Agents|urological agents|mesh-ancestor
56172674|NCT05612074|Nitric Oxide|nitric oxide|mesh-list
56172675|NCT05612074|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56172676|NCT05612074|Autonomic Agents|autonomic agents|mesh-ancestor
56172677|NCT05612074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172678|NCT05612074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172679|NCT05612074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56172680|NCT05612074|Respiratory System Agents|respiratory system agents|mesh-ancestor
56172681|NCT05612074|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56172683|NCT05612074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172684|NCT05612074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787505|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56172685|NCT05612074|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56172686|NCT05612074|Vasodilator Agents|vasodilator agents|mesh-ancestor
56172687|NCT05612074|Gasotransmitters|gasotransmitters|mesh-ancestor
56172688|NCT05612074|Protective Agents|protective agents|mesh-ancestor
56172689|NCT05604599|Fentanyl|fentanyl|mesh-list
56172690|NCT05604599|Dexmedetomidine|dexmedetomidine|mesh-list
56172691|NCT05604599|Propofol|propofol|mesh-list
56172692|NCT05604599|Isoflurane|isoflurane|mesh-list
56172693|NCT05604599|Atracurium|atracurium|mesh-list
56172694|NCT05604599|Cisatracurium|cisatracurium|mesh-list
56172695|NCT05604599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56172696|NCT05604599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172697|NCT05604599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172698|NCT05604599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56172699|NCT05604599|Anesthetics, General|anesthetics, general|mesh-ancestor
56172700|NCT05604599|Anesthetics|anesthetics|mesh-ancestor
56172701|NCT05604599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172702|NCT05604599|Analgesics|analgesics|mesh-ancestor
56172703|NCT05604599|Sensory System Agents|sensory system agents|mesh-ancestor
56172704|NCT05604599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172705|NCT05604599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56172706|NCT05604599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56172707|NCT05604599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56172708|NCT05604599|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172709|NCT05604599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172710|NCT05604599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172711|NCT05604599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56172712|NCT05604599|Narcotics|narcotics|mesh-ancestor
56172713|NCT05604599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56172714|NCT05604599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56172718|NCT05604599|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56100395|NCT00002894|Paclitaxel|paclitaxel|mesh-list
56172719|NCT05604599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56172720|NCT05604599|Cholinergic Agents|cholinergic agents|mesh-ancestor
56172721|NCT05602636|Midazolam|midazolam|mesh-list
56172722|NCT05602636|Bupivacaine|bupivacaine|mesh-list
56172723|NCT05602636|Anesthetics, Local|anesthetics, local|mesh-ancestor
56172724|NCT05602636|Anesthetics|anesthetics|mesh-ancestor
56172725|NCT05602636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172726|NCT05602636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172727|NCT05602636|Sensory System Agents|sensory system agents|mesh-ancestor
56172728|NCT05602636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172729|NCT05602636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56662752|NCT02736071|Celecoxib|celecoxib|mesh-list
56662753|NCT02736071|Tramadol|tramadol|mesh-list
56662754|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56662755|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56662756|NCT02736071|Analgesics|analgesics|mesh-ancestor
56662757|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
56662758|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662759|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662760|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56662761|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56662762|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56662763|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56662764|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662765|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662766|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56662767|NCT02736071|Narcotics|narcotics|mesh-ancestor
56662768|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662769|NCT00690300|Docetaxel|docetaxel|mesh-list
56662770|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
56662771|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662772|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
56224133|NCT01299480|Vaccines|vaccines|mesh-list
56172730|NCT05602636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56172731|NCT05602636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56172732|NCT05602636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56172733|NCT05602636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56172734|NCT05602636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56172735|NCT05602636|Anesthetics, General|anesthetics, general|mesh-ancestor
56172736|NCT05602636|GABA Modulators|gaba modulators|mesh-ancestor
56172737|NCT05602636|GABA Agents|gaba agents|mesh-ancestor
56172738|NCT05602636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172739|NCT05602636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172740|NCT05602519|Fentanyl|fentanyl|mesh-list
56172742|NCT05602519|Rocuronium|rocuronium|mesh-list
56172743|NCT05602519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56172744|NCT05602519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172745|NCT05602519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172746|NCT05602519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56172747|NCT05602519|Anesthetics, General|anesthetics, general|mesh-ancestor
56172748|NCT05602519|Anesthetics|anesthetics|mesh-ancestor
56172749|NCT05602519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56172750|NCT05602519|Narcotics|narcotics|mesh-ancestor
56172751|NCT05602519|Analgesics|analgesics|mesh-ancestor
56172752|NCT05602519|Sensory System Agents|sensory system agents|mesh-ancestor
56172753|NCT05602519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172754|NCT05602519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56172755|NCT05602519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56172756|NCT05602519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56172757|NCT05602519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56172758|NCT05586802|Anastrozole|anastrozole|mesh-list
56172759|NCT05586802|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56172761|NCT05586802|Androgens|androgens|mesh-ancestor
56172762|NCT05586802|Hormones|hormones|mesh-ancestor
56172763|NCT05586802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56172764|NCT05586802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662773|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
56662774|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
56662775|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662776|NCT02741219|Sufentanil|sufentanil|mesh-list
56662777|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
56662778|NCT02741219|Dsuvia|dsuvia|mesh-list
56662779|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56662780|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662781|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662782|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56662783|NCT02741219|Analgesics|analgesics|mesh-ancestor
56662784|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
56662785|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662786|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56662787|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56662788|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56662789|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
56662790|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172765|NCT05586802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56172766|NCT05586802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172767|NCT05586802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56172768|NCT05586802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56172769|NCT05586802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172770|NCT05586802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172772|NCT05586802|Hormone Antagonists|hormone antagonists|mesh-ancestor
56172773|NCT05586802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56172774|NCT05583110|Trastuzumab|trastuzumab|mesh-list
56172775|NCT05583110|Vinorelbine|vinorelbine|mesh-list
56172776|NCT05583110|Tucatinib|tucatinib|mesh-list
56172777|NCT05583110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56172778|NCT05583110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172779|NCT05583110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56172780|NCT05583110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56172781|NCT05583110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56172782|NCT05583110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56172783|NCT05583110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172784|NCT05583110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56172785|NCT05583110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172787|NCT05581823|Anticonvulsants|anticonvulsants|mesh-ancestor
56172788|NCT05581823|Antimanic Agents|antimanic agents|mesh-ancestor
56172789|NCT05581823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56172790|NCT05581823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172799|NCT05581823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172800|NCT05581823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56172801|NCT05581823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56172802|NCT05574504|Avelumab|avelumab|mesh-list
56172803|NCT05574504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56172804|NCT05574504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56172805|NCT05574504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172806|NCT05574504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172807|NCT05543837|Capsaicin|capsaicin|mesh-list
56172808|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
56172809|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
56172810|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
56172811|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172812|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662791|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662792|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56662793|NCT02741219|Narcotics|narcotics|mesh-ancestor
56662794|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56662795|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56662796|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
56662797|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
56662798|NCT00690534|Insulin|insulin|mesh-list
56662799|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56662800|NCT00690534|Nitroprusside|nitroprusside|mesh-list
56662801|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56662802|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662803|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56172817|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56172818|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56172819|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56172820|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56172821|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56172822|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56172823|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172824|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787659|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
56172826|NCT05486026|Analgesics|analgesics|mesh-ancestor
56172827|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
56172828|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172829|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
56172830|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56172831|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
56172832|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172833|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172834|NCT05483465|Niacinamide|niacinamide|mesh-list
56172836|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
56172837|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
56172838|NCT05483465|Vitamins|vitamins|mesh-ancestor
56172839|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
56172840|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172841|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56172842|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
56172843|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172844|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56172845|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
56172846|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
56172847|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
56172848|NCT05468099|Povidone|povidone|mesh-list
56172849|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56172850|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56172851|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
56172853|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
56172854|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
56172855|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
56172856|NCT05451940|Hematinics|hematinics|mesh-list
56172857|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172858|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
56172859|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172860|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172861|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56172862|NCT05419427|Denosumab|denosumab|mesh-list
56172865|NCT05411107|Iloprost|iloprost|mesh-list
56172866|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56172867|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
56172868|NCT05408091|Antibodies|antibodies|mesh-list
55787688|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56172869|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56172870|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
56172871|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662804|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
56662805|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56662806|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662807|NCT00991705|Atorvastatin|atorvastatin|mesh-list
56662808|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56662809|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56662810|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
56662811|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662812|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56662813|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56662814|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662815|NCT02735837|Doxycycline|doxycycline|mesh-list
56662816|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56662817|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662818|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
56662819|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56662820|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56662821|NCT02625558|Riociguat|riociguat|mesh-list
56662822|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
56662823|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662824|NCT00685230|Antivenins|antivenins|mesh-list
56662825|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
56662826|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662827|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56662828|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
56662829|NCT00991783|Digoxin|digoxin|mesh-list
56662830|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56662831|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56662832|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662833|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662834|NCT00991783|Protective Agents|protective agents|mesh-ancestor
56662835|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662836|NCT00690768|Bevacizumab|bevacizumab|mesh-list
56662837|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56662843|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
56662844|NCT00690846|Adalimumab|adalimumab|mesh-list
56308978|NCT00056446|Vatalanib|vatalanib|mesh-list
56662845|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56662846|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56662847|NCT05591105|Lidocaine|lidocaine|mesh-list
56662848|NCT05591105|Ketamine|ketamine|mesh-list
56662849|NCT05591105|Anesthetics, Local|anesthetics, local|mesh-ancestor
56662850|NCT05591105|Anesthetics|anesthetics|mesh-ancestor
56662851|NCT05591105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662852|NCT05591105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662853|NCT05591105|Sensory System Agents|sensory system agents|mesh-ancestor
56662854|NCT05591105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662855|NCT05591105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56662856|NCT05591105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56662857|NCT05591105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56662858|NCT05591105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56662859|NCT05591105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662860|NCT05591105|Analgesics|analgesics|mesh-ancestor
56662861|NCT05591105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56662862|NCT05591105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56662863|NCT05591105|Anesthetics, General|anesthetics, general|mesh-ancestor
56662864|NCT05591105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56662865|NCT05591105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56662866|NCT05591105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662867|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
56662868|NCT04683679|Olaparib|olaparib|mesh-list
56662869|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56662870|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662871|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56172872|NCT05379686|Glucagon|glucagon|mesh-list
56172873|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56172874|NCT05379686|Hormones|hormones|mesh-ancestor
56172875|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56172876|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172877|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
56172878|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172879|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56172880|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172881|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172882|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
56172883|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56172884|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662872|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662873|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662874|NCT00685464|Abciximab|abciximab|mesh-list
56662875|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
56662876|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56662877|NCT02740829|Glucagon|glucagon|mesh-list
56662878|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56662879|NCT02740829|Hormones|hormones|mesh-ancestor
56662880|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662881|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662882|NCT00685542|Diacetylrhein|diacetylrhein|mesh-list
56662883|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56662884|NCT02741063|Oxytocin|oxytocin|mesh-list
56662885|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
56662886|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56662887|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662888|NCT04138836|Itraconazole|itraconazole|mesh-list
56662889|NCT04138836|Midazolam|midazolam|mesh-list
56662890|NCT04138836|Esomeprazole|esomeprazole|mesh-list
56662891|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56662892|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56662893|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56662894|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662895|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56662896|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56662897|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55787718|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56172885|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56172886|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
56172887|NCT05352672|Cemiplimab|cemiplimab|mesh-list
56172888|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56172889|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172891|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56172892|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172893|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172894|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172895|NCT05342844|Analgesics|analgesics|mesh-ancestor
56172896|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
56172897|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172898|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56172899|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56172900|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56172901|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172902|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172903|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172904|NCT05337540|Hylan|hylan|mesh-list
56172905|NCT05337540|Viscosupplements|viscosupplements|mesh-ancestor
56172906|NCT05337540|Protective Agents|protective agents|mesh-ancestor
56172907|NCT05337540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172908|NCT05334472|Ofatumumab|ofatumumab|mesh-list
56662898|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56662899|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
56662900|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
56662901|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
56662902|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
56662903|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662904|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662905|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56662906|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56662907|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56662908|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662909|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
56662910|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662911|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56662912|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56662913|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56662914|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
56662915|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224267|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
56172909|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172910|NCT05332067|Omalizumab|omalizumab|mesh-list
56172911|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56172912|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56172913|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56172914|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
56172915|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
56172916|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172917|NCT05323617|Cyclosporine|cyclosporine|mesh-list
56172918|NCT05323617|Cyclosporins|cyclosporins|mesh-list
56172919|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56172920|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172921|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172922|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56172923|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
56172924|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172925|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
56172926|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56172927|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
56172928|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172929|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56172930|NCT05301608|Psilocybin|psilocybin|mesh-list
56172931|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56172932|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
56172933|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172934|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56172937|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172938|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172939|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56172941|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56172942|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56172943|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56172944|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172945|NCT05284019|Analgesics|analgesics|mesh-ancestor
56172946|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
56005091|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
56662916|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56662917|NCT00922584|Sorafenib|sorafenib|mesh-list
56309052|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
56662918|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662919|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56662920|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662921|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662922|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
56662923|NCT02735603|Naltrexone|naltrexone|mesh-list
56662924|NCT02735603|Bupropion|bupropion|mesh-list
56662925|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56662926|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56662927|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56662928|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56662929|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56662930|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662931|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662932|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662933|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56662934|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56662935|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
56662936|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662937|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56662938|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
56662939|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662940|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56662941|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56662942|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56662943|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
56662944|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172947|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172948|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172949|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56172950|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55787773|NCT04940273|Analgesics|analgesics|mesh-ancestor
56172951|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56172952|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
56172953|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172954|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
56172955|NCT05283408|Esketamine|esketamine|mesh-list
56172956|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56172957|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172958|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172959|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56662945|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56662946|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56662947|NCT00685776|Anacetrapib|anacetrapib|mesh-list
56662948|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56662949|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56662950|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
56662951|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56662952|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56662953|NCT00685854|Ranibizumab|ranibizumab|mesh-list
56662954|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56662955|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56662956|NCT00685854|Growth Substances|growth substances|mesh-ancestor
56662957|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662958|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
56662959|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662960|NCT04270409|Dexamethasone|dexamethasone|mesh-list
56662961|NCT04270409|Lenalidomide|lenalidomide|mesh-list
56662962|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56662963|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
56662964|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
56662965|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662966|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662967|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56662968|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
56172960|NCT05283408|Analgesics|analgesics|mesh-ancestor
56172961|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
56172962|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172963|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56172964|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56172966|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
56172967|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172968|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172969|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
56172970|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56172971|NCT05275439|Azacitidine|azacitidine|mesh-list
56172973|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56172975|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172976|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172977|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172978|NCT05271162|Empagliflozin|empagliflozin|mesh-list
56172979|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56172980|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787812|NCT04938011|Progesterone|progesterone|mesh-list
56172981|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56172982|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172983|NCT05257083|Dexamethasone|dexamethasone|mesh-list
56172984|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
56172985|NCT05257083|Fludarabine|fludarabine|mesh-list
56172986|NCT05257083|Lenalidomide|lenalidomide|mesh-list
56172987|NCT05257083|Bortezomib|bortezomib|mesh-list
56172988|NCT05257083|Daratumumab|daratumumab|mesh-list
56172989|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56662969|NCT04270409|Hormones|hormones|mesh-ancestor
56662970|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662971|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56662972|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56662973|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
56662974|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56662975|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56172990|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
56172991|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172992|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56172993|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56172994|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
56172995|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172996|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172997|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56172998|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56172999|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
56173000|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
56173001|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173002|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56173003|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
56173004|NCT05257083|Hormones|hormones|mesh-ancestor
55787821|NCT04946825|Nicotine|nicotine|mesh-list
56173005|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56173006|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56173008|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56173009|NCT05257083|Growth Substances|growth substances|mesh-ancestor
56173010|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
56173012|NCT05249634|Androgens|androgens|mesh-ancestor
56173015|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173016|NCT05245071|Maytansine|maytansine|mesh-list
56173017|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56173021|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
56173022|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173023|NCT05217342|Diuretics|diuretics|mesh-list
56173024|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
56173025|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173026|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55787852|NCT04946669|Abatacept|abatacept|mesh-list
56173027|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56173028|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
56173030|NCT05199714|Pancrelipase|pancrelipase|mesh-list
56173031|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56173032|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173033|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173034|NCT05193370|Vasopressins|vasopressins|mesh-list
56173035|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
56173036|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
56173037|NCT05193370|Giapreza|giapreza|mesh-list
56173038|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
56173039|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
56173040|NCT05193370|Coagulants|coagulants|mesh-ancestor
56173043|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
56173044|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173045|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56173046|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
56173047|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173048|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173050|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
56173051|NCT05172947|Resveratrol|resveratrol|mesh-list
56173052|NCT05172947|Antioxidants|antioxidants|mesh-ancestor
56173053|NCT05172947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787878|NCT04946123|Selenium|selenium|mesh-list
56173054|NCT05172947|Protective Agents|protective agents|mesh-ancestor
56173055|NCT05172947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173056|NCT05172947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173057|NCT05172947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56173058|NCT05170607|Antibodies|antibodies|mesh-list
56662976|NCT04270409|Growth Substances|growth substances|mesh-ancestor
56662977|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
56662978|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
56662979|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
56662980|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56662981|NCT04003207|Hormones|hormones|mesh-list
56662982|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56662983|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662984|NCT04582435|Insulin|insulin|mesh-list
56662985|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56662986|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56662987|NCT05295355|Bromides|bromides|mesh-list
56662988|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
56662989|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56662990|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
56662991|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56662992|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309126|NCT02969746|Antidotes|antidotes|mesh-ancestor
56662993|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56662994|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
56662995|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
56662996|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56662997|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
56662998|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56662999|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663000|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
56663001|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
56663002|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56663003|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56663004|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
56663005|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663006|NCT01564303|Expectorants|expectorants|mesh-ancestor
56663007|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
56663008|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56663009|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
56663010|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663011|NCT01564303|Protective Agents|protective agents|mesh-ancestor
56663014|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56663015|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663016|NCT00674232|Misoprostol|misoprostol|mesh-list
56663017|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56663018|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
56663019|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56663020|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663021|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56663022|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56663023|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
56663024|NCT00674310|Ropinirole|ropinirole|mesh-list
56663025|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56663026|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56663027|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
56663028|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
56663029|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663030|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663031|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173059|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
56173060|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173061|NCT05156710|Rituximab|rituximab|mesh-list
56173062|NCT05156710|Tacrolimus|tacrolimus|mesh-list
55787885|NCT04945577|Vitamin D|vitamin d|mesh-list
56173063|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
56173064|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56173065|NCT05156710|Antibodies|antibodies|mesh-list
56173066|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56173067|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
56173068|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56173069|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173070|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173071|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
56173072|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173073|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173074|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56173075|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56173076|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173077|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173078|NCT05147220|Teriflunomide|teriflunomide|mesh-list
56173079|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56173080|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56173081|NCT05147220|Analgesics|analgesics|mesh-ancestor
56173082|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
55787890|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
55787903|NCT02655679|Ether|ether|mesh-list
56173083|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173084|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173085|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56173086|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173087|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56173091|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
56173092|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173093|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173094|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
56173095|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56173096|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
56173097|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173098|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
56173099|NCT05099718|Protective Agents|protective agents|mesh-ancestor
56663032|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
56663033|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56663034|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56663035|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
56224394|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56173100|NCT05081180|Lenvatinib|lenvatinib|mesh-list
56173101|NCT05081180|Avelumab|avelumab|mesh-list
56173102|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173103|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56173104|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173105|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173106|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173107|NCT05078827|Fluorouracil|fluorouracil|mesh-list
56173108|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
56173109|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173110|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56173111|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173112|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56173113|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
56173114|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173115|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56173116|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56173117|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173118|NCT05065164|Denosumab|denosumab|mesh-list
56173119|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56173120|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173121|NCT05062044|Folic Acid|folic acid|mesh-list
56173122|NCT05062044|Hematinics|hematinics|mesh-ancestor
56173126|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173127|NCT05057819|Empagliflozin|empagliflozin|mesh-list
56173128|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56173129|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173130|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173131|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173135|NCT05044819|Cannabidiol|cannabidiol|mesh-list
56173136|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
56173137|NCT05037812|Ketorolac|ketorolac|mesh-list
56173138|NCT05037812|Clonidine|clonidine|mesh-list
56173139|NCT05037812|Epinephrine|epinephrine|mesh-list
56173140|NCT05037812|Morphine|morphine|mesh-list
56173141|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56173142|NCT05037812|Narcotics|narcotics|mesh-ancestor
56173143|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787914|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
56173144|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173145|NCT05037812|Analgesics|analgesics|mesh-ancestor
56173146|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
56173147|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173148|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56173149|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56173150|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
56173151|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173152|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173153|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56173154|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56173155|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
56173156|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56173157|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
56173158|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
56173159|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
56173160|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56173161|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56173162|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56173163|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56173164|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173165|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56173166|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173167|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56173168|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
56173169|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56173181|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173182|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56663036|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663037|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56663038|NCT05273359|Benralizumab|benralizumab|mesh-list
56663039|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56173183|NCT05019638|Narcotics|narcotics|mesh-ancestor
56173184|NCT05019638|Analgesics|analgesics|mesh-ancestor
56173185|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56173186|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56173187|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
56173188|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173189|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173190|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56173191|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56173200|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56173201|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173202|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56173203|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173204|NCT04997993|Leflunomide|leflunomide|mesh-list
56173205|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173206|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173207|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56173208|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
56173209|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787928|NCT04472611|Colchicine|colchicine|mesh-list
56173217|NCT04907253|Quercetin|quercetin|mesh-list
56173218|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
56173219|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173220|NCT04907253|Protective Agents|protective agents|mesh-ancestor
56173221|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173222|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56173223|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56173224|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56173225|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56173226|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173227|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
56173228|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173229|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173230|NCT04884360|Olaparib|olaparib|mesh-list
56173231|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56173232|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173233|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173234|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173235|NCT04854512|Metformin|metformin|mesh-list
56173236|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173237|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173258|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
56173259|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173260|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
56173261|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56173262|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56173263|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173264|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
56173265|NCT04797156|Coagulants|coagulants|mesh-ancestor
56173266|NCT04772300|Sirolimus|sirolimus|mesh-list
56173267|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56173268|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56173272|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56173273|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
56173274|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173275|NCT04759144|Insulin|insulin|mesh-list
56173276|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56173277|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
56173278|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
56173279|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56173280|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173281|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173282|NCT04756037|Relugolix|relugolix|mesh-list
56173283|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
56173284|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
56173285|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56663040|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
56663041|NCT05265247|Esomeprazole|esomeprazole|mesh-list
56663042|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56663043|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56663044|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56663045|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663046|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663047|NCT04251533|Paclitaxel|paclitaxel|mesh-list
56663048|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56663049|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663050|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
56663051|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663052|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
56663053|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663054|NCT03823300|Aflibercept|aflibercept|mesh-list
56663055|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56173286|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173287|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56173288|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173289|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173290|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173291|NCT04679376|Atorvastatin|atorvastatin|mesh-list
56173292|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56173293|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56173294|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
56173295|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173296|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56173297|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56173298|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173299|NCT04677959|Fluticasone|fluticasone|mesh-list
56173300|NCT04677959|Xhance|xhance|mesh-list
56173301|NCT04677959|Albuterol|albuterol|mesh-list
56173302|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56173303|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56173304|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56173305|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
56173306|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173307|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173308|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56173309|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
55787970|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173310|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
56173311|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56173312|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56173313|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56173314|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56173315|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
56173316|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173317|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173318|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
56173319|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56173320|NCT04671043|Caffeine|caffeine|mesh-list
56173321|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56173322|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173323|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56173324|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173325|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663056|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56663057|NCT03823300|Growth Substances|growth substances|mesh-ancestor
56663058|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663059|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
56663060|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663061|NCT00537745|Naltrexone|naltrexone|mesh-list
56663062|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56663063|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56663064|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663065|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
56663066|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663067|NCT00686322|Paclitaxel|paclitaxel|mesh-list
56663068|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56663070|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56663071|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663072|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
56663073|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663074|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
56663075|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663076|NCT02734511|Propofol|propofol|mesh-list
56663077|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56663078|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663079|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663080|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56663081|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
56663082|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
56224426|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
56173326|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56173327|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56173328|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
56173329|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173330|NCT04643002|Dexamethasone|dexamethasone|mesh-list
56173331|NCT04643002|Pomalidomide|pomalidomide|mesh-list
56173332|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56173333|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
56173334|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
56173335|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173336|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173337|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56173338|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
56173339|NCT04643002|Hormones|hormones|mesh-ancestor
56173344|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56173345|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56173346|NCT04643002|Growth Substances|growth substances|mesh-ancestor
56173347|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
56173348|NCT04641975|Mirabegron|mirabegron|mesh-list
56173349|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56173350|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56173351|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56663083|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56663084|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
56663085|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663086|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56663087|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56663088|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663089|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
56663090|NCT02739815|Coagulants|coagulants|mesh-ancestor
56663091|NCT00720616|Insulin|insulin|mesh-list
56663092|NCT00720616|Hormones|hormones|mesh-list
56663093|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56663094|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663095|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56663096|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
56663097|NCT00720772|Antidotes|antidotes|mesh-ancestor
56663098|NCT00720772|Protective Agents|protective agents|mesh-ancestor
56663099|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663100|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
56663101|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663102|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
56663103|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56663104|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663105|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
56663106|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
56663107|NCT00720850|Lenalidomide|lenalidomide|mesh-list
56224452|NCT01690572|Paclitaxel|paclitaxel|mesh-list
56173352|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
56173353|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173354|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173355|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173356|NCT04641975|Urological Agents|urological agents|mesh-ancestor
56173357|NCT04624230|Tofacitinib|tofacitinib|mesh-list
55788000|NCT04935515|Anticoagulants|anticoagulants|mesh-list
56173359|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173360|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173361|NCT04612920|Acetaminophen|acetaminophen|mesh-list
56173362|NCT04612920|Ibuprofen|ibuprofen|mesh-list
56173363|NCT04612920|Oxycodone|oxycodone|mesh-list
56173364|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56173365|NCT04612920|Analgesics|analgesics|mesh-ancestor
56173366|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
55788017|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
56173367|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173368|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173369|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
56173370|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56173371|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56173372|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173373|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56173374|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888853|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663108|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
56663109|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663110|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56663111|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56663112|NCT00720850|Growth Substances|growth substances|mesh-ancestor
56663113|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
56663114|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663115|NCT05493995|Gemcitabine|gemcitabine|mesh-list
56663116|NCT05493995|Paclitaxel|paclitaxel|mesh-list
56663117|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56663118|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663119|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
56663120|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663121|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
56173375|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173376|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56173377|NCT04612920|Narcotics|narcotics|mesh-ancestor
55788020|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55788021|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
55788022|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55788023|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
55788024|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788027|NCT04299373|Ethanol|ethanol|mesh-list
56173378|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56173379|NCT04570293|Lidocaine|lidocaine|mesh-list
56173380|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
56173381|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
56173382|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56173383|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173384|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
56173385|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173386|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56173387|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56173388|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55788033|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
56173389|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56173390|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173391|NCT04569084|Edaravone|edaravone|mesh-list
56173392|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56173393|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
56173394|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173395|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56173396|NCT04569084|Protective Agents|protective agents|mesh-ancestor
56173397|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173398|NCT04560595|Caffeine|caffeine|mesh-list
56173399|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56173400|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788050|NCT04516993|Analgesics|analgesics|mesh-ancestor
56173401|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56173402|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173403|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173405|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56173406|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
56173407|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173408|NCT04551222|Probenecid|probenecid|mesh-list
56173409|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
56173410|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
56173411|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173412|NCT04551222|Renal Agents|renal agents|mesh-ancestor
56173413|NCT04550260|Cisplatin|cisplatin|mesh-list
56173414|NCT04550260|Fluorouracil|fluorouracil|mesh-list
56173415|NCT04550260|Capecitabine|capecitabine|mesh-list
56663122|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663123|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56663124|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
56663125|NCT05493995|Antiviral Agents|antiviral agents|mesh-ancestor
56663126|NCT05493995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663127|NCT05493995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663128|NCT05493995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663129|NCT05493995|Immunologic Factors|immunologic factors|mesh-ancestor
56663130|NCT05493995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663131|NCT03785158|Melatonin|melatonin|mesh-list
56663132|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
56663133|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663134|NCT03785158|Protective Agents|protective agents|mesh-ancestor
56663135|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663136|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663137|NCT05116891|Leucovorin|leucovorin|mesh-list
56663138|NCT05116891|Gemcitabine|gemcitabine|mesh-list
56663139|NCT05116891|Cisplatin|cisplatin|mesh-list
56663140|NCT05116891|Docetaxel|docetaxel|mesh-list
56663141|NCT05116891|Fluorouracil|fluorouracil|mesh-list
56663142|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
56663143|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663144|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56663145|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
56663146|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663147|NCT05116891|Antiviral Agents|antiviral agents|mesh-ancestor
56663148|NCT05116891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663149|NCT05116891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663150|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663151|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
56663152|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663153|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
56173416|NCT04550260|Durvalumab|durvalumab|mesh-list
56173417|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173418|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
56173419|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173420|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56173421|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56173422|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
56173423|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173424|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173425|NCT04540705|Nivolumab|nivolumab|mesh-list
56173426|NCT04540705|Axitinib|axitinib|mesh-list
56173427|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173428|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663154|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663155|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
56663157|NCT05116891|Protective Agents|protective agents|mesh-ancestor
56663158|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
56663159|NCT05116891|Vitamins|vitamins|mesh-ancestor
56663160|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
56663161|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56663162|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56663163|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
56663164|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663165|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663166|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663167|NCT02733809|Sorafenib|sorafenib|mesh-list
56663168|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663169|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56663170|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663171|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663172|NCT00717340|Paclitaxel|paclitaxel|mesh-list
56663173|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56663174|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663175|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
56663176|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663177|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
56663178|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663179|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56663180|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56663181|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663182|NCT00874848|Paclitaxel|paclitaxel|mesh-list
56663183|NCT00874848|Carboplatin|carboplatin|mesh-list
56663184|NCT00874848|Cetuximab|cetuximab|mesh-list
56663185|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56173429|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56173430|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173431|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56173432|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173433|NCT04531462|Empagliflozin|empagliflozin|mesh-list
56173434|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56173435|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173436|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173437|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173438|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
56173439|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56173440|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
56173441|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663186|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56663187|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663188|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
56663189|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663190|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
56663191|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663192|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56663193|NCT04912063|Azacitidine|azacitidine|mesh-list
56663194|NCT04912063|Venetoclax|venetoclax|mesh-list
56663195|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56663196|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
56663197|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663198|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663199|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663200|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
56663201|NCT00691236|Doxorubicin|doxorubicin|mesh-list
56663202|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56663203|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663204|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56663205|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56663206|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663207|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663208|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56663209|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663210|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
56663211|NCT04137978|Diuretics|diuretics|mesh-ancestor
56173442|NCT04520139|Expectorants|expectorants|mesh-ancestor
56173443|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
56173444|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56173445|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
56173446|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178599|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178600|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
56178601|NCT02729701|Estrogens|estrogens|mesh-list
56178602|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56173448|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173449|NCT04520139|Antidotes|antidotes|mesh-ancestor
56173474|NCT04512105|Venetoclax|venetoclax|mesh-list
56173475|NCT04512105|Pitavastatin|pitavastatin|mesh-list
56173476|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173477|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56173478|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56173479|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56173480|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
56173481|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173482|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173483|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56663212|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
56663213|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663214|NCT04137978|Expectorants|expectorants|mesh-ancestor
56663215|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
56663216|NCT05408065|Triamcinolone|triamcinolone|mesh-list
56663217|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56224573|NCT01691053|Spironolactone|spironolactone|mesh-list
56173484|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
56173485|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
56173486|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173487|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173488|NCT04504318|Enoxaparin|enoxaparin|mesh-list
56173489|NCT04504318|Apixaban|apixaban|mesh-list
56173490|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
56173491|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56173492|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56173493|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173494|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56173495|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
56173496|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56173497|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
56173498|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173499|NCT04501120|Azacitidine|azacitidine|mesh-list
56173502|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173504|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173505|NCT04497142|Levetiracetam|levetiracetam|mesh-list
56173506|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
56173507|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
56173508|NCT04491877|Vaccines|vaccines|mesh-list
56173509|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
56173510|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173511|NCT04477317|Epinephrine|epinephrine|mesh-list
56173512|NCT04477317|Racepinephrine|racepinephrine|mesh-list
56173513|NCT04477317|Nordefrin|nordefrin|mesh-list
56173514|NCT04477317|Mepivacaine|mepivacaine|mesh-list
56173515|NCT04477317|Carticaine|carticaine|mesh-list
56173516|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
56173517|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56173518|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56173519|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
56173520|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173521|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173522|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173523|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56173524|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56173525|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
56173526|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173527|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56173528|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
56173529|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
56173530|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
56173531|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56173532|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
56173533|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
56173534|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56173535|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
56173536|NCT04469959|Levodopa|levodopa|mesh-list
56173537|NCT04469959|Carbidopa|carbidopa|mesh-list
56173538|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56173539|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56173540|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56173541|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
56173542|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173543|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173544|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173545|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56173546|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173547|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56173548|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
56173549|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
56173550|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
56173551|NCT04441034|Convulsants|convulsants|mesh-list
56309351|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663218|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56663219|NCT05408065|Cortisone|cortisone|mesh-list
56663220|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
56663221|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56663222|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56663223|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
56663224|NCT05408065|Hormones|hormones|mesh-ancestor
56663225|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56663226|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663227|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663228|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
56663229|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663230|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663231|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56663232|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
56663233|NCT05408065|Protective Agents|protective agents|mesh-ancestor
56663234|NCT00691392|Linezolid|linezolid|mesh-list
56663235|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56663236|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663237|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56663238|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663239|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663240|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56663241|NCT02625168|Afatinib|afatinib|mesh-list
56663242|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663243|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56663244|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663245|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663246|NCT00717730|Vitamins|vitamins|mesh-list
56663247|NCT00717730|Folic Acid|folic acid|mesh-list
56663248|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
56173552|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
56173553|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56173554|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56173555|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173556|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
55788201|NCT05406999|Prednisolone|prednisolone|mesh-list
56173557|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173558|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173560|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173561|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173562|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
56173563|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56663249|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
56663250|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
56663251|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
56663252|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663253|NCT00717730|Hematinics|hematinics|mesh-ancestor
56663254|NCT00691470|Warfarin|warfarin|mesh-list
56663255|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
56663256|NCT05407597|Icatibant|icatibant|mesh-list
56663257|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56663258|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56663259|NCT05407597|Analgesics|analgesics|mesh-ancestor
56663260|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
56663261|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663262|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663263|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56663264|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56663265|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56663266|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56663267|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663268|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56663269|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663270|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
56663271|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
56224606|NCT01691469|Montelukast|montelukast|mesh-list
56173564|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
56173565|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56173566|NCT04381897|Expectorants|expectorants|mesh-ancestor
56173567|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
56173568|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56173569|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
56173570|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173571|NCT04381897|Protective Agents|protective agents|mesh-ancestor
56173572|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173573|NCT04381897|Antidotes|antidotes|mesh-ancestor
56173574|NCT04344262|Atracurium|atracurium|mesh-list
56173583|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173584|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173586|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56173588|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173589|NCT04291521|Ketamine|ketamine|mesh-list
56173590|NCT04291521|Propofol|propofol|mesh-list
56173591|NCT04291521|Etomidate|etomidate|mesh-list
56173592|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56173593|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56173594|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173595|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56173596|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
56173597|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
56173598|NCT04291521|Analgesics|analgesics|mesh-ancestor
56173599|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
56173600|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173601|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55888854|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
56663272|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663273|NCT00717808|Tranilast|tranilast|mesh-list
56663274|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
56663275|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56663276|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56663277|NCT00717808|Analgesics|analgesics|mesh-ancestor
56663278|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
56663279|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663280|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663281|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56663282|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56663283|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56663284|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56663285|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663286|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56663287|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56663288|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
56663289|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
56663290|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663291|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56663292|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56663293|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
56309425|NCT00060112|Immunologic Factors|immunologic factors|mesh-ancestor
56663294|NCT02738177|Isosorbide|isosorbide|mesh-list
56663295|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56663296|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56663297|NCT02738177|Misoprostol|misoprostol|mesh-list
56663298|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56663299|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
56663300|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56663301|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663302|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56663303|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56663304|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
56663305|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56663306|NCT02738177|Diuretics|diuretics|mesh-ancestor
56663307|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
56663308|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
56663309|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56663310|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663311|NCT04043806|Ivacaftor|ivacaftor|mesh-list
56663312|NCT04043806|Elexacaftor|elexacaftor|mesh-list
56663313|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56663314|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56663315|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663316|NCT05294965|Fenoterol|fenoterol|mesh-list
56663317|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56663318|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
56663319|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663320|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663321|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56663322|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
56663323|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
56663324|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
56663325|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56663326|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56663327|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56663328|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56663329|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
56663330|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173602|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56173603|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56173604|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173605|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173606|NCT04288427|Finasteride|finasteride|mesh-list
56173607|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56173608|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56173609|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173610|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173611|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
56173612|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56173613|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173614|NCT04288427|Urological Agents|urological agents|mesh-ancestor
56173615|NCT04280601|Vitamin D|vitamin d|mesh-list
56173616|NCT04280601|Vitamins|vitamins|mesh-ancestor
56173617|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
56173618|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173619|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56173620|NCT04263064|Clonidine|clonidine|mesh-list
56173621|NCT04263064|Analgesics|analgesics|mesh-ancestor
56173622|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
56173623|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101304|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
56173624|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173625|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56173626|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
56173627|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
56663331|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663332|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56663333|NCT02737943|Analgesics|analgesics|mesh-list
56663334|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663335|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
56663336|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663337|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663338|NCT05290753|Erythromycin|erythromycin|mesh-list
56663339|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56663340|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663341|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56663342|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56663343|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663344|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663345|NCT02737709|Paclitaxel|paclitaxel|mesh-list
56663346|NCT02737709|Carboplatin|carboplatin|mesh-list
56663347|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56663348|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663349|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
56663350|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663351|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
56663352|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663353|NCT02572960|Vitamin D|vitamin d|mesh-list
56663354|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
56663355|NCT02572960|Valsartan|valsartan|mesh-list
56663356|NCT02572960|Vitamins|vitamins|mesh-ancestor
56663357|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
56663358|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663359|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56663360|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56663361|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56663362|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56663363|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56663370|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56663371|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
56663372|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56663373|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
56663374|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56663375|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663376|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56663377|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56663378|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663379|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56663380|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56663381|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56663382|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
56663383|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663384|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56663385|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56663386|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663387|NCT05624957|Lidocaine|lidocaine|mesh-list
56663388|NCT05624957|Epinephrine|epinephrine|mesh-list
56663389|NCT05624957|Racepinephrine|racepinephrine|mesh-list
56663390|NCT05624957|Epinephryl borate|epinephryl borate|mesh-list
56663391|NCT05624957|Anesthetics, Local|anesthetics, local|mesh-ancestor
56173628|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56173629|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56173630|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56173631|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
56173632|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173633|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173634|NCT04195399|Imidazole|imidazole|mesh-list
56173635|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173636|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173640|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56173641|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173643|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173644|NCT04189744|Metronidazole|metronidazole|mesh-list
56173646|NCT04189744|Piperaquine|piperaquine|mesh-list
56173647|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
56173648|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56173649|NCT04189744|Artenimol|artenimol|mesh-list
56173650|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56173651|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56173652|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56173653|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56173654|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
56173655|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56173656|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173657|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173658|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56173659|NCT04189744|Renal Agents|renal agents|mesh-ancestor
56173660|NCT04157348|Benralizumab|benralizumab|mesh-list
56173661|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56663392|NCT05624957|Anesthetics|anesthetics|mesh-ancestor
56663393|NCT05624957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663394|NCT05624957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663395|NCT05624957|Sensory System Agents|sensory system agents|mesh-ancestor
56663396|NCT05624957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663397|NCT05624957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56663398|NCT05624957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56663399|NCT05624957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56663400|NCT05624957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56663401|NCT05624957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173662|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
56173667|NCT04131309|Bortezomib|bortezomib|mesh-list
56173668|NCT04131309|Daratumumab|daratumumab|mesh-list
56173669|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56173670|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
56173671|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
56173672|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173673|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173674|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56173675|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
56173676|NCT04131309|Hormones|hormones|mesh-ancestor
56173677|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56173678|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56173679|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173680|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56173681|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
56173682|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56173683|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56173684|NCT04117945|Cetuximab|cetuximab|mesh-list
56173685|NCT04117945|Panitumumab|panitumumab|mesh-list
56173686|NCT04117945|Irinotecan|irinotecan|mesh-list
56173687|NCT04117945|Antibodies|antibodies|mesh-list
56173688|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
56173689|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56173690|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
56173691|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173692|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173693|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56173694|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56173695|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173696|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173698|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173699|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56101379|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56173700|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56173701|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173702|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173703|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56173704|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
56173705|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56173706|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866532|NCT01919723|Ticagrelor|ticagrelor|mesh-list
56173708|NCT04091217|Atezolizumab|atezolizumab|mesh-list
56173709|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173710|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173711|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56173712|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56173713|NCT04091217|Growth Substances|growth substances|mesh-ancestor
56173714|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173718|NCT04090567|Cediranib|cediranib|mesh-list
56173720|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663402|NCT05624957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56663403|NCT05624957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56663404|NCT05624957|Adrenergic Agents|adrenergic agents|mesh-ancestor
56663405|NCT05624957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663406|NCT05624957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56663407|NCT05624957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56663408|NCT05624957|Autonomic Agents|autonomic agents|mesh-ancestor
56663409|NCT05624957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56663410|NCT05624957|Respiratory System Agents|respiratory system agents|mesh-ancestor
56663411|NCT05624957|Mydriatics|mydriatics|mesh-ancestor
56663412|NCT05624957|Sympathomimetics|sympathomimetics|mesh-ancestor
56663413|NCT05624957|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56663414|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56663415|NCT00721552|Prednisolone|prednisolone|mesh-list
56663416|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56663417|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
56663418|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56173721|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173722|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124675|NCT01428882|Midazolam|midazolam|mesh-list
56173723|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
56173724|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56173725|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56173726|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
56173727|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56173728|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173729|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173730|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173731|NCT04046900|Metronidazole|metronidazole|mesh-list
56173732|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56173733|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56173734|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56173735|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56173736|NCT04040959|Niacinamide|niacinamide|mesh-list
56173738|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
56173739|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
56173740|NCT04040959|Vitamins|vitamins|mesh-ancestor
56173741|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
56173742|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173743|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56173744|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
56173745|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173746|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56173747|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
56173748|NCT04039464|Bosentan|bosentan|mesh-list
56173749|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
56173750|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
56173751|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56173752|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56173753|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173754|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173755|NCT04039464|Urological Agents|urological agents|mesh-ancestor
56178627|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
56173776|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
56173777|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173778|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173779|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173781|NCT03965689|Carboplatin|carboplatin|mesh-list
56173782|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56173783|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56663419|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
56663420|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56663421|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
56663422|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56663423|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
56663424|NCT00721552|Hormones|hormones|mesh-ancestor
56663425|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56663426|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663427|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56663428|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663429|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
56663430|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
56663431|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663432|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56663433|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56224778|NCT01693081|Apomorphine|apomorphine|mesh-list
56173784|NCT03965689|Pevonedistat|pevonedistat|mesh-list
56173785|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56173786|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173787|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
56173788|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
56173789|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
56125362|NCT04009668|Adalimumab|adalimumab|mesh-list
56173790|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173791|NCT03960008|Doxorubicin|doxorubicin|mesh-list
56173792|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56173793|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56173794|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173795|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56173796|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56173797|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173798|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173799|NCT03959423|Insulin|insulin|mesh-list
56173800|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173801|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173803|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56173804|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56173805|NCT03930953|Rituximab|rituximab|mesh-list
56173806|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
56173807|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173808|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173809|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
56173813|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173814|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173815|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56173816|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56173817|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
56173818|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56173819|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56173820|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56173821|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173822|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
56173823|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173824|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173825|NCT03835065|Calpastatin|calpastatin|mesh-list
56173826|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56173827|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
56173828|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173829|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663434|NCT00721552|Protective Agents|protective agents|mesh-ancestor
56663435|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56663436|NCT00721552|Incretins|incretins|mesh-ancestor
56663437|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56663438|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
56663439|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663440|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663441|NCT04069078|Scopolamine|scopolamine|mesh-list
56663442|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56663443|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56663444|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
56663445|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
56663446|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663447|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663448|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56663449|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
56663450|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56663451|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
56663452|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663492|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56663493|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56663494|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56663495|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663496|NCT00718276|Vitamin D|vitamin d|mesh-list
56663497|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
56663498|NCT00718276|Vitamins|vitamins|mesh-ancestor
56663499|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
56663500|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663501|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56663502|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56663503|NCT00718354|Cisplatin|cisplatin|mesh-list
56663504|NCT00718354|Carboplatin|carboplatin|mesh-list
56663505|NCT00718354|Fluorouracil|fluorouracil|mesh-list
56663506|NCT00718354|Capecitabine|capecitabine|mesh-list
56663507|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
56663508|NCT00718354|Epirubicin|epirubicin|mesh-list
56663509|NCT00718354|Enoxaparin|enoxaparin|mesh-list
56663510|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663511|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
56663512|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663513|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56663514|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663515|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
56309651|NCT00061438|Meropenem|meropenem|mesh-list
56663516|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663517|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56663518|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56663519|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56173831|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
56173832|NCT03786783|Melphalan|melphalan|mesh-list
56173833|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
56173834|NCT03786783|Thiotepa|thiotepa|mesh-list
56173835|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56173836|NCT03786783|Cisplatin|cisplatin|mesh-list
56173837|NCT03786783|Carboplatin|carboplatin|mesh-list
56173838|NCT03786783|Doxorubicin|doxorubicin|mesh-list
56173839|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56173840|NCT03786783|Etoposide|etoposide|mesh-list
56173841|NCT03786783|Vincristine|vincristine|mesh-list
56173842|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
56173843|NCT03786783|Daunorubicin|daunorubicin|mesh-list
56173844|NCT03786783|Topotecan|topotecan|mesh-list
56173846|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
56173847|NCT03786783|Dinutuximab|dinutuximab|mesh-list
56173848|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
56173849|NCT03786783|Razoxane|razoxane|mesh-list
56173850|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
56173851|NCT03786783|Isotretinoin|isotretinoin|mesh-list
56173852|NCT03786783|Sargramostim|sargramostim|mesh-list
56173853|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663520|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663521|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
56663522|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56663523|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56663524|NCT00536809|Capecitabine|capecitabine|mesh-list
56663525|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
56663526|NCT00536809|Lapatinib|lapatinib|mesh-list
56663527|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56663528|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
56663529|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224882|NCT01693640|Abatacept|abatacept|mesh-list
56173854|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
56173855|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173856|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173857|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56173858|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
56173859|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173860|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173861|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56173862|NCT03786783|Vitamins|vitamins|mesh-ancestor
56173863|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
56173864|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56173865|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56173866|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56173867|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173868|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56173869|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
56173870|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
56173871|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
56173872|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56173873|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
56173874|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
56173875|NCT03786783|Protective Agents|protective agents|mesh-ancestor
56173876|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56173877|NCT03785587|Bromides|bromides|mesh-list
56173878|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
56173879|NCT03769181|Cemiplimab|cemiplimab|mesh-list
56173880|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173881|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173882|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56173883|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56173884|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173885|NCT03735875|Venetoclax|venetoclax|mesh-list
56173886|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173887|NCT03670056|Nivolumab|nivolumab|mesh-list
56173888|NCT03670056|Ipilimumab|ipilimumab|mesh-list
56173890|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173891|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56173892|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173895|NCT03654833|Atezolizumab|atezolizumab|mesh-list
56173896|NCT03654833|Niraparib|niraparib|mesh-list
56173897|NCT03654833|Rucaparib|rucaparib|mesh-list
56173898|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173899|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173900|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56173901|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56173902|NCT03654833|Growth Substances|growth substances|mesh-ancestor
56173903|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173904|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
56173905|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56173906|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173907|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173909|NCT03639935|Rucaparib|rucaparib|mesh-list
56173910|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173911|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173912|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56663530|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663531|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56663532|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663533|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
56663534|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
56663535|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663536|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56663537|NCT05270863|Carbachol|carbachol|mesh-list
56663538|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56663539|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56663540|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56663541|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56663542|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
56663543|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173913|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173914|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56173915|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173916|NCT03635333|Nicotine|nicotine|mesh-list
56173917|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56173918|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
56173919|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173920|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173921|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56126002|NCT03023982|Morphine|morphine|mesh-list
56173922|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56173923|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
56173924|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56173925|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173926|NCT03634839|Nicotine|nicotine|mesh-list
56173927|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56101609|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173928|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
56173929|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173930|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173931|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56173932|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56173933|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
56173934|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213173|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173935|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126344|NCT04149678|Cyclosporine|cyclosporine|mesh-list
56173937|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
56173938|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
56173939|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173940|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173941|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56173942|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173943|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
56173944|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173946|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173947|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173948|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56173949|NCT03426904|Leucovorin|leucovorin|mesh-list
56173950|NCT03426904|Fluorouracil|fluorouracil|mesh-list
56173951|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
56173952|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
56173953|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173954|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56173955|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173956|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663544|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663545|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663546|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56663547|NCT05270863|Miotics|miotics|mesh-ancestor
56663548|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
56663549|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663550|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56663551|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
56663552|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56663553|NCT05270863|Analgesics|analgesics|mesh-ancestor
56663554|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
56663555|NCT05270863|Protective Agents|protective agents|mesh-ancestor
56663556|NCT04067986|Apatinib|apatinib|mesh-list
56663557|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663558|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56663559|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663560|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663561|NCT00536731|Budesonide|budesonide|mesh-list
56224901|NCT01693718|Fluorouracil|fluorouracil|mesh-list
56173957|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
56173958|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173959|NCT03426904|Antidotes|antidotes|mesh-ancestor
56173960|NCT03426904|Protective Agents|protective agents|mesh-ancestor
56173962|NCT03426904|Vitamins|vitamins|mesh-ancestor
56173963|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
56173964|NCT03383575|Azacitidine|azacitidine|mesh-list
56173965|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56173966|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
56173967|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173968|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173969|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173970|NCT03332667|Vorinostat|vorinostat|mesh-list
56173971|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56173972|NCT03332667|Dinutuximab|dinutuximab|mesh-list
56173973|NCT03332667|Sargramostim|sargramostim|mesh-list
56173974|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
56173975|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173976|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173977|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56173978|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173979|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173980|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56173981|NCT03287778|Pyridoxine|pyridoxine|mesh-list
56173982|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
56173983|NCT03287778|Vitamins|vitamins|mesh-ancestor
56173984|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
56173985|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173986|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
56173987|NCT03273413|Pravastatin|pravastatin|mesh-list
56173989|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56173990|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
56173991|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56173992|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56173993|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56173994|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173995|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56173996|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56173997|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
56663562|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56663563|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56663564|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
56663565|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56663566|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56663567|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
56663568|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663569|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663570|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
56663571|NCT00536731|Hormones|hormones|mesh-ancestor
56663572|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56663573|NCT02571712|Timolol|timolol|mesh-list
56663574|NCT02571712|Bimatoprost|bimatoprost|mesh-list
56663575|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56663576|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56663577|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
56663578|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663579|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663580|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663581|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56663582|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56663583|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
56663584|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56663585|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224923|NCT01693822|Axitinib|axitinib|mesh-list
56173998|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173999|NCT03182244|Cytarabine|cytarabine|mesh-list
56174000|NCT03182244|Fludarabine|fludarabine|mesh-list
56174001|NCT03182244|Etoposide|etoposide|mesh-list
56174002|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
56174003|NCT03182244|Lenograstim|lenograstim|mesh-list
56174004|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174005|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56174006|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
56174007|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174008|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56174009|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
56174010|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174011|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56174012|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56174013|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56174014|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174015|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
56174016|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174017|NCT03182244|Analgesics|analgesics|mesh-ancestor
56174018|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
56213174|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174019|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663586|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663587|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56663588|NCT02730845|Analgesics|analgesics|mesh-ancestor
56663589|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
56663590|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663591|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56663592|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56663593|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56547644|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663594|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
56663595|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663596|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663597|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
56663598|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56663599|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663600|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56663601|NCT02730689|Ezetimibe|ezetimibe|mesh-list
56663602|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56663603|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56663604|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
56663605|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663606|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56663607|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56663608|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663609|NCT03579316|Olaparib|olaparib|mesh-list
56174020|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56174021|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56174022|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174023|NCT03075527|Durvalumab|durvalumab|mesh-list
56174024|NCT03075527|Tremelimumab|tremelimumab|mesh-list
56174025|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174026|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174027|NCT03074539|Riociguat|riociguat|mesh-list
56174028|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
56174029|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174030|NCT03030131|Durvalumab|durvalumab|mesh-list
56174031|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174032|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174033|NCT03011021|Liraglutide|liraglutide|mesh-list
56174034|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56174035|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174036|NCT03011021|Incretins|incretins|mesh-ancestor
56174037|NCT03011021|Hormones|hormones|mesh-ancestor
56174041|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
56174042|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174043|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56174044|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56174045|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663610|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56663611|NCT03579316|Adavosertib|adavosertib|mesh-list
56663612|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663613|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663614|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663615|NCT02730533|Esomeprazole|esomeprazole|mesh-list
56663616|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56663617|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56174046|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174047|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56174048|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56174049|NCT02995252|Hematinics|hematinics|mesh-ancestor
56174050|NCT02983578|Durvalumab|durvalumab|mesh-list
56174051|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
56174052|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56174054|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174055|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174056|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
56174057|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174058|NCT02932826|Insulin|insulin|mesh-list
56174059|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56174060|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174061|NCT02860000|Fulvestrant|fulvestrant|mesh-list
56174062|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56174063|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174064|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56174065|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56174066|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
56174067|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174068|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174069|NCT02846623|Atezolizumab|atezolizumab|mesh-list
56174070|NCT02846623|Venetoclax|venetoclax|mesh-list
56174071|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
56174072|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56174073|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174074|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
56174075|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174076|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174077|NCT02844816|Atezolizumab|atezolizumab|mesh-list
56174078|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56174079|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174080|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
56174081|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101759|NCT00001561|Antibodies|antibodies|mesh-list
56174083|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
56174084|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174085|NCT02817360|Losartan|losartan|mesh-list
56174086|NCT02817360|Valsartan|valsartan|mesh-list
56174087|NCT02817360|Carvedilol|carvedilol|mesh-list
56174088|NCT02817360|Candesartan|candesartan|mesh-list
56174089|NCT02817360|Ramipril|ramipril|mesh-list
56174090|NCT02817360|Enalapril|enalapril|mesh-list
56174091|NCT02817360|Lisinopril|lisinopril|mesh-list
56174092|NCT02817360|Irbesartan|irbesartan|mesh-list
56174093|NCT02817360|Nebivolol|nebivolol|mesh-list
56174094|NCT02817360|Bisoprolol|bisoprolol|mesh-list
56174095|NCT02817360|Perindopril|perindopril|mesh-list
56174096|NCT02817360|Captopril|captopril|mesh-list
56174097|NCT02817360|Quinapril|quinapril|mesh-list
56174098|NCT02817360|Trandolapril|trandolapril|mesh-list
56174099|NCT02817360|Fosinopril|fosinopril|mesh-list
56174100|NCT02817360|Eprosartan|eprosartan|mesh-list
56174101|NCT02817360|Zofenopril|zofenopril|mesh-list
56174102|NCT02817360|Spirapril|spirapril|mesh-list
56174103|NCT02817360|Cilazapril|cilazapril|mesh-list
56174104|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56174105|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56174106|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56174107|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56174108|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174109|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56174110|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56663618|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56663619|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663620|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663621|NCT00536575|Bortezomib|bortezomib|mesh-list
56663622|NCT00536575|Sorafenib|sorafenib|mesh-list
56663623|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663624|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56663625|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663626|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174111|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
56174112|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174113|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174114|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
56174115|NCT02817360|Protective Agents|protective agents|mesh-ancestor
56174118|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56174119|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
56174120|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56174121|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56174122|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56174123|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
56174124|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174125|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56174126|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56174128|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56174130|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
56127357|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56174131|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174132|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56174133|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
56174135|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
56174136|NCT02811133|Vitamins|vitamins|mesh-ancestor
56174137|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
56174138|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174139|NCT02782949|Curcumin|curcumin|mesh-list
56174140|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56174141|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56174142|NCT02782949|Analgesics|analgesics|mesh-ancestor
56174143|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
56174144|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174145|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174146|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174147|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174148|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174149|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174150|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174151|NCT02743806|Vedolizumab|vedolizumab|mesh-list
56174152|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56174153|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
56174154|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174156|NCT02689778|Analgesics|analgesics|mesh-ancestor
56174157|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
56127480|NCT03747120|Paclitaxel|paclitaxel|mesh-list
56174158|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174159|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174160|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56174161|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56174162|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174163|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174164|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174165|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56174167|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56174168|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174169|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174170|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56663627|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56663628|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56663629|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
56663630|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663631|NCT03214250|Gemcitabine|gemcitabine|mesh-list
56663632|NCT03214250|Paclitaxel|paclitaxel|mesh-list
56663633|NCT03214250|Nivolumab|nivolumab|mesh-list
56174171|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56174172|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174173|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
56174174|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174175|NCT02659384|Aspirin|aspirin|mesh-list
56174176|NCT02659384|Bevacizumab|bevacizumab|mesh-list
56174177|NCT02659384|Atezolizumab|atezolizumab|mesh-list
56174178|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174179|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174180|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56174181|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56174182|NCT02659384|Growth Substances|growth substances|mesh-ancestor
56174183|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174184|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
56127609|NCT00003816|Etoposide|etoposide|mesh-list
56174185|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56174186|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56174188|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
56174191|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174192|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56174193|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56174194|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174195|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56174196|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56174197|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174198|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
56174199|NCT02659306|Metformin|metformin|mesh-list
56174200|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56174201|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174202|NCT02591147|Fluorides|fluorides|mesh-list
56174203|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
56174204|NCT02591147|Protective Agents|protective agents|mesh-ancestor
56174205|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174207|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56174208|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
56174209|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174210|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
56174211|NCT02588872|Protective Agents|protective agents|mesh-ancestor
56174212|NCT02579161|Ciprofloxacin|ciprofloxacin|mesh-list
56174213|NCT02579161|Clindamycin|clindamycin|mesh-list
56174214|NCT02579161|Gentamicins|gentamicins|mesh-list
56174215|NCT02579161|Penicillins|penicillins|mesh-list
56174216|NCT02579161|Ampicillin|ampicillin|mesh-list
56174217|NCT02579161|Cephalosporins|cephalosporins|mesh-list
56174218|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
56174219|NCT02579161|Lincosamides|lincosamides|mesh-list
56174220|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56174221|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174222|NCT02579161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56174223|NCT02579161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56174224|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174225|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174226|NCT02579161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174227|NCT02579161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56174228|NCT02579161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56174229|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56174230|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56174231|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
56174232|NCT02538510|Vorinostat|vorinostat|mesh-list
56174233|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174234|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174235|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56101905|NCT00002155|Zidovudine|zidovudine|mesh-list
56174236|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663634|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56663635|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663636|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
56663637|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663638|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
56663639|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663640|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56663641|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
56663642|NCT03214250|Antiviral Agents|antiviral agents|mesh-ancestor
56663643|NCT03214250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224989|NCT05288374|Analgesics|analgesics|mesh-ancestor
56174237|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174238|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
56174239|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174240|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174241|NCT02419040|Lidocaine|lidocaine|mesh-list
56174242|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
56174243|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
56174244|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56174245|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174246|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
56174247|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174248|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56174249|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56174250|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56174251|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56174252|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174253|NCT02387203|Amoxicillin|amoxicillin|mesh-list
56174254|NCT02387203|Clarithromycin|clarithromycin|mesh-list
56174255|NCT02387203|Lansoprazole|lansoprazole|mesh-list
56174256|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56174257|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174258|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56174259|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174260|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174261|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56174265|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56174266|NCT02381353|Bupivacaine|bupivacaine|mesh-list
56174267|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
56174268|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
56174269|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56174270|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174271|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
56174272|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174274|NCT02296229|Hormones|hormones|mesh-ancestor
56128278|NCT00085566|Everolimus|everolimus|mesh-list
56174275|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174276|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174277|NCT02264678|Carboplatin|carboplatin|mesh-list
56174278|NCT02264678|Durvalumab|durvalumab|mesh-list
56174279|NCT02264678|Olaparib|olaparib|mesh-list
56174280|NCT02264678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56174281|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174282|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174283|NCT02264678|Immunologic Factors|immunologic factors|mesh-ancestor
56174284|NCT02264678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128350|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
56174285|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56174286|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174287|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174288|NCT02192398|Guanfacine|guanfacine|mesh-list
56174289|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56174290|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56663644|NCT03214250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663645|NCT03214250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663646|NCT03214250|Immunologic Factors|immunologic factors|mesh-ancestor
56663647|NCT03214250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663648|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56663649|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56663650|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
56663651|NCT00722098|Vaccines|vaccines|mesh-list
56663652|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
56663653|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663654|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663655|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56663656|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56174291|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56174292|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56174293|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
56174294|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174295|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174296|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174297|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
56174298|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174299|NCT02031419|Rituximab|rituximab|mesh-list
56174300|NCT02031419|Spebrutinib|spebrutinib|mesh-list
56174301|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174302|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174303|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
56174304|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174305|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174306|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56174307|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101999|NCT00002179|Lamivudine|lamivudine|mesh-list
56174308|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174309|NCT01992653|Prednisone|prednisone|mesh-list
56174310|NCT01992653|Prednisolone|prednisolone|mesh-list
56174311|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
56174312|NCT01992653|Rituximab|rituximab|mesh-list
56174313|NCT01992653|Doxorubicin|doxorubicin|mesh-list
56174314|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
56174315|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56174316|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
56174317|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174318|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174319|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56174320|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
56174321|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174322|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174323|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56174324|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174325|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56174326|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56174327|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56174328|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174329|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174330|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
56174332|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174334|NCT01972217|Prednisone|prednisone|mesh-list
56174335|NCT01972217|Prednisolone|prednisolone|mesh-list
56174336|NCT01972217|Olaparib|olaparib|mesh-list
56174337|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174338|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
56174339|NCT01972217|Hormones|hormones|mesh-ancestor
56174340|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56663657|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
56663658|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663659|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663660|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56663661|NCT04186871|Abatacept|abatacept|mesh-list
56663662|NCT04186871|Branebrutinib|branebrutinib|mesh-list
56663663|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56663664|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663665|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663666|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663667|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
56309803|NCT00061984|Doxorubicin|doxorubicin|mesh-list
56663668|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663669|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56663670|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56663671|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663672|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
56174341|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174342|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56174343|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174344|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56174345|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174346|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174347|NCT01969578|Paclitaxel|paclitaxel|mesh-list
56174348|NCT01969578|Carboplatin|carboplatin|mesh-list
56174349|NCT01969578|Doxorubicin|doxorubicin|mesh-list
56174350|NCT01969578|Bicalutamide|bicalutamide|mesh-list
56174351|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56128683|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
56128751|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56128752|NCT05687760|Calcium|calcium|mesh-list
56174352|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56174353|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174354|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
56174355|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
56174356|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56174357|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174358|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56174359|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56174360|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56174361|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174362|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
56174363|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
56174364|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174365|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174366|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
56174367|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56174368|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
56174369|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56174370|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56174371|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56174372|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
56174373|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
56174374|NCT01861106|Busulfan|busulfan|mesh-list
56174375|NCT01861106|Fludarabine|fludarabine|mesh-list
56174376|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
56174378|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56663673|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
56663674|NCT00992095|Buprenorphine|buprenorphine|mesh-list
56663675|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56663676|NCT00992095|Narcotics|narcotics|mesh-ancestor
56663677|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663678|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663679|NCT00992095|Analgesics|analgesics|mesh-ancestor
56663680|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
56663681|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663682|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56663683|NCT00653354|Valdecoxib|valdecoxib|mesh-list
56663684|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56663685|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56663686|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663687|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663688|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56663689|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56663690|NCT00653354|Analgesics|analgesics|mesh-ancestor
56663691|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
56174379|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56174380|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
56174381|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174382|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102065|NCT00383396|Cyclosporine|cyclosporine|mesh-list
56174383|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56174384|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
56174385|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174386|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174387|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56174388|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56174389|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
56174390|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56174391|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174392|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56174393|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56174394|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
56174395|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56174396|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129236|NCT02084706|Lidocaine|lidocaine|mesh-list
56174397|NCT01850303|Gemcitabine|gemcitabine|mesh-list
56174398|NCT01850303|Pemetrexed|pemetrexed|mesh-list
56174399|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56174400|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
56174401|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174402|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174403|NCT01850303|Antiviral Agents|antiviral agents|mesh-ancestor
56174405|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174406|NCT01850303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56174407|NCT01850303|Immunologic Factors|immunologic factors|mesh-ancestor
56174408|NCT01850303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174409|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56174410|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56174412|NCT01763671|Docetaxel|docetaxel|mesh-list
56174413|NCT01763671|Bevacizumab|bevacizumab|mesh-list
56174414|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56174415|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663692|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663693|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663694|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56663695|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56663696|NCT00712504|Docetaxel|docetaxel|mesh-list
56663697|NCT00712504|Sunitinib|sunitinib|mesh-list
56663698|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663699|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
56663700|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663701|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
56663702|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663703|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56663704|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56663705|NCT00712504|Growth Substances|growth substances|mesh-ancestor
56663706|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663707|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
56174416|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
56174417|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
56174418|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
56174419|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129517|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56174420|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174421|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56174422|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56174423|NCT01763671|Growth Substances|growth substances|mesh-ancestor
56174424|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174425|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
56174427|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56174428|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174429|NCT01696435|Vitamin D|vitamin d|mesh-list
56174430|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
56174431|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
56174432|NCT01696435|Vitamins|vitamins|mesh-list
56174433|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
56174434|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174435|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56174436|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56174437|NCT01682083|Trametinib|trametinib|mesh-list
56174438|NCT01682083|Dabrafenib|dabrafenib|mesh-list
56174439|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174440|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56174441|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174442|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174443|NCT01681264|Guanfacine|guanfacine|mesh-list
56174444|NCT01681264|Morphine|morphine|mesh-list
56174445|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56174446|NCT01681264|Narcotics|narcotics|mesh-ancestor
56174447|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178703|NCT02642094|Sirolimus|sirolimus|mesh-list
56174448|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174449|NCT01681264|Analgesics|analgesics|mesh-ancestor
56174450|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
56174451|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174452|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56129865|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
56174453|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56174454|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56174455|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56174456|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
56174457|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663708|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56663709|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663710|NCT00653510|Insulin|insulin|mesh-list
56663711|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56663712|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56663713|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663714|NCT02694653|Acetaminophen|acetaminophen|mesh-list
56663715|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56663716|NCT02694653|Analgesics|analgesics|mesh-ancestor
56663717|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
56663718|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663719|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663720|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
56663721|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
56663722|NCT00722956|Atorvastatin|atorvastatin|mesh-list
56663723|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56174458|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174459|NCT01654276|Febuxostat|febuxostat|mesh-list
56174460|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
56174461|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174462|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56174463|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
56174464|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174465|NCT01500551|Tofacitinib|tofacitinib|mesh-list
56174466|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56174467|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174468|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174469|NCT00590122|Levodopa|levodopa|mesh-list
56174470|NCT00590122|Carbidopa|carbidopa|mesh-list
56174471|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56174472|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56174473|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56174474|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
56129944|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
56174475|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174478|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56174479|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174480|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56174481|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
56174482|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
56174483|NCT00309192|Triamcinolone|triamcinolone|mesh-list
56174484|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56174485|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56174486|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56174487|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174488|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
56174489|NCT00309192|Hormones|hormones|mesh-ancestor
56174490|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174491|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174492|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56174493|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
56174494|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174495|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174496|NCT00295893|Paclitaxel|paclitaxel|mesh-list
56174497|NCT00295893|Docetaxel|docetaxel|mesh-list
56174498|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
56174499|NCT00295893|Carboplatin|carboplatin|mesh-list
56663724|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56663725|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
56663726|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663727|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56663728|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56663729|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663730|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56663731|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56663732|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56663733|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
56663734|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663735|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56663736|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663737|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663738|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663739|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56663740|NCT02729285|Ketorolac|ketorolac|mesh-list
56663741|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56663742|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56663743|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56663744|NCT02729285|Analgesics|analgesics|mesh-ancestor
56663745|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
56174500|NCT00295893|Doxorubicin|doxorubicin|mesh-list
56174501|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56174502|NCT00295893|Trastuzumab|trastuzumab|mesh-list
56174503|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56174504|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174505|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
56174506|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
56174507|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
56174508|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174509|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56174510|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
56174511|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174512|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174513|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56174514|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
56174515|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56174516|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56174517|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56174518|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56174519|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174520|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174521|NCT00110591|Leronlimab|leronlimab|mesh-list
56174522|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56174523|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56130104|NCT01929798|Pancrelipase|pancrelipase|mesh-list
56174524|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174525|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56174526|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56174527|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
56005092|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
56663746|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663747|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663748|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56663749|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56663750|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56663751|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174528|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174529|NCT01689246|Methylene Blue|methylene blue|mesh-list
56174531|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102207|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
56174532|NCT01685268|Prednisone|prednisone|mesh-list
56174533|NCT01685268|Prednisolone|prednisolone|mesh-list
56174534|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
56174535|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174536|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
56174537|NCT01685268|Hormones|hormones|mesh-ancestor
56174538|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174539|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174540|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56174541|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174542|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56174543|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174544|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174545|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
56174546|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56174549|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174550|NCT01683084|Telmisartan|telmisartan|mesh-list
56174551|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56174552|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56174553|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56174554|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174555|NCT04823442|Bisoprolol|bisoprolol|mesh-list
56174556|NCT04823442|Mirabegron|mirabegron|mesh-list
56174557|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56174558|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56174559|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56174560|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56174561|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174562|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174563|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174564|NCT04823442|Urological Agents|urological agents|mesh-ancestor
56174565|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56174566|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
56174567|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
56174568|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174569|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56174570|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56174571|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56174572|NCT04826484|Bupivacaine|bupivacaine|mesh-list
56174573|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
56174574|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
56174575|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56174576|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178708|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
56174577|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
56174578|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174579|NCT01384448|Dobutamine|dobutamine|mesh-list
56174580|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56174581|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
56174582|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
56174583|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174584|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174585|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56174586|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56174587|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56174588|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
56174589|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663752|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174590|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174591|NCT01384448|Protective Agents|protective agents|mesh-ancestor
56174592|NCT01384578|Vitamins|vitamins|mesh-list
56174593|NCT01384578|Vitamin E|vitamin e|mesh-list
56130477|NCT03064854|Paclitaxel|paclitaxel|mesh-list
56174594|NCT01384578|Tocopherols|tocopherols|mesh-list
56174595|NCT01384578|Tocotrienols|tocotrienols|mesh-list
56174596|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
56174598|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
56174599|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174600|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
56174601|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174602|NCT01384578|Protective Agents|protective agents|mesh-ancestor
56174603|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56174604|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102283|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
56174605|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56174606|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56174607|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
56174608|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56174609|NCT01384643|Propofol|propofol|mesh-list
56174610|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56174611|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130632|NCT04559646|Hemostatics|hemostatics|mesh-list
56174612|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174613|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56174614|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
56174615|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
56174616|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56174618|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56174619|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56174620|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174622|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56174623|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
56174624|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174625|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56174626|NCT01384695|Proflavine|proflavine|mesh-list
56174627|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56174628|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174629|NCT01384708|Proflavine|proflavine|mesh-list
56174630|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56174631|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174632|NCT01384799|Cisplatin|cisplatin|mesh-list
56174633|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174634|NCT01384812|Dinoprostone|dinoprostone|mesh-list
56174635|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
56174636|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56174637|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174638|NCT01384864|Proflavine|proflavine|mesh-list
56174639|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56174640|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174641|NCT01384903|Antithrombins|antithrombins|mesh-list
56174642|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
56174643|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56174644|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
56174645|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174646|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174647|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
56174648|NCT01384994|Folic Acid|folic acid|mesh-list
56174649|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
56174651|NCT01384994|Fluorouracil|fluorouracil|mesh-list
56174652|NCT01384994|Panitumumab|panitumumab|mesh-list
56174653|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174654|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
56174655|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174656|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56174657|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56174658|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
56174659|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174660|NCT01384994|Hematinics|hematinics|mesh-ancestor
56174661|NCT01384994|Vitamins|vitamins|mesh-ancestor
56174662|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
56174663|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174664|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
56174665|NCT01385020|Red yeast rice|red yeast rice|mesh-list
56174666|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56663753|NCT00722176|Risperidone|risperidone|mesh-list
56663754|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56663755|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
56663756|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663757|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663758|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663759|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56663760|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56663761|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663762|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56663763|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56663764|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
56663765|NCT02729441|Ramipril|ramipril|mesh-list
56663766|NCT02729441|Perindopril|perindopril|mesh-list
56663767|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56663768|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
56663769|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663770|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663771|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56663775|NCT04181333|Trastuzumab|trastuzumab|mesh-list
56663776|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56663777|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663778|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
56663779|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56663780|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663781|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663782|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56663783|NCT00636545|Oblimersen|oblimersen|mesh-list
56663784|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663785|NCT00722488|Pevonedistat|pevonedistat|mesh-list
56663786|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663787|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663788|NCT00652106|Timolol|timolol|mesh-list
56174667|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
56174668|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174669|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56174670|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56131302|NCT03820908|Bisantrene|bisantrene|mesh-list
56174671|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56663789|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56663790|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56663791|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56663792|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56663793|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56663794|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
56663795|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663796|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663797|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663798|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56663799|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56174672|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174673|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56174674|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56174675|NCT01385124|Cannabidiol|cannabidiol|mesh-list
56174676|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
56174678|NCT01385228|Docetaxel|docetaxel|mesh-list
56174679|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174680|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
56131386|NCT03829332|Lenvatinib|lenvatinib|mesh-list
56174681|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
56174682|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
56174683|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174684|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174685|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
56174686|NCT01385228|Hormones|hormones|mesh-ancestor
56174687|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174688|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174689|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56174690|NCT01385345|Vitamin D|vitamin d|mesh-list
56174691|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
56174692|NCT01385345|Vitamins|vitamins|mesh-ancestor
56174693|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
56174696|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56174697|NCT01385527|Triamcinolone|triamcinolone|mesh-list
56174698|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56131440|NCT02905110|Methotrexate|methotrexate|mesh-list
56174699|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
56174700|NCT01385527|Hormones|hormones|mesh-ancestor
56213175|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56213176|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
56174701|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174702|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174703|NCT01385631|Ezetimibe|ezetimibe|mesh-list
56174704|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56174705|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56174706|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
56174707|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174708|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56174709|NCT01385683|Clarithromycin|clarithromycin|mesh-list
56174710|NCT01385683|Dabigatran|dabigatran|mesh-list
56174711|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56174712|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174713|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56174714|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174715|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174716|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56174717|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56174718|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
56131651|NCT03822546|Nicotine|nicotine|mesh-list
56174719|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56174720|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
56131780|NCT02811510|Hormones|hormones|mesh-ancestor
56174721|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
56663800|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56663801|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56663802|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56663803|NCT00723268|Prednisolone|prednisolone|mesh-list
56663804|NCT00723268|Colchicine|colchicine|mesh-list
56225146|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
56174722|NCT01385735|Rasagiline|rasagiline|mesh-list
56131848|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
56174723|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56174724|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174725|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174726|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56174727|NCT01385735|Protective Agents|protective agents|mesh-ancestor
56174728|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174729|NCT01385826|Antibodies|antibodies|mesh-list
56174730|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56174731|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
56174732|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174733|NCT01385891|Etoposide|etoposide|mesh-list
56174734|NCT01385891|Clofarabine|clofarabine|mesh-list
56174735|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56174736|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174737|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56174738|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56174739|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131921|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
56174740|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174741|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56174742|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
56174743|NCT01385956|Gemcitabine|gemcitabine|mesh-list
56174744|NCT01385956|Pasireotide|pasireotide|mesh-list
56174745|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56213177|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56174747|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174748|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174749|NCT01385956|Antiviral Agents|antiviral agents|mesh-ancestor
56174750|NCT01385956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174751|NCT01385956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174752|NCT01385956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56174753|NCT01385956|Immunologic Factors|immunologic factors|mesh-ancestor
56174754|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174755|NCT01385956|Hormones|hormones|mesh-ancestor
56174756|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174757|NCT01386086|Aripiprazole|aripiprazole|mesh-list
56132275|NCT02624544|Desonide|desonide|mesh-list
56174758|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
56174762|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56174763|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174764|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
56174766|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174767|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174768|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56174769|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56174770|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
56174771|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56174772|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56174773|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56174774|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56174775|NCT01386151|Mitogens|mitogens|mesh-list
56174776|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
56174777|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174778|NCT01386164|Vaccines|vaccines|mesh-list
56174779|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
56174780|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174781|NCT01386177|Doxazosin|doxazosin|mesh-list
56174782|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56174783|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
56174784|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174785|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56174786|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
56663805|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56663806|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
56663807|NCT00723268|Hormones|hormones|mesh-ancestor
56663808|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56663809|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663810|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56663811|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663812|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
56663813|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56663814|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
56663815|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
56663816|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
56663817|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663818|NCT00874770|Ribavirin|ribavirin|mesh-list
56663819|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56663820|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
56663821|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663822|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
56663823|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663824|NCT00536263|Interferons|interferons|mesh-list
56663825|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
56663826|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
56663827|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56663828|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663829|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
56663830|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663831|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
56663832|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663833|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
56663834|NCT00578344|Busulfan|busulfan|mesh-list
56663835|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
56663836|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56174787|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174788|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174789|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56174790|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56174791|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56174792|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
56174793|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56174794|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56174795|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56132466|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56174797|NCT01386229|Ketamine|ketamine|mesh-list
56174798|NCT01386229|Etomidate|etomidate|mesh-list
56174799|NCT01386229|Analgesics|analgesics|mesh-ancestor
56663837|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
56663838|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663839|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56663840|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56663841|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
56663842|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663843|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663844|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56663845|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56663846|NCT00653588|Atorvastatin|atorvastatin|mesh-list
56663847|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56663848|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56663849|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56663850|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
56663851|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663852|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56663853|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56663854|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663855|NCT00723346|Asparaginase|asparaginase|mesh-list
56663856|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663857|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
56663858|NCT02571400|Analgesics|analgesics|mesh-list
56663859|NCT02571400|Narcotics|narcotics|mesh-ancestor
56663860|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663861|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663862|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
56663863|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663864|NCT02641652|Sertraline|sertraline|mesh-list
56663865|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
56663866|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56663867|NCT02641652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56663868|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56663869|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56663871|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56663875|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663876|NCT02571166|Valacyclovir|valacyclovir|mesh-list
56663877|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
56663878|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663879|NCT00686478|Interferons|interferons|mesh-list
56663880|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
56663881|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
56663882|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663883|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
56663884|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663885|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
56663886|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663887|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
56663888|NCT00723424|Digoxin|digoxin|mesh-list
56663889|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56663890|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56663891|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663892|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663893|NCT00723424|Protective Agents|protective agents|mesh-ancestor
56663894|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663895|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56174800|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
56174801|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174802|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174803|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56174804|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56174805|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
56174806|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
56174807|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56174808|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56174809|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56174810|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174811|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174812|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56174813|NCT01386242|Interferons|interferons|mesh-list
56174814|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174815|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
56132530|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
56174816|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174817|NCT01386255|Baclofen|baclofen|mesh-list
56174818|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56174819|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174820|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56174821|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174822|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56174823|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
56174824|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
56174825|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174826|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174827|NCT01386268|Factor VIII|factor viii|mesh-list
56174828|NCT01386268|Coagulants|coagulants|mesh-ancestor
56663896|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56663897|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56663898|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
56663899|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663900|NCT02641340|Fentanyl|fentanyl|mesh-list
56663901|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56663902|NCT02641340|Narcotics|narcotics|mesh-ancestor
56663903|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56663904|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663905|NCT02641340|Analgesics|analgesics|mesh-ancestor
56663906|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
56663907|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663908|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56663909|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56225243|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
56174829|NCT01386294|Tenofovir|tenofovir|mesh-list
56174830|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
56174843|NCT01386346|Azacitidine|azacitidine|mesh-list
56174844|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
56174845|NCT01386346|Epirubicin|epirubicin|mesh-list
56174846|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56174847|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
56174848|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174849|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174850|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174851|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56174852|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56174853|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56132727|NCT02104986|Cisplatin|cisplatin|mesh-list
56174855|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56174856|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174857|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
56174858|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174859|NCT01386398|Bortezomib|bortezomib|mesh-list
56174860|NCT01386398|Vorinostat|vorinostat|mesh-list
56174861|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174862|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56174863|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174864|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174866|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174867|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174868|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
56174869|NCT01386567|Citric Acid|citric acid|mesh-list
56174870|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
56174871|NCT01386567|Enclomiphene|enclomiphene|mesh-list
56174873|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
56174874|NCT01386567|Testosterone|testosterone|mesh-list
56174875|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
56174876|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
56174877|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56174878|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
56174879|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56174880|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
56174881|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
56174882|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174883|NCT01386567|Androgens|androgens|mesh-ancestor
56174884|NCT01386567|Hormones|hormones|mesh-ancestor
56174885|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174886|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174887|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56174888|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174889|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
56663910|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
56663911|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
56663912|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
56663913|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56663914|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56225255|NCT05294679|Propofol|propofol|mesh-list
56174890|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56174891|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
56174892|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56174893|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
56174894|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56174895|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56174897|NCT01386580|Doxorubicin|doxorubicin|mesh-list
56174898|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56174899|NCT01386580|Trastuzumab|trastuzumab|mesh-list
56174900|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56174901|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174902|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56174903|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56174904|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174905|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174906|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56174907|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
56174908|NCT01386593|Rifampin|rifampin|mesh-list
56174909|NCT01386593|Fluconazole|fluconazole|mesh-list
56174910|NCT01386593|Paroxetine|paroxetine|mesh-list
56174911|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56174912|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174913|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56174914|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56174915|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174916|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174917|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56174918|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56174919|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56174920|NCT01386593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56174921|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56174922|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56174923|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56174924|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
56174925|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174926|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56174927|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
56174928|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56174929|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56174930|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
56174931|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56174932|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56174933|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
56174934|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174935|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56174936|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56174937|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56174938|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
56174939|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
56174940|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56174941|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56174942|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56174943|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56174944|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56174945|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56174946|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56174947|NCT01386658|Icatibant|icatibant|mesh-list
56174948|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56174949|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56174950|NCT01386658|Analgesics|analgesics|mesh-ancestor
56174952|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663915|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663916|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
56663917|NCT02625948|Coagulants|coagulants|mesh-ancestor
56663918|NCT02571556|Dexamethasone|dexamethasone|mesh-list
56663919|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56663920|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56663921|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56663922|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
56663923|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
56663924|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56663925|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663926|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56663927|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
56663928|NCT02571556|Hormones|hormones|mesh-ancestor
56663929|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56663930|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56663931|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663932|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56663971|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663972|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56663973|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663974|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
56174953|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174954|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174955|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56174956|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56174957|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56174958|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174959|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56174960|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132925|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
56174961|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
56174962|NCT01386671|Metformin|metformin|mesh-list
56174963|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56174964|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174965|NCT01386736|Vitamin D|vitamin d|mesh-list
56174966|NCT01386736|Vitamins|vitamins|mesh-ancestor
56174971|NCT01386853|Pitavastatin|pitavastatin|mesh-list
56174972|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56174973|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56174974|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
56174975|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174976|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56178751|NCT02636322|Growth Substances|growth substances|mesh-ancestor
56174977|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56174978|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174979|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
56174980|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56174981|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174982|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174984|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174985|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174987|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
56174988|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56174989|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174990|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56174991|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
56174992|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174993|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174994|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56174995|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
56174996|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
56133044|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56174998|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174999|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56175000|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56175001|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56175002|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56175003|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175004|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175006|NCT01387048|Azelaic acid|azelaic acid|mesh-list
56175007|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56175008|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56175009|NCT01387048|Analgesics|analgesics|mesh-ancestor
56175010|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
56175011|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175012|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175013|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56175014|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56175015|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
56175016|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175017|NCT01387087|Peficitinib|peficitinib|mesh-list
56175018|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175019|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663975|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
56663976|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56663977|NCT00686556|Cyclosporine|cyclosporine|mesh-list
56663978|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
56663979|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
56663980|NCT00686556|Fludarabine|fludarabine|mesh-list
56663981|NCT00686556|Cyclosporins|cyclosporins|mesh-list
56663982|NCT00686556|Lenograstim|lenograstim|mesh-list
56663983|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56663984|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
56175020|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175021|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
56175022|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175023|NCT01387191|Epoprostenol|epoprostenol|mesh-list
56175024|NCT01387191|Tezosentan|tezosentan|mesh-list
56175025|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56175026|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56175027|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
56175028|NCT01387204|Trametinib|trametinib|mesh-list
56133179|NCT04756050|Epinephrine|epinephrine|mesh-list
56175029|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175030|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56175031|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175032|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175033|NCT01387243|Orlistat|orlistat|mesh-list
56175034|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175035|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175036|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56175037|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56175038|NCT01387295|Capecitabine|capecitabine|mesh-list
56175039|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
56175040|NCT01387295|Trastuzumab|trastuzumab|mesh-list
56175041|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56175042|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
56175043|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175044|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175045|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175046|NCT01387373|Capecitabine|capecitabine|mesh-list
56175047|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
56175048|NCT01387373|Trastuzumab|trastuzumab|mesh-list
56175049|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56175050|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
56175051|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175052|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175053|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175054|NCT01387399|Cisplatin|cisplatin|mesh-list
56175055|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175056|NCT01387425|Varenicline|varenicline|mesh-list
56175057|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56175058|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56175059|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
56175060|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175061|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175062|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133291|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
56133292|NCT03969420|Growth Substances|growth substances|mesh-ancestor
56133293|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133294|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133295|NCT01740492|Ketamine|ketamine|mesh-list
56133296|NCT01740492|Analgesics|analgesics|mesh-ancestor
56133297|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
56133298|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133299|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133300|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56175064|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
56175066|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56175067|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175068|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
56663985|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56663986|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56663987|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56663988|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
56663989|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56663990|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56663991|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56663992|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56663993|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
56663994|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56663995|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56663996|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56663997|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56663998|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56663999|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
56664000|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56664001|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56664002|NCT04070482|Tenofovir|tenofovir|mesh-list
56664003|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
56664004|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664005|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56664006|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56664007|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664008|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664009|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56664010|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56664011|NCT04166786|Ethanol|ethanol|mesh-list
56664012|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
56664013|NCT04166786|Petrolatum|petrolatum|mesh-list
56175069|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175070|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56175071|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56175072|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56175073|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56175074|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175075|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
56175076|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56175077|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
56175078|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133344|NCT04777968|Fluorides|fluorides|mesh-list
56133345|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
56175079|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
56175080|NCT01387620|Protective Agents|protective agents|mesh-ancestor
56175081|NCT01387880|Everolimus|everolimus|mesh-list
56175082|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664014|NCT04166786|Testosterone|testosterone|mesh-list
56664015|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
56664016|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
56664017|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56664018|NCT04166786|Androgens|androgens|mesh-ancestor
56664019|NCT04166786|Hormones|hormones|mesh-ancestor
56664020|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664021|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664022|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664023|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664024|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
56664025|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56664026|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664027|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56664028|NCT04166786|Emollients|emollients|mesh-ancestor
56664029|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
56664030|NCT02727647|Factor VIII|factor viii|mesh-list
56175083|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175084|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
56175085|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175086|NCT01387906|Bimatoprost|bimatoprost|mesh-list
56175087|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56175088|NCT01387997|Antibodies|antibodies|mesh-list
56175089|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
56175090|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175091|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
56175092|NCT01388023|Listerine|listerine|mesh-list
56175093|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56175094|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175096|NCT01388036|Esmolol|esmolol|mesh-list
56175097|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56175098|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56175099|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56175100|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
56175101|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133612|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175102|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175105|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
56175106|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175107|NCT01388062|Antibodies|antibodies|mesh-list
56175108|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
56175109|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175110|NCT01388075|Rifampin|rifampin|mesh-list
56133685|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
56175111|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56175112|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
56175113|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56175114|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175115|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
56175116|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56175117|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175118|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175119|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56175120|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56175121|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56133749|NCT02505750|Capecitabine|capecitabine|mesh-list
56175122|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56175123|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56664031|NCT02727647|Coagulants|coagulants|mesh-ancestor
56664032|NCT00723502|Amoxicillin|amoxicillin|mesh-list
56664033|NCT00723502|Finafloxacin|finafloxacin|mesh-list
56664034|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
56664035|NCT00723502|Esomeprazole|esomeprazole|mesh-list
56664036|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56664037|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664038|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56664039|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664040|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56664041|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664042|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310263|NCT00065884|Valproic Acid|valproic acid|mesh-list
56664043|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56664044|NCT00723502|Renal Agents|renal agents|mesh-ancestor
56664045|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56664046|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56175124|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56175125|NCT01388088|Amiloride|amiloride|mesh-list
56175126|NCT01388088|Spironolactone|spironolactone|mesh-list
56175127|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56175128|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
56102812|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56175129|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133813|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
56175130|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175131|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56175133|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
56175134|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56175135|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56175136|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56175137|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175138|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56175139|NCT01388101|Antibodies|antibodies|mesh-list
56175140|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
56175141|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175142|NCT01388114|Antibodies|antibodies|mesh-list
56175143|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
56133884|NCT04531176|Liraglutide|liraglutide|mesh-list
56175144|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175145|NCT01388153|Acarbose|acarbose|mesh-list
56175146|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56175147|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175148|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175149|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56175150|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175152|NCT01388270|Calcium heparin|calcium heparin|mesh-list
56175153|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
56175154|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56175155|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56175156|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175157|NCT01388322|Enoxaparin|enoxaparin|mesh-list
56175158|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
56175159|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56175160|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56175161|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175162|NCT01388387|Tacrolimus|tacrolimus|mesh-list
56175163|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175164|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
56664047|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664048|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56664049|NCT02727881|Squalamine|squalamine|mesh-list
56664050|NCT02727881|Ranibizumab|ranibizumab|mesh-list
56175165|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175166|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56175167|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134065|NCT00256776|Bortezomib|bortezomib|mesh-list
56175168|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175169|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56175170|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175171|NCT01388439|Oseltamivir|oseltamivir|mesh-list
56175172|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
56175176|NCT01388517|Vitamin D|vitamin d|mesh-list
56175177|NCT01388517|Calcitriol|calcitriol|mesh-list
56175178|NCT01388517|Petrolatum|petrolatum|mesh-list
56175179|NCT01388517|Tacrolimus|tacrolimus|mesh-list
56175180|NCT01388517|Vitamins|vitamins|mesh-ancestor
56175181|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
56175182|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175183|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56175184|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175185|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
56175186|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56175187|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175188|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175189|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56175190|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56175191|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56175192|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56175193|NCT01388517|Emollients|emollients|mesh-ancestor
56175194|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
56175195|NCT01388582|Copper|copper|mesh-list
56175196|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
56175197|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
56175198|NCT01388582|Etonogestrel|etonogestrel|mesh-list
56175199|NCT01388582|Desogestrel|desogestrel|mesh-list
56175200|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
56175201|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56175202|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175203|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56175204|NCT01388582|Trace Elements|trace elements|mesh-ancestor
56175205|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
56175206|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56175207|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56175208|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56175209|NCT01388582|Progestins|progestins|mesh-ancestor
56175210|NCT01388582|Hormones|hormones|mesh-ancestor
56175211|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56175212|NCT01388595|Fluticasone|fluticasone|mesh-list
56175214|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56175215|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56175216|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
56175217|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175218|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175219|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56175220|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
56175221|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
56175222|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56175223|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56175224|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56175225|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56175226|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
56175227|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175228|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175230|NCT01388621|Carboplatin|carboplatin|mesh-list
56175231|NCT01388621|Doxorubicin|doxorubicin|mesh-list
56175232|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56175233|NCT01388621|Panitumumab|panitumumab|mesh-list
56175234|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175235|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56175236|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
56175237|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664051|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56664052|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56664053|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56664054|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56664055|NCT02727881|Growth Substances|growth substances|mesh-ancestor
56664056|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175238|NCT01388621|Antiviral Agents|antiviral agents|mesh-ancestor
56175239|NCT01388621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175240|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175241|NCT01388621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175242|NCT01388621|Immunologic Factors|immunologic factors|mesh-ancestor
56175243|NCT01388621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175244|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56175245|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56175246|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56175247|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175249|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56175250|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56175251|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56175253|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
56175254|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175255|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175256|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175257|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
56175258|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56175259|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
56175260|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56175261|NCT01388738|Protective Agents|protective agents|mesh-ancestor
56175262|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175263|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
56175264|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56175265|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
56175266|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175267|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175268|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56175269|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
56175270|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56175271|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
56175272|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175273|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175274|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56175275|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
56175276|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
56175277|NCT01388842|Protective Agents|protective agents|mesh-ancestor
56175278|NCT01388855|Vitamin D|vitamin d|mesh-list
56175279|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
56175280|NCT01388855|Vitamins|vitamins|mesh-ancestor
56175281|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
56175282|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175283|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56175284|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56175285|NCT01388959|Rituximab|rituximab|mesh-list
56175286|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175287|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175288|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
56175289|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175290|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56175291|NCT01389063|Maraviroc|maraviroc|mesh-list
56175292|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56175293|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56175294|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175295|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56175296|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56175297|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
56175298|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175299|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56175300|NCT01389167|Naltrexone|naltrexone|mesh-list
56175301|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56664057|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
56664058|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664059|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56664060|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664061|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56664062|NCT02727881|Protective Agents|protective agents|mesh-ancestor
56664063|NCT01564381|Resveratrol|resveratrol|mesh-list
56664064|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
56664065|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175302|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56175303|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175304|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
56175305|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175306|NCT01389193|Ibudilast|ibudilast|mesh-list
56175307|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56175308|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
56175309|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175310|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175311|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56175312|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
56175313|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56175314|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175315|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175316|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56175317|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
56175318|NCT01389206|Bosentan|bosentan|mesh-list
56175319|NCT01389206|Selexipag|selexipag|mesh-list
56175320|NCT01389206|Iloprost|iloprost|mesh-list
56175321|NCT01389206|Macitentan|macitentan|mesh-list
56175325|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56175326|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175327|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56175328|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56175329|NCT01389271|Iloprost|iloprost|mesh-list
56175330|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56175331|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
56175332|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56175333|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56175334|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56175335|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
56175336|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175337|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56134597|NCT02096718|Afatinib|afatinib|mesh-list
56175338|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56175339|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175340|NCT01389401|Omeprazole|omeprazole|mesh-list
56175341|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56175342|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56175343|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56175344|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175345|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175346|NCT01389414|Gemcitabine|gemcitabine|mesh-list
56175347|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
56175348|NCT01389414|Panitumumab|panitumumab|mesh-list
56175349|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56175350|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
56213178|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56175351|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175352|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175354|NCT01389414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175355|NCT01389414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175356|NCT01389414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175357|NCT01389414|Immunologic Factors|immunologic factors|mesh-ancestor
56175358|NCT01389414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175359|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175360|NCT01389427|Sirolimus|sirolimus|mesh-list
56664066|NCT01564381|Protective Agents|protective agents|mesh-ancestor
56664067|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664068|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664069|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56664070|NCT04164524|Gentamicins|gentamicins|mesh-list
56664071|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56664072|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664073|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56664074|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664075|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664076|NCT00723658|Cytarabine|cytarabine|mesh-list
56664077|NCT00723658|Thalidomide|thalidomide|mesh-list
56664078|NCT00723658|Dexamethasone|dexamethasone|mesh-list
56664079|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
56664080|NCT00723658|Melphalan|melphalan|mesh-list
56664081|NCT00723658|Carmustine|carmustine|mesh-list
56664082|NCT00723658|Rituximab|rituximab|mesh-list
56664083|NCT00723658|Doxorubicin|doxorubicin|mesh-list
56664084|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56664085|NCT00723658|Etoposide|etoposide|mesh-list
56664086|NCT00723658|Bortezomib|bortezomib|mesh-list
56664087|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56664088|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
56664089|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664090|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664091|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56664092|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
56664093|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664094|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664095|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56664096|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56664097|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664098|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
56664099|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
56664100|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664107|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56664108|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56664109|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664110|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56664111|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56664112|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
56664113|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
56664114|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664115|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
56664116|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56225454|NCT05296005|Leucovorin|leucovorin|mesh-list
56175361|NCT01389427|Prednisone|prednisone|mesh-list
56175362|NCT01389427|Doxorubicin|doxorubicin|mesh-list
56175363|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
56175364|NCT01389427|Vincristine|vincristine|mesh-list
56175365|NCT01389427|Rituximab|rituximab|mesh-list
56175366|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56175367|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175368|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56175369|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175370|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
56178804|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
56175371|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175372|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
56175373|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175374|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56175375|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56175376|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
56175377|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175378|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56175379|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134782|NCT00296322|Mitomycins|mitomycins|mesh-list
56175381|NCT01389427|Hormones|hormones|mesh-ancestor
56175382|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56175383|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56175384|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56175385|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
56175386|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
56175387|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
56175388|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175389|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56175391|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175392|NCT01389440|Gemcitabine|gemcitabine|mesh-list
56175393|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56175394|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56175395|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
56175396|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175397|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175398|NCT01389440|Antiviral Agents|antiviral agents|mesh-ancestor
56175399|NCT01389440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175400|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175401|NCT01389440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175402|NCT01389440|Immunologic Factors|immunologic factors|mesh-ancestor
56175403|NCT01389440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175404|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56175405|NCT01389505|Bevacizumab|bevacizumab|mesh-list
56175406|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175407|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175408|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56175409|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56175410|NCT01389505|Growth Substances|growth substances|mesh-ancestor
56175411|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175412|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
56175413|NCT01389544|Ritonavir|ritonavir|mesh-list
56175414|NCT01389544|Methadone|methadone|mesh-list
56664117|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56664118|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56664119|NCT00723658|Growth Substances|growth substances|mesh-ancestor
56664120|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
56664121|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
56664122|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175415|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56175416|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56175417|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
56175418|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175419|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175420|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56175421|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56175422|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
56175423|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175424|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56175425|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56175426|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56175428|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56175429|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175430|NCT01389544|Analgesics|analgesics|mesh-ancestor
56175431|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
56175432|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175433|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
56175434|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
56175435|NCT01389557|Primaquine|primaquine|mesh-list
56175436|NCT01389557|Piperaquine|piperaquine|mesh-list
56175437|NCT01389557|Artenimol|artenimol|mesh-list
56175438|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
56175439|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56175440|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56175441|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175442|NCT01389609|Doxazosin|doxazosin|mesh-list
56175443|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56175444|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56135017|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
56175445|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56175446|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56175447|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
56175448|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175449|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175450|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175451|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56175453|NCT01389713|Enclomiphene|enclomiphene|mesh-list
56135302|NCT00338598|Glycine|glycine|mesh-list
56175454|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
56175455|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56175456|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
56175457|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56175458|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175459|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56175460|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
56135580|NCT00360360|Carboplatin|carboplatin|mesh-list
56175461|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56135654|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175462|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56175466|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
56175467|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56135874|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56175468|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56175469|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175471|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56175472|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175473|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
56175474|NCT01389791|Rocuronium|rocuronium|mesh-list
56175475|NCT01389791|Analgesics|analgesics|mesh-ancestor
56175476|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
56175477|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175478|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175479|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
56664123|NCT02638142|Furosemide|furosemide|mesh-list
56664124|NCT02638142|Diuretics|diuretics|mesh-ancestor
56664125|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
56664126|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664127|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56664128|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56664129|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664130|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
56664131|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
56664132|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
56664133|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56664134|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56664135|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664136|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664137|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664138|NCT03562195|Albuterol|albuterol|mesh-list
56664139|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56664140|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
56225469|NCT05296005|Antidotes|antidotes|mesh-ancestor
56175480|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56175481|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56175482|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
56175483|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56175485|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136236|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
56175486|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56175487|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
56175488|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56175489|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56175490|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56175491|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56175492|NCT01389908|Olanzapine|olanzapine|mesh-list
56175493|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
56175494|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
56175495|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175496|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175497|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56175498|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56175499|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56175500|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56175501|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56136451|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
56175502|NCT01389908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56175503|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56175504|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56213179|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56175505|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175506|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175507|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
56175510|NCT01390012|BB 1101|bb 1101|mesh-list
56136813|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
56175511|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56175512|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
56175513|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
56664141|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664142|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664143|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56664144|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
56664145|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
56664146|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56664147|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56664148|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56664149|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56664150|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
56175514|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175515|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137124|NCT00449748|Everolimus|everolimus|mesh-list
56175516|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56175517|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
56175519|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137193|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
56175520|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56175521|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175522|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
56175523|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137369|NCT00527124|Prednisone|prednisone|mesh-list
56175524|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175525|NCT01390051|Tinzaparin|tinzaparin|mesh-list
56175526|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56175527|NCT01390051|Dalteparin|dalteparin|mesh-list
56175528|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
56175529|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56175530|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56175534|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
56175535|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175536|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175537|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175539|NCT01390324|Naratriptan|naratriptan|mesh-list
56175540|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56175541|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56175543|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
56175544|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138152|NCT04304274|Morphine|morphine|mesh-list
56138221|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175545|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175546|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56175547|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56175548|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
56175549|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56175550|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175551|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175552|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56175553|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56175554|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56175555|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
56175556|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175557|NCT01390337|Cytarabine|cytarabine|mesh-list
56175558|NCT01390337|Daunorubicin|daunorubicin|mesh-list
56175559|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56175561|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138442|NCT05766540|Dopamine Agents|dopamine agents|mesh-ancestor
56175562|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175563|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
56175564|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175565|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175566|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
56175567|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175568|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56664151|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664152|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664153|NCT00686868|Ofatumumab|ofatumumab|mesh-list
56664154|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664155|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
56664156|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56664157|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664158|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56664159|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56664160|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225493|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175569|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56175570|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56175571|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175573|NCT01390480|Vitamin D|vitamin d|mesh-list
56175574|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56175575|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175576|NCT01390480|Vitamins|vitamins|mesh-ancestor
56175577|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
56175578|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56175579|NCT01390506|Selenious Acid|selenious acid|mesh-list
56175580|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
56175581|NCT01390506|Trace Elements|trace elements|mesh-ancestor
56175582|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
56175583|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175585|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175586|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175587|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
56175588|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175589|NCT01390571|Temozolomide|temozolomide|mesh-list
56175590|NCT01390571|Olaparib|olaparib|mesh-list
56175591|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56175592|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
56175593|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175595|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56175596|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175597|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
56175598|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56175599|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175600|NCT01390662|Vitamin D|vitamin d|mesh-list
56175601|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
56175602|NCT01390662|Vitamins|vitamins|mesh-ancestor
56175603|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
56175604|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175605|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56175608|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
56175609|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175610|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56175611|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175612|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175613|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
56175614|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175615|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56175616|NCT01390792|Zanamivir|zanamivir|mesh-list
56175617|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
56175618|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175619|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175620|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175621|NCT01390805|Valacyclovir|valacyclovir|mesh-list
56175622|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
56175623|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175624|NCT01390883|PENTA|penta|mesh-list
56175625|NCT01390883|Fondaparinux|fondaparinux|mesh-list
56175626|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56175627|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
56175628|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56664161|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664162|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664163|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56664164|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56664165|NCT03650894|Nivolumab|nivolumab|mesh-list
56664166|NCT03650894|Ipilimumab|ipilimumab|mesh-list
56664167|NCT03650894|Bicalutamide|bicalutamide|mesh-list
56664168|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56664169|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664170|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56664171|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664172|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
56664173|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
56664174|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664175|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664176|NCT03090776|Ketamine|ketamine|mesh-list
56664177|NCT03090776|Analgesics|analgesics|mesh-ancestor
56664178|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
56664179|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664180|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664181|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56664182|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56664183|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
56664184|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
56664185|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56664186|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56664187|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56664188|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664189|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664190|NCT02645864|Irinotecan|irinotecan|mesh-list
56664201|NCT02574130|Amikacin|amikacin|mesh-list
56664202|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56664203|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664204|NCT00652184|Valacyclovir|valacyclovir|mesh-list
56664205|NCT00652184|Sorivudine|sorivudine|mesh-list
56664206|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
56175629|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
56175630|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175631|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139474|NCT04937166|Venetoclax|venetoclax|mesh-list
56175632|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
56175633|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56175634|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56175635|NCT01390896|PENTA|penta|mesh-list
56175636|NCT01390896|Fondaparinux|fondaparinux|mesh-list
56175637|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56175638|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
56175639|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56175640|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
56175641|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178813|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
56175642|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175643|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
56175644|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56175645|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56175646|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
56175647|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56175648|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56175649|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56175650|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56139522|NCT04893109|Maytansine|maytansine|mesh-list
56175651|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175652|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
56175653|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175654|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175656|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175657|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56175658|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
56139797|NCT04477304|Analgesics|analgesics|mesh-ancestor
56175659|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139888|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
56175660|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175661|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56175662|NCT01390935|Diuretics|diuretics|mesh-ancestor
56175663|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
56175664|NCT01390961|Pheniramine|pheniramine|mesh-list
56175665|NCT01390961|Naphazoline|naphazoline|mesh-list
56175666|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175667|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56175668|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56175669|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
56175670|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175671|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175672|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
56175673|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56175674|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
56175676|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
56140106|NCT04083235|Vitamins|vitamins|mesh-ancestor
56175677|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
56175678|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
56175680|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56175681|NCT01391052|Norethindrone|norethindrone|mesh-list
56175682|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
56175683|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56175684|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56175685|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56175686|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
56175687|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56175688|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140469|NCT03188705|Aspirin|aspirin|mesh-list
56175689|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56664207|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175690|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56175691|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
56175692|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
56178828|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
56175694|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56175695|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175696|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140769|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
56140838|NCT01285817|Celecoxib|celecoxib|mesh-list
56175697|NCT01391104|Urological Agents|urological agents|mesh-ancestor
56175699|NCT01391156|Finasteride|finasteride|mesh-list
56175700|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56175702|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56175703|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56175704|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141125|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56175705|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175706|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
56141275|NCT04365036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175707|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56175708|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175709|NCT01391156|Urological Agents|urological agents|mesh-ancestor
56141579|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
56175710|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56175711|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56141743|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
56175712|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56175713|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56175714|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175716|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175717|NCT01391221|Analgesics|analgesics|mesh-ancestor
56175718|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
56142019|NCT05417100|Analgesics|analgesics|mesh-ancestor
56175719|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175720|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
56175721|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56175723|NCT01391260|Gefitinib|gefitinib|mesh-list
56175724|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175725|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56175726|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142311|NCT03016260|Analgesics|analgesics|mesh-ancestor
56175727|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175730|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
56175731|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175732|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56175733|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
56175734|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
56175735|NCT01391377|Vitamins|vitamins|mesh-ancestor
56175736|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
56175737|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175738|NCT01391390|Melatonin|melatonin|mesh-list
56175739|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
56175740|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175741|NCT01391390|Protective Agents|protective agents|mesh-ancestor
56175742|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175743|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56175744|NCT01391403|Artemisinins|artemisinins|mesh-list
56175745|NCT01391403|Artemisinin|artemisinin|mesh-list
56175746|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
56175747|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56175748|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56175749|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175750|NCT01391520|Deferiprone|deferiprone|mesh-list
56178850|NCT02427581|Poly ICLC|poly iclc|mesh-list
56175751|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56175753|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
56175754|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175755|NCT01391572|Fluorouracil|fluorouracil|mesh-list
56175756|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175757|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
56175758|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142734|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664208|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664209|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664210|NCT02726867|Lacosamide|lacosamide|mesh-list
56175759|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56142806|NCT02641782|Isotretinoin|isotretinoin|mesh-list
56175760|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175761|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
56175762|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143044|NCT00582660|Celecoxib|celecoxib|mesh-list
56175764|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
56175765|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
56143101|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175766|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56175767|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175768|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
56175769|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143247|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
56175770|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56175771|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56175772|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56175773|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56175774|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175775|NCT01391624|Mineral Oil|mineral oil|mesh-list
56175776|NCT01391624|Emollients|emollients|mesh-ancestor
56175777|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
56175778|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56175779|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56175780|NCT01391689|Protective Agents|protective agents|mesh-ancestor
56143835|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56175781|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175782|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175783|NCT01391715|Rabeprazole|rabeprazole|mesh-list
56175784|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56175785|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56143910|NCT00720330|Lidocaine|lidocaine|mesh-list
56175786|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56175788|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175789|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
56143989|NCT00728910|Vitamins|vitamins|mesh-ancestor
56175790|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56175792|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56175793|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175794|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56144283|NCT00762450|Triclosan|triclosan|mesh-list
56175797|NCT01392014|Artenimol|artenimol|mesh-list
56175798|NCT01392014|Artemisinins|artemisinins|mesh-list
56175799|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
56175800|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56175801|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56175802|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175804|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175805|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175806|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
56175807|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56175808|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
56175809|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175810|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175811|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56175812|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
56175813|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56175814|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
56175815|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175816|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175818|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
56175819|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
56175820|NCT01392144|Protective Agents|protective agents|mesh-ancestor
56175821|NCT01392157|Copper|copper|mesh-list
56175823|NCT01392157|Trace Elements|trace elements|mesh-ancestor
56175824|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
56175825|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175826|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56175827|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
56175828|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55931380|NCT02240199|Lidocaine|lidocaine|mesh-list
56664211|NCT02726867|Ketamine|ketamine|mesh-list
56664212|NCT02726867|Levetiracetam|levetiracetam|mesh-list
56664213|NCT02726867|Phenobarbital|phenobarbital|mesh-list
56664214|NCT02726867|Analgesics|analgesics|mesh-ancestor
56664215|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
56664216|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664217|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664218|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56664219|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56664220|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
56664221|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
56664222|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56664223|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56664224|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56664225|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664226|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664227|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
56664228|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
56225553|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56175829|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56175830|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56175831|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56175833|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175834|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175835|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56175837|NCT01392209|Growth Substances|growth substances|mesh-ancestor
56175838|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175839|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
56175840|NCT01392287|Memantine|memantine|mesh-list
56175841|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56175842|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56175843|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
56175844|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175845|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175846|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175847|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56175848|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56175849|NCT01392430|Azithromycin|azithromycin|mesh-list
56175850|NCT01392430|Dapsone|dapsone|mesh-list
56175851|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56175852|NCT01392430|Itraconazole|itraconazole|mesh-list
56175853|NCT01392430|Fluconazole|fluconazole|mesh-list
56175854|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56175855|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175856|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
56175857|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56175858|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56175859|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175860|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175861|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56175862|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
56175863|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56175864|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175865|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56664229|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56664230|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56664231|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56664232|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56664233|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
56664234|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
56664235|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56664236|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56664237|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56664238|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56664239|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
56664240|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56664241|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56664242|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56664243|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56664244|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664245|NCT00873366|Tamoxifen|tamoxifen|mesh-list
56664246|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
56664247|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664248|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56664249|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
56664250|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56175866|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56175867|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56175868|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
56175869|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56175870|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56175871|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56175872|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
56175873|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56175875|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56103597|NCT00003518|Gemcitabine|gemcitabine|mesh-list
56175877|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
56175878|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56175879|NCT01392534|Diuretics|diuretics|mesh-ancestor
56175880|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
56175881|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175883|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56175884|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175885|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56175887|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
56175888|NCT01392612|Hematinics|hematinics|mesh-ancestor
56175889|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
56175891|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56175893|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175894|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175895|NCT01392638|Urological Agents|urological agents|mesh-ancestor
56175896|NCT01392716|Rituximab|rituximab|mesh-list
56175905|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56175906|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56175907|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56175908|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
56175909|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175910|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175911|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56175912|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56175913|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
56175914|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175915|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56175916|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56175917|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56175918|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56175919|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56175920|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56175921|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
56175923|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175924|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175925|NCT01392768|Levetiracetam|levetiracetam|mesh-list
56175926|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
56175927|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
56175928|NCT01392794|Ramosetron|ramosetron|mesh-list
56175929|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
56175930|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
56175931|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175932|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175933|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56175934|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56175936|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56175937|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175939|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56175940|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175941|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
56175942|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175944|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
56175945|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56175946|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56175947|NCT01392833|Prednisolone|prednisolone|mesh-list
56175948|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
56175949|NCT01392833|Azathioprine|azathioprine|mesh-list
56175950|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56175951|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
56175952|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56175953|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
56175954|NCT01392833|Hormones|hormones|mesh-ancestor
56175955|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56175956|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664277|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664278|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56175957|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56175958|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175959|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
56175960|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
56175961|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175962|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56175963|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56175964|NCT01392833|Protective Agents|protective agents|mesh-ancestor
56175965|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
56175966|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175967|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56175968|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56175972|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56175973|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175974|NCT01392898|Incretins|incretins|mesh-ancestor
56175975|NCT01392898|Hormones|hormones|mesh-ancestor
56175976|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56175977|NCT01392911|Rifampin|rifampin|mesh-list
56175978|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56175979|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
56175980|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56175981|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175982|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
56175983|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56175984|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175986|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56175987|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56175988|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56175989|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56175990|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56175991|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56175994|NCT01393080|Paclitaxel|paclitaxel|mesh-list
56175995|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175996|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175997|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56175998|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
56175999|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
56176001|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176002|NCT01393145|Fluticasone|fluticasone|mesh-list
56176004|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
56176005|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56176006|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56176007|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56176008|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56176009|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
56176010|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176011|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176012|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56176013|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
56176014|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
56176015|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56176016|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56176017|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56176018|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56176019|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
56176021|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176022|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
56176023|NCT01393145|Hormones|hormones|mesh-ancestor
56176024|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176025|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
56176027|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56176028|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176029|NCT01393288|Lorazepam|lorazepam|mesh-list
56176030|NCT01393288|Ondansetron|ondansetron|mesh-list
56176031|NCT01393288|Aprepitant|aprepitant|mesh-list
56176032|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
56176033|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
56176034|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176035|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664279|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56664280|NCT04164368|Growth Substances|growth substances|mesh-ancestor
56664281|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
56664282|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664283|NCT02726555|Atorvastatin|atorvastatin|mesh-list
56664284|NCT02726555|Red yeast rice|red yeast rice|mesh-list
56664285|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56664286|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56664287|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
56664288|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664289|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56664290|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56664291|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664292|NCT00536107|Docetaxel|docetaxel|mesh-list
56664293|NCT00536107|Gefitinib|gefitinib|mesh-list
56664294|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664295|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56664296|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56664297|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56664298|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225627|NCT05236608|Nivolumab|nivolumab|mesh-list
56176036|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56176039|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56176040|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
56176041|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176042|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176043|NCT01393288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56176044|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56176045|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176046|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176047|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56176048|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56176049|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
56176050|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56176051|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
56176052|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
56176054|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56176055|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56176056|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
56176057|NCT01393548|Brompheniramine|brompheniramine|mesh-list
56176058|NCT01393548|Phenylephrine|phenylephrine|mesh-list
56176059|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
56176060|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
56176062|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56176063|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
56176064|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
56176065|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176066|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176067|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
56176068|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56176069|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
56176070|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
56176071|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56176072|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56176073|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56664299|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56664300|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664301|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
56664302|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56664303|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
56664304|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664305|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664306|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56664307|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
56664308|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664309|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664310|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56664311|NCT00724360|Trastuzumab|trastuzumab|mesh-list
56664312|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56664313|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664314|NCT02637830|Fluorides|fluorides|mesh-list
56664315|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
56664316|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
56664317|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
56664318|NCT02637830|Protective Agents|protective agents|mesh-ancestor
56664319|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664320|NCT00687258|Vitamin E|vitamin e|mesh-list
56664321|NCT00687258|Vitamins|vitamins|mesh-ancestor
56664322|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
56664323|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664324|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
56664325|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664326|NCT00687258|Protective Agents|protective agents|mesh-ancestor
56664327|NCT04001569|Paclitaxel|paclitaxel|mesh-list
56664329|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664343|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
56664344|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56664345|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664346|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664347|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
56664348|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56664349|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664350|NCT02733107|Etoposide|etoposide|mesh-list
56664351|NCT02733107|Apatinib|apatinib|mesh-list
56664352|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56664353|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664354|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56664355|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56664356|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664357|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664358|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56176074|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
56176075|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176076|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176078|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56176079|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56176080|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56176081|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56176082|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
56176083|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
56176084|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56176086|NCT01393574|Methylphenidate|methylphenidate|mesh-list
56176087|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
56176088|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176090|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176091|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176092|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56176093|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56176094|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56176095|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176096|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
56176098|NCT01393756|Lenalidomide|lenalidomide|mesh-list
56176099|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
56176100|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176101|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56176102|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56176103|NCT01393756|Growth Substances|growth substances|mesh-ancestor
56176104|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
56176105|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176106|NCT01393769|Melphalan|melphalan|mesh-list
56176107|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56176108|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
56176109|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176111|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56176112|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176113|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
56176114|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176115|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
56176117|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
56176118|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56176119|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56664359|NCT00675012|Capecitabine|capecitabine|mesh-list
56664360|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
56664361|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56664362|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
56664363|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664364|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225709|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
56176121|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176122|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176124|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
56176125|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
56176126|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
56176127|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176128|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176129|NCT01393912|Crenolanib|crenolanib|mesh-list
56176130|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176131|NCT01393925|Parecoxib|parecoxib|mesh-list
56176132|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56176133|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56176134|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176135|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176136|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56176140|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176141|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176142|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56176143|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56176144|NCT01394029|Deferasirox|deferasirox|mesh-list
56176145|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56176146|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
56176147|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
56176148|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176150|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56176151|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176152|NCT01394133|Ritonavir|ritonavir|mesh-list
56176153|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56176154|NCT01394133|Tenofovir|tenofovir|mesh-list
56176155|NCT01394133|Emtricitabine|emtricitabine|mesh-list
56176156|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56178926|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
56176157|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56176159|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176160|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176161|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56176162|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56176163|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
56176164|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176165|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56176166|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56176167|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56176169|NCT01394224|Levetiracetam|levetiracetam|mesh-list
56176170|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
56176171|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
56176172|NCT01394263|Goserelin|goserelin|mesh-list
56176173|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56176174|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176175|NCT01394341|Liraglutide|liraglutide|mesh-list
56176176|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56176177|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176178|NCT01394341|Incretins|incretins|mesh-ancestor
56176179|NCT01394341|Hormones|hormones|mesh-ancestor
56176180|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176181|NCT01394354|Dexamethasone|dexamethasone|mesh-list
56176182|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
56176183|NCT01394354|Doxorubicin|doxorubicin|mesh-list
56176184|NCT01394354|Bortezomib|bortezomib|mesh-list
56176185|NCT01394354|Vorinostat|vorinostat|mesh-list
56176186|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56176187|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
56176188|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
56664365|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56664366|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
56664367|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56664368|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56664369|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225715|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56176189|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176190|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176191|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56176192|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
56176193|NCT01394354|Hormones|hormones|mesh-ancestor
56213180|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56176194|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176195|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56176196|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176197|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56176199|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56176200|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176201|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176202|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56176204|NCT01394406|Analgesics|analgesics|mesh-ancestor
56176205|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
56176206|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176207|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176208|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56176209|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56176210|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
56176211|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
56176212|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176221|NCT01394419|Expectorants|expectorants|mesh-ancestor
56176222|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
56176223|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56176224|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
56176225|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176226|NCT01394419|Protective Agents|protective agents|mesh-ancestor
56176227|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176228|NCT01394419|Antidotes|antidotes|mesh-ancestor
56176229|NCT01394445|Physostigmine|physostigmine|mesh-list
56176231|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176232|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176233|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
56176234|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176235|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176236|NCT01394445|Miotics|miotics|mesh-ancestor
56176238|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176239|NCT01394458|Ethanol|ethanol|mesh-list
56176240|NCT01394458|Heparin|heparin|mesh-list
56176241|NCT01394458|Citric Acid|citric acid|mesh-list
56176242|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
56176244|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56176245|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
56176246|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
56176247|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176248|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56176249|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56176250|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56176251|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176252|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176253|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103958|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
56176254|NCT01394471|Oxytocin|oxytocin|mesh-list
56176255|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
56176256|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56176258|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
56176259|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
56176260|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176261|NCT01394497|Expectorants|expectorants|mesh-ancestor
56176262|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
56176263|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56176264|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
56664370|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664371|NCT00652262|Urological Agents|urological agents|mesh-ancestor
56664372|NCT02640794|Aspirin|aspirin|mesh-list
56664373|NCT02640794|Clopidogrel|clopidogrel|mesh-list
56664374|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56664375|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56664376|NCT02640794|Analgesics|analgesics|mesh-ancestor
56664377|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
56176265|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176266|NCT01394497|Protective Agents|protective agents|mesh-ancestor
56176267|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176269|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
56176270|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176271|NCT01394653|Ramosetron|ramosetron|mesh-list
56176272|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
56176273|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
56176274|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176275|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176276|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56176277|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56176278|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
56178942|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176279|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176280|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176281|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
56176282|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176292|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176294|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56176295|NCT01394731|Narcotics|narcotics|mesh-ancestor
56176296|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176297|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56176298|NCT01394757|Ketamine|ketamine|mesh-list
56176299|NCT01394757|Esketamine|esketamine|mesh-list
56176300|NCT01394757|Analgesics|analgesics|mesh-ancestor
56176301|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
56176302|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176303|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176304|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56176305|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56176306|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
56176307|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
56176308|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176309|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56176310|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56176311|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176312|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176313|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
56176314|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176316|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56176317|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56176318|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176319|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176320|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56176321|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176322|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
56176323|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56176324|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
56176325|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176326|NCT01394796|Protective Agents|protective agents|mesh-ancestor
56176327|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176328|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56176329|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56176330|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176331|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56176332|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56664378|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664379|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664380|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664381|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664382|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56664383|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56664384|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664385|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56664386|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56664387|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664388|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
56664389|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56664390|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56664391|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56664392|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
56664393|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664394|NCT00724672|Adalimumab|adalimumab|mesh-list
56176333|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
56176334|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56176335|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56176336|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
56176337|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176338|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176339|NCT01394848|Everolimus|everolimus|mesh-list
56176340|NCT01394848|Clopidogrel|clopidogrel|mesh-list
56176341|NCT01394848|Atorvastatin|atorvastatin|mesh-list
56176342|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56176343|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56176345|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176346|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56176355|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56176356|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56176357|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
56176358|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176360|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56176361|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176362|NCT01394913|Etanercept|etanercept|mesh-list
56176363|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56176364|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56176365|NCT01394913|Analgesics|analgesics|mesh-ancestor
56176366|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
56176367|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176368|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176369|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56176370|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56176371|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56176372|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176373|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
56176375|NCT01395069|Nepafenac|nepafenac|mesh-list
56176376|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56176377|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56176378|NCT01395069|Analgesics|analgesics|mesh-ancestor
56176379|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
56176380|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176381|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176382|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664395|NCT00724672|Etanercept|etanercept|mesh-list
56664396|NCT00724672|Infliximab|infliximab|mesh-list
56664397|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664398|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664399|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
56664400|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664401|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56664402|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56664403|NCT00724672|Analgesics|analgesics|mesh-ancestor
56664404|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
56664405|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664406|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664407|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56664408|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
56664409|NCT02624856|Dexamethasone|dexamethasone|mesh-list
56664410|NCT02624856|Bupivacaine|bupivacaine|mesh-list
56664411|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56547646|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
56664412|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
56664413|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
56664414|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664415|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664416|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664417|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
56664418|NCT02624856|Hormones|hormones|mesh-ancestor
56176383|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56176384|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56176385|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176386|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176387|NCT01395147|Vortioxetine|vortioxetine|mesh-list
56176388|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
56176389|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176390|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56176391|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56176392|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176393|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176394|NCT01395147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56176395|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56176396|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176397|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176398|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176400|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56176401|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56176402|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56176403|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56176404|NCT01395199|Amlodipine|amlodipine|mesh-list
56176405|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56176406|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56176409|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56176410|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176411|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
56176412|NCT01395251|Prednisolone|prednisolone|mesh-list
56664419|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664420|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664421|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664422|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
56664423|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
56664424|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56664425|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
56664426|NCT02646020|Loratadine|loratadine|mesh-list
56664427|NCT02646020|Aprepitant|aprepitant|mesh-list
56664428|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
56664429|NCT02646020|Desloratadine|desloratadine|mesh-list
56664430|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
56664431|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
56664432|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664433|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664434|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664435|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56664436|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664437|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664438|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56664439|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
56664440|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56664441|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56664442|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
56664443|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
56664444|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
56664445|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
56664446|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56664447|NCT03735979|Argatroban|argatroban|mesh-list
56176413|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
56176414|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56176415|NCT01395251|Hormones|hormones|mesh-ancestor
56176416|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176417|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176418|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56176419|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176420|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
56176421|NCT01395290|Vitamin D|vitamin d|mesh-list
56176422|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56176423|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176424|NCT01395290|Vitamins|vitamins|mesh-ancestor
56176425|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
56176426|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56176427|NCT01395381|Albendazole|albendazole|mesh-list
56176428|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
56176429|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56176430|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664448|NCT03735979|Eptifibatide|eptifibatide|mesh-list
56664449|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
56664450|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56664451|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
56664452|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664453|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664454|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
56664455|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56664456|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56664457|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
56664458|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
56664459|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664460|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56664461|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56664462|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664463|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56664464|NCT00992797|Vitamin D|vitamin d|mesh-list
56664465|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
56664466|NCT00992797|Vitamins|vitamins|mesh-ancestor
56664467|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
56664468|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664469|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56664470|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56176431|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
56176432|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56176433|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56176434|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
56176435|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
56176436|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
56176437|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176438|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176439|NCT01395420|Ceftazidime|ceftazidime|mesh-list
56176441|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56176442|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176443|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56176444|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176445|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176446|NCT01395433|Dexetimide|dexetimide|mesh-list
56176447|NCT01395433|Citalopram|citalopram|mesh-list
56176448|NCT01395433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56176449|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56176450|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176451|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176452|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176453|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
56176454|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176455|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56176456|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
56176457|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176458|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56176459|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56176460|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
56664471|NCT02725541|Trastuzumab|trastuzumab|mesh-list
56664472|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56664473|NCT02725541|Maytansine|maytansine|mesh-list
56664474|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56664475|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664476|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56664477|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
56664478|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
56664479|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
56664480|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664481|NCT00911066|Azacitidine|azacitidine|mesh-list
56664482|NCT00911066|Pevonedistat|pevonedistat|mesh-list
56664483|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56664484|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
56664485|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664486|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310633|NCT00068653|Celecoxib|celecoxib|mesh-list
56664487|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664488|NCT02733341|Ticagrelor|ticagrelor|mesh-list
56664490|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56176461|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
56176462|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176463|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56176464|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56176465|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
56176466|NCT01395485|Brodalumab|brodalumab|mesh-list
56176467|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
56176468|NCT01395589|Vitamin D|vitamin d|mesh-list
56176469|NCT01395589|Vitamins|vitamins|mesh-ancestor
56176470|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
56176471|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176472|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56176474|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56176475|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56176476|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
56176477|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
56176478|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176479|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176480|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176487|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176488|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
56176489|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56176490|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176491|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176492|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56176493|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56176494|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56176495|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56176496|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56176497|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56176498|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56176499|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56176500|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
56176501|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56176502|NCT01395667|Leucovorin|leucovorin|mesh-list
56664491|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56664492|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56664493|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56176503|NCT01395667|Fluorouracil|fluorouracil|mesh-list
56176504|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
56176505|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176506|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176507|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
56176508|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176509|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56176510|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176511|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
56176512|NCT01395667|Antidotes|antidotes|mesh-ancestor
56176513|NCT01395667|Protective Agents|protective agents|mesh-ancestor
56176514|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
56176515|NCT01395667|Vitamins|vitamins|mesh-ancestor
56176516|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
56176517|NCT01395732|Bosentan|bosentan|mesh-list
56176518|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56176519|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56176520|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176521|NCT01395849|Fluticasone|fluticasone|mesh-list
56176522|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56176523|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56176524|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56176525|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56176526|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
56176527|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176528|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176529|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56176530|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
56176531|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
56176532|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56176533|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56176534|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56176535|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56176536|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
56176537|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176538|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176539|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
56176540|NCT01395849|Hormones|hormones|mesh-ancestor
56176541|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176542|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
56176543|NCT01395862|Fluticasone|fluticasone|mesh-list
56176544|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56176545|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56176546|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56176547|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56176548|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
56176549|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176550|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176551|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56176556|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56176557|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56176558|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
56176559|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176560|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176562|NCT01395862|Hormones|hormones|mesh-ancestor
56176563|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176564|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
56176565|NCT01395875|Fluticasone|fluticasone|mesh-list
56176566|NCT01395875|Xhance|xhance|mesh-list
56176567|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56176568|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56176569|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56176570|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56176571|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
56176572|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176573|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176574|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56664494|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
56664495|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664496|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664497|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664498|NCT00692172|Alefacept|alefacept|mesh-list
56664499|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
56664500|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
56664501|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664502|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56664503|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56664504|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56664505|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
56664506|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664507|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56664508|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56664509|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
56664510|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
56176575|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
56176576|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
56176577|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56176578|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56176579|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56176580|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56176581|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
56176582|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176583|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176584|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
56176585|NCT01395927|Canagliflozin|canagliflozin|mesh-list
56176586|NCT01395927|Rifampin|rifampin|mesh-list
56176587|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56176588|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
56176589|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56176590|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176591|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
56176592|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56176593|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178994|NCT01729754|Etanercept|etanercept|mesh-list
56176594|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176595|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56176596|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56176597|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56176598|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56176599|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56176600|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56176601|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56176602|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56176603|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176604|NCT01395953|Buspirone|buspirone|mesh-list
56176605|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56176606|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56176607|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176608|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176609|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176610|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56176611|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
56176612|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664511|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56664512|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56664513|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56664514|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
56664515|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56664516|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664517|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56664518|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56176613|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176614|NCT01395992|Asenapine|asenapine|mesh-list
56176615|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56176616|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56176617|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176618|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176619|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176620|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
56176621|NCT01396200|Sirolimus|sirolimus|mesh-list
56176625|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176626|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104343|NCT00004112|Hormones|hormones|mesh-ancestor
56176627|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176628|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56176629|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56176630|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56176631|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176632|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
56176633|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176634|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
56176635|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176636|NCT01396291|Asenapine|asenapine|mesh-list
56176637|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56176638|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56176639|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176640|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176641|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176642|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56176643|NCT01396304|Calcium|calcium|mesh-list
56176644|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56176645|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176646|NCT01396304|Laxatives|laxatives|mesh-ancestor
56176647|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56176648|NCT01396564|Metformin|metformin|mesh-list
56176649|NCT01396564|Pioglitazone|pioglitazone|mesh-list
56176650|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56176651|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176652|NCT01396642|Emollients|emollients|mesh-list
56176653|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
56176654|NCT01396655|Docetaxel|docetaxel|mesh-list
56176655|NCT01396655|Doxorubicin|doxorubicin|mesh-list
56176656|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176657|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
56176658|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
56176659|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
56176660|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176661|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56176662|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56176663|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56176664|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176665|NCT01396668|Gemcitabine|gemcitabine|mesh-list
56176666|NCT01396668|Capecitabine|capecitabine|mesh-list
56176667|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176668|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56176669|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
56176670|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176671|NCT01396668|Antiviral Agents|antiviral agents|mesh-ancestor
56176672|NCT01396668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176673|NCT01396668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931381|NCT02240199|Pregabalin|pregabalin|mesh-list
56664519|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56664520|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664521|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664522|NCT03675139|Progestins|progestins|mesh-ancestor
56664523|NCT03675139|Hormones|hormones|mesh-ancestor
56664524|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176674|NCT01396668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176675|NCT01396668|Immunologic Factors|immunologic factors|mesh-ancestor
56176676|NCT01396668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176677|NCT01396681|Gemcitabine|gemcitabine|mesh-list
56176678|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176679|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56176680|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
56176681|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176682|NCT01396681|Antiviral Agents|antiviral agents|mesh-ancestor
56176683|NCT01396681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176684|NCT01396681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176685|NCT01396681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176686|NCT01396681|Immunologic Factors|immunologic factors|mesh-ancestor
56176687|NCT01396681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176689|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
56176690|NCT01396707|Trastuzumab|trastuzumab|mesh-list
56176691|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56176692|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
56176693|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176694|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176695|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56176702|NCT01396720|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56176703|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56176704|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176705|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176706|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176707|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
56176708|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56176709|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
56176710|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56176711|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56176712|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176713|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56176714|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
56176715|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
56176716|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176717|NCT01396733|Protective Agents|protective agents|mesh-ancestor
56176718|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176719|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
56176720|NCT01396733|Vitamins|vitamins|mesh-ancestor
56176721|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
56176722|NCT01397006|Pregabalin|pregabalin|mesh-list
56176723|NCT01397006|Analgesics|analgesics|mesh-ancestor
56176724|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
56176725|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176726|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176727|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
56176728|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56176729|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176730|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176731|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56176732|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56176733|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56176734|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176735|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176736|NCT01397019|Leucovorin|leucovorin|mesh-list
56176737|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
56176738|NCT01397019|Irinotecan|irinotecan|mesh-list
56176739|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176740|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56176741|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56664525|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
56664526|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56664527|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56664528|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664529|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
56664530|NCT02645552|Coagulants|coagulants|mesh-ancestor
56664531|NCT00692328|Levodopa|levodopa|mesh-list
56664532|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56664533|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56664534|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
56664535|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664536|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664537|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664538|NCT03415828|Ethanol|ethanol|mesh-list
56664539|NCT03415828|Prednisolone|prednisolone|mesh-list
56225807|NCT05057273|Adalimumab|adalimumab|mesh-list
56176742|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176743|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176744|NCT01397019|Antidotes|antidotes|mesh-ancestor
56176745|NCT01397019|Protective Agents|protective agents|mesh-ancestor
56176746|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176747|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
56176748|NCT01397019|Vitamins|vitamins|mesh-ancestor
56176749|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
56176750|NCT01397097|Etonogestrel|etonogestrel|mesh-list
56176751|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56176752|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
56176753|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56176754|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176755|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56176756|NCT01397175|Everolimus|everolimus|mesh-list
56176757|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176758|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176759|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
56176760|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176761|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
56176762|NCT01397214|Megestrol|megestrol|mesh-list
56176763|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56176764|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176780|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56176781|NCT01397331|Propofol|propofol|mesh-list
56176782|NCT01397331|Isoflurane|isoflurane|mesh-list
56176783|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56176784|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176785|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176786|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56176787|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
56176789|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56176790|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
56176791|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
56176792|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176793|NCT05268835|Clindamycin|clindamycin|mesh-list
56176794|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56176795|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176796|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56176797|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176798|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176799|NCT05268718|Voriconazole|voriconazole|mesh-list
56176800|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56176801|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56176802|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
56664540|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56664541|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
56664542|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56664543|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
56664544|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56664545|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
56664546|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664547|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
56664548|NCT03415828|Hormones|hormones|mesh-ancestor
56664549|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664550|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664551|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664552|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664553|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
56664554|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
56664555|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664556|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664557|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56664558|NCT03415828|Protective Agents|protective agents|mesh-ancestor
56664559|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56664560|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664561|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56664562|NCT00687648|Prednisolone|prednisolone|mesh-list
56664563|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
56176803|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176804|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56176805|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56176806|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176807|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176808|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56176809|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
56176810|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176811|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176812|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56176814|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56176815|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176816|NCT05268627|Incretins|incretins|mesh-ancestor
56176818|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176819|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
56176820|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
56176821|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176822|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56176824|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176825|NCT05267977|Cephalosporins|cephalosporins|mesh-list
56176826|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56176827|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176828|NCT05186558|Gemcitabine|gemcitabine|mesh-list
56176829|NCT05186558|Rituximab|rituximab|mesh-list
56176830|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
56176831|NCT05186558|Lenalidomide|lenalidomide|mesh-list
55931382|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
56664564|NCT00687648|Methotrexate|methotrexate|mesh-list
56664565|NCT00687648|Letrozole|letrozole|mesh-list
56664566|NCT00687648|Anastrozole|anastrozole|mesh-list
56664567|NCT00687648|Exemestane|exemestane|mesh-list
56664568|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56664569|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
56664570|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664571|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664572|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56664573|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
56664574|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664575|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225843|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56176832|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56176833|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176834|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
56176835|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176836|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56176837|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56176838|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
56176839|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176840|NCT05186558|Antiviral Agents|antiviral agents|mesh-ancestor
56176841|NCT05186558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176842|NCT05186558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176843|NCT05186558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176844|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56176845|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56176846|NCT05186558|Growth Substances|growth substances|mesh-ancestor
56176847|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
56176848|NCT05092698|Vitamin D|vitamin d|mesh-list
56104567|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
56176850|NCT05092698|Vitamins|vitamins|mesh-ancestor
56176851|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
56176852|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176853|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56176854|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56176856|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
56176857|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56176858|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176859|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176860|NCT04975269|Diuretics|diuretics|mesh-ancestor
56176861|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
56176862|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176863|NCT04965870|Trifluridine|trifluridine|mesh-list
56176864|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
56176865|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176866|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
56176867|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176868|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
56176869|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56176870|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176871|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56176872|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
56176873|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
56176874|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176875|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176876|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
56176877|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176878|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56176880|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56176881|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176882|NCT04500756|Metformin|metformin|mesh-list
56664576|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56664577|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56664578|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
56176883|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56176884|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176885|NCT04472416|Analgesics|analgesics|mesh-list
56176886|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
56176887|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176888|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176889|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
56176890|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
56176891|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56176892|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56176893|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176894|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176895|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176896|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56176897|NCT04453449|Midazolam|midazolam|mesh-list
56176898|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56176899|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56176900|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176901|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176902|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56176903|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56176904|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176905|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56176906|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
56176907|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
56176908|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
56176909|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
56176910|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176911|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176912|NCT04415333|Butyric Acid|butyric acid|mesh-list
56176913|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
56176914|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
56176915|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176916|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176917|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176918|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
56176919|NCT04093596|Fludarabine|fludarabine|mesh-list
56176920|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176922|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176923|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104690|NCT00002785|Cobalt|cobalt|mesh-list
56176924|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56176925|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
56176926|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176927|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176928|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56176933|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176934|NCT03283813|Inositol|inositol|mesh-list
56176935|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
56176936|NCT03283813|Vitamins|vitamins|mesh-ancestor
56176937|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
56176938|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176939|NCT03283384|Letrozole|letrozole|mesh-list
56176940|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176941|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56176942|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56176943|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176944|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176945|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56176946|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
56213182|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56176947|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176948|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176949|NCT03245827|Clomiphene|clomiphene|mesh-list
56176950|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56176951|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
56213183|NCT02890329|Ipilimumab|ipilimumab|mesh-list
56213184|NCT02890329|Decitabine|decitabine|mesh-list
56176952|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798194|NCT05421065|Ketamine|ketamine|mesh-list
56225853|NCT04989049|Folic Acid|folic acid|mesh-list
56225854|NCT04989049|Hematinics|hematinics|mesh-ancestor
56225855|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
56225856|NCT04989049|Vitamins|vitamins|mesh-ancestor
56225857|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
56225858|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664579|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56664580|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56664581|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
56664582|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
56664583|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664584|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56664585|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56664586|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664587|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
56664588|NCT00687648|Hormones|hormones|mesh-ancestor
56664589|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664590|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664591|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56664592|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56664593|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56664594|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
56664595|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
56664596|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
56225859|NCT04984044|Vitamin D|vitamin d|mesh-list
56176953|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176954|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56176955|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
56176956|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56176957|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56176958|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56176959|NCT03129321|Econazole|econazole|mesh-list
56176960|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
56176961|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176962|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56176963|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56176964|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176965|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176966|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56176967|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
56176968|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56176969|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176970|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
56176971|NCT03107611|Tacrolimus|tacrolimus|mesh-list
56176972|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56176973|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56176974|NCT03107611|Analgesics|analgesics|mesh-ancestor
56176975|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
56176976|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176977|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664597|NCT00725218|Analgesics|analgesics|mesh-ancestor
56664598|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
56664599|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664600|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864234|NCT01969721|Xhance|xhance|mesh-list
56176978|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56176979|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56176980|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
56176981|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176982|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
56176983|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56176984|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213185|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56176985|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176986|NCT03040726|Palonosetron|palonosetron|mesh-list
56176987|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
56176988|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
56176989|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176990|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176991|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56176992|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56176993|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56176994|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
56176997|NCT02607956|Dolutegravir|dolutegravir|mesh-list
56176998|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56176999|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56177000|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56177001|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177002|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177003|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56177004|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56177005|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
56177006|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177007|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56177008|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56177009|NCT02499666|Clopidogrel|clopidogrel|mesh-list
56177010|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56177011|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56177012|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56177013|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56177014|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
56177015|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177016|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177017|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177019|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56177020|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177021|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56177022|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177023|NCT02094716|Permethrin|permethrin|mesh-list
56177024|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177025|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177026|NCT01460810|Silicon|silicon|mesh-list
56177027|NCT01460810|Trace Elements|trace elements|mesh-ancestor
56177028|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
56177029|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177030|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
56177031|NCT01175356|Melphalan|melphalan|mesh-list
56177032|NCT01175356|Busulfan|busulfan|mesh-list
56177033|NCT01175356|Doxorubicin|doxorubicin|mesh-list
56177034|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56177036|NCT01175356|Vincristine|vincristine|mesh-list
56177037|NCT01175356|Topotecan|topotecan|mesh-list
56177038|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
56177039|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56177040|NCT01175356|Isotretinoin|isotretinoin|mesh-list
56177041|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177042|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
56177043|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177044|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177045|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56177046|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
56664601|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56664602|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56664603|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664604|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664605|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56664606|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664607|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664608|NCT02732795|Morphine|morphine|mesh-list
56664609|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56177047|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177048|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177049|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56177050|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56177051|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56177052|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56177053|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177054|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56177055|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
56177056|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
56177057|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
56177058|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56177059|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
56177060|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56177061|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
56177062|NCT00667329|Rituximab|rituximab|mesh-list
56177063|NCT00667329|Cladribine|cladribine|mesh-list
56177064|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177065|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
56177066|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177068|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56177069|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
56177070|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177071|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177072|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56177073|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56177074|NCT00492167|Antibodies|antibodies|mesh-list
56177075|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56177076|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
56177077|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177078|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
56177079|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177080|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56177081|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177082|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177083|NCT05274191|Maleic acid|maleic acid|mesh-list
56177084|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177085|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177086|NCT05274139|Cytarabine|cytarabine|mesh-list
56177087|NCT05274139|Dexamethasone|dexamethasone|mesh-list
56177088|NCT05274139|Temozolomide|temozolomide|mesh-list
56177089|NCT05274139|Fotemustine|fotemustine|mesh-list
56177090|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56177091|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
56177092|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
56177093|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177094|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177095|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56177096|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
56177097|NCT05274139|Hormones|hormones|mesh-ancestor
56177098|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56177099|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56177100|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177101|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177102|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56177103|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
56664610|NCT02732795|Narcotics|narcotics|mesh-ancestor
56664611|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56664612|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664613|NCT02732795|Analgesics|analgesics|mesh-ancestor
56177104|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
56177105|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177106|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177107|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
56177108|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56177109|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
56177111|NCT05274113|Ropivacaine|ropivacaine|mesh-list
56177112|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56177113|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
56177114|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
56177115|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177116|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177117|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56177119|NCT05274113|Hormones|hormones|mesh-ancestor
56177120|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56177121|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56177122|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177123|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
56177124|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
56177125|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177126|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
56177127|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56177128|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
56177129|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177130|NCT05273944|Doxorubicin|doxorubicin|mesh-list
56177131|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56177132|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56177133|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177134|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56177135|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56177136|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177137|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177138|NCT05273528|Vaccines|vaccines|mesh-list
56177139|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
56177140|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177141|NCT05273398|Diazepam|diazepam|mesh-list
56177142|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56177144|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
56177145|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
56177146|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177147|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177148|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56177149|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56177150|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177151|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56177152|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56177153|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56177154|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56177155|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56177156|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56177157|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
56177158|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
56177159|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
56177160|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
56177161|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177162|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177163|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56177164|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177165|NCT05272462|Minoxidil|minoxidil|mesh-list
56177166|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56177167|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
56177168|NCT05272371|Dinutuximab|dinutuximab|mesh-list
56177169|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177170|NCT05271539|Dexamethasone|dexamethasone|mesh-list
56177171|NCT05271539|Ranibizumab|ranibizumab|mesh-list
56177172|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56177173|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
56177174|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
56177175|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664614|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
56664615|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664616|NCT05373004|Empagliflozin|empagliflozin|mesh-list
56664617|NCT05373004|Enalapril|enalapril|mesh-list
56664618|NCT05373004|Enalaprilat|enalaprilat|mesh-list
56664619|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56664620|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664621|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55864621|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177176|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177177|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56177178|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
56177179|NCT05271539|Hormones|hormones|mesh-ancestor
56177180|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56177181|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56177182|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177183|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56177184|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56177185|NCT05271539|Growth Substances|growth substances|mesh-ancestor
56177186|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
56177187|NCT05271448|Losartan|losartan|mesh-list
56177188|NCT05271448|Valsartan|valsartan|mesh-list
56177189|NCT05271448|Candesartan|candesartan|mesh-list
56177190|NCT05271448|Ramipril|ramipril|mesh-list
56177191|NCT05271448|Enalapril|enalapril|mesh-list
56177192|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56177193|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56177194|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56177195|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56177196|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177197|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56177198|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
56177199|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177200|NCT05271370|Leronlimab|leronlimab|mesh-list
56177201|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
56177202|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56177203|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56177204|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177205|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56177206|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56177207|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
56177208|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177209|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
56177210|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177211|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
56177212|NCT05271253|Bupivacaine|bupivacaine|mesh-list
56177213|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
56177214|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
56177215|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177216|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177217|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
56177218|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177225|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
56177226|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177227|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177228|NCT05271188|Anesthetics|anesthetics|mesh-list
56177229|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
56177230|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177231|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177232|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
56177233|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177234|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
56177235|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56177236|NCT05271136|Protective Agents|protective agents|mesh-ancestor
56177237|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177238|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
56664622|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664623|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664624|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56664625|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
56664626|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56177239|NCT05271058|Dexamethasone|dexamethasone|mesh-list
56177240|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
56177241|NCT05271058|Triamcinolone|triamcinolone|mesh-list
56177242|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56177243|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56177244|NCT05271058|BB 1101|bb 1101|mesh-list
56177245|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56177246|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56177247|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
56177248|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
56177249|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177250|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177251|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56177252|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
56177253|NCT05271058|Hormones|hormones|mesh-ancestor
56177254|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56177255|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56177256|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177257|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
56177258|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177259|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177260|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177261|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
56177262|NCT05271045|Vitamin D|vitamin d|mesh-list
56177263|NCT05271045|Vitamin A|vitamin a|mesh-list
56177264|NCT05271045|Vitamins|vitamins|mesh-ancestor
56177265|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
56177266|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177267|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56177268|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56177269|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56177270|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177271|NCT05270434|Dipyrone|dipyrone|mesh-list
56177272|NCT05270434|Meperidine|meperidine|mesh-list
56177273|NCT05270434|Morphine|morphine|mesh-list
56177274|NCT05270434|Buprenorphine|buprenorphine|mesh-list
56177275|NCT05270434|Analgesics|analgesics|mesh-list
56177276|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56177277|NCT05270434|Narcotics|narcotics|mesh-ancestor
56177278|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177279|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177280|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
56177281|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177282|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56177283|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56177284|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56177285|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56177286|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56177287|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177288|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
56177289|NCT05270421|Furosemide|furosemide|mesh-list
56177291|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
56177292|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177293|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56177294|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56177295|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177296|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
56177297|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56177298|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177299|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
56177300|NCT05270343|Vitamin D|vitamin d|mesh-list
56177301|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56177302|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177303|NCT05270343|Vitamins|vitamins|mesh-ancestor
56177304|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
56177305|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56664627|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56664628|NCT00655616|Montelukast|montelukast|mesh-list
56177306|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
56177307|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56177308|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
56177309|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177310|NCT05269654|Mannitol|mannitol|mesh-list
56177311|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56177312|NCT05269654|Diuretics|diuretics|mesh-ancestor
56177313|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
56177314|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177315|NCT05253846|Fluorouracil|fluorouracil|mesh-list
56177316|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
56177317|NCT05253846|Irinotecan|irinotecan|mesh-list
56177318|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
56177319|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177320|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56177321|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177322|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177323|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
56177324|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177325|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56177326|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56177327|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177329|NCT05250141|Carbidopa|carbidopa|mesh-list
56177330|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56177331|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56177332|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
56177333|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177334|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177335|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177336|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56177337|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177338|NCT05248724|Ketorolac|ketorolac|mesh-list
56177339|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56177340|NCT05248724|Epinephrine|epinephrine|mesh-list
56177341|NCT05248724|Racepinephrine|racepinephrine|mesh-list
56177342|NCT05248724|Morphine|morphine|mesh-list
56177343|NCT05248724|Ropivacaine|ropivacaine|mesh-list
56177344|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
56177345|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56177346|NCT05248724|Narcotics|narcotics|mesh-ancestor
56177347|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177348|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177349|NCT05248724|Analgesics|analgesics|mesh-ancestor
56177350|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
56177351|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177352|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
56177353|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
56177354|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56177355|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56177356|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56177357|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177358|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56177359|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177360|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177361|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56177362|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56177363|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
56177364|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177365|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56177366|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56177375|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177376|NCT05232006|Niraparib|niraparib|mesh-list
56105110|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
56177377|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56177378|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177379|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177382|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
56177383|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56177384|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56177385|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177386|NCT05207280|Terlipressin|terlipressin|mesh-list
56177387|NCT05207280|Norepinephrine|norepinephrine|mesh-list
56177388|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56177389|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56664629|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56664630|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
56177390|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56177391|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56177392|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
56177393|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177394|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177395|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177396|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
56177397|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
56177398|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177399|NCT05173142|Gemcitabine|gemcitabine|mesh-list
56177400|NCT05173142|Docetaxel|docetaxel|mesh-list
56177401|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177402|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56177403|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
56177404|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177405|NCT05173142|Antiviral Agents|antiviral agents|mesh-ancestor
56177406|NCT05173142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177407|NCT05173142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177408|NCT05173142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177409|NCT05173142|Immunologic Factors|immunologic factors|mesh-ancestor
56177410|NCT05173142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177411|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
56177412|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
56177413|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
56177414|NCT05166746|Clindamycin|clindamycin|mesh-list
56177415|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
56177416|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
56177417|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56177418|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177419|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56177420|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213186|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177421|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177422|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
56177423|NCT05165875|Lidocaine|lidocaine|mesh-list
56177424|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
56177425|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
56177426|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177427|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177428|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
56177429|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177430|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56177431|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56177432|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56177433|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56177434|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177435|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56177437|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56177438|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177439|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56177440|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177441|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
56177442|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56177443|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177444|NCT05142267|Oxycodone|oxycodone|mesh-list
56177445|NCT05142267|Naloxone|naloxone|mesh-list
56177446|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56177447|NCT05142267|Narcotics|narcotics|mesh-ancestor
56177448|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177449|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177450|NCT05142267|Analgesics|analgesics|mesh-ancestor
56177451|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
56105182|NCT05477875|Hormones|hormones|mesh-ancestor
56177459|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
56177460|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
56177461|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177462|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177463|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56177464|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
56177465|NCT05138029|Hormones|hormones|mesh-ancestor
56177466|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664631|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664632|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664633|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56664634|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
56664635|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56664636|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56664637|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56664638|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
56664639|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664640|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664641|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56664642|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
56664643|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664644|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56664645|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56664646|NCT00713440|Acetaminophen|acetaminophen|mesh-list
56664647|NCT00713440|Prednisolone|prednisolone|mesh-list
56177467|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56177468|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177469|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
56177470|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177471|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177472|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56177473|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56177474|NCT05138029|Growth Substances|growth substances|mesh-ancestor
56177475|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
56177476|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56177477|NCT05137119|Vancomycin|vancomycin|mesh-list
56177478|NCT05137119|Clindamycin|clindamycin|mesh-list
56177479|NCT05137119|Cefazolin|cefazolin|mesh-list
56177480|NCT05137119|Daptomycin|daptomycin|mesh-list
56177481|NCT05137119|Penicillins|penicillins|mesh-list
56177482|NCT05137119|Penicillin G|penicillin g|mesh-list
56177483|NCT05137119|Lincomycin|lincomycin|mesh-list
56177484|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177485|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56177486|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177487|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177488|NCT05135039|Canagliflozin|canagliflozin|mesh-list
56177489|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56177490|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177491|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56177492|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177500|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
56177501|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56177502|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
56177503|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56177504|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
56177505|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177506|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177507|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
56177508|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
56177509|NCT05088928|Apixaban|apixaban|mesh-list
56177510|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56177511|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
56177512|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56664648|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56664649|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
56664650|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56664651|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
56664652|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56664653|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
56664654|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664655|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
56664656|NCT00713440|Hormones|hormones|mesh-ancestor
56664657|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664658|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664659|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664660|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664661|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
56177513|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
56177514|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177515|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177516|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
56177517|NCT05087771|Naltrexone|naltrexone|mesh-list
56177518|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56177519|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56177520|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177521|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
56177522|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177523|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
56177524|NCT05075122|Sargramostim|sargramostim|mesh-list
56177525|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56177528|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177529|NCT05067439|Efavirenz|efavirenz|mesh-list
56177530|NCT05067439|Caffeine|caffeine|mesh-list
56177531|NCT05067439|Omeprazole|omeprazole|mesh-list
56177532|NCT05067439|Abrocitinib|abrocitinib|mesh-list
56177533|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56177534|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177535|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56177536|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177537|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177538|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56177539|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56177540|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
56177541|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177542|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56177543|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56177544|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56177545|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56177546|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56177547|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
56177548|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177549|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56177550|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56177551|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56177552|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56177553|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56177554|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56177555|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56177556|NCT05064137|Listerine|listerine|mesh-list
56177557|NCT05064137|Fluorides|fluorides|mesh-list
56177558|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
56177559|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
56177560|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
56177561|NCT05064137|Protective Agents|protective agents|mesh-ancestor
56664662|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
56664663|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664664|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664665|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56664666|NCT00713440|Protective Agents|protective agents|mesh-ancestor
56177562|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177563|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56177564|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177565|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
56177566|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
56177567|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177568|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
56177569|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177570|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177571|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
56177572|NCT05052528|Rituximab|rituximab|mesh-list
56177573|NCT05052528|Fludarabine|fludarabine|mesh-list
56177574|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
56177575|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56177577|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
56177578|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56177579|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177580|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
56177581|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177582|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177583|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56177584|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
56177585|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177586|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177587|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56177588|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56177589|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
56177590|NCT05051150|Epinephrine|epinephrine|mesh-list
56177591|NCT05051150|Racepinephrine|racepinephrine|mesh-list
56177592|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
56177593|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56177594|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56177595|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
56177596|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177597|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177598|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177599|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56177601|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
56177602|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177603|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56105329|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
56177604|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
56177605|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
56177606|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
56177607|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56177610|NCT05045313|Warfarin|warfarin|mesh-list
56177611|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
56177612|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56177613|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56177614|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177615|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177616|NCT05045313|Protective Agents|protective agents|mesh-ancestor
56177617|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177618|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
56177619|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
56177620|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177621|NCT05045313|Renal Agents|renal agents|mesh-ancestor
56177622|NCT05007561|Naltrexone|naltrexone|mesh-list
56177624|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56177625|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177626|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
56177627|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177628|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56177629|NCT05002738|Desogestrel|desogestrel|mesh-list
56177630|NCT05002738|Estradiol|estradiol|mesh-list
56177631|NCT05002738|Estrogens|estrogens|mesh-ancestor
56177632|NCT05002738|Hormones|hormones|mesh-ancestor
56664667|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56664668|NCT00713440|Analgesics|analgesics|mesh-ancestor
56664669|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
56664670|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
56664671|NCT00993109|Valsartan|valsartan|mesh-list
56664672|NCT00993109|Nifedipine|nifedipine|mesh-list
56664673|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56664674|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56664675|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56664676|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664677|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56664678|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56664679|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56664680|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664681|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
56664682|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
56664683|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56664684|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
56664685|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
56664686|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
56664687|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56664688|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664689|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
56664690|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664691|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
56664692|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
56664693|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
56664694|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664695|NCT00675246|Betamethasone|betamethasone|mesh-list
56664696|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
56664697|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664698|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
56664699|NCT00675246|Hormones|hormones|mesh-ancestor
56664700|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664702|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56664706|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664707|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56664708|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664709|NCT02732405|Grazoprevir|grazoprevir|mesh-list
56664710|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
56177633|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56177634|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177635|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56177636|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
56177637|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56177638|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56177639|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56177640|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56177641|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56177642|NCT05002738|Progestins|progestins|mesh-ancestor
56177643|NCT05001724|Docetaxel|docetaxel|mesh-list
56177644|NCT05001724|Lenvatinib|lenvatinib|mesh-list
56177645|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177646|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
56177647|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
56177648|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
56177649|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177650|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56177651|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177652|NCT04961801|Methotrexate|methotrexate|mesh-list
56177653|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
56177654|NCT04961801|Tacrolimus|tacrolimus|mesh-list
56177655|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56177656|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
56177657|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56177658|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177659|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56177660|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
56177661|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177662|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177663|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
56177664|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177665|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56177666|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177667|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
56177668|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177669|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56177670|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56177671|NCT04919564|Furosemide|furosemide|mesh-list
56177672|NCT04919564|Diuretics|diuretics|mesh-ancestor
56177673|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
56177674|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177675|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55798183|NCT04921111|Antacids|antacids|mesh-ancestor
56177677|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177678|NCT04918823|Cyclosporine|cyclosporine|mesh-list
56177679|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56177680|NCT04918823|Cyclosporins|cyclosporins|mesh-list
56177682|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177683|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177684|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
56177685|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177686|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
56177687|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177688|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
56177689|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177695|NCT04886284|Ertapenem|ertapenem|mesh-list
56177696|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56177697|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177698|NCT04870333|Ciclesonide|ciclesonide|mesh-list
56177699|NCT04870333|Niclosamide|niclosamide|mesh-list
56177700|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
56177701|NCT04870333|Hormones|hormones|mesh-ancestor
56177702|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56177703|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664711|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664712|NCT04001725|Metformin|metformin|mesh-list
56664714|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664715|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
56664716|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
56664717|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664718|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664719|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664720|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
56664721|NCT04001725|Hormones|hormones|mesh-ancestor
56177704|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56177705|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
56177706|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56177707|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
56177708|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56177709|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177710|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
56177711|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
56177712|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56177713|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177714|NCT04801641|Nabilone|nabilone|mesh-list
56177715|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
56177716|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
56177717|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177718|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177719|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56177720|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56177721|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56177722|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177723|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56177724|NCT04783376|Insulin|insulin|mesh-list
56177725|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56177726|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56177727|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177728|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
56177729|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56177730|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177732|NCT04760912|Anesthetics|anesthetics|mesh-list
56177733|NCT04760912|Rocuronium|rocuronium|mesh-list
56177734|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177735|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177736|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
56177737|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56177738|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56177739|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56177740|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177741|NCT04710641|Sorafenib|sorafenib|mesh-list
56177742|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177743|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56177744|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177745|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177746|NCT04706767|Lidocaine|lidocaine|mesh-list
56177747|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
56177748|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
56177749|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
56177750|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177751|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177752|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
56177753|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177754|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56177774|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177775|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
55864416|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
56177778|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177779|NCT04682626|Vitamins|vitamins|mesh-ancestor
56177780|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
56177781|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56177804|NCT04604691|Blinatumomab|blinatumomab|mesh-list
56664722|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664723|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664724|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664725|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56664726|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56664727|NCT00713674|Mupirocin|mupirocin|mesh-list
56664728|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664729|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56664730|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664731|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664732|NCT00885482|Ritonavir|ritonavir|mesh-list
56664733|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56664734|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56664735|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56664736|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
56664737|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664738|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664739|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56664740|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56177805|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177806|NCT04580381|Natalizumab|natalizumab|mesh-list
56177807|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
56177808|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177809|NCT04579848|Folic Acid|folic acid|mesh-list
56177810|NCT04579848|Methotrexate|methotrexate|mesh-list
56177811|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56177812|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
56177813|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56177814|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177815|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56177816|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
56177817|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177818|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177819|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
56177820|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177821|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56177822|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177823|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
56177824|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177825|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56177826|NCT04579848|Hematinics|hematinics|mesh-ancestor
56177827|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
56177828|NCT04579848|Vitamins|vitamins|mesh-ancestor
56177829|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
56177830|NCT04530006|Amantadine|amantadine|mesh-list
56177831|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56177832|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56177833|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
56177834|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177835|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
56177836|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177837|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177838|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177839|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56177841|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
56177842|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664741|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
56664742|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664743|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56664744|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56664745|NCT04139226|CC-11050|cc-11050|mesh-list
56664746|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56664747|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56664748|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664749|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664750|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
56664751|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
56664752|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56664753|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
56664754|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177844|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56177845|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
56177846|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177847|NCT04476745|Vitamin D|vitamin d|mesh-list
56177848|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
56177849|NCT04476745|Vitamins|vitamins|mesh-ancestor
56177850|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
56177851|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177852|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56177853|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56177854|NCT04433390|Naloxegol|naloxegol|mesh-list
56177855|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56177856|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177857|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
56177858|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177859|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
56177860|NCT04399746|Vitamin D|vitamin d|mesh-list
56177861|NCT04399746|Azithromycin|azithromycin|mesh-list
56177862|NCT04399746|Ivermectin|ivermectin|mesh-list
56177863|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56177864|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177865|NCT04399746|Vitamins|vitamins|mesh-ancestor
56177866|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
56177867|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56177868|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56177869|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177870|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56177871|NCT04391608|Tenofovir|tenofovir|mesh-list
56177872|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
56177873|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177874|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56177875|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56177876|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177878|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56177879|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56177880|NCT04368091|Sirolimus|sirolimus|mesh-list
56177881|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56177882|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177883|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56177884|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177886|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56177887|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
56177888|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177889|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
56177890|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56177891|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56177892|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177893|NCT04302168|Choline|choline|mesh-list
56664755|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664756|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56664757|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
56664758|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664759|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664760|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56664761|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56664762|NCT02645240|Heparin|heparin|mesh-list
56664763|NCT02645240|Calcium heparin|calcium heparin|mesh-list
56177894|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
56177896|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
56177897|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177898|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56177899|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56177901|NCT04301271|Simvastatin|simvastatin|mesh-list
56177902|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56177903|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56177904|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
56177905|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177906|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56177907|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56177908|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177909|NCT04287049|Azithromycin|azithromycin|mesh-list
56177910|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56177911|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56177913|NCT04245644|Metformin|metformin|mesh-list
56177914|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56177915|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56177916|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177917|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56177918|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56177919|NCT04245644|Analgesics|analgesics|mesh-ancestor
56177920|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
56177921|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177922|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56177923|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177924|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56177925|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56177926|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177927|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56177928|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56177929|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177930|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
56177931|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
56177932|NCT04238845|Vitamin A|vitamin a|mesh-list
56177933|NCT04238845|Vitamins|vitamins|mesh-ancestor
56177934|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
56177935|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177936|NCT04223037|Vaccines|vaccines|mesh-list
56177937|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
56177938|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177939|NCT04186663|Fluorides|fluorides|mesh-list
56177940|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
56177942|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177943|NCT04108026|Durvalumab|durvalumab|mesh-list
56177944|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56177945|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177946|NCT04095104|Topiramate|topiramate|mesh-list
56177947|NCT04095104|Phentermine|phentermine|mesh-list
56177948|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
56177949|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56177950|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177951|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56177952|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
56177953|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56177954|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
56664764|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56664765|NCT02645240|Tinzaparin|tinzaparin|mesh-list
56664766|NCT02645240|Dalteparin|dalteparin|mesh-list
56664767|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
56664768|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56664769|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56664770|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664771|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56664772|NCT01306045|Sunitinib|sunitinib|mesh-list
56664773|NCT01306045|Lapatinib|lapatinib|mesh-list
56664774|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177955|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
56137523|NCT02128230|Cisplatin|cisplatin|mesh-list
56177957|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
56177958|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56177959|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177960|NCT04074512|Copper|copper|mesh-list
56177961|NCT04074512|Trace Elements|trace elements|mesh-ancestor
56177962|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
56177963|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177964|NCT04044729|Cannabidiol|cannabidiol|mesh-list
56177965|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
56177966|NCT04011150|Fentanyl|fentanyl|mesh-list
56177967|NCT04011150|Ropivacaine|ropivacaine|mesh-list
56177968|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
56177969|NCT04011150|Anesthetics|anesthetics|mesh-list
56177970|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56177971|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177972|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
56177973|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56177974|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56177975|NCT04011150|Narcotics|narcotics|mesh-ancestor
56177976|NCT04011150|Analgesics|analgesics|mesh-ancestor
56177977|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56177978|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56177979|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
56177980|NCT04008082|Lenvatinib|lenvatinib|mesh-list
56177981|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177982|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56177983|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177984|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177985|NCT03974243|Chiauranib|chiauranib|mesh-list
56177986|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177987|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56177988|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56177989|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177990|NCT03967925|Prednisone|prednisone|mesh-list
56177991|NCT03967925|Prednisolone|prednisolone|mesh-list
56177992|NCT03967925|Rituximab|rituximab|mesh-list
56177993|NCT03967925|Belimumab|belimumab|mesh-list
56177994|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56177995|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177996|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
56177997|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56177998|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177999|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178000|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
56178001|NCT03967925|Hormones|hormones|mesh-ancestor
56178002|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178003|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56178004|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178006|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
56178007|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178008|NCT03932318|Azacitidine|azacitidine|mesh-list
56178009|NCT03932318|Venetoclax|venetoclax|mesh-list
56178010|NCT03932318|Lintuzumab|lintuzumab|mesh-list
56178011|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56178012|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
55798195|NCT05421065|Psilocybin|psilocybin|mesh-list
56664775|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56664776|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664777|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664778|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56664779|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56664780|NCT01306045|Growth Substances|growth substances|mesh-ancestor
56178013|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178014|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178015|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178016|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178017|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56178018|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
56178019|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56178020|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178021|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178022|NCT03897439|Bupropion|bupropion|mesh-list
56178023|NCT03897439|Nicotine|nicotine|mesh-list
56178024|NCT03897439|Varenicline|varenicline|mesh-list
56178025|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56178026|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
56178027|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178028|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178029|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56178030|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56178031|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
56178032|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56178033|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178034|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56178035|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
56178036|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56178037|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56178038|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56178039|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56178040|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
56178041|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56178042|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56178043|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178044|NCT03883412|Liraglutide|liraglutide|mesh-list
56178045|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56178046|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178047|NCT03883412|Incretins|incretins|mesh-ancestor
56178048|NCT03883412|Hormones|hormones|mesh-ancestor
56178049|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178050|NCT03867682|Venetoclax|venetoclax|mesh-list
56178051|NCT03867682|Lintuzumab|lintuzumab|mesh-list
56178052|NCT03867682|Spironolactone|spironolactone|mesh-list
56178053|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178054|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56178055|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
56178056|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178057|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178058|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56178059|NCT03867682|Diuretics|diuretics|mesh-ancestor
56178060|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
56178061|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56105781|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
56178062|NCT03858621|Fentanyl|fentanyl|mesh-list
56178063|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56178064|NCT03858621|Narcotics|narcotics|mesh-ancestor
56178065|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178066|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178067|NCT03858621|Analgesics|analgesics|mesh-ancestor
56178068|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
56178069|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178070|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56178071|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56178072|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
56664781|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664782|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
56664783|NCT00688194|Letrozole|letrozole|mesh-list
56664784|NCT00688194|Fulvestrant|fulvestrant|mesh-list
56664785|NCT00688194|Lapatinib|lapatinib|mesh-list
56664786|NCT00688194|Anastrozole|anastrozole|mesh-list
56664787|NCT00688194|Exemestane|exemestane|mesh-list
56664788|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664789|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56178073|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
56178074|NCT03845270|Docetaxel|docetaxel|mesh-list
56178075|NCT03845270|Trastuzumab|trastuzumab|mesh-list
56178076|NCT03845270|Pertuzumab|pertuzumab|mesh-list
56178077|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178078|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
56178079|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
56178080|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
56178081|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178082|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178083|NCT03777462|Gemcitabine|gemcitabine|mesh-list
56178084|NCT03777462|Paclitaxel|paclitaxel|mesh-list
56178085|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56178086|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56178087|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178088|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
56178089|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
56178090|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
56178091|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178092|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56178093|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
56178094|NCT03777462|Antiviral Agents|antiviral agents|mesh-ancestor
56178095|NCT03777462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178096|NCT03777462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178097|NCT03777462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178098|NCT03777462|Immunologic Factors|immunologic factors|mesh-ancestor
56178099|NCT03777462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178100|NCT03758170|Dexamethasone|dexamethasone|mesh-list
56178101|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178102|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
56178103|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
56178104|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178105|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178106|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56178107|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
56178109|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178111|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178112|NCT03733119|TIC10 compound|tic10 compound|mesh-list
56178113|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178114|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56178115|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56178116|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178117|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
56178118|NCT03705962|Tobramycin|tobramycin|mesh-list
56178119|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56178120|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178121|NCT03705338|Propofol|propofol|mesh-list
56178122|NCT03705338|Anesthetics|anesthetics|mesh-list
56178123|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
56178124|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56178125|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178126|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178127|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56178129|NCT03704285|Anesthetics|anesthetics|mesh-list
56178130|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
56178131|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56178132|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178133|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178134|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56178135|NCT03696537|Fludarabine|fludarabine|mesh-list
56178136|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664790|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56664791|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664792|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664793|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56664794|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
56664795|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56664796|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664797|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56664798|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56664799|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56664800|NCT00653744|Atorvastatin|atorvastatin|mesh-list
56664801|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56664802|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56664803|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56664804|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
56664805|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664806|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56226039|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178137|NCT03665207|Insulin|insulin|mesh-list
56178138|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56178139|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178140|NCT03661996|Lidocaine|lidocaine|mesh-list
56178141|NCT03661996|Epinephrine|epinephrine|mesh-list
56178142|NCT03661996|Capsaicin|capsaicin|mesh-list
56178143|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
56178145|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178146|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178147|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
56178148|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178149|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56178150|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56178151|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56178152|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56179165|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56178153|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178154|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56178155|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56178156|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56178157|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56178158|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56178159|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56178160|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
56178161|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56178162|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
56178164|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
56178165|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56178166|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
56178167|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
56178168|NCT03659799|Insulin|insulin|mesh-list
56178169|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56178170|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
56178171|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56178172|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178173|NCT03620903|Rituximab|rituximab|mesh-list
56178174|NCT03620903|Bortezomib|bortezomib|mesh-list
56664807|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56664808|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664809|NCT03322267|Cisplatin|cisplatin|mesh-list
56664810|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
56664811|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664812|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56664813|NCT00652496|Bimatoprost|bimatoprost|mesh-list
56664814|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56178175|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178176|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178178|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178179|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56178180|NCT03563690|Celecoxib|celecoxib|mesh-list
56178181|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56178182|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56178183|NCT03563690|Analgesics|analgesics|mesh-ancestor
56178184|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
56178185|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178187|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178188|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56178189|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56178190|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56178191|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178192|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178193|NCT03555877|Letrozole|letrozole|mesh-list
56178194|NCT03555877|Fulvestrant|fulvestrant|mesh-list
56178195|NCT03555877|Anastrozole|anastrozole|mesh-list
56178196|NCT03555877|Exemestane|exemestane|mesh-list
56178197|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178198|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56178199|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56178200|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178201|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178202|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56178203|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
56178204|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178205|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178206|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56178207|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56178208|NCT03522584|Durvalumab|durvalumab|mesh-list
56178209|NCT03522584|Ipilimumab|ipilimumab|mesh-list
56178211|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
56178212|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56178213|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
56178214|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178215|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178216|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
56178217|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178218|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56178219|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178220|NCT03439124|Cephalosporins|cephalosporins|mesh-list
56178221|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
56178222|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56178223|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56178224|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178226|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178227|NCT03399617|Micronutrients|micronutrients|mesh-list
56178229|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178230|NCT03386162|Fulvestrant|fulvestrant|mesh-list
56178231|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56178232|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178233|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56178234|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56178235|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
56178236|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178237|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664815|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56664816|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56664817|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
55866321|NCT00883168|Xhance|xhance|mesh-list
56178238|NCT03360214|Bupivacaine|bupivacaine|mesh-list
56178239|NCT03360214|Ropivacaine|ropivacaine|mesh-list
56178240|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
56178241|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
56178242|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178243|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178244|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
56178245|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178246|NCT03359239|Atezolizumab|atezolizumab|mesh-list
56178248|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178249|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
56178250|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
56178251|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178252|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
56178254|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56178255|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178256|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178257|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
56178258|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56178259|NCT03328676|Protective Agents|protective agents|mesh-ancestor
56178260|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178261|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56178262|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56178263|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
56178264|NCT03317405|Tamoxifen|tamoxifen|mesh-list
56178276|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178278|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56178279|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178280|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178282|NCT03289325|Analgesics|analgesics|mesh-ancestor
56178283|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
56178284|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178285|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56178286|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56178287|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56178288|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
56178289|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56178290|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178291|NCT03276533|Lidocaine|lidocaine|mesh-list
56178292|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
56178293|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
56178294|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
56178295|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178296|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178297|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
56178298|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178299|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56178300|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56178301|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56178302|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56178303|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178304|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56178305|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56178307|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56178308|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56178309|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56178310|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
56178311|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56178312|NCT03254394|Lidocaine|lidocaine|mesh-list
56178313|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
56178314|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
56178315|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178316|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178317|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
56178318|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178319|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56178321|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56178322|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56664818|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56664819|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664820|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56664821|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56664822|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664823|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664824|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664825|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56178323|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178324|NCT03203876|Nivolumab|nivolumab|mesh-list
56178325|NCT03203876|Ipilimumab|ipilimumab|mesh-list
56178326|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178327|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178328|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56178329|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178331|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
56178332|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
56178333|NCT03191240|Coagulants|coagulants|mesh-ancestor
56178334|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56178335|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56178336|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
56178337|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178338|NCT03180294|Bupropion|bupropion|mesh-list
56178339|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56178340|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
56178341|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56178342|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56178343|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56178344|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56178345|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178346|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
56178347|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56178348|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178349|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56178350|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56178351|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178352|NCT03141671|Prednisone|prednisone|mesh-list
56178353|NCT03141671|Bicalutamide|bicalutamide|mesh-list
56178354|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178355|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
56178357|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178358|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178359|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56178360|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178361|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
56178362|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
56178363|NCT03137173|Vancomycin|vancomycin|mesh-list
56178364|NCT03137173|Aztreonam|aztreonam|mesh-list
56106084|NCT00004700|Mitogens|mitogens|mesh-list
56178366|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56178367|NCT03137173|Cephalosporins|cephalosporins|mesh-list
56178368|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56178369|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178370|NCT03078855|Vitamin D|vitamin d|mesh-list
56178371|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
56178372|NCT03078855|Rituximab|rituximab|mesh-list
56178373|NCT03078855|Vitamins|vitamins|mesh-ancestor
56178374|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
56178375|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178376|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178377|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178378|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
56178379|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56178380|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56178381|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56178382|NCT03071601|Lidocaine|lidocaine|mesh-list
56178383|NCT03071601|Epinephrine|epinephrine|mesh-list
56664826|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56664827|NCT00993343|Cyclosporine|cyclosporine|mesh-list
56664828|NCT00993343|Sirolimus|sirolimus|mesh-list
56664829|NCT00993343|Methotrexate|methotrexate|mesh-list
56664830|NCT00993343|Tacrolimus|tacrolimus|mesh-list
56664831|NCT00993343|Cyclosporins|cyclosporins|mesh-list
56664832|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56664833|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
56664834|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56664835|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664836|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56664837|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
56226076|NCT04696380|Nicotine|nicotine|mesh-list
56178384|NCT03071601|Prilocaine|prilocaine|mesh-list
56178385|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56178386|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
56178387|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
56178388|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178389|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178390|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
56178391|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178392|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56178393|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56178394|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56178395|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56178396|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178397|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56178399|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
56178400|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56178401|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56178402|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56178403|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
56178404|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56178405|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
56178406|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
56178407|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
56178408|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56178409|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56178410|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56178411|NCT03061903|Laxatives|laxatives|mesh-ancestor
56178412|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56178413|NCT03061643|Docetaxel|docetaxel|mesh-list
56178414|NCT03061643|Androgens|androgens|mesh-list
56178415|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178416|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
56178417|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
56178418|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
56178419|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178420|NCT03061643|Hormones|hormones|mesh-ancestor
56178421|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178422|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178423|NCT03061630|Gemcitabine|gemcitabine|mesh-list
56178424|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178425|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56178426|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
56178427|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178428|NCT03061630|Antiviral Agents|antiviral agents|mesh-ancestor
56178429|NCT03061630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178430|NCT03061630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178431|NCT03061630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178432|NCT03061630|Immunologic Factors|immunologic factors|mesh-ancestor
56178433|NCT03061630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178434|NCT03055390|Scopolamine|scopolamine|mesh-list
56664838|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664839|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664840|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
56664841|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664842|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56664843|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56664844|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
56664845|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664846|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56664847|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56664848|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
56664849|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664850|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56664851|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56664852|NCT02974049|Ivermectin|ivermectin|mesh-list
56664853|NCT02974049|Albendazole|albendazole|mesh-list
56664854|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
56664855|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56664856|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178435|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56178436|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56178437|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
56178438|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
56178439|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106158|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178440|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178441|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56178442|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
56178443|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56178444|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
56178445|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56178446|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178447|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56178448|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
56178449|NCT03038802|Vaccines|vaccines|mesh-list
56178450|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
56178451|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178452|NCT03012672|Cytarabine|cytarabine|mesh-list
56178453|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56178454|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
56178455|NCT03012672|Cladribine|cladribine|mesh-list
56178456|NCT03012672|Lenograstim|lenograstim|mesh-list
56178457|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56178458|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
56178459|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178460|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178461|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
56178462|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178463|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178464|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
56178465|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178466|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56178467|NCT03012672|Analgesics|analgesics|mesh-ancestor
56178468|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
56178469|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137524|NCT02128230|Doxorubicin|doxorubicin|mesh-list
56178470|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56664857|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
56664858|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
56664859|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56664860|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56664861|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
56664862|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547647|NCT01175135|Risperidone|risperidone|mesh-list
56178471|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56178472|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178473|NCT03011775|Aspirin|aspirin|mesh-list
56178474|NCT03011775|Pioglitazone|pioglitazone|mesh-list
56178475|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56178476|NCT03011775|Ramipril|ramipril|mesh-list
56178477|NCT03011775|Bisoprolol|bisoprolol|mesh-list
56178478|NCT03011775|Isosorbide|isosorbide|mesh-list
56178479|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56178480|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56178481|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
56178482|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56178483|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56178484|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178485|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56178486|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56178487|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
56178488|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178489|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56178490|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56178491|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178492|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56178493|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56178494|NCT03011775|Analgesics|analgesics|mesh-ancestor
56178495|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
56178496|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178497|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178498|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56178499|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56178500|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56178501|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56178502|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
56178503|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56178504|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
56178505|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56178506|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
56178507|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
56178508|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56178509|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56178510|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56178511|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
56178512|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106239|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
56178513|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56178514|NCT03011775|Diuretics|diuretics|mesh-ancestor
56178515|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
56178516|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56178517|NCT02960997|Sirolimus|sirolimus|mesh-list
56178518|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56178519|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178520|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56178521|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178522|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
56178523|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178524|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
56178525|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178526|NCT02924480|Lidocaine|lidocaine|mesh-list
56178527|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
56178528|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
56178529|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178530|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178531|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
56178532|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178533|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56664863|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
56664864|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178534|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56178535|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56178536|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56178537|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178538|NCT02924064|Metformin|metformin|mesh-list
56178539|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56178540|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178541|NCT02889900|Olaparib|olaparib|mesh-list
56178542|NCT02889900|Cediranib|cediranib|mesh-list
56178543|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56178544|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137525|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56178546|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178547|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56178548|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56178549|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
56178550|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56178552|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178553|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
56178554|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178555|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
56178556|NCT02873819|Sargramostim|sargramostim|mesh-list
56178557|NCT02873819|Poly ICLC|poly iclc|mesh-list
56178558|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178559|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
56178560|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178561|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56178562|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56178563|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
56178564|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178565|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178566|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56178567|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
56178568|NCT02872467|Oxytocin|oxytocin|mesh-list
56178569|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
56178570|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56178571|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178572|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
56178573|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56178574|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
56178575|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56178576|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178577|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56178578|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56178579|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56178580|NCT02810457|Paclitaxel|paclitaxel|mesh-list
56178581|NCT02810457|Bevacizumab|bevacizumab|mesh-list
56178582|NCT02810457|Carboplatin|carboplatin|mesh-list
56178583|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56178584|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178585|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
56178586|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
56178587|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
56178588|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178589|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178590|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56178591|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56178592|NCT02810457|Growth Substances|growth substances|mesh-ancestor
56178593|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178594|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
56178595|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
56178596|NCT02745535|Velpatasvir|velpatasvir|mesh-list
56178597|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56178598|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
56178603|NCT02729701|Hormones|hormones|mesh-ancestor
56178604|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178605|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178606|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56178607|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56664865|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664866|NCT02974049|Filaricides|filaricides|mesh-ancestor
56664867|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
56664868|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56226109|NCT04659382|Bevacizumab|bevacizumab|mesh-list
56178608|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
56178609|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56178628|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
56178629|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178630|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
56178631|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
56178632|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178633|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178634|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56178635|NCT02719314|Hormones|hormones|mesh-ancestor
56178636|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178637|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56178638|NCT02719314|Protective Agents|protective agents|mesh-ancestor
56178648|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56178649|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178650|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178651|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56178652|NCT02711826|Analgesics|analgesics|mesh-ancestor
56178653|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
56178654|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178655|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
56178656|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178657|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56178658|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56178659|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
56178660|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56178661|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178662|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56178663|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56178664|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178665|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
56178666|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
56178667|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
56178668|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
56178669|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56178670|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56178671|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
56178672|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
56178673|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56178674|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56178675|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
56178676|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
56178677|NCT02684253|Nivolumab|nivolumab|mesh-list
56178678|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178679|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178680|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56178681|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178682|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56178683|NCT02666794|Sufentanil|sufentanil|mesh-list
56178684|NCT02666794|Morphine|morphine|mesh-list
56178686|NCT02666794|Bupivacaine|bupivacaine|mesh-list
56178687|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
56178688|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
56178689|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56178690|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178691|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
56178692|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178693|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56178694|NCT02666794|Narcotics|narcotics|mesh-ancestor
56178695|NCT02666794|Analgesics|analgesics|mesh-ancestor
56178696|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56178697|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56178698|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
56178699|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
56178700|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
56178701|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178702|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178704|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56664869|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664870|NCT02637284|BPC 157|bpc 157|mesh-list
56664871|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56664872|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664873|NCT04138992|Bevacizumab|bevacizumab|mesh-list
56178705|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178706|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56178707|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178709|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178710|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
56178711|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178717|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56178719|NCT02636322|Vincristine|vincristine|mesh-list
56178720|NCT02636322|Lenalidomide|lenalidomide|mesh-list
56178721|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
56178722|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
56178723|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56178724|NCT02636322|Antibodies|antibodies|mesh-list
56178725|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
56178726|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56178727|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178728|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
56178729|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178730|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56178731|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56178732|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
56178733|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178734|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178735|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56178736|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56178737|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56178738|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56178739|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178740|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178741|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
56178742|NCT02636322|Hormones|hormones|mesh-ancestor
56178743|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178744|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56106457|NCT04456699|Leucovorin|leucovorin|mesh-list
56178745|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56178746|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
56178747|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
56178748|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
56178749|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56178750|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56178752|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
56178753|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
56178754|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
56178755|NCT02619552|Prednisone|prednisone|mesh-list
56178756|NCT02619552|Budesonide|budesonide|mesh-list
56178757|NCT02619552|Adalimumab|adalimumab|mesh-list
56178758|NCT02619552|Infliximab|infliximab|mesh-list
56178759|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
56178760|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178761|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
56178762|NCT02619552|Hormones|hormones|mesh-ancestor
56178763|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178764|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178765|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56178766|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178767|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56178768|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
56178769|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178770|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56178771|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
56178772|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56178773|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
56178774|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56178775|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178776|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
56178777|NCT02578368|Leucovorin|leucovorin|mesh-list
56178778|NCT02578368|Docetaxel|docetaxel|mesh-list
56178779|NCT02578368|Fluorouracil|fluorouracil|mesh-list
56178780|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
56664874|NCT04138992|Cisplatin|cisplatin|mesh-list
56664875|NCT04138992|Docetaxel|docetaxel|mesh-list
56664876|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56664877|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664878|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56664879|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56664880|NCT04138992|Growth Substances|growth substances|mesh-ancestor
56664881|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664882|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
56178781|NCT02578368|Trastuzumab|trastuzumab|mesh-list
56178782|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
56178783|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178784|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56178785|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56178786|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56137526|NCT02128230|Etoposide|etoposide|mesh-list
56178789|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
56178790|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56178791|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178792|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
56178793|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178794|NCT02578368|Antidotes|antidotes|mesh-ancestor
56178795|NCT02578368|Protective Agents|protective agents|mesh-ancestor
56178796|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
56178797|NCT02578368|Vitamins|vitamins|mesh-ancestor
56178798|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
56178799|NCT02575963|Cytarabine|cytarabine|mesh-list
56178800|NCT02575963|Lintuzumab|lintuzumab|mesh-list
56178801|NCT02575963|Furosemide|furosemide|mesh-list
56178802|NCT02575963|Spironolactone|spironolactone|mesh-list
56178803|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56178805|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178806|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178807|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
56178808|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178809|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178810|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
56178811|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178812|NCT02575963|Diuretics|diuretics|mesh-ancestor
56178814|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56178815|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56178816|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56178817|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
56178818|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178819|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56178820|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56106534|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56178821|NCT02539225|Paclitaxel|paclitaxel|mesh-list
56178822|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
56178823|NCT02539225|Ramucirumab|ramucirumab|mesh-list
56178824|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56178825|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178826|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
56178827|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
56178829|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178830|NCT02535650|Tipifarnib|tipifarnib|mesh-list
56178831|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178832|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
56178833|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56178834|NCT02527681|Cephalosporins|cephalosporins|mesh-list
56178835|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56178836|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178837|NCT02526017|Nivolumab|nivolumab|mesh-list
56178838|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178839|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178840|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56178841|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178842|NCT02516657|Liraglutide|liraglutide|mesh-list
56664883|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56664884|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56664885|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56226123|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
56178843|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56178844|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178845|NCT02516657|Incretins|incretins|mesh-ancestor
56178846|NCT02516657|Hormones|hormones|mesh-ancestor
56178847|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178849|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56178851|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
56178852|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
56178853|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178854|NCT02427581|Laxatives|laxatives|mesh-ancestor
56178855|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56178856|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
56178857|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178858|NCT02423525|Afatinib|afatinib|mesh-list
56178859|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178860|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56178861|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178862|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178863|NCT02369653|Apixaban|apixaban|mesh-list
56178865|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56178866|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
56178867|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56178868|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
56178869|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178870|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178871|NCT02326974|Pertuzumab|pertuzumab|mesh-list
56178872|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178873|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178874|NCT02293109|Leucovorin|leucovorin|mesh-list
56178875|NCT02293109|Cytarabine|cytarabine|mesh-list
56178876|NCT02293109|Dexamethasone|dexamethasone|mesh-list
56178877|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
56178878|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56178879|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56178880|NCT02293109|Prednisolone|prednisolone|mesh-list
56178881|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
56178882|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
56178883|NCT02293109|Rituximab|rituximab|mesh-list
56178884|NCT02293109|Doxorubicin|doxorubicin|mesh-list
56178885|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56178886|NCT02293109|Methotrexate|methotrexate|mesh-list
56178887|NCT02293109|Vincristine|vincristine|mesh-list
56178888|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56178889|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
56178890|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
56178891|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178892|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
56178893|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178894|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56178895|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56178896|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
56178897|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178898|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178899|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56178900|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178901|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56178903|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
56178904|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178905|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56178906|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
56178907|NCT02293109|Hormones|hormones|mesh-ancestor
56178908|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178909|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56178910|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56178911|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56178912|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56178913|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178914|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56178915|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
56664886|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664887|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56664888|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56664889|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664890|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664891|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56664892|NCT04137588|Growth Substances|growth substances|mesh-ancestor
56664893|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664894|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
56664895|NCT02721329|Acetaminophen|acetaminophen|mesh-list
56664896|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56664897|NCT02721329|Analgesics|analgesics|mesh-ancestor
56664898|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
56664899|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664900|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664901|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
56664902|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56664903|NCT03179449|Hematinics|hematinics|mesh-ancestor
56664904|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56664905|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56178916|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56178917|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56178918|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
56178919|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
56178920|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56178921|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56178922|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
56178923|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56178924|NCT02293109|Antidotes|antidotes|mesh-ancestor
56178925|NCT02293109|Protective Agents|protective agents|mesh-ancestor
56178927|NCT02293109|Vitamins|vitamins|mesh-ancestor
56178928|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
56178929|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56178930|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
56178931|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
56178932|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
56178933|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56178935|NCT02195986|Estrogens|estrogens|mesh-ancestor
56178936|NCT02195986|Hormones|hormones|mesh-ancestor
56178937|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178938|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178939|NCT02183883|Afatinib|afatinib|mesh-list
56178940|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178941|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56178943|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178946|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178948|NCT01982630|Hormones|hormones|mesh-ancestor
56178949|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178950|NCT01982448|Paclitaxel|paclitaxel|mesh-list
56178951|NCT01982448|Cisplatin|cisplatin|mesh-list
56178952|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56178953|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178954|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
56664906|NCT02637128|Artesunate|artesunate|mesh-list
56664907|NCT02637128|Lumefantrine|lumefantrine|mesh-list
56664908|NCT02637128|Artemether|artemether|mesh-list
56664909|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56664910|NCT02637128|Amodiaquine|amodiaquine|mesh-list
56664911|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
56664912|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56664913|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56664914|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664915|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664916|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
56664917|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
56664918|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56664919|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
56664920|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
56178955|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
56178956|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
56178957|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178958|NCT01951469|Pemetrexed|pemetrexed|mesh-list
56178959|NCT01951469|Gefitinib|gefitinib|mesh-list
56178960|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178961|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178962|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178963|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56178964|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56178965|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56178966|NCT01940809|Nivolumab|nivolumab|mesh-list
56178967|NCT01940809|Ipilimumab|ipilimumab|mesh-list
56178968|NCT01940809|Trametinib|trametinib|mesh-list
56178969|NCT01940809|Dabrafenib|dabrafenib|mesh-list
56178970|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178971|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178972|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56178973|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178974|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56178975|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106683|NCT04353661|Azithromycin|azithromycin|mesh-list
56178976|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56178977|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56178978|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178979|NCT01879228|Incretins|incretins|mesh-ancestor
56178980|NCT01879228|Hormones|hormones|mesh-ancestor
56178981|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178982|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56178983|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
56178984|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56178985|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178986|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
56178987|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56178988|NCT01740297|Ipilimumab|ipilimumab|mesh-list
56178989|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56178990|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56178991|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178992|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56178993|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178995|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56178996|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56178997|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56178998|NCT01729754|Analgesics|analgesics|mesh-ancestor
56178999|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
56179000|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179001|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664921|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56664922|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56664923|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56664924|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
56179002|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56179003|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56179004|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56179005|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56179006|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
56179007|NCT01622998|Nicotine|nicotine|mesh-list
56179008|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56179009|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
56179010|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179011|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179012|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56179013|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56179014|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
56179015|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137527|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
56179017|NCT01595620|Dronabinol|dronabinol|mesh-list
56179018|NCT01595620|Capsaicin|capsaicin|mesh-list
56179019|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
56179020|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179021|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179022|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56179023|NCT01595620|Analgesics|analgesics|mesh-ancestor
56179024|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
56179025|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179026|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56179027|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56179028|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179029|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179030|NCT01595620|Hormones|hormones|mesh-ancestor
56179031|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179032|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
56179033|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
56179034|NCT01591629|Dronabinol|dronabinol|mesh-list
56179035|NCT01591629|Naloxone|naloxone|mesh-list
56179036|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56179037|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179038|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
56179039|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179040|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
56179041|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179042|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56179043|NCT01591629|Analgesics|analgesics|mesh-ancestor
56179044|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56179045|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56179046|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179047|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179048|NCT01591629|Hormones|hormones|mesh-ancestor
56179049|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179050|NCT01515306|Paclitaxel|paclitaxel|mesh-list
56179051|NCT01515306|Ramucirumab|ramucirumab|mesh-list
56179052|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56179053|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179054|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
56179055|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
56179056|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
56179057|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179058|NCT01513187|Interferons|interferons|mesh-list
56179059|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
56179060|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
56179061|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179062|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
56179063|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179064|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
56179065|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179066|NCT01433965|Lenalidomide|lenalidomide|mesh-list
56179067|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
56179068|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179069|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56664925|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56664926|NCT00585247|Imiquimod|imiquimod|mesh-list
56664927|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56664928|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
56664929|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179070|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56179071|NCT01433965|Growth Substances|growth substances|mesh-ancestor
56179072|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
56179073|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179074|NCT01360593|Gemcitabine|gemcitabine|mesh-list
56179075|NCT01360593|Capecitabine|capecitabine|mesh-list
56179076|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56179077|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
56179078|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179079|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179080|NCT01360593|Antiviral Agents|antiviral agents|mesh-ancestor
56179081|NCT01360593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179082|NCT01360593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179083|NCT01360593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56179084|NCT01360593|Immunologic Factors|immunologic factors|mesh-ancestor
56179085|NCT01360593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179086|NCT01354977|Resveratrol|resveratrol|mesh-list
56179087|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
56179088|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179089|NCT01354977|Protective Agents|protective agents|mesh-ancestor
56179091|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179092|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56179093|NCT01334606|Insulin|insulin|mesh-list
56179094|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179095|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179096|NCT01226732|Capecitabine|capecitabine|mesh-list
56179097|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56179098|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
56179099|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179100|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179101|NCT00962988|Bupropion|bupropion|mesh-list
56179102|NCT00962988|Nicotine|nicotine|mesh-list
56179103|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56179104|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
56179105|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179106|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179107|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56179108|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56179109|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
56179110|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179111|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179112|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56179113|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
56179114|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179115|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56179116|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56179117|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56179118|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
56179119|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56179120|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56179121|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179122|NCT00920621|Vitamin D|vitamin d|mesh-list
56179123|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
56179124|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
56179125|NCT00920621|Vitamins|vitamins|mesh-list
56179127|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179128|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56179129|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56179130|NCT00785525|Lenograstim|lenograstim|mesh-list
56179131|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56179132|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
56179133|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179134|NCT00768820|Risperidone|risperidone|mesh-list
56179135|NCT00768820|Methylphenidate|methylphenidate|mesh-list
56179136|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56179137|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
56664930|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664931|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
56664932|NCT04002349|Budesonide|budesonide|mesh-list
56664933|NCT04002349|Levocabastine|levocabastine|mesh-list
56664934|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664935|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56664936|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
56664937|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664938|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664939|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56664940|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
56664941|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
56664943|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226169|NCT04577001|Letrozole|letrozole|mesh-list
56179138|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179139|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179140|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179142|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56179143|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179144|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179145|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56179146|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
56179147|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56179148|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56179149|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56179150|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56179151|NCT00678730|Dronabinol|dronabinol|mesh-list
56179152|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
56179153|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179154|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179155|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56179156|NCT00678730|Analgesics|analgesics|mesh-ancestor
56179157|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
56179158|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179159|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56179160|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56179161|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179162|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179163|NCT00678730|Hormones|hormones|mesh-ancestor
56137528|NCT02128230|Lenalidomide|lenalidomide|mesh-list
56179168|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56179169|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179170|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179171|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56179172|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56179173|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179174|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56179175|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56179176|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56179177|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179178|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
56179179|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179180|NCT00447122|Gemcitabine|gemcitabine|mesh-list
56179181|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
56179182|NCT00447122|Lapatinib|lapatinib|mesh-list
56179183|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56179184|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
56179185|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179186|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664944|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56664945|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56664946|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
56664947|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
56664948|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664949|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664950|NCT00688428|Aspirin|aspirin|mesh-list
56664951|NCT00688428|Esomeprazole|esomeprazole|mesh-list
56664952|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56664953|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56179187|NCT00447122|Antiviral Agents|antiviral agents|mesh-ancestor
56179188|NCT00447122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179189|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179190|NCT00447122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56179191|NCT00447122|Immunologic Factors|immunologic factors|mesh-ancestor
56179192|NCT00447122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179193|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56179194|NCT00430040|Carvedilol|carvedilol|mesh-list
56179195|NCT00430040|Lisinopril|lisinopril|mesh-list
56179196|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56179197|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56179198|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
56179199|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179200|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179201|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179202|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56179203|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
56179204|NCT00430040|Protective Agents|protective agents|mesh-ancestor
56179205|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56179206|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56179207|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56179208|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
56179209|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56179210|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56179211|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56179212|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
56179213|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179214|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56179215|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
56179216|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56179217|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
56179218|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56179219|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179220|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56179221|NCT00066963|Fluorides|fluorides|mesh-list
56179222|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
56179223|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
56179224|NCT00066963|Protective Agents|protective agents|mesh-ancestor
56179225|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179226|NCT01397500|Testosterone|testosterone|mesh-list
56179227|NCT01397500|Androgens|androgens|mesh-ancestor
56179228|NCT01397500|Hormones|hormones|mesh-ancestor
56179229|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179230|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179231|NCT01397513|Aspirin|aspirin|mesh-list
56179232|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56179233|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56179234|NCT01397513|Analgesics|analgesics|mesh-ancestor
56179236|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179237|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179238|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56179239|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56179240|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56179241|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56664954|NCT00688428|Analgesics|analgesics|mesh-ancestor
56664955|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
56664956|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56664957|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664958|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56664959|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56664960|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56664961|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56664962|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664963|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56179242|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179243|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56179244|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56179245|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179246|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
56179247|NCT01397630|Oxytocin|oxytocin|mesh-list
56179248|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
56179249|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56179250|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179251|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
56179252|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179253|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
56179254|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179255|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179256|NCT01397994|Nicorandil|nicorandil|mesh-list
56179257|NCT01397994|Atenolol|atenolol|mesh-list
56179258|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56179259|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56179260|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
56179261|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
56179262|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179263|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179264|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56179265|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56179266|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56179267|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
56179268|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179269|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179270|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
56179271|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
56179273|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
56179274|NCT01398033|Paclitaxel|paclitaxel|mesh-list
56179275|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56179276|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179277|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
56179278|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
56179279|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
56179280|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179281|NCT01398046|Dasatinib|dasatinib|mesh-list
56179282|NCT01398046|Rabeprazole|rabeprazole|mesh-list
56179283|NCT01398046|Betaine|betaine|mesh-list
56179284|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179285|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56179286|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179287|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179288|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56179289|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56179290|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56179291|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
56179292|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56179293|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
56179294|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56179295|NCT01398072|Azithromycin|azithromycin|mesh-list
56179296|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
56179297|NCT01398072|Doxycycline|doxycycline|mesh-list
56664964|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56664965|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664966|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
56664967|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56664968|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56664969|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56664970|NCT03317158|Gemcitabine|gemcitabine|mesh-list
56664971|NCT03317158|Docetaxel|docetaxel|mesh-list
56664972|NCT03317158|Durvalumab|durvalumab|mesh-list
56664973|NCT03317158|Tremelimumab|tremelimumab|mesh-list
56664974|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56664975|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
56664976|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56664977|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
56664978|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664979|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56664980|NCT03317158|Antiviral Agents|antiviral agents|mesh-ancestor
56664981|NCT03317158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179298|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56179299|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179300|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56179301|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56179302|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179303|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179304|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179305|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
56179306|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56179307|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56179308|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
56179309|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
56179310|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56179311|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
56179314|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56179315|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
56179316|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56179317|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56179318|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56179319|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
56179320|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179321|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179322|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56179323|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56179324|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56179325|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
56179327|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56179328|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
56179329|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179330|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179331|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179332|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56179333|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56179334|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179335|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179336|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
56179337|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
56179338|NCT01398202|Vitamin D|vitamin d|mesh-list
56179339|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
56179340|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56179341|NCT01398202|Calcifediol|calcifediol|mesh-list
56179342|NCT01398202|Vitamins|vitamins|mesh-ancestor
56664982|NCT03317158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56664983|NCT03317158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56664984|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
56664985|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56664986|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
56664987|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
56664988|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
56664989|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56664990|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56664991|NCT02724761|Epinephrine|epinephrine|mesh-list
56664992|NCT02724761|Racepinephrine|racepinephrine|mesh-list
56664993|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
56664994|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56664995|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56664996|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
56179343|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
56179344|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179345|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56179346|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56179347|NCT01398267|Lisinopril|lisinopril|mesh-list
56179348|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56179349|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
56179350|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179351|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179352|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56179353|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56179354|NCT01398267|Protective Agents|protective agents|mesh-ancestor
56179355|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179356|NCT01398293|Ritonavir|ritonavir|mesh-list
56179357|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
56179358|NCT01398293|Lactams|lactams|mesh-list
56179359|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56179360|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56179361|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56179362|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
56179363|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179364|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179365|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56179366|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56179367|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
56179368|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179369|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56179370|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56179371|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56179372|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56179373|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56179374|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179375|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56179376|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
56179377|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56179378|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179379|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56179380|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56179381|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56179382|NCT01398371|Digoxin|digoxin|mesh-list
56137529|NCT02128230|Lenograstim|lenograstim|mesh-list
56179384|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56179385|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179386|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179387|NCT01398371|Protective Agents|protective agents|mesh-ancestor
56664997|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56664998|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56664999|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665000|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56665001|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56179388|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179389|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
56179390|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56179391|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
56179392|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179393|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179394|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56179395|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
56179396|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56179397|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
56179398|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179399|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179400|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56179401|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
56179414|NCT01398592|Hormones|hormones|mesh-ancestor
56179403|NCT01398384|Protective Agents|protective agents|mesh-ancestor
56179404|NCT01398501|Sorafenib|sorafenib|mesh-list
56179405|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179406|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56179407|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179408|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179409|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56179410|NCT01398592|Vildagliptin|vildagliptin|mesh-list
56179411|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179412|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179413|NCT01398592|Incretins|incretins|mesh-ancestor
56179415|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180278|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180279|NCT01404377|Ropivacaine|ropivacaine|mesh-list
56180280|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
56180281|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
56180282|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180283|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180284|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
56180285|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180286|NCT01404442|Midazolam|midazolam|mesh-list
56180287|NCT01404442|Ketamine|ketamine|mesh-list
56180288|NCT01404442|Analgesics|analgesics|mesh-ancestor
56180289|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
56180290|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180291|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180292|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56180293|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56180294|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
56180295|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
56180296|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180297|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56180298|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56180299|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180300|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180301|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56180302|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56180303|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56180304|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56180305|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56180306|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
56180307|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
56180308|NCT01404468|Lidocaine|lidocaine|mesh-list
56180309|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
56180310|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
56180311|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180312|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180313|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
56180314|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665002|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
56665003|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665004|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56665005|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
56665006|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
56665007|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
56180315|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56180316|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56180317|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56180318|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137530|NCT02128230|BB 1101|bb 1101|mesh-list
56180319|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180320|NCT01404507|Abciximab|abciximab|mesh-list
56180321|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
56180322|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56180323|NCT01404598|Naproxen|naproxen|mesh-list
56180324|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56180325|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56180326|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56180327|NCT01404598|Analgesics|analgesics|mesh-ancestor
56180328|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
56180329|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180330|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180331|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180332|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56180333|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
56180334|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56180335|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180336|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179416|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56179417|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
56179418|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179419|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179420|NCT01398618|Rifampin|rifampin|mesh-list
56179421|NCT01398618|Isoniazid|isoniazid|mesh-list
56179422|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56179423|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
56179424|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56179425|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179426|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
56179427|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56179428|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179429|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179430|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56179431|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56179432|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56179433|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56179434|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56179435|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56179436|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56179437|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56179438|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
56179439|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56180337|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56180338|NCT01404637|Tamsulosin|tamsulosin|mesh-list
56180339|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56180340|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56180341|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56180342|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
56180343|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180344|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180345|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180346|NCT01404637|Urological Agents|urological agents|mesh-ancestor
56180407|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180408|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56180409|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56665008|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56665009|NCT04350190|Apatinib|apatinib|mesh-list
56665010|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665011|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56665012|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665013|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665014|NCT02721173|Clindamycin|clindamycin|mesh-list
56311161|NCT00072319|Epirubicin|epirubicin|mesh-list
56665015|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
56665016|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
56665017|NCT02721173|Adapalene|adapalene|mesh-list
56665018|NCT02721173|Tazarotene|tazarotene|mesh-list
56665019|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56665020|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665021|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56665022|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665023|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665024|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56180410|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56180411|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
56180412|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180413|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180414|NCT01404793|Rocuronium|rocuronium|mesh-list
56180415|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56180416|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56180417|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56180418|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180419|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179440|NCT01398657|Androgens|androgens|mesh-list
56179441|NCT01398657|Hormones|hormones|mesh-ancestor
56179442|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179443|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179444|NCT01398670|Insulin|insulin|mesh-list
56179445|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56179446|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
56179448|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179449|NCT01398722|Insulin|insulin|mesh-list
56180420|NCT01404806|Dolutegravir|dolutegravir|mesh-list
56180421|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56180422|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56180423|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180424|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180425|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56180426|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56180427|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
56180428|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180429|NCT01404819|Anesthetics|anesthetics|mesh-list
56180430|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180431|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180432|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56180433|NCT01404871|Citalopram|citalopram|mesh-list
56180434|NCT01404871|Clomipramine|clomipramine|mesh-list
56180435|NCT01404871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56180436|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56180437|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56180438|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180439|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665025|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56665026|NCT02721173|Analgesics|analgesics|mesh-ancestor
56665027|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
56665028|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665029|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665030|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56665031|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56665032|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
56665033|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
56665034|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
56665035|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
56665036|NCT00713986|Protective Agents|protective agents|mesh-ancestor
56665037|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665038|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
56665039|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56665040|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56180440|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
56180441|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180442|NCT01404871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56180443|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
56180444|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56180445|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180446|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56180447|NCT01404871|Analgesics|analgesics|mesh-ancestor
56180448|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
56180449|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
56180450|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56180451|NCT01405079|Vinorelbine|vinorelbine|mesh-list
56180452|NCT01405079|Gefitinib|gefitinib|mesh-list
56180453|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180454|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56180455|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
56180456|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
56180457|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
56180458|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180459|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56180460|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180461|NCT01405118|Metformin|metformin|mesh-list
56180462|NCT01405118|Tofacitinib|tofacitinib|mesh-list
56180463|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56180464|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180465|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56180466|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180467|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180468|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
56180469|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56180470|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56180471|NCT01405131|Prednisolone|prednisolone|mesh-list
56180472|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
56180473|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56179450|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56179451|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179452|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179453|NCT01398995|Insulin|insulin|mesh-list
56179454|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179455|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179456|NCT01399086|Fulvestrant|fulvestrant|mesh-list
56179457|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56179458|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798196|NCT05421065|Analgesics|analgesics|mesh-ancestor
56665041|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665042|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56665043|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665044|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665045|NCT04137432|Oxytocin|oxytocin|mesh-list
56665046|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
56665047|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56665048|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665049|NCT00885170|Vitamin D|vitamin d|mesh-list
56665050|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
56665051|NCT00885170|Calcium|calcium|mesh-list
56665052|NCT00885170|Vitamins|vitamins|mesh-ancestor
56665053|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
56665054|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665055|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56665056|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56665057|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
56665058|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56665059|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665060|NCT05342467|Dinoprostone|dinoprostone|mesh-list
56665061|NCT05342467|Gemeprost|gemeprost|mesh-list
56665062|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
56665063|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56665064|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665065|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56665066|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
56665067|NCT02720783|Econazole|econazole|mesh-list
56665068|NCT02720783|Benzydamine|benzydamine|mesh-list
56665069|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56665070|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
56665071|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665072|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56226287|NCT04430517|Niacinamide|niacinamide|mesh-list
56179459|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56180474|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
56180475|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55749966|NCT02512055|Atropine|atropine|mesh-list
56180793|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56180794|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56180796|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180797|NCT01406535|Urological Agents|urological agents|mesh-ancestor
56180798|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56180799|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55798230|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
56665073|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56665074|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665075|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665076|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56665077|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
56665078|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56665079|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665080|NCT00714064|Edetic Acid|edetic acid|mesh-list
56665081|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56665082|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
56665083|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
56665084|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665085|NCT00714064|Antidotes|antidotes|mesh-ancestor
56665086|NCT00714064|Protective Agents|protective agents|mesh-ancestor
56665087|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
56125713|NCT04196946|Fentanyl|fentanyl|mesh-list
56180800|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180802|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56180803|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56180804|NCT01406639|Growth Substances|growth substances|mesh-ancestor
56180805|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180806|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
56180807|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180808|NCT01406678|Sufentanil|sufentanil|mesh-list
56180809|NCT01406678|Dsuvia|dsuvia|mesh-list
56180810|NCT01406678|Isoflurane|isoflurane|mesh-list
56180811|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
56180812|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180813|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180814|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56180815|NCT01406678|Narcotics|narcotics|mesh-ancestor
56180816|NCT01406678|Analgesics|analgesics|mesh-ancestor
56180817|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
56180818|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180819|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56180820|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56180821|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
56180822|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56180823|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
56180824|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
56180825|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56180826|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180827|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
56180828|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180829|NCT01406704|Protective Agents|protective agents|mesh-ancestor
56180830|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
56180831|NCT01406704|Vitamins|vitamins|mesh-ancestor
56180832|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
56180833|NCT01406782|Rituximab|rituximab|mesh-list
56180834|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56180835|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180836|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
56180837|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180838|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56180839|NCT01407016|Metronidazole|metronidazole|mesh-list
56180840|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180841|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56180842|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56180843|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56180844|NCT01407211|Vitamin A|vitamin a|mesh-list
56665088|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
56665089|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665090|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56665091|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
56180845|NCT01407211|Vitamins|vitamins|mesh-ancestor
56180846|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
56180847|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180848|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
56180849|NCT01407237|Giapreza|giapreza|mesh-list
56180850|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
56179460|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56179461|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
56179462|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179463|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179464|NCT01399151|Vitamin D|vitamin d|mesh-list
56179465|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
56179466|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
56179467|NCT01399151|Vitamins|vitamins|mesh-list
56179468|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
56179469|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179470|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56179471|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56179472|NCT01399216|Fucoidan|fucoidan|mesh-list
56179473|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56179474|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56179475|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
56179476|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179477|NCT01399242|Everolimus|everolimus|mesh-list
56179478|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56179479|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
56180952|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
56180953|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180954|NCT01408160|Cytarabine|cytarabine|mesh-list
56180955|NCT01408160|Immunotoxins|immunotoxins|mesh-list
56180956|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56180957|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
56180958|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180959|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180960|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
56180961|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180962|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180963|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
56180964|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180965|NCT01408173|Caffeine|caffeine|mesh-list
56180966|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
56180967|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180968|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56180969|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180970|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56180971|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180972|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56180973|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56180974|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
56180975|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180976|NCT01408186|Rabeprazole|rabeprazole|mesh-list
56180977|NCT01408186|Famotidine|famotidine|mesh-list
56180978|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56180979|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56180980|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56180981|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180982|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180983|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56180984|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
56180985|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
56180986|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180987|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179480|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179481|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179482|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
56180988|NCT01408199|Lenalidomide|lenalidomide|mesh-list
56180989|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
56180990|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665092|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56665093|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
56665094|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56665095|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180991|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56180992|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56180993|NCT01408199|Growth Substances|growth substances|mesh-ancestor
56180994|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
56180995|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180997|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
56180998|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56180999|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181000|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
56181001|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181002|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56181003|NCT01408394|Ecopipam|ecopipam|mesh-list
56181004|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56181005|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56181006|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56181007|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181008|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56181009|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56181010|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
56108748|NCT00004099|Leucovorin|leucovorin|mesh-list
56181011|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181012|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181014|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
56181015|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
56181226|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56181227|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56181228|NCT01409499|Sorafenib|sorafenib|mesh-list
56181229|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181230|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56181231|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181232|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181281|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56181283|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56181284|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
56181285|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
56181286|NCT01409694|Vitamin D|vitamin d|mesh-list
56181287|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
56181288|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
56181289|NCT01409694|Vitamins|vitamins|mesh-list
56181290|NCT01409694|Memantine|memantine|mesh-list
56181291|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
56181292|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181293|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56181294|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56181295|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56181296|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56181297|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
56181298|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181299|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181300|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56181301|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56181302|NCT01409733|Doxorubicin|doxorubicin|mesh-list
56181303|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56181304|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181305|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56181306|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56181307|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181308|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181309|NCT01409772|Ethanol|ethanol|mesh-list
56181310|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56181311|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181312|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56181313|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181314|NCT01410162|Tacrolimus|tacrolimus|mesh-list
56181315|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181316|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
56179483|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179484|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665096|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665097|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56665098|NCT02720705|Analgesics|analgesics|mesh-ancestor
56665099|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
56665100|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665101|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56665102|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56665103|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56179485|NCT01399346|Insulin|insulin|mesh-list
56179486|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56179487|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
56179488|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
56179489|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56179490|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179491|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179492|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56181317|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181318|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56181319|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181320|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181357|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
56181358|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181359|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56181360|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181777|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56181779|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181780|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
56181781|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56181782|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
56181783|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56181784|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181785|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56181786|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56181787|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56181788|NCT01414231|Cytarabine|cytarabine|mesh-list
56181789|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56181790|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
56181791|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181792|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181793|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
56181794|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181795|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181796|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
56181797|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181798|NCT01414465|Orlistat|orlistat|mesh-list
56181799|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181800|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181801|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56181802|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56181803|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56181804|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
56181805|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181806|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
56181807|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
56181808|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56181810|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56181811|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56181812|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181813|NCT01414556|Incretins|incretins|mesh-ancestor
56181814|NCT01414556|Hormones|hormones|mesh-ancestor
56181815|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181816|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181817|NCT01414569|Dexamethasone|dexamethasone|mesh-list
56181818|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
56181819|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56665104|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
56665105|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665106|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665107|NCT02720471|Anesthetics|anesthetics|mesh-list
56665108|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
56665109|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665110|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181820|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
56181821|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
56181822|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181823|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179493|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56179494|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56179495|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179496|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179497|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179498|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56179499|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56179501|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181824|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181825|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
56181826|NCT01414569|Hormones|hormones|mesh-ancestor
56181827|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181828|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56181829|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181830|NCT01414608|Paclitaxel|paclitaxel|mesh-list
56181831|NCT01414608|Cisplatin|cisplatin|mesh-list
56181832|NCT01414608|Carboplatin|carboplatin|mesh-list
56181833|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56181834|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56181835|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881965|NCT03004612|Metformin|metformin|mesh-list
56181943|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181944|NCT01415505|Diuretics|diuretics|mesh-ancestor
56181945|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
56181946|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181947|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56181948|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56181949|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
56181950|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56181951|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56181952|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56181953|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
56181954|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181955|NCT01415557|Micronutrients|micronutrients|mesh-list
56181956|NCT01415557|Trace Elements|trace elements|mesh-list
56181957|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181958|NCT01415596|Albuterol|albuterol|mesh-list
56181959|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56181960|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
56181961|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181962|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181963|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56181964|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
56181965|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
56181966|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56182012|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182014|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56182015|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
56182016|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182017|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182018|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56182019|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56182020|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56182021|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56182022|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56665111|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
56665112|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665113|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56665114|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
56665115|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56665116|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56665117|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56226347|NCT04310150|Hemostatics|hemostatics|mesh-list
56182023|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182024|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56182025|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
56182027|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182028|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56182029|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56182030|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
56179502|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179503|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56179504|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56179505|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
56179506|NCT01399463|Paclitaxel|paclitaxel|mesh-list
56179507|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56179508|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179509|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
56179510|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
56179511|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
56182031|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
56182032|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
56182033|NCT01415778|Bicalutamide|bicalutamide|mesh-list
56182064|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
56182065|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182066|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56182067|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56182068|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
56182069|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182070|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182071|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56182072|NCT01416116|Lidocaine|lidocaine|mesh-list
56182073|NCT01416116|Tramadol|tramadol|mesh-list
56182074|NCT01416116|Capsaicin|capsaicin|mesh-list
56182075|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
56182076|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
56182077|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56182078|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182079|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
56182115|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56182116|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56182117|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56182355|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182356|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56182391|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
56182392|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182393|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56182394|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
56182395|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
56182396|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
56182397|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56182398|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56182399|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56182433|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56182434|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56182435|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
56182436|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182438|NCT01418274|Citalopram|citalopram|mesh-list
56182439|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56182440|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56182441|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
56182442|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665118|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665119|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665121|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
56665122|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665123|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
56665124|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183575|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56183576|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183577|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56183578|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55887833|NCT03309618|Valsartan|valsartan|mesh-list
56184064|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56184065|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
56184066|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184067|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889147|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179512|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179513|NCT01399515|Valproic Acid|valproic acid|mesh-list
56179514|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
56179515|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179516|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179517|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
56179521|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56179522|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179523|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179524|NCT01399645|Insulin|insulin|mesh-list
56179525|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56179526|NCT01399645|Metformin|metformin|mesh-list
56179527|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
56179528|NCT01399645|Liraglutide|liraglutide|mesh-list
56179529|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179530|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179531|NCT01399645|Incretins|incretins|mesh-ancestor
56179532|NCT01399645|Hormones|hormones|mesh-ancestor
56179533|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179534|NCT01399840|Talazoparib|talazoparib|mesh-list
56179535|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56179536|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184104|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56184105|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184106|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56184107|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56184108|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
56184109|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56184110|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
56184764|NCT01427322|Lapatinib|lapatinib|mesh-list
55891526|NCT05633914|Antimitotic Agents|antimitotic agents|mesh-ancestor
56184837|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184838|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184839|NCT01427985|Analgesics|analgesics|mesh-ancestor
56184840|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
56184841|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184842|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56184843|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56184844|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
56185068|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185069|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
56185070|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185071|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185072|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56185073|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185074|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
56185076|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
56185077|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179537|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179538|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179539|NCT01399853|Vaccines|vaccines|mesh-list
56665125|NCT00688896|Pravastatin|pravastatin|mesh-list
56665126|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
56665127|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56665128|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56179540|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
56179541|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179542|NCT01400009|Vitamin D|vitamin d|mesh-list
56179543|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
56179544|NCT01400009|Vitamins|vitamins|mesh-ancestor
56179545|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
56179546|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179547|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56179548|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56179549|NCT01400022|Cortisone|cortisone|mesh-list
56179550|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56179551|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
56179552|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179553|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56179554|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179555|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179556|NCT01400100|Octreotide|octreotide|mesh-list
56185078|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185079|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
56185080|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185081|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56185082|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
56185083|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56185084|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137533|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185085|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185086|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56185088|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56185089|NCT01429545|Nifedipine|nifedipine|mesh-list
56185090|NCT01429545|Vasotocin|vasotocin|mesh-list
56185091|NCT01429545|Atosiban|atosiban|mesh-list
56185092|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56185093|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56185094|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185095|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56185096|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185097|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
56185098|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
56185099|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56185100|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
56185101|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185102|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
56185103|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56185104|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56185105|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185106|NCT01429610|Cytarabine|cytarabine|mesh-list
56185107|NCT01429610|Rituximab|rituximab|mesh-list
56185108|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56185109|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185110|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
56185111|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179557|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56179558|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56179559|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56179560|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179562|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56179563|NCT01400165|Trazodone|trazodone|mesh-list
56179564|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
56179565|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179566|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56179567|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56179568|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179569|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179570|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56179571|NCT01400165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56179572|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56179573|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56665129|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
56665130|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107293|NCT00003397|Paclitaxel|paclitaxel|mesh-list
56179574|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179575|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179576|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
56179577|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56179578|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56179579|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56179580|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
56179581|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56179582|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56185112|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185113|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56185114|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
56185115|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185116|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
56185117|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185118|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56185119|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
56185120|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56185121|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185122|NCT01429701|Gentamicins|gentamicins|mesh-list
56185123|NCT01429701|Polymyxins|polymyxins|mesh-list
56185124|NCT01429701|Polymyxin B|polymyxin b|mesh-list
56185125|NCT01429701|Prednisolone|prednisolone|mesh-list
56185126|NCT01429701|Betamethasone|betamethasone|mesh-list
56185127|NCT01429701|Benzocaine|benzocaine|mesh-list
56185128|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892626|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55892627|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
55892628|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753873|NCT04911959|Lenvatinib|lenvatinib|mesh-list
56179583|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
56187031|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56187032|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
56187033|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56187034|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56187035|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
56187036|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187037|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
56187038|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56187039|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56187040|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56187041|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
56187042|NCT04585542|Laxatives|laxatives|mesh-ancestor
56187043|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56187044|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
56187045|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
56187046|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187047|NCT04502602|Niraparib|niraparib|mesh-list
56187048|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56187049|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187050|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187051|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187052|NCT04375202|Colchicine|colchicine|mesh-list
56187053|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
56187054|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187055|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
56187056|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
56187057|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
56187058|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187059|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187060|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
56187061|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56187062|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56187063|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56187064|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
56187065|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56187066|NCT04343885|Docetaxel|docetaxel|mesh-list
56187067|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
56187068|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187069|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
56187070|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
56665131|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56665132|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56665133|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665134|NCT02724293|Pregabalin|pregabalin|mesh-list
56665135|NCT02724293|Analgesics|analgesics|mesh-ancestor
56226367|NCT04294147|Analgesics|analgesics|mesh-ancestor
56187071|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
56187072|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187073|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56187074|NCT04332393|Metformin|metformin|mesh-list
56187075|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187076|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187077|NCT04329572|Azithromycin|azithromycin|mesh-list
56187078|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
56187079|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56187080|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56187081|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
56187082|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56187083|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56187084|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187085|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187086|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187087|NCT04322552|Apatinib|apatinib|mesh-list
56187088|NCT04322552|Digoxin|digoxin|mesh-list
56187089|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187090|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56187091|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187092|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187093|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56187094|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56187095|NCT04322552|Protective Agents|protective agents|mesh-ancestor
56187188|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179586|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179587|NCT01400217|Beclomethasone|beclomethasone|mesh-list
56179588|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56179589|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
56187847|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
56188430|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56188431|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
56188432|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188433|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188434|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56188435|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56188615|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56188616|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56188617|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56188618|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56188620|NCT01445236|Tacrolimus|tacrolimus|mesh-list
56188621|NCT01445236|Cyclosporins|cyclosporins|mesh-list
56188622|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188623|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
56188624|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188625|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56188626|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188627|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188628|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
56188629|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188630|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
56188631|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56188632|NCT01445262|Levocetirizine|levocetirizine|mesh-list
56188633|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56188634|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56188635|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
56188636|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
56188637|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188638|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188639|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188640|NCT01445340|Romidepsin|romidepsin|mesh-list
56188641|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56188642|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665136|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
56665137|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665138|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188643|NCT01445379|Ipilimumab|ipilimumab|mesh-list
56188644|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56188645|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188646|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56188647|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179590|NCT01400217|Hormones|hormones|mesh-ancestor
56188649|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56188650|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188651|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188652|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188653|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56188654|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56188655|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
56188656|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188657|NCT01445405|Cetuximab|cetuximab|mesh-list
56188658|NCT01445405|Bortezomib|bortezomib|mesh-list
56188659|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188660|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56188661|NCT01445418|Carboplatin|carboplatin|mesh-list
56188662|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188663|NCT01445431|Mineral Oil|mineral oil|mesh-list
56188664|NCT01445431|Emollients|emollients|mesh-ancestor
56188665|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
56188666|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
56188667|NCT01445522|Veliparib|veliparib|mesh-list
56188668|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188669|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
56188670|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188671|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56188672|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56188673|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
56188674|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188675|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188676|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56188677|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56188678|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188679|NCT01445561|Interleukin-2|interleukin-2|mesh-list
56188680|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188681|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56188682|NCT01445561|Analgesics|analgesics|mesh-ancestor
56188683|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
56188684|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188685|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188687|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188688|NCT01445600|Retapamulin|retapamulin|mesh-list
56188689|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55757248|NCT02456207|Rituximab|rituximab|mesh-list
56188746|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
56188747|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188748|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188749|NCT01446094|Regadenoson|regadenoson|mesh-list
56188750|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56188751|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56188752|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
56188753|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
56188754|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188755|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188756|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188757|NCT01446107|Fluorides|fluorides|mesh-list
56188758|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
56188759|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
56188760|NCT01446107|Protective Agents|protective agents|mesh-ancestor
56188761|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188762|NCT01446120|Insulin|insulin|mesh-list
56188763|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56188764|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
56188765|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
56188766|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
56188767|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55931606|NCT04193501|Protective Agents|protective agents|mesh-ancestor
56665139|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
56665140|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56188768|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188769|NCT01446211|Gusperimus|gusperimus|mesh-list
56188770|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
56188771|NCT01446211|Methotrexate|methotrexate|mesh-list
56188772|NCT01446211|Azathioprine|azathioprine|mesh-list
56188773|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
56188774|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188775|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
56188776|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188777|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56188778|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56137534|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56179594|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
56179595|NCT01400256|Valsartan|valsartan|mesh-list
56179596|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56179597|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56179598|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56179599|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179600|NCT01400308|Mupirocin|mupirocin|mesh-list
56179601|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56179602|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179603|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56179604|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179605|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179606|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
56179607|NCT01400464|Prednisone|prednisone|mesh-list
56179608|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56179609|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
56179610|NCT01400464|Hormones|hormones|mesh-ancestor
56179611|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179612|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179613|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56179614|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179615|NCT01400568|Fluticasone|fluticasone|mesh-list
56179616|NCT01400568|Xhance|xhance|mesh-list
56179617|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56188779|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
56188780|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188781|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188782|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56188783|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56188784|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
56188785|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56188786|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56188787|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
56188788|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
56188789|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188790|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56188791|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56188792|NCT01446211|Hormones|hormones|mesh-ancestor
56188793|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56188794|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56188795|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179618|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56179619|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
56179620|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179621|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179622|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56179623|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
56179624|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
56179625|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56179626|NCT01400633|Decitabine|decitabine|mesh-list
56179627|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56179628|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
56179629|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179630|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179631|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179632|NCT01400646|Vitamins|vitamins|mesh-list
56179633|NCT01400646|Vitamin K|vitamin k|mesh-list
56179634|NCT01400646|Warfarin|warfarin|mesh-list
56179635|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
56179636|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
56665141|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56665142|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665143|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56179637|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179638|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
56179639|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56179640|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
56179641|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56179642|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
56179643|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188796|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56189759|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190003|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190005|NCT01463774|Metformin|metformin|mesh-list
56190006|NCT01463774|Canagliflozin|canagliflozin|mesh-list
56190007|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190008|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190009|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56190010|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190011|NCT01463813|Vitamin D|vitamin d|mesh-list
56190012|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
56190013|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
56190014|NCT01463813|Vitamins|vitamins|mesh-list
56190015|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
56190016|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179644|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190017|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56190018|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56190019|NCT01463852|Vincristine|vincristine|mesh-list
56190020|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56190245|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56190246|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56190247|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190248|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56190249|NCT01467258|Amantadine|amantadine|mesh-list
56190250|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56190251|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56190252|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
56118017|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
56190253|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190254|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
56190255|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190256|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190257|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190258|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56190259|NCT01467258|Analgesics|analgesics|mesh-ancestor
56190260|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
56190261|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190262|NCT01467297|Levofloxacin|levofloxacin|mesh-list
56190263|NCT01467297|Ofloxacin|ofloxacin|mesh-list
56190264|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56190265|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190266|NCT01467297|Renal Agents|renal agents|mesh-ancestor
56190267|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56190268|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56190269|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56190270|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190271|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190272|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190273|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56190274|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56190275|NCT01467310|Trametinib|trametinib|mesh-list
56190276|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190277|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56190278|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190279|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190280|NCT01467323|Insulin|insulin|mesh-list
56190281|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56190282|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
56190283|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
56665144|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56665145|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56665146|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665147|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56665148|NCT05092828|Morphine|morphine|mesh-list
56665149|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56665150|NCT05092828|Narcotics|narcotics|mesh-ancestor
56665151|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665152|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665153|NCT05092828|Analgesics|analgesics|mesh-ancestor
56665154|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
56665155|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665156|NCT04137198|Sufentanil|sufentanil|mesh-list
56665157|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56665158|NCT04137198|Narcotics|narcotics|mesh-ancestor
56665159|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665160|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665161|NCT04137198|Analgesics|analgesics|mesh-ancestor
56665162|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
56665163|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665164|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56190284|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190285|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190286|NCT01467362|Desonide|desonide|mesh-list
56190288|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56190289|NCT01467362|Emollients|emollients|mesh-ancestor
56190290|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
56190291|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
56190292|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
56190293|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190294|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190295|NCT01467401|Insulin|insulin|mesh-list
56190296|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56190297|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
56190298|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
56190299|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190300|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190301|NCT01467414|Insulin|insulin|mesh-list
56190302|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190303|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190304|NCT01467518|Dolutegravir|dolutegravir|mesh-list
56190305|NCT01467518|Methadone|methadone|mesh-list
56190306|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56190307|NCT01467518|Narcotics|narcotics|mesh-ancestor
56190308|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56190309|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190310|NCT01467518|Analgesics|analgesics|mesh-ancestor
56190311|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
56190312|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179645|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56179646|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56179647|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
56179648|NCT01400646|Coagulants|coagulants|mesh-ancestor
56179649|NCT01400672|Imiquimod|imiquimod|mesh-list
56179650|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56179651|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
56179652|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179653|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665165|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56665166|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
56665167|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
56665168|NCT00995293|Docetaxel|docetaxel|mesh-list
56665169|NCT00995293|Fluorouracil|fluorouracil|mesh-list
56665170|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665171|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
56665172|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
56665173|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
56665174|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665175|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
56665176|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56665177|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665178|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
56665179|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665180|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
56665181|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
56665182|NCT00692952|Nonoxynol|nonoxynol|mesh-list
56665183|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56665184|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665185|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56665186|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665187|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56665188|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56665189|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56665190|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56665191|NCT02639858|Docetaxel|docetaxel|mesh-list
56665192|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665193|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
56665194|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
56665195|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
56665196|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665197|NCT00689208|Atropine|atropine|mesh-list
56179654|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
56179655|NCT01400685|Rituximab|rituximab|mesh-list
56179656|NCT01400685|Lenalidomide|lenalidomide|mesh-list
56179657|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56179658|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56190313|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
56190314|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
56190315|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56190316|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56190317|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190318|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665198|NCT00689208|Physostigmine|physostigmine|mesh-list
56665199|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56665200|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56665201|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56665202|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
56665203|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665204|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665205|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56665206|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
56190319|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56190320|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56190321|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
56192311|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56192312|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192313|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56192314|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56192315|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56192316|NCT01480492|Telbivudine|telbivudine|mesh-list
56192317|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
56192318|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192319|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56192320|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192321|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192322|NCT01480531|Clevidipine|clevidipine|mesh-list
56192323|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56192324|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192325|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192326|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56192506|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
56192507|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
56192508|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56193198|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56193199|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56193200|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56193202|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193203|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56193237|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193239|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56193241|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193242|NCT01486485|Nafamostat|nafamostat|mesh-list
56193243|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56193244|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56193245|NCT01486485|Analgesics|analgesics|mesh-ancestor
56193246|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
56193247|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193248|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193249|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56179659|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179660|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
56179661|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179662|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56179663|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56179664|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56179665|NCT01400685|Growth Substances|growth substances|mesh-ancestor
56179666|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
56179667|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56179668|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
56179669|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179670|NCT01400737|Ibuprofen|ibuprofen|mesh-list
56179671|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56179672|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56179673|NCT01400737|Analgesics|analgesics|mesh-ancestor
56179674|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
56665207|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
56665208|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
56665209|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56665210|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56665211|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
56665212|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665213|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665214|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56665215|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665216|NCT00689208|Miotics|miotics|mesh-ancestor
56665217|NCT00726466|Ranibizumab|ranibizumab|mesh-list
56665218|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56665219|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56193250|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56193251|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
56193252|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
56193253|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193254|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193255|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56193256|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56193257|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56193258|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193259|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
56193261|NCT01486511|Hematinics|hematinics|mesh-ancestor
56193262|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56193263|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
56193264|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
56193265|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56193266|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
56193267|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
56193268|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56193269|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
56193270|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
56193271|NCT01486602|Paclitaxel|paclitaxel|mesh-list
56193272|NCT01486602|Carboplatin|carboplatin|mesh-list
56193273|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56193274|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193275|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
56193276|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
56193277|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
56193278|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193279|NCT01486706|Gabapentin|gabapentin|mesh-list
56193280|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
56193281|NCT01486706|Analgesics|analgesics|mesh-ancestor
56193282|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
56193283|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193284|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193285|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
56193286|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56193287|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56193288|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193289|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193290|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56193291|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56179675|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179676|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179677|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56179678|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56179679|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56179680|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179682|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
56179683|NCT01400750|Tobramycin|tobramycin|mesh-list
56179684|NCT01400750|Colistin|colistin|mesh-list
56665220|NCT00726466|Growth Substances|growth substances|mesh-ancestor
56665221|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665222|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
56665223|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665224|NCT02694263|Pioglitazone|pioglitazone|mesh-list
56665225|NCT02694263|Glimepiride|glimepiride|mesh-list
56665226|NCT02694263|Canagliflozin|canagliflozin|mesh-list
56665227|NCT02694263|Repaglinide|repaglinide|mesh-list
56665228|NCT02694263|Gliclazide|gliclazide|mesh-list
56665229|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56665230|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665231|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56665232|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665233|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
56665234|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56665235|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665236|NCT04139070|Bleomycin|bleomycin|mesh-list
56665237|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56665238|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665239|NCT00693030|Sirolimus|sirolimus|mesh-list
56665240|NCT00693030|Paclitaxel|paclitaxel|mesh-list
56665241|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56179685|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56179686|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179687|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56179688|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56179689|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179690|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179691|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179692|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56179693|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56179694|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
56179695|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
56193292|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193293|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193294|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
56193295|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56193296|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56193297|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
56193298|NCT01486706|Urological Agents|urological agents|mesh-ancestor
56193299|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56193328|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
56193329|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
56193330|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
56121105|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193331|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
56193332|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
56193333|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193334|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193335|NCT01486953|Sevoflurane|sevoflurane|mesh-list
56193336|NCT01486953|Desflurane|desflurane|mesh-list
56193337|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56193338|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56193339|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
56665242|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311389|NCT00073411|Analgesics|analgesics|mesh-ancestor
56665243|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
56665244|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
56665245|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
56665246|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665247|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56665248|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665249|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56665250|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
56665251|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665252|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
56665253|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665254|NCT00653822|Alefacept|alefacept|mesh-list
56665255|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
56665256|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
56665257|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665258|NCT04137276|Vitamins|vitamins|mesh-list
56665259|NCT04137276|Thiamine|thiamine|mesh-list
56665260|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
56226490|NCT04136262|Methotrexate|methotrexate|mesh-list
56193340|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
56193341|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193342|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193343|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56193344|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56193345|NCT01486979|Estradiol|estradiol|mesh-list
56193346|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56179696|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179697|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179698|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
56179699|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179700|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179701|NCT01400828|Desloratadine|desloratadine|mesh-list
56179702|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56179703|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
56179704|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179705|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179706|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179707|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56179708|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56179709|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
56179710|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
56179712|NCT01400867|Clindamycin|clindamycin|mesh-list
56179713|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
56179714|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
56179715|NCT01400867|Cefazolin|cefazolin|mesh-list
56179716|NCT01400867|Linezolid|linezolid|mesh-list
56179717|NCT01400867|Cephalexin|cephalexin|mesh-list
56179718|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56179719|NCT01400867|Aztreonam|aztreonam|mesh-list
56179720|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56179721|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179722|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56179723|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179724|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179725|NCT01400945|Pantoprazole|pantoprazole|mesh-list
56665261|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
56665262|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665263|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
56665264|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56665265|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665266|NCT02723981|Vitamins|vitamins|mesh-list
56665267|NCT02723981|Vitamin K|vitamin k|mesh-list
56665268|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
56665269|NCT02723981|Dabigatran|dabigatran|mesh-list
56665270|NCT02723981|Anticoagulants|anticoagulants|mesh-list
56665271|NCT02723981|Clopidogrel|clopidogrel|mesh-list
56665272|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
56665273|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226506|NCT04133922|Insulin|insulin|mesh-list
56193347|NCT01486979|Estrogens|estrogens|mesh-ancestor
56193442|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
56193443|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193444|NCT01487629|Bevacizumab|bevacizumab|mesh-list
56193445|NCT01487629|Ranibizumab|ranibizumab|mesh-list
56193446|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56193447|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193448|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56193449|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56193450|NCT01487629|Growth Substances|growth substances|mesh-ancestor
56193451|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193452|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
56193453|NCT01487785|Gemcitabine|gemcitabine|mesh-list
56193454|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56193455|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
56193456|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193457|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193458|NCT01487785|Antiviral Agents|antiviral agents|mesh-ancestor
56179726|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56179727|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56179728|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56179729|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179730|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179731|NCT01401036|Umirolimus|umirolimus|mesh-list
56179732|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56179733|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56179734|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
56179735|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179736|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
56179737|NCT01401075|Doxifluridine|doxifluridine|mesh-list
56179738|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193459|NCT01487785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193460|NCT01487785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193461|NCT01487785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193462|NCT01487785|Immunologic Factors|immunologic factors|mesh-ancestor
56193463|NCT01487785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193464|NCT01487798|Insulin|insulin|mesh-list
56193465|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56193466|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
56193467|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
56193468|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56193469|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193470|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193471|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
56193472|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
56193473|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56193474|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193475|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193476|NCT01487993|Metformin|metformin|mesh-list
56193477|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55931644|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
56665274|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56665275|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56665276|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56665277|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56665278|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
56665279|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665280|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665281|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56665282|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
56226521|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56193478|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193479|NCT01488045|Fentanyl|fentanyl|mesh-list
56193480|NCT01488045|Midazolam|midazolam|mesh-list
56121254|NCT01606800|Ribavirin|ribavirin|mesh-list
56193481|NCT01488045|Propofol|propofol|mesh-list
56193482|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56193483|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193484|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193485|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56193486|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
56193488|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56193489|NCT01488045|Narcotics|narcotics|mesh-ancestor
56193490|NCT01488045|Analgesics|analgesics|mesh-ancestor
56193491|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
56193492|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193493|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56193494|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56193495|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56193496|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193497|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
56193498|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
56193499|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193500|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194619|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56194620|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
56194621|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194622|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194623|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56194624|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56194703|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179740|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56179741|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
56194704|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
56194705|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194706|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
56194707|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194708|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56194709|NCT01494636|Lidocaine|lidocaine|mesh-list
56194710|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56194711|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
56194712|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
56194713|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194714|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194715|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
56194716|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194717|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56194718|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56194719|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56194720|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56194721|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194722|NCT01494688|Paclitaxel|paclitaxel|mesh-list
56194723|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56195117|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
56195118|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195119|NCT01497002|Cytarabine|cytarabine|mesh-list
56665283|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56665284|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
56665285|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665286|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56665287|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56665288|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
56665289|NCT02723981|Coagulants|coagulants|mesh-ancestor
56665290|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
56665291|NCT00912444|Docetaxel|docetaxel|mesh-list
56665292|NCT00912444|Doxorubicin|doxorubicin|mesh-list
56665293|NCT00912444|Epirubicin|epirubicin|mesh-list
56665294|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195120|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56195121|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
56195122|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195123|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195124|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
56195125|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195126|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195127|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
56195128|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195143|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195144|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195145|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56195146|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
56195148|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195149|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56195150|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195151|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
56195152|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56195153|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56195154|NCT01497093|Growth Substances|growth substances|mesh-ancestor
56195155|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
56195156|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195157|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
56195158|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56195159|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195160|NCT01497132|Vitamin D|vitamin d|mesh-list
56195161|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
56195162|NCT01497132|Vitamins|vitamins|mesh-ancestor
56195163|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
56195164|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195165|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56195166|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56195167|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
56195168|NCT01497145|Hematinics|hematinics|mesh-ancestor
56195169|NCT01497288|Fentanyl|fentanyl|mesh-list
56195170|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56195171|NCT01497288|Narcotics|narcotics|mesh-ancestor
56195172|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56195173|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195174|NCT01497288|Analgesics|analgesics|mesh-ancestor
56195175|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
56195176|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195177|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56195178|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56195179|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
56179742|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179743|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56179745|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179746|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56179747|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
56195181|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
56195182|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
56195183|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195184|NCT01497431|Selenium|selenium|mesh-list
56665295|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
56665296|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665297|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56665298|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56195185|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
56195186|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
56195187|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195188|NCT01497431|Protective Agents|protective agents|mesh-ancestor
56195189|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195190|NCT01497431|Trace Elements|trace elements|mesh-ancestor
56195191|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
56195192|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56195193|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195194|NCT01497444|Sorafenib|sorafenib|mesh-list
56195428|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56195429|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
56196331|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196333|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196334|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56196335|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56196336|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56196337|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
56196338|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56196340|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
56196341|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196342|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196343|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196344|NCT01503372|Leucovorin|leucovorin|mesh-list
56196345|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
56196346|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196347|NCT01503372|Antidotes|antidotes|mesh-ancestor
56196348|NCT01503372|Protective Agents|protective agents|mesh-ancestor
56196349|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196350|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
56196351|NCT01503372|Vitamins|vitamins|mesh-ancestor
56196352|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
56196353|NCT01503385|Celecoxib|celecoxib|mesh-list
56196354|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56196355|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56196356|NCT01503385|Analgesics|analgesics|mesh-ancestor
56196357|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
56196358|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196359|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196360|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56196361|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196362|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56196363|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56196364|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196365|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196366|NCT01503398|Olanzapine|olanzapine|mesh-list
56196367|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
56196368|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
56196369|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196370|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196371|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56196372|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56196373|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56196374|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196375|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196376|NCT01503398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56196377|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56196378|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56179748|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179749|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
56179750|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56179751|NCT01401179|Clarithromycin|clarithromycin|mesh-list
56179752|NCT01401179|Cefazolin|cefazolin|mesh-list
56179753|NCT01401179|Erythromycin|erythromycin|mesh-list
56179754|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
56179755|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56179756|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
56179757|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56665299|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
56665300|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665301|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665302|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56665303|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
56665304|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
56665305|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
56665306|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56665307|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56665308|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56179759|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56179761|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179762|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56196379|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196380|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196381|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
56196382|NCT01503424|Olanzapine|olanzapine|mesh-list
56196383|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
56196384|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
56196385|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196386|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196387|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56196388|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56196389|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56196390|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196391|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196392|NCT01503424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56196393|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56196394|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196395|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196396|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196397|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
56196398|NCT01503437|Olanzapine|olanzapine|mesh-list
56196399|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
56196400|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
56196401|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196402|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196403|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56196404|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56196405|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56197012|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197014|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56197015|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56197016|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
56197017|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
56197018|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197019|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197020|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716393|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56197288|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197290|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197291|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197292|NCT01507285|Incretins|incretins|mesh-ancestor
56197293|NCT01507285|Hormones|hormones|mesh-ancestor
56197294|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179763|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56179764|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56179765|NCT01401192|Gemcitabine|gemcitabine|mesh-list
56179766|NCT01401192|Cisplatin|cisplatin|mesh-list
56179767|NCT01401192|Pemetrexed|pemetrexed|mesh-list
56179768|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179769|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56179770|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
56665309|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665310|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
56665311|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665312|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56665313|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665314|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665315|NCT00726700|Prednisone|prednisone|mesh-list
56665316|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
56665317|NCT00726700|Rituximab|rituximab|mesh-list
56665318|NCT00726700|Doxorubicin|doxorubicin|mesh-list
56665319|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56665320|NCT00726700|Vincristine|vincristine|mesh-list
56665321|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547648|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56665322|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
56665323|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665324|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56665325|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56665326|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
56665327|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665328|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665329|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56665330|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56665331|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56226550|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
56179771|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179772|NCT01401192|Antiviral Agents|antiviral agents|mesh-ancestor
56179773|NCT01401192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179774|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197295|NCT01507311|Liraglutide|liraglutide|mesh-list
56197296|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197297|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197298|NCT01507311|Incretins|incretins|mesh-ancestor
56197299|NCT01507311|Hormones|hormones|mesh-ancestor
56197300|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197301|NCT01507337|Liraglutide|liraglutide|mesh-list
56197302|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197303|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197304|NCT01507337|Incretins|incretins|mesh-ancestor
56197306|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197307|NCT01507363|Gabapentin|gabapentin|mesh-list
56197308|NCT01507363|Analgesics|analgesics|mesh-ancestor
56197310|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197311|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197312|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
56197313|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56197314|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56197315|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56197316|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56197317|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56665332|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56665333|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56665334|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665335|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56665336|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
56665337|NCT00726700|Hormones|hormones|mesh-ancestor
56665338|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56665339|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56665340|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56665341|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56665342|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56665343|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56665344|NCT02723903|Fluoxetine|fluoxetine|mesh-list
56665345|NCT02723903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56665346|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56665347|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56665348|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226576|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
56197318|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56197319|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197320|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197321|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
56197322|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56197323|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56197324|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197325|NCT01507389|Liraglutide|liraglutide|mesh-list
56197326|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197327|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197328|NCT01507389|Incretins|incretins|mesh-ancestor
56197329|NCT01507389|Hormones|hormones|mesh-ancestor
56197330|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197331|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
56197332|NCT01507428|Misonidazole|misonidazole|mesh-list
56197333|NCT01507428|Paclitaxel|paclitaxel|mesh-list
56197334|NCT01507428|Carboplatin|carboplatin|mesh-list
56197335|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56197336|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56197337|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56197338|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197339|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
56197340|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
56197341|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
56197342|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197343|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56197344|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
56197345|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
56197346|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179775|NCT01401192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197347|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56197348|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56197349|NCT01507454|Estradiol|estradiol|mesh-list
56197350|NCT01507454|Estrogens|estrogens|mesh-ancestor
56197351|NCT01507454|Hormones|hormones|mesh-ancestor
56197352|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197353|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197354|NCT01507467|Nimorazole|nimorazole|mesh-list
56197355|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56665349|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665350|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
56127168|NCT05353062|Epinephrine|epinephrine|mesh-list
56197356|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56197357|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56197358|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197359|NCT01507480|Bevacizumab|bevacizumab|mesh-list
55718288|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197975|NCT01511029|Pramipexole|pramipexole|mesh-list
56197976|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56197977|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197978|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56197979|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56197980|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198732|NCT01514695|Analgesics|analgesics|mesh-ancestor
56198733|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
56198734|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198735|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56198736|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56198737|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
56198738|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
56198808|NCT01514942|Folic Acid|folic acid|mesh-list
56198865|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198866|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
56198867|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
56198868|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
56198869|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198870|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56198871|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
56198872|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198873|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56198874|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
56198875|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198876|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56198877|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
56198878|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56198879|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56198880|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56126650|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
56198881|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
56198882|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56198883|NCT01515228|Protective Agents|protective agents|mesh-ancestor
56198884|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56198885|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56198886|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198887|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56198888|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56198889|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198890|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198891|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56198892|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56198893|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198894|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
56198895|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198897|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
56198898|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
56198900|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56198901|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198902|NCT01515553|Incretins|incretins|mesh-ancestor
56198903|NCT01515553|Hormones|hormones|mesh-ancestor
56198904|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198905|NCT01515579|Liraglutide|liraglutide|mesh-list
56198906|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56198907|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198908|NCT01515579|Incretins|incretins|mesh-ancestor
56198909|NCT01515579|Hormones|hormones|mesh-ancestor
56179776|NCT01401192|Immunologic Factors|immunologic factors|mesh-ancestor
56179777|NCT01401192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179778|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56179779|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56179781|NCT01401387|Pancrelipase|pancrelipase|mesh-list
56179782|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56179783|NCT01401491|Clozapine|clozapine|mesh-list
56179784|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
56665351|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665352|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56665353|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
56665354|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56665355|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56665356|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56665357|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665358|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
56665359|NCT00675714|Itraconazole|itraconazole|mesh-list
56665360|NCT00675714|Fluconazole|fluconazole|mesh-list
56665361|NCT00675714|Ketoconazole|ketoconazole|mesh-list
56665362|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
56665363|NCT00675714|Propranolol|propranolol|mesh-list
56665364|NCT00675714|Metoprolol|metoprolol|mesh-list
56665365|NCT00675714|Hormones|hormones|mesh-list
56665366|NCT00675714|Testosterone|testosterone|mesh-list
56665367|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
56665368|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
56665369|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56665370|NCT00675714|Oxandrolone|oxandrolone|mesh-list
56665371|NCT00675714|Nandrolone|nandrolone|mesh-list
56665372|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
56665373|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56665374|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665375|NCT00675714|Androgens|androgens|mesh-ancestor
56179785|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56179786|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
56179787|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179788|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179789|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179790|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56179791|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56179792|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179793|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179794|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
56179795|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
56179796|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56179797|NCT01401491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56179798|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56179799|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56179800|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56179801|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
56179802|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56198910|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198911|NCT01515592|Liraglutide|liraglutide|mesh-list
56198912|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56198913|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198914|NCT01515592|Incretins|incretins|mesh-ancestor
56198915|NCT01515592|Hormones|hormones|mesh-ancestor
56198916|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56665376|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56665377|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665378|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
56665379|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
56665380|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665381|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56665382|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56665383|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665384|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665385|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56665386|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
56665387|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56665388|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56665389|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56665390|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
56665391|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665392|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56665393|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56311544|NCT00074737|Cytarabine|cytarabine|mesh-list
56198917|NCT01515683|Anesthetics|anesthetics|mesh-list
56198918|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198919|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198920|NCT01515774|Pramipexole|pramipexole|mesh-list
56198921|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
56198922|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198923|NCT01515774|Protective Agents|protective agents|mesh-ancestor
56198924|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198925|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56198926|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56198927|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
56198929|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198930|NCT01515813|Tenofovir|tenofovir|mesh-list
56179803|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56179804|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179805|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56179806|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56179807|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56179808|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56179809|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179810|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
56179811|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179812|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179813|NCT01401933|Rifampin|rifampin|mesh-list
56179814|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56179815|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
56179816|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56179817|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179818|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
56179819|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56179820|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198931|NCT01515813|Emtricitabine|emtricitabine|mesh-list
56198932|NCT01515813|Efavirenz|efavirenz|mesh-list
56198933|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55753072|NCT05713721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665394|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
56665395|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
56665396|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
56665397|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665398|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56665399|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56226638|NCT03922451|Cefazolin|cefazolin|mesh-list
56198934|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56198935|NCT01515813|Pravastatin|pravastatin|mesh-list
56198936|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
55767152|NCT04591431|Trastuzumab|trastuzumab|mesh-list
56199053|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56199054|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56199055|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199056|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56199057|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56199058|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199179|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56199180|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199181|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56199182|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
56199183|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56199184|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
56199185|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199188|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
56199189|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
56199190|NCT01516866|Protective Agents|protective agents|mesh-ancestor
56199191|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199192|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56199193|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199194|NCT01516944|Capecitabine|capecitabine|mesh-list
56199195|NCT01516944|Tegafur|tegafur|mesh-list
56199196|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
56199197|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56199198|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
56199199|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199200|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199201|NCT01516996|Docetaxel|docetaxel|mesh-list
56199367|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56199368|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
56179821|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179822|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56179823|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56179824|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56179825|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56179826|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56179827|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56179828|NCT01402024|Aprepitant|aprepitant|mesh-list
56179829|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
56179830|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
56179831|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179832|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179833|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56179834|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56179835|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199502|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56199503|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56199504|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
56199505|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199506|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199538|NCT01518712|Metformin|metformin|mesh-list
56199539|NCT01518712|Canagliflozin|canagliflozin|mesh-list
56199540|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199541|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199542|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56199543|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665400|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56665401|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56665402|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56665403|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56665404|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
56665405|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56665406|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
56199544|NCT01518725|Vitamin D|vitamin d|mesh-list
56199545|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
56199546|NCT01518725|Vitamins|vitamins|mesh-ancestor
56199547|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
56199548|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199549|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56199986|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56199987|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56199988|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56199989|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
56199990|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213214|NCT02567409|Gemcitabine|gemcitabine|mesh-list
56200281|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200282|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
56200283|NCT01523093|Ondansetron|ondansetron|mesh-list
56200284|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
56200285|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
56200286|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200287|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200288|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56200289|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
56200290|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
56200291|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56200292|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
56200293|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200294|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200295|NCT01523093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56200296|NCT01523093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56200297|NCT01523093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200298|NCT01523093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56200299|NCT01523093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56200300|NCT01523119|Ondansetron|ondansetron|mesh-list
56200301|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
56179836|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179837|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
56179838|NCT01402076|Midazolam|midazolam|mesh-list
56179839|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56179840|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56179841|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179842|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179843|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56179844|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56179845|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179846|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56179847|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
56179848|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
56179849|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
56179850|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
56179851|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200302|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
56200303|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200304|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200305|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56200306|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
56200307|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
56200308|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56200309|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
56200310|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200311|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200312|NCT01523119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56200313|NCT01523119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56200314|NCT01523119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200315|NCT01523119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56665407|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665408|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
56665409|NCT05290727|Protective Agents|protective agents|mesh-ancestor
56665410|NCT00729976|Ibuprofen|ibuprofen|mesh-list
56665411|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56665412|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56665413|NCT00729976|Analgesics|analgesics|mesh-ancestor
56665414|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
56665415|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665416|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665417|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200316|NCT01523119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56200317|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
56200318|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200319|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
56200320|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56200321|NCT01523314|Dexamethasone|dexamethasone|mesh-list
56200322|NCT01523314|Bevacizumab|bevacizumab|mesh-list
56200323|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56200324|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200325|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
56200326|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
56200327|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200328|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200329|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56200330|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
56200332|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200333|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56200334|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200335|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56200336|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56200337|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56200338|NCT01523314|Growth Substances|growth substances|mesh-ancestor
56200339|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
56200938|NCT01526525|Parecoxib|parecoxib|mesh-list
56200939|NCT01526525|Ketamine|ketamine|mesh-list
56200940|NCT01526525|Morphine|morphine|mesh-list
56200941|NCT01526525|Tramadol|tramadol|mesh-list
56200942|NCT01526525|Analgesics|analgesics|mesh-ancestor
56200943|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
56200944|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200945|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179852|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179853|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179854|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56179855|NCT01402089|Sunitinib|sunitinib|mesh-list
56179856|NCT01402089|Midazolam|midazolam|mesh-list
56179857|NCT01402089|Caffeine|caffeine|mesh-list
56179858|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56179859|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56200946|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56201161|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201162|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201163|NCT01527474|Citalopram|citalopram|mesh-list
56201164|NCT01527474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56201165|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56201166|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55735541|NCT03126539|Sulforaphane|sulforaphane|mesh-list
56201251|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201252|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
56201290|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
56201291|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201292|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201425|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
56201426|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665418|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56665419|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56665420|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665421|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226660|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
56201427|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56201428|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56201429|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201430|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201431|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56201432|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56201433|NCT01528930|Amikacin|amikacin|mesh-list
56201463|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201464|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
56201465|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201466|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
56201467|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201468|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56201469|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201470|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201472|NCT01529164|Fluorouracil|fluorouracil|mesh-list
56201473|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
56201474|NCT01529164|Endostar protein|endostar protein|mesh-list
56201475|NCT01529164|Endostatins|endostatins|mesh-list
56201476|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
56201477|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201478|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56201479|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201480|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201482|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201653|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56201655|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55736330|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56201686|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201687|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201689|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56201690|NCT01530022|Analgesics|analgesics|mesh-ancestor
56201691|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
56201692|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201693|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56201694|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56201762|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201763|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201764|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56201765|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56201766|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201767|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56179860|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179861|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179862|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56179863|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56179864|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179865|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56201769|NCT01530451|Coagulants|coagulants|mesh-ancestor
56201770|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56202222|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202223|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56202224|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56202225|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
56202226|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202227|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202228|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56202229|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
56202230|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56202231|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56202232|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202233|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665422|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
56665423|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
56665424|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56202234|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56202235|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56202236|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
56202237|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56202238|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56202239|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56202240|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56202241|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56202243|NCT01533220|Naphazoline|naphazoline|mesh-list
56202244|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202245|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56202246|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56202247|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
56202248|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202249|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202250|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
56202251|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56202252|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
56202253|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
56202254|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
56202255|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56202256|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
56202257|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
56202258|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56202259|NCT01533272|Tenofovir|tenofovir|mesh-list
56202260|NCT01533272|Emtricitabine|emtricitabine|mesh-list
56202261|NCT01533272|Lopinavir|lopinavir|mesh-list
56202262|NCT01533272|Maraviroc|maraviroc|mesh-list
56202263|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
56202264|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202265|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56202266|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56202267|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202268|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202269|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56202270|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56202271|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56202272|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56202273|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
56202274|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56202275|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56202276|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56202277|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56202278|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56202279|NCT01533324|Leucovorin|leucovorin|mesh-list
56202280|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56202281|NCT01533324|Antidotes|antidotes|mesh-ancestor
56202282|NCT01533324|Protective Agents|protective agents|mesh-ancestor
56179866|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
56179867|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
56179868|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
56179869|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
56179870|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179871|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179872|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179873|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56107595|NCT01120249|Everolimus|everolimus|mesh-list
56179874|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179875|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56179876|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56179877|NCT01402089|Growth Substances|growth substances|mesh-ancestor
56179878|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
56179879|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56179880|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56202283|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202284|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
56202403|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202404|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
56202405|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56665425|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56665426|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665427|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56665428|NCT02451553|Capecitabine|capecitabine|mesh-list
56665429|NCT02451553|Afatinib|afatinib|mesh-list
56665430|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56665431|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
56665432|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665433|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665434|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56665435|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665436|NCT02636816|Carbetocin|carbetocin|mesh-list
56665437|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
56665438|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56202406|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202407|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202408|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56202572|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56202573|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56202574|NCT01535079|Ibuprofen|ibuprofen|mesh-list
56202575|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56202576|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56202577|NCT01535079|Analgesics|analgesics|mesh-ancestor
56202578|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
56202579|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202580|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202581|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56202582|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56202583|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56202584|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202585|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202586|NCT01535092|Silybin|silybin|mesh-list
56202587|NCT01535092|Protective Agents|protective agents|mesh-ancestor
56202588|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202589|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56202590|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202591|NCT01535157|Ketoconazole|ketoconazole|mesh-list
56202592|NCT01535157|Fenretinide|fenretinide|mesh-list
56202593|NCT01535157|Retinamide|retinamide|mesh-list
56202594|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
56202595|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202596|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56202597|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56202598|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202599|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202600|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56202601|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
56202602|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56202604|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56179881|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56179882|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56179883|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
56179885|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56179886|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179887|NCT01402193|Anastrozole|anastrozole|mesh-list
56179888|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56179889|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179890|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56179891|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56665439|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665440|NCT00730054|Clonidine|clonidine|mesh-list
56665441|NCT00730054|Remifentanil|remifentanil|mesh-list
56665442|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56665443|NCT00730054|Narcotics|narcotics|mesh-ancestor
56665444|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665445|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665446|NCT00730054|Analgesics|analgesics|mesh-ancestor
56665447|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
56665448|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179892|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179893|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179894|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56179895|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
56202605|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202606|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56202607|NCT01535157|Protective Agents|protective agents|mesh-ancestor
56202608|NCT01535170|Lactoferrin|lactoferrin|mesh-list
56202609|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202610|NCT01535183|Irinotecan|irinotecan|mesh-list
56202611|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56202612|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56202613|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202614|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202615|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202616|NCT01535417|Celecoxib|celecoxib|mesh-list
56202617|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56202618|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56202619|NCT01535417|Analgesics|analgesics|mesh-ancestor
56202620|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
56202621|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202622|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202623|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56202624|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56202625|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56202626|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56202627|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202628|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202629|NCT01535469|Fluconazole|fluconazole|mesh-list
56202630|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
56202631|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202632|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56202633|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56202634|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202635|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202636|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56202637|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
56202638|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56202639|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202640|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56202641|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56202642|NCT01535495|Propranolol|propranolol|mesh-list
56202643|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56202644|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56202645|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
56202646|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202647|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179896|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179897|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179898|NCT01402245|Vaccines|vaccines|mesh-list
56179899|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55871627|NCT01023724|Ketorolac|ketorolac|mesh-list
55753074|NCT05713721|Protective Agents|protective agents|mesh-ancestor
56665449|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56665450|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
56665451|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
56665452|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56665453|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56665454|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56665455|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
56665456|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665457|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665458|NCT00866619|Vaccines|vaccines|mesh-list
56665459|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
56665460|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665461|NCT00693108|Testosterone|testosterone|mesh-list
56665462|NCT00693108|Androgens|androgens|mesh-ancestor
56665463|NCT00693108|Hormones|hormones|mesh-ancestor
56202648|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202649|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56202650|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56202651|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
56202652|NCT01535547|Isavuconazole|isavuconazole|mesh-list
56202653|NCT01535547|Tacrolimus|tacrolimus|mesh-list
56202654|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202655|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
56202656|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202657|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56202658|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202659|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202660|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
56202661|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202662|NCT01535612|Insulin|insulin|mesh-list
56202663|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202664|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202665|NCT01535677|Metformin|metformin|mesh-list
56202666|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
56202667|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202668|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202669|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56202670|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202671|NCT01535690|Methylene Blue|methylene blue|mesh-list
56202672|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202673|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202674|NCT01535768|Travoprost|travoprost|mesh-list
56202675|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56202676|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56202677|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56202678|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56202679|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56202680|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56202681|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56202682|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
56202683|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202684|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202685|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202686|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
56202687|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56202688|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56202689|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202690|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
56202691|NCT01535781|Coagulants|coagulants|mesh-ancestor
56202692|NCT01535820|Ortho Evra|ortho evra|mesh-list
56202693|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56665464|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56665465|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665466|NCT00884390|Factor VIII|factor viii|mesh-list
56665467|NCT00884390|Coagulants|coagulants|mesh-ancestor
56665468|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
56665469|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56665470|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
56665471|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665472|NCT02723669|Expectorants|expectorants|mesh-ancestor
56665473|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
56665474|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56665475|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
56665476|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665477|NCT02723669|Protective Agents|protective agents|mesh-ancestor
56665478|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665479|NCT02723669|Antidotes|antidotes|mesh-ancestor
56665480|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56665481|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
56665482|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665483|NCT00689442|Atorvastatin|atorvastatin|mesh-list
56665484|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
56202694|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
56202695|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56202696|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202697|NCT01535859|Cabergoline|cabergoline|mesh-list
56202698|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56202699|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56202700|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
56202701|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
56202702|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202703|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202704|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202705|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56202706|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56130433|NCT01926288|Entecavir|entecavir|mesh-list
56202707|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
56202708|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202709|NCT01535989|Sirolimus|sirolimus|mesh-list
56202710|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56202711|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56179900|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
56179901|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179902|NCT01402297|Acetovanillone|acetovanillone|mesh-list
56202712|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202713|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56202714|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202715|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
56202716|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202717|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
56202718|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202719|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56202720|NCT01536002|Propofol|propofol|mesh-list
56202721|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56202722|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665485|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56665486|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56665487|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
56665488|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665489|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56665490|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56665491|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665492|NCT02625636|Glucagon|glucagon|mesh-list
56665493|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56665494|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56665495|NCT02625636|Hormones|hormones|mesh-ancestor
56665496|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226724|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202723|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740655|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
56202724|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56202729|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
56202730|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
56202731|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56202732|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
56202733|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56202734|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202735|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202736|NCT01536054|Sirolimus|sirolimus|mesh-list
56202737|NCT01536054|Sargramostim|sargramostim|mesh-list
56202738|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56202739|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202740|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56202741|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202742|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
56202743|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202744|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
56202745|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202746|NCT01536132|Simendan|simendan|mesh-list
56202747|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56202748|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
56202749|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56202750|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56202751|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202752|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202753|NCT01536132|Protective Agents|protective agents|mesh-ancestor
56202754|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202755|NCT01536158|Acetaminophen|acetaminophen|mesh-list
56202756|NCT01536158|Ibuprofen|ibuprofen|mesh-list
56202757|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56202758|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56202759|NCT01536158|Analgesics|analgesics|mesh-ancestor
56202760|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
56202761|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202762|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202763|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56202764|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56202765|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56202766|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202767|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202768|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
56202770|NCT01536223|Docetaxel|docetaxel|mesh-list
56202771|NCT01536223|Fluorouracil|fluorouracil|mesh-list
56202772|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202773|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
56202774|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
56665497|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665498|NCT02625636|Incretins|incretins|mesh-ancestor
56665499|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
56665500|NCT03012100|Vaccines|vaccines|mesh-list
56665501|NCT03012100|Sargramostim|sargramostim|mesh-list
56665502|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
56665503|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665504|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202775|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
56202776|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202777|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
56202778|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56202779|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202780|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
56202781|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202782|NCT01536249|Pramipexole|pramipexole|mesh-list
56179903|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56179904|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56179905|NCT01402297|Analgesics|analgesics|mesh-ancestor
56202783|NCT01536249|Cimetidine|cimetidine|mesh-list
56202784|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56202785|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56202786|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56202787|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
56202788|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
56202789|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202790|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202791|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202792|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56202793|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56202794|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202795|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
56202796|NCT01536249|Protective Agents|protective agents|mesh-ancestor
56202798|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56202799|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
56202800|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
56202801|NCT01536301|Morphine|morphine|mesh-list
56202802|NCT01536301|Oxycodone|oxycodone|mesh-list
56202803|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56202804|NCT01536301|Narcotics|narcotics|mesh-ancestor
56202805|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56202806|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202807|NCT01536301|Analgesics|analgesics|mesh-ancestor
56202808|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
56202809|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202811|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56202812|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56202813|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
56202814|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202815|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202816|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202817|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56202818|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56202819|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56202820|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56202821|NCT01536431|Insulin|insulin|mesh-list
56202822|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56202823|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202824|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202825|NCT01536470|Norepinephrine|norepinephrine|mesh-list
56202826|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56202827|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56202828|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
56202829|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202830|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202831|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202832|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
56202833|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
56665505|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56665506|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56665507|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
56665508|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665509|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665510|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56665511|NCT02379247|Paclitaxel|paclitaxel|mesh-list
56665512|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56665513|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665514|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
56665515|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
56127927|NCT04403724|Analgesics|analgesics|mesh-ancestor
56202834|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202835|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56202836|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
56202837|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
56202838|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56202839|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202840|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202841|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
56202842|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
56202843|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56202844|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202845|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202846|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
56202847|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
56202848|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56202849|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202850|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202851|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
56179906|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
56179907|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179908|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179909|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56179910|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56179911|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
56179912|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179913|NCT01402297|Protective Agents|protective agents|mesh-ancestor
56179914|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179915|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56179916|NCT01402336|Cetrorelix|cetrorelix|mesh-list
56179917|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56179918|NCT01402336|Hormones|hormones|mesh-ancestor
56179919|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179920|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179921|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
56179922|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56179923|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
56179924|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56179925|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56179926|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56202852|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
56202853|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56202854|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202855|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202856|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
56202857|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
56202858|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56202859|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56665516|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
56665517|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665518|NCT00689520|Vitamin K|vitamin k|mesh-list
56665519|NCT00689520|Tinzaparin|tinzaparin|mesh-list
56665520|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56665521|NCT00689520|Dalteparin|dalteparin|mesh-list
56665522|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
56665523|NCT00689520|Vitamins|vitamins|mesh-ancestor
56665524|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
56665525|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665526|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56202860|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202861|NCT01536665|Liraglutide|liraglutide|mesh-list
56202862|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202863|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202864|NCT01536665|Incretins|incretins|mesh-ancestor
56202865|NCT01536665|Hormones|hormones|mesh-ancestor
56202866|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56202867|NCT01536691|Ondansetron|ondansetron|mesh-list
56202868|NCT01536691|Aprepitant|aprepitant|mesh-list
56202869|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
56202870|NCT01536691|Ramosetron|ramosetron|mesh-list
56202871|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
56202872|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
56202873|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202874|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202875|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56202876|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
56202877|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
56202878|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56202879|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
56202880|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179928|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56179929|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
56179930|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
56179932|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56179933|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
56179934|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179935|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179936|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56179937|NCT01402583|Ribavirin|ribavirin|mesh-list
56179938|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
56179939|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179940|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
56179941|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179942|NCT01402596|Midazolam|midazolam|mesh-list
56179943|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
56179944|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56179945|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56179946|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179947|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179948|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56179949|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56179950|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56179951|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56179952|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
56179953|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
56179954|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
56179955|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
56179956|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179957|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179958|NCT01402622|Propofol|propofol|mesh-list
56179959|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
56179960|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56202881|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202882|NCT01536691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56202883|NCT01536691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56665527|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56665528|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665529|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
56665530|NCT00689520|Coagulants|coagulants|mesh-ancestor
56665531|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
56665532|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56665533|NCT02723513|Xenon|xenon|mesh-list
56665534|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56665535|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
56665536|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
56665537|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665538|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665539|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
56665540|NCT02916862|Calcium|calcium|mesh-list
56665541|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56202884|NCT01536691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56202885|NCT01536691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56202886|NCT01536691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56202887|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56202888|NCT01536717|Carticaine|carticaine|mesh-list
56202889|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
56202890|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
56202891|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179961|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179962|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56202892|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202893|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
56202894|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202896|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202897|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56202898|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202899|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202900|NCT01536873|Dolutegravir|dolutegravir|mesh-list
56202901|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56202902|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56202903|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202904|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202905|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56202906|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56202907|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
56202908|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202909|NCT01537055|Amoxicillin|amoxicillin|mesh-list
56202910|NCT01537055|Levofloxacin|levofloxacin|mesh-list
56202911|NCT01537055|Ofloxacin|ofloxacin|mesh-list
56202912|NCT01537055|Lansoprazole|lansoprazole|mesh-list
56202913|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
56202914|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56202915|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202916|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56202917|NCT01537055|Renal Agents|renal agents|mesh-ancestor
56202918|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56202919|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56202920|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202921|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202922|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202923|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56202924|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56202925|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56202926|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56202927|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56202928|NCT01537094|Vitamins|vitamins|mesh-list
56202929|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
56665542|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665543|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56665544|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56665545|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56665546|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56202930|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
56202931|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740831|NCT02051309|Guanfacine|guanfacine|mesh-list
56202932|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
56202933|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202934|NCT01537094|Protective Agents|protective agents|mesh-ancestor
56202935|NCT01537107|Sirolimus|sirolimus|mesh-list
56202936|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56202937|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56202938|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202939|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56202940|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202941|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
56202942|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202943|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
56202944|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202945|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56202946|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202947|NCT01537146|Ropivacaine|ropivacaine|mesh-list
56202948|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
56202949|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
56202950|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56202951|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202952|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
56202953|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202954|NCT01537250|Levofloxacin|levofloxacin|mesh-list
56202955|NCT01537250|Ofloxacin|ofloxacin|mesh-list
56202956|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56202957|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202958|NCT01537250|Renal Agents|renal agents|mesh-ancestor
56202959|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56202960|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56202961|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56202962|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179963|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56179964|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
56202963|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202964|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202965|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56202966|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56202968|NCT01537354|Beractant|beractant|mesh-list
56202969|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56202970|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
56202971|NCT01537380|Cefazolin|cefazolin|mesh-list
56202972|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56202973|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202974|NCT01537471|Meclizine|meclizine|mesh-list
56202975|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
56202976|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
56202977|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
56202978|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202979|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202980|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56202981|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56202982|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
56202983|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
56202984|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202985|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202986|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56202987|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
56202988|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56202989|NCT01537575|Antibodies|antibodies|mesh-list
56202990|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
56202991|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56202992|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
56202993|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665547|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
56665548|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665549|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665550|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665551|NCT02723279|Urological Agents|urological agents|mesh-ancestor
56665552|NCT02615301|Vitamin D|vitamin d|mesh-list
56665553|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
56665554|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
56665555|NCT02615301|Vitamins|vitamins|mesh-list
56665556|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
56665557|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665558|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56202994|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56202995|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202996|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56202997|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
56202998|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202999|NCT01537744|Azacitidine|azacitidine|mesh-list
56203000|NCT01537744|Romidepsin|romidepsin|mesh-list
56203001|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56203002|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
56203003|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203004|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203005|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203006|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56203007|NCT01537770|Lidocaine|lidocaine|mesh-list
56203008|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
56130739|NCT04275024|Calcipotriene|calcipotriene|mesh-list
56203009|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
56203010|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203011|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203012|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
56203013|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203014|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56203015|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56203016|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56203017|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56203018|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203019|NCT01537809|Vitamin D|vitamin d|mesh-list
56203020|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
56203021|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
56203022|NCT01537809|Vitamins|vitamins|mesh-list
56203023|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
56203024|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203025|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56203026|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56203027|NCT01537861|Thalidomide|thalidomide|mesh-list
56203028|NCT01537861|Dexamethasone|dexamethasone|mesh-list
56203029|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
56203030|NCT01537861|Lenalidomide|lenalidomide|mesh-list
56203031|NCT01537861|Bortezomib|bortezomib|mesh-list
56203032|NCT01537861|Pomalidomide|pomalidomide|mesh-list
56203033|NCT01537861|Lenograstim|lenograstim|mesh-list
56203034|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56203035|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
56179965|NCT01402674|Phentermine|phentermine|mesh-list
56179966|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56179967|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179968|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
56179969|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56179970|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
56179971|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
56179972|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179973|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
56179974|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665559|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56665560|NCT02570230|Ketamine|ketamine|mesh-list
56665561|NCT02570230|Analgesics|analgesics|mesh-ancestor
56665562|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
56665563|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665564|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665565|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56665566|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56665567|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
56179975|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179976|NCT01402843|Valsartan|valsartan|mesh-list
56179977|NCT01402843|Pitavastatin|pitavastatin|mesh-list
56179978|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56179979|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56203036|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203037|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55740921|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203038|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56203039|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
56203040|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203041|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203042|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56203043|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203044|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
56203045|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
56203046|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203047|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203048|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
56203049|NCT01537861|Hormones|hormones|mesh-ancestor
56203050|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203051|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56203052|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56203053|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56203054|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56203055|NCT01537861|Growth Substances|growth substances|mesh-ancestor
56203056|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
56203057|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
56203058|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56203059|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203060|NCT01538095|Trebananib|trebananib|mesh-list
56203061|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56203062|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56203063|NCT01538095|Growth Substances|growth substances|mesh-ancestor
56203064|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203065|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
56203066|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203067|NCT01538108|Paclitaxel|paclitaxel|mesh-list
56203068|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56203069|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203070|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
56203071|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
56203072|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
56203073|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203074|NCT01538225|Nabiximols|nabiximols|mesh-list
56203075|NCT01538225|Analgesics|analgesics|mesh-ancestor
56203076|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
56203077|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203078|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203079|NCT01538316|Genistein|genistein|mesh-list
56179980|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56179981|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179982|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56179983|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56179984|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56203080|NCT01538316|Quercetin|quercetin|mesh-list
56665568|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
56665569|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665570|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56665571|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56203081|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
56130813|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
56203082|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203083|NCT01538316|Protective Agents|protective agents|mesh-ancestor
56203084|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203085|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56203086|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203087|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56203088|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203089|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
56203090|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55741015|NCT03377725|Decitabine|decitabine|mesh-list
56203094|NCT01538329|Amantadine|amantadine|mesh-list
56203095|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56203096|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56203097|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
56203098|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203099|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
56203100|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203101|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203102|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203103|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56203104|NCT01538329|Analgesics|analgesics|mesh-ancestor
56203105|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
56203106|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203107|NCT01538381|Afatinib|afatinib|mesh-list
56203108|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203109|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56203110|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203111|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203112|NCT01538394|Nicotine|nicotine|mesh-list
56203113|NCT01538394|Varenicline|varenicline|mesh-list
56203114|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56203115|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
56203116|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203117|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203118|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56203119|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56203120|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
56203121|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203122|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203123|NCT01538446|Clopidogrel|clopidogrel|mesh-list
56203124|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56203125|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56203126|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56203127|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56203128|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56203129|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
56203130|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203131|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203132|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203133|NCT01538459|Dexamethasone|dexamethasone|mesh-list
56203134|NCT01538459|Bupivacaine|bupivacaine|mesh-list
56203135|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203136|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
56203137|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
56203138|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203139|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203140|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203141|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
56203142|NCT01538459|Hormones|hormones|mesh-ancestor
56179985|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
56179986|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56179987|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56179988|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
56179989|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55872201|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
56665572|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665573|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665574|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
56665575|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
56665576|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665577|NCT02718911|Durvalumab|durvalumab|mesh-list
56203143|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203144|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56203145|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203146|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
56203147|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
56203148|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203149|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
56203150|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
56203151|NCT01538485|Vitamin D|vitamin d|mesh-list
56203152|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56203153|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203154|NCT01538485|Vitamins|vitamins|mesh-ancestor
56203155|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
56203156|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56203157|NCT01538511|Insulin|insulin|mesh-list
56203158|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56203160|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
56203161|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56203162|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
56203163|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56203164|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203165|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203166|NCT01538537|ON 01910|on 01910|mesh-list
56203167|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203168|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56203169|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203170|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203171|NCT01538563|ON 01910|on 01910|mesh-list
56203172|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203173|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56203174|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203175|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203176|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
56203177|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203178|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203179|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
56203180|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203181|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203182|NCT01538641|Gemcitabine|gemcitabine|mesh-list
56203183|NCT01538641|Rituximab|rituximab|mesh-list
56203184|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
56203185|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56203186|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203187|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
56203188|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203189|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56203190|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56203191|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
56203192|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203193|NCT01538641|Antiviral Agents|antiviral agents|mesh-ancestor
56203194|NCT01538641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203195|NCT01538641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203196|NCT01538641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56203197|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
56203198|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56203199|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203200|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56203201|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56203202|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203203|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203204|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798450|NCT04916509|Palbociclib|palbociclib|mesh-list
56665578|NCT02718911|Tremelimumab|tremelimumab|mesh-list
56665579|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56665580|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665581|NCT00697905|Gemcitabine|gemcitabine|mesh-list
56665582|NCT00697905|Carboplatin|carboplatin|mesh-list
56665583|NCT00697905|Fluorouracil|fluorouracil|mesh-list
56665584|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665585|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56203205|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56179990|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56179991|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179992|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
56203206|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56203207|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
56203208|NCT01538693|Dexetimide|dexetimide|mesh-list
56203209|NCT01538693|Citalopram|citalopram|mesh-list
56203210|NCT01538693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56203211|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56203212|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56203213|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203214|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203215|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
56203216|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203217|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56203218|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
56203219|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56203220|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56203221|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56203222|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
56203223|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
56203224|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203225|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56203226|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56203227|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
56203228|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
56203229|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
56203230|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203231|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56203232|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
56130959|NCT04127058|Iloperidone|iloperidone|mesh-list
56203233|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
56203234|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56203235|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56203236|NCT01538732|Alitretinoin|alitretinoin|mesh-list
56203237|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203238|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
56203239|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
56203240|NCT01538771|Hematinics|hematinics|mesh-ancestor
56203242|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56203243|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56203244|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203245|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56203246|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
56203247|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
56203248|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203249|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203250|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203251|NCT01538849|Esomeprazole|esomeprazole|mesh-list
56203252|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56203253|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203254|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56203255|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203256|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203258|NCT01538875|Hydralazine|hydralazine|mesh-list
56203259|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56203260|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56203261|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
56203262|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665586|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
56665587|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665588|NCT00697905|Antiviral Agents|antiviral agents|mesh-ancestor
56665589|NCT00697905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665590|NCT00697905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665591|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665592|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
56665593|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665594|NCT02718755|Cytarabine|cytarabine|mesh-list
56665595|NCT02718755|Fludarabine|fludarabine|mesh-list
56203263|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203264|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203265|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56203266|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
56203267|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
56203268|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203269|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56203270|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56203271|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
56203272|NCT01538901|Imiquimod|imiquimod|mesh-list
56203273|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56203274|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
56179993|NCT01402882|Coagulants|coagulants|mesh-ancestor
56179994|NCT01403025|Liraglutide|liraglutide|mesh-list
56179995|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56179996|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179997|NCT01403025|Incretins|incretins|mesh-ancestor
56179998|NCT01403025|Hormones|hormones|mesh-ancestor
56179999|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180000|NCT01403103|Vitamin D|vitamin d|mesh-list
56180001|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
56180002|NCT01403103|Vitamins|vitamins|mesh-ancestor
56180003|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
56180004|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180005|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56180006|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56180007|NCT01403168|Analgesics|analgesics|mesh-list
56180008|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
56203275|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203276|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203277|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
56203278|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56203279|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
56203280|NCT01538927|Coagulants|coagulants|mesh-ancestor
56203281|NCT01538940|Vaccines|vaccines|mesh-list
56203282|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
56203283|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203284|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56203285|NCT01538953|Disinfectants|disinfectants|mesh-list
56203287|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203288|NCT01539018|Sorafenib|sorafenib|mesh-list
56203289|NCT01539018|Tegafur|tegafur|mesh-list
56203290|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203291|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55741183|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56203293|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203294|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56203295|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
56203296|NCT01539031|Donepezil|donepezil|mesh-list
56203297|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56203298|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203299|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203300|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
56203301|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203302|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203303|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
56203304|NCT01539044|Atropine|atropine|mesh-list
56203305|NCT01539044|Neostigmine|neostigmine|mesh-list
56665596|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
56665597|NCT02718755|Asparaginase|asparaginase|mesh-list
56665598|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665599|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56665600|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
56665601|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665602|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665603|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
56665604|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665605|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
56665606|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665607|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
56665608|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56665609|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665610|NCT00730288|Vaccines|vaccines|mesh-list
56226841|NCT03693677|Paclitaxel|paclitaxel|mesh-list
56203306|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56203307|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56203308|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56203309|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
56203310|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203311|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203312|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56203313|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
56203314|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
56203315|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
56203316|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56203317|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56203318|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
56203319|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203320|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180009|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180010|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180012|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56180013|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
56180014|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180015|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
56180016|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180017|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
56203321|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56203322|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203323|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56203324|NCT01539174|Prednisone|prednisone|mesh-list
56203325|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
56203326|NCT01539174|Rituximab|rituximab|mesh-list
56203327|NCT01539174|Doxorubicin|doxorubicin|mesh-list
56203328|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56203329|NCT01539174|Vincristine|vincristine|mesh-list
56203330|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56203331|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
56203332|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203333|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56203334|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56203335|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
56203336|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203337|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203338|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56203339|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56203340|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56665611|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
56665612|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665613|NCT00872898|Memantine|memantine|mesh-list
56665614|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56665615|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56665616|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
56665617|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665618|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665619|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547650|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665620|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56203341|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56203342|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56203344|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203345|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
56203346|NCT01539174|Hormones|hormones|mesh-ancestor
56203347|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203348|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56203349|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56203350|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
56203351|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
56203352|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
56203353|NCT01539265|Silodosin|silodosin|mesh-list
56203354|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56203355|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56203356|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56203357|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
56203358|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203359|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203360|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203361|NCT01539265|Urological Agents|urological agents|mesh-ancestor
56203362|NCT01539330|Voriconazole|voriconazole|mesh-list
56203363|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
56203364|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203365|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56203366|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56203367|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203368|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203369|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56203370|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
56203371|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203372|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203373|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56203374|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
56203375|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56203376|NCT01539408|Misoprostol|misoprostol|mesh-list
56180018|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180019|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
56203377|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56203378|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
56203379|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56203380|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203381|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56203382|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203383|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
56203384|NCT01539473|Tedizolid|tedizolid|mesh-list
56203385|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
56203387|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56203388|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203389|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
56203390|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
56203391|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665621|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56665623|NCT02723435|Staurosporine|staurosporine|mesh-list
56203392|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203393|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56203394|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56203395|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56203396|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203397|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
56203398|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203399|NCT01539564|Minocycline|minocycline|mesh-list
56203400|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56203401|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203402|NCT01539577|Dexamethasone|dexamethasone|mesh-list
56203403|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203404|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
56203405|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
56203406|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203407|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203408|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203409|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
56203410|NCT01539577|Hormones|hormones|mesh-ancestor
56203411|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203412|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56203413|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203414|NCT01539603|Sirolimus|sirolimus|mesh-list
56203415|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56203416|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741293|NCT03370705|Captopril|captopril|mesh-list
56203417|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56203418|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203419|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
56203420|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56203421|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
56203422|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203423|NCT01539616|Fenofibrate|fenofibrate|mesh-list
56203424|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56203425|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
56203426|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203427|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56203428|NCT01539655|Omeprazole|omeprazole|mesh-list
56203429|NCT01539655|Ranitidine|ranitidine|mesh-list
56203430|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56203431|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56203432|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203433|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56203434|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203435|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203436|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56203437|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
56203438|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
56203439|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203440|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203441|NCT01539681|Sorafenib|sorafenib|mesh-list
56203442|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203443|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56203444|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203445|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203446|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
56203447|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56203448|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56180020|NCT01403285|Molgramostim|molgramostim|mesh-list
56180021|NCT01403285|Imiquimod|imiquimod|mesh-list
56180022|NCT01403285|Sargramostim|sargramostim|mesh-list
56180023|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56203449|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
56203450|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203451|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203452|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203453|NCT01539707|Urological Agents|urological agents|mesh-ancestor
56203455|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
56203456|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56203457|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
56131188|NCT02959164|Gemcitabine|gemcitabine|mesh-list
56203458|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56665624|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665625|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56665626|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665627|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665628|NCT02718677|Factor VIII|factor viii|mesh-list
56665629|NCT02718677|Coagulants|coagulants|mesh-ancestor
56203459|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203461|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56203462|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56203463|NCT01539733|Haloperidol|haloperidol|mesh-list
56203464|NCT01539733|Olanzapine|olanzapine|mesh-list
56203465|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
56203466|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
56203467|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
56203468|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203469|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203470|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203471|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56203472|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56203473|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203474|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56203475|NCT01539733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56203476|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56203477|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56203478|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203479|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203480|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
56203481|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56203482|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
56203483|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56203484|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55741369|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
56203485|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
56203486|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56203487|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
56203488|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203489|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56203490|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56203491|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
56203492|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203493|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203494|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56203496|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56203497|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56203498|NCT01540032|Analgesics|analgesics|mesh-ancestor
56203499|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
56203500|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203501|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203502|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203503|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56203505|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203506|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203507|NCT01540084|Propofol|propofol|mesh-list
56203508|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56203509|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203510|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203511|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56203512|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
56203513|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
56203514|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
56203515|NCT01540110|Docetaxel|docetaxel|mesh-list
56203516|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56203517|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
56180024|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
56180025|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180026|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56203518|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203519|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55798451|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56665630|NCT04132011|Morphine|morphine|mesh-list
56665631|NCT04132011|Oxycodone|oxycodone|mesh-list
56665632|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
56665633|NCT04132011|Hydromorphone|hydromorphone|mesh-list
56665634|NCT04132011|Narcotics|narcotics|mesh-ancestor
56665635|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56665636|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665637|NCT04132011|Analgesics|analgesics|mesh-ancestor
56226860|NCT03673826|Lenalidomide|lenalidomide|mesh-list
56203520|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56203521|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
56203522|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203523|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203524|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56203525|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56203526|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56203527|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56203528|NCT01540136|Nedaplatin|nedaplatin|mesh-list
56203529|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203530|NCT01540240|Zidovudine|zidovudine|mesh-list
56203531|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
56203532|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203533|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56203534|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56203535|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203536|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
56203537|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203538|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56203539|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56203540|NCT01540435|Bevacizumab|bevacizumab|mesh-list
56203541|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56203542|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203543|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56203544|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56203545|NCT01540435|Growth Substances|growth substances|mesh-ancestor
56203546|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203547|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
56203548|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
56203549|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56203550|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56203551|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203552|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203553|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56203554|NCT01540500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56203555|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56203556|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56203557|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203558|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203559|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
56203560|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56203561|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
56203562|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56203563|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56203564|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203565|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56203567|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203568|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56203569|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203570|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203571|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56203572|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56203573|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56203574|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56203575|NCT01540682|Cetuximab|cetuximab|mesh-list
56203576|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56203577|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665638|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
56665639|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665640|NCT00693576|Simvastatin|simvastatin|mesh-list
56665641|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56665642|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56665643|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
56665644|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226867|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
56203578|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56203579|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56203580|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
56203581|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203582|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203583|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56180027|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56203584|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
56203585|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
56203587|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203588|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
56203589|NCT01540721|Acetaminophen|acetaminophen|mesh-list
56203590|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56203591|NCT01540721|Analgesics|analgesics|mesh-ancestor
56203592|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
56203593|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203594|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203595|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
56203596|NCT01540734|Acetaminophen|acetaminophen|mesh-list
56203597|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56203598|NCT01540734|Analgesics|analgesics|mesh-ancestor
56203599|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
56203600|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203601|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203602|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
56203603|NCT01540747|Folic Acid|folic acid|mesh-list
56203604|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
56203605|NCT01540747|Inositol|inositol|mesh-list
56203606|NCT01540747|Melatonin|melatonin|mesh-list
56203607|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
56203608|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203609|NCT01540747|Protective Agents|protective agents|mesh-ancestor
56203610|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203611|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203612|NCT01540747|Hematinics|hematinics|mesh-ancestor
56203613|NCT01540747|Vitamins|vitamins|mesh-ancestor
56203614|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
56203615|NCT01540812|Cytarabine|cytarabine|mesh-list
56203616|NCT01540812|Dexamethasone|dexamethasone|mesh-list
56203617|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
56203618|NCT01540812|Prednisone|prednisone|mesh-list
56203619|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
56203620|NCT01540812|Fludarabine|fludarabine|mesh-list
56203621|NCT01540812|Vincristine|vincristine|mesh-list
56203622|NCT01540812|Daunorubicin|daunorubicin|mesh-list
56203623|NCT01540812|Idarubicin|idarubicin|mesh-list
56203624|NCT01540812|Methotrexate|methotrexate|mesh-list
56203625|NCT01540812|Pegaspargase|pegaspargase|mesh-list
56203626|NCT01540812|Asparaginase|asparaginase|mesh-list
56203627|NCT01540812|BB 1101|bb 1101|mesh-list
56203628|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203629|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
56203630|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
56203631|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203632|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203633|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203634|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
56203635|NCT01540812|Hormones|hormones|mesh-ancestor
56203636|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203637|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56203638|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203639|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
56203640|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665645|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56665646|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56665647|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665648|NCT04116047|Durvalumab|durvalumab|mesh-list
55855810|NCT04149574|Nivolumab|nivolumab|mesh-list
56203641|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203642|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56203643|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
56203644|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56203645|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
56203646|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
56203647|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203648|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56203649|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56203650|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56203651|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56203652|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56203657|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56203658|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
56203659|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56203660|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56180028|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
56180029|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180030|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180031|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56180032|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56180033|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
56180034|NCT01403363|Fentanyl|fentanyl|mesh-list
56180035|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56180036|NCT01403363|Narcotics|narcotics|mesh-ancestor
56180037|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180038|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180039|NCT01403363|Analgesics|analgesics|mesh-ancestor
56180040|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
56180041|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180042|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56180043|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56180044|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
56203661|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56203662|NCT01540877|Anesthetics|anesthetics|mesh-list
56203663|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56203664|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
56203665|NCT01540877|Capsaicin|capsaicin|mesh-list
56203666|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203667|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203668|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
56203669|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203670|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
56203671|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
56203672|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56203673|NCT01541059|Ropivacaine|ropivacaine|mesh-list
56203674|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
56203675|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
56203676|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203677|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203678|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
56203679|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203680|NCT01541072|Lenograstim|lenograstim|mesh-list
56203681|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56203682|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
56203683|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203684|NCT01541085|Ritonavir|ritonavir|mesh-list
56203685|NCT01541085|Darunavir|darunavir|mesh-list
56203686|NCT01541085|Efavirenz|efavirenz|mesh-list
56203687|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56203688|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56203689|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
56203690|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203691|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203692|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56203693|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56665649|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665650|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56665651|NCT00693732|Citalopram|citalopram|mesh-list
56665652|NCT00693732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56665653|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56665654|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56665655|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665656|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665657|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
56665658|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665659|NCT00693732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56665660|NCT00693732|Antidepressive Agents|antidepressive agents|mesh-ancestor
56665661|NCT00693732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56665662|NCT00689598|Spironolactone|spironolactone|mesh-list
56665663|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56665664|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
56665665|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56665666|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226877|NCT03662685|Coal Tar|coal tar|mesh-list
56203694|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
56203695|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741584|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203696|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56203697|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56203698|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56203699|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56203700|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56180045|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
56180046|NCT01403389|Eculizumab|eculizumab|mesh-list
55872821|NCT01893281|Hormones|hormones|mesh-ancestor
56203701|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56203702|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56203709|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203710|NCT01541124|Analgesics|analgesics|mesh-ancestor
56203711|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
56203712|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203713|NCT01541137|Diclofenac|diclofenac|mesh-list
56203714|NCT01541137|Parecoxib|parecoxib|mesh-list
56203715|NCT01541137|Valdecoxib|valdecoxib|mesh-list
56203716|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56203717|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56203718|NCT01541137|Analgesics|analgesics|mesh-ancestor
56203719|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
56203720|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203721|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203722|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203723|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56203724|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56203725|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203726|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203727|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56203728|NCT01541189|Valsartan|valsartan|mesh-list
56665667|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56665668|NCT00689598|Diuretics|diuretics|mesh-ancestor
56665669|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
56665670|NCT04163354|Listerine|listerine|mesh-list
56665671|NCT04163354|Fluorides|fluorides|mesh-list
56665672|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
56665673|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
56665674|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
56665675|NCT04163354|Protective Agents|protective agents|mesh-ancestor
56665676|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665677|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56665678|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665679|NCT04131621|Nivolumab|nivolumab|mesh-list
56665680|NCT04131621|Ipilimumab|ipilimumab|mesh-list
56665681|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56203729|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56203730|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56203731|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56203732|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203734|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56203735|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56203736|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56203737|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203738|NCT01541280|Azacitidine|azacitidine|mesh-list
56203739|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56203740|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
56203741|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203742|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203743|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203744|NCT01541293|Lidocaine|lidocaine|mesh-list
56203745|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
56203746|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
56203747|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203748|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203749|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
56203750|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203751|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56203752|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56203753|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56203754|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56203755|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203756|NCT01541332|Dexamethasone|dexamethasone|mesh-list
56203757|NCT01541332|Doxorubicin|doxorubicin|mesh-list
56203758|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56203759|NCT01541332|Pomalidomide|pomalidomide|mesh-list
56203760|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203761|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
56203762|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
56203763|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203764|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203765|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56203766|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
56203767|NCT01541332|Hormones|hormones|mesh-ancestor
56203768|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203769|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56180047|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56180048|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180050|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180051|NCT01403415|Sirolimus|sirolimus|mesh-list
56180052|NCT01403415|Dexamethasone|dexamethasone|mesh-list
56665682|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665683|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56665684|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665685|NCT00689832|Fluticasone|fluticasone|mesh-list
56665686|NCT00689832|Tacrolimus|tacrolimus|mesh-list
56180053|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
56180054|NCT01403415|Methotrexate|methotrexate|mesh-list
56180055|NCT01403415|Vincristine|vincristine|mesh-list
56180056|NCT01403415|Asparaginase|asparaginase|mesh-list
56180057|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
56180058|NCT01403415|Pegaspargase|pegaspargase|mesh-list
56180059|NCT01403415|BB 1101|bb 1101|mesh-list
56180060|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180061|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
56180062|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
56180063|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180064|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203770|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203771|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56203772|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56203773|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56203774|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203775|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203776|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
56203777|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56203778|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56203779|NCT01541332|Growth Substances|growth substances|mesh-ancestor
56203780|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56203781|NCT01541436|Capsaicin|capsaicin|mesh-list
56203782|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
56203783|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
56203784|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
56203785|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203786|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203787|NCT01541475|Dexetimide|dexetimide|mesh-list
56203788|NCT01541475|Citalopram|citalopram|mesh-list
56203789|NCT01541475|Bupropion|bupropion|mesh-list
56203790|NCT01541475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56203791|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56203792|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56203793|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203794|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203795|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
56203796|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203797|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56203798|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
56203799|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56203800|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56203801|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56203802|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
56203803|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
56203804|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203805|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56203806|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56203807|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
56203808|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56203809|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
56203810|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56203811|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56180065|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56180066|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
56203812|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203813|NCT01541605|Methylphenidate|methylphenidate|mesh-list
56203814|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56203815|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203816|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56203817|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56203818|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56203819|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203820|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
56665687|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665688|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
56665689|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665690|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56665691|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665692|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665693|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56665694|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56665695|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
56665696|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665697|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56665698|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
56665699|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
56665700|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56665701|NCT02718521|Isosorbide|isosorbide|mesh-list
56665702|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56665703|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56665704|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56665705|NCT02718521|Diuretics|diuretics|mesh-ancestor
56665706|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
56226915|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56203821|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203822|NCT01541631|Albendazole|albendazole|mesh-list
56203823|NCT01541631|Praziquantel|praziquantel|mesh-list
56203824|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
56203825|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56203826|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203827|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
56203828|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56203829|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56203830|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
56203831|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
56203832|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
56203833|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203834|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203835|NCT01541670|Antibodies|antibodies|mesh-list
56203836|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
56203837|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203838|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56203839|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56203840|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56203841|NCT01541943|Losartan|losartan|mesh-list
56203842|NCT01541943|Atorvastatin|atorvastatin|mesh-list
56203843|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56203844|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56203845|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
56203846|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203847|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56203848|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56203849|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203850|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56203851|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56203852|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56203853|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56203854|NCT01541956|Metformin|metformin|mesh-list
56665707|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665708|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
56665709|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56665710|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665711|NCT02718599|Terlipressin|terlipressin|mesh-list
56665712|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56665713|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56665714|NCT00693966|Vaccines|vaccines|mesh-list
56203855|NCT01541956|Vildagliptin|vildagliptin|mesh-list
56203856|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203857|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203858|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56203859|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
56203860|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203861|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203862|NCT01542047|Carboplatin|carboplatin|mesh-list
56203863|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203864|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
56203865|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
56203866|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56203867|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203868|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203869|NCT01542099|Remifentanil|remifentanil|mesh-list
56203870|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56203871|NCT01542099|Narcotics|narcotics|mesh-ancestor
56203872|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203873|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203874|NCT01542099|Analgesics|analgesics|mesh-ancestor
56203875|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
56203876|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203877|NCT01542138|Niacinamide|niacinamide|mesh-list
56203878|NCT01542138|Niacin|niacin|mesh-list
56203879|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
56203880|NCT01542138|Desonide|desonide|mesh-list
56203881|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
56203882|NCT01542138|Vitamins|vitamins|mesh-ancestor
56203883|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
55873024|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56203884|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203885|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56203886|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
56203887|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203888|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56203889|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
56203890|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203891|NCT01542190|Ketorolac|ketorolac|mesh-list
56203892|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56203893|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56203894|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56203895|NCT01542190|Analgesics|analgesics|mesh-ancestor
56203896|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
56203897|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203898|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203899|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56203900|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56203901|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56203902|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203903|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203904|NCT01542242|Liraglutide|liraglutide|mesh-list
56203905|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203906|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203907|NCT01542242|Incretins|incretins|mesh-ancestor
56203908|NCT01542242|Hormones|hormones|mesh-ancestor
56203909|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203910|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
56203911|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56203912|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203913|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665715|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
56665716|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665717|NCT00694044|Varenicline|varenicline|mesh-list
56665718|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56665719|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56665720|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
56665721|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665722|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665723|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665724|NCT02722811|Etanercept|etanercept|mesh-list
56665725|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56665726|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56665727|NCT02722811|Analgesics|analgesics|mesh-ancestor
56665728|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
56665729|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665730|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665731|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56665732|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56665733|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56665734|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665735|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
56665736|NCT04136886|Cisplatin|cisplatin|mesh-list
56665737|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203914|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56203915|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56203916|NCT01542268|Protective Agents|protective agents|mesh-ancestor
56203917|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203918|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
56203919|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56203920|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
56203921|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
56203922|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203923|NCT01542424|Insulin|insulin|mesh-list
56203924|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56203925|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
56203926|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
56203927|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
56203928|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56203929|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203930|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203931|NCT01542437|Afatinib|afatinib|mesh-list
56203932|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203933|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56203934|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203935|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203936|NCT01542450|Insulin|insulin|mesh-list
56203937|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56203938|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
56203939|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
56203940|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
56203941|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
56203942|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55931815|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
56665738|NCT00534313|Abatacept|abatacept|mesh-list
56665739|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56665740|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665741|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56203943|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203944|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
56203945|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203946|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203947|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
56203948|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203949|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203950|NCT01542489|Insulin|insulin|mesh-list
56203951|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56203952|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
56203953|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
56203954|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56203955|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203956|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
56180068|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180069|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56180070|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180071|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56180072|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
56180073|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56180074|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56180075|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
56180076|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180077|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
56203957|NCT01542697|Analgesics|analgesics|mesh-ancestor
56203958|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
56203959|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56203960|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203961|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
55741817|NCT04523077|Antibodies|antibodies|mesh-list
56203962|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56203963|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56203965|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56203966|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56203967|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741853|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
56203968|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56203969|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
56203970|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56203971|NCT01542710|Timolol|timolol|mesh-list
56203972|NCT01542710|Bimatoprost|bimatoprost|mesh-list
56203973|NCT01542710|Travoprost|travoprost|mesh-list
56203974|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56203975|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56203976|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
56203977|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56203978|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203979|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56203980|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56203981|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56203982|NCT01542723|Nadroparin|nadroparin|mesh-list
56203983|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
56203984|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56203985|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56203986|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203987|NCT01542762|Nadroparin|nadroparin|mesh-list
56203988|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
56203989|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56203990|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56203991|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203992|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
56203993|NCT01542801|Norfloxacin|norfloxacin|mesh-list
56203994|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56203995|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56203996|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56203997|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56665742|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665743|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
56665744|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665745|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56665746|NCT00694200|Bevacizumab|bevacizumab|mesh-list
56665747|NCT00694200|Vinorelbine|vinorelbine|mesh-list
56665748|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56203998|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203999|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204000|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204001|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56204002|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56204004|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
56204005|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204006|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204007|NCT01542918|Rituximab|rituximab|mesh-list
56204008|NCT01542918|Lenalidomide|lenalidomide|mesh-list
56180078|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873163|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
56204009|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56204010|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204011|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
56204012|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204013|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204014|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56204015|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56204016|NCT01542918|Growth Substances|growth substances|mesh-ancestor
56204017|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
56204018|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56204019|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
56204020|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204021|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56204022|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56204023|NCT01543139|Valproic Acid|valproic acid|mesh-list
56204024|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
56204025|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204026|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204027|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
56204028|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204029|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204030|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
56204031|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56204032|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204033|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56204034|NCT01543165|Ketorolac|ketorolac|mesh-list
56204035|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56204036|NCT01543165|Morphine|morphine|mesh-list
56204037|NCT01543165|Analgesics|analgesics|mesh-list
56204038|NCT01543165|Nefopam|nefopam|mesh-list
56204039|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56204040|NCT01543165|Narcotics|narcotics|mesh-ancestor
56204041|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204048|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204049|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56204050|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204051|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204052|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
56204053|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56204054|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56204055|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56204056|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204057|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
56204058|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204059|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204060|NCT01543347|Temocillin|temocillin|mesh-list
56204061|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56204062|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204063|NCT01543386|Curcumin|curcumin|mesh-list
56204064|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56665749|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665750|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56665751|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56665752|NCT00694200|Growth Substances|growth substances|mesh-ancestor
56665753|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665754|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
56665755|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56665756|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56665757|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56665758|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56665759|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665760|NCT02722733|Cytarabine|cytarabine|mesh-list
56665761|NCT02722733|Lenograstim|lenograstim|mesh-list
56665762|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56665763|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
56665764|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665765|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56665766|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
56204065|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56204066|NCT01543386|Analgesics|analgesics|mesh-ancestor
56204067|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
56204068|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204069|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204070|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204071|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204072|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204073|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204074|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204075|NCT01543399|Tibolone|tibolone|mesh-list
56204076|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
56204077|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
56204078|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204079|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180079|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56180080|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180081|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
56180082|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56180083|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56180084|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56180085|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
56180086|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
56180087|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
56180088|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56180089|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180090|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56180091|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
56180092|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
56204080|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56204081|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56204082|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204083|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56204084|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
56204086|NCT01543464|Temozolomide|temozolomide|mesh-list
56204087|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56204088|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
55931984|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226990|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56665767|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665768|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665769|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
56665770|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665771|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665772|NCT02722421|Efavirenz|efavirenz|mesh-list
56665773|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
56665774|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56665775|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56665776|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204089|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204090|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204091|NCT01543555|Atorvastatin|atorvastatin|mesh-list
56204092|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56204093|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56204094|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
56204097|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56204098|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204099|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
56204100|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
56204101|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56204102|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204103|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204104|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
56204105|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56204106|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204107|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204108|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
56204109|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56204110|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
56204111|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204112|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
56204113|NCT01543737|Protective Agents|protective agents|mesh-ancestor
56204114|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
56204115|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56204116|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56204117|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204118|NCT01543906|Retinol acetate|retinol acetate|mesh-list
55742014|NCT03364075|Analgesics|analgesics|mesh-ancestor
56204119|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56204120|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
56204121|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204122|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56204123|NCT01543906|Protective Agents|protective agents|mesh-ancestor
56204124|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204125|NCT01543932|Clopidogrel|clopidogrel|mesh-list
56180093|NCT01403415|Analgesics|analgesics|mesh-ancestor
56180094|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
56180095|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56180096|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56180097|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
56204126|NCT01543932|Ticagrelor|ticagrelor|mesh-list
56204127|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56204128|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56204129|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56204130|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56204131|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56204132|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
56131887|NCT01458054|Ritonavir|ritonavir|mesh-list
56204133|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204134|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204135|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227017|NCT03523520|Naltrexone|naltrexone|mesh-list
56227018|NCT03523520|Bromides|bromides|mesh-list
56227019|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
56227020|NCT03523520|Naloxegol|naloxegol|mesh-list
56227021|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
56665777|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227022|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56665778|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
56665779|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665780|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56665781|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56665782|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56665783|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56665784|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56665785|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56665786|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56665787|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
56665788|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56665789|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665790|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56665791|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56665792|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56665793|NCT02617290|Clopidogrel|clopidogrel|mesh-list
56665794|NCT02617290|Ticagrelor|ticagrelor|mesh-list
56665795|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56665796|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56665797|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56665798|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56129428|NCT01847274|Niraparib|niraparib|mesh-list
56204136|NCT01543945|Dexamethasone|dexamethasone|mesh-list
56204137|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
56204138|NCT01543945|Ondansetron|ondansetron|mesh-list
56204139|NCT01543945|Antiemetics|antiemetics|mesh-list
56204140|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
56204141|NCT01543945|BB 1101|bb 1101|mesh-list
56204142|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204143|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
56204144|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204145|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204146|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56204147|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
56204148|NCT01543945|Hormones|hormones|mesh-ancestor
56204149|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204150|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56204151|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665799|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
56665800|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665801|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665802|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665803|NCT02717819|Vitamin D|vitamin d|mesh-list
56665804|NCT02717819|Vitamins|vitamins|mesh-ancestor
56665805|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
56665806|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665807|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56665808|NCT02007655|Apixaban|apixaban|mesh-list
56665809|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56665810|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
56665811|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56665812|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
56665813|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665814|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665815|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
56665816|NCT02611960|Gemcitabine|gemcitabine|mesh-list
56665817|NCT02611960|Capecitabine|capecitabine|mesh-list
56665818|NCT02611960|Docetaxel|docetaxel|mesh-list
56665819|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
56665820|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56665821|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
56665822|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204152|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
55742049|NCT04841499|Niacin|niacin|mesh-list
56204153|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204154|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204155|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
56204156|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
56204157|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56204158|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
56204159|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204161|NCT01543945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56204162|NCT01543945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204163|NCT01543945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56204164|NCT01543945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56204165|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56204166|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
56204167|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
56204168|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56204169|NCT01543971|Lenograstim|lenograstim|mesh-list
56204170|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56204171|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
56204172|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204173|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56204174|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
56204175|NCT01544140|Midazolam|midazolam|mesh-list
56204176|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56204177|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56204178|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204179|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204180|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56204181|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56665823|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665824|NCT02611960|Antiviral Agents|antiviral agents|mesh-ancestor
56665825|NCT02611960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665826|NCT02611960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665827|NCT02611960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665828|NCT02611960|Immunologic Factors|immunologic factors|mesh-ancestor
56204182|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56204183|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56204184|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
56204185|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
56204186|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
56204187|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
56204188|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204189|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204190|NCT01544192|Tocopherols|tocopherols|mesh-list
56204191|NCT01544192|Vitamin E|vitamin e|mesh-list
56180098|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56180099|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
56180100|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180101|NCT01403506|Expectorants|expectorants|mesh-ancestor
56204192|NCT01544192|Tocotrienols|tocotrienols|mesh-list
56204193|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
56204194|NCT01544192|Antioxidants|antioxidants|mesh-list
56204195|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204196|NCT01544192|Protective Agents|protective agents|mesh-ancestor
56204197|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204198|NCT01544192|Vitamins|vitamins|mesh-ancestor
56204199|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
56204200|NCT01544283|Triamcinolone|triamcinolone|mesh-list
56204201|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56204202|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56204203|NCT01544283|Lidocaine|lidocaine|mesh-list
56204204|NCT01544283|Tetracaine|tetracaine|mesh-list
56204205|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56204206|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
56204207|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
56204208|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204209|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204210|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
56204211|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204212|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56204213|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56204214|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56204215|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56204216|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204217|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204219|NCT01544283|Hormones|hormones|mesh-ancestor
56204220|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204221|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56204222|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
56204223|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204224|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
56204225|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204226|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
56204227|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
56204228|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
56204229|NCT01544504|Norepinephrine|norepinephrine|mesh-list
56204230|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56204231|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56204232|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
56204233|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204234|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204236|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
56204237|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
56204238|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204239|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56204240|NCT01544517|Amoxicillin|amoxicillin|mesh-list
56204241|NCT01544517|Levofloxacin|levofloxacin|mesh-list
56204242|NCT01544517|Ofloxacin|ofloxacin|mesh-list
56204243|NCT01544517|Tinidazole|tinidazole|mesh-list
56204244|NCT01544517|Esomeprazole|esomeprazole|mesh-list
56204245|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56204246|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56665829|NCT02611960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665830|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
56665831|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
56665832|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
56227125|NCT03383380|Sirolimus|sirolimus|mesh-list
56204247|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204248|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56204249|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56204250|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204251|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204252|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56204253|NCT01544517|Renal Agents|renal agents|mesh-ancestor
56204254|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56204255|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56204256|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204257|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56204258|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56204259|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
56204260|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56180102|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
56204261|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56204262|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56204263|NCT01544634|Beclomethasone|beclomethasone|mesh-list
56204264|NCT01544634|Propranolol|propranolol|mesh-list
56204265|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56204266|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56204267|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56204268|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204269|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204270|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204271|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56204272|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56204273|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
56204274|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204275|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
56204277|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204278|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56204279|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
56204280|NCT01544673|Linezolid|linezolid|mesh-list
56204281|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56204282|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204283|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56204284|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204285|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204287|NCT01544725|Propofol|propofol|mesh-list
56204288|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56204289|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204290|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204291|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56204292|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
56204293|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
56204294|NCT01544725|Analgesics|analgesics|mesh-ancestor
56204295|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
56204296|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204297|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56204298|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56204299|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56204300|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204301|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204302|NCT01544751|Metformin|metformin|mesh-list
56204303|NCT01544751|Atorvastatin|atorvastatin|mesh-list
56204304|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204305|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204306|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56204307|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56204308|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
56204309|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204310|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56204311|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56665833|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56665834|NCT05298462|Antibodies|antibodies|mesh-list
56665835|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
56665836|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665837|NCT00730366|Chloroquine|chloroquine|mesh-list
56665838|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
56665839|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
56665840|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56665841|NCT00730366|Amebicides|amebicides|mesh-ancestor
56665842|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56665843|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56665844|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204312|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204313|NCT01544829|Theobromine|theobromine|mesh-list
56204314|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56204315|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
56204316|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204317|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204318|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56204319|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
56204320|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
56204321|NCT01544842|Triamcinolone|triamcinolone|mesh-list
56204322|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56204323|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56204324|NCT01544842|Tacrolimus|tacrolimus|mesh-list
56204325|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56204326|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56204327|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
56204328|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204329|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56204330|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204331|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204332|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204333|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
56204334|NCT01544842|Hormones|hormones|mesh-ancestor
56180103|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56204335|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204336|NCT01544881|Insulin|insulin|mesh-list
56204337|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204338|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204339|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56204340|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
56204341|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56204342|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
56204343|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204344|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204345|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56204346|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56204347|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56204348|NCT01544907|Paclitaxel|paclitaxel|mesh-list
56204349|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56204350|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204351|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
55742253|NCT00700791|Vitamin E|vitamin e|mesh-list
56204352|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
56204353|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
56204354|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204356|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56204357|NCT01544959|Esmolol|esmolol|mesh-list
56204358|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56204359|NCT01544959|Narcotics|narcotics|mesh-ancestor
56204360|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204361|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204363|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
56665845|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
56665846|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56665847|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56665848|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665849|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665850|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56665852|NCT02722343|Tenofovir|tenofovir|mesh-list
56665853|NCT02722343|Emtricitabine|emtricitabine|mesh-list
56665854|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56665855|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
56665856|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665857|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56665858|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56665859|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665860|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665861|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56665862|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56665863|NCT00694590|Plerixafor|plerixafor|mesh-list
56665864|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56665865|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56665866|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
56665867|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665868|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56665869|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665870|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204364|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204365|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56204366|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56204367|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
56204368|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
56204369|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56204370|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
56204371|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742307|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204372|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204373|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56204374|NCT01544972|Acetaminophen|acetaminophen|mesh-list
56204375|NCT01544972|Ibuprofen|ibuprofen|mesh-list
56204376|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56204377|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56204378|NCT01544972|Analgesics|analgesics|mesh-ancestor
56204379|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
56204380|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204381|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204382|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204383|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204384|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56204385|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798801|NCT03053167|Irinotecan|irinotecan|mesh-list
56665871|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665872|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56665873|NCT03903406|Dexamethasone|dexamethasone|mesh-list
56665874|NCT03903406|Lenalidomide|lenalidomide|mesh-list
56665875|NCT03903406|Ixazomib|ixazomib|mesh-list
56665876|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56665877|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
56665878|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
56665879|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665880|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227164|NCT03234686|Deferiprone|deferiprone|mesh-list
56204386|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204387|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
56204388|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56204389|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204390|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204391|NCT01545024|Incretins|incretins|mesh-ancestor
56204392|NCT01545024|Hormones|hormones|mesh-ancestor
56204393|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204394|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56204395|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
56204396|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204397|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204398|NCT01545284|Acitretin|acitretin|mesh-list
56204399|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
56204400|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
56204401|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
56204402|NCT01545297|Remifentanil|remifentanil|mesh-list
56204403|NCT01545297|Propofol|propofol|mesh-list
56204404|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55742361|NCT04468425|Tofacitinib|tofacitinib|mesh-list
56204405|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180104|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
56180105|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204406|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204407|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56204408|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
56204409|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
56204410|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56204411|NCT01545297|Analgesics|analgesics|mesh-ancestor
56204412|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
56204413|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204414|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56204415|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56204416|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56204417|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
56204418|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204419|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204420|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56204421|NCT01545297|Narcotics|narcotics|mesh-ancestor
56204422|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
56204423|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204424|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56204425|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204426|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204427|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56204428|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
56204429|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204430|NCT01545479|Captopril|captopril|mesh-list
56204431|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56204432|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
56204433|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204434|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204435|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56204436|NCT01545635|Thrombin|thrombin|mesh-list
56665881|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56665882|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
56665883|NCT03903406|Hormones|hormones|mesh-ancestor
56665884|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56665885|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56665886|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204437|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
56204438|NCT01545635|Coagulants|coagulants|mesh-ancestor
56204439|NCT01545778|Oxycodone|oxycodone|mesh-list
56204440|NCT01545778|Tapentadol|tapentadol|mesh-list
56204441|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56204442|NCT01545778|Narcotics|narcotics|mesh-ancestor
56204443|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204444|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204445|NCT01545778|Analgesics|analgesics|mesh-ancestor
56204446|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
56204447|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204448|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56204449|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56204450|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56204451|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204452|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
56204453|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204454|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
56204455|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204456|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204457|NCT01545804|Lenalidomide|lenalidomide|mesh-list
56204458|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
56204459|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204460|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56204461|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56204462|NCT01545804|Growth Substances|growth substances|mesh-ancestor
56204463|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
56204464|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204465|NCT01545830|Vitamin D|vitamin d|mesh-list
56204466|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
56204467|NCT01545830|Vitamins|vitamins|mesh-ancestor
56204468|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
56204469|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204470|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56144850|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204471|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56204472|NCT01545856|Levodopa|levodopa|mesh-list
56204473|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56204474|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56204475|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
56204476|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180106|NCT01403506|Protective Agents|protective agents|mesh-ancestor
56180107|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180108|NCT01403506|Antidotes|antidotes|mesh-ancestor
56180109|NCT01403545|Curcumin|curcumin|mesh-list
56204477|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204478|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204479|NCT01545947|Azacitidine|azacitidine|mesh-list
56204480|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56204481|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56204482|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
56204483|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204484|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204485|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204486|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56204487|NCT01546051|BCI-838|bci-838|mesh-list
56204488|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56204489|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56204490|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204491|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204492|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204493|NCT01546090|Alprazolam|alprazolam|mesh-list
56204494|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56665887|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
56204495|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204496|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204497|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56204498|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56204499|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56204500|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
56204501|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
56204502|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204503|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204504|NCT01546103|Vitamin D|vitamin d|mesh-list
56204505|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
56204506|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
56204507|NCT01546103|Vitamins|vitamins|mesh-list
56204508|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
56204509|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204510|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56204511|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56204512|NCT01546116|Lamivudine|lamivudine|mesh-list
56204513|NCT01546116|Adefovir|adefovir|mesh-list
56204514|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56204515|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56204516|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56204517|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204518|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204519|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
56204520|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204521|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56204522|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56204523|NCT01546389|Chloroquine|chloroquine|mesh-list
56204524|NCT01546389|Amebicides|amebicides|mesh-ancestor
56204525|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56204528|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
56204529|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204530|NCT01546558|Metformin|metformin|mesh-list
56204531|NCT01546558|Ranolazine|ranolazine|mesh-list
56204532|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204533|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204534|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56204535|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56204536|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204537|NCT01546597|Metformin|metformin|mesh-list
56204538|NCT01546597|Ranolazine|ranolazine|mesh-list
56204539|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204540|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204541|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56204542|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56204543|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204544|NCT01546701|Morphine|morphine|mesh-list
56204545|NCT01546701|Buprenorphine|buprenorphine|mesh-list
56180110|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56180111|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873727|NCT01082380|Crizotinib|crizotinib|mesh-list
56204546|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56204547|NCT01546701|Narcotics|narcotics|mesh-ancestor
56204548|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204549|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204550|NCT01546701|Analgesics|analgesics|mesh-ancestor
56204551|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
56204552|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204553|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56204555|NCT01546896|Buspirone|buspirone|mesh-list
56204556|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56204557|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204558|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204559|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56204560|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56204561|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56204562|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
56204563|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
56204564|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204565|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204566|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56204567|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
56204568|NCT01546935|Oseltamivir|oseltamivir|mesh-list
56204569|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
56204570|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665888|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56665889|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56665890|NCT03903406|Growth Substances|growth substances|mesh-ancestor
56665891|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
56665892|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
56665893|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665894|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665895|NCT00594204|Varenicline|varenicline|mesh-list
56665896|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56665897|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56665898|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
56665899|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56665900|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665901|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665902|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
56665903|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665904|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56665905|NCT00999271|Hormones|hormones|mesh-list
56665906|NCT00999271|Incretins|incretins|mesh-list
56665907|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56665908|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204571|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204572|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204573|NCT01546961|Chloroquine|chloroquine|mesh-list
56204574|NCT01546961|Amebicides|amebicides|mesh-ancestor
56204575|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56204576|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56204577|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204578|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
56204579|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204580|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
56204581|NCT01547104|Glimepiride|glimepiride|mesh-list
56204582|NCT01547104|Linagliptin|linagliptin|mesh-list
56204583|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56204584|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204585|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204586|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56204587|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
56204588|NCT01547104|Incretins|incretins|mesh-ancestor
56204589|NCT01547104|Hormones|hormones|mesh-ancestor
56204590|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204591|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56204592|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
56204593|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144947|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204594|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204595|NCT01547143|Cyclosporine|cyclosporine|mesh-list
56204596|NCT01547143|Dexamethasone|dexamethasone|mesh-list
56204598|NCT01547143|Cyclosporins|cyclosporins|mesh-list
56204599|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
56204600|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204601|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
56204602|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
56204603|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56665909|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56665910|NCT04620304|UB-421|ub-421|mesh-list
56665911|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56665912|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
56665913|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204604|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204605|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56204606|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
56204607|NCT01547143|Hormones|hormones|mesh-ancestor
56204608|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204609|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56204610|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204611|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204612|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204613|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56204614|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56204615|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56204616|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180112|NCT01403545|Analgesics|analgesics|mesh-ancestor
56180113|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
56180114|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873794|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
56204617|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
56204618|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
56204619|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204620|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
56204621|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204622|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56204623|NCT01547169|Insulin|insulin|mesh-list
56204624|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56204625|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
56204626|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204627|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204628|NCT01547221|Clotrimazole|clotrimazole|mesh-list
56204629|NCT01547221|Miconazole|miconazole|mesh-list
56204630|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56204631|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204632|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
56204633|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56204634|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56204635|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204636|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204637|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56204638|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
56204639|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204640|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204641|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56204642|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56204643|NCT01547312|Interferons|interferons|mesh-list
56204644|NCT01547312|Ribavirin|ribavirin|mesh-list
56204645|NCT01547312|Grazoprevir|grazoprevir|mesh-list
56204646|NCT01547312|Liver Extracts|liver extracts|mesh-list
56204647|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204648|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
56204649|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204650|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
56204651|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204652|NCT01547312|Hematinics|hematinics|mesh-ancestor
56204653|NCT01547325|Doxycycline|doxycycline|mesh-list
56204654|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56204655|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204656|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
56204657|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56204658|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56204659|NCT01547377|Zinc|zinc|mesh-list
56204660|NCT01547377|Selenium|selenium|mesh-list
56204661|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56204662|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56204663|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56132387|NCT05585814|Pembrolizumab|pembrolizumab|mesh-list
56204664|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
56204665|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665914|NCT02716961|Gemcitabine|gemcitabine|mesh-list
56665915|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665916|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56665917|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
56665918|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665919|NCT02716961|Antiviral Agents|antiviral agents|mesh-ancestor
56665920|NCT02716961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665921|NCT02716961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665922|NCT02716961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665923|NCT02716961|Immunologic Factors|immunologic factors|mesh-ancestor
56665924|NCT02716961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665925|NCT02704156|Gemcitabine|gemcitabine|mesh-list
56665926|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
56665927|NCT02704156|Trametinib|trametinib|mesh-list
56665928|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56665929|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
56665930|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204666|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56204667|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56204668|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204669|NCT01547377|Trace Elements|trace elements|mesh-ancestor
56204670|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
56204671|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204672|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
56204673|NCT01547377|Protective Agents|protective agents|mesh-ancestor
56204675|NCT01547416|Ropivacaine|ropivacaine|mesh-list
56204676|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
56204677|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
56204678|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204679|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204680|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
56204681|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204682|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56204683|NCT01547416|Narcotics|narcotics|mesh-ancestor
56204684|NCT01547416|Analgesics|analgesics|mesh-ancestor
56204685|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56180115|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180116|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180117|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204686|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56204687|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
56204688|NCT01547455|Atorvastatin|atorvastatin|mesh-list
56204689|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56204690|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56204691|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
56204692|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204693|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56204694|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56204695|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204696|NCT01547494|Vitamins|vitamins|mesh-list
56204697|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
56204698|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204699|NCT01547520|Meperidine|meperidine|mesh-list
56204700|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56204701|NCT01547520|Narcotics|narcotics|mesh-ancestor
56204702|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204703|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204704|NCT01547520|Analgesics|analgesics|mesh-ancestor
56204705|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
56665931|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665932|NCT02704156|Antiviral Agents|antiviral agents|mesh-ancestor
56665933|NCT02704156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665934|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665935|NCT02704156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56665936|NCT02704156|Immunologic Factors|immunologic factors|mesh-ancestor
56204706|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204707|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56204708|NCT01547546|GDC-0084|gdc-0084|mesh-list
56204709|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204710|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204711|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
56204712|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56204713|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56145051|NCT00835224|Midodrine|midodrine|mesh-list
56204714|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204715|NCT01548001|Methotrexate|methotrexate|mesh-list
56204716|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56204717|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
56204718|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56204719|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204720|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56204721|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
56204722|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204723|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204724|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
56204725|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204726|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56204727|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56204728|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
56204729|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204730|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56204731|NCT01548027|Anesthetics|anesthetics|mesh-list
56204732|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
56204733|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204734|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204735|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
56204736|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204737|NCT01548066|Valproic Acid|valproic acid|mesh-list
56204738|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
56204739|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204740|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204741|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
56204742|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204743|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204744|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
56204745|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56204746|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204747|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56145087|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
56204749|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56204750|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56204751|NCT01548118|Vaccines|vaccines|mesh-list
56204752|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
56204753|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204754|NCT01548144|Pemetrexed|pemetrexed|mesh-list
56204755|NCT01548144|Crizotinib|crizotinib|mesh-list
56204756|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204757|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204758|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204759|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56204760|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56204761|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56204762|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56204763|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56204764|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56204765|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
56204766|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204767|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56665937|NCT02704156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665938|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56665939|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56665940|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
56665941|NCT00912678|Tacrolimus|tacrolimus|mesh-list
56665942|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55802933|NCT05553067|Antibodies|antibodies|mesh-list
56204768|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56204769|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204770|NCT01548170|Ketoconazole|ketoconazole|mesh-list
56204771|NCT01548170|Sunitinib|sunitinib|mesh-list
56204772|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204773|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56204774|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56204775|NCT01548170|Growth Substances|growth substances|mesh-ancestor
56204776|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204777|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
56204778|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56204779|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204780|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204781|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
56145130|NCT00856050|Letrozole|letrozole|mesh-list
56204782|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204783|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56204784|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56204785|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56204786|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
56204787|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204788|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56204789|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
56204790|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56204791|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204792|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204793|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56204794|NCT01548209|Analgesics|analgesics|mesh-ancestor
56204795|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
56204796|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204797|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56204798|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56204799|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56204800|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
56204801|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204802|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204803|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
56204804|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
56204805|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56204806|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204807|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204808|NCT01548248|Insulin|insulin|mesh-list
56204809|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56204810|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
56204811|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
56132542|NCT04390152|Ritonavir|ritonavir|mesh-list
56204812|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56204813|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204814|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
56204822|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204824|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56204825|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56180118|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180119|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180120|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180121|NCT01403662|Minocycline|minocycline|mesh-list
55874010|NCT04361656|Lubiprostone|lubiprostone|mesh-list
56204826|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
56204827|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204828|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56665943|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
56665944|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665945|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56665946|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665947|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665948|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56665949|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56665950|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56227227|NCT05437471|Progestins|progestins|mesh-ancestor
56204829|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56204830|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204831|NCT01548482|Sirolimus|sirolimus|mesh-list
56204832|NCT01548482|Trebananib|trebananib|mesh-list
56204833|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56204834|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204835|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56204836|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204837|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
56204838|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56204839|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
56204840|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204841|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56204842|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56204843|NCT01548482|Growth Substances|growth substances|mesh-ancestor
56204844|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
56204845|NCT01548521|Oxytocin|oxytocin|mesh-list
56204846|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
56204847|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56204848|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204849|NCT01548560|Dapivirine|dapivirine|mesh-list
56204850|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56204851|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56204852|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
56204853|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204854|NCT01548612|Nitroprusside|nitroprusside|mesh-list
56204855|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56204856|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
56204857|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56204858|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204859|NCT01548677|Trastuzumab|trastuzumab|mesh-list
56204860|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56204861|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204862|NCT01548703|BCI-838|bci-838|mesh-list
56204863|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56204864|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56204865|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204866|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204867|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204868|NCT01548794|Lidocaine|lidocaine|mesh-list
56204869|NCT01548794|Bupivacaine|bupivacaine|mesh-list
56204870|NCT01548794|Anesthetics|anesthetics|mesh-list
56204871|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
56204872|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56204873|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204874|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
56204875|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204876|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56204880|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204882|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204883|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56204884|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
56204885|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132616|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
56204887|NCT01548859|Sevoflurane|sevoflurane|mesh-list
56204888|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55798805|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665951|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
56665952|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56665953|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56665954|NCT00995839|Terlipressin|terlipressin|mesh-list
56204889|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56204890|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180122|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56180123|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180124|NCT01403740|Cyclosporine|cyclosporine|mesh-list
56180125|NCT01403740|Rituximab|rituximab|mesh-list
56180126|NCT01403740|Azathioprine|azathioprine|mesh-list
56180127|NCT01403740|Cyclosporins|cyclosporins|mesh-list
56180128|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56180129|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180130|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
56180131|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180132|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204891|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204892|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56204893|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56204894|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56204895|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56204896|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
56204897|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
56204898|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
56204899|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
56204900|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204901|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204902|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56204903|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56204904|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
56204905|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56204906|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
56204907|NCT01548911|Calicheamicins|calicheamicins|mesh-list
56204908|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56204909|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204910|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56204911|NCT01548924|Paclitaxel|paclitaxel|mesh-list
56204912|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56204913|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204914|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
56204915|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
56204916|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
56204917|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204918|NCT01548950|Bosentan|bosentan|mesh-list
56204919|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
56204920|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
56204921|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56204922|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56204923|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204924|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204925|NCT01548950|Urological Agents|urological agents|mesh-ancestor
56204926|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56204927|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56204928|NCT01549093|Gemcitabine|gemcitabine|mesh-list
56204929|NCT01549093|Carboplatin|carboplatin|mesh-list
56204930|NCT01549093|Endostar protein|endostar protein|mesh-list
56204931|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204932|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56204933|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
56204934|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204935|NCT01549093|Antiviral Agents|antiviral agents|mesh-ancestor
56145350|NCT00894504|Gemcitabine|gemcitabine|mesh-list
56204937|NCT01549093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204938|NCT01549093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56204939|NCT01549093|Immunologic Factors|immunologic factors|mesh-ancestor
56204940|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204941|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56204942|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56204943|NCT01549093|Growth Substances|growth substances|mesh-ancestor
56204944|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
56204946|NCT01549158|Furosemide|furosemide|mesh-list
56180133|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665955|NCT00995839|Vasopressins|vasopressins|mesh-list
56665956|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
56665957|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
56665958|NCT00995839|Coagulants|coagulants|mesh-ancestor
56665959|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56665960|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56665961|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
56665962|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665963|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56665964|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
56665965|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
56665966|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665967|NCT00994513|Protective Agents|protective agents|mesh-ancestor
56665968|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665969|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
56665970|NCT00994513|Vitamins|vitamins|mesh-ancestor
56665971|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
56665972|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
56665973|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56665974|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665975|NCT04577404|Edaravone|edaravone|mesh-list
56180134|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180135|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180136|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
56204947|NCT01549158|Diuretics|diuretics|mesh-ancestor
56204948|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
56204949|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204950|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56204951|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56204952|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204953|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56204954|NCT01549171|Iloprost|iloprost|mesh-list
56204955|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56204956|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
56204957|NCT01549236|Benzonidazole|benzonidazole|mesh-list
56204958|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56204959|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
56204960|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204961|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56204962|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56204963|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56204964|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204965|NCT01549301|Lenograstim|lenograstim|mesh-list
56204966|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56204967|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
56204968|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204969|NCT01549418|Aspirin|aspirin|mesh-list
56204970|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56204971|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56204972|NCT01549418|Analgesics|analgesics|mesh-ancestor
56204973|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
56204974|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204975|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204976|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204977|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56204978|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56665976|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56665977|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
56665978|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665979|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56665980|NCT04577404|Protective Agents|protective agents|mesh-ancestor
56665981|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665982|NCT00995917|Vitamin K|vitamin k|mesh-list
56665983|NCT00995917|Vitamins|vitamins|mesh-ancestor
56665984|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
56665985|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665986|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56665987|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56665988|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665989|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
56665990|NCT00995917|Coagulants|coagulants|mesh-ancestor
56665991|NCT02616822|Resveratrol|resveratrol|mesh-list
56665992|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
56665993|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56665994|NCT02616822|Protective Agents|protective agents|mesh-ancestor
56665995|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56665996|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56665997|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56665998|NCT00912756|Cilostazol|cilostazol|mesh-list
56665999|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56666000|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
56666001|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666002|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666003|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56666004|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
56666005|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56227255|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
56204979|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56204980|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204981|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56204982|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56204983|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204984|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
56204985|NCT01549431|Dexamethasone|dexamethasone|mesh-list
56204986|NCT01549431|Panobinostat|panobinostat|mesh-list
56204987|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204988|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
56204989|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
56204990|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204991|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204992|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56666006|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56666007|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666008|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56666009|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
56666010|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56666011|NCT00912756|Protective Agents|protective agents|mesh-ancestor
56666012|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56666013|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56666014|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666015|NCT04426240|Cyclosporine|cyclosporine|mesh-list
56666016|NCT04426240|Cyclosporins|cyclosporins|mesh-list
56666017|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666018|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666019|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666020|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
56666021|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666022|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
56666023|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666024|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
56666025|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666026|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56666027|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
56666028|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56666029|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666030|NCT00999349|Silymarin|silymarin|mesh-list
56666031|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
56666032|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666033|NCT00999349|Protective Agents|protective agents|mesh-ancestor
56666034|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204993|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
56204994|NCT01549431|Hormones|hormones|mesh-ancestor
56204995|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56204996|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56204997|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56204998|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56204999|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205000|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205001|NCT01549496|Amlodipine|amlodipine|mesh-list
56205002|NCT01549496|Diltiazem|diltiazem|mesh-list
56205003|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56205004|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56205005|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56205006|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799507|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
56666035|NCT02621112|Imiquimod|imiquimod|mesh-list
56666036|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56666037|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
56666038|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666039|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666040|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
56666041|NCT04000789|Vitamins|vitamins|mesh-list
56666042|NCT04000789|Vitamin E|vitamin e|mesh-list
56666043|NCT04000789|Vitamin A|vitamin a|mesh-list
56666044|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
56666045|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
56666046|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666047|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
56666048|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666049|NCT04000789|Protective Agents|protective agents|mesh-ancestor
56666050|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56666051|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
56666052|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
56666053|NCT00697554|Vaccines|vaccines|mesh-list
56666054|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
56666055|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666056|NCT02329847|Nivolumab|nivolumab|mesh-list
56666057|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666058|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666059|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56666060|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666061|NCT00731068|Mitogens|mitogens|mesh-list
56666062|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
56227316|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
56205007|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56180138|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
56180139|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56205012|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56205013|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145417|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205014|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205015|NCT01549574|Crizotinib|crizotinib|mesh-list
56205016|NCT01549574|Esomeprazole|esomeprazole|mesh-list
56205017|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56205018|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205019|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56205020|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205021|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205022|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205023|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56205024|NCT01549600|Psyllium|psyllium|mesh-list
56205025|NCT01549600|Cathartics|cathartics|mesh-ancestor
56205026|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205027|NCT01549691|Alprazolam|alprazolam|mesh-list
56666063|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666064|NCT00866307|Cytarabine|cytarabine|mesh-list
56666065|NCT00866307|Dexamethasone|dexamethasone|mesh-list
56666066|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
56666067|NCT00866307|Prednisone|prednisone|mesh-list
56666068|NCT00866307|Cortisone|cortisone|mesh-list
56666069|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
56666070|NCT00866307|Doxorubicin|doxorubicin|mesh-list
56666071|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56666072|NCT00866307|Methotrexate|methotrexate|mesh-list
56666073|NCT00866307|Vincristine|vincristine|mesh-list
56666074|NCT00866307|Daunorubicin|daunorubicin|mesh-list
56666075|NCT00866307|Asparaginase|asparaginase|mesh-list
56666076|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
56666077|NCT00866307|Pegaspargase|pegaspargase|mesh-list
56666078|NCT00866307|Thioguanine|thioguanine|mesh-list
56666079|NCT00866307|BB 1101|bb 1101|mesh-list
56666080|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
56666081|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666082|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
56666083|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666084|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666085|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56666086|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
56666087|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666088|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666089|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56666090|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666091|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
56666092|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
56666093|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666094|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56666095|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
56666096|NCT00866307|Hormones|hormones|mesh-ancestor
56666097|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56227339|NCT04765514|Temozolomide|temozolomide|mesh-list
56666106|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56666107|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56666108|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
56666109|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
56666110|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56666111|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56666112|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
56666113|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666114|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56666115|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
56666116|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
56666117|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
56666118|NCT00731146|Anesthetics|anesthetics|mesh-list
56666119|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56666120|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666121|NCT02716415|Menthol|menthol|mesh-list
56205028|NCT01549691|Zopiclone|zopiclone|mesh-list
56205029|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56205030|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205031|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205032|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56205033|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56205034|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56205035|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
56132768|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56205036|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
56205037|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205038|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205039|NCT01549704|Ropivacaine|ropivacaine|mesh-list
56205040|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
56205041|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
56205042|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205043|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205044|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
56205045|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205046|NCT01549743|Celecoxib|celecoxib|mesh-list
56205047|NCT01549743|Rebamipide|rebamipide|mesh-list
56205048|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56205049|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56205050|NCT01549743|Analgesics|analgesics|mesh-ancestor
56205051|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
56205052|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205053|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205054|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205055|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205056|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56205057|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56205058|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205059|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205060|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56205061|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205063|NCT01549743|Protective Agents|protective agents|mesh-ancestor
56205064|NCT01549795|Capecitabine|capecitabine|mesh-list
56205065|NCT01549795|Liver Extracts|liver extracts|mesh-list
56205066|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56205067|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
56205068|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205069|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205070|NCT01549795|Hematinics|hematinics|mesh-ancestor
56205071|NCT01549847|Piracetam|piracetam|mesh-list
56666122|NCT02716415|Petrolatum|petrolatum|mesh-list
56666123|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
56666124|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
56666125|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
56666126|NCT02716415|Emollients|emollients|mesh-ancestor
56666127|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
56666128|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56666129|NCT02716415|Protective Agents|protective agents|mesh-ancestor
56666130|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666131|NCT02616354|Imipenem|imipenem|mesh-list
56666132|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56666133|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666134|NCT00731224|Rivastigmine|rivastigmine|mesh-list
56205072|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56205073|NCT01549847|Protective Agents|protective agents|mesh-ancestor
56205074|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205075|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
56205076|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
56205077|NCT01549938|Vitamin D|vitamin d|mesh-list
56205078|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56205079|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205080|NCT01549938|Vitamins|vitamins|mesh-ancestor
56205081|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
56180140|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
56180141|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56205082|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56205083|NCT01549990|Sevoflurane|sevoflurane|mesh-list
56205084|NCT01549990|Desflurane|desflurane|mesh-list
56205085|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56205086|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56205087|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
56205088|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
56205089|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205090|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205091|NCT01550055|Irinotecan|irinotecan|mesh-list
56205092|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56205093|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56205094|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205095|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205096|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205097|NCT01550107|Allopurinol|allopurinol|mesh-list
56205098|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
56205099|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205100|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205101|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
56205102|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205103|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56205104|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
56205105|NCT01550107|Protective Agents|protective agents|mesh-ancestor
56205106|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205107|NCT01550146|Dexamethasone|dexamethasone|mesh-list
56205108|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
56205109|NCT01550146|BB 1101|bb 1101|mesh-list
56205110|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205111|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
56205112|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
56205113|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205114|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205116|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
56205117|NCT01550146|Hormones|hormones|mesh-ancestor
56145531|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205118|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205119|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56205120|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205121|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
56205122|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666135|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56666136|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666137|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666138|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
56666139|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56666140|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666141|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56666142|NCT00731224|Protective Agents|protective agents|mesh-ancestor
56666143|NCT00531427|Buprenorphine|buprenorphine|mesh-list
56666144|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56666145|NCT00531427|Narcotics|narcotics|mesh-ancestor
56666146|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56666147|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666148|NCT00531427|Analgesics|analgesics|mesh-ancestor
56666149|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
56666150|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666151|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56666152|NCT00731302|Aspirin|aspirin|mesh-list
56666153|NCT00731302|Meloxicam|meloxicam|mesh-list
56666154|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56666155|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56666156|NCT00731302|Analgesics|analgesics|mesh-ancestor
56666157|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
56666158|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666159|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227410|NCT03563742|Tenofovir|tenofovir|mesh-list
56205123|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205124|NCT01550302|Bupivacaine|bupivacaine|mesh-list
56205125|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
56205126|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
56205127|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205128|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205129|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
56205130|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205131|NCT01550354|Alfentanil|alfentanil|mesh-list
56205132|NCT01550354|Propofol|propofol|mesh-list
56205133|NCT01550354|Rocuronium|rocuronium|mesh-list
56205134|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56205135|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205136|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205137|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56205138|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
56205139|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
56205140|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56205141|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56205142|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56205143|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205144|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56205145|NCT01550354|Narcotics|narcotics|mesh-ancestor
56205146|NCT01550354|Analgesics|analgesics|mesh-ancestor
56666160|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666161|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666162|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56666163|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56666164|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666165|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56666166|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56666167|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666168|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
56666169|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56666170|NCT00871728|Itraconazole|itraconazole|mesh-list
56666171|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
56666172|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666173|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56666174|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56666175|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666176|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666177|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56666178|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
56666179|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666180|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666181|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56666182|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56666183|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666184|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
56666185|NCT00999427|Povidone|povidone|mesh-list
56666186|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
56205147|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
56205148|NCT01550419|Atorvastatin|atorvastatin|mesh-list
56205149|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56205150|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56180143|NCT01403818|Mitiglinide|mitiglinide|mesh-list
56180144|NCT01403818|Calcium|calcium|mesh-list
56180145|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56180146|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180147|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56180148|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180149|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56180150|NCT01403844|Carotenoids|carotenoids|mesh-list
56180151|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
56180152|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180153|NCT01403844|Protective Agents|protective agents|mesh-ancestor
56180154|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180155|NCT01403896|Plerixafor|plerixafor|mesh-list
56180156|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56666187|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
56666188|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56666189|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666190|NCT04189211|Trastuzumab|trastuzumab|mesh-list
56666191|NCT04189211|Maytansine|maytansine|mesh-list
56666192|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666193|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666194|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56666195|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
56666196|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
56666197|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
56666198|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666199|NCT00364780|XL647|xl647|mesh-list
56666200|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666201|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56666202|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666203|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180157|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56180158|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
56180159|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180160|NCT01403948|BI 836826|bi 836826|mesh-list
56180161|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56180162|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205153|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56205154|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56205155|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205156|NCT01550445|Prednisolone|prednisolone|mesh-list
56205157|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205158|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
56205159|NCT01550445|Hormones|hormones|mesh-ancestor
56205160|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205161|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205162|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56205163|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205164|NCT01550458|Mibefradil|mibefradil|mesh-list
56205165|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56205166|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56205167|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56205168|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205169|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56205170|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205171|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
56205172|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56205173|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56205174|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205175|NCT01550640|Remifentanil|remifentanil|mesh-list
56205176|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56205177|NCT01550640|Narcotics|narcotics|mesh-ancestor
56205178|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205179|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205180|NCT01550640|Analgesics|analgesics|mesh-ancestor
56205181|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
56205182|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205183|NCT01550653|Liraglutide|liraglutide|mesh-list
56205184|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56205185|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666204|NCT00868998|Gemcitabine|gemcitabine|mesh-list
56666205|NCT00868998|Capecitabine|capecitabine|mesh-list
56666206|NCT00868998|Docetaxel|docetaxel|mesh-list
56666207|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56666208|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
56666209|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666210|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666211|NCT00868998|Antiviral Agents|antiviral agents|mesh-ancestor
56666212|NCT00868998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666213|NCT00868998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666214|NCT00868998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666215|NCT00868998|Immunologic Factors|immunologic factors|mesh-ancestor
56227477|NCT02663908|Leuprolide|leuprolide|mesh-list
56205186|NCT01550653|Incretins|incretins|mesh-ancestor
55874416|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
56205187|NCT01550653|Hormones|hormones|mesh-ancestor
56205188|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205190|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56205191|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205192|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205193|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56205194|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
56205195|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
56205196|NCT01550848|Gemcitabine|gemcitabine|mesh-list
56205197|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56205198|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56205199|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
56205200|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205201|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205202|NCT01550848|Antiviral Agents|antiviral agents|mesh-ancestor
56205203|NCT01550848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205204|NCT01550848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205205|NCT01550848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56205206|NCT01550848|Immunologic Factors|immunologic factors|mesh-ancestor
56205207|NCT01550848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205208|NCT01550900|Metformin|metformin|mesh-list
56205209|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56205210|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205211|NCT01550926|Orlistat|orlistat|mesh-list
56205212|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205213|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205214|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56205215|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56205216|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
56205217|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
56205218|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56205219|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56205220|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205221|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205222|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205223|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205224|NCT01551147|Montelukast|montelukast|mesh-list
56205225|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56205226|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
56205227|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56205228|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
56205229|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205230|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205231|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56205232|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56205233|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205234|NCT01551225|Citalopram|citalopram|mesh-list
56205235|NCT01551225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56666216|NCT00868998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666217|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
56666218|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
56666219|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
56666220|NCT00996151|Testosterone|testosterone|mesh-list
56666221|NCT00996151|Androgens|androgens|mesh-ancestor
56666222|NCT00996151|Hormones|hormones|mesh-ancestor
56666223|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666224|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666225|NCT04131231|Aldesleukin|aldesleukin|mesh-list
56666226|NCT04131231|Methotrexate|methotrexate|mesh-list
56666227|NCT04131231|Interleukin-2|interleukin-2|mesh-list
56312391|NCT00080080|Docetaxel|docetaxel|mesh-list
56666228|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56666229|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
56666230|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56666231|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666232|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56666233|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
56666234|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666235|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666236|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
56666237|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666238|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56666239|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666240|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
56666241|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666242|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56666243|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56666244|NCT04131231|Analgesics|analgesics|mesh-ancestor
56666245|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
56666246|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666247|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56666248|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56666249|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
56666255|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666256|NCT00996229|Resveratrol|resveratrol|mesh-list
56666257|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
56666258|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666259|NCT00996229|Protective Agents|protective agents|mesh-ancestor
56666260|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666261|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666262|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56666263|NCT02712671|Interferons|interferons|mesh-list
56666264|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
56666265|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666266|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
56666267|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666268|NCT02614833|Paclitaxel|paclitaxel|mesh-list
56666269|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56666270|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666271|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
56666272|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
56666273|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
56666274|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666275|NCT00999505|Amantadine|amantadine|mesh-list
56666276|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56666277|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56666278|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
56666279|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666280|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
56666281|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56666282|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666283|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205236|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56205237|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56205238|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205239|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205240|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
56205241|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205242|NCT01551225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56205243|NCT01551225|Antidepressive Agents|antidepressive agents|mesh-ancestor
56205244|NCT01551225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56205245|NCT01551290|Infliximab|infliximab|mesh-list
56205246|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
56205247|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205248|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205249|NCT01551329|Ketamine|ketamine|mesh-list
56205250|NCT01551329|Analgesics|analgesics|mesh-ancestor
56205251|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
56205252|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666284|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56666285|NCT00999505|Analgesics|analgesics|mesh-ancestor
56666286|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
56666287|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666288|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
56666289|NCT00996385|Bortezomib|bortezomib|mesh-list
56666290|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666291|NCT00533845|Bupivacaine|bupivacaine|mesh-list
56666292|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
56666293|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
56666294|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56666295|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666296|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
56666297|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666298|NCT02752763|Dextrans|dextrans|mesh-list
56666299|NCT02752763|Povidone|povidone|mesh-list
56666300|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56666301|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
56666302|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56666303|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
56666304|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
56666305|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
56666306|NCT05257447|Baclofen|baclofen|mesh-list
56666307|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
56666308|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56666309|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666310|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56666311|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666312|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56666313|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
56666314|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
56666315|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56666316|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666318|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56666319|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56666320|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
56666321|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56666322|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205253|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666323|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666324|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56666325|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56666326|NCT02752841|Vitamin D|vitamin d|mesh-list
56666327|NCT02752841|Vitamins|vitamins|mesh-ancestor
56666328|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
56666329|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666330|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56666331|NCT03971669|Vaccines|vaccines|mesh-list
56666332|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
56666333|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205254|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56205255|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56205256|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
56205257|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
56205258|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205259|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56180164|NCT01404000|Antidotes|antidotes|mesh-ancestor
56180165|NCT01404000|Protective Agents|protective agents|mesh-ancestor
56180166|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180167|NCT01404013|Montelukast|montelukast|mesh-list
56180168|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56180169|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56180170|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
56180171|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56180172|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
56180173|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180174|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180175|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56180176|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56180177|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180178|NCT01404104|Sirolimus|sirolimus|mesh-list
56180179|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56180180|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205260|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56205261|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205262|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205264|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56205265|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56205266|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56205267|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205268|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56205269|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205270|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
56205271|NCT01551394|Gentamicins|gentamicins|mesh-list
56205272|NCT01551394|Meropenem|meropenem|mesh-list
56205273|NCT01551394|Ampicillin|ampicillin|mesh-list
56205274|NCT01551394|Cefotaxime|cefotaxime|mesh-list
56205275|NCT01551394|Cefoxitin|cefoxitin|mesh-list
56205276|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56205277|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205278|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56205279|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205280|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205281|NCT01551459|Sunitinib|sunitinib|mesh-list
56205282|NCT01551459|Dacarbazine|dacarbazine|mesh-list
56205283|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205284|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56205285|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56205286|NCT01551459|Growth Substances|growth substances|mesh-ancestor
56205287|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205288|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
56205289|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56666334|NCT02715869|Sevoflurane|sevoflurane|mesh-list
56666335|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56666336|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56666337|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
56666338|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
56666339|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56666340|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666341|NCT00532441|Docetaxel|docetaxel|mesh-list
56666342|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56666343|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666344|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
56666345|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
56666346|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
56666347|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666348|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56666349|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666350|NCT00999739|Vaccines|vaccines|mesh-list
56666351|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56666352|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
56666353|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666354|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56666355|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56666356|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56666357|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666358|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
56666359|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56666360|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
56666361|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
56666362|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
56666363|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
56666364|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56666365|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56227606|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
56205290|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205291|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205292|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56205293|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
56205294|NCT01551485|Zolpidem|zolpidem|mesh-list
56205295|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56205296|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56180181|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56666366|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56666367|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666368|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666369|NCT00857259|Everolimus|everolimus|mesh-list
56666370|NCT00857259|Ranibizumab|ranibizumab|mesh-list
56666371|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666372|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666373|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
56666374|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666375|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56666376|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56666377|NCT00857259|Growth Substances|growth substances|mesh-ancestor
56666378|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
56666379|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56312517|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666380|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666381|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666382|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56666383|NCT04000633|Lidocaine|lidocaine|mesh-list
56666384|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
56666385|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
56666386|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56666387|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666388|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
56666389|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666390|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56666391|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56666392|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56666393|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56666394|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666395|NCT00994825|Simendan|simendan|mesh-list
56666396|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56666397|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
56666404|NCT02752529|Tacrolimus|tacrolimus|mesh-list
56666405|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666406|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
56666407|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666408|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56666409|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666410|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666411|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
56666412|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
56666413|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56666414|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
56666415|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666416|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666417|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666418|NCT02620800|Leucovorin|leucovorin|mesh-list
56666419|NCT02620800|Paclitaxel|paclitaxel|mesh-list
56666420|NCT02620800|Bevacizumab|bevacizumab|mesh-list
56666421|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
56666422|NCT02620800|Calcium|calcium|mesh-list
56666423|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
56666424|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56666425|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666440|NCT02620800|Vitamins|vitamins|mesh-ancestor
56666458|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56666459|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56666460|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56666461|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56666462|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
56666464|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
56666465|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
56666466|NCT00996697|Budesonide|budesonide|mesh-list
56666467|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
56666468|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
56666469|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56666470|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666471|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56666472|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
56666473|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666474|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666475|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56666476|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
56666477|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
56666478|NCT00996697|Hormones|hormones|mesh-ancestor
56666479|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666480|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56666481|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56666482|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56666483|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
56666484|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56666485|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666486|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
56666487|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56666488|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
56666489|NCT04526795|Cytarabine|cytarabine|mesh-list
56666490|NCT04526795|Fludarabine|fludarabine|mesh-list
56666491|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666492|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227745|NCT02973321|Metformin|metformin|mesh-list
56180182|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180183|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
56180184|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180185|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
56180186|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666493|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
56666494|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666495|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666496|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
56666497|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666498|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
56666499|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666500|NCT00999973|Mitomycins|mitomycins|mesh-list
56666501|NCT00999973|Mitomycin|mitomycin|mesh-list
56666502|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56666503|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666504|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
56666505|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666506|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56666507|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666508|NCT02715947|Methotrexate|methotrexate|mesh-list
56666514|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
56666550|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56666551|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666552|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
56666553|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
56666554|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56666555|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56666556|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666557|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56666558|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666559|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56666560|NCT00997009|Paclitaxel|paclitaxel|mesh-list
56666561|NCT00997009|Carboplatin|carboplatin|mesh-list
56666562|NCT00997009|Cetuximab|cetuximab|mesh-list
56666563|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56666564|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666565|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
56666566|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
56666567|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
56666568|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666569|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666570|NCT02712125|Isosorbide|isosorbide|mesh-list
56666571|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56666572|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56666573|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56666574|NCT02712125|Diuretics|diuretics|mesh-ancestor
56666575|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
56666576|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666577|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
56666578|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56666579|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666580|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
56666581|NCT00994981|Analgesics|analgesics|mesh-ancestor
56666582|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
56666583|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666584|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180187|NCT01404117|Interferons|interferons|mesh-list
56180188|NCT01404117|Interferon-beta|interferon-beta|mesh-list
56180189|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
56180190|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
56666585|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
56666586|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56666587|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56666588|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
56666589|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56666590|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56666591|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666592|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56666593|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
56666594|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56666595|NCT02715479|Dolutegravir|dolutegravir|mesh-list
56666596|NCT02715479|BMS-955176|bms-955176|mesh-list
56666597|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56666598|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56666599|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666600|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666601|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56666602|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56312740|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
56666603|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
56666604|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666605|NCT01000441|Adalimumab|adalimumab|mesh-list
56666606|NCT01000441|Etanercept|etanercept|mesh-list
56666607|NCT01000441|Rituximab|rituximab|mesh-list
56666608|NCT01000441|Abatacept|abatacept|mesh-list
56666609|NCT01000441|Infliximab|infliximab|mesh-list
56666610|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666611|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666612|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
56666613|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666620|NCT01000441|Analgesics|analgesics|mesh-ancestor
56666630|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
56666631|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
56666632|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56666633|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666634|NCT01000597|Fluticasone|fluticasone|mesh-list
56666635|NCT01000597|Xhance|xhance|mesh-list
56666636|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666637|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56666638|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
56666639|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666640|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180191|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180192|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
56180193|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180194|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
56180195|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180196|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56205297|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205298|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205299|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56205300|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
56205301|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
56205302|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205303|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205304|NCT01551511|Dronabinol|dronabinol|mesh-list
56205305|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
56205306|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205307|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56205308|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56205309|NCT01551511|Analgesics|analgesics|mesh-ancestor
56205310|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
56205311|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205312|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56205313|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56205314|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205315|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205316|NCT01551511|Hormones|hormones|mesh-ancestor
56205317|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205318|NCT01551589|Docetaxel|docetaxel|mesh-list
56205319|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205320|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
56205322|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
56205323|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205324|NCT01551615|Metformin|metformin|mesh-list
56205325|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56205326|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205327|NCT01551628|BCT-100|bct-100|mesh-list
56205328|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205329|NCT01551641|Thalidomide|thalidomide|mesh-list
56205330|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56205331|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
56205332|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205333|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
56205334|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56205335|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205336|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56205337|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56205338|NCT01551641|Growth Substances|growth substances|mesh-ancestor
56205339|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
56205340|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205341|NCT01551667|Antibodies|antibodies|mesh-list
56205342|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
56180197|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180198|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205343|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666641|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56666642|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
56666643|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
56666644|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56666645|NCT02751593|Dexamethasone|dexamethasone|mesh-list
56666646|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666647|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
56666648|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
56666649|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666650|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666651|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56666652|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
56666653|NCT02751593|Hormones|hormones|mesh-ancestor
56666654|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666655|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56666656|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666657|NCT00997399|Panobinostat|panobinostat|mesh-list
56666658|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666659|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56666660|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666661|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666662|NCT00997477|Budesonide|budesonide|mesh-list
56666663|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
56666664|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666665|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56666666|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
56666667|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666668|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666669|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56666670|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
56666671|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
56666672|NCT00997477|Hormones|hormones|mesh-ancestor
56205345|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56205346|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205347|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205348|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205349|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56205350|NCT01551719|Vancomycin|vancomycin|mesh-list
56205351|NCT01551719|Linezolid|linezolid|mesh-list
56205352|NCT01551719|Daptomycin|daptomycin|mesh-list
56205353|NCT01551719|Penicillins|penicillins|mesh-list
56205354|NCT01551719|Tigecycline|tigecycline|mesh-list
56205355|NCT01551719|Cephalosporins|cephalosporins|mesh-list
56205356|NCT01551719|Teicoplanin|teicoplanin|mesh-list
56666673|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666674|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56666675|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56666676|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56666677|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
56312821|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
56666678|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312893|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56666679|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666681|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
56666682|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666683|NCT05170789|Dexamethasone|dexamethasone|mesh-list
56666684|NCT05170789|Elotuzumab|elotuzumab|mesh-list
56666685|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666686|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
56666687|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
56666688|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666689|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666690|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56666691|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
56666692|NCT05170789|Hormones|hormones|mesh-ancestor
56666693|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666694|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56666695|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666696|NCT02693951|Cefotiam|cefotiam|mesh-list
56666697|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56666698|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666699|NCT00997711|Sirolimus|sirolimus|mesh-list
56666700|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56666708|NCT01001143|Decitabine|decitabine|mesh-list
56666717|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56666718|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
56666719|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666720|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666721|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56666722|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
56666723|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
56666724|NCT02715167|Hormones|hormones|mesh-ancestor
56666725|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666726|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56666727|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56666728|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56666729|NCT02620566|Bupivacaine|bupivacaine|mesh-list
56666730|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
56666731|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
56666732|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56666733|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666734|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
56666735|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666736|NCT00855465|Riociguat|riociguat|mesh-list
56666737|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
56666738|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666739|NCT02714699|Diclofenac|diclofenac|mesh-list
56666740|NCT02714699|Scopolamine|scopolamine|mesh-list
56666741|NCT02714699|Bromides|bromides|mesh-list
56666742|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56666743|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56666744|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56666745|NCT02714699|Analgesics|analgesics|mesh-ancestor
56666746|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
56666747|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666757|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
56666758|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56666759|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
56666760|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56666761|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
56666762|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56666763|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56666764|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
56666765|NCT01004419|Fulvestrant|fulvestrant|mesh-list
56666766|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56666767|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666768|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56666769|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56666770|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
56666771|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666772|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666773|NCT02714855|Apixaban|apixaban|mesh-list
56666774|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56666775|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
56666776|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56666777|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
56666778|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666779|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666780|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
56666781|NCT02712203|Vaccines|vaccines|mesh-list
56666782|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
56228043|NCT02355379|Fluorouracil|fluorouracil|mesh-list
56205357|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205358|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56205359|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205360|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205361|NCT01551797|Acetaminophen|acetaminophen|mesh-list
56205362|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56205363|NCT01551797|Analgesics|analgesics|mesh-ancestor
56205364|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
56205365|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205366|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205367|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
56205368|NCT01551810|Vaccines|vaccines|mesh-list
56205369|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
56205370|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205371|NCT01551823|Vaccines|vaccines|mesh-list
56205372|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
56205373|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205374|NCT01551836|Acetaminophen|acetaminophen|mesh-list
56205375|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56205376|NCT01551836|Analgesics|analgesics|mesh-ancestor
56205377|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
56205378|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666783|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666784|NCT04189055|Irinotecan|irinotecan|mesh-list
56666785|NCT04189055|Cetuximab|cetuximab|mesh-list
56666786|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56666787|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56666788|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666789|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666790|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666791|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666792|NCT00696930|Edotreotide|edotreotide|mesh-list
56666793|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56666794|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666795|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
56666796|NCT00598442|Hematinics|hematinics|mesh-ancestor
56666797|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
56666798|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
56666799|NCT02714543|Antioxidants|antioxidants|mesh-list
56666800|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666801|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56666802|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
56666803|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666804|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
56666805|NCT02714543|Protective Agents|protective agents|mesh-ancestor
56666806|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666807|NCT02714231|Diclofenac|diclofenac|mesh-list
56666808|NCT02714231|Scopolamine|scopolamine|mesh-list
56666809|NCT02714231|Bromides|bromides|mesh-list
56666810|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56666832|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
56666833|NCT00855309|Acyclovir|acyclovir|mesh-list
56666834|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
56666835|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666836|NCT00532129|Rituximab|rituximab|mesh-list
56666837|NCT00532129|Chlorambucil|chlorambucil|mesh-list
56666838|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666839|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666840|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
56666841|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666842|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666843|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56666844|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
56666845|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666846|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56666847|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56666848|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666849|NCT04163588|Metolazone|metolazone|mesh-list
56666850|NCT04163588|Diuretics|diuretics|mesh-list
56666851|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56666852|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
56666853|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228116|NCT02185820|Dexamethasone|dexamethasone|mesh-list
56205379|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205380|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
56205381|NCT01552005|Saxagliptin|saxagliptin|mesh-list
56205382|NCT01552005|Incretins|incretins|mesh-ancestor
56205383|NCT01552005|Hormones|hormones|mesh-ancestor
56205384|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205385|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205386|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56205387|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
56205388|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205389|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205390|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56205391|NCT01552018|Saxagliptin|saxagliptin|mesh-list
56205392|NCT01552018|Incretins|incretins|mesh-ancestor
56205393|NCT01552018|Hormones|hormones|mesh-ancestor
56137535|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56205394|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205395|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205396|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56205397|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
56205398|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205399|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205400|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56205402|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56205403|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
56205404|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205405|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666854|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56666855|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666856|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56666857|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56666858|NCT05167513|Metformin|metformin|mesh-list
56666859|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56666860|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56666861|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666862|NCT05167513|Incretins|incretins|mesh-ancestor
56666863|NCT05167513|Hormones|hormones|mesh-ancestor
56666864|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666865|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56666866|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
56666867|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666868|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666869|NCT00654056|Insulin|insulin|mesh-list
56666870|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56666871|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56666872|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666873|NCT00854373|Hormones|hormones|mesh-list
56666874|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56666875|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666876|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666877|NCT00611507|Fluorouracil|fluorouracil|mesh-list
56666878|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
56666886|NCT01001845|Vitamin E|vitamin e|mesh-list
56666900|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666901|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666902|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56666903|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56666904|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666905|NCT00853905|Triamcinolone|triamcinolone|mesh-list
56666906|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56666907|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56666908|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56666909|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56666910|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56666911|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
56666912|NCT00853905|Hormones|hormones|mesh-ancestor
56666913|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56666914|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666915|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666916|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
56666917|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666918|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666919|NCT00998101|Carboplatin|carboplatin|mesh-list
56666920|NCT00998101|Cetuximab|cetuximab|mesh-list
56666921|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56666922|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56666923|NCT04234217|Niacin|niacin|mesh-list
56666924|NCT04234217|Niacinamide|niacinamide|mesh-list
56666925|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
56666926|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56666927|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
56666928|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666929|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56666930|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
56666931|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
56666932|NCT04234217|Vitamins|vitamins|mesh-ancestor
56666933|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
56228190|NCT02050919|Sorafenib|sorafenib|mesh-list
56205406|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56205407|NCT01552044|Diuretics|diuretics|mesh-ancestor
56205408|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
56205409|NCT01552122|Vitamin D|vitamin d|mesh-list
56666934|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666935|NCT01002079|Rifampin|rifampin|mesh-list
56666936|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56666937|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
56666938|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56666939|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56666940|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
56666941|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56666942|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56666943|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666944|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56666945|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56666946|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56666947|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56666948|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56666949|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56666950|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
56666951|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56666952|NCT05429567|Fentanyl|fentanyl|mesh-list
56666953|NCT05429567|Bupivacaine|bupivacaine|mesh-list
56666954|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
56666955|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
56666956|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56666957|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666958|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
56666959|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56666960|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56666961|NCT05429567|Narcotics|narcotics|mesh-ancestor
56666980|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666981|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
56666982|NCT01002157|Coagulants|coagulants|mesh-ancestor
56666983|NCT01004497|Cytarabine|cytarabine|mesh-list
56666984|NCT01004497|Dexamethasone|dexamethasone|mesh-list
56666985|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
56666986|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
56666987|NCT01004497|Vincristine|vincristine|mesh-list
56666988|NCT01004497|Daunorubicin|daunorubicin|mesh-list
56666989|NCT01004497|Dasatinib|dasatinib|mesh-list
56666990|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
56666991|NCT01004497|BB 1101|bb 1101|mesh-list
56666992|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56666993|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
56666994|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56666995|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56666996|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56666997|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
56666998|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56666999|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205410|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
56205411|NCT01552122|Alendronate|alendronate|mesh-list
56205412|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
56205413|NCT01552122|Calcium|calcium|mesh-list
56205414|NCT01552122|Vitamins|vitamins|mesh-ancestor
56205415|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
56180199|NCT01404130|Isotretinoin|isotretinoin|mesh-list
56180200|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
56180201|NCT01404156|Leucovorin|leucovorin|mesh-list
56180202|NCT01404156|Paclitaxel|paclitaxel|mesh-list
56180203|NCT01404156|Docetaxel|docetaxel|mesh-list
56180204|NCT01404156|Carboplatin|carboplatin|mesh-list
56180205|NCT01404156|Fluorouracil|fluorouracil|mesh-list
56180206|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
56180207|NCT01404156|Epirubicin|epirubicin|mesh-list
56180208|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56180209|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180210|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
56205416|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205417|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56205418|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56205419|NCT01552122|Antacids|antacids|mesh-ancestor
56205420|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205421|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205422|NCT01552148|Morphine|morphine|mesh-list
56205423|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56205424|NCT01552148|Narcotics|narcotics|mesh-ancestor
56205425|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205426|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205427|NCT01552148|Analgesics|analgesics|mesh-ancestor
56205428|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
56205429|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205430|NCT01552187|Colchicine|colchicine|mesh-list
56205431|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
56205432|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205433|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
56205434|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
56205435|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
56205436|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205437|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205438|NCT01552330|Artesunate|artesunate|mesh-list
56667000|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56667001|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667002|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
56667003|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
56667004|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667005|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56667006|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
56667007|NCT01004497|Hormones|hormones|mesh-ancestor
56667008|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667009|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56667010|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
56667011|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667012|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56667013|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
56667014|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
56667015|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667016|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56667017|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
56667018|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
56667019|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
56667020|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56667021|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56667022|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56667023|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667024|NCT01004497|Analgesics|analgesics|mesh-ancestor
56667025|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
56667026|NCT02713841|Insulin|insulin|mesh-list
56667027|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56667049|NCT02615496|Aflibercept|aflibercept|mesh-list
56667050|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56667051|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56667052|NCT02615496|Growth Substances|growth substances|mesh-ancestor
56667053|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667054|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
56667055|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667056|NCT01004731|Gemcitabine|gemcitabine|mesh-list
56667057|NCT01004731|Carboplatin|carboplatin|mesh-list
56667059|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667060|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56667061|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
56667062|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667063|NCT01004731|Antiviral Agents|antiviral agents|mesh-ancestor
56667064|NCT01004731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667065|NCT01004731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667066|NCT01004731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56667067|NCT01004731|Immunologic Factors|immunologic factors|mesh-ancestor
56667068|NCT01004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228330|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56205439|NCT01552330|Primaquine|primaquine|mesh-list
56205440|NCT01552330|Pyronaridine|pyronaridine|mesh-list
56205441|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
56205442|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56205443|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56205444|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205445|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205446|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
56205447|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
56205448|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56205449|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
56205450|NCT01552629|Cyclosporine|cyclosporine|mesh-list
56205451|NCT01552629|Cyclosporins|cyclosporins|mesh-list
56205452|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205453|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205454|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56205455|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
56205456|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205457|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
56205458|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205459|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
56205460|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205461|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56205462|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
56205463|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56205464|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205465|NCT01552798|Aspirin|aspirin|mesh-list
56205466|NCT01552798|Acetaminophen|acetaminophen|mesh-list
56205467|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56205468|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56205469|NCT01552798|Analgesics|analgesics|mesh-ancestor
56205470|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
56205471|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205472|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180211|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
56180212|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933170|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
56667069|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56667070|NCT02714075|Zinc|zinc|mesh-list
56667071|NCT02714075|Iron|iron|mesh-list
56667072|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
56667073|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
56667074|NCT02714075|Citric Acid|citric acid|mesh-list
56667075|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
56667076|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
56667077|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56667078|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
56667079|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
56228350|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56180213|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180214|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
56180215|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55874760|NCT04722822|Vaccines|vaccines|mesh-list
56205473|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205474|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205475|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56205476|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56205477|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205478|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56205479|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56205480|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205481|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
56205482|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56205483|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
56205484|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56205485|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56205486|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56205487|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133231|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
56205488|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205489|NCT01552850|Oxycodone|oxycodone|mesh-list
56205490|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56205491|NCT01552850|Narcotics|narcotics|mesh-ancestor
56205492|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205493|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205494|NCT01552850|Analgesics|analgesics|mesh-ancestor
56205495|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
56205496|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205497|NCT01552863|Oxycodone|oxycodone|mesh-list
56205498|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56205499|NCT01552863|Narcotics|narcotics|mesh-ancestor
56205500|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205501|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205502|NCT01552863|Analgesics|analgesics|mesh-ancestor
56205503|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
56205504|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205505|NCT01552967|Capecitabine|capecitabine|mesh-list
56205506|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56205507|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
56205508|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205509|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205510|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
56205511|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205512|NCT01552993|Acetaminophen|acetaminophen|mesh-list
56205513|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56205514|NCT01552993|Analgesics|analgesics|mesh-ancestor
56205515|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
56205516|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205517|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205518|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
56205519|NCT01553006|Cefditoren|cefditoren|mesh-list
56205520|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
56205521|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56205522|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205523|NCT01553019|Gemcitabine|gemcitabine|mesh-list
56667080|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667081|NCT02714075|Trace Elements|trace elements|mesh-ancestor
56667082|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
56667083|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667084|NCT02714075|Astringents|astringents|mesh-ancestor
56667085|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
56667086|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
56667087|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56667088|NCT02714075|Protective Agents|protective agents|mesh-ancestor
56667089|NCT02636426|Sorafenib|sorafenib|mesh-list
56667090|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667091|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667092|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667093|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667094|NCT02713763|Sunitinib|sunitinib|mesh-list
56667095|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205524|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56205525|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
56205526|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205527|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205528|NCT01553019|Antiviral Agents|antiviral agents|mesh-ancestor
56205529|NCT01553019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205530|NCT01553019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205531|NCT01553019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56205532|NCT01553019|Immunologic Factors|immunologic factors|mesh-ancestor
56205533|NCT01553019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205534|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
56205535|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56180216|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180217|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
56180218|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180219|NCT01404156|Antidotes|antidotes|mesh-ancestor
56180220|NCT01404156|Protective Agents|protective agents|mesh-ancestor
56180221|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
56180222|NCT01404156|Vitamins|vitamins|mesh-ancestor
56180223|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
56180224|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56180225|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56180226|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56180227|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180228|NCT01404169|Donepezil|donepezil|mesh-list
56180229|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56205536|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
56205537|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56205538|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205539|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56205540|NCT01553357|Dexamethasone|dexamethasone|mesh-list
56205541|NCT01553357|Lenalidomide|lenalidomide|mesh-list
56205542|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205543|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
56205544|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
56205545|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205546|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205547|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205548|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
56205549|NCT01553357|Hormones|hormones|mesh-ancestor
56205550|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205551|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56205552|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205553|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
56667096|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56205554|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56205555|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56205556|NCT01553357|Growth Substances|growth substances|mesh-ancestor
56205557|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
56205558|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
56205559|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
56205560|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
56205561|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56133307|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205562|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56205563|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205564|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205565|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205566|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56205567|NCT01553500|Cathartics|cathartics|mesh-ancestor
56205568|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205569|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56205570|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
56205571|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
56205572|NCT01553721|Udenafil|udenafil|mesh-list
56205573|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56205574|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56205575|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205576|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205577|NCT01553773|Estradiol|estradiol|mesh-list
56205578|NCT01553773|Estrogens|estrogens|mesh-ancestor
56205579|NCT01553773|Hormones|hormones|mesh-ancestor
56205580|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205581|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205582|NCT01553786|Lenalidomide|lenalidomide|mesh-list
56205583|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
56180230|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205584|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205585|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56205586|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56205587|NCT01553786|Growth Substances|growth substances|mesh-ancestor
56205588|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
56205589|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205590|NCT01553903|Tamoxifen|tamoxifen|mesh-list
56205591|NCT01553903|Letrozole|letrozole|mesh-list
56205592|NCT01553903|Anastrozole|anastrozole|mesh-list
56205593|NCT01553903|Exemestane|exemestane|mesh-list
56205594|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205595|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56205596|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56205597|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205598|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205599|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56205600|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
56205601|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205602|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205603|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56205604|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56205605|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56205606|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56205608|NCT01553942|Afatinib|afatinib|mesh-list
56205609|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205610|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205611|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205612|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56205613|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56205614|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56205615|NCT01553981|Tadalafil|tadalafil|mesh-list
56205616|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
56205617|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56205618|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56205619|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205620|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205621|NCT01553981|Urological Agents|urological agents|mesh-ancestor
56205622|NCT01554059|Bevacizumab|bevacizumab|mesh-list
56205623|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
56205624|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56667097|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56667098|NCT02713763|Growth Substances|growth substances|mesh-ancestor
56667099|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667100|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
56667101|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667102|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667103|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667104|NCT00867360|Mifepristone|mifepristone|mesh-list
56667105|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56667106|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
56667107|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56228371|NCT01499082|Insulin|insulin|mesh-list
56205625|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205626|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56205627|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56205628|NCT01554059|Growth Substances|growth substances|mesh-ancestor
56205629|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205630|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
56205631|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
56205632|NCT01554111|Cathartics|cathartics|mesh-ancestor
56205633|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205634|NCT01554124|Meropenem|meropenem|mesh-list
56205635|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56205636|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205637|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56205638|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56205639|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
56205640|NCT01554345|Vitamin E|vitamin e|mesh-list
56205642|NCT01554345|Vitamins|vitamins|mesh-ancestor
56205643|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
56205644|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205645|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
56205646|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205647|NCT01554345|Protective Agents|protective agents|mesh-ancestor
56205648|NCT01554345|Trace Elements|trace elements|mesh-ancestor
56205649|NCT01554397|Cisplatin|cisplatin|mesh-list
56205650|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205651|NCT01554540|Treprostinil|treprostinil|mesh-list
56205652|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56205653|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56205654|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56205655|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56205656|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
56205657|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205658|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205659|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56180231|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180232|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
56180233|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180234|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180235|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
56180236|NCT01404182|Vaccines|vaccines|mesh-list
56205660|NCT01554631|Acarbose|acarbose|mesh-list
56205661|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56205662|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205663|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205664|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56205665|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205666|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56205667|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56205668|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205669|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
56205670|NCT01554813|Vaccines|vaccines|mesh-list
56667108|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667109|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56667110|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56667111|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56667112|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
56667113|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56667114|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56667115|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
56667116|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667117|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
56667118|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56667119|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56667120|NCT00656552|Citalopram|citalopram|mesh-list
56667121|NCT00656552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56667122|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56667123|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56667124|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205671|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
56205672|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205673|NCT01554826|Vaccines|vaccines|mesh-list
56205674|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
56205675|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205676|NCT01554852|Thalidomide|thalidomide|mesh-list
56205677|NCT01554852|Dexamethasone|dexamethasone|mesh-list
56205678|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
56205679|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
56205680|NCT01554852|Melphalan|melphalan|mesh-list
56205681|NCT01554852|Lenalidomide|lenalidomide|mesh-list
56205682|NCT01554852|Bortezomib|bortezomib|mesh-list
56205683|NCT01554852|Vorinostat|vorinostat|mesh-list
56205684|NCT01554852|BB 1101|bb 1101|mesh-list
56205685|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56205686|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
56205687|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205688|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205689|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56205690|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
56205691|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205692|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205693|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56205694|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205695|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
56205696|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
56205697|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205698|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205700|NCT01554852|Hormones|hormones|mesh-ancestor
56205701|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205702|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56205703|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
56205704|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205705|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56205706|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56205707|NCT01554852|Growth Substances|growth substances|mesh-ancestor
56205708|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
56205709|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
56667125|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667126|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
56667127|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667128|NCT00656552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56667129|NCT00656552|Antidepressive Agents|antidepressive agents|mesh-ancestor
56667130|NCT00656552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56667131|NCT01004809|Dutasteride|dutasteride|mesh-list
56667132|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56667133|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56667134|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667135|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667136|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
56667137|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667138|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667139|NCT00883688|Bevacizumab|bevacizumab|mesh-list
56667140|NCT00883688|Lapatinib|lapatinib|mesh-list
56667141|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56667142|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667143|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56667144|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56667145|NCT00883688|Growth Substances|growth substances|mesh-ancestor
56667146|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667147|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
56667148|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667149|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667150|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667170|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56667171|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
56667172|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667173|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56667174|NCT04219865|Protective Agents|protective agents|mesh-ancestor
56667175|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667176|NCT01002703|Prednisone|prednisone|mesh-list
56667177|NCT01002703|Lenalidomide|lenalidomide|mesh-list
56667178|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56667179|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667180|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
56667181|NCT01002703|Hormones|hormones|mesh-ancestor
56667182|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667183|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667184|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56667185|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667186|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
56667187|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56667188|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56667189|NCT01002703|Growth Substances|growth substances|mesh-ancestor
56667190|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
56667191|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56667192|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
56667193|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667194|NCT02639234|Nivolumab|nivolumab|mesh-list
56667195|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56667196|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667214|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56667215|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667216|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56667217|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56667218|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56667219|NCT02713139|Metronidazole|metronidazole|mesh-list
56667220|NCT02713139|Clotrimazole|clotrimazole|mesh-list
56667221|NCT02713139|Miconazole|miconazole|mesh-list
56667222|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667223|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56667224|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56667225|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56667226|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56667227|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
56667228|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56667229|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56667230|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667231|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667232|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56667233|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
56667234|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667235|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667236|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56667237|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56205710|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56205711|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205712|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56205713|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
56205714|NCT01554930|Mannitol|mannitol|mesh-list
56205715|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
56205716|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205717|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
56205718|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
56205720|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205721|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205722|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
56205723|NCT01554930|Hormones|hormones|mesh-ancestor
56205724|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205725|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56205726|NCT01554930|Protective Agents|protective agents|mesh-ancestor
56205727|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
56205728|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56205729|NCT01554930|Diuretics|diuretics|mesh-ancestor
56205730|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
56205731|NCT01554969|Capecitabine|capecitabine|mesh-list
56205732|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56205733|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
56205734|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667238|NCT01005121|Colchicine|colchicine|mesh-list
56667239|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
56667240|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56667241|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
56667242|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
56667243|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
56667244|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667245|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667246|NCT02711579|Celecoxib|celecoxib|mesh-list
56667247|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56667248|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56667249|NCT02711579|Analgesics|analgesics|mesh-ancestor
56667250|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
56667251|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667252|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667253|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667254|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56667255|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56667256|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56667257|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667258|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667259|NCT00611195|Remifentanil|remifentanil|mesh-list
56667260|NCT00611195|Propofol|propofol|mesh-list
56667261|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56667262|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667263|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667264|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56667265|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
56667266|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
56667267|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56667268|NCT00611195|Narcotics|narcotics|mesh-ancestor
56667269|NCT00611195|Analgesics|analgesics|mesh-ancestor
56667270|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
56667271|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667277|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667278|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667279|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667280|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56667281|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
56667282|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56667283|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
56667284|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667285|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
56667286|NCT04117893|Protective Agents|protective agents|mesh-ancestor
56667287|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56667288|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56667289|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56667290|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667291|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667292|NCT04117893|Analgesics|analgesics|mesh-ancestor
56667293|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
56667294|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667295|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
56667296|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56667297|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
56667298|NCT02615574|Interferons|interferons|mesh-list
56667299|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56205735|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205736|NCT01554995|Linezolid|linezolid|mesh-list
56205737|NCT01554995|Delpazolid|delpazolid|mesh-list
56205738|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56205739|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205740|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56205741|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205742|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205743|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56205744|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56205745|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205746|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56205747|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205748|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
56205749|NCT01555060|Hematinics|hematinics|mesh-ancestor
56205750|NCT01555099|Budesonide|budesonide|mesh-list
56205751|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205752|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56205753|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
56205754|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205755|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205756|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56205757|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
56205758|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
56205759|NCT01555099|Hormones|hormones|mesh-ancestor
56667300|NCT02615574|Celecoxib|celecoxib|mesh-list
56667301|NCT02615574|Vaccines|vaccines|mesh-list
56667302|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
56667303|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667304|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667305|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
56667306|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667307|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56667308|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56667309|NCT02615574|Analgesics|analgesics|mesh-ancestor
56667310|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
56667311|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667312|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667313|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56667314|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56667315|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56667316|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667317|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667318|NCT02708693|Triamcinolone|triamcinolone|mesh-list
56667319|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56667320|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56667321|NCT02708693|Lidocaine|lidocaine|mesh-list
56667322|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56667323|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
56667324|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
56667325|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667326|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667348|NCT02638922|Hormones|hormones|mesh-ancestor
56667349|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667350|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667351|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56667352|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
56667353|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56667354|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56667355|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56667356|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56667357|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56667358|NCT01005199|Everolimus|everolimus|mesh-list
56667359|NCT01005199|Sorafenib|sorafenib|mesh-list
56667360|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667361|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56667362|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
56667363|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667364|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667365|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667366|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667367|NCT02711189|Oxytocin|oxytocin|mesh-list
56667368|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
56667369|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56667370|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667371|NCT02635802|Lidocaine|lidocaine|mesh-list
56667372|NCT02635802|Midazolam|midazolam|mesh-list
56667373|NCT02635802|Remifentanil|remifentanil|mesh-list
56667374|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
56667375|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
56667376|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667377|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667378|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
56667379|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667380|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56667381|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56667382|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56667383|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56228641|NCT00551928|Prednisone|prednisone|mesh-list
56667384|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667385|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56667386|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56667387|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56667388|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56667389|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56667390|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56667391|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
56667392|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
56667393|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
56667394|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667395|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56667396|NCT02635802|Narcotics|narcotics|mesh-ancestor
56667397|NCT02635802|Analgesics|analgesics|mesh-ancestor
56667398|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56667399|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
56667400|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667401|NCT03940703|Osimertinib|osimertinib|mesh-list
56667402|NCT03940703|Tepotinib|tepotinib|mesh-list
56667403|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667404|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667405|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667406|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667407|NCT00657410|Dexamethasone|dexamethasone|mesh-list
56667408|NCT00657410|Prednisone|prednisone|mesh-list
56667409|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667410|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
56667411|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
56667412|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667413|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667414|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56667415|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
56667416|NCT00657410|Hormones|hormones|mesh-ancestor
56228669|NCT00379340|Doxorubicin|doxorubicin|mesh-list
56205760|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205761|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
56205762|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56205763|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
56205764|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205765|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205766|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56205767|NCT01555112|Protective Agents|protective agents|mesh-ancestor
56667417|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667418|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56667419|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313565|NCT00139555|Amlodipine|amlodipine|mesh-list
56667420|NCT01009021|Diclofenac|diclofenac|mesh-list
56667421|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56667422|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56667423|NCT01009021|Analgesics|analgesics|mesh-ancestor
56667424|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
56667425|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667426|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667427|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667428|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205768|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56205769|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56205770|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205771|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205772|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
56205773|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205774|NCT01555190|Folic Acid|folic acid|mesh-list
56205775|NCT01555190|Inositol|inositol|mesh-list
56205776|NCT01555190|Hematinics|hematinics|mesh-ancestor
56205777|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
56205778|NCT01555190|Vitamins|vitamins|mesh-ancestor
56205779|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
56205780|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205781|NCT01555216|Ropivacaine|ropivacaine|mesh-list
56205782|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
56205783|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
56205784|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205785|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205786|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
56205787|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56205788|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
56205789|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56205790|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56205791|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
56205792|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205793|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56205794|NCT01555476|Ibuprofen|ibuprofen|mesh-list
56205795|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56205796|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56205797|NCT01555476|Analgesics|analgesics|mesh-ancestor
56205798|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
56205799|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180237|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
56180238|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205800|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205801|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205802|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205803|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56205804|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205805|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205807|NCT01555580|Sargramostim|sargramostim|mesh-list
56205808|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
56205809|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205810|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205811|NCT01555632|Atorvastatin|atorvastatin|mesh-list
56205812|NCT01555632|Calcium|calcium|mesh-list
56205813|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56205814|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667429|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56667430|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667431|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667432|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
56667433|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56667434|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667435|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667436|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56667437|NCT01005433|Analgesics|analgesics|mesh-ancestor
56667438|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
56667439|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667440|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56667441|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56667442|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56667443|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
56667444|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667445|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667446|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56667447|NCT00654446|Simvastatin|simvastatin|mesh-list
56667448|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56667449|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56667450|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
56667451|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667452|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56667453|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56667454|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667455|NCT01003483|Orlistat|orlistat|mesh-list
56667456|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228715|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56205815|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56205816|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56205817|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
56205818|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205819|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56205820|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56205821|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205822|NCT01555658|Heparin|heparin|mesh-list
56205823|NCT01555658|Bivalirudin|bivalirudin|mesh-list
56205824|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
56205825|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56205826|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56205827|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667457|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667458|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56667459|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56667460|NCT00592839|Estrogens|estrogens|mesh-list
56667461|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56667462|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
56667463|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
56667464|NCT00592839|Hormones|hormones|mesh-ancestor
56667465|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228746|NCT01694134|Hormones|hormones|mesh-ancestor
56205828|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
56205829|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56205830|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
56205831|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205832|NCT01555710|Carboplatin|carboplatin|mesh-list
56205833|NCT01555710|Etoposide|etoposide|mesh-list
56205834|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
56205835|NCT01555710|Ifosfamide|ifosfamide|mesh-list
56205836|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205837|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56205838|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56205839|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56205840|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205841|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205842|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146099|NCT01007994|Enalapril|enalapril|mesh-list
56205843|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
56205844|NCT01555788|Pancrelipase|pancrelipase|mesh-list
56205845|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205846|NCT01555814|Amisulpride|amisulpride|mesh-list
56205847|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56205848|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56205849|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56205850|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205851|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56205852|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56205853|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
56205854|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205855|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205856|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56205857|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
56205858|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56205859|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205860|NCT01555866|Isavuconazole|isavuconazole|mesh-list
56205861|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
56205862|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205863|NCT01555879|Abatacept|abatacept|mesh-list
56205864|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56205865|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133607|NCT00060528|Metronidazole|metronidazole|mesh-list
56205866|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205867|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56205868|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
56180239|NCT01404312|Pyridoxine|pyridoxine|mesh-list
56180240|NCT01404312|Pyridoxal|pyridoxal|mesh-list
56180241|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
56180242|NCT01404312|Isoniazid|isoniazid|mesh-list
56180243|NCT01404312|Rifapentine|rifapentine|mesh-list
56180244|NCT01404312|Vitamins|vitamins|mesh-ancestor
56180245|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
56180246|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180247|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
56180248|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
56180249|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56180250|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875170|NCT03468348|Analgesics|analgesics|mesh-ancestor
56205869|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667466|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667467|NCT01009177|Bosentan|bosentan|mesh-list
56667468|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56667469|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56667470|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667471|NCT00598832|Adapalene|adapalene|mesh-list
56205870|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205871|NCT01555918|Isavuconazole|isavuconazole|mesh-list
56205872|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
56205873|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205874|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
56205875|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56205877|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205878|NCT01555970|Expectorants|expectorants|mesh-ancestor
56205879|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
56205880|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56205881|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
56205882|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205883|NCT01555970|Protective Agents|protective agents|mesh-ancestor
56205884|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205885|NCT01555970|Antidotes|antidotes|mesh-ancestor
56205886|NCT01556035|Lenalidomide|lenalidomide|mesh-list
56205887|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
56205888|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205889|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56205890|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56205891|NCT01556035|Growth Substances|growth substances|mesh-ancestor
56205892|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
56205893|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205894|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56205895|NCT01556191|Fulvestrant|fulvestrant|mesh-list
56205896|NCT01556191|Gefitinib|gefitinib|mesh-list
56205897|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205898|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56205899|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205900|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205901|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56205902|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56205903|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56205904|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
56205905|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205906|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205907|NCT01556321|Caffeine|caffeine|mesh-list
56205908|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56205909|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205910|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56205911|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205912|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205913|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56205914|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56205915|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
56205916|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205917|NCT01556334|Azithromycin|azithromycin|mesh-list
56205918|NCT01556334|Erythromycin|erythromycin|mesh-list
56205919|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
56205920|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56205921|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
56107975|NCT00003589|Immunologic Factors|immunologic factors|mesh-ancestor
56180251|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56180252|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56180253|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
56180254|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180255|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56180256|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56180258|NCT01404338|Halobetasol|halobetasol|mesh-list
56180259|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56180260|NCT01404364|Triamcinolone|triamcinolone|mesh-list
56180261|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
56180262|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667472|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56667473|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56667474|NCT00598832|Analgesics|analgesics|mesh-ancestor
56667475|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
56667476|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667477|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667478|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667479|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56667480|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
56667481|NCT01003561|Anesthetics|anesthetics|mesh-list
56667482|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667483|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667484|NCT02711267|Acyclovir|acyclovir|mesh-list
56180263|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
56180264|NCT01404364|Hormones|hormones|mesh-ancestor
56205922|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56146139|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
56205923|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205924|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56205925|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56205926|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205927|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205928|NCT01556477|Lenalidomide|lenalidomide|mesh-list
56205929|NCT01556477|Azacitidine|azacitidine|mesh-list
56205930|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
56205931|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205932|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56205933|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56205934|NCT01556477|Growth Substances|growth substances|mesh-ancestor
56205935|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
56205936|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205937|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56205938|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
56205939|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205940|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205942|NCT01556529|Antidotes|antidotes|mesh-ancestor
56205943|NCT01556529|Protective Agents|protective agents|mesh-ancestor
56205944|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205945|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
56205946|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
56205947|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205948|NCT01556542|Paclitaxel|paclitaxel|mesh-list
56146183|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56205949|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56205950|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205951|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
56205952|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
56205953|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
56205954|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205955|NCT01556646|Tolvaptan|tolvaptan|mesh-list
56205956|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56205957|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205958|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
56205959|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205960|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
56205961|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
56205962|NCT01556672|Adalimumab|adalimumab|mesh-list
56205963|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56205964|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56205965|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
56205966|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56205967|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
56667485|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
56667486|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667487|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
56667488|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56205968|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180265|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180266|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875315|NCT01219738|Budesonide|budesonide|mesh-list
56205969|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205970|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56205971|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
56205972|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56205973|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
56205974|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205975|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205976|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56205977|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
56205978|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
56205979|NCT01556698|Protective Agents|protective agents|mesh-ancestor
56205980|NCT01556737|Genistein|genistein|mesh-list
56205981|NCT01556737|Daidzein|daidzein|mesh-list
56205982|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56205983|NCT01556737|Protective Agents|protective agents|mesh-ancestor
56205984|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205985|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205986|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56205987|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146228|NCT05395962|Carboplatin|carboplatin|mesh-list
56205988|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205989|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
56205990|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56205991|NCT01556737|Estrogens|estrogens|mesh-ancestor
56205992|NCT01556737|Hormones|hormones|mesh-ancestor
56205993|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56205994|NCT01556815|Sorafenib|sorafenib|mesh-list
56205995|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
56205996|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205997|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56205998|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56205999|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206000|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56206001|NCT01556815|Estrogens|estrogens|mesh-ancestor
56206002|NCT01556815|Hormones|hormones|mesh-ancestor
56206003|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206004|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206005|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56206006|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56206007|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206008|NCT01557075|Atorvastatin|atorvastatin|mesh-list
56206009|NCT01557075|Pravastatin|pravastatin|mesh-list
56206010|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56206011|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56206012|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56206013|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
56206014|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206015|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56206017|NCT01557114|Ipilimumab|ipilimumab|mesh-list
56206018|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56206019|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206020|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56206021|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206022|NCT01557127|Sorafenib|sorafenib|mesh-list
56206023|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206024|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56206025|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206026|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206027|NCT01557140|Carvedilol|carvedilol|mesh-list
56206028|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56206029|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56146262|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
56667489|NCT04459871|Thrombin|thrombin|mesh-list
56667490|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
56667491|NCT04459871|Coagulants|coagulants|mesh-ancestor
56667492|NCT02708459|Morphine|morphine|mesh-list
56206031|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206032|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206033|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206034|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56206035|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
56180267|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180269|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
56206036|NCT01557140|Protective Agents|protective agents|mesh-ancestor
56206037|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56206038|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206039|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56206040|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
56206041|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56206042|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56206043|NCT01557153|Amlodipine|amlodipine|mesh-list
56206044|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56206045|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56206046|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206047|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206048|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56206049|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206050|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
56206051|NCT01557257|Naltrexone|naltrexone|mesh-list
56206052|NCT01557257|Oxycodone|oxycodone|mesh-list
56206053|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56206054|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56206055|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206056|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
56206057|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206058|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56206059|NCT01557257|Narcotics|narcotics|mesh-ancestor
56206060|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206061|NCT01557257|Analgesics|analgesics|mesh-ancestor
56206062|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
56206063|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56206064|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206065|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206066|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56206067|NCT01557270|Analgesics|analgesics|mesh-ancestor
56206068|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
56206069|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206070|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56206071|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55742443|NCT02889237|Vitamins|vitamins|mesh-list
56206072|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56206073|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
56206074|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206075|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206076|NCT01557335|Aspirin|aspirin|mesh-list
56206077|NCT01557335|Omeprazole|omeprazole|mesh-list
56206079|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56206080|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56206081|NCT01557335|Analgesics|analgesics|mesh-ancestor
56206082|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
56206083|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206084|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206085|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206086|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206087|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56206088|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56206089|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206090|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56206091|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56206092|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206093|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
56206094|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56206095|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56667493|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56667494|NCT02708459|Narcotics|narcotics|mesh-ancestor
56313643|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
56313721|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
56667495|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667496|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667497|NCT02708459|Analgesics|analgesics|mesh-ancestor
56667498|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
56667499|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667500|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
56667501|NCT01005979|Rituximab|rituximab|mesh-list
56206096|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56206097|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
56206098|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206099|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56206100|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56206101|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56206102|NCT01557374|Abatacept|abatacept|mesh-list
56180270|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180271|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56180272|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56180273|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56180274|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206103|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56206104|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206105|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206106|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56206107|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
56206108|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206109|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206110|NCT01557439|Levocetirizine|levocetirizine|mesh-list
56206111|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56206112|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56206113|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
56206114|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
56206115|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206116|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206117|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206118|NCT01557478|Melatonin|melatonin|mesh-list
56206119|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
56206120|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206121|NCT01557478|Protective Agents|protective agents|mesh-ancestor
56206122|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206123|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206124|NCT01557634|Insulin|insulin|mesh-list
56206125|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56206126|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206127|NCT01557647|Treprostinil|treprostinil|mesh-list
56206128|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56206129|NCT01557660|Treprostinil|treprostinil|mesh-list
56206130|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56206131|NCT01557712|Ketamine|ketamine|mesh-list
56206132|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56206133|NCT01557712|Analgesics|analgesics|mesh-ancestor
56206134|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
56206135|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206136|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206137|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56206138|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56206139|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
56206140|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
56206141|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206142|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56206143|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56206144|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667502|NCT01005979|Lenalidomide|lenalidomide|mesh-list
56667503|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56667504|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
56667505|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667506|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56667507|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56667508|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
56667509|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667510|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667511|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56667512|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56206145|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206146|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56206147|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56206148|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206149|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56206150|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
56206151|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56206152|NCT01557764|Trastuzumab|trastuzumab|mesh-list
56206153|NCT01557764|Lapatinib|lapatinib|mesh-list
56206154|NCT01557764|Antibodies|antibodies|mesh-list
56206155|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56206156|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
56206157|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206158|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56206159|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206160|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133910|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206161|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206162|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206163|NCT01557816|Naproxen|naproxen|mesh-list
56180275|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56180276|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56180277|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
56180347|NCT01404676|Glimepiride|glimepiride|mesh-list
56180348|NCT01404676|Vildagliptin|vildagliptin|mesh-list
56180349|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56180350|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56180351|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180352|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180353|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
56180354|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56180355|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
56180356|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180357|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206164|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56206165|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56206166|NCT01557816|Analgesics|analgesics|mesh-ancestor
56206167|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
56206168|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206169|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206170|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206171|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206172|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
56206173|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56206174|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206175|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206176|NCT01557829|Silicon|silicon|mesh-list
56206177|NCT01557829|Trace Elements|trace elements|mesh-ancestor
56206178|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
56206179|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206180|NCT01557907|Insulin|insulin|mesh-list
56667513|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56667514|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56667515|NCT01005979|Growth Substances|growth substances|mesh-ancestor
56667516|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
56667517|NCT00913029|Timolol|timolol|mesh-list
56667518|NCT00913029|Latanoprost|latanoprost|mesh-list
56667519|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56667520|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56667521|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
56667522|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667523|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667524|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667525|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56667526|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56667527|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56667528|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56667529|NCT01006057|Insulin|insulin|mesh-list
56206181|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56206182|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56206183|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206184|NCT01557985|Bupivacaine|bupivacaine|mesh-list
56206185|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
56206186|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
56206187|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206188|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206189|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
56206190|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206191|NCT01558011|Docetaxel|docetaxel|mesh-list
56206192|NCT01558011|Capecitabine|capecitabine|mesh-list
56206193|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
56206194|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206195|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
56206196|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
56206197|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
55742531|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
56206198|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206199|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56206200|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
56206201|NCT01558167|Rituximab|rituximab|mesh-list
56206202|NCT01558167|Lenalidomide|lenalidomide|mesh-list
56206203|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56206204|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56206205|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206206|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
56206207|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206208|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206209|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56206210|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56206211|NCT01558167|Growth Substances|growth substances|mesh-ancestor
56206212|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
56206213|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56206214|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
56206215|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206216|NCT01558193|Vitamins|vitamins|mesh-list
56180359|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56180360|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180361|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180362|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56180363|NCT01404689|Analgesics|analgesics|mesh-ancestor
56667530|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56667531|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
56667532|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56667533|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667534|NCT00853125|Sunitinib|sunitinib|mesh-list
56180364|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
56180365|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180366|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56180367|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56180368|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56206217|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
56206218|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
56206219|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206220|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56206221|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56206222|NCT01558193|Analgesics|analgesics|mesh-ancestor
56206223|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
56206224|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206225|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206226|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206227|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56206228|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
56206229|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206230|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56206231|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
56206232|NCT01558245|Kallikreins|kallikreins|mesh-list
56206233|NCT01558245|Coagulants|coagulants|mesh-ancestor
56206234|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56206235|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
56206236|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56206237|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206238|NCT01558310|Ustekinumab|ustekinumab|mesh-list
56206239|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
56206240|NCT01558336|Praziquantel|praziquantel|mesh-list
56206241|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
56206242|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56206243|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206244|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56206245|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206246|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
56206247|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206248|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
56206249|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
56206250|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56206251|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56206252|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206253|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206254|NCT01558466|Urological Agents|urological agents|mesh-ancestor
56206255|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56206256|NCT01558622|Ketoprofen|ketoprofen|mesh-list
56206257|NCT01558622|Meperidine|meperidine|mesh-list
56206258|NCT01558622|Tramadol|tramadol|mesh-list
56206259|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206260|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206261|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56206262|NCT01558622|Narcotics|narcotics|mesh-ancestor
56206263|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206264|NCT01558622|Analgesics|analgesics|mesh-ancestor
56206265|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
56206266|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206267|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56206268|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56206269|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180369|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
55875638|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206270|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206271|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56206272|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56206273|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206275|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
56206276|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667535|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667536|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56667537|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56667538|NCT00853125|Growth Substances|growth substances|mesh-ancestor
56667539|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667540|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
56667541|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667542|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228820|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
56206277|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206279|NCT01558713|Bupivacaine|bupivacaine|mesh-list
56206280|NCT01558713|Ropivacaine|ropivacaine|mesh-list
56206281|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
56206282|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
56206284|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206285|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206286|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
56206287|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206288|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56206289|NCT01558713|Narcotics|narcotics|mesh-ancestor
56206290|NCT01558713|Analgesics|analgesics|mesh-ancestor
56206291|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56206292|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56206293|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
56206294|NCT01558830|Ranolazine|ranolazine|mesh-list
56206295|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56206296|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206297|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206298|NCT01558869|Capecitabine|capecitabine|mesh-list
56206299|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
56206300|NCT01558869|Irinotecan|irinotecan|mesh-list
56206301|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56206302|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
56206303|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206304|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206305|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56206306|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56206307|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206308|NCT01558934|Lofexidine|lofexidine|mesh-list
56206309|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56206310|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56206311|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206312|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
56206313|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206314|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56206315|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56206316|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56206317|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
56206318|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206319|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206320|NCT01558960|Melphalan|melphalan|mesh-list
56206321|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56206322|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
56206323|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206324|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206325|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56206326|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56206327|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
56206328|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206329|NCT01558986|Cefazolin|cefazolin|mesh-list
56206330|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56206331|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206332|NCT01559025|Vildagliptin|vildagliptin|mesh-list
56206333|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56206334|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56206335|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667543|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667544|NCT02707913|Amlodipine|amlodipine|mesh-list
56667545|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56667546|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56667547|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206336|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
56206337|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206338|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206339|NCT01559051|Anesthetics|anesthetics|mesh-list
56180371|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180372|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
56180373|NCT01404702|Aldesleukin|aldesleukin|mesh-list
56180374|NCT01404702|Interleukin-2|interleukin-2|mesh-list
56180375|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180376|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56180377|NCT01404702|Analgesics|analgesics|mesh-ancestor
56180378|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
56180379|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180380|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180381|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56206340|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206341|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206342|NCT01559142|Azathioprine|azathioprine|mesh-list
56206343|NCT01559142|Infliximab|infliximab|mesh-list
56206344|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56206345|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56206346|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206347|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
56206348|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206349|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56206350|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206351|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56206352|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
56206353|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206354|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56206355|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56206356|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56206357|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206358|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206359|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56206360|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56206361|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56206362|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
56206363|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206364|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206365|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56206366|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56206367|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
56206368|NCT01559285|Ropivacaine|ropivacaine|mesh-list
56206369|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
56206370|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
56206371|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206372|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206373|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
56206374|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206375|NCT01559298|Aspirin|aspirin|mesh-list
56206376|NCT01559298|Clopidogrel|clopidogrel|mesh-list
56206377|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56206378|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56206379|NCT01559298|Analgesics|analgesics|mesh-ancestor
56206380|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
56206381|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206382|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206383|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206384|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206385|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56206386|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56134142|NCT00179478|Interferons|interferons|mesh-list
56206387|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667548|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667549|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56667550|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667551|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
56667552|NCT02710877|Sufentanil|sufentanil|mesh-list
56667553|NCT02710877|Dsuvia|dsuvia|mesh-list
56667554|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
56667555|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56667556|NCT02710877|Narcotics|narcotics|mesh-ancestor
56667557|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667558|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667559|NCT02710877|Analgesics|analgesics|mesh-ancestor
56667560|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
56667561|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667562|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56667563|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56667564|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
56667565|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
56667566|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
56667567|NCT05550337|Trifarotene|trifarotene|mesh-list
56667568|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
56667569|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56667570|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206388|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56206389|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56206390|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206391|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
56180382|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56180383|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
56180384|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180385|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56180386|NCT01404715|Metformin|metformin|mesh-list
56180387|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
56180388|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56180389|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180390|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180391|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56180392|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180393|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180394|NCT01404741|Azacitidine|azacitidine|mesh-list
56180395|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56180396|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
56180397|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180399|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180400|NCT01404767|Metoprolol|metoprolol|mesh-list
56206392|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56206393|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56206394|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56206395|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
56206396|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206397|NCT01559480|Desogestrel|desogestrel|mesh-list
56206398|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56206399|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56667572|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56667573|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667574|NCT02707445|Clopidogrel|clopidogrel|mesh-list
56667575|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56667576|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56667577|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56667578|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56206400|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56206401|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
56206402|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56206403|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206404|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56206405|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56206406|NCT01559480|Progestins|progestins|mesh-ancestor
56206408|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206409|NCT01559545|Metronidazole|metronidazole|mesh-list
56206410|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206411|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56206412|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56206413|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56206414|NCT01559584|Triamcinolone|triamcinolone|mesh-list
56206415|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56206416|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56206417|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56206418|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206419|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
56206420|NCT01559584|Hormones|hormones|mesh-ancestor
56206421|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206422|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206423|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56206424|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
56206425|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206426|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206427|NCT01559727|Prednisone|prednisone|mesh-list
56206428|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180402|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56180403|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56180404|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
56206429|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
56206430|NCT01559727|Hormones|hormones|mesh-ancestor
56206431|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206432|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206433|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56206434|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206435|NCT01559740|Bupivacaine|bupivacaine|mesh-list
56206436|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
56206437|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
56206438|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206439|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206440|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
56206441|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206442|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56206443|NCT01559753|Amoxicillin|amoxicillin|mesh-list
56206444|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
56206445|NCT01559753|Tobramycin|tobramycin|mesh-list
55742690|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56206446|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56206447|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
56206448|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
56206450|NCT01559753|Cefoxitin|cefoxitin|mesh-list
56206451|NCT01559753|Netilmicin|netilmicin|mesh-list
56206452|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206453|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56206454|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206455|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206456|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56206457|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
56667579|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
56667580|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667581|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667582|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667583|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
56667584|NCT03999775|Vitamin D|vitamin d|mesh-list
56667585|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
56667586|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
56667587|NCT03999775|Vitamins|vitamins|mesh-list
56667588|NCT03999775|Calcium|calcium|mesh-list
56667589|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
56667590|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667591|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56132081|NCT01459380|Veliparib|veliparib|mesh-list
56206458|NCT01559974|Vitamin D|vitamin d|mesh-list
56206459|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56206466|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206467|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
56206468|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206469|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206470|NCT05570669|Simethicone|simethicone|mesh-list
56206471|NCT05570669|Sodium sulfate|sodium sulfate|mesh-list
56206472|NCT05570669|Antifoaming Agents|antifoaming agents|mesh-ancestor
56206473|NCT05570669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206474|NCT05570669|Emollients|emollients|mesh-ancestor
56206475|NCT05570669|Dermatologic Agents|dermatologic agents|mesh-ancestor
56206476|NCT05570669|Cathartics|cathartics|mesh-ancestor
56206477|NCT05570669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56206478|NCT05570409|Mycophenolic Acid|mycophenolic acid|mesh-list
56206479|NCT05570409|Prednisolone|prednisolone|mesh-list
56206480|NCT05570409|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56206481|NCT05570409|Methylprednisolone|methylprednisolone|mesh-list
56206482|NCT05570409|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56206483|NCT05570409|Prednisolone acetate|prednisolone acetate|mesh-list
56206484|NCT05570409|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56206485|NCT05570409|Prednisolone phosphate|prednisolone phosphate|mesh-list
56206486|NCT05570409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56206487|NCT05570409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206488|NCT05570409|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56206489|NCT05570409|Antitubercular Agents|antitubercular agents|mesh-ancestor
56206490|NCT05570409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56206491|NCT05570409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206492|NCT05570409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206493|NCT05570409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206494|NCT05570409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206495|NCT05570409|Glucocorticoids|glucocorticoids|mesh-ancestor
56206496|NCT05570409|Hormones|hormones|mesh-ancestor
56206497|NCT05570409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180405|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
56180406|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180476|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
56180477|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
56206498|NCT05570409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206499|NCT05570409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56206500|NCT05570409|Antiemetics|antiemetics|mesh-ancestor
56206501|NCT05570409|Autonomic Agents|autonomic agents|mesh-ancestor
56206502|NCT05570409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206503|NCT05570409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56206504|NCT05570409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56206505|NCT05570409|Protective Agents|protective agents|mesh-ancestor
56206506|NCT05570383|Antacids|antacids|mesh-list
56206507|NCT05570383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206508|NCT05570383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56206509|NCT05570110|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
56667592|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56667593|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56667594|NCT02706977|Carbidopa|carbidopa|mesh-list
56667595|NCT02706977|Levodopa|levodopa|mesh-list
56667596|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56667597|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
56667598|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667599|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56667600|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56667601|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
56667602|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
56667603|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667604|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228878|NCT01695174|Rifaximin|rifaximin|mesh-list
56206510|NCT05570110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206511|NCT05570084|Tamsulosin|tamsulosin|mesh-list
56206512|NCT05570084|Silodosin|silodosin|mesh-list
56206513|NCT05570084|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56206514|NCT05570084|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56206515|NCT05570084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56206516|NCT05570084|Adrenergic Agents|adrenergic agents|mesh-ancestor
56206517|NCT05570084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206518|NCT05570084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206519|NCT05570084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206520|NCT05570084|Urological Agents|urological agents|mesh-ancestor
56206521|NCT05569668|Paclitaxel|paclitaxel|mesh-list
56206522|NCT05569668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56206523|NCT05569668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206524|NCT05569668|Tubulin Modulators|tubulin modulators|mesh-ancestor
56206525|NCT05569668|Antimitotic Agents|antimitotic agents|mesh-ancestor
56206526|NCT05569668|Mitosis Modulators|mitosis modulators|mesh-ancestor
56206527|NCT05569668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206528|NCT05569655|Furosemide|furosemide|mesh-list
56206529|NCT05569655|Tolvaptan|tolvaptan|mesh-list
56206530|NCT05569655|Diuretics|diuretics|mesh-ancestor
56206531|NCT05569655|Natriuretic Agents|natriuretic agents|mesh-ancestor
56206532|NCT05569655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206533|NCT05569655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56206534|NCT05569655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206535|NCT05569655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134286|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206536|NCT05569655|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56206537|NCT05569590|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56206538|NCT05569590|Propolis|propolis|mesh-list
56206539|NCT05569590|Fluorides|fluorides|mesh-list
56206540|NCT05569590|Fluorides, Topical|fluorides, topical|mesh-list
56206541|NCT05569590|Cariostatic Agents|cariostatic agents|mesh-ancestor
56206542|NCT05569590|Protective Agents|protective agents|mesh-ancestor
56206543|NCT05569590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206544|NCT05569590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56206545|NCT05569590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206546|NCT05569577|Estrogens|estrogens|mesh-list
56206547|NCT05569577|Dydrogesterone|dydrogesterone|mesh-list
56206548|NCT05569577|Hormones|hormones|mesh-ancestor
56206549|NCT05569577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206550|NCT05569577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206551|NCT05569577|Progestins|progestins|mesh-ancestor
56206552|NCT05569031|Lofexidine|lofexidine|mesh-list
56206553|NCT05569031|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56206554|NCT05569031|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56206555|NCT05569031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56667605|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56667606|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667607|NCT05733715|Pembrolizumab|pembrolizumab|mesh-list
56667608|NCT05733715|Lenvatinib|lenvatinib|mesh-list
56228889|NCT01695226|Analgesics|analgesics|mesh-ancestor
56206556|NCT05569031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206557|NCT05569031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206558|NCT05569031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206559|NCT05569031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206560|NCT05569031|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56206561|NCT05569031|Antidepressive Agents|antidepressive agents|mesh-ancestor
56206562|NCT05569031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56206563|NCT05569031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56206564|NCT05569031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56206565|NCT05569031|Sensory System Agents|sensory system agents|mesh-ancestor
56206566|NCT05569031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180478|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180479|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875983|NCT01215292|Acyline|acyline|mesh-list
56206567|NCT05569031|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56206568|NCT05569031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56206569|NCT05569031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56206570|NCT05569031|Adrenergic Agents|adrenergic agents|mesh-ancestor
56206571|NCT05568953|Vaccines|vaccines|mesh-list
56206572|NCT05568953|Immunologic Factors|immunologic factors|mesh-ancestor
56206573|NCT05568953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206574|NCT05564741|Norepinephrine|norepinephrine|mesh-list
56206575|NCT05564741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56206576|NCT05564741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56206577|NCT05564741|Adrenergic Agents|adrenergic agents|mesh-ancestor
56206578|NCT05564741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206579|NCT05564741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206580|NCT05564741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206581|NCT05564741|Sympathomimetics|sympathomimetics|mesh-ancestor
56206582|NCT05564741|Autonomic Agents|autonomic agents|mesh-ancestor
56206583|NCT05564741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206584|NCT05564741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56206592|NCT05522582|Methotrexate|methotrexate|mesh-list
56206593|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56206594|NCT05522582|Antibodies|antibodies|mesh-list
56206595|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56206596|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
56206597|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206598|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56206599|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
56206600|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56206601|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56206602|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
56206604|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206605|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
56206606|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206607|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56206608|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134368|NCT00202722|Remifentanil|remifentanil|mesh-list
56206609|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206610|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56206611|NCT05491304|Dexamethasone|dexamethasone|mesh-list
56206612|NCT05491304|Etoposide|etoposide|mesh-list
56206613|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206614|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
56206615|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
56206616|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206617|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206618|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56206619|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
56206621|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206622|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56206623|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206624|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56206625|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56667609|NCT05733715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56667610|NCT05733715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667611|NCT05733715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667612|NCT05733715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667613|NCT05733715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667614|NCT02707211|Antibodies|antibodies|mesh-list
56667615|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
56667616|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
56667617|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667618|NCT01006525|Zolpidem|zolpidem|mesh-list
56667619|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56667620|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56206626|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56206627|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206628|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206629|NCT05461794|Docetaxel|docetaxel|mesh-list
56206630|NCT05461794|Irinotecan|irinotecan|mesh-list
56206631|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206632|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
56206633|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
56206634|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
56180480|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56180482|NCT01405131|Hormones|hormones|mesh-ancestor
56180483|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180484|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56180485|NCT01405131|Protective Agents|protective agents|mesh-ancestor
56180486|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56180487|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180488|NCT01405144|Fluorouracil|fluorouracil|mesh-list
56180489|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
56180490|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180491|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56180492|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180493|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56206635|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206636|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56206637|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56206638|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206639|NCT05391555|Remifentanil|remifentanil|mesh-list
56206640|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56206641|NCT05391555|Narcotics|narcotics|mesh-ancestor
56206642|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206643|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206644|NCT05391555|Analgesics|analgesics|mesh-ancestor
56206645|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
56206646|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206647|NCT05388773|Carboplatin|carboplatin|mesh-list
56206648|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206649|NCT05388656|Estradiol|estradiol|mesh-list
56206650|NCT05388656|Progesterone|progesterone|mesh-list
56206651|NCT05388656|Estrogens|estrogens|mesh-ancestor
56206652|NCT05388656|Hormones|hormones|mesh-ancestor
56206653|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206654|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206655|NCT05388656|Progestins|progestins|mesh-ancestor
56206656|NCT05378113|Lidocaine|lidocaine|mesh-list
56206657|NCT05378113|Ondansetron|ondansetron|mesh-list
56206658|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
56206659|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
56206660|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206661|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206662|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
56206663|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206671|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56667621|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667622|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667623|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56667624|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
56667625|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
56667626|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667627|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667628|NCT05246111|Topotecan|topotecan|mesh-list
56667629|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56667630|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56667631|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667632|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228904|NCT01695356|Benzophenone|benzophenone|mesh-list
56206672|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
56206673|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
56206674|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56206675|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
56206676|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206677|NCT05378113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56206678|NCT05378113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56206679|NCT05378113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56206680|NCT05378113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56134435|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
56206681|NCT05372393|Anesthetics|anesthetics|mesh-list
56206682|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206683|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206684|NCT05229965|Acetaminophen|acetaminophen|mesh-list
56206687|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56206688|NCT05229965|Analgesics|analgesics|mesh-ancestor
56206689|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
56206690|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206691|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206692|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
56206693|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56206694|NCT05229965|Narcotics|narcotics|mesh-ancestor
56206695|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206696|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
56206697|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
56206698|NCT05229965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56206699|NCT05229965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56206700|NCT05229965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206701|NCT05229965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206702|NCT05229965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56206703|NCT05229965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56206704|NCT05229965|Purinergic Agents|purinergic agents|mesh-ancestor
56206705|NCT05229965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206706|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
56206708|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56206709|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56206710|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206711|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206712|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
56206713|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
56206714|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
56206715|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206716|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
56206717|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
56206718|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56206719|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56206720|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
56206721|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
56206722|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667633|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667634|NCT01006681|Vaccines|vaccines|mesh-list
56667635|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56667636|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
56667637|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667638|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56667639|NCT05733403|Norepinephrine|norepinephrine|mesh-list
56228919|NCT01695733|Vaccines|vaccines|mesh-list
56206723|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206724|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56206725|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
56206726|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
56206727|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
56206728|NCT05166811|Analgesics|analgesics|mesh-ancestor
56206729|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
56206730|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206731|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206732|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
55798942|NCT02492997|Glycerol|glycerol|mesh-list
56206740|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
56206741|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56206742|NCT05137080|Dexamethasone|dexamethasone|mesh-list
56206743|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206744|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
56206745|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
56206746|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206747|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206748|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56206749|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
56206750|NCT05137080|Hormones|hormones|mesh-ancestor
56206751|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206752|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56206753|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206754|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
56206755|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56206756|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206757|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56206758|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56134511|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
56206759|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206760|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206761|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206762|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
56206763|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56206764|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206765|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56206766|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206767|NCT04787731|Lidocaine|lidocaine|mesh-list
56206768|NCT04787731|Bupivacaine|bupivacaine|mesh-list
56206769|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
56206770|NCT04787731|Anesthetics|anesthetics|mesh-list
56206771|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206772|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206773|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
56206774|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206775|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56206776|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56206777|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56206778|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206779|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206780|NCT04713358|Nalmefene|nalmefene|mesh-list
56206781|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56206782|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206783|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
56206784|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206785|NCT04707872|Antibodies|antibodies|mesh-list
56206786|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
56206787|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206788|NCT04696952|Zopiclone|zopiclone|mesh-list
56667640|NCT05733403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56667641|NCT05733403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56667642|NCT05733403|Adrenergic Agents|adrenergic agents|mesh-ancestor
56667643|NCT05733403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667644|NCT05733403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667645|NCT05733403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667646|NCT05733403|Sympathomimetics|sympathomimetics|mesh-ancestor
56667647|NCT05733403|Autonomic Agents|autonomic agents|mesh-ancestor
56667648|NCT05733403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206789|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56206790|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206791|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206792|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56206793|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56206794|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206795|NCT04571619|Buprenorphine|buprenorphine|mesh-list
56206797|NCT04571619|Narcotics|narcotics|mesh-ancestor
56206798|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206799|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206800|NCT04571619|Analgesics|analgesics|mesh-ancestor
56206801|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
56206802|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206803|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56206804|NCT04496999|Midostaurin|midostaurin|mesh-list
56206805|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206806|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56206807|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206808|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206809|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
56206810|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56206811|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206812|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56206813|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206814|NCT04474366|Ropivacaine|ropivacaine|mesh-list
56206815|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
56206816|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
56206817|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206818|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206819|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
56206820|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206821|NCT04464265|Propofol|propofol|mesh-list
56206822|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56206823|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742965|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
56206824|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206825|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56206826|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
56206827|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
56206828|NCT04437303|Anticoagulants|anticoagulants|mesh-list
56206829|NCT04424511|Azithromycin|azithromycin|mesh-list
56180496|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
56180497|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55876260|NCT03435900|Metronidazole|metronidazole|mesh-list
56206830|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56206831|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206832|NCT04421079|Resveratrol|resveratrol|mesh-list
56206833|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
56206834|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206835|NCT04421079|Protective Agents|protective agents|mesh-ancestor
56206836|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206837|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206838|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56206839|NCT04410406|Ivermectin|ivermectin|mesh-list
56206840|NCT04410406|Albendazole|albendazole|mesh-list
56206841|NCT04410406|Moxidectin|moxidectin|mesh-list
56206842|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
56667649|NCT05733403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56667650|NCT03893903|Avelumab|avelumab|mesh-list
56667651|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56667652|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667653|NCT02706509|Tramadol|tramadol|mesh-list
56667654|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206843|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206844|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56206845|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206846|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
56206847|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
56206848|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56206849|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56206850|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
56206851|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
56206852|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
56206853|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206854|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
56206855|NCT04410406|Filaricides|filaricides|mesh-ancestor
56206856|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56206857|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206858|NCT04393506|Apatinib|apatinib|mesh-list
56206859|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56206860|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206861|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56206862|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206863|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206864|NCT04349826|Azithromycin|azithromycin|mesh-list
56206865|NCT04349826|Cefixime|cefixime|mesh-list
56206866|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55743008|NCT03955575|Hormones|hormones|mesh-ancestor
56206867|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206869|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56206870|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206873|NCT04298853|Narcotics|narcotics|mesh-ancestor
56206874|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206875|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206876|NCT04298853|Analgesics|analgesics|mesh-ancestor
56206877|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
56206878|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206879|NCT04232683|Tamsulosin|tamsulosin|mesh-list
56206880|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56206881|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56206882|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56206883|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
56206884|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206885|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206886|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206887|NCT04232683|Urological Agents|urological agents|mesh-ancestor
56206888|NCT04227483|Prednisolone|prednisolone|mesh-list
56206889|NCT04227483|Deflazacort|deflazacort|mesh-list
56206890|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206891|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
56206892|NCT04227483|Hormones|hormones|mesh-ancestor
56206893|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206894|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206895|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56206896|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206897|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56206898|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
56206899|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
56206900|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56206901|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56180498|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56206902|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206903|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
56206904|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
56206905|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206906|NCT04182672|Triamcinolone|triamcinolone|mesh-list
56206907|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56667655|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667656|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56667657|NCT02706509|Narcotics|narcotics|mesh-ancestor
56667658|NCT02706509|Analgesics|analgesics|mesh-ancestor
56667659|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
56667660|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667661|NCT02710409|Vaccines|vaccines|mesh-list
56667662|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
56667663|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667664|NCT02253316|Dexamethasone|dexamethasone|mesh-list
56667665|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
56667666|NCT02253316|Lenalidomide|lenalidomide|mesh-list
56667667|NCT02253316|Ixazomib|ixazomib|mesh-list
56667668|NCT02253316|BB 1101|bb 1101|mesh-list
56667669|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667670|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
56667671|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
56667672|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667673|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667674|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56667675|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
56206908|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56206909|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56206910|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206911|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
56206913|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56206914|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206915|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56206916|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
56206917|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206918|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206919|NCT04101227|Ondansetron|ondansetron|mesh-list
56206920|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
56206921|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
56206922|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206923|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206924|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56206925|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
56206926|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
56206927|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56206928|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
56206929|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206930|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206931|NCT04101227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56206932|NCT04101227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56206933|NCT04101227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206934|NCT04101227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56206935|NCT04101227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56206936|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
56206937|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206938|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206939|NCT04047004|Doxorubicin|doxorubicin|mesh-list
56206940|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206941|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56206942|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56206943|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56667676|NCT02253316|Hormones|hormones|mesh-ancestor
56667677|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667678|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56667679|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667680|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
56667681|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667682|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667683|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
56667684|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56667685|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56667686|NCT02253316|Growth Substances|growth substances|mesh-ancestor
56667687|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
56667688|NCT00529087|Bromides|bromides|mesh-list
56667689|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
56667690|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
56667691|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56206944|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206945|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206947|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56206948|NCT03972280|Lenograstim|lenograstim|mesh-list
56206949|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
56206950|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206951|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56206952|NCT03893435|Valsartan|valsartan|mesh-list
56206953|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55743070|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56206954|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56206955|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56206956|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56206957|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206959|NCT03813121|Ketamine|ketamine|mesh-list
56206960|NCT03813121|Analgesics|analgesics|mesh-ancestor
56206961|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
56206962|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206963|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206964|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56206965|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56206966|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
56206967|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
56206968|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206969|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56206970|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56206971|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180500|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
56180501|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56180502|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
56180503|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56206972|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206973|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56206974|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56206975|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56206976|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56206977|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56206978|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
56206979|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
56206980|NCT03782064|Nivolumab|nivolumab|mesh-list
56206981|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56206982|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667692|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667693|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
56667694|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667695|NCT04318210|Tenofovir|tenofovir|mesh-list
56667696|NCT04318210|Emtricitabine|emtricitabine|mesh-list
56667697|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
56667698|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206983|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56206984|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206986|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56206987|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
56206988|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56206989|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206990|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56206991|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56206992|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
56206993|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206994|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206995|NCT03691714|Cetuximab|cetuximab|mesh-list
56206996|NCT03691714|Durvalumab|durvalumab|mesh-list
56206997|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56206998|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207000|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
56207001|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
56207002|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207003|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207004|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
56207005|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207006|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56207007|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56207008|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56207009|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56207010|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207011|NCT03572049|Itraconazole|itraconazole|mesh-list
56207012|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56207013|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
56137536|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
56207014|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207015|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56207016|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56207017|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207018|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207019|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56207020|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
56207021|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207022|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207023|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56207024|NCT03471507|Diclofenac|diclofenac|mesh-list
56207025|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56207026|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56207027|NCT03471507|Analgesics|analgesics|mesh-ancestor
56207028|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
56207029|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207030|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207031|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56207032|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207033|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56207034|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207035|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180504|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
56180505|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
56180506|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180507|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180508|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56180509|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
56180510|NCT01405157|Hormones|hormones|mesh-ancestor
56667699|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56667700|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56667701|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667702|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667703|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56180511|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180512|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56180513|NCT01405157|Protective Agents|protective agents|mesh-ancestor
56180514|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56180515|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180516|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
56180517|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56180518|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56180519|NCT01405170|Prednisolone|prednisolone|mesh-list
56207036|NCT03470922|Nivolumab|nivolumab|mesh-list
56207037|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56207038|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207039|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56207040|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207041|NCT03468335|Irinotecan|irinotecan|mesh-list
56207042|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56207043|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56207044|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207045|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207046|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207047|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56207048|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207049|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207050|NCT03345810|Gemcitabine|gemcitabine|mesh-list
56207051|NCT03345810|Paclitaxel|paclitaxel|mesh-list
56207052|NCT03345810|Vinorelbine|vinorelbine|mesh-list
56207053|NCT03345810|Carboplatin|carboplatin|mesh-list
56207054|NCT03345810|Durvalumab|durvalumab|mesh-list
56207055|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56207056|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207057|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56207058|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56207059|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56207060|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207061|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56207062|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
56207063|NCT03345810|Antiviral Agents|antiviral agents|mesh-ancestor
56207064|NCT03345810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207065|NCT03345810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207066|NCT03345810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207067|NCT03345810|Immunologic Factors|immunologic factors|mesh-ancestor
56207068|NCT03345810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207069|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56207070|NCT03326947|Docetaxel|docetaxel|mesh-list
56207071|NCT03326947|Fluorouracil|fluorouracil|mesh-list
56207072|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207073|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
56207074|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
56207075|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
56207076|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207077|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
56207078|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56180520|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
56180521|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56180522|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
56180523|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180524|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
56180525|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
56207079|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207080|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
56207081|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207082|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
56207083|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207084|NCT03205423|Gabapentin|gabapentin|mesh-list
56667704|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56207085|NCT03205423|Analgesics|analgesics|mesh-ancestor
56207086|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
56207087|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207088|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207089|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
56207090|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56207091|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56207092|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207093|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207094|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56207095|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56207096|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207097|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207098|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
56207099|NCT03104400|Adalimumab|adalimumab|mesh-list
56207100|NCT03104400|Upadacitinib|upadacitinib|mesh-list
56207101|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56207102|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207103|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56207104|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56207105|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207106|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207107|NCT03104374|Upadacitinib|upadacitinib|mesh-list
56207108|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56207109|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56207110|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207111|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207112|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207113|NCT03008369|Lenvatinib|lenvatinib|mesh-list
56207114|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207115|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56207116|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207117|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207118|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
56207119|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56207120|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56207121|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207122|NCT02918409|Tobramycin|tobramycin|mesh-list
56207123|NCT02918409|Colistin|colistin|mesh-list
56207124|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56207125|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207127|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
56207128|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207129|NCT02917772|Nivolumab|nivolumab|mesh-list
56207130|NCT02917772|Ipilimumab|ipilimumab|mesh-list
56207131|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56207132|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207133|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56207134|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207135|NCT02909686|Curcumin|curcumin|mesh-list
56207136|NCT02909686|Resveratrol|resveratrol|mesh-list
56207137|NCT02909686|Pycnogenols|pycnogenols|mesh-list
56207138|NCT02909686|Turmeric extract|turmeric extract|mesh-list
56207139|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56207140|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56207141|NCT02909686|Analgesics|analgesics|mesh-ancestor
56207142|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
56207144|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180526|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180527|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180528|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56180529|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
56180530|NCT01405170|Hormones|hormones|mesh-ancestor
56180531|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180532|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56180533|NCT01405170|Protective Agents|protective agents|mesh-ancestor
56180534|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56180535|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180536|NCT01405235|Paclitaxel|paclitaxel|mesh-list
56180537|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56207145|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56207146|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207147|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667705|NCT04535141|Olanzapine|olanzapine|mesh-list
56667706|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
56667707|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
56667708|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667709|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667710|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56667711|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56667712|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56667713|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667714|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56667715|NCT04535141|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56667716|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56667717|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56313872|NCT02315534|Temozolomide|temozolomide|mesh-list
56667718|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667719|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667720|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
56667721|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56667722|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
56667723|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667724|NCT00870870|Gemcitabine|gemcitabine|mesh-list
56667725|NCT00870870|Carboplatin|carboplatin|mesh-list
56667726|NCT00870870|Cetuximab|cetuximab|mesh-list
56667727|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56667728|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667729|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56667730|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
56667731|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667732|NCT00870870|Antiviral Agents|antiviral agents|mesh-ancestor
56667733|NCT00870870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667734|NCT00870870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667735|NCT00870870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56667736|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
56667737|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667738|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56667739|NCT04120636|Celecoxib|celecoxib|mesh-list
56207148|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207149|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667740|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56667741|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56667742|NCT04120636|Analgesics|analgesics|mesh-ancestor
56667743|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
56667744|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667745|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667746|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667747|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56667748|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56667749|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56667750|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667751|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667752|NCT00731926|Vitamins|vitamins|mesh-list
56667753|NCT00731926|Vitamin E|vitamin e|mesh-list
56667754|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
56229027|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
56207150|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
56207151|NCT02909686|Protective Agents|protective agents|mesh-ancestor
56207152|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56207153|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56207154|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
56207155|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56207156|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
56207157|NCT02713373|Cetuximab|cetuximab|mesh-list
56207158|NCT02713373|Antibodies|antibodies|mesh-list
56207159|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
56207160|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56207161|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
56207162|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207163|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207164|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
56207165|NCT02686593|Clofarabine|clofarabine|mesh-list
56207166|NCT02686593|Analgesics|analgesics|mesh-ancestor
56207167|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
56207168|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207169|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207170|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207171|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56207172|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56207173|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207174|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207175|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56207176|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
56207177|NCT02658487|Cytarabine|cytarabine|mesh-list
56207178|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56207179|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
56207180|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207181|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207182|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
56207183|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207184|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207185|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
56207186|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207187|NCT02583282|Doxycycline|doxycycline|mesh-list
56207188|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56207189|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207190|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
56207191|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56207192|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56207193|NCT02553941|Azacitidine|azacitidine|mesh-list
56667755|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667756|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
56667757|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667758|NCT00731926|Protective Agents|protective agents|mesh-ancestor
56667759|NCT05053087|Ropivacaine|ropivacaine|mesh-list
56667760|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
56667761|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
56667762|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667763|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667764|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
56667765|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667766|NCT00732082|Gemcitabine|gemcitabine|mesh-list
56667767|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56667768|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
56667769|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667770|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667771|NCT00732082|Antiviral Agents|antiviral agents|mesh-ancestor
56667772|NCT00732082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667773|NCT00732082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667774|NCT00732082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56667775|NCT00732082|Immunologic Factors|immunologic factors|mesh-ancestor
56667776|NCT00732082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207194|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56207195|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
56180538|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56180539|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207196|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207197|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207198|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207199|NCT02546492|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56207200|NCT02546492|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56207202|NCT02546492|Hormones|hormones|mesh-ancestor
56207203|NCT02546492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207204|NCT02546492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207205|NCT02546492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207206|NCT02546492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207207|NCT02527564|Suvorexant|suvorexant|mesh-list
56207208|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56207209|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56207210|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207211|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207212|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56207213|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207214|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207215|NCT02339168|Metformin|metformin|mesh-list
56207216|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56207217|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207218|NCT02179749|Mifepristone|mifepristone|mesh-list
56207219|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56667777|NCT00611741|Furosemide|furosemide|mesh-list
56667778|NCT00611741|Diuretics|diuretics|mesh-ancestor
56667779|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
56667780|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667781|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56667782|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56667783|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667784|NCT02022982|Palbociclib|palbociclib|mesh-list
56667785|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667786|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667787|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667788|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667789|NCT04134468|Gemcitabine|gemcitabine|mesh-list
56207220|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
56207221|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56207222|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207223|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56207224|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56207225|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56207226|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
56207227|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56207228|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56207229|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
56207230|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207231|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
56207232|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56207233|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56207234|NCT02065609|Trastuzumab|trastuzumab|mesh-list
56207235|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56207236|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207237|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
56207238|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56207239|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56207240|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207241|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
56207242|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
56207243|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55743257|NCT05638399|Denosumab|denosumab|mesh-list
56207244|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56207245|NCT01703949|Nivolumab|nivolumab|mesh-list
56207246|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56207247|NCT01703949|Antibodies|antibodies|mesh-list
56207248|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
56207249|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56207250|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
56207251|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
56207252|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207253|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207254|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56207255|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207256|NCT00700882|Dasatinib|dasatinib|mesh-list
56207257|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207258|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56207259|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207260|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207261|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
56207262|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56180540|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
56180541|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
56180542|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933285|NCT05582993|Factor VIII|factor viii|mesh-list
56667790|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56667791|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56667792|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
56667793|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667794|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667795|NCT04134468|Antiviral Agents|antiviral agents|mesh-ancestor
56667796|NCT04134468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667797|NCT04134468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667798|NCT04134468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56667799|NCT04134468|Immunologic Factors|immunologic factors|mesh-ancestor
56180543|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207263|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56207264|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
56207265|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
56207266|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207267|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207268|NCT01561482|Metformin|metformin|mesh-list
56207269|NCT01561482|Simvastatin|simvastatin|mesh-list
56207270|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56207271|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207272|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56207277|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56207278|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207280|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207281|NCT01562704|Acetaminophen|acetaminophen|mesh-list
56207282|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56207283|NCT01562704|Analgesics|analgesics|mesh-ancestor
56207284|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
56207285|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207286|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207287|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
56207289|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56207290|NCT01564095|Tacrolimus|tacrolimus|mesh-list
56207291|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207292|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
56207293|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207294|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56207295|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207296|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207297|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56207298|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
56207299|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207300|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
56207301|NCT01564238|Calcium|calcium|mesh-list
56207302|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56207303|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207304|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56207305|NCT01564576|Bromides|bromides|mesh-list
56207306|NCT01564576|Rocuronium|rocuronium|mesh-list
56207307|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
56207308|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56207309|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56207311|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207312|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207313|NCT01564823|Metronidazole|metronidazole|mesh-list
56207314|NCT01564823|Adalimumab|adalimumab|mesh-list
56207315|NCT01564823|Azathioprine|azathioprine|mesh-list
56207316|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56207317|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207318|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207319|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56207320|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56207321|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56207322|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
56207323|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667800|NCT04134468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667801|NCT02709863|Propofol|propofol|mesh-list
56667802|NCT02709863|Sevoflurane|sevoflurane|mesh-list
56667803|NCT02709863|Desflurane|desflurane|mesh-list
56133024|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
56207324|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56207325|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207326|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207327|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
56207328|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207329|NCT01565239|Thrombin|thrombin|mesh-list
56207330|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
56207331|NCT01565239|Coagulants|coagulants|mesh-ancestor
56207332|NCT01565265|Cetrorelix|cetrorelix|mesh-list
56180544|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
56180545|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56180546|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56180547|NCT01405248|Protective Agents|protective agents|mesh-ancestor
56180548|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180549|NCT01405326|Adalimumab|adalimumab|mesh-list
56180550|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180551|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56180552|NCT01405339|Budesonide|budesonide|mesh-list
56180553|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180554|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56180555|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
56180556|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180557|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180558|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56180559|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
56180560|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
56180561|NCT01405339|Hormones|hormones|mesh-ancestor
56180562|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180563|NCT01405352|Vitamin A|vitamin a|mesh-list
56207333|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56207334|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56207335|NCT01565265|Hormones|hormones|mesh-ancestor
56207336|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207337|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207338|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56207339|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
56207340|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56207341|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
56207342|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
56207343|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56207344|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56207345|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56207346|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56207347|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207348|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
56207349|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207350|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207351|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56207352|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207353|NCT01566422|Vancomycin|vancomycin|mesh-list
56207354|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56207355|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207356|NCT01566760|Fesoterodine|fesoterodine|mesh-list
56207357|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56207358|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56207359|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
56207360|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207361|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207362|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207363|NCT01566760|Urological Agents|urological agents|mesh-ancestor
56207365|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56207366|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56207367|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
56207368|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
56180564|NCT01405352|Vitamins|vitamins|mesh-ancestor
56180565|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
56180566|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667804|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56667805|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667806|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667807|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56667808|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
56667809|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
56667810|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56667811|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56667812|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
56667813|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56667814|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667815|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56667816|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667817|NCT02619786|Colistin|colistin|mesh-list
56667818|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56667819|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667820|NCT00697086|Dronedarone|dronedarone|mesh-list
56667821|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56667822|NCT04066660|Fucoidan|fucoidan|mesh-list
56667823|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56667824|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56667825|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
56667826|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667827|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
56667828|NCT00697164|Hematinics|hematinics|mesh-ancestor
56667829|NCT00694980|Etrolizumab|etrolizumab|mesh-list
56667830|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56667831|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
56207369|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207370|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207371|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207372|NCT01567072|Ibuprofen|ibuprofen|mesh-list
56207373|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56207374|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56207375|NCT01567072|Analgesics|analgesics|mesh-ancestor
56207376|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
56207377|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207378|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207379|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56207380|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207381|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56207382|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207383|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207384|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56207385|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
56207386|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56207387|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55933286|NCT05582993|Coagulants|coagulants|mesh-ancestor
56667832|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667833|NCT00612755|Ribavirin|ribavirin|mesh-list
56667834|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56667835|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
56667836|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667837|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
56667838|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667839|NCT04132674|Tenofovir|tenofovir|mesh-list
56667840|NCT04132674|Emtricitabine|emtricitabine|mesh-list
56667841|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56667842|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
56667843|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667844|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56667845|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56667846|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667847|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667848|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56667849|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56667850|NCT00612287|Buprenorphine|buprenorphine|mesh-list
56667851|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56667852|NCT00612287|Narcotics|narcotics|mesh-ancestor
56667853|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667854|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667855|NCT00612287|Analgesics|analgesics|mesh-ancestor
56667856|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
56667857|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667858|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56667859|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
56207388|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207389|NCT01568632|Imetelstat|imetelstat|mesh-list
56207390|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
56207391|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207392|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207393|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56207394|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
56207395|NCT01568645|Carvedilol|carvedilol|mesh-list
56207396|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207397|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56207398|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207399|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207400|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56207401|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56207402|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
56207403|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207404|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207405|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56207406|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
56207407|NCT01568645|Protective Agents|protective agents|mesh-ancestor
56667860|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
56667861|NCT00732784|Calcium|calcium|mesh-list
56667862|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56667863|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667864|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667865|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667866|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667867|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667868|NCT00732784|Antacids|antacids|mesh-ancestor
56667869|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314030|NCT00142129|Bortezomib|bortezomib|mesh-list
56667870|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56667871|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
56667872|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56667873|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
56667874|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667875|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56667876|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
56207408|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56207409|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56207410|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56207411|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
56207412|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56207413|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56207415|NCT01568684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56207416|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56207417|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56207418|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207419|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207420|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
56207421|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207422|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56207423|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
56207424|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207425|NCT01569685|Sertraline|sertraline|mesh-list
56207426|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56207427|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
56135190|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
56207428|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207429|NCT01569685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56207430|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56207431|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56207432|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207433|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207434|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
56180567|NCT01405365|Metronidazole|metronidazole|mesh-list
56180568|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180569|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56180570|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56207435|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743389|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
56207436|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56207437|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56207438|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56667877|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56667878|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667879|NCT02947126|Antidotes|antidotes|mesh-ancestor
56667880|NCT02947126|Protective Agents|protective agents|mesh-ancestor
56667881|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667882|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
56667883|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
56667884|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56667885|NCT04492553|Testosterone|testosterone|mesh-list
56667886|NCT04492553|Androgens|androgens|mesh-ancestor
56667887|NCT04492553|Hormones|hormones|mesh-ancestor
56667888|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667889|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667890|NCT00871494|Azithromycin|azithromycin|mesh-list
56667891|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56667892|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667893|NCT01007539|Choline|choline|mesh-list
56667894|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56667895|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
56667896|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56667897|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
56667898|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667899|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207439|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56207440|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
56207441|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207442|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207444|NCT01570088|Hematinics|hematinics|mesh-ancestor
56207445|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
56207447|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
56207448|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207454|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56207455|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56207456|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
56207457|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207458|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207459|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56207460|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
56207461|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
56207462|NCT01570478|Hormones|hormones|mesh-ancestor
56207463|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207464|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
56207465|NCT01570504|Ivermectin|ivermectin|mesh-list
56207466|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56207467|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207468|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56207469|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207470|NCT01570569|Losartan|losartan|mesh-list
56207471|NCT01570569|Midazolam|midazolam|mesh-list
56207472|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
56207473|NCT01570569|Caffeine|caffeine|mesh-list
56207474|NCT01570569|Omeprazole|omeprazole|mesh-list
56207475|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56667900|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56667901|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
56667902|NCT03635164|Durvalumab|durvalumab|mesh-list
56667903|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56667904|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207476|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56207477|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207478|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207479|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56207480|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56207481|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207482|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56207483|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
56207484|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
56207485|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
56207486|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
56207487|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207488|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207489|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56207490|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56207491|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56207492|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56207493|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56207494|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56207495|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207496|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56207497|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56207498|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
56207499|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56207500|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207501|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56207502|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
56180571|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56180572|NCT01405430|Bevacizumab|bevacizumab|mesh-list
56180573|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56180574|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180575|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56180576|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56180577|NCT01405430|Growth Substances|growth substances|mesh-ancestor
56180578|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180579|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
56180580|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
56180581|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56180582|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56180583|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56180584|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56180585|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180586|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
56207503|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
56207504|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56207505|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56207508|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56207509|NCT01570582|Carboplatin|carboplatin|mesh-list
56207510|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56207511|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207512|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56207513|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56207514|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56207515|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207516|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56207517|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
56207518|NCT01570582|Antiviral Agents|antiviral agents|mesh-ancestor
56207519|NCT01570582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207520|NCT01570582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207521|NCT01570582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207522|NCT01570582|Immunologic Factors|immunologic factors|mesh-ancestor
56207523|NCT01570582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207524|NCT01570608|Ranibizumab|ranibizumab|mesh-list
56207525|NCT01570608|Verteporfin|verteporfin|mesh-list
56667905|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56667906|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56667907|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667908|NCT04137185|Hormones|hormones|mesh-list
56667909|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667910|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667911|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
56667912|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56667913|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667914|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56667915|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56667916|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56207526|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56207527|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56207528|NCT01570608|Growth Substances|growth substances|mesh-ancestor
56207529|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207530|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
56207531|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207532|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56207533|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
56207534|NCT01570660|Pioglitazone|pioglitazone|mesh-list
56207535|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56207536|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207537|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
56207538|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207539|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
56207540|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207541|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207542|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56207543|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
56207544|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207545|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180587|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180588|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207546|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56207548|NCT01570790|Combretastatin|combretastatin|mesh-list
56207549|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56207550|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207551|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
56207552|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
56207553|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56207554|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207555|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56207556|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
56207557|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207558|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56207559|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56207560|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207561|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207562|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56207563|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
56207564|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207565|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56207566|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56207567|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207568|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207569|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56207570|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
56207571|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207572|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56667917|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56667918|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667919|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56667920|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667921|NCT00529789|Analgesics|analgesics|mesh-ancestor
56667922|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
56667923|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667924|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
56667925|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56667926|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
56667927|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56667928|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56667929|NCT00611819|Interferons|interferons|mesh-list
56667930|NCT00611819|Ribavirin|ribavirin|mesh-list
56667931|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56667932|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
56229202|NCT01697618|Insulin|insulin|mesh-list
56207573|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56207574|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207575|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207576|NCT01570985|Triamcinolone|triamcinolone|mesh-list
56207577|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56207578|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56207579|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56207580|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56207581|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
56207582|NCT01570985|Hormones|hormones|mesh-ancestor
56207583|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207584|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207585|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207586|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
56207587|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207588|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207589|NCT01571024|Leucovorin|leucovorin|mesh-list
56207590|NCT01571024|Fluorouracil|fluorouracil|mesh-list
56207591|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
56207592|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
56207593|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207594|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56207595|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207596|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207597|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
56207598|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207599|NCT01571024|Antidotes|antidotes|mesh-ancestor
56207600|NCT01571024|Protective Agents|protective agents|mesh-ancestor
56207601|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
56207602|NCT01571024|Vitamins|vitamins|mesh-ancestor
56207603|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
56207604|NCT01571037|Milrinone|milrinone|mesh-list
56207605|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56207606|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56207607|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
56207608|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56207609|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56207610|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207611|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207612|NCT01571037|Protective Agents|protective agents|mesh-ancestor
56207613|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207615|NCT01571050|Antacids|antacids|mesh-ancestor
56667933|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667934|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
56667935|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667936|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
56667937|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667938|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
56667939|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667940|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
56667941|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56667942|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667943|NCT03782207|Atezolizumab|atezolizumab|mesh-list
56667944|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667945|NCT02619162|Letrozole|letrozole|mesh-list
56667946|NCT02619162|Nintedanib|nintedanib|mesh-list
56547651|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667947|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207616|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180589|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56180590|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180591|NCT01405521|Vaccines|vaccines|mesh-list
56180592|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
56180593|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180594|NCT01405573|Sorafenib|sorafenib|mesh-list
56180595|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180596|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56180597|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180598|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207617|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207618|NCT01571063|Vitamin D|vitamin d|mesh-list
56207619|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
56207620|NCT01571063|Vitamins|vitamins|mesh-ancestor
56207621|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
56207622|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207623|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56207624|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56207625|NCT01571167|Varenicline|varenicline|mesh-list
56207626|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56207627|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56207628|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
56207629|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207630|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207631|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207632|NCT01571206|Infliximab|infliximab|mesh-list
56207633|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
56207634|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207635|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207636|NCT01571219|Infliximab|infliximab|mesh-list
56207637|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
56207638|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207639|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207640|NCT01571323|Misoprostol|misoprostol|mesh-list
56207641|NCT01571323|Oxytocin|oxytocin|mesh-list
56207642|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
56207643|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56207644|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207645|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56207646|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
56207647|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56207648|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207649|NCT01571414|Ritonavir|ritonavir|mesh-list
56667948|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56667949|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56667950|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667951|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667952|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56667953|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
56667954|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667955|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667956|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56667957|NCT04018690|Triamcinolone|triamcinolone|mesh-list
56667958|NCT04018690|Ropivacaine|ropivacaine|mesh-list
56667959|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
56667960|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
56229231|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55743570|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56207650|NCT01571414|Lopinavir|lopinavir|mesh-list
56207651|NCT01571414|Efavirenz|efavirenz|mesh-list
56207652|NCT01571414|Rifampin|rifampin|mesh-list
56207653|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56207654|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56207655|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
56207656|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207657|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207658|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56207659|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56207660|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
56207661|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207662|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56207663|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56207664|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56207665|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56207666|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56207667|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56207668|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56207669|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56207670|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56207671|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56180600|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56180606|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56180607|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56180608|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
56180609|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
56180610|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
56180611|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
56207672|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
56207673|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56207674|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
56207675|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56207676|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56207677|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56207678|NCT01571570|Simeprevir|simeprevir|mesh-list
56207679|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
56207680|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207681|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
56207682|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207683|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207684|NCT01571583|Interferons|interferons|mesh-list
56207685|NCT01571583|Ribavirin|ribavirin|mesh-list
56207686|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
56207687|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
56667961|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667962|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667963|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
56667964|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56667965|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56667966|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
56667967|NCT04018690|Hormones|hormones|mesh-ancestor
56667968|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56667969|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
56667970|NCT05327023|Sirolimus|sirolimus|mesh-list
56667971|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
56667972|NCT05327023|Busulfan|busulfan|mesh-list
56667973|NCT05327023|Fludarabine|fludarabine|mesh-list
56667974|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56667975|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
56667976|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667977|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56667978|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56667979|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
56667980|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56667981|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56667982|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56207688|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56207689|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207690|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
56207691|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207692|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
56207693|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207694|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
56207695|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207696|NCT01571609|Insulin|insulin|mesh-list
56207697|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56207698|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207699|NCT01571648|Azacitidine|azacitidine|mesh-list
56207700|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56207701|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
56207702|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207703|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207704|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207705|NCT01571687|Antioxidants|antioxidants|mesh-list
56207706|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207707|NCT01571687|Protective Agents|protective agents|mesh-ancestor
56207708|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207709|NCT01571791|Ketorolac|ketorolac|mesh-list
56207710|NCT01571791|Lidocaine|lidocaine|mesh-list
56207711|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
56207712|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
56207713|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207714|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207715|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
56207716|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207717|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56667983|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56667984|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56667985|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
56667986|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56667987|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56667988|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56667989|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
56667990|NCT00697866|Vaccines|vaccines|mesh-list
56207718|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56207719|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56207720|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56207721|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180612|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180613|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180614|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
56180615|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56180616|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180617|NCT01405846|Gefitinib|gefitinib|mesh-list
56180618|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180619|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55877270|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
56207722|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56207723|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56207724|NCT01571791|Analgesics|analgesics|mesh-ancestor
56207725|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56207726|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56207727|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56207728|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207729|NCT01571804|Pregabalin|pregabalin|mesh-list
56207730|NCT01571804|Analgesics|analgesics|mesh-ancestor
56207731|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
56207732|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207733|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207734|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
56207735|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56207736|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56207737|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207738|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56207739|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56207740|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56207741|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207742|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207743|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
56207744|NCT01571856|Astringents|astringents|mesh-ancestor
56207745|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207746|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
56207747|NCT01571882|Policosanol|policosanol|mesh-list
56207748|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56207749|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56207750|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
56207751|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207752|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56207753|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56207754|NCT01571908|Rocuronium|rocuronium|mesh-list
56207755|NCT01571908|Succinylcholine|succinylcholine|mesh-list
56207756|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56207757|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56207758|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56207759|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207760|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207761|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56207762|NCT01571921|Tocotrienols|tocotrienols|mesh-list
56207763|NCT01571921|Vitamin E|vitamin e|mesh-list
56207764|NCT01571921|Tocopherols|tocopherols|mesh-list
56207765|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
55743670|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888855|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667991|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
56667992|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56667993|NCT00733564|Lidocaine|lidocaine|mesh-list
56667994|NCT00733564|Propofol|propofol|mesh-list
56667995|NCT00733564|Sevoflurane|sevoflurane|mesh-list
56667996|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
56667997|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
56667998|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56667999|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668000|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
56668001|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668002|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56668003|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56668004|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56668005|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56668006|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668007|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56668008|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56668009|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
56668010|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56668011|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56668012|NCT00727870|Glycerol|glycerol|mesh-list
56668013|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56668014|NCT00727870|Protective Agents|protective agents|mesh-ancestor
56668015|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668016|NCT01007695|Valproic Acid|valproic acid|mesh-list
56668017|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
56668018|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668019|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668020|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
56668021|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207766|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207767|NCT01571921|Protective Agents|protective agents|mesh-ancestor
56207768|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207769|NCT01571921|Vitamins|vitamins|mesh-ancestor
56207770|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
56207771|NCT01571960|Vaccines|vaccines|mesh-list
56207772|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
56207773|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207774|NCT01572012|Ondansetron|ondansetron|mesh-list
56207775|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
56207776|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
56207777|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207778|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668022|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668023|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
56668024|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56668025|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668026|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56668027|NCT02709473|Remifentanil|remifentanil|mesh-list
56668028|NCT02709473|Propofol|propofol|mesh-list
56668029|NCT02709473|Rocuronium|rocuronium|mesh-list
56668030|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56668031|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668032|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668033|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56180620|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180621|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180622|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
56180623|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56180624|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
56180625|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180626|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180627|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
56180628|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180629|NCT01405989|Ketoconazole|ketoconazole|mesh-list
56180630|NCT01405989|Darexaban|darexaban|mesh-list
56180631|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
56180632|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180633|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56207779|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207780|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
56207781|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
56207782|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56207783|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
56207792|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56207793|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
56207794|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207795|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56207796|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207798|NCT01572116|Epinephrine|epinephrine|mesh-list
56207799|NCT01572116|Racepinephrine|racepinephrine|mesh-list
56207800|NCT01572116|Sufentanil|sufentanil|mesh-list
56207801|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
56207802|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
56207803|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
56207804|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207805|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207806|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
56207807|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207808|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56207809|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56207810|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56207811|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56207812|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207813|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56207814|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56207815|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
56207816|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207817|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56207818|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56207820|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56207821|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
56207822|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
56207823|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
56207824|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56207825|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56207826|NCT01572116|Narcotics|narcotics|mesh-ancestor
56207827|NCT01572116|Analgesics|analgesics|mesh-ancestor
56668034|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
56668035|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
56668036|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56668037|NCT02709473|Narcotics|narcotics|mesh-ancestor
56668038|NCT02709473|Analgesics|analgesics|mesh-ancestor
56668039|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
56668040|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668041|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56668042|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56668043|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56668044|NCT00866658|Lixisenatide|lixisenatide|mesh-list
56668045|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56668046|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668047|NCT04942067|Dexamethasone|dexamethasone|mesh-list
56668048|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
56668049|NCT04942067|Lenalidomide|lenalidomide|mesh-list
56668050|NCT04942067|Daratumumab|daratumumab|mesh-list
56668051|NCT04942067|Pomalidomide|pomalidomide|mesh-list
56668052|NCT04942067|BB 1101|bb 1101|mesh-list
56668053|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56668054|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
56668055|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
56668056|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668057|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668058|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668059|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
56668060|NCT04942067|Hormones|hormones|mesh-ancestor
56668061|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668062|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56668063|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668064|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
56668065|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804977|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804978|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55804979|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804980|NCT04085887|Panitumumab|panitumumab|mesh-list
55804981|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804982|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668066|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668067|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
56668068|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56668069|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56668070|NCT04942067|Growth Substances|growth substances|mesh-ancestor
56668071|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
56207828|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56180634|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56180635|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180636|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180637|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56180638|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
56180639|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180640|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180641|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56180642|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56180643|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
56180644|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56180645|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
56180646|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
56180647|NCT01406002|Rifampin|rifampin|mesh-list
56180648|NCT01406002|Darexaban|darexaban|mesh-list
55877405|NCT04396977|Histamine|histamine|mesh-list
56207829|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56207830|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
56207831|NCT01572129|Clopidogrel|clopidogrel|mesh-list
56207832|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56207833|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56207834|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56207835|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56207836|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
56207837|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207838|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207839|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207840|NCT01572181|Fludarabine|fludarabine|mesh-list
56207841|NCT01572181|Busulfan|busulfan|mesh-list
56207842|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
56207843|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207844|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207845|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207846|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
56207847|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207848|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
56207849|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56207850|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56207851|NCT01572259|Hormones|hormones|mesh-list
55743729|NCT02509273|Analgesics|analgesics|mesh-ancestor
56207852|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207853|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207855|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
56207856|NCT01572285|BB 1101|bb 1101|mesh-list
56207857|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56207858|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
56207859|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
56207860|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207861|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207862|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207863|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
56207864|NCT01572285|Hormones|hormones|mesh-ancestor
56207865|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207866|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56207867|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207868|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
56207869|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180649|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56180650|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
56180651|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56668072|NCT01007773|Fentanyl|fentanyl|mesh-list
56668073|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
56668074|NCT01007773|Propofol|propofol|mesh-list
56668075|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56668076|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668077|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668078|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56668079|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
56668080|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
56668081|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56668082|NCT01007773|Analgesics|analgesics|mesh-ancestor
56668083|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
56668084|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668085|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56668086|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56668087|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56668088|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
56668089|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180652|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180653|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
56180654|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56180655|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180656|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180657|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56180658|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56180659|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56180660|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56180661|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56180662|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56180663|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56180664|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
56180665|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56180666|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
56180667|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
56180668|NCT01406080|Adapalene|adapalene|mesh-list
56180669|NCT01406080|Tretinoin|tretinoin|mesh-list
56180670|NCT01406080|Emollients|emollients|mesh-list
56180671|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56207870|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207871|NCT01572324|Leucovorin|leucovorin|mesh-list
56207872|NCT01572324|Fluorouracil|fluorouracil|mesh-list
56207873|NCT01572324|Capecitabine|capecitabine|mesh-list
56207874|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
56207875|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
56207876|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207877|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56207878|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207879|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207880|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
56207881|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207882|NCT01572324|Antidotes|antidotes|mesh-ancestor
56207883|NCT01572324|Protective Agents|protective agents|mesh-ancestor
56207884|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
56207885|NCT01572324|Vitamins|vitamins|mesh-ancestor
56207886|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
56207893|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207894|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56207895|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56668090|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668091|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56668092|NCT01007773|Narcotics|narcotics|mesh-ancestor
56668093|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56668094|NCT02615340|Melatonin|melatonin|mesh-list
56668095|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
56668096|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668097|NCT02615340|Protective Agents|protective agents|mesh-ancestor
56314237|NCT02972216|Docetaxel|docetaxel|mesh-list
56668098|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668099|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668100|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
56668101|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668102|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
56229354|NCT01698645|Analgesics|analgesics|mesh-ancestor
56207896|NCT01572350|Growth Substances|growth substances|mesh-ancestor
56207897|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207898|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
56207899|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180672|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56180674|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
56180675|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877508|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207900|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
56207901|NCT01572350|Hormones|hormones|mesh-ancestor
56207902|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56207903|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207904|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
56207905|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207906|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207907|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
56207908|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
56207909|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56207910|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56207911|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207912|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207913|NCT01572363|Urological Agents|urological agents|mesh-ancestor
56207914|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
56207915|NCT01572454|Remifentanil|remifentanil|mesh-list
56207916|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56207917|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207918|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207919|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56207920|NCT01572454|Analgesics|analgesics|mesh-ancestor
56207921|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
56207922|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207923|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56207924|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56207925|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56207926|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56207927|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207928|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207929|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56207930|NCT01572454|Narcotics|narcotics|mesh-ancestor
56207931|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
56207932|NCT01572545|Denosumab|denosumab|mesh-list
56207933|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56207934|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207935|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
56207936|NCT01572558|Meropenem|meropenem|mesh-list
56668103|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668104|NCT04899791|Protective Agents|protective agents|mesh-ancestor
56668105|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668106|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56668107|NCT02615106|Endostar protein|endostar protein|mesh-list
56668108|NCT02615106|Endostatins|endostatins|mesh-list
56229369|NCT01698749|Dexamethasone|dexamethasone|mesh-list
56207937|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56207938|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207939|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56207940|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56207941|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207942|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207943|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207944|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56207945|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56207946|NCT01572597|Metronidazole|metronidazole|mesh-list
56207947|NCT01572597|Clarithromycin|clarithromycin|mesh-list
56207948|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
56207949|NCT01572597|Rabeprazole|rabeprazole|mesh-list
56207950|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207951|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56135710|NCT00309738|Simvastatin|simvastatin|mesh-list
56207952|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56207954|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56207955|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56207956|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56207957|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207958|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207959|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56207960|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56207961|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56207962|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
56207963|NCT01572597|Expectorants|expectorants|mesh-ancestor
56180676|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180677|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180678|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56180679|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
56180680|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180681|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
56180682|NCT01406132|Peficitinib|peficitinib|mesh-list
56180683|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180684|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180685|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180686|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
56180687|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180688|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
56180689|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56180690|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56180691|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
56180692|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180693|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180694|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180695|NCT01406158|Urological Agents|urological agents|mesh-ancestor
56180696|NCT01406171|Isavuconazole|isavuconazole|mesh-list
56180698|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56207964|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
56207965|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56207966|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
56207967|NCT01572597|Protective Agents|protective agents|mesh-ancestor
56207968|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207969|NCT01572623|Clopidogrel|clopidogrel|mesh-list
56207970|NCT01572623|Atorvastatin|atorvastatin|mesh-list
56207971|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56207972|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56207973|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
56207974|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888857|NCT01775501|Protective Agents|protective agents|mesh-ancestor
56668109|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56668110|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56668111|NCT02615106|Growth Substances|growth substances|mesh-ancestor
56668112|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668113|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
56668114|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668115|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
56668116|NCT04930237|Bisacodyl|bisacodyl|mesh-list
56668117|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
56668118|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
56668119|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56207975|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56207976|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56207977|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56207978|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56207979|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56207980|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56207981|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56207982|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
56207983|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207984|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207985|NCT01572649|Lixisenatide|lixisenatide|mesh-list
56207986|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56207987|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207989|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56207990|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
56180700|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180701|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180702|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56180703|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56180704|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56180705|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56180706|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
56180707|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
56180708|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
56180709|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
56180710|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180711|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180712|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
56180713|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56207991|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207992|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207993|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56207994|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56207995|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
56207996|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56207997|NCT01572805|Melatonin|melatonin|mesh-list
56207998|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
56207999|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208000|NCT01572805|Protective Agents|protective agents|mesh-ancestor
56208001|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208002|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208003|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
56208004|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
56208005|NCT01572831|Protective Agents|protective agents|mesh-ancestor
56208006|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208007|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
56208008|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56208009|NCT01572857|Antibodies|antibodies|mesh-list
56208010|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
56208011|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208012|NCT01572961|Aspirin|aspirin|mesh-list
56208013|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56208014|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56668120|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
56668121|NCT04930237|Calcium|calcium|mesh-list
56668122|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56668123|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668124|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668125|NCT04930237|Cathartics|cathartics|mesh-ancestor
56668126|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668127|NCT04930237|Laxatives|laxatives|mesh-ancestor
56668128|NCT04930237|Antacids|antacids|mesh-ancestor
56668129|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56668130|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
56668131|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668132|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
56668133|NCT02615262|Dexamethasone|dexamethasone|mesh-list
56668134|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56668135|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
56668136|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
56668137|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668138|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668139|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668140|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
56668141|NCT02615262|Hormones|hormones|mesh-ancestor
56668142|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668143|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56668144|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668145|NCT00733720|Naltrexone|naltrexone|mesh-list
56668146|NCT00733720|Buprenorphine|buprenorphine|mesh-list
56208015|NCT01572961|Analgesics|analgesics|mesh-ancestor
56208016|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
56208017|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208018|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208019|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208020|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56208021|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56208022|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56208023|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208024|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56208025|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56208026|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208027|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
56208028|NCT01573013|Iron|iron|mesh-list
56208029|NCT01573013|Trace Elements|trace elements|mesh-ancestor
56208030|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
56208031|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208032|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56208033|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56208034|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56208035|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
56180714|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
56180715|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
56668147|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56668148|NCT00733720|Naloxone|naloxone|mesh-list
56668149|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56668150|NCT00733720|Narcotics|narcotics|mesh-ancestor
56668151|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668152|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668153|NCT00733720|Analgesics|analgesics|mesh-ancestor
56668154|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
56668155|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668156|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56668157|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56668158|NCT05732389|Nivolumab|nivolumab|mesh-list
56668159|NCT05732389|Ipilimumab|ipilimumab|mesh-list
56668160|NCT05732389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56668161|NCT05732389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668162|NCT05732389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56668163|NCT05732389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668164|NCT02624388|Genistein|genistein|mesh-list
56180716|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56180717|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208036|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208037|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56208038|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56208040|NCT01573286|Glucagon|glucagon|mesh-list
56208041|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56208042|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208043|NCT01573286|Hormones|hormones|mesh-ancestor
56208044|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208045|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208046|NCT01573286|Incretins|incretins|mesh-ancestor
56208047|NCT01573338|Carboplatin|carboplatin|mesh-list
56208048|NCT01573338|Etoposide|etoposide|mesh-list
56208049|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208050|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56208051|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56208052|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56208053|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208054|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208055|NCT01573377|Metformin|metformin|mesh-list
56208056|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
56208057|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56208058|NCT01573377|Cyproterone|cyproterone|mesh-list
56208059|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56208060|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208061|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56208062|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56208065|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56208066|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56208067|NCT01573377|Estrogens|estrogens|mesh-ancestor
56208068|NCT01573377|Hormones|hormones|mesh-ancestor
56208069|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208070|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
56208071|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
56208072|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208073|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56208074|NCT01573468|Capecitabine|capecitabine|mesh-list
56208075|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56668165|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56668166|NCT02624388|Protective Agents|protective agents|mesh-ancestor
56668167|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668168|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668169|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56668170|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668171|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668172|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
56668173|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56668175|NCT02624388|Hormones|hormones|mesh-ancestor
56668176|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668177|NCT00727948|Aspirin|aspirin|mesh-list
56668178|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56668179|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56668180|NCT00727948|Analgesics|analgesics|mesh-ancestor
56668181|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
56668182|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668183|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668184|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56668185|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56668186|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56668187|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56208076|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
56208077|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208078|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208079|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56208080|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
56208081|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56208082|NCT01573598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56208083|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56208084|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56208085|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208086|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208087|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
56208088|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208089|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56208090|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56208091|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56208092|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56208093|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
56208094|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208095|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208096|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56208097|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56208098|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56208099|NCT01573663|Dipropizine|dipropizine|mesh-list
56208100|NCT01573663|Ambroxol|ambroxol|mesh-list
56208101|NCT01573663|Expectorants|expectorants|mesh-ancestor
56208102|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
56668188|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668189|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56668190|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56668191|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668192|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
56668193|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56668194|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
56668195|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56668196|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
56668197|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56668198|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668199|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56668200|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56668201|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668202|NCT05580016|Plasminogen|plasminogen|mesh-list
56668203|NCT05580016|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56668204|NCT05580016|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56180718|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56180719|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56180720|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180721|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208103|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
56208104|NCT01573715|Cisatracurium|cisatracurium|mesh-list
56208105|NCT01573715|Atracurium|atracurium|mesh-list
56208106|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56208107|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56208108|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208109|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208110|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56208111|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56208112|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56208113|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
56208114|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208115|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208116|NCT01573741|Ketamine|ketamine|mesh-list
56208117|NCT01573741|Analgesics|analgesics|mesh-ancestor
56208118|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
56208119|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208120|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208121|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56208122|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56208123|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
56208124|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
56208125|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208126|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56208127|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56208128|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208138|NCT01573975|Rabeprazole|rabeprazole|mesh-list
56208139|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56208140|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208141|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56208142|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208143|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208144|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56208145|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888858|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
56668205|NCT05580016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668206|NCT05730673|Leronlimab|leronlimab|mesh-list
56668207|NCT05730673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56668208|NCT05730673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56668209|NCT05730673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668210|NCT05730673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56668211|NCT05730673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56668212|NCT05730673|Antiviral Agents|antiviral agents|mesh-ancestor
56668213|NCT05730673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668214|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
56668215|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56668216|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
56668217|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668218|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668219|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56668220|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
56668221|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56668222|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
56668223|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668224|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668225|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56668226|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
56668227|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
56668228|NCT04134078|Protective Agents|protective agents|mesh-ancestor
56668229|NCT03871829|Dexamethasone|dexamethasone|mesh-list
56668230|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
56668231|NCT03871829|BB 1101|bb 1101|mesh-list
56668232|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56668233|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
56668234|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
56208146|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56208147|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56208148|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56208149|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
56208150|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208151|NCT01574027|Vitamin D|vitamin d|mesh-list
56208152|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
56208153|NCT01574027|Vitamins|vitamins|mesh-ancestor
56208154|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
56208155|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208156|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56208157|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56208158|NCT01574092|Irinotecan|irinotecan|mesh-list
56208159|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208160|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56208161|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56668235|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668236|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668237|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668238|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
56668239|NCT03871829|Hormones|hormones|mesh-ancestor
56668240|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668241|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56668242|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208162|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208163|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208164|NCT01574131|Fenofibrate|fenofibrate|mesh-list
56208165|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56208166|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
56208167|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208168|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56180722|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180723|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180724|NCT01406262|Incretins|incretins|mesh-ancestor
56180725|NCT01406262|Hormones|hormones|mesh-ancestor
56208169|NCT01574261|Inositol|inositol|mesh-list
56208170|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
56208171|NCT01574261|Vitamins|vitamins|mesh-ancestor
56208172|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
56208173|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208174|NCT01574313|Tocopherols|tocopherols|mesh-list
56208175|NCT01574313|Vitamin E|vitamin e|mesh-list
56208176|NCT01574313|Tocotrienols|tocotrienols|mesh-list
56208177|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
56208178|NCT01574313|Niacin|niacin|mesh-list
56208179|NCT01574313|Diphenidol|diphenidol|mesh-list
56208180|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
56208181|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208182|NCT01574313|Protective Agents|protective agents|mesh-ancestor
56208183|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208184|NCT01574313|Vitamins|vitamins|mesh-ancestor
56208185|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
56208186|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56208187|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
56208188|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56208189|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
56208190|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
56208191|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
56208192|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
56208193|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743965|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
56208194|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208196|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56208197|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56208198|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208199|NCT01574638|Rifapentine|rifapentine|mesh-list
56208200|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56208201|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
56208202|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56208203|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208204|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
56208205|NCT01574742|Minocycline|minocycline|mesh-list
56208206|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56208207|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208208|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
56208209|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56208210|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208211|NCT01575158|Citalopram|citalopram|mesh-list
56208212|NCT01575158|Clomipramine|clomipramine|mesh-list
56208213|NCT01575158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56208214|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56208215|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56208216|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208217|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208218|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
56668243|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
56668244|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668245|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668246|NCT00738556|Sirolimus|sirolimus|mesh-list
56668247|NCT00738556|Paclitaxel|paclitaxel|mesh-list
56668248|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56668249|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668250|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56668251|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56668252|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56668253|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668254|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56668255|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668256|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56668257|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
56668258|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56668259|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
56668260|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668261|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
56668262|NCT00597584|Hematinics|hematinics|mesh-ancestor
56668263|NCT00529633|Thalidomide|thalidomide|mesh-list
56668264|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56668265|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
56668266|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668267|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
56668268|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56668269|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668270|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56668271|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56668272|NCT00529633|Growth Substances|growth substances|mesh-ancestor
56208219|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208220|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56208221|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
56208222|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56208223|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56208224|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
56208225|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56208226|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208227|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
56208228|NCT01575301|Liraglutide|liraglutide|mesh-list
56208229|NCT01575301|Exenatide|exenatide|mesh-list
56208230|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56208231|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208232|NCT01575301|Incretins|incretins|mesh-ancestor
56208233|NCT01575301|Hormones|hormones|mesh-ancestor
56208234|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668273|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
56668274|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668275|NCT01366144|Paclitaxel|paclitaxel|mesh-list
56668276|NCT01366144|Carboplatin|carboplatin|mesh-list
56668277|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56668278|NCT01366144|Veliparib|veliparib|mesh-list
56668279|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56668280|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668281|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
56668282|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
56668283|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
56668284|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668285|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56668286|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668287|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56668288|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
56668289|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668290|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56668291|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56668292|NCT00657488|Thalidomide|thalidomide|mesh-list
56668293|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56668294|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
56668295|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668296|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
56668297|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56668298|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668299|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56668300|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56668301|NCT00657488|Growth Substances|growth substances|mesh-ancestor
56668302|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
56668303|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668304|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56668316|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668317|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668318|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668319|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56668320|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56668321|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668322|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56668324|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
56668325|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
56668326|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
56668327|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56668328|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56668329|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56668330|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56668331|NCT03860597|Memantine|memantine|mesh-list
56668332|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56668333|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56668334|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
56668335|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668336|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668337|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668338|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56668339|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56668340|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56668341|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56668342|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56668343|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
56668344|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668345|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668346|NCT00695604|Fluticasone|fluticasone|mesh-list
56668347|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56668348|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56208235|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56208236|NCT01575405|Tenofovir|tenofovir|mesh-list
56208237|NCT01575405|Glycerol|glycerol|mesh-list
56208238|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
56208239|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208240|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56180726|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180727|NCT01406275|Amoxicillin|amoxicillin|mesh-list
56180728|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
56668349|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
56668350|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668351|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180729|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
55877903|NCT01354444|Carvedilol|carvedilol|mesh-list
56208241|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56208242|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208243|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208244|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56208245|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56208246|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56208247|NCT01575405|Protective Agents|protective agents|mesh-ancestor
56208248|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208249|NCT01575418|Tenofovir|tenofovir|mesh-list
56208250|NCT01575418|Glycerol|glycerol|mesh-list
56208251|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
56208252|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208253|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56208254|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56208255|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208256|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208257|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56208258|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56208259|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56208260|NCT01575418|Protective Agents|protective agents|mesh-ancestor
56208261|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208263|NCT01575483|Incretins|incretins|mesh-ancestor
56208264|NCT01575483|Hormones|hormones|mesh-ancestor
56208265|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208266|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208267|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56208268|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
56208269|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208270|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208271|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56208272|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56208274|NCT01575613|Artemether|artemether|mesh-list
56208275|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56208276|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
56208277|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56208278|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56208279|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208280|NCT01575626|Sevoflurane|sevoflurane|mesh-list
56208281|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56208282|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56208283|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
56208284|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
56208285|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208286|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208287|NCT01575639|Prednisolone|prednisolone|mesh-list
56208288|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208289|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
56208290|NCT01575639|Hormones|hormones|mesh-ancestor
56208291|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208292|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208293|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56208294|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208295|NCT01575652|Lisinopril|lisinopril|mesh-list
56208296|NCT01575652|Perindopril|perindopril|mesh-list
56208297|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56208298|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56208299|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
56208300|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208301|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56208302|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56208303|NCT01575652|Protective Agents|protective agents|mesh-ancestor
56208304|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208305|NCT01575678|Melatonin|melatonin|mesh-list
56208306|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
56180730|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56180731|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888859|NCT01775501|Vitamins|vitamins|mesh-ancestor
56668352|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56668353|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
56668354|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
56668355|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56668356|NCT00654524|Vitamin D|vitamin d|mesh-list
56668357|NCT00654524|Goserelin|goserelin|mesh-list
56668358|NCT00654524|Hormones|hormones|mesh-list
56668359|NCT00654524|Vitamins|vitamins|mesh-ancestor
56668360|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
56668361|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668362|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56668363|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668364|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56668365|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668366|NCT05260619|Lenalidomide|lenalidomide|mesh-list
56668367|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
56668368|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229615|NCT01700400|Pemetrexed|pemetrexed|mesh-list
56180732|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56180733|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208307|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208308|NCT01575678|Protective Agents|protective agents|mesh-ancestor
56208309|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208310|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208311|NCT01575717|Vitamin D|vitamin d|mesh-list
56208312|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
56208313|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
56208314|NCT01575717|Vitamins|vitamins|mesh-list
56208315|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
56208316|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208317|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56208318|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56208319|NCT01575782|Chloroquine|chloroquine|mesh-list
56208320|NCT01575782|Amebicides|amebicides|mesh-ancestor
56208321|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56208322|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56208323|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208324|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
56208325|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56208326|NCT01575795|Ticagrelor|ticagrelor|mesh-list
56208327|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56208328|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56208329|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56136088|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
56208330|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56208331|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
56208332|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208333|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208334|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208335|NCT01576029|Docetaxel|docetaxel|mesh-list
56208336|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208337|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
56208338|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
56208339|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
56208340|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208342|NCT01576094|Milrinone|milrinone|mesh-list
56208343|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56208344|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
55888860|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
56668369|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56668370|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56668371|NCT05260619|Growth Substances|growth substances|mesh-ancestor
56668372|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
56668373|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668374|NCT00695682|Infliximab|infliximab|mesh-list
56668375|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
56668376|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668377|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56668378|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56668379|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56668380|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668381|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
56668382|NCT03828773|Fluconazole|fluconazole|mesh-list
56668383|NCT03828773|Posaconazole|posaconazole|mesh-list
56668384|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
56668385|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668386|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56668387|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56668388|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314535|NCT05594602|Carbamazepine|carbamazepine|mesh-list
56314536|NCT05594602|Antifungal Agents|antifungal agents|mesh-ancestor
56314537|NCT05594602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314538|NCT05594602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56314539|NCT05594602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56314540|NCT05594602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314541|NCT05594602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314542|NCT05594602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56208345|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56208346|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56208347|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208348|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208349|NCT01576094|Protective Agents|protective agents|mesh-ancestor
56208350|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208351|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56208352|NCT01576185|Sorafenib|sorafenib|mesh-list
56208353|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208354|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56208355|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208356|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208357|NCT01576263|Ropivacaine|ropivacaine|mesh-list
56208358|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
56208359|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
56208360|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208361|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933287|NCT04346823|Sevoflurane|sevoflurane|mesh-list
56668389|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668390|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56668391|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
56668392|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668393|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668394|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56668395|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56668396|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56668397|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56668398|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56668399|NCT00530257|Methylphenidate|methylphenidate|mesh-list
56668400|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56668401|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668402|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56668403|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56668404|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56668405|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668406|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
56668407|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668408|NCT00738868|Cetuximab|cetuximab|mesh-list
56668409|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56668410|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668411|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56668412|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
56668413|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56668414|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56668415|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668416|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668417|NCT00657644|Urological Agents|urological agents|mesh-ancestor
56668418|NCT00869778|Vaccines|vaccines|mesh-list
56668428|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668429|NCT04162028|Ketamine|ketamine|mesh-list
56668430|NCT04162028|Analgesics|analgesics|mesh-ancestor
56668431|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
56668432|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668433|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668434|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56668435|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56668436|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
56668437|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
56668438|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668439|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56668440|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56668441|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668442|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668443|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
56668444|NCT00656786|Vitamin K|vitamin k|mesh-list
56668445|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56668446|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56668447|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668448|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
56668449|NCT00656786|Coagulants|coagulants|mesh-ancestor
56668450|NCT00656786|Vitamins|vitamins|mesh-ancestor
56668451|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
56229693|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
56208362|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
56208363|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208364|NCT01576315|Itraconazole|itraconazole|mesh-list
56208365|NCT01576315|Voriconazole|voriconazole|mesh-list
56208366|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
56208367|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208368|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56208369|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56208370|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208371|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878041|NCT04352062|Ofloxacin|ofloxacin|mesh-list
55878042|NCT04352062|Melatonin|melatonin|mesh-list
56208372|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56208373|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
56208374|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208375|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208376|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56208377|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
56208378|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56208379|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56208380|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208381|NCT01576419|Celecoxib|celecoxib|mesh-list
56208382|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56208383|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56668452|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668453|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
56668454|NCT01008631|Antidotes|antidotes|mesh-ancestor
56668455|NCT01008631|Protective Agents|protective agents|mesh-ancestor
56668456|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668457|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
56668458|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668459|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
56668460|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56208384|NCT01576419|Analgesics|analgesics|mesh-ancestor
56208385|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
56208386|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208387|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208388|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208389|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56208390|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56208391|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56208392|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208393|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208394|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56208395|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56208396|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208398|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
56208399|NCT01576627|Trace Elements|trace elements|mesh-ancestor
56208400|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
56208401|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208402|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
56208404|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56208405|NCT01576627|Protective Agents|protective agents|mesh-ancestor
56208407|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56208408|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
56208409|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56208413|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208414|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
56208415|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208416|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208417|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56208418|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56208419|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208420|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56208421|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56208422|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56208423|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208424|NCT01576692|Aldesleukin|aldesleukin|mesh-list
56208425|NCT01576692|Antibodies|antibodies|mesh-list
56208426|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
56208427|NCT01576692|Sargramostim|sargramostim|mesh-list
56208428|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
56208429|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208430|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208431|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56208432|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56208433|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
56208434|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208435|NCT01576731|Tenofovir|tenofovir|mesh-list
56208436|NCT01576731|Emtricitabine|emtricitabine|mesh-list
56208437|NCT01576731|Lopinavir|lopinavir|mesh-list
56208438|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
56208439|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
56208440|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208441|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56208442|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56208443|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208444|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878115|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56208445|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56314630|NCT01807455|Lidocaine|lidocaine|mesh-list
56668461|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668462|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
56668463|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
56668465|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56668466|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668467|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56668468|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56668469|NCT00734890|Growth Substances|growth substances|mesh-ancestor
56668470|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668471|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
56668472|NCT05325190|Granisetron|granisetron|mesh-list
56668473|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
56668474|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
56668475|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668476|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668477|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668478|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56668479|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
56668480|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668481|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668482|NCT02624310|Droxidopa|droxidopa|mesh-list
56668483|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56668484|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56208446|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56208447|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56208448|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56208449|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
56208450|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56208451|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56208452|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56208453|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56208455|NCT01576770|Tetracaine|tetracaine|mesh-list
56208456|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
56208457|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
56208458|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
56208459|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208460|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208461|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
56208462|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208463|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56208464|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56208465|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56208466|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56208467|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208468|NCT01576848|Caseins|caseins|mesh-list
56208469|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
56208470|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
56208471|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208472|NCT01577017|Letrozole|letrozole|mesh-list
56208473|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56208474|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668485|NCT00612521|Adenosine|adenosine|mesh-list
56668486|NCT00612521|Analgesics|analgesics|mesh-ancestor
56668487|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
56668488|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668489|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668490|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56668491|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
56668492|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56668493|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
56668494|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
56668495|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668496|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668497|NCT00735124|Gabapentin|gabapentin|mesh-list
56668498|NCT00735124|Analgesics|analgesics|mesh-ancestor
56668499|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
56668500|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668501|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668502|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
56668503|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56668504|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56668505|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668506|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56668507|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56668508|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56668509|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668510|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668511|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
56668512|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
56668513|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56668514|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56668515|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56668516|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56668517|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668518|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
56668523|NCT04246541|Acetaminophen|acetaminophen|mesh-list
56668524|NCT04246541|Ketorolac|ketorolac|mesh-list
56668525|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56668526|NCT04246541|Oxycodone|oxycodone|mesh-list
56668527|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56668528|NCT04246541|Analgesics|analgesics|mesh-ancestor
56668529|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
56668530|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668531|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668532|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
56668533|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56668534|NCT04246541|Narcotics|narcotics|mesh-ancestor
56668535|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668546|NCT04902859|Clonidine|clonidine|mesh-list
56668547|NCT04902859|Analgesics|analgesics|mesh-ancestor
56668548|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
56668549|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668550|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668551|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56668552|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
56668553|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
56668554|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56668555|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56668556|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56668557|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
56668558|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668559|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668560|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56668561|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56668572|NCT04180943|Bupivacaine|bupivacaine|mesh-list
56668573|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
56668574|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
56668575|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668586|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
56668587|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56668588|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
56668589|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
56668590|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56668591|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56668592|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56668593|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
56668594|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668595|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668596|NCT05011357|Protective Agents|protective agents|mesh-ancestor
56668597|NCT00711880|Nabiximols|nabiximols|mesh-list
56668598|NCT00711880|Analgesics|analgesics|mesh-ancestor
56668599|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
56668600|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668601|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668602|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
56668603|NCT02693483|Povidone|povidone|mesh-list
56668604|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
56208475|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56208476|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208477|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208478|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56208479|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
55799309|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
56208481|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208482|NCT01577043|Racecadotril|racecadotril|mesh-list
56208483|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
56208484|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208485|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
56208486|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208487|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208488|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
56208489|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56208490|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208491|NCT01577121|Indomethacin|indomethacin|mesh-list
56208492|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56208493|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56208494|NCT01577121|Analgesics|analgesics|mesh-ancestor
56208495|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
56208496|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208497|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208498|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208499|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56208500|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
56208501|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
56208502|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56208503|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56208504|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208505|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208506|NCT01577199|Clomiphene|clomiphene|mesh-list
56208507|NCT01577199|Enclomiphene|enclomiphene|mesh-list
56208508|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
56208509|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56208510|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
56208511|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668605|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
56668606|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56668607|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668608|NCT04873063|Beclomethasone|beclomethasone|mesh-list
56668609|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56668610|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
56314765|NCT05461807|Apixaban|apixaban|mesh-list
56668612|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668613|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668614|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56668615|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
56668616|NCT00739414|Panobinostat|panobinostat|mesh-list
56668617|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668618|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56668619|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668620|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668621|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
56668622|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
56668623|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56668624|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668626|NCT00735280|Calcium heparin|calcium heparin|mesh-list
56668627|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
56668628|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56668629|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56668630|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668631|NCT00612989|Temozolomide|temozolomide|mesh-list
56668632|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56668633|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56668634|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
56229850|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208512|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208513|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56208514|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
56208515|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56208516|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56180734|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180737|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56180738|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
56180739|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56180740|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
56180741|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180742|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180743|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
56668635|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668636|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668637|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668638|NCT05215405|Venetoclax|venetoclax|mesh-list
56668639|NCT05215405|Navitoclax|navitoclax|mesh-list
56668640|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668641|NCT00613067|Citalopram|citalopram|mesh-list
56668642|NCT00613067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56668643|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56668644|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56668645|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668646|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668647|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
56180744|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55878200|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
56208517|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56208518|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
56208519|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56208520|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208521|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56208522|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56208523|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208524|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208525|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208526|NCT01577368|Tazobactam|tazobactam|mesh-list
56208527|NCT01577368|Piperacillin|piperacillin|mesh-list
56208528|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56208529|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56208530|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208531|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56208532|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208533|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208534|NCT01577407|Nefopam|nefopam|mesh-list
56208535|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56208536|NCT01577407|Analgesics|analgesics|mesh-ancestor
55744271|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
56208537|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
56208538|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208539|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208540|NCT01577459|Tedizolid|tedizolid|mesh-list
56208541|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
56208542|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56208543|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208544|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
56208545|NCT01577524|Povidone|povidone|mesh-list
56208546|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
56208547|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
56208548|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56208549|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208550|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56208551|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
56208553|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56208554|NCT01577589|Cephalosporins|cephalosporins|mesh-list
55744307|NCT02492581|Nalmefene|nalmefene|mesh-list
56208555|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56208556|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208557|NCT01577693|Dutasteride|dutasteride|mesh-list
56208558|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56208559|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56208560|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208561|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208562|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
55888861|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56668648|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668649|NCT00613067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56668650|NCT00613067|Antidepressive Agents|antidepressive agents|mesh-ancestor
56668651|NCT00613067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56668652|NCT04851301|Naloxone|naloxone|mesh-list
56668653|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56668654|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668655|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
56668656|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668657|NCT04649489|Bevacizumab|bevacizumab|mesh-list
56668658|NCT04649489|Atezolizumab|atezolizumab|mesh-list
56668659|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56668660|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56229894|NCT01701921|Pregabalin|pregabalin|mesh-list
56208563|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208564|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208565|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56208566|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
56208567|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208568|NCT01577849|Vitamin D|vitamin d|mesh-list
56208569|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
56180745|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56180746|NCT01406327|Ambrisentan|ambrisentan|mesh-list
56180747|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56180748|NCT01406392|Misoprostol|misoprostol|mesh-list
56180749|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56180750|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
56180751|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56180752|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180753|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56180754|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56180755|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
56180756|NCT01406431|Valsartan|valsartan|mesh-list
56180757|NCT01406431|Pitavastatin|pitavastatin|mesh-list
56180758|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56208570|NCT01577849|Vitamins|vitamins|mesh-ancestor
56208571|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
56208572|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208573|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56208574|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56208575|NCT01577862|Rifampin|rifampin|mesh-list
56208576|NCT01577862|Colistin|colistin|mesh-list
56208577|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56208578|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
56208579|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56208580|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208581|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
56208582|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56208583|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208584|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208585|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56208586|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56208587|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56208588|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56208589|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56208590|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56208591|NCT01577914|Carvedilol|carvedilol|mesh-list
56208592|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56208593|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56208594|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
56208595|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668661|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668662|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56668663|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56668664|NCT04649489|Growth Substances|growth substances|mesh-ancestor
56668665|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668666|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
56668667|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
56668668|NCT00613145|Capecitabine|capecitabine|mesh-list
56668669|NCT00613145|Sorafenib|sorafenib|mesh-list
56668670|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56668671|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
56668672|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668673|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668674|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56668675|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668676|NCT00853047|Octreotide|octreotide|mesh-list
56668677|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668678|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56668679|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668680|NCT04570085|Caffeine|caffeine|mesh-list
56668681|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56668682|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668683|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56668684|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668685|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668686|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56668687|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56668688|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
56668689|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668690|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56668691|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
56668692|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56668693|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
56668694|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668695|NCT00529399|Antacids|antacids|mesh-ancestor
56668696|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668697|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668698|NCT04117087|Nivolumab|nivolumab|mesh-list
56668699|NCT04117087|Ipilimumab|ipilimumab|mesh-list
56668700|NCT04117087|Poly ICLC|poly iclc|mesh-list
56668701|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56668702|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668703|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56668704|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668705|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
56668706|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
56668707|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668708|NCT05268419|Ethanol|ethanol|mesh-list
56668709|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56668710|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668711|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668712|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668713|NCT00852969|Niacin|niacin|mesh-list
56668714|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56668715|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
56668716|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229947|NCT01702207|Tacrolimus|tacrolimus|mesh-list
56208596|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208597|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208598|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56208599|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
56208600|NCT01577914|Protective Agents|protective agents|mesh-ancestor
56208601|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56208602|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55744358|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
56208603|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56208604|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
56208605|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56208606|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56208608|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
56208609|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
56208610|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208611|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208612|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
56208613|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208614|NCT01577992|Levodopa|levodopa|mesh-list
56208615|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56208616|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56180759|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56180760|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56180761|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180762|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56180763|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56180764|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56180765|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
56180766|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180767|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56180768|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
56180770|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
56180771|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56180772|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56668717|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56668718|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
56668719|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
56668720|NCT00852969|Vitamins|vitamins|mesh-ancestor
56668721|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
56668722|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668723|NCT00613457|Cytarabine|cytarabine|mesh-list
56668724|NCT00613457|Dexamethasone|dexamethasone|mesh-list
56668725|NCT00613457|Prednisone|prednisone|mesh-list
56668726|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
56668727|NCT00613457|Ifosfamide|ifosfamide|mesh-list
56668728|NCT00613457|Doxorubicin|doxorubicin|mesh-list
56668729|NCT00613457|Methotrexate|methotrexate|mesh-list
56668730|NCT00613457|Etoposide|etoposide|mesh-list
56668731|NCT00613457|Vincristine|vincristine|mesh-list
56668732|NCT00613457|Daunorubicin|daunorubicin|mesh-list
56668733|NCT00613457|Asparaginase|asparaginase|mesh-list
56668734|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
56668735|NCT00613457|Thioguanine|thioguanine|mesh-list
56668736|NCT00613457|Vindesine|vindesine|mesh-list
56668737|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56668738|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
56668739|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668740|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56668741|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56668742|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
56668743|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668744|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668745|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56668746|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56668747|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
56668748|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
56668749|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668750|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668751|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
56668752|NCT00613457|Hormones|hormones|mesh-ancestor
56180773|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
56180774|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
56180775|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180776|NCT01406496|Insulin|insulin|mesh-list
55878321|NCT03009604|Simethicone|simethicone|mesh-list
56208617|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
56208618|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208619|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208620|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208621|NCT01578057|Ethanol|ethanol|mesh-list
55888862|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668753|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668754|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56668755|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56668756|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56668757|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56668758|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668759|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56668760|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
56208622|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56208623|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208624|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208625|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208626|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
56208627|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208628|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
56208629|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
56208630|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
56208631|NCT01578109|Sorafenib|sorafenib|mesh-list
56208632|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208633|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56208634|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208635|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208636|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
56208637|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56208638|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208639|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208640|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56208641|NCT01578161|Analgesics|analgesics|mesh-ancestor
56208642|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
56208643|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208644|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56208645|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56208646|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56208647|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
56208648|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208649|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208650|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
56208651|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56208652|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180777|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56180778|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56180779|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180780|NCT01406522|Tacrine|tacrine|mesh-list
56180781|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56180782|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208660|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56208661|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
56208662|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208663|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208664|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
56208665|NCT01578200|Calcium|calcium|mesh-list
56208666|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56208667|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208668|NCT01578200|Antacids|antacids|mesh-ancestor
56208669|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208670|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208671|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
56208672|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208673|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56208674|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208675|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208676|NCT01578252|Ondansetron|ondansetron|mesh-list
56208677|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
56208678|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
56668761|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56668762|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547652|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668763|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
56668764|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
56668765|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56668766|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56668767|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56668768|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
56668769|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668770|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
56668771|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
56668772|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
56668774|NCT04131582|Empagliflozin|empagliflozin|mesh-list
56668775|NCT04131582|Linagliptin|linagliptin|mesh-list
56668776|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56668777|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668778|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56668779|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668780|NCT04131582|Incretins|incretins|mesh-ancestor
56668781|NCT04131582|Hormones|hormones|mesh-ancestor
56668782|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668783|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56668784|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
56668785|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668786|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56668787|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
56668788|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56668789|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56668790|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56668791|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668792|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668793|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56668794|NCT05267873|Vortioxetine|vortioxetine|mesh-list
56208679|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208680|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208681|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208682|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
56668795|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56668796|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56668797|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56668798|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668799|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668800|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668801|NCT05267873|Analgesics|analgesics|mesh-ancestor
56668802|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
56668803|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668804|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
56668805|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56208683|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
56208684|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56208685|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
56208686|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208687|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208688|NCT01578252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56208689|NCT01578252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56208690|NCT01578252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208691|NCT01578252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56208692|NCT01578252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56208694|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
56208695|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
56208696|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208697|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208698|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208699|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
56208700|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
56208701|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56208702|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
56208703|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208704|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208705|NCT01578265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56208706|NCT01578265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56208707|NCT01578265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56208708|NCT01578265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56208709|NCT01578265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56208710|NCT01578304|Fesoterodine|fesoterodine|mesh-list
56208711|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56208712|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56208713|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
56208714|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208715|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180783|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180784|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
56180785|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56180786|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180787|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56180788|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
56180789|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56180790|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
56180791|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56180792|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
56180795|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180851|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56180852|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56180853|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
56180854|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180855|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180856|NCT01407289|Insulin|insulin|mesh-list
56180857|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
56668806|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
56668807|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56668808|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56668809|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668810|NCT05267873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56668811|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
56668812|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56180858|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
56180859|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56180860|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208716|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208717|NCT01578304|Urological Agents|urological agents|mesh-ancestor
56208718|NCT01578343|Dexamethasone|dexamethasone|mesh-list
56208719|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
56208720|NCT01578343|Fludarabine|fludarabine|mesh-list
56208721|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
56208722|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
56208723|NCT01578343|Vorinostat|vorinostat|mesh-list
56208724|NCT01578343|BB 1101|bb 1101|mesh-list
56208725|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208726|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
56208727|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
56208728|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208729|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208730|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208731|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
56208732|NCT01578343|Hormones|hormones|mesh-ancestor
56208733|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208734|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56208735|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208736|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
56208737|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208738|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208739|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56208740|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
56208741|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56208742|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
56208743|NCT01578343|Analgesics|analgesics|mesh-ancestor
56208744|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
56208745|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56208746|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56208747|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56208748|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
56208749|NCT01578434|Vitamin D|vitamin d|mesh-list
56208750|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
56208751|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
56208752|NCT01578434|Vitamins|vitamins|mesh-list
56208753|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
56208754|NCT01578434|Calcium|calcium|mesh-list
56208755|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
56208756|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208757|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56208758|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56208759|NCT01578434|Antacids|antacids|mesh-ancestor
56208760|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208761|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208762|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56208764|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56208765|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
56208766|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56208767|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208768|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56208769|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56208770|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56208771|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208772|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56208773|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56180861|NCT01407432|Folic Acid|folic acid|mesh-list
56180862|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
56180863|NCT01407432|Hematinics|hematinics|mesh-ancestor
56668813|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56668814|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56668815|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56668816|NCT00695994|Gemcitabine|gemcitabine|mesh-list
56668817|NCT00695994|Carboplatin|carboplatin|mesh-list
56668818|NCT00695994|Docetaxel|docetaxel|mesh-list
56668819|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668820|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56668821|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
56668822|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668823|NCT00695994|Antiviral Agents|antiviral agents|mesh-ancestor
56668824|NCT00695994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668825|NCT00695994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668826|NCT00695994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56668827|NCT00695994|Immunologic Factors|immunologic factors|mesh-ancestor
56668828|NCT00695994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668829|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
56668830|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
56668831|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
56668832|NCT00711802|Daptomycin|daptomycin|mesh-list
56668833|NCT00711802|Cloxacillin|cloxacillin|mesh-list
56668834|NCT00711802|Oxacillin|oxacillin|mesh-list
56668835|NCT00711802|Nafcillin|nafcillin|mesh-list
56668836|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56668837|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668838|NCT00851877|Paclitaxel|paclitaxel|mesh-list
56668839|NCT00851877|Cetuximab|cetuximab|mesh-list
56668840|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56668841|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668842|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
56668843|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
56668844|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
56668845|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668846|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56668847|NCT00613223|Etoposide|etoposide|mesh-list
56668848|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
56668849|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56668850|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668851|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56668852|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56668853|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668854|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668855|NCT00882908|Ribavirin|ribavirin|mesh-list
56668856|NCT00882908|Simeprevir|simeprevir|mesh-list
56668857|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
56668858|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668859|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
56668860|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668861|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
56668862|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668863|NCT03580967|Vortioxetine|vortioxetine|mesh-list
56180864|NCT01407432|Vitamins|vitamins|mesh-ancestor
56180866|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180867|NCT01407471|Clobetasol|clobetasol|mesh-list
56180868|NCT01407471|Spironolactone|spironolactone|mesh-list
56180869|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56180870|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
56180871|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180872|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180873|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56180874|NCT01407471|Diuretics|diuretics|mesh-ancestor
56180875|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
55878530|NCT01849055|Celecoxib|celecoxib|mesh-list
56208774|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56208775|NCT01578473|Vitamin D|vitamin d|mesh-list
56208776|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
56208777|NCT01578473|Vitamins|vitamins|mesh-list
56208778|NCT01578473|Vitamin E|vitamin e|mesh-list
56208779|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
56208780|NCT01578473|Testosterone|testosterone|mesh-list
56208781|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
56208782|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
56208783|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56208784|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
56208785|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208786|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56208787|NCT01578473|Androgens|androgens|mesh-ancestor
56208788|NCT01578473|Hormones|hormones|mesh-ancestor
56208789|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208790|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56208791|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208792|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
56208793|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
56208794|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208795|NCT01578473|Protective Agents|protective agents|mesh-ancestor
56208796|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56208797|NCT01578564|SOR-C13|sor-c13|mesh-list
56208798|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208799|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56208800|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56208801|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208802|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56208803|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208804|NCT01578603|Calcium|calcium|mesh-list
56208805|NCT01578603|Caseins|caseins|mesh-list
56208806|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56208807|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208808|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
56208809|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
56208810|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208811|NCT01578629|Aspirin|aspirin|mesh-list
56668864|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
56668865|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56668866|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56668867|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56668868|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668869|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668870|NCT03580967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56668871|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56668872|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56668873|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668874|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668875|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
56668876|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56668877|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56668878|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56668879|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56668880|NCT00851799|Ritonavir|ritonavir|mesh-list
56668881|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56668882|NCT00851799|Darunavir|darunavir|mesh-list
56668883|NCT00851799|Tenofovir|tenofovir|mesh-list
56668884|NCT00851799|Emtricitabine|emtricitabine|mesh-list
56668885|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
56668886|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56668887|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56668888|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56668889|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
56668890|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668891|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668892|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56668893|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56668894|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
56668895|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668896|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56668897|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56668898|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56208812|NCT01578629|Vitamin E|vitamin e|mesh-list
56668899|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56668900|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56668901|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56668902|NCT00711646|Nabiximols|nabiximols|mesh-list
56668903|NCT00711646|Analgesics|analgesics|mesh-ancestor
56668904|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
56668905|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668906|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668907|NCT00501826|Cytarabine|cytarabine|mesh-list
56668908|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
56668909|NCT00501826|Dexamethasone|dexamethasone|mesh-list
56668910|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
56668911|NCT00501826|Prednisone|prednisone|mesh-list
56668912|NCT00501826|Cortisone|cortisone|mesh-list
56668913|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
56668914|NCT00501826|Doxorubicin|doxorubicin|mesh-list
56668915|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56668916|NCT00501826|Methotrexate|methotrexate|mesh-list
56668917|NCT00501826|Vincristine|vincristine|mesh-list
56668918|NCT00501826|Asparaginase|asparaginase|mesh-list
56668919|NCT00501826|Venetoclax|venetoclax|mesh-list
56208813|NCT01578629|Tocopherols|tocopherols|mesh-list
56208814|NCT01578629|Tocotrienols|tocotrienols|mesh-list
56208815|NCT01578629|Vitamins|vitamins|mesh-ancestor
56208816|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
56208817|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208818|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56180876|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180877|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
56180878|NCT01407471|Hormones|hormones|mesh-ancestor
56180879|NCT01407484|Prednisone|prednisone|mesh-list
56180880|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56180881|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
56180882|NCT01407484|Hormones|hormones|mesh-ancestor
56180883|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180884|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180885|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56180886|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180887|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56180888|NCT01407679|Alitretinoin|alitretinoin|mesh-list
56180889|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208819|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56208820|NCT01578629|Analgesics|analgesics|mesh-ancestor
56208821|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
56208822|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208823|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208825|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56208826|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56208827|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208828|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56208829|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56208830|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208832|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
56208833|NCT01578629|Protective Agents|protective agents|mesh-ancestor
56208834|NCT01578668|Pemetrexed|pemetrexed|mesh-list
56208835|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56208836|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208837|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208838|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208839|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56668920|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
56668921|NCT00501826|Pegaspargase|pegaspargase|mesh-list
56668922|NCT00501826|BB 1101|bb 1101|mesh-list
56668923|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56668924|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
56668925|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668926|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56668927|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56668928|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
56668929|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668930|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668931|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56668932|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208840|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56208841|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56208842|NCT01578720|Aflibercept|aflibercept|mesh-list
56208843|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56208844|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56208845|NCT01578720|Growth Substances|growth substances|mesh-ancestor
56208846|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208847|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
56208848|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208849|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
56208851|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
56208852|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208853|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208854|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56208855|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56208856|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
56208857|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56208858|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56208859|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
56208860|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208861|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208862|NCT01578889|Vaccines|vaccines|mesh-list
56208863|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
56208864|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208865|NCT01578928|Pasireotide|pasireotide|mesh-list
56208866|NCT01578928|Hormones|hormones|mesh-ancestor
56208867|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56180891|NCT01407822|Gemcitabine|gemcitabine|mesh-list
56180892|NCT01407822|Cisplatin|cisplatin|mesh-list
56180893|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56180894|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208868|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208869|NCT01579019|Ritonavir|ritonavir|mesh-list
56208870|NCT01579019|Ribavirin|ribavirin|mesh-list
56208871|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56208872|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56208873|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56208874|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
56208875|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56208876|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208877|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56208878|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56208879|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
56208880|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208881|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56208882|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56208883|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
56208884|NCT01579058|Bisoprolol|bisoprolol|mesh-list
56208885|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56208886|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
56668933|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
56668934|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
56668935|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668936|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56668937|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
56668938|NCT00501826|Hormones|hormones|mesh-ancestor
56668939|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56668940|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56668941|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
56668942|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56668943|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56668944|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56668945|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56668946|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56668947|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
56668948|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56668949|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56668950|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
56668951|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
56668952|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56668953|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56668954|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
56668955|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56668956|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56668957|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
56668958|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
56668959|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
56668960|NCT04117191|Tryptophan|tryptophan|mesh-list
56668961|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56668962|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
56668963|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56668964|NCT00520975|Paclitaxel|paclitaxel|mesh-list
56668965|NCT00520975|Bevacizumab|bevacizumab|mesh-list
56230174|NCT01703754|Ifosfamide|ifosfamide|mesh-list
56208887|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
56208888|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208889|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208890|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56208891|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56208892|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56668966|NCT00520975|Carboplatin|carboplatin|mesh-list
56668967|NCT00520975|Trastuzumab|trastuzumab|mesh-list
56668968|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56668969|NCT00520975|Antibodies|antibodies|mesh-list
56668970|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
56668971|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56668972|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56668973|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56668974|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
56208893|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
56208894|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208895|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208896|NCT01579110|Levamisole|levamisole|mesh-list
56208897|NCT01579110|Prednisone|prednisone|mesh-list
56208898|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208899|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
56208900|NCT01579110|Hormones|hormones|mesh-ancestor
56208901|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208902|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208903|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56208904|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208905|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56208906|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
56208907|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
56208908|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
56208909|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56208910|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208911|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56208912|NCT01579149|Plerixafor|plerixafor|mesh-list
56208913|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56208914|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56208915|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
56208916|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208917|NCT01579201|Carbetocin|carbetocin|mesh-list
56208918|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
56208919|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56208920|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208921|NCT01579227|Tamoxifen|tamoxifen|mesh-list
56208922|NCT01579227|Tocotrienols|tocotrienols|mesh-list
56208923|NCT01579227|Vitamin E|vitamin e|mesh-list
56208924|NCT01579227|Tocopherols|tocopherols|mesh-list
56208925|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56136696|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
56208926|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
56208927|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208928|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208929|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56208930|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56208931|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56208932|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56208933|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56180895|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56180896|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
56180897|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180898|NCT01407822|Antiviral Agents|antiviral agents|mesh-ancestor
56180899|NCT01407822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180900|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180901|NCT01407822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180902|NCT01407822|Immunologic Factors|immunologic factors|mesh-ancestor
56180903|NCT01407822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180904|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56180906|NCT01407848|Diuretics|diuretics|mesh-ancestor
56180907|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
56180908|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180909|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56180910|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56180911|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668975|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
56668976|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
56668977|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56668978|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56180912|NCT01407887|Artesunate|artesunate|mesh-list
56208934|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
56208935|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208936|NCT01579227|Protective Agents|protective agents|mesh-ancestor
56208937|NCT01579227|Vitamins|vitamins|mesh-ancestor
56208938|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
56208939|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56208940|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56208941|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56208942|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56208943|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208944|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208945|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208946|NCT01579279|Analgesics|analgesics|mesh-ancestor
56208947|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
56208948|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208949|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
56208950|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56208951|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
56208952|NCT01579383|Sumatriptan|sumatriptan|mesh-list
56208953|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56208954|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56208955|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56208956|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
56208957|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208958|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208959|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208960|NCT01579448|Vaccines|vaccines|mesh-list
56208961|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
56208962|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208964|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56208965|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56208966|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56208967|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
56208968|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208969|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208970|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180913|NCT01407887|Amodiaquine|amodiaquine|mesh-list
56180914|NCT01407887|Methylene Blue|methylene blue|mesh-list
56180915|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
56180916|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56180917|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56180918|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180919|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180920|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
56180921|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
56180922|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56180923|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
56180924|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56180925|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180926|NCT01408004|Everolimus|everolimus|mesh-list
56180927|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180928|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180929|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
56180930|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180931|NCT01408056|Mupirocin|mupirocin|mesh-list
56180932|NCT01408056|Timolol|timolol|mesh-list
56180933|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56208971|NCT01579461|Urological Agents|urological agents|mesh-ancestor
56208972|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
56208973|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56208974|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56208975|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56208976|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56208977|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208978|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
56668979|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56668980|NCT00520975|Growth Substances|growth substances|mesh-ancestor
56668981|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668982|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
56668983|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
56668984|NCT00614159|Ketamine|ketamine|mesh-list
56668985|NCT00614159|Propofol|propofol|mesh-list
56668986|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56668987|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56668988|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56668989|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56668991|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
56668992|NCT00614159|Analgesics|analgesics|mesh-ancestor
56208979|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56208980|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208981|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56208982|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208983|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
56208984|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56208985|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56208987|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
56208988|NCT01579539|Esomeprazole|esomeprazole|mesh-list
56208989|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56208990|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
56208991|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56208992|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
56208993|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
56208994|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208995|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208996|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56208997|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
56208998|NCT01579539|Hormones|hormones|mesh-ancestor
56208999|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209000|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56209001|NCT01579539|Protective Agents|protective agents|mesh-ancestor
56209002|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56209003|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209004|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56209005|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56209006|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209007|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180934|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55878831|NCT03418974|Atorvastatin|atorvastatin|mesh-list
56209008|NCT01579630|Pemetrexed|pemetrexed|mesh-list
56209009|NCT01579630|Gefitinib|gefitinib|mesh-list
56209010|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209011|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209012|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209013|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56209014|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56209015|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56209016|NCT01579695|Tesamorelin|tesamorelin|mesh-list
56209017|NCT01579695|Growth Substances|growth substances|mesh-ancestor
56209018|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209019|NCT01579734|Tamoxifen|tamoxifen|mesh-list
56209020|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56209021|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
56209022|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209023|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209024|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56209025|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209026|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56668993|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
56668994|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56668995|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56668996|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56668997|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56668998|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56668999|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669000|NCT05042531|Azacitidine|azacitidine|mesh-list
56669001|NCT05042531|Dasatinib|dasatinib|mesh-list
56669002|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56669003|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
56669004|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209027|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56209028|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56209029|NCT01579760|Aflibercept|aflibercept|mesh-list
56209030|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56209031|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56209032|NCT01579760|Growth Substances|growth substances|mesh-ancestor
56209033|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209034|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
56209035|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209036|NCT01579786|Acetaminophen|acetaminophen|mesh-list
56209037|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56209038|NCT01579786|Analgesics|analgesics|mesh-ancestor
56209039|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
56209040|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209041|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209042|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
56209043|NCT01579838|Eculizumab|eculizumab|mesh-list
56209044|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56209045|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209046|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
56209047|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209048|NCT01579864|Rocuronium|rocuronium|mesh-list
56209049|NCT01579864|Succinylcholine|succinylcholine|mesh-list
56209050|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56209051|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56209052|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56209053|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209054|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209055|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56209056|NCT01579890|Diclofenac|diclofenac|mesh-list
56209057|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56209058|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56209059|NCT01579890|Analgesics|analgesics|mesh-ancestor
56209060|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
56209061|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209062|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209063|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56209064|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56209065|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56209066|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209067|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209068|NCT01579903|Factor VIII|factor viii|mesh-list
56209069|NCT01579903|Coagulants|coagulants|mesh-ancestor
56209070|NCT01579929|Etoposide|etoposide|mesh-list
56209071|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136847|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209072|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56209073|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56209074|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56669005|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669006|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669007|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56669008|NCT00851721|Factor VIII|factor viii|mesh-list
56669009|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
56669010|NCT00851721|Coagulants|coagulants|mesh-ancestor
56669011|NCT04071119|Oxytocin|oxytocin|mesh-list
56669012|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
56669013|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56669014|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669015|NCT02634476|Ethanol|ethanol|mesh-list
56669016|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56669017|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669018|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669019|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669020|NCT04385303|Lorecivivint|lorecivivint|mesh-list
56669021|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56669022|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56669023|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56669024|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56180937|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56180938|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180939|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56180945|NCT01408095|Glimepiride|glimepiride|mesh-list
56209075|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209076|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209077|NCT01579994|Crizotinib|crizotinib|mesh-list
56209078|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209079|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56209080|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209081|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209082|NCT01580228|Ofatumumab|ofatumumab|mesh-list
56209083|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209084|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
56209085|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56209086|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56209087|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
56209088|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56209089|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
56209090|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56209091|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209092|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56209093|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56209094|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209095|NCT01581476|Quinapril|quinapril|mesh-list
56209096|NCT01581476|Atorvastatin|atorvastatin|mesh-list
56209097|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56209098|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56209099|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56209100|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
56209101|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209102|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56209103|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56209104|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209105|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
56669025|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
56669026|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669027|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56669028|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56669029|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669030|NCT00740194|Estradiol|estradiol|mesh-list
56669031|NCT00740194|Estrogens|estrogens|mesh-ancestor
56669032|NCT00740194|Hormones|hormones|mesh-ancestor
56669033|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230257|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
56209106|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56209107|NCT01582321|Cantharidin|cantharidin|mesh-list
56209108|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209109|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209110|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
56209111|NCT01582438|Citric Acid|citric acid|mesh-list
56209112|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
56209113|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
56209114|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56209115|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
56209116|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
56209117|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209118|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
56209119|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56209120|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56209121|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209122|NCT01582438|Urological Agents|urological agents|mesh-ancestor
56209123|NCT01582711|Isoniazid|isoniazid|mesh-list
56209124|NCT01582711|Rifapentine|rifapentine|mesh-list
56209125|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
56209126|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56209127|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209128|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56209129|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56209130|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
56180946|NCT01408095|Globalagliatin|globalagliatin|mesh-list
56180947|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56180948|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56180949|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180950|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56180951|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
56181016|NCT01408498|Testosterone|testosterone|mesh-list
56181017|NCT01408498|Androgens|androgens|mesh-ancestor
56181018|NCT01408498|Hormones|hormones|mesh-ancestor
56181019|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799406|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
56181026|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181027|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56181028|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181029|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
56181030|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56181031|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56181032|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
56181033|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181034|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
56181035|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
56181036|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181037|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56181038|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56181039|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56181040|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56181041|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56181042|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56209131|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669034|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669035|NCT04159142|Paclitaxel|paclitaxel|mesh-list
56669036|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56669037|NCT04159142|Carboplatin|carboplatin|mesh-list
56669038|NCT04159142|Capecitabine|capecitabine|mesh-list
56669039|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56669040|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669041|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
56669042|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
56669043|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
56669044|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669045|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56669046|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
56669047|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56669048|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
56669049|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56669050|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56669051|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669052|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669053|NCT00654680|Urological Agents|urological agents|mesh-ancestor
56669054|NCT00520741|Lacosamide|lacosamide|mesh-list
56669055|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
56669056|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56669057|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56669058|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669059|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669060|NCT03682289|Durvalumab|durvalumab|mesh-list
56669061|NCT03682289|Olaparib|olaparib|mesh-list
56669062|NCT03682289|Adenosine|adenosine|mesh-list
56669063|NCT03682289|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56315217|NCT02423876|Hydromorphone|hydromorphone|mesh-list
56669064|NCT03682289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56209132|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56209133|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56209134|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
56209136|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
56209137|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
56209138|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56209139|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209140|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209141|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209142|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56669065|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669066|NCT03682289|Immunologic Factors|immunologic factors|mesh-ancestor
56669067|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669068|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56669069|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669070|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669071|NCT03682289|Analgesics|analgesics|mesh-ancestor
56669072|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
56669073|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669074|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56669075|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
56669076|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56669077|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
56669078|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
56669079|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669080|NCT00729118|Lenalidomide|lenalidomide|mesh-list
56669081|NCT00729118|Vorinostat|vorinostat|mesh-list
56669082|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
56669083|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669084|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56669085|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56669086|NCT00729118|Growth Substances|growth substances|mesh-ancestor
56669087|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
56669088|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669089|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56669090|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669091|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209143|NCT01583426|Paclitaxel|paclitaxel|mesh-list
56209144|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56209145|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56209146|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209147|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
56209148|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
56209149|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
56181043|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181044|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
56181045|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181046|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181047|NCT01408680|Ubiquinone|ubiquinone|mesh-list
56181048|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
56181049|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
56181050|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181051|NCT01408680|Vitamins|vitamins|mesh-ancestor
56181052|NCT01408797|Bortezomib|bortezomib|mesh-list
56181053|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181054|NCT01408810|Infliximab|infliximab|mesh-list
56181055|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
56181056|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56669092|NCT04064632|Darunavir|darunavir|mesh-list
56669093|NCT04064632|Cobicistat|cobicistat|mesh-list
56669094|NCT04064632|Rilpivirine|rilpivirine|mesh-list
56669095|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56669096|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56669097|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56669098|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
56669099|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669100|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669101|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56669102|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56669103|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
56669104|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669105|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56669106|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56669107|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56669108|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56669109|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
56669110|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56669111|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
56181057|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56181058|NCT01408836|Prednisolone|prednisolone|mesh-list
56181059|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56181060|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
56181061|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56209150|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209151|NCT01583972|Vitamin A|vitamin a|mesh-list
56209152|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
56209153|NCT01583972|Vitamins|vitamins|mesh-ancestor
56209154|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
56209155|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209156|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
56209157|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209158|NCT01583972|Protective Agents|protective agents|mesh-ancestor
56209159|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56209160|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209161|NCT01584362|Oxfendazole|oxfendazole|mesh-list
56209162|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
56209163|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56209164|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209165|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
56209166|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
56209167|NCT01584921|Hematinics|hematinics|mesh-ancestor
56209168|NCT01586013|Propofol|propofol|mesh-list
56209169|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56209170|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209171|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209172|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56209173|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
56209174|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
56209175|NCT01586845|Cyclosporine|cyclosporine|mesh-list
56209176|NCT01586845|Tacrolimus|tacrolimus|mesh-list
56209177|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209178|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
56209179|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209180|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56209181|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669112|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56669113|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56669114|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56669115|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669116|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669117|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
56669118|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
56669119|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209182|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209183|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
56209184|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209185|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
56209186|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56209187|NCT01587339|Pregabalin|pregabalin|mesh-list
56209188|NCT01587339|Zonisamide|zonisamide|mesh-list
56209189|NCT01587339|Lacosamide|lacosamide|mesh-list
56209190|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56209191|NCT01587339|Ezogabine|ezogabine|mesh-list
56209192|NCT01587339|Analgesics|analgesics|mesh-ancestor
56181062|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
56181063|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56181064|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
56181065|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181066|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
56181067|NCT01408836|Hormones|hormones|mesh-ancestor
56181068|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181069|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181070|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56181071|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181072|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
56181073|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
56181074|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181075|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181076|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56181077|NCT01408836|Protective Agents|protective agents|mesh-ancestor
56181078|NCT01408849|Omeprazole|omeprazole|mesh-list
56181079|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56181080|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181081|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56181082|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181083|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181084|NCT01408927|Aspirin|aspirin|mesh-list
56181085|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56181086|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56209193|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
56209194|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209195|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209196|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
56209197|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56209198|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56209199|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209200|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56209201|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56209202|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56209203|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209204|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56209205|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56209206|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56209207|NCT01587378|Metformin|metformin|mesh-list
56209208|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56209209|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209211|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56209212|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209213|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
56209214|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
56209215|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
56209216|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669120|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56669121|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56669122|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
56669123|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669124|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669125|NCT00882362|Aripiprazole|aripiprazole|mesh-list
56669126|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
56669127|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56669128|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56669129|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56669130|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669131|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669132|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
56669133|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
56669134|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669135|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669136|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56315294|NCT04033276|Rituximab|rituximab|mesh-list
56547653|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56181087|NCT01408927|Analgesics|analgesics|mesh-ancestor
56181088|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
56181089|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181090|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181091|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181092|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56181093|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56181094|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56181095|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181096|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56181097|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56181098|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181099|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
56181100|NCT01408953|Bevacizumab|bevacizumab|mesh-list
56181101|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56181102|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209217|NCT01587625|Oxytocin|oxytocin|mesh-list
56209218|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
56209219|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56209220|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209221|NCT01587820|Cisplatin|cisplatin|mesh-list
56209222|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136998|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56209223|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56209224|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56209225|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209226|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
56209227|NCT01588171|Enoxaparin|enoxaparin|mesh-list
56209228|NCT01588171|Bemiparin|bemiparin|mesh-list
56209229|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
56209230|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56209231|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56209232|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209233|NCT01588873|Desogestrel|desogestrel|mesh-list
56209234|NCT01588873|NuvaRing|nuvaring|mesh-list
56209235|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56209236|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56669137|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56669138|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
56669139|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56669140|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56669141|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56669142|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56669143|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
56669144|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56669145|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56669146|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
56669147|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669148|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56209237|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56209238|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
56209239|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56209240|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209241|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56209242|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56209243|NCT01588873|Progestins|progestins|mesh-ancestor
56209244|NCT01588873|Hormones|hormones|mesh-ancestor
56209245|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209246|NCT01589367|Metformin|metformin|mesh-list
56209247|NCT01589367|Letrozole|letrozole|mesh-list
56209248|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56209249|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209250|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209251|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56209252|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56209253|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209254|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209255|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56209256|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
56209257|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209258|NCT01589432|Lidocaine|lidocaine|mesh-list
56181104|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55879190|NCT03411252|Mirabegron|mirabegron|mesh-list
56209259|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
56209260|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
56209261|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209262|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209263|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
56209264|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209265|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56209271|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
56209272|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56209273|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
56209274|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56209275|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209276|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56209277|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56209278|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209279|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209280|NCT01589861|Lapatinib|lapatinib|mesh-list
56209281|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209282|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56209283|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209284|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209285|NCT01590173|Prednisolone|prednisolone|mesh-list
56209286|NCT01590173|Heparin|heparin|mesh-list
56209287|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56209288|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
56209289|NCT01590173|Hormones|hormones|mesh-ancestor
55888863|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
56669149|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56669150|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669151|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669152|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56669153|NCT00636935|Clindamycin|clindamycin|mesh-list
56669154|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
56669155|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
56209290|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209291|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209292|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56209293|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209294|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
56209295|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56209296|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56209297|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209299|NCT01590199|Pasireotide|pasireotide|mesh-list
56209300|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209301|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209302|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
56209303|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209304|NCT01590199|Hormones|hormones|mesh-ancestor
56209305|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209306|NCT01590225|Ribavirin|ribavirin|mesh-list
56209307|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56209308|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
56209309|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
56209310|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209311|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
56209312|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209313|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
56209314|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209315|NCT01590342|Diclofenac|diclofenac|mesh-list
56209316|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56209317|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56209318|NCT01590342|Analgesics|analgesics|mesh-ancestor
56209319|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
56209320|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209321|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209322|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56209323|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56209324|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56209325|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209326|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209327|NCT01590537|Copper|copper|mesh-list
56181105|NCT01408953|Growth Substances|growth substances|mesh-ancestor
56181106|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181107|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
56181108|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
56181109|NCT01408979|Analgesics|analgesics|mesh-ancestor
56181110|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
56181111|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799494|NCT01596127|Rituximab|rituximab|mesh-list
56181115|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56181116|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
56181117|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56181118|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56181119|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181120|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56181121|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
56181122|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56181124|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56181125|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
56181126|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181127|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181128|NCT01409005|Antiviral Agents|antiviral agents|mesh-ancestor
56181129|NCT01409005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181130|NCT01409005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669156|NCT00636935|Dapsone|dapsone|mesh-list
56669157|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56669158|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56669159|NCT00636935|Primaquine|primaquine|mesh-list
56669160|NCT00636935|Trimethoprim|trimethoprim|mesh-list
56669161|NCT00636935|Atovaquone|atovaquone|mesh-list
56669162|NCT00636935|Pentamidine|pentamidine|mesh-list
56669163|NCT00636935|Prednisone|prednisone|mesh-list
56669164|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56669165|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
56669166|NCT00636935|Hormones|hormones|mesh-ancestor
56669167|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669168|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669169|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56669170|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669171|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669172|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
56669173|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56669174|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669175|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669176|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
56181131|NCT01409005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181132|NCT01409005|Immunologic Factors|immunologic factors|mesh-ancestor
56181133|NCT01409005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181134|NCT01409018|Itraconazole|itraconazole|mesh-list
56181135|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56181136|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
56181137|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181138|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56181139|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56209328|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
56209329|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56209330|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
56209331|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56181140|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181141|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181142|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56181143|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
56181144|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181145|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181146|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56181147|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56181148|NCT01409148|Antibodies|antibodies|mesh-list
56209332|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209333|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56209334|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56209335|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56209336|NCT01590537|Trace Elements|trace elements|mesh-ancestor
56209337|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
56209338|NCT01590641|Vesatolimod|vesatolimod|mesh-list
56209339|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
56209340|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209341|NCT01590654|Vesatolimod|vesatolimod|mesh-list
56209342|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
56209343|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669177|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56669178|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56669179|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56135628|NCT03983226|Taxane|taxane|mesh-list
56209344|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
56209345|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56209346|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56209347|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56209348|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56209349|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209350|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
56209351|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56209352|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209353|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56209354|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209355|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56209356|NCT01590732|Carboplatin|carboplatin|mesh-list
56209357|NCT01590732|Etoposide|etoposide|mesh-list
56209358|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
56209359|NCT01590732|Ifosfamide|ifosfamide|mesh-list
56209360|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
56209361|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
56209362|NCT01590732|Romidepsin|romidepsin|mesh-list
56209363|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209364|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56209365|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56209366|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56209367|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209368|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209369|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209370|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56209371|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
56137149|NCT00548418|Topotecan|topotecan|mesh-list
56209372|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
56209373|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
56209374|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
56209375|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
56209376|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
56209377|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56209378|NCT01590823|Dabigatran|dabigatran|mesh-list
56209379|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
56209380|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56209381|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
56209382|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209383|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209384|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
56209385|NCT01590836|Insulin|insulin|mesh-list
56209386|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56209387|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
56181149|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56181150|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
56209388|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
56209389|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56209390|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209391|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
56209392|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
56209393|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56209394|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56209395|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209396|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56209397|NCT01590901|Probucol|probucol|mesh-list
56209398|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56209399|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56209400|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
56209401|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209402|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56209404|NCT01590901|Protective Agents|protective agents|mesh-ancestor
56209405|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209406|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
56209407|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209408|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
56209409|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209410|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56209411|NCT01591031|Sevoflurane|sevoflurane|mesh-list
56669180|NCT00636935|Renal Agents|renal agents|mesh-ancestor
56669181|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56669182|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56669183|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56669184|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56669185|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
56669186|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
56669187|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56669188|NCT00654758|Paclitaxel|paclitaxel|mesh-list
56669189|NCT00654758|Carboplatin|carboplatin|mesh-list
56669190|NCT00654758|Volociximab|volociximab|mesh-list
56669191|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56669192|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56669193|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669194|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
56209412|NCT01591031|Rocuronium|rocuronium|mesh-list
56209413|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56209414|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56209415|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
56209416|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
56209417|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209418|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209419|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56209420|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56209421|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56209422|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209423|NCT01591070|Tacrolimus|tacrolimus|mesh-list
56209424|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209425|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
56209426|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209427|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56209428|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209429|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209430|NCT01591083|Esomeprazole|esomeprazole|mesh-list
56209431|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56209432|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56209433|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56209434|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209435|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209436|NCT01591122|Prednisone|prednisone|mesh-list
56209437|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
56209438|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56209439|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
56209440|NCT01591122|Hormones|hormones|mesh-ancestor
56209441|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209443|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56209444|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209445|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56209446|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209447|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787555|NCT04431713|Incretins|incretins|mesh-ancestor
56209448|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
56137251|NCT00553098|Antibodies|antibodies|mesh-list
56209449|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56209450|NCT01591135|Paclitaxel|paclitaxel|mesh-list
56209451|NCT01591135|Fluorouracil|fluorouracil|mesh-list
56209452|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56209453|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209454|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
56209455|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
56209456|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
56669195|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
56669196|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
56669197|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669198|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56669199|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56669200|NCT00654758|Growth Substances|growth substances|mesh-ancestor
56669201|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669202|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
56669203|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
56669204|NCT00656864|Pioglitazone|pioglitazone|mesh-list
56669205|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56669206|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669207|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
56669208|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56669209|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669210|NCT00613613|Fenofibrate|fenofibrate|mesh-list
56669211|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56669212|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
56669219|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669220|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
56669221|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669222|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56669223|NCT00850395|Maraviroc|maraviroc|mesh-list
56669224|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56230427|NCT01705249|Estradiol|estradiol|mesh-list
56209457|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209458|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
56181151|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181152|NCT01409174|Interferons|interferons|mesh-list
56181153|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
56181154|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
56181155|NCT01409174|Aldesleukin|aldesleukin|mesh-list
56181156|NCT01409174|Cisplatin|cisplatin|mesh-list
56181157|NCT01409174|Temozolomide|temozolomide|mesh-list
56181158|NCT01409174|Ipilimumab|ipilimumab|mesh-list
56181159|NCT01409174|Interleukin-2|interleukin-2|mesh-list
56108898|NCT00003799|Leucovorin|leucovorin|mesh-list
56181160|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181161|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
56181162|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181163|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56181164|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
56181165|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181166|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56181167|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56181168|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
56181169|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879459|NCT03399708|Apremilast|apremilast|mesh-list
56209459|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56209460|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209461|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
56669225|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56669226|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669227|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56669228|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56669229|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
56669230|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669231|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56669232|NCT04188431|Dexamethasone|dexamethasone|mesh-list
56669233|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56209462|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209463|NCT01591148|Propofol|propofol|mesh-list
56209464|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56209465|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209466|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209467|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56209468|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
56209469|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
56209470|NCT01591226|Mannitol|mannitol|mesh-list
56209471|NCT01591226|Caffeine|caffeine|mesh-list
56209472|NCT01591226|Citric Acid|citric acid|mesh-list
56209473|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
56209474|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
56209475|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56209476|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
56209477|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
56209478|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209479|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56209480|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209481|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56209482|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209483|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56209484|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56209485|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
56209486|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56209487|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56209489|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
56209491|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
56209492|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
56209493|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209494|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209495|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56209496|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
56209497|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
56181170|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56181171|NCT01409174|Analgesics|analgesics|mesh-ancestor
56181172|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
56181173|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181174|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56181175|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56181176|NCT01409187|Interferons|interferons|mesh-list
56181177|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
56181178|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
56181179|NCT01409187|Aldesleukin|aldesleukin|mesh-list
56181180|NCT01409187|Ipilimumab|ipilimumab|mesh-list
56181181|NCT01409187|Interleukin-2|interleukin-2|mesh-list
56181182|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181183|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
56181184|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181185|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56181186|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56181187|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181188|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
56181189|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181190|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56181191|NCT01409187|Analgesics|analgesics|mesh-ancestor
55879516|NCT01430182|Morphine|morphine|mesh-list
56209498|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56209499|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
56669234|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
56669235|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
56669236|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669237|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669238|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56669239|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
56669240|NCT04188431|Hormones|hormones|mesh-ancestor
56669241|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669242|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56669243|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669244|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56669245|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
56669246|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
56669247|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669248|NCT03630809|Vaccines|vaccines|mesh-list
56669249|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
56209500|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56209501|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209502|NCT01591291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56209503|NCT01591291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56209504|NCT01591291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209505|NCT01591291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56209506|NCT01591291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56209507|NCT01591421|Panitumumab|panitumumab|mesh-list
56209508|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56209509|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209510|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56209511|NCT01591434|Laxatives|laxatives|mesh-ancestor
56209512|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56209513|NCT01591551|Natalizumab|natalizumab|mesh-list
56209514|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
56209515|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209517|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
56209518|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209519|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56209520|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
56209521|NCT01591850|Ritonavir|ritonavir|mesh-list
56209522|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56209523|NCT01591850|Rifampin|rifampin|mesh-list
56209524|NCT01591850|Ketoconazole|ketoconazole|mesh-list
56209525|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56209526|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56209527|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
55788413|NCT04513639|Dexamethasone|dexamethasone|mesh-list
56209528|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209529|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209530|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56181192|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
56181193|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181195|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56181196|NCT01409278|Ropivacaine|ropivacaine|mesh-list
56181197|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
56181198|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
56181199|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56181200|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181201|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
56181202|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181203|NCT01409369|Charcoal|charcoal|mesh-list
56181204|NCT01409369|Antidotes|antidotes|mesh-ancestor
56669250|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669251|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
56669252|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
56669253|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56669254|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669255|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669256|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56669257|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669258|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56669259|NCT00736294|Ramipril|ramipril|mesh-list
56669260|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56669261|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
56181205|NCT01409369|Protective Agents|protective agents|mesh-ancestor
56181206|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181207|NCT01409395|Metformin|metformin|mesh-list
56181208|NCT01409395|Nizatidine|nizatidine|mesh-list
56181209|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56181210|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181211|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56181212|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181213|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56181214|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
56181216|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181217|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181218|NCT01409408|Amlodipine|amlodipine|mesh-list
56181219|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56181220|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56181221|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56181222|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181223|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56181224|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181225|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
56209531|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56209532|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
56209533|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209534|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56209535|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56209536|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56209537|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
56209538|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56209539|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
56209540|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56209541|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56209542|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56209543|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56209544|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56209545|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56209546|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56209547|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
56209548|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56209549|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56209550|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
56209551|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209552|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209553|NCT01591889|Tinidazole|tinidazole|mesh-list
56209554|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
56209555|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788521|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
56669262|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669263|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669264|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56669269|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
56669270|NCT00512707|Testosterone|testosterone|mesh-list
56669271|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669272|NCT00512707|Androgens|androgens|mesh-ancestor
56669273|NCT00512707|Hormones|hormones|mesh-ancestor
56230488|NCT01705470|Furosemide|furosemide|mesh-list
56209556|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56209557|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209558|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56209559|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56209560|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56209561|NCT01591902|Tesamorelin|tesamorelin|mesh-list
56209562|NCT01591902|Growth Substances|growth substances|mesh-ancestor
56209563|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209564|NCT01591980|Pregabalin|pregabalin|mesh-list
56209565|NCT01591980|Analgesics|analgesics|mesh-ancestor
56209566|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
56209567|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209568|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209569|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
56209570|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56209571|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55788587|NCT03662815|Sargramostim|sargramostim|mesh-list
56209572|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209573|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56209574|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56209575|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56209576|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209577|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56209578|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
56209580|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56209581|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56209582|NCT01592019|Analgesics|analgesics|mesh-ancestor
56209583|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
56209584|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209585|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209586|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56209587|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56209588|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56209589|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209590|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209591|NCT01592032|Vancomycin|vancomycin|mesh-list
56209592|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56209593|NCT01592032|Linezolid|linezolid|mesh-list
56209594|NCT01592032|Daptomycin|daptomycin|mesh-list
56209595|NCT01592032|Tigecycline|tigecycline|mesh-list
56209596|NCT01592032|Teicoplanin|teicoplanin|mesh-list
56209597|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
56209598|NCT01592032|Heparin|heparin|mesh-list
56209599|NCT01592032|Calcium heparin|calcium heparin|mesh-list
56209600|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56209601|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
56209602|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56181234|NCT01409603|Darexaban|darexaban|mesh-list
56181235|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56181236|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56181237|NCT01409603|Analgesics|analgesics|mesh-ancestor
56181238|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
56181239|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181240|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181241|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181242|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56181243|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
56181244|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56181245|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669274|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669275|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669276|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
56669277|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56669278|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56669279|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669280|NCT00512707|Urological Agents|urological agents|mesh-ancestor
56669281|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56669282|NCT05213221|Lenvatinib|lenvatinib|mesh-list
56669283|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230503|NCT01705639|Melatonin|melatonin|mesh-list
56181246|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181247|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56181248|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
56181249|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56181250|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
56181251|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
56181252|NCT01409616|Aspirin|aspirin|mesh-list
56209603|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56209604|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209605|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56209606|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209608|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209609|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56209610|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209611|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209612|NCT01592162|Remifentanil|remifentanil|mesh-list
56209613|NCT01592162|Propofol|propofol|mesh-list
56209614|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56209615|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209616|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209617|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56209618|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
56209619|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
56209620|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56209621|NCT01592162|Narcotics|narcotics|mesh-ancestor
56209622|NCT01592162|Analgesics|analgesics|mesh-ancestor
56209623|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
56209624|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209625|NCT01592201|Olanzapine|olanzapine|mesh-list
56209626|NCT01592201|Risperidone|risperidone|mesh-list
56209627|NCT01592201|Aripiprazole|aripiprazole|mesh-list
56209628|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
56209629|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56209630|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
56209631|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56209632|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209633|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209634|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56209635|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209636|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56209637|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56209638|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
56209639|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
56209640|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
56209641|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181254|NCT01409616|Salicylates|salicylates|mesh-list
56181255|NCT01409616|Darexaban|darexaban|mesh-list
56181256|NCT01409616|Clopidogrel|clopidogrel|mesh-list
56181257|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56181258|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56181259|NCT01409616|Analgesics|analgesics|mesh-ancestor
56181260|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
56181261|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181262|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669284|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56669285|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669286|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669287|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
56669288|NCT03471767|Bupropion|bupropion|mesh-list
56669289|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56669290|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
56669291|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56669292|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56669293|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56669294|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669295|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669296|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
56669297|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669298|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669299|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56669300|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56669301|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669302|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
56669303|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
56669304|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56669305|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56230526|NCT01705795|Antibodies|antibodies|mesh-list
56181263|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56209642|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56209643|NCT01592201|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56209644|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56209645|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56209646|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
56209647|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
56209648|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56209649|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56209650|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56209651|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56209652|NCT01592214|Benzocaine|benzocaine|mesh-list
56209653|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
56209654|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
56209655|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209656|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209657|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
56209658|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209659|NCT01592227|Acetaminophen|acetaminophen|mesh-list
56209660|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56209661|NCT01592227|Analgesics|analgesics|mesh-ancestor
56209662|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
56209663|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209664|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669306|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56669307|NCT00849693|Fluoxetine|fluoxetine|mesh-list
56669308|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56669309|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56669310|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669311|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669312|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669313|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669314|NCT00849693|Analgesics|analgesics|mesh-ancestor
56669315|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
56669316|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669317|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
56669318|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56669319|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
56669320|NCT00849693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56669321|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
56669322|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56669323|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56669324|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56669325|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669326|NCT00736606|Simvastatin|simvastatin|mesh-list
56669327|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56669328|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56669329|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
56669330|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669331|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56669332|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56669333|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669334|NCT00527605|Dutasteride|dutasteride|mesh-list
56669335|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56669336|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56669345|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669346|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669347|NCT04865939|Antiviral Agents|antiviral agents|mesh-ancestor
56669348|NCT04865939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669349|NCT04865939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669350|NCT04865939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56669351|NCT04865939|Immunologic Factors|immunologic factors|mesh-ancestor
56669352|NCT04865939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669353|NCT00741052|Azithromycin|azithromycin|mesh-list
56315553|NCT02638519|Xenon|xenon|mesh-list
56669355|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56669356|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669357|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56669358|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56669359|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669360|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669361|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669362|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56669363|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56669364|NCT04116411|Valganciclovir|valganciclovir|mesh-list
56669365|NCT04116411|Temozolomide|temozolomide|mesh-list
56669366|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56669367|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
56669368|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669369|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669370|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
56669371|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209665|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
56209666|NCT01592253|Sirolimus|sirolimus|mesh-list
56209667|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56209668|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209669|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56209670|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209671|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
56209672|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209673|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
56209674|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209675|NCT01592279|Liraglutide|liraglutide|mesh-list
56209676|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56209677|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209678|NCT01592279|Incretins|incretins|mesh-ancestor
56209679|NCT01592279|Hormones|hormones|mesh-ancestor
56209680|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209682|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56209683|NCT01592305|Tenofovir|tenofovir|mesh-list
56209684|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56209685|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56669372|NCT00706953|Doxorubicin|doxorubicin|mesh-list
56669373|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56669374|NCT00706953|Bortezomib|bortezomib|mesh-list
56669375|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56669376|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209686|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
56209687|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209688|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209689|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56209690|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56209691|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
56209692|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209693|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56209694|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56209695|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56209696|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56181264|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56181265|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56181266|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56181267|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181268|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56181269|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56181270|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181271|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
56181272|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56181273|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56181274|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56181275|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
56181276|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181277|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181278|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
56181279|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
56181280|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
56181282|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
56181322|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
56181323|NCT01410201|BB 1101|bb 1101|mesh-list
56181324|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181325|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
56181326|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
56181327|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181328|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181329|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181330|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
56181331|NCT01410201|Hormones|hormones|mesh-ancestor
56181332|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181333|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56181334|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181335|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
56181336|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181337|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181338|NCT01410214|Cisplatin|cisplatin|mesh-list
56181339|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56181340|NCT01410214|Vinorelbine|vinorelbine|mesh-list
56181341|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181342|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56181343|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181344|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181345|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56181346|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
56181347|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
56181348|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
56181349|NCT01410370|Endostar protein|endostar protein|mesh-list
56181350|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56181351|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56181352|NCT01410370|Growth Substances|growth substances|mesh-ancestor
56181353|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181354|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56181355|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181356|NCT01410630|Telbivudine|telbivudine|mesh-list
56181361|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669377|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56669378|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56669379|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669380|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669381|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
56181362|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
56181363|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56181364|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181365|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
56181366|NCT01410708|Dasatinib|dasatinib|mesh-list
56181367|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181368|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56181369|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181370|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181371|NCT01410747|Tacrolimus|tacrolimus|mesh-list
56181372|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209698|NCT01592318|Lactams|lactams|mesh-list
56209699|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56209700|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56209701|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
56209702|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209703|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209704|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56209705|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56209706|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
56209707|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209708|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56209709|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56209710|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56209711|NCT01592526|Nicotine|nicotine|mesh-list
56209712|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56209713|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
56209714|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209715|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209716|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56209717|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56209718|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
56209719|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56209720|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209721|NCT01592630|Ropivacaine|ropivacaine|mesh-list
56209722|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
56209723|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
56209724|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209725|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209726|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
56209727|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209728|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
56209729|NCT01592981|Rituximab|rituximab|mesh-list
56209730|NCT01592981|Fludarabine|fludarabine|mesh-list
56209731|NCT01592981|Bortezomib|bortezomib|mesh-list
56209732|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209733|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
56209734|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209735|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56209736|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55788975|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
56209737|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
56209738|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209739|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209740|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56209741|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56209743|NCT01593033|Trace Elements|trace elements|mesh-list
56209744|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209745|NCT01593046|Cabotegravir|cabotegravir|mesh-list
56209746|NCT01593046|Rilpivirine|rilpivirine|mesh-list
56209747|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56209748|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56209749|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181373|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
56181374|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669382|NCT03462017|Acetylcholine|acetylcholine|mesh-list
56669383|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
56669384|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56669385|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56669386|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669387|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669388|NCT03462017|Urological Agents|urological agents|mesh-ancestor
56669389|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56669390|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
56136225|NCT00384774|Lasmiditan|lasmiditan|mesh-list
56181375|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56181376|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181377|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181378|NCT01410916|Eculizumab|eculizumab|mesh-list
56181379|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56181380|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181381|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
56181382|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181383|NCT01410968|Poly ICLC|poly iclc|mesh-list
56209750|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209751|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56209752|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56209753|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
56209754|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56209755|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56209756|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56209757|NCT01593124|Imiquimod|imiquimod|mesh-list
56209758|NCT01593124|Nonoxynol|nonoxynol|mesh-list
56209759|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56209760|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
56209761|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209762|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209763|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
56209764|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56209765|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56209766|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56209767|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
56209768|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56209769|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56209770|NCT01593137|Metformin|metformin|mesh-list
56209771|NCT01593137|Liraglutide|liraglutide|mesh-list
56209772|NCT01593137|Glimepiride|glimepiride|mesh-list
56209773|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56209774|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209775|NCT01593137|Incretins|incretins|mesh-ancestor
56209776|NCT01593137|Hormones|hormones|mesh-ancestor
56209777|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209778|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56209779|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56209780|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
56209781|NCT01593150|Dabigatran|dabigatran|mesh-list
56209782|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
55789012|NCT04101643|Evolocumab|evolocumab|mesh-list
56209783|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56209784|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
56209785|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209786|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209787|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
56209788|NCT01593163|Ibuprofen|ibuprofen|mesh-list
56209789|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56209790|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56209791|NCT01593163|Analgesics|analgesics|mesh-ancestor
56209792|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
56209793|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209794|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209795|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56669391|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669392|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669393|NCT00913419|Amitriptyline|amitriptyline|mesh-list
56209796|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56209797|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56209798|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209799|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209800|NCT01593280|Morphine|morphine|mesh-list
56209801|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56209802|NCT01593280|Narcotics|narcotics|mesh-ancestor
56181384|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
56181385|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
56181386|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181387|NCT01411072|Gemcitabine|gemcitabine|mesh-list
56181388|NCT01411072|Fluorouracil|fluorouracil|mesh-list
56181389|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56181390|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
56181391|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209803|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209804|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209805|NCT01593280|Analgesics|analgesics|mesh-ancestor
56209806|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
56209807|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209808|NCT01593293|Pemetrexed|pemetrexed|mesh-list
56209809|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209810|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209811|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209812|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56209813|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56209814|NCT01593306|Paclitaxel|paclitaxel|mesh-list
56209815|NCT01593306|Cisplatin|cisplatin|mesh-list
56209816|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56209817|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209818|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
56209819|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
56209820|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
55744451|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
56209821|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209823|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
56209824|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
56209825|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209826|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209827|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
56209828|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209829|NCT01593332|Rituximab|rituximab|mesh-list
56209830|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56209831|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209832|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
56209833|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209834|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56209835|NCT01593371|Metformin|metformin|mesh-list
56209836|NCT01593371|Pioglitazone|pioglitazone|mesh-list
56209837|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56209838|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209839|NCT01593397|Fentanyl|fentanyl|mesh-list
56209840|NCT01593397|Propofol|propofol|mesh-list
56209841|NCT01593397|Anesthetics|anesthetics|mesh-list
56209842|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56209843|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209844|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209845|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56209846|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
56209847|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56209848|NCT01593397|Narcotics|narcotics|mesh-ancestor
56209849|NCT01593397|Analgesics|analgesics|mesh-ancestor
56209850|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
56209851|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209852|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56209853|NCT01593410|Dexamethasone|dexamethasone|mesh-list
56209854|NCT01593410|Lenalidomide|lenalidomide|mesh-list
56209855|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56209856|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
56209857|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
56209858|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669394|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
56669395|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56669396|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
56669397|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56669398|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56669399|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669400|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56669401|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669402|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56669403|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669404|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56669405|NCT00913419|Analgesics|analgesics|mesh-ancestor
56669406|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
56209860|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56209861|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
56181392|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181394|NCT01411072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181395|NCT01411072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181396|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181397|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
56209863|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209864|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56209865|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209866|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
56209867|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56209868|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56209869|NCT01593410|Growth Substances|growth substances|mesh-ancestor
56209870|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
56209871|NCT01593501|Vitamin D|vitamin d|mesh-list
56209872|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
56209873|NCT01593501|Vitamins|vitamins|mesh-ancestor
56209874|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
56209875|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209876|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56209877|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56209878|NCT01593514|Lactitol|lactitol|mesh-list
56209879|NCT01593514|Vaccines|vaccines|mesh-list
56209880|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
56209881|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209882|NCT01593514|Cathartics|cathartics|mesh-ancestor
56209883|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56209884|NCT01593566|Bupivacaine|bupivacaine|mesh-list
56209885|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
56209886|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
56209887|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209888|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209889|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
56209890|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209891|NCT01593605|Resveratrol|resveratrol|mesh-list
56209892|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
56209893|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209894|NCT01593605|Protective Agents|protective agents|mesh-ancestor
56209895|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209896|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209897|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56209898|NCT01593644|Adenosine|adenosine|mesh-list
56209899|NCT01593644|Dipyridamole|dipyridamole|mesh-list
56209900|NCT01593644|Analgesics|analgesics|mesh-ancestor
56209901|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
56209902|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209903|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137677|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669407|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56669408|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56669409|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669410|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669411|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
56669412|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669413|NCT00711412|Capecitabine|capecitabine|mesh-list
56669414|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
56669415|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56669416|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
56669417|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669418|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669419|NCT03915769|Ozanimod|ozanimod|mesh-list
56669420|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56669421|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669422|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56669423|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
56669424|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669425|NCT01840007|Metformin|metformin|mesh-list
56669426|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56669427|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669428|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
56669429|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56669430|NCT03885037|Infliximab|infliximab|mesh-list
56669431|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
56669432|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56669433|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56669434|NCT03746951|Ropivacaine|ropivacaine|mesh-list
56669435|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
56669436|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
56669437|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669438|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669439|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
56669440|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669441|NCT00577408|Naltrexone|naltrexone|mesh-list
56669442|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56669443|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56669445|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
56669446|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669447|NCT03391193|Vaccines|vaccines|mesh-list
56669448|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
56669449|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669450|NCT00741364|Vitamin D|vitamin d|mesh-list
56669451|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
56669452|NCT00741364|Vitamins|vitamins|mesh-ancestor
56669453|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
56669454|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669455|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56669456|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56669457|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56669458|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56669459|NCT03332303|Estradiol|estradiol|mesh-list
56669460|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56669461|NCT03332303|Estrogens|estrogens|mesh-ancestor
56669462|NCT03332303|Hormones|hormones|mesh-ancestor
56669463|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669464|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669465|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56669466|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
56669467|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56669468|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56669469|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56669470|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
56669471|NCT00614471|Entecavir|entecavir|mesh-list
56669472|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
56669473|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669474|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
56669475|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669476|NCT05742256|Sufentanil|sufentanil|mesh-list
56669477|NCT05742256|Oxycodone|oxycodone|mesh-list
56669478|NCT05742256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56209904|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56209905|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
56209906|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56209907|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
56209908|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
56209909|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56209910|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209911|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56669479|NCT05742256|Narcotics|narcotics|mesh-ancestor
56669480|NCT05742256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669481|NCT05742256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669482|NCT05742256|Analgesics|analgesics|mesh-ancestor
56669483|NCT05742256|Sensory System Agents|sensory system agents|mesh-ancestor
56669484|NCT05742256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669485|NCT05742256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56669486|NCT05742256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56669487|NCT05742256|Anesthetics, General|anesthetics, general|mesh-ancestor
56669488|NCT05742256|Anesthetics|anesthetics|mesh-ancestor
56669489|NCT00828009|Paclitaxel|paclitaxel|mesh-list
56669490|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
56669491|NCT00828009|Bevacizumab|bevacizumab|mesh-list
56669492|NCT00828009|Carboplatin|carboplatin|mesh-list
56669493|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56669494|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669495|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
56669496|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
56669497|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
56669498|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669499|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56669500|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
56209912|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209913|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56209914|NCT01593774|Melatonin|melatonin|mesh-list
56209915|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
56209916|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209917|NCT01593774|Protective Agents|protective agents|mesh-ancestor
56209918|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209919|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209920|NCT01593826|Budesonide|budesonide|mesh-list
56209921|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
56209922|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56209923|NCT01593826|Charcoal|charcoal|mesh-list
56209924|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181398|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181399|NCT01411098|Etoposide|etoposide|mesh-list
56181400|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
56181401|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181402|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56181403|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56181404|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56181405|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181406|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181407|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56181408|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55880101|NCT03390972|Analgesics|analgesics|mesh-ancestor
56209925|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56209926|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
56209927|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209928|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209929|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56209930|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
56209931|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
56209932|NCT01593826|Hormones|hormones|mesh-ancestor
56669501|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669502|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56669503|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56669504|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
56669505|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56669506|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56669507|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56669508|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56669509|NCT00828009|Growth Substances|growth substances|mesh-ancestor
56669510|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
56669511|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56669512|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
56669513|NCT00713596|Coagulants|coagulants|mesh-ancestor
56669514|NCT00729664|Atezolizumab|atezolizumab|mesh-list
56669515|NCT00729664|BMS-936559|bms-936559|mesh-list
56669516|NCT00729664|Antibodies|antibodies|mesh-list
56669517|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
56669518|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56209933|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209934|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56209935|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56209936|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56209937|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
56209938|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56209939|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209940|NCT01593826|Antidotes|antidotes|mesh-ancestor
56209941|NCT01593826|Protective Agents|protective agents|mesh-ancestor
56209942|NCT01593930|Lidocaine|lidocaine|mesh-list
56209943|NCT01593930|Carticaine|carticaine|mesh-list
56209944|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
56209945|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
56209946|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209947|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209948|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
56209949|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209950|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56209951|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56209952|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56209953|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56209954|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209955|NCT01593995|Mitogens|mitogens|mesh-list
56209956|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
56209957|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209958|NCT01594047|Ketamine|ketamine|mesh-list
56209959|NCT01594047|Methadone|methadone|mesh-list
56209960|NCT01594047|Analgesics|analgesics|mesh-ancestor
56209961|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
56209962|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56209963|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209964|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56209965|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56209966|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
56209967|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
56209968|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56209969|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56209970|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56209971|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888864|NCT04346667|Chloroquine|chloroquine|mesh-list
56669519|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
56669520|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669521|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669522|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56669523|NCT04229615|Apatinib|apatinib|mesh-list
56669524|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669525|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56669526|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669527|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669528|NCT00881894|Rotigotine|rotigotine|mesh-list
56669529|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
56669530|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
56669531|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669532|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669533|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669534|NCT02638376|Riboflavin|riboflavin|mesh-list
56669535|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56669536|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56669537|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
56669538|NCT02638376|Vitamins|vitamins|mesh-ancestor
56669539|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
56669540|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669541|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56209972|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209973|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56181409|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56181410|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
56181411|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181412|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56181413|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56181414|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181415|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
56181416|NCT01411124|Promethazine|promethazine|mesh-list
56181418|NCT01411124|Analgesics|analgesics|mesh-ancestor
55880167|NCT03390738|Nivolumab|nivolumab|mesh-list
56209974|NCT01594047|Narcotics|narcotics|mesh-ancestor
56209975|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
56209976|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
56209977|NCT01594060|Insulin|insulin|mesh-list
56209978|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56137753|NCT05198232|TEMPO|tempo|mesh-list
56209982|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209983|NCT01594099|Paclitaxel|paclitaxel|mesh-list
56209984|NCT01594099|Cisplatin|cisplatin|mesh-list
56209985|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56209986|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209987|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
56209988|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
56209989|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
56209990|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209991|NCT01594177|Paclitaxel|paclitaxel|mesh-list
56209992|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
56209993|NCT01594177|Trastuzumab|trastuzumab|mesh-list
56209994|NCT01594177|Epirubicin|epirubicin|mesh-list
56669542|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
56669543|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
56669544|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56669545|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56669546|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669547|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
56669548|NCT00827931|Coagulants|coagulants|mesh-ancestor
56669549|NCT04158674|Simendan|simendan|mesh-list
56669550|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56669551|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
56669552|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56669553|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56669554|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669555|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669556|NCT04158674|Protective Agents|protective agents|mesh-ancestor
56669557|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669558|NCT00526669|Capecitabine|capecitabine|mesh-list
56669559|NCT00526669|Lapatinib|lapatinib|mesh-list
56669560|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56669561|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
56669562|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669563|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669564|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56669565|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669566|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
56669567|NCT03640949|Vasopressins|vasopressins|mesh-list
56669568|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
56669569|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56669570|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
56669571|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
56669572|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669573|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669574|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56669575|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
56669576|NCT03640949|Hormones|hormones|mesh-ancestor
56669578|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56669582|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56669583|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56669584|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
56669585|NCT00827775|Carvedilol|carvedilol|mesh-list
56669586|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56669587|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56669588|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
56669589|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669590|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669591|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669592|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56669593|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
56669594|NCT00827775|Protective Agents|protective agents|mesh-ancestor
56209995|NCT01594177|Afatinib|afatinib|mesh-list
55744633|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
56209996|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56209997|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209998|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
56209999|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
56210000|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
56210001|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210002|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56210003|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
56210004|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210005|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210006|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56210007|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
56210008|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56210009|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56210010|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56210011|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56210012|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56210013|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210014|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744686|NCT05464303|Antibodies|antibodies|mesh-list
55744687|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55744688|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
55744689|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55744690|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
55744691|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744705|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
55744706|NCT03322735|Fludarabine|fludarabine|mesh-list
55744707|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55744708|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
55744709|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744710|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210016|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56210018|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56181419|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
56181420|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181421|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181422|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
56210019|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210020|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
56210021|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210022|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210023|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56210024|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
56210025|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210026|NCT01594242|Bortezomib|bortezomib|mesh-list
56210027|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210028|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
56669595|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56669596|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669597|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56669598|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
56669599|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56669600|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56669601|NCT02544308|Dexamethasone|dexamethasone|mesh-list
56669602|NCT02544308|Lenalidomide|lenalidomide|mesh-list
56669603|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56669604|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
56669605|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
56669606|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669607|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669608|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56669609|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
56669610|NCT02544308|Hormones|hormones|mesh-ancestor
56669611|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669612|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56669613|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669614|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
56669615|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56669616|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56669617|NCT02544308|Growth Substances|growth substances|mesh-ancestor
56669618|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
56669619|NCT00707187|Tadalafil|tadalafil|mesh-list
56669620|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
56669621|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56669622|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56669623|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669624|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669625|NCT00707187|Urological Agents|urological agents|mesh-ancestor
56210029|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56210030|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210031|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56210032|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56210033|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210034|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210035|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210036|NCT01594268|Everolimus|everolimus|mesh-list
56210037|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210038|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56210039|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
55888865|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
56669626|NCT03998761|Progesterone|progesterone|mesh-list
56669627|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
56669628|NCT03998761|Progestins|progestins|mesh-ancestor
56669629|NCT03998761|Hormones|hormones|mesh-ancestor
56669630|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669631|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669632|NCT00658580|Etoposide|etoposide|mesh-list
56669633|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
56669634|NCT00658580|Epirubicin|epirubicin|mesh-list
56669635|NCT00658580|Ifosfamide|ifosfamide|mesh-list
56669636|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669637|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56669638|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56669639|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56669640|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669641|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669642|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56669643|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56669644|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
56669645|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56669646|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669647|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56669648|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669649|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669650|NCT03435107|Durvalumab|durvalumab|mesh-list
56669651|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56669652|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669653|NCT03612791|Atezolizumab|atezolizumab|mesh-list
56669654|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669655|NCT00827541|Tigecycline|tigecycline|mesh-list
56669656|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56669669|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
56669670|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
56669671|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56669672|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56669673|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669674|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56669675|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56669676|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56669677|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210040|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210041|NCT01594346|Vitamin E|vitamin e|mesh-list
56210042|NCT01594346|Tocopherols|tocopherols|mesh-list
56210043|NCT01594346|Tocotrienols|tocotrienols|mesh-list
56210044|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
56210045|NCT01594346|Vitamins|vitamins|mesh-ancestor
56210046|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
56210047|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210048|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
56210049|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137841|NCT02783430|Ketamine|ketamine|mesh-list
56210050|NCT01594346|Protective Agents|protective agents|mesh-ancestor
56210051|NCT01594489|Aminophylline|aminophylline|mesh-list
56210052|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56210053|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
56210054|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210055|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210056|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56210057|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
56210058|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56210059|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56210060|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210061|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210062|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56210063|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56210064|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
56210065|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210066|NCT01594489|Protective Agents|protective agents|mesh-ancestor
56210067|NCT01594502|Dutasteride|dutasteride|mesh-list
56210068|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56210069|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56210070|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210071|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210072|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
56210073|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56210074|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210076|NCT01594619|Naloxegol|naloxegol|mesh-list
56210077|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56210078|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56210079|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56210080|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210081|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56210082|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210083|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
56210084|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56181423|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56181424|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56181425|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56181426|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56181427|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56181428|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56181429|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181430|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181431|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
56181432|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56669678|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669679|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56669680|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56669681|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56669682|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
56669683|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669684|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669685|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56669686|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56669687|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
56669688|NCT00707421|Fluorometholone|fluorometholone|mesh-list
56669689|NCT00707421|Ketorolac|ketorolac|mesh-list
56669690|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56669691|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56669692|NCT00707421|Analgesics|analgesics|mesh-ancestor
56210085|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
56210086|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210087|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
56210088|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56210089|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56210090|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210091|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
56210092|NCT01594671|Coagulants|coagulants|mesh-ancestor
56210093|NCT01594697|Metformin|metformin|mesh-list
56210094|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56210095|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210096|NCT01594775|Oxytocin|oxytocin|mesh-list
56210097|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
56210098|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210099|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210100|NCT01594866|Dexetimide|dexetimide|mesh-list
56210101|NCT01594866|Citalopram|citalopram|mesh-list
56210102|NCT01594866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56210103|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56210106|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210107|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
56210108|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210109|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56210110|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
56210111|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56210112|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56210113|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56210114|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
56210115|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
56210116|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210117|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56210118|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56210119|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
56210120|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
56210121|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56210122|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
56210123|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210124|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210125|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56210126|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56210127|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56210128|NCT01594905|Tenofovir|tenofovir|mesh-list
56210129|NCT01594905|Entecavir|entecavir|mesh-list
56210130|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
56210131|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210132|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56669693|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
56669694|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669695|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669696|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56669697|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56669698|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56669699|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669700|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669701|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
56669702|NCT00707421|Hormones|hormones|mesh-ancestor
56669703|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669704|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56210133|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56210134|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210135|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210136|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56210137|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56210138|NCT01594918|Prednisone|prednisone|mesh-list
56181433|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56181434|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
56181435|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
56181436|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
56181437|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
56181438|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181439|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56181440|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
56181441|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
56181442|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56181443|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
56181444|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
56181445|NCT01411176|Menthol|menthol|mesh-list
56181446|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
56181447|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
56181448|NCT01411189|Menthol|menthol|mesh-list
56181449|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
56181450|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
56181451|NCT01411202|Doxycycline|doxycycline|mesh-list
56181452|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56181453|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181454|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
56181455|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56210139|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
56210140|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56210141|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
56210142|NCT01594918|Hormones|hormones|mesh-ancestor
56210143|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56210144|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210145|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56210146|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210147|NCT01594918|Analgesics|analgesics|mesh-ancestor
56210148|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
56210149|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210150|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56210151|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56210152|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210153|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210154|NCT01595009|Everolimus|everolimus|mesh-list
55744863|NCT02485015|Apatinib|apatinib|mesh-list
56210155|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210156|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56210157|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
56210158|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210159|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
56210161|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56669705|NCT03570437|Paclitaxel|paclitaxel|mesh-list
56669706|NCT03570437|Olaparib|olaparib|mesh-list
56669707|NCT03570437|Cediranib|cediranib|mesh-list
56669708|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56669709|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669710|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
56669711|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
56669712|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
56669713|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669714|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56669715|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669716|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56669717|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56669718|NCT00826449|Dasatinib|dasatinib|mesh-list
56669719|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669720|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56669721|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210162|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210163|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56210164|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56210165|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56210166|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56210167|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
56210168|NCT01595152|Fesoterodine|fesoterodine|mesh-list
56210169|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56210170|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56210171|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
56181456|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56181457|NCT01411254|Betamethasone|betamethasone|mesh-list
56181458|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
55880417|NCT02208466|Fluoxetine|fluoxetine|mesh-list
56210172|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210173|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210174|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210175|NCT01595152|Urological Agents|urological agents|mesh-ancestor
56210176|NCT01595334|Cetrorelix|cetrorelix|mesh-list
56210177|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56210178|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
56210179|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210180|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210181|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
56210182|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56210183|NCT01595399|Atropine|atropine|mesh-list
56210184|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56210185|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56210186|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56210187|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
56210188|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210189|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210190|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56210191|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
56210192|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
56210193|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
56210194|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55744922|NCT02486341|Insulin|insulin|mesh-list
56210195|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56210196|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
56210197|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888866|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56669722|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669723|NCT03632213|Losartan|losartan|mesh-list
56669724|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56669725|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56669726|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56669727|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56669728|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669729|NCT00825825|Citalopram|citalopram|mesh-list
56669730|NCT00825825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56669731|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56669732|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669733|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669734|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669735|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
56669736|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669737|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56669738|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
56669739|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56669740|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56669741|NCT03802487|Charcoal|charcoal|mesh-list
56669742|NCT03802487|Antidotes|antidotes|mesh-ancestor
56669743|NCT03802487|Protective Agents|protective agents|mesh-ancestor
56669744|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669745|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56669746|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669747|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56669763|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56669764|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
56669765|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56669766|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56669767|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669768|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669769|NCT00654914|Urological Agents|urological agents|mesh-ancestor
56669770|NCT00865566|Vaccines|vaccines|mesh-list
56669771|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
56669772|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669773|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
56669774|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669775|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669776|NCT00710554|Nabiximols|nabiximols|mesh-list
56669777|NCT00710554|Analgesics|analgesics|mesh-ancestor
56669778|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
56669779|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669780|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669781|NCT00659048|Ciclesonide|ciclesonide|mesh-list
56669782|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
56669783|NCT00659048|Hormones|hormones|mesh-ancestor
56669784|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669785|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669786|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56669787|NCT02623920|Rituximab|rituximab|mesh-list
56669788|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56669789|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56669790|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56669791|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669792|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
56669793|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669794|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56669795|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56230983|NCT01708876|Analgesics|analgesics|mesh-ancestor
56210198|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210199|NCT01595425|Esomeprazole|esomeprazole|mesh-list
56210200|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56210201|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56210202|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56210203|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669796|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
56669797|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669798|NCT00525499|Androgens|androgens|mesh-list
56669799|NCT00525499|Hormones|hormones|mesh-ancestor
56669800|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669801|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315974|NCT01464723|Ranibizumab|ranibizumab|mesh-list
56669802|NCT04576546|Inositol|inositol|mesh-list
56669803|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
56669804|NCT04576546|Vitamins|vitamins|mesh-ancestor
56669805|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
56669806|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669807|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
56669808|NCT02617680|Desflurane|desflurane|mesh-list
56669809|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56669810|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
56669811|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669812|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669813|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56669814|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
56669815|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56669816|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
56669817|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669818|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669819|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56669820|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
56669821|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
56669822|NCT02617680|Protective Agents|protective agents|mesh-ancestor
56669823|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56669824|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
56669825|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
56669826|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669827|NCT02568280|Insulin|insulin|mesh-list
56669828|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56669829|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
56669830|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
56669832|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56669834|NCT00525265|Tolvaptan|tolvaptan|mesh-list
56669835|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56669836|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669837|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
56231051|NCT01709682|Amiodarone|amiodarone|mesh-list
56210204|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210205|NCT01595594|Doxycycline|doxycycline|mesh-list
56210206|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56210207|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210208|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
56210209|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56210210|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56210211|NCT01595633|Tenofovir|tenofovir|mesh-list
56210212|NCT01595633|Adefovir|adefovir|mesh-list
56210213|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
56210214|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210215|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56210216|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56210218|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210219|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56210220|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56210221|NCT01595685|Entecavir|entecavir|mesh-list
56210222|NCT01595685|Telbivudine|telbivudine|mesh-list
56210223|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
56210224|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210225|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56210226|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210229|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56210230|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
56210231|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210232|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210233|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56210234|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56210235|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56210236|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56210237|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
56210238|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56210239|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56181459|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56181460|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
56181461|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56181462|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181463|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
56181464|NCT01411254|Hormones|hormones|mesh-ancestor
56181465|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181466|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181467|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56181468|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
56181469|NCT01411280|Methylphenidate|methylphenidate|mesh-list
56181470|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55880483|NCT01468558|Ketoconazole|ketoconazole|mesh-list
56210240|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210241|NCT01595737|Simendan|simendan|mesh-list
56210242|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56210243|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
56210244|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55744986|NCT03317197|Vasopressins|vasopressins|mesh-list
56210245|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56210246|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210247|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210248|NCT01595737|Protective Agents|protective agents|mesh-ancestor
56210249|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210250|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
56210251|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56210252|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56210253|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210254|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
56210255|NCT01595763|Coagulants|coagulants|mesh-ancestor
56210256|NCT01595789|Liraglutide|liraglutide|mesh-list
56669838|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669839|NCT04158830|Aspirin|aspirin|mesh-list
56669840|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56669841|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56669842|NCT04158830|Analgesics|analgesics|mesh-ancestor
56669843|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
56669844|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669845|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669846|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56669847|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56669848|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56669849|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56669850|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669851|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56669852|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56669853|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669854|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
56669855|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
56669856|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
56669857|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56669858|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56669859|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669860|NCT02617758|Fentanyl|fentanyl|mesh-list
56669861|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56669862|NCT02617758|Narcotics|narcotics|mesh-ancestor
56669863|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56669864|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669865|NCT02617758|Analgesics|analgesics|mesh-ancestor
56669866|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
56669867|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669868|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56669869|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56669870|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
56669871|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
56669878|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669879|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56669880|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56669881|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56669882|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669883|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669884|NCT00865098|Cetuximab|cetuximab|mesh-list
56669885|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56669886|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669887|NCT00880100|Pancrelipase|pancrelipase|mesh-list
56669888|NCT00880100|Pancreatin|pancreatin|mesh-list
56669889|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56669890|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
56669891|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
56669892|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56669893|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56669894|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669895|NCT00659594|Ciclesonide|ciclesonide|mesh-list
56231095|NCT01709825|Renal Agents|renal agents|mesh-ancestor
56210257|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56210258|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210259|NCT01595789|Incretins|incretins|mesh-ancestor
56210260|NCT01595789|Hormones|hormones|mesh-ancestor
56210261|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56210262|NCT01595815|Calcium|calcium|mesh-list
56210263|NCT01595815|Ionophores|ionophores|mesh-list
56210264|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
56210265|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56210266|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210267|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56210268|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210269|NCT01595828|Pitavastatin|pitavastatin|mesh-list
56210270|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56210271|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56210272|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56210273|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
56210274|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210275|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210276|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56210277|NCT01595867|Naltrexone|naltrexone|mesh-list
56210279|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56210280|NCT01595867|Narcotics|narcotics|mesh-ancestor
56210281|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210282|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210283|NCT01595867|Analgesics|analgesics|mesh-ancestor
56181474|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56181475|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181476|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
56181477|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181478|NCT01411410|Paclitaxel|paclitaxel|mesh-list
56181479|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56181480|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210287|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56210288|NCT01595880|Metformin|metformin|mesh-list
56669896|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
56669897|NCT00659594|Hormones|hormones|mesh-ancestor
56669898|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669899|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669900|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56669901|NCT05541016|Cisplatin|cisplatin|mesh-list
56210289|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56210290|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210291|NCT01595893|Vitamin D|vitamin d|mesh-list
56210292|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
56210293|NCT01595893|Vitamins|vitamins|mesh-ancestor
56210294|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
56210295|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745032|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
56210296|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56210297|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56210298|NCT01595958|Cyclosporine|cyclosporine|mesh-list
56210299|NCT01595958|Cyclosporins|cyclosporins|mesh-list
56210300|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210301|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210302|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56210303|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
56210304|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210305|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
56210306|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210307|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
56210308|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210309|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56210310|NCT01595984|Cyclosporine|cyclosporine|mesh-list
56210311|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
56210312|NCT01595984|Everolimus|everolimus|mesh-list
56210313|NCT01595984|Cyclosporins|cyclosporins|mesh-list
56210314|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210315|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210316|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56210317|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
56210318|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210319|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
56210320|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210321|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
56210322|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210323|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56210324|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210325|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56210326|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56210327|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
56210328|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56210330|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
56210331|NCT01596010|Estradiol|estradiol|mesh-list
56210332|NCT01596010|Estrogens|estrogens|mesh-ancestor
56210333|NCT01596010|Hormones|hormones|mesh-ancestor
56210334|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56210335|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210336|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56210337|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
56210338|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210339|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56210340|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56210341|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56181481|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
56210347|NCT01596114|Protective Agents|protective agents|mesh-ancestor
56210348|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210349|NCT01596140|Sirolimus|sirolimus|mesh-list
56210350|NCT01596140|Everolimus|everolimus|mesh-list
56210351|NCT01596140|Vemurafenib|vemurafenib|mesh-list
56210352|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210353|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138148|NCT04405908|Antacids|antacids|mesh-ancestor
56210354|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
56210355|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210356|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669902|NCT05541016|Docetaxel|docetaxel|mesh-list
56669903|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669904|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
56669905|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
56669906|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
56669907|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669908|NCT04158050|Omalizumab|omalizumab|mesh-list
56669909|NCT04158050|Antibodies|antibodies|mesh-list
56669910|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
56669911|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669912|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56210357|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56210358|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210359|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56210360|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
56210361|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56210362|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210363|NCT01596166|Ketorolac|ketorolac|mesh-list
56210364|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56210365|NCT01596166|Metoclopramide|metoclopramide|mesh-list
56210366|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56210367|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56210368|NCT01596166|Analgesics|analgesics|mesh-ancestor
56210369|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
56210370|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210371|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210372|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56210373|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210374|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56210375|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210376|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210377|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
56210378|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
56210379|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56210380|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56210381|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56210382|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
56210383|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210384|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56210385|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56210386|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210387|NCT01596296|Dinoprostone|dinoprostone|mesh-list
56210388|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
56210389|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210390|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210391|NCT01596387|Propofol|propofol|mesh-list
56210392|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56210393|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210394|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210395|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56210396|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
56210397|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
56210398|NCT01596400|Granisetron|granisetron|mesh-list
56210399|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
56210400|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
56210401|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210402|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210403|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56210404|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56210405|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
56210406|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210407|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210408|NCT01596413|Granisetron|granisetron|mesh-list
56210409|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
56181486|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181487|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56669913|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56669914|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56669915|NCT00659750|Ciclesonide|ciclesonide|mesh-list
56669916|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
56669917|NCT00659750|Hormones|hormones|mesh-ancestor
56669918|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56669919|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669920|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56669921|NCT00697476|Topotecan|topotecan|mesh-list
56669922|NCT00697476|Vorinostat|vorinostat|mesh-list
56669923|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56669924|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56669925|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669926|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669927|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669928|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56669929|NCT00660062|Dexetimide|dexetimide|mesh-list
56669930|NCT00660062|Citalopram|citalopram|mesh-list
56669931|NCT00660062|Nortriptyline|nortriptyline|mesh-list
56669932|NCT00660062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56669933|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56669934|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669935|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669936|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56669937|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
56669938|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669939|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56669940|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
56669941|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56669942|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56669943|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56669944|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
56181488|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181489|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181490|NCT01411436|Sorafenib|sorafenib|mesh-list
56181491|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181492|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56181493|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181494|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181495|NCT01411514|Prednisone|prednisone|mesh-list
56210413|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56669945|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
56669946|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56669947|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56669948|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56669949|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
56669950|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56669951|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56316124|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56669952|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
56669953|NCT04063540|Amiloride|amiloride|mesh-list
56669954|NCT04063540|Diuretics|diuretics|mesh-ancestor
56669955|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
56669956|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669957|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56669958|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56231159|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
56210414|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56210415|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
56210416|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210417|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210418|NCT01596426|Granisetron|granisetron|mesh-list
56210419|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
56210420|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
56210421|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210422|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210423|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56210424|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56210425|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
56210426|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210427|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210429|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56210430|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
56210432|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210433|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
56210434|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210435|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
56210436|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210437|NCT01596556|Nicotine|nicotine|mesh-list
56210438|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56210439|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
56210440|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210441|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210442|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56210443|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56210444|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
56210445|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210446|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210447|NCT01596634|Lactoferrin|lactoferrin|mesh-list
56210448|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210449|NCT01596647|Diclofenac|diclofenac|mesh-list
56210450|NCT01596647|Midazolam|midazolam|mesh-list
56210451|NCT01596647|Caffeine|caffeine|mesh-list
56210452|NCT01596647|Omeprazole|omeprazole|mesh-list
56210453|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56210454|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55745226|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56210455|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210456|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210457|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56210458|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56669959|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56669960|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669961|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56669962|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56669963|NCT04161560|Cetuximab|cetuximab|mesh-list
56669964|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56669965|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669966|NCT00518011|Gemcitabine|gemcitabine|mesh-list
56669967|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56669968|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56669969|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
56669970|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56669971|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56669972|NCT00518011|Antiviral Agents|antiviral agents|mesh-ancestor
56669973|NCT00518011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669974|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669975|NCT00518011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56669976|NCT00518011|Immunologic Factors|immunologic factors|mesh-ancestor
56669977|NCT00518011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669978|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56669979|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
56669980|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
56669981|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56669982|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56669983|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56669984|NCT02633930|Amoxicillin|amoxicillin|mesh-list
56669985|NCT02633930|Clarithromycin|clarithromycin|mesh-list
56669986|NCT02633930|Lansoprazole|lansoprazole|mesh-list
56669987|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
56669988|NCT02633930|Bismuth|bismuth|mesh-list
56669989|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56669990|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56669992|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56669998|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56669999|NCT02633930|Antacids|antacids|mesh-ancestor
56670000|NCT00698334|Rifampin|rifampin|mesh-list
56670001|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
56670002|NCT00698334|Ethambutol|ethambutol|mesh-list
56670003|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56670004|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
56670005|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56670006|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670007|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
56670008|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56670009|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231215|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210459|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56210460|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56210461|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
56210462|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
56210463|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
56210464|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
56210465|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181496|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181497|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
56181498|NCT01411514|Hormones|hormones|mesh-ancestor
55799664|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181499|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181500|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181501|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56181502|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181503|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56181504|NCT01411670|Protein C|protein c|mesh-list
56181505|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
56181506|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56210466|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210467|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56210468|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56210469|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210470|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56210471|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56210472|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
56210473|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56210474|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56210475|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56210476|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56210477|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56210478|NCT01596647|Analgesics|analgesics|mesh-ancestor
56210479|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
56210480|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210481|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56210482|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210483|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56210484|NCT01596660|Bupivacaine|bupivacaine|mesh-list
56210485|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
56210486|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
56210487|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210488|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210489|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
56210490|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210491|NCT01596673|Hydrocodone|hydrocodone|mesh-list
56210492|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56210493|NCT01596673|Narcotics|narcotics|mesh-ancestor
56210494|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210495|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210496|NCT01596673|Analgesics|analgesics|mesh-ancestor
56210497|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
56670010|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670011|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56670012|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56670013|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56670014|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56670015|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56670016|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56670017|NCT04161482|Furosemide|furosemide|mesh-list
56670018|NCT04161482|Diuretics|diuretics|mesh-ancestor
56670019|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
56670020|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670021|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56210498|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210499|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
56210500|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
56210501|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
56210502|NCT01596686|Cathartics|cathartics|mesh-ancestor
56210503|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56210504|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
56210505|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56210506|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56210507|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210508|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
56210509|NCT01596738|Coagulants|coagulants|mesh-ancestor
56210510|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
56210511|NCT01596764|Naloxone|naloxone|mesh-list
56210512|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
56210513|NCT01596764|Loperamide|loperamide|mesh-list
56210514|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
56210515|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55745318|NCT05243355|Endostatins|endostatins|mesh-list
56210516|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210518|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210519|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181507|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56181508|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181509|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181510|NCT01411735|Enalapril|enalapril|mesh-list
56181511|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56181512|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
56181513|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210520|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210521|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56210522|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56210523|NCT01596764|Analgesics|analgesics|mesh-ancestor
56210524|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56210525|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210526|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
56210528|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
56210530|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
56210531|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56210532|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210533|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56210534|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56210535|NCT01596777|Analgesics|analgesics|mesh-ancestor
56210536|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
56210537|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210538|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210539|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56210540|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210541|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56210542|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56670022|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56670023|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670024|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
56670025|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56670026|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670027|NCT02633696|Silybin|silybin|mesh-list
56670028|NCT02633696|Silymarin|silymarin|mesh-list
56670029|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
56670030|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670031|NCT02633696|Protective Agents|protective agents|mesh-ancestor
56670032|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670033|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56670034|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670035|NCT02633852|Aflibercept|aflibercept|mesh-list
56670036|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56670037|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56670038|NCT02633852|Growth Substances|growth substances|mesh-ancestor
56670039|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670040|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
56670041|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670042|NCT02633774|Propafenone|propafenone|mesh-list
56670043|NCT02633774|Apixaban|apixaban|mesh-list
56670044|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56670045|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
56670046|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56670047|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
56670048|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670049|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670068|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
56670069|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670070|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
56670071|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56670072|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56670073|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670074|NCT00517933|Urological Agents|urological agents|mesh-ancestor
56670075|NCT02633384|Sorbitol|sorbitol|mesh-list
56670076|NCT02633384|SMOFlipid|smoflipid|mesh-list
56670077|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56670078|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56670079|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56670080|NCT02633384|Cathartics|cathartics|mesh-ancestor
56670081|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56670082|NCT02633462|Inositol|inositol|mesh-list
56670083|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
56670084|NCT02633462|Vitamins|vitamins|mesh-ancestor
56670085|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
56670086|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670087|NCT02638064|Surgiflo|surgiflo|mesh-list
56670088|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
56670089|NCT02638064|Coagulants|coagulants|mesh-ancestor
56670090|NCT04119336|Dexamethasone|dexamethasone|mesh-list
56210543|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
56210544|NCT01596803|Vitamin E|vitamin e|mesh-list
56210545|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
56210546|NCT01596803|Tocopherols|tocopherols|mesh-list
56210547|NCT01596803|Antioxidants|antioxidants|mesh-list
56210548|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210549|NCT01596803|Protective Agents|protective agents|mesh-ancestor
56210550|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210551|NCT01596803|Vitamins|vitamins|mesh-ancestor
56210552|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
56210553|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
56210554|NCT01596855|Hematinics|hematinics|mesh-ancestor
56210555|NCT01596868|Gemcitabine|gemcitabine|mesh-list
56210556|NCT01596868|Cisplatin|cisplatin|mesh-list
56210557|NCT01596868|Docetaxel|docetaxel|mesh-list
56210558|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210559|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56210560|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
56210561|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210562|NCT01596868|Antiviral Agents|antiviral agents|mesh-ancestor
56210563|NCT01596868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210564|NCT01596868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210565|NCT01596868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56210566|NCT01596868|Immunologic Factors|immunologic factors|mesh-ancestor
56210567|NCT01596868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210568|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
56210569|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
56210570|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
56210571|NCT01596894|Azithromycin|azithromycin|mesh-list
56210572|NCT01596894|Metronidazole|metronidazole|mesh-list
56210573|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56210574|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210575|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56210576|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56210577|NCT01596907|Ephedrine|ephedrine|mesh-list
56210578|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
56670091|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
56670092|NCT04119336|Nivolumab|nivolumab|mesh-list
56670093|NCT04119336|Ixazomib|ixazomib|mesh-list
56670094|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670095|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
56670096|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670097|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670098|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56670099|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
56670100|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670101|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670102|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56670103|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56670104|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
56670105|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
56670106|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670107|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56670108|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
56670109|NCT04119336|Hormones|hormones|mesh-ancestor
56670110|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670111|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56670112|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670113|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56670114|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
56670115|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670116|NCT00114101|Lenalidomide|lenalidomide|mesh-list
56670117|NCT00114101|Melphalan|melphalan|mesh-list
56670118|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
56670119|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56670120|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
56670121|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670122|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56670123|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56670124|NCT00114101|Growth Substances|growth substances|mesh-ancestor
56670125|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
56670126|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670127|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56670129|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670130|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56670131|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670132|NCT00655148|Vaccines|vaccines|mesh-list
56670133|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
56670134|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670135|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56670136|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56670137|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
56670138|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670139|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670140|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56670141|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
56670142|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
56670143|NCT00857766|Hormones|hormones|mesh-ancestor
56670144|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670145|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
56670146|NCT04161404|Metformin|metformin|mesh-list
56670147|NCT04161404|Andrographolide|andrographolide|mesh-list
56670148|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56670149|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670150|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56670151|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56670152|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56670153|NCT04161404|Analgesics|analgesics|mesh-ancestor
56670154|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
56210579|NCT01596907|Caffeine|caffeine|mesh-list
56210580|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56210581|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210582|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56210583|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181514|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181515|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56210584|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210585|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56210586|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56210587|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
56210588|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210589|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
56210590|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
56210591|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210592|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56210593|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
56210594|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56210595|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56210596|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
56210597|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
56210598|NCT01596998|Epinephrine|epinephrine|mesh-list
56670155|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670156|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670157|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56670158|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56670159|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670160|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
56670161|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56670162|NCT00517699|Cytarabine|cytarabine|mesh-list
56670163|NCT00517699|Rituximab|rituximab|mesh-list
56670164|NCT00517699|Methotrexate|methotrexate|mesh-list
56670165|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670166|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210599|NCT01596998|Racepinephrine|racepinephrine|mesh-list
56210600|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
56210601|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
56210602|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56210605|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210606|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210607|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210608|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56210609|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56210610|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
56210611|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210612|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56210613|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
56210615|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
56210616|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56210617|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
56210618|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
56210619|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210620|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
56210621|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56210622|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
56210623|NCT01597011|Coagulants|coagulants|mesh-ancestor
56210624|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
56210625|NCT01597167|Analgesics|analgesics|mesh-ancestor
56210626|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
56210627|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210628|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210629|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
56210630|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210631|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56210632|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
56210633|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56210634|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56210635|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210636|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56210637|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
56210638|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210640|NCT01597206|Trace Elements|trace elements|mesh-ancestor
56210641|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
56210642|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210643|NCT01597232|Chrysarobin|chrysarobin|mesh-list
56210644|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56210645|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56210646|NCT01597232|Analgesics|analgesics|mesh-ancestor
56210647|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
56210648|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210649|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210650|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56210651|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210652|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
55745550|NCT02475499|Biguanides|biguanides|mesh-list
56181517|NCT01411930|Aripiprazole|aripiprazole|mesh-list
56181518|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
56670167|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
56670168|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670169|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670170|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56670171|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
56670172|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56670173|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56670174|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
56670175|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670176|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
56670177|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670178|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56670179|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670180|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56670181|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
56670182|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670183|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
56670184|NCT03096275|Hormones|hormones|mesh-ancestor
56670185|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670186|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181519|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
56181520|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181521|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181522|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181523|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56181524|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56181525|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56181526|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56181527|NCT01411930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56181528|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56181529|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56181530|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181531|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181532|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
55880947|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
56210653|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56210654|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56210655|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210656|NCT01597310|Pramipexole|pramipexole|mesh-list
56210657|NCT01597310|Warfarin|warfarin|mesh-list
55799721|NCT04371445|Prednisolone|prednisolone|mesh-list
56210666|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
56210668|NCT01597336|Plasminogen|plasminogen|mesh-list
56210669|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56210670|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56210671|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56210672|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210673|NCT01597427|Clonidine|clonidine|mesh-list
56210674|NCT01597427|Analgesics|analgesics|mesh-ancestor
56210675|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
56210676|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210677|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210678|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56670187|NCT04161014|Nintedanib|nintedanib|mesh-list
56670188|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670189|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56670190|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670191|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670192|NCT04491643|Megestrol|megestrol|mesh-list
56670193|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
56670194|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56670195|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56670196|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56670197|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
56670198|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670199|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56670200|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56670201|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670202|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56670203|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56670204|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56670205|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
56670206|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56670207|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670208|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56670209|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56670210|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56670211|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670212|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
56670213|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56670214|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
56670215|NCT00699504|Cangrelor|cangrelor|mesh-list
56210679|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
56210680|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
56210681|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56210682|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56210683|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56210684|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
56210685|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210686|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210687|NCT01597518|Riluzole|riluzole|mesh-list
56210688|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
56210689|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55745669|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
56210690|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56210691|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181533|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
56670216|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56670217|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670218|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56670219|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56670220|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670221|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670222|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670223|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670224|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56670225|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56231440|NCT01711515|Cisplatin|cisplatin|mesh-list
56181534|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
56181535|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
56109274|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
55881001|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
56210692|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210693|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210694|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56210695|NCT01597518|Protective Agents|protective agents|mesh-ancestor
56210697|NCT01597531|Orlistat|orlistat|mesh-list
56210698|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56210699|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210700|NCT01597531|Incretins|incretins|mesh-ancestor
56210701|NCT01597531|Hormones|hormones|mesh-ancestor
56210702|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56210704|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210705|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56210706|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56210707|NCT01597609|Sibutramine|sibutramine|mesh-list
56210708|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
56210709|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56210710|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
56210711|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56210712|NCT01597648|Maraviroc|maraviroc|mesh-list
56210713|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56210714|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56210715|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56210716|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210717|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56210718|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56210719|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
56210720|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799735|NCT04371445|Hormones|hormones|mesh-ancestor
56210721|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56210722|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56210723|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56210724|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210725|NCT01597661|Bupropion|bupropion|mesh-list
56210726|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
56210727|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55745780|NCT02474563|Bortezomib|bortezomib|mesh-list
56210728|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56210729|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56210730|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56210731|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56210732|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210733|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
56210734|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210735|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210736|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56210737|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56210738|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670226|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56670227|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56670228|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
56670229|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670230|NCT02997605|Prednisone|prednisone|mesh-list
56670231|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
56670232|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
56670233|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56670234|NCT02997605|Hormones|hormones|mesh-ancestor
56670235|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670236|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670237|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56670238|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670239|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
56670240|NCT03767543|Lixisenatide|lixisenatide|mesh-list
56670241|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56670242|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670243|NCT00857454|Testosterone|testosterone|mesh-list
56670244|NCT00857454|Androgens|androgens|mesh-ancestor
56670245|NCT00857454|Hormones|hormones|mesh-ancestor
56670246|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670247|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670248|NCT00660140|Gemcitabine|gemcitabine|mesh-list
56670249|NCT00660140|Carboplatin|carboplatin|mesh-list
56670250|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670251|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56670252|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
56670253|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670254|NCT00660140|Antiviral Agents|antiviral agents|mesh-ancestor
56670255|NCT00660140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670256|NCT00660140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670257|NCT00660140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670258|NCT00660140|Immunologic Factors|immunologic factors|mesh-ancestor
56670259|NCT00660140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670260|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
56670261|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56670262|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670265|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
56670266|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56670267|NCT00525031|Temozolomide|temozolomide|mesh-list
56670268|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670269|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
56670270|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670271|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56670272|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
56670273|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210739|NCT01597700|Ezetimibe|ezetimibe|mesh-list
56210740|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56210741|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56210742|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
56210743|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210744|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56210745|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
56210746|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56210747|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210748|NCT01597726|Misoprostol|misoprostol|mesh-list
56210749|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56210750|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
56210751|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210752|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210753|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56210754|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56210755|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
56210756|NCT01597765|Vitamins|vitamins|mesh-list
56210757|NCT01597765|Vitamin E|vitamin e|mesh-list
56181536|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56181537|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56181538|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56181539|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56181540|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56181541|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56181542|NCT01411969|Phenylephrine|phenylephrine|mesh-list
56181543|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
56181544|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56181545|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56181546|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
56210758|NCT01597765|Tocopherols|tocopherols|mesh-list
56210759|NCT01597765|Tocotrienols|tocotrienols|mesh-list
56210760|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
56210761|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
56210762|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56210763|NCT01597765|Deferiprone|deferiprone|mesh-list
56210764|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
56210765|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210766|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
56210767|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210768|NCT01597765|Expectorants|expectorants|mesh-ancestor
56210769|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
56210770|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56210771|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
56210772|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210773|NCT01597765|Protective Agents|protective agents|mesh-ancestor
56210774|NCT01597765|Antidotes|antidotes|mesh-ancestor
56210775|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56210776|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
56210777|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
56210778|NCT01597817|Chitosan|chitosan|mesh-list
56210779|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56210780|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56210781|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
56210782|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210783|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56210784|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
56210785|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
56210786|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
56210787|NCT01597817|Coagulants|coagulants|mesh-ancestor
56210788|NCT01597895|Maraviroc|maraviroc|mesh-list
56670274|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
56670275|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670276|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
56670277|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
56670278|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
56670279|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56670280|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670281|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56670282|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56670283|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
56670284|NCT00857220|Eszopiclone|eszopiclone|mesh-list
56670285|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56670286|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56670287|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670288|NCT00524173|Tenofovir|tenofovir|mesh-list
56670289|NCT00524173|Emtricitabine|emtricitabine|mesh-list
56670290|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
56670291|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670292|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56670293|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56670294|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670295|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670296|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56670297|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56670298|NCT02704481|Misoprostol|misoprostol|mesh-list
56670299|NCT02704481|Mifepristone|mifepristone|mesh-list
56670300|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56670301|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
56670302|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56670303|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670304|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56670305|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56670316|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
56670317|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56670318|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56670319|NCT02614482|Fesoterodine|fesoterodine|mesh-list
56670320|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56670321|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56670322|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
56670323|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670324|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547655|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56670325|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670326|NCT02614482|Urological Agents|urological agents|mesh-ancestor
56210789|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56210790|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56210791|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210792|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56210793|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56210794|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
56210795|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210796|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56210797|NCT01597934|Tenofovir|tenofovir|mesh-list
56210798|NCT01597934|Entecavir|entecavir|mesh-list
56210799|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56210800|NCT01597934|Adefovir|adefovir|mesh-list
56210801|NCT01597934|Lamivudine|lamivudine|mesh-list
56210802|NCT01597934|Telbivudine|telbivudine|mesh-list
56210803|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
56210804|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210805|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56210806|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56210807|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210808|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210809|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56210810|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56210811|NCT01597986|Isavuconazole|isavuconazole|mesh-list
56210812|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56138585|NCT05765682|Bupivacaine|bupivacaine|mesh-list
56210813|NCT01597986|Norethindrone|norethindrone|mesh-list
56181548|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181549|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181550|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
56181551|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
56210814|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
56210815|NCT01597986|Norinyl|norinyl|mesh-list
56210816|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
56210817|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
56210818|NCT01597986|Estradiol|estradiol|mesh-list
56210819|NCT01597986|Estrogens|estrogens|mesh-ancestor
56210820|NCT01597986|Hormones|hormones|mesh-ancestor
56210821|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56210822|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210823|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56210824|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210825|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56210826|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56210827|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56210828|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
56210829|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210830|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56210831|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
56210832|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56210833|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56210834|NCT01598012|Analgesics|analgesics|mesh-ancestor
56670328|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
56670329|NCT04476277|Vitamins|vitamins|mesh-ancestor
56670330|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
56670331|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670332|NCT04713709|Naloxone|naloxone|mesh-list
56670333|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56670334|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670335|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
56670336|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670337|NCT00879710|Simvastatin|simvastatin|mesh-list
56670338|NCT00879710|Ezetimibe|ezetimibe|mesh-list
56670339|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56670340|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56670341|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
56670342|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670343|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56670344|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56670345|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670346|NCT02703857|Cefoxitin|cefoxitin|mesh-list
56670347|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56670348|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670349|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
56670350|NCT02623062|Antacids|antacids|mesh-ancestor
56670351|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670352|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56670353|NCT00597506|Bevacizumab|bevacizumab|mesh-list
56670354|NCT00597506|Everolimus|everolimus|mesh-list
56670355|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670356|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670357|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56670358|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56670359|NCT00597506|Growth Substances|growth substances|mesh-ancestor
56670360|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670361|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
56670362|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56210835|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
56210836|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210837|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210838|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56670363|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
56670364|NCT04711837|Propofol|propofol|mesh-list
56670365|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56670366|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56670367|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670368|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56670369|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
56670370|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
56670371|NCT03393611|Cytarabine|cytarabine|mesh-list
56670372|NCT03393611|Fludarabine|fludarabine|mesh-list
56670373|NCT03393611|Melphalan|melphalan|mesh-list
56670374|NCT03393611|Daunorubicin|daunorubicin|mesh-list
56670375|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
56670376|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670377|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56670378|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
56670379|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670380|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670381|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
56670382|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670383|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
56670384|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670385|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56670386|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
56670387|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56670388|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56670389|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56670390|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56670391|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670392|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
56670393|NCT04032548|Propolis|propolis|mesh-list
56670394|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56670395|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670396|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
56670397|NCT04032236|Caffeine|caffeine|mesh-list
56231583|NCT01712139|Diuretics|diuretics|mesh-ancestor
56210839|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210840|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56210841|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210842|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210843|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
56210844|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56670398|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56670399|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670400|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56670406|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670407|NCT02313389|Rituximab|rituximab|mesh-list
56670408|NCT02313389|Methotrexate|methotrexate|mesh-list
56670409|NCT02313389|Temozolomide|temozolomide|mesh-list
56670410|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670411|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670412|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
56670413|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670414|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670415|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56670416|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
56670417|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56670418|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56670419|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
56670420|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670421|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
56670422|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670423|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56670424|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670425|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56670426|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56670427|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
56670428|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56670429|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
56670430|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670434|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
56670435|NCT02632916|Denosumab|denosumab|mesh-list
56670436|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56670437|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670438|NCT00881504|Bevacizumab|bevacizumab|mesh-list
56670445|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
56670448|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56670449|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56670450|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56670451|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
56670452|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670453|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56670454|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56670455|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210845|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
56210846|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56210847|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
56210848|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210849|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210850|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
56210851|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
56210852|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56210853|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
56210854|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56210855|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
56210856|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210857|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210861|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210863|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210864|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210865|NCT01598337|Aspirin|aspirin|mesh-list
56210866|NCT01598337|Tirofiban|tirofiban|mesh-list
56210867|NCT01598337|Clopidogrel|clopidogrel|mesh-list
56210868|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56210869|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56210870|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56210871|NCT01598337|Analgesics|analgesics|mesh-ancestor
56210872|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
56210873|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210874|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210875|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56210876|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210877|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56210878|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56181552|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181553|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
56181554|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56181555|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
56181556|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56210879|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210880|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56210881|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56210882|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210883|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
56210884|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56210885|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56210886|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56210887|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
56210888|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210889|NCT01598363|Digoxin|digoxin|mesh-list
56210890|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56210891|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56210892|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56210893|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
56210894|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210895|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56210896|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56210897|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888867|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56670456|NCT02131493|Gemcitabine|gemcitabine|mesh-list
56670457|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56670458|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
56670459|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670460|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670461|NCT02131493|Antiviral Agents|antiviral agents|mesh-ancestor
56670462|NCT02131493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670463|NCT02131493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670464|NCT02131493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670465|NCT02131493|Immunologic Factors|immunologic factors|mesh-ancestor
56670466|NCT02131493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670467|NCT02096159|Trimethoprim|trimethoprim|mesh-list
56670468|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56670469|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
56670470|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56670471|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670472|NCT02096159|Renal Agents|renal agents|mesh-ancestor
56670473|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
56670474|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56670475|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56670476|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56670477|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670478|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670479|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56231663|NCT01712828|Quinidine|quinidine|mesh-list
56210898|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56210899|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56210900|NCT01598363|Protective Agents|protective agents|mesh-ancestor
56210901|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210902|NCT01598402|Amoxicillin|amoxicillin|mesh-list
56210903|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
56210904|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
56210905|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56210906|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210907|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210908|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210909|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56210911|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56210912|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
56210913|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
56210914|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
55746034|NCT02476903|Protective Agents|protective agents|mesh-ancestor
56210915|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56210916|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56210917|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
56210918|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56210919|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56210920|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56210921|NCT01598558|Rituximab|rituximab|mesh-list
56210922|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56210923|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670480|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56670481|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56670482|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56670483|NCT02632136|Bupivacaine|bupivacaine|mesh-list
56670484|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
56670485|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
56670486|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56670487|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670488|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
56670489|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670490|NCT00660920|Ponatinib|ponatinib|mesh-list
56670491|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670492|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56670493|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670494|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210924|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
56210925|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210927|NCT01598584|Gemcitabine|gemcitabine|mesh-list
56210928|NCT01598584|Mirtazapine|mirtazapine|mesh-list
56210929|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56210930|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
55746080|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
56210931|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210932|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56210933|NCT01598584|Antiviral Agents|antiviral agents|mesh-ancestor
56210934|NCT01598584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56210935|NCT01598584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210936|NCT01598584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56210937|NCT01598584|Immunologic Factors|immunologic factors|mesh-ancestor
56210938|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210939|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
56210940|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56210941|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56210942|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
56181557|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
56181558|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56181559|NCT01411969|Protective Agents|protective agents|mesh-ancestor
56181560|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
56181561|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56181562|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56181563|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181564|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
56181565|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181566|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181567|NCT01412073|Misoprostol|misoprostol|mesh-list
56181569|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
56181570|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56181571|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181572|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56210943|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
56210944|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210945|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56210946|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56210947|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56210948|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56210949|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56210950|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56210951|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
55933361|NCT03070704|Hormones|hormones|mesh-ancestor
56670495|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
56670496|NCT01936831|Pyridoxal|pyridoxal|mesh-list
56670497|NCT01936831|Pyridoxine|pyridoxine|mesh-list
56670498|NCT01936831|Isoniazid|isoniazid|mesh-list
56670499|NCT01936831|Vitamins|vitamins|mesh-ancestor
56670500|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
56670501|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670502|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
56670503|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
56670504|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56670505|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670506|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56670507|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56670508|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
56670509|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670510|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56670511|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
56670512|NCT00615173|Azathioprine|azathioprine|mesh-list
56670513|NCT00615173|Tacrolimus|tacrolimus|mesh-list
56670514|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670515|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
56670516|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670517|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670518|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56670519|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
56210952|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56210953|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56210954|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
56210955|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56210956|NCT01598623|Oxytocin|oxytocin|mesh-list
56210957|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
56210958|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56210959|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210960|NCT01598649|Mannitol|mannitol|mesh-list
56210961|NCT01598649|Caseins|caseins|mesh-list
56210962|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56210963|NCT01598649|Diuretics|diuretics|mesh-ancestor
55746201|NCT02757859|Pancrelipase|pancrelipase|mesh-list
56210964|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
56210965|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210967|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
56210968|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210970|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56210971|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210972|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
56210973|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
56210974|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210975|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
56210976|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210977|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210978|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
56210979|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56210980|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56670520|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670521|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670522|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56670523|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56670524|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670525|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
56670526|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56670527|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56670528|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
56670529|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56210981|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56210982|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56210983|NCT01598883|Heparin|heparin|mesh-list
56210987|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56181573|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
56181574|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56181575|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181577|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181578|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56181579|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
56181580|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181581|NCT01412307|Lenalidomide|lenalidomide|mesh-list
56181582|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56181583|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
56181584|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181585|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56181586|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56181587|NCT01412307|Growth Substances|growth substances|mesh-ancestor
56181588|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
56181589|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181590|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56181591|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
56181592|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181593|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
56181594|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56181595|NCT01412385|Antibodies|antibodies|mesh-list
56181596|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
56181597|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56181598|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
56181599|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
56181600|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181601|NCT01412411|Micronutrients|micronutrients|mesh-list
56181602|NCT01412411|Trace Elements|trace elements|mesh-list
56181603|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181604|NCT01412437|Verapamil|verapamil|mesh-list
56210988|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56210989|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210990|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56210991|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
56210992|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210993|NCT01598948|Mipomersen|mipomersen|mesh-list
56210994|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56210995|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56210996|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
56210997|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210998|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56210999|NCT01599000|Lumefantrine|lumefantrine|mesh-list
56211000|NCT01599000|Artemether|artemether|mesh-list
56181605|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56181606|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56181607|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56181608|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181609|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56181610|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670530|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56670531|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670532|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670533|NCT00660998|Urological Agents|urological agents|mesh-ancestor
56670534|NCT00657254|Sorafenib|sorafenib|mesh-list
56670535|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670536|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56670537|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670538|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670539|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
56670540|NCT01455389|Promethazine|promethazine|mesh-list
56670541|NCT01455389|Dexamethasone|dexamethasone|mesh-list
56670542|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56670543|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56670544|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
56670545|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
56670546|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547656|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56670547|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316727|NCT00014573|Aldesleukin|aldesleukin|mesh-list
56670551|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670553|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670554|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56137724|NCT05353374|Petrolatum|petrolatum|mesh-list
56181611|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
56181613|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181614|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181615|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
56181616|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181617|NCT01412567|Vaccines|vaccines|mesh-list
56181618|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
56181619|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181620|NCT01412632|Remifentanil|remifentanil|mesh-list
56181621|NCT01412632|Propofol|propofol|mesh-list
56181622|NCT01412632|Prilocaine|prilocaine|mesh-list
56181623|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56181624|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56181625|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181626|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56181627|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
56181628|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
56181629|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56181630|NCT01412632|Narcotics|narcotics|mesh-ancestor
56181631|NCT01412632|Analgesics|analgesics|mesh-ancestor
55799859|NCT05526911|Midazolam|midazolam|mesh-list
56181634|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
56181635|NCT01412645|Resveratrol|resveratrol|mesh-list
56181636|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
55881376|NCT03374280|Pemetrexed|pemetrexed|mesh-list
55746320|NCT03744793|Pemetrexed|pemetrexed|mesh-list
56211001|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56211002|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
56211003|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56670555|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670556|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670557|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56670558|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56670559|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56670560|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
56670561|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
56231767|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
56211004|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56211005|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211006|NCT01599013|Gemcitabine|gemcitabine|mesh-list
56211007|NCT01599013|Carboplatin|carboplatin|mesh-list
56211008|NCT01599013|Vinblastine|vinblastine|mesh-list
55746379|NCT03309163|Narcotics|narcotics|mesh-ancestor
56211009|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211010|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211011|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
56211012|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181637|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181639|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181640|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181641|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56181642|NCT01412658|Glycerol|glycerol|mesh-list
56181643|NCT01412658|Caseins|caseins|mesh-list
56181644|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56181645|NCT01412658|Protective Agents|protective agents|mesh-ancestor
56181646|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181647|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
56181648|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
56181649|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181650|NCT01412671|Sorafenib|sorafenib|mesh-list
56181651|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181652|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56211013|NCT01599013|Antiviral Agents|antiviral agents|mesh-ancestor
56211014|NCT01599013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211015|NCT01599013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211016|NCT01599013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211017|NCT01599013|Immunologic Factors|immunologic factors|mesh-ancestor
56211018|NCT01599013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211019|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56211020|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
56211021|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211022|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
56211023|NCT01599078|Paclitaxel|paclitaxel|mesh-list
56211024|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56211025|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211026|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
56211027|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211028|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
56211029|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211030|NCT01599117|Udenafil|udenafil|mesh-list
56211031|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56211032|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56211033|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211034|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211035|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56211036|NCT01599130|Entecavir|entecavir|mesh-list
56211037|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
56211038|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211039|NCT01599273|Triamcinolone|triamcinolone|mesh-list
56211040|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56211041|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
56211042|NCT01599273|Hormones|hormones|mesh-ancestor
56138811|NCT05715931|Vitamins|vitamins|mesh-ancestor
55746505|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
56211043|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211044|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211047|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
56670562|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
56670563|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56670564|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
56670565|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
56670566|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670567|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56670568|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
56670569|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
56670570|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56670571|NCT00661076|Adefovir|adefovir|mesh-list
56670572|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56670573|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
56670574|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670575|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56670576|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56670577|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670578|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670579|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
56670580|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56670584|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56670585|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
56670586|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56670587|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56670588|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670589|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670590|NCT00661700|Urological Agents|urological agents|mesh-ancestor
56670591|NCT00613769|Metronidazole|metronidazole|mesh-list
56670592|NCT00613769|Trimethoprim|trimethoprim|mesh-list
56670593|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
56670594|NCT00613769|Cefuroxime|cefuroxime|mesh-list
56670595|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
56670596|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56670597|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670598|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56670606|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670607|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56670608|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56670609|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56670610|NCT00661154|Bevacizumab|bevacizumab|mesh-list
56670611|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670612|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670613|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56670614|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56670615|NCT00661154|Growth Substances|growth substances|mesh-ancestor
56670616|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670617|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
56670618|NCT00523705|Citalopram|citalopram|mesh-list
56211048|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211049|NCT01599338|Liraglutide|liraglutide|mesh-list
56211050|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56211051|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211052|NCT01599338|Incretins|incretins|mesh-ancestor
56211056|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56181653|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181654|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211057|NCT01599364|Lamivudine|lamivudine|mesh-list
56211058|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56211059|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56211060|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
56211061|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211062|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211063|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56211064|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56211065|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
56211066|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211067|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56211068|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56211069|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56211070|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56211071|NCT01599377|Tofacitinib|tofacitinib|mesh-list
56211072|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56211073|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211074|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211075|NCT05691088|Acetaminophen|acetaminophen|mesh-list
56211076|NCT05691088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56211077|NCT05691088|Analgesics|analgesics|mesh-ancestor
56211078|NCT05691088|Sensory System Agents|sensory system agents|mesh-ancestor
56211079|NCT05691088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211080|NCT05691088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211081|NCT05691088|Antipyretics|antipyretics|mesh-ancestor
56211082|NCT05691010|Paclitaxel|paclitaxel|mesh-list
56211083|NCT05691010|Carboplatin|carboplatin|mesh-list
55746563|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211090|NCT05690984|Dexamethasone|dexamethasone|mesh-list
56211091|NCT05690984|Lenalidomide|lenalidomide|mesh-list
56211092|NCT05690984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56211093|NCT05690984|Antiemetics|antiemetics|mesh-ancestor
56211094|NCT05690984|Autonomic Agents|autonomic agents|mesh-ancestor
56211095|NCT05690984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211096|NCT05690984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211097|NCT05690984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56211098|NCT05690984|Glucocorticoids|glucocorticoids|mesh-ancestor
56211099|NCT05690984|Hormones|hormones|mesh-ancestor
56211100|NCT05690984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211101|NCT05690984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56670619|NCT00523705|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56670620|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56547657|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56670621|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56670622|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670623|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670624|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
56670625|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670626|NCT00523705|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56670627|NCT00523705|Antidepressive Agents|antidepressive agents|mesh-ancestor
56670628|NCT00523705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56670629|NCT00193427|Gemcitabine|gemcitabine|mesh-list
56670630|NCT00193427|Carboplatin|carboplatin|mesh-list
56670631|NCT00193427|Docetaxel|docetaxel|mesh-list
56670632|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670633|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56670634|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
56670635|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670636|NCT00193427|Antiviral Agents|antiviral agents|mesh-ancestor
56670637|NCT00193427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670638|NCT00193427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670639|NCT00193427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670640|NCT00193427|Immunologic Factors|immunologic factors|mesh-ancestor
56670641|NCT00193427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670642|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
56670643|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211102|NCT05690984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211103|NCT05690984|Immunologic Factors|immunologic factors|mesh-ancestor
56211104|NCT05690984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56211105|NCT05690984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56211106|NCT05690984|Growth Substances|growth substances|mesh-ancestor
56211107|NCT05690984|Growth Inhibitors|growth inhibitors|mesh-ancestor
56211108|NCT05690802|Palonosetron|palonosetron|mesh-list
56211109|NCT05690802|Antiemetics|antiemetics|mesh-ancestor
56211110|NCT05690802|Autonomic Agents|autonomic agents|mesh-ancestor
56211111|NCT05690802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211112|NCT05690802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211113|NCT05690802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56211114|NCT05690802|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56211115|NCT05690802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56211116|NCT05690802|Serotonin Agents|serotonin agents|mesh-ancestor
56211117|NCT05690802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211118|NCT05690802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746596|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
56211139|NCT05690646|Protease Inhibitors|protease inhibitors|mesh-ancestor
56211140|NCT05690646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211141|NCT05690646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211142|NCT05690646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56670644|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
56670645|NCT00665678|Paroxetine|paroxetine|mesh-list
56670646|NCT00665678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56670647|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56670648|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56670649|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670650|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670651|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
56670652|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670653|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56670654|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
56670655|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56670656|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56670657|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56670658|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670659|NCT05345327|Metformin|metformin|mesh-list
56211143|NCT05690646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56211144|NCT05690646|Antiviral Agents|antiviral agents|mesh-ancestor
56211145|NCT05690646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211146|NCT05690646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56181656|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56181657|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56181658|NCT01412840|Analgesics|analgesics|mesh-ancestor
56181659|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
56181660|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181661|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181662|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181663|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56181664|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56211152|NCT05690321|Narcotics|narcotics|mesh-ancestor
56211153|NCT05690321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211154|NCT05690321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211155|NCT05690321|Analgesics|analgesics|mesh-ancestor
56211156|NCT05690321|Sensory System Agents|sensory system agents|mesh-ancestor
56211157|NCT05690321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211158|NCT05690321|Antidiarrheals|antidiarrheals|mesh-ancestor
56211159|NCT05690321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56211160|NCT05690321|Antitussive Agents|antitussive agents|mesh-ancestor
56211161|NCT05690321|Respiratory System Agents|respiratory system agents|mesh-ancestor
56211162|NCT05690282|Acetaminophen|acetaminophen|mesh-list
56211163|NCT05690282|Ibuprofen|ibuprofen|mesh-list
56211165|NCT05690282|Bupivacaine|bupivacaine|mesh-list
56211166|NCT05690282|Anesthetics, Local|anesthetics, local|mesh-ancestor
56211167|NCT05690282|Anesthetics|anesthetics|mesh-ancestor
56211168|NCT05690282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211169|NCT05690282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211170|NCT05690282|Sensory System Agents|sensory system agents|mesh-ancestor
56211171|NCT05690282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211172|NCT05690282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56211173|NCT05690282|Analgesics|analgesics|mesh-ancestor
56211174|NCT05690282|Antipyretics|antipyretics|mesh-ancestor
56211175|NCT05690282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56211176|NCT05690282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56211177|NCT05690282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56211178|NCT05690282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56211179|NCT05690282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211180|NCT05690282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211181|NCT05690282|Anticonvulsants|anticonvulsants|mesh-ancestor
56670660|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
56670661|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56670662|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670663|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56670664|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670665|NCT00523549|Amlodipine|amlodipine|mesh-list
56670666|NCT00523549|Valsartan|valsartan|mesh-list
56670667|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56670668|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56670669|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56670670|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670671|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56670672|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670673|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
56670674|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56670675|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56670676|NCT04215653|Rabeprazole|rabeprazole|mesh-list
56670677|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56670678|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56670679|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56670680|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670681|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670682|NCT02706119|Insulin|insulin|mesh-list
56670683|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56670684|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
56670685|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56670686|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670687|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
56670688|NCT02631668|Hematinics|hematinics|mesh-ancestor
56670689|NCT00665756|Mitomycins|mitomycins|mesh-list
56670690|NCT00665756|Mitomycin|mitomycin|mesh-list
56670691|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56670692|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670693|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
56316874|NCT00275730|Indomethacin|indomethacin|mesh-list
56670694|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211182|NCT05690282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56670695|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56670696|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670697|NCT00661856|Genistein|genistein|mesh-list
56670698|NCT00661856|Daidzein|daidzein|mesh-list
56670699|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56670700|NCT00661856|Protective Agents|protective agents|mesh-ancestor
56670701|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670702|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670703|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56670704|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670705|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670706|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
56670707|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56670708|NCT00661856|Estrogens|estrogens|mesh-ancestor
56670709|NCT00661856|Hormones|hormones|mesh-ancestor
56670710|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670711|NCT04215731|Leucovorin|leucovorin|mesh-list
56670712|NCT04215731|Bevacizumab|bevacizumab|mesh-list
56670713|NCT04215731|Fluorouracil|fluorouracil|mesh-list
56670714|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
56670715|NCT04215731|Irinotecan|irinotecan|mesh-list
56670716|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
56670717|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670718|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670719|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56670720|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56670721|NCT04215731|Growth Substances|growth substances|mesh-ancestor
56670722|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670723|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
56670724|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
56670725|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670726|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56670727|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670728|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
56211183|NCT05690282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56211184|NCT05690282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56211185|NCT05690282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56211186|NCT05690282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56211187|NCT05690282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211188|NCT05690282|Antimanic Agents|antimanic agents|mesh-ancestor
56211189|NCT05690204|Colchicine|colchicine|mesh-list
56211190|NCT05690204|Gout Suppressants|gout suppressants|mesh-ancestor
56670729|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56670730|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56670731|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670732|NCT04215731|Antidotes|antidotes|mesh-ancestor
56670733|NCT04215731|Protective Agents|protective agents|mesh-ancestor
56670734|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
56670735|NCT04215731|Vitamins|vitamins|mesh-ancestor
56670736|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
56670737|NCT00665834|Atorvastatin|atorvastatin|mesh-list
56670738|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56670739|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56670740|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56670741|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
56670742|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670743|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56670744|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56670745|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670746|NCT02704013|Oxybutynin|oxybutynin|mesh-list
56137940|NCT05175768|Niacin|niacin|mesh-list
56211191|NCT05690204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56211192|NCT05690204|Tubulin Modulators|tubulin modulators|mesh-ancestor
56211193|NCT05690204|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211194|NCT05690204|Mitosis Modulators|mitosis modulators|mesh-ancestor
56211195|NCT05690204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211196|NCT05690204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211197|NCT05690191|Rituximab|rituximab|mesh-list
56211198|NCT05690191|Lenalidomide|lenalidomide|mesh-list
56211199|NCT05690191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56211200|NCT05690191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211201|NCT05690191|Immunologic Factors|immunologic factors|mesh-ancestor
56211202|NCT05690191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211203|NCT05690191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56211204|NCT05690191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56211205|NCT05690191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56211206|NCT05690191|Growth Substances|growth substances|mesh-ancestor
56211207|NCT05690191|Growth Inhibitors|growth inhibitors|mesh-ancestor
56211208|NCT05689996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56181665|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211213|NCT05689983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56211214|NCT05689983|Autonomic Agents|autonomic agents|mesh-ancestor
56211215|NCT05689983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211216|NCT05689983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211217|NCT05689983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56211218|NCT05689983|Respiratory System Agents|respiratory system agents|mesh-ancestor
56211219|NCT05689983|Glucocorticoids|glucocorticoids|mesh-ancestor
56211221|NCT05689983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211222|NCT05689983|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56211223|NCT05689983|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56211224|NCT05689983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56211225|NCT05689983|Adrenergic Agents|adrenergic agents|mesh-ancestor
56211226|NCT05689983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211227|NCT05689983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211228|NCT05689957|Rocuronium|rocuronium|mesh-list
56211229|NCT05689957|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56211230|NCT05689957|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56211231|NCT05689957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56211232|NCT05689957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670747|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
56670748|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
56670749|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670750|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670751|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56670752|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56670753|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
56670754|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670755|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670756|NCT02704013|Urological Agents|urological agents|mesh-ancestor
56670757|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
56670758|NCT00665990|Bevacizumab|bevacizumab|mesh-list
56670759|NCT00665990|Sorafenib|sorafenib|mesh-list
56670760|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670761|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
56231949|NCT01714102|Protective Agents|protective agents|mesh-ancestor
56211233|NCT05689957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211234|NCT05689671|Paclitaxel|paclitaxel|mesh-list
56211235|NCT05689671|Carboplatin|carboplatin|mesh-list
56211236|NCT05689671|Pembrolizumab|pembrolizumab|mesh-list
56211237|NCT05689671|Pemetrexed|pemetrexed|mesh-list
56211238|NCT05689671|Atezolizumab|atezolizumab|mesh-list
56211239|NCT05689671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56211240|NCT05689671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211241|NCT05689671|Tubulin Modulators|tubulin modulators|mesh-ancestor
56211242|NCT05689671|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211243|NCT05689671|Mitosis Modulators|mitosis modulators|mesh-ancestor
56211244|NCT05689671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211245|NCT05689671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56211246|NCT05689671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211247|NCT05689671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56211248|NCT05689671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56211249|NCT05689632|Vitamin D|vitamin d|mesh-list
56211250|NCT05689632|Ergocalciferols|ergocalciferols|mesh-list
56211251|NCT05689632|Cholecalciferol|cholecalciferol|mesh-list
56211253|NCT05689632|Micronutrients|micronutrients|mesh-ancestor
56211254|NCT05689632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211255|NCT05689632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56211256|NCT05689632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56211257|NCT05689619|Silybin|silybin|mesh-list
56211258|NCT05689619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56211259|NCT05689619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211260|NCT05689619|Protective Agents|protective agents|mesh-ancestor
56211261|NCT05689619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211262|NCT05689463|Immunoglobulins|immunoglobulins|mesh-list
56211263|NCT05689463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56211264|NCT05689463|Antibodies|antibodies|mesh-list
56211265|NCT05689463|Immunologic Factors|immunologic factors|mesh-ancestor
56211266|NCT05689463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211267|NCT05689242|Dexmedetomidine|dexmedetomidine|mesh-list
56211268|NCT05689242|Nalbuphine|nalbuphine|mesh-list
56211269|NCT05689242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56211270|NCT05689242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211271|NCT05689242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211272|NCT05689242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56211274|NCT05689242|Sensory System Agents|sensory system agents|mesh-ancestor
56211275|NCT05689242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211276|NCT05689242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56211277|NCT05689242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56211278|NCT05689242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56670762|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670763|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670764|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56670765|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
56670766|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670767|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670768|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56670769|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56547658|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
56670770|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56670771|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56670772|NCT00665990|Growth Substances|growth substances|mesh-ancestor
56670773|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
56670774|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56670775|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670776|NCT04289779|Atezolizumab|atezolizumab|mesh-list
56670777|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670778|NCT00666068|Hormones|hormones|mesh-list
56670779|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56670780|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
56231964|NCT01714128|Estrogens|estrogens|mesh-ancestor
56211279|NCT05689242|Adrenergic Agents|adrenergic agents|mesh-ancestor
56211280|NCT05689242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181682|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181683|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56181684|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56181685|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181686|NCT01413022|Antidotes|antidotes|mesh-ancestor
56211281|NCT05689242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211282|NCT05689242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56211283|NCT05689242|Narcotics|narcotics|mesh-ancestor
55789035|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211284|NCT05689229|Colistin|colistin|mesh-list
56211285|NCT05689229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56211286|NCT05689229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211287|NCT05689151|Abrocitinib|abrocitinib|mesh-list
56211288|NCT05689151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56211289|NCT05689151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211290|NCT05689151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211291|NCT05688046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56211292|NCT05688046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56211293|NCT05688046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211294|NCT05688046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746802|NCT02466919|Ofloxacin|ofloxacin|mesh-list
56211295|NCT05688046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56211296|NCT05688046|Growth Substances|growth substances|mesh-ancestor
56211297|NCT05688046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211298|NCT05688046|Growth Inhibitors|growth inhibitors|mesh-ancestor
55746866|NCT05727163|Analgesics|analgesics|mesh-ancestor
55746924|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56181687|NCT01413022|Protective Agents|protective agents|mesh-ancestor
56181688|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
56181690|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
56670781|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670782|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670783|NCT00700102|Bevacizumab|bevacizumab|mesh-list
56670784|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670785|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670786|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56670787|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55881745|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
56211317|NCT05646563|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56211318|NCT05646563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747001|NCT04298203|Phentermine|phentermine|mesh-list
56211331|NCT05618366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211332|NCT05618132|Acetylcholine|acetylcholine|mesh-list
56211333|NCT05618132|Vasodilator Agents|vasodilator agents|mesh-ancestor
56211334|NCT05618132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56211335|NCT05618132|Cholinergic Agents|cholinergic agents|mesh-ancestor
56211336|NCT05618132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211337|NCT05618132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211338|NCT05618132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211339|NCT05610072|Acetylcysteine|acetylcysteine|mesh-list
56211340|NCT05610072|Hydromorphone|hydromorphone|mesh-list
56211341|NCT05610072|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56211342|NCT05610072|Antiviral Agents|antiviral agents|mesh-ancestor
56211343|NCT05610072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211344|NCT05610072|Expectorants|expectorants|mesh-ancestor
56211345|NCT05610072|Respiratory System Agents|respiratory system agents|mesh-ancestor
56211346|NCT05610072|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56211347|NCT05610072|Antioxidants|antioxidants|mesh-ancestor
55747063|NCT04150861|Hormones|hormones|mesh-ancestor
56211348|NCT05610072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211349|NCT05610072|Protective Agents|protective agents|mesh-ancestor
56211350|NCT05610072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211351|NCT05610072|Antidotes|antidotes|mesh-ancestor
56211352|NCT05610072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56211353|NCT05610072|Narcotics|narcotics|mesh-ancestor
56211354|NCT05610072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211355|NCT05610072|Analgesics|analgesics|mesh-ancestor
56211356|NCT05610072|Sensory System Agents|sensory system agents|mesh-ancestor
56211357|NCT05610072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211358|NCT05593497|Abiraterone Acetate|abiraterone acetate|mesh-list
56211359|NCT05593497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211360|NCT05593497|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56211361|NCT05593497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211362|NCT05593497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211363|NCT05593497|Hormone Antagonists|hormone antagonists|mesh-ancestor
56211364|NCT05593497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211365|NCT05593497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211366|NCT05593497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56211367|NCT05553808|Docetaxel|docetaxel|mesh-list
56211368|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211369|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
56211370|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211371|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
56211372|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211373|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56211374|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
56211375|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211376|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56211377|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56211378|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
56211379|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211380|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211381|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56211382|NCT05540184|Allopurinol|allopurinol|mesh-list
56211383|NCT05540184|Trimetazidine|trimetazidine|mesh-list
56211384|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
55933513|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
56670788|NCT00700102|Growth Substances|growth substances|mesh-ancestor
56670789|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670790|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
56670791|NCT02705729|Methamphetamine|methamphetamine|mesh-list
56670792|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56670793|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670794|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
56670795|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
56670796|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670797|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
56670798|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670799|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670800|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
56670801|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56670802|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56670803|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56211385|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211386|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211387|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
56211388|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56211389|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56211390|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
56181692|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56181693|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56181694|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56181695|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181696|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181697|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181698|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56181699|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
56181700|NCT01413048|Protective Agents|protective agents|mesh-ancestor
56181701|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56181702|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55881815|NCT03005704|Analgesics|analgesics|mesh-ancestor
56211391|NCT05540184|Protective Agents|protective agents|mesh-ancestor
56211392|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211393|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
56211394|NCT05493761|Denosumab|denosumab|mesh-list
56211395|NCT05493761|Alendronate|alendronate|mesh-list
56211396|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56211397|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211398|NCT05475483|Bevantolol|bevantolol|mesh-list
56211399|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56211400|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56211401|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56211402|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
56211403|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211404|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211405|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211406|NCT05473195|Isoniazid|isoniazid|mesh-list
56211407|NCT05473195|Ethionamide|ethionamide|mesh-list
56211408|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
56211409|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55747145|NCT03337087|Leucovorin|leucovorin|mesh-list
56211410|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211411|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56211412|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56211413|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
56670804|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56670805|NCT02705573|Mannitol|mannitol|mesh-list
56670806|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56670807|NCT02705573|Diuretics|diuretics|mesh-ancestor
56670808|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
56670809|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670810|NCT00613847|Trastuzumab|trastuzumab|mesh-list
56670811|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56670812|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670813|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670814|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670815|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
56670816|NCT00516295|Bevacizumab|bevacizumab|mesh-list
56670817|NCT00516295|Vincristine|vincristine|mesh-list
56670818|NCT00516295|Topotecan|topotecan|mesh-list
56670819|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56670820|NCT00516295|Antibodies|antibodies|mesh-list
56670821|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
56670822|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56670823|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670824|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
56670825|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670826|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670827|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56670828|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
56670829|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670830|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670831|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56670832|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56232010|NCT01714388|Remifentanil|remifentanil|mesh-list
56211414|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211415|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56211416|NCT05442216|Azacitidine|azacitidine|mesh-list
56211417|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211418|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
56211419|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211420|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211421|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211422|NCT05422053|Insulin|insulin|mesh-list
56211423|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56211424|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211425|NCT05419505|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
56211426|NCT05419505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56211427|NCT05419505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211428|NCT05419505|Hemostatics|hemostatics|mesh-ancestor
56211429|NCT05419505|Coagulants|coagulants|mesh-ancestor
56670833|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56670834|NCT00516295|Growth Substances|growth substances|mesh-ancestor
56670835|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
56670836|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56670837|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
56670838|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
56670839|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
56670840|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56670841|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56670842|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670843|NCT03362099|Bupropion|bupropion|mesh-list
56670844|NCT03362099|Varenicline|varenicline|mesh-list
56670845|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56670846|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
56670847|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56670848|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56670849|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56670850|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56670851|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670852|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
56670853|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670854|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670855|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56670856|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56670857|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670858|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56670859|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56670860|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
56670861|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
56670862|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56670863|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
56670864|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56670865|NCT02705651|Somatostatin|somatostatin|mesh-list
56670866|NCT02705651|Hormones|hormones|mesh-ancestor
56670867|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56670868|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670869|NCT00738088|Gliclazide|gliclazide|mesh-list
56670870|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56670871|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670872|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
56670873|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56670874|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
56670875|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
56670876|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56670877|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670878|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56670879|NCT02703233|Analgesics|analgesics|mesh-ancestor
56138173|NCT00614406|Celecoxib|celecoxib|mesh-list
56211430|NCT05414240|Ibudilast|ibudilast|mesh-list
56211431|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56211432|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
56211433|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211434|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211435|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56211436|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
56211437|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56211438|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211439|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181703|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56181704|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
56181705|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56181706|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56181707|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
56181708|NCT01413230|Vitamin D|vitamin d|mesh-list
56181709|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56181710|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181711|NCT01413230|Vitamins|vitamins|mesh-ancestor
56181712|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
56181713|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56181714|NCT01413477|Calcitriol|calcitriol|mesh-list
56181715|NCT01413477|Betamethasone|betamethasone|mesh-list
56181716|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
56181717|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56181718|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
56181719|NCT01413477|Calcipotriene|calcipotriene|mesh-list
56181720|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56181721|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181722|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
56181723|NCT01413477|Hormones|hormones|mesh-ancestor
56181724|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181725|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181726|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56181727|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
56181728|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
56181729|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56181730|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56181731|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56181732|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181733|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56181734|NCT01413477|Vitamins|vitamins|mesh-ancestor
56181735|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
56181736|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56181737|NCT01413490|Rimantadine|rimantadine|mesh-list
56181738|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
55881877|NCT03005548|Analgesics|analgesics|mesh-ancestor
56211440|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56181739|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181740|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56181741|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181742|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181743|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
56670880|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
56670881|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670882|NCT05740618|Mannitol|mannitol|mesh-list
56670883|NCT05740618|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56670884|NCT05740618|Diuretics|diuretics|mesh-ancestor
56670885|NCT05740618|Natriuretic Agents|natriuretic agents|mesh-ancestor
56670886|NCT05740618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670887|NCT04152941|Olaparib|olaparib|mesh-list
56670888|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56232091|NCT01714765|Everolimus|everolimus|mesh-list
56181744|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181745|NCT01413620|Vitamins|vitamins|mesh-list
56181746|NCT01413620|Vitamin E|vitamin e|mesh-list
56181747|NCT01413620|Tocopherols|tocopherols|mesh-list
56181748|NCT01413620|Tocotrienols|tocotrienols|mesh-list
56181749|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
56181750|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
56181751|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181752|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
56181753|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181754|NCT01413620|Protective Agents|protective agents|mesh-ancestor
56181755|NCT01413711|Vigabatrin|vigabatrin|mesh-list
56181756|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
56181757|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181758|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181759|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
56181760|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181761|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181762|NCT01413763|Imiquimod|imiquimod|mesh-list
56181763|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56181764|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
56181765|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181766|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181767|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
56181769|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56211441|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
56211442|NCT05403502|Insulin|insulin|mesh-list
56211443|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56211444|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211445|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
56211446|NCT05400122|Fludarabine|fludarabine|mesh-list
56211447|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
56211448|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211449|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
56211450|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211451|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747252|NCT03295825|Heparin|heparin|mesh-list
56211452|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56211453|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
56211454|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211455|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211456|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56181770|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56181771|NCT01413854|Analgesics|analgesics|mesh-ancestor
56181772|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
56181773|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181774|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181775|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56181776|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56181778|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109580|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56181836|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
56181837|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
56181838|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
56181839|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181840|NCT01414816|Interferons|interferons|mesh-list
56181841|NCT01414816|Interferon-beta|interferon-beta|mesh-list
56181842|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
56670889|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670890|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670891|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670892|NCT04062760|Diuretics|diuretics|mesh-list
56670893|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
56670894|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670895|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
56670896|NCT03384277|Rituximab|rituximab|mesh-list
56670897|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670898|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
56670899|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670900|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670901|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56670902|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
56670903|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670904|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670905|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56670906|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670907|NCT04804007|Etoposide|etoposide|mesh-list
56670908|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56670909|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56670910|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56670911|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56670912|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670913|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670914|NCT02702843|Xenon|xenon|mesh-list
56670915|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56232097|NCT01714817|Prednisone|prednisone|mesh-list
56181843|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181844|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
56181845|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181846|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
56181847|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181848|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56181849|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
56181850|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56211457|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211458|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
56211459|NCT05344911|Remifentanil|remifentanil|mesh-list
56211462|NCT05344911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56211463|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211464|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211465|NCT05344911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56211466|NCT05344911|Anesthetics, General|anesthetics, general|mesh-ancestor
56211467|NCT05344911|Anesthetics|anesthetics|mesh-ancestor
56211468|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56670916|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
56670917|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
56547659|NCT02669641|Choline|choline|mesh-list
56670918|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56670919|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670921|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
56670922|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56670923|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56670924|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670925|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56670926|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670927|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56670928|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56670929|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56670930|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56670931|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56670932|NCT02704715|Anesthetics|anesthetics|mesh-list
56670933|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56670934|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670935|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
56670936|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56670937|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56670938|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
56670939|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56670940|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56670941|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56670942|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670943|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670944|NCT00615875|Naproxen|naproxen|mesh-list
56670945|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56670946|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56670947|NCT00615875|Analgesics|analgesics|mesh-ancestor
56670948|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
56670949|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670950|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670951|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56670952|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670953|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
56670954|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56670955|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670956|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670957|NCT04126135|Nicotine|nicotine|mesh-list
56670958|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56670959|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
56670960|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670961|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670962|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56670963|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56670964|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
56670965|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670966|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670967|NCT02630888|Memantine|memantine|mesh-list
56670968|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56670969|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56670970|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
56670971|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56670972|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670973|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670974|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56670975|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56670976|NCT04767841|Metformin|metformin|mesh-list
56670977|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56670978|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670979|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
56670980|NCT00666302|Tacrolimus|tacrolimus|mesh-list
56670981|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56670982|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
56670983|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56670984|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56670985|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56670986|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56670987|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56211469|NCT05344911|Narcotics|narcotics|mesh-ancestor
56670988|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56670989|NCT00666302|Analgesics|analgesics|mesh-ancestor
56670990|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
56670991|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56670992|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56670993|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56670994|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
56670995|NCT00671372|Bevacizumab|bevacizumab|mesh-list
56670996|NCT00671372|Cetuximab|cetuximab|mesh-list
56670997|NCT00671372|Irinotecan|irinotecan|mesh-list
56670998|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56670999|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671000|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56671001|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56671002|NCT00671372|Growth Substances|growth substances|mesh-ancestor
56671003|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671004|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
56671005|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56671006|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56671007|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671008|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671009|NCT00856986|Metformin|metformin|mesh-list
56671010|NCT00856986|Liraglutide|liraglutide|mesh-list
56671011|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
56671012|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56671013|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671014|NCT00856986|Incretins|incretins|mesh-ancestor
56671015|NCT00856986|Hormones|hormones|mesh-ancestor
56671016|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56671017|NCT00666692|Paclitaxel|paclitaxel|mesh-list
56671018|NCT00666692|Bevacizumab|bevacizumab|mesh-list
56211470|NCT05344911|Analgesics|analgesics|mesh-ancestor
56211471|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
56211472|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211473|NCT05344417|Iodine|iodine|mesh-list
56211474|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56211475|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211476|NCT05344417|Trace Elements|trace elements|mesh-ancestor
56211477|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
56211478|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211480|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56211481|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211483|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56211484|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211485|NCT05281328|Octreotide|octreotide|mesh-list
56211486|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56671019|NCT00666692|Carboplatin|carboplatin|mesh-list
56671020|NCT00666692|Volociximab|volociximab|mesh-list
56671021|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56671022|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56671023|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671024|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
56671025|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
56671026|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
56232222|NCT01715493|Muramidase|muramidase|mesh-list
56211487|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56211488|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211489|NCT05267626|Aldesleukin|aldesleukin|mesh-list
56211490|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211491|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56211492|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56211493|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
56211494|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211495|NCT05265208|Capecitabine|capecitabine|mesh-list
56211496|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211498|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211499|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211501|NCT05251376|Methadone|methadone|mesh-list
56211502|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56211503|NCT05251376|Narcotics|narcotics|mesh-ancestor
56211504|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211505|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211506|NCT05251376|Analgesics|analgesics|mesh-ancestor
56211507|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
56181851|NCT01414868|Montelukast|montelukast|mesh-list
56181852|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
56181853|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56181854|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
56181855|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
56181856|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56181857|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181858|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56181859|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56181860|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181861|NCT01414881|Mipomersen|mipomersen|mesh-list
56181862|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56211508|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211509|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
56211510|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
56211511|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56211512|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211513|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211514|NCT05191797|Atezolizumab|atezolizumab|mesh-list
56211515|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
56211516|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56211517|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
56211518|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211519|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
56211520|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211521|NCT05191446|Ethanol|ethanol|mesh-list
56211522|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56211523|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211524|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211525|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211526|NCT05189483|Paclitaxel|paclitaxel|mesh-list
56211527|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56211528|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56211529|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211530|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
56211531|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211532|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
56211533|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211534|NCT05188820|Cortisone|cortisone|mesh-list
56671027|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671028|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56671029|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56671030|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56671031|NCT00666692|Growth Substances|growth substances|mesh-ancestor
56671032|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671033|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
56671034|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
56671035|NCT00707746|Mipomersen|mipomersen|mesh-list
56671036|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56671037|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56671038|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
56671039|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671040|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56671041|NCT00666770|Gabapentin|gabapentin|mesh-list
56671042|NCT00666770|Analgesics|analgesics|mesh-ancestor
56671043|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
56671044|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671045|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671046|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
56671047|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56671048|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56671049|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211535|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56211536|NCT05177055|Methamphetamine|methamphetamine|mesh-list
56211537|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56211538|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211539|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
56211540|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
56211541|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211542|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
55747676|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56211545|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
56211546|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56211547|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56211548|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56211549|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56211550|NCT05156281|Teriflunomide|teriflunomide|mesh-list
56211551|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56211552|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56211553|NCT05156281|Analgesics|analgesics|mesh-ancestor
56211554|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
56211555|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211556|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181863|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56181864|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
56181865|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181866|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56181867|NCT01414972|Vitamin A|vitamin a|mesh-list
56211557|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56671050|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56671051|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56232251|NCT01715597|Protective Agents|protective agents|mesh-ancestor
56211558|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56211559|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211560|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
56211561|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56211562|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
56211563|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211567|NCT05121974|Azithromycin|azithromycin|mesh-list
56211568|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
56211569|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56211570|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211571|NCT05106192|Triamcinolone|triamcinolone|mesh-list
56211572|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56211573|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56211574|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
56211575|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56211577|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56211578|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56211579|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
56211581|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211582|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211583|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211584|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
56211586|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211587|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
56211588|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56211589|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211590|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
56211591|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56211592|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211593|NCT05065866|Azacitidine|azacitidine|mesh-list
56211594|NCT05065866|Cc-486|cc-486|mesh-list
56211595|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211596|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
56211597|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211598|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211599|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211600|NCT05064878|Fenfluramine|fenfluramine|mesh-list
56211601|NCT05064878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56211602|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56211603|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56211604|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211605|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211606|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
56211607|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211608|NCT04994977|Carboplatin|carboplatin|mesh-list
56211609|NCT04994977|Melphalan|melphalan|mesh-list
56211610|NCT04994977|Topotecan|topotecan|mesh-list
56211611|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211612|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56211613|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
56211614|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211615|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56211616|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211617|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
56211618|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211619|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56211620|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56211621|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211622|NCT04969250|Vaccines|vaccines|mesh-list
56211623|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
56211624|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211625|NCT04965077|Antibodies|antibodies|mesh-list
56211626|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56211627|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
56181868|NCT01414972|Vitamins|vitamins|mesh-ancestor
56181869|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
56181870|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181871|NCT01414998|Nicotine|nicotine|mesh-list
56181872|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56181873|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
56671052|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56671053|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671054|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671055|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
56671056|NCT04188353|Mannitol|mannitol|mesh-list
56671057|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56671058|NCT04188353|Diuretics|diuretics|mesh-ancestor
56671059|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
56671060|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671061|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
56671062|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
56671063|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671064|NCT02630420|Cetuximab|cetuximab|mesh-list
56671065|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56317265|NCT00016133|Vitamins|vitamins|mesh-ancestor
56671066|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671067|NCT00667082|Vorinostat|vorinostat|mesh-list
56671068|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56671069|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56671070|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671071|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671072|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671073|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
56671074|NCT05343299|Lidocaine|lidocaine|mesh-list
56671075|NCT05343299|Ropivacaine|ropivacaine|mesh-list
56671076|NCT05343299|Anesthetics|anesthetics|mesh-list
56671077|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
56671078|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56671079|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671080|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
56671081|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671082|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56671083|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56671084|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56671085|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56671087|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
56671089|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671090|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
56671091|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671092|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56671093|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671094|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671095|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56671096|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56671097|NCT00667160|Analgesics|analgesics|mesh-ancestor
56671098|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
56671099|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671100|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56671101|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671102|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
56671103|NCT02701673|Pyridoxine|pyridoxine|mesh-list
56671104|NCT02701673|Gemcitabine|gemcitabine|mesh-list
56671105|NCT02701673|Azacitidine|azacitidine|mesh-list
56671106|NCT02701673|Melphalan|melphalan|mesh-list
56671107|NCT02701673|Busulfan|busulfan|mesh-list
56671108|NCT02701673|Belinostat|belinostat|mesh-list
56671109|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56671110|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
56671111|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671112|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671113|NCT02701673|Antiviral Agents|antiviral agents|mesh-ancestor
56671114|NCT02701673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671115|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671116|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671117|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
56671118|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671119|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56671120|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
56671133|NCT00856830|Irinotecan|irinotecan|mesh-list
56671134|NCT00856830|Etoposide|etoposide|mesh-list
56671135|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56671136|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671137|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56671138|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56671139|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671140|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671141|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56671142|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56671143|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56547660|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
56671144|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
56671145|NCT02614404|Piperaquine|piperaquine|mesh-list
56671146|NCT02614404|Artenimol|artenimol|mesh-list
56671147|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
56671148|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671149|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56671150|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181874|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56181875|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181876|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56181877|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56181878|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
56181879|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181880|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181881|NCT01415011|Afatinib|afatinib|mesh-list
56181882|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181883|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56181884|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181885|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181886|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
56181887|NCT01415128|Desipramine|desipramine|mesh-list
56181888|NCT01415128|Omeprazole|omeprazole|mesh-list
56181889|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56181890|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181891|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56181892|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181893|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211628|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211629|NCT04950426|Propranolol|propranolol|mesh-list
56211630|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56211631|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56211632|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
56211633|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211634|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211635|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211636|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56211637|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56211638|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
56211640|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56211641|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211642|NCT04925479|Niacinamide|niacinamide|mesh-list
56211643|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
56211644|NCT04925479|Vitamins|vitamins|mesh-ancestor
56211645|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
56139417|NCT05009069|Fluorouracil|fluorouracil|mesh-list
56671151|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671152|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
56671153|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56671154|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56671155|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671156|NCT00522301|Sorafenib|sorafenib|mesh-list
56671157|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671158|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56671159|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671160|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671161|NCT00662636|Dasatinib|dasatinib|mesh-list
56671162|NCT00662636|Lapatinib|lapatinib|mesh-list
56671163|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671164|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56671165|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671166|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671167|NCT05726344|Lactulose|lactulose|mesh-list
56671168|NCT05726344|Bisacodyl|bisacodyl|mesh-list
56211646|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211647|NCT04896320|Tucatinib|tucatinib|mesh-list
56211648|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211649|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56211650|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211651|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181894|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56181895|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181896|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56181897|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
56181898|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56181899|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56181900|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56181901|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56181902|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
56181903|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181904|NCT01415141|Ribavirin|ribavirin|mesh-list
56181905|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56181906|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
56181907|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181908|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
56109656|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181909|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181910|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56181911|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
56181912|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
56181913|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
56181914|NCT01415336|Doxorubicin|doxorubicin|mesh-list
55882208|NCT03371550|Docetaxel|docetaxel|mesh-list
56211652|NCT04886531|Trastuzumab|trastuzumab|mesh-list
56211653|NCT04886531|Letrozole|letrozole|mesh-list
56211654|NCT04886531|Anastrozole|anastrozole|mesh-list
56211655|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56211656|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211657|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56211658|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56211659|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211660|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211661|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56211662|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
56671169|NCT05726344|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56671170|NCT05726344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56671171|NCT05726344|Cathartics|cathartics|mesh-ancestor
56671172|NCT05726344|Laxatives|laxatives|mesh-ancestor
56671173|NCT00506389|Mirtazapine|mirtazapine|mesh-list
56671174|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
56671175|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56671176|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56671177|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
56671178|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
56671179|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671180|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671181|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671182|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56671183|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56671184|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56671185|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56671186|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56671187|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56671188|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
56671189|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56671190|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56671191|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
56211663|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211665|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56211667|NCT04873557|Trace Elements|trace elements|mesh-ancestor
56211668|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
56211669|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211670|NCT04856566|Ethanol|ethanol|mesh-list
56211671|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56211672|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211673|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211674|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211675|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
56211676|NCT04848337|Lenvatinib|lenvatinib|mesh-list
56211677|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56211678|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211679|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56211680|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181915|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56181916|NCT01415336|Capecitabine|capecitabine|mesh-list
56181917|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181918|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
55882259|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56211681|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211682|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
56211683|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56211684|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211685|NCT04808505|Miglustat|miglustat|mesh-list
56211686|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211687|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671192|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56671193|NCT00667472|Ranibizumab|ranibizumab|mesh-list
56671194|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56671195|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56138641|NCT05765266|Hormones|hormones|mesh-ancestor
56211688|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56211689|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56211690|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
56211691|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211692|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56211693|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56211694|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211695|NCT04789616|Maraviroc|maraviroc|mesh-list
56211696|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55748085|NCT03297463|Ipilimumab|ipilimumab|mesh-list
56211697|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56211698|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211699|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56211700|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56211701|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
56211702|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211703|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56211704|NCT04785300|Dasatinib|dasatinib|mesh-list
56211705|NCT04785300|Quercetin|quercetin|mesh-list
56211706|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748141|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
56211707|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56211708|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211709|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211710|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
56211711|NCT04785300|Protective Agents|protective agents|mesh-ancestor
56211712|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211713|NCT04753216|Bevacizumab|bevacizumab|mesh-list
56211714|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56211715|NCT04753216|Irinotecan|irinotecan|mesh-list
56211716|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
56211717|NCT04753216|Antibodies|antibodies|mesh-list
56211718|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
56211719|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56211720|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
56211721|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211722|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56211723|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56211724|NCT04753216|Growth Substances|growth substances|mesh-ancestor
56211725|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211726|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
56211727|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
56211728|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56211729|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56211730|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211731|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181920|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56181921|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56181922|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
56181923|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181924|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181925|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56181926|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56181927|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56181928|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56181929|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181930|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56181931|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
56181932|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56181933|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56181934|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56181935|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56181936|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181937|NCT01415505|Valsartan|valsartan|mesh-list
56181938|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56181939|NCT01415505|Nebivolol|nebivolol|mesh-list
56671196|NCT00667472|Growth Substances|growth substances|mesh-ancestor
56671197|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671198|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
56671199|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181940|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56181941|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56181942|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56181967|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56181968|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56181969|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56181970|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56181971|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56181972|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181973|NCT01415687|Bisacodyl|bisacodyl|mesh-list
56181974|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
56181975|NCT01415687|Citric Acid|citric acid|mesh-list
56181976|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
56181977|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
56181978|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56181979|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
56181980|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
56181981|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181982|NCT01415687|Cathartics|cathartics|mesh-ancestor
56211746|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56211747|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56211748|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211749|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56211750|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211751|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56211752|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211754|NCT04714619|Anastrozole|anastrozole|mesh-list
56211755|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211756|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56211757|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56211758|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211759|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211760|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56211761|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
56211762|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211763|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211764|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56211765|NCT04690855|Atezolizumab|atezolizumab|mesh-list
56211766|NCT04690855|Talazoparib|talazoparib|mesh-list
56211767|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211768|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56211769|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748316|NCT03358277|Methylphenidate|methylphenidate|mesh-list
56211770|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211771|NCT04689945|Morphine|morphine|mesh-list
56211772|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56211773|NCT04689945|Narcotics|narcotics|mesh-ancestor
56211774|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211775|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211776|NCT04689945|Analgesics|analgesics|mesh-ancestor
56211777|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
56211778|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211779|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56211780|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
56211781|NCT04643574|Fludarabine|fludarabine|mesh-list
56211782|NCT04643574|Interleukin-2|interleukin-2|mesh-list
56211783|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211784|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
56211785|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211786|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56211787|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56211788|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
56181983|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56181985|NCT01415713|Leucovorin|leucovorin|mesh-list
56181986|NCT01415713|Gemcitabine|gemcitabine|mesh-list
56181987|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
56181988|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56671200|NCT05705128|Dexmedetomidine|dexmedetomidine|mesh-list
56671201|NCT05705128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56671202|NCT05705128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56671203|NCT05705128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671204|NCT05705128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56671205|NCT05705128|Analgesics|analgesics|mesh-ancestor
56671206|NCT05705128|Sensory System Agents|sensory system agents|mesh-ancestor
56671207|NCT05705128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671208|NCT05705128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56671209|NCT05705128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56671210|NCT05705128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56671211|NCT05705128|Adrenergic Agents|adrenergic agents|mesh-ancestor
56671212|NCT05705128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671213|NCT05705128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671214|NCT00662714|Insulin|insulin|mesh-list
56671215|NCT00662714|Repaglinide|repaglinide|mesh-list
56671216|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56671217|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
56671218|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56671219|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671220|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56671221|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
56671222|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56671223|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56671224|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671225|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671226|NCT00668018|Urological Agents|urological agents|mesh-ancestor
56181989|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
56181990|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181991|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56181992|NCT01415713|Antiviral Agents|antiviral agents|mesh-ancestor
56181993|NCT01415713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56181994|NCT01415713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56181995|NCT01415713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56181996|NCT01415713|Immunologic Factors|immunologic factors|mesh-ancestor
56181997|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181998|NCT01415713|Antidotes|antidotes|mesh-ancestor
56181999|NCT01415713|Protective Agents|protective agents|mesh-ancestor
56182000|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
56182001|NCT01415713|Vitamins|vitamins|mesh-ancestor
56182002|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
56182003|NCT01415765|Prednisone|prednisone|mesh-list
56182004|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
56182005|NCT01415765|Rituximab|rituximab|mesh-list
56182006|NCT01415765|Doxorubicin|doxorubicin|mesh-list
56182007|NCT01415765|Etoposide|etoposide|mesh-list
56182008|NCT01415765|Vincristine|vincristine|mesh-list
56182009|NCT01415765|Pevonedistat|pevonedistat|mesh-list
56182010|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671227|NCT00871338|Vaccines|vaccines|mesh-list
56671228|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56671229|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
56671230|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182011|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
56182013|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56182034|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
56182035|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
56182036|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182037|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182038|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182039|NCT01415791|Bicalutamide|bicalutamide|mesh-list
56182040|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
56182041|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
56182042|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182043|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182044|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182045|NCT01415895|Clonidine|clonidine|mesh-list
56182046|NCT01415895|Naltrexone|naltrexone|mesh-list
56182047|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56182048|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56182049|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182050|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
56182051|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182052|NCT01415895|Analgesics|analgesics|mesh-ancestor
56182053|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56182054|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
56182055|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
56182056|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56182057|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56182058|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56182059|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
56182060|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182061|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182063|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56182080|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182081|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56182082|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56182083|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56182084|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182085|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182086|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56182087|NCT01416116|Narcotics|narcotics|mesh-ancestor
56182088|NCT01416116|Analgesics|analgesics|mesh-ancestor
56182089|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
56182090|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
56182091|NCT01416207|Interferons|interferons|mesh-list
56182092|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
56182093|NCT01416207|Interferon-beta|interferon-beta|mesh-list
56182094|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182095|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
56182096|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182097|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56182098|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
56182099|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182100|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
56182101|NCT01416220|Paroxetine|paroxetine|mesh-list
56182102|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
56182103|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56182104|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182105|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182106|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
56182107|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56182108|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56182109|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182110|NCT01416220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56182111|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56182112|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182113|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182114|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
55882475|NCT03357822|Interferons|interferons|mesh-list
56671231|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
56671232|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56671233|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
56671234|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671235|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
56671236|NCT04130100|Protective Agents|protective agents|mesh-ancestor
56671237|NCT00597116|Vinorelbine|vinorelbine|mesh-list
56671238|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56671239|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671240|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
56232432|NCT01716858|Sulforaphane|sulforaphane|mesh-list
56182118|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
56182119|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56182120|NCT01416337|Trametinib|trametinib|mesh-list
56182121|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182122|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56182123|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182124|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182125|NCT01416350|Azithromycin|azithromycin|mesh-list
56182126|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56182127|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211789|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211790|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211791|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56211792|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56211793|NCT04643574|Analgesics|analgesics|mesh-ancestor
55748365|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56211795|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139567|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
56211822|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211823|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56211824|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211826|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56211827|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56211828|NCT04541173|Bevacizumab|bevacizumab|mesh-list
56211829|NCT04541173|Atezolizumab|atezolizumab|mesh-list
56211830|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56211831|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211832|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56211833|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56211834|NCT04541173|Growth Substances|growth substances|mesh-ancestor
56211835|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211836|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
56211837|NCT04530747|Metformin|metformin|mesh-list
56211838|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56211839|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211840|NCT04464174|Gemcitabine|gemcitabine|mesh-list
56211841|NCT04464174|Carboplatin|carboplatin|mesh-list
56211842|NCT04464174|Capecitabine|capecitabine|mesh-list
56211843|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211844|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211845|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
56211846|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211847|NCT04464174|Antiviral Agents|antiviral agents|mesh-ancestor
56211848|NCT04464174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211849|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211850|NCT04464174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211851|NCT04464174|Immunologic Factors|immunologic factors|mesh-ancestor
56211852|NCT04464174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211853|NCT04463498|Methamphetamine|methamphetamine|mesh-list
56211854|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56211855|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211856|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
56211857|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
55939153|NCT04989413|Hormones|hormones|mesh-ancestor
56671241|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
56671242|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
56232439|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
56211858|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211859|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
56211860|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211861|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211862|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
56211863|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56211864|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56211865|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56211866|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56211867|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
56211869|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
56182128|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56182129|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56182130|NCT01416480|Theobromine|theobromine|mesh-list
56182131|NCT01416480|Dipropizine|dipropizine|mesh-list
56182132|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56182133|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
56182134|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182135|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882574|NCT03556384|Temozolomide|temozolomide|mesh-list
56211870|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
56211871|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56211872|NCT04456296|Androgens|androgens|mesh-ancestor
56211873|NCT04456296|Hormones|hormones|mesh-ancestor
56211874|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211875|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211876|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56211877|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211878|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
56211879|NCT04420598|Trastuzumab|trastuzumab|mesh-list
56211880|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56211881|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211882|NCT04408118|Paclitaxel|paclitaxel|mesh-list
56211883|NCT04408118|Atezolizumab|atezolizumab|mesh-list
56211884|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56211885|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211886|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56211887|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211888|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56211889|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211890|NCT04403321|Tacrolimus|tacrolimus|mesh-list
56211891|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211892|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
56211893|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211894|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56211895|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211896|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211897|NCT04332744|Talazoparib|talazoparib|mesh-list
56211898|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56211899|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211900|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211901|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211903|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56211904|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211905|NCT04265755|Analgesics|analgesics|mesh-ancestor
56211906|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
56211907|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211908|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211909|NCT04246372|Tofacitinib|tofacitinib|mesh-list
56211910|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55748645|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
56211911|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211912|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211913|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
56211914|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56211915|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56211916|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
56211917|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
56671243|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671244|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56671245|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
56671246|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56671247|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56671248|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671249|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671250|NCT00668096|Urological Agents|urological agents|mesh-ancestor
56671251|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56671252|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
56671253|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
56671254|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56671255|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211918|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56211919|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211920|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
56211921|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211922|NCT04217278|Cytarabine|cytarabine|mesh-list
56211923|NCT04217278|Fludarabine|fludarabine|mesh-list
56211924|NCT04217278|Busulfan|busulfan|mesh-list
56211925|NCT04217278|Thiotepa|thiotepa|mesh-list
56211926|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182136|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56182137|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
56182138|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
56182139|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
56182140|NCT01416558|Paclitaxel|paclitaxel|mesh-list
56182141|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56182142|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182143|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
56182144|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
56182145|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
56182146|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182147|NCT01416649|Exenatide|exenatide|mesh-list
56182148|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56211927|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211928|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
56211929|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211930|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211931|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
55748700|NCT04507217|Pemetrexed|pemetrexed|mesh-list
56211932|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211933|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
56211934|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211935|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
56211936|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56211937|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56211938|NCT04182334|TEMPO|tempo|mesh-list
56211939|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
56211940|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211941|NCT04182334|Protective Agents|protective agents|mesh-ancestor
56211942|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211943|NCT04123444|Iloprost|iloprost|mesh-list
56211944|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56211945|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
56211946|NCT04098250|Erenumab|erenumab|mesh-list
56211947|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56211948|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211950|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
56211951|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939770|NCT01289457|Fludarabine|fludarabine|mesh-list
56671256|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56671257|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671258|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671259|NCT03252587|BMS-986165|bms-986165|mesh-list
56211952|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211953|NCT04003103|Islatravir|islatravir|mesh-list
56211954|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
56211955|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211956|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211957|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211958|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55748807|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748809|NCT03258931|Cytarabine|cytarabine|mesh-list
56211959|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56211960|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56211961|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
56211962|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
56211963|NCT04002115|Busulfan|busulfan|mesh-list
56211964|NCT04002115|Fludarabine|fludarabine|mesh-list
56211965|NCT04002115|Clofarabine|clofarabine|mesh-list
56211966|NCT04002115|Tacrolimus|tacrolimus|mesh-list
56211967|NCT04002115|Lenograstim|lenograstim|mesh-list
56211968|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56211969|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
56211970|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211971|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56211972|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56211973|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
56182149|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182150|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56182151|NCT01416649|Incretins|incretins|mesh-ancestor
56182152|NCT01416649|Hormones|hormones|mesh-ancestor
56182153|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182154|NCT01416662|Gemcitabine|gemcitabine|mesh-list
56182155|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56182156|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
56182157|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182158|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182159|NCT01416662|Antiviral Agents|antiviral agents|mesh-ancestor
56182160|NCT01416662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182161|NCT01416662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182162|NCT01416662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55882702|NCT03364764|Sirolimus|sirolimus|mesh-list
56211974|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211975|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211976|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56211977|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211978|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
56211979|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56211980|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211981|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56211982|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56211983|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
56211984|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56211985|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211986|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56211987|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56211988|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
56211989|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211990|NCT03978598|Etonogestrel|etonogestrel|mesh-list
56211991|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56211992|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
56211993|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56211994|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211995|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56211996|NCT03967197|Lidocaine|lidocaine|mesh-list
56211997|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
56211999|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212000|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212001|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
56212002|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671260|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
56671261|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56671262|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671263|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671264|NCT02630264|Paclitaxel|paclitaxel|mesh-list
56671265|NCT02630264|Endostatins|endostatins|mesh-list
56671266|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56671267|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671268|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
56671269|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
56671270|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
56671271|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671272|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56671273|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56671274|NCT02630264|Growth Substances|growth substances|mesh-ancestor
56671275|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212003|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56212004|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56212005|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56212006|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56212007|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212008|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
56212009|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56212010|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56212011|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56212012|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56212013|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212014|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
56212015|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212016|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212017|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56182163|NCT01416662|Immunologic Factors|immunologic factors|mesh-ancestor
56182164|NCT01416662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182166|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
56182167|NCT01416701|Vitamins|vitamins|mesh-list
56182168|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
56182169|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182170|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56182171|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56182172|NCT01416870|Bicalutamide|bicalutamide|mesh-list
56182173|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
56182174|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
56182175|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182176|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182177|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182178|NCT01416883|Bicalutamide|bicalutamide|mesh-list
56182179|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
56182180|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
56182181|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182182|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212018|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212019|NCT03935646|Adderall|adderall|mesh-list
56212020|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56212021|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212023|NCT03926026|Xhance|xhance|mesh-list
56671276|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
56671277|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
56671278|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
56671279|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
56671280|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56671281|NCT00668330|Calcium|calcium|mesh-list
56671282|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56671283|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671284|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56671285|NCT00668330|Vitamins|vitamins|mesh-ancestor
56671286|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
56671287|NCT01012687|Perindopril|perindopril|mesh-list
56671288|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56671289|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
56671290|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671291|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671292|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56671293|NCT00662948|Rituximab|rituximab|mesh-list
56671294|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56671295|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671296|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
56671297|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671298|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671299|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
56212024|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56212025|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56212026|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
56212027|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212028|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212029|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56212030|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
56212031|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
56212032|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56212033|NCT03875573|Durvalumab|durvalumab|mesh-list
56212034|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212035|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212036|NCT03871153|Paclitaxel|paclitaxel|mesh-list
56212037|NCT03871153|Carboplatin|carboplatin|mesh-list
56212038|NCT03871153|Durvalumab|durvalumab|mesh-list
56212039|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212040|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212042|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212043|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212044|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212045|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212046|NCT03672630|Azithromycin|azithromycin|mesh-list
56212047|NCT03672630|Rifampin|rifampin|mesh-list
56212048|NCT03672630|Ethambutol|ethambutol|mesh-list
56212049|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56212050|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212051|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56212052|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
56671300|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56671301|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
56671302|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56671303|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
56671304|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671305|NCT00672464|Metformin|metformin|mesh-list
56671306|NCT00672464|Olanzapine|olanzapine|mesh-list
56671307|NCT00672464|Simvastatin|simvastatin|mesh-list
56671308|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56671309|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671310|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56671311|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56671312|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
56671313|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671314|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56671315|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56671316|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671317|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
56671318|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
56671319|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671320|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56671321|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56671322|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56671323|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56671324|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56671325|NCT00672464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56671326|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56671327|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56671328|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671329|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
56671330|NCT02701595|Amoxicillin|amoxicillin|mesh-list
56671331|NCT02701595|Vancomycin|vancomycin|mesh-list
56212053|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
56212054|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56182183|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182184|NCT01416909|Laxatives|laxatives|mesh-list
56182185|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56182186|NCT01416948|Methylphenidate|methylphenidate|mesh-list
56182187|NCT01416948|Galantamine|galantamine|mesh-list
56182188|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56182189|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182190|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56182191|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56182192|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56671332|NCT02701595|Gentamicins|gentamicins|mesh-list
56671333|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
56671334|NCT02701595|Penicillins|penicillins|mesh-list
56671335|NCT02701595|Penicillin G|penicillin g|mesh-list
56671336|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56182193|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182194|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
56182197|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182198|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
56182199|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56182200|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
56182201|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182202|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
56182203|NCT01416961|Etoposide|etoposide|mesh-list
56182204|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
56182205|NCT01416961|Cisplatin|cisplatin|mesh-list
56182206|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56182207|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212055|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212056|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212057|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56212058|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56212059|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55748933|NCT05513807|Niacin|niacin|mesh-list
56212060|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56212061|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56212062|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56212064|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212065|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212066|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55748994|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
56212067|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212068|NCT03536728|Eflornithine|eflornithine|mesh-list
56212069|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212070|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56212071|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56212072|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56212073|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212074|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56212075|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212076|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212077|NCT03517423|Brivaracetam|brivaracetam|mesh-list
56182208|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56182209|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56182211|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182212|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
56182213|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56182214|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
56182215|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182216|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56182217|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56182218|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
56182219|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182220|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182221|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56182222|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56182223|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
56182224|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56182225|NCT01417065|Sirolimus|sirolimus|mesh-list
56182226|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56182227|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182228|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56212078|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
56212079|NCT03470675|Ketamine|ketamine|mesh-list
56212080|NCT03470675|Morphine|morphine|mesh-list
56212081|NCT03470675|Analgesics|analgesics|mesh-ancestor
56212082|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
56212083|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212084|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212085|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56212086|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56671337|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
56671338|NCT02701595|Netilmicin|netilmicin|mesh-list
56671339|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56671340|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671341|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56671342|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671343|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671344|NCT00668642|Dutasteride|dutasteride|mesh-list
56671345|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56671346|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56671347|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671348|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671349|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
56232534|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
56212087|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
56212088|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
56212089|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212090|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56212091|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56212092|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212106|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212107|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212109|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56212110|NCT03462251|Growth Substances|growth substances|mesh-ancestor
56182229|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182230|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
56182231|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56182232|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
56182233|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182235|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
56182236|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212111|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212112|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
56212113|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56212114|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
56212115|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56212116|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56212117|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56212118|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
56212119|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56212120|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56212121|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212122|NCT03418038|Vitamins|vitamins|mesh-list
56212123|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
56212124|NCT03418038|Gemcitabine|gemcitabine|mesh-list
56212125|NCT03418038|Cytarabine|cytarabine|mesh-list
56212126|NCT03418038|Dexamethasone|dexamethasone|mesh-list
56212127|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
56212128|NCT03418038|Rituximab|rituximab|mesh-list
56212129|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56212130|NCT03418038|Cisplatin|cisplatin|mesh-list
56212131|NCT03418038|Carboplatin|carboplatin|mesh-list
56212132|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
56212133|NCT03418038|Etoposide|etoposide|mesh-list
56212134|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
56212135|NCT03418038|Ifosfamide|ifosfamide|mesh-list
56212136|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
56212137|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
56212138|NCT03418038|Antibodies|antibodies|mesh-list
56212139|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
56212140|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56212141|NCT03418038|BB 1101|bb 1101|mesh-list
55749216|NCT03346187|Fenofibrate|fenofibrate|mesh-list
56671350|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56671351|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671352|NCT02698553|Bupropion|bupropion|mesh-list
56671353|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56671354|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
56671355|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56671356|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56671357|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56671358|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56671359|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671360|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
56671361|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671362|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671363|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56671364|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56671365|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671366|NCT00663182|Entecavir|entecavir|mesh-list
56671367|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
56671368|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671369|NCT00616031|Paclitaxel|paclitaxel|mesh-list
56671370|NCT00616031|Carboplatin|carboplatin|mesh-list
56212142|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
56212143|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212144|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
56212145|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212146|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212147|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56212148|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
56212149|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
56212150|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212151|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56212152|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
56212154|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56212156|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
56212157|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212158|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212159|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56212160|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
56212161|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
56212162|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212163|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212164|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212165|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56212166|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56212167|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
56212168|NCT03418038|Protective Agents|protective agents|mesh-ancestor
56212169|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212170|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
56212171|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
56212172|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
56182238|NCT01417273|Vitamins|vitamins|mesh-ancestor
56182239|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
56671371|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
56671372|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56671373|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182240|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182241|NCT01417351|Vitamin D|vitamin d|mesh-list
56182242|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
56182243|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
56182244|NCT01417351|Vitamins|vitamins|mesh-list
56182245|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
56182246|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182247|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56182248|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56182249|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
56182250|NCT01417364|Testosterone|testosterone|mesh-list
56182251|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
56182252|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
56182253|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56212174|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212175|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212176|NCT03409718|Cimetidine|cimetidine|mesh-list
56212177|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56212178|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56212179|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56212180|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
56212181|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
56212182|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212183|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212184|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212185|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56212186|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56212187|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212188|NCT03404778|Cimetidine|cimetidine|mesh-list
56212189|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56212190|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56212191|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56212192|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
56212193|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
56212194|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212195|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212196|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212197|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56212198|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56212199|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212200|NCT03392246|Osimertinib|osimertinib|mesh-list
56212201|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212202|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56212203|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212204|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212205|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
56212206|NCT03340766|Blinatumomab|blinatumomab|mesh-list
56212207|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212208|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212209|NCT03317457|Doxorubicin|doxorubicin|mesh-list
56212210|NCT03317457|Durvalumab|durvalumab|mesh-list
56212211|NCT03317457|Tremelimumab|tremelimumab|mesh-list
56212213|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212214|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56212215|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56182254|NCT01417364|Androgens|androgens|mesh-ancestor
56182255|NCT01417364|Hormones|hormones|mesh-ancestor
56182256|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182257|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182258|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56182259|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182260|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
56182261|NCT01417390|Gemcitabine|gemcitabine|mesh-list
56182262|NCT01417390|Cisplatin|cisplatin|mesh-list
56182263|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182264|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56182265|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
56182266|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182267|NCT01417390|Antiviral Agents|antiviral agents|mesh-ancestor
56182268|NCT01417390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671374|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
56671375|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
56671376|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
56671377|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671378|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
56671379|NCT04213937|Paclitaxel|paclitaxel|mesh-list
56671380|NCT04213937|Topotecan|topotecan|mesh-list
56671381|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56671382|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671383|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
56671384|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
56671385|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
56671386|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671387|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56671388|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56671389|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671390|NCT02701517|Cyclosporine|cyclosporine|mesh-list
56671391|NCT02701517|Methotrexate|methotrexate|mesh-list
56671392|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
56671393|NCT02701517|Cyclosporins|cyclosporins|mesh-list
56671394|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56671395|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
56671396|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56671397|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671398|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56182269|NCT01417390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182270|NCT01417390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56182271|NCT01417390|Immunologic Factors|immunologic factors|mesh-ancestor
55883052|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
56212217|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212218|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212219|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
56212220|NCT03294954|Fludarabine|fludarabine|mesh-list
56212221|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212222|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
56212223|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212224|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212225|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212226|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
56212227|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212228|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212229|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56212231|NCT03274414|Etoposide|etoposide|mesh-list
56212232|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212233|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212234|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56212235|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56212236|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212237|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671399|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
56671400|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671401|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671402|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
56671403|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671404|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56671405|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671406|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
56671407|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671408|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56671409|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
56671410|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671411|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56671412|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56671413|NCT02630108|Epirubicin|epirubicin|mesh-list
56671414|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
56671415|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56671416|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671417|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56671418|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56671419|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212239|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56212240|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
56212241|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212242|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212243|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56212244|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56212245|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
56212246|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212247|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212248|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
55749550|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212249|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212250|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212252|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56212253|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56212254|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
56182272|NCT01417390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182273|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
56182274|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
56182275|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56182276|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56182277|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182278|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182279|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182280|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56182281|NCT01417429|Galantamine|galantamine|mesh-list
56182282|NCT01417429|Nicotine|nicotine|mesh-list
56182283|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56182284|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
56182291|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182292|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56182293|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182294|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56671420|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671421|NCT00505921|Cytarabine|cytarabine|mesh-list
56671422|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
56671423|NCT00505921|Melphalan|melphalan|mesh-list
56671424|NCT00505921|Carmustine|carmustine|mesh-list
56671425|NCT00505921|Fludarabine|fludarabine|mesh-list
56671426|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
56671427|NCT00505921|Etoposide|etoposide|mesh-list
56671428|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
56671429|NCT00505921|Molgramostim|molgramostim|mesh-list
56671430|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
56671431|NCT00505921|Sargramostim|sargramostim|mesh-list
56671432|NCT00505921|Lenograstim|lenograstim|mesh-list
56671433|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671434|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
56182295|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
56182296|NCT01417494|Leucovorin|leucovorin|mesh-list
56182297|NCT01417494|Bevacizumab|bevacizumab|mesh-list
56182298|NCT01417494|Fluorouracil|fluorouracil|mesh-list
56182299|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
56182300|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56182301|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182302|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56182303|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56182304|NCT01417494|Growth Substances|growth substances|mesh-ancestor
56182305|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182306|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
56182307|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
56182308|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212255|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182309|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56182311|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
56182312|NCT01417494|Antidotes|antidotes|mesh-ancestor
56182313|NCT01417494|Protective Agents|protective agents|mesh-ancestor
56182314|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
56182315|NCT01417494|Vitamins|vitamins|mesh-ancestor
56182316|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
56182317|NCT01417572|Lidocaine|lidocaine|mesh-list
56182318|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
56182319|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
56182320|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212256|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56212257|NCT05705492|Olanzapine|olanzapine|mesh-list
56212258|NCT05705492|Antiemetics|antiemetics|mesh-ancestor
56212259|NCT05705492|Autonomic Agents|autonomic agents|mesh-ancestor
56212260|NCT05705492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212261|NCT05705492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212262|NCT05705492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56212264|NCT05705492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56212265|NCT05705492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212266|NCT05705492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56212267|NCT05705492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56212268|NCT05705492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56212269|NCT05705492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56212270|NCT05705492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212271|NCT05705492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212272|NCT05705492|Serotonin Agents|serotonin agents|mesh-ancestor
56212273|NCT05705466|Pembrolizumab|pembrolizumab|mesh-list
56212274|NCT05705466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212275|NCT05705466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212276|NCT05705388|Liraglutide|liraglutide|mesh-list
56212277|NCT05705388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56212278|NCT05705388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212279|NCT05705388|Incretins|incretins|mesh-ancestor
56212280|NCT05705388|Hormones|hormones|mesh-ancestor
55939771|NCT01289457|Idarubicin|idarubicin|mesh-list
56671435|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671436|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671437|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212281|NCT05705388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56212282|NCT05705336|Tranexamic Acid|tranexamic acid|mesh-list
56212283|NCT05705336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56212284|NCT05705336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56212285|NCT05705336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212286|NCT05705336|Hemostatics|hemostatics|mesh-ancestor
56212287|NCT05705336|Coagulants|coagulants|mesh-ancestor
56212288|NCT05705089|Warfarin|warfarin|mesh-list
56212289|NCT05705089|Rivaroxaban|rivaroxaban|mesh-list
56212290|NCT05705089|Anticoagulants|anticoagulants|mesh-ancestor
56212291|NCT05705089|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56212292|NCT05705089|Antithrombins|antithrombins|mesh-ancestor
56212293|NCT05705089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56212294|NCT05705089|Protease Inhibitors|protease inhibitors|mesh-ancestor
56212295|NCT05705089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212296|NCT05705089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212297|NCT05705037|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
56212298|NCT05705037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55749735|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
56212300|NCT05705037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212301|NCT05705037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212302|NCT05705037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212303|NCT05704959|Povidone-Iodine|povidone-iodine|mesh-list
56212304|NCT05704959|Povidone|povidone|mesh-list
56212305|NCT05704959|Plasma Substitutes|plasma substitutes|mesh-ancestor
56212306|NCT05704959|Blood Substitutes|blood substitutes|mesh-ancestor
56212307|NCT05704959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56212308|NCT05704959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212309|NCT05704894|Epoetin Alfa|epoetin alfa|mesh-list
56212310|NCT05704894|Hematinics|hematinics|mesh-ancestor
56182321|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182322|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
56182323|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182324|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56182325|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56182326|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56182327|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182328|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182329|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56182330|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56182331|NCT01417754|Toremifene|toremifene|mesh-list
56182332|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56182333|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182334|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56182335|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56182336|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
56182337|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182338|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182339|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56182340|NCT01417767|Decitabine|decitabine|mesh-list
56182341|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56182342|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
56182343|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182344|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182345|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182346|NCT01417806|Topotecan|topotecan|mesh-list
56182347|NCT01417806|Pasireotide|pasireotide|mesh-list
56182348|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56182349|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56182350|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182351|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182352|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182353|NCT01417806|Hormones|hormones|mesh-ancestor
56182354|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182357|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56182358|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56671438|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
56671439|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671440|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671441|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56671442|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56671443|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
56671444|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
56671445|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671446|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56671447|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56671448|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56671449|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671450|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56671451|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56671453|NCT04729205|Mitomycin|mitomycin|mesh-list
56671454|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56182359|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56182360|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56182361|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
56110118|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
56182362|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182363|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182364|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182366|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56182367|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
56182368|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
56182369|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56182370|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182371|NCT01417923|Vitamin D|vitamin d|mesh-list
56182372|NCT01417923|Vitamins|vitamins|mesh-ancestor
56182373|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
56182374|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182389|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56182390|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56182400|NCT01418118|Protective Agents|protective agents|mesh-ancestor
56182401|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
56182402|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
56182405|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56182406|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56182407|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
56182408|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182409|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182410|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182411|NCT01418144|Ropivacaine|ropivacaine|mesh-list
56182412|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
56182413|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
56182414|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56182415|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182416|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
56182417|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182418|NCT01418157|Acetazolamide|acetazolamide|mesh-list
56182419|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
56182420|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56182421|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182422|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182423|NCT01418157|Diuretics|diuretics|mesh-ancestor
56182424|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
56182425|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671455|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671456|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
56671457|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671458|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56671459|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671460|NCT00669344|Rivastigmine|rivastigmine|mesh-list
56671461|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56671462|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671463|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671464|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
56671465|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671466|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671467|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56671468|NCT00669344|Protective Agents|protective agents|mesh-ancestor
56671469|NCT02701127|Niacinamide|niacinamide|mesh-list
56671470|NCT02701127|Niacin|niacin|mesh-list
56671471|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
56671472|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
56671473|NCT02701127|Vitamins|vitamins|mesh-ancestor
56671474|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
56671475|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671476|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56671477|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
56182426|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
56182427|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
56182428|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
56182429|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56182430|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182431|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
56182432|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182437|NCT01418274|Ritonavir|ritonavir|mesh-list
56182443|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182444|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56182445|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56182446|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
56182447|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182448|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56182449|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56182450|NCT01418274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56182451|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56182452|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182453|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182454|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
56182455|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883324|NCT05584644|Palbociclib|palbociclib|mesh-list
56212311|NCT05704829|Trastuzumab|trastuzumab|mesh-list
56212312|NCT05704829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212313|NCT05704829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212314|NCT05704816|Anesthetics|anesthetics|mesh-list
56212315|NCT05704816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212316|NCT05704816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212317|NCT05704634|Cemiplimab|cemiplimab|mesh-list
56671478|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671479|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56671480|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
56671481|NCT02700893|Atropine|atropine|mesh-list
56671482|NCT02700893|Sufentanil|sufentanil|mesh-list
56671483|NCT02700893|Propofol|propofol|mesh-list
56671484|NCT02700893|Atracurium|atracurium|mesh-list
56671485|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56671486|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56671487|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671488|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56671489|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
56671490|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
56671491|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56671492|NCT02700893|Narcotics|narcotics|mesh-ancestor
56671493|NCT02700893|Analgesics|analgesics|mesh-ancestor
56671494|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
56212318|NCT05704634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212319|NCT05704634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212320|NCT05704595|Diuretics|diuretics|mesh-list
56212321|NCT05704595|Natriuretic Agents|natriuretic agents|mesh-ancestor
56212322|NCT05704595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212323|NCT05704400|Rituximab|rituximab|mesh-list
56212324|NCT05704400|Daratumumab|daratumumab|mesh-list
56212325|NCT05704400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212326|NCT05704400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212327|NCT05704400|Immunologic Factors|immunologic factors|mesh-ancestor
56212328|NCT05704400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212329|NCT05704400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212330|NCT05704374|Pregabalin|pregabalin|mesh-list
56212331|NCT05704374|Analgesics|analgesics|mesh-ancestor
56212332|NCT05704374|Sensory System Agents|sensory system agents|mesh-ancestor
56212333|NCT05704374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212334|NCT05704374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212335|NCT05704374|Anticonvulsants|anticonvulsants|mesh-ancestor
56212337|NCT05704374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56212338|NCT05704374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212339|NCT05704374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56212340|NCT05704374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56212341|NCT05704374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56212342|NCT05704374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212343|NCT05704374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56212344|NCT05704166|Pirfenidone|pirfenidone|mesh-list
56212345|NCT05704166|Analgesics|analgesics|mesh-ancestor
56212346|NCT05704166|Sensory System Agents|sensory system agents|mesh-ancestor
56212347|NCT05704166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212348|NCT05704166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212349|NCT05704166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56212350|NCT05704166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56212351|NCT05704166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56212352|NCT05704166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212353|NCT05704166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212354|NCT05704114|Tazarotene|tazarotene|mesh-list
56212355|NCT05704114|Dermatologic Agents|dermatologic agents|mesh-ancestor
56212356|NCT05704114|Keratolytic Agents|keratolytic agents|mesh-ancestor
56212357|NCT05704088|Dapagliflozin|dapagliflozin|mesh-list
56182456|NCT01418274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56182457|NCT01418274|Antidepressive Agents|antidepressive agents|mesh-ancestor
56182458|NCT01418274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56182459|NCT01418417|Pantoprazole|pantoprazole|mesh-list
56182460|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56671495|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671496|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56671497|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56671498|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56671499|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
56671500|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56671501|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
56671502|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
56671503|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
56671504|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56671505|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56671506|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
56671507|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671508|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182461|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56182462|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56182463|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182464|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182465|NCT01418430|Daclizumab|daclizumab|mesh-list
56182466|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56182467|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
56182468|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182469|NCT01418443|Pantoprazole|pantoprazole|mesh-list
56182470|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56182471|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56182472|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56182473|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212358|NCT05704088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56212359|NCT05704088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212360|NCT05704088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56212361|NCT05704088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212362|NCT05703997|Atezolizumab|atezolizumab|mesh-list
56212363|NCT05703997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212364|NCT05703984|Metformin|metformin|mesh-list
56212365|NCT05703984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749967|NCT02512055|Ketamine|ketamine|mesh-list
56212366|NCT05703984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212367|NCT05703854|Cyclophosphamide|cyclophosphamide|mesh-list
56212368|NCT05703854|Fludarabine|fludarabine|mesh-list
56212369|NCT05703854|Fludarabine phosphate|fludarabine phosphate|mesh-list
56212370|NCT05703854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212371|NCT05703854|Immunologic Factors|immunologic factors|mesh-ancestor
56212372|NCT05703854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212373|NCT05703854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212374|NCT05703854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212375|NCT05703854|Alkylating Agents|alkylating agents|mesh-ancestor
56212376|NCT05703854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212377|NCT05703854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212378|NCT05703854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56212379|NCT05703854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56212380|NCT05703854|Antimetabolites|antimetabolites|mesh-ancestor
56212381|NCT05703672|Varenicline|varenicline|mesh-list
56212382|NCT05703672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56212383|NCT05703672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56212384|NCT05703672|Cholinergic Agents|cholinergic agents|mesh-ancestor
56212385|NCT05703672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212386|NCT05703672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212387|NCT05703672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212388|NCT05703659|Sulfalene|sulfalene|mesh-list
56212389|NCT05703659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671509|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56671510|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56671511|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56671512|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56671513|NCT04213781|Sufentanil|sufentanil|mesh-list
56671514|NCT04213781|Propofol|propofol|mesh-list
56671515|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56671516|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56671517|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232699|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
56212390|NCT05703659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56212391|NCT05703659|Renal Agents|renal agents|mesh-ancestor
56212392|NCT05703659|Antimalarials|antimalarials|mesh-ancestor
56212393|NCT05703659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56212394|NCT05703659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56212395|NCT05703555|Maytansine|maytansine|mesh-list
56212396|NCT05703555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56182474|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182475|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56182476|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182477|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56182478|NCT01418534|Isosorbide|isosorbide|mesh-list
56182479|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56182480|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56212397|NCT05703555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212398|NCT05703555|Tubulin Modulators|tubulin modulators|mesh-ancestor
55750133|NCT03121313|Tegafur|tegafur|mesh-list
56212405|NCT05703425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56212406|NCT05703425|Analgesics|analgesics|mesh-ancestor
56212407|NCT05703425|Sensory System Agents|sensory system agents|mesh-ancestor
56212408|NCT05703425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212409|NCT05703425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212410|NCT05703425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56212411|NCT05703425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212412|NCT05703425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56212413|NCT05703373|Micronutrients|micronutrients|mesh-list
56212414|NCT05703373|Trace Elements|trace elements|mesh-list
56212415|NCT05703373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212417|NCT05702190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55750270|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
55750272|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750273|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56212418|NCT05702190|Narcotics|narcotics|mesh-ancestor
55750343|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
56212419|NCT05702190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212420|NCT05702190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212421|NCT05702190|Analgesics|analgesics|mesh-ancestor
56212422|NCT05702190|Sensory System Agents|sensory system agents|mesh-ancestor
56212423|NCT05702190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212424|NCT05702190|Antidiarrheals|antidiarrheals|mesh-ancestor
56212425|NCT05702190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56212426|NCT05702190|Antitussive Agents|antitussive agents|mesh-ancestor
56212427|NCT05702190|Respiratory System Agents|respiratory system agents|mesh-ancestor
56212428|NCT05701124|Ranibizumab|ranibizumab|mesh-list
56212429|NCT05701124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56212430|NCT05701124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56212431|NCT05701124|Growth Substances|growth substances|mesh-ancestor
56212432|NCT05701124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212433|NCT05701124|Growth Inhibitors|growth inhibitors|mesh-ancestor
56212434|NCT05701124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212442|NCT05688085|Amlodipine|amlodipine|mesh-list
56212443|NCT05688085|Irbesartan|irbesartan|mesh-list
56212444|NCT05688085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56212445|NCT05688085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56212446|NCT05688085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56212447|NCT05688085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671518|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56671519|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
56671520|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
56671521|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56671522|NCT04213781|Narcotics|narcotics|mesh-ancestor
56671523|NCT04213781|Analgesics|analgesics|mesh-ancestor
56671524|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
56671525|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671526|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56671527|NCT00505687|Rotigotine|rotigotine|mesh-list
56671528|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
56671529|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
56671530|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671531|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671532|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671533|NCT00669656|Vitamin D|vitamin d|mesh-list
56671534|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
56671535|NCT00669656|Vitamins|vitamins|mesh-list
56212448|NCT05688085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56212449|NCT05688085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212450|NCT05688085|Vasodilator Agents|vasodilator agents|mesh-ancestor
56212451|NCT05688085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56212452|NCT05688085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56212453|NCT05645380|Cyclophosphamide|cyclophosphamide|mesh-list
56212454|NCT05645380|Carboplatin|carboplatin|mesh-list
56212455|NCT05645380|Docetaxel|docetaxel|mesh-list
56212456|NCT05645380|Doxorubicin|doxorubicin|mesh-list
56212457|NCT05645380|Pembrolizumab|pembrolizumab|mesh-list
55750620|NCT03341117|Antacids|antacids|mesh-ancestor
56212459|NCT05645380|Immunologic Factors|immunologic factors|mesh-ancestor
56212460|NCT05645380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212461|NCT05645380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212462|NCT05645380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212463|NCT05645380|Alkylating Agents|alkylating agents|mesh-ancestor
56212464|NCT05645380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212465|NCT05645380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212466|NCT05645380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56212467|NCT05645380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56182481|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56182482|NCT01418534|Diuretics|diuretics|mesh-ancestor
56182483|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
56182484|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182485|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
56182486|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56182487|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182488|NCT01418547|Isosorbide|isosorbide|mesh-list
56182489|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56182490|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56182491|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56182492|NCT01418547|Diuretics|diuretics|mesh-ancestor
56182493|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
56182494|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182495|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
56182496|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56182497|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182498|NCT01418586|Alfuzosin|alfuzosin|mesh-list
56182499|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56182500|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56182501|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56182502|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
56671536|NCT00669656|Vitamin E|vitamin e|mesh-list
56671537|NCT00669656|Tocopherols|tocopherols|mesh-list
56671538|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
56671539|NCT00669656|Selenium|selenium|mesh-list
56671540|NCT00669656|Lycopene|lycopene|mesh-list
56671541|NCT00669656|Daidzein|daidzein|mesh-list
56671542|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
56671543|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671544|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56671545|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56671546|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
56671547|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671548|NCT00669656|Protective Agents|protective agents|mesh-ancestor
56671549|NCT00669656|Trace Elements|trace elements|mesh-ancestor
56671550|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56232726|NCT01718613|Vasopressins|vasopressins|mesh-list
56182503|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182504|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182505|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182506|NCT01418586|Urological Agents|urological agents|mesh-ancestor
56182507|NCT01418599|Alfuzosin|alfuzosin|mesh-list
56212468|NCT05645380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212469|NCT05645380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212470|NCT05645380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56212472|NCT05645380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140255|NCT03783026|Apremilast|apremilast|mesh-list
56212473|NCT05645380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750828|NCT05053893|Valsartan|valsartan|mesh-list
56212474|NCT05645380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212475|NCT05641246|Diclofenac|diclofenac|mesh-list
56212476|NCT05641246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56212477|NCT05641246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56212478|NCT05641246|Analgesics|analgesics|mesh-ancestor
56212479|NCT05641246|Sensory System Agents|sensory system agents|mesh-ancestor
56212480|NCT05641246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212481|NCT05641246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212482|NCT05641246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56212483|NCT05641246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212484|NCT05641246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56212485|NCT05641246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212486|NCT05641246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212487|NCT05610735|Doxorubicin|doxorubicin|mesh-list
56212488|NCT05610735|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56182508|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56182509|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56182510|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56182511|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
56182513|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182514|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182516|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56182517|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56182518|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56182519|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182520|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182521|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182522|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182523|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56182524|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
56182525|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56671551|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56671552|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56671553|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671554|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
56671555|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56671556|NCT00669656|Estrogens|estrogens|mesh-ancestor
56671557|NCT00669656|Hormones|hormones|mesh-ancestor
56671558|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56671559|NCT03067051|Verteporfin|verteporfin|mesh-list
56671560|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56671561|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
56671562|NCT00672776|Paroxetine|paroxetine|mesh-list
56671563|NCT00672776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56671564|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56671565|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232737|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182526|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56182527|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56182528|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56182529|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182530|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182531|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182532|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182533|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56182534|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
56212489|NCT05610735|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56212490|NCT05610735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212491|NCT05610735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56212492|NCT05610735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56212493|NCT05610735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212494|NCT05610735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212495|NCT05584709|Immunoconjugates|immunoconjugates|mesh-list
56212496|NCT05584709|Immunologic Factors|immunologic factors|mesh-ancestor
56212497|NCT05584709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212498|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
56212499|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
55751110|NCT03335423|Metformin|metformin|mesh-list
56212500|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56212501|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212502|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182535|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56182537|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56182538|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55883593|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56212503|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212504|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56212505|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
56212506|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
56212507|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212508|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212509|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212510|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
56212511|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
56212513|NCT05476939|TIC10 compound|tic10 compound|mesh-list
56212514|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212515|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671566|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671567|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671568|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
56671569|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671570|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56671571|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
56671572|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56671573|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56671574|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56671575|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671576|NCT03000439|Tofacitinib|tofacitinib|mesh-list
56671577|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56212516|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
56212517|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212518|NCT05458232|Tadalafil|tadalafil|mesh-list
56212519|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
56212520|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56212521|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56212522|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212523|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212524|NCT05458232|Urological Agents|urological agents|mesh-ancestor
56212525|NCT05429502|Temozolomide|temozolomide|mesh-list
56212526|NCT05429502|Topotecan|topotecan|mesh-list
56212527|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212528|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
56212529|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212530|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212531|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56212547|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
56212548|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212549|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140330|NCT03591731|Nivolumab|nivolumab|mesh-list
56212550|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212552|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56212553|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212554|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
56212555|NCT05030506|Lenvatinib|lenvatinib|mesh-list
56212556|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212557|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212558|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56212559|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212560|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212561|NCT04979052|Interferons|interferons|mesh-list
56212562|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
56212563|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212564|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
56212565|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212566|NCT04948333|Niacinamide|niacinamide|mesh-list
56212567|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
56212568|NCT04948333|Vitamins|vitamins|mesh-ancestor
56212569|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
56212570|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182539|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182540|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182541|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182542|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182543|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56182544|NCT01418651|Analgesics|analgesics|mesh-ancestor
56182545|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
56182546|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182547|NCT01418729|Pravastatin|pravastatin|mesh-list
56671578|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671579|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671580|NCT00616187|Interferons|interferons|mesh-list
56671581|NCT00616187|Interferon-beta|interferon-beta|mesh-list
56671582|NCT00616187|Atorvastatin|atorvastatin|mesh-list
56671583|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671584|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
56671585|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671586|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56671587|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56671588|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
56671589|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671590|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56671591|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56182548|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56182549|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56182550|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
56182551|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182552|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56182553|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56212571|NCT04935359|Gemcitabine|gemcitabine|mesh-list
56212572|NCT04935359|Paclitaxel|paclitaxel|mesh-list
56212573|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212574|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212575|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
56212576|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212577|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212578|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212579|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56212580|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
55751513|NCT03093129|Artesunate|artesunate|mesh-list
56212598|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212599|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212600|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56212601|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56212602|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
56212603|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56212604|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212605|NCT04911621|Temozolomide|temozolomide|mesh-list
55751695|NCT05015361|Propofol|propofol|mesh-list
56212606|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212607|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
56212608|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212609|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212611|NCT04881240|Fludarabine|fludarabine|mesh-list
56212612|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212613|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
56182554|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182555|NCT01418742|Doxycycline|doxycycline|mesh-list
56182556|NCT01418742|Panitumumab|panitumumab|mesh-list
56182557|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56182558|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182559|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
56182560|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56182561|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56182562|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56182563|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182565|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56182566|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182567|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56671592|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671593|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
56671594|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671595|NCT00663338|Rotigotine|rotigotine|mesh-list
56547661|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56671596|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
56671597|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
56671598|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671599|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182568|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182569|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
56182570|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212614|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212615|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212616|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212617|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
56212618|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212619|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212620|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56212621|NCT04877522|Niacinamide|niacinamide|mesh-list
56212622|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
56212623|NCT04877522|Dasatinib|dasatinib|mesh-list
55800404|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
56212624|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140401|NCT03497676|Rilpivirine|rilpivirine|mesh-list
56212629|NCT04877522|Vitamins|vitamins|mesh-ancestor
56212630|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
56212631|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212632|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56212633|NCT04855266|Hematinics|hematinics|mesh-ancestor
56212634|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
56212635|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
56212636|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56212637|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56212638|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
56212639|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212640|NCT04764643|Expectorants|expectorants|mesh-ancestor
56212641|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
56212642|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56212643|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
55751876|NCT03228043|Apatinib|apatinib|mesh-list
56212644|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212645|NCT04764643|Protective Agents|protective agents|mesh-ancestor
56212646|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212647|NCT04764643|Antidotes|antidotes|mesh-ancestor
56212648|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
56212649|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56212650|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
56212651|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
56212652|NCT04706429|Trientine|trientine|mesh-list
56212653|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
56212654|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
56212655|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212656|NCT04625803|Apatinib|apatinib|mesh-list
56212657|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212658|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56212659|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212660|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182571|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
56182572|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182574|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182575|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56182576|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182577|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182578|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
56182579|NCT01419119|Vitamin D|vitamin d|mesh-list
55883798|NCT02515734|Vitamins|vitamins|mesh-ancestor
56212666|NCT04558892|Enoxaparin|enoxaparin|mesh-list
56212667|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
56671600|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671601|NCT02992015|Gemcitabine|gemcitabine|mesh-list
56671602|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56671603|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
56671604|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671605|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671606|NCT02992015|Antiviral Agents|antiviral agents|mesh-ancestor
56671607|NCT02992015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671608|NCT02992015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671609|NCT02992015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671610|NCT02992015|Immunologic Factors|immunologic factors|mesh-ancestor
56671611|NCT02992015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671612|NCT01009567|Cabergoline|cabergoline|mesh-list
56671613|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56671614|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56671615|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
56671616|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
56212668|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56212669|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56212670|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212671|NCT04551885|Aldesleukin|aldesleukin|mesh-list
56212672|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
56212673|NCT04551885|Fludarabine|fludarabine|mesh-list
56212674|NCT04551885|Avelumab|avelumab|mesh-list
56212675|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212676|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
56212677|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212678|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212679|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212680|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
56212681|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212682|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212683|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56212684|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56212685|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56212686|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
56212687|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212688|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212689|NCT04524000|Fulvestrant|fulvestrant|mesh-list
56212690|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56212691|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751948|NCT03078777|Fexofenadine|fexofenadine|mesh-list
56212692|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56212693|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56212694|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
56212695|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56212696|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212698|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
55752024|NCT03319823|Diuretics|diuretics|mesh-ancestor
56212708|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56212709|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212710|NCT04402073|Vincristine|vincristine|mesh-list
56212711|NCT04402073|Lomustine|lomustine|mesh-list
56212712|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212713|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212714|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
56212715|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212716|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
56671617|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671618|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232806|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
56212717|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212718|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212719|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
56212720|NCT04381832|Docetaxel|docetaxel|mesh-list
56212721|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182580|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56182581|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56110365|NCT02106156|Ribavirin|ribavirin|mesh-list
55883851|NCT04497792|Metformin|metformin|mesh-list
56212722|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
56212723|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212724|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212725|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212726|NCT04304820|Cyclosporine|cyclosporine|mesh-list
56212727|NCT04304820|Cyclosporins|cyclosporins|mesh-list
56212728|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56212729|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212730|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212731|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212732|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
55752165|NCT02487407|Simendan|simendan|mesh-list
56212733|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212734|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
56212735|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212736|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
56212737|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212738|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56212739|NCT04231877|Prednisone|prednisone|mesh-list
56212740|NCT04231877|Cortisone|cortisone|mesh-list
56212741|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
56212742|NCT04231877|Rituximab|rituximab|mesh-list
56212743|NCT04231877|Doxorubicin|doxorubicin|mesh-list
56212744|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56212745|NCT04231877|Etoposide|etoposide|mesh-list
56212746|NCT04231877|Daunorubicin|daunorubicin|mesh-list
56212747|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
56212748|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56212749|NCT04231877|Antibodies|antibodies|mesh-list
56212750|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
56212751|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56212752|NCT04231877|Lenograstim|lenograstim|mesh-list
56212753|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
56212754|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212755|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
56212756|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212757|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212758|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212759|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
56212760|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212761|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212762|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56212763|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56212774|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
56140550|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56212775|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
55752329|NCT03321773|Bismuth|bismuth|mesh-list
56212776|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
56212777|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212778|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212779|NCT04199728|Liraglutide|liraglutide|mesh-list
56212780|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56212781|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212782|NCT04199728|Incretins|incretins|mesh-ancestor
56212783|NCT04199728|Hormones|hormones|mesh-ancestor
56212784|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56212785|NCT04166435|Temozolomide|temozolomide|mesh-list
56212786|NCT04166435|Olaparib|olaparib|mesh-list
56212787|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212788|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
56182582|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182583|NCT01419119|Vitamins|vitamins|mesh-ancestor
56182584|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
56671619|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671620|NCT00669812|Cytarabine|cytarabine|mesh-list
56671621|NCT00669812|Prednisolone|prednisolone|mesh-list
56671622|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
56671623|NCT00669812|Melphalan|melphalan|mesh-list
56671624|NCT00669812|Ifosfamide|ifosfamide|mesh-list
56671625|NCT00669812|Carmustine|carmustine|mesh-list
56671626|NCT00669812|Doxorubicin|doxorubicin|mesh-list
56671627|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56671628|NCT00669812|Methotrexate|methotrexate|mesh-list
56671629|NCT00669812|Etoposide|etoposide|mesh-list
56671630|NCT00669812|Vincristine|vincristine|mesh-list
56182585|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56182586|NCT01419132|Furosemide|furosemide|mesh-list
56182587|NCT01419132|Diuretics|diuretics|mesh-list
56212789|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212790|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212791|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56212792|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212793|NCT04162015|Carboplatin|carboplatin|mesh-list
56212794|NCT04162015|Nivolumab|nivolumab|mesh-list
56212796|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212797|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212798|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56212799|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212800|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212801|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56212802|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56212803|NCT04077515|Sirolimus|sirolimus|mesh-list
56212804|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56212805|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212806|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56212807|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212808|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
56212809|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212810|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
56212811|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212812|NCT04037527|Gemcitabine|gemcitabine|mesh-list
56212813|NCT04037527|Docetaxel|docetaxel|mesh-list
56212814|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56212815|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
56212816|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212817|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212818|NCT04037527|Antiviral Agents|antiviral agents|mesh-ancestor
55800495|NCT04894643|Immunologic Factors|immunologic factors|mesh-ancestor
56212829|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56212830|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
56212831|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56212832|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212833|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56212834|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212835|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56212836|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56212837|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56212838|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
56212839|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212840|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56212841|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212842|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212843|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
56212844|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56212845|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212846|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56212848|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
56212849|NCT03980769|Thiotepa|thiotepa|mesh-list
56212850|NCT03980769|Treosulfan|treosulfan|mesh-list
56671631|NCT00669812|Epirubicin|epirubicin|mesh-list
56671632|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671633|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
56671634|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671635|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671636|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56671637|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
56671638|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671639|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671640|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56671641|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56212851|NCT03980769|Busulfan|busulfan|mesh-list
56140626|NCT02368886|Clobetasol|clobetasol|mesh-list
56212852|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56182589|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182590|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56182591|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182592|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182593|NCT01419262|Vitamin D|vitamin d|mesh-list
56182594|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
55884014|NCT04499118|Paclitaxel|paclitaxel|mesh-list
56212854|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212855|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56212856|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
56212857|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212858|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212859|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
56212860|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212861|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212862|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
56212863|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56212865|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56212866|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56212867|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56212868|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56212869|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
56212870|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212871|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212872|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212873|NCT03975829|Trametinib|trametinib|mesh-list
56212874|NCT03975829|Dabrafenib|dabrafenib|mesh-list
56212875|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212876|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56212880|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212881|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
56212883|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56212884|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212885|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212886|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212887|NCT03936153|Abexinostat|abexinostat|mesh-list
56212888|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56212889|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212890|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212892|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212893|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212894|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56212895|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212896|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212897|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212898|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
56212899|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56671642|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56671643|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56671644|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671645|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56671646|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
56671647|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56671648|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56671649|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
56671650|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
56671651|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56212900|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
56212901|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56212902|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
56212903|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212904|NCT03914612|Paclitaxel|paclitaxel|mesh-list
56212905|NCT03914612|Carboplatin|carboplatin|mesh-list
56212906|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
56212907|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56212908|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212909|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212910|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
55752634|NCT03317327|Nivolumab|nivolumab|mesh-list
56212911|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56182595|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
56182596|NCT01419262|Vitamins|vitamins|mesh-list
56182597|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
56212912|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212913|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212914|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212915|NCT03841110|Aldesleukin|aldesleukin|mesh-list
56212916|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
56212917|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
56212918|NCT03841110|Nivolumab|nivolumab|mesh-list
56212919|NCT03841110|Fludarabine|fludarabine|mesh-list
56212920|NCT03841110|Atezolizumab|atezolizumab|mesh-list
56212921|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212922|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
55752678|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752679|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
55752680|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
55752681|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56212923|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212924|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56212925|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56212926|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
56212927|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212928|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212929|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56212930|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56212931|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56212933|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56212935|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212936|NCT03810313|Aflibercept|aflibercept|mesh-list
56212937|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56212938|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56212939|NCT03810313|Growth Substances|growth substances|mesh-ancestor
56212940|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212941|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
56212942|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212943|NCT03802630|Aflibercept|aflibercept|mesh-list
56212946|NCT03802630|Growth Substances|growth substances|mesh-ancestor
56212947|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212948|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
56212949|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212950|NCT03785691|Ondansetron|ondansetron|mesh-list
56212951|NCT03785691|Mirtazapine|mirtazapine|mesh-list
56212952|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
56671652|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56671653|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212953|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
56212954|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56212955|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212956|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56212957|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
56212958|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
56212959|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56212960|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
56212961|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212962|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212963|NCT03785691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56212964|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56212965|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212966|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56212967|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56212968|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
56212969|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56212970|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
56212971|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
56212972|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56212973|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56212974|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56212975|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
56212976|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56212977|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56182598|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182599|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56182600|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56182601|NCT01419340|Donepezil|donepezil|mesh-list
56182602|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56182603|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182604|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182605|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
56182606|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182607|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182608|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
56182609|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56182610|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56182611|NCT01419353|Estradiol|estradiol|mesh-list
56182612|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56182613|NCT01419353|Estrogens|estrogens|mesh-ancestor
56182614|NCT01419353|Hormones|hormones|mesh-ancestor
56182615|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182616|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182617|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56182618|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
56182619|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56182620|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56182621|NCT01419366|Donepezil|donepezil|mesh-list
56182622|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56182623|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182624|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212979|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56212980|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212981|NCT03780829|Renal Agents|renal agents|mesh-ancestor
56212982|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56212983|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
56212984|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56212985|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
56212986|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212987|NCT03736863|Apatinib|apatinib|mesh-list
56212988|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212989|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56212991|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212993|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56212994|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56212995|NCT03710564|Growth Substances|growth substances|mesh-ancestor
55939772|NCT01289457|Clofarabine|clofarabine|mesh-list
56671654|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
56671655|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671656|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56671657|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56671658|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56671659|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56671660|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
56671661|NCT00669812|Hormones|hormones|mesh-ancestor
56671662|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56671663|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56671664|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56671665|NCT02697851|Cobicistat|cobicistat|mesh-list
56671666|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
56671667|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56671668|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56671669|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56671670|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56671671|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
56671672|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547662|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
56671673|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671674|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56671675|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56671676|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56671677|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56212996|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212997|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
56182625|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
56182626|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182627|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182628|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
56182629|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
56182630|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182631|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
56182632|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56182633|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56182634|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182635|NCT01419392|Urological Agents|urological agents|mesh-ancestor
56182636|NCT01419405|Pregabalin|pregabalin|mesh-list
56182637|NCT01419405|Remifentanil|remifentanil|mesh-list
56182638|NCT01419405|Analgesics|analgesics|mesh-ancestor
56182639|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
56182640|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182641|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182642|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
56182643|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56212998|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213000|NCT03703492|Estrogens|estrogens|mesh-ancestor
56213001|NCT03703492|Hormones|hormones|mesh-ancestor
56213002|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56671678|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56671679|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
56671680|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671681|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671683|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56671684|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
56671685|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671686|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56671687|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56213003|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213005|NCT03624127|BMS-986165|bms-986165|mesh-list
55753026|NCT03202615|Lactoferrin|lactoferrin|mesh-list
56213006|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56213007|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56213008|NCT03624127|Analgesics|analgesics|mesh-ancestor
56213009|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
56213010|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213011|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213012|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56213013|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213014|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56213015|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55753064|NCT05713721|Dopamine|dopamine|mesh-list
56213016|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213017|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213018|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
56213019|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213020|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
56213021|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
56213022|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
56213023|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213024|NCT03597568|Resveratrol|resveratrol|mesh-list
56213025|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
56213026|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213027|NCT03597568|Protective Agents|protective agents|mesh-ancestor
56213028|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213029|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213030|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56213031|NCT03499899|Carboplatin|carboplatin|mesh-list
56213032|NCT03499899|Spartalizumab|spartalizumab|mesh-list
56213033|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213034|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56213035|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182644|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182645|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182646|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56182647|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56182648|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56182649|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56182650|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56182651|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56182652|NCT01419405|Narcotics|narcotics|mesh-ancestor
56182653|NCT01419457|Favipiravir|favipiravir|mesh-list
56182654|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
56182655|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182656|NCT01419548|Paclitaxel|paclitaxel|mesh-list
56182657|NCT01419548|Carboplatin|carboplatin|mesh-list
56182659|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56182660|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182661|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
56182662|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
56182663|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
56182664|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182665|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56671688|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56671689|NCT02697851|Estrogens|estrogens|mesh-ancestor
56671690|NCT02697851|Hormones|hormones|mesh-ancestor
56671691|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56671692|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56671693|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56671694|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56671695|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56671696|NCT01012843|Amoxicillin|amoxicillin|mesh-list
56671697|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
56671698|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
56671699|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56671700|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56671701|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671702|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56671703|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671704|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671705|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
56671706|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
56671707|NCT00669890|Busulfan|busulfan|mesh-list
56671708|NCT00669890|Methotrexate|methotrexate|mesh-list
56671709|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
56671710|NCT00669890|Tacrolimus|tacrolimus|mesh-list
56671711|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
56182666|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182667|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56182668|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182669|NCT01419691|Auranofin|auranofin|mesh-list
56182670|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56182671|NCT01419730|Vitamin D|vitamin d|mesh-list
56182672|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
56182673|NCT01419730|Vitamins|vitamins|mesh-ancestor
56182674|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
56182675|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182676|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56182677|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56182678|NCT01419821|Vitamin D|vitamin d|mesh-list
56182679|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
56182680|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
56213036|NCT03481634|Aflibercept|aflibercept|mesh-list
56213037|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56213038|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56213039|NCT03481634|Growth Substances|growth substances|mesh-ancestor
56213040|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182681|NCT01419821|Vitamins|vitamins|mesh-list
56182682|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
56182683|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182684|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56182685|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56182686|NCT01419847|Ciclopirox|ciclopirox|mesh-list
56182687|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
56182688|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182689|NCT01419873|Insulin|insulin|mesh-list
56671712|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671713|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
56671714|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671715|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671716|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56671717|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
56671718|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671719|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671720|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56671721|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56671722|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
56671723|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56671724|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56671725|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
56671726|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
56671727|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671728|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56671729|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56671730|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56671731|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56671732|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56671733|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
56671734|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56671735|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232906|NCT01719419|Orlistat|orlistat|mesh-list
56182690|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56182691|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56182692|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182693|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56182694|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56182695|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182696|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56182697|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
56182698|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182699|NCT01420094|Aspirin|aspirin|mesh-list
56182700|NCT01420094|Acetaminophen|acetaminophen|mesh-list
56213041|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
56213042|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213043|NCT03476642|Epinephrine|epinephrine|mesh-list
56213044|NCT03476642|Ropivacaine|ropivacaine|mesh-list
56213045|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
56213046|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
56213047|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213048|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213049|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
56213050|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213051|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56213052|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56671736|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56671737|NCT02697929|Neostigmine|neostigmine|mesh-list
56671738|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56671739|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671740|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671741|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
56671742|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671743|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671744|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56232925|NCT01719601|Tapentadol|tapentadol|mesh-list
56213053|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
56213054|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213055|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213056|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56213057|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56213058|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
56213059|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56213060|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
56213061|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
56213062|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
56213063|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56213064|NCT03460756|Ganaxolone|ganaxolone|mesh-list
56213065|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
56213066|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213067|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213068|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213070|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
56213071|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
56213072|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213073|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213074|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56213075|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182701|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56182702|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56182703|NCT01420094|Analgesics|analgesics|mesh-ancestor
56182704|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
56182705|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182706|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182707|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56182708|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56182709|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56182710|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56182711|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182712|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56182713|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56182714|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182715|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
56182716|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
56182717|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56182718|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
56182719|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
56182720|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56182721|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182722|NCT01420302|Insulin|insulin|mesh-list
56182723|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56182724|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56182725|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182726|NCT01420328|Simvastatin|simvastatin|mesh-list
56182727|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56182728|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56213076|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213077|NCT03289910|Carboplatin|carboplatin|mesh-list
56213078|NCT03289910|Topotecan|topotecan|mesh-list
56213079|NCT03289910|Veliparib|veliparib|mesh-list
56213080|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671745|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
56671746|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671747|NCT00505375|Abatacept|abatacept|mesh-list
56671748|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56671749|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671750|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671751|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671752|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
56671753|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671754|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671755|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
56671756|NCT02700347|Allopurinol|allopurinol|mesh-list
56671757|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
56671758|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671759|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671760|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
56671761|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671762|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56671763|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
56671764|NCT02700347|Protective Agents|protective agents|mesh-ancestor
56671765|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671766|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
56671767|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56671768|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671769|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
56671770|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56213081|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56213082|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56213083|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213084|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213085|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56213086|NCT03245151|Everolimus|everolimus|mesh-list
56213087|NCT03245151|Lenvatinib|lenvatinib|mesh-list
56213088|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213089|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56213090|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
56213091|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213092|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213093|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213094|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182729|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56182730|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
56182731|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182732|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56182733|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56182734|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884392|NCT03343548|Analgesics|analgesics|mesh-ancestor
56213095|NCT03171025|Nivolumab|nivolumab|mesh-list
56213096|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56671771|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671772|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56671773|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
56671774|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56671775|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671776|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671777|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671778|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56671779|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
56671780|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56671781|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56671782|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56671783|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56671784|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671785|NCT00673088|Ropinirole|ropinirole|mesh-list
56671786|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56671787|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56671788|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
56671789|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
56671790|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671791|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671792|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671793|NCT00504829|Atorvastatin|atorvastatin|mesh-list
56671794|NCT00504829|Fenofibrate|fenofibrate|mesh-list
56671795|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56671796|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56671797|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
56671798|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671799|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56671800|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56671801|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671802|NCT02701205|Etanercept|etanercept|mesh-list
56671803|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56671804|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56671809|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56671810|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671811|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56671812|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671813|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
56671814|NCT00670436|Paclitaxel|paclitaxel|mesh-list
56671815|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56671816|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56671817|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671818|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
56671819|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
56318008|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
56671821|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671822|NCT02699879|Pirfenidone|pirfenidone|mesh-list
56671823|NCT02699879|Analgesics|analgesics|mesh-ancestor
56671824|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
56671825|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671826|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671827|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56671828|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56671829|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56671830|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56671831|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671832|NCT02699723|Itraconazole|itraconazole|mesh-list
56671833|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
56671834|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
56671835|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671836|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56671837|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56671838|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671839|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213097|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213098|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56213099|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213100|NCT03149003|Bevacizumab|bevacizumab|mesh-list
56213101|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213102|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213103|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56213105|NCT03149003|Growth Substances|growth substances|mesh-ancestor
56213106|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213107|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
56213108|NCT03148275|Trametinib|trametinib|mesh-list
56671840|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56671841|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
56671842|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56671843|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671844|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56671845|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671846|NCT02699645|Amlodipine|amlodipine|mesh-list
56671847|NCT02699645|Telmisartan|telmisartan|mesh-list
56671848|NCT02699645|Indapamide|indapamide|mesh-list
56671849|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56671850|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56671851|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56671852|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671853|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56671854|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671855|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
56671856|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56671857|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56671858|NCT02699645|Diuretics|diuretics|mesh-ancestor
56671859|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
56671860|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56671861|NCT04152434|Erenumab|erenumab|mesh-list
56671862|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56671863|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671864|NCT04152434|Analgesics|analgesics|mesh-ancestor
56671865|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
56671866|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671867|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671868|NCT00615797|Penicillins|penicillins|mesh-list
56671869|NCT00615797|Penicillin V|penicillin v|mesh-list
56671870|NCT00615797|Haloperidol|haloperidol|mesh-list
56671871|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
56671872|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
56671873|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56671874|NCT00615797|Antibodies|antibodies|mesh-list
56213109|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213110|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56671875|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
56671876|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56671877|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
56671878|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671879|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
56671880|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
56671881|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671882|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56671883|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56671884|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56671885|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56671886|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56671887|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56671888|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
56671889|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671890|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671891|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56671892|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56671893|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671894|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
56671896|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56671897|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
56671898|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671899|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671900|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671901|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
56671902|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
56671903|NCT00705016|Fluorouracil|fluorouracil|mesh-list
56671904|NCT00705016|Cetuximab|cetuximab|mesh-list
56671905|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671906|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
56671907|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671908|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56671909|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56671913|NCT00595868|Varenicline|varenicline|mesh-list
56671915|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56671916|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
56671917|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671918|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671919|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671920|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
56671921|NCT02699801|Propofol|propofol|mesh-list
56671922|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56671923|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56671924|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671925|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56671926|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
56671927|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
56671928|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56671929|NCT02699801|Analgesics|analgesics|mesh-ancestor
56671930|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
56671931|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671932|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56671933|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56671934|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56671935|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
56671936|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671937|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671938|NCT02727907|Interferons|interferons|mesh-list
56671939|NCT02727907|Interferon-beta|interferon-beta|mesh-list
56671940|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
56671941|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213111|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213112|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213113|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
56213114|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56213115|NCT03106454|Norethindrone|norethindrone|mesh-list
56213116|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
56213117|NCT03106454|Estradiol|estradiol|mesh-list
56213118|NCT03106454|Estrogens|estrogens|mesh-ancestor
56213119|NCT03106454|Hormones|hormones|mesh-ancestor
56213120|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753214|NCT03212677|Iron|iron|mesh-list
56213121|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213122|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56213123|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
56213124|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56213125|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56213126|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56213127|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56213128|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56213129|NCT03106454|Trace Elements|trace elements|mesh-ancestor
56213130|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
56213131|NCT03040973|Gefitinib|gefitinib|mesh-list
56671942|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
56671943|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56671944|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
56671945|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671946|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56671947|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56671948|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
56671949|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56671950|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56671951|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671952|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671953|NCT00663728|Urological Agents|urological agents|mesh-ancestor
56671954|NCT05685004|Temozolomide|temozolomide|mesh-list
56671955|NCT05685004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56671956|NCT05685004|Alkylating Agents|alkylating agents|mesh-ancestor
56213132|NCT03040973|Osimertinib|osimertinib|mesh-list
56213133|NCT03040973|Nazartinib|nazartinib|mesh-list
56213134|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213135|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213136|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213137|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213138|NCT02990806|Infliximab|infliximab|mesh-list
56213139|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
56213140|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56213141|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213142|NCT02965703|Aspirin|aspirin|mesh-list
56213143|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56213144|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56213145|NCT02965703|Analgesics|analgesics|mesh-ancestor
56213146|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
56213147|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213148|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213149|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56213150|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213151|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56213152|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56182735|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56182736|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56182737|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182738|NCT01420341|Renal Agents|renal agents|mesh-ancestor
56182739|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56182740|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
56182741|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56182742|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56182743|NCT01420367|Metronidazole|metronidazole|mesh-list
56182744|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182745|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56182746|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56182747|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56182749|NCT01420406|Vitamins|vitamins|mesh-ancestor
56182750|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
56182751|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182752|NCT01420471|Triamcinolone|triamcinolone|mesh-list
56182753|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56182754|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56182755|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56182756|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56182757|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
56182758|NCT01420471|Hormones|hormones|mesh-ancestor
56182759|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56671957|NCT05685004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671958|NCT05685004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671959|NCT01009801|Doxorubicin|doxorubicin|mesh-list
56671960|NCT01009801|Everolimus|everolimus|mesh-list
56671961|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56671962|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671963|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56671964|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56671965|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56671966|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671967|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233145|NCT01724723|Entecavir|entecavir|mesh-list
56182760|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182761|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56213153|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213154|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56213155|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56213156|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213157|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
56213159|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56213160|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
56213161|NCT02938442|Doxorubicin|doxorubicin|mesh-list
56213162|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56213163|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56213164|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
56213165|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165426|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165427|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165428|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165429|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165430|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56165431|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165432|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165433|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165434|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165435|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
56182762|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
56182763|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182764|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182765|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
56182766|NCT01420523|Maraviroc|maraviroc|mesh-list
56182767|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56182768|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56182769|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
56182770|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182771|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56182772|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56182773|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182774|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182775|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56182776|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56182777|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56182778|NCT01420575|Olanzapine|olanzapine|mesh-list
56182779|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
56165436|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56165437|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56165438|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165439|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56165440|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56165441|NCT00002904|Trabectedin|trabectedin|mesh-list
56165442|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165443|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
56671968|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
56671969|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671970|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56671971|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56671972|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56671973|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56671974|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56671975|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56671976|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671977|NCT00617045|Analgesics|analgesics|mesh-ancestor
56671978|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
56671979|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671980|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
56671981|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56671982|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
56671983|NCT02629718|Paclitaxel|paclitaxel|mesh-list
56671984|NCT02629718|Carboplatin|carboplatin|mesh-list
56671985|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56671986|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56671987|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
56671988|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
56671989|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
56671990|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165444|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165445|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165447|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165448|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165449|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165450|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165451|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165452|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165453|NCT00002928|Paclitaxel|paclitaxel|mesh-list
56165454|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165455|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165456|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165457|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165458|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165459|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165460|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
56165461|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165462|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
56165463|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165464|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165465|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56165466|NCT00002946|Penclomedine|penclomedine|mesh-list
56165467|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165468|NCT00002952|Interleukin-12|interleukin-12|mesh-list
56671991|NCT01009879|Etanercept|etanercept|mesh-list
56671992|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56671993|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56671994|NCT01009879|Analgesics|analgesics|mesh-ancestor
56671995|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
56671996|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56671997|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56671998|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56671999|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672000|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672001|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165469|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56182787|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56182788|NCT01420575|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56182789|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56182790|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182791|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182792|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182793|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
56182794|NCT01420666|Acetaminophen|acetaminophen|mesh-list
56182795|NCT01420666|Ibuprofen|ibuprofen|mesh-list
56182796|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56182797|NCT01420666|Analgesics|analgesics|mesh-ancestor
56182798|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
56182799|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182800|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182801|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
56182802|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56182803|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56182804|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56182805|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56182806|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182807|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182808|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
56182809|NCT01420692|Gliclazide|gliclazide|mesh-list
56182810|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56182811|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182812|NCT01420822|Fluticasone|fluticasone|mesh-list
56165475|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
56165476|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165477|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56165478|NCT00002964|Trioxsalen|trioxsalen|mesh-list
56165479|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165480|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
56165481|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56165482|NCT00002970|Cytarabine|cytarabine|mesh-list
56165483|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
56182813|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56182814|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56182815|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
56182816|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182817|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182818|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56182819|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
56182820|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
56182821|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56182822|NCT01420900|Tacrine|tacrine|mesh-list
56182823|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56182824|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182825|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182826|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
56165487|NCT00002970|Methotrexate|methotrexate|mesh-list
56165488|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56165489|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
55940787|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
56672002|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
56672003|NCT01009957|Everolimus|everolimus|mesh-list
56672004|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672005|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672006|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
56672007|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672008|NCT04062370|Ranibizumab|ranibizumab|mesh-list
56672009|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56672010|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56672011|NCT04062370|Growth Substances|growth substances|mesh-ancestor
56672012|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672013|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56672014|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672015|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
56672016|NCT01015183|Astringents|astringents|mesh-ancestor
56672017|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672018|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
56672019|NCT00856284|Metformin|metformin|mesh-list
56672020|NCT00856284|Alogliptin|alogliptin|mesh-list
56672021|NCT00856284|Glipizide|glipizide|mesh-list
56672022|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672023|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672024|NCT00856284|Incretins|incretins|mesh-ancestor
56672025|NCT00856284|Hormones|hormones|mesh-ancestor
56672026|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56672027|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56165490|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56165491|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165492|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165493|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
56165494|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165495|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165496|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
56165497|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165498|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56165499|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165500|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
56165501|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165502|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56165503|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
56165504|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165505|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56165507|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56165508|NCT00002976|Hormones|hormones|mesh-ancestor
56165509|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56165510|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165511|NCT00002982|Cytarabine|cytarabine|mesh-list
56165512|NCT00002982|Carboplatin|carboplatin|mesh-list
56165513|NCT00002982|Etoposide|etoposide|mesh-list
56182836|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672028|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
56672029|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672030|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672031|NCT05057494|Venetoclax|venetoclax|mesh-list
56672032|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
56672033|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
56672034|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672035|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56672036|NCT00510289|Sorafenib|sorafenib|mesh-list
56672037|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672038|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56672039|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672040|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672041|NCT01013155|Perindopril|perindopril|mesh-list
56318282|NCT05576675|Dsuvia|dsuvia|mesh-list
56672042|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56672043|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
56672044|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672045|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672046|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56672047|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
56672048|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56233220|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
56182837|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182838|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
56182839|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56182840|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56182841|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182842|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56182843|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56182844|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56182845|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884646|NCT01709422|Narcotics|narcotics|mesh-ancestor
56165514|NCT00002982|Melphalan|melphalan|mesh-list
56165515|NCT00002982|Ifosfamide|ifosfamide|mesh-list
56165516|NCT00002982|Carmustine|carmustine|mesh-list
56165517|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165518|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165519|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56165520|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165521|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165522|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165523|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165525|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
56165526|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165527|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165528|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
56165536|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165537|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165538|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165539|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672049|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672050|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56672051|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56672052|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672053|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672054|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672055|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56672056|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56672058|NCT01015339|Capecitabine|capecitabine|mesh-list
56672059|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56672060|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672061|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
56672062|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
56672063|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
56672064|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672065|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56672066|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
56672067|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56672068|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
56672069|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672070|NCT02622906|Pasireotide|pasireotide|mesh-list
56672071|NCT02622906|Hormones|hormones|mesh-ancestor
56672072|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56672073|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672074|NCT00673556|Alefacept|alefacept|mesh-list
56672075|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56672076|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
56672077|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672078|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56672079|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
56672080|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56672091|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56672092|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672093|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672094|NCT04061824|Olmesartan|olmesartan|mesh-list
56672095|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
56672096|NCT04061824|Giapreza|giapreza|mesh-list
56672097|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56672098|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
56672099|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56672100|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56672101|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56672102|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
56672103|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672104|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56672105|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56672106|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672107|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56672108|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56672109|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56672110|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56672111|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
56672112|NCT04212533|Vitamin D|vitamin d|mesh-list
56672113|NCT04212533|Vitamins|vitamins|mesh-ancestor
56672114|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
56672115|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672116|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56672118|NCT04155554|Lamivudine|lamivudine|mesh-list
56672119|NCT04155554|Emtricitabine|emtricitabine|mesh-list
56672120|NCT04155554|Dolutegravir|dolutegravir|mesh-list
56672121|NCT04155554|Abacavir|abacavir|mesh-list
56672123|NCT04155554|Triumeq|triumeq|mesh-list
56672138|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56672139|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672140|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672141|NCT00856206|Rilonacept|rilonacept|mesh-list
56672142|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56672143|NCT03997279|Amoxicillin|amoxicillin|mesh-list
56672144|NCT03997279|Metronidazole|metronidazole|mesh-list
56672145|NCT03997279|Clarithromycin|clarithromycin|mesh-list
56672146|NCT03997279|Rabeprazole|rabeprazole|mesh-list
56672147|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56672148|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672149|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56672150|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56672151|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56672152|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672153|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672154|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56672155|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56672156|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56672157|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672158|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56672159|NCT00920998|Z 338|z 338|mesh-list
56672160|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56672161|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672162|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672163|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
56672164|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165540|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165541|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
56165542|NCT00002994|Interleukin-2|interleukin-2|mesh-list
56165543|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165544|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56165545|NCT00002994|Analgesics|analgesics|mesh-ancestor
56165546|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
56165547|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165548|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165549|NCT00003000|Fentanyl|fentanyl|mesh-list
56165550|NCT00003000|Morphine|morphine|mesh-list
56165551|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56165552|NCT00003000|Narcotics|narcotics|mesh-ancestor
56165553|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56165554|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165555|NCT00003000|Analgesics|analgesics|mesh-ancestor
56165556|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
56165557|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165558|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56165559|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56165560|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
56672165|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672166|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672167|NCT00593112|Methylphenidate|methylphenidate|mesh-list
56672168|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56672169|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672170|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56672171|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56672172|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56672173|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672174|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
56672175|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672176|NCT05323565|Dexamethasone|dexamethasone|mesh-list
56672177|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
56672178|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56672179|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
56672180|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
56672181|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672182|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672183|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672184|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
56672185|NCT05323565|Hormones|hormones|mesh-ancestor
56672186|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56672187|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56672188|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672189|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318392|NCT00020943|Leucovorin|leucovorin|mesh-list
56672190|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56672191|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672193|NCT05323565|Analgesics|analgesics|mesh-ancestor
56672207|NCT00676286|Choline|choline|mesh-list
56672208|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
56672209|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56672210|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
56672211|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672212|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672213|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56672214|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
56672215|NCT00699894|Ondansetron|ondansetron|mesh-list
56672216|NCT00699894|Aprepitant|aprepitant|mesh-list
56672217|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
56672218|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
56672219|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672220|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672221|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672222|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
56672223|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
56141041|NCT04379310|Calcium|calcium|mesh-list
56165561|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
56165562|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
56165563|NCT00003012|Fluorouracil|fluorouracil|mesh-list
56165564|NCT00003012|Methotrexate|methotrexate|mesh-list
56165565|NCT00003012|Epirubicin|epirubicin|mesh-list
56165566|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165567|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
56182846|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56182847|NCT01421043|Triazolam|triazolam|mesh-list
56182848|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56182849|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56182850|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56165568|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165569|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165570|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165571|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
56165572|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165573|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165574|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165575|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
56165576|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165577|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56165578|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
56165579|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56165580|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
56165581|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165582|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56165583|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56165584|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56165585|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56165586|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165587|NCT00003018|Leucovorin|leucovorin|mesh-list
56165588|NCT00003018|Fluorouracil|fluorouracil|mesh-list
56165589|NCT00003018|Mitomycins|mitomycins|mesh-list
56165590|NCT00003018|Mitomycin|mitomycin|mesh-list
56165591|NCT00003018|Dipyridamole|dipyridamole|mesh-list
56165592|NCT00003018|Calcium|calcium|mesh-list
56165593|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
56165594|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56165597|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165598|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165599|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165600|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672224|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56672225|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
56672226|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672227|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672228|NCT00699894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56672229|NCT00699894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56165601|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
56165602|NCT00003018|Antidotes|antidotes|mesh-ancestor
56165603|NCT00003018|Protective Agents|protective agents|mesh-ancestor
56165604|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
56165605|NCT00003018|Vitamins|vitamins|mesh-ancestor
56165606|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
56165607|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56165608|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
56165609|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56165610|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165611|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56165612|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56165613|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
56165614|NCT00003048|Amifostine|amifostine|mesh-list
56165615|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56165616|NCT00003048|Protective Agents|protective agents|mesh-ancestor
56165617|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165618|NCT00003054|Paclitaxel|paclitaxel|mesh-list
56165619|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165620|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165621|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165622|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165623|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165624|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165625|NCT00003060|Cyclosporine|cyclosporine|mesh-list
56165626|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
56165627|NCT00003060|Busulfan|busulfan|mesh-list
56165628|NCT00003060|Methotrexate|methotrexate|mesh-list
56165629|NCT00003060|Cyclosporins|cyclosporins|mesh-list
56165630|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165631|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
56165632|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165633|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165634|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165635|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
56182851|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56182853|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56182854|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
56182855|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
56182856|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165636|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165637|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165638|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55753891|NCT04891809|Dexamethasone|dexamethasone|mesh-list
56165639|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56165640|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
56165641|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56165642|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165643|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
56165644|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
56165645|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165646|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56165647|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56165648|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
56165649|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165650|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56165651|NCT00003066|Docetaxel|docetaxel|mesh-list
56165652|NCT00003066|Estramustine|estramustine|mesh-list
56165653|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165654|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165655|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165656|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165657|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165658|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56672230|NCT00699894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672231|NCT00699894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56672232|NCT00699894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56672233|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56672234|NCT05634148|Dexmedetomidine|dexmedetomidine|mesh-list
56672235|NCT05634148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56672236|NCT05634148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672237|NCT05634148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672238|NCT05634148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56672239|NCT05634148|Analgesics|analgesics|mesh-ancestor
56672240|NCT05634148|Sensory System Agents|sensory system agents|mesh-ancestor
56672241|NCT05634148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672242|NCT05634148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56672243|NCT05634148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56672244|NCT05634148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56672245|NCT05634148|Adrenergic Agents|adrenergic agents|mesh-ancestor
56672246|NCT05634148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233431|NCT01731067|Analgesics|analgesics|mesh-ancestor
56165659|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
56165660|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56165661|NCT00003072|Paclitaxel|paclitaxel|mesh-list
56165662|NCT00003072|Carboplatin|carboplatin|mesh-list
56165663|NCT00003072|Amifostine|amifostine|mesh-list
56165676|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165678|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165679|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
56165680|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754134|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56165681|NCT00003084|Ketoconazole|ketoconazole|mesh-list
56165682|NCT00003084|Paclitaxel|paclitaxel|mesh-list
56165683|NCT00003084|Etoposide|etoposide|mesh-list
56165684|NCT00003084|Vinblastine|vinblastine|mesh-list
56165685|NCT00003084|Doxorubicin|doxorubicin|mesh-list
56165686|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56165687|NCT00003084|Estramustine|estramustine|mesh-list
56165688|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165689|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165690|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165691|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165692|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165693|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165694|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56165695|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56165696|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165697|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182857|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182858|NCT01421121|Vaccines|vaccines|mesh-list
56182859|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
56182860|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182861|NCT01421160|Citric Acid|citric acid|mesh-list
56182862|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
56182863|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
56182864|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56182865|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
56182866|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
56182867|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182868|NCT01421173|Gemcitabine|gemcitabine|mesh-list
56182869|NCT01421173|Dexamethasone|dexamethasone|mesh-list
56672247|NCT05634148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672248|NCT00664196|Hormones|hormones|mesh-list
56672249|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56672250|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672251|NCT00616499|Gefitinib|gefitinib|mesh-list
56672252|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672253|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56672254|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672255|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672256|NCT05317936|Venetoclax|venetoclax|mesh-list
56672257|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672258|NCT02614248|Protective Agents|protective agents|mesh-list
56672259|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672260|NCT00491179|Interferons|interferons|mesh-list
56672261|NCT00491179|Ribavirin|ribavirin|mesh-list
56672262|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
56672263|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
56672264|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56318461|NCT00021099|Epothilones|epothilones|mesh-list
56672265|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672266|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
56672267|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672268|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
56672269|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672270|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
56672271|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672272|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
56233440|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
56233441|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56233442|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
56233447|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56182870|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
56182871|NCT01421173|Rituximab|rituximab|mesh-list
56182872|NCT01421173|Melphalan|melphalan|mesh-list
56182873|NCT01421173|Busulfan|busulfan|mesh-list
56182874|NCT01421173|Vorinostat|vorinostat|mesh-list
56182875|NCT01421173|BB 1101|bb 1101|mesh-list
56182876|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56182877|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182878|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
56182879|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884851|NCT01690546|Naltrexone|naltrexone|mesh-list
56165698|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
56165699|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165700|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56165701|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56672273|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
56672274|NCT04502095|Levofloxacin|levofloxacin|mesh-list
56672275|NCT04502095|Ofloxacin|ofloxacin|mesh-list
56672276|NCT04502095|Trimethoprim|trimethoprim|mesh-list
56672277|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56672278|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
56672279|NCT04502095|Clindamycin|clindamycin|mesh-list
56672280|NCT04502095|Ertapenem|ertapenem|mesh-list
56672281|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
56672282|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56672283|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672284|NCT04502095|Renal Agents|renal agents|mesh-ancestor
56672285|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56672286|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56672287|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56672288|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672289|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672290|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672291|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56672292|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56672293|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56672294|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
56672295|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56672296|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56672297|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56672298|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56672299|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56672300|NCT05301322|Vaccines|vaccines|mesh-list
56672301|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
56672302|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672303|NCT00674102|Vadimezan|vadimezan|mesh-list
56672304|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672305|NCT00503581|Megestrol|megestrol|mesh-list
56672306|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
56672307|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56233469|NCT01731184|Midazolam|midazolam|mesh-list
56165702|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56165710|NCT00003090|Aldesleukin|aldesleukin|mesh-list
56165711|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165712|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56165713|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56165714|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
56672308|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56672309|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56672310|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
56672311|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56672312|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672313|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56672314|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56672315|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56672316|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672317|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
56672318|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56672319|NCT00677144|Capecitabine|capecitabine|mesh-list
56233503|NCT01731431|Glyburide|glyburide|mesh-list
56165715|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165716|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
56165717|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165718|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56165719|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
56165720|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165721|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
56165722|NCT00003114|Lomustine|lomustine|mesh-list
56165723|NCT00003114|Etoposide|etoposide|mesh-list
56165724|NCT00003114|Procarbazine|procarbazine|mesh-list
56165725|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165726|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
56165727|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165728|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165729|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56182880|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56182881|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56182882|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
56182883|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
56182884|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182885|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56182887|NCT01421173|Hormones|hormones|mesh-ancestor
56182888|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56182889|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56182890|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56182891|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
56182892|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182893|NCT01421173|Antiviral Agents|antiviral agents|mesh-ancestor
56182894|NCT01421173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182895|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182896|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56182897|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56182898|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
56182899|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56182900|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56182901|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
56165730|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
56165731|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165732|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165733|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165734|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165735|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56165736|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165737|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754462|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56165739|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165740|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165741|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
56672320|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
56672321|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56672322|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
56672323|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672324|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672325|NCT00703534|Lesogaberan|lesogaberan|mesh-list
56672326|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672327|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56672328|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
56672329|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
56672330|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672331|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672332|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672333|NCT00503425|Rituximab|rituximab|mesh-list
56672334|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56672335|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672336|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
56318536|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
56672337|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672338|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672339|NCT00863772|Tanezumab|tanezumab|mesh-list
56672340|NCT00863772|Analgesics|analgesics|mesh-ancestor
56672341|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
56672342|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672343|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672345|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56672346|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672347|NCT04914676|Cytarabine|cytarabine|mesh-list
56165742|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165743|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165744|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165745|NCT00003126|Aldesleukin|aldesleukin|mesh-list
56165746|NCT00003126|Interleukin-2|interleukin-2|mesh-list
56165747|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165748|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56165749|NCT00003126|Analgesics|analgesics|mesh-ancestor
55754594|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165751|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165752|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165753|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56165754|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56165755|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
56165756|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165757|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
56165758|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165759|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56672348|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56672349|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
56672350|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672351|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672352|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
56672353|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672354|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672355|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
56672356|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672357|NCT00677300|Ritonavir|ritonavir|mesh-list
56672358|NCT00677300|Darunavir|darunavir|mesh-list
56672359|NCT00677300|Tenofovir|tenofovir|mesh-list
56672360|NCT00677300|Emtricitabine|emtricitabine|mesh-list
56672361|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
56672362|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56672363|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56672364|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
56672365|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672366|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672367|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56672368|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56672369|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
56672370|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672371|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56672372|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56672373|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56672374|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56672375|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56672376|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56165760|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
56182903|NCT01421212|Antibodies|antibodies|mesh-list
56182904|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
56182905|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56182906|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56165761|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165762|NCT00003144|Gemcitabine|gemcitabine|mesh-list
56165763|NCT00003144|Amifostine|amifostine|mesh-list
56165764|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165765|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165766|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
56165767|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165768|NCT00003144|Antiviral Agents|antiviral agents|mesh-ancestor
56165769|NCT00003144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165770|NCT00003144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165771|NCT00003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165772|NCT00003144|Immunologic Factors|immunologic factors|mesh-ancestor
56672377|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56672378|NCT02628392|Firuglipel|firuglipel|mesh-list
56672379|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672380|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672381|NCT02628392|Incretins|incretins|mesh-ancestor
56672382|NCT02628392|Hormones|hormones|mesh-ancestor
56672383|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56672384|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56672385|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
56672386|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672387|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672388|NCT00664586|Masoprocol|masoprocol|mesh-list
56672389|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
56672390|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672391|NCT00664586|Protective Agents|protective agents|mesh-ancestor
56672392|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672393|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56165773|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165774|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56165775|NCT00003144|Protective Agents|protective agents|mesh-ancestor
55754739|NCT03301181|Itraconazole|itraconazole|mesh-list
56165776|NCT00003150|Prednisone|prednisone|mesh-list
56165777|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
56165778|NCT00003150|Rituximab|rituximab|mesh-list
56165779|NCT00003150|Doxorubicin|doxorubicin|mesh-list
56165780|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56165781|NCT00003150|Vincristine|vincristine|mesh-list
56165782|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165783|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
56165784|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165785|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165786|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165787|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
55754796|NCT02467595|Fentanyl|fentanyl|mesh-list
56165788|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165789|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165790|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165791|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56165792|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56165793|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56165794|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165795|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165796|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56165797|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
56165798|NCT00003150|Hormones|hormones|mesh-ancestor
56165799|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56165800|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56165801|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56093455|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
56165802|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165803|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165804|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165805|NCT00003156|Topotecan|topotecan|mesh-list
56165806|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56165807|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165808|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165809|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672394|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672395|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56672396|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56672397|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56672398|NCT00664586|Analgesics|analgesics|mesh-ancestor
56672399|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
56672400|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672401|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56672402|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672403|NCT00502801|Doripenem|doripenem|mesh-list
56672404|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56672405|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672406|NCT04154852|Folic Acid|folic acid|mesh-list
56672407|NCT04154852|Adalimumab|adalimumab|mesh-list
56672408|NCT04154852|Methotrexate|methotrexate|mesh-list
56672409|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56672410|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
56672411|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56672412|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672413|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56318612|NCT00021567|Interferons|interferons|mesh-list
56672414|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
56672415|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672416|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672417|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56672418|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672419|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56672420|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672421|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
56672422|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672423|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56672424|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56672425|NCT04154852|Hematinics|hematinics|mesh-ancestor
56672426|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
56672427|NCT04154852|Vitamins|vitamins|mesh-ancestor
56672428|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
56672429|NCT00921154|Ivermectin|ivermectin|mesh-list
56165810|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165811|NCT00003174|Cladribine|cladribine|mesh-list
56165812|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
56672430|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56672431|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672432|NCT01015651|Remifentanil|remifentanil|mesh-list
56672433|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56672434|NCT01015651|Narcotics|narcotics|mesh-ancestor
56672435|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672436|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672437|NCT01015651|Analgesics|analgesics|mesh-ancestor
56672438|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
56672439|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672440|NCT04907968|Carboplatin|carboplatin|mesh-list
56672441|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672442|NCT00674414|Trastuzumab|trastuzumab|mesh-list
56672443|NCT00674414|Everolimus|everolimus|mesh-list
56672444|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56672445|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672446|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672447|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
56672448|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672449|NCT05570422|Cisplatin|cisplatin|mesh-list
56672450|NCT05570422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672451|NCT05272930|Dienogest|dienogest|mesh-list
56672452|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56672453|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
56672454|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56672455|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672456|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56672457|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56672458|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56672459|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56672460|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
56672461|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56672462|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56672463|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672464|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56672465|NCT00855894|Pertuzumab|pertuzumab|mesh-list
56672466|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165813|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672467|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56672468|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672469|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672470|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56672471|NCT02566096|Morphine|morphine|mesh-list
56672472|NCT02566096|Bupivacaine|bupivacaine|mesh-list
56672473|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
56672474|NCT02566096|Anesthetics|anesthetics|mesh-list
56672475|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672476|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672477|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
56672478|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672479|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56672480|NCT02566096|Narcotics|narcotics|mesh-ancestor
56672481|NCT02566096|Analgesics|analgesics|mesh-ancestor
56672482|NCT04482244|Cannabidiol|cannabidiol|mesh-list
56672483|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
56672484|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56233660|NCT01732367|Lamivudine|lamivudine|mesh-list
56165814|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165815|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
56165816|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165817|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56165819|NCT00003198|Ifosfamide|ifosfamide|mesh-list
56165820|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56165821|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165822|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165823|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165824|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182907|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
56182908|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
56182909|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182911|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56182912|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
56182913|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
56182914|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
56165825|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165826|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
56165827|NCT00003204|Prednisone|prednisone|mesh-list
56165828|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
56165829|NCT00003204|Rituximab|rituximab|mesh-list
56165830|NCT00003204|Fludarabine|fludarabine|mesh-list
56165831|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
56165832|NCT00003204|Vincristine|vincristine|mesh-list
56165833|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165834|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
56165835|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165836|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165837|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165838|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
56165839|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165840|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165841|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165842|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755039|NCT05655689|Natamycin|natamycin|mesh-list
56165843|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56165844|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
56165846|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56672485|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56672486|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
56672487|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
56318686|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56672488|NCT02628860|Hematinics|hematinics|mesh-ancestor
56672489|NCT05267470|Paclitaxel|paclitaxel|mesh-list
56672490|NCT05267470|Docetaxel|docetaxel|mesh-list
56672491|NCT05267470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56672492|NCT05267470|Carboplatin|carboplatin|mesh-list
56672493|NCT05267470|Pembrolizumab|pembrolizumab|mesh-list
56672494|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
56672495|NCT05267470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165847|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56165848|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165849|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
56165850|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165851|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165852|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165853|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165854|NCT00003210|Interleukin-12|interleukin-12|mesh-list
56165855|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56165856|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
55755160|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
56165857|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165858|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56165859|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56165860|NCT00003210|Growth Substances|growth substances|mesh-ancestor
56165861|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
56165862|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165863|NCT00003216|Gemcitabine|gemcitabine|mesh-list
56165864|NCT00003216|Fluorouracil|fluorouracil|mesh-list
56165865|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165866|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
56165867|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165868|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165869|NCT00003216|Antiviral Agents|antiviral agents|mesh-ancestor
56165870|NCT00003216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165871|NCT00003216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165872|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165873|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
56165874|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165875|NCT00003234|Vinorelbine|vinorelbine|mesh-list
56165877|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165878|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165879|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165880|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165881|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165882|NCT00003240|Vinorelbine|vinorelbine|mesh-list
56165884|NCT00003240|Mitomycins|mitomycins|mesh-list
56165885|NCT00003240|Mitomycin|mitomycin|mesh-list
56165886|NCT00003240|Vinblastine|vinblastine|mesh-list
56165887|NCT00003240|Vindesine|vindesine|mesh-list
56182915|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
56182926|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56182927|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56182928|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56182929|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56182930|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56182931|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182932|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
56182933|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
56182934|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56182935|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182936|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56182937|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56182938|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55885094|NCT01712230|Leuprolide|leuprolide|mesh-list
56165888|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672496|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672497|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56672498|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56672499|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56672500|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672501|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56672502|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56672503|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672504|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672505|NCT00855738|Topiramate|topiramate|mesh-list
56672506|NCT00855738|Pregabalin|pregabalin|mesh-list
56672507|NCT00855738|Lamotrigine|lamotrigine|mesh-list
56165889|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165890|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165891|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165892|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165893|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165894|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165895|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
56165896|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56165897|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56165898|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165899|NCT00003252|Amifostine|amifostine|mesh-list
56165900|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56165901|NCT00003252|Protective Agents|protective agents|mesh-ancestor
56165902|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165903|NCT00003264|Gemcitabine|gemcitabine|mesh-list
56165904|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165905|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165906|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
56165907|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165908|NCT00003264|Antiviral Agents|antiviral agents|mesh-ancestor
56165909|NCT00003264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165910|NCT00003264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182939|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56182940|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182941|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182942|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182943|NCT01421706|Clarithromycin|clarithromycin|mesh-list
56182944|NCT01421706|Sibutramine|sibutramine|mesh-list
56182945|NCT01421706|Clopidogrel|clopidogrel|mesh-list
56182946|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56182947|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56182948|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56182949|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56182950|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
56182951|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182952|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182953|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182958|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56165911|NCT00003264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165912|NCT00003264|Immunologic Factors|immunologic factors|mesh-ancestor
56165913|NCT00003264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165914|NCT00003276|Irinotecan|irinotecan|mesh-list
56165915|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56165916|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165917|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755410|NCT04424225|Vitamins|vitamins|mesh-ancestor
56165918|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165920|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
56165921|NCT00003288|Tirapazamine|tirapazamine|mesh-list
55940788|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
56672508|NCT00855738|Zonisamide|zonisamide|mesh-list
56672509|NCT00855738|Gabapentin|gabapentin|mesh-list
56672510|NCT00855738|Levetiracetam|levetiracetam|mesh-list
56672511|NCT00855738|Tiagabine|tiagabine|mesh-list
56672512|NCT00855738|Analgesics|analgesics|mesh-ancestor
56672513|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
56672514|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672515|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672516|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
56672517|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56672518|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56672519|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672520|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56672521|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56672522|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56672523|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672524|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56672525|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56672526|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56672527|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672528|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
56672529|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672530|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
56672531|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56672532|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56672533|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56672534|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56672535|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
56672536|NCT02628002|Regadenoson|regadenoson|mesh-list
56672537|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56672538|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56672539|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
56672540|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
56672541|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233699|NCT01732744|Cathartics|cathartics|mesh-ancestor
56165922|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165923|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
56165924|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165925|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165926|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56672542|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672543|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672544|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56672545|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
56672546|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56672547|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56672548|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672549|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672550|NCT00665054|Urological Agents|urological agents|mesh-ancestor
56672551|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
56672552|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
56672553|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672554|NCT02622672|Vitamins|vitamins|mesh-ancestor
56672555|NCT04152356|Sorafenib|sorafenib|mesh-list
56672556|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672557|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56672558|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672559|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672560|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
56672561|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672562|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56672563|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672564|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318762|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56672566|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56672567|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
56672568|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
56672569|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672570|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672585|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56672586|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672587|NCT00678236|Gentamicins|gentamicins|mesh-list
56672588|NCT00678236|Cimetidine|cimetidine|mesh-list
56672589|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56672590|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672591|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56672592|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
56672593|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
56672594|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672595|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165927|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
56165928|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165929|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165930|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165931|NCT00003294|Paclitaxel|paclitaxel|mesh-list
56165932|NCT00003294|Carboplatin|carboplatin|mesh-list
56165933|NCT00003294|Amifostine|amifostine|mesh-list
56165934|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165935|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165936|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165937|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165938|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165939|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755482|NCT04872257|Vitamin D|vitamin d|mesh-list
56165940|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165941|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56165942|NCT00003294|Protective Agents|protective agents|mesh-ancestor
56165943|NCT00003330|Interleukin-12|interleukin-12|mesh-list
56182959|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56182960|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
56182961|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56182962|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
56182963|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56182964|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
56182965|NCT01421901|Ertapenem|ertapenem|mesh-list
56182966|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56182967|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182968|NCT01421914|Bupivacaine|bupivacaine|mesh-list
56182969|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
56182970|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
56182971|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56182972|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182973|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
56182974|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885195|NCT00706992|Vaccines|vaccines|mesh-list
56165944|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56165945|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
56165946|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165947|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56165948|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56165949|NCT00003330|Growth Substances|growth substances|mesh-ancestor
56165950|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
56165951|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165952|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
56165953|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
56165954|NCT00003336|Melphalan|melphalan|mesh-list
56165955|NCT00003336|Busulfan|busulfan|mesh-list
56165956|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56165957|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165958|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
56165959|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165960|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165973|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940789|NCT00634049|Isavuconazole|isavuconazole|mesh-list
56672596|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672597|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56672598|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56672599|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672600|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56672601|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672602|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56672603|NCT00678314|Ropivacaine|ropivacaine|mesh-list
56672604|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
56672605|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
56672606|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672607|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672608|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
56672609|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672610|NCT02566720|Amantadine|amantadine|mesh-list
56672611|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56672612|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56672613|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
56672614|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672615|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
56672616|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672617|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672618|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672619|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56672620|NCT02566720|Analgesics|analgesics|mesh-ancestor
56672621|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
56672622|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672623|NCT00675194|Capecitabine|capecitabine|mesh-list
56672624|NCT00675194|Irinotecan|irinotecan|mesh-list
56672625|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672626|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56672627|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
56672628|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672629|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56672630|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56672631|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672632|NCT04767022|Paclitaxel|paclitaxel|mesh-list
55940790|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
56672633|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56672634|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56672635|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672636|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
56672637|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
56672638|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
56318840|NCT00022971|Rituximab|rituximab|mesh-list
56672639|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672640|NCT00665522|Fentanyl|fentanyl|mesh-list
56672641|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56672642|NCT00665522|Narcotics|narcotics|mesh-ancestor
56672643|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672644|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672645|NCT00665522|Analgesics|analgesics|mesh-ancestor
56672646|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
56672647|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672648|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56672649|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56672650|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
56672651|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
56672652|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
56672653|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56672654|NCT00678626|Docetaxel|docetaxel|mesh-list
56672655|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672656|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56672657|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56233827|NCT01733823|Nimorazole|nimorazole|mesh-list
56165974|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56165976|NCT00003342|Gemcitabine|gemcitabine|mesh-list
56165977|NCT00003342|Paclitaxel|paclitaxel|mesh-list
56165978|NCT00003342|Carboplatin|carboplatin|mesh-list
56165979|NCT00003342|Doxorubicin|doxorubicin|mesh-list
55755571|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56165980|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56165981|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165982|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165983|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165984|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165985|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
56182975|NCT01421927|Lenalidomide|lenalidomide|mesh-list
56182976|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
56182977|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182978|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56182979|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56182980|NCT01421927|Growth Substances|growth substances|mesh-ancestor
56182981|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
56182982|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56182983|NCT01421940|Udenafil|udenafil|mesh-list
56182984|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56165986|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165987|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56672658|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56672659|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672660|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56672661|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
56672662|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56672663|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56672664|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672665|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672666|NCT00678704|Urological Agents|urological agents|mesh-ancestor
56672667|NCT00678782|Etanercept|etanercept|mesh-list
56672668|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56233853|NCT01733979|Iron|iron|mesh-list
56165988|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
56165989|NCT00003342|Antiviral Agents|antiviral agents|mesh-ancestor
56165990|NCT00003342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56165991|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165992|NCT00003342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56165993|NCT00003342|Immunologic Factors|immunologic factors|mesh-ancestor
56165994|NCT00003342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165995|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56165996|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56165997|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56165998|NCT00003348|Carmustine|carmustine|mesh-list
56165999|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56166000|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166001|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
56166002|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166003|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166004|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166005|NCT00003360|Antibodies|antibodies|mesh-list
56166006|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56166007|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
55755631|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166008|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166009|NCT00003372|Topotecan|topotecan|mesh-list
55800595|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166022|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166023|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166024|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166025|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
56166026|NCT00003378|Antiviral Agents|antiviral agents|mesh-ancestor
56166027|NCT00003378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166028|NCT00003378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166029|NCT00003378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166030|NCT00003378|Immunologic Factors|immunologic factors|mesh-ancestor
56166031|NCT00003378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166032|NCT00003390|Irofulven|irofulven|mesh-list
56166033|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166034|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
56166035|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166036|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166037|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
56166038|NCT00003396|Melphalan|melphalan|mesh-list
56166039|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56182985|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56182986|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182987|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885320|NCT02493894|Cefazolin|cefazolin|mesh-list
56166040|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166041|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
56166042|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166043|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672669|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56672670|NCT00678782|Analgesics|analgesics|mesh-ancestor
56672671|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
56672672|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672673|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672674|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56672675|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672676|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672677|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672678|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
56672679|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
56672680|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56672681|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672682|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672683|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672684|NCT04061200|Empagliflozin|empagliflozin|mesh-list
56672685|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56672686|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672687|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672688|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672689|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
56672690|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56672691|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672692|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56672693|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672694|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166044|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166045|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
56166046|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166047|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166048|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166049|NCT00003402|Dexamethasone|dexamethasone|mesh-list
56166050|NCT00003402|Paclitaxel|paclitaxel|mesh-list
56166051|NCT00003402|Etoposide|etoposide|mesh-list
56166052|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
56166053|NCT00003402|Melphalan|melphalan|mesh-list
56166054|NCT00003402|Carmustine|carmustine|mesh-list
56166055|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166056|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166057|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166058|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166059|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166060|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166061|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166062|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
56672695|NCT02565862|Metformin|metformin|mesh-list
56672696|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672697|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672698|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56672699|NCT00665600|Albuterol|albuterol|mesh-list
56672700|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56672701|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
56672702|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672703|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672704|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56672705|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
56672706|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
56672707|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56672708|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56672709|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56672710|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56672711|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
56318916|NCT00023244|Trimethoprim|trimethoprim|mesh-list
56672712|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56166063|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166064|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166065|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166066|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
56166067|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166076|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56166077|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166078|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166079|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166080|NCT00003408|Interferons|interferons|mesh-list
56166081|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
56166082|NCT00003408|Aldesleukin|aldesleukin|mesh-list
56166083|NCT00003408|Sargramostim|sargramostim|mesh-list
56166084|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166085|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
56166086|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166087|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
56166088|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166089|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56166090|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56166091|NCT00003414|Interferons|interferons|mesh-list
56166092|NCT00003414|Aldesleukin|aldesleukin|mesh-list
56166093|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
56166094|NCT00003414|Cyclosporine|cyclosporine|mesh-list
56166095|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
56166096|NCT00003414|Busulfan|busulfan|mesh-list
56166097|NCT00003414|Cyclosporins|cyclosporins|mesh-list
56166098|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166099|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
56166100|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166101|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166102|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166103|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
56166104|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166105|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166106|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56182989|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56182990|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182991|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56672713|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672714|NCT04060888|Ustekinumab|ustekinumab|mesh-list
56672715|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
56672716|NCT00879398|Fesoterodine|fesoterodine|mesh-list
56672717|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56672718|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56672719|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
56672720|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672721|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672722|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672723|NCT00879398|Urological Agents|urological agents|mesh-ancestor
56672724|NCT00679250|Cetirizine|cetirizine|mesh-list
56672725|NCT00679250|Levocetirizine|levocetirizine|mesh-list
56672726|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56672727|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56672728|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
56672729|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
56672730|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672731|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672732|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672733|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56672734|NCT00696436|Valsartan|valsartan|mesh-list
56672735|NCT00696436|Olmesartan|olmesartan|mesh-list
56672736|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56672737|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56672738|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56672739|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56672740|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672741|NCT00878072|Famciclovir|famciclovir|mesh-list
55745615|NCT03101085|Equol|equol|mesh-list
56182992|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182993|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182994|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56182995|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56182996|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
56182997|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182998|NCT01421992|Methylphenidate|methylphenidate|mesh-list
56182999|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56183000|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183001|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56183002|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56183003|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56672742|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
56672743|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672744|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56672745|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672746|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672747|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
56672748|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672749|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672750|NCT03045341|Naltrexone|naltrexone|mesh-list
56672751|NCT03045341|Bupropion|bupropion|mesh-list
56672752|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56672753|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56672754|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672755|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
56672756|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672757|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56672758|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
56672759|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56672760|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56672761|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56672762|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56672763|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672764|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
56672765|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672766|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56183004|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183005|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
56183006|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183008|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56183009|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183010|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56183011|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56183012|NCT01422018|Growth Substances|growth substances|mesh-ancestor
56183013|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166107|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
56166108|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166109|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166110|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
56166115|NCT00003426|Gemcitabine|gemcitabine|mesh-list
56166116|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166117|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
56166118|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166119|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166120|NCT00003426|Antiviral Agents|antiviral agents|mesh-ancestor
56166121|NCT00003426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166122|NCT00003426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166123|NCT00003426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672767|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56672768|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672769|NCT00679484|Candesartan|candesartan|mesh-list
56672770|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
56672771|NCT00679484|Olmesartan|olmesartan|mesh-list
56672772|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56672773|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56672774|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56672775|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56672776|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672777|NCT00679640|Candesartan|candesartan|mesh-list
56672778|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56672779|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56672780|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56672781|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672782|NCT00921388|Varenicline|varenicline|mesh-list
56672783|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56672784|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56672785|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
56672786|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672787|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672788|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672789|NCT04211987|Cytarabine|cytarabine|mesh-list
56672790|NCT04211987|Methotrexate|methotrexate|mesh-list
56672791|NCT04211987|Etoposide|etoposide|mesh-list
56672792|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56672793|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
56672794|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672795|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672796|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
56672797|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672798|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233964|NCT01734915|Iproplatin|iproplatin|mesh-list
56166124|NCT00003426|Immunologic Factors|immunologic factors|mesh-ancestor
56166125|NCT00003426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166126|NCT00003444|Interferons|interferons|mesh-list
56166127|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
56166128|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183014|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
56183015|NCT01422096|Leuprolide|leuprolide|mesh-list
56183016|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56183017|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
56672799|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
56672800|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672801|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56672802|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56672803|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56672804|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672805|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56672806|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
56672807|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56672808|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
56672809|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56672810|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672811|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56672812|NCT04212065|Buprenorphine|buprenorphine|mesh-list
56672813|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56672814|NCT04212065|Narcotics|narcotics|mesh-ancestor
56672815|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672816|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672817|NCT04212065|Analgesics|analgesics|mesh-ancestor
56672818|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
56672819|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672820|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56672821|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
56672822|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56672823|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56672824|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
56672825|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56672826|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56672827|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672828|NCT00617513|Prucalopride|prucalopride|mesh-list
56183018|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56183019|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183020|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56183021|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183022|NCT01422109|Aspirin|aspirin|mesh-list
56183023|NCT01422109|Clopidogrel|clopidogrel|mesh-list
56183024|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56183025|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56183026|NCT01422109|Analgesics|analgesics|mesh-ancestor
56183027|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
56183028|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183029|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183030|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183031|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56183032|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56672829|NCT00617513|Laxatives|laxatives|mesh-ancestor
56672830|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672831|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56672832|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56672833|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
56672834|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672835|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672836|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672837|NCT04061512|Dexamethasone|dexamethasone|mesh-list
56672838|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
56672839|NCT04061512|Rituximab|rituximab|mesh-list
56672840|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672841|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
56672842|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183033|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56183034|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183035|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56166129|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
55756170|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
55756171|NCT01670721|Vitamins|vitamins|mesh-ancestor
55756172|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
55756173|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55756174|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56166130|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166131|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
56166132|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166134|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
56166135|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166136|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166137|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
56166138|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166139|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166140|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166141|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166143|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166144|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
56166145|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166146|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166147|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56166148|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166149|NCT00003540|Gemcitabine|gemcitabine|mesh-list
56166150|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166151|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
56166152|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166153|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166154|NCT00003540|Antiviral Agents|antiviral agents|mesh-ancestor
56166155|NCT00003540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183036|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56183037|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183039|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56183040|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55756295|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56166157|NCT00003540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166158|NCT00003540|Immunologic Factors|immunologic factors|mesh-ancestor
56166159|NCT00003540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166160|NCT00003546|Gemcitabine|gemcitabine|mesh-list
56166161|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166162|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
55888868|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672843|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672844|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56672845|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
56672846|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166163|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166164|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756356|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56166165|NCT00003546|Antiviral Agents|antiviral agents|mesh-ancestor
56166166|NCT00003546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166167|NCT00003546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166168|NCT00003546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166169|NCT00003546|Immunologic Factors|immunologic factors|mesh-ancestor
56166170|NCT00003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166171|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
56166172|NCT00003552|Fludarabine|fludarabine|mesh-list
56166173|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56166174|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166175|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
56166176|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166177|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166178|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166179|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
56166180|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166181|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166182|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166183|NCT00003558|Leucovorin|leucovorin|mesh-list
56166184|NCT00003558|Paclitaxel|paclitaxel|mesh-list
56166185|NCT00003558|Etoposide|etoposide|mesh-list
56166186|NCT00003558|Carboplatin|carboplatin|mesh-list
56166187|NCT00003558|Fluorouracil|fluorouracil|mesh-list
56166188|NCT00003558|Calcium|calcium|mesh-list
56166189|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
56166190|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166191|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166192|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166193|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166194|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166195|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166196|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56166197|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166198|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
56166199|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166200|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166201|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
56166202|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55756510|NCT02711137|Paclitaxel|paclitaxel|mesh-list
56166203|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166204|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166205|NCT00003558|Antidotes|antidotes|mesh-ancestor
56166206|NCT00003558|Protective Agents|protective agents|mesh-ancestor
56166207|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
56166208|NCT00003558|Vitamins|vitamins|mesh-ancestor
56166209|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
56166210|NCT00003564|Procarbazine|procarbazine|mesh-list
56166211|NCT00003564|Isotretinoin|isotretinoin|mesh-list
56166212|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166213|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
56166214|NCT00003576|Fluorouracil|fluorouracil|mesh-list
56166215|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166216|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
56166217|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166218|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166219|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183041|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56183042|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
56183043|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183044|NCT01422122|Vitamin D|vitamin d|mesh-list
56183045|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
56183046|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
56183047|NCT01422122|Vitamins|vitamins|mesh-list
56183048|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
56183049|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183050|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56672847|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672848|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56672849|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56672850|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56672851|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
56672852|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
56672853|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672854|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672855|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
56672856|NCT04061512|Hormones|hormones|mesh-ancestor
56672857|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183051|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56183052|NCT01422291|Acetaminophen|acetaminophen|mesh-list
56183053|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56183054|NCT01422291|Morphine|morphine|mesh-list
56183055|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56183056|NCT01422291|Narcotics|narcotics|mesh-ancestor
56183057|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56183058|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183059|NCT01422291|Analgesics|analgesics|mesh-ancestor
56183060|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
56183061|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183062|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56183063|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
56183064|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56183065|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885564|NCT01726738|Trametinib|trametinib|mesh-list
55756528|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56166220|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
56166221|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166222|NCT00003582|Paclitaxel|paclitaxel|mesh-list
56166223|NCT00003582|Fluorouracil|fluorouracil|mesh-list
56166224|NCT00003582|Amifostine|amifostine|mesh-list
56166225|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166226|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166227|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166228|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166229|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166230|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166231|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
56166232|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166233|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166234|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
56166235|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756590|NCT03291899|Folfirinox|folfirinox|mesh-list
56166236|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56166237|NCT00003582|Protective Agents|protective agents|mesh-ancestor
56166239|NCT00003594|Fluorouracil|fluorouracil|mesh-list
56166240|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
56166241|NCT00003594|Irinotecan|irinotecan|mesh-list
56166242|NCT00003594|Calcium|calcium|mesh-list
56166243|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
56166244|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56166245|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183066|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56183067|NCT01422317|Tocopherols|tocopherols|mesh-list
56183068|NCT01422317|Vitamin E|vitamin e|mesh-list
56183069|NCT01422317|Tocotrienols|tocotrienols|mesh-list
56183070|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
56183071|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
56183072|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183073|NCT01422317|Protective Agents|protective agents|mesh-ancestor
56183074|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183075|NCT01422317|Vitamins|vitamins|mesh-ancestor
56183076|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
56183077|NCT01422330|Etravirine|etravirine|mesh-list
55888869|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672858|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56319074|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
56672859|NCT02627222|Vitamin A|vitamin a|mesh-list
56672860|NCT02627222|Provitamins|provitamins|mesh-list
56672861|NCT02627222|Vitamins|vitamins|mesh-ancestor
56672862|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
56672863|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672864|NCT00594854|Diclofenac|diclofenac|mesh-list
56672865|NCT00594854|Arthrotec|arthrotec|mesh-list
56672866|NCT00594854|Misoprostol|misoprostol|mesh-list
56234058|NCT01735344|Lisinopril|lisinopril|mesh-list
56183078|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56183079|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55885618|NCT02491086|Nicotine|nicotine|mesh-list
56166246|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
56166247|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166248|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166249|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166250|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166251|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
56166252|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56166253|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166255|NCT00003594|Antidotes|antidotes|mesh-ancestor
56166256|NCT00003594|Protective Agents|protective agents|mesh-ancestor
56166257|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
56166258|NCT00003594|Vitamins|vitamins|mesh-ancestor
56166259|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
56166260|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
56166261|NCT00003600|Hematinics|hematinics|mesh-ancestor
56166262|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
56166264|NCT00003606|Epirubicin|epirubicin|mesh-list
56166265|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166266|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
56166267|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166277|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166278|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56166279|NCT00003612|Paclitaxel|paclitaxel|mesh-list
56166280|NCT00003612|Carboplatin|carboplatin|mesh-list
56166281|NCT00003612|Trastuzumab|trastuzumab|mesh-list
56166282|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55756767|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
56166283|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166284|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166285|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166286|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166287|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166288|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56166289|NCT00003624|Paclitaxel|paclitaxel|mesh-list
56166290|NCT00003624|Amifostine|amifostine|mesh-list
56166291|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166292|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166293|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166294|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166295|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
56183080|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183081|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183082|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
56166296|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166297|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56166298|NCT00003624|Protective Agents|protective agents|mesh-ancestor
56166299|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166300|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
56166301|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166302|NCT00003636|Carboplatin|carboplatin|mesh-list
56166303|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166304|NCT00003642|Fluorouracil|fluorouracil|mesh-list
56166305|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166306|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
56166307|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672867|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56672868|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
56672869|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56672870|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672871|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56672872|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56672873|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
56672874|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56672875|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56672876|NCT00594854|Analgesics|analgesics|mesh-ancestor
56672877|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
56672878|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672879|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56672880|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672881|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56672882|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672883|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672884|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56672885|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56672886|NCT00684632|Fentanyl|fentanyl|mesh-list
56672887|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56672888|NCT00684632|Narcotics|narcotics|mesh-ancestor
56166308|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166309|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166310|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
56166311|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166312|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56166313|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56166314|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166316|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166317|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
56166318|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166319|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166320|NCT00003678|Tamoxifen|tamoxifen|mesh-list
55756957|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166321|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56166322|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
56166323|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56166324|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166325|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55800628|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
56166337|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56166338|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166339|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166340|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
56166341|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56166342|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56166343|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
56166344|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56166345|NCT00003690|Carboplatin|carboplatin|mesh-list
56166347|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672889|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56672890|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672891|NCT00684632|Analgesics|analgesics|mesh-ancestor
56672892|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
56672893|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672894|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56672895|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56672896|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
56672897|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
56672898|NCT00855582|Tadalafil|tadalafil|mesh-list
56672899|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
56672900|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56672901|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56672902|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672903|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672904|NCT00855582|Urological Agents|urological agents|mesh-ancestor
56672905|NCT00619541|Fluorouracil|fluorouracil|mesh-list
56166348|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
56166349|NCT00003690|Growth Substances|growth substances|mesh-ancestor
56166350|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166351|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56166352|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166353|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166354|NCT00003696|Paclitaxel|paclitaxel|mesh-list
56166355|NCT00003696|Etoposide|etoposide|mesh-list
56166356|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
56166357|NCT00003696|Carboplatin|carboplatin|mesh-list
56166358|NCT00003696|Doxorubicin|doxorubicin|mesh-list
56166359|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56166360|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166361|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183083|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183085|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
56183086|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183087|NCT01422499|Vorinostat|vorinostat|mesh-list
56183088|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183089|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56183090|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183091|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183092|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56183093|NCT01422590|Mitiglinide|mitiglinide|mesh-list
56183094|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56183095|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183096|NCT01422590|Incretins|incretins|mesh-ancestor
56183097|NCT01422590|Hormones|hormones|mesh-ancestor
56183098|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183099|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56183100|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
56183101|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183102|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183103|NCT01422603|Clofarabine|clofarabine|mesh-list
56183104|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56183105|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
56183106|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183107|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183108|NCT01422616|Metoprolol|metoprolol|mesh-list
56183109|NCT01422616|Clonidine|clonidine|mesh-list
56166368|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672906|NCT00619541|Sorafenib|sorafenib|mesh-list
56672907|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
56672908|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672909|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56672910|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672911|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672912|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
56672913|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672914|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56672915|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672916|NCT00680498|Ranibizumab|ranibizumab|mesh-list
56672917|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56166369|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166370|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166371|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
56166372|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166373|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56166374|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166375|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166376|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166377|NCT00003708|Temozolomide|temozolomide|mesh-list
56183113|NCT01422616|Phentolamine|phentolamine|mesh-list
56183114|NCT01422616|Urapidil|urapidil|mesh-list
56183115|NCT01422616|Enalaprilat|enalaprilat|mesh-list
56183116|NCT01422616|Enalapril|enalapril|mesh-list
56183117|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56183118|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
56183119|NCT01422616|Esmolol|esmolol|mesh-list
56183120|NCT01422616|Glycerol|glycerol|mesh-list
56183121|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56183122|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56183123|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
56183124|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
56183125|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183126|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183127|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56183128|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56183129|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56183130|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
56166378|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166379|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
56166380|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166381|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166382|NCT00003714|NSC 366140|nsc 366140|mesh-list
56166383|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166384|NCT00003720|Semaxinib|semaxinib|mesh-list
56166385|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56166386|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56166387|NCT00003720|Growth Substances|growth substances|mesh-ancestor
56166388|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166389|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
56166390|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166391|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56166392|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166393|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166395|NCT00003732|Carboplatin|carboplatin|mesh-list
56166396|NCT00003732|Topotecan|topotecan|mesh-list
56166397|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166398|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166399|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166400|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166401|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166402|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166403|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56672918|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56672919|NCT00680498|Growth Substances|growth substances|mesh-ancestor
56672920|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672921|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
56672922|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672923|NCT00684866|Albuterol|albuterol|mesh-list
56672924|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56672925|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
56672926|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672927|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672928|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56672929|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
56672930|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
56672931|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56672932|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56672933|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56672934|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56319151|NCT00024453|Teicoplanin|teicoplanin|mesh-list
56672935|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
56672936|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56672937|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672938|NCT00854724|Puerarin|puerarin|mesh-list
56672939|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
56672940|NCT00619697|Insulin|insulin|mesh-list
56672941|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56672942|NCT00619697|Metformin|metformin|mesh-list
56672943|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
56672944|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
56672945|NCT00619697|Glimepiride|glimepiride|mesh-list
56672946|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
56672947|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56672948|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672949|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672950|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56672951|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56672952|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
56672953|NCT00680654|Riociguat|riociguat|mesh-list
56234114|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
56672954|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
56672955|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672956|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56672957|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56672958|NCT00680732|Folic Acid|folic acid|mesh-list
56672959|NCT00680732|Micronutrients|micronutrients|mesh-list
56672960|NCT00680732|Trace Elements|trace elements|mesh-list
56672961|NCT00680732|Chloroquine|chloroquine|mesh-list
56672962|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
56672963|NCT00680732|Hematinics|hematinics|mesh-ancestor
56672964|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
56672965|NCT00680732|Vitamins|vitamins|mesh-ancestor
56672966|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672967|NCT00680732|Amebicides|amebicides|mesh-ancestor
56166404|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166405|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166407|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166408|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
56166409|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166410|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183132|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183133|NCT01422616|Analgesics|analgesics|mesh-ancestor
56183134|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
56183135|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56183136|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56183137|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56183138|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56183139|NCT01422616|Protective Agents|protective agents|mesh-ancestor
56183140|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
56183141|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56183142|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56183143|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
56183144|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56183145|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56183146|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56183147|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56183148|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56183149|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56183150|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
56183151|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56183152|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
55885851|NCT01746940|Cocaine|cocaine|mesh-list
56166421|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757377|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
56166422|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166423|NCT00003762|Antiviral Agents|antiviral agents|mesh-ancestor
56166424|NCT00003762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166425|NCT00003762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166426|NCT00003762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166427|NCT00003762|Immunologic Factors|immunologic factors|mesh-ancestor
56166428|NCT00003762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166429|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166430|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166431|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166432|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
56166433|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166434|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166435|NCT00003780|Gemcitabine|gemcitabine|mesh-list
56166436|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166437|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
56166438|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757518|NCT04967469|Calcitriol|calcitriol|mesh-list
56166439|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56672968|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56672969|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56672970|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56672971|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
56672972|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56672973|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56672974|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672975|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672976|NCT00698932|Saxagliptin|saxagliptin|mesh-list
56672977|NCT00698932|Incretins|incretins|mesh-ancestor
56672978|NCT00698932|Hormones|hormones|mesh-ancestor
56672979|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56672980|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672981|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56672982|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
56672983|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56672984|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672985|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56672986|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
56672987|NCT02566252|Albuterol|albuterol|mesh-list
56672988|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
56672989|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56672990|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
56672991|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56672992|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56672993|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56672994|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
56672995|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
56672996|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56672997|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56672998|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56166440|NCT00003780|Antiviral Agents|antiviral agents|mesh-ancestor
56166441|NCT00003780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166442|NCT00003780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166443|NCT00003780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166444|NCT00003780|Immunologic Factors|immunologic factors|mesh-ancestor
56166445|NCT00003780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166446|NCT00003786|Irofulven|irofulven|mesh-list
56183153|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183154|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
56183155|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183156|NCT01422733|Dexamethasone|dexamethasone|mesh-list
56166449|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56672999|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56673000|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
56673001|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673002|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673003|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56673004|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
56673005|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673006|NCT00823719|Ofatumumab|ofatumumab|mesh-list
56673007|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56319222|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56673008|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673009|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
56673010|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673011|NCT03953170|Teduglutide|teduglutide|mesh-list
56673012|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56673013|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56673014|NCT03953170|Protective Agents|protective agents|mesh-ancestor
56673015|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673016|NCT00708591|Sirolimus|sirolimus|mesh-list
56673017|NCT00708591|Ketoconazole|ketoconazole|mesh-list
56673018|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56673019|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673020|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56673021|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673022|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
56673023|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673024|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
56673025|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673026|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56673027|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56673028|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673029|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673030|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56166452|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56166453|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
56166454|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166455|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
56166456|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166457|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56166458|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
56166459|NCT00003804|Dactinomycin|dactinomycin|mesh-list
56673031|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
56673032|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234222|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
56166460|NCT00003804|Vincristine|vincristine|mesh-list
55757628|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
56166461|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166462|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166463|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166464|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166465|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166466|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166467|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56166468|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166469|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56166470|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56166471|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166472|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56166473|NCT00003810|Gemcitabine|gemcitabine|mesh-list
56166474|NCT00003810|Docetaxel|docetaxel|mesh-list
56166475|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166476|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
56166477|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166478|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166479|NCT00003810|Antiviral Agents|antiviral agents|mesh-ancestor
56166480|NCT00003810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166481|NCT00003810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166482|NCT00003810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166483|NCT00003810|Immunologic Factors|immunologic factors|mesh-ancestor
56166484|NCT00003810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166485|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166486|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166487|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166488|NCT00003828|Vinorelbine|vinorelbine|mesh-list
56166489|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166490|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166491|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166492|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166493|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166494|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166495|NCT00003834|Leucovorin|leucovorin|mesh-list
56166496|NCT00003834|Fluorouracil|fluorouracil|mesh-list
56166497|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
56166498|NCT00003834|Calcium|calcium|mesh-list
56166499|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
56183167|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183168|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56183169|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183176|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183177|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56166500|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56166501|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166502|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
56166503|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166504|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166505|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166506|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166507|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
56166508|NCT00003834|Antidotes|antidotes|mesh-ancestor
56166509|NCT00003834|Protective Agents|protective agents|mesh-ancestor
56166510|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
56166511|NCT00003834|Vitamins|vitamins|mesh-ancestor
56166512|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
56166513|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
56166514|NCT00003846|Thiotepa|thiotepa|mesh-list
56166515|NCT00003846|Carboplatin|carboplatin|mesh-list
56166516|NCT00003846|Vincristine|vincristine|mesh-list
56166517|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166518|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
56166519|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166520|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166521|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166522|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
56673033|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56673034|NCT04595266|Leucovorin|leucovorin|mesh-list
56673035|NCT04595266|Bevacizumab|bevacizumab|mesh-list
56673036|NCT04595266|Fluorouracil|fluorouracil|mesh-list
56673037|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
56673038|NCT04595266|Irinotecan|irinotecan|mesh-list
56673039|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56673040|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673041|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56673042|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56673043|NCT04595266|Growth Substances|growth substances|mesh-ancestor
56673044|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757939|NCT04947267|Mepivacaine|mepivacaine|mesh-list
56166523|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166524|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166525|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166526|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166527|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166528|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166529|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166530|NCT00003852|Paclitaxel|paclitaxel|mesh-list
56166531|NCT00003852|Etoposide|etoposide|mesh-list
56166532|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
56166533|NCT00003852|Carboplatin|carboplatin|mesh-list
56166534|NCT00003852|Epirubicin|epirubicin|mesh-list
56166535|NCT00003852|Ifosfamide|ifosfamide|mesh-list
56166536|NCT00003852|Thiotepa|thiotepa|mesh-list
56166537|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166538|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166539|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166540|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166541|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166542|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166543|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166544|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
56166545|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166546|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166547|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166548|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
56166549|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166550|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166551|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166552|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166553|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56166555|NCT00003858|Analgesics|analgesics|mesh-ancestor
56166556|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
56166557|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56166558|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166559|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166560|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166561|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166562|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166563|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166565|NCT00003864|Docetaxel|docetaxel|mesh-list
56166566|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166567|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166568|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166569|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166570|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166571|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
56166572|NCT00003870|Methotrexate|methotrexate|mesh-list
56166573|NCT00003870|Antibodies|antibodies|mesh-list
56166574|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56166575|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166576|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
56673045|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
56673046|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
56673047|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673048|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56673049|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673050|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
56673051|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56673052|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56673053|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673054|NCT04595266|Antidotes|antidotes|mesh-ancestor
56673055|NCT04595266|Protective Agents|protective agents|mesh-ancestor
56673056|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
56673057|NCT04595266|Vitamins|vitamins|mesh-ancestor
56673058|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
56673059|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
56673060|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56673061|NCT00708747|Antibodies|antibodies|mesh-list
56673062|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
56673063|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673064|NCT00685022|Albuterol|albuterol|mesh-list
56673065|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56673066|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
56673067|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56166577|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166578|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166579|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166580|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
56166581|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166582|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166583|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166584|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56166585|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
56166586|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56166587|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166588|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
56166589|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
56166590|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166591|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56166592|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56166593|NCT00003876|Carmustine|carmustine|mesh-list
56166594|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55758182|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
56166595|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
56166596|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166597|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166598|NCT00003888|Docetaxel|docetaxel|mesh-list
56166599|NCT00003888|Fluorouracil|fluorouracil|mesh-list
56166600|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166601|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166602|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166603|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166604|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166605|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
56673068|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673069|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56673070|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
56673071|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
56673072|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56673073|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56673074|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56673075|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56673076|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
56673077|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673078|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673079|NCT03787264|Venetoclax|venetoclax|mesh-list
56673080|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56673081|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
56673082|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
56319295|NCT05023382|Protective Agents|protective agents|mesh-ancestor
56673083|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673084|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56673085|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
56673086|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673087|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56673089|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
56673090|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673091|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
56673092|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56673093|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56673094|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
56673095|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673096|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673097|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673098|NCT00685100|Triamcinolone|triamcinolone|mesh-list
56673099|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673100|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
56673107|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56673108|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56673109|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673110|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673111|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673112|NCT00637091|Irinotecan|irinotecan|mesh-list
56673113|NCT00637091|Cetuximab|cetuximab|mesh-list
56673114|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56673115|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56673116|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673117|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673118|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673119|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56673120|NCT04213391|Sulforaphane|sulforaphane|mesh-list
56673121|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56673122|NCT04213391|Protective Agents|protective agents|mesh-ancestor
56673123|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673124|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673125|NCT03714958|Trametinib|trametinib|mesh-list
56673126|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673127|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56673128|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673129|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673130|NCT00709137|Amiloride|amiloride|mesh-list
56673131|NCT00709137|Spironolactone|spironolactone|mesh-list
56673132|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56673133|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
56673144|NCT04150172|Rebamipide|rebamipide|mesh-list
56673152|NCT02325011|Fluconazole|fluconazole|mesh-list
56673153|NCT02325011|Nabiximols|nabiximols|mesh-list
56673154|NCT02325011|Dronabinol|dronabinol|mesh-list
56673155|NCT02325011|Cannabidiol|cannabidiol|mesh-list
56673156|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
56673157|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673158|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56673159|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56673160|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673161|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673162|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56673163|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
56673164|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673165|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673166|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56673167|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56673168|NCT02325011|Analgesics|analgesics|mesh-ancestor
56673169|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
56673170|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673171|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
56673172|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
56673173|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56673174|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56673175|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56673176|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56673177|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673178|NCT02325011|Hormones|hormones|mesh-ancestor
56673179|NCT00577096|Thalidomide|thalidomide|mesh-list
56673180|NCT00577096|Dexamethasone|dexamethasone|mesh-list
56673181|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
56673182|NCT00577096|Melphalan|melphalan|mesh-list
56673183|NCT00577096|Cisplatin|cisplatin|mesh-list
56673184|NCT00577096|Doxorubicin|doxorubicin|mesh-list
56673185|NCT00577096|Etoposide|etoposide|mesh-list
56673186|NCT00577096|Vincristine|vincristine|mesh-list
56673187|NCT00577096|Heparin|heparin|mesh-list
56673188|NCT00577096|Calcium heparin|calcium heparin|mesh-list
56673189|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56673193|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673194|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
56673195|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673196|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673197|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56673198|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
56673199|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673200|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673201|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56673202|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673203|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
56673204|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
56673205|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673206|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56673207|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
56673208|NCT00577096|Hormones|hormones|mesh-ancestor
56673209|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673210|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56673211|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673212|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56673213|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56673214|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56673215|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56673216|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
56673217|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
56673218|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
56673219|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
56673220|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56673221|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56673222|NCT00577096|Hematinics|hematinics|mesh-ancestor
56673223|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
56673224|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56673225|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673226|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56673227|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56673228|NCT00577096|Growth Substances|growth substances|mesh-ancestor
56673232|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56673233|NCT02625506|Narcotics|narcotics|mesh-ancestor
56673234|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673235|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673237|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
56673238|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673239|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
56673240|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
56673241|NCT04209959|Nifekalant|nifekalant|mesh-list
56166606|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166607|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166608|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
56166609|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166610|NCT00003894|Thalidomide|thalidomide|mesh-list
56166611|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166612|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
56166613|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166614|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
56166615|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56166616|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166617|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56166618|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56166619|NCT00003894|Growth Substances|growth substances|mesh-ancestor
56166620|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
56166621|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166622|NCT00003900|Docetaxel|docetaxel|mesh-list
56166623|NCT00003900|Irinotecan|irinotecan|mesh-list
56166624|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166625|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
56183179|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183180|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56166626|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166627|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166628|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166629|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56166630|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166631|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166632|NCT00003906|Tamoxifen|tamoxifen|mesh-list
56166633|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56166634|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56166635|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
56166646|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166647|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56166648|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166649|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166650|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166651|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166652|NCT00003924|Interferons|interferons|mesh-list
56166653|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
56166654|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166655|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
56166656|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166657|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
56166658|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166659|NCT00003930|Gemcitabine|gemcitabine|mesh-list
56166660|NCT00003930|Paclitaxel|paclitaxel|mesh-list
56166661|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166662|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166663|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166664|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166665|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166666|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166667|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166668|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
56166669|NCT00003930|Antiviral Agents|antiviral agents|mesh-ancestor
56166670|NCT00003930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166671|NCT00003930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166672|NCT00003930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673242|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56673243|NCT04209803|Minoxidil|minoxidil|mesh-list
56673244|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56673245|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
56673246|NCT02567032|Oxytocin|oxytocin|mesh-list
56673247|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
56673248|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56673249|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673250|NCT00618059|Pilocarpine|pilocarpine|mesh-list
56673251|NCT00618059|Miotics|miotics|mesh-ancestor
56673252|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
56673253|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673254|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673255|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56673256|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56673257|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
56673258|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673259|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673260|NCT00863304|Naproxen|naproxen|mesh-list
56673261|NCT00863304|Tanezumab|tanezumab|mesh-list
56673262|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56673263|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56673264|NCT00863304|Analgesics|analgesics|mesh-ancestor
56673265|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
56673266|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673267|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166673|NCT00003930|Immunologic Factors|immunologic factors|mesh-ancestor
56166674|NCT00003930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166675|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
56166676|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56166677|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
56166678|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166679|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166680|NCT00003954|Cyclosporine|cyclosporine|mesh-list
56166681|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
56166682|NCT00003954|Melphalan|melphalan|mesh-list
56166683|NCT00003954|Cyclosporins|cyclosporins|mesh-list
56166684|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166685|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166686|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166687|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
56166688|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758473|NCT03057015|Hormones|hormones|mesh-ancestor
56166689|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
56166690|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166691|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
56166692|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166693|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56166694|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56166695|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183181|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673268|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673269|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673270|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
56673271|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56673272|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673273|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673274|NCT03603808|Vaccines|vaccines|mesh-list
56673275|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
56673276|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673277|NCT04909073|Afatinib|afatinib|mesh-list
56673278|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673279|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56673280|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673281|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673282|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
56673283|NCT00695110|Testosterone|testosterone|mesh-list
56673284|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
56673285|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
56673286|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56673287|NCT00695110|Androgens|androgens|mesh-ancestor
56673288|NCT00695110|Hormones|hormones|mesh-ancestor
56673289|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673290|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673291|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56673292|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673293|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
56673294|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
56673295|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56673296|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673297|NCT03264352|Amlodipine|amlodipine|mesh-list
56673298|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56673299|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56673300|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56673309|NCT04897919|Artenimol|artenimol|mesh-list
56673310|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
56673311|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56319524|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
56319599|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
56673312|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56673313|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673314|NCT00594386|Rotigotine|rotigotine|mesh-list
56673315|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
56673316|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
56673317|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673318|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673319|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673320|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56673321|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
56673322|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56673323|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56673324|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56673325|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56673326|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673327|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
56673328|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673329|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673330|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56673331|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673332|NCT03466450|Temozolomide|temozolomide|mesh-list
56673333|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56183182|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
56183183|NCT01422954|Chloroquine|chloroquine|mesh-list
56183184|NCT01422954|Mefloquine|mefloquine|mesh-list
56183185|NCT01422954|Proguanil|proguanil|mesh-list
56183186|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56183188|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56183189|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56183190|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183191|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
56183192|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56183193|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
56183194|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166696|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56166697|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
56166698|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56166699|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166700|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
56166701|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166703|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56166704|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56166705|NCT00003960|Prednisolone|prednisolone|mesh-list
56166706|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
56166707|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
56673334|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
56673335|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673336|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673337|NCT00690560|Prednisone|prednisone|mesh-list
56673338|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
56673339|NCT00690560|Rituximab|rituximab|mesh-list
56673340|NCT00690560|Doxorubicin|doxorubicin|mesh-list
56673341|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56673342|NCT00690560|Vincristine|vincristine|mesh-list
56673343|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673344|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
56673345|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673346|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673347|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56673348|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
56673349|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673350|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673351|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56673352|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56673353|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56673354|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56673355|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56673356|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673357|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673358|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
56673359|NCT00690560|Hormones|hormones|mesh-ancestor
56673360|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673361|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56673362|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56673363|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
56673364|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
56673365|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
56673366|NCT00742690|Terlipressin|terlipressin|mesh-list
56673367|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56673375|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56673376|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673377|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
56673378|NCT00742768|Coagulants|coagulants|mesh-ancestor
56673379|NCT00862992|Cariprazine|cariprazine|mesh-list
56673380|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56673381|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56673382|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673383|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673384|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56673385|NCT02565316|Sertraline|sertraline|mesh-list
56673386|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
56673387|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56234571|NCT01738867|Naltrexone|naltrexone|mesh-list
56166708|NCT00003960|Busulfan|busulfan|mesh-list
56166709|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56166710|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
56166711|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166712|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
56166713|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166714|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166715|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166716|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
56166717|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166718|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166719|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166720|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56166721|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
56166722|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
56166723|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56166724|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56166725|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
56166726|NCT00003960|Hormones|hormones|mesh-ancestor
56166727|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56166728|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56166729|NCT00003960|Protective Agents|protective agents|mesh-ancestor
56166730|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56166731|NCT00003966|Defibrotide|defibrotide|mesh-list
56166732|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56166733|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56166734|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166735|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56166736|NCT00003972|Tamoxifen|tamoxifen|mesh-list
56166737|NCT00003972|Paclitaxel|paclitaxel|mesh-list
56166738|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
56166739|NCT00003972|Carboplatin|carboplatin|mesh-list
56166740|NCT00003972|Melphalan|melphalan|mesh-list
56166741|NCT00003972|Busulfan|busulfan|mesh-list
56166742|NCT00003972|Thiotepa|thiotepa|mesh-list
56166743|NCT00003972|Sargramostim|sargramostim|mesh-list
56166744|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166745|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166746|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
56183196|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56183197|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56183198|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
56183199|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183200|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166747|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166748|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166749|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758702|NCT04918953|Hormones|hormones|mesh-ancestor
56166750|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166751|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
56673388|NCT02565316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56673389|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56673390|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56673391|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673392|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673393|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
56673394|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673395|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56673396|NCT00742846|Triamcinolone|triamcinolone|mesh-list
56673397|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56673398|NCT00742846|Lidocaine|lidocaine|mesh-list
56673399|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56673400|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
56673401|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
56673402|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673403|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673404|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
56673405|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673406|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56673407|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56673408|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56673409|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56673410|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673411|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673412|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
56673413|NCT00742846|Hormones|hormones|mesh-ancestor
56673414|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673415|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673416|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
56673417|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673418|NCT00690872|Gemcitabine|gemcitabine|mesh-list
56673419|NCT00690872|Carboplatin|carboplatin|mesh-list
56166752|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166753|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166754|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166755|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
56166756|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166757|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56166758|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
55943369|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
56673420|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673421|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56673422|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
56673423|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673424|NCT00690872|Antiviral Agents|antiviral agents|mesh-ancestor
56673425|NCT00690872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673426|NCT00690872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673427|NCT00690872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673428|NCT00690872|Immunologic Factors|immunologic factors|mesh-ancestor
56673429|NCT00690872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673430|NCT00694096|Sunitinib|sunitinib|mesh-list
56673431|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673432|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56234606|NCT01739127|Risperidone|risperidone|mesh-list
56166759|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56166760|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56166761|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56166762|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56166763|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56166764|NCT00003984|Lintuzumab|lintuzumab|mesh-list
56166765|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56166766|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166767|NCT00003996|Etoposide|etoposide|mesh-list
56166768|NCT00003996|Carmustine|carmustine|mesh-list
56166769|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166770|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166771|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166772|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166773|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166774|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166775|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166776|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
56166777|NCT00004002|Bortezomib|bortezomib|mesh-list
56166778|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166779|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
56166780|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56166781|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
56166782|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166783|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166784|NCT00004014|Doxorubicin|doxorubicin|mesh-list
56166785|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56166786|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56166787|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166788|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166789|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56094418|NCT03633487|Expectorants|expectorants|mesh-ancestor
56166790|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166791|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166792|NCT00004032|Interferons|interferons|mesh-list
56166793|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
56166794|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166795|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
56166796|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166797|NCT00004050|Interleukin-2|interleukin-2|mesh-list
56166798|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166799|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56166800|NCT00004050|Analgesics|analgesics|mesh-ancestor
56166801|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
56166802|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56166803|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166804|NCT00004056|Cytarabine|cytarabine|mesh-list
56673433|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56673434|NCT00694096|Growth Substances|growth substances|mesh-ancestor
56673435|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673436|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
56673437|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56673438|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673439|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673440|NCT04808531|Oxycodone|oxycodone|mesh-list
56673441|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56673442|NCT04808531|Narcotics|narcotics|mesh-ancestor
56673443|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673444|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673445|NCT04808531|Analgesics|analgesics|mesh-ancestor
56673446|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
56673447|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673448|NCT00690950|Dutasteride|dutasteride|mesh-list
56673449|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56673450|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56673451|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673452|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673453|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
56673454|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673455|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673456|NCT02622126|Atropine|atropine|mesh-list
56673457|NCT02622126|Ephedrine|ephedrine|mesh-list
56673458|NCT02622126|Morphine|morphine|mesh-list
56673459|NCT02622126|Bupivacaine|bupivacaine|mesh-list
56166805|NCT00004056|Thioguanine|thioguanine|mesh-list
56166806|NCT00004056|Melphalan|melphalan|mesh-list
56166807|NCT00004056|Daunorubicin|daunorubicin|mesh-list
56166808|NCT00004056|Asparaginase|asparaginase|mesh-list
56183201|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183202|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
56183203|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
56183204|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183205|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56183206|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
56183207|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
56183208|NCT01423032|Fludarabine|fludarabine|mesh-list
56183209|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56183210|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183211|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183212|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56183213|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
56166809|NCT00004056|Lenograstim|lenograstim|mesh-list
56166810|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166811|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
55943370|NCT01361217|Caffeine|caffeine|mesh-list
56673460|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
56673462|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673463|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673464|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
56673465|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673466|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56673467|NCT02622126|Narcotics|narcotics|mesh-ancestor
56673468|NCT02622126|Analgesics|analgesics|mesh-ancestor
56673469|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56673470|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56673471|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56673472|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
56673473|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56673474|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
56673475|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
56673476|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
56673477|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56673478|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56673479|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
56673480|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234642|NCT01739218|Carboplatin|carboplatin|mesh-list
56166812|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166813|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166814|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
56166815|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166816|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166817|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
56166818|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166819|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55758926|NCT02155738|Analgesics|analgesics|mesh-ancestor
55758927|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
56166820|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166821|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
56166822|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166823|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56166824|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166825|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166826|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166828|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166829|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
56166830|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166831|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166832|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166833|NCT00004068|Irinotecan|irinotecan|mesh-list
56166834|NCT00004068|Temozolomide|temozolomide|mesh-list
55758991|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
56166835|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56166836|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166837|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166838|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166839|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166840|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166841|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
56166842|NCT00004074|Carboplatin|carboplatin|mesh-list
56166843|NCT00004074|Trastuzumab|trastuzumab|mesh-list
55943371|NCT01361217|Fluoxetine|fluoxetine|mesh-list
56673481|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673482|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56673483|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
56673484|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56673485|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
56673486|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
56673487|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56673488|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673489|NCT00685568|Celecoxib|celecoxib|mesh-list
56673490|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56673491|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56673492|NCT00685568|Analgesics|analgesics|mesh-ancestor
56673493|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
56673494|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673495|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673496|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673497|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673498|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56166844|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56166845|NCT00004074|Interleukin-12|interleukin-12|mesh-list
56166846|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166847|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56166848|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56166849|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
56166850|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166851|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56166852|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56166853|NCT00004074|Growth Substances|growth substances|mesh-ancestor
56166854|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
56183214|NCT01423123|Paclitaxel|paclitaxel|mesh-list
56183215|NCT01423123|Trastuzumab|trastuzumab|mesh-list
56183216|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56183217|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183218|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
56183219|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
56183220|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
56183221|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183222|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56183223|NCT01423175|Clofarabine|clofarabine|mesh-list
56183224|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56183225|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
56183226|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183227|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183228|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56183229|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56183230|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56183231|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56183232|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183233|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56183234|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56183235|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56183236|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56183237|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
56166855|NCT00004086|Cytarabine|cytarabine|mesh-list
56673499|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56673500|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673501|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166856|NCT00004086|Etoposide|etoposide|mesh-list
56166857|NCT00004086|Ifosfamide|ifosfamide|mesh-list
56166858|NCT00004086|Epratuzumab|epratuzumab|mesh-list
56166859|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166860|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166861|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166862|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166863|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166864|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166865|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166866|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
56094497|NCT00634322|Leucovorin|leucovorin|mesh-list
56166867|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
56166868|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166869|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166870|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
56166871|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166872|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166873|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
55759100|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
56166874|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56166875|NCT00004104|Interferons|interferons|mesh-list
56166876|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
56166877|NCT00004104|Interleukin-2|interleukin-2|mesh-list
56166878|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166879|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
56183238|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183239|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183240|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56183241|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56183242|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
56183243|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56183244|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56183245|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
56166880|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166881|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
56166882|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166883|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56166884|NCT00004104|Analgesics|analgesics|mesh-ancestor
56166885|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
56166886|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56166887|NCT00004110|Etoposide|etoposide|mesh-list
56166888|NCT00004110|Isotretinoin|isotretinoin|mesh-list
56166889|NCT00004110|Antibodies|antibodies|mesh-list
56166890|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56166891|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
56166892|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166893|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166894|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166895|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166896|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166897|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166898|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166899|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
56166900|NCT00004122|Interferons|interferons|mesh-list
56166901|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
56166902|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
56166903|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166904|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
56166905|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166906|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
56166907|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166908|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56166909|NCT00004128|Cytarabine|cytarabine|mesh-list
56166910|NCT00004128|Aldesleukin|aldesleukin|mesh-list
56166911|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
56166912|NCT00004128|Busulfan|busulfan|mesh-list
56166913|NCT00004128|Etoposide|etoposide|mesh-list
56166914|NCT00004128|Daunorubicin|daunorubicin|mesh-list
56166915|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166916|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
56673502|NCT02626208|ST 1435|st 1435|mesh-list
56673503|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
56166917|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166918|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166919|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166920|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
56166921|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166922|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166923|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166924|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166925|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166926|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166927|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166928|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166929|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
56166930|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
56166931|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166932|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56166933|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56166934|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56166935|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56166939|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56183246|NCT01423292|Bupivacaine|bupivacaine|mesh-list
56183247|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
56183248|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
56183249|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56183250|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183251|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
56183252|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183253|NCT01423305|Budesonide|budesonide|mesh-list
56183254|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
56183255|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56183256|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183257|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56183258|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
56183259|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183260|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183261|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56183262|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
56183264|NCT01423305|Hormones|hormones|mesh-ancestor
56183265|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183266|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56183267|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56183268|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56183269|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
56183270|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886481|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759258|NCT03050229|Empagliflozin|empagliflozin|mesh-list
56166940|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
56166941|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166942|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094580|NCT00377143|Warfarin|warfarin|mesh-list
56166943|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166944|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166945|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
56166946|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166947|NCT00004164|Leucovorin|leucovorin|mesh-list
56166948|NCT00004164|Docetaxel|docetaxel|mesh-list
56166949|NCT00004164|Fluorouracil|fluorouracil|mesh-list
56166950|NCT00004164|Calcium|calcium|mesh-list
56166951|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
56166952|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166953|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
55759317|NCT02181634|Gemcitabine|gemcitabine|mesh-list
56166954|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166955|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166956|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166957|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56166958|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166959|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
56166960|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166961|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183271|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673504|NCT02626208|Estradiol|estradiol|mesh-list
56673505|NCT02626208|Estrogens|estrogens|mesh-ancestor
56673506|NCT02626208|Hormones|hormones|mesh-ancestor
55810248|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183272|NCT01423370|Tadalafil|tadalafil|mesh-list
56183273|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
56183274|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56183275|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56166962|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
56166963|NCT00004164|Antidotes|antidotes|mesh-ancestor
56166964|NCT00004164|Protective Agents|protective agents|mesh-ancestor
56166965|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
56166966|NCT00004164|Vitamins|vitamins|mesh-ancestor
56166967|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
56166968|NCT00004176|Etoposide|etoposide|mesh-list
56166969|NCT00004176|Amifostine|amifostine|mesh-list
56166970|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166971|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166972|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166973|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166974|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166975|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166988|NCT00004188|Topotecan|topotecan|mesh-list
56166989|NCT00004188|Isotretinoin|isotretinoin|mesh-list
56166990|NCT00004188|Lenograstim|lenograstim|mesh-list
56166991|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166992|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
56166993|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166994|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166995|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166996|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
56166997|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166998|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166999|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56167000|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56167001|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56167002|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55759502|NCT05255913|Fluorides|fluorides|mesh-list
56167003|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167004|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56167005|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56167006|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56167007|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167008|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167009|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56167010|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
56167011|NCT00004194|Fludarabine|fludarabine|mesh-list
56167012|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
56167013|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167014|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167015|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
56167016|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167017|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167018|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
56167019|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167020|NCT00004200|Temozolomide|temozolomide|mesh-list
56167021|NCT00004200|Prinomastat|prinomastat|mesh-list
56167022|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56167023|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
56167024|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167025|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167026|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
56167027|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
56183276|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183277|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183278|NCT01423370|Urological Agents|urological agents|mesh-ancestor
56183279|NCT01423435|Beraprost|beraprost|mesh-list
56183280|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56167028|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167030|NCT00004206|Fluorouracil|fluorouracil|mesh-list
56167031|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
56167032|NCT00004206|Calcium|calcium|mesh-list
56167033|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
56167034|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56673507|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673508|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673509|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56673510|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56673511|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56673512|NCT04210739|Betamethasone|betamethasone|mesh-list
56673513|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
56673514|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56673515|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
56673516|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56673517|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
56167035|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167036|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
56167037|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167040|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167042|NCT00004206|Antidotes|antidotes|mesh-ancestor
56167043|NCT00004206|Protective Agents|protective agents|mesh-ancestor
56167044|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
56167045|NCT00004206|Vitamins|vitamins|mesh-ancestor
56167046|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
56167047|NCT00004212|Exatecan|exatecan|mesh-list
56167048|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56167049|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56167050|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167051|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167052|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167054|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
56167055|NCT00004218|Chlorambucil|chlorambucil|mesh-list
56167056|NCT00004218|Doxorubicin|doxorubicin|mesh-list
56167057|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56167058|NCT00004218|Fludarabine|fludarabine|mesh-list
56167059|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
56167060|NCT00004218|Vincristine|vincristine|mesh-list
56167061|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167062|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
56167063|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167064|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167065|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56167066|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
56167067|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167068|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167069|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56167070|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56167071|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56167072|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56167073|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167074|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167075|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
56167076|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56167077|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
56167078|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167079|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167080|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167081|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
56167082|NCT00004218|Hormones|hormones|mesh-ancestor
56167083|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167084|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56167085|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
56167086|NCT00004224|Etoposide|etoposide|mesh-list
56167087|NCT00004224|Vincristine|vincristine|mesh-list
56167088|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167089|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
56167090|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167091|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673518|NCT04210739|Hormones|hormones|mesh-ancestor
56673519|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167092|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56167093|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
56167094|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167095|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183281|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
56183283|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56167096|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56094723|NCT04499924|Paclitaxel|paclitaxel|mesh-list
56167097|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56167098|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56167099|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56167100|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167101|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
56167102|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167103|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167104|NCT00004236|Doxorubicin|doxorubicin|mesh-list
56167105|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56167106|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56167107|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167108|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56167109|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56167110|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167111|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167113|NCT00004242|Fluorouracil|fluorouracil|mesh-list
56167114|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
56167115|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167116|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
56167117|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167118|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167119|NCT00004242|Antiviral Agents|antiviral agents|mesh-ancestor
56167120|NCT00004242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760000|NCT03045471|Hormones|hormones|mesh-ancestor
56167121|NCT00004242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167122|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167123|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
56167124|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167126|NCT00004248|Doxorubicin|doxorubicin|mesh-list
56167127|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56167128|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56167129|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167130|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56167131|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56167132|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167133|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167134|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56167135|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56167136|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
56167137|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167138|NCT00004254|Raltitrexed|raltitrexed|mesh-list
56167139|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167140|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
56167141|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167142|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167143|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56167144|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167145|NCT00004260|Rituximab|rituximab|mesh-list
56167146|NCT00004260|Interleukin-12|interleukin-12|mesh-list
56167147|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56167148|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167149|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
56167150|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167151|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167152|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56167153|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56167154|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56167155|NCT00004260|Growth Substances|growth substances|mesh-ancestor
56167156|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
56167157|NCT00004266|Lisinopril|lisinopril|mesh-list
56167158|NCT00004266|Nifedipine|nifedipine|mesh-list
56167159|NCT00004266|Simvastatin|simvastatin|mesh-list
56167160|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56167161|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56673520|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673521|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673522|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56673523|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
56167162|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
56167163|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167164|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56167165|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56167166|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183284|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183285|NCT01423500|Fludarabine|fludarabine|mesh-list
56183286|NCT01423500|Etoposide|etoposide|mesh-list
56183287|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
56183288|NCT01423500|Thiotepa|thiotepa|mesh-list
56167167|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56167168|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56167169|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56167170|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167171|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
56167173|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56167174|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56167175|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
56167176|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56167177|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56167178|NCT00004266|Protective Agents|protective agents|mesh-ancestor
56167179|NCT00004278|Ganciclovir|ganciclovir|mesh-list
56167180|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56167181|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
56167182|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167183|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56167184|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167185|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167186|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
56167187|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
56167188|NCT00004284|Diuretics|diuretics|mesh-ancestor
56167189|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
56167190|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167191|NCT00004284|Expectorants|expectorants|mesh-ancestor
56167192|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
56167193|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
56167194|NCT00004284|Protective Agents|protective agents|mesh-ancestor
56167195|NCT00004344|Leuprolide|leuprolide|mesh-list
56167196|NCT00004344|Testosterone|testosterone|mesh-list
56167197|NCT00004344|Androgens|androgens|mesh-ancestor
56167198|NCT00004344|Hormones|hormones|mesh-ancestor
56167199|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167200|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167201|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56167202|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167203|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56167204|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
56167205|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56167206|NCT00004368|Colchicine|colchicine|mesh-list
56167207|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
56167208|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167209|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
56167210|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167211|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167212|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167213|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167214|NCT00004380|Methocarbamol|methocarbamol|mesh-list
56167215|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56167216|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167217|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56167218|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167219|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56167220|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167221|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167222|NCT00004404|Clotrimazole|clotrimazole|mesh-list
56167223|NCT00004404|Miconazole|miconazole|mesh-list
56167224|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
55760275|NCT02504177|Anticoagulants|anticoagulants|mesh-list
56673524|NCT00696540|Albuterol|albuterol|mesh-list
56673525|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56673526|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
56673527|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673528|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673529|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56673530|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
56673531|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
56673532|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56673533|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56319748|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
56673534|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56673535|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56673536|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
56673537|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673538|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673539|NCT04212845|Dexamethasone|dexamethasone|mesh-list
56673540|NCT04212845|Bupivacaine|bupivacaine|mesh-list
56673541|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673542|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
56673543|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
56673544|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167226|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
56167227|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167228|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167229|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56167230|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56167231|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167232|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
56167233|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56167234|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56183289|NCT01423500|Treosulfan|treosulfan|mesh-list
56183290|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183291|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183292|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167235|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56167236|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
56167237|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167238|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167239|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56167240|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56167241|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56167242|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
56167243|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167244|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56167245|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56167246|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
56167247|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56167248|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56167249|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56167250|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56673545|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673546|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56673547|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
56673548|NCT04212845|Hormones|hormones|mesh-ancestor
56673549|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673550|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56673551|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673552|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
56673553|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
56673554|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673555|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
56673556|NCT00620165|Levetiracetam|levetiracetam|mesh-list
56673557|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
56673558|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
56673559|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
56673560|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
56673561|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56673562|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673563|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
56673564|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673565|NCT00685958|Enoxaparin|enoxaparin|mesh-list
56673566|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
56673567|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56673568|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56673569|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673570|NCT04138472|Lidocaine|lidocaine|mesh-list
56673571|NCT04138472|Fentanyl|fentanyl|mesh-list
56673572|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
56673573|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
56673574|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
56673575|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673576|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673587|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56673588|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56673589|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56673590|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
56673591|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673592|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56673593|NCT04138472|Narcotics|narcotics|mesh-ancestor
56673594|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56673595|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56673596|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
56673597|NCT00620789|Dexetimide|dexetimide|mesh-list
56673598|NCT00620789|Citalopram|citalopram|mesh-list
56673599|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
56673600|NCT00620789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56673601|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56673602|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56234768|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167251|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167252|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
56167253|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167254|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167256|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167257|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
56167258|NCT00004422|Antibodies|antibodies|mesh-list
56167259|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
56167260|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56167261|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56167262|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
56167263|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167264|NCT00004440|Ibuprofen|ibuprofen|mesh-list
56167265|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56167266|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56167267|NCT00004440|Analgesics|analgesics|mesh-ancestor
56167268|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
56167269|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167270|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167271|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167272|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167273|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56167274|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167275|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167276|NCT00004446|Fluoxetine|fluoxetine|mesh-list
56167277|NCT00004446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56167278|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56167279|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56167280|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167281|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167282|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
56167283|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167284|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56167285|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
56167286|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56167287|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56167288|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56167289|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167290|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
56167291|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673603|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673604|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167292|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
56167293|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167294|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167295|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56167296|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
56167297|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167298|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183293|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
56183294|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183295|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56183296|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56183297|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56183298|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886891|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
56167299|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56167300|NCT00004482|Cyclosporine|cyclosporine|mesh-list
56167301|NCT00004482|Prednisone|prednisone|mesh-list
56167302|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
56167303|NCT00004482|Cyclosporins|cyclosporins|mesh-list
56167304|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
56167305|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167306|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
56167308|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167309|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167310|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56167311|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167312|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167313|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167314|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167315|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
56167316|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
56167317|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167318|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
56167319|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167320|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56167322|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
56167338|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167339|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56167341|NCT00004554|Sertraline|sertraline|mesh-list
56167342|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56167343|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56167344|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167345|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
56167346|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167347|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
56167348|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56167349|NCT00004554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56167350|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56167351|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56167352|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167353|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167355|NCT00004578|Ritonavir|ritonavir|mesh-list
56167356|NCT00004578|Lopinavir|lopinavir|mesh-list
56167357|NCT00004578|Lamivudine|lamivudine|mesh-list
56167358|NCT00004578|Stavudine|stavudine|mesh-list
56167359|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56167360|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56167361|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
56167362|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167363|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167364|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56183299|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56183300|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
56183301|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56183302|NCT01423539|Rituximab|rituximab|mesh-list
56183303|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56183304|NCT01423539|Navitoclax|navitoclax|mesh-list
56183305|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56183306|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183307|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
56673605|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
56673606|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234787|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56183308|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183309|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56183310|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56183311|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
56183312|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183313|NCT01423591|Infliximab|infliximab|mesh-list
56183314|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
56183315|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56183316|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56183317|NCT01423695|Paclitaxel|paclitaxel|mesh-list
56167365|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56167366|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
56167367|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800729|NCT03042325|Alogliptin|alogliptin|mesh-list
56167369|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56167370|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56167371|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56167372|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
56167373|NCT00004644|Acyclovir|acyclovir|mesh-list
56167374|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
56167375|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167376|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56167377|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
56167378|NCT00004650|Estrogens|estrogens|mesh-list
56167379|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56167380|NCT00004650|Hormones|hormones|mesh-ancestor
56167381|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167382|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167383|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56167384|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56167385|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56167386|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
56167387|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56167388|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56167389|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56167390|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56167391|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56167392|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167393|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56167394|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56167395|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
56167396|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167398|NCT00004686|Methotrexate|methotrexate|mesh-list
56167399|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167400|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
56167401|NCT00004686|Hormones|hormones|mesh-ancestor
56167402|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183318|NCT01423695|Trastuzumab|trastuzumab|mesh-list
56183319|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56183320|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183321|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
56183322|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
56183323|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
56183324|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183325|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56183326|NCT01423708|Everolimus|everolimus|mesh-list
56183327|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183328|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183329|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
56183330|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183331|NCT01423747|Fludarabine|fludarabine|mesh-list
56183332|NCT01423747|Etoposide|etoposide|mesh-list
56183333|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
56183334|NCT01423747|Thiotepa|thiotepa|mesh-list
56183335|NCT01423747|Treosulfan|treosulfan|mesh-list
56183336|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183337|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183338|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183339|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
56673607|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56673608|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56673609|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56673610|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56673611|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
56673612|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
56673613|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673614|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56673615|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56673616|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
56673617|NCT00691184|Terbinafine|terbinafine|mesh-list
56673618|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
56673619|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673620|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673621|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673622|NCT00854100|Cariprazine|cariprazine|mesh-list
56673623|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
56673624|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56673625|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56673626|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56673627|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673628|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673629|NCT00691262|Tacrolimus|tacrolimus|mesh-list
56673630|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673631|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
56673632|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167403|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167404|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55760780|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56167405|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167406|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56167407|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
56167408|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56167409|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167410|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
56167411|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167412|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
56167413|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167414|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56167415|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167416|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
56167417|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167418|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56167420|NCT00004728|Warfarin|warfarin|mesh-list
56167421|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56167422|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56167423|NCT00004728|Analgesics|analgesics|mesh-ancestor
56167424|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
56673633|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56673634|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673635|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673636|NCT00620867|Ibuprofen|ibuprofen|mesh-list
56673637|NCT00620867|Celecoxib|celecoxib|mesh-list
56673638|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56673639|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56673640|NCT00620867|Analgesics|analgesics|mesh-ancestor
56673641|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
56673642|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673643|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673644|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167425|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167426|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167427|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167428|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167429|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56167430|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56167431|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167432|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56183340|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183341|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56183342|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56183343|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56183344|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183345|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56183346|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
56183347|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56183348|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
56183349|NCT01423838|Oxybutynin|oxybutynin|mesh-list
56183350|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56183351|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56183352|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
56183353|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887061|NCT02474706|Cefoxitin|cefoxitin|mesh-list
56167433|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55760830|NCT04843839|Nepafenac|nepafenac|mesh-list
56167434|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167435|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
56167436|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
56167437|NCT00004734|Folic Acid|folic acid|mesh-list
56167438|NCT00004734|Pyridoxine|pyridoxine|mesh-list
56167439|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
56167440|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
56167441|NCT00004734|Hematinics|hematinics|mesh-ancestor
56167442|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
56167443|NCT00004734|Vitamins|vitamins|mesh-ancestor
56167444|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
56167445|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167446|NCT00004740|Isoniazid|isoniazid|mesh-list
56167447|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
56167448|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56167449|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167450|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56167451|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56167452|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
56167453|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167454|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56167455|NCT00004758|Pyridoxine|pyridoxine|mesh-list
56167456|NCT00004758|Carbamazepine|carbamazepine|mesh-list
56167457|NCT00004758|Valproic Acid|valproic acid|mesh-list
56167458|NCT00004758|Nitrazepam|nitrazepam|mesh-list
56167459|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56167460|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
56167461|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943372|NCT01361217|Omeprazole|omeprazole|mesh-list
56673645|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673646|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56673647|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673648|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673649|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56673650|NCT04271917|Acetaminophen|acetaminophen|mesh-list
56673651|NCT04271917|Ibuprofen|ibuprofen|mesh-list
56673652|NCT04271917|Cannabidiol|cannabidiol|mesh-list
56673653|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56673654|NCT04271917|Analgesics|analgesics|mesh-ancestor
56673655|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
56673656|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673657|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673658|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
56673659|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56673660|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673661|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673662|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56673663|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673664|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673665|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
56673666|NCT04122222|Vaccines|vaccines|mesh-list
56673667|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
56673668|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673669|NCT00686114|Paclitaxel|paclitaxel|mesh-list
56673670|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56673671|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56673672|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673673|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
56673689|NCT00698724|Prednisolone|prednisolone|mesh-list
56673690|NCT00698724|Bromfenac|bromfenac|mesh-list
56673691|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56673692|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
56167462|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167463|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
56167464|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167465|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167466|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
56167467|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56167468|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56167469|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56167470|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56167471|NCT00004758|Analgesics|analgesics|mesh-ancestor
56167472|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
56167473|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167474|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56167475|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56167476|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56167477|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56167478|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
56167479|NCT00004758|Vitamins|vitamins|mesh-ancestor
56167480|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
56183354|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183355|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183356|NCT01423838|Urological Agents|urological agents|mesh-ancestor
56183357|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
56183358|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
56183359|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183360|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56183361|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56183362|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
56183363|NCT01423864|Prednisolone|prednisolone|mesh-list
56183364|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
56183365|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56183366|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56167481|NCT00004758|Hormones|hormones|mesh-ancestor
56167482|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167483|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56167484|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56167485|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
56167486|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
56167487|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
56167488|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761109|NCT04851015|Trimethoprim|trimethoprim|mesh-list
56167489|NCT00004770|Protective Agents|protective agents|mesh-ancestor
56167490|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167491|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
56167492|NCT00004770|Vitamins|vitamins|mesh-ancestor
56167493|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
56167494|NCT00004776|Topiramate|topiramate|mesh-list
56167495|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
55761254|NCT04821765|Paclitaxel|paclitaxel|mesh-list
56167497|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167498|NCT00004794|Cidofovir|cidofovir|mesh-list
56167499|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
56167500|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167501|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167502|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167504|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
56167505|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167506|NCT00004842|Budesonide|budesonide|mesh-list
56167507|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167508|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56167509|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
56167510|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167511|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167512|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56167513|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
56167514|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
56167515|NCT00004842|Hormones|hormones|mesh-ancestor
56167516|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167517|NCT00004854|Carvedilol|carvedilol|mesh-list
56673693|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673694|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
56673695|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
56673696|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673697|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673698|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56673699|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
56673700|NCT00698724|Hormones|hormones|mesh-ancestor
56673701|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56673702|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56673703|NCT00698724|Protective Agents|protective agents|mesh-ancestor
56673704|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56673705|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234873|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167518|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56167519|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56167520|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
56167521|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761399|NCT02601573|Ribavirin|ribavirin|mesh-list
56167522|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167523|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167524|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56167525|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
56167526|NCT00004854|Protective Agents|protective agents|mesh-ancestor
56167527|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56167528|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56183367|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
56183368|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183369|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
56183370|NCT01423864|Hormones|hormones|mesh-ancestor
56183371|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183372|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183373|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56183374|NCT01423864|Protective Agents|protective agents|mesh-ancestor
56183375|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56183376|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183377|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
56183378|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
56183379|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183380|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56167532|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56167533|NCT00004860|Leucovorin|leucovorin|mesh-list
56167534|NCT00004860|Tegafur|tegafur|mesh-list
56167535|NCT00004860|Calcium|calcium|mesh-list
56167536|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
56167537|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55761468|NCT04411875|Amlodipine|amlodipine|mesh-list
56167538|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167539|NCT00004860|Antidotes|antidotes|mesh-ancestor
56167540|NCT00004860|Protective Agents|protective agents|mesh-ancestor
56167541|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
56167542|NCT00004860|Vitamins|vitamins|mesh-ancestor
56167543|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
56167544|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167545|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
56213166|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167546|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167547|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213167|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56167549|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56167550|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56673706|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56673707|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56673708|NCT00698724|Analgesics|analgesics|mesh-ancestor
56673709|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
56673710|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673711|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
56673712|NCT00686192|Calcium|calcium|mesh-list
56673713|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56673714|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673715|NCT00686192|Antacids|antacids|mesh-ancestor
56673716|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673717|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56673718|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
56673719|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56673720|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56673721|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673722|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
56673723|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
56673724|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
56673725|NCT00922610|Hematinics|hematinics|mesh-ancestor
56673726|NCT04117698|Ethambutol|ethambutol|mesh-list
56673727|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
56673728|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56673729|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673730|NCT04118322|Peppermint oil|peppermint oil|mesh-list
56673731|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
56673732|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
56673733|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673734|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673735|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56673736|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
56673737|NCT00698802|Insulin|insulin|mesh-list
56673738|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56673739|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56673740|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673741|NCT04147013|Celecoxib|celecoxib|mesh-list
56673742|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56167551|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167552|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167553|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673743|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56673744|NCT04147013|Analgesics|analgesics|mesh-ancestor
56673745|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
56673746|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673747|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673748|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56673749|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673750|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56673751|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56673752|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673753|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673754|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56673755|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
56673756|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56673757|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56673758|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56673759|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673760|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673761|NCT02621970|Cisplatin|cisplatin|mesh-list
56673762|NCT02621970|Docetaxel|docetaxel|mesh-list
56673763|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673764|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
56673765|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
56673766|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
56673767|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673768|NCT00820755|Cetuximab|cetuximab|mesh-list
56673769|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56673770|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167554|NCT00004872|Endostatins|endostatins|mesh-list
56167555|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167556|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56167557|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56167558|NCT00004872|Growth Substances|growth substances|mesh-ancestor
56167559|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167560|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
56167561|NCT00004878|Cytarabine|cytarabine|mesh-list
56167562|NCT00004878|Methotrexate|methotrexate|mesh-list
56167563|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
56167564|NCT00004878|Fludarabine|fludarabine|mesh-list
56167565|NCT00004878|Idarubicin|idarubicin|mesh-list
56167566|NCT00004878|Tacrolimus|tacrolimus|mesh-list
56167567|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55761934|NCT05615727|GABA Agents|gaba agents|mesh-ancestor
56183385|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183386|NCT01424111|Citalopram|citalopram|mesh-list
56183387|NCT01424111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56183388|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55943373|NCT01361217|Lovastatin|lovastatin|mesh-list
56673771|NCT00700128|Frovatriptan|frovatriptan|mesh-list
56673772|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56673773|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
56673774|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56673775|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673776|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673777|NCT04662515|Warfarin|warfarin|mesh-list
56673778|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
56673779|NCT04662515|Dabigatran|dabigatran|mesh-list
56673780|NCT04662515|Apixaban|apixaban|mesh-list
56673781|NCT04662515|Edoxaban|edoxaban|mesh-list
56673782|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
56673783|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56673784|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
56673785|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56673786|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
56673787|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673788|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673789|NCT04660097|Etoposide|etoposide|mesh-list
56673790|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
56673791|NCT04660097|Durvalumab|durvalumab|mesh-list
56673792|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56673793|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56673794|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673795|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56673796|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56673797|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673798|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673799|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56673800|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
56673801|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673802|NCT00621101|Sirolimus|sirolimus|mesh-list
56673803|NCT00621101|Ezetimibe|ezetimibe|mesh-list
56673804|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56234962|NCT01741558|Vitamins|vitamins|mesh-ancestor
56183389|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56183390|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183391|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167568|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
56167569|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56167570|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167571|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167572|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
56673805|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673806|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56673807|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673808|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
56673809|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673810|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
56673811|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673812|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56673813|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56673814|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
56673815|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673816|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56673817|NCT00709215|Cordycepin|cordycepin|mesh-list
56673818|NCT00709215|Pentostatin|pentostatin|mesh-list
56673819|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673820|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56673821|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673822|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673823|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
56673824|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673825|NCT00699036|Metformin|metformin|mesh-list
56673826|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
56673827|NCT00699036|Losartan|losartan|mesh-list
56167573|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167574|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167575|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
56167576|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167577|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56167578|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55762073|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167579|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
56167580|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167581|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56167583|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213168|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167597|NCT00004884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167598|NCT00004884|Immunologic Factors|immunologic factors|mesh-ancestor
56167599|NCT00004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167600|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
56167601|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167602|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167603|NCT00004890|Aldesleukin|aldesleukin|mesh-list
56167604|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167605|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56167606|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56167607|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
56167608|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167609|NCT00004920|Raltitrexed|raltitrexed|mesh-list
56167610|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167611|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167612|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
56167613|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167614|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56167615|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673828|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56673829|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673830|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56673831|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56673832|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56673833|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56673834|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167617|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
56167618|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
56167619|NCT00004926|Vitamins|vitamins|mesh-ancestor
56167620|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
56167621|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167622|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56167623|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56167624|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167625|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
56167626|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167627|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56183392|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
56183393|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183394|NCT01424111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56183395|NCT01424111|Antidepressive Agents|antidepressive agents|mesh-ancestor
56183396|NCT01424111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56183397|NCT01424124|Montelukast|montelukast|mesh-list
56183398|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56183399|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
56183400|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56183401|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
56183402|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183403|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183404|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56183405|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56183406|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183407|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56183408|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56183409|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
56183410|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167633|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56167634|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56167635|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167636|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167637|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56167638|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
56167639|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167640|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167641|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56167642|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56167643|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
56167644|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56167645|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167647|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56167648|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167650|NCT00004998|Zidovudine|zidovudine|mesh-list
56167651|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56167652|NCT00004998|Capravirine|capravirine|mesh-list
56167653|NCT00004998|Nelfinavir|nelfinavir|mesh-list
56167654|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56167655|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56167656|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167657|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167658|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
56167659|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167660|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56673835|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56673836|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
56673837|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673838|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167661|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56183411|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183412|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56183413|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
56183414|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
56183415|NCT01424137|Hormones|hormones|mesh-ancestor
56183416|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183417|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
56183418|NCT01424176|Pramipexole|pramipexole|mesh-list
56183419|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
56183420|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183421|NCT01424176|Protective Agents|protective agents|mesh-ancestor
56183422|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183423|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56183424|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56183425|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
56183426|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
56183427|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183428|NCT01424241|Octreotide|octreotide|mesh-list
56183429|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56183430|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56183431|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183432|NCT01424319|Atrasentan|atrasentan|mesh-list
56183433|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183434|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56183435|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56183436|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183437|NCT01424332|Aspirin|aspirin|mesh-list
56183438|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
56183439|NCT01424332|Salicylates|salicylates|mesh-list
56167662|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
56167663|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56167664|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56167665|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
56167666|NCT00005010|Irbesartan|irbesartan|mesh-list
56167667|NCT00005010|Pravastatin|pravastatin|mesh-list
56167668|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56167669|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55763114|NCT02112448|Acetaminophen|acetaminophen|mesh-list
56183441|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56183442|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56183444|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
56183445|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183446|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183447|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183448|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56183449|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56183450|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56183451|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183452|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56183453|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56183454|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183455|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
56183456|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183457|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
56183458|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
56183459|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
56183460|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56167679|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167680|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56167681|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56167683|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167684|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167685|NCT00005028|Paclitaxel|paclitaxel|mesh-list
56167686|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
56167687|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56167688|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673839|NCT00913497|Insulin|insulin|mesh-list
56673840|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56673841|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
56673842|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
56673843|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56673844|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673845|NCT00819741|Metformin|metformin|mesh-list
56673846|NCT00819741|Repaglinide|repaglinide|mesh-list
56673847|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56673848|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673849|NCT04208555|Terconazole|terconazole|mesh-list
56673850|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
56673851|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673852|NCT00621725|Cediranib|cediranib|mesh-list
56673853|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673854|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56673855|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673856|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673857|NCT00862134|Docetaxel|docetaxel|mesh-list
56673858|NCT00862134|Lenograstim|lenograstim|mesh-list
56673859|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673860|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
56673861|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
56673862|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167689|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56167690|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167691|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167692|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167693|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56167694|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
55763418|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
56167695|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167696|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
56167697|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167699|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56167700|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167701|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
56167702|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167704|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167705|NCT00005064|Bortezomib|bortezomib|mesh-list
56167706|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167707|NCT00005070|Irofulven|irofulven|mesh-list
56167708|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56167709|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
56167710|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167711|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167712|NCT00005076|Irinotecan|irinotecan|mesh-list
56167713|NCT00005076|Cetuximab|cetuximab|mesh-list
56183462|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56183463|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
56183464|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
56183465|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56167714|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55763674|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
56167716|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673863|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673864|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56673865|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
56673866|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673867|NCT00700284|Dapivirine|dapivirine|mesh-list
56673868|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56167717|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167718|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167719|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56167720|NCT00005088|Cisplatin|cisplatin|mesh-list
56167721|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167722|NCT00005094|Celecoxib|celecoxib|mesh-list
56167723|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56167724|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56167725|NCT00005094|Analgesics|analgesics|mesh-ancestor
56167726|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
56167727|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167728|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167729|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167730|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167731|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55763953|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
56167732|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56167733|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167734|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167735|NCT00005106|Lamivudine|lamivudine|mesh-list
56167736|NCT00005106|Zidovudine|zidovudine|mesh-list
56167737|NCT00005106|Abacavir|abacavir|mesh-list
56167738|NCT00005106|Stavudine|stavudine|mesh-list
56167739|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56167740|NCT00005106|Nelfinavir|nelfinavir|mesh-list
56167741|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55764097|NCT00977483|Vitamins|vitamins|mesh-ancestor
56167742|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56167743|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167744|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167745|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
56167746|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167747|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55764382|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
56167748|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56167749|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
56167750|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55764457|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
56167751|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55764529|NCT02440841|Itraconazole|itraconazole|mesh-list
56167752|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
56167753|NCT00005118|Ritonavir|ritonavir|mesh-list
56167754|NCT00005118|Indinavir|indinavir|mesh-list
56167755|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55764674|NCT05532501|Oxytocin|oxytocin|mesh-list
56167756|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56167757|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
56167758|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167759|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167760|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56167761|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56167762|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
56167763|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167764|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56167765|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56167766|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56167767|NCT00005520|Candesartan|candesartan|mesh-list
56167768|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56167769|NCT00005520|Diuretics|diuretics|mesh-ancestor
56167770|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
56167771|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167772|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56167773|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56167774|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673869|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56673870|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
56673871|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673872|NCT00618527|Interferons|interferons|mesh-list
56673873|NCT00618527|Interferon-beta|interferon-beta|mesh-list
56673874|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
56673875|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
56673876|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673877|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
56673878|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673879|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56673880|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56673881|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
56673882|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56673883|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673884|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673885|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
56673886|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673887|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56673888|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56673889|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56673890|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56673891|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56673892|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56673893|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56673894|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673895|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
56673896|NCT04115982|Vitamin D|vitamin d|mesh-list
56673897|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56673898|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673899|NCT04115982|Vitamins|vitamins|mesh-ancestor
56673900|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
56673901|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56673902|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
56673905|NCT01010581|Folic Acid|folic acid|mesh-list
56673909|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56673910|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673911|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320124|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
56673912|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
56673913|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673914|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673915|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
56673916|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673917|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56673918|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56673919|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
56673920|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56673921|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56673922|NCT01010581|Hematinics|hematinics|mesh-ancestor
56673923|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
56673924|NCT01010581|Vitamins|vitamins|mesh-ancestor
56673925|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
56673926|NCT04382885|Cariprazine|cariprazine|mesh-list
56673927|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56673928|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56673929|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56673930|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673931|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56673932|NCT04208945|Colistin|colistin|mesh-list
56673933|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56673934|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673935|NCT01016041|Paclitaxel|paclitaxel|mesh-list
56673936|NCT01016041|Everolimus|everolimus|mesh-list
56673937|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56673953|NCT05662397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673954|NCT02696837|Rocuronium|rocuronium|mesh-list
56673955|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56673956|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56673957|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56673958|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56673959|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673960|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
56673961|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56673962|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
56673963|NCT00490555|Testosterone|testosterone|mesh-list
56673964|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
56673965|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
56673966|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56673967|NCT00490555|Dutasteride|dutasteride|mesh-list
56673968|NCT00490555|Androgens|androgens|mesh-ancestor
56673969|NCT00490555|Hormones|hormones|mesh-ancestor
56673970|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183466|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
56183467|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183468|NCT01424384|Citalopram|citalopram|mesh-list
56183469|NCT01424384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56183470|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55887532|NCT01375608|Decitabine|decitabine|mesh-list
56167775|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56167776|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56167777|NCT00005574|Gentamicins|gentamicins|mesh-list
55765099|NCT05518383|Idarubicin|idarubicin|mesh-list
56167778|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56167779|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167780|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56167781|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167782|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167783|NCT00005580|Fludarabine|fludarabine|mesh-list
56167784|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
56167785|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
56167786|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765316|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
56167788|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
56167789|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167790|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167791|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
55765456|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56167792|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167793|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56167794|NCT00005586|Leucovorin|leucovorin|mesh-list
56167795|NCT00005586|Fluorouracil|fluorouracil|mesh-list
56167796|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
56167797|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
56167798|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167799|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167800|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167801|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56167802|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
56167803|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167804|NCT00005586|Antidotes|antidotes|mesh-ancestor
56167805|NCT00005586|Protective Agents|protective agents|mesh-ancestor
56167806|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
56673971|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56673972|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56673973|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56673974|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
56673975|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56673976|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56673977|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56673978|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56673979|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
56673980|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56673981|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56673982|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56673983|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
56673984|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56320205|NCT00029874|Minocycline|minocycline|mesh-list
56320206|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56320207|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320208|NCT00030030|Silymarin|silymarin|mesh-list
56673985|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56673986|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56673987|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56673988|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
56673989|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56673990|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56673991|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56673992|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56673993|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56674004|NCT00049595|Prednisone|prednisone|mesh-list
56674013|NCT00049595|Procarbazine|procarbazine|mesh-list
56674014|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674015|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
56674016|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674017|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56674018|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56674019|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
56674020|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674021|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674022|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56674023|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56674024|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56674025|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56674026|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674027|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56674028|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
56674029|NCT00049595|Hormones|hormones|mesh-ancestor
56674030|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674031|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56674032|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56167807|NCT00005586|Vitamins|vitamins|mesh-ancestor
56167808|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
56167809|NCT00005592|Rituximab|rituximab|mesh-list
56167810|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56167811|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56167812|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167813|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
56167814|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167815|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167816|NCT00005598|Azacitidine|azacitidine|mesh-list
56167817|NCT00005598|Amifostine|amifostine|mesh-list
56167818|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167819|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
56167820|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765731|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55765732|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56215625|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56215626|NCT01619761|Rituximab|rituximab|mesh-list
56215627|NCT01619761|Fludarabine|fludarabine|mesh-list
56215628|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
56215629|NCT01619761|Lenalidomide|lenalidomide|mesh-list
56215630|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56215631|NCT01619761|Tacrolimus|tacrolimus|mesh-list
56215632|NCT01619761|Antibodies|antibodies|mesh-list
56215633|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
56215634|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56215635|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56215636|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
56215637|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215638|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56215639|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56215640|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
56183471|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56183472|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183473|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674033|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674034|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
56674035|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674036|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56674037|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
56674038|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674039|NCT03854227|Docetaxel|docetaxel|mesh-list
56674040|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674041|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674042|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
56674043|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674044|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674045|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
56674046|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56674047|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56183474|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
56183475|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183476|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56183477|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
56183478|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56183479|NCT01424449|Aripiprazole|aripiprazole|mesh-list
56183483|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56183484|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56183485|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183486|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
56183487|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
56183488|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183489|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183490|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56183491|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56183492|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
56183493|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56183494|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56183495|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56183496|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56183497|NCT01424618|Leuprolide|leuprolide|mesh-list
56183498|NCT01424618|Ganirelix|ganirelix|mesh-list
56183499|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56183500|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
56183501|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56183502|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183503|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56183504|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183505|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
56215641|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215642|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215643|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56183506|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183507|NCT01424709|Gemcitabine|gemcitabine|mesh-list
56183508|NCT01424709|Cisplatin|cisplatin|mesh-list
56183509|NCT01424709|Docetaxel|docetaxel|mesh-list
56183510|NCT01424709|Irinotecan|irinotecan|mesh-list
56183511|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183512|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56183513|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
56183514|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183515|NCT01424709|Antiviral Agents|antiviral agents|mesh-ancestor
56183516|NCT01424709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183517|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674048|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674049|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56674050|NCT02626754|Sunitinib|sunitinib|mesh-list
56674051|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674052|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56674053|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56674054|NCT02626754|Growth Substances|growth substances|mesh-ancestor
56674055|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674056|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
56674057|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56674058|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674059|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674060|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
56674061|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56674062|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235234|NCT01743066|Vitamin E|vitamin e|mesh-list
56183518|NCT01424709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183519|NCT01424709|Immunologic Factors|immunologic factors|mesh-ancestor
56183520|NCT01424709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183521|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
56183522|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
56183523|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
56183524|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56183525|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56183526|NCT01424761|Ubiquinone|ubiquinone|mesh-list
56215644|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56215645|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
56215646|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56215647|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215648|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56215649|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56215650|NCT01619761|Growth Substances|growth substances|mesh-ancestor
56215651|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
56215652|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56215653|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56215654|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
56215655|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56215656|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215657|NCT01619813|Prednisone|prednisone|mesh-list
56215658|NCT01619813|Docetaxel|docetaxel|mesh-list
55791898|NCT00783133|Fexofenadine|fexofenadine|mesh-list
56217249|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217250|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56217251|NCT01630564|Aldesleukin|aldesleukin|mesh-list
56217252|NCT01630564|Interleukin-2|interleukin-2|mesh-list
56217253|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217254|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217255|NCT01630564|Analgesics|analgesics|mesh-ancestor
56217256|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
56217263|NCT01630642|Clopidogrel|clopidogrel|mesh-list
56217264|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56217265|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56217266|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56217267|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56217268|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
56183527|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
56183528|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
56183529|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183530|NCT01424761|Vitamins|vitamins|mesh-ancestor
56183531|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
56183532|NCT01424826|Rifampin|rifampin|mesh-list
56674063|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674064|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56674065|NCT00691886|Analgesics|analgesics|mesh-ancestor
56674066|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
56674067|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674068|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56183533|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56183534|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56183535|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
56183536|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183537|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56183538|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55793439|NCT05260359|Ethanol|ethanol|mesh-list
56218341|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
56218342|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
56218343|NCT01637025|Coagulants|coagulants|mesh-ancestor
56218344|NCT01637155|Vitamin D|vitamin d|mesh-list
56218345|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
56218346|NCT01637155|Vitamins|vitamins|mesh-ancestor
56218347|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
56218348|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218349|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56218350|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56218351|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56218352|NCT01637194|Cetuximab|cetuximab|mesh-list
56218353|NCT01637194|Everolimus|everolimus|mesh-list
56218354|NCT01637194|Antibodies|antibodies|mesh-list
56218355|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
56218356|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56218357|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
56218358|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218359|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218360|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218361|NCT01637233|Ritonavir|ritonavir|mesh-list
56218362|NCT01637233|Lopinavir|lopinavir|mesh-list
56218363|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56218364|NCT01637233|Darunavir|darunavir|mesh-list
56218365|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
56218366|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56218367|NCT01637233|Tenofovir|tenofovir|mesh-list
56218368|NCT01637233|Lamivudine|lamivudine|mesh-list
56218369|NCT01637233|Zidovudine|zidovudine|mesh-list
56218370|NCT01637233|Emtricitabine|emtricitabine|mesh-list
56218371|NCT01637233|Maraviroc|maraviroc|mesh-list
56218372|NCT01637233|Abacavir|abacavir|mesh-list
56218373|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
56218374|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56218375|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
56218376|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56218377|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218378|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218379|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56218380|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56218381|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
55794468|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794469|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
55794470|NCT04801511|Vitamins|vitamins|mesh-ancestor
55794471|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
55794472|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794473|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
56219475|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
56219476|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219477|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56219478|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56219479|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219481|NCT01651923|Calcium heparin|calcium heparin|mesh-list
56219482|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
56219483|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56219484|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56183539|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183540|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219485|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221031|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674069|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56674070|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56674071|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56235247|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
56221032|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56221033|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
56221755|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221756|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56221757|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223115|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56223116|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223117|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56223118|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223119|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223120|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
56223121|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56223122|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56223123|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56223124|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56223125|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55799044|NCT04397107|Aldesleukin|aldesleukin|mesh-list
56223526|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223527|NCT04504331|Tamoxifen|tamoxifen|mesh-list
56223528|NCT04504331|Infigratinib|infigratinib|mesh-list
56223529|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56223530|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
56223531|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223809|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56223810|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56223811|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56223813|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
56223814|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
56223815|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223816|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223817|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56223818|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223819|NCT03476109|Omalizumab|omalizumab|mesh-list
56223820|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56223821|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56223822|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
56224206|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56224208|NCT01686126|Metformin|metformin|mesh-list
56224209|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
56224210|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56224211|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224212|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56224717|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224718|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
56224719|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56224720|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56224721|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56224723|NCT01692678|Trabectedin|trabectedin|mesh-list
55800637|NCT02564471|Atovaquone|atovaquone|mesh-list
56224810|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56224811|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224812|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224813|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56224814|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56224815|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224816|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224817|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56224818|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
56224819|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224820|NCT01693302|Insulin|insulin|mesh-list
56224821|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56224822|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56183541|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56183542|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
56183543|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56183544|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
56674072|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674073|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674074|NCT04138004|Lubiprostone|lubiprostone|mesh-list
56674075|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56674076|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674077|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674078|NCT00621491|Warfarin|warfarin|mesh-list
56674079|NCT00621491|Anticoagulants|anticoagulants|mesh-list
56674080|NCT00622349|Gemcitabine|gemcitabine|mesh-list
56674081|NCT00622349|Cisplatin|cisplatin|mesh-list
56674082|NCT00622349|Docetaxel|docetaxel|mesh-list
56674083|NCT00622349|Ifosfamide|ifosfamide|mesh-list
56183545|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56183546|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56183547|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56183548|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56183549|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56183550|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56183551|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56183552|NCT01424839|Cisplatin|cisplatin|mesh-list
56183553|NCT01424839|Carboplatin|carboplatin|mesh-list
56183554|NCT01424839|Etoposide|etoposide|mesh-list
56183555|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
56183556|NCT01424839|Ifosfamide|ifosfamide|mesh-list
56183557|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
56183558|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183559|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56183560|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56183561|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56183562|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183563|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183564|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56183565|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
56183566|NCT01424891|Simvastatin|simvastatin|mesh-list
56183567|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56183568|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56183569|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
56183570|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183571|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56183572|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56183573|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183574|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
56183579|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183580|NCT01425073|Renal Agents|renal agents|mesh-ancestor
56183581|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56183582|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
56183583|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56183584|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56183585|NCT01425099|Dolutegravir|dolutegravir|mesh-list
56183586|NCT01425099|Prednisone|prednisone|mesh-list
56183587|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183588|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
56183589|NCT01425099|Hormones|hormones|mesh-ancestor
56183590|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183591|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183592|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56183593|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183594|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56183595|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56183596|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183597|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183598|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55887870|NCT00557440|Hormones|hormones|mesh-ancestor
56224828|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674084|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
56674085|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674086|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56674087|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
56674088|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674089|NCT00622349|Antiviral Agents|antiviral agents|mesh-ancestor
56674090|NCT00622349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674091|NCT00622349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674092|NCT00622349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674093|NCT00622349|Immunologic Factors|immunologic factors|mesh-ancestor
56674094|NCT00622349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674095|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674096|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
56674097|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674098|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56674099|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
56674100|NCT03471143|Betadex|betadex|mesh-list
56235269|NCT01743157|Ipilimumab|ipilimumab|mesh-list
56224829|NCT01693328|Analgesics|analgesics|mesh-ancestor
56224830|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
56224831|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224832|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56224833|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56224834|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
56224835|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
56224836|NCT01693380|Vaccines|vaccines|mesh-list
56224837|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
55800812|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56224844|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
56224845|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224846|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
56224847|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225216|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225217|NCT05294926|Rocuronium|rocuronium|mesh-list
56225218|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55801120|NCT04839913|Antibodies|antibodies|mesh-list
56225279|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225280|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225281|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
56225282|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225283|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56225284|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56225285|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56225286|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56225287|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183599|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56183600|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
56183601|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183602|NCT01425125|Tolvaptan|tolvaptan|mesh-list
56183603|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55887920|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
56225288|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56225289|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56225290|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
56225291|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225292|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56225293|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56674101|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
56674102|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674103|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
56674104|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56674105|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56674106|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
56674107|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674108|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56674109|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
56674110|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56674111|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56674112|NCT05368181|Prednisolone|prednisolone|mesh-list
56674113|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
56674114|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56674115|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
56225294|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
56225295|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56225296|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
56225297|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
56225298|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
56225299|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56225300|NCT05294536|Liraglutide|liraglutide|mesh-list
56225301|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56225302|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225303|NCT05294536|Incretins|incretins|mesh-ancestor
56225304|NCT05294536|Hormones|hormones|mesh-ancestor
56225305|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56225306|NCT05294484|Indapamide|indapamide|mesh-list
56225307|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56225308|NCT05294484|Diuretics|diuretics|mesh-ancestor
56225309|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
56225310|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225311|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56225312|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56225313|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225314|NCT05294406|Piperaquine|piperaquine|mesh-list
56225315|NCT05294406|Artenimol|artenimol|mesh-list
56225316|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
55801185|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
56225443|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225444|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56225445|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
56225446|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225447|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225448|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56225536|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56225537|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
56225540|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56225541|NCT05267431|Methotrexate|methotrexate|mesh-list
56225542|NCT05267431|Hydroquinone|hydroquinone|mesh-list
56225543|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56225544|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
56225596|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225597|NCT05264584|Antidotes|antidotes|mesh-ancestor
56225598|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
56225599|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225600|NCT05262686|Aldesleukin|aldesleukin|mesh-list
56225601|NCT05262686|Interleukin-2|interleukin-2|mesh-list
56225602|NCT05262686|Belimumab|belimumab|mesh-list
56225603|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225604|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56674116|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56674117|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
56674118|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
56674119|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674120|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674121|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56674122|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
56674123|NCT05368181|Hormones|hormones|mesh-ancestor
56674124|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674125|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56674126|NCT05368181|Protective Agents|protective agents|mesh-ancestor
56674127|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56674128|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674129|NCT05662163|Anesthetics|anesthetics|mesh-list
56674130|NCT05662163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56320354|NCT03852407|Fludarabine|fludarabine|mesh-list
56674131|NCT05662163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674132|NCT02666105|Exemestane|exemestane|mesh-list
56674133|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674134|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56674135|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56674136|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674137|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674138|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56674139|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
56674140|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674141|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674143|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56674144|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674145|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56674146|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674147|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
56674148|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674149|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
56674150|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674151|NCT00622817|Epinephrine|epinephrine|mesh-list
56674152|NCT00622817|Xylometazoline|xylometazoline|mesh-list
56674153|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56674154|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56674155|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
56674156|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674157|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674158|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674159|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56674160|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56674161|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
56674162|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674163|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56674164|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
56674165|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
56674166|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
56674167|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56674168|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
56674169|NCT02432417|Chloroquine|chloroquine|mesh-list
56674170|NCT02432417|Amebicides|amebicides|mesh-ancestor
56674171|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56674172|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56674173|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674174|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
56674175|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56674176|NCT00692120|Vitamin D|vitamin d|mesh-list
56674177|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
56674178|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
56674179|NCT00692120|Vitamins|vitamins|mesh-list
56674180|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
56674181|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674182|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56674183|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56674184|NCT02364713|Gemcitabine|gemcitabine|mesh-list
56674185|NCT02364713|Paclitaxel|paclitaxel|mesh-list
56674186|NCT02364713|Bevacizumab|bevacizumab|mesh-list
56674187|NCT02364713|Doxorubicin|doxorubicin|mesh-list
56674188|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56674189|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56674190|NCT02364713|Topotecan|topotecan|mesh-list
56674192|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
56674193|NCT02364713|Antibodies|antibodies|mesh-list
56674194|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
56674195|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56674196|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
56674197|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56674198|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674199|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674200|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
56674201|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674202|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674203|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56674204|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56674205|NCT02364713|Growth Substances|growth substances|mesh-ancestor
56674206|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674207|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
56674208|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
56674209|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56674210|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
56674211|NCT02364713|Antiviral Agents|antiviral agents|mesh-ancestor
56674212|NCT02364713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674213|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674214|NCT02364713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674215|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56674216|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56674217|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56674218|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56674219|NCT00819585|Colchicine|colchicine|mesh-list
56674220|NCT00819585|Allopurinol|allopurinol|mesh-list
56674221|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56674222|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
56674223|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56674224|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674225|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
56225605|NCT05262686|Analgesics|analgesics|mesh-ancestor
56225606|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
56225607|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225608|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225609|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56225610|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
56225611|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56225612|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56225613|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
56225614|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225615|NCT05238506|Lidocaine|lidocaine|mesh-list
56674226|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674227|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674228|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674229|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
56674230|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674231|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56674232|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
56674233|NCT00819585|Protective Agents|protective agents|mesh-ancestor
56674234|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674235|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
56674236|NCT00687206|Valsartan|valsartan|mesh-list
56674237|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56674238|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56674239|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56674240|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674241|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
56674242|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56674243|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674244|NCT02358395|Sorafenib|sorafenib|mesh-list
56674245|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674246|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56674247|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674248|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674249|NCT00692354|Tosedostat|tosedostat|mesh-list
56674250|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674251|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674252|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56674253|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
56674254|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674255|NCT03928847|Protective Agents|protective agents|mesh-ancestor
56674256|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674257|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56674258|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56674261|NCT02624726|Leucovorin|leucovorin|mesh-list
56674266|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
56674267|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674268|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56674269|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674270|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674271|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
56674272|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674273|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56674274|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56674275|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674276|NCT02624726|Antidotes|antidotes|mesh-ancestor
56674277|NCT02624726|Protective Agents|protective agents|mesh-ancestor
56674278|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
56674279|NCT02624726|Vitamins|vitamins|mesh-ancestor
56674280|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
56674281|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56674282|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56674283|NCT02624726|Growth Substances|growth substances|mesh-ancestor
56320505|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56674284|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
56674285|NCT00681746|Flumazenil|flumazenil|mesh-list
56225616|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
56183604|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183605|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
56183606|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183607|NCT01425164|Carvedilol|carvedilol|mesh-list
56183608|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56183609|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56183610|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
56183611|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225617|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
56225618|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225619|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225620|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
56225621|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225622|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56225623|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55801447|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225675|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
56225676|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225677|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56225678|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56225679|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56225680|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
56225681|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225682|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225683|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56225684|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56225685|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56225686|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56225687|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56225688|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
56225690|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
56225691|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
56674286|NCT00681746|Antidotes|antidotes|mesh-ancestor
56674287|NCT00681746|Protective Agents|protective agents|mesh-ancestor
56674288|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674289|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
56674290|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
56674291|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674292|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674293|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56674294|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
56674295|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674296|NCT00819039|Ondansetron|ondansetron|mesh-list
56674298|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
56674299|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
56674300|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674301|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674302|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56674303|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
56674304|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
56674305|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56674306|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
56674307|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674308|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674309|NCT00819039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56674310|NCT00819039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56674311|NCT00819039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674312|NCT00819039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56674313|NCT00819039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56674314|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56674315|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
56674316|NCT00692510|Midazolam|midazolam|mesh-list
56674317|NCT00692510|Caffeine|caffeine|mesh-list
56674318|NCT00692510|Bupropion|bupropion|mesh-list
56674319|NCT00692510|Omeprazole|omeprazole|mesh-list
56674320|NCT00692510|Bilirubin|bilirubin|mesh-list
56674321|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56674322|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56235459|NCT01744236|Incretins|incretins|mesh-ancestor
55801784|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55801785|NCT04820101|Analgesics|analgesics|mesh-ancestor
55801786|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
55943374|NCT01361217|L 647318|l 647318|mesh-list
56674323|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674324|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674325|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56674326|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56674327|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56674328|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56674329|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
56674330|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
56674331|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
56674332|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
56674333|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674334|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674335|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56674336|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56674337|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674338|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56674339|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56674340|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
55801787|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801794|NCT04819867|Propolis|propolis|mesh-list
56227371|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227372|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227373|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56227374|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227375|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227376|NCT04312009|Losartan|losartan|mesh-list
56227377|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56227378|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56227523|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55801577|NCT02424591|Ketamine|ketamine|mesh-list
56227525|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56227526|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227527|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55803210|NCT02582671|Ritonavir|ritonavir|mesh-list
56227670|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227671|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
56227673|NCT03012815|Lorazepam|lorazepam|mesh-list
56227674|NCT03012815|Valproic Acid|valproic acid|mesh-list
56227675|NCT03012815|Analgesics|analgesics|mesh-ancestor
56227676|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
56227677|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227678|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227702|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
56227703|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227704|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
56227705|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
56227706|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
56227707|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227708|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
56227709|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56183612|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183613|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183614|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56183615|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
56183616|NCT01425164|Protective Agents|protective agents|mesh-ancestor
56183617|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56674341|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56674342|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56674343|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56674344|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56674345|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
56183618|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56183619|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56183620|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
56183621|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56183622|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56183623|NCT01425216|Sorafenib|sorafenib|mesh-list
56183624|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888058|NCT03302208|Pregabalin|pregabalin|mesh-list
56227710|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227711|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
56227712|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227713|NCT03006432|Antidotes|antidotes|mesh-ancestor
56227714|NCT03006432|Protective Agents|protective agents|mesh-ancestor
56227715|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
56227716|NCT03006432|Vitamins|vitamins|mesh-ancestor
56227717|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
56227718|NCT03006432|Hematinics|hematinics|mesh-ancestor
56227719|NCT03003065|Temoporfin|temoporfin|mesh-list
56227720|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227721|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56227722|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
56227723|NCT03001011|Sevelamer|sevelamer|mesh-list
56227724|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
56227725|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
56227726|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227727|NCT02993757|Vaccines|vaccines|mesh-list
56227728|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
56227729|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227730|NCT02979535|Vaccines|vaccines|mesh-list
56227731|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
56227732|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227733|NCT02978716|Gemcitabine|gemcitabine|mesh-list
56227734|NCT02978716|Carboplatin|carboplatin|mesh-list
56227735|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227736|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227737|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
56227788|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227789|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
56227790|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56227791|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56227792|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
56227793|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56227794|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56227796|NCT02886286|Morphine|morphine|mesh-list
56227797|NCT02886286|Hydromorphone|hydromorphone|mesh-list
56227798|NCT02886286|Bupivacaine|bupivacaine|mesh-list
56227799|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
56227800|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
56227801|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56227802|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227803|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
56227804|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227807|NCT02886286|Analgesics|analgesics|mesh-ancestor
56227808|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56227809|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56227810|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
56183628|NCT01425242|Amlodipine|amlodipine|mesh-list
56183629|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56183630|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56183631|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56183632|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111395|NCT02036502|Hormones|hormones|mesh-ancestor
55888118|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227811|NCT02865187|Vitamin D|vitamin d|mesh-list
56227812|NCT02865187|Vitamins|vitamins|mesh-ancestor
56227813|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
56227814|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227815|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56674346|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56674347|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56674348|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674349|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
56674350|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56674351|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56674352|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56674353|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
56674354|NCT00692510|Protective Agents|protective agents|mesh-ancestor
56674355|NCT00500539|Omalizumab|omalizumab|mesh-list
56674356|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56235515|NCT01744444|Gabapentin|gabapentin|mesh-list
56227820|NCT02787551|Metformin|metformin|mesh-list
56227821|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
56227822|NCT02787551|Pioglitazone|pioglitazone|mesh-list
56227823|NCT02787551|Liraglutide|liraglutide|mesh-list
56227824|NCT02787551|Exenatide|exenatide|mesh-list
56227825|NCT02787551|Dulaglutide|dulaglutide|mesh-list
56227826|NCT02787551|Lixisenatide|lixisenatide|mesh-list
56227827|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56227828|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56227829|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
56227830|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227831|NCT02787551|Incretins|incretins|mesh-ancestor
56227832|NCT02787551|Hormones|hormones|mesh-ancestor
55803463|NCT05696509|Anesthetics, General|anesthetics, general|mesh-ancestor
56227895|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227900|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
56227901|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227902|NCT02584829|Interferons|interferons|mesh-list
56227903|NCT02584829|Interferon-beta|interferon-beta|mesh-list
56227904|NCT02584829|Avelumab|avelumab|mesh-list
56227905|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56227906|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227907|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
56227908|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227909|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227910|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
55803558|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
56227983|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
56227984|NCT02381652|Hormones|hormones|mesh-ancestor
56227985|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56227986|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227987|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227988|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
56227989|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227990|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227991|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56227992|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
56227993|NCT02381652|Protective Agents|protective agents|mesh-ancestor
56227994|NCT02368301|Dexamethasone|dexamethasone|mesh-list
56227995|NCT02368301|Lenalidomide|lenalidomide|mesh-list
56227996|NCT02368301|Elotuzumab|elotuzumab|mesh-list
56227997|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56227998|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
55803655|NCT04016389|Paclitaxel|paclitaxel|mesh-list
56228030|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228032|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228033|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56228034|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56183633|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56183634|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183635|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
56183636|NCT01425320|Dapsone|dapsone|mesh-list
56183637|NCT01425320|Adapalene|adapalene|mesh-list
56183638|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56674357|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56674358|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
56674359|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
56674360|NCT00687518|Hematinics|hematinics|mesh-ancestor
56674361|NCT02303795|Warfarin|warfarin|mesh-list
56674362|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
56674363|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
56674364|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56674365|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
56674366|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56674367|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
56674368|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674369|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674370|NCT04187417|Tetracaine|tetracaine|mesh-list
56674371|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
56674372|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
56674373|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674374|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674375|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
56674376|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674377|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56674378|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
56674379|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56674380|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56674381|NCT00818883|Diuretics|diuretics|mesh-ancestor
56674382|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
56674383|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674384|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56674385|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674386|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674401|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56674402|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56674403|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56674404|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56674405|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56674406|NCT02167763|Copper|copper|mesh-list
56674407|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
56674408|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56674409|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674410|NCT02167763|Trace Elements|trace elements|mesh-ancestor
56674411|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
56674412|NCT00508027|Simvastatin|simvastatin|mesh-list
56674413|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56674414|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56674415|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
56674416|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674417|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56674418|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56674419|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674420|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56674421|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56674422|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56674423|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674424|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674425|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56674426|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56674427|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56674428|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56674429|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
56674430|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183639|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56183640|NCT01425320|Analgesics|analgesics|mesh-ancestor
56183641|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
56183642|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183643|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183644|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183645|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56183646|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
56228035|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56228036|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
56228037|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051969|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674431|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674432|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56674433|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56674434|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
56674435|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56674436|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56674437|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
56674438|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56674439|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56674440|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674441|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56674442|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56674443|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674444|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674445|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
56674446|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674447|NCT00681902|Lidocaine|lidocaine|mesh-list
56674448|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
56674449|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
56674450|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674451|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674452|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
56674453|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674454|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56674455|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56235605|NCT01745263|Vitamin D|vitamin d|mesh-list
56228038|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228040|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
56228041|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
56228042|NCT02355379|Capecitabine|capecitabine|mesh-list
56228096|NCT02204241|Dexamethasone|dexamethasone|mesh-list
56228097|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
56228098|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228099|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
56228100|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228101|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228102|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56228103|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
56228104|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228105|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228106|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56228107|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228108|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
56228109|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
56228110|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674456|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56674457|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56674458|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674459|NCT04185857|Olmesartan|olmesartan|mesh-list
56674460|NCT04185857|Canrenone|canrenone|mesh-list
56674461|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56674462|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56674463|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56674464|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674465|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56674466|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
56674467|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674468|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674469|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56674470|NCT04185857|Diuretics|diuretics|mesh-ancestor
56674471|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
56674472|NCT01016509|Insulin|insulin|mesh-list
56674473|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56674474|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56674475|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674476|NCT00639119|Ropinirole|ropinirole|mesh-list
56674477|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56674478|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56674479|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
56674480|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
56674481|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228111|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228112|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
56228113|NCT02204241|Hormones|hormones|mesh-ancestor
56228114|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228115|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228167|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
56228168|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56228169|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56228170|NCT02106195|Belumosudil|belumosudil|mesh-list
56228171|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56228172|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228173|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228174|NCT02075177|Ketoconazole|ketoconazole|mesh-list
56228175|NCT02075177|Fenretinide|fenretinide|mesh-list
56228176|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
56228177|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228178|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56228179|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56228180|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228181|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674482|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674483|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674484|NCT01010893|Vaccines|vaccines|mesh-list
56674485|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
56674486|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674487|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56674488|NCT01011127|Pravastatin|pravastatin|mesh-list
56674489|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56674490|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56674491|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
56674492|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674493|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56228182|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56228183|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
56228184|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183647|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183649|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56183650|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56183651|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56183652|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183653|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183654|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
56183655|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56183656|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56183657|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56183658|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56183659|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
56183660|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183661|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56183662|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56183663|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183664|NCT01425411|Valsartan|valsartan|mesh-list
56228185|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803831|NCT02575339|Sorafenib|sorafenib|mesh-list
56228247|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56228248|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
56228249|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228250|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228251|NCT01943825|Vaccines|vaccines|mesh-list
56228252|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
56228258|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228259|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
56228260|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228261|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56228262|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56228309|NCT01828840|Narcotics|narcotics|mesh-ancestor
56228310|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228311|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228312|NCT01828840|Analgesics|analgesics|mesh-ancestor
56228313|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
56228314|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228315|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56228316|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56228317|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
56228318|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
56228319|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
56228320|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
56228321|NCT01817751|Sorafenib|sorafenib|mesh-list
56228322|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
56228323|NCT01817751|Valproic Acid|valproic acid|mesh-list
56228324|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228325|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674494|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56674495|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674496|NCT00912548|Tamoxifen|tamoxifen|mesh-list
56674497|NCT00912548|Goserelin|goserelin|mesh-list
56674498|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56674499|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
56674500|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674501|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674502|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56674503|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674504|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56674505|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56674506|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56674507|NCT01016665|Anastrozole|anastrozole|mesh-list
56674508|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320738|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
56674509|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674510|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56674511|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56674512|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674513|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674514|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56674515|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
56674516|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674517|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674518|NCT00681980|Valproic Acid|valproic acid|mesh-list
56674519|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
56674520|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674521|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674522|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
56674523|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674524|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674525|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
56674526|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56674527|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56674528|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56674529|NCT00692900|Docetaxel|docetaxel|mesh-list
56674530|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
56674531|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674532|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674533|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
56674534|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674535|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674536|NCT03800381|Rifampin|rifampin|mesh-list
56674537|NCT03800381|Isoniazid|isoniazid|mesh-list
56674538|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
56674539|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56674540|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
56674541|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56674542|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674543|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
56674544|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56674545|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674546|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674583|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56674584|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674585|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
56674586|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56674587|NCT04145336|Indomethacin|indomethacin|mesh-list
56674588|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56674589|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56674590|NCT04145336|Analgesics|analgesics|mesh-ancestor
56674591|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
56674592|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674593|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674594|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56674595|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56674602|NCT00499681|Letrozole|letrozole|mesh-list
56674645|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674646|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674647|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
56674648|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674649|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56674650|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56674651|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
56674652|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56674653|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
56674654|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56674655|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56674656|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56674657|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56674658|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674660|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56674661|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56674662|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
56674663|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674664|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674665|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56674666|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
56674667|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
56674668|NCT01946711|Hormones|hormones|mesh-ancestor
56674669|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674670|NCT00693446|Sirolimus|sirolimus|mesh-list
56674671|NCT00693446|Tacrolimus|tacrolimus|mesh-list
56674684|NCT00693524|Prednisone|prednisone|mesh-list
56674693|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674694|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56674695|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
56674696|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56674697|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674698|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674699|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56674700|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56674701|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
56674702|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56674703|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56674704|NCT00693602|Asparaginase|asparaginase|mesh-list
56674705|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674706|NCT00682214|Vitamin D|vitamin d|mesh-list
56674753|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674754|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56674755|NCT00810069|Analgesics|analgesics|mesh-ancestor
56674756|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
56674757|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
56674758|NCT00693758|Adenosine|adenosine|mesh-list
56674759|NCT00693758|Analgesics|analgesics|mesh-ancestor
56674760|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
56674761|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674762|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674816|NCT00489541|Paclitaxel|paclitaxel|mesh-list
56674817|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56674818|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56674819|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
56674820|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
56674821|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
56674822|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674823|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
56674824|NCT00689156|Docetaxel|docetaxel|mesh-list
56674882|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56674883|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56674884|NCT01011205|Protective Agents|protective agents|mesh-ancestor
56674885|NCT00809835|Galantamine|galantamine|mesh-list
56674886|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56674887|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56674888|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56674889|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
56674890|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56674891|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674892|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56674893|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
56674894|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56674895|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
56674896|NCT01014559|Oxycodone|oxycodone|mesh-list
56674944|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56674945|NCT04136600|Antibodies|antibodies|mesh-list
56674946|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
56674948|NCT00809757|Albuterol|albuterol|mesh-list
56675016|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
56675017|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
56675018|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
56675026|NCT02624570|Midostaurin|midostaurin|mesh-list
56675088|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
56675089|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56675090|NCT00689858|Protective Agents|protective agents|mesh-ancestor
56675091|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56675092|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56675093|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675094|NCT00695630|Flumazenil|flumazenil|mesh-list
56675095|NCT00695630|Antidotes|antidotes|mesh-ancestor
56675096|NCT00695630|Protective Agents|protective agents|mesh-ancestor
56675097|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675098|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
56675099|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
56675100|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675101|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675102|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56675103|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56675104|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56675105|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675106|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675107|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56675108|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56675109|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56675110|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56675111|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
56675112|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675113|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675114|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56675115|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56675116|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
56675117|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56675118|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56675119|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
56675120|NCT00690014|Probenecid|probenecid|mesh-list
56675121|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
56675122|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
56675129|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675130|NCT01475123|Nicorandil|nicorandil|mesh-list
56675131|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56675132|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56675133|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
56675134|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
56675198|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56675199|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56675200|NCT02622854|Insulin|insulin|mesh-list
56675201|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56675202|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675203|NCT02616770|Perflubron|perflubron|mesh-list
56675204|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56675205|NCT00499369|Leucovorin|leucovorin|mesh-list
56675206|NCT00499369|Bevacizumab|bevacizumab|mesh-list
56675207|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56675265|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675266|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675267|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675268|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56675269|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
56675334|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56321553|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
56675335|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
56675336|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675337|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56675402|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
56675403|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
56675404|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675475|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56675476|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56675477|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56675478|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675479|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675480|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675481|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56675482|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
56675497|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
56675500|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675568|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
56675569|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
56675570|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56675571|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675572|NCT00697034|Capsaicin|capsaicin|mesh-list
56675573|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
56675574|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56675575|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
56675576|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56675577|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675578|NCT00506779|Paclitaxel|paclitaxel|mesh-list
56675579|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
56675580|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56675581|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675582|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
56675583|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
56675584|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
56675585|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675586|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56675587|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56675588|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
56675589|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56675590|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
56675591|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
56675592|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56675593|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675594|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56675595|NCT04185233|Analgesics|analgesics|mesh-ancestor
56675596|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
56675617|NCT02686385|Hormones|hormones|mesh-ancestor
56675618|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56675619|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675620|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56675621|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56675622|NCT02686385|Protective Agents|protective agents|mesh-ancestor
56675623|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
56675624|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56675625|NCT02686385|Expectorants|expectorants|mesh-ancestor
56675626|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
56675627|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56675628|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
56675630|NCT02686385|Antidotes|antidotes|mesh-ancestor
56675679|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675680|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675751|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
56675752|NCT00639587|Cetirizine|cetirizine|mesh-list
56675753|NCT00639587|Ketotifen|ketotifen|mesh-list
56675754|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56675823|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56675824|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
56675825|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56675826|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56675827|NCT00496015|Analgesics|analgesics|mesh-ancestor
56675830|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
56675891|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56675892|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56675893|NCT00847626|Diuretics|diuretics|mesh-ancestor
56675898|NCT04115904|Ibuprofen|ibuprofen|mesh-list
56675957|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56675958|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676029|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
56676030|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676031|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676032|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676033|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676034|NCT04127084|Empagliflozin|empagliflozin|mesh-list
56676099|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676100|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56676101|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
56676102|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
56676104|NCT02619578|Narcotics|narcotics|mesh-ancestor
56676169|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676170|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676171|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676172|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56676173|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676174|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
56676175|NCT02619266|Megestrol|megestrol|mesh-list
56676176|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
56676235|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676236|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56676237|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
56676238|NCT00849186|Sunitinib|sunitinib|mesh-list
56676239|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676240|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56676241|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56676242|NCT00849186|Growth Substances|growth substances|mesh-ancestor
56676243|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676244|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
56676245|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56676246|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676247|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676248|NCT00692770|Sorafenib|sorafenib|mesh-list
56676249|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676250|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56676251|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676252|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676253|NCT00867308|Lenalidomide|lenalidomide|mesh-list
56676254|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
56676255|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676256|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56676257|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56676258|NCT00867308|Growth Substances|growth substances|mesh-ancestor
56676261|NCT02618876|Nalbuphine|nalbuphine|mesh-list
56676283|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676284|NCT00866918|Vitamins|vitamins|mesh-list
56676285|NCT00866918|Vitamin A|vitamin a|mesh-list
56676286|NCT00866918|Cytarabine|cytarabine|mesh-list
56676287|NCT00866918|Methotrexate|methotrexate|mesh-list
56676288|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
56676354|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56676355|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56676356|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
56676357|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676358|NCT04184921|Aspirin|aspirin|mesh-list
56676359|NCT04184921|Osimertinib|osimertinib|mesh-list
56676360|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56676361|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676362|NCT04184921|Analgesics|analgesics|mesh-ancestor
56676363|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
56676364|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676365|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676366|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56676367|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56676413|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56676414|NCT02688803|Paclitaxel|paclitaxel|mesh-list
56676415|NCT02688803|Docetaxel|docetaxel|mesh-list
56676416|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56676418|NCT02688803|Doxorubicin|doxorubicin|mesh-list
56676485|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676486|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676487|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56676488|NCT00869960|Ritonavir|ritonavir|mesh-list
56676489|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56676490|NCT00869960|Tenofovir|tenofovir|mesh-list
56676491|NCT00869960|Emtricitabine|emtricitabine|mesh-list
56676492|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56676493|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56676494|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
56676495|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56676496|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676497|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56676498|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56676499|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
56676500|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676505|NCT02618564|Sennosides|sennosides|mesh-list
56676543|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676544|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56676545|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56676546|NCT02618096|Oxytocin|oxytocin|mesh-list
56676547|NCT02618096|Dinoprostone|dinoprostone|mesh-list
56676548|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
56676549|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56676612|NCT00697892|Efavirenz|efavirenz|mesh-list
56676613|NCT00697892|Lumefantrine|lumefantrine|mesh-list
56676614|NCT00697892|Artemether|artemether|mesh-list
56676683|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
56676684|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56676685|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676686|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676687|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56676688|NCT00909935|Analgesics|analgesics|mesh-ancestor
56676689|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
56676690|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56676691|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56676692|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56676693|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56676694|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
56676695|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676696|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676697|NCT00857948|Ivermectin|ivermectin|mesh-list
56676698|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56676699|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676700|NCT02688491|Sunitinib|sunitinib|mesh-list
56676701|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56676702|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56676703|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56676737|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56676738|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56676739|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
56676740|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
56676741|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56676742|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56676743|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676744|NCT02617862|Anesthetics|anesthetics|mesh-list
56676745|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56676747|NCT00601835|Vaccines|vaccines|mesh-list
56676801|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
56676802|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56676803|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
56676804|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
56676805|NCT02682485|Metronidazole|metronidazole|mesh-list
56676806|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
56676807|NCT02682485|Neomycin|neomycin|mesh-list
56676870|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56676871|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
56676873|NCT04076579|Olaparib|olaparib|mesh-list
56676941|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
56676942|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56676943|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56676944|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
56676945|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56676946|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677011|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56677012|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56677013|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677014|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677015|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
56677016|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677017|NCT00921700|Acetaminophen|acetaminophen|mesh-list
56677018|NCT00921700|Ibuprofen|ibuprofen|mesh-list
56677019|NCT00921700|Codeine|codeine|mesh-list
56677020|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56677021|NCT00921700|Analgesics|analgesics|mesh-ancestor
56677040|NCT03996577|Lidocaine|lidocaine|mesh-list
56677073|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677074|NCT00743782|Hormones|hormones|mesh-list
56677075|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
56677077|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677144|NCT00466687|Bevacizumab|bevacizumab|mesh-list
56677145|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56677146|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56677147|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677216|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677217|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56677218|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
56677219|NCT04181645|Antiviral Agents|antiviral agents|mesh-ancestor
56677220|NCT04181645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677221|NCT04181645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677359|NCT02537561|Antiviral Agents|antiviral agents|mesh-ancestor
56677360|NCT02537561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677361|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56677362|NCT02537561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56677363|NCT02537561|Immunologic Factors|immunologic factors|mesh-ancestor
56677366|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
56677428|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56677429|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56677430|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677431|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
56677432|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677495|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
56677496|NCT02678507|Narcotics|narcotics|mesh-ancestor
56677497|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56677498|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677499|NCT02678507|Analgesics|analgesics|mesh-ancestor
56677500|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
56677501|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56677502|NCT00464737|Rotigotine|rotigotine|mesh-list
56677503|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
56677504|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
56677505|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56677508|NCT05658887|Gabapentin|gabapentin|mesh-list
56677558|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56677559|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56677560|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56677561|NCT00453349|Renal Agents|renal agents|mesh-ancestor
56677564|NCT02675153|Sirolimus|sirolimus|mesh-list
56677630|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677631|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56677632|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
56677633|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56677634|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677651|NCT02676323|Leucovorin|leucovorin|mesh-list
56677700|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
56677701|NCT05348213|Tofacitinib|tofacitinib|mesh-list
56677702|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56677703|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
56677704|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56677728|NCT02674139|Copper|copper|mesh-list
56677772|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677773|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
56677774|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56677775|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56677844|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677845|NCT05179733|Rituximab|rituximab|mesh-list
56677846|NCT05179733|Lenalidomide|lenalidomide|mesh-list
56677847|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
56677849|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677914|NCT00645125|Cefdinir|cefdinir|mesh-list
56677915|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56677916|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56677917|NCT02669459|Imiquimod|imiquimod|mesh-list
56677918|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56677919|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
56677920|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56677921|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56677922|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
56677923|NCT04176887|Phenytoin|phenytoin|mesh-list
56677924|NCT04176887|Levetiracetam|levetiracetam|mesh-list
56677935|NCT00645203|Cefdinir|cefdinir|mesh-list
56677982|NCT02537171|Apatinib|apatinib|mesh-list
56678050|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56678051|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
56678052|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678053|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678054|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56678108|NCT02666417|Iron|iron|mesh-list
56678117|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56678118|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678119|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56678120|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56678121|NCT00910637|Progestins|progestins|mesh-ancestor
56678122|NCT00910637|Hormones|hormones|mesh-ancestor
56678123|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56678184|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678185|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678253|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56678254|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56678255|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56678256|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
56678257|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56678258|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678259|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56678260|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
56678261|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
56678262|NCT00646529|Hormones|hormones|mesh-ancestor
56678263|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56678264|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56678265|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56678266|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56678267|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
56678268|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678269|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678270|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
56678271|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56678272|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678273|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
56678274|NCT00646607|Leucovorin|leucovorin|mesh-list
56678275|NCT00646607|Fluorouracil|fluorouracil|mesh-list
56678276|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
56678277|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
56678278|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
56678279|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678280|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56678298|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56678299|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56678300|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
56678301|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678302|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678304|NCT00856388|Fludarabine|fludarabine|mesh-list
56678368|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56678369|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
56678373|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56678438|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
56678439|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678440|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678441|NCT04170179|Lenvatinib|lenvatinib|mesh-list
56678442|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56678443|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56678444|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678445|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678446|NCT02659085|Ketamine|ketamine|mesh-list
56678447|NCT02659085|Analgesics|analgesics|mesh-ancestor
56678448|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
56678453|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
56678498|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56678499|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56678500|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56678501|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
56678502|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678567|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56678568|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56678569|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678572|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
56678637|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56678638|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678639|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678640|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
56678641|NCT02654093|Vitamin D|vitamin d|mesh-list
56678705|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56678706|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56678707|NCT00600821|Paclitaxel|paclitaxel|mesh-list
56678708|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56678776|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678777|NCT00649649|Quinapril|quinapril|mesh-list
56678778|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56678779|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
56678780|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56678781|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678782|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56678841|NCT00650273|Azithromycin|azithromycin|mesh-list
56678842|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56678843|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56678845|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56678914|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56678915|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56678916|NCT05298020|Growth Substances|growth substances|mesh-ancestor
56678917|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
56678918|NCT04170647|Plasminogen|plasminogen|mesh-list
56678919|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56678920|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56678921|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678922|NCT02661347|Risperidone|risperidone|mesh-list
56678923|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56678924|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
56678925|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56678926|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56678927|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56678973|NCT02661191|Vitamins|vitamins|mesh-ancestor
56678974|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
56678975|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56678976|NCT00691210|Niacinamide|niacinamide|mesh-list
56678977|NCT00691210|Niacin|niacin|mesh-list
56678978|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
56678979|NCT00691210|Etoposide|etoposide|mesh-list
56678980|NCT00691210|Vorinostat|vorinostat|mesh-list
56678981|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56679042|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
56679043|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679044|NCT02651519|Ropivacaine|ropivacaine|mesh-list
56679045|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
56679046|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
56679047|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679111|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679112|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
56679113|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679114|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56679115|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
56679122|NCT00649103|Quinapril|quinapril|mesh-list
56679181|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56679182|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679183|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
56679184|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679185|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
56679186|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679249|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
56679250|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56679251|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679252|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56679253|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
56679254|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679255|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679256|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
56679257|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679314|NCT00651599|Estrogens|estrogens|mesh-ancestor
56679315|NCT00651599|Hormones|hormones|mesh-ancestor
56679316|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56679317|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679386|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56679387|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56679388|NCT00652925|Analgesics|analgesics|mesh-ancestor
56679399|NCT00653003|Leflunomide|leflunomide|mesh-list
56679459|NCT03245489|Clopidogrel|clopidogrel|mesh-list
56679531|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56679532|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679533|NCT02641457|Ranibizumab|ranibizumab|mesh-list
56679534|NCT02641457|Aflibercept|aflibercept|mesh-list
56679535|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56679557|NCT02641301|Morphine|morphine|mesh-list
56679602|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679603|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56679604|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56679605|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679606|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679607|NCT02645903|Morphine|morphine|mesh-list
56679608|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56679609|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56679671|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
56679672|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
56679673|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
56679674|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56679675|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56679676|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56679677|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
56679678|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56679679|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
56679680|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56679681|NCT00652379|Octreotide|octreotide|mesh-list
56679682|NCT00652379|Lanreotide|lanreotide|mesh-list
56679683|NCT00652379|Somatostatin|somatostatin|mesh-list
56679684|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56679685|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56679686|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679731|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56679732|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56679733|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56679734|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679735|NCT00654173|Atorvastatin|atorvastatin|mesh-list
56679800|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56679801|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56679802|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56679803|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56679804|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
56679869|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56679943|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56679944|NCT00744718|Growth Substances|growth substances|mesh-ancestor
56679945|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680015|NCT00845676|Ribavirin|ribavirin|mesh-list
56680016|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
56680017|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
56680018|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56680019|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680020|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
56680021|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680022|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
56680023|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680024|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
56680025|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680026|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
56680027|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680028|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
56680029|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680030|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680031|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56326298|NCT05772546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680071|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680072|NCT00703638|Pemetrexed|pemetrexed|mesh-list
56680073|NCT00703638|Sorafenib|sorafenib|mesh-list
56680074|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680075|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680076|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680142|NCT02118467|Norepinephrine|norepinephrine|mesh-list
56680143|NCT02118467|Synephrine|synephrine|mesh-list
56680144|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56680145|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56680146|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
56680147|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680148|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680210|NCT00686686|Infliximab|infliximab|mesh-list
56680211|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
56680212|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56680213|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680214|NCT02637167|Rifaximin|rifaximin|mesh-list
56680218|NCT04057300|Aspirin|aspirin|mesh-list
56680280|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680281|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680282|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56680283|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56680284|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56680285|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
56680286|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680287|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680288|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
56680289|NCT00656123|Molgramostim|molgramostim|mesh-list
56680344|NCT00750334|Clofarabine|clofarabine|mesh-list
56680345|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56680346|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
56680347|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680348|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680349|NCT00745186|Glucagon|glucagon|mesh-list
56680350|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56680351|NCT00745186|Hormones|hormones|mesh-ancestor
56680352|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56680353|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680354|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
56680355|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56680356|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
56680357|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680358|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
56680359|NCT00750724|Protective Agents|protective agents|mesh-ancestor
56680360|NCT00752518|Bortezomib|bortezomib|mesh-list
56680361|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680362|NCT00752596|Azimilide|azimilide|mesh-list
56680363|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56680364|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56680365|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680366|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680367|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56680368|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680369|NCT00750802|Lorazepam|lorazepam|mesh-list
56228326|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56228327|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228328|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
56228432|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183665|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56183666|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56183667|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56183668|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183669|NCT01425424|Vitamin D|vitamin d|mesh-list
56183670|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
56183671|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
56183672|NCT01425424|Vitamins|vitamins|mesh-list
56183673|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
56183674|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183675|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56183676|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56183677|NCT01425476|Vitamin D|vitamin d|mesh-list
56183678|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
56183679|NCT01425476|Celecoxib|celecoxib|mesh-list
56183680|NCT01425476|Vitamins|vitamins|mesh-ancestor
56183681|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
56183682|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680370|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
56680371|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
56680372|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
56680373|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680374|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680375|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56680376|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56680377|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680378|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56680379|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56680380|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56680381|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
56680382|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
56680383|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680384|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183683|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56183684|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56183685|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56183686|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56228433|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228434|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
56228435|NCT01346787|Hormones|hormones|mesh-ancestor
56228436|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228437|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228439|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
56228440|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228441|NCT01204242|Lidocaine|lidocaine|mesh-list
56228442|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
56228443|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
56228444|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228445|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228446|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
56228447|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228448|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56228449|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56228477|NCT01160107|Prednisone|prednisone|mesh-list
56228483|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228484|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228485|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228486|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56228487|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
56228488|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228489|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56228490|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183688|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
56183689|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183690|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183691|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56183692|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56228491|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
56228492|NCT01150045|Leucovorin|leucovorin|mesh-list
56228493|NCT01150045|Celecoxib|celecoxib|mesh-list
56228494|NCT01150045|Fluorouracil|fluorouracil|mesh-list
56228495|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
56228496|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
56228558|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56228559|NCT00945009|Vincristine|vincristine|mesh-list
56228560|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56228561|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228562|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56680385|NCT00751270|Valacyclovir|valacyclovir|mesh-list
56680386|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
56680387|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680388|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56680389|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
56680390|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56680391|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55804213|NCT04292743|Leucovorin|leucovorin|mesh-list
56228612|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
56228613|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228614|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56228615|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228616|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228617|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
56228618|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228619|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
56228620|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228621|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56228622|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228623|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56228624|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
56228625|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56228626|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228627|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
56228628|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
56228629|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228630|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228631|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
56228632|NCT00579527|Hormones|hormones|mesh-ancestor
56228633|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229561|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56229562|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229564|NCT01699932|Glimepiride|glimepiride|mesh-list
56229565|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56229566|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229567|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56229568|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229569|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
56229570|NCT01699997|Oxytocin|oxytocin|mesh-list
56229571|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
56229572|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56229684|NCT01700790|Ritonavir|ritonavir|mesh-list
56229685|NCT01700790|Lopinavir|lopinavir|mesh-list
56229686|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56229687|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56229688|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
56229689|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229690|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229692|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55805314|NCT05487001|Hormones|hormones|mesh-ancestor
56229787|NCT01701349|Carboplatin|carboplatin|mesh-list
56229788|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56229789|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805412|NCT03937219|Nivolumab|nivolumab|mesh-list
56229822|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
56229823|NCT01701518|Dexamethasone|dexamethasone|mesh-list
56229824|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229825|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
56229826|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
56229827|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183693|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56183694|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183695|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183696|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
56183697|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56183698|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56183700|NCT01425580|Liraglutide|liraglutide|mesh-list
56183701|NCT01425580|Glimepiride|glimepiride|mesh-list
56183702|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55888420|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56101031|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
56680392|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56680393|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680394|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680395|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
56680396|NCT00576628|Hematinics|hematinics|mesh-ancestor
56229828|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229829|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229830|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
56229831|NCT01701518|Hormones|hormones|mesh-ancestor
56230564|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230565|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56230566|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56230567|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56230568|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56230569|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230571|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55806177|NCT05458453|Esketamine|esketamine|mesh-list
56230666|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56230667|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230793|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56230794|NCT01707823|Analgesics|analgesics|mesh-ancestor
56230795|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
56230796|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806415|NCT05494385|Gabapentin|gabapentin|mesh-list
56230870|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
56230871|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230872|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230873|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56230874|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56230875|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56230876|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56230877|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230878|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56230879|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56230880|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230963|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230964|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
56230965|NCT01708876|Artesunate|artesunate|mesh-list
56230966|NCT01708876|Chloroquine|chloroquine|mesh-list
56230967|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56230968|NCT01708876|Primaquine|primaquine|mesh-list
56230969|NCT01708876|Mefloquine|mefloquine|mesh-list
56230970|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
56230971|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56230972|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56230973|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230974|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230975|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
56230976|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
56230977|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56230978|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
56230979|NCT01708876|Amebicides|amebicides|mesh-ancestor
56231049|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806658|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
56231086|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231087|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56231088|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56231089|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
56231090|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56183706|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183707|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56183708|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183709|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
56183710|NCT01425619|Lidocaine|lidocaine|mesh-list
56183711|NCT01425619|Prilocaine|prilocaine|mesh-list
56183712|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
56183713|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
56183714|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55888487|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
56231208|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56231209|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231210|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56680397|NCT00683878|Pioglitazone|pioglitazone|mesh-list
56680398|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
56680399|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56680400|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56680401|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231211|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231212|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231213|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
56231214|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
56231270|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56231271|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231272|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231273|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231274|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
56231275|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56231276|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56231277|NCT01710696|Estradiol|estradiol|mesh-list
56231278|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56231279|NCT01710696|Estrogens|estrogens|mesh-ancestor
56231280|NCT01710696|Hormones|hormones|mesh-ancestor
56231281|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56231282|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231283|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56231284|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
56231285|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231286|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56231287|NCT01710722|Ephedrine|ephedrine|mesh-list
56231288|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
56231345|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231346|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
56231524|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56231525|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
56231526|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231527|NCT01711827|Isavuconazole|isavuconazole|mesh-list
56231529|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231530|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
56231531|NCT01711827|Hormones|hormones|mesh-ancestor
56231532|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56231533|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231534|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56231535|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231647|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231648|NCT01712568|Ropinirole|ropinirole|mesh-list
56231649|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56231650|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56231651|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
56231652|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
55807254|NCT05405725|Denosumab|denosumab|mesh-list
56231804|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
56231805|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231806|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231807|NCT01713387|Antiviral Agents|antiviral agents|mesh-ancestor
56183715|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183716|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
56183717|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183718|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56183719|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56183720|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56183721|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56183724|NCT01425658|Fentanyl|fentanyl|mesh-list
56183725|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56183726|NCT01425658|Narcotics|narcotics|mesh-ancestor
56183727|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56183728|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183729|NCT01425658|Analgesics|analgesics|mesh-ancestor
56183730|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
56183731|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183732|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56183733|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56183734|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
56183735|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
56680402|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56680403|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326674|NCT05655949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236379|NCT01749319|Baclofen|baclofen|mesh-list
56183736|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56183737|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
56183738|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
56183739|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56183740|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56183741|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56183742|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
55888552|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
55888553|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
55888554|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55888555|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55888556|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231808|NCT01713387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231809|NCT01713387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231810|NCT01713387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56231811|NCT01713387|Immunologic Factors|immunologic factors|mesh-ancestor
56232072|NCT01714570|Piperacillin|piperacillin|mesh-list
56232073|NCT01714570|Imipenem|imipenem|mesh-list
56232287|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232289|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56232321|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
56183743|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183744|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183745|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
56183746|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56183747|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56183748|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183749|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
56183750|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
56183751|NCT01425736|Cisplatin|cisplatin|mesh-list
56183752|NCT01425736|Docetaxel|docetaxel|mesh-list
56183753|NCT01425736|Fluorouracil|fluorouracil|mesh-list
56183754|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
56183755|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183756|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
56183757|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
56183758|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
56183759|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183760|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
56232322|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232323|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56232324|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56232325|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232326|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232327|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56232328|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56232329|NCT01716260|Chloroquine|chloroquine|mesh-list
56232330|NCT01716260|Primaquine|primaquine|mesh-list
56232331|NCT01716260|Amebicides|amebicides|mesh-ancestor
56232332|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56232993|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
56232994|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232995|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232996|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55808545|NCT05166343|Epinephrine|epinephrine|mesh-list
56233099|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233100|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
56233101|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56233102|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56233103|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233274|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56233275|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233276|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56233277|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56233278|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233279|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233280|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326675|NCT05655949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680404|NCT00884741|Bevacizumab|bevacizumab|mesh-list
56680406|NCT00884741|Temozolomide|temozolomide|mesh-list
56680407|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
56680408|NCT00884741|Antibodies|antibodies|mesh-list
56680409|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
56233281|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56233282|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56233313|NCT01730222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233314|NCT01730222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233315|NCT01730222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233316|NCT01730222|Immunologic Factors|immunologic factors|mesh-ancestor
56233317|NCT01730222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233318|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
56233319|NCT01730287|Calcium|calcium|mesh-list
56233320|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56233321|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233322|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56183761|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56183762|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183763|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
56183764|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183765|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56183766|NCT01425775|Vitamin D|vitamin d|mesh-list
56183767|NCT01425775|Vitamins|vitamins|mesh-ancestor
56183768|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
56183769|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183770|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56183771|NCT05386446|Interferons|interferons|mesh-list
56183772|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
56183773|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183774|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
56183775|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183776|NCT05386290|Mesalamine|mesalamine|mesh-list
56183777|NCT05386290|Infliximab|infliximab|mesh-list
56183778|NCT05386290|Ustekinumab|ustekinumab|mesh-list
56183779|NCT05386290|Vedolizumab|vedolizumab|mesh-list
56183780|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
56183781|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56183782|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233323|NCT01730326|Acetaminophen|acetaminophen|mesh-list
56233324|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56233325|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56233326|NCT01730326|Analgesics|analgesics|mesh-ancestor
56233327|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
56233328|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233387|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
56233388|NCT01731067|Caffeine|caffeine|mesh-list
56233389|NCT01731067|Bupropion|bupropion|mesh-list
56233390|NCT01731067|Omeprazole|omeprazole|mesh-list
56233391|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56233392|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56233393|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233394|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233395|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56233396|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56233397|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56233398|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56233399|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
56233400|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
56233401|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
56233761|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233762|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233763|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56233764|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233766|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233767|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233768|NCT01733394|Lamotrigine|lamotrigine|mesh-list
56233769|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
56233770|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56233771|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56233772|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233773|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56680410|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56680411|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
56680412|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680413|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56233821|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111542|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
56183783|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56183784|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56183786|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
56183787|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183788|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183789|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183790|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56183791|NCT05386186|Glimepiride|glimepiride|mesh-list
56183792|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56183793|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56183794|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234292|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56234293|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234294|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234295|NCT01736891|Rasagiline|rasagiline|mesh-list
56234296|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56234297|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809822|NCT02472847|Analgesics|analgesics|mesh-ancestor
56234326|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56234327|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56234328|NCT01737177|Growth Substances|growth substances|mesh-ancestor
56234329|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
56234330|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56234331|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
56234332|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234333|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
56234334|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234335|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
56234336|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56234337|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56234338|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234339|NCT01737203|Urological Agents|urological agents|mesh-ancestor
56234340|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
56234341|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56234342|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234343|NCT01737294|Capsaicin|capsaicin|mesh-list
56234379|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234381|NCT01737541|Fluoxetine|fluoxetine|mesh-list
56234416|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
56234417|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
56234418|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56234419|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56234482|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56234483|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
56234484|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234486|NCT01738243|Protective Agents|protective agents|mesh-ancestor
56234487|NCT01738282|Baclofen|baclofen|mesh-list
56234488|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56234489|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234490|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56234491|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234554|NCT01738802|Micronutrients|micronutrients|mesh-list
56234555|NCT01738802|Trace Elements|trace elements|mesh-list
56234556|NCT01738802|Antioxidants|antioxidants|mesh-list
56234557|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234558|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234559|NCT01738802|Protective Agents|protective agents|mesh-ancestor
56234560|NCT01738815|Valproic Acid|valproic acid|mesh-list
56234758|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183795|NCT05386186|Incretins|incretins|mesh-ancestor
56183796|NCT05386186|Hormones|hormones|mesh-ancestor
56183797|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183798|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
56183799|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680414|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56680415|NCT00884741|Growth Substances|growth substances|mesh-ancestor
56236389|NCT01749371|Vitamins|vitamins|mesh-list
56183800|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183801|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56183802|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183803|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
56183804|NCT05386160|Ranibizumab|ranibizumab|mesh-list
56183805|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56183806|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56183807|NCT05386160|Growth Substances|growth substances|mesh-ancestor
56183808|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183809|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
56183810|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183811|NCT05386121|Fentanyl|fentanyl|mesh-list
56183812|NCT05386121|Meperidine|meperidine|mesh-list
56183813|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56183814|NCT05386121|Narcotics|narcotics|mesh-ancestor
56183815|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56183816|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183817|NCT05386121|Analgesics|analgesics|mesh-ancestor
56183818|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
56183819|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183820|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56183821|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56183822|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
56234759|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56234760|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234761|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
56234762|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234763|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234764|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
56234765|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
56234766|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56234767|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
56234854|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56234855|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234856|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234858|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234859|NCT01741038|Cetuximab|cetuximab|mesh-list
56234860|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56234861|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234862|NCT01741077|Folic Acid|folic acid|mesh-list
56234863|NCT01741077|Hematinics|hematinics|mesh-ancestor
56234864|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
56234865|NCT01741077|Vitamins|vitamins|mesh-ancestor
56183823|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
56183824|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
56183825|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56183826|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183827|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
56183828|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183829|NCT05385887|Metronidazole|metronidazole|mesh-list
56183830|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
56183831|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183832|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56183833|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56183834|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56183835|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56183836|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56183837|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183838|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183839|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183840|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56183841|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56183842|NCT05385861|Carboplatin|carboplatin|mesh-list
56183843|NCT05385861|Irinotecan|irinotecan|mesh-list
56183844|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183845|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56183846|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56183847|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183848|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183849|NCT05385744|Teriflunomide|teriflunomide|mesh-list
56680416|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680417|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
56680418|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
56680419|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56680420|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
56680421|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680422|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56680423|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56183850|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56183851|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56183852|NCT05385744|Analgesics|analgesics|mesh-ancestor
56183853|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
56183854|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183855|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183856|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183857|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234866|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
56234867|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234868|NCT01741142|Citalopram|citalopram|mesh-list
56234869|NCT01741142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56234870|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56183858|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56183859|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
56183860|NCT05385185|Endostatins|endostatins|mesh-list
56183861|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183862|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56183863|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56183864|NCT05385185|Growth Substances|growth substances|mesh-ancestor
56183865|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183866|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
56183867|NCT05385094|Cystatins|cystatins|mesh-list
56183868|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56183869|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
56183870|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183871|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183872|NCT05385068|Niraparib|niraparib|mesh-list
56183873|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56183874|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183875|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183876|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183877|NCT05385029|Carbimazole|carbimazole|mesh-list
56183878|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
56183879|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
56183880|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183881|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183882|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
56183883|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56183884|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56183885|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56183886|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56183887|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183888|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
56183889|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888856|NCT01775501|Antidotes|antidotes|mesh-ancestor
55810387|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56235077|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56235078|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235079|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56235080|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56235081|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56235083|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56183890|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183891|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56183892|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183893|NCT05379374|Morphine|morphine|mesh-list
56680424|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56680425|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
56680426|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680427|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56680428|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56680429|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183894|NCT05379374|Bupivacaine|bupivacaine|mesh-list
56183895|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
56183896|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
56183897|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56183898|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183899|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
56183900|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183901|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56183902|NCT05379374|Narcotics|narcotics|mesh-ancestor
56183903|NCT05379374|Analgesics|analgesics|mesh-ancestor
56183904|NCT05375708|Bevacizumab|bevacizumab|mesh-list
56183905|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56183906|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183907|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56183908|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56183909|NCT05375708|Growth Substances|growth substances|mesh-ancestor
56183910|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183911|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
56183912|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56183913|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56183914|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56183915|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183916|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183917|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56183918|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888898|NCT01775189|Analgesics|analgesics|mesh-ancestor
56235113|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
56235114|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56235115|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235116|NCT01742637|Analgesics|analgesics|mesh-ancestor
56235117|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
56235118|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235119|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235120|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235121|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235122|NCT01742663|Diclofenac|diclofenac|mesh-list
56235123|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56235124|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235125|NCT01742663|Analgesics|analgesics|mesh-ancestor
56235126|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
56235173|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56183919|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183920|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
56183921|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183922|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56183923|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56183924|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183925|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
56183926|NCT05176379|Fluconazole|fluconazole|mesh-list
56183927|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
56183928|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56183929|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56183930|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56183931|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183932|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111691|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183940|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
56183941|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56183942|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
56183943|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183944|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680430|NCT00598481|Busulfan|busulfan|mesh-list
56680431|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
56680432|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680433|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680434|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
56680435|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680436|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56680437|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680438|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56680439|NCT04159649|Letrozole|letrozole|mesh-list
56680440|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680441|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56680442|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56183945|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56183946|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
56183947|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
56183948|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56183949|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
56183950|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888944|NCT03832816|Dronabinol|dronabinol|mesh-list
56235174|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56235175|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56235176|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56235177|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
56235178|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235179|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235180|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
56235181|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
56235182|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
56235183|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56235184|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
56235185|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56235186|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56235187|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56235188|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235362|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
56235431|NCT01744184|Midazolam|midazolam|mesh-list
56235432|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
56235433|NCT01744184|Entonox|entonox|mesh-list
56235434|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56235435|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56183951|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183952|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
56183953|NCT04850378|Dalteparin|dalteparin|mesh-list
56183954|NCT04850378|Tinzaparin|tinzaparin|mesh-list
56183955|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56183956|NCT04850378|Apixaban|apixaban|mesh-list
56183957|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56183958|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
56183959|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56183960|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
56183961|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56183962|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183963|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
56183964|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56183965|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56183974|NCT04809103|Cisplatin|cisplatin|mesh-list
56183975|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56183976|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56183977|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56183978|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183980|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
56183981|NCT04765371|Prednisolone|prednisolone|mesh-list
56680443|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680444|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680445|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56680446|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
56680447|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56680448|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680449|NCT00880763|Interferons|interferons|mesh-list
56680450|NCT00880763|Ribavirin|ribavirin|mesh-list
56680451|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680452|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
56183982|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56183983|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
56183984|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56183985|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
56183986|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56183987|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
56183988|NCT04765371|BB 1101|bb 1101|mesh-list
56235436|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235555|NCT01744756|Growth Substances|growth substances|mesh-ancestor
56235556|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235557|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
56235558|NCT01744873|Bisoprolol|bisoprolol|mesh-list
56235559|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56235560|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
56235561|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
56235562|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235563|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235564|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56235565|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56235566|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56235567|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
56235568|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235749|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56235751|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
56235752|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56183989|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183991|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
56183992|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183993|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183994|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56183995|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
56183996|NCT04765371|Hormones|hormones|mesh-ancestor
56183997|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183998|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56183999|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184000|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
56184001|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184002|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184003|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56184004|NCT04765371|Protective Agents|protective agents|mesh-ancestor
56184005|NCT04744363|Ustekinumab|ustekinumab|mesh-list
56184006|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
56184007|NCT04729517|Azelastine|azelastine|mesh-list
56184008|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56184009|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
56184010|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184011|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184012|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56235753|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56235754|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235755|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56235756|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235757|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235758|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56680453|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680454|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
56680455|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680456|NCT00884273|Goserelin|goserelin|mesh-list
56680457|NCT00884273|Bicalutamide|bicalutamide|mesh-list
56680458|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56680459|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235759|NCT01746199|Renal Agents|renal agents|mesh-ancestor
56235760|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56235761|NCT01746251|Afatinib|afatinib|mesh-list
56235762|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235763|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56235764|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235765|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235766|NCT01746277|Docetaxel|docetaxel|mesh-list
56235767|NCT01746277|Pemetrexed|pemetrexed|mesh-list
56235768|NCT01746277|Gefitinib|gefitinib|mesh-list
56235769|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237388|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
56237389|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
56237390|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237391|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237392|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
56237393|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237394|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56237835|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237837|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
56237838|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184013|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
56184014|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56184015|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184016|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184017|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56184018|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56184019|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56184020|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
56184021|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
56184022|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184023|NCT04698525|Valproic Acid|valproic acid|mesh-list
56184024|NCT04698525|Memantine|memantine|mesh-list
56184025|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56184026|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56184027|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
56184028|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889091|NCT04127019|Paclitaxel|paclitaxel|mesh-list
56237839|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56237840|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237841|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
56237842|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237843|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56237844|NCT01758666|Antidotes|antidotes|mesh-ancestor
56237845|NCT01758666|Protective Agents|protective agents|mesh-ancestor
56237846|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
56237847|NCT01758666|Vitamins|vitamins|mesh-ancestor
56237848|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
56237849|NCT01758744|Treprostinil|treprostinil|mesh-list
56237979|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56237980|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56237981|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56237982|NCT01759706|Narcotics|narcotics|mesh-ancestor
56237983|NCT01759706|Analgesics|analgesics|mesh-ancestor
56237984|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
56237985|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56237986|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56237987|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
56237988|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
56237989|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
56237990|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56238155|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238157|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56238158|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56680460|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
56680461|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
56680462|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56680463|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680464|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
56680465|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56238159|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238160|NCT01760278|Cetrorelix|cetrorelix|mesh-list
56238202|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238203|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56238204|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56238205|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238206|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
56238207|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56238208|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56238209|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
56238210|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56238211|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56238212|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238213|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
56238214|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238215|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238216|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56184029|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184030|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184031|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56184032|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56184034|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184035|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
56184036|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
56184037|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56184038|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184039|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56184040|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
56184041|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56184042|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56184043|NCT04673162|Prednisolone|prednisolone|mesh-list
56184044|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
56184045|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56184046|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
56184047|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184048|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
56184049|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
56184050|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184051|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184052|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184053|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
56184055|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184056|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56184057|NCT04673162|Protective Agents|protective agents|mesh-ancestor
56184058|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56184059|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184060|NCT04638660|Phentolamine|phentolamine|mesh-list
56184061|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56184062|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56184063|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56184068|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184069|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56184071|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184072|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184073|NCT04560556|Antibodies|antibodies|mesh-list
56184074|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
56184075|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184076|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
56184077|NCT04425902|Metoprolol|metoprolol|mesh-list
56184078|NCT04425902|Digoxin|digoxin|mesh-list
56184079|NCT04425902|Midazolam|midazolam|mesh-list
56184080|NCT04425902|Caffeine|caffeine|mesh-list
56184081|NCT04425902|Omeprazole|omeprazole|mesh-list
56184082|NCT04425902|Pravastatin|pravastatin|mesh-list
56680466|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56680467|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680468|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56680469|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56680470|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
56184083|NCT04425902|Montelukast|montelukast|mesh-list
56184084|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56184085|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56184086|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184087|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184088|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56184089|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56184090|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56184091|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56184092|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
56184093|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
56184094|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
56184095|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
56184096|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184097|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184098|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56184099|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56184100|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184101|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56184102|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56184103|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
56184111|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184112|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56184113|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56184114|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56184115|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56184116|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
56184117|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
56184118|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184119|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56184120|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56184121|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56184122|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
56184123|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56184124|NCT04425902|Protective Agents|protective agents|mesh-ancestor
56184125|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56184126|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56184127|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
56184128|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56184129|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56184130|NCT04425902|Analgesics|analgesics|mesh-ancestor
56184131|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
56184132|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56184133|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56184134|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184135|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184136|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56184137|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56184138|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184139|NCT04370093|Pioglitazone|pioglitazone|mesh-list
56184140|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56184141|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184142|NCT04311762|Cisplatin|cisplatin|mesh-list
56184143|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184144|NCT04203472|Budesonide|budesonide|mesh-list
56184145|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238217|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238218|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56238219|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
56238220|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
56184146|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56184147|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
56184148|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184149|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326755|NCT05630755|Islatravir|islatravir|mesh-list
56326756|NCT05630755|Antiviral Agents|antiviral agents|mesh-ancestor
56326757|NCT05630755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326758|NCT05630755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326759|NCT05630755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326760|NCT05630755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56236437|NCT01749475|Midazolam|midazolam|mesh-list
56184150|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56184151|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
56184152|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
56184154|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184155|NCT04166071|Naltrexone|naltrexone|mesh-list
56184156|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56184157|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56184158|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184159|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
56111911|NCT01985334|Bromides|bromides|mesh-list
56184160|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184161|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56184162|NCT04072146|Varenicline|varenicline|mesh-list
56184163|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56184164|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56184165|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
56184166|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889254|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238221|NCT01760577|Protective Agents|protective agents|mesh-ancestor
56238223|NCT01760642|Ketoconazole|ketoconazole|mesh-list
56238254|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56238255|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56238256|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
56238257|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238258|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56238260|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
56238261|NCT01760694|Irinotecan|irinotecan|mesh-list
56238262|NCT01760694|Folfirinox|folfirinox|mesh-list
56238263|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238264|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56238265|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56238418|NCT01761513|Esomeprazole|esomeprazole|mesh-list
56238419|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56238420|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56238421|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56238422|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238423|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238424|NCT01761526|Rotigotine|rotigotine|mesh-list
56238425|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
56238426|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
56238427|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238428|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238429|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238430|NCT01761552|Atropine|atropine|mesh-list
56238431|NCT01761552|Neostigmine|neostigmine|mesh-list
56238432|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56238433|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56238434|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56238435|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
56184167|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184168|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184169|NCT03996265|Bupropion|bupropion|mesh-list
56184170|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56184172|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56184173|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56184174|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56184175|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56184176|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184177|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
56184178|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184179|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680471|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680472|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56680473|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
56680474|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56680475|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56680476|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680477|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680478|NCT00657839|Urological Agents|urological agents|mesh-ancestor
56680479|NCT00884117|Oseltamivir|oseltamivir|mesh-list
56680480|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
56680481|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680482|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680483|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680484|NCT04159181|Lactulose|lactulose|mesh-list
56680485|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
56680486|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184180|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56184181|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56184182|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184184|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56184185|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184186|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184187|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184188|NCT03882463|Insulin|insulin|mesh-list
56184189|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56238436|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238437|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238438|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56238439|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
56238440|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
56238441|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
56238442|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56238443|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56238444|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
56238445|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238446|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238447|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56238448|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238449|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56238450|NCT01761656|Atorvastatin|atorvastatin|mesh-list
56238451|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56238452|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56238453|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
56238454|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238455|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56238456|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56238457|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238459|NCT01761669|Vitamins|vitamins|mesh-ancestor
56238460|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
56184190|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184191|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
56184192|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184193|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
56184194|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184195|NCT03821649|Naloxone|naloxone|mesh-list
56238461|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238462|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56238463|NCT01761916|Clonidine|clonidine|mesh-list
56680487|NCT04159181|Cathartics|cathartics|mesh-ancestor
56680488|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
56680489|NCT00884039|Anecortave|anecortave|mesh-list
56680490|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56680491|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56680492|NCT00884039|Growth Substances|growth substances|mesh-ancestor
56238464|NCT01761916|Captopril|captopril|mesh-list
56238563|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238564|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238565|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
56238566|NCT01762319|Pyridoxal|pyridoxal|mesh-list
56238567|NCT01762319|Pyridoxine|pyridoxine|mesh-list
56238568|NCT01762319|Misoprostol|misoprostol|mesh-list
56238697|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56238698|NCT01762787|Protective Agents|protective agents|mesh-ancestor
56238782|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
56238783|NCT01763424|Calcipotriene|calcipotriene|mesh-list
56238784|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
56238785|NCT01763424|Vitamins|vitamins|mesh-ancestor
56238786|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
56238787|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238788|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56238789|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
56238790|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238791|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56238792|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
56238793|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
56238794|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56238797|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56238798|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56238799|NCT01763437|Tetracycline|tetracycline|mesh-list
56238800|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238801|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238802|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56238803|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238804|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238805|NCT01763450|Bevacizumab|bevacizumab|mesh-list
55814158|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
56238839|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
56238840|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
56238841|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
56238842|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238843|NCT01763541|Anastrozole|anastrozole|mesh-list
56238844|NCT01763541|Leuprolide|leuprolide|mesh-list
56238845|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56238871|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56238873|NCT01763658|Hormones|hormones|mesh-ancestor
56238874|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238875|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56238876|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238877|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238878|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56238879|NCT01763658|Protective Agents|protective agents|mesh-ancestor
56238880|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
56238881|NCT01763710|Paclitaxel|paclitaxel|mesh-list
56238882|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56238883|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56238884|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238885|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
56238886|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
56238887|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
56238888|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238889|NCT01763749|Clopidogrel|clopidogrel|mesh-list
56238890|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56184196|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56184197|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184198|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
56184199|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184200|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
56184201|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
56184202|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
56680493|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680494|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
56680495|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184203|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184204|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184205|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
56184206|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184207|NCT03771612|Naproxen|naproxen|mesh-list
56184208|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56184209|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238891|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55814249|NCT02116803|Fulvestrant|fulvestrant|mesh-list
56238927|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56238929|NCT01764178|Pitavastatin|pitavastatin|mesh-list
56238930|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56238947|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56238948|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238950|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56238951|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56238952|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56238953|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
56238954|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238955|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56238956|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56238957|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238958|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56238959|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56238960|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56238961|NCT01764451|Simvastatin|simvastatin|mesh-list
56238963|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56238964|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
56238965|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238966|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56238967|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56238968|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238969|NCT01764555|Acetaminophen|acetaminophen|mesh-list
56238970|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238971|NCT01764555|Analgesics|analgesics|mesh-ancestor
56238972|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
56238973|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238974|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238975|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
56238977|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238978|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
56238979|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238980|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56238981|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238982|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238983|NCT01764672|Methylphenidate|methylphenidate|mesh-list
56238984|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56238985|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239017|NCT01764867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56239018|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56184210|NCT03771612|Analgesics|analgesics|mesh-ancestor
56184211|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
56184212|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184213|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184214|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184215|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184216|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
56184217|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56184218|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184219|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184220|NCT03759028|Acetaminophen|acetaminophen|mesh-list
56184221|NCT03759028|Ibuprofen|ibuprofen|mesh-list
56184222|NCT03759028|Oxycodone|oxycodone|mesh-list
56184223|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56184224|NCT03759028|Analgesics|analgesics|mesh-ancestor
56184225|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
56680496|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56680497|NCT00657995|Pancrelipase|pancrelipase|mesh-list
56680498|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56680499|NCT02632565|Lidocaine|lidocaine|mesh-list
56680500|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
56680501|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
56680502|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184226|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239019|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239020|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239022|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
56239023|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239024|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56239025|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
56239026|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56239027|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56239028|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56239029|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
56239030|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
55814392|NCT01656395|Montelukast|montelukast|mesh-list
56239053|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56239055|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56239056|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56239057|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56239058|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
56239059|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56239060|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56239061|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
56239062|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239063|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239064|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239065|NCT01764893|Urological Agents|urological agents|mesh-ancestor
56239066|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
56239067|NCT01765010|Vitamin D|vitamin d|mesh-list
56239068|NCT01765010|Calcitriol|calcitriol|mesh-list
56239069|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
56239070|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56239071|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55800843|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
56239077|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239078|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239079|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56239193|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239194|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184227|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184229|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56184230|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184231|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184232|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56184233|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184234|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184235|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56184236|NCT03759028|Narcotics|narcotics|mesh-ancestor
56184237|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184238|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
56184239|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184240|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184241|NCT03737292|Bupivacaine|bupivacaine|mesh-list
56184242|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
56184243|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
56184244|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184245|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184246|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
56239195|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56239196|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239197|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56680503|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680504|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
56680505|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680506|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56236465|NCT01749579|Fentanyl|fentanyl|mesh-list
56239198|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56239199|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
56239235|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56239236|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
56239237|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239238|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239317|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239318|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
56239319|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239320|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56239321|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56239322|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
56239323|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56239324|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56239325|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
56239326|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239327|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56239328|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56239329|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56239330|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
56239331|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239359|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56239360|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56239361|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
56239363|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239364|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239365|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56239366|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
56239367|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239368|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184247|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184248|NCT03734211|Evolocumab|evolocumab|mesh-list
56184249|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56184250|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56184251|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
56184252|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184253|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56184254|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
56184255|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56184256|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56184257|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184259|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
56184260|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56184261|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56184262|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889604|NCT01903798|Rilonacept|rilonacept|mesh-list
56239369|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
56239370|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
56239371|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
56239372|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239373|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56239374|NCT01766843|Charcoal|charcoal|mesh-list
56239375|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56239376|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
56239377|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239408|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56239409|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56239410|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56239411|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239413|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
56239414|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239415|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56239416|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680507|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56680508|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56680509|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680510|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680511|NCT04158947|Trastuzumab|trastuzumab|mesh-list
56239417|NCT01767272|Fexofenadine|fexofenadine|mesh-list
56239418|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56239419|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56239420|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56239421|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
56239422|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
56239450|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239451|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239452|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56239453|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239454|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56239455|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
56239456|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239457|NCT01767428|Acetaminophen|acetaminophen|mesh-list
56239458|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56239459|NCT01767428|Analgesics|analgesics|mesh-ancestor
56239460|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
56239461|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239462|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239463|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
56239464|NCT01767454|Ipilimumab|ipilimumab|mesh-list
56239488|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239489|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184263|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184264|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56184265|NCT03708198|Bupivacaine|bupivacaine|mesh-list
56184266|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
56184267|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
56184268|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184269|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184270|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
56184271|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184272|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
56184273|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55889662|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239490|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
56239491|NCT01767545|Hormones|hormones|mesh-ancestor
56239492|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239493|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56239494|NCT01767571|Cephalexin|cephalexin|mesh-list
56239495|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239496|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239497|NCT01767584|Cephalexin|cephalexin|mesh-list
56239498|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239499|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239501|NCT01767610|Fenofibrate|fenofibrate|mesh-list
56239502|NCT01767610|Pitavastatin|pitavastatin|mesh-list
56239503|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56239504|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
56239505|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239506|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56239507|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56239508|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56239509|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239510|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
56239511|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56239512|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56239513|NCT01767623|Vemurafenib|vemurafenib|mesh-list
55814876|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
56239538|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239539|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
56239540|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56239541|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
56239542|NCT01768078|Hormones|hormones|mesh-ancestor
56680512|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56680513|NCT04158947|Afatinib|afatinib|mesh-list
56680514|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56680515|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680516|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56680517|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239543|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239544|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239545|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56239546|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
56239547|NCT01768182|Leucovorin|leucovorin|mesh-list
56239548|NCT01768182|Folic Acid|folic acid|mesh-list
56239549|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
56239550|NCT01768182|Antidotes|antidotes|mesh-ancestor
56239551|NCT01768182|Protective Agents|protective agents|mesh-ancestor
56239552|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239553|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
56239554|NCT01768182|Vitamins|vitamins|mesh-ancestor
56239555|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
56239556|NCT01768182|Hematinics|hematinics|mesh-ancestor
56239557|NCT01768195|Entecavir|entecavir|mesh-list
56239558|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
56239559|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239560|NCT01768208|Saxagliptin|saxagliptin|mesh-list
56239561|NCT01768208|Incretins|incretins|mesh-ancestor
56239562|NCT01768208|Hormones|hormones|mesh-ancestor
56239563|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239564|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239565|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56184274|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184275|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184276|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56184277|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56184278|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
56184279|NCT03512405|Blinatumomab|blinatumomab|mesh-list
56184280|NCT03512405|Antibodies|antibodies|mesh-list
56184281|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
56184282|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56184283|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
56184284|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56184285|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
55889726|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
56239566|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
56239567|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814929|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
56239599|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
56239600|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
56239601|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
56239602|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239603|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239604|NCT01768299|Misoprostol|misoprostol|mesh-list
56239605|NCT01768299|Mifepristone|mifepristone|mesh-list
56239606|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56239607|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
56239608|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56239609|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239610|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55814981|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
56239641|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239642|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56239643|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239644|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239645|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56239650|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56239651|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815020|NCT05056883|Ivermectin|ivermectin|mesh-list
56239686|NCT01768390|Protective Agents|protective agents|mesh-ancestor
56239687|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239688|NCT01768455|Glimepiride|glimepiride|mesh-list
56239689|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56239690|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56680518|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680519|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
56680520|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
56239691|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239692|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56239693|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
56239694|NCT01768481|Atorvastatin|atorvastatin|mesh-list
55815065|NCT05018117|Nicotine|nicotine|mesh-list
56239738|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56239739|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56239740|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239742|NCT01768741|Hematinics|hematinics|mesh-ancestor
56239743|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
56239744|NCT01768780|Bupivacaine|bupivacaine|mesh-list
56239745|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56239746|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
56239747|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
56239748|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239749|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239750|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
56239751|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239752|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56184286|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184287|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184288|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184289|NCT03507699|Nivolumab|nivolumab|mesh-list
56184290|NCT03507699|Ipilimumab|ipilimumab|mesh-list
56184291|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184292|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184293|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56184294|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184295|NCT03495713|Nivolumab|nivolumab|mesh-list
56184296|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184297|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184298|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56184299|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184300|NCT03444753|Nivolumab|nivolumab|mesh-list
56184301|NCT03444753|Ipilimumab|ipilimumab|mesh-list
56184302|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184303|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184304|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56184305|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184306|NCT03142035|Dienogest|dienogest|mesh-list
56184307|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56184308|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
56184309|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56184310|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184311|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56184312|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55889789|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
56239753|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56239754|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
56239851|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
56239852|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56239853|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239854|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239855|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56239856|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239857|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239858|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
56239859|NCT01769482|Udenafil|udenafil|mesh-list
56239860|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56239861|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56239866|NCT01769625|Celecoxib|celecoxib|mesh-list
56239867|NCT01769625|Vitamins|vitamins|mesh-ancestor
56184313|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56184314|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56184315|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
56184316|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184317|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56184318|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680521|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
56680522|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56680523|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
56680524|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680525|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
56680526|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680527|NCT04163237|Sorafenib|sorafenib|mesh-list
56680528|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680529|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56680530|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680531|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680532|NCT00880685|Memantine|memantine|mesh-list
56184319|NCT02786875|Vitamin D|vitamin d|mesh-list
56184320|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
56184321|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
56184322|NCT02786875|Vitamins|vitamins|mesh-list
56184323|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
56184324|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184325|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56184326|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56184327|NCT02767882|Dexamethasone|dexamethasone|mesh-list
56184328|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184329|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
56184330|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
55889833|NCT01915108|Remifentanil|remifentanil|mesh-list
56239868|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
56239869|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239870|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56239871|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56239872|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56239873|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56239874|NCT01769625|Analgesics|analgesics|mesh-ancestor
56239875|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
56239876|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239877|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56239878|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56239879|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56240164|NCT01770795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240166|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56240167|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
56240168|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56240169|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
56240170|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240171|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240172|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56240173|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56240174|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240175|NCT01770964|Pregabalin|pregabalin|mesh-list
56240176|NCT01770964|Analgesics|analgesics|mesh-ancestor
56240177|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
56240178|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240179|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240180|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
56240181|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56240182|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56240183|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240184|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56240185|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56240186|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56240187|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184331|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902014|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
56680533|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56680534|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56680535|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
56680536|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680537|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680538|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680539|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56680540|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56680541|NCT02612298|Metoprolol|metoprolol|mesh-list
56680542|NCT02612298|Arotinolol|arotinolol|mesh-list
56680543|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56680544|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56680545|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
56680546|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
56680547|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680548|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680549|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56236490|NCT01750060|Narcotics|narcotics|mesh-ancestor
56184332|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184333|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184334|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
56184335|NCT02767882|Hormones|hormones|mesh-ancestor
56184336|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184337|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56184338|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184339|NCT02547662|Dexamethasone|dexamethasone|mesh-list
56184340|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
56184341|NCT02547662|Pomalidomide|pomalidomide|mesh-list
56184349|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184350|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184352|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
56184353|NCT02547662|Hormones|hormones|mesh-ancestor
56184354|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184355|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56184356|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240188|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56240189|NCT01771081|Ranibizumab|ranibizumab|mesh-list
56240223|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56240224|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240225|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
56240226|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56240227|NCT01771328|Cortisone|cortisone|mesh-list
56240228|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240229|NCT01771406|Nebivolol|nebivolol|mesh-list
56240230|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56240231|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
56240256|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56240258|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240259|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56240260|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56240261|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56240262|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
56240263|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240264|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56240265|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56680550|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56680551|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56680552|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
56680553|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680554|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680555|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56680556|NCT00880607|Morphine|morphine|mesh-list
56680557|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56680558|NCT00880607|Narcotics|narcotics|mesh-ancestor
56680559|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680560|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680561|NCT00880607|Analgesics|analgesics|mesh-ancestor
56680562|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
56680563|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680564|NCT00656435|Bevacizumab|bevacizumab|mesh-list
56680565|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56240266|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56240267|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56240268|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56184357|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184358|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
56184359|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184360|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
56184361|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56184362|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56184363|NCT02547662|Growth Substances|growth substances|mesh-ancestor
56184364|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
56184365|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56184366|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
56184367|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184368|NCT02246257|Metformin|metformin|mesh-list
56184369|NCT02246257|Losartan|losartan|mesh-list
56184370|NCT02246257|Simvastatin|simvastatin|mesh-list
56240269|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240270|NCT05318365|Laxatives|laxatives|mesh-ancestor
56240271|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56240272|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56240273|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56240274|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240275|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
56240276|NCT01771822|Ibuprofen|ibuprofen|mesh-list
56240277|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56240278|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56240279|NCT01771822|Analgesics|analgesics|mesh-ancestor
56240280|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
56240281|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240309|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56240310|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56240311|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800857|NCT03041935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56240313|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240314|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
56240315|NCT01772056|Fluticasone|fluticasone|mesh-list
56240316|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240317|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56240318|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
56240319|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240320|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680566|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680567|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56680568|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56680569|NCT00656435|Growth Substances|growth substances|mesh-ancestor
56680570|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680571|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
56680572|NCT02636231|Endostatins|endostatins|mesh-list
56680573|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56680574|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56680575|NCT02636231|Growth Substances|growth substances|mesh-ancestor
56680576|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680577|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
56240321|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56240322|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
56240323|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
56240324|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56240325|NCT01772212|Terbinafine|terbinafine|mesh-list
56240326|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
55815687|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
56240384|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56240385|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56240387|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240388|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56240389|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
56240390|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240391|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240392|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56240393|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
56240394|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
56240395|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
56240396|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
56240397|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56240398|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240399|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56184371|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56184372|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184373|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56184374|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56184375|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
56184376|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184377|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56184378|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56184379|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184380|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56184381|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56184382|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56184383|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56112138|NCT01959672|Antidotes|antidotes|mesh-ancestor
56184384|NCT02197221|Bortezomib|bortezomib|mesh-list
56240400|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56240401|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240402|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240403|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240474|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56240610|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
56240611|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
56240612|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56240613|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240614|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
56240615|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240616|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56680578|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680579|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56680580|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56680581|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56680582|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
56680583|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680584|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56240617|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56240618|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56240619|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56240620|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240621|NCT01774474|Dexamethasone|dexamethasone|mesh-list
56240653|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56240654|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56240656|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
56240657|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240658|NCT01774565|Insulin|insulin|mesh-list
56240659|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56240660|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55800862|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240664|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
56240665|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56240666|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56240667|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240668|NCT01774812|Vitamins|vitamins|mesh-ancestor
56240669|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
56240670|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56240671|NCT01774838|Clopidogrel|clopidogrel|mesh-list
56240672|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56240673|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56240674|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56240675|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56240676|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56240677|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
56240743|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
56240744|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56184385|NCT02197221|Melphalan|melphalan|mesh-list
56184386|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184387|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56184388|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
56184389|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184390|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56184391|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184392|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
56184393|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184394|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
56184395|NCT02094794|Etoposide|etoposide|mesh-list
56184396|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
56184397|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184398|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
56184399|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184400|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184401|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56184402|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
56184403|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184404|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184405|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56184406|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56184407|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56184408|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56184409|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184410|NCT02010385|Octreotide|octreotide|mesh-list
56184411|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184412|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56184413|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184414|NCT01949714|Epinephrine|epinephrine|mesh-list
56184415|NCT01949714|Racepinephrine|racepinephrine|mesh-list
56184416|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
56680585|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56680586|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680587|NCT00656591|Methotrexate|methotrexate|mesh-list
56680588|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56680589|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
56680590|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56236543|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184417|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56240745|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240746|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56240747|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56240748|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240749|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240750|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240903|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240904|NCT01777477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240905|NCT01777477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184418|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56184419|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
56184420|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184421|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184422|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184423|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56184424|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56184425|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
56184426|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184427|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56184428|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
56240908|NCT01777477|Amebicides|amebicides|mesh-ancestor
56240909|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56240910|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56240911|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
56240912|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240913|NCT01777503|Clopidogrel|clopidogrel|mesh-list
56240914|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56240915|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56240916|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56240917|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56240918|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56240919|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
56240982|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56240983|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240984|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56240985|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240986|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240987|NCT01778114|Vitamin D|vitamin d|mesh-list
56240988|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
56240989|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
56240990|NCT01778114|Vitamins|vitamins|mesh-list
56240991|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
56240992|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240993|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55816353|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56241066|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56241067|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56241069|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56241070|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56241071|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
56241107|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56241108|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56241110|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
56241111|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241112|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241113|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56241114|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56241115|NCT01779284|Timolol|timolol|mesh-list
56241116|NCT01779284|Travoprost|travoprost|mesh-list
56680591|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680592|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56680593|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
56680594|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680595|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680596|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
56680597|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241117|NCT01779284|Latanoprost|latanoprost|mesh-list
56241118|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56241119|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56241120|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
56241121|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241122|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241123|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241124|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56241125|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56241126|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56241127|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56241128|NCT01779362|Metformin|metformin|mesh-list
56184429|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
56184430|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
56184431|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56184432|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56184433|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56184434|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
56184435|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184436|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184437|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
56184438|NCT01231906|Ifosfamide|ifosfamide|mesh-list
56184439|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
56184440|NCT01231906|Doxorubicin|doxorubicin|mesh-list
56184441|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56184442|NCT01231906|Etoposide|etoposide|mesh-list
56184443|NCT01231906|Vincristine|vincristine|mesh-list
56184444|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
56184445|NCT01231906|Topotecan|topotecan|mesh-list
56184446|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
56184447|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
56184448|NCT01231906|Razoxane|razoxane|mesh-list
56184449|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
56184450|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184451|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
56184452|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184453|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184454|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56184455|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
56184456|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184457|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241129|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
56241130|NCT01779362|Liraglutide|liraglutide|mesh-list
56241131|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241132|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241167|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56241168|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56241169|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
56241170|NCT01779466|Coagulants|coagulants|mesh-ancestor
56241171|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56241172|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
56241249|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241250|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56241251|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56241252|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
56241253|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241254|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241255|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56241257|NCT01779908|Vitamins|vitamins|mesh-ancestor
56241258|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
56241259|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680598|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56680599|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680600|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
56680601|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680602|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56680603|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56236550|NCT01750437|Esomeprazole|esomeprazole|mesh-list
56112213|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56184458|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56184459|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56184460|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56184461|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56184462|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184463|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56184464|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
56184465|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
56184466|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
56184467|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56184468|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
56184469|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56184470|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56184471|NCT01231906|Protective Agents|protective agents|mesh-ancestor
56184472|NCT00223145|Goserelin|goserelin|mesh-list
56184473|NCT00223145|Bicalutamide|bicalutamide|mesh-list
56184474|NCT00223145|Androgens|androgens|mesh-list
56184475|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56184476|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184477|NCT00223145|Hormones|hormones|mesh-ancestor
56184478|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184479|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184480|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
56184481|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
56241260|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56241261|NCT01779921|Thrombin|thrombin|mesh-list
56241262|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
56241263|NCT01779921|Coagulants|coagulants|mesh-ancestor
56241264|NCT01780051|Metformin|metformin|mesh-list
56241265|NCT01780051|Repaglinide|repaglinide|mesh-list
56241266|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241267|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241268|NCT01780181|Gemcitabine|gemcitabine|mesh-list
56241269|NCT01780181|Docetaxel|docetaxel|mesh-list
56241270|NCT01780181|Vinorelbine|vinorelbine|mesh-list
56241317|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
56241318|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241319|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241320|NCT01780311|Sotalol|sotalol|mesh-list
56241321|NCT01780311|Flecainide|flecainide|mesh-list
56241322|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56241323|NCT01780311|Propafenone|propafenone|mesh-list
56241324|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56241325|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56241326|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
56241327|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241328|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241410|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56241411|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241412|NCT01780883|Melatonin|melatonin|mesh-list
56241413|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
56241653|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56241654|NCT01782924|Brodalumab|brodalumab|mesh-list
56184482|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56184483|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56184484|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56184485|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56184486|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184487|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184488|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184489|NCT01425827|Analgesics|analgesics|mesh-ancestor
56184490|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
56101419|NCT00001993|Zidovudine|zidovudine|mesh-list
56680604|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56680605|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56680606|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680607|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184491|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184492|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
56184493|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56184494|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
56184495|NCT01425840|Lidocaine|lidocaine|mesh-list
56184496|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
56184497|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
56184498|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241655|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
56241656|NCT01782937|Brodalumab|brodalumab|mesh-list
56241657|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
56241658|NCT01782950|Rifampin|rifampin|mesh-list
56241659|NCT01782950|Isoniazid|isoniazid|mesh-list
56241660|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
56241661|NCT01782950|Ethambutol|ethambutol|mesh-list
56241662|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56241663|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
56241664|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56241665|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241666|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
56241667|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56241668|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241669|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817032|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
56241700|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56241701|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
56241703|NCT01783106|Hormones|hormones|mesh-ancestor
56241704|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241705|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
56241706|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56241707|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56241708|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241709|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241710|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241711|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56241809|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241810|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56241811|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56241812|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241813|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241814|NCT01784250|Propranolol|propranolol|mesh-list
56241815|NCT01784250|Clonidine|clonidine|mesh-list
56241816|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56241817|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55817179|NCT02408120|Insulin|insulin|mesh-list
56241855|NCT01784315|Analgesics|analgesics|mesh-ancestor
56241856|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
56241925|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
56241926|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184499|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184500|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
56184501|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184502|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56184503|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56184504|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56184505|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56184506|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184508|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56184509|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184510|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56184511|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56184512|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184513|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184514|NCT01426022|Ethanol|ethanol|mesh-list
56184515|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56680608|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680609|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680610|NCT00658931|Analgesics|analgesics|mesh-ancestor
56680611|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
56680612|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56326900|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326901|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56326902|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56326903|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
56326904|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326911|NCT05458479|Fluoxetine|fluoxetine|mesh-list
56680613|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
56680614|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56680615|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
56680616|NCT00834912|Tramadol|tramadol|mesh-list
56680617|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56680618|NCT00834912|Narcotics|narcotics|mesh-ancestor
56680619|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680620|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680621|NCT00834912|Analgesics|analgesics|mesh-ancestor
56184516|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56184517|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184518|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184519|NCT01426074|Bevacizumab|bevacizumab|mesh-list
56184520|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184521|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184522|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56184523|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56184524|NCT01426074|Growth Substances|growth substances|mesh-ancestor
56184525|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184526|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
56184527|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56184528|NCT01426087|Somatostatin|somatostatin|mesh-list
56184529|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56184530|NCT01426087|Hormones|hormones|mesh-ancestor
56112306|NCT01930188|Incretins|incretins|mesh-ancestor
56184531|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184532|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890330|NCT04840641|Efavirenz|efavirenz|mesh-list
56184533|NCT01426100|Telmisartan|telmisartan|mesh-list
56184534|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56184535|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56184536|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56184537|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184538|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
56184539|NCT01426165|Analgesics|analgesics|mesh-ancestor
56184540|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
56184541|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184542|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241927|NCT01784978|Everolimus|everolimus|mesh-list
56241928|NCT01784978|Sunitinib|sunitinib|mesh-list
56241929|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241930|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241931|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
56241932|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817293|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
56680622|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
56680623|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680624|NCT02535689|Tofacitinib|tofacitinib|mesh-list
56680625|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56680626|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680627|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680628|NCT02632331|Gabapentin|gabapentin|mesh-list
56680629|NCT02632331|Analgesics|analgesics|mesh-ancestor
56680630|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
56680631|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680632|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680633|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
56680634|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56241954|NCT01785030|Analgesics|analgesics|mesh-ancestor
56241955|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
56241956|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241957|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56241958|NCT01785043|Liraglutide|liraglutide|mesh-list
56241959|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241960|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241961|NCT01785043|Incretins|incretins|mesh-ancestor
56241962|NCT01785043|Hormones|hormones|mesh-ancestor
56241963|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241964|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56241965|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
56241966|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241967|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241968|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56241969|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
56241970|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241971|NCT01785108|Vitamin D|vitamin d|mesh-list
56241972|NCT01785108|Ibuprofen|ibuprofen|mesh-list
56241973|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
56241974|NCT01785108|Vitamins|vitamins|mesh-ancestor
56241975|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
56241976|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241977|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56241978|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56241979|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56241980|NCT01785108|Analgesics|analgesics|mesh-ancestor
56241981|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
56241982|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241983|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56241984|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56241985|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56241986|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241987|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241988|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56241989|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
56241990|NCT01785290|Haloperidol|haloperidol|mesh-list
56241991|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
56241992|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
56241993|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
56241994|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241995|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241996|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56241997|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56241998|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56241999|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242000|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56242001|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56184543|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
56184544|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680635|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56680636|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680637|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56680638|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56680639|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56680640|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680641|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680642|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
56184545|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56184546|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
56184547|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56184548|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56184549|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184550|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56184551|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
56184552|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56184553|NCT01426256|Vitamin D|vitamin d|mesh-list
56184554|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
56242002|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
56242003|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242004|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242005|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56242006|NCT01785446|Sufentanil|sufentanil|mesh-list
56242007|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
56242009|NCT01785446|Atracurium|atracurium|mesh-list
56242010|NCT01785446|Cisatracurium|cisatracurium|mesh-list
56242011|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56242012|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242013|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242014|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242015|NCT01785446|Analgesics|analgesics|mesh-ancestor
56242016|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
56242017|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242018|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56242019|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56242020|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56242021|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
56242022|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242023|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242024|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56242025|NCT01785446|Narcotics|narcotics|mesh-ancestor
56242026|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56242027|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56242028|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
56242120|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56242121|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242122|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
56242123|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242165|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
56242166|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
56242167|NCT01786070|Hormones|hormones|mesh-ancestor
56242168|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242169|NCT01786200|Aspirin|aspirin|mesh-list
56242170|NCT01786200|Ibuprofen|ibuprofen|mesh-list
56242171|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56242172|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242173|NCT01786200|Analgesics|analgesics|mesh-ancestor
56242174|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
56242175|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242176|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242177|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242178|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242179|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56242180|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56242181|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680643|NCT04162535|Lidocaine|lidocaine|mesh-list
56680644|NCT04162535|Propofol|propofol|mesh-list
56680645|NCT04162535|Anesthetics|anesthetics|mesh-list
56680646|NCT04162535|Sevoflurane|sevoflurane|mesh-list
56680647|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56680648|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
56680649|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680650|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680651|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
56236596|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242182|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56242183|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56242184|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242185|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
56184555|NCT01426256|Vitamins|vitamins|mesh-ancestor
56184556|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
56184557|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184558|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56184559|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56184560|NCT01426334|Cyclosporine|cyclosporine|mesh-list
56184561|NCT01426334|Dasatinib|dasatinib|mesh-list
56184562|NCT01426334|Cyclosporins|cyclosporins|mesh-list
56184563|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184564|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184565|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184566|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
56184567|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184568|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
56184569|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242186|NCT01786226|Mifepristone|mifepristone|mesh-list
56242187|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56242188|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
56242189|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242190|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242191|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56242192|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56242193|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56242194|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
56242195|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56242196|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56242197|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
56242198|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242199|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
56242200|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56242201|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56242202|NCT01786382|Midazolam|midazolam|mesh-list
56242203|NCT01786382|Omeprazole|omeprazole|mesh-list
56242204|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56242205|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56242206|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242207|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242208|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56242209|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56242210|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56242211|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56242212|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
56242213|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
56242214|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
56242215|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
56242216|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242217|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242218|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56242219|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56242220|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56242257|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242258|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680652|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680653|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56680654|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56680655|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56242259|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
56242260|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817614|NCT02278471|Diuretics|diuretics|mesh-ancestor
56242313|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242314|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56242315|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56242317|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56184570|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
56184571|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184572|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56184573|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184574|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56184575|NCT01426399|Metformin|metformin|mesh-list
56184576|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56184577|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184578|NCT01426464|Latanoprost|latanoprost|mesh-list
56184579|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56184580|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56184581|NCT01426490|Vitamins|vitamins|mesh-list
56184582|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
56184583|NCT01426490|Folic Acid|folic acid|mesh-list
56184584|NCT01426490|Pyridoxine|pyridoxine|mesh-list
56184585|NCT01426490|Pyridoxal|pyridoxal|mesh-list
56184586|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
56184587|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
56184588|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
56184589|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184590|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
56184594|NCT01426542|Topiramate|topiramate|mesh-list
56242318|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242319|NCT01787474|Cytarabine|cytarabine|mesh-list
56242320|NCT01787474|Fludarabine|fludarabine|mesh-list
56242321|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
56242322|NCT01787474|Lenograstim|lenograstim|mesh-list
56242323|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242324|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56242325|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
56242326|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242327|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56242328|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
56242329|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242384|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56242385|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242386|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242387|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56242388|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56242389|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56242422|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56242423|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56242425|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242426|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
56242428|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56242429|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242430|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242431|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242469|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56242470|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56242471|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
56242472|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184595|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
56184596|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56184597|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184598|NCT01426633|Gemcitabine|gemcitabine|mesh-list
56184599|NCT01426633|Trabectedin|trabectedin|mesh-list
56184600|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56184601|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
56184602|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184603|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680656|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680657|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680658|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56680659|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
56184604|NCT01426633|Antiviral Agents|antiviral agents|mesh-ancestor
56184605|NCT01426633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112357|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
56184606|NCT01426633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184607|NCT01426633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56242473|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56242474|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56242475|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
56242476|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242477|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56242478|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56242479|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56242480|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56242482|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
56242483|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
56242484|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242485|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242486|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56242487|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56242488|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
56242489|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242490|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242491|NCT01788670|Ethanol|ethanol|mesh-list
56242568|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242667|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242668|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242669|NCT01789879|Efavirenz|efavirenz|mesh-list
56242670|NCT01789879|Nevirapine|nevirapine|mesh-list
56242671|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
56242674|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242675|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242759|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242761|NCT01792804|Renal Agents|renal agents|mesh-ancestor
56242762|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
56242763|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56242764|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56242765|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56242766|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56242767|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56242768|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56242802|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56242803|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56242804|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56242805|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242944|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242945|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56242946|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56242948|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56184608|NCT01426633|Immunologic Factors|immunologic factors|mesh-ancestor
56184609|NCT01426633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184610|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56184611|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
56242949|NCT01798836|Estradiol|estradiol|mesh-list
56242950|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56242951|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56242952|NCT01798836|Estrogens|estrogens|mesh-ancestor
56242953|NCT01798836|Hormones|hormones|mesh-ancestor
56242954|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242955|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242956|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56242957|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
56242958|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242959|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56680660|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56680661|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56680662|NCT02632019|Gemcitabine|gemcitabine|mesh-list
56680663|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56242960|NCT01798901|Decitabine|decitabine|mesh-list
56242961|NCT01798901|Azacitidine|azacitidine|mesh-list
55818311|NCT04687761|Cytarabine|cytarabine|mesh-list
56243022|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243024|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56243025|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56243026|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243027|NCT01800292|Urological Agents|urological agents|mesh-ancestor
56243028|NCT01800357|Aspirin|aspirin|mesh-list
56243029|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
56243030|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56243031|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56243032|NCT01800357|Analgesics|analgesics|mesh-ancestor
56243033|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
56243034|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243089|NCT01800630|Immunologic Factors|immunologic factors|mesh-ancestor
56243090|NCT01800630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243091|NCT01800643|Busulfan|busulfan|mesh-list
56243092|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
56243121|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56243122|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243123|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
56243125|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56243126|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56243127|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56243128|NCT01800799|Analgesics|analgesics|mesh-ancestor
56243129|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
56243130|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243131|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243132|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56243133|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56243134|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55818484|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
56243268|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56243271|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243277|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243278|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243279|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
56243280|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56243281|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243282|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243283|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56243284|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56243285|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56243286|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56243287|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56243288|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56243290|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
56243291|NCT01802593|Azathioprine|azathioprine|mesh-list
56184613|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184614|NCT01426737|Vildagliptin|vildagliptin|mesh-list
56184615|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56184616|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184617|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56243292|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56243293|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
56243294|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56243295|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243296|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56243297|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
56243298|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243299|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243300|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
56243301|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243302|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56680664|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
56680665|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680666|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680667|NCT02632019|Antiviral Agents|antiviral agents|mesh-ancestor
56680668|NCT02632019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812097|NCT02217345|Hormones|hormones|mesh-list
56243303|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243304|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
56243305|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56243306|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56243307|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
56243308|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56243309|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
56243310|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243311|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243312|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56243313|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
56243314|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56243315|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
56243316|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243317|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243318|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56243319|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
56243320|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
56243321|NCT01802619|Protective Agents|protective agents|mesh-ancestor
56243322|NCT01802645|Leucovorin|leucovorin|mesh-list
56243323|NCT01802645|Folic Acid|folic acid|mesh-list
56243324|NCT01802645|Bevacizumab|bevacizumab|mesh-list
56243325|NCT01802645|Cetuximab|cetuximab|mesh-list
56243326|NCT01802645|Fluorouracil|fluorouracil|mesh-list
56243327|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
56243328|NCT01802645|Irinotecan|irinotecan|mesh-list
56243329|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
56243330|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56243331|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243332|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56243333|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56243334|NCT01802645|Growth Substances|growth substances|mesh-ancestor
56243335|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243336|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
56243337|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
56243338|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243339|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56243451|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
56243452|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
56243453|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
56243454|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243455|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56243456|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56243457|NCT01803503|Growth Substances|growth substances|mesh-ancestor
56243458|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243459|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
56243460|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56243461|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243462|NCT01803659|Vitamin A|vitamin a|mesh-list
56243463|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
56243464|NCT01803659|Carotenoids|carotenoids|mesh-list
56184619|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890807|NCT05740150|Taurolidine|taurolidine|mesh-list
56243465|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
56243466|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243467|NCT01803659|Protective Agents|protective agents|mesh-ancestor
56243468|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243469|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56243470|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243471|NCT01803659|Vitamins|vitamins|mesh-ancestor
56243472|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
56243473|NCT01803763|Omalizumab|omalizumab|mesh-list
56243530|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243531|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243532|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680669|NCT02632019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680670|NCT02632019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680671|NCT02632019|Immunologic Factors|immunologic factors|mesh-ancestor
56680672|NCT02632019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243533|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
56243534|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243535|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
56243536|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243537|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
56243538|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56243539|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56243540|NCT01804374|Everolimus|everolimus|mesh-list
56243542|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243543|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243654|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56243655|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243657|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56243658|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56243659|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243660|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243661|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56243662|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
56243663|NCT01807767|Everolimus|everolimus|mesh-list
56243664|NCT01807767|Tacrolimus|tacrolimus|mesh-list
56243665|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243666|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
56243667|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243668|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56243669|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243670|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243696|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
56243697|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243698|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56243699|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56243700|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56243701|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56243702|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243704|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56243705|NCT01808014|Analgesics|analgesics|mesh-ancestor
56243706|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
56243707|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243708|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243709|NCT01808131|Lesinurad|lesinurad|mesh-list
56243710|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
56243711|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56243717|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
56243718|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819059|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56243754|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243756|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243757|NCT01808521|Antidotes|antidotes|mesh-ancestor
56243758|NCT01808586|Dexamethasone|dexamethasone|mesh-list
56243759|NCT01808586|Betamethasone|betamethasone|mesh-list
56243760|NCT01808586|Lidocaine|lidocaine|mesh-list
56243761|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56243762|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
56243791|NCT01808638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243792|NCT01808638|Immunologic Factors|immunologic factors|mesh-ancestor
56184620|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184621|NCT01426802|Vildagliptin|vildagliptin|mesh-list
56184622|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56184623|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184624|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56184625|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
56184626|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184627|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184628|NCT01426815|Golimumab|golimumab|mesh-list
56184629|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56184630|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56243793|NCT01808638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243795|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56680673|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56680674|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
56680675|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
56680676|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56680677|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56680678|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56680679|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680680|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680681|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56326973|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326974|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326975|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56326976|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326980|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680682|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680683|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
56680684|NCT04158713|Piperaquine|piperaquine|mesh-list
56680685|NCT04158713|Artenimol|artenimol|mesh-list
56680686|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
56680687|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56680688|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56243796|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
56243797|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
56243798|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243799|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243800|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243801|NCT01808898|Bupivacaine|bupivacaine|mesh-list
56243802|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
56243803|NCT01808898|Mepivacaine|mepivacaine|mesh-list
56243804|NCT01808898|Anesthetics|anesthetics|mesh-list
56243901|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56243902|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56243903|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243904|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243905|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56243906|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
56243907|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
56243908|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243909|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243910|NCT01809743|Adenosine|adenosine|mesh-list
56243911|NCT01809743|Regadenoson|regadenoson|mesh-list
56243912|NCT01809743|Analgesics|analgesics|mesh-ancestor
56243913|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
56243914|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243946|NCT01809925|Psyllium|psyllium|mesh-list
56243947|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
56243948|NCT01809925|Cathartics|cathartics|mesh-ancestor
56243949|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56243950|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
56243951|NCT01810185|Naltrexone|naltrexone|mesh-list
56243952|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56243953|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56243954|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243955|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
56243956|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243957|NCT01810237|Dabigatran|dabigatran|mesh-list
56680689|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680690|NCT00659321|Nicotine|nicotine|mesh-list
56680691|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56680692|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
56680693|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680694|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680695|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56680696|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56680697|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
56680698|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680699|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243958|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
56244016|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56244017|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
56244018|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
56244019|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244020|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56244021|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
56244027|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
56244028|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56244029|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
55819308|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
56244057|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244058|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56184631|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184632|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
56184633|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184634|NCT01426880|Paclitaxel|paclitaxel|mesh-list
56184635|NCT01426880|Carboplatin|carboplatin|mesh-list
56244059|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
56244060|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
56244061|NCT01810848|Hylan|hylan|mesh-list
56244062|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56244063|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
56244064|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244065|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
56244066|NCT01810848|Protective Agents|protective agents|mesh-ancestor
56244067|NCT01810887|Ritonavir|ritonavir|mesh-list
56244068|NCT01810887|Darunavir|darunavir|mesh-list
56244069|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56244070|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56244071|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
56244072|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244073|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244074|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56244075|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56244076|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
56244077|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244078|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56244079|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55819344|NCT01796470|Idelalisib|idelalisib|mesh-list
56244105|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244106|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56244107|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56244108|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
56244109|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56244111|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56244112|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
56244113|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56244114|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244115|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56244116|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56244117|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56244118|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
56244119|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56244120|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56680700|NCT00659399|PENTA|penta|mesh-list
56680701|NCT00659399|Fondaparinux|fondaparinux|mesh-list
56680702|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56680703|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
56680704|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56680705|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
56680706|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680707|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680708|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
56680709|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56680710|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56680711|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
56680712|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56236652|NCT01750983|Ipilimumab|ipilimumab|mesh-list
56244121|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
56244122|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244123|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
56244124|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56244125|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56244126|NCT01811160|Melatonin|melatonin|mesh-list
56244127|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
56244128|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244129|NCT01811160|Protective Agents|protective agents|mesh-ancestor
56244144|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244145|NCT01811251|Analgesics|analgesics|mesh-ancestor
56244146|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
56244147|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
56244148|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56244149|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56244150|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244151|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56244152|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56244153|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56244155|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56244156|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
56244157|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244159|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56244160|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56244161|NCT01811381|Analgesics|analgesics|mesh-ancestor
56184636|NCT01426880|Lapatinib|lapatinib|mesh-list
56184637|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56244162|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
56244163|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244164|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244165|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244166|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244167|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244168|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244169|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244170|NCT01811459|Haloperidol|haloperidol|mesh-list
56244171|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56244172|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
56244173|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
56244174|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56244175|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56244176|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56244177|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244178|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244179|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
56244180|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
56244181|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244182|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56680713|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680714|NCT00911339|Atorvastatin|atorvastatin|mesh-list
56680715|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56680716|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56680717|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
56244183|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56244184|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
56244185|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244186|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244187|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56244188|NCT01811615|Ethanol|ethanol|mesh-list
56244189|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56244201|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244202|NCT01811810|Androgens|androgens|mesh-list
56244203|NCT01811810|Hormones|hormones|mesh-ancestor
56244204|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244205|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244206|NCT01811836|Zinc|zinc|mesh-list
56244207|NCT01811836|Trace Elements|trace elements|mesh-ancestor
56244208|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
56244209|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244210|NCT01811849|Insulin|insulin|mesh-list
56244211|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56244212|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
56244213|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56244214|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244215|NCT01812018|Gemcitabine|gemcitabine|mesh-list
56244216|NCT01812018|Docetaxel|docetaxel|mesh-list
56244217|NCT01812018|Endostar protein|endostar protein|mesh-list
56244218|NCT01812018|Endostatins|endostatins|mesh-list
56244219|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56244220|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
56244221|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244222|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244223|NCT01812018|Antiviral Agents|antiviral agents|mesh-ancestor
56244224|NCT01812018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244225|NCT01812018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244226|NCT01812018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244227|NCT01812018|Immunologic Factors|immunologic factors|mesh-ancestor
56244228|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244229|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56244230|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56244231|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56244232|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56244233|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56244234|NCT01812018|Growth Substances|growth substances|mesh-ancestor
56244235|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
56244236|NCT01812096|Bortezomib|bortezomib|mesh-list
56244237|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244238|NCT01812122|Glimepiride|glimepiride|mesh-list
56244241|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56244242|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244243|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244244|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
56244245|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56184638|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184639|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
56184640|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
56184641|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
56184642|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184643|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56184644|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184645|NCT01426906|Rifampin|rifampin|mesh-list
56184646|NCT01426906|Ketoconazole|ketoconazole|mesh-list
56184647|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56184648|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
56184649|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56184650|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56184651|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
56184652|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56184653|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891096|NCT02766465|Tacrolimus|tacrolimus|mesh-list
56244246|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
56680718|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680719|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56680720|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56680721|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680722|NCT04158167|Oxytocin|oxytocin|mesh-list
56244247|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244248|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244249|NCT01812135|Vaccines|vaccines|mesh-list
56244250|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
56244251|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244252|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
56244253|NCT01812200|Dabigatran|dabigatran|mesh-list
56244254|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
56244255|NCT01812200|Ticagrelor|ticagrelor|mesh-list
56244256|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56244274|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244275|NCT01812330|Clopidogrel|clopidogrel|mesh-list
56244276|NCT01812330|Ticagrelor|ticagrelor|mesh-list
56244277|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56244278|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56244279|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56244280|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56244281|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
56244282|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244283|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244284|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244285|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
56244286|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56244287|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
56244288|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
56244289|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244290|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244291|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56244292|NCT01812356|Analgesics|analgesics|mesh-ancestor
56244293|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
56244294|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244295|NCT01812369|Gemcitabine|gemcitabine|mesh-list
56244296|NCT01812369|Doxorubicin|doxorubicin|mesh-list
56244297|NCT01812369|Vinblastine|vinblastine|mesh-list
56244298|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56244299|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
56244300|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244301|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244302|NCT01812369|Antiviral Agents|antiviral agents|mesh-ancestor
56244303|NCT01812369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244304|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244305|NCT01812369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184654|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184655|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55891155|NCT02983383|Anesthetics|anesthetics|mesh-list
56244306|NCT01812369|Immunologic Factors|immunologic factors|mesh-ancestor
56244307|NCT01812369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244308|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56244309|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56244313|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
56244330|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244331|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244332|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244333|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244334|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56244335|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244336|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244337|NCT01812551|Alendronate|alendronate|mesh-list
56244338|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56244339|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244340|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
56244341|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56680723|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
56680724|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56680725|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680726|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56680727|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56680728|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56680729|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56680730|NCT02635607|Ganirelix|ganirelix|mesh-list
56680731|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
56244342|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56244343|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
56244344|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244345|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244346|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244347|NCT01812720|Dexamethasone|dexamethasone|mesh-list
56244348|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244349|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
56244350|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
56244351|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244352|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244353|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244354|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
56244355|NCT01812720|Hormones|hormones|mesh-ancestor
56244356|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244357|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56244358|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244359|NCT01812889|TOL-463|tol-463|mesh-list
56244360|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244361|NCT01812928|Diclofenac|diclofenac|mesh-list
56244362|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56244363|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56244364|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56244365|NCT01812928|Analgesics|analgesics|mesh-ancestor
56244366|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
56244367|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244368|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244369|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244370|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56244397|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244398|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56244399|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244400|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244401|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56244402|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56244403|NCT01812954|Analgesics|analgesics|mesh-ancestor
56244404|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
56244405|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244406|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
56244407|NCT01812967|Caseins|caseins|mesh-list
56244408|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
56244409|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
56244410|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244411|NCT01813162|Tenofovir|tenofovir|mesh-list
56244412|NCT01813162|Metronidazole|metronidazole|mesh-list
56244413|NCT01813162|Terconazole|terconazole|mesh-list
56244414|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
56184656|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56244415|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
56244416|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244417|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56244418|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56244419|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244420|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244433|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56244434|NCT01813201|Androgens|androgens|mesh-ancestor
56244435|NCT01813201|Hormones|hormones|mesh-ancestor
56269008|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56680732|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56680733|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
56680734|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56680735|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680736|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56680737|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56680738|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680739|NCT02635607|Hormones|hormones|mesh-ancestor
56680740|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56680741|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
56680742|NCT00660257|Vaccines|vaccines|mesh-list
56680743|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
56680744|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680745|NCT00844428|Eculizumab|eculizumab|mesh-list
56680746|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56680747|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680748|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
56680749|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680750|NCT00660335|Secretin|secretin|mesh-list
56244436|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244437|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244438|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56244439|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244440|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
56244441|NCT01813240|Minocycline|minocycline|mesh-list
56244442|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56244443|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244444|NCT01813253|Irinotecan|irinotecan|mesh-list
56244445|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
56244446|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56244447|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56244448|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244449|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244450|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244451|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56244452|NCT01813318|Acamprosate|acamprosate|mesh-list
56244453|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56244454|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
56244455|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56244456|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244457|NCT01813461|Isavuconazole|isavuconazole|mesh-list
56244458|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
56244459|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244460|NCT01813487|Entecavir|entecavir|mesh-list
56244461|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
56244462|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244463|NCT01813513|Simeprevir|simeprevir|mesh-list
56244464|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
56244465|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244466|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
56244467|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244468|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244469|NCT01813552|Ritonavir|ritonavir|mesh-list
56244470|NCT01813552|Omeprazole|omeprazole|mesh-list
56244471|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56244472|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56680751|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56680752|NCT00660335|Hormones|hormones|mesh-ancestor
56680753|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56680754|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680755|NCT00707772|Ribavirin|ribavirin|mesh-list
56244473|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
56244474|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244475|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244476|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56244477|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56244478|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
56244479|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244480|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56244481|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56244482|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56244483|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244484|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56244485|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
56244486|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56244487|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
56244488|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244509|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56244510|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
56244511|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56244512|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56244513|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
56244514|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244515|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
56244516|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244517|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56184657|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56184658|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56184659|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56184660|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56184661|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
56184662|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56184663|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56184664|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56184665|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
56184666|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184667|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184668|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56184670|NCT01426971|Caffeine|caffeine|mesh-list
56184671|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56184672|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56244518|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
56244519|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244520|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56244521|NCT01813643|Risperidone|risperidone|mesh-list
56244522|NCT01813643|Aripiprazole|aripiprazole|mesh-list
56244523|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56244524|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
56244525|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244526|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244527|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244528|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56244529|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56244530|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244531|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56244532|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56244533|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
56244534|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
56244535|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
56244536|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56244537|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56244538|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56101420|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
56327049|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
56327050|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56327056|NCT05220046|Psilocybin|psilocybin|mesh-list
56680756|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56680758|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
56680759|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680760|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
56680761|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244539|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56244541|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
56244542|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56244565|NCT01813812|Rebamipide|rebamipide|mesh-list
56244566|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56244567|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244568|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
56244569|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244570|NCT01813812|Protective Agents|protective agents|mesh-ancestor
56244571|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244572|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244573|NCT01813955|Papaverine|papaverine|mesh-list
56244574|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56244575|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244576|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244577|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
56244578|NCT01813955|Urological Agents|urological agents|mesh-ancestor
56244579|NCT01813981|Caffeine|caffeine|mesh-list
56244580|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56184674|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
56184675|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184676|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184677|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184678|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184679|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56184680|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184681|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184682|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56184683|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56184684|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56184685|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56184686|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
56184687|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184688|NCT01426984|Methylphenidate|methylphenidate|mesh-list
56184689|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56184690|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184691|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56184692|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56184693|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56184694|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184695|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
56184696|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244581|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244582|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56244583|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244584|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244585|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56244586|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56244587|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
56244588|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244589|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56244590|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56244591|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56244592|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
56244625|NCT01814098|Antidepressive Agents|antidepressive agents|mesh-ancestor
56244626|NCT01814098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56244628|NCT01814163|Bevacizumab|bevacizumab|mesh-list
56680762|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
56680763|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680764|NCT00834834|Fluoxetine|fluoxetine|mesh-list
56680765|NCT00834834|Citalopram|citalopram|mesh-list
56680766|NCT00834834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56680767|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56680768|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680769|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680770|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244629|NCT01814163|Carboplatin|carboplatin|mesh-list
56244630|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56244631|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819919|NCT02079519|Bevacizumab|bevacizumab|mesh-list
56244700|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244701|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244702|NCT01814423|Filaricides|filaricides|mesh-ancestor
56244703|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
56184697|NCT01427114|Prednisolone|prednisolone|mesh-list
56184698|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
56184699|NCT01427114|Rituximab|rituximab|mesh-list
56184700|NCT01427114|Vincristine|vincristine|mesh-list
56184701|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184702|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
56184703|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184704|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184705|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56184706|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
56184707|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184708|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184709|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56184710|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184711|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56184712|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
56184713|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
56244704|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
56244705|NCT01814449|Letrozole|letrozole|mesh-list
56244706|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244707|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56244708|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56244709|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244710|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244711|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56244712|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
56244713|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244733|NCT01814501|Fluorouracil|fluorouracil|mesh-list
56244734|NCT01814501|Irinotecan|irinotecan|mesh-list
56244735|NCT01814501|Panitumumab|panitumumab|mesh-list
56244736|NCT01814501|Calcium|calcium|mesh-list
56244737|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
56244738|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56244739|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244740|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
56244741|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244742|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56244743|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244744|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244745|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
56244746|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56244747|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56244748|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244749|NCT01814501|Antidotes|antidotes|mesh-ancestor
56244750|NCT01814501|Protective Agents|protective agents|mesh-ancestor
56244751|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
56244752|NCT01814501|Vitamins|vitamins|mesh-ancestor
56244753|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
56244754|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56244755|NCT01814514|Timolol|timolol|mesh-list
56680771|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
56680772|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680773|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56680774|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
56680775|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56680776|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56680777|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56680778|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680779|NCT00834366|Tramadol|tramadol|mesh-list
56680780|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56680781|NCT00834366|Narcotics|narcotics|mesh-ancestor
56680782|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680783|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680784|NCT00834366|Analgesics|analgesics|mesh-ancestor
56680785|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
56680786|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680787|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
56244756|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56244757|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56244758|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
56244760|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244761|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244762|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56244763|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56244764|NCT01814618|Budesonide|budesonide|mesh-list
56184714|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
56184715|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184716|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
56184717|NCT01427114|Hormones|hormones|mesh-ancestor
56184718|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184719|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56184720|NCT01427127|Ramosetron|ramosetron|mesh-list
56184721|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
56184722|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
56184723|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184724|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184725|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244765|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244766|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56244767|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
56244768|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244769|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244770|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56244771|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
56244795|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56244797|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56244798|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56244799|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56244800|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56244801|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56244802|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56244803|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56244804|NCT01814826|Azacitidine|azacitidine|mesh-list
56244805|NCT01814826|Pevonedistat|pevonedistat|mesh-list
56244806|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56244807|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
56680788|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56680789|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680790|NCT00660647|Adalimumab|adalimumab|mesh-list
56680791|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56680792|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680793|NCT04156451|Furosemide|furosemide|mesh-list
56680794|NCT04156451|Diuretics|diuretics|mesh-ancestor
56680795|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
56680796|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680797|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56680798|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56244808|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244809|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244810|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244811|NCT01814865|Prednisone|prednisone|mesh-list
56244812|NCT01814865|Anastrozole|anastrozole|mesh-list
56244813|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
56244814|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56244815|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244816|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
56244817|NCT01814865|Hormones|hormones|mesh-ancestor
56244818|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244819|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820081|NCT04575922|Nivolumab|nivolumab|mesh-list
56244834|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
56244835|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56244836|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244838|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
56244839|NCT01815021|Calcium|calcium|mesh-list
56244840|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56244841|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244842|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56244843|NCT01815021|Antacids|antacids|mesh-ancestor
56244844|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244845|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244846|NCT01815047|Vitamin D|vitamin d|mesh-list
56244847|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
56244848|NCT01815047|Vitamins|vitamins|mesh-ancestor
56244849|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
56244850|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244851|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56244852|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56244853|NCT01815073|Vaccines|vaccines|mesh-list
56184727|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
56184728|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184729|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184730|NCT01427192|Acetazolamide|acetazolamide|mesh-list
56184731|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
56184732|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56184733|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184734|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184735|NCT01427192|Diuretics|diuretics|mesh-ancestor
56184736|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
56184737|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184738|NCT01427205|Cetuximab|cetuximab|mesh-list
56184739|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184740|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184741|NCT01427244|Trastuzumab|trastuzumab|mesh-list
56184742|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184743|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184744|NCT01427270|Oxycodone|oxycodone|mesh-list
56184745|NCT01427270|Naloxone|naloxone|mesh-list
56184746|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56184747|NCT01427270|Narcotics|narcotics|mesh-ancestor
56184748|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680799|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680800|NCT00660725|Gemcitabine|gemcitabine|mesh-list
56680801|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
56680802|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56184749|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184750|NCT01427270|Analgesics|analgesics|mesh-ancestor
56184751|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
56184752|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184753|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56184754|NCT01427283|Oxycodone|oxycodone|mesh-list
56184755|NCT01427283|Naloxone|naloxone|mesh-list
56184756|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56184757|NCT01427283|Narcotics|narcotics|mesh-ancestor
56184758|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184759|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184760|NCT01427283|Analgesics|analgesics|mesh-ancestor
56184761|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
56184762|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184763|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56184765|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184766|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56184767|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184768|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184769|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
56184770|NCT01427335|Calcium|calcium|mesh-list
56184771|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56184772|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184773|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56184774|NCT01427387|Linaclotide|linaclotide|mesh-list
56184775|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55891563|NCT02712801|Lopinavir|lopinavir|mesh-list
55891564|NCT02712801|Lamivudine|lamivudine|mesh-list
55891565|NCT02712801|Zidovudine|zidovudine|mesh-list
55891566|NCT02712801|Nevirapine|nevirapine|mesh-list
55891567|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55891568|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55891569|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
56244854|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
56244855|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244856|NCT01815125|Ondansetron|ondansetron|mesh-list
56244857|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
56244858|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
56244859|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244860|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244861|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244862|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
56244863|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
56244864|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56244865|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
56244866|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244867|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244868|NCT01815125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56244869|NCT01815125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56244870|NCT01815125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244871|NCT01815125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56244872|NCT01815125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56244873|NCT01815203|Caffeine|caffeine|mesh-list
56244874|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56244875|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244876|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56244877|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244878|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244879|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56244903|NCT01815307|Gemcitabine|gemcitabine|mesh-list
56244905|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
56244906|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244907|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244908|NCT01815307|Antiviral Agents|antiviral agents|mesh-ancestor
56244909|NCT01815307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244910|NCT01815307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244911|NCT01815307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244912|NCT01815307|Immunologic Factors|immunologic factors|mesh-ancestor
56680803|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
56680804|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680805|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680806|NCT00660725|Antiviral Agents|antiviral agents|mesh-ancestor
56244913|NCT01815307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244914|NCT01815437|Vitamin D|vitamin d|mesh-list
56244915|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
56244916|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
56244917|NCT01815437|Vitamins|vitamins|mesh-list
56184776|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
56184777|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184778|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184779|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
56184780|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56184781|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56184782|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56184783|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56184784|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184785|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
56184786|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184787|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184788|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56184789|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184791|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184792|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56184793|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184794|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184795|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56184796|NCT01427491|Laxatives|laxatives|mesh-ancestor
56184797|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184798|NCT01427582|Trabectedin|trabectedin|mesh-list
56184799|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56184800|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
56184801|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891638|NCT02143401|Sorafenib|sorafenib|mesh-list
56244918|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
56244919|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244920|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56244921|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56244922|NCT01815528|Catumaxomab|catumaxomab|mesh-list
56244923|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244924|NCT01815541|Teicoplanin|teicoplanin|mesh-list
56244925|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56244926|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244927|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
56244928|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56244929|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244951|NCT01816035|Trastuzumab|trastuzumab|mesh-list
56244952|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56244953|NCT01816035|Maytansine|maytansine|mesh-list
56244954|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
56244955|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56244956|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244957|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56184802|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184804|NCT01427686|Dopamine|dopamine|mesh-list
56184805|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56184806|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
56184807|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
56184808|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184809|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184810|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56184811|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56184812|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56184813|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
56184814|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184815|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184816|NCT01427686|Protective Agents|protective agents|mesh-ancestor
56184817|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
56184819|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
56101424|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680807|NCT00660725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680808|NCT00660725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680809|NCT00660725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56680810|NCT00660725|Immunologic Factors|immunologic factors|mesh-ancestor
56680811|NCT00660725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680812|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56236731|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184820|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184821|NCT01427842|Vancomycin|vancomycin|mesh-list
56184822|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56184823|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56184824|NCT01427868|Maleic acid|maleic acid|mesh-list
56184825|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184826|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184827|NCT01427946|Everolimus|everolimus|mesh-list
56112587|NCT01222871|Hormones|hormones|mesh-ancestor
56184828|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184829|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184830|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
56184831|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184832|NCT01427985|Atropine|atropine|mesh-list
56184833|NCT01427985|Fentanyl|fentanyl|mesh-list
56184834|NCT01427985|Mivacurium|mivacurium|mesh-list
56184835|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56184836|NCT01427985|Narcotics|narcotics|mesh-ancestor
56184845|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
56184846|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56184847|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56184848|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
56184849|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56184850|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
56184851|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
56184852|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
56184853|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56184854|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56184855|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
56184856|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56184857|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184858|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56184859|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56184860|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56184861|NCT01428037|Misoprostol|misoprostol|mesh-list
56184862|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56184863|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
56184864|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56184865|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184866|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56184867|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184868|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
56184869|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56184870|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
56184871|NCT01428154|Hematinics|hematinics|mesh-ancestor
56184872|NCT01428180|Ibuprofen|ibuprofen|mesh-list
56184873|NCT01428180|Indomethacin|indomethacin|mesh-list
56184874|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56184875|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56184876|NCT01428180|Analgesics|analgesics|mesh-ancestor
56184877|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
56184878|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184879|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184880|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184881|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184882|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56184883|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184884|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184885|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
56184886|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
56184887|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56184888|NCT01428284|Canagliflozin|canagliflozin|mesh-list
56184889|NCT01428284|Probenecid|probenecid|mesh-list
56680813|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56680814|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56680815|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680816|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236741|NCT01751763|Sorafenib|sorafenib|mesh-list
56184890|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56184891|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184892|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56184893|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184894|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
56184895|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
56184896|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56184897|NCT01428284|Renal Agents|renal agents|mesh-ancestor
56184898|NCT01428375|Acetaminophen|acetaminophen|mesh-list
56184899|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56184900|NCT01428375|Analgesics|analgesics|mesh-ancestor
56184901|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
55800894|NCT02609659|Ribavirin|ribavirin|mesh-list
56184907|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184908|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184909|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56184910|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56184911|NCT01428388|Growth Substances|growth substances|mesh-ancestor
56184912|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184913|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
56184914|NCT01428414|Paclitaxel|paclitaxel|mesh-list
56184915|NCT01428414|Carboplatin|carboplatin|mesh-list
56244958|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
56244959|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
56244960|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
56244961|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244962|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
56244963|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244964|NCT01816191|Diltiazem|diltiazem|mesh-list
56244965|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56244966|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56244967|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56184916|NCT01428414|Trastuzumab|trastuzumab|mesh-list
56184917|NCT01428414|Epirubicin|epirubicin|mesh-list
56184918|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56184919|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244968|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244969|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56244970|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244971|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
56244972|NCT01816321|Ganirelix|ganirelix|mesh-list
56244973|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
56244974|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244975|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244976|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
56244977|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56244978|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56244979|NCT01816334|Prednisolone|prednisolone|mesh-list
56244980|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
56244981|NCT01816334|Ketoprofen|ketoprofen|mesh-list
56245008|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
56245009|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
56245010|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
56245011|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245012|NCT01816490|Silybin|silybin|mesh-list
56245013|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56245014|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245015|NCT01816490|Protective Agents|protective agents|mesh-ancestor
56245016|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245017|NCT01816529|Diltiazem|diltiazem|mesh-list
56245018|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245019|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56245020|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680817|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245021|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245022|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245023|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245024|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245025|NCT01816555|Vitamin D|vitamin d|mesh-list
56245026|NCT01816555|Vitamins|vitamins|mesh-ancestor
56245027|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
56245028|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245057|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
56245058|NCT01816646|Cidofovir|cidofovir|mesh-list
56245059|NCT01816646|Probenecid|probenecid|mesh-list
56245060|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
56245061|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
56245062|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56245063|NCT01816646|Renal Agents|renal agents|mesh-ancestor
56245064|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
56245065|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245070|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245071|NCT01816789|Buserelin|buserelin|mesh-list
56245072|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56245073|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
56245074|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56245075|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245076|NCT01816958|Ketamine|ketamine|mesh-list
56245077|NCT01816958|Analgesics|analgesics|mesh-ancestor
56245078|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
56245107|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56245108|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56245109|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56245110|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56245111|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
56245112|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56245113|NCT01817257|Heparin|heparin|mesh-list
56245114|NCT01817257|Enoxaparin|enoxaparin|mesh-list
56245115|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56245116|NCT01817257|Tinzaparin|tinzaparin|mesh-list
56245117|NCT01817257|Dalteparin|dalteparin|mesh-list
56245118|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
56245119|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56184920|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
56184921|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
56184922|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
56184923|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184924|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56184925|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56184926|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56184927|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56184928|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184929|NCT01428427|Gemcitabine|gemcitabine|mesh-list
56184930|NCT01428427|Trametinib|trametinib|mesh-list
56184931|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56184932|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
55891858|NCT02293096|Metoprolol|metoprolol|mesh-list
55891859|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
55891860|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55891861|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55891862|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
56245120|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56245121|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245122|NCT01817283|Triptolide|triptolide|mesh-list
56245123|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56245124|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245156|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245157|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245158|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245159|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56245160|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
56245161|NCT01817348|Lidocaine|lidocaine|mesh-list
56245162|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
56245163|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
56245164|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245165|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245166|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
56245167|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245193|NCT01817439|Amiodarone|amiodarone|mesh-list
56245194|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56680818|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680819|NCT00844194|Analgesics|analgesics|mesh-ancestor
56680820|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
56680821|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680822|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
56680823|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56680824|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
56680825|NCT00660803|Fulvestrant|fulvestrant|mesh-list
56680826|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56680827|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680828|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56245195|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245196|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56245197|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245198|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245199|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56245200|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56245201|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56245202|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245203|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56245205|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56245206|NCT01817699|Vitamin D|vitamin d|mesh-list
56245207|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
56245208|NCT01817699|Vitamins|vitamins|mesh-ancestor
56245209|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
56245210|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245211|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56245212|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245213|NCT01817803|Metolazone|metolazone|mesh-list
56184933|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184934|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184935|NCT01428427|Antiviral Agents|antiviral agents|mesh-ancestor
56184936|NCT01428427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56184937|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184938|NCT01428427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56184939|NCT01428427|Immunologic Factors|immunologic factors|mesh-ancestor
56184940|NCT01428427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184941|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56184942|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56184943|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
56184944|NCT01428492|Dexamethasone|dexamethasone|mesh-list
56184945|NCT01428492|Bortezomib|bortezomib|mesh-list
56245214|NCT01817803|Furosemide|furosemide|mesh-list
56245242|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245243|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245244|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
56245245|NCT01817868|Factor VIII|factor viii|mesh-list
56245246|NCT01817868|Coagulants|coagulants|mesh-ancestor
56245247|NCT01817894|Eflornithine|eflornithine|mesh-list
56245248|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245249|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56245250|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56245251|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56245252|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245253|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56245254|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245255|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245256|NCT01817972|Azathioprine|azathioprine|mesh-list
55820525|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
56245281|NCT01818648|Incretins|incretins|mesh-ancestor
56245283|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245284|NCT01818713|Doxorubicin|doxorubicin|mesh-list
56245285|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56245286|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56245287|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56680829|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56680830|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
56680831|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56680832|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680833|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56680834|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
56236754|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
56245288|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56245289|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56245290|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245291|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245292|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
56245293|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
56245294|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245295|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
56245296|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245297|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245298|NCT01818856|Ritonavir|ritonavir|mesh-list
56245299|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56245300|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56245301|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56245302|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
56245303|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820577|NCT02357459|FX006|fx006|mesh-list
56245325|NCT01818908|Doxorubicin|doxorubicin|mesh-list
56245326|NCT01818908|Etoposide|etoposide|mesh-list
56245327|NCT01818908|Vincristine|vincristine|mesh-list
56245328|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56245329|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
56245330|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245331|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56245332|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56245333|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
56245334|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245335|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184946|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184947|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
56184948|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
56184949|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184950|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184951|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56184952|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
56245336|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56245337|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56245338|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56245339|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56245340|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245341|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56245342|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
56245343|NCT01818908|Hormones|hormones|mesh-ancestor
56245344|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245345|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56245346|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56245347|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
56245348|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
56245349|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
56245350|NCT01818973|Bevacizumab|bevacizumab|mesh-list
56245351|NCT01818973|Capecitabine|capecitabine|mesh-list
56245352|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
56245353|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56245354|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245355|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55820618|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56245425|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245426|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245427|NCT01819402|Pioglitazone|pioglitazone|mesh-list
56245428|NCT01819402|Glimepiride|glimepiride|mesh-list
56245429|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56680835|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56680836|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56680837|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680838|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680839|NCT00661115|Urological Agents|urological agents|mesh-ancestor
56680840|NCT04157699|Tenofovir|tenofovir|mesh-list
56680841|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
56680842|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680843|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56680844|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56680845|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680846|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680847|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56680848|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56680849|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
56680850|NCT00665717|Pravastatin|pravastatin|mesh-list
56245430|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245431|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56245432|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56245433|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
56245434|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56245435|NCT01819441|Perindopril|perindopril|mesh-list
56245436|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245437|NCT01819441|Diuretics|diuretics|mesh-ancestor
56245438|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
56245439|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820708|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56245460|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245462|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245463|NCT01819649|Trace Elements|trace elements|mesh-ancestor
56245464|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
56245465|NCT01819701|Ubiquinone|ubiquinone|mesh-list
56245466|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
56245467|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
56245468|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245469|NCT01819701|Vitamins|vitamins|mesh-ancestor
56245470|NCT01819779|Amlodipine|amlodipine|mesh-list
56245471|NCT01819779|Valsartan|valsartan|mesh-list
56245472|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56245473|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245474|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56245475|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245476|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245477|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245478|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245479|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245480|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56245481|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56245482|NCT01819857|Ondansetron|ondansetron|mesh-list
56245483|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
56245484|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
56184954|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56184955|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56184956|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56184957|NCT01428518|Lamotrigine|lamotrigine|mesh-list
56184958|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
56184959|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56184960|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680851|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56680852|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56680853|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
56680854|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56184961|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184962|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56184963|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184964|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56184965|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56184966|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56184967|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56184968|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56184970|NCT01428531|Fondaparinux|fondaparinux|mesh-list
56184971|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56184972|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
56184973|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56184974|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
56184975|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184976|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184977|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
56245485|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245486|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245487|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56245488|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
56245489|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
56245490|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56245491|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
56245527|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245528|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56245529|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245530|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245563|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
56245564|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
56245565|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245567|NCT01820325|Carboplatin|carboplatin|mesh-list
56245568|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56245569|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245570|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
56245571|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
56245572|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
56245573|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245606|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245607|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
56245608|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56184978|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56184979|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56184980|NCT01428544|PENTA|penta|mesh-list
56184981|NCT01428544|Fondaparinux|fondaparinux|mesh-list
55892107|NCT05072704|Sufentanil|sufentanil|mesh-list
56245609|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245610|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245611|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245612|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
56245613|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
56245614|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
56245615|NCT01820767|Atorvastatin|atorvastatin|mesh-list
56245616|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55820888|NCT02006667|Trastuzumab|trastuzumab|mesh-list
56245639|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245640|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245641|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56245642|NCT01820858|Paclitaxel|paclitaxel|mesh-list
56245644|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56245645|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245646|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
56245647|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
56245648|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
56245649|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245650|NCT01820897|Trimethoprim|trimethoprim|mesh-list
56245651|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56680855|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56680856|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56680857|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680858|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245652|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
56245653|NCT01820897|Fosfomycin|fosfomycin|mesh-list
56245654|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56245655|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245656|NCT01820897|Renal Agents|renal agents|mesh-ancestor
56245657|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
56245658|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56245659|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56245660|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56245661|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245662|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245663|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56245664|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56245665|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56245666|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56245667|NCT01820962|Heparin|heparin|mesh-list
56245668|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
55820932|NCT01982331|Vaccines|vaccines|mesh-list
56245697|NCT01821040|Hormones|hormones|mesh-ancestor
56245698|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245699|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245700|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56245701|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245702|NCT01821066|Tamoxifen|tamoxifen|mesh-list
56245703|NCT01821066|Palbociclib|palbociclib|mesh-list
56245704|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56245705|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
56245706|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245707|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245708|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56245709|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245710|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55820985|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245729|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245730|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
56245731|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56245732|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56245733|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245734|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56245735|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56245736|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56245737|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245738|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245739|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
56245740|NCT01821248|Gemcitabine|gemcitabine|mesh-list
56184982|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56184983|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
56184984|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55892183|NCT01949337|Prednisone|prednisone|mesh-list
56245741|NCT01821248|Cisplatin|cisplatin|mesh-list
56245742|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245743|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56245744|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
56245745|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245746|NCT01821248|Antiviral Agents|antiviral agents|mesh-ancestor
56245747|NCT01821248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245748|NCT01821248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245749|NCT01821248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56245750|NCT01821248|Immunologic Factors|immunologic factors|mesh-ancestor
56245751|NCT01821248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245752|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
56245753|NCT01821261|Fluorides|fluorides|mesh-list
56245754|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
56245755|NCT01821261|Protective Agents|protective agents|mesh-ancestor
56245756|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245757|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56245758|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680859|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56680860|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56680861|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
56680862|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56245759|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
56245760|NCT01821274|Diltiazem|diltiazem|mesh-list
56245761|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245762|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56245763|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245764|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245779|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245780|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245782|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56245783|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245784|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245785|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245786|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56245787|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56245788|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245789|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56245791|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
56245792|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
56245793|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56245794|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56245795|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56245796|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245797|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245798|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
56245799|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245800|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245801|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56245802|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245803|NCT01821612|Leucovorin|leucovorin|mesh-list
56245804|NCT01821612|Gemcitabine|gemcitabine|mesh-list
56245805|NCT01821612|Fluorouracil|fluorouracil|mesh-list
56245806|NCT01821612|Capecitabine|capecitabine|mesh-list
56245807|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
56245808|NCT01821612|Irinotecan|irinotecan|mesh-list
56245809|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56245810|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
56245811|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245812|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245813|NCT01821612|Antiviral Agents|antiviral agents|mesh-ancestor
56245814|NCT01821612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245815|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245816|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56245817|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
56245818|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245819|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56245820|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56245821|NCT01821612|Antidotes|antidotes|mesh-ancestor
56245822|NCT01821612|Protective Agents|protective agents|mesh-ancestor
56245823|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
56245824|NCT01821612|Vitamins|vitamins|mesh-ancestor
56184985|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
56184986|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56184987|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184988|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
56184989|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56184990|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56184991|NCT01428622|Olodaterol|olodaterol|mesh-list
56184992|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56184993|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
56184994|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184995|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184996|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56184997|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
56184998|NCT01428817|Carbetocin|carbetocin|mesh-list
56184999|NCT01428817|Oxytocin|oxytocin|mesh-list
56245852|NCT01821989|Lactoferrin|lactoferrin|mesh-list
56245853|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245854|NCT01822028|Miglustat|miglustat|mesh-list
56680863|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56680864|NCT02611596|Ranolazine|ranolazine|mesh-list
56680865|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56245855|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
56245856|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245857|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245858|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56245859|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56245860|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
56245861|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245862|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56245863|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56245864|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245865|NCT01822080|Dienogest|dienogest|mesh-list
56245866|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56245867|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
56245868|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56245869|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245870|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56245871|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56245872|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56245886|NCT01822405|Vitamin E|vitamin e|mesh-list
56245887|NCT01822405|Tocotrienols|tocotrienols|mesh-list
56245888|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
56245889|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
56245890|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56245891|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245893|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56245894|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56245896|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245897|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245898|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56245899|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
56245900|NCT01822405|Vitamins|vitamins|mesh-ancestor
56245901|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
56245902|NCT01822418|S 20098|s 20098|mesh-list
56245903|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56245904|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245905|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245906|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56245907|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245908|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245909|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245910|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56245911|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
56185000|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
56185001|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56185002|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185003|NCT01428908|Vaccines|vaccines|mesh-list
56185004|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
56245912|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56245913|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245914|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56245915|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
56245916|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56245917|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245918|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245919|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245920|NCT01822509|Nivolumab|nivolumab|mesh-list
56245921|NCT01822509|Ipilimumab|ipilimumab|mesh-list
56245922|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56245923|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245924|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56245925|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245926|NCT01822600|Omeprazole|omeprazole|mesh-list
56245927|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56245928|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56245929|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56245930|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245931|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245965|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56245966|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680866|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56680867|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680868|NCT00661349|Ritonavir|ritonavir|mesh-list
56680869|NCT00661349|Lopinavir|lopinavir|mesh-list
56680870|NCT00661349|Nevirapine|nevirapine|mesh-list
56680871|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56236783|NCT01752153|Deferoxamine|deferoxamine|mesh-list
56245967|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56245968|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56245998|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
56245999|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246000|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246002|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56246003|NCT01822951|Protective Agents|protective agents|mesh-ancestor
56246004|NCT01822977|Omeprazole|omeprazole|mesh-list
56246005|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56246006|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56246007|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56246008|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246009|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246010|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
56246011|NCT01823029|Hematinics|hematinics|mesh-ancestor
56246012|NCT01823042|Azathioprine|azathioprine|mesh-list
56246013|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
55821297|NCT04836637|Calcium|calcium|mesh-list
56246046|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
56246047|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246048|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246050|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246051|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246078|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246079|NCT01823744|Micronutrients|micronutrients|mesh-list
56246080|NCT01823744|Trace Elements|trace elements|mesh-list
56246087|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246088|NCT01823809|Adenosine|adenosine|mesh-list
56246089|NCT01823809|Analgesics|analgesics|mesh-ancestor
56246090|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
56246091|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246092|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246093|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56246094|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
56246095|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56246096|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
56246097|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
56246098|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185005|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185006|NCT01428986|Maraviroc|maraviroc|mesh-list
56185007|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56185008|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56185009|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185010|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56185011|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56185012|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
56185013|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185014|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56185015|NCT01429025|Rituximab|rituximab|mesh-list
56185016|NCT01429025|Lenalidomide|lenalidomide|mesh-list
56185017|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56185018|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56185019|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185020|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
56185021|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185022|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185023|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56185024|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56185025|NCT01429025|Growth Substances|growth substances|mesh-ancestor
56246099|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246100|NCT01823848|Mineral Oil|mineral oil|mesh-list
56246101|NCT01823848|Emollients|emollients|mesh-ancestor
56246128|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56680872|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56680873|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
56680874|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680875|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680876|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56246129|NCT01824225|Growth Substances|growth substances|mesh-ancestor
56246130|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246131|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
56246132|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246133|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
56246134|NCT01824238|Anacetrapib|anacetrapib|mesh-list
56246135|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56246136|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56246137|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
56246138|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246139|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56246140|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246141|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56246142|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246143|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
56246144|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56246145|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
56246146|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56246147|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
56246148|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246149|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56246150|NCT01824264|Licogliflozin|licogliflozin|mesh-list
56246180|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56246181|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246182|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246183|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246186|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56185026|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
56185027|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56185028|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
56185029|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185030|NCT01429090|Methantheline|methantheline|mesh-list
56185031|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56185032|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56185033|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
56185034|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185035|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185036|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185037|NCT01429129|Nicotine|nicotine|mesh-list
56185038|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56185039|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
56185040|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185041|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185042|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55892447|NCT01989910|Efavirenz|efavirenz|mesh-list
56246187|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
56246188|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56246189|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56246190|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56246191|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246192|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56246210|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56246211|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246212|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246213|NCT01824758|Lidocaine|lidocaine|mesh-list
56246214|NCT01824758|Rocuronium|rocuronium|mesh-list
56246215|NCT01824758|Esmolol|esmolol|mesh-list
56246216|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
56246217|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
56246218|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246219|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246220|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
56246221|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680877|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56680878|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
56680879|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680880|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56680881|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56680882|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56680883|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56680884|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56680885|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56680886|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56680887|NCT00665873|Amoxicillin|amoxicillin|mesh-list
56680888|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
56680889|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
56680890|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56680891|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680892|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
56680893|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680894|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680895|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56680896|NCT00707850|Ribavirin|ribavirin|mesh-list
56680897|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56680898|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
56680899|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
56680900|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680901|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
56680902|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680903|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
56680904|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680905|NCT00665951|Ritonavir|ritonavir|mesh-list
56680906|NCT00665951|Lopinavir|lopinavir|mesh-list
56680907|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56680908|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56680909|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
56680910|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680911|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680912|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56246222|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56246223|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56680913|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56680914|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
56680915|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56680916|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56680917|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56246224|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56246225|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246226|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246227|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56246228|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56246229|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56246230|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56246231|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56246232|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56246233|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56246234|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246235|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
56246236|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56246237|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56246238|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56246239|NCT01824992|Interferons|interferons|mesh-list
56185043|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56185044|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
56185045|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246240|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246241|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
56246242|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246243|NCT01825031|Azithromycin|azithromycin|mesh-list
56246244|NCT01825031|Isoniazid|isoniazid|mesh-list
56246245|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
56246246|NCT01825031|Fluconazole|fluconazole|mesh-list
56246247|NCT01825031|Albendazole|albendazole|mesh-list
56246248|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56246249|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246250|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56246251|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56246281|NCT01825044|Cyclosporins|cyclosporins|mesh-list
56246282|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246283|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246284|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56246285|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
56246286|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246287|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
56246288|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246289|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
56246290|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56246291|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56246293|NCT01825083|Analgesics|analgesics|mesh-ancestor
56246294|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
56246295|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246365|NCT01825603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246366|NCT01825603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246367|NCT01825603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56246368|NCT01825603|Immunologic Factors|immunologic factors|mesh-ancestor
56246369|NCT01825603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246370|NCT01825616|Vitamin D|vitamin d|mesh-list
56246371|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
56246372|NCT01825616|Vitamins|vitamins|mesh-ancestor
56246373|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
56246374|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246375|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55821671|NCT05309629|Carboplatin|carboplatin|mesh-list
56246442|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56246443|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56246444|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56246445|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
56246446|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246447|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246448|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246449|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56680918|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56680919|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56680920|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
56680921|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680922|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246450|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
56246451|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
56246452|NCT01826279|Resveratrol|resveratrol|mesh-list
56246453|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
56246454|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246484|NCT01826916|Analgesics|analgesics|mesh-ancestor
56246485|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
56246486|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246487|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246488|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56246489|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56246490|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56246491|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56246492|NCT01827007|Polygeline|polygeline|mesh-list
56246493|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
56246494|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
56246495|NCT01827020|Lidocaine|lidocaine|mesh-list
56246496|NCT01827020|Ketamine|ketamine|mesh-list
56246497|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
56246498|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
56246499|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246500|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246501|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
56246529|NCT01827137|Sargramostim|sargramostim|mesh-list
56246530|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
56185046|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185047|NCT01429181|Methadone|methadone|mesh-list
56185048|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56185049|NCT01429181|Narcotics|narcotics|mesh-ancestor
56185050|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185051|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185052|NCT01429181|Analgesics|analgesics|mesh-ancestor
56185053|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
56185054|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185055|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
56112804|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56185056|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
56185057|NCT01429337|Midostaurin|midostaurin|mesh-list
56185058|NCT01429337|Staurosporine|staurosporine|mesh-list
56185059|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185060|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56185061|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185062|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246531|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246532|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56246533|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56246534|NCT01827137|Growth Substances|growth substances|mesh-ancestor
56246535|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
56246536|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246537|NCT01827202|Candesartan|candesartan|mesh-list
56246538|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56246539|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56246540|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56246541|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246542|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
56246543|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
56246544|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246545|NCT01827280|Vildagliptin|vildagliptin|mesh-list
56246546|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56246547|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246549|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
56246550|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246551|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246553|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
56246554|NCT01827293|Lorazepam|lorazepam|mesh-list
56680923|NCT00878969|Valsartan|valsartan|mesh-list
56680924|NCT00878969|Ramipril|ramipril|mesh-list
56680925|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56680926|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56680927|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56246555|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
56246556|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
56246557|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
56246558|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246559|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246560|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56246561|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56246562|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246563|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56246564|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56246565|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56246566|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
56246567|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
56246568|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246569|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246570|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
56246571|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
56185064|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56185065|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56185066|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56185067|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56185075|NCT01429415|Analgesics|analgesics|mesh-ancestor
56185129|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
56185130|NCT01429701|Hormones|hormones|mesh-ancestor
56185131|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185132|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185133|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56185134|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185135|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185136|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56246572|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56246573|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
56246574|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
56246575|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56246576|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56246577|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
56246578|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
56246579|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
56246580|NCT01827345|Vitamin D|vitamin d|mesh-list
56246581|NCT01827345|Vitamins|vitamins|mesh-ancestor
56246582|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
56246583|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246584|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56246585|NCT01827397|Vaccines|vaccines|mesh-list
56246586|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
56246587|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246588|NCT01827540|Dolutegravir|dolutegravir|mesh-list
56246589|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
56246590|NCT01827540|Midazolam|midazolam|mesh-list
56246591|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56246592|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56246593|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246594|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246596|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56246597|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56246598|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56246599|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
56246600|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
56246601|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
56246602|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
56246603|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246604|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246605|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56246606|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56246607|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246608|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56246609|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56680928|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56680929|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680930|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
56246610|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
56246611|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246612|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56246613|NCT01827618|Sirolimus|sirolimus|mesh-list
56246614|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56246615|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246616|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56246617|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246618|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
56246619|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56246620|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
56246621|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246622|NCT01827722|Dexamethasone|dexamethasone|mesh-list
56246623|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
56246645|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246646|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56246647|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56246648|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
56246649|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246650|NCT01827865|Etodolac|etodolac|mesh-list
56246651|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56246652|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56185137|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
56185138|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56185139|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185140|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56185141|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185142|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185143|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
56185145|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185146|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
56185147|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
56185148|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56185149|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56185150|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
56185151|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185152|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185153|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185154|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
56246653|NCT01827865|Analgesics|analgesics|mesh-ancestor
56246654|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
56246655|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246656|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246657|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56246658|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56246659|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56246660|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56246661|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246662|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246663|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56246664|NCT01827878|Lisinopril|lisinopril|mesh-list
56246665|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
56246666|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56246667|NCT01827878|Diuretics|diuretics|mesh-ancestor
56246668|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
56246669|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246670|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56246671|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246672|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246673|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56246674|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
56246675|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821965|NCT01777282|Biguanides|biguanides|mesh-list
56246695|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246697|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246698|NCT01828359|Losartan|losartan|mesh-list
56680931|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680932|NCT00843492|PENTA|penta|mesh-list
56680933|NCT00843492|Nadroparin|nadroparin|mesh-list
56680934|NCT00843492|Fondaparinux|fondaparinux|mesh-list
56680935|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56680936|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
56246699|NCT01828359|Amlodipine|amlodipine|mesh-list
56246700|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56246701|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56246702|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246703|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246704|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56246705|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246706|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
56246707|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56185155|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
56185156|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185157|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
56185158|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56185159|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
56185160|NCT01429818|Metformin|metformin|mesh-list
56185161|NCT01429818|Glimepiride|glimepiride|mesh-list
56185162|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56185163|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185164|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56185165|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56185166|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
56185167|NCT01429831|Aripiprazole|aripiprazole|mesh-list
56185168|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
56185169|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56185170|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56185171|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56185172|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185173|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185174|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
56185175|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
56185176|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185177|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185178|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56246708|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56246709|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56246710|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
56246711|NCT01828385|Analgesics|analgesics|mesh-ancestor
56246712|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
56246713|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246714|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246715|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
56246716|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246717|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56246718|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
56246719|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56246720|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246721|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246722|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56246723|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
56246724|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56246725|NCT01828437|Pyridoxine|pyridoxine|mesh-list
56246726|NCT01828437|Prednisolone|prednisolone|mesh-list
56246727|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56246728|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
56246729|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56246730|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
56246760|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246761|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246763|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
56246764|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185179|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56185180|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
56185181|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56185182|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56680937|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56680938|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
56185183|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56185184|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56185185|NCT01429844|Cyclosporine|cyclosporine|mesh-list
56185186|NCT01429844|Tacrolimus|tacrolimus|mesh-list
56185187|NCT01429844|Cyclosporins|cyclosporins|mesh-list
56185188|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56185189|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
56185190|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185191|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56185192|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185193|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185194|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
56185195|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185196|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
56185197|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185198|NCT01429870|Triamcinolone|triamcinolone|mesh-list
56185199|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185200|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
56185201|NCT01429870|Hormones|hormones|mesh-ancestor
56185202|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185203|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185204|NCT01429935|Ibuprofen|ibuprofen|mesh-list
56185205|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56246765|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56246766|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56246768|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
56246769|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
56246770|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246771|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246772|NCT01828606|Ionophores|ionophores|mesh-ancestor
56246773|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246774|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
56246775|NCT01828736|Gemcitabine|gemcitabine|mesh-list
56246813|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246815|NCT01829178|Docetaxel|docetaxel|mesh-list
56246816|NCT01829178|Fluorouracil|fluorouracil|mesh-list
56246851|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56246852|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56246853|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
56246854|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246855|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246856|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246857|NCT01829685|Entecavir|entecavir|mesh-list
56246858|NCT01829685|Adefovir|adefovir|mesh-list
56246859|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
56112963|NCT02057237|Mitotane|mitotane|mesh-list
56185206|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56185207|NCT01429935|Analgesics|analgesics|mesh-ancestor
56185208|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
56185209|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185210|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185211|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185212|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185213|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56185214|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892868|NCT01999348|Timolol|timolol|mesh-list
56246860|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246861|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56246896|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246897|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246898|NCT01829893|Tamsulosin|tamsulosin|mesh-list
56246899|NCT01829893|Finasteride|finasteride|mesh-list
55822179|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246930|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
56246931|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
56246932|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246933|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56246934|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56246935|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56246936|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246938|NCT01830530|Nifedipine|nifedipine|mesh-list
56246939|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56680939|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680940|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680941|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
56680942|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56680943|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56680944|NCT00666107|Vaccines|vaccines|mesh-list
56246940|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55822220|NCT02217709|Phenelzine|phenelzine|mesh-list
56246970|NCT01832350|Quinidine|quinidine|mesh-list
56246971|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
56246972|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
56246973|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
56246974|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56246975|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56246978|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246979|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56246980|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56246981|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
56246982|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55822263|NCT01707004|Vidarabine|vidarabine|mesh-list
56247013|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247014|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247015|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247016|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
56247017|NCT01834820|Hormones|hormones|mesh-ancestor
56247018|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247019|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56247020|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247021|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56247022|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56247023|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
56247024|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822306|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
56247093|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247119|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247120|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
56247121|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247122|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56247123|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56247124|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56185215|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185216|NCT01430013|Endostar protein|endostar protein|mesh-list
56185217|NCT01430013|Endostatins|endostatins|mesh-list
56247125|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247126|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247127|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56247128|NCT01837446|Narcotics|narcotics|mesh-ancestor
56247129|NCT01837446|Analgesics|analgesics|mesh-ancestor
56247130|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56247131|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56247133|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
56247134|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247135|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56247136|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
56247137|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
56247138|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247139|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56247140|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
56247141|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
56247142|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56247143|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
56247144|NCT01837446|Antacids|antacids|mesh-ancestor
56247145|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56247146|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56247188|NCT01840384|Micronutrients|micronutrients|mesh-list
56247189|NCT01840384|Trace Elements|trace elements|mesh-list
56247190|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247191|NCT01840423|Levodopa|levodopa|mesh-list
56247192|NCT01840423|Carbidopa|carbidopa|mesh-list
56247193|NCT01840423|Entacapone|entacapone|mesh-list
56680945|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
56236853|NCT01752699|Analgesics|analgesics|mesh-ancestor
56247194|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56247195|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56247196|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
56247197|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247198|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247199|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247200|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56247201|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247202|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56247203|NCT01840449|Lanreotide|lanreotide|mesh-list
56247204|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247205|NCT01840683|Heparin|heparin|mesh-list
56247206|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
56247207|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56247208|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56247209|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247211|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56247212|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56247213|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
56247214|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
56247215|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247216|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247217|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247219|NCT01840774|Analgesics|analgesics|mesh-list
56247220|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
56247221|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247222|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247252|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247253|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247254|NCT01841099|Mesalamine|mesalamine|mesh-list
56247255|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56247256|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56247257|NCT01841099|Analgesics|analgesics|mesh-ancestor
56247258|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
56247259|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247260|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247261|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56247262|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56247263|NCT01841112|BI 409306|bi 409306|mesh-list
56247264|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56247265|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185218|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56247266|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247292|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247293|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
56247294|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
56247295|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
56247296|NCT01841294|Lidocaine|lidocaine|mesh-list
56247297|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
56247298|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
56247299|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247300|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247301|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
56247302|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247303|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56247304|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56247305|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56247306|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247307|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247308|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
56247309|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56247310|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
56247311|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822592|NCT00630565|Busulfan|busulfan|mesh-list
56247368|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56247369|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247370|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56247371|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
56247372|NCT01841515|Coagulants|coagulants|mesh-ancestor
56247373|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56680946|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680947|NCT00666185|Fluconazole|fluconazole|mesh-list
56680948|NCT00666185|Micafungin|micafungin|mesh-list
56680949|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
56680950|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236854|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
56247374|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
56247375|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247376|NCT01841658|Folic Acid|folic acid|mesh-list
56247377|NCT01841658|Hematinics|hematinics|mesh-ancestor
56247378|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
56247379|NCT01841658|Vitamins|vitamins|mesh-ancestor
56247380|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
56247381|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247382|NCT01841684|Anacetrapib|anacetrapib|mesh-list
56247383|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56247384|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56247385|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
56247386|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247387|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56247388|NCT01841775|Interferons|interferons|mesh-list
56247389|NCT01841775|Ribavirin|ribavirin|mesh-list
56247390|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247391|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
56247392|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247394|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247395|NCT01841827|Cilostazol|cilostazol|mesh-list
56247396|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56247397|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
56247398|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247399|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247400|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56247401|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
56247402|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56247403|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56247404|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247439|NCT01842230|Amlodipine|amlodipine|mesh-list
56247440|NCT01842230|Telmisartan|telmisartan|mesh-list
56247441|NCT01842230|Atorvastatin|atorvastatin|mesh-list
56247442|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56247443|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56247444|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
56247445|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247446|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56247447|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56247448|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247449|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55822731|NCT01646177|Etanercept|etanercept|mesh-list
56247475|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
56185219|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56185220|NCT01430013|Growth Substances|growth substances|mesh-ancestor
56185221|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185222|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
56185223|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247476|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56247477|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56247478|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
56247479|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56247480|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247481|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56247482|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
56247483|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56247484|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247485|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247486|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247487|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
56247488|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247489|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56247490|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247491|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680951|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56680952|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56680953|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680954|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56680955|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56680956|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
56680957|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56680958|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680959|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56680960|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56680961|NCT00913224|Diclofenac|diclofenac|mesh-list
56680962|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56680963|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56680964|NCT00913224|Analgesics|analgesics|mesh-ancestor
56680965|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
56680966|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680967|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680968|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56327279|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
56236859|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56236860|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
56247492|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
56247493|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247494|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822774|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
56247529|NCT01842893|Analgesics|analgesics|mesh-ancestor
56247530|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
56247531|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247532|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56247568|NCT01843088|Diuretics|diuretics|mesh-ancestor
56247569|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
56247570|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247571|NCT01843127|Exenatide|exenatide|mesh-list
56247572|NCT01843127|Ranolazine|ranolazine|mesh-list
56247573|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56247592|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247594|NCT01843179|Cytarabine|cytarabine|mesh-list
56247595|NCT01843179|Sulindac|sulindac|mesh-list
56247596|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56247597|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
56247598|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247599|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247600|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
56247601|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247602|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56247603|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
56247604|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247605|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56247606|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56247607|NCT01843179|Analgesics|analgesics|mesh-ancestor
56327280|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
56327281|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327282|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56327283|NCT04799288|Teriflunomide|teriflunomide|mesh-list
56236881|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56247608|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
56247609|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247610|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56247611|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56247612|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56247613|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247614|NCT01843257|Ethanol|ethanol|mesh-list
56247615|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56247616|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247617|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247618|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247619|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
56247620|NCT01843296|Fentanyl|fentanyl|mesh-list
56247621|NCT01843296|Bupivacaine|bupivacaine|mesh-list
56247622|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
56247623|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
56247624|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247625|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247626|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
56185225|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56247627|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822902|NCT02251717|Ledipasvir|ledipasvir|mesh-list
56247661|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247663|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56247664|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
56247665|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56247666|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247667|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56247668|NCT01843530|Cortisone|cortisone|mesh-list
56247669|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56247699|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247700|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
56247701|NCT01843738|Vemurafenib|vemurafenib|mesh-list
56247702|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247703|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56247704|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247705|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247706|NCT01843829|Paclitaxel|paclitaxel|mesh-list
56247707|NCT01843829|Carboplatin|carboplatin|mesh-list
56247708|NCT01843829|Capecitabine|capecitabine|mesh-list
56247709|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
56247710|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56247711|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247712|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
56247713|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
56247714|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
56247715|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247745|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56247746|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
56247747|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
56247748|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
56247749|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56247750|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
56247751|NCT01843868|Hormones|hormones|mesh-ancestor
56247752|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247753|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56247754|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
56247755|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247756|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247757|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
56247758|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
56247759|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56247760|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
56247761|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247762|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56247763|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56327284|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56327285|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56327286|NCT04799288|Analgesics|analgesics|mesh-ancestor
56680969|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56680970|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56680971|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56680972|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823048|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247788|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56247789|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247790|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56247791|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247792|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
56247793|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
56247794|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247796|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
56247797|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56247798|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56247799|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247800|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247801|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247802|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
56247803|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
56247804|NCT01844323|Palbociclib|palbociclib|mesh-list
56247805|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247806|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56247807|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247808|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247810|NCT01844401|Procaterol|procaterol|mesh-list
56247811|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56247812|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
56185226|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
56185227|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185228|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185229|NCT01430052|Antiviral Agents|antiviral agents|mesh-ancestor
56185230|NCT01430052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185231|NCT01430052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185232|NCT01430052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56185233|NCT01430052|Immunologic Factors|immunologic factors|mesh-ancestor
56185234|NCT01430052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185236|NCT01430065|Peficitinib|peficitinib|mesh-list
56185237|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56185238|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
56185239|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185240|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56185241|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185242|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185243|NCT01430078|Niacinamide|niacinamide|mesh-list
56185244|NCT01430078|Peficitinib|peficitinib|mesh-list
56185245|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185246|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185247|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56185248|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
56247813|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247814|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247815|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56247847|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247848|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56247850|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
56247851|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
56247852|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247853|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247854|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56247855|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56247856|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
56247857|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247921|NCT01845064|Kallikreins|kallikreins|mesh-list
56247922|NCT01845064|Coagulants|coagulants|mesh-ancestor
56680973|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
56680974|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680975|NCT00661973|Budesonide|budesonide|mesh-list
56680976|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56680977|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56680978|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
56680979|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680980|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680981|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56680982|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
56680983|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
56680984|NCT00661973|Hormones|hormones|mesh-ancestor
56680985|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56680986|NCT00666575|Gabapentin|gabapentin|mesh-list
56680987|NCT00666575|Analgesics|analgesics|mesh-ancestor
56680988|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
56680989|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56680990|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56680991|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
56680992|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56680993|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56680994|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56680995|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56680996|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56680997|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56680998|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56680999|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681000|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
56681001|NCT00666653|Pramipexole|pramipexole|mesh-list
56681002|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
56681003|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681004|NCT00666653|Protective Agents|protective agents|mesh-ancestor
56681005|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681014|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
56681015|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56681016|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56681017|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681018|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681019|NCT00666809|Urological Agents|urological agents|mesh-ancestor
56681020|NCT00666887|Minocycline|minocycline|mesh-list
56681021|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56681022|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681023|NCT00667043|Fentanyl|fentanyl|mesh-list
56681024|NCT00667043|Midazolam|midazolam|mesh-list
56681025|NCT00667043|Remifentanil|remifentanil|mesh-list
56247923|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56247924|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
56247925|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56247926|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247927|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
56247928|NCT01845090|Calcium|calcium|mesh-list
56247929|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56247930|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247931|NCT01845090|Antacids|antacids|mesh-ancestor
56247932|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247933|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247934|NCT01845142|Vitamin D|vitamin d|mesh-list
56247935|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
56247936|NCT01845142|Vitamins|vitamins|mesh-ancestor
56247937|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
56185249|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185250|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
56185251|NCT01430078|Vitamins|vitamins|mesh-ancestor
56185252|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
56185253|NCT01430195|Afamelanotide|afamelanotide|mesh-list
56247938|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247939|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56247941|NCT01845194|Metoprolol|metoprolol|mesh-list
56247942|NCT01845194|Talinolol|talinolol|mesh-list
56247943|NCT01845194|Torsemide|torsemide|mesh-list
56247976|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
56247977|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56247978|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56247979|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
56247980|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56247981|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56247982|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56247983|NCT01845194|Narcotics|narcotics|mesh-ancestor
56247984|NCT01845194|Analgesics|analgesics|mesh-ancestor
55823266|NCT02301143|Gemcitabine|gemcitabine|mesh-list
56248007|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248008|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56248009|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248010|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
56248011|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56248012|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56248014|NCT01845298|Rifamycins|rifamycins|mesh-list
56248015|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56248016|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
56248017|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56248018|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248019|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
56248020|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56248021|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248022|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248023|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56248024|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56248025|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56681026|NCT00667043|Propofol|propofol|mesh-list
56681027|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56681028|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56681029|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681030|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56681031|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
56248026|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56248027|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56248028|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56248029|NCT01845337|Capecitabine|capecitabine|mesh-list
56248030|NCT01845337|Tegafur|tegafur|mesh-list
56248031|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56248032|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
56248033|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248034|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248035|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
56248068|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
56248069|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56248070|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
56248071|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248072|NCT01845610|Manganese|manganese|mesh-list
56248073|NCT01845610|Trace Elements|trace elements|mesh-ancestor
56248074|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
56248075|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248076|NCT01845675|Temozolomide|temozolomide|mesh-list
56248077|NCT01845675|Dacarbazine|dacarbazine|mesh-list
56248078|NCT01845675|Endostatins|endostatins|mesh-list
56248097|NCT01845701|Piperaquine|piperaquine|mesh-list
56248098|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56248099|NCT01845701|Amodiaquine|amodiaquine|mesh-list
56248101|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
56248102|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56248103|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56248104|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248105|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248106|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
56248107|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
56248108|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56248109|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
56185254|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
56185255|NCT01430234|Pancreatin|pancreatin|mesh-list
56185256|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56185257|NCT01430260|Ciclesonide|ciclesonide|mesh-list
56185258|NCT01430260|Cetirizine|cetirizine|mesh-list
56185259|NCT01430260|Levocetirizine|levocetirizine|mesh-list
56185260|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
56185261|NCT01430260|Hormones|hormones|mesh-ancestor
56185262|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185263|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185264|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56185265|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56185266|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56185267|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
56185268|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
56185269|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185270|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185271|NCT01430312|Azelaic acid|azelaic acid|mesh-list
56185272|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185273|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56185274|NCT01430520|Citalopram|citalopram|mesh-list
56185275|NCT01430520|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56185276|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56185277|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56185278|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185279|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185280|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
56185281|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113041|NCT01938833|Paclitaxel|paclitaxel|mesh-list
56185282|NCT01430520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56185283|NCT01430520|Antidepressive Agents|antidepressive agents|mesh-ancestor
56185284|NCT01430520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681032|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
56681033|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56681034|NCT00667043|Narcotics|narcotics|mesh-ancestor
56681035|NCT00667043|Analgesics|analgesics|mesh-ancestor
56681036|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
56681037|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681038|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56681039|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56681040|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56681041|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681042|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
56681043|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
55812374|NCT02388997|Omalizumab|omalizumab|mesh-list
56185285|NCT01430533|Azelaic acid|azelaic acid|mesh-list
56248110|NCT01845727|Amphotericin B|amphotericin b|mesh-list
56248111|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56248112|NCT01845727|Amebicides|amebicides|mesh-ancestor
56248113|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56248114|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56248115|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248116|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56248117|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
56248118|NCT01845844|Ranibizumab|ranibizumab|mesh-list
56248119|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56185286|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185287|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
56185288|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
56185289|NCT01430650|Urological Agents|urological agents|mesh-ancestor
56185291|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
56185292|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185293|NCT01430793|Vitamin D|vitamin d|mesh-list
56185294|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
56185295|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
56185296|NCT01430793|Vitamins|vitamins|mesh-list
56185297|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
56185298|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185299|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56185300|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56185301|NCT01430806|Dronedarone|dronedarone|mesh-list
56248120|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56248121|NCT01845844|Growth Substances|growth substances|mesh-ancestor
56248122|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248123|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
56248124|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248125|NCT01846026|Vitamin D|vitamin d|mesh-list
56248126|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
56248127|NCT01846026|Vitamins|vitamins|mesh-ancestor
56248128|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
56248129|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248130|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56248131|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56248132|NCT01846117|Vitamin D|vitamin d|mesh-list
56248133|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
56248134|NCT01846117|Vitamins|vitamins|mesh-ancestor
56248135|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
56248136|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248160|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248161|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
56248162|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248163|NCT01846325|Protective Agents|protective agents|mesh-ancestor
56248164|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56248165|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56248166|NCT01846364|Protective Agents|protective agents|mesh-ancestor
56248167|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248168|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248169|NCT01846390|Gemcitabine|gemcitabine|mesh-list
56248170|NCT01846390|Dexamethasone|dexamethasone|mesh-list
56248171|NCT01846390|Romidepsin|romidepsin|mesh-list
56327362|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
56681044|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681045|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681046|NCT02631473|Ritonavir|ritonavir|mesh-list
56248172|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56248173|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
56248176|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248177|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56248178|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
56248179|NCT01846390|Hormones|hormones|mesh-ancestor
56248180|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248181|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56248182|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248183|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56248184|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
56248185|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248186|NCT01846390|Antiviral Agents|antiviral agents|mesh-ancestor
56248187|NCT01846390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185302|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56185303|NCT01430910|Ceftazidime|ceftazidime|mesh-list
56185304|NCT01430910|Avibactam|avibactam|mesh-list
56185305|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56185306|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185307|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56185308|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893451|NCT03287388|Rocuronium|rocuronium|mesh-list
56248188|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248189|NCT01846390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56248216|NCT01846832|Simeprevir|simeprevir|mesh-list
56248217|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248218|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
56248219|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248220|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
56248221|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248222|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
56248223|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248224|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
56248225|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248226|NCT01846962|Fluticasone|fluticasone|mesh-list
56248227|NCT01846962|Budesonide|budesonide|mesh-list
56248228|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56248229|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56248230|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
56248231|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248232|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248233|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56248234|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
56248235|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
56248236|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56248237|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
56248238|NCT01846962|Hormones|hormones|mesh-ancestor
55823512|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
56248255|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248256|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
56248257|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248258|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248259|NCT01847157|Anesthetics|anesthetics|mesh-list
56248260|NCT01847157|Prilocaine|prilocaine|mesh-list
56248261|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56248262|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248263|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
56248264|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
56248265|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248266|NCT01847235|Temozolomide|temozolomide|mesh-list
56248267|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56248268|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
56248269|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248270|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248271|NCT01847326|Paclitaxel|paclitaxel|mesh-list
56248272|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56248273|NCT01847326|Carboplatin|carboplatin|mesh-list
56248274|NCT01847326|Fluorouracil|fluorouracil|mesh-list
56681047|NCT02631473|Lopinavir|lopinavir|mesh-list
56681048|NCT02631473|Efavirenz|efavirenz|mesh-list
56681049|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56681050|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56248275|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
56248276|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56248277|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248278|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56248279|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56248280|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56248281|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248283|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56248284|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56248285|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
56248286|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248287|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
56248288|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185309|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185310|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56185311|NCT01430923|Latanoprost|latanoprost|mesh-list
56185312|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56185313|NCT01431053|Aspirin|aspirin|mesh-list
56185314|NCT01431053|Exemestane|exemestane|mesh-list
56185315|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56185316|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56185317|NCT01431053|Analgesics|analgesics|mesh-ancestor
56185318|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
56185319|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185320|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185321|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185322|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185323|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55893522|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893523|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55893524|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55893525|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
55893526|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893527|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893528|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
55893529|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55893530|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
55893531|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55893532|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893533|NCT03286296|Antibodies|antibodies|mesh-list
55893540|NCT03285906|Apatinib|apatinib|mesh-list
56248289|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56248290|NCT01847339|Bupivacaine|bupivacaine|mesh-list
56248291|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
56248292|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
56248293|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56248294|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823569|NCT02299388|Hormones|hormones|mesh-ancestor
56248323|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248324|NCT01847599|Capecitabine|capecitabine|mesh-list
56248325|NCT01847599|Lapatinib|lapatinib|mesh-list
56248326|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56248327|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
56248328|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248329|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248330|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56248331|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248332|NCT01847612|Methylene Blue|methylene blue|mesh-list
56248333|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248334|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248335|NCT01847664|Rifamycins|rifamycins|mesh-list
56185324|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56185325|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185326|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56185327|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56185328|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185329|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
56185330|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681051|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
56681052|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681053|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185331|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56185332|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56185333|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56185334|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
56185335|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185336|NCT01431092|Melatonin|melatonin|mesh-list
56185337|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
55893585|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
56248336|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
56248337|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56248338|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248339|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56248341|NCT01847677|Bevacizumab|bevacizumab|mesh-list
56248375|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248376|NCT01847872|Vaccines|vaccines|mesh-list
56248377|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
56248378|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248379|NCT01847976|Doxycycline|doxycycline|mesh-list
56248380|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56248381|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823669|NCT02201329|Azacitidine|azacitidine|mesh-list
56248412|NCT01848132|Bortezomib|bortezomib|mesh-list
56248413|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56248414|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
56248415|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248416|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56248417|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56248418|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
56248419|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248420|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248421|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56248422|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56248423|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56248424|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56248425|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56248426|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248427|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55823715|NCT02201251|Topiramate|topiramate|mesh-list
56248452|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
56248454|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
56248455|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56248456|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
56248457|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248458|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248459|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248460|NCT01848340|Cabotegravir|cabotegravir|mesh-list
56248461|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56248462|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56248463|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248464|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248465|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56248466|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56248467|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
56185338|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185339|NCT01431092|Protective Agents|protective agents|mesh-ancestor
56185340|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185341|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185342|NCT01431118|Camphor|camphor|mesh-list
56185343|NCT01431118|Salicylates|salicylates|mesh-list
56185344|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
56185345|NCT01431118|Menthol|menthol|mesh-list
56185346|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56185347|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185348|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
56185349|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
56185350|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56185351|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56185352|NCT01431118|Analgesics|analgesics|mesh-ancestor
56185353|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
56103222|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
56681054|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56681055|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56681056|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
56681057|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681058|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56681059|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56681060|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56185354|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185355|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893645|NCT04389567|Famotidine|famotidine|mesh-list
56248468|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248469|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56248470|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248471|NCT01848613|Vinorelbine|vinorelbine|mesh-list
56248472|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56248473|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248474|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
56248475|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
56248476|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
55823753|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56248510|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56248511|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56248512|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248513|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248514|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56248515|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56248516|NCT01848769|Beclomethasone|beclomethasone|mesh-list
56248517|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
56248539|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56248540|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56248541|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56248542|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248543|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56248544|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248545|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
56248546|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
56248547|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248548|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
56248549|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248550|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248551|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56248552|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
56248553|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56248554|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
56248555|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248556|NCT01849016|Expectorants|expectorants|mesh-ancestor
56248557|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
56185356|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185357|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185358|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56248558|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56248559|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
56248560|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248561|NCT01849016|Protective Agents|protective agents|mesh-ancestor
56248562|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248563|NCT01849016|Antidotes|antidotes|mesh-ancestor
56248564|NCT01849042|Donepezil|donepezil|mesh-list
56248565|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56248566|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248567|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248568|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
56248569|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248598|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248599|NCT01849640|Primaquine|primaquine|mesh-list
56248600|NCT01849640|Piperaquine|piperaquine|mesh-list
56248601|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
56681061|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56681062|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56681063|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56681064|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56681065|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56236925|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
56248602|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56248603|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56248604|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248605|NCT01849666|Vemurafenib|vemurafenib|mesh-list
56248606|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
56248607|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248608|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56248609|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248610|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248611|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
56248612|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
56248613|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56248614|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56248615|NCT01849835|Menthol|menthol|mesh-list
56248616|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
56248617|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
56248618|NCT01849861|Methimazole|methimazole|mesh-list
56248638|NCT01849926|Renal Agents|renal agents|mesh-ancestor
56248639|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56248640|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56248641|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
56248642|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248643|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
56248644|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56248645|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56248646|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248647|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56248648|NCT01850017|Analgesics|analgesics|mesh-ancestor
56248649|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
56248650|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248651|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56248652|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56248653|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56248654|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
56248655|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248656|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248657|NCT01850095|Azelaic acid|azelaic acid|mesh-list
56248658|NCT01850095|Estradiol|estradiol|mesh-list
56248659|NCT01850095|Estrogens|estrogens|mesh-ancestor
56248660|NCT01850095|Hormones|hormones|mesh-ancestor
56248661|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248662|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248663|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248664|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
56248665|NCT01850121|Infliximab|infliximab|mesh-list
56248666|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
56248667|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56248668|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56248669|NCT01850147|Sunitinib|sunitinib|mesh-list
56248670|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248671|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56248672|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56248717|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248718|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
56248719|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
56185359|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248720|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248721|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
56248722|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56248723|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
56248724|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56248726|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56248727|NCT01850511|Protective Agents|protective agents|mesh-ancestor
56681066|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56681067|NCT00825162|Vaccines|vaccines|mesh-list
56681068|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
56681069|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681070|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56681071|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
56681072|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56681073|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56681074|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248728|NCT01850628|Paclitaxel|paclitaxel|mesh-list
56248729|NCT01850628|Trastuzumab|trastuzumab|mesh-list
56248730|NCT01850628|Pertuzumab|pertuzumab|mesh-list
56248731|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56248732|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248733|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
56248734|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
55824035|NCT01629589|Vaccines|vaccines|mesh-list
56248767|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
56248768|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248769|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248770|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248771|NCT01850979|Tacrolimus|tacrolimus|mesh-list
56248772|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56248773|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
56248774|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248775|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56248803|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56248804|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56248805|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56248806|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
56248807|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56248809|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248810|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248811|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248812|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56248813|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56248814|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248815|NCT01851265|Olaparib|olaparib|mesh-list
56248816|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56248817|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248818|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248819|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248820|NCT01851278|Triamcinolone|triamcinolone|mesh-list
56248821|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56248822|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55824101|NCT04865159|Tipifarnib|tipifarnib|mesh-list
56248840|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248841|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56248842|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
56248843|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56248844|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
56248845|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248846|NCT01851473|Quinine|quinine|mesh-list
56248847|NCT01851473|Acetazolamide|acetazolamide|mesh-list
56248848|NCT01851473|Cocaine|cocaine|mesh-list
56248849|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
56248850|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56248851|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248852|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248853|NCT01851473|Diuretics|diuretics|mesh-ancestor
56248854|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
56248855|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248856|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
56248857|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
56248858|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56248859|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
56681075|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681076|NCT00662441|Urological Agents|urological agents|mesh-ancestor
56681077|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56681078|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681079|NCT00911573|Vancomycin|vancomycin|mesh-list
56681080|NCT00911573|Clindamycin|clindamycin|mesh-list
56681081|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
56681082|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
56681083|NCT00911573|Tigecycline|tigecycline|mesh-list
56248860|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248861|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56248862|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56248863|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56248864|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56248865|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
56248866|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248867|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
56248868|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56185360|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185362|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
56185363|NCT01431326|Tazobactam|tazobactam|mesh-list
56185364|NCT01431326|Piperacillin|piperacillin|mesh-list
56185365|NCT01431326|Tobramycin|tobramycin|mesh-list
56248869|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56248870|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248871|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56248872|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56248873|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56248874|NCT01851473|Analgesics|analgesics|mesh-ancestor
56248875|NCT01851486|Clonidine|clonidine|mesh-list
56248876|NCT01851486|Naloxone|naloxone|mesh-list
56248877|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56248878|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248879|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
55824150|NCT02289833|Trastuzumab|trastuzumab|mesh-list
56248908|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248909|NCT01851733|Doxorubicin|doxorubicin|mesh-list
56248910|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56248911|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248912|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56248913|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56248914|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248915|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248916|NCT01851759|Cinepazide|cinepazide|mesh-list
56248917|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
56248918|NCT01851824|Vemurafenib|vemurafenib|mesh-list
56248919|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
56248920|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248921|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56248922|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248923|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248924|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
56248925|NCT01851850|Opicapone|opicapone|mesh-list
56248950|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56248951|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248952|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56248953|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248954|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248955|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56248956|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56248958|NCT01851980|Diuretics|diuretics|mesh-ancestor
56248959|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
56248960|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248961|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56248962|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56248963|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248964|NCT01851993|Ondansetron|ondansetron|mesh-list
56681084|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56681085|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681086|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56681087|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681088|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248965|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
56248966|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
56248967|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248968|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248969|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56248970|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
56248971|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
56248972|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56248973|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
56248974|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248975|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248976|NCT01851993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56248977|NCT01851993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56248978|NCT01851993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56248988|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
56248989|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248990|NCT01852318|Fexofenadine|fexofenadine|mesh-list
56248991|NCT01852318|Pregabalin|pregabalin|mesh-list
56248992|NCT01852318|Analgesics|analgesics|mesh-ancestor
56248993|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
56248994|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185367|NCT01431326|Fosfomycin|fosfomycin|mesh-list
56185368|NCT01431326|Cefepime|cefepime|mesh-list
56185369|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56185370|NCT01431326|Nafcillin|nafcillin|mesh-list
56185371|NCT01431326|Cidofovir|cidofovir|mesh-list
56185372|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
56185373|NCT01431326|Bosentan|bosentan|mesh-list
56185374|NCT01431326|Labetalol|labetalol|mesh-list
56185375|NCT01431326|Nifedipine|nifedipine|mesh-list
56185376|NCT01431326|Spironolactone|spironolactone|mesh-list
56185377|NCT01431326|Pentobarbital|pentobarbital|mesh-list
56185378|NCT01431326|Oxycodone|oxycodone|mesh-list
56185379|NCT01431326|Alfentanil|alfentanil|mesh-list
56185380|NCT01431326|Haloperidol|haloperidol|mesh-list
56185381|NCT01431326|Zolpidem|zolpidem|mesh-list
56185382|NCT01431326|Ziprasidone|ziprasidone|mesh-list
56248995|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248996|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
56248997|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56248998|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56248999|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249000|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56249001|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56249002|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56249003|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249004|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56249005|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56249006|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56249007|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56249008|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
56249009|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
56249010|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249011|NCT01852409|Bevacizumab|bevacizumab|mesh-list
56249012|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56249013|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249014|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56249015|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56249016|NCT01852409|Growth Substances|growth substances|mesh-ancestor
56249017|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249018|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
56249019|NCT01852461|Poractant alfa|poractant alfa|mesh-list
56249020|NCT01852461|Beractant|beractant|mesh-list
56249021|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56249022|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
56249023|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
56249024|NCT01852539|Propofol|propofol|mesh-list
56249025|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56681089|NCT00667433|Tenofovir|tenofovir|mesh-list
56681090|NCT00667433|Emtricitabine|emtricitabine|mesh-list
56681091|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
56681092|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56681093|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
56681094|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249026|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249027|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249028|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56249029|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
56249030|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
56249031|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56249032|NCT01852539|Analgesics|analgesics|mesh-ancestor
56249033|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
56249034|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249035|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56249036|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56249037|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56249038|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
56249039|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249040|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249041|NCT01852565|Diltiazem|diltiazem|mesh-list
56249042|NCT01852565|Darapladib|darapladib|mesh-list
56249043|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56249044|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56249060|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56249061|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
56249062|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249063|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249064|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56249065|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56249066|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56249067|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56249068|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
56249070|NCT01852630|Cefepime|cefepime|mesh-list
56249071|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56249072|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249073|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
56249074|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
56249075|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56249076|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56249077|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249078|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56249079|NCT01852903|Vitamins|vitamins|mesh-list
56249080|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
56249081|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
56249082|NCT01852903|Calcium|calcium|mesh-list
56249083|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
56249084|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249085|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56249086|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
56249087|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249088|NCT01852903|Protective Agents|protective agents|mesh-ancestor
56249089|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
56249090|NCT01852994|Testosterone|testosterone|mesh-list
56249091|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
56249092|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
56249093|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56249094|NCT01852994|Androgens|androgens|mesh-ancestor
56249096|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249097|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249098|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56249099|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249100|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
56249101|NCT01853111|Aldesleukin|aldesleukin|mesh-list
56249102|NCT01853111|Interleukin-2|interleukin-2|mesh-list
56249103|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249104|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56249105|NCT01853111|Analgesics|analgesics|mesh-ancestor
56249106|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
56681095|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56681096|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56681097|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681098|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681099|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56681100|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56681101|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56681102|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56681103|NCT00662519|Lenograstim|lenograstim|mesh-list
56681104|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56681105|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
56681106|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681107|NCT00667901|Riluzole|riluzole|mesh-list
56681108|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
56681109|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56681110|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56681111|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681112|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681113|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681114|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56681115|NCT00667901|Protective Agents|protective agents|mesh-ancestor
56681116|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56681117|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
56327443|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
56681118|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56249107|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824375|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56249193|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56249194|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56249196|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
56249197|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249198|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249199|NCT01854021|Anesthetics|anesthetics|mesh-list
56249200|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249201|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249202|NCT01854073|Scopolamine|scopolamine|mesh-list
56249203|NCT01854073|Bromides|bromides|mesh-list
56249204|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56249205|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
56249206|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56249207|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
56249208|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
56249209|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249210|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249211|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249212|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
56249213|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56249214|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
56249215|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185385|NCT01431326|Molindone|molindone|mesh-list
56681119|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56681120|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681121|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681122|NCT00667979|Urological Agents|urological agents|mesh-ancestor
56681123|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56681124|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
56681125|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56681126|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56681127|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681128|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681129|NCT00668057|Urological Agents|urological agents|mesh-ancestor
56681130|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56681131|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
56681132|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56681133|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56681134|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185386|NCT01431326|Warfarin|warfarin|mesh-list
56185387|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
56185389|NCT01431326|Rocuronium|rocuronium|mesh-list
56249216|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249217|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56249218|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
56249219|NCT01854086|Diphosphonates|diphosphonates|mesh-list
56249220|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56249221|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249222|NCT01854203|Gemcitabine|gemcitabine|mesh-list
56249223|NCT01854203|Cisplatin|cisplatin|mesh-list
56249224|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249225|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56249226|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
56249227|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249228|NCT01854203|Antiviral Agents|antiviral agents|mesh-ancestor
56249229|NCT01854203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249230|NCT01854203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249231|NCT01854203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249232|NCT01854203|Immunologic Factors|immunologic factors|mesh-ancestor
56249269|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249270|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56249271|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56249272|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
56249273|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56249299|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
56249300|NCT01854515|Hormones|hormones|mesh-ancestor
56249301|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249302|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56249303|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249304|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56249305|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56249306|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
56249307|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
56249308|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249309|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249310|NCT01854606|Everolimus|everolimus|mesh-list
56249311|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249312|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249313|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
56249314|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681135|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681136|NCT00668135|Urological Agents|urological agents|mesh-ancestor
56681137|NCT02630303|Coal Tar|coal tar|mesh-list
56681138|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
56681139|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
56236999|NCT01754181|Insulin|insulin|mesh-list
56249315|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
56249316|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56249317|NCT01854723|Insulin|insulin|mesh-list
56249318|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56249319|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
56249320|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
56249321|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
56249322|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
56249341|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56249342|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56249343|NCT01854970|Esomeprazole|esomeprazole|mesh-list
56249344|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56249345|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249346|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56249347|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249348|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249349|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
56249350|NCT01855009|Vitamin D|vitamin d|mesh-list
56249351|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
56249352|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
56249353|NCT01855009|Calcium|calcium|mesh-list
56249354|NCT01855009|Vitamins|vitamins|mesh-ancestor
56249355|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
56249356|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249357|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56249358|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56249359|NCT01855009|Antacids|antacids|mesh-ancestor
56249360|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185390|NCT01431326|Vecuronium Bromide|vecuronium bromide|mesh-list
56249361|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249362|NCT01855061|Midazolam|midazolam|mesh-list
56249363|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56249364|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56249365|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249366|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249367|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56249368|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56249369|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56249370|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56249371|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
56249372|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
56249373|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
56249374|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
56249375|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249376|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249377|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
56249378|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56249379|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
56249380|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56249381|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
56249402|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249403|NCT01855256|Urological Agents|urological agents|mesh-ancestor
56249405|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
56249406|NCT01855321|Vitamins|vitamins|mesh-ancestor
56249407|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
56249408|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249409|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56249410|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56249411|NCT01855334|Spironolactone|spironolactone|mesh-list
56249412|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56249413|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
56249414|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249415|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249416|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56249417|NCT01855334|Diuretics|diuretics|mesh-ancestor
56681140|NCT04155983|Ropivacaine|ropivacaine|mesh-list
56681141|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
56681142|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
56681143|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249418|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
56249419|NCT01855386|Liver Extracts|liver extracts|mesh-list
56249420|NCT01855386|Hematinics|hematinics|mesh-ancestor
56249421|NCT01855490|Exenatide|exenatide|mesh-list
56249422|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56249423|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249424|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56249425|NCT01855490|Incretins|incretins|mesh-ancestor
56249426|NCT01855490|Hormones|hormones|mesh-ancestor
56249427|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249428|NCT01855516|Heparin|heparin|mesh-list
56249429|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
56249430|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56249431|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56249432|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249433|NCT01855529|Ropivacaine|ropivacaine|mesh-list
56249434|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
56249435|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
56249436|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249454|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249455|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56249456|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
56249457|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249458|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249459|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
56249460|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249461|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56249462|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249463|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
56249464|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56249465|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56249466|NCT01855581|Ketamine|ketamine|mesh-list
56249467|NCT01855581|Propofol|propofol|mesh-list
56249468|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56249469|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249470|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249471|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56185392|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185393|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
56185394|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
56185395|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185396|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185397|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56185398|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
56185400|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185401|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56185402|NCT01431326|Protective Agents|protective agents|mesh-ancestor
56185403|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185404|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56185405|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56185406|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185407|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
56185408|NCT01431326|Coagulants|coagulants|mesh-ancestor
56249472|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
56249474|NCT01855581|Analgesics|analgesics|mesh-ancestor
56249475|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
56249476|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249477|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56249478|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56249479|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56249480|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249481|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249482|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
56249483|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
56249484|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56249485|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249486|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681144|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249487|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
56249488|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56249489|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249490|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249491|NCT01855711|Alosetron|alosetron|mesh-list
56249492|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249493|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56249494|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
56249526|NCT01855984|Vitamin E|vitamin e|mesh-list
56249527|NCT01855984|Tocopherols|tocopherols|mesh-list
56249528|NCT01855984|Tocovid|tocovid|mesh-list
56249529|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
56249530|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249531|NCT01855984|Protective Agents|protective agents|mesh-ancestor
56249532|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249533|NCT01855984|Vitamins|vitamins|mesh-ancestor
56249534|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
56249535|NCT01856023|Aldesleukin|aldesleukin|mesh-list
56249536|NCT01856023|Ipilimumab|ipilimumab|mesh-list
56249537|NCT01856023|Interleukin-2|interleukin-2|mesh-list
56249538|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56249539|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249641|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
56249642|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249643|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249644|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249645|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56185409|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56185410|NCT01431326|Narcotics|narcotics|mesh-ancestor
56185411|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249679|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56249680|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
56249681|NCT01856959|Albuterol|albuterol|mesh-list
56249682|NCT01856959|Analgesics|analgesics|mesh-ancestor
56249683|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
56249684|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249685|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249686|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
56249687|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249688|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56249709|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56249710|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249711|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56249712|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249713|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
56249714|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56249715|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56249716|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56249717|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56249718|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
56249719|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56249720|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56249721|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
56249722|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249723|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
56249724|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56249725|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56249727|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56249728|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249729|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249730|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56249731|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
56249732|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
56249733|NCT01857011|Iron|iron|mesh-list
56249734|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56249735|NCT01857011|Teferrol|teferrol|mesh-list
56249736|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
56249737|NCT01857011|Trace Elements|trace elements|mesh-ancestor
56249738|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
56249739|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249740|NCT01857011|Hematinics|hematinics|mesh-ancestor
56249741|NCT01857024|Sevelamer|sevelamer|mesh-list
56249742|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
56249775|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681145|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
56681146|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681147|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56681148|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56681149|NCT00668603|Estradiol|estradiol|mesh-list
56249776|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
56249777|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249778|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56249779|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56249780|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249781|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249782|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56249783|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
56249784|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249817|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249818|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249819|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56249820|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
56249821|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
56249822|NCT01857479|Hormones|hormones|mesh-ancestor
56249823|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249824|NCT01857479|Amebicides|amebicides|mesh-ancestor
56249825|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56249826|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56249827|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249828|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55825108|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
56249850|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56249851|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249852|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56185412|NCT01431326|Analgesics|analgesics|mesh-ancestor
55894326|NCT04389801|Deferoxamine|deferoxamine|mesh-list
56249853|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56249854|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249855|NCT01857596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56249856|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
56249857|NCT01857609|Metformin|metformin|mesh-list
56249858|NCT01857609|Rabeprazole|rabeprazole|mesh-list
56249859|NCT01857609|Pantoprazole|pantoprazole|mesh-list
56249860|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56249861|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249862|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56249863|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249864|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56249865|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249866|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249867|NCT01857726|Doxorubicin|doxorubicin|mesh-list
56249868|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249869|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56249870|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56249871|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56249872|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249873|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249874|NCT01857752|Temozolomide|temozolomide|mesh-list
56249875|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56249876|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
56249877|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249878|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249879|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56249880|NCT01857804|Amoxicillin|amoxicillin|mesh-list
56249881|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
56249882|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56249915|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249916|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56249917|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56249918|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
55871981|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
56249919|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249920|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56269009|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56681150|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56681151|NCT00668603|Estrogens|estrogens|mesh-ancestor
56681152|NCT00668603|Hormones|hormones|mesh-ancestor
56681153|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56681154|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249921|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56249922|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249923|NCT01857856|Eplerenone|eplerenone|mesh-list
56249924|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56249925|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
56249948|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249949|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
56249950|NCT01857999|Losartan|losartan|mesh-list
56249951|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56249952|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56249953|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56249954|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56249955|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249956|NCT01858025|Fluorouracil|fluorouracil|mesh-list
56249957|NCT01858025|Mitomycins|mitomycins|mesh-list
56249958|NCT01858025|Mitomycin|mitomycin|mesh-list
56249959|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
56249960|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249961|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56249962|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249963|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249964|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
56249965|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249966|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56249967|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
56249968|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56249969|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249970|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
56249971|NCT01858051|Vitamin D|vitamin d|mesh-list
56249972|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56249973|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249974|NCT01858051|Vitamins|vitamins|mesh-ancestor
56249975|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
56249976|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56249977|NCT01858077|Everolimus|everolimus|mesh-list
56185413|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
56185414|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
56185415|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56185416|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185417|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56185418|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56185419|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56185420|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56185421|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56185422|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185423|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56185424|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56250052|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250053|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250054|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56250055|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
56250056|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56250058|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56250130|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250131|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56250132|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250133|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250134|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56250135|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56250167|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56250168|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250169|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681155|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56681156|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
56681157|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56681158|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56681159|NCT00662987|Amoxicillin|amoxicillin|mesh-list
56681160|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56681161|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681162|NCT00668759|Amiodarone|amiodarone|mesh-list
56681163|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56681164|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
56681165|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56681166|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681167|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681168|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56681169|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56681170|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56681171|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681172|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56681173|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56250170|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250171|NCT01858662|Antidotes|antidotes|mesh-ancestor
56250172|NCT01858662|Protective Agents|protective agents|mesh-ancestor
56250173|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250174|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
56250175|NCT01858662|Vitamins|vitamins|mesh-ancestor
56250176|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
56250177|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56250178|NCT01858792|Belimumab|belimumab|mesh-list
56250179|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56250212|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
56250213|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56250214|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250215|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56250216|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56250217|NCT01859234|Growth Substances|growth substances|mesh-ancestor
56250218|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250219|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
56250220|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56250221|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250249|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56250250|NCT01859481|Eletriptan|eletriptan|mesh-list
56250251|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56250252|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
56250253|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250254|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250255|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250256|NCT01859585|Ketorolac|ketorolac|mesh-list
56250257|NCT01859585|Parecoxib|parecoxib|mesh-list
56250258|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56250259|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56250260|NCT01859585|Analgesics|analgesics|mesh-ancestor
56185425|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56185426|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
56681174|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56681175|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56681176|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56681177|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56681178|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56681179|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681180|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681181|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56681182|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56681183|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
56681184|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681185|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681186|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56185427|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56250261|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
56250262|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250263|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250264|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250265|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250266|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56250267|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250268|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250287|NCT01859728|Irinotecan|irinotecan|mesh-list
56250288|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250289|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56250290|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
56250291|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250292|NCT01859728|Antiviral Agents|antiviral agents|mesh-ancestor
56250293|NCT01859728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250294|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872364|NCT03233139|Paclitaxel|paclitaxel|mesh-list
56250295|NCT01859728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56250296|NCT01859728|Immunologic Factors|immunologic factors|mesh-ancestor
56250297|NCT01859728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250298|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56250299|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250300|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
56250301|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56250302|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56250303|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
56250304|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250305|NCT01859858|Curcumin|curcumin|mesh-list
56250306|NCT01859858|Irinotecan|irinotecan|mesh-list
56250307|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56250308|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250309|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250310|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250311|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250312|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56250313|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56250314|NCT01859858|Analgesics|analgesics|mesh-ancestor
56250315|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
56250316|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250317|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250318|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250319|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250320|NCT01860014|Poractant alfa|poractant alfa|mesh-list
56250321|NCT01860014|Beractant|beractant|mesh-list
56250322|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56250323|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
56681187|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56681188|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
56681189|NCT00663221|Vitamin D|vitamin d|mesh-list
56681190|NCT00663221|Calcium|calcium|mesh-list
56681191|NCT00663221|Vitamins|vitamins|mesh-ancestor
56250324|NCT01860066|Fluticasone|fluticasone|mesh-list
56250325|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55825585|NCT01691794|Ritonavir|ritonavir|mesh-list
56250360|NCT01860144|Growth Substances|growth substances|mesh-ancestor
56250361|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250380|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250381|NCT01860235|Anesthetics|anesthetics|mesh-list
56250382|NCT01860235|Benzocaine|benzocaine|mesh-list
56250383|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
56250384|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250385|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250386|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
56250387|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250388|NCT01860300|Amoxicillin|amoxicillin|mesh-list
56250389|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
56250390|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
56250391|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56250392|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56250393|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250394|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56250395|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250396|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185428|NCT01431326|Diuretics|diuretics|mesh-ancestor
56185429|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
56185430|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56185431|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56113176|NCT01754987|Vitamins|vitamins|mesh-ancestor
56185432|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56185433|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
56185434|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
56185435|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56185436|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56185437|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56250397|NCT01860391|Fluorides|fluorides|mesh-list
56250398|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
56250399|NCT01860391|Protective Agents|protective agents|mesh-ancestor
56250400|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250401|NCT01860417|Mepivacaine|mepivacaine|mesh-list
56250402|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
56250403|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
56250404|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250405|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250406|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
56250407|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250408|NCT01860469|Vancomycin|vancomycin|mesh-list
56250409|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56250410|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250411|NCT01860482|Rabeprazole|rabeprazole|mesh-list
56250412|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56250413|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56250414|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56250415|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250416|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250437|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56250438|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56250439|NCT01860638|Growth Substances|growth substances|mesh-ancestor
56250440|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250441|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
56250442|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56250443|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
56250444|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250445|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
56250446|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250447|NCT01860690|Methotrexate|methotrexate|mesh-list
56250448|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56250449|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
56250450|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56250451|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681192|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
56681193|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681194|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56681195|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56681196|NCT00824850|Vaccines|vaccines|mesh-list
56250452|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56250453|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
56250454|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250455|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250456|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
56250457|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250458|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56250459|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56250460|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
56250461|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250462|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56250463|NCT01860716|Melatonin|melatonin|mesh-list
56250464|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
56250465|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250466|NCT01860716|Protective Agents|protective agents|mesh-ancestor
56250467|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250468|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250469|NCT01860729|Anacetrapib|anacetrapib|mesh-list
56185438|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56185439|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56185440|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56185441|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
56185442|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825734|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56250498|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56250499|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
56250501|NCT01860833|Celecoxib|celecoxib|mesh-list
56250502|NCT01860833|Diclofenac|diclofenac|mesh-list
56250503|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56250504|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56250505|NCT01860833|Analgesics|analgesics|mesh-ancestor
56250506|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
56250507|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250508|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250509|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250510|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250511|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56250512|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250513|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825791|NCT04274894|Testosterone|testosterone|mesh-list
56250550|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56250551|NCT01861223|Afatinib|afatinib|mesh-list
56250552|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
56250553|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250589|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250590|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250591|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56250592|NCT01861626|Isotretinoin|isotretinoin|mesh-list
56250630|NCT01862003|Antidotes|antidotes|mesh-ancestor
56250631|NCT01862003|Protective Agents|protective agents|mesh-ancestor
55825918|NCT01469156|Ranibizumab|ranibizumab|mesh-list
56250667|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250668|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56250669|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56250670|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
56250696|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
56250697|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
56250698|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250699|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250700|NCT01862835|Anastrozole|anastrozole|mesh-list
56250701|NCT01862835|Testosterone|testosterone|mesh-list
56250702|NCT01862835|Estrogens|estrogens|mesh-list
56250703|NCT01862835|Androgens|androgens|mesh-ancestor
56250704|NCT01862835|Hormones|hormones|mesh-ancestor
56250705|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56250706|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681197|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56681198|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
56681199|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681200|NCT00596687|Insulin|insulin|mesh-list
56681201|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56250707|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56250708|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250709|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56250710|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56250711|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250712|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250713|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56250714|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
56250715|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
56250716|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56250717|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250718|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56250747|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
56250748|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250749|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
56250750|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250751|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56250752|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56250754|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56250755|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250756|NCT01863147|Incretins|incretins|mesh-ancestor
56250757|NCT01863147|Hormones|hormones|mesh-ancestor
56250758|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185443|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56185444|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56185445|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56185446|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56250759|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56250760|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
56250761|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250762|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250763|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56250764|NCT01863173|Metoprolol|metoprolol|mesh-list
56250765|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56250766|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56250789|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250791|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56250792|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250793|NCT01863238|Ivacaftor|ivacaftor|mesh-list
56250794|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56250795|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250796|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250797|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56250798|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56250799|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56250800|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250801|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250802|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
56250803|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250804|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250805|NCT01863277|Melatonin|melatonin|mesh-list
56250806|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
56250807|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250808|NCT01863277|Protective Agents|protective agents|mesh-ancestor
56250809|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250810|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250811|NCT01863355|Fentanyl|fentanyl|mesh-list
56250812|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56250813|NCT01863355|Narcotics|narcotics|mesh-ancestor
56250814|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250815|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250853|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681202|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
56681203|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
56681204|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56681205|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681206|NCT02631239|Dexamethasone|dexamethasone|mesh-list
56250854|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250888|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250889|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250890|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56250892|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
56250925|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56250927|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56250928|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250929|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56250930|NCT01863823|Amoxicillin|amoxicillin|mesh-list
56250931|NCT01863823|Tetracycline|tetracycline|mesh-list
55826213|NCT01630135|Fluticasone|fluticasone|mesh-list
56250956|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56250957|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56250958|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56250959|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56250961|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250962|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56250963|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56250964|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250966|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
56250967|NCT01864057|Vitamins|vitamins|mesh-ancestor
56250968|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
56250969|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250970|NCT01864070|Everolimus|everolimus|mesh-list
56250971|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250973|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
56250974|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185447|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
56185448|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
56185449|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56185450|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
56185451|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56185452|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56185453|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
56185454|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
56185455|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56185456|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56185457|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56185458|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
56185459|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56185460|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56185461|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
55894742|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
56250975|NCT01864083|Fluorides|fluorides|mesh-list
56250976|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
56250977|NCT01864083|Protective Agents|protective agents|mesh-ancestor
56250978|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250979|NCT01864096|Metformin|metformin|mesh-list
56250980|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56250981|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250982|NCT01864161|Iron|iron|mesh-list
56250983|NCT01864161|Trace Elements|trace elements|mesh-ancestor
56251017|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
56251018|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251019|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251020|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251021|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56251022|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56251023|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251024|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251025|NCT01864551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56251080|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
56251081|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251082|NCT01865188|Amlodipine|amlodipine|mesh-list
56251083|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56681207|NCT02631239|Methotrexate|methotrexate|mesh-list
56681208|NCT02631239|Etoposide|etoposide|mesh-list
56681209|NCT02631239|Pegaspargase|pegaspargase|mesh-list
56681210|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56681211|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
56681212|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
56681213|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681214|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251084|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56251085|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56251086|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56251087|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251088|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56251089|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251090|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
56251091|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56251092|NCT01865201|Mannitol|mannitol|mesh-list
56251093|NCT01865201|Edaravone|edaravone|mesh-list
56251094|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56251120|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56251121|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
56251122|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56251123|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
56251124|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251125|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251126|NCT01865318|Insulin|insulin|mesh-list
56251127|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251128|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251129|NCT01865331|Insulin|insulin|mesh-list
56185462|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56185463|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
56185464|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56185465|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56185466|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
56185467|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
56185468|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
56185469|NCT01431326|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56185470|NCT01431326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56185471|NCT01431326|Cholinergic Agents|cholinergic agents|mesh-ancestor
56185472|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56185473|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
56185474|NCT01431352|Letrozole|letrozole|mesh-list
56185475|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185476|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56185477|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56185478|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185479|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185480|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56185481|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
55894813|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56251130|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56251131|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
56251132|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
56251133|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251134|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251135|NCT01865500|Prednisolone|prednisolone|mesh-list
56251136|NCT01865500|Budesonide|budesonide|mesh-list
56251137|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56251138|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
56251139|NCT01865500|Hormones|hormones|mesh-ancestor
56251140|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56251141|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251142|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56251143|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251144|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
56251145|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251146|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55826415|NCT01598311|Vancomycin|vancomycin|mesh-list
56251183|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681215|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56681216|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
56681217|NCT02631239|Hormones|hormones|mesh-ancestor
56681218|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56681219|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56681220|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681221|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56681222|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
56681223|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56237060|NCT01754831|Fluorides|fluorides|mesh-list
56251184|NCT01865916|Vitamins|vitamins|mesh-ancestor
56251185|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
55826466|NCT02207816|Vaccines|vaccines|mesh-list
56251217|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251218|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
56251219|NCT01866254|Morphine|morphine|mesh-list
56251220|NCT01866254|Hydromorphone|hydromorphone|mesh-list
56251221|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56251222|NCT01866254|Narcotics|narcotics|mesh-ancestor
56251223|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251224|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251225|NCT01866254|Analgesics|analgesics|mesh-ancestor
56251226|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
55826498|NCT02240108|Rifaximin|rifaximin|mesh-list
56251261|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251263|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
56251264|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
55826546|NCT02129647|Axitinib|axitinib|mesh-list
56185482|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185483|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251287|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56251288|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
56251289|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251290|NCT01866644|Expectorants|expectorants|mesh-ancestor
56251291|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
56251292|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56251293|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
56251294|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251295|NCT01866644|Protective Agents|protective agents|mesh-ancestor
56251296|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251297|NCT01866644|Antidotes|antidotes|mesh-ancestor
56251298|NCT01867138|Vancomycin|vancomycin|mesh-list
56251299|NCT01867138|Cefazolin|cefazolin|mesh-list
56251300|NCT01867138|Amikacin|amikacin|mesh-list
56251301|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56251302|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251303|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56251304|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56251305|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56251306|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56251307|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251308|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251309|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251310|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56251311|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
56251312|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251313|NCT01867268|Acetazolamide|acetazolamide|mesh-list
56251314|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
56251315|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56251316|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251317|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251318|NCT01867268|Diuretics|diuretics|mesh-ancestor
56251352|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251353|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
56251354|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56681224|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56681225|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
56681226|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237069|NCT01754870|Rituximab|rituximab|mesh-list
56251355|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251356|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
56251357|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56251394|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56251395|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56251396|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251397|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56251398|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56251399|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56251400|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
56251433|NCT01868048|Analgesics|analgesics|mesh-ancestor
56251434|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
56251435|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251436|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251437|NCT01868113|Fluticasone|fluticasone|mesh-list
56251439|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56251440|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56251441|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
56251442|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251443|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251444|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56251445|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
56251446|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
56251447|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56251482|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
56251483|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251485|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56251486|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
56251487|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251488|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251489|NCT01868555|Insulin|insulin|mesh-list
56251490|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56251491|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
56251492|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
56185484|NCT01431404|Etanercept|etanercept|mesh-list
56185485|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55826757|NCT02175277|Hematinics|hematinics|mesh-ancestor
56251519|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
56251520|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56251521|NCT01868802|Ketamine|ketamine|mesh-list
56251522|NCT01868802|Analgesics|analgesics|mesh-ancestor
56251523|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
56251524|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251525|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251526|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56251527|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56251528|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
56251529|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
56251530|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251531|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56251532|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56251533|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251534|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251535|NCT01868880|Bisoprolol|bisoprolol|mesh-list
56251536|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56251537|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56251538|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
56251539|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826803|NCT01587274|Naproxen|naproxen|mesh-list
56251608|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56251610|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
56251611|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251612|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56251613|NCT01869309|Ticagrelor|ticagrelor|mesh-list
56251614|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56251615|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56251616|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56681227|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
56681228|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681229|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56681230|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681231|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
56251647|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251648|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251649|NCT01869621|Metformin|metformin|mesh-list
56251650|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251651|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251652|NCT01869673|Anesthetics|anesthetics|mesh-list
56251653|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251654|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251655|NCT01869751|Prucalopride|prucalopride|mesh-list
56251656|NCT01869751|Laxatives|laxatives|mesh-ancestor
56251657|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251686|NCT01869907|Analgesics|analgesics|mesh-ancestor
56251687|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
56251688|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251689|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251690|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56251691|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56251692|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56251693|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251694|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
56251695|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251696|NCT01869946|Ropivacaine|ropivacaine|mesh-list
56251697|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
56251698|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
56251699|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251700|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251701|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
55826963|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
56251730|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56251731|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56251733|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251734|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
56251735|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56251736|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56251737|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56251738|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251739|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251740|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
56251741|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56251742|NCT01870115|Vitamin D|vitamin d|mesh-list
56185486|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56185487|NCT01431404|Analgesics|analgesics|mesh-ancestor
56185488|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
56185489|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185490|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185491|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185492|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185493|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56185494|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56185495|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
56251743|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
56251744|NCT01870115|Melatonin|melatonin|mesh-list
56251745|NCT01870115|Vitamins|vitamins|mesh-ancestor
56251746|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
56251747|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251748|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56251749|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251750|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56251781|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56251783|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
56251784|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56251785|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56251786|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251787|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56251788|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56681232|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56681233|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56681234|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56681235|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56681236|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56251789|NCT01870128|Analgesics|analgesics|mesh-ancestor
56251790|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
56251791|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56251792|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56251793|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827063|NCT04859465|Doxorubicin|doxorubicin|mesh-list
56251820|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56251821|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56251822|NCT01870427|Growth Substances|growth substances|mesh-ancestor
56251823|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251824|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
56251825|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251826|NCT01870440|Dexamethasone|dexamethasone|mesh-list
56251828|NCT01870440|BB 1101|bb 1101|mesh-list
56251829|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56251830|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
56251831|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
56251832|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251833|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251834|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251835|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
56251836|NCT01870440|Hormones|hormones|mesh-ancestor
56251837|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56251838|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56251839|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251840|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
56251841|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827099|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251876|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251877|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
56251878|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
56251879|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56251880|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
56251881|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251914|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251916|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56251917|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56251918|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56251919|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
56251920|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185497|NCT01431430|Vitamin D|vitamin d|mesh-list
56185498|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56185499|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185500|NCT01431430|Vitamins|vitamins|mesh-ancestor
56185501|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
56185502|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56185503|NCT01431443|Theobromine|theobromine|mesh-list
56185504|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56185505|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
56185506|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185507|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185508|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55895097|NCT00789399|PENTA|penta|mesh-list
56251921|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56251922|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56251958|NCT01871311|Cetuximab|cetuximab|mesh-list
56251959|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56251960|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252025|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252027|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252028|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
56252029|NCT01871662|Protective Agents|protective agents|mesh-ancestor
56252030|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56252031|NCT01871675|Rituximab|rituximab|mesh-list
56252032|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56681237|NCT00663377|Losartan|losartan|mesh-list
56681238|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56681239|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56252033|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56252034|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252035|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
56252036|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252037|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252038|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56252039|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
56252040|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252041|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
56252076|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56252077|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56252078|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252079|NCT01871740|Folic Acid|folic acid|mesh-list
56252115|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
56252116|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252117|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252118|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252119|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56252139|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56252140|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56252141|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
56252151|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
56252152|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252153|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56252154|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56252155|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
56252156|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
56185509|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
55895143|NCT02455362|Analgesics|analgesics|mesh-ancestor
56252157|NCT01871961|Methotrexate|methotrexate|mesh-list
56252158|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56252159|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
56252160|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56252161|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252162|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56252163|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
56252164|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252165|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252166|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
56252167|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252168|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56252169|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252170|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
56252171|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252172|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56252173|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56252174|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
56252175|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56252176|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56252203|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252204|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
56252205|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
56252206|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
56252207|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
56252208|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252209|NCT01872351|Protective Agents|protective agents|mesh-ancestor
56252210|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252211|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
56252213|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
56252214|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
56252215|NCT01872403|Paclitaxel|paclitaxel|mesh-list
56252216|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56252217|NCT01872403|Carboplatin|carboplatin|mesh-list
56252218|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56252219|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252220|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
56252221|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
56252222|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
56252223|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681240|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56681241|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56681242|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681243|NCT00669149|Aspirin|aspirin|mesh-list
56681244|NCT00669149|Heparin|heparin|mesh-list
56252248|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
56252249|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
56252250|NCT01872494|Pentazocine|pentazocine|mesh-list
56252251|NCT01872494|Palonosetron|palonosetron|mesh-list
56252252|NCT01872494|Ropivacaine|ropivacaine|mesh-list
56252253|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
56252254|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
56252255|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252256|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252257|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
56252258|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252259|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
56252260|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
56252261|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56252262|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56252263|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56252264|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
56252265|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252266|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252267|NCT01872494|Analgesics|analgesics|mesh-ancestor
56252268|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56252269|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56252270|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252271|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252272|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56252273|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252297|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
56252298|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
56252299|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56252300|NCT01872754|Narcotics|narcotics|mesh-ancestor
56252301|NCT01872754|Analgesics|analgesics|mesh-ancestor
56252302|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
56185510|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
56185511|NCT01431456|Nadroparin|nadroparin|mesh-list
56185512|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
56185513|NCT01431456|Dabigatran|dabigatran|mesh-list
56185514|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56113266|NCT00608777|Hormones|hormones|mesh-ancestor
56185515|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
56185516|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56185517|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
56185518|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185519|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185520|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
56185521|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56185522|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56252303|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252304|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
56252305|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56252306|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252307|NCT01872832|Verinurad|verinurad|mesh-list
56252308|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
56252309|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252310|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56252311|NCT01872845|Pravastatin|pravastatin|mesh-list
56252312|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56252313|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56252314|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
56252315|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252316|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56252317|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56252318|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252319|NCT01872858|Aspirin|aspirin|mesh-list
55874368|NCT01922817|Hormones|hormones|mesh-ancestor
56252320|NCT01872858|Cilostazol|cilostazol|mesh-list
56252321|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56252322|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56252323|NCT01872858|Analgesics|analgesics|mesh-ancestor
56681245|NCT00669149|Enoxaparin|enoxaparin|mesh-list
56681246|NCT00669149|Bivalirudin|bivalirudin|mesh-list
56681247|NCT00669149|Clopidogrel|clopidogrel|mesh-list
56681248|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56681249|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56681250|NCT00669149|Analgesics|analgesics|mesh-ancestor
56681251|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
56681252|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237082|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
56252324|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
56252325|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252326|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252327|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252328|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55827579|NCT04524689|Maytansine|maytansine|mesh-list
56252364|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56252365|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56252366|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
56252367|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
56000884|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252396|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56252397|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252398|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874441|NCT01180036|Cyclosporine|cyclosporine|mesh-list
56252399|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56252400|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56252401|NCT01873001|Pioglitazone|pioglitazone|mesh-list
56252402|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
56252403|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56252409|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
56252410|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56252439|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
56185523|NCT01431495|Clopidogrel|clopidogrel|mesh-list
56185524|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56185525|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55895277|NCT02357290|Expectorants|expectorants|mesh-ancestor
56252440|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252441|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56252442|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
56252443|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
56252444|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
56252445|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56252446|NCT01873157|Bortezomib|bortezomib|mesh-list
56252447|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252448|NCT01873222|Sirolimus|sirolimus|mesh-list
56252449|NCT01873222|Umirolimus|umirolimus|mesh-list
56252450|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252451|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252452|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
56252453|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252454|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252455|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252456|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56000885|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
56252488|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56252489|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252490|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56252491|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56252492|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252493|NCT01873430|Melatonin|melatonin|mesh-list
56252494|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
56252495|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252496|NCT01873430|Protective Agents|protective agents|mesh-ancestor
56252497|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252498|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252499|NCT01873443|Folic Acid|folic acid|mesh-list
56252500|NCT01873443|Rituximab|rituximab|mesh-list
56000886|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
56681253|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681254|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56681255|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252515|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252517|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252518|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252519|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56252520|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56252521|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252522|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252523|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252524|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56252525|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56252526|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
56252527|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
56252528|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56252529|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56252530|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252531|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
56252532|NCT01873768|Coagulants|coagulants|mesh-ancestor
56252533|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
56252534|NCT01873807|Etoposide|etoposide|mesh-list
56252535|NCT01873807|Idarubicin|idarubicin|mesh-list
56252536|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252537|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
56252538|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252539|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252540|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56252541|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
56252549|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56252550|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
56252551|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
56185526|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56185527|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55895367|NCT03238482|Xhance|xhance|mesh-list
56252552|NCT01873820|Calcium|calcium|mesh-list
56252553|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56252554|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252555|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
56252556|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252557|NCT01873820|Protective Agents|protective agents|mesh-ancestor
56252558|NCT01873820|Vitamins|vitamins|mesh-ancestor
56252559|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
56252560|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
56252561|NCT01873833|Capecitabine|capecitabine|mesh-list
56252562|NCT01873833|Trastuzumab|trastuzumab|mesh-list
56252585|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
56252586|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252587|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
56252588|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252589|NCT01874028|Trientine|trientine|mesh-list
56252590|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
56252591|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
56252592|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252593|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
56252594|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252595|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
56252596|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
56252597|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
56252598|NCT01874080|Metformin|metformin|mesh-list
56252599|NCT01874080|Saxagliptin|saxagliptin|mesh-list
56252600|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56252601|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252602|NCT01874080|Incretins|incretins|mesh-ancestor
56252603|NCT01874080|Hormones|hormones|mesh-ancestor
56252604|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56252605|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56252606|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
56252607|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252608|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252609|NCT01874171|Cetuximab|cetuximab|mesh-list
56252610|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252611|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56681256|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56681257|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56681258|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681259|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56681260|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56681261|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327585|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327586|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56327587|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
56327589|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56681263|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56681264|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56681265|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56681266|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
56681267|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681268|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
56681269|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
56681270|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56681271|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
56681272|NCT00663455|Cyclosporine|cyclosporine|mesh-list
56681273|NCT00663455|Cyclosporins|cyclosporins|mesh-list
56681274|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681275|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681276|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681277|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
56681278|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681279|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
56681280|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681281|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
56681282|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56681283|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56681284|NCT00669695|Atorvastatin|atorvastatin|mesh-list
56681285|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56681286|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56681287|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
56237090|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56252612|NCT01874236|Bupivacaine|bupivacaine|mesh-list
56681288|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681289|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56237128|NCT01755182|Hormones|hormones|mesh-ancestor
56252613|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
56252614|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
56252615|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252647|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56252648|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252649|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252650|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
56252651|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252652|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252653|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
56252654|NCT01874574|Protective Agents|protective agents|mesh-ancestor
56252655|NCT01874639|Hemostatics|hemostatics|mesh-list
56252656|NCT01874639|Coagulants|coagulants|mesh-ancestor
56252657|NCT01874678|Cisplatin|cisplatin|mesh-list
56252658|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252659|NCT01874717|Midazolam|midazolam|mesh-list
56252660|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56252661|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56252728|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56252729|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252776|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252778|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
56252779|NCT01875757|Vitamins|vitamins|mesh-ancestor
56252780|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
56252781|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252782|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56252783|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56252784|NCT01875822|Curcumin|curcumin|mesh-list
56252785|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56252786|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56252787|NCT01875822|Analgesics|analgesics|mesh-ancestor
56185528|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
56185529|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185530|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185531|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185532|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56185533|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
56185534|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185535|NCT01431612|Phenylephrine|phenylephrine|mesh-list
56185536|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
56185537|NCT01431612|Esmolol|esmolol|mesh-list
56185538|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56185539|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
56185540|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
56252788|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
55828054|NCT02188784|Trace Elements|trace elements|mesh-ancestor
56252916|NCT01876615|Analgesics|analgesics|mesh-ancestor
56252917|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
56252918|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252919|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828194|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
56253005|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253054|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253055|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253056|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56253057|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
56253058|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
56253059|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56253060|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
56253061|NCT01877954|Hormones|hormones|mesh-ancestor
56253062|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253063|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56253064|NCT01878136|Plasminogen|plasminogen|mesh-list
56253065|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56253066|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56253067|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253068|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
56253094|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681290|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56681291|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681292|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56237131|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
56253095|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
56253096|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253097|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56253098|NCT01878357|Primaquine|primaquine|mesh-list
56253099|NCT01878357|Piperaquine|piperaquine|mesh-list
56253100|NCT01878357|Artenimol|artenimol|mesh-list
56253101|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
56253102|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56253103|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56253104|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253105|NCT01878422|Leucovorin|leucovorin|mesh-list
56253106|NCT01878422|Bevacizumab|bevacizumab|mesh-list
56253107|NCT01878422|Cetuximab|cetuximab|mesh-list
56253108|NCT01878422|Fluorouracil|fluorouracil|mesh-list
56253109|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
56253110|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56253111|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253112|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56253113|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56253114|NCT01878422|Growth Substances|growth substances|mesh-ancestor
56253115|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253116|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
56253117|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
56253218|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253219|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253221|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56253222|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185541|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185542|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185543|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
56185544|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56185545|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
56185546|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
56185547|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56185548|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56185549|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56185550|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
56185551|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895488|NCT03240120|Tinzaparin|tinzaparin|mesh-list
56253223|NCT01879202|Methylphenidate|methylphenidate|mesh-list
56253908|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56253909|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56253910|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
56253911|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
56253912|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253913|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253914|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56253916|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56253917|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
56253918|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253919|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253920|NCT01884909|Metoprolol|metoprolol|mesh-list
56253921|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56253922|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56253923|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
56253924|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
55829156|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
56254329|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254330|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254368|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
55829602|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254813|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254814|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56254815|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56254817|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56254818|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
56254819|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254821|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56681293|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681294|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56681295|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681296|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254822|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56254823|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254824|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
56254825|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
56254826|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56254827|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56254828|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254829|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254830|NCT01889966|Urological Agents|urological agents|mesh-ancestor
56254831|NCT01889979|Tramadol|tramadol|mesh-list
56254832|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56254833|NCT01889979|Narcotics|narcotics|mesh-ancestor
56254834|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254835|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254836|NCT01889979|Analgesics|analgesics|mesh-ancestor
56254837|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
56254838|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254839|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
56254840|NCT01890538|Piracetam|piracetam|mesh-list
56254841|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
56254842|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
56254843|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185552|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185553|NCT01431612|Protective Agents|protective agents|mesh-ancestor
56185554|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56185555|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56185556|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56185557|NCT01431690|Warfarin|warfarin|mesh-list
56185558|NCT01431690|Anticoagulants|anticoagulants|mesh-list
56185559|NCT01431729|Propolis|propolis|mesh-list
56185560|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185561|NCT01431742|Buprenorphine|buprenorphine|mesh-list
56185562|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56185563|NCT01431742|Narcotics|narcotics|mesh-ancestor
56185564|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185565|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185566|NCT01431742|Analgesics|analgesics|mesh-ancestor
56185567|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
56185568|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185569|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56185570|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56185571|NCT01431781|Somatostatin|somatostatin|mesh-list
56185572|NCT01431781|Hormones|hormones|mesh-ancestor
56254844|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254845|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56254846|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56254847|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
56254848|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
56254868|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254869|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254870|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56254871|NCT01891487|Bimatoprost|bimatoprost|mesh-list
56254872|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56254873|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
56254874|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254875|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
56254876|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56254877|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254878|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
56254879|NCT01893229|Valproic Acid|valproic acid|mesh-list
56254880|NCT01893229|Olanzapine|olanzapine|mesh-list
56254881|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56254882|NCT01893229|Ziprasidone|ziprasidone|mesh-list
56254883|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
55876916|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56254884|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
56254885|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
56254886|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254887|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254888|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56681297|NCT00669773|Docetaxel|docetaxel|mesh-list
56681298|NCT00669773|Doxorubicin|doxorubicin|mesh-list
56681299|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56681300|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681301|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
56254889|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56254890|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254891|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254892|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254893|NCT01893229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56254894|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56254895|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56254896|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254897|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185573|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254898|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
56254899|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
56254900|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254901|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
56254902|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
56254903|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
56254904|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55830110|NCT02131064|Carboplatin|carboplatin|mesh-list
56255170|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56255171|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255172|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255173|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56255174|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
56255232|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
56255233|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255234|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255235|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56255236|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56255237|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56255238|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255239|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255241|NCT01900847|Morphine|morphine|mesh-list
56255242|NCT01900847|Analgesics|analgesics|mesh-ancestor
56255243|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
56255244|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255245|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255246|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56255247|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56255248|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
56255249|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
56255250|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255251|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56255252|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56255253|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255254|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255255|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56255256|NCT01900847|Narcotics|narcotics|mesh-ancestor
56255257|NCT01900860|Vitamin D|vitamin d|mesh-list
56255258|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
56255259|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
56255260|NCT01900860|Vitamins|vitamins|mesh-list
56255261|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
56255262|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255263|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56255264|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56255265|NCT01900886|Ribavirin|ribavirin|mesh-list
56255266|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56255267|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
56255268|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255298|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56255299|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56255300|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255301|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56255302|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56255303|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681302|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
56255304|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
56255305|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
56255306|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255307|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255308|NCT01901120|Mirabegron|mirabegron|mesh-list
56255309|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56255310|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56255311|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56255312|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255313|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255314|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255315|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255316|NCT01901120|Urological Agents|urological agents|mesh-ancestor
56255317|NCT01901172|Posaconazole|posaconazole|mesh-list
56255318|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
56255319|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255320|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56185574|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185575|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
56185576|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56185577|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185578|NCT01431924|Fluticasone|fluticasone|mesh-list
56185579|NCT01431924|Xhance|xhance|mesh-list
56185580|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56185581|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185582|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56185583|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
56255321|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56255322|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56255323|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56255324|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56255325|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255326|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255617|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56255618|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255619|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56255620|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
56255621|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
56255622|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56255623|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56255624|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
56255625|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56255626|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56255627|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255628|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255810|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56255811|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255812|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56255813|NCT01904539|Cathartics|cathartics|mesh-ancestor
56255814|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56255815|NCT01904591|Vitamin E|vitamin e|mesh-list
56255816|NCT01904591|Selenium|selenium|mesh-list
56255817|NCT01904591|Vitamins|vitamins|mesh-ancestor
56255818|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
56255819|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255820|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
56255821|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255822|NCT01904591|Protective Agents|protective agents|mesh-ancestor
56255823|NCT01904591|Trace Elements|trace elements|mesh-ancestor
56255824|NCT01904643|Cytarabine|cytarabine|mesh-list
56255825|NCT01904643|Etoposide|etoposide|mesh-list
56255826|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
56255827|NCT01904643|Lenalidomide|lenalidomide|mesh-list
55831038|NCT01483690|Analgesics|analgesics|mesh-ancestor
56255853|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255855|NCT01904695|Diuretics|diuretics|mesh-list
56255856|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56255857|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56255858|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
56255859|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255860|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
56255861|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255862|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255863|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681303|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
56255864|NCT01904734|Clomiphene|clomiphene|mesh-list
56255865|NCT01904734|Enclomiphene|enclomiphene|mesh-list
56255866|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
56255867|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56255868|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
56255869|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56255870|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255871|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56255872|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
56255873|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56185584|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185585|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255874|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56255975|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
56255976|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255977|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
56255978|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255979|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255980|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255981|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56255982|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56255983|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56255984|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56255985|NCT01905501|Anesthetics|anesthetics|mesh-list
56255986|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255987|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255988|NCT01905566|Clopidogrel|clopidogrel|mesh-list
56255989|NCT01905566|Ticagrelor|ticagrelor|mesh-list
56255990|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56255991|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56255992|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56255993|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56255994|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
56255995|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255996|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255997|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255998|NCT01905618|Nicotine|nicotine|mesh-list
56255999|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56256000|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
56256001|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256002|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256003|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56256004|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56256005|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
56256006|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256007|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256008|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
56256009|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56256010|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
56256011|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256334|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56256337|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256338|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
56256339|NCT01907880|Pamidronate|pamidronate|mesh-list
56256340|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56256341|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256343|NCT01907984|Midazolam|midazolam|mesh-list
56256344|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56256345|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56256346|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256347|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256348|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56256349|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56256350|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56256351|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56256352|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
56256353|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
56256354|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
56256355|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
56256356|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256357|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103223|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
56681304|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681305|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56681306|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56681307|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56681308|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681309|NCT00824616|Insulin|insulin|mesh-list
56681310|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56681311|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681312|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56681313|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
56681314|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56681315|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56681316|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681317|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681318|NCT00663845|Urological Agents|urological agents|mesh-ancestor
56681319|NCT00708240|Citalopram|citalopram|mesh-list
56327659|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56327660|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
56327661|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327662|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327663|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56327664|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
56327665|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56327666|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56327667|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56327668|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56327669|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
56327670|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56327671|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56327672|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327673|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56256358|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56256359|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56256360|NCT01907984|Analgesics|analgesics|mesh-ancestor
56256361|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
56256362|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256363|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256364|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185586|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56185587|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
56185588|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
56681320|NCT00708240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56681321|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56681322|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681323|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681324|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681325|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
56681326|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681327|NCT00708240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56681328|NCT00708240|Antidepressive Agents|antidepressive agents|mesh-ancestor
56681329|NCT00708240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681330|NCT04155515|Ribavirin|ribavirin|mesh-list
56681331|NCT04155515|Yimitasvir|yimitasvir|mesh-list
56681332|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
56681333|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681334|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
56681335|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681336|NCT00664001|Antioxidants|antioxidants|mesh-list
56681337|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681338|NCT00664001|Protective Agents|protective agents|mesh-ancestor
56681339|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681340|NCT00824382|Olodaterol|olodaterol|mesh-list
56681341|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56681342|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
56681343|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681344|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681345|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56681346|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
56681347|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55812613|NCT04771767|Analgesics|analgesics|mesh-ancestor
56256365|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56256366|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256368|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
56256369|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
56256370|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256371|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256372|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
56256373|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256374|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56256375|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55831566|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
56256409|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
56256410|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256411|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56256412|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
56681348|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56681349|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
56681350|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56681351|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681352|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56681353|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56256413|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
56256414|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56256415|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56256416|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56256417|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55831618|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
56256573|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256574|NCT01909830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256575|NCT01909830|Immunologic Factors|immunologic factors|mesh-ancestor
56256576|NCT01909830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256577|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56256578|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56256579|NCT01909843|Gontivimab|gontivimab|mesh-list
56256580|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
56256581|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256582|NCT01909856|Dexamethasone|dexamethasone|mesh-list
56256583|NCT01909856|Palonosetron|palonosetron|mesh-list
56256584|NCT01909856|Granisetron|granisetron|mesh-list
56256585|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256586|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
56256587|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
55831797|NCT01630811|Quinidine|quinidine|mesh-list
56256788|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
56256789|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56256790|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56256791|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56256795|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256796|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
56256797|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256798|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256799|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56256800|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
56256801|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256802|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256803|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56256804|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
56256805|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256806|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
56256807|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256808|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256809|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56256810|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
56256811|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256812|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256813|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56256814|NCT01910883|Finafloxacin|finafloxacin|mesh-list
56256815|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
55831999|NCT01451398|Insulin|insulin|mesh-list
56256845|NCT01911195|Isoflurane|isoflurane|mesh-list
56256846|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56256847|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
56256848|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
56185589|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55895891|NCT02359006|Minocycline|minocycline|mesh-list
56256849|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256850|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256851|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
56256852|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56256853|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
56256854|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256856|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56256857|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256858|NCT01911299|Choline|choline|mesh-list
56681354|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56681355|NCT00708318|Fentanyl|fentanyl|mesh-list
56681356|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56681357|NCT00708318|Narcotics|narcotics|mesh-ancestor
56681358|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56681359|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681360|NCT00708318|Analgesics|analgesics|mesh-ancestor
56681361|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
56681362|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681363|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56681364|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56681365|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
56681366|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
56681367|NCT00670475|Piroxicam|piroxicam|mesh-list
56681368|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56681369|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56256859|NCT01911299|Glycerol|glycerol|mesh-list
56256860|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
56256861|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56256862|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
56256889|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56256890|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56256891|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56256892|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56256893|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256894|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
56256895|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256896|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256897|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56256898|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256899|NCT01911455|Acamprosate|acamprosate|mesh-list
56256900|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56256902|NCT01911468|Liraglutide|liraglutide|mesh-list
56256903|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56256904|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56256905|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256906|NCT01911468|Incretins|incretins|mesh-ancestor
56256907|NCT01911468|Hormones|hormones|mesh-ancestor
56256908|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256909|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
56256936|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256937|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256938|NCT01911598|Paclitaxel|paclitaxel|mesh-list
56256939|NCT01911598|Carboplatin|carboplatin|mesh-list
56256940|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56256941|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256942|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
56256943|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
56256944|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
56256945|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256951|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56256952|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56256953|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256954|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
56256955|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56256956|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
56256957|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256958|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
56256994|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56256995|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
56681370|NCT00670475|Analgesics|analgesics|mesh-ancestor
56681371|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
56681372|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681373|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681374|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56681375|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256996|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256997|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256998|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56256999|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56257000|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
56257036|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257037|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56257038|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56257039|NCT01912118|Remifentanil|remifentanil|mesh-list
56257040|NCT01912118|Propofol|propofol|mesh-list
56257041|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55832333|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56257167|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56257169|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56185590|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56257170|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257171|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56257172|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56257173|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257174|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257175|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257176|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257177|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56257178|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56257179|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
56257180|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257181|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56257182|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257183|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257184|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
56257185|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257186|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257187|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56257188|NCT01913054|Fentanyl|fentanyl|mesh-list
56257189|NCT01913054|Propofol|propofol|mesh-list
56257190|NCT01913054|Etomidate|etomidate|mesh-list
56257191|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56257192|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257193|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832372|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
56257227|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
56257228|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257229|NCT01913444|Antithrombins|antithrombins|mesh-list
56257230|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
56257231|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56257232|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
56257233|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257234|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257235|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
56257236|NCT01913691|Ipilimumab|ipilimumab|mesh-list
56257253|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
56257254|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
56257255|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56257256|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56257257|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800954|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56257266|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257268|NCT01913990|Dexamethasone|dexamethasone|mesh-list
56257269|NCT01913990|Ondansetron|ondansetron|mesh-list
56257270|NCT01913990|Aprepitant|aprepitant|mesh-list
56257271|NCT01913990|Antiemetics|antiemetics|mesh-list
56257272|NCT01913990|Emetics|emetics|mesh-list
56681376|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56681377|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681378|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681379|NCT04154033|Naltrexone|naltrexone|mesh-list
56257273|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56257274|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
56257275|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257276|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257277|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56257278|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
56257279|NCT01913990|Hormones|hormones|mesh-ancestor
56257280|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257281|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56257282|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257283|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
56257284|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
56257285|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56257286|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
56257287|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257288|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257289|NCT01913990|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56257290|NCT01913990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56185591|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56185592|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56185593|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
56185594|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185595|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185596|NCT01432028|Drospirenone|drospirenone|mesh-list
56185597|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56185598|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56185600|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56185601|NCT01432028|Progesterone|progesterone|mesh-list
56185602|NCT01432028|Estrogens|estrogens|mesh-ancestor
56185603|NCT01432028|Hormones|hormones|mesh-ancestor
56185604|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185605|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185606|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56185607|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
56185608|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56185609|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56185610|NCT01432028|Progestins|progestins|mesh-ancestor
56185611|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56185612|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
56185613|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56185614|NCT01432028|Diuretics|diuretics|mesh-ancestor
56257291|NCT01913990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257292|NCT01913990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56257293|NCT01913990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56257294|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56257295|NCT01914042|Morphine|morphine|mesh-list
56257311|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
56257312|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56257313|NCT01914081|Resveratrol|resveratrol|mesh-list
56257314|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
56257315|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257316|NCT01914081|Protective Agents|protective agents|mesh-ancestor
56257317|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257319|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56257320|NCT01914133|Acarbose|acarbose|mesh-list
56257321|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
56257322|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257323|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257324|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56257325|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257326|NCT01914146|Insulin|insulin|mesh-list
56257327|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56257328|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56257329|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257330|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
56257331|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56681380|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56681381|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56681382|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681383|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
56681384|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681385|NCT05530356|Dextrans|dextrans|mesh-list
56681386|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
56681387|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
56257332|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56185615|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
56185616|NCT01432080|Azithromycin|azithromycin|mesh-list
56185617|NCT01432080|Prednisone|prednisone|mesh-list
56257333|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257334|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
56257335|NCT01914211|Coagulants|coagulants|mesh-ancestor
56257336|NCT01914237|Castor Oil|castor oil|mesh-list
56257337|NCT01914237|Cathartics|cathartics|mesh-ancestor
56257338|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56257339|NCT01914250|Analgesics|analgesics|mesh-list
56257340|NCT01914250|Tetracaine|tetracaine|mesh-list
56257341|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
56257342|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257343|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257344|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
56257345|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
56257346|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257347|NCT01914380|Aflibercept|aflibercept|mesh-list
56257348|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56257349|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56257350|NCT01914380|Growth Substances|growth substances|mesh-ancestor
56257351|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257352|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
56257353|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257354|NCT01914419|Oxytocin|oxytocin|mesh-list
56257465|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56257466|NCT01915069|Protective Agents|protective agents|mesh-ancestor
56257467|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56257468|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56257469|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257471|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56257472|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257473|NCT01915134|Gemcitabine|gemcitabine|mesh-list
56257573|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257574|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
56257575|NCT01915979|Betamethasone|betamethasone|mesh-list
56257576|NCT01915979|Mitogens|mitogens|mesh-list
56257577|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56257578|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257579|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56257580|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
56257581|NCT01915979|Hormones|hormones|mesh-ancestor
56257582|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257583|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257753|NCT01916915|Narcotics|narcotics|mesh-ancestor
56257754|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257755|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257756|NCT01916915|Analgesics|analgesics|mesh-ancestor
56257757|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
56257758|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257759|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
56257760|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
56257761|NCT01916954|Lumefantrine|lumefantrine|mesh-list
56257762|NCT01916954|Artemether|artemether|mesh-list
56257763|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56257764|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
56257765|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56257766|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56257767|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257768|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
56257769|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56103224|NCT00002882|Aldesleukin|aldesleukin|mesh-list
56681388|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
56681389|NCT00664313|Linezolid|linezolid|mesh-list
56681390|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56681391|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681392|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56327734|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56681393|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681394|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681396|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681397|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56681398|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681399|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681400|NCT00833040|Sufentanil|sufentanil|mesh-list
56681401|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56681402|NCT00833040|Narcotics|narcotics|mesh-ancestor
56681403|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56681404|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681405|NCT00833040|Analgesics|analgesics|mesh-ancestor
56257770|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257771|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257772|NCT01917032|Folic Acid|folic acid|mesh-list
56257773|NCT01917032|Vitamin A|vitamin a|mesh-list
56257774|NCT01917032|Micronutrients|micronutrients|mesh-list
56257775|NCT01917032|Trace Elements|trace elements|mesh-list
56257776|NCT01917032|Tretinoin|tretinoin|mesh-list
56257777|NCT01917032|Vitamins|vitamins|mesh-ancestor
55832958|NCT02128217|Ribavirin|ribavirin|mesh-list
56257951|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257952|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56257953|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56257954|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56257955|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56257956|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257961|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
55880004|NCT01445626|Dexamethasone|dexamethasone|mesh-list
56257980|NCT01917890|Curcumin|curcumin|mesh-list
56257981|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56257982|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56257983|NCT01917890|Analgesics|analgesics|mesh-ancestor
56257984|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
56257985|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258014|NCT01918124|Paclitaxel|paclitaxel|mesh-list
56258015|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
56258016|NCT01918124|Cisplatin|cisplatin|mesh-list
56258017|NCT01918124|Carboplatin|carboplatin|mesh-list
56258018|NCT01918124|Doxorubicin|doxorubicin|mesh-list
56258019|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56258020|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258021|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
56258022|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
56258023|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
56258024|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258025|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56258026|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
56258027|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258028|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56258029|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56258030|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
56258031|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56681406|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
56681407|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681408|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56681409|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55833211|NCT02042443|Vitamins|vitamins|mesh-ancestor
56185631|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185632|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56185633|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
56185634|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56185635|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185636|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56185637|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56185638|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56185639|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
56185640|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185641|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185642|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56185643|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56185644|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56185645|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56185646|NCT01432106|Valsartan|valsartan|mesh-list
56185647|NCT01432106|Ramipril|ramipril|mesh-list
55896223|NCT04555577|Peposertib|peposertib|mesh-list
56258150|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258152|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56258153|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56258154|NCT01918878|Growth Substances|growth substances|mesh-ancestor
56258155|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258156|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
56258157|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258158|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
56258159|NCT01918904|Antidotes|antidotes|mesh-ancestor
56258160|NCT01918904|Protective Agents|protective agents|mesh-ancestor
56258161|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258162|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
56258163|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258164|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
56258165|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56258166|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258167|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
56258168|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
56258169|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
56258170|NCT01918917|Morphine|morphine|mesh-list
56258171|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
56258172|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56258173|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258174|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258175|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56258176|NCT01918917|Analgesics|analgesics|mesh-ancestor
56258177|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
56258244|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258245|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
56258246|NCT01919346|Eculizumab|eculizumab|mesh-list
56258247|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56258248|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56258249|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
56258250|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258251|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
56258252|NCT01919424|Miotics|miotics|mesh-ancestor
56258253|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
56258254|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258255|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258256|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56185648|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56185649|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56185650|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56185651|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185652|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56185653|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
56185654|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185655|NCT01432119|Cetuximab|cetuximab|mesh-list
56681410|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
56681411|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
56681412|NCT02629835|Dexamethasone|dexamethasone|mesh-list
56681413|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
56681414|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56681415|NCT02629835|BB 1101|bb 1101|mesh-list
56237227|NCT01755559|Artesunate|artesunate|mesh-list
56185656|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56185657|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56185658|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185659|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55896279|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
56258257|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56258258|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
56258259|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56258260|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56258261|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
56258262|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258263|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258264|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
56258265|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56258266|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
56258267|NCT01919593|Povidone|povidone|mesh-list
56258268|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55880299|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
56258269|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258270|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
56258271|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
56258272|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
56258273|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
56258274|NCT01919788|Insulin|insulin|mesh-list
56258275|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56258276|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258277|NCT01919879|Cetuximab|cetuximab|mesh-list
56258278|NCT01919879|Afatinib|afatinib|mesh-list
56258279|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56258280|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258281|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56258282|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258283|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258284|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
55833453|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
56258319|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56258320|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56258321|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56258322|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
56258323|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56258429|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258430|NCT01923974|Protective Agents|protective agents|mesh-ancestor
56258431|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258432|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258433|NCT01924013|Vitamin D|vitamin d|mesh-list
56258434|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
56258460|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56258461|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56258462|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56258463|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
56258464|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258465|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185660|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185661|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185662|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56185663|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
56185664|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113445|NCT00500045|Niacin|niacin|mesh-list
56185665|NCT01432223|Paclitaxel|paclitaxel|mesh-list
56185666|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56185667|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185668|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
56681416|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56681417|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
56681418|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
56681419|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681420|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681421|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56185669|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
56185670|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
56185671|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185672|NCT01432249|Etanercept|etanercept|mesh-list
56258466|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
56258467|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
56258468|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56258469|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56258470|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56258471|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56258472|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
56258474|NCT01927679|Antioxidants|antioxidants|mesh-list
56258475|NCT01927679|Vitamins|vitamins|mesh-ancestor
56258476|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
56258477|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258478|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258479|NCT01927679|Protective Agents|protective agents|mesh-ancestor
56258480|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
56258481|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56258482|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
56258483|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258523|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258524|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
56258525|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
56258526|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
56258527|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258529|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56258530|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56258531|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258532|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258533|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56258534|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56258535|NCT01930318|Analgesics|analgesics|mesh-ancestor
56258536|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
56258537|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258538|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258539|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56258540|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56258541|NCT01930331|Piperaquine|piperaquine|mesh-list
56258542|NCT01930331|Artenimol|artenimol|mesh-list
56258543|NCT01930331|Artemisinins|artemisinins|mesh-list
56258544|NCT01930331|Artemisinin|artemisinin|mesh-list
56258545|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
56258546|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56258547|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56258548|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258549|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56258550|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
56258551|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
56258552|NCT01930396|Heparin|heparin|mesh-list
56258553|NCT01930396|Calcium heparin|calcium heparin|mesh-list
56185673|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56185674|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56185675|NCT01432249|Analgesics|analgesics|mesh-ancestor
56185676|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
56185677|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185678|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185679|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185680|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185681|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56185682|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56185683|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
56185684|NCT01432470|Oxytocin|oxytocin|mesh-list
56681422|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
56681423|NCT02629835|Hormones|hormones|mesh-ancestor
56681424|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56681425|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56681426|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185685|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
56185686|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56185687|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185688|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
56185689|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185690|NCT01432496|Ropivacaine|ropivacaine|mesh-list
56185691|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
56185692|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
56185693|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185694|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185695|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
56185696|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185697|NCT01432522|Epinephrine|epinephrine|mesh-list
56185698|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56185699|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56185700|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
56185701|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185702|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185703|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258554|NCT01930396|Tinzaparin|tinzaparin|mesh-list
56258555|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56258556|NCT01930396|Dalteparin|dalteparin|mesh-list
56258557|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
56258558|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56258559|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56258560|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258561|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
56258584|NCT01930552|Growth Substances|growth substances|mesh-ancestor
56258585|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
56258586|NCT01930591|Clopidogrel|clopidogrel|mesh-list
56258587|NCT01930591|Ticagrelor|ticagrelor|mesh-list
56258588|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56185704|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56185705|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56185706|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
56185707|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185708|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56185709|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
56185710|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
56185711|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
56185712|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56185713|NCT01432587|Diflunisal|diflunisal|mesh-list
56258589|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56258590|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56258591|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56258592|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
56258593|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258594|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258595|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258596|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
56258597|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56258598|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56258599|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56258600|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258601|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258602|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56258603|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56258604|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258605|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
56258606|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258607|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56258608|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56258609|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56258610|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56681427|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
56681428|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681429|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258611|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258612|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55833781|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
56258678|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56258679|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56258680|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56258681|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258683|NCT01930916|Antibodies|antibodies|mesh-list
56258684|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
56258685|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
56258686|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
56258687|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258688|NCT01930955|Amoxicillin|amoxicillin|mesh-list
56258689|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56258690|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258691|NCT01931085|Triclabendazole|triclabendazole|mesh-list
56258714|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258715|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56258717|NCT01931215|Analgesics|analgesics|mesh-ancestor
56258718|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
56258719|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258720|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
56258721|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56258722|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
56258723|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
56258724|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56258725|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56258726|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56258727|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
56258728|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258729|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258730|NCT01931293|Folic Acid|folic acid|mesh-list
56185714|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56185715|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56185716|NCT01432587|Analgesics|analgesics|mesh-ancestor
56185717|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
56185718|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185719|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185720|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185721|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185722|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56185723|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185724|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185725|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
56258731|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
56258732|NCT01931293|Vitamins|vitamins|mesh-ancestor
56258733|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
56258734|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258735|NCT01931293|Hematinics|hematinics|mesh-ancestor
56258736|NCT01931306|Afatinib|afatinib|mesh-list
56258737|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258738|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56258739|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258740|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258741|NCT01931319|Baclofen|baclofen|mesh-list
56258742|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56258743|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258744|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56258745|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258746|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56258747|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
56258769|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
56258770|NCT01931501|Montelukast|montelukast|mesh-list
56258771|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56258772|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
56258773|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56258774|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
56258775|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56681430|NCT00664469|Atorvastatin|atorvastatin|mesh-list
56681431|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56681432|NCT00664469|Simvastatin|simvastatin|mesh-list
56258776|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258777|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56258778|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56258779|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258780|NCT01931514|Montelukast|montelukast|mesh-list
56258781|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56258782|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
56258783|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56258784|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
56258785|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56258786|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258787|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56258788|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56258789|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258790|NCT01931592|Gentamicins|gentamicins|mesh-list
56258791|NCT01931592|Colistin|colistin|mesh-list
56258792|NCT01931592|Fosfomycin|fosfomycin|mesh-list
56258793|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56258794|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258795|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56258796|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258797|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258798|NCT01931657|Mifepristone|mifepristone|mesh-list
56258799|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
56258841|NCT01932177|Sorafenib|sorafenib|mesh-list
56185727|NCT01432665|Androgens|androgens|mesh-ancestor
56185728|NCT01432665|Hormones|hormones|mesh-ancestor
56185729|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185730|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185731|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
56185732|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56185733|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56185734|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185735|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185736|NCT01432665|Urological Agents|urological agents|mesh-ancestor
56185737|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
56185738|NCT01432704|Vitamin D|vitamin d|mesh-list
56185739|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56185740|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185741|NCT01432704|Vitamins|vitamins|mesh-ancestor
56185742|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
56185743|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56185744|NCT01432717|Luspatercept|luspatercept|mesh-list
56185745|NCT01432717|Hematinics|hematinics|mesh-ancestor
56185746|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
56185747|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56185748|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56185749|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56185750|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56185751|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185752|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
56185753|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896568|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258842|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258843|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56258844|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
56258845|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258846|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56258847|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258848|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258849|NCT01932203|Aspirin|aspirin|mesh-list
56258850|NCT01932203|Cilostazol|cilostazol|mesh-list
56258851|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56258852|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56258853|NCT01932203|Analgesics|analgesics|mesh-ancestor
56258854|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
56258855|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258856|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681433|NCT00664469|Ezetimibe|ezetimibe|mesh-list
56681434|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56681435|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56681436|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
56681437|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681438|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56681439|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56681440|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681441|NCT00843024|Naproxen|naproxen|mesh-list
56681442|NCT00843024|Sumatriptan|sumatriptan|mesh-list
56681443|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56681444|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56681445|NCT00843024|Analgesics|analgesics|mesh-ancestor
56681446|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
56681447|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681448|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681449|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56681450|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56681451|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
56681452|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56681453|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681454|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681455|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56681456|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56681457|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56681458|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
56258857|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56258858|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56185754|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185755|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56185756|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896638|NCT02451072|Ketanserin|ketanserin|mesh-list
56258859|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56258907|NCT01932372|Etanercept|etanercept|mesh-list
56258908|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
56258909|NCT01932372|Tofacitinib|tofacitinib|mesh-list
56258910|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56258911|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56258912|NCT01932372|Analgesics|analgesics|mesh-ancestor
56258913|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
56258914|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258915|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258916|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56258917|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56258918|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56258919|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
56258920|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56681459|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681460|NCT04154813|Topiramate|topiramate|mesh-list
56681461|NCT04154813|Fluoxetine|fluoxetine|mesh-list
56681462|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
56681463|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56681464|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681465|NCT04154813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56681466|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56681467|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681468|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681469|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681470|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
56681471|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56681472|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
56681473|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681474|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56681475|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56681476|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681477|NCT00664703|Methylphenidate|methylphenidate|mesh-list
56681478|NCT00664703|Lobeline|lobeline|mesh-list
56681479|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56258921|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258922|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258923|NCT01932385|Sorafenib|sorafenib|mesh-list
56258924|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258925|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56258926|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258927|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258928|NCT01932424|Propofol|propofol|mesh-list
56258929|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56258930|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258931|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258932|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56258933|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
56258934|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
56258935|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
56258956|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56258957|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
56258958|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258959|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258960|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56258961|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56258962|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
56258963|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56258964|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56258965|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
56258966|NCT01932554|Ibuprofen|ibuprofen|mesh-list
56258967|NCT01932554|Fentanyl|fentanyl|mesh-list
56258968|NCT01932554|Morphine|morphine|mesh-list
56258969|NCT01932554|Hydromorphone|hydromorphone|mesh-list
56258970|NCT01932554|Narcotics|narcotics|mesh-list
56258971|NCT01932554|Abciximab|abciximab|mesh-list
56258972|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56103225|NCT00002882|Cisplatin|cisplatin|mesh-list
56681480|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681481|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56681482|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56681483|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681484|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681485|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
56681486|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258973|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258974|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258975|NCT01932554|Analgesics|analgesics|mesh-ancestor
56258976|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
56258977|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258978|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56258979|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56258980|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
56258981|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
56258982|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56258983|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56258984|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56258985|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56258986|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56258987|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258988|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258989|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
56258990|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56259025|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56259026|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56259027|NCT01933022|Leuprolide|leuprolide|mesh-list
56185757|NCT01432821|Apomorphine|apomorphine|mesh-list
56185758|NCT01432821|Emetics|emetics|mesh-ancestor
56185759|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185760|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
56185761|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185762|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56185763|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
56185764|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
56185765|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185766|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185767|NCT01432873|Selenium|selenium|mesh-list
56185768|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
56185769|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185770|NCT01432873|Protective Agents|protective agents|mesh-ancestor
56185771|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185772|NCT01432873|Trace Elements|trace elements|mesh-ancestor
56185773|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
56185774|NCT01432977|Acetaminophen|acetaminophen|mesh-list
56259028|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56259029|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
56259030|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56259031|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259032|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56259066|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56259067|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259068|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56259070|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259071|NCT01933516|Rituximab|rituximab|mesh-list
56259072|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56259073|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259074|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
56259124|NCT01934023|Varenicline|varenicline|mesh-list
56259125|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56259126|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56259127|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
56259128|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259129|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259130|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681487|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56681488|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
56681489|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681490|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56681491|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56681492|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
56681493|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
56681494|NCT00670787|Losartan|losartan|mesh-list
56681495|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56681496|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56681497|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56681498|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56681499|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56681500|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681501|NCT00670787|Diuretics|diuretics|mesh-ancestor
56681502|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
56681503|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681504|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56681505|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681506|NCT00664781|Rucaparib|rucaparib|mesh-list
56681507|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56681508|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237306|NCT01755923|Docetaxel|docetaxel|mesh-list
56259131|NCT01934049|Anesthetics|anesthetics|mesh-list
56259132|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259133|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259134|NCT01934088|Fentanyl|fentanyl|mesh-list
56259135|NCT01934088|Midazolam|midazolam|mesh-list
56259136|NCT01934088|Propofol|propofol|mesh-list
56259137|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56259138|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259139|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259140|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56259141|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
56259142|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
56259143|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56259144|NCT01934088|Narcotics|narcotics|mesh-ancestor
56259145|NCT01934088|Analgesics|analgesics|mesh-ancestor
56259146|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
56259147|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259148|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56259149|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56259150|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56259151|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56185775|NCT01432977|Droperidol|droperidol|mesh-list
56185776|NCT01432977|Ondansetron|ondansetron|mesh-list
56185777|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56185778|NCT01432977|Analgesics|analgesics|mesh-ancestor
56259152|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
56259153|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
56259154|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259155|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259156|NCT01934127|Vaccines|vaccines|mesh-list
56681509|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681510|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681511|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
56681512|NCT00832650|Fesoterodine|fesoterodine|mesh-list
56681513|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56681514|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56681515|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
56681516|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237324|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259157|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
56259158|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259159|NCT01934166|Nalmefene|nalmefene|mesh-list
56259160|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56259161|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259162|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
56259163|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259164|NCT01934361|Carboplatin|carboplatin|mesh-list
56259165|NCT01934361|Lomustine|lomustine|mesh-list
56259166|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259167|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56259168|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
56259169|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259170|NCT01934569|Losartan|losartan|mesh-list
56259171|NCT01934569|Midazolam|midazolam|mesh-list
56259172|NCT01934569|Caffeine|caffeine|mesh-list
56259173|NCT01934569|Omeprazole|omeprazole|mesh-list
56259174|NCT01934569|Pravastatin|pravastatin|mesh-list
56259175|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56259176|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56259177|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834333|NCT01846611|Dexamethasone|dexamethasone|mesh-list
56259192|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56259193|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56259194|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56259195|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259196|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56259197|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56259198|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
56259199|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56259200|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259201|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56259202|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56259203|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56259205|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56259206|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56259207|NCT01934634|Gemcitabine|gemcitabine|mesh-list
56259208|NCT01934634|Paclitaxel|paclitaxel|mesh-list
56259209|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56259210|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259211|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
56259212|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
56259213|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
56259214|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259215|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56259216|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
56259217|NCT01934634|Antiviral Agents|antiviral agents|mesh-ancestor
56259218|NCT01934634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259219|NCT01934634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259220|NCT01934634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56259221|NCT01934634|Immunologic Factors|immunologic factors|mesh-ancestor
56259222|NCT01934634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259223|NCT01934712|Insulin|insulin|mesh-list
56259224|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56259225|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
56259226|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
56259227|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56681517|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681518|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681519|NCT00832650|Urological Agents|urological agents|mesh-ancestor
56681520|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
56681521|NCT04153487|Vitamins|vitamins|mesh-ancestor
56681522|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
56681523|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681524|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
56681525|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681526|NCT04153487|Protective Agents|protective agents|mesh-ancestor
56681527|NCT00708396|Citalopram|citalopram|mesh-list
56681528|NCT00708396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56681529|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56681530|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681531|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681532|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327885|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
56327886|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327887|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327888|NCT04172675|Antiviral Agents|antiviral agents|mesh-ancestor
56327889|NCT04172675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56327890|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327891|NCT04172675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681533|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
56259228|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56259229|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259230|NCT01934777|Vitamin E|vitamin e|mesh-list
56259231|NCT01934777|Choline|choline|mesh-list
56259232|NCT01934777|Vitamins|vitamins|mesh-ancestor
56259233|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
56259234|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259235|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
56185779|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
56185780|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259236|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259237|NCT01934777|Protective Agents|protective agents|mesh-ancestor
56259238|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
56259262|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56259264|NCT01934933|Analgesics|analgesics|mesh-ancestor
56259265|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
56259266|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259267|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259268|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56259269|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56259270|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56259271|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56259272|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259273|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259274|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56681534|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681535|NCT00708396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56681536|NCT00708396|Antidepressive Agents|antidepressive agents|mesh-ancestor
56681537|NCT00708396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681538|NCT00665093|Insulin|insulin|mesh-list
56681539|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56681540|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
56681541|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
56681542|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
56681543|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56681544|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56681545|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681546|NCT00595517|Esomeprazole|esomeprazole|mesh-list
56681547|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56681548|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56681549|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56681550|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681551|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681552|NCT00911651|Bromides|bromides|mesh-list
56681553|NCT00911651|Albuterol|albuterol|mesh-list
56681554|NCT00911651|Ipratropium|ipratropium|mesh-list
56681555|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
56681556|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56681557|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
56681558|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681559|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681560|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56681561|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
56681562|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
56681563|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56681564|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56681565|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56681566|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56681567|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
56681575|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56681576|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56681577|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681578|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56681579|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56681580|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681581|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681582|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681583|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56681584|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
56681585|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56681586|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681587|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56681588|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56681589|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56681590|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56681591|NCT00665327|Renal Agents|renal agents|mesh-ancestor
56681592|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56681593|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56681594|NCT00823836|Ropinirole|ropinirole|mesh-list
56681595|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56681596|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56681597|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
56681598|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
56681599|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681600|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681601|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259275|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56259276|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
56259277|NCT01935063|Lidocaine|lidocaine|mesh-list
56259278|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
56259279|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
56259280|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259281|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259282|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
56259283|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259284|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56259285|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56259286|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56259287|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56259288|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259289|NCT01935089|Interferons|interferons|mesh-list
56259347|NCT01935492|Capecitabine|capecitabine|mesh-list
56681602|NCT04154735|Rifaximin|rifaximin|mesh-list
56681603|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
56681604|NCT04154735|Fludarabine|fludarabine|mesh-list
56681605|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
56681606|NCT04154735|Tacrolimus|tacrolimus|mesh-list
56681607|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327968|NCT04081389|Analgesics|analgesics|mesh-ancestor
56681608|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
56681609|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681610|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56681611|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56681612|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
56681613|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259348|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56259349|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259350|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
56259351|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
56259352|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
56259353|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259354|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56259355|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56259356|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56259357|NCT01935492|Growth Substances|growth substances|mesh-ancestor
56259358|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259359|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
56259360|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56259361|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56259362|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56259363|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259364|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56259365|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
56259367|NCT01935505|Nicotine|nicotine|mesh-list
56259368|NCT01935505|Varenicline|varenicline|mesh-list
56259369|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56259370|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
56259371|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259372|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259373|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56259374|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56259375|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
56259376|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259377|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259378|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56259379|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
56259419|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259420|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259421|NCT01935557|Heparin|heparin|mesh-list
56259422|NCT01935557|Calcium heparin|calcium heparin|mesh-list
56259423|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
56259424|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56185781|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185782|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
56185783|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
56185784|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
56185785|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259425|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56259426|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259427|NCT01935596|Ropivacaine|ropivacaine|mesh-list
56259428|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
56259429|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
56259430|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
56259431|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259432|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681614|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681615|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56681616|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56681617|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681618|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56681619|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56681620|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681621|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259433|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
56259434|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259435|NCT01935648|Ropivacaine|ropivacaine|mesh-list
56259436|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
56259437|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
56259438|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259439|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259440|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
56259441|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259442|NCT01935674|Ritonavir|ritonavir|mesh-list
56259443|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56259444|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56259445|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56259446|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
56259447|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259448|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259449|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56259450|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56259451|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
56259452|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259453|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56259454|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56259455|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56259474|NCT01935817|Vitamin E|vitamin e|mesh-list
56259475|NCT01935817|Silybin|silybin|mesh-list
56259476|NCT01935817|Vitamins|vitamins|mesh-ancestor
56259477|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
56259478|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259479|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
56259480|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802786|NCT02399163|Fluorides|fluorides|mesh-list
56259482|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56259483|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259484|NCT01935830|Ritonavir|ritonavir|mesh-list
56259485|NCT01935830|Efavirenz|efavirenz|mesh-list
56259486|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56259487|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56259488|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
56259489|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259490|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259491|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56259492|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56259493|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
56259494|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259495|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56259496|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56259497|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56259498|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56259499|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56259500|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56259501|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56259502|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56259503|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56259504|NCT01935869|Petrolatum|petrolatum|mesh-list
56259505|NCT01935869|Emollients|emollients|mesh-ancestor
56259506|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
56259507|NCT01935882|Lumefantrine|lumefantrine|mesh-list
56259508|NCT01935882|Artemether|artemether|mesh-list
56185786|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
56681622|NCT00705042|Etanercept|etanercept|mesh-list
56681623|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56681624|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56681625|NCT00705042|Analgesics|analgesics|mesh-ancestor
56681626|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
56681627|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681628|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681629|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56681630|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56681631|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56681632|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681633|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
56681634|NCT00879437|Bevacizumab|bevacizumab|mesh-list
56681635|NCT00879437|Valproic Acid|valproic acid|mesh-list
56681636|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56681637|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681638|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56681639|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56681640|NCT00879437|Growth Substances|growth substances|mesh-ancestor
56681641|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681642|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
56681643|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
56681644|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185787|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
56185788|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56185789|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
56259509|NCT01935882|Primaquine|primaquine|mesh-list
56259510|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56259511|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
56259512|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55834675|NCT02050321|Acitretin|acitretin|mesh-list
56259571|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
56259572|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259573|NCT01936103|Atorvastatin|atorvastatin|mesh-list
56259574|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56259575|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56259576|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
56259577|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259578|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56259579|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56259580|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259581|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
56259582|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
56259583|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56259584|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
56259585|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259586|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56259587|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56259588|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
56259589|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56259781|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
56259782|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259783|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
56681645|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681646|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
56681647|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681648|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
56681649|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56681650|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56681651|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681652|NCT00665639|Caspofungin|caspofungin|mesh-list
56681653|NCT00665639|Micafungin|micafungin|mesh-list
56681654|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
56681655|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681656|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681657|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681658|NCT04153253|Aflibercept|aflibercept|mesh-list
56681659|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56681660|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56259784|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259785|NCT01937611|Midazolam|midazolam|mesh-list
56259786|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
56259787|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56259788|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259789|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259790|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56259791|NCT01937611|Analgesics|analgesics|mesh-ancestor
56259792|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
56259793|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259823|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259825|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259826|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
56259827|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56259828|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
56259829|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259830|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259831|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56259832|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
56259833|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56259834|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
56259835|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259836|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259837|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56259838|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
56259839|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
56259840|NCT01937754|Protective Agents|protective agents|mesh-ancestor
56259873|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56259874|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259875|NCT01938092|Diazepam|diazepam|mesh-list
56259876|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56259877|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
56259878|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
56259879|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
56259880|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259881|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259882|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259883|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56259884|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259885|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56185790|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897028|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56681661|NCT04153253|Growth Substances|growth substances|mesh-ancestor
56681662|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681663|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
56681664|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681665|NCT00671645|Bevacizumab|bevacizumab|mesh-list
56681666|NCT00671645|Capecitabine|capecitabine|mesh-list
56681667|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56681668|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681669|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56259886|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56259887|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56259888|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56259889|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56259890|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56259891|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
56259892|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
56259915|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259916|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56259917|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56259918|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56259920|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56259921|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259922|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56259923|NCT01938235|Incretins|incretins|mesh-ancestor
56259924|NCT01938235|Hormones|hormones|mesh-ancestor
56259925|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56259926|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
56259927|NCT01938300|Analgesics|analgesics|mesh-ancestor
56259928|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
56259929|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881933|NCT03000946|Hormones|hormones|mesh-ancestor
56259930|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259931|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
56259932|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259934|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
56259935|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56259936|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56259937|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259938|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56259939|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
56259940|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56259941|NCT01938417|Tobramycin|tobramycin|mesh-list
56259942|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56259943|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259944|NCT01938443|Trametinib|trametinib|mesh-list
56259945|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260034|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260035|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
56260036|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56260037|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
56260038|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
56260039|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
56260040|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260041|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56260042|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56260043|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260044|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56260045|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56260046|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56260047|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56260048|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56260049|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56260050|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
56260051|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
56260052|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
56260053|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
56260054|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260055|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681670|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56681671|NCT00671645|Growth Substances|growth substances|mesh-ancestor
56681672|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681673|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
56681674|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56328036|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56328037|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56328038|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56328039|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56328040|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681675|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
56681676|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681677|NCT02629523|Afatinib|afatinib|mesh-list
56681678|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681679|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56681680|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681681|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681682|NCT00671801|Irinotecan|irinotecan|mesh-list
56681683|NCT00671801|Lenalidomide|lenalidomide|mesh-list
56681684|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56681685|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56681686|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260056|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56260057|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260058|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56260059|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56260060|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
56260061|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
56260062|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
56260063|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
56260064|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260065|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56260066|NCT01939327|Rituximab|rituximab|mesh-list
56260067|NCT01939327|Lenalidomide|lenalidomide|mesh-list
56260068|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260069|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185791|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185792|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56185793|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56185794|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185795|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56185796|NCT01432977|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56185797|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56185798|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56185799|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56185800|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
56185801|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56185802|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
56185803|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185804|NCT01433289|Protective Agents|protective agents|mesh-ancestor
56681687|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681688|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681689|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
56681690|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681691|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56681692|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56681693|NCT00671801|Growth Substances|growth substances|mesh-ancestor
56681694|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
56681695|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
56681696|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56681697|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
56681698|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681699|NCT00676559|Ranibizumab|ranibizumab|mesh-list
56681700|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56681701|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56681702|NCT00676559|Growth Substances|growth substances|mesh-ancestor
56681703|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681704|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
56681705|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681706|NCT00672113|Nifedipine|nifedipine|mesh-list
56681707|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56681708|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681709|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681710|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56681711|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681712|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
56185805|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185806|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56185807|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55897103|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
56260070|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
56260071|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260072|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56260073|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56260074|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56260075|NCT01939327|Growth Substances|growth substances|mesh-ancestor
56260101|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260102|NCT01939418|Antiviral Agents|antiviral agents|mesh-ancestor
56260103|NCT01939418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260104|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260105|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56260106|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
56260107|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260109|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56260110|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260111|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
56681713|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
56681714|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56681715|NCT00676637|Timolol|timolol|mesh-list
56681716|NCT00676637|Travoprost|travoprost|mesh-list
56681717|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56681718|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56681719|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56681720|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56681721|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
56681722|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681723|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681724|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681725|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56681726|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56681727|NCT00672347|Clonidine|clonidine|mesh-list
56681728|NCT00672347|Morphine|morphine|mesh-list
56681729|NCT00672347|Bupivacaine|bupivacaine|mesh-list
56681730|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
56681731|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
56681732|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56681733|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237536|NCT01757106|Sevoflurane|sevoflurane|mesh-list
56260112|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260113|NCT01939457|Misoprostol|misoprostol|mesh-list
56260114|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56260115|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
56260116|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56260117|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260118|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56260119|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56260120|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
56260121|NCT01939483|Irinotecan|irinotecan|mesh-list
56260122|NCT01939483|Camptothecin|camptothecin|mesh-list
56260123|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56260124|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56260125|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260126|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260127|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260128|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56260206|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56260207|NCT01939743|Diclofenac|diclofenac|mesh-list
56260208|NCT01939743|Lidocaine|lidocaine|mesh-list
56185808|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185809|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56185810|NCT01433445|Panobinostat|panobinostat|mesh-list
56185811|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185812|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56185813|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185814|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185815|NCT01433614|Paclitaxel|paclitaxel|mesh-list
56185816|NCT01433614|Capecitabine|capecitabine|mesh-list
56185817|NCT01433614|Epirubicin|epirubicin|mesh-list
56185818|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56185819|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185820|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
56185821|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
56681734|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
56681735|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681736|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56681737|NCT00672347|Narcotics|narcotics|mesh-ancestor
56681738|NCT00672347|Analgesics|analgesics|mesh-ancestor
56681739|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56681740|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
56681741|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
56681742|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56681743|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56681744|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56681745|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
56681746|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185822|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
56185823|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185824|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56185825|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
56185826|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56185827|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56185828|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56185829|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185830|NCT01433627|Hirudins|hirudins|mesh-list
56185831|NCT01433627|Bivalirudin|bivalirudin|mesh-list
56185832|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
56185833|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56185834|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
56185835|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185836|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260209|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
56260210|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
56260211|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260212|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260213|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
56260214|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260215|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56260216|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56260217|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55835375|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
56260373|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260375|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260376|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260377|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
56260378|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56260379|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56260380|NCT01940965|Lixisenatide|lixisenatide|mesh-list
56185837|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
56185838|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56185839|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56260381|NCT01940965|Biguanides|biguanides|mesh-list
56260382|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56260383|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260384|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
56260385|NCT01940978|Methylphenidate|methylphenidate|mesh-list
56260386|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56260387|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260388|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56260389|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56260390|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260391|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260392|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
56260393|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260394|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
56681747|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681748|NCT00676871|Blinatumomab|blinatumomab|mesh-list
56681749|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681750|NCT00677027|Lentinan|lentinan|mesh-list
56681751|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56681752|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
56681753|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681754|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681756|NCT00595127|Fludarabine|fludarabine|mesh-list
56681757|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681758|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
56681759|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681760|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56681761|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56681762|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
56681763|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681764|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681765|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56681766|NCT00672659|Dexetimide|dexetimide|mesh-list
56681767|NCT00672659|Pipamperone|pipamperone|mesh-list
56681768|NCT00672659|Citalopram|citalopram|mesh-list
56681769|NCT00672659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56681770|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56681771|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56237568|NCT01757236|Renal Agents|renal agents|mesh-ancestor
56260395|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56260396|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56260397|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56260435|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56260436|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260572|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260575|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
56260576|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56260577|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
56260578|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260579|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260580|NCT01941979|Antidotes|antidotes|mesh-ancestor
56260581|NCT01941979|Protective Agents|protective agents|mesh-ancestor
56260582|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260583|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
56260584|NCT01941979|Vitamins|vitamins|mesh-ancestor
56260585|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
56260586|NCT01942070|Everolimus|everolimus|mesh-list
56260587|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260588|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56260589|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
56260590|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260591|NCT01942109|Torsemide|torsemide|mesh-list
56260592|NCT01942109|Furosemide|furosemide|mesh-list
56260593|NCT01942109|Diuretics|diuretics|mesh-ancestor
56260594|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
56681772|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681773|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681774|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
56681775|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681776|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56681777|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
56681778|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681779|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56681780|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56681781|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
56681782|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
56681783|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681784|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56681785|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56260595|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260596|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56260597|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260598|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260599|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56260600|NCT01942174|Methotrexate|methotrexate|mesh-list
56260601|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56260602|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56260603|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
56260604|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56260632|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56260633|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56260634|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260635|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
56260636|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56260637|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56260638|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
56260639|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56260640|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56260641|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56260642|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56260643|NCT01942291|Niacin|niacin|mesh-list
56260644|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
56260645|NCT01942291|Vitamins|vitamins|mesh-ancestor
56260646|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
56260647|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260648|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
56260649|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56185840|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
56185841|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56260650|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
56260651|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260652|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56260653|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
56260654|NCT01942304|Calcium|calcium|mesh-list
56260655|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56260656|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260657|NCT01942343|Droperidol|droperidol|mesh-list
56260658|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56260659|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
56260660|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
56260661|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260662|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260663|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56681786|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
56681787|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56681788|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56681789|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56681790|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56681791|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56681792|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56681793|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681794|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56681795|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56681796|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260664|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56260665|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56260666|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261009|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56261010|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56261013|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56261014|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
56261015|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
56261016|NCT01945099|Insulin|insulin|mesh-list
56261017|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56261018|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261019|NCT01945268|Vaccines|vaccines|mesh-list
56261020|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
56261021|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261022|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
56261023|NCT01945437|Analgesics|analgesics|mesh-ancestor
56261024|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
56261025|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261026|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261027|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
56261028|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261029|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56261030|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
56261031|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56261032|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261033|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261034|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56261035|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
56261036|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56261037|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56261038|NCT01945450|Clindamycin|clindamycin|mesh-list
56261039|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
56261075|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
56261076|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
56261077|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261078|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261187|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261188|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261189|NCT05165082|Timolol|timolol|mesh-list
56261190|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56261191|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56261192|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261193|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56261194|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56261195|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
56261196|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261197|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261198|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56261199|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56261200|NCT05155527|Ivermectin|ivermectin|mesh-list
56261201|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56681797|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681798|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
56681799|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681800|NCT00677261|Anesthetics|anesthetics|mesh-list
56681801|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
56681802|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56681803|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681804|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
56681805|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681806|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
56681807|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56681808|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56681809|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681810|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
56681811|NCT00912119|Coagulants|coagulants|mesh-ancestor
56681812|NCT00677339|Vitamin D|vitamin d|mesh-list
56681813|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
56681814|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
56681815|NCT00677339|Vitamins|vitamins|mesh-list
56681816|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
56261202|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261203|NCT05151146|Metformin|metformin|mesh-list
56261321|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56261322|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56185842|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897348|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261323|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56261324|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
56261325|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261326|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261327|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
56261328|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
56261329|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56261330|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
56261331|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261332|NCT04538053|Cefazolin|cefazolin|mesh-list
56261333|NCT04538053|Cephalexin|cephalexin|mesh-list
56261334|NCT04538053|Floxacillin|floxacillin|mesh-list
56261636|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56261637|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261638|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56261639|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56261640|NCT02330562|Growth Substances|growth substances|mesh-ancestor
56261641|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261642|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
56261644|NCT02138617|Bevacizumab|bevacizumab|mesh-list
56261648|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56261649|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261650|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56261651|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56261652|NCT02138617|Growth Substances|growth substances|mesh-ancestor
56261653|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261654|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
56261655|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
56000891|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56261778|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103583|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
56681817|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681818|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56681819|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56681820|NCT00672971|Permethrin|permethrin|mesh-list
56681821|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681822|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681823|NCT00673205|Bicalutamide|bicalutamide|mesh-list
56681824|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
56681825|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
56328188|NCT03543969|Nivolumab|nivolumab|mesh-list
56681826|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56681827|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681828|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681829|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56681830|NCT00677729|Albuterol|albuterol|mesh-list
56681831|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56681832|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
56681833|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681834|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681835|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56681836|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
56681837|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
56681838|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56681839|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56681840|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56681841|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56681842|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
56681843|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681845|NCT02628197|Vitamin D|vitamin d|mesh-list
56681847|NCT02628197|Vitamins|vitamins|mesh-ancestor
56681848|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
56681849|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681850|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56681851|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56681852|NCT00673829|Interleukin-2|interleukin-2|mesh-list
56681853|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681854|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56681855|NCT00673829|Analgesics|analgesics|mesh-ancestor
56681856|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
56681857|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681858|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681859|NCT04152629|Methylphenidate|methylphenidate|mesh-list
56681860|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56681861|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56681862|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681863|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56681864|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56681865|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56681866|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681867|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
56681868|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681869|NCT02535299|Metformin|metformin|mesh-list
56681870|NCT02535299|Liraglutide|liraglutide|mesh-list
56261779|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261780|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
56261781|NCT05411744|Isoniazid|isoniazid|mesh-list
56261782|NCT05411744|Rifapentine|rifapentine|mesh-list
56261783|NCT05411744|Vitamins|vitamins|mesh-ancestor
56261784|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
56261785|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261786|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
56261787|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
56261788|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56261789|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261790|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56261791|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56261792|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
56261793|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261794|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56261795|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56261796|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
55836932|NCT01970462|Hormones|hormones|mesh-ancestor
56261860|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56261861|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56261862|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
56261863|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261864|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261865|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681871|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56681872|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681873|NCT02535299|Incretins|incretins|mesh-ancestor
56681874|NCT02535299|Hormones|hormones|mesh-ancestor
56681875|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56681876|NCT00674063|Alefacept|alefacept|mesh-list
56681877|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
56681878|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
56681879|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681880|NCT04151459|Metformin|metformin|mesh-list
56681881|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56681882|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681883|NCT00674141|Dexamethasone|dexamethasone|mesh-list
56681884|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56681885|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
56681886|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
56681887|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681888|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681889|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56681890|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
56681891|NCT00674141|Hormones|hormones|mesh-ancestor
56681892|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56681893|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56681894|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681895|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56681896|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
56681897|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237657|NCT01757808|Ranolazine|ranolazine|mesh-list
56261866|NCT05077800|Losartan|losartan|mesh-list
56261867|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56261868|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56261869|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56261934|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56261935|NCT04792385|Diuretics|diuretics|mesh-ancestor
56261936|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
56261937|NCT04777006|Amitriptyline|amitriptyline|mesh-list
56261938|NCT04777006|Fluoxetine|fluoxetine|mesh-list
56261939|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
56261940|NCT04777006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56261941|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56261942|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55837076|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56185843|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185844|NCT01433705|Regadenoson|regadenoson|mesh-list
56185845|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261978|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261980|NCT04721821|Tofacitinib|tofacitinib|mesh-list
56681898|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681899|NCT02627807|Gemcitabine|gemcitabine|mesh-list
56681900|NCT02627807|Cisplatin|cisplatin|mesh-list
56681902|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681903|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56681904|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
56681905|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681906|NCT02627807|Antiviral Agents|antiviral agents|mesh-ancestor
56681907|NCT02627807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681908|NCT02627807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681909|NCT02627807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681910|NCT02627807|Immunologic Factors|immunologic factors|mesh-ancestor
56681911|NCT02627807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681912|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
55837117|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262396|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56262397|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262399|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
56262400|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262401|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262402|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
56262403|NCT00572169|Hormones|hormones|mesh-ancestor
56262404|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262405|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56262406|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56262407|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56262408|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56262409|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262415|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56262416|NCT00572169|Growth Substances|growth substances|mesh-ancestor
56262525|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56262526|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56262527|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56262528|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56262529|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56262530|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56262531|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262858|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
56262859|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262860|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262861|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
56262862|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
56262863|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262864|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262865|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
56262866|NCT03626922|Hormones|hormones|mesh-ancestor
56262867|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262868|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56262869|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262957|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56262958|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56262959|NCT03052933|Gemcitabine|gemcitabine|mesh-list
56262960|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56262961|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
56262962|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262963|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262964|NCT03052933|Antiviral Agents|antiviral agents|mesh-ancestor
56262965|NCT03052933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262966|NCT03052933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262967|NCT03052933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681913|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
56681914|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
56681915|NCT00678431|Resveratrol|resveratrol|mesh-list
56681916|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
56681917|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681918|NCT00678431|Protective Agents|protective agents|mesh-ancestor
56681919|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681920|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681921|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56681922|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56681923|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56237692|NCT01758029|Hormones|hormones|mesh-ancestor
56262968|NCT03052933|Immunologic Factors|immunologic factors|mesh-ancestor
56262969|NCT03052933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262970|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
56262971|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262972|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262973|NCT02959697|Lidocaine|lidocaine|mesh-list
56262974|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
56263010|NCT02518009|Androgens|androgens|mesh-list
56263011|NCT02518009|Hormones|hormones|mesh-ancestor
56263012|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838137|NCT04053712|Glucagon|glucagon|mesh-list
56263044|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
56263045|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
56263046|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263047|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56263048|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263049|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56185846|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56263050|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
56263051|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263052|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56263053|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263054|NCT01498458|Capecitabine|capecitabine|mesh-list
56263055|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56263056|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
56263124|NCT01945892|Hormones|hormones|mesh-ancestor
56263125|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263126|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56263127|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263128|NCT01945957|Oxytocin|oxytocin|mesh-list
56263129|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
56263130|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56263131|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263132|NCT01945983|Norepinephrine|norepinephrine|mesh-list
56263133|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56263134|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56263135|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
56263136|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263137|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838227|NCT01791153|Prednisone|prednisone|mesh-list
56263209|NCT01946555|Hydromorphone|hydromorphone|mesh-list
56263210|NCT01946555|Tapentadol|tapentadol|mesh-list
56263211|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56263212|NCT01946555|Narcotics|narcotics|mesh-ancestor
56263213|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263214|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263215|NCT01946555|Analgesics|analgesics|mesh-ancestor
56263216|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
56263217|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263218|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56263219|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56263220|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
56263221|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
56681924|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
56681925|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681926|NCT00674687|Gabapentin|gabapentin|mesh-list
56681927|NCT00674687|Analgesics|analgesics|mesh-ancestor
56681928|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
56681929|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56681930|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681931|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
56681932|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56681933|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56237696|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263222|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56263223|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
56263224|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
56263225|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56263226|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56263227|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56263228|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263229|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
56263230|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263231|NCT01946568|Dalbavancin|dalbavancin|mesh-list
56263232|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56263233|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263234|NCT01946594|Acetaminophen|acetaminophen|mesh-list
56263235|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56263236|NCT01946594|Analgesics|analgesics|mesh-ancestor
56263237|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
56263238|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263239|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263240|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
56263241|NCT01946607|Citalopram|citalopram|mesh-list
56263242|NCT01946607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56263243|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56263244|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56263245|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263246|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263247|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
56263248|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263249|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56263250|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
56263251|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56263252|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
56263253|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56263254|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
56263255|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263256|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263257|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56185847|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55897572|NCT05718466|Bevacizumab|bevacizumab|mesh-list
56263258|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
56263286|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56263287|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56263288|NCT01946984|Analgesics|analgesics|mesh-ancestor
56263289|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
56263290|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263291|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263292|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263293|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263294|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56263295|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263296|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263297|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56681934|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56681935|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56681936|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56681937|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56681938|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56681939|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681940|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
56681941|NCT00656747|Amoxicillin|amoxicillin|mesh-list
56681942|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
56681943|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
56681944|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
56681945|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56263298|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
56263299|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263300|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
56263302|NCT01947062|Etoposide|etoposide|mesh-list
56263303|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
55838396|NCT01942993|Vemurafenib|vemurafenib|mesh-list
56263336|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
56263337|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56263338|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263339|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
56263340|NCT01947205|Acetaminophen|acetaminophen|mesh-list
56263341|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56263342|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56263374|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56263375|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263377|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56263378|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
56263379|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56263380|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263381|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
56263382|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56263383|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263384|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263385|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55885378|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56263386|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56263387|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56263388|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56263389|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56263390|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56263392|NCT01947790|Pioglitazone|pioglitazone|mesh-list
56263393|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56263463|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56263464|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263465|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263466|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56263498|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263499|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56263500|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263501|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
56263502|NCT01948336|Ketamine|ketamine|mesh-list
56263503|NCT01948336|Propofol|propofol|mesh-list
56263504|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56263505|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263506|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263507|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56263508|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
56263509|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
56263510|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56263511|NCT01948336|Analgesics|analgesics|mesh-ancestor
56681946|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56681947|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56681948|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681949|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56681950|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56681951|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681952|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681953|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681954|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56681955|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
56681956|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56681957|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263512|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
56263513|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263584|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
56185848|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
56185849|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
56185850|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185851|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185853|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56185854|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185855|NCT01433770|Alefacept|alefacept|mesh-list
56185856|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
56263585|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263586|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55838682|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
56263611|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263612|NCT01949038|Alprazolam|alprazolam|mesh-list
56263613|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56263614|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263615|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263616|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56263617|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56263618|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56263619|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
56263620|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
56263621|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263622|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263623|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
56263624|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263625|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
56263626|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
56263630|NCT01949129|Thiotepa|thiotepa|mesh-list
56263631|NCT01949129|Treosulfan|treosulfan|mesh-list
56263632|NCT01949129|Fludarabine|fludarabine|mesh-list
56263633|NCT01949129|Etoposide|etoposide|mesh-list
56263634|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
56263635|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56263636|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
56263637|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56263672|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
56263673|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56263674|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263675|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
55838768|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56263690|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263691|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56263692|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56263694|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
56263695|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56263696|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56263697|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
56681958|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56681959|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56681960|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56681961|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56681962|NCT00678743|Simvastatin|simvastatin|mesh-list
56681963|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56681964|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56681965|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
56681966|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681967|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56681968|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56681969|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681970|NCT04152317|Misoprostol|misoprostol|mesh-list
56681971|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56681972|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
56237731|NCT01758146|Tamoxifen|tamoxifen|mesh-list
56263698|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
56263699|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263700|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263701|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263702|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56263703|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56263704|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263705|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56263706|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56263707|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56263708|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
56263709|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56263710|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56263711|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
56263712|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56263713|NCT01949675|Vaccines|vaccines|mesh-list
56263714|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
56263715|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185857|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
56185858|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185859|NCT01433887|Ribavirin|ribavirin|mesh-list
56185860|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56185861|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
55897706|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263716|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56263717|NCT01949766|Glycerol|glycerol|mesh-list
56263718|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56263719|NCT01949766|Protective Agents|protective agents|mesh-ancestor
56263720|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263721|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263722|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
56263723|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56263724|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
56263725|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263726|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
56263727|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263728|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263729|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56263730|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
56263731|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263732|NCT01949818|Prednisone|prednisone|mesh-list
56263733|NCT01949818|Prednisolone|prednisolone|mesh-list
56263734|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
56328336|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681973|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56681974|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681975|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56681976|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56681977|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
56681978|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56681979|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
56681980|NCT02628665|Trioxsalen|trioxsalen|mesh-list
56681981|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
56681982|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237749|NCT01758185|Vaccines|vaccines|mesh-list
56263735|NCT01949818|Doxorubicin|doxorubicin|mesh-list
56263736|NCT01949818|Vincristine|vincristine|mesh-list
56263737|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56263738|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
56263770|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263771|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263772|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56263773|NCT01949948|Tenecteplase|tenecteplase|mesh-list
56263774|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56263775|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56263776|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263777|NCT01950000|Fentanyl|fentanyl|mesh-list
56263778|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56263779|NCT01950000|Narcotics|narcotics|mesh-ancestor
56263780|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263801|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263802|NCT01950182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56263803|NCT01950182|Immunologic Factors|immunologic factors|mesh-ancestor
56263804|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263805|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56263806|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56263807|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
56263808|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
56263809|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
56263810|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56263811|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
56263812|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263813|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56263814|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56263815|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56263816|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56263817|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56263818|NCT01950195|Ipilimumab|ipilimumab|mesh-list
56263819|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56263820|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263821|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56263822|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263823|NCT01950416|Clopidogrel|clopidogrel|mesh-list
56263824|NCT01950416|Ticagrelor|ticagrelor|mesh-list
56263825|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56263826|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56263827|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56263828|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56263829|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
56185862|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185864|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56185865|NCT01433900|Latanoprost|latanoprost|mesh-list
56185866|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56185867|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56185868|NCT01433952|Thiamine|thiamine|mesh-list
56681983|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
56681984|NCT00678977|Gemcitabine|gemcitabine|mesh-list
56681985|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56681986|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56681987|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
56681988|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56681989|NCT00678977|Antiviral Agents|antiviral agents|mesh-ancestor
56681990|NCT00678977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681991|NCT00678977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56681992|NCT00678977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56681993|NCT00678977|Immunologic Factors|immunologic factors|mesh-ancestor
56681994|NCT00678977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56681995|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56681996|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56681997|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56681998|NCT00674921|Renal Agents|renal agents|mesh-ancestor
56681999|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682000|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
56682001|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56682002|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56185869|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
56185870|NCT01433952|Vitamins|vitamins|mesh-ancestor
56185871|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
56185872|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185873|NCT01434017|Dexamethasone|dexamethasone|mesh-list
56185874|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
56185875|NCT01434017|Droperidol|droperidol|mesh-list
56185876|NCT01434017|Ondansetron|ondansetron|mesh-list
56185877|NCT01434017|BB 1101|bb 1101|mesh-list
56263830|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263831|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263832|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263833|NCT01950481|Ceritinib|ceritinib|mesh-list
56263834|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838911|NCT01912963|Pertuzumab|pertuzumab|mesh-list
55838965|NCT01970995|Menthol|menthol|mesh-list
56263892|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263893|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263894|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56263896|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263897|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263898|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56263899|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
56263900|NCT01950793|Protective Agents|protective agents|mesh-ancestor
56263901|NCT01950884|Ezetimibe|ezetimibe|mesh-list
56263902|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56263903|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56263904|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
56263905|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263906|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56263907|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
56263908|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263909|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
56263910|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56263911|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56263912|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682003|NCT00674999|Bacitracin|bacitracin|mesh-list
56682004|NCT00674999|Nystatin|nystatin|mesh-list
56682005|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56682006|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682007|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682008|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
56682009|NCT00674999|Ionophores|ionophores|mesh-ancestor
56682010|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682011|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682012|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
56682013|NCT00882713|Hematinics|hematinics|mesh-ancestor
56682014|NCT04151381|Aminophylline|aminophylline|mesh-list
56682015|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56682016|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
56682017|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682018|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263913|NCT01950923|Urological Agents|urological agents|mesh-ancestor
56263914|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56263915|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
56263916|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
56263917|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56263918|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56263920|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56263921|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
56263922|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263923|NCT01951053|Citalopram|citalopram|mesh-list
56263924|NCT01951053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56263943|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
56263944|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
56263945|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
56263946|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263947|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263948|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263949|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56185878|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56185879|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
56185880|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
56185881|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185882|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185883|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56185884|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
56185885|NCT01434017|Hormones|hormones|mesh-ancestor
56185886|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185887|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56185888|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185889|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
56185890|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185891|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185892|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
56113629|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
56185893|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
56185894|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56185895|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
56185896|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185897|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56263950|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263951|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56263952|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56263953|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56263954|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
56682019|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56682020|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
56682021|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56682022|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56682023|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682024|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682025|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56682026|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56328416|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
56682027|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
56328417|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
56328418|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56328419|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56328420|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56328421|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
56328422|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328423|NCT03007147|Antidotes|antidotes|mesh-ancestor
56328424|NCT03007147|Protective Agents|protective agents|mesh-ancestor
56328425|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
56328426|NCT03007147|Vitamins|vitamins|mesh-ancestor
56263955|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
56263956|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263957|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263959|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56263960|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263961|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263962|NCT01951404|Allopurinol|allopurinol|mesh-list
56263963|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
56263964|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263965|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263966|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
56263967|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263968|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56263969|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
56263970|NCT01951404|Protective Agents|protective agents|mesh-ancestor
56263971|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263972|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56263973|NCT01951430|Cephalosporins|cephalosporins|mesh-list
56263974|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56263975|NCT01951430|Itraconazole|itraconazole|mesh-list
56263976|NCT01951430|Fluconazole|fluconazole|mesh-list
56263977|NCT01951430|Posaconazole|posaconazole|mesh-list
56263978|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
56263979|NCT01951430|Clotrimazole|clotrimazole|mesh-list
56263980|NCT01951430|Miconazole|miconazole|mesh-list
56263981|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264007|NCT01951482|Growth Substances|growth substances|mesh-ancestor
56264008|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264009|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
56264010|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56185899|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56185900|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56264011|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264012|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56264013|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56328427|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
56328428|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56328429|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
56328430|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
56328431|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
56328432|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56328433|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56328434|NCT03007147|Hematinics|hematinics|mesh-ancestor
56328435|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
56328436|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56682028|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682029|NCT04151381|Protective Agents|protective agents|mesh-ancestor
56682030|NCT00809133|Paclitaxel|paclitaxel|mesh-list
56682031|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56682032|NCT00809133|Bevacizumab|bevacizumab|mesh-list
56682033|NCT00809133|Carboplatin|carboplatin|mesh-list
56682034|NCT00809133|Afatinib|afatinib|mesh-list
56682035|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56682036|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682037|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682038|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682039|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682040|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682041|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56682042|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56682043|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56682044|NCT00809133|Growth Substances|growth substances|mesh-ancestor
56682045|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682046|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
56682047|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56682048|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682049|NCT00912275|Vinorelbine|vinorelbine|mesh-list
56682063|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
56682064|NCT02627573|Busulfan|busulfan|mesh-list
56682065|NCT02627573|Fludarabine|fludarabine|mesh-list
56682066|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
56682067|NCT02627573|Tacrolimus|tacrolimus|mesh-list
56682068|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
56682069|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682070|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
56682071|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682072|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682073|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56682074|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
56682075|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682076|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682077|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56682078|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56682079|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
56682080|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56682081|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682082|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56682083|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56682084|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
56682085|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682086|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682087|NCT00675545|Carboplatin|carboplatin|mesh-list
56682088|NCT00675545|Docetaxel|docetaxel|mesh-list
56264014|NCT01951508|Methylphenidate|methylphenidate|mesh-list
56264015|NCT01951508|Modafinil|modafinil|mesh-list
56264016|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56264017|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264018|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56264019|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56264020|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264021|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264022|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
56264023|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264024|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56264025|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56264026|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56264057|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56264058|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
56264059|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
56264060|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
56264061|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56264062|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56264063|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
56264064|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264065|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264066|NCT01951846|Nintedanib|nintedanib|mesh-list
56264067|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682089|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682090|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682091|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682092|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682093|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682094|NCT00679523|Tavaborole|tavaborole|mesh-list
56682095|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56682096|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
56682097|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682098|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
56682099|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682100|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682101|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56682102|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682103|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682104|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264068|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56264069|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264070|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264086|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56264088|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56264089|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56264090|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264091|NCT01951911|Ketamine|ketamine|mesh-list
56264092|NCT01951911|Analgesics|analgesics|mesh-ancestor
56264093|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
56264094|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264095|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264096|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56264097|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56264098|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
56264099|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
56264100|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264101|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56264102|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56264103|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264104|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264105|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
56264106|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56264107|NCT01951924|Antibodies|antibodies|mesh-list
56264108|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
56264109|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
56264110|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264111|NCT01952314|Naftopidil|naftopidil|mesh-list
56264112|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56264113|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56264114|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264115|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264116|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264117|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264118|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56264119|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56185901|NCT01434017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56185902|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56185903|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56185904|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56682105|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682106|NCT00808899|Sirolimus|sirolimus|mesh-list
56682107|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
56682108|NCT00808899|Doxorubicin|doxorubicin|mesh-list
56682109|NCT00808899|Irinotecan|irinotecan|mesh-list
56682110|NCT00808899|Etoposide|etoposide|mesh-list
56682111|NCT00808899|Topotecan|topotecan|mesh-list
56682112|NCT00808899|Tretinoin|tretinoin|mesh-list
56682113|NCT00808899|Isotretinoin|isotretinoin|mesh-list
56682114|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682115|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
56682116|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682117|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682118|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56682119|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
56682120|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682121|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682122|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56682123|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56682124|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56682125|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682126|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682127|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56682128|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56682129|NCT00808899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682130|NCT00808899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682131|NCT00808899|Antifungal Agents|antifungal agents|mesh-ancestor
56682132|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
56682133|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
56682134|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
56682135|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56185905|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
56264120|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264121|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56264122|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56264123|NCT01952561|Dapivirine|dapivirine|mesh-list
56264124|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56264125|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55839200|NCT01895270|Isradipine|isradipine|mesh-list
56264159|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264160|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264161|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56264163|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264164|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
56264165|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
56264166|NCT01952756|Cilostazol|cilostazol|mesh-list
56682136|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682137|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682138|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56682139|NCT00808665|Analgesics|analgesics|mesh-ancestor
56682140|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
56682141|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682142|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56682143|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56682144|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56682145|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
56682146|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682147|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682148|NCT00808509|Adalimumab|adalimumab|mesh-list
56682149|NCT00808509|Methotrexate|methotrexate|mesh-list
56682150|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56682151|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
56682152|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56682153|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682154|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56682155|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
56682156|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682157|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682158|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
56237923|NCT01759524|Analgesics|analgesics|mesh-ancestor
56264167|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56264184|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56264185|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264186|NCT01952886|Ondansetron|ondansetron|mesh-list
56264187|NCT01952886|Granisetron|granisetron|mesh-list
56264188|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
56264189|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
56264190|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264191|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264192|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56264193|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
56264194|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
56264195|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56264196|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
56264197|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264198|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264199|NCT01952886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56264200|NCT01952886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56264201|NCT01952886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264202|NCT01952886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56264203|NCT01952886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56264204|NCT01952951|Fluorouracil|fluorouracil|mesh-list
56264205|NCT01952951|Capecitabine|capecitabine|mesh-list
56264206|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
56264207|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
55902125|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
56682159|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682160|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56682161|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682162|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
56682163|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682164|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56682165|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56682166|NCT04444869|Cisplatin|cisplatin|mesh-list
56682167|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682168|NCT04276857|Leucovorin|leucovorin|mesh-list
56682169|NCT04276857|Gemcitabine|gemcitabine|mesh-list
56682170|NCT04276857|Paclitaxel|paclitaxel|mesh-list
56682171|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
56682172|NCT04276857|Irinotecan|irinotecan|mesh-list
56682173|NCT04276857|Folfirinox|folfirinox|mesh-list
56682174|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56682175|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682176|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682177|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682178|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682179|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682180|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56682181|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
56682182|NCT04276857|Antiviral Agents|antiviral agents|mesh-ancestor
56682183|NCT04276857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682184|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682185|NCT04276857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682186|NCT04276857|Immunologic Factors|immunologic factors|mesh-ancestor
56682187|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682188|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56682189|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682191|NCT04276857|Protective Agents|protective agents|mesh-ancestor
56682192|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
56682205|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56682206|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56682207|NCT00807573|Growth Substances|growth substances|mesh-ancestor
56682208|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682209|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
56682210|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682211|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56682212|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56682213|NCT00842712|Gemcitabine|gemcitabine|mesh-list
56682214|NCT00842712|Cisplatin|cisplatin|mesh-list
56682215|NCT00842712|Cetuximab|cetuximab|mesh-list
56682216|NCT00842712|Vinorelbine|vinorelbine|mesh-list
56682217|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682218|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56682219|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
56682220|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682221|NCT00842712|Antiviral Agents|antiviral agents|mesh-ancestor
56682222|NCT00842712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682223|NCT00842712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682224|NCT00842712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682225|NCT00842712|Immunologic Factors|immunologic factors|mesh-ancestor
56682226|NCT00842712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682227|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56682228|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56682229|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682230|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682231|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682232|NCT00705120|Cyclosporine|cyclosporine|mesh-list
56682233|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
56682234|NCT00705120|Busulfan|busulfan|mesh-list
56682235|NCT00705120|Cyclosporins|cyclosporins|mesh-list
56682236|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682237|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
56682238|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682239|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56264208|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264209|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56264210|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264211|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886201|NCT04955236|Analgesics|analgesics|mesh-ancestor
56264212|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
56682240|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56682241|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
56682242|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682243|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682244|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56682245|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682246|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
56682247|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682248|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
56682249|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56682250|NCT00842244|Capecitabine|capecitabine|mesh-list
56682251|NCT00842244|Axitinib|axitinib|mesh-list
56682252|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682253|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56682254|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
56682255|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682256|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56682257|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682258|NCT00832416|Tramadol|tramadol|mesh-list
56682259|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56682260|NCT00832416|Narcotics|narcotics|mesh-ancestor
56682261|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682262|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682263|NCT00832416|Analgesics|analgesics|mesh-ancestor
56682264|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
56682265|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682266|NCT00705198|Temozolomide|temozolomide|mesh-list
56682267|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56682268|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
56682269|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264213|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264214|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
56264215|NCT01953107|Trace Elements|trace elements|mesh-ancestor
56264216|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
56264217|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264218|NCT01953172|Tocotrienols|tocotrienols|mesh-list
56264219|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
56264220|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
56264221|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264222|NCT01953172|Protective Agents|protective agents|mesh-ancestor
56264223|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264225|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
56264226|NCT01953367|Tobramycin|tobramycin|mesh-list
56264251|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682270|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682271|NCT00702936|Telmisartan|telmisartan|mesh-list
56682272|NCT00702936|Ramipril|ramipril|mesh-list
56682273|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56682274|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56682275|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56682276|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682277|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56682278|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
56682279|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682280|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56682281|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56682282|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56682283|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682284|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682285|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264252|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
56264253|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
56264254|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
56264255|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264256|NCT01953536|Folic Acid|folic acid|mesh-list
56264257|NCT01953536|Paclitaxel|paclitaxel|mesh-list
56264258|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56264259|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56185906|NCT01434069|Leucovorin|leucovorin|mesh-list
56185907|NCT01434069|Fluorouracil|fluorouracil|mesh-list
56185908|NCT01434069|Pasireotide|pasireotide|mesh-list
56185909|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
56185910|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185911|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56185912|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185913|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56264260|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264261|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
56264262|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
56264263|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
56264264|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264265|NCT01953536|Hematinics|hematinics|mesh-ancestor
56264266|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
56264267|NCT01953536|Vitamins|vitamins|mesh-ancestor
56264268|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
56264269|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264270|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
56264271|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56264272|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
56264273|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56264274|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264275|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56264276|NCT01953731|Rifampin|rifampin|mesh-list
56264277|NCT01953731|Palbociclib|palbociclib|mesh-list
56264293|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56264294|NCT01953744|Fluconazole|fluconazole|mesh-list
56264295|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56264296|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
56264297|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264298|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56682286|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682287|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
56682288|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56682290|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
56682291|NCT00683644|Trace Elements|trace elements|mesh-ancestor
56682292|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
56682293|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682294|NCT00683644|Astringents|astringents|mesh-ancestor
56682295|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
56682296|NCT00753064|Prazosin|prazosin|mesh-list
56682297|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56682298|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56682299|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56682300|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56264299|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56264300|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264301|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264302|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56264303|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
56264304|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56264305|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264306|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56264307|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56264308|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56264309|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56264310|NCT01953757|Vitamins|vitamins|mesh-list
56264311|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
56264312|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
56264313|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
56264314|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
56264315|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264316|NCT01953757|Hematinics|hematinics|mesh-ancestor
56264317|NCT01953770|Cytarabine|cytarabine|mesh-list
56264318|NCT01953770|Prednisone|prednisone|mesh-list
56264319|NCT01953770|Methotrexate|methotrexate|mesh-list
56264320|NCT01953770|Daunorubicin|daunorubicin|mesh-list
56264321|NCT01953770|Asparaginase|asparaginase|mesh-list
56264322|NCT01953770|Pegaspargase|pegaspargase|mesh-list
56264323|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56264324|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
56264325|NCT01953770|Hormones|hormones|mesh-ancestor
56264326|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56264327|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264328|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56264329|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264330|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56264331|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
56264332|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56264333|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55839406|NCT01780545|Docetaxel|docetaxel|mesh-list
56264361|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56185914|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
56185915|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185916|NCT01434069|Antidotes|antidotes|mesh-ancestor
56185917|NCT01434069|Protective Agents|protective agents|mesh-ancestor
56185918|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
56185919|NCT01434069|Vitamins|vitamins|mesh-ancestor
56185920|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
56185921|NCT01434069|Hormones|hormones|mesh-ancestor
56185922|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56185923|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
56185924|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56185925|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
56682301|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
56682302|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682303|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682304|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682305|NCT00751738|Azimilide|azimilide|mesh-list
56682306|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56682307|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56682308|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682309|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682310|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56682311|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682312|NCT04060264|Eculizumab|eculizumab|mesh-list
56682313|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56682314|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682315|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
56682316|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682317|NCT00684814|Zolpidem|zolpidem|mesh-list
56682318|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56682319|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56682320|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682321|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682322|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56682323|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
56682324|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
56682325|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682326|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682327|NCT00576472|Methylphenidate|methylphenidate|mesh-list
56682328|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56682329|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682330|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56682331|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56682337|NCT00823212|Ticlopidine|ticlopidine|mesh-list
56682340|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56682341|NCT00823212|Analgesics|analgesics|mesh-ancestor
56682342|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
56682343|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682344|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682345|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56682346|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682347|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56682348|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56682349|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682350|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56185926|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185927|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185928|NCT01434134|Metoprolol|metoprolol|mesh-list
56185929|NCT01434134|Candesartan|candesartan|mesh-list
56185930|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56185931|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56185932|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
56185933|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
56185934|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56185935|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185936|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56185937|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56264362|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
56264363|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264364|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56264365|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56264366|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264367|NCT01953848|Tamsulosin|tamsulosin|mesh-list
56264368|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
56264369|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56264370|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56264371|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56264372|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264373|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264374|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264375|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264376|NCT01953848|Urological Agents|urological agents|mesh-ancestor
56264377|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56264378|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56264408|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56264409|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264410|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56264411|NCT01953978|Narcotics|narcotics|mesh-ancestor
56264412|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264413|NCT01953978|Analgesics|analgesics|mesh-ancestor
56264414|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
56264415|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56264416|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56185939|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264417|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56264418|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56264419|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264420|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264421|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
56264422|NCT01954030|Bevacizumab|bevacizumab|mesh-list
56264423|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
56264424|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56264425|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264458|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56264459|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
56682351|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56682352|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682353|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
56682354|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56682355|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56682356|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56682357|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
56682358|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682359|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56682360|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56682361|NCT02561494|Nefopam|nefopam|mesh-list
56682362|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56682363|NCT02561494|Analgesics|analgesics|mesh-ancestor
56682364|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
56682365|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264460|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264461|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
56264462|NCT01954108|Protective Agents|protective agents|mesh-ancestor
56264463|NCT01954186|Oxytocin|oxytocin|mesh-list
56264464|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
55839554|NCT01397890|Hormones|hormones|mesh-ancestor
56264492|NCT01954368|Narcotics|narcotics|mesh-ancestor
56264493|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264494|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264495|NCT01954368|Analgesics|analgesics|mesh-ancestor
56264496|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
56264497|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264498|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56264499|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56264500|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
56264501|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
56264502|NCT01954693|Everolimus|everolimus|mesh-list
56264503|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264504|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56264505|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
56264506|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264507|NCT01954732|Metformin|metformin|mesh-list
56264508|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56264509|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264510|NCT01954784|Cyclosporine|cyclosporine|mesh-list
56264511|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
56264512|NCT01954784|Fludarabine|fludarabine|mesh-list
56264513|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
56264549|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
56264550|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264551|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
56264552|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
56264553|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264554|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
56264555|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264586|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886587|NCT02481180|T0001|t0001|mesh-list
56264587|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264588|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56264589|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56264590|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
56264591|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56264592|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264593|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264594|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
56264595|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682366|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682367|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56682368|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56682369|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
56682370|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
56682371|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
56682372|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682373|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
56682374|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
56682375|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56682376|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682377|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682378|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56682379|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682380|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56682381|NCT00755950|Silymarin|silymarin|mesh-list
56682382|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
56682383|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682384|NCT00755950|Protective Agents|protective agents|mesh-ancestor
56682385|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682386|NCT00705354|Bacitracin|bacitracin|mesh-list
56682387|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56682388|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682389|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682390|NCT00575380|Azithromycin|azithromycin|mesh-list
56682391|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
56682392|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56682393|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56682394|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56682395|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682396|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682397|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56682398|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682404|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56682405|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682406|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56682407|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56682408|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56682410|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
56682411|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
56682412|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682413|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682414|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
56682415|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682416|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56238161|NCT01760278|Hormones|hormones|mesh-list
56264596|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264597|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
56264629|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56264630|NCT01955200|Cilostazol|cilostazol|mesh-list
56264631|NCT01955200|Clopidogrel|clopidogrel|mesh-list
56264632|NCT01955200|Ticagrelor|ticagrelor|mesh-list
56264633|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56264634|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56264635|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56264636|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56264637|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
56264638|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264639|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264640|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839729|NCT01859702|Hormones|hormones|mesh-ancestor
56185940|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56185941|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185942|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56185943|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56185944|NCT01434147|Bevacizumab|bevacizumab|mesh-list
56185945|NCT01434147|Capecitabine|capecitabine|mesh-list
56185946|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
56185947|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56185948|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185949|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56185950|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56185951|NCT01434147|Growth Substances|growth substances|mesh-ancestor
56185952|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185953|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
56185954|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56185955|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
56185956|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185957|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
56185958|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56185959|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
56185960|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56185961|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185962|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56185963|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56185964|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56185965|NCT01434173|Amoxicillin|amoxicillin|mesh-list
56185966|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
56185967|NCT01434173|Clarithromycin|clarithromycin|mesh-list
56185968|NCT01434173|Doxycycline|doxycycline|mesh-list
56185969|NCT01434173|Levofloxacin|levofloxacin|mesh-list
56185970|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
56185971|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
56185972|NCT01434173|Cefuroxime|cefuroxime|mesh-list
56185973|NCT01434173|Telithromycin|telithromycin|mesh-list
56682417|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56682418|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56682419|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682420|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682421|NCT00756184|Travoprost|travoprost|mesh-list
56682422|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56682423|NCT00756340|Bevacizumab|bevacizumab|mesh-list
56682424|NCT00756340|Everolimus|everolimus|mesh-list
56682425|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56682426|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682427|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56682428|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56682429|NCT00756340|Growth Substances|growth substances|mesh-ancestor
56682430|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682431|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
56682432|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682433|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
56682434|NCT00705510|Cyclosporine|cyclosporine|mesh-list
56682435|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56682436|NCT00705510|Cyclosporins|cyclosporins|mesh-list
56682437|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682438|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682439|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682440|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
56682441|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682442|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
56682465|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56682466|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56682467|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682468|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56682469|NCT05403580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56682470|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56682471|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682472|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682473|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682474|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
56682475|NCT05428306|Acetaminophen|acetaminophen|mesh-list
56328875|NCT00038922|Oprelvekin|oprelvekin|mesh-list
56682476|NCT05428306|Ibuprofen|ibuprofen|mesh-list
56682477|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56682479|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
56682480|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682481|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682482|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
56682483|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56682484|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56682485|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682486|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56682487|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682488|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682489|NCT05424796|Hemostatics|hemostatics|mesh-list
56682490|NCT05424796|Coagulants|coagulants|mesh-ancestor
56682491|NCT00757198|Remifentanil|remifentanil|mesh-list
56682492|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56682493|NCT00757198|Narcotics|narcotics|mesh-ancestor
56682494|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682495|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682508|NCT00679432|Hormones|hormones|mesh-ancestor
56682509|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56682510|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
56682511|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56682512|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56682513|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682514|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
56682515|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
56682516|NCT04050826|Lidocaine|lidocaine|mesh-list
56682517|NCT04050826|Prilocaine|prilocaine|mesh-list
56682518|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
56682519|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
56682520|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682521|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682522|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
56682523|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682524|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56682525|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56682526|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56682527|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682528|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682529|NCT00757978|Memantine|memantine|mesh-list
56682530|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56682531|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56682532|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
56682533|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682534|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682535|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682536|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56682537|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56682538|NCT00754702|Vinorelbine|vinorelbine|mesh-list
56682539|NCT00754702|Lapatinib|lapatinib|mesh-list
56682540|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56185974|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56185975|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56185976|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898237|NCT04552223|Nivolumab|nivolumab|mesh-list
56185977|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56185978|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56185979|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682541|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682542|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682543|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682544|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682545|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682546|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56682547|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682548|NCT00754780|Pirfenidone|pirfenidone|mesh-list
56682549|NCT00754780|Analgesics|analgesics|mesh-ancestor
56682550|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
56328947|NCT00039117|Cytarabine|cytarabine|mesh-list
56238309|NCT01760824|Antacids|antacids|mesh-ancestor
56185980|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56185981|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56185982|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56185983|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
56185984|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56185985|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56185986|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56185987|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56185988|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55898277|NCT01705691|Paclitaxel|paclitaxel|mesh-list
56264666|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56264668|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264669|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264670|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264671|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56264672|NCT01955421|Gefitinib|gefitinib|mesh-list
56264673|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264674|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56264675|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264676|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264677|NCT01955512|Clopidogrel|clopidogrel|mesh-list
56264678|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56264679|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56264680|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56264681|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56264682|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
56264683|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264684|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264685|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264686|NCT01955577|Vitamin D|vitamin d|mesh-list
56264687|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
56264688|NCT01955577|Vitamins|vitamins|mesh-ancestor
56264689|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
56264747|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
56264748|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
56264749|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264750|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56264751|NCT01955824|Lidocaine|lidocaine|mesh-list
56264752|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
56264753|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
56264754|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264755|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264756|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
56264757|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264758|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56264759|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56264760|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56264761|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264762|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264763|NCT01955967|Lidocaine|lidocaine|mesh-list
56682551|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682552|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682553|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56682554|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56682555|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56682556|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682557|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682558|NCT00822900|Progesterone|progesterone|mesh-list
56682559|NCT00822900|Progestins|progestins|mesh-ancestor
56682560|NCT00822900|Hormones|hormones|mesh-ancestor
56238311|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264764|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
56264765|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
56264766|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839862|NCT04565301|Dexamethasone|dexamethasone|mesh-list
56264791|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56264792|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56185989|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56185990|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56185991|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56185992|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
56185993|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56264793|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264794|NCT01956305|Metformin|metformin|mesh-list
56264795|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56264796|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264797|NCT01956474|Riboflavin|riboflavin|mesh-list
56264798|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
56264799|NCT01956474|Vitamins|vitamins|mesh-ancestor
56264800|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
56264801|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264802|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56264803|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
56264804|NCT01956487|Propafenone|propafenone|mesh-list
56264805|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56264806|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56264807|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56264808|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264809|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264810|NCT01956591|Oxybutynin|oxybutynin|mesh-list
56264811|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
56264812|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
56264813|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264814|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264837|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56264838|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264839|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
56264840|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264841|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56264842|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56264843|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56264844|NCT01956695|Growth Substances|growth substances|mesh-ancestor
56264845|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
56264847|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56264848|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
56264849|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264850|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264851|NCT01956786|Amlodipine|amlodipine|mesh-list
56264852|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56264853|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56264854|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264855|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264856|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56682561|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56682562|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682563|NCT00682786|Fluorouracil|fluorouracil|mesh-list
56682564|NCT00682786|Irinotecan|irinotecan|mesh-list
56682565|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
56682566|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682567|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56682568|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682569|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682570|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
56682571|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682572|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56682573|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682574|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682575|NCT00840450|Paclitaxel|paclitaxel|mesh-list
56682576|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56682577|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
56682578|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56682579|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682580|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
56264857|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264858|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
56264859|NCT01956864|Vitamin D|vitamin d|mesh-list
56264860|NCT01956864|Vitamins|vitamins|mesh-ancestor
56264861|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
56264862|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264863|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56264864|NCT01956929|Metformin|metformin|mesh-list
56264865|NCT01956929|Lactulose|lactulose|mesh-list
56264866|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56264898|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
56264899|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56264901|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264902|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
56264903|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
56264904|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
56264905|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264906|NCT01957046|Laxatives|laxatives|mesh-list
56264907|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56264908|NCT01957189|Tamsulosin|tamsulosin|mesh-list
56264909|NCT01957189|Dutasteride|dutasteride|mesh-list
56264944|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264946|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56185994|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56185995|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56185996|NCT01434173|Renal Agents|renal agents|mesh-ancestor
56185997|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56185998|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56185999|NCT01434212|Interferons|interferons|mesh-list
56186000|NCT01434212|Ribavirin|ribavirin|mesh-list
56186001|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
56186002|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
56264955|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264956|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56264957|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682581|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682582|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682583|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682584|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56682585|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682586|NCT00754858|Belotecan|belotecan|mesh-list
56682587|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682588|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56682589|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682590|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682591|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682592|NCT00755014|Ethanol|ethanol|mesh-list
56682593|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56682594|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682595|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682596|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682597|NCT00705588|Tadalafil|tadalafil|mesh-list
56682598|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56682599|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
56682600|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56238340|NCT01761071|Analgesics|analgesics|mesh-ancestor
56264958|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
56264959|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56264960|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264961|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56264963|NCT01957449|Propranolol|propranolol|mesh-list
56264965|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56264966|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56264967|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264968|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264969|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264970|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264971|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56264972|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56264973|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
56264974|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
56264975|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
56264976|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264977|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56264978|NCT01957540|Ticagrelor|ticagrelor|mesh-list
56264979|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56264980|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56264981|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56264982|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56264983|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56264984|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
56264985|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264986|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264987|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264988|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
56264989|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56682601|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56682602|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682603|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682604|NCT00705588|Urological Agents|urological agents|mesh-ancestor
56682605|NCT00755170|Bevacizumab|bevacizumab|mesh-list
56682606|NCT00755170|Vinorelbine|vinorelbine|mesh-list
56682607|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56682608|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682609|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56682610|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56682611|NCT00755170|Growth Substances|growth substances|mesh-ancestor
56682612|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682613|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
56238358|NCT01761149|Remifentanil|remifentanil|mesh-list
56264990|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56264991|NCT01957631|Prednisolone|prednisolone|mesh-list
56264992|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
56264993|NCT01957631|Bupivacaine|bupivacaine|mesh-list
56264994|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56264995|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
56264996|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
56264997|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
56264998|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264999|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265000|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
56265001|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265002|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56265003|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
56265004|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
56265005|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56265006|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
56265007|NCT01957631|Hormones|hormones|mesh-ancestor
56265008|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265009|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56265010|NCT01957631|Protective Agents|protective agents|mesh-ancestor
56265011|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56265012|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265013|NCT01957839|Cabergoline|cabergoline|mesh-list
56186003|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186004|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
56186005|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186006|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
56186007|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186008|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
56186009|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186010|NCT01434225|Bumetanide|bumetanide|mesh-list
56265014|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56265038|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265039|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56265040|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
56265041|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
56265042|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56265043|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56265044|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56265045|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56265046|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56265047|NCT01958372|Etoposide|etoposide|mesh-list
56265048|NCT01958372|Pemetrexed|pemetrexed|mesh-list
56265049|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265050|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56265051|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56682614|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56682615|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682616|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682617|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682618|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682619|NCT00705822|Prednisone|prednisone|mesh-list
56682620|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
56682621|NCT00705822|Docetaxel|docetaxel|mesh-list
56682622|NCT00705822|Estramustine|estramustine|mesh-list
56682623|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329024|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
56682624|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682625|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682626|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682627|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682628|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56265052|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56265053|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265054|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265055|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56265056|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56265057|NCT01958580|Gemcitabine|gemcitabine|mesh-list
56265058|NCT01958580|Docetaxel|docetaxel|mesh-list
56265059|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56265060|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
56265061|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265062|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265063|NCT01958580|Antiviral Agents|antiviral agents|mesh-ancestor
56265064|NCT01958580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56265065|NCT01958580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265066|NCT01958580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265067|NCT01958580|Immunologic Factors|immunologic factors|mesh-ancestor
56265091|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56265092|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
56265093|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265094|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265095|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56265096|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
56265097|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
56265098|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56265099|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56265100|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56265101|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56265102|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265103|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265104|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265105|NCT01958866|Acetaminophen|acetaminophen|mesh-list
56265106|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56265108|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
56265109|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265110|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265111|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
56265112|NCT01958905|Lumefantrine|lumefantrine|mesh-list
56265113|NCT01958905|Artemether|artemether|mesh-list
56265114|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56265115|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
56265116|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56265117|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56265118|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56265119|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
56682629|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
56682630|NCT00705822|Hormones|hormones|mesh-ancestor
56682631|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56682632|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682633|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56682634|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56682635|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
56682636|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
56682637|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682638|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682639|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56682640|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682641|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682642|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682643|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682644|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56682645|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56186011|NCT01434225|Diuretics|diuretics|mesh-ancestor
56186012|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
56186013|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186014|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56186015|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56186016|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186017|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
56186018|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56186019|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56186020|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56186021|NCT01434303|Trastuzumab|trastuzumab|mesh-list
56186022|NCT01434303|Lapatinib|lapatinib|mesh-list
56186023|NCT01434303|Entinostat|entinostat|mesh-list
56186024|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56186025|NCT01434303|Antibodies|antibodies|mesh-list
56186026|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
56186027|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56186028|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56186029|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
56186030|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186031|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186032|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56186033|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186034|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186035|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56186036|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56186037|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
56186038|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265120|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56265121|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
56265154|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56265155|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
56265156|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265157|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56265158|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265160|NCT01959074|Naftopidil|naftopidil|mesh-list
56265161|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56265188|NCT01959191|Clopidogrel|clopidogrel|mesh-list
56682646|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56682647|NCT00703170|Sirolimus|sirolimus|mesh-list
56682648|NCT00703170|Doxorubicin|doxorubicin|mesh-list
56682649|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56682650|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56682651|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682652|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56682653|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682654|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682655|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682656|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682657|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682658|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
56682659|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682707|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56682708|NCT00679042|Incretins|incretins|mesh-ancestor
56682710|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56682711|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56682712|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56682713|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56682714|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56682715|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265189|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56265190|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56265191|NCT01959191|Analgesics|analgesics|mesh-ancestor
56265192|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
56265193|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265194|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265195|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56186039|NCT01434381|Antacids|antacids|mesh-ancestor
56186040|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186041|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56186042|NCT01434394|Cetuximab|cetuximab|mesh-list
56265197|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56265198|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56265199|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265200|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56265201|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56265202|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265203|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
56265204|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56265205|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56265206|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56265207|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
56265235|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
56265236|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265237|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265238|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265239|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
56265240|NCT01959477|Busulfan|busulfan|mesh-list
56265241|NCT01959477|Etoposide|etoposide|mesh-list
56265242|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
56265243|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265244|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
56265245|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265246|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56265247|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56265248|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
56265249|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265250|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265251|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56265252|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56265253|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56265269|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
56265270|NCT01959828|Protective Agents|protective agents|mesh-ancestor
56265271|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56265272|NCT01959854|Laxatives|laxatives|mesh-ancestor
56265273|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56265274|NCT01960023|Cetuximab|cetuximab|mesh-list
56265275|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56265276|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265277|NCT01960049|Ropivacaine|ropivacaine|mesh-list
56265278|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265279|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
56265280|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265281|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265282|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
56265283|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265284|NCT01960153|Tadalafil|tadalafil|mesh-list
56265285|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
56682716|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682717|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56682718|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682719|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682720|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
56682721|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682722|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
56682723|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
56682724|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56682725|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
56265286|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56265287|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56265288|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265289|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265290|NCT01960153|Urological Agents|urological agents|mesh-ancestor
56265291|NCT01960179|Lixisenatide|lixisenatide|mesh-list
56265292|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56265293|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265294|NCT01960205|Metformin|metformin|mesh-list
56265295|NCT01960205|Saxagliptin|saxagliptin|mesh-list
56265296|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56265297|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265298|NCT01960205|Incretins|incretins|mesh-ancestor
56265299|NCT01960205|Hormones|hormones|mesh-ancestor
56265300|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265301|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56265302|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
56265303|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265304|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265305|NCT01960283|Methotrexate|methotrexate|mesh-list
56186043|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56186044|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186045|NCT01434459|Gemcitabine|gemcitabine|mesh-list
56186046|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56186047|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
56186048|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186049|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186050|NCT01434459|Antiviral Agents|antiviral agents|mesh-ancestor
56186051|NCT01434459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186052|NCT01434459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186053|NCT01434459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265306|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56265307|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
56265308|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56265309|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265310|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56265311|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
56265312|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265342|NCT01960569|Hirudins|hirudins|mesh-list
56265343|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
56265344|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56265345|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
56265346|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265347|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265348|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
56265349|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56265350|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56265351|NCT01960595|Fentanyl|fentanyl|mesh-list
56265352|NCT01960595|Bupivacaine|bupivacaine|mesh-list
56265353|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265354|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
56265355|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265356|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682726|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682727|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682728|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56682729|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
56682730|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56682731|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56682732|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56682733|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
56682734|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682735|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682736|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
56682737|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56682738|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
56682739|NCT00758368|Apomorphine|apomorphine|mesh-list
56682740|NCT00758368|Emetics|emetics|mesh-ancestor
56682741|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682742|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
56682743|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682744|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56682745|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
56682746|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
56682747|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682748|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682749|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
56682750|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56682751|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682752|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682753|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56682754|NCT05435560|Analgesics|analgesics|mesh-ancestor
56682755|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
56265357|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
56265358|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265359|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56265360|NCT01960595|Narcotics|narcotics|mesh-ancestor
56265361|NCT01960595|Analgesics|analgesics|mesh-ancestor
56265362|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56265395|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265396|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265397|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
56265398|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265399|NCT01961180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56265400|NCT01961180|Antidepressive Agents|antidepressive agents|mesh-ancestor
56265401|NCT01961180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56682756|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682757|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56682758|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56682759|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56682760|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
56682761|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682762|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682763|NCT00680992|Denosumab|denosumab|mesh-list
56682764|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
56682765|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
56682766|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
56682767|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682768|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56682769|NCT02559154|Thalidomide|thalidomide|mesh-list
56682770|NCT02559154|Dexamethasone|dexamethasone|mesh-list
56265402|NCT01961193|Silicon|silicon|mesh-list
56265467|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265468|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
56265469|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265470|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265471|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
56265472|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265473|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56265474|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
56265475|NCT01961752|Hormones|hormones|mesh-ancestor
56265476|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265477|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265478|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
55887472|NCT01862614|Epinephrine|epinephrine|mesh-list
56265479|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265480|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265481|NCT01961830|Arbekacin|arbekacin|mesh-list
56186054|NCT01434459|Immunologic Factors|immunologic factors|mesh-ancestor
56186055|NCT01434459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186056|NCT01434849|Timolol|timolol|mesh-list
56186057|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186058|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56186059|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56186060|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
56186061|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186062|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186063|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56186064|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56186065|NCT01434862|Pramlintide|pramlintide|mesh-list
56186066|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
56186067|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56186068|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186069|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
56186070|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56186071|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
56186072|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186073|NCT01434888|Timolol|timolol|mesh-list
56186074|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56186075|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56186076|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56186077|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56186078|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
56186079|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186080|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682771|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
56682772|NCT02559154|Doxorubicin|doxorubicin|mesh-list
56682773|NCT02559154|Bortezomib|bortezomib|mesh-list
56682775|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
56682776|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682777|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682778|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56682779|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
56682780|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682781|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682782|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56682783|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56682784|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
56682785|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
56682786|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682787|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56682788|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
56682789|NCT02559154|Hormones|hormones|mesh-ancestor
56682790|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56682791|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56682792|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56682793|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56682794|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682795|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682796|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
56682797|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56682798|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682799|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56682800|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56682801|NCT02559154|Growth Substances|growth substances|mesh-ancestor
56682802|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
56682803|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
56682804|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
56682805|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682807|NCT05747469|Lidocaine|lidocaine|mesh-list
56682812|NCT05747469|Sensory System Agents|sensory system agents|mesh-ancestor
56682813|NCT05747469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682814|NCT05747469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56682815|NCT05747469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56682816|NCT05747469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56682817|NCT05747469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682818|NCT05747469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682819|NCT00804843|Niacin|niacin|mesh-list
56682820|NCT00804843|Atorvastatin|atorvastatin|mesh-list
56682821|NCT00804843|Simvastatin|simvastatin|mesh-list
56682822|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56682823|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56682824|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
56682825|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186081|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186082|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56186083|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56186084|NCT01434901|Bethanechol|bethanechol|mesh-list
56186085|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56265482|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56265483|NCT01961843|Prednisone|prednisone|mesh-list
56265484|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
55840569|NCT00210184|Fluorouracil|fluorouracil|mesh-list
56265516|NCT01962181|Methylphenidate|methylphenidate|mesh-list
56265517|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56265518|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265519|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56265520|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56265521|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56186086|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
56186087|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265522|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265523|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
55840623|NCT03593434|Xenon|xenon|mesh-list
56265552|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265553|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
56265554|NCT01962454|Testosterone|testosterone|mesh-list
56265555|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
56265556|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
56265557|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56265558|NCT01962454|Androgens|androgens|mesh-ancestor
56265559|NCT01962454|Hormones|hormones|mesh-ancestor
56265560|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265561|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265562|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56265563|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265564|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
56265565|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
56265566|NCT01962571|Hematinics|hematinics|mesh-ancestor
56265567|NCT01962831|Dinoprostone|dinoprostone|mesh-list
56265568|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
56265569|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56265570|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265571|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56265572|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
56265580|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265581|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265582|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56265583|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56269010|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56682826|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56682827|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56682828|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682829|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
56682830|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
56682831|NCT00804843|Vitamins|vitamins|mesh-ancestor
56682832|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
56682833|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682834|NCT00822120|Prednisone|prednisone|mesh-list
56682835|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
56682836|NCT00822120|Dacarbazine|dacarbazine|mesh-list
56682837|NCT00822120|Doxorubicin|doxorubicin|mesh-list
56682838|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56682839|NCT00822120|Etoposide|etoposide|mesh-list
56682840|NCT00822120|Vincristine|vincristine|mesh-list
56682841|NCT00822120|Bleomycin|bleomycin|mesh-list
56265584|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265585|NCT01963299|Clonidine|clonidine|mesh-list
56265586|NCT01963299|Ropivacaine|ropivacaine|mesh-list
56265587|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265588|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
56265589|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265590|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265591|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
56265592|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265593|NCT01963299|Analgesics|analgesics|mesh-ancestor
56265594|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56265595|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
56265596|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
56265597|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56265598|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56265599|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56265600|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265601|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265602|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265603|NCT01963325|Paclitaxel|paclitaxel|mesh-list
56265604|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56265605|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56265606|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265607|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
56265608|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
56265609|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
56265610|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265611|NCT01963390|Testosterone|testosterone|mesh-list
56265612|NCT01963390|Androgens|androgens|mesh-ancestor
56265613|NCT01963390|Hormones|hormones|mesh-ancestor
56265614|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265615|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265616|NCT01963416|Micronutrients|micronutrients|mesh-list
56265617|NCT01963416|Trace Elements|trace elements|mesh-list
56265618|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265619|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56265620|NCT01963442|Lactams|lactams|mesh-list
56265621|NCT01963442|beta-Lactams|beta-lactams|mesh-list
56265622|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56265623|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56265624|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56265625|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265626|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186088|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186089|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56186090|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56682842|NCT00822120|Vinblastine|vinblastine|mesh-list
56682843|NCT00822120|Procarbazine|procarbazine|mesh-list
56682844|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682845|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
56682846|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682847|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56682848|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56682849|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
56329329|NCT00040053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56682850|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238606|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
56186091|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
56186092|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898839|NCT05720026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265627|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
55887661|NCT02473302|Vitamin E|vitamin e|mesh-list
56265628|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265629|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265630|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56265631|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56265632|NCT01963546|Analgesics|analgesics|mesh-ancestor
56265633|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
56265634|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265635|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56265636|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56265637|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56265638|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265639|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265653|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56265654|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265655|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56265656|NCT01963663|Metformin|metformin|mesh-list
56265657|NCT01963663|Pioglitazone|pioglitazone|mesh-list
56265658|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56265659|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265660|NCT01963702|Capecitabine|capecitabine|mesh-list
56265661|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
56265662|NCT01963702|Docetaxel|docetaxel|mesh-list
56265663|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56265664|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
56265665|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265666|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265667|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
56265668|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
56265669|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
56265670|NCT01963741|Histamine|histamine|mesh-list
56265671|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
56265672|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
56265673|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265674|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265675|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265676|NCT01963754|Epinephrine|epinephrine|mesh-list
56265677|NCT01963754|Racepinephrine|racepinephrine|mesh-list
56265678|NCT01963754|Anesthetics|anesthetics|mesh-list
56265679|NCT01963754|Carticaine|carticaine|mesh-list
56265680|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
56265681|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265682|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265683|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56265684|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56265685|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265686|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265687|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265688|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56265689|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56682851|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682852|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56682853|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56682854|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56682855|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56682856|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682857|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56682858|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
56682859|NCT00822120|Hormones|hormones|mesh-ancestor
56682860|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56682861|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56682862|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56682863|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682864|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
56682865|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
56682866|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
56682867|NCT00804687|Ephedrine|ephedrine|mesh-list
56682868|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56682869|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
56682870|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682871|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682872|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56682873|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
56682874|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
56682875|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56682876|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56682877|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
56682878|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265690|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
56265691|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265692|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56265693|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
56265694|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
56265695|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
56265696|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56265697|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265698|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
56265699|NCT01963832|Fluoxetine|fluoxetine|mesh-list
56265700|NCT01963832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55840777|NCT03978442|Bupropion|bupropion|mesh-list
56265718|NCT01963962|Copper|copper|mesh-list
56265719|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
56186093|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186094|NCT01434914|Octenidine|octenidine|mesh-list
56186095|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186096|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56186097|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56186098|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
56186099|NCT01435083|Coagulants|coagulants|mesh-ancestor
56682879|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682880|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682881|NCT05741385|Metoprolol|metoprolol|mesh-list
56682882|NCT05741385|Midazolam|midazolam|mesh-list
56682883|NCT05741385|Caffeine|caffeine|mesh-list
56682884|NCT05741385|Omeprazole|omeprazole|mesh-list
56682885|NCT05741385|Warfarin|warfarin|mesh-list
56682886|NCT05741385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56682887|NCT05741385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56682888|NCT05741385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682889|NCT05741385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682890|NCT05741385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56682891|NCT05741385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56682892|NCT05741385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56682893|NCT05741385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56682894|NCT05741385|Anesthetics, General|anesthetics, general|mesh-ancestor
56682895|NCT05741385|Anesthetics|anesthetics|mesh-ancestor
56682896|NCT05741385|GABA Modulators|gaba modulators|mesh-ancestor
56682897|NCT05741385|GABA Agents|gaba agents|mesh-ancestor
56682898|NCT05741385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56682899|NCT05741385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682900|NCT05741385|Anticoagulants|anticoagulants|mesh-ancestor
56682901|NCT05741385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56682902|NCT05741385|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56682903|NCT05741385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238643|NCT01762657|Cyclosporine|cyclosporine|mesh-list
56186100|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56186101|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
56186102|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186103|NCT01435161|Telmisartan|telmisartan|mesh-list
56186104|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
56186105|NCT01435161|Nifedipine|nifedipine|mesh-list
56186106|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56186107|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56186108|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186109|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56186110|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56186111|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56186112|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186113|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
56186114|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
56186115|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56186116|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56186117|NCT01435200|Hematinics|hematinics|mesh-ancestor
56186118|NCT01435213|Insulin|insulin|mesh-list
56186119|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56186121|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56186122|NCT01435213|Atipamezole|atipamezole|mesh-list
56186123|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56186124|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186125|NCT01435213|Analgesics|analgesics|mesh-ancestor
56682904|NCT05741385|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56682905|NCT05741385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56682906|NCT05741385|Purinergic Agents|purinergic agents|mesh-ancestor
56682907|NCT05741385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56682908|NCT05741385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56682909|NCT05741385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56682910|NCT05741385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56682911|NCT05741385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56682912|NCT05741385|Sympatholytics|sympatholytics|mesh-ancestor
56682913|NCT05741385|Autonomic Agents|autonomic agents|mesh-ancestor
56682914|NCT05741385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682915|NCT05741385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56682916|NCT05741385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56682917|NCT05741385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56682918|NCT05741385|Adrenergic Agents|adrenergic agents|mesh-ancestor
56682919|NCT00678652|Vaccines|vaccines|mesh-list
56682920|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
56682921|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682922|NCT02607657|Eplerenone|eplerenone|mesh-list
56682923|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56682924|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
56682925|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56682926|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682927|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56682928|NCT02607657|Diuretics|diuretics|mesh-ancestor
56682929|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
56682930|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56682931|NCT00574912|Insulin|insulin|mesh-list
56682932|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56682933|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
56682934|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56682935|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682936|NCT00922896|Gemcitabine|gemcitabine|mesh-list
56682937|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56682938|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682939|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56682941|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682942|NCT00922896|Antiviral Agents|antiviral agents|mesh-ancestor
56682943|NCT00922896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682944|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682945|NCT00922896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682946|NCT00922896|Immunologic Factors|immunologic factors|mesh-ancestor
56682947|NCT00922896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682948|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56682949|NCT00761020|Mefloquine|mefloquine|mesh-list
56682950|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
56682951|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56682952|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56682953|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682954|NCT00804141|Bromides|bromides|mesh-list
56682955|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
56682956|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
56682957|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56682958|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682959|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
56682960|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682961|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
56682962|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682963|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56682964|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682965|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682966|NCT02607579|Ropivacaine|ropivacaine|mesh-list
56682967|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
56682968|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
56682969|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56682970|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682971|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
56238701|NCT01762826|Vitamins|vitamins|mesh-ancestor
56186126|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
56265720|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56265721|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
56265722|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56265723|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265724|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56265725|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56265726|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56265727|NCT01963962|Trace Elements|trace elements|mesh-ancestor
56265728|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
56265729|NCT01964001|Vitamins|vitamins|mesh-list
55902126|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
56682972|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56682973|NCT03539367|Acetazolamide|acetazolamide|mesh-list
56682974|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
56682975|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56682976|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682977|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682978|NCT03539367|Diuretics|diuretics|mesh-ancestor
56682979|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
56682980|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682981|NCT02607423|Gemcitabine|gemcitabine|mesh-list
56682982|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
56682983|NCT02607423|Cisplatin|cisplatin|mesh-list
56682984|NCT02607423|Docetaxel|docetaxel|mesh-list
56682985|NCT02607423|Pemetrexed|pemetrexed|mesh-list
56682986|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56682987|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56682988|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56682989|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
56682990|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56682991|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
56682992|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56682993|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56682994|NCT02607423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56682995|NCT02607423|Immunologic Factors|immunologic factors|mesh-ancestor
56682996|NCT02607423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56682997|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
56682998|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
56186127|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186128|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56186129|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56186130|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
56186131|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
55898954|NCT05625802|Sensory System Agents|sensory system agents|mesh-ancestor
56265730|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
56265731|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
56265732|NCT01964001|Pyridoxal|pyridoxal|mesh-list
56265733|NCT01964001|Pyridoxine|pyridoxine|mesh-list
56265734|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
56265735|NCT01964001|Ubiquinone|ubiquinone|mesh-list
56265737|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265738|NCT01964027|Irinotecan|irinotecan|mesh-list
56265739|NCT01964027|Epirubicin|epirubicin|mesh-list
56265740|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56265741|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56265742|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265743|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265744|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265745|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56265746|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56265747|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
56265748|NCT01964040|Bupivacaine|bupivacaine|mesh-list
56682999|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
56683000|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56683001|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56683002|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56683003|NCT03416361|Vitamin D|vitamin d|mesh-list
56683004|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
56683005|NCT03416361|Vitamins|vitamins|mesh-ancestor
56683006|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
56683007|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683008|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56683009|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56683010|NCT00761254|Domperidone|domperidone|mesh-list
56683011|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
56683012|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
56683013|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683014|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683015|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56683016|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56683017|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
56683018|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683019|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683020|NCT00761332|Teriparatide|teriparatide|mesh-list
56683021|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56683022|NCT00761332|Diphosphonates|diphosphonates|mesh-list
56683023|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56683050|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683051|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56683052|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56683053|NCT00761644|Growth Substances|growth substances|mesh-ancestor
56683054|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683055|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
56683056|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56683057|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56683058|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56683059|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683060|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683061|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683062|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683063|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
56683064|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683065|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
56683066|NCT02559388|Montelukast|montelukast|mesh-list
56683067|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56683068|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
56683069|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56683070|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
56683071|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56683072|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683073|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56683074|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56683075|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683076|NCT03168256|Apremilast|apremilast|mesh-list
56683077|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56683078|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56683079|NCT03168256|Analgesics|analgesics|mesh-ancestor
56683080|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
56683088|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683089|NCT00761722|Azacitidine|azacitidine|mesh-list
56683090|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56683091|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
56683092|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683093|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683094|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683095|NCT04507906|Nivolumab|nivolumab|mesh-list
56683096|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683097|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683098|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56683099|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683100|NCT03078010|Tazobactam|tazobactam|mesh-list
56683101|NCT03078010|Piperacillin|piperacillin|mesh-list
56683102|NCT03078010|Cefepime|cefepime|mesh-list
56683103|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56683104|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683105|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683106|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56683107|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683108|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683109|NCT00762190|Insulin|insulin|mesh-list
56683110|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56683111|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683112|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683136|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683137|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683138|NCT00762736|Pioglitazone|pioglitazone|mesh-list
56683139|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56683140|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683141|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683142|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56683143|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56683144|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683145|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
56683146|NCT02915224|Chlorambucil|chlorambucil|mesh-list
56683147|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683148|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329561|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
56683149|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56683150|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
56683151|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683152|NCT02912572|Avelumab|avelumab|mesh-list
56683153|NCT02912572|Axitinib|axitinib|mesh-list
56683154|NCT02912572|Talazoparib|talazoparib|mesh-list
56683155|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683156|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683157|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56683158|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683159|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683160|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56683161|NCT02870920|Durvalumab|durvalumab|mesh-list
56683162|NCT02870920|Tremelimumab|tremelimumab|mesh-list
56683163|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683164|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683165|NCT02813824|Aspirin|aspirin|mesh-list
56683166|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
56683167|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56683168|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56683169|NCT02813824|Analgesics|analgesics|mesh-ancestor
56683172|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683173|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683174|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683175|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56683176|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56683177|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683178|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56683179|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56683180|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683181|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
56683182|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56683183|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683184|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683185|NCT00673894|Incretins|incretins|mesh-ancestor
56683186|NCT00673894|Hormones|hormones|mesh-ancestor
56683187|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56683188|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56683227|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683228|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683229|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56683230|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683231|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
56683232|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683233|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
56683234|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683235|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683236|NCT02559232|Anticoagulants|anticoagulants|mesh-list
56683237|NCT00673816|Sunitinib|sunitinib|mesh-list
56683238|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683239|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56683240|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56683241|NCT00673816|Growth Substances|growth substances|mesh-ancestor
56683242|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683243|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
56683244|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56683245|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683246|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683247|NCT00763906|Norepinephrine|norepinephrine|mesh-list
56683248|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56683249|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56683250|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
56683251|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683252|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683253|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683254|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
56683255|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
56683256|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683273|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56683274|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56683275|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
56683276|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683277|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683278|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56683279|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56683280|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
56683281|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683282|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56683283|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56683284|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56683285|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56683286|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56683287|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56683288|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56683289|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56683290|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56683291|NCT00764140|Mitogens|mitogens|mesh-list
56683292|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
56683293|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683294|NCT00672958|Vortioxetine|vortioxetine|mesh-list
56683320|NCT00759226|Folic Acid|folic acid|mesh-list
56683321|NCT00759226|Gemcitabine|gemcitabine|mesh-list
56683322|NCT00759226|Cisplatin|cisplatin|mesh-list
56683323|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
56683324|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683325|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56683326|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
56683327|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683328|NCT00759226|Antiviral Agents|antiviral agents|mesh-ancestor
56683329|NCT00759226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683330|NCT00759226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683331|NCT00759226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683332|NCT00759226|Immunologic Factors|immunologic factors|mesh-ancestor
56683333|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683334|NCT00759226|Antidotes|antidotes|mesh-ancestor
56683335|NCT00759226|Protective Agents|protective agents|mesh-ancestor
56683336|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
56683337|NCT00759226|Vitamins|vitamins|mesh-ancestor
56683338|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
56683339|NCT00759226|Hematinics|hematinics|mesh-ancestor
56683340|NCT00672646|Naproxen|naproxen|mesh-list
56683341|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56683342|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56683343|NCT00672646|Analgesics|analgesics|mesh-ancestor
56683344|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
56683345|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239080|NCT01765023|Metformin|metformin|mesh-list
56265749|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265750|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
56265751|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265752|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265753|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
56265754|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265755|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56265756|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56265757|NCT01964040|Analgesics|analgesics|mesh-ancestor
56265758|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56265759|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56265760|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56265778|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56265780|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265782|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56265783|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265784|NCT01964183|Mirabegron|mirabegron|mesh-list
56265785|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56265786|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56265787|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56265788|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56265789|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265790|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265791|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683346|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683347|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683348|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683349|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
56683350|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56683351|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683352|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683353|NCT00759460|Olanzapine|olanzapine|mesh-list
56683354|NCT00759460|Sertindole|sertindole|mesh-list
56683355|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
56683356|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
56683357|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683358|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683359|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56683360|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56683361|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56683362|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683363|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56683364|NCT00759460|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56683365|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56683366|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239113|NCT01765374|Rituximab|rituximab|mesh-list
56265792|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265793|NCT01964183|Urological Agents|urological agents|mesh-ancestor
56265794|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56265795|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56265796|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
56265797|NCT01964248|Lidocaine|lidocaine|mesh-list
56265798|NCT01964248|Prilocaine|prilocaine|mesh-list
56265799|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56265800|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265801|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
56265802|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265803|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265804|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
56265805|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265806|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56265807|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56265808|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56265809|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56265810|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265811|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56265812|NCT01964287|Leucovorin|leucovorin|mesh-list
56186132|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56186133|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56186134|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56186135|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186136|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186137|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56186138|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56186139|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56683367|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683368|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683369|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
56683370|NCT00765154|Ritonavir|ritonavir|mesh-list
56683371|NCT00765154|Darunavir|darunavir|mesh-list
56683372|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56683373|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56683374|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
56683375|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683376|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683377|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56683378|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56683379|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
56683380|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683381|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56683382|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56683383|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56683384|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
56683385|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56683386|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56683387|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56683388|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683389|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683390|NCT00770302|Saxagliptin|saxagliptin|mesh-list
56683391|NCT00770302|Incretins|incretins|mesh-ancestor
56683392|NCT00770302|Hormones|hormones|mesh-ancestor
56683393|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56683394|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683395|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56683396|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
56683397|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683398|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683399|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56186140|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
56186141|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56186142|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56186143|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56186144|NCT01435252|Cetuximab|cetuximab|mesh-list
56186145|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683400|NCT02557984|Naltrexone|naltrexone|mesh-list
56683401|NCT02557984|Amisulpride|amisulpride|mesh-list
56683402|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56683403|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56683404|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683405|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
56683406|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683407|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56683408|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56683409|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683410|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56683411|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56683412|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
56683413|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683414|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683415|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56683416|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
56683417|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56683418|NCT00759928|Sorafenib|sorafenib|mesh-list
56683419|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683420|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56683421|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683422|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683423|NCT00670930|Omalizumab|omalizumab|mesh-list
56683424|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56683425|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56683426|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
56683427|NCT00770536|Doxorubicin|doxorubicin|mesh-list
56683428|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56683429|NCT00770536|Topotecan|topotecan|mesh-list
56683430|NCT00770536|Trebananib|trebananib|mesh-list
56683431|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56683432|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683433|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56683440|NCT00770536|Growth Substances|growth substances|mesh-ancestor
56683441|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683442|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
56683443|NCT00771004|Pioglitazone|pioglitazone|mesh-list
56683444|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683445|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683446|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
56683447|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683448|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
56683449|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683450|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683451|NCT00820950|Betamethasone|betamethasone|mesh-list
56683452|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
56683453|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56683454|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
56683455|NCT00820950|Calcipotriene|calcipotriene|mesh-list
56683456|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56683457|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683458|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
56683460|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56683461|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683462|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56683463|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
56683464|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
56683465|NCT00765934|Lidocaine|lidocaine|mesh-list
56683466|NCT00765934|Tetracaine|tetracaine|mesh-list
56683467|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
56683468|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
56683469|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683470|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683471|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
56683472|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683473|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56683474|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56683475|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56683480|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683481|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56683482|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
56683483|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683484|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683485|NCT00670306|Cetrorelix|cetrorelix|mesh-list
56683486|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56683487|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
56683488|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56683489|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683490|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
56683491|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56683492|NCT00709254|Fentanyl|fentanyl|mesh-list
56683493|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56683494|NCT00709254|Narcotics|narcotics|mesh-ancestor
56683495|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683496|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683497|NCT00709254|Analgesics|analgesics|mesh-ancestor
56683498|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
56683499|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683500|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56683501|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56683502|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
56683503|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
56683504|NCT00760318|Levetiracetam|levetiracetam|mesh-list
56683505|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
56683506|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
56683507|NCT00591630|Cytarabine|cytarabine|mesh-list
56683508|NCT00591630|Rituximab|rituximab|mesh-list
56683509|NCT00591630|Etoposide|etoposide|mesh-list
56683510|NCT00591630|Melphalan|melphalan|mesh-list
56683511|NCT00591630|Carmustine|carmustine|mesh-list
56683512|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683513|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683514|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
56683515|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239249|NCT01765946|Metformin|metformin|mesh-list
56186149|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
56186150|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186151|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56186152|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888215|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683516|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683517|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56683518|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56683519|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56683520|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683521|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683522|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56683523|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
56683524|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
56683525|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683526|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683527|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56683528|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
56683529|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56683531|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
56683532|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56239273|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
56186153|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265813|NCT01964287|Gemcitabine|gemcitabine|mesh-list
56265814|NCT01964287|Paclitaxel|paclitaxel|mesh-list
56265841|NCT01964365|Fenofibrate|fenofibrate|mesh-list
56265842|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56265843|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56265844|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
56265845|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265846|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56265847|NCT01964391|Paclitaxel|paclitaxel|mesh-list
56265848|NCT01964391|Docetaxel|docetaxel|mesh-list
56265849|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
56265850|NCT01964391|Carboplatin|carboplatin|mesh-list
56265851|NCT01964391|Doxorubicin|doxorubicin|mesh-list
56265852|NCT01964391|Trastuzumab|trastuzumab|mesh-list
56265853|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56265854|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265855|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
56265856|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
56265857|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
56265858|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265859|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265860|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
56265861|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265862|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56265863|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56265864|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
56265865|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56265866|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56265890|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186154|NCT01435343|Cytarabine|cytarabine|mesh-list
56186155|NCT01435343|Plerixafor|plerixafor|mesh-list
56186156|NCT01435343|Fludarabine|fludarabine|mesh-list
56186157|NCT01435343|Idarubicin|idarubicin|mesh-list
56186158|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186159|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56186160|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
56186161|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186162|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265891|NCT01964534|Antiviral Agents|antiviral agents|mesh-ancestor
56265892|NCT01964534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683533|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56683534|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56683535|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
56683536|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683537|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683538|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683539|NCT00771394|Urological Agents|urological agents|mesh-ancestor
56683540|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56683541|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56683542|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
56683543|NCT00670228|Insulin|insulin|mesh-list
56683544|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56683545|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
56683546|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
56683547|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683548|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683549|NCT00766246|Bevacizumab|bevacizumab|mesh-list
56683550|NCT00766246|Carboplatin|carboplatin|mesh-list
56683551|NCT00766246|Docetaxel|docetaxel|mesh-list
56683552|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683553|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683554|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56683555|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56683556|NCT00766246|Growth Substances|growth substances|mesh-ancestor
56683557|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683558|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
56683559|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
56683560|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
56683561|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
56683563|NCT00766402|Acetaminophen|acetaminophen|mesh-list
56683578|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56683579|NCT00766402|Narcotics|narcotics|mesh-ancestor
56683580|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683581|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56683582|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683583|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683584|NCT00760864|Methotrexate|methotrexate|mesh-list
56683585|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56683586|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
56683587|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56683588|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683589|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56683590|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
56683591|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683592|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683593|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
56683594|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683595|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56683596|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683597|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
56683598|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56683599|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56683601|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683602|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
56683603|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683604|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56683624|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683625|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683626|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683627|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56683628|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
56683629|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56683630|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
56683631|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56683632|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56683633|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
56683634|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683635|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56683636|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56683637|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683638|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683639|NCT00775294|Maraviroc|maraviroc|mesh-list
56683640|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56683641|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56683642|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683643|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56683644|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56683645|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
56683646|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683647|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56683648|NCT00772798|Paclitaxel|paclitaxel|mesh-list
56683649|NCT00772798|Carboplatin|carboplatin|mesh-list
56683650|NCT00772798|Vorinostat|vorinostat|mesh-list
56683651|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56683652|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683668|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683669|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683670|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56683671|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683672|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683673|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56683674|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56683676|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683677|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683678|NCT04047940|Metformin|metformin|mesh-list
56683679|NCT04047940|Valsartan|valsartan|mesh-list
56683680|NCT04047940|Atorvastatin|atorvastatin|mesh-list
56683681|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683682|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683683|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56683684|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56683685|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
56683686|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683687|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56683688|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56683689|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683690|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56683691|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56683692|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56683693|NCT00773188|Bevacizumab|bevacizumab|mesh-list
56683694|NCT00773188|Vinorelbine|vinorelbine|mesh-list
56683695|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56683696|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683707|NCT00767260|Insulin|insulin|mesh-list
56683713|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56683714|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683715|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683716|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
56683717|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56683718|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
56683719|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683720|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683721|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56683722|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
56683723|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56683724|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
56683725|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683726|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683727|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56683728|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
56683729|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
56683730|NCT00773578|Protective Agents|protective agents|mesh-ancestor
56683731|NCT00775762|Aspirin|aspirin|mesh-list
56683732|NCT00775762|Clopidogrel|clopidogrel|mesh-list
56683733|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56683734|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56683735|NCT00775762|Analgesics|analgesics|mesh-ancestor
56683747|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
56683762|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56683763|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56683764|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
56683765|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
56683766|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56683767|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56683768|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56683769|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683770|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56683771|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
56683772|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
56683773|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683774|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683775|NCT00773812|Mecamylamine|mecamylamine|mesh-list
56683776|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56683777|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56683778|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
56683779|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683780|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683781|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56683782|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56683783|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
56683784|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683812|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56683813|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
56683814|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56683815|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683816|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56683817|NCT00668200|Vitamin D|vitamin d|mesh-list
56683818|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
56683819|NCT00668200|Calcium|calcium|mesh-list
56683820|NCT00668200|Vitamins|vitamins|mesh-ancestor
56683821|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
56683822|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683823|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56683824|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56683825|NCT00679601|Tavaborole|tavaborole|mesh-list
56683826|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
56683827|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683828|NCT00675779|Atorvastatin|atorvastatin|mesh-list
56683829|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
56683830|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
56683831|NCT00675779|Dacuronium|dacuronium|mesh-list
56683832|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56683833|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56683834|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
56683835|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683836|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56683837|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56683838|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683839|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56683840|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683841|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56683842|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56683855|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683856|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683857|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56683858|NCT04151147|Mitogens|mitogens|mesh-list
56683859|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
56683860|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683861|NCT00774358|Aldesleukin|aldesleukin|mesh-list
56683862|NCT00774358|Interleukin-2|interleukin-2|mesh-list
56683863|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683864|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56683865|NCT00774358|Analgesics|analgesics|mesh-ancestor
56683866|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
56683867|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683868|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683869|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56683870|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56683871|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
56683872|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683873|NCT02627417|Dapsone|dapsone|mesh-list
56683874|NCT02627417|Prednisone|prednisone|mesh-list
56683875|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56683876|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
56683877|NCT02627417|Hormones|hormones|mesh-ancestor
56683878|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56683879|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683880|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56683881|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683882|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683883|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
56683884|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56683885|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56683899|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683900|NCT02634515|Insulin|insulin|mesh-list
56683901|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56683902|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56683903|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683904|NCT00705900|Calcipotriene|calcipotriene|mesh-list
56683905|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
56683906|NCT00679835|Daptomycin|daptomycin|mesh-list
56683907|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683908|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683909|NCT00774904|Losartan|losartan|mesh-list
56683910|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56683911|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56683912|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56683913|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56683914|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683915|NCT00829296|Metoprolol|metoprolol|mesh-list
56683916|NCT00829296|Nebivolol|nebivolol|mesh-list
56683917|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56683918|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56683919|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
56683920|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
56683921|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56683922|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683923|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56683924|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56683925|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56683926|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
56683927|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683928|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683929|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
56683930|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56683940|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683941|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56683942|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683943|NCT00881621|Capecitabine|capecitabine|mesh-list
56683944|NCT00881621|Lapatinib|lapatinib|mesh-list
56683945|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56683946|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
56683947|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683948|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683949|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56683950|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56683951|NCT00779194|Sirolimus|sirolimus|mesh-list
56683952|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683953|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683954|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56683955|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56683956|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
56265893|NCT01964534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265894|NCT01964534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265895|NCT01964534|Immunologic Factors|immunologic factors|mesh-ancestor
56265896|NCT01964534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265897|NCT01964573|Rotigotine|rotigotine|mesh-list
56265898|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
56265899|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
56265900|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265901|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265902|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265903|NCT01964586|Lidocaine|lidocaine|mesh-list
56265904|NCT01964586|Epinephrine|epinephrine|mesh-list
56265905|NCT01964586|Racepinephrine|racepinephrine|mesh-list
56265906|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
56265907|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
56265908|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265909|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
56265910|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265911|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265912|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
56265913|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265914|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56265915|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56265916|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56265946|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265948|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265949|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56265960|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
56265961|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56265962|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
56265977|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265978|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265979|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
56265980|NCT01964846|Protective Agents|protective agents|mesh-ancestor
56265981|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56265982|NCT01964911|Ropivacaine|ropivacaine|mesh-list
56265983|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265984|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
56265985|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265986|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265987|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
56683957|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56683958|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
56683959|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683960|NCT02634281|Varenicline|varenicline|mesh-list
56683961|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56683962|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56683963|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
56683964|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683965|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683966|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683967|NCT00818766|Vancomycin|vancomycin|mesh-list
56683968|NCT00818766|Cefazolin|cefazolin|mesh-list
56683969|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56683970|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56683971|NCT00779350|Sertraline|sertraline|mesh-list
56683972|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
56683973|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56683974|NCT00779350|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56683975|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56683976|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56683977|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56683978|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56683979|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
56683980|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56683981|NCT00705978|Pancreatin|pancreatin|mesh-list
56683982|NCT00705978|Pancrelipase|pancrelipase|mesh-list
56683983|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56683984|NCT02556970|Acetaminophen|acetaminophen|mesh-list
56683985|NCT02556970|Diclofenac|diclofenac|mesh-list
56683986|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
56684002|NCT00594815|Leucovorin|leucovorin|mesh-list
56684003|NCT00594815|Cytarabine|cytarabine|mesh-list
56684004|NCT00594815|Rituximab|rituximab|mesh-list
56684005|NCT00594815|Methotrexate|methotrexate|mesh-list
56684006|NCT00594815|Vincristine|vincristine|mesh-list
56684007|NCT00594815|Procarbazine|procarbazine|mesh-list
56684008|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56684009|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684010|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
56684011|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684012|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56684013|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56684014|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
56684015|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56684016|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56684017|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
56684018|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684019|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56684020|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684021|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56684022|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56684023|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56684024|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
56684025|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684026|NCT00594815|Antidotes|antidotes|mesh-ancestor
56265988|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265989|NCT01965041|Aflibercept|aflibercept|mesh-list
56265990|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56265991|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56265992|NCT01965041|Growth Substances|growth substances|mesh-ancestor
56265993|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186163|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
56186164|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186165|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
56186166|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186167|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56186168|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56186169|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56186170|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186171|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56186172|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56186173|NCT01435395|Bevacizumab|bevacizumab|mesh-list
56186174|NCT01435395|Temozolomide|temozolomide|mesh-list
56186175|NCT01435395|Bortezomib|bortezomib|mesh-list
56186176|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56186177|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186178|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56186179|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56186180|NCT01435395|Growth Substances|growth substances|mesh-ancestor
55899147|NCT00358384|Betamethasone|betamethasone|mesh-list
56265994|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
56265995|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265996|NCT01965080|Exemestane|exemestane|mesh-list
56265997|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684027|NCT00594815|Protective Agents|protective agents|mesh-ancestor
56684028|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
56684029|NCT00594815|Vitamins|vitamins|mesh-ancestor
56684030|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
56684031|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56684032|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
56684033|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
56684034|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
56684035|NCT00776542|Minocycline|minocycline|mesh-list
56684036|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684037|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684038|NCT00776620|Glimepiride|glimepiride|mesh-list
56684039|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56684040|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56684041|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684042|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56684043|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
56330486|NCT00024206|Orantinib|orantinib|mesh-list
56684044|NCT00776698|Bevacizumab|bevacizumab|mesh-list
56684045|NCT00776698|Etoposide|etoposide|mesh-list
56265998|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56265999|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56266000|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266001|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266002|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56266003|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56266004|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266005|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266006|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56266007|NCT01965275|Gefitinib|gefitinib|mesh-list
56266008|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266009|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55800992|NCT04866355|Ibuprofen|ibuprofen|mesh-list
56266012|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
56266013|NCT01965301|Promethazine|promethazine|mesh-list
56266014|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56266015|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56266016|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266017|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266018|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
56266019|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
56266020|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
56266021|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266022|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
56266023|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
56266024|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56266025|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56266052|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
56266053|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56266054|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266055|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266057|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56186181|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186182|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
56186183|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56186184|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
56186185|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684046|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56684047|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684048|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56684049|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56684050|NCT00776698|Growth Substances|growth substances|mesh-ancestor
56684051|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684052|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
56684053|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56684054|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56684055|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56684056|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684057|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684058|NCT00820248|Panitumumab|panitumumab|mesh-list
56684059|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684060|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56684061|NCT04150757|Ketamine|ketamine|mesh-list
56684062|NCT04150757|Analgesics|analgesics|mesh-ancestor
56684063|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
56684064|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684065|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684066|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56684067|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56684068|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
56684069|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
56684070|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684071|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56684072|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56684073|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684074|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186186|NCT01435486|Caffeine|caffeine|mesh-list
56186187|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
56186188|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186189|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56186190|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186191|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56186192|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186193|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56186194|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56186195|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
56186196|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186198|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56684075|NCT04150289|Panobinostat|panobinostat|mesh-list
56684076|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684077|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56684078|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684079|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684080|NCT04150367|Rifampin|rifampin|mesh-list
56684081|NCT04150367|Isoniazid|isoniazid|mesh-list
56684082|NCT04150367|Ethambutol|ethambutol|mesh-list
56684083|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56684084|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56684085|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
56684086|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684087|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684088|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
56684089|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56684090|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684091|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684092|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56684093|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56684094|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56684095|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56684096|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56684125|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684126|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684127|NCT00684827|Albuterol|albuterol|mesh-list
56684128|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56684129|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
56684130|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684131|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684132|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56684133|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
56684134|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
56684135|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56684136|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56684137|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56684138|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56684139|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
56684140|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684141|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684142|NCT00820170|Paclitaxel|paclitaxel|mesh-list
56684143|NCT00820170|Dasatinib|dasatinib|mesh-list
56684144|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56684145|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684146|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
56684147|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
56684148|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
56684149|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684150|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56684151|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684152|NCT02627027|Metformin|metformin|mesh-list
56684153|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56684154|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684155|NCT00709332|Folic Acid|folic acid|mesh-list
56684156|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56684157|NCT00709332|Norgestimate|norgestimate|mesh-list
56684158|NCT00709332|Estradiol|estradiol|mesh-list
56684159|NCT00709332|Estrogens|estrogens|mesh-ancestor
56684160|NCT00709332|Hormones|hormones|mesh-ancestor
56239880|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56186199|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
56186200|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684161|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684162|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684163|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56684164|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
56684165|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56684166|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56684167|NCT00709332|Hematinics|hematinics|mesh-ancestor
56684168|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
56684169|NCT00709332|Vitamins|vitamins|mesh-ancestor
56684170|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
56684171|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56684172|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56684173|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56684174|NCT00684905|Leuprolide|leuprolide|mesh-list
56684175|NCT00684905|Bicalutamide|bicalutamide|mesh-list
56684176|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56684177|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
56684178|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56684179|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684180|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56684181|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684182|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
56684183|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
56684184|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684185|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
56684186|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
56684187|NCT00685061|Daclizumab|daclizumab|mesh-list
56684188|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
56684189|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684190|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56684191|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56684192|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330629|NCT00052455|Lomustine|lomustine|mesh-list
56684193|NCT02633813|Naftifine|naftifine|mesh-list
56684194|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
56684195|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186201|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56186202|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56186203|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
56684197|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56684198|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
56684199|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684200|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684201|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56684202|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
56684203|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
56684204|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56684205|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56684206|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56684207|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56684208|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56684209|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684210|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684211|NCT02626247|Vitamin A|vitamin a|mesh-list
56684212|NCT02626247|Vitamins|vitamins|mesh-ancestor
56684213|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
56684214|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684215|NCT05758818|Moxifloxacin|moxifloxacin|mesh-list
56684216|NCT05758818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684217|NCT05758818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684218|NCT05758818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56684219|NCT05758818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56684220|NCT05758818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239950|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186204|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186205|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186206|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56186207|NCT01435707|Triamcinolone|triamcinolone|mesh-list
56186208|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56266058|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
56266059|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56266060|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56266061|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56266062|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56266063|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266064|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
56266065|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266066|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266067|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56266068|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56266069|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266070|NCT01965522|Vitamin D|vitamin d|mesh-list
56266071|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
56266072|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
56266073|NCT01965522|Vitamins|vitamins|mesh-list
56266074|NCT01965522|Melatonin|melatonin|mesh-list
55841162|NCT04021108|Nivolumab|nivolumab|mesh-list
56186209|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56684221|NCT05758818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684222|NCT05758818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684223|NCT00828984|Laxatives|laxatives|mesh-list
56684224|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56684225|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684226|NCT00819390|Chloroquine|chloroquine|mesh-list
56684227|NCT00819390|Amebicides|amebicides|mesh-ancestor
56684228|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56684229|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56684230|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684231|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
56684232|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56684233|NCT00876395|Paclitaxel|paclitaxel|mesh-list
56684234|NCT00876395|Trastuzumab|trastuzumab|mesh-list
56684235|NCT00876395|Everolimus|everolimus|mesh-list
56684236|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56684237|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684238|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
56684239|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
56684240|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
56684241|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684242|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56684243|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56684244|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
56239976|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
56186210|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56186211|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56186212|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
56186214|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186215|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186216|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56186217|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
56186218|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186219|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186221|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56186222|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266106|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266107|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266108|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
56266109|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56266110|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56266111|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266112|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
56266113|NCT01965730|Coagulants|coagulants|mesh-ancestor
56266114|NCT01965925|Modafinil|modafinil|mesh-list
55841217|NCT04747678|Ivermectin|ivermectin|mesh-list
56266147|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56266148|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56266149|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266150|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56684245|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684246|NCT05758662|Listerine|listerine|mesh-list
56684247|NCT05758662|Fluorides|fluorides|mesh-list
56684248|NCT05758662|Sodium Fluoride|sodium fluoride|mesh-list
56684249|NCT05758662|Cariostatic Agents|cariostatic agents|mesh-ancestor
56684250|NCT05758662|Protective Agents|protective agents|mesh-ancestor
56684251|NCT05758662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684252|NCT05758662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56684253|NCT05758662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684254|NCT02633657|Gabapentin|gabapentin|mesh-list
56684255|NCT02633657|Analgesics|analgesics|mesh-ancestor
56684256|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
56684257|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684258|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684259|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
56684260|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56684261|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56684262|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684263|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56684264|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56684265|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56684266|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684267|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684268|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
56684269|NCT02626169|Clopidogrel|clopidogrel|mesh-list
56684270|NCT02626169|Ticagrelor|ticagrelor|mesh-list
56684271|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56684272|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56684273|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56684274|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56684275|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
56684276|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684277|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684278|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684279|NCT04139915|Dactolisib|dactolisib|mesh-list
56266151|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266152|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266153|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
56104395|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
56684280|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684281|NCT04148183|Metformin|metformin|mesh-list
56684282|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
56684283|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56684284|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684285|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56684286|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56684287|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56684288|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
56684289|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684290|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56684291|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56684292|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684293|NCT02633579|Erythromycin|erythromycin|mesh-list
56684294|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
56684295|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56684296|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
56684297|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
56684298|NCT02633579|Atropine|atropine|mesh-list
56684299|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56684300|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56684301|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55888147|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266155|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56266156|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55841254|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
56266189|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56266190|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
56266191|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266192|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266193|NCT01966484|Succinylcholine|succinylcholine|mesh-list
56266194|NCT01966484|Mivacurium|mivacurium|mesh-list
56266195|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56266196|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55841305|NCT04026022|Fentanyl|fentanyl|mesh-list
56266218|NCT01966627|Hematinics|hematinics|mesh-ancestor
56266219|NCT01966653|Fosfomycin|fosfomycin|mesh-list
56266220|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
56266221|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56266222|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266223|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56266224|NCT01966653|Renal Agents|renal agents|mesh-ancestor
56266225|NCT01966692|Fluticasone|fluticasone|mesh-list
56266226|NCT01966692|Xhance|xhance|mesh-list
56266227|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55888222|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
56266228|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56266229|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
56266230|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266231|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266232|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56266233|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
56266234|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
56186223|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56186224|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684302|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
56684303|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684304|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684305|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56684306|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
56684307|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
56684308|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
56684309|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56684310|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56684311|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
56684312|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684313|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684314|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684315|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684316|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684317|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56684318|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684319|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
56684320|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56684321|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
56684322|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684323|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684324|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56684325|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
56684326|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56684327|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56684328|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56684329|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
56684330|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240055|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56186225|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266235|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56266236|NCT01966783|Budesonide|budesonide|mesh-list
56266237|NCT01966783|Mesalamine|mesalamine|mesh-list
56266238|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56266239|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56266240|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
56266241|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266242|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266243|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56266244|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
56266245|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
56266246|NCT01966783|Hormones|hormones|mesh-ancestor
56684331|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684332|NCT00685607|Simethicone|simethicone|mesh-list
56684333|NCT00685607|Loperamide|loperamide|mesh-list
56684334|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
56684335|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684336|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
56684337|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684338|NCT00685607|Emollients|emollients|mesh-ancestor
56684339|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
56684340|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
56684341|NCT00657059|Prednisone|prednisone|mesh-list
56684342|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
56684343|NCT00657059|Irbesartan|irbesartan|mesh-list
56684344|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56684345|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
56684346|NCT00657059|Hormones|hormones|mesh-ancestor
56684347|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684348|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684349|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56684350|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684351|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56684352|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56684353|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
56684354|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684355|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684357|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684358|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
56684359|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
56684360|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684361|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684362|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56684363|NCT00657059|Protective Agents|protective agents|mesh-ancestor
56266247|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841333|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266255|NCT01966822|Dolutegravir|dolutegravir|mesh-list
56266256|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
56266257|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56266258|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266259|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266260|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56266261|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56266262|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
56684364|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56684365|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56684366|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56684367|NCT00667732|Exenatide|exenatide|mesh-list
56684368|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56684369|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684370|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56684371|NCT00667732|Incretins|incretins|mesh-ancestor
56684372|NCT00667732|Hormones|hormones|mesh-ancestor
56684373|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684374|NCT04161209|Citalopram|citalopram|mesh-list
56684375|NCT04161209|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56684376|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56684377|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56684378|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684379|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684380|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
56684381|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684382|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56684383|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
56684384|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56684385|NCT04161053|Rifaximin|rifaximin|mesh-list
56684386|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
56240121|NCT01770470|Chitosan|chitosan|mesh-list
56266263|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266264|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56266265|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56266266|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56266267|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56266268|NCT01966913|Bevacizumab|bevacizumab|mesh-list
56266269|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56266270|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266271|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56266272|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56266273|NCT01966913|Growth Substances|growth substances|mesh-ancestor
56266274|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266275|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
56266276|NCT01967017|Lidocaine|lidocaine|mesh-list
56266277|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
56266278|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
56266279|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266280|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266281|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
56266282|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266283|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56266284|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56266285|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56266286|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888216|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56684387|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684388|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684389|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684390|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56684391|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56684392|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
56684393|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56684394|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56684395|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
56684396|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684397|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684398|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56684399|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
56684400|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56684401|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56684402|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56684403|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
56684404|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684405|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684406|NCT00681785|Dalteparin|dalteparin|mesh-list
56684407|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56684408|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
56684409|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56684437|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684438|NCT00657137|Capecitabine|capecitabine|mesh-list
56684439|NCT00657137|Lapatinib|lapatinib|mesh-list
56684440|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56684441|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
56684442|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684443|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684444|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56684445|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684446|NCT00777244|Mitotane|mitotane|mesh-list
56684447|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56684448|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684449|NCT04160897|Tenofovir|tenofovir|mesh-list
56684450|NCT04160897|Entecavir|entecavir|mesh-list
56684451|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
56684452|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684453|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56684454|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56684455|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684456|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684457|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56684458|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56684459|NCT00777322|Riboflavin|riboflavin|mesh-list
56684460|NCT00777322|Dextrans|dextrans|mesh-list
56684461|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
56684462|NCT00777322|Vitamins|vitamins|mesh-ancestor
56684463|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
56684464|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684465|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56684466|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
56684467|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
56684468|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
56684469|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
56684471|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
56684480|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56684481|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56684482|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56684483|NCT02556268|Triumeq|triumeq|mesh-list
56684484|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
56684485|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56684486|NCT02556268|Riociguat|riociguat|mesh-list
56684487|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
56684488|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
56684489|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684490|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
56684491|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684492|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56684493|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56684494|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684495|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56684496|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56684497|NCT00875615|Carboplatin|carboplatin|mesh-list
56684498|NCT00875615|Sorafenib|sorafenib|mesh-list
56684499|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684500|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56684501|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684529|NCT00768508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56684530|NCT00768508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56684531|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
56684532|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56684533|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56684534|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56684535|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56684536|NCT00777478|Sunitinib|sunitinib|mesh-list
56684537|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684538|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56684539|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56684540|NCT00777478|Growth Substances|growth substances|mesh-ancestor
56684541|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684542|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
56684543|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56684544|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684545|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684546|NCT00780598|Tosedostat|tosedostat|mesh-list
56684547|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684548|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684549|NCT00780754|Dutasteride|dutasteride|mesh-list
56684550|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56684551|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56684552|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684553|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684554|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
56684555|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684574|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684575|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56684576|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
56684577|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
56684578|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684579|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684580|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
56684581|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
56684582|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
56684583|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684584|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56684585|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684586|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56684587|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56684588|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56684589|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
56684590|NCT02556658|Anesthetics|anesthetics|mesh-list
56684591|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684592|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684593|NCT00682721|Valacyclovir|valacyclovir|mesh-list
56684594|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
56684595|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266287|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266288|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56266289|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266290|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56266291|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266292|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266293|NCT01967199|Paclitaxel|paclitaxel|mesh-list
56266294|NCT01967199|Everolimus|everolimus|mesh-list
56266295|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56266296|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266297|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
56266298|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
56266299|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
56266300|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266301|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56266302|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
56266303|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266304|NCT01967251|Udenafil|udenafil|mesh-list
56266305|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56266306|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56186226|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56186227|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56186228|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
56186229|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186230|NCT01435902|Fluticasone|fluticasone|mesh-list
56186231|NCT01435902|Xhance|xhance|mesh-list
56186232|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56186233|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56186234|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
56186235|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186236|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684596|NCT02556814|Dexamethasone|dexamethasone|mesh-list
56684597|NCT02556814|Caffeic acid|caffeic acid|mesh-list
56684598|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56684599|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
56684600|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
56684601|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684602|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684603|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684604|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
56684605|NCT02556814|Hormones|hormones|mesh-ancestor
56684606|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684607|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56684608|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684609|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
56684610|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186237|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56186238|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
56186239|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
56186240|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56186241|NCT01435915|Ropinirole|ropinirole|mesh-list
56186242|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56186243|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56186244|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
56186245|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
56186246|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186247|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186248|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186249|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56186250|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55899379|NCT05292586|Hormones|hormones|mesh-ancestor
56266307|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266308|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266309|NCT01967264|Udenafil|udenafil|mesh-list
56266310|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56266311|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56266312|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266313|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266314|NCT01967368|Vaccines|vaccines|mesh-list
55841390|NCT04026880|Hormones|hormones|mesh-ancestor
56266319|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266321|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
56266322|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266323|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
56266324|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266325|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266326|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
56266327|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56266328|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56266329|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56266330|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56266331|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
56266332|NCT01967459|Vitamin D|vitamin d|mesh-list
56266333|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56186251|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56186252|NCT01435941|Analgesics|analgesics|mesh-ancestor
56186253|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
56186254|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186255|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186256|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56684611|NCT02556814|Protective Agents|protective agents|mesh-ancestor
56684612|NCT00682955|Zinc|zinc|mesh-list
56684613|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
56684614|NCT00682955|Trace Elements|trace elements|mesh-ancestor
56684615|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
56684616|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684617|NCT00682955|Astringents|astringents|mesh-ancestor
56684618|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
56684619|NCT00686621|Posaconazole|posaconazole|mesh-list
56684620|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
56684621|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684622|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56684623|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56684624|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56684625|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56684626|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56684627|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684628|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684629|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56684630|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
56684631|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684632|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684633|NCT00683111|Esomeprazole|esomeprazole|mesh-list
56684634|NCT00683111|Famotidine|famotidine|mesh-list
56684635|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56684636|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684637|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56684645|NCT04138901|Ropivacaine|ropivacaine|mesh-list
56684659|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684660|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56684661|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
56684662|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
56684663|NCT04142411|Protective Agents|protective agents|mesh-ancestor
56684664|NCT00683189|Warfarin|warfarin|mesh-list
56684665|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
56684666|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
56684667|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684668|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
56684669|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56684670|NCT00667576|Protective Agents|protective agents|mesh-ancestor
56684671|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684672|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56684673|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
56684674|NCT04141787|Cefazolin|cefazolin|mesh-list
56684675|NCT04141787|Daptomycin|daptomycin|mesh-list
56684676|NCT04141787|Cloxacillin|cloxacillin|mesh-list
56684677|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684678|NCT02557594|Tenofovir|tenofovir|mesh-list
56684679|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
56684680|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684681|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56684682|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56684683|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684684|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684685|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56684686|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56684687|NCT00687011|Dexamethasone|dexamethasone|mesh-list
56684688|NCT00687011|Palonosetron|palonosetron|mesh-list
56684689|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56684690|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
56684691|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
56684692|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684693|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684694|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240406|NCT01772641|Varenicline|varenicline|mesh-list
56186258|NCT01435954|Tamsulosin|tamsulosin|mesh-list
56186259|NCT01435954|Finasteride|finasteride|mesh-list
56186260|NCT01435954|Silodosin|silodosin|mesh-list
56186261|NCT01435954|Terazosin|terazosin|mesh-list
56186262|NCT01435954|Alfuzosin|alfuzosin|mesh-list
56186263|NCT01435954|Dutasteride|dutasteride|mesh-list
56104888|NCT04472767|Nivolumab|nivolumab|mesh-list
56684695|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
56684696|NCT00687011|Hormones|hormones|mesh-ancestor
56684697|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684698|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56684699|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684700|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56684701|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56684702|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
56684703|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684704|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684705|NCT00683267|Capsaicin|capsaicin|mesh-list
56684706|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
56684707|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
56684708|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
56684709|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684710|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684711|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56684712|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56684713|NCT00687245|Esomeprazole|esomeprazole|mesh-list
56684714|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56684715|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684716|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56684717|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684718|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684719|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56684720|NCT00690521|Metolazone|metolazone|mesh-list
56684721|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56684722|NCT00690521|Diuretics|diuretics|mesh-ancestor
56684723|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
56684724|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684725|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56684726|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56684727|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684728|NCT00666718|Insulin|insulin|mesh-list
56684729|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56684730|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
56684732|NCT00666718|Protamines|protamines|mesh-list
56684733|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56684734|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684735|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
56684736|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684737|NCT00666718|Coagulants|coagulants|mesh-ancestor
56684738|NCT00683735|Metformin|metformin|mesh-list
56684739|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56684740|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56684741|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684742|NCT00683735|Incretins|incretins|mesh-ancestor
56684743|NCT00683735|Hormones|hormones|mesh-ancestor
56684744|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684745|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56684746|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
56186264|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55899429|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55899430|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266334|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266335|NCT01967459|Vitamins|vitamins|mesh-ancestor
56266336|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
56266337|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56266338|NCT01967472|Artesunate|artesunate|mesh-list
56266339|NCT01967472|Lumefantrine|lumefantrine|mesh-list
56266340|NCT01967472|Artemether|artemether|mesh-list
56266341|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56266342|NCT01967472|Amodiaquine|amodiaquine|mesh-list
56266343|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
56266344|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56266345|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56266346|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266347|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266348|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
56266349|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
56266350|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56266351|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
56266352|NCT01967498|Montelukast|montelukast|mesh-list
56266353|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56266354|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
56266355|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56266356|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
56266357|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266358|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266359|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56266360|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56266361|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266362|NCT01967524|Ropivacaine|ropivacaine|mesh-list
56266363|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56266364|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
56266365|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56266366|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
56266368|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266369|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266370|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
56266371|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266372|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56266373|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56266374|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266375|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
56684747|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684748|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684749|NCT04139681|Menthol|menthol|mesh-list
56684750|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
56684751|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
56684752|NCT04047394|Rasburicase|rasburicase|mesh-list
56684753|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
56684754|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56684755|NCT02625779|Valproic Acid|valproic acid|mesh-list
56684756|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
56684757|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684758|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684759|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
56240487|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56266376|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266377|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56266378|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56266379|NCT01967758|Amoxicillin|amoxicillin|mesh-list
56186265|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56186266|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56186267|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
56186269|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186270|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186271|NCT01435954|Urological Agents|urological agents|mesh-ancestor
56186272|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56186273|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56186274|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186275|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
56186276|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186277|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56186278|NCT01435980|Exenatide|exenatide|mesh-list
56186279|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56186280|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186281|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56266380|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56266381|NCT01967758|Trimethoprim|trimethoprim|mesh-list
56266382|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
56266383|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841457|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
56266394|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56266395|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56266397|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
56266398|NCT01967823|Fludarabine|fludarabine|mesh-list
56266399|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56266400|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
56266401|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266402|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266403|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56266404|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
56266405|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266406|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266407|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56266408|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56266409|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56266410|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
56266411|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266412|NCT01967875|Docetaxel|docetaxel|mesh-list
56266413|NCT01967875|Capecitabine|capecitabine|mesh-list
56266414|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266415|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
56266416|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
56266417|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
56684760|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684761|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684762|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
56684763|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56684764|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684765|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56684766|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
56684767|NCT00667420|Epirubicin|epirubicin|mesh-list
56684768|NCT00667420|Panitumumab|panitumumab|mesh-list
56684769|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684770|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684771|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56684772|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56684773|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56684774|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684775|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56684776|NCT04141319|Ketorolac|ketorolac|mesh-list
56684777|NCT04141319|Epinephrine|epinephrine|mesh-list
56684778|NCT04141319|Ropivacaine|ropivacaine|mesh-list
56684779|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
56684780|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
56684781|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684782|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684783|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
56240501|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
56266418|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266419|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56266420|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
56266421|NCT01967927|Imidazole|imidazole|mesh-list
56266422|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266423|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266424|NCT01967979|Itraconazole|itraconazole|mesh-list
56266425|NCT01967979|Fluoxetine|fluoxetine|mesh-list
56266426|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
56266427|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266428|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56266429|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56266430|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186282|NCT01435980|Incretins|incretins|mesh-ancestor
56186283|NCT01435980|Hormones|hormones|mesh-ancestor
56186284|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186285|NCT01436123|Everolimus|everolimus|mesh-list
56186286|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266431|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266432|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56266433|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
56266434|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266435|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266436|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56684784|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684785|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56684786|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56684787|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
56684788|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684789|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684790|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56684791|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56684792|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
56684793|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56684794|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
56684795|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
56684796|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
56684797|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56684798|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56684799|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56684800|NCT04141319|Analgesics|analgesics|mesh-ancestor
56684801|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56684802|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56684803|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56684804|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684805|NCT00683891|Clozapine|clozapine|mesh-list
56684806|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56684807|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
56684808|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266437|NCT01967979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56266438|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56266439|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56266440|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266441|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
56266442|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56266443|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
56266444|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56266445|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56266461|NCT01968005|Analgesics|analgesics|mesh-ancestor
56266462|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56266463|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266464|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56266465|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56266466|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266467|NCT01968018|Acetaminophen|acetaminophen|mesh-list
56266468|NCT01968018|Tramadol|tramadol|mesh-list
56266469|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56266470|NCT01968018|Analgesics|analgesics|mesh-ancestor
56266471|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
56266472|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266473|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266474|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
56266475|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56266476|NCT01968018|Narcotics|narcotics|mesh-ancestor
56684809|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684810|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684811|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56684812|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56684813|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684814|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56684815|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
56684816|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
56684817|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
56684818|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56684819|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684820|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56684821|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
56684822|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684823|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684824|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684825|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684826|NCT00778024|Fluoxetine|fluoxetine|mesh-list
56684827|NCT00778024|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56684828|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56684829|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56684830|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684831|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684832|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
56684833|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684834|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56684835|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
56684836|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56266477|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266478|NCT01968044|Linagliptin|linagliptin|mesh-list
56266479|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56266480|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266481|NCT01968044|Incretins|incretins|mesh-ancestor
56266482|NCT01968044|Hormones|hormones|mesh-ancestor
56266483|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266484|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56266485|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
56266486|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266487|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266488|NCT01968083|Vaccines|vaccines|mesh-list
56266489|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
56266490|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266491|NCT01968161|Asenapine|asenapine|mesh-list
56266492|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56684837|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56684838|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56684839|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684840|NCT00853658|Enalapril|enalapril|mesh-list
56684841|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56684842|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
56684843|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684844|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684845|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56684846|NCT00690677|Panobinostat|panobinostat|mesh-list
56684847|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684848|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56684849|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684850|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684851|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56684852|NCT00781300|Dexamethasone|dexamethasone|mesh-list
56684853|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56684854|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
56684855|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
56684856|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684857|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684858|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56684859|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
56684860|NCT00781300|Hormones|hormones|mesh-ancestor
56684861|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56684862|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56684863|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684864|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56684865|NCT00781378|Plasminogen|plasminogen|mesh-list
56684866|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56684879|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684880|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56684881|NCT00769054|Ropivacaine|ropivacaine|mesh-list
56684882|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
56684883|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
56684884|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56684885|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684886|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
56684887|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684888|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
56684889|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56684890|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
56684891|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684892|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266493|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56266494|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266495|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266496|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56266497|NCT01968200|Enalapril|enalapril|mesh-list
56266498|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56266499|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
56266500|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266501|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841587|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
56266523|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
56266526|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56266527|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266528|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56266529|NCT01968486|Ranibizumab|ranibizumab|mesh-list
56266530|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56266531|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56186287|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56186288|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
56186289|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186290|NCT01436188|Ibuprofen|ibuprofen|mesh-list
55899624|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
56266532|NCT01968486|Growth Substances|growth substances|mesh-ancestor
56266533|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266534|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
56266535|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266536|NCT01968564|Curcumin|curcumin|mesh-list
56266537|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56266538|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56266539|NCT01968564|Analgesics|analgesics|mesh-ancestor
56266540|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
56266541|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266542|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266543|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56266544|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266545|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266546|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266547|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266548|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56266549|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56266550|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56266551|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
56266552|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266553|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56266554|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56266555|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684893|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56684894|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
56684895|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684896|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684897|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56684898|NCT00666328|Clevidipine|clevidipine|mesh-list
56684899|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56684900|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56684901|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684902|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56684903|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684904|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56684905|NCT00778180|Furosemide|furosemide|mesh-list
56684906|NCT00778180|Diuretics|diuretics|mesh-ancestor
56684907|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
56684908|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684909|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56684910|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56684911|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684912|NCT00769210|Simvastatin|simvastatin|mesh-list
56684913|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56684914|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56684915|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
56684917|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56684941|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56684942|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56684943|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
56684944|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684945|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56684946|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56684947|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684948|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
56684949|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
56684950|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56684951|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684952|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684953|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56684954|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56684955|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684956|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684957|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56684958|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56684959|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
56684960|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56684961|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684962|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56684963|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56684964|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56684965|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56684966|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56684967|NCT00778414|Amoxicillin|amoxicillin|mesh-list
56684968|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
56684969|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
56240678|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266571|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266572|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56266573|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56266574|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56266575|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
56266576|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
56266578|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56266579|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56266580|NCT01968798|Analgesics|analgesics|mesh-ancestor
56266581|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
56266582|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56684970|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56684971|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56684972|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684973|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56684974|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684975|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56684976|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
56684977|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
56684978|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
56684979|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684980|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
56684981|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56684982|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
56684983|NCT00769288|Growth Substances|growth substances|mesh-ancestor
56684984|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684985|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
56684986|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56684987|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684988|NCT00688805|Propranolol|propranolol|mesh-list
56684989|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56684990|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56684991|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
56684992|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56684993|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56684994|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56684995|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56684996|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56684997|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
56684998|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
56684999|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
56685000|NCT04136639|Fluorides|fluorides|mesh-list
56685001|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
56685010|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56685011|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56685012|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
56685013|NCT02613026|Docetaxel|docetaxel|mesh-list
56685014|NCT02613026|Pirarubicin|pirarubicin|mesh-list
56685015|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685016|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
56685017|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685018|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685019|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56685020|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
56685021|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685022|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685023|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56685024|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
56685025|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
56685026|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
56685027|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56685028|NCT00778726|Benazepril|benazepril|mesh-list
56685029|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56685030|NCT00778726|Diuretics|diuretics|mesh-ancestor
56685031|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
56685032|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685033|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56685034|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56685035|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685036|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56685037|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
56685038|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685039|NCT00688883|Fludarabine|fludarabine|mesh-list
56685040|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
56685041|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685042|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56685043|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
56685044|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685045|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56266583|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266584|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685046|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
56685047|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685048|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
56685049|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56685050|NCT00769522|Rituximab|rituximab|mesh-list
56685051|NCT00769522|Fludarabine|fludarabine|mesh-list
56685052|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685053|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
56685054|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685055|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685056|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56685057|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
56685058|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685059|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685060|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56685061|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685062|NCT00688961|Aspirin|aspirin|mesh-list
56685063|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56685064|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56685065|NCT00688961|Analgesics|analgesics|mesh-ancestor
56685066|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
56685067|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685068|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685069|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685070|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266585|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266586|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56266587|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56266588|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266589|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56266590|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56266591|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266592|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
56266593|NCT01968850|Vitamin D|vitamin d|mesh-list
56266594|NCT01968850|Alendronate|alendronate|mesh-list
56266595|NCT01968850|Vitamins|vitamins|mesh-ancestor
56266596|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
56266597|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266598|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56266599|NCT01968915|Paclitaxel|paclitaxel|mesh-list
56266600|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56266601|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266602|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
56266603|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
56266604|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
56266605|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266606|NCT01969006|Bupivacaine|bupivacaine|mesh-list
56266607|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
56266608|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
56104889|NCT04472767|Ipilimumab|ipilimumab|mesh-list
56685071|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56685072|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56685073|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685074|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56685075|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56685076|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685077|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
56685078|NCT00782470|Factor VIII|factor viii|mesh-list
56685079|NCT00782470|Coagulants|coagulants|mesh-ancestor
56685080|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
56685081|NCT00865280|Linezolid|linezolid|mesh-list
56685082|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56685083|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685084|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56685085|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56685086|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685087|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685088|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685089|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56685090|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56685091|NCT00782548|Morphine|morphine|mesh-list
56685092|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56685093|NCT00782548|Narcotics|narcotics|mesh-ancestor
56685094|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685095|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685097|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
56685098|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685099|NCT00689195|Curcumin|curcumin|mesh-list
56240817|NCT01776515|Tramadol|tramadol|mesh-list
56266609|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266610|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266611|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
56186291|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56186292|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56186293|NCT01436188|Analgesics|analgesics|mesh-ancestor
56186294|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
56186295|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186296|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186297|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56266612|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266613|NCT01969019|Prednisone|prednisone|mesh-list
56266614|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
56266615|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56266616|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56266617|NCT01969019|Prednisolone|prednisolone|mesh-list
56266650|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
56685100|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56685101|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56685102|NCT00689195|Analgesics|analgesics|mesh-ancestor
56685103|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
56685104|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685105|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685106|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685107|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685108|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685109|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685110|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685111|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56685112|NCT00865124|Spironolactone|spironolactone|mesh-list
56685113|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56685114|NCT00865124|Diuretics|diuretics|mesh-ancestor
56685115|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
56240839|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56266651|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56266652|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
56266653|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266654|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266655|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56266656|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
56266657|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56266659|NCT01969071|Dobutamine|dobutamine|mesh-list
56266660|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56266683|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56266684|NCT01969149|Hormones|hormones|mesh-ancestor
56266685|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266686|NCT01969318|Metformin|metformin|mesh-list
56266687|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56266688|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266689|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56266690|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56266691|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266692|NCT01969357|Incretins|incretins|mesh-ancestor
56266693|NCT01969357|Hormones|hormones|mesh-ancestor
56266694|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266695|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56266696|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
56266697|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266698|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266699|NCT01969617|Naltrexone|naltrexone|mesh-list
56266700|NCT01969617|Nalmefene|nalmefene|mesh-list
56266701|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56266702|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266703|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
56266704|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266705|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56266706|NCT01969656|Calcitriol|calcitriol|mesh-list
56266707|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56266708|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266709|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56266710|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56266711|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266746|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56266748|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685116|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685117|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56685118|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56685119|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685120|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56685121|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
56685122|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685123|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56685124|NCT00691067|Mifepristone|mifepristone|mesh-list
56685125|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56685126|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
56685127|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56685128|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685129|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56685130|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56685131|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56266776|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266777|NCT01969942|Melphalan|melphalan|mesh-list
56266778|NCT01969942|Busulfan|busulfan|mesh-list
56266779|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56266780|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
56266781|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266782|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266783|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56266784|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56266785|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
56266786|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266787|NCT01969955|Paclitaxel|paclitaxel|mesh-list
56266788|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56186298|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56186299|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56186300|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266789|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56266790|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266791|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
56266792|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
56266793|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
55841912|NCT03588988|Analgesics|analgesics|mesh-ancestor
56266816|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56266817|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
56266818|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56266819|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56266820|NCT01970072|Midazolam|midazolam|mesh-list
56266821|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56266822|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56266823|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266824|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266825|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56266826|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56266827|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56266828|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56266829|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
56266830|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
56266831|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
56266832|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
56685132|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
56685133|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56685134|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56685135|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
56685136|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685137|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
56685138|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56685139|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56685140|NCT00691145|Tacrolimus|tacrolimus|mesh-list
56685141|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685142|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
56685143|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685144|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56685145|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685146|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685147|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56685148|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56685149|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56685150|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
56685151|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685152|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685153|NCT00694967|Progestins|progestins|mesh-ancestor
56685154|NCT00694967|Hormones|hormones|mesh-ancestor
56685155|NCT00695045|Morphine|morphine|mesh-list
56685156|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56685157|NCT00695045|Narcotics|narcotics|mesh-ancestor
56685158|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685175|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56685176|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56685177|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
56685178|NCT00819234|Pramlintide|pramlintide|mesh-list
56685179|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56685180|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685181|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
56685183|NCT00695201|Floxuridine|floxuridine|mesh-list
56685184|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685185|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56685186|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56685187|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685188|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685189|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56685190|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
56685191|NCT00689585|Ethosuximide|ethosuximide|mesh-list
56685192|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
56685193|NCT00667342|Bevacizumab|bevacizumab|mesh-list
56685194|NCT00667342|Doxorubicin|doxorubicin|mesh-list
56685195|NCT00667342|Methotrexate|methotrexate|mesh-list
56685196|NCT00667342|Etoposide|etoposide|mesh-list
56685197|NCT00667342|Ifosfamide|ifosfamide|mesh-list
56685198|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685199|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685200|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56685201|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56685202|NCT00667342|Growth Substances|growth substances|mesh-ancestor
56685203|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685204|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
56685205|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56685206|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56685207|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56685208|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266833|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266834|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266835|NCT01970202|Enoxaparin|enoxaparin|mesh-list
56266836|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
56266837|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
56266838|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56266839|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56266840|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266841|NCT01970215|Atorvastatin|atorvastatin|mesh-list
56266842|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56685209|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685210|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56685211|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
56685212|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56685213|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56685214|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
56685215|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
56685216|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56685217|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685218|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
56685219|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685220|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56685221|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56685222|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56685223|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
56685224|NCT00783016|Morphine|morphine|mesh-list
56685225|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56685226|NCT00783016|Narcotics|narcotics|mesh-ancestor
56685227|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685228|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685229|NCT00783016|Analgesics|analgesics|mesh-ancestor
56685230|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
56685231|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685232|NCT00769990|Genistein|genistein|mesh-list
56685233|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56685234|NCT00769990|Protective Agents|protective agents|mesh-ancestor
56685235|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685236|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685237|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56685238|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685251|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56685252|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685253|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685254|NCT02555800|Cidofovir|cidofovir|mesh-list
56685255|NCT02555800|Bevacizumab|bevacizumab|mesh-list
56685256|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685257|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685258|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56685259|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56685260|NCT02555800|Growth Substances|growth substances|mesh-ancestor
56685261|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685262|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
56685263|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
56685264|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685265|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685266|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685267|NCT00783172|Gemcitabine|gemcitabine|mesh-list
56685268|NCT00783172|Mitogens|mitogens|mesh-list
56685269|NCT00783172|Enkephalins|enkephalins|mesh-list
56685270|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56685271|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
56685272|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685273|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685274|NCT00783172|Antiviral Agents|antiviral agents|mesh-ancestor
56685275|NCT00783172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685276|NCT00783172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685277|NCT00783172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685278|NCT00783172|Immunologic Factors|immunologic factors|mesh-ancestor
56266843|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56266844|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56266845|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
55841942|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
56266876|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
56266877|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
56266878|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
56266879|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266880|NCT01970748|Propranolol|propranolol|mesh-list
56266881|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56266882|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56266883|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
56266884|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266885|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266886|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266887|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56266888|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56266920|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685279|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685280|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
56685281|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685282|NCT00783250|Albuterol|albuterol|mesh-list
56685283|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
56685284|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56685285|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
56685286|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685287|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685288|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56685289|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
56685290|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
56266921|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
56266922|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266923|NCT01971242|Exenatide|exenatide|mesh-list
56266924|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56266925|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266926|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56266927|NCT01971242|Incretins|incretins|mesh-ancestor
56266928|NCT01971242|Hormones|hormones|mesh-ancestor
56266929|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266930|NCT01971268|Cimetidine|cimetidine|mesh-list
56266931|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56266932|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56266933|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56266944|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56266945|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266946|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
56266947|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
56266948|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
56266949|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899836|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
56266950|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56266952|NCT01971281|Antiviral Agents|antiviral agents|mesh-ancestor
56266953|NCT01971281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266954|NCT01971281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266955|NCT01971281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56266956|NCT01971281|Immunologic Factors|immunologic factors|mesh-ancestor
56266957|NCT01971281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266958|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
56266959|NCT01971411|Vitamin D|vitamin d|mesh-list
56266960|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
56266961|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
56266962|NCT01971411|Vitamins|vitamins|mesh-list
56266963|NCT01971411|Calcium|calcium|mesh-list
56266964|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
56266965|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266966|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56266967|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56266968|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
56266969|NCT01971424|Antacids|antacids|mesh-ancestor
56266970|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266971|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56266972|NCT01971450|Iloprost|iloprost|mesh-list
56266973|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56266974|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
56266976|NCT01971489|Cisplatin|cisplatin|mesh-list
56266977|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266978|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56266979|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
56266980|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266981|NCT01971489|Antiviral Agents|antiviral agents|mesh-ancestor
56266982|NCT01971489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266983|NCT01971489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266984|NCT01971489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685291|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56685292|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
56685293|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685294|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685295|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
56685296|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56685297|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56685298|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56685299|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56685300|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
56685301|NCT02555644|Cetuximab|cetuximab|mesh-list
56685302|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685303|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685304|NCT00871403|Pemetrexed|pemetrexed|mesh-list
56685305|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685306|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685307|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685308|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56685309|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56685310|NCT00691379|Paclitaxel|paclitaxel|mesh-list
56685311|NCT00691379|Bevacizumab|bevacizumab|mesh-list
56685312|NCT00691379|Carboplatin|carboplatin|mesh-list
56685313|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56685314|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685315|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
56685316|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
56685317|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
56685318|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685319|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685320|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56685321|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56685322|NCT00691379|Growth Substances|growth substances|mesh-ancestor
56685323|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685324|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
56685331|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685332|NCT04136015|Dasatinib|dasatinib|mesh-list
56685333|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685334|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56685335|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685336|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685337|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
56685338|NCT02624063|Simeprevir|simeprevir|mesh-list
56685339|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
56685340|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685341|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
56685342|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685343|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266985|NCT01971489|Immunologic Factors|immunologic factors|mesh-ancestor
56266986|NCT01971489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266987|NCT01971515|Tamoxifen|tamoxifen|mesh-list
56266988|NCT01971515|Trastuzumab|trastuzumab|mesh-list
56266989|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56266990|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266991|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56266992|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
56266993|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266994|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266995|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56266996|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56266997|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56267015|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267017|NCT01971658|Thalidomide|thalidomide|mesh-list
56267018|NCT01971658|Dexamethasone|dexamethasone|mesh-list
56267019|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
56267020|NCT01971658|Bortezomib|bortezomib|mesh-list
56267021|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56267022|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
56267023|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267024|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56267025|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56267026|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
56267027|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267028|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267029|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56267030|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267031|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
56267032|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
56267033|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267034|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56267035|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
56267036|NCT01971658|Hormones|hormones|mesh-ancestor
56267037|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267038|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267039|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
56267040|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56267041|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267042|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56186301|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186303|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
56186304|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186305|NCT01436474|Varenicline|varenicline|mesh-list
56186306|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56186307|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56186308|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
56186309|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685344|NCT05298683|Acetaminophen|acetaminophen|mesh-list
56685345|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
56685346|NCT05298683|Promethazine|promethazine|mesh-list
56685347|NCT05298683|Dexamethasone|dexamethasone|mesh-list
56685348|NCT05298683|Pomalidomide|pomalidomide|mesh-list
56685349|NCT05298683|Ranitidine|ranitidine|mesh-list
56685350|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56685351|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685352|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
56685353|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
56685354|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685355|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685356|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56685357|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
56685358|NCT05298683|Hormones|hormones|mesh-ancestor
56685359|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685360|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56685361|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685362|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56685363|NCT05298683|Analgesics|analgesics|mesh-ancestor
56685364|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
56685365|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
56685366|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
56685367|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56685368|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56685369|NCT05298683|Growth Substances|growth substances|mesh-ancestor
56685394|NCT02624141|Hematinics|hematinics|mesh-ancestor
56685395|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
56685396|NCT00691613|Hematinics|hematinics|mesh-ancestor
56685397|NCT00460603|Bevacizumab|bevacizumab|mesh-list
56685398|NCT00460603|Axitinib|axitinib|mesh-list
56685399|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685400|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685401|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56685402|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56685403|NCT00460603|Growth Substances|growth substances|mesh-ancestor
56685404|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685405|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
56685406|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56685407|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685408|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685409|NCT00696059|Adalimumab|adalimumab|mesh-list
56685410|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685411|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685412|NCT00700466|Metoprolol|metoprolol|mesh-list
56685413|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56685414|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56685415|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56685416|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
56685417|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
56685418|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685419|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685420|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56685421|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56685422|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
56685423|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685424|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685425|NCT00700544|Norethandrolone|norethandrolone|mesh-list
56685426|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
56685427|NCT00700544|Hormones|hormones|mesh-ancestor
56685428|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685435|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685436|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56685437|NCT02621489|Incretins|incretins|mesh-ancestor
56685438|NCT02621489|Hormones|hormones|mesh-ancestor
56685439|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685440|NCT02612792|Atorvastatin|atorvastatin|mesh-list
56685441|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56685442|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56685443|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
56685444|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685445|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56685446|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56685447|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685448|NCT00662038|Pirfenidone|pirfenidone|mesh-list
56685449|NCT00662038|Analgesics|analgesics|mesh-ancestor
56685450|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
56685451|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685452|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685453|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56685454|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56685455|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685456|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685457|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685458|NCT00701792|Liver Extracts|liver extracts|mesh-list
56685459|NCT00701792|Hematinics|hematinics|mesh-ancestor
56685460|NCT00784498|Midazolam|midazolam|mesh-list
56685461|NCT00784498|Ketamine|ketamine|mesh-list
56685462|NCT00784498|Propofol|propofol|mesh-list
56685463|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56685464|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685465|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685466|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56685467|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
56685468|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
56685469|NCT00784498|Analgesics|analgesics|mesh-ancestor
56685470|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
56241174|NCT01779479|Paclitaxel|paclitaxel|mesh-list
56186310|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267043|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56685471|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685472|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56685473|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56685474|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56685475|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685476|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685477|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56685478|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56685479|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56685480|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56685481|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
56685482|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
56685483|NCT01022983|Simendan|simendan|mesh-list
56685484|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56241220|NCT01779830|Zolpidem|zolpidem|mesh-list
56267044|NCT01971658|Growth Substances|growth substances|mesh-ancestor
56267045|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
56267046|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
56267047|NCT01971684|Sirolimus|sirolimus|mesh-list
56267048|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
56267049|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267050|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
56267051|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267052|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56267053|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56267054|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
55842148|NCT02335294|Analgesics|analgesics|mesh-ancestor
56267086|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267087|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
56267088|NCT01972113|Coagulants|coagulants|mesh-ancestor
56267089|NCT01972230|Remifentanil|remifentanil|mesh-list
56267090|NCT01972230|Sevoflurane|sevoflurane|mesh-list
56267091|NCT01972230|Propofol|propofol|mesh-list
56267092|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56267093|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56267094|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
56267095|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
56267096|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267097|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267098|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56267099|NCT01972230|Narcotics|narcotics|mesh-ancestor
56267100|NCT01972230|Analgesics|analgesics|mesh-ancestor
56267101|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
56267135|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267136|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56267137|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56267138|NCT01972490|Growth Substances|growth substances|mesh-ancestor
56267139|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267140|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
55842258|NCT03584074|Celecoxib|celecoxib|mesh-list
56267162|NCT01972763|Ranibizumab|ranibizumab|mesh-list
56267163|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56267164|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56267165|NCT01972763|Growth Substances|growth substances|mesh-ancestor
56267166|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267167|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
56267168|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267169|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56267170|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
56267171|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
56267172|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
56267173|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56105384|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
56685485|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
56685486|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56685487|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56685488|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685489|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685490|NCT01022983|Protective Agents|protective agents|mesh-ancestor
56685491|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685492|NCT00912860|Interferons|interferons|mesh-list
56685493|NCT00912860|Interferon-beta|interferon-beta|mesh-list
56685494|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
56685495|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685496|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
56685497|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685498|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
56685499|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685500|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56685501|NCT02623673|Dexamethasone|dexamethasone|mesh-list
56685502|NCT02623673|Bevacizumab|bevacizumab|mesh-list
56685503|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685504|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685505|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56685506|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56685507|NCT02623673|Growth Substances|growth substances|mesh-ancestor
56685508|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685509|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56685510|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685511|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
56685512|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
56685532|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56685533|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
56685534|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685535|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
56685536|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56685537|NCT00459979|Sunitinib|sunitinib|mesh-list
56685538|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685539|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56685540|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56685541|NCT00459979|Growth Substances|growth substances|mesh-ancestor
56685542|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685543|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331992|NCT00423696|Vitamins|vitamins|mesh-ancestor
56685544|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56685545|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241272|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
56267174|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267175|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56267176|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267177|NCT01972906|Ibuprofen|ibuprofen|mesh-list
56267178|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56267179|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56267180|NCT01972906|Analgesics|analgesics|mesh-ancestor
56267181|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
56186311|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186312|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56186313|NCT01436513|Estrogens|estrogens|mesh-ancestor
56186314|NCT01436513|Hormones|hormones|mesh-ancestor
56186315|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186316|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186317|NCT01436539|Adefovir|adefovir|mesh-list
56186318|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56186319|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
56186320|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
56186321|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186322|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56186323|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56186324|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186325|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186326|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56186327|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
56186328|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56186329|NCT01436578|Posaconazole|posaconazole|mesh-list
56186330|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
56186331|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186332|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56186333|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56186334|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55899986|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
56267182|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267183|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267184|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267185|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56267186|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56267187|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267188|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267189|NCT01972984|Anastrozole|anastrozole|mesh-list
56267190|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267191|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267220|NCT01973101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685546|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685547|NCT00783484|Maraviroc|maraviroc|mesh-list
56685548|NCT00783484|Darunavir|darunavir|mesh-list
56685549|NCT00783484|Midazolam|midazolam|mesh-list
56685550|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56685551|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56685552|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685553|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685554|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56685555|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56685556|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56685557|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56685558|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
56685559|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
56685560|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
56685561|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
56685562|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685563|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685564|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56685565|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56685566|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56685567|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56685568|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
56685569|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685570|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56685571|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56685572|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56685573|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
56685574|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685575|NCT00828672|Bevacizumab|bevacizumab|mesh-list
56685576|NCT00828672|Capecitabine|capecitabine|mesh-list
56685577|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
56685589|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56685590|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685591|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685592|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56685593|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
56685594|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685595|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685596|NCT00873119|Paclitaxel|paclitaxel|mesh-list
56685597|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56685598|NCT00873119|Carboplatin|carboplatin|mesh-list
56685599|NCT00873119|Belinostat|belinostat|mesh-list
56685600|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56685601|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685602|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
56685603|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
56685604|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
56685605|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685606|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56685607|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685608|NCT00661726|Decitabine|decitabine|mesh-list
56685609|NCT00661726|Azacitidine|azacitidine|mesh-list
56685610|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56685611|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
56241330|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
56267221|NCT01973101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56267222|NCT01973101|Immunologic Factors|immunologic factors|mesh-ancestor
56267223|NCT01973101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267224|NCT01973114|Latanoprost|latanoprost|mesh-list
56267225|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56267226|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56267228|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56267229|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267230|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
56267231|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267232|NCT01973309|Paclitaxel|paclitaxel|mesh-list
56186335|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56186336|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56186337|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267233|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56267234|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267235|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
56267236|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
56267237|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
56267238|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267239|NCT01973322|Vaccines|vaccines|mesh-list
56267240|NCT01973322|Complement Factor H|complement factor h|mesh-list
56267241|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
56267273|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267275|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
56267276|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
56685612|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685613|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685614|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685615|NCT00706680|Cyclosporine|cyclosporine|mesh-list
56685616|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
56685617|NCT00706680|Prednisone|prednisone|mesh-list
56685618|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56685619|NCT00706680|Cyclosporins|cyclosporins|mesh-list
56685620|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
56685621|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685622|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
56685623|NCT00706680|Hormones|hormones|mesh-ancestor
56685624|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685625|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685626|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56685627|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685628|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685629|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685630|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685631|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
56685632|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
56685633|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685634|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56685635|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56241355|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56267277|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267278|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56267280|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56267281|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267282|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56267283|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
56267284|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267285|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267286|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267287|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56267320|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267321|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56267322|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
56267323|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56267324|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56267325|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
56267326|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
56267327|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267328|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56267329|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
56267346|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56267347|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267348|NCT01973920|Insulin|insulin|mesh-list
56685636|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56685637|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56685638|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56685639|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
56685640|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56685641|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56685642|NCT00706680|Protective Agents|protective agents|mesh-ancestor
56685643|NCT02624999|Cisplatin|cisplatin|mesh-list
56685644|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685645|NCT02612480|Aspirin|aspirin|mesh-list
56685646|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
56685647|NCT02612480|Clopidogrel|clopidogrel|mesh-list
56685648|NCT02612480|Ticagrelor|ticagrelor|mesh-list
56685649|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56685650|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56685651|NCT02612480|Analgesics|analgesics|mesh-ancestor
56685652|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
56685653|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685654|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685655|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685656|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685657|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56685658|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56685659|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685660|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56685661|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56685662|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685663|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
56685664|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56685665|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56685666|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56685667|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
56685668|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685669|NCT00784966|Etanercept|etanercept|mesh-list
56685670|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56685675|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685676|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56685677|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685678|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56685679|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685680|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
56685681|NCT02623595|Molgramostim|molgramostim|mesh-list
56685682|NCT02623595|Sargramostim|sargramostim|mesh-list
56685683|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
56685684|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685685|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685686|NCT00665392|Docetaxel|docetaxel|mesh-list
56685687|NCT00665392|Fluorouracil|fluorouracil|mesh-list
56685688|NCT00665392|Cetuximab|cetuximab|mesh-list
56685689|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685690|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
56685691|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
56685692|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
56685693|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685694|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
56685695|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56685696|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685697|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
56685698|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685699|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685701|NCT00851630|Zidovudine|zidovudine|mesh-list
56685702|NCT00851630|Abacavir|abacavir|mesh-list
56685703|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56685704|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56685705|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685706|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685707|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
56685708|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685709|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56241420|NCT01780909|Loperamide|loperamide|mesh-list
56267349|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56267350|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267351|NCT01973933|Metformin|metformin|mesh-list
56267352|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
56267353|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56267354|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267355|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
56685710|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56685711|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
56685712|NCT05298761|Lidocaine|lidocaine|mesh-list
56685713|NCT05298761|Nalbuphine|nalbuphine|mesh-list
56685714|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56685715|NCT05298761|Narcotics|narcotics|mesh-ancestor
56685716|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685717|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685718|NCT05298761|Analgesics|analgesics|mesh-ancestor
56685719|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
56685720|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685721|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
56685722|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
56685723|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56685724|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56267356|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56267357|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56267358|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267359|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56267360|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267361|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267362|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
56267363|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56267364|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56267365|NCT01974024|Prednisolone|prednisolone|mesh-list
56267366|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
56267375|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
56267376|NCT01974024|Hormones|hormones|mesh-ancestor
56267377|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267378|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56267379|NCT01974024|Protective Agents|protective agents|mesh-ancestor
56267380|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267381|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267382|NCT01974037|Capsaicin|capsaicin|mesh-list
56267383|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
56267384|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
56267385|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
56267386|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267387|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267388|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
55842478|NCT01670890|Cisplatin|cisplatin|mesh-list
56267415|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267416|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56267417|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56267418|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267419|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267420|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56267421|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
56267422|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267423|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267424|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56267425|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56267427|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56267428|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267429|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
56267430|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
56267431|NCT01974518|Rituximab|rituximab|mesh-list
56267432|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56267433|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
56267434|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685725|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56685726|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56685727|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685728|NCT00459667|Interferons|interferons|mesh-list
56685729|NCT00459667|Interferon-beta|interferon-beta|mesh-list
56685730|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
56685731|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685732|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
56685733|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685734|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
56685735|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685736|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56685737|NCT02621255|Bupivacaine|bupivacaine|mesh-list
56685738|NCT02621255|Anesthetics|anesthetics|mesh-list
56685739|NCT02621255|Sevoflurane|sevoflurane|mesh-list
56685740|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
56685741|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685742|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685743|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
56685744|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685745|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56685746|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56685747|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
56685748|NCT00828204|Interferons|interferons|mesh-list
56685749|NCT00828204|Interferon-beta|interferon-beta|mesh-list
56685750|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
56685751|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685752|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
56685753|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685754|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
56685755|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685756|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56685757|NCT00696215|Rasagiline|rasagiline|mesh-list
56685758|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56685759|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241460|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267435|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842538|NCT03154918|Hormones|hormones|mesh-ancestor
56267498|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56267499|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
56685760|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685761|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56685762|NCT00696215|Protective Agents|protective agents|mesh-ancestor
56685763|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685764|NCT00784186|Misoprostol|misoprostol|mesh-list
56685765|NCT00784186|Mifepristone|mifepristone|mesh-list
56685766|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56685767|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
56685768|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56685769|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685770|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56685771|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56685772|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
56332220|NCT00030563|Irinotecan|irinotecan|mesh-list
56685773|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56685774|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56685775|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56685776|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56685777|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
56685778|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56685779|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56685780|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
56685781|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56685782|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
56685783|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56685784|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56685785|NCT00851552|Rituximab|rituximab|mesh-list
56685786|NCT00851552|Doxorubicin|doxorubicin|mesh-list
56685787|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56685788|NCT00851552|Bortezomib|bortezomib|mesh-list
56685789|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685790|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685791|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
56685792|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685793|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56267500|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
56267501|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
56267502|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685794|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56685795|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56685796|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56685797|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685798|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685799|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
56685800|NCT00785122|Molgramostim|molgramostim|mesh-list
56685801|NCT00785122|Imiquimod|imiquimod|mesh-list
56685802|NCT00785122|Sargramostim|sargramostim|mesh-list
56685803|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685804|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
56685805|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685806|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685807|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56685808|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
56685809|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685810|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685811|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56685812|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56685813|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
56685814|NCT04116554|Bupivacaine|bupivacaine|mesh-list
56685815|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
56685816|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
56685817|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685818|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685819|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
56685820|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685821|NCT00700856|Pioglitazone|pioglitazone|mesh-list
56685822|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56267503|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56267504|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56267505|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56267506|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
56267507|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267508|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56267509|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56267510|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267512|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56267513|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56267514|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56267515|NCT01975259|Hormones|hormones|mesh-ancestor
56267516|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267517|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267518|NCT01975259|Incretins|incretins|mesh-ancestor
56267519|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
56685823|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685824|NCT00790114|Midazolam|midazolam|mesh-list
56685825|NCT00790114|Caffeine|caffeine|mesh-list
56685826|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56685827|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56685828|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56685829|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685830|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56685831|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56685832|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56685833|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56685834|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
56685835|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
56685836|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
56267549|NCT01975441|Filaricides|filaricides|mesh-ancestor
56267551|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56267552|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267553|NCT01975454|Capecitabine|capecitabine|mesh-list
56267554|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
56267555|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56267556|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
56267557|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267558|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267559|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56267560|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56267561|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56267562|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267563|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267579|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56267580|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56267581|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56267582|NCT01975727|Dexamethasone|dexamethasone|mesh-list
56267583|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
56267584|NCT01975727|BB 1101|bb 1101|mesh-list
56186338|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267585|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267586|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
56267587|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
56267588|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267589|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267590|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56267591|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
56267592|NCT01975727|Hormones|hormones|mesh-ancestor
56267593|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267594|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267595|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267596|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
56267597|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267598|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267599|NCT01975753|Fentanyl|fentanyl|mesh-list
56267600|NCT01975753|Morphine|morphine|mesh-list
56267601|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56267602|NCT01975753|Narcotics|narcotics|mesh-ancestor
56267603|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267604|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267605|NCT01975753|Analgesics|analgesics|mesh-ancestor
56267606|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
56267607|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267608|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56267609|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56267610|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
56267611|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
56685837|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
56685838|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685839|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685840|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56685841|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56685842|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685843|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56685844|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56685845|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
56685846|NCT01023139|Sibutramine|sibutramine|mesh-list
56685847|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
56685848|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56685849|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
56685850|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56685851|NCT00459043|Docetaxel|docetaxel|mesh-list
56685852|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685853|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
56685854|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
56685855|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
56685856|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685857|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
56267612|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
56267613|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56267614|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
56267615|NCT01975805|Povidone|povidone|mesh-list
56267616|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56267617|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267618|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
56267619|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
56267620|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
56267621|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
56267622|NCT01975961|Telmisartan|telmisartan|mesh-list
56267623|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56267624|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56267625|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56267626|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
56267627|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267649|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
56267650|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267651|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267652|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56267653|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56267654|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56267655|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267656|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56267657|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
56267658|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
56267659|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
56267661|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56267662|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56267664|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267665|NCT01976195|Thalidomide|thalidomide|mesh-list
56267666|NCT01976195|Dexamethasone|dexamethasone|mesh-list
56267667|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267668|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
56267669|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
56685858|NCT00795262|Quinapril|quinapril|mesh-list
56685859|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
56685860|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685861|NCT00795262|Protective Agents|protective agents|mesh-ancestor
56685862|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685863|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
56685864|NCT00795262|Vitamins|vitamins|mesh-ancestor
56685865|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
56685866|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56685867|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
56685868|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685869|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56685870|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
56685871|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56685872|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56685873|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
56685874|NCT00817206|Tacrolimus|tacrolimus|mesh-list
56685875|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56685876|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
56685877|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685878|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56685879|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685880|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685881|NCT02611518|Metformin|metformin|mesh-list
56685882|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56685883|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56685884|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685885|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56685886|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56685887|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
56685888|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685889|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56685890|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56685891|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685892|NCT01023607|Atorvastatin|atorvastatin|mesh-list
56685893|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56267670|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267671|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267672|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56685894|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56685895|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56685896|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
56685897|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685898|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56685899|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56685900|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685901|NCT00665002|Sargramostim|sargramostim|mesh-list
56685902|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56685903|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
56685904|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685905|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56685906|NCT00660010|Leuprolide|leuprolide|mesh-list
56685907|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56685908|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
56685909|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56685910|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685911|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56685912|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685913|NCT04015908|Acetaminophen|acetaminophen|mesh-list
56685914|NCT04015908|Celecoxib|celecoxib|mesh-list
56685915|NCT04015908|Pregabalin|pregabalin|mesh-list
56685916|NCT04015908|Oxycodone|oxycodone|mesh-list
56685917|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56685918|NCT04015908|Analgesics|analgesics|mesh-ancestor
56685919|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
56685920|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56685921|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685922|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
56332367|NCT00058227|Rituximab|rituximab|mesh-list
56685939|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685940|NCT00790816|Lapatinib|lapatinib|mesh-list
56685941|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
56685942|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56685943|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685944|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685945|NCT00873041|Deferasirox|deferasirox|mesh-list
56685946|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56685947|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
56685948|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
56685949|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685950|NCT00795496|Histamine|histamine|mesh-list
56685951|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
56685952|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
56685953|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685954|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685955|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685956|NCT00795574|Infliximab|infliximab|mesh-list
56685957|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
56685958|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56685959|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56685960|NCT00785434|Citalopram|citalopram|mesh-list
56685961|NCT00785434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56685962|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56685963|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56685964|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685965|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56685966|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
56685967|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685968|NCT00785434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56685971|NCT00790894|Epothilones|epothilones|mesh-list
56685981|NCT02623127|Growth Substances|growth substances|mesh-ancestor
56685982|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56685983|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
56685984|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56685985|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685986|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685987|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
56685988|NCT05263492|Lenvatinib|lenvatinib|mesh-list
56685989|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56685990|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56685991|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56685992|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56685993|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56685994|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
56685995|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56685996|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
56685997|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332464|NCT04711889|Urinastatin|urinastatin|mesh-list
56685999|NCT04134611|Protective Agents|protective agents|mesh-ancestor
56686000|NCT02620631|Morphine|morphine|mesh-list
56686001|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56686002|NCT02620631|Narcotics|narcotics|mesh-ancestor
56686003|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686004|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686005|NCT02620631|Analgesics|analgesics|mesh-ancestor
56686006|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
56686007|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686008|NCT04030572|Clonidine|clonidine|mesh-list
56686009|NCT04030572|Analgesics|analgesics|mesh-ancestor
56686010|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
56686011|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241718|NCT01783197|Paclitaxel|paclitaxel|mesh-list
56267673|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
56267674|NCT01976195|Hormones|hormones|mesh-ancestor
56267675|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267676|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267677|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267678|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56267679|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
56186339|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56186340|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
56186341|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267680|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
56686012|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686013|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56686014|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
56686015|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
56686016|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56686017|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56686018|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56686019|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
56686020|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686021|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686022|NCT00795808|Metformin|metformin|mesh-list
56686023|NCT00795808|Clomiphene|clomiphene|mesh-list
56686024|NCT00795808|Enclomiphene|enclomiphene|mesh-list
56686025|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
56686026|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56686027|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686028|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56686029|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
56686030|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56686031|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56686032|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
56686033|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56686034|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56686035|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56686036|NCT04135781|Paclitaxel|paclitaxel|mesh-list
56686037|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56686038|NCT04135781|Capecitabine|capecitabine|mesh-list
56686039|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
56686040|NCT04135781|Tegafur|tegafur|mesh-list
56686041|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56686042|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686043|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
56686044|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
56267681|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56267701|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267702|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267703|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56267704|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267706|NCT01976676|Hematinics|hematinics|mesh-ancestor
56267707|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
56267708|NCT01976676|Vitamins|vitamins|mesh-ancestor
56267709|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
56267710|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686045|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
56686046|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686047|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56686048|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
56686049|NCT04135313|Capecitabine|capecitabine|mesh-list
56686050|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
56686051|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56686052|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
56686053|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686054|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686055|NCT00692159|Pemetrexed|pemetrexed|mesh-list
56686056|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686057|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686058|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686059|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56686060|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56686061|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
56686062|NCT00692315|Vitamins|vitamins|mesh-ancestor
56686063|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
56686064|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686065|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
56686066|NCT02623049|Anticoagulants|anticoagulants|mesh-list
56686067|NCT02608944|Adenosine|adenosine|mesh-list
56686068|NCT02608944|Regadenoson|regadenoson|mesh-list
56686069|NCT02608944|Analgesics|analgesics|mesh-ancestor
56686070|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
56686071|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686072|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686073|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56686074|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
56686075|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56686076|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
56686081|NCT00913614|SR 46349B|sr 46349b|mesh-list
56686087|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
56686088|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686089|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686090|NCT00664534|Insulin|insulin|mesh-list
56686091|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56686092|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
56686093|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
56686094|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56686095|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686096|NCT00913848|Valproic Acid|valproic acid|mesh-list
56686097|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
56686098|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686099|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686100|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
56686101|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686102|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686103|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
56686104|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56686105|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686106|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56686107|NCT02620163|Amlodipine|amlodipine|mesh-list
56686108|NCT02620163|Telmisartan|telmisartan|mesh-list
56686109|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
56686110|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56686111|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56686112|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56686113|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56686114|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686115|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56686116|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686117|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
56686118|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56686119|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56686120|NCT02620163|Diuretics|diuretics|mesh-ancestor
56686121|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
56686122|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56686125|NCT00570310|Pregabalin|pregabalin|mesh-list
56686126|NCT00570310|Analgesics|analgesics|mesh-ancestor
56686127|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
56686128|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686129|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686130|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
56686131|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56686132|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56686133|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686134|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56686135|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56686136|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56686137|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686138|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56686139|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
56686140|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
56686141|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56267711|NCT01976780|Artesunate|artesunate|mesh-list
56267712|NCT01976780|Lumefantrine|lumefantrine|mesh-list
56267713|NCT01976780|Artemether|artemether|mesh-list
56267714|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56267715|NCT01976780|Mefloquine|mefloquine|mesh-list
56267716|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
56267717|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56267718|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56267719|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267720|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267721|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
56267722|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
56267723|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56267724|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
56267725|NCT01976923|Bevacizumab|bevacizumab|mesh-list
56267726|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56267727|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267728|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56267729|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56267730|NCT01976923|Growth Substances|growth substances|mesh-ancestor
56267731|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267732|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
56267733|NCT01976936|Lovastatin|lovastatin|mesh-list
56267734|NCT01976936|L 647318|l 647318|mesh-list
56267735|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
56267736|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56267737|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56267738|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
56267739|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267764|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267765|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267766|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267767|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56267768|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56267769|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267770|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56267771|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56267773|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
56267774|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
56267775|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801011|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
56686142|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56686143|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686144|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
56686145|NCT00664066|Hematinics|hematinics|mesh-ancestor
56686146|NCT04676958|Vitamin K|vitamin k|mesh-list
56686147|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
56332594|NCT00031655|Cyclosporins|cyclosporins|mesh-list
56686148|NCT04676958|Vitamins|vitamins|mesh-ancestor
56686149|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
56686150|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686151|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56686152|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56686153|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686154|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
56686155|NCT04676958|Coagulants|coagulants|mesh-ancestor
56686156|NCT02619929|Vinorelbine|vinorelbine|mesh-list
56686157|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56686158|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686159|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
56267778|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56267779|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267780|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
56267781|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267782|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
56267783|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
56267784|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
56267785|NCT01977339|Bupivacaine|bupivacaine|mesh-list
56267786|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
56267787|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
56267788|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267789|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267790|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
56267820|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267821|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56267823|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56267824|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56267825|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
56267826|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267827|NCT01977989|Vancomycin|vancomycin|mesh-list
56267828|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56267829|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267830|NCT01978015|Timolol|timolol|mesh-list
56267848|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
56267849|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
56267850|NCT01978041|Fluorides|fluorides|mesh-list
56267851|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
56267852|NCT01978041|Protective Agents|protective agents|mesh-ancestor
56267853|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267854|NCT01978301|Triamcinolone|triamcinolone|mesh-list
56267855|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56267856|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56267857|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56267858|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267859|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
56267860|NCT01978301|Hormones|hormones|mesh-ancestor
56267861|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267862|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267863|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56267864|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
56686160|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
56686161|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
56686162|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686163|NCT00796198|Latanoprost|latanoprost|mesh-list
56686164|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56686165|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56686166|NCT02622503|Rituximab|rituximab|mesh-list
56686167|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56686168|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686169|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
56686170|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686171|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686172|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56686173|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
56686174|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686175|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56686176|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56686177|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56686178|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686179|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686180|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56686181|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56686182|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56686183|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
56686184|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686185|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686186|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56686187|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56686188|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
56686189|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56686190|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56686191|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56686200|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56686201|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56686202|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
56686203|NCT00786058|Fluorouracil|fluorouracil|mesh-list
56686204|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
56686205|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686206|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56686207|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686208|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686209|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
56686210|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686211|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
56686212|NCT00871169|Irinotecan|irinotecan|mesh-list
56686213|NCT00871169|Cetuximab|cetuximab|mesh-list
56686214|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686215|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56686216|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56686217|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686218|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686219|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56267865|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267866|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267867|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
56267868|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
56267869|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267870|NCT01978405|Protective Agents|protective agents|mesh-ancestor
56267871|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267872|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
56267873|NCT01978405|Vitamins|vitamins|mesh-ancestor
56267874|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
56267875|NCT01978418|Albuterol|albuterol|mesh-list
56267876|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56267877|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
56267878|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267879|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267880|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56267881|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
56267883|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56267884|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56267885|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56267886|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56267887|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
56267888|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267889|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267890|NCT01978457|Propranolol|propranolol|mesh-list
56267891|NCT01978457|Cocaine|cocaine|mesh-list
56267909|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267911|NCT01978483|Denosumab|denosumab|mesh-list
56267912|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56267913|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267914|NCT01978496|Eletriptan|eletriptan|mesh-list
56267915|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56267919|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267920|NCT01978665|Prednisone|prednisone|mesh-list
56267921|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686220|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56686291|NCT00851318|Methotrexate|methotrexate|mesh-list
56686292|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
56686293|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56332741|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686295|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56686296|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686297|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56686298|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
56686299|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686300|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686301|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
56686302|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686303|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56686304|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686305|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
56686306|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686307|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56686308|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
56686309|NCT00786370|Propofol|propofol|mesh-list
56242029|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
56267922|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
56267923|NCT01978665|Hormones|hormones|mesh-ancestor
56267924|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267925|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267926|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267927|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267928|NCT01978678|Budesonide|budesonide|mesh-list
56267929|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267930|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56267931|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
56267932|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267933|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267934|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56267935|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
56186342|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267936|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
56267937|NCT01978678|Hormones|hormones|mesh-ancestor
56267938|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267939|NCT01978704|Insulin|insulin|mesh-list
56267940|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56267941|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56267942|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267943|NCT01978717|Anesthetics|anesthetics|mesh-list
56267944|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267945|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843037|NCT01566435|Fluorouracil|fluorouracil|mesh-list
56267973|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267974|NCT01978873|Protective Agents|protective agents|mesh-ancestor
56267976|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
56267977|NCT01978873|Estrogens|estrogens|mesh-ancestor
56267978|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267979|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267980|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
56267981|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56267982|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56686310|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56686311|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686312|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686313|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56686314|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
56686315|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
56686316|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56686317|NCT00786370|Analgesics|analgesics|mesh-ancestor
56686318|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
56686319|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686320|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56686321|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56686322|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56686323|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
56686324|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686325|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686326|NCT00796900|Dantrolene|dantrolene|mesh-list
56686327|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56686328|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686329|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56686330|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686331|NCT00791830|Irbesartan|irbesartan|mesh-list
56686332|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56686333|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56686334|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56686335|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686336|NCT00786448|Darifenacin|darifenacin|mesh-list
56686337|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56686338|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56686339|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
56686340|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686341|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686342|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686343|NCT00786448|Urological Agents|urological agents|mesh-ancestor
56267983|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267984|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
56267985|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56686344|NCT04137653|Paclitaxel|paclitaxel|mesh-list
56686345|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56686346|NCT04137653|Carboplatin|carboplatin|mesh-list
56686347|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56686348|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686349|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
56686350|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
56686351|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
56686352|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686353|NCT00797056|Aspirin|aspirin|mesh-list
56686354|NCT00797056|Clopidogrel|clopidogrel|mesh-list
56686355|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56686356|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56686357|NCT00797056|Analgesics|analgesics|mesh-ancestor
56686358|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
56686359|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686360|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686361|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686362|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686363|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56686364|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56686365|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332816|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56686366|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56686368|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686369|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
56686370|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56686371|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56686372|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56686373|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
56686374|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686375|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
56686376|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
56686377|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
56686379|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56686382|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686383|NCT00697151|Aspirin|aspirin|mesh-list
56686384|NCT00697151|Warfarin|warfarin|mesh-list
56686385|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56686386|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56686387|NCT00697151|Analgesics|analgesics|mesh-ancestor
56686388|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
56686389|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686390|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686391|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686392|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686393|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56267986|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
56267987|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56267988|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56267989|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267990|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267991|NCT01979354|Morphine|morphine|mesh-list
56267992|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56267993|NCT01979354|Narcotics|narcotics|mesh-ancestor
56267994|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268025|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268026|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56268027|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56268029|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
55890035|NCT01606319|Ibuprofen|ibuprofen|mesh-list
56268030|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268031|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268032|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56268033|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56268034|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56268035|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56268036|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56268037|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
56268039|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
56268040|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
56268041|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56268042|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56268043|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55801017|NCT02607865|Incretins|incretins|mesh-ancestor
56268044|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268046|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56268047|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56268048|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56268049|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56268050|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
56268051|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268052|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268053|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56268054|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56268055|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
56268056|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56268057|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56268058|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
56268059|NCT01979965|Ranolazine|ranolazine|mesh-list
56268060|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56268061|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56268062|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268063|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
56268064|NCT01980004|Diuretics|diuretics|mesh-ancestor
56268065|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
56186344|NCT01436825|Coagulants|coagulants|mesh-ancestor
56186345|NCT01436838|Interferons|interferons|mesh-list
56686394|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56686395|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686396|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56686397|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56686398|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686399|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
56686400|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
56686401|NCT02621957|Pravastatin|pravastatin|mesh-list
56686402|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56686403|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56686404|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
56686405|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686406|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56686407|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56686408|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686409|NCT00851084|Leucovorin|leucovorin|mesh-list
56686410|NCT00851084|Folic Acid|folic acid|mesh-list
56686411|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
56686412|NCT00851084|Aflibercept|aflibercept|mesh-list
56686413|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
56686414|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268066|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268067|NCT01980004|Expectorants|expectorants|mesh-ancestor
56268068|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
56268069|NCT01980069|Neostigmine|neostigmine|mesh-list
56268070|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56268071|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268072|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268073|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
56268074|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268075|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268076|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56268077|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
56268116|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268117|NCT01980407|Antidotes|antidotes|mesh-ancestor
55843224|NCT01590771|Glimepiride|glimepiride|mesh-list
56268147|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56268148|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
56268150|NCT01980550|Nicotine|nicotine|mesh-list
56268151|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56268152|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
56268153|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268154|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268155|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56268156|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56268157|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
56268158|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268159|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268160|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56268161|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56268162|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
56268163|NCT01980667|Cisplatin|cisplatin|mesh-list
56268191|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56268192|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56268193|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686415|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56686416|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56686417|NCT00851084|Growth Substances|growth substances|mesh-ancestor
56686418|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686419|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
56686420|NCT00851084|Antidotes|antidotes|mesh-ancestor
56686421|NCT00851084|Protective Agents|protective agents|mesh-ancestor
56686422|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
56686423|NCT00851084|Vitamins|vitamins|mesh-ancestor
56686483|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56686484|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686485|NCT00661492|Analgesics|analgesics|mesh-ancestor
56686486|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
56686487|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686488|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686489|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56686490|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56686491|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686492|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686493|NCT00693251|Sirolimus|sirolimus|mesh-list
56686494|NCT00693251|Paclitaxel|paclitaxel|mesh-list
56686495|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56686496|NCT00693251|Everolimus|everolimus|mesh-list
56686497|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56686498|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686499|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
56686500|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
56686501|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
56686502|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686503|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686504|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
56686505|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686506|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56686507|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686508|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56686509|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
56686510|NCT00792376|Diclofenac|diclofenac|mesh-list
56686511|NCT00792376|Etoricoxib|etoricoxib|mesh-list
56686512|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56686513|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56686514|NCT00792376|Analgesics|analgesics|mesh-ancestor
56686515|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
56332976|NCT00033059|Tolcapone|tolcapone|mesh-list
56686522|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686523|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56686524|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56686525|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56686526|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56686527|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686528|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686529|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56686530|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56686531|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56686532|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
56686533|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686534|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686535|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56686536|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56686537|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
56686538|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
56686540|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
56686541|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56686542|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56686543|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
56686544|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
56686545|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686546|NCT00869999|Rituximab|rituximab|mesh-list
56686547|NCT00869999|Everolimus|everolimus|mesh-list
56686548|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56268194|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56268195|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56268196|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56268197|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268198|NCT01980849|Nadroparin|nadroparin|mesh-list
56268199|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
56268200|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56268201|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56268202|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268203|NCT01980966|Oseltamivir|oseltamivir|mesh-list
56268204|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
56268205|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268206|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268207|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268208|NCT01980979|Treprostinil|treprostinil|mesh-list
56268209|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56268210|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
56268211|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56268212|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268213|NCT01981278|Tapentadol|tapentadol|mesh-list
56268214|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56268219|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
56106167|NCT00005576|Isotretinoin|isotretinoin|mesh-list
56686549|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686550|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
56686551|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686552|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686553|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686554|NCT04030988|Dexamethasone|dexamethasone|mesh-list
56686555|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686556|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
56686557|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
56686558|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686559|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686560|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56686561|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
56686562|NCT04030988|Hormones|hormones|mesh-ancestor
56686563|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56686564|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56686565|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686566|NCT00703352|Eplerenone|eplerenone|mesh-list
56686567|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56686568|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
56686569|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56686570|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686571|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56686572|NCT00703352|Diuretics|diuretics|mesh-ancestor
56686573|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
56686574|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56686575|NCT00703430|Memantine|memantine|mesh-list
56686576|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56686577|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56686593|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686594|NCT02618603|Triamcinolone|triamcinolone|mesh-list
56686595|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56686596|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56686597|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
56686598|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56686599|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56686600|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56686601|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56686602|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56686603|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686604|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
56686605|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686606|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686607|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686608|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
56686609|NCT02618603|Hormones|hormones|mesh-ancestor
56686610|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268220|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268221|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56268222|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56268223|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56268224|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268225|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
56268226|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268228|NCT01981291|Mepivacaine|mepivacaine|mesh-list
56268229|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
56268230|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268231|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268232|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
56268233|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268234|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
56186346|NCT01436838|Interferon-beta|interferon-beta|mesh-list
56186347|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
56186348|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186349|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
56186350|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186351|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
56186352|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186353|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56186354|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
56186355|NCT01436916|Vitamin D|vitamin d|mesh-list
56186356|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55900555|NCT03183024|Benralizumab|benralizumab|mesh-list
56268235|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56268236|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
56268237|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268238|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
56268239|NCT01981330|Protective Agents|protective agents|mesh-ancestor
56268240|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
56268241|NCT01981369|Propofol|propofol|mesh-list
56268242|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56268243|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268244|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268245|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56686611|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686612|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
56686613|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686614|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56686615|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686616|NCT02616497|Aspirin|aspirin|mesh-list
56686617|NCT02616497|Triflusal|triflusal|mesh-list
56686618|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56686619|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56686620|NCT02616497|Analgesics|analgesics|mesh-ancestor
56686621|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
56686622|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686623|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686624|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686625|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686626|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56686627|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56686628|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686629|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56686630|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56686631|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686632|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
56686633|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56686634|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686635|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56686636|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686637|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686638|NCT05755854|Cyclophosphamide|cyclophosphamide|mesh-list
56686639|NCT05755854|Fludarabine|fludarabine|mesh-list
56686640|NCT05755854|Fludarabine phosphate|fludarabine phosphate|mesh-list
56686641|NCT05755854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686642|NCT05755854|Immunologic Factors|immunologic factors|mesh-ancestor
56686643|NCT05755854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686644|NCT05755854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686650|NCT05755854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56686651|NCT05755854|Antimetabolites|antimetabolites|mesh-ancestor
56686652|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
56686653|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686654|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56686655|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686656|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686657|NCT04669002|Olaparib|olaparib|mesh-list
56686658|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56686659|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686660|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686661|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686662|NCT02616419|Lidocaine|lidocaine|mesh-list
56686663|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
56686664|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
56686665|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686666|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686667|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
56686668|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686669|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56686670|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56686671|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56686672|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56686673|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686674|NCT04668300|Durvalumab|durvalumab|mesh-list
56686675|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
56686676|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56686677|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
56686678|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56686679|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686680|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
56686682|NCT04982848|Talazoparib|talazoparib|mesh-list
56686691|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686692|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
56686693|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686694|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686695|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56686696|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
56686697|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686698|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686699|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56686700|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
56268246|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
56268247|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
56268248|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56268249|NCT01981369|Analgesics|analgesics|mesh-ancestor
56268250|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
56268251|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268252|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56268253|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56268254|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56268255|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
56268256|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268257|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268258|NCT01981447|Lacosamide|lacosamide|mesh-list
56268259|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
56268260|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56268261|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56268262|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56268263|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268264|NCT01981460|Methylene Blue|methylene blue|mesh-list
56268265|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268290|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268291|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268292|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
56268293|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268295|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
56268296|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56268297|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56268298|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56268299|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268300|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268301|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
56268302|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
56268303|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268304|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268305|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56268306|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56268307|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
56268308|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56268309|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56268310|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56186357|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186359|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
56186360|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56186361|NCT01436929|Silymarin|silymarin|mesh-list
56186362|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
56186363|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186364|NCT01436929|Protective Agents|protective agents|mesh-ancestor
56186365|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186366|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
56186367|NCT01436994|Carbimazole|carbimazole|mesh-list
56186368|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
56186369|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686701|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56686702|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
56686703|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
56686704|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
56686705|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56686706|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56686707|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56686708|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686709|NCT00809328|Azithromycin|azithromycin|mesh-list
56686710|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56686711|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686712|NCT00798148|Carboplatin|carboplatin|mesh-list
56686713|NCT00798148|Etoposide|etoposide|mesh-list
56686714|NCT00798148|Melphalan|melphalan|mesh-list
56686715|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686716|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56686717|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56686718|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56686719|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686720|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686721|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56686722|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
56686723|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56686724|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686725|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
56686726|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686750|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56686751|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686752|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686753|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
56686754|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686755|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56686756|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56686757|NCT02615873|Levodopa|levodopa|mesh-list
56686758|NCT02615873|Carbidopa|carbidopa|mesh-list
56686759|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56686760|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56686761|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56686762|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
56186370|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
55900616|NCT02426736|Hormones|hormones|mesh-ancestor
56268311|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56268312|NCT01981889|Prednisone|prednisone|mesh-list
56268313|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56268314|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
56268315|NCT01981889|Hormones|hormones|mesh-ancestor
56268349|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
56268350|NCT01982201|Renal Agents|renal agents|mesh-ancestor
56268351|NCT01982396|Lamivudine|lamivudine|mesh-list
56268352|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56268353|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56268354|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843463|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268385|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
56268386|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268387|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268388|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56268389|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268390|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268391|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268392|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268393|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56268394|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
56268395|NCT01982760|Coagulants|coagulants|mesh-ancestor
56268396|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56268397|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
56268432|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268433|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268434|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
56268435|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268436|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56268437|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56268438|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
56268474|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56268476|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56268477|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
56268478|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
56268479|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268505|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56268507|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
56268508|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268509|NCT01983475|Denosumab|denosumab|mesh-list
56268510|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56268511|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268512|NCT01983501|Tucatinib|tucatinib|mesh-list
56268513|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268514|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268515|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56186371|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
56686763|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686764|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686765|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686766|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56686767|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686768|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56686769|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
56686770|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
56686771|NCT00814164|Daunorubicin|daunorubicin|mesh-list
56686772|NCT00814164|Clofarabine|clofarabine|mesh-list
56686773|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56686774|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686775|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56686776|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56686777|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686778|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686779|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56686780|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
56686781|NCT02609334|Pemirolast|pemirolast|mesh-list
56686782|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
56686783|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
56186372|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186373|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268516|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268517|NCT01983514|Oxytocin|oxytocin|mesh-list
56268518|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
56268519|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56268520|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268521|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
56268522|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56268523|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56268525|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
56268526|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56268527|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
55843631|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
56268549|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268550|NCT01983722|Stiripentol|stiripentol|mesh-list
56268551|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
56268553|NCT01983735|Amlodipine|amlodipine|mesh-list
56268554|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56268555|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56268556|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55890555|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268557|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268558|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56268559|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268560|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
56268561|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56268562|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
56268563|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56268564|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
56268565|NCT01983735|Vitamins|vitamins|mesh-ancestor
56268566|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
56268567|NCT01983761|Vidarabine|vidarabine|mesh-list
56686784|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686785|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686786|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686787|NCT00659230|Dopamine|dopamine|mesh-list
56686788|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56686789|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
56686790|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
56686791|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686792|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686793|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
56686794|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242522|NCT01788969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56268568|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
56268569|NCT01983761|Fludarabine|fludarabine|mesh-list
56268570|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
56268571|NCT01983761|Melphalan|melphalan|mesh-list
56268572|NCT01983761|Busulfan|busulfan|mesh-list
56268573|NCT01983761|Clofarabine|clofarabine|mesh-list
56268574|NCT01983761|Tacrolimus|tacrolimus|mesh-list
56268575|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268576|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
56268577|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268578|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56268579|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
56268580|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268581|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56268582|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
56268583|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268615|NCT01983943|Protective Agents|protective agents|mesh-ancestor
56268616|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268617|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56268618|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
56268619|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
56268620|NCT01984008|Citric Acid|citric acid|mesh-list
56268621|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
56268622|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
56268623|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56268624|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
56268625|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
56268626|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268627|NCT01984008|Cathartics|cathartics|mesh-ancestor
56268628|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268665|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268666|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56268667|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
56268668|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56268669|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56268670|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
55843767|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268704|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56268705|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56186374|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56186375|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
56186376|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186377|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55900755|NCT01702025|Aminophylline|aminophylline|mesh-list
56268706|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
56268707|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
56268708|NCT01984567|Vitamin E|vitamin e|mesh-list
56268709|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
56268710|NCT01984567|Vitamins|vitamins|mesh-ancestor
56268711|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
56268712|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268748|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268749|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
56268750|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
56686795|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686796|NCT00659230|Protective Agents|protective agents|mesh-ancestor
56686797|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
56686798|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56686799|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
56686800|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686801|NCT00809094|Expectorants|expectorants|mesh-ancestor
56686802|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
56686803|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56686804|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
56686805|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686806|NCT00809094|Protective Agents|protective agents|mesh-ancestor
56686807|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686808|NCT00809094|Antidotes|antidotes|mesh-ancestor
56686809|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56686810|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
56686811|NCT02615639|Entecavir|entecavir|mesh-list
56686812|NCT02615639|Telbivudine|telbivudine|mesh-list
56686813|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
56686814|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56686815|NCT02615639|Vaccines|vaccines|mesh-list
56333265|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
56686816|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
56686818|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
56686819|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686820|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56686821|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686822|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686823|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686824|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
56686825|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56686826|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56686827|NCT00798616|Prednisolone|prednisolone|mesh-list
56686828|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
56686829|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56686830|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
56686831|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686832|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
56686834|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686835|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686836|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56686837|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
56686838|NCT00798616|Hormones|hormones|mesh-ancestor
56686839|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56686840|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56686841|NCT00798616|Protective Agents|protective agents|mesh-ancestor
56686842|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56686843|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686844|NCT02618057|Levofloxacin|levofloxacin|mesh-list
56686845|NCT02618057|Ofloxacin|ofloxacin|mesh-list
56686846|NCT02618057|Prednisolone|prednisolone|mesh-list
56686847|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686848|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
56686849|NCT02618057|Hormones|hormones|mesh-ancestor
56686850|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56686851|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686852|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56686853|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686854|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56686855|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686856|NCT02618057|Renal Agents|renal agents|mesh-ancestor
56686857|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56686858|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56686859|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56268751|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268752|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268753|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268754|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56268755|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56268791|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56268792|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268793|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
56268794|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56268795|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
56268830|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
56268831|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56268832|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56268833|NCT01985477|Growth Substances|growth substances|mesh-ancestor
56268834|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
56268835|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
56268836|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
56268837|NCT01985594|Nifedipine|nifedipine|mesh-list
56268865|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
56268866|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
56268867|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
56268868|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56686860|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686861|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686862|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56686863|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56686864|NCT04137029|Bromides|bromides|mesh-list
56686865|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
56686866|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
56686867|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56686868|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
56686869|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686870|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686871|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56686872|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
56686873|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56686874|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56686875|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56686876|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
56686877|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56686878|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686879|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
56686880|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56686881|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
56686882|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
56686883|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
56686884|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56686885|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56686886|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
56686887|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268869|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56268870|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56268871|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268872|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
56268873|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56268874|NCT01985724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56268875|NCT01985750|Cycloserine|cycloserine|mesh-list
56268876|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56268877|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268878|NCT01985750|Renal Agents|renal agents|mesh-ancestor
56268879|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56268880|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
56268881|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56268882|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
56268883|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268884|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
55843974|NCT03088384|Ketamine|ketamine|mesh-list
56268911|NCT01985828|Hormones|hormones|mesh-ancestor
56686888|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56686889|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56686890|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686891|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686892|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56686893|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686894|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56686895|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686896|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686897|NCT00798772|Micronutrients|micronutrients|mesh-list
56686898|NCT00798772|Trace Elements|trace elements|mesh-list
56686899|NCT00798772|Antioxidants|antioxidants|mesh-list
56686900|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686901|NCT00798772|Protective Agents|protective agents|mesh-ancestor
56686902|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268912|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268913|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268914|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
56268915|NCT01985841|Docetaxel|docetaxel|mesh-list
56268916|NCT01985841|Fluorouracil|fluorouracil|mesh-list
56268917|NCT01985841|Epirubicin|epirubicin|mesh-list
56268918|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56268919|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
56268920|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268921|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268922|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56268923|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
56268924|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268925|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268926|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56268927|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
56268928|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
56186378|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56186380|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56186381|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56186382|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56186383|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56186384|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
56186385|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186386|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186387|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186388|NCT01437189|Sertraline|sertraline|mesh-list
56186389|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
56186390|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56186391|NCT01437189|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56186392|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56186393|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56186394|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186396|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
56186397|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186398|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
56186399|NCT01437228|Povidone|povidone|mesh-list
56186400|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
56186401|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
56186402|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56186403|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186404|NCT01437293|Carbidopa|carbidopa|mesh-list
56186405|NCT01437293|Entacapone|entacapone|mesh-list
56686903|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
56686904|NCT05073822|Tacrolimus|tacrolimus|mesh-list
56686905|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56686906|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
56686907|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686908|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56686909|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686910|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686911|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56686912|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686913|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56686914|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
56686915|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56686916|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686917|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56686918|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56686919|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
56686920|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686921|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686922|NCT00788164|Imiquimod|imiquimod|mesh-list
56686923|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56686924|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
56686925|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686926|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56686927|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
56686928|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
56686929|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
56686930|NCT02615561|Vitamins|vitamins|mesh-ancestor
56686931|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
56686932|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686933|NCT00793234|Enoxaparin|enoxaparin|mesh-list
56686934|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
56686938|NCT00697775|Vaccines|vaccines|mesh-list
56686945|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686946|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
56686947|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686948|NCT00788242|Insulin|insulin|mesh-list
56686949|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56686950|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686951|NCT04031027|Apremilast|apremilast|mesh-list
56686952|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56686953|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56686954|NCT04031027|Analgesics|analgesics|mesh-ancestor
56686955|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
56686956|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686957|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686958|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686959|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242676|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
56186406|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56186407|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56186408|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
56186409|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186410|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900817|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
56268929|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
56268930|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
56268931|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56268932|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56268933|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56268934|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56268964|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56186411|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186412|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56186413|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186414|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56186415|NCT01437306|Lofexidine|lofexidine|mesh-list
56186416|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56268965|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56268966|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56268968|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268969|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268970|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268971|NCT01986127|Adalimumab|adalimumab|mesh-list
56268972|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56268973|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268974|NCT01986192|Warfarin|warfarin|mesh-list
56268975|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
56268976|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
56268977|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56268978|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
56268979|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56268980|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
55844071|NCT03519646|Eliglustat|eliglustat|mesh-list
56268981|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268982|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268983|NCT01986270|Sumatriptan|sumatriptan|mesh-list
56268984|NCT01986270|Eletriptan|eletriptan|mesh-list
56268985|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56268986|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56268987|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56268988|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
56686960|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56686961|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56686962|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686963|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686964|NCT02609802|Sevoflurane|sevoflurane|mesh-list
56686965|NCT02609802|Desflurane|desflurane|mesh-list
56686966|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56686968|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
56686969|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
56686970|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56686971|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686972|NCT02609646|Vancomycin|vancomycin|mesh-list
56686973|NCT02609646|Meropenem|meropenem|mesh-list
56686974|NCT02609646|Tazobactam|tazobactam|mesh-list
56686975|NCT02609646|Linezolid|linezolid|mesh-list
56686976|NCT02609646|Piperacillin|piperacillin|mesh-list
56686977|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56686978|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56686979|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56686980|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56686981|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56686982|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56686983|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56686984|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
56686985|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56686986|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
56686987|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56686988|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
56686989|NCT02610504|Protective Agents|protective agents|mesh-ancestor
56686990|NCT04132583|Diclofenac|diclofenac|mesh-list
56686991|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56686992|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56686993|NCT04132583|Analgesics|analgesics|mesh-ancestor
56686994|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
56686995|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56686996|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242708|NCT01789892|Hormones|hormones|mesh-ancestor
56268989|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106168|NCT00005576|Antibodies|antibodies|mesh-list
56686997|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56686998|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56686999|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56687000|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687001|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687002|NCT05754762|Remifentanil|remifentanil|mesh-list
56687003|NCT05754762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56687004|NCT05754762|Narcotics|narcotics|mesh-ancestor
56687005|NCT05754762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687006|NCT05754762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687007|NCT05754762|Analgesics|analgesics|mesh-ancestor
56687008|NCT05754762|Sensory System Agents|sensory system agents|mesh-ancestor
56687009|NCT05754762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687010|NCT05757648|Anesthetics|anesthetics|mesh-list
56687011|NCT05757648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687012|NCT05757648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687013|NCT00914004|Desipramine|desipramine|mesh-list
56687014|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56687015|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
56687016|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56687017|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687018|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687019|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56687020|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56687021|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687022|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
56687023|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687024|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687025|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
56687026|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687027|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56687028|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687038|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56687039|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56333493|NCT00034892|Olanzapine|olanzapine|mesh-list
56687040|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687042|NCT00697385|Coagulants|coagulants|mesh-ancestor
56687043|NCT00451555|Fulvestrant|fulvestrant|mesh-list
56687044|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56687045|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687046|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56687047|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56687048|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
56687049|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56687050|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687051|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
56687052|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56687053|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
56687054|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56687055|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687056|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
56687057|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
56687058|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
56687059|NCT05754684|Aldesleukin|aldesleukin|mesh-list
56687060|NCT05754684|Interleukin-2|interleukin-2|mesh-list
56687061|NCT05754684|Molgramostim|molgramostim|mesh-list
56687062|NCT05754684|Dinutuximab|dinutuximab|mesh-list
56687063|NCT05754684|Spironolactone|spironolactone|mesh-list
56687064|NCT05754684|Sargramostim|sargramostim|mesh-list
56687065|NCT05754684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687066|NCT05754684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56687067|NCT05754684|Analgesics|analgesics|mesh-ancestor
56687068|NCT05754684|Sensory System Agents|sensory system agents|mesh-ancestor
56687069|NCT05754684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687070|NCT05754684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687071|NCT05754684|Immunologic Factors|immunologic factors|mesh-ancestor
56687072|NCT05754684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56242769|NCT01793038|Clomiphene|clomiphene|mesh-list
56687078|NCT05754684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56687079|NCT05754684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56687080|NCT05754684|Diuretics|diuretics|mesh-ancestor
56687081|NCT05754684|Natriuretic Agents|natriuretic agents|mesh-ancestor
56687082|NCT00694187|Zaleplon|zaleplon|mesh-list
56687083|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
56687084|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56687085|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687086|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687087|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
56687088|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
56687089|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687090|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687091|NCT02617121|Gabapentin|gabapentin|mesh-list
56687092|NCT02617121|Ramosetron|ramosetron|mesh-list
56687093|NCT02617121|Analgesics|analgesics|mesh-ancestor
56687094|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
56687095|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687096|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687097|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
56687098|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56687099|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56687100|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687101|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56687102|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56687103|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56687104|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687105|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687106|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
56687107|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
56473685|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473686|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56473687|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473688|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56473689|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56473690|NCT05142098|Analgesics|analgesics|mesh-ancestor
56473691|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
56473692|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56473693|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56473712|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56473713|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473715|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
56106169|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56687108|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
56687109|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56687110|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56687111|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
56687112|NCT02609490|Olmesartan|olmesartan|mesh-list
56687113|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56687114|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56687115|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56333616|NCT00062556|Niacin|niacin|mesh-list
56333642|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56687116|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56687117|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56687118|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687119|NCT02610348|Vaccines|vaccines|mesh-list
56687120|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56687121|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
56687122|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473716|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473717|NCT05141240|Palbociclib|palbociclib|mesh-list
56473718|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473719|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56473720|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473721|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473722|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
56473723|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
56473724|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473725|NCT05148377|Heparin|heparin|mesh-list
56473726|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
56473727|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56473728|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56473729|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473730|NCT00524160|Fentanyl|fentanyl|mesh-list
56473731|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56473732|NCT00524160|Narcotics|narcotics|mesh-ancestor
56473733|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473734|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473735|NCT00524160|Analgesics|analgesics|mesh-ancestor
56473736|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
56473737|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473738|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56473739|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56473740|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
56473742|NCT00524199|Mesna|mesna|mesh-list
56473743|NCT00524199|Protective Agents|protective agents|mesh-ancestor
56473744|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473745|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56473746|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56473747|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56473748|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
56473749|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473750|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473753|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56473755|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56473757|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
56473758|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473759|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56473760|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888217|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56687123|NCT05757336|Gemcitabine|gemcitabine|mesh-list
56687124|NCT05757336|Paclitaxel|paclitaxel|mesh-list
56687125|NCT05757336|Bevacizumab|bevacizumab|mesh-list
56687126|NCT05757336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56687127|NCT05757336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687128|NCT05757336|Tubulin Modulators|tubulin modulators|mesh-ancestor
56687129|NCT05757336|Antimitotic Agents|antimitotic agents|mesh-ancestor
56687130|NCT05757336|Mitosis Modulators|mitosis modulators|mesh-ancestor
56687131|NCT05757336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687132|NCT05757336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56687133|NCT05757336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56687134|NCT05757336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56687135|NCT05757336|Growth Substances|growth substances|mesh-ancestor
56687136|NCT05757336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687137|NCT05757336|Growth Inhibitors|growth inhibitors|mesh-ancestor
56687138|NCT05757336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56687139|NCT05757336|Antimetabolites|antimetabolites|mesh-ancestor
56687140|NCT05757336|Antiviral Agents|antiviral agents|mesh-ancestor
56687141|NCT05757336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687142|NCT05757336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687143|NCT05757336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56687144|NCT05757336|Immunologic Factors|immunologic factors|mesh-ancestor
56687145|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56687146|NCT00871871|Isosorbide|isosorbide|mesh-list
56687147|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56687148|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56687149|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56687150|NCT00871871|Diuretics|diuretics|mesh-ancestor
56687151|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
56687152|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242854|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473761|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473762|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56473763|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56473764|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
56473765|NCT00524433|Tezosentan|tezosentan|mesh-list
56473766|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
56473767|NCT02947932|Indomethacin|indomethacin|mesh-list
56473768|NCT02947932|Resveratrol|resveratrol|mesh-list
56473769|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
56473770|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473771|NCT02947932|Protective Agents|protective agents|mesh-ancestor
56473772|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473773|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473774|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56687153|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56687154|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687155|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687156|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56687157|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
56687158|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56687159|NCT02608788|Ketorolac|ketorolac|mesh-list
56687160|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56687161|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56687162|NCT02608788|Analgesics|analgesics|mesh-ancestor
56687163|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
56687164|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687165|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687166|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687167|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56687168|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56687169|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687170|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687171|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
56687172|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56687173|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
56687174|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56687175|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687176|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56687177|NCT04961190|Paroxetine|paroxetine|mesh-list
56687178|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56687179|NCT04961190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56687180|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56687181|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687182|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687183|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687184|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
56687185|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687186|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56473775|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56687187|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
56687188|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56687189|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56687190|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56687191|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687192|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56687193|NCT00849680|Vaccines|vaccines|mesh-list
56687194|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
56687195|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687196|NCT00866723|Bevacizumab|bevacizumab|mesh-list
56687197|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56687198|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687199|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56687200|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56687201|NCT00866723|Growth Substances|growth substances|mesh-ancestor
56687202|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687203|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
56687204|NCT04118855|Axitinib|axitinib|mesh-list
56687205|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687206|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56687207|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687208|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687209|NCT02613455|Triamcinolone|triamcinolone|mesh-list
56687210|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56687211|NCT02613455|Lidocaine|lidocaine|mesh-list
56687212|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
56687213|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
56687215|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687232|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687233|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56687234|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56687235|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
56687236|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687237|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56687238|NCT04130399|Folfirinox|folfirinox|mesh-list
56687239|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687240|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
56687241|NCT00849056|Incretins|incretins|mesh-ancestor
56687242|NCT00849056|Hormones|hormones|mesh-ancestor
56687243|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56687244|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687245|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56687246|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
56687247|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56687248|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56687249|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56687250|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687251|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687252|NCT00706862|Lactoferrin|lactoferrin|mesh-list
56687253|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
56242968|NCT01799863|Ketorolac|ketorolac|mesh-list
56473776|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56473777|NCT02947932|Analgesics|analgesics|mesh-ancestor
56473778|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
56473779|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473780|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473781|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56473782|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
56473783|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
56473784|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56473785|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56473786|NCT05146154|Imipenem|imipenem|mesh-list
56473787|NCT05146154|Relebactam|relebactam|mesh-list
56473788|NCT05146154|Cilastatin|cilastatin|mesh-list
56473789|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56473790|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473791|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
56473792|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473793|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473794|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56473795|NCT00524667|Fludarabine|fludarabine|mesh-list
56473796|NCT00524667|Valproic Acid|valproic acid|mesh-list
56473797|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473798|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473799|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473800|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
56473801|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473802|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
56473803|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473804|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
56473805|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56473806|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687254|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687255|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687256|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56687257|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56687258|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56687259|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
56687260|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687261|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56687262|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56473807|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56473808|NCT00524706|Leucovorin|leucovorin|mesh-list
56473809|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
56473810|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473811|NCT00524706|Antidotes|antidotes|mesh-ancestor
56473812|NCT00524706|Protective Agents|protective agents|mesh-ancestor
56473813|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473814|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
56473816|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
56473817|NCT00507143|Irinotecan|irinotecan|mesh-list
56473818|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56473819|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56473820|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473821|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473822|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473823|NCT02947620|Metformin|metformin|mesh-list
56473824|NCT02947620|Atorvastatin|atorvastatin|mesh-list
56473825|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56473826|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473835|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56473836|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56473837|NCT00525993|Analgesics|analgesics|mesh-ancestor
56473838|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
56473839|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473840|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473841|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473842|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56473843|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56473844|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56473845|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473846|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473847|NCT05147753|Moxonidine|moxonidine|mesh-list
56473848|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56473849|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
56473850|NCT02947854|Poly ICLC|poly iclc|mesh-list
56473851|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56473852|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
56473853|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
56473854|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473855|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56473856|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
56473857|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
56473858|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56473859|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56473860|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56473861|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56473862|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473863|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
56473864|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473865|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473866|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56473867|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473868|NCT00507221|Albendazole|albendazole|mesh-list
56473869|NCT00507221|Praziquantel|praziquantel|mesh-list
56473870|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
56473871|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56473872|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687263|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687265|NCT00837434|Etanercept|etanercept|mesh-list
56687266|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687267|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56687268|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56687269|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56687270|NCT00837434|Analgesics|analgesics|mesh-ancestor
56687271|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
56687272|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687273|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687274|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56687275|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56687276|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
56687277|NCT00703742|Citalopram|citalopram|mesh-list
56687278|NCT00703742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56687279|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56687280|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687281|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687282|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687283|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
56687284|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687285|NCT00703742|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56687286|NCT00703742|Antidepressive Agents|antidepressive agents|mesh-ancestor
56687287|NCT00703742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56687288|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56687289|NCT00702182|Vinorelbine|vinorelbine|mesh-list
56687290|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687291|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56687292|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687293|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687307|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
56687308|NCT00702416|Narcotics|narcotics|mesh-list
56687309|NCT00702416|Analgesics|analgesics|mesh-list
56687310|NCT00702416|Anesthetics|anesthetics|mesh-list
56687311|NCT00702416|Ropivacaine|ropivacaine|mesh-list
56687312|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
56687313|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687314|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687315|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
56687316|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687317|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56687318|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56687319|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
56687320|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56687321|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
56687322|NCT00827918|Olanzapine|olanzapine|mesh-list
56687323|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
56687324|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
56687325|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687326|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473873|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
56473874|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56473875|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56473876|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
56473877|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
56473878|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
56473879|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473880|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473881|NCT02947737|Gentamicins|gentamicins|mesh-list
56473882|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56473883|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473884|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56473885|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473886|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473887|NCT05146895|Imiquimod|imiquimod|mesh-list
56473888|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56473889|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
56473890|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473891|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473892|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
56473897|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473899|NCT05144243|Venetoclax|venetoclax|mesh-list
56473900|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56473901|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
56473902|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473903|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473904|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221893|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473905|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
56473906|NCT00524901|Hematinics|hematinics|mesh-ancestor
56473907|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
56473908|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
56473909|NCT02954588|Vitamins|vitamins|mesh-ancestor
56473910|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
56473911|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473912|NCT02954549|Vitamin D|vitamin d|mesh-list
56473913|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
56473914|NCT02954549|Vitamins|vitamins|mesh-ancestor
56473915|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
56687327|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56687328|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56687329|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56687330|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687331|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56687332|NCT00827918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56687333|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56687334|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687335|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687336|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687337|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
56687338|NCT00813150|Dexamethasone|dexamethasone|mesh-list
56687339|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
56687340|NCT00813150|Bortezomib|bortezomib|mesh-list
56687341|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56687342|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
56687343|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687344|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56687345|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56687346|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
56687347|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687348|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687349|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56687350|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687351|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
56687352|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
56687353|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687354|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56687355|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
56687356|NCT00813150|Hormones|hormones|mesh-ancestor
56687357|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56687358|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56687359|NCT00807846|Celecoxib|celecoxib|mesh-list
56687360|NCT00807846|Naproxen|naproxen|mesh-list
56687362|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56687365|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687366|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687367|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687368|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56687369|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56687370|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56687371|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687372|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687373|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
56687374|NCT00810108|Ritonavir|ritonavir|mesh-list
56687375|NCT00810108|Lopinavir|lopinavir|mesh-list
56687376|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56687377|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56687378|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
56687379|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687380|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687381|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56687382|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56687383|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
56687384|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687385|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56687386|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56687387|NCT00827606|Atorvastatin|atorvastatin|mesh-list
56687388|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56687389|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56687390|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
56687391|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687392|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56687393|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56687408|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56687409|NCT00663052|Analgesics|analgesics|mesh-ancestor
56687410|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
56398593|NCT00149981|Everolimus|everolimus|mesh-list
56687411|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687412|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687413|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687414|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56687415|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56687416|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56687417|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
56687418|NCT05599880|Bortezomib|bortezomib|mesh-list
56687419|NCT05599880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687420|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56687421|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687422|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56687423|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687424|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687425|NCT00826748|Beclomethasone|beclomethasone|mesh-list
56687426|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687427|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
56687428|NCT00826748|Hormones|hormones|mesh-ancestor
56687429|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56687430|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473916|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473917|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56473918|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56473919|NCT05145608|Lamotrigine|lamotrigine|mesh-list
56473920|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
56473921|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56473922|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56473923|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473924|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56473925|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473926|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56473927|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56473928|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473929|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56473930|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56473931|NCT02946294|Epinephrine|epinephrine|mesh-list
56473932|NCT02946294|Racepinephrine|racepinephrine|mesh-list
56473933|NCT02946294|Bupivacaine|bupivacaine|mesh-list
56473934|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
56473935|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
56473936|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
56473937|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473938|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473939|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
56473940|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473941|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56687431|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56687432|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
56687433|NCT00922844|Sevoflurane|sevoflurane|mesh-list
56687434|NCT00922844|Isoflurane|isoflurane|mesh-list
56687435|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56687436|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56687437|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
56687438|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
56687439|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687440|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687441|NCT00707330|Clarithromycin|clarithromycin|mesh-list
56473942|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56473943|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
56473944|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473945|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473946|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56473947|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56473948|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
56473949|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56473950|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
56473951|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
56473952|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
56473953|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56473954|NCT05146232|Anesthetics|anesthetics|mesh-list
56473955|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473956|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473957|NCT00525096|Celecoxib|celecoxib|mesh-list
56473958|NCT00525096|Exemestane|exemestane|mesh-list
56473959|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56473960|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56473961|NCT00525096|Analgesics|analgesics|mesh-ancestor
56473962|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
56473963|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56473967|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56473968|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56473969|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473970|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473971|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473972|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56473973|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56473974|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56473975|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
56473976|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56473978|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
56473979|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473980|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
56473981|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473982|NCT02276859|Insulin|insulin|mesh-list
56473983|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56473984|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
56473985|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
56473986|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
56473987|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56473988|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473989|NCT05143970|Trastuzumab|trastuzumab|mesh-list
56473990|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56473991|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473992|NCT05147090|Empagliflozin|empagliflozin|mesh-list
56473993|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56473994|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473995|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56473996|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473997|NCT00525252|Baclofen|baclofen|mesh-list
56473998|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56687442|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56687443|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687444|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56687445|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687446|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687447|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56687448|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56687449|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
56687450|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687451|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56687452|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687453|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687454|NCT00788320|Vitamin D|vitamin d|mesh-list
56687455|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
56687456|NCT00788320|Vitamins|vitamins|mesh-ancestor
56687457|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
56687458|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687459|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56687460|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56473999|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474000|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56474001|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474002|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56474003|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
56474004|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
56474005|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474006|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474007|NCT02947113|Etoposide|etoposide|mesh-list
56474008|NCT02947113|Pemetrexed|pemetrexed|mesh-list
56474009|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474010|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56474011|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56474012|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56474013|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474014|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474015|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56474016|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56474017|NCT02276690|Hepcidins|hepcidins|mesh-list
56474018|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474019|NCT02947269|Prucalopride|prucalopride|mesh-list
56474020|NCT02947269|Laxatives|laxatives|mesh-ancestor
56474021|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56474022|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56474023|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56474024|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
56474025|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474026|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474027|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474028|NCT00526305|Cytarabine|cytarabine|mesh-list
56474029|NCT00526305|Dexamethasone|dexamethasone|mesh-list
56474030|NCT00526305|Prednisone|prednisone|mesh-list
56474031|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
56474032|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
56474033|NCT00526305|Vincristine|vincristine|mesh-list
56474034|NCT00526305|Daunorubicin|daunorubicin|mesh-list
56687461|NCT00807144|Tacrolimus|tacrolimus|mesh-list
56687462|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56687463|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
56687464|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687465|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56687466|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687467|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687468|NCT00799240|Cisplatin|cisplatin|mesh-list
56687469|NCT00799240|Pemetrexed|pemetrexed|mesh-list
56687470|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56687471|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687472|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687473|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687474|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56687475|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56687476|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
56687477|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687478|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
56687479|NCT00591006|Phenytoin|phenytoin|mesh-list
56687480|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687481|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
56687482|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56474035|NCT00526305|Asparaginase|asparaginase|mesh-list
56474036|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
56474037|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
56474041|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474042|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56474043|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
56474044|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474045|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474046|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56474047|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56474048|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
56474049|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
56474050|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474051|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56474052|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
56474053|NCT00526305|Hormones|hormones|mesh-ancestor
56474054|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474055|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56474056|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56474057|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
56474058|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474059|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
56474060|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56474061|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
56474062|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
56474063|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474064|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56474065|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56474066|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56474067|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474068|NCT00526305|Analgesics|analgesics|mesh-ancestor
56687483|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56398672|NCT02914015|Analgesics|analgesics|mesh-ancestor
56687484|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687485|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687486|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56687487|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56687488|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56687489|NCT00844844|Eculizumab|eculizumab|mesh-list
56687490|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56687491|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56687492|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
56687493|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687494|NCT05748054|Fluorides|fluorides|mesh-list
56687495|NCT05748054|Cariostatic Agents|cariostatic agents|mesh-ancestor
56687496|NCT05748054|Protective Agents|protective agents|mesh-ancestor
56687497|NCT05748054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687498|NCT00702572|Paclitaxel|paclitaxel|mesh-list
56687499|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56687500|NCT00702572|Bevacizumab|bevacizumab|mesh-list
56687501|NCT00702572|Carboplatin|carboplatin|mesh-list
56687502|NCT00702572|Vorinostat|vorinostat|mesh-list
56687503|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56687504|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687505|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
56687506|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474069|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
56474070|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56474071|NCT02276768|Trimebutine|trimebutine|mesh-list
56474072|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56474073|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
56474074|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
56474075|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474076|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474077|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
56474078|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
56474079|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56474080|NCT00525408|Docetaxel|docetaxel|mesh-list
56474081|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474082|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56474083|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474084|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56474085|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474086|NCT00525447|Dexamethasone|dexamethasone|mesh-list
56474087|NCT00525447|Lenalidomide|lenalidomide|mesh-list
56474088|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
56474089|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56474090|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
56474091|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
56474092|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474093|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474094|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56687507|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
56687508|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687509|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56687510|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56687511|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56687512|NCT00702572|Growth Substances|growth substances|mesh-ancestor
56687513|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687514|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
56687515|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56687516|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687517|NCT00793468|Nicotine|nicotine|mesh-list
56687518|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56687519|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
56687520|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687521|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687522|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56687523|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56687524|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
56687525|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687526|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687527|NCT00836810|Prednisone|prednisone|mesh-list
56687528|NCT00836810|Prednisolone|prednisolone|mesh-list
56687529|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56687530|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
56687531|NCT00836810|Hormones|hormones|mesh-ancestor
56687532|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56687533|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687534|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56687535|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687536|NCT00658684|Fesoterodine|fesoterodine|mesh-list
56687537|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56687538|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56687539|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
56687540|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687545|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56687546|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
56687547|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687548|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687614|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
56687615|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687616|NCT00801034|Calcium|calcium|mesh-list
56687617|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56687618|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687619|NCT04130477|Nickel|nickel|mesh-list
56687620|NCT04130477|Trace Elements|trace elements|mesh-ancestor
56687621|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
56687622|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687623|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
56687624|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56687625|NCT00702728|Furosemide|furosemide|mesh-list
56687626|NCT00702728|Diuretics|diuretics|mesh-ancestor
56687627|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
56687628|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687629|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56687630|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687631|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687632|NCT04132115|Vancomycin|vancomycin|mesh-list
56687633|NCT04132115|Gentamicins|gentamicins|mesh-list
56687634|NCT04132115|Meropenem|meropenem|mesh-list
56687635|NCT04132115|Tazobactam|tazobactam|mesh-list
56687636|NCT04132115|Linezolid|linezolid|mesh-list
56474095|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
56474096|NCT00525447|Hormones|hormones|mesh-ancestor
56474097|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474098|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56474099|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474100|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
56474101|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56474102|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56474103|NCT00525447|Growth Substances|growth substances|mesh-ancestor
56474104|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
56474105|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56474106|NCT00525486|Nifedipine|nifedipine|mesh-list
56474107|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56474108|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56474109|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474114|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56474115|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56474116|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
56474117|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474118|NCT02946060|TEMPO|tempo|mesh-list
56474119|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
56474120|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474121|NCT02946060|Protective Agents|protective agents|mesh-ancestor
56474122|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474123|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56474124|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56474125|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
56474126|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474127|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687637|NCT04132115|Piperacillin|piperacillin|mesh-list
56687638|NCT04132115|Daptomycin|daptomycin|mesh-list
56687639|NCT04132115|Amikacin|amikacin|mesh-list
56687640|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56687641|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
56687642|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56687643|NCT04132115|Acyclovir|acyclovir|mesh-list
56687644|NCT04132115|Ganciclovir|ganciclovir|mesh-list
56687645|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56687646|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687647|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56687648|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687649|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687650|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56687651|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
56687652|NCT00801268|Emodin|emodin|mesh-list
56474128|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56474129|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
56474130|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56474131|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56474132|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56474133|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
56474134|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474135|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474137|NCT00525642|Docetaxel|docetaxel|mesh-list
56474138|NCT00525642|Doxorubicin|doxorubicin|mesh-list
56474139|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56474140|NCT00525642|Epirubicin|epirubicin|mesh-list
56474141|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474142|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
56474143|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474144|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474145|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56474146|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
56474147|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474148|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474149|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56474150|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
56474151|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474152|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
56474153|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56474154|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56474155|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56474156|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474157|NCT00525681|Cyclosporine|cyclosporine|mesh-list
56474158|NCT00525681|Tacrolimus|tacrolimus|mesh-list
56474159|NCT00525681|Cyclosporins|cyclosporins|mesh-list
56474160|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474161|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
56474162|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474163|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56474164|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474165|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474166|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
56474167|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474168|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
56474169|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474170|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
56474171|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56474172|NCT02945982|Entecavir|entecavir|mesh-list
56474173|NCT02945982|Carvedilol|carvedilol|mesh-list
56474174|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
56474175|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687653|NCT00801268|Cathartics|cathartics|mesh-ancestor
56687654|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56687655|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56687656|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687657|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687658|NCT02614937|Squalamine|squalamine|mesh-list
56687659|NCT02614937|Ranibizumab|ranibizumab|mesh-list
56687660|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56687661|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56687662|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56687663|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56687664|NCT02614937|Growth Substances|growth substances|mesh-ancestor
56687665|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687666|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
56687667|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687668|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56687669|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687670|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56687671|NCT02614937|Protective Agents|protective agents|mesh-ancestor
56687672|NCT00707642|Vaccines|vaccines|mesh-list
56687673|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
56243397|NCT01802970|Paclitaxel|paclitaxel|mesh-list
56474176|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56474177|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56474178|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
56474179|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474180|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474181|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474182|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56474183|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
56474186|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56474187|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56474188|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
56474189|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56474190|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56474191|NCT02954393|Amoxicillin|amoxicillin|mesh-list
56474192|NCT02954393|Metronidazole|metronidazole|mesh-list
56474193|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56474194|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474195|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56474196|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56474197|NCT02954276|Sumatriptan|sumatriptan|mesh-list
56474198|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56474199|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56474200|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56474201|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
56474202|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474203|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474204|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474205|NCT00507494|Pioglitazone|pioglitazone|mesh-list
56474206|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56474207|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474208|NCT00526617|Temozolomide|temozolomide|mesh-list
56474209|NCT00526617|Veliparib|veliparib|mesh-list
56106170|NCT00005576|Sargramostim|sargramostim|mesh-list
56687674|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687675|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
56687676|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56687677|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56687678|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687679|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56687680|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56687681|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687682|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687683|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687684|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56687685|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
56687686|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56687687|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687688|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56687689|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56687690|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56687691|NCT00789646|Lidocaine|lidocaine|mesh-list
56687692|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
56687693|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
56687694|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687695|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687696|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
56687697|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687698|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56474210|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56474211|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
56474212|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474213|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474214|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56474215|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474216|NCT00507845|Felodipine|felodipine|mesh-list
56474217|NCT00507845|Ramipril|ramipril|mesh-list
56474218|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56474219|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
56474220|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474221|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474222|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56474223|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56474224|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56474225|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56474226|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56474227|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474228|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
56474229|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
56474230|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
56687699|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56687700|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56687701|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687702|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687703|NCT00856973|Eszopiclone|eszopiclone|mesh-list
56687704|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56687705|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687706|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398893|NCT02912182|Hormones|hormones|mesh-ancestor
56687707|NCT00794638|Rituximab|rituximab|mesh-list
56687708|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56687709|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56687710|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687711|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
56687712|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687713|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56687714|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56687715|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
56687716|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687717|NCT00801580|Doxorubicin|doxorubicin|mesh-list
56687718|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56687719|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56687720|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687721|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56687746|NCT00801736|Cisplatin|cisplatin|mesh-list
56687747|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56687748|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687749|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
56687750|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
56687751|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
56687752|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687753|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
56687754|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56687755|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56687756|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687757|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
56687758|NCT02606994|Lidocaine|lidocaine|mesh-list
56687759|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
56687760|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
56687761|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687762|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687763|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
56687764|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687765|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56687766|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56687767|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56687768|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687769|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474231|NCT00525759|Docetaxel|docetaxel|mesh-list
56474232|NCT00525759|Fluorouracil|fluorouracil|mesh-list
56474233|NCT00525759|Epirubicin|epirubicin|mesh-list
56474234|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474235|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
56474236|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474237|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474238|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56474239|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
56474240|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474241|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474242|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56474243|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
56474244|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474245|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
56474246|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
56474247|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56474248|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56474249|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56474250|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56474251|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474252|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56474253|NCT00507962|Cisplatin|cisplatin|mesh-list
56687770|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56687771|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56687772|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
56687773|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
56687774|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56687775|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56687776|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
56687777|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
56687778|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687779|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56687780|NCT00844376|Atorvastatin|atorvastatin|mesh-list
56687781|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56398966|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687782|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56687784|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687785|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56687786|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56687787|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687788|NCT04046302|Dinoprostone|dinoprostone|mesh-list
56687789|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
56687790|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56687791|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687792|NCT00914394|Phenylephrine|phenylephrine|mesh-list
56687793|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
56687794|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56687795|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56687796|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
56687797|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
56687798|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687799|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687800|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
56687815|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687816|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687817|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687818|NCT00658606|Alefacept|alefacept|mesh-list
56687819|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
56687820|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
56687821|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687822|NCT00795106|Capsaicin|capsaicin|mesh-list
56687823|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
56687824|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56687825|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
56687826|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687827|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687828|NCT00589290|Belinostat|belinostat|mesh-list
56687829|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687830|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56687831|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687832|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687833|NCT00802048|Ropivacaine|ropivacaine|mesh-list
56687834|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
56687835|NCT00802048|Anesthetics|anesthetics|mesh-list
56687836|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687837|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474254|NCT00507962|Doxorubicin|doxorubicin|mesh-list
56474255|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56474256|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474257|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56474258|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56474260|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474261|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474262|NCT00508040|Interferons|interferons|mesh-list
56474263|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
56474264|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
56474265|NCT00508040|Prednisone|prednisone|mesh-list
56474266|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56474267|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
56474268|NCT00508040|Hormones|hormones|mesh-ancestor
56474269|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474270|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474271|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56474272|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474273|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
56474274|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474275|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
56474276|NCT00508664|Docetaxel|docetaxel|mesh-list
56474277|NCT00508664|Fluorouracil|fluorouracil|mesh-list
56474278|NCT00508664|Cetuximab|cetuximab|mesh-list
56474279|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474280|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
56474281|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474282|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
56474283|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687838|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
56687839|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687840|NCT00809536|Metformin|metformin|mesh-list
56687841|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56687842|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687843|NCT00809692|Histamine|histamine|mesh-list
56687844|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
56687845|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
56687846|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
56687847|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687848|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687849|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687850|NCT00843284|Pregabalin|pregabalin|mesh-list
56687851|NCT00843284|Analgesics|analgesics|mesh-ancestor
56687852|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
56687853|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687854|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687855|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
56687856|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56687857|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687858|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687859|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56687861|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56687862|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687863|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56474284|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
56474285|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56474286|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474287|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
56474288|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474289|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56474290|NCT02946684|Letrozole|letrozole|mesh-list
56474291|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56474292|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474293|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56474294|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474295|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474296|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56474297|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
56474298|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474299|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474300|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
56474301|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56474302|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
56474303|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56474304|NCT02946801|Listerine|listerine|mesh-list
56474305|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
56474306|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56687864|NCT00802282|Psilocybin|psilocybin|mesh-list
56687865|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
56687866|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687867|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56687868|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
56687869|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56687870|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687871|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56687872|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
56687873|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56687874|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687875|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687876|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687877|NCT00825812|Atropine|atropine|mesh-list
56687878|NCT00825812|Neostigmine|neostigmine|mesh-list
56687879|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56687880|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56687881|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56687882|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
56687883|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687884|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687885|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56687886|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
56687887|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
56687888|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
56687889|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56687890|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56687891|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
56687892|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687893|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687894|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56687895|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56687896|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56687897|NCT00802594|Pafuramidine|pafuramidine|mesh-list
56687898|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56687899|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56687900|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56474307|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687901|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687902|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56687903|NCT00707876|Hematinics|hematinics|mesh-ancestor
56687904|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56687905|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56687906|NCT02606448|Bupivacaine|bupivacaine|mesh-list
56687907|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
56687908|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
56687909|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56687910|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687911|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
56687912|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687913|NCT05746572|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56687914|NCT05746572|Hallucinogens|hallucinogens|mesh-ancestor
56687915|NCT05746572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687916|NCT05746572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56687917|NCT05746572|Serotonin Agents|serotonin agents|mesh-ancestor
56687918|NCT05746572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56687919|NCT05746572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687920|NCT05746572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56687921|NCT05746572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56687922|NCT05746572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56687923|NCT05746572|Adrenergic Agents|adrenergic agents|mesh-ancestor
56687924|NCT00802828|Famotidine|famotidine|mesh-list
56687925|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56687926|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56687927|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56687928|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
56687929|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
56687946|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56687947|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687948|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56687949|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
56687950|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
56687951|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56687952|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
56687953|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56687954|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56687955|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687956|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
56687957|NCT00824564|Coagulants|coagulants|mesh-ancestor
56687958|NCT00803374|Ipilimumab|ipilimumab|mesh-list
56687959|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56687960|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56687961|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56687962|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56687963|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687964|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
56687965|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687966|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
56687967|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
56687968|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56687969|NCT00803530|Protective Agents|protective agents|mesh-ancestor
56687970|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56687993|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56687994|NCT00803842|Doxycycline|doxycycline|mesh-list
56474308|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
56474309|NCT02946801|Protective Agents|protective agents|mesh-ancestor
56474310|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474311|NCT02953847|Rifampin|rifampin|mesh-list
56474312|NCT02953847|Isoniazid|isoniazid|mesh-list
56474313|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56474314|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
56474315|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56474316|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474317|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
56474318|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56474319|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474320|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474321|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56474322|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56474323|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56474324|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56474325|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56474326|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56474327|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56474328|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56474329|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
56474330|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56474331|NCT00526695|Sevoflurane|sevoflurane|mesh-list
56334576|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474332|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56474333|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56474334|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
56474335|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
56474336|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56474337|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474338|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
56474339|NCT00526929|Hematinics|hematinics|mesh-ancestor
56474340|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
56474341|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
56474342|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474343|NCT00526734|Melphalan|melphalan|mesh-list
56474344|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
56474345|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474346|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56474347|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
56474348|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474349|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474350|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56474351|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474352|NCT00508859|Sertraline|sertraline|mesh-list
56474353|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
56474354|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56474355|NCT00508859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56474356|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56474357|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56474358|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474359|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474360|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
56474361|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474362|NCT00508898|Calcitriol|calcitriol|mesh-list
56474363|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56474364|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474365|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56474366|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56474367|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474368|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56474369|NCT00508898|Vitamins|vitamins|mesh-ancestor
56474370|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
56474371|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56474372|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
56474373|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56474374|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
56474375|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474376|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
56687995|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56687996|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56687997|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
56687998|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56687999|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56688000|NCT00658528|Esomeprazole|esomeprazole|mesh-list
56688001|NCT00658528|Rabeprazole|rabeprazole|mesh-list
56688002|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56688003|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56688004|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56688005|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688006|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688007|NCT02864394|Docetaxel|docetaxel|mesh-list
56688008|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
56688009|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688010|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
56688011|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
56688012|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
56688013|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688014|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688015|NCT00856583|Risperidone|risperidone|mesh-list
56688017|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56688018|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
56688019|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688020|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688021|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688022|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56688023|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56688024|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688025|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56688026|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56688027|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
56688028|NCT05753436|Curcumin|curcumin|mesh-list
56688038|NCT05753436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688039|NCT05753436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688040|NCT05753280|Vitamin D|vitamin d|mesh-list
56688041|NCT05753280|Vitamins|vitamins|mesh-ancestor
56688042|NCT05753280|Micronutrients|micronutrients|mesh-ancestor
56688043|NCT05753280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688044|NCT05753280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56688045|NCT05739942|Temozolomide|temozolomide|mesh-list
56688046|NCT05739942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56688047|NCT05739942|Alkylating Agents|alkylating agents|mesh-ancestor
56688048|NCT05739942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688049|NCT05739942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688050|NCT00824408|Pemetrexed|pemetrexed|mesh-list
56688051|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688052|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688053|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688054|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56688055|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56688056|NCT02611700|Paclitaxel|paclitaxel|mesh-list
56688057|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56688058|NCT02611700|Cisplatin|cisplatin|mesh-list
56688059|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
56688060|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56688061|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688062|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56688063|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56688064|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56688065|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688066|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688067|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56688080|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56688081|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688082|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688083|NCT00834080|Naltrexone|naltrexone|mesh-list
56688084|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56688085|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56688086|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688087|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
56688088|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688089|NCT00823472|Ganirelix|ganirelix|mesh-list
56688090|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
56688091|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688092|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688093|NCT04118699|Rifaximin|rifaximin|mesh-list
56688094|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56688095|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688096|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56688097|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
56688098|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56688099|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56688100|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56688101|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
56688102|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688103|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688104|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688105|NCT04130087|Selegiline|selegiline|mesh-list
56688106|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
56688107|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56474377|NCT04692558|Protective Agents|protective agents|mesh-ancestor
56474378|NCT02952599|Edoxaban|edoxaban|mesh-list
56474379|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56474380|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
56474381|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56474382|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
56474383|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474384|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474385|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
56474386|NCT00510419|Sumatriptan|sumatriptan|mesh-list
56474387|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56474388|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56474389|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56474390|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
56474391|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474392|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474393|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688108|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56688109|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56688110|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56688111|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688112|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688113|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56688114|NCT04130087|Protective Agents|protective agents|mesh-ancestor
56688115|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688116|NCT00652366|Gemcitabine|gemcitabine|mesh-list
56688117|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56688118|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56688119|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
56688120|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688121|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688122|NCT00652366|Antiviral Agents|antiviral agents|mesh-ancestor
56688123|NCT00652366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688124|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688125|NCT00652366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56688126|NCT00652366|Immunologic Factors|immunologic factors|mesh-ancestor
56688127|NCT00652366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688128|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56688129|NCT00841568|Tolvaptan|tolvaptan|mesh-list
56688130|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56688131|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688132|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
56688133|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688134|NCT00855959|Budesonide|budesonide|mesh-list
56688135|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688136|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56688137|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
56688138|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688139|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688140|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56688141|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
56474394|NCT00510536|Acetaminophen|acetaminophen|mesh-list
56474395|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56474396|NCT00510536|Analgesics|analgesics|mesh-ancestor
56474397|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
56688142|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
56688143|NCT00855959|Hormones|hormones|mesh-ancestor
56688144|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688145|NCT00704600|Nelfinavir|nelfinavir|mesh-list
56688146|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56688147|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56688148|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
56688149|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688150|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688151|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56688152|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56688153|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
56688154|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688155|NCT00699881|Cetuximab|cetuximab|mesh-list
56688156|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688157|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688158|NCT00708578|Metformin|metformin|mesh-list
56688159|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
56688160|NCT00708578|Glimepiride|glimepiride|mesh-list
56688161|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56688162|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688163|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56688164|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56688165|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
56688166|NCT00704678|Sevelamer|sevelamer|mesh-list
56688167|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
56688168|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
56688169|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688170|NCT00708656|Mesalamine|mesalamine|mesh-list
56688171|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56688172|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56688186|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56688187|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56688188|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688189|NCT03307785|Paclitaxel|paclitaxel|mesh-list
56688190|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56688191|NCT03307785|Bevacizumab|bevacizumab|mesh-list
56688192|NCT03307785|Carboplatin|carboplatin|mesh-list
56688193|NCT03307785|Pemetrexed|pemetrexed|mesh-list
56688194|NCT03307785|Niraparib|niraparib|mesh-list
56688195|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56688196|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688197|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
56688198|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
56688199|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
56688200|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688201|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688202|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56688203|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56688204|NCT03307785|Growth Substances|growth substances|mesh-ancestor
56688205|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688206|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
56688207|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688208|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56688209|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56688210|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56688211|NCT00804310|Lapatinib|lapatinib|mesh-list
56688212|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688213|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56688214|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688215|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688229|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56688230|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56688231|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56688232|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688233|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56688234|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56688235|NCT00708812|Growth Substances|growth substances|mesh-ancestor
56688236|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688237|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
56688238|NCT04127747|Rituximab|rituximab|mesh-list
56688239|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688240|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688241|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
56688242|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688243|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688244|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
56688245|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56688246|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56688247|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56688248|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56688249|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688250|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
56688251|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688252|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474398|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474399|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474400|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
56474401|NCT03458715|Empagliflozin|empagliflozin|mesh-list
56474402|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56474403|NCT03458715|Linagliptin|linagliptin|mesh-list
56474404|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56474410|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474412|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474413|NCT00510614|Tinidazole|tinidazole|mesh-list
56474414|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
56474415|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474416|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56474417|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474418|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56474419|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56474420|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56474421|NCT00508976|Lidocaine|lidocaine|mesh-list
56474422|NCT00508976|Bupivacaine|bupivacaine|mesh-list
56474423|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
56474424|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
56474425|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56474426|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474427|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
56688253|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56688254|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688255|NCT00822770|Plerixafor|plerixafor|mesh-list
56688256|NCT00822770|Fludarabine|fludarabine|mesh-list
56688257|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
56688258|NCT00822770|Busulfan|busulfan|mesh-list
56688259|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
56688260|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56688261|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688262|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56688263|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
56688264|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688265|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56688266|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
56688267|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688268|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
56688269|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688270|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
56688271|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56688272|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56688273|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56688274|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56688275|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56688276|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56688277|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56688278|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56688279|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688280|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688281|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
56688293|NCT02607111|Dalteparin|dalteparin|mesh-list
56688296|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
56688297|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56688298|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56688299|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688300|NCT00703196|Folic Acid|folic acid|mesh-list
56688301|NCT00703196|Hematinics|hematinics|mesh-ancestor
56688302|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
56688303|NCT00703196|Vitamins|vitamins|mesh-ancestor
56688304|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
56688305|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688306|NCT05720325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56688307|NCT05720325|Immunologic Factors|immunologic factors|mesh-ancestor
56688308|NCT05720325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688309|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
56688310|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56688311|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
56688312|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688313|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688314|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
56688315|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688316|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
56688317|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
56688318|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56688319|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56688320|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688322|NCT00914277|Urological Agents|urological agents|mesh-ancestor
56688346|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56688347|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
56688348|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56688349|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56688350|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688351|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56688352|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56688353|NCT02607696|Zolpidem|zolpidem|mesh-list
56688354|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56688355|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56688356|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688357|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688358|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56688359|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
56688360|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
56688361|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688362|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688363|NCT00839852|Cariprazine|cariprazine|mesh-list
56688364|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56688365|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56688366|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688367|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688368|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56688369|NCT02604849|Gentamicins|gentamicins|mesh-list
56688396|NCT00865709|Fluorouracil|fluorouracil|mesh-list
56688397|NCT00865709|Sorafenib|sorafenib|mesh-list
56688398|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
56688399|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688400|NCT00865709|Antidotes|antidotes|mesh-ancestor
56688401|NCT00865709|Protective Agents|protective agents|mesh-ancestor
56688402|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688403|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
56688404|NCT00865709|Vitamins|vitamins|mesh-ancestor
56688405|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
56688406|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
56688407|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688408|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56688409|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56688410|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
56688413|NCT00839306|Rabeprazole|rabeprazole|mesh-list
56688458|NCT02607774|Midazolam|midazolam|mesh-list
56688459|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56688460|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56688461|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688462|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688463|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56688464|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56688465|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56688466|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56688467|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
56688468|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
56688523|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56688524|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688525|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56688526|NCT00803634|Diuretics|diuretics|mesh-ancestor
56688527|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
56688528|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56688529|NCT00838526|Rabeprazole|rabeprazole|mesh-list
56688530|NCT00838526|Ranitidine|ranitidine|mesh-list
56688531|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56688532|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56688533|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56688534|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56688535|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688536|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688537|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56688538|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
56688539|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
56688542|NCT00914472|Heparin|heparin|mesh-list
56688582|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
56688583|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688584|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56688585|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56688586|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
56688587|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688588|NCT00705692|Levamisole|levamisole|mesh-list
56688589|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56688590|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
56688591|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688592|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
56688593|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
56688594|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56688595|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688596|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688597|NCT05756504|Ketorolac|ketorolac|mesh-list
56688641|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
56688642|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
56688643|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
56688644|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688645|NCT03537924|Acetazolamide|acetazolamide|mesh-list
56688646|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
56688647|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56688648|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688649|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688650|NCT03537924|Diuretics|diuretics|mesh-ancestor
56688651|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
56688652|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688653|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56688654|NCT00590538|Genistein|genistein|mesh-list
56688655|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688656|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56688657|NCT00590538|Protective Agents|protective agents|mesh-ancestor
56688658|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688659|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56688660|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688661|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688662|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
56688663|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56688664|NCT00590538|Estrogens|estrogens|mesh-ancestor
56688665|NCT00590538|Hormones|hormones|mesh-ancestor
56688667|NCT02608320|Fentanyl|fentanyl|mesh-list
56688691|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56688692|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56688693|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
56688694|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688695|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688696|NCT01731444|Protective Agents|protective agents|mesh-ancestor
56688697|NCT05728944|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56688698|NCT05728944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56688699|NCT05728944|Aceclidine|aceclidine|mesh-list
56688709|NCT05728944|Miotics|miotics|mesh-ancestor
56688757|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56688758|NCT01227876|Prednisolone|prednisolone|mesh-list
56688759|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
56688760|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56688761|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
56688762|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688763|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
56688764|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
56688765|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688766|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688767|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56688768|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
56688769|NCT01227876|Hormones|hormones|mesh-ancestor
56688770|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688771|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56688772|NCT01227876|Protective Agents|protective agents|mesh-ancestor
56688773|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56688774|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688775|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
56688776|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56688778|NCT05297292|Ranibizumab|ranibizumab|mesh-list
56688812|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
56688813|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688814|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688815|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688816|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688817|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56688818|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56688819|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688820|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56688821|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56688822|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688823|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
56688824|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56688825|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688826|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688827|NCT03161652|Ranibizumab|ranibizumab|mesh-list
56688828|NCT03161652|Dopamine|dopamine|mesh-list
56688829|NCT03161652|Sulpiride|sulpiride|mesh-list
56688830|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56688831|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56688832|NCT03161652|Growth Substances|growth substances|mesh-ancestor
56688833|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688863|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688864|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
56688865|NCT02605746|Ceritinib|ceritinib|mesh-list
56688866|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688867|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56688868|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688869|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688870|NCT04109859|Methylene Blue|methylene blue|mesh-list
56688871|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688872|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688873|NCT05752734|Dexamethasone|dexamethasone|mesh-list
56688874|NCT05752734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688875|NCT05752734|Antiemetics|antiemetics|mesh-ancestor
56688876|NCT05752734|Autonomic Agents|autonomic agents|mesh-ancestor
56688877|NCT05752734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688878|NCT05752734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688879|NCT05752734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56688880|NCT05752734|Glucocorticoids|glucocorticoids|mesh-ancestor
56688881|NCT05752734|Hormones|hormones|mesh-ancestor
56688882|NCT05752734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688883|NCT05752734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56688884|NCT05752734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688885|NCT00790023|Ciclesonide|ciclesonide|mesh-list
56688886|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
56688887|NCT00790023|Hormones|hormones|mesh-ancestor
56688888|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56688889|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688890|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56688891|NCT00588822|Rituximab|rituximab|mesh-list
56688892|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688893|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688894|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
56688895|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688903|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56688904|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56688905|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688906|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56688907|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56688908|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56688909|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
56688910|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688911|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688912|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56688913|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56400077|NCT02935933|Morphine|morphine|mesh-list
56688914|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
56688915|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56688916|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56688917|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56688918|NCT00789555|Analgesics|analgesics|mesh-ancestor
56688919|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
56688920|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688921|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688922|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688923|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688924|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56688925|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56688926|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56688927|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
56688928|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
56688929|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688930|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688931|NCT03770455|Avelumab|avelumab|mesh-list
56688932|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56688933|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688934|NCT01026337|Sunitinib|sunitinib|mesh-list
56688935|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56688936|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56688937|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56474428|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688938|NCT01026337|Growth Substances|growth substances|mesh-ancestor
56688939|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688940|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
56688941|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56688942|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688943|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688944|NCT03746275|Aspirin|aspirin|mesh-list
56688945|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
56688946|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56688947|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56688948|NCT03746275|Analgesics|analgesics|mesh-ancestor
56688949|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
56688950|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56688951|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56688952|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56688953|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56688954|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56688955|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56688956|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688957|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56688958|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56688959|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688960|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
56688961|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56688962|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
56688963|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56688964|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
56688965|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
56688966|NCT01026415|Rifampin|rifampin|mesh-list
56688967|NCT01026415|Ketoconazole|ketoconazole|mesh-list
56688983|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56688984|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56688985|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56688986|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
56688987|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56400157|NCT02935582|Hormones|hormones|mesh-ancestor
56688988|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56688989|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
56688990|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56688991|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56688992|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56688993|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56688994|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56688995|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56688996|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56688997|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56689011|NCT02604966|Artesunate|artesunate|mesh-list
56689037|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
56689038|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689039|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689040|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56689041|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56689042|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56689043|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56689044|NCT00450619|Analgesics|analgesics|mesh-ancestor
56689045|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
56689046|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689047|NCT00802074|Ritonavir|ritonavir|mesh-list
56689048|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
56689049|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
56689050|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56689051|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56689052|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
56689053|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689054|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689055|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56689056|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56689057|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
56689058|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689059|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56689060|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56689061|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56689087|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689088|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689089|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
56689090|NCT00450385|Hormones|hormones|mesh-ancestor
56689091|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689092|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56689093|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56689094|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
56689095|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
56689096|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
56689097|NCT00588354|Triamcinolone|triamcinolone|mesh-list
56689098|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56689099|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56689100|NCT00588354|Lidocaine|lidocaine|mesh-list
56689101|NCT00588354|Clonidine|clonidine|mesh-list
56689146|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
56689147|NCT01019395|Daptomycin|daptomycin|mesh-list
56689148|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56689149|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689150|NCT00830960|Clopidogrel|clopidogrel|mesh-list
56689151|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56689152|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56689153|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56689154|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56689155|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56689156|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
56689157|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689158|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689159|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689160|NCT01026961|Acetaminophen|acetaminophen|mesh-list
56689161|NCT01026961|Dimethindene|dimethindene|mesh-list
56689162|NCT01026961|Phenylephrine|phenylephrine|mesh-list
56689163|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
56689164|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56689165|NCT01026961|Analgesics|analgesics|mesh-ancestor
56689166|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
56689167|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689168|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689169|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
56689171|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56689198|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
56689199|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689200|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56689201|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
56689202|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56689203|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689204|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689205|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56689206|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689207|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689208|NCT03849313|Adalimumab|adalimumab|mesh-list
56689209|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689210|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689211|NCT04111614|Tofacitinib|tofacitinib|mesh-list
56689212|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56689213|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689214|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689215|NCT01023919|Sirolimus|sirolimus|mesh-list
56689216|NCT01023919|Paclitaxel|paclitaxel|mesh-list
56689217|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56689218|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689233|NCT00830804|Ritonavir|ritonavir|mesh-list
56689251|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56689252|NCT00789477|Growth Substances|growth substances|mesh-ancestor
56689253|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689254|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
56689255|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689256|NCT01024075|Dexamethasone|dexamethasone|mesh-list
56689257|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689258|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
56689259|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
56689260|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689261|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689262|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56689263|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
56689264|NCT01024075|Hormones|hormones|mesh-ancestor
56689265|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689266|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56689267|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689268|NCT05756348|Protective Agents|protective agents|mesh-list
56689269|NCT05756348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689270|NCT00913874|Valproic Acid|valproic acid|mesh-list
56689271|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
56689272|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689273|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689274|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
56689275|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689276|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689300|NCT02603679|Goserelin|goserelin|mesh-list
56689301|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56689302|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56689303|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689304|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
56689305|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
56689306|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
56689307|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689308|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56689309|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689310|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56689311|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
56689312|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689313|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689314|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56689315|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56689316|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56689317|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56689318|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56689319|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
56689320|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
56689321|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689322|NCT02605434|Levodopa|levodopa|mesh-list
56689323|NCT02605434|Carbidopa|carbidopa|mesh-list
56689324|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56689325|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56689326|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56689346|NCT05758298|Cholinergic Agents|cholinergic agents|mesh-ancestor
56689347|NCT05758298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689348|NCT05758298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689349|NCT00789321|Amlodipine|amlodipine|mesh-list
56689350|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56689351|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56689352|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56689353|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689354|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56689355|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689356|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
56689357|NCT00811928|Fluconazole|fluconazole|mesh-list
56689358|NCT00811928|Posaconazole|posaconazole|mesh-list
56689359|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
56689360|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689361|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56689362|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56689363|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400533|NCT04690309|Insulin|insulin|mesh-list
56689364|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689365|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56689366|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
56689367|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689368|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689369|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56689370|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56689374|NCT00448669|Tenofovir|tenofovir|mesh-list
56689389|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56689390|NCT00591734|Growth Substances|growth substances|mesh-ancestor
56689391|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689392|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
56689393|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689394|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
56689395|NCT00848549|Carbamazepine|carbamazepine|mesh-list
56689396|NCT00848549|Zonisamide|zonisamide|mesh-list
56689397|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
56689398|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
56689399|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56689400|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689401|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689402|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56689403|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56689404|NCT00848549|Analgesics|analgesics|mesh-ancestor
56689405|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
56689406|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689407|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56689408|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56689409|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689410|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56689411|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56689412|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56689413|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56689414|NCT00788151|Vaccines|vaccines|mesh-list
56689415|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56689416|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
56689417|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689418|NCT04116359|Cisplatin|cisplatin|mesh-list
56689419|NCT04116359|Etoposide|etoposide|mesh-list
56689432|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
56689433|NCT04118153|Abatacept|abatacept|mesh-list
56689434|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56689435|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689436|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400611|NCT02924974|Lidocaine|lidocaine|mesh-list
56689437|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689438|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
56689439|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689440|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689441|NCT00848393|Fentanyl|fentanyl|mesh-list
56689442|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
56689443|NCT00848393|Citric Acid|citric acid|mesh-list
56689444|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
56689445|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56689446|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689447|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689448|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56689449|NCT00848393|Analgesics|analgesics|mesh-ancestor
56689450|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
56689451|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689452|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56689453|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56689454|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56689455|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
56689456|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689458|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56689481|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56689482|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
56689483|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689484|NCT00787917|Omalizumab|omalizumab|mesh-list
56689485|NCT00787917|Itraconazole|itraconazole|mesh-list
56689486|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
56689487|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689488|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56689489|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56689490|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689491|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689492|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56689493|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
56689494|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689495|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689496|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56689497|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56689498|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56689499|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
56689500|NCT05758064|Dydrogesterone|dydrogesterone|mesh-list
56689501|NCT05758064|Progestins|progestins|mesh-ancestor
56689502|NCT05758064|Hormones|hormones|mesh-ancestor
56689503|NCT05758064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689504|NCT05758064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689505|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56689506|NCT00829244|Hormones|hormones|mesh-ancestor
56689507|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689509|NCT00787605|Amlodipine|amlodipine|mesh-list
56689525|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56689526|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56689527|NCT00448591|Growth Substances|growth substances|mesh-ancestor
56689528|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689529|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
56689530|NCT00787527|Prednisone|prednisone|mesh-list
56689531|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
56689532|NCT00787527|Doxorubicin|doxorubicin|mesh-list
56689533|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56689534|NCT00787527|Vincristine|vincristine|mesh-list
56689535|NCT00787527|Vorinostat|vorinostat|mesh-list
56689536|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689537|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
56689538|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689539|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689540|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56689541|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
56689542|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689543|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689544|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56689545|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56689546|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56689547|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56689548|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689549|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689550|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
56689551|NCT00787527|Hormones|hormones|mesh-ancestor
56689575|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56689576|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689577|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689578|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56689579|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56689580|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56689581|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
56689582|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
56689583|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689584|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689585|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
56400750|NCT02923258|Docetaxel|docetaxel|mesh-list
56689586|NCT00448435|Fluticasone|fluticasone|mesh-list
56689587|NCT00448435|Xhance|xhance|mesh-list
56689588|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56689589|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56689590|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689591|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56689592|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
56689593|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689594|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689595|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56689628|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56689629|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
56689630|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
56689631|NCT02602743|Analgesics|analgesics|mesh-ancestor
56689632|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
56689633|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689634|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56689635|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56689636|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56689637|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689638|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689639|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56689640|NCT02602743|Narcotics|narcotics|mesh-ancestor
56689641|NCT00807118|Fesoterodine|fesoterodine|mesh-list
56689642|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56689643|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56689644|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
56689645|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689646|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689647|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689648|NCT00807118|Urological Agents|urological agents|mesh-ancestor
56689649|NCT00448279|Trastuzumab|trastuzumab|mesh-list
56689650|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56689651|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689652|NCT00804856|Cytarabine|cytarabine|mesh-list
56689653|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56689654|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
56689655|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689656|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689657|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
56689658|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689659|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689670|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689671|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689672|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
56689673|NCT00807196|Rituximab|rituximab|mesh-list
56689674|NCT00807196|Fludarabine|fludarabine|mesh-list
56689675|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689676|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
56689677|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689678|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689679|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56689680|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
56689681|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689682|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689683|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56689684|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56689685|NCT00448123|Tamsulosin|tamsulosin|mesh-list
56689686|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56689687|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56689688|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56689689|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
56689690|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689691|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689692|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689693|NCT00448123|Urological Agents|urological agents|mesh-ancestor
56689694|NCT00804934|Ranibizumab|ranibizumab|mesh-list
56689695|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56689696|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56689697|NCT00804934|Growth Substances|growth substances|mesh-ancestor
56689714|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
56689715|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689716|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689717|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689718|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689719|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56689720|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689721|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689722|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
56689723|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689724|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56689725|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56689726|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56689727|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
56689728|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56689729|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56689730|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
56689731|NCT00810862|Lactitol|lactitol|mesh-list
56689732|NCT00810862|Cathartics|cathartics|mesh-ancestor
56689733|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56689734|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56689765|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56689766|NCT00651118|Fluticasone|fluticasone|mesh-list
56689767|NCT00651118|Xhance|xhance|mesh-list
56689768|NCT00651118|Azelastine|azelastine|mesh-list
56689769|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689770|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56689771|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
56689772|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689773|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689774|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56689775|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
56689776|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
56689777|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56689778|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56689779|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689780|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689781|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56689782|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56689783|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
56689784|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
56689785|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689786|NCT00447265|Etanercept|etanercept|mesh-list
56689787|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56689788|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56689789|NCT00447265|Analgesics|analgesics|mesh-ancestor
56689790|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
56689791|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689792|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689793|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56689794|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689795|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56689796|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56689797|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
56689798|NCT03641755|Olaparib|olaparib|mesh-list
56689799|NCT03641755|Sapacitabine|sapacitabine|mesh-list
56689805|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
56689806|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
56689807|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689808|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689809|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
56689810|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689811|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56689812|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56689813|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56689814|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56689815|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689816|NCT00457639|Cholic Acids|cholic acids|mesh-list
56689817|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56689818|NCT00800202|Paclitaxel|paclitaxel|mesh-list
56689819|NCT00800202|Bevacizumab|bevacizumab|mesh-list
56689820|NCT00800202|Carboplatin|carboplatin|mesh-list
56689821|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56689822|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56689823|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689824|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
56689825|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
56689826|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
56689827|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689828|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56689829|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56689830|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56689831|NCT00800202|Growth Substances|growth substances|mesh-ancestor
56689832|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689833|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
56689834|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56689835|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689847|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56689848|NCT05146804|Sulforaphane|sulforaphane|mesh-list
56689849|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56689850|NCT05146804|Protective Agents|protective agents|mesh-ancestor
56689851|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689852|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689853|NCT00655486|Lacosamide|lacosamide|mesh-list
56689854|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
56689855|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56689856|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56689857|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56689858|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689859|NCT04111302|Dezocine|dezocine|mesh-list
56689860|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56689861|NCT04111302|Narcotics|narcotics|mesh-ancestor
56689862|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689863|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689864|NCT04111302|Analgesics|analgesics|mesh-ancestor
56689865|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
56689866|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689867|NCT04111848|Ketamine|ketamine|mesh-list
56689868|NCT04111848|Analgesics|analgesics|mesh-ancestor
56689869|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
56689870|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689871|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689872|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56689873|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56689874|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
56689875|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
56689876|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689878|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56689889|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56689890|NCT00654940|Pregabalin|pregabalin|mesh-list
56689891|NCT00654940|Analgesics|analgesics|mesh-ancestor
56689892|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
56689893|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689894|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689895|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
56689896|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56689897|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56689898|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689899|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56689900|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56689901|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56689902|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56689903|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56689904|NCT00588666|Gemcitabine|gemcitabine|mesh-list
56689905|NCT00588666|Bevacizumab|bevacizumab|mesh-list
56689906|NCT00588666|Carboplatin|carboplatin|mesh-list
56689907|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56689908|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689909|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56689911|NCT00588666|Growth Substances|growth substances|mesh-ancestor
56689940|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56689941|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56689942|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56689943|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56689944|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
56689945|NCT01019785|Vitamin D|vitamin d|mesh-list
56689946|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56689947|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689948|NCT01019785|Vitamins|vitamins|mesh-ancestor
56689949|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
56689950|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56689951|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
56689952|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56689953|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56689954|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689955|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
56689956|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56689957|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689958|NCT01024543|Phenylephrine|phenylephrine|mesh-list
56401151|NCT04865029|Estradiol|estradiol|mesh-list
56689960|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
56689961|NCT01024543|Giapreza|giapreza|mesh-list
56689962|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
56689963|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56689964|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
56689965|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
56689966|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56689967|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56689968|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
56689969|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56689986|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689987|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56689988|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56689989|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689990|NCT00811408|Cidofovir|cidofovir|mesh-list
56689991|NCT00811408|Carboplatin|carboplatin|mesh-list
56689992|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56689993|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
56689994|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56689995|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56689996|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56689997|NCT00446797|Celecoxib|celecoxib|mesh-list
56689998|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56689999|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56690000|NCT00446797|Analgesics|analgesics|mesh-ancestor
56690001|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
56690002|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690003|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690040|NCT04114188|Prednisolone|prednisolone|mesh-list
56690041|NCT04114188|Infliximab|infliximab|mesh-list
56690042|NCT04114188|Tacrolimus|tacrolimus|mesh-list
56690043|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
56690044|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56690045|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
56690046|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56690047|NCT04114188|Antibodies|antibodies|mesh-list
56690048|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690049|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
56690050|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690051|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56690052|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690053|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690054|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690055|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
56690101|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56690102|NCT00446641|Protective Agents|protective agents|mesh-ancestor
56690103|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56690104|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56690105|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690106|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56690107|NCT00646282|Vitamins|vitamins|mesh-ancestor
56690108|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
56690109|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690110|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56690111|NCT00792636|Naproxen|naproxen|mesh-list
56690112|NCT00792636|Sumatriptan|sumatriptan|mesh-list
56690113|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56690114|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56690115|NCT00792636|Analgesics|analgesics|mesh-ancestor
56690116|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
56690117|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690118|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690119|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690120|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690121|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
56690122|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56690123|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690124|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690125|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56690126|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56690130|NCT00446563|Losartan|losartan|mesh-list
56690148|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56690149|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690150|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56690151|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690152|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56690153|NCT00863057|Methadone|methadone|mesh-list
56690154|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56690155|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56690156|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56690157|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690158|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690159|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690208|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690209|NCT00808054|Lidocaine|lidocaine|mesh-list
56690210|NCT00808054|Prilocaine|prilocaine|mesh-list
56690211|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
56690212|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
56690213|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690214|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690215|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
56690216|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690217|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56690218|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56690219|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56690220|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56690221|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690222|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
56690223|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
56690224|NCT00814528|Imiquimod|imiquimod|mesh-list
56690225|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56690226|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
56690227|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690228|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690229|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
56690230|NCT00814606|Ribavirin|ribavirin|mesh-list
56690231|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56690232|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
56690233|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690234|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
56690235|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690236|NCT00814762|Vaccines|vaccines|mesh-list
56690237|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
56690238|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690239|NCT05652660|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56690240|NCT05652660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56690241|NCT05652660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56690242|NCT05652660|Antimetabolites|antimetabolites|mesh-ancestor
56690247|NCT00654238|Sorafenib|sorafenib|mesh-list
56690248|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690249|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56690250|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690251|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690252|NCT00862979|Cyclosporine|cyclosporine|mesh-list
56690253|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
56690254|NCT00862979|Everolimus|everolimus|mesh-list
56690255|NCT00862979|Tacrolimus|tacrolimus|mesh-list
56690256|NCT00862979|Cyclosporins|cyclosporins|mesh-list
56690257|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690258|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
56690259|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690260|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56690261|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690262|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690263|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
56690264|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690265|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690266|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690267|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690268|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56690269|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56690270|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
56690271|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56690272|NCT02605356|Dexamethasone|dexamethasone|mesh-list
56690274|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56690275|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690276|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
56690277|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
56690278|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690293|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690294|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690295|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56690296|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56690297|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56690298|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690299|NCT04113954|Prilocaine|prilocaine|mesh-list
56690300|NCT04113954|Mepivacaine|mepivacaine|mesh-list
56690301|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
56690302|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
56690303|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690304|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690305|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
56690306|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690307|NCT00812344|Ketoconazole|ketoconazole|mesh-list
56690308|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
56690309|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690310|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56690311|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56690312|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690313|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690314|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56690315|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
56690316|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690317|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690318|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56690319|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
56690320|NCT00446251|Rituximab|rituximab|mesh-list
56690321|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56690322|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690323|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
56690324|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690325|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690331|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690332|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690333|NCT00812422|Ibuprofen|ibuprofen|mesh-list
56690334|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56690335|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56690337|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
56690338|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690339|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690340|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690341|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690342|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56690343|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690344|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690345|NCT04110834|Itraconazole|itraconazole|mesh-list
56690346|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56690347|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
56690348|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690349|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56690350|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56690351|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690352|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690353|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56690354|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
56690356|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690379|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
56690380|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690381|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690382|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56690383|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56690384|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690385|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
56690386|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56690387|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690388|NCT02551276|Albuterol|albuterol|mesh-list
56690389|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56690390|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
56690391|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690392|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690393|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56690394|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
56690395|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
56690396|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56690397|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56690398|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56690399|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56690400|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
56690401|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690402|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690425|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56690426|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56690427|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56690428|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690429|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
56690430|NCT04117919|Hormones|hormones|mesh-ancestor
56690431|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690432|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690433|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690434|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
56690435|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690436|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690437|NCT00701285|Pravastatin|pravastatin|mesh-list
56690438|NCT00701285|Pitavastatin|pitavastatin|mesh-list
56690439|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56690440|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56690441|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
56690442|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690443|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56690444|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56690445|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690446|NCT00700037|Atorvastatin|atorvastatin|mesh-list
56690447|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56690448|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56690449|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
56690450|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690451|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56690452|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56690454|NCT00815542|Dinoprostone|dinoprostone|mesh-list
56690469|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690470|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
56690471|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
56690472|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690473|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690474|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56690475|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56690476|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
56690477|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690478|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56401653|NCT00535951|Panobinostat|panobinostat|mesh-list
56690479|NCT04110132|Bupivacaine|bupivacaine|mesh-list
56690480|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
56690481|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
56690482|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690483|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690484|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
56690529|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56690530|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56690531|NCT02604420|Eculizumab|eculizumab|mesh-list
56690532|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56690533|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690534|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
56690535|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690536|NCT04110210|Morphine|morphine|mesh-list
56690537|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56690538|NCT04110210|Narcotics|narcotics|mesh-ancestor
56690539|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690540|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690541|NCT04110210|Analgesics|analgesics|mesh-ancestor
56690542|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
56690543|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690544|NCT00647296|Pramipexole|pramipexole|mesh-list
56690545|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
56690546|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690547|NCT00647296|Protective Agents|protective agents|mesh-ancestor
56690548|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690549|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56690550|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56690551|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
56690552|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
56690553|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690554|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56690555|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
56690556|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690558|NCT00646906|Acetaminophen|acetaminophen|mesh-list
56690559|NCT00646906|Ibuprofen|ibuprofen|mesh-list
56690560|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56690574|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
56690575|NCT00813436|Oxytocin|oxytocin|mesh-list
56690576|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
56690577|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56690578|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690579|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56690580|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56690581|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56690582|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
56690583|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690584|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56690585|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56690586|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690587|NCT00815854|Folic Acid|folic acid|mesh-list
56690588|NCT00815854|Hematinics|hematinics|mesh-ancestor
56690589|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
56690590|NCT00815854|Vitamins|vitamins|mesh-ancestor
56690591|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
56690592|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690593|NCT00817648|Risperidone|risperidone|mesh-list
56690594|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56690595|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56690596|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
56690597|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690598|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690599|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690600|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56690601|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56690602|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690603|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56690604|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56690605|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
56690606|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
56690607|NCT00829010|Vaccines|vaccines|mesh-list
56690608|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56690609|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
56690610|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690611|NCT00644332|Ranolazine|ranolazine|mesh-list
56690612|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56690613|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56690614|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690615|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
56690616|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
56690617|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56690618|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56690619|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690620|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690621|NCT00808912|Urological Agents|urological agents|mesh-ancestor
56690622|NCT02551042|Factor VIII|factor viii|mesh-list
56690623|NCT02551042|Coagulants|coagulants|mesh-ancestor
56690624|NCT00445939|Adalimumab|adalimumab|mesh-list
56690625|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690626|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690627|NCT00816244|Atorvastatin|atorvastatin|mesh-list
56690628|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56690629|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56690630|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
56401802|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56690631|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690632|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56690633|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56690634|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690635|NCT00817960|Methylphenidate|methylphenidate|mesh-list
56690636|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56690637|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690638|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56690639|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56690640|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56690653|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56690654|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
56690655|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
56690656|NCT00482053|Carmustine|carmustine|mesh-list
56690657|NCT00482053|Rituximab|rituximab|mesh-list
56690658|NCT00482053|Etoposide|etoposide|mesh-list
56690659|NCT00482053|Cyclosporins|cyclosporins|mesh-list
56690660|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56690661|NCT00482053|Lenograstim|lenograstim|mesh-list
56690662|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690663|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
56690664|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690665|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56690666|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56690667|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
56690668|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690669|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690670|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56690671|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56690672|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56690673|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56690674|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56690675|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690676|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56690677|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
56690678|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690679|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690680|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56690681|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56690682|NCT00482053|Analgesics|analgesics|mesh-ancestor
56690683|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
56690684|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690685|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
56690686|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56690687|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56690688|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
56690689|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56246377|NCT01825720|Insulin|insulin|mesh-list
56474429|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56106171|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
56690690|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690691|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
56690692|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
56690693|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56690694|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
56690695|NCT00482053|Hormones|hormones|mesh-ancestor
56690696|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690697|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56690698|NCT00482053|Protective Agents|protective agents|mesh-ancestor
56690699|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56690700|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56690701|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56690702|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56690703|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
56690704|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
56690705|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56690706|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
56690708|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56690709|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56690710|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
56690711|NCT00455923|Fluticasone|fluticasone|mesh-list
56690712|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56690713|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56690714|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
56690715|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690716|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690717|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56690718|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
56690719|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
56690720|NCT00455923|Hormones|hormones|mesh-ancestor
56690726|NCT00642616|Insulin|insulin|mesh-list
56690736|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
56690737|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690738|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690739|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56690740|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56690741|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690742|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56690743|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
56690744|NCT00809068|Hormones|hormones|mesh-ancestor
56690745|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56690746|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56690747|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
56690748|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
56690749|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56690750|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56690751|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690752|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690753|NCT01027117|Urological Agents|urological agents|mesh-ancestor
56690754|NCT03995563|Dexamethasone|dexamethasone|mesh-list
56690755|NCT03995563|Ropivacaine|ropivacaine|mesh-list
56690756|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690757|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
56690758|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
56690759|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56690760|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690761|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56690762|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
56690763|NCT03995563|Hormones|hormones|mesh-ancestor
56690771|NCT04122625|Nivolumab|nivolumab|mesh-list
56690781|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56690783|NCT00445003|Growth Substances|growth substances|mesh-ancestor
56690784|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690785|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
56690786|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690787|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690788|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
56690789|NCT00445003|Hormones|hormones|mesh-ancestor
56690790|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690791|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690792|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
56690793|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690794|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690795|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56690796|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56690797|NCT00642460|Methotrexate|methotrexate|mesh-list
56690798|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56690799|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
56690800|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56690801|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690802|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56690803|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
56690804|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690805|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690806|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
56690807|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690828|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
56690829|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56690901|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56690902|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690903|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56690904|NCT00641056|Incretins|incretins|mesh-ancestor
56690905|NCT00641056|Hormones|hormones|mesh-ancestor
56690906|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690907|NCT00569374|Modafinil|modafinil|mesh-list
56690908|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56690909|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690910|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56690911|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56690912|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56690913|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690914|NCT00828464|Clobetasol|clobetasol|mesh-list
56690915|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56690916|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
56690917|NCT00828464|Hormones|hormones|mesh-ancestor
56690918|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56690919|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690921|NCT00816712|Testosterone|testosterone|mesh-list
56690956|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56690957|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56690958|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690959|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690960|NCT00818350|Sunitinib|sunitinib|mesh-list
56690961|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56690962|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56690963|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56690964|NCT00818350|Growth Substances|growth substances|mesh-ancestor
56690965|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56690966|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
56690967|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56690968|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56690969|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56690970|NCT00810602|Vorinostat|vorinostat|mesh-list
56690971|NCT00810602|Tacrolimus|tacrolimus|mesh-list
56690972|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56690973|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
56690975|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56691010|NCT00821392|Febuxostat|febuxostat|mesh-list
56691011|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
56691012|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691013|NCT00591578|Valsartan|valsartan|mesh-list
56691014|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56691015|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56691016|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56691017|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56691018|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691019|NCT00797862|Amlodipine|amlodipine|mesh-list
56691020|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56691021|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56691022|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56691023|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691024|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691025|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56691026|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691027|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
56691028|NCT00797862|Diuretics|diuretics|mesh-ancestor
56691029|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
56691030|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56691031|NCT00817258|Cisplatin|cisplatin|mesh-list
56691032|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691033|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
56691034|NCT00794820|Rituximab|rituximab|mesh-list
56691035|NCT00794820|Fludarabine|fludarabine|mesh-list
56691036|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
56691037|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56691038|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
56691039|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691040|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691054|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691055|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
56691056|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
56691057|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
56691058|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691059|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56691060|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
56691061|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691062|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691063|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56691064|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
56691065|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56691066|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56691067|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56691068|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56691069|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691070|NCT05227742|Psilocybin|psilocybin|mesh-list
56691071|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
56691072|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691073|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691074|NCT00818584|Micafungin|micafungin|mesh-list
56691075|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
56691076|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691077|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56691078|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691079|NCT00923000|Morphine|morphine|mesh-list
56691080|NCT00923000|Nalbuphine|nalbuphine|mesh-list
56691081|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56691082|NCT00923000|Narcotics|narcotics|mesh-ancestor
56691083|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691084|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691085|NCT00923000|Analgesics|analgesics|mesh-ancestor
56691086|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
56691087|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691088|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
56691089|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691090|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
56691094|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56691095|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
56691096|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691097|NCT00913952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56691098|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56691099|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691100|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691101|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691102|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
56691103|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691104|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
56691105|NCT04581382|Nivolumab|nivolumab|mesh-list
56691106|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56691107|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691108|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56691109|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691110|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56691111|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56691112|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56691113|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691114|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
56691115|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
56691116|NCT03840811|Cefixime|cefixime|mesh-list
56691117|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56691118|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691119|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56691120|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56691121|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691122|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691123|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691126|NCT05755334|Ropivacaine|ropivacaine|mesh-list
56691136|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691137|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691138|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56691139|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56691140|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56691141|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691142|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691143|NCT00640510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56691144|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56691145|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691146|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691147|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691148|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
56691149|NCT00913718|Fluoxetine|fluoxetine|mesh-list
56691150|NCT00913718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56691151|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56402331|NCT00157859|Renal Agents|renal agents|mesh-ancestor
56691152|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691153|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691154|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691155|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
56691156|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691157|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56691158|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
56691159|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691160|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56691161|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56691162|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691163|NCT00813800|Varenicline|varenicline|mesh-list
56691164|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56691165|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56691166|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
56691167|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691173|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56691174|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56691175|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691176|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691177|NCT00794664|Mipomersen|mipomersen|mesh-list
56691178|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56691179|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56691180|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
56691181|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691182|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56691183|NCT00444535|Bevacizumab|bevacizumab|mesh-list
56691184|NCT00444535|Lapatinib|lapatinib|mesh-list
56691185|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56691186|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691187|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56691188|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56691189|NCT00444535|Growth Substances|growth substances|mesh-ancestor
56691190|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691191|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
56691192|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56691193|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691194|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691195|NCT04110288|Paclitaxel|paclitaxel|mesh-list
56691196|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56691197|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691198|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
56691199|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
56691200|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
56691201|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691202|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
56691204|NCT00826306|Protective Agents|protective agents|mesh-ancestor
56691216|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691217|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56691218|NCT00821782|Renal Agents|renal agents|mesh-ancestor
56691219|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56691220|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56691221|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691222|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691223|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691224|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56402407|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
56691225|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56691226|NCT00847613|Tofacitinib|tofacitinib|mesh-list
56691227|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56691228|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691229|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691230|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
56691231|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691232|NCT00807092|Insulin|insulin|mesh-list
56691233|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56691234|NCT00807092|Metformin|metformin|mesh-list
56691235|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
56691236|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
56691237|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56691238|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56691239|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691240|NCT04112550|Acetaminophen|acetaminophen|mesh-list
56691241|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56691242|NCT04112550|Oxycodone|oxycodone|mesh-list
56691243|NCT04112550|Methadone|methadone|mesh-list
56691258|NCT00640042|Morphine|morphine|mesh-list
56691259|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56691260|NCT00640042|Narcotics|narcotics|mesh-ancestor
56691261|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691262|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691263|NCT00640042|Analgesics|analgesics|mesh-ancestor
56691264|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
56691265|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691266|NCT00807014|Adapalene|adapalene|mesh-list
56691267|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56691268|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56691269|NCT00807014|Analgesics|analgesics|mesh-ancestor
56691270|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
56691271|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691272|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691273|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56691274|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691275|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
56691276|NCT00794040|Methylphenidate|methylphenidate|mesh-list
56691277|NCT00794040|Citalopram|citalopram|mesh-list
56691278|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56691279|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691280|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56691281|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56691282|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691283|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691284|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
56691285|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691286|NCT00794040|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56691287|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
56691288|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56691302|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691303|NCT00813488|Fentanyl|fentanyl|mesh-list
56691304|NCT00813488|Oxycodone|oxycodone|mesh-list
56691305|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56691306|NCT00813488|Narcotics|narcotics|mesh-ancestor
56691307|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691308|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691309|NCT00813488|Analgesics|analgesics|mesh-ancestor
56691310|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
56691311|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691312|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56691313|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56691314|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
56691315|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
56691316|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56691317|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56691318|NCT00797316|Diuretics|diuretics|mesh-ancestor
56691319|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
56691320|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691321|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56691322|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691323|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691324|NCT05640336|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56691325|NCT05640336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56691326|NCT05640336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691327|NCT05640336|Antitubercular Agents|antitubercular agents|mesh-ancestor
56691328|NCT05753696|Losartan|losartan|mesh-list
56691329|NCT05753696|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56691330|NCT05753696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56691331|NCT05753696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56691332|NCT05753696|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56691333|NCT05753696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56691334|NCT05753696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474430|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56474431|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56474432|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56474433|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474434|NCT04692285|Zolpidem|zolpidem|mesh-list
56474435|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56474436|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56691335|NCT04107480|Dopamine|dopamine|mesh-list
56691336|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
56691337|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56691338|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
56691339|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
56691340|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691341|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691342|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
56691343|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691344|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691345|NCT04107480|Protective Agents|protective agents|mesh-ancestor
56691346|NCT05753618|Lenograstim|lenograstim|mesh-list
56691347|NCT05753618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56691348|NCT05753618|Immunologic Factors|immunologic factors|mesh-ancestor
56691349|NCT05753618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691350|NCT00915408|Dexamethasone|dexamethasone|mesh-list
56691351|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
56691352|NCT00915408|Lenalidomide|lenalidomide|mesh-list
56691353|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56691354|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
56691355|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691356|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691357|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56691358|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
56691359|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691360|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691361|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56691362|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56691363|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
56691364|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
56691365|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691366|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56691367|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
56691368|NCT00915408|Hormones|hormones|mesh-ancestor
56691369|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691370|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56691371|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56691372|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56691373|NCT00915408|Growth Substances|growth substances|mesh-ancestor
56691374|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
56691375|NCT05573724|Itraconazole|itraconazole|mesh-list
56691376|NCT05573724|Antifungal Agents|antifungal agents|mesh-ancestor
56691377|NCT05573724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691378|NCT05573724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56691379|NCT05573724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56691380|NCT05573724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691381|NCT05573724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691382|NCT05573724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56691383|NCT05573724|Hormone Antagonists|hormone antagonists|mesh-ancestor
56691384|NCT05573724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691385|NCT05573724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691386|NCT05573724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56691387|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56691388|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
56691389|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56691390|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
56691391|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56691392|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691393|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56691398|NCT00791076|Hormones|hormones|mesh-ancestor
56691419|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56691420|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
56691421|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691422|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691423|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56691424|NCT00625378|Sorafenib|sorafenib|mesh-list
56691425|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691426|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56691427|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691428|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691429|NCT00806624|Warfarin|warfarin|mesh-list
56691430|NCT00806624|Edoxaban|edoxaban|mesh-list
56691431|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
56691432|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56691433|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
56691434|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56691435|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
56691436|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691437|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691438|NCT00624832|Omalizumab|omalizumab|mesh-list
56691439|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56691440|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56691441|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
56474437|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56474438|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474439|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56474440|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
56474441|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
56474442|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474443|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474444|NCT00509015|Artesunate|artesunate|mesh-list
56474445|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
56474446|NCT00509015|Primaquine|primaquine|mesh-list
56474447|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
56474448|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56474449|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
56474450|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56474451|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56474452|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474453|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474454|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
56474455|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
56474456|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56474457|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
56474458|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56474459|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474460|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474461|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56474462|NCT00509015|Renal Agents|renal agents|mesh-ancestor
56474463|NCT00528060|Ritonavir|ritonavir|mesh-list
56474464|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56474465|NCT00528060|Tenofovir|tenofovir|mesh-list
56474466|NCT00528060|Emtricitabine|emtricitabine|mesh-list
56106705|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56691442|NCT05753150|Primaquine|primaquine|mesh-list
56691443|NCT05753150|Tafenoquine|tafenoquine|mesh-list
56691444|NCT05753150|Antimalarials|antimalarials|mesh-ancestor
56691445|NCT05753150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56691446|NCT05753150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56691447|NCT05753150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691448|NCT00826852|Carboplatin|carboplatin|mesh-list
56691449|NCT00826852|Docetaxel|docetaxel|mesh-list
56691450|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691451|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
56691452|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
56691453|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
56691454|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691455|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
56691456|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
56691457|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691458|NCT00826930|Protective Agents|protective agents|mesh-ancestor
56691459|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691460|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56691461|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691463|NCT00913796|Diuretics|diuretics|mesh-ancestor
56691498|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56691499|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56691500|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691501|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691502|NCT02608112|Methotrexate|methotrexate|mesh-list
56691503|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56691504|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
56691505|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56691506|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691507|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56691508|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
56691509|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691510|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691511|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
56691512|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691513|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56691514|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56691515|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
56691516|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691517|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56691518|NCT04375384|Cetuximab|cetuximab|mesh-list
56691519|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56691520|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691521|NCT02549326|Vitamin D|vitamin d|mesh-list
56691522|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
56691523|NCT02549326|Vitamins|vitamins|mesh-ancestor
56691524|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
56691525|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691526|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56691542|NCT00819676|Protective Agents|protective agents|mesh-ancestor
56691543|NCT00827320|Levetiracetam|levetiracetam|mesh-list
56691544|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
56691545|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
56691546|NCT00819754|Bevacizumab|bevacizumab|mesh-list
56691547|NCT00819754|Capecitabine|capecitabine|mesh-list
56691548|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
56691549|NCT00819754|Irinotecan|irinotecan|mesh-list
56691550|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56691551|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691552|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56691553|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56691554|NCT00819754|Growth Substances|growth substances|mesh-ancestor
56691555|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691556|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
56691557|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56691558|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
56691559|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691560|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56691561|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56691562|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691563|NCT04563520|Coagulants|coagulants|mesh-list
56691564|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
56691565|NCT00819988|Pregabalin|pregabalin|mesh-list
56691566|NCT00819988|Analgesics|analgesics|mesh-ancestor
56691567|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
56691568|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691569|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691590|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691591|NCT00700193|Vaccines|vaccines|mesh-list
56691592|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
56691593|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691594|NCT00846521|Acarbose|acarbose|mesh-list
56691595|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56691596|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691597|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691598|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56691599|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691600|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56691601|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56691602|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56691603|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56691604|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56691605|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
56691606|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56691607|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691608|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691609|NCT00862823|Tenofovir|tenofovir|mesh-list
56691610|NCT00862823|Emtricitabine|emtricitabine|mesh-list
56691611|NCT00862823|Efavirenz|efavirenz|mesh-list
56691612|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
56691613|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691614|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56691615|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56691616|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691617|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691618|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56691619|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56691620|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56691621|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56691622|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56691623|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56691624|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56691625|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56691626|NCT00790842|Dexamethasone|dexamethasone|mesh-list
56691627|NCT00790842|Lenalidomide|lenalidomide|mesh-list
56691628|NCT00790842|Heparin|heparin|mesh-list
56691629|NCT00790842|Calcium heparin|calcium heparin|mesh-list
56691630|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56691631|NCT00790842|Tinzaparin|tinzaparin|mesh-list
56691632|NCT00790842|Dalteparin|dalteparin|mesh-list
56691633|NCT00790842|Anticoagulants|anticoagulants|mesh-list
56691634|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56691635|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
56691636|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
56691637|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691638|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691639|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56691640|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
56691641|NCT00790842|Hormones|hormones|mesh-ancestor
56691642|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691643|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56691644|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691653|NCT04104204|Morphine|morphine|mesh-list
56691683|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691684|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56691685|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691686|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56691687|NCT00574288|Protective Agents|protective agents|mesh-ancestor
56691688|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
56691692|NCT00790452|Aspirin|aspirin|mesh-list
56691693|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56691694|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56691695|NCT00790452|Analgesics|analgesics|mesh-ancestor
56691696|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
56691697|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691698|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691699|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56691700|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691701|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56691702|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56691703|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691704|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56691705|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56691706|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691707|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
56691708|NCT00823030|Lidocaine|lidocaine|mesh-list
56691709|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
56691710|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
56691711|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691712|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691713|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
56691714|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691715|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56691725|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
56691726|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691727|NCT00626392|Aspirin|aspirin|mesh-list
56691728|NCT00626392|Niacin|niacin|mesh-list
56691729|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56691730|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56691731|NCT00626392|Analgesics|analgesics|mesh-ancestor
56691732|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
56691733|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691734|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691735|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56691736|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691737|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56691738|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56691739|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691740|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56691741|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56691742|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691743|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
56691744|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56691745|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
56691746|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56691747|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
56691748|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
56691749|NCT00626392|Vitamins|vitamins|mesh-ancestor
56691750|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
56691751|NCT00820690|Paclitaxel|paclitaxel|mesh-list
56691774|NCT00624052|Telmisartan|telmisartan|mesh-list
56691775|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56691776|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56691777|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691778|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691779|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56691780|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691781|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
56691782|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56691783|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56691784|NCT00821080|Sirolimus|sirolimus|mesh-list
56691785|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56691786|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691787|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56691788|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691789|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
56691790|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56691791|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
56691792|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691793|NCT04044430|Nivolumab|nivolumab|mesh-list
56691794|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56691795|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691796|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56691797|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691798|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56691799|NCT00821158|Antioxidants|antioxidants|mesh-list
56691800|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691801|NCT00821158|Protective Agents|protective agents|mesh-ancestor
56691802|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691803|NCT02548936|Simvastatin|simvastatin|mesh-list
56691804|NCT02548936|Ezetimibe|ezetimibe|mesh-list
56691805|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56691806|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56691811|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56691812|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691813|NCT00828802|Lenalidomide|lenalidomide|mesh-list
56691814|NCT00828802|Decitabine|decitabine|mesh-list
56691815|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
56691816|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691817|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56691818|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56691819|NCT00828802|Growth Substances|growth substances|mesh-ancestor
56691820|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
56691821|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691822|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56691823|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
56691824|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691825|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691826|NCT00785577|Pregabalin|pregabalin|mesh-list
56691827|NCT00785577|Analgesics|analgesics|mesh-ancestor
56691828|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
56691829|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691830|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691831|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
56691832|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56691833|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56691834|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691835|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56691836|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56691837|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56691838|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691839|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691840|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
56691841|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56691842|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
56691843|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691844|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
56691850|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691851|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691852|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56691853|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56691854|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56691855|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56691856|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56691857|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
56691858|NCT02548780|Doxorubicin|doxorubicin|mesh-list
56691859|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56691860|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691861|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56691862|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56691863|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691864|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691865|NCT04105023|Genistein|genistein|mesh-list
56691866|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56691867|NCT04105023|Protective Agents|protective agents|mesh-ancestor
56691868|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691904|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56691905|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56691906|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
56691907|NCT02550418|Budesonide|budesonide|mesh-list
56691908|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56691909|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56691910|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
56691911|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56691912|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691913|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56691914|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
56691915|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
56691916|NCT02550418|Hormones|hormones|mesh-ancestor
56691917|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691918|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56691919|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56691920|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56691921|NCT00829114|Estradiol|estradiol|mesh-list
56691922|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56691923|NCT00829114|Estrogens|estrogens|mesh-ancestor
56691924|NCT00829114|Hormones|hormones|mesh-ancestor
56691925|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691926|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691927|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56691928|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
56691929|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56691930|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56691931|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56691932|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56691933|NCT00790296|Hormones|hormones|mesh-list
56691934|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
56691935|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56691945|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56691946|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
56691947|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
56691948|NCT02548468|Fludarabine|fludarabine|mesh-list
56691949|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
56691950|NCT02548468|Tacrolimus|tacrolimus|mesh-list
56691951|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56691952|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
56691953|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56691954|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56691955|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56691956|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
56691957|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691958|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56691959|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56691960|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56691961|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
56691962|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56691963|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56691964|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691965|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56691966|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56691967|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
56691968|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56691969|NCT00829660|Acarbose|acarbose|mesh-list
56691970|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56691971|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691972|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56691975|NCT00915564|Simeprevir|simeprevir|mesh-list
56691991|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
56691992|NCT02603406|Hematinics|hematinics|mesh-ancestor
56691993|NCT04106700|Apixaban|apixaban|mesh-list
56691994|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56691995|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
56691996|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56691997|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
56691998|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56691999|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692000|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
56692001|NCT00831376|Albuterol|albuterol|mesh-list
56692002|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56692003|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
56692004|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692005|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692006|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56692007|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
56692008|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
56692009|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56692010|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56692011|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56692012|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56692013|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
56692014|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692015|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692016|NCT02602470|Metronidazole|metronidazole|mesh-list
56692017|NCT02602470|Azelaic acid|azelaic acid|mesh-list
56692018|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56692033|NCT05567406|Belumosudil|belumosudil|mesh-list
56692038|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
56692039|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56692040|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
56692041|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56692042|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692043|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692044|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692045|NCT00824200|Urological Agents|urological agents|mesh-ancestor
56692046|NCT00829894|Risperidone|risperidone|mesh-list
56692047|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56403238|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
56692048|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
56692049|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692050|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692051|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692052|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56692053|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56692054|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692055|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56692056|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56692057|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
56692058|NCT00622726|Bevacizumab|bevacizumab|mesh-list
56692059|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56692087|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
56692088|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
56692089|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
56692090|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56692091|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
56692092|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56692093|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692094|NCT00832234|Dexamethasone|dexamethasone|mesh-list
56692095|NCT00832234|Rituximab|rituximab|mesh-list
56692096|NCT00832234|Bortezomib|bortezomib|mesh-list
56692097|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56692098|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692099|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
56692100|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692101|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692102|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692103|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
56692104|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
56692105|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692106|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692107|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
56692108|NCT00832234|Hormones|hormones|mesh-ancestor
56692109|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56692110|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56692111|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
56692112|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
56692113|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692114|NCT05036980|Protective Agents|protective agents|mesh-ancestor
56692115|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692116|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56692117|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692118|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56692128|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56692129|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
56692130|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692131|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692132|NCT05565378|Pembrolizumab|pembrolizumab|mesh-list
56692133|NCT05565378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56692134|NCT05565378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692135|NCT04102566|Ibuprofen|ibuprofen|mesh-list
56692136|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56692137|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56692138|NCT04102566|Analgesics|analgesics|mesh-ancestor
56692139|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
56692140|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692141|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692142|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692143|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692144|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56692145|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692146|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692147|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
56692148|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
56692149|NCT04102176|Protective Agents|protective agents|mesh-ancestor
56692150|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692151|NCT00783432|Azelastine|azelastine|mesh-list
56692152|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56692153|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
56692154|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692155|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692156|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56692157|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
56692158|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56692159|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692160|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692161|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56247859|NCT01844674|Vemurafenib|vemurafenib|mesh-list
56474467|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56474468|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56474469|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
56474470|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692162|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56692163|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56692164|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
56692165|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
56692166|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692167|NCT00789360|Loxapine|loxapine|mesh-list
56692168|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56692169|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56692170|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692171|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692172|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56692173|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56692174|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
56692175|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692176|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692177|NCT05526924|Fluorouracil|fluorouracil|mesh-list
56692178|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
56692179|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
56692180|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692181|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56692182|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692183|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56692184|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
56692185|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692186|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
56692187|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692210|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692211|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56692212|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692213|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
56692214|NCT00774852|Hormones|hormones|mesh-ancestor
56692215|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56692216|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56692217|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56692218|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
56692219|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56692220|NCT00774306|Phenytoin|phenytoin|mesh-list
56692221|NCT00774306|Levetiracetam|levetiracetam|mesh-list
56692222|NCT00774306|Valproic Acid|valproic acid|mesh-list
56692223|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
56692224|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
56692225|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692226|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692227|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
56692228|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692229|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692230|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
56692231|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56692232|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692233|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56692234|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56692235|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56692236|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56692237|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56692238|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56692239|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
56692240|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56692241|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
56692252|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692253|NCT00781326|Nimodipine|nimodipine|mesh-list
56692254|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56692255|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56692256|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56692257|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692258|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56692259|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692260|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
56692261|NCT00773838|Dexamethasone|dexamethasone|mesh-list
56692262|NCT00773838|Bortezomib|bortezomib|mesh-list
56692263|NCT00773838|Vorinostat|vorinostat|mesh-list
56692264|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692265|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
56692266|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
56692267|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692268|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692269|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692270|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
56692271|NCT00773838|Hormones|hormones|mesh-ancestor
56692272|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56692273|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56692304|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692305|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692306|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692307|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692308|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56692309|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56692310|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692311|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56692312|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56692313|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692314|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
56692315|NCT00787254|Lansoprazole|lansoprazole|mesh-list
56692316|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
56692317|NCT00787254|Gefarnate|gefarnate|mesh-list
56692318|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56692319|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692320|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56692321|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692322|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692323|NCT00922402|Insulin|insulin|mesh-list
56692324|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56692325|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692326|NCT02550028|Levetiracetam|levetiracetam|mesh-list
56692327|NCT02550028|Phenobarbital|phenobarbital|mesh-list
56692328|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
56692329|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
56692330|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56692331|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692332|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692333|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56692334|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56692335|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692346|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692347|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692348|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
56692349|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692350|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
56692351|NCT00825058|Paroxetine|paroxetine|mesh-list
56692352|NCT00825058|Amibegron|amibegron|mesh-list
56692353|NCT00825058|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56692354|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56692355|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56692356|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692357|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692358|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
56692359|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692360|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56692361|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
56692362|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56692363|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56692401|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692402|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56692403|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
56692404|NCT00838396|Baclofen|baclofen|mesh-list
56692405|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56692406|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692407|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56692408|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692409|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56692410|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
56692411|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
56692412|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692413|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692414|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
56692415|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56692416|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692417|NCT00833326|Docetaxel|docetaxel|mesh-list
56692418|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
56692419|NCT00833326|Mitogens|mitogens|mesh-list
56692420|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692421|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56692422|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56692424|NCT00833404|Nicotine|nicotine|mesh-list
56692455|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56692456|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
56692457|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
56692458|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56692459|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
56692460|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56692461|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56692462|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692463|NCT00853385|Adalimumab|adalimumab|mesh-list
56692464|NCT00853385|Tofacitinib|tofacitinib|mesh-list
56692465|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692466|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692467|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56692468|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692469|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692470|NCT00622336|Lenalidomide|lenalidomide|mesh-list
56692471|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
56692472|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692473|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56692474|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56692475|NCT00622336|Growth Substances|growth substances|mesh-ancestor
56692476|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
56692477|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692478|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56692479|NCT00846365|Olmesartan|olmesartan|mesh-list
56692480|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56692502|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56692503|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56692504|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692505|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692506|NCT02601924|Anesthetics|anesthetics|mesh-list
56692507|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
56692508|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692509|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692510|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
56692511|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692512|NCT00840112|Vitamin E|vitamin e|mesh-list
56692513|NCT00840112|Tocopherols|tocopherols|mesh-list
56692514|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
56692515|NCT00840112|Vitamins|vitamins|mesh-ancestor
56692516|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
56692517|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692560|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692561|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56692562|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692563|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56692564|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56692565|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
56692566|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692567|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56692568|NCT00840346|Panobinostat|panobinostat|mesh-list
56692569|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692570|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56692571|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692572|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692573|NCT04105140|Oxytocin|oxytocin|mesh-list
56692574|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
56692575|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56692576|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692577|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
56692578|NCT00840580|Levofloxacin|levofloxacin|mesh-list
56692579|NCT00840580|Ofloxacin|ofloxacin|mesh-list
56692580|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56692581|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56692582|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56692583|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56692584|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692585|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56692586|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56692587|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692589|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692606|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
56692607|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
56692608|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56692609|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692610|NCT00835744|Clomiphene|clomiphene|mesh-list
56692611|NCT00835744|Enclomiphene|enclomiphene|mesh-list
56692612|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
56692613|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56692614|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
56692615|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56692616|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692617|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56692618|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
56692619|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56692620|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56692621|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56692622|NCT00778830|Cetuximab|cetuximab|mesh-list
56692623|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56692624|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692625|NCT00772668|Prednisone|prednisone|mesh-list
56692626|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
56692627|NCT00772668|Rituximab|rituximab|mesh-list
56692628|NCT00772668|Bortezomib|bortezomib|mesh-list
56692629|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56692630|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
56692631|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692632|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692633|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56692634|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
56692635|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692636|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692637|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56692638|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56692647|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
56692648|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56692649|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56692650|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692651|NCT00784875|Zolpidem|zolpidem|mesh-list
56692652|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56692653|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56692654|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692655|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692656|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56692657|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
56692658|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
56692659|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692660|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692661|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
56692662|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56692663|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692664|NCT00701909|Ketamine|ketamine|mesh-list
56692665|NCT00701909|Morphine|morphine|mesh-list
56692666|NCT00701909|Analgesics|analgesics|mesh-ancestor
56692667|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
56692668|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692669|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692670|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56692671|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56692672|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
56692673|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
56692674|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692693|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692694|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692695|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
56692696|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56692697|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56692698|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692699|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56692700|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56692701|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56692702|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692703|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56692704|NCT00853073|Bevacizumab|bevacizumab|mesh-list
56692705|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56692706|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692707|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56692708|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56692709|NCT00853073|Growth Substances|growth substances|mesh-ancestor
56692710|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692711|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
56692712|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
56692713|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56692714|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56692716|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
56692740|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56692741|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56692742|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692743|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692744|NCT00862121|Mesalamine|mesalamine|mesh-list
56692745|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56692746|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56692747|NCT00862121|Analgesics|analgesics|mesh-ancestor
56692748|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
56692749|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692750|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692751|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56692752|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692753|NCT00784719|Cyclosporine|cyclosporine|mesh-list
56692754|NCT00784719|Cyclosporins|cyclosporins|mesh-list
56692755|NCT00784719|Tofacitinib|tofacitinib|mesh-list
56692756|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692757|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692758|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56692759|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
56692760|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692761|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
56692762|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692763|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
56692764|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692765|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56692766|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56692767|NCT00852917|Tramadol|tramadol|mesh-list
56692768|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56692769|NCT00852917|Narcotics|narcotics|mesh-ancestor
56692770|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692771|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692772|NCT00852917|Analgesics|analgesics|mesh-ancestor
56692782|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56692783|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692784|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56692785|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56692786|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56692787|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
56692788|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692789|NCT00700583|Urological Agents|urological agents|mesh-ancestor
56692790|NCT00913055|Octreotide|octreotide|mesh-list
56692791|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692792|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56692793|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692794|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56692795|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56692796|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692797|NCT00845429|Vaccines|vaccines|mesh-list
56692798|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
56692799|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692800|NCT00844883|Sorafenib|sorafenib|mesh-list
56692801|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692802|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56692834|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692835|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692836|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
56692837|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692838|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56692839|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56692840|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
56692841|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692842|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56692843|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56692844|NCT00851591|Psyllium|psyllium|mesh-list
56692845|NCT00851591|Cathartics|cathartics|mesh-ancestor
56692846|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56692847|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
56692848|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56692849|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56692850|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692851|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56692852|NCT02612363|Analgesics|analgesics|mesh-ancestor
56692853|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
56692854|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56692855|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56692856|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56692857|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56692858|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
56692859|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692860|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692880|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56692881|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56692882|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692883|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56692884|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56692885|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56692886|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
56692887|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56692888|NCT00766467|Modafinil|modafinil|mesh-list
56692889|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56692890|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692891|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56692892|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56692893|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56692894|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692895|NCT00850499|Rituximab|rituximab|mesh-list
56692896|NCT00850499|Fludarabine|fludarabine|mesh-list
56692897|NCT00850499|Bortezomib|bortezomib|mesh-list
56692898|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56692934|NCT00765063|Dalteparin|dalteparin|mesh-list
56692935|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
56692936|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56692937|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56692938|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692939|NCT00764751|Calcipotriene|calcipotriene|mesh-list
56692940|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
56692941|NCT00764517|Rituximab|rituximab|mesh-list
56692942|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56692943|NCT00764517|Vorinostat|vorinostat|mesh-list
56692944|NCT00764517|Cladribine|cladribine|mesh-list
56692945|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56692947|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
56692948|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56692949|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
56692950|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692951|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56692952|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56692953|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56692954|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474471|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474472|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56474473|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56474474|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
56474476|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56474477|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56474478|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56474479|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56474480|NCT00527085|Cinacalcet|cinacalcet|mesh-list
56474481|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56474482|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474483|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56474484|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
56474485|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474486|NCT00509327|Bisacodyl|bisacodyl|mesh-list
56474487|NCT00509327|Cathartics|cathartics|mesh-ancestor
56474488|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56474489|NCT00509327|Laxatives|laxatives|mesh-ancestor
56474490|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
56474491|NCT00509405|Diuretics|diuretics|mesh-ancestor
56474492|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
56474493|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474494|NCT00509405|Expectorants|expectorants|mesh-ancestor
56474495|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
56474496|NCT00509561|Capecitabine|capecitabine|mesh-list
56474497|NCT00509561|Cetuximab|cetuximab|mesh-list
56474498|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474499|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56474500|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
56474501|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474502|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56474503|NCT00509639|Metronidazole|metronidazole|mesh-list
56474504|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474505|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56474506|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56474507|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56474508|NCT00528177|Morphine|morphine|mesh-list
56692955|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692956|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56692957|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56692958|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
56692959|NCT00764361|Doxycycline|doxycycline|mesh-list
56692960|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56692961|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56692962|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
56692963|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56692964|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56692965|NCT00763971|Methylphenidate|methylphenidate|mesh-list
56692966|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56692967|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56692968|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692969|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56692970|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56692971|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56692972|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56692973|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
56692974|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56692975|NCT00763815|Metformin|metformin|mesh-list
56692976|NCT00763815|Pioglitazone|pioglitazone|mesh-list
56692977|NCT00763815|Lixisenatide|lixisenatide|mesh-list
56692978|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56692979|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56692980|NCT00763269|Silicon|silicon|mesh-list
56692981|NCT00763269|Triclosan|triclosan|mesh-list
56692982|NCT00763269|Fluorides|fluorides|mesh-list
56692983|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
56693001|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693002|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56693003|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56693004|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56693005|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
56693006|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693007|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693008|NCT00763035|Protective Agents|protective agents|mesh-ancestor
56693009|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56693010|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56693011|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
56693012|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
56693013|NCT00844649|Gemcitabine|gemcitabine|mesh-list
56693014|NCT00844649|Paclitaxel|paclitaxel|mesh-list
56693015|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56693016|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56693017|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693018|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
56693019|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
56693020|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
56404207|NCT00184899|Heparin|heparin|mesh-list
56693021|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693022|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56693023|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
56693024|NCT00844649|Antiviral Agents|antiviral agents|mesh-ancestor
56693025|NCT00844649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693026|NCT00844649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693027|NCT00844649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693028|NCT00844649|Immunologic Factors|immunologic factors|mesh-ancestor
56693029|NCT00844649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693030|NCT04098861|Timolol|timolol|mesh-list
56693031|NCT04098861|Latanoprost|latanoprost|mesh-list
56693041|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56693042|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
56693043|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693044|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
56693045|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693046|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693047|NCT00849875|Dacarbazine|dacarbazine|mesh-list
56693048|NCT00849875|Imidazole|imidazole|mesh-list
56693049|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56693050|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
56693051|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693052|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693053|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693054|NCT00844415|Dabigatran|dabigatran|mesh-list
56693055|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
56693056|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56693057|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
56693058|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693059|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693060|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
56693061|NCT00843635|Tadalafil|tadalafil|mesh-list
56693062|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
56693063|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56693064|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56693065|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693066|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693068|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
56693087|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693088|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693089|NCT00842309|Cycloserine|cycloserine|mesh-list
56693090|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56693091|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693092|NCT00842309|Renal Agents|renal agents|mesh-ancestor
56693093|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56404283|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56693094|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
56693095|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56693096|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
56693097|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693098|NCT00842153|Clobetasol|clobetasol|mesh-list
56693099|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56693100|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
56693101|NCT00842153|Hormones|hormones|mesh-ancestor
56693103|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693141|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
56693142|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56693143|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693144|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56693145|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56693146|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56693147|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56693148|NCT00703313|Renal Agents|renal agents|mesh-ancestor
56693149|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56693150|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56693151|NCT00703079|Octreotide|octreotide|mesh-list
56693152|NCT00703079|Lanreotide|lanreotide|mesh-list
56693153|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56693154|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56693155|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693156|NCT00840827|Cyclosporine|cyclosporine|mesh-list
56693157|NCT00840827|Lenalidomide|lenalidomide|mesh-list
56693158|NCT00840827|Cyclosporins|cyclosporins|mesh-list
56693159|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693160|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693161|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693162|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
56693163|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693164|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
56693165|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693166|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
56404382|NCT00161486|Acyline|acyline|mesh-list
56693167|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693168|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56693186|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56693187|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693188|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693189|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56693190|NCT04030715|Bismuth|bismuth|mesh-list
56693191|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693192|NCT04030715|Antacids|antacids|mesh-ancestor
56693193|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693194|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56693195|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56693196|NCT00592007|Fulvestrant|fulvestrant|mesh-list
56693197|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693198|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56693199|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693200|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693201|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56693202|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56693203|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56693204|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
56693205|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693206|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693235|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693236|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56693237|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
56693238|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56404444|NCT00550303|Estrogens|estrogens|mesh-list
56693240|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56693241|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693242|NCT00839423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56693302|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693303|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56693304|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693305|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56693306|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56693307|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693308|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56693309|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56693310|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693311|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
56693312|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693313|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
56693314|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56693364|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
56693365|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
56693366|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693367|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693368|NCT00784836|Interferons|interferons|mesh-list
56693369|NCT00784836|Interferon-beta|interferon-beta|mesh-list
56693370|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
56693371|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693372|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
56693373|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693374|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
56693375|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693376|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56693377|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
56693378|NCT04104984|Progesterone|progesterone|mesh-list
56693379|NCT04104984|Progestins|progestins|mesh-ancestor
56693380|NCT04104984|Hormones|hormones|mesh-ancestor
56693381|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693382|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693383|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56693384|NCT00767520|Dasatinib|dasatinib|mesh-list
56693385|NCT00767520|Exemestane|exemestane|mesh-list
56693386|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693387|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56693388|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404594|NCT00551239|Rituximab|rituximab|mesh-list
56693389|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693390|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56693391|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56693392|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56693393|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
56693394|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693395|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693396|NCT00858845|Clonidine|clonidine|mesh-list
56693397|NCT00858845|Analgesics|analgesics|mesh-ancestor
56693398|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
56693399|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249109|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56693400|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693401|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56693402|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
56693403|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
56693404|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56693405|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56693406|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56693407|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
56693408|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693409|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693410|NCT05591339|BCG Vaccine|bcg vaccine|mesh-list
56693411|NCT05591339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56693412|NCT05591339|Immunologic Factors|immunologic factors|mesh-ancestor
56693413|NCT05591339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693414|NCT00770562|Dexamethasone|dexamethasone|mesh-list
56693415|NCT00770562|Rituximab|rituximab|mesh-list
56693416|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693417|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693418|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
56693419|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693420|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693421|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56693422|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
56693423|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
56693424|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693425|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56693426|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
56693427|NCT00770562|Hormones|hormones|mesh-ancestor
56693428|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693429|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56693430|NCT00836693|Tadalafil|tadalafil|mesh-list
56693431|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
56693432|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56693433|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56474509|NCT00528177|Oxycodone|oxycodone|mesh-list
56474510|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56474511|NCT00528177|Narcotics|narcotics|mesh-ancestor
56474512|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56474513|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474515|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
56693434|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693435|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693436|NCT00836693|Urological Agents|urological agents|mesh-ancestor
56693437|NCT00770484|Propranolol|propranolol|mesh-list
56693438|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56693439|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56693440|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
56693441|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693442|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693443|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693444|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56693445|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56693446|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
56693447|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56693448|NCT00835679|Cetuximab|cetuximab|mesh-list
56693449|NCT00835679|Dasatinib|dasatinib|mesh-list
56693450|NCT00835679|Antibodies|antibodies|mesh-list
56693451|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
56693493|NCT05500092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693494|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693495|NCT05500092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693496|NCT05500092|Immunologic Factors|immunologic factors|mesh-ancestor
56693497|NCT05500092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693498|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
56693499|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
56693500|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
56693501|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693502|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56693503|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56693504|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56693505|NCT00916500|Cisplatin|cisplatin|mesh-list
56693506|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693507|NCT03110094|Adalimumab|adalimumab|mesh-list
56693508|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56693509|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693510|NCT02600988|Vitamin D|vitamin d|mesh-list
56693511|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
56693512|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
56693513|NCT02600988|Vitamins|vitamins|mesh-list
56693514|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
56693515|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693516|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56693517|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56693518|NCT04097574|Menthol|menthol|mesh-list
56693519|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
56693520|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
56693521|NCT00766038|Hormones|hormones|mesh-list
56693522|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693523|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693524|NCT00765882|Linaclotide|linaclotide|mesh-list
56693525|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56693526|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
56693528|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56693534|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56693535|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693536|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56693537|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693538|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
56693539|NCT00828113|Varenicline|varenicline|mesh-list
56693540|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56693541|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56693542|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
56693543|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693544|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693545|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693546|NCT00707135|Sirolimus|sirolimus|mesh-list
56693547|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56693548|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693549|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56693550|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693551|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
56693552|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693553|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
56693554|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693555|NCT00769704|Molgramostim|molgramostim|mesh-list
56693556|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56693557|NCT00769704|Sargramostim|sargramostim|mesh-list
56693558|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
56693562|NCT00818753|Heparin|heparin|mesh-list
56693584|NCT00765726|Factor VIII|factor viii|mesh-list
56693585|NCT00765726|Coagulants|coagulants|mesh-ancestor
56693586|NCT04100226|Vitamin D|vitamin d|mesh-list
56693587|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
56693588|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
56693589|NCT04100226|Vitamins|vitamins|mesh-ancestor
56693590|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
56693591|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693592|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56693593|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56693594|NCT04100226|Antacids|antacids|mesh-ancestor
56693595|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693596|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56693597|NCT00765336|Minocycline|minocycline|mesh-list
56693598|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56693599|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693600|NCT00818519|Drospirenone|drospirenone|mesh-list
56693601|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56693608|NCT00827567|Everolimus|everolimus|mesh-list
56693641|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56693642|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56693643|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693644|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
56693645|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693646|NCT05752916|Clopidogrel|clopidogrel|mesh-list
56693647|NCT05752916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56693648|NCT05752916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693649|NCT05752916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693650|NCT05752916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56693651|NCT05752916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56693652|NCT05752916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56693653|NCT05752916|Purinergic Agents|purinergic agents|mesh-ancestor
56693654|NCT05752916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693655|NCT03990896|Talazoparib|talazoparib|mesh-list
56693656|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56693657|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693658|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693691|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693692|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693693|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56693694|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693695|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56693696|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56693697|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56693698|NCT03908060|Morphine|morphine|mesh-list
56693699|NCT03908060|Methadone|methadone|mesh-list
56693700|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56693701|NCT03908060|Narcotics|narcotics|mesh-ancestor
56693702|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693703|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693704|NCT03908060|Analgesics|analgesics|mesh-ancestor
56693705|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
56693706|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693747|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693748|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
56693749|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693750|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56693751|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
56693752|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693753|NCT03684980|Leucovorin|leucovorin|mesh-list
56693754|NCT03684980|Rituximab|rituximab|mesh-list
56693755|NCT03684980|Methotrexate|methotrexate|mesh-list
56693756|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693757|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693758|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
56693759|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693760|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693761|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56693762|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
56693763|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56693764|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56693765|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
56693766|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693767|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
56693768|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693769|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56693770|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56693771|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56693772|NCT03684980|Antidotes|antidotes|mesh-ancestor
56693773|NCT03684980|Protective Agents|protective agents|mesh-ancestor
56693774|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
56693775|NCT03684980|Vitamins|vitamins|mesh-ancestor
56693776|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
56693777|NCT00761319|Travoprost|travoprost|mesh-list
56693791|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
56693792|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
56693793|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693794|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693795|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693796|NCT00707369|Amoxicillin|amoxicillin|mesh-list
56693797|NCT00707369|Metronidazole|metronidazole|mesh-list
56693798|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56693799|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693800|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56693801|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56693802|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56693803|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56693804|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693805|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56693806|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693807|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693808|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
56693809|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693810|NCT00704951|Posaconazole|posaconazole|mesh-list
56693811|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
56693812|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693813|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56693814|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56693815|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56693816|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56693817|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56693818|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693819|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693820|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56693821|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
56693822|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693823|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693824|NCT00759915|Morphine|morphine|mesh-list
56693825|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55871606|NCT03373851|Sufentanil|sufentanil|mesh-list
56474516|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693826|NCT00759915|Narcotics|narcotics|mesh-ancestor
56693827|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693828|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693829|NCT00759915|Analgesics|analgesics|mesh-ancestor
56693830|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
56693831|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693832|NCT00759759|Morphine|morphine|mesh-list
56693833|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56693834|NCT00759759|Narcotics|narcotics|mesh-ancestor
56693835|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693836|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693837|NCT00759759|Analgesics|analgesics|mesh-ancestor
56693838|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
56693839|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693841|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56693842|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
56693843|NCT00759681|Coagulants|coagulants|mesh-ancestor
56693844|NCT00826241|Temozolomide|temozolomide|mesh-list
56693845|NCT00826241|Lapatinib|lapatinib|mesh-list
56693846|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56693847|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
56693848|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693849|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693850|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56693851|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693852|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
56693853|NCT04097847|Tocopherols|tocopherols|mesh-list
56693854|NCT04097847|Vitamin E|vitamin e|mesh-list
56693855|NCT04097847|Tocotrienols|tocotrienols|mesh-list
56693856|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
56693857|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
56693858|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56249578|NCT01856166|Sufentanil|sufentanil|mesh-list
56474517|NCT00509678|Rituximab|rituximab|mesh-list
56474518|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56474519|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474520|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
56474521|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474522|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474523|NCT00528216|Capsaicin|capsaicin|mesh-list
56474524|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
56474525|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
56474526|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
56474527|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474528|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474529|NCT00528255|Misoprostol|misoprostol|mesh-list
56693859|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693860|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693861|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56693862|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56693863|NCT04097847|Protective Agents|protective agents|mesh-ancestor
56693864|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693865|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
56693866|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56693867|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
56693868|NCT04097847|Vitamins|vitamins|mesh-ancestor
56693869|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
56693870|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56693871|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
56693872|NCT00762372|Sevoflurane|sevoflurane|mesh-list
56693873|NCT00762372|Desflurane|desflurane|mesh-list
56693874|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56693875|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56693876|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
56693877|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
56693878|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56693879|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693880|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56693881|NCT00762372|Analgesics|analgesics|mesh-ancestor
56693882|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
56693883|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56693884|NCT00833261|Paclitaxel|paclitaxel|mesh-list
56693885|NCT00833261|Cetuximab|cetuximab|mesh-list
56693886|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56693887|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693888|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
56693889|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
56693890|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
56693891|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693892|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693893|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56693899|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56693900|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
56693901|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693902|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693903|NCT00752622|Infliximab|infliximab|mesh-list
56693904|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56693905|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56693906|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56693907|NCT00754650|Bevacizumab|bevacizumab|mesh-list
56693908|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56693909|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693910|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56405105|NCT03541447|Octreotide|octreotide|mesh-list
56693911|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56693912|NCT00754650|Growth Substances|growth substances|mesh-ancestor
56693913|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693914|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
56693915|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56693916|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56693917|NCT00825305|Vaccines|vaccines|mesh-list
56693918|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
56693919|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693920|NCT00754572|Methotrexate|methotrexate|mesh-list
56693921|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56693922|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
56693923|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56693924|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693925|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56693926|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
56693927|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693928|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693929|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
56693940|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56693941|NCT04095390|Capecitabine|capecitabine|mesh-list
56693942|NCT04095390|Letrozole|letrozole|mesh-list
56693943|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56693944|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
56693945|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693946|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56693947|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56693948|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56693949|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56693950|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56693951|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
56693952|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56693953|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693954|NCT00754338|Dipivefrin|dipivefrin|mesh-list
56693955|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56693956|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
56693957|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693958|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693959|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693960|NCT00708149|Lansoprazole|lansoprazole|mesh-list
56693992|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56693993|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
56693994|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56693995|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56693996|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56693997|NCT00831701|Urological Agents|urological agents|mesh-ancestor
56693998|NCT00705419|Tenofovir|tenofovir|mesh-list
56693999|NCT00705419|Emtricitabine|emtricitabine|mesh-list
56694000|NCT00705419|Maleic acid|maleic acid|mesh-list
56694001|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
56694002|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694003|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56694004|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56694005|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694006|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694007|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56694008|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56694009|NCT05425355|Acetaminophen|acetaminophen|mesh-list
56694010|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56694011|NCT05425355|Analgesics|analgesics|mesh-ancestor
56694012|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
56694013|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694014|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694015|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
56694016|NCT04093713|Nordefrin|nordefrin|mesh-list
56694017|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56694018|NCT00831311|Vaccines|vaccines|mesh-list
56694019|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
56694020|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694021|NCT00831233|Goserelin|goserelin|mesh-list
56694022|NCT00831233|Bicalutamide|bicalutamide|mesh-list
56694023|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56694024|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694035|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56694036|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
56694037|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
56694038|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694039|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694040|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56694041|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
56694042|NCT05438277|Hormones|hormones|mesh-ancestor
56694043|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694044|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56694045|NCT05438277|Protective Agents|protective agents|mesh-ancestor
56694046|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56694047|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
56694048|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694049|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694050|NCT00761280|Temozolomide|temozolomide|mesh-list
56694051|NCT00761280|Carmustine|carmustine|mesh-list
56694052|NCT00761280|Lomustine|lomustine|mesh-list
56694053|NCT00761280|Trabedersen|trabedersen|mesh-list
56694054|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56694055|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
56694056|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694057|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694058|NCT00916890|Fentanyl|fentanyl|mesh-list
56694059|NCT00916890|Morphine|morphine|mesh-list
56694060|NCT00916890|Oxycodone|oxycodone|mesh-list
56405245|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694061|NCT00916890|Buprenorphine|buprenorphine|mesh-list
56694062|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56694063|NCT00916890|Narcotics|narcotics|mesh-ancestor
56694064|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694065|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694079|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
56694080|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56694081|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56694082|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694083|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56694084|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56694085|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56694086|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694087|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694088|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
56694089|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56694090|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56694091|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56694092|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694093|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694094|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694095|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694096|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
56694097|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56694131|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56694132|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
56694133|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694134|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694135|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56405320|NCT01628029|Melatonin|melatonin|mesh-list
56694136|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694137|NCT02608034|Itraconazole|itraconazole|mesh-list
56694138|NCT02608034|Rifampin|rifampin|mesh-list
56694139|NCT02608034|Vemurafenib|vemurafenib|mesh-list
56694140|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
56694141|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694142|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56694143|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56694144|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694145|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694146|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56694147|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
56694148|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694149|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694150|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56694151|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56694152|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
56694153|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56694154|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
56694155|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56694156|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56694157|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56694164|NCT00589784|Sunitinib|sunitinib|mesh-list
56694170|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694171|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
56694172|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56694173|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694174|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694175|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56694176|NCT05750264|Ibuprofen|ibuprofen|mesh-list
56694177|NCT05750264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56694178|NCT05750264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56694179|NCT05750264|Analgesics|analgesics|mesh-ancestor
56694180|NCT05750264|Sensory System Agents|sensory system agents|mesh-ancestor
56694181|NCT05750264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694182|NCT05750264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694183|NCT05750264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56694184|NCT05750264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56694185|NCT05750264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56694186|NCT05750264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694187|NCT05750264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694188|NCT05742854|Oxytocin|oxytocin|mesh-list
56694189|NCT05742854|Carbetocin|carbetocin|mesh-list
56694190|NCT05742854|Oxytocics|oxytocics|mesh-ancestor
56694193|NCT00823979|Etravirine|etravirine|mesh-list
56694222|NCT05741372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56694223|NCT05741372|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56694224|NCT05741372|Protective Agents|protective agents|mesh-ancestor
56694225|NCT00823901|Clindamycin|clindamycin|mesh-list
56694226|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
56694227|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
56694228|NCT00823901|Tretinoin|tretinoin|mesh-list
56694229|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56694230|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694231|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56694232|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694233|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694234|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694235|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
56694236|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56694237|NCT00823823|Calpastatin|calpastatin|mesh-list
56694238|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56694239|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
56694240|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694241|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694242|NCT02926898|Fenfluramine|fenfluramine|mesh-list
56694243|NCT02926898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56694244|NCT02926898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56694245|NCT02926898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694246|NCT02926898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694247|NCT02926898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694248|NCT02926898|Serotonin Agents|serotonin agents|mesh-ancestor
56694249|NCT02926898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694250|NCT00759564|Lactams|lactams|mesh-list
56694251|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56694252|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694253|NCT00816023|Ecallantide|ecallantide|mesh-list
56694254|NCT00816023|Analgesics|analgesics|mesh-ancestor
56694255|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
56694256|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694257|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249983|NCT01858090|Promethazine|promethazine|mesh-list
56694258|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56694259|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56694260|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56694261|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56694262|NCT00815633|Alefacept|alefacept|mesh-list
56694263|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
56694264|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
56694265|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694266|NCT03631784|Paclitaxel|paclitaxel|mesh-list
56694267|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56694268|NCT03631784|Carboplatin|carboplatin|mesh-list
56694269|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
56694270|NCT03631784|Pemetrexed|pemetrexed|mesh-list
56694271|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56694272|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694273|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
56694274|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
56694275|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
56694276|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694277|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56694278|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694279|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56694280|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56694281|NCT02610881|Iron|iron|mesh-list
56694282|NCT02610881|Trace Elements|trace elements|mesh-list
56694283|NCT02610881|Folic Acid|folic acid|mesh-list
56694284|NCT02610881|Micronutrients|micronutrients|mesh-list
56405474|NCT05208307|Dexamethasone|dexamethasone|mesh-list
56694285|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694286|NCT02610881|Hematinics|hematinics|mesh-ancestor
56694287|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
56694288|NCT02610881|Vitamins|vitamins|mesh-ancestor
56694289|NCT00830765|Progesterone|progesterone|mesh-list
56694290|NCT00830765|Progestins|progestins|mesh-ancestor
56694291|NCT00830765|Hormones|hormones|mesh-ancestor
56694293|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694300|NCT04093206|Protective Agents|protective agents|mesh-ancestor
56694301|NCT05754710|Tofacitinib|tofacitinib|mesh-list
56694302|NCT05754710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56694303|NCT05754710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694304|NCT05754710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694305|NCT00830375|Memantine|memantine|mesh-list
56694306|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56694307|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56694308|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
56694309|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694310|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694311|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694312|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56694313|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56694314|NCT00708539|Progesterone|progesterone|mesh-list
56694315|NCT00708539|Progestins|progestins|mesh-ancestor
56474530|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56474531|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
56474532|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56474533|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474534|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56474535|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56474536|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
56474537|NCT02953106|Fluticasone|fluticasone|mesh-list
56474538|NCT02953106|Azelastine|azelastine|mesh-list
56474539|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56474540|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56474541|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
56474542|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474543|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474544|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56474545|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
56474546|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56474547|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56474548|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56474549|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474550|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474553|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
56474554|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
56474555|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474557|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56474558|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474559|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
56474560|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474561|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56474562|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474563|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474564|NCT00509834|Lactoferrin|lactoferrin|mesh-list
56474565|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474566|NCT03459404|Sufentanil|sufentanil|mesh-list
56474567|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56474568|NCT03459404|Narcotics|narcotics|mesh-ancestor
56474569|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56474570|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474571|NCT03459404|Analgesics|analgesics|mesh-ancestor
56474572|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
56474573|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474574|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56474575|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56694316|NCT00708539|Hormones|hormones|mesh-ancestor
56694317|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694318|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694319|NCT00914420|Trapidil|trapidil|mesh-list
56694320|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56694321|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694322|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694323|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56694324|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
56694325|NCT04094532|Bupivacaine|bupivacaine|mesh-list
56694326|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
56694327|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
56694328|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694329|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694330|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
56694331|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694332|NCT00708773|Irinotecan|irinotecan|mesh-list
56694333|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56694334|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56694335|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694336|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474576|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
56474577|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
56474578|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
56474579|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56474580|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56474581|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56474582|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56474583|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474584|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
56474585|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222577|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474586|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474587|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56474588|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474589|NCT00510965|Ranibizumab|ranibizumab|mesh-list
56474590|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56474591|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56474592|NCT00510965|Growth Substances|growth substances|mesh-ancestor
56474593|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474594|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
56474595|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474596|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
56474597|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56474598|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56474599|NCT00509990|Analgesics|analgesics|mesh-ancestor
56474600|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
56474601|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474602|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474603|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56474604|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474605|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
56694337|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694338|NCT05758259|Vitamin D|vitamin d|mesh-list
56694339|NCT05758259|Ergocalciferols|ergocalciferols|mesh-list
56694340|NCT05758259|Cholecalciferol|cholecalciferol|mesh-list
56694341|NCT05758259|Vitamins|vitamins|mesh-list
56694342|NCT05758259|Micronutrients|micronutrients|mesh-ancestor
56694343|NCT05758259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694344|NCT05758259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56694345|NCT05758259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56694346|NCT00803738|Terconazole|terconazole|mesh-list
56694347|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
56694348|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694349|NCT00591266|Amlodipine|amlodipine|mesh-list
56694350|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56694351|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56694352|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56694353|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694354|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694355|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56694356|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694357|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
56694358|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56405550|NCT05117398|Dalbavancin|dalbavancin|mesh-list
56694359|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56694361|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
56694362|NCT04093050|Coagulants|coagulants|mesh-ancestor
56694363|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56694364|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56694365|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
56694366|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694367|NCT00758394|Listerine|listerine|mesh-list
56694368|NCT00758394|Triclosan|triclosan|mesh-list
56694369|NCT00758394|Fluorides|fluorides|mesh-list
56694370|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
56694371|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
56694379|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
56694380|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694381|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56694382|NCT04450394|Insulin|insulin|mesh-list
56694383|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56694384|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694385|NCT00758160|Methylphenidate|methylphenidate|mesh-list
56694386|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56694387|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694388|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56694389|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56694390|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694391|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694392|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
56694393|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694394|NCT02606552|Aspirin|aspirin|mesh-list
56694395|NCT02606552|Clopidogrel|clopidogrel|mesh-list
56694396|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56694397|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56694398|NCT02606552|Analgesics|analgesics|mesh-ancestor
56694399|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
56694400|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694401|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694402|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56694403|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56694404|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56694405|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56694406|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694407|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56694410|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
56694421|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56694422|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694423|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694424|NCT02608736|Valproic Acid|valproic acid|mesh-list
56694425|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
56694426|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694427|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694428|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
56694429|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694430|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694431|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
56694432|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56405620|NCT00164216|Artesunate|artesunate|mesh-list
56694433|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694434|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56694435|NCT04094142|Lenalidomide|lenalidomide|mesh-list
56694436|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
56694437|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694438|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
56694439|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694440|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56694441|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56694442|NCT04094142|Growth Substances|growth substances|mesh-ancestor
56694443|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
56694444|NCT02607410|Insulin|insulin|mesh-list
56694445|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56694446|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56694447|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
56694448|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
56694449|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
56694450|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
56694451|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56694454|NCT02607410|Incretins|incretins|mesh-ancestor
56694462|NCT05694260|Antimetabolites|antimetabolites|mesh-ancestor
56694463|NCT05694260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694464|NCT05694260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56694465|NCT05694260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694466|NCT05694260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56694467|NCT05694260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694468|NCT05693090|Osimertinib|osimertinib|mesh-list
56694469|NCT05693090|Tipifarnib|tipifarnib|mesh-list
56694470|NCT05693090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694471|NCT05693090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56694472|NCT05693090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694473|NCT05693090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694474|NCT00751296|Lenalidomide|lenalidomide|mesh-list
56694475|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
56694476|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694477|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56694478|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56694479|NCT00751296|Growth Substances|growth substances|mesh-ancestor
56694480|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
56694481|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694482|NCT04093518|Estradiol|estradiol|mesh-list
56694483|NCT04093518|Estrogens|estrogens|mesh-ancestor
56694484|NCT04093518|Hormones|hormones|mesh-ancestor
56694485|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694486|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694487|NCT02606084|Esketamine|esketamine|mesh-list
56694488|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
56694510|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56694511|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56694512|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694513|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694514|NCT00751881|Teriflunomide|teriflunomide|mesh-list
56694515|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56694516|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56694517|NCT00751881|Analgesics|analgesics|mesh-ancestor
56694518|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
56694519|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694520|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694521|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56694522|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56694523|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56694524|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
56694525|NCT02386826|Bevacizumab|bevacizumab|mesh-list
56694566|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
56694567|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694568|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694569|NCT05406726|Palmidrol|palmidrol|mesh-list
56694570|NCT05406726|Analgesics|analgesics|mesh-ancestor
56694571|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
56694572|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694573|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694574|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56694575|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56694576|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56694577|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56694578|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
56694579|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694580|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56694581|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56694582|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694583|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694584|NCT05406726|Hormones|hormones|mesh-ancestor
56694585|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694586|NCT02599623|Anesthetics|anesthetics|mesh-list
56694587|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694588|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694589|NCT02597400|Metformin|metformin|mesh-list
56694590|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56694591|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694592|NCT00830063|Naproxen|naproxen|mesh-list
56694593|NCT00830063|Tanezumab|tanezumab|mesh-list
56694594|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56694595|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56694596|NCT00830063|Analgesics|analgesics|mesh-ancestor
56694597|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
56694598|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694599|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694600|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56694601|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56694602|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
56694603|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56694604|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694605|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694606|NCT04092621|Amiodarone|amiodarone|mesh-list
56694607|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56694608|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
56694609|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56694610|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694611|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694612|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56694613|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56694614|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56694615|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694616|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56694617|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56694618|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56694619|NCT04092387|Nicotine|nicotine|mesh-list
56694621|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
56694655|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56694656|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56694657|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694658|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694659|NCT04020003|Protective Agents|protective agents|mesh-ancestor
56694660|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694661|NCT03977142|Chrysarobin|chrysarobin|mesh-list
56694662|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56694663|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56694664|NCT03977142|Analgesics|analgesics|mesh-ancestor
56694665|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
56694666|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694667|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694668|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56694669|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56694670|NCT00751023|Modafinil|modafinil|mesh-list
56694671|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56694672|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694677|NCT00917592|Amoxicillin|amoxicillin|mesh-list
56694707|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56694708|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56694709|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
56694710|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56694711|NCT00750867|Antibodies|antibodies|mesh-list
56694712|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
56694713|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56694714|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
56694715|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694716|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
56694717|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
56694718|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694719|NCT04091763|Polidocanol|polidocanol|mesh-list
56694720|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56694721|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56694722|NCT00829829|Rilonacept|rilonacept|mesh-list
56694723|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56694724|NCT05419089|Cisplatin|cisplatin|mesh-list
56694725|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694726|NCT00829439|Levodopa|levodopa|mesh-list
56694727|NCT00829439|Carbidopa|carbidopa|mesh-list
56694728|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56694729|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56694730|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
56694731|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694732|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694733|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694734|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56694735|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694736|NCT02599077|Dienogest|dienogest|mesh-list
56694751|NCT00829283|Orlistat|orlistat|mesh-list
56694753|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694754|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694755|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56694756|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56694757|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
56694758|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56694759|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
56694760|NCT05758025|Parathyroid Hormone|parathyroid hormone|mesh-list
56694761|NCT05758025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56694762|NCT05758025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694763|NCT00706277|Fentanyl|fentanyl|mesh-list
56694764|NCT00706277|Remifentanil|remifentanil|mesh-list
56694765|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
56694766|NCT00706277|Propofol|propofol|mesh-list
56694767|NCT00706277|Sevoflurane|sevoflurane|mesh-list
56694768|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56694769|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694770|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694771|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56694772|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
56694773|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
56694774|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56694775|NCT00706277|Narcotics|narcotics|mesh-ancestor
56694776|NCT00706277|Analgesics|analgesics|mesh-ancestor
56694777|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
56694778|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694779|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56694780|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56694781|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56694782|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56694783|NCT00749463|Nicotine|nicotine|mesh-list
56694784|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56694785|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
56694786|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694787|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694788|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56694792|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694793|NCT05413161|Omalizumab|omalizumab|mesh-list
56694794|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56694795|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56694796|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56694797|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
56694798|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
56405995|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56694799|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694800|NCT00821327|Gemcitabine|gemcitabine|mesh-list
56694801|NCT00821327|Sunitinib|sunitinib|mesh-list
56694802|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694803|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56694804|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
56694805|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694806|NCT00821327|Antiviral Agents|antiviral agents|mesh-ancestor
56694807|NCT00821327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694808|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694809|NCT00821327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56694810|NCT00821327|Immunologic Factors|immunologic factors|mesh-ancestor
56694811|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694812|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56694813|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56694814|NCT00821327|Growth Substances|growth substances|mesh-ancestor
56694815|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
56694816|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56694817|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56694818|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
56694819|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694820|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56694821|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56694822|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
56694823|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56694824|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694825|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56694830|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
56694831|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694832|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694833|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56694834|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
56694835|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694837|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
56694838|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56694839|NCT00743652|Vaccines|vaccines|mesh-list
56694840|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56694841|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
56694842|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694843|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
56694844|NCT00748215|Loperamide|loperamide|mesh-list
56694845|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
56694846|NCT00748215|Calcium|calcium|mesh-list
56694847|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56694848|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694849|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56694850|NCT00917163|Sirolimus|sirolimus|mesh-list
56694851|NCT00917163|Everolimus|everolimus|mesh-list
56694852|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694853|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56694854|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
56694855|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694856|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56694857|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694858|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56694859|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
56694860|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56694861|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694862|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56694863|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694864|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694865|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
56694866|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56694869|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694870|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56694871|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56694872|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694873|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694874|NCT05377905|Doxorubicin|doxorubicin|mesh-list
56694875|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56694876|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56694877|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694878|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56694879|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56694880|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694881|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694882|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
56694883|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56694884|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694885|NCT04091178|Vitamin D|vitamin d|mesh-list
56694886|NCT04091178|Vitamins|vitamins|mesh-ancestor
56694887|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
56694888|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694889|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56694890|NCT00917358|Interferons|interferons|mesh-list
56694891|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
56694892|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
56694893|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56694894|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694895|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
56694896|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694897|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
56694898|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694899|NCT00743340|Emtricitabine|emtricitabine|mesh-list
56694900|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
56694901|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56694902|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56694903|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56694909|NCT00749190|Empagliflozin|empagliflozin|mesh-list
56694910|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56694911|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694912|NCT00749190|Incretins|incretins|mesh-ancestor
56694913|NCT00749190|Hormones|hormones|mesh-ancestor
56694914|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56694915|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56694916|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
56694917|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694918|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694919|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56694920|NCT00748566|Ziprasidone|ziprasidone|mesh-list
56694921|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56694922|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
56694923|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694924|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694925|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694926|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56694927|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56694928|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56694929|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56694930|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56694931|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
56694932|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
56694934|NCT02597166|Ledipasvir|ledipasvir|mesh-list
56694957|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56694958|NCT00738699|Farletuzumab|farletuzumab|mesh-list
56694959|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56694960|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694961|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
56694962|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
56694963|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
56694964|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694965|NCT00814307|Tofacitinib|tofacitinib|mesh-list
56694966|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56694967|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56694968|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694969|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
56694970|NCT02596776|Propranolol|propranolol|mesh-list
56694971|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56694972|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56694973|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
56694974|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56694975|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56694976|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56694977|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56694978|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56694979|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
56694980|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56694981|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56694982|NCT02596776|Protective Agents|protective agents|mesh-ancestor
56694983|NCT00748098|Gabapentin|gabapentin|mesh-list
56695004|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695005|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56695006|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
56695007|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695008|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695009|NCT00737529|Lenalidomide|lenalidomide|mesh-list
56695010|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
56695011|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695012|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56695013|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56695014|NCT00737529|Growth Substances|growth substances|mesh-ancestor
56695015|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
56695016|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695017|NCT00813917|Varenicline|varenicline|mesh-list
56695018|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56695019|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56695020|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
56695021|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695022|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695023|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695024|NCT02598102|Diclofenac|diclofenac|mesh-list
56695025|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56695039|NCT02595918|Nivolumab|nivolumab|mesh-list
56695053|NCT05756777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695054|NCT05756777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695055|NCT05756777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695056|NCT02594241|Prednisolone|prednisolone|mesh-list
56695057|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56695058|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
56695059|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56695060|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
56695061|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56695062|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
56695063|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695064|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
56695065|NCT02594241|Hormones|hormones|mesh-ancestor
56695066|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695067|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695068|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56695069|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695070|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
56695071|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
56695072|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695073|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695074|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56695075|NCT02594241|Protective Agents|protective agents|mesh-ancestor
56695076|NCT00585975|Bromfenac|bromfenac|mesh-list
56695077|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56695078|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56695079|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56695080|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56695081|NCT00585975|Analgesics|analgesics|mesh-ancestor
56695082|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
56695083|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695084|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695085|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695086|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695087|NCT00918021|Olanzapine|olanzapine|mesh-list
56695088|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
56695091|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695092|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695093|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56695094|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56695095|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695096|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56695097|NCT00918021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56695098|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56695099|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56695100|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695101|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695102|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
56695103|NCT00585585|Betahistine|betahistine|mesh-list
56695104|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
56695105|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
56695106|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
56695107|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695108|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695109|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695110|NCT02593695|Fluoxetine|fluoxetine|mesh-list
56695111|NCT02593695|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56695112|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56695113|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56695114|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695115|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695116|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
56695117|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695118|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56695119|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
56695120|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56695121|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56695122|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56695129|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695130|NCT00819767|Valsartan|valsartan|mesh-list
56695131|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56695132|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56695133|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56695134|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695135|NCT04088175|Menthol|menthol|mesh-list
56695136|NCT04088175|Nicotine|nicotine|mesh-list
56695137|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56695138|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
56695139|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695140|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695141|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56695142|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56695143|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
56695144|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695145|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695146|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
56695147|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
56695148|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
56695149|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695150|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
56695151|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56695152|NCT05756621|Topiramate|topiramate|mesh-list
56695153|NCT05756621|Lacosamide|lacosamide|mesh-list
56695154|NCT05756621|Phenytoin|phenytoin|mesh-list
56695155|NCT05756621|Midazolam|midazolam|mesh-list
56695156|NCT05756621|Ketamine|ketamine|mesh-list
56695157|NCT05756621|Levetiracetam|levetiracetam|mesh-list
56695158|NCT05756621|Thiopental|thiopental|mesh-list
56695159|NCT05756621|Anticonvulsants|anticonvulsants|mesh-list
56695160|NCT05756621|Propofol|propofol|mesh-list
56695161|NCT05756621|Anesthetics|anesthetics|mesh-list
56695162|NCT05756621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56695163|NCT05756621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695165|NCT05756621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56695171|NCT05756621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56695172|NCT05756621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56695173|NCT05756621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695174|NCT05756621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695175|NCT05756621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56695176|NCT05756621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56695177|NCT05756621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56695178|NCT05756621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56695179|NCT05756621|GABA Modulators|gaba modulators|mesh-ancestor
56695180|NCT05756621|GABA Agents|gaba agents|mesh-ancestor
56695181|NCT05756621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56695182|NCT05756621|Nootropic Agents|nootropic agents|mesh-ancestor
56695183|NCT05756621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56695184|NCT05756621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56695185|NCT05756621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56695186|NCT05756621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56695187|NCT05756621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56695188|NCT05221229|Liraglutide|liraglutide|mesh-list
56695189|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56695190|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695191|NCT05221229|Incretins|incretins|mesh-ancestor
56695192|NCT05221229|Hormones|hormones|mesh-ancestor
56695193|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695194|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
56695198|NCT00732303|Pemetrexed|pemetrexed|mesh-list
56695220|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56695221|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695222|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695223|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56695224|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56406436|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56406437|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56406438|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
56406439|NCT05259631|Propofol|propofol|mesh-list
56406440|NCT05259631|Sevoflurane|sevoflurane|mesh-list
56406441|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56406442|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56406443|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406444|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56406445|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
56406446|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
56406447|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56406448|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56406474|NCT00408135|Telithromycin|telithromycin|mesh-list
56406475|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56406476|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56406477|NCT00407225|Difluprednate|difluprednate|mesh-list
56406478|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
56406479|NCT00407225|Hormones|hormones|mesh-ancestor
56406480|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56406481|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406482|NCT05124067|Dexamethasone|dexamethasone|mesh-list
56406483|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
56406484|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
56406485|NCT05124067|Ondansetron|ondansetron|mesh-list
56406486|NCT05124067|BB 1101|bb 1101|mesh-list
56406487|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695225|NCT02593383|Analgesics|analgesics|mesh-ancestor
56695230|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695237|NCT02609087|Sevoflurane|sevoflurane|mesh-list
56695238|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56695239|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695240|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695241|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56695242|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
56695243|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
56695244|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56695245|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56695246|NCT00731133|Disulfiram|disulfiram|mesh-list
56695247|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56695248|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56695249|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695250|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695251|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56695252|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56695253|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695254|NCT00730275|Incretins|incretins|mesh-ancestor
56695255|NCT00730275|Hormones|hormones|mesh-ancestor
56695256|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695257|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56695258|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
56695259|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695260|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474606|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474607|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
56474608|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56474609|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474610|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474611|NCT03459911|Losartan|losartan|mesh-list
56474612|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56474613|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56474614|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56474615|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56474616|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474617|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
56474618|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56474619|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
56474620|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474621|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
56474622|NCT03459833|Protective Agents|protective agents|mesh-ancestor
56474624|NCT05648487|Immunologic Factors|immunologic factors|mesh-ancestor
56474625|NCT05648487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474626|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56474627|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
56474628|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474629|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56474630|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695261|NCT04793711|Decanoic acid|decanoic acid|mesh-list
56695262|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
56695263|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695264|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
56695265|NCT00729651|Vitamin D|vitamin d|mesh-list
56695266|NCT00729651|Alendronate|alendronate|mesh-list
56695267|NCT00729651|Calcium|calcium|mesh-list
56695268|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56695269|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695270|NCT00729651|Vitamins|vitamins|mesh-ancestor
56695271|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
56695272|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56695273|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
56695274|NCT00729183|Vitamin D|vitamin d|mesh-list
56695275|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
56695276|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
56695277|NCT00729183|Calcium|calcium|mesh-list
56695278|NCT00729183|Vitamins|vitamins|mesh-ancestor
56695279|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
56695280|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695281|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56695282|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56695283|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695284|NCT00729183|Antacids|antacids|mesh-ancestor
56695285|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695286|NCT00811733|Ofatumumab|ofatumumab|mesh-list
56695287|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695288|NCT00728949|Tamoxifen|tamoxifen|mesh-list
56695289|NCT00728949|Letrozole|letrozole|mesh-list
56695290|NCT00728949|Fulvestrant|fulvestrant|mesh-list
56695291|NCT00728949|Anastrozole|anastrozole|mesh-list
56695292|NCT00728949|Exemestane|exemestane|mesh-list
56695308|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
56695309|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56695310|NCT04773353|Hormones|hormones|mesh-ancestor
56695311|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695312|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695313|NCT00918177|Levodopa|levodopa|mesh-list
56695314|NCT00918177|Carbidopa|carbidopa|mesh-list
56695315|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56695316|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56695317|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56695318|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
56695319|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695320|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695321|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695322|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56695323|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695324|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56695325|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
56695326|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
56695327|NCT00728481|Budesonide|budesonide|mesh-list
56695328|NCT00728481|Esomeprazole|esomeprazole|mesh-list
56695329|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695330|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56695358|NCT02592915|Clonidine|clonidine|mesh-list
56695359|NCT02592915|Anesthetics|anesthetics|mesh-list
56695360|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695361|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695362|NCT02592915|Analgesics|analgesics|mesh-ancestor
56695363|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
56695364|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695365|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56695366|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
56695367|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
56695368|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56695369|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56695370|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56695371|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
56695372|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695373|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406586|NCT00195000|Cytarabine|cytarabine|mesh-list
56695374|NCT00727311|Ribavirin|ribavirin|mesh-list
56695375|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56695376|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
56695377|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
56695378|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695379|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
56695380|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695381|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
56695382|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695383|NCT00726999|Morphine|morphine|mesh-list
56695384|NCT00726999|Gabapentin|gabapentin|mesh-list
56695385|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56695386|NCT00726999|Narcotics|narcotics|mesh-ancestor
56695387|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695388|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695389|NCT00726999|Analgesics|analgesics|mesh-ancestor
56695390|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
56695391|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695392|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
56695397|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56695398|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695399|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695400|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
56695401|NCT00585351|Ranitidine|ranitidine|mesh-list
56695402|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56695403|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56695404|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695405|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56695406|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
56695407|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
56695408|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695409|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695410|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695411|NCT00813293|Sorafenib|sorafenib|mesh-list
56695412|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695413|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56695414|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695415|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695416|NCT00726609|Posaconazole|posaconazole|mesh-list
56695417|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
56695418|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695419|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56695420|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56695421|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56695422|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56695423|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56695424|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695425|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695426|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56695427|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
56695437|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695438|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695439|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
56695440|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695441|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56695442|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
56695443|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56695444|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56695445|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56695446|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695447|NCT05754242|Ascorbic Acid|ascorbic acid|mesh-list
56695448|NCT05754242|Vitamins|vitamins|mesh-ancestor
56406658|NCT00177567|Lamotrigine|lamotrigine|mesh-list
56695449|NCT05754242|Micronutrients|micronutrients|mesh-ancestor
56695450|NCT05754242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695451|NCT05754242|Antioxidants|antioxidants|mesh-ancestor
56695452|NCT05754242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695453|NCT05754242|Protective Agents|protective agents|mesh-ancestor
56695454|NCT05728736|Lemborexant|lemborexant|mesh-list
56695455|NCT05728736|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56695456|NCT05728736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695457|NCT05728736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695458|NCT05728736|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56695459|NCT05728736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56695460|NCT05728736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695461|NCT05728736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695462|NCT00809783|Tanezumab|tanezumab|mesh-list
56695463|NCT00809783|Analgesics|analgesics|mesh-ancestor
56695464|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
56695465|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695466|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695467|NCT05675462|Lenvatinib|lenvatinib|mesh-list
56695468|NCT05675462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695469|NCT05675462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56695474|NCT02608658|Antibodies|antibodies|mesh-list
56695475|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
56695476|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695477|NCT00807248|Gaboxadol|gaboxadol|mesh-list
56695478|NCT00807248|Dexetimide|dexetimide|mesh-list
56695479|NCT00807248|Citalopram|citalopram|mesh-list
56695480|NCT00807248|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56695481|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56695482|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56695483|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695484|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695485|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
56695486|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695487|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56695488|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
56695489|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56695490|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56695491|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56695492|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
56695493|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
56695494|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695529|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
56695530|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56695531|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
56695532|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695533|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695534|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56695535|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
56695536|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56695537|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56695538|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56695539|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
56695540|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695541|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695542|NCT02605772|Metformin|metformin|mesh-list
56695543|NCT02605772|Saxagliptin|saxagliptin|mesh-list
56695544|NCT02605772|Acarbose|acarbose|mesh-list
56695545|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56695546|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695547|NCT02605772|Incretins|incretins|mesh-ancestor
56695548|NCT02605772|Hormones|hormones|mesh-ancestor
56695549|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695550|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56695551|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
56695552|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695553|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695554|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56695555|NCT04115462|Morphine|morphine|mesh-list
56695556|NCT04115462|Histamine|histamine|mesh-list
56695557|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
56695558|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56695559|NCT04115462|Narcotics|narcotics|mesh-ancestor
56695560|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695561|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695562|NCT04115462|Analgesics|analgesics|mesh-ancestor
56695569|NCT02605460|Plerixafor|plerixafor|mesh-list
56695570|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
56695571|NCT02605460|Busulfan|busulfan|mesh-list
56695572|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56695573|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
56695574|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695575|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695576|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56695577|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
56695578|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695579|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695580|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56695581|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56695582|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56695583|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
56695584|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695585|NCT00797108|Amoxicillin|amoxicillin|mesh-list
56695586|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
56695587|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
56695588|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
56695589|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56695590|NCT00797108|Lactams|lactams|mesh-list
56695591|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56695592|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695593|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56695594|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695595|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695596|NCT03236324|Epinephrine|epinephrine|mesh-list
56695597|NCT03236324|Bupivacaine|bupivacaine|mesh-list
56695598|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
56695599|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
56695600|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695601|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695602|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
56695610|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56695611|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
56695612|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56695613|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
56695614|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
56695615|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
56695616|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56695617|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
56695618|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56695619|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695620|NCT05720390|Quinine|quinine|mesh-list
56695621|NCT05720390|Antimalarials|antimalarials|mesh-ancestor
56695622|NCT05720390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56695623|NCT05720390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56695624|NCT05720390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695625|NCT05720390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56695626|NCT05720390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695627|NCT05720390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56695628|NCT05720390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695629|NCT05720390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56695630|NCT05720390|Analgesics|analgesics|mesh-ancestor
56695631|NCT05720390|Sensory System Agents|sensory system agents|mesh-ancestor
56695632|NCT04112498|Nivolumab|nivolumab|mesh-list
56695633|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56695634|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695635|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56695636|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695637|NCT00742560|Dexamethasone|dexamethasone|mesh-list
56695638|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
56695639|NCT00742560|Lenalidomide|lenalidomide|mesh-list
56695640|NCT00742560|Elotuzumab|elotuzumab|mesh-list
56695641|NCT00742560|BB 1101|bb 1101|mesh-list
56695655|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695656|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
56695657|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56695658|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56695659|NCT00742560|Growth Substances|growth substances|mesh-ancestor
56695660|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
56695661|NCT02604914|Levodopa|levodopa|mesh-list
56695662|NCT02604914|Carbidopa|carbidopa|mesh-list
56695663|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56695664|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56695665|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56695666|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
56695667|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695668|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695669|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695670|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56695671|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56406884|NCT02906059|Irinotecan|irinotecan|mesh-list
56695672|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56695673|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
56695674|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
56695675|NCT00796718|Capecitabine|capecitabine|mesh-list
56695676|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56695677|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
56695678|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695679|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695680|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
56695681|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56695682|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56695683|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
56695684|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695685|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56695696|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56695697|NCT04025840|Hormones|hormones|mesh-ancestor
56695698|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695699|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56695700|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695701|NCT00589472|Vorinostat|vorinostat|mesh-list
56695702|NCT00589472|Leuprolide|leuprolide|mesh-list
56695703|NCT00589472|Goserelin|goserelin|mesh-list
56695704|NCT00589472|Bicalutamide|bicalutamide|mesh-list
56695705|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695706|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56695707|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695708|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695709|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56695710|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
56695711|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56695712|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695713|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56695714|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
56695715|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
56695716|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695717|NCT02608931|Dronabinol|dronabinol|mesh-list
56695718|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
56695719|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695720|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56695721|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56695743|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695744|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695745|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
56695746|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56695747|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
56695748|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695749|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
56695750|NCT02595606|Protective Agents|protective agents|mesh-ancestor
56695752|NCT05757167|Artemether|artemether|mesh-list
56695753|NCT05757167|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56695754|NCT05757167|Antimalarials|antimalarials|mesh-ancestor
56695755|NCT05757167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56695756|NCT05757167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56695757|NCT05757167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695758|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
56695759|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
56695760|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56695761|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56695762|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
56695763|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695764|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695765|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695766|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695767|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56695768|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695769|NCT04570475|Vitamin D|vitamin d|mesh-list
56695770|NCT04570475|Vitamins|vitamins|mesh-ancestor
56695771|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
56695772|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695773|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56695774|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56695775|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56695776|NCT00739596|Amlodipine|amlodipine|mesh-list
56695777|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56695778|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56695779|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56474631|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474632|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
56474633|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695780|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56695781|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695782|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56695783|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695784|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
56695785|NCT00739596|Diuretics|diuretics|mesh-ancestor
56695786|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
56695787|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56695788|NCT00742326|Pioglitazone|pioglitazone|mesh-list
56695789|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56695790|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695791|NCT04088604|Fluorouracil|fluorouracil|mesh-list
56695792|NCT04088604|Irinotecan|irinotecan|mesh-list
56695793|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
56695794|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695795|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56695796|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695797|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56695798|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
56695799|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695800|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56695801|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56695802|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695803|NCT02597868|Capecitabine|capecitabine|mesh-list
56695804|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56695805|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
56695806|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695807|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695808|NCT00811187|Lidocaine|lidocaine|mesh-list
56695809|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
56695810|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
56695811|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695819|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695820|NCT00917748|Docetaxel|docetaxel|mesh-list
56695821|NCT00917748|Modafinil|modafinil|mesh-list
56695822|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695823|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
56407043|NCT02904538|Hormones|hormones|mesh-ancestor
56695824|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
56695825|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
56695826|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695827|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56695828|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695829|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56695830|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56695831|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56695832|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
56695833|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56695834|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695836|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
56695837|NCT00591149|Cetuximab|cetuximab|mesh-list
56695838|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695839|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
56695840|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
56695841|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
56695842|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695843|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56695844|NCT00735072|Maraviroc|maraviroc|mesh-list
56695845|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56695846|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56695847|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695848|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56695849|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56695862|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56695863|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
56695864|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695865|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695866|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56695867|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
56695868|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695869|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695870|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56695871|NCT00801632|Prednisone|prednisone|mesh-list
56695872|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
56695873|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
56695874|NCT00801632|Rituximab|rituximab|mesh-list
56695875|NCT00801632|Tacrolimus|tacrolimus|mesh-list
56695876|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56695877|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
56695878|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695879|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56695880|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56695881|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
56695882|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695883|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56695884|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56695885|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56695886|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56695887|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
56695888|NCT00801632|Hormones|hormones|mesh-ancestor
56695889|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56695907|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56695908|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
56695909|NCT04111484|Protective Agents|protective agents|mesh-ancestor
56695911|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
56695912|NCT04111328|Dsuvia|dsuvia|mesh-list
56695913|NCT04111328|Hydromorphone|hydromorphone|mesh-list
56695914|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56695915|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56695916|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695917|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56695918|NCT04111328|Analgesics|analgesics|mesh-ancestor
56695919|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
56695920|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695921|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56695922|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56695923|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56695924|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
56695925|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695926|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695927|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56695928|NCT04111328|Narcotics|narcotics|mesh-ancestor
56695929|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56695930|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56695931|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
56695932|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
56695933|NCT00806819|Folic Acid|folic acid|mesh-list
56695934|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
56695935|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
56695936|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
56695957|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56695958|NCT00806819|Hematinics|hematinics|mesh-ancestor
56695959|NCT00806819|Vitamins|vitamins|mesh-ancestor
56695960|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
56695961|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56695962|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
56695963|NCT04109534|Miotics|miotics|mesh-ancestor
56695964|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
56695965|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56695966|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56695967|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56695968|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56695969|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
56695970|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56695971|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56407188|NCT00168350|Memantine|memantine|mesh-list
56695972|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
56695973|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56695974|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695975|NCT05753735|Amoxicillin|amoxicillin|mesh-list
56695976|NCT05753735|Tazobactam|tazobactam|mesh-list
56695977|NCT05753735|Piperacillin|piperacillin|mesh-list
56695978|NCT05753735|Clavulanic Acids|clavulanic acids|mesh-list
56695979|NCT05753735|Clavulanic Acid|clavulanic acid|mesh-list
56695980|NCT05753735|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56695981|NCT05753735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56695982|NCT05753735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56695983|NCT05753735|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56695984|NCT05753735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56695985|NCT05753735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56695986|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
56695987|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56696001|NCT02605694|Hormones|hormones|mesh-ancestor
56696002|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696003|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56696004|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
56696005|NCT02604134|Fluorides|fluorides|mesh-list
56696006|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
56696007|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
56696008|NCT02604134|Protective Agents|protective agents|mesh-ancestor
56696009|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696010|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56696011|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696012|NCT00800540|Timolol|timolol|mesh-list
56696013|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56696014|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56696015|NCT00800540|Brinzolamide|brinzolamide|mesh-list
56696016|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56696017|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56696018|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56696019|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
56696020|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696021|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696022|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696023|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56696024|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56696025|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56696027|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56696050|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56407261|NCT02902666|Acetaminophen|acetaminophen|mesh-list
56696051|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696052|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
56696053|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56696054|NCT04110860|Voriconazole|voriconazole|mesh-list
56696055|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
56696056|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696057|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56696058|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56696059|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696060|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696061|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56696062|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
56696063|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696064|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696065|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56696066|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
56696067|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56696068|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696069|NCT04114526|Nicotine|nicotine|mesh-list
56696070|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56696071|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
56696072|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696073|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696074|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56696075|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56696076|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
56696077|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696078|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696079|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
56696080|NCT00915200|Silybin|silybin|mesh-list
56696081|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56696088|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696089|NCT00915200|Protective Agents|protective agents|mesh-ancestor
56696090|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696091|NCT00915200|Antidotes|antidotes|mesh-ancestor
56696092|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56696093|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696094|NCT00588146|Interferons|interferons|mesh-list
56696095|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
56696096|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
56696097|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56696098|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696099|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
56696100|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696101|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
56696102|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696103|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56696104|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
56696105|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696106|NCT00799058|Dapivirine|dapivirine|mesh-list
56696107|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56696108|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56696109|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
56696110|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696111|NCT00725985|Cladribine|cladribine|mesh-list
56696112|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696113|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56696114|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
56696115|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696116|NCT00793910|Gabapentin|gabapentin|mesh-list
56696117|NCT00793910|Analgesics|analgesics|mesh-ancestor
56696118|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
56696119|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696120|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474634|NCT04692051|Gemcitabine|gemcitabine|mesh-list
56696129|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696131|NCT05589818|Pembrolizumab|pembrolizumab|mesh-list
56696132|NCT05589818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56696133|NCT05589818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696134|NCT01019941|Docetaxel|docetaxel|mesh-list
56696135|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696136|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
56696137|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
56696138|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
56696139|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696140|NCT04113668|Diflunisal|diflunisal|mesh-list
56696141|NCT04113668|BMS-986165|bms-986165|mesh-list
56696142|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
56696143|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56696144|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696145|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696146|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56696147|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56696148|NCT04113668|Analgesics|analgesics|mesh-ancestor
56696149|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
56696150|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696151|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696152|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56696153|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56696154|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56696155|NCT00444145|Lansoprazole|lansoprazole|mesh-list
56696156|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56696157|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56696158|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56696159|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696160|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696161|NCT04107896|Tamsulosin|tamsulosin|mesh-list
56696162|NCT04107896|Silodosin|silodosin|mesh-list
56696163|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56696164|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56696168|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696169|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696170|NCT04107896|Urological Agents|urological agents|mesh-ancestor
56696171|NCT01024777|Vitamin D|vitamin d|mesh-list
56696172|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
56696173|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
56696174|NCT01024777|Vitamins|vitamins|mesh-list
56696175|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
56696176|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696177|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56696178|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56696179|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56696180|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
56696181|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56696182|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
56696183|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56696184|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56696185|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56696186|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696187|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696188|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696189|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696190|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
56696191|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56696192|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56696193|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56696194|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696195|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56696196|NCT00725205|Ribavirin|ribavirin|mesh-list
56696197|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56696198|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
56696199|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
56407443|NCT00178620|Reteplase|reteplase|mesh-list
56696200|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696202|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251961|NCT01871363|Capecitabine|capecitabine|mesh-list
56474636|NCT04692051|Cisplatin|cisplatin|mesh-list
56696203|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
56696204|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696205|NCT04071769|Xenon|xenon|mesh-list
56696206|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56696207|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
56696208|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
56696209|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696210|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696211|NCT00443755|Metformin|metformin|mesh-list
56696212|NCT00443755|Pioglitazone|pioglitazone|mesh-list
56696213|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56696214|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696215|NCT04107740|TA 0910|ta 0910|mesh-list
56696216|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
56696217|NCT00724971|Rituximab|rituximab|mesh-list
56696218|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56696219|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56696220|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696221|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
56696222|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696223|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56696224|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56696225|NCT00443599|Insulin|insulin|mesh-list
56696226|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56696227|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56696228|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696229|NCT04107428|Somatostatin|somatostatin|mesh-list
56696230|NCT04107428|Hormones|hormones|mesh-ancestor
56696231|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696233|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
56696249|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696250|NCT00724893|Interferons|interferons|mesh-list
56696251|NCT00724893|Ribavirin|ribavirin|mesh-list
56696252|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
56696253|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
56696254|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56696255|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696256|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
56696257|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696258|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
56696259|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696260|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
56696261|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696262|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56696263|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56696264|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
56696265|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56696266|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56696267|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56696268|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696269|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696270|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56696271|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56696272|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56696273|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
56696274|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696275|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696276|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56696277|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56696278|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
56696279|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56696280|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56696281|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
56696282|NCT00724815|Sumatriptan|sumatriptan|mesh-list
56696283|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56696288|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696289|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696290|NCT00798590|Glucagon|glucagon|mesh-list
56696291|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56696292|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56696293|NCT00798590|Hormones|hormones|mesh-ancestor
56696294|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696295|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696296|NCT00798590|Incretins|incretins|mesh-ancestor
56696297|NCT00481195|Modafinil|modafinil|mesh-list
56696298|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56696299|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696300|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56696301|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56696302|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56696303|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696304|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
56696305|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696306|NCT01027429|Amoxicillin|amoxicillin|mesh-list
56696307|NCT01027429|Gentamicins|gentamicins|mesh-list
56696308|NCT01027429|Penicillins|penicillins|mesh-list
56696309|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
56696310|NCT01027429|Penicillin G|penicillin g|mesh-list
56696311|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56696312|NCT01027429|Procaine|procaine|mesh-list
56696313|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56696314|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696315|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56696316|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696317|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696318|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
56696319|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
56696320|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696328|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696329|NCT01020253|Vitamins|vitamins|mesh-ancestor
56696330|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
56696331|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
56696332|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696333|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
56696334|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56696335|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56696336|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696337|NCT00454207|Urological Agents|urological agents|mesh-ancestor
56696338|NCT01020331|Memantine|memantine|mesh-list
56696339|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56696340|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56696341|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
56696342|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696343|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696344|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696345|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56696384|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696385|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56696386|NCT02593734|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56696387|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56696388|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56696389|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56696390|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
56696391|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56696392|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56696393|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696394|NCT00798434|Fesoterodine|fesoterodine|mesh-list
56696395|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56696396|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56696397|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
56696398|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696399|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696400|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696401|NCT00798434|Urological Agents|urological agents|mesh-ancestor
56696402|NCT04106804|Abatacept|abatacept|mesh-list
56696403|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56696404|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696405|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696406|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56696407|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
56696408|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696430|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56696431|NCT04106726|Ivermectin|ivermectin|mesh-list
56696432|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56696433|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696434|NCT05555732|Carboplatin|carboplatin|mesh-list
56696435|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
56696436|NCT05555732|Pemetrexed|pemetrexed|mesh-list
56696437|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696438|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56696439|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696440|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696441|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56696442|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56696443|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
56696444|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56696445|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696446|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696447|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56696448|NCT00723957|Paclitaxel|paclitaxel|mesh-list
56696449|NCT00723957|Carboplatin|carboplatin|mesh-list
56696450|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56696451|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696452|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
56696453|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
56696454|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
56696482|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56696483|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56696484|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56696485|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56696486|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696487|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
56696488|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
56696489|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696490|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696491|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56696492|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56696493|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56696494|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
56696495|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56407712|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56696496|NCT00797966|Citalopram|citalopram|mesh-list
56696497|NCT00797966|Fluoxetine|fluoxetine|mesh-list
56696498|NCT00797966|Paroxetine|paroxetine|mesh-list
56696499|NCT00797966|Sertraline|sertraline|mesh-list
56696500|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56696501|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
56696507|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
56696532|NCT00723255|Sirolimus|sirolimus|mesh-list
56696533|NCT00723255|Bevacizumab|bevacizumab|mesh-list
56696534|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56696535|NCT00723255|Antibodies|antibodies|mesh-list
56696536|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
56696537|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56696538|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696539|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56696540|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56696541|NCT00723255|Growth Substances|growth substances|mesh-ancestor
56696542|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696543|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
56696544|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
56696545|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56696546|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696547|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56696548|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
56696549|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56696550|NCT00791258|Amlodipine|amlodipine|mesh-list
56696551|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56696552|NCT00791258|Olmesartan|olmesartan|mesh-list
56696553|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56696554|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56696555|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56696556|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56696557|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696558|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56696559|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696560|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
56696561|NCT00791258|Diuretics|diuretics|mesh-ancestor
56696562|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
56696563|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56696564|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56696565|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56696573|NCT00723021|Zileuton|zileuton|mesh-list
56696574|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56696575|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56696576|NCT00723021|Analgesics|analgesics|mesh-ancestor
56696577|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
56696578|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696579|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696580|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56696581|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56696582|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56696583|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696584|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696585|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56696586|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
56696587|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696588|NCT05359653|Clemastine|clemastine|mesh-list
56696589|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
56696590|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
56696591|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56696592|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
56696593|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
56696594|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696595|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696596|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696597|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56696598|NCT04087317|Acetaminophen|acetaminophen|mesh-list
56696599|NCT04087317|Ibuprofen|ibuprofen|mesh-list
56696600|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56696618|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696619|NCT02608619|Choline|choline|mesh-list
56696620|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
56696621|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56696622|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
56696623|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696624|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56696625|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56696626|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
56696627|NCT05754203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56696628|NCT05754203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696629|NCT05754203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696630|NCT02591667|Bevacizumab|bevacizumab|mesh-list
56696631|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56696632|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696633|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56696634|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56696635|NCT02591667|Growth Substances|growth substances|mesh-ancestor
56696636|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696637|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
56696638|NCT00807599|Dexamethasone|dexamethasone|mesh-list
56696639|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
56696640|NCT00807599|Lenalidomide|lenalidomide|mesh-list
56696641|NCT00807599|Melphalan|melphalan|mesh-list
56696642|NCT00807599|BB 1101|bb 1101|mesh-list
56696643|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56407861|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56696644|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
56696645|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
56696650|NCT00807599|Hormones|hormones|mesh-ancestor
56696663|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
56696664|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56696665|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56696666|NCT00788372|Fentanyl|fentanyl|mesh-list
56696667|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56696668|NCT00788372|Narcotics|narcotics|mesh-ancestor
56696669|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696670|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696671|NCT00788372|Analgesics|analgesics|mesh-ancestor
56696672|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
56696673|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696674|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56696675|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56696676|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
56696677|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
56696678|NCT00738582|Pemetrexed|pemetrexed|mesh-list
56696679|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696680|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696681|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696682|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56696683|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56696684|NCT05753657|Pioglitazone|pioglitazone|mesh-list
56696685|NCT05753657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56696686|NCT05753657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696687|NCT00720759|Cycloserine|cycloserine|mesh-list
56696688|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56696689|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696690|NCT00720759|Renal Agents|renal agents|mesh-ancestor
56696691|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56696692|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
56696693|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56407935|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
56696722|NCT00810407|Rifabutin|rifabutin|mesh-list
56696723|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56696724|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696725|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56696726|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
56696727|NCT00720057|Naproxen|naproxen|mesh-list
56696728|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56696729|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56696730|NCT00720057|Analgesics|analgesics|mesh-ancestor
56696731|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
56696732|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696733|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696734|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56696735|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56696767|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696768|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696769|NCT02609711|Candesartan|candesartan|mesh-list
56696770|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
56696771|NCT02609711|Atorvastatin|atorvastatin|mesh-list
56696772|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56696773|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56696774|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
56696775|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696776|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56696777|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56696778|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696779|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56696780|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56696781|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56696782|NCT05748665|Etomidate|etomidate|mesh-list
56696783|NCT05748665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56696784|NCT05748665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56696785|NCT05748665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696786|NCT05748665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56696787|NCT05748665|Anesthetics, General|anesthetics, general|mesh-ancestor
56696819|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
56696820|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56696821|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
56696822|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696823|NCT05745701|Cyclosporine|cyclosporine|mesh-list
56696824|NCT05745701|Itraconazole|itraconazole|mesh-list
56696825|NCT05745701|Cyclosporins|cyclosporins|mesh-list
56696826|NCT05745701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696827|NCT05745701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696828|NCT05745701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56696829|NCT05745701|Immunologic Factors|immunologic factors|mesh-ancestor
56696830|NCT05745701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696831|NCT05745701|Antifungal Agents|antifungal agents|mesh-ancestor
56696832|NCT05745701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696833|NCT05745701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56696834|NCT05745701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56696835|NCT05745701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56696836|NCT05745701|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56696837|NCT05745701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56696838|NCT05745701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56696839|NCT05745701|Hormone Antagonists|hormone antagonists|mesh-ancestor
56696840|NCT05745701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696841|NCT05745701|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56696842|NCT00727272|Quinine|quinine|mesh-list
56696843|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
56696844|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56696845|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56696846|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696847|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56696863|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
56696864|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696865|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696866|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56408088|NCT00170768|Oxybutynin|oxybutynin|mesh-list
56696867|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56696868|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56696869|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
56696870|NCT02592720|Tenecteplase|tenecteplase|mesh-list
56696871|NCT02592720|Tirofiban|tirofiban|mesh-list
56696872|NCT02592720|Bivalirudin|bivalirudin|mesh-list
56696873|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
56696874|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56696875|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
56696876|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696877|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696878|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
56696879|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56696880|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56696881|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56696882|NCT02608073|Capecitabine|capecitabine|mesh-list
56696883|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696884|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56696885|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
56696886|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696887|NCT04041791|Amoxicillin|amoxicillin|mesh-list
56696888|NCT04041791|Gentamicins|gentamicins|mesh-list
56696889|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
56696890|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
56696891|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
56696892|NCT04041791|Penicillins|penicillins|mesh-list
56696893|NCT04041791|Ampicillin|ampicillin|mesh-list
56252664|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56474637|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56474638|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474639|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
56474640|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474641|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
56474642|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474643|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56474644|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
56474645|NCT04692051|Antiviral Agents|antiviral agents|mesh-ancestor
56474646|NCT04692051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474647|NCT04692051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696894|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56696895|NCT04041791|Penicillin G|penicillin g|mesh-list
56696896|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56696897|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
56696898|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56696899|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696900|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56696901|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696902|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696903|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56696904|NCT02605226|Bicalutamide|bicalutamide|mesh-list
56696905|NCT02605226|Hormones|hormones|mesh-list
56696906|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56696907|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696908|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696909|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
56696910|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
56696911|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56696912|NCT05571878|Insulin Lispro|insulin lispro|mesh-list
56696913|NCT05571878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56696914|NCT05571878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696915|NCT05753189|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56696916|NCT05753189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56696917|NCT05753189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56696918|NCT05753189|Aceclidine|aceclidine|mesh-list
56696919|NCT05753189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56696920|NCT05753189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56696921|NCT05753189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56696922|NCT05753189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56696923|NCT05753189|Adrenergic Agents|adrenergic agents|mesh-ancestor
56696924|NCT05753189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56696925|NCT05753189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696926|NCT05753189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696927|NCT05753189|Miotics|miotics|mesh-ancestor
56696928|NCT05753189|Autonomic Agents|autonomic agents|mesh-ancestor
56696932|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56696933|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696934|NCT03648437|Acetaminophen|acetaminophen|mesh-list
56696935|NCT03648437|Ibuprofen|ibuprofen|mesh-list
56696936|NCT03648437|Indomethacin|indomethacin|mesh-list
56696937|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56696938|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56696939|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56696940|NCT03648437|Analgesics|analgesics|mesh-ancestor
56696941|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
56696942|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696943|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696944|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56696945|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56696946|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56474648|NCT04692051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474649|NCT04692051|Immunologic Factors|immunologic factors|mesh-ancestor
56474650|NCT04692051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474651|NCT00528723|Albuterol|albuterol|mesh-list
56474652|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56474653|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
56474654|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474655|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474656|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56474657|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
56474658|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
56474659|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56474660|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56474661|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56474662|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56474663|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
56474664|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474665|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474666|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
56474667|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474668|NCT01580514|Exenatide|exenatide|mesh-list
56474669|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56474670|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474671|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56474672|NCT01580514|Incretins|incretins|mesh-ancestor
56474673|NCT01580514|Hormones|hormones|mesh-ancestor
56474674|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474675|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
56474676|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56474677|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474678|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
56474679|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474680|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56474681|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
56474682|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56474683|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56474684|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56474685|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56474686|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474687|NCT02953184|Vitamins|vitamins|mesh-list
56474688|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
56474689|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
56474690|NCT02953184|Docetaxel|docetaxel|mesh-list
56474691|NCT02953184|Doxorubicin|doxorubicin|mesh-list
56474692|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56474693|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
56474694|NCT02953184|Razoxane|razoxane|mesh-list
56696947|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696948|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696949|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
56696950|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
56696951|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
56696952|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56696953|NCT00806351|Caspofungin|caspofungin|mesh-list
56696954|NCT00806351|Anidulafungin|anidulafungin|mesh-list
56696955|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
56696956|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56696957|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56696958|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56696959|NCT03995251|Testosterone|testosterone|mesh-list
56696960|NCT03995251|Androgens|androgens|mesh-ancestor
56696961|NCT03995251|Hormones|hormones|mesh-ancestor
56696962|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696963|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696964|NCT01031017|Progesterone|progesterone|mesh-list
56696965|NCT01031017|Progestins|progestins|mesh-ancestor
56696966|NCT01031017|Hormones|hormones|mesh-ancestor
56696967|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56696968|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696969|NCT03742531|Oxytocin|oxytocin|mesh-list
56696970|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
56696971|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56696972|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696973|NCT05738135|Aminophylline|aminophylline|mesh-list
56696974|NCT05738135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56696975|NCT05738135|Autonomic Agents|autonomic agents|mesh-ancestor
56696976|NCT05738135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696977|NCT05738135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696991|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
56696992|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56696993|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56696994|NCT05737355|Red yeast rice|red yeast rice|mesh-list
56696995|NCT05737355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56696996|NCT05737355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56696997|NCT05737355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56696998|NCT05737355|Antimetabolites|antimetabolites|mesh-ancestor
56696999|NCT05737355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697000|NCT05737355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697001|NCT05737355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56697002|NCT03540017|Cisplatin|cisplatin|mesh-list
56697003|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697004|NCT02606981|Vitamins|vitamins|mesh-list
56697005|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
56697006|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
56697007|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697008|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
56697009|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697010|NCT02606981|Protective Agents|protective agents|mesh-ancestor
56697011|NCT05733611|Bevacizumab|bevacizumab|mesh-list
56697012|NCT05733611|Atezolizumab|atezolizumab|mesh-list
56474695|NCT02953184|Pirarubicin|pirarubicin|mesh-list
56474696|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474697|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
56474698|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474699|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474702|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474703|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474704|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56474705|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
56474706|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
56474707|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474708|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
56474709|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56474710|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56474711|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56474712|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474713|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56474714|NCT02953184|Protective Agents|protective agents|mesh-ancestor
56474715|NCT00515229|Amitriptyline|amitriptyline|mesh-list
56474716|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56474717|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
56474718|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56474719|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56474720|NCT00515229|Analgesics|analgesics|mesh-ancestor
56474721|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
56474722|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474723|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474724|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56474725|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56474726|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56474727|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828118|NCT03943901|Prednisone|prednisone|mesh-list
56474728|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
56474729|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474730|NCT00511316|Montelukast|montelukast|mesh-list
56474731|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56474732|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
56474733|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56474734|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
56474735|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474736|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474737|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56474738|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56474739|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474740|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
56474741|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56474742|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474743|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56474744|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
56474745|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56474746|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474747|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474748|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474749|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
56474750|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56474751|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56474752|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474753|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474754|NCT01356966|Folic Acid|folic acid|mesh-list
56474755|NCT01356966|Hematinics|hematinics|mesh-ancestor
56474756|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
56474757|NCT01356966|Vitamins|vitamins|mesh-ancestor
56474758|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
56474759|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474760|NCT02944734|Amlodipine|amlodipine|mesh-list
56474761|NCT02944734|Candesartan|candesartan|mesh-list
56474762|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
56474763|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56474764|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56474765|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56474766|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474767|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56474768|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474771|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56474773|NCT00510263|Prednisolone|prednisolone|mesh-list
56474774|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56474775|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
56474776|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56474777|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
56474778|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56474779|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
56474780|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56474781|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
56474783|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474784|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474785|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56474786|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474787|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
56474788|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
56474789|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474790|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56474791|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56474792|NCT00510263|Protective Agents|protective agents|mesh-ancestor
56474793|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
56474794|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474795|NCT00511628|Risperidone|risperidone|mesh-list
56474796|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56474797|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
56474798|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474799|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474800|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474801|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56697013|NCT05733611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56697014|NCT05733611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697015|NCT05733611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56697016|NCT05733611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56408225|NCT05349448|Triamcinolone|triamcinolone|mesh-list
56697017|NCT05733611|Growth Substances|growth substances|mesh-ancestor
56697018|NCT05733611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697019|NCT05733611|Growth Inhibitors|growth inhibitors|mesh-ancestor
56697020|NCT00914888|Metronidazole|metronidazole|mesh-list
56697021|NCT00914888|Clarithromycin|clarithromycin|mesh-list
56697022|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
56697023|NCT00914888|Tigecycline|tigecycline|mesh-list
56697024|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697025|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56697026|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56697027|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56697028|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56697029|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697030|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697031|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56697032|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56474802|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56474803|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56474804|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56474805|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56474806|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
56474807|NCT00529425|Ropivacaine|ropivacaine|mesh-list
56474808|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
56474809|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
56474810|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56474811|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474812|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
56474813|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474815|NCT02950935|Progestins|progestins|mesh-ancestor
56474816|NCT02950935|Hormones|hormones|mesh-ancestor
56474817|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474818|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474819|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
56474820|NCT00529620|Piperaquine|piperaquine|mesh-list
56474821|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
56474822|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56474823|NCT00529620|Amodiaquine|amodiaquine|mesh-list
56474824|NCT00529620|Artenimol|artenimol|mesh-list
56474825|NCT00529620|Sulfalene|sulfalene|mesh-list
56474826|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
56474827|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56474828|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56474829|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474830|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56474831|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474832|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474833|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56474834|NCT00529620|Renal Agents|renal agents|mesh-ancestor
56474835|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
56106706|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56697033|NCT02603198|Epinephrine|epinephrine|mesh-list
56697034|NCT02603198|Nordefrin|nordefrin|mesh-list
56697035|NCT02603198|Anesthetics|anesthetics|mesh-list
56697036|NCT02603198|Mepivacaine|mepivacaine|mesh-list
56697037|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697038|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697039|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56697040|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56697041|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697042|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697043|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697044|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56697045|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697046|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
56697047|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697048|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697049|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697050|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
56697051|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
56697052|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56697053|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
56697054|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
56697055|NCT00719043|Vaccines|vaccines|mesh-list
56474836|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56474837|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474838|NCT00513032|Methylene Blue|methylene blue|mesh-list
56474839|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474840|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474841|NCT00513110|Caffeine|caffeine|mesh-list
56474842|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56474843|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474846|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474847|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56474848|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56474849|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
56474850|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474852|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474853|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474854|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474855|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56474856|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56474857|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
56474858|NCT00511823|Granisetron|granisetron|mesh-list
56474859|NCT00511823|Casopitant|casopitant|mesh-list
56474860|NCT00511823|Dolasetron|dolasetron|mesh-list
56474861|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56474862|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474863|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
56474864|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
56474865|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56474866|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56474867|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56474868|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
56697056|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
56697057|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697058|NCT05545280|Glycopyrrolate|glycopyrrolate|mesh-list
56697059|NCT05545280|Neostigmine|neostigmine|mesh-list
56474869|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474870|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474871|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56474872|NCT00515736|Vitamins|vitamins|mesh-list
56474873|NCT00515736|Vitamin E|vitamin e|mesh-list
56474874|NCT00515736|Thiamine|thiamine|mesh-list
56474875|NCT00515736|Zinc|zinc|mesh-list
56474876|NCT00515736|Selenium|selenium|mesh-list
56474877|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
56474878|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474879|NCT00515736|Trace Elements|trace elements|mesh-ancestor
56474880|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
56474881|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474882|NCT00515736|Protective Agents|protective agents|mesh-ancestor
56474883|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
56474884|NCT00511940|Acamprosate|acamprosate|mesh-list
56474885|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56474886|NCT00513149|Clopidogrel|clopidogrel|mesh-list
56474887|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56474888|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56474889|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56474891|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
56474892|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56474893|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474894|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474895|NCT02944227|Ranibizumab|ranibizumab|mesh-list
56474896|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56474897|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56474898|NCT02944227|Growth Substances|growth substances|mesh-ancestor
56474899|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474900|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
56474901|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474902|NCT00513188|Leucovorin|leucovorin|mesh-list
56474903|NCT00513188|Cytarabine|cytarabine|mesh-list
56474904|NCT00513188|Prednisone|prednisone|mesh-list
56474905|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
56474906|NCT00513188|Doxorubicin|doxorubicin|mesh-list
56474907|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56474908|NCT00513188|Methotrexate|methotrexate|mesh-list
56474909|NCT00513188|Vincristine|vincristine|mesh-list
56474910|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
56474911|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
56474912|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474913|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
56474914|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474915|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474916|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56474917|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
56474918|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474919|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474929|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56474930|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56474932|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56474933|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56474934|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
56474935|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
56474936|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56474937|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56474938|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
56474939|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474940|NCT00513188|Antidotes|antidotes|mesh-ancestor
56474941|NCT00513188|Protective Agents|protective agents|mesh-ancestor
56474942|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
56474943|NCT00513188|Vitamins|vitamins|mesh-ancestor
56474944|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
56474945|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56474946|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56474947|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474948|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56474949|NCT00513266|Leucovorin|leucovorin|mesh-list
56474950|NCT00513266|Bevacizumab|bevacizumab|mesh-list
56697060|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56697061|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697062|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697063|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
56697064|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697065|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697066|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56697067|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
56697068|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697069|NCT05545280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56697070|NCT05545280|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56697071|NCT05545280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56697072|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
56697073|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56697074|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
56697075|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56697076|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
56697077|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697078|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697079|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
56697080|NCT00718887|Entecavir|entecavir|mesh-list
56697081|NCT00718887|Adefovir|adefovir|mesh-list
56697082|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
56697083|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697084|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56697085|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56697086|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697087|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474951|NCT00513266|Cetuximab|cetuximab|mesh-list
56474952|NCT00513266|Fluorouracil|fluorouracil|mesh-list
56474953|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
56474954|NCT00513266|Irinotecan|irinotecan|mesh-list
56474955|NCT00513266|Calcium|calcium|mesh-list
56474956|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
56474957|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56474958|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474959|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56474960|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56474961|NCT00513266|Growth Substances|growth substances|mesh-ancestor
56474962|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474963|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
56474964|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56474965|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
56474966|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474967|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56474968|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474969|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
56697088|NCT00786188|Paroxetine|paroxetine|mesh-list
56697089|NCT00786188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56697090|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56697091|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56697092|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697093|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697094|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
56697095|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697096|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56697097|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
56697099|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56697100|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56697101|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697102|NCT00733824|Plerixafor|plerixafor|mesh-list
56697103|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56697104|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56697105|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
56697106|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697107|NCT00718809|Saracatinib|saracatinib|mesh-list
56697108|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697109|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697110|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697111|NCT00585039|Albuterol|albuterol|mesh-list
56697112|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697113|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
56697114|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697115|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697116|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697117|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697118|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
56697119|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56697120|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56697121|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56697126|NCT04085913|Lidocaine|lidocaine|mesh-list
56697128|NCT04085913|Racepinephrine|racepinephrine|mesh-list
56697129|NCT04085913|Bupivacaine|bupivacaine|mesh-list
56697130|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
56697131|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
56697132|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
56697133|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697134|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697135|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
56697136|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697137|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56697138|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56697139|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56697140|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56697141|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697142|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56697143|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56697144|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697145|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697146|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56697147|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697148|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
56697149|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697150|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697151|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
56474970|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56474971|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56474972|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474973|NCT00513266|Antidotes|antidotes|mesh-ancestor
56474974|NCT00513266|Protective Agents|protective agents|mesh-ancestor
56474975|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
56474977|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
56474978|NCT00513383|Paclitaxel|paclitaxel|mesh-list
56474979|NCT00513383|Docetaxel|docetaxel|mesh-list
56474980|NCT00513383|Carboplatin|carboplatin|mesh-list
56474981|NCT00513383|Fluorouracil|fluorouracil|mesh-list
56474982|NCT00513383|Panitumumab|panitumumab|mesh-list
56474983|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56474984|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56474985|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
56474986|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
56474987|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
56474988|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474989|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
56474993|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474994|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56474995|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
56474997|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
56474998|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56474999|NCT00515892|Immunotoxins|immunotoxins|mesh-list
56475000|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
56475001|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475002|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697152|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
56697153|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56697154|NCT00806195|Vaccines|vaccines|mesh-list
56697155|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56475003|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56475004|NCT00513539|Trioxsalen|trioxsalen|mesh-list
56475005|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475006|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
56475007|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56475008|NCT00511979|Insulin|insulin|mesh-list
56475009|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56475010|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56475011|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475012|NCT00513578|Sargramostim|sargramostim|mesh-list
56475013|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
56475014|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
56475015|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475016|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56475017|NCT00513656|Oxycodone|oxycodone|mesh-list
56475018|NCT00513656|Naloxone|naloxone|mesh-list
56475019|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56475020|NCT00513656|Narcotics|narcotics|mesh-ancestor
56475021|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475022|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475023|NCT00513656|Analgesics|analgesics|mesh-ancestor
56475024|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
56475025|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475026|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56475027|NCT00530127|Deferiprone|deferiprone|mesh-list
56475028|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56475029|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
56475030|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
56475031|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475032|NCT04691934|Anesthetics|anesthetics|mesh-list
56475033|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475034|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475035|NCT00512057|Allopurinol|allopurinol|mesh-list
56475036|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
56475037|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475038|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475039|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
56475040|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56475041|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56475042|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
56475043|NCT00512057|Protective Agents|protective agents|mesh-ancestor
56475044|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475045|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
56475046|NCT00513929|Astringents|astringents|mesh-ancestor
56475047|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475048|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
56475049|NCT00513968|Adefovir|adefovir|mesh-list
56475050|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
56475051|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475052|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56475053|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56475054|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475055|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475056|NCT02944500|Liraglutide|liraglutide|mesh-list
56475057|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56475058|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475059|NCT02944500|Incretins|incretins|mesh-ancestor
56475060|NCT02944500|Hormones|hormones|mesh-ancestor
56475061|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56475062|NCT03459248|Anesthetics|anesthetics|mesh-list
56475063|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475068|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
56475069|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475070|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475071|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56475072|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56475073|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56475074|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475075|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56697156|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
56697157|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697158|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56697159|NCT03462329|Doxycycline|doxycycline|mesh-list
56697160|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697161|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
56697162|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56697163|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56697164|NCT05728151|Epinephrine|epinephrine|mesh-list
56697165|NCT05728151|Levobupivacaine|levobupivacaine|mesh-list
56697166|NCT05728151|Mepivacaine|mepivacaine|mesh-list
56697167|NCT05728151|Carticaine|carticaine|mesh-list
56697168|NCT05728151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56697169|NCT05728151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56697170|NCT05728151|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697171|NCT05728151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697172|NCT05728151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697173|NCT05728151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697174|NCT05728151|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56697175|NCT05728151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697176|NCT05728151|Autonomic Agents|autonomic agents|mesh-ancestor
56697177|NCT05728151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697178|NCT05728151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697179|NCT05728151|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697180|NCT05728151|Mydriatics|mydriatics|mesh-ancestor
56475076|NCT00512291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56475077|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56475078|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56475079|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475080|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475081|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
56475082|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56475083|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
56475084|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56475085|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56475086|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475087|NCT00514163|Gemcitabine|gemcitabine|mesh-list
56475088|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56475089|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
56475090|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475091|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475092|NCT00514163|Antiviral Agents|antiviral agents|mesh-ancestor
56475093|NCT00514163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475094|NCT00514163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475095|NCT00514163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475096|NCT00514163|Immunologic Factors|immunologic factors|mesh-ancestor
56475097|NCT00514163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475098|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
56475099|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56106707|NCT02210702|Norethindrone|norethindrone|mesh-list
56697181|NCT05728151|Sympathomimetics|sympathomimetics|mesh-ancestor
56697182|NCT05728151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56697183|NCT05728151|Anesthetics, Local|anesthetics, local|mesh-ancestor
56697184|NCT05728151|Anesthetics|anesthetics|mesh-ancestor
56697185|NCT05728151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697186|NCT05728151|Sensory System Agents|sensory system agents|mesh-ancestor
56697187|NCT00733746|Gemcitabine|gemcitabine|mesh-list
56697188|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56697189|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56697190|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
56697191|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697192|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697193|NCT00733746|Antiviral Agents|antiviral agents|mesh-ancestor
56697194|NCT00733746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697195|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697196|NCT00733746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56697197|NCT00733746|Immunologic Factors|immunologic factors|mesh-ancestor
56697198|NCT00733746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697199|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56697200|NCT03422705|Lisinopril|lisinopril|mesh-list
56697201|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56697202|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
56697203|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697204|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697205|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56697206|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56697207|NCT03422705|Protective Agents|protective agents|mesh-ancestor
56697208|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697209|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56697210|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56697211|NCT02607293|Hormones|hormones|mesh-ancestor
56697212|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697213|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697214|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
56697215|NCT02607371|Apixaban|apixaban|mesh-list
56697216|NCT02607371|Edoxaban|edoxaban|mesh-list
56697217|NCT02607371|Dabigatran|dabigatran|mesh-list
56697219|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
56697220|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56697221|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
56697222|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697223|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697224|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
56697225|NCT04085757|Dinoprostone|dinoprostone|mesh-list
56697226|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
56697227|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56697228|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697229|NCT00727194|Eculizumab|eculizumab|mesh-list
56697230|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56697231|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56697232|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
56697233|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697234|NCT00717093|Varenicline|varenicline|mesh-list
56697235|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56697236|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56697237|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
56253007|NCT01877577|Vitamin D|vitamin d|mesh-list
56475100|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475101|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56475102|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56475103|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56475104|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475105|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
56475106|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475107|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56475108|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
56475109|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475110|NCT00512408|Testosterone|testosterone|mesh-list
56475111|NCT00512408|Androgens|androgens|mesh-ancestor
56475112|NCT00512408|Hormones|hormones|mesh-ancestor
56475113|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56475114|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475115|NCT00530400|Cefuroxime|cefuroxime|mesh-list
56475116|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
56475117|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56475118|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475119|NCT00531336|Bevacizumab|bevacizumab|mesh-list
56475120|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475121|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475122|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56475123|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475124|NCT00531336|Growth Substances|growth substances|mesh-ancestor
56475125|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475126|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
56475127|NCT00530478|Donepezil|donepezil|mesh-list
56475128|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56475129|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475130|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475131|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
56475132|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475133|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475137|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56697238|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697239|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697240|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697241|NCT00716859|Timolol|timolol|mesh-list
56697242|NCT00716859|Latanoprost|latanoprost|mesh-list
56697243|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56697244|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56697245|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697246|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697247|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697248|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697249|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56697250|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56697251|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56697252|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56697253|NCT00590135|Atorvastatin|atorvastatin|mesh-list
56697254|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56697255|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56697256|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
56697257|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697258|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56697259|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56697260|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697261|NCT00589667|Gemcitabine|gemcitabine|mesh-list
56697262|NCT00589667|Pemetrexed|pemetrexed|mesh-list
56697263|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56697264|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
56697265|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697281|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697282|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56697283|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56697284|NCT05752799|Analgesics, Opioid|analgesics, opioid|mesh-list
56697285|NCT05752799|Anesthetics|anesthetics|mesh-list
56697286|NCT05752799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697287|NCT05752799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697288|NCT05752799|Narcotics|narcotics|mesh-ancestor
56697289|NCT05752799|Analgesics|analgesics|mesh-ancestor
56697290|NCT05752799|Sensory System Agents|sensory system agents|mesh-ancestor
56697291|NCT05752799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697292|NCT00737100|Bromides|bromides|mesh-list
56697293|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
56697294|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697295|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
56697296|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697297|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697298|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697299|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697300|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
56697301|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56697302|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
56697303|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697304|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697305|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
56697306|NCT00732498|Cytarabine|cytarabine|mesh-list
56697307|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
56697330|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697331|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56697332|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56697333|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
56697334|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
56697335|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697336|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56697337|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
56697338|NCT00732498|Hormones|hormones|mesh-ancestor
56697339|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697340|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56697341|NCT00732498|Protective Agents|protective agents|mesh-ancestor
56697342|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56697343|NCT00790400|Everolimus|everolimus|mesh-list
56697344|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697345|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56697346|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
56697347|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697348|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56697349|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56697350|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56697351|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697352|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697353|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56697354|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56697355|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56475138|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475139|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475140|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56475141|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
56475142|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
56475143|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475144|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475145|NCT00512486|Benralizumab|benralizumab|mesh-list
56475146|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56475147|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
56475148|NCT00530595|Losartan|losartan|mesh-list
56475149|NCT00530595|Valsartan|valsartan|mesh-list
56475150|NCT00530595|Candesartan|candesartan|mesh-list
56475151|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56475152|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56475153|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56475154|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475155|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56475156|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
56475157|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56475158|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56475159|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697356|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
56697357|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697358|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697359|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56697360|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56697361|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
56697362|NCT04087668|Anesthetics|anesthetics|mesh-list
56697363|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697364|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697365|NCT02602652|Vaccines|vaccines|mesh-list
56697366|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
56697367|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475160|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
56475161|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
56475162|NCT02944110|Glucagon|glucagon|mesh-list
56475163|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56475164|NCT02944110|Hormones|hormones|mesh-ancestor
56475165|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56475166|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475167|NCT02951975|Dexamethasone|dexamethasone|mesh-list
56475168|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56475169|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
56475170|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
56475171|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475172|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475173|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56475174|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
56475175|NCT02951975|Hormones|hormones|mesh-ancestor
56475176|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56475177|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56475178|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475179|NCT00514397|Temozolomide|temozolomide|mesh-list
56475180|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
56475181|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56475182|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
56475183|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475184|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475185|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56475186|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
56475187|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
56475188|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475189|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475190|NCT00531687|Gemcitabine|gemcitabine|mesh-list
56475191|NCT00531687|Paclitaxel|paclitaxel|mesh-list
56475192|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56475193|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475194|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
56475195|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
56475196|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
56475197|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475198|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56475199|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
56475200|NCT00531687|Antiviral Agents|antiviral agents|mesh-ancestor
56475201|NCT00531687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475202|NCT00531687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475203|NCT00531687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475204|NCT00531687|Immunologic Factors|immunologic factors|mesh-ancestor
56475205|NCT00531687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475206|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56475214|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475215|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475216|NCT00530868|Bevacizumab|bevacizumab|mesh-list
56475217|NCT00530868|Letrozole|letrozole|mesh-list
56697368|NCT02593500|Budesonide|budesonide|mesh-list
56697369|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56697370|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697371|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
56697372|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697373|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697374|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697375|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697376|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
56697377|NCT02593500|Hormones|hormones|mesh-ancestor
56697378|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697379|NCT02594358|Caffeine|caffeine|mesh-list
56697380|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56697381|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697382|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56697383|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697384|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697385|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56697386|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56697387|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
56697388|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697389|NCT00716625|Sunitinib|sunitinib|mesh-list
56697390|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697391|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56697392|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475218|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475219|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475220|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56475221|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475222|NCT00530868|Growth Substances|growth substances|mesh-ancestor
56475223|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475224|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
56475225|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56475226|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56475227|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475228|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475229|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56475230|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
56475231|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56475232|NCT00530907|Bevacizumab|bevacizumab|mesh-list
56475233|NCT00530907|Valproic Acid|valproic acid|mesh-list
56475234|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475235|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475236|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56475237|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475238|NCT00530907|Growth Substances|growth substances|mesh-ancestor
56475239|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697393|NCT00716625|Growth Substances|growth substances|mesh-ancestor
56697394|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697395|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
56697396|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56697397|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697398|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697399|NCT00785486|Quinine|quinine|mesh-list
56697400|NCT00785486|Midazolam|midazolam|mesh-list
56697401|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56697402|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56697403|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697404|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697405|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56697406|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56697407|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56697408|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56697409|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
56697410|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
56697411|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
56697412|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
56697413|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697414|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697415|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
56697416|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56697417|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56697418|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697419|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56697420|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56697421|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697422|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56697423|NCT00785486|Analgesics|analgesics|mesh-ancestor
56697424|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
56697425|NCT00917904|Dapivirine|dapivirine|mesh-list
56697426|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56697427|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56697428|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
56697434|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697435|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
56697436|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697437|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56697438|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56697439|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56697440|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56697441|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475240|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
56475241|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
56475242|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475243|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475244|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
56475245|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475246|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
56475247|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56475248|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475249|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56475250|NCT00531024|Bevacizumab|bevacizumab|mesh-list
56475251|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475252|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475253|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56475254|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475255|NCT00531024|Growth Substances|growth substances|mesh-ancestor
56475256|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475257|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
56475258|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
56475259|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
56475260|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
56475261|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56475262|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475263|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
56475264|NCT00531063|Everolimus|everolimus|mesh-list
56475265|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223264|NCT05383196|Paclitaxel|paclitaxel|mesh-list
56475266|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475267|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
56475268|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475269|NCT02943798|Paclitaxel|paclitaxel|mesh-list
56475270|NCT02943798|Etoposide|etoposide|mesh-list
56475271|NCT02943798|Carboplatin|carboplatin|mesh-list
56475272|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56475273|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475274|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
56475275|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
56475280|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475281|NCT02943369|Ticagrelor|ticagrelor|mesh-list
56475282|NCT02943369|Cangrelor|cangrelor|mesh-list
56475283|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56475284|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56475285|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56475286|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56475287|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
56475288|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475289|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475290|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475291|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
56475292|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56475293|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56475294|NCT00514748|Analgesics|analgesics|mesh-ancestor
56475295|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
56475296|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475297|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475298|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56475299|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56475300|NCT00515957|Antibodies|antibodies|mesh-list
56697442|NCT02590653|Atorvastatin|atorvastatin|mesh-list
56697443|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56697444|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56697445|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
56697446|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697447|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56697448|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56697449|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697450|NCT00915746|Ketoconazole|ketoconazole|mesh-list
56697451|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
56697452|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697453|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56697454|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56697455|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697456|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697457|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56697458|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
56697459|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697460|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697461|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56697462|NCT03215927|Abatacept|abatacept|mesh-list
56697463|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56697464|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697465|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697466|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56697467|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
56697468|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408673|NCT02908711|Ropivacaine|ropivacaine|mesh-list
56697469|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56697470|NCT00736944|Cisplatin|cisplatin|mesh-list
56475301|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
56475302|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475303|NCT02943642|Vorinostat|vorinostat|mesh-list
56475304|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475305|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56475306|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475307|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475308|NCT04695509|Propofol|propofol|mesh-list
56475309|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56475310|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475311|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475312|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56697471|NCT00736944|Cetuximab|cetuximab|mesh-list
56697472|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56697473|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697474|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56697475|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
56697476|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56697477|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697478|NCT04084977|Antibodies|antibodies|mesh-list
56697479|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
56697480|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697481|NCT04107194|Amoxicillin|amoxicillin|mesh-list
56697482|NCT04107194|Metronidazole|metronidazole|mesh-list
56697483|NCT04107194|Clarithromycin|clarithromycin|mesh-list
56697484|NCT04107194|Levofloxacin|levofloxacin|mesh-list
56697485|NCT04107194|Tetracycline|tetracycline|mesh-list
56697486|NCT04107194|Rifabutin|rifabutin|mesh-list
56697487|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56697488|NCT04107194|Pantoprazole|pantoprazole|mesh-list
56697489|NCT04107194|Bismuth|bismuth|mesh-list
56697490|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56697491|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697492|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56697493|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56697494|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56697495|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253262|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
56475313|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
56475314|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
56475315|NCT02943135|Lidocaine|lidocaine|mesh-list
56475316|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
56475317|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
56475318|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475319|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475320|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
56475321|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475322|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56475323|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56475324|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56475325|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56475326|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475327|NCT02951234|Aspirin|aspirin|mesh-list
56475328|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56475329|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
56475330|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56475331|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56475332|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56475333|NCT02951234|Analgesics|analgesics|mesh-ancestor
56475334|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
56475335|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475336|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475337|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223332|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
56475338|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56697496|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697497|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56697498|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56697499|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56697500|NCT04107194|Renal Agents|renal agents|mesh-ancestor
56697501|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56697502|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56697503|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697504|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56475339|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56475340|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56475341|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475342|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56475344|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475345|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
56475346|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
56475347|NCT02943252|Apatinib|apatinib|mesh-list
56475348|NCT02943252|Tegafur|tegafur|mesh-list
56475349|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475350|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56475351|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475352|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475353|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56475354|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
56475355|NCT00514982|Adalimumab|adalimumab|mesh-list
56475356|NCT00514982|Mesalamine|mesalamine|mesh-list
56475357|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
56475358|NCT00514982|Infliximab|infliximab|mesh-list
56475359|NCT00514982|Tacrolimus|tacrolimus|mesh-list
56475360|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475361|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
56475362|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475363|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56475364|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475365|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475366|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56475367|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56475368|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
56475369|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56475370|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
56475371|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56475372|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475373|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56475374|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56475375|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56475376|NCT00514982|Analgesics|analgesics|mesh-ancestor
56475377|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
56475378|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475379|NCT00531999|Ritonavir|ritonavir|mesh-list
56475380|NCT00531999|Lopinavir|lopinavir|mesh-list
56475381|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
56475382|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56475383|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56475384|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
56475385|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475386|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475387|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56475388|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56475389|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
56475390|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475391|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56475392|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56475393|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56475394|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56475395|NCT05319912|Molybdenum|molybdenum|mesh-list
56697505|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56697506|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56697507|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56697508|NCT04107194|Antacids|antacids|mesh-ancestor
56697509|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56697510|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
56697511|NCT02590263|Temozolomide|temozolomide|mesh-list
56697512|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56697513|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
56697514|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697515|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697516|NCT00736476|Vaccines|vaccines|mesh-list
56697517|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
56697518|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697519|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
56697520|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56475396|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56475397|NCT05319912|Choline|choline|mesh-list
56475398|NCT05319912|Omeprazole|omeprazole|mesh-list
56475399|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56475400|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56475401|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56475402|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475403|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475404|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
56475405|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56475406|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
56475407|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56475408|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
56475409|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
56475410|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
56475411|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56475412|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475413|NCT05319912|Growth Substances|growth substances|mesh-ancestor
56475414|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223412|NCT05047640|Vaccines|vaccines|mesh-list
56475415|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
56475416|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475417|NCT05319912|Trace Elements|trace elements|mesh-ancestor
56475418|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
56475433|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475434|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56475435|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
56475436|NCT05319834|Aspirin|aspirin|mesh-list
56475437|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56475438|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56475439|NCT05319834|Analgesics|analgesics|mesh-ancestor
56475440|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
56475441|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475442|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475443|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56475444|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56475445|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56475446|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56475447|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475448|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56475449|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56475450|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475451|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
56475452|NCT00515255|Minocycline|minocycline|mesh-list
56697521|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697522|NCT05642078|Vaccines|vaccines|mesh-list
56697523|NCT05642078|Immunologic Factors|immunologic factors|mesh-ancestor
56697524|NCT05642078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697525|NCT04019496|Calcitonin|calcitonin|mesh-list
56697526|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
56697527|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56697528|NCT04019496|Antibodies|antibodies|mesh-list
56697529|NCT04019496|Katacalcin|katacalcin|mesh-list
56697530|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
56697531|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697532|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56697533|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56697534|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
56697535|NCT05717153|Eflornithine|eflornithine|mesh-list
56697536|NCT05717153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697537|NCT05717153|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56697538|NCT05717153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56697539|NCT05717153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56697540|NCT05717153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697541|NCT05717153|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56697542|NCT05717153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475453|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56475454|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475455|NCT00516113|Paroxetine|paroxetine|mesh-list
56475456|NCT00516113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56475457|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56475458|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56475459|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475460|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475461|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
56475462|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475463|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56475464|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
56475465|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56475466|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56475467|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56475468|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475469|NCT04695197|Artesunate|artesunate|mesh-list
56475470|NCT04695197|Lumefantrine|lumefantrine|mesh-list
56475471|NCT04695197|Artemether|artemether|mesh-list
56475472|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56475473|NCT04695197|Pyronaridine|pyronaridine|mesh-list
56475474|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
56475475|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56475476|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56475477|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475478|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475479|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
56475480|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
56475484|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
56475485|NCT00516152|Fludarabine|fludarabine|mesh-list
56475486|NCT00516152|Busulfan|busulfan|mesh-list
56475487|NCT00516152|Tacrolimus|tacrolimus|mesh-list
56475488|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56697543|NCT05717153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697544|NCT00918489|Vorinostat|vorinostat|mesh-list
56697545|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697546|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56697547|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697548|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697550|NCT05690087|Anesthetics, Local|anesthetics, local|mesh-ancestor
56697551|NCT05690087|Anesthetics|anesthetics|mesh-ancestor
56697552|NCT05690087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697553|NCT05690087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697554|NCT05690087|Sensory System Agents|sensory system agents|mesh-ancestor
56697555|NCT05690087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697556|NCT05690087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56697557|NCT05690087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56697558|NCT05690087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56697559|NCT05690087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56697560|NCT05690087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697561|NCT02604992|Dronabinol|dronabinol|mesh-list
56697562|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
56475489|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
56475490|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56475491|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475492|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56475493|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
56475494|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475495|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475496|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
56475497|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475498|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56475499|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475500|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
56475501|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56475502|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56475503|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56475504|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
56475505|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56475506|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56475507|NCT00516191|Doxorubicin|doxorubicin|mesh-list
56475508|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56475509|NCT00516191|Bortezomib|bortezomib|mesh-list
56475510|NCT00516191|Melphalan|melphalan|mesh-list
56475511|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56475512|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475513|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56475514|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56475515|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475516|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475517|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56475518|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
56475519|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56475520|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475521|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
56106708|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
56697563|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697564|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56697565|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56697566|NCT02604992|Analgesics|analgesics|mesh-ancestor
56697567|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
56697568|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697569|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56697570|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56697571|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697572|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697573|NCT02604992|Hormones|hormones|mesh-ancestor
56253350|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
56475522|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475523|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
56475524|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56475525|NCT00515450|Antibodies|antibodies|mesh-list
56475526|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
56475527|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56475528|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
56475529|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475530|NCT00515489|Risperidone|risperidone|mesh-list
56475531|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56475532|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
56475533|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475534|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475535|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475536|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56475537|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56475538|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475539|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56475540|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56475541|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
56475542|NCT02941575|Methamphetamine|methamphetamine|mesh-list
56475543|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56475544|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475545|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
56475546|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
56475547|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475548|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
56475549|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475550|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475551|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
56475552|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56475553|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56475558|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475559|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475560|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475561|NCT02951039|Edoxaban|edoxaban|mesh-list
56475562|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56475563|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
56475564|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56475565|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
56475566|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475567|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475568|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
56475569|NCT02951117|Dexamethasone|dexamethasone|mesh-list
56475570|NCT02951117|Venetoclax|venetoclax|mesh-list
56475571|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56475572|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
56475573|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
56475574|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475575|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475576|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56697574|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697575|NCT05665595|Pembrolizumab|pembrolizumab|mesh-list
56697576|NCT05665595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56697577|NCT05665595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697578|NCT03899597|Oxytocin|oxytocin|mesh-list
56697579|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
56697580|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56697581|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697582|NCT00714285|Vaccines|vaccines|mesh-list
56697583|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
56697584|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697585|NCT02823665|Atropine|atropine|mesh-list
56697586|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56697587|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56697588|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697589|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
56697590|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697591|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697592|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56253363|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
56475577|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
56475578|NCT02951117|Hormones|hormones|mesh-ancestor
56475579|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56475580|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56475581|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475582|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
56475583|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475584|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475585|NCT00515684|Bevacizumab|bevacizumab|mesh-list
56475586|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475587|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475588|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56475589|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475590|NCT00515684|Growth Substances|growth substances|mesh-ancestor
56475591|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475592|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
56475593|NCT05317767|Vaccines|vaccines|mesh-list
56475594|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
56475595|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475596|NCT00515801|Glyburide|glyburide|mesh-list
56475597|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56475598|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475600|NCT05317611|Bupivacaine|bupivacaine|mesh-list
56475601|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
56475602|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
56475603|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475604|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475605|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
56475606|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475607|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
56475608|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
56475609|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56475610|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
56475611|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
56475612|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56475613|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
56697593|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697594|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
56697595|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
56697596|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56697597|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56697598|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
56697599|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697600|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697601|NCT05751317|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56697602|NCT05751317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697603|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
56697604|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697605|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
56697606|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697607|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697608|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697609|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697610|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
56697611|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56697612|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
56697613|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697614|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697615|NCT04015557|Acetaminophen|acetaminophen|mesh-list
56697616|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
56697617|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56253382|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
56475614|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475615|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475616|NCT05317611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56475617|NCT05317611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56475618|NCT05317611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56475619|NCT05317611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56475620|NCT05317572|Morphine|morphine|mesh-list
56475621|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56475622|NCT05317572|Narcotics|narcotics|mesh-ancestor
56475623|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475624|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475625|NCT05317572|Analgesics|analgesics|mesh-ancestor
56475626|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
56475627|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475631|NCT00516425|Epirubicin|epirubicin|mesh-list
56475632|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475633|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
56475634|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475635|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56475636|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56475637|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
56475638|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697618|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56697619|NCT04015557|Analgesics|analgesics|mesh-ancestor
56697620|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
56697621|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697622|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697623|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
56697624|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
56697625|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697626|NCT04015557|Expectorants|expectorants|mesh-ancestor
56697627|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697628|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56697629|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
56697630|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253408|NCT01880619|Tamsulosin|tamsulosin|mesh-list
56475639|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475640|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56475641|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56475642|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56475643|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56475644|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475646|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475647|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475648|NCT00516464|Ranibizumab|ranibizumab|mesh-list
56475649|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56475650|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475651|NCT00516464|Growth Substances|growth substances|mesh-ancestor
56475652|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475653|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
56475654|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475655|NCT00516542|Letrozole|letrozole|mesh-list
56475656|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475657|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56475658|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56475659|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475660|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475661|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56475662|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
56475663|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56475664|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475665|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
56475666|NCT03458481|Yimitasvir|yimitasvir|mesh-list
56475667|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
56475668|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475669|NCT02949752|Aripiprazole|aripiprazole|mesh-list
56475670|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
56475671|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56475672|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56475673|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56475674|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475675|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475676|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
56475677|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
56475678|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475679|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475680|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56475681|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56475682|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
56475683|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56475684|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56475685|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56475686|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56697631|NCT04015557|Protective Agents|protective agents|mesh-ancestor
56697632|NCT04015557|Antidotes|antidotes|mesh-ancestor
56697633|NCT00784784|Zanamivir|zanamivir|mesh-list
56697634|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
56697635|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697636|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697637|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475687|NCT02942550|Bromides|bromides|mesh-list
56475688|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
56475689|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
56475690|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56475691|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475692|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
56475693|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475694|NCT04694612|Remdesivir|remdesivir|mesh-list
56475695|NCT04694612|Favipiravir|favipiravir|mesh-list
56475696|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
56475697|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475698|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
56475699|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475700|NCT02941224|Sirolimus|sirolimus|mesh-list
56475701|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56475703|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56475704|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475706|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475707|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
56475708|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475709|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
56475710|NCT00516854|Clidinium|clidinium|mesh-list
56475711|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56475712|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56475713|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475714|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475715|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56475716|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56475717|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56475718|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
56475719|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
56475720|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475721|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475722|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
56475723|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
56475724|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475725|NCT02940990|Gemcitabine|gemcitabine|mesh-list
56475726|NCT02940990|Paclitaxel|paclitaxel|mesh-list
56475727|NCT02940990|Etoposide|etoposide|mesh-list
56475728|NCT02940990|Vinorelbine|vinorelbine|mesh-list
56475729|NCT02940990|Docetaxel|docetaxel|mesh-list
56475730|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56475731|NCT02940990|Carboplatin|carboplatin|mesh-list
56475732|NCT02940990|Pemetrexed|pemetrexed|mesh-list
56475733|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56475734|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475735|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
56475736|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
56475737|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
56475738|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475739|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56475740|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
56475741|NCT02940990|Antiviral Agents|antiviral agents|mesh-ancestor
56475742|NCT02940990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475743|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475744|NCT02940990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475745|NCT02940990|Immunologic Factors|immunologic factors|mesh-ancestor
56475746|NCT02940990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475747|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56475748|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56334602|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
56475750|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56475751|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
56475752|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56475753|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56697638|NCT00587288|Reslizumab|reslizumab|mesh-list
56697639|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697640|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697641|NCT00800735|Interferons|interferons|mesh-list
56697642|NCT00800735|Ribavirin|ribavirin|mesh-list
56697643|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
56697644|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
56697645|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56697646|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697647|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
56697648|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697649|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
56697650|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697651|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
56697652|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697653|NCT05324163|Celecoxib|celecoxib|mesh-list
56697654|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56697655|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56697656|NCT05324163|Analgesics|analgesics|mesh-ancestor
56697657|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
56697658|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697659|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697660|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56697661|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56697662|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56697663|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56475754|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56475755|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
56475756|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475757|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56475758|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56475759|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475760|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475761|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56475762|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56475763|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
56475764|NCT00518375|Cyclosporine|cyclosporine|mesh-list
56475765|NCT00518375|Sirolimus|sirolimus|mesh-list
56475766|NCT00518375|Cyclosporins|cyclosporins|mesh-list
56475767|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475768|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475769|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475770|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
56475771|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475772|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
56475773|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475774|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
56475775|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56475776|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56475777|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56697664|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697665|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697666|NCT00730158|Irinotecan|irinotecan|mesh-list
56697667|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56697668|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56475781|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475782|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475783|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56475784|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475785|NCT02942043|Growth Substances|growth substances|mesh-ancestor
56475786|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475787|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
56475788|NCT00516971|Esomeprazole|esomeprazole|mesh-list
56475789|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56475790|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56475791|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56475792|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475793|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475794|NCT00518570|Levetiracetam|levetiracetam|mesh-list
56475795|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
56475796|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
56223782|NCT03517176|Gemcitabine|gemcitabine|mesh-list
56475797|NCT03458208|Metformin|metformin|mesh-list
56475798|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56475799|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475800|NCT00517283|Exenatide|exenatide|mesh-list
56475801|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56475802|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475803|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56475804|NCT00517283|Incretins|incretins|mesh-ancestor
56475805|NCT00517283|Hormones|hormones|mesh-ancestor
56475806|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56475807|NCT02940912|Apomorphine|apomorphine|mesh-list
56475808|NCT02940912|Emetics|emetics|mesh-ancestor
56475809|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475810|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
56475811|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475812|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56475813|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
56475814|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
56475815|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475816|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475817|NCT00517322|Ramipril|ramipril|mesh-list
56475818|NCT00517322|Irbesartan|irbesartan|mesh-list
56475819|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56475820|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
56475821|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475822|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475823|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56475824|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56475825|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56475827|NCT02939430|Neostigmine|neostigmine|mesh-list
56475828|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56475829|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56475830|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56475831|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
56475832|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475833|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475834|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56475835|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
56475836|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
56475837|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
56475838|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56475839|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56475840|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
56475841|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475842|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475843|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56475844|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475845|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56697669|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697670|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697671|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697672|NCT04114643|Thrombin|thrombin|mesh-list
56697673|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
56697674|NCT04114643|Coagulants|coagulants|mesh-ancestor
56697675|NCT02989662|Mifepristone|mifepristone|mesh-list
56697676|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56697677|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
56697678|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56697679|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697680|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56697681|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56697682|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56697683|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
56697684|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56697685|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56697686|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
56475846|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
56475847|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
56475848|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56475849|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475850|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475852|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56475853|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475854|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475855|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
56475856|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
56475857|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
56475858|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475860|NCT02940756|Lumefantrine|lumefantrine|mesh-list
56475861|NCT02940756|Artemether|artemether|mesh-list
56475862|NCT02940756|Piperaquine|piperaquine|mesh-list
56475863|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56475864|NCT02940756|Amodiaquine|amodiaquine|mesh-list
56475865|NCT02940756|Artenimol|artenimol|mesh-list
56475866|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
56475867|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56475868|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56475869|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475870|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475871|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
56223858|NCT03362515|Furosemide|furosemide|mesh-list
56475872|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
56475873|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56475874|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
56475875|NCT02939547|Betadex|betadex|mesh-list
56475876|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
56475877|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475878|NCT02941068|Fluconazole|fluconazole|mesh-list
56475879|NCT02941068|Caspofungin|caspofungin|mesh-list
56475880|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
56475881|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475882|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56475883|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56475884|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475885|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475886|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56697687|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697688|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
56697689|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56697690|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56697691|NCT00784550|Fluticasone|fluticasone|mesh-list
56697692|NCT00784550|Xhance|xhance|mesh-list
56697693|NCT00784550|Bromides|bromides|mesh-list
56697694|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
56697695|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56697696|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56408901|NCT00202917|Fludarabine|fludarabine|mesh-list
56697697|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697699|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697700|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697701|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697702|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
56475887|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
56475888|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56475889|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475890|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56475891|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56475892|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
56475893|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475894|NCT02939274|Verteporfin|verteporfin|mesh-list
56475895|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56475896|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
56475897|NCT04694183|Paclitaxel|paclitaxel|mesh-list
56475898|NCT04694183|Antibodies|antibodies|mesh-list
56475899|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
56475900|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56475901|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475902|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
56475903|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
56475904|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
56475905|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475906|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
56475907|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475908|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
56475909|NCT04998240|Paraproteins|paraproteins|mesh-list
56475910|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
56475911|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475912|NCT00517946|Cetirizine|cetirizine|mesh-list
56475913|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
56475914|NCT00517946|Ephedrine|ephedrine|mesh-list
56475915|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56475916|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56475917|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56475918|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
56475919|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
56475920|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475921|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475922|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475923|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56475924|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
56475925|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475928|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
56475929|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56475930|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56475931|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
56475932|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697703|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56697704|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56697705|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
56697706|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56697707|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
56697708|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697709|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697710|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56697711|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56697712|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56697713|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697714|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
56697715|NCT05298423|Paclitaxel|paclitaxel|mesh-list
56697716|NCT05298423|Etoposide|etoposide|mesh-list
56697717|NCT05298423|Carboplatin|carboplatin|mesh-list
56697718|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
56697719|NCT05298423|Pemetrexed|pemetrexed|mesh-list
56697720|NCT05298423|Durvalumab|durvalumab|mesh-list
56697721|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56697722|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697723|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
56697724|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
56697725|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
56475934|NCT04988685|Paclitaxel|paclitaxel|mesh-list
56475935|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56475936|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475937|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
56475938|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
56475939|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
56475940|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475941|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56475942|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475943|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56475944|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
56475945|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56475946|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
56475947|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475948|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56475949|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56475950|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56475951|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56475952|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475953|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475954|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475955|NCT00517985|Analgesics|analgesics|mesh-ancestor
56475956|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
56475957|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475958|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
56475959|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56475960|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
56475961|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56475962|NCT04690920|Remdesivir|remdesivir|mesh-list
56475963|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106709|NCT02210702|Estradiol|estradiol|mesh-list
56697726|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697727|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56697728|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56697729|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56697730|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697731|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56697732|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56697733|NCT00729690|Pregabalin|pregabalin|mesh-list
56697734|NCT00729690|Analgesics|analgesics|mesh-ancestor
56697735|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
56697736|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697737|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697738|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
56697739|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56697740|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56697741|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697742|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56697743|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56697744|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56697745|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697746|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56697747|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
56697748|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56697749|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697750|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697751|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56697752|NCT04027829|Analgesics|analgesics|mesh-ancestor
56697753|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
56697754|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697755|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56697756|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56475964|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475965|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
56475966|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
56475967|NCT00518102|Becaplermin|becaplermin|mesh-list
56475968|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
56475969|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56475970|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56475971|NCT00518102|Growth Substances|growth substances|mesh-ancestor
56697757|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56697758|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697759|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697760|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697761|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56697762|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56697763|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56697764|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697765|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697766|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56697767|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56697768|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56697769|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
56475972|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475973|NCT02939235|Morphine|morphine|mesh-list
56475974|NCT02939235|Metoclopramide|metoclopramide|mesh-list
56475975|NCT02939235|Ticagrelor|ticagrelor|mesh-list
56475976|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56475977|NCT02939235|Narcotics|narcotics|mesh-ancestor
56475978|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56475979|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475980|NCT02939235|Analgesics|analgesics|mesh-ancestor
56475981|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
56475982|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56475983|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56475984|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56475985|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56475986|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56475987|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
56475988|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56475989|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475990|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
56475991|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
56475992|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56475993|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56475994|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56475995|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
56475996|NCT00518141|Aspirin|aspirin|mesh-list
56475997|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
56475998|NCT00518141|Salicylates|salicylates|mesh-list
56476003|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56476004|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56476005|NCT00518141|Analgesics|analgesics|mesh-ancestor
56476006|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
56476007|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476008|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476009|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476010|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56476011|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56476012|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476013|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476014|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56476015|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56476016|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56476017|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
56476018|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
56476019|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56476020|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56476021|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476022|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
56476023|NCT02938962|Coagulants|coagulants|mesh-ancestor
56476024|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
56408971|NCT00203034|Rasagiline|rasagiline|mesh-list
56697770|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697771|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697772|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56697773|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56697774|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
56697775|NCT00729612|Paclitaxel|paclitaxel|mesh-list
56697776|NCT00729612|Carboplatin|carboplatin|mesh-list
56697777|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56697778|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56697779|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697780|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
56697781|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56697782|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56697783|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697784|NCT05684913|Hemostatics|hemostatics|mesh-list
56697785|NCT05684913|Coagulants|coagulants|mesh-ancestor
56697786|NCT00585546|Clenbuterol|clenbuterol|mesh-list
56697787|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56697788|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56476025|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476026|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
56476027|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476028|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476029|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56476030|NCT00519116|Sirolimus|sirolimus|mesh-list
56476031|NCT00519116|Tacrolimus|tacrolimus|mesh-list
56476032|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476033|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
56476034|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476035|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56476036|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476037|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476038|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56476039|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476040|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56476041|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476042|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
56476043|NCT04691076|Fentanyl|fentanyl|mesh-list
56476044|NCT04691076|Propofol|propofol|mesh-list
56476045|NCT04691076|Esketamine|esketamine|mesh-list
56476046|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56476047|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476048|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476049|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56476050|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
56476051|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
56476052|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56476053|NCT04691076|Narcotics|narcotics|mesh-ancestor
56476054|NCT04691076|Analgesics|analgesics|mesh-ancestor
56476055|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
56476056|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476057|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56476058|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
56476059|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56476060|NCT02949206|Thrombin|thrombin|mesh-list
56476061|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
56476062|NCT02949206|Coagulants|coagulants|mesh-ancestor
56697789|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697790|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697791|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697792|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697793|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56697794|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
56697795|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697796|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56697797|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
56697798|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
56697799|NCT05288283|Cannabidiol|cannabidiol|mesh-list
56697800|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
56697801|NCT00768248|Ropivacaine|ropivacaine|mesh-list
56697802|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
56253584|NCT01882530|Ketoprofen|ketoprofen|mesh-list
56476063|NCT05108454|Micronutrients|micronutrients|mesh-list
56476064|NCT05108454|Trace Elements|trace elements|mesh-list
56476065|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476066|NCT04690608|Triamcinolone|triamcinolone|mesh-list
56476067|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56476068|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56476069|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56476070|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476071|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
56476072|NCT04690608|Hormones|hormones|mesh-ancestor
56476074|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476075|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476076|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
56476077|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476078|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476079|NCT02940561|Methotrexate|methotrexate|mesh-list
56476080|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56476081|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
56476082|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56476083|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476084|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476085|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
56476086|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476087|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476088|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
56476089|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476090|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56476091|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476092|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
56476093|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56476094|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56476095|NCT02940366|Atorvastatin|atorvastatin|mesh-list
56476096|NCT02940366|Pitavastatin|pitavastatin|mesh-list
56476097|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56224079|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476098|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56476099|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
56476100|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476101|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56476102|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56476103|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476104|NCT02940405|Ketorolac|ketorolac|mesh-list
56476105|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56476106|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56476107|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56476108|NCT02940405|Analgesics|analgesics|mesh-ancestor
56697803|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
56697804|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697805|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697806|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
56697807|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697808|NCT02589717|Atezolizumab|atezolizumab|mesh-list
56697809|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697810|NCT02602028|Colchicine|colchicine|mesh-list
56697811|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
56697812|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56697813|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56697814|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56697815|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56697816|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697817|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697818|NCT04103684|Dexamethasone|dexamethasone|mesh-list
56697819|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
56697820|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56697821|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56697822|NCT04103684|Prednisolone|prednisolone|mesh-list
56697823|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
56697824|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56697825|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
56697826|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476109|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
56476110|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476111|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476112|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476113|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56476114|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56476115|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476116|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476117|NCT02940444|Heparin|heparin|mesh-list
56476118|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
56476119|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56476120|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56476121|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476122|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
56476123|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56476124|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476125|NCT04690647|Dexamethasone|dexamethasone|mesh-list
56476126|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56476127|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476128|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
56476129|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
56476130|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476131|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476132|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476133|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
56476134|NCT04690647|Hormones|hormones|mesh-ancestor
56476135|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697827|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
56697828|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
56697829|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697830|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697831|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56697832|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
56697833|NCT04103684|Hormones|hormones|mesh-ancestor
56697834|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697835|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56697836|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697837|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56697838|NCT04103684|Protective Agents|protective agents|mesh-ancestor
56697839|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56697840|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56476136|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56476137|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476138|NCT04690647|Analgesics|analgesics|mesh-ancestor
56476139|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
56476140|NCT00519467|Artesunate|artesunate|mesh-list
56476141|NCT00519467|Dapsone|dapsone|mesh-list
56476142|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
56476143|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
56476144|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56476148|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
56476149|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
56476150|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56476151|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
56476152|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56476153|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476154|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476155|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
56476156|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56476157|NCT02940483|Azacitidine|azacitidine|mesh-list
56476158|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476159|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
56476160|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476161|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476162|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476163|NCT04974684|Apixaban|apixaban|mesh-list
56476164|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56476165|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
56476166|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56476167|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
56476168|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476169|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476170|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
56476171|NCT00520091|Celecoxib|celecoxib|mesh-list
56476172|NCT00520091|Irinotecan|irinotecan|mesh-list
56224153|NCT01682577|Perindopril|perindopril|mesh-list
56476173|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476174|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56476175|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56476176|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476177|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476178|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56476179|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56476180|NCT00520091|Analgesics|analgesics|mesh-ancestor
56476181|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
56476182|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476183|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476184|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476185|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56697841|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697842|NCT05257629|Nicotine|nicotine|mesh-list
56697843|NCT05257629|Varenicline|varenicline|mesh-list
56697844|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56697845|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
56697846|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697847|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697848|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56697849|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56697850|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
56697851|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697852|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697853|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
56697854|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55828909|NCT01533688|Cathartics|cathartics|mesh-ancestor
56476186|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56476187|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56476188|NCT00520169|Ketamine|ketamine|mesh-list
56476189|NCT00520169|Analgesics|analgesics|mesh-ancestor
56476190|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
56476191|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476192|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476193|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56476194|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56476195|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
56476196|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
56476197|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476198|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56476199|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56476200|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476201|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476202|NCT00520247|Folic Acid|folic acid|mesh-list
56476203|NCT00520247|Enalapril|enalapril|mesh-list
56476204|NCT00520247|Hematinics|hematinics|mesh-ancestor
56476205|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
56476206|NCT00520247|Vitamins|vitamins|mesh-ancestor
56476207|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
56476208|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476209|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56476210|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
56476211|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476212|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476213|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56476214|NCT00520325|Lectins|lectins|mesh-list
56476215|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
56476216|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
56476221|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56476222|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56476223|NCT00520442|Analgesics|analgesics|mesh-ancestor
56476224|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
56476225|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476226|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476227|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476228|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56476229|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56476230|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476231|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476232|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56476233|NCT00520442|Narcotics|narcotics|mesh-ancestor
56697855|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56697856|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
56697857|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56697858|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697859|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56697860|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56697861|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56697862|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56697863|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56697864|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56697865|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56697866|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697867|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697868|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697869|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
56697870|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56697871|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
56476234|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476235|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
56476236|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56476237|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
56476238|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56476239|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476240|NCT02939898|Letrozole|letrozole|mesh-list
56476241|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56476242|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476243|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56476244|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476245|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476246|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56476247|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
56476248|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224226|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476249|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476250|NCT00520754|Levocetirizine|levocetirizine|mesh-list
56476251|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56476252|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56476253|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
56476254|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
56476255|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476256|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476257|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476258|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
56476259|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
56476260|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56476261|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56476262|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476263|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476264|NCT02277132|Urological Agents|urological agents|mesh-ancestor
56476265|NCT00520949|Amoxicillin|amoxicillin|mesh-list
56476266|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56476267|NCT00520949|Furazolidone|furazolidone|mesh-list
56476268|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56476269|NCT00520949|Esomeprazole|esomeprazole|mesh-list
56476270|NCT00520949|Bismuth|bismuth|mesh-list
56476271|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56697872|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697874|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56697875|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
56697876|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56697877|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697878|NCT00439309|Thrombin|thrombin|mesh-list
56697879|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56697880|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
56697881|NCT00439309|Coagulants|coagulants|mesh-ancestor
56697882|NCT00479167|Bortezomib|bortezomib|mesh-list
56697883|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
56697884|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697885|NCT05253651|Leucovorin|leucovorin|mesh-list
56697886|NCT05253651|Bevacizumab|bevacizumab|mesh-list
56697887|NCT05253651|Trastuzumab|trastuzumab|mesh-list
56697888|NCT05253651|Cetuximab|cetuximab|mesh-list
56697889|NCT05253651|Fluorouracil|fluorouracil|mesh-list
56697890|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
56697891|NCT05253651|Tucatinib|tucatinib|mesh-list
56697892|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
56697893|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56697894|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476272|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476273|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56476274|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476275|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56476276|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476277|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476278|NCT00520949|Antacids|antacids|mesh-ancestor
56476279|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56476280|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56476281|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56476282|NCT00520949|Renal Agents|renal agents|mesh-ancestor
56476283|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56476284|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56476285|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56476286|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56476290|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56476292|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
56476293|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476294|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476295|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56476296|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56476297|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56476298|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
56476299|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476300|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476301|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56476302|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56476303|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56476304|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
56476305|NCT02938182|Clopidogrel|clopidogrel|mesh-list
56476306|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56476307|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56476308|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56476309|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56476310|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
56697895|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56697896|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56697897|NCT05253651|Growth Substances|growth substances|mesh-ancestor
56476311|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476312|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476313|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476314|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
56476315|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
56476316|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476317|NCT00521612|Sevoflurane|sevoflurane|mesh-list
56476318|NCT00521612|Isoflurane|isoflurane|mesh-list
56476319|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56224306|NCT01690091|Metformin|metformin|mesh-list
56476320|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56476321|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
56476323|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476324|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476325|NCT00521261|Antibodies|antibodies|mesh-list
56476326|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56476327|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
56476328|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476329|NCT02931591|Metformin|metformin|mesh-list
56476330|NCT02931591|Hormones|hormones|mesh-list
56476331|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56476332|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334618|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56476333|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476334|NCT00521300|Octreotide|octreotide|mesh-list
56476335|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476336|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56476337|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476338|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
56476339|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56476340|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476341|NCT00523133|Naltrexone|naltrexone|mesh-list
56476342|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56476343|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56476344|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476345|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
56476346|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476347|NCT02937792|Bupivacaine|bupivacaine|mesh-list
56476348|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
56476349|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
56476350|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476351|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476352|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
56476353|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476354|NCT02931474|Tesamorelin|tesamorelin|mesh-list
56476355|NCT02931474|Growth Substances|growth substances|mesh-ancestor
56476356|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476357|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
56476359|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
56476360|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
56476361|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
56476362|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476363|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476364|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
56476365|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476366|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56476367|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56476368|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56476369|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56476370|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476371|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56476372|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
56476373|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
56476374|NCT02931357|Protective Agents|protective agents|mesh-ancestor
56476375|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56476376|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476377|NCT02937519|Cisplatin|cisplatin|mesh-list
56476378|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476379|NCT00521963|Infliximab|infliximab|mesh-list
56476380|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
56697898|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697899|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
56253681|NCT01883505|Carbidopa|carbidopa|mesh-list
56476381|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476382|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56476383|NCT02937402|Dimercaprol|dimercaprol|mesh-list
56476384|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
56476385|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
56476386|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476387|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
56476388|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
56476389|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476390|NCT02937363|Protective Agents|protective agents|mesh-ancestor
56476391|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476392|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
56476393|NCT02937363|Vitamins|vitamins|mesh-ancestor
56476394|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
56476395|NCT02948348|Capecitabine|capecitabine|mesh-list
56476396|NCT02948348|Nivolumab|nivolumab|mesh-list
56476397|NCT02948348|Ipilimumab|ipilimumab|mesh-list
56476398|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476399|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
56476400|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476401|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476402|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56476403|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56476405|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476406|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476407|NCT00522158|Atorvastatin|atorvastatin|mesh-list
56476408|NCT00522158|Simvastatin|simvastatin|mesh-list
56476409|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56476410|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56476411|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
56476412|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476413|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56476414|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56476415|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476433|NCT02931123|Rifaximin|rifaximin|mesh-list
56476434|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56476435|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476436|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476437|NCT02936934|Morphine|morphine|mesh-list
56476438|NCT02936934|Oxycodone|oxycodone|mesh-list
56476439|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56476440|NCT02936934|Narcotics|narcotics|mesh-ancestor
56476441|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476442|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476443|NCT02936934|Analgesics|analgesics|mesh-ancestor
56476444|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
56476445|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476446|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
56476447|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56476448|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476449|NCT00522509|Floxuridine|floxuridine|mesh-list
56476450|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476451|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
56476453|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476454|NCT00522587|Remifentanil|remifentanil|mesh-list
56476455|NCT00522587|Sevoflurane|sevoflurane|mesh-list
56476456|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56476457|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56476458|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
56476459|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
56476460|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476461|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476462|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56476463|NCT00522587|Narcotics|narcotics|mesh-ancestor
56476464|NCT00522587|Analgesics|analgesics|mesh-ancestor
56476465|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
56476466|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476467|NCT00522665|Irinotecan|irinotecan|mesh-list
56476468|NCT00522665|Cetuximab|cetuximab|mesh-list
56476469|NCT00522665|Everolimus|everolimus|mesh-list
56476470|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56476471|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56697900|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
56697901|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697902|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56697903|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56697904|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
56697905|NCT05253651|Antidotes|antidotes|mesh-ancestor
56697906|NCT05253651|Protective Agents|protective agents|mesh-ancestor
56697907|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
56697908|NCT05253651|Vitamins|vitamins|mesh-ancestor
56697909|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
56697910|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56697911|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697912|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
56697913|NCT05232825|Promethazine|promethazine|mesh-list
56697914|NCT05232825|Dexamethasone|dexamethasone|mesh-list
56476472|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476473|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476474|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476475|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56476476|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476478|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476479|NCT00522743|Hormones|hormones|mesh-list
56476480|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476481|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476482|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56476483|NCT02937012|Bezafibrate|bezafibrate|mesh-list
56476484|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56476485|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476486|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56476487|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
56476488|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476489|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56476490|NCT00522782|Budesonide|budesonide|mesh-list
56476491|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
56476492|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476493|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56476494|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
56476495|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476496|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476497|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56476498|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
56476499|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
56476500|NCT00522782|Hormones|hormones|mesh-ancestor
56476501|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476502|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56476503|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
56476504|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476505|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476506|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56476507|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
56476508|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
56476509|NCT00522782|Protective Agents|protective agents|mesh-ancestor
56476510|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56476511|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
56476512|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56476513|NCT00522821|Antibodies|antibodies|mesh-list
56476514|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
56476515|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56476516|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476517|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
56476518|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697915|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
56697916|NCT05232825|Desloratadine|desloratadine|mesh-list
56697917|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
56697918|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56697919|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
56697920|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
56697921|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697922|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697923|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56697924|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
56697925|NCT05232825|Hormones|hormones|mesh-ancestor
56697926|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697927|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56697928|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697929|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56697930|NCT05232825|Protective Agents|protective agents|mesh-ancestor
56697931|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56697932|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56697933|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697934|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
56697935|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
56697936|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
56697937|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56697938|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
56697939|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
56476519|NCT02936895|Vitamin D|vitamin d|mesh-list
56476520|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
56476521|NCT02936895|Vitamins|vitamins|mesh-ancestor
56476522|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
56476523|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476524|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56476525|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56476526|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56476527|NCT00522938|Tosedostat|tosedostat|mesh-list
56476529|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56476531|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476532|NCT04694105|Dexamethasone|dexamethasone|mesh-list
56476533|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
56476534|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476535|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
56476536|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
56476537|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476538|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476539|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476540|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
56476541|NCT04694105|Hormones|hormones|mesh-ancestor
56476542|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476543|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56476544|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476545|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56476546|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697940|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697941|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697942|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56697943|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
56697944|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
56697945|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
56697946|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56697947|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
56697948|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56697949|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
56253723|NCT01884038|Treprostinil|treprostinil|mesh-list
56476547|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56476548|NCT04694105|Analgesics|analgesics|mesh-ancestor
56224527|NCT01690832|Fenoldopam|fenoldopam|mesh-list
56476549|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
56476550|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56476551|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56476553|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
56476554|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476555|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476556|NCT02930733|Bupivacaine|bupivacaine|mesh-list
56476557|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
56476558|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
56476559|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476560|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476561|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
56476562|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476563|NCT00523055|Lidocaine|lidocaine|mesh-list
56476564|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
56476565|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
56476566|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476567|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476568|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
56476569|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476570|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56476571|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56476572|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56476573|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56476574|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476575|NCT00523289|Bupivacaine|bupivacaine|mesh-list
56476576|NCT00523289|Ropivacaine|ropivacaine|mesh-list
56476577|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
56476578|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
56476579|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476580|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476581|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
56476582|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476583|NCT00524381|Etanercept|etanercept|mesh-list
56476584|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56476585|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56476586|NCT00524381|Analgesics|analgesics|mesh-ancestor
56476587|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
56476588|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476589|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476590|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476591|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56476592|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476593|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476594|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
56476595|NCT04502667|Vitamin D|vitamin d|mesh-list
56476596|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
56476597|NCT04502667|Vitamins|vitamins|mesh-ancestor
56476598|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
56476599|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697950|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56697951|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56697952|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56697953|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56697954|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697955|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
56697956|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697957|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697958|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56697959|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697960|NCT00725010|Temozolomide|temozolomide|mesh-list
56697961|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56253733|NCT01884116|Analgesics|analgesics|mesh-ancestor
56476600|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56476605|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476606|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
56476607|NCT00523406|Hormones|hormones|mesh-ancestor
56476608|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476609|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476610|NCT00524615|Spironolactone|spironolactone|mesh-list
56476611|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56476612|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
56476613|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476614|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476615|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56476616|NCT00524615|Diuretics|diuretics|mesh-ancestor
56476617|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
56476618|NCT00523445|Varenicline|varenicline|mesh-list
56476619|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56476620|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56476621|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
56476622|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476623|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476624|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476625|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
56476626|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56476627|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56476628|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476629|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
56476630|NCT02936661|Coagulants|coagulants|mesh-ancestor
56476631|NCT02948075|Paclitaxel|paclitaxel|mesh-list
56476632|NCT02948075|Carboplatin|carboplatin|mesh-list
56476633|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56476634|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476635|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
56476636|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
56476637|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
56476638|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476639|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
56476640|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
56476641|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56476642|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56476643|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476644|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476645|NCT02930811|Urological Agents|urological agents|mesh-ancestor
56476646|NCT02947880|Bumetanide|bumetanide|mesh-list
56476647|NCT02947880|Diuretics|diuretics|mesh-ancestor
56476648|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
56476649|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888218|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56697962|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
56697963|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697964|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697965|NCT05216055|Dexamethasone|dexamethasone|mesh-list
56697966|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
56697967|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
56697968|NCT05216055|Bupivacaine|bupivacaine|mesh-list
56697969|NCT05216055|Ropivacaine|ropivacaine|mesh-list
56697970|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56697971|NCT05216055|BB 1101|bb 1101|mesh-list
56476650|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56476651|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56476652|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476653|NCT04748172|Antibodies|antibodies|mesh-list
56476654|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
56476655|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476656|NCT00523757|Spironolactone|spironolactone|mesh-list
56476657|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56476658|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
56476659|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476660|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476661|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56476662|NCT00523757|Diuretics|diuretics|mesh-ancestor
56476663|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
56476664|NCT00524693|Montelukast|montelukast|mesh-list
56476665|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56476666|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
56476667|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56476668|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
56476669|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476671|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56476672|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56476673|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476674|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56476675|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56476676|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476677|NCT02936427|Dexamethasone|dexamethasone|mesh-list
56476678|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
56476679|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56476680|NCT02936427|BB 1101|bb 1101|mesh-list
56476681|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56476682|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
56476683|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
56476684|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476685|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476686|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56476687|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
56476688|NCT02936427|Hormones|hormones|mesh-ancestor
56476689|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476690|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56476691|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476692|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
56476693|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476694|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476696|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56476697|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476698|NCT02947763|Metronidazole|metronidazole|mesh-list
56476699|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
56476700|NCT02947763|Minocycline|minocycline|mesh-list
56476701|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476702|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56476703|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56476704|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56476705|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56697972|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56697973|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
56697974|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
56697975|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56697976|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56697977|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56697978|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
56697979|NCT05216055|Hormones|hormones|mesh-ancestor
56697980|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56697981|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56697982|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56697983|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
56697984|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
56697985|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56697986|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
56697987|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55875800|NCT01160848|Ethanol|ethanol|mesh-list
56476706|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56476707|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476708|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476709|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476710|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56476711|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56476713|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476714|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
56476715|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476716|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56476717|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476718|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476719|NCT00524069|Gemcitabine|gemcitabine|mesh-list
56476720|NCT00524069|Bevacizumab|bevacizumab|mesh-list
56476721|NCT00524069|Capecitabine|capecitabine|mesh-list
56476722|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56476723|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476724|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56476725|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56476726|NCT00524069|Growth Substances|growth substances|mesh-ancestor
56476727|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476728|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
56476729|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476730|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
56476731|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476732|NCT00524069|Antiviral Agents|antiviral agents|mesh-ancestor
56476733|NCT00524069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476734|NCT00524069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476735|NCT00524069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476736|NCT00524069|Immunologic Factors|immunologic factors|mesh-ancestor
56476737|NCT00524810|Docetaxel|docetaxel|mesh-list
56476738|NCT00524810|Doxorubicin|doxorubicin|mesh-list
56476739|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56476740|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476741|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56476742|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56476743|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56476744|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476747|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56476748|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697988|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56697989|NCT05216055|Analgesics|analgesics|mesh-ancestor
56697990|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56697991|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56697992|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56697993|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
56697994|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56697995|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56697996|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
56697997|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56697998|NCT00767000|Metformin|metformin|mesh-list
56697999|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
56409218|NCT01930357|Vaccines|vaccines|mesh-list
56698000|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56698001|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476749|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
56476750|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56476751|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476752|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
56476753|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56476754|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
56476755|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
56476756|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476757|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476758|NCT00524966|Hemostatics|hemostatics|mesh-list
56476759|NCT00524966|Coagulants|coagulants|mesh-ancestor
56476760|NCT02276846|Paclitaxel|paclitaxel|mesh-list
56476761|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56476762|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476763|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
56476764|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56476765|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
56476766|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476767|NCT02935725|Ketamine|ketamine|mesh-list
56476768|NCT02935725|Analgesics|analgesics|mesh-ancestor
56476769|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
56224743|NCT01692808|Vitamins|vitamins|mesh-list
56476770|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476771|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476772|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56476773|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56476774|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
56476775|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
56476776|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476777|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56476778|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56476779|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476780|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476781|NCT02935764|Leucovorin|leucovorin|mesh-list
56476782|NCT02935764|Fluorouracil|fluorouracil|mesh-list
56476783|NCT02935764|Irinotecan|irinotecan|mesh-list
56476784|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
56476785|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476786|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476787|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476788|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476789|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
56476790|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476791|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56476792|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56476793|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698002|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56698003|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698004|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698005|NCT00724932|Atropine|atropine|mesh-list
56698006|NCT00724932|Bromides|bromides|mesh-list
56698007|NCT00724932|Rocuronium|rocuronium|mesh-list
56698008|NCT00724932|Neostigmine|neostigmine|mesh-list
56698009|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
56698010|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56698011|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56698012|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56698013|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698014|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698015|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56698016|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56698017|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56698018|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
56253780|NCT01884402|Ribavirin|ribavirin|mesh-list
56476794|NCT02935764|Antidotes|antidotes|mesh-ancestor
56476795|NCT02935764|Protective Agents|protective agents|mesh-ancestor
56476796|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
56476797|NCT02935764|Vitamins|vitamins|mesh-ancestor
56476798|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
56476799|NCT02935998|Ziprasidone|ziprasidone|mesh-list
56476800|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56476801|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
56476802|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476803|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476804|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476805|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56476806|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56476807|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476808|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56476809|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56476810|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
56476811|NCT02930109|Cytarabine|cytarabine|mesh-list
56476812|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476813|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
56476814|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476815|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476816|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
56476817|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476820|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476822|NCT00524186|Fluorouracil|fluorouracil|mesh-list
56476823|NCT00524186|Irinotecan|irinotecan|mesh-list
56476824|NCT00524186|Sunitinib|sunitinib|mesh-list
56476825|NCT00524186|Calcium|calcium|mesh-list
56476826|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
56476827|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56476828|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476829|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
56476830|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476831|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476832|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476833|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476834|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
56476835|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56476836|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56476837|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698019|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56698020|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
56698021|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
56698022|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
56698023|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56476838|NCT00524186|Antidotes|antidotes|mesh-ancestor
56476839|NCT00524186|Protective Agents|protective agents|mesh-ancestor
56476840|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
56476841|NCT00524186|Vitamins|vitamins|mesh-ancestor
56476842|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
56476843|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56476844|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56476845|NCT00524186|Growth Substances|growth substances|mesh-ancestor
56476846|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
56476847|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56476849|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
56476850|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476851|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56476852|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56476853|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
56476854|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476855|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
56476856|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56476857|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
56476858|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476859|NCT02930031|Expectorants|expectorants|mesh-ancestor
56476860|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
56476861|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56476862|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
56476863|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476864|NCT02930031|Protective Agents|protective agents|mesh-ancestor
56476865|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476866|NCT02930031|Antidotes|antidotes|mesh-ancestor
56476868|NCT00525200|Cisplatin|cisplatin|mesh-list
56476869|NCT00525200|Fluorouracil|fluorouracil|mesh-list
56476870|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476871|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56476872|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56476873|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56476874|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476875|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
56476876|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476877|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476878|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
56476879|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476880|NCT02930265|Liraglutide|liraglutide|mesh-list
56476881|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56476882|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476883|NCT02930265|Incretins|incretins|mesh-ancestor
56476884|NCT02930265|Hormones|hormones|mesh-ancestor
56476885|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476886|NCT02947178|Bupivacaine|bupivacaine|mesh-list
56476887|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
56476888|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
56476889|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476890|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476891|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
56476892|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476893|NCT02929797|Gemcitabine|gemcitabine|mesh-list
56476894|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476896|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476897|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476898|NCT02929797|Antiviral Agents|antiviral agents|mesh-ancestor
56476899|NCT02929797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476900|NCT02929797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476901|NCT02929797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476902|NCT02929797|Immunologic Factors|immunologic factors|mesh-ancestor
56476903|NCT02929797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476905|NCT00525239|Lopinavir|lopinavir|mesh-list
56476906|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56476907|NCT00525239|Efavirenz|efavirenz|mesh-list
56476908|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56476909|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56698024|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56698025|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
56698026|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253799|NCT01884428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476910|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
56476911|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476912|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476913|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56476914|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56476915|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
56476916|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476917|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56476918|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56224895|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476919|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56476920|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56476921|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56476922|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56476923|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56476924|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56476925|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56476926|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
56476927|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56476928|NCT02947334|Bococizumab|bococizumab|mesh-list
56476929|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56476930|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56476931|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
56476932|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476933|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56476934|NCT00525278|Levocetirizine|levocetirizine|mesh-list
56476935|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56476936|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56476937|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
56476938|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
56476939|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476940|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476941|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476942|NCT02929719|Dapsone|dapsone|mesh-list
56476943|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476944|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
56476945|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56476946|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56476947|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56476948|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476949|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476950|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
56476951|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56476952|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56476953|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476954|NCT02929524|Ketamine|ketamine|mesh-list
56476955|NCT02929524|Analgesics|analgesics|mesh-ancestor
56476956|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
56476957|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56476958|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476959|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56476960|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56476961|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
56476962|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
56476963|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56476964|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56476965|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56476966|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56476967|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476969|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
56476970|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476971|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56476972|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476973|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698027|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698028|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56698029|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698030|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56698031|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56698032|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56698033|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698034|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698035|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56698036|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
56698037|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56698038|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698039|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56698040|NCT04083807|Thrombin|thrombin|mesh-list
56698041|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
56698042|NCT04083807|Coagulants|coagulants|mesh-ancestor
56698043|NCT05163483|Bevacizumab|bevacizumab|mesh-list
56698044|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56698045|NCT05163483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698046|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698047|NCT05163483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56698048|NCT05163483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56476974|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
56476975|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476976|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56476977|NCT00526175|Cytarabine|cytarabine|mesh-list
56476978|NCT00526175|Prednisone|prednisone|mesh-list
56476979|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
56476980|NCT00526175|Methotrexate|methotrexate|mesh-list
56476981|NCT00526175|Vincristine|vincristine|mesh-list
56476982|NCT00526175|Daunorubicin|daunorubicin|mesh-list
56476983|NCT00526175|Asparaginase|asparaginase|mesh-list
56476984|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
56476985|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476986|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
56476987|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476988|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56476989|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56476990|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
56476991|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476992|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476993|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56476994|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224986|NCT05288374|Celecoxib|celecoxib|mesh-list
56476995|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
56476996|NCT00526175|Hormones|hormones|mesh-ancestor
56476997|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476998|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56476999|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56477000|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
56477001|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56477002|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56698049|NCT05163483|Growth Substances|growth substances|mesh-ancestor
56698050|NCT05163483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698051|NCT05163483|Growth Inhibitors|growth inhibitors|mesh-ancestor
56698052|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477003|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
56477004|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
56477005|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477006|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56477007|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56477008|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56477009|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
56477010|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
56477011|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
56477012|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
56477013|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477014|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56477015|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56477016|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56477017|NCT02929563|Pantoprazole|pantoprazole|mesh-list
56477018|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56477019|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56477020|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56477021|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477022|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477023|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
56477024|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56477025|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
56477026|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477027|NCT00525551|Expectorants|expectorants|mesh-ancestor
56477028|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
56477029|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56477030|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
56477031|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477032|NCT00525551|Protective Agents|protective agents|mesh-ancestor
56477033|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477034|NCT00525551|Antidotes|antidotes|mesh-ancestor
56477035|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
56477036|NCT04288323|Edetic Acid|edetic acid|mesh-list
56477037|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
56477038|NCT04288323|Antidotes|antidotes|mesh-ancestor
56477039|NCT04288323|Protective Agents|protective agents|mesh-ancestor
56477040|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477041|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
56477043|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477044|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56477046|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56477047|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56477048|NCT02946359|Bevacizumab|bevacizumab|mesh-list
56477049|NCT02946359|Crizotinib|crizotinib|mesh-list
56477050|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56477051|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477052|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56477053|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56477054|NCT02946359|Growth Substances|growth substances|mesh-ancestor
56477055|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477056|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
56477057|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56477058|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477059|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477060|NCT02946437|Midazolam|midazolam|mesh-list
56477061|NCT02946437|Propofol|propofol|mesh-list
56477062|NCT02946437|Sevoflurane|sevoflurane|mesh-list
56477063|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56477064|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477065|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477066|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56477067|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
56477068|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
56477069|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56477070|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56477071|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56225041|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
56698053|NCT05511038|Aflibercept|aflibercept|mesh-list
56698054|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56698055|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56698056|NCT05511038|Growth Substances|growth substances|mesh-ancestor
56698057|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698058|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
56698059|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698060|NCT05161533|Cisplatin|cisplatin|mesh-list
56698061|NCT05161533|Carboplatin|carboplatin|mesh-list
56698062|NCT05161533|Etoposide|etoposide|mesh-list
56698063|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
56698064|NCT05161533|Durvalumab|durvalumab|mesh-list
56698065|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
56698066|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
56698067|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56477073|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
56477074|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
56477075|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477076|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477077|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56477078|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56477079|NCT02946632|Metformin|metformin|mesh-list
56477080|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56477081|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
56477082|NCT02946632|Glimepiride|glimepiride|mesh-list
56477083|NCT02946632|Saxagliptin|saxagliptin|mesh-list
56477084|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56477085|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477086|NCT02946632|Incretins|incretins|mesh-ancestor
56477087|NCT02946632|Hormones|hormones|mesh-ancestor
56477088|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56477089|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56477090|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
56477091|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477092|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477093|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56477094|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56477095|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56477096|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
56477097|NCT02929134|Doxycycline|doxycycline|mesh-list
56477098|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56477099|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477100|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
56477101|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56477102|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56477103|NCT02929212|Acetaminophen|acetaminophen|mesh-list
56477104|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56477105|NCT02929212|Analgesics|analgesics|mesh-ancestor
56477106|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
56477107|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477108|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477109|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
56477110|NCT02929251|Adalimumab|adalimumab|mesh-list
56477111|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56477112|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477113|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477114|NCT02929095|Midazolam|midazolam|mesh-list
56477115|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
56477116|NCT02929095|Remifentanil|remifentanil|mesh-list
56477117|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56477120|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56477121|NCT02929095|Analgesics|analgesics|mesh-ancestor
56477122|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
56477123|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477124|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56698068|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
56698069|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698070|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56698071|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56698072|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56698073|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698074|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698075|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698077|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698078|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
56698079|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
56477125|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56477126|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56477127|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
56477128|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477129|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477130|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56477131|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56477132|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56477133|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56477134|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56477135|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
56477136|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
56477137|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
56477138|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
56477139|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56477140|NCT02929095|Narcotics|narcotics|mesh-ancestor
56477141|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56477142|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56477143|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477144|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56477145|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
56477146|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477147|NCT00525668|Protective Agents|protective agents|mesh-ancestor
56477148|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477149|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56477150|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56477151|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477152|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56477153|NCT00525707|Tezosentan|tezosentan|mesh-list
56477155|NCT00526214|Celecoxib|celecoxib|mesh-list
56477156|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56477157|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56477158|NCT00526214|Analgesics|analgesics|mesh-ancestor
56477159|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
56477160|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477161|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477162|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477163|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477164|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56477165|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56477166|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477167|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477168|NCT02928510|Idelalisib|idelalisib|mesh-list
56477169|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477170|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477171|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477172|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
56477173|NCT02946944|Apixaban|apixaban|mesh-list
56477174|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
56477175|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56477176|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56477177|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698080|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
56698081|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
56698082|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
56698083|NCT00766142|Leucovorin|leucovorin|mesh-list
56698084|NCT00766142|Fluorouracil|fluorouracil|mesh-list
56698085|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
56698086|NCT00766142|Cetuximab|cetuximab|mesh-list
56698087|NCT00766142|Calcium|calcium|mesh-list
56698088|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
56698089|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56698090|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698091|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
56698092|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698093|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56698094|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698095|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698096|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
56698097|NCT00766142|Antidotes|antidotes|mesh-ancestor
56698098|NCT00766142|Protective Agents|protective agents|mesh-ancestor
56698099|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
56698100|NCT00766142|Vitamins|vitamins|mesh-ancestor
56698101|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
56698102|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698103|NCT00916526|Mannitol|mannitol|mesh-list
56698104|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56698105|NCT00916526|Diuretics|diuretics|mesh-ancestor
56698106|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
56698107|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698108|NCT00724854|Ribavirin|ribavirin|mesh-list
56698109|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56698110|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
56698111|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
56698112|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698113|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
56698114|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253850|NCT01884506|Vitamins|vitamins|mesh-ancestor
56477178|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477179|NCT02946944|Urological Agents|urological agents|mesh-ancestor
56477180|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56477181|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
56477182|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56477183|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56477184|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
56477185|NCT02947061|Docetaxel|docetaxel|mesh-list
56698115|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
56698116|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698117|NCT04083651|Bromides|bromides|mesh-list
56698118|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
56698119|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
56698120|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56698121|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698122|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
56698123|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698124|NCT00728988|Atorvastatin|atorvastatin|mesh-list
56698125|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56698126|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56698127|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
56698128|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698129|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56698130|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56698131|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698132|NCT05133531|Ravulizumab|ravulizumab|mesh-list
56698133|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56698134|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698135|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
56698136|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698137|NCT04087746|Ranibizumab|ranibizumab|mesh-list
56698138|NCT04087746|Aflibercept|aflibercept|mesh-list
56698139|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56698140|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56698141|NCT04087746|Growth Substances|growth substances|mesh-ancestor
56698142|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698149|NCT02588937|Entecavir|entecavir|mesh-list
56698161|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56698162|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
56698163|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
56698164|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
56698165|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
56698166|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698167|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698168|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56698169|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56698170|NCT04083105|Analgesics|analgesics|mesh-ancestor
56698171|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
56698172|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698173|NCT00735696|Paclitaxel|paclitaxel|mesh-list
56698174|NCT00735696|Carboplatin|carboplatin|mesh-list
56698175|NCT00735696|Ramucirumab|ramucirumab|mesh-list
56698176|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56477186|NCT02947061|Capecitabine|capecitabine|mesh-list
56477187|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477188|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
56477189|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
56477190|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
56477191|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477193|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
56477194|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
56477195|NCT02928315|Analgesics|analgesics|mesh-ancestor
56477196|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
56477197|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477198|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477199|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
56477200|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477201|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56477202|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
56477203|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56477204|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56477205|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477206|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56477207|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
56477208|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56477209|NCT00526409|Cytarabine|cytarabine|mesh-list
56477210|NCT00526409|Prednisolone|prednisolone|mesh-list
56477211|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
56477212|NCT00526409|Methotrexate|methotrexate|mesh-list
56477213|NCT00526409|Vincristine|vincristine|mesh-list
56477214|NCT00526409|Daunorubicin|daunorubicin|mesh-list
56477215|NCT00526409|Asparaginase|asparaginase|mesh-list
56477216|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56477217|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
56477218|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477219|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477220|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56477221|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
56477222|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477223|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477224|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56477225|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56477226|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
56477227|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55978287|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
56477228|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56477229|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
56477230|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56698177|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698178|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
56698179|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
56698180|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
56698181|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698182|NCT02593968|Interferons|interferons|mesh-list
56698183|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698184|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
56698185|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698186|NCT02588547|Granisetron|granisetron|mesh-list
56698187|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
56477231|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477232|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56477233|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56477234|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56477235|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
56477236|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
56477237|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
56477238|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477239|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
56477240|NCT00526409|Hormones|hormones|mesh-ancestor
56477241|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56477242|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56477243|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
56477244|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477245|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56477246|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56477247|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56477248|NCT00526448|Ribavirin|ribavirin|mesh-list
56477249|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56477250|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
56477251|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477252|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
56477253|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477254|NCT02946671|Nivolumab|nivolumab|mesh-list
56477255|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
56477256|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56477257|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477258|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56477259|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477260|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
56477261|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56477262|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56477263|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477267|NCT02945280|Apixaban|apixaban|mesh-list
56477268|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56477269|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
56477270|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56477271|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
56477272|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477273|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477274|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
56477275|NCT04692623|Insulin|insulin|mesh-list
56477276|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56477277|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
56477278|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
56477279|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56477280|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477281|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56477282|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477283|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56477284|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56477285|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477286|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107428|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
56698188|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
56698189|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698190|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698191|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56698192|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56698193|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
56698194|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698195|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698196|NCT00478231|Maraviroc|maraviroc|mesh-list
56698197|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56698198|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56698199|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477287|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477288|NCT02945241|Vancomycin|vancomycin|mesh-list
56477289|NCT02945241|Cystatins|cystatins|mesh-list
56477290|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56477291|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477292|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56477293|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
56477294|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477295|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477296|NCT00526643|Gemcitabine|gemcitabine|mesh-list
56477297|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225275|NCT05294640|Lidocaine|lidocaine|mesh-list
56477298|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56477299|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
56477300|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477301|NCT00526643|Antiviral Agents|antiviral agents|mesh-ancestor
56477302|NCT00526643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477303|NCT00526643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477304|NCT00526643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56477305|NCT00526643|Immunologic Factors|immunologic factors|mesh-ancestor
56477306|NCT00526643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477307|NCT02945163|Tenofovir|tenofovir|mesh-list
56477308|NCT02945163|Lamivudine|lamivudine|mesh-list
56477309|NCT02945163|Efavirenz|efavirenz|mesh-list
56477310|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
56477311|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477312|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56477313|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56477314|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477315|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477316|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56477317|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56477318|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56477319|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56477320|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56477321|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56477322|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56477323|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56477324|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
56477325|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56477326|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477327|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477328|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56477329|NCT00526760|Analgesics|analgesics|mesh-ancestor
56477330|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
56477331|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477332|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56477333|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56698200|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56698201|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56698202|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
56698203|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698204|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56698205|NCT00474175|Benzocaine|benzocaine|mesh-list
56698206|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
56698207|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
56698208|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698209|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477334|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56477337|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477339|NCT02927379|Ketamine|ketamine|mesh-list
56477340|NCT02927379|Bupivacaine|bupivacaine|mesh-list
56477341|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
56477342|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
56477343|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477344|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477345|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
56477346|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477347|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56477348|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56477349|NCT02927379|Analgesics|analgesics|mesh-ancestor
56477350|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56477351|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56477352|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56477353|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
56477354|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477355|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477356|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56477357|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56477358|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
56477359|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56477360|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56477361|NCT00526877|Risperidone|risperidone|mesh-list
56477362|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56477363|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
56477364|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477365|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477366|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477367|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56477368|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56477369|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477370|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56477371|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56477372|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
56477373|NCT02927496|Doxycycline|doxycycline|mesh-list
56477374|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56477375|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477376|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
56477377|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56477378|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56477379|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56477380|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477381|NCT00527033|Mirabegron|mirabegron|mesh-list
56477382|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56477383|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56477384|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56477385|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
56477386|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477387|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477388|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477389|NCT00527033|Urological Agents|urological agents|mesh-ancestor
56477390|NCT02945072|Sevoflurane|sevoflurane|mesh-list
56477391|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56698210|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
56698211|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698212|NCT03002389|Fluticasone|fluticasone|mesh-list
56698213|NCT03002389|Xhance|xhance|mesh-list
56698214|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477392|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56477393|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
56477394|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
56477395|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477396|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477397|NCT02924922|Mannitol|mannitol|mesh-list
56477398|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56477399|NCT02924922|Diuretics|diuretics|mesh-ancestor
56477400|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
56477401|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477402|NCT04692896|Lidocaine|lidocaine|mesh-list
56477403|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
56477404|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
56477405|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477406|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477407|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
56477409|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56477410|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56477411|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56477412|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56477413|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477414|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
56477415|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56477416|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
56477417|NCT00528008|Povidone|povidone|mesh-list
56477418|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56477419|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477420|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
56477421|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
56477422|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
56477423|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
56477424|NCT04692740|Chlorambucil|chlorambucil|mesh-list
56477425|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56477426|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
56477427|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477428|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477429|NCT02925000|Vinorelbine|vinorelbine|mesh-list
56477430|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56477431|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477432|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
56477433|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
56477434|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
56477435|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477436|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
56477437|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56477438|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56477439|NCT02945696|Ropivacaine|ropivacaine|mesh-list
56477440|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
56477441|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
56477442|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477443|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477444|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
56477445|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477446|NCT02924766|Prednisone|prednisone|mesh-list
56477449|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477450|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
56477451|NCT02924766|Hormones|hormones|mesh-ancestor
56477452|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56477453|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477454|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56477455|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477456|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56477457|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477458|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477459|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
56477460|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56698215|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56698216|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
56698217|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698218|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698219|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56698220|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
56698221|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
56698222|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56698223|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56698224|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
56698225|NCT04082949|Coagulants|coagulants|mesh-ancestor
56698226|NCT01020643|Propofol|propofol|mesh-list
56698227|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56698228|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698229|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698230|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56698231|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
56477461|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56477462|NCT00528281|Pemetrexed|pemetrexed|mesh-list
56477463|NCT00528281|Lapatinib|lapatinib|mesh-list
56477464|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477465|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477466|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477467|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56477468|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56477469|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56477470|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
56477471|NCT01580501|Tadalafil|tadalafil|mesh-list
56477472|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
56477473|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56477474|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56477475|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477476|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477477|NCT01580501|Urological Agents|urological agents|mesh-ancestor
56477478|NCT02924532|Hormones|hormones|mesh-list
56477479|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
56477480|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56477481|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477483|NCT00528359|Olanzapine|olanzapine|mesh-list
56477484|NCT00528359|Risperidone|risperidone|mesh-list
56477485|NCT00528359|Aripiprazole|aripiprazole|mesh-list
56477486|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56477487|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56477488|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
56477489|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477490|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477491|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477492|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56477493|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56477494|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477495|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56477496|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56477497|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
56477498|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
56477499|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
56477500|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477501|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56477502|NCT00528359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56477503|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56698232|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
56698233|NCT03537391|Fluorides|fluorides|mesh-list
56698234|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
56698235|NCT03537391|Protective Agents|protective agents|mesh-ancestor
56698236|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698237|NCT04082715|Celecoxib|celecoxib|mesh-list
56698238|NCT04082715|Levodopa|levodopa|mesh-list
56698239|NCT04082715|Carbidopa|carbidopa|mesh-list
56698240|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56698241|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56698242|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56698243|NCT04082715|Analgesics|analgesics|mesh-ancestor
56698244|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
56698245|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698246|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698247|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56698248|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56698249|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56698250|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56698251|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698252|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698253|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56477504|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56477505|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
56477506|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
56477507|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56477508|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56477509|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56477510|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56477511|NCT02924727|Valsartan|valsartan|mesh-list
56477512|NCT02924727|Ramipril|ramipril|mesh-list
56477513|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56477514|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56477515|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56477516|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56477517|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225499|NCT05273242|Artesunate|artesunate|mesh-list
56477518|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56477519|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
56477520|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477521|NCT00527150|Varenicline|varenicline|mesh-list
56477522|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56477523|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56477524|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
56477525|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477526|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477527|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477528|NCT00527228|Deflazacort|deflazacort|mesh-list
56477529|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477530|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56477531|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
56477532|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698254|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56698255|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
56698256|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698257|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56698258|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56698259|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
56698260|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
56698261|NCT00443209|Rizatriptan|rizatriptan|mesh-list
56698262|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56698263|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
56698264|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698265|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477533|NCT00527267|Cinacalcet|cinacalcet|mesh-list
56477534|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56477535|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477536|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56477537|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
56477538|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56477539|NCT02924454|Metoprolol|metoprolol|mesh-list
56477540|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56477541|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56477542|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
56477543|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56477544|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56477545|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
56477546|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
56477547|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477548|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477549|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56477550|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56477551|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56477552|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56477555|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56477557|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56477558|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477559|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56477560|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56477561|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477562|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477563|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477564|NCT00528515|Propofol|propofol|mesh-list
56477565|NCT00528515|Desflurane|desflurane|mesh-list
56477566|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56477567|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477568|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477569|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56477570|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
56477571|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
56477572|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56477573|NCT02923986|Dasatinib|dasatinib|mesh-list
56477574|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477575|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56477576|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477577|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477578|NCT02926248|Colchicine|colchicine|mesh-list
56477579|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
56477580|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477581|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56477582|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56477583|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56477584|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698266|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698267|NCT02588235|Atorvastatin|atorvastatin|mesh-list
56698268|NCT02588235|Ezetimibe|ezetimibe|mesh-list
56698269|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56698270|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56698271|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
56698272|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698273|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56698274|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56698275|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698276|NCT01020955|Mecasermin|mecasermin|mesh-list
56698277|NCT01020955|Growth Substances|growth substances|mesh-ancestor
56698278|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698279|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
56698280|NCT03519997|Bavituximab|bavituximab|mesh-list
56698281|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698282|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698283|NCT04082793|Diclofenac|diclofenac|mesh-list
56698284|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56698285|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56698286|NCT04082793|Analgesics|analgesics|mesh-ancestor
56698287|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
56698288|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698289|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698290|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56698291|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56698292|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56698293|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698294|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698295|NCT00439231|Lenalidomide|lenalidomide|mesh-list
56698296|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
56698297|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698298|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56477585|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477586|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
56477587|NCT00528593|Hematinics|hematinics|mesh-ancestor
56477588|NCT02926326|Azithromycin|azithromycin|mesh-list
56477589|NCT02926326|Acumapimod|acumapimod|mesh-list
56477590|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56477591|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477592|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56477593|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698299|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56698300|NCT00439231|Growth Substances|growth substances|mesh-ancestor
56698301|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
56698302|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698303|NCT00783692|Vedolizumab|vedolizumab|mesh-list
56698304|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56698305|NCT04973163|Midazolam|midazolam|mesh-list
56698306|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56698307|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56698308|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698309|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698310|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56698311|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56698312|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56698313|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56698314|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
56698316|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
56698317|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
56698318|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698319|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698320|NCT00783224|Fluticasone|fluticasone|mesh-list
56698321|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
56698322|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56698323|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56698324|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
56698325|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698326|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698327|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56698328|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
56698329|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
56698330|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56698331|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56698332|NCT04082559|Metronidazole|metronidazole|mesh-list
56698333|NCT04082559|Doxycycline|doxycycline|mesh-list
56698334|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
56477594|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477595|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
56477596|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
56477597|NCT00528827|Nicardipine|nicardipine|mesh-list
56477598|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56477599|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56477600|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56698335|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56698336|NCT04082559|Complement Factor H|complement factor h|mesh-list
56698337|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698338|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
56698339|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56698340|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56698341|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
56698342|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56698343|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56698344|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698345|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698346|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477601|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477602|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56477603|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477604|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
56477605|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
56477606|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56477607|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
56477608|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56477609|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
56477610|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477611|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477612|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
56477613|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56477614|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477615|NCT04691687|Furosemide|furosemide|mesh-list
56477616|NCT04691687|Diuretics|diuretics|mesh-ancestor
56477617|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
56477618|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477619|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56477620|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56477621|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477622|NCT04107675|Cyclosporine|cyclosporine|mesh-list
56477623|NCT04107675|Cyclosporins|cyclosporins|mesh-list
56477624|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477627|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
56477628|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477629|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
56477630|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477631|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
56477632|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477633|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56477634|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
56477635|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56477636|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477637|NCT02923869|Bupivacaine|bupivacaine|mesh-list
56477638|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
56477639|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
56477640|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
56477641|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477642|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477643|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
56477644|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477645|NCT02923791|Lenograstim|lenograstim|mesh-list
56477646|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56477647|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
56477648|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477650|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56477651|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56477652|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
56477653|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698347|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56698348|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56698349|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56698350|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698351|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
56698352|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698353|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
56698354|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56698355|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56698356|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698357|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
56698358|NCT02587845|Coagulants|coagulants|mesh-ancestor
56698359|NCT00765674|Amlodipine|amlodipine|mesh-list
56698360|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56698361|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56698362|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56254107|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477654|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477655|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477656|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56477657|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56477658|NCT00527501|Travoprost|travoprost|mesh-list
56477659|NCT00527501|Brinzolamide|brinzolamide|mesh-list
56477660|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56477661|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56477662|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477663|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477664|NCT00527540|Interferons|interferons|mesh-list
56477665|NCT00527540|Ribavirin|ribavirin|mesh-list
56225651|NCT05215548|Afatinib|afatinib|mesh-list
56477666|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
56477667|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
56477668|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56477669|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477670|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
56477671|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477672|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
56477673|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477674|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
56477675|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477676|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
56477678|NCT02926053|Interleukin-2|interleukin-2|mesh-list
56477679|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56477680|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
56477681|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477682|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477683|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56477684|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
56477685|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477686|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477687|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56477688|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56477689|NCT02926053|Analgesics|analgesics|mesh-ancestor
56477690|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
56477691|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477692|NCT00527657|Thalidomide|thalidomide|mesh-list
56477693|NCT00527657|Temozolomide|temozolomide|mesh-list
56477694|NCT00527657|Lomustine|lomustine|mesh-list
56698363|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56698364|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698365|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56698366|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698367|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
56698368|NCT00765674|Diuretics|diuretics|mesh-ancestor
56698369|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
56698370|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56698371|NCT04933617|Prednisone|prednisone|mesh-list
56698372|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
56698373|NCT04933617|Rituximab|rituximab|mesh-list
56698374|NCT04933617|Doxorubicin|doxorubicin|mesh-list
56477695|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56477696|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
56477697|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477699|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56477700|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
56477701|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477702|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
56477703|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56477704|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477705|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56477706|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56477707|NCT00527657|Growth Substances|growth substances|mesh-ancestor
56477708|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
56477709|NCT00528983|Azacitidine|azacitidine|mesh-list
56477710|NCT00528983|Cc-486|cc-486|mesh-list
56477711|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56477712|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
56477713|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477714|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477715|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477716|NCT00529022|Carboplatin|carboplatin|mesh-list
56477717|NCT00529022|Azacitidine|azacitidine|mesh-list
56477718|NCT00529022|Valproic Acid|valproic acid|mesh-list
56477719|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477720|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56477721|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
56477722|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477723|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477724|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
56477725|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
56477726|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477727|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477728|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
56477729|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56477730|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477731|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56477732|NCT02923557|Pirarubicin|pirarubicin|mesh-list
56225727|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477733|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225728|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225729|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
56225730|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
56225731|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334640|NCT00066846|Vitamins|vitamins|mesh-ancestor
56225732|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225748|NCT05129137|Nefopam|nefopam|mesh-list
56477734|NCT02925975|Carvedilol|carvedilol|mesh-list
56477735|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56477736|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56477737|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
56477738|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56107429|NCT00003421|Prednisolone|prednisolone|mesh-list
56698375|NCT04933617|Etoposide|etoposide|mesh-list
56698376|NCT04933617|Vincristine|vincristine|mesh-list
56698377|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698378|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
56698379|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698380|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56698381|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56698382|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
56698383|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698384|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698385|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56698386|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698387|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56698388|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56698389|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56698390|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698391|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56698392|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
56698393|NCT04933617|Hormones|hormones|mesh-ancestor
56698394|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56698395|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56698396|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56698397|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
56477739|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477740|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477741|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56477742|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
56477743|NCT02925975|Protective Agents|protective agents|mesh-ancestor
56477744|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56477745|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56477746|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56477747|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
56477748|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56477749|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56477750|NCT02945033|Aspirin|aspirin|mesh-list
56477751|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56477752|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56477753|NCT02945033|Analgesics|analgesics|mesh-ancestor
56477754|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
56477755|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477756|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477757|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477758|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477759|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56477760|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56477761|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477762|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56477763|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56698398|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
56698399|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
56698400|NCT00586898|Ketoconazole|ketoconazole|mesh-list
56698401|NCT00586898|Bicalutamide|bicalutamide|mesh-list
56698402|NCT00586898|Testosterone|testosterone|mesh-list
56698403|NCT00586898|Estrogens|estrogens|mesh-list
56698404|NCT00586898|Androgens|androgens|mesh-ancestor
56698405|NCT00586898|Hormones|hormones|mesh-ancestor
56698406|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56698407|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698408|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698409|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
56698410|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698411|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56698412|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56698413|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698414|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698415|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56698416|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
56477767|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
56477768|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477769|NCT00529295|Misoprostol|misoprostol|mesh-list
56477770|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56477771|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
56477772|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56477773|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477774|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56477775|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56477776|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
56477777|NCT02922933|Entinostat|entinostat|mesh-list
56477778|NCT02922933|Omeprazole|omeprazole|mesh-list
56477779|NCT02922933|Famotidine|famotidine|mesh-list
56477780|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56477781|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56477782|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56477783|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477784|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477785|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56477786|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
56477787|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
56477788|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477789|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477790|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477791|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56477792|NCT02945267|Tegafur|tegafur|mesh-list
56477793|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
56477794|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56477795|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
56477796|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477797|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477798|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56477799|NCT00529646|APD791|apd791|mesh-list
56477800|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56477801|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56477802|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
56477803|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888219|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698417|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56698418|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
56698419|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
56698420|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698421|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698422|NCT04099238|Warfarin|warfarin|mesh-list
56698423|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
56698424|NCT04099238|Dabigatran|dabigatran|mesh-list
56698425|NCT04099238|Apixaban|apixaban|mesh-list
56698426|NCT04099238|Anticoagulants|anticoagulants|mesh-list
56698427|NCT04099238|Edoxaban|edoxaban|mesh-list
56698428|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
56698429|NCT04099238|Phenindione|phenindione|mesh-list
56698430|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56698431|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
56698432|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56698433|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
56698434|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698435|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698436|NCT04932135|Hormones|hormones|mesh-list
56698437|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56477804|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477805|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477806|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
56477807|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477808|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
56477809|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56477810|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477811|NCT00529880|Cytarabine|cytarabine|mesh-list
56477812|NCT00529880|Fludarabine|fludarabine|mesh-list
56477813|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477814|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56477815|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
56477816|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477817|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56477818|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
56477819|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477820|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
56477821|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477822|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56477823|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477824|NCT00531089|Rituximab|rituximab|mesh-list
56477825|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56477826|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477827|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
56477828|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477829|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477830|NCT02922699|Omeprazole|omeprazole|mesh-list
56477831|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56477832|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56477833|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56477834|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477835|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477836|NCT02922660|Remifentanil|remifentanil|mesh-list
56477837|NCT02922660|Anesthetics|anesthetics|mesh-list
56477838|NCT02922660|Propofol|propofol|mesh-list
56477840|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698438|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698439|NCT04924101|Cisplatin|cisplatin|mesh-list
56698440|NCT04924101|Carboplatin|carboplatin|mesh-list
56698441|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
56698442|NCT04924101|Etoposide|etoposide|mesh-list
56698443|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
56698444|NCT04924101|Lenvatinib|lenvatinib|mesh-list
56698445|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698446|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698447|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56698448|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56698449|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56254197|NCT01886638|Abacavir|abacavir|mesh-list
56477841|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477842|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56477843|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56477844|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
56477845|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56477847|NCT02922660|Analgesics|analgesics|mesh-ancestor
56477848|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
56477849|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477850|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56477851|NCT02922465|Clopidogrel|clopidogrel|mesh-list
56477852|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56477853|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56477854|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56477855|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56477856|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
56477857|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477858|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477859|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477860|NCT02944292|Propofol|propofol|mesh-list
56477861|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56477862|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477863|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477864|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56477865|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
56477866|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
56477867|NCT02922426|Olanzapine|olanzapine|mesh-list
56477868|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
56477869|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
56477870|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477871|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477872|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56477873|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56477874|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56477875|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477876|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56477877|NCT02922426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56477878|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56477879|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56477880|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477882|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
56477883|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
56477884|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56477885|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
56477886|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477887|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56477888|NCT02925351|Clofarabine|clofarabine|mesh-list
56477889|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56477890|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
56477891|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477892|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698450|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698451|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698452|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56698453|NCT04101812|Doxorubicin|doxorubicin|mesh-list
56698454|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56698455|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56698456|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698457|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56698458|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56698459|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698460|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698461|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56698462|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56698463|NCT04923867|Estradiol|estradiol|mesh-list
56477893|NCT00531167|Lamivudine|lamivudine|mesh-list
56477894|NCT00531167|Adefovir|adefovir|mesh-list
56477895|NCT00531167|Entecavir|entecavir|mesh-list
56477896|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56477897|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56477898|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477899|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477900|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
56477901|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477902|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56477903|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56477904|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
56477905|NCT02944214|Febuxostat|febuxostat|mesh-list
56477906|NCT02944214|Benzbromarone|benzbromarone|mesh-list
56477907|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
56477908|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477909|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
56477910|NCT02944214|Renal Agents|renal agents|mesh-ancestor
56477911|NCT02922075|Amoxicillin|amoxicillin|mesh-list
56477912|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
56477913|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56477914|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477919|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56477920|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56477921|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56477922|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
56477924|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
56477925|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
56477926|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56477927|NCT02922348|Hormones|hormones|mesh-list
56477928|NCT02922348|Estradiol|estradiol|mesh-list
56477929|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56477930|NCT02922348|Progestins|progestins|mesh-list
56477931|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56477932|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477933|NCT02922348|Estrogens|estrogens|mesh-ancestor
56477934|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56477935|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56477936|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56477937|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56477938|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56477939|NCT02922387|Varenicline|varenicline|mesh-list
56477940|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56477941|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56477942|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
56477943|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477944|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477945|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477946|NCT00531323|Etravirine|etravirine|mesh-list
56698464|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56698465|NCT04923867|Estrogens|estrogens|mesh-ancestor
56698466|NCT04923867|Hormones|hormones|mesh-ancestor
56698467|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56698468|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698469|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56698470|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
56698471|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56698472|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56698473|NCT02587533|Dopamine|dopamine|mesh-list
56698474|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56698475|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
56698476|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
56477947|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56477948|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56477949|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477950|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477951|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
56477952|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56477953|NCT00531362|Aspirin|aspirin|mesh-list
56477954|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56477955|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56477956|NCT00531362|Analgesics|analgesics|mesh-ancestor
56477957|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
56477958|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477959|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477960|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56477961|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56477962|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56477963|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56477964|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477965|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56477966|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56477967|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477968|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
56477969|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
56477970|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477971|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477972|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477973|NCT00531440|Everolimus|everolimus|mesh-list
56477974|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477975|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56477976|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
56477977|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477978|NCT02944526|Ropivacaine|ropivacaine|mesh-list
56477979|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
56477980|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
56477981|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477982|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477983|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
56477984|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477985|NCT04000854|Calcium|calcium|mesh-list
56477987|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477988|NCT00530387|Ibuprofen|ibuprofen|mesh-list
56477989|NCT00530387|Diclofenac|diclofenac|mesh-list
56477990|NCT00530387|Ketoprofen|ketoprofen|mesh-list
56477991|NCT00530387|Piroxicam|piroxicam|mesh-list
56477992|NCT00530387|Salicylates|salicylates|mesh-list
56477993|NCT00530387|Etofenamate|etofenamate|mesh-list
56477994|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
56477995|NCT00530387|Homosalate|homosalate|mesh-list
56477996|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
56477997|NCT00530387|Benzophenone|benzophenone|mesh-list
55888220|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
56698477|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698478|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698479|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
56698480|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698481|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698482|NCT02587533|Protective Agents|protective agents|mesh-ancestor
56698483|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
56698484|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698485|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
56698486|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698487|NCT04847661|Mefloquine|mefloquine|mesh-list
56698488|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
56254235|NCT01887184|Analgesics|analgesics|mesh-ancestor
56477998|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56477999|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56478000|NCT00530387|Analgesics|analgesics|mesh-ancestor
56478001|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
56478002|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478003|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478004|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478005|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478006|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56478007|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478008|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478009|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56478010|NCT00530387|Protective Agents|protective agents|mesh-ancestor
56478011|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
56478012|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56478013|NCT04689165|Vaccines|vaccines|mesh-list
56478014|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
56478015|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478016|NCT00530582|Progesterone|progesterone|mesh-list
56478017|NCT00530582|Progestins|progestins|mesh-ancestor
56478018|NCT00530582|Hormones|hormones|mesh-ancestor
56478019|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478020|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478021|NCT02944175|Neostigmine|neostigmine|mesh-list
56478022|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56478023|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478024|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478025|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
56478026|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334647|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
56478027|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478028|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56478029|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
56478030|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478031|NCT03950817|Ketamine|ketamine|mesh-list
56478032|NCT03950817|Analgesics|analgesics|mesh-ancestor
56478033|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
56478034|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478035|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478036|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56478037|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56478038|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
56478039|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
56478040|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478041|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56478042|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56478043|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478044|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698489|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56698490|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56698491|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698492|NCT00919815|Cyclosporine|cyclosporine|mesh-list
56698493|NCT00919815|Prednisolone|prednisolone|mesh-list
56698494|NCT00919815|Cyclosporins|cyclosporins|mesh-list
56698495|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698496|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698497|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698498|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
56698499|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698500|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
56698501|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698502|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56698503|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56698504|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56698505|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56698506|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
56698507|NCT00919815|Hormones|hormones|mesh-ancestor
56698508|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254244|NCT01887197|Mannitol|mannitol|mesh-list
56478045|NCT02917746|Imiquimod|imiquimod|mesh-list
56478046|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56478047|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
56478048|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478049|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478050|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
56478051|NCT00531557|Ritonavir|ritonavir|mesh-list
56478052|NCT00531557|Darunavir|darunavir|mesh-list
56478053|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56478054|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56478055|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
56478056|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478057|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478058|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56478059|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56478065|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
56478066|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56478067|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56478068|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56478069|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56478070|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478071|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478072|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56478073|NCT00531596|Protective Agents|protective agents|mesh-ancestor
56478074|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478075|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56478076|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56478077|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56478078|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
56478079|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56478080|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478081|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56478082|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
56478083|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56698509|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56698510|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698511|NCT04835805|Nivolumab|nivolumab|mesh-list
56698512|NCT04835805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698513|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698514|NCT04835805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56698515|NCT04835805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698516|NCT00796991|Paclitaxel|paclitaxel|mesh-list
56698517|NCT00796991|Carboplatin|carboplatin|mesh-list
56698518|NCT00796991|Ipilimumab|ipilimumab|mesh-list
56698519|NCT00796991|Dacarbazine|dacarbazine|mesh-list
56698520|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56698521|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698522|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
56698523|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
56698524|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
56698525|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698526|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698527|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56698528|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56478084|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478085|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478086|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478087|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56478088|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56478089|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478090|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
56478091|NCT00531674|Tocopherols|tocopherols|mesh-list
56478092|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
56478093|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478094|NCT00531674|Protective Agents|protective agents|mesh-ancestor
56478095|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478096|NCT00531674|Vitamins|vitamins|mesh-ancestor
56478097|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
56478098|NCT00530972|Ribavirin|ribavirin|mesh-list
56478099|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56478100|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
56478101|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478102|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
56478103|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478105|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478106|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478107|NCT02943356|Tadalafil|tadalafil|mesh-list
56478108|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
56478109|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56478110|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56478111|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478112|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478113|NCT02943356|Urological Agents|urological agents|mesh-ancestor
56478114|NCT02917512|Cyclosporine|cyclosporine|mesh-list
56478116|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478117|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478118|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698529|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
56698530|NCT05678205|Cyclophosphamide|cyclophosphamide|mesh-list
56698531|NCT05678205|Fludarabine|fludarabine|mesh-list
56698532|NCT05678205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409726|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
56698533|NCT05678205|Immunologic Factors|immunologic factors|mesh-ancestor
56698543|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698544|NCT00914771|Vaccines|vaccines|mesh-list
56698545|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
56698546|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698547|NCT02586987|Durvalumab|durvalumab|mesh-list
56698548|NCT02586987|Tremelimumab|tremelimumab|mesh-list
56698549|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698550|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698560|NCT02586753|Paclitaxel|paclitaxel|mesh-list
56478119|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
56478120|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478121|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
56478122|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478123|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
56478124|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478125|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56478126|NCT02943902|Vaccines|vaccines|mesh-list
56478127|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56478128|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
56478129|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478130|NCT00531908|Furosemide|furosemide|mesh-list
56478131|NCT00531908|Diuretics|diuretics|mesh-ancestor
56478135|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56478136|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478137|NCT03403569|Triptolide|triptolide|mesh-list
56478138|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56478139|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478140|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56478141|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
56478142|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56478143|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56478144|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
56478145|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56478146|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
56478147|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478148|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478149|NCT00531791|Prednisone|prednisone|mesh-list
56478150|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478151|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
56478152|NCT00531791|Hormones|hormones|mesh-ancestor
56478153|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478154|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478155|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56478156|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478157|NCT02921178|Omalizumab|omalizumab|mesh-list
56478158|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56478159|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56478160|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
56478161|NCT00531986|Lopinavir|lopinavir|mesh-list
56478162|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56478163|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56478164|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
56478165|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478166|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478167|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56478168|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56698561|NCT02586753|Cisplatin|cisplatin|mesh-list
56698562|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56698563|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698564|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
56698565|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
56698566|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
56698567|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698568|NCT00799487|Methylphenidate|methylphenidate|mesh-list
56698569|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56698570|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698571|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56698572|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56698573|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56698574|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698575|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
56698576|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698577|NCT04713657|Propranolol|propranolol|mesh-list
56698578|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56698579|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56698580|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
56698581|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698582|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698583|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698584|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56698585|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56698586|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
56698587|NCT00799409|Methylphenidate|methylphenidate|mesh-list
56698588|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56698589|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698590|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56698591|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56698592|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56698593|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698596|NCT00782210|Olodaterol|olodaterol|mesh-list
56698597|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56698598|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
56698599|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698600|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698601|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56698602|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
56698603|NCT01558115|Denosumab|denosumab|mesh-list
56698604|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56698605|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698606|NCT02605265|Capecitabine|capecitabine|mesh-list
56698607|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
56698608|NCT02605265|Irinotecan|irinotecan|mesh-list
56698609|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56698610|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
56698611|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698612|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698613|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56698614|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56698615|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698616|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56698617|NCT05561673|Vaccines|vaccines|mesh-list
56698618|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
56698619|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698620|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56698621|NCT05561673|Antacids|antacids|mesh-ancestor
56698622|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698623|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56698624|NCT04101500|Aminophylline|aminophylline|mesh-list
56698625|NCT04101500|Bromides|bromides|mesh-list
56698626|NCT04101500|Ipratropium|ipratropium|mesh-list
56698627|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
56698628|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56698629|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
56698630|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698631|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698632|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56698633|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56698636|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698637|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698638|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56698639|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56698640|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698641|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56698642|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56698643|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
56698644|NCT04101500|Protective Agents|protective agents|mesh-ancestor
56698645|NCT02586441|Bromides|bromides|mesh-list
56698646|NCT02586441|Propofol|propofol|mesh-list
56698647|NCT02586441|Rocuronium|rocuronium|mesh-list
56698648|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56698649|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478169|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
56478170|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478171|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56478172|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56478174|NCT05319899|Choline|choline|mesh-list
56478175|NCT05319899|Omeprazole|omeprazole|mesh-list
56478176|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56478177|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56478178|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56478179|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478180|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478181|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
56478182|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56478183|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
56478184|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56478185|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
56478186|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
56478187|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
56478188|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56226189|NCT04562831|Niacin|niacin|mesh-list
56478189|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56478190|NCT05319899|Growth Substances|growth substances|mesh-ancestor
56478191|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478192|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
56478193|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478194|NCT02920827|Dapivirine|dapivirine|mesh-list
56478195|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56478196|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56478197|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
56478198|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478199|NCT02942888|Niacinamide|niacinamide|mesh-list
56478200|NCT02942888|Niacin|niacin|mesh-list
56478201|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
56478202|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
56478203|NCT02942888|Vitamins|vitamins|mesh-ancestor
56478204|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
56478208|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478209|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56478210|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
56478211|NCT02920905|Lidocaine|lidocaine|mesh-list
56478212|NCT02920905|Atracurium|atracurium|mesh-list
56478213|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
56478214|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
56478215|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478216|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478217|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
56478218|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478219|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56478220|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56478221|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56698650|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698651|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56698652|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
56698653|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
56698654|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
56698655|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56698656|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56698657|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56698658|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698659|NCT02586363|Entecavir|entecavir|mesh-list
56698660|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
56698661|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698662|NCT02586129|Metformin|metformin|mesh-list
56698663|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56698664|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56698665|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698666|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56698667|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56698668|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
56478222|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56478223|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478224|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56478225|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56478226|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56478227|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56478228|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56478229|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
56478230|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478231|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
56478232|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56478233|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478234|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56478235|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56478236|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478237|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478238|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478239|NCT02920515|Leuprolide|leuprolide|mesh-list
56478240|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56478241|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
56478242|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56478243|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478244|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56478245|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478246|NCT02917005|Palbociclib|palbociclib|mesh-list
56478247|NCT02917005|Exemestane|exemestane|mesh-list
56478248|NCT02917005|Goserelin|goserelin|mesh-list
56478249|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478250|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56478251|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478252|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478253|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56478254|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56478255|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56478256|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
56478257|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478258|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698669|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698670|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56698671|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56698672|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698673|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
56698674|NCT04081077|Linezolid|linezolid|mesh-list
56698675|NCT04081077|Bedaquiline|bedaquiline|mesh-list
56698676|NCT04081077|Clofazimine|clofazimine|mesh-list
56698677|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56698678|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698679|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56698680|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56698681|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698682|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698683|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478259|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56478260|NCT02942810|Cefepime|cefepime|mesh-list
56478261|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56478262|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478263|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56478264|NCT02920710|Hormones|hormones|mesh-ancestor
56478265|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478266|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478267|NCT02941913|Palonosetron|palonosetron|mesh-list
56478268|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
56478269|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
56478270|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478271|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478272|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56478273|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56478274|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56478275|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
56478279|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478280|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56478281|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478282|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478284|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
56478285|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
56478286|NCT02920593|Vitamins|vitamins|mesh-list
56478287|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
56478288|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478289|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56478290|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56478291|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
56478292|NCT02942732|Vitamin D|vitamin d|mesh-list
56478293|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56478294|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478295|NCT02942732|Vitamins|vitamins|mesh-ancestor
56478296|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
56478297|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56478298|NCT02942420|Bucillamine|bucillamine|mesh-list
56478299|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56478300|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56478301|NCT02942420|Analgesics|analgesics|mesh-ancestor
56478302|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
56478303|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478304|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478305|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478306|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56698684|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56698685|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
56698686|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56698687|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
56698688|NCT04669665|Ketamine|ketamine|mesh-list
56698689|NCT04669665|Analgesics|analgesics|mesh-ancestor
56698690|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
56698691|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698692|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698693|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56698694|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56698695|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
56698696|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
56698697|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698698|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56698699|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56698700|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478307|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
56478308|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478309|NCT02942420|Protective Agents|protective agents|mesh-ancestor
56478310|NCT02920359|Leuprolide|leuprolide|mesh-list
56478311|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56478312|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
56478313|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56478314|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478315|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56478316|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478317|NCT02916654|Iron|iron|mesh-list
56478318|NCT02916654|Trace Elements|trace elements|mesh-ancestor
56478319|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
56478320|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478321|NCT02941562|Leucovorin|leucovorin|mesh-list
56478322|NCT02941562|Fluorouracil|fluorouracil|mesh-list
56478323|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
56478324|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
56478325|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478326|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56478327|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478328|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56478329|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
56478330|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478331|NCT02941562|Antidotes|antidotes|mesh-ancestor
56478332|NCT02941562|Protective Agents|protective agents|mesh-ancestor
56478333|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
56478334|NCT02941562|Vitamins|vitamins|mesh-ancestor
56478335|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
56478336|NCT02916420|Dexamethasone|dexamethasone|mesh-list
56226328|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56226329|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226330|NCT04353284|Gabexate|gabexate|mesh-list
56226331|NCT04353284|Camostat|camostat|mesh-list
56478337|NCT02916420|Pomalidomide|pomalidomide|mesh-list
56478338|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478339|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
56478340|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
56478341|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478342|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478343|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56478344|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
56478345|NCT02916420|Hormones|hormones|mesh-ancestor
56698701|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698702|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
56698703|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
56698704|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56698705|NCT02586051|Antibodies|antibodies|mesh-list
56698706|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
56698707|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56698708|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
56698709|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698710|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478347|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56478348|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478349|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
56478350|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56478351|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56478352|NCT02916420|Growth Substances|growth substances|mesh-ancestor
56478353|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
56478354|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
56478355|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
56478356|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56478357|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56478358|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478359|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478360|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478361|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478362|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
56478363|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56478364|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56478365|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478366|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
56478367|NCT03458468|Coagulants|coagulants|mesh-ancestor
56478368|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56478369|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56478370|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56478371|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478372|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
56478373|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478374|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478375|NCT02916381|Anesthetics|anesthetics|mesh-list
56478376|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478377|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478378|NCT02920047|Amlodipine|amlodipine|mesh-list
56478379|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56478380|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56478381|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56478382|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478383|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56478384|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478385|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
56478386|NCT02941016|Evolocumab|evolocumab|mesh-list
56478387|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56478388|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56478389|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
56478390|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478391|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56478392|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
56478393|NCT05220722|Nivolumab|nivolumab|mesh-list
56478394|NCT05220722|Ipilimumab|ipilimumab|mesh-list
56478395|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478396|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478397|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56478398|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478399|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
56478400|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698711|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698712|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
56698713|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
56698714|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478401|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56478402|NCT02941445|Metformin|metformin|mesh-list
56226402|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
56226403|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56226404|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
56226405|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226406|NCT04238546|Sirolimus|sirolimus|mesh-list
56226407|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56226408|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226409|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56478403|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56478404|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56478405|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478406|NCT02941445|Incretins|incretins|mesh-ancestor
56478407|NCT02941445|Hormones|hormones|mesh-ancestor
56478408|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478409|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56478420|NCT02919501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56478421|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56478422|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56478423|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478424|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478426|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56478427|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56478428|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56478429|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56478430|NCT02919579|Esketamine|esketamine|mesh-list
56478431|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
56478432|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56478433|NCT05317676|Palmidrol|palmidrol|mesh-list
56478434|NCT05317676|Analgesics|analgesics|mesh-ancestor
56478435|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
56478436|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478437|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478438|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56478439|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56478440|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478441|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478442|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
56478443|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478444|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56478445|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56478446|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478447|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478448|NCT05317676|Hormones|hormones|mesh-ancestor
56478449|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478450|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56478451|NCT02940821|Fluorides|fluorides|mesh-list
56478452|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
56478453|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
56478454|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
56478455|NCT02940821|Protective Agents|protective agents|mesh-ancestor
56478456|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478457|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56478458|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478460|NCT02941601|Carboplatin|carboplatin|mesh-list
56478461|NCT02941601|Necitumumab|necitumumab|mesh-list
56478462|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478463|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56478464|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
56478465|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478466|NCT02941601|Antiviral Agents|antiviral agents|mesh-ancestor
56478467|NCT02941601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478468|NCT02941601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478469|NCT02941601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56478470|NCT02941601|Immunologic Factors|immunologic factors|mesh-ancestor
56698715|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56698716|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698717|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698718|NCT00763958|Buprenorphine|buprenorphine|mesh-list
56478471|NCT02941601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478472|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478473|NCT03160638|Azithromycin|azithromycin|mesh-list
56478474|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56478475|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478476|NCT02919462|Cisplatin|cisplatin|mesh-list
56478477|NCT02919462|Pemetrexed|pemetrexed|mesh-list
56478478|NCT02919462|Vinorelbine|vinorelbine|mesh-list
56478479|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478480|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478481|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478482|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56478483|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56478484|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56478485|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
56478486|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
56478487|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
56478488|NCT02941367|Metformin|metformin|mesh-list
56478489|NCT02941367|Lixisenatide|lixisenatide|mesh-list
56478490|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56478491|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478492|NCT03153150|Warfarin|warfarin|mesh-list
56478493|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
56478494|NCT03153150|Dabigatran|dabigatran|mesh-list
56478495|NCT03153150|Apixaban|apixaban|mesh-list
56478496|NCT03153150|Edoxaban|edoxaban|mesh-list
56478497|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
56478498|NCT03153150|Phenindione|phenindione|mesh-list
56478499|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
56478500|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56478501|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
56478502|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56478503|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
56478504|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478505|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478506|NCT02916147|Propofol|propofol|mesh-list
56478507|NCT02916147|Sevoflurane|sevoflurane|mesh-list
56478508|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56478509|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478510|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478511|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56478512|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
56478513|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
56478514|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56478515|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56478516|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
56478517|NCT05302388|Promethazine|promethazine|mesh-list
56478518|NCT05302388|Dexamethasone|dexamethasone|mesh-list
56478519|NCT05302388|Prednisolone|prednisolone|mesh-list
56478520|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56478521|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
56478522|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56478523|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
56478524|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56478525|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
56478526|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478527|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
56478528|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
56478529|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478530|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478531|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56478532|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
56478533|NCT05302388|Hormones|hormones|mesh-ancestor
56478534|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478535|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55979616|NCT02352363|Levodopa|levodopa|mesh-list
56478536|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478537|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56478538|NCT05302388|Protective Agents|protective agents|mesh-ancestor
56478539|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56698719|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56698720|NCT00763958|Narcotics|narcotics|mesh-ancestor
56698721|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698722|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698723|NCT00763958|Analgesics|analgesics|mesh-ancestor
56698724|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
56698725|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698726|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56698727|NCT04101578|Cyclosporine|cyclosporine|mesh-list
56698728|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
56698729|NCT04101578|Prednisone|prednisone|mesh-list
56698730|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
56698731|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
56698732|NCT04101578|Methotrexate|methotrexate|mesh-list
56698733|NCT04101578|Azathioprine|azathioprine|mesh-list
56254448|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254449|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254450|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56254451|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254452|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478540|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56478541|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478542|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
56478543|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
56478544|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
56478545|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56478546|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
56478547|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
56478548|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478549|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478550|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56478551|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
56478556|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
56478557|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478558|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478559|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
56478560|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478561|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56478562|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56478563|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478564|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478565|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
56478566|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478567|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478569|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56478570|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
56478571|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478572|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
56478573|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56478574|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478575|NCT02277041|Misoprostol|misoprostol|mesh-list
56478576|NCT02277041|Carbetocin|carbetocin|mesh-list
56478577|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56478578|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
56478579|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56478580|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698734|NCT04101578|Bromides|bromides|mesh-list
56698735|NCT04101578|Tacrolimus|tacrolimus|mesh-list
56698736|NCT04101578|Cyclosporins|cyclosporins|mesh-list
56698737|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56698738|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
56698739|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56698740|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
56698741|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56698742|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56698743|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
56698744|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698745|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56698746|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56698747|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
56698748|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698749|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698750|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56698751|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56698752|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
56698753|NCT04101578|Hormones|hormones|mesh-ancestor
56478581|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56478582|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56478583|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
56478584|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
56478585|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56478586|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
56478587|NCT02915289|Povidone|povidone|mesh-list
56478588|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56478589|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478590|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
56478591|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
56478592|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
56478593|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
56478594|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
56478595|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56478596|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478597|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
56478598|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478599|NCT02939417|Protective Agents|protective agents|mesh-ancestor
56478600|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478601|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
56478602|NCT05034536|Infliximab|infliximab|mesh-list
56478603|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478604|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478605|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56478606|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56478607|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478608|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56478609|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478610|NCT02915172|Capecitabine|capecitabine|mesh-list
56478611|NCT02915172|Lenvatinib|lenvatinib|mesh-list
56478612|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56478613|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
56478614|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478615|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478616|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56478617|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478618|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
56698754|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56698755|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56698756|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56698757|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
56698758|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56698759|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56698760|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
56698761|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
56698762|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698763|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56698764|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56698765|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56698766|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
56698767|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478619|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56478620|NCT02938988|Methylene Blue|methylene blue|mesh-list
56478621|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478622|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478623|NCT02915055|Acetaminophen|acetaminophen|mesh-list
56478624|NCT02915055|Ibuprofen|ibuprofen|mesh-list
56478625|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56478630|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478631|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478632|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
56478633|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56478634|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478635|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478636|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56478637|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478638|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478639|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56478640|NCT02915055|Narcotics|narcotics|mesh-ancestor
56478641|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478642|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
56478643|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478644|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478645|NCT02918760|Gabapentin|gabapentin|mesh-list
56478646|NCT02918760|Analgesics|analgesics|mesh-ancestor
56478647|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
56478648|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478649|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478650|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
56478651|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56478652|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56478653|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478654|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56478655|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56478656|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56478657|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478658|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478659|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
56478660|NCT04690751|Cenobamate|cenobamate|mesh-list
56478661|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
56478662|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
56478663|NCT03458078|Midazolam|midazolam|mesh-list
56478664|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56478665|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56478666|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478667|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698768|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56698769|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56698770|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
56698771|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56698772|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
56698773|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
56698774|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698775|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56698776|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56698777|NCT04101578|Protective Agents|protective agents|mesh-ancestor
56698778|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
56698779|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56698780|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
56698781|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698782|NCT00763256|Triclosan|triclosan|mesh-list
56698783|NCT00763256|Fluorides|fluorides|mesh-list
56698784|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
56254494|NCT01888289|Isotretinoin|isotretinoin|mesh-list
56478668|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56478669|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56478670|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56478671|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56478672|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
56478673|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
56478674|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
56478675|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
56478676|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478677|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478678|NCT03458078|Analgesics|analgesics|mesh-ancestor
56478679|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
56478680|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478681|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56478682|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
56478683|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56478684|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56478685|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56478686|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
56478687|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56478688|NCT04690556|Ranibizumab|ranibizumab|mesh-list
56478689|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56478690|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56478691|NCT04690556|Growth Substances|growth substances|mesh-ancestor
56478692|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478693|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
56478694|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478695|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56478696|NCT01294579|Ofatumumab|ofatumumab|mesh-list
56478697|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56478702|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56478703|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56478704|NCT02914626|Growth Substances|growth substances|mesh-ancestor
56478705|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478706|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
56478707|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478708|NCT02918331|Dexamethasone|dexamethasone|mesh-list
56478709|NCT02918331|Lenalidomide|lenalidomide|mesh-list
56478710|NCT02918331|Daratumumab|daratumumab|mesh-list
56478711|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478712|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
56478713|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
56698785|NCT00763256|Protective Agents|protective agents|mesh-ancestor
56698786|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698787|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56698788|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698789|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56698790|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56698791|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
56698792|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698793|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56698794|NCT02585973|Cisplatin|cisplatin|mesh-list
56698795|NCT02585973|Adavosertib|adavosertib|mesh-list
56698796|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698797|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698798|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698799|NCT00920283|Cobalt|cobalt|mesh-list
56478714|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478715|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478716|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56478717|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
56478718|NCT02918331|Hormones|hormones|mesh-ancestor
56478719|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478720|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56478721|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478722|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
56478723|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56478724|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56478725|NCT02918331|Growth Substances|growth substances|mesh-ancestor
56478726|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
56478727|NCT02918136|Cortisone|cortisone|mesh-list
56478728|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478729|NCT01294462|Aspirin|aspirin|mesh-list
56478730|NCT01294462|Clopidogrel|clopidogrel|mesh-list
56478731|NCT01294462|Ticagrelor|ticagrelor|mesh-list
56478732|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56478733|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56478734|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56478735|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56478736|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
56478737|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478738|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478739|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478740|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56478741|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56478742|NCT01294462|Analgesics|analgesics|mesh-ancestor
56478743|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
56478744|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478745|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478746|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478747|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56478748|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56478749|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56478750|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478751|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
56478752|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
56478753|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56478754|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478755|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56478756|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478757|NCT02910570|Liraglutide|liraglutide|mesh-list
56698800|NCT00920283|Trace Elements|trace elements|mesh-ancestor
56698801|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
56698802|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698803|NCT00583947|Albuterol|albuterol|mesh-list
56698804|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
56698805|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56698806|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
56698807|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698808|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698809|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56698810|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
56698811|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
56698812|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56698813|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56698814|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56698815|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56698816|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
56698817|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698818|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698819|NCT00772928|Vaccines|vaccines|mesh-list
56698820|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56698821|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
56698822|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698823|NCT00762164|Simvastatin|simvastatin|mesh-list
56478758|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56478759|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478760|NCT02910570|Incretins|incretins|mesh-ancestor
56478761|NCT02910570|Hormones|hormones|mesh-ancestor
56478762|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478763|NCT03077685|Paclitaxel|paclitaxel|mesh-list
56478764|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56478765|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478766|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
56478767|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
56478768|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
56478772|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56478773|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478774|NCT04817033|Midazolam|midazolam|mesh-list
56478775|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
56478776|NCT04817033|Anesthetics|anesthetics|mesh-list
56478777|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478778|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478779|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56478780|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56478781|NCT04817033|Analgesics|analgesics|mesh-ancestor
56478782|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
56478783|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478784|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56478785|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56478786|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56478787|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
56107430|NCT00003421|Doxorubicin|doxorubicin|mesh-list
56698824|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56698825|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56698826|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56698827|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
56698828|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698829|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56698830|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56698831|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698832|NCT00761774|Brivaracetam|brivaracetam|mesh-list
56698833|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
56698834|NCT04080375|Dinoprostone|dinoprostone|mesh-list
56698835|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
56698836|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56698837|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698838|NCT00781274|Ribavirin|ribavirin|mesh-list
56698839|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56698840|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
56698841|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698842|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
56478788|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478789|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478790|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56478791|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56478792|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56478793|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56478794|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56478795|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
56478796|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
56478797|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
56478798|NCT01292473|Omalizumab|omalizumab|mesh-list
56478799|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56478800|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56478801|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
56478802|NCT02938286|Epinephrine|epinephrine|mesh-list
56478803|NCT02938286|Carticaine|carticaine|mesh-list
56478804|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56478805|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56478806|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
56478807|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478808|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478809|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478810|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56478811|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56478812|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
56478813|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478814|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56478815|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
56478816|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
56478817|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
56478818|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56478819|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
56478820|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
56478821|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478822|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
56478823|NCT01292239|Ribavirin|ribavirin|mesh-list
56478824|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56478825|NCT01292239|Simeprevir|simeprevir|mesh-list
56698843|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698844|NCT05538663|Gemcitabine|gemcitabine|mesh-list
56698845|NCT05538663|Docetaxel|docetaxel|mesh-list
56698846|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
56698847|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56698848|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
56698849|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698850|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698851|NCT05538663|Antiviral Agents|antiviral agents|mesh-ancestor
56698852|NCT05538663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698853|NCT05538663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698854|NCT05538663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698855|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
56698856|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698857|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
56698858|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
56698859|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
56698860|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56478826|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
56478827|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478828|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
56478829|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478830|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
56478831|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478832|NCT05600179|Dexamethasone|dexamethasone|mesh-list
56478833|NCT05600179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478834|NCT05600179|Antiemetics|antiemetics|mesh-ancestor
56478835|NCT05600179|Autonomic Agents|autonomic agents|mesh-ancestor
56478836|NCT05600179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478837|NCT05600179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478839|NCT05600179|Glucocorticoids|glucocorticoids|mesh-ancestor
56478840|NCT05600179|Hormones|hormones|mesh-ancestor
56478841|NCT05600179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478842|NCT05600179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56478843|NCT05600179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478845|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
56478846|NCT02937662|Idarubicin|idarubicin|mesh-list
56478847|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56478848|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
56478849|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478850|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478851|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56478852|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
56478853|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478854|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478855|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56478856|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56478857|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
56478858|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
56478859|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478860|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56478861|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56478862|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56478863|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478864|NCT01290757|Dabigatran|dabigatran|mesh-list
56478865|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
56478866|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56478867|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
56698861|NCT05520177|Ranibizumab|ranibizumab|mesh-list
56698862|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56478868|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478869|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478870|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
56478871|NCT02937857|Antipyretics|antipyretics|mesh-list
56478872|NCT02937857|Expectorants|expectorants|mesh-list
56478873|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
56478874|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478875|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
56478876|NCT04324060|Danazol|danazol|mesh-list
56478877|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56478878|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
56478879|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478880|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478881|NCT01290718|Capecitabine|capecitabine|mesh-list
56478882|NCT01290718|Trastuzumab|trastuzumab|mesh-list
56478883|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56478884|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
56478885|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478886|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478887|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478888|NCT04324294|Pancrelipase|pancrelipase|mesh-list
56478889|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56478890|NCT02937896|Ketorolac|ketorolac|mesh-list
56478891|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56478892|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56478893|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56478894|NCT02937896|Analgesics|analgesics|mesh-ancestor
56478895|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
56478896|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478897|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478898|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56478899|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478900|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56478901|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478902|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478903|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
56478904|NCT02937896|Coagulants|coagulants|mesh-ancestor
56478905|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56478906|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
56478907|NCT04688151|Rituximab|rituximab|mesh-list
56478908|NCT04688151|Durvalumab|durvalumab|mesh-list
56478909|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
56478910|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478911|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478912|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
56478913|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478914|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478915|NCT02937779|Tenofovir|tenofovir|mesh-list
56478916|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
56478917|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478918|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56478919|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56478922|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56478923|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56478924|NCT01290679|Ribavirin|ribavirin|mesh-list
56478925|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56478926|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56478927|NCT01290679|Simeprevir|simeprevir|mesh-list
56478928|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
56478929|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478930|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
56478931|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478932|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
56478933|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478934|NCT03457389|Cabergoline|cabergoline|mesh-list
56478935|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56226931|NCT03606980|BB 1101|bb 1101|mesh-list
56478937|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
56478938|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
56478939|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478940|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478941|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478942|NCT02890186|Remifentanil|remifentanil|mesh-list
56478943|NCT02890186|Propofol|propofol|mesh-list
56698863|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56698864|NCT05520177|Growth Substances|growth substances|mesh-ancestor
56698865|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698866|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
56478944|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56478945|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478946|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478947|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56478948|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
56478949|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
56478950|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56478951|NCT02890186|Narcotics|narcotics|mesh-ancestor
56478952|NCT02890186|Analgesics|analgesics|mesh-ancestor
56478953|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
56478954|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56478955|NCT02909751|Tocotrienols|tocotrienols|mesh-list
56478956|NCT02909751|Vitamin E|vitamin e|mesh-list
56478957|NCT02909751|Tocopherols|tocopherols|mesh-list
56478958|NCT02909751|Docetaxel|docetaxel|mesh-list
56478959|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
56478960|NCT02909751|Trastuzumab|trastuzumab|mesh-list
56478961|NCT02909751|Epirubicin|epirubicin|mesh-list
56478962|NCT02909751|Pertuzumab|pertuzumab|mesh-list
56478963|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478964|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
56478965|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
56478966|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
56478967|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478968|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56478969|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
56478970|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478971|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56478972|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56478973|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
56478974|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56478975|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56478976|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56478977|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56478978|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56478979|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478980|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
56478981|NCT02909751|Protective Agents|protective agents|mesh-ancestor
56478982|NCT02909751|Vitamins|vitamins|mesh-ancestor
56478983|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
56478984|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
56478985|NCT02909712|Piperaquine|piperaquine|mesh-list
56478986|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
56478987|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56478988|NCT02909712|Artenimol|artenimol|mesh-list
56478989|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
56478990|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56478991|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56478992|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478993|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56478994|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478995|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478996|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56479004|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56479005|NCT01290601|Primaquine|primaquine|mesh-list
56479006|NCT01290601|Tafenoquine|tafenoquine|mesh-list
56479007|NCT01290601|Amebicides|amebicides|mesh-ancestor
56479008|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56479009|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56479010|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479011|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
56479012|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479013|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56479014|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56479015|NCT01290601|Analgesics|analgesics|mesh-ancestor
56479016|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
56479017|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479018|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479019|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479020|NCT01290601|Filaricides|filaricides|mesh-ancestor
56479021|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
56698867|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698868|NCT00780416|Ribavirin|ribavirin|mesh-list
56698869|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56698870|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
56698871|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
56698872|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698873|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
56698874|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698875|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
56698876|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698877|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
56698878|NCT02584881|Narcotics|narcotics|mesh-ancestor
56698879|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254584|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56479022|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
56479023|NCT02978391|Epinephrine|epinephrine|mesh-list
56479024|NCT02978391|Hemostatics|hemostatics|mesh-list
56479025|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56479026|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56479027|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
56479028|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479029|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479030|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479031|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56479032|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56479033|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
56479034|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479035|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56479036|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
56479037|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
56479038|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
56479039|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56479040|NCT02978391|Coagulants|coagulants|mesh-ancestor
56479041|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
56479042|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56479043|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479044|NCT04688346|Epinephrine|epinephrine|mesh-list
56479045|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56479046|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56479047|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
56479048|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165422|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479049|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479050|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479051|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56479052|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56479053|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
56479054|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479055|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56479056|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
56479057|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
56479058|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
56479059|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56479060|NCT01289821|Leucovorin|leucovorin|mesh-list
56479061|NCT01289821|Folic Acid|folic acid|mesh-list
56479062|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
56479063|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
56479064|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479065|NCT01289821|Antidotes|antidotes|mesh-ancestor
56479066|NCT01289821|Protective Agents|protective agents|mesh-ancestor
56479067|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479068|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
56227110|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
56698880|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698881|NCT02584881|Analgesics|analgesics|mesh-ancestor
56698882|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
56698883|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698884|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56698885|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
56698886|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56698887|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56698888|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56698889|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698890|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698891|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698892|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56698893|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56698894|NCT04607421|Leucovorin|leucovorin|mesh-list
56698895|NCT04607421|Bevacizumab|bevacizumab|mesh-list
56698896|NCT04607421|Cetuximab|cetuximab|mesh-list
56698897|NCT04607421|Fluorouracil|fluorouracil|mesh-list
56698898|NCT04607421|Capecitabine|capecitabine|mesh-list
56698899|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
56698900|NCT04607421|Irinotecan|irinotecan|mesh-list
56698901|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56698902|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698903|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56698904|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56698905|NCT04607421|Growth Substances|growth substances|mesh-ancestor
56698906|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698907|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
56698908|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
56698909|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698910|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56698911|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698912|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
56698913|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56698914|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56254618|NCT01888796|Hormones|hormones|mesh-ancestor
56227111|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56227112|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227113|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
56698915|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56698917|NCT04607421|Protective Agents|protective agents|mesh-ancestor
56698918|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
56698919|NCT04607421|Vitamins|vitamins|mesh-ancestor
56698920|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
56698921|NCT00761306|Vortioxetine|vortioxetine|mesh-list
56698922|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
56698923|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56698924|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56698925|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56698926|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698927|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698928|NCT00761306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56698929|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56698930|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56698931|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698932|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56698933|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
56698934|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56698935|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56698936|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56698937|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56698938|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
56698939|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56698940|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
56698941|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698942|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227114|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227120|NCT03426293|Heparin|heparin|mesh-list
56479069|NCT01289821|Vitamins|vitamins|mesh-ancestor
56479070|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
56479071|NCT01289821|Hematinics|hematinics|mesh-ancestor
56479072|NCT02913768|Ondansetron|ondansetron|mesh-list
56479073|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
56479074|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
56479075|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479076|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479077|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56479078|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
56479079|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
56479080|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56479081|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
56479082|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479083|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479084|NCT02913768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56479085|NCT02913768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56479086|NCT02913768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698943|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56698944|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
56698945|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
56698946|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56698947|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
56698948|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479087|NCT02913768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56479088|NCT02913768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56479089|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
56479090|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56479091|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479092|NCT01289782|Ribavirin|ribavirin|mesh-list
56479093|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56479094|NCT01289782|Simeprevir|simeprevir|mesh-list
56479095|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
56479096|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479097|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
56479098|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479099|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
56479100|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479101|NCT02913417|Nivolumab|nivolumab|mesh-list
56479102|NCT02913417|Ipilimumab|ipilimumab|mesh-list
56479103|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56479104|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479105|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56479106|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479107|NCT02936492|Clobetasol|clobetasol|mesh-list
56479108|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479109|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
56479110|NCT02936492|Hormones|hormones|mesh-ancestor
56479111|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56479112|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479113|NCT02913573|Bupivacaine|bupivacaine|mesh-list
56479114|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
56479115|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
56479116|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479117|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479118|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
56479119|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479120|NCT01289353|Carboplatin|carboplatin|mesh-list
56479121|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479122|NCT02913300|Lidocaine|lidocaine|mesh-list
56479123|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56479124|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
56479125|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
56479126|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479127|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479128|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
56479129|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479130|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56479131|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56479132|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56479133|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56479134|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479136|NCT02936375|Azathioprine|azathioprine|mesh-list
56479137|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56479138|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
56479139|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479140|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479141|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56479142|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
56479143|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479144|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479145|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56479146|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
56479147|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56479149|NCT02913690|Vitamins|vitamins|mesh-ancestor
56479150|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
56479151|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698949|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698950|NCT04079517|Tamoxifen|tamoxifen|mesh-list
56698951|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56698952|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
56698953|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56698954|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698955|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56698956|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698957|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56698958|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56698959|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56698960|NCT00761150|Acetaminophen|acetaminophen|mesh-list
56698961|NCT00761150|Hydrocodone|hydrocodone|mesh-list
56479152|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
56479153|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479154|NCT02913690|Protective Agents|protective agents|mesh-ancestor
56479155|NCT01289119|Metformin|metformin|mesh-list
56479156|NCT01289119|Pioglitazone|pioglitazone|mesh-list
56479157|NCT01289119|Alogliptin|alogliptin|mesh-list
56479158|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56479159|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479160|NCT01289119|Incretins|incretins|mesh-ancestor
56479161|NCT01289119|Hormones|hormones|mesh-ancestor
56479162|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56479163|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56479164|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
56479165|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479166|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479167|NCT01287832|Vancomycin|vancomycin|mesh-list
56479168|NCT01287832|Daptomycin|daptomycin|mesh-list
56479169|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56479170|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479171|NCT02913066|Cisplatin|cisplatin|mesh-list
56479172|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479173|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56479174|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479175|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56479176|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479177|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479178|NCT02912793|Betadex|betadex|mesh-list
56479179|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
56479180|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479181|NCT02935751|Apixaban|apixaban|mesh-list
56479182|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56479183|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
56479184|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56479185|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
56479186|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479187|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479188|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
56479189|NCT02935790|Nivolumab|nivolumab|mesh-list
56479190|NCT02935790|Ipilimumab|ipilimumab|mesh-list
56479191|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56479192|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479193|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56479194|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479195|NCT02912637|Xenon|xenon|mesh-list
56479196|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56479197|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
56479198|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
56479199|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698962|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56698963|NCT00761150|Analgesics|analgesics|mesh-ancestor
56698964|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
56698965|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698966|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698967|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
56698968|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56698969|NCT00761150|Narcotics|narcotics|mesh-ancestor
56698970|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56698971|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
56698972|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
56698973|NCT00583557|Belimumab|belimumab|mesh-list
56698974|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56698975|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
56698976|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698977|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56698978|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56698979|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56698980|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698981|NCT04580121|Acetaminophen|acetaminophen|mesh-list
56698982|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
56698983|NCT04580121|Promethazine|promethazine|mesh-list
56698984|NCT04580121|Dexamethasone|dexamethasone|mesh-list
56698985|NCT04580121|Dasatinib|dasatinib|mesh-list
56698986|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56698987|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
56410179|NCT04230187|Antidotes|antidotes|mesh-ancestor
56698988|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
56698989|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56698990|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56698991|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56698992|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
56698993|NCT04580121|Hormones|hormones|mesh-ancestor
56698994|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56698995|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56479200|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479201|NCT02912910|Labetalol|labetalol|mesh-list
56479202|NCT02912910|Nifedipine|nifedipine|mesh-list
56479203|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56479204|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56479205|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56698996|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56698997|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56698998|NCT04580121|Analgesics|analgesics|mesh-ancestor
56698999|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
56699000|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
56699001|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56699002|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699003|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699004|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56699005|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56699006|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699007|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
56479206|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56479207|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479208|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
56479209|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
56479212|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56479214|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479215|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56479216|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
56479217|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
56479218|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479219|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56479220|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56479221|NCT02935829|Locust bean gum|locust bean gum|mesh-list
56479222|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
56479223|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56479224|NCT02912676|Methotrexate|methotrexate|mesh-list
56479225|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
56479226|NCT02912676|Thioguanine|thioguanine|mesh-list
56479227|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56479228|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
56479229|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56479230|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479231|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56479232|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
56479233|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479234|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479235|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
56479236|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479237|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56479238|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56479239|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
56479240|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479241|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56479242|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
56479243|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56479244|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56479245|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479246|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
56479247|NCT02935985|Coagulants|coagulants|mesh-ancestor
56479248|NCT02912169|Anesthetics|anesthetics|mesh-list
56479249|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479250|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479251|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56479252|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479253|NCT02935959|Midazolam|midazolam|mesh-list
56479254|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
56479255|NCT02935959|Ketamine|ketamine|mesh-list
56479256|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56479257|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479258|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479259|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56699008|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
56699009|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56699010|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
56699011|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
56699012|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699013|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56699014|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
56699015|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
56699016|NCT00760838|Azithromycin|azithromycin|mesh-list
56699017|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56699018|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699019|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
56699020|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56699021|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56699022|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56699023|NCT02584335|Lidocaine|lidocaine|mesh-list
56699024|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56699025|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
56699026|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
56699027|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699028|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699029|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
56699030|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479260|NCT02935959|Analgesics|analgesics|mesh-ancestor
56479261|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
56479262|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479263|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56479264|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56479265|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56479266|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
56479267|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479268|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479269|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56479270|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56479271|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
56479272|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
56479273|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56479274|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56479275|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56479276|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56479277|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56479278|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56479279|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
56479280|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
56479281|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
56479282|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56479284|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479285|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
56479286|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
56479288|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56479289|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479290|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479291|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56479292|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
56699031|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56699032|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56699033|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56699034|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699035|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699036|NCT00437281|Pregabalin|pregabalin|mesh-list
56699037|NCT00437281|Analgesics|analgesics|mesh-ancestor
56699038|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
56699039|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699040|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699041|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
56699042|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56699043|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699044|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699045|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56699046|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56699047|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56699048|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699049|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56699050|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
56479294|NCT02912247|Adalimumab|adalimumab|mesh-list
56479295|NCT02912247|Antibodies|antibodies|mesh-list
56479296|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56479297|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
56479298|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479299|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479300|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479301|NCT02935010|Amoxicillin|amoxicillin|mesh-list
56479302|NCT02935010|Metronidazole|metronidazole|mesh-list
56479303|NCT02935010|Clarithromycin|clarithromycin|mesh-list
56479304|NCT02935010|Levofloxacin|levofloxacin|mesh-list
56479305|NCT02935010|Ofloxacin|ofloxacin|mesh-list
56479306|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
56479307|NCT02935010|Esomeprazole|esomeprazole|mesh-list
56479308|NCT02935010|Bismuth|bismuth|mesh-list
56479309|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479310|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56479311|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479312|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56479313|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56479314|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56479315|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56479316|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56479317|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479318|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56479319|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56479320|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56479321|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56479322|NCT02935010|Renal Agents|renal agents|mesh-ancestor
56479323|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56479324|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56479325|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479326|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56479327|NCT02935010|Antacids|antacids|mesh-ancestor
56699051|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
56699052|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
56699053|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56699054|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56699055|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
56699056|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
56699057|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699058|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699059|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56699060|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
56699061|NCT04548999|Hormones|hormones|mesh-ancestor
56699062|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56699067|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699068|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699070|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
56699071|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
56699072|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254746|NCT01889407|Idarubicin|idarubicin|mesh-list
56479328|NCT02935010|Diuretics|diuretics|mesh-ancestor
56479329|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
56479330|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479331|NCT02935010|Expectorants|expectorants|mesh-ancestor
56479332|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
56479333|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56479334|NCT02935530|Tinzaparin|tinzaparin|mesh-list
56479335|NCT02935530|Dalteparin|dalteparin|mesh-list
56479336|NCT02935530|Argatroban|argatroban|mesh-list
56479337|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
56479338|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56479339|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56479340|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479341|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
56479342|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56479343|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
56479344|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479345|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56479346|NCT02934464|Leucovorin|leucovorin|mesh-list
56479347|NCT02934464|Paclitaxel|paclitaxel|mesh-list
56479348|NCT02934464|Ramucirumab|ramucirumab|mesh-list
56479349|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
56479350|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
56479351|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56479352|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479353|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
56479354|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
56479355|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
56479356|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479357|NCT02934464|Antidotes|antidotes|mesh-ancestor
56479358|NCT02934464|Protective Agents|protective agents|mesh-ancestor
56479359|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479360|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
56479361|NCT02934464|Vitamins|vitamins|mesh-ancestor
56479363|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56479364|NCT02934035|Citalopram|citalopram|mesh-list
56479365|NCT02934035|Fluoxetine|fluoxetine|mesh-list
56479366|NCT02934035|Paroxetine|paroxetine|mesh-list
56479367|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56479368|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
56479369|NCT02934035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56479370|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56699073|NCT05468073|Aldesleukin|aldesleukin|mesh-list
56699074|NCT05468073|Interleukin-2|interleukin-2|mesh-list
56699075|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699076|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56699077|NCT05468073|Analgesics|analgesics|mesh-ancestor
56479371|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56479372|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479373|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479374|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
56479375|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479376|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56479377|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56479378|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479379|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56479381|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
56479382|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
56479383|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56479384|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56479385|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479386|NCT02934152|Amoxicillin|amoxicillin|mesh-list
56479387|NCT02934152|Clarithromycin|clarithromycin|mesh-list
56479388|NCT02934152|Rabeprazole|rabeprazole|mesh-list
56479389|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56479390|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479391|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56479392|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479393|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479394|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56479395|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56479396|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56479397|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56479398|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56479399|NCT02935335|Menotropins|menotropins|mesh-list
56479400|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56479401|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
56479402|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56479403|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479404|NCT02911662|Cephalexin|cephalexin|mesh-list
56479405|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
56479406|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56479407|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479408|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56479409|NCT02911662|Renal Agents|renal agents|mesh-ancestor
56479410|NCT02935101|Prednisolone|prednisolone|mesh-list
56334671|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
56479411|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56479412|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
56479413|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56479414|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
56479415|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56479416|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
56479417|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479418|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
56479420|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56479421|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479422|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56479423|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479424|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
56479425|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
56479426|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479427|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56479428|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56479429|NCT02935101|Protective Agents|protective agents|mesh-ancestor
56479430|NCT04689971|Vitamins|vitamins|mesh-list
56479431|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
56479432|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
56479433|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479434|NCT02934945|Budesonide|budesonide|mesh-list
56479435|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
56479436|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479437|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56699078|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
56699079|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699080|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699081|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56699082|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56699083|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
56699084|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479439|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479440|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479441|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56479442|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
56479443|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
56479444|NCT02934945|Hormones|hormones|mesh-ancestor
56479445|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56479446|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56479447|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56479448|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56479449|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
56479450|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479451|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479452|NCT02933645|Insulin|insulin|mesh-list
56479453|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56479454|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56227449|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479455|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479456|NCT02911701|Acetaminophen|acetaminophen|mesh-list
56479457|NCT02911701|Ibuprofen|ibuprofen|mesh-list
56479458|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56479459|NCT02911701|Analgesics|analgesics|mesh-ancestor
56479460|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
56479461|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479462|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479463|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
56479464|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56479465|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479466|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479467|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56479468|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479469|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479470|NCT02933684|Cycloserine|cycloserine|mesh-list
56479471|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56479472|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479473|NCT02933684|Renal Agents|renal agents|mesh-ancestor
56479474|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56479475|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
56479476|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56479477|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
56479478|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479479|NCT02933333|Molgramostim|molgramostim|mesh-list
56479480|NCT02933333|Lenograstim|lenograstim|mesh-list
56479481|NCT02933333|Sargramostim|sargramostim|mesh-list
56479482|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56479483|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
56479484|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479485|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479486|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
56479487|NCT02670252|Busulfan|busulfan|mesh-list
56479488|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56479489|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
56479490|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479491|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479492|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56479493|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
56479494|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479495|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479496|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56479497|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
56479498|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
56699089|NCT05674695|Omalizumab|omalizumab|mesh-list
56699090|NCT05674695|Cyclosporine|cyclosporine|mesh-list
56699091|NCT05674695|Methotrexate|methotrexate|mesh-list
56699092|NCT05674695|Upadacitinib|upadacitinib|mesh-list
56699093|NCT05674695|Cyclosporins|cyclosporins|mesh-list
56254756|NCT01889446|Calcium|calcium|mesh-list
56479499|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56479500|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56479501|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479502|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56479503|NCT02933099|Dexamethasone|dexamethasone|mesh-list
56479504|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
56479505|NCT02933099|Aprepitant|aprepitant|mesh-list
56479506|NCT02933099|Palonosetron|palonosetron|mesh-list
56479507|NCT02933099|BB 1101|bb 1101|mesh-list
56479508|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479509|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
56479510|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
56479511|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479514|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
56479516|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56479517|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56479518|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479519|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
56479520|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479521|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479522|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56479523|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479524|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56479525|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56479526|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
56479527|NCT04630886|Lidocaine|lidocaine|mesh-list
56479528|NCT04630886|Epinephrine|epinephrine|mesh-list
56479529|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
56227524|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
56479530|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
56479531|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
56479532|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56334682|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
56479534|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
56479535|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479536|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56479537|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56479538|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56479539|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56479540|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479541|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56479542|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56479543|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
56479544|NCT04630886|Coagulants|coagulants|mesh-ancestor
56479545|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56479546|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56479547|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56479548|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479549|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56479550|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56479551|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
56479552|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56479553|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
56479554|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
56479555|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
56479556|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56479557|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
56479558|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56479559|NCT02934906|Antibodies|antibodies|mesh-list
56479560|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
56479561|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56479562|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
56479563|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479564|NCT02911350|Paclitaxel|paclitaxel|mesh-list
56479565|NCT02911350|Hormones|hormones|mesh-list
56479566|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56479567|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479568|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
56699094|NCT05674695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56699095|NCT05674695|Abortifacient Agents|abortifacient agents|mesh-ancestor
56699096|NCT05674695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56254759|NCT01889498|Acetazolamide|acetazolamide|mesh-list
56479569|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
56479570|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
56479571|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479572|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56479573|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479574|NCT02932397|Propofol|propofol|mesh-list
56479575|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56479576|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479577|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479578|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56479579|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
56479580|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
56479581|NCT02911272|Oxytocin|oxytocin|mesh-list
56479582|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
56479583|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56479589|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479590|NCT02932007|Chloroquine|chloroquine|mesh-list
56479591|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56479592|NCT02932007|Amebicides|amebicides|mesh-ancestor
56479593|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56479594|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56479595|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479596|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
56479597|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479598|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56479599|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56479600|NCT02932007|Analgesics|analgesics|mesh-ancestor
56479601|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
56479602|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479603|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479604|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479605|NCT02932007|Filaricides|filaricides|mesh-ancestor
56479606|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
56479607|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
56479608|NCT02910882|Gemcitabine|gemcitabine|mesh-list
56479609|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56479610|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
56479611|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479612|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479613|NCT02910882|Antiviral Agents|antiviral agents|mesh-ancestor
56479614|NCT02910882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479615|NCT02910882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479616|NCT02910882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56479617|NCT02910882|Immunologic Factors|immunologic factors|mesh-ancestor
56479618|NCT02910882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479619|NCT02910765|Methylene Blue|methylene blue|mesh-list
56479620|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479621|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479622|NCT02925026|Lactoferrin|lactoferrin|mesh-list
56479624|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479625|NCT02665143|Nintedanib|nintedanib|mesh-list
56479626|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479627|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56479628|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479629|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479630|NCT02924987|Aflibercept|aflibercept|mesh-list
56479631|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56479632|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56479633|NCT02924987|Growth Substances|growth substances|mesh-ancestor
56479634|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479635|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
56479636|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479637|NCT02924909|Paclitaxel|paclitaxel|mesh-list
56479638|NCT02924909|Carboplatin|carboplatin|mesh-list
56479639|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56479640|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479641|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
56479642|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
56699097|NCT05674695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699098|NCT05674695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56479643|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
56479644|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479645|NCT02934321|Erythritol|erythritol|mesh-list
56479646|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
56479647|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
56479648|NCT02924753|Fludarabine|fludarabine|mesh-list
56479649|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56479650|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
56479651|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479652|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479653|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56479654|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
56479657|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56479658|NCT02924675|Pregabalin|pregabalin|mesh-list
56479659|NCT02924675|Analgesics|analgesics|mesh-ancestor
56479660|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
56479661|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479662|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479663|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
56479664|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56479665|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56479666|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479667|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56479668|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56479669|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56479670|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479671|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56479672|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
56479673|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56479674|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56479675|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479676|NCT02924285|Amiodarone|amiodarone|mesh-list
56479677|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56479678|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
56479679|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56227697|NCT03006432|Leucovorin|leucovorin|mesh-list
56479680|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55980774|NCT04112823|Hormones|hormones|mesh-ancestor
56479681|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479682|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56479683|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56479684|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56479685|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479686|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56479687|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56479688|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56479689|NCT01287520|Carboplatin|carboplatin|mesh-list
56479690|NCT01287520|Pemetrexed|pemetrexed|mesh-list
56479691|NCT01287520|Ranitidine|ranitidine|mesh-list
56479692|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56479693|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479694|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479695|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479696|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56479697|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56479698|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56479699|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56479700|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56479701|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
56479702|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
56479703|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479704|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479705|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
56479706|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56479707|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56479708|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56479709|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479710|NCT02923934|Nivolumab|nivolumab|mesh-list
56479711|NCT02923934|Ipilimumab|ipilimumab|mesh-list
56479712|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56699099|NCT05674695|Antimetabolites|antimetabolites|mesh-ancestor
56699100|NCT05674695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699101|NCT05674695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699102|NCT05674695|Dermatologic Agents|dermatologic agents|mesh-ancestor
56479713|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479714|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56479715|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479716|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
56479717|NCT01287364|Ciclesonide|ciclesonide|mesh-list
56479718|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56479719|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
56479720|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56479721|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
56479722|NCT01287364|Hormones|hormones|mesh-ancestor
56479723|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56479728|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
56479729|NCT02924090|Ketamine|ketamine|mesh-list
56479730|NCT02924090|Etomidate|etomidate|mesh-list
56479731|NCT02924090|Analgesics|analgesics|mesh-ancestor
56479732|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
56479733|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479734|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479735|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56479736|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56479737|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
56479738|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
56479739|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479740|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56479741|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56479742|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479743|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479744|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56479745|NCT04137770|Ketorolac|ketorolac|mesh-list
56479746|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56479747|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56479748|NCT04137770|Analgesics|analgesics|mesh-ancestor
56479749|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
56479750|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479751|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479752|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56227756|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56479753|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479754|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56479755|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479756|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479757|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
56479759|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479760|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56479761|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56479762|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479763|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479764|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56479765|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56479766|NCT04049084|Adenosine|adenosine|mesh-list
56479767|NCT04049084|Analgesics|analgesics|mesh-ancestor
56479768|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
56479769|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479770|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479771|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56479772|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
56479773|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56479774|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
56479775|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
56479776|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479777|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479778|NCT02923856|Clarithromycin|clarithromycin|mesh-list
56479779|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56479780|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479781|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56699103|NCT05674695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699104|NCT05674695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56254768|NCT01889576|Antacids|antacids|mesh-ancestor
56479782|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479783|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479784|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56479785|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56479786|NCT02934204|Methotrexate|methotrexate|mesh-list
56479787|NCT02934204|Temozolomide|temozolomide|mesh-list
56479788|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56479789|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
56479790|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56479791|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479792|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56479795|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479796|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
56479797|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479798|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56479799|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56479800|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
56479801|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479802|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56479803|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56479804|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
56479805|NCT01286077|Bortezomib|bortezomib|mesh-list
56479806|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479807|NCT05590936|Ondansetron|ondansetron|mesh-list
56479808|NCT05590936|Dimenhydrinate|dimenhydrinate|mesh-list
56479809|NCT05590936|Antiemetics|antiemetics|mesh-ancestor
56479810|NCT05590936|Autonomic Agents|autonomic agents|mesh-ancestor
56479811|NCT05590936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479812|NCT05590936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479813|NCT05590936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56479814|NCT05590936|Antipruritics|antipruritics|mesh-ancestor
56479815|NCT05590936|Dermatologic Agents|dermatologic agents|mesh-ancestor
56479816|NCT05590936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56479817|NCT05590936|Serotonin Agents|serotonin agents|mesh-ancestor
56479818|NCT05590936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479819|NCT05590936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479820|NCT05590936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56479821|NCT05590936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56479822|NCT05590936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479823|NCT05590936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56479825|NCT05590936|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56479826|NCT05590936|Histamine Antagonists|histamine antagonists|mesh-ancestor
56479827|NCT05590936|Histamine Agents|histamine agents|mesh-ancestor
56479828|NCT02933814|Bupivacaine|bupivacaine|mesh-list
56479829|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
56479830|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
56479831|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56479832|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479833|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
56479834|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479835|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
56479836|NCT02933775|Fludarabine|fludarabine|mesh-list
56479837|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56479838|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
56479839|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479840|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479841|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56479842|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
56479843|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479844|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479845|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56479846|NCT02923583|Abatacept|abatacept|mesh-list
56479847|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56479848|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479849|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479850|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56479851|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
56479852|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479853|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56699105|NCT05674695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56699106|NCT05674695|Immunologic Factors|immunologic factors|mesh-ancestor
56699107|NCT05674695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56479854|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
56479855|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
56479856|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479857|NCT02923388|Vitamins|vitamins|mesh-list
56479858|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
56479859|NCT02923388|Pyridoxine|pyridoxine|mesh-list
56479860|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
56479861|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
56479862|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
56479863|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479864|NCT02933658|Amlodipine|amlodipine|mesh-list
56479865|NCT02933658|Telmisartan|telmisartan|mesh-list
56479866|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56479867|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55787755|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
56479868|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56479869|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56479870|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479871|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56479872|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479873|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
56479874|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56479875|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56479876|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
56479877|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56479878|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56479879|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479880|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56479881|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56479883|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56479884|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
56479885|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
56479886|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56479887|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56479888|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479889|NCT00532194|Cediranib|cediranib|mesh-list
56479890|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479891|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56479892|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479893|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479894|NCT00532272|Letrozole|letrozole|mesh-list
56479895|NCT00532272|Goserelin|goserelin|mesh-list
56479896|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479897|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56334709|NCT00396929|Paclitaxel|paclitaxel|mesh-list
56479898|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56479900|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479901|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56479903|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56479904|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479905|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56479906|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
56479907|NCT02922803|Vitamin D|vitamin d|mesh-list
56479908|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
56479909|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
56479910|NCT02922803|Vitamins|vitamins|mesh-list
56479911|NCT02922803|Calcium|calcium|mesh-list
56479912|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
56479913|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479914|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56479915|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56479916|NCT02834559|Fluorouracil|fluorouracil|mesh-list
56479917|NCT02834559|Heparin|heparin|mesh-list
56479918|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56479919|NCT02834559|Tinzaparin|tinzaparin|mesh-list
56479920|NCT02834559|Dalteparin|dalteparin|mesh-list
56479921|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
56479922|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479923|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56479924|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479925|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56699108|NCT05674695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56699109|NCT05674695|Antifungal Agents|antifungal agents|mesh-ancestor
56479926|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
56479927|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479928|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
56479929|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56479930|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56479931|NCT02922686|Floxacillin|floxacillin|mesh-list
56479932|NCT02922686|Penicillin V|penicillin v|mesh-list
56479933|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56479934|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479935|NCT02922491|Vitamin E|vitamin e|mesh-list
56479936|NCT02922491|Vitamins|vitamins|mesh-ancestor
56479937|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
56479938|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479939|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
56479940|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479941|NCT02922491|Protective Agents|protective agents|mesh-ancestor
56479942|NCT02922179|Insulin|insulin|mesh-list
56479943|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
56479944|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56479948|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479949|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
56479950|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
56479951|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
56479952|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479953|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56479954|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56479955|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56479956|NCT01285609|Paclitaxel|paclitaxel|mesh-list
56479957|NCT01285609|Carboplatin|carboplatin|mesh-list
56479958|NCT01285609|Ipilimumab|ipilimumab|mesh-list
56479959|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56479960|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479961|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
56479962|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
56479963|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
56479964|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479965|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56479966|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56479967|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
56479968|NCT03981341|Estrogens|estrogens|mesh-list
56479969|NCT03981341|Hormones|hormones|mesh-ancestor
56479970|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56479971|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479972|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56479973|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56479974|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
56479975|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56479976|NCT03924440|Nonoxynol|nonoxynol|mesh-list
56479977|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56479978|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56479979|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479980|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56479981|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
56479982|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56479983|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56479984|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
56479985|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56479986|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
56479987|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56479988|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479989|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56479990|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
56479991|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
56479992|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56479993|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
56479994|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56479995|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479996|NCT01284634|Cannabidiol|cannabidiol|mesh-list
56479997|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
56479998|NCT02932722|Anesthetics|anesthetics|mesh-list
56479999|NCT02932722|Propofol|propofol|mesh-list
56480000|NCT02932722|Sevoflurane|sevoflurane|mesh-list
56699110|NCT05674695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699111|NCT05674695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56699112|NCT05674695|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56699113|NCT05674695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56699114|NCT05674695|Respiratory System Agents|respiratory system agents|mesh-ancestor
56480001|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480002|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480003|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56480004|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56480005|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
56480006|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56480007|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56480008|NCT02932761|Goserelin|goserelin|mesh-list
56480009|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56480010|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480011|NCT01283971|Adalimumab|adalimumab|mesh-list
56480012|NCT01283971|Methotrexate|methotrexate|mesh-list
56480013|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56480014|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
56480015|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56480016|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480017|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56480020|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480021|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
56480022|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480023|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56480024|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56480025|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
56480026|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56480027|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56480028|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480029|NCT02921282|Dopamine|dopamine|mesh-list
56480030|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56480031|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
56480032|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
56480033|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480034|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480035|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
56480036|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480037|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480038|NCT02921282|Protective Agents|protective agents|mesh-ancestor
56480039|NCT02921360|Aspirin|aspirin|mesh-list
56480040|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56480041|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56480042|NCT02921360|Analgesics|analgesics|mesh-ancestor
56480043|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
56480044|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480045|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480046|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480047|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56480048|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56480049|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56480050|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480051|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56480052|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56480053|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480054|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
56480055|NCT02932605|Cannabidiol|cannabidiol|mesh-list
56480056|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
56480057|NCT02921204|Vitamin D|vitamin d|mesh-list
56480058|NCT02921204|Vitamins|vitamins|mesh-ancestor
56480059|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
56480060|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480061|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56480062|NCT01283581|Vancomycin|vancomycin|mesh-list
56480063|NCT01283581|Linezolid|linezolid|mesh-list
56480064|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56480065|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480066|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56480067|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699115|NCT05674695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56480068|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480069|NCT01283542|Pasireotide|pasireotide|mesh-list
56480070|NCT01283542|Hormones|hormones|mesh-ancestor
56480071|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480072|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480073|NCT01283464|Vitamin A|vitamin a|mesh-list
56480074|NCT01283464|Tretinoin|tretinoin|mesh-list
56480075|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480076|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
56480077|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
56480078|NCT01283464|Vitamins|vitamins|mesh-ancestor
56480079|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
56480080|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480081|NCT02932488|Sumatriptan|sumatriptan|mesh-list
56480082|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56480083|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56480084|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56480085|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
56480086|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480087|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480088|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480089|NCT02921165|Aspirin|aspirin|mesh-list
56480090|NCT02921165|Analgesics|analgesics|mesh-list
56480091|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56480095|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480096|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480097|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56480098|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56480099|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56480100|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480101|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56480102|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56480103|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480105|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
56480106|NCT01283386|Chlorambucil|chlorambucil|mesh-list
56480107|NCT01283386|Rituximab|rituximab|mesh-list
56480108|NCT01283386|Fludarabine|fludarabine|mesh-list
56480109|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56480110|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
56480111|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480112|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56480113|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56480114|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
56480115|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480116|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480117|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56480118|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56480119|NCT02920931|Tenofovir|tenofovir|mesh-list
56480120|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
56480121|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480122|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56334714|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
56480123|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56480125|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480126|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56480127|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56480128|NCT01283152|Lactulose|lactulose|mesh-list
56480129|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56480130|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56480132|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56480133|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56480134|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56480135|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480136|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480137|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480138|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480139|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56480140|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
56480141|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56480142|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
56480143|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56480144|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
56699116|NCT05674695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56699117|NCT02596269|Nefopam|nefopam|mesh-list
56699118|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56699119|NCT02596269|Analgesics|analgesics|mesh-ancestor
56699120|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
56699121|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480145|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480146|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480147|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56480148|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
56480149|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
56480150|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56480151|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
56480152|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480153|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480154|NCT02932566|Pirfenidone|pirfenidone|mesh-list
56480155|NCT02932566|Analgesics|analgesics|mesh-ancestor
56480156|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
56480157|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480158|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480159|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56480160|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56480161|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480164|NCT00532389|Panobinostat|panobinostat|mesh-list
56480165|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480166|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56480167|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480168|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480169|NCT02932644|Vitamin D|vitamin d|mesh-list
56480170|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
56480171|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
56480172|NCT02932644|Vitamins|vitamins|mesh-list
56480173|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
56480174|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480175|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56480176|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56480177|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
56480178|NCT05466708|Ketamine|ketamine|mesh-list
56480179|NCT05466708|Esketamine|esketamine|mesh-list
56480180|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56480181|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480182|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480183|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56480184|NCT05466708|Analgesics|analgesics|mesh-ancestor
56480185|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
56480186|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480187|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56480188|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56480189|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56480190|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
56480191|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480192|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480193|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56547730|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547732|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56547733|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56547734|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
56547735|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547736|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56547737|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56547738|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547739|NCT00645229|Ziprasidone|ziprasidone|mesh-list
56547740|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56547741|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
56547742|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547743|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547744|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699122|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699123|NCT00741039|Vaccines|vaccines|mesh-list
56699124|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56699125|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
56699126|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699127|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56254785|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
56547745|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56547746|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56547747|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547748|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56547749|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56547750|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
56547751|NCT01172873|Cycloserine|cycloserine|mesh-list
56547752|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56547753|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547754|NCT01172873|Renal Agents|renal agents|mesh-ancestor
56547755|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56547756|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
56547757|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56547758|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
56547759|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547761|NCT02886299|Fenofibrate|fenofibrate|mesh-list
56547762|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56547763|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56547764|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
56547765|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547766|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56547767|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56547768|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547769|NCT00925600|Denosumab|denosumab|mesh-list
56547770|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56547771|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547776|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56547777|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56547778|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547779|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547780|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56547781|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56547782|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56547783|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
56547784|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547785|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547786|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56547787|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56547788|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
56547790|NCT02668861|Budesonide|budesonide|mesh-list
56547791|NCT02668861|Vitamins|vitamins|mesh-ancestor
56547792|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
56547793|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547794|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56547795|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56547796|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56547797|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
56547798|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547799|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56547800|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
56547801|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
56547802|NCT02668861|Hormones|hormones|mesh-ancestor
56547803|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547805|NCT00968253|Dexamethasone|dexamethasone|mesh-list
56547806|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
56547807|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56547808|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56547809|NCT00968253|Prednisolone|prednisolone|mesh-list
56547810|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
56547811|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
56547812|NCT00968253|Doxorubicin|doxorubicin|mesh-list
56699128|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56699129|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699130|NCT04454229|Penicillins|penicillins|mesh-list
56699131|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56699132|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699133|NCT04078659|Lidocaine|lidocaine|mesh-list
56699134|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
56699135|NCT04078659|Fentanyl|fentanyl|mesh-list
56699136|NCT04078659|Propofol|propofol|mesh-list
56699137|NCT04078659|Atracurium|atracurium|mesh-list
56699138|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
56699139|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
56699140|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699142|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
56699143|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699144|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56699145|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56699146|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56699147|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699148|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699149|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56699183|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699184|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
56699185|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56699186|NCT00760214|Ramipril|ramipril|mesh-list
56699187|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56699188|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56699189|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
56699190|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699191|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699192|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56699193|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56699194|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56699195|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
56699196|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56699197|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
56699198|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56699199|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699237|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56699238|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56699239|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699240|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699241|NCT02582307|Acetaminophen|acetaminophen|mesh-list
56699242|NCT02582307|Scopolamine|scopolamine|mesh-list
56699243|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56699244|NCT02582307|Analgesics|analgesics|mesh-list
56699245|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56699246|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
56699247|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699248|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699249|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
56699250|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56699251|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
56699252|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
56699253|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56699254|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
56699255|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56699256|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
56699257|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699258|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699259|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56699260|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
56699261|NCT02689245|Tenofovir|tenofovir|mesh-list
56699262|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
56699263|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699264|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56699265|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56699266|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699267|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699268|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56699269|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56699270|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
56699271|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699272|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56547813|NCT00968253|Methotrexate|methotrexate|mesh-list
56547814|NCT00968253|Vincristine|vincristine|mesh-list
56547815|NCT00968253|Everolimus|everolimus|mesh-list
56547816|NCT00968253|Lenograstim|lenograstim|mesh-list
56699273|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699274|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699275|NCT00772148|Tacrolimus|tacrolimus|mesh-list
56699276|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56699277|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
56699278|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699279|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56699280|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699281|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699282|NCT02689089|Rifapentine|rifapentine|mesh-list
56699283|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56699284|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
56699285|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56699287|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
56699288|NCT00759902|Morphine|morphine|mesh-list
56699289|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56699290|NCT00759902|Narcotics|narcotics|mesh-ancestor
56547817|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56547818|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
56547819|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547820|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
56547821|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547822|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56547823|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56547824|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
56547825|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547826|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547827|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56547828|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56547829|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
56547830|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
56547831|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547832|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56547833|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
56547834|NCT00968253|Hormones|hormones|mesh-ancestor
56547835|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547836|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56547837|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56547838|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56547839|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56547840|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547841|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56547842|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
56547843|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547846|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
56547847|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56547848|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56547849|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
56547850|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547851|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56547852|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
56547853|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547854|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
56547855|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56547856|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56547857|NCT00968253|Protective Agents|protective agents|mesh-ancestor
56547858|NCT00646009|Fluticasone|fluticasone|mesh-list
56547859|NCT00646009|Budesonide|budesonide|mesh-list
56547860|NCT00646009|Albuterol|albuterol|mesh-list
56699291|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699292|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699293|NCT00759902|Analgesics|analgesics|mesh-ancestor
56699294|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
56699295|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699296|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
56699297|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
56699298|NCT04077957|Etanercept|etanercept|mesh-list
56699299|NCT04077957|Methotrexate|methotrexate|mesh-list
56699300|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56699301|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
56699302|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56699303|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699304|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56699305|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
56699306|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699307|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699308|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
56699309|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699310|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56699311|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56699312|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
56699313|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56699314|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56699315|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
56699316|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56699317|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56699318|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699319|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56699320|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56699321|NCT04077957|Analgesics|analgesics|mesh-ancestor
56547861|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
56547862|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56547863|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56547864|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56547865|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56547866|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
56547867|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547868|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547869|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56547870|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
56547871|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
56547872|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56547873|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
56699322|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
56699323|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699324|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56699325|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56699326|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
56699327|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699328|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56699329|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
56699330|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
56699331|NCT04102670|Protective Agents|protective agents|mesh-ancestor
56699332|NCT04114097|Betamethasone|betamethasone|mesh-list
56699333|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
56699334|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56699335|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
56699336|NCT04114097|Tacrolimus|tacrolimus|mesh-list
56699337|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56699338|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56699339|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
56699340|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699341|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56699342|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699343|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699344|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56699345|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
56699346|NCT04114097|Hormones|hormones|mesh-ancestor
56699347|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56699348|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56547874|NCT00646009|Hormones|hormones|mesh-ancestor
56547875|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547876|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56547877|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56547878|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56547879|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
56547880|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547881|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547882|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
56547883|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547884|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
56547885|NCT00646087|Ketamine|ketamine|mesh-list
56547886|NCT00646087|Analgesics|analgesics|mesh-ancestor
56547887|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
56547888|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547889|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547890|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56547891|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56547892|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
56547893|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
56699349|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
56699350|NCT04325217|Nintedanib|nintedanib|mesh-list
56699351|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699352|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56699353|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699354|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699355|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56699356|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56699357|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699358|NCT04323189|Incretins|incretins|mesh-ancestor
56699359|NCT04323189|Hormones|hormones|mesh-ancestor
56699360|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56699361|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56699362|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
56699363|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699364|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699365|NCT00772070|Vaccines|vaccines|mesh-list
56699366|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
56699367|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699368|NCT00796757|Interferons|interferons|mesh-list
56699369|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
56699370|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
56699371|NCT00796757|Bevacizumab|bevacizumab|mesh-list
56699372|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56699373|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699374|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56699375|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56699376|NCT00796757|Growth Substances|growth substances|mesh-ancestor
56547894|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547895|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56547896|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56547897|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56547898|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547899|NCT04255576|Vitamin D|vitamin d|mesh-list
56547900|NCT04255576|Calcium|calcium|mesh-list
56547901|NCT04255576|Vitamins|vitamins|mesh-ancestor
56547902|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
56547903|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547904|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56547905|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56547906|NCT04255498|Etanercept|etanercept|mesh-list
56547907|NCT04255498|Mifepristone|mifepristone|mesh-list
56547908|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56296172|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
56547909|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56547910|NCT04255498|Analgesics|analgesics|mesh-ancestor
56699377|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699378|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
56699379|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
56699380|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699381|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
56699382|NCT00759356|Morphine|morphine|mesh-list
56699383|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56699384|NCT00759356|Narcotics|narcotics|mesh-ancestor
56699385|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699386|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699387|NCT00759356|Analgesics|analgesics|mesh-ancestor
56699388|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
56699389|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699390|NCT05637515|Adalimumab|adalimumab|mesh-list
56699391|NCT05637515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56699392|NCT05637515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56699393|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56699394|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56699395|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699396|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699397|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56699398|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699399|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699400|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
56699401|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699402|NCT04102592|Permethrin|permethrin|mesh-list
56699403|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699404|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699405|NCT04113551|Guanfacine|guanfacine|mesh-list
56699406|NCT04113551|Methylphenidate|methylphenidate|mesh-list
56699407|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55877080|NCT02977494|Bortezomib|bortezomib|mesh-list
56547911|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
56547912|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547913|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547914|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56547915|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56547916|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56547919|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56547920|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
56547921|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547922|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56547923|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56699408|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56699409|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56699410|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699411|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699412|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
56699413|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699414|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699415|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56699416|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56699417|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
56699418|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56699419|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56699420|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56699421|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56699422|NCT00798317|Plasminogen|plasminogen|mesh-list
56699423|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56699424|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56699425|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699426|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
56699427|NCT00077285|Ifosfamide|ifosfamide|mesh-list
56699428|NCT00077285|Carboplatin|carboplatin|mesh-list
56547924|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56547925|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
56547926|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56547927|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56547928|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
56547929|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547930|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
56547931|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56547932|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56547933|NCT02666209|Dexamethasone|dexamethasone|mesh-list
56547934|NCT02666209|Lenalidomide|lenalidomide|mesh-list
56547935|NCT02666209|Bortezomib|bortezomib|mesh-list
56547936|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56547937|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
56547938|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
56547939|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547940|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547941|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56547942|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
56547943|NCT02666209|Hormones|hormones|mesh-ancestor
56547944|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547945|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56547946|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547947|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
56547948|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56547949|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56547950|NCT02666209|Growth Substances|growth substances|mesh-ancestor
56547951|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
56547952|NCT00964743|Cytarabine|cytarabine|mesh-list
56547953|NCT00964743|Sorafenib|sorafenib|mesh-list
56547954|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56699429|NCT00077285|Doxorubicin|doxorubicin|mesh-list
56699430|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56699431|NCT00077285|Irinotecan|irinotecan|mesh-list
56699432|NCT00077285|Etoposide|etoposide|mesh-list
56699433|NCT00077285|Vincristine|vincristine|mesh-list
56699434|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
56699435|NCT00077285|Razoxane|razoxane|mesh-list
56547663|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699436|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56699437|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
56699438|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699439|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56699440|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56699441|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
56699442|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699443|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699444|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56699445|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56699446|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56699447|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56699448|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699449|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56699450|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56699451|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
56699452|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
56699453|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
56699454|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56699455|NCT00077285|Protective Agents|protective agents|mesh-ancestor
56699456|NCT00771914|Aspirin|aspirin|mesh-list
56699457|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56699458|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56699459|NCT00771914|Analgesics|analgesics|mesh-ancestor
56699460|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
56547955|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
56547956|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547957|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547958|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
56547959|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547960|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547961|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
56547962|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547963|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56699461|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699462|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699463|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56699464|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56699465|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56699466|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56699467|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699468|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56699469|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56699470|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699471|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
56699472|NCT04307511|Aspirin|aspirin|mesh-list
56699473|NCT04307511|Ticagrelor|ticagrelor|mesh-list
56699474|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56699475|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56699476|NCT04307511|Analgesics|analgesics|mesh-ancestor
56699477|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
56699478|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547964|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547965|NCT02862327|Dexamethasone|dexamethasone|mesh-list
56547966|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
56547967|NCT02862327|Ropivacaine|ropivacaine|mesh-list
56547968|NCT02862327|BB 1101|bb 1101|mesh-list
56547969|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56547970|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
56547971|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
56547972|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547973|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547974|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56547975|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
56547976|NCT02862327|Hormones|hormones|mesh-ancestor
56547977|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56547978|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56547979|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547980|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
56547981|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56547982|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547983|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
56547985|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547986|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
56547987|NCT04945720|Durvalumab|durvalumab|mesh-list
56547988|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56547989|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56547990|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547992|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547993|NCT02666365|Cefazolin|cefazolin|mesh-list
56547994|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56547995|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56547996|NCT02666443|Dexamethasone|dexamethasone|mesh-list
56547997|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
56547998|NCT02666443|BB 1101|bb 1101|mesh-list
56547999|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56548000|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
56548001|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
56548002|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548003|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548004|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56699479|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699480|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56699481|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56699482|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56699483|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56699484|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699485|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56699486|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56699487|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699488|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
56699489|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56699490|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56699491|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56699492|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
56699493|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699494|NCT00779324|Amantadine|amantadine|mesh-list
56699495|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56699496|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56699497|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
56699498|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699499|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
56699500|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699501|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699502|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699503|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56699504|NCT00779324|Analgesics|analgesics|mesh-ancestor
56699505|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
56699506|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699507|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
56699508|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56699509|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56699510|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699511|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
56699519|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56699520|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
56699521|NCT00771758|Oxycodone|oxycodone|mesh-list
56699522|NCT00771758|Tapentadol|tapentadol|mesh-list
56699523|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56699524|NCT00771758|Narcotics|narcotics|mesh-ancestor
56699525|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699526|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699527|NCT00771758|Analgesics|analgesics|mesh-ancestor
56699528|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
56699529|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699530|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56699531|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56699532|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699533|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699534|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56699535|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699536|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
56699537|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56699538|NCT02581371|Protective Agents|protective agents|mesh-ancestor
56699539|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699540|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
56699541|NCT02688465|Apomorphine|apomorphine|mesh-list
56699542|NCT02688465|Emetics|emetics|mesh-ancestor
56699543|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548005|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
56548006|NCT02666443|Hormones|hormones|mesh-ancestor
56548007|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548008|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56548009|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548010|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
56548011|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548012|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548013|NCT01130532|Tadalafil|tadalafil|mesh-list
56548014|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
56548015|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56548016|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56548017|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548018|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548019|NCT01130532|Urological Agents|urological agents|mesh-ancestor
56548020|NCT04258306|Resveratrol|resveratrol|mesh-list
56548021|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
56548022|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548023|NCT04258306|Protective Agents|protective agents|mesh-ancestor
56548024|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548025|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548026|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56548028|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
56548029|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888291|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56699544|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
56699545|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699546|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56699547|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
56699548|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
56699549|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699550|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699551|NCT00758498|Modafinil|modafinil|mesh-list
56699552|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56699553|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699554|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56699555|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56699556|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56699557|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548030|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548031|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
56548032|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548033|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548034|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
56548035|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56548036|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548037|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548038|NCT00972777|Besifloxacin|besifloxacin|mesh-list
56548039|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56548040|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548041|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56548042|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56548043|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548044|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548045|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548046|NCT04254874|Interferons|interferons|mesh-list
56548047|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548048|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
56548049|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548050|NCT02667223|Bococizumab|bococizumab|mesh-list
56548051|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56548052|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56548053|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
56548054|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548055|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56548056|NCT02863809|Riboflavin|riboflavin|mesh-list
56548057|NCT02863809|Dextrans|dextrans|mesh-list
56548058|NCT02863809|Vitamins|vitamins|mesh-ancestor
56548059|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
56548060|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548062|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56548063|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
56548064|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
56548065|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
56548066|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
56548067|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
56548068|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56548070|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548071|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
56548072|NCT00918736|Protective Agents|protective agents|mesh-ancestor
56548073|NCT02666053|Fostemsavir|fostemsavir|mesh-list
56548074|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56548075|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56548076|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
56548077|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699558|NCT00798161|Metformin|metformin|mesh-list
56699559|NCT00798161|Linagliptin|linagliptin|mesh-list
56699560|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56699561|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699562|NCT00798161|Incretins|incretins|mesh-ancestor
56699563|NCT00798161|Hormones|hormones|mesh-ancestor
56699564|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56699565|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56699566|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
56699567|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699568|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699569|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
56699570|NCT02581683|Ropivacaine|ropivacaine|mesh-list
56699571|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
56699572|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
56699573|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699574|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699575|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
56699576|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699612|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56699613|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56699614|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
56699615|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699616|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56699617|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
56699618|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
56548078|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56548079|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56548080|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548081|NCT03412773|Sorafenib|sorafenib|mesh-list
56548082|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548083|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56548084|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548085|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548086|NCT04257838|Meropenem|meropenem|mesh-list
56548087|NCT04257838|Tazobactam|tazobactam|mesh-list
56548088|NCT04257838|Piperacillin|piperacillin|mesh-list
56548089|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56548090|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56548091|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548092|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56548093|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548094|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548095|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
56548096|NCT01172639|Prednisone|prednisone|mesh-list
56548097|NCT01172639|Methotrexate|methotrexate|mesh-list
56548098|NCT01172639|Leflunomide|leflunomide|mesh-list
56548099|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56548100|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
56548101|NCT01172639|Hormones|hormones|mesh-ancestor
56548102|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548103|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548104|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56548105|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548106|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56548108|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56548109|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56548110|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
56548111|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548112|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
56548113|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548114|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56548115|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548116|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
56548117|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56548118|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56548119|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548120|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56548121|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56548122|NCT01172639|Analgesics|analgesics|mesh-ancestor
56548123|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
56548124|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548125|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56548126|NCT01225562|Ticagrelor|ticagrelor|mesh-list
56548127|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56548128|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56548129|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56548130|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56548131|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
56548132|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548133|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548134|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548135|NCT00925288|Vaccines|vaccines|mesh-list
56548136|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
56548137|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548138|NCT01143714|Petrolatum|petrolatum|mesh-list
56699619|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
56699620|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56699621|NCT04186299|Analgesics|analgesics|mesh-ancestor
56699622|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
56699623|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56699624|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
56699625|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56699626|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
56699627|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
56699628|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699629|NCT04115423|Adalimumab|adalimumab|mesh-list
56699630|NCT04115423|Etanercept|etanercept|mesh-list
56699631|NCT04115423|Golimumab|golimumab|mesh-list
56699632|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56699633|NCT04115423|Infliximab|infliximab|mesh-list
56699634|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56699635|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56699636|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
56699637|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56699638|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56699639|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56699640|NCT04115423|Analgesics|analgesics|mesh-ancestor
56699641|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
56699644|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56699677|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699678|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56699679|NCT00914693|Gestodene|gestodene|mesh-list
56699680|NCT00914693|Femovan|femovan|mesh-list
56699681|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56699682|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56699683|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56699684|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
56699685|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56699686|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699687|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56699688|NCT00914693|Estrogens|estrogens|mesh-ancestor
56699689|NCT00914693|Hormones|hormones|mesh-ancestor
56699690|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56699691|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56699692|NCT00914693|Progestins|progestins|mesh-ancestor
56699693|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56699694|NCT00915083|Amrubicin|amrubicin|mesh-list
56699695|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699696|NCT00802529|Gentamicins|gentamicins|mesh-list
56699697|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
56699698|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56699699|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56699700|NCT00802529|Prednisolone|prednisolone|mesh-list
56699701|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
56699702|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56255331|NCT01901198|Interferons|interferons|mesh-list
56548139|NCT01143714|Emollients|emollients|mesh-ancestor
56548140|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
56548141|NCT04920682|Iodine|iodine|mesh-list
56548142|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56548143|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548145|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
56548146|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548147|NCT04174339|Apatinib|apatinib|mesh-list
56548148|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548149|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56548150|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548151|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548152|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56548153|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
56548154|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548155|NCT00925132|Temozolomide|temozolomide|mesh-list
56548156|NCT00925132|Decitabine|decitabine|mesh-list
56548157|NCT00925132|Panobinostat|panobinostat|mesh-list
56548158|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56548159|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
56548160|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548161|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548162|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56699703|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
56699704|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56699705|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
56699706|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
56699707|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699708|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699709|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56699710|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
56699711|NCT00802529|Hormones|hormones|mesh-ancestor
56699712|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56699713|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56699714|NCT00802529|Protective Agents|protective agents|mesh-ancestor
56699715|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56699716|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699717|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56699718|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699719|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56699720|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699721|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699722|NCT02605811|Temozolomide|temozolomide|mesh-list
56699723|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56548163|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
56548164|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548165|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56548166|NCT02862015|Gemcitabine|gemcitabine|mesh-list
56548167|NCT02862015|Folfirinox|folfirinox|mesh-list
56548168|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56548169|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
56548170|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548171|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548172|NCT02862015|Antiviral Agents|antiviral agents|mesh-ancestor
56548173|NCT02862015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548174|NCT02862015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548175|NCT02862015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548176|NCT02862015|Immunologic Factors|immunologic factors|mesh-ancestor
56548177|NCT02862015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548178|NCT01143402|Temozolomide|temozolomide|mesh-list
56548179|NCT01143402|Dacarbazine|dacarbazine|mesh-list
56548180|NCT01143402|Imidazole|imidazole|mesh-list
56548181|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56548182|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
56548183|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548184|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548185|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548186|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
56548187|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56548188|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
56548189|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
56548190|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548191|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548192|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56548193|NCT00646945|Analgesics|analgesics|mesh-ancestor
56548194|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
56699724|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
56699725|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699726|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699727|NCT00758264|Vaccines|vaccines|mesh-list
56699728|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56699729|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
56699730|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56410936|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
56699760|NCT05629949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699761|NCT05629949|Tubulin Modulators|tubulin modulators|mesh-ancestor
56699762|NCT05629949|Antimitotic Agents|antimitotic agents|mesh-ancestor
56699763|NCT05629949|Mitosis Modulators|mitosis modulators|mesh-ancestor
56699764|NCT05629949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699765|NCT05629949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56699767|NCT05628233|Antiemetics|antiemetics|mesh-ancestor
56699768|NCT05628233|Autonomic Agents|autonomic agents|mesh-ancestor
56699769|NCT05628233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699770|NCT05628233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699771|NCT05628233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56699772|NCT05628233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56699773|NCT05628233|Serotonin Agents|serotonin agents|mesh-ancestor
56699774|NCT05628233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699775|NCT05628233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699776|NCT04109261|Palbociclib|palbociclib|mesh-list
56699777|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699778|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56699779|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699780|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699781|NCT04109339|Oxytocin|oxytocin|mesh-list
56699782|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
56699783|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56699784|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699785|NCT00757172|Docetaxel|docetaxel|mesh-list
56699786|NCT00757172|Panitumumab|panitumumab|mesh-list
56699787|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548195|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548196|NCT00629889|Pregabalin|pregabalin|mesh-list
56548197|NCT00629889|Levetiracetam|levetiracetam|mesh-list
56548198|NCT00629889|Analgesics|analgesics|mesh-ancestor
56548199|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
56699788|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
56699789|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
56699790|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
56699791|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699792|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56699793|NCT00797225|Leuprolide|leuprolide|mesh-list
56699794|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56699795|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
56699796|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56699797|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699798|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56699799|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699800|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
56699801|NCT05277285|Antidotes|antidotes|mesh-ancestor
56699802|NCT05277285|Protective Agents|protective agents|mesh-ancestor
56699803|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699804|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
56699805|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699806|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
56411009|NCT00200460|Nebivolol|nebivolol|mesh-list
56699807|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56699808|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699809|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
56699810|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
56699811|NCT04110665|Acetaminophen|acetaminophen|mesh-list
56699812|NCT04110665|Morphine|morphine|mesh-list
56699813|NCT04110665|Oxycodone|oxycodone|mesh-list
56699814|NCT04110665|Tramadol|tramadol|mesh-list
56699815|NCT04110665|Nefopam|nefopam|mesh-list
56699816|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56699817|NCT04110665|Narcotics|narcotics|mesh-ancestor
56699818|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699819|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699820|NCT04110665|Analgesics|analgesics|mesh-ancestor
56699821|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
56699822|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255408|NCT01901861|Hormones|hormones|mesh-ancestor
56548200|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548201|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548202|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
56548203|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56699823|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56699824|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
56699825|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56699826|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
56699827|NCT00638859|Telithromycin|telithromycin|mesh-list
56699828|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56699829|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699830|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
56699831|NCT04042701|Trastuzumab|trastuzumab|mesh-list
56699832|NCT04042701|Camptothecin|camptothecin|mesh-list
56699833|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
56699834|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56699835|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699836|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56699837|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56699838|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56699839|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699840|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699841|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
56699842|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699843|NCT02537847|Ertapenem|ertapenem|mesh-list
56699844|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
56699845|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
56699846|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56699847|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699848|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56699849|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548204|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56548205|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548206|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56548207|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56548208|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56548209|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548210|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548211|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
56548212|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
56548213|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56548214|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548215|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
56548216|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56548217|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56548218|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56548220|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548222|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548223|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548224|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56548225|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548226|NCT00630045|Capecitabine|capecitabine|mesh-list
56699850|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699851|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56699852|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56699853|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699854|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56699855|NCT04033029|Tazobactam|tazobactam|mesh-list
56699856|NCT04033029|Piperacillin|piperacillin|mesh-list
56699857|NCT04033029|Daptomycin|daptomycin|mesh-list
56699858|NCT04033029|Ceftazidime|ceftazidime|mesh-list
56699859|NCT04033029|Cefepime|cefepime|mesh-list
56699860|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56699861|NCT04033029|Ceftolozane|ceftolozane|mesh-list
56699862|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56699863|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56699864|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699865|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699866|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
56699867|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56699868|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699869|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699870|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56699871|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56699872|NCT02687841|Protective Agents|protective agents|mesh-ancestor
56699873|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699874|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
56699875|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56699876|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
56699877|NCT00778622|Metformin|metformin|mesh-list
56699878|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56699879|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699880|NCT00777920|Ambrisentan|ambrisentan|mesh-list
56548227|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
56548228|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56548229|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
56548230|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548231|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548232|NCT02861859|Olanzapine|olanzapine|mesh-list
56548233|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
56548234|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
56548235|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548236|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548237|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56548238|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56548239|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56548240|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699881|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56699882|NCT04236141|Rituximab|rituximab|mesh-list
56699883|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56699884|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56699885|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699886|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
56699887|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699888|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56699889|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56699890|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
56699891|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699892|NCT04097444|Leucovorin|leucovorin|mesh-list
56699893|NCT04097444|Bevacizumab|bevacizumab|mesh-list
56699894|NCT04097444|Fluorouracil|fluorouracil|mesh-list
56699895|NCT04097444|Capecitabine|capecitabine|mesh-list
56699896|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
56699897|NCT04097444|Irinotecan|irinotecan|mesh-list
56699898|NCT04097444|Calcium|calcium|mesh-list
56699899|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
56699900|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56699901|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699902|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56699903|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56699904|NCT04097444|Growth Substances|growth substances|mesh-ancestor
56699905|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699906|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
56699907|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56699908|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
56699909|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699910|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56699911|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56699912|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
56699913|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56699914|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56699915|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699916|NCT04097444|Antidotes|antidotes|mesh-ancestor
56548241|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548242|NCT02861859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56548243|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56699917|NCT04097444|Protective Agents|protective agents|mesh-ancestor
56699918|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
56699919|NCT04097444|Vitamins|vitamins|mesh-ancestor
56699920|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
56699921|NCT04097288|Dexetimide|dexetimide|mesh-list
56699922|NCT04097288|Citalopram|citalopram|mesh-list
56699923|NCT04097288|Reboxetine|reboxetine|mesh-list
56699924|NCT04097288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56699925|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56699926|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699927|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699928|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699929|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
56699930|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699931|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56699932|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
56699933|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56699934|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56699935|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56699936|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
56699937|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
56699938|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699939|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56699940|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56699941|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
56699942|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56699943|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
56699944|NCT04231539|Nicotine|nicotine|mesh-list
56699945|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56699946|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
56699947|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699948|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699949|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56699950|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56699951|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
56699952|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699953|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548244|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699954|NCT04219449|Protein C|protein c|mesh-list
56699955|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
56699956|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56699957|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56699958|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699959|NCT04209855|Paclitaxel|paclitaxel|mesh-list
56699960|NCT04209855|Maytansine|maytansine|mesh-list
56699961|NCT04209855|Doxorubicin|doxorubicin|mesh-list
56699962|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56699963|NCT04209855|Topotecan|topotecan|mesh-list
56699964|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56411152|NCT00557713|Bevacizumab|bevacizumab|mesh-list
56699965|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56699966|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
56699967|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
56699968|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
56255570|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56548245|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548246|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548247|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
56548248|NCT00647023|Metformin|metformin|mesh-list
56548249|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56548250|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548251|NCT00924898|Tenofovir|tenofovir|mesh-list
56548253|NCT00924898|Efavirenz|efavirenz|mesh-list
56548254|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
56548255|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548256|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56548257|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56548258|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548259|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548260|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56548261|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56548262|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56548263|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56548264|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56548265|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56548266|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56548267|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56548268|NCT01167192|Carboplatin|carboplatin|mesh-list
56548269|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548270|NCT00646321|Budesonide|budesonide|mesh-list
56548271|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
56548272|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56548273|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56548274|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56548275|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
56548276|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548277|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548278|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56548279|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
56548280|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
56548281|NCT00646321|Hormones|hormones|mesh-ancestor
56548282|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56296553|NCT00006482|Gemcitabine|gemcitabine|mesh-list
56296564|NCT03809988|Letrozole|letrozole|mesh-list
56548283|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56548284|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56548285|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56699969|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699970|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56699971|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56699972|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56699973|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56699974|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56699976|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56699977|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56699978|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56699979|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56699980|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699981|NCT04076865|Lidocaine|lidocaine|mesh-list
56699982|NCT04076865|Histamine|histamine|mesh-list
56699983|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
56699984|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
56699985|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56699986|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56699987|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
56699988|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56699989|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56699990|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56699991|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56699992|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56699993|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56699994|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
56699995|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
56699996|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56699997|NCT00770588|Gefitinib|gefitinib|mesh-list
56699998|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700002|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
56700012|NCT02604797|Dsuvia|dsuvia|mesh-list
56700013|NCT02604797|Nalbuphine|nalbuphine|mesh-list
56700014|NCT02604797|Ramosetron|ramosetron|mesh-list
56700015|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56700016|NCT02604797|Narcotics|narcotics|mesh-ancestor
56700017|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700018|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700019|NCT02604797|Analgesics|analgesics|mesh-ancestor
56700020|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
56700021|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700022|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56700023|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56700024|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
56700025|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
56700026|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56700027|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56700028|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700029|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700030|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56700031|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700032|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700033|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
56255629|NCT01903070|Linagliptin|linagliptin|mesh-list
56255630|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56255631|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255632|NCT01903070|Incretins|incretins|mesh-ancestor
56548286|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
56548287|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548288|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548292|NCT01166958|Teriparatide|teriparatide|mesh-list
56548293|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56548294|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56548295|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548296|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56548297|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56548298|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
56548299|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548300|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56548301|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56548302|NCT01170221|Linezolid|linezolid|mesh-list
56548303|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
56548304|NCT01170221|Tedizolid|tedizolid|mesh-list
56548305|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56548306|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548307|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56548308|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548309|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548310|NCT04254640|Cytarabine|cytarabine|mesh-list
56548311|NCT04254640|Cladribine|cladribine|mesh-list
56548312|NCT04254640|Aclarubicin|aclarubicin|mesh-list
56700034|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
56700035|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700036|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56700037|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
56700038|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700039|NCT00777608|Donepezil|donepezil|mesh-list
56411235|NCT04652323|Calcium|calcium|mesh-list
56700040|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56700041|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700042|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700043|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
56700044|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700045|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700046|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
56700047|NCT00792935|Metformin|metformin|mesh-list
56700048|NCT00792935|Glimepiride|glimepiride|mesh-list
56700049|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56700050|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255649|NCT01903083|Immunologic Factors|immunologic factors|mesh-ancestor
56548313|NCT04254640|Lenograstim|lenograstim|mesh-list
56548314|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56548315|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
56548316|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548317|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548318|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
56548319|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334723|NCT00399165|Testosterone|testosterone|mesh-list
56548320|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548321|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
56548322|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548323|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56548324|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56548325|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56548326|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56548327|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548328|NCT01166646|Clobetasol|clobetasol|mesh-list
56548329|NCT01166646|Halobetasol|halobetasol|mesh-list
56548330|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56548331|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56548332|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
56548333|NCT01166646|Hormones|hormones|mesh-ancestor
56548334|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548335|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548336|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56548337|NCT01129284|Hormones|hormones|mesh-ancestor
56548338|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548339|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548340|NCT00647257|Losartan|losartan|mesh-list
56548341|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56548342|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56548343|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56548344|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56548345|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548346|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
56548347|NCT04895761|Letrozole|letrozole|mesh-list
56548348|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548349|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
56700051|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56700052|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700053|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
56700054|NCT03904563|Bevacizumab|bevacizumab|mesh-list
56700055|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56700056|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700057|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56700058|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56700059|NCT03904563|Growth Substances|growth substances|mesh-ancestor
56700060|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700061|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
56700062|NCT00770510|Zolpidem|zolpidem|mesh-list
56700063|NCT00770510|Eszopiclone|eszopiclone|mesh-list
56700064|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56700065|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56700066|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700067|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700068|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56700069|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
56700070|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
56700071|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700072|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700073|NCT04077255|Paclitaxel|paclitaxel|mesh-list
56700074|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56700075|NCT04077255|Antibodies|antibodies|mesh-list
56700076|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56700077|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700078|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
56700079|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
56700080|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
56700081|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548350|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548351|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56548352|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56548353|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
56548354|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548355|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548356|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56548357|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56548358|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56548359|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548362|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700082|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
56700083|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700084|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56700085|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56700086|NCT00770432|Laxatives|laxatives|mesh-ancestor
56700087|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700088|NCT00792701|Gemcitabine|gemcitabine|mesh-list
56700089|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700090|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56700091|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
56700092|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700093|NCT00792701|Antiviral Agents|antiviral agents|mesh-ancestor
56700094|NCT00792701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700095|NCT00792701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700096|NCT00792701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700097|NCT00792701|Immunologic Factors|immunologic factors|mesh-ancestor
56700098|NCT00792701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700099|NCT03772353|Letrozole|letrozole|mesh-list
56700100|NCT03772353|Fulvestrant|fulvestrant|mesh-list
56700101|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700102|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56700103|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56548364|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
56548365|NCT01166178|Calcium|calcium|mesh-list
56548366|NCT01166178|Vitamins|vitamins|mesh-ancestor
56548367|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
56548368|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548369|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56548370|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56548371|NCT00924820|Bevacizumab|bevacizumab|mesh-list
56548372|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56548373|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548374|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56548375|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56548376|NCT00924820|Growth Substances|growth substances|mesh-ancestor
56548377|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548378|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
56548379|NCT01225172|Letrozole|letrozole|mesh-list
56548380|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548381|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56548382|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56548383|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548384|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548385|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56548386|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
56548387|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548388|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548389|NCT02665039|Gemcitabine|gemcitabine|mesh-list
56548390|NCT02665039|Carboplatin|carboplatin|mesh-list
56548391|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548392|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56548393|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
56548394|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700104|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700105|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700106|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56700107|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
56700108|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700109|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700110|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56700111|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56700112|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
56700113|NCT05559983|Vaccines|vaccines|mesh-list
56700114|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
56700115|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56411305|NCT00206154|Budesonide|budesonide|mesh-list
56700116|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56700117|NCT05559983|Antacids|antacids|mesh-ancestor
56700118|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700119|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700120|NCT03765567|Vancomycin|vancomycin|mesh-list
56700121|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700122|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700123|NCT00777296|Amikacin|amikacin|mesh-list
56700124|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700125|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700126|NCT00756470|Paclitaxel|paclitaxel|mesh-list
56700127|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
56700128|NCT00756470|Fluorouracil|fluorouracil|mesh-list
56700129|NCT00756470|Epirubicin|epirubicin|mesh-list
56700130|NCT00756470|Lapatinib|lapatinib|mesh-list
56700131|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56700132|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700133|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56700134|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56700135|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56700136|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700137|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700138|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
56255724|NCT01903824|Modafinil|modafinil|mesh-list
56548395|NCT02665039|Antiviral Agents|antiviral agents|mesh-ancestor
56548396|NCT02665039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700139|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700140|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700141|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56700142|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
56700143|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56700144|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
56700145|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56700146|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56700147|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56700148|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56700149|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700150|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56700151|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
56700152|NCT05501678|Promethazine|promethazine|mesh-list
56700153|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56700154|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56700155|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700156|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700157|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
56700158|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
56700159|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
56548397|NCT02665039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548398|NCT02665039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548399|NCT02665039|Immunologic Factors|immunologic factors|mesh-ancestor
56548400|NCT02665039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548401|NCT00647491|Adalimumab|adalimumab|mesh-list
56548402|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56548403|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56548404|NCT04252456|Leucovorin|leucovorin|mesh-list
56548405|NCT04252456|Folic Acid|folic acid|mesh-list
56548406|NCT04252456|Fluorouracil|fluorouracil|mesh-list
56548407|NCT04252456|Aflibercept|aflibercept|mesh-list
56548408|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
56548409|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
56548410|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548411|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56548412|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548413|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548414|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
56548415|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548416|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56548417|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56548418|NCT04252456|Growth Substances|growth substances|mesh-ancestor
56548419|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
56548420|NCT04252456|Antidotes|antidotes|mesh-ancestor
56548421|NCT04252456|Protective Agents|protective agents|mesh-ancestor
56548422|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
56548423|NCT04252456|Vitamins|vitamins|mesh-ancestor
56548424|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
56548425|NCT04252456|Hematinics|hematinics|mesh-ancestor
56548426|NCT02665351|Peramivir|peramivir|mesh-list
56548427|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
56548428|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548429|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548430|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548431|NCT01222520|Amlodipine|amlodipine|mesh-list
56700160|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700161|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
56700162|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
56700163|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700164|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56700165|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
56700166|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
56700167|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700168|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700169|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56700170|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
56700171|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
56700172|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
56548432|NCT01222520|Telmisartan|telmisartan|mesh-list
56296702|NCT00107263|Letrozole|letrozole|mesh-list
56548433|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56548436|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56548437|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548438|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56548439|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548440|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
56548441|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56548442|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56548443|NCT04172311|Levetiracetam|levetiracetam|mesh-list
56548444|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
56548445|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
56548446|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
56548447|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
56548448|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548449|NCT01221350|Protective Agents|protective agents|mesh-ancestor
56548450|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548451|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
56548452|NCT01221350|Vitamins|vitamins|mesh-ancestor
56548453|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
56548454|NCT00647647|Terbinafine|terbinafine|mesh-list
56548455|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
56548456|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548457|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548458|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548459|NCT01221272|Ranolazine|ranolazine|mesh-list
56548460|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56548461|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56548462|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548463|NCT01220414|Naltrexone|naltrexone|mesh-list
56548464|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56548465|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56548466|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548467|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
56548468|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548469|NCT01128894|Liraglutide|liraglutide|mesh-list
56548470|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
56548471|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56548472|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548473|NCT01128894|Incretins|incretins|mesh-ancestor
56548474|NCT01128894|Hormones|hormones|mesh-ancestor
56548475|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548476|NCT01220180|Pregabalin|pregabalin|mesh-list
56548477|NCT01220180|Analgesics|analgesics|mesh-ancestor
56548478|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
56548479|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548480|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548481|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
56548482|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56700173|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56700174|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700175|NCT00727506|Afatinib|afatinib|mesh-list
56700176|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700177|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56700178|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700179|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700180|NCT00789815|Midazolam|midazolam|mesh-list
56700181|NCT00789815|Propofol|propofol|mesh-list
56700182|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56700183|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700184|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700185|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56700186|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
56700187|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
56700188|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56411376|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
56700189|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56700190|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56700191|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56700192|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
56700194|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700195|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700196|NCT00721578|Voriconazole|voriconazole|mesh-list
56700197|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
56700198|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700199|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56700200|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56700201|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700217|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56700218|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56700219|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700220|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700221|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700222|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
56700223|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56700224|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700225|NCT04166487|Paclitaxel|paclitaxel|mesh-list
56700226|NCT04166487|Carboplatin|carboplatin|mesh-list
56700227|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
56700228|NCT04166487|Pemetrexed|pemetrexed|mesh-list
56700229|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56700230|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700231|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
56700232|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
56700233|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
56700234|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700235|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56700236|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700237|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56700238|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56700239|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56700240|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56700241|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700263|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700264|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700265|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700266|NCT00721110|Lidocaine|lidocaine|mesh-list
56700267|NCT00721110|Ketamine|ketamine|mesh-list
56700268|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
56700269|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
56700270|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700271|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700272|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
56700273|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700274|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56700275|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56700276|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56700277|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56700278|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700279|NCT00721110|Analgesics|analgesics|mesh-ancestor
56700280|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56700281|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56700282|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
56700283|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56700284|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56700285|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700286|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
56700287|NCT05073237|Estrogens|estrogens|mesh-list
56255876|NCT01904747|Palbociclib|palbociclib|mesh-list
56548483|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56548484|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548485|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56548486|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56548487|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56548488|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548489|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548490|NCT01220024|Bupivacaine|bupivacaine|mesh-list
56548491|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
56548492|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
56548493|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548494|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548495|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
56548496|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548497|NCT00625248|Anticoagulants|anticoagulants|mesh-list
56548498|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56548499|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56548500|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56548501|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56548502|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548503|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700288|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56700289|NCT05073237|Hormones|hormones|mesh-ancestor
56700290|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700291|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700292|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56700293|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56700294|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
56700295|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56700296|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
56700297|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
56700298|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
56700299|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56700300|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700301|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
56700302|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700303|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56700304|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56700305|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700306|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700307|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700308|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56700309|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
56700310|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700311|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
56700312|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700313|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700314|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
56700315|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56700316|NCT04033263|Fluorides|fluorides|mesh-list
56700317|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
56700318|NCT04033263|Protective Agents|protective agents|mesh-ancestor
56700319|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700320|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56700321|NCT04075227|Dexamethasone|dexamethasone|mesh-list
56548504|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548505|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56548507|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56548508|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
56548509|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700322|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700323|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
56700324|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
56700325|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700326|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700327|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700328|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
56700329|NCT04075227|Hormones|hormones|mesh-ancestor
56700330|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700331|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56700332|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700333|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56700334|NCT00585078|Capecitabine|capecitabine|mesh-list
56700335|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
56700336|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56411525|NCT00560443|Narcotics|narcotics|mesh-ancestor
56700337|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
56700338|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700339|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700340|NCT00720876|Rituximab|rituximab|mesh-list
56700341|NCT00720876|Vorinostat|vorinostat|mesh-list
56700342|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56548510|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548511|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56548512|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56548513|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
56548514|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56548515|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56548516|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
56548518|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56548519|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56548520|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548521|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548522|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548523|NCT05125146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56548524|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56548525|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56548526|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548527|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548528|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
56548529|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56548530|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
56548531|NCT01165554|Flutemetamol|flutemetamol|mesh-list
56548532|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56548533|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548534|NCT01218308|Vaccines|vaccines|mesh-list
56548535|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
56548536|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548537|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
56548538|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56548539|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56548540|NCT02887976|Prednisolone|prednisolone|mesh-list
56700343|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700344|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
56700345|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700346|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700347|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56700348|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700349|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700350|NCT00789581|Paclitaxel|paclitaxel|mesh-list
56700351|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
56700352|NCT00789581|Doxorubicin|doxorubicin|mesh-list
56700353|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56700354|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56700355|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700356|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
56700357|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
56700358|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
56700359|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700360|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700400|NCT05674539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700401|NCT05674539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56700402|NCT05674539|Alkylating Agents|alkylating agents|mesh-ancestor
56700403|NCT05674539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56700404|NCT00717522|Pomalidomide|pomalidomide|mesh-list
56700405|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
56700406|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700407|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56700408|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56700409|NCT00717522|Growth Substances|growth substances|mesh-ancestor
56700410|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
56700411|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700412|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
56700413|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700415|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700416|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700417|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56700418|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700419|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56700420|NCT03475953|Avelumab|avelumab|mesh-list
56700421|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56700422|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56700423|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700424|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
56700425|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700426|NCT00582933|Vidarabine|vidarabine|mesh-list
56700427|NCT00582933|Fludarabine|fludarabine|mesh-list
56256012|NCT01905696|Expectorants|expectorants|mesh-ancestor
56548541|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
56548542|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
56548543|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56548544|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
56548545|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56548546|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
56548547|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
56548548|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548549|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548550|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56548551|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
56548552|NCT02887976|Hormones|hormones|mesh-ancestor
56548553|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548554|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56548555|NCT02887976|Protective Agents|protective agents|mesh-ancestor
56548556|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56548557|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548558|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56548559|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107431|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56700428|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
56700429|NCT00582933|Melphalan|melphalan|mesh-list
56700430|NCT00582933|Busulfan|busulfan|mesh-list
56700431|NCT00582933|Lenograstim|lenograstim|mesh-list
56700432|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700433|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56700434|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
56700435|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700436|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700437|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
56700438|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700439|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
56700440|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700441|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56700442|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
56700443|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56700444|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56700445|NCT00791765|Etanercept|etanercept|mesh-list
56700446|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56700447|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56700448|NCT00791765|Analgesics|analgesics|mesh-ancestor
56700449|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
56548560|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548561|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
56548562|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56548563|NCT01165320|Caspofungin|caspofungin|mesh-list
56548564|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
56548565|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548566|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548567|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548568|NCT01217606|Timolol|timolol|mesh-list
56548569|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56548570|NCT01217606|Bimatoprost|bimatoprost|mesh-list
56548571|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56548572|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56548573|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56548574|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56548575|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
56548576|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548578|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548579|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56548580|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56548581|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56548582|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56548583|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56548584|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56548585|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
56548586|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548587|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56548588|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56548589|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548590|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548592|NCT01217060|Docetaxel|docetaxel|mesh-list
56548593|NCT01217060|Fluorouracil|fluorouracil|mesh-list
56700450|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700451|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700452|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700453|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700454|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700455|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700456|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
56700457|NCT03648021|Acetaminophen|acetaminophen|mesh-list
56700458|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56700459|NCT03648021|Analgesics|analgesics|mesh-ancestor
56700460|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
56700461|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700462|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700463|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
56700464|NCT00789191|Metformin|metformin|mesh-list
56700465|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56700466|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
56700467|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56700468|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700469|NCT00789191|Incretins|incretins|mesh-ancestor
56700470|NCT00789191|Hormones|hormones|mesh-ancestor
56733202|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56548594|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56548595|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
56548596|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
56548597|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548598|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548599|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56548600|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
56548601|NCT01217060|Hormones|hormones|mesh-ancestor
56548602|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548603|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56548604|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548605|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
56548606|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
56548607|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
56334734|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
56548608|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548609|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
56548610|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56548611|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548612|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
56548613|NCT01170065|Nintedanib|nintedanib|mesh-list
56548614|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548615|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56548616|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548617|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548618|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56548619|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548620|NCT00966693|Thalidomide|thalidomide|mesh-list
56548621|NCT00966693|Dexamethasone|dexamethasone|mesh-list
56548622|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
56548623|NCT00966693|Lenalidomide|lenalidomide|mesh-list
56548624|NCT00966693|Ichthammol|ichthammol|mesh-list
56548625|NCT00966693|BB 1101|bb 1101|mesh-list
56548626|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700471|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700472|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56700473|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
56700474|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700475|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700476|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56700477|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700478|NCT02603315|Mitogens|mitogens|mesh-list
56700479|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
56700480|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56700481|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700482|NCT02603315|Growth Substances|growth substances|mesh-ancestor
56700483|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700484|NCT00789035|Metformin|metformin|mesh-list
56700485|NCT00789035|Empagliflozin|empagliflozin|mesh-list
56700486|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56411671|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
56700487|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700488|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56700489|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700491|NCT04108013|Carboplatin|carboplatin|mesh-list
56700492|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56700493|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700494|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
56700495|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56700496|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
56700497|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700498|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
56700499|NCT04105985|Tetracaine|tetracaine|mesh-list
56700500|NCT04105985|Carticaine|carticaine|mesh-list
56700501|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
56700502|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
56700503|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700504|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700505|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
56548627|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
56548628|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
56548629|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700506|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700507|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56700508|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56700509|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
56700510|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700511|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700512|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
56700513|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
56700514|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
56700515|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56700516|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
56700517|NCT04074213|Clozapine|clozapine|mesh-list
56700518|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56700519|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
56700520|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700521|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700522|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700523|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56700524|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56700525|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700526|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56700527|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
56700528|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
56700529|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56700530|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56700531|NCT04110587|Analgesics|analgesics|mesh-list
56700532|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
56700533|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700534|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56700535|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
56700536|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548630|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548631|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56548632|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
56548633|NCT00966693|Hormones|hormones|mesh-ancestor
56548634|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548635|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56548636|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548637|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
56548638|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56548639|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56548640|NCT00966693|Growth Substances|growth substances|mesh-ancestor
56548641|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
56700537|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
56700538|NCT04110587|Protective Agents|protective agents|mesh-ancestor
56700539|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
56700540|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700541|NCT05594147|Sorafenib|sorafenib|mesh-list
56700542|NCT05594147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700543|NCT05594147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56700544|NCT05594147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700545|NCT05594147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700546|NCT03616587|Everolimus|everolimus|mesh-list
56700547|NCT03616587|Palbociclib|palbociclib|mesh-list
56700548|NCT03616587|Anastrozole|anastrozole|mesh-list
56700549|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700550|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700551|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
56700552|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700553|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56700554|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700555|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700556|NCT03616587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56700557|NCT03616587|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56700558|NCT03616587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56256155|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
56548642|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548643|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
56548644|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56548645|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548646|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
56548647|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548648|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548649|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
56548650|NCT01215968|Dulaglutide|dulaglutide|mesh-list
56548652|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548654|NCT02663713|Ticagrelor|ticagrelor|mesh-list
56548655|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56548656|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56548657|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56548658|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56548659|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
56548660|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548661|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548662|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548663|NCT02664649|Apixaban|apixaban|mesh-list
56548664|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
56548665|NCT02664649|Anticoagulants|anticoagulants|mesh-list
56548666|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
56548667|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56548668|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
56548669|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548670|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548671|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
56548672|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56700559|NCT03616587|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56700560|NCT03616587|Hormone Antagonists|hormone antagonists|mesh-ancestor
56700561|NCT03616587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700562|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
56700563|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56700564|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700565|NCT03578367|Niacinamide|niacinamide|mesh-list
56700566|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
56700567|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700568|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56700569|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700570|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700571|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
56548673|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56548674|NCT02664493|Prednisolone|prednisolone|mesh-list
56548675|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
56548676|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56548677|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
56548678|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56548679|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
56548680|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
56548681|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982242|NCT00867217|Vitamin D|vitamin d|mesh-list
56548682|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548683|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56548684|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
56548685|NCT02664493|Hormones|hormones|mesh-ancestor
56548686|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548687|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56548688|NCT02664493|Protective Agents|protective agents|mesh-ancestor
56548689|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56548690|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548691|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
56548692|NCT00963807|Alovudine|alovudine|mesh-list
56548693|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
56548694|NCT00963807|Cisplatin|cisplatin|mesh-list
56548695|NCT00963807|Docetaxel|docetaxel|mesh-list
56548696|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56548697|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548698|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
56548699|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
56548700|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
56548701|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548702|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56548703|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
56548704|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
56548705|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548706|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56548707|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56548708|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548709|NCT01142466|Interferons|interferons|mesh-list
56548710|NCT01142466|Interferon-beta|interferon-beta|mesh-list
56548711|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
56548712|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548713|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
56548714|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548715|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
56548716|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548717|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56548718|NCT00648505|Metformin|metformin|mesh-list
56548719|NCT00648505|Glipizide|glipizide|mesh-list
56548720|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56548721|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700572|NCT03578367|Vitamins|vitamins|mesh-ancestor
56700573|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
56700574|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700575|NCT02626455|Prednisone|prednisone|mesh-list
56700576|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
56700577|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56700578|NCT02626455|Rituximab|rituximab|mesh-list
56700579|NCT02626455|Doxorubicin|doxorubicin|mesh-list
56700580|NCT02626455|Vincristine|vincristine|mesh-list
56700581|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700582|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
56700583|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700584|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700585|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56700586|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
56700587|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700588|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700589|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56700590|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56256186|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
56548722|NCT01215734|Vaccines|vaccines|mesh-list
56548723|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
56548724|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548725|NCT02863185|Atorvastatin|atorvastatin|mesh-list
56548726|NCT02863185|Pitavastatin|pitavastatin|mesh-list
56548727|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56548728|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56548729|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
56548730|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548731|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56548732|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56548733|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548734|NCT00647881|Paroxetine|paroxetine|mesh-list
56548735|NCT00647881|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56548736|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56548737|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56548738|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548739|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548740|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
56548741|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548742|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56548743|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
56548744|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548745|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56548746|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56548747|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548748|NCT04174261|Clopidogrel|clopidogrel|mesh-list
56548749|NCT04174261|Ticagrelor|ticagrelor|mesh-list
56548750|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56548751|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56548752|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56548753|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56548754|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
56548755|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548756|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700591|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56700592|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56700593|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56700594|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700595|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700596|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
56700597|NCT02626455|Hormones|hormones|mesh-ancestor
56700598|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700599|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56700600|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56700601|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
56700602|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
56700603|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
56700604|NCT03534453|Olaparib|olaparib|mesh-list
56700605|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56700606|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700607|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548757|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548758|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
56548759|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56548760|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548762|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56548763|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56548764|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56548765|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548766|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
56548767|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
56548768|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
56548769|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548770|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
56548771|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548772|NCT00910741|Gemcitabine|gemcitabine|mesh-list
56548773|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56548774|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
56548775|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548776|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548777|NCT00910741|Antiviral Agents|antiviral agents|mesh-ancestor
56548778|NCT00910741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548779|NCT00910741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548780|NCT00910741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548781|NCT00910741|Immunologic Factors|immunologic factors|mesh-ancestor
56548782|NCT00910741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548783|NCT00647959|Doxycycline|doxycycline|mesh-list
56548784|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56548785|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548786|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
56548787|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56548788|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56548789|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
56548790|NCT03602235|Melphalan|melphalan|mesh-list
56548791|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56548792|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
56548793|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548794|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548795|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56700608|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700609|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
56700610|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56700611|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700612|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
56700613|NCT02579733|Azathioprine|azathioprine|mesh-list
56700614|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
56700615|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700616|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56700617|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700618|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700619|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
56700620|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700621|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700622|NCT03326193|Bevacizumab|bevacizumab|mesh-list
56700623|NCT03326193|Niraparib|niraparib|mesh-list
56700624|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56700625|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700626|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56700627|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56700628|NCT03326193|Growth Substances|growth substances|mesh-ancestor
56700629|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700630|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
56700631|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56700632|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700633|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548796|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548797|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
56548798|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548799|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
56548801|NCT03602235|Vitamins|vitamins|mesh-ancestor
56548802|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
56548803|NCT00648583|Ondansetron|ondansetron|mesh-list
56548804|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
56548805|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
56548806|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548807|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548808|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56548809|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
56548810|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56548811|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56548812|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
56548813|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548814|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548815|NCT00648583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56548816|NCT00648583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56548817|NCT00648583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548818|NCT00648583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56700634|NCT02517099|Azithromycin|azithromycin|mesh-list
56700635|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56700636|NCT02517099|Beclomethasone|beclomethasone|mesh-list
56411819|NCT00186810|Busulfan|busulfan|mesh-list
56700637|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700638|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700639|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56700640|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700641|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700642|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700643|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
56700644|NCT02517099|Hormones|hormones|mesh-ancestor
56700645|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700646|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700647|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56700648|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
56700649|NCT02478099|Atezolizumab|atezolizumab|mesh-list
56700650|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700651|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
56700652|NCT02473263|Tazobactam|tazobactam|mesh-list
56700653|NCT02473263|Piperacillin|piperacillin|mesh-list
56700654|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56700655|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
56700656|NCT02473263|Norepinephrine|norepinephrine|mesh-list
56700657|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256255|NCT01907373|Renal Agents|renal agents|mesh-ancestor
56548819|NCT00648583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56548820|NCT03809481|Danaparoid|danaparoid|mesh-list
56548821|NCT03809481|Argatroban|argatroban|mesh-list
56548822|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
56548823|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56548824|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
56548825|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548826|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548827|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
56548828|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56548829|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56548830|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56548832|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
56548833|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
56548834|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548835|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548836|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56548837|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56548838|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
56548839|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548840|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548841|NCT00649129|Urological Agents|urological agents|mesh-ancestor
56548842|NCT01127646|Methylphenidate|methylphenidate|mesh-list
56548843|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56700658|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56700659|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56700660|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
56700661|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700662|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700663|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700664|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
56700665|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
56700666|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700667|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56700668|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700669|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700670|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56700671|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700672|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
56700673|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
56700674|NCT03249831|Pentostatin|pentostatin|mesh-list
56700675|NCT03249831|Tacrolimus|tacrolimus|mesh-list
56700676|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
56700677|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56700678|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700679|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
56700680|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700681|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700682|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56700683|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
56733203|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
56548844|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56548845|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548846|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56548847|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56548848|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56548849|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548850|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
56548851|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548852|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56548853|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
56548854|NCT02660047|Liraglutide|liraglutide|mesh-list
56548855|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56548856|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548857|NCT02660047|Incretins|incretins|mesh-ancestor
56548858|NCT02660047|Hormones|hormones|mesh-ancestor
56548859|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56548860|NCT00648661|Dexetimide|dexetimide|mesh-list
56548861|NCT00648661|Citalopram|citalopram|mesh-list
56548862|NCT00648661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56548863|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56548864|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56700684|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700685|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700686|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56700687|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56700688|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700689|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56700690|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56700691|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
56700692|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700693|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700694|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56700695|NCT03222609|Navitoclax|navitoclax|mesh-list
56700696|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700697|NCT00437203|Gemcitabine|gemcitabine|mesh-list
56700698|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56256308|NCT01907685|Docetaxel|docetaxel|mesh-list
56548865|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548866|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548867|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
56548868|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548869|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56548870|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
56548871|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548872|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56548873|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56548874|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
56548876|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548877|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56548878|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56548879|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
56548881|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56548882|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548883|NCT04171687|Clopidogrel|clopidogrel|mesh-list
56548884|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56548885|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56548886|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56548887|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56548888|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
56548889|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548890|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548891|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548893|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
56548894|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548895|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56548896|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56548897|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548898|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548899|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56548900|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56548901|NCT03391869|Nivolumab|nivolumab|mesh-list
56548902|NCT03391869|Ipilimumab|ipilimumab|mesh-list
56548903|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56548904|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548905|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56548906|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548907|NCT02663323|Sirolimus|sirolimus|mesh-list
56548908|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56700699|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
56700700|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548909|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548910|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56548911|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548912|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
56548913|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548914|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
56548915|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548916|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56548917|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
56548918|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548919|NCT04285281|Gabapentin|gabapentin|mesh-list
56548920|NCT04285281|Analgesics|analgesics|mesh-ancestor
56548921|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
56548922|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548923|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548924|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
56548925|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56548926|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56548927|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56548928|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548929|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56548930|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56548931|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548932|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548933|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
56548934|NCT02659657|Interleukin-2|interleukin-2|mesh-list
56548935|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548936|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56548937|NCT02659657|Analgesics|analgesics|mesh-ancestor
56548938|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
56548939|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548940|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548941|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56548942|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
56548943|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548944|NCT00648193|Paroxetine|paroxetine|mesh-list
56548945|NCT00648193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56548946|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56548947|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56548949|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56548951|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548952|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56548953|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
56548954|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56548955|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56548956|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56548957|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548959|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56548960|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548961|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56548962|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
56548963|NCT02664103|Capecitabine|capecitabine|mesh-list
56548964|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56548965|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
56548966|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548967|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56548968|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56548969|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
56548970|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548971|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56548972|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56548973|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56548974|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
56548975|NCT02662855|Favipiravir|favipiravir|mesh-list
56548976|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
56548977|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56548978|NCT00648271|Metoprolol|metoprolol|mesh-list
56548979|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56548980|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56700701|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700702|NCT00437203|Antiviral Agents|antiviral agents|mesh-ancestor
56700703|NCT00437203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700704|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700705|NCT00437203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700706|NCT00437203|Immunologic Factors|immunologic factors|mesh-ancestor
56700707|NCT00437203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700708|NCT02419287|Crizotinib|crizotinib|mesh-list
56700709|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700710|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56700711|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56411899|NCT00201981|Rebamipide|rebamipide|mesh-list
56700712|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700713|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56700714|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56700720|NCT00437125|Analgesics|analgesics|mesh-ancestor
56700758|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56700759|NCT02600780|Allopurinol|allopurinol|mesh-list
56700760|NCT02600780|Febuxostat|febuxostat|mesh-list
56700761|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
56700762|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700763|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700764|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
56700765|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700766|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56700767|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
56700768|NCT02600780|Protective Agents|protective agents|mesh-ancestor
56700769|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700770|NCT00582309|Insulin|insulin|mesh-list
56700771|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56700772|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56700773|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700774|NCT00443053|PENTA|penta|mesh-list
56700775|NCT00443053|Fondaparinux|fondaparinux|mesh-list
56700776|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56700777|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
56700778|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56700779|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
56700780|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700781|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700782|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
56700783|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56700784|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56700785|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56700786|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56700787|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
56700788|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56700789|NCT00720798|Analgesics|analgesics|mesh-ancestor
56700790|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
56700793|NCT01816971|Dexamethasone|dexamethasone|mesh-list
56700802|NCT01816971|Hormones|hormones|mesh-ancestor
56700803|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700804|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56700805|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700806|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
56700807|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56700808|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56700809|NCT01816971|Growth Substances|growth substances|mesh-ancestor
56700810|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
56700811|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
56700812|NCT01021267|Urological Agents|urological agents|mesh-ancestor
56700813|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
56700814|NCT00717366|Hematinics|hematinics|mesh-ancestor
56700815|NCT02939989|Ribavirin|ribavirin|mesh-list
56700816|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
56700817|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
56700818|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700819|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
56700820|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700821|NCT04096742|Tretinoin|tretinoin|mesh-list
56700822|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700823|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
56700824|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
56700825|NCT04085640|Ropivacaine|ropivacaine|mesh-list
56700826|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
56700827|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
56700828|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700829|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700830|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
56700831|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700832|NCT01031719|Vaccines|vaccines|mesh-list
56700833|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
56700834|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700835|NCT00723606|Haloperidol|haloperidol|mesh-list
56548981|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
56548982|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
56548983|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56548984|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548985|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56548986|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56548987|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56548988|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
56548989|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700836|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
56700837|NCT00723606|Ziprasidone|ziprasidone|mesh-list
56700838|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
56700839|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
56700840|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700841|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700842|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700843|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56700844|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56700845|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700846|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56700847|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56700848|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
56700849|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700850|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700851|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56700852|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56700853|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
56700854|NCT01021501|Nifedipine|nifedipine|mesh-list
56700855|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56700856|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56700857|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700858|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56700859|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700860|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
56700861|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
56700862|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56700863|NCT01021579|Metformin|metformin|mesh-list
56700864|NCT01021579|Simvastatin|simvastatin|mesh-list
56700865|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56700866|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700867|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56700868|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56700869|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
56700870|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548990|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548991|NCT00648349|Rabeprazole|rabeprazole|mesh-list
56548992|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56548993|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700871|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56700872|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56700873|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700874|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56700875|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56700876|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700877|NCT01021735|Adalimumab|adalimumab|mesh-list
56700878|NCT01021735|Etanercept|etanercept|mesh-list
56700879|NCT01021735|Rituximab|rituximab|mesh-list
56700880|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56700881|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700882|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
56700883|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56548994|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56548995|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56548996|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548997|NCT00649207|Veliparib|veliparib|mesh-list
56548998|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56548999|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549000|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549001|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549002|NCT00920686|Sumatriptan|sumatriptan|mesh-list
56549003|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56549004|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56549005|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56549006|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
56549007|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549008|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549009|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549010|NCT00648427|Paroxetine|paroxetine|mesh-list
56549011|NCT00648427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56549012|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56549013|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549014|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549015|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549016|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
56549017|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549018|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56549020|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56549021|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56549022|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56549023|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549025|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
56549026|NCT04170751|Norepinephrine|norepinephrine|mesh-list
56549027|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56297305|NCT00111046|Narcotics|narcotics|mesh-ancestor
56549028|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56549029|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
56549030|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549031|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549032|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549033|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
56549034|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
56549035|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549036|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56549037|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
56549038|NCT04170751|Coagulants|coagulants|mesh-ancestor
56549039|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56549040|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
56549041|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
56700884|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56700885|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700886|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56700887|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56700888|NCT01021735|Analgesics|analgesics|mesh-ancestor
56700889|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
56700890|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700891|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700892|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56700893|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
56700894|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700895|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
56700896|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56700897|NCT00436501|Docetaxel|docetaxel|mesh-list
56700898|NCT00436501|Aflibercept|aflibercept|mesh-list
56700899|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
56700900|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700901|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
56700902|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
56700903|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
56700904|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700905|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56700906|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56700907|NCT00436501|Growth Substances|growth substances|mesh-ancestor
56700908|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549042|NCT02659033|Cefotaxime|cefotaxime|mesh-list
56549043|NCT02659033|Cefoxitin|cefoxitin|mesh-list
56549044|NCT02659033|Cephalosporins|cephalosporins|mesh-list
56549045|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56549046|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549047|NCT04170595|Trastuzumab|trastuzumab|mesh-list
56549048|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56549049|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549050|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
56549051|NCT00648973|Promethazine|promethazine|mesh-list
56549052|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
56549053|NCT00648973|Ephedrine|ephedrine|mesh-list
56549054|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56549055|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56549056|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549057|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549058|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
56549059|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
56549060|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
56549061|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549062|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
56549063|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
56549064|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56549065|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56549066|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
56549067|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
56549068|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700909|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
56700910|NCT00755846|Alogliptin|alogliptin|mesh-list
56700911|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56700912|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700913|NCT00755846|Incretins|incretins|mesh-ancestor
56700914|NCT00755846|Hormones|hormones|mesh-ancestor
56700915|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700916|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56700917|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
56700918|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700919|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700920|NCT03850093|Bisoprolol|bisoprolol|mesh-list
56700921|NCT03850093|Gabapentin|gabapentin|mesh-list
56700922|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700923|NCT03850093|Analgesics|analgesics|mesh-ancestor
56700924|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
56700925|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700926|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
56549069|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549070|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56549071|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
56549072|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
56549073|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56549074|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56549075|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
56549076|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
56549077|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56549078|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56549079|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
56549080|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
56549081|NCT02662309|Atezolizumab|atezolizumab|mesh-list
56549082|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549083|NCT04032691|Clonidine|clonidine|mesh-list
56549084|NCT04032691|Analgesics|analgesics|mesh-ancestor
56549085|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
56549086|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549087|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549088|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56549089|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
56549090|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
56549091|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56549092|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56549093|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56549094|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
56549095|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549096|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549097|NCT02658799|Diclofenac|diclofenac|mesh-list
56549098|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56549099|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56549100|NCT02658799|Analgesics|analgesics|mesh-ancestor
56549101|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
56549102|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549103|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549104|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56549105|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56549106|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56549107|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700927|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56700928|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56700929|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56700930|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56700931|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56700932|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56700933|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56700934|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700935|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
56700936|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56700937|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
56700938|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
56700939|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56700940|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56700941|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56700942|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
56700943|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
56700944|NCT00442117|Budesonide|budesonide|mesh-list
56700945|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56700946|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56700947|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
56700948|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56700949|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700950|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56700951|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
56700952|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
56700953|NCT00442117|Hormones|hormones|mesh-ancestor
56700954|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56700955|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
56700972|NCT04072263|Carboplatin|carboplatin|mesh-list
56700973|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56700974|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700975|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
56700976|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
56700977|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
56700978|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700979|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
56549108|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549109|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56549110|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56549111|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549112|NCT02655757|Incretins|incretins|mesh-ancestor
56549113|NCT02655757|Hormones|hormones|mesh-ancestor
56549114|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56549115|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56549116|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
56549117|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549118|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549119|NCT01214720|Bevacizumab|bevacizumab|mesh-list
56549120|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56549121|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549122|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56549123|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56549124|NCT01214720|Growth Substances|growth substances|mesh-ancestor
56549125|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549126|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
56549127|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
56549128|NCT02655913|Vitamins|vitamins|mesh-ancestor
56549129|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
56549130|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549131|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
56549132|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549133|NCT02655913|Protective Agents|protective agents|mesh-ancestor
56549134|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
56549135|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56549136|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549137|NCT00649285|Renal Agents|renal agents|mesh-ancestor
56549138|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56549139|NCT04169269|Enoxaparin|enoxaparin|mesh-list
56549140|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
56549141|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56549142|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
56549143|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56549144|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
56549145|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549146|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549147|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
56549148|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56549149|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56549150|NCT02661373|Cobicistat|cobicistat|mesh-list
56549151|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56549152|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56549153|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
56549154|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549155|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56549156|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56549157|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549158|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549159|NCT00649051|Metolazone|metolazone|mesh-list
56549160|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56549161|NCT00649051|Diuretics|diuretics|mesh-ancestor
56549162|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
56549163|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549164|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56549165|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888292|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700980|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56700981|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
56700982|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700983|NCT00441727|Esomeprazole|esomeprazole|mesh-list
56700984|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56700985|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56700986|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56700987|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700988|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700989|NCT00770120|Everolimus|everolimus|mesh-list
56700990|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56700991|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56549166|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549167|NCT04168879|Bupivacaine|bupivacaine|mesh-list
56549168|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
56549169|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
56549170|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549171|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549173|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549174|NCT00649987|Albuterol|albuterol|mesh-list
56549175|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56549176|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
56549177|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549178|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549179|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56549180|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
56549181|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
56549182|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56549183|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56549184|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56549185|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56549186|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
56549187|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549188|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549189|NCT01142232|Lenalidomide|lenalidomide|mesh-list
56549190|NCT01142232|Melphalan|melphalan|mesh-list
56549191|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
56549192|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549193|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56549194|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56549195|NCT01142232|Growth Substances|growth substances|mesh-ancestor
56549196|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
56549197|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549198|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56549199|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
56549200|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549201|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56549202|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56549203|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
56549204|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56549205|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
56549206|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549207|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
56549208|NCT02536807|Protective Agents|protective agents|mesh-ancestor
56549210|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549211|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
56549212|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
56549213|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
56549214|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549215|NCT02536417|Melatonin|melatonin|mesh-list
56549216|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
56549217|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700992|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
56700993|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56700994|NCT03996655|Neostigmine|neostigmine|mesh-list
56700995|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56700996|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56700997|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56700998|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
56700999|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701000|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701001|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56701002|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
56701003|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701004|NCT01032109|Bevacizumab|bevacizumab|mesh-list
56701005|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56549218|NCT02536417|Protective Agents|protective agents|mesh-ancestor
56549219|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549220|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549221|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56549222|NCT01140906|Vortioxetine|vortioxetine|mesh-list
56549223|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56549224|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56549225|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549226|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549227|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549228|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549229|NCT01140906|Analgesics|analgesics|mesh-ancestor
56549230|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
56549231|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549232|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
56549233|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56549234|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
56549235|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56549236|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56549237|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549238|NCT01140906|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56549239|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
56549240|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56549241|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56549242|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56549245|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56549246|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56549247|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56549248|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
56549249|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
56549250|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549251|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549252|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549254|NCT04170439|Metformin|metformin|mesh-list
56549255|NCT04170439|Citric Acid|citric acid|mesh-list
56549256|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
56549257|NCT04170439|Clomiphene|clomiphene|mesh-list
56549258|NCT04170439|Enclomiphene|enclomiphene|mesh-list
56549259|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
56549260|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56549261|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549262|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
56549263|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56549264|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
56549265|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
55888293|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701006|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701007|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56701008|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56701009|NCT01032109|Growth Substances|growth substances|mesh-ancestor
56701010|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701011|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
56701012|NCT04100330|Cytarabine|cytarabine|mesh-list
56701013|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56701014|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
56701015|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701017|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
56701018|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733204|NCT00400946|Hormones|hormones|mesh-ancestor
56549266|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549267|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56549268|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
56549269|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56549270|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56549271|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
56549272|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56549273|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56549274|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56549275|NCT04170439|Trace Elements|trace elements|mesh-ancestor
56549276|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
56549277|NCT00649363|Ondansetron|ondansetron|mesh-list
56549278|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
56549279|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
56549280|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549281|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549282|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56549283|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
56549284|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
56549285|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56549286|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
56549287|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549288|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549289|NCT00649363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56549290|NCT00649363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56549291|NCT00649363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549292|NCT00649363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56549293|NCT00649363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56549294|NCT03531645|Fulvestrant|fulvestrant|mesh-list
56549295|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56549296|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549297|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56549298|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56549299|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
56549300|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56549301|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549302|NCT02654743|Sulforaphane|sulforaphane|mesh-list
56549303|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56549304|NCT02654743|Protective Agents|protective agents|mesh-ancestor
56549305|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549306|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549307|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
56549308|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56549309|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56549310|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549311|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56549312|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56701019|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701020|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
56701021|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701022|NCT00436345|Remifentanil|remifentanil|mesh-list
56701023|NCT00436345|Propofol|propofol|mesh-list
56701024|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56701025|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701026|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701027|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56701028|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
56701029|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
56701030|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56701031|NCT00436345|Narcotics|narcotics|mesh-ancestor
56701032|NCT00436345|Analgesics|analgesics|mesh-ancestor
56701033|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
56701034|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701035|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56701036|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56701037|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56701038|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
56549313|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549314|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549315|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549319|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549320|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56549321|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56549322|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56549323|NCT03493425|Cisplatin|cisplatin|mesh-list
56549324|NCT03493425|Carboplatin|carboplatin|mesh-list
56549325|NCT03493425|Docetaxel|docetaxel|mesh-list
56549326|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549327|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
56549328|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
56549329|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297606|NCT00112684|Alvocidib|alvocidib|mesh-list
56549330|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549331|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56549332|NCT00649441|Quinapril|quinapril|mesh-list
56549333|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56549334|NCT00649441|Diuretics|diuretics|mesh-ancestor
56549335|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
56549336|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549337|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56549338|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549339|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480194|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56549340|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56549341|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
56549342|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549344|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56549345|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549346|NCT02654665|Incretins|incretins|mesh-ancestor
56549347|NCT02654665|Hormones|hormones|mesh-ancestor
56549348|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56549349|NCT02658721|Diclofenac|diclofenac|mesh-list
56549350|NCT02658721|Lidocaine|lidocaine|mesh-list
56549351|NCT02658721|Atropine|atropine|mesh-list
56701039|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701040|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701041|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56701042|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56701043|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
56701044|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701045|NCT01032187|Amphotericin B|amphotericin b|mesh-list
56701046|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56701047|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56701048|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56701049|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
56701050|NCT01032187|Amebicides|amebicides|mesh-ancestor
56701051|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56701052|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56701053|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701054|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56701055|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
56256659|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
56549352|NCT02658721|Ephedrine|ephedrine|mesh-list
56549353|NCT02658721|Fentanyl|fentanyl|mesh-list
56549354|NCT02658721|Midazolam|midazolam|mesh-list
56549355|NCT02658721|Tramadol|tramadol|mesh-list
56549356|NCT02658721|Ondansetron|ondansetron|mesh-list
56549357|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
56549358|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
56549359|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549360|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549361|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
56549362|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549363|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56549364|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56549365|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56549366|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549367|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549368|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56549369|NCT02658721|Narcotics|narcotics|mesh-ancestor
56549370|NCT02658721|Analgesics|analgesics|mesh-ancestor
56549371|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56549372|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56549373|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
56549374|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56549375|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56549376|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56549377|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56549378|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
56549379|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
56549380|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549381|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
56549382|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
56549383|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56549384|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
56549385|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
56549386|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56549387|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
56549388|NCT02658721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56549389|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56549391|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56549393|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56549394|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549395|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56701056|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56701057|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701058|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
56701059|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56701060|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56701061|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701062|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
56701063|NCT03361345|Coagulants|coagulants|mesh-ancestor
56701064|NCT00769184|Clobetasol|clobetasol|mesh-list
56701065|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56701066|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
56701067|NCT00769184|Hormones|hormones|mesh-ancestor
56701068|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56701069|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701070|NCT00768560|Nifedipine|nifedipine|mesh-list
56701071|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56701072|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56701073|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701074|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56701075|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701076|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
56701077|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
56701078|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56701079|NCT00468559|Esomeprazole|esomeprazole|mesh-list
56701080|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56701081|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701082|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56701083|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256665|NCT01910259|Amiloride|amiloride|mesh-list
56549396|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56549397|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
56549398|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
56549399|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
56549400|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56549401|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56549402|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
56549403|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56549404|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
56549405|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56297675|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
56549406|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
56549407|NCT04283877|Methylphenidate|methylphenidate|mesh-list
56549408|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56549409|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549410|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56549411|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56701084|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701085|NCT00754442|Teriparatide|teriparatide|mesh-list
56701086|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56701087|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701088|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56701089|NCT00754052|Donepezil|donepezil|mesh-list
56701090|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56701091|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701092|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549412|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549413|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549414|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
56549415|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549416|NCT00629967|Interferons|interferons|mesh-list
56549417|NCT00629967|Ribavirin|ribavirin|mesh-list
56549418|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
56549419|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
56549420|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56549421|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549422|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
56549423|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549424|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
56549425|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549426|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
56549427|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549428|NCT02654587|Docetaxel|docetaxel|mesh-list
56549429|NCT02654587|Pemetrexed|pemetrexed|mesh-list
56549430|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549431|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56549432|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56549433|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
56549434|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549435|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549436|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56549437|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56549438|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
56549439|NCT01122264|Tadalafil|tadalafil|mesh-list
56549440|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549441|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
56549442|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56549443|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56549444|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549445|NCT01122264|Urological Agents|urological agents|mesh-ancestor
56549446|NCT03288675|Serotonin|serotonin|mesh-list
56549447|NCT03288675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56549448|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56549449|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
56549450|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549451|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549452|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549453|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56549454|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549455|NCT00920218|Vaccines|vaccines|mesh-list
56549456|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
56549457|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549458|NCT00649519|Amlodipine|amlodipine|mesh-list
56549459|NCT00649519|Benazepril|benazepril|mesh-list
56549460|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56549461|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56549462|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549464|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56549466|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
56549467|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56549468|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
56701093|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
56701094|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701095|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701096|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
56701097|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56701098|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
56701099|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56701100|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56701101|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56701102|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701103|NCT00753896|Exenatide|exenatide|mesh-list
56701104|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56549469|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549470|NCT00629811|Mitogens|mitogens|mesh-list
56549471|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
56549472|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549473|NCT02652091|Interferons|interferons|mesh-list
56549474|NCT02652091|Interferon-beta|interferon-beta|mesh-list
56549475|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
56549476|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549477|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
56549478|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549479|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
56549480|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297753|NCT00007865|Rituximab|rituximab|mesh-list
56549482|NCT00625560|Lamivudine|lamivudine|mesh-list
56549483|NCT00625560|Entecavir|entecavir|mesh-list
56549484|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56549485|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56549486|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549487|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549488|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
56549489|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549490|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56549491|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56549492|NCT00650455|Naproxen|naproxen|mesh-list
56549493|NCT00650455|Valdecoxib|valdecoxib|mesh-list
56549494|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56549495|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56549496|NCT00650455|Analgesics|analgesics|mesh-ancestor
56549497|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
56549498|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549499|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549500|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56549501|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56549502|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
56549503|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56549504|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549505|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549506|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56549507|NCT02654041|Methimazole|methimazole|mesh-list
56549508|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
56549509|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
56549510|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56549511|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549512|NCT02658409|Vaccines|vaccines|mesh-list
56549513|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
56549514|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549515|NCT01121562|Sunitinib|sunitinib|mesh-list
56549516|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549517|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56549518|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56549519|NCT01121562|Growth Substances|growth substances|mesh-ancestor
56701105|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701106|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56701107|NCT00753896|Incretins|incretins|mesh-ancestor
56701108|NCT00753896|Hormones|hormones|mesh-ancestor
56701109|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56701110|NCT05430152|Naltrexone|naltrexone|mesh-list
56701111|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56701112|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56701113|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701114|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
56701115|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701116|NCT02927067|Valganciclovir|valganciclovir|mesh-list
56701117|NCT02927067|Maribavir|maribavir|mesh-list
56701118|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
56701119|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701120|NCT02600468|Abatacept|abatacept|mesh-list
56701121|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56701122|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701123|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701124|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701125|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
56701126|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549520|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549521|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
56549522|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56549523|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549524|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549525|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56549526|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56549527|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
56549528|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549529|NCT02658253|Antacids|antacids|mesh-ancestor
56549530|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549531|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56549532|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
56549533|NCT02651623|Sertraline|sertraline|mesh-list
56549534|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55864381|NCT05103358|Sirolimus|sirolimus|mesh-list
56549537|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56549538|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549539|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549540|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549541|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549542|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
56549543|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56549544|NCT02651623|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56549545|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56549546|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549547|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549548|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
56549549|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56549550|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56701127|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56701128|NCT02598596|Azathioprine|azathioprine|mesh-list
56701129|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
56701130|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701131|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56701132|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701133|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701134|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
56701135|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701136|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56701137|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56701138|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56701139|NCT01771107|Doxorubicin|doxorubicin|mesh-list
56701140|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56701141|NCT01771107|Dacarbazine|dacarbazine|mesh-list
56701142|NCT01771107|Vinblastine|vinblastine|mesh-list
56701143|NCT01771107|Antibodies|antibodies|mesh-list
56701144|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
56701145|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56701146|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
56701147|NCT01771107|Imidazole|imidazole|mesh-list
56701148|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
56701149|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701150|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701151|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56701152|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56701153|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56701154|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701155|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701156|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56701157|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
56701158|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56701159|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701160|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56701161|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701162|NCT00586508|Bevacizumab|bevacizumab|mesh-list
56256759|NCT01910545|OTS167|ots167|mesh-list
56549551|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56549552|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56701163|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
56701164|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56701165|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701166|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56701167|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56701168|NCT00586508|Growth Substances|growth substances|mesh-ancestor
56701169|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701170|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
56701171|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
56701172|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701173|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
56701174|NCT00581919|Vitamins|vitamins|mesh-ancestor
56701175|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
56701176|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
56701177|NCT00723528|Ustekinumab|ustekinumab|mesh-list
56701178|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
56701179|NCT02892123|Paclitaxel|paclitaxel|mesh-list
56701180|NCT02892123|Vinorelbine|vinorelbine|mesh-list
56701181|NCT02892123|Capecitabine|capecitabine|mesh-list
56701182|NCT02892123|Tucatinib|tucatinib|mesh-list
56701183|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56701184|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701185|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701186|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
56701208|NCT00916760|Antacids|antacids|mesh-ancestor
56701216|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56701217|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56701218|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701219|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56701220|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701221|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56701222|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56701223|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701224|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56701225|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56701226|NCT02599532|Apixaban|apixaban|mesh-list
56701227|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56701228|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
56701229|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56701230|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
56701231|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701232|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701233|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
56701234|NCT04085094|Pilocarpine|pilocarpine|mesh-list
56701235|NCT04085094|Miotics|miotics|mesh-ancestor
56701236|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
56701237|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701238|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701239|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56701240|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56701241|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
56412437|NCT01054248|Artesunate|artesunate|mesh-list
56701242|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701243|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701260|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56701261|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701262|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701263|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
56701264|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701265|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701266|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56701267|NCT00585312|Celecoxib|celecoxib|mesh-list
56701268|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56701269|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56701270|NCT00585312|Analgesics|analgesics|mesh-ancestor
56701271|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
56701272|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701273|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701274|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56701275|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56701276|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56701277|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56701278|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701279|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701280|NCT00753506|Artemisinins|artemisinins|mesh-list
56701281|NCT00753506|Artemisinin|artemisinin|mesh-list
56701282|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
56701283|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56701284|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56701285|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701286|NCT00720096|Doxorubicin|doxorubicin|mesh-list
56701307|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
56701308|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
56701309|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701310|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701311|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701312|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
56701313|NCT02577783|Hormones|hormones|mesh-ancestor
56701314|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56701315|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56701316|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701317|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
56701318|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701319|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701320|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56701321|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56701322|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56701323|NCT00918450|Navitoclax|navitoclax|mesh-list
56701324|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701325|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
56701326|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56701327|NCT02591628|Diuretics|diuretics|mesh-ancestor
56701328|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
56701329|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701330|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56701331|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56701332|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701354|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701355|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701356|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
56701357|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56701358|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701359|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
56701360|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701361|NCT02576223|Ropivacaine|ropivacaine|mesh-list
56701362|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
56701363|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
56701364|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701365|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701366|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
56701367|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701368|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
56701369|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701370|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56701371|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
56701372|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701373|NCT02577393|Protective Agents|protective agents|mesh-ancestor
56701374|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701375|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56701376|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56701377|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701378|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56701379|NCT02597114|Insulin|insulin|mesh-list
56701380|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56701381|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56701382|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701383|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
56701384|NCT00716976|Antidotes|antidotes|mesh-ancestor
56701385|NCT00716976|Protective Agents|protective agents|mesh-ancestor
56701386|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701387|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
56701395|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701396|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56701397|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
56701398|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
56701399|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701400|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701401|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701402|NCT00743366|Riboflavin|riboflavin|mesh-list
56701403|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56701404|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
56701405|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56701406|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56701407|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56701408|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701409|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701410|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
56701411|NCT00743366|Vitamins|vitamins|mesh-ancestor
56701412|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
56701413|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56701414|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
56701415|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
56701416|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
56701417|NCT01760655|Busulfan|busulfan|mesh-list
56701418|NCT01760655|Methyl Methanesulfonate|methyl methanesulfonate|mesh-list
56701419|NCT01760655|Fludarabine|fludarabine|mesh-list
56701420|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
56701421|NCT01760655|Tacrolimus|tacrolimus|mesh-list
56701422|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701423|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
56701424|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701425|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56701426|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56701427|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
56701428|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701429|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701432|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
56701436|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56701437|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56701438|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
56701439|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56701440|NCT00743288|Melphalan|melphalan|mesh-list
56701441|NCT00743288|Panobinostat|panobinostat|mesh-list
56701442|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56701443|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
56701444|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701445|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701446|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56701447|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701448|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
56701449|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701450|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56701451|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56412653|NCT00583258|Alfuzosin|alfuzosin|mesh-list
56257052|NCT01912378|Oxytocin|oxytocin|mesh-list
56297830|NCT00113815|Topiramate|topiramate|mesh-list
56549553|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549554|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549555|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549556|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
56549557|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56549558|NCT00650221|Pravastatin|pravastatin|mesh-list
56549559|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56549560|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56549561|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
56549562|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549563|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56549564|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56549565|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549566|NCT01169675|Pemetrexed|pemetrexed|mesh-list
56549567|NCT01169675|Afatinib|afatinib|mesh-list
56549568|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549569|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549570|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549571|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56549572|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56701474|NCT02579187|Anesthetics|anesthetics|mesh-list
56701475|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701476|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701477|NCT02598440|Alendronate|alendronate|mesh-list
56701478|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
56701479|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56701480|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701481|NCT00750308|Ramipril|ramipril|mesh-list
56701482|NCT00750308|Tadalafil|tadalafil|mesh-list
56701483|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
56701484|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56701485|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56701486|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701487|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701488|NCT00750308|Urological Agents|urological agents|mesh-ancestor
56701489|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56701490|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
56701491|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56701492|NCT05392790|Calcium|calcium|mesh-list
56701493|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56701494|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701495|NCT02597036|Zansecimab|zansecimab|mesh-list
56701496|NCT02597036|Paclitaxel|paclitaxel|mesh-list
56701497|NCT02597036|Ramucirumab|ramucirumab|mesh-list
56701498|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56701499|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701500|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701501|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
56701502|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701503|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549573|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56549574|NCT00650533|Glimepiride|glimepiride|mesh-list
56549575|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56549576|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56549577|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549578|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56549579|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
56549580|NCT02881866|Furosemide|furosemide|mesh-list
56549581|NCT02881866|Diuretics|diuretics|mesh-ancestor
56549582|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
56549583|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701504|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
56701505|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701506|NCT02596880|Ribavirin|ribavirin|mesh-list
56701507|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
56701508|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
56701509|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701510|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
56701511|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701512|NCT04071639|Ubiquinone|ubiquinone|mesh-list
56701513|NCT04071639|Haloperidol|haloperidol|mesh-list
56701514|NCT04071639|Risperidone|risperidone|mesh-list
56701515|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
56701516|NCT04071639|Sertraline|sertraline|mesh-list
56701517|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
56701518|NCT04071639|Idebenone|idebenone|mesh-list
56701519|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56701520|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
56701521|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701522|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701523|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701524|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56701525|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56701526|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701527|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56701528|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56701529|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
56701530|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
56701531|NCT04071639|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56701532|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56701533|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56701534|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
56701535|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
56701536|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701537|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701538|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56412726|NCT00181688|Anastrozole|anastrozole|mesh-list
56701539|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
56701540|NCT04071639|Protective Agents|protective agents|mesh-ancestor
56701541|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
56701543|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
56701544|NCT04089176|Oxytocin|oxytocin|mesh-list
56701545|NCT04089176|Carbetocin|carbetocin|mesh-list
56701546|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
56701547|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56701548|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701549|NCT00334815|Bevacizumab|bevacizumab|mesh-list
56701550|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56701551|NCT00334815|Cisplatin|cisplatin|mesh-list
56701552|NCT00334815|Docetaxel|docetaxel|mesh-list
56701553|NCT00334815|Etoposide|etoposide|mesh-list
56701554|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
56701555|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
56701556|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
56701557|NCT00334815|Antibodies|antibodies|mesh-list
56701558|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
56701559|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56701560|NCT00334815|Lenograstim|lenograstim|mesh-list
56701561|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
56701562|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701563|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56701564|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56701565|NCT00334815|Growth Substances|growth substances|mesh-ancestor
56701566|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701567|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
56701598|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56701599|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56701600|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701601|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701602|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56701603|NCT02575755|Renal Agents|renal agents|mesh-ancestor
56701604|NCT00746798|Vaccines|vaccines|mesh-list
56701605|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
56701606|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701607|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56701608|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56701609|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56701610|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56701611|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701612|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
56701613|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701614|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701615|NCT01298193|Phenothiazine|phenothiazine|mesh-list
56701616|NCT01298193|Droperidol|droperidol|mesh-list
56701617|NCT01298193|Haloperidol|haloperidol|mesh-list
56701618|NCT01298193|Aprepitant|aprepitant|mesh-list
56701619|NCT01298193|Metoclopramide|metoclopramide|mesh-list
56701620|NCT01298193|Domperidone|domperidone|mesh-list
56701621|NCT01298193|Alizapride|alizapride|mesh-list
56701622|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
56701624|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
56701625|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701626|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701627|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701628|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56701629|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701630|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701640|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56701641|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
56701642|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56701643|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56701644|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701645|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
56701646|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701647|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
56701648|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56701649|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56701650|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701651|NCT02590536|Urological Agents|urological agents|mesh-ancestor
56701652|NCT04086264|Azacitidine|azacitidine|mesh-list
56701653|NCT04086264|Decitabine|decitabine|mesh-list
56701654|NCT04086264|Venetoclax|venetoclax|mesh-list
56701655|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56701656|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
56701663|NCT04756401|Ichthammol|ichthammol|mesh-list
56701699|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701700|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701701|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
56701702|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56701703|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701704|NCT02578719|Bupivacaine|bupivacaine|mesh-list
56701705|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
56701706|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
56701707|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701708|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701709|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
56701710|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701711|NCT00742508|Carvedilol|carvedilol|mesh-list
56701712|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56701713|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56701719|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
56701757|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
56701758|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701759|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56701760|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56701761|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56701762|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56701763|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
56701764|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
56701765|NCT00719706|Vitamins|vitamins|mesh-ancestor
56701766|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
56701767|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701768|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
56701769|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
56701770|NCT02575521|Propofol|propofol|mesh-list
56701771|NCT02575521|Sevoflurane|sevoflurane|mesh-list
56701772|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56701773|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701774|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701775|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56701776|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
56701777|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
56701778|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56701779|NCT02575521|Analgesics|analgesics|mesh-ancestor
56701780|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
56701781|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701782|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56701783|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56701784|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56701785|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
56701786|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701787|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701788|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56701789|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56701790|NCT02576457|BMS-936559|bms-936559|mesh-list
56701791|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56549584|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56549585|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549586|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549587|NCT00924664|Tanezumab|tanezumab|mesh-list
56549588|NCT00924664|Analgesics|analgesics|mesh-ancestor
55888294|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56701792|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701793|NCT05276102|Emollients|emollients|mesh-list
56701794|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
56701795|NCT02596100|Betrixaban|betrixaban|mesh-list
56701796|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56701797|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
56701798|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56701799|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
56701800|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701801|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701802|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
56701803|NCT01192971|Apatinib|apatinib|mesh-list
56701804|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701805|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56701806|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701807|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701808|NCT00719472|Antipyretics|antipyretics|mesh-list
56701809|NCT00719472|Prednisone|prednisone|mesh-list
56701810|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
56701811|NCT00719472|Rituximab|rituximab|mesh-list
56701812|NCT00719472|Doxorubicin|doxorubicin|mesh-list
56701813|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56701814|NCT00719472|Vincristine|vincristine|mesh-list
56701815|NCT00719472|Analgesics|analgesics|mesh-list
56701816|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
56701817|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56701818|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701819|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
56701820|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701821|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56701822|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56701823|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
56701824|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701825|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701826|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56701827|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56549589|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
56549590|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549591|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549592|NCT02653651|Lidocaine|lidocaine|mesh-list
56549593|NCT02653651|Ketamine|ketamine|mesh-list
56701828|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56701829|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56701830|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56701831|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701832|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56701833|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
56701834|NCT00719472|Hormones|hormones|mesh-ancestor
56701835|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56701836|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56701837|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56701838|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701839|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56701840|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701841|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
56701842|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701843|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
56701844|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701845|NCT00579501|Dexamethasone|dexamethasone|mesh-list
56701846|NCT00579501|Trabectedin|trabectedin|mesh-list
56701847|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56701848|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
56549594|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
56549595|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
56549596|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549597|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549598|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
56549599|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549600|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56549601|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56549602|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56549603|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864524|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549604|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549606|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56549607|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56549608|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
56549609|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56549610|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56549611|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549612|NCT02651311|Ibuprofen|ibuprofen|mesh-list
56549613|NCT02651311|Fentanyl|fentanyl|mesh-list
56549614|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56549615|NCT02651311|Narcotics|narcotics|mesh-ancestor
56549616|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549617|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549618|NCT02651311|Analgesics|analgesics|mesh-ancestor
56549619|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
56549620|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549621|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56549622|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56549623|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
56549624|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
56549625|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56413023|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
56701849|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
56701850|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701851|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701852|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56701853|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
56701854|NCT00579501|Hormones|hormones|mesh-ancestor
56701855|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56701856|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56701857|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701858|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56701859|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
56701860|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701877|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
56701878|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56701879|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701880|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56701881|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56701882|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701883|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701884|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701885|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56701886|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56549626|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56549627|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56549628|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56549629|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56549630|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549631|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549632|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
56549633|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56549634|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56701887|NCT02576301|Cytarabine|cytarabine|mesh-list
56701888|NCT02576301|Combretastatin|combretastatin|mesh-list
56701889|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56701890|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
56701891|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701892|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701893|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
56701894|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701895|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701896|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
56701897|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701898|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56701899|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701900|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
56257474|NCT01915134|Cisplatin|cisplatin|mesh-list
56549635|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549637|NCT02653261|Coagulants|coagulants|mesh-ancestor
56549638|NCT02653339|Loratadine|loratadine|mesh-list
56549639|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
56549640|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
56549641|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56549642|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56549643|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56549644|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
56549645|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
56549646|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549647|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549648|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549649|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56549650|NCT00649597|Benazepril|benazepril|mesh-list
56549651|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56549652|NCT00649597|Diuretics|diuretics|mesh-ancestor
56549653|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
56549654|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549655|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56549656|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549657|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549658|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56549659|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
56549660|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549661|NCT02653027|Ivacaftor|ivacaftor|mesh-list
56549662|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56549663|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56549664|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549665|NCT02652793|Lamivudine|lamivudine|mesh-list
56549666|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56549667|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56549668|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56549669|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549670|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549671|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
56549672|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549673|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56549674|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56549675|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56549676|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56549677|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
56549680|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
56549681|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701901|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701902|NCT04086186|Bupivacaine|bupivacaine|mesh-list
56701903|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
56701904|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
56701905|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701906|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701907|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
56701908|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701909|NCT00741338|Cyclosporine|cyclosporine|mesh-list
56701910|NCT00741338|Azathioprine|azathioprine|mesh-list
56701911|NCT00741338|Cyclosporins|cyclosporins|mesh-list
56701912|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701913|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701914|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701915|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
56701916|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701917|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
56701918|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701919|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
56701920|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56257494|NCT01915264|Metformin|metformin|mesh-list
56549682|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549683|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549684|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56549685|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56549686|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549687|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56549688|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56549689|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
56549690|NCT00600067|Topiramate|topiramate|mesh-list
56549691|NCT00600067|Phentermine|phentermine|mesh-list
56549692|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
56549693|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56549694|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549695|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56549696|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
56549697|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56549698|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
56549699|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
56549700|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549701|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
56549702|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549703|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549704|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
56549705|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56549706|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56549707|NCT02650609|Prednisolone|prednisolone|mesh-list
56549708|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
56549709|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56549710|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
56549711|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56549712|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
56549713|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
56549714|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549715|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549716|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56413099|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
56701921|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56701922|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
56701923|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56701924|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701925|NCT02598830|Vitamin D|vitamin d|mesh-list
56701926|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
56701927|NCT02598830|Vitamins|vitamins|mesh-ancestor
56701928|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
56701929|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701930|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56701931|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56701932|NCT02578251|Acetaminophen|acetaminophen|mesh-list
56701933|NCT02578251|Meperidine|meperidine|mesh-list
56701934|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56549717|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
56549718|NCT02650609|Hormones|hormones|mesh-ancestor
56549719|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56549720|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56549721|NCT02650609|Protective Agents|protective agents|mesh-ancestor
56549722|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56549723|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549724|NCT02652871|Cytarabine|cytarabine|mesh-list
56549725|NCT02652871|Idarubicin|idarubicin|mesh-list
56549726|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56549727|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
56549728|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549729|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549730|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
56549731|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549732|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56549733|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
56549734|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549735|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56549736|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56549737|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56549738|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549739|NCT00650299|Alprazolam|alprazolam|mesh-list
56549740|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56549741|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549742|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549743|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56549744|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56549745|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56549746|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
56549747|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
56549748|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549749|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549750|NCT04168099|Cefotaxime|cefotaxime|mesh-list
56549751|NCT04168099|Cefoxitin|cefoxitin|mesh-list
56549752|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
56549758|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549760|NCT04283487|Levan|levan|mesh-list
56549761|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549762|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
56549763|NCT04283331|Propoxycaine|propoxycaine|mesh-list
56549764|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
56549765|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
56549766|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549767|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549768|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
56549769|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549770|NCT02657473|Tobramycin|tobramycin|mesh-list
56701935|NCT02578251|Analgesics|analgesics|mesh-ancestor
56701936|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
56701937|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701938|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701939|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
56701940|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56701941|NCT02578251|Narcotics|narcotics|mesh-ancestor
56701942|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56701943|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56701944|NCT05285358|Gemcitabine|gemcitabine|mesh-list
56701945|NCT05285358|Paclitaxel|paclitaxel|mesh-list
56701946|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56701947|NCT05285358|Cisplatin|cisplatin|mesh-list
56701948|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56701949|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56701950|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56701951|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56701952|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701953|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701954|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56701955|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
56701956|NCT05285358|Antiviral Agents|antiviral agents|mesh-ancestor
56257526|NCT01915472|Irinotecan|irinotecan|mesh-list
56549771|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56549772|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56549773|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549774|NCT02652637|Metronidazole|metronidazole|mesh-list
56549775|NCT02652637|Neomycin|neomycin|mesh-list
56549776|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549777|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56549778|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56549779|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56549780|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56549781|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549782|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549783|NCT00649675|Meloxicam|meloxicam|mesh-list
56549784|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56549785|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56549786|NCT00649675|Analgesics|analgesics|mesh-ancestor
56549787|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
56549788|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549789|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549790|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56549791|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56549792|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56549793|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56549794|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549795|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549797|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56549798|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549799|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56549800|NCT02860923|Incretins|incretins|mesh-ancestor
56549801|NCT02860923|Hormones|hormones|mesh-ancestor
55888295|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56701957|NCT05285358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56701958|NCT05285358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701959|NCT05285358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56701960|NCT05285358|Immunologic Factors|immunologic factors|mesh-ancestor
56701961|NCT05285358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701962|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
56701963|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
56701964|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56701965|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
56701966|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56701967|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701968|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56701969|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
56701970|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56701971|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56701972|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56701973|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
56701974|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701975|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701976|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56701977|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
56701978|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56701979|NCT02590224|Glycine|glycine|mesh-list
56701980|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
56701981|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56701982|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56701983|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56701984|NCT00709449|Papaverine|papaverine|mesh-list
56701985|NCT00709449|Moxaverine|moxaverine|mesh-list
56701986|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
56701987|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
56701991|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56701999|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702000|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702001|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702002|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56702003|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56702004|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702005|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56702006|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56702007|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
56702008|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
56702009|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
56702010|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56549802|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56549803|NCT01121406|Gemcitabine|gemcitabine|mesh-list
56549804|NCT01121406|Paclitaxel|paclitaxel|mesh-list
56549805|NCT01121406|Doxorubicin|doxorubicin|mesh-list
56549806|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56549807|NCT01121406|Topotecan|topotecan|mesh-list
56549808|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56549809|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549810|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
56549811|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
56549812|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
56549813|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549814|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56549815|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
56549816|NCT01121406|Antiviral Agents|antiviral agents|mesh-ancestor
56549817|NCT01121406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549818|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549819|NCT01121406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56549820|NCT01121406|Immunologic Factors|immunologic factors|mesh-ancestor
56549821|NCT01121406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549822|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56549823|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56549830|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56549831|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549832|NCT02652325|Trace Elements|trace elements|mesh-ancestor
56549833|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
56549834|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549835|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
56549836|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
56549837|NCT00960687|Fenofibrate|fenofibrate|mesh-list
56549838|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
56549839|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56549840|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
56549841|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549842|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56549843|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56549844|NCT00920140|Trametinib|trametinib|mesh-list
56549845|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549846|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56549847|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549848|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549849|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
56549850|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56549851|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549852|NCT01120626|Donepezil|donepezil|mesh-list
56549853|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56549854|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298131|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56549855|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549857|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702011|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56702012|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56702013|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56702015|NCT02574975|Adenosine|adenosine|mesh-list
56702016|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
56702017|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
56702018|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702019|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56702020|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
56702021|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702022|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702023|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56702024|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
56702025|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
56702026|NCT02574975|Hormones|hormones|mesh-ancestor
56702027|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56702028|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56702029|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56702030|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56702031|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
56702032|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702033|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702034|NCT02574975|Analgesics|analgesics|mesh-ancestor
56702035|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
56702036|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56702037|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
56702038|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56702039|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
56702040|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
56702041|NCT02574975|Miotics|miotics|mesh-ancestor
56702042|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56702043|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56702044|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55879664|NCT04697693|Citalopram|citalopram|mesh-list
56549858|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549859|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
56549860|NCT00650377|Finasteride|finasteride|mesh-list
56549861|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56549862|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56549864|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702045|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56702046|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
56702047|NCT00718770|Bexarotene|bexarotene|mesh-list
56702048|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702049|NCT04084158|Paclitaxel|paclitaxel|mesh-list
56702050|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56702051|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56702052|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702053|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
56702054|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
56702055|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
56702056|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702057|NCT00714519|Castor Oil|castor oil|mesh-list
56702058|NCT00714519|Cathartics|cathartics|mesh-ancestor
56702059|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56702060|NCT00714948|Gemcitabine|gemcitabine|mesh-list
56702061|NCT00714948|Sorafenib|sorafenib|mesh-list
56702062|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702063|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56702064|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
56702065|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702066|NCT00714948|Antiviral Agents|antiviral agents|mesh-ancestor
56702067|NCT00714948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702068|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702069|NCT00714948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56702070|NCT00714948|Immunologic Factors|immunologic factors|mesh-ancestor
56549865|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
56549866|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56549867|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549868|NCT00650377|Urological Agents|urological agents|mesh-ancestor
56549869|NCT02649751|Roscovitine|roscovitine|mesh-list
56549870|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549871|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
56549872|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549873|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56549874|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549875|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549876|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56549877|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56549878|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56549879|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
56549880|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549881|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56549882|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56549883|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549884|NCT00924508|Triamcinolone|triamcinolone|mesh-list
56549885|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56549886|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56549887|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56549888|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702071|NCT00714948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702072|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56702073|NCT00714714|Adapalene|adapalene|mesh-list
56702074|NCT00714714|Tretinoin|tretinoin|mesh-list
56702075|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56702077|NCT00714714|Analgesics|analgesics|mesh-ancestor
56702078|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
56702079|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702080|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702081|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702082|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702083|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
56702084|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702085|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
56702086|NCT00441337|Nivolumab|nivolumab|mesh-list
56702087|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702088|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702089|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56702090|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549889|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
56549890|NCT00924508|Hormones|hormones|mesh-ancestor
56549891|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56549892|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549893|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56549896|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549898|NCT00650923|Aflibercept|aflibercept|mesh-list
56549899|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
56549900|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56549901|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
56549902|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549903|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549904|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56549905|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56549906|NCT00650923|Growth Substances|growth substances|mesh-ancestor
56549907|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549908|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
56549909|NCT00637858|Lycopene|lycopene|mesh-list
56549910|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56549911|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
56549912|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549913|NCT00637858|Protective Agents|protective agents|mesh-ancestor
56549914|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549915|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56549916|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56549917|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549918|NCT02657161|Vaccines|vaccines|mesh-list
56549919|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
56549920|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549921|NCT01139580|Calcipotriene|calcipotriene|mesh-list
56549922|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
56549923|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
56549924|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
56549925|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
56549926|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
56549927|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
56702091|NCT00578877|Nonoxynol|nonoxynol|mesh-list
56702092|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56702093|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56702094|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702095|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56702096|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
56702097|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56702098|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56702099|NCT02573727|Terlipressin|terlipressin|mesh-list
56702100|NCT02573727|Epinephrine|epinephrine|mesh-list
56702101|NCT02573727|Racepinephrine|racepinephrine|mesh-list
56702102|NCT02573727|Norepinephrine|norepinephrine|mesh-list
56702103|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
56702104|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56702105|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56549928|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549929|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56549930|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
56549931|NCT04251832|Antidotes|antidotes|mesh-ancestor
56549932|NCT04251832|Protective Agents|protective agents|mesh-ancestor
56549933|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549935|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549936|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
56549937|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56549938|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549939|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
56549940|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
56549941|NCT02656771|Metronidazole|metronidazole|mesh-list
56549942|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549943|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56549944|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56549945|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56549946|NCT00917644|Atorvastatin|atorvastatin|mesh-list
56549947|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56549948|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56549949|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
56549950|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549951|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56549952|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56549953|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549954|NCT00625170|Haloperidol|haloperidol|mesh-list
56549955|NCT00625170|Olanzapine|olanzapine|mesh-list
56549956|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
56549957|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
56549958|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
56549959|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56549960|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549961|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56549962|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56549963|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56549964|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56549965|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56549966|NCT00625170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56549967|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56549969|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549970|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56549971|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
56549972|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56549973|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
56549974|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56549975|NCT00599755|Gemcitabine|gemcitabine|mesh-list
56549976|NCT00599755|Carboplatin|carboplatin|mesh-list
56702106|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
56702107|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702108|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702109|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702110|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56702111|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56702112|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
56702113|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702114|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56702115|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
56702116|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
56702117|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
56702118|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56702119|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56702120|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
56702121|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
56702122|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56702123|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56702124|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702125|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56549977|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549978|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56549979|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
56549980|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549981|NCT00599755|Antiviral Agents|antiviral agents|mesh-ancestor
56549982|NCT00599755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549983|NCT00599755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549984|NCT00599755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56549985|NCT00599755|Immunologic Factors|immunologic factors|mesh-ancestor
56549986|NCT00599755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549987|NCT04251364|Acetazolamide|acetazolamide|mesh-list
56549988|NCT04251364|Atorvastatin|atorvastatin|mesh-list
56549989|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56549990|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56549991|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
56549992|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549993|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56549994|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56549995|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549996|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
56549997|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56549998|NCT04251364|Diuretics|diuretics|mesh-ancestor
56549999|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
56550000|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550001|NCT04811014|Buprenorphine|buprenorphine|mesh-list
56550002|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56550004|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56550005|NCT04811014|Narcotics|narcotics|mesh-ancestor
56550006|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550007|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550008|NCT04811014|Analgesics|analgesics|mesh-ancestor
56550009|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
56550010|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702126|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
56702127|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702128|NCT00918528|Mitomycins|mitomycins|mesh-list
56702129|NCT00918528|Mitomycin|mitomycin|mesh-list
56702130|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56702131|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702132|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
56702133|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702134|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56702135|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702136|NCT00468481|Drospirenone|drospirenone|mesh-list
56702137|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56702138|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56702139|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56702140|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56702141|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56702142|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
56702143|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56702144|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702145|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56702146|NCT00468481|Estrogens|estrogens|mesh-ancestor
56702147|NCT00468481|Hormones|hormones|mesh-ancestor
56702148|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56702149|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56702150|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
56702151|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56702152|NCT00468481|Diuretics|diuretics|mesh-ancestor
56702153|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
56702154|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
56702155|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56702156|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550011|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56550012|NCT02648425|Leucovorin|leucovorin|mesh-list
56550013|NCT02648425|Cisplatin|cisplatin|mesh-list
56550014|NCT02648425|Fluorouracil|fluorouracil|mesh-list
56550015|NCT02648425|Capecitabine|capecitabine|mesh-list
56550016|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550017|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
56550018|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550019|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56550020|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550021|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
56550022|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702157|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
56702158|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702159|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
56702160|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702161|NCT03949153|Nivolumab|nivolumab|mesh-list
56702162|NCT03949153|Ipilimumab|ipilimumab|mesh-list
56702163|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702164|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702165|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56702166|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702167|NCT05254002|Empagliflozin|empagliflozin|mesh-list
56702168|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56702169|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702170|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56702171|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702172|NCT00709917|Repaglinide|repaglinide|mesh-list
56702173|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56702174|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702175|NCT02574741|Aripiprazole|aripiprazole|mesh-list
56702176|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
56702177|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56702178|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56702179|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56702180|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702181|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702205|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702206|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702207|NCT02589444|Vitamin D|vitamin d|mesh-list
56702208|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
56702209|NCT02589444|Vitamins|vitamins|mesh-ancestor
56702210|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
56702211|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702212|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56702213|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56702214|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56702215|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702216|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702217|NCT00435487|Heparin|heparin|mesh-list
56702218|NCT00435487|Calcium heparin|calcium heparin|mesh-list
56702219|NCT00435487|Dalteparin|dalteparin|mesh-list
56702220|NCT00435487|Tinzaparin|tinzaparin|mesh-list
56702221|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56702222|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
56702223|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56702224|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56702225|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702226|NCT02589678|Vaccines|vaccines|mesh-list
56702227|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
56702228|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702229|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56702230|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
56702231|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56702232|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
56257779|NCT01917032|Hematinics|hematinics|mesh-ancestor
56550023|NCT02648425|Antidotes|antidotes|mesh-ancestor
56550024|NCT02648425|Protective Agents|protective agents|mesh-ancestor
56550025|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
56550026|NCT02648425|Vitamins|vitamins|mesh-ancestor
56550027|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
56550028|NCT02648503|Atropine|atropine|mesh-list
56550029|NCT02648503|Rocuronium|rocuronium|mesh-list
56550030|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56550031|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56550032|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56550033|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
56550034|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550035|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550036|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56550037|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
56550038|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
56550039|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
56550040|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56550041|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56702233|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56702234|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702235|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56702236|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56702237|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702238|NCT02591004|Nifedipine|nifedipine|mesh-list
56702239|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56702240|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56702241|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702242|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55833036|NCT02062645|Valsartan|valsartan|mesh-list
56550042|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
56550043|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550044|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550045|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56550047|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56550048|NCT05253508|Lidocaine|lidocaine|mesh-list
56550049|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
56550050|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
56550051|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550052|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550053|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
56550054|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550055|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56550056|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56550057|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56550058|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550059|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550060|NCT04666948|Vancomycin|vancomycin|mesh-list
56550061|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56550062|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550063|NCT04524130|Lidocaine|lidocaine|mesh-list
56550064|NCT04524130|Ketamine|ketamine|mesh-list
56550065|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
56550066|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
56550067|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550068|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550069|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
56550070|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550071|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56550072|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56550073|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56550074|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550075|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550076|NCT04524130|Analgesics|analgesics|mesh-ancestor
56298356|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56550077|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56550078|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56550079|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
56550080|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56550081|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56550082|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550083|NCT00649831|Amoxicillin|amoxicillin|mesh-list
56550084|NCT00649831|Azithromycin|azithromycin|mesh-list
56550085|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56550086|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550087|NCT03969901|Relebactam|relebactam|mesh-list
56550088|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56550089|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550090|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550091|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56702243|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702244|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
56702245|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
56702246|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56702247|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
56702248|NCT05310786|Narcotics|narcotics|mesh-ancestor
56702249|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702250|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702251|NCT05310786|Analgesics|analgesics|mesh-ancestor
56702252|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
56702253|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702254|NCT04085562|Amlodipine|amlodipine|mesh-list
56702255|NCT04085562|Bisoprolol|bisoprolol|mesh-list
56702256|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56702257|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56702258|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56702259|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702260|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56702261|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702262|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
56702263|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
56702264|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
56702265|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257820|NCT01917149|Metoprolol|metoprolol|mesh-list
56550092|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550093|NCT02648659|Amoxicillin|amoxicillin|mesh-list
56550094|NCT02648659|Metronidazole|metronidazole|mesh-list
56550095|NCT02648659|Clarithromycin|clarithromycin|mesh-list
56550096|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56550097|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550098|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56550099|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56550100|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56550101|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550102|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550103|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56550104|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56550105|NCT01125930|Tretinoin|tretinoin|mesh-list
56550106|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550107|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
56550108|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
56550109|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
56550110|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550111|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56550112|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550113|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550114|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
55865632|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550116|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550117|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56550118|NCT00651235|Losartan|losartan|mesh-list
56702266|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56702267|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56702268|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56702269|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
56702270|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702271|NCT05048238|Tofacitinib|tofacitinib|mesh-list
56702272|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56702273|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702274|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702275|NCT05683626|Adalimumab|adalimumab|mesh-list
56702276|NCT05683626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702277|NCT05683626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702278|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56702279|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56702280|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702281|NCT05168202|Azacitidine|azacitidine|mesh-list
56702282|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56702283|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
56702284|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702285|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702286|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702287|NCT02588196|Dexamethasone|dexamethasone|mesh-list
56702288|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
56702289|NCT02588196|BB 1101|bb 1101|mesh-list
56702290|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702291|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
56702292|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
56702293|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702294|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702295|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56413467|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702296|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
56550119|NCT00651235|Propranolol|propranolol|mesh-list
56550120|NCT00651235|Atenolol|atenolol|mesh-list
56550121|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56550122|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56550123|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56550124|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56550125|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550126|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56550127|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56550128|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
56550129|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702297|NCT02588196|Hormones|hormones|mesh-ancestor
56702298|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56702299|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56702300|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702301|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
56702302|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702303|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702304|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56702305|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
56702306|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702307|NCT00579345|Vaccines|vaccines|mesh-list
56702308|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
56702309|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702310|NCT00715377|Benztropine|benztropine|mesh-list
56550130|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550131|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
56550132|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
56550133|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
56550134|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550135|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56550136|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
56550137|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56550138|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
56550139|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550140|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56550141|NCT04015219|Lifitegrast|lifitegrast|mesh-list
56550142|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56550143|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
56550144|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56550145|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550146|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56550147|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550148|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
56550149|NCT01168973|Docetaxel|docetaxel|mesh-list
56550150|NCT01168973|Ramucirumab|ramucirumab|mesh-list
56550151|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56550152|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550153|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
56550155|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
56550156|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550157|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
56550158|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550159|NCT04747912|Dexamethasone|dexamethasone|mesh-list
56550160|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
56550161|NCT04747912|Methotrexate|methotrexate|mesh-list
56550162|NCT04747912|Vincristine|vincristine|mesh-list
56550163|NCT04747912|Dasatinib|dasatinib|mesh-list
56550164|NCT04747912|Ponatinib|ponatinib|mesh-list
56550165|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56550166|NCT04747912|BB 1101|bb 1101|mesh-list
56550167|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550168|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
56550169|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
56550170|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550171|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550172|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550173|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
56550174|NCT04747912|Hormones|hormones|mesh-ancestor
56550175|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550176|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56550177|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550178|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
56702311|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56702312|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56702313|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
56702314|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
56702315|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702316|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702317|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56702318|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56702319|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
56702320|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702321|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702322|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56702323|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56702324|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56702325|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
56702326|NCT05023980|Rituximab|rituximab|mesh-list
56702327|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56702328|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702329|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702330|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
56702331|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702332|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702333|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56702334|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
56550179|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550180|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550181|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56550182|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
56550183|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56550184|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56550185|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
56550186|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
56550187|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56550188|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550189|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
56550191|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56550192|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56550194|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
56550195|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
56550196|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56550197|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56550198|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56550199|NCT00631618|Sunitinib|sunitinib|mesh-list
56550200|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550201|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56550202|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56550203|NCT00631618|Growth Substances|growth substances|mesh-ancestor
56550204|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702335|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702336|NCT00715455|Heparin|heparin|mesh-list
56702337|NCT00715455|Calcium heparin|calcium heparin|mesh-list
56702338|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
56702339|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56702340|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56702341|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702342|NCT02574663|Leucovorin|leucovorin|mesh-list
56702343|NCT02574663|Folic Acid|folic acid|mesh-list
56702344|NCT02574663|Gemcitabine|gemcitabine|mesh-list
56702345|NCT02574663|Paclitaxel|paclitaxel|mesh-list
56702346|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56702347|NCT02574663|Bevacizumab|bevacizumab|mesh-list
56702348|NCT02574663|Fluorouracil|fluorouracil|mesh-list
56702349|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
56702350|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
56702351|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56702352|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702353|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
56702354|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
56550205|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
56550206|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56550207|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550208|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550209|NCT04431778|Ethosuximide|ethosuximide|mesh-list
56550210|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
56550211|NCT04669132|Olanzapine|olanzapine|mesh-list
56550212|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
56550213|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
56550214|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550215|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550216|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550217|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56550218|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56550219|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550220|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56550221|NCT04669132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56550222|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56550223|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550224|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550225|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550226|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
56550227|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
56550228|NCT01168349|Hematinics|hematinics|mesh-ancestor
56550229|NCT00915772|Metformin|metformin|mesh-list
56550230|NCT00915772|Linagliptin|linagliptin|mesh-list
56550231|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56550232|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550233|NCT00915772|Incretins|incretins|mesh-ancestor
56550234|NCT00915772|Hormones|hormones|mesh-ancestor
56550235|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550236|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56550237|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
56550238|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550239|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550240|NCT00632086|Aspirin|aspirin|mesh-list
56550241|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56550242|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56702355|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
56702356|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702357|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702358|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56702359|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56702360|NCT02574663|Growth Substances|growth substances|mesh-ancestor
56702361|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702362|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
56702363|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56702364|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
56702365|NCT02574663|Antiviral Agents|antiviral agents|mesh-ancestor
56702366|NCT02574663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702367|NCT02574663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702368|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56702369|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
56413543|NCT00477295|Carbamazepine|carbamazepine|mesh-list
56702370|NCT02574663|Antidotes|antidotes|mesh-ancestor
56702371|NCT02574663|Protective Agents|protective agents|mesh-ancestor
56702372|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
56702409|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
56702410|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702411|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56702412|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702413|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
56702414|NCT00919542|Hormones|hormones|mesh-ancestor
56702415|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56702416|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56702417|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702418|NCT04240626|Acetaminophen|acetaminophen|mesh-list
56702419|NCT04240626|Scopolamine|scopolamine|mesh-list
56702420|NCT04240626|Oxycodone|oxycodone|mesh-list
56702421|NCT04240626|Gabapentin|gabapentin|mesh-list
56702422|NCT04240626|Hydromorphone|hydromorphone|mesh-list
56702423|NCT04240626|Hydrocodone|hydrocodone|mesh-list
56702424|NCT04240626|Bupivacaine|bupivacaine|mesh-list
56702425|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
56702426|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56702427|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56702428|NCT04240626|Analgesics|analgesics|mesh-ancestor
56702429|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
56702430|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702431|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702432|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
56702433|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56702434|NCT04240626|Narcotics|narcotics|mesh-ancestor
56702435|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702436|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
56702437|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56702438|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56702459|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
56702460|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56702461|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56702462|NCT00719121|Adapalene|adapalene|mesh-list
56702463|NCT00719121|R 115866|r 115866|mesh-list
56702464|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56702465|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56702466|NCT00719121|Analgesics|analgesics|mesh-ancestor
56702467|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
56702468|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702469|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702470|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702471|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702472|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
56702473|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56702474|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702475|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702476|NCT00719199|Cetuximab|cetuximab|mesh-list
56702477|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702478|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702479|NCT02589288|Ropivacaine|ropivacaine|mesh-list
56702480|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
56702481|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
56702482|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702483|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702484|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
56702485|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702486|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
56702487|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56702488|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
56258036|NCT01918150|Cobalt|cobalt|mesh-list
56550243|NCT00632086|Analgesics|analgesics|mesh-ancestor
56550244|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
56550245|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550246|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550247|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550248|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56550249|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56550250|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56550251|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550252|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56550253|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56550254|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550255|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
56702489|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702490|NCT00716001|Expectorants|expectorants|mesh-ancestor
56702491|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
56702492|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56702493|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
56702494|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702495|NCT00716001|Protective Agents|protective agents|mesh-ancestor
56702496|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702497|NCT00716001|Antidotes|antidotes|mesh-ancestor
56702498|NCT05136846|Paclitaxel|paclitaxel|mesh-list
56702499|NCT05136846|Carboplatin|carboplatin|mesh-list
56702500|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56702501|NCT05136846|Durvalumab|durvalumab|mesh-list
56702502|NCT05136846|Papaverine|papaverine|mesh-list
56702503|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
56702504|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56702505|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
56702506|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56702507|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702508|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
56702509|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56702510|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
56702511|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702512|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702513|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
56702514|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702515|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56702516|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702517|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
56702518|NCT05136846|Urological Agents|urological agents|mesh-ancestor
56702519|NCT04994808|Fludarabine|fludarabine|mesh-list
56702520|NCT04994808|Clofarabine|clofarabine|mesh-list
56702521|NCT04994808|Treosulfan|treosulfan|mesh-list
56702522|NCT04994808|Busulfan|busulfan|mesh-list
56702523|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702524|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56550256|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
56550257|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56550258|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550259|NCT00912964|Mirabegron|mirabegron|mesh-list
56550260|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56550261|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56702525|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
56702581|NCT04978272|Artenimol|artenimol|mesh-list
56702582|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
56702583|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56702584|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56702585|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702586|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
56702587|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56702588|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702589|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702590|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56702591|NCT04973124|Analgesics|analgesics|mesh-ancestor
56702592|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
56702593|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702594|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56702595|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56702596|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56702597|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
56702598|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702599|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702600|NCT04971720|Valsartan|valsartan|mesh-list
56702601|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56702602|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56702603|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56702604|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56702605|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702606|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
56702607|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702608|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
56702609|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56550262|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56550266|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550267|NCT00912964|Urological Agents|urological agents|mesh-ancestor
56550268|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
56550269|NCT02641639|Combretastatin|combretastatin|mesh-list
56550270|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56550271|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550272|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
56550273|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
56550274|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
56550275|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550276|NCT02647567|Caffeine|caffeine|mesh-list
56550277|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56702610|NCT00719745|Tacrolimus|tacrolimus|mesh-list
56702611|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56702612|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
56702613|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702614|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56702615|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702616|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702617|NCT02587416|Atorvastatin|atorvastatin|mesh-list
56702618|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56702619|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56702620|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
56702621|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702622|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56702623|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56702624|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702625|NCT00719823|Maraviroc|maraviroc|mesh-list
56702626|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56702627|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56702628|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702629|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56702630|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56702631|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
56702632|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702661|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702662|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702663|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56702664|NCT00720135|Analgesics|analgesics|mesh-ancestor
56702665|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
56702666|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702667|NCT02588118|Propofol|propofol|mesh-list
56702668|NCT02588118|Cisatracurium|cisatracurium|mesh-list
56702669|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56702670|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702671|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702672|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56702673|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
56702674|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
56550278|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550279|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56550280|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550281|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550282|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56550283|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56550284|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
56550285|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550286|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56550287|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56550288|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
56550289|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550290|NCT02647489|Antacids|antacids|mesh-ancestor
56550291|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550292|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550293|NCT04577716|Listerine|listerine|mesh-list
56550294|NCT04577716|Fluorides|fluorides|mesh-list
56550295|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
56550296|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
56550297|NCT04577716|Protective Agents|protective agents|mesh-ancestor
56550298|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550299|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56550300|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550301|NCT00910897|Thalidomide|thalidomide|mesh-list
56550302|NCT00910897|Dexamethasone|dexamethasone|mesh-list
56550303|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
56298597|NCT00118183|Cetuximab|cetuximab|mesh-list
56550304|NCT00910897|Bortezomib|bortezomib|mesh-list
56550305|NCT00910897|BB 1101|bb 1101|mesh-list
56550306|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550307|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
56550308|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
56550309|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550310|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550311|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550312|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
56550313|NCT00910897|Hormones|hormones|mesh-ancestor
56550314|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550315|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56550316|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550317|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
56550318|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550319|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550320|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550321|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
56550322|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
56550323|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56550324|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550325|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56702675|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56702676|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56702677|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702678|NCT00716391|Cisplatin|cisplatin|mesh-list
56702679|NCT00716391|Cetuximab|cetuximab|mesh-list
56702680|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702681|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702682|NCT00716469|Talaporfin|talaporfin|mesh-list
56702683|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702684|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56702685|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
56702686|NCT04068207|Minocycline|minocycline|mesh-list
56702687|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56702688|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702689|NCT04082598|Amoxicillin|amoxicillin|mesh-list
56702690|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
56702691|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
56702692|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56702693|NCT04082598|Lactoferrin|lactoferrin|mesh-list
56702694|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56702695|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702696|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56702697|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702698|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702699|NCT03895203|Adalimumab|adalimumab|mesh-list
56702700|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702701|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702702|NCT04958226|Midazolam|midazolam|mesh-list
56702703|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56702704|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56702705|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702706|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702707|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56702708|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56702709|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56702710|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56702711|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
56702712|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
56550326|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56702713|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
56702714|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
56702715|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702716|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702717|NCT00716547|Celecoxib|celecoxib|mesh-list
56702718|NCT00716547|Ketoprofen|ketoprofen|mesh-list
56702719|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56702720|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56702721|NCT00716547|Analgesics|analgesics|mesh-ancestor
56702722|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
56702723|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702724|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702725|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702726|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702727|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56702728|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56702732|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
56702774|NCT00720447|Carmustine|carmustine|mesh-list
56702775|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56702776|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702777|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56702778|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56702779|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702780|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702781|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56702782|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
56702783|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
56702784|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702785|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56702786|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
56702787|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702788|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56702789|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
56702790|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56702791|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702792|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
56702793|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56702794|NCT04828824|Norgestimate|norgestimate|mesh-list
56702795|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56702796|NCT04828824|Estradiol|estradiol|mesh-list
56702797|NCT04828824|Estrogens|estrogens|mesh-ancestor
56702798|NCT04828824|Hormones|hormones|mesh-ancestor
56702799|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56702800|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702801|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56702802|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
56702803|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56702804|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56702805|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56702806|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56702813|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702814|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702815|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56702816|NCT00578565|Rituximab|rituximab|mesh-list
56702817|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702818|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702819|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
56702820|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702821|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56702822|NCT02572089|Naloxone|naloxone|mesh-list
56702823|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56702824|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702825|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
56702826|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702827|NCT02588742|Melatonin|melatonin|mesh-list
56702828|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
56702829|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702830|NCT02588742|Protective Agents|protective agents|mesh-ancestor
56702831|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702832|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702833|NCT05108688|Sumatriptan|sumatriptan|mesh-list
56702834|NCT05108688|Mirtazapine|mirtazapine|mesh-list
56702835|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56702836|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56702837|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56702838|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
56702839|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702840|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702841|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702842|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
56702843|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56702844|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56702845|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
56702846|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
55880411|NCT01557868|Hylan|hylan|mesh-list
56550327|NCT00910897|Growth Substances|growth substances|mesh-ancestor
56550328|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
56550329|NCT00651547|Budesonide|budesonide|mesh-list
56702847|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56702848|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56702849|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56702850|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56702851|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56702852|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56702853|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
56702854|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56702855|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56702856|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56702857|NCT00720603|Plerixafor|plerixafor|mesh-list
56702858|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56702859|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56702860|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
56702861|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702862|NCT04936854|Sirolimus|sirolimus|mesh-list
56702863|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
56702864|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56702865|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56702866|NCT04936854|Prednisolone|prednisolone|mesh-list
56702867|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
56702868|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56702869|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
56702870|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56702871|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702872|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56702873|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702874|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
56702875|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56702876|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
56702877|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702878|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56702879|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
56702880|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
56702881|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550330|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
56550331|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550332|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56550333|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
56550334|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702882|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56702883|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
56702884|NCT04936854|Hormones|hormones|mesh-ancestor
56702885|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56702886|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56702887|NCT04936854|Protective Agents|protective agents|mesh-ancestor
56702888|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56702889|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
56702890|NCT00711789|Giapreza|giapreza|mesh-list
56702891|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
56702892|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56702893|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56702894|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
56702895|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702896|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702897|NCT00741260|Capecitabine|capecitabine|mesh-list
56702898|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56702899|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
56702900|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702901|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702902|NCT02587260|Clopidogrel|clopidogrel|mesh-list
56414108|NCT00210990|Doripenem|doripenem|mesh-list
56702903|NCT02587260|Ticagrelor|ticagrelor|mesh-list
56702904|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56702905|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56702906|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56702907|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56702908|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56702909|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
56702910|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702911|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702912|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702913|NCT02596256|Docetaxel|docetaxel|mesh-list
56702914|NCT02596256|Apatinib|apatinib|mesh-list
56702921|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702922|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
56702923|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56702924|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56702925|NCT00717561|Amoxicillin|amoxicillin|mesh-list
56702926|NCT00717561|Azithromycin|azithromycin|mesh-list
56702927|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
56702928|NCT00717561|Clarithromycin|clarithromycin|mesh-list
56702929|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
56702930|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
56702931|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
56702932|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56702933|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56702934|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56702935|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56702936|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56702937|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56702938|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702939|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702940|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702941|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56702942|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
56702943|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56702944|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702945|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56702972|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
56702973|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56702974|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56702975|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56702976|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
56702977|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
56702978|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56702979|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56702980|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56702981|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702982|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56702983|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56702984|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
56702985|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
56702986|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56702988|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
56702989|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56702990|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56702991|NCT00721305|Lovastatin|lovastatin|mesh-list
56702992|NCT00721305|L 647318|l 647318|mesh-list
56550337|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
56550338|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
56550339|NCT00651547|Hormones|hormones|mesh-ancestor
56550340|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550341|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56550342|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56550343|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56550344|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
56550345|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550346|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550347|NCT00912808|Donepezil|donepezil|mesh-list
56550348|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56550349|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550350|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550351|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
56550352|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550353|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550354|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
56550355|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
56550356|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56550357|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56550358|NCT02647255|Prednisolone|prednisolone|mesh-list
56550359|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
56550360|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56550361|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
56550362|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550363|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
56550364|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
56550365|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550366|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550367|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550368|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
56550369|NCT02647255|Hormones|hormones|mesh-ancestor
56550370|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56702993|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
56702994|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56702995|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56702996|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
56702997|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56702998|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56702999|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56703000|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703001|NCT00717951|Capecitabine|capecitabine|mesh-list
56703002|NCT00717951|Docetaxel|docetaxel|mesh-list
56703003|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703004|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56703005|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
56703006|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703007|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
56703008|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
56703009|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
56703010|NCT02572947|Dolutegravir|dolutegravir|mesh-list
56703011|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56703049|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56703050|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
56703051|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703052|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
56703053|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414252|NCT00185510|Hormones|hormones|mesh-ancestor
56703054|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56703055|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703056|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56703057|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
56703058|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703060|NCT05683782|Epoetin Alfa|epoetin alfa|mesh-list
56703061|NCT05683782|Hematinics|hematinics|mesh-ancestor
56703062|NCT05683782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56703063|NCT05683782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56703064|NCT05683782|Antimetabolites|antimetabolites|mesh-ancestor
56703065|NCT05683782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703066|NCT05683782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56703067|NCT05683782|Chelating Agents|chelating agents|mesh-ancestor
56703068|NCT05683782|Sequestering Agents|sequestering agents|mesh-ancestor
56703069|NCT05683782|Hemostatics|hemostatics|mesh-ancestor
56703070|NCT05683782|Coagulants|coagulants|mesh-ancestor
56703103|NCT05676684|Natriuretic Agents|natriuretic agents|mesh-ancestor
56703104|NCT04070469|Amoxicillin|amoxicillin|mesh-list
56703105|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56703106|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703107|NCT00712647|Beta Carotene|beta carotene|mesh-list
56703108|NCT00712647|Vitamin A|vitamin a|mesh-list
56703109|NCT00712647|Carotenoids|carotenoids|mesh-list
56703110|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
56703111|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703112|NCT00712647|Protective Agents|protective agents|mesh-ancestor
56703113|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703114|NCT00712647|Provitamins|provitamins|mesh-ancestor
56703115|NCT00712647|Vitamins|vitamins|mesh-ancestor
56703116|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
56703117|NCT00788957|Panitumumab|panitumumab|mesh-list
56703118|NCT00788957|Rilotumumab|rilotumumab|mesh-list
56703119|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56703120|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703121|NCT04067817|Phenylephrine|phenylephrine|mesh-list
56703122|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
56703123|NCT04067817|Norepinephrine|norepinephrine|mesh-list
56703124|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56703125|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56703126|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
56703127|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
56414303|NCT00211341|Vitamin A|vitamin a|mesh-list
56703128|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703129|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258617|NCT01930734|Dobutamine|dobutamine|mesh-list
56550371|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56550372|NCT02647255|Protective Agents|protective agents|mesh-ancestor
56550373|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56550374|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550376|NCT04329442|Emtricitabine|emtricitabine|mesh-list
56550377|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
56550378|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298662|NCT02710734|Mitomycins|mitomycins|mesh-list
56550379|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56550380|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56550382|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550383|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56550384|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56550385|NCT04414228|Anesthetics|anesthetics|mesh-list
56550386|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550387|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550388|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
56550389|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550390|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56550391|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
56550392|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56550393|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
56107432|NCT00003421|Bleomycin|bleomycin|mesh-list
56703130|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
56703131|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
56703132|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
56703133|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56703134|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56703135|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56703136|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
56703137|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703138|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703139|NCT04067817|Protective Agents|protective agents|mesh-ancestor
56703140|NCT00740636|Temozolomide|temozolomide|mesh-list
56703141|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56258639|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
56550394|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550395|NCT04407754|Inositol|inositol|mesh-list
56550396|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
56550397|NCT04407754|Vitamins|vitamins|mesh-ancestor
56550398|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
56550399|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550400|NCT03017833|Metformin|metformin|mesh-list
56550401|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56550402|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550403|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
56550404|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56550405|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
56550406|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550407|NCT00652639|Clonazepam|clonazepam|mesh-list
56550408|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
56550409|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
56550411|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550412|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550413|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550414|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
56550415|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
56550416|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550417|NCT02644915|Edaravone|edaravone|mesh-list
56550418|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56550419|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
56550420|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550421|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56550422|NCT02644915|Protective Agents|protective agents|mesh-ancestor
56550423|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550424|NCT03889756|Midazolam|midazolam|mesh-list
56550425|NCT03889756|Ketamine|ketamine|mesh-list
56550426|NCT03889756|Analgesics|analgesics|mesh-ancestor
56550427|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
56550428|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550429|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550430|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56550431|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56550432|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
56550433|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
56550434|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550435|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56550436|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56550437|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550438|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550439|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56550440|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56550441|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56550442|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56550443|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56550444|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
56703142|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
56703143|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703144|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703145|NCT02603159|Capecitabine|capecitabine|mesh-list
56703146|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56703147|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
56703148|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703149|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703150|NCT02595554|Paclitaxel|paclitaxel|mesh-list
56703151|NCT02595554|Cisplatin|cisplatin|mesh-list
56703152|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56703153|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703154|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
56703155|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
56703156|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
56703157|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703158|NCT04069065|Tacrolimus|tacrolimus|mesh-list
56703159|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703160|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
56703161|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703162|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56703163|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703164|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703165|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
56703166|NCT04070391|Pyridoxal|pyridoxal|mesh-list
56703167|NCT04070391|Pyridoxine|pyridoxine|mesh-list
56703168|NCT04070391|Vitamins|vitamins|mesh-ancestor
56703169|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
56703170|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703171|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
56703172|NCT05615051|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56703186|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703187|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56703188|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56703189|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56703190|NCT02603081|Ebselen|ebselen|mesh-list
56703191|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56703192|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56703193|NCT02603081|Analgesics|analgesics|mesh-ancestor
56703194|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
56703195|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703196|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703197|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703198|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703199|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56703200|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56703201|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
56703202|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703203|NCT02603081|Protective Agents|protective agents|mesh-ancestor
56703204|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56703205|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703238|NCT00722475|Antibodies|antibodies|mesh-list
56703239|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
56703240|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56703241|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
56703242|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703243|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
56703244|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56703245|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703246|NCT00915239|Pantoprazole|pantoprazole|mesh-list
56703247|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56703248|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56703249|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56703250|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703251|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703252|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56703253|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703254|NCT00722631|Pioglitazone|pioglitazone|mesh-list
56703255|NCT00722631|Glimepiride|glimepiride|mesh-list
56703256|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56703257|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703258|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56703259|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703293|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703294|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703295|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56703296|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703297|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703298|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703299|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703300|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
56703301|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
56703302|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703303|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
56703304|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703305|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56550445|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
56550446|NCT00651703|Imiquimod|imiquimod|mesh-list
56550447|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56550448|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56550449|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
56550450|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480195|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
56550451|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550452|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
56550453|NCT02964585|Canagliflozin|canagliflozin|mesh-list
56550454|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56550455|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550456|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56550457|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550458|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56550459|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
56550460|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550461|NCT03196180|Fluorouracil|fluorouracil|mesh-list
56550462|NCT03196180|Imiquimod|imiquimod|mesh-list
56550463|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
56550464|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550465|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56550466|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550467|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550468|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
56550469|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550470|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56550471|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
56550472|NCT00651781|Bortezomib|bortezomib|mesh-list
56550473|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550474|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
56550475|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56550476|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56550477|NCT00957801|Prednisolone|prednisolone|mesh-list
56550478|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
56550479|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
56550480|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56550481|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
56550482|NCT00957801|Testosterone|testosterone|mesh-list
56550483|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
56550488|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
56550489|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550490|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550491|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550492|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
56550493|NCT00957801|Hormones|hormones|mesh-ancestor
56550494|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550495|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56703306|NCT04107779|Menthol|menthol|mesh-list
56703307|NCT04107779|Nicotine|nicotine|mesh-list
56703308|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56703309|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
56703310|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703311|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703312|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56703313|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56703314|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
56703315|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703316|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703317|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
56703318|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
56703319|NCT04067505|Nadroparin|nadroparin|mesh-list
56703320|NCT04067505|Warfarin|warfarin|mesh-list
56703321|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
56703322|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
56703323|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56703324|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
56703325|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56703326|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
56703327|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703328|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703329|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56703330|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56703331|NCT00794963|Metformin|metformin|mesh-list
56703332|NCT00794963|Orlistat|orlistat|mesh-list
56703333|NCT00794963|Irbesartan|irbesartan|mesh-list
56703334|NCT00794963|Fenofibrate|fenofibrate|mesh-list
56703335|NCT00794963|Pravastatin|pravastatin|mesh-list
56703336|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56703354|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703355|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703356|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703357|NCT05673135|Antihypertensive Agents|antihypertensive agents|mesh-list
56414521|NCT00212082|Docetaxel|docetaxel|mesh-list
56703358|NCT00722709|Ropivacaine|ropivacaine|mesh-list
56703359|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
56703360|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
56703361|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56703362|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703363|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
56703364|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703365|NCT04105205|Apramycin|apramycin|mesh-list
56703366|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56703367|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703368|NCT00794573|Varenicline|varenicline|mesh-list
56703369|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56703370|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56703371|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
56703372|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703373|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703374|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703375|NCT05061654|Tazobactam|tazobactam|mesh-list
56703376|NCT05061654|Ceftolozane|ceftolozane|mesh-list
56703377|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56703378|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56703379|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258860|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56550496|NCT00957801|Protective Agents|protective agents|mesh-ancestor
56550497|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56550498|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550499|NCT00957801|Androgens|androgens|mesh-ancestor
56550500|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
56550501|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
56550502|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56550503|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56550504|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550505|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
56550506|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
56550507|NCT02646709|Ketamine|ketamine|mesh-list
56550508|NCT02646709|Rocuronium|rocuronium|mesh-list
56550509|NCT02646709|Analgesics|analgesics|mesh-ancestor
56550510|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
56550511|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550512|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550513|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56550514|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56550515|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
56703380|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56703381|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703382|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703383|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56703384|NCT05061654|Renal Agents|renal agents|mesh-ancestor
56703385|NCT04070079|Tenofovir|tenofovir|mesh-list
56703386|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
56703387|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703388|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56703389|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56703390|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703391|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703392|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56703393|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56703394|NCT00739934|Voriconazole|voriconazole|mesh-list
56703395|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
56703396|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703397|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56703398|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56703399|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703400|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703402|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
56703430|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56703431|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56703432|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56703433|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56703434|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56703435|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
56703436|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703437|NCT00713739|Urological Agents|urological agents|mesh-ancestor
56703438|NCT02595476|Remifentanil|remifentanil|mesh-list
56703439|NCT02595476|Propofol|propofol|mesh-list
56703440|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56703441|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56703442|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703443|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56703444|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
56703445|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
56703446|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56703447|NCT02595476|Narcotics|narcotics|mesh-ancestor
56703448|NCT02595476|Analgesics|analgesics|mesh-ancestor
56703449|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
56703450|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703485|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703486|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703487|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703488|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703489|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
56703490|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
56703491|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703492|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
56703493|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703494|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703495|NCT00920244|Atropine|atropine|mesh-list
56703496|NCT00920244|Amiodarone|amiodarone|mesh-list
56703497|NCT00920244|Epinephrine|epinephrine|mesh-list
56703498|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56703499|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56703500|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
56703501|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703502|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703503|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703504|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56703505|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56703506|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
56703507|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703508|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56414673|NCT02963051|Copper|copper|mesh-list
56703510|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
56703511|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
56703512|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56703513|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56703514|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56703515|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
56703516|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56703517|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56703518|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
56703527|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56703528|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56703529|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56703530|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
56703531|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703532|NCT00723879|Ribavirin|ribavirin|mesh-list
56703533|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56703534|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
56703535|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703536|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
56703537|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703538|NCT03907605|Hormones|hormones|mesh-list
56703539|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703540|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703541|NCT00435409|Capecitabine|capecitabine|mesh-list
56703542|NCT00435409|Sunitinib|sunitinib|mesh-list
56703543|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56703544|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
56703545|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703546|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703547|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56703548|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56703549|NCT00435409|Growth Substances|growth substances|mesh-ancestor
56703550|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703551|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
56703552|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56703553|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703554|NCT00724035|Fentanyl|fentanyl|mesh-list
56703555|NCT00724035|Midazolam|midazolam|mesh-list
56703556|NCT00724035|Analgesics|analgesics|mesh-list
56703557|NCT00724035|Anesthetics|anesthetics|mesh-list
56703558|NCT00724035|Ropivacaine|ropivacaine|mesh-list
56703565|NCT00724035|Narcotics|narcotics|mesh-ancestor
56703569|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56703570|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56703571|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56703572|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56703573|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
56703574|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
56703575|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56703576|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703577|NCT04126824|Triamcinolone|triamcinolone|mesh-list
56703578|NCT04126824|Bupivacaine|bupivacaine|mesh-list
56703579|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
56703580|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
56703581|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56703582|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703583|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
56703584|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703585|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703586|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
56703587|NCT04126824|Hormones|hormones|mesh-ancestor
56703588|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56703589|NCT00724113|Lidocaine|lidocaine|mesh-list
56703590|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
56703591|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
56703592|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56703593|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703594|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
56703595|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703596|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56703597|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56703598|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56703599|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56703600|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703601|NCT04070001|Ibuprofen|ibuprofen|mesh-list
56703602|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56703603|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56703604|NCT04070001|Analgesics|analgesics|mesh-ancestor
56550516|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
56703605|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
56703606|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703607|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703608|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703609|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703610|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56703611|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703612|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703613|NCT00435019|Insulin|insulin|mesh-list
56703614|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56703615|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
56703622|NCT00724581|Amiodarone|amiodarone|mesh-list
56703667|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
56703668|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703669|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703670|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56703671|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
56703672|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703673|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703674|NCT00577863|Teriparatide|teriparatide|mesh-list
56703675|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56703676|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703677|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56703678|NCT04663308|Volixibat|volixibat|mesh-list
56703679|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56703680|NCT04956627|Itraconazole|itraconazole|mesh-list
56703727|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703728|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56703729|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56703730|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
56703731|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703732|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56703733|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56703734|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
56703735|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
56703736|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56703737|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56703738|NCT00920088|Analgesics|analgesics|mesh-ancestor
56703739|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
56703740|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703741|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56703742|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56703743|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703744|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703745|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56703746|NCT04018833|Ranibizumab|ranibizumab|mesh-list
56703747|NCT04018833|Aflibercept|aflibercept|mesh-list
56703748|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56703749|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56703780|NCT04066881|Vaccines|vaccines|mesh-list
56703781|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
56703782|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703783|NCT04620291|UB-421|ub-421|mesh-list
56703784|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56703785|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
56703786|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703787|NCT04657068|Gemcitabine|gemcitabine|mesh-list
56703788|NCT04657068|Irinotecan|irinotecan|mesh-list
56703789|NCT04657068|Camptothecin|camptothecin|mesh-list
56703790|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56703791|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
56703792|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703793|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703794|NCT04657068|Antiviral Agents|antiviral agents|mesh-ancestor
56703795|NCT04657068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703796|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703797|NCT04657068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703798|NCT04657068|Immunologic Factors|immunologic factors|mesh-ancestor
56703799|NCT04657068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703800|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56703801|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56703802|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56703803|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56703804|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
56703805|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56703806|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703807|NCT00794417|Pemetrexed|pemetrexed|mesh-list
56703808|NCT00794417|Aflibercept|aflibercept|mesh-list
56703809|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703811|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703812|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56703813|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56703814|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56703815|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56259290|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
56550517|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550518|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56550519|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56703816|NCT00794417|Growth Substances|growth substances|mesh-ancestor
56703817|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703818|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
56703819|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56703820|NCT04406727|UB-421|ub-421|mesh-list
56703821|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
56703822|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703823|NCT04483206|Melphalan|melphalan|mesh-list
56703824|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56703825|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
56703826|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703827|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703828|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56703829|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703830|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
56703831|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703832|NCT00725829|Simvastatin|simvastatin|mesh-list
56703833|NCT00725829|Ezetimibe|ezetimibe|mesh-list
56703834|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56703835|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56703836|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
56703869|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703870|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703871|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56703872|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56703873|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703874|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56703875|NCT04471428|Docetaxel|docetaxel|mesh-list
56703876|NCT04471428|Atezolizumab|atezolizumab|mesh-list
56703877|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703878|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
56703879|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
56703880|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
56415045|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
56703881|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703882|NCT02603783|Capsaicin|capsaicin|mesh-list
56703883|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
56703884|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
56703885|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
56703886|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703887|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703888|NCT04254627|Etanercept|etanercept|mesh-list
56703889|NCT04254627|Mifepristone|mifepristone|mesh-list
56550520|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550521|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550522|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56550523|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56550524|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56550526|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56550527|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56550528|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56550529|NCT02640313|Choline|choline|mesh-list
56550530|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
56550531|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56550532|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
56550533|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550534|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550535|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56550536|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
56550537|NCT02953509|Gemcitabine|gemcitabine|mesh-list
56550538|NCT02953509|Rituximab|rituximab|mesh-list
56550539|NCT02953509|Magrolimab|magrolimab|mesh-list
56550540|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
56550541|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56550542|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550543|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
56550544|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550545|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56550546|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56550547|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
56550548|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550549|NCT02953509|Antiviral Agents|antiviral agents|mesh-ancestor
56550550|NCT02953509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550551|NCT02953509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550552|NCT02953509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703890|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56703891|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56703892|NCT04254627|Analgesics|analgesics|mesh-ancestor
56703893|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
56703894|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56703895|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703896|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56703897|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56703898|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56703899|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703900|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
56703901|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56703902|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
56703903|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56703904|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56703905|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56703906|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56703907|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
56703945|NCT04639986|Capecitabine|capecitabine|mesh-list
56703946|NCT04639986|Vinorelbine|vinorelbine|mesh-list
56703947|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56703948|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
56703949|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56703950|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56703951|NCT04639986|Antiviral Agents|antiviral agents|mesh-ancestor
56703952|NCT04639986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56703953|NCT04639986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415122|NCT00190307|Aspirin|aspirin|mesh-list
56703954|NCT04639986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56703955|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
56703956|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56703957|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56703958|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
56703959|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
56703960|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
56703961|NCT04126317|Aflibercept|aflibercept|mesh-list
56703962|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56704002|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56704003|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704004|NCT04110119|Diclofenac|diclofenac|mesh-list
56704005|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56704006|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56704007|NCT04110119|Analgesics|analgesics|mesh-ancestor
56704008|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
56704009|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704010|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704011|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704012|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704013|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56704014|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704015|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704016|NCT00726687|Capecitabine|capecitabine|mesh-list
56704017|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56704018|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
56704019|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704020|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704021|NCT00727077|Interferons|interferons|mesh-list
56704022|NCT00727077|Ribavirin|ribavirin|mesh-list
56704023|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
56704024|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
56704025|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704026|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
56704027|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704028|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
56704029|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704030|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
56704031|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704032|NCT02585388|Letrozole|letrozole|mesh-list
56704033|NCT02585388|Vinorelbine|vinorelbine|mesh-list
56550553|NCT02955823|Dexamethasone|dexamethasone|mesh-list
56550554|NCT02955823|Rituximab|rituximab|mesh-list
56550555|NCT02955823|Lenalidomide|lenalidomide|mesh-list
56550556|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56550557|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550560|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56550561|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550562|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
56550563|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
56550564|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550565|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550566|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
56704034|NCT02585388|Anastrozole|anastrozole|mesh-list
56704035|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704036|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56704037|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56704038|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704039|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704040|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56704041|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
56704042|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704043|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704044|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56704045|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
56704046|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
56704047|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
56704048|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56704049|NCT04080336|Misoprostol|misoprostol|mesh-list
56704050|NCT04080336|Dinoprostone|dinoprostone|mesh-list
56704051|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56704052|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
56704053|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56704054|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704055|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56704056|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56704057|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
56704058|NCT00793871|Sunitinib|sunitinib|mesh-list
56704059|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704060|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56704068|NCT05466474|Dacarbazine|dacarbazine|mesh-list
56704079|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56704080|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704081|NCT04066257|Metronidazole|metronidazole|mesh-list
56704082|NCT04066257|Tetracycline|tetracycline|mesh-list
56704083|NCT04066257|Bismuth|bismuth|mesh-list
56704084|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704085|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56704086|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56704087|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56704088|NCT04066257|Antacids|antacids|mesh-ancestor
56704089|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704090|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56704091|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56704092|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704093|NCT03655821|Pemetrexed|pemetrexed|mesh-list
56704094|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704095|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704096|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704097|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56704098|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56704099|NCT04524702|Gemcitabine|gemcitabine|mesh-list
56704100|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
56704101|NCT04524702|Paclitaxel|paclitaxel|mesh-list
56704102|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56704103|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56704104|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704105|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
56704106|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
56704107|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
56550567|NCT02955823|Hormones|hormones|mesh-ancestor
56550568|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550569|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56550570|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56550571|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56550572|NCT02955823|Growth Substances|growth substances|mesh-ancestor
56550573|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
56550574|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56550575|NCT02646397|Fosinopril|fosinopril|mesh-list
56550576|NCT02646397|Benidipine|benidipine|mesh-list
56550577|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56550578|NCT02646397|Diuretics|diuretics|mesh-ancestor
56550579|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
56550580|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550581|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56550582|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550583|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704108|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704109|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56704110|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
56704111|NCT04524702|Antiviral Agents|antiviral agents|mesh-ancestor
56704112|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704113|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704114|NCT04524702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704115|NCT04524702|Immunologic Factors|immunologic factors|mesh-ancestor
56704116|NCT04524702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704117|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
56704118|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56704119|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56704120|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704121|NCT00730197|Albuterol|albuterol|mesh-list
56704122|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56704123|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
56704124|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704125|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704126|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56704127|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
56704128|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
56704129|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56704130|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56704131|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56704132|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56704133|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
56704134|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704135|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704136|NCT00727545|Chelating Agents|chelating agents|mesh-list
56704137|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
56259618|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56550584|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56550585|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
56550586|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550587|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56550588|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56550589|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
56550590|NCT00652795|Doxycycline|doxycycline|mesh-list
56550591|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56550592|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550593|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
56550594|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56550595|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56550596|NCT00911170|Bevacizumab|bevacizumab|mesh-list
56704138|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704139|NCT02582892|Vitamin D|vitamin d|mesh-list
56704140|NCT02582892|Vitamins|vitamins|mesh-ancestor
56704141|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
56704142|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704143|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56704144|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
56704145|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
56704146|NCT00730509|Vitamins|vitamins|mesh-ancestor
56704147|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
56704148|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704149|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
56704150|NCT00730509|Hematinics|hematinics|mesh-ancestor
56704151|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
56704152|NCT02582736|Haloperidol|haloperidol|mesh-list
56704153|NCT02582736|Pimozide|pimozide|mesh-list
56704154|NCT02582736|Olanzapine|olanzapine|mesh-list
56704155|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
56550597|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56550598|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550599|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55984180|NCT04458610|Rituximab|rituximab|mesh-list
56550601|NCT00911170|Growth Substances|growth substances|mesh-ancestor
56550602|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550603|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
56550604|NCT00910975|Interferons|interferons|mesh-list
56550605|NCT00910975|Ribavirin|ribavirin|mesh-list
56550606|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
56298888|NCT04727437|Warfarin|warfarin|mesh-list
56550607|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
56550608|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56550609|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550610|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
56550611|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550612|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
56550613|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550614|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
56550615|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550616|NCT01167881|Glimepiride|glimepiride|mesh-list
56550617|NCT01167881|Empagliflozin|empagliflozin|mesh-list
56550618|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56550619|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56550620|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550621|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550622|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
56550623|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56550624|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550625|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
56550626|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56550627|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550628|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
56550629|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56550630|NCT02639767|Pemetrexed|pemetrexed|mesh-list
56550631|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550632|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550633|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550634|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56550635|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56550637|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
56550638|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
56550639|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704156|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
56704157|NCT02582736|Risperidone|risperidone|mesh-list
56704158|NCT02582736|Aripiprazole|aripiprazole|mesh-list
56704159|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56704160|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56704161|NCT02582736|Ziprasidone|ziprasidone|mesh-list
56704162|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
56704163|NCT02582736|Clozapine|clozapine|mesh-list
56704164|NCT02582736|Loxapine|loxapine|mesh-list
56704165|NCT02582736|Perphenazine|perphenazine|mesh-list
56704166|NCT02582736|Fluphenazine|fluphenazine|mesh-list
56704167|NCT02582736|Flupenthixol|flupenthixol|mesh-list
56704168|NCT02582736|Thioridazine|thioridazine|mesh-list
56704169|NCT02582736|Clopenthixol|clopenthixol|mesh-list
56704170|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
56704171|NCT02582736|Fluspirilene|fluspirilene|mesh-list
56704172|NCT02582736|Thiothixene|thiothixene|mesh-list
56704173|NCT02582736|Mesoridazine|mesoridazine|mesh-list
56704174|NCT02582736|Chlormezanone|chlormezanone|mesh-list
56704175|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
56704176|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56415374|NCT00221052|Diclofenac|diclofenac|mesh-list
56704177|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
56704178|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704179|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259665|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56550640|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550641|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
56550642|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550643|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
56550644|NCT00960063|Temozolomide|temozolomide|mesh-list
56550645|NCT00960063|Ifosfamide|ifosfamide|mesh-list
56550646|NCT00960063|Doxorubicin|doxorubicin|mesh-list
56550647|NCT00960063|Irinotecan|irinotecan|mesh-list
56550648|NCT00960063|Etoposide|etoposide|mesh-list
56550649|NCT00960063|Vincristine|vincristine|mesh-list
56550650|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550651|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
56550652|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550653|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56550654|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56550655|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
56550656|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550657|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550658|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56550659|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56550660|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56550661|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56550662|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550663|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56550664|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56550665|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
56550666|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
56550667|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
56550668|NCT02646319|Sirolimus|sirolimus|mesh-list
56550669|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56550670|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107433|NCT00003421|Etoposide|etoposide|mesh-list
56704180|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704181|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56704182|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704183|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56704184|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56704185|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
56704186|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
56704188|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704189|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56704190|NCT02582736|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56704191|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56704192|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56704193|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
56704194|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
56704195|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56704196|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56550671|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56550672|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550673|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
56550674|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550675|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
56550676|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550677|NCT00653965|Atorvastatin|atorvastatin|mesh-list
56550678|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56550679|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56550680|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56550681|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
56550682|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550683|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56550684|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56550685|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550686|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
56550687|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56550688|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56550689|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56550690|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56550691|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550692|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550693|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
56550694|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550695|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550696|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56550697|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550698|NCT00912340|Trastuzumab|trastuzumab|mesh-list
56550699|NCT00912340|Everolimus|everolimus|mesh-list
56550700|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56550701|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550702|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550703|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
56550704|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550705|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
56550708|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56550709|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550710|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550711|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
56550712|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704197|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56704198|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56704199|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56704200|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
56704201|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
56704202|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56704203|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
56704204|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56704205|NCT02582736|Analgesics|analgesics|mesh-ancestor
56704206|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
56704207|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56704208|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56704209|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56704210|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
56704211|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56704212|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56704213|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704214|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56704215|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56704216|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704217|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704218|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550713|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550714|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56550715|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550716|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56550717|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56550718|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550719|NCT01119846|Incretins|incretins|mesh-ancestor
56550720|NCT01119846|Hormones|hormones|mesh-ancestor
56550721|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550722|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56550723|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
56550724|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550725|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550726|NCT03775525|Capecitabine|capecitabine|mesh-list
56550727|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56550728|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
56550729|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550730|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550731|NCT00654043|Torsemide|torsemide|mesh-list
56550732|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56550733|NCT00654043|Diuretics|diuretics|mesh-ancestor
56550734|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
56550735|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550736|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56550737|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550738|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550739|NCT04167007|Gemcitabine|gemcitabine|mesh-list
56550740|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56704219|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56704220|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
56704221|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56704222|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704223|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56704224|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56704225|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56704226|NCT04396236|Lasmiditan|lasmiditan|mesh-list
56704227|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56704228|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
56704229|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704230|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704231|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704232|NCT00735345|Docetaxel|docetaxel|mesh-list
56704233|NCT00735345|Cetuximab|cetuximab|mesh-list
56704234|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704235|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
56704236|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
56704237|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
56704238|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704239|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56704240|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
56704241|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56704242|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704243|NCT00727935|Lidocaine|lidocaine|mesh-list
56704244|NCT00727935|Ropivacaine|ropivacaine|mesh-list
56704245|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
56704246|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
56704247|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550741|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
56550742|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550743|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550744|NCT04167007|Antiviral Agents|antiviral agents|mesh-ancestor
56550745|NCT04167007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550746|NCT04167007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550747|NCT04167007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550748|NCT04167007|Immunologic Factors|immunologic factors|mesh-ancestor
56550749|NCT04167007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550750|NCT03686332|Atezolizumab|atezolizumab|mesh-list
56550751|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56550752|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550753|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
56550754|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299039|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
56550755|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56550756|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56704248|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704249|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
56704250|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704251|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56704252|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56704253|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56704254|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56704255|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704256|NCT00728013|Atorvastatin|atorvastatin|mesh-list
56704257|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56704258|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56704259|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
56704260|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704261|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56704262|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56704263|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704264|NCT00577707|Pemetrexed|pemetrexed|mesh-list
56704265|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56704266|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704267|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704268|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704269|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56704270|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56704271|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56704272|NCT00730821|Nintedanib|nintedanib|mesh-list
56704273|NCT00730821|Afatinib|afatinib|mesh-list
56704274|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704275|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56704276|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704290|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
56704291|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56704292|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56704293|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
56704294|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704295|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704296|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704297|NCT04064619|Urological Agents|urological agents|mesh-ancestor
56704298|NCT00730977|Mannitol|mannitol|mesh-list
56704299|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56704300|NCT00730977|Diuretics|diuretics|mesh-ancestor
56704301|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
56704302|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704303|NCT00728715|Budesonide|budesonide|mesh-list
56704304|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
56704305|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704306|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56704307|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
56704308|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704309|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704310|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56704311|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
56704312|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
56704313|NCT00728715|Hormones|hormones|mesh-ancestor
56704314|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704315|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56704316|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56704317|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56704335|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56704337|NCT00731289|Protective Agents|protective agents|mesh-ancestor
56704338|NCT00736515|Insulin|insulin|mesh-list
56550758|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56550759|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56550760|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550761|NCT03421288|Leucovorin|leucovorin|mesh-list
56550762|NCT03421288|Docetaxel|docetaxel|mesh-list
56550763|NCT03421288|Fluorouracil|fluorouracil|mesh-list
56550764|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
56550765|NCT03421288|Atezolizumab|atezolizumab|mesh-list
56550766|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550767|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
56550768|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
56550769|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
56550770|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550771|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
56550772|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56550773|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550774|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
56550775|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550776|NCT03421288|Antidotes|antidotes|mesh-ancestor
56550777|NCT03421288|Protective Agents|protective agents|mesh-ancestor
56550778|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
56550781|NCT01166945|Amoxicillin|amoxicillin|mesh-list
56550782|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
56550783|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
56550784|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56550785|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56550786|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550787|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56550788|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550789|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550790|NCT02639533|Pregabalin|pregabalin|mesh-list
56550791|NCT02639533|Analgesics|analgesics|mesh-ancestor
56550792|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
56550793|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550794|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550795|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
56550796|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56550797|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550798|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550799|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56550800|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56550801|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56550802|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550803|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56550804|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
56550805|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56550806|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56550807|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550808|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
56550809|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
56550810|NCT00910000|Gemcitabine|gemcitabine|mesh-list
56550811|NCT00910000|Carboplatin|carboplatin|mesh-list
56550812|NCT00910000|Vorinostat|vorinostat|mesh-list
56550814|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56550815|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
56550816|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550817|NCT00910000|Antiviral Agents|antiviral agents|mesh-ancestor
56550818|NCT00910000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550819|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550820|NCT00910000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56550821|NCT00910000|Immunologic Factors|immunologic factors|mesh-ancestor
56550822|NCT00910000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550823|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56550824|NCT02885909|Insulin|insulin|mesh-list
56550825|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56550826|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550827|NCT05657171|Cyproterone Acetate|cyproterone acetate|mesh-list
56550828|NCT05657171|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56550829|NCT05657171|Estradiol|estradiol|mesh-list
56550830|NCT05657171|Cyproterone|cyproterone|mesh-list
56550831|NCT05657171|Estrogens|estrogens|mesh-ancestor
56550832|NCT05657171|Hormones|hormones|mesh-ancestor
56107434|NCT00003421|Vincristine|vincristine|mesh-list
56704339|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56704340|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
56704341|NCT00736515|Gliclazide|gliclazide|mesh-list
56704342|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56704343|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704344|NCT00045201|Irinotecan|irinotecan|mesh-list
56704345|NCT00045201|Camptothecin|camptothecin|mesh-list
56704346|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56704347|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56704348|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56704349|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704350|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704351|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704352|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56704353|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56704354|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56704355|NCT00731367|Laxatives|laxatives|mesh-ancestor
56704356|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56704357|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56704358|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56704359|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704360|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704361|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
56704362|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704363|NCT05601531|Calcitriol|calcitriol|mesh-list
56704364|NCT05601531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56704365|NCT05601531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704385|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56704386|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56704387|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704388|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704389|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
56704390|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704391|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56704392|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56704393|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
56704394|NCT00736983|Adalimumab|adalimumab|mesh-list
56704395|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704396|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704397|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56704398|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704399|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56704400|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56704401|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704402|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704403|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704404|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56704405|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56415568|NCT00123539|Estrogens|estrogens|mesh-list
56704437|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
56704438|NCT02569515|Hematinics|hematinics|mesh-ancestor
56704439|NCT00737373|Leucovorin|leucovorin|mesh-list
56704440|NCT00737373|Folic Acid|folic acid|mesh-list
56704441|NCT00737373|Docetaxel|docetaxel|mesh-list
56704442|NCT00737373|Fluorouracil|fluorouracil|mesh-list
56704443|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
56704444|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
56704445|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704446|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
56704447|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
56704448|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
56704449|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704450|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
56704451|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56550833|NCT05657171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550834|NCT05657171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550835|NCT05657171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56550837|NCT05657171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56550838|NCT05657171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56550839|NCT05657171|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56550840|NCT05657171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56550841|NCT05657171|Androgen Antagonists|androgen antagonists|mesh-ancestor
56550842|NCT05657171|Hormone Antagonists|hormone antagonists|mesh-ancestor
56550843|NCT05657171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550844|NCT05657171|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56550845|NCT00652873|Cabergoline|cabergoline|mesh-list
56550846|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56550847|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56550848|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
56550849|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
56550850|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550851|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550852|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550853|NCT00652171|Lamotrigine|lamotrigine|mesh-list
56550854|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
56550855|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56550857|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550858|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56550859|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550861|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56550862|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550863|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56550864|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56550865|NCT01119768|Esomeprazole|esomeprazole|mesh-list
56550866|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56550867|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550868|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56550869|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550870|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550871|NCT01165307|Naproxen|naproxen|mesh-list
56550872|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
56550873|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
56550874|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
56550875|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56550876|NCT01165307|Estradiol|estradiol|mesh-list
56550877|NCT01165307|Estrogens|estrogens|mesh-ancestor
56550878|NCT01165307|Hormones|hormones|mesh-ancestor
56550879|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550880|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550881|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56550882|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56704452|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704453|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
56704454|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704455|NCT00737373|Antidotes|antidotes|mesh-ancestor
56704456|NCT00737373|Protective Agents|protective agents|mesh-ancestor
56704457|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
56704458|NCT00737373|Vitamins|vitamins|mesh-ancestor
56704459|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
56704460|NCT00737373|Hematinics|hematinics|mesh-ancestor
56704461|NCT00729495|Celecoxib|celecoxib|mesh-list
56704462|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56704463|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56704464|NCT00729495|Analgesics|analgesics|mesh-ancestor
56704465|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
56704466|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704467|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704468|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704469|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704470|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56704471|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56704472|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704473|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704474|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
56704475|NCT00737685|Fludarabine|fludarabine|mesh-list
56704476|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
56704477|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704478|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
56704479|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704480|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56415625|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704481|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56704482|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
56550883|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56550884|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56550885|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56550886|NCT01165307|Analgesics|analgesics|mesh-ancestor
56550887|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
56550888|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550889|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550890|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56550891|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
56550892|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56550893|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550894|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704483|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704484|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704485|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56704486|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
56704487|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56704488|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
56704489|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704490|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704491|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56704492|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
56704493|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56704494|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
56704495|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704496|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704497|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56704498|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
56704499|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
56704500|NCT00732537|Protective Agents|protective agents|mesh-ancestor
56704501|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56704502|NCT00732693|Norethindrone|norethindrone|mesh-list
56704503|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
56704504|NCT00732693|Estradiol|estradiol|mesh-list
56704505|NCT00732693|Progesterone|progesterone|mesh-list
56704506|NCT00732693|Estrogens|estrogens|mesh-ancestor
56704507|NCT00732693|Hormones|hormones|mesh-ancestor
56704508|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550895|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56550896|NCT02639143|Clopidogrel|clopidogrel|mesh-list
56550897|NCT02639143|Ticagrelor|ticagrelor|mesh-list
56550898|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56550899|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56550900|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56550901|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56550902|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
56550903|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550904|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550905|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550906|NCT02644057|Dobutamine|dobutamine|mesh-list
56550907|NCT02644057|Milrinone|milrinone|mesh-list
56550908|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56550909|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
56550910|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
56550911|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550912|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550913|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56550914|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56550915|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56550916|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
56550917|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704509|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704510|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56704511|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
56704512|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56704513|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56704514|NCT00732693|Progestins|progestins|mesh-ancestor
56704515|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56704516|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56704517|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56704518|NCT00729963|Sibutramine|sibutramine|mesh-list
56704519|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
56704520|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56704521|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
56704522|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56704523|NCT00737997|Morphine|morphine|mesh-list
56704524|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56704525|NCT00737997|Narcotics|narcotics|mesh-ancestor
56704567|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
56704568|NCT00712335|Fluticasone|fluticasone|mesh-list
56704569|NCT00712335|Xhance|xhance|mesh-list
56704570|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56704571|NCT00712335|Montelukast|montelukast|mesh-list
56704572|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
56704573|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704574|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56704575|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
56704576|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704577|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704578|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56704579|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
56704580|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
56704581|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56704582|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56704583|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56704584|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56704585|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
56704586|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704587|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704588|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
56704589|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704618|NCT00738621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56704619|NCT00738621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704620|NCT00738621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56704621|NCT00738621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56704622|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56704623|NCT00733239|Cycloserine|cycloserine|mesh-list
56704624|NCT00733239|Verapamil|verapamil|mesh-list
56704625|NCT00733239|Diltiazem|diltiazem|mesh-list
56704626|NCT00733239|Isradipine|isradipine|mesh-list
56704627|NCT00733239|Nifedipine|nifedipine|mesh-list
56704628|NCT00733239|Gabapentin|gabapentin|mesh-list
56704629|NCT00733239|Naloxone|naloxone|mesh-list
56704630|NCT00733239|Analgesics|analgesics|mesh-ancestor
56704631|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
56704632|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704633|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704634|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
56704635|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56704636|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56550918|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550919|NCT02644057|Protective Agents|protective agents|mesh-ancestor
56550920|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56550921|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
56550922|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56550923|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56550924|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550925|NCT00654277|Ondansetron|ondansetron|mesh-list
56550926|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
56550927|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
56550942|NCT01124838|Prednisone|prednisone|mesh-list
56550943|NCT01124838|Adalimumab|adalimumab|mesh-list
56550944|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550945|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
56550946|NCT01124838|Hormones|hormones|mesh-ancestor
56550947|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550948|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550949|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56550950|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550951|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56550952|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56550953|NCT00630435|Estrogens|estrogens|mesh-ancestor
56550954|NCT00630435|Hormones|hormones|mesh-ancestor
56550955|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550956|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550957|NCT02858193|Carbocysteine|carbocysteine|mesh-list
56550958|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56550959|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56550960|NCT02858193|Expectorants|expectorants|mesh-ancestor
56550961|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
56550962|NCT02581215|Ramucirumab|ramucirumab|mesh-list
56550963|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550965|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56550966|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56550967|NCT04282941|Analgesics|analgesics|mesh-ancestor
56550968|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
56550969|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550970|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550971|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550972|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56550973|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56704637|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704638|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56704639|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56704640|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56704641|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704642|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704643|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
56704644|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56704645|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56704646|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56704647|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56704648|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
56704649|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
56704650|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56704651|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56704652|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704653|NCT00733239|Renal Agents|renal agents|mesh-ancestor
56704654|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56704655|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
56704656|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56704657|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
56704658|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56704659|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56704660|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
56704661|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56704662|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704663|NCT04065165|Lanreotide|lanreotide|mesh-list
56704664|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704665|NCT00577629|Cytarabine|cytarabine|mesh-list
56704666|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
56704667|NCT00577629|Rituximab|rituximab|mesh-list
56550974|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56550975|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550976|NCT00910858|Lenalidomide|lenalidomide|mesh-list
56550977|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
56550978|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
56550979|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550980|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56550981|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56550982|NCT00910858|Growth Substances|growth substances|mesh-ancestor
56550983|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
56550984|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550985|NCT00910858|Hematinics|hematinics|mesh-ancestor
56550987|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56550988|NCT02859285|Estradiol|estradiol|mesh-list
56704668|NCT00577629|Doxorubicin|doxorubicin|mesh-list
56704669|NCT00577629|Etoposide|etoposide|mesh-list
56704670|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704671|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
56704672|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704673|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704674|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56704675|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
56704676|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704677|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704678|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56704679|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56704680|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56704681|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56704682|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56704683|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704684|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56704685|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56704686|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
56704687|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
56704688|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704689|NCT00733317|Budesonide|budesonide|mesh-list
56704690|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704691|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56704692|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
56704693|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704694|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704695|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56704696|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
56704712|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704713|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704714|NCT00733473|Budesonide|budesonide|mesh-list
56704715|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704716|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56550989|NCT02859285|Estrogens|estrogens|mesh-ancestor
56550990|NCT02859285|Hormones|hormones|mesh-ancestor
56550991|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550992|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550994|NCT04260412|Cathartics|cathartics|mesh-ancestor
56550995|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550996|NCT03223155|Nivolumab|nivolumab|mesh-list
56550997|NCT03223155|Ipilimumab|ipilimumab|mesh-list
56550998|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56550999|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551000|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56551001|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551002|NCT04476550|Lenograstim|lenograstim|mesh-list
56551003|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56551004|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
56551005|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551006|NCT00598975|Irinotecan|irinotecan|mesh-list
56551007|NCT00598975|Cetuximab|cetuximab|mesh-list
56551008|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
56551009|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56551010|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56551011|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551012|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551013|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551014|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551015|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56551016|NCT01124604|Tapentadol|tapentadol|mesh-list
56551017|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56551018|NCT01124604|Narcotics|narcotics|mesh-ancestor
56551019|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551020|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551021|NCT01124604|Analgesics|analgesics|mesh-ancestor
56551022|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
56551023|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551024|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56551025|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56551026|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56551027|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551028|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
56551029|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551030|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56551031|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
56551032|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56551033|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
56551034|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56551035|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551036|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56551037|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56551038|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551039|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
56551040|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551041|NCT01124448|Growth Substances|growth substances|mesh-ancestor
56551042|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551043|NCT02638909|Ceritinib|ceritinib|mesh-list
56551044|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551045|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56551046|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551047|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551048|NCT02643823|Methotrexate|methotrexate|mesh-list
56551049|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
56551050|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56551051|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
56551052|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56551053|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704717|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
56704718|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704719|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704720|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56704721|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
56704722|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
56704723|NCT00733473|Hormones|hormones|mesh-ancestor
56704724|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704725|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56704726|NCT00710385|Buprenorphine|buprenorphine|mesh-list
56704727|NCT00710385|Heroin|heroin|mesh-list
56704728|NCT00710385|Naloxone|naloxone|mesh-list
56704729|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56260222|NCT01939743|Analgesics|analgesics|mesh-ancestor
56551054|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56551055|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
56551056|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551057|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551058|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
56551059|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551060|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56551061|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551062|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
56551063|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56551067|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56551068|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56551069|NCT02638831|Analgesics|analgesics|mesh-ancestor
56551070|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
56551071|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551072|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551073|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56551074|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56551075|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56551076|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551077|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551078|NCT01136772|Haloperidol|haloperidol|mesh-list
56551079|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56551080|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
56551081|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56551082|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56551083|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551084|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551085|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56551086|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56551087|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56551088|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
56551089|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551090|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551091|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56551092|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56551093|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
56551094|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
56551095|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
56551096|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551097|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56551098|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56551099|NCT00909532|Ivacaftor|ivacaftor|mesh-list
56551100|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56551101|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56551102|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704730|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704731|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
56704732|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704733|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56704734|NCT00710385|Narcotics|narcotics|mesh-ancestor
56704735|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704736|NCT00710385|Analgesics|analgesics|mesh-ancestor
56704737|NCT04063527|Paclitaxel|paclitaxel|mesh-list
56704738|NCT04063527|Carboplatin|carboplatin|mesh-list
56704739|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56704740|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704741|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
56704742|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
56704743|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
56704744|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704745|NCT00738777|Tamoxifen|tamoxifen|mesh-list
56704746|NCT00738777|Fulvestrant|fulvestrant|mesh-list
56704747|NCT00738777|Anastrozole|anastrozole|mesh-list
56704748|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56704749|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
56260234|NCT01939886|Mefloquine|mefloquine|mesh-list
56551103|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56551104|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551105|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551106|NCT01136382|Budesonide|budesonide|mesh-list
56551107|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56551108|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56551109|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
56551110|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551111|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551112|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56551113|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
56551114|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
56551115|NCT01136382|Hormones|hormones|mesh-ancestor
56551116|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551117|NCT03513562|Venetoclax|venetoclax|mesh-list
56551118|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551119|NCT04257448|Gemcitabine|gemcitabine|mesh-list
56551120|NCT04257448|Paclitaxel|paclitaxel|mesh-list
56551121|NCT04257448|Lenalidomide|lenalidomide|mesh-list
56551122|NCT04257448|Azacitidine|azacitidine|mesh-list
56551123|NCT04257448|Durvalumab|durvalumab|mesh-list
56551124|NCT04257448|Romidepsin|romidepsin|mesh-list
56551125|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56551126|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551127|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
56551128|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
56551129|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
56551130|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551131|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56551132|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
56551133|NCT04257448|Antiviral Agents|antiviral agents|mesh-ancestor
56551134|NCT04257448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551135|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551136|NCT04257448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551137|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
56551138|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107435|NCT00003421|Dacarbazine|dacarbazine|mesh-list
56704750|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704751|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704752|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56704753|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704754|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56704755|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56704756|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56704757|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56704758|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56704759|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56704760|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704761|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704762|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
56704763|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56704764|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704765|NCT05549661|Onvansertib|onvansertib|mesh-list
56551140|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551141|NCT04257448|Growth Substances|growth substances|mesh-ancestor
56551142|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551143|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551144|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56551145|NCT02731729|Nivolumab|nivolumab|mesh-list
56551146|NCT02731729|Ipilimumab|ipilimumab|mesh-list
56551147|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551148|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551149|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56551150|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551151|NCT02645461|Palmidrol|palmidrol|mesh-list
56551152|NCT02645461|Riluzole|riluzole|mesh-list
56551153|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
56551154|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56551155|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56551156|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551157|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551158|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551159|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56551160|NCT02645461|Protective Agents|protective agents|mesh-ancestor
56551161|NCT02645461|Analgesics|analgesics|mesh-ancestor
56551162|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
56551163|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551164|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56551165|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56551166|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56551167|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56551168|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
56551169|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551170|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56551171|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56551172|NCT02645461|Hormones|hormones|mesh-ancestor
56551173|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551174|NCT00654589|Deferasirox|deferasirox|mesh-list
56551175|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56551176|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
56551177|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
56551178|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704766|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56704767|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704768|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704769|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56704770|NCT04063449|Endostar protein|endostar protein|mesh-list
56704771|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704772|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704773|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56704774|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56704775|NCT04063449|Growth Substances|growth substances|mesh-ancestor
56704776|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704777|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
56704778|NCT00700011|Clofarabine|clofarabine|mesh-list
56704779|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56704780|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
56704781|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704782|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704783|NCT05512767|Capecitabine|capecitabine|mesh-list
56415920|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
56704784|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56704785|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
56704786|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704787|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704788|NCT02567955|Vaccines|vaccines|mesh-list
56704789|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
56704790|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704791|NCT02568423|Mirikizumab|mirikizumab|mesh-list
56704792|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56704793|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56704794|NCT02568423|Analgesics|analgesics|mesh-ancestor
56551179|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56551180|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56551181|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56551182|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
56551183|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551184|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56551185|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56551186|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551187|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56551188|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56551189|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56551190|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56704795|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
56704796|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704797|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704798|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704799|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704800|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56704801|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56704802|NCT00921063|Alprazolam|alprazolam|mesh-list
56704803|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56704804|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56704805|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704806|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56704807|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56704808|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56704809|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
56704810|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
56704811|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704812|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704813|NCT00707031|Metformin|metformin|mesh-list
56704814|NCT00707031|Exenatide|exenatide|mesh-list
56704815|NCT00707031|Lixisenatide|lixisenatide|mesh-list
56704816|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56704817|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704818|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56704819|NCT00707031|Incretins|incretins|mesh-ancestor
56704820|NCT00707031|Hormones|hormones|mesh-ancestor
56704821|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704822|NCT00711477|Naltrexone|naltrexone|mesh-list
56704823|NCT00711477|Bupropion|bupropion|mesh-list
56704824|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56704825|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56704826|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704827|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
56704828|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551191|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56551192|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56551193|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56551194|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
56551195|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551196|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551197|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551198|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
56704829|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56704830|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
56704831|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56704832|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56704833|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56704834|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56704835|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704836|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
56704837|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704838|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56704839|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56704840|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704841|NCT00734474|Metformin|metformin|mesh-list
56704842|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56704843|NCT00734474|Dulaglutide|dulaglutide|mesh-list
56704844|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56704845|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551199|NCT01119066|Melphalan|melphalan|mesh-list
56551200|NCT01119066|Busulfan|busulfan|mesh-list
56551201|NCT01119066|Thiotepa|thiotepa|mesh-list
56551202|NCT01119066|Fludarabine|fludarabine|mesh-list
56551203|NCT01119066|Clofarabine|clofarabine|mesh-list
56551204|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551205|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
56551206|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551207|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56551208|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56551209|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
56551210|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551211|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551213|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56551214|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
56551215|NCT00910624|Ribavirin|ribavirin|mesh-list
56551216|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56551217|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
56551218|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551219|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
56551220|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551221|NCT00654667|Resveratrol|resveratrol|mesh-list
56551222|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
56551223|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551224|NCT00654667|Protective Agents|protective agents|mesh-ancestor
56551225|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551226|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551227|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56551228|NCT01123980|Insulin|insulin|mesh-list
56551229|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56551230|NCT01123980|Metformin|metformin|mesh-list
56551231|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
56551232|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
56551233|NCT01123980|Glimepiride|glimepiride|mesh-list
56551234|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
56551235|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56551236|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56551237|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551238|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56551239|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551240|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
56704846|NCT00734474|Incretins|incretins|mesh-ancestor
56704847|NCT00734474|Hormones|hormones|mesh-ancestor
56704848|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704849|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56704850|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
56704851|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704852|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704853|NCT00583362|Belimumab|belimumab|mesh-list
56704854|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704855|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
56704856|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704857|NCT00577473|Mesalamine|mesalamine|mesh-list
56704858|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56415994|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704860|NCT00577473|Analgesics|analgesics|mesh-ancestor
56704861|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
56704862|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56704863|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704864|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56704865|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704866|NCT00740103|Semapimod|semapimod|mesh-list
56704867|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56704868|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56704869|NCT00740103|Analgesics|analgesics|mesh-ancestor
56704895|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56704896|NCT02568111|Interferons|interferons|mesh-list
56704897|NCT02568111|Interferon-beta|interferon-beta|mesh-list
56704898|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
56704899|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56704900|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704901|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
56704902|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704903|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
56704904|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704905|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56704906|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56704907|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56704908|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56704909|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
56704910|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56704911|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704912|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56704913|NCT05711667|Acetic Acid|acetic acid|mesh-list
56704914|NCT05711667|Letermovir|letermovir|mesh-list
56704915|NCT05711667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56704916|NCT05711667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704917|NCT05711667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704918|NCT05711667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704919|NCT05711667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704920|NCT05711667|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56704921|NCT05711667|Antiviral Agents|antiviral agents|mesh-ancestor
56704922|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
56704923|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
56704924|NCT04384692|Melphalan|melphalan|mesh-list
56704925|NCT04384692|Busulfan|busulfan|mesh-list
56704926|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
56704927|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56704928|NCT04384692|Methotrexate|methotrexate|mesh-list
56704929|NCT04384692|Fludarabine|fludarabine|mesh-list
56704930|NCT04384692|Tacrolimus|tacrolimus|mesh-list
56704931|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704934|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56704935|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56704936|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
56704937|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704938|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704939|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56704940|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56704941|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
56704942|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56704943|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56704944|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
56704945|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
56704946|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56704947|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56704948|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56704949|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56704950|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56704951|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56704952|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
56704953|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56704954|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704955|NCT00785291|Paclitaxel|paclitaxel|mesh-list
56704956|NCT00785291|Epothilones|epothilones|mesh-list
56704957|NCT00785291|Epothilone B|epothilone b|mesh-list
56704958|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56704959|NCT00785291|Bevacizumab|bevacizumab|mesh-list
56704960|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56551241|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56551242|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56551243|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56551244|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56551245|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
56551246|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551247|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56551248|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56551249|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551250|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56551251|NCT04164823|Analgesics|analgesics|mesh-list
56551252|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
56551253|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551254|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551256|NCT02857959|Penicillin G|penicillin g|mesh-list
56551257|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56551258|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
56551259|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56551260|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56704961|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
56704962|NCT00785291|Antibodies|antibodies|mesh-list
56704963|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
56704964|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56704965|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
56704966|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56704967|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704968|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
56704969|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
56704970|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
56704971|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704972|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56704973|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56704974|NCT00785291|Growth Substances|growth substances|mesh-ancestor
56704975|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704976|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
56704977|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
56704978|NCT05501769|Everolimus|everolimus|mesh-list
56704979|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704980|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56704981|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
56704982|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56704983|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56704984|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56704985|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
56704986|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
56704987|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56704988|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56704989|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704990|NCT04655157|Nivolumab|nivolumab|mesh-list
56704991|NCT04655157|Ipilimumab|ipilimumab|mesh-list
56704992|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56704993|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56704994|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56704995|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56704996|NCT00740259|Flunarizine|flunarizine|mesh-list
56551261|NCT02643433|Vaccines|vaccines|mesh-list
56551262|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
56107436|NCT00003421|Vinblastine|vinblastine|mesh-list
56704997|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
56704998|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56704999|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56705000|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705001|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56705002|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705003|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56705004|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
56705005|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
56705006|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705007|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
56705008|NCT05700045|Dexmedetomidine|dexmedetomidine|mesh-list
56416182|NCT00192842|Curcumin|curcumin|mesh-list
56705009|NCT05700045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56705010|NCT05700045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705011|NCT05700045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705012|NCT05700045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56705014|NCT05700045|Sensory System Agents|sensory system agents|mesh-ancestor
56705015|NCT05700045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705016|NCT05700045|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56705017|NCT05700045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56705018|NCT05700045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56705019|NCT05700045|Adrenergic Agents|adrenergic agents|mesh-ancestor
56705020|NCT05700045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551263|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551264|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
56551265|NCT00632476|Vitamins|vitamins|mesh-ancestor
56551266|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
56551267|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551268|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
56551269|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551270|NCT00632476|Protective Agents|protective agents|mesh-ancestor
56551271|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
56551272|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551273|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551274|NCT03770338|Teriparatide|teriparatide|mesh-list
56551275|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56551276|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551277|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56551278|NCT01198522|Gemcitabine|gemcitabine|mesh-list
56551279|NCT01198522|Antibodies|antibodies|mesh-list
56551280|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56551281|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
56551282|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551283|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56551284|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
56551285|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551286|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705021|NCT05700045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705022|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
56705023|NCT04063839|Grazoprevir|grazoprevir|mesh-list
56705024|NCT04063839|Ledipasvir|ledipasvir|mesh-list
56705025|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56705026|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
56705027|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705028|NCT04079088|Interferons|interferons|mesh-list
56705029|NCT04079088|Interferon-beta|interferon-beta|mesh-list
56705030|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
56705031|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
56705032|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
56705033|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551287|NCT01198522|Antiviral Agents|antiviral agents|mesh-ancestor
56551289|NCT01198522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551290|NCT01198522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551292|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56551293|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
56551294|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551295|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551296|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56551297|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
56551298|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56551299|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56551300|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56551301|NCT01134250|Paclitaxel|paclitaxel|mesh-list
56551302|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56551303|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551304|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
56551305|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
56551306|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
56551307|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551308|NCT01118520|Amlodipine|amlodipine|mesh-list
56551309|NCT01118520|Perindopril|perindopril|mesh-list
56551310|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56551311|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56551312|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56551313|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551314|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56551315|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551316|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
56551317|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56551318|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
56551319|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551320|NCT01135992|Insulin|insulin|mesh-list
56551321|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56551322|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
56551323|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56551324|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551325|NCT03734770|Progesterone|progesterone|mesh-list
56551326|NCT03734770|Progestins|progestins|mesh-ancestor
56551327|NCT03734770|Hormones|hormones|mesh-ancestor
56551328|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551329|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551331|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
56551332|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551333|NCT00956943|Nicotine|nicotine|mesh-list
56551334|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56551335|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
56551336|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551337|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551338|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56551339|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56551340|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
56705034|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
56705035|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705036|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
56705037|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260539|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
56551341|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551342|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551343|NCT01135914|Ranibizumab|ranibizumab|mesh-list
56551344|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551345|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551346|NCT01135914|Growth Substances|growth substances|mesh-ancestor
56551347|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551348|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551349|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551350|NCT00907738|Vorinostat|vorinostat|mesh-list
56551351|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551352|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56551353|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551354|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551355|NCT02829723|Spartalizumab|spartalizumab|mesh-list
56551356|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56551357|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551358|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551359|NCT01123356|Lenalidomide|lenalidomide|mesh-list
56551360|NCT01123356|Ofatumumab|ofatumumab|mesh-list
56551361|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
56551363|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551364|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551365|NCT01123356|Growth Substances|growth substances|mesh-ancestor
56551366|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551367|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551369|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
56551370|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
56551371|NCT02858817|Atovaquone|atovaquone|mesh-list
56551372|NCT02858817|Proguanil|proguanil|mesh-list
56551373|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56551374|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551375|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
56551376|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56551377|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56551378|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551379|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551380|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
56551381|NCT02883192|Ondansetron|ondansetron|mesh-list
56551382|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
56551383|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
56551384|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551385|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551386|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56551387|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
56551388|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
56551389|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56551390|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
56551391|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551392|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551393|NCT02883192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56551394|NCT02883192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56551395|NCT02883192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551396|NCT02883192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56551397|NCT02883192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56551398|NCT03922048|Bupivacaine|bupivacaine|mesh-list
56551399|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
56551400|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
56551401|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551402|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551403|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
56551404|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551405|NCT00632554|Prednisolone|prednisolone|mesh-list
56551406|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56551407|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
56551408|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56551409|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
56705038|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56705039|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56705040|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56705041|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
56705042|NCT00785213|Quinine|quinine|mesh-list
56705043|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56705044|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705045|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
56705046|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56705047|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56705048|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551410|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56551411|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
56551412|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56551413|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
56551414|NCT00632554|Hormones|hormones|mesh-ancestor
56551415|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551416|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551417|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56551418|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551419|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
56551420|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
56551421|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551422|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56551423|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56551424|NCT00632554|Protective Agents|protective agents|mesh-ancestor
56551425|NCT03082209|Bevacizumab|bevacizumab|mesh-list
56551426|NCT03082209|Venetoclax|venetoclax|mesh-list
56551427|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551428|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551429|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551430|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551431|NCT03082209|Growth Substances|growth substances|mesh-ancestor
56551432|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551433|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551434|NCT02224144|Vitamin D|vitamin d|mesh-list
56551435|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
56551436|NCT02224144|Calcitriol|calcitriol|mesh-list
56551437|NCT02224144|Vitamins|vitamins|mesh-ancestor
56551439|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551440|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56551441|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56551442|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56551443|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56551444|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551445|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56551447|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
56551448|NCT04280289|Cannabidiol|cannabidiol|mesh-list
56551449|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
56551450|NCT03302728|Lenalidomide|lenalidomide|mesh-list
56551451|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56551452|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
56551453|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551454|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551455|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551456|NCT03302728|Growth Substances|growth substances|mesh-ancestor
56551457|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551458|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551459|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551460|NCT03839914|Vancomycin|vancomycin|mesh-list
56551461|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56551462|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551463|NCT03832972|Estrogens|estrogens|mesh-list
56551464|NCT03832972|Hormones|hormones|mesh-ancestor
56551465|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551466|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551467|NCT02860299|Heparin|heparin|mesh-list
56705049|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56705050|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56705051|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705052|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56705053|NCT00785213|Analgesics|analgesics|mesh-ancestor
56705054|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
56705055|NCT02583594|Loratadine|loratadine|mesh-list
56705056|NCT02583594|Acyclovir|acyclovir|mesh-list
56705057|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
56705058|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
56705059|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56705060|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56705061|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
56705062|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
56705063|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705064|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705065|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56705066|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
56705067|NCT02583594|Hormones|hormones|mesh-ancestor
56705068|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56705069|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56705070|NCT02583594|Protective Agents|protective agents|mesh-ancestor
56705071|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705104|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705105|NCT00734162|Tenofovir|tenofovir|mesh-list
56705106|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
56705107|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705108|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56705109|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56705110|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705111|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705112|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56705113|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56705114|NCT04342572|Melphalan|melphalan|mesh-list
56551468|NCT02860299|Calcium heparin|calcium heparin|mesh-list
56551469|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
56551470|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551471|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56551472|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56551473|NCT05374564|Flutemetamol|flutemetamol|mesh-list
56551474|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56551475|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551476|NCT02858505|Iron|iron|mesh-list
56551477|NCT02858505|Trace Elements|trace elements|mesh-ancestor
56551478|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
56551479|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551480|NCT01518556|Idarubicin|idarubicin|mesh-list
56551481|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56551482|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551483|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56551484|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56551485|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551486|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551487|NCT03002103|Gemcitabine|gemcitabine|mesh-list
56551488|NCT03002103|Paclitaxel|paclitaxel|mesh-list
56551489|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56551490|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551491|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
56551492|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
56551493|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
56551494|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551495|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56551496|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
56551497|NCT03002103|Antiviral Agents|antiviral agents|mesh-ancestor
56551498|NCT03002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551499|NCT03002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551500|NCT03002103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551501|NCT03002103|Immunologic Factors|immunologic factors|mesh-ancestor
56551502|NCT03002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551503|NCT02994069|Cisplatin|cisplatin|mesh-list
56551504|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551505|NCT02860221|Epinephrine|epinephrine|mesh-list
56551506|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
56551507|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56551508|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56551509|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551510|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
56551511|NCT02860221|Coagulants|coagulants|mesh-ancestor
56551512|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56551516|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551517|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56551518|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56551520|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551521|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56551522|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
56551523|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
56551524|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
56705115|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56705116|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
56705117|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705118|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705119|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56705120|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56705121|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
56705122|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705123|NCT00740493|Warfarin|warfarin|mesh-list
56705124|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
56705125|NCT00740571|Pregabalin|pregabalin|mesh-list
56705126|NCT00740571|Amitriptyline|amitriptyline|mesh-list
56705127|NCT00740571|Analgesics|analgesics|mesh-ancestor
56705128|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
56705129|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705130|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705131|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
56705132|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56705133|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56705134|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705168|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705169|NCT02595242|Prednisone|prednisone|mesh-list
56705170|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
56705171|NCT02595242|Vincristine|vincristine|mesh-list
56705172|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56705173|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
56705174|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705175|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56705176|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56705177|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
56705178|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705179|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705180|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56705181|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56705182|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
56705183|NCT02595242|Hormones|hormones|mesh-ancestor
56705184|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56705185|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56260667|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56551525|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56551526|NCT01874353|Olaparib|olaparib|mesh-list
56551527|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56551528|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551529|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551530|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551531|NCT02857569|Nivolumab|nivolumab|mesh-list
56551532|NCT02857569|Ipilimumab|ipilimumab|mesh-list
56551533|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551534|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551535|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56551536|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551537|NCT04164355|Tadalafil|tadalafil|mesh-list
56551538|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
56551539|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56551540|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56551541|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551542|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551543|NCT04164355|Urological Agents|urological agents|mesh-ancestor
56551544|NCT01605253|Eszopiclone|eszopiclone|mesh-list
56551545|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56551546|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551547|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551548|NCT00655135|Vedolizumab|vedolizumab|mesh-list
56551549|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56551551|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56551552|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551553|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56551554|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551555|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
56551556|NCT02635867|Calcium|calcium|mesh-list
56551557|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56551558|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551559|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56551560|NCT00955305|Paclitaxel|paclitaxel|mesh-list
56705186|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56705187|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
56705188|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
56705189|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
56705190|NCT04487106|Azacitidine|azacitidine|mesh-list
56705191|NCT04487106|Venetoclax|venetoclax|mesh-list
56705192|NCT04487106|Trametinib|trametinib|mesh-list
56705193|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705194|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
56705195|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705196|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705197|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705198|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56705199|NCT00740883|Warfarin|warfarin|mesh-list
56705200|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
56705201|NCT02568033|Paclitaxel|paclitaxel|mesh-list
56705202|NCT02568033|Docetaxel|docetaxel|mesh-list
56705203|NCT02568033|Carboplatin|carboplatin|mesh-list
56705204|NCT02568033|Pemetrexed|pemetrexed|mesh-list
56260687|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56551561|NCT00955305|Bevacizumab|bevacizumab|mesh-list
56551562|NCT00955305|Carboplatin|carboplatin|mesh-list
56551563|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56551564|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551565|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
56551566|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
56551567|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
56551568|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551569|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551570|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551571|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551572|NCT00955305|Growth Substances|growth substances|mesh-ancestor
56551573|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551574|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551575|NCT00656695|Cyclosporine|cyclosporine|mesh-list
56551576|NCT00656695|Cyclosporins|cyclosporins|mesh-list
56551577|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
56551578|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551579|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
56551580|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551581|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551582|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551583|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
56299871|NCT00020488|Leucovorin|leucovorin|mesh-list
56551584|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551585|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56551586|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56551587|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
56551588|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56551589|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
56551590|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551591|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
56551592|NCT04204083|Protective Agents|protective agents|mesh-ancestor
56551593|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
56551594|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
56551595|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56551596|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56551597|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551598|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705205|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56705206|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705207|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
56705208|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
56705209|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
56705210|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705211|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705212|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56705213|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56705214|NCT00582972|Omeprazole|omeprazole|mesh-list
56705215|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56705216|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56705217|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56705218|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705219|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705220|NCT05224401|Amoxicillin|amoxicillin|mesh-list
56705221|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
56705222|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56705223|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
56705224|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
56705225|NCT05224401|Ertapenem|ertapenem|mesh-list
56705226|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
56705227|NCT05224401|Trimethoprim|trimethoprim|mesh-list
56705228|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
56551599|NCT00598585|Urological Agents|urological agents|mesh-ancestor
56551600|NCT02815995|Durvalumab|durvalumab|mesh-list
56551601|NCT02815995|Tremelimumab|tremelimumab|mesh-list
56551602|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551603|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551604|NCT02635243|Glucagon|glucagon|mesh-list
56551605|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551606|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56551607|NCT02635243|Hormones|hormones|mesh-ancestor
56551608|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551609|NCT00953667|Niacin|niacin|mesh-list
56551610|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56551611|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
56551612|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551613|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56551614|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
56551615|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
56551616|NCT00953667|Vitamins|vitamins|mesh-ancestor
56551617|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
56551618|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551619|NCT02857491|Ranibizumab|ranibizumab|mesh-list
56551620|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551621|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551622|NCT02857491|Growth Substances|growth substances|mesh-ancestor
56551623|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551624|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551625|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551626|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
56551627|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
56705229|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56705230|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705231|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56705232|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56705233|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705234|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705235|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56416370|NCT00193388|Topotecan|topotecan|mesh-list
56705236|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56705237|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56705238|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56705239|NCT05224401|Renal Agents|renal agents|mesh-ancestor
56705240|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
56705241|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56705242|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56705243|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56705244|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56551628|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551629|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
56551630|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551631|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56551632|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56551633|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
56551634|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551635|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551636|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56551637|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56551638|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56551639|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
56551640|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56551641|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551642|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551643|NCT02856867|Leucovorin|leucovorin|mesh-list
56551644|NCT02856867|Fluorouracil|fluorouracil|mesh-list
56551645|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
56551646|NCT02856867|Nintedanib|nintedanib|mesh-list
56551647|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
56551648|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551649|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56551650|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551651|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551652|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
56551653|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551654|NCT02856867|Antidotes|antidotes|mesh-ancestor
56551655|NCT02856867|Protective Agents|protective agents|mesh-ancestor
56299947|NCT00020644|Immunologic Factors|immunologic factors|mesh-ancestor
56551656|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
56551657|NCT02856867|Vitamins|vitamins|mesh-ancestor
56551658|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
56551659|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56551662|NCT00630513|Ertapenem|ertapenem|mesh-list
56551663|NCT00630513|Sulbactam|sulbactam|mesh-list
56551664|NCT00630513|Sultamicillin|sultamicillin|mesh-list
56551665|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56551666|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551667|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56551668|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551669|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705245|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56705246|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56705247|NCT00918086|Vitamin D|vitamin d|mesh-list
56705248|NCT00918086|Vitamins|vitamins|mesh-ancestor
56705249|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
56705250|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705251|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56705252|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
56705253|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
56705254|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
56705255|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705256|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705257|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
56705258|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705259|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
56705260|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260743|NCT01943058|Megestrol|megestrol|mesh-list
56551670|NCT02157051|Vaccines|vaccines|mesh-list
56551671|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
56551672|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551673|NCT01208662|Dexamethasone|dexamethasone|mesh-list
56551674|NCT01208662|Lenalidomide|lenalidomide|mesh-list
56551675|NCT01208662|Bortezomib|bortezomib|mesh-list
56551676|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56551677|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
56551678|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
56551679|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551680|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551681|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56551682|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
56551683|NCT01208662|Hormones|hormones|mesh-ancestor
56551684|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551685|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56551686|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551687|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
56551688|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551689|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551690|NCT01208662|Growth Substances|growth substances|mesh-ancestor
55956589|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
56551691|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551692|NCT05287360|Apatinib|apatinib|mesh-list
56551693|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551694|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56551695|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551696|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551697|NCT00954447|Linagliptin|linagliptin|mesh-list
56551698|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56551699|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551700|NCT00954447|Incretins|incretins|mesh-ancestor
56551701|NCT00954447|Hormones|hormones|mesh-ancestor
56551702|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551703|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56551704|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
56551705|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551706|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551707|NCT00903760|Decitabine|decitabine|mesh-list
56551708|NCT00903760|Clofarabine|clofarabine|mesh-list
56551709|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56551710|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
56705261|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705262|NCT04366908|Calcifediol|calcifediol|mesh-list
56551711|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551712|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551713|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551714|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
56551715|NCT05273554|Lenvatinib|lenvatinib|mesh-list
56551716|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551717|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551718|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56551719|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551720|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551721|NCT05177614|Micronutrients|micronutrients|mesh-list
56551722|NCT05177614|Trace Elements|trace elements|mesh-list
56551723|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551724|NCT02823028|Nicotine|nicotine|mesh-list
56551725|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56551726|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
56551727|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551728|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551729|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56551730|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56551731|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
56551732|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551733|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551736|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551737|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56551738|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56551739|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551740|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551741|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56551742|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56551744|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56551745|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551746|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56551747|NCT02794402|Incretins|incretins|mesh-ancestor
56551748|NCT02794402|Hormones|hormones|mesh-ancestor
56551749|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551750|NCT00883051|Lasmiditan|lasmiditan|mesh-list
56551751|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56551752|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
56551753|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551754|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551755|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551756|NCT02783092|Cannabidiol|cannabidiol|mesh-list
56551757|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
56551758|NCT03395587|Temozolomide|temozolomide|mesh-list
56551759|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56551760|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
56551761|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334801|NCT00071136|Antiviral Agents|antiviral agents|mesh-ancestor
56551762|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551764|NCT00903682|Etravirine|etravirine|mesh-list
56551765|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56551766|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56551767|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551768|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551769|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
56551770|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551771|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56551772|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56551773|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56551774|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56551775|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56551776|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56551777|NCT00655603|Pancrelipase|pancrelipase|mesh-list
56551778|NCT00655603|Hormones|hormones|mesh-list
56551779|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551780|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551781|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56551782|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56705263|NCT04366908|Vitamins|vitamins|mesh-ancestor
56705264|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
56705265|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705266|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56705267|NCT04102020|Azacitidine|azacitidine|mesh-list
56705268|NCT04102020|Venetoclax|venetoclax|mesh-list
56705269|NCT04102020|Cc-486|cc-486|mesh-list
56705270|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705271|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
56705272|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705273|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705274|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705275|NCT00711243|Docetaxel|docetaxel|mesh-list
56705276|NCT00711243|Fluorouracil|fluorouracil|mesh-list
56705277|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
56705278|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705279|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
56705280|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
56705281|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
56705282|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705283|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
56705284|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705285|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56705286|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
56705287|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705288|NCT04366518|Scopolamine|scopolamine|mesh-list
56705289|NCT04366518|Rivastigmine|rivastigmine|mesh-list
56705290|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56705291|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56705292|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882754|NCT04509258|Antidotes|antidotes|mesh-ancestor
56551783|NCT00655681|Pamidronate|pamidronate|mesh-list
56551784|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56551785|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551786|NCT04221568|Fentanyl|fentanyl|mesh-list
56551787|NCT04221568|Bupivacaine|bupivacaine|mesh-list
56551788|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
56551789|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
56551790|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
56551791|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551792|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551793|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
56551794|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551795|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56551796|NCT04221568|Narcotics|narcotics|mesh-ancestor
56551797|NCT04221568|Analgesics|analgesics|mesh-ancestor
56551798|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56107437|NCT00003421|Procarbazine|procarbazine|mesh-list
56705293|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705294|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
56705295|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705296|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705297|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56551799|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56551800|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
56551801|NCT01135524|Buprenorphine|buprenorphine|mesh-list
56551802|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56551803|NCT01135524|Narcotics|narcotics|mesh-ancestor
56551804|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551805|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551806|NCT01135524|Analgesics|analgesics|mesh-ancestor
56551810|NCT00948675|Paclitaxel|paclitaxel|mesh-list
56551811|NCT00948675|Bevacizumab|bevacizumab|mesh-list
56551812|NCT00948675|Carboplatin|carboplatin|mesh-list
56551813|NCT00948675|Pemetrexed|pemetrexed|mesh-list
56551814|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56551815|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551816|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
56551817|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
56551818|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
56551819|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551820|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56551821|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551822|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551823|NCT00948675|Growth Substances|growth substances|mesh-ancestor
56551824|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551825|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551826|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551827|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56551828|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56551829|NCT02642497|Ketamine|ketamine|mesh-list
56551830|NCT02642497|Analgesics|analgesics|mesh-ancestor
56551831|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
56551832|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551833|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551834|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56551835|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56551836|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
56551837|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
56551838|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551839|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56551840|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56551841|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551842|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551843|NCT04273581|Thalidomide|thalidomide|mesh-list
56551844|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56551845|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
56551846|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551847|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
56551848|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56551849|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551850|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551851|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551852|NCT04273581|Growth Substances|growth substances|mesh-ancestor
56551853|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551854|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551855|NCT01110408|Amoxicillin|amoxicillin|mesh-list
56551856|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
56551857|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
56551858|NCT01110408|Cefepime|cefepime|mesh-list
56551859|NCT01110408|Doripenem|doripenem|mesh-list
56551860|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56551861|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56551862|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551863|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56551864|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551865|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551866|NCT00953043|Lubiprostone|lubiprostone|mesh-list
56705298|NCT04366518|Protective Agents|protective agents|mesh-ancestor
56705299|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56705300|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
56705301|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
56705302|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705303|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56705304|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
56705305|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56705306|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56705307|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
56705308|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
56705309|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56705310|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
56705311|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705312|NCT04076436|Fosfomycin|fosfomycin|mesh-list
56705313|NCT04076436|Lactams|lactams|mesh-list
56705314|NCT04076436|beta-Lactams|beta-lactams|mesh-list
56705315|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56705316|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705317|NCT05526417|Coal Tar|coal tar|mesh-list
56705318|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
56705319|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
56705320|NCT04096170|Lidocaine|lidocaine|mesh-list
56705321|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
56705322|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
56705323|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705324|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551867|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56551868|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56551869|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551870|NCT02850484|Budesonide|budesonide|mesh-list
56551871|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
56551872|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56551873|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56551874|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
56551875|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551876|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551877|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56551878|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
56551880|NCT02850484|Hormones|hormones|mesh-ancestor
56551881|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551882|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56551883|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56551884|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56551885|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
56551886|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551887|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551888|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
56551889|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56551890|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
56551891|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56705325|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
56705326|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705327|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56705328|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56705329|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56705330|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56705331|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705332|NCT00741117|Bilirubin|bilirubin|mesh-list
56705333|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
56705334|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705335|NCT00741117|Protective Agents|protective agents|mesh-ancestor
56705336|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705337|NCT00732992|Pemetrexed|pemetrexed|mesh-list
56705338|NCT00732992|Sunitinib|sunitinib|mesh-list
56705339|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705340|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705341|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705342|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56705343|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56705344|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56705345|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56705346|NCT00732992|Growth Substances|growth substances|mesh-ancestor
56705347|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705348|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
56705349|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56705350|NCT00741195|Bevacizumab|bevacizumab|mesh-list
56705351|NCT00741195|Docetaxel|docetaxel|mesh-list
56705352|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705353|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836000|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
56551892|NCT00948441|Ethanol|ethanol|mesh-list
56551893|NCT00948441|Heparin|heparin|mesh-list
56551894|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
56551895|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56551896|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56551897|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551898|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56551899|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551900|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551901|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551902|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
56551903|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56705354|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56705355|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56705356|NCT00741195|Growth Substances|growth substances|mesh-ancestor
56705357|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705358|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
56705359|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
56705360|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
56705361|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
56705362|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705363|NCT05338632|Naloxone|naloxone|mesh-list
56705364|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56705365|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705366|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
56705367|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705368|NCT00732758|Vitamin D|vitamin d|mesh-list
56260838|NCT01943760|Tramadol|tramadol|mesh-list
56551904|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56551905|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551906|NCT00630903|Methoxsalen|methoxsalen|mesh-list
56551907|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56551908|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
56551909|NCT02883426|Vaccines|vaccines|mesh-list
56551910|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
56551911|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551912|NCT02849548|Suvorexant|suvorexant|mesh-list
56551913|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56551914|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56551915|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551916|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551917|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56551918|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551919|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551920|NCT02849236|Ropivacaine|ropivacaine|mesh-list
56551921|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
56551922|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
56551923|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56551924|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551925|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
56551926|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551927|NCT02856789|Hemostatics|hemostatics|mesh-list
56551928|NCT02856789|Coagulants|coagulants|mesh-ancestor
56551929|NCT01117350|Metformin|metformin|mesh-list
56551930|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
56551931|NCT01117350|Liraglutide|liraglutide|mesh-list
56551932|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56551933|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551934|NCT01117350|Incretins|incretins|mesh-ancestor
56551935|NCT01117350|Hormones|hormones|mesh-ancestor
56551936|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551937|NCT00952731|Tamoxifen|tamoxifen|mesh-list
56551938|NCT00952731|Afimoxifene|afimoxifene|mesh-list
56551939|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56551940|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
56551941|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56551942|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551943|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56551944|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551945|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56551946|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56705369|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
56705370|NCT00732758|Vitamins|vitamins|mesh-ancestor
56705371|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
56705372|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705373|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56705374|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56705375|NCT04082754|Antibodies|antibodies|mesh-list
56705376|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56705377|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
56705378|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705379|NCT00741351|Fentanyl|fentanyl|mesh-list
56705380|NCT00741351|Remifentanil|remifentanil|mesh-list
56551947|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56551948|NCT04202224|Acetaminophen|acetaminophen|mesh-list
56551949|NCT04202224|Ibuprofen|ibuprofen|mesh-list
56551950|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56551951|NCT04202224|Analgesics|analgesics|mesh-ancestor
56551952|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
56551955|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
56551956|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56551957|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56551958|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56551959|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56551960|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551961|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551962|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56551963|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
56551964|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551966|NCT02848612|Calcium heparin|calcium heparin|mesh-list
56551967|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
56551968|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56551969|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56551970|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551971|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56551972|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56551973|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56551974|NCT04235062|Furosemide|furosemide|mesh-list
56551975|NCT04235062|Calcium|calcium|mesh-list
56551976|NCT04235062|Diuretics|diuretics|mesh-list
56551977|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56551978|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56551979|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551980|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
56551981|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56551982|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551984|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56551985|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551986|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56551987|NCT02848768|Growth Substances|growth substances|mesh-ancestor
56551988|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551989|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
56551990|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56551991|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551992|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56551993|NCT02848300|Bimatoprost|bimatoprost|mesh-list
56551994|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56551995|NCT00953745|Aripiprazole|aripiprazole|mesh-list
56551996|NCT00953745|Citalopram|citalopram|mesh-list
56551997|NCT00953745|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56551998|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56551999|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56552000|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552001|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705381|NCT00741351|Propofol|propofol|mesh-list
56705382|NCT00741351|Sevoflurane|sevoflurane|mesh-list
56705383|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56705384|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705385|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705386|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56705387|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
56705388|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
56705389|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56705390|NCT00741351|Narcotics|narcotics|mesh-ancestor
56705391|NCT00741351|Analgesics|analgesics|mesh-ancestor
56705392|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
56705393|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705394|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56705395|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56705396|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56705397|NCT05580003|Midazolam|midazolam|mesh-list
56552002|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
56552003|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552004|NCT00953745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56552005|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
56552006|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56552007|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56552008|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56552009|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552010|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
56552011|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
56552012|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56552013|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56552014|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56552015|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56552016|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56552017|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56552018|NCT04202380|Azithromycin|azithromycin|mesh-list
56552019|NCT04202380|Ampicillin|ampicillin|mesh-list
56552020|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552021|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552022|NCT02847442|Levodopa|levodopa|mesh-list
56552023|NCT02847442|Opicapone|opicapone|mesh-list
56552024|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
56552025|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
56552028|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
56552029|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552030|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552031|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552032|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56552033|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552034|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56552035|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
56552036|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56552037|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
56552038|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56552039|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552040|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56552041|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56552042|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552043|NCT04716712|Azithromycin|azithromycin|mesh-list
56552044|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552045|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705398|NCT05580003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56705399|NCT05580003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56705400|NCT05580003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705401|NCT05580003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705402|NCT05580003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56705403|NCT05580003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56705404|NCT05580003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56705405|NCT05580003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56705406|NCT05580003|Anesthetics, General|anesthetics, general|mesh-ancestor
56705407|NCT05580003|Anesthetics|anesthetics|mesh-ancestor
56705408|NCT05580003|GABA Modulators|gaba modulators|mesh-ancestor
56705409|NCT05580003|GABA Agents|gaba agents|mesh-ancestor
56705410|NCT05580003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705411|NCT05580003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552046|NCT01478698|Plasminogen|plasminogen|mesh-list
56552047|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56552048|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56552049|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56552050|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552051|NCT01199380|Nicotine|nicotine|mesh-list
56552052|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56552053|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
56480196|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
56552054|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552055|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552056|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56552057|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56552058|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
56552059|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552060|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552061|NCT02847286|Dapivirine|dapivirine|mesh-list
56552062|NCT02847286|Clotrimazole|clotrimazole|mesh-list
56552063|NCT02847286|Miconazole|miconazole|mesh-list
56552064|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56552065|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56552066|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
56552067|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552068|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56552069|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
56552070|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56552071|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56552072|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552073|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552074|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56552075|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
56552076|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552077|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552078|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56552079|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56552080|NCT00902668|Lovastatin|lovastatin|mesh-list
56552081|NCT00902668|L 647318|l 647318|mesh-list
56552082|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
56552083|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56552084|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56552085|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
56552086|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552087|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56552088|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56552089|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552090|NCT00433420|Paclitaxel|paclitaxel|mesh-list
56552091|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
56705412|NCT02582190|Colchicine|colchicine|mesh-list
56705413|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
56705414|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56705415|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
56705416|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
56705417|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
56705418|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705419|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705420|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56705421|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56705422|NCT04277442|Nivolumab|nivolumab|mesh-list
56705423|NCT04277442|Decitabine|decitabine|mesh-list
56705424|NCT04277442|Venetoclax|venetoclax|mesh-list
56705425|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705426|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552092|NCT00433420|Fluorouracil|fluorouracil|mesh-list
56552093|NCT00433420|Epirubicin|epirubicin|mesh-list
56552094|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56552095|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552096|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
56552097|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
56552100|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56552101|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
56552102|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552103|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552104|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56552105|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
56552106|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56552107|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
56300402|NCT00000146|Prednisone|prednisone|mesh-list
56552108|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56552109|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56552110|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56552111|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56552112|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552113|NCT05014828|Lenvatinib|lenvatinib|mesh-list
56552114|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552115|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56552116|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552117|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552118|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
56552119|NCT04202068|Sulbactam|sulbactam|mesh-list
56552120|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552121|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552122|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56552123|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552124|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552125|NCT02850250|Cefuroxime|cefuroxime|mesh-list
56552126|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
56552127|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552128|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552129|NCT05012644|Palbociclib|palbociclib|mesh-list
56552130|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56552131|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552132|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56552133|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552134|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552135|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56552136|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56552137|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
56552138|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552139|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705427|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56705428|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705429|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705430|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
56705431|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705432|NCT05742243|Insulin|insulin|mesh-list
56705433|NCT05742243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56705434|NCT05742243|Abatacept|abatacept|mesh-list
56705435|NCT05742243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56705436|NCT05742243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705437|NCT05742243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56705438|NCT05742243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705439|NCT05742243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705440|NCT05742243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56705441|NCT05742243|Immunologic Factors|immunologic factors|mesh-ancestor
56705442|NCT05742243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56705443|NCT04076748|Sufentanil|sufentanil|mesh-list
56705444|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56705445|NCT04076748|Narcotics|narcotics|mesh-ancestor
56260901|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
56552140|NCT02846506|Metformin|metformin|mesh-list
56552141|NCT02846506|Canagliflozin|canagliflozin|mesh-list
56552142|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56552143|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552144|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56552145|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552146|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
56552147|NCT02846428|Docetaxel|docetaxel|mesh-list
56552148|NCT02846428|Fluorouracil|fluorouracil|mesh-list
56552149|NCT02846428|Capecitabine|capecitabine|mesh-list
56552150|NCT02846428|Epirubicin|epirubicin|mesh-list
56552151|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56552152|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
56552153|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552154|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552155|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56552156|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
56552157|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552158|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552159|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56552160|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
56552161|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
56552162|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
56552163|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
56552164|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56552165|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56552166|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56552167|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56552168|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552169|NCT03561376|Petrolatum|petrolatum|mesh-list
56552172|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
56552173|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
56552174|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56552175|NCT03561376|Protective Agents|protective agents|mesh-ancestor
56552176|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552177|NCT02844712|beta-Lactams|beta-lactams|mesh-list
56552178|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56705446|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705447|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705448|NCT04076748|Analgesics|analgesics|mesh-ancestor
56705449|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
56705450|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705451|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56705452|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56705453|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
56705454|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
56705455|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
56705456|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
56705457|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705458|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
56705459|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56705460|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56705461|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56705462|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56705463|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705464|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
56705465|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705466|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705467|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56705468|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705469|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
56705470|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56705471|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56260917|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552179|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552180|NCT00947349|Interferons|interferons|mesh-list
56552181|NCT00947349|Ribavirin|ribavirin|mesh-list
56552182|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552183|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
56552184|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552185|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
56552186|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552187|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56552188|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56552189|NCT03425812|Analgesics|analgesics|mesh-ancestor
56552190|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
56552191|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552192|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552193|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552194|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552195|NCT02845804|Everolimus|everolimus|mesh-list
56552196|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552197|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56552198|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
56107438|NCT00003421|Chlorambucil|chlorambucil|mesh-list
56705472|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705473|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
56705474|NCT04272606|Coagulants|coagulants|mesh-ancestor
56705475|NCT04262466|Pembrolizumab|pembrolizumab|mesh-list
56705476|NCT04262466|Atezolizumab|atezolizumab|mesh-list
56705477|NCT04262466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705478|NCT04262466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705479|NCT04255602|Ticagrelor|ticagrelor|mesh-list
56705480|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56705481|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56705482|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56705483|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56705484|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
56705485|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705486|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552199|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552200|NCT02844634|Tenofovir|tenofovir|mesh-list
56552201|NCT02844634|Emtricitabine|emtricitabine|mesh-list
56552202|NCT02844634|Doxycycline|doxycycline|mesh-list
56552203|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
56552204|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552205|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56552206|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56552207|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552208|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552209|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56552210|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56552211|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552212|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
56552213|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56552214|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56552215|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56552216|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
56552217|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552218|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552219|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552220|NCT00952419|Vaccines|vaccines|mesh-list
56552221|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
56552222|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552223|NCT02844322|Rituximab|rituximab|mesh-list
56552224|NCT02844322|Bortezomib|bortezomib|mesh-list
56552225|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56552226|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552227|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
56552228|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552229|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552230|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56552231|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56552232|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552233|NCT01996605|Oxytocin|oxytocin|mesh-list
56552234|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
56552235|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56552236|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552237|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56552238|NCT00630981|Citalopram|citalopram|mesh-list
56552239|NCT00630981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56552240|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56552241|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56552242|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705487|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705488|NCT00738530|Interferons|interferons|mesh-list
56705489|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
56705490|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
56705491|NCT00738530|Bevacizumab|bevacizumab|mesh-list
56705492|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705493|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705494|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56705495|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56705496|NCT00738530|Growth Substances|growth substances|mesh-ancestor
56705497|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705498|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
56705499|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
56705500|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705501|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
56705502|NCT04077684|Interleukin-2|interleukin-2|mesh-list
56705503|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705504|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56705505|NCT04077684|Analgesics|analgesics|mesh-ancestor
56705506|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
56705507|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705508|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705509|NCT00711009|Ritonavir|ritonavir|mesh-list
56705510|NCT00711009|Lopinavir|lopinavir|mesh-list
56705511|NCT00711009|Tenofovir|tenofovir|mesh-list
56705512|NCT00711009|Emtricitabine|emtricitabine|mesh-list
56705513|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
56705514|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56705515|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56705516|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56705517|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
56705518|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552243|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552244|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
56552248|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56552249|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56552250|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56552251|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552252|NCT00952341|Dexamethasone|dexamethasone|mesh-list
56552253|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
56552254|NCT00952341|Aprepitant|aprepitant|mesh-list
56552255|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
56552256|NCT00952341|Granisetron|granisetron|mesh-list
56552257|NCT00952341|BB 1101|bb 1101|mesh-list
56552258|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552259|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
56705519|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705520|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56705521|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56705522|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
56705523|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705524|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56705525|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56705526|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56705527|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56705528|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56705529|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56705530|NCT05674656|Dolutegravir|dolutegravir|mesh-list
56705531|NCT05674656|Rilpivirine|rilpivirine|mesh-list
56705532|NCT05674656|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
56705533|NCT05674656|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56705534|NCT05674656|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56705535|NCT05674656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705536|NCT05674656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705537|NCT05674656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56705538|NCT05674656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56705539|NCT05674656|Antiviral Agents|antiviral agents|mesh-ancestor
56705570|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705571|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
56705572|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705573|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705574|NCT00577005|Levetiracetam|levetiracetam|mesh-list
56705575|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
56705576|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
56705577|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
56705578|NCT02581566|Bupivacaine|bupivacaine|mesh-list
56705579|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
56705580|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
56705581|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705582|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705583|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
56705584|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705585|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56705586|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56705587|NCT02581566|Analgesics|analgesics|mesh-ancestor
56705588|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56705589|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56705590|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56705591|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
56705592|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705593|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705594|NCT04209192|Amikacin|amikacin|mesh-list
56705595|NCT04209192|Fosfomycin|fosfomycin|mesh-list
56705596|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56705597|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705598|NCT04003506|Bupivacaine|bupivacaine|mesh-list
56705599|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
56705600|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
56705601|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705602|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705603|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
56705604|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705609|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705610|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705611|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
56705612|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705613|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56705614|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
56705615|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56705616|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56705617|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705618|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56705619|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705620|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56705621|NCT04062357|Lidocaine|lidocaine|mesh-list
56705622|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
56705623|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
56705624|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705625|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705626|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
56705627|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705628|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56705629|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56705630|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56705631|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56705632|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705633|NCT04482309|Trastuzumab|trastuzumab|mesh-list
56705634|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705635|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705636|NCT05190120|Ropivacaine|ropivacaine|mesh-list
56705637|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
56705638|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
56261079|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
56552260|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
56300552|NCT02024607|Leucovorin|leucovorin|mesh-list
56552261|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552262|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552263|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56552264|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
56552265|NCT00952341|Hormones|hormones|mesh-ancestor
56552266|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552267|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56705639|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705640|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705641|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
56705642|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705643|NCT00738374|Rituximab|rituximab|mesh-list
56705644|NCT00738374|Chlorambucil|chlorambucil|mesh-list
56705645|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705646|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705647|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
56705648|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705649|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56705650|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56705651|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
56705652|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705653|NCT02581176|Apixaban|apixaban|mesh-list
56705654|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56705655|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
56705656|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56705657|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
56705658|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705659|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705660|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
56705661|NCT00697593|Antibodies|antibodies|mesh-list
56705662|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56705663|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
56705664|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552268|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552269|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
56552270|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552271|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552272|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56552273|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552274|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56552275|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
56552276|NCT02845024|Doxycycline|doxycycline|mesh-list
56552277|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552278|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552279|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
56552280|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56552281|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56552282|NCT05242120|Anesthetics|anesthetics|mesh-list
56552283|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552284|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552285|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
56552286|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
56552287|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
56552288|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552289|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705665|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56705666|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56705667|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56705668|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
56705669|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56705670|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705671|NCT04183452|Progestins|progestins|mesh-ancestor
56705672|NCT04183452|Hormones|hormones|mesh-ancestor
56705673|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56705674|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56705675|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56705676|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705677|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705678|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56705679|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56705680|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705681|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
56705682|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705683|NCT04445025|Leuprolide|leuprolide|mesh-list
56705684|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56705685|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
56705686|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56705687|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705688|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56261133|NCT05410483|Docetaxel|docetaxel|mesh-list
56552290|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
56552291|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552292|NCT02844790|Insulin|insulin|mesh-list
56552293|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
56552294|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56552295|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552296|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
56552297|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552298|NCT04410328|Aspirin|aspirin|mesh-list
56552299|NCT04410328|Dipyridamole|dipyridamole|mesh-list
56552300|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56552301|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56552302|NCT04410328|Analgesics|analgesics|mesh-ancestor
56552303|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
56552304|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552305|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552306|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552307|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552308|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56552309|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56552310|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552311|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56552312|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56552313|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705689|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705690|NCT02580474|Asunaprevir|asunaprevir|mesh-list
56705691|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
56705692|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705693|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705694|NCT04166604|Trifluridine|trifluridine|mesh-list
56705695|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
56705696|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705697|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
56705698|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705699|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
56705700|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56705701|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
56705702|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56705703|NCT00738062|Droxidopa|droxidopa|mesh-list
56705704|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56705705|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56705706|NCT04156074|Vitamin D|vitamin d|mesh-list
56705707|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
56705708|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
56705709|NCT04156074|Vitamins|vitamins|mesh-list
56705710|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
56705711|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705712|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56705713|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56705714|NCT04062045|Ropivacaine|ropivacaine|mesh-list
56705715|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
56705716|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
56705717|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705721|NCT03733314|Quetmolimab|quetmolimab|mesh-list
56705737|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705738|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
56705739|NCT03709680|Temozolomide|temozolomide|mesh-list
56705740|NCT03709680|Irinotecan|irinotecan|mesh-list
56705741|NCT03709680|Topotecan|topotecan|mesh-list
56705742|NCT03709680|Palbociclib|palbociclib|mesh-list
56705743|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56705744|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
56705745|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705746|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56705747|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56705748|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
56705749|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705750|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705751|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56705752|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56705753|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56705754|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705755|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56705756|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
56705757|NCT04995003|Nivolumab|nivolumab|mesh-list
56705758|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56261204|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56552314|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
56552315|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56552316|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
56552319|NCT02852577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56552320|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56552321|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56552322|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552323|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552324|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
56552325|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552326|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56552327|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
56552328|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56552329|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56552330|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56552331|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552332|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
56552333|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
56552334|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
56552335|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
56552337|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56552338|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
56552339|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552340|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552341|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56552342|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
56552343|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552344|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552345|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56552346|NCT04201990|Apatinib|apatinib|mesh-list
56705759|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705760|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552347|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552348|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56552349|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552350|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552351|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
56552352|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
56552353|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56552354|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56552355|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552356|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552357|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552358|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552359|NCT00901186|Ranibizumab|ranibizumab|mesh-list
56552360|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56552361|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56552362|NCT00901186|Growth Substances|growth substances|mesh-ancestor
56552363|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552364|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
56552365|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552366|NCT05040880|Telmisartan|telmisartan|mesh-list
56552367|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56552368|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56552369|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56552370|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552371|NCT04073290|Rifaximin|rifaximin|mesh-list
56552372|NCT04073290|Lactulose|lactulose|mesh-list
56552373|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552374|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552375|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56552376|NCT03763162|Dexamethasone|dexamethasone|mesh-list
56552377|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
56552378|NCT03763162|Bortezomib|bortezomib|mesh-list
56552379|NCT03763162|Daratumumab|daratumumab|mesh-list
56552380|NCT03763162|Ixazomib|ixazomib|mesh-list
56552381|NCT03763162|Ichthammol|ichthammol|mesh-list
56552382|NCT03763162|BB 1101|bb 1101|mesh-list
56552383|NCT03763162|Glycine|glycine|mesh-list
56552384|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552385|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
56552386|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
56552387|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552388|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552389|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56552390|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
56552391|NCT03763162|Hormones|hormones|mesh-ancestor
56552392|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552395|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
56552396|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552397|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552398|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
56552399|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
56552400|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56334829|NCT00067509|Estrogens|estrogens|mesh-list
56552408|NCT03936790|Ropivacaine|ropivacaine|mesh-list
56552409|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
56552410|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
56300716|NCT00023725|Semaxinib|semaxinib|mesh-list
56552411|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552412|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552413|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
56552414|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552415|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56552416|NCT03936790|Narcotics|narcotics|mesh-ancestor
56552417|NCT03936790|Analgesics|analgesics|mesh-ancestor
56552418|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56552419|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56552420|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
56552421|NCT04782700|Prednisone|prednisone|mesh-list
56552422|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552423|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
56552424|NCT04782700|Hormones|hormones|mesh-ancestor
56552425|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552426|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108467|NCT00003133|Doxorubicin|doxorubicin|mesh-list
56705761|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705762|NCT03505320|Leucovorin|leucovorin|mesh-list
56705763|NCT03505320|Folic Acid|folic acid|mesh-list
56705764|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
56705765|NCT03505320|Nivolumab|nivolumab|mesh-list
56705766|NCT03505320|Fluorouracil|fluorouracil|mesh-list
56705767|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
56705768|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
56705769|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705770|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705771|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
56705772|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705773|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705774|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56705775|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
56705776|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705777|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56705778|NCT03505320|Antidotes|antidotes|mesh-ancestor
56705779|NCT03505320|Protective Agents|protective agents|mesh-ancestor
56705780|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
56705781|NCT03505320|Vitamins|vitamins|mesh-ancestor
56705782|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
56705783|NCT03505320|Hematinics|hematinics|mesh-ancestor
56705784|NCT03502668|Decitabine|decitabine|mesh-list
56705785|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705786|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
56552427|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56552428|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552429|NCT03711448|Prednisone|prednisone|mesh-list
56552430|NCT03711448|Ustekinumab|ustekinumab|mesh-list
56552431|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552432|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
56552433|NCT03711448|Hormones|hormones|mesh-ancestor
56552434|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552435|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552436|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56552437|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552438|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
56552439|NCT00885703|Fluconazole|fluconazole|mesh-list
56552440|NCT00885703|Amphotericin B|amphotericin b|mesh-list
56552441|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56552442|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56552443|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
56552444|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
56552445|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552446|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56552447|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56552448|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552449|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552450|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56552451|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
56108468|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56705787|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705788|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705789|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705790|NCT04902729|Oxytocin|oxytocin|mesh-list
56705791|NCT04902729|Carbetocin|carbetocin|mesh-list
56705792|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
56705793|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56705794|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705795|NCT03498378|Cetuximab|cetuximab|mesh-list
56705796|NCT03498378|Avelumab|avelumab|mesh-list
56705797|NCT03498378|Palbociclib|palbociclib|mesh-list
56705798|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705799|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705800|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56705801|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705802|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705803|NCT03493932|Nivolumab|nivolumab|mesh-list
56705804|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705805|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705806|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56552452|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552453|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552454|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56552455|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56552456|NCT00885703|Amebicides|amebicides|mesh-ancestor
56552457|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56552458|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56552459|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552460|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56552461|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56552462|NCT02642419|Aspirin|aspirin|mesh-list
56552463|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
56552464|NCT02642419|Clopidogrel|clopidogrel|mesh-list
56552465|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56552466|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56552467|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56552468|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56552469|NCT02642419|Analgesics|analgesics|mesh-ancestor
56552470|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
56552471|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552472|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552473|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552474|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552475|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56552477|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552478|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56552479|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552481|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56552482|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56552483|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56552484|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
56552485|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552486|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56552488|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56705807|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705808|NCT04211259|Loratadine|loratadine|mesh-list
56705809|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
56705810|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
56705811|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56705812|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56705813|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56705814|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
56705815|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
56705816|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56705817|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705818|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705819|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
56705820|NCT00698685|Pentostatin|pentostatin|mesh-list
56705821|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705822|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705823|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56705824|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705825|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705826|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
56705827|NCT04972968|Hormones|hormones|mesh-ancestor
56705828|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552489|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
56552490|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
56552491|NCT00901576|Methylphenidate|methylphenidate|mesh-list
56552492|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56552493|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552494|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56552495|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56552496|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56552497|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552498|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
56552499|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552500|NCT00655837|Gemcitabine|gemcitabine|mesh-list
56552501|NCT00655837|Rituximab|rituximab|mesh-list
56552502|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
56552503|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56552504|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552505|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
56552506|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552507|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552508|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56552509|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
56552510|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552511|NCT00655837|Antiviral Agents|antiviral agents|mesh-ancestor
56552512|NCT00655837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552513|NCT00655837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552514|NCT00655837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56552515|NCT00655915|Betamethasone|betamethasone|mesh-list
56552516|NCT00655915|Lidocaine|lidocaine|mesh-list
56552517|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
56705829|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923639|NCT03729869|Progesterone|progesterone|mesh-list
56923640|NCT03729869|Progestins|progestins|mesh-ancestor
56923641|NCT03729869|Hormones|hormones|mesh-ancestor
56923642|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923643|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923647|NCT03711604|Tenalisib|tenalisib|mesh-list
56416974|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
56923648|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
56705830|NCT00737438|Bevacizumab|bevacizumab|mesh-list
56705831|NCT00737438|Docetaxel|docetaxel|mesh-list
56705832|NCT00737438|Capecitabine|capecitabine|mesh-list
56705833|NCT00737438|Irinotecan|irinotecan|mesh-list
56705834|NCT00737438|Epirubicin|epirubicin|mesh-list
56705835|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705836|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705837|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56705838|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56705839|NCT00737438|Growth Substances|growth substances|mesh-ancestor
56705840|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705841|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
56705842|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
56705843|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
56705844|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
56705845|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705846|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705847|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
56705848|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56705849|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56705850|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705851|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56705857|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
56705858|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705859|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705860|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
56705861|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56705862|NCT00737048|Narcotics|narcotics|mesh-ancestor
56705863|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705864|NCT02593448|Anesthetics|anesthetics|mesh-list
56705865|NCT02593448|Propofol|propofol|mesh-list
56705866|NCT02593448|Sevoflurane|sevoflurane|mesh-list
56705867|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705868|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552518|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
56552519|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552520|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552521|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
56552522|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552523|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56552524|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56552525|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56552526|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56552527|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552528|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552529|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
56552530|NCT00655915|Hormones|hormones|mesh-ancestor
56552531|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552532|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56552533|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
56552534|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
56552535|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56552536|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552537|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552538|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56552539|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56552540|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552541|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552542|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552543|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552544|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56552548|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56552549|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
56552551|NCT00656773|Sufentanil|sufentanil|mesh-list
56552552|NCT00656773|Morphine|morphine|mesh-list
56552553|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56552554|NCT00656773|Narcotics|narcotics|mesh-ancestor
56552555|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552556|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552557|NCT00656773|Analgesics|analgesics|mesh-ancestor
56552558|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
56552559|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552560|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56552561|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56552562|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
56552564|NCT00882583|Cisplatin|cisplatin|mesh-list
56552565|NCT00882583|Cetuximab|cetuximab|mesh-list
56552566|NCT00882583|Dasatinib|dasatinib|mesh-list
56552567|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552568|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56552569|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56552570|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552571|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552572|NCT04481308|Fentanyl|fentanyl|mesh-list
56705869|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56705870|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56705871|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
56705872|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56705873|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56552573|NCT04481308|Propofol|propofol|mesh-list
56552574|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56552575|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552576|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552577|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56552578|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
56552579|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
56552580|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56552581|NCT04481308|Narcotics|narcotics|mesh-ancestor
56552582|NCT04481308|Analgesics|analgesics|mesh-ancestor
56552583|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
56552584|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552585|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56552586|NCT02634541|Adalimumab|adalimumab|mesh-list
56552587|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552588|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552589|NCT04475848|Midazolam|midazolam|mesh-list
56552590|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56552591|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56552592|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552593|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552594|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56552595|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56552596|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56552597|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56552598|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
56552599|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
56552600|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
56552601|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
56552602|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552603|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552604|NCT00599521|Adapalene|adapalene|mesh-list
56552605|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56552606|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56552607|NCT00599521|Analgesics|analgesics|mesh-ancestor
56552608|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
56552609|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552610|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552611|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552612|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552613|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
56552614|NCT04201678|Anesthetics|anesthetics|mesh-list
56552615|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552616|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552617|NCT00653341|Insulin|insulin|mesh-list
56552618|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56552619|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
56552620|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
56552621|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
56552623|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56552625|NCT02642263|Carbetocin|carbetocin|mesh-list
56552626|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
56552627|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56552628|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552629|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
56552630|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552631|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
56552632|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56552633|NCT02636803|Albendazole|albendazole|mesh-list
56552634|NCT02636803|Oxfendazole|oxfendazole|mesh-list
56300937|NCT00024310|Vitamins|vitamins|mesh-ancestor
56552635|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
56552636|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56552637|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552638|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
56552639|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56552640|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56552641|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
56552642|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
56705874|NCT02592746|Capecitabine|capecitabine|mesh-list
56705875|NCT02592746|Palbociclib|palbociclib|mesh-list
56705876|NCT02592746|Leuprolide|leuprolide|mesh-list
56705877|NCT02592746|Exemestane|exemestane|mesh-list
56705878|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705879|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
56705880|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705881|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705882|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56705883|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705884|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56705885|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
56705886|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56705887|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705888|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55836532|NCT02020031|Vancomycin|vancomycin|mesh-list
56552643|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
56552644|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552645|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552646|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
56552647|NCT02634463|Olanzapine|olanzapine|mesh-list
56552648|NCT02634463|Risperidone|risperidone|mesh-list
56552649|NCT02634463|Aripiprazole|aripiprazole|mesh-list
56552650|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56552651|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56552652|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
56552653|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552654|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552655|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552656|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56552657|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56552658|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552659|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56552660|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56552661|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
56552662|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
56552663|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
56552664|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552665|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56552666|NCT02634463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56552667|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56552668|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56552669|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
56552670|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
56552671|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56552672|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56552673|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56552674|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56552675|NCT00882115|Sulforaphane|sulforaphane|mesh-list
56552676|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56552677|NCT00882115|Protective Agents|protective agents|mesh-ancestor
56552678|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552679|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552680|NCT00653419|Buspirone|buspirone|mesh-list
56552681|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56552682|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56552683|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552684|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552685|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56552686|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56705889|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56705890|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56705891|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56705892|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
56705893|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56705894|NCT03365622|Acetaminophen|acetaminophen|mesh-list
56705895|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56705896|NCT03365622|Analgesics|analgesics|mesh-ancestor
56705897|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
56705898|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56705899|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552687|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
56552688|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552689|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552690|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56552691|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56552692|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56552693|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552694|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
56552695|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56552696|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
56552697|NCT00656929|Vitamin D|vitamin d|mesh-list
56552700|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
56552701|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552702|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56552703|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56552705|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56552706|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
56552707|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56552708|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552709|NCT02153632|Amantadine|amantadine|mesh-list
56552710|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56552711|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56552712|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
56552713|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552714|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
56552715|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552716|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552717|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552718|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56552720|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
56552721|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552722|NCT01934452|Sunitinib|sunitinib|mesh-list
56552723|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552724|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56552725|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56552726|NCT01934452|Growth Substances|growth substances|mesh-ancestor
56552727|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552728|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
56552729|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56552730|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552731|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552732|NCT03524326|Cetuximab|cetuximab|mesh-list
56552733|NCT03524326|Lenvatinib|lenvatinib|mesh-list
56552734|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56552735|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552736|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56552737|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552738|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552739|NCT01236430|Atorvastatin|atorvastatin|mesh-list
56552740|NCT01236430|Ezetimibe|ezetimibe|mesh-list
56552741|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56552742|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56552743|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
56705900|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
56705901|NCT00731120|Vortioxetine|vortioxetine|mesh-list
56705902|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
56417041|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
56705903|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56705904|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56705905|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56923649|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705906|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56705907|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705908|NCT00731120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56705909|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56705910|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56705911|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705912|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261375|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56552744|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552745|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56552746|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56552747|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552748|NCT00726856|Ezetimibe|ezetimibe|mesh-list
56552749|NCT00726856|Fenofibrate|fenofibrate|mesh-list
56552750|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56552751|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56552752|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
56552753|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552754|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56552755|NCT00651274|Ezetimibe|ezetimibe|mesh-list
56552756|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56552757|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56552758|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
56552759|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552760|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56552761|NCT04608448|Sirolimus|sirolimus|mesh-list
56552762|NCT04608448|Petrolatum|petrolatum|mesh-list
56552763|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552764|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552765|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56552766|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552767|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
56552768|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56552769|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
56552770|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552771|NCT04608448|Emollients|emollients|mesh-ancestor
56552772|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
56552775|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
56552776|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
56552777|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552778|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552779|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56552780|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56552781|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56552782|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552783|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56552784|NCT00212836|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56552785|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56552786|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56108610|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
56705914|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56705915|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56705916|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56705917|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56705918|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
56705919|NCT02580006|Hematinics|hematinics|mesh-ancestor
56705920|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56705921|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56705922|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705923|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
56705924|NCT02787642|Olaparib|olaparib|mesh-list
56705925|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56705926|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705927|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705928|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705929|NCT04075188|Aflibercept|aflibercept|mesh-list
56705930|NCT04075188|Verteporfin|verteporfin|mesh-list
56705931|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56705932|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56705933|NCT04075188|Growth Substances|growth substances|mesh-ancestor
56705934|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705935|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
56705936|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705937|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56705938|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
56705939|NCT00726986|Etoposide|etoposide|mesh-list
56705940|NCT00726986|Sorafenib|sorafenib|mesh-list
56705941|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705942|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56705943|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56705944|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56705945|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552787|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552788|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552789|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
56552790|NCT00805324|Desloratadine|desloratadine|mesh-list
56552791|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56552792|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
56552793|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552794|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552795|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552796|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56705946|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705947|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56705948|NCT03337698|Linagliptin|linagliptin|mesh-list
56705949|NCT03337698|Gemcitabine|gemcitabine|mesh-list
56705950|NCT03337698|Bevacizumab|bevacizumab|mesh-list
56705951|NCT03337698|Carboplatin|carboplatin|mesh-list
56705952|NCT03337698|Docetaxel|docetaxel|mesh-list
56705953|NCT03337698|Pemetrexed|pemetrexed|mesh-list
56705954|NCT03337698|Atezolizumab|atezolizumab|mesh-list
56705955|NCT03337698|Evolocumab|evolocumab|mesh-list
56705956|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56705957|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705958|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56705959|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56705960|NCT03337698|Growth Substances|growth substances|mesh-ancestor
56705961|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705962|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
56705963|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56705964|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
56705965|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705966|NCT03337698|Antiviral Agents|antiviral agents|mesh-ancestor
56705967|NCT03337698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56705968|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705969|NCT03337698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56705970|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
56705971|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
56705972|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
56705973|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
56705974|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56705975|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56705976|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56705977|NCT03337698|Incretins|incretins|mesh-ancestor
56705978|NCT03337698|Hormones|hormones|mesh-ancestor
56705979|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56417119|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
56261412|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56552797|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56552798|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
56552799|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
56552800|NCT00157924|Atorvastatin|atorvastatin|mesh-list
56552801|NCT00157924|Simvastatin|simvastatin|mesh-list
56552802|NCT00157924|Ezetimibe|ezetimibe|mesh-list
56705980|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56705981|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
56705982|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56705983|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56705984|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56705985|NCT00696657|Liraglutide|liraglutide|mesh-list
56705986|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56705987|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56705988|NCT00696657|Incretins|incretins|mesh-ancestor
56705989|NCT00696657|Hormones|hormones|mesh-ancestor
56705990|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56705991|NCT00726752|Axitinib|axitinib|mesh-list
56705992|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56705993|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56705994|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56705995|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56705996|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
56705997|NCT02594462|Etonogestrel|etonogestrel|mesh-list
56705998|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56705999|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706000|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56706001|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56706002|NCT02664558|Ubenimex|ubenimex|mesh-list
56706003|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56706004|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
56552803|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56552804|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56552805|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
56552806|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552807|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56552808|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56552809|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552810|NCT00794794|Cetirizine|cetirizine|mesh-list
56552811|NCT00794794|Desloratadine|desloratadine|mesh-list
56552812|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56552813|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56552814|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56552815|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
56552816|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
56552817|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552818|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552819|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552820|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56552821|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
56552822|NCT03612466|Plerixafor|plerixafor|mesh-list
56552823|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
56552824|NCT03612466|Calcium|calcium|mesh-list
56552825|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56552826|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706005|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706006|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56706007|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706008|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56706009|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706010|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
56706011|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706012|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706013|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56706014|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56706015|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
56706016|NCT02566707|Lamivudine|lamivudine|mesh-list
56706017|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56706018|NCT02566707|Dolutegravir|dolutegravir|mesh-list
56706019|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56706020|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56706021|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706022|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706023|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
56706024|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706025|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56706026|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56706027|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56706028|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56706029|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
56706030|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56706031|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56706032|NCT04063683|Paclitaxel|paclitaxel|mesh-list
56706033|NCT04063683|Cisplatin|cisplatin|mesh-list
56552827|NCT03612466|Antacids|antacids|mesh-ancestor
56552828|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552829|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56552830|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56552831|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56552832|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
56552833|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552834|NCT00142558|Indomethacin|indomethacin|mesh-list
56552835|NCT00142558|Etoricoxib|etoricoxib|mesh-list
56552836|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552837|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552838|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552839|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56552840|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56552841|NCT00142558|Analgesics|analgesics|mesh-ancestor
56552842|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
56552843|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552844|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56706034|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56706035|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706036|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
56706037|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
56706038|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
56706039|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706040|NCT00921531|Thalidomide|thalidomide|mesh-list
56706041|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56706042|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
56706043|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706044|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
56706045|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56706046|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706047|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56706048|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56706049|NCT00921531|Growth Substances|growth substances|mesh-ancestor
56706050|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
56706051|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706052|NCT00730028|Clindamycin|clindamycin|mesh-list
56706053|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
56706054|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
56552845|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
56552846|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
56552847|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56552849|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552850|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56552851|NCT02842294|Bevacizumab|bevacizumab|mesh-list
56552852|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56552853|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552854|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56552855|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56552856|NCT02842294|Growth Substances|growth substances|mesh-ancestor
56552857|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552858|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
56552859|NCT02841982|Morphine|morphine|mesh-list
56552860|NCT02841982|Ropivacaine|ropivacaine|mesh-list
56552861|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56552862|NCT02841982|Narcotics|narcotics|mesh-ancestor
56552863|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552864|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552865|NCT02841982|Analgesics|analgesics|mesh-ancestor
56552866|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
56552867|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552868|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
56552869|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
56552870|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
56552871|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56552872|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56552873|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552874|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56552875|NCT02843698|Analgesics|analgesics|mesh-ancestor
56552876|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
56552877|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552878|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56706055|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56706056|NCT00730028|Trimethoprim|trimethoprim|mesh-list
56706057|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
56706058|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56706059|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706060|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56706061|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706062|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706063|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56706064|NCT00730028|Renal Agents|renal agents|mesh-ancestor
56706065|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
56706066|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56706067|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56706068|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56706069|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56706070|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56706071|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56706072|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
56706073|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56706074|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706075|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
56706076|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56706077|NCT04083495|Fludarabine|fludarabine|mesh-list
56706078|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56706079|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
56706080|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706081|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56706082|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56706083|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
56261514|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56552879|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56552880|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56552881|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
56552882|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552883|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552884|NCT00690898|Lanreotide|lanreotide|mesh-list
56552885|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552886|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
56552887|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
56552888|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56552889|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56552890|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552891|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56552892|NCT00895414|Doxorubicin|doxorubicin|mesh-list
56706084|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706085|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706086|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56706087|NCT04088084|Palmidrol|palmidrol|mesh-list
55874876|NCT01145638|Iron|iron|mesh-list
56552893|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56552894|NCT00895414|Enalapril|enalapril|mesh-list
56552895|NCT00895414|Enalaprilat|enalaprilat|mesh-list
56552896|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56552897|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552898|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56552899|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56552900|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552901|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552902|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56552903|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
56552904|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56552905|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56552906|NCT01822288|Tibolone|tibolone|mesh-list
56552907|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
56552908|NCT01822288|Estradiol|estradiol|mesh-list
56552909|NCT01822288|Estrogens|estrogens|mesh-ancestor
56552910|NCT01822288|Hormones|hormones|mesh-ancestor
56552911|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552912|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552913|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56552914|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
56552915|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56552916|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56552917|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56552918|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56552919|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56552920|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56552921|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56552932|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56552933|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56552934|NCT01212770|Analgesics|analgesics|mesh-ancestor
56552935|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
56552936|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552937|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552938|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552940|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56552941|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56552942|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56552943|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552944|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56552945|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
56552946|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
56552947|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56552948|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56552949|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56552950|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56552951|NCT01212770|Growth Substances|growth substances|mesh-ancestor
56552952|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
56552953|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552954|NCT05334316|Dexamethasone|dexamethasone|mesh-list
56552955|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552956|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
56552957|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
56552958|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552959|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552960|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56552961|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
56552962|NCT05334316|Hormones|hormones|mesh-ancestor
56552963|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56552964|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56552965|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552966|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
56552967|NCT00598273|Hematinics|hematinics|mesh-ancestor
56552968|NCT02636491|Insulin|insulin|mesh-list
56706088|NCT04088084|Analgesics|analgesics|mesh-ancestor
56706089|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
56706090|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706091|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706092|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56706093|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56706094|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56706095|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56552969|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56552970|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56552971|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552972|NCT00657007|Belimumab|belimumab|mesh-list
56552973|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56552974|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
56552975|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552976|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
56552977|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56552978|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56552979|NCT04318652|Prednisolone|prednisolone|mesh-list
56552980|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
56552981|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56552982|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56552983|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
56552984|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56552985|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
56552986|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
56552987|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56552988|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552989|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56552990|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
56552993|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56552994|NCT04318652|Protective Agents|protective agents|mesh-ancestor
56552995|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56552997|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56552998|NCT02633995|Anesthetics|anesthetics|mesh-list
56552999|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553000|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553001|NCT02633683|Gabapentin|gabapentin|mesh-list
56553002|NCT02633683|Analgesics|analgesics|mesh-ancestor
56553003|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
56553004|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553005|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553006|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
56553007|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56553008|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56553009|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553010|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56553011|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56553012|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56553013|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553014|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553015|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
56553016|NCT01211522|Haloperidol|haloperidol|mesh-list
56553017|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
56553018|NCT01211522|Ziprasidone|ziprasidone|mesh-list
56553019|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
56553020|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
56553021|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553022|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553023|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56553024|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56553025|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56553026|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553027|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56553028|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56553029|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
56553030|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56108884|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
56706096|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
56706097|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706098|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56706099|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56706100|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706101|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706102|NCT04088084|Hormones|hormones|mesh-ancestor
56706103|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706104|NCT02593370|Lidocaine|lidocaine|mesh-list
56706105|NCT02593370|Epinephrine|epinephrine|mesh-list
56706106|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56706107|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
56706108|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
56706109|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706110|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706111|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
56706112|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706113|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56706114|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56706115|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56706116|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56553031|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553032|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56553033|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56553034|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
56553035|NCT05404724|Itraconazole|itraconazole|mesh-list
56553036|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
56553037|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553038|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56553039|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56553040|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553041|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553042|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56553043|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
56553044|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553045|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553046|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56553047|NCT03314935|Leucovorin|leucovorin|mesh-list
56553048|NCT03314935|Gemcitabine|gemcitabine|mesh-list
56553049|NCT03314935|Paclitaxel|paclitaxel|mesh-list
56553050|NCT03314935|Fluorouracil|fluorouracil|mesh-list
56553051|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
56553052|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56553053|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553054|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
56553055|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
56553056|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
56553057|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553058|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56706117|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706118|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56706119|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56706120|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
56706121|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706122|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56706123|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56706124|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
56706125|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56706126|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
56706127|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
56417265|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
56706129|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56706130|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
56706131|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
56706132|NCT00918320|Temozolomide|temozolomide|mesh-list
56706133|NCT00918320|Topotecan|topotecan|mesh-list
56706134|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56706135|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
56706136|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706137|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706138|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56706139|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56706140|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706141|NCT00729560|Flutamide|flutamide|mesh-list
56706142|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
56706143|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
56706144|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706145|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706146|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56706147|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706148|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
56553059|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
56553060|NCT03314935|Antiviral Agents|antiviral agents|mesh-ancestor
56553061|NCT03314935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553062|NCT03314935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553063|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56553066|NCT03314935|Antidotes|antidotes|mesh-ancestor
56553067|NCT03314935|Protective Agents|protective agents|mesh-ancestor
56553068|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
56553069|NCT03314935|Vitamins|vitamins|mesh-ancestor
56553070|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
56553071|NCT02633761|Misoprostol|misoprostol|mesh-list
56553072|NCT02633761|Mifepristone|mifepristone|mesh-list
56108886|NCT00004141|Molgramostim|molgramostim|mesh-list
56706149|NCT03199053|Saxagliptin|saxagliptin|mesh-list
56706150|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56706151|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706152|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56706153|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706154|NCT03199053|Incretins|incretins|mesh-ancestor
56706155|NCT03199053|Hormones|hormones|mesh-ancestor
56706156|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706157|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56706158|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
56706159|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706160|NCT00736190|Tenofovir|tenofovir|mesh-list
56706161|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
56706162|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706163|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56706164|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56706165|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706166|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706167|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56706168|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56706169|NCT04686279|Tenofovir|tenofovir|mesh-list
56706170|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
56706171|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706172|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56706173|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56706174|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706179|NCT00729326|Exenatide|exenatide|mesh-list
56706195|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
56706196|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706197|NCT00698451|Bevacizumab|bevacizumab|mesh-list
56706198|NCT00698451|Carboplatin|carboplatin|mesh-list
56706199|NCT00698451|Doxorubicin|doxorubicin|mesh-list
56706200|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56706201|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56706202|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706203|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56706204|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56706205|NCT00698451|Growth Substances|growth substances|mesh-ancestor
56706206|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706207|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
56706208|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56706209|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56706210|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56706211|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706212|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706213|NCT02996487|Vancomycin|vancomycin|mesh-list
56706214|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56706215|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706216|NCT04035837|Interferons|interferons|mesh-list
56706217|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
56706218|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706219|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
56706220|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706221|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
56706222|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706223|NCT03980925|Carboplatin|carboplatin|mesh-list
56706224|NCT03980925|Nivolumab|nivolumab|mesh-list
56706225|NCT03980925|Etoposide|etoposide|mesh-list
56261666|NCT02138617|Vitamins|vitamins|mesh-ancestor
56553073|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56553074|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
56553075|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56553076|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553077|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56553078|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56553079|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
56553080|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56553081|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56553082|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56553083|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56553084|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
55888345|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56706226|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706227|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56706228|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56706229|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706230|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56706231|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56706232|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56706233|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706234|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
56706235|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56706236|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56706237|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56706238|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
56706239|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56706240|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
56706241|NCT03966807|Nicotine|nicotine|mesh-list
56706242|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56706243|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
56706244|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706245|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706246|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56706247|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56706248|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
56706249|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553085|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56553086|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56553087|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
56553088|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553089|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
56553090|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56553091|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56553093|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56553094|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56553095|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
56553096|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553097|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553098|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553099|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56553100|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553101|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
56553102|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56553103|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553104|NCT00657397|Methadone|methadone|mesh-list
56553105|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56553106|NCT00657397|Narcotics|narcotics|mesh-ancestor
56553107|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553108|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553109|NCT00657397|Analgesics|analgesics|mesh-ancestor
56706250|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706251|NCT02565693|Aspirin|aspirin|mesh-list
56706252|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
56706253|NCT02565693|Dipyridamole|dipyridamole|mesh-list
56706254|NCT02565693|Apixaban|apixaban|mesh-list
56706255|NCT02565693|Clopidogrel|clopidogrel|mesh-list
56706256|NCT02565693|Calcium|calcium|mesh-list
56706257|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56706258|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706259|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56706260|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56706261|NCT02565693|Analgesics|analgesics|mesh-ancestor
56706262|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
56553110|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
56553111|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553112|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
56553113|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
56553114|NCT04160611|Midazolam|midazolam|mesh-list
56553115|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56553116|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56553117|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553118|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553119|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56553120|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56553121|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56553122|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56553123|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
56553124|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
56553125|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
56553126|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
56553127|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553128|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553129|NCT04161001|Amlodipine|amlodipine|mesh-list
56553130|NCT04161001|Olmesartan|olmesartan|mesh-list
56553131|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56553132|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
56553133|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56553134|NCT04161001|Ezetimibe|ezetimibe|mesh-list
56553135|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56553136|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56553137|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56553138|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553139|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56553140|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553142|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56553143|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56553144|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
56553145|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56553146|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56553147|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553148|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56553149|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56553150|NCT00881569|Efatutazone|efatutazone|mesh-list
56553151|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553152|NCT00657163|Fluoxetine|fluoxetine|mesh-list
56553153|NCT00657163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56553154|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56553155|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56553156|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553157|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553158|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
56706263|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706264|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56706265|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56706266|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56706267|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56706268|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706269|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56706270|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56706271|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706272|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
56706273|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56706274|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56706275|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56706276|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
56706277|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706278|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56706279|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
56706280|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56706281|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
56706282|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
56706283|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56706284|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
56706285|NCT04061655|Iron|iron|mesh-list
56706286|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56706287|NCT04061655|Trace Elements|trace elements|mesh-ancestor
56706288|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
56706289|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706290|NCT04061655|Hematinics|hematinics|mesh-ancestor
56706291|NCT04061265|Lidocaine|lidocaine|mesh-list
56706292|NCT04061265|Epinephrine|epinephrine|mesh-list
56706293|NCT04061265|Carticaine|carticaine|mesh-list
56706294|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
56706295|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
56261714|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553159|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553160|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56553161|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
56553162|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56553163|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56553164|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56553165|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553166|NCT02636101|Betamethasone|betamethasone|mesh-list
56553167|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
56553168|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56706296|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706297|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706298|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
56706299|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706300|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56706301|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56706302|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56706303|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261744|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
56553169|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
56553170|NCT02636101|Calcipotriene|calcipotriene|mesh-list
56553171|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56553172|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553173|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
56553174|NCT02636101|Hormones|hormones|mesh-ancestor
56553175|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553176|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553177|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56553178|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
56553179|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
56553180|NCT00657475|Heparin|heparin|mesh-list
56553181|NCT00657475|Calcium heparin|calcium heparin|mesh-list
56553182|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
56553183|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56553184|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56553185|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553186|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
56553187|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
56553188|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56553189|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56553190|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553191|NCT04159597|Upadacitinib|upadacitinib|mesh-list
56553192|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56553193|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56553194|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553195|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553196|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553197|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56553198|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
56553199|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56553200|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56553201|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553202|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553203|NCT00661219|Urological Agents|urological agents|mesh-ancestor
56553204|NCT02382406|Paclitaxel|paclitaxel|mesh-list
56553205|NCT02382406|Carboplatin|carboplatin|mesh-list
56553206|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
56553207|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56553208|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553209|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
56553211|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
56553212|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553213|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56553215|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56553216|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56553217|NCT00665743|Analgesics|analgesics|mesh-ancestor
56553218|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
56553219|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553220|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553221|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553222|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553223|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
56553224|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56706304|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706305|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56706306|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56706307|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
56706308|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706309|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56706310|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56706311|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
56706312|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56706313|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
56706314|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
56706315|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
56706316|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56706317|NCT02592980|Warfarin|warfarin|mesh-list
56706318|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
56706319|NCT00727844|Linezolid|linezolid|mesh-list
56706320|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56706321|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706322|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56706323|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706324|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706325|NCT00735878|Carboplatin|carboplatin|mesh-list
56706326|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706327|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56706328|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
56706329|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56706352|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706353|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706354|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
56706355|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706356|NCT00724958|Infliximab|infliximab|mesh-list
56706357|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
56706358|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56706359|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56706360|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
56706361|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56706362|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
56706363|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706364|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
56706365|NCT04088006|Protective Agents|protective agents|mesh-ancestor
56706366|NCT00695565|Clonidine|clonidine|mesh-list
56706367|NCT00695565|Analgesics|analgesics|mesh-ancestor
56706368|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
56706369|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706370|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706371|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56706372|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
56706373|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
56706374|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56706375|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56706376|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56706377|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
56553225|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553226|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553227|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56553228|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
56553229|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56553230|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56553231|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553232|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553233|NCT00661297|Urological Agents|urological agents|mesh-ancestor
56553234|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
56553235|NCT00879775|Caffeine|caffeine|mesh-list
56553236|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56553237|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553238|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56553239|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553240|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553241|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56553242|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56553243|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
56553244|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553245|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
56553246|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553247|NCT00894790|Celecoxib|celecoxib|mesh-list
56553248|NCT00894790|Diclofenac|diclofenac|mesh-list
56706378|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706379|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706380|NCT00727532|Sorafenib|sorafenib|mesh-list
56706381|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706382|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56706383|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706384|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706385|NCT00721214|Azacitidine|azacitidine|mesh-list
56706386|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56706387|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
56706388|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706389|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706390|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706391|NCT00720902|Hormones|hormones|mesh-list
56706392|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56706393|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706394|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706395|NCT02592278|Listerine|listerine|mesh-list
56706396|NCT02592278|Fluorides|fluorides|mesh-list
56706397|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
56706398|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
56706399|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
56706400|NCT02592278|Protective Agents|protective agents|mesh-ancestor
56706401|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706402|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56706403|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706404|NCT00695019|Interferons|interferons|mesh-list
56706405|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
56706406|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
56706407|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56706408|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706409|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
56706416|NCT00742911|Copper|copper|mesh-list
56706421|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56706422|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56706423|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706424|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706425|NCT00694707|Risperidone|risperidone|mesh-list
56706426|NCT00694707|Cariprazine|cariprazine|mesh-list
56706427|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56706428|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
56706429|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706430|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706432|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56706433|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56706434|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706435|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56706436|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56706437|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
56706438|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
56706439|NCT00692913|Vitamin D|vitamin d|mesh-list
56706440|NCT00692913|Alendronate|alendronate|mesh-list
56706441|NCT00692913|Calcium|calcium|mesh-list
56706442|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56706443|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706444|NCT00692913|Vitamins|vitamins|mesh-ancestor
56706445|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
56706446|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56706447|NCT00694551|Poly I-C|poly i-c|mesh-list
56706448|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56706449|NCT00694551|Vaccines|vaccines|mesh-list
56706450|NCT00694551|Poly ICLC|poly iclc|mesh-list
56706451|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
56706452|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706453|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
56706454|NCT00694551|Laxatives|laxatives|mesh-ancestor
56706455|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56706456|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
56261884|NCT04927585|Vaccines|vaccines|mesh-list
56553249|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56553250|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56553251|NCT00894790|Analgesics|analgesics|mesh-ancestor
56553252|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
56553253|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553254|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706457|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706458|NCT02603705|Oxycodone|oxycodone|mesh-list
56706459|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56706460|NCT02603705|Narcotics|narcotics|mesh-ancestor
56706461|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706462|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706463|NCT02603705|Analgesics|analgesics|mesh-ancestor
56706464|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
56706465|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706466|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56706467|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
56706468|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56706469|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706470|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56706471|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56706472|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706473|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706474|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
56706475|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706476|NCT00915785|Azacitidine|azacitidine|mesh-list
56706477|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56706478|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
56706479|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706480|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706481|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706482|NCT00776009|Methylphenidate|methylphenidate|mesh-list
56706483|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56706484|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56706485|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706486|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56706490|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
56706497|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56706498|NCT00720356|Growth Substances|growth substances|mesh-ancestor
56706499|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706500|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
56706501|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56706502|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417660|NCT00411333|Hormones|hormones|mesh-ancestor
56706503|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706504|NCT00745953|Valsartan|valsartan|mesh-list
56706505|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56706506|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56706507|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56706508|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56706509|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706510|NCT00745953|Diuretics|diuretics|mesh-ancestor
56706511|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
56706512|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706513|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56706514|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706515|NCT00720278|Azelastine|azelastine|mesh-list
56706516|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56706517|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
56706518|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706519|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706520|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56706521|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
56706522|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56706523|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706524|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706525|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56706526|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56706527|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56706528|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
56706531|NCT00746031|Goserelin|goserelin|mesh-list
56706534|NCT00746031|Hormones|hormones|mesh-ancestor
56706535|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706536|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706537|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56706538|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706539|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56706540|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
56706541|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56706542|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
56706543|NCT00720122|Insulin|insulin|mesh-list
56706544|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56706545|NCT00720122|Mitogens|mitogens|mesh-list
56706546|NCT00720122|Mecasermin|mecasermin|mesh-list
56706547|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56706548|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706549|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
56706550|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706551|NCT00720122|Growth Substances|growth substances|mesh-ancestor
56553255|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553256|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553257|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56553258|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56553259|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553260|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553261|NCT00665977|Triamcinolone|triamcinolone|mesh-list
56553262|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56553263|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56553264|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56553265|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553266|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
56553267|NCT00665977|Hormones|hormones|mesh-ancestor
56553268|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553269|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553270|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56553271|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
56553272|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553273|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553274|NCT00666055|Ritonavir|ritonavir|mesh-list
56553275|NCT00666055|Lopinavir|lopinavir|mesh-list
56553276|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56553277|NCT00666055|Tenofovir|tenofovir|mesh-list
56553278|NCT00666055|Lamivudine|lamivudine|mesh-list
56553279|NCT00666055|Zidovudine|zidovudine|mesh-list
56553280|NCT00666055|Emtricitabine|emtricitabine|mesh-list
56553281|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
56553282|NCT00666055|Maraviroc|maraviroc|mesh-list
56553283|NCT00666055|Efavirenz|efavirenz|mesh-list
56553285|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56553286|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56553288|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553289|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553290|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56553291|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56553292|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
56553293|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553294|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56553295|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56553296|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56706552|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
56706553|NCT04085744|Lidocaine|lidocaine|mesh-list
56706554|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
56706555|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
56706556|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706557|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706558|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
56706559|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706560|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56706561|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56706562|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56706563|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706564|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706565|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56706566|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56706567|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56706568|NCT00743847|Varenicline|varenicline|mesh-list
56706569|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56706570|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56706571|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
56706572|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706573|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706574|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706575|NCT00717860|Caspofungin|caspofungin|mesh-list
56547664|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56706576|NCT00717860|Micafungin|micafungin|mesh-list
56706577|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
56706578|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706579|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706580|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706581|NCT05365802|FAPI-46|fapi-46|mesh-list
56553297|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56553298|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
56553299|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56553300|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56553301|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56553302|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56553303|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56553304|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56553305|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56553306|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55888346|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
56706582|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56706583|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706584|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
56706585|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56706586|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56706587|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
56706588|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706589|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56706590|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56706591|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706592|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706593|NCT02592122|Bromides|bromides|mesh-list
56706594|NCT02592122|Albuterol|albuterol|mesh-list
56706595|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
56706596|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56706597|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
56706598|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706599|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706600|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56706601|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
56706602|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
56706603|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56706604|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56706605|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56706606|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56553307|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56553308|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56553309|NCT00661375|Sorafenib|sorafenib|mesh-list
56553310|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553311|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56553312|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553313|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553314|NCT00911287|Oxymorphone|oxymorphone|mesh-list
56553315|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56553316|NCT00911287|Narcotics|narcotics|mesh-ancestor
56553317|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553318|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553319|NCT00911287|Analgesics|analgesics|mesh-ancestor
56553320|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
56553321|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553322|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56553323|NCT04494880|Bupivacaine|bupivacaine|mesh-list
56553324|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
56553325|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
56553326|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553327|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553328|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
56553329|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553330|NCT02631031|Valsartan|valsartan|mesh-list
56553331|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56706607|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
56706608|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706609|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706610|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
56706611|NCT00923637|Pemetrexed|pemetrexed|mesh-list
56706612|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706613|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706614|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706615|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56706616|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56706617|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
56706618|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56706619|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706620|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56706621|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
56553332|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56553333|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56553334|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553335|NCT02839408|Azithromycin|azithromycin|mesh-list
56553336|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56553337|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553338|NCT02837614|Acetaminophen|acetaminophen|mesh-list
56553339|NCT02837614|Amoxicillin|amoxicillin|mesh-list
56553340|NCT02837614|Dexamethasone|dexamethasone|mesh-list
56553341|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
56553342|NCT02837614|BB 1101|bb 1101|mesh-list
56553343|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553344|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
56553345|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
56553346|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553347|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553348|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56553349|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
56553350|NCT02837614|Hormones|hormones|mesh-ancestor
56553351|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553352|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56553353|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553354|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
56553355|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553356|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553357|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56553360|NCT02837614|Analgesics|analgesics|mesh-ancestor
56553361|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
56553362|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
56553363|NCT02839486|Vancomycin|vancomycin|mesh-list
56553364|NCT02839486|Cefoxitin|cefoxitin|mesh-list
56553365|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56553366|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553367|NCT00879229|Ambrisentan|ambrisentan|mesh-list
56553368|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56553369|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
56553370|NCT04249570|Povidone|povidone|mesh-list
56553371|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
56553372|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
56553373|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56553374|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553375|NCT02837770|Diclofenac|diclofenac|mesh-list
56553376|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56553377|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
56553378|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56553379|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56706622|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56706623|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706624|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706625|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706626|NCT01090089|Dexamethasone|dexamethasone|mesh-list
56706627|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
56706628|NCT01090089|Lenalidomide|lenalidomide|mesh-list
56706629|NCT01090089|BB 1101|bb 1101|mesh-list
56706630|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56706631|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
56706632|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
56706633|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706634|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706635|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56706636|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
56706637|NCT01090089|Hormones|hormones|mesh-ancestor
56706638|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706639|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56706640|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706641|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
56706642|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706643|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706644|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
56706645|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56706646|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56706647|NCT01090089|Growth Substances|growth substances|mesh-ancestor
56553380|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56553381|NCT02837770|Analgesics|analgesics|mesh-ancestor
56553382|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
56553383|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553384|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553385|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553386|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301699|NCT00027625|Temozolomide|temozolomide|mesh-list
56553387|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56553388|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553389|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553390|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
56553391|NCT00878995|Testosterone|testosterone|mesh-list
56553392|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
56553393|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
56553394|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56553395|NCT00878995|Androgens|androgens|mesh-ancestor
56553396|NCT00878995|Hormones|hormones|mesh-ancestor
56553397|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553398|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553399|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56553400|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706648|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
56706649|NCT00689793|Iron|iron|mesh-list
56706650|NCT00689793|Trace Elements|trace elements|mesh-ancestor
56417794|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56706651|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
56706652|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706654|NCT04086290|Hormones|hormones|mesh-ancestor
56706655|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706656|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706657|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
56706658|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56706659|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56706660|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
56706661|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
56706662|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262095|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
56553401|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
56553402|NCT02837146|Methotrexate|methotrexate|mesh-list
56553403|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56553404|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
56553405|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56553406|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553407|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56553408|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
56553409|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553410|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553411|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
56553412|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553413|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56553414|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56553415|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
56553416|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553417|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56553418|NCT00657865|Ramipril|ramipril|mesh-list
56553419|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56553420|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
56553421|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553422|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553423|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56553424|NCT00661765|Varenicline|varenicline|mesh-list
56553425|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56553426|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56553427|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
56553428|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553429|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553430|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553432|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56553433|NCT00657943|Metformin|metformin|mesh-list
56553434|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
56553435|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
56553436|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56553437|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
56553438|NCT00657943|Protamines|protamines|mesh-list
56553439|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56553440|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553441|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
56553442|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553443|NCT00657943|Coagulants|coagulants|mesh-ancestor
56553444|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
56706663|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706664|NCT02563353|Teriparatide|teriparatide|mesh-list
56706665|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56706666|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706667|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56706668|NCT00688701|Lixisenatide|lixisenatide|mesh-list
56706669|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56706670|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706671|NCT00744549|Vitamin D|vitamin d|mesh-list
56706672|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
56706673|NCT00744549|Vitamins|vitamins|mesh-list
56706674|NCT00744549|Vitamin E|vitamin e|mesh-list
56706675|NCT00744549|Selenium|selenium|mesh-list
56706676|NCT00744549|Lycopene|lycopene|mesh-list
56706677|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
56706678|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706679|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56706680|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56706681|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
56706682|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262110|NCT03993327|Antibodies|antibodies|mesh-list
56553445|NCT04249804|Analgesics|analgesics|mesh-ancestor
56553446|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
56553447|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553448|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553449|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
56553450|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553451|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56553452|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
56553453|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56553454|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56553455|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553456|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56553457|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
56553458|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56553459|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
56553460|NCT02631109|Doxorubicin|doxorubicin|mesh-list
56553461|NCT02631109|Etoposide|etoposide|mesh-list
56553462|NCT02631109|Pegaspargase|pegaspargase|mesh-list
56553463|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56553464|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553465|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56553466|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56553467|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553468|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553469|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56553470|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553471|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
56553472|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
56553473|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553474|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553475|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56553476|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
56553477|NCT02631109|Hormones|hormones|mesh-ancestor
56051695|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56706683|NCT00744549|Protective Agents|protective agents|mesh-ancestor
56706684|NCT00744549|Trace Elements|trace elements|mesh-ancestor
56706685|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56706686|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56706687|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56706688|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706689|NCT00746655|Cisplatin|cisplatin|mesh-list
56706690|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706691|NCT04060719|Rifampin|rifampin|mesh-list
56706692|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56706693|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
56706694|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56706695|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706696|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
56706697|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56706698|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706699|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706700|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56706701|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56706702|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56706703|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56706704|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56706705|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56553478|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553479|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56553480|NCT02631109|Protective Agents|protective agents|mesh-ancestor
56553481|NCT02630485|Inositol|inositol|mesh-list
56553482|NCT02630485|Letrozole|letrozole|mesh-list
56553483|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553484|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56553485|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56553486|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553487|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553488|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56553489|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
56553490|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553491|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553492|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
56553493|NCT02630485|Vitamins|vitamins|mesh-ancestor
56553494|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
56553495|NCT00894556|Sumatriptan|sumatriptan|mesh-list
56553496|NCT00894556|Rizatriptan|rizatriptan|mesh-list
56553497|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56553498|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56553499|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56553500|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
56553501|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553502|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553503|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706706|NCT00741429|Insulin|insulin|mesh-list
56706707|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56706708|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706709|NCT00741507|Ethanol|ethanol|mesh-list
56706710|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56706711|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706712|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706713|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706714|NCT00688623|Everolimus|everolimus|mesh-list
56706715|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706716|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56706717|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
56706718|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706719|NCT02563821|Clonidine|clonidine|mesh-list
56706720|NCT02563821|Sufentanil|sufentanil|mesh-list
56262156|NCT03539055|Dabigatran|dabigatran|mesh-list
56553504|NCT01210352|Oxymorphone|oxymorphone|mesh-list
56553505|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56553507|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553508|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553509|NCT01210352|Analgesics|analgesics|mesh-ancestor
56553519|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553520|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553522|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56553523|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553524|NCT00658099|Insulin|insulin|mesh-list
56553525|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56553526|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
56553527|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
56553528|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
56553529|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
56553530|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56553531|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553542|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56553543|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
56553544|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56553545|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56553546|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553547|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553548|NCT00658177|Urological Agents|urological agents|mesh-ancestor
56553550|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
56553551|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553552|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56553553|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
56553554|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553555|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553556|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56553557|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
56553558|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
56553559|NCT00658255|Hormones|hormones|mesh-ancestor
56553560|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553561|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56553562|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56553563|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56553564|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
56553565|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553566|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553567|NCT02836288|Ketamine|ketamine|mesh-list
56553568|NCT02836288|Analgesics|analgesics|mesh-ancestor
56553569|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
56553570|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706721|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
56706722|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56706723|NCT02563821|Narcotics|narcotics|mesh-ancestor
56706724|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56417870|NCT00196586|Analgesics|analgesics|mesh-ancestor
56706725|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706726|NCT02563821|Analgesics|analgesics|mesh-ancestor
56706727|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
56706728|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706729|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56706730|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56706731|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
56706732|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
56706733|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56706734|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
56706735|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
56706736|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56706737|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56706738|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56706739|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
56706740|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706741|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706742|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
56706743|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
56706744|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56706745|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
56706746|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706747|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56706748|NCT04085354|Vitamins|vitamins|mesh-list
56706749|NCT04085354|Folic Acid|folic acid|mesh-list
56706750|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
56706751|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
56706752|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
56262168|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553571|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553572|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56553573|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56553574|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
56553575|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
56553576|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553577|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56553578|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56553579|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706753|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706754|NCT04085354|Hematinics|hematinics|mesh-ancestor
56706755|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
56706756|NCT00719810|Tigecycline|tigecycline|mesh-list
56706757|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
56706758|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56706759|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706760|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56706761|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706762|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706763|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56706764|NCT00723710|Interferons|interferons|mesh-list
56706765|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
56706766|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
56706767|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706768|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
56706769|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706770|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
56706771|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706772|NCT00688545|Celecoxib|celecoxib|mesh-list
56706773|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56706774|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56706775|NCT00688545|Analgesics|analgesics|mesh-ancestor
56706776|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
56706777|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706778|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706779|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56706780|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56706781|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56706782|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56706783|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706784|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706785|NCT04060407|Nivolumab|nivolumab|mesh-list
56706786|NCT04060407|Ipilimumab|ipilimumab|mesh-list
56706787|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262198|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553580|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553581|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56706788|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56706789|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56706790|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706791|NCT00741585|Atenolol|atenolol|mesh-list
56706792|NCT00741585|Amlodipine|amlodipine|mesh-list
56706793|NCT00741585|Valsartan|valsartan|mesh-list
56706794|NCT00741585|Telmisartan|telmisartan|mesh-list
56706795|NCT00741585|Carvedilol|carvedilol|mesh-list
56706796|NCT00741585|Candesartan|candesartan|mesh-list
56706797|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
56706798|NCT00741585|Ramipril|ramipril|mesh-list
56706799|NCT00741585|Olmesartan|olmesartan|mesh-list
56417947|NCT00208260|Leucovorin|leucovorin|mesh-list
56706800|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56706801|NCT00741585|Enalapril|enalapril|mesh-list
56706802|NCT00741585|Enalaprilat|enalaprilat|mesh-list
56706803|NCT00741585|Lisinopril|lisinopril|mesh-list
56553582|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
56553583|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56553584|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56553585|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56553586|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553587|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553588|NCT01208402|Esmolol|esmolol|mesh-list
56553589|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56553590|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56553591|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56553592|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56553593|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553594|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553595|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553596|NCT01208324|Estrogens|estrogens|mesh-list
56553597|NCT01208324|Hormones|hormones|mesh-ancestor
56553598|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553599|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553601|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56553602|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553603|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
56553604|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56553605|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56553606|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553607|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56553608|NCT02835742|Sargramostim|sargramostim|mesh-list
56301917|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56553609|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
56553610|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553611|NCT05326360|Ramosetron|ramosetron|mesh-list
56553612|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
56553613|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
56553614|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553615|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553616|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56553617|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56553618|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
56553619|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553620|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553621|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
56553622|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56553623|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553624|NCT01207388|Blinatumomab|blinatumomab|mesh-list
56553625|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553626|NCT02835664|Niacinamide|niacinamide|mesh-list
56553627|NCT02835664|Niacin|niacin|mesh-list
56553628|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
56706804|NCT00741585|Irbesartan|irbesartan|mesh-list
56706805|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
56706806|NCT00741585|Quinapril|quinapril|mesh-list
56706807|NCT00741585|Lercanidipine|lercanidipine|mesh-list
56706808|NCT00741585|Manidipine|manidipine|mesh-list
56706809|NCT00741585|Doxazosin|doxazosin|mesh-list
56706810|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56706811|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706812|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706813|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56706814|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706815|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
56706816|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56706817|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56706818|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56706819|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56706820|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
56553629|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
56553630|NCT02835664|Vitamins|vitamins|mesh-ancestor
56553631|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
56553632|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553633|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56553634|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
56553635|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553636|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56553637|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
56553638|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
56553639|NCT02838472|Vitamins|vitamins|mesh-ancestor
56553640|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
56553641|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553642|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
56553643|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553644|NCT02838472|Protective Agents|protective agents|mesh-ancestor
56553645|NCT00666991|Paclitaxel|paclitaxel|mesh-list
56553646|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56553647|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553648|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
56553649|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
56553650|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
56553651|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553652|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56553653|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
56553654|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56553655|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
56553656|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56553657|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553658|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56553659|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56553660|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553661|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56553662|NCT00667147|Paclitaxel|paclitaxel|mesh-list
56553663|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553664|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56553665|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
56553666|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
56553667|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
56553668|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553669|NCT02835586|Paclitaxel|paclitaxel|mesh-list
56706821|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706822|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
56706823|NCT00741585|Protective Agents|protective agents|mesh-ancestor
56706824|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56706825|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56706826|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56706827|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
56706828|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706829|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56706830|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56706831|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
56706832|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
56706833|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706834|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56706835|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
56706836|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
56706837|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56706838|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56706839|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706840|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706841|NCT00746967|Urological Agents|urological agents|mesh-ancestor
56706842|NCT02563041|Heparin|heparin|mesh-list
56706843|NCT02563041|Calcium heparin|calcium heparin|mesh-list
56706844|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
56706845|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706846|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56706847|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56706848|NCT00741663|Furosemide|furosemide|mesh-list
56553670|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56553671|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553672|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
56553673|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
56553675|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553676|NCT00667303|Antibodies|antibodies|mesh-list
56553677|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
56553678|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553679|NCT02838238|Capecitabine|capecitabine|mesh-list
56553680|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56553681|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
56553682|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553683|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553684|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56553685|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553686|NCT00667771|Naltrexone|naltrexone|mesh-list
56553687|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56553688|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56706849|NCT00741663|Spironolactone|spironolactone|mesh-list
56706850|NCT00741663|Diuretics|diuretics|mesh-ancestor
56706851|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
56706852|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706853|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56706854|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706855|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706856|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56262287|NCT02625610|Fluorouracil|fluorouracil|mesh-list
56553689|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553690|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
56553691|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553692|NCT01206764|Everolimus|everolimus|mesh-list
56553693|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553694|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56553695|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
56553696|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553697|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
56553698|NCT00667927|Busulfan|busulfan|mesh-list
56553699|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56553700|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
56553701|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553702|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553703|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56553704|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
56553705|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553706|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553707|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56553708|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56553709|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
56553710|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56553711|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56553712|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553713|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553714|NCT00668005|Urological Agents|urological agents|mesh-ancestor
56553715|NCT00668239|Triamcinolone|triamcinolone|mesh-list
56553716|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553717|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
56553718|NCT00668239|Hormones|hormones|mesh-ancestor
56553719|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553720|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553721|NCT02631499|Epirubicin|epirubicin|mesh-list
56553722|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
56553723|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56553724|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553725|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56553726|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56553727|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553728|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553729|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
56553730|NCT00662233|Ifosfamide|ifosfamide|mesh-list
56553731|NCT00662233|Doxorubicin|doxorubicin|mesh-list
56553732|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56553733|NCT00662233|Etoposide|etoposide|mesh-list
56553734|NCT00662233|Vincristine|vincristine|mesh-list
56553735|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56553736|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
56553737|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553738|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553739|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56553740|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
56553741|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553742|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553743|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56706857|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
56706858|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706859|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56706860|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
56706861|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56706862|NCT00741741|Rilpivirine|rilpivirine|mesh-list
56706863|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56706864|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56706865|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56706866|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706867|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
56706868|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706869|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56706870|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56706871|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56706872|NCT00745173|Estrogens|estrogens|mesh-ancestor
56706873|NCT00745173|Hormones|hormones|mesh-ancestor
56706874|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56706875|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706876|NCT04060095|Anesthetics|anesthetics|mesh-list
56706877|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706878|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706879|NCT00741897|Fexofenadine|fexofenadine|mesh-list
56706880|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56706881|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56706882|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56706883|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
56706884|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
56706885|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553744|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56553745|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56553746|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56553747|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553750|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
56553751|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
56553752|NCT00658957|Gentamicins|gentamicins|mesh-list
56553753|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56553754|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553755|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56553756|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553757|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553758|NCT00662467|Aspirin|aspirin|mesh-list
56553759|NCT00662467|Warfarin|warfarin|mesh-list
56553760|NCT00662467|Clopidogrel|clopidogrel|mesh-list
56553761|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56706886|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706887|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706888|NCT00745407|Fenofibrate|fenofibrate|mesh-list
56706889|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56706890|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
56706891|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706892|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56706893|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
56706894|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56706895|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706896|NCT00747279|Insulin|insulin|mesh-list
56706897|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56706898|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706899|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
56706900|NCT00742287|Procyanidin|procyanidin|mesh-list
56706901|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
56706902|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706903|NCT00742287|Protective Agents|protective agents|mesh-ancestor
56706904|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706905|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56706906|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56706907|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706908|NCT00747669|Lidocaine|lidocaine|mesh-list
56706909|NCT00747669|Tetracaine|tetracaine|mesh-list
56706910|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
56706911|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
56553762|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56553763|NCT00662467|Analgesics|analgesics|mesh-ancestor
56553764|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
56553765|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553766|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553767|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553768|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553769|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56553770|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56553771|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553772|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56553773|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56553774|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553775|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
56553776|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56553777|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56553778|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56553779|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
56553780|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553781|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
56553782|NCT00668941|Vitamin D|vitamin d|mesh-list
56553783|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
56553784|NCT00668941|Alendronate|alendronate|mesh-list
56553785|NCT00668941|Teriparatide|teriparatide|mesh-list
56553786|NCT00668941|Calcium|calcium|mesh-list
56706912|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706913|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706914|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
56706915|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56706916|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56706917|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56706918|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56706919|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706920|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706921|NCT00690573|Adalimumab|adalimumab|mesh-list
56706922|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56706923|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56706924|NCT00719264|Interferons|interferons|mesh-list
56706925|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
56706926|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
56706927|NCT00719264|Bevacizumab|bevacizumab|mesh-list
56706928|NCT00719264|Everolimus|everolimus|mesh-list
56706929|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56706930|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553787|NCT00668941|Vitamins|vitamins|mesh-ancestor
56553788|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
56553789|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553790|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56553791|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56553792|NCT00894322|Exenatide|exenatide|mesh-list
56553793|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56553794|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553795|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56553796|NCT00894322|Incretins|incretins|mesh-ancestor
56553797|NCT00894322|Hormones|hormones|mesh-ancestor
56553798|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553799|NCT05323708|Denosumab|denosumab|mesh-list
56553800|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56553801|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553802|NCT00633412|Esomeprazole|esomeprazole|mesh-list
56553803|NCT00633412|Ranitidine|ranitidine|mesh-list
56553804|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56553805|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56553806|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56553807|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56553808|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553809|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553810|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56553811|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
56553812|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
56553813|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553814|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553816|NCT04250116|Clopidogrel|clopidogrel|mesh-list
56553817|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56553818|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56553819|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56553820|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56553821|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
56553822|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553825|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56706931|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56706932|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56706933|NCT00719264|Growth Substances|growth substances|mesh-ancestor
56706934|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706935|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
56706936|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
56706937|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56706938|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56706939|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
56706940|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56706941|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56706942|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56706943|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706944|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706945|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
56706946|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56706947|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418092|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
56706948|NCT00751959|Poractant alfa|poractant alfa|mesh-list
56706949|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56706950|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
56706951|NCT00723554|Iloprost|iloprost|mesh-list
56706952|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56706953|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
56706954|NCT00687219|Ribavirin|ribavirin|mesh-list
56706955|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56706956|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
56706957|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706975|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
56706976|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
56706977|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56706978|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
56706979|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56706980|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56706981|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56706982|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56706983|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56706984|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56706985|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56706986|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
56706987|NCT02562183|Kallikreins|kallikreins|mesh-list
56706988|NCT02562183|Coagulants|coagulants|mesh-ancestor
56706989|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56706990|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
56706991|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56706992|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56706993|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56706994|NCT00723398|Pitavastatin|pitavastatin|mesh-list
56706995|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56706996|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56706997|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56706998|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
56706999|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707000|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707001|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56707002|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56707003|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
56707004|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707005|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707006|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56262418|NCT00323856|Factor VIII|factor viii|mesh-list
56553826|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
56553827|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56553828|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
56553829|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553830|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
56553831|NCT00659113|Tegafur|tegafur|mesh-list
56707007|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56707008|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56707009|NCT00716456|Cetuximab|cetuximab|mesh-list
56707010|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56707011|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56707012|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707013|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56707014|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707015|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707016|NCT00684645|Sunitinib|sunitinib|mesh-list
56707017|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707018|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56553832|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553833|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56553834|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
56302143|NCT00028717|Rituximab|rituximab|mesh-list
56553835|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553836|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
56553837|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56553838|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
56553839|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553840|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553841|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56553842|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
56553843|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56553844|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56553845|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56553846|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56553847|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553848|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553850|NCT02630095|Warfarin|warfarin|mesh-list
56553851|NCT02630095|Calcium|calcium|mesh-list
56553852|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56553853|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553854|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
56553855|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56553856|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56553857|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553858|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56553859|NCT00669487|Lamivudine|lamivudine|mesh-list
56553860|NCT00669487|Stavudine|stavudine|mesh-list
56553861|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56553862|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56553863|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553864|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553865|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
56553866|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553867|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56553868|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56553869|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
56553870|NCT00669565|Bavituximab|bavituximab|mesh-list
56553871|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56553872|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553873|NCT00669643|Rifampin|rifampin|mesh-list
56553874|NCT00669643|Dapsone|dapsone|mesh-list
56553875|NCT00669643|Clofazimine|clofazimine|mesh-list
56553876|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56553877|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
56553878|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56553879|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553880|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
56553881|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56707019|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56707020|NCT00684645|Growth Substances|growth substances|mesh-ancestor
56707021|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707022|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
56707023|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56707024|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418194|NCT00208611|Vitamins|vitamins|mesh-list
56707025|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707026|NCT00752037|Ritonavir|ritonavir|mesh-list
56707027|NCT00752037|Lopinavir|lopinavir|mesh-list
56707028|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
56707029|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56707030|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56707031|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
56707032|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707033|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707034|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56707035|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56707036|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
56707037|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707038|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56553882|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553883|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553884|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56553885|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56553886|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56553887|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56553888|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56553889|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56553890|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
56553891|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56553892|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56553893|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56553894|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56553896|NCT00669721|Calcium heparin|calcium heparin|mesh-list
56553897|NCT00669721|Nadroparin|nadroparin|mesh-list
56553898|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
56553899|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56553900|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56553901|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553902|NCT00894166|Bupropion|bupropion|mesh-list
56553903|NCT00894166|Nicotine|nicotine|mesh-list
56553904|NCT00894166|Varenicline|varenicline|mesh-list
56553905|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56553906|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
56553907|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553908|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553909|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56553910|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56553911|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
56553912|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56553913|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553914|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56051696|NCT01783574|Androgens|androgens|mesh-ancestor
56707039|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56707040|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56707041|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56707042|NCT00716144|R 115866|r 115866|mesh-list
56707043|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56707044|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707045|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707046|NCT00752115|Paclitaxel|paclitaxel|mesh-list
56707047|NCT00752115|Carboplatin|carboplatin|mesh-list
56707048|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
56707049|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56707050|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707051|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
56707052|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
56707053|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
56707054|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707055|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
56707056|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56707057|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56707058|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707059|NCT00752115|Urological Agents|urological agents|mesh-ancestor
56707060|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
56707061|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
56707062|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56707063|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707064|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56707065|NCT00749385|Naproxen|naproxen|mesh-list
56707066|NCT00749385|Esomeprazole|esomeprazole|mesh-list
56707067|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56707068|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707069|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56707070|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707071|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707079|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707080|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
56707081|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56707082|NCT00748059|Propranolol|propranolol|mesh-list
56707083|NCT00748059|Atropine|atropine|mesh-list
56707084|NCT00748059|Clonidine|clonidine|mesh-list
56707085|NCT00748059|Nitroprusside|nitroprusside|mesh-list
56707086|NCT00748059|Methyldopa|methyldopa|mesh-list
56707087|NCT00748059|Phenylephrine|phenylephrine|mesh-list
56707088|NCT00748059|Isoproterenol|isoproterenol|mesh-list
56707089|NCT00748059|Metoclopramide|metoclopramide|mesh-list
56707090|NCT00748059|Yohimbine|yohimbine|mesh-list
56707091|NCT00748059|Tyramine|tyramine|mesh-list
56707092|NCT00748059|Edrophonium|edrophonium|mesh-list
56707093|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56707094|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56707095|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
56707096|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707097|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707098|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707099|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56707100|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56707101|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
56707102|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56707103|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
56707104|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
56707105|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56553915|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
56553916|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56553917|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56553918|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56553919|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56553920|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
56553921|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56553922|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56553923|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553924|NCT00659503|Ciclesonide|ciclesonide|mesh-list
56553925|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
56553926|NCT00659503|Hormones|hormones|mesh-ancestor
56553927|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553928|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553929|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56553930|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
56553931|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56553932|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56553933|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553934|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
56553935|NCT00670345|Coagulants|coagulants|mesh-ancestor
56553936|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
56553937|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56553938|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553939|NCT00670423|Sirolimus|sirolimus|mesh-list
56553940|NCT00670423|Bortezomib|bortezomib|mesh-list
56707106|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
56707107|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56707108|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
56707109|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
56707110|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56707111|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56707112|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56707113|NCT00748059|Protective Agents|protective agents|mesh-ancestor
56707114|NCT00748059|Analgesics|analgesics|mesh-ancestor
56707115|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
56707116|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
56707117|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56707118|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56553941|NCT00670423|Tacrolimus|tacrolimus|mesh-list
56553942|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56553943|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
56553944|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553945|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56553946|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553947|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553948|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553949|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56553950|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553951|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56553952|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
56553953|NCT00659659|Benralizumab|benralizumab|mesh-list
56553954|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56553955|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
56553957|NCT00670501|Teriparatide|teriparatide|mesh-list
56553958|NCT00670501|Calcium|calcium|mesh-list
56553959|NCT00670501|Vitamins|vitamins|mesh-ancestor
56553960|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
56553961|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553962|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56553963|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56553964|NCT00663247|Mesalamine|mesalamine|mesh-list
56553965|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56553966|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56553967|NCT00663247|Analgesics|analgesics|mesh-ancestor
56553968|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
56553969|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127642|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553972|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553973|NCT01163747|Methotrexate|methotrexate|mesh-list
56553974|NCT01163747|Vaccines|vaccines|mesh-list
56553975|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56553976|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
56553977|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553978|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56553979|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
56553980|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56553981|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56553982|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
56553983|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553984|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56553985|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
56553986|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56553987|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56553988|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56553989|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56553990|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56553991|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56707119|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56707120|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56707121|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
56707122|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56707123|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56707124|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
56707125|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
56707126|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707127|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56707128|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56707129|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
56707130|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56707131|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56707132|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56707133|NCT00748059|Urological Agents|urological agents|mesh-ancestor
56707134|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56707135|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56707136|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56707137|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56707138|NCT00748059|Antidotes|antidotes|mesh-ancestor
56707139|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56707140|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707141|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
56707142|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56707143|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707144|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707145|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707146|NCT00576381|Analgesics|analgesics|mesh-ancestor
56707147|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
56553992|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
56553993|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553994|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56553995|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56553997|NCT05657015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56553998|NCT05657015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56553999|NCT05657015|Antimetabolites|antimetabolites|mesh-ancestor
56554000|NCT05657015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554001|NCT05657015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56554002|NCT05657015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56554003|NCT05657015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554004|NCT02887313|Leucovorin|leucovorin|mesh-list
56554005|NCT02887313|Fluorouracil|fluorouracil|mesh-list
56554006|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
56554007|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
56554008|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707148|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707149|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56707150|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56707151|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56707152|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
56707153|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707154|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707155|NCT02562417|Dexamethasone|dexamethasone|mesh-list
56707156|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707157|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
56707158|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
56707159|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707160|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707161|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707162|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
56707163|NCT02562417|Hormones|hormones|mesh-ancestor
56707164|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707165|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56707166|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707167|NCT00749619|Taurolidine|taurolidine|mesh-list
56707168|NCT00749619|Heparin|heparin|mesh-list
56707169|NCT00749619|Calcium heparin|calcium heparin|mesh-list
56707170|NCT00749619|Citric Acid|citric acid|mesh-list
56707171|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
56707172|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56707173|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
56554009|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56554010|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554011|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554012|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
56554013|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554014|NCT02887313|Antidotes|antidotes|mesh-ancestor
56554015|NCT02887313|Protective Agents|protective agents|mesh-ancestor
56554016|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
56554017|NCT02887313|Vitamins|vitamins|mesh-ancestor
56554018|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
56554019|NCT01206140|Sirolimus|sirolimus|mesh-list
56554020|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56554021|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554022|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56554023|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554024|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
56554025|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554026|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
56554027|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554028|NCT01162421|Adalimumab|adalimumab|mesh-list
56554029|NCT01162421|Methotrexate|methotrexate|mesh-list
56554030|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56554032|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56554033|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554034|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56707174|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56707175|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
56707176|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
56707177|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707178|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56707179|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56707180|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707181|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56707182|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707183|NCT00748371|Aspirin|aspirin|mesh-list
56707184|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56707185|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707186|NCT00748371|Analgesics|analgesics|mesh-ancestor
56707187|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
56707188|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707189|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554035|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
56554036|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554037|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554038|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
56554039|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554040|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56554041|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554042|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
56554043|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554044|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56554047|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56554049|NCT02885441|Analgesics|analgesics|mesh-ancestor
56554050|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
56554051|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554052|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554053|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554054|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554055|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56554056|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554057|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554058|NCT02885597|Methotrexate|methotrexate|mesh-list
56302369|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554059|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56554060|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
56554061|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56554062|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554063|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56554064|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
56554065|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554066|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554067|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
56554068|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554069|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56554070|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554071|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
56554072|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554073|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56554074|NCT01188551|Fentanyl|fentanyl|mesh-list
56554075|NCT01188551|Midazolam|midazolam|mesh-list
56554076|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
56554077|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56051697|NCT01783574|Hormones|hormones|mesh-ancestor
56707190|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707191|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707192|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56707193|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56707194|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707195|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56554078|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554079|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554080|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56554081|NCT01188551|Analgesics|analgesics|mesh-ancestor
56554082|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
56554083|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554084|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56554085|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56554086|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56554087|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
56554088|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554089|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554090|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56554091|NCT01188551|Narcotics|narcotics|mesh-ancestor
56554092|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56554093|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56554094|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
56554095|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
56554096|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56554097|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56554098|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554099|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
56554100|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
56554101|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
56554102|NCT01161407|Calcium|calcium|mesh-list
56554103|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56554104|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554105|NCT01161407|Antacids|antacids|mesh-ancestor
56554106|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554107|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554108|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56554109|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554110|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56554111|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554112|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554113|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56554114|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56554115|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56554118|NCT01159769|Analgesics|analgesics|mesh-ancestor
56554119|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
56554120|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554121|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554122|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554123|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554124|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56554125|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56554126|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56554127|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
56554128|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
56554129|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554130|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554131|NCT01185821|Siponimod|siponimod|mesh-list
56554132|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56554133|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554134|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554135|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
56554136|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554138|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554139|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
56554140|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554141|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707196|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56707197|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707198|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
56707199|NCT00749853|Buserelin|buserelin|mesh-list
56707200|NCT00749853|Hormones|hormones|mesh-list
56707201|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56707202|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707203|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707204|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56707205|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
56707206|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56707207|NCT00684567|Temozolomide|temozolomide|mesh-list
56707208|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56707209|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
56707210|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707211|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707212|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56707213|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56707214|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56707215|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707216|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707217|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56707218|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56707219|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56707220|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
56707221|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707222|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707223|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56707224|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56707225|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
56707226|NCT04053621|Thiamine|thiamine|mesh-list
56707227|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
56707228|NCT04053621|Metformin|metformin|mesh-list
56707229|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56707230|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707231|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
56554142|NCT00891904|Cetuximab|cetuximab|mesh-list
56554143|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56707232|NCT04053621|Vitamins|vitamins|mesh-ancestor
56707233|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
56707234|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
56707235|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554144|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554145|NCT02834260|Dexamethasone|dexamethasone|mesh-list
56554146|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554147|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
56554148|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
56554149|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554150|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554151|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554152|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
56554153|NCT02834260|Hormones|hormones|mesh-ancestor
56554154|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554155|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56554156|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554157|NCT01157351|Olanzapine|olanzapine|mesh-list
56554158|NCT01157351|Risperidone|risperidone|mesh-list
56554159|NCT01157351|Aripiprazole|aripiprazole|mesh-list
56554160|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56554161|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56554162|NCT01157351|Perphenazine|perphenazine|mesh-list
56554163|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56554164|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
56554165|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554166|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554167|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554168|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56554169|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56554170|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554171|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554172|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56554173|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
56554174|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
56554175|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
56554176|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554177|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554178|NCT01157351|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56554179|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56554180|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56554181|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
56554183|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56554184|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56554185|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56554186|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56554187|NCT02831686|Dexamethasone|dexamethasone|mesh-list
56554188|NCT02831686|Ixazomib|ixazomib|mesh-list
56554189|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554192|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554193|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554194|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554195|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
56554196|NCT02831686|Hormones|hormones|mesh-ancestor
56554197|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554198|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56554199|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554200|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
56554201|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554202|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554203|NCT00633490|Apatinib|apatinib|mesh-list
56554204|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554205|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56554206|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554207|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554208|NCT02831374|Anesthetics|anesthetics|mesh-list
56554209|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554210|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554211|NCT02831218|Aspirin|aspirin|mesh-list
56554212|NCT02831218|Clopidogrel|clopidogrel|mesh-list
56554213|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56554214|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707236|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56707237|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707238|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707239|NCT02562651|Doxycycline|doxycycline|mesh-list
56707240|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56707241|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707242|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
56707243|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56707244|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56707245|NCT00748527|Carboplatin|carboplatin|mesh-list
56707246|NCT00748527|Decitabine|decitabine|mesh-list
56707247|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707248|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56707249|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
56707250|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707251|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707252|NCT00686829|Maleic acid|maleic acid|mesh-list
56707253|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707254|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707255|NCT00687297|Carboplatin|carboplatin|mesh-list
56707257|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707258|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
56707259|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
56707260|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
56707261|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707262|NCT00684177|Retapamulin|retapamulin|mesh-list
56707263|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56707264|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707265|NCT00686595|Infliximab|infliximab|mesh-list
56707266|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
56707267|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707268|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707269|NCT00752661|Tramadol|tramadol|mesh-list
56262684|NCT04910386|Gemcitabine|gemcitabine|mesh-list
56554215|NCT02831218|Analgesics|analgesics|mesh-ancestor
56554216|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
56554217|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554218|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554219|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554220|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554221|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56554222|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56108887|NCT00004141|Sargramostim|sargramostim|mesh-list
56707270|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56707271|NCT00752661|Narcotics|narcotics|mesh-ancestor
56707272|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707273|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707274|NCT00752661|Analgesics|analgesics|mesh-ancestor
56707275|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
56707276|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707277|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
56707278|NCT00576303|Hematinics|hematinics|mesh-ancestor
56707279|NCT00752739|Selenium|selenium|mesh-list
56707280|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
55876217|NCT04276389|Paclitaxel|paclitaxel|mesh-list
56554223|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554224|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56554225|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56554226|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554227|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
56554228|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56554229|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56554230|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56554231|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
56554232|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554233|NCT02833480|Fluticasone|fluticasone|mesh-list
56554234|NCT02833480|Budesonide|budesonide|mesh-list
56554235|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
56554236|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554237|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56554238|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
56554239|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554240|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554241|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56554242|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
56554243|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
56554244|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56554245|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
56554246|NCT02833480|Hormones|hormones|mesh-ancestor
56554247|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554248|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56554249|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56554250|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56554251|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
56554252|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554253|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554254|NCT04201054|Fluconazole|fluconazole|mesh-list
56554255|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
56554256|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554257|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56554258|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56554259|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554260|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554261|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56554263|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554264|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554265|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56554266|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56554268|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56554269|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56554270|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56554271|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
56554272|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
56554273|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554274|NCT00891202|Eliglustat|eliglustat|mesh-list
56554275|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707281|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707282|NCT00752739|Protective Agents|protective agents|mesh-ancestor
56707283|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554276|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554277|NCT02830906|Ondansetron|ondansetron|mesh-list
56554278|NCT02830906|Ramosetron|ramosetron|mesh-list
56554279|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
56554280|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
56554281|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302594|NCT00000524|Cyclosporine|cyclosporine|mesh-list
56554282|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554283|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554284|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
56554285|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56554286|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56554287|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
56554288|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554289|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554290|NCT02830906|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56554291|NCT02830906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56554292|NCT02830906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554293|NCT02830906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554294|NCT02830906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56554295|NCT02832778|Tenofovir|tenofovir|mesh-list
56554296|NCT02832778|Lamivudine|lamivudine|mesh-list
56554297|NCT02832778|Zidovudine|zidovudine|mesh-list
56554298|NCT02832778|Emtricitabine|emtricitabine|mesh-list
56554299|NCT02832778|Efavirenz|efavirenz|mesh-list
56554300|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56554301|NCT02832778|Isoniazid|isoniazid|mesh-list
56554302|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
56554303|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554304|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56554305|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56554306|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554307|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554308|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56554309|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56554310|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
56554311|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56554312|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56554313|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56554314|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56554315|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56554316|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56554317|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
56554318|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56554319|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56554320|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56554321|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56554322|NCT01185509|Trastuzumab|trastuzumab|mesh-list
56554323|NCT01185509|Vinorelbine|vinorelbine|mesh-list
56554324|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56554325|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554326|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56554327|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
56554328|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
56554329|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
56554330|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554331|NCT04247230|Tetracaine|tetracaine|mesh-list
56554332|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
56554333|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
56554334|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554335|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554336|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
56554337|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554339|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
56554340|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
56554341|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554342|NCT02831842|Bevacizumab|bevacizumab|mesh-list
56554343|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262725|NCT04547946|Trametinib|trametinib|mesh-list
56262726|NCT04547946|Dabrafenib|dabrafenib|mesh-list
56262727|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262728|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56262729|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707284|NCT00752739|Trace Elements|trace elements|mesh-ancestor
56707285|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
56707286|NCT00755781|Cyclosporine|cyclosporine|mesh-list
56707287|NCT00755781|Cyclosporins|cyclosporins|mesh-list
56707288|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707289|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707290|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56707291|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
56707292|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707293|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
56707294|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707295|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
56707296|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707297|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56707298|NCT00755859|Prednisone|prednisone|mesh-list
56707299|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56707300|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56707301|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
56707302|NCT00755859|Prednisolone|prednisolone|mesh-list
56707303|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
56707304|NCT00755859|Azathioprine|azathioprine|mesh-list
56707305|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56707306|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
56707307|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
56707308|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707309|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56707310|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707311|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56707312|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
56707321|NCT00755859|Protective Agents|protective agents|mesh-ancestor
56707322|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
56707323|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
56707324|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707325|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707326|NCT00686517|Interferons|interferons|mesh-list
56707327|NCT00686517|Ribavirin|ribavirin|mesh-list
56707328|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
56707329|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
56707330|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56707331|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707332|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
56707333|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707334|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
56707335|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707336|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
56707337|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707338|NCT00571701|Celecoxib|celecoxib|mesh-list
56707339|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56707340|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707341|NCT00571701|Analgesics|analgesics|mesh-ancestor
56707342|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
56707343|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707344|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707345|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707346|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56262764|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554344|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554345|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56554346|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56554347|NCT02831842|Growth Substances|growth substances|mesh-ancestor
56554348|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554349|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
56554350|NCT02830048|Glyburide|glyburide|mesh-list
56554351|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56554352|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554353|NCT02830126|Anesthetics|anesthetics|mesh-list
56554354|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554355|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554356|NCT02828566|Ketamine|ketamine|mesh-list
56554357|NCT02828566|Analgesics|analgesics|mesh-ancestor
56554358|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
56554359|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554360|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554361|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56554362|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56554363|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
56554364|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
56554365|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707347|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56707348|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56707349|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707350|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707351|NCT00686127|Lidocaine|lidocaine|mesh-list
56707352|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
56707353|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
56707354|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707355|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707356|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
56707357|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707358|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56707359|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56707360|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56707361|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56707362|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707363|NCT00718718|Methotrexate|methotrexate|mesh-list
56554366|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56554367|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56554368|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554369|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554370|NCT04245046|Amlodipine|amlodipine|mesh-list
56554371|NCT04245046|Candesartan|candesartan|mesh-list
56554372|NCT04245046|Atorvastatin|atorvastatin|mesh-list
56554373|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56554374|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56554375|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
56554376|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554377|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56554378|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56554379|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554380|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56554381|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56554382|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56554383|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56554384|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554385|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
56554386|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56554387|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56554388|NCT02828176|Anesthetics|anesthetics|mesh-list
56554389|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56334871|NCT03439865|Ivacaftor|ivacaftor|mesh-list
56554390|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554391|NCT00633568|Cisplatin|cisplatin|mesh-list
56554392|NCT00633568|Docetaxel|docetaxel|mesh-list
56554393|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554394|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
56554395|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
56554396|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
56554397|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554398|NCT02829424|Methotrexate|methotrexate|mesh-list
56554399|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56554400|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
56554401|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56554402|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707364|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56707365|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56707366|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
56707367|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56707368|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707369|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56707370|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
56707371|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707372|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707373|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
56707374|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707375|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56707376|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56707377|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
56707378|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707379|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56707380|NCT00683787|Docetaxel|docetaxel|mesh-list
56707381|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707382|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
56554403|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56554404|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
56554405|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554406|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554407|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
56554408|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554409|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56554410|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554411|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
56554412|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554413|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56554415|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56554416|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56554417|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554418|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
56554419|NCT02829346|Coagulants|coagulants|mesh-ancestor
56554420|NCT05210764|Ketamine|ketamine|mesh-list
56554421|NCT05210764|Anesthetics|anesthetics|mesh-list
56554422|NCT05210764|Propofol|propofol|mesh-list
56554423|NCT05210764|Sevoflurane|sevoflurane|mesh-list
56554424|NCT05210764|Esketamine|esketamine|mesh-list
56554425|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554426|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554427|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56554428|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56554429|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
56302742|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554430|NCT05210764|Analgesics|analgesics|mesh-ancestor
56554431|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
56554432|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554433|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56554434|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56554435|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56554436|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554437|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554438|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56707383|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
56707384|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
56707385|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707386|NCT05393271|Midazolam|midazolam|mesh-list
56707387|NCT05393271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56707388|NCT05393271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56707389|NCT05393271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707390|NCT05393271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707391|NCT05393271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56707392|NCT05393271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56707393|NCT05393271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56707394|NCT05393271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56707395|NCT05393271|Anesthetics, General|anesthetics, general|mesh-ancestor
56707396|NCT05393271|Anesthetics|anesthetics|mesh-ancestor
56707397|NCT05393271|GABA Modulators|gaba modulators|mesh-ancestor
56707398|NCT05393271|GABA Agents|gaba agents|mesh-ancestor
56707399|NCT05393271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707400|NCT05393271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707401|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
56707402|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707403|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
56707404|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707405|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707406|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56707408|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56707409|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56707410|NCT00750399|Growth Substances|growth substances|mesh-ancestor
56707411|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707412|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
56707413|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707427|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707428|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
56707429|NCT00718640|Hormones|hormones|mesh-ancestor
56707430|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707431|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56707432|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707433|NCT00753051|Haloperidol|haloperidol|mesh-list
56707434|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
56707435|NCT00753051|Clozapine|clozapine|mesh-list
56707436|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
56707437|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
56707438|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707439|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707440|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707441|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56707442|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56707443|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707444|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56707445|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56707446|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
56707447|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707448|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707449|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56262875|NCT03626922|Hematinics|hematinics|mesh-ancestor
56554439|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56554440|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
56554441|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554443|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56554444|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56554445|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
56554446|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554447|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554448|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554449|NCT01116648|Olaparib|olaparib|mesh-list
56554450|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56554451|NCT01116648|Cediranib|cediranib|mesh-list
56554452|NCT01116648|Maleic acid|maleic acid|mesh-list
56554453|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554454|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554455|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554456|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56554457|NCT04243954|Morphine|morphine|mesh-list
56554458|NCT04243954|Hydromorphone|hydromorphone|mesh-list
56554459|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56554460|NCT04243954|Narcotics|narcotics|mesh-ancestor
56554461|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554462|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554463|NCT04243954|Analgesics|analgesics|mesh-ancestor
56554464|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
56554465|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554466|NCT02827942|Amoxicillin|amoxicillin|mesh-list
56554467|NCT02827942|Metronidazole|metronidazole|mesh-list
56707450|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56707451|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
56707452|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
56707453|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
56707454|NCT00753207|Epirubicin|epirubicin|mesh-list
56707455|NCT00753207|Lapatinib|lapatinib|mesh-list
56707456|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56707457|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707458|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56707459|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56707460|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707461|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707462|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56707463|NCT00715910|Vaccines|vaccines|mesh-list
56707464|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
56707465|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707466|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56707467|NCT00715676|Vitamins|vitamins|mesh-ancestor
56554468|NCT02827942|Clarithromycin|clarithromycin|mesh-list
56554469|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56554470|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554471|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56554472|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56554473|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56554474|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554475|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554476|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56554477|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56554478|NCT00889252|Ketotifen|ketotifen|mesh-list
56554479|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
56554480|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
56554481|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56128166|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
56554482|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
56554483|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
56554484|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554485|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554486|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554487|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56554488|NCT00670813|Modafinil|modafinil|mesh-list
56554489|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56554490|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554491|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56554492|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56554493|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56554494|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554495|NCT01110330|Ketoconazole|ketoconazole|mesh-list
56554496|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
56554497|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554498|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56554499|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56554500|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554501|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554502|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56554503|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
56554504|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707468|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
56707469|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707470|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56707471|NCT00718328|Simvastatin|simvastatin|mesh-list
56707472|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56707473|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56707474|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
56707475|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707476|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56707477|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56707478|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707479|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56707480|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56707481|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56707482|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56707483|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707484|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707485|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707486|NCT02590874|Analgesics|analgesics|mesh-ancestor
56707487|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
56707488|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707489|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
56707490|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554506|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56554507|NCT00663481|Leucovorin|leucovorin|mesh-list
56554508|NCT00663481|Antidotes|antidotes|mesh-ancestor
56554509|NCT00663481|Protective Agents|protective agents|mesh-ancestor
56554510|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554511|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
56554512|NCT00663481|Vitamins|vitamins|mesh-ancestor
56554513|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
56554514|NCT04308954|Flumazenil|flumazenil|mesh-list
56554515|NCT04308954|Antidotes|antidotes|mesh-ancestor
56554516|NCT04308954|Protective Agents|protective agents|mesh-ancestor
56554517|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554518|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
56554519|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
56554520|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554521|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554522|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
56554523|NCT00596947|Prednisone|prednisone|mesh-list
56554524|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
56554525|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56554526|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56554527|NCT00596947|Prednisolone|prednisolone|mesh-list
56554528|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
56554529|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56554530|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
56554531|NCT00596947|Tacrolimus|tacrolimus|mesh-list
56554532|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
56707491|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
56707492|NCT00715520|Levodopa|levodopa|mesh-list
56707493|NCT00715520|Carbidopa|carbidopa|mesh-list
56707494|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56707495|NCT00715520|Methylphenidate|methylphenidate|mesh-list
56707496|NCT00715520|Amphetamine|amphetamine|mesh-list
56707497|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56707498|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707499|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56707500|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56707501|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56707502|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707503|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
56707504|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707505|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56707506|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56707507|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56707508|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707509|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
56707510|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
56707511|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707512|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
56707513|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56707514|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56707515|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
56707516|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
56707517|NCT00680901|Capecitabine|capecitabine|mesh-list
56707518|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
56707519|NCT00680901|Lapatinib|lapatinib|mesh-list
56707537|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707538|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707539|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56707540|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56707541|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707542|NCT00790205|Incretins|incretins|mesh-ancestor
56707543|NCT00790205|Hormones|hormones|mesh-ancestor
56707544|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707545|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56707546|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
56707547|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707548|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707549|NCT04056039|Colchicine|colchicine|mesh-list
56707550|NCT04056039|Atorvastatin|atorvastatin|mesh-list
56707551|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56707552|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56707553|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
56707554|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707555|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56707556|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56707557|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707558|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
56707559|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707560|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
56707561|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
56707562|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
56707563|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707564|NCT00715208|Prednisone|prednisone|mesh-list
56707565|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
56707566|NCT00715208|Rituximab|rituximab|mesh-list
56707567|NCT00715208|Doxorubicin|doxorubicin|mesh-list
56707568|NCT00715208|Bortezomib|bortezomib|mesh-list
56707569|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56707570|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
56707571|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707576|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707577|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56707578|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56707579|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56707580|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56707581|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56707582|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707583|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707584|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
56707585|NCT00715208|Hormones|hormones|mesh-ancestor
56707586|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707587|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56707588|NCT00919178|Vaccines|vaccines|mesh-list
56707589|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
56707590|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707591|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
56707592|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56707593|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56707594|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56707595|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56707596|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707597|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
56707598|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707599|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707600|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56707601|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707602|NCT00775463|Treprostinil|treprostinil|mesh-list
56707603|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56707604|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
56707605|NCT02589782|Linezolid|linezolid|mesh-list
56707620|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56707621|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
56707622|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56707623|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707624|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56707625|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
56707626|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707627|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707628|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
56547665|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56707629|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707630|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56707631|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56707632|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
56707633|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707634|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56707636|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
56707637|NCT05533775|Carboplatin|carboplatin|mesh-list
56707638|NCT05533775|Etoposide|etoposide|mesh-list
56707639|NCT05533775|Ifosfamide|ifosfamide|mesh-list
56707640|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56707641|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707642|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
56707643|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707644|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707645|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56707646|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56707647|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56707648|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707649|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707650|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56707651|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
56707652|NCT02590016|Insulin|insulin|mesh-list
56707653|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
56707654|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56707656|NCT00768053|Etanercept|etanercept|mesh-list
56707658|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707659|NCT00768053|Analgesics|analgesics|mesh-ancestor
56707660|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
56707661|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707662|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707663|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707664|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707665|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707666|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56707667|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
56707668|NCT00683475|Prednisone|prednisone|mesh-list
56707669|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
56707670|NCT00683475|Ramucirumab|ramucirumab|mesh-list
56707671|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56707672|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707673|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
56707674|NCT00683475|Hormones|hormones|mesh-ancestor
56707675|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707676|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707677|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56707678|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707679|NCT00683475|Analgesics|analgesics|mesh-ancestor
56707680|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
56707681|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707682|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56707683|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56707684|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707685|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707686|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
56707687|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56707703|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418851|NCT02963324|Ivermectin|ivermectin|mesh-list
56707704|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56707705|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56707706|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56707707|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707708|NCT00757029|Norepinephrine|norepinephrine|mesh-list
56707709|NCT00757029|Methylphenidate|methylphenidate|mesh-list
56707710|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56707711|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707712|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56707713|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56707714|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56707715|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707716|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
56707717|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707718|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56707719|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56707720|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
56707721|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
56707722|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
56707723|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707724|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56554533|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56554534|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554535|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
56554536|NCT00596947|Hormones|hormones|mesh-ancestor
56554537|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988116|NCT04355455|Citalopram|citalopram|mesh-list
56554538|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554539|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56554540|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554541|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554542|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
56554543|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56554544|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554545|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554546|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56554547|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56554548|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
56554549|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56554550|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554551|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
56554552|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
56554553|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554554|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554555|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56554556|NCT00596947|Protective Agents|protective agents|mesh-ancestor
56554558|NCT04155697|Ethanol|ethanol|mesh-list
56707725|NCT04101929|Irinotecan|irinotecan|mesh-list
56707726|NCT04101929|Apatinib|apatinib|mesh-list
56707727|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56707728|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56707729|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707730|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707731|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707732|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56707733|NCT00918632|Axitinib|axitinib|mesh-list
56707734|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707735|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56707736|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707737|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707738|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
56707739|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56707740|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
56707741|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707742|NCT00751257|Expectorants|expectorants|mesh-ancestor
56707743|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
56707744|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56707745|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
56707746|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707747|NCT00751257|Protective Agents|protective agents|mesh-ancestor
56707748|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707749|NCT00751257|Antidotes|antidotes|mesh-ancestor
56707750|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
56707751|NCT00757185|Testosterone|testosterone|mesh-list
56707752|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
56707753|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
56707754|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56707755|NCT00757185|Ganirelix|ganirelix|mesh-list
56707756|NCT00757185|Androgens|androgens|mesh-ancestor
56707757|NCT00757185|Hormones|hormones|mesh-ancestor
56263170|NCT01946295|Famotidine|famotidine|mesh-list
56554559|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56554560|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554561|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
56554562|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554563|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554564|NCT00663559|Sunitinib|sunitinib|mesh-list
56554565|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554566|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56554567|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56554568|NCT00663559|Growth Substances|growth substances|mesh-ancestor
56707758|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707759|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707760|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56707761|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707762|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
56707763|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
56707764|NCT00751491|Clopidogrel|clopidogrel|mesh-list
56707765|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56707766|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56707767|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56707768|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56707819|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
56707820|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707821|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56707822|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56707823|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56707824|NCT00753909|Growth Substances|growth substances|mesh-ancestor
56707825|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707826|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
56707827|NCT05132582|Trastuzumab|trastuzumab|mesh-list
56707828|NCT05132582|Pertuzumab|pertuzumab|mesh-list
56707829|NCT05132582|Tucatinib|tucatinib|mesh-list
56707830|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56707831|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707832|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56707833|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707834|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707835|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
56707836|NCT02560155|Mupirocin|mupirocin|mesh-list
56707837|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56707838|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707839|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
56707840|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56707841|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56707842|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707843|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707844|NCT02559921|Vaccines|vaccines|mesh-list
56707845|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
56707846|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707868|NCT00784277|Oxycodone|oxycodone|mesh-list
56707869|NCT00784277|Tapentadol|tapentadol|mesh-list
56707870|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56707871|NCT00784277|Narcotics|narcotics|mesh-ancestor
56707872|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707873|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707874|NCT00784277|Analgesics|analgesics|mesh-ancestor
56707875|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
56707876|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707877|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56707878|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56707879|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56707880|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707881|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
56707882|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56707883|NCT05113784|Meplazumab|meplazumab|mesh-list
56707884|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
56707885|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707886|NCT05684744|Methotrexate|methotrexate|mesh-list
56707887|NCT05684744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56707888|NCT05684744|Abortifacient Agents|abortifacient agents|mesh-ancestor
56707889|NCT05684744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56707890|NCT05684744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707891|NCT05684744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56707892|NCT05684744|Antimetabolites|antimetabolites|mesh-ancestor
56707893|NCT05684744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707894|NCT05684744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707895|NCT05684744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56707896|NCT05684744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707897|NCT05684744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56707898|NCT05684744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56707899|NCT05684744|Immunologic Factors|immunologic factors|mesh-ancestor
56707907|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707908|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707909|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707910|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707911|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707912|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56707913|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
56707914|NCT05109728|Temozolomide|temozolomide|mesh-list
56707915|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56707916|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56707917|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56707918|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
56707919|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707920|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707921|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
56707922|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
56707923|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56707924|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
56707925|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56707926|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56707927|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707928|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
56707929|NCT05099276|Coagulants|coagulants|mesh-ancestor
56707930|NCT00682929|Dronabinol|dronabinol|mesh-list
56707931|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
56707932|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707933|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56707953|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
56707954|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56707955|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
56707956|NCT00758199|Hormones|hormones|mesh-ancestor
56707957|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56707958|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707959|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56707960|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56707961|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
56707962|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
56707963|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56707964|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56707965|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56707966|NCT00758199|Protective Agents|protective agents|mesh-ancestor
56707967|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56707968|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56707969|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56707970|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56707971|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707972|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707973|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56707974|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
56707975|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56707976|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56707977|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56707978|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56707979|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56707980|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56707981|NCT00758199|Analgesics|analgesics|mesh-ancestor
56707982|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
56707983|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56707984|NCT05683808|Apixaban|apixaban|mesh-list
56707985|NCT05683808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56707986|NCT05683808|Antithrombins|antithrombins|mesh-ancestor
56554569|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554570|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
56554571|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56554572|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554573|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554574|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
56707987|NCT05683808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56707988|NCT05683808|Protease Inhibitors|protease inhibitors|mesh-ancestor
56707989|NCT05683808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56707990|NCT05683808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56707991|NCT05683808|Anticoagulants|anticoagulants|mesh-ancestor
56707992|NCT05077904|Alprazolam|alprazolam|mesh-list
56707993|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56707994|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56707995|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56707996|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56707997|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56707998|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56707999|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
56708000|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
56708001|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708002|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708003|NCT00680745|Metformin|metformin|mesh-list
56708004|NCT00680745|Pioglitazone|pioglitazone|mesh-list
56708005|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
56708006|NCT00680745|Glimepiride|glimepiride|mesh-list
56708007|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
56708008|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56708009|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708010|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56708011|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708012|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56708013|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708014|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
56708015|NCT05434377|Vitamin D|vitamin d|mesh-list
56708016|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
56708017|NCT05434377|Vitamins|vitamins|mesh-ancestor
56708018|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
56708019|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708020|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56708021|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56708022|NCT05428293|Acetaminophen|acetaminophen|mesh-list
56708027|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708028|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708029|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
56708030|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56708031|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708032|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708033|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56708034|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708035|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708036|NCT05427825|Anesthetics|anesthetics|mesh-list
56708037|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56708038|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708039|NCT00680121|Benphothiamine|benphothiamine|mesh-list
56708040|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56708041|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
56708042|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708043|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
56708044|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
56708045|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708046|NCT00754689|Metformin|metformin|mesh-list
56708047|NCT00754689|Rimonabant|rimonabant|mesh-list
56708048|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56708049|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708050|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56708051|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56708052|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56708053|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708054|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708071|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708072|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708073|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708074|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708075|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
56708076|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56708077|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708078|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708080|NCT00679341|Trastuzumab|trastuzumab|mesh-list
56708081|NCT00679341|Maytansine|maytansine|mesh-list
56708082|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56708083|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708084|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
56708085|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708086|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708087|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708088|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708089|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56708090|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
56708091|NCT00680043|Hematinics|hematinics|mesh-ancestor
56708092|NCT05065190|Nintedanib|nintedanib|mesh-list
56708093|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708094|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56708095|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708096|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708097|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56708098|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56708099|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708100|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56708101|NCT00682539|Triamcinolone|triamcinolone|mesh-list
56708102|NCT00682539|Bevacizumab|bevacizumab|mesh-list
56708103|NCT00682539|Ranibizumab|ranibizumab|mesh-list
56708104|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708105|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708106|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56708107|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56554575|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708108|NCT00682539|Growth Substances|growth substances|mesh-ancestor
56708109|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708110|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
56708111|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708112|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
56708113|NCT00682539|Hormones|hormones|mesh-ancestor
56708114|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708115|NCT00682461|Nicotine|nicotine|mesh-list
56708116|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56708117|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
56708118|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708119|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708120|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56708121|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56708122|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
56708123|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708124|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708125|NCT00921765|Ketamine|ketamine|mesh-list
56708126|NCT00921765|Naloxone|naloxone|mesh-list
56708127|NCT00921765|Analgesics|analgesics|mesh-ancestor
56708128|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
56708129|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708130|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708131|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56708132|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56708133|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
56708134|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
56708135|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56708136|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56708137|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56708138|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708139|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708140|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56708141|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
56708143|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56708147|NCT00755157|Docetaxel|docetaxel|mesh-list
56708148|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708149|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708150|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56708151|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56708152|NCT00755157|Growth Substances|growth substances|mesh-ancestor
56708153|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708154|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
56708155|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
56708156|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708157|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708158|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708160|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56708161|NCT00919880|Carboplatin|carboplatin|mesh-list
56708162|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56708163|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708164|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
56708165|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708166|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708167|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708168|NCT04844606|Mirikizumab|mirikizumab|mesh-list
56708169|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56708170|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56708171|NCT04844606|Analgesics|analgesics|mesh-ancestor
56708181|NCT00755313|Docetaxel|docetaxel|mesh-list
56708198|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708199|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56708200|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56708201|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56708202|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708203|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708204|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56708205|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56708206|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56708207|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
56708208|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708209|NCT04082858|Midazolam|midazolam|mesh-list
56708210|NCT04082858|Ketamine|ketamine|mesh-list
56708211|NCT04082858|Analgesics|analgesics|mesh-ancestor
56708212|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
56708213|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708214|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708215|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56708216|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56708217|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
56708218|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
56708219|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56708220|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56708221|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56708222|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708223|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708224|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56708225|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56708226|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56708227|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56708228|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56708229|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
56708230|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
56708231|NCT05683574|Etoricoxib|etoricoxib|mesh-list
56708232|NCT05683574|Amitriptyline|amitriptyline|mesh-list
56708237|NCT05683574|Sensory System Agents|sensory system agents|mesh-ancestor
56708238|NCT05683574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708239|NCT05683574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708240|NCT05683574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708241|NCT05683574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708242|NCT05683574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56708243|NCT05683574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56708244|NCT05683574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708245|NCT05683574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708246|NCT05683574|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56708247|NCT05683574|Antidepressive Agents|antidepressive agents|mesh-ancestor
56708248|NCT05683574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56708249|NCT05683574|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56708297|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708298|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56708299|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
56708300|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56708301|NCT05004350|Fluorouracil|fluorouracil|mesh-list
56708302|NCT05004350|Irinotecan|irinotecan|mesh-list
56708303|NCT05004350|Cetuximab|cetuximab|mesh-list
56708304|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
56708305|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708306|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56708307|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708308|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708309|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
56708310|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708311|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56708312|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56708313|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708314|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708315|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
56708316|NCT05122221|Fludarabine|fludarabine|mesh-list
56708317|NCT05122221|Interleukin-2|interleukin-2|mesh-list
56708318|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708319|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
56708320|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708321|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708322|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56708323|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
56708324|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708325|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708326|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56708327|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56708339|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708340|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
56708341|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708342|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56708343|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708344|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708345|NCT02587130|Ketamine|ketamine|mesh-list
56708346|NCT02587130|Analgesics|analgesics|mesh-ancestor
56708347|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
56708348|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708349|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708350|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56708351|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56708352|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
56708353|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
56708354|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56708355|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56708356|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56708394|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708395|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708396|NCT00678795|Nabiximols|nabiximols|mesh-list
56708397|NCT00678795|Analgesics|analgesics|mesh-ancestor
56708398|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
56708399|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708400|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708401|NCT04774406|Olaparib|olaparib|mesh-list
56708402|NCT04774406|Niraparib|niraparib|mesh-list
56708403|NCT04774406|Veliparib|veliparib|mesh-list
56708404|NCT04774406|Talazoparib|talazoparib|mesh-list
56708405|NCT04774406|Rucaparib|rucaparib|mesh-list
56708406|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56708407|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708408|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708409|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708410|NCT03417687|Xenon|xenon|mesh-list
56708411|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56708412|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
56708413|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
56708414|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56708415|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708416|NCT04767698|Belimumab|belimumab|mesh-list
56708417|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
56708418|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708419|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
56708420|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708421|NCT05674994|Prednisone|prednisone|mesh-list
56708422|NCT05674994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708423|NCT05674994|Glucocorticoids|glucocorticoids|mesh-ancestor
56708424|NCT05674994|Hormones|hormones|mesh-ancestor
56708425|NCT05674994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708426|NCT05674994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708427|NCT05674994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56708428|NCT05674994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708429|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56708430|NCT03205137|Amlodipine|amlodipine|mesh-list
56708431|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56708433|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56708434|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
56708435|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56708436|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56708437|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56708438|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708439|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56708440|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708441|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
56708442|NCT03205137|Diuretics|diuretics|mesh-ancestor
56708443|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
56708444|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56708445|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56708446|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56708447|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
56708448|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708449|NCT00678561|Tofacitinib|tofacitinib|mesh-list
56708450|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56708451|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708485|NCT05683340|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56708486|NCT05683340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56708487|NCT05683340|Antimetabolites|antimetabolites|mesh-ancestor
56708488|NCT05683340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708489|NCT05683340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56708490|NCT05683340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708491|NCT05683340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56708492|NCT05683340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708493|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
56708494|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
56708495|NCT04904588|Melphalan|melphalan|mesh-list
56708496|NCT04904588|Busulfan|busulfan|mesh-list
56708497|NCT04904588|Fludarabine|fludarabine|mesh-list
56708498|NCT04904588|Tacrolimus|tacrolimus|mesh-list
56708499|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708500|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
56708501|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708502|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708503|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56708504|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
56708539|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56708540|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708541|NCT02586194|Peficitinib|peficitinib|mesh-list
56708542|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708543|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708544|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708545|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
56708546|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708547|NCT00761241|Gemcitabine|gemcitabine|mesh-list
56708548|NCT00761241|Interferons|interferons|mesh-list
56708549|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
56708550|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56708551|NCT00761241|Docetaxel|docetaxel|mesh-list
56708552|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
56708553|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56708554|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
56708555|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708556|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708557|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
56708558|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708559|NCT00761241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708560|NCT00761241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708561|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
56708562|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708563|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
56708564|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708565|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708587|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56708588|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708589|NCT02981979|Prednisone|prednisone|mesh-list
56708590|NCT02981979|Leflunomide|leflunomide|mesh-list
56708591|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708592|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
56708593|NCT02981979|Hormones|hormones|mesh-ancestor
56708594|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708595|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708596|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56708597|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708598|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708599|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708600|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708601|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
56708602|NCT04049409|Trastuzumab|trastuzumab|mesh-list
56708603|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708604|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708605|NCT00920660|Prednisolone|prednisolone|mesh-list
56708606|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708607|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
56708608|NCT00920660|Hormones|hormones|mesh-ancestor
56708609|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708610|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708611|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56708612|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708613|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
56708614|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56708616|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56708630|NCT00675597|Vinorelbine|vinorelbine|mesh-list
56708631|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708632|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708633|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56708634|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56708635|NCT00675597|Growth Substances|growth substances|mesh-ancestor
56708636|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708637|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
56708638|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
56708639|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708640|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708641|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708642|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56708643|NCT02677545|Aspirin|aspirin|mesh-list
56708644|NCT02677545|Clopidogrel|clopidogrel|mesh-list
56708645|NCT02677545|Ticagrelor|ticagrelor|mesh-list
56708647|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56708688|NCT00675441|Growth Substances|growth substances|mesh-ancestor
56708689|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
56708690|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708691|NCT02559297|Sevoflurane|sevoflurane|mesh-list
56708692|NCT02559297|Desflurane|desflurane|mesh-list
56708693|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56708694|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56708695|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
56708696|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
56708697|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56708698|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708699|NCT02558517|Prednisone|prednisone|mesh-list
56708700|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708701|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
56708702|NCT02558517|Hormones|hormones|mesh-ancestor
56708703|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708704|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708705|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56708706|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708707|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56708708|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708709|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56708710|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708711|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708712|NCT00673179|Leucovorin|leucovorin|mesh-list
56708713|NCT00673179|Gemcitabine|gemcitabine|mesh-list
56708714|NCT00673179|Doxorubicin|doxorubicin|mesh-list
56708715|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56708716|NCT00673179|Methotrexate|methotrexate|mesh-list
56708717|NCT00673179|Ifosfamide|ifosfamide|mesh-list
56708718|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
56708719|NCT00673179|Razoxane|razoxane|mesh-list
56708720|NCT00673179|Sargramostim|sargramostim|mesh-list
56708721|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708723|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
56708731|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56708732|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56708733|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56708734|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56708735|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
56708736|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56708737|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
56708738|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56708739|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708740|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56708741|NCT00673179|Antidotes|antidotes|mesh-ancestor
56708742|NCT00673179|Protective Agents|protective agents|mesh-ancestor
56708743|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
56708744|NCT00673179|Vitamins|vitamins|mesh-ancestor
56708745|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
56708746|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56708747|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
56708791|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56708792|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
56708793|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708794|NCT04521686|Antiviral Agents|antiviral agents|mesh-ancestor
56708795|NCT04521686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708796|NCT04521686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708797|NCT04521686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708798|NCT04521686|Immunologic Factors|immunologic factors|mesh-ancestor
56708799|NCT04521686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708800|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708801|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56708802|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56708803|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
56708804|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56708805|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56708806|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
56708807|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56708808|NCT04430738|Leucovorin|leucovorin|mesh-list
56708809|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
56708810|NCT04430738|Trastuzumab|trastuzumab|mesh-list
56708811|NCT04430738|Fluorouracil|fluorouracil|mesh-list
56708812|NCT04430738|Capecitabine|capecitabine|mesh-list
56708813|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
56708814|NCT04430738|Tucatinib|tucatinib|mesh-list
56708815|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56708842|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56708843|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708844|NCT02582996|Acetaminophen|acetaminophen|mesh-list
56708845|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
56708846|NCT02582996|Metoclopramide|metoclopramide|mesh-list
56708847|NCT02582996|Caffeine|caffeine|mesh-list
56708848|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56708849|NCT02582996|Analgesics|analgesics|mesh-ancestor
56708850|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
56708851|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708852|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708853|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
56708854|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56708855|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56708856|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56708857|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708862|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
56708904|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56708905|NCT00764907|Methotrexate|methotrexate|mesh-list
56708906|NCT00764907|Etoposide|etoposide|mesh-list
56708907|NCT00764907|Vincristine|vincristine|mesh-list
56708908|NCT00764907|Daunorubicin|daunorubicin|mesh-list
56547666|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
56708909|NCT00764907|Asparaginase|asparaginase|mesh-list
56708910|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
56708911|NCT00764907|Thioguanine|thioguanine|mesh-list
56708912|NCT00764907|Vindesine|vindesine|mesh-list
56708913|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
56708914|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56708915|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
56708916|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708917|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56708918|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56708919|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
56708920|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708921|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56708922|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56708923|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56708924|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
56708925|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
56708926|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56708927|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56708928|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
56708929|NCT00764907|Hormones|hormones|mesh-ancestor
56708930|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56708931|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56708952|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
56708953|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
56708954|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
56708955|NCT02583698|Carvedilol|carvedilol|mesh-list
56708956|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56708957|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56708958|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
56708959|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56708960|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56708961|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56708962|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56708963|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
56708964|NCT02583698|Protective Agents|protective agents|mesh-ancestor
56708965|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56708966|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56708967|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56708968|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
56708969|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56708970|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56708971|NCT04632992|Paclitaxel|paclitaxel|mesh-list
56708972|NCT04632992|Maytansine|maytansine|mesh-list
56708973|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56708974|NCT04632992|Trastuzumab|trastuzumab|mesh-list
56708975|NCT04632992|Atezolizumab|atezolizumab|mesh-list
56708976|NCT04632992|Pertuzumab|pertuzumab|mesh-list
56708977|NCT04632992|Tucatinib|tucatinib|mesh-list
56708978|NCT04632992|Pralsetinib|pralsetinib|mesh-list
56708979|NCT04632992|Entrectinib|entrectinib|mesh-list
56708980|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56708998|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56708999|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56709000|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56709001|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709002|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56709003|NCT00762255|Bevacizumab|bevacizumab|mesh-list
56709004|NCT00762255|Irinotecan|irinotecan|mesh-list
56709005|NCT00762255|Vorinostat|vorinostat|mesh-list
56709006|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56709007|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709008|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56709009|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56709010|NCT00762255|Growth Substances|growth substances|mesh-ancestor
56709011|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709012|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
56709013|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56709014|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56709015|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709016|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709017|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56709018|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56709019|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56709020|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709021|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
56709022|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56709023|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56709024|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56709025|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56709026|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709027|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
56709028|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709029|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709032|NCT05332730|Golimumab|golimumab|mesh-list
56709038|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709039|NCT02581826|Silodosin|silodosin|mesh-list
56709040|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56709041|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56709042|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56709043|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
56709044|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709045|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709046|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709047|NCT02581826|Urological Agents|urological agents|mesh-ancestor
56709048|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56709049|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
56709050|NCT04340882|Docetaxel|docetaxel|mesh-list
56709051|NCT04340882|Ramucirumab|ramucirumab|mesh-list
56709052|NCT04340882|Antibodies|antibodies|mesh-list
56709053|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
56709054|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56709055|NCT04340882|Lexatumumab|lexatumumab|mesh-list
56709056|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
56709057|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709058|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709059|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
56709060|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
56709061|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
56709062|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709063|NCT00765921|Ranibizumab|ranibizumab|mesh-list
56709064|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56709086|NCT02585258|Glucocorticoids|glucocorticoids|mesh-ancestor
56709087|NCT02585258|Hormones|hormones|mesh-ancestor
56709088|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709089|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709090|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56709091|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709092|NCT00762567|Phenylephrine|phenylephrine|mesh-list
56709093|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
56709094|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
56709095|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56709096|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
56709097|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
56709098|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709099|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709100|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
56709101|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56709102|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
56709103|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56709104|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56709105|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56709106|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
56709107|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709108|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709109|NCT00762567|Protective Agents|protective agents|mesh-ancestor
56709110|NCT04338620|Paclitaxel|paclitaxel|mesh-list
56709111|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56709112|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56709113|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709114|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
56709115|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
56709116|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
56709117|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709118|NCT00923234|Lenalidomide|lenalidomide|mesh-list
56709126|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709127|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56709128|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
56709129|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709130|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709131|NCT04323956|Prednisone|prednisone|mesh-list
56709132|NCT04323956|Cortisone|cortisone|mesh-list
56709133|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
56709134|NCT04323956|Rituximab|rituximab|mesh-list
56709135|NCT04323956|Doxorubicin|doxorubicin|mesh-list
56709136|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56709137|NCT04323956|Vincristine|vincristine|mesh-list
56709138|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56709139|NCT04323956|Antibodies|antibodies|mesh-list
56709140|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
56709141|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56709142|NCT04323956|Lenograstim|lenograstim|mesh-list
56709143|NCT04323956|Immunoconjugates|immunoconjugates|mesh-list
56709144|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56709145|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
56709146|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709147|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56709148|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56709149|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
56709150|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709151|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709152|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56709153|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56709154|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56709155|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56709156|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709157|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56709171|NCT00674661|Vitamins|vitamins|mesh-ancestor
56709172|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
56709173|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709174|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56709175|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
56709176|NCT00766545|Cilostazol|cilostazol|mesh-list
56709177|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56709178|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
56709179|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709180|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709181|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56709182|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
56709183|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56709184|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56709185|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709186|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56709187|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
56709188|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56709189|NCT00766545|Protective Agents|protective agents|mesh-ancestor
56709190|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56709191|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56709192|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709193|NCT02558205|Liver Extracts|liver extracts|mesh-list
56709194|NCT02558205|Hematinics|hematinics|mesh-ancestor
56709195|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
56709196|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56709197|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56709198|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56709199|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56709200|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709206|NCT00766857|Insulin|insulin|mesh-list
56709215|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709216|NCT02558283|Lidocaine|lidocaine|mesh-list
56709217|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
56709218|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
56709219|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709220|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709221|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
56709222|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709223|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56709224|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56709225|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56709226|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56709227|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709228|NCT04394858|Temozolomide|temozolomide|mesh-list
56709229|NCT04394858|Olaparib|olaparib|mesh-list
56709230|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56709231|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56709232|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
56709233|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709234|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709235|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709236|NCT00767091|Rivastigmine|rivastigmine|mesh-list
56709237|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
56709238|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709262|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56709263|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
56709264|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709265|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709266|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
56709267|NCT00671931|Propofol|propofol|mesh-list
56709268|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56709269|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709270|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709271|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56709272|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
56709273|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
56709274|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56709275|NCT00671931|Analgesics|analgesics|mesh-ancestor
56709276|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
56709277|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709278|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56709279|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56709280|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56709281|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
56709282|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709283|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709284|NCT00767559|PENTA|penta|mesh-list
56709285|NCT00767559|Warfarin|warfarin|mesh-list
56709286|NCT00767559|Fondaparinux|fondaparinux|mesh-list
56709287|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
56709288|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56709289|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
56709290|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56709291|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
56709292|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709293|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709294|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56709295|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56709296|NCT00767715|Haloperidol|haloperidol|mesh-list
56709297|NCT00767715|Olanzapine|olanzapine|mesh-list
56554576|NCT00888940|Ecallantide|ecallantide|mesh-list
56554577|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
56554578|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56554579|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56554580|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709298|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
56709299|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
56709300|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
56709301|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709302|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709303|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56709304|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56709305|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56709306|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709307|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56709308|NCT00767715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56709309|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56709310|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56709311|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709312|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709313|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
56709314|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56709315|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
56709316|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56709317|NCT00762957|Metformin|metformin|mesh-list
56709318|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56709319|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709320|NCT00759993|Chromium|chromium|mesh-list
56709321|NCT00759993|Trace Elements|trace elements|mesh-ancestor
56709322|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
56709323|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709324|NCT00673881|Choline|choline|mesh-list
56709325|NCT00673881|Fenofibrate|fenofibrate|mesh-list
56709346|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56709347|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709348|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709349|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
56709350|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709351|NCT00767871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56709352|NCT00767871|Antidepressive Agents|antidepressive agents|mesh-ancestor
56709353|NCT00767871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56709354|NCT00760149|Rifampin|rifampin|mesh-list
56709355|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56709356|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
56709357|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56709358|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709359|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
56709360|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56709361|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709362|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709363|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56709364|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56420502|NCT04997941|Tamoxifen|tamoxifen|mesh-list
56709365|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56709366|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56709367|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56709369|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56709393|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56709394|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
56709395|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
56709396|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
56709397|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56709398|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56709399|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56709400|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56709401|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
56709402|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709403|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709404|NCT04077944|Trace Elements|trace elements|mesh-list
56709405|NCT04077944|Micronutrients|micronutrients|mesh-list
56709406|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709407|NCT02558751|Vaccines|vaccines|mesh-list
56709408|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56709409|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
56709410|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709411|NCT02807636|Gemcitabine|gemcitabine|mesh-list
56709412|NCT02807636|Carboplatin|carboplatin|mesh-list
56709413|NCT02807636|Atezolizumab|atezolizumab|mesh-list
56709414|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709415|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56709444|NCT02558595|Niacinamide|niacinamide|mesh-list
56709445|NCT02558595|Niacin|niacin|mesh-list
56709446|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
56709447|NCT02558595|Vitamins|vitamins|mesh-ancestor
56709448|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
56709449|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709450|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
56709451|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56709452|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
56709453|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709454|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56709455|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
56709456|NCT00760695|Dronabinol|dronabinol|mesh-list
56709457|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
56709458|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709459|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56709460|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56709461|NCT00760695|Analgesics|analgesics|mesh-ancestor
56709462|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
56709463|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709464|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56709465|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56709466|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709467|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709468|NCT00760695|Hormones|hormones|mesh-ancestor
56709469|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709470|NCT02582372|Fentanyl|fentanyl|mesh-list
56709471|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
56709472|NCT02582372|Bupivacaine|bupivacaine|mesh-list
56709473|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
56709474|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
56709475|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709476|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709487|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709488|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56709489|NCT02582372|Narcotics|narcotics|mesh-ancestor
56709490|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56709491|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56709492|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
56709493|NCT00768729|Sirolimus|sirolimus|mesh-list
56709494|NCT00768729|Azathioprine|azathioprine|mesh-list
56709495|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56709496|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709497|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56709498|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709499|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
56709500|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56709501|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
56709502|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709503|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
56709504|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709505|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56709506|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56709507|NCT00768963|Ranibizumab|ranibizumab|mesh-list
56709508|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56709509|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56709510|NCT00768963|Growth Substances|growth substances|mesh-ancestor
56709511|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709512|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
56709513|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709514|NCT04612790|Benralizumab|benralizumab|mesh-list
56709515|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56709516|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56709517|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
56709518|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56709519|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56709520|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56709521|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56709522|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709526|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56709527|NCT00770445|Metformin|metformin|mesh-list
56709528|NCT00770445|Pioglitazone|pioglitazone|mesh-list
56709529|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56709530|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709531|NCT04077398|Ropivacaine|ropivacaine|mesh-list
56709532|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
56709533|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
56709536|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
56709595|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56709596|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
56709597|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709598|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56709599|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56709600|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56709601|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
56709602|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709603|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56709604|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56709605|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56709606|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709607|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
56709608|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56709609|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56709610|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
56709611|NCT04048317|Doxorubicin|doxorubicin|mesh-list
56709612|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56709613|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
56709614|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56709645|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56709646|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
56709647|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56709648|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709649|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56709650|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56709651|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56709652|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709653|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56709654|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56709655|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56709656|NCT00775125|Ritonavir|ritonavir|mesh-list
56709657|NCT00775125|Darunavir|darunavir|mesh-list
56709658|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
56709659|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56709660|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56709661|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
56709662|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709663|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709664|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56709665|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56709666|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
56709697|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56709698|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709699|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
56709700|NCT00771303|Coagulants|coagulants|mesh-ancestor
56709701|NCT05674526|Cetuximab|cetuximab|mesh-list
56709702|NCT05674526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56709703|NCT05674526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709704|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56709705|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56709706|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709707|NCT04125836|Octreotide|octreotide|mesh-list
56709708|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56709709|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56709710|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709711|NCT00771459|Ropivacaine|ropivacaine|mesh-list
56709712|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
56709713|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
56709714|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709715|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709716|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
56709717|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709718|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
56709719|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709720|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56709721|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709722|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709723|NCT00775359|Fenofibrate|fenofibrate|mesh-list
56709724|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56709725|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
56709726|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709727|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56709728|NCT05338502|Omeprazole|omeprazole|mesh-list
56709729|NCT05338502|Ranitidine|ranitidine|mesh-list
56709737|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
56709738|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
56709739|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709740|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709741|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
56709742|NCT02557269|Azelastine|azelastine|mesh-list
56709743|NCT02557269|Prednisolone|prednisolone|mesh-list
56709744|NCT02557269|Xylometazoline|xylometazoline|mesh-list
56709745|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56709746|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
56709747|NCT02557269|Hormones|hormones|mesh-ancestor
56709748|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56709749|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709750|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56709751|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709752|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
56709753|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709754|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
56709755|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56709756|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56709757|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56709758|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
56709759|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56709760|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709761|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709762|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56709769|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
56709784|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56709785|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709786|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
56709787|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
56709788|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
56709789|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709790|NCT00775749|Nicotine|nicotine|mesh-list
56709791|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56709792|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
56709793|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709794|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709795|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56709796|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56709797|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
56709798|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709799|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709800|NCT00775827|Fenofibrate|fenofibrate|mesh-list
56709801|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56709802|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
56709803|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709804|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56709805|NCT00775905|Amlodipine|amlodipine|mesh-list
56709806|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56709807|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56709808|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56709809|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709813|NCT00772161|Methylphenidate|methylphenidate|mesh-list
56709829|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709830|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709831|NCT05153408|Carboplatin|carboplatin|mesh-list
56709832|NCT05153408|Pemetrexed|pemetrexed|mesh-list
56709833|NCT05153408|Osimertinib|osimertinib|mesh-list
56709834|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709835|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709836|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709837|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56709838|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56709839|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56709840|NCT00779493|Curcumin|curcumin|mesh-list
56709841|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709842|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56709844|NCT00779493|Analgesics|analgesics|mesh-ancestor
56709888|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
56421023|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
56709889|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56709890|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56709891|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56709892|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56709893|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
56709894|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
56709895|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709896|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709897|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56709898|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56709899|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
56709900|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56709901|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56709902|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56709903|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56709904|NCT02579642|Ketamine|ketamine|mesh-list
56709905|NCT02579642|Analgesics|analgesics|mesh-ancestor
56709906|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
56709907|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56709908|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709909|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56709910|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56709911|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
56709912|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
56709915|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56709933|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
56709934|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56709935|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56709936|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709937|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56709938|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709939|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56709940|NCT00667251|Paclitaxel|paclitaxel|mesh-list
56709941|NCT00667251|Docetaxel|docetaxel|mesh-list
56709942|NCT00667251|Trastuzumab|trastuzumab|mesh-list
56709943|NCT00667251|Lapatinib|lapatinib|mesh-list
56709944|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56709945|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709946|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
56709947|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
56709948|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
56709949|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709950|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56709951|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56709952|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709953|NCT04063124|Dasatinib|dasatinib|mesh-list
56709954|NCT04063124|Quercetin|quercetin|mesh-list
56709955|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709956|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56709957|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709958|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709959|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
56709960|NCT04063124|Protective Agents|protective agents|mesh-ancestor
56709961|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421145|NCT05427721|Thymol|thymol|mesh-list
56709962|NCT04060862|Fulvestrant|fulvestrant|mesh-list
56709963|NCT04060862|Palbociclib|palbociclib|mesh-list
56709964|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56709973|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709974|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
56709975|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56709976|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
56709977|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56709978|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709979|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709980|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56709981|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56709982|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709983|NCT00780039|Carboplatin|carboplatin|mesh-list
56709984|NCT00780039|Doxorubicin|doxorubicin|mesh-list
56709985|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56709986|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709987|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56709988|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56709989|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56709990|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56709991|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56709992|NCT00776763|Bevacizumab|bevacizumab|mesh-list
56709993|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56709994|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56709995|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56709996|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56709997|NCT00776763|Growth Substances|growth substances|mesh-ancestor
56709998|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56709999|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
56710000|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
56710001|NCT00772551|Ezetimibe|ezetimibe|mesh-list
56710002|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56710003|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56710004|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
56710005|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710006|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56710007|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56710008|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56710009|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
56710010|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710011|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56710012|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56710013|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710014|NCT00776841|Cholic Acids|cholic acids|mesh-list
56710015|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
56710016|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56710017|NCT02556879|Liver Extracts|liver extracts|mesh-list
56710018|NCT02556879|Antibodies|antibodies|mesh-list
56710019|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
56710020|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710021|NCT02556879|Hematinics|hematinics|mesh-ancestor
56710022|NCT00772863|Docetaxel|docetaxel|mesh-list
56710023|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710024|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
56710025|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
56710026|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
56710027|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710028|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56710029|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56710030|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
56710031|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710032|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710033|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710034|NCT00667719|Amlodipine|amlodipine|mesh-list
56710035|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56710057|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56710058|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
56710059|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710060|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710061|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56710062|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56710063|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
56710064|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710065|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710066|NCT02579564|Gemcitabine|gemcitabine|mesh-list
56710067|NCT02579564|Paclitaxel|paclitaxel|mesh-list
56710068|NCT02579564|Vinorelbine|vinorelbine|mesh-list
56710069|NCT02579564|Pemetrexed|pemetrexed|mesh-list
56710070|NCT02579564|Endostar protein|endostar protein|mesh-list
56710071|NCT02579564|Endostatins|endostatins|mesh-list
56710072|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56710073|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710074|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
56710075|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
56710076|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
56710077|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710078|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56710079|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
56710080|NCT02579564|Antiviral Agents|antiviral agents|mesh-ancestor
56710081|NCT02579564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710082|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710083|NCT02579564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56710084|NCT02579564|Immunologic Factors|immunologic factors|mesh-ancestor
56710085|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710086|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56710087|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56710088|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56710090|NCT02579564|Growth Substances|growth substances|mesh-ancestor
56710100|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56710101|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56710102|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
56710103|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
56710104|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
56710105|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
56710106|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710107|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710108|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
56710109|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
56710110|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56421240|NCT00238797|Gefitinib|gefitinib|mesh-list
56710111|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56710112|NCT03704480|Durvalumab|durvalumab|mesh-list
56710113|NCT03704480|Tremelimumab|tremelimumab|mesh-list
56710114|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56710115|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710116|NCT03699254|Valganciclovir|valganciclovir|mesh-list
56710117|NCT03699254|Ganciclovir|ganciclovir|mesh-list
56710118|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56710119|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
56710120|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710121|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56710122|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710123|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710124|NCT00570687|Insulin|insulin|mesh-list
56710125|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56710126|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710147|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710148|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
56710149|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710150|NCT00777543|Ferulic acid|ferulic acid|mesh-list
56710151|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56710152|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56710153|NCT00777543|Analgesics|analgesics|mesh-ancestor
56710154|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
56710155|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710156|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710157|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56710158|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56710215|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710216|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56710217|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56710218|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
56710219|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710220|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710221|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710222|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56710223|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56710224|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
56710225|NCT03363464|Empagliflozin|empagliflozin|mesh-list
56710226|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56710229|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56710276|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56710277|NCT01033903|Misoprostol|misoprostol|mesh-list
56710278|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56710279|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
56710280|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56710281|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710282|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56710283|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56710284|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
56710285|NCT03953300|Benralizumab|benralizumab|mesh-list
56710286|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56710287|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
56710288|NCT03281954|Atezolizumab|atezolizumab|mesh-list
56710289|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710290|NCT03526250|Palbociclib|palbociclib|mesh-list
56710291|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710292|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56710293|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710334|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56710335|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710336|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56710337|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710338|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710339|NCT05118477|Caffeine|caffeine|mesh-list
56710340|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56710341|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710342|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56710343|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710344|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710345|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56710346|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56710347|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
56710348|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710349|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56710350|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56710351|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56710389|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710390|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710391|NCT00778011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56710392|NCT00778011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56710393|NCT00778011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56710394|NCT00778011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56710395|NCT00778011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56710396|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56710397|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56710398|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
56710399|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56710400|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
56710401|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56710402|NCT00778089|Protective Agents|protective agents|mesh-ancestor
56710403|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710404|NCT00433381|Bevacizumab|bevacizumab|mesh-list
56710405|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56710406|NCT00433381|Irinotecan|irinotecan|mesh-list
56710407|NCT00433381|Temozolomide|temozolomide|mesh-list
56710408|NCT00433381|Camptothecin|camptothecin|mesh-list
56710409|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
56710410|NCT00433381|Antibodies|antibodies|mesh-list
56710411|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
56421554|NCT00239421|Xhance|xhance|mesh-list
56710412|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56710413|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
56710439|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710440|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56710441|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56710442|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56710443|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56710444|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56710445|NCT00778245|Cefprozil|cefprozil|mesh-list
56710446|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56710447|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710448|NCT00778401|Gabapentin|gabapentin|mesh-list
56710449|NCT00778401|Analgesics|analgesics|mesh-ancestor
56710450|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
56710451|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710452|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710453|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
56710454|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56710455|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56710456|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56710457|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56710458|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56710459|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56710460|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710461|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710489|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56710490|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56710491|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710492|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56710494|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710495|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
56710496|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56710497|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56710498|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
56710499|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710500|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56710501|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56710502|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710503|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710504|NCT00774111|Dolutegravir|dolutegravir|mesh-list
56710505|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56710506|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56710507|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710508|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710509|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56710510|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56710511|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
56710512|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710513|NCT00778791|Metformin|metformin|mesh-list
56710514|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56710515|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710516|NCT00774189|Clarithromycin|clarithromycin|mesh-list
56710517|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56710520|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710534|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56710535|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710536|NCT00781521|Renal Agents|renal agents|mesh-ancestor
56710537|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56710538|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56710539|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56710540|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710541|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710542|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710543|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56710544|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56710545|NCT00774501|Anesthetics|anesthetics|mesh-list
56710595|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56710596|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56710597|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
56710598|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56710599|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56710600|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
56710601|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56710602|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
56710603|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56710604|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56710605|NCT00774969|Metronidazole|metronidazole|mesh-list
56710606|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710607|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56710608|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56710609|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56710610|NCT00785109|Vitamin K|vitamin k|mesh-list
56710611|NCT00785109|Vitamins|vitamins|mesh-ancestor
56710612|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
56710613|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710614|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56710615|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56710616|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710617|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
56710618|NCT00785109|Coagulants|coagulants|mesh-ancestor
56710619|NCT00662025|Capecitabine|capecitabine|mesh-list
56710643|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56710644|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56710645|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
56710646|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56710647|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56710648|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56710650|NCT00782301|Etravirine|etravirine|mesh-list
56710651|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56710652|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56710653|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710654|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56710655|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56710656|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
56710657|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710658|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56710659|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56710660|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56710661|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710662|NCT00785421|Leucovorin|leucovorin|mesh-list
56710663|NCT00785421|Folic Acid|folic acid|mesh-list
56710664|NCT00785421|Gemcitabine|gemcitabine|mesh-list
56710665|NCT00785421|Cisplatin|cisplatin|mesh-list
56710666|NCT00785421|Enoxaparin|enoxaparin|mesh-list
56710667|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
56710668|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
56710669|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710670|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56710671|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
56710672|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710673|NCT00785421|Antiviral Agents|antiviral agents|mesh-ancestor
56710674|NCT00785421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710675|NCT00785421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710676|NCT00785421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56710687|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56710688|NCT00790179|Ropivacaine|ropivacaine|mesh-list
56710689|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
56710690|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
56710691|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56710692|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710693|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
56710694|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710695|NCT00790413|Rituximab|rituximab|mesh-list
56710696|NCT00790413|Fludarabine|fludarabine|mesh-list
56710697|NCT00790413|Thiotepa|thiotepa|mesh-list
56710698|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56710699|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56710700|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710701|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
56710702|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710703|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56710704|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710705|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56710706|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56710707|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
56421846|NCT00243945|Rotigotine|rotigotine|mesh-list
56710708|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56710709|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56710710|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56710711|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
56710712|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56710713|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56710714|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710715|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710716|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710729|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
56710730|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710731|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56710732|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56710733|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56710734|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56710735|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
56710736|NCT00790881|Lumefantrine|lumefantrine|mesh-list
56710737|NCT00790881|Artemether|artemether|mesh-list
56710738|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56710739|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
56710740|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56710741|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56710742|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56710743|NCT01029769|Olanzapine|olanzapine|mesh-list
56710744|NCT01029769|Amisulpride|amisulpride|mesh-list
56710745|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
56710746|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
56710747|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56710748|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710749|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56710750|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56710751|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56710752|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56710753|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56710754|NCT01029769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56710755|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56710756|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56710757|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710758|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710759|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
56710760|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56710771|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56710772|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56710773|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56710774|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56710775|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56710776|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56710777|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710778|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
56710779|NCT02799602|Docetaxel|docetaxel|mesh-list
56710780|NCT02799602|Androgens|androgens|mesh-list
56710781|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710782|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
56710783|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
56710784|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
56710785|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56710787|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56710788|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710789|NCT03929666|Leucovorin|leucovorin|mesh-list
56710790|NCT03929666|Gemcitabine|gemcitabine|mesh-list
56710791|NCT03929666|Bevacizumab|bevacizumab|mesh-list
56710792|NCT03929666|Fluorouracil|fluorouracil|mesh-list
56710793|NCT03929666|Capecitabine|capecitabine|mesh-list
56710826|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710827|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56710828|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
56710829|NCT02581046|Hormones|hormones|mesh-ancestor
56710830|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56710894|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56710895|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
56710896|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56710897|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56710898|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56710962|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56710963|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
56710964|NCT02400242|Hormones|hormones|mesh-ancestor
56710965|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56710966|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56710967|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56710968|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
56710969|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56710970|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56710971|NCT02400242|Growth Substances|growth substances|mesh-ancestor
56711024|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711025|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711026|NCT02580734|Melatonin|melatonin|mesh-list
56711027|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
56711028|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711029|NCT02580734|Protective Agents|protective agents|mesh-ancestor
56711030|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711031|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711032|NCT00427999|Pioglitazone|pioglitazone|mesh-list
56711033|NCT00427999|Dexamethasone|dexamethasone|mesh-list
56711034|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
56711035|NCT00427999|Etoricoxib|etoricoxib|mesh-list
56711036|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
56711037|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56711038|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
56711039|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
56711040|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711044|NCT00427999|Hormones|hormones|mesh-ancestor
56711083|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
56711085|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711086|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56711087|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56711088|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711089|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56711090|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56711091|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711092|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56711093|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
56711094|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711095|NCT04038086|Insulin|insulin|mesh-list
56711096|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56711097|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711098|NCT04072640|Voriconazole|voriconazole|mesh-list
56711099|NCT04072640|Amphotericin B|amphotericin b|mesh-list
56711100|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56711101|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56711102|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
56711103|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
56711114|NCT04072640|Amebicides|amebicides|mesh-ancestor
56711134|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
56711135|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711136|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711137|NCT00427921|Adalimumab|adalimumab|mesh-list
56711138|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56711139|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56711140|NCT00432991|Ephedrine|ephedrine|mesh-list
56711141|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56711142|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711143|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
56711144|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
56711145|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711146|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56711147|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
56711150|NCT00580970|Lovastatin|lovastatin|mesh-list
56711193|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56711194|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
56711195|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56711196|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56711197|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56711198|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
56711199|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711200|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711201|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56711202|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56711203|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
56711204|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56711205|NCT04046679|Bleomycin|bleomycin|mesh-list
56711206|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56711207|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711208|NCT00786279|Ethanol|ethanol|mesh-list
56711209|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56711210|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711211|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711212|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711213|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56711214|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56711215|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56711216|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711217|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711218|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56711219|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56711220|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56711221|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
56711222|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711224|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56711234|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711235|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
56711236|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711237|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56711238|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
56711239|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711240|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711241|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56711242|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56711243|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56711244|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711245|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711246|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56711247|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56711248|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56711249|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
56711250|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711251|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711252|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56711253|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56711254|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
56711255|NCT00440401|Thrombin|thrombin|mesh-list
56711285|NCT00791505|Renal Agents|renal agents|mesh-ancestor
56711286|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
56711287|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56711288|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56711289|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56711290|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56711291|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56711292|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56711293|NCT02598960|Nivolumab|nivolumab|mesh-list
56711294|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711295|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711296|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56711297|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711298|NCT00426361|Vaccines|vaccines|mesh-list
56711299|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
56711300|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711301|NCT00665847|Etravirine|etravirine|mesh-list
56711302|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56711303|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56711304|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711305|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711306|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
56711307|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711308|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56711309|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56711310|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711311|NCT00783081|Cilostazol|cilostazol|mesh-list
56711312|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56711313|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
56711314|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711315|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711316|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56711317|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
56711318|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56711319|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56554581|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
56711322|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
56711323|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56711324|NCT00783081|Protective Agents|protective agents|mesh-ancestor
56711325|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56711326|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56711327|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711328|NCT00426127|Docetaxel|docetaxel|mesh-list
56711329|NCT00426127|Doxorubicin|doxorubicin|mesh-list
56711330|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56711331|NCT00426127|Enoxaparin|enoxaparin|mesh-list
56711332|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711333|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
56711334|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
56711335|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
56711336|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711337|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56711338|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56711339|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56711340|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711341|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
56711342|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56711343|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56711344|NCT02554851|Mitogens|mitogens|mesh-list
56711345|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
56711346|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711347|NCT02535078|Durvalumab|durvalumab|mesh-list
56711348|NCT02535078|Tremelimumab|tremelimumab|mesh-list
56711349|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711350|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711371|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
56711372|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56711373|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56711374|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711375|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711376|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56711377|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56711378|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56711379|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56711380|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56711381|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
56711382|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56711383|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711384|NCT00791739|Pregabalin|pregabalin|mesh-list
56711385|NCT00791739|Trazodone|trazodone|mesh-list
56711386|NCT00791739|Analgesics|analgesics|mesh-ancestor
56711387|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
56711388|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711389|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711390|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
56711391|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56711392|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56711421|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56711422|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
56711423|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711424|NCT00783393|Temozolomide|temozolomide|mesh-list
56711425|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56711426|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
56711427|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711428|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711429|NCT00783471|Docetaxel|docetaxel|mesh-list
56711430|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56711431|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711432|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
56711433|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
56711434|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
56711435|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711436|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56711437|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711438|NCT02460900|Varenicline|varenicline|mesh-list
56711439|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56711440|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56711441|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
56711442|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711443|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711444|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711445|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56711446|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
56711447|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
56711448|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711449|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
56711451|NCT02075840|Crizotinib|crizotinib|mesh-list
56711464|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711465|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711466|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711467|NCT00425113|Metronidazole|metronidazole|mesh-list
56711468|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711469|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56711470|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56711471|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56711472|NCT04895280|Triamcinolone|triamcinolone|mesh-list
56711473|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56711474|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56711475|NCT04895280|Ketorolac|ketorolac|mesh-list
56711476|NCT04895280|Bupivacaine|bupivacaine|mesh-list
56711477|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56711478|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
56711479|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
56711480|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711481|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711482|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
56711483|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711484|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56711485|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
56711486|NCT04895280|Hormones|hormones|mesh-ancestor
56711487|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711488|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56711489|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
56711490|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711491|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711492|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56711493|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56711508|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56711509|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
56711510|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
56711511|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711512|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56711513|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
56711514|NCT03994783|Hormones|hormones|mesh-ancestor
56711515|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711516|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56711517|NCT03994783|Protective Agents|protective agents|mesh-ancestor
56711518|NCT00440011|Bimatoprost|bimatoprost|mesh-list
56711519|NCT00440011|Travoprost|travoprost|mesh-list
56711574|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56711575|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56711576|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
56711577|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
56711578|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711579|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711580|NCT00495716|Acyclovir|acyclovir|mesh-list
56711581|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
56711582|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711583|NCT00784017|Asparaginase|asparaginase|mesh-list
56711584|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711585|NCT04074122|Adenosine|adenosine|mesh-list
56711586|NCT04074122|Isoproterenol|isoproterenol|mesh-list
56711587|NCT04074122|Epinephrine|epinephrine|mesh-list
56711588|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56711589|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56711590|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
56711591|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711592|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711632|NCT00788463|Beclomethasone|beclomethasone|mesh-list
56711633|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56711634|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
56711635|NCT00788463|Hormones|hormones|mesh-ancestor
56711636|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711637|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711638|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56711639|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
56711640|NCT00579254|Amlodipine|amlodipine|mesh-list
56711641|NCT00579254|Atorvastatin|atorvastatin|mesh-list
56711642|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56711643|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56711644|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
56711645|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711646|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56711647|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56711648|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711649|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56711650|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56711651|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56711652|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56711653|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711654|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
56711655|NCT00793221|Sirolimus|sirolimus|mesh-list
56711656|NCT00793221|Everolimus|everolimus|mesh-list
56711657|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711658|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56711659|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
56711660|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711677|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
56711678|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711679|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711680|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56711681|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56711683|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56711684|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56711685|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56711686|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56711687|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711688|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
56711689|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711690|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711691|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56711692|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711693|NCT01773278|Antioxidants|antioxidants|mesh-list
56711694|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711695|NCT01773278|Protective Agents|protective agents|mesh-ancestor
56711696|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711697|NCT00788931|Paclitaxel|paclitaxel|mesh-list
56711698|NCT00788931|Trastuzumab|trastuzumab|mesh-list
56711699|NCT00788931|Panobinostat|panobinostat|mesh-list
56711700|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56711701|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711702|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
56711703|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
56711704|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
56711705|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711706|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711707|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56711708|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711717|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56711718|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711719|NCT00709982|Folic Acid|folic acid|mesh-list
56711720|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56711721|NCT00709982|Norgestimate|norgestimate|mesh-list
56711722|NCT00709982|Estradiol|estradiol|mesh-list
56711723|NCT00709982|Estrogens|estrogens|mesh-ancestor
56711724|NCT00709982|Hormones|hormones|mesh-ancestor
56711725|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56711726|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711727|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56711728|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
56711729|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56711730|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56711731|NCT00709982|Hematinics|hematinics|mesh-ancestor
56711732|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
56711733|NCT00709982|Vitamins|vitamins|mesh-ancestor
56711734|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
56711735|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56711736|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56711737|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56711773|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711774|NCT00711308|Vitamin K|vitamin k|mesh-list
56711775|NCT00711308|Tinzaparin|tinzaparin|mesh-list
56711776|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56711777|NCT00711308|Dalteparin|dalteparin|mesh-list
56711778|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
56711779|NCT00711308|Vitamins|vitamins|mesh-ancestor
56711780|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
56711781|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711782|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56711783|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56711784|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711785|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
56711786|NCT00711308|Coagulants|coagulants|mesh-ancestor
56711787|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
56711788|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56711789|NCT02601911|Acetaminophen|acetaminophen|mesh-list
56711790|NCT02601911|Ketorolac|ketorolac|mesh-list
56711791|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56711792|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56711793|NCT02601911|Analgesics|analgesics|mesh-ancestor
56711794|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
56711795|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711796|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711797|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
56711798|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56711799|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56711800|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56711801|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56711823|NCT00767039|Poractant alfa|poractant alfa|mesh-list
56711824|NCT00767039|Beractant|beractant|mesh-list
56711825|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56711826|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
56711827|NCT01572506|Biotin|biotin|mesh-list
56711828|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
56711829|NCT01572506|Vitamins|vitamins|mesh-ancestor
56711830|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
56711831|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422960|NCT00245661|Temazepam|temazepam|mesh-list
56711832|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56711833|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56711834|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711835|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56711836|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
56711837|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711838|NCT02577770|Caffeine|caffeine|mesh-list
56711839|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56711840|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711841|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56711842|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711843|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711844|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56711845|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56711846|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
56711847|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711848|NCT00129896|Docetaxel|docetaxel|mesh-list
56711849|NCT00129896|Doxorubicin|doxorubicin|mesh-list
56711850|NCT00129896|Trastuzumab|trastuzumab|mesh-list
56711851|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711866|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711867|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56711868|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56711869|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
56711870|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56711871|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
56711872|NCT02574338|Urological Agents|urological agents|mesh-ancestor
56711873|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
56711874|NCT03070392|Ipilimumab|ipilimumab|mesh-list
56711875|NCT03070392|Dacarbazine|dacarbazine|mesh-list
56711876|NCT03070392|Imidazole|imidazole|mesh-list
56711877|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56711878|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711879|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56711880|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711881|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56711882|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
56711883|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711884|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
56711885|NCT00711698|Narcotics|narcotics|mesh-ancestor
56711886|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56711887|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711888|NCT00711698|Analgesics|analgesics|mesh-ancestor
56711889|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
56711890|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56711891|NCT00795171|Docetaxel|docetaxel|mesh-list
56711892|NCT00795171|Sunitinib|sunitinib|mesh-list
56711893|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56711894|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
56711895|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
56711896|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
56711897|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711898|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56711909|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
56711910|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56711911|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
56711912|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56711913|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711914|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
56711915|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56711916|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711917|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711918|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56711919|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56711920|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56711921|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56711922|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56711926|NCT00711854|Renal Agents|renal agents|mesh-ancestor
56711968|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711969|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56711970|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
56711971|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56711972|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56711973|NCT03015792|Growth Substances|growth substances|mesh-ancestor
56711974|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
56711975|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
56711976|NCT00789165|Quinidine|quinidine|mesh-list
56711977|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56711978|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56711979|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
56711980|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56711981|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423105|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
56711982|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56711983|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56711984|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
56711985|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56711986|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56711987|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56711988|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56711989|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56711990|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56711991|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
56711992|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56712015|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
56712016|NCT00793377|Docetaxel|docetaxel|mesh-list
56712017|NCT00793377|Doxorubicin|doxorubicin|mesh-list
56712018|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56712019|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56712020|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
56712021|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712022|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712023|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56712024|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
56712025|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712026|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712027|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56712028|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
56712029|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
56712030|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
56712031|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56712032|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56712033|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56712034|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712035|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56712036|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
56712037|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712038|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56712039|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56712040|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56712041|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56712042|NCT00662259|Alprazolam|alprazolam|mesh-list
56712043|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56712044|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712045|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712046|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56712047|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56712048|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56712049|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
56712050|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
56554582|NCT00888940|Coagulants|coagulants|mesh-ancestor
56554583|NCT00888940|Analgesics|analgesics|mesh-ancestor
56712051|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712052|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712053|NCT00712790|Sorafenib|sorafenib|mesh-list
56712054|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712055|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56712056|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712057|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712058|NCT00660699|Gemcitabine|gemcitabine|mesh-list
56712059|NCT00660699|Docetaxel|docetaxel|mesh-list
56712060|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56712061|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
56712062|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712063|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712064|NCT00660699|Antiviral Agents|antiviral agents|mesh-ancestor
56712065|NCT00660699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712066|NCT00660699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712067|NCT00660699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56712068|NCT00660699|Immunologic Factors|immunologic factors|mesh-ancestor
56712069|NCT00660699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712070|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
56712071|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
56712072|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
56712073|NCT02577068|Propacetamol|propacetamol|mesh-list
56712074|NCT02577068|Nefopam|nefopam|mesh-list
56712075|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56712076|NCT02577068|Analgesics|analgesics|mesh-ancestor
56712077|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
56712099|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56712100|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
56712101|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712102|NCT00582036|Insulin|insulin|mesh-list
56712103|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56712104|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56712105|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712106|NCT00581360|Doxorubicin|doxorubicin|mesh-list
56712107|NCT00581360|Bortezomib|bortezomib|mesh-list
56712108|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56712109|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712110|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56712111|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56712112|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712113|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712114|NCT01650792|Aspirin|aspirin|mesh-list
56712115|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56712116|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56712117|NCT01650792|Analgesics|analgesics|mesh-ancestor
56712118|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
56712119|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712120|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712121|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56712122|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712123|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56712124|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56712125|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712126|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56712127|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56712143|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
56712144|NCT00582738|Everolimus|everolimus|mesh-list
56712145|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712146|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56712147|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
56712148|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712149|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
56712150|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56712151|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56712152|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712153|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56712154|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56712155|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712157|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712204|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
56712205|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712206|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712207|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56712208|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56712209|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
56712210|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
56712211|NCT00793845|Melphalan|melphalan|mesh-list
56712212|NCT00793845|Thiotepa|thiotepa|mesh-list
56712213|NCT00793845|Carboplatin|carboplatin|mesh-list
56712214|NCT00793845|Etoposide|etoposide|mesh-list
56712215|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56712216|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
56712217|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712218|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712219|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56712220|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
56712221|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712222|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712223|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56712225|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56712258|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712259|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
56712260|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712261|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
56712262|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712263|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56712264|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56712265|NCT00772577|Ramipril|ramipril|mesh-list
56712266|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56712267|NCT00772577|Diuretics|diuretics|mesh-ancestor
56712268|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
56712269|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712270|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56712271|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56712272|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712273|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56712274|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
56712275|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712276|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
56712277|NCT02345850|Methotrexate|methotrexate|mesh-list
56712311|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712312|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56712313|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56712314|NCT05485805|Analgesics|analgesics|mesh-ancestor
56712315|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
56712316|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712317|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56712318|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712319|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
56712320|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56712321|NCT04073550|Topotecan|topotecan|mesh-list
56712322|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56712323|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56712324|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712325|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712326|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712327|NCT02576600|Remifentanil|remifentanil|mesh-list
56712328|NCT02576600|Propofol|propofol|mesh-list
56712329|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56712330|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712331|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712332|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56712333|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
56712334|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
56712361|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712362|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56712363|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
56712364|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712365|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
56712366|NCT04046133|Capecitabine|capecitabine|mesh-list
56712367|NCT04046133|Mitomycins|mitomycins|mesh-list
56712368|NCT04046133|Mitomycin|mitomycin|mesh-list
56712369|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56712370|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712371|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56712372|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
56712373|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712374|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56712375|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
56712376|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56712377|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712378|NCT02573714|Ketamine|ketamine|mesh-list
56712379|NCT02573714|Analgesics|analgesics|mesh-ancestor
56712380|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
56712381|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712382|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712383|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56712384|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56712385|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
56712386|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
56712387|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712388|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56712389|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56712390|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712392|NCT00794235|Sorafenib|sorafenib|mesh-list
56712402|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712403|NCT02575664|Buprenorphine|buprenorphine|mesh-list
56712404|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56712405|NCT02575664|Narcotics|narcotics|mesh-ancestor
56712406|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712407|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712408|NCT02575664|Analgesics|analgesics|mesh-ancestor
56712409|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
56712410|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712411|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56712412|NCT00796497|Ondansetron|ondansetron|mesh-list
56712413|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
56712414|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
56712415|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712416|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712417|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56712418|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
56712462|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712463|NCT00794625|Valproic Acid|valproic acid|mesh-list
56712464|NCT00794625|Risperidone|risperidone|mesh-list
56712465|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
56712466|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56712467|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
56712468|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712469|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712470|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712471|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56712472|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56712473|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712474|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56712475|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56712476|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
56712477|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
56712478|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712479|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
56712480|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
56712485|NCT02577432|Fentanyl|fentanyl|mesh-list
56712518|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712519|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712520|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56712521|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56712522|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
56712523|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
56712524|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56712525|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
56712526|NCT00801411|Docetaxel|docetaxel|mesh-list
56712527|NCT00801411|Doxorubicin|doxorubicin|mesh-list
56712528|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56712529|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56712530|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
56712531|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712532|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56712533|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56712534|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
56712535|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712536|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712537|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56712538|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
56712539|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
56712540|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
56712541|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56712542|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56712543|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56712544|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712566|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56712567|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56712568|NCT00714584|Naltrexone|naltrexone|mesh-list
56712569|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56712570|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56712571|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712572|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
56712573|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712574|NCT00621244|Panobinostat|panobinostat|mesh-list
56712575|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712576|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56712577|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712578|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712579|NCT00916409|Temozolomide|temozolomide|mesh-list
56423701|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
56712580|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56712581|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
56712582|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712583|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712585|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
56712586|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56712587|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712588|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712589|NCT00714740|Diuretics|diuretics|mesh-ancestor
56712590|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
56712591|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712592|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
56712593|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
56712594|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56712595|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56712609|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
56712610|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712611|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56712612|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56712613|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712614|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56712615|NCT00795015|Insulin|insulin|mesh-list
56712616|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56712617|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56712618|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712619|NCT00796887|Niacin|niacin|mesh-list
56712620|NCT00796887|Niacinamide|niacinamide|mesh-list
56712621|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
56712622|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56712623|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
56712624|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712625|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56712626|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
56712628|NCT00796887|Vitamins|vitamins|mesh-ancestor
56712665|NCT00765245|Growth Substances|growth substances|mesh-ancestor
56712666|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
56712667|NCT00801879|Mupirocin|mupirocin|mesh-list
56712668|NCT00801879|Calcium|calcium|mesh-list
56712669|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56712670|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712671|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56712672|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712673|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56712674|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712675|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712676|NCT00718484|Doxorubicin|doxorubicin|mesh-list
56712677|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56712678|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
56712679|NCT00718484|Ifosfamide|ifosfamide|mesh-list
56712680|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56712681|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712682|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56712683|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56712684|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712685|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712686|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56712687|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
56712688|NCT00841126|Iron|iron|mesh-list
56712689|NCT00841126|Trace Elements|trace elements|mesh-ancestor
56712690|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
56712691|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712692|NCT00805857|Tipranavir|tipranavir|mesh-list
56712693|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56712694|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56712695|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
56712696|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712697|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
56712698|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56712699|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56712700|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56712704|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
56712705|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712706|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56712707|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712708|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712709|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56712710|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
56712711|NCT00836134|Bupivacaine|bupivacaine|mesh-list
56712712|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
56712713|NCT00836134|Anesthetics|anesthetics|mesh-list
56712714|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712715|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712716|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
56712717|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712718|NCT00782795|Pioglitazone|pioglitazone|mesh-list
56712719|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56712720|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712721|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
56712722|NCT02573558|Propofol|propofol|mesh-list
56712723|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56712724|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712725|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712726|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56547669|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56712727|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
56712728|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
56712729|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56712730|NCT02573558|Analgesics|analgesics|mesh-ancestor
56712731|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
56712734|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56712748|NCT00764699|Growth Substances|growth substances|mesh-ancestor
56712749|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712750|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56712751|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56712752|NCT00844012|Estradiol|estradiol|mesh-list
56712753|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56712754|NCT00844012|Estrogens|estrogens|mesh-ancestor
56712755|NCT00844012|Hormones|hormones|mesh-ancestor
56712756|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712757|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712758|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56712759|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
56712760|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56712761|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56712762|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56712763|NCT02574962|Hormones|hormones|mesh-ancestor
56712764|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712765|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712766|NCT00802035|Baclofen|baclofen|mesh-list
56712767|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56712768|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712769|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56712770|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712771|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56712772|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
56712795|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56712796|NCT00782717|Prednisolone|prednisolone|mesh-list
56712797|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56712798|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
56712799|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56712800|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
56712801|NCT00782717|Nepafenac|nepafenac|mesh-list
56712802|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56712803|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
56712804|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56712805|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
56712806|NCT00782717|Hormones|hormones|mesh-ancestor
56712807|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712808|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712854|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56712855|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56712856|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712857|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56712858|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712859|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56712860|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
56712861|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56712862|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
56712863|NCT00656019|Vitamin D|vitamin d|mesh-list
56712864|NCT00656019|Calcipotriene|calcipotriene|mesh-list
56712865|NCT00656019|Vitamins|vitamins|mesh-ancestor
56712866|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
56712867|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712868|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56712869|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
56712870|NCT00841438|Abciximab|abciximab|mesh-list
56712871|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
56712872|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56712873|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
56712874|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
56712875|NCT04068974|Apatinib|apatinib|mesh-list
56712876|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712877|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56712880|NCT00836368|Vitamin E|vitamin e|mesh-list
56712908|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
56712909|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712910|NCT00844168|Sorafenib|sorafenib|mesh-list
56712911|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56712912|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56712913|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712914|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712915|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
56712916|NCT00764465|Ritonavir|ritonavir|mesh-list
56712917|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
56712918|NCT00764465|Maraviroc|maraviroc|mesh-list
56712919|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56712920|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56712921|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
56712922|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712923|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712924|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56712925|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56712926|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
56712927|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56712928|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56712929|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56712930|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56712931|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56712932|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56712933|NCT00655863|Pioglitazone|pioglitazone|mesh-list
56712934|NCT00655863|Alogliptin|alogliptin|mesh-list
56712935|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56712936|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712937|NCT00655863|Incretins|incretins|mesh-ancestor
56712938|NCT00655863|Hormones|hormones|mesh-ancestor
56712939|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712940|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56712941|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
56712948|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712949|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56712950|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
56712951|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56712952|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56712953|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56712954|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56712956|NCT00781937|Liraglutide|liraglutide|mesh-list
56712957|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56712958|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712959|NCT00781937|Incretins|incretins|mesh-ancestor
56712960|NCT00781937|Hormones|hormones|mesh-ancestor
56712961|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712962|NCT00802581|Anesthetics|anesthetics|mesh-list
56712963|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
56712964|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56712965|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712966|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
56712967|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56712968|NCT00719108|Insulin|insulin|mesh-list
56712969|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56712970|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56712971|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712972|NCT00842140|Metformin|metformin|mesh-list
56712973|NCT00842140|Spironolactone|spironolactone|mesh-list
56712974|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
56712975|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
56712976|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56712977|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712978|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56712992|NCT00806169|Growth Substances|growth substances|mesh-ancestor
56712993|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56712994|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
56712995|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56712996|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
56712997|NCT00806169|Hormones|hormones|mesh-ancestor
56712998|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56712999|NCT00844324|Candesartan|candesartan|mesh-list
56713000|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
56713001|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56713002|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56713003|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56713004|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713005|NCT00802815|Etanercept|etanercept|mesh-list
56713006|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56713007|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56713008|NCT00802815|Analgesics|analgesics|mesh-ancestor
56713009|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
56713010|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713011|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713012|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713013|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56713014|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56713015|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713016|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
56713017|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
56713018|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
56713019|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56713020|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56713021|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713022|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713023|NCT04100759|Urological Agents|urological agents|mesh-ancestor
56713024|NCT00836914|Idelalisib|idelalisib|mesh-list
56713031|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
56713032|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713033|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56713034|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56713035|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713036|NCT00806247|Tapentadol|tapentadol|mesh-list
56713037|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56713038|NCT00806247|Narcotics|narcotics|mesh-ancestor
56713039|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56713040|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713041|NCT00806247|Analgesics|analgesics|mesh-ancestor
56713042|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
56713043|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713044|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56713045|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56713046|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56713047|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713048|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
56713049|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713050|NCT00797745|Ritonavir|ritonavir|mesh-list
56713051|NCT00797745|Ribavirin|ribavirin|mesh-list
56713052|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56713053|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56713054|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56713055|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
56713056|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713057|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713058|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56713059|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56713060|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
56713061|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713062|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56713063|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56713064|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
56713070|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713071|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713072|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56713073|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713074|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56713075|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56713076|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56713077|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56713078|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56713079|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713080|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713081|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
56713082|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56713083|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
56713084|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56713085|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56713086|NCT00842452|Topotecan|topotecan|mesh-list
56713087|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56713088|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56713089|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713090|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713091|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713092|NCT02552745|Parecoxib|parecoxib|mesh-list
56713093|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56713116|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56713117|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56713118|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56713119|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56713120|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56713121|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56713122|NCT00439777|Enoxaparin|enoxaparin|mesh-list
56713123|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
56713124|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56713125|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
56713126|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56713127|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
56713128|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713129|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713130|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
56713131|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56713132|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56713133|NCT00842686|Bevacizumab|bevacizumab|mesh-list
56713134|NCT00842686|Capecitabine|capecitabine|mesh-list
56713135|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56713170|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56713171|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56713172|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713173|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713174|NCT00844792|Vitamin D|vitamin d|mesh-list
56713175|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
56713176|NCT00844792|Vitamins|vitamins|mesh-list
56713177|NCT00844792|Vitamin E|vitamin e|mesh-list
56713178|NCT00844792|Selenium|selenium|mesh-list
56713179|NCT00844792|Lycopene|lycopene|mesh-list
56713180|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
56713181|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713182|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56713183|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56713184|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
56713185|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713186|NCT00844792|Protective Agents|protective agents|mesh-ancestor
56713187|NCT00844792|Trace Elements|trace elements|mesh-ancestor
56713188|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713189|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56713190|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56713191|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713192|NCT00719420|Amoxicillin|amoxicillin|mesh-list
56713193|NCT00719420|Metronidazole|metronidazole|mesh-list
56713194|NCT00719420|Clarithromycin|clarithromycin|mesh-list
56713195|NCT00719420|Omeprazole|omeprazole|mesh-list
56713196|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56713197|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713198|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56713199|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56713200|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56713201|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56713215|NCT00716612|Ubiquinone|ubiquinone|mesh-list
56713216|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
56713217|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
56713218|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713219|NCT00716612|Vitamins|vitamins|mesh-ancestor
56713220|NCT00842920|Simvastatin|simvastatin|mesh-list
56713221|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56713222|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56713223|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
56713224|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713225|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56713226|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56713227|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713228|NCT00842998|Trastuzumab|trastuzumab|mesh-list
56713229|NCT00842998|Lapatinib|lapatinib|mesh-list
56713230|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56713231|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713232|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56713233|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713234|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713235|NCT00716846|Atorvastatin|atorvastatin|mesh-list
56713236|NCT00716846|Simvastatin|simvastatin|mesh-list
56713237|NCT00716846|Pitavastatin|pitavastatin|mesh-list
56713238|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56713239|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56713240|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
56713241|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713242|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56713243|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56713244|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713245|NCT00620854|Calcitonin|calcitonin|mesh-list
56713246|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
56713247|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56713248|NCT00620854|Katacalcin|katacalcin|mesh-list
56713255|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56713256|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56713257|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56713258|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
56713259|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713260|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713261|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713262|NCT00430027|Capecitabine|capecitabine|mesh-list
56713263|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
56713264|NCT00430027|Cetuximab|cetuximab|mesh-list
56713265|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56713266|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
56713267|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713268|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713269|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56713270|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
56713271|NCT00792948|Leucovorin|leucovorin|mesh-list
56713272|NCT00792948|Folic Acid|folic acid|mesh-list
56713273|NCT00792948|Cytarabine|cytarabine|mesh-list
56713274|NCT00792948|Sirolimus|sirolimus|mesh-list
56713275|NCT00792948|Dexamethasone|dexamethasone|mesh-list
56713276|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
56713277|NCT00792948|Prednisone|prednisone|mesh-list
56713278|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
56713279|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56713280|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56713281|NCT00792948|Prednisolone|prednisolone|mesh-list
56713282|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
56713283|NCT00792948|Cortisone|cortisone|mesh-list
56713284|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
56713285|NCT00792948|Doxorubicin|doxorubicin|mesh-list
56713286|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56713287|NCT00792948|Methotrexate|methotrexate|mesh-list
56713288|NCT00792948|Etoposide|etoposide|mesh-list
56713289|NCT00792948|Vincristine|vincristine|mesh-list
56713290|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
56713300|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713301|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
56713302|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713303|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56713304|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56713305|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
56713306|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713307|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713308|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56713309|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713310|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
56713311|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
56713312|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713313|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56713314|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
56713315|NCT00792948|Hormones|hormones|mesh-ancestor
56713316|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713317|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56713318|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
56713319|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713320|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56713321|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56713322|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56713323|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56713324|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56713325|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56713326|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
56713327|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56424447|NCT00412802|Enoxaparin|enoxaparin|mesh-list
56713328|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56713329|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
56713340|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
56713341|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56713342|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56713343|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
56713344|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
56713345|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
56713346|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56713347|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
56713348|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56713349|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56713350|NCT00792948|Hematinics|hematinics|mesh-ancestor
56713351|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
56713352|NCT04766229|Gabapentin|gabapentin|mesh-list
56713353|NCT04766229|Citalopram|citalopram|mesh-list
56713354|NCT04766229|Analgesics|analgesics|mesh-ancestor
56713355|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
56713356|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713357|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713358|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
56713359|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56713360|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56713361|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56713362|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56713363|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56713364|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56713365|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713366|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713367|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
56713368|NCT04766229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56713369|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56713370|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56713371|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
56713372|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56713373|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
56713374|NCT04068506|Gabapentin|gabapentin|mesh-list
56713380|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56713381|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56713382|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56713383|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56713384|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56713385|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56713386|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713387|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713388|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
56713389|NCT00803907|Imiquimod|imiquimod|mesh-list
56713390|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
56713391|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56713392|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713393|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713394|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
56713395|NCT00843154|Candesartan|candesartan|mesh-list
56713396|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56713397|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56713398|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56713399|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713400|NCT00429793|Sirolimus|sirolimus|mesh-list
56713401|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56713402|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713403|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56424523|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
56713404|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713405|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
56713406|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713407|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
56713408|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713409|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
56713410|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56713412|NCT00806871|Prednisolone|prednisolone|mesh-list
56713420|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713421|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56713422|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
56713423|NCT00806871|Hormones|hormones|mesh-ancestor
56713424|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713425|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56713426|NCT00806871|Protective Agents|protective agents|mesh-ancestor
56713427|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56713428|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713429|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
56713430|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56713431|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713432|NCT04069208|Cytarabine|cytarabine|mesh-list
56713433|NCT04069208|Idarubicin|idarubicin|mesh-list
56713434|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56713435|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
56713436|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713437|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713438|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
56713439|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713440|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713441|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
56713442|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713443|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56713444|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56713445|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56713446|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713468|NCT00763451|Lixisenatide|lixisenatide|mesh-list
56713469|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56713470|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713471|NCT00762762|Triclosan|triclosan|mesh-list
56713472|NCT00762762|Fluorides|fluorides|mesh-list
56713473|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
56713474|NCT00762762|Protective Agents|protective agents|mesh-ancestor
56713475|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713476|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56713477|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713478|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56713479|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56713480|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
56713481|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713482|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56713483|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
56713484|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56713485|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56713486|NCT00424489|Prednisolone|prednisolone|mesh-list
56713487|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
56713488|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
56713489|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56713490|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
56713491|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713492|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
56713493|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713518|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56713519|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56713520|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
56713521|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713522|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713523|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56713524|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56713525|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56713526|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56713527|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713528|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56713529|NCT01034683|Leucovorin|leucovorin|mesh-list
56713530|NCT01034683|Antidotes|antidotes|mesh-ancestor
56713531|NCT01034683|Protective Agents|protective agents|mesh-ancestor
56713532|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713533|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
56713534|NCT01034683|Vitamins|vitamins|mesh-ancestor
56713535|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
56713536|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
56713537|NCT00717470|Prednisone|prednisone|mesh-list
56713538|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
56713539|NCT00717470|Tacrolimus|tacrolimus|mesh-list
56713540|NCT00717470|Basiliximab|basiliximab|mesh-list
56713541|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713542|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
56713543|NCT00717470|Hormones|hormones|mesh-ancestor
56713544|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713545|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713546|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56713547|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713564|NCT00631566|Mupirocin|mupirocin|mesh-list
56713637|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56713638|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56713639|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56713640|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713642|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56713643|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
56713644|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56713645|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713646|NCT02576808|Loratadine|loratadine|mesh-list
56713647|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
56713648|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
56713649|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56713650|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56713651|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56713652|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
56713653|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
56713654|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713655|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713656|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713657|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
56713658|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
56713659|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713660|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56713661|NCT04073160|Durvalumab|durvalumab|mesh-list
56713662|NCT04073160|Tremelimumab|tremelimumab|mesh-list
56713663|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56713664|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713665|NCT00417079|Prednisone|prednisone|mesh-list
56713666|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
56713667|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713668|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
56713669|NCT00417079|Hormones|hormones|mesh-ancestor
56713670|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713677|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56713678|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56713679|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713680|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713681|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56713682|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56713683|NCT00429169|Bupropion|bupropion|mesh-list
56713684|NCT00429169|Paroxetine|paroxetine|mesh-list
56713685|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56713686|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
56713687|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56713688|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56713689|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56713690|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56713691|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713692|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
56713693|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713694|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713695|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56713696|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56713697|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713698|NCT00429169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56713699|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
56713700|NCT01037491|Aspirin|aspirin|mesh-list
56713701|NCT01037491|Rabeprazole|rabeprazole|mesh-list
56713702|NCT01037491|Clopidogrel|clopidogrel|mesh-list
56713703|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56424823|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
56713704|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56713705|NCT01037491|Analgesics|analgesics|mesh-ancestor
56713719|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56713720|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56713721|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
56713722|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56713723|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56713724|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56713725|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56713726|NCT01033279|Warfarin|warfarin|mesh-list
56713727|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
56713728|NCT01188096|Poly ICLC|poly iclc|mesh-list
56713729|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
56713730|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
56713731|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713732|NCT04745832|Prednisone|prednisone|mesh-list
56713733|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
56713781|NCT02578602|Protective Agents|protective agents|mesh-ancestor
56713782|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713783|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
56713784|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
56713785|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713786|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56713787|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
56713788|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56713789|NCT00128856|Gemcitabine|gemcitabine|mesh-list
56713790|NCT00128856|Paclitaxel|paclitaxel|mesh-list
56713791|NCT00128856|Doxorubicin|doxorubicin|mesh-list
56713792|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56713793|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713794|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
56713795|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
56713796|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
56713797|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713798|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56713799|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
56713800|NCT00128856|Antiviral Agents|antiviral agents|mesh-ancestor
56713801|NCT00128856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713802|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713803|NCT00128856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713833|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713834|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56713835|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713836|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713837|NCT00709644|Folic Acid|folic acid|mesh-list
56713838|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56713839|NCT00709644|Norgestimate|norgestimate|mesh-list
56713840|NCT00709644|Estradiol|estradiol|mesh-list
56713841|NCT00709644|Estrogens|estrogens|mesh-ancestor
56713842|NCT00709644|Hormones|hormones|mesh-ancestor
56713843|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713844|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713845|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56713846|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
56713847|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56713848|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56713849|NCT00709644|Hematinics|hematinics|mesh-ancestor
56713850|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
56713851|NCT00709644|Vitamins|vitamins|mesh-ancestor
56713852|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
56713853|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56713854|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56713855|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56713856|NCT00415597|Naltrexone|naltrexone|mesh-list
56713857|NCT00415597|Morphine|morphine|mesh-list
56713858|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56713859|NCT00415597|Narcotics|narcotics|mesh-ancestor
56713860|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56713861|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713862|NCT00415597|Analgesics|analgesics|mesh-ancestor
56713863|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
56713880|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713881|NCT00714558|Analgesics|analgesics|mesh-ancestor
56713882|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
56713883|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713884|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56713885|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56713886|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
56713887|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
56713888|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56713889|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56713890|NCT02575638|Camptothecin|camptothecin|mesh-list
56713891|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56713892|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713893|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56713894|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56713895|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713896|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713897|NCT02573610|Levofloxacin|levofloxacin|mesh-list
56713898|NCT02573610|Ofloxacin|ofloxacin|mesh-list
56713899|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56713900|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713901|NCT02573610|Renal Agents|renal agents|mesh-ancestor
56713902|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56713903|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56713904|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56713905|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713906|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713907|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713908|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56713909|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56713910|NCT02574468|Dexamethasone|dexamethasone|mesh-list
56713911|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
56713912|NCT02574468|BB 1101|bb 1101|mesh-list
56713913|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56713914|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
56713915|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
56269300|NCT01988649|Oxytocin|oxytocin|mesh-list
56554584|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
56108993|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
56713916|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56713917|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713918|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56713919|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
56713920|NCT02574468|Hormones|hormones|mesh-ancestor
56713921|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713922|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56713923|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713924|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
56713925|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713926|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713927|NCT00710268|Bevacizumab|bevacizumab|mesh-list
56713928|NCT00710268|Olaparib|olaparib|mesh-list
56713929|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56713930|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56425041|NCT04606225|Losartan|losartan|mesh-list
56713931|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56713932|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56713933|NCT00710268|Growth Substances|growth substances|mesh-ancestor
56713934|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713935|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
56713936|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56713937|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713938|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713939|NCT02575248|Dienogest|dienogest|mesh-list
56713940|NCT02575248|Clomiphene|clomiphene|mesh-list
56713941|NCT02575248|Enclomiphene|enclomiphene|mesh-list
56713942|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
56713943|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56713944|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
56713945|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56713946|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713954|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56713955|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56713956|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56713957|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56713958|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56713959|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713960|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56713961|NCT00710736|Fluorouracil|fluorouracil|mesh-list
56713962|NCT00710736|Capecitabine|capecitabine|mesh-list
56713963|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
56713964|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713965|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56713966|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56713967|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713968|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
56713969|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713970|NCT00620542|Atorvastatin|atorvastatin|mesh-list
56713971|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56713972|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56713973|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56713974|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
56713975|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56713976|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56713977|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56713978|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56713979|NCT04070742|Minocycline|minocycline|mesh-list
56713980|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56713981|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56713982|NCT00851344|Cetirizine|cetirizine|mesh-list
56713983|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56713984|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56713985|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56713986|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
56713987|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
56713988|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56109019|NCT04329403|Adapalene|adapalene|mesh-list
56713990|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713991|NCT04523922|Oxytocin|oxytocin|mesh-list
56713992|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
56713993|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56713994|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56713995|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56713996|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
56713997|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56713998|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
56713999|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714000|NCT00711204|Donepezil|donepezil|mesh-list
56714001|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56714002|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714003|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714004|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
56714005|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714006|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714008|NCT00845338|Darifenacin|darifenacin|mesh-list
56714009|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56714010|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56714011|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
56714012|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714013|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714014|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714043|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714044|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714045|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56714046|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
56714047|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56714048|NCT04097470|Decitabine|decitabine|mesh-list
56714049|NCT04097470|Midostaurin|midostaurin|mesh-list
56714050|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56714051|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
56714052|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714053|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714054|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714055|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56714056|NCT04041934|Tryptophan|tryptophan|mesh-list
56714057|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56714058|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
56714059|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56714060|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56714061|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56714062|NCT00845572|Risperidone|risperidone|mesh-list
56714063|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56714064|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
56714065|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714066|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714067|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714068|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56714069|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56714070|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714071|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56714072|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56714073|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
56714084|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714085|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56714087|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56714088|NCT04502550|Propofol|propofol|mesh-list
56714089|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56714090|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714091|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714092|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56714093|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
56714094|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
56714095|NCT04227184|Trospium chloride|trospium chloride|mesh-list
56714096|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
56714097|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
56714098|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714099|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714100|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56714101|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56714102|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
56714103|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714104|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714105|NCT04227184|Urological Agents|urological agents|mesh-ancestor
56714106|NCT02545972|Tacrolimus|tacrolimus|mesh-list
56714107|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714108|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
56714109|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714133|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714134|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714135|NCT00845884|Bevacizumab|bevacizumab|mesh-list
56714136|NCT00845884|Cisplatin|cisplatin|mesh-list
56714137|NCT00845884|Docetaxel|docetaxel|mesh-list
56714138|NCT00845884|Capecitabine|capecitabine|mesh-list
56714139|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714140|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714141|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56714142|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56714143|NCT00845884|Growth Substances|growth substances|mesh-ancestor
56714144|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714145|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
56714146|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
56714147|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
56714148|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
56714149|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714150|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56714151|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
56714152|NCT00923806|Aldesleukin|aldesleukin|mesh-list
56714153|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714154|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56714155|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56714156|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
56714157|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714159|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
56714160|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56714161|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
56714162|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56714163|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56714164|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
56714165|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714177|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714178|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714179|NCT02545738|Liraglutide|liraglutide|mesh-list
56714180|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56714181|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714182|NCT02545738|Incretins|incretins|mesh-ancestor
56714183|NCT02545738|Hormones|hormones|mesh-ancestor
56714184|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56714185|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
56714186|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56714187|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
56714188|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714189|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714190|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56714191|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
56714192|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56714193|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
56714194|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714195|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714196|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56714197|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
56714198|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
56714199|NCT00848302|Protective Agents|protective agents|mesh-ancestor
56714200|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
56714201|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714202|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
56714203|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714204|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714205|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56714206|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
56714208|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714220|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714221|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56714222|NCT00712374|Renal Agents|renal agents|mesh-ancestor
56714223|NCT02573220|Leucovorin|leucovorin|mesh-list
56714224|NCT02573220|Fluorouracil|fluorouracil|mesh-list
56714225|NCT02573220|Irinotecan|irinotecan|mesh-list
56714226|NCT02573220|Cetuximab|cetuximab|mesh-list
56714227|NCT02573220|Camptothecin|camptothecin|mesh-list
56714228|NCT02573220|Calcium|calcium|mesh-list
56714229|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
56714230|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56425342|NCT00252369|Coagulants|coagulants|mesh-ancestor
56714231|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714232|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
56714233|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714234|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56714235|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714236|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714237|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
56714238|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56714239|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56714240|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714241|NCT02573220|Antidotes|antidotes|mesh-ancestor
56714242|NCT02573220|Protective Agents|protective agents|mesh-ancestor
56714243|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
56714244|NCT02573220|Vitamins|vitamins|mesh-ancestor
56714245|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
56714246|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714247|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56714248|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
56714249|NCT00712452|Vinblastine|vinblastine|mesh-list
56714250|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714251|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
56714252|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714253|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714254|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56714259|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56714260|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
56714261|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
56714262|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
56714263|NCT00618982|Sorafenib|sorafenib|mesh-list
56714264|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714265|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56714266|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714267|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714268|NCT02544880|Tadalafil|tadalafil|mesh-list
56714269|NCT02544880|Vaccines|vaccines|mesh-list
56714270|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
56714271|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714272|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
56714273|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56714274|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56714275|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714276|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714277|NCT02544880|Urological Agents|urological agents|mesh-ancestor
56714278|NCT00856570|Warfarin|warfarin|mesh-list
56714279|NCT00856570|Mirabegron|mirabegron|mesh-list
56714280|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
56714281|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56714282|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56714283|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56714284|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
56714285|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714307|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714308|NCT00856882|Caseins|caseins|mesh-list
56714309|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
56714310|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
56714311|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714312|NCT00712686|Olanzapine|olanzapine|mesh-list
56714313|NCT00712686|Aripiprazole|aripiprazole|mesh-list
56714314|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
56714315|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
56714316|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714317|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714318|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56714319|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56714320|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56714321|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714322|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56714323|NCT00712686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56714324|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56714325|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56714326|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714327|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714360|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714361|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714362|NCT00848458|Azelaic acid|azelaic acid|mesh-list
56714363|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714364|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
56714365|NCT00578786|Ambrisentan|ambrisentan|mesh-list
56714366|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56714367|NCT00424255|Lapatinib|lapatinib|mesh-list
56714368|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714369|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56714370|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714371|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714372|NCT02574156|Insulin|insulin|mesh-list
56714373|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56714374|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714375|NCT00848692|Rituximab|rituximab|mesh-list
56714376|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714377|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714378|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
56714379|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714380|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714381|NCT00848770|Norepinephrine|norepinephrine|mesh-list
56425491|NCT00565708|Aspirin|aspirin|mesh-list
56714382|NCT00848770|Esmolol|esmolol|mesh-list
56714383|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56714396|NCT00717704|Dasatinib|dasatinib|mesh-list
56714408|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714409|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56714410|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
56714411|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56714412|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714413|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56714414|NCT02571296|Progesterone|progesterone|mesh-list
56714415|NCT02571296|Progestins|progestins|mesh-ancestor
56714416|NCT02571296|Hormones|hormones|mesh-ancestor
56714417|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56714418|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714419|NCT00857038|Doxycycline|doxycycline|mesh-list
56714420|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56714421|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714422|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
56714423|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56714424|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56714425|NCT00857116|Albendazole|albendazole|mesh-list
56714426|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
56714427|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56714428|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714429|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
56714430|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56714431|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56714432|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
56714433|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
56714434|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
56714435|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714436|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714437|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
56714438|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56714450|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714451|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714452|NCT00717938|Carboplatin|carboplatin|mesh-list
56714453|NCT00717938|Etoposide|etoposide|mesh-list
56714454|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
56714455|NCT00717938|Cisplatin|cisplatin|mesh-list
56714456|NCT00717938|Enoxaparin|enoxaparin|mesh-list
56714457|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
56714458|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714459|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56714460|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56714461|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56714462|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714463|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714464|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
56714465|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56714466|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56714468|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56714469|NCT00857428|Narcotics|narcotics|mesh-ancestor
56714470|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714471|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714472|NCT00857428|Analgesics|analgesics|mesh-ancestor
56714473|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
56714474|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714475|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56714476|NCT04018768|Acetaminophen|acetaminophen|mesh-list
56714477|NCT04018768|Ibuprofen|ibuprofen|mesh-list
56714478|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56714479|NCT04018768|Oxycodone|oxycodone|mesh-list
56714481|NCT04018768|Analgesics|analgesics|mesh-ancestor
56714497|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56714498|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
56714499|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714500|NCT00848848|Vaccines|vaccines|mesh-list
56714501|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
56714502|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714503|NCT02573922|Oxycodone|oxycodone|mesh-list
56714504|NCT02573922|Naloxone|naloxone|mesh-list
56714505|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56714506|NCT02573922|Narcotics|narcotics|mesh-ancestor
56714507|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714508|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714509|NCT02573922|Analgesics|analgesics|mesh-ancestor
56714510|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
56714511|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714512|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56714513|NCT00852436|Pregabalin|pregabalin|mesh-list
56714514|NCT00852436|Analgesics|analgesics|mesh-ancestor
56714515|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
56714516|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714517|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714518|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
56714519|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56714520|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56714521|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714548|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56714549|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714550|NCT00720512|Antidotes|antidotes|mesh-ancestor
56714551|NCT00720512|Protective Agents|protective agents|mesh-ancestor
56714552|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
56714553|NCT00720512|Vitamins|vitamins|mesh-ancestor
56714554|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
56714555|NCT04069286|Amoxicillin|amoxicillin|mesh-list
56714556|NCT04069286|Omeprazole|omeprazole|mesh-list
56714557|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56714558|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714559|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56714560|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56714561|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56714562|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714563|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714564|NCT00713622|Zonisamide|zonisamide|mesh-list
56714565|NCT00713622|Valproic Acid|valproic acid|mesh-list
56714566|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
56714567|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714568|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714569|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
56714570|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714571|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714572|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
56714573|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56714574|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714575|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56714576|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56714577|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56714578|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56714579|NCT00718172|Ribavirin|ribavirin|mesh-list
56714580|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
56714582|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
56714590|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714591|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714592|NCT03992456|Trifluridine|trifluridine|mesh-list
56714593|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56714594|NCT03992456|Panitumumab|panitumumab|mesh-list
56714595|NCT03992456|Antibodies|antibodies|mesh-list
56714596|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
56714597|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56714598|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
56714599|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714600|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714601|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
56714602|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714603|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
56714604|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714605|NCT00618826|Gemcitabine|gemcitabine|mesh-list
56714606|NCT00618826|Paclitaxel|paclitaxel|mesh-list
56714607|NCT00618826|Bevacizumab|bevacizumab|mesh-list
56714608|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56714609|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714645|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714646|NCT00849082|Goserelin|goserelin|mesh-list
56714647|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
56714648|NCT00849082|Cyproterone|cyproterone|mesh-list
56714649|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56714650|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714651|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
56714652|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
56714653|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56714654|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714655|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56714656|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
56714657|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56714658|NCT03472040|Berotralstat|berotralstat|mesh-list
56714659|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714660|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714661|NCT00849160|Darunavir|darunavir|mesh-list
56714662|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56714702|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714703|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714704|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
56714705|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56714706|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714707|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56714708|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
56714709|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56714710|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714711|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714712|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714713|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
56714714|NCT00720408|Tacrolimus|tacrolimus|mesh-list
56714715|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714716|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
56714717|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714718|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56714719|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714720|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714721|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56714722|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714723|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56714724|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
56714725|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56714726|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56714727|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
56714728|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56714747|NCT05373680|Metformin|metformin|mesh-list
56714748|NCT05373680|Empagliflozin|empagliflozin|mesh-list
56714749|NCT05373680|Biguanides|biguanides|mesh-list
56714750|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56714751|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714752|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56714753|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714754|NCT04018378|Varenicline|varenicline|mesh-list
56714755|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56714756|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56714757|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
56714758|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714759|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714760|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714761|NCT00849550|Bevacizumab|bevacizumab|mesh-list
56714762|NCT00849550|Capecitabine|capecitabine|mesh-list
56714763|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
56714764|NCT00849550|Everolimus|everolimus|mesh-list
56714765|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714766|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714767|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56714768|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56714769|NCT00849550|Growth Substances|growth substances|mesh-ancestor
56714770|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714771|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
56714772|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56714773|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
56714774|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714775|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714776|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
56714777|NCT03816488|Metformin|metformin|mesh-list
56714778|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56714779|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56714780|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714788|NCT00858676|Acarbose|acarbose|mesh-list
56714789|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56714790|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714791|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714792|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56714793|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714794|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
56714795|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56714796|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714797|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
56714798|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714799|NCT00723164|Fentanyl|fentanyl|mesh-list
56714800|NCT00723164|Midazolam|midazolam|mesh-list
56714801|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56714802|NCT00723164|Narcotics|narcotics|mesh-ancestor
56714803|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714804|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714805|NCT00723164|Analgesics|analgesics|mesh-ancestor
56714806|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
56714807|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714808|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56714809|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56714810|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
56714811|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
56714812|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56714813|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56714814|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56714815|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56714816|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
56714817|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
56714818|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714819|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714820|NCT00723242|Ribavirin|ribavirin|mesh-list
56714821|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
56714823|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
56714829|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56714830|NCT00720824|Anesthetics|anesthetics|mesh-list
56714831|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56714832|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
56714833|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714834|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714835|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
56714836|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714838|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56714839|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714840|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714841|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56714842|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56714843|NCT05373134|Protective Agents|protective agents|mesh-ancestor
56714844|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714845|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
56714846|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56714847|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
56714848|NCT00723320|Atorvastatin|atorvastatin|mesh-list
56714849|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56714850|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56714879|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56714880|NCT04067024|Anesthetics|anesthetics|mesh-list
56714881|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714882|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714883|NCT00618748|Olanzapine|olanzapine|mesh-list
56714884|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
56714885|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
56714886|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56714887|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714888|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56714889|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56714890|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56714891|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56714892|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56714893|NCT00618748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56714894|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56714895|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56714896|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714897|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714898|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
56714899|NCT04067102|Paclitaxel|paclitaxel|mesh-list
56714900|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56714901|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
56714902|NCT04067102|Carboplatin|carboplatin|mesh-list
56714903|NCT04067102|Epirubicin|epirubicin|mesh-list
56714904|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56714905|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714906|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
56714907|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
56714908|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
56714909|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714910|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714911|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
56714912|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714913|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714914|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56714917|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56714918|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56714919|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56714920|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714922|NCT05659290|Capecitabine|capecitabine|mesh-list
56714923|NCT05659290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714924|NCT05659290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714925|NCT05659290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56714926|NCT05659290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56714927|NCT05659290|Growth Substances|growth substances|mesh-ancestor
56714928|NCT05659290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714929|NCT05659290|Growth Inhibitors|growth inhibitors|mesh-ancestor
56714930|NCT05659290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56714931|NCT05659290|Antimetabolites|antimetabolites|mesh-ancestor
56714932|NCT05659290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714933|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
56714934|NCT00717678|Tacrolimus|tacrolimus|mesh-list
56714935|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56714936|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
56714937|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714938|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56714939|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714940|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714941|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56714942|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714943|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56714944|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
56714964|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
56714965|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
56714966|NCT02571842|Prednisolone|prednisolone|mesh-list
56714967|NCT02571842|Rituximab|rituximab|mesh-list
56714968|NCT02571842|Enalapril|enalapril|mesh-list
56714969|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56714970|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56714971|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
56714972|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714973|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56714974|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56714975|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
56714976|NCT02571842|Hormones|hormones|mesh-ancestor
56714977|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56714978|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56714979|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56714980|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
56714981|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56714982|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714983|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56714984|NCT00721448|Ticagrelor|ticagrelor|mesh-list
56714985|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56714986|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56714987|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56714988|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56714989|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
56714990|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56714991|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56714992|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56714993|NCT00853216|Oxycodone|oxycodone|mesh-list
56714994|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56715005|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715006|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
56715007|NCT04961528|Coagulants|coagulants|mesh-ancestor
56715008|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56715009|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56715010|NCT00721032|Amiodarone|amiodarone|mesh-list
56715011|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56715012|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
56715013|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56715014|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56715015|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715016|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56715017|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56715018|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56715019|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715020|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56715021|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56715022|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56715023|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56715024|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56715025|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56715026|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715027|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715028|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56715029|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56715050|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715051|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56715052|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
56715053|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56715055|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715056|NCT00717834|Formaldehyde|formaldehyde|mesh-list
56715057|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
56715058|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715059|NCT00658359|Cyclosporine|cyclosporine|mesh-list
56715060|NCT00658359|Cyclosporins|cyclosporins|mesh-list
56715061|NCT00658359|Tofacitinib|tofacitinib|mesh-list
56715062|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715063|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715064|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56715065|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
56715066|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715067|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
56715068|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715069|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
56715070|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56715071|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56715072|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56715073|NCT00853450|Clopidogrel|clopidogrel|mesh-list
56715074|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56715075|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56715076|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56715077|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56715078|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
56715079|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715080|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715081|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715082|NCT04066790|Paclitaxel|paclitaxel|mesh-list
56715083|NCT04066790|Trastuzumab|trastuzumab|mesh-list
56715084|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56715085|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715086|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
56715087|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
56715089|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715090|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56715091|NCT00721526|Disulfiram|disulfiram|mesh-list
56715092|NCT00721526|Lorazepam|lorazepam|mesh-list
56715093|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
56715094|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
56715095|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
56715096|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715097|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715098|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715099|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56715100|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56715101|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56715102|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56715103|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56715104|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
56715105|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
56715106|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715107|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715108|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56715109|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56715110|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715111|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56715112|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
56715113|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
56715114|NCT02571192|Volixibat|volixibat|mesh-list
56715115|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56715116|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
56715117|NCT00724022|Prednisolone|prednisolone|mesh-list
56715118|NCT00724022|Tacrolimus|tacrolimus|mesh-list
56715119|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
56715120|NCT00724022|Basiliximab|basiliximab|mesh-list
56715121|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56715122|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
56715124|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56715130|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715131|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56715132|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715133|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56715134|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56715135|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
56715136|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56715137|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715138|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
56715139|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56715140|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715141|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56715142|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56715143|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715144|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715145|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715146|NCT00717990|Bevacizumab|bevacizumab|mesh-list
56715147|NCT00717990|Capecitabine|capecitabine|mesh-list
56715148|NCT00717990|Irinotecan|irinotecan|mesh-list
56715149|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56715150|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715151|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56715152|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56715153|NCT00717990|Growth Substances|growth substances|mesh-ancestor
56715154|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715155|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
56715156|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56715157|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
56715158|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715159|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56715160|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56715161|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715162|NCT02572986|Permethrin|permethrin|mesh-list
56715169|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
56715170|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715171|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715172|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56715173|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56715174|NCT00853684|Growth Substances|growth substances|mesh-ancestor
56715175|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715176|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
56715177|NCT00723060|Citalopram|citalopram|mesh-list
56715178|NCT00723060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56715179|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56715180|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56715181|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715182|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715183|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
56715184|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715185|NCT00723060|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56715186|NCT00723060|Antidepressive Agents|antidepressive agents|mesh-ancestor
56715187|NCT00723060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56715188|NCT02571140|Teriparatide|teriparatide|mesh-list
56715189|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
56715190|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56715191|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715192|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56715193|NCT00723216|Enoxaparin|enoxaparin|mesh-list
56715194|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
56715195|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56715198|NCT00724178|Vitamin D|vitamin d|mesh-list
56715215|NCT00718146|Vaccines|vaccines|mesh-list
56715216|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
56715217|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715218|NCT00860626|Interferons|interferons|mesh-list
56715219|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715220|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
56715221|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715222|NCT00724256|Ceftibuten|ceftibuten|mesh-list
56715223|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56715224|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715225|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
56715226|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715227|NCT01005914|Cytarabine|cytarabine|mesh-list
56715228|NCT01005914|Dexamethasone|dexamethasone|mesh-list
56715229|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
56715230|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56715231|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56715232|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
56715233|NCT01005914|Doxorubicin|doxorubicin|mesh-list
56715234|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56715235|NCT01005914|Methotrexate|methotrexate|mesh-list
56715236|NCT01005914|Vincristine|vincristine|mesh-list
56715237|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
56715238|NCT01005914|Asparaginase|asparaginase|mesh-list
56715239|NCT01005914|Pegaspargase|pegaspargase|mesh-list
56715240|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56715241|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
56715242|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715243|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56715244|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56715245|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
56715246|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715247|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715248|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56715249|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715250|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
56715251|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
56715252|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715253|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554585|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715254|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
56715255|NCT01005914|Hormones|hormones|mesh-ancestor
56715256|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715257|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56715258|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56715259|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56715260|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56715261|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715262|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56715263|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
56715264|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56715265|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56715266|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
56715267|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
56715268|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56715269|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56715270|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
56715271|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715272|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56715273|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
56715274|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
56715275|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
56715276|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56715277|NCT01005914|Protective Agents|protective agents|mesh-ancestor
56715278|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56715279|NCT00854230|Naltrexone|naltrexone|mesh-list
56715280|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56715281|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56715285|NCT00861016|Metoprolol|metoprolol|mesh-list
56715299|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56715300|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56715301|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56715302|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
56715303|NCT00721916|Leucovorin|leucovorin|mesh-list
56715304|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
56715305|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715306|NCT00721916|Antidotes|antidotes|mesh-ancestor
56715307|NCT00721916|Protective Agents|protective agents|mesh-ancestor
56715308|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715309|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
56715310|NCT00721916|Vitamins|vitamins|mesh-ancestor
56715311|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
56715312|NCT00861250|Dexamethasone|dexamethasone|mesh-list
56715313|NCT00861250|Bortezomib|bortezomib|mesh-list
56715314|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715315|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
56715316|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
56715317|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715318|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715319|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715320|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
56715321|NCT00861250|Hormones|hormones|mesh-ancestor
56715322|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715323|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56715324|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715325|NCT00722150|Artesunate|artesunate|mesh-list
56715326|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
56715327|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56715348|NCT00861094|Protective Agents|protective agents|mesh-ancestor
56715349|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
56715350|NCT00861094|Vitamins|vitamins|mesh-ancestor
56715351|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
56715352|NCT00861094|Hematinics|hematinics|mesh-ancestor
56715353|NCT00807261|Gemcitabine|gemcitabine|mesh-list
56715354|NCT00807261|Docetaxel|docetaxel|mesh-list
56715355|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56715356|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
56715357|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715358|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715359|NCT00807261|Antiviral Agents|antiviral agents|mesh-ancestor
56715360|NCT00807261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715361|NCT00807261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715362|NCT00807261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56715363|NCT00807261|Immunologic Factors|immunologic factors|mesh-ancestor
56715364|NCT00807261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715365|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
56715366|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
56715367|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
56715369|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56715370|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715371|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56715372|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
56715373|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715374|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715375|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56715400|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56715401|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56715402|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
56715403|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715404|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715405|NCT00861406|Interferons|interferons|mesh-list
56715406|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
56715407|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
56715408|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56715409|NCT00861406|Vaccines|vaccines|mesh-list
56715410|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
56715411|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715412|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715413|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
56715414|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715415|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
56715416|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
56715417|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715418|NCT00865384|Mirtazapine|mirtazapine|mesh-list
56715419|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
56715420|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56715421|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56715422|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
56715423|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
56715424|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715425|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715426|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715427|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56715428|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56715429|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56715430|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56426545|NCT00250068|Rubitecan|rubitecan|mesh-list
56715443|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
56715444|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715445|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56715446|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56715447|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
56715448|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715449|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715450|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56715451|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56715452|NCT00724724|Aspirin|aspirin|mesh-list
56715453|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
56715454|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56715455|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56715456|NCT00724724|Analgesics|analgesics|mesh-ancestor
56715457|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
56715460|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715499|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56715500|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56715501|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
56715502|NCT04130204|Colchicine|colchicine|mesh-list
56715503|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
56715504|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56715505|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
56715506|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
56715507|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
56715508|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715509|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715510|NCT00723918|Methadone|methadone|mesh-list
56715511|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56715512|NCT00723918|Narcotics|narcotics|mesh-ancestor
56715513|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56715514|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715515|NCT00723918|Analgesics|analgesics|mesh-ancestor
56715516|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
56715517|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715518|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
56715519|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
56715520|NCT00865540|Prednisolone|prednisolone|mesh-list
56715521|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56715522|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
56715523|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56715524|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
56715525|NCT00865540|Ketorolac|ketorolac|mesh-list
56715526|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56715527|NCT00865540|Nepafenac|nepafenac|mesh-list
56715528|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56715529|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
56715531|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
56715544|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56715545|NCT00865540|Analgesics|analgesics|mesh-ancestor
56715546|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
56715547|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56715548|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56715549|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715550|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715551|NCT00865618|Eplerenone|eplerenone|mesh-list
56715552|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56715553|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
56715554|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715555|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715556|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56715557|NCT00865618|Diuretics|diuretics|mesh-ancestor
56715558|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
56715559|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56715560|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56715561|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
56715562|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56715563|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56715564|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715565|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715566|NCT00655629|Urological Agents|urological agents|mesh-ancestor
56715567|NCT00865696|Mirtazapine|mirtazapine|mesh-list
56715568|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
56715569|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56715570|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56715571|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
56715572|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
56715573|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715575|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715584|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56715585|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
56715586|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56715587|NCT00724802|Triacetin|triacetin|mesh-list
56715588|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
56715589|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715590|NCT02545114|Tolvaptan|tolvaptan|mesh-list
56715591|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56715592|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715593|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
56715594|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715595|NCT00724880|Clopidogrel|clopidogrel|mesh-list
56715596|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56715597|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56715598|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56715599|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56715600|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
56715601|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715602|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715603|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715604|NCT00724074|Bupivacaine|bupivacaine|mesh-list
56715605|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
56715606|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
56715607|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56715608|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715609|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
56715610|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715611|NCT00854776|Lansoprazole|lansoprazole|mesh-list
56715612|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
56715622|NCT00854776|Antacids|antacids|mesh-ancestor
56715628|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715629|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715630|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
56715631|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56715632|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56715633|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56715634|NCT00861640|Omeprazole|omeprazole|mesh-list
56715635|NCT00861640|Rabeprazole|rabeprazole|mesh-list
56715636|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56715637|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715638|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56715639|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715640|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715641|NCT00724230|Ribavirin|ribavirin|mesh-list
56715642|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56715643|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
56715644|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
56715645|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715646|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
56715647|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715648|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
56715649|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715650|NCT05373108|Macitentan|macitentan|mesh-list
56715680|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56715681|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56715682|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56715683|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715684|NCT00724542|Voglibose|voglibose|mesh-list
56715685|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56715686|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715687|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56715688|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715689|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715690|NCT00724620|Ribavirin|ribavirin|mesh-list
56715691|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56715692|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
56715693|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715694|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
56715695|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715696|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56715697|NCT00866008|Ganirelix|ganirelix|mesh-list
56715698|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
56715699|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56715700|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
56715701|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56715702|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715703|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56715704|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56715705|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715706|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
56715707|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715708|NCT02571426|Propofol|propofol|mesh-list
56715709|NCT02571426|Sevoflurane|sevoflurane|mesh-list
56715710|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56715712|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715721|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56715722|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715723|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56715724|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715725|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715726|NCT03491540|Laxatives|laxatives|mesh-ancestor
56715727|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715728|NCT03491540|Amebicides|amebicides|mesh-ancestor
56715729|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56715730|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56715731|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56715732|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56715733|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715734|NCT00861874|Sirolimus|sirolimus|mesh-list
56426851|NCT00568789|Zolpidem|zolpidem|mesh-list
56715735|NCT00861874|Decitabine|decitabine|mesh-list
56715736|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56715737|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
56715738|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715739|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715740|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715741|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56715742|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715743|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56715744|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
56715745|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56715746|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
56715747|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715748|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
56715749|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715750|NCT04067856|Dexamethasone|dexamethasone|mesh-list
56715751|NCT04067856|Bevacizumab|bevacizumab|mesh-list
56715752|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56715763|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715764|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
56715765|NCT04067856|Hormones|hormones|mesh-ancestor
56715766|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715767|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56715768|NCT04042714|Trifluridine|trifluridine|mesh-list
56715769|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
56715770|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715771|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
56715772|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715773|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56715774|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715775|NCT03613116|Vitamin D|vitamin d|mesh-list
56715776|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
56715777|NCT03613116|Vitamins|vitamins|mesh-ancestor
56715778|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
56715779|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715780|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56715781|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56715782|NCT00725348|R 115866|r 115866|mesh-list
56715783|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56715784|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715785|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715786|NCT00577772|Rifaximin|rifaximin|mesh-list
56715787|NCT00577772|Lactulose|lactulose|mesh-list
56715791|NCT00578136|Bupivacaine|bupivacaine|mesh-list
56715812|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
56715813|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715814|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715815|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56715816|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56715817|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
56715818|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715819|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56715820|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56715821|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56715822|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56715823|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56715825|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715826|NCT02553603|Hormones|hormones|mesh-list
56715827|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56715828|NCT02553603|Tesamorelin|tesamorelin|mesh-list
56715830|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715869|NCT00312728|Growth Substances|growth substances|mesh-ancestor
56715870|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715871|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
56715872|NCT00804921|Bevacizumab|bevacizumab|mesh-list
56715873|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56715874|NCT00804921|Acetazolamide|acetazolamide|mesh-list
56715875|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56715876|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715877|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56715878|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56715879|NCT00804921|Growth Substances|growth substances|mesh-ancestor
56715880|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715881|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
56715882|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56715883|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56715884|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56715885|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56715886|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
56715887|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56715888|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715889|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
56715890|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56715891|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715892|NCT00804921|Diuretics|diuretics|mesh-ancestor
56715893|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
56715894|NCT00866944|Leucovorin|leucovorin|mesh-list
56715895|NCT00866944|Fluorouracil|fluorouracil|mesh-list
56715896|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
56715897|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56715898|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
56715899|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715914|NCT00577824|Incretins|incretins|mesh-ancestor
56715915|NCT00577824|Hormones|hormones|mesh-ancestor
56715916|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56715917|NCT02632448|Gemcitabine|gemcitabine|mesh-list
56715918|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56715919|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
56715920|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715921|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56715922|NCT02632448|Antiviral Agents|antiviral agents|mesh-ancestor
56715923|NCT02632448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715924|NCT02632448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715925|NCT02632448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56715926|NCT02632448|Immunologic Factors|immunologic factors|mesh-ancestor
56715927|NCT02632448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715928|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
56715929|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
56715930|NCT04046289|Calcium|calcium|mesh-list
56715931|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56715932|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715933|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56715934|NCT04046289|Antacids|antacids|mesh-ancestor
56715935|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715936|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56715937|NCT00807807|Folic Acid|folic acid|mesh-list
56715938|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
56715939|NCT00807807|Hematinics|hematinics|mesh-ancestor
56715940|NCT00807807|Vitamins|vitamins|mesh-ancestor
56715941|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
56715942|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715943|NCT03011814|Lenalidomide|lenalidomide|mesh-list
56715944|NCT03011814|Durvalumab|durvalumab|mesh-list
56715945|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
56715946|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56715947|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
56715957|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
56715958|NCT00870298|Warfarin|warfarin|mesh-list
56715959|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
56715960|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56715961|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56715962|NCT00870298|Renal Agents|renal agents|mesh-ancestor
56715963|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
56715964|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56715965|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56715966|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56715967|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56715968|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56715969|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56715970|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56715971|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56715972|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
56715973|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56715974|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
56715975|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56715976|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
56715977|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56715978|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56715979|NCT00730418|Doxazosin|doxazosin|mesh-list
56715980|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56715981|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56715982|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56716005|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56716006|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716007|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56716008|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56716009|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
56716010|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716011|NCT03906136|Adalimumab|adalimumab|mesh-list
56716012|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716013|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716014|NCT00725400|Cetuximab|cetuximab|mesh-list
56716015|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56716016|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716017|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56716018|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56716019|NCT00798915|Incretins|incretins|mesh-ancestor
56716020|NCT00798915|Hormones|hormones|mesh-ancestor
56716021|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56716022|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716023|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
56716024|NCT00798993|Vitamin D|vitamin d|mesh-list
56716025|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56716026|NCT00798993|Calcifediol|calcifediol|mesh-list
56716027|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56716028|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716029|NCT00798993|Vitamins|vitamins|mesh-ancestor
56716030|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
56716031|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56716032|NCT00862108|Methylphenidate|methylphenidate|mesh-list
56716033|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56716034|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716035|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56716036|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56716037|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56716038|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716044|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56716045|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
56716046|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716047|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716048|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56716049|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
56716050|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56716051|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56716052|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56716053|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
56716054|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716055|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716056|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716057|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
56716058|NCT00862264|Hormones|hormones|mesh-ancestor
56716059|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56716060|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
56716061|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56716062|NCT00730574|Vitamins|vitamins|mesh-list
56716063|NCT00730574|Folic Acid|folic acid|mesh-list
56716064|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
56716065|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
56716066|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
56716067|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
56716069|NCT00730574|Hematinics|hematinics|mesh-ancestor
56716094|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716095|NCT01951274|Serlopitant|serlopitant|mesh-list
56716165|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716166|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716167|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
56716168|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716169|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56716170|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
56716171|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56716172|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56716173|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56716174|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716175|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56716176|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
56716177|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56716178|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56716179|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716180|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716181|NCT00725790|Urological Agents|urological agents|mesh-ancestor
56716182|NCT00731276|Irinotecan|irinotecan|mesh-list
56716183|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56716184|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56716185|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716186|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716187|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716189|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
56716190|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56716191|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716192|NCT00725946|Trace Elements|trace elements|mesh-ancestor
56716193|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
56716194|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716208|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56716209|NCT00726804|Adalimumab|adalimumab|mesh-list
56716210|NCT00726804|Etanercept|etanercept|mesh-list
56716211|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716212|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716213|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56716214|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56716215|NCT00726804|Analgesics|analgesics|mesh-ancestor
56716216|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
56716217|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716218|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716219|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56716220|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716221|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
56716222|NCT00726960|Buprenorphine|buprenorphine|mesh-list
56716223|NCT00726960|Aprepitant|aprepitant|mesh-list
56716224|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56716225|NCT00726960|Narcotics|narcotics|mesh-ancestor
56716226|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56716227|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716228|NCT00726960|Analgesics|analgesics|mesh-ancestor
56716229|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
56716261|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716262|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56716263|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716265|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56716266|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56716267|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56716268|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56716269|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716270|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56716271|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716272|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
56716273|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56716274|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56716275|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
56716276|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56716277|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56716278|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716279|NCT02915198|Metformin|metformin|mesh-list
56716280|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56716281|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716282|NCT00726570|Heparin|heparin|mesh-list
56716316|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716317|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56716318|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56716319|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
56716320|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56716321|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56716322|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56716323|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56716324|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56716325|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
56716326|NCT00726726|Coagulants|coagulants|mesh-ancestor
56716327|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
56716328|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
56716329|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56716330|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56716331|NCT02914938|Rituximab|rituximab|mesh-list
56716332|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
56716333|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56716334|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716335|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
56716336|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716337|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716338|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56716339|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716341|NCT00654381|Inositol|inositol|mesh-list
56716367|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56716368|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56716369|NCT00805311|Analgesics|analgesics|mesh-ancestor
56716370|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
56716371|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716372|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716373|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716374|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716375|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56716376|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56716377|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716378|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56716379|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56716426|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716427|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716428|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56716429|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
56716430|NCT00732446|Hormones|hormones|mesh-ancestor
56716431|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56716432|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56716433|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716434|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
56716435|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716436|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716437|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56716438|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716439|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56716440|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56716441|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56716442|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
56716443|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56716444|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56716445|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56716446|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56716447|NCT00732524|Glipizide|glipizide|mesh-list
56716448|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56716449|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716450|NCT00657267|Temozolomide|temozolomide|mesh-list
56716451|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56716452|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
56716455|NCT00733850|Gemcitabine|gemcitabine|mesh-list
56716470|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716471|NCT00799071|Posaconazole|posaconazole|mesh-list
56716472|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
56716473|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716474|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56716475|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56716476|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56716477|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56716478|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56716479|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716480|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716481|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56716482|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
56716483|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56716484|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716485|NCT00732836|Paclitaxel|paclitaxel|mesh-list
56716486|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56716487|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56716489|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
56716490|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
56716491|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
56716492|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716493|NCT00799149|Etoricoxib|etoricoxib|mesh-list
56716494|NCT00799149|Gabapentin|gabapentin|mesh-list
56716495|NCT00799149|Analgesics|analgesics|mesh-ancestor
56716496|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
56716497|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716498|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716499|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
56716500|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56716513|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56716514|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56716515|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716516|NCT00732914|Sorafenib|sorafenib|mesh-list
56716517|NCT00732914|Sunitinib|sunitinib|mesh-list
56716518|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716519|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56716520|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716521|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716522|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56716523|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56716524|NCT00732914|Growth Substances|growth substances|mesh-ancestor
56716525|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716526|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
56716527|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
56716528|NCT00808275|Calcium|calcium|mesh-list
56716529|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56716530|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716531|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56716532|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
56716533|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56716534|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716535|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56716536|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56716537|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716538|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716539|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716540|NCT00728000|Gemcitabine|gemcitabine|mesh-list
56716541|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
56716542|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56716543|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56716544|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
56716555|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
56716556|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716557|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56716558|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56716559|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56427676|NCT00225875|Rituximab|rituximab|mesh-list
56716560|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716561|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56716562|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56716563|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
56716564|NCT04213794|Cisplatin|cisplatin|mesh-list
56716565|NCT04213794|Doxorubicin|doxorubicin|mesh-list
56716566|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56716567|NCT04213794|Daunorubicin|daunorubicin|mesh-list
56716568|NCT04213794|Antidotes|antidotes|mesh-list
56716569|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716570|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56716571|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56716572|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56716573|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716574|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716575|NCT04213794|Protective Agents|protective agents|mesh-ancestor
56716576|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716577|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
56716578|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
56716579|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56716580|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716581|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
56716582|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
56716583|NCT00728078|Thalidomide|thalidomide|mesh-list
56716584|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716585|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
56716586|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716587|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
56716588|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56716595|NCT04066088|Guanfacine|guanfacine|mesh-list
56716596|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56716597|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56716598|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56716599|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56716600|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
56716601|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716602|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716603|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716604|NCT00733148|Insulin|insulin|mesh-list
56716605|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56716606|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716607|NCT00730392|Etanercept|etanercept|mesh-list
56716608|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56716609|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56716610|NCT00730392|Analgesics|analgesics|mesh-ancestor
56716611|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
56716612|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716613|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716614|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716615|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716616|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56716617|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716618|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
56716619|NCT01528046|Metformin|metformin|mesh-list
56716620|NCT01528046|Irinotecan|irinotecan|mesh-list
56716621|NCT01528046|Camptothecin|camptothecin|mesh-list
56716622|NCT01528046|Vincristine|vincristine|mesh-list
56716623|NCT01528046|Temozolomide|temozolomide|mesh-list
56716624|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56716625|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716626|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56716627|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56716637|NCT00652899|Aldesleukin|aldesleukin|mesh-list
56716638|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
56716639|NCT00652899|Fludarabine|fludarabine|mesh-list
56716640|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
56716641|NCT00652899|Interleukin-2|interleukin-2|mesh-list
56716642|NCT00652899|Allopurinol|allopurinol|mesh-list
56716643|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716644|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
56716645|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716646|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716647|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56716648|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
56716649|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716650|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716651|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56716652|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56716653|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
56716654|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
56716655|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716656|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56716657|NCT00652899|Analgesics|analgesics|mesh-ancestor
56716658|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
56716691|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716692|NCT02569554|Rabeprazole|rabeprazole|mesh-list
56716693|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56716694|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56716695|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56716696|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716697|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716698|NCT00734318|Fluticasone|fluticasone|mesh-list
56716699|NCT00734318|Xhance|xhance|mesh-list
56716700|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
56716701|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56716702|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
56716703|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716704|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716705|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56716706|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
56716707|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56716708|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56427820|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716709|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56716710|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
56716711|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716712|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716713|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716714|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
56716715|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56716716|NCT00733616|Docetaxel|docetaxel|mesh-list
56716717|NCT00733616|Capecitabine|capecitabine|mesh-list
56716718|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
56716719|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716720|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
56716721|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
56716722|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
56716723|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716724|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56716730|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716731|NCT00728832|Analgesics|analgesics|mesh-ancestor
56716732|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
56716733|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716734|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56716735|NCT00728312|Aripiprazole|aripiprazole|mesh-list
56716736|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
56716737|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56716738|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56716739|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56716740|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56716741|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716742|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
56716743|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
56716744|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716745|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716746|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56716747|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56716748|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
56716749|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56716750|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56716751|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56716752|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56716753|NCT00728546|Isoniazid|isoniazid|mesh-list
56716754|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
56716755|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56716756|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56716757|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56716758|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56716759|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
56716760|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716761|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56716762|NCT01081262|Paclitaxel|paclitaxel|mesh-list
56716763|NCT01081262|Bevacizumab|bevacizumab|mesh-list
56716764|NCT01081262|Carboplatin|carboplatin|mesh-list
56716765|NCT01081262|Capecitabine|capecitabine|mesh-list
56716768|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56716769|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
56716770|NCT01081262|Antibodies|antibodies|mesh-list
56716771|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
56716772|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56716773|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
56716774|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56716775|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716776|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
56716777|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
56716778|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
56716779|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716780|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56716781|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56716782|NCT01081262|Growth Substances|growth substances|mesh-ancestor
56716783|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716784|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56716785|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
56716786|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56716787|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
56716799|NCT04066296|Bupivacaine|bupivacaine|mesh-list
56716822|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
56716823|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716824|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716825|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56716826|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
56716827|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
56716828|NCT00868426|Hormones|hormones|mesh-ancestor
56716829|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56716830|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56716831|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56716832|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56716833|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
56716834|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56716835|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716836|NCT00868426|Antidotes|antidotes|mesh-ancestor
56716837|NCT00868426|Protective Agents|protective agents|mesh-ancestor
56716838|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
56716839|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
56716840|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716841|NCT00868738|Vitamin D|vitamin d|mesh-list
56716842|NCT00868738|Vitamins|vitamins|mesh-ancestor
56716843|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
56716844|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716845|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56716873|NCT00799539|Prednisone|prednisone|mesh-list
56716874|NCT00799539|Bortezomib|bortezomib|mesh-list
56716875|NCT00799539|Melphalan|melphalan|mesh-list
56716876|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716877|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
56716878|NCT00799539|Hormones|hormones|mesh-ancestor
56716879|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56716880|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716881|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56716882|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716883|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56716884|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
56716885|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716886|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56716887|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716888|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
56716889|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
56716890|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
56716891|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56716892|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
56716893|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716894|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716895|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716896|NCT00738842|Ticagrelor|ticagrelor|mesh-list
56716897|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56716898|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56716899|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56716905|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
56716919|NCT00729300|Disulfiram|disulfiram|mesh-list
56716920|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56716921|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56716922|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716923|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716924|NCT00808743|Celecoxib|celecoxib|mesh-list
56716925|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56716926|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56716927|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56716928|NCT00808743|Analgesics|analgesics|mesh-ancestor
56716929|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
56716930|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716931|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716932|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716933|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716934|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56716935|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56716936|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716937|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716938|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56716939|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56716940|NCT00869596|Fluticasone|fluticasone|mesh-list
56716941|NCT00869596|Xhance|xhance|mesh-list
56716970|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56716971|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56716972|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
56716973|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716974|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56716975|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56716976|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716977|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56716978|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56716979|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
56716980|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56716981|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56716982|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56716983|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56716984|NCT03728478|Analgesics|analgesics|mesh-ancestor
56716985|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
56716986|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56716987|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56716988|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56716989|NCT00653523|Simvastatin|simvastatin|mesh-list
56716990|NCT00653523|Ezetimibe|ezetimibe|mesh-list
56716991|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56716992|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56716993|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
56716994|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56716995|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56716996|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56716997|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56716998|NCT00869752|Etoposide|etoposide|mesh-list
56716999|NCT00869752|Antibodies|antibodies|mesh-list
56717000|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56717001|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
56717002|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717003|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717009|NCT00808977|Mesalamine|mesalamine|mesh-list
56717010|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56717011|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56717012|NCT00808977|Analgesics|analgesics|mesh-ancestor
56717013|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
56717014|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717015|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717016|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56717017|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56717018|NCT00735020|Vaccines|vaccines|mesh-list
56717019|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
56717020|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717021|NCT04065906|Methylphenidate|methylphenidate|mesh-list
56717022|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56717023|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56717024|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717025|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56717026|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56717027|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56717028|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717029|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
56717030|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717031|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56717032|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
56717033|NCT00739388|Azacitidine|azacitidine|mesh-list
56717034|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56717035|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
56717036|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717037|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717038|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717039|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
56717040|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
56717049|NCT00862966|Heparin|heparin|mesh-list
56717050|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
56717051|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717052|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56717053|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56717054|NCT02569320|Dexamethasone|dexamethasone|mesh-list
56717055|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
56717056|NCT02569320|Pomalidomide|pomalidomide|mesh-list
56717057|NCT02569320|Ichthammol|ichthammol|mesh-list
56717058|NCT02569320|BB 1101|bb 1101|mesh-list
56717059|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56717060|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56717061|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
56717062|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
56717063|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717064|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717065|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56717066|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
56717067|NCT02569320|Hormones|hormones|mesh-ancestor
56717068|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717069|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56717070|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717104|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
56717105|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717106|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717107|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717108|NCT00870142|Amlodipine|amlodipine|mesh-list
56717109|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56717110|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56717111|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56717112|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717113|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56717114|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717115|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
56717116|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56717117|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56717118|NCT00870220|Estradiol|estradiol|mesh-list
56717119|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56717120|NCT00870220|Estrogens|estrogens|mesh-ancestor
56717121|NCT00870220|Hormones|hormones|mesh-ancestor
56717122|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717123|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717124|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56717125|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
56717126|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56717153|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717154|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
56717155|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56717156|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56717157|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56717158|NCT00871156|Analgesics|analgesics|mesh-ancestor
56717159|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
56717160|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717161|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428274|NCT00227942|Zolpidem|zolpidem|mesh-list
56717162|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56717163|NCT00871156|Filaricides|filaricides|mesh-ancestor
56717164|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
56717165|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
56717166|NCT00734448|Inositol|inositol|mesh-list
56717167|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
56717168|NCT00734448|Vitamins|vitamins|mesh-ancestor
56717169|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
56717170|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717171|NCT00876226|Citalopram|citalopram|mesh-list
56717172|NCT00876226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56717173|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56717174|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56717175|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717176|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717177|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
56717178|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717182|NCT00734526|Temozolomide|temozolomide|mesh-list
56717200|NCT00729404|Estrogens|estrogens|mesh-ancestor
56717201|NCT00729404|Hormones|hormones|mesh-ancestor
56717202|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717203|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56717204|NCT00729404|Progestins|progestins|mesh-ancestor
56717205|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56717206|NCT00731952|Bortezomib|bortezomib|mesh-list
56717207|NCT00731952|Vorinostat|vorinostat|mesh-list
56717208|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717209|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56717210|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717211|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717212|NCT04065932|BMS-986165|bms-986165|mesh-list
56717213|NCT04065932|Famotidine|famotidine|mesh-list
56717214|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56717215|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56717216|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56717217|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
56717218|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
56717219|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717220|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717221|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717222|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
56717223|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56717224|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717225|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56717248|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
56717249|NCT05225974|Liraglutide|liraglutide|mesh-list
56717250|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56717251|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717252|NCT05225974|Incretins|incretins|mesh-ancestor
56717253|NCT05225974|Hormones|hormones|mesh-ancestor
56717254|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717255|NCT01139970|Temozolomide|temozolomide|mesh-list
56717256|NCT01139970|Veliparib|veliparib|mesh-list
56717257|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56717258|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
56717259|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717260|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717261|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56717262|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717263|NCT00729638|Lenalidomide|lenalidomide|mesh-list
56717264|NCT00729638|Everolimus|everolimus|mesh-list
56717265|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
56717266|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717267|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56717268|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56717269|NCT00729638|Growth Substances|growth substances|mesh-ancestor
56717270|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
56717271|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717272|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56717273|NCT00734682|Irinotecan|irinotecan|mesh-list
56717274|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56717297|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56717298|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717299|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56717300|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56717301|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
56717302|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56717303|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717304|NCT05575440|Fluorides|fluorides|mesh-list
56717305|NCT05575440|Cariostatic Agents|cariostatic agents|mesh-ancestor
56717306|NCT05575440|Protective Agents|protective agents|mesh-ancestor
56717307|NCT05575440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717308|NCT02099058|Nivolumab|nivolumab|mesh-list
56717309|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56717310|NCT02099058|Osimertinib|osimertinib|mesh-list
56717311|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56717312|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56717313|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717314|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56717315|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717316|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56717318|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
56717319|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717320|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
56717321|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
56717322|NCT00729794|Vasopressins|vasopressins|mesh-list
56717323|NCT00729794|Arginine Vasopressin|arginine vasopressin|mesh-list
56717324|NCT00729794|Epinephrine|epinephrine|mesh-list
56717325|NCT00729794|Racepinephrine|racepinephrine|mesh-list
56717326|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
56717327|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56717328|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
56717329|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
56717330|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717342|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717343|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56717344|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56717345|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56717346|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
56717347|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
56717348|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
56717349|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56717350|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
56717351|NCT00729794|Coagulants|coagulants|mesh-ancestor
56717352|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56717353|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
56717354|NCT00871546|Bortezomib|bortezomib|mesh-list
56717355|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
56717356|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717357|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56717358|NCT03778294|Temozolomide|temozolomide|mesh-list
56717359|NCT03778294|Levodopa|levodopa|mesh-list
56717360|NCT03778294|Fluorides|fluorides|mesh-list
56717361|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56717362|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
56717363|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717364|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717365|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
56717366|NCT03778294|Protective Agents|protective agents|mesh-ancestor
56717367|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717368|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
56717369|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554586|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554587|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56554588|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56554589|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554590|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554591|NCT02826070|Adefovir|adefovir|mesh-list
56554592|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56554593|NCT02826070|Telbivudine|telbivudine|mesh-list
56554594|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
56554595|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554596|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56554597|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56554598|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554599|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554600|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
56554601|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
56554602|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554603|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554604|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56554605|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
56717370|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56717371|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56717372|NCT00732186|Ipilimumab|ipilimumab|mesh-list
56717373|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56717374|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717375|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56717376|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717377|NCT04039828|Zinc|zinc|mesh-list
56717378|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
56717379|NCT04039828|Trace Elements|trace elements|mesh-ancestor
56717380|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
56717381|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717382|NCT04039828|Astringents|astringents|mesh-ancestor
56717383|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
56717384|NCT00876772|Olanzapine|olanzapine|mesh-list
56717385|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
56717386|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
56717387|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717388|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717389|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56428501|NCT00191308|Pemetrexed|pemetrexed|mesh-list
56717390|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56717391|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56717392|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717393|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56717394|NCT00876772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56717395|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56717396|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56717397|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717398|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717399|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
56717400|NCT00729950|Ipilimumab|ipilimumab|mesh-list
56717401|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56717402|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717403|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56554606|NCT00671203|Erythromycin|erythromycin|mesh-list
56554607|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
56554608|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56554609|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
56554610|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56109228|NCT00003877|Paclitaxel|paclitaxel|mesh-list
56272823|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56272824|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56272825|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
56272826|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
56272827|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272828|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56272829|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56272830|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272832|NCT05312970|Polidocanol|polidocanol|mesh-list
56717404|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717405|NCT00616018|Acetaminophen|acetaminophen|mesh-list
56717406|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56717407|NCT00616018|Analgesics|analgesics|mesh-ancestor
56717408|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
56717409|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717410|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717411|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
56717412|NCT00740948|Rituximab|rituximab|mesh-list
56717413|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56717414|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717415|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
56717416|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717417|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56717447|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717448|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717449|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56717450|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717451|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
56717452|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
56717453|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717454|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56717455|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56717456|NCT05157412|Protective Agents|protective agents|mesh-ancestor
56717457|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56717458|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717459|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
56717460|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56717461|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56717462|NCT00732420|Topotecan|topotecan|mesh-list
56717463|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56717464|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56717465|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428578|NCT00236223|Ketamine|ketamine|mesh-list
56717466|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717467|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717468|NCT00735228|Pancrelipase|pancrelipase|mesh-list
56717469|NCT00735228|Pancreatin|pancreatin|mesh-list
56717470|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56717471|NCT00739128|Vaccines|vaccines|mesh-list
56717472|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
56717473|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717474|NCT00863668|Tenofovir|tenofovir|mesh-list
56717475|NCT00863668|Emtricitabine|emtricitabine|mesh-list
56717476|NCT00863668|Efavirenz|efavirenz|mesh-list
56717477|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
56717478|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56717488|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56717489|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56717490|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56717491|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56717492|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56717493|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56717494|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56717495|NCT00872248|Anesthetics|anesthetics|mesh-list
56717496|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717497|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717498|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
56717499|NCT00732576|Vitamin K|vitamin k|mesh-list
56717500|NCT00732576|Vitamin MK 7|vitamin mk 7|mesh-list
56717501|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56717502|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56717503|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717504|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
56717505|NCT00732576|Coagulants|coagulants|mesh-ancestor
56717506|NCT00732576|Vitamins|vitamins|mesh-ancestor
56717507|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
56717508|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717509|NCT00863902|Cetirizine|cetirizine|mesh-list
56717510|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56717511|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56717512|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56717513|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
56717514|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
56717515|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717516|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717517|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717518|NCT00732810|Capecitabine|capecitabine|mesh-list
56717519|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56717529|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717530|NCT00732888|Antacids|antacids|mesh-ancestor
56717531|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717532|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56717533|NCT00732966|Losartan|losartan|mesh-list
56717534|NCT00732966|Valsartan|valsartan|mesh-list
56717535|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56717536|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56717537|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56428643|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717538|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717539|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56717540|NCT02568618|Analgesics|analgesics|mesh-list
56717541|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
56717542|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717543|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717544|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56717545|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
56717546|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56717547|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
56717548|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56717549|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717550|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56717551|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56717577|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717578|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56717579|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56717580|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
56717581|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
56717582|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717583|NCT00863980|Telmisartan|telmisartan|mesh-list
56717584|NCT00863980|Candesartan|candesartan|mesh-list
56717585|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
56717586|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56717587|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56717588|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56717589|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717590|NCT00415519|Edaravone|edaravone|mesh-list
56717591|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56717592|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
56717593|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717594|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56717595|NCT00415519|Protective Agents|protective agents|mesh-ancestor
56717596|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717597|NCT05741294|Tirbanibulin|tirbanibulin|mesh-list
56717598|NCT05741294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717629|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56717630|NCT00423943|Modafinil|modafinil|mesh-list
56717631|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56717632|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717633|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56717634|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56717635|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56717636|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717637|NCT00736346|Paroxetine|paroxetine|mesh-list
56717638|NCT00736346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56717639|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56717640|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56717641|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717642|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717643|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
56717644|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717645|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56717646|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
56717647|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56717648|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56717649|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56717650|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717651|NCT00864058|Gabapentin|gabapentin|mesh-list
56717652|NCT00864058|Analgesics|analgesics|mesh-ancestor
56717653|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
56717654|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717655|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717656|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
56717657|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56717658|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56717659|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717660|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56717667|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56717668|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
56717669|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56717670|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717671|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56717672|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56717673|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56717674|NCT00864214|Hormones|hormones|mesh-list
56717675|NCT00864214|Estradiol|estradiol|mesh-list
56717676|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717677|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717678|NCT00864214|Estrogens|estrogens|mesh-ancestor
56717679|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
56717680|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56717681|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717682|NCT00428389|Rivastigmine|rivastigmine|mesh-list
56717683|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56717684|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717685|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717687|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717688|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717689|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56717690|NCT00428389|Protective Agents|protective agents|mesh-ancestor
56717691|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
56717692|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56717693|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717694|NCT02568488|Metformin|metformin|mesh-list
56717695|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56717696|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717697|NCT01324063|Cytarabine|cytarabine|mesh-list
56717698|NCT01324063|Daunorubicin|daunorubicin|mesh-list
56717699|NCT01324063|Amsacrine|amsacrine|mesh-list
56717700|NCT01324063|Sargramostim|sargramostim|mesh-list
56717701|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56717702|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
56717703|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717704|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717706|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56717707|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56717708|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
56717709|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717710|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56717711|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56717712|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56717713|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717714|NCT00864448|Ramipril|ramipril|mesh-list
56717715|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56717716|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
56717717|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717718|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717719|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56717720|NCT00406315|Ziprasidone|ziprasidone|mesh-list
56717721|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56717722|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
56717723|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717724|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717725|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717726|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56717727|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56717728|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717729|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56717730|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56717731|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
56717732|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56717733|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
56717734|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56717735|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56717736|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56717738|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273202|NCT04620382|Midodrine|midodrine|mesh-list
56273203|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
56273204|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
56717747|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56717748|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56717749|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56717750|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717751|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717752|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56717753|NCT00864526|Narcotics|narcotics|mesh-ancestor
56717754|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717755|NCT00864604|Nabumetone|nabumetone|mesh-list
56717756|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56717757|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56717758|NCT00864604|Analgesics|analgesics|mesh-ancestor
56717759|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
56717760|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56717761|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717762|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56717763|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56717764|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56717765|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56717766|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717767|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717768|NCT04064138|Anesthetics|anesthetics|mesh-list
56717769|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717770|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717771|NCT01323751|Ricolinostat|ricolinostat|mesh-list
56717772|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717773|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56717774|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717775|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717785|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717786|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
56717787|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56717788|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56717789|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56717790|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56717791|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56717792|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56717793|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56717794|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717795|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
56717796|NCT03743662|Bevacizumab|bevacizumab|mesh-list
56717797|NCT03743662|Nivolumab|nivolumab|mesh-list
56717798|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56717799|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717844|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56717845|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56717846|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
56717847|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56717848|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
56717849|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56717850|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56717851|NCT00573430|Candesartan|candesartan|mesh-list
56717852|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
56717853|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56717854|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56717855|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56717856|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717902|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56717903|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56717904|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56717905|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56717906|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717907|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56717908|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56717909|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56717910|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56717911|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56717912|NCT00736164|Selenium|selenium|mesh-list
56717913|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
56717914|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717915|NCT00736164|Protective Agents|protective agents|mesh-ancestor
56717916|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56717917|NCT00736164|Trace Elements|trace elements|mesh-ancestor
56717918|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
56717919|NCT00739830|Sirolimus|sirolimus|mesh-list
56717920|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56717921|NCT00739830|Megestrol|megestrol|mesh-list
56717922|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
56717923|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
56717924|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56717925|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56717926|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56717927|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
56717951|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717952|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717953|NCT00733434|Alprostadil|alprostadil|mesh-list
56717954|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56717955|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
56717956|NCT00733434|Urological Agents|urological agents|mesh-ancestor
56717957|NCT00736320|Vincristine|vincristine|mesh-list
56717958|NCT00736320|Doxorubicin|doxorubicin|mesh-list
56717959|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56717960|NCT00736320|Dacarbazine|dacarbazine|mesh-list
56717961|NCT00736320|Bleomycin|bleomycin|mesh-list
56717962|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56717963|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56717964|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
56717965|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
56717966|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
56717967|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717968|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56717969|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56717970|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56717971|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56717972|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56717973|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
56717974|NCT04065282|Capecitabine|capecitabine|mesh-list
56717975|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
56717976|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56717977|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
56717978|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56717979|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429103|NCT00200252|Oxytocin|oxytocin|mesh-list
56717996|NCT00739986|Semapimod|semapimod|mesh-list
56717997|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56717998|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56717999|NCT00739986|Analgesics|analgesics|mesh-ancestor
56718000|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
56718001|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718002|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718003|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56718004|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56718005|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718006|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
56718007|NCT00736970|Sirolimus|sirolimus|mesh-list
56718008|NCT00736970|Trastuzumab|trastuzumab|mesh-list
56718009|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56718010|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718011|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56718012|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718013|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56718014|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
56718015|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718016|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
56718017|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718018|NCT00873340|Interferons|interferons|mesh-list
56718019|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
56718020|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718021|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
56718022|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718023|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56718024|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
56718025|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718026|NCT00740064|Lamivudine|lamivudine|mesh-list
56718027|NCT00740064|Abacavir|abacavir|mesh-list
56718028|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
56718031|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718039|NCT00614926|Modafinil|modafinil|mesh-list
56718040|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56718041|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718042|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56718043|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56718044|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56718045|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718046|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
56718047|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
56718048|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56718049|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56718050|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718051|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718052|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718053|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56718054|NCT00879892|Xenon|xenon|mesh-list
56718055|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56718056|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
56718057|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
56718058|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718059|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718061|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56718062|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
56718063|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718064|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718065|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718066|NCT00740142|Lactulose|lactulose|mesh-list
56718067|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
56718074|NCT00873652|Vaccines|vaccines|mesh-list
56718085|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
56718086|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56718087|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
56718088|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718089|NCT05224492|Sulforaphane|sulforaphane|mesh-list
56718090|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56718091|NCT05224492|Protective Agents|protective agents|mesh-ancestor
56718092|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718093|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718094|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56718095|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
56718096|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56718097|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56718098|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56718099|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718100|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718101|NCT04039126|Iodine|iodine|mesh-list
56718102|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
56718103|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
56718104|NCT04039126|Tetracycline|tetracycline|mesh-list
56718105|NCT04039126|Povidone|povidone|mesh-list
56718106|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56718107|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718108|NCT04039126|Trace Elements|trace elements|mesh-ancestor
56718109|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
56718110|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718111|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
56718112|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
56718113|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56718114|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56718115|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718116|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718117|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
56718118|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
56718119|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
56718120|NCT00873808|Tetracycline|tetracycline|mesh-list
56718121|NCT00873808|Demeclocycline|demeclocycline|mesh-list
56718125|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718126|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56718127|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718128|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718129|NCT04064190|Durvalumab|durvalumab|mesh-list
56718130|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56718131|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718132|NCT00873886|Oseltamivir|oseltamivir|mesh-list
56718133|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
56718134|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718135|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718136|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718137|NCT00880282|Sirolimus|sirolimus|mesh-list
56718138|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56718139|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56718140|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718141|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56718142|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718143|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
56718144|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718145|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
56718146|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718147|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56718148|NCT00874042|Gemcitabine|gemcitabine|mesh-list
56718149|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56718150|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
56718151|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718173|NCT00879424|Vitamins|vitamins|mesh-ancestor
56718174|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
56718175|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718176|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56718177|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56718178|NCT00710684|Donepezil|donepezil|mesh-list
56718179|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56718180|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718181|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718182|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
56718183|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718184|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718185|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
56718186|NCT00710606|NuvaRing|nuvaring|mesh-list
56718187|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56718188|NCT00710606|Desogestrel|desogestrel|mesh-list
56718189|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56718190|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
56718191|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56718192|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718193|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56718194|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56718195|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56718196|NCT00710606|Estrogens|estrogens|mesh-ancestor
56718197|NCT00710606|Hormones|hormones|mesh-ancestor
56718198|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718199|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56718200|NCT00710606|Progestins|progestins|mesh-ancestor
56718201|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
56718202|NCT00713544|Etanercept|etanercept|mesh-list
56718203|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56718205|NCT00713544|Analgesics|analgesics|mesh-ancestor
56273641|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56273642|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
56273643|NCT03737968|Durvalumab|durvalumab|mesh-list
56718211|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56718212|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718213|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
56718214|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56718215|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718216|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56718217|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56718218|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
56718219|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718220|NCT00737126|Folic Acid|folic acid|mesh-list
56718221|NCT00737126|Hematinics|hematinics|mesh-ancestor
56718222|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
56718223|NCT00737126|Vitamins|vitamins|mesh-ancestor
56718224|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
56718225|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718226|NCT04063046|Anesthetics|anesthetics|mesh-list
56718227|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718229|NCT05529056|Atropine|atropine|mesh-list
56718262|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718263|NCT00741078|Amlodipine|amlodipine|mesh-list
56718264|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56718265|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56718266|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56718267|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718268|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56718269|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718270|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
56718271|NCT02568800|Cefepime|cefepime|mesh-list
56718272|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56718273|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718274|NCT00741234|Azacitidine|azacitidine|mesh-list
56718275|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56718276|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
56718277|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718278|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718279|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718280|NCT00713258|Alendronate|alendronate|mesh-list
56718281|NCT00713258|Hormones|hormones|mesh-list
56718282|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
56718283|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718284|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718285|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56718286|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56718287|NCT00710034|Nicotine|nicotine|mesh-list
56718288|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56718289|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
56718290|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718291|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718292|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56718293|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56718294|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
56718300|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718301|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718302|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56718303|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
56718304|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
56718305|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56718306|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56718307|NCT00414973|Teriparatide|teriparatide|mesh-list
56718308|NCT00414973|Calcitonin|calcitonin|mesh-list
56718309|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
56718310|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56718311|NCT00414973|Katacalcin|katacalcin|mesh-list
56718312|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56718313|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718314|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56718315|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
56718316|NCT00423085|Rivastigmine|rivastigmine|mesh-list
56718317|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56718318|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718319|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718320|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
56718321|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718322|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718323|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56718324|NCT00423085|Protective Agents|protective agents|mesh-ancestor
56718325|NCT00414661|Tofacitinib|tofacitinib|mesh-list
56718326|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56718327|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718328|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718329|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
56718330|NCT01608451|Vitamin D|vitamin d|mesh-list
56718331|NCT01608451|Progesterone|progesterone|mesh-list
56718343|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
56718344|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718345|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56718346|NCT00708708|Etanercept|etanercept|mesh-list
56718347|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56718348|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56718349|NCT00708708|Analgesics|analgesics|mesh-ancestor
56718350|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
56718351|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718352|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718353|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56718354|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56718355|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56718356|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718357|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
56718358|NCT00404755|Citalopram|citalopram|mesh-list
56718359|NCT00404755|Bupropion|bupropion|mesh-list
56718360|NCT00404755|Imipramine|imipramine|mesh-list
56718361|NCT00404755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56718362|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56718363|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56718364|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718365|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718366|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
56718367|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718368|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56718369|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
56718370|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56718371|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56273822|NCT03153319|Adalimumab|adalimumab|mesh-list
56273823|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273824|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273825|NCT03145272|Oxycodone|oxycodone|mesh-list
56718386|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718387|NCT05740566|Topotecan|topotecan|mesh-list
56718388|NCT05740566|Amrubicin|amrubicin|mesh-list
56718389|NCT05740566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56718390|NCT05740566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56718391|NCT05740566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718392|NCT05740566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718393|NCT05740566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718394|NCT00737256|Aripiprazole|aripiprazole|mesh-list
56718395|NCT00737256|Perphenazine|perphenazine|mesh-list
56718396|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
56718397|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56718398|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56718399|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56718400|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718401|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718402|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
56718403|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
56718404|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718405|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718406|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56718407|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56718408|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
56718409|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56718410|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56718411|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56718412|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56718424|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56718425|NCT05740488|Hormones|hormones|mesh-list
56718426|NCT05740488|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56718427|NCT05740488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718428|NCT05740488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718429|NCT05742126|Heparin|heparin|mesh-list
56718430|NCT05742126|Calcium heparin|calcium heparin|mesh-list
56429551|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
56718431|NCT05742126|Anticoagulants|anticoagulants|mesh-ancestor
56718432|NCT05742126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56718433|NCT05742126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56718434|NCT05742126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718435|NCT00882856|Bisoprolol|bisoprolol|mesh-list
56718436|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56718437|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
56718438|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
56718439|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718440|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718441|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56718442|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56718443|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56718444|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
56718445|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718446|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718447|NCT00880672|Dutasteride|dutasteride|mesh-list
56718448|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56718449|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56718450|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718451|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718452|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
56718453|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718454|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718455|NCT00737724|Efavirenz|efavirenz|mesh-list
56718457|NCT00737724|Isoniazid|isoniazid|mesh-list
56718460|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718461|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718462|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
56718463|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718464|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56718465|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56718466|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56718467|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56718468|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56718469|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56718470|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56718471|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56718472|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
56718473|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56718474|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56718475|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56718476|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
56718477|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56718478|NCT00880828|Acetaminophen|acetaminophen|mesh-list
56718479|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56718480|NCT00880828|Analgesics|analgesics|mesh-ancestor
56718481|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
56718482|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718483|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718484|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
56718485|NCT00712920|Azelastine|azelastine|mesh-list
56718486|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56718506|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56718507|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718508|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56718509|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56718510|NCT00874744|Growth Substances|growth substances|mesh-ancestor
56718511|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718512|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
56718513|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56718514|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
56718516|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718517|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718518|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
56718519|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718520|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718521|NCT05736744|Magnesium Sulfate|magnesium sulfate|mesh-list
56718522|NCT05736744|Bromides|bromides|mesh-list
56718523|NCT05736744|Rocuronium|rocuronium|mesh-list
56718524|NCT05736744|Atracurium|atracurium|mesh-list
56718525|NCT05736744|Cisatracurium|cisatracurium|mesh-list
56718526|NCT05736744|Anticonvulsants|anticonvulsants|mesh-ancestor
56718527|NCT05736744|Analgesics|analgesics|mesh-ancestor
56718528|NCT05736744|Sensory System Agents|sensory system agents|mesh-ancestor
56718529|NCT05736744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718530|NCT05736744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718557|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
56718558|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56718559|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
56718560|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718561|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56718562|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718563|NCT05741814|Propofol|propofol|mesh-list
56718564|NCT05741814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56718565|NCT05741814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718566|NCT05741814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718567|NCT05741814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56718568|NCT05741814|Anesthetics, General|anesthetics, general|mesh-ancestor
56718569|NCT05741814|Anesthetics|anesthetics|mesh-ancestor
56718570|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
56718571|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56718572|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
56718573|NCT04721626|Tetracycline|tetracycline|mesh-list
56718574|NCT04721626|Doxycycline|doxycycline|mesh-list
56718575|NCT04721626|Povidone|povidone|mesh-list
56718576|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56718577|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718578|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
56718579|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
56718580|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
56718581|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
56718582|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56718583|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56718584|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718585|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718586|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
56718587|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56718588|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56718602|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
56718675|NCT05741502|GABA Agents|gaba agents|mesh-ancestor
56718676|NCT00710424|Nabiximols|nabiximols|mesh-list
56718677|NCT00710424|Analgesics|analgesics|mesh-ancestor
56718678|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
56718679|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718680|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718681|NCT00612586|Leucovorin|leucovorin|mesh-list
56718682|NCT00612586|Bevacizumab|bevacizumab|mesh-list
56718683|NCT00612586|Fluorouracil|fluorouracil|mesh-list
56718684|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56718685|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718686|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56718687|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56718688|NCT00612586|Growth Substances|growth substances|mesh-ancestor
56718689|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718690|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
56718691|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
56718692|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718693|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56718694|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718695|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
56718696|NCT00612586|Antidotes|antidotes|mesh-ancestor
56718697|NCT00612586|Protective Agents|protective agents|mesh-ancestor
56718698|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
56718699|NCT00612586|Vitamins|vitamins|mesh-ancestor
56718700|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
56718701|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
56718702|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56718703|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56718704|NCT00614380|Amlodipine|amlodipine|mesh-list
56718705|NCT00614380|Telmisartan|telmisartan|mesh-list
56718706|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56718707|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56718720|NCT00738192|Citric Acid|citric acid|mesh-list
56718721|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
56718722|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56718723|NCT00738192|Narcotics|narcotics|mesh-ancestor
56718724|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718725|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718726|NCT00738192|Analgesics|analgesics|mesh-ancestor
56718727|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
56718728|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718729|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56718730|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56718731|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
56718732|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
56718733|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
56718734|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56718735|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
56718736|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
56718737|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718738|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
56718739|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
56718740|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56718741|NCT05500170|Niacinamide|niacinamide|mesh-list
56718742|NCT05500170|Niacin|niacin|mesh-list
56718743|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
56718744|NCT05500170|Vitamins|vitamins|mesh-ancestor
56718745|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
56718746|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718772|NCT00612508|Estradiol|estradiol|mesh-list
56718773|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56718774|NCT00612508|Estrogens|estrogens|mesh-ancestor
56718775|NCT00612508|Hormones|hormones|mesh-ancestor
56718776|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718777|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718778|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56718779|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
56718780|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56718781|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56718782|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56718783|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56718784|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56718785|NCT00612508|Progestins|progestins|mesh-ancestor
56718786|NCT00881218|Regadenoson|regadenoson|mesh-list
56718787|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56718788|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56718789|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
56718790|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
56718791|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718792|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718793|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718794|NCT00613834|Lidocaine|lidocaine|mesh-list
56718795|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
56718796|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
56718797|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718798|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718799|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
56718800|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718801|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56718814|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56718815|NCT04012138|Insulin|insulin|mesh-list
56718816|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56718817|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
56718818|NCT04012138|Albuterol|albuterol|mesh-list
56718819|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56718820|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718821|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56718822|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
56718823|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718824|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56718825|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
56718826|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
56718827|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56718828|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56718829|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56718830|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56718831|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
56718832|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718833|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718834|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
56718835|NCT03912298|Narcotics|narcotics|mesh-ancestor
56718838|NCT03912298|Analgesics|analgesics|mesh-ancestor
56718867|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56718868|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718869|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56718870|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56718871|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
56718872|NCT00613366|Antacids|antacids|mesh-ancestor
56718873|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718874|NCT00612352|Ethanol|ethanol|mesh-list
56718875|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56718876|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718877|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718878|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718879|NCT00884416|Sorafenib|sorafenib|mesh-list
56718880|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718881|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56718882|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718883|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718884|NCT00884494|Insulin|insulin|mesh-list
56718885|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56718886|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718888|NCT00881686|Analgesics|analgesics|mesh-ancestor
56718889|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
56718890|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718891|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718892|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56718893|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
56718916|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718917|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
56718918|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56718919|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56718920|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718921|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56718922|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56718923|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56718924|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56718925|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718926|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
56718927|NCT02542930|Thymalfasin|thymalfasin|mesh-list
56718928|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56718929|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
56718930|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718931|NCT00881764|Anesthetics|anesthetics|mesh-list
56718932|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718933|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718934|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
56718935|NCT04038034|Vitamins|vitamins|mesh-ancestor
56718936|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
56718937|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718938|NCT04037878|Tramadol|tramadol|mesh-list
56718939|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56718940|NCT04037878|Narcotics|narcotics|mesh-ancestor
56718941|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56718943|NCT04037878|Analgesics|analgesics|mesh-ancestor
56718965|NCT00651261|Daunorubicin|daunorubicin|mesh-list
56718966|NCT00651261|Midostaurin|midostaurin|mesh-list
56718967|NCT00651261|BB 1101|bb 1101|mesh-list
56718968|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56718969|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
56718970|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
56718971|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56718972|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56718973|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56718974|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
56718975|NCT00651261|Hormones|hormones|mesh-ancestor
56718976|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718977|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56718978|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56718979|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56718980|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
56718981|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56718982|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
56718983|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56718984|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56718985|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
56718986|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56718987|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56718988|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56718989|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56718990|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56718991|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
56718992|NCT00885820|Prednisone|prednisone|mesh-list
56718993|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
56718994|NCT00885820|Tacrolimus|tacrolimus|mesh-list
56718995|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56718996|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
56718997|NCT00885820|Hormones|hormones|mesh-ancestor
56718998|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56718999|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719000|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56719004|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56719005|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719006|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719007|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
56719008|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
56719009|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719010|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56719011|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56719012|NCT00885820|Protective Agents|protective agents|mesh-ancestor
56719013|NCT02567838|Lidocaine|lidocaine|mesh-list
56719014|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
56719015|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
56719016|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719017|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719018|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
56719019|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719020|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56719021|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56719022|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56719023|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719024|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719025|NCT05093322|Gemcitabine|gemcitabine|mesh-list
56719056|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56719057|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719058|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56719059|NCT00800319|ALKS-33|alks-33|mesh-list
56719060|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56719061|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719062|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
56719063|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719064|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56719065|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
56719066|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719067|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
56719068|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56719069|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
56719070|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719071|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56719072|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56719073|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56719074|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719075|NCT00810849|Prednisolone|prednisolone|mesh-list
56719076|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56719077|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
56719078|NCT00810849|Hormones|hormones|mesh-ancestor
56719079|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56719080|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719081|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56719082|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719083|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
56719100|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56719101|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56719102|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56719103|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
56719104|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
56719105|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719106|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56719107|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56719108|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
56719109|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56719110|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719111|NCT00811083|Succimer|succimer|mesh-list
56719112|NCT00811083|Antidotes|antidotes|mesh-ancestor
56719113|NCT00811083|Protective Agents|protective agents|mesh-ancestor
56719114|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719115|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
56719116|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
56719117|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719118|NCT00642759|Paclitaxel|paclitaxel|mesh-list
56719119|NCT00642759|Bevacizumab|bevacizumab|mesh-list
56719120|NCT00642759|Carboplatin|carboplatin|mesh-list
56719121|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56719122|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719123|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
56719124|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
56719125|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
56719126|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719127|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56719128|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56719129|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56719130|NCT00642759|Growth Substances|growth substances|mesh-ancestor
56719131|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719142|NCT00611026|Fesoterodine|fesoterodine|mesh-list
56719143|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56719144|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56719145|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56719146|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
56719147|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719148|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719149|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719150|NCT00611026|Urological Agents|urological agents|mesh-ancestor
56719151|NCT02552589|Fluorides|fluorides|mesh-list
56719152|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
56719153|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
56719154|NCT02552589|Protective Agents|protective agents|mesh-ancestor
56719155|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719156|NCT00811239|Antivenins|antivenins|mesh-list
56719157|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
56719158|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719159|NCT00814047|Yohimbine|yohimbine|mesh-list
56719160|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
56719161|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
56719162|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719163|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719164|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56719165|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56719166|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56719167|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
56719168|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719169|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719170|NCT00814047|Urological Agents|urological agents|mesh-ancestor
56719171|NCT00814125|Tamoxifen|tamoxifen|mesh-list
56719172|NCT00814125|Anastrozole|anastrozole|mesh-list
56719173|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56719174|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
56719175|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56719182|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56719183|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56719184|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719185|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719186|NCT00817713|Ivermectin|ivermectin|mesh-list
56719187|NCT00817713|Albendazole|albendazole|mesh-list
56719188|NCT00817713|Praziquantel|praziquantel|mesh-list
56719189|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56719190|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719191|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
56719192|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
56719193|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56719194|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56719195|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
56719196|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
56719197|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
56719198|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719199|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719200|NCT00422383|Rituximab|rituximab|mesh-list
56719201|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56719202|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719203|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
56719204|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719205|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56719206|NCT00814281|Montelukast|montelukast|mesh-list
56719207|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56719208|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
56719209|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56719210|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
56719211|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56719212|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719213|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56719214|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56719223|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
56719224|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
56719225|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
56719226|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56719227|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719228|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
56719229|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
56719230|NCT00422227|Etanercept|etanercept|mesh-list
56719231|NCT00422227|Methotrexate|methotrexate|mesh-list
56719232|NCT00422227|Leflunomide|leflunomide|mesh-list
56719233|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56719234|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
56719235|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56719236|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719237|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56719238|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
56719239|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719240|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719241|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
56719242|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719243|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56719244|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719245|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
56719246|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56719247|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56719248|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
56719249|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56719273|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56719274|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56719275|NCT00814593|Carmustine|carmustine|mesh-list
56719276|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56719277|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
56719278|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719279|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719280|NCT00421993|Adapalene|adapalene|mesh-list
56719281|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56719282|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56719283|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
56719284|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56719285|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56719286|NCT00421993|Analgesics|analgesics|mesh-ancestor
56719287|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
56719288|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719289|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719290|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56719291|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56719292|NCT00884884|Topiramate|topiramate|mesh-list
56719293|NCT00884884|Aripiprazole|aripiprazole|mesh-list
56719294|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
56719295|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56719296|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56719297|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56719298|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719299|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719300|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
56719301|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
56719302|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719317|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719318|NCT02551029|Capsaicin|capsaicin|mesh-list
56719319|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
56719320|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
56719321|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
56719322|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719323|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719324|NCT00812019|Vaccines|vaccines|mesh-list
56719325|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56719326|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
56719327|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719328|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56719329|NCT00413959|Dexamethasone|dexamethasone|mesh-list
56719330|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
56719331|NCT00413959|Rituximab|rituximab|mesh-list
56719332|NCT00413959|Bortezomib|bortezomib|mesh-list
56719333|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719334|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
56719335|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719336|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56719337|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56719338|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
56719339|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719340|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719341|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56719342|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56719343|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56719345|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
56719346|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719347|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56719348|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
56719349|NCT00413959|Hormones|hormones|mesh-ancestor
56719361|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719362|NCT00611884|Insulin|insulin|mesh-list
56719363|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56719364|NCT00611884|Metformin|metformin|mesh-list
56719365|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
56719366|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
56719367|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56719368|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719369|NCT00611806|Folic Acid|folic acid|mesh-list
56719370|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
56719371|NCT00611806|Hematinics|hematinics|mesh-ancestor
56719372|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
56719373|NCT00611806|Vitamins|vitamins|mesh-ancestor
56719374|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
56719375|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719376|NCT00413413|Amlodipine|amlodipine|mesh-list
56719377|NCT00413413|Valsartan|valsartan|mesh-list
56719378|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56719379|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56719380|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719381|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719382|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56719383|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719384|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
56719385|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56719386|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56719387|NCT00886132|Sunitinib|sunitinib|mesh-list
56719388|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719389|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56719390|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56719391|NCT00886132|Growth Substances|growth substances|mesh-ancestor
56719392|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719393|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
56719394|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56719395|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719402|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719403|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719404|NCT01041235|Docetaxel|docetaxel|mesh-list
56719405|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719406|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
56719407|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
56719408|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
56719409|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719410|NCT01041313|Memantine|memantine|mesh-list
56719411|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56719412|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56719413|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
56719414|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719415|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719416|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719417|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56719418|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56719419|NCT00610714|Paclitaxel|paclitaxel|mesh-list
56719458|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
56719459|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
56719460|NCT00402727|Amoxicillin|amoxicillin|mesh-list
56719461|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
56719462|NCT00402727|Tazobactam|tazobactam|mesh-list
56719463|NCT00402727|Piperacillin|piperacillin|mesh-list
56719464|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
56719465|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
56719466|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56719467|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56719468|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56719469|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719470|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56719471|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56719472|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719473|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719474|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719475|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56719476|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
56719477|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56719478|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719479|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56719480|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56719481|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56719482|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56719483|NCT00923494|Ropivacaine|ropivacaine|mesh-list
56719484|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
56719485|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
56719486|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719487|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719488|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
56719489|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719490|NCT00888784|Propranolol|propranolol|mesh-list
56719498|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56719499|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
56719500|NCT00886678|Carboplatin|carboplatin|mesh-list
56719501|NCT00886678|Pemetrexed|pemetrexed|mesh-list
56719502|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719503|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719504|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719505|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56719506|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56719507|NCT00402337|Linaclotide|linaclotide|mesh-list
56719508|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56719509|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
56719510|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719511|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56719557|NCT00818103|Interferons|interferons|mesh-list
56719558|NCT00818103|Atorvastatin|atorvastatin|mesh-list
56719559|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719560|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
56719561|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719562|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56719563|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56719564|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
56719565|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719566|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56719567|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56719568|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719569|NCT00642369|Haloperidol|haloperidol|mesh-list
56719570|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56719571|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
56719572|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
56719573|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56719574|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56719575|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56719576|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719577|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719578|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
56719579|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
56719580|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719581|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56719582|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56719583|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
56719584|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719585|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719586|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56719588|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719589|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719590|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
56719591|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719592|NCT00889642|Lidocaine|lidocaine|mesh-list
56719599|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719600|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
56719601|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719602|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56719603|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56719604|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56719605|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719606|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719607|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56719608|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56719609|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
56719610|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719611|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56719612|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56719613|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
56719614|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56719615|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
56719616|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
56719617|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
56719618|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56719619|NCT02541526|Mirtazapine|mirtazapine|mesh-list
56719620|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
56719621|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56719622|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56719623|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
56719624|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
56719625|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719626|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719627|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719628|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56719629|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56719630|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719631|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56719632|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56719636|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56719637|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
56719638|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56719639|NCT01037959|Norfloxacin|norfloxacin|mesh-list
56719640|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56719641|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719642|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56719643|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56719644|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719645|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719646|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719647|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56719648|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56719649|NCT01038037|Carboplatin|carboplatin|mesh-list
56719650|NCT01038037|Vinorelbine|vinorelbine|mesh-list
56719651|NCT01038037|Panitumumab|panitumumab|mesh-list
56719652|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719653|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56719654|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
56719655|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
56719656|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
56719657|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719658|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56719659|NCT00645099|Olanzapine|olanzapine|mesh-list
56719684|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56719685|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719686|NCT01038349|Methotrexate|methotrexate|mesh-list
56719687|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56719688|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
56719689|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56719690|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719691|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56719692|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
56719693|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719694|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719695|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
56719696|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719697|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56719698|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719699|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
56719700|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56719701|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56719702|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
56719703|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
56719704|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56719705|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719706|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56719707|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56719708|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719709|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430820|NCT00234299|Analgesics|analgesics|mesh-ancestor
56719710|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719711|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56719712|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56719713|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56719714|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
56719720|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719721|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56719722|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719723|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719724|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56719725|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719726|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56719727|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719728|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
56719729|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56719730|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
56719731|NCT01038583|Aspirin|aspirin|mesh-list
56719732|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56719733|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56719734|NCT01038583|Analgesics|analgesics|mesh-ancestor
56719735|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
56719736|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719737|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719738|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56719739|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56719740|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56719741|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56719742|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719743|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56719744|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56719745|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719746|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
56719747|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
56719748|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56719749|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
56719750|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719751|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719752|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56719753|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
56719754|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56719757|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719758|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56719759|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
56719760|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
56719761|NCT02551107|Protective Agents|protective agents|mesh-ancestor
56719762|NCT01038661|Docetaxel|docetaxel|mesh-list
56719763|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719764|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
56719765|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
56719766|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
56719767|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719768|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
56719769|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
56719770|NCT01038817|Protective Agents|protective agents|mesh-ancestor
56719771|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719772|NCT00420511|Metformin|metformin|mesh-list
56719773|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56719774|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56719775|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719776|NCT00420511|Incretins|incretins|mesh-ancestor
56719777|NCT00420511|Hormones|hormones|mesh-ancestor
56719783|NCT01038895|Ramipril|ramipril|mesh-list
56719809|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
56719810|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56719811|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56719812|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56719813|NCT00402103|Amlodipine|amlodipine|mesh-list
56719814|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56719815|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56719816|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56719817|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719818|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719819|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56719820|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719821|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
56719822|NCT00402103|Diuretics|diuretics|mesh-ancestor
56719823|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
56719824|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56719825|NCT00812175|Sorafenib|sorafenib|mesh-list
56719826|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719827|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56719828|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719829|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719830|NCT00815373|Timolol|timolol|mesh-list
56719831|NCT00815373|Dorzolamide|dorzolamide|mesh-list
56719860|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719861|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
56719862|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56719863|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
56719864|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719865|NCT00641043|Pioglitazone|pioglitazone|mesh-list
56719866|NCT00641043|Linagliptin|linagliptin|mesh-list
56719867|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56719868|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719869|NCT00641043|Incretins|incretins|mesh-ancestor
56719870|NCT00641043|Hormones|hormones|mesh-ancestor
56719871|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56719872|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56719873|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
56719874|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719875|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719876|NCT02567916|Propofol|propofol|mesh-list
56719877|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56719878|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56719879|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719880|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56719881|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
56719882|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
56719883|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56719884|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56719885|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719886|NCT03994393|Durvalumab|durvalumab|mesh-list
56719887|NCT03994393|Tremelimumab|tremelimumab|mesh-list
56719888|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56719889|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56719904|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56719905|NCT00818415|Analgesics|analgesics|mesh-ancestor
56719906|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
56719907|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719908|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719909|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56719910|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56719911|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
56719912|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56719913|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719914|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719915|NCT00815841|Methylphenidate|methylphenidate|mesh-list
56719916|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56719917|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719918|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56719919|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56719920|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719921|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719922|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
56719923|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719924|NCT03897192|Bevacizumab|bevacizumab|mesh-list
56719925|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56719933|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
56719954|NCT00890110|Growth Substances|growth substances|mesh-ancestor
56719955|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
56719956|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56719957|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56719958|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719959|NCT02566824|Methylphenidate|methylphenidate|mesh-list
56719960|NCT02566824|Amphetamine|amphetamine|mesh-list
56719961|NCT02566824|Adderall|adderall|mesh-list
56719962|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
56719963|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56719964|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719965|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56719966|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56719967|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56719968|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56719969|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
56719970|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56719971|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
56719972|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
56719973|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56719974|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
56719975|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56719976|NCT00890188|Thalidomide|thalidomide|mesh-list
56719977|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56719978|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
56719979|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56719988|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
56720001|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
56720002|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720003|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720004|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56720005|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
56431117|NCT00260988|Dalteparin|dalteparin|mesh-list
56720006|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720007|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720008|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56720009|NCT00888082|Goserelin|goserelin|mesh-list
56720010|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56720011|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720012|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
56720013|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56720014|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
56720015|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720016|NCT00627705|Expectorants|expectorants|mesh-ancestor
56720017|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
56720018|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56720019|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
56720020|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720021|NCT00627705|Protective Agents|protective agents|mesh-ancestor
56720022|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720023|NCT00627705|Antidotes|antidotes|mesh-ancestor
56720024|NCT00610168|Vaccines|vaccines|mesh-list
56720025|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
56720026|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720050|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720051|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720052|NCT00890500|Sirolimus|sirolimus|mesh-list
56720053|NCT00890500|Fludarabine|fludarabine|mesh-list
56720054|NCT00890500|Melphalan|melphalan|mesh-list
56720055|NCT00890500|Tacrolimus|tacrolimus|mesh-list
56720056|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56720057|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720058|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720059|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720060|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
56720061|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720062|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56720063|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720064|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56720065|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720066|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56720067|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
56720068|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56720069|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
56720070|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56720071|NCT04061772|Prednisone|prednisone|mesh-list
56720072|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
56720073|NCT04061772|Etoposide|etoposide|mesh-list
56720074|NCT04061772|Bortezomib|bortezomib|mesh-list
56720075|NCT04061772|Epirubicin|epirubicin|mesh-list
56720076|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720077|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
56720078|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720079|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720080|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56720081|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
56720082|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720083|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720084|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56720085|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56720086|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
56720089|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56720090|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56720091|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56720092|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56720093|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720094|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56720095|NCT00644787|Fentanyl|fentanyl|mesh-list
56720096|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56720097|NCT00644787|Narcotics|narcotics|mesh-ancestor
56720098|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720099|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720100|NCT00644787|Analgesics|analgesics|mesh-ancestor
56720101|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
56720102|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720103|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56720104|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56720105|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
56720106|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
56720107|NCT00821301|Fluphenazine|fluphenazine|mesh-list
56720144|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56720145|NCT00821535|Maraviroc|maraviroc|mesh-list
56720146|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56720147|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56720148|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720149|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56720150|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56720151|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
56720152|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720153|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56720154|NCT04062006|Aldesleukin|aldesleukin|mesh-list
56720155|NCT04062006|Interleukin-2|interleukin-2|mesh-list
56720156|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720157|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56431274|NCT04548700|Prednisone|prednisone|mesh-list
56720158|NCT04062006|Analgesics|analgesics|mesh-ancestor
56720204|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
56720205|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
56720206|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720207|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720208|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56720209|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
56720210|NCT00627393|Hormones|hormones|mesh-ancestor
56720211|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56720212|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56720213|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720214|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
56720215|NCT00577122|Methotrexate|methotrexate|mesh-list
56720216|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56720217|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
56720218|NCT00577122|Progesterone|progesterone|mesh-list
56720219|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720220|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
56720221|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720222|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720223|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56720224|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
56720225|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720226|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720227|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56720228|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56720232|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
56720252|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
56720253|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720254|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720255|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56720256|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56720257|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
56720258|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720259|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720260|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56720261|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56720262|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56720263|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56720264|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56720265|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56720266|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56720267|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56720268|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56720269|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56720270|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720271|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720272|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720273|NCT00696774|Analgesics|analgesics|mesh-ancestor
56720299|NCT00698646|Diuretics|diuretics|mesh-ancestor
56720307|NCT04625907|Ifosfamide|ifosfamide|mesh-list
56720373|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56720374|NCT00696696|Gemcitabine|gemcitabine|mesh-list
56720375|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56720376|NCT00696696|Sorafenib|sorafenib|mesh-list
56720377|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56720378|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
56720379|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720380|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720381|NCT00696696|Antiviral Agents|antiviral agents|mesh-ancestor
56720382|NCT00696696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720383|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720384|NCT00696696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720385|NCT00696696|Immunologic Factors|immunologic factors|mesh-ancestor
56720386|NCT00696696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720387|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56720388|NCT00822393|Busulfan|busulfan|mesh-list
56720389|NCT00822393|Treosulfan|treosulfan|mesh-list
56720390|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
56720391|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720392|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720393|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
56720394|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720395|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56720396|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720397|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56720398|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
56720399|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
56720400|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56720421|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
56720422|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720423|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720424|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56720425|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
56720426|NCT00892996|Hormones|hormones|mesh-ancestor
56720427|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56720428|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56720429|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720430|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
56720431|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720432|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720433|NCT00891670|Aspirin|aspirin|mesh-list
56720434|NCT00891670|Cilostazol|cilostazol|mesh-list
56720435|NCT00891670|Clopidogrel|clopidogrel|mesh-list
56720436|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56720437|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56720438|NCT00891670|Analgesics|analgesics|mesh-ancestor
56720439|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
56720440|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720441|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720442|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56720443|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720444|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56720445|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56720446|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720447|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56720448|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56720449|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720450|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
56720451|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56720452|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56720453|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56720454|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
56720455|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720458|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56720459|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
56720460|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
56720461|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56720462|NCT00891670|Protective Agents|protective agents|mesh-ancestor
56720463|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56720464|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56720465|NCT00699192|Amlodipine|amlodipine|mesh-list
56720466|NCT00699192|Valsartan|valsartan|mesh-list
56720467|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56720468|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56720469|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56720470|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720471|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56720472|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720473|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
56720474|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56720475|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56720476|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56720477|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
56720478|NCT00921180|Entecavir|entecavir|mesh-list
56720479|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
56720480|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720481|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
56720482|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720483|NCT04161066|Psilocybin|psilocybin|mesh-list
56720484|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
56720485|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720486|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56720487|NCT04671810|Eculizumab|eculizumab|mesh-list
56720488|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56720500|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720501|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56720502|NCT04668144|Cangrelor|cangrelor|mesh-list
56720503|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56720504|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56720505|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56720506|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56720507|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
56720508|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720509|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720510|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720511|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56720512|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56720513|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56720557|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
56720558|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720559|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56720560|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56720561|NCT01041625|Apremilast|apremilast|mesh-list
56720562|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56720563|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56720564|NCT01041625|Analgesics|analgesics|mesh-ancestor
56720565|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
56720566|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720567|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720568|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56720569|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720570|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56720571|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56720572|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720573|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720574|NCT02566356|Oxytocin|oxytocin|mesh-list
56720575|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
56720576|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56720577|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720578|NCT00892450|Oxybutynin|oxybutynin|mesh-list
56720610|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56720611|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
56720612|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720613|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720614|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
56720678|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720679|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
56720680|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56431794|NCT00236366|Analgesics|analgesics|mesh-ancestor
56720681|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56720682|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56720683|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
56720684|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720685|NCT00696072|Letrozole|letrozole|mesh-list
56720686|NCT00696072|Dasatinib|dasatinib|mesh-list
56720687|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720688|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56720689|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56720690|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720691|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720738|NCT00817011|Fluoxetine|fluoxetine|mesh-list
56720739|NCT00817011|Paroxetine|paroxetine|mesh-list
56720740|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56720741|NCT00817011|Citalopram|citalopram|mesh-list
56720742|NCT00817011|Sertraline|sertraline|mesh-list
56720743|NCT00817011|Nortriptyline|nortriptyline|mesh-list
56720744|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56720745|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
56720746|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56720747|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56720748|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56720749|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56720750|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720751|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
56720752|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720753|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720754|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56720755|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56720756|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720757|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56720758|NCT00817011|Analgesics|analgesics|mesh-ancestor
56720759|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
56720760|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720761|NCT00817011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56720762|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
56720763|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56720765|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
56720784|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
56720785|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720786|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56720787|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56720788|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56720789|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
56720790|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720791|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720792|NCT00400153|Ipratropium|ipratropium|mesh-list
56720793|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56720794|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
56720795|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720796|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720797|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56720798|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
56720799|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56720843|NCT04063358|Growth Substances|growth substances|mesh-ancestor
56720844|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720845|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
56720846|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720847|NCT00631917|Ramipril|ramipril|mesh-list
56720848|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56720849|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
56720850|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720851|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720852|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56720853|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
56720854|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56720855|NCT00419341|Antibodies|antibodies|mesh-list
56720856|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
56720857|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720858|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
56720859|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56720860|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720861|NCT03922620|Bupivacaine|bupivacaine|mesh-list
56720862|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
56720863|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
56720864|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720865|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720866|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
56720867|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720868|NCT00419263|Peramivir|peramivir|mesh-list
56720869|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
56720870|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720871|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720872|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720887|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
56720888|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720889|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720890|NCT04060914|Clopidogrel|clopidogrel|mesh-list
56720891|NCT04060914|Ticagrelor|ticagrelor|mesh-list
56720892|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56720893|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56720894|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56720895|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56720896|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
56720897|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720898|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720899|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720900|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
56720901|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720902|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56720903|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56720904|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56432037|NCT00236834|Ofloxacin|ofloxacin|mesh-list
56720905|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56720906|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720907|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
56720908|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720909|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720910|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
56720911|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56720912|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
56720913|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720914|NCT02094625|Expectorants|expectorants|mesh-ancestor
56720915|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
56720916|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56720917|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
56720918|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720919|NCT02094625|Protective Agents|protective agents|mesh-ancestor
56720926|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720927|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56720928|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
56720929|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56720930|NCT02085265|Telmisartan|telmisartan|mesh-list
56720931|NCT02085265|Perindopril|perindopril|mesh-list
56720932|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56720933|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56720934|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56720935|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720936|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56720937|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
56720938|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56720939|NCT00699842|Lenalidomide|lenalidomide|mesh-list
56720940|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
56720941|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720942|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56720943|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56720944|NCT00699842|Growth Substances|growth substances|mesh-ancestor
56720945|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
56720946|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720947|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
56720948|NCT00399529|Trastuzumab|trastuzumab|mesh-list
56720949|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56720950|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
56720951|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720952|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56720953|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56720954|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
56720956|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720970|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720971|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56720972|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56720973|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56720974|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56720975|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56720976|NCT00712712|Acetaminophen|acetaminophen|mesh-list
56720977|NCT00712712|Morphine|morphine|mesh-list
56720978|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56720979|NCT00712712|Narcotics|narcotics|mesh-ancestor
56720980|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56720981|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720983|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
56720984|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56720985|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56720986|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
56720987|NCT00411151|Sunitinib|sunitinib|mesh-list
56720988|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56720989|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56720990|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56720991|NCT00411151|Growth Substances|growth substances|mesh-ancestor
56720992|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56720993|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
56720994|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56720995|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721020|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56721021|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56721022|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721023|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721024|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
56721025|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56721026|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56721027|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56721028|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56721029|NCT00699608|Zopiclone|zopiclone|mesh-list
56721030|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56721031|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721032|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721033|NCT00895570|Modafinil|modafinil|mesh-list
56721034|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56721035|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721036|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56721037|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56721038|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56721039|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721040|NCT00895648|Pemetrexed|pemetrexed|mesh-list
56721041|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721042|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721043|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721044|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56721045|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56721063|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56721064|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56721065|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
56721066|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721067|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721068|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721069|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56721070|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56721071|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
56721072|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
56721073|NCT00895882|Interferons|interferons|mesh-list
56721074|NCT00895882|Ribavirin|ribavirin|mesh-list
56721075|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721076|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
56721077|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721078|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
56721079|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721080|NCT00706706|Sunitinib|sunitinib|mesh-list
56721081|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721082|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56721083|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56721084|NCT00706706|Growth Substances|growth substances|mesh-ancestor
56721085|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721086|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
56721087|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56721088|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721089|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721090|NCT00894010|Carbamazepine|carbamazepine|mesh-list
56721091|NCT00894010|Levetiracetam|levetiracetam|mesh-list
56721092|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
56721107|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56721108|NCT00895960|Temozolomide|temozolomide|mesh-list
56721109|NCT00895960|Dasatinib|dasatinib|mesh-list
56721110|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56721111|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
56721112|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721113|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721114|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56721115|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721116|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
56721117|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56721118|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721119|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56721120|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
56721121|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56721122|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721123|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721124|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721125|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56721126|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56721127|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56721128|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56721129|NCT00921128|Muscimol|muscimol|mesh-list
56721130|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56721131|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
56721132|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
56721153|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
56721154|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721155|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721156|NCT04486716|Ofatumumab|ofatumumab|mesh-list
56721157|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721158|NCT00410605|Dexamethasone|dexamethasone|mesh-list
56721159|NCT00410605|Bevacizumab|bevacizumab|mesh-list
56721160|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56721161|NCT00410605|Lenalidomide|lenalidomide|mesh-list
56721162|NCT00410605|Antibodies|antibodies|mesh-list
56721163|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
56721164|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56721165|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721166|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56721167|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56721168|NCT00410605|Growth Substances|growth substances|mesh-ancestor
56721169|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721170|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
56721178|NCT00410605|Hormones|hormones|mesh-ancestor
56721211|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721212|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56721213|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56721214|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721215|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721216|NCT00897130|Azacitidine|azacitidine|mesh-list
56721217|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56721218|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
56721219|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721220|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721221|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721222|NCT00398047|Mitogens|mitogens|mesh-list
56721223|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
56721224|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721225|NCT00631371|Interferons|interferons|mesh-list
56721226|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
56721227|NCT00631371|Sirolimus|sirolimus|mesh-list
56721228|NCT00631371|Bevacizumab|bevacizumab|mesh-list
56721229|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56721230|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721231|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56721232|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56721233|NCT00631371|Growth Substances|growth substances|mesh-ancestor
56721234|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721235|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
56721236|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
56721237|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721238|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
56721239|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56721240|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56721256|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56721257|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
56721258|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
56721259|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721260|NCT04016740|Analgesics|analgesics|mesh-ancestor
56721261|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
56721262|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721263|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56721264|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56721265|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56721266|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56721267|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721268|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721269|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56721270|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56721271|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56721272|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
56721273|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56721274|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56721275|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56721276|NCT04016740|Narcotics|narcotics|mesh-ancestor
56721277|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56721278|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56721279|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56721280|NCT02540512|Acetaminophen|acetaminophen|mesh-list
56721281|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56721282|NCT02540512|Hydrocodone|hydrocodone|mesh-list
56721283|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721284|NCT02540512|Analgesics|analgesics|mesh-ancestor
56721285|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
56721286|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721287|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721288|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
56721289|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56721290|NCT02540512|Narcotics|narcotics|mesh-ancestor
56721291|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721293|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
56721294|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56721295|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721296|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721297|NCT00897520|Interferons|interferons|mesh-list
56721298|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
56721299|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721300|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
56721301|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721302|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
56721303|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721304|NCT00894634|Brompheniramine|brompheniramine|mesh-list
56721305|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721306|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56721307|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
56721308|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
56721309|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721310|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721311|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56721312|NCT00894712|Sulforaphane|sulforaphane|mesh-list
56721350|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721351|NCT00397189|Protective Agents|protective agents|mesh-ancestor
56721352|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721353|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721354|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
56721355|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56721356|NCT01035619|Moxidectin|moxidectin|mesh-list
56721357|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
56721358|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56721359|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721360|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
56721361|NCT04044651|Nivolumab|nivolumab|mesh-list
56721362|NCT04044651|Lenvatinib|lenvatinib|mesh-list
56721363|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56721364|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721365|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56721366|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721367|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56721368|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721369|NCT00606034|Insulin|insulin|mesh-list
56721370|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56721371|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721372|NCT00819975|Caseins|caseins|mesh-list
56721373|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
56721374|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
56721375|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721376|NCT04044417|Curcumin|curcumin|mesh-list
56721377|NCT04044417|Simvastatin|simvastatin|mesh-list
56721378|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56721396|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56721397|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721398|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721399|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56721400|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56721401|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56721402|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
56721403|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721404|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721405|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56721406|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56721407|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
56721408|NCT00820053|Epirubicin|epirubicin|mesh-list
56721409|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
56721410|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56721411|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721412|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56721413|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56721414|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721415|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721416|NCT00572728|Alovudine|alovudine|mesh-list
56721417|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
56721418|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
56721419|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721420|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
56721421|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721422|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56721423|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56721424|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721425|NCT00699374|Sorafenib|sorafenib|mesh-list
56721426|NCT00699374|Sunitinib|sunitinib|mesh-list
56721427|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721428|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56721429|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721435|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
56721436|NCT00898534|Chrysarobin|chrysarobin|mesh-list
56721437|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56721438|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721439|NCT00898534|Analgesics|analgesics|mesh-ancestor
56721440|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
56721441|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721442|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721443|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721444|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721445|NCT00606892|Nicotine|nicotine|mesh-list
56721446|NCT00606892|Varenicline|varenicline|mesh-list
56721447|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56721448|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
56721449|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721450|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721451|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56721452|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56721453|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
56721454|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721455|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721456|NCT03680053|Cetrorelix|cetrorelix|mesh-list
56721489|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721563|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721564|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
56721565|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721566|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56721567|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56721568|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721569|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
56721570|NCT00824811|Hormones|hormones|mesh-ancestor
56721571|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56721572|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56721573|NCT00606580|Paromomycin|paromomycin|mesh-list
56721574|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56721575|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721576|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56721577|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56721578|NCT02550327|Gemcitabine|gemcitabine|mesh-list
56721579|NCT02550327|Paclitaxel|paclitaxel|mesh-list
56721580|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56721581|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56721582|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721583|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
56432698|NCT02216227|Vancomycin|vancomycin|mesh-list
56721584|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
56721585|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
56721586|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721587|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56721613|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721614|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56721615|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56721616|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
56721617|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721618|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721619|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56721620|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
56721621|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56721622|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56721623|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56721624|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56721625|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
56721626|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56721627|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56721628|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721629|NCT00606502|Vitamins|vitamins|mesh-list
56721630|NCT00606502|Folic Acid|folic acid|mesh-list
56721631|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
56721632|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
56721633|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56721634|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
56721635|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
56721636|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721637|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721638|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56721639|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721640|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721641|NCT00606502|Hematinics|hematinics|mesh-ancestor
56721642|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56721643|NCT00825123|Metoprolol|metoprolol|mesh-list
56721644|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56721654|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721655|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721656|NCT00826839|Leuprolide|leuprolide|mesh-list
56721657|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
56721658|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
56721659|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56721660|NCT00826839|Ganirelix|ganirelix|mesh-list
56721661|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56721662|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721663|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56721664|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
56721665|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56721666|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721667|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56721668|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
56721669|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56721670|NCT04017988|Ethanol|ethanol|mesh-list
56721671|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56721672|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721673|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56721674|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721675|NCT00825201|Paclitaxel|paclitaxel|mesh-list
56721676|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56721677|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56721684|NCT00820911|Everolimus|everolimus|mesh-list
56721702|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56721703|NCT00605722|Growth Substances|growth substances|mesh-ancestor
56721704|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721705|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
56721706|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56721707|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721708|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721709|NCT00882076|Etoposide|etoposide|mesh-list
56721710|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
56721711|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
56721712|NCT00882076|Clofarabine|clofarabine|mesh-list
56721713|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56721714|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721715|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56721716|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56721717|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721718|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721719|NCT00882076|Analgesics|analgesics|mesh-ancestor
56721720|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
56721721|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721722|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721723|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56721724|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
56721725|NCT00827151|Estrogens|estrogens|mesh-list
56721726|NCT00827151|Hormones|hormones|mesh-ancestor
56721727|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56721728|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721729|NCT00882154|Cefdinir|cefdinir|mesh-list
56721730|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56721731|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721732|NCT00825591|Melatonin|melatonin|mesh-list
56721744|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
56721745|NCT03417154|Nivolumab|nivolumab|mesh-list
56721746|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56721747|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
56721748|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721749|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721750|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56721751|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
56721752|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721753|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721754|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56721755|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56721756|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56721757|NCT00900172|Paclitaxel|paclitaxel|mesh-list
56721758|NCT00900172|Bevacizumab|bevacizumab|mesh-list
56721759|NCT00900172|Carboplatin|carboplatin|mesh-list
56721760|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56721761|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721762|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
56721763|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
56721764|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
56721765|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721766|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56721767|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56721794|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721795|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721796|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56721797|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56721798|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721799|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56721800|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56721801|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721802|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
56721803|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56721804|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56721805|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56721806|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
56721807|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721809|NCT00396877|Clopidogrel|clopidogrel|mesh-list
56721853|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721854|NCT00882700|Cefdinir|cefdinir|mesh-list
56721855|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56721856|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721857|NCT00408499|Cetuximab|cetuximab|mesh-list
56721858|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56721859|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56721860|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721861|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56721862|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721863|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721864|NCT00837369|Regadenoson|regadenoson|mesh-list
56721865|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56721866|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56721912|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721913|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
56721914|NCT00908362|Hormones|hormones|mesh-ancestor
56721915|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56721916|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
56721917|NCT02549469|Naproxen|naproxen|mesh-list
56721918|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56721919|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56721920|NCT02549469|Analgesics|analgesics|mesh-ancestor
56721921|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
56721922|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721923|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721924|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56721925|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56721926|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
56721927|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56721928|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56721929|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721930|NCT02548533|Lidocaine|lidocaine|mesh-list
56721931|NCT02548533|Epinephrine|epinephrine|mesh-list
56721932|NCT02548533|Prilocaine|prilocaine|mesh-list
56721933|NCT02548533|Carticaine|carticaine|mesh-list
56721934|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56721935|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
56721936|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
56721961|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721962|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56721963|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
56721964|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56721965|NCT02538172|Valganciclovir|valganciclovir|mesh-list
56721966|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
56721967|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56721968|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
56721969|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
56721970|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
56721971|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56721972|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
56721973|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
56721974|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721975|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721976|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721977|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56721978|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
56721979|NCT00908674|Cyproterone|cyproterone|mesh-list
56721980|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
56721981|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
56721982|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56721983|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721984|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56721985|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56721986|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
56721987|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56721988|NCT00621777|Varenicline|varenicline|mesh-list
56721989|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56721990|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56721991|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
56554611|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554612|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554613|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56554614|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554615|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554616|NCT04157803|Acetic Acid|acetic acid|mesh-list
56554617|NCT04157803|Retinol acetate|retinol acetate|mesh-list
56554618|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56554619|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554620|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56554621|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
56109229|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
56721992|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56721993|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56721994|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56721995|NCT02538718|Ritodrine|ritodrine|mesh-list
56721996|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
56721997|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
56721998|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56721999|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722000|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
56722001|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56722002|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56722003|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56722004|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56722005|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
56722006|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722007|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722008|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
56722009|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
56722010|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56722011|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56722012|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722013|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722014|NCT00902512|Urological Agents|urological agents|mesh-ancestor
56722015|NCT00827307|Tamoxifen|tamoxifen|mesh-list
56722016|NCT00827307|Goserelin|goserelin|mesh-list
56722026|NCT00837915|Loratadine|loratadine|mesh-list
56722039|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56722040|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
56722041|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722042|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56722043|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
56722044|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
56722045|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56722047|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
56722107|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
56722108|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722109|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722110|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56722111|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56722112|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56722113|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
56722114|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722115|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722116|NCT01042873|Protective Agents|protective agents|mesh-ancestor
56722117|NCT01042951|Vaccines|vaccines|mesh-list
56722118|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
56722119|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722120|NCT01037023|Topotecan|topotecan|mesh-list
56722121|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56722122|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56722123|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722124|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722125|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722126|NCT00604708|Vaccines|vaccines|mesh-list
56722127|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
56722128|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722129|NCT00909688|BLI-489|bli-489|mesh-list
56722130|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56722131|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722155|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722156|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56722157|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56722158|NCT04034836|Analgesics|analgesics|mesh-ancestor
56722159|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56722160|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722161|NCT00407797|Pregabalin|pregabalin|mesh-list
56722162|NCT00407797|Analgesics|analgesics|mesh-ancestor
56722163|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
56722164|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722165|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722166|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
56722167|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56722168|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722169|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722170|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56722171|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56722172|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56722173|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722174|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56722175|NCT00903292|Pemetrexed|pemetrexed|mesh-list
56722176|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56722177|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722178|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722179|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722203|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56722204|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
56722277|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722278|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
56722279|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722280|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722281|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56722282|NCT00623103|Protective Agents|protective agents|mesh-ancestor
56722283|NCT01043341|Vaccines|vaccines|mesh-list
56722284|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
56722285|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722286|NCT01043419|Xenon|xenon|mesh-list
56722287|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56722288|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
56722289|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
56722290|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722291|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722292|NCT01037335|Morphine|morphine|mesh-list
56722293|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56722294|NCT01037335|Narcotics|narcotics|mesh-ancestor
56722295|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722296|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722297|NCT01037335|Analgesics|analgesics|mesh-ancestor
56722298|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
56722299|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722300|NCT04015492|Factor VIII|factor viii|mesh-list
56722301|NCT04015492|BAX 855|bax 855|mesh-list
56722302|NCT04015492|Coagulants|coagulants|mesh-ancestor
56722303|NCT00904462|Lidocaine|lidocaine|mesh-list
56722304|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
56722305|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
56722306|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722307|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722308|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
56722315|NCT00396565|Olanzapine|olanzapine|mesh-list
56722320|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722321|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56722322|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56722323|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56722324|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722325|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56722326|NCT00396565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56722327|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56722328|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722329|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722330|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722331|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
56722332|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56722333|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56722334|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56722335|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56722336|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
56722337|NCT00904540|Lidocaine|lidocaine|mesh-list
56722338|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
56722339|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
56722340|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722341|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722342|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
56722343|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722344|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56722349|NCT00906880|Eflornithine|eflornithine|mesh-list
56722366|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722367|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
56722368|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56722369|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
56722370|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722371|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56722372|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56722373|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
56722374|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56722375|NCT00394771|Estradiol|estradiol|mesh-list
56722376|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56722377|NCT00394771|Estrogens|estrogens|mesh-ancestor
56722378|NCT00394771|Hormones|hormones|mesh-ancestor
56722379|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56722380|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722381|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56722382|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
56722383|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56722384|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56722385|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56722386|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56722387|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56722418|NCT00567580|Bicalutamide|bicalutamide|mesh-list
56722419|NCT00567580|Buserelin|buserelin|mesh-list
56722420|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56722421|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
56722422|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56722423|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722424|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56722425|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722426|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
56722427|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
56722428|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56722429|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
56722430|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56722431|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
56722432|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56722433|NCT04060836|Factor VIII|factor viii|mesh-list
56722434|NCT04060836|Coagulants|coagulants|mesh-ancestor
56722435|NCT00693420|Bimatoprost|bimatoprost|mesh-list
56722436|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56722437|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56722438|NCT04034524|Insulin|insulin|mesh-list
56722439|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56722440|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56722441|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722442|NCT00925912|Bupivacaine|bupivacaine|mesh-list
56722443|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
56722444|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
56722445|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722449|NCT00695136|Donepezil|donepezil|mesh-list
56722465|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
56722466|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56722467|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56722468|NCT02710890|Lacosamide|lacosamide|mesh-list
56722469|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
56722470|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56722471|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56722472|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56433591|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56722473|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722474|NCT00605176|Imiquimod|imiquimod|mesh-list
56722475|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56722476|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
56722477|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722478|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722479|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
56722480|NCT00743028|Navitoclax|navitoclax|mesh-list
56722481|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722482|NCT00926302|Levetiracetam|levetiracetam|mesh-list
56722483|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
56722484|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
56722485|NCT00907036|Cyclosporine|cyclosporine|mesh-list
56722486|NCT00907036|Fludarabine|fludarabine|mesh-list
56722487|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
56722488|NCT00907036|Melphalan|melphalan|mesh-list
56722489|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
56722490|NCT00907036|Cyclosporins|cyclosporins|mesh-list
56722491|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722492|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56722493|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
56722494|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277941|NCT02040662|Morphine|morphine|mesh-list
56722508|NCT00926614|Pioglitazone|pioglitazone|mesh-list
56722509|NCT00926614|Atorvastatin|atorvastatin|mesh-list
56722510|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56722511|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56722512|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
56722513|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722514|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56722515|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56722516|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722517|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56722518|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722519|NCT00907114|Ketorolac|ketorolac|mesh-list
56722520|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56722521|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56722522|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56722523|NCT00907114|Analgesics|analgesics|mesh-ancestor
56722524|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
56722525|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722526|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722564|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56722565|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56722566|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
56722567|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722568|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722569|NCT00926926|Urological Agents|urological agents|mesh-ancestor
56722570|NCT00396253|Tenecteplase|tenecteplase|mesh-list
56722571|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56722572|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56722573|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722574|NCT00927004|Etoricoxib|etoricoxib|mesh-list
56722575|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56722576|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56722577|NCT00927004|Analgesics|analgesics|mesh-ancestor
56722578|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
56722579|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722580|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722581|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56722582|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722583|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56722584|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56722585|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722586|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722587|NCT00931450|Sunitinib|sunitinib|mesh-list
56722588|NCT00931450|Exemestane|exemestane|mesh-list
56722611|NCT00928798|Sirolimus|sirolimus|mesh-list
56722612|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56722613|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722614|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56722615|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722616|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
56722617|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56722618|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
56722619|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722620|NCT00931840|Irinotecan|irinotecan|mesh-list
56722621|NCT00931840|Cetuximab|cetuximab|mesh-list
56722622|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56722623|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56433750|NCT01649479|Antibodies|antibodies|mesh-list
56722624|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722625|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722626|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722627|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56722628|NCT04034368|Tenofovir|tenofovir|mesh-list
56722629|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
56722630|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722631|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56722632|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56722633|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722634|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722635|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56722636|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56722637|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
56722638|NCT00907270|Vitamin D|vitamin d|mesh-list
56722639|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56722640|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722654|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722655|NCT00907504|Antiviral Agents|antiviral agents|mesh-ancestor
56722656|NCT00907504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722657|NCT00907504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722658|NCT00907504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56722659|NCT00907504|Immunologic Factors|immunologic factors|mesh-ancestor
56722660|NCT00907504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722661|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
56722662|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56722663|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56722664|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722665|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56722666|NCT00932386|Analgesics|analgesics|mesh-ancestor
56722667|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
56722668|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722669|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56722670|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56722709|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56722710|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722711|NCT01043575|Rifampin|rifampin|mesh-list
56722712|NCT01043575|Rifapentine|rifapentine|mesh-list
56722713|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56722714|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
56722715|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56722716|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722717|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
56722718|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56722719|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722720|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722721|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56722722|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56722723|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56722724|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56722725|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56722726|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56722727|NCT01045837|Prednisolone|prednisolone|mesh-list
56722728|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56722729|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
56722730|NCT01045837|Hormones|hormones|mesh-ancestor
56722731|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56722735|NCT00567268|Gabapentin|gabapentin|mesh-list
56722757|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56722758|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56722759|NCT04014556|Growth Substances|growth substances|mesh-ancestor
56722760|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722761|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
56722762|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722763|NCT00929812|Glucagon|glucagon|mesh-list
56722764|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56722765|NCT00929812|Hormones|hormones|mesh-ancestor
56722766|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56722767|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722768|NCT00907972|Vitamin D|vitamin d|mesh-list
56722769|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
56722770|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
56722771|NCT00907972|Vitamins|vitamins|mesh-list
56722772|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
56722773|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722774|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56722775|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56722776|NCT03799744|Durvalumab|durvalumab|mesh-list
56722777|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56722778|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722779|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
56722780|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56722781|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56722782|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56722783|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722784|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722785|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
56722786|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722787|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722788|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56722798|NCT00933790|Ethambutol|ethambutol|mesh-list
56722799|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56722800|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
56722801|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56722802|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722803|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
56722804|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56722805|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722806|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722807|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56722808|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56722809|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56722810|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56722811|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56722812|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56722813|NCT00566254|Zonisamide|zonisamide|mesh-list
56722814|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
56722815|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56722816|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722817|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722818|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56722819|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722820|NCT00930202|Conivaptan|conivaptan|mesh-list
56722821|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56722822|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722823|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
56722842|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56722843|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722844|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
56722846|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722847|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56722848|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56722849|NCT00393367|Protective Agents|protective agents|mesh-ancestor
56722850|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56722851|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56722852|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
56722853|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
56722854|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
56722855|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56722856|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56722857|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56722858|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56722859|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
56722860|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722861|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722862|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56722863|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
56722864|NCT00395629|Deferasirox|deferasirox|mesh-list
56722865|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56722866|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
56722867|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
56722868|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722869|NCT00392665|Sulindac|sulindac|mesh-list
56722870|NCT00392665|Bevacizumab|bevacizumab|mesh-list
56722871|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56722887|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56722888|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722889|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56722890|NCT01043965|Metformin|metformin|mesh-list
56722891|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56722892|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722893|NCT00622869|Everolimus|everolimus|mesh-list
56722894|NCT00622869|Tacrolimus|tacrolimus|mesh-list
56722895|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56722896|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
56722897|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722898|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56722899|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722900|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722901|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722902|NCT00366457|Gemcitabine|gemcitabine|mesh-list
56722903|NCT00366457|Bevacizumab|bevacizumab|mesh-list
56722904|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56722905|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56722906|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722907|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56722908|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56722909|NCT00366457|Growth Substances|growth substances|mesh-ancestor
56722910|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722911|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
56722912|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56722913|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
56722914|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722915|NCT00366457|Antiviral Agents|antiviral agents|mesh-ancestor
56722916|NCT00366457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56722930|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722931|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
56722932|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722933|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56722934|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
56722935|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56722936|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56722937|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56722938|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722939|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56722940|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56722941|NCT01049347|Analgesics|analgesics|mesh-ancestor
56722942|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
56722943|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56722944|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56722945|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
56722946|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
56722947|NCT01049425|Docetaxel|docetaxel|mesh-list
56722948|NCT01049425|Epirubicin|epirubicin|mesh-list
56722949|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56722950|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
56722951|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722952|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56722953|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56722954|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
56722955|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722956|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56722957|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56722958|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
56722959|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
56722960|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
56722961|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56722962|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56722963|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56722964|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56722965|NCT00838227|Modafinil|modafinil|mesh-list
56554622|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722966|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56722967|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722968|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56722969|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56722970|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56722971|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722972|NCT00366301|Metformin|metformin|mesh-list
56722973|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
56722974|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56722975|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722976|NCT00838305|Citalopram|citalopram|mesh-list
56722977|NCT00838305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56722978|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56722979|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56722980|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56722981|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56722982|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
56722983|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56722984|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56722985|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
56722986|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56722987|NCT00622713|Rivastigmine|rivastigmine|mesh-list
56722988|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56722989|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434112|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
56723011|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56723012|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
56723013|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56723014|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56723015|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56723016|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56723017|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56723018|NCT00391807|Norethindrone|norethindrone|mesh-list
56723019|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
56723020|NCT00391807|Estradiol|estradiol|mesh-list
56723021|NCT00391807|Estrogens|estrogens|mesh-ancestor
56723022|NCT00391807|Hormones|hormones|mesh-ancestor
56723023|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723024|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723025|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56723026|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
56723027|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56723028|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56723029|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56723030|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56723031|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56723032|NCT00624585|Dasatinib|dasatinib|mesh-list
56723033|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723034|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56723035|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723036|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723037|NCT01046383|Caseins|caseins|mesh-list
56723038|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
56723039|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
56723056|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56723057|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
56723058|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56723059|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56723060|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56723061|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
56723062|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434193|NCT02219191|Puerarin|puerarin|mesh-list
56723063|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723065|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56723066|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
56723067|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56723068|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723069|NCT00622401|Interleukin-12|interleukin-12|mesh-list
56723070|NCT00622401|Vaccines|vaccines|mesh-list
56723071|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
56723072|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723073|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56723074|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56723075|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56723076|NCT00622401|Growth Substances|growth substances|mesh-ancestor
56723077|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
56723078|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723110|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
56723111|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56723112|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
56723113|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723114|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723115|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
56723116|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56723117|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56723118|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56723119|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
56723120|NCT00839163|Coagulants|coagulants|mesh-ancestor
56723121|NCT02549001|Amorolfine|amorolfine|mesh-list
56723122|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
56723123|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723124|NCT00621543|Copper|copper|mesh-list
56723125|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
56723126|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56723127|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
56723128|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56723129|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723130|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56723131|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56723132|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56723133|NCT00621543|Trace Elements|trace elements|mesh-ancestor
56723134|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
56723135|NCT00623805|Bevacizumab|bevacizumab|mesh-list
56723136|NCT00623805|Capecitabine|capecitabine|mesh-list
56723137|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
56723138|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56723139|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723140|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56723141|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56723142|NCT00623805|Growth Substances|growth substances|mesh-ancestor
56723143|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723153|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56723154|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
56723155|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
56723156|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56723157|NCT02548923|Analgesics|analgesics|mesh-ancestor
56723158|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
56723159|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723160|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56723161|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56723162|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56723163|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
56723164|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723165|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723166|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56723167|NCT00832221|Raclopride|raclopride|mesh-list
56723168|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
56723169|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56723170|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56723171|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56723172|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723173|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723174|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56723175|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
56723176|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723177|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723178|NCT00839397|Paroxetine|paroxetine|mesh-list
56723179|NCT00839397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56723180|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56723197|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
56723198|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723199|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723200|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723201|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723202|NCT00621309|Rifampin|rifampin|mesh-list
56723203|NCT00621309|Rifamycins|rifamycins|mesh-list
56723204|NCT00621309|Sulforaphane|sulforaphane|mesh-list
56723205|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56723206|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
56723207|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56723208|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723209|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
56723210|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56723211|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723212|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723213|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56723214|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56434335|NCT00241982|Prednisolone|prednisolone|mesh-list
56723219|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56723251|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
56723252|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723253|NCT00691938|Decitabine|decitabine|mesh-list
56723254|NCT00691938|Panobinostat|panobinostat|mesh-list
56723255|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56723256|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
56723257|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723258|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723259|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723260|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56723261|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
56723262|NCT00365365|Bevacizumab|bevacizumab|mesh-list
56723263|NCT00365365|Carboplatin|carboplatin|mesh-list
56723264|NCT00365365|Docetaxel|docetaxel|mesh-list
56723265|NCT00365365|Doxorubicin|doxorubicin|mesh-list
56723266|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56723267|NCT00365365|Trastuzumab|trastuzumab|mesh-list
56723268|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723269|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
56723270|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723271|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723272|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56723273|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
56723274|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723275|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723276|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56723277|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56723278|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56723279|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56723280|NCT00365365|Growth Substances|growth substances|mesh-ancestor
56723281|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
56723282|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
56723283|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
56723284|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
56723285|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56723286|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56723290|NCT01046461|Aprepitant|aprepitant|mesh-list
56723291|NCT01046461|Ramosetron|ramosetron|mesh-list
56723292|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723293|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
56723294|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
56723295|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723296|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723297|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56723298|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
56723299|NCT01046461|Hormones|hormones|mesh-ancestor
56723300|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723301|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56723302|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723303|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56723304|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723305|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723306|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56723307|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
56723308|NCT00623727|Factor VIII|factor viii|mesh-list
56723309|NCT00623727|Coagulants|coagulants|mesh-ancestor
56723310|NCT01046539|Buprenorphine|buprenorphine|mesh-list
56723311|NCT01046539|ALKS-33|alks-33|mesh-list
56723312|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56723313|NCT01046539|Narcotics|narcotics|mesh-ancestor
56723314|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723315|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723316|NCT01046539|Analgesics|analgesics|mesh-ancestor
56723317|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
56723318|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723319|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56723320|NCT01044199|Vaccines|vaccines|mesh-list
56723321|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
56723322|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723323|NCT00828789|Tenofovir|tenofovir|mesh-list
56723324|NCT00828789|Efavirenz|efavirenz|mesh-list
56723325|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
56723326|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723327|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56723328|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56723329|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723330|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723331|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56723332|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56723333|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56723334|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56723335|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56723336|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56723337|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56723338|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56723339|NCT00930358|Anesthetics|anesthetics|mesh-list
56723340|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723341|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723342|NCT00372775|Sunitinib|sunitinib|mesh-list
56723343|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723344|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56723345|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56723346|NCT00372775|Growth Substances|growth substances|mesh-ancestor
56723347|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723348|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
56723349|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56723350|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723351|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723352|NCT00936676|Rasagiline|rasagiline|mesh-list
56723353|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56723354|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723355|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723356|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56723357|NCT00936676|Protective Agents|protective agents|mesh-ancestor
56723358|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723359|NCT00839787|Morphine|morphine|mesh-list
56434488|NCT00242762|Docetaxel|docetaxel|mesh-list
56723366|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723367|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56723368|NCT00934258|Fenofibrate|fenofibrate|mesh-list
56723369|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56723370|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56723371|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
56723372|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723373|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56723374|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56723375|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723376|NCT00372697|Octreotide|octreotide|mesh-list
56723377|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56723378|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56723379|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723380|NCT00934414|Insulin|insulin|mesh-list
56723381|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56723382|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723383|NCT00930514|Rituximab|rituximab|mesh-list
56723384|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56723385|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723386|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
56723387|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723388|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723389|NCT00936988|Cinacalcet|cinacalcet|mesh-list
56723390|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56723391|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723392|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56723398|NCT00934492|Renal Agents|renal agents|mesh-ancestor
56723412|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56723413|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56723414|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56723415|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
56723416|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723417|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56723418|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56723419|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723420|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56723421|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56723422|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56723423|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56723424|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
56723425|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
56723426|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723427|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723428|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
56723429|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
56723430|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56723431|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56723432|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723433|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723434|NCT00937144|Urological Agents|urological agents|mesh-ancestor
56723435|NCT00566098|Melphalan|melphalan|mesh-list
56723436|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56723437|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
56723438|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723439|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723440|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56723441|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723442|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
56723445|NCT00937300|Fludarabine|fludarabine|mesh-list
56723453|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
56723454|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723455|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723456|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56723457|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56723458|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
56723459|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56723460|NCT00937300|Analgesics|analgesics|mesh-ancestor
56723461|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
56723462|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723463|NCT02226276|Copper|copper|mesh-list
56723464|NCT02226276|Trastuzumab|trastuzumab|mesh-list
56723465|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56723466|NCT02226276|Maytansine|maytansine|mesh-list
56723467|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56723468|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
56723469|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56723470|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723471|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723472|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56723473|NCT02226276|Trace Elements|trace elements|mesh-ancestor
56723474|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
56723475|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723476|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56723477|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
56723478|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
56723479|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
56723480|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
56723481|NCT00935116|Etoricoxib|etoricoxib|mesh-list
56723482|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56723483|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56723484|NCT00935116|Analgesics|analgesics|mesh-ancestor
56723485|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
56723486|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723493|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723494|NCT00931138|Cytarabine|cytarabine|mesh-list
56723495|NCT00931138|Daunorubicin|daunorubicin|mesh-list
56723496|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56723497|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723498|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56723499|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56723500|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723501|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723502|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56723503|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
56723504|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
56723505|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723506|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723507|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
56723508|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723509|NCT00935194|Oseltamivir|oseltamivir|mesh-list
56723510|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
56723511|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723512|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723513|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723514|NCT00690378|Imipenem|imipenem|mesh-list
56723515|NCT00690378|Ceftazidime|ceftazidime|mesh-list
56723516|NCT00690378|Avibactam|avibactam|mesh-list
56723517|NCT00690378|Cilastatin|cilastatin|mesh-list
56723518|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56723519|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723520|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
56723521|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723522|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723523|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56723524|NCT00574275|Gemcitabine|gemcitabine|mesh-list
56723525|NCT00574275|Aflibercept|aflibercept|mesh-list
56723535|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723536|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56723537|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56723538|NCT00574275|Growth Substances|growth substances|mesh-ancestor
56723539|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
56723540|NCT01742832|Citalopram|citalopram|mesh-list
56723541|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56723542|NCT01742832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56723543|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56723544|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56723545|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723546|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723547|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
56723548|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723549|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56723550|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
56723551|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56723552|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56723553|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56723554|NCT00833079|Tacrolimus|tacrolimus|mesh-list
56723555|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56723556|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
56723557|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723558|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56723559|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723560|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723561|NCT00935506|Aspirin|aspirin|mesh-list
56723562|NCT00935506|Clopidogrel|clopidogrel|mesh-list
56723563|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56723564|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56723565|NCT00935506|Analgesics|analgesics|mesh-ancestor
56723566|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
56723567|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723570|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723573|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723574|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56723575|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56723576|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723577|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
56723578|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56723579|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56723580|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56723581|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
56723582|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723583|NCT00833157|Ibuprofen|ibuprofen|mesh-list
56723584|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56723585|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56723586|NCT00833157|Analgesics|analgesics|mesh-ancestor
56723587|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
56723588|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723589|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723590|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723591|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723592|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56723593|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723594|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723599|NCT04285671|Trastuzumab|trastuzumab|mesh-list
56723623|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
56723624|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
56723625|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56723626|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
56723627|NCT00829257|Hormones|hormones|mesh-ancestor
56723628|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723629|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
56723630|NCT03978832|Risperidone|risperidone|mesh-list
56723631|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56723632|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
56723633|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723634|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723635|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723636|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56723637|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56723638|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723639|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56723640|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56723641|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
56723642|NCT00840333|Levofloxacin|levofloxacin|mesh-list
56723643|NCT00840333|Ofloxacin|ofloxacin|mesh-list
56723644|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56723645|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723646|NCT00840333|Renal Agents|renal agents|mesh-ancestor
56723647|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56723648|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56723649|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56723650|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723651|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723652|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723653|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56723654|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56723655|NCT00840489|Ribavirin|ribavirin|mesh-list
56723656|NCT00840489|Colchicine|colchicine|mesh-list
56723657|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
56723659|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
56723662|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723663|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56723664|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56723665|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56723666|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723667|NCT00743496|Antibodies|antibodies|mesh-list
56723668|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
56723669|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723670|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56723671|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56723672|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56723673|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56723674|NCT00840645|Mirabegron|mirabegron|mesh-list
56723675|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56723676|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56723677|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56723678|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
56723679|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723680|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723681|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723682|NCT00840645|Urological Agents|urological agents|mesh-ancestor
56723683|NCT00566722|Adalimumab|adalimumab|mesh-list
56723684|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723685|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723686|NCT00691704|Prednisone|prednisone|mesh-list
56723687|NCT00691704|Lenalidomide|lenalidomide|mesh-list
56723712|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56723713|NCT00829647|Growth Substances|growth substances|mesh-ancestor
56723714|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
56723715|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723716|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56723717|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723718|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723719|NCT00939328|Rituximab|rituximab|mesh-list
56723720|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56723721|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56723722|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723723|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
56723724|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723725|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723726|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56723727|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
56723728|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723729|NCT00829881|Betahistine|betahistine|mesh-list
56723730|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
56723731|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
56723732|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
56723733|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723734|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723735|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723736|NCT00840801|Vaccines|vaccines|mesh-list
56723737|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
56723738|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723739|NCT04014244|Triamcinolone|triamcinolone|mesh-list
56723740|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56723741|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56723745|NCT04014244|Hormones|hormones|mesh-ancestor
56723754|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56723755|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56723756|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56723757|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56723758|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
56723759|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723760|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723761|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723762|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
56723763|NCT00937924|Promethazine|promethazine|mesh-list
56723764|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56723765|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56723766|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723767|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723768|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
56723769|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
56723770|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
56723771|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723772|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
56723773|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
56723774|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56723775|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56723776|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
56723777|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
56723778|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723779|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723780|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56723781|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
56723782|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
56723783|NCT00743886|Mitogens|mitogens|mesh-list
56723784|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
56723785|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723786|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
56723787|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56723794|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723795|NCT00830193|Protective Agents|protective agents|mesh-ancestor
56723796|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723797|NCT00830193|Antidotes|antidotes|mesh-ancestor
56723798|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
56723799|NCT00938158|Incretins|incretins|mesh-ancestor
56723800|NCT00938158|Hormones|hormones|mesh-ancestor
56723801|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723802|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723803|NCT00840957|Infliximab|infliximab|mesh-list
56723804|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
56723805|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56723806|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56723807|NCT00743964|Capecitabine|capecitabine|mesh-list
56723808|NCT00743964|Epirubicin|epirubicin|mesh-list
56723809|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723810|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56723811|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
56723812|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723813|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56723814|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56723815|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56434935|NCT00245024|Sulindac|sulindac|mesh-list
56723816|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723817|NCT00830349|Risperidone|risperidone|mesh-list
56723818|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56723819|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
56723820|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723821|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723840|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56723841|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56723842|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56723843|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56723844|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
56723845|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56723846|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723847|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56723848|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
56723849|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
56723850|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56723851|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56723852|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56723853|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56723854|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
56723855|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56723856|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723857|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
56723858|NCT00830505|Hormones|hormones|mesh-ancestor
56723859|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723860|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
56723861|NCT00566020|Lamotrigine|lamotrigine|mesh-list
56723862|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
56723863|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56723864|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56723865|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723866|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56723867|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723868|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56723874|NCT02563782|Tacrolimus|tacrolimus|mesh-list
56723881|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56723882|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723883|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56723884|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
56723885|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56723886|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723887|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56723888|NCT00841191|Siltuximab|siltuximab|mesh-list
56723889|NCT00841191|Antibodies|antibodies|mesh-list
56435003|NCT00245336|Thrombin|thrombin|mesh-list
56723890|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
56723891|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56723892|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
56723893|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723894|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723895|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
56723896|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
56723897|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
56723898|NCT00843453|Vitamins|vitamins|mesh-ancestor
56723899|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
56723900|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723901|NCT00843453|Hematinics|hematinics|mesh-ancestor
56723902|NCT00921726|Oseltamivir|oseltamivir|mesh-list
56723903|NCT00921726|Zanamivir|zanamivir|mesh-list
56723935|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723936|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56723937|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
56723938|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56723939|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723940|NCT00744354|Doxorubicin|doxorubicin|mesh-list
56723941|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56723942|NCT00744354|Bortezomib|bortezomib|mesh-list
56723943|NCT00744354|Vorinostat|vorinostat|mesh-list
56723944|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56723945|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56723946|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56723947|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56723948|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723949|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723950|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56723951|NCT04043325|Antibodies|antibodies|mesh-list
56723952|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
56723953|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723954|NCT00936520|Lifitegrast|lifitegrast|mesh-list
56723955|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56723956|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56723957|NCT00835029|Clotrimazole|clotrimazole|mesh-list
56723958|NCT00835029|Miconazole|miconazole|mesh-list
56723959|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56723960|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56723961|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
56723962|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56723963|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56723964|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723966|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56723976|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723977|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56723978|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56723979|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56723980|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56723981|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56723982|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56723983|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
56723984|NCT00690612|Candesartan|candesartan|mesh-list
56723985|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
56723986|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56723987|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56723988|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56723989|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723990|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
56723991|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
56723992|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56723993|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56723994|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723995|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56723996|NCT00742014|Urological Agents|urological agents|mesh-ancestor
56723997|NCT00742092|Miglustat|miglustat|mesh-list
56723998|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56723999|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724000|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56724022|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56724023|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56724024|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724025|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724026|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724027|NCT04249167|Paclitaxel|paclitaxel|mesh-list
56724028|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56724029|NCT04249167|Atezolizumab|atezolizumab|mesh-list
56724030|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56724031|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56724032|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724033|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
56724034|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
56724035|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
56724036|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724037|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
56724038|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724039|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56724040|NCT00621153|Candesartan|candesartan|mesh-list
56724041|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
56724042|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56724043|NCT00621153|Diuretics|diuretics|mesh-ancestor
56724044|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
56724045|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724046|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56724047|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56724048|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724049|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56724050|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56724051|NCT05447910|Letrozole|letrozole|mesh-list
56724052|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724053|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56724054|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56724055|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724059|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724060|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724061|NCT00574119|Spironolactone|spironolactone|mesh-list
56724062|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56724063|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
56724064|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724065|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724066|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56724067|NCT00574119|Diuretics|diuretics|mesh-ancestor
56724068|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
56724069|NCT00705614|Infliximab|infliximab|mesh-list
56724070|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
56724071|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724072|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724073|NCT00844155|Oseltamivir|oseltamivir|mesh-list
56724074|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
56724075|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724076|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724077|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724078|NCT05669924|Methylphenidate|methylphenidate|mesh-list
56724079|NCT05669924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56724080|NCT05669924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724081|NCT05669924|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56724082|NCT05669924|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56724083|NCT05669924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56724084|NCT05669924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724085|NCT05669924|Dopamine Agents|dopamine agents|mesh-ancestor
56724086|NCT05669924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724087|NCT00844233|Irinotecan|irinotecan|mesh-list
56724088|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56724089|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56724090|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724091|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724092|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724095|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724096|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56724097|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724098|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56724099|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56724100|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724101|NCT02547597|Atenolol|atenolol|mesh-list
56724102|NCT02547597|Carvedilol|carvedilol|mesh-list
56724103|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56724104|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56724105|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724106|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724107|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724108|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724109|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56724110|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
56724111|NCT02547597|Protective Agents|protective agents|mesh-ancestor
56724112|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56724113|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56724114|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56724115|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
56724116|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56724117|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56724118|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56724119|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
56724120|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
56724121|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724122|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56724123|NCT00842127|Methylphenidate|methylphenidate|mesh-list
56724130|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
56724137|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724138|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
56724139|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
56724140|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724141|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724142|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724143|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
56724144|NCT00835965|Hormones|hormones|mesh-ancestor
56724145|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724146|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56724147|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724148|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
56724149|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724150|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724151|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56724152|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724153|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
56724154|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56724155|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56724156|NCT05667740|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56724157|NCT05667740|Immunologic Factors|immunologic factors|mesh-ancestor
56724158|NCT05667740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724159|NCT00842205|Interferons|interferons|mesh-list
56724160|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724161|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
56724162|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724164|NCT00738296|Ezetimibe|ezetimibe|mesh-list
56435302|NCT00284427|Protective Agents|protective agents|mesh-ancestor
56724184|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724186|NCT05667428|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56724187|NCT05667428|Fertility Agents|fertility agents|mesh-ancestor
56724188|NCT05667428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56724189|NCT05667428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724190|NCT05667428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56724191|NCT05667428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724192|NCT05664542|Dexmedetomidine|dexmedetomidine|mesh-list
56724193|NCT05664542|Ropivacaine|ropivacaine|mesh-list
56724194|NCT05664542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56724195|NCT05664542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724196|NCT05664542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724197|NCT05664542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56724198|NCT05664542|Analgesics|analgesics|mesh-ancestor
56724199|NCT05664542|Sensory System Agents|sensory system agents|mesh-ancestor
56724200|NCT05664542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724201|NCT05664542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56724202|NCT05664542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56724203|NCT05664542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56724204|NCT05664542|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724205|NCT05664542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724206|NCT05664542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724207|NCT05664542|Anesthetics, Local|anesthetics, local|mesh-ancestor
56724208|NCT05664542|Anesthetics|anesthetics|mesh-ancestor
56724209|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
56724210|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56724211|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724212|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
56724213|NCT00562978|Etoposide|etoposide|mesh-list
56724214|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56724215|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
56279671|NCT00006027|Paclitaxel|paclitaxel|mesh-list
56724224|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56724225|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56724226|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724227|NCT05661188|Atezolizumab|atezolizumab|mesh-list
56724228|NCT05661188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724229|NCT00842595|Prednisone|prednisone|mesh-list
56724230|NCT00842595|Rituximab|rituximab|mesh-list
56724231|NCT00842595|Vinorelbine|vinorelbine|mesh-list
56724232|NCT00842595|Ifosfamide|ifosfamide|mesh-list
56724233|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
56724234|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56724235|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724236|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
56724237|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724238|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724239|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724240|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
56724241|NCT00842595|Hormones|hormones|mesh-ancestor
56724242|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724245|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
56724282|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724283|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56724284|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724285|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
56724286|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56724287|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56724288|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
56724289|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
56724290|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56724291|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56724292|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724293|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56724294|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56724295|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56724296|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724297|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56724298|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56724299|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
56724300|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56724301|NCT00940420|Ribavirin|ribavirin|mesh-list
56724302|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56724303|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
56724304|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
56724305|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724306|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
56724307|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724308|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
56724309|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724310|NCT00842907|Tretinoin|tretinoin|mesh-list
56724311|NCT00842907|Isotretinoin|isotretinoin|mesh-list
56724312|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724313|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
56724314|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
56724315|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56724316|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56724321|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56724322|NCT00940654|Analgesics|analgesics|mesh-ancestor
56724323|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
56724324|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724325|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724326|NCT00843063|Pantoprazole|pantoprazole|mesh-list
56724327|NCT00843063|Famotidine|famotidine|mesh-list
56724328|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56724329|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724330|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56724331|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724332|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724333|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56724334|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
56724335|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
56724336|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724337|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724339|NCT04013464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56724340|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56724341|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56724342|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724343|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724344|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
56724345|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724346|NCT04013464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56724347|NCT04013464|Antidepressive Agents|antidepressive agents|mesh-ancestor
56724348|NCT04013464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56724349|NCT04012918|Capecitabine|capecitabine|mesh-list
56724350|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56724351|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56724352|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
56724363|NCT00939718|Vitamins|vitamins|mesh-ancestor
56724364|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
56724365|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724366|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
56724367|NCT00939718|Hematinics|hematinics|mesh-ancestor
56724368|NCT00836667|Sertraline|sertraline|mesh-list
56724369|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
56724370|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56724371|NCT00836667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56724372|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56724373|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56724374|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724375|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724376|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
56724377|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724378|NCT00845559|Exenatide|exenatide|mesh-list
56724379|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56724380|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724381|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56724382|NCT00845559|Incretins|incretins|mesh-ancestor
56724383|NCT00845559|Hormones|hormones|mesh-ancestor
56724384|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724385|NCT00836823|Alfuzosin|alfuzosin|mesh-list
56724386|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56724387|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56724388|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56724389|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724390|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724391|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724392|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724393|NCT00836823|Urological Agents|urological agents|mesh-ancestor
56724394|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
56724395|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
56724400|NCT05107778|Entecavir|entecavir|mesh-list
56724404|NCT00372619|Methotrexate|methotrexate|mesh-list
56724405|NCT00372619|Clofarabine|clofarabine|mesh-list
56724406|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56724407|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
56724408|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56724409|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724410|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56724411|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
56724412|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724413|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724414|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
56724415|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724416|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56724417|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56724418|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
56724419|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724420|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56724421|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
56724422|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724424|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56724425|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56724426|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56724427|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
56724428|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724429|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56724430|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56724431|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724432|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56724439|NCT04400474|Atezolizumab|atezolizumab|mesh-list
56724448|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724449|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56724450|NCT02566226|Narcotics|narcotics|mesh-ancestor
56724451|NCT02566226|Analgesics|analgesics|mesh-ancestor
56724452|NCT00837135|Vaccines|vaccines|mesh-list
56724453|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
56724454|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724455|NCT00562588|Dipyridamole|dipyridamole|mesh-list
56724456|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56724457|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56724458|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724459|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724460|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56724461|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
56724462|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
56724463|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56724464|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
56724465|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56724466|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
56724467|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724468|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724469|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
56724470|NCT02546349|Fluticasone|fluticasone|mesh-list
56724471|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
56724493|NCT02546349|Hormones|hormones|mesh-ancestor
56724500|NCT00372385|Ribavirin|ribavirin|mesh-list
56724501|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
56724502|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
56724503|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56724504|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724505|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
56724506|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724507|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
56724508|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724509|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
56724510|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724511|NCT03830281|Insulin|insulin|mesh-list
56724512|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56724513|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
56724514|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56724515|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724516|NCT00563368|Topiramate|topiramate|mesh-list
56724517|NCT00563368|Phentermine|phentermine|mesh-list
56724518|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
56724519|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56724520|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724521|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56724522|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
56724523|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56724524|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
56724525|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
56724526|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724527|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724528|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724530|NCT00390013|Gabapentin|gabapentin|mesh-list
56724548|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56724549|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56724550|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
56724551|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
56724552|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724553|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724554|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724555|NCT00561730|Pantoprazole|pantoprazole|mesh-list
56724615|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56724616|NCT00687804|Growth Substances|growth substances|mesh-ancestor
56724617|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724618|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
56724619|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724620|NCT02563704|Artesunate|artesunate|mesh-list
56724621|NCT02563704|Quinine|quinine|mesh-list
56724622|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
56724623|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56724624|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56724625|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56724626|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724627|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
56724628|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
56724629|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56724630|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
56724631|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56724632|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724633|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56724634|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724635|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56724636|NCT02563704|Analgesics|analgesics|mesh-ancestor
56724637|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
56724638|NCT00848523|Panobinostat|panobinostat|mesh-list
56724639|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724640|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56724666|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56724667|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56724668|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724669|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724670|NCT05602064|Acetaminophen|acetaminophen|mesh-list
56724671|NCT05602064|Ibuprofen|ibuprofen|mesh-list
56724672|NCT05602064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56724673|NCT05602064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56724674|NCT05602064|Analgesics|analgesics|mesh-ancestor
56724675|NCT05602064|Sensory System Agents|sensory system agents|mesh-ancestor
56724676|NCT05602064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724677|NCT05602064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724678|NCT05602064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724679|NCT05602064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724680|NCT05602064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56724681|NCT05602064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724682|NCT05602064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724683|NCT05602064|Antipyretics|antipyretics|mesh-ancestor
56724684|NCT00744666|Prednisolone|prednisolone|mesh-list
56724685|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56724686|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724687|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
56724688|NCT00744666|Hormones|hormones|mesh-ancestor
56724689|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724690|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724691|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56724692|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724693|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56724694|NCT04013620|Abatacept|abatacept|mesh-list
56724695|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56724696|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724697|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724698|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56724706|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
56724707|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724708|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724709|NCT00848679|Lidocaine|lidocaine|mesh-list
56724710|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
56435831|NCT00285675|Vitamins|vitamins|mesh-ancestor
56724711|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
56724712|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724713|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724714|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
56724715|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724716|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56724717|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56724718|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56724719|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56724720|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724721|NCT04012606|Carboplatin|carboplatin|mesh-list
56724722|NCT04012606|Etoposide|etoposide|mesh-list
56724723|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724724|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56724725|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56724726|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56724727|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724728|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724729|NCT05565560|Apremilast|apremilast|mesh-list
56724730|NCT05565560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56724752|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
56724753|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724754|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724755|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724756|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
56724757|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
56724758|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724759|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724760|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
56724761|NCT02545959|Hormones|hormones|mesh-ancestor
56724762|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724763|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56724764|NCT02545959|Protective Agents|protective agents|mesh-ancestor
56724765|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56724766|NCT00744900|Pemetrexed|pemetrexed|mesh-list
56724767|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724768|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724769|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724770|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56724771|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56724772|NCT00727090|Conivaptan|conivaptan|mesh-list
56724773|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56724774|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724775|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
56724776|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724777|NCT00689052|Pramipexole|pramipexole|mesh-list
56724778|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
56724779|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724780|NCT00689052|Protective Agents|protective agents|mesh-ancestor
56724781|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724782|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56724783|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56724792|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724793|NCT02565212|Montelukast|montelukast|mesh-list
56724794|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56724795|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
56724796|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56724797|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
56724798|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724799|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724800|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56724801|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56724802|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724803|NCT00747708|Lenograstim|lenograstim|mesh-list
56724804|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56724805|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
56724806|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724807|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56724808|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
56724809|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724810|NCT02562144|Lidocaine|lidocaine|mesh-list
56724811|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
56724812|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
56724813|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724814|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724815|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
56724816|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724817|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56724818|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56724819|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56724820|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56724822|NCT02562300|Misoprostol|misoprostol|mesh-list
56724832|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56724833|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56724834|NCT00945178|Analgesics|analgesics|mesh-ancestor
56724835|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
56724836|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724837|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724838|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724839|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724840|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
56724841|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56724842|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724843|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724844|NCT00749346|Pemetrexed|pemetrexed|mesh-list
56724845|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724846|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724847|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724848|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56724849|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56724850|NCT02562690|Thrombin|thrombin|mesh-list
56724851|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
56724852|NCT02562690|Coagulants|coagulants|mesh-ancestor
56724853|NCT00576758|Rituximab|rituximab|mesh-list
56724854|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
56724855|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56724856|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724857|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
56724858|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724859|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56724860|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56724861|NCT00923676|Fenofibrate|fenofibrate|mesh-list
56724862|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56724863|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56724864|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
56724865|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724872|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724873|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56724874|NCT00921284|Analgesics|analgesics|mesh-ancestor
56724875|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
56724876|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724877|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56724878|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56724879|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56724880|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724881|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724882|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724883|NCT02565680|Prednisone|prednisone|mesh-list
56724884|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724885|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
56724886|NCT02565680|Hormones|hormones|mesh-ancestor
56724887|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724888|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724889|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56724890|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724891|NCT00749502|Niraparib|niraparib|mesh-list
56724892|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56724893|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724894|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724895|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724896|NCT00560794|Blinatumomab|blinatumomab|mesh-list
56724897|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56724898|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724899|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
56724900|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724915|NCT00950404|Urological Agents|urological agents|mesh-ancestor
56724916|NCT00749814|Melatonin|melatonin|mesh-list
56724917|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
56724918|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724919|NCT00749814|Protective Agents|protective agents|mesh-ancestor
56724920|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724921|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724922|NCT00748176|Anesthetics|anesthetics|mesh-list
56724923|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56724924|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724925|NCT00619359|Dexamethasone|dexamethasone|mesh-list
56724926|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
56724927|NCT00619359|Ondansetron|ondansetron|mesh-list
56724928|NCT00619359|Aprepitant|aprepitant|mesh-list
56724929|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
56724930|NCT00619359|BB 1101|bb 1101|mesh-list
56724931|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56724932|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
56724933|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
56724934|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724935|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724936|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56724937|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
56724938|NCT00619359|Hormones|hormones|mesh-ancestor
56724939|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56724940|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56724941|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56724942|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
56724943|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56724962|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
56724963|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
56724964|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56724965|NCT00848991|Analgesics|analgesics|mesh-ancestor
56724966|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
56724967|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724968|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56724969|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56724970|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56724971|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724972|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724973|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724974|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56724975|NCT00950794|Tulobuterol|tulobuterol|mesh-list
56724976|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56724977|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
56724978|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56724979|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56724980|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56724981|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
56724982|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56724983|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56724984|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56724985|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
56724986|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56724987|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56724988|NCT00852189|Folic Acid|folic acid|mesh-list
56724989|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
56724990|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
56724991|NCT00852189|Hematinics|hematinics|mesh-ancestor
56724992|NCT00852189|Vitamins|vitamins|mesh-ancestor
56724993|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
56724994|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725004|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56725005|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725006|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56725007|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725008|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725009|NCT00372229|Valganciclovir|valganciclovir|mesh-list
56725010|NCT00372229|Ganciclovir|ganciclovir|mesh-list
56725011|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56725012|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
56725013|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725014|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56725015|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725016|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725017|NCT05301010|Docetaxel|docetaxel|mesh-list
56725018|NCT05301010|Trastuzumab|trastuzumab|mesh-list
56725019|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725020|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
56725021|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
56725022|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
56725023|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725024|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56725025|NCT00855699|Acamprosate|acamprosate|mesh-list
56725026|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56725027|NCT00855777|Ibuprofen|ibuprofen|mesh-list
56725028|NCT00855777|Etoricoxib|etoricoxib|mesh-list
56725029|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56725030|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725031|NCT00855777|Analgesics|analgesics|mesh-ancestor
56725032|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
56725033|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725034|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725047|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56725048|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
56725049|NCT04012294|Protective Agents|protective agents|mesh-ancestor
56725050|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725051|NCT00849459|Interleukin-12|interleukin-12|mesh-list
56725052|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56725053|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
56725054|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725055|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56725056|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56725057|NCT00849459|Growth Substances|growth substances|mesh-ancestor
56725058|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
56725059|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725060|NCT00852345|Clofazimine|clofazimine|mesh-list
56725061|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56725062|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
56725063|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725064|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725065|NCT00852423|Artesunate|artesunate|mesh-list
56725066|NCT00852423|Lumefantrine|lumefantrine|mesh-list
56725067|NCT00852423|Artemether|artemether|mesh-list
56725068|NCT00852423|Piperaquine|piperaquine|mesh-list
56725069|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56725070|NCT00852423|Amodiaquine|amodiaquine|mesh-list
56725101|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725102|NCT01049815|Antacids|antacids|mesh-ancestor
56725103|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725104|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56725105|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
56725106|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
56725107|NCT00849615|Leucovorin|leucovorin|mesh-list
56725108|NCT00849615|Folic Acid|folic acid|mesh-list
56725109|NCT00849615|Docetaxel|docetaxel|mesh-list
56725110|NCT00849615|Fluorouracil|fluorouracil|mesh-list
56725111|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
56725112|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
56725113|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725114|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
56725115|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
56725116|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
56725117|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725118|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
56725119|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56725120|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725121|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
56725122|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725123|NCT00849615|Antidotes|antidotes|mesh-ancestor
56725124|NCT00849615|Protective Agents|protective agents|mesh-ancestor
56725125|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
56725126|NCT00849615|Vitamins|vitamins|mesh-ancestor
56725127|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
56725128|NCT00849615|Hematinics|hematinics|mesh-ancestor
56725129|NCT00946036|Sertraline|sertraline|mesh-list
56725130|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
56725131|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725132|NCT00946036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56725133|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56725134|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725146|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725147|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56725148|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
56725149|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725150|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725151|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56725152|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
56725153|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
56725154|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
56725155|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56725156|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56725157|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56725158|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725159|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
56725160|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56725161|NCT05323058|Benzydamine|benzydamine|mesh-list
56725162|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56725163|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
56436291|NCT01641406|Docetaxel|docetaxel|mesh-list
56725164|NCT01046773|Vitamin D|vitamin d|mesh-list
56725165|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56725166|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725167|NCT01046773|Vitamins|vitamins|mesh-ancestor
56725168|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
56725169|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56725170|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
56725171|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56725172|NCT00850005|Antibodies|antibodies|mesh-list
56725173|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
56725174|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56725175|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
56725176|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725177|NCT00852579|Azithromycin|azithromycin|mesh-list
56725178|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725180|NCT00942136|Dolutegravir|dolutegravir|mesh-list
56725187|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56725188|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56725189|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56725190|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56725191|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
56725192|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725193|NCT04228965|Varenicline|varenicline|mesh-list
56725194|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56725195|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56725196|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
56725197|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725198|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725199|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725200|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
56725201|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725202|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
56725203|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725204|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725205|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56725206|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
56725207|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725208|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725209|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56725210|NCT00942214|Natalizumab|natalizumab|mesh-list
56725211|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
56725212|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725213|NCT00850161|Insulin|insulin|mesh-list
56725214|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56725215|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
56725216|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56725217|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725218|NCT00951574|Nadroparin|nadroparin|mesh-list
56725219|NCT00951574|Calcium|calcium|mesh-list
56725222|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
56725229|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725230|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
56725231|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725232|NCT00856089|Retapamulin|retapamulin|mesh-list
56725233|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725234|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725235|NCT00686712|Insulin|insulin|mesh-list
56725236|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56436351|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725237|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
56725238|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
56725239|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
56725240|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
56725241|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56725242|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725243|NCT00748644|Rituximab|rituximab|mesh-list
56725244|NCT00748644|Azathioprine|azathioprine|mesh-list
56725245|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56725246|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725247|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
56725248|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725249|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725250|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
56725251|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725252|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56725253|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725254|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56725255|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56725256|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725257|NCT00686634|Incretins|incretins|mesh-ancestor
56725258|NCT00686634|Hormones|hormones|mesh-ancestor
56725273|NCT00942526|Ionophores|ionophores|mesh-ancestor
56725274|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725275|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725276|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
56725277|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56725278|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
56725279|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725280|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
56725281|NCT03967444|Protective Agents|protective agents|mesh-ancestor
56725282|NCT05300854|Anesthetics|anesthetics|mesh-list
56725283|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56725284|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725285|NCT00946504|Glipizide|glipizide|mesh-list
56725286|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56725287|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725288|NCT00619983|Gabapentin|gabapentin|mesh-list
56725289|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56725290|NCT00619983|Donepezil|donepezil|mesh-list
56725291|NCT00619983|Analgesics|analgesics|mesh-ancestor
56725292|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
56725293|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725294|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725295|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
56725296|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56725297|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56725298|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56725299|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725300|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56725319|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725320|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725321|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
56725322|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725323|NCT04144023|Molgramostim|molgramostim|mesh-list
56725324|NCT04144023|Vaccines|vaccines|mesh-list
56725325|NCT04144023|Sargramostim|sargramostim|mesh-list
56725326|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
56725327|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725328|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725329|NCT00853983|Saracatinib|saracatinib|mesh-list
56725330|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725331|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725332|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725333|NCT00750048|Acetaminophen|acetaminophen|mesh-list
56725334|NCT00750048|Naloxone|naloxone|mesh-list
56725335|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725336|NCT00750048|Analgesics|analgesics|mesh-ancestor
56725337|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
56725338|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725339|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725340|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
56725341|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56725342|NCT00942838|Cisplatin|cisplatin|mesh-list
56725343|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725344|NCT04057014|Amoxicillin|amoxicillin|mesh-list
56725345|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725346|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725347|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56725348|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725349|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56725350|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725351|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725362|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
56725363|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725364|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725365|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56725366|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
56725367|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725368|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725369|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56725370|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725371|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
56725372|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725373|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
56725374|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56725375|NCT00755820|Cycloserine|cycloserine|mesh-list
56725376|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56725377|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725378|NCT00755820|Renal Agents|renal agents|mesh-ancestor
56725379|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56725380|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
56725381|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725382|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
56725383|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725384|NCT00752154|Curcumin|curcumin|mesh-list
56725385|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56725386|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725387|NCT00752154|Analgesics|analgesics|mesh-ancestor
56725388|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
56725389|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725390|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725391|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56725392|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725393|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725394|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725402|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725403|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725404|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725406|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56725407|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56725408|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
56725409|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725410|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
56725411|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725412|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725413|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725414|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725415|NCT00755898|Analgesics|analgesics|mesh-ancestor
56725416|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
56725417|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725418|NCT00750126|Fludarabine|fludarabine|mesh-list
56725419|NCT00750126|Busulfan|busulfan|mesh-list
56725420|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
56725421|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725422|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725423|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725424|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
56725425|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725426|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
56725427|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56725428|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56725429|NCT00755976|Sulindac|sulindac|mesh-list
56725430|NCT00755976|Epirubicin|epirubicin|mesh-list
56725431|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56725432|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725433|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56725434|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56725435|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725436|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725437|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56554623|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56554624|NCT04157803|Protective Agents|protective agents|mesh-ancestor
56554625|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725438|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725439|NCT00755976|Analgesics|analgesics|mesh-ancestor
56725440|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
56725441|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725442|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725443|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56725444|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725445|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56725446|NCT00752310|Darunavir|darunavir|mesh-list
56725447|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56725448|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56725449|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
56725450|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725451|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725452|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56725453|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56725454|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
56725455|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725456|NCT00943462|Temozolomide|temozolomide|mesh-list
56725457|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56725458|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
56725459|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725460|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725461|NCT02560974|Capecitabine|capecitabine|mesh-list
56725462|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
56725463|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56725487|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56725488|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56725489|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725490|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725491|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725492|NCT00952432|Analgesics|analgesics|mesh-ancestor
56725493|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
56725494|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725495|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56725496|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725497|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725498|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56725499|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56725500|NCT00861315|Amikacin|amikacin|mesh-list
56725501|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725502|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725503|NCT00943540|Lamivudine|lamivudine|mesh-list
56725504|NCT00943540|Emtricitabine|emtricitabine|mesh-list
56725505|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
56725506|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56725507|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56725508|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56725509|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725510|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725511|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
56725512|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725513|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56725514|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56725533|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
56725534|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
56725535|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725536|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
56725537|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725538|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725539|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
56725540|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56436660|NCT00280839|Topiramate|topiramate|mesh-list
56725541|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56725542|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725543|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56725544|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
56725545|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725546|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725547|NCT00943930|Analgesics|analgesics|mesh-ancestor
56725548|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
56725549|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56725550|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56725551|NCT00943930|Hormones|hormones|mesh-ancestor
56725552|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56725553|NCT00854763|Olmesartan|olmesartan|mesh-list
56725554|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56725555|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56725556|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56725557|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725558|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
56725559|NCT00854841|Dasatinib|dasatinib|mesh-list
56725560|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725561|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56725562|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725570|NCT02807467|Propofol|propofol|mesh-list
56725573|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725574|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56725575|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
56725576|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
56725577|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725578|NCT02807467|Analgesics|analgesics|mesh-ancestor
56725579|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
56725580|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725581|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56725582|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56725583|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56725584|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
56725585|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725586|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725587|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
56725588|NCT00861783|Irinotecan|irinotecan|mesh-list
56725589|NCT00861783|Camptothecin|camptothecin|mesh-list
56725590|NCT00861783|ON 01910|on 01910|mesh-list
56725591|NCT00861783|Glycine|glycine|mesh-list
56725592|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725593|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56725594|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56725595|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725596|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725597|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56725598|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56725599|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
56725600|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725601|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725602|NCT00947128|Ondansetron|ondansetron|mesh-list
56725603|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
56725604|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
56725605|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725606|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725607|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554626|NCT04157959|Febuxostat|febuxostat|mesh-list
56554627|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
56554628|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554629|NCT00660283|Temozolomide|temozolomide|mesh-list
56554630|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56725608|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
56725609|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
56725610|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56725611|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
56725612|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725613|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725614|NCT00947128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56436724|NCT02279875|Rifampin|rifampin|mesh-list
56725615|NCT00947128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56725616|NCT00947128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56725672|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725673|NCT00952978|Omeprazole|omeprazole|mesh-list
56725674|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56725675|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56725676|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56725677|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725678|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725679|NCT00861939|Bupropion|bupropion|mesh-list
56725680|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56725681|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
56725682|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725683|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56725684|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56725685|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725686|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725687|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
56725688|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725689|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725690|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56725691|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56725692|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725693|NCT00953134|Folic Acid|folic acid|mesh-list
56725694|NCT00953134|Micronutrients|micronutrients|mesh-list
56725695|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
56725696|NCT00953134|Trace Elements|trace elements|mesh-list
56725697|NCT00953134|Hematinics|hematinics|mesh-ancestor
56725698|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
56725699|NCT00953134|Vitamins|vitamins|mesh-ancestor
56725700|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725701|NCT00944398|Vitamins|vitamins|mesh-list
56725702|NCT00944398|Zinc|zinc|mesh-list
56725712|NCT00947596|Atropine|atropine|mesh-list
56725717|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725718|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725719|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56725720|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
56725721|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
56725722|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
56725723|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56725724|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56725725|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
56725726|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725727|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725728|NCT00865059|Gabapentin|gabapentin|mesh-list
56725729|NCT00865059|Analgesics|analgesics|mesh-ancestor
56725730|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
56725731|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725732|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725733|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
56725734|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56725735|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56725736|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56725737|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725738|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56725739|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56725740|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725741|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725742|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
56725743|NCT00865137|Tacrolimus|tacrolimus|mesh-list
56725744|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725745|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
56725746|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725747|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56725748|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725749|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725750|NCT00862095|Topiramate|topiramate|mesh-list
56554631|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
56554634|NCT00663949|Captopril|captopril|mesh-list
56554635|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
56554636|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56554637|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109230|NCT00003877|Carboplatin|carboplatin|mesh-list
56725751|NCT00862095|Propranolol|propranolol|mesh-list
56725752|NCT00862095|Amitriptyline|amitriptyline|mesh-list
56725753|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56725754|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56725755|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
56725756|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725757|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725758|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725759|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56725760|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56725761|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
56725762|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
56725763|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56725764|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56725765|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
56725766|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56725767|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725769|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
56725770|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725771|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56725772|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56725773|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725774|NCT04054128|Heparin|heparin|mesh-list
56725775|NCT04054128|Calcium heparin|calcium heparin|mesh-list
56725776|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
56725777|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56725778|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56725798|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
56725799|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725800|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725801|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56725802|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56725803|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725804|NCT00865449|Spironolactone|spironolactone|mesh-list
56725805|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56725806|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
56725807|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56725808|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725809|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56725810|NCT00865449|Diuretics|diuretics|mesh-ancestor
56725811|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
56725812|NCT00858195|Indomethacin|indomethacin|mesh-list
56725813|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56725814|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56725815|NCT00858195|Analgesics|analgesics|mesh-ancestor
56725816|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
56725817|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725818|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725819|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56725820|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725821|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
56725822|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
56554638|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554639|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56554640|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56554641|NCT00663949|Protective Agents|protective agents|mesh-ancestor
56554642|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554643|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
56554644|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56554645|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
56554646|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56554647|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
56554648|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56554649|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56554650|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56554651|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554652|NCT00888238|Incretins|incretins|mesh-ancestor
56554653|NCT00888238|Hormones|hormones|mesh-ancestor
56554654|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554655|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56554656|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
56554657|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554658|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554659|NCT05660356|Hormones|hormones|mesh-list
56725823|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56725824|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56725825|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725826|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725827|NCT00858273|Insulin|insulin|mesh-list
56725828|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56725829|NCT00858273|Antioxidants|antioxidants|mesh-list
56725830|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56725831|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725832|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725833|NCT00858273|Protective Agents|protective agents|mesh-ancestor
56725834|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
56725835|NCT00618813|Ifosfamide|ifosfamide|mesh-list
56725836|NCT00618813|Doxorubicin|doxorubicin|mesh-list
56725837|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56725838|NCT00618813|Etoposide|etoposide|mesh-list
56725839|NCT00618813|Vincristine|vincristine|mesh-list
56725840|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
56725841|NCT00618813|Topotecan|topotecan|mesh-list
56725843|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
56725844|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725845|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56725846|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56725847|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
56725848|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725849|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725850|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56725860|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
56725873|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56725874|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
56725875|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725876|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725877|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56725878|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56725879|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56725880|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56725881|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725882|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56725883|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
56725884|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
56725885|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
56725886|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
56725887|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
56725888|NCT00858429|Capecitabine|capecitabine|mesh-list
56725889|NCT00858429|Doxifluridine|doxifluridine|mesh-list
56725890|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56725891|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
56725892|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725893|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725894|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725895|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
56725896|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725897|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
56725898|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56725899|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
56725900|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56725901|NCT02566928|Bacitracin|bacitracin|mesh-list
56725902|NCT02566928|Mupirocin|mupirocin|mesh-list
56725903|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56725904|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56725905|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
56725906|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
56725907|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56725908|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56725911|NCT00865605|Clobetasol|clobetasol|mesh-list
56725912|NCT00865605|Halobetasol|halobetasol|mesh-list
56725913|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56725914|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56725915|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
56725916|NCT00865605|Hormones|hormones|mesh-ancestor
56725917|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56725918|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725919|NCT00956644|Amlodipine|amlodipine|mesh-list
56725920|NCT00956644|Irbesartan|irbesartan|mesh-list
56725921|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56725922|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56725923|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56725924|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725925|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56725926|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725927|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
56725928|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56725929|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56725930|NCT00858663|Everolimus|everolimus|mesh-list
56725931|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725932|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56725933|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
56725934|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725935|NCT02544789|Clofarabine|clofarabine|mesh-list
56725936|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56725937|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
56725938|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725939|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725940|NCT02565836|Thrombin|thrombin|mesh-list
56725941|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
56725954|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725955|NCT00865839|Metformin|metformin|mesh-list
56725956|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56725957|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725958|NCT00865917|Metoprolol|metoprolol|mesh-list
56725959|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56725960|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56725961|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56725962|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
56725963|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
56725964|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56725965|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725966|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56725967|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56725968|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
56725969|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56725970|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725971|NCT00696410|Zinc|zinc|mesh-list
56725972|NCT00696410|Trace Elements|trace elements|mesh-ancestor
56725973|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
56725974|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725975|NCT00858897|Insulin|insulin|mesh-list
56725976|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56725977|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56725978|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56725979|NCT00683904|Carboplatin|carboplatin|mesh-list
56725980|NCT00683904|Epothilones|epothilones|mesh-list
56725981|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56725982|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
56725983|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
56725984|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
56725985|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56725986|NCT00862329|Caseins|caseins|mesh-list
56725987|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
56725995|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56725996|NCT00752466|Topiramate|topiramate|mesh-list
56725997|NCT00752466|Flunarizine|flunarizine|mesh-list
56725998|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
56725999|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56726000|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726001|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56726002|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56726003|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726004|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56726005|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56726006|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
56726007|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
56726008|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726009|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
56726010|NCT00957190|Timolol|timolol|mesh-list
56726054|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56726055|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726056|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56726057|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56726058|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
56726059|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56726060|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56726061|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56726062|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56726063|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
56726064|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56726065|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56726066|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
56726067|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56726068|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
56726069|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56726070|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56726071|NCT00752544|Simeprevir|simeprevir|mesh-list
56726072|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
56726073|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726074|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
56726075|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726076|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726077|NCT00751062|Timolol|timolol|mesh-list
56726078|NCT00751062|Latanoprost|latanoprost|mesh-list
56726079|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56726080|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56726081|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
56726082|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726085|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56726097|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726098|NCT00954304|Loperamide|loperamide|mesh-list
56726099|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
56726100|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56726101|NCT00363415|Carboplatin|carboplatin|mesh-list
56726102|NCT00363415|Etoposide|etoposide|mesh-list
56726103|NCT00363415|Pemetrexed|pemetrexed|mesh-list
56726104|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726105|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56726106|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56726107|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56726108|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726109|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726110|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56726111|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56726112|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
56726113|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56726114|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56726115|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726116|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56726117|NCT00752934|Baclofen|baclofen|mesh-list
56726118|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56726119|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726120|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56726121|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726122|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56726123|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
56726124|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
56726125|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726126|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726127|NCT00696020|Bromides|bromides|mesh-list
56726128|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
56726129|NCT00696020|Olodaterol|olodaterol|mesh-list
56726130|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56726131|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
56726138|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
56726139|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726140|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726141|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
56437256|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56726142|NCT00576576|Atorvastatin|atorvastatin|mesh-list
56726143|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56726144|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56726145|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
56726146|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726147|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56726148|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56726149|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726150|NCT00751764|Moxidectin|moxidectin|mesh-list
56726151|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
56726152|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56726153|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726154|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
56726155|NCT00757458|Propofol|propofol|mesh-list
56726156|NCT00757458|Edetic Acid|edetic acid|mesh-list
56726157|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
56726192|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
56726193|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
56726194|NCT00757692|Bicalutamide|bicalutamide|mesh-list
56726195|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
56726196|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
56726197|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56726198|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726199|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726200|NCT00753168|Timolol|timolol|mesh-list
56726201|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56726202|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56726203|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726204|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56726205|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56726206|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
56726207|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726208|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726209|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56726210|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56726211|NCT02565602|Vitamin D|vitamin d|mesh-list
56726212|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
56726213|NCT02565602|Vitamins|vitamins|mesh-ancestor
56726214|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
56726215|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726216|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56726217|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56726218|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
56726219|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
56726220|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56726221|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56726222|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726235|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726236|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726237|NCT00695864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56726238|NCT00695864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56726239|NCT00695864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726240|NCT00695864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56726241|NCT00695864|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56726242|NCT00684996|Bevacizumab|bevacizumab|mesh-list
56726243|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56726244|NCT00684996|Antibodies|antibodies|mesh-list
56726245|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
56726246|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56726247|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726248|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56726249|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56726250|NCT00684996|Growth Substances|growth substances|mesh-ancestor
56726251|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726252|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
56726253|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
56726254|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
56726255|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56726256|NCT05325008|Antibodies|antibodies|mesh-list
56726257|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
56726258|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56726259|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
56726260|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726261|NCT00684762|Cilostazol|cilostazol|mesh-list
56726262|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56726263|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
56726264|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726265|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726266|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56726267|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
56726268|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56726269|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56726274|NCT00684762|Protective Agents|protective agents|mesh-ancestor
56726275|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56726276|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56726277|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726278|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
56726279|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56726280|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726281|NCT00695786|Rituximab|rituximab|mesh-list
56726282|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56726283|NCT00695786|Lenalidomide|lenalidomide|mesh-list
56726284|NCT00695786|Antibodies|antibodies|mesh-list
56726285|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
56726286|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56726287|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
56726288|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726289|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726290|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56726291|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56726292|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56726293|NCT00695786|Growth Substances|growth substances|mesh-ancestor
56726294|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
56437407|NCT01686217|Niacinamide|niacinamide|mesh-list
56726295|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56726296|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
56726297|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726298|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56726299|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56726300|NCT00387127|Lapatinib|lapatinib|mesh-list
56726301|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726302|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56726303|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726318|NCT00695396|Hematinics|hematinics|mesh-ancestor
56726319|NCT00753402|Epinephrine|epinephrine|mesh-list
56726320|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56726321|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56726322|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56726323|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726324|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726325|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726326|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56726327|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56726328|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
56726329|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726330|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56726331|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
56726332|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
56726333|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
56726334|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56726335|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
56726336|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726337|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
56726338|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
56726339|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
56726340|NCT00758004|Atorvastatin|atorvastatin|mesh-list
56726341|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56726342|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56726343|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
56726344|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726345|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56726346|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56726347|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554660|NCT05660356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554661|NCT05660356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554662|NCT02825914|Caseins|caseins|mesh-list
56554663|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
56554664|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
56554665|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554666|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
56554667|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56554668|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56554669|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554670|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
56554671|NCT00671281|Coagulants|coagulants|mesh-ancestor
56554672|NCT04155229|Acetaminophen|acetaminophen|mesh-list
56554673|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56726348|NCT05388006|Durvalumab|durvalumab|mesh-list
56726349|NCT05388006|Venetoclax|venetoclax|mesh-list
56726350|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
56726351|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
56726352|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56726353|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
56726354|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56726355|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726356|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
56726357|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726358|NCT02656706|Nivolumab|nivolumab|mesh-list
56726359|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56726360|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726361|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56726362|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726363|NCT04049916|Artesunate|artesunate|mesh-list
56726364|NCT04049916|Primaquine|primaquine|mesh-list
56726365|NCT04049916|Piperaquine|piperaquine|mesh-list
56726366|NCT04049916|Artenimol|artenimol|mesh-list
56726367|NCT04049916|Pyronaridine|pyronaridine|mesh-list
56726368|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
56726369|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56726370|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56726371|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726372|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726373|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
56726374|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
56726375|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56726376|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
56726377|NCT00753558|Gentamicins|gentamicins|mesh-list
56726378|NCT00753558|Polymyxins|polymyxins|mesh-list
56726379|NCT00753558|Colistin|colistin|mesh-list
56726380|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56726381|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726382|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56726383|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726384|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726385|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
56726389|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
56726390|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56726391|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
56726392|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56726393|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
56726394|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
56726395|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726396|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726397|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56726398|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
56726399|NCT00753792|Hormones|hormones|mesh-ancestor
56726400|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56726401|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56726402|NCT00753792|Protective Agents|protective agents|mesh-ancestor
56726403|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56726404|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726405|NCT00575094|Tigecycline|tigecycline|mesh-list
56726406|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56726407|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726408|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56726409|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726410|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726411|NCT00553696|Sunitinib|sunitinib|mesh-list
56726412|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726413|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56726414|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56726415|NCT00553696|Growth Substances|growth substances|mesh-ancestor
56726416|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726417|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
56726432|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56726433|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
56726434|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56726435|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56726436|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56726437|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726438|NCT00617409|Paclitaxel|paclitaxel|mesh-list
56726439|NCT00617409|Tretinoin|tretinoin|mesh-list
56726440|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56726441|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726442|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
56726443|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
56726444|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
56726445|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726450|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
56726489|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56726490|NCT00866853|Simeprevir|simeprevir|mesh-list
56726491|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
56726492|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726493|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
56726494|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726495|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726496|NCT04685876|Bupivacaine|bupivacaine|mesh-list
56726497|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
56726498|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
56726499|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726500|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726501|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
56726502|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726503|NCT00682890|Metformin|metformin|mesh-list
56726504|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56726505|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726506|NCT02565368|Metformin|metformin|mesh-list
56726507|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56726508|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726509|NCT03992365|Bisacodyl|bisacodyl|mesh-list
56726510|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
56726511|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56726512|NCT03992365|Cathartics|cathartics|mesh-ancestor
56726513|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56726514|NCT03992365|Laxatives|laxatives|mesh-ancestor
56726515|NCT00921804|Risperidone|risperidone|mesh-list
56726516|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56726517|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
56726518|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726519|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726520|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437636|NCT00288249|Sagopilone|sagopilone|mesh-list
56726521|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56726522|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56726523|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726524|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56726525|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56726527|NCT04011280|Varenicline|varenicline|mesh-list
56726528|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56726529|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56726530|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
56726531|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726532|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726533|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726534|NCT00859911|Micronutrients|micronutrients|mesh-list
56726535|NCT00859911|Trace Elements|trace elements|mesh-list
56726536|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726537|NCT00698516|Bevacizumab|bevacizumab|mesh-list
56726538|NCT00698516|Topotecan|topotecan|mesh-list
56726539|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56726540|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726541|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56726542|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56726543|NCT00698516|Growth Substances|growth substances|mesh-ancestor
56726544|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726545|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
56726546|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56726547|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56726548|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726549|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726550|NCT00679302|Trimethoprim|trimethoprim|mesh-list
56726551|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56726552|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
56726553|NCT00679302|Simethicone|simethicone|mesh-list
56726554|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56726555|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726556|NCT00679302|Renal Agents|renal agents|mesh-ancestor
56726557|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
56726558|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56726559|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56726560|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56726561|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726566|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
56726567|NCT00679302|Emollients|emollients|mesh-ancestor
56726568|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
56726569|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56726570|NCT04011124|Rifampin|rifampin|mesh-list
56726571|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56726572|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
56726573|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56726574|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726575|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
56726576|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56726577|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726578|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726579|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56726580|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56726581|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56726582|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55992954|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56554674|NCT04155229|Oxycodone|oxycodone|mesh-list
56554675|NCT04155229|Hydrocodone|hydrocodone|mesh-list
56554676|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56554677|NCT04155229|Analgesics|analgesics|mesh-ancestor
56554678|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
56554679|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554680|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554681|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
56554682|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56554683|NCT04155229|Narcotics|narcotics|mesh-ancestor
56554684|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554685|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
56554686|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
56554687|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56554688|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554689|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554690|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
56554691|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56554692|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554693|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
56554695|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56554696|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56554697|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554698|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554699|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554700|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56554701|NCT05660278|Caseins|caseins|mesh-list
56554702|NCT05660278|Chelating Agents|chelating agents|mesh-ancestor
56554703|NCT05660278|Sequestering Agents|sequestering agents|mesh-ancestor
56128398|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
56554705|NCT04153123|Epinephrine|epinephrine|mesh-list
56554706|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56554707|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56554708|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
56554709|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554710|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554711|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554712|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56554713|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56554714|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
56726583|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56726584|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56726585|NCT00862875|Insulin|insulin|mesh-list
56726586|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56726587|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
56726588|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
56726589|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56726590|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726591|NCT02544165|Caffeine|caffeine|mesh-list
56726592|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56726593|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726594|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56726595|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726596|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726597|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56726598|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56726599|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
56726600|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726602|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56726603|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56726604|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
56726605|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
56726606|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726607|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726608|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56726609|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
56726610|NCT05343156|Hormones|hormones|mesh-ancestor
56726611|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56726612|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56726613|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726615|NCT00955162|Buprenorphine|buprenorphine|mesh-list
56726627|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56726628|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56726629|NCT00949546|Analgesics|analgesics|mesh-ancestor
56726630|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
56726631|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726632|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726633|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56726634|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56726635|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56726636|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56726637|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
56726638|NCT05291364|Ethanol|ethanol|mesh-list
56726639|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
56726640|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56726641|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726642|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726643|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56726644|NCT05291364|Analgesics|analgesics|mesh-ancestor
56726645|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
56726646|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726647|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56726648|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56726655|NCT00949624|Docetaxel|docetaxel|mesh-list
56726678|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726679|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56726680|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
56726681|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726682|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56726683|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56726684|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726685|NCT04005339|Antidotes|antidotes|mesh-ancestor
56726686|NCT04005339|Protective Agents|protective agents|mesh-ancestor
56726687|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
56726688|NCT04005339|Vitamins|vitamins|mesh-ancestor
56726689|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
56726690|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
56726691|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56726692|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726693|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726694|NCT02544243|Gemcitabine|gemcitabine|mesh-list
56726695|NCT02544243|Vinorelbine|vinorelbine|mesh-list
56726696|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726697|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56726698|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
56726699|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726700|NCT02544243|Antiviral Agents|antiviral agents|mesh-ancestor
56726701|NCT02544243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726702|NCT02544243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726703|NCT02544243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56726704|NCT02544243|Immunologic Factors|immunologic factors|mesh-ancestor
56726705|NCT02544243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726706|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56726707|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
56726708|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
56726709|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
56726710|NCT04011670|Caffeine|caffeine|mesh-list
56726711|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56726712|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726714|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726717|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56726718|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
56726719|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726720|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
56726721|NCT01581073|Hematinics|hematinics|mesh-ancestor
56726722|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
56726723|NCT00742820|Calcium|calcium|mesh-list
56726724|NCT00742820|Calcium acetate|calcium acetate|mesh-list
56726725|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56726726|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726727|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56726728|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
56726729|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
56726730|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726731|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56726732|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
56726733|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
56726734|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56726735|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726736|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
56726737|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726738|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56726739|NCT00742976|Insulin|insulin|mesh-list
56726740|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56726741|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
56726742|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
56726743|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
56726744|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
56726746|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726747|NCT00571662|Cyclosporine|cyclosporine|mesh-list
56726748|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
56726749|NCT00571662|Pentostatin|pentostatin|mesh-list
56726750|NCT00571662|Cyclosporins|cyclosporins|mesh-list
56726751|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993105|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56554715|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554716|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56554717|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
56554718|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
56554719|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
56554720|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56554721|NCT00671593|Phenol|phenol|mesh-list
56726752|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726753|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56726754|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
56726755|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726756|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
56726757|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56726758|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56726759|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56726760|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56726761|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56726762|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726763|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56726764|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
56726765|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56726766|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56726767|NCT00955240|Fluorouracil|fluorouracil|mesh-list
56726768|NCT00955240|Cetuximab|cetuximab|mesh-list
56726769|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726770|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
56726771|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726772|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56726773|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56726774|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
56726775|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726776|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56726777|NCT03387085|Leucovorin|leucovorin|mesh-list
56726778|NCT03387085|Paclitaxel|paclitaxel|mesh-list
56726779|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
56726780|NCT03387085|Bevacizumab|bevacizumab|mesh-list
56726781|NCT03387085|Fluorouracil|fluorouracil|mesh-list
56726782|NCT03387085|Capecitabine|capecitabine|mesh-list
56726796|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56726797|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56726798|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56726799|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56726800|NCT03387085|Growth Substances|growth substances|mesh-ancestor
56726801|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
56726802|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
56726803|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56726804|NCT03387085|Antidotes|antidotes|mesh-ancestor
56726805|NCT03387085|Protective Agents|protective agents|mesh-ancestor
56726806|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
56726807|NCT03387085|Vitamins|vitamins|mesh-ancestor
56726808|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
56726809|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
56726810|NCT00867867|Trace Elements|trace elements|mesh-ancestor
56726811|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
56726812|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726855|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56726856|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56726857|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
56726858|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56726859|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56726860|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
56726861|NCT00863187|Rituximab|rituximab|mesh-list
56726862|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56726863|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56726864|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
56726865|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726866|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56726867|NCT00754884|Calcitonin|calcitonin|mesh-list
56726868|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
56726869|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56726870|NCT00754884|Glycerol|glycerol|mesh-list
56726871|NCT00754884|Katacalcin|katacalcin|mesh-list
56726872|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56726873|NCT00754884|Protective Agents|protective agents|mesh-ancestor
56726874|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726875|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56726876|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56726878|NCT00371761|Interferons|interferons|mesh-list
56726907|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56726908|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726909|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56726910|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
56726911|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56726912|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56726913|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56726914|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
56726915|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726916|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726917|NCT05300386|Citalopram|citalopram|mesh-list
56726918|NCT05300386|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56726919|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56726920|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56726921|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726922|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726923|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
56726924|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726925|NCT05300386|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56726926|NCT05300386|Antidepressive Agents|antidepressive agents|mesh-ancestor
56726927|NCT05300386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56726928|NCT00863499|Methylphenidate|methylphenidate|mesh-list
56726929|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56726930|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726931|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56726932|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56726933|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56726934|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726935|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
56726936|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56726937|NCT00755118|Leucovorin|leucovorin|mesh-list
56726946|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56726947|NCT00755118|Growth Substances|growth substances|mesh-ancestor
56726948|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56726949|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
56726950|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
56726951|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726952|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56726953|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56726954|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
56726955|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56726956|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56726957|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56726958|NCT00755118|Antidotes|antidotes|mesh-ancestor
56726959|NCT00755118|Protective Agents|protective agents|mesh-ancestor
56726960|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
56726961|NCT00755118|Vitamins|vitamins|mesh-ancestor
56726962|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
56726963|NCT00755352|Pravastatin|pravastatin|mesh-list
56726964|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56726965|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56726966|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56726967|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
56726968|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56726969|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56726970|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56726972|NCT00549640|Methylphenidate|methylphenidate|mesh-list
56726994|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56726995|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56726996|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56726997|NCT00863577|Bemiparin|bemiparin|mesh-list
56726998|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
56726999|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
56727000|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56727001|NCT00868413|Rituximab|rituximab|mesh-list
56727002|NCT00868413|Fludarabine|fludarabine|mesh-list
56727003|NCT00868413|Navitoclax|navitoclax|mesh-list
56727004|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56727005|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
56727006|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727007|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56727008|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56727009|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
56727010|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727011|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727012|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56727013|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56727014|NCT03897348|Lacosamide|lacosamide|mesh-list
56727015|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
56727016|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56727017|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56727018|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727019|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727020|NCT04010578|Vitamin D|vitamin d|mesh-list
56727021|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
56727022|NCT04010578|Vitamins|vitamins|mesh-ancestor
56727023|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
56727024|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727025|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56727026|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56554722|NCT00671593|Glycerol|glycerol|mesh-list
56554723|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56554724|NCT00671593|Protective Agents|protective agents|mesh-ancestor
56554725|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554726|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56554727|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554728|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
56303041|NCT00032305|Visilizumab|visilizumab|mesh-list
56554729|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56727027|NCT00868491|Cisplatin|cisplatin|mesh-list
56727028|NCT00868491|Docetaxel|docetaxel|mesh-list
56727029|NCT00868491|Fluorouracil|fluorouracil|mesh-list
56727030|NCT00868491|Cetuximab|cetuximab|mesh-list
56727031|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727032|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
56727033|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
56727034|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
56727035|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727036|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
56727037|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56727038|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56727039|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
56727040|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727041|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56727042|NCT00955630|Ranibizumab|ranibizumab|mesh-list
56727043|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56727044|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56727045|NCT00955630|Growth Substances|growth substances|mesh-ancestor
56727046|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727047|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
56727048|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727049|NCT00868569|Leucovorin|leucovorin|mesh-list
56727050|NCT00868569|Fluorouracil|fluorouracil|mesh-list
56727051|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
56727052|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
56554730|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56554731|NCT01104870|Treprostinil|treprostinil|mesh-list
56554732|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56554733|NCT02632279|Tryptophan|tryptophan|mesh-list
56554734|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56554735|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
56554736|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554737|NCT00664417|Vaccines|vaccines|mesh-list
56554738|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
56554739|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554740|NCT04031755|Minocycline|minocycline|mesh-list
56554741|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56554742|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554743|NCT01104792|Cariprazine|cariprazine|mesh-list
56554744|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56554745|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56554746|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554747|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554748|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554749|NCT01205126|Oxycodone|oxycodone|mesh-list
56554750|NCT01205126|Hydromorphone|hydromorphone|mesh-list
56554751|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56554752|NCT01205126|Narcotics|narcotics|mesh-ancestor
56554753|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554754|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554755|NCT01205126|Analgesics|analgesics|mesh-ancestor
56554756|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
56727053|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727054|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56727055|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727056|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56727057|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
56727058|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727059|NCT00868569|Antidotes|antidotes|mesh-ancestor
56727060|NCT00868569|Protective Agents|protective agents|mesh-ancestor
56727061|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
56727062|NCT00868569|Vitamins|vitamins|mesh-ancestor
56727063|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
56727071|NCT00863733|Acetic Acid|acetic acid|mesh-list
56727072|NCT00863733|Vadimezan|vadimezan|mesh-list
56727073|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56727074|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727075|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727076|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56727077|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56727078|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56727079|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727080|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727081|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727082|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56727083|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56727084|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
56727085|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727086|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727100|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56727101|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
56727102|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727103|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727104|NCT03936777|Fenfluramine|fenfluramine|mesh-list
56727105|NCT03936777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56727106|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56727107|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727108|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727109|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727110|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
56727111|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727112|NCT04237012|Dexamethasone|dexamethasone|mesh-list
56727113|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
56727114|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727115|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
56727116|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
56727117|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727118|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727119|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56727121|NCT04237012|Hormones|hormones|mesh-ancestor
56727122|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56727123|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56727124|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727125|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56727126|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56727127|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56727128|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
56727129|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56727130|NCT00863889|Prednisolone|prednisolone|mesh-list
56727131|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
56727132|NCT00863889|Lidocaine|lidocaine|mesh-list
56727133|NCT00863889|Bupivacaine|bupivacaine|mesh-list
56727134|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56727135|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
56727136|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
56727139|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727140|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
56727141|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727142|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56727143|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56727144|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56727145|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727146|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727147|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727148|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
56727149|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
56727150|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56727151|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
56727152|NCT00863889|Hormones|hormones|mesh-ancestor
56727153|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56727154|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56727155|NCT00863889|Protective Agents|protective agents|mesh-ancestor
56727156|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56727157|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727158|NCT00677352|Sertraline|sertraline|mesh-list
56727159|NCT00677352|Paroxetine|paroxetine|mesh-list
56727160|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
56727161|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727162|NCT00677352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56727163|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56727164|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727165|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727167|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
56727183|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727184|NCT00864045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56727185|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56727186|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727187|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727188|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727189|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
56727190|NCT00755508|Gabapentin|gabapentin|mesh-list
56727191|NCT00755508|Analgesics|analgesics|mesh-ancestor
56727192|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
56727193|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727194|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727195|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
56727196|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56727197|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56727198|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727199|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727200|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56727201|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56727202|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727203|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727204|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
56727205|NCT03680352|Cefepime|cefepime|mesh-list
56727206|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
56727207|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56727208|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727209|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56727210|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727227|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727228|NCT00864357|Ibuprofen|ibuprofen|mesh-list
56727229|NCT00864357|Oxycodone|oxycodone|mesh-list
56727230|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56727231|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56727232|NCT00864357|Analgesics|analgesics|mesh-ancestor
56727233|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
56727234|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727235|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727236|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727237|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56727238|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56727239|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727240|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727241|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56727242|NCT00864357|Narcotics|narcotics|mesh-ancestor
56727243|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727244|NCT00864435|Carvedilol|carvedilol|mesh-list
56727245|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56727246|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56727247|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
56727248|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727249|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727277|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727278|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727279|NCT00864591|Adenosine|adenosine|mesh-list
56727280|NCT00864591|Analgesics|analgesics|mesh-ancestor
56727281|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
56727282|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727283|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727284|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56727285|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
56727286|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56727287|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
56727288|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
56727289|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727290|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727291|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
56727292|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56727293|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56727294|NCT05350384|Prednisolone|prednisolone|mesh-list
56727295|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
56727296|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56727297|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
56727298|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727299|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
56727300|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
56727301|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727302|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727303|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56727304|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
56727305|NCT05350384|Hormones|hormones|mesh-ancestor
56727306|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56727307|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56727311|NCT00870441|Valacyclovir|valacyclovir|mesh-list
56727319|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727320|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727321|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56727322|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56727323|NCT00864669|Metformin|metformin|mesh-list
56727324|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56727325|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727326|NCT00864747|Propranolol|propranolol|mesh-list
56727327|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56727328|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56727329|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
56727330|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727331|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727332|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727333|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56727334|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56727335|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
56727336|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56727337|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56727338|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
56727339|NCT02559102|Anesthetics|anesthetics|mesh-list
56727340|NCT02559102|Sevoflurane|sevoflurane|mesh-list
56727341|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727342|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727343|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56727344|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56727345|NCT02559102|Analgesics|analgesics|mesh-ancestor
56727346|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
56727347|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727348|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56727349|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56727350|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56727351|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
56727352|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727358|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727359|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727360|NCT00864825|Allopurinol|allopurinol|mesh-list
56727361|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
56727362|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727363|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727364|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
56727365|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56727366|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56727367|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
56727368|NCT00864825|Protective Agents|protective agents|mesh-ancestor
56727369|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727370|NCT00956176|Cidofovir|cidofovir|mesh-list
56727371|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
56727372|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727373|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727374|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727375|NCT00864981|Bupropion|bupropion|mesh-list
56727376|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56727377|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
56727378|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727379|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56727380|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56727381|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727382|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727383|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
56727384|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727404|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727405|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56727406|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
56727407|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
56727408|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56727409|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56727410|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56727411|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56727412|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
56727413|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727414|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727415|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
56727417|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
56727418|NCT04039815|Vitamins|vitamins|mesh-ancestor
56727419|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
56727420|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727421|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727422|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
56727423|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
56727424|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727425|NCT04039815|Protective Agents|protective agents|mesh-ancestor
56727426|NCT03559192|Aticaprant|aticaprant|mesh-list
56727427|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56727428|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727429|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
56727430|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727431|NCT00870987|Vaccines|vaccines|mesh-list
56727453|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
56727454|NCT00616239|Salicylates|salicylates|mesh-list
56727455|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727456|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
56727457|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
56727458|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
56727459|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56727460|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56727461|NCT00616239|Analgesics|analgesics|mesh-ancestor
56727462|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
56727463|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727464|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727465|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727466|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56727467|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56727468|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727469|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727470|NCT00547534|Rituximab|rituximab|mesh-list
56727471|NCT00547534|Bortezomib|bortezomib|mesh-list
56727472|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56727473|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56727474|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727475|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
56727476|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727477|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56727478|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56727479|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
56727480|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727481|NCT00871455|Baclofen|baclofen|mesh-list
56727482|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56727497|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
56727498|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727499|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727500|NCT00877149|Telbivudine|telbivudine|mesh-list
56727501|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
56727502|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727503|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56727504|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727505|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727506|NCT02968108|Ustekinumab|ustekinumab|mesh-list
56727507|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
56727508|NCT00877227|Leucovorin|leucovorin|mesh-list
56727509|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56727510|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
56727511|NCT00877227|Antidotes|antidotes|mesh-ancestor
56727512|NCT00877227|Protective Agents|protective agents|mesh-ancestor
56727513|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727514|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
56727515|NCT00877227|Vitamins|vitamins|mesh-ancestor
56727516|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
56727517|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
56727518|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56727519|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727520|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56727521|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56727522|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
56727523|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727524|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55993882|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
56554757|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554758|NCT02629627|Metformin|metformin|mesh-list
56554759|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56334878|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
56554760|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554761|NCT05046522|Palmidrol|palmidrol|mesh-list
56554762|NCT05046522|Analgesics|analgesics|mesh-ancestor
56554763|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
56554764|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554765|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554766|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56554767|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56554768|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554769|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56727525|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
56727526|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727527|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
56727528|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
56727529|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727530|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727531|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727532|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
56727533|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
56727534|NCT00877539|Fluticasone|fluticasone|mesh-list
56727535|NCT00877539|Xhance|xhance|mesh-list
56727536|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727537|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56727538|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
56727539|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727540|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727541|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56727542|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
56727543|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
56727544|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56727545|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56727546|NCT00872235|Quinapril|quinapril|mesh-list
56727547|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56727548|NCT00872235|Diuretics|diuretics|mesh-ancestor
56727549|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
56727550|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727552|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727574|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727575|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56727576|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
56727577|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
56727578|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
56727579|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
56727580|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56727581|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56727582|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56727583|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56727584|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727585|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56727587|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56727588|NCT00872781|Diuretics|diuretics|mesh-ancestor
56727589|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
56727590|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727591|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56727592|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727593|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727594|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56727595|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
56727596|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727597|NCT00384085|Insulin|insulin|mesh-list
56727598|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56727599|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
56727600|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
56727601|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56727602|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727603|NCT00361231|Gemcitabine|gemcitabine|mesh-list
56727604|NCT00361231|Bevacizumab|bevacizumab|mesh-list
56727605|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
56727619|NCT00361231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56727620|NCT00361231|Immunologic Factors|immunologic factors|mesh-ancestor
56727621|NCT00676650|Prednisone|prednisone|mesh-list
56727622|NCT00676650|Sunitinib|sunitinib|mesh-list
56727623|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727624|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
56727625|NCT00676650|Hormones|hormones|mesh-ancestor
56727626|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56727627|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727628|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56727629|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727630|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56727631|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56727632|NCT00676650|Growth Substances|growth substances|mesh-ancestor
56727633|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
56727634|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56727635|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727636|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727637|NCT01045369|Etravirine|etravirine|mesh-list
56727638|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56727639|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56727640|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727641|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727642|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
56727643|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727644|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
56727645|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56727646|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
56727647|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727648|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727649|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56727651|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
56727660|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727661|NCT00878631|Dextrans|dextrans|mesh-list
56727662|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
56727663|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
56727664|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
56727665|NCT00382993|Naproxen|naproxen|mesh-list
56727666|NCT00382993|Sumatriptan|sumatriptan|mesh-list
56727667|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56727668|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56727669|NCT00382993|Analgesics|analgesics|mesh-ancestor
56727670|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
56727671|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727672|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727673|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56727674|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56727675|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
56727676|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56727677|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727678|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727679|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56727680|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56727681|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56727682|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
56727683|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727684|NCT00760968|Methotrexate|methotrexate|mesh-list
56727685|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56727686|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
56727687|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56727688|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727689|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56727704|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56727705|NCT00878865|Alprazolam|alprazolam|mesh-list
56727706|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56727707|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727708|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727709|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56727710|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56727711|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727712|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
56727713|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
56727714|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727715|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727716|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56727717|NCT00873483|Gestodene|gestodene|mesh-list
56727718|NCT00873483|Femovan|femovan|mesh-list
56727719|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56727720|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56727721|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56727722|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
56727723|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56727724|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727725|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56727726|NCT00873483|Estrogens|estrogens|mesh-ancestor
56727727|NCT00873483|Hormones|hormones|mesh-ancestor
56727728|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56727729|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56727730|NCT00873483|Progestins|progestins|mesh-ancestor
56727731|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56727732|NCT01050517|Ivermectin|ivermectin|mesh-list
56727733|NCT01050517|Albendazole|albendazole|mesh-list
56727734|NCT01050517|Praziquantel|praziquantel|mesh-list
56727735|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56727736|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727737|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
56727738|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
56727739|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56727744|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727745|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727746|NCT02534467|Montelukast|montelukast|mesh-list
56727747|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56727748|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
56727749|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56727750|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
56727751|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56727752|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727753|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56727754|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56727755|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727756|NCT01050595|Naltrexone|naltrexone|mesh-list
56727757|NCT01050595|Bromides|bromides|mesh-list
56727758|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
56727759|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
56727760|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56727761|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727762|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
56727763|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727764|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56727765|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
56727766|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727767|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
56727768|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56727769|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56727770|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727771|NCT00878943|Urological Agents|urological agents|mesh-ancestor
56727772|NCT00873639|Insulin|insulin|mesh-list
56727773|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56727774|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
56727775|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
56727776|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56727777|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727782|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727783|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
56727784|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56727785|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727786|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727787|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56727788|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56727789|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56727790|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727791|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727792|NCT00879099|Timolol|timolol|mesh-list
56727793|NCT00879099|Paroxetine|paroxetine|mesh-list
56727794|NCT00879099|Maleic acid|maleic acid|mesh-list
56727795|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727796|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727797|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56727798|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56727799|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
56727800|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727801|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727802|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56727803|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56727804|NCT00879099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56727805|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56727806|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727807|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
56727808|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56727809|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
56727810|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727811|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56727812|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56727822|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56727823|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56727824|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
56727825|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727826|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727827|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727828|NCT00676338|Metformin|metformin|mesh-list
56727829|NCT00676338|Pioglitazone|pioglitazone|mesh-list
56727830|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56727831|NCT00676338|Exenatide|exenatide|mesh-list
56727832|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56727833|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727834|NCT00676338|Incretins|incretins|mesh-ancestor
56727835|NCT00676338|Hormones|hormones|mesh-ancestor
56727836|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56727837|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56727838|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
56727839|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727840|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727841|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56727842|NCT02534623|Fentanyl|fentanyl|mesh-list
56727843|NCT02534623|Bupivacaine|bupivacaine|mesh-list
56727844|NCT02534623|Anesthetics|anesthetics|mesh-list
56727845|NCT02534623|Propofol|propofol|mesh-list
56727846|NCT02534623|Sevoflurane|sevoflurane|mesh-list
56727847|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
56727848|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727849|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727850|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
56727851|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56727852|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56727853|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56727854|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
56727855|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56727856|NCT02534623|Narcotics|narcotics|mesh-ancestor
56727857|NCT02534623|Analgesics|analgesics|mesh-ancestor
56727858|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56727859|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56554770|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
56727860|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56727861|NCT00873795|Aripiprazole|aripiprazole|mesh-list
56727862|NCT00873795|Sertraline|sertraline|mesh-list
56727863|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
56727864|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56727865|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56727866|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56727867|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56727868|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727869|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
56727870|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
56727871|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727872|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727873|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56727874|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56727875|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
56727876|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56727877|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56727878|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56727879|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56727880|NCT00873795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56727881|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56727882|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56727883|NCT00873951|Caseins|caseins|mesh-list
56727884|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
56727885|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
56727886|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727887|NCT00874107|Paclitaxel|paclitaxel|mesh-list
56727888|NCT00874107|Bevacizumab|bevacizumab|mesh-list
56727889|NCT00874107|Carboplatin|carboplatin|mesh-list
56727904|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727905|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727906|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
56727907|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56727908|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727909|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56727910|NCT00879723|Vitamins|vitamins|mesh-list
56727911|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
56727912|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727913|NCT00874419|Gemcitabine|gemcitabine|mesh-list
56727914|NCT00874419|Carboplatin|carboplatin|mesh-list
56727915|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56727916|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727917|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56727918|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
56727919|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56727920|NCT00874419|Antiviral Agents|antiviral agents|mesh-ancestor
56727921|NCT00874419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727922|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56727923|NCT00874419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56727924|NCT00874419|Immunologic Factors|immunologic factors|mesh-ancestor
56727925|NCT00874419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727926|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56727927|NCT00381043|Acamprosate|acamprosate|mesh-list
56727928|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56727929|NCT01050985|Sirolimus|sirolimus|mesh-list
56727930|NCT01050985|Capecitabine|capecitabine|mesh-list
56727931|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56727951|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56727952|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
56727953|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56727954|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56727955|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56727956|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56727957|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56727958|NCT00874575|Vitamin D|vitamin d|mesh-list
56727959|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
56727960|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
56727961|NCT00874575|Vitamins|vitamins|mesh-list
56727962|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
56727963|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727964|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56727965|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56727966|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
56727967|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56727968|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56727969|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
56727970|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56727971|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
56727972|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56727973|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56727974|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56727975|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56728001|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
56728002|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
56728003|NCT00875355|Temozolomide|temozolomide|mesh-list
56728004|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56728005|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
56728006|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728007|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728008|NCT00678288|Interferons|interferons|mesh-list
56728009|NCT00678288|Sorafenib|sorafenib|mesh-list
56728010|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728011|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
56728012|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728013|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56728014|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728015|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728016|NCT00880815|Rituximab|rituximab|mesh-list
56728017|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56728018|NCT00880815|Methotrexate|methotrexate|mesh-list
56728019|NCT00880815|Fludarabine|fludarabine|mesh-list
56728020|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56728021|NCT00880815|Antibodies|antibodies|mesh-list
56728022|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
56728023|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56728024|NCT00880815|Tacrolimus|tacrolimus|mesh-list
56728025|NCT00880815|Lenograstim|lenograstim|mesh-list
56728026|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
56728027|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56728028|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
56728029|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728030|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728031|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56728032|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56728033|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
56728034|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56728035|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56728036|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
56554771|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554772|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56554773|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56554774|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554775|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728037|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728038|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56728039|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728040|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56728041|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56728042|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56728043|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56728044|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56728045|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56728046|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
56728047|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56728048|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56728049|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56728050|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728051|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728052|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728053|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728054|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
56728055|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728056|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
56728057|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728058|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56728059|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728060|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728061|NCT00881127|Cetirizine|cetirizine|mesh-list
56728062|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
56728063|NCT00881127|Ephedrine|ephedrine|mesh-list
56728064|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56554776|NCT05046522|Hormones|hormones|mesh-ancestor
56728079|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56728080|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
56728081|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
56728082|NCT00369265|Lansoprazole|lansoprazole|mesh-list
56728083|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
56728084|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56728085|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56728086|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56728087|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728088|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728089|NCT00875745|Sorafenib|sorafenib|mesh-list
56728090|NCT00875745|Vorinostat|vorinostat|mesh-list
56728091|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728092|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56728093|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728094|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728096|NCT00368875|Paclitaxel|paclitaxel|mesh-list
56728097|NCT00368875|Bevacizumab|bevacizumab|mesh-list
56728098|NCT00368875|Vorinostat|vorinostat|mesh-list
56728099|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56728100|NCT00368875|Antibodies|antibodies|mesh-list
56728101|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
56728102|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56728103|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56728104|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728105|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
56728106|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
56728130|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56728131|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728132|NCT00613821|Lidocaine|lidocaine|mesh-list
56728133|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
56728134|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
56728135|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728136|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728137|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
56728138|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728139|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56728140|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56728141|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56728142|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728143|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728144|NCT00882765|Genistein|genistein|mesh-list
56728145|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56728146|NCT00882765|Protective Agents|protective agents|mesh-ancestor
56728147|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728148|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728185|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
56728186|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728187|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728188|NCT00883155|Bupropion|bupropion|mesh-list
56728189|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56728190|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
56728191|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728192|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56728193|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56728194|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728195|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728196|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
56728197|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728198|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728199|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56728200|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56728201|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728202|NCT00881673|Dexamethasone|dexamethasone|mesh-list
56728203|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56728204|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56728205|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56728206|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
56728235|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56728236|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56728237|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
56728238|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728239|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728240|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
56728241|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56728242|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56728243|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56728244|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
56728245|NCT00612807|Bupropion|bupropion|mesh-list
56728246|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56728247|NCT00612807|Sertraline|sertraline|mesh-list
56728248|NCT00612807|Nortriptyline|nortriptyline|mesh-list
56728249|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56728293|NCT00963040|Oxytocin|oxytocin|mesh-list
56728294|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
56728295|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56728296|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728297|NCT04038411|Etoposide|etoposide|mesh-list
56728298|NCT04038411|Lenalidomide|lenalidomide|mesh-list
56728299|NCT04038411|Antibodies|antibodies|mesh-list
56728300|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
56728301|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728302|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56728303|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728304|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56728305|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56728306|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728307|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728308|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56728309|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56728310|NCT04038411|Growth Substances|growth substances|mesh-ancestor
56728311|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
56728312|NCT04155424|Eculizumab|eculizumab|mesh-list
56728313|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56728314|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56728348|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728349|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56728350|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56728351|NCT00883623|Growth Substances|growth substances|mesh-ancestor
56728352|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
56728353|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728354|NCT00959218|Dronabinol|dronabinol|mesh-list
56728355|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
56728356|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728357|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728358|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56728359|NCT00959218|Analgesics|analgesics|mesh-ancestor
56728360|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
56728361|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728362|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56728363|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56728364|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728365|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728366|NCT00959218|Hormones|hormones|mesh-ancestor
56728367|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728368|NCT00678210|Tofacitinib|tofacitinib|mesh-list
56728369|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56728370|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728371|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728372|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56728373|NCT00611715|Letrozole|letrozole|mesh-list
56728374|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728375|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56728384|NCT04722718|Paclitaxel|paclitaxel|mesh-list
56728393|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728394|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56728395|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728396|NCT00761670|Risperidone|risperidone|mesh-list
56728397|NCT00761670|Amisulpride|amisulpride|mesh-list
56728398|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56728399|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
56728400|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728401|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728402|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728403|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56728404|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56728405|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728406|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728407|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56728408|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
56728409|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56728410|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
56728411|NCT00963664|Interferons|interferons|mesh-list
56728412|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
56728413|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
56728414|NCT00963664|Lovastatin|lovastatin|mesh-list
56728415|NCT00963664|L 647318|l 647318|mesh-list
56728416|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
56728444|NCT00761904|Diuretics|diuretics|mesh-ancestor
56728445|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
56728446|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728447|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56728448|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728449|NCT00963976|Enalapril|enalapril|mesh-list
56728450|NCT00963976|Hydralazine|hydralazine|mesh-list
56728451|NCT00963976|Labetalol|labetalol|mesh-list
56728452|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56728453|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
56728454|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728455|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728456|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56728457|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
56728458|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56728459|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56728460|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
56728461|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728462|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728463|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
56728464|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
56728465|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56439597|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
56728466|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56728467|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56728469|NCT02558868|Irinotecan|irinotecan|mesh-list
56728480|NCT00883935|Ritonavir|ritonavir|mesh-list
56728492|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56728493|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56728494|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56728495|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56728496|NCT00675948|Nabiximols|nabiximols|mesh-list
56728497|NCT00675948|Analgesics|analgesics|mesh-ancestor
56728498|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
56728499|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728500|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728501|NCT00885885|Panitumumab|panitumumab|mesh-list
56728502|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56728503|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728504|NCT00610935|Peramivir|peramivir|mesh-list
56728505|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
56728506|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728507|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728508|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728509|NCT02303028|Topotecan|topotecan|mesh-list
56728510|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56728511|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56728512|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728513|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728514|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728515|NCT02287818|Febuxostat|febuxostat|mesh-list
56728516|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
56728517|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56728518|NCT00762060|Anesthetics|anesthetics|mesh-list
56728519|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
56728520|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728521|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728522|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
56728523|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728524|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56728525|NCT00610857|Antibodies|antibodies|mesh-list
56728526|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
55994884|NCT03609047|Paclitaxel|paclitaxel|mesh-list
56128410|NCT01678716|Micronutrients|micronutrients|mesh-list
56554778|NCT00946647|Azacitidine|azacitidine|mesh-list
56554779|NCT00946647|Panobinostat|panobinostat|mesh-list
56554780|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56728527|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56728528|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
56728529|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728530|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728531|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
56728532|NCT00672984|Guanfacine|guanfacine|mesh-list
56728533|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56728534|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728535|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56728536|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56728537|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439667|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56728538|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728539|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728540|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728541|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56728542|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56728543|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56728544|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56728545|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
56728546|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728547|NCT02543697|Epinephrine|epinephrine|mesh-list
56728548|NCT02543697|Racepinephrine|racepinephrine|mesh-list
56728549|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
56728550|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56728551|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56728552|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
56728553|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728554|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728555|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728556|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56728558|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
56728569|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728570|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56728571|NCT00886275|Analgesics|analgesics|mesh-ancestor
56728572|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
56728573|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728574|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56728575|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56728576|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56728577|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
56728578|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728579|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728580|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56728581|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56728582|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56728583|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728584|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56728585|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
56728586|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
56728587|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
56728588|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
56728589|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
56728590|NCT04017897|Nivolumab|nivolumab|mesh-list
56728591|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56728592|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728593|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56728594|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728595|NCT02542137|Thymalfasin|thymalfasin|mesh-list
56728596|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56728597|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
56728615|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56728616|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728617|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728618|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
56728619|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728620|NCT00884481|Natalizumab|natalizumab|mesh-list
56728621|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
56728622|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728623|NCT02543229|Ranibizumab|ranibizumab|mesh-list
56728624|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56728625|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56728626|NCT02543229|Growth Substances|growth substances|mesh-ancestor
56728627|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728628|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
56728629|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728630|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
56728631|NCT02543073|Hormones|hormones|mesh-ancestor
56728632|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728633|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728634|NCT00546364|Docetaxel|docetaxel|mesh-list
56728635|NCT00546364|Capecitabine|capecitabine|mesh-list
56728636|NCT00546364|Epothilones|epothilones|mesh-list
56728637|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728638|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
56728639|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
56728640|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
56728641|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728642|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56728643|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
56728644|NCT00887211|Sirolimus|sirolimus|mesh-list
56728645|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56728646|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728657|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728658|NCT00964288|Lidocaine|lidocaine|mesh-list
56728659|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
56728660|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
56728661|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728662|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728663|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
56728664|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728665|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56728666|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56728667|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56728668|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728669|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728670|NCT00964756|Ganciclovir|ganciclovir|mesh-list
56728671|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56728672|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
56728673|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728674|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56728675|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728676|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728677|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56728678|NCT00964834|Doxycycline|doxycycline|mesh-list
56728679|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56728680|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728681|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
56728682|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
56728705|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56728706|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728707|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728708|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56728709|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
56728710|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
56728711|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56728712|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
56728713|NCT04017741|Hormones|hormones|mesh-ancestor
56728714|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728715|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56728716|NCT04017741|Protective Agents|protective agents|mesh-ancestor
56728717|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56728718|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728719|NCT00546052|Losartan|losartan|mesh-list
56728720|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56728721|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56728722|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56728723|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56728724|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56728725|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728726|NCT00546052|Diuretics|diuretics|mesh-ancestor
56728727|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
56728728|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728729|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56728731|NCT00887601|Donepezil|donepezil|mesh-list
56728750|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728751|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728752|NCT00887757|Antiviral Agents|antiviral agents|mesh-ancestor
56728753|NCT00887757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728754|NCT00887757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728755|NCT00887757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56728756|NCT00887757|Immunologic Factors|immunologic factors|mesh-ancestor
56728757|NCT00887757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728758|NCT04392921|Amiodarone|amiodarone|mesh-list
56728759|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56728760|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
56728761|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56728762|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56439909|NCT00424931|Modafinil|modafinil|mesh-list
56728763|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728764|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56728765|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56728766|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56728767|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728768|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56728769|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56728770|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56728771|NCT00673920|Methotrexate|methotrexate|mesh-list
56728772|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
56728773|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56728774|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
56728775|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56728776|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728777|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56728778|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
56728789|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56728790|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
56728791|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728792|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728793|NCT00379795|Ranibizumab|ranibizumab|mesh-list
56728794|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56728795|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56728796|NCT00379795|Growth Substances|growth substances|mesh-ancestor
56728797|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728798|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
56728799|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728800|NCT04588948|Aflibercept|aflibercept|mesh-list
56728801|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56728802|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56728803|NCT04588948|Growth Substances|growth substances|mesh-ancestor
56728804|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728805|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
56728806|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728807|NCT00765024|Ivermectin|ivermectin|mesh-list
56728808|NCT00765024|Albendazole|albendazole|mesh-list
56728809|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56728810|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728811|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
56728812|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
56728813|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56728814|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56728815|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
56728816|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
56728817|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
56728818|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728819|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728820|NCT02557932|Bismuth|bismuth|mesh-list
56728821|NCT02557932|Antacids|antacids|mesh-ancestor
56728822|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728823|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554781|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
56554782|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554783|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554784|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728824|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
56728825|NCT00960232|Vitamin D|vitamin d|mesh-list
56728826|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56728827|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728828|NCT00960232|Vitamins|vitamins|mesh-ancestor
56728829|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
56728830|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56728831|NCT04577014|Gemcitabine|gemcitabine|mesh-list
56728832|NCT04577014|Docetaxel|docetaxel|mesh-list
56728833|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56728834|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
56728835|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728836|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728837|NCT04577014|Antiviral Agents|antiviral agents|mesh-ancestor
56728838|NCT04577014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728839|NCT04577014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728840|NCT04577014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56728841|NCT04577014|Immunologic Factors|immunologic factors|mesh-ancestor
56728842|NCT04577014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728843|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
56728844|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
56728845|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
56728846|NCT05282550|Trazodone|trazodone|mesh-list
56728847|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56728848|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56728849|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728850|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728851|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728852|NCT05282550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56728860|NCT00960310|Bicalutamide|bicalutamide|mesh-list
56728869|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
56728870|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728871|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728872|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
56728873|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56728874|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728875|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728876|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56728877|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56728878|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56728879|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728880|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728881|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56728882|NCT00610155|Narcotics|narcotics|mesh-ancestor
56728883|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
56728884|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56728885|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
56728886|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728887|NCT00960544|Capecitabine|capecitabine|mesh-list
56728888|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56728889|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
56728890|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728891|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728892|NCT04488952|Anesthetics|anesthetics|mesh-list
56728893|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728894|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728895|NCT00888303|Dexamethasone|dexamethasone|mesh-list
56728896|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56728897|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
56728898|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
56728899|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728900|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728901|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56728902|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
56728903|NCT00888303|Hormones|hormones|mesh-ancestor
55995273|NCT03565666|Insulin|insulin|mesh-list
56728906|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728907|NCT00967642|Insulin|insulin|mesh-list
56728908|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56728909|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56440041|NCT00261170|Bupropion|bupropion|mesh-list
56728910|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
56728911|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728912|NCT00762918|Vitamin D|vitamin d|mesh-list
56728913|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
56728914|NCT00762918|Vitamins|vitamins|mesh-ancestor
56728915|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
56728916|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728917|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56728918|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56728919|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56728920|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56728921|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56728922|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56728923|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728924|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
56728925|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56728926|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728927|NCT00759720|Glyburide|glyburide|mesh-list
56728928|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56728929|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728930|NCT00379639|Gemcitabine|gemcitabine|mesh-list
56728931|NCT00379639|Romidepsin|romidepsin|mesh-list
56728932|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56728933|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
56728934|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728935|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728936|NCT00379639|Antiviral Agents|antiviral agents|mesh-ancestor
56728937|NCT00379639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56728938|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728939|NCT00379639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554785|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56554786|NCT05117736|Valsartan|valsartan|mesh-list
56554787|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56554788|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56728940|NCT00379639|Immunologic Factors|immunologic factors|mesh-ancestor
56728941|NCT00379639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728942|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56728943|NCT00609765|Dexamethasone|dexamethasone|mesh-list
56728944|NCT00609765|Bevacizumab|bevacizumab|mesh-list
56728945|NCT00609765|Doxorubicin|doxorubicin|mesh-list
56728946|NCT00609765|Fluorouracil|fluorouracil|mesh-list
56728947|NCT00609765|Streptozocin|streptozocin|mesh-list
56728948|NCT00609765|Ondansetron|ondansetron|mesh-list
56728949|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56728950|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56728951|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56728952|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56728953|NCT00609765|Growth Substances|growth substances|mesh-ancestor
56728954|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728955|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
56728956|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56728957|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
56728958|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
56728959|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56728960|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56728961|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
56728962|NCT00609765|Hormones|hormones|mesh-ancestor
56728963|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56728964|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56728965|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56728966|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56728967|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56728968|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56728969|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728970|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
56728971|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56728972|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56728973|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
56728974|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
56728980|NCT00609765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56728981|NCT00609765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56728982|NCT00609765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728983|NCT00609765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56728984|NCT01051219|Losartan|losartan|mesh-list
56728985|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56728986|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56728987|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56728988|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56728989|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56728991|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56728992|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
56728993|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56728994|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56728995|NCT00766350|Amitriptyline|amitriptyline|mesh-list
56728996|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56728997|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
56728998|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56728999|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56729000|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56729001|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56729002|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729003|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56729004|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56729005|NCT00766350|Analgesics|analgesics|mesh-ancestor
56729006|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
56729007|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729008|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56729009|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56729010|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56729011|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729014|NCT00889161|Curcumin|curcumin|mesh-list
56729021|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729022|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56729023|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729024|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729025|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729026|NCT03992755|Treprostinil|treprostinil|mesh-list
56729027|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56729028|NCT01563328|Dolutegravir|dolutegravir|mesh-list
56729029|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56729030|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56729031|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729032|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729033|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56729034|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56729035|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
56729036|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729037|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
56729038|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56729039|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729040|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56729041|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56729042|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729043|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729044|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729045|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56729046|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56729069|NCT00766662|Renal Agents|renal agents|mesh-ancestor
56729070|NCT00965926|Mirabegron|mirabegron|mesh-list
56729071|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56729072|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56729073|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56729074|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
56729075|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729076|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729077|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729078|NCT00965926|Urological Agents|urological agents|mesh-ancestor
56729079|NCT00966004|Mirabegron|mirabegron|mesh-list
56729080|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56729081|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56729082|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56729083|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56729084|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
56729085|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729086|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729087|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729092|NCT00966082|Propranolol|propranolol|mesh-list
56729124|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56729125|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56729126|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
56729127|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729128|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729129|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56729130|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56729131|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
56729132|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729133|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56440268|NCT00299091|Efavirenz|efavirenz|mesh-list
56729134|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56729135|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56729136|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56729137|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
56729138|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56729139|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56729140|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56729141|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56729142|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56729144|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56729145|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56729173|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729174|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
56729175|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729176|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56729177|NCT00766896|Aspirin|aspirin|mesh-list
56729178|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56729179|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56729180|NCT00766896|Analgesics|analgesics|mesh-ancestor
56729181|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
56729182|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729183|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729184|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729185|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56729186|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56729187|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56729188|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729189|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56729190|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56729191|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729192|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
56729193|NCT00763620|Dimercaprol|dimercaprol|mesh-list
56729194|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
56729195|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
56729196|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729197|NCT00973804|Sirolimus|sirolimus|mesh-list
56729198|NCT00973804|Tacrolimus|tacrolimus|mesh-list
56729199|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729200|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
56729201|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729202|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56729203|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729216|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729217|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729218|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729219|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56729220|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56729221|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729222|NCT00973882|Carboplatin|carboplatin|mesh-list
56729223|NCT00973882|Etoposide|etoposide|mesh-list
56729224|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729225|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56729226|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56729227|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56729228|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729229|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729230|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56729231|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56729232|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
56729233|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729234|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729235|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56729236|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
56729237|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56729238|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56729239|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56729240|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
56729241|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729242|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729243|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
56729244|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56729245|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56729246|NCT05279482|Prednisolone|prednisolone|mesh-list
56729247|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
56729254|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729255|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729256|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
56729257|NCT05279482|Hormones|hormones|mesh-ancestor
56729258|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729259|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56729260|NCT05279482|Protective Agents|protective agents|mesh-ancestor
56729261|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56729262|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729263|NCT00890175|Loxapine|loxapine|mesh-list
56729264|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56729265|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56729266|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56729267|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729268|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56729269|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56729270|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
56729271|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729272|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729273|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56729274|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56729275|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729276|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56729277|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729278|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729279|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56729280|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56729282|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56729283|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56729284|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
56729285|NCT00890253|Prednisone|prednisone|mesh-list
56729286|NCT00890253|Prednisolone|prednisolone|mesh-list
56729287|NCT00890253|Everolimus|everolimus|mesh-list
56729288|NCT00890253|Basiliximab|basiliximab|mesh-list
56729289|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729290|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
56729291|NCT00890253|Hormones|hormones|mesh-ancestor
56729292|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729293|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729294|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56729295|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729296|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729297|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
56729298|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56729299|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56729300|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
56729301|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56729302|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729303|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729304|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729305|NCT00674154|Vitamin D|vitamin d|mesh-list
56729351|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729352|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729353|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
56729354|NCT00608517|Hormones|hormones|mesh-ancestor
56440501|NCT00263276|Metformin|metformin|mesh-list
56729355|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729356|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56729357|NCT00608517|Protective Agents|protective agents|mesh-ancestor
56729358|NCT00966706|Gemcitabine|gemcitabine|mesh-list
56729359|NCT00966706|Docetaxel|docetaxel|mesh-list
56729360|NCT00966706|Capecitabine|capecitabine|mesh-list
56729361|NCT00966706|Epirubicin|epirubicin|mesh-list
56729362|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729363|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56729364|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
56729365|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729366|NCT00966706|Antiviral Agents|antiviral agents|mesh-ancestor
56729367|NCT00966706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729368|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729369|NCT00966706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729370|NCT00966706|Immunologic Factors|immunologic factors|mesh-ancestor
56729371|NCT00966706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729372|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
56729373|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
56729374|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
56729375|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56729376|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56729377|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56729378|NCT00893061|Tamoxifen|tamoxifen|mesh-list
56729379|NCT00893061|Letrozole|letrozole|mesh-list
56729396|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56729397|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729398|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56729399|NCT00974272|Incretins|incretins|mesh-ancestor
56729400|NCT00974272|Hormones|hormones|mesh-ancestor
56729401|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729402|NCT00974428|Wobenzym|wobenzym|mesh-list
56729403|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56729404|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
56729405|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729406|NCT00974584|Paclitaxel|paclitaxel|mesh-list
56729407|NCT00974584|Bevacizumab|bevacizumab|mesh-list
56729408|NCT00974584|Carboplatin|carboplatin|mesh-list
56729409|NCT00974584|Pemetrexed|pemetrexed|mesh-list
56729410|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56729411|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729412|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
56729413|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
56729414|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
56729415|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729416|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56729417|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56729418|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56729425|NCT00608205|Fluorouracil|fluorouracil|mesh-list
56729447|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
56729448|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
56729449|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56729450|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729451|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
56729452|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729453|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56729454|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56729455|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56729456|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56729457|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729458|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56729459|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56729460|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
55995851|NCT04343092|Ivermectin|ivermectin|mesh-list
56554789|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56554790|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56554791|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554792|NCT04157491|Antibodies|antibodies|mesh-list
56554793|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
56554794|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554795|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56554796|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56554797|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56554798|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56554799|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554800|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554801|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554802|NCT00660751|Analgesics|analgesics|mesh-ancestor
56554803|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
56554804|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554805|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
56554806|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554807|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
56554808|NCT00664963|Sirolimus|sirolimus|mesh-list
56554809|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56554810|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554811|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56554812|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554813|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
56554814|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554815|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
56554816|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554817|NCT00672295|Paclitaxel|paclitaxel|mesh-list
56554818|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56554819|NCT00672295|Carboplatin|carboplatin|mesh-list
56554820|NCT00672295|Dasatinib|dasatinib|mesh-list
56554821|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56554822|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554823|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
56554824|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
56554825|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
56554826|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554827|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56554828|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554829|NCT00665041|Quinagolide|quinagolide|mesh-list
56554830|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
56729461|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729462|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56729463|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56729464|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
56729465|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56729466|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
56729467|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
56729468|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
56729469|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56729470|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
56729471|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56729472|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
56729473|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729474|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
56729475|NCT00890487|Protective Agents|protective agents|mesh-ancestor
56729476|NCT00890565|Granisetron|granisetron|mesh-list
56729477|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
56729478|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
56729479|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729480|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729481|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729482|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56729483|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
56729484|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729485|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729486|NCT00890643|Prazosin|prazosin|mesh-list
56729487|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56729488|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56729489|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56729490|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56729507|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56729508|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
56729509|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56729510|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729511|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729512|NCT00767598|Urological Agents|urological agents|mesh-ancestor
56729513|NCT00670800|Metformin|metformin|mesh-list
56729514|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56729515|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729516|NCT00764166|Docetaxel|docetaxel|mesh-list
56729517|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56729518|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729519|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
56729520|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
56729521|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
56729522|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729523|NCT00764166|Hormones|hormones|mesh-ancestor
56729524|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729525|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729526|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
56729527|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56729528|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56729529|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56729530|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56729531|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729553|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56729554|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729555|NCT00764244|Triamcinolone|triamcinolone|mesh-list
56729556|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56729557|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56729558|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56729559|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729560|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
56729561|NCT00764244|Hormones|hormones|mesh-ancestor
56729562|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729563|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729564|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729565|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
56729616|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729617|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729618|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
56729619|NCT00609609|Hormones|hormones|mesh-ancestor
56729620|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729621|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56729622|NCT00609609|Protective Agents|protective agents|mesh-ancestor
56729623|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56729624|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729625|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56729626|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56729627|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56729628|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56729629|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729630|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729631|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729632|NCT00673452|Analgesics|analgesics|mesh-ancestor
56729633|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
56729634|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729635|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
56729636|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56729637|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
56729638|NCT00967174|Nicotine|nicotine|mesh-list
56729639|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56729640|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
56729641|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729642|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729643|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56729644|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56729645|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
56729646|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56729647|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729648|NCT00967252|Atorvastatin|atorvastatin|mesh-list
56729649|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56729652|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729653|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56729654|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56729655|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729656|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
56729657|NCT00890955|Amrubicin|amrubicin|mesh-list
56729658|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729659|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
56729660|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729661|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56729662|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56729663|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
56729664|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729665|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729666|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56729667|NCT00975052|Metformin|metformin|mesh-list
56729668|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56729669|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56729670|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729671|NCT00975052|Incretins|incretins|mesh-ancestor
56729672|NCT00975052|Hormones|hormones|mesh-ancestor
56729673|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729674|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56729675|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
56729676|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729677|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729678|NCT00891033|Bortezomib|bortezomib|mesh-list
56729679|NCT00891033|Panobinostat|panobinostat|mesh-list
56729680|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729681|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56729682|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729694|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
56729695|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56729696|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56729697|NCT00968578|Prednisolone|prednisolone|mesh-list
56729698|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
56729699|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56729700|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
56729701|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729702|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
56729703|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
56729704|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729705|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729706|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729707|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
56729708|NCT00968578|Hormones|hormones|mesh-ancestor
56729709|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729710|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56729711|NCT00968578|Protective Agents|protective agents|mesh-ancestor
56729712|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56729713|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729749|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
56729750|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729751|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56729752|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56729753|NCT00378703|Growth Substances|growth substances|mesh-ancestor
56729754|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729755|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
56729756|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
56729757|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56729758|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729759|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729760|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56729761|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729762|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56729763|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
56729764|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729765|NCT00893451|Vitamin D|vitamin d|mesh-list
56729766|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
56729767|NCT00893451|Vitamins|vitamins|mesh-ancestor
56729768|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
56729769|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729770|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56729771|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56729772|NCT00967408|Citalopram|citalopram|mesh-list
56729773|NCT00967408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56729774|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56729783|NCT00891423|Meropenem|meropenem|mesh-list
56729797|NCT00891579|Pemetrexed|pemetrexed|mesh-list
56729798|NCT00891579|Gefitinib|gefitinib|mesh-list
56729799|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729800|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729801|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729802|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56729803|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56729804|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56729805|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
56729806|NCT00968734|Vitamin D|vitamin d|mesh-list
56729807|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56729808|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729809|NCT00968734|Vitamins|vitamins|mesh-ancestor
56729810|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
56729811|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56729812|NCT03620643|Fulvestrant|fulvestrant|mesh-list
56729813|NCT03620643|Crizotinib|crizotinib|mesh-list
56729814|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56729815|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729853|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
56729854|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729855|NCT00975754|Budesonide|budesonide|mesh-list
56729856|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729857|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56729858|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
56729859|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729860|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729861|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56729862|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
56729863|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
56729864|NCT00975754|Hormones|hormones|mesh-ancestor
56729865|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56729866|NCT01045681|Dexamethasone|dexamethasone|mesh-list
56729867|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
56729868|NCT01045681|Bortezomib|bortezomib|mesh-list
56729869|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56729870|NCT01045681|BB 1101|bb 1101|mesh-list
56729871|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56729872|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
56729873|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
56729874|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56729875|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729876|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56729904|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56729905|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729906|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
56729907|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729908|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56729909|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729910|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
56729911|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729912|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56729913|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
56729914|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56729915|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729916|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56729917|NCT00975988|Lapatinib|lapatinib|mesh-list
56729918|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729919|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56729920|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729921|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729922|NCT00976066|Naltrexone|naltrexone|mesh-list
56729923|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56729924|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56729956|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56729957|NCT00976222|Ranibizumab|ranibizumab|mesh-list
56729958|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56729959|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56729960|NCT00976222|Growth Substances|growth substances|mesh-ancestor
56729961|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729962|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56729963|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729964|NCT00976300|Cyclosporine|cyclosporine|mesh-list
56729965|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
56729966|NCT00976300|Cyclosporins|cyclosporins|mesh-list
56729967|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56729968|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
56729969|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729970|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56729971|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56729972|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
56729973|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56729974|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729975|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56729976|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56729977|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
56729978|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56729979|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
56729980|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56729981|NCT00979966|Sirolimus|sirolimus|mesh-list
56729982|NCT00979966|Sunitinib|sunitinib|mesh-list
56729983|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56729984|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56729985|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56729986|NCT00979966|Growth Substances|growth substances|mesh-ancestor
56729987|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56729988|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
56729998|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
56729999|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56730000|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
56730001|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730002|NCT00969904|Expectorants|expectorants|mesh-ancestor
56730003|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
56730004|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56730005|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
56730006|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730007|NCT00969904|Protective Agents|protective agents|mesh-ancestor
56730008|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730009|NCT00969904|Antidotes|antidotes|mesh-ancestor
56730010|NCT00976690|Mesalamine|mesalamine|mesh-list
56730011|NCT00976690|Azathioprine|azathioprine|mesh-list
56730012|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
56730013|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730014|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56730015|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730016|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56730017|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
56730018|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730019|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56730020|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56730021|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56730022|NCT00976690|Analgesics|analgesics|mesh-ancestor
56730023|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
56730024|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730025|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56730026|NCT00976768|Fluorouracil|fluorouracil|mesh-list
56730027|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
56730028|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
56730029|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730030|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56730031|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730032|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996406|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
56554831|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
56554832|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554833|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730033|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
56730034|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730035|NCT00608985|Zolpidem|zolpidem|mesh-list
56730036|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56730037|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56730038|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730039|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730040|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56730041|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
56730042|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
56730043|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730044|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730045|NCT00969982|Misoprostol|misoprostol|mesh-list
56730046|NCT00969982|Mifepristone|mifepristone|mesh-list
56730047|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56730048|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
56730049|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56730050|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730051|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56730052|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56730053|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
56730054|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56730055|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56730056|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56730057|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56730058|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
56730059|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56730078|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56730079|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56730080|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
56730081|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730082|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730083|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56730084|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56730085|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
56730086|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
56730087|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
56730088|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56730089|NCT00892125|Analgesics|analgesics|mesh-ancestor
56730090|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
56730091|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730092|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56730093|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56730094|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56730095|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56730096|NCT00980356|Vildagliptin|vildagliptin|mesh-list
56730097|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56730098|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730099|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56554834|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554835|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
56554837|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
56554838|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554839|NCT04152655|Vitamins|vitamins|mesh-ancestor
56554840|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
56554841|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554842|NCT04152655|Protective Agents|protective agents|mesh-ancestor
56554843|NCT00665119|Remifentanil|remifentanil|mesh-list
56554844|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56554845|NCT00665119|Narcotics|narcotics|mesh-ancestor
56554846|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554847|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554848|NCT00665119|Analgesics|analgesics|mesh-ancestor
55855430|NCT00389818|Prednisone|prednisone|mesh-list
56554850|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554851|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56554852|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56554853|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56554854|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56554855|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554856|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554857|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554858|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
56554859|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554860|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
56554861|NCT00672763|Vitamin D|vitamin d|mesh-list
56554862|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
56554863|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
56554864|NCT00672763|Vitamins|vitamins|mesh-list
56730100|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
56730101|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730102|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730103|NCT00368251|Brivaracetam|brivaracetam|mesh-list
56730104|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
56730105|NCT00893841|Pramipexole|pramipexole|mesh-list
56730106|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56730107|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
56730108|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56730109|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56730110|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56730111|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730112|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730113|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
56730114|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730115|NCT00893841|Protective Agents|protective agents|mesh-ancestor
56730116|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56730117|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56730118|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
56730119|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
56730121|NCT00378079|Methadone|methadone|mesh-list
56730156|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56730157|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56730158|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56730159|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730160|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730161|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56730162|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56730163|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
56730164|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730165|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730166|NCT00978172|Artesunate|artesunate|mesh-list
56730167|NCT00978172|Mefloquine|mefloquine|mesh-list
56730168|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
56730169|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56730170|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56730171|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730172|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730173|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
56730174|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
56730175|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56730176|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
56730177|NCT03923530|Eplerenone|eplerenone|mesh-list
56730183|NCT03923530|Diuretics|diuretics|mesh-ancestor
56730209|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
56730210|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56730211|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56730212|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56730213|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56730214|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56730215|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56730216|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56730217|NCT00970996|Interferons|interferons|mesh-list
56730218|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
56730219|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
56730220|NCT00970996|Paclitaxel|paclitaxel|mesh-list
56730221|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56730222|NCT00970996|Cisplatin|cisplatin|mesh-list
56730223|NCT00970996|Temozolomide|temozolomide|mesh-list
56730224|NCT00970996|Interleukin-2|interleukin-2|mesh-list
56730225|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56730226|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730227|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
56730228|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
56554865|NCT00672763|Calcium|calcium|mesh-list
56554866|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
56554867|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554868|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56554869|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56554870|NCT04154449|Insulin|insulin|mesh-list
56554871|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56554872|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554873|NCT00661063|Clonidine|clonidine|mesh-list
56554874|NCT00661063|Ketamine|ketamine|mesh-list
56554875|NCT00661063|Analgesics|analgesics|mesh-ancestor
56554876|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
56554877|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554878|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554879|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56554880|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56554881|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
56554882|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
56554883|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56554884|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56554885|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56554886|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554887|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554888|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56554889|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
56554890|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
56554891|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56554892|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56554893|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56554894|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
56554895|NCT00672919|Pioglitazone|pioglitazone|mesh-list
56554896|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56554897|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554898|NCT01109316|Insulin|insulin|mesh-list
56554899|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56554900|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
56730229|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
56730230|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730231|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
56730232|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730233|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56730234|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
56730235|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
56730236|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730237|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56730238|NCT00970996|Analgesics|analgesics|mesh-ancestor
56730239|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
56554901|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
56554902|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56554903|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554904|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56554905|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56554906|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
56554907|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56554908|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
56554909|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56554910|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554911|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56554912|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56554913|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554915|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56554916|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56554917|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554918|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
56554919|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56554920|NCT00887068|Azacitidine|azacitidine|mesh-list
56554921|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56554922|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
56554923|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554927|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
56554928|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554929|NCT00886834|Misoprostol|misoprostol|mesh-list
56554930|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56554931|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
56554932|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56554933|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554934|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56554935|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56554936|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
56554937|NCT00880009|Letrozole|letrozole|mesh-list
56554938|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554939|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56554940|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56554941|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554942|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554943|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56554944|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
56554945|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554946|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554947|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56554948|NCT00676039|Citalopram|citalopram|mesh-list
56554949|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56554950|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56554951|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56554952|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554953|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56554954|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730240|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730241|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
56730242|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56730243|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730244|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
56730245|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730246|NCT00869193|Protective Agents|protective agents|mesh-ancestor
56730247|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730248|NCT04009018|Anesthetics|anesthetics|mesh-list
56730249|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730250|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730251|NCT00869271|Leucovorin|leucovorin|mesh-list
56730252|NCT00869271|Fluorouracil|fluorouracil|mesh-list
56730253|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
56730254|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
56730255|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730256|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56730257|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730258|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56730260|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730261|NCT00869271|Antidotes|antidotes|mesh-ancestor
56730262|NCT00869271|Protective Agents|protective agents|mesh-ancestor
56730263|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
56730264|NCT00869271|Vitamins|vitamins|mesh-ancestor
56730265|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
56730266|NCT00971074|Hylan|hylan|mesh-list
56730267|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
56730268|NCT00971074|Protective Agents|protective agents|mesh-ancestor
56730269|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730270|NCT00971152|Menotropins|menotropins|mesh-list
56730271|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56730272|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
56730273|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56554955|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56554956|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
56554957|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56554958|NCT00676039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56554959|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
56554960|NCT01104636|Varenicline|varenicline|mesh-list
56554961|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56554962|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56554963|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
56554964|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730274|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730275|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
56730276|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56730277|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730278|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56730279|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
56730280|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56730281|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730282|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730283|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730284|NCT00978328|Oxycodone|oxycodone|mesh-list
56730285|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56730286|NCT00978328|Narcotics|narcotics|mesh-ancestor
56730287|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730288|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730289|NCT00978328|Analgesics|analgesics|mesh-ancestor
56730290|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
56730291|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730292|NCT00892359|Anidulafungin|anidulafungin|mesh-list
56730293|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
56730294|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730295|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56730296|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56730297|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56554965|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554966|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554967|NCT04931602|Vitamin D|vitamin d|mesh-list
56554968|NCT04931602|Vitamins|vitamins|mesh-ancestor
56554969|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
56554970|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554971|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56554972|NCT04157257|Tenofovir|tenofovir|mesh-list
56554973|NCT04157257|Entecavir|entecavir|mesh-list
56554974|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
56554975|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554976|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56554977|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56554978|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554979|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554980|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56554981|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56554982|NCT04152889|Docetaxel|docetaxel|mesh-list
56554983|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554984|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
56554985|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
56554986|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
56554987|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554988|NCT00602511|Thalidomide|thalidomide|mesh-list
56554989|NCT00602511|Bortezomib|bortezomib|mesh-list
56554990|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554991|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56554992|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
56730298|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730299|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730300|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56730301|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56730302|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56730303|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
56730304|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730305|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730306|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56730307|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56730308|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
56730309|NCT03992911|Carboplatin|carboplatin|mesh-list
56730310|NCT03992911|Etoposide|etoposide|mesh-list
56730311|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
56730312|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730313|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56730314|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56730315|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56730316|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730317|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554993|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56554994|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
56554995|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56554996|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56554997|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56554998|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56554999|NCT00602511|Growth Substances|growth substances|mesh-ancestor
56555000|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
56555001|NCT02826616|Trimetazidine|trimetazidine|mesh-list
56555002|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
56555003|NCT00676117|Loxoprofen|loxoprofen|mesh-list
56555004|NCT00676117|Esomeprazole|esomeprazole|mesh-list
56555005|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56555006|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555007|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56555008|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555009|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555010|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56555011|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56555012|NCT00676117|Analgesics|analgesics|mesh-ancestor
56555013|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
56555014|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555015|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555016|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555017|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555018|NCT01104558|Bisoprolol|bisoprolol|mesh-list
56555019|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56555020|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
56555021|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
56555022|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555023|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555024|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56555025|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56730318|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
56730319|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56730320|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
56730321|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730322|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730323|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56730324|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
56730325|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56730326|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56730327|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56730328|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
56730329|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730330|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730331|NCT00377455|Bosentan|bosentan|mesh-list
56730332|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56730333|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56730334|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730335|NCT00895557|Varenicline|varenicline|mesh-list
56730336|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56730337|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56730338|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
55996719|NCT03011905|Narcotics|narcotics|mesh-ancestor
56555026|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56555027|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
56555028|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555029|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555030|NCT00602589|Levofloxacin|levofloxacin|mesh-list
56555031|NCT00602589|Ofloxacin|ofloxacin|mesh-list
56555032|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56555033|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555034|NCT00602589|Renal Agents|renal agents|mesh-ancestor
56555035|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56555036|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56555037|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56555038|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555039|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555040|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555041|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56555042|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56555043|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
56555044|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
56555045|NCT02856087|Remifentanil|remifentanil|mesh-list
56555046|NCT02856087|Naloxone|naloxone|mesh-list
56555047|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56555048|NCT02856087|Narcotics|narcotics|mesh-ancestor
56555049|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555050|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555051|NCT02856087|Analgesics|analgesics|mesh-ancestor
56555052|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
56555053|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555054|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56555055|NCT00676429|Ziprasidone|ziprasidone|mesh-list
56109231|NCT00003877|Thiotepa|thiotepa|mesh-list
56730339|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730340|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730341|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730342|NCT00869973|Dexamethasone|dexamethasone|mesh-list
56730343|NCT00869973|Aprepitant|aprepitant|mesh-list
56730344|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56730345|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
56730346|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
56730347|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730348|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730349|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56730350|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
56730351|NCT00869973|Hormones|hormones|mesh-ancestor
56730352|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730353|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56730354|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730355|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56730356|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730357|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730358|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
56730359|NCT04955158|Ketamine|ketamine|mesh-list
56730360|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56730361|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730362|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730363|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56730364|NCT04955158|Analgesics|analgesics|mesh-ancestor
56730365|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
56730366|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730367|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56730368|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56555056|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56555057|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
56555058|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555059|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555060|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555061|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56555062|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56555063|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555064|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56555065|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56555066|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
56555067|NCT02629315|Formaldehyde|formaldehyde|mesh-list
56730369|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56730370|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56730371|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730372|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730373|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56730374|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56730375|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
56730376|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
56730377|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56730378|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56730379|NCT04008784|Triamcinolone|triamcinolone|mesh-list
56730380|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56730381|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56730382|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56730383|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56730384|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
56730385|NCT04008784|Hormones|hormones|mesh-ancestor
56730386|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730425|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730426|NCT00978796|Incretins|incretins|mesh-ancestor
56730427|NCT00978796|Hormones|hormones|mesh-ancestor
56730428|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730429|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56730430|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
56730431|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730432|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730433|NCT00894231|Levocetirizine|levocetirizine|mesh-list
56730434|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56730435|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56730436|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
56730437|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
56730438|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730439|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730440|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730481|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
56730482|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730483|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56730484|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
56730485|NCT05178628|Antiviral Agents|antiviral agents|mesh-ancestor
56730486|NCT05178628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730487|NCT05178628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730488|NCT05178628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56730489|NCT05178628|Immunologic Factors|immunologic factors|mesh-ancestor
56730490|NCT05178628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730491|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
56730492|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56730493|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56730494|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56730495|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56730496|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56730540|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56730541|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
56730542|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56730543|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56730544|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56730545|NCT00901407|Lamotrigine|lamotrigine|mesh-list
56730546|NCT00901407|Paroxetine|paroxetine|mesh-list
56730547|NCT00901407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56730548|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56730549|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56730550|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730551|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730552|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
56730553|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441683|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
56730554|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56730555|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
56730556|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56730557|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56730558|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56730559|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730560|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
56730561|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56730562|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56730563|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56730564|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56730565|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730566|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56730567|NCT00984724|Nicotine|nicotine|mesh-list
56730568|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56730581|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56730582|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730583|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56730584|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
56730585|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730586|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730587|NCT00972712|Bortezomib|bortezomib|mesh-list
56730588|NCT00972712|Tipifarnib|tipifarnib|mesh-list
56730589|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730590|NCT02539641|Hormones|hormones|mesh-list
56730591|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730592|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730593|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56730594|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56730595|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56730596|NCT00544882|Desogestrel|desogestrel|mesh-list
56730597|NCT00544882|Oviol|oviol|mesh-list
56730598|NCT00544882|Estradiol|estradiol|mesh-list
56730599|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56730600|NCT00544882|Estrogens|estrogens|mesh-ancestor
56730601|NCT00544882|Hormones|hormones|mesh-ancestor
56730602|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730603|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730604|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56730605|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
56730606|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56730607|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56730608|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56730609|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56730610|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56730611|NCT00544882|Progestins|progestins|mesh-ancestor
56730612|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56730613|NCT04035603|Cycloserine|cycloserine|mesh-list
56730614|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56555068|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
56555069|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555070|NCT01204658|Vaccines|vaccines|mesh-list
56555071|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56555073|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555074|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56555075|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
56555076|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56730615|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730616|NCT04035603|Renal Agents|renal agents|mesh-ancestor
56730617|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56730618|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
56730619|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56730620|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
56730621|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730622|NCT00606801|Galantamine|galantamine|mesh-list
56730623|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56730624|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730625|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730626|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
56730627|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730628|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730629|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56730630|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
56730631|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730632|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
56730633|NCT00972790|Bupivacaine|bupivacaine|mesh-list
56730634|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
56730635|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
56730636|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730637|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730638|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
56730639|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730640|NCT00901875|Buprenorphine|buprenorphine|mesh-list
56730641|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56730642|NCT00901875|Naloxone|naloxone|mesh-list
56555077|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56555078|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56555079|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555080|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555081|NCT01104246|Testosterone|testosterone|mesh-list
56555082|NCT01104246|Androgens|androgens|mesh-ancestor
56555083|NCT01104246|Hormones|hormones|mesh-ancestor
56555084|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555085|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555086|NCT00676741|Insulin|insulin|mesh-list
56555087|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56555088|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
56555089|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
56555090|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56555091|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
56555092|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
56555093|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56555094|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56555095|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730643|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56730644|NCT00901875|Narcotics|narcotics|mesh-ancestor
56730645|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730646|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730647|NCT00901875|Analgesics|analgesics|mesh-ancestor
56730648|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
56730649|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730650|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56730651|NCT00972946|Dextrans|dextrans|mesh-list
56730652|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
56730653|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
56730654|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
56730655|NCT00606177|Aripiprazole|aripiprazole|mesh-list
56730656|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
56730657|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56730658|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56730659|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56730660|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730661|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730662|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
56730663|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
56730664|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730665|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730666|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56730667|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56730668|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
56730669|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56730670|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56730671|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56730672|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56730673|NCT00985270|Rifampin|rifampin|mesh-list
56730674|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56730675|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
56730676|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56730683|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56730684|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56730685|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56730686|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56730687|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56730688|NCT00359281|Niacin|niacin|mesh-list
56730689|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
56730690|NCT00359281|Atorvastatin|atorvastatin|mesh-list
56730691|NCT00359281|Simvastatin|simvastatin|mesh-list
56730692|NCT00359281|Ezetimibe|ezetimibe|mesh-list
56730693|NCT00359281|Fenofibrate|fenofibrate|mesh-list
56730694|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56730695|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56730696|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
56730697|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730698|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56730699|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56730700|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730701|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
56730702|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
56730703|NCT00359281|Vitamins|vitamins|mesh-ancestor
56730704|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
56730705|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730707|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
56730708|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56730709|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56730710|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730711|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56730712|NCT00902031|Sennosides|sennosides|mesh-list
56730713|NCT00902031|Senna Extract|senna extract|mesh-list
56730714|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
56730724|NCT00973336|Vitamin D|vitamin d|mesh-list
56730730|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56730731|NCT00902187|Fesoterodine|fesoterodine|mesh-list
56730732|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56730733|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56730734|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
56730735|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730736|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730737|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730738|NCT00902187|Urological Agents|urological agents|mesh-ancestor
56730739|NCT01052311|Niacin|niacin|mesh-list
56730740|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56730741|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
56730742|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730743|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56730744|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
56730745|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
56730746|NCT01052311|Vitamins|vitamins|mesh-ancestor
56730747|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
56730748|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730749|NCT00988078|Metformin|metformin|mesh-list
56730750|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56730751|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730752|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
56730753|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
56730754|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56730755|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56730756|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730757|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56555096|NCT01103778|Bortezomib|bortezomib|mesh-list
56555097|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555098|NCT00673621|Albuterol|albuterol|mesh-list
56555099|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
56555100|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555101|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56555102|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
56555103|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555104|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56555105|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
56555106|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
56555107|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56555108|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56555109|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56555110|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56555111|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
56555112|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555113|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555115|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56555116|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56730758|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56730759|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730760|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730761|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730762|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56730763|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
56730764|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56730765|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730766|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56730767|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56730768|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56730769|NCT00982540|Caspofungin|caspofungin|mesh-list
56730770|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
56730771|NCT00982540|Clotrimazole|clotrimazole|mesh-list
56730772|NCT00982540|Miconazole|miconazole|mesh-list
56730773|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730774|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730775|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730776|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56730777|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56730795|NCT00982618|Lidocaine|lidocaine|mesh-list
56730809|NCT00982618|Narcotics|narcotics|mesh-ancestor
56730810|NCT00982618|Analgesics|analgesics|mesh-ancestor
56730811|NCT00895167|Curcumin|curcumin|mesh-list
56730812|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56730813|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56730814|NCT00895167|Analgesics|analgesics|mesh-ancestor
56730815|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
56730816|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730817|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730818|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56730819|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56730820|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56730821|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730822|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730823|NCT00902421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56730824|NCT00902421|Serotonin|serotonin|mesh-list
56730825|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56730826|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56730827|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56730828|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730829|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730830|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
56730831|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730832|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56730833|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56730834|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
56730835|NCT00985660|Nisoldipine|nisoldipine|mesh-list
56730844|NCT00350545|Prednisone|prednisone|mesh-list
56730856|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730857|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56730858|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56730859|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56730860|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730861|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730862|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
56730863|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56730864|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
56730865|NCT04006054|Midazolam|midazolam|mesh-list
56730866|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
56730867|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56730868|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730869|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730870|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56730871|NCT04006054|Analgesics|analgesics|mesh-ancestor
56730872|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
56730873|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730874|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56730875|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56730876|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56730877|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
56730878|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730879|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730880|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56730881|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56730882|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56730883|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56730884|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56730885|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
56730886|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
56555117|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56555118|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56555119|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
56555120|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
56555121|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56555122|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
56555123|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56555124|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
56555125|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555126|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555127|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
56555128|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56730887|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
56730888|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
56730889|NCT00897975|Red yeast rice|red yeast rice|mesh-list
56730890|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56730891|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56730892|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56730893|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
56730894|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730895|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56730896|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56730897|NCT01052389|Haloperidol|haloperidol|mesh-list
56730898|NCT01052389|Olanzapine|olanzapine|mesh-list
56730899|NCT01052389|Aripiprazole|aripiprazole|mesh-list
56730900|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
56730901|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
56730902|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
56730903|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730904|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730905|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56730906|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56730907|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56730908|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56730909|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56730910|NCT01052389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56730911|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56730912|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56730913|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730914|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730915|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
56730916|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
56730933|NCT00349921|Analgesics|analgesics|mesh-ancestor
56730934|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
56730935|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730936|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730937|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56730938|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
56730939|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
56730940|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56730941|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56730942|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56730943|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
56730944|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730945|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730946|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56730947|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
56730948|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56730949|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
56730950|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
56730951|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56730952|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
56730953|NCT00902655|Coagulants|coagulants|mesh-ancestor
56730954|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56730955|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
56730956|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730957|NCT01052623|Clonidine|clonidine|mesh-list
56730958|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56730959|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56730960|NCT01052623|Estradiol|estradiol|mesh-list
56730961|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56730962|NCT01052623|Hormones|hormones|mesh-ancestor
56730963|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56730964|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56730965|NCT01052623|Estrogens|estrogens|mesh-ancestor
56730966|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56730967|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
56730968|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56730969|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56730971|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
56730972|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56730973|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56730974|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
56730975|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
56730976|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56730977|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56730978|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56730979|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
56730980|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56730981|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56730982|NCT00902811|Artesunate|artesunate|mesh-list
56730983|NCT00902811|Amodiaquine|amodiaquine|mesh-list
56730984|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
56730985|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56730986|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56730987|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731028|NCT00902967|Atorvastatin|atorvastatin|mesh-list
56731029|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56731030|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56731031|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
56731032|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731033|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56731034|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56731035|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731036|NCT00903045|Propiverine|propiverine|mesh-list
56731037|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
56731038|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
56731039|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731040|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731041|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56731042|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56731043|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
56731057|NCT04035525|Ubiquinone|ubiquinone|mesh-list
56731083|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
56731084|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56731085|NCT04035135|Antibodies|antibodies|mesh-list
56731086|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
56731087|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56731088|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
56731089|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731090|NCT00903279|Retapamulin|retapamulin|mesh-list
56731091|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56555129|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56555130|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56555131|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56555132|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555133|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555134|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555135|NCT00945945|Analgesics|analgesics|mesh-ancestor
56555136|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
56555137|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555138|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
56555139|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56555140|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
56555141|NCT01112982|Colchicine|colchicine|mesh-list
56555142|NCT01112982|Febuxostat|febuxostat|mesh-list
56555143|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
56555144|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555145|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
56555146|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555147|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
56555148|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555149|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555151|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56555152|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56555153|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
56555154|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555155|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555156|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
56555157|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56555158|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
56555159|NCT00676819|Insulin|insulin|mesh-list
56555160|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56555161|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
56555162|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56555163|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555164|NCT00625794|Nicotine|nicotine|mesh-list
56555165|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56555166|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
56555167|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555168|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555169|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56555170|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56555171|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
56555172|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555173|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555174|NCT01203098|Enoxaparin|enoxaparin|mesh-list
56555175|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
56555176|NCT01203098|Edoxaban|edoxaban|mesh-list
56555177|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
56555178|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56555179|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56555180|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555181|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56555182|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
56555183|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56555184|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
56555185|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555186|NCT05032794|Bisacodyl|bisacodyl|mesh-list
56555187|NCT05032794|Cathartics|cathartics|mesh-ancestor
56555188|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555189|NCT05032794|Laxatives|laxatives|mesh-ancestor
56731092|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731093|NCT00605865|Sertraline|sertraline|mesh-list
56731094|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
56731095|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56731096|NCT00605865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56731097|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56731098|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56731099|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731100|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731101|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
56731102|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731103|NCT00922467|Esmolol|esmolol|mesh-list
56731104|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56731105|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56731106|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56731107|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
56731108|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731109|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731110|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731111|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
56731112|NCT00903747|Prucalopride|prucalopride|mesh-list
56731113|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56731114|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731115|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56731116|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56555190|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56555191|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555192|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56555193|NCT01108458|Pertuzumab|pertuzumab|mesh-list
56555194|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555195|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56555196|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555197|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555198|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56555199|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56555200|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555201|NCT00680485|Ketoconazole|ketoconazole|mesh-list
56555202|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
56555203|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555204|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56555205|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56555206|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555207|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555208|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56555209|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
56555210|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731117|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731118|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731119|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731120|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731121|NCT00903747|Laxatives|laxatives|mesh-ancestor
56731122|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56731123|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56731124|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56731125|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
56731126|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731127|NCT02538627|Trametinib|trametinib|mesh-list
56731128|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731129|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56731130|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731131|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731132|NCT00903825|Lidocaine|lidocaine|mesh-list
56731133|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
56731134|NCT00903825|Anesthetics|anesthetics|mesh-list
56731135|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731136|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731137|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
56731138|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731139|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56731166|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56731167|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731168|NCT01055821|Interferons|interferons|mesh-list
56731169|NCT01055821|Ribavirin|ribavirin|mesh-list
56731170|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731171|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
56731172|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731173|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
56731174|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731175|NCT00904293|Warfarin|warfarin|mesh-list
56731176|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
56731177|NCT00904449|Oxymorphone|oxymorphone|mesh-list
56731178|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56731179|NCT00904449|Narcotics|narcotics|mesh-ancestor
56731180|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731181|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731182|NCT00904449|Analgesics|analgesics|mesh-ancestor
56731183|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
56731184|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731185|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56731186|NCT00348595|Lenalidomide|lenalidomide|mesh-list
56731187|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
56731188|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731189|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56731190|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56731191|NCT00348595|Growth Substances|growth substances|mesh-ancestor
56731192|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
56731193|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731194|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
56731195|NCT02538939|Antidotes|antidotes|mesh-ancestor
56731196|NCT02538939|Protective Agents|protective agents|mesh-ancestor
56731197|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731198|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
56731199|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731200|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
56555211|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555212|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56555213|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
56555214|NCT00680563|Hematinics|hematinics|mesh-ancestor
56555215|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
56555216|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731201|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56731202|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731203|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
56731204|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
56731205|NCT00904605|Celecoxib|celecoxib|mesh-list
56731206|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56731207|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56731208|NCT00904605|Analgesics|analgesics|mesh-ancestor
56731209|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
56731210|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731211|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731212|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731213|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56731214|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56731215|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56731216|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731217|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731218|NCT00905073|Cyclosporine|cyclosporine|mesh-list
56731219|NCT00905073|Methotrexate|methotrexate|mesh-list
56731220|NCT00905073|Cyclosporins|cyclosporins|mesh-list
56731221|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56731255|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56731256|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731257|NCT00348283|Adalimumab|adalimumab|mesh-list
56731258|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731259|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56731260|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
56731261|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56731262|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731263|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56731264|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
56731265|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56731266|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731267|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731268|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731269|NCT00336583|Cytarabine|cytarabine|mesh-list
56731270|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
56731271|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
56731272|NCT00336583|Etoposide|etoposide|mesh-list
56731273|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731274|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56731275|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56731276|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56731277|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731278|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731305|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
56731306|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56731307|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56731308|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731309|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
56731310|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
56731311|NCT03987529|Propofol|propofol|mesh-list
56731312|NCT03987529|Sevoflurane|sevoflurane|mesh-list
56731313|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56731314|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731315|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731316|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56731317|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
56731318|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
56731319|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56731320|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56731321|NCT00335959|Capecitabine|capecitabine|mesh-list
56731322|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
56731323|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56731324|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
56731325|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731326|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731327|NCT01053169|Thrombin|thrombin|mesh-list
56731328|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
56731329|NCT01053169|Coagulants|coagulants|mesh-ancestor
56731330|NCT01059331|Pregabalin|pregabalin|mesh-list
56731331|NCT01059331|Analgesics|analgesics|mesh-ancestor
56731332|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
56731333|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731334|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731335|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
56731336|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56731337|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56731338|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731339|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56731346|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56731347|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56731348|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56731349|NCT01059955|BB 1101|bb 1101|mesh-list
56731350|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731351|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
56731352|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
56731353|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731354|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731355|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56731356|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
56731357|NCT01059955|Hormones|hormones|mesh-ancestor
56731358|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731359|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56731360|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731361|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
56731362|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731363|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731364|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
56731365|NCT01060189|Urinastatin|urinastatin|mesh-list
56731366|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56731367|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56731368|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731369|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
56731370|NCT01060189|Coagulants|coagulants|mesh-ancestor
56731396|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
56731397|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
56731398|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731399|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
56731400|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731401|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
56731402|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731403|NCT01060501|Antidotes|antidotes|mesh-ancestor
56731404|NCT01060501|Protective Agents|protective agents|mesh-ancestor
56731405|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
56731406|NCT01060501|Vitamins|vitamins|mesh-ancestor
56731407|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
56731408|NCT01060501|Hematinics|hematinics|mesh-ancestor
56731409|NCT00671658|Cytarabine|cytarabine|mesh-list
56731410|NCT00671658|Dexamethasone|dexamethasone|mesh-list
56731411|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
56731412|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56731413|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56731414|NCT00671658|Prednisolone|prednisolone|mesh-list
56731415|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
56731416|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
56731417|NCT00671658|Rituximab|rituximab|mesh-list
56731418|NCT00671658|Doxorubicin|doxorubicin|mesh-list
56731419|NCT00671658|Methotrexate|methotrexate|mesh-list
56731420|NCT00671658|Vincristine|vincristine|mesh-list
56731421|NCT00671658|Asparaginase|asparaginase|mesh-list
56731422|NCT00671658|Pegaspargase|pegaspargase|mesh-list
56731423|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56731424|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
56731425|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731426|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
56731427|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555217|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
56555218|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56555219|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555220|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
56555221|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56128871|NCT03338244|Azithromycin|azithromycin|mesh-list
56555225|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56555226|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56555227|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
56555228|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555229|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56555230|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56555231|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555232|NCT01201850|Bevacizumab|bevacizumab|mesh-list
56555233|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56555234|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555235|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56555236|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56731428|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56731429|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56731430|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
56731431|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731432|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731433|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56731434|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56731435|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731436|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
56731437|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
56731438|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731439|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56731440|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
56731441|NCT00671658|Hormones|hormones|mesh-ancestor
56731442|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731443|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56731444|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56731445|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56731446|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56731447|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731448|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56731449|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
56731450|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56731451|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56731452|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
56731453|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
56731454|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56731455|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56731456|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
56731457|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555237|NCT01201850|Growth Substances|growth substances|mesh-ancestor
56555238|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555239|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
56555240|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
56555241|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56555242|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56555243|NCT02825056|Morphine|morphine|mesh-list
56555244|NCT02825056|Bupivacaine|bupivacaine|mesh-list
56555245|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
56555246|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
56555247|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555248|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555249|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
56731458|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56731459|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
56731460|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
56731461|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
56731462|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56731463|NCT00671658|Protective Agents|protective agents|mesh-ancestor
56731464|NCT00764712|Insulin|insulin|mesh-list
56731465|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56731466|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731467|NCT00768456|Ropivacaine|ropivacaine|mesh-list
56731468|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
56731469|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
56731470|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731471|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731472|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
56731473|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731474|NCT00768612|Risperidone|risperidone|mesh-list
56731475|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56731476|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
56731477|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731478|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731479|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731480|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56731481|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56731482|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731483|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56731484|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56731485|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
56731486|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
56731487|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555250|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555251|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56555252|NCT02825056|Narcotics|narcotics|mesh-ancestor
56555253|NCT02825056|Analgesics|analgesics|mesh-ancestor
56555254|NCT02826772|Androgens|androgens|mesh-list
56555255|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
56555256|NCT02826772|Hormones|hormones|mesh-ancestor
56555257|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555258|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555259|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
56555260|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
56555261|NCT00674011|Bevacizumab|bevacizumab|mesh-list
56555262|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56555263|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555264|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56109438|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56731488|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731489|NCT04048200|Fentanyl|fentanyl|mesh-list
56731490|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
56731491|NCT04048200|Ketamine|ketamine|mesh-list
56731492|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
56731493|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56731494|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731495|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731496|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56731497|NCT04048200|Analgesics|analgesics|mesh-ancestor
56731498|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
56731499|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731500|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56731501|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56731502|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56731503|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
56731504|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731505|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731506|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56731507|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56731508|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
56731509|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
56731510|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56731511|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56731537|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731538|NCT00768690|Ketoconazole|ketoconazole|mesh-list
56731539|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
56731540|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731541|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56731542|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56731543|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731544|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731545|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56731546|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
56731547|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731548|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731549|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56731550|NCT00768768|Terbinafine|terbinafine|mesh-list
56731551|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
56731552|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731553|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731554|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731555|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56731556|NCT00775086|Norelgestromin|norelgestromin|mesh-list
56731557|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
56731558|NCT00775086|Estradiol|estradiol|mesh-list
56731559|NCT00775086|Estrogens|estrogens|mesh-ancestor
56731560|NCT00775086|Hormones|hormones|mesh-ancestor
56731561|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997953|NCT03824834|Narcotics|narcotics|mesh-ancestor
56555265|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56555266|NCT00674011|Growth Substances|growth substances|mesh-ancestor
56555267|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555268|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
56555269|NCT00674089|Vitamin A|vitamin a|mesh-list
56555270|NCT00674089|Vitamins|vitamins|mesh-ancestor
56555271|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
56555272|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555274|NCT01200992|Mitomycin|mitomycin|mesh-list
56555275|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56555276|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555277|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
56555278|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555279|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56555280|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555281|NCT02824666|Fallypride|fallypride|mesh-list
56555282|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56555283|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56555284|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
56555285|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555286|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731562|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731563|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56731564|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56731565|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56731566|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56731567|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56731568|NCT02557854|Doxorubicin|doxorubicin|mesh-list
56731569|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56731570|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56731571|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731572|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56731573|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56731574|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731575|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731576|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
56731577|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
56731578|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
56731579|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731580|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731581|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
56731582|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731583|NCT00986050|Sirolimus|sirolimus|mesh-list
56731584|NCT00986050|Abciximab|abciximab|mesh-list
56731585|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56731586|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731587|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56731588|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731608|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731609|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731610|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56731611|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
56731612|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
56731613|NCT00771342|Protective Agents|protective agents|mesh-ancestor
56731614|NCT00775164|Metformin|metformin|mesh-list
56731615|NCT00775164|Pioglitazone|pioglitazone|mesh-list
56731616|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56731617|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731618|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
56731619|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56731620|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56731621|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
56731622|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731623|NCT04767256|Dexamethasone|dexamethasone|mesh-list
56731624|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
56731625|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731664|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56731665|NCT00988780|Efavirenz|efavirenz|mesh-list
56731666|NCT00988780|Maraviroc|maraviroc|mesh-list
56731667|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56731668|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56731669|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731670|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731671|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
56731672|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731673|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56731674|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56731675|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56731676|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56731677|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56731723|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731724|NCT03860428|Acetaminophen|acetaminophen|mesh-list
56731725|NCT03860428|Ibuprofen|ibuprofen|mesh-list
56731726|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
56731727|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56731728|NCT03860428|Analgesics|analgesics|mesh-ancestor
56731729|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
56731730|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56731731|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731732|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
56731733|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56731734|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731735|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56731736|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731737|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731738|NCT00771888|Lanreotide|lanreotide|mesh-list
56731739|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731740|NCT00605475|Metformin|metformin|mesh-list
56731741|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56731742|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731743|NCT00986596|Vitamin D|vitamin d|mesh-list
56731744|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
56731745|NCT00986596|Vitamins|vitamins|mesh-ancestor
56731746|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
56731747|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731748|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56731749|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56731750|NCT00769470|Carboplatin|carboplatin|mesh-list
56731751|NCT00769470|Docetaxel|docetaxel|mesh-list
56731752|NCT00769470|Trastuzumab|trastuzumab|mesh-list
56731753|NCT00769470|Lapatinib|lapatinib|mesh-list
56731754|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731755|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56555287|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555288|NCT00674167|Docetaxel|docetaxel|mesh-list
56555289|NCT00674167|Capecitabine|capecitabine|mesh-list
56555290|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555291|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
56555292|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555293|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
56555294|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555299|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555300|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555302|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56731756|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56731757|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56731758|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731759|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56731760|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56731761|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731763|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56731764|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56731765|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
56731766|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56731767|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731768|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731769|NCT00605319|Urological Agents|urological agents|mesh-ancestor
56731770|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56731771|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
56731772|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56731773|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56731774|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56731775|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56731776|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731777|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
56731778|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
56731779|NCT00908661|Coagulants|coagulants|mesh-ancestor
56731780|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
56731808|NCT00769548|Goserelin|goserelin|mesh-list
56731809|NCT00769548|Flutamide|flutamide|mesh-list
56731810|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56731811|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731812|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
56731813|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
56731814|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731815|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731816|NCT05277675|Bevacizumab|bevacizumab|mesh-list
56731817|NCT05277675|Lenvatinib|lenvatinib|mesh-list
56731818|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56731819|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731820|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56731821|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56731822|NCT05277675|Growth Substances|growth substances|mesh-ancestor
56731823|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731824|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
56731825|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56731826|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731827|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555303|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56555304|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
56555305|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
56555306|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555307|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555308|NCT02824510|Insulin|insulin|mesh-list
56555309|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56555310|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
56555311|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56555312|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555313|NCT00674245|Pantoprazole|pantoprazole|mesh-list
56555314|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56555315|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555316|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56555317|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555318|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555319|NCT00878215|Liver Extracts|liver extracts|mesh-list
56555320|NCT00878215|Hematinics|hematinics|mesh-ancestor
56555321|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
56555322|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555323|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
56555324|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56555325|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56555326|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555327|NCT02628847|Urological Agents|urological agents|mesh-ancestor
56555328|NCT00677443|Capecitabine|capecitabine|mesh-list
56555329|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
56555330|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56555331|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
56555332|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555333|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555334|NCT00674557|Exemestane|exemestane|mesh-list
56555335|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56555336|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555337|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56731828|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
56731829|NCT03984409|Diuretics|diuretics|mesh-ancestor
56731830|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
56731831|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731832|NCT03984409|Expectorants|expectorants|mesh-ancestor
56731833|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
56731834|NCT00983554|Anastrozole|anastrozole|mesh-list
56731835|NCT00983554|Testosterone|testosterone|mesh-list
56731836|NCT00983554|Dutasteride|dutasteride|mesh-list
56731837|NCT00983554|Androgens|androgens|mesh-ancestor
56731838|NCT00983554|Hormones|hormones|mesh-ancestor
56731839|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731840|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731841|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56731842|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731843|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56731844|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56731845|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731846|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731847|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
56731848|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56731849|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56731850|NCT05004987|Dexetimide|dexetimide|mesh-list
56731851|NCT05004987|Citalopram|citalopram|mesh-list
56731880|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56731881|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
56731882|NCT00908817|Hormones|hormones|mesh-ancestor
56731883|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56731884|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731885|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731886|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
56731887|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731888|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731889|NCT00332839|Cyclosporine|cyclosporine|mesh-list
56731890|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
56731891|NCT00332839|Everolimus|everolimus|mesh-list
56731892|NCT00332839|Tacrolimus|tacrolimus|mesh-list
56731893|NCT00332839|Cyclosporins|cyclosporins|mesh-list
56731894|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731895|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
56731896|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731897|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56731898|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731899|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731900|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
56731934|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56731935|NCT00909051|Acarbose|acarbose|mesh-list
56731936|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56731937|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731938|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731939|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56731940|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731941|NCT00983944|Prednisone|prednisone|mesh-list
56731942|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
56731943|NCT00983944|Rituximab|rituximab|mesh-list
56731944|NCT00983944|Doxorubicin|doxorubicin|mesh-list
56731945|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56731946|NCT00983944|Etoposide|etoposide|mesh-list
56731947|NCT00983944|Vincristine|vincristine|mesh-list
56731948|NCT00983944|Bleomycin|bleomycin|mesh-list
56731949|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56731950|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
56731951|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56731952|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56731953|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56731954|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
56731955|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731956|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731957|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56731958|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56731959|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56731960|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56731962|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731980|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731981|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56731982|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56731983|NCT02538003|Delpazolid|delpazolid|mesh-list
56731984|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
56731985|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56731986|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731987|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56731988|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56731989|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731990|NCT00909129|Interferons|interferons|mesh-list
56731991|NCT00909129|Ribavirin|ribavirin|mesh-list
56731992|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
56731993|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56731994|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56731995|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
56731996|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56731997|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
56731998|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56731999|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
56732000|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732001|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56732002|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
56732003|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56732004|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56732005|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732006|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56732007|NCT01053325|Renal Agents|renal agents|mesh-ancestor
55998394|NCT01455506|Busulfan|busulfan|mesh-list
56555338|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56555339|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555340|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555341|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56555342|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
56555343|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555344|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555345|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
56555346|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
56555347|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56555348|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56555349|NCT00674557|Growth Substances|growth substances|mesh-ancestor
56555350|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
56555352|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56555353|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555354|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732008|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56732009|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56732010|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
56732011|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732012|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56732013|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
56732014|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732015|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732016|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56732017|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56732018|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56732019|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
56732020|NCT00927615|Abciximab|abciximab|mesh-list
56732021|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
56732022|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56732023|NCT03990103|Paclitaxel|paclitaxel|mesh-list
56732024|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56732025|NCT03990103|Bevacizumab|bevacizumab|mesh-list
56732026|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
56732027|NCT03990103|Tegafur|tegafur|mesh-list
56732028|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56732029|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732030|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
56732060|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732061|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
56732062|NCT01581151|Hormones|hormones|mesh-ancestor
56732063|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56732064|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56732065|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732066|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56732067|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56732068|NCT01581151|Growth Substances|growth substances|mesh-ancestor
56732069|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
56732070|NCT01053481|Vitamin D|vitamin d|mesh-list
56732071|NCT01053481|Vitamins|vitamins|mesh-ancestor
56732072|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
56732073|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732074|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56732075|NCT00927771|Azelaic acid|azelaic acid|mesh-list
56732076|NCT00927771|Hydroquinone|hydroquinone|mesh-list
56732077|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732078|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
56732079|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
56732080|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732081|NCT00927771|Protective Agents|protective agents|mesh-ancestor
56732082|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732083|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56732084|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
56732085|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732086|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
56732087|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732088|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56732089|NCT01053637|Acetaminophen|acetaminophen|mesh-list
56732090|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56732091|NCT01053637|Hydrocodone|hydrocodone|mesh-list
56732092|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56732093|NCT01053637|Analgesics|analgesics|mesh-ancestor
56732094|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
56732097|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
56732100|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56732101|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
56732102|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
56732103|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56732104|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56732105|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56732106|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
56732107|NCT00928161|Lansoprazole|lansoprazole|mesh-list
56732108|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56732109|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732110|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56732111|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732112|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732113|NCT00909519|Naproxen|naproxen|mesh-list
56732114|NCT00909519|Furosemide|furosemide|mesh-list
56732115|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56732116|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56732117|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56732118|NCT00909519|Analgesics|analgesics|mesh-ancestor
56732119|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
56732120|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732121|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732122|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56732123|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56732124|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
56732125|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56732126|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732127|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732128|NCT00909519|Diuretics|diuretics|mesh-ancestor
56732129|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
56732130|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56555355|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56555356|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555357|NCT00674713|Ondansetron|ondansetron|mesh-list
56555358|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56555359|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
56555360|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
56555361|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555362|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555363|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555364|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
56555365|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
56732131|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56732132|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56732133|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56732134|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56732135|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56732136|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
56732137|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732138|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56732139|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56732140|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732141|NCT00907179|Pemetrexed|pemetrexed|mesh-list
56732142|NCT00907179|Panobinostat|panobinostat|mesh-list
56732143|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732144|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732145|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732146|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56732147|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56732148|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56732149|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
56732150|NCT00544648|Paclitaxel|paclitaxel|mesh-list
56732151|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56732152|NCT00544648|Carboplatin|carboplatin|mesh-list
56732184|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732185|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56732186|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56732187|NCT01053949|Growth Substances|growth substances|mesh-ancestor
56732188|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
56732189|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732190|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732191|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
56732192|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56732193|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732194|NCT00987376|Choline|choline|mesh-list
56732195|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
56732196|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56732197|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
56732198|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732199|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732200|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56732201|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
56732202|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
56732203|NCT00987454|Hematinics|hematinics|mesh-ancestor
56443337|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56732204|NCT04005664|Phenylephrine|phenylephrine|mesh-list
56732205|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
56732206|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56732207|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
56732208|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
56732209|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732210|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732211|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
56732212|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56732213|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
56732214|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
56732215|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56732216|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56732217|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56732218|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
56732219|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732220|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732221|NCT04005664|Protective Agents|protective agents|mesh-ancestor
56732222|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56732223|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56732224|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56732225|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56732226|NCT00924573|Metformin|metformin|mesh-list
56732227|NCT00924573|Glimepiride|glimepiride|mesh-list
56732228|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732229|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732230|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56732231|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732232|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
56732233|NCT01054027|Phenylephrine|phenylephrine|mesh-list
56732234|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
56732235|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
56732236|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56732237|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
56732238|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
56732239|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732240|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732241|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
56732242|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56732243|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
56732244|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
56732245|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56732246|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56732247|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56732248|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
56732249|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732250|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732251|NCT01054027|Protective Agents|protective agents|mesh-ancestor
56555366|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56555368|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555369|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555370|NCT00674713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56555371|NCT00674713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56555372|NCT00674713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555373|NCT00674713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56555374|NCT00674713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56555375|NCT04241380|Heparin|heparin|mesh-list
56555376|NCT04241380|Anticoagulants|anticoagulants|mesh-list
56555377|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56555378|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56555379|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56109888|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
56732252|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
56732253|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56732254|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56732255|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
56732256|NCT01054105|Iloprost|iloprost|mesh-list
56732257|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56732258|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
56732259|NCT00330343|Naloxone|naloxone|mesh-list
56732260|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56732261|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732262|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
56732263|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732264|NCT00987766|Gemcitabine|gemcitabine|mesh-list
56732265|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
56732266|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56732267|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56732268|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
56732269|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732270|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732271|NCT00987766|Antiviral Agents|antiviral agents|mesh-ancestor
56732272|NCT00987766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732273|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732274|NCT00987766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732275|NCT00987766|Immunologic Factors|immunologic factors|mesh-ancestor
56732276|NCT00987766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732277|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56732278|NCT04005430|Dexamethasone|dexamethasone|mesh-list
56732279|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
56555380|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555381|NCT02824354|Nalmefene|nalmefene|mesh-list
56555382|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56555383|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555384|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
56555385|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555386|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
56555387|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56555388|NCT02823496|Protective Agents|protective agents|mesh-ancestor
56555389|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555390|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
56555391|NCT00677755|Misoprostol|misoprostol|mesh-list
56555392|NCT00677755|Mifepristone|mifepristone|mesh-list
56555393|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56555394|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
56555395|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56555396|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555397|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56555398|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56555399|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
56732280|NCT04005430|BB 1101|bb 1101|mesh-list
56732281|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56732282|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
56732283|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
56443413|NCT00309855|Anastrozole|anastrozole|mesh-list
56732284|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732285|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732286|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732287|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
56732288|NCT04005430|Hormones|hormones|mesh-ancestor
56732289|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56732290|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56732291|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732292|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
56732293|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732294|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732295|NCT00330187|Bupropion|bupropion|mesh-list
56732296|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56732297|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
56732298|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56732299|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56732300|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56732301|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56732302|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732303|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
56732304|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732305|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732306|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56732307|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56732308|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732309|NCT00987844|Prucalopride|prucalopride|mesh-list
56732310|NCT00987844|Laxatives|laxatives|mesh-ancestor
56732319|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56732320|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56732321|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
56732322|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
56732323|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732324|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732325|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732326|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
56732327|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56732328|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
56732329|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732330|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732331|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56732332|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
56732333|NCT04864444|Primaquine|primaquine|mesh-list
56732334|NCT04864444|Piperaquine|piperaquine|mesh-list
56732335|NCT04864444|Artenimol|artenimol|mesh-list
56732336|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
56732337|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56732338|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56732339|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732340|NCT00329797|Vitamin D|vitamin d|mesh-list
56732341|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
56732342|NCT00329797|Calcium|calcium|mesh-list
56732343|NCT00329797|Vitamins|vitamins|mesh-ancestor
56732344|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
56732345|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732346|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56732347|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56732348|NCT00541450|Metformin|metformin|mesh-list
56732349|NCT00541450|Pioglitazone|pioglitazone|mesh-list
56732350|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56732351|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732352|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732353|NCT00541450|Incretins|incretins|mesh-ancestor
56732354|NCT00541450|Hormones|hormones|mesh-ancestor
56555400|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56555401|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56555402|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56555403|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56555404|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
56555405|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56555406|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56555407|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
56732355|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56732356|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56732357|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
56732358|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732359|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732360|NCT01056679|Doxorubicin|doxorubicin|mesh-list
56732361|NCT01056679|Lenalidomide|lenalidomide|mesh-list
56732362|NCT01056679|Vinblastine|vinblastine|mesh-list
56732363|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56732364|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732365|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56732366|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56732367|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732368|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732369|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
56732370|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732371|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56732372|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56732373|NCT01056679|Growth Substances|growth substances|mesh-ancestor
56732374|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
56732375|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56732376|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
56732377|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555408|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555409|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
56555410|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56555411|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56555412|NCT02824042|Itraconazole|itraconazole|mesh-list
56555413|NCT02824042|Maytansine|maytansine|mesh-list
56555414|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
56555415|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555416|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56555417|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56555418|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555419|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555420|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56555421|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
56555422|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555423|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555424|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56555425|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56555426|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555427|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56555428|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555429|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56555430|NCT00675181|Melatonin|melatonin|mesh-list
56555431|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
56110983|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
56732378|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
56732379|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56732380|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56732381|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
56732382|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732383|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732384|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732385|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56732386|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
56732387|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732388|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732389|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732390|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732391|NCT05709574|Tadalafil|tadalafil|mesh-list
56732392|NCT05709574|Vasodilator Agents|vasodilator agents|mesh-ancestor
56732393|NCT05709574|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56732394|NCT05709574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56732395|NCT05709574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732396|NCT05709574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732397|NCT05709574|Urological Agents|urological agents|mesh-ancestor
56732398|NCT05546242|Dolutegravir|dolutegravir|mesh-list
56732399|NCT05546242|Cabotegravir|cabotegravir|mesh-list
56732400|NCT05546242|Rilpivirine|rilpivirine|mesh-list
56732401|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56732427|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
56732428|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732429|NCT03150004|Analgesics|analgesics|mesh-ancestor
56732430|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
56732431|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732432|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56732433|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56732434|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732435|NCT00540124|Tadalafil|tadalafil|mesh-list
56732436|NCT00540124|Tamsulosin|tamsulosin|mesh-list
56732437|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
56732438|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56732439|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56732440|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732441|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732442|NCT00540124|Urological Agents|urological agents|mesh-ancestor
56732443|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56732444|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56732445|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56732446|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
56732447|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732448|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732449|NCT00540046|Copper|copper|mesh-list
56732450|NCT00540046|Trace Elements|trace elements|mesh-ancestor
56732453|NCT05677126|Copper|copper|mesh-list
56732480|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732481|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732482|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
56732483|NCT00689936|Hormones|hormones|mesh-ancestor
56732484|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56732485|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56732486|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732487|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
56732488|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732489|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732490|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
56732491|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56732492|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56732493|NCT00689936|Growth Substances|growth substances|mesh-ancestor
56732494|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
56732495|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56732496|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
56732497|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56732498|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732499|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
56732500|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56732501|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732502|NCT05661682|Zinc|zinc|mesh-list
56732503|NCT05661682|Copper|copper|mesh-list
56732533|NCT05473234|Amoxicillin|amoxicillin|mesh-list
56732534|NCT05473234|Azithromycin|azithromycin|mesh-list
56732535|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56732536|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732537|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
56732538|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56732539|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732540|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56732541|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56732542|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
56732543|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732544|NCT00671034|Cytarabine|cytarabine|mesh-list
56732545|NCT00671034|Dexamethasone|dexamethasone|mesh-list
56732546|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
56732547|NCT00671034|Prednisone|prednisone|mesh-list
56732548|NCT00671034|Cortisone|cortisone|mesh-list
56732549|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
56732550|NCT00671034|Doxorubicin|doxorubicin|mesh-list
56732551|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56732552|NCT00671034|Methotrexate|methotrexate|mesh-list
56732553|NCT00671034|Vincristine|vincristine|mesh-list
56732554|NCT00671034|Daunorubicin|daunorubicin|mesh-list
56732555|NCT00671034|Asparaginase|asparaginase|mesh-list
56732556|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
56732557|NCT00671034|Pegaspargase|pegaspargase|mesh-list
56732558|NCT00671034|Thioguanine|thioguanine|mesh-list
56732559|NCT00671034|BB 1101|bb 1101|mesh-list
56732560|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
56732561|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732562|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
56732563|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732564|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56732565|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56732566|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
56732567|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732568|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732569|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56732570|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56732571|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
56732572|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
56555432|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732573|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732574|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732575|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
56732576|NCT00671034|Hormones|hormones|mesh-ancestor
56732577|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56732578|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56732579|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
56732580|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732581|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56732582|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56732583|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56732584|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56732585|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
56732586|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56443726|NCT00316875|Lapatinib|lapatinib|mesh-list
56732587|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56732588|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
56732589|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56732590|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56732591|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56732593|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732594|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56732595|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
56732596|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
56732597|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
56732598|NCT04622228|Carboplatin|carboplatin|mesh-list
56732599|NCT04622228|Etoposide|etoposide|mesh-list
56732600|NCT04622228|Atezolizumab|atezolizumab|mesh-list
56732601|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732602|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56732603|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56732604|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56732605|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732606|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732607|NCT04425070|Gemcitabine|gemcitabine|mesh-list
56732612|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732613|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56732614|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
56732615|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732616|NCT04425070|Antiviral Agents|antiviral agents|mesh-ancestor
56732617|NCT04425070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732618|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732619|NCT04425070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732620|NCT04425070|Immunologic Factors|immunologic factors|mesh-ancestor
56732621|NCT04425070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732622|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56732623|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56732624|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56732625|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56732626|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
56732627|NCT04607954|Durvalumab|durvalumab|mesh-list
56732628|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
56732629|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56732630|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
56732631|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56732632|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732633|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
56732634|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732635|NCT00743678|Cetuximab|cetuximab|mesh-list
56732636|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56732637|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732638|NCT02679508|Lansoprazole|lansoprazole|mesh-list
56732639|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
56732640|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56732641|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732656|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732657|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
56732658|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732659|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56732660|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732661|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
56732662|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56732663|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56732664|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
56732665|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732666|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56443787|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732667|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56732668|NCT04047654|Anticoagulants|anticoagulants|mesh-list
56732669|NCT00772356|Insulin|insulin|mesh-list
56732670|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56732671|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732672|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732673|NCT03762850|Dapagliflozin|dapagliflozin|mesh-list
56732674|NCT03762850|Irbesartan|irbesartan|mesh-list
56732675|NCT03762850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56732676|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732677|NCT03762850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732678|NCT03762850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732679|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56732680|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56732681|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56732682|NCT04321330|Atezolizumab|atezolizumab|mesh-list
56732683|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732684|NCT04394182|Ritonavir|ritonavir|mesh-list
56732685|NCT04394182|Lopinavir|lopinavir|mesh-list
56732686|NCT04394182|Azithromycin|azithromycin|mesh-list
56732687|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
56732688|NCT04394182|Tazobactam|tazobactam|mesh-list
56732689|NCT04394182|Piperacillin|piperacillin|mesh-list
56555433|NCT00675181|Protective Agents|protective agents|mesh-ancestor
56555434|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555435|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555436|NCT04241458|Midazolam|midazolam|mesh-list
56555437|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56555438|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56129086|NCT04400136|Lansoprazole|lansoprazole|mesh-list
56732690|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56732691|NCT04394182|Heparin|heparin|mesh-list
56732692|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56732693|NCT04394182|Tinzaparin|tinzaparin|mesh-list
56732694|NCT04394182|Dalteparin|dalteparin|mesh-list
56732695|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56732696|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56732697|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
56732698|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732699|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732700|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56732701|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56732702|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
56732703|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732704|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56732705|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56732706|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
56732707|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56732748|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732749|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
56732750|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732751|NCT00539734|Ranibizumab|ranibizumab|mesh-list
56732752|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56732753|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56732754|NCT00539734|Growth Substances|growth substances|mesh-ancestor
56732755|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732756|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
56732757|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732758|NCT04004572|Pegaspargase|pegaspargase|mesh-list
56732759|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732760|NCT04050436|Cemiplimab|cemiplimab|mesh-list
56732761|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56732762|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732763|NCT01093976|Dronabinol|dronabinol|mesh-list
56732764|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
56732765|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732766|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56732767|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56732768|NCT01093976|Analgesics|analgesics|mesh-ancestor
56732769|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
56732770|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732771|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56732772|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56732773|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732774|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732775|NCT01093976|Hormones|hormones|mesh-ancestor
56732776|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56732777|NCT00329719|Sirolimus|sirolimus|mesh-list
56732778|NCT00329719|Sorafenib|sorafenib|mesh-list
56732779|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732780|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55999148|NCT03527264|Nivolumab|nivolumab|mesh-list
56732787|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732788|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
56732789|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732790|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
56732791|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56732792|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
56732793|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
56732794|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56732795|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732796|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56732797|NCT04008628|Analgesics|analgesics|mesh-ancestor
56732798|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
56732799|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732800|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
56732801|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56732802|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56732803|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56732804|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732805|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56732806|NCT00743834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56732807|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56732808|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56732809|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732810|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732811|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
56732812|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56732813|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
56732814|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56732815|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56732816|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555439|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555440|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555441|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56555442|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56555443|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56555444|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56555445|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
56555447|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
56555448|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
56555449|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555450|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555451|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
56555452|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
56443939|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732817|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56732818|NCT00743912|Rifaximin|rifaximin|mesh-list
56732819|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56732820|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732821|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732822|NCT04060472|Paclitaxel|paclitaxel|mesh-list
56732823|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
56732824|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56732825|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56732826|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732827|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56732831|NCT00329641|Paclitaxel|paclitaxel|mesh-list
56732881|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732882|NCT00924963|Lidocaine|lidocaine|mesh-list
56732883|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
56732884|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
56732885|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56732886|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732887|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
56732888|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732889|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56732890|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56732891|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56732892|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56732893|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732894|NCT00669864|Metformin|metformin|mesh-list
56732895|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
56732896|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
56732897|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56732898|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732899|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732900|NCT00770172|Lenograstim|lenograstim|mesh-list
56732901|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56732902|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
56732903|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732904|NCT00776022|Cetirizine|cetirizine|mesh-list
56732905|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56732906|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56732907|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56732908|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
56732909|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
56732910|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56732911|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732916|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732919|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732920|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56732921|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56732922|NCT00779220|Methotrexate|methotrexate|mesh-list
56732923|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
56732924|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56732925|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
56732926|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56732927|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732928|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56732929|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
56732930|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732931|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732932|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
56732933|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732934|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56732935|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732936|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
55999320|NCT01459406|Levan|levan|mesh-list
56555453|NCT00681343|Daclizumab|daclizumab|mesh-list
56555454|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
56555455|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555456|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56555457|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56555458|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555459|NCT02823808|Glimepiride|glimepiride|mesh-list
56555460|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56555461|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56555462|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555463|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56555464|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
56555465|NCT04151719|Bromides|bromides|mesh-list
56555466|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
56555467|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
56555468|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56555469|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555470|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
56555471|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555472|NCT02822482|Cetuximab|cetuximab|mesh-list
56555473|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56555474|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555475|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
56555476|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
56555477|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56555478|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56555479|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555480|NCT04240834|Aspirin|aspirin|mesh-list
56555481|NCT04240834|Ticagrelor|ticagrelor|mesh-list
56555482|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56555483|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56555484|NCT04240834|Analgesics|analgesics|mesh-ancestor
56555485|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
56555486|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555487|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555488|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555489|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555490|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56732937|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56732938|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56732939|NCT00779376|Zidovudine|zidovudine|mesh-list
56732940|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
56732941|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732942|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56732943|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56732944|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732945|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
56732946|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732947|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56732948|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56732949|NCT00779454|Gemcitabine|gemcitabine|mesh-list
56732950|NCT00779454|Capecitabine|capecitabine|mesh-list
56732951|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
56732952|NCT00779454|Panitumumab|panitumumab|mesh-list
56732953|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56732954|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
56732955|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732956|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56732957|NCT00779454|Antiviral Agents|antiviral agents|mesh-ancestor
56732958|NCT00779454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56732959|NCT00779454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732960|NCT00779454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732961|NCT00779454|Immunologic Factors|immunologic factors|mesh-ancestor
56732962|NCT00779454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732963|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56732964|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
56732965|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
56555491|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56555492|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555493|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56555494|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56555495|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555496|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
56555497|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56555498|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56555499|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56555500|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
56555501|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555502|NCT01200758|Prednisone|prednisone|mesh-list
56555503|NCT01200758|Prednisolone|prednisolone|mesh-list
56555504|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
56555505|NCT01200758|Rituximab|rituximab|mesh-list
56555506|NCT01200758|Doxorubicin|doxorubicin|mesh-list
56555507|NCT01200758|Vincristine|vincristine|mesh-list
56555508|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732966|NCT00773058|Hormones|hormones|mesh-ancestor
56732967|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56732968|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732969|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56732970|NCT00776334|Fosinopril|fosinopril|mesh-list
56732971|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56732972|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
56732973|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56732974|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56732975|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56732976|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56732977|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
56732978|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732979|NCT00667992|Budesonide|budesonide|mesh-list
56732980|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56732981|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56732982|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
56732983|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56732984|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732985|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56732986|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
56732987|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
56555509|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
56555510|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555511|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56555512|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56555513|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
56555514|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555516|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56555517|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56555518|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56555519|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56555520|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56555522|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555523|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
56555524|NCT01200758|Hormones|hormones|mesh-ancestor
56555525|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56555526|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56555527|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56555528|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
56555529|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
56555530|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
56555531|NCT02823106|Verapamil|verapamil|mesh-list
56555532|NCT02823106|Choline|choline|mesh-list
56555533|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56555534|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
56555535|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56555536|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
56555537|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555538|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56732988|NCT00667992|Hormones|hormones|mesh-ancestor
56732989|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56732990|NCT00776490|Glimepiride|glimepiride|mesh-list
56732991|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56732992|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56732993|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56732994|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56732995|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
56732996|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56732997|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56732998|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
56732999|NCT00779922|Lenalidomide|lenalidomide|mesh-list
56733000|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
56733001|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733002|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56733003|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733004|NCT00779922|Growth Substances|growth substances|mesh-ancestor
56733005|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733006|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733007|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56733008|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56733009|NCT00776646|Diuretics|diuretics|mesh-ancestor
56733010|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
56733011|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733012|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56733013|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733014|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733015|NCT00776724|Docetaxel|docetaxel|mesh-list
56733016|NCT00776724|Epirubicin|epirubicin|mesh-list
56733017|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733018|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
56733027|NCT00776802|Etoposide|etoposide|mesh-list
56733031|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733032|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733033|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56733034|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
56733035|NCT00776802|Hormones|hormones|mesh-ancestor
56733036|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733037|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56733038|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733039|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56733040|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56733041|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56444172|NCT00318318|Estrogens|estrogens|mesh-ancestor
56733042|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733043|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733044|NCT00773916|Methylphenidate|methylphenidate|mesh-list
56733045|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56733046|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733047|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56733048|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56733049|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733050|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733051|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
56733052|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733053|NCT00774072|Tobramycin|tobramycin|mesh-list
56733054|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56733055|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733056|NCT00780780|Triamcinolone|triamcinolone|mesh-list
56733057|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56733058|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56733059|NCT00780780|Nepafenac|nepafenac|mesh-list
56733060|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56733061|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733062|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
56733068|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733069|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733070|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56733071|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56733072|NCT00780780|Analgesics|analgesics|mesh-ancestor
56733073|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
56733074|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733075|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733076|NCT00780858|Ganirelix|ganirelix|mesh-list
56733077|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
56733078|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733079|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733080|NCT00777114|Bortezomib|bortezomib|mesh-list
56733081|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733082|NCT00669396|Copper|copper|mesh-list
56733083|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
56733084|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56733085|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
55934708|NCT03864419|Hormones|hormones|mesh-ancestor
56555539|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56555540|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
56555541|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56555542|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56555543|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56555544|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56555545|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555546|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
56555547|NCT02821858|Odalasvir|odalasvir|mesh-list
56555548|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
56555549|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56555550|NCT00876343|Aripiprazole|aripiprazole|mesh-list
56555551|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
56555552|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56555553|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56555554|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56555555|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555556|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555557|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
56303878|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
56555558|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
55989137|NCT01908465|Ebastine|ebastine|mesh-list
56555559|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56555560|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56555561|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56555562|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56555563|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
56555564|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56555565|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56555566|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56555567|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56555568|NCT02627989|Diflucortolone|diflucortolone|mesh-list
56555569|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
56555570|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555571|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
56555572|NCT02627989|Hormones|hormones|mesh-ancestor
56555573|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733086|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56733087|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733088|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56733089|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56733090|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56733091|NCT00669396|Trace Elements|trace elements|mesh-ancestor
56733092|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
56733093|NCT00774462|Rituximab|rituximab|mesh-list
56733094|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56733095|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733096|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
56733097|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733098|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733099|NCT00669318|Rituximab|rituximab|mesh-list
56733100|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
56733101|NCT00669318|Pentostatin|pentostatin|mesh-list
56733102|NCT00669318|Sargramostim|sargramostim|mesh-list
56733103|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56733104|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733105|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
56733106|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733107|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733108|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56733109|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733110|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733111|NCT00774540|Ketorolac|ketorolac|mesh-list
56733112|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56733113|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56733114|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56733115|NCT00774540|Analgesics|analgesics|mesh-ancestor
56733116|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
56733117|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733118|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733119|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733120|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999502|NCT05493618|Hormones|hormones|mesh-ancestor
56733124|NCT00669240|Varenicline|varenicline|mesh-list
56733125|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56733126|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56733127|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
56733128|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733129|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733130|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733131|NCT00669162|Docetaxel|docetaxel|mesh-list
56733132|NCT00669162|Leuprolide|leuprolide|mesh-list
56733133|NCT00669162|Goserelin|goserelin|mesh-list
56733134|NCT00669162|Bicalutamide|bicalutamide|mesh-list
56733135|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733136|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
56733137|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
56733138|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
56733139|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733140|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56733141|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
56733142|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56733143|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733144|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56733145|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
56733146|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
56733147|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733148|NCT00774696|Clarithromycin|clarithromycin|mesh-list
56733149|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56733150|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733151|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56733152|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733153|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733154|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56733155|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56733205|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733206|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56733207|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56733208|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56733209|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56733210|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733211|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56733212|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
56733213|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56733214|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56733215|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
56733216|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56733217|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56733218|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56733219|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56733220|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
56733221|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733222|NCT00400946|Antidotes|antidotes|mesh-ancestor
56733223|NCT00400946|Protective Agents|protective agents|mesh-ancestor
56733224|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
56733225|NCT00400946|Vitamins|vitamins|mesh-ancestor
56733226|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
56733227|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
56733228|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
56733229|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
56733230|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56733231|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56733232|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
56733233|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56733234|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
56733244|NCT00744224|Exenatide|exenatide|mesh-list
56733250|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56733251|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
56733252|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733253|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
56733254|NCT00744224|Hormones|hormones|mesh-ancestor
56733255|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733256|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733257|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56733258|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733259|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
56733260|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
56733261|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733262|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56733263|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56733264|NCT00744224|Protective Agents|protective agents|mesh-ancestor
56733265|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56733266|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56733267|NCT00744224|Incretins|incretins|mesh-ancestor
56444390|NCT00284531|Daclizumab|daclizumab|mesh-list
56733268|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
56733269|NCT00744302|Calcium|calcium|mesh-list
56733270|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56733271|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733272|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56733273|NCT00666588|Cytarabine|cytarabine|mesh-list
56733274|NCT00666588|Etoposide|etoposide|mesh-list
56733275|NCT00666588|Idarubicin|idarubicin|mesh-list
56733276|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
56733277|NCT00666588|Bortezomib|bortezomib|mesh-list
56733278|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56733279|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733280|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56733281|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56733282|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733284|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56733291|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56733292|NCT00689390|Ribavirin|ribavirin|mesh-list
56733293|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56733294|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
56733295|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733296|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
56733297|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733298|NCT00567879|Trastuzumab|trastuzumab|mesh-list
56733299|NCT00567879|Panobinostat|panobinostat|mesh-list
56733300|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56733301|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733302|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56733303|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733304|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733305|NCT00781404|Adenosine|adenosine|mesh-list
56733306|NCT00781404|Analgesics|analgesics|mesh-ancestor
56733307|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
56733308|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733309|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733310|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56733311|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
56733312|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56733313|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
56733314|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
56733315|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733316|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733317|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56733318|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733319|NCT00777504|Growth Substances|growth substances|mesh-ancestor
56733320|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005997|NCT00002590|Leucovorin|leucovorin|mesh-list
56733334|NCT00603915|Gemcitabine|gemcitabine|mesh-list
56733335|NCT00603915|Carboplatin|carboplatin|mesh-list
56733336|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56733337|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733338|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56733339|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
56733340|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733341|NCT00603915|Antiviral Agents|antiviral agents|mesh-ancestor
56733342|NCT00603915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733343|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733344|NCT00603915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56733345|NCT00603915|Immunologic Factors|immunologic factors|mesh-ancestor
56733346|NCT00603915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733347|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56733348|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56733350|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56733351|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
56733352|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
56733353|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
56733354|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
56733355|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
56733356|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56733357|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733358|NCT00926055|Simvastatin|simvastatin|mesh-list
56733359|NCT00926055|Ezetimibe|ezetimibe|mesh-list
56733360|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56733361|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56733362|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56733363|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
56733364|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733365|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56733367|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733377|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733378|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733379|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733380|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733381|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56733382|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733383|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733384|NCT00691028|Infliximab|infliximab|mesh-list
56733385|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
56733386|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56733387|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733388|NCT00690794|Travoprost|travoprost|mesh-list
56733389|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56733390|NCT00690794|Latanoprost|latanoprost|mesh-list
56733391|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56733392|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56733393|NCT00666276|Linezolid|linezolid|mesh-list
56733394|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56733395|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733396|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56733397|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733398|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733399|NCT00567255|Naltrexone|naltrexone|mesh-list
56733400|NCT00567255|Bupropion|bupropion|mesh-list
56733401|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56733402|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56733403|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733404|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
56733405|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733406|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56733407|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
56733408|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56733409|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56733410|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56733411|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733412|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733414|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733415|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56733416|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56733417|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733418|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
56444537|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
56733419|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56733420|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733422|NCT00784446|Capecitabine|capecitabine|mesh-list
56733423|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
56733424|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
56733425|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56733426|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733427|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56733428|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733429|NCT00784446|Growth Substances|growth substances|mesh-ancestor
56733430|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733431|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733432|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56733433|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
56733434|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733435|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56733436|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733437|NCT00744536|Lenalidomide|lenalidomide|mesh-list
56733438|NCT00744536|Melphalan|melphalan|mesh-list
56733439|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
56733440|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733441|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56733442|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733458|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56733459|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733460|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733461|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
56733462|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733463|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56733464|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56733465|NCT00784680|Tamoxifen|tamoxifen|mesh-list
56733466|NCT00784680|Anastrozole|anastrozole|mesh-list
56733467|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56733468|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
56733469|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733470|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733471|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56733472|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733473|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56733474|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56733475|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56733476|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56733477|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56733478|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733479|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733480|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
56733506|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733507|NCT00931437|Vitamin K|vitamin k|mesh-list
56733508|NCT00931437|Vitamins|vitamins|mesh-ancestor
56733509|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
56733510|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733511|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56733512|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56733513|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733514|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
56733515|NCT00931437|Coagulants|coagulants|mesh-ancestor
56733516|NCT00742040|Captopril|captopril|mesh-list
56733517|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56733518|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
56733519|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733520|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733521|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56733522|NCT00926757|Entecavir|entecavir|mesh-list
56733565|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733566|NCT00745004|Ondansetron|ondansetron|mesh-list
56733567|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
56733568|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
56733569|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733570|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733571|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56733572|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
56733573|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
56733574|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56733575|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
56733576|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733577|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733578|NCT00745004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56733579|NCT00745004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56733580|NCT00745004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56733581|NCT00745004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56733582|NCT00745004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56733583|NCT05450978|Lamotrigine|lamotrigine|mesh-list
56733584|NCT05450978|Levetiracetam|levetiracetam|mesh-list
56733585|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
56733586|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
56733587|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56733588|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733589|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733590|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56733591|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733613|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56733614|NCT00777972|Diuretics|diuretics|mesh-ancestor
56733615|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
56733616|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733617|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56733618|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733619|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733620|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56733621|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
56733622|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733623|NCT00778050|Amoxicillin|amoxicillin|mesh-list
56733624|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56733625|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733626|NCT00746486|Budesonide|budesonide|mesh-list
56733627|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733628|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56733629|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
56733630|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733631|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733632|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56733633|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
56733634|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
56733635|NCT00746486|Hormones|hormones|mesh-ancestor
56733636|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733637|NCT00778128|Gemcitabine|gemcitabine|mesh-list
56733638|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56733639|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
56733640|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733641|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733651|NCT00749138|Tamoxifen|tamoxifen|mesh-list
56733656|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56733657|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733658|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56733659|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56733660|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56733661|NCT02563340|Rituximab|rituximab|mesh-list
56733662|NCT02563340|Bortezomib|bortezomib|mesh-list
56733663|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56733664|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733665|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
56733666|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733667|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733668|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
56733669|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56733670|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
56733671|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733672|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733673|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56733674|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
56733675|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56733676|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
56733677|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733678|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733679|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56733680|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
56733681|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
56733682|NCT00782652|Protective Agents|protective agents|mesh-ancestor
56733683|NCT00785382|Pregabalin|pregabalin|mesh-list
56733684|NCT00785382|Analgesics|analgesics|mesh-ancestor
56733685|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
56733686|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733687|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733688|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
56733689|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56733690|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56733694|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56733695|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56733696|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56733697|NCT00667368|Metronidazole|metronidazole|mesh-list
56733698|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56733699|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56733700|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56733701|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56733702|NCT00785460|Benphothiamine|benphothiamine|mesh-list
56733703|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56733704|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
56733705|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733706|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
56733707|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
56733708|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733709|NCT00567567|Vitamin A|vitamin a|mesh-list
56733710|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
56733711|NCT00567567|Melphalan|melphalan|mesh-list
56733712|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
56733713|NCT00567567|Thiotepa|thiotepa|mesh-list
56733714|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56733715|NCT00567567|Cisplatin|cisplatin|mesh-list
56733716|NCT00567567|Carboplatin|carboplatin|mesh-list
56733717|NCT00567567|Doxorubicin|doxorubicin|mesh-list
56733718|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56733719|NCT00567567|Etoposide|etoposide|mesh-list
56733720|NCT00567567|Vincristine|vincristine|mesh-list
56733722|NCT00567567|Topotecan|topotecan|mesh-list
56733723|NCT00567567|Tretinoin|tretinoin|mesh-list
56733724|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
56733725|NCT00567567|Isotretinoin|isotretinoin|mesh-list
56733726|NCT00567567|Lenograstim|lenograstim|mesh-list
56733727|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56733728|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
56733729|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733730|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733731|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56733732|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
56733734|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733737|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
56733738|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56733739|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56733740|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56733741|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733742|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56733743|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56733744|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
56733745|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
56733746|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
56733747|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56733748|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
56733749|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
56733750|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
56733751|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
56733752|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56733753|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56733754|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733755|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733756|NCT00666198|Urological Agents|urological agents|mesh-ancestor
56733757|NCT00778596|Prednisolone|prednisolone|mesh-list
56733758|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733759|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
56733760|NCT00778596|Hormones|hormones|mesh-ancestor
56733761|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733762|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733763|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56733764|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733765|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56733766|NCT00778674|Benazepril|benazepril|mesh-list
56733767|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56733768|NCT00778674|Diuretics|diuretics|mesh-ancestor
56733769|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
56733775|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
56733776|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733777|NCT00778752|Lenalidomide|lenalidomide|mesh-list
56733778|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
56733779|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733780|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56733781|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733782|NCT00778752|Growth Substances|growth substances|mesh-ancestor
56733783|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733784|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733785|NCT00926835|Lamotrigine|lamotrigine|mesh-list
56733786|NCT00926835|Dexetimide|dexetimide|mesh-list
56733787|NCT00926835|Aripiprazole|aripiprazole|mesh-list
56733788|NCT00926835|Mirtazapine|mirtazapine|mesh-list
56733789|NCT00926835|Citalopram|citalopram|mesh-list
56733790|NCT00926835|Bupropion|bupropion|mesh-list
56733791|NCT00926835|Paroxetine|paroxetine|mesh-list
56733792|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56733793|NCT00926835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56733794|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56733795|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56444911|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56733796|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733797|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733798|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
56733799|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733800|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56733801|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
56733802|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56733803|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56733804|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56733821|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56733822|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56733823|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56733824|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56733825|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56733826|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56733827|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
56733828|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56733829|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56733830|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56733831|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56733832|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
56733833|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
56733834|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56733835|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56733836|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56733837|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56733838|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
56733839|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56733840|NCT00930033|Sunitinib|sunitinib|mesh-list
56733841|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733842|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56733843|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733844|NCT00930033|Growth Substances|growth substances|mesh-ancestor
56733845|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733846|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733847|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56733848|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733849|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733850|NCT00664560|Celecoxib|celecoxib|mesh-list
56733851|NCT00664560|Antacids|antacids|mesh-list
56733852|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56733860|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56733861|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56733862|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733863|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733864|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56733865|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56733866|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56733867|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56733868|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
56733869|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733870|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56733871|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56733872|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733873|NCT00688688|Mirabegron|mirabegron|mesh-list
56733874|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56733875|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56733876|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56733877|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56733878|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
56733879|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56733880|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733881|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733882|NCT00688688|Urological Agents|urological agents|mesh-ancestor
56733883|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56733884|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56733885|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
56733886|NCT00930189|Triamcinolone|triamcinolone|mesh-list
56733887|NCT00930189|Ranibizumab|ranibizumab|mesh-list
56733888|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56733903|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56733904|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
56733905|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56733906|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733907|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56733908|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56733909|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56733910|NCT00937131|Rituximab|rituximab|mesh-list
56733911|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56733912|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733913|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
56733914|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733915|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733916|NCT00778908|Cisplatin|cisplatin|mesh-list
56733917|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733918|NCT02561468|Nefopam|nefopam|mesh-list
56733919|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56733920|NCT02561468|Analgesics|analgesics|mesh-ancestor
56733921|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
56733922|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733923|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733924|NCT02555748|Sunitinib|sunitinib|mesh-list
56733925|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56733926|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56733927|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56733928|NCT02555748|Growth Substances|growth substances|mesh-ancestor
56733929|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733930|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
56733931|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56733932|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733933|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733934|NCT00930345|Sunitinib|sunitinib|mesh-list
56733945|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56733946|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733947|NCT00746720|Etoricoxib|etoricoxib|mesh-list
56733948|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56733949|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56733950|NCT00746720|Analgesics|analgesics|mesh-ancestor
56733951|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
56733952|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733953|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733954|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56733955|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56733956|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56733957|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56733958|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56733959|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56733960|NCT00686972|Glucagon|glucagon|mesh-list
56733961|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56733962|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56733963|NCT00686972|Hormones|hormones|mesh-ancestor
56733964|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56733965|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733966|NCT00686972|Incretins|incretins|mesh-ancestor
56733967|NCT00665652|Lenalidomide|lenalidomide|mesh-list
56733968|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
56733969|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733994|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56733995|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56733996|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56733997|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
56733998|NCT04498923|Hormones|hormones|mesh-ancestor
56733999|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734000|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56734001|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734002|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
56734003|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
56734004|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734005|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
56734006|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56734007|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56734008|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
56734009|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734010|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734011|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56734012|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56734013|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56734014|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
56734015|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
56734016|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
56734017|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56734018|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
56734019|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56734020|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
56734021|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56734022|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
56734023|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734024|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734025|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
56734026|NCT04046874|Analgesics|analgesics|mesh-list
56734027|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
56734033|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734034|NCT00786318|Ziprasidone|ziprasidone|mesh-list
56734035|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56734036|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
56734037|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734038|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734039|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734040|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56734041|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56734042|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734043|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734044|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56734045|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
56734046|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56734047|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56734048|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56734049|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734050|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734051|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734052|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56734053|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56734054|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
56734055|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734056|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734057|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56734058|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56734059|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
56734060|NCT00937911|Darexaban|darexaban|mesh-list
56734061|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56734062|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
56734063|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56734064|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
56734065|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734068|NCT00930891|Bevacizumab|bevacizumab|mesh-list
56734073|NCT00930891|Growth Substances|growth substances|mesh-ancestor
56734074|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734075|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
56734076|NCT00938379|Insect Repellents|insect repellents|mesh-list
56734077|NCT00938379|Protective Agents|protective agents|mesh-ancestor
56734078|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734079|NCT00661830|Gemcitabine|gemcitabine|mesh-list
56734080|NCT00661830|Sorafenib|sorafenib|mesh-list
56734081|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56734082|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
56734083|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734084|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734085|NCT00661830|Antiviral Agents|antiviral agents|mesh-ancestor
56734086|NCT00661830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734087|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734088|NCT00661830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734089|NCT00661830|Immunologic Factors|immunologic factors|mesh-ancestor
56734090|NCT00661830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734091|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56734092|NCT00932529|Olanzapine|olanzapine|mesh-list
56734093|NCT00932529|Risperidone|risperidone|mesh-list
56734094|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56734095|NCT00932529|Ziprasidone|ziprasidone|mesh-list
56734096|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56734097|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
56734098|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734099|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734100|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734101|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56734102|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56734119|NCT00783744|Glimepiride|glimepiride|mesh-list
56734120|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
56734121|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
56734122|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
56734123|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56734124|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734125|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56734126|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734127|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
56734128|NCT00932685|Midazolam|midazolam|mesh-list
56734129|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56734130|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56734131|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734132|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734133|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56734134|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56734135|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734136|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56734137|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
56734138|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
56734139|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
56734140|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
56734141|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734142|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734143|NCT00931125|Ranibizumab|ranibizumab|mesh-list
56734144|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56734145|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56734146|NCT00931125|Growth Substances|growth substances|mesh-ancestor
56734147|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734148|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
56734149|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734150|NCT00932763|Amlodipine|amlodipine|mesh-list
56734151|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56734152|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56734153|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56734157|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
56734158|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56734159|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
56734160|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734161|NCT00783900|Metoprolol|metoprolol|mesh-list
56734162|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56734163|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56734164|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
56734165|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
56734166|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734167|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734168|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56734169|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56734170|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56734171|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
56734172|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734173|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734174|NCT00938613|Budesonide|budesonide|mesh-list
56734175|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734176|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56734177|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
56734178|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734179|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734180|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56734181|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
56734182|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
56734183|NCT00938613|Hormones|hormones|mesh-ancestor
56734184|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734204|NCT00931203|Analgesics|analgesics|mesh-ancestor
56734205|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
56734206|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734207|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734208|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734209|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734210|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56734211|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56734212|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734213|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734214|NCT00565773|Sirolimus|sirolimus|mesh-list
56734215|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
56734216|NCT00565773|Abatacept|abatacept|mesh-list
56734217|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56734218|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734219|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56734220|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734221|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
56734222|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734223|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
56734224|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734225|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56734226|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56734227|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734228|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734229|NCT00570492|Fluticasone|fluticasone|mesh-list
56734231|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734232|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56734233|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
56734234|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734235|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734236|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56734240|NCT00931281|Ritonavir|ritonavir|mesh-list
56734246|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56734247|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56734248|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
56734249|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734250|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56734251|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56734255|NCT04014855|Lactoferrin|lactoferrin|mesh-list
56734256|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734257|NCT03401320|Letrozole|letrozole|mesh-list
56734258|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734259|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56734260|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56734261|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734262|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734263|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56734264|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
56734265|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734266|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734267|NCT00571922|Acamprosate|acamprosate|mesh-list
56734268|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56734269|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
56734270|NCT00933231|Prednisone|prednisone|mesh-list
56734271|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
56734272|NCT00933231|Ramipril|ramipril|mesh-list
56734273|NCT00933231|Irbesartan|irbesartan|mesh-list
56734274|NCT00933231|Tacrolimus|tacrolimus|mesh-list
56734275|NCT00933231|Basiliximab|basiliximab|mesh-list
56734276|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734277|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
56190155|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
56190156|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
56190157|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56190158|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
56190159|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190160|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190161|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56190162|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
56190163|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56190164|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56190165|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56190166|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
56029135|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56029136|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029137|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029138|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56734278|NCT00933231|Hormones|hormones|mesh-ancestor
56734279|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734280|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734281|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56734282|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734283|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734284|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
56734285|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56734286|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734287|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734288|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
56734289|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
56734290|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734291|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56734292|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56734293|NCT00933231|Protective Agents|protective agents|mesh-ancestor
56734294|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56734295|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56734296|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
56734297|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56734298|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734299|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56734300|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
56734301|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56734302|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56734304|NCT03489525|Antibodies|antibodies|mesh-list
56734325|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734326|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734327|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734328|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56734329|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56734331|NCT04059224|Dabrafenib|dabrafenib|mesh-list
56734332|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734333|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56734334|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734335|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734336|NCT00686894|Infliximab|infliximab|mesh-list
56734337|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
56734338|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56734339|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734340|NCT00328627|Pioglitazone|pioglitazone|mesh-list
56734341|NCT00328627|Alogliptin|alogliptin|mesh-list
56734342|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56734343|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734344|NCT00328627|Incretins|incretins|mesh-ancestor
56734345|NCT00328627|Hormones|hormones|mesh-ancestor
56734346|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734347|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56734348|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
56734349|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734350|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734374|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56734375|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56734376|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734377|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
56734378|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56734379|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
56734380|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56734381|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
56734382|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
56734383|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
56734384|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
56734385|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56734386|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734387|NCT00663858|Cetrorelix|cetrorelix|mesh-list
56734388|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56734389|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
56734390|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56734391|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734392|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
56734393|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734394|NCT05223400|Clindamycin|clindamycin|mesh-list
56734395|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
56734396|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
56445510|NCT00289445|Antidotes|antidotes|mesh-ancestor
56734397|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56734398|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734399|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56734400|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734401|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734402|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
56734403|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56734404|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
56734405|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734406|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734412|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734413|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56734414|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
56734415|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
56734416|NCT00790608|Protective Agents|protective agents|mesh-ancestor
56734417|NCT00749450|Fluorouracil|fluorouracil|mesh-list
56734418|NCT00749450|Capecitabine|capecitabine|mesh-list
56734419|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
56734420|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
56734421|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734422|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56734423|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734424|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734425|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
56734426|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734427|NCT00795444|Maraviroc|maraviroc|mesh-list
56734428|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56734429|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56734430|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734431|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56734432|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56734433|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
56734434|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734435|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56734436|NCT02561936|Rilpivirine|rilpivirine|mesh-list
56734437|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56734438|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56734439|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734440|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734441|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
56734442|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734443|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56734444|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56734445|NCT00752648|Simeprevir|simeprevir|mesh-list
56734446|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
56734447|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734448|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
55756348|NCT04980105|Prednisolone|prednisolone|mesh-list
56734449|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734450|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734451|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
56734452|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56734453|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56734454|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734455|NCT00752882|Ceftazidime|ceftazidime|mesh-list
56734456|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56734457|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734458|NCT01060735|Vitamin D|vitamin d|mesh-list
56734459|NCT01060735|Vitamins|vitamins|mesh-ancestor
56734460|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
56734461|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734462|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56734463|NCT02555358|Docetaxel|docetaxel|mesh-list
56734464|NCT02555358|Capecitabine|capecitabine|mesh-list
56734465|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
56734466|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734467|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56734468|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56734469|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56734470|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734471|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56734472|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
56734473|NCT00683774|Diazoxide|diazoxide|mesh-list
56734474|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56734475|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
56734476|NCT00787410|Gefitinib|gefitinib|mesh-list
56734495|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56734496|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56734497|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734498|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
56734499|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56734500|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56734501|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56734502|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
56734503|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734504|NCT00790998|Ivermectin|ivermectin|mesh-list
56734505|NCT00790998|Moxidectin|moxidectin|mesh-list
56734506|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56734507|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734508|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
56734509|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
56734510|NCT02555046|Anesthetics|anesthetics|mesh-list
56734511|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734512|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734513|NCT00354679|Bevacizumab|bevacizumab|mesh-list
56734514|NCT00354679|Irinotecan|irinotecan|mesh-list
56734515|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56734516|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734517|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56734518|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56734519|NCT00354679|Growth Substances|growth substances|mesh-ancestor
56734520|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734521|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
56734522|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56734523|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56734524|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734525|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734538|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734539|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734540|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
56734541|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734542|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734543|NCT02022592|Midazolam|midazolam|mesh-list
56734544|NCT02022592|Lormetazepam|lormetazepam|mesh-list
56734545|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56734546|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56734547|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734548|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734549|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56734550|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56734551|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734552|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56734553|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
56734554|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
56734555|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
56734556|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
56734557|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734558|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734559|NCT00683618|Atorvastatin|atorvastatin|mesh-list
56734560|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56734561|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56734562|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56734563|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
56734564|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734587|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
56734588|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734589|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56734590|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56734591|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56734592|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56734593|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56734594|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56734595|NCT00795678|Gemcitabine|gemcitabine|mesh-list
56734596|NCT00795678|Paclitaxel|paclitaxel|mesh-list
56734597|NCT00795678|Vinorelbine|vinorelbine|mesh-list
56734598|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56734599|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
56734600|NCT00795678|Doxorubicin|doxorubicin|mesh-list
56734601|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56734602|NCT00795678|Capecitabine|capecitabine|mesh-list
56734603|NCT00795678|Trastuzumab|trastuzumab|mesh-list
56734604|NCT00795678|Lapatinib|lapatinib|mesh-list
56734605|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56734606|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734607|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
56734608|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
56734609|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
56734610|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734611|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734612|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
56734613|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734614|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734615|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56734616|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
56734617|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56734618|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56734619|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
56734620|NCT00795678|Antiviral Agents|antiviral agents|mesh-ancestor
56734621|NCT00795678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734622|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734627|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56734628|NCT00753038|Paclitaxel|paclitaxel|mesh-list
56734629|NCT00753038|Carboplatin|carboplatin|mesh-list
56734630|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56734631|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734632|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
56734633|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
56734634|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56734635|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734636|NCT00795756|Cytarabine|cytarabine|mesh-list
56734637|NCT00795756|Methotrexate|methotrexate|mesh-list
56734638|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56734639|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
56734640|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56734641|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734642|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56734643|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
56734644|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734645|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734646|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
56734647|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734648|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56734649|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734650|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
56734651|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734653|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
56734674|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
56734675|NCT01563952|Sirolimus|sirolimus|mesh-list
56734676|NCT01563952|Umirolimus|umirolimus|mesh-list
56734677|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56734678|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734679|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56734680|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734681|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
56734682|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734683|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
56734684|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734685|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734686|NCT00795912|Atorvastatin|atorvastatin|mesh-list
56734687|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56734688|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56734689|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
56734690|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734691|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56734692|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56734693|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734694|NCT00788034|Vortioxetine|vortioxetine|mesh-list
56734695|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
56734696|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734697|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56734698|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56734699|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734700|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734701|NCT00788034|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56734702|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56734703|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56734704|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734705|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734706|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
56734707|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56734708|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56007348|NCT01063049|Bisacodyl|bisacodyl|mesh-list
56734710|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56734711|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
56734712|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56734713|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
56734714|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56734715|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734716|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56734717|NCT00688064|Doxycycline|doxycycline|mesh-list
56734719|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56734720|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734721|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
56734722|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56734723|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56734724|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56734725|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56734726|NCT00688064|Analgesics|analgesics|mesh-ancestor
56734727|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
56734728|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734729|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734730|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734731|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734732|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
56734733|NCT00788112|Vorinostat|vorinostat|mesh-list
56734734|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734735|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56734736|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734737|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734738|NCT03112174|Venetoclax|venetoclax|mesh-list
56734739|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734740|NCT00749918|Vitamin D|vitamin d|mesh-list
56734741|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
56734742|NCT00749918|Vitamins|vitamins|mesh-ancestor
56734743|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
56734744|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734745|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56734746|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56734747|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
56734748|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734749|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
56734750|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56734751|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56734752|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734753|NCT04058132|Urological Agents|urological agents|mesh-ancestor
56734754|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56734755|NCT00791544|Sorafenib|sorafenib|mesh-list
56734756|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734757|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56734758|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734759|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734760|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56734761|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
56734762|NCT05171686|Torsemide|torsemide|mesh-list
56734763|NCT05171686|Furosemide|furosemide|mesh-list
56734764|NCT05171686|Bumetanide|bumetanide|mesh-list
56734765|NCT05171686|Diuretics|diuretics|mesh-list
56734766|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56734767|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
56734768|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734769|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56734770|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56734771|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734772|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56734773|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56734774|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56734775|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56734776|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
56734777|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734778|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56734780|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734788|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734789|NCT00683384|Etanercept|etanercept|mesh-list
56734790|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56734791|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56734792|NCT00683384|Analgesics|analgesics|mesh-ancestor
56734793|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
56734794|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734795|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734796|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734797|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734798|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56734799|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734800|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
56734801|NCT00753740|Camptothecin|camptothecin|mesh-list
56734802|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56734803|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734804|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56734805|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56734806|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734807|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734808|NCT00326911|Gemcitabine|gemcitabine|mesh-list
56734809|NCT00326911|Bevacizumab|bevacizumab|mesh-list
56734810|NCT00326911|Cetuximab|cetuximab|mesh-list
56734811|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56734812|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734813|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56734814|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56734815|NCT00326911|Growth Substances|growth substances|mesh-ancestor
56734816|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734817|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
56734818|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56734819|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
56734820|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734821|NCT00326911|Antiviral Agents|antiviral agents|mesh-ancestor
56734828|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56734829|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734830|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734831|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734832|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56734833|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56734834|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
56734835|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734836|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734837|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56734838|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56734839|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
56734840|NCT00747110|Budesonide|budesonide|mesh-list
56734841|NCT00747110|Mesalamine|mesalamine|mesh-list
56734842|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56734843|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56734844|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
56734845|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734846|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734847|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56734848|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56734849|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
56734850|NCT00747110|Hormones|hormones|mesh-ancestor
56734851|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56734852|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56734853|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56734854|NCT00747110|Analgesics|analgesics|mesh-ancestor
56734855|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
56734856|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56734872|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734873|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
56734874|NCT01057615|Vitamins|vitamins|mesh-ancestor
56734875|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
56734876|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734877|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
56734878|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734879|NCT01057615|Protective Agents|protective agents|mesh-ancestor
56734880|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
56734881|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56734882|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
56734883|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734884|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734885|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56734886|NCT00788424|Protective Agents|protective agents|mesh-ancestor
56734887|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56734888|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56734889|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734890|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734891|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
56734892|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56734893|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
56734894|NCT00791856|Testosterone|testosterone|mesh-list
56734895|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
56734896|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
56734897|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56734898|NCT00791856|Androgens|androgens|mesh-ancestor
56734899|NCT00791856|Hormones|hormones|mesh-ancestor
56734918|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734919|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
56734920|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56734921|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
56734922|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734924|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56734925|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
56734926|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734927|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734928|NCT00990418|Fentanyl|fentanyl|mesh-list
56734929|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56734930|NCT00990418|Narcotics|narcotics|mesh-ancestor
56734931|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734932|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734933|NCT00990418|Analgesics|analgesics|mesh-ancestor
56734934|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
56734935|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56734936|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56734937|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56734938|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
56734939|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
56734940|NCT02562950|Midazolam|midazolam|mesh-list
56734941|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56734942|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56734943|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56734944|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734945|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56734946|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56734947|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734948|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56734949|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
56734950|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
56734951|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
56734952|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
56734953|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734954|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734957|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56734958|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56734959|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734960|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56734961|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56734962|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56734963|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
56734964|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56734965|NCT00687440|Docetaxel|docetaxel|mesh-list
56734966|NCT00687440|Doxorubicin|doxorubicin|mesh-list
56734967|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56734968|NCT00687440|Trastuzumab|trastuzumab|mesh-list
56734969|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56734970|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
56734971|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
56734972|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
56734973|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56734974|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56734975|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56734976|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56734977|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56734978|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56734979|NCT02554734|Levodopa|levodopa|mesh-list
56734980|NCT02554734|Carbidopa|carbidopa|mesh-list
56734981|NCT02554734|Entacapone|entacapone|mesh-list
56734982|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56734983|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56734984|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
56735002|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56735004|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735005|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56735006|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56735007|NCT00755066|Fluticasone|fluticasone|mesh-list
56735008|NCT00755066|Xhance|xhance|mesh-list
56735009|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735010|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56735011|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
56735012|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735013|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735014|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56735015|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
56735016|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
56735017|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56735018|NCT00990574|Anesthetics|anesthetics|mesh-list
56735019|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735020|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735021|NCT00659490|Naproxen|naproxen|mesh-list
56735022|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56735023|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56735024|NCT00659490|Analgesics|analgesics|mesh-ancestor
56735025|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
56735026|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735027|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735028|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735029|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56735030|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
56735060|NCT00792246|Voriconazole|voriconazole|mesh-list
56735061|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
56735062|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735063|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56735064|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56735065|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735066|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735067|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56735068|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
56735069|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735070|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735071|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56735072|NCT00539500|Carboplatin|carboplatin|mesh-list
56735073|NCT00539500|Etoposide|etoposide|mesh-list
56735074|NCT00539500|Melphalan|melphalan|mesh-list
56735075|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735076|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56735077|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56735078|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56735079|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735080|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735081|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56735082|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
56735083|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56735084|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735085|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
56735086|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735095|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735096|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
56735097|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735098|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56735099|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56735100|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56735101|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56735102|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56735103|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56735104|NCT00990808|Atorvastatin|atorvastatin|mesh-list
56735105|NCT00990808|Anacetrapib|anacetrapib|mesh-list
56735106|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56735107|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56735108|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
56735109|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735110|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56735111|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56735112|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735113|NCT00797160|Propofol|propofol|mesh-list
56735114|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56735115|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735116|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735117|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56735118|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
56735119|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
56735120|NCT00682448|Metformin|metformin|mesh-list
56735121|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56735122|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735123|NCT04003792|Bevacizumab|bevacizumab|mesh-list
56735124|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
56735125|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56735126|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735132|NCT00990886|Oxybutynin|oxybutynin|mesh-list
56735135|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735136|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735137|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56735138|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56735139|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
56735140|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735141|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735142|NCT00990886|Urological Agents|urological agents|mesh-ancestor
56735143|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
56735144|NCT00797394|Urological Agents|urological agents|mesh-ancestor
56735145|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56735147|NCT00681824|Aprotinin|aprotinin|mesh-list
56735148|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
56735149|NCT00681824|Coagulants|coagulants|mesh-ancestor
56735150|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56735151|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56735152|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
56735153|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735154|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735155|NCT00797472|Bleomycin|bleomycin|mesh-list
56735156|NCT00797472|Dacarbazine|dacarbazine|mesh-list
56735157|NCT00797472|Vinblastine|vinblastine|mesh-list
56735158|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56735159|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735160|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735161|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56735162|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
56735163|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56735164|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56735165|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56735180|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56735181|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
56735182|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735183|NCT00539188|Protective Agents|protective agents|mesh-ancestor
56735184|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735185|NCT00539188|Antidotes|antidotes|mesh-ancestor
56735186|NCT00681590|Vitamin D|vitamin d|mesh-list
56735187|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
56735188|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
56735189|NCT00681590|Vitamins|vitamins|mesh-list
56735190|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
56735191|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735192|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56735193|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56735194|NCT05359432|Empagliflozin|empagliflozin|mesh-list
56735195|NCT05359432|Vildagliptin|vildagliptin|mesh-list
56735196|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56735197|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735198|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56735199|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735200|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56735201|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
56735202|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735203|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56735204|NCT00755534|Capecitabine|capecitabine|mesh-list
56735205|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
56735206|NCT00755534|Irinotecan|irinotecan|mesh-list
56735207|NCT00755534|Cetuximab|cetuximab|mesh-list
56735208|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56735209|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
56735210|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735211|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735212|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56735213|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56735214|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735215|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56735218|NCT00326599|Cediranib|cediranib|mesh-list
56735219|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735220|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56735221|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
56735222|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735223|NCT00326599|Antiviral Agents|antiviral agents|mesh-ancestor
56735224|NCT00326599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735225|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735226|NCT00326599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735227|NCT00326599|Immunologic Factors|immunologic factors|mesh-ancestor
56735228|NCT00326599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735229|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56735231|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56735232|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
56735233|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735234|NCT00750386|Paclitaxel|paclitaxel|mesh-list
56735235|NCT00750386|Carboplatin|carboplatin|mesh-list
56735236|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56735237|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735238|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
56735239|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
56735240|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
56735241|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735242|NCT00539032|Vaccines|vaccines|mesh-list
56735243|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
56735244|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735245|NCT00685802|Cilostazol|cilostazol|mesh-list
56735246|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56735247|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
56735265|NCT01054651|Praziquantel|praziquantel|mesh-list
56735266|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
56735267|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56735268|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56735269|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735270|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735271|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
56735272|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
56735273|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56735274|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
56735275|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56735276|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735277|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735278|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56735279|NCT01054651|Renal Agents|renal agents|mesh-ancestor
56735280|NCT00792714|Mannitol|mannitol|mesh-list
56735281|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56735282|NCT00792714|Diuretics|diuretics|mesh-ancestor
56735283|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
56735284|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735285|NCT04961554|Anesthetics|anesthetics|mesh-list
56735286|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735287|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735288|NCT00354601|Docetaxel|docetaxel|mesh-list
56735289|NCT00354601|Capecitabine|capecitabine|mesh-list
56735290|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735291|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
56735292|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
56735293|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
56735294|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735295|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56735296|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
56735297|NCT01563640|Permethrin|permethrin|mesh-list
56446414|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
56735298|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735306|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735307|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735308|NCT00750620|Urological Agents|urological agents|mesh-ancestor
56735309|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
56735310|NCT03827473|Prednisone|prednisone|mesh-list
56735311|NCT03827473|Cortisone|cortisone|mesh-list
56735312|NCT03827473|Docetaxel|docetaxel|mesh-list
56735313|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
56735314|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
56735315|NCT03827473|Hormones|hormones|mesh-list
56735316|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56735317|NCT03827473|Androgens|androgens|mesh-list
56735318|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
56735319|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735320|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
56735321|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
56735322|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
56735323|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735324|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735325|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
56735326|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735327|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735328|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56735329|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56735330|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735331|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
56735332|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56735333|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
56735334|NCT03827473|Protective Agents|protective agents|mesh-ancestor
56735353|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735354|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56735355|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56735356|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735357|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
56735358|NCT00747968|Exenatide|exenatide|mesh-list
56735359|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56735360|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735361|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56735362|NCT00747968|Incretins|incretins|mesh-ancestor
56735363|NCT00747968|Hormones|hormones|mesh-ancestor
56735364|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735365|NCT00755924|Acetic Acid|acetic acid|mesh-list
56735366|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56735367|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735368|NCT00800748|Ribavirin|ribavirin|mesh-list
56735369|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56735370|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
56735371|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735372|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
56735373|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735374|NCT05426174|Vaccines|vaccines|mesh-list
56735375|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
56735376|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735378|NCT00798252|Docetaxel|docetaxel|mesh-list
56735379|NCT00798252|Doxorubicin|doxorubicin|mesh-list
56735380|NCT00798252|Capecitabine|capecitabine|mesh-list
56735381|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56735382|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735383|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
56735384|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
56735385|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
56735395|NCT00326209|Mesalamine|mesalamine|mesh-list
56735399|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
56735400|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735401|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735402|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735403|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56735404|NCT00537940|Pregabalin|pregabalin|mesh-list
56735405|NCT00537940|Gabapentin|gabapentin|mesh-list
56735406|NCT00537940|Analgesics|analgesics|mesh-ancestor
56735407|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
56735408|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735409|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735410|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
56735411|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56735412|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56735413|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735414|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56735415|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56735416|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56735417|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735418|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56735419|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56735420|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56735421|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735422|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
56735423|NCT00661362|Metformin|metformin|mesh-list
56735424|NCT00661362|Saxagliptin|saxagliptin|mesh-list
56735425|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56735426|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735427|NCT00661362|Incretins|incretins|mesh-ancestor
56735428|NCT00661362|Hormones|hormones|mesh-ancestor
56735429|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735430|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56735431|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
56735432|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735433|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735434|NCT05392946|Dexamethasone|dexamethasone|mesh-list
56029139|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56735435|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
56735436|NCT05392946|Bortezomib|bortezomib|mesh-list
56735437|NCT05392946|Daratumumab|daratumumab|mesh-list
56735438|NCT05392946|Ichthammol|ichthammol|mesh-list
56735439|NCT05392946|BB 1101|bb 1101|mesh-list
56735440|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735441|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
56735442|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
56735443|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735444|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735445|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56735446|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
56735447|NCT05392946|Hormones|hormones|mesh-ancestor
56735448|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735449|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56735450|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735451|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
56735452|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735453|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735454|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56735455|NCT00748202|Complement C1s|complement c1s|mesh-list
56735456|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56735457|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56735458|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
56735459|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735460|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56735461|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735462|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56735463|NCT00325897|Azithromycin|azithromycin|mesh-list
56735480|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56735481|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735482|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
56735483|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
56735484|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56735485|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56735486|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735487|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735488|NCT00793338|Urological Agents|urological agents|mesh-ancestor
56735489|NCT05406856|Cisplatin|cisplatin|mesh-list
56735490|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735491|NCT00344773|Gefitinib|gefitinib|mesh-list
56735492|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735493|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56735494|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735495|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735496|NCT02554344|Curcumin|curcumin|mesh-list
56735497|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56735498|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56735499|NCT02554344|Analgesics|analgesics|mesh-ancestor
56735500|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
56735501|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735502|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735503|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735504|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56735505|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735506|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735507|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735508|NCT01055041|Budesonide|budesonide|mesh-list
56735509|NCT01055041|Doxofylline|doxofylline|mesh-list
56735510|NCT01055041|Montelukast|montelukast|mesh-list
56735511|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735512|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56735521|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56735522|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
56735523|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56735524|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56735525|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735526|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
56735527|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56735528|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735529|NCT00325819|Acetaminophen|acetaminophen|mesh-list
56735530|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56735531|NCT00325819|Analgesics|analgesics|mesh-ancestor
56735532|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
56735533|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735534|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735535|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
56735536|NCT00748358|Sunitinib|sunitinib|mesh-list
56735537|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735538|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56735539|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56735540|NCT00748358|Growth Substances|growth substances|mesh-ancestor
56735541|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735542|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
56735543|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56735544|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735546|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
56735570|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
56735571|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735572|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735573|NCT00687362|Infliximab|infliximab|mesh-list
56735574|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
56735575|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56735576|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56735577|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56735578|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56735579|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
56735580|NCT00751478|Naltrexone|naltrexone|mesh-list
56735581|NCT00751478|Morphine|morphine|mesh-list
56735582|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56735583|NCT00751478|Narcotics|narcotics|mesh-ancestor
56735584|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735585|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735586|NCT00751478|Analgesics|analgesics|mesh-ancestor
56735587|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
56735588|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735589|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56735590|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56735591|NCT00751556|Naproxen|naproxen|mesh-list
56735592|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56735593|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56735594|NCT00751556|Analgesics|analgesics|mesh-ancestor
56735595|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
56735596|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735597|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735598|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735599|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56735600|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
56735615|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56735616|NCT00685334|Olanzapine|olanzapine|mesh-list
56735617|NCT00685334|Aripiprazole|aripiprazole|mesh-list
56735618|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
56735619|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
56735620|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735621|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735622|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56735623|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56735624|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56735625|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735626|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56735627|NCT00685334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56735628|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56735629|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56735630|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735631|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735632|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
56735633|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
56735634|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
56735635|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
56735636|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56735637|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56735638|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56735639|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56735640|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56735641|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56735642|NCT00801294|Nintedanib|nintedanib|mesh-list
56735643|NCT00801294|Afatinib|afatinib|mesh-list
56735644|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735645|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56735646|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735648|NCT04013919|Insulin|insulin|mesh-list
56735657|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56735658|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735659|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735660|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56735661|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56735662|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56735663|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56735664|NCT00685178|Topiramate|topiramate|mesh-list
56735665|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
56735666|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56735667|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735668|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
56735669|NCT00537394|Maraviroc|maraviroc|mesh-list
56735670|NCT00537394|Darunavir|darunavir|mesh-list
56735671|NCT00537394|Tipranavir|tipranavir|mesh-list
56735672|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
56735673|NCT00537394|Etravirine|etravirine|mesh-list
56735674|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56735675|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56735676|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
56735677|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735678|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56735679|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56735680|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735681|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735682|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56735691|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
56735707|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735708|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735709|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
56735710|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735711|NCT00352885|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56735712|NCT00352885|Antidepressive Agents|antidepressive agents|mesh-ancestor
56735713|NCT00352885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56735714|NCT00933387|Paclitaxel|paclitaxel|mesh-list
56735715|NCT00933387|Cetuximab|cetuximab|mesh-list
56735716|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56735717|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735718|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
56735719|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
56735720|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
56735721|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735722|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56735723|NCT00660660|Esomeprazole|esomeprazole|mesh-list
56735724|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56735725|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56735726|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56735727|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735728|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735729|NCT02560766|Gabapentin|gabapentin|mesh-list
56735730|NCT02560766|Analgesics|analgesics|mesh-ancestor
56735731|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
56735732|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735733|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735734|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
56735735|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56735736|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56735750|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
56446857|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
56735751|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735752|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56735753|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735754|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735755|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735756|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
56735758|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735759|NCT05359354|Vaccines|vaccines|mesh-list
56735760|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
56735761|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735762|NCT00344305|Vaccines|vaccines|mesh-list
56735763|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
56735764|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735765|NCT00933777|Everolimus|everolimus|mesh-list
56735766|NCT00933777|Sorafenib|sorafenib|mesh-list
56735767|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735768|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735769|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
56735770|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735771|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56735772|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735773|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735774|NCT00801450|Triamcinolone|triamcinolone|mesh-list
56735799|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56735800|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56735801|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735802|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735803|NCT01060891|Colistin|colistin|mesh-list
56735804|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56735805|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735806|NCT04003402|Ethanol|ethanol|mesh-list
56735807|NCT04003402|ASP8062|asp8062|mesh-list
56735808|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56735809|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735810|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735811|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735812|NCT04003402|Analgesics|analgesics|mesh-ancestor
56735813|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
56735814|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735815|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
56735816|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
56735817|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735818|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735819|NCT00576056|Sorafenib|sorafenib|mesh-list
56735820|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735821|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56735822|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735823|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735824|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
56735825|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
56735826|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735827|NCT05360602|Protective Agents|protective agents|mesh-ancestor
56735845|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
56735846|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735847|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735848|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
56735849|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735850|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56735851|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
56735852|NCT00991744|Hormones|hormones|mesh-ancestor
56735853|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56735854|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56735855|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
56735856|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
56735857|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56735858|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56735859|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56735860|NCT00991744|Protective Agents|protective agents|mesh-ancestor
56735861|NCT00798876|Vitamin E|vitamin e|mesh-list
56735862|NCT00798876|Vitamins|vitamins|mesh-ancestor
56735863|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
56735864|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735865|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
56735866|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735867|NCT00798876|Protective Agents|protective agents|mesh-ancestor
56735868|NCT00989404|Zanamivir|zanamivir|mesh-list
56735869|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
56735870|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735871|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735873|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56735892|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735893|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735894|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735895|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56735896|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56735897|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56735898|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735899|NCT00798954|Sirolimus|sirolimus|mesh-list
56735900|NCT00798954|Paclitaxel|paclitaxel|mesh-list
56735901|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56735902|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735903|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
56735904|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
56735905|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
56735906|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735907|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56735908|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735909|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56735910|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
56029140|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56029141|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56029142|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56029143|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
56029144|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
56029145|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56029146|NCT01428245|Estradiol|estradiol|mesh-list
56029147|NCT01428245|Estrogens|estrogens|mesh-list
56029148|NCT01428245|Progesterone|progesterone|mesh-list
56029149|NCT01428245|Hormones|hormones|mesh-ancestor
56029150|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56029151|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029152|NCT01428245|Progestins|progestins|mesh-ancestor
56029153|NCT00877370|Ertapenem|ertapenem|mesh-list
56029154|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56029190|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
56029191|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
56029192|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56029193|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029194|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56029195|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029301|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56029302|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56190168|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190169|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
56190170|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56190171|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
56190172|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56190173|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
56190175|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190176|NCT01466829|Hormones|hormones|mesh-list
56190177|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
56029345|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
56029346|NCT01654536|Hormones|hormones|mesh-ancestor
56029347|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56029348|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029349|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56735911|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735912|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
56735913|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735914|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56735915|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56735916|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56735917|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
56735918|NCT00934167|Heparin|heparin|mesh-list
56735919|NCT00934167|Calcium heparin|calcium heparin|mesh-list
56735920|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
56735921|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56735922|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56735923|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735924|NCT00801606|Zinc|zinc|mesh-list
56735925|NCT00801606|Trace Elements|trace elements|mesh-list
56735926|NCT00801606|Micronutrients|micronutrients|mesh-list
56735927|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735928|NCT00934245|Vaccines|vaccines|mesh-list
56735929|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
56735930|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735931|NCT02560688|Clopidogrel|clopidogrel|mesh-list
56735932|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56735933|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56735934|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56735935|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56735936|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
56735937|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56735938|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735939|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735940|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
56735941|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
56735955|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56735956|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735957|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56735958|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56735959|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
56735960|NCT00575666|Insulin|insulin|mesh-list
56735961|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56735962|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735963|NCT00934479|Lubiprostone|lubiprostone|mesh-list
56735964|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56735965|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56735966|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735967|NCT00658632|Esomeprazole|esomeprazole|mesh-list
56735968|NCT00658632|Rabeprazole|rabeprazole|mesh-list
56735969|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56735970|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56735971|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56735972|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56735973|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56735974|NCT00677534|Vitamin D|vitamin d|mesh-list
56447083|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56735975|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
56735976|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
56735978|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
56735979|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735980|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56735981|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56735982|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
56735983|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
56735984|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
56735985|NCT00660348|Morphine|morphine|mesh-list
56735986|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56735987|NCT00660348|Narcotics|narcotics|mesh-ancestor
56735988|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56735989|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735990|NCT00660348|Analgesics|analgesics|mesh-ancestor
56735993|NCT03734198|Daratumumab|daratumumab|mesh-list
56735994|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56735995|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56735996|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
56735997|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56735998|NCT01564108|Ranibizumab|ranibizumab|mesh-list
56735999|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56736000|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56736001|NCT01564108|Growth Substances|growth substances|mesh-ancestor
56736002|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736003|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
56736004|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736005|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
56736006|NCT00801918|Ifosfamide|ifosfamide|mesh-list
56736007|NCT00801918|Etoposide|etoposide|mesh-list
56736008|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
56736009|NCT00801918|Interleukin-2|interleukin-2|mesh-list
56736010|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736011|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
56736012|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736013|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736014|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56736015|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
56736016|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736017|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736018|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56736019|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56736020|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56736021|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56736022|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736023|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56736024|NCT00801918|Analgesics|analgesics|mesh-ancestor
56736025|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
56736026|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736027|NCT00799188|Everolimus|everolimus|mesh-list
56736028|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736029|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736033|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56736034|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
56736035|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736036|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736037|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736038|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56736039|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56736040|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736041|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56736042|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56736043|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
56736044|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
56736045|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
56736046|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736047|NCT05408104|Tolvaptan|tolvaptan|mesh-list
56736048|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56736049|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736050|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
56736051|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736052|NCT04837716|Bevacizumab|bevacizumab|mesh-list
56736053|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56736054|NCT04837716|Carboplatin|carboplatin|mesh-list
56736055|NCT04837716|Pemetrexed|pemetrexed|mesh-list
56736056|NCT04837716|Ensartinib|ensartinib|mesh-list
56736057|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
56736058|NCT04837716|Antibodies|antibodies|mesh-list
56736059|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
56736060|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56736061|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
56736062|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736063|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56736064|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56736065|NCT04837716|Growth Substances|growth substances|mesh-ancestor
56736066|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736067|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
56008710|NCT01896518|Nicotine|nicotine|mesh-list
56029350|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
55804690|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
56736068|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
56736069|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736070|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736071|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56736072|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56736073|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56736074|NCT00343291|Paclitaxel|paclitaxel|mesh-list
56736075|NCT00343291|Bevacizumab|bevacizumab|mesh-list
56736076|NCT00343291|Carboplatin|carboplatin|mesh-list
56736077|NCT00343291|Cetuximab|cetuximab|mesh-list
56736078|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56736079|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736080|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
56736081|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
56736082|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
56736083|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736084|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56736085|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56736086|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56736087|NCT00343291|Growth Substances|growth substances|mesh-ancestor
56736088|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736089|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
56736090|NCT05407870|Propofol|propofol|mesh-list
56736091|NCT05407870|Etomidate|etomidate|mesh-list
56736092|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56736093|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736094|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736095|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56736096|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
56736097|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
56736098|NCT03988231|Enoxaparin|enoxaparin|mesh-list
56736110|NCT00658788|Calcitriol|calcitriol|mesh-list
56736112|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56736113|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736114|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56736115|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56736116|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736117|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56736118|NCT00658788|Vitamins|vitamins|mesh-ancestor
56736119|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
56736120|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56736121|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736122|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
56736123|NCT00658788|Hormones|hormones|mesh-ancestor
56736124|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736125|NCT01060969|Acetazolamide|acetazolamide|mesh-list
56736126|NCT01060969|Tadalafil|tadalafil|mesh-list
56447238|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
56736127|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
56736128|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56736129|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56736130|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736131|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736132|NCT01060969|Urological Agents|urological agents|mesh-ancestor
56736133|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
56736134|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56736135|NCT01060969|Diuretics|diuretics|mesh-ancestor
56736136|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
56736137|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736138|NCT05407246|Hemay005|hemay005|mesh-list
56736139|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
56736140|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56736141|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56736142|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736152|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56736153|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56736154|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56736155|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736156|NCT05590312|Anesthetics|anesthetics|mesh-list
56736157|NCT05590312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736158|NCT05590312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736159|NCT00802230|Terbutaline|terbutaline|mesh-list
56736160|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56736161|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
56736162|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736163|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736164|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56736165|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
56736166|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
56736167|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
56736168|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56736169|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56736170|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56736171|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56736172|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
56736173|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736174|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736175|NCT00802308|Morphine|morphine|mesh-list
56736176|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56736177|NCT00802308|Narcotics|narcotics|mesh-ancestor
56736178|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736179|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736180|NCT00802308|Analgesics|analgesics|mesh-ancestor
56736181|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
56736182|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736183|NCT00562965|Dexamethasone|dexamethasone|mesh-list
56736184|NCT00562965|Prednisone|prednisone|mesh-list
56736185|NCT00562965|Prednisolone|prednisolone|mesh-list
56736194|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736195|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736196|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56736197|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
56736198|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736199|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736200|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56736201|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56736202|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736203|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
56736204|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
56736205|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736206|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736207|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
56736208|NCT00562965|Hormones|hormones|mesh-ancestor
56736209|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736210|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56736211|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56736212|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
56736213|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
56736214|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
56736215|NCT00562965|Analgesics|analgesics|mesh-ancestor
56736216|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
56736217|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56736218|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56736219|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736220|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56736221|NCT05406934|Infliximab|infliximab|mesh-list
56736222|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
56736223|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736237|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736238|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56736239|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56736240|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736241|NCT00800358|Calcitriol|calcitriol|mesh-list
56736242|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56736243|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736244|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56736245|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56736246|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736247|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56736248|NCT00800358|Vitamins|vitamins|mesh-ancestor
56736249|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
56736250|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56736251|NCT00934713|Montelukast|montelukast|mesh-list
56736252|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56736253|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
56736254|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56736255|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
56736256|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736257|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029367|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56029368|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
55756572|NCT00761371|Imiquimod|imiquimod|mesh-list
56029370|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029371|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029372|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029373|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
56029374|NCT03439280|Hormones|hormones|mesh-ancestor
56029375|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56029376|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56029377|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029378|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
56029379|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56029380|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56029381|NCT03439280|Growth Substances|growth substances|mesh-ancestor
56029382|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
56029383|NCT00828074|Sorafenib|sorafenib|mesh-list
56029384|NCT00828074|Vinorelbine|vinorelbine|mesh-list
56029385|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029386|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56029387|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029388|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029389|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56029390|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
56029391|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
56029392|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
56029393|NCT03434444|Propranolol|propranolol|mesh-list
56029394|NCT03434444|Oxytocin|oxytocin|mesh-list
56029395|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
56029396|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56736258|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56736259|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56736260|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736261|NCT01057849|Olanzapine|olanzapine|mesh-list
56736262|NCT01057849|Risperidone|risperidone|mesh-list
56736263|NCT01057849|Aripiprazole|aripiprazole|mesh-list
56736264|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56736265|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
56736266|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736267|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736268|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736269|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56736270|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56736271|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736272|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56736273|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56736274|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
56736275|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
56736276|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
56736277|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736278|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736279|NCT01057849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56736280|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56736281|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56736282|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
56736283|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
56736305|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56736306|NCT00939939|Glimepiride|glimepiride|mesh-list
56736307|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56736308|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736309|NCT00939939|Incretins|incretins|mesh-ancestor
56736310|NCT00939939|Hormones|hormones|mesh-ancestor
56736311|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736312|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56736313|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
56736314|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736315|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736316|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56736317|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736318|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
56736319|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56736320|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56736321|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736322|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736323|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
56736324|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736325|NCT00805662|Oxytocin|oxytocin|mesh-list
56736326|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
56736327|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56736328|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736329|NCT00803166|Clobetasol|clobetasol|mesh-list
56736330|NCT00803166|Halobetasol|halobetasol|mesh-list
56736331|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56736332|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736333|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
56736334|NCT00803166|Hormones|hormones|mesh-ancestor
56736335|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736336|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736346|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56736347|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
56736348|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736349|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736350|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736351|NCT00935415|Montelukast|montelukast|mesh-list
56736352|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56736353|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
56736354|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56736355|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
56736356|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736357|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736358|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56736359|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56736360|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736361|NCT00935571|Remifentanil|remifentanil|mesh-list
56736362|NCT00935571|Propofol|propofol|mesh-list
56736363|NCT00935571|Sevoflurane|sevoflurane|mesh-list
56736364|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56736365|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736398|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736399|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
56736400|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56736401|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56736402|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56736403|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56736404|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56736405|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56736406|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56736407|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56736408|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
56736409|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56736410|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
56736411|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56736412|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56736413|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56736414|NCT00935805|Insulin|insulin|mesh-list
56736415|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56736416|NCT00935805|Metformin|metformin|mesh-list
56736417|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
56736418|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
56736419|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
56736420|NCT00935805|Glyburide|glyburide|mesh-list
56447535|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
56736421|NCT00935805|Propranolol|propranolol|mesh-list
56736422|NCT00935805|Amlodipine|amlodipine|mesh-list
56736423|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56736424|NCT00935805|Captopril|captopril|mesh-list
56736425|NCT00935805|Diuretics|diuretics|mesh-list
56736442|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
56736443|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736444|NCT00935961|Docetaxel|docetaxel|mesh-list
56736445|NCT00935961|Everolimus|everolimus|mesh-list
56736446|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736447|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
56736448|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
56736449|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
56736450|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736451|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736452|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
56736453|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736455|NCT01055431|Trace Elements|trace elements|mesh-ancestor
56736456|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
56736457|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736458|NCT00803556|Paclitaxel|paclitaxel|mesh-list
56736459|NCT00803556|Trastuzumab|trastuzumab|mesh-list
56736460|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56736461|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736462|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56736463|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56736464|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56736465|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736466|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56736467|NCT00936195|Ritonavir|ritonavir|mesh-list
56736468|NCT00936195|Lopinavir|lopinavir|mesh-list
56736469|NCT00936195|Tenofovir|tenofovir|mesh-list
56736470|NCT00936195|Lamivudine|lamivudine|mesh-list
56736471|NCT00936195|Zidovudine|zidovudine|mesh-list
56736472|NCT00936195|Emtricitabine|emtricitabine|mesh-list
56736473|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56736474|NCT00936195|Efavirenz|efavirenz|mesh-list
56736475|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56736476|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56736477|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
56736478|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736485|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56736486|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56736487|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56736488|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
56736489|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56736490|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56736491|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56736492|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56736493|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56736494|NCT00680186|Warfarin|warfarin|mesh-list
56736495|NCT00680186|Dabigatran|dabigatran|mesh-list
56736496|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
56736497|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
56736498|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56736499|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
56736500|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736501|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736502|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56736503|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56736504|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
56736505|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736506|NCT00936429|Antacids|antacids|mesh-ancestor
56736507|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736508|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736509|NCT00656292|Simvastatin|simvastatin|mesh-list
56736510|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56736511|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56736512|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
56736513|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736514|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56736515|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56736516|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736517|NCT00352417|Atreleuton|atreleuton|mesh-list
56736518|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56736519|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009165|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736520|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736521|NCT00944541|Maraviroc|maraviroc|mesh-list
56736522|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56736523|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56736524|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736525|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56736526|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56736527|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
56736528|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56736529|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56736530|NCT00944619|Insulin|insulin|mesh-list
56736531|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56736532|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736533|NCT00323869|Gemcitabine|gemcitabine|mesh-list
56736534|NCT00323869|Bevacizumab|bevacizumab|mesh-list
56736535|NCT00323869|Carboplatin|carboplatin|mesh-list
56736536|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56736537|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736538|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56736539|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56736540|NCT00323869|Growth Substances|growth substances|mesh-ancestor
56736541|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736542|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
56736543|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56736544|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
56736545|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736546|NCT00323869|Antiviral Agents|antiviral agents|mesh-ancestor
56736547|NCT00323869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56736548|NCT00323869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736549|NCT00323869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736550|NCT00323869|Immunologic Factors|immunologic factors|mesh-ancestor
56736551|NCT00323557|Molgramostim|molgramostim|mesh-list
56736552|NCT00323557|Sargramostim|sargramostim|mesh-list
56736553|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56736554|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
56736557|NCT00558363|Dutasteride|dutasteride|mesh-list
56736558|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56736559|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56736560|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736561|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736562|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
56736563|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736564|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736565|NCT00323479|Anastrozole|anastrozole|mesh-list
56736566|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56736567|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736568|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56736569|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56736570|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736571|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736572|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56736573|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
56736574|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736575|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736576|NCT00352105|Fluorouracil|fluorouracil|mesh-list
56736577|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736578|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
56736579|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736580|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56736581|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736582|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
56736583|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736601|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736602|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
56736603|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
56736604|NCT00944853|Zinc|zinc|mesh-list
56736605|NCT00944853|Trace Elements|trace elements|mesh-ancestor
56736606|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
56736607|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736608|NCT03985891|Antibodies|antibodies|mesh-list
56736609|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56736610|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
56736611|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736612|NCT00350779|Metformin|metformin|mesh-list
56736613|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56736614|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
56736615|NCT00350779|Glipizide|glipizide|mesh-list
56736616|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56736617|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736618|NCT00350779|Incretins|incretins|mesh-ancestor
56736619|NCT00350779|Hormones|hormones|mesh-ancestor
56736620|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736621|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56736622|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
56736623|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736624|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736625|NCT00656136|Afatinib|afatinib|mesh-list
56736626|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736627|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56736628|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736629|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736630|NCT00676520|Everolimus|everolimus|mesh-list
56736631|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736632|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736633|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
56736634|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736635|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
56736642|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56736643|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56736644|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56736645|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736646|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447759|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
56736647|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736648|NCT00322621|Analgesics|analgesics|mesh-ancestor
56736649|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
56736650|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736651|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
56736652|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56736653|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
56736654|NCT02558972|Droxidopa|droxidopa|mesh-list
56736655|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56736656|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56736657|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
56736658|NCT00809718|Rifapentine|rifapentine|mesh-list
56736659|NCT00809718|Rifampin|rifampin|mesh-list
56736660|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56736661|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56736662|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
56736663|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56736664|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56736665|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56736666|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736667|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736668|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56736669|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
56736670|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56029397|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029398|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56029399|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56029400|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
56029401|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029402|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029403|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56029404|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56029405|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
56029406|NCT04382300|Thalidomide|thalidomide|mesh-list
56029407|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029408|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
56029409|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804691|NCT02371629|Bromides|bromides|mesh-list
56736671|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
56736672|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56736673|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56736674|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56736675|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56736676|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56736677|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56736678|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56736679|NCT05427266|Bupivacaine|bupivacaine|mesh-list
56736680|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
56736681|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
56736682|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736683|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736684|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
56736685|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736686|NCT00575042|Fenofibrate|fenofibrate|mesh-list
56736687|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56736688|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
56736689|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736690|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56736691|NCT00656058|Montelukast|montelukast|mesh-list
56736722|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
56736723|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
56736724|NCT00655980|Vitamins|vitamins|mesh-ancestor
56736725|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
56736726|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736727|NCT00655980|Hematinics|hematinics|mesh-ancestor
56736728|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
56736729|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56736730|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
56736731|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
56736732|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736733|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56736734|NCT00655980|Analgesics|analgesics|mesh-ancestor
56736735|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
56736736|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736737|NCT01063621|Apomorphine|apomorphine|mesh-list
56736738|NCT01063621|Emetics|emetics|mesh-ancestor
56736739|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736740|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
56736741|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736742|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56736743|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
56736744|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
56736745|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736746|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736747|NCT02533141|Simvastatin|simvastatin|mesh-list
56736748|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56736749|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56736750|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
56736751|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736752|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56736767|NCT05589454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56736768|NCT05589454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56736769|NCT05589454|Antimetabolites|antimetabolites|mesh-ancestor
56736770|NCT05589454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736771|NCT05589454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56736772|NCT05589454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56736773|NCT05589454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736774|NCT00803946|Ibuprofen|ibuprofen|mesh-list
56736775|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56736776|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56736777|NCT00803946|Analgesics|analgesics|mesh-ancestor
56736778|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
56736779|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736780|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736781|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736782|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736783|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56736784|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736785|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736786|NCT00676130|Trimethoprim|trimethoprim|mesh-list
56736787|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56736788|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
56736789|NCT00676130|Cephalexin|cephalexin|mesh-list
56736790|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56736791|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56736792|NCT00676130|Renal Agents|renal agents|mesh-ancestor
56736793|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
56736794|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56736795|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56736796|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56736797|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736798|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736800|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56736807|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
56736808|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56736809|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
56736810|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736811|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
56736812|NCT05436002|Protective Agents|protective agents|mesh-ancestor
56736813|NCT02560376|Exenatide|exenatide|mesh-list
56736814|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56736815|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736816|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56736817|NCT02560376|Incretins|incretins|mesh-ancestor
56736818|NCT02560376|Hormones|hormones|mesh-ancestor
56736819|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736820|NCT00535288|Mirtazapine|mirtazapine|mesh-list
56736821|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736822|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
56736823|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56736824|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56736825|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
56736826|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
56736827|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736828|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736829|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56736830|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56736831|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56736832|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56736833|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56736834|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56736835|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
56736836|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56736837|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56736838|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
56736848|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736849|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56736850|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736851|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736852|NCT02560220|Mitomycins|mitomycins|mesh-list
56736853|NCT02560220|Mitomycin|mitomycin|mesh-list
56736854|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56736855|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736856|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
56736857|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736858|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56736859|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736860|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
56736861|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56736862|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
56736863|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736864|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56736865|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56736866|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736867|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
56736868|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
56736869|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56736870|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736871|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447984|NCT00304460|Aldesleukin|aldesleukin|mesh-list
56736872|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736874|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56736875|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736876|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736877|NCT05435378|Vitamins|vitamins|mesh-list
56736878|NCT05435378|Folic Acid|folic acid|mesh-list
56736879|NCT05435378|Niacinamide|niacinamide|mesh-list
56736880|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
56736881|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
56736883|NCT05435378|Hematinics|hematinics|mesh-ancestor
56736888|NCT05589220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736889|NCT05589220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56736890|NCT05589220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56736891|NCT05589220|Cholinergic Agents|cholinergic agents|mesh-ancestor
56736892|NCT05589220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736893|NCT05589220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736894|NCT03895840|Triamcinolone|triamcinolone|mesh-list
56736895|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56736896|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56736897|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56736898|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736899|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
56736900|NCT03895840|Hormones|hormones|mesh-ancestor
56736901|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56736902|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736903|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736904|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
56736905|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736906|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736907|NCT00310375|Ezogabine|ezogabine|mesh-list
56736908|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
56736909|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56736910|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736911|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
56736912|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56736913|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56736914|NCT00309907|Prednisolone|prednisolone|mesh-list
56736915|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
56736916|NCT00309907|Etanercept|etanercept|mesh-list
56736920|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
56736932|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56736933|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56736934|NCT00309907|Analgesics|analgesics|mesh-ancestor
56736935|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
56736936|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736937|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56736938|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
56736939|NCT00655824|Ofatumumab|ofatumumab|mesh-list
56736940|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56736941|NCT03985969|Indomethacin|indomethacin|mesh-list
56736942|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56448056|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736943|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56736944|NCT03985969|Analgesics|analgesics|mesh-ancestor
56736945|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
56736946|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736947|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736948|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56736949|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56736950|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
56736951|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
56736952|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56736953|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56736954|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56736955|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736956|NCT01061437|Lansoprazole|lansoprazole|mesh-list
56736957|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
56736958|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56736963|NCT00575588|Metformin|metformin|mesh-list
56736977|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
56736978|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56736979|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56736980|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736981|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56736982|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56736983|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
56736984|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56736985|NCT00810030|Hematinics|hematinics|mesh-ancestor
56736986|NCT00675428|Natalizumab|natalizumab|mesh-list
56736987|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
56736988|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736989|NCT00760916|Treprostinil|treprostinil|mesh-list
56736990|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56736991|NCT05011760|Amphetamine|amphetamine|mesh-list
56736992|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
56736993|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56736994|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56736995|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
56736996|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
56736997|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56736998|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
56736999|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737000|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737001|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
56009715|NCT00003262|Bleomycin|bleomycin|mesh-list
56737026|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56737027|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56737028|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737030|NCT02559674|Paclitaxel|paclitaxel|mesh-list
56737031|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56737032|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737033|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
56737034|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
56737035|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
56737036|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737037|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56737038|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
56737039|NCT02559674|Antiviral Agents|antiviral agents|mesh-ancestor
56737040|NCT02559674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737041|NCT02559674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737042|NCT02559674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737043|NCT02559674|Immunologic Factors|immunologic factors|mesh-ancestor
56737044|NCT02559674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737045|NCT00761540|Liraglutide|liraglutide|mesh-list
56737046|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56737047|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737048|NCT00761540|Incretins|incretins|mesh-ancestor
56737049|NCT00761540|Hormones|hormones|mesh-ancestor
56737050|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56737051|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56737052|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56737072|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737073|NCT01299753|Propranolol|propranolol|mesh-list
56737074|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56737075|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56737076|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
56737077|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737078|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737079|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737080|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56737081|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56737082|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
56737083|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
56737084|NCT02559440|Phenylephrine|phenylephrine|mesh-list
56737085|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
56737086|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56737087|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
56737088|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56737089|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56737090|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56737091|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
56737092|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737093|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737094|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737095|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
56737096|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
56737097|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737098|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
56737099|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56737100|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
56737101|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56737102|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
56737115|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737116|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
56737117|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737118|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56737119|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737120|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737121|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
56737122|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737123|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737124|NCT00940719|Vitamin D|vitamin d|mesh-list
56737125|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
56737126|NCT00940719|Vitamins|vitamins|mesh-ancestor
56737127|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
56737128|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737129|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56737130|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56737131|NCT00940953|Azelastine|azelastine|mesh-list
56737132|NCT00940953|Budesonide|budesonide|mesh-list
56737133|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56737134|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56737135|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
56737136|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737137|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737165|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56737166|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56737167|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56737168|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56448271|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56737169|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737170|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
56737171|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
56737172|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737173|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
56737174|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56737175|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737176|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56737177|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56737178|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
56737179|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
56737180|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
56737181|NCT00561951|Fesoterodine|fesoterodine|mesh-list
56737182|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56737183|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56737184|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
56737185|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737186|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737187|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737188|NCT00561951|Urological Agents|urological agents|mesh-ancestor
56737189|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
56737190|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56737191|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737192|NCT00762398|Chrysarobin|chrysarobin|mesh-list
56737193|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56737194|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56737195|NCT00762398|Analgesics|analgesics|mesh-ancestor
56737196|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
56737206|NCT00322387|Plerixafor|plerixafor|mesh-list
56737207|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56737208|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56737209|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
56737210|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737211|NCT00561015|Ribavirin|ribavirin|mesh-list
56737212|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
56737213|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56737214|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
56737215|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737216|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
56737217|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737218|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737219|NCT04012047|Cromakalim|cromakalim|mesh-list
56737220|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56737221|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56737222|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
56737223|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737224|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737225|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56737226|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
56737227|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
56737228|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
56737229|NCT00941265|Levodopa|levodopa|mesh-list
56737230|NCT00941265|Benserazide|benserazide|mesh-list
56737231|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56737232|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56737233|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
56737234|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737236|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737254|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737255|NCT00652626|Azacitidine|azacitidine|mesh-list
56737256|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56737257|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
56737258|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737259|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737260|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737261|NCT00560703|Doxycycline|doxycycline|mesh-list
56737262|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56737263|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737264|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
56737265|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56737266|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56737267|NCT00308737|Insulin|insulin|mesh-list
56737268|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56737269|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737270|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56737271|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
56737272|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737273|NCT00941499|Leucovorin|leucovorin|mesh-list
56737274|NCT00941499|Bevacizumab|bevacizumab|mesh-list
56737275|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56737276|NCT00941499|Cetuximab|cetuximab|mesh-list
56737277|NCT00941499|Fluorouracil|fluorouracil|mesh-list
56737278|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
56737279|NCT00941499|Antibodies|antibodies|mesh-list
56737280|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
56737281|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56737282|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737283|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56737284|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56737285|NCT00941499|Growth Substances|growth substances|mesh-ancestor
56737286|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737287|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
56737288|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
56737296|NCT00941499|Vitamins|vitamins|mesh-ancestor
56737297|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
56737298|NCT04752384|Buprenorphine|buprenorphine|mesh-list
56737299|NCT04752384|Tramadol|tramadol|mesh-list
56737300|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56737301|NCT04752384|Narcotics|narcotics|mesh-ancestor
56737302|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737303|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737304|NCT04752384|Analgesics|analgesics|mesh-ancestor
56737305|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
56737306|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737307|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56737308|NCT04743804|Ravulizumab|ravulizumab|mesh-list
56737309|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56737310|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737311|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
56737312|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737313|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
56737314|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
56737315|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56737352|NCT00941967|Gemcitabine|gemcitabine|mesh-list
56737353|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
56737354|NCT00941967|Sorafenib|sorafenib|mesh-list
56737355|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56737356|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
56737357|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737358|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737359|NCT00941967|Antiviral Agents|antiviral agents|mesh-ancestor
56737360|NCT00941967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737361|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737362|NCT00941967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737363|NCT00941967|Immunologic Factors|immunologic factors|mesh-ancestor
56737364|NCT00941967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737365|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56737366|NCT00655746|Dasatinib|dasatinib|mesh-list
56737367|NCT00655746|Omeprazole|omeprazole|mesh-list
56737368|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56737369|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56737370|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56737371|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737372|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737373|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737374|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56737375|NCT00338455|Dobutamine|dobutamine|mesh-list
56737376|NCT00338455|Milrinone|milrinone|mesh-list
56737377|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56737378|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56737379|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
56737380|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
56737381|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737382|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737383|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56737384|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56737385|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56737393|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56737394|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56737395|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737396|NCT00678392|Sorafenib|sorafenib|mesh-list
56737397|NCT00678392|Axitinib|axitinib|mesh-list
56737398|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737399|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56737400|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737401|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737402|NCT00950391|Tacrolimus|tacrolimus|mesh-list
56737403|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737404|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
56737405|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737406|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56737407|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737408|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737409|NCT00804336|Everolimus|everolimus|mesh-list
56737410|NCT00804336|Pasireotide|pasireotide|mesh-list
56737411|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737412|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737413|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
56737414|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737415|NCT00804336|Hormones|hormones|mesh-ancestor
56737416|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56737417|NCT00942201|Dexamethasone|dexamethasone|mesh-list
56737418|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
56737419|NCT00942201|BB 1101|bb 1101|mesh-list
56737420|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56737421|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
56737422|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
56737425|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56737438|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
56737439|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737440|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737441|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
56737442|NCT00946179|Vaccines|vaccines|mesh-list
56737443|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
56737444|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737445|NCT00950625|Lidocaine|lidocaine|mesh-list
56737446|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
56737447|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
56737448|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737449|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737450|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
56737451|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737452|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56737453|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56029451|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56029452|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56029453|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56029454|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
56029490|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
56029491|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56029492|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56029493|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
56029494|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
56029495|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56029496|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029530|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56029531|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56029532|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029534|NCT01512797|Hormones|hormones|mesh-ancestor
56029535|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56029536|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56029562|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56029563|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
56029564|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
56029565|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56029566|NCT02203019|Analgesics|analgesics|mesh-ancestor
56029567|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
56029568|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029569|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56029570|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56029571|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56029572|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
56029573|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029574|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029575|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56029576|NCT02203019|Narcotics|narcotics|mesh-ancestor
56029577|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56029578|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
56190192|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56190193|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
56190194|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
56190195|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190196|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56190197|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56190198|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190199|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56737454|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56737455|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56737456|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737457|NCT00942591|Interferons|interferons|mesh-list
56737458|NCT00942591|Interferon-beta|interferon-beta|mesh-list
56737459|NCT00942591|Atorvastatin|atorvastatin|mesh-list
56737460|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
56737461|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737462|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
56737463|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737464|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56737465|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56737466|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
56737467|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737468|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56737469|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56737470|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737471|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
56737472|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737473|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56737474|NCT00946335|Temozolomide|temozolomide|mesh-list
56737475|NCT00946335|Veliparib|veliparib|mesh-list
56737476|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56737477|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
56737478|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737479|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737480|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56737481|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737482|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
56737483|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56737496|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737497|NCT00760448|Insulin|insulin|mesh-list
56737498|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56737499|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
56737500|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
56737501|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
56737502|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
56737503|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56737504|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737505|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56737506|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56737507|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56737508|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56737509|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737510|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737511|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737512|NCT00763178|Analgesics|analgesics|mesh-ancestor
56737513|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
56737514|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737515|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
56737516|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56737517|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
56737518|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56737519|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56737520|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737521|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
56737522|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737523|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
56737524|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737525|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56737540|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737541|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
56737542|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56737543|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56737544|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737545|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56737546|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56448647|NCT00333918|Analgesics|analgesics|mesh-ancestor
56737547|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
56737548|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56737549|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
56737550|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56737551|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737552|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56737553|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737554|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56737555|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
56737556|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
56737557|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737558|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56737559|NCT00806754|Ciclesonide|ciclesonide|mesh-list
56737560|NCT00806754|Azelastine|azelastine|mesh-list
56737561|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
56737562|NCT00806754|Hormones|hormones|mesh-ancestor
56737563|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56737564|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737565|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56737566|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56737567|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
56737568|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737569|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56737582|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737583|NCT00322153|Memantine|memantine|mesh-list
56737584|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56737585|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56737586|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
56737587|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737588|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737589|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737590|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56737591|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56737592|NCT00806910|Conivaptan|conivaptan|mesh-list
56737593|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56737594|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737595|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
56737596|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737597|NCT00807066|Gefitinib|gefitinib|mesh-list
56737598|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737599|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56737600|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737601|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737602|NCT00804960|Letrozole|letrozole|mesh-list
56737603|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737604|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56737605|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56737606|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737607|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737608|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56737609|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
56737610|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56737611|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737612|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
56737613|NCT00805116|Vitamins|vitamins|mesh-ancestor
56737614|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
56737615|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190200|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
56190201|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190202|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56190203|NCT01466959|Protective Agents|protective agents|mesh-ancestor
56737616|NCT03985735|Anesthetics|anesthetics|mesh-list
56737617|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737618|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737619|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56737620|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56737621|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737622|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56737623|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56737624|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56737625|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737626|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
56737627|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737628|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56737629|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56737630|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56737631|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737632|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
56737633|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56737634|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
56737635|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56737636|NCT00672620|Vortioxetine|vortioxetine|mesh-list
56737637|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56737638|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56737639|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56737640|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737641|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737642|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737643|NCT00672620|Analgesics|analgesics|mesh-ancestor
56737644|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
56737645|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737646|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
56737647|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56737648|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
56737649|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56737652|NCT00672620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56737653|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
56737654|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56737655|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56737656|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56737657|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56737658|NCT00764972|Sorafenib|sorafenib|mesh-list
56737659|NCT00764972|Vinorelbine|vinorelbine|mesh-list
56737660|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737661|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56737662|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737663|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737664|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56737665|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
56737666|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
56737667|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
56737668|NCT00673790|Losartan|losartan|mesh-list
56737669|NCT00673790|Lisinopril|lisinopril|mesh-list
56737670|NCT00673790|Nebivolol|nebivolol|mesh-list
56737671|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56737672|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56737673|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56737674|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56737675|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737676|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56737677|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
56737678|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737679|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56737680|NCT00673790|Protective Agents|protective agents|mesh-ancestor
56737681|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737688|NCT00763646|Docetaxel|docetaxel|mesh-list
56737695|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
56737696|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
56737697|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737698|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737699|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
56737700|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737701|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56737702|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56737703|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56737704|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56737705|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737707|NCT00657150|Dabigatran|dabigatran|mesh-list
56737708|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
56737709|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56737710|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56737711|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737712|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
56737713|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56737714|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
56190204|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190205|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
56029621|NCT03247088|Lenograstim|lenograstim|mesh-list
56029622|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029623|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
56029624|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029625|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029626|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56029627|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
56029628|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029629|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029630|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56029631|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56029632|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029633|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56029634|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56029635|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56029636|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
56029637|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56029708|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56029709|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
56029710|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
56029711|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029712|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029713|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
56029714|NCT03808610|Hormones|hormones|mesh-ancestor
56029750|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029752|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
56029753|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190206|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56190207|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190208|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56190209|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
56190210|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56190211|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737715|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737716|NCT00770354|Letrozole|letrozole|mesh-list
56737717|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737718|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56737719|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56737720|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737721|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737722|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56737723|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
56737724|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56737725|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737726|NCT00670748|Aldesleukin|aldesleukin|mesh-list
56737727|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
56737728|NCT00670748|Fludarabine|fludarabine|mesh-list
56737729|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
56737730|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737731|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
56737732|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737733|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56737734|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56737735|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
56737736|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737737|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737738|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56737739|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56737740|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
56737741|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56737742|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56737743|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
56737744|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737745|NCT00646776|Ritonavir|ritonavir|mesh-list
56737758|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56737759|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56737760|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56737761|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
56737762|NCT02558114|Ribavirin|ribavirin|mesh-list
56737763|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
56737764|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737765|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
56737766|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737767|NCT00770666|Bupropion|bupropion|mesh-list
56737768|NCT00770666|Nicotine|nicotine|mesh-list
56737769|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56737770|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
56737771|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737772|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737773|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56737774|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56737775|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
56737776|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737777|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737778|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56737779|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
56737780|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56737781|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56737782|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56737783|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56737784|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
56737785|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56737786|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56737787|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737788|NCT00764036|Artesunate|artesunate|mesh-list
56737789|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
56737790|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56737799|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56737800|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56737801|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737802|NCT00811200|Triamcinolone|triamcinolone|mesh-list
56737803|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56737804|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56737805|NCT00811200|Ranibizumab|ranibizumab|mesh-list
56737806|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56737807|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56737808|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56737809|NCT00811200|Growth Substances|growth substances|mesh-ancestor
56737810|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737811|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
56737812|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737813|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56737814|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
56737815|NCT00811200|Hormones|hormones|mesh-ancestor
56737816|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56737817|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56737818|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
56737819|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737820|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737821|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
56737822|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56737823|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56737824|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56737825|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
56737826|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737827|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56737828|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56737829|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737830|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56622932|NCT02806362|Ritonavir|ritonavir|mesh-list
56737839|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737840|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737841|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56737842|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56737843|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56737844|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
56737845|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737846|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737847|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56737848|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56737849|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
56737851|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
56737852|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
56737853|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737854|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737855|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56737856|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56737857|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56737858|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737859|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56737860|NCT00770744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56737861|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56737862|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56737863|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737864|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737865|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
56737866|NCT00655668|Lenalidomide|lenalidomide|mesh-list
56737867|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
56737868|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737869|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56737870|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56737871|NCT00655668|Growth Substances|growth substances|mesh-ancestor
56737872|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
56737874|NCT00770900|Montelukast|montelukast|mesh-list
56737878|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
56737879|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56737880|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737881|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56737882|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56737883|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737884|NCT00766220|Irinotecan|irinotecan|mesh-list
56737885|NCT00766220|Cetuximab|cetuximab|mesh-list
56737886|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56737887|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56737888|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737889|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737890|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56737891|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56737892|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
56737893|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56737894|NCT00770978|Cephalosporins|cephalosporins|mesh-list
56737895|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56737896|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737897|NCT00764426|Ethanol|ethanol|mesh-list
56737898|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56737899|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737900|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737901|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737902|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
56737903|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
56737925|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737926|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56737927|NCT04048226|Analgesics|analgesics|mesh-ancestor
56737928|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
56737929|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56737930|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56737931|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56737932|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56737933|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
56737934|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737935|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737936|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56737937|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56737938|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
56737939|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
56737940|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56737941|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56737942|NCT00811746|Eszopiclone|eszopiclone|mesh-list
56737943|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56737944|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737945|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737946|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
56737947|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
56737948|NCT04048070|Sufentanil|sufentanil|mesh-list
56737949|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56737950|NCT04048070|Narcotics|narcotics|mesh-ancestor
56737951|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56737952|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737967|NCT00571064|Donepezil|donepezil|mesh-list
56737970|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56737971|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
56737972|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56737973|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56737974|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
56737975|NCT00811980|Vancomycin|vancomycin|mesh-list
56737976|NCT00811980|Linezolid|linezolid|mesh-list
56737977|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56737978|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56737979|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56737980|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56737981|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738033|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738034|NCT05589064|Vitamin D|vitamin d|mesh-list
56738035|NCT05589064|Cholecalciferol|cholecalciferol|mesh-list
56738036|NCT05589064|Vitamins|vitamins|mesh-ancestor
56738037|NCT05589064|Micronutrients|micronutrients|mesh-ancestor
56738038|NCT05589064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738039|NCT05589064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56738040|NCT05589064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56738041|NCT00807690|Tacrolimus|tacrolimus|mesh-list
56738042|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738043|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
56738044|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738045|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56738046|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738047|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738048|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56738049|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
56738050|NCT00814008|Insulin|insulin|mesh-list
56738051|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56738089|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738090|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56738091|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
56738092|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56738093|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
56738094|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
56738095|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
56738096|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
56738097|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56738098|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
56738099|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738100|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738101|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56738102|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
56738103|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56738104|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
56738105|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738106|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738107|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56738108|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
56738109|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
56738110|NCT00771368|Protective Agents|protective agents|mesh-ancestor
56738111|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
56738112|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56738113|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738114|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738115|NCT00771680|Insulin|insulin|mesh-list
56738116|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56738117|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
56738118|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
56738119|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56738120|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
56738121|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
56738123|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56738128|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738129|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738130|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
56738131|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56738132|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
56738133|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738134|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
56738135|NCT00669032|Protective Agents|protective agents|mesh-ancestor
56738136|NCT00775580|Atenolol|atenolol|mesh-list
56738137|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56738138|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56738139|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
56738140|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
56449242|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738141|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738142|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738143|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56738144|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56738145|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56738146|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
56738147|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738148|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738149|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
56738150|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56738151|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56738152|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738153|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
56738154|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738171|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738172|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738173|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
56738174|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56738175|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738176|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56738177|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
56738178|NCT00321919|Hematinics|hematinics|mesh-ancestor
56738179|NCT00812214|Eszopiclone|eszopiclone|mesh-list
56738180|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56738181|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738182|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738183|NCT00560391|Dexamethasone|dexamethasone|mesh-list
56738184|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
56738185|NCT00560391|Lenalidomide|lenalidomide|mesh-list
56738186|NCT00560391|Dasatinib|dasatinib|mesh-list
56738187|NCT00560391|BB 1101|bb 1101|mesh-list
56738188|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56738189|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
56738190|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
56738191|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738192|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738193|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56738194|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
56738195|NCT00560391|Hormones|hormones|mesh-ancestor
56738196|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56738197|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56738198|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738199|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
56738200|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738201|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738202|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
56738203|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56738204|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56738213|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
56738214|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56738215|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56738216|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738217|NCT04047914|Mupirocin|mupirocin|mesh-list
56738218|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738219|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738220|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56738221|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738222|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738223|NCT00537238|Pregabalin|pregabalin|mesh-list
56738224|NCT00537238|Levetiracetam|levetiracetam|mesh-list
56738225|NCT00537238|Analgesics|analgesics|mesh-ancestor
56738226|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
56738227|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738228|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738229|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
56738230|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56738231|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56738232|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738233|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56738264|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56738265|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738266|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
56738267|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738268|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
56738269|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738270|NCT00946491|Haloperidol|haloperidol|mesh-list
56738271|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
56738272|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
56738273|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
56738274|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738275|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738276|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56738277|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56738278|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56738279|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738280|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56738281|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56738282|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
56738283|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738284|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738285|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56738286|NCT05355610|Gentamicins|gentamicins|mesh-list
56738287|NCT05355610|Dexamethasone|dexamethasone|mesh-list
56738288|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
56738289|NCT05355610|BB 1101|bb 1101|mesh-list
56738290|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56738291|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
56738292|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
56738293|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738294|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738295|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56738296|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
56738297|NCT05355610|Hormones|hormones|mesh-ancestor
56738298|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56738299|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56738301|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
56738302|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738303|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738304|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738305|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738306|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56738307|NCT00552669|Sirolimus|sirolimus|mesh-list
56738308|NCT00552669|Paclitaxel|paclitaxel|mesh-list
56738309|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56738310|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738311|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56738312|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56738313|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56738314|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738315|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738316|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738317|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56738318|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
56738319|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738320|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
56738321|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738322|NCT00943059|Acipimox|acipimox|mesh-list
56738323|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56738324|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
56738325|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738326|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56738327|NCT00943137|Fluorouracil|fluorouracil|mesh-list
56738328|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
56738350|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738351|NCT05406700|Niraparib|niraparib|mesh-list
56738352|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56738353|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738354|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738355|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738356|NCT00768404|Phentermine|phentermine|mesh-list
56738357|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56738358|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738359|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
56738360|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56738361|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
56738362|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
56738363|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738364|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
56738365|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738366|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449469|NCT00307619|Topiramate|topiramate|mesh-list
56738367|NCT05406622|Sirolimus|sirolimus|mesh-list
56738368|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738369|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738370|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56738371|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738372|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
56738373|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738374|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
56738375|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738376|NCT00776282|Loratadine|loratadine|mesh-list
56738377|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
56738378|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
56738379|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56738393|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
56738394|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738395|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56738396|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
56738397|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56738398|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56738399|NCT00776360|Oxytocin|oxytocin|mesh-list
56738400|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
56738401|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56738402|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738403|NCT00946725|Atenolol|atenolol|mesh-list
56738404|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56738405|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56738406|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
56738407|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
56738408|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738409|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738410|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56738411|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56738412|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56738413|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
56738414|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738415|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738416|NCT03041740|Perflubron|perflubron|mesh-list
56738417|NCT03041740|Bromides|bromides|mesh-list
56738418|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
56738419|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56738420|NCT00772694|Sorafenib|sorafenib|mesh-list
56738421|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738422|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56738423|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738424|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738436|NCT00952029|Irinotecan|irinotecan|mesh-list
56738437|NCT00952029|Calcium|calcium|mesh-list
56738438|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
56738439|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56738440|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738441|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56449549|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56738442|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56738443|NCT00952029|Growth Substances|growth substances|mesh-ancestor
56738444|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738445|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
56738446|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56738447|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
56738448|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738449|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56738450|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738451|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
56738452|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56738453|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56738454|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738455|NCT00952029|Antidotes|antidotes|mesh-ancestor
56738456|NCT00952029|Protective Agents|protective agents|mesh-ancestor
56738457|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
56738458|NCT00952029|Vitamins|vitamins|mesh-ancestor
56738459|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
56738460|NCT00667862|Panobinostat|panobinostat|mesh-list
56738461|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738462|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56738463|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738464|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738465|NCT00952185|Antibodies|antibodies|mesh-list
56738466|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
56738467|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738468|NCT00776516|Rifampin|rifampin|mesh-list
56738469|NCT00776516|Mirabegron|mirabegron|mesh-list
56738471|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
56738475|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56738476|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738477|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738478|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56738479|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56738480|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56738481|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56738482|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56738483|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56738484|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56738485|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56738486|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56738487|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
56738488|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738489|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738490|NCT00776516|Urological Agents|urological agents|mesh-ancestor
56738491|NCT00768638|Atorvastatin|atorvastatin|mesh-list
56738492|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56738493|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56738494|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
56738495|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738496|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56738497|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56738498|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738499|NCT02557958|Azithromycin|azithromycin|mesh-list
56738500|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738501|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738502|NCT00776672|Fosinopril|fosinopril|mesh-list
56738503|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56738504|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
56738505|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738506|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738512|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738513|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738514|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738515|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56738516|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56738517|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738518|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56738519|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56738520|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
56738521|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56738522|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56738523|NCT00570908|Capecitabine|capecitabine|mesh-list
56738524|NCT00570908|Sunitinib|sunitinib|mesh-list
56738525|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56738526|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
56738527|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738528|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738529|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56738530|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56738531|NCT00570908|Growth Substances|growth substances|mesh-ancestor
56738532|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738533|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
56738534|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56738535|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738536|NCT00781391|Warfarin|warfarin|mesh-list
56738537|NCT00781391|Edoxaban|edoxaban|mesh-list
56738538|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
56738539|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56738540|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
56738541|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56738542|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
56738543|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738544|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738545|NCT00773084|Lisinopril|lisinopril|mesh-list
56738546|NCT00773084|Spironolactone|spironolactone|mesh-list
56738547|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56738549|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56738550|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738551|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56738552|NCT00773084|Diuretics|diuretics|mesh-ancestor
56738553|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
56738554|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56738555|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
56738556|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738557|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738558|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56738559|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56738560|NCT00773084|Protective Agents|protective agents|mesh-ancestor
56738561|NCT00534976|Montelukast|montelukast|mesh-list
56738562|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56738563|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
56738564|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56738565|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
56738566|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56738567|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738568|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56738569|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56738570|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738571|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56738572|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
56738573|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56738574|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56738575|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56738576|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738577|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738578|NCT00776828|Cilostazol|cilostazol|mesh-list
56738579|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56190212|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190213|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190215|NCT01467115|Docetaxel|docetaxel|mesh-list
56190216|NCT01467115|Fluorouracil|fluorouracil|mesh-list
56190217|NCT01467115|Cetuximab|cetuximab|mesh-list
56190218|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
56190219|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
56190220|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190221|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
56011311|NCT05659329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738580|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
56738581|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738582|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738583|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56738584|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
56738585|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56738586|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56738587|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738588|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56738589|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
56738590|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56738591|NCT00776828|Protective Agents|protective agents|mesh-ancestor
56738592|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56738593|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56738594|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738595|NCT01063933|Peramivir|peramivir|mesh-list
56738596|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
56738597|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738598|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738599|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738600|NCT02556866|Prednisone|prednisone|mesh-list
56738601|NCT02556866|Rituximab|rituximab|mesh-list
56738602|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56738603|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738604|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
56738605|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738606|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56738607|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56738608|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
56738609|NCT02556866|Hormones|hormones|mesh-ancestor
56738610|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56738611|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56738612|NCT05327296|Propofol|propofol|mesh-list
56738613|NCT05327296|Isoflurane|isoflurane|mesh-list
56738614|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56190222|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
56738616|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738617|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56738618|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
56738619|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
56738620|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56738621|NCT00308113|Ubiquinone|ubiquinone|mesh-list
56738622|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
56738623|NCT00308113|Prednisone|prednisone|mesh-list
56738624|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56738625|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
56738626|NCT00308113|Hormones|hormones|mesh-ancestor
56738627|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56738628|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738629|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56738630|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738631|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
56738632|NCT00308113|Vitamins|vitamins|mesh-ancestor
56738633|NCT03903640|Nivolumab|nivolumab|mesh-list
56738634|NCT03903640|Ipilimumab|ipilimumab|mesh-list
56738635|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56738636|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738637|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56738638|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738639|NCT03982849|Silymarin|silymarin|mesh-list
56738640|NCT03982849|Hydroquinone|hydroquinone|mesh-list
56738641|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
56738642|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738643|NCT03982849|Protective Agents|protective agents|mesh-ancestor
56738644|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738645|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56738646|NCT05357872|Anesthetics|anesthetics|mesh-list
56738647|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738648|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738649|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56738650|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
56738651|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738654|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738655|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738656|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56738657|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56738658|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56738659|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56738660|NCT02293954|Antibodies|antibodies|mesh-list
56738661|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56738662|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
56738663|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738664|NCT00777218|Topiramate|topiramate|mesh-list
56738665|NCT00777218|Propranolol|propranolol|mesh-list
56738666|NCT00777218|Zonisamide|zonisamide|mesh-list
56738667|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56738668|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56738669|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
56738670|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738671|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738672|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738673|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56738674|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56738675|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
56738676|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
56738677|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56738678|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56190223|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
56029754|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56029755|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029756|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
56029757|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029758|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56029760|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
56029766|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
56029767|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56029768|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56029769|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56029772|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
56029773|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029774|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029775|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56029776|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029777|NCT02504892|Everolimus|everolimus|mesh-list
56029778|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029779|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029780|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
56029781|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029782|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56029783|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
56029784|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029785|NCT00890162|Omalizumab|omalizumab|mesh-list
56011411|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56011412|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56011413|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
56011414|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
56011415|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
56011416|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56738679|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56738680|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56738681|NCT04047758|Letrozole|letrozole|mesh-list
56738682|NCT04047758|Palbociclib|palbociclib|mesh-list
56738683|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738684|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56738685|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56738686|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738687|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738688|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56738689|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
56738690|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56738691|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738692|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56738693|NCT00307801|Dienogest|dienogest|mesh-list
56738694|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56738695|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56738696|NCT00307801|Estradiol|estradiol|mesh-list
56738697|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56738698|NCT00307801|Estrogens|estrogens|mesh-ancestor
56738699|NCT00307801|Hormones|hormones|mesh-ancestor
56738700|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56738701|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738702|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56738703|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
56738704|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56738705|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56738706|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56738712|NCT00671060|Misoprostol|misoprostol|mesh-list
56738713|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56738714|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
56738715|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56738716|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738717|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56738718|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56738719|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
56738720|NCT05354986|Povidone|povidone|mesh-list
56738721|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
56738722|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
56738723|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
56738724|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56738725|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56738726|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
56738727|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738728|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738729|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738730|NCT00773552|Urological Agents|urological agents|mesh-ancestor
56738731|NCT04002700|Haloperidol|haloperidol|mesh-list
56738732|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
56738733|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
56738734|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
56738735|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
56738736|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738737|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738738|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56738739|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56738740|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56449863|NCT00309920|Hematinics|hematinics|mesh-ancestor
56738741|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56738742|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56738743|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
56738744|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738745|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029786|NCT00890162|Epinephrine|epinephrine|mesh-list
56029787|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56029788|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56029789|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
56029790|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738746|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56738747|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
56738749|NCT04098653|Decitabine|decitabine|mesh-list
56738750|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56738751|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
56738752|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738753|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56738754|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56738755|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
56738756|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738757|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738758|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56738759|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56738760|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
56738761|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738762|NCT05297123|Tretinoin|tretinoin|mesh-list
56738763|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
56738764|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738765|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
56738766|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
56738767|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56738768|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738769|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56738770|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738771|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738772|NCT00773630|Cilostazol|cilostazol|mesh-list
56738773|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56738774|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
56738775|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738793|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56738794|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738795|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
56738796|NCT03646474|Coagulants|coagulants|mesh-ancestor
56738797|NCT00808002|Tenofovir|tenofovir|mesh-list
56738798|NCT00808002|Emtricitabine|emtricitabine|mesh-list
56738799|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
56738800|NCT00808002|Maraviroc|maraviroc|mesh-list
56738801|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
56738802|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738803|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56738804|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56738805|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738806|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738807|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56738808|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56738809|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56738810|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56738811|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56738812|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56738813|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56738814|NCT00307489|Tenofovir|tenofovir|mesh-list
56738815|NCT00307489|Emtricitabine|emtricitabine|mesh-list
56029791|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029792|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029841|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029842|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56029844|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56029845|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
56029846|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56029847|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029848|NCT01519271|Rivastigmine|rivastigmine|mesh-list
56029849|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56029850|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029851|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029852|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
56029853|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029854|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029855|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56029856|NCT01519271|Protective Agents|protective agents|mesh-ancestor
56029933|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56029934|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029935|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029936|NCT00837902|Atenolol|atenolol|mesh-list
56029937|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56029938|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56029968|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56029969|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
56029970|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029971|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029972|NCT01437605|Poly I-C|poly i-c|mesh-list
56738816|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
56738817|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738818|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56738819|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56738820|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738821|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738822|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56738823|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56738824|NCT00812292|Rilpivirine|rilpivirine|mesh-list
56738825|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56738826|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56738827|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738828|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738829|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
56738830|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738831|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56738832|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56738833|NCT00812370|Bivalirudin|bivalirudin|mesh-list
56738834|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
56738835|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56738836|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
56738837|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738838|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738839|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
56738840|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56738841|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56738842|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
56738843|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56738844|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56738845|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
56738846|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738847|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56738848|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56738857|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738858|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738859|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56738860|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
56738861|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56738862|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
56738863|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738864|NCT00770042|Ritonavir|ritonavir|mesh-list
56738865|NCT00770042|Ketoconazole|ketoconazole|mesh-list
56738866|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56738867|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56738868|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
56738869|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738870|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738871|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56738872|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56738873|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
56738874|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738875|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56738876|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56738877|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
56738878|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56738879|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56738880|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
56738881|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56738882|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738883|NCT00654186|Lenalidomide|lenalidomide|mesh-list
56738884|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
56738885|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738886|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56738887|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56738888|NCT00654186|Growth Substances|growth substances|mesh-ancestor
56738889|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
56011646|NCT05252598|Psilocybin|psilocybin|mesh-list
56011647|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
56011648|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011649|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56011650|NCT05232929|Risdiplam|risdiplam|mesh-list
56011651|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56738896|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
56738897|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738898|NCT03979105|Ketamine|ketamine|mesh-list
56738899|NCT03979105|Analgesics|analgesics|mesh-ancestor
56738900|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
56738901|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56738902|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738903|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56738904|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56738905|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
56738906|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
56738907|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56738908|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56738909|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56738910|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56738942|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56738943|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56738944|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56738945|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56738946|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56738947|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56738948|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
56738949|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
56738950|NCT00321685|Leucovorin|leucovorin|mesh-list
56738951|NCT00321685|Folic Acid|folic acid|mesh-list
56738952|NCT00321685|Bevacizumab|bevacizumab|mesh-list
56738953|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56738954|NCT00321685|Fluorouracil|fluorouracil|mesh-list
56738955|NCT00321685|Capecitabine|capecitabine|mesh-list
56738956|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
56738957|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
56738958|NCT00321685|Antibodies|antibodies|mesh-list
56738959|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
56738960|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56738961|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
56738962|NCT00321685|Calcium|calcium|mesh-list
56738963|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
56738964|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738965|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56450068|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
56738966|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56738967|NCT00321685|Growth Substances|growth substances|mesh-ancestor
56738968|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738969|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
56738970|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
56738971|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56738972|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56738973|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
56738975|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56738986|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
56738987|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56738988|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
56738989|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56738990|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56738991|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56738992|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56738993|NCT00777998|Growth Substances|growth substances|mesh-ancestor
56738994|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
56738995|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56738996|NCT00777998|Trace Elements|trace elements|mesh-ancestor
56738997|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
56738998|NCT05348200|Clobetasol|clobetasol|mesh-list
56738999|NCT05348200|Lidocaine|lidocaine|mesh-list
56739000|NCT05348200|Halobetasol|halobetasol|mesh-list
56739001|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
56739002|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
56739003|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56739004|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739005|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
56739006|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739007|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56739008|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56739009|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56739010|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56739011|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739012|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56739013|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56739014|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
56739015|NCT05348200|Hormones|hormones|mesh-ancestor
56739016|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739017|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
56011730|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56029973|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
56029974|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
56029975|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029976|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
56190228|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
56190229|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190230|NCT01467115|Antidotes|antidotes|mesh-ancestor
56190231|NCT01467115|Protective Agents|protective agents|mesh-ancestor
56190232|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
56739018|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56739019|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
56739020|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739021|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
56739022|NCT00778076|Protective Agents|protective agents|mesh-ancestor
56739023|NCT00306787|Valacyclovir|valacyclovir|mesh-list
56739024|NCT00306787|Famciclovir|famciclovir|mesh-list
56739025|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
56739026|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739027|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56739028|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739029|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739030|NCT00778232|Gabapentin|gabapentin|mesh-list
56739031|NCT00778232|Analgesics|analgesics|mesh-ancestor
56739032|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
56739033|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739034|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739035|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
56739036|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56739037|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56739038|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56739039|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56739040|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56739041|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56739042|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739067|NCT05123092|Morphine|morphine|mesh-list
56739068|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56739069|NCT05123092|Narcotics|narcotics|mesh-ancestor
56739070|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56739071|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739072|NCT05123092|Analgesics|analgesics|mesh-ancestor
56739073|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
56739074|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739075|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56739076|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56739077|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739078|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56739079|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739080|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739093|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
56739094|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
56739095|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739096|NCT00667394|Bevacizumab|bevacizumab|mesh-list
56739097|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56739098|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739099|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56739100|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56739101|NCT00667394|Growth Substances|growth substances|mesh-ancestor
56739102|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739103|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
56739104|NCT05357326|Atropine|atropine|mesh-list
56739105|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56739106|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56739107|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56739113|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56739114|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
56739115|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
56739116|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
56739117|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56739118|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56739119|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
56739120|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739121|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739122|NCT00778466|Metformin|metformin|mesh-list
56739123|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56739124|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739125|NCT00761735|Ribavirin|ribavirin|mesh-list
56739126|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56739127|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
56739128|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739129|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
56739130|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739131|NCT00569946|Axitinib|axitinib|mesh-list
56739132|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739133|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56739134|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739135|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739136|NCT00778544|Amoxicillin|amoxicillin|mesh-list
56739137|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
56739138|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
56739139|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56739140|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56739141|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739158|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56739159|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56739160|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
56739161|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56739162|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56739163|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56739164|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56739165|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
56739166|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
56739167|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739168|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739169|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739170|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56739171|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56739172|NCT05265910|Analgesics|analgesics|mesh-ancestor
56739173|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
56739174|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739175|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56739176|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56739177|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
56739178|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
56739179|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
56739180|NCT00814866|Adalimumab|adalimumab|mesh-list
56739181|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56739182|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56739183|NCT00991978|Bevacizumab|bevacizumab|mesh-list
56739184|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
56739185|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56739186|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739187|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56739203|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56739204|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739205|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56739206|NCT00295633|Metformin|metformin|mesh-list
56739207|NCT00295633|Pioglitazone|pioglitazone|mesh-list
56739208|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
56739209|NCT00295633|Saxagliptin|saxagliptin|mesh-list
56739210|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56739211|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739212|NCT00295633|Incretins|incretins|mesh-ancestor
56739213|NCT00295633|Hormones|hormones|mesh-ancestor
56739214|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739215|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56739216|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
56739217|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739218|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739219|NCT00570674|Paclitaxel|paclitaxel|mesh-list
56739220|NCT00570674|Carboplatin|carboplatin|mesh-list
56739221|NCT00570674|Cetuximab|cetuximab|mesh-list
56739222|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56739223|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56739224|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739225|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
56739226|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
56739227|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
56739228|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739230|NCT05013502|Empagliflozin|empagliflozin|mesh-list
56739251|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56739252|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56739253|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
56739254|NCT00768989|Ritonavir|ritonavir|mesh-list
56739255|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56739256|NCT00768989|Tenofovir|tenofovir|mesh-list
56739257|NCT00768989|Emtricitabine|emtricitabine|mesh-list
56739258|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
56739259|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56739260|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56739261|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
56739262|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739263|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739264|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56739265|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56739266|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
56739267|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739268|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56739269|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56739270|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56739271|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56739272|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56739273|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56739274|NCT00779714|Cytarabine|cytarabine|mesh-list
56739275|NCT00779714|Paclitaxel|paclitaxel|mesh-list
56739276|NCT00779714|Cisplatin|cisplatin|mesh-list
56739277|NCT00779714|Dacarbazine|dacarbazine|mesh-list
56739278|NCT00779714|Treosulfan|treosulfan|mesh-list
56739279|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56739280|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739281|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
56739282|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
56739283|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
56739294|NCT00812760|Levodopa|levodopa|mesh-list
56739295|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56739296|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56739297|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
56739298|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739299|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739300|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739301|NCT00814944|Sirolimus|sirolimus|mesh-list
56739302|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56739303|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739304|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56739305|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739306|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
56739307|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739308|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
56739309|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739310|NCT00779792|Triamcinolone|triamcinolone|mesh-list
56739311|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56739312|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56739313|NCT00779792|Clobetasol|clobetasol|mesh-list
56739314|NCT00779792|Mineral Oil|mineral oil|mesh-list
56739315|NCT00779792|Tacrolimus|tacrolimus|mesh-list
56739316|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56739317|NCT00779792|Glycerol|glycerol|mesh-list
56739318|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739319|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
56739320|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739321|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56739322|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739323|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739324|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56739325|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
56739326|NCT00779792|Hormones|hormones|mesh-ancestor
56739327|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739328|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56739335|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56739336|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739337|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
56739338|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739339|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56739340|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56739341|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
56739342|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739343|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
56739344|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739345|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739346|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56739347|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
56739348|NCT02551536|Fexofenadine|fexofenadine|mesh-list
56739349|NCT02551536|Montelukast|montelukast|mesh-list
56739350|NCT02551536|Levocetirizine|levocetirizine|mesh-list
56739351|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56739352|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
56739353|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56739354|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
56739355|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739356|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739357|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56739358|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56739359|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739360|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56739361|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56739362|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56739363|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
56739364|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
56739366|NCT00815022|Fentanyl|fentanyl|mesh-list
56739376|NCT00815022|Narcotics|narcotics|mesh-ancestor
56739377|NCT00815022|Analgesics|analgesics|mesh-ancestor
56739378|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56739379|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56739380|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
56739381|NCT02315326|Rituximab|rituximab|mesh-list
56739382|NCT02315326|Methotrexate|methotrexate|mesh-list
56739383|NCT02315326|Procarbazine|procarbazine|mesh-list
56739384|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56739385|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739386|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
56739387|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739388|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56739389|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56739390|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
56739391|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56739392|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56739393|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
56739394|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739395|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
56739396|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739397|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56739398|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739399|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56739400|NCT00774722|Metronidazole|metronidazole|mesh-list
56739401|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739402|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56739403|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56739405|NCT00808392|Vaccines|vaccines|mesh-list
56739423|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
56739424|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
56739425|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739426|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739427|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
56739428|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739429|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56739430|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56739431|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
56739432|NCT00780104|Analgesics|analgesics|mesh-ancestor
56739433|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
56739434|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739435|NCT04047680|Ritonavir|ritonavir|mesh-list
56739436|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
56739437|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56739438|NCT04047680|Grazoprevir|grazoprevir|mesh-list
56739439|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56739440|NCT04047680|Ledipasvir|ledipasvir|mesh-list
56739441|NCT04047680|Velpatasvir|velpatasvir|mesh-list
56739442|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56739443|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56739444|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56739445|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
56739446|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739447|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739448|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56739449|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56739450|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
56739451|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739452|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56739453|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56739454|NCT00774878|Fulvestrant|fulvestrant|mesh-list
56739455|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56739456|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739457|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56739458|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56012200|NCT04485949|Temozolomide|temozolomide|mesh-list
56190233|NCT01467115|Vitamins|vitamins|mesh-ancestor
56739459|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
56739460|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739461|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739462|NCT00815256|Riboflavin|riboflavin|mesh-list
56739463|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
56739464|NCT00815256|Vitamins|vitamins|mesh-ancestor
56739465|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
56739466|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739467|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56739468|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
56739469|NCT00778778|Cefprozil|cefprozil|mesh-list
56739470|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56739471|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739472|NCT00305773|Vorinostat|vorinostat|mesh-list
56739473|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739474|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56739475|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739476|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739477|NCT00780182|Brincidofovir|brincidofovir|mesh-list
56739478|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
56739479|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739480|NCT00812994|Citalopram|citalopram|mesh-list
56739481|NCT00812994|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56739482|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56739483|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56739484|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739485|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739486|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
56739496|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
56739505|NCT00784472|Narcotics|narcotics|mesh-ancestor
56739506|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56739507|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739508|NCT00784472|Analgesics|analgesics|mesh-ancestor
56739509|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
56739510|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739511|NCT00779012|Infliximab|infliximab|mesh-list
56739512|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
56739513|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56739514|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56739515|NCT00647556|Adapalene|adapalene|mesh-list
56739516|NCT00647556|Tretinoin|tretinoin|mesh-list
56739517|NCT00647556|Emollients|emollients|mesh-list
56739518|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56739519|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56739520|NCT00647556|Analgesics|analgesics|mesh-ancestor
56739521|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
56739522|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739523|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739524|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56739525|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56739526|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56739527|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739528|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
56739529|NCT03978559|Trimethoprim|trimethoprim|mesh-list
56739530|NCT03978559|Caspofungin|caspofungin|mesh-list
56739531|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
56739532|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
56739555|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56739556|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
56739557|NCT00813072|Docetaxel|docetaxel|mesh-list
56739558|NCT00813072|Irinotecan|irinotecan|mesh-list
56739559|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739560|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
56739561|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
56739562|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
56739563|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739564|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56739565|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56739566|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739567|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56739568|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56450676|NCT00344409|Hematinics|hematinics|mesh-ancestor
56739569|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739570|NCT00813228|Incretins|incretins|mesh-ancestor
56739571|NCT00813228|Hormones|hormones|mesh-ancestor
56739572|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739573|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56739575|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739576|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739577|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
56739578|NCT00808704|Hematinics|hematinics|mesh-ancestor
56739579|NCT00320515|Pemetrexed|pemetrexed|mesh-list
56739580|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739585|NCT03982381|Metformin|metformin|mesh-list
56739604|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739605|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739606|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
56739607|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739608|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
56739609|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56739610|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56739611|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
56739612|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
56739613|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56739614|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56739615|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739616|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739617|NCT00815646|Urological Agents|urological agents|mesh-ancestor
56739618|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
56739619|NCT01066351|Hematinics|hematinics|mesh-ancestor
56739620|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56739621|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56739622|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739623|NCT00661778|Bevacizumab|bevacizumab|mesh-list
56739624|NCT00661778|Docetaxel|docetaxel|mesh-list
56739625|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56739626|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739627|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56739628|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56739629|NCT00661778|Growth Substances|growth substances|mesh-ancestor
56739630|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739631|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
56739632|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56739633|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56739634|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56739636|NCT01062139|Cetirizine|cetirizine|mesh-list
56739645|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56450748|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
56739646|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56739647|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56739648|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56739649|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56739650|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739651|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
56739652|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739653|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739655|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56739656|NCT00653328|Atrasentan|atrasentan|mesh-list
56739657|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56739658|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739659|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56739660|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56739661|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739662|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739663|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56739664|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56739665|NCT01664182|Bevacizumab|bevacizumab|mesh-list
56739666|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56739667|NCT01664182|Sunitinib|sunitinib|mesh-list
56739668|NCT01664182|Trebananib|trebananib|mesh-list
56739669|NCT01664182|Sorafenib|sorafenib|mesh-list
56739671|NCT01664182|Antibodies|antibodies|mesh-list
56739693|NCT00809172|Methotrexate|methotrexate|mesh-list
56739694|NCT00809172|Cyclosporins|cyclosporins|mesh-list
56739695|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56739696|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
56739697|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56739698|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739699|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56739700|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
56739701|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739702|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739703|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
56739704|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739705|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56739706|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739707|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
56739708|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56739709|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56739710|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
56739711|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739712|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56739713|NCT00784862|Tamoxifen|tamoxifen|mesh-list
56739714|NCT00784862|Anastrozole|anastrozole|mesh-list
56739715|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56739716|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
56739717|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739718|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739719|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56739720|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739721|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56739722|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56739723|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56739724|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56739725|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56739726|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739727|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739729|NCT00784940|Anastrozole|anastrozole|mesh-list
56739731|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
56739732|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739733|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739734|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56739735|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739736|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56739737|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56739738|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56739739|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56739740|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56739741|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739742|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739743|NCT00790244|Doxorubicin|doxorubicin|mesh-list
56739744|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56739745|NCT00790244|Ifosfamide|ifosfamide|mesh-list
56739746|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
56739747|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56739748|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739749|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56739750|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56739751|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739752|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739753|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56739754|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
56739755|NCT00785018|Complement C1s|complement c1s|mesh-list
56739756|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56739757|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56739758|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
56739759|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739760|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56190234|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
56190235|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56190236|NCT01467115|Hematinics|hematinics|mesh-ancestor
56190237|NCT01467141|Insulin|insulin|mesh-list
56190238|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56190239|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
56190240|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
56190241|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
56190242|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
56190243|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190244|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739761|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739762|NCT00534352|Ritonavir|ritonavir|mesh-list
56739763|NCT00534352|Darunavir|darunavir|mesh-list
56739764|NCT00534352|Etravirine|etravirine|mesh-list
56739765|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56739766|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56739767|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
56739768|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739769|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739770|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56739771|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56739772|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
56739773|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739774|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56739775|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56739776|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56739777|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56739778|NCT00642174|Clopidogrel|clopidogrel|mesh-list
56739779|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56739780|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56739781|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56739782|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56739783|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56739784|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
56739785|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739786|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739787|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739788|NCT02550444|Clonidine|clonidine|mesh-list
56739789|NCT02550444|Analgesics|analgesics|mesh-ancestor
56739790|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
56739791|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029977|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029978|NCT02684006|Sunitinib|sunitinib|mesh-list
56029979|NCT02684006|Avelumab|avelumab|mesh-list
56029980|NCT02684006|Axitinib|axitinib|mesh-list
56029981|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029982|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56029983|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56030015|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030016|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030017|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56030018|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
56030019|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56739793|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56739794|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
56739795|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
56739796|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56739797|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56739798|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56739799|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
56739800|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739801|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739802|NCT00665366|Valproic Acid|valproic acid|mesh-list
56739803|NCT00665366|Aripiprazole|aripiprazole|mesh-list
56739804|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
56739805|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56739806|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56739807|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56739808|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56739809|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739810|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
56739811|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
56739812|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739813|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739814|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56739815|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56739816|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
56739817|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56739818|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56739840|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
56739841|NCT02556008|Cannabidiol|cannabidiol|mesh-list
56739842|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
56739843|NCT00992524|Misoprostol|misoprostol|mesh-list
56739844|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56739845|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
56739846|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56739847|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739848|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56739849|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56739850|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
56739851|NCT00642018|Prednisone|prednisone|mesh-list
56739852|NCT00642018|Docetaxel|docetaxel|mesh-list
56739853|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739854|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56739855|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56739856|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56739857|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739858|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56739859|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
56739860|NCT00642018|Hormones|hormones|mesh-ancestor
56739861|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739862|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739863|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56739864|NCT00532948|Capecitabine|capecitabine|mesh-list
56739865|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56739866|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
56739867|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739869|NCT00998920|Equol|equol|mesh-list
56739870|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
56739871|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56739872|NCT00998920|Estrogens|estrogens|mesh-ancestor
56739885|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739886|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739887|NCT00995332|Cytarabine|cytarabine|mesh-list
56739888|NCT00995332|Tretinoin|tretinoin|mesh-list
56739889|NCT00995332|Valproic Acid|valproic acid|mesh-list
56739890|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56739891|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
56739892|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739893|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56739894|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
56739895|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739896|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56739897|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
56739898|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739899|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
56739900|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
56739901|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
56739902|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739903|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
56739904|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739905|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
56739906|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56739907|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56739908|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56739909|NCT00992914|Lidocaine|lidocaine|mesh-list
56739910|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
56739911|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
56739912|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56739913|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739914|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
56739915|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739916|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56739917|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56739918|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56739919|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030020|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56030021|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56030022|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
56030254|NCT04380818|Tinzaparin|tinzaparin|mesh-list
56030288|NCT01831700|Lisinopril|lisinopril|mesh-list
56739920|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739921|NCT00999232|Erythromycin|erythromycin|mesh-list
56739922|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
56739923|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56739924|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
56739925|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56739926|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739927|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56739928|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56739929|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739930|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739931|NCT00993070|Capsaicin|capsaicin|mesh-list
56739932|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
56739933|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
56739934|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
56739935|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56739936|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739937|NCT00993304|Liraglutide|liraglutide|mesh-list
56739938|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56739939|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030289|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
56030290|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56030291|NCT01831700|Diuretics|diuretics|mesh-ancestor
56030292|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
56030293|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811192|NCT02527707|Lonafarnib|lonafarnib|mesh-list
56030333|NCT01532141|Opicapone|opicapone|mesh-list
56030334|NCT01532141|Rasagiline|rasagiline|mesh-list
56030335|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56030336|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030337|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030370|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
56030371|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56030372|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030373|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56030374|NCT01832558|Diuretics|diuretics|mesh-ancestor
56030375|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
56030376|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56030377|NCT02476422|Ibuprofen|ibuprofen|mesh-list
56030378|NCT02476422|Diclofenac|diclofenac|mesh-list
56030379|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56030380|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56030381|NCT02476422|Analgesics|analgesics|mesh-ancestor
56030414|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030415|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030417|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56030418|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030419|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56030420|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030421|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
56030422|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56030485|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030487|NCT01833728|Propacetamol|propacetamol|mesh-list
56739940|NCT00993304|Incretins|incretins|mesh-ancestor
56739941|NCT00993304|Hormones|hormones|mesh-ancestor
56451050|NCT00349596|Decitabine|decitabine|mesh-list
56739942|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739943|NCT05189002|Dalteparin|dalteparin|mesh-list
56739944|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
56739945|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56739946|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56739947|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739948|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56739949|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
56739950|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56739951|NCT00644358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56739952|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56739953|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56739954|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739955|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56739956|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
56739957|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739958|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56739959|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56739960|NCT00993694|Dapsone|dapsone|mesh-list
56739961|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739962|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
56739963|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56739964|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56739965|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56739966|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739967|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739968|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
56739969|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56739970|NCT00640926|Radezolid|radezolid|mesh-list
56739971|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
56739972|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56739973|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56739974|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56739975|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56739976|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56739977|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56739978|NCT00821496|Norethindrone|norethindrone|mesh-list
56739979|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
56739980|NCT00821496|Norinyl|norinyl|mesh-list
56739981|NCT00821496|Estradiol|estradiol|mesh-list
56739982|NCT00821496|Estrogens|estrogens|mesh-ancestor
56739983|NCT00821496|Hormones|hormones|mesh-ancestor
56739984|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56739985|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56739986|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56739987|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
56739988|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56739989|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56739990|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56739991|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56739992|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56739993|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56739994|NCT02550912|Vitamin D|vitamin d|mesh-list
56739995|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
56739996|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
56739997|NCT02550912|Vitamins|vitamins|mesh-list
56739998|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
56739999|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740000|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56740001|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56740002|NCT00999700|Cisplatin|cisplatin|mesh-list
56740003|NCT00999700|Docetaxel|docetaxel|mesh-list
56740004|NCT00999700|Fluorouracil|fluorouracil|mesh-list
56740005|NCT00999700|Cetuximab|cetuximab|mesh-list
56740006|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740007|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56740008|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56740009|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56740010|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740011|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
56030488|NCT01833728|Nefopam|nefopam|mesh-list
56030489|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56030490|NCT01833728|Analgesics|analgesics|mesh-ancestor
56030491|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
56030492|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740012|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56740013|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56740014|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
56740015|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740016|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56740017|NCT00818298|Ziprasidone|ziprasidone|mesh-list
56740018|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56740019|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
56740020|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740021|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740022|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740023|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56740024|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56740025|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740026|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56740027|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56740028|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
56740029|NCT00821574|Valsartan|valsartan|mesh-list
56740030|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56740031|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56740032|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56740033|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56740034|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740035|NCT00821574|Diuretics|diuretics|mesh-ancestor
56740036|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
56740037|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740038|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56740039|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56740040|NCT00995800|Fluticasone|fluticasone|mesh-list
56740041|NCT00995800|Xhance|xhance|mesh-list
56740042|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
56740043|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740044|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56012788|NCT00199056|Cytarabine|cytarabine|mesh-list
56030493|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030494|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56030495|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56030496|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030497|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
56740045|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
56740046|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740047|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740048|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56740049|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
56740050|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740051|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56740052|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56740053|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56740054|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56740055|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
56740056|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740057|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740058|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56740059|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
56740060|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56740061|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
56740062|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740063|NCT00319501|Diazepam|diazepam|mesh-list
56740064|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56740065|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
56740066|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
56740067|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
56740068|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740069|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740070|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56740071|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56740072|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740073|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56740074|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56740089|NCT00994006|Cathartics|cathartics|mesh-ancestor
56451203|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740090|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56740091|NCT00994006|Antacids|antacids|mesh-ancestor
56740092|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740093|NCT00818610|Amoxicillin|amoxicillin|mesh-list
56740094|NCT00818610|Clarithromycin|clarithromycin|mesh-list
56740095|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56740096|NCT00818610|Cefuroxime|cefuroxime|mesh-list
56740097|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
56740098|NCT00818610|Lactams|lactams|mesh-list
56740099|NCT00818610|beta-Lactams|beta-lactams|mesh-list
56740100|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56740101|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740102|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56740103|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740104|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740105|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56740106|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56740107|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56740108|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56740109|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56740110|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56740111|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740112|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740113|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56740114|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56740115|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56740116|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
56740117|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740118|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740119|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56740120|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56740121|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
56740128|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56740129|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56740130|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740131|NCT00994396|Vitamin D|vitamin d|mesh-list
56740132|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
56740133|NCT00994396|Vitamins|vitamins|mesh-ancestor
56740134|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
56740135|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740136|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56740137|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56740138|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
56740139|NCT00816426|Rifampin|rifampin|mesh-list
56740140|NCT00816426|Isoniazid|isoniazid|mesh-list
56740141|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
56740142|NCT00816426|Kanamycin|kanamycin|mesh-list
56740143|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56740144|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740145|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56740146|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56740147|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740148|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740149|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740150|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56740151|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
56740152|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
56740153|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56740154|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56740155|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56030498|NCT03213392|Anesthetics|anesthetics|mesh-list
56030499|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030500|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030501|NCT03219788|Remifentanil|remifentanil|mesh-list
56030502|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56030503|NCT03219788|Narcotics|narcotics|mesh-ancestor
56030504|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030505|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030540|NCT00899600|Analgesics|analgesics|mesh-ancestor
56030541|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
56030542|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030543|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030544|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56190322|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190323|NCT01467531|Dolutegravir|dolutegravir|mesh-list
56190324|NCT01467531|Cabotegravir|cabotegravir|mesh-list
56190325|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56190326|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56190327|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740156|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56740157|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56740158|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56740159|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56740160|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56740161|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56740162|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
56740163|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56740164|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56740165|NCT00996190|Phenylephrine|phenylephrine|mesh-list
56740166|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
56740168|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
56740169|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
56740170|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740171|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740172|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
56740173|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56740174|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
56740175|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
56740176|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56740177|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56740178|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56740179|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
56740180|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740181|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740182|NCT00996190|Protective Agents|protective agents|mesh-ancestor
56740183|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
56740184|NCT00640224|Drospirenone|drospirenone|mesh-list
56740185|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56740186|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56740187|NCT00640224|Estradiol|estradiol|mesh-list
56740188|NCT00640224|Estrogens|estrogens|mesh-ancestor
56740189|NCT00640224|Hormones|hormones|mesh-ancestor
56740190|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740191|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740195|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56740196|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56740197|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56740198|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56740199|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56740200|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
56740201|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56740202|NCT00640224|Diuretics|diuretics|mesh-ancestor
56740203|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
56740204|NCT01000792|Cetirizine|cetirizine|mesh-list
56740205|NCT01000792|Levocetirizine|levocetirizine|mesh-list
56740206|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56740207|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56740208|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
56740209|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
56740210|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740211|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740212|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740213|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56740214|NCT02550756|Capsaicin|capsaicin|mesh-list
56740215|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
56740216|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740217|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
56740218|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740219|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740220|NCT01001260|Aspirin|aspirin|mesh-list
56740221|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56740222|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56740223|NCT01001260|Analgesics|analgesics|mesh-ancestor
56740224|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
56740225|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740238|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
56740239|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451354|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
56740240|NCT00996424|Expectorants|expectorants|mesh-ancestor
56740241|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
56740242|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56740243|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
56740244|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740245|NCT00996424|Protective Agents|protective agents|mesh-ancestor
56740246|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740247|NCT00996424|Antidotes|antidotes|mesh-ancestor
56740248|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
56740249|NCT05220280|Infliximab|infliximab|mesh-list
56740250|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740251|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56740252|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740253|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740254|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740255|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56740256|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56740257|NCT00318643|Mitomycins|mitomycins|mesh-list
56740258|NCT00318643|Mitomycin|mitomycin|mesh-list
56740259|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56740260|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740261|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
56740262|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740263|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56740264|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740265|NCT00994708|Esomeprazole|esomeprazole|mesh-list
56740266|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56740267|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56740268|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56740269|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740280|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740281|NCT01066429|Dexamethasone|dexamethasone|mesh-list
56740282|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
56740283|NCT01066429|BB 1101|bb 1101|mesh-list
56740284|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740285|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740286|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740287|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
56740288|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
56740289|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740290|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56740291|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
56740292|NCT01066429|Hormones|hormones|mesh-ancestor
56740293|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740294|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56740295|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
56740296|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740297|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740298|NCT00994786|Pregabalin|pregabalin|mesh-list
56740299|NCT00994786|Analgesics|analgesics|mesh-ancestor
56740300|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
56740333|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
56740334|NCT01003054|Busulfan|busulfan|mesh-list
56740335|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
56740336|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56740337|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
56740338|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740339|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56740340|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56740341|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
56740342|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740343|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740344|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56740345|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56740346|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740347|NCT01004068|Clomiphene|clomiphene|mesh-list
56740348|NCT01004068|Enclomiphene|enclomiphene|mesh-list
56740349|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
56740350|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56740351|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
56740352|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740353|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740354|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56740355|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
56740356|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56740357|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56740358|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56740359|NCT01004224|Infigratinib|infigratinib|mesh-list
56740360|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740361|NCT00530920|Ritonavir|ritonavir|mesh-list
56740362|NCT00530920|Tipranavir|tipranavir|mesh-list
56740363|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56740364|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56740375|NCT01004380|Farletuzumab|farletuzumab|mesh-list
56740376|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740377|NCT01003522|Anesthetics|anesthetics|mesh-list
56740378|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
56740379|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740380|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740381|NCT01003678|Clofarabine|clofarabine|mesh-list
56740382|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56740383|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
56740384|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740385|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740386|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
56740387|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740388|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
56740389|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
56740390|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740391|NCT04000126|Lidocaine|lidocaine|mesh-list
56740392|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
56740393|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
56740394|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740395|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740396|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
56740397|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801356|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56030657|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030658|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56030659|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030660|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
56030661|NCT03212456|Ropivacaine|ropivacaine|mesh-list
56030662|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
56030663|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
56030664|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030665|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030666|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
56030667|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030790|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
56030791|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030792|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56030793|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030828|NCT02501928|Fesoterodine|fesoterodine|mesh-list
56030829|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56030830|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56030831|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
56030832|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030833|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030834|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030865|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
56030866|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
56030867|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
56030869|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
56030870|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
56030871|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56740398|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56740399|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56740400|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56740401|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56740402|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740403|NCT01008982|Belimumab|belimumab|mesh-list
56740404|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56740405|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
56740406|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740407|NCT01005160|Metformin|metformin|mesh-list
56740408|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56740409|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740410|NCT05230810|Fulvestrant|fulvestrant|mesh-list
56740411|NCT05230810|Tucatinib|tucatinib|mesh-list
56740412|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56740413|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740414|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56740415|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56740416|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
56740417|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740418|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740419|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56740420|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740421|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740422|NCT01005238|Lamivudine|lamivudine|mesh-list
56740423|NCT01005238|Telbivudine|telbivudine|mesh-list
56740424|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56740425|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56030872|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
56030873|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030874|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030875|NCT01837394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56030876|NCT01837394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56030877|NCT01837394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56030878|NCT01837394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56030879|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56030880|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56030908|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56030909|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56030911|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030912|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
56030913|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56030914|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190342|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56740426|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740427|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740428|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
56740429|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740430|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56740431|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56740432|NCT01005472|Temozolomide|temozolomide|mesh-list
56740433|NCT01005472|Sunitinib|sunitinib|mesh-list
56740434|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56740435|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
56740436|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740437|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740438|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56740439|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56740440|NCT01005472|Growth Substances|growth substances|mesh-ancestor
56740441|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740442|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
56740443|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56740444|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740445|NCT01005550|Ropivacaine|ropivacaine|mesh-list
56740446|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
56740447|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
56740448|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740449|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740450|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
56740451|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740452|NCT03999580|Vitamin D|vitamin d|mesh-list
56740453|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
56740454|NCT03999580|Vitamins|vitamins|mesh-ancestor
56740455|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
56740472|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56740473|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740474|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56740475|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
56740476|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740477|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740478|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56740479|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
56740480|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740481|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56740482|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
56740483|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56740484|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
56740485|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740486|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740487|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56740488|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56740489|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56740490|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
56740491|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
56740492|NCT00530842|Hormones|hormones|mesh-ancestor
56190343|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56190344|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56190345|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190347|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56190348|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190349|NCT01467687|Verapamil|verapamil|mesh-list
56190350|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56190351|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56190352|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56190353|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190354|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56190355|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190356|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
56190357|NCT01467804|Sertraline|sertraline|mesh-list
56190358|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
56190359|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56190360|NCT01467804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56190361|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56190362|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56190363|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190364|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811290|NCT05190705|Hormones|hormones|mesh-ancestor
56031046|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56031047|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56031079|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56031080|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56031081|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031082|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031083|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
56740493|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740494|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
56740495|NCT01005784|Cetrorelix|cetrorelix|mesh-list
56740496|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56740497|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
56740498|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56740499|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740500|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
56740501|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740502|NCT05154136|Itraconazole|itraconazole|mesh-list
56740503|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
56740504|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740505|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56740506|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56740507|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740508|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740509|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56740510|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
56740511|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740512|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740513|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56740514|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56740515|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740516|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56740517|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740518|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740519|NCT05733598|Bevacizumab|bevacizumab|mesh-list
56740535|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740536|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
56740537|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56451715|NCT00346749|Xhance|xhance|mesh-list
56740538|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740539|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56740540|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
56740541|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740543|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
56740544|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740545|NCT01006876|Warfarin|warfarin|mesh-list
56740546|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
56740547|NCT03882424|Bevacizumab|bevacizumab|mesh-list
56740548|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56740549|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740550|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56740551|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56740552|NCT03882424|Growth Substances|growth substances|mesh-ancestor
56740553|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740554|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
56740555|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
56740556|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
56740557|NCT03879772|Beclomethasone|beclomethasone|mesh-list
56740558|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740559|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740560|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740561|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56740562|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
56740563|NCT03879772|Hormones|hormones|mesh-ancestor
56740564|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740565|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740566|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56740567|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
56740568|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
56740569|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56740574|NCT05732506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56740575|NCT05732506|Antithrombins|antithrombins|mesh-ancestor
56740576|NCT05732506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56740577|NCT05732506|Protease Inhibitors|protease inhibitors|mesh-ancestor
56740578|NCT05732506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740579|NCT05732506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740580|NCT05732506|Anticoagulants|anticoagulants|mesh-ancestor
56740581|NCT01007500|Dexamethasone|dexamethasone|mesh-list
56740582|NCT01007500|Ondansetron|ondansetron|mesh-list
56740583|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740584|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
56740585|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
56740586|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740587|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740588|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56740589|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
56740590|NCT01007500|Hormones|hormones|mesh-ancestor
56740591|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740592|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56740593|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740594|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
56740595|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740596|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56740597|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
56740598|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740599|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740600|NCT01007500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56740601|NCT01007500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56740602|NCT01007500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740603|NCT01007500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56740604|NCT01007500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56740605|NCT01007578|Paclitaxel|paclitaxel|mesh-list
56031084|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031085|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56031086|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56031087|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
56190373|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56190374|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56190375|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190376|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190377|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190378|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56031088|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56740606|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56740607|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740608|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
56740609|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
56740610|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56740611|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740612|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
56740613|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56740614|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
56740615|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740616|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
56740617|NCT05130814|Protective Agents|protective agents|mesh-ancestor
56740618|NCT05129722|Empagliflozin|empagliflozin|mesh-list
56740619|NCT05129722|Eplerenone|eplerenone|mesh-list
56740620|NCT05129722|Bumetanide|bumetanide|mesh-list
56740621|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56740622|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740623|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56740624|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740625|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56031089|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031090|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031091|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56031092|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56031093|NCT03836222|Protective Agents|protective agents|mesh-ancestor
56031167|NCT01720394|Dinoprostone|dinoprostone|mesh-list
56031168|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
56031169|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56031170|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031171|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56031172|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56031207|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
56031208|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031209|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031210|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031211|NCT03409874|Diclofenac|diclofenac|mesh-list
56031212|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56031213|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56031242|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56031244|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
56031245|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
56031246|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
55758444|NCT05269030|Ivermectin|ivermectin|mesh-list
56031247|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031249|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
56031250|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56031251|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031252|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
56031253|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
56031254|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56031255|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56031282|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
56031283|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56740626|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
56740627|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740628|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56740629|NCT05129722|Diuretics|diuretics|mesh-ancestor
56740630|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
56740631|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56740632|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56740633|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56740634|NCT00642954|Dexamethasone|dexamethasone|mesh-list
56740635|NCT00642954|Lenalidomide|lenalidomide|mesh-list
56740636|NCT00642954|Vorinostat|vorinostat|mesh-list
56740637|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740638|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
56740639|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
56740640|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740641|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740642|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56740643|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
56740644|NCT00642954|Hormones|hormones|mesh-ancestor
56740645|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740646|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56740647|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740648|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
56740649|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56740650|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56740651|NCT00642954|Growth Substances|growth substances|mesh-ancestor
56740652|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
56740653|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56740654|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740671|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56740672|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56740673|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740674|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
56740675|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740676|NCT00640146|Bromides|bromides|mesh-list
56740677|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
56740678|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
56740679|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56740680|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740681|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
56740682|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740683|NCT00819078|Bupropion|bupropion|mesh-list
56740684|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56740685|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
56740686|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56740687|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56740688|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56740689|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56740690|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740691|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
56740692|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740693|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740694|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56740695|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56740696|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740697|NCT01007968|Panobinostat|panobinostat|mesh-list
56740698|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740718|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740719|NCT00530218|Ganciclovir|ganciclovir|mesh-list
56740720|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56740721|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
56740722|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740723|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56740724|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740725|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740726|NCT00761267|Fluconazole|fluconazole|mesh-list
56740727|NCT00761267|Anidulafungin|anidulafungin|mesh-list
56740728|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
56740729|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740730|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56740731|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56740732|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740733|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740734|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56740735|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
56740736|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740737|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740738|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56740739|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56740740|NCT00303667|Vidarabine|vidarabine|mesh-list
56740741|NCT00303667|Aldesleukin|aldesleukin|mesh-list
56740742|NCT00303667|Cyclosporine|cyclosporine|mesh-list
56740743|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
56740744|NCT00303667|Fludarabine|fludarabine|mesh-list
56740745|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
56740746|NCT00303667|Interleukin-2|interleukin-2|mesh-list
56740747|NCT00303667|Cyclosporins|cyclosporins|mesh-list
56740748|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
56740749|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56740750|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
56740751|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740752|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56740753|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56740754|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
56740755|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740756|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740757|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56740758|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56740759|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
56740760|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
56740761|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740762|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740763|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
56451878|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
56740764|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
56740765|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56740766|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56740767|NCT00303667|Analgesics|analgesics|mesh-ancestor
56740768|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
56740769|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740770|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56740771|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56740772|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56740773|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56740774|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56740775|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740776|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740777|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56740778|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56740779|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56740780|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
56740800|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
56740801|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740802|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56740803|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740804|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740805|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56740806|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56740807|NCT00302731|Hormones|hormones|mesh-list
56740808|NCT00302731|Estradiol|estradiol|mesh-list
56740809|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56740810|NCT00302731|Progesterone|progesterone|mesh-list
56740811|NCT00302731|Estrogens|estrogens|mesh-list
56740812|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740813|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740814|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56740815|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
56740816|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56740817|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56740818|NCT00302731|Progestins|progestins|mesh-ancestor
56740819|NCT00780143|Cytarabine|cytarabine|mesh-list
56740820|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56740821|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
56740822|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740823|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740824|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
56740825|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740826|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56740827|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
56740828|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740829|NCT00779909|Vitamin D|vitamin d|mesh-list
56740830|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
56740831|NCT00779909|Vitamins|vitamins|mesh-ancestor
56740832|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
56740833|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740834|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56740835|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56740836|NCT05559112|Vitamin D|vitamin d|mesh-list
56740838|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
56740839|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740840|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56740841|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
56740842|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56740843|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740844|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56740845|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740846|NCT00302107|Mirtazapine|mirtazapine|mesh-list
56740847|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
56740848|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56740849|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56740850|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
56740851|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
56740852|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56740853|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740854|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740855|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56740856|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56740857|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56740858|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56740859|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56740860|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56740861|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
56740862|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56740863|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56740864|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
56740865|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56740866|NCT02602301|Oxytocin|oxytocin|mesh-list
56740867|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
56740879|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56740880|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740881|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56740882|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740883|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56740884|NCT00759941|Latanoprost|latanoprost|mesh-list
56740885|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56740886|NCT00759941|Brinzolamide|brinzolamide|mesh-list
56740887|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56740888|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740889|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740890|NCT00315445|Acetaminophen|acetaminophen|mesh-list
56740891|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56740892|NCT00315445|Oxycodone|oxycodone|mesh-list
56740893|NCT00315445|Buprenorphine|buprenorphine|mesh-list
56740894|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56740895|NCT00315445|Analgesics|analgesics|mesh-ancestor
56740896|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
56740897|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740898|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740899|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
56740900|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56740901|NCT00315445|Narcotics|narcotics|mesh-ancestor
56740903|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56740929|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
56740930|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740931|NCT00315055|Vaccines|vaccines|mesh-list
56740932|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
56740933|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740934|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
56740935|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56740936|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740937|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
56740938|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740939|NCT00293293|Taxane|taxane|mesh-list
56740940|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740941|NCT05774639|Omalizumab|omalizumab|mesh-list
56740942|NCT05774639|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56740943|NCT05774639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56740944|NCT05774639|Respiratory System Agents|respiratory system agents|mesh-ancestor
56740945|NCT05774626|Contraceptive Agents|contraceptive agents|mesh-list
56740946|NCT05774626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56740947|NCT05774626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740948|NCT05774574|Cannabidiol|cannabidiol|mesh-list
56740949|NCT05774574|Anticonvulsants|anticonvulsants|mesh-ancestor
56740950|NCT05774275|Doxorubicin|doxorubicin|mesh-list
56740951|NCT05774275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56740952|NCT05774275|Antibodies|antibodies|mesh-list
56740953|NCT05774275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56740954|NCT05774275|Immunologic Factors|immunologic factors|mesh-ancestor
56740955|NCT05774275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740956|NCT05774275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56740957|NCT05774275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740958|NCT05774275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56740959|NCT05774275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56740960|NCT05774275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740961|NCT05774275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740972|NCT05774236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740973|NCT05774028|Gemcitabine|gemcitabine|mesh-list
56740974|NCT05774028|Dexamethasone|dexamethasone|mesh-list
56740975|NCT05774028|Etoposide|etoposide|mesh-list
56740976|NCT05774028|Mitoxantrone|mitoxantrone|mesh-list
56740977|NCT05774028|Pegaspargase|pegaspargase|mesh-list
56740978|NCT05774028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56740979|NCT05774028|Antiemetics|antiemetics|mesh-ancestor
56740980|NCT05774028|Autonomic Agents|autonomic agents|mesh-ancestor
56740981|NCT05774028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56740982|NCT05774028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56740983|NCT05774028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56740984|NCT05774028|Glucocorticoids|glucocorticoids|mesh-ancestor
56740985|NCT05774028|Hormones|hormones|mesh-ancestor
56740986|NCT05774028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56740987|NCT05774028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56740988|NCT05774028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56740989|NCT05774028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56740990|NCT05774028|Antimetabolites|antimetabolites|mesh-ancestor
56740991|NCT05774028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56740992|NCT05774028|Antiviral Agents|antiviral agents|mesh-ancestor
56740993|NCT05774028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56740994|NCT05774028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56740995|NCT05774028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741023|NCT05773911|Chelating Agents|chelating agents|mesh-ancestor
56741024|NCT05773911|Sequestering Agents|sequestering agents|mesh-ancestor
56741025|NCT05773911|Hemostatics|hemostatics|mesh-ancestor
56741026|NCT05773911|Coagulants|coagulants|mesh-ancestor
56741027|NCT05773859|Vaccines|vaccines|mesh-list
56741028|NCT05773859|Immunologic Factors|immunologic factors|mesh-ancestor
56741029|NCT05773859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741030|NCT05773846|Ropivacaine|ropivacaine|mesh-list
56741031|NCT05773846|Anesthetics, Local|anesthetics, local|mesh-ancestor
56741032|NCT05773846|Anesthetics|anesthetics|mesh-ancestor
56741033|NCT05773846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741034|NCT05773846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741035|NCT05773846|Sensory System Agents|sensory system agents|mesh-ancestor
56741036|NCT05773846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741037|NCT05773807|Propofol|propofol|mesh-list
56741038|NCT05773807|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56741039|NCT05773807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741040|NCT05773807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741041|NCT05773807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56741042|NCT05773807|Anesthetics, General|anesthetics, general|mesh-ancestor
56741043|NCT05773807|Anesthetics|anesthetics|mesh-ancestor
56741044|NCT05773664|Dexamethasone|dexamethasone|mesh-list
56741045|NCT05773664|Dexamethasone acetate|dexamethasone acetate|mesh-list
56741046|NCT05773664|Ichthammol|ichthammol|mesh-list
56741047|NCT05773664|BB 1101|bb 1101|mesh-list
56741048|NCT05773664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56741049|NCT05773664|Antiemetics|antiemetics|mesh-ancestor
56741050|NCT05773664|Autonomic Agents|autonomic agents|mesh-ancestor
56741051|NCT05773664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741052|NCT05773664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741053|NCT05773664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56741070|NCT05773326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56741071|NCT05773326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741072|NCT05773326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56741073|NCT05773326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741074|NCT05773326|Antifungal Agents|antifungal agents|mesh-ancestor
56741075|NCT05773326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741076|NCT05773326|Immunologic Factors|immunologic factors|mesh-ancestor
56741077|NCT05773326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741078|NCT05773274|Everolimus|everolimus|mesh-list
56741079|NCT05773274|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56741080|NCT05773274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741081|NCT05773274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741082|NCT05773274|Immunologic Factors|immunologic factors|mesh-ancestor
56741083|NCT05773274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741084|NCT05773274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741085|NCT05773274|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56741086|NCT05773183|Testosterone|testosterone|mesh-list
56741087|NCT05773183|Androgens|androgens|mesh-ancestor
56741088|NCT05773183|Hormones|hormones|mesh-ancestor
56741089|NCT05773183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741090|NCT05773183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741091|NCT05773092|Osimertinib|osimertinib|mesh-list
56741092|NCT05773092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741093|NCT05773092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56741094|NCT05773092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741095|NCT05773092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741096|NCT05769868|Esmolol|esmolol|mesh-list
56741097|NCT05769868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56741098|NCT05769868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56741099|NCT05769868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56741100|NCT05769868|Adrenergic Agents|adrenergic agents|mesh-ancestor
56741101|NCT05769868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741102|NCT05769868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741103|NCT05769868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741104|NCT05767398|Zanubrutinib|zanubrutinib|mesh-list
56741105|NCT05767398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031284|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
56741107|NCT05767398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741108|NCT05767398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741109|NCT05742438|Lidocaine|lidocaine|mesh-list
56741110|NCT05742438|Dexmedetomidine|dexmedetomidine|mesh-list
56741111|NCT05742438|Morphine|morphine|mesh-list
56741112|NCT05742438|Anesthetics, Local|anesthetics, local|mesh-ancestor
56741113|NCT05742438|Anesthetics|anesthetics|mesh-ancestor
56741114|NCT05742438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741115|NCT05742438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741116|NCT05742438|Sensory System Agents|sensory system agents|mesh-ancestor
56741117|NCT05742438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741118|NCT05742438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56741119|NCT05742438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56741170|NCT05695027|Micronutrients|micronutrients|mesh-ancestor
56741171|NCT05695027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741172|NCT05695027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56741173|NCT05695027|Antimetabolites|antimetabolites|mesh-ancestor
56741174|NCT05695027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741175|NCT05695027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56741176|NCT05695027|Vasodilator Agents|vasodilator agents|mesh-ancestor
56741177|NCT05692999|Pembrolizumab|pembrolizumab|mesh-list
56741178|NCT05692999|Pemetrexed|pemetrexed|mesh-list
56741179|NCT05692999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741180|NCT05692999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741181|NCT05692999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741182|NCT05692999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741183|NCT05692999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56741184|NCT05692999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56741185|NCT05679024|Apixaban|apixaban|mesh-list
56741186|NCT05679024|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56741187|NCT05679024|Antithrombins|antithrombins|mesh-ancestor
56741188|NCT05679024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56741189|NCT05679024|Protease Inhibitors|protease inhibitors|mesh-ancestor
56741190|NCT05679024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741191|NCT05679024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741192|NCT05679024|Anticoagulants|anticoagulants|mesh-ancestor
56741193|NCT05667922|Tacrolimus|tacrolimus|mesh-list
56741194|NCT05667922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741195|NCT05667922|Immunologic Factors|immunologic factors|mesh-ancestor
56741196|NCT05667922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741197|NCT05667922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56741198|NCT05667922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741200|NCT05667909|Rituximab|rituximab|mesh-list
56741214|NCT05667896|Hormones|hormones|mesh-ancestor
56923650|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741215|NCT05667896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741216|NCT05667883|Cyclophosphamide|cyclophosphamide|mesh-list
56741217|NCT05667883|Glucocorticoids|glucocorticoids|mesh-list
56741218|NCT05667883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741219|NCT05667883|Immunologic Factors|immunologic factors|mesh-ancestor
56741220|NCT05667883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741221|NCT05667883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741222|NCT05667883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56741223|NCT05667883|Alkylating Agents|alkylating agents|mesh-ancestor
56741224|NCT05667883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741225|NCT05667883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741226|NCT05667883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56741228|NCT05667883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741229|NCT05667805|Thrombin|thrombin|mesh-list
56741230|NCT05667805|Hemostatics|hemostatics|mesh-ancestor
56741231|NCT05667805|Coagulants|coagulants|mesh-ancestor
56741232|NCT05660746|Infliximab|infliximab|mesh-list
56741233|NCT05660746|Dermatologic Agents|dermatologic agents|mesh-ancestor
56741234|NCT05660746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56741235|NCT05660746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741236|NCT05659381|Cisplatin|cisplatin|mesh-list
56741237|NCT05659381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741245|NCT05644496|Meloxicam|meloxicam|mesh-list
56741246|NCT05644496|Bupivacaine|bupivacaine|mesh-list
56741247|NCT05644496|Anesthetics, Local|anesthetics, local|mesh-ancestor
56741248|NCT05644496|Anesthetics|anesthetics|mesh-ancestor
56741249|NCT05644496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741250|NCT05644496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741251|NCT05644496|Sensory System Agents|sensory system agents|mesh-ancestor
56013985|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56031285|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56031286|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031287|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56741252|NCT05644496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741253|NCT05644496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56741254|NCT05644496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56741255|NCT05644496|Analgesics|analgesics|mesh-ancestor
56741256|NCT05644496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56741257|NCT05644496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741258|NCT05644496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56741259|NCT05644496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56741260|NCT05644496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741261|NCT05644496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741262|NCT05613608|Cannabidiol|cannabidiol|mesh-list
56741263|NCT05613608|Anticonvulsants|anticonvulsants|mesh-ancestor
56741264|NCT05601973|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56741265|NCT05601973|Lazertinib|lazertinib|mesh-list
56741266|NCT05601973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56741267|NCT05601973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741268|NCT05601973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741269|NCT05601973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741270|NCT05601973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741274|NCT05592613|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56741275|NCT05592613|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56741276|NCT05592613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56741277|NCT05592613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56741278|NCT05592613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741279|NCT05592613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741280|NCT05592613|Antiviral Agents|antiviral agents|mesh-ancestor
56741281|NCT05592613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741295|NCT05578872|Pembrolizumab|pembrolizumab|mesh-list
56741296|NCT05578872|Ipilimumab|ipilimumab|mesh-list
56741297|NCT05578872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741298|NCT05578872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741299|NCT05578872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56741300|NCT05578872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741301|NCT05567562|Clopidogrel|clopidogrel|mesh-list
56741302|NCT05567562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741303|NCT05567562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741304|NCT05567562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56741305|NCT05567562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56741306|NCT05567562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56741307|NCT05567562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56741308|NCT05567562|Purinergic Agents|purinergic agents|mesh-ancestor
56741309|NCT05567562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741310|NCT05556265|BMS-986165|bms-986165|mesh-list
56741311|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
56741312|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56741313|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741314|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741315|NCT05554978|Landiolol|landiolol|mesh-list
56741346|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56741347|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56741348|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56741349|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741350|NCT05546866|Osimertinib|osimertinib|mesh-list
56741351|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741352|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56741353|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741354|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741355|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
56741356|NCT05545969|Lenvatinib|lenvatinib|mesh-list
56741357|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741358|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741359|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56741360|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923651|NCT03688451|Rituximab|rituximab|mesh-list
56741361|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741362|NCT05543642|Vaccines|vaccines|mesh-list
56741363|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
56741364|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741365|NCT05538897|Megestrol|megestrol|mesh-list
56741366|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
56014118|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56031288|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56031289|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56031290|NCT01721798|Trace Elements|trace elements|mesh-ancestor
56031291|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
56031341|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56031375|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
56190380|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56190381|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190382|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56031376|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031377|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031378|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56031379|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56031414|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031415|NCT01728818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56031416|NCT01728818|Immunologic Factors|immunologic factors|mesh-ancestor
56031417|NCT01728818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031418|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56031419|NCT01728974|Anesthetics|anesthetics|mesh-list
56031420|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031421|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031458|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56031459|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56031460|NCT03406676|Methylene Blue|methylene blue|mesh-list
56031493|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
56031494|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031495|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56031496|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56031497|NCT01723202|Trametinib|trametinib|mesh-list
56031498|NCT01723202|Dabrafenib|dabrafenib|mesh-list
56741367|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56741368|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56741369|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56741370|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
56741371|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56741372|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741373|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56741374|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56741375|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56741376|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741377|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
56741378|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56741379|NCT05525247|Gemcitabine|gemcitabine|mesh-list
56741380|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56741381|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
56741382|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741383|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741384|NCT05525247|Antiviral Agents|antiviral agents|mesh-ancestor
56741385|NCT05525247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741386|NCT05525247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741387|NCT05525247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741388|NCT05525247|Immunologic Factors|immunologic factors|mesh-ancestor
56741390|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56741418|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741419|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56741420|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741421|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
56741422|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741423|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56741424|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
56741425|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741426|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56741427|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
56741428|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
56741429|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
56741430|NCT05475678|Carboplatin|carboplatin|mesh-list
56741431|NCT05475678|Docetaxel|docetaxel|mesh-list
56741432|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741433|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
56741434|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
56741480|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56741481|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741482|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56741483|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
56741484|NCT05453500|Hormones|hormones|mesh-ancestor
56741485|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741486|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56741487|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56741488|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
56741489|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
56741490|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
56741491|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
56741492|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
56741493|NCT05438888|Warfarin|warfarin|mesh-list
56741494|NCT05438888|Apixaban|apixaban|mesh-list
56741495|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
56741496|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56741497|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
56741498|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56741499|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
56741500|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741533|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56741534|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
56741535|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56741536|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56741537|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
56741538|NCT05335928|Abatacept|abatacept|mesh-list
56741539|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56741540|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741541|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741542|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741543|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
56741544|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741545|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741546|NCT05325775|SR 142801|sr 142801|mesh-list
56741547|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56741548|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56741549|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741550|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741551|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56741552|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
56741553|NCT05325281|Gemcitabine|gemcitabine|mesh-list
56741554|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56741555|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
56741556|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741584|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741585|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56452724|NCT01058655|Everolimus|everolimus|mesh-list
56741586|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
56741587|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
56741588|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741590|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741591|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741592|NCT05260008|Epinephrine|epinephrine|mesh-list
56741593|NCT05260008|Bupivacaine|bupivacaine|mesh-list
56741594|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
56741595|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
56741596|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741597|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741598|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
56741599|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741600|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56741601|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56741602|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
56741603|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741604|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741605|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56741606|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56741607|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
56741608|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56741609|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
56741610|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
56741611|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
56741612|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56741613|NCT05255276|Itraconazole|itraconazole|mesh-list
56741614|NCT05255276|Rifampin|rifampin|mesh-list
56741626|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56741627|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
56741628|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56741629|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
56741630|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56741631|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56741632|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56741633|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56741634|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56741635|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56741636|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56741637|NCT05253833|Allopurinol|allopurinol|mesh-list
56741638|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
56741639|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741640|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741641|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
56741642|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741643|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56741644|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
56741645|NCT05253833|Protective Agents|protective agents|mesh-ancestor
56741646|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741647|NCT05246514|Trastuzumab|trastuzumab|mesh-list
56741648|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741649|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741650|NCT05243199|Valsartan|valsartan|mesh-list
56741651|NCT05243199|Irbesartan|irbesartan|mesh-list
56741652|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56741653|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56741669|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741670|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56741671|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741672|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
56741673|NCT05227716|Analgesics|analgesics|mesh-ancestor
56741674|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
56741675|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741676|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741677|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
56741678|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741679|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56741680|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
56741681|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56741682|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56741683|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741684|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56741685|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
56741686|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56741687|NCT05222555|Lenalidomide|lenalidomide|mesh-list
56741688|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
56741689|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741690|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56741691|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56741692|NCT05222555|Growth Substances|growth substances|mesh-ancestor
56741693|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
56741694|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741695|NCT05201248|Prednisone|prednisone|mesh-list
56741696|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
56741697|NCT05201248|Rituximab|rituximab|mesh-list
56741698|NCT05201248|Doxorubicin|doxorubicin|mesh-list
56741699|NCT05201248|Vincristine|vincristine|mesh-list
56741700|NCT05201248|Lenalidomide|lenalidomide|mesh-list
56741701|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741702|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
56741704|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741708|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741709|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56741710|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741711|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56741712|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56741713|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56741714|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741715|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56741716|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
56741717|NCT05201248|Hormones|hormones|mesh-ancestor
56741718|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741719|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56741720|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56741721|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56741722|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56741767|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56741768|NCT05169593|Adalimumab|adalimumab|mesh-list
56741769|NCT05169593|Infliximab|infliximab|mesh-list
56741770|NCT05169593|Ustekinumab|ustekinumab|mesh-list
56741771|NCT05169593|Vedolizumab|vedolizumab|mesh-list
56741772|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56741773|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741774|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
56741775|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56741776|NCT05136196|Nivolumab|nivolumab|mesh-list
56741777|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741778|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741779|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56741780|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741797|NCT05115110|Risdiplam|risdiplam|mesh-list
56741798|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56741799|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741800|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741801|NCT05101564|Tamoxifen|tamoxifen|mesh-list
56741802|NCT05101564|Fulvestrant|fulvestrant|mesh-list
56741803|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56741804|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
56741805|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741806|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741807|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56741816|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741817|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56741818|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56741819|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56741820|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
56741821|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
56741822|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741823|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741824|NCT05076175|Ozanimod|ozanimod|mesh-list
56741825|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56741826|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741827|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56741828|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
56741829|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741830|NCT05073484|Antibodies|antibodies|mesh-list
56741831|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
56741832|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
56741833|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741834|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
56741835|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741836|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741837|NCT05061550|Paclitaxel|paclitaxel|mesh-list
56741838|NCT05061550|Cisplatin|cisplatin|mesh-list
56741839|NCT05061550|Carboplatin|carboplatin|mesh-list
56741840|NCT05061550|Pemetrexed|pemetrexed|mesh-list
56741841|NCT05061550|Durvalumab|durvalumab|mesh-list
56741842|NCT05061550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56741843|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741844|NCT05061550|Tubulin Modulators|tubulin modulators|mesh-ancestor
56741852|NCT05047172|Aspirin|aspirin|mesh-list
56741863|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741864|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56741865|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56741866|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741867|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56741868|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56741869|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741870|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
56741871|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56741872|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56741873|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56741874|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
56741875|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741876|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56741877|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
56741878|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56741879|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
56741880|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
56741881|NCT05038228|Vitamin K|vitamin k|mesh-list
56741882|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
56741883|NCT05038228|Apixaban|apixaban|mesh-list
56741884|NCT05038228|Dabigatran|dabigatran|mesh-list
56741885|NCT05038228|Vitamins|vitamins|mesh-ancestor
56741886|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
56741887|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741888|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56031499|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031500|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56031537|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
56031538|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031566|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031568|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031569|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56031570|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
56031571|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
56031572|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031573|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031574|NCT01722656|Aflibercept|aflibercept|mesh-list
56031575|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55801377|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
56031665|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031666|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56031667|NCT01049984|Protective Agents|protective agents|mesh-ancestor
56190383|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
56190384|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56190385|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
56190386|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190387|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56031668|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031669|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56741889|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
56741890|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56741891|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
56741892|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741893|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741894|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
56741895|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56741896|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56741897|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
56741898|NCT05038228|Coagulants|coagulants|mesh-ancestor
56741899|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
56741900|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56741901|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
56741902|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741903|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
56741904|NCT05025865|Protective Agents|protective agents|mesh-ancestor
56741908|NCT05005741|Dulaglutide|dulaglutide|mesh-list
56741909|NCT05005741|Glucagon|glucagon|mesh-list
56741910|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56741911|NCT05005741|Incretins|incretins|mesh-ancestor
56741912|NCT05005741|Hormones|hormones|mesh-ancestor
56741913|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741914|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741915|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56741916|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56741917|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56741918|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56741919|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56741920|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
56741921|NCT04995029|Buprenorphine|buprenorphine|mesh-list
56741922|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56741923|NCT04995029|Narcotics|narcotics|mesh-ancestor
56741934|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741935|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56741936|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56741937|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741938|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
56741939|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56741940|NCT04994717|Blinatumomab|blinatumomab|mesh-list
56741941|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741942|NCT04976855|Buprenorphine|buprenorphine|mesh-list
56741943|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56741944|NCT04976855|Naloxone|naloxone|mesh-list
56741945|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56741946|NCT04976855|Narcotics|narcotics|mesh-ancestor
56741947|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56741948|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741949|NCT04976855|Analgesics|analgesics|mesh-ancestor
56741950|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
56741951|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741952|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56453072|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56453073|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56453074|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
56453075|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56453076|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453077|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741953|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
56741954|NCT04976634|Lenvatinib|lenvatinib|mesh-list
56741955|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741956|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741957|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56741958|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56741959|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56741960|NCT04975997|Dexamethasone|dexamethasone|mesh-list
56741961|NCT04975997|Bortezomib|bortezomib|mesh-list
56741962|NCT04975997|Daratumumab|daratumumab|mesh-list
56741963|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56741966|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56741967|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741968|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56741969|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
56741970|NCT04975997|Hormones|hormones|mesh-ancestor
56741971|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56741972|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56741973|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741974|NCT04974216|Rituximab|rituximab|mesh-list
56741975|NCT04974216|Lenalidomide|lenalidomide|mesh-list
56741976|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56741977|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56741978|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
56741979|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56741980|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56741981|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56741982|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56741983|NCT04974216|Growth Substances|growth substances|mesh-ancestor
56741984|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
56742023|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742024|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742025|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56742026|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
56742027|NCT04907227|Hormones|hormones|mesh-ancestor
56742028|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742029|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56742030|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742031|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742032|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742034|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742035|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742036|NCT04895358|Paclitaxel|paclitaxel|mesh-list
56742037|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56742038|NCT04895358|Doxorubicin|doxorubicin|mesh-list
56742039|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56742040|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
56742041|NCT04895358|Capecitabine|capecitabine|mesh-list
56742042|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56742043|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742044|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742045|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742046|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742048|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56742074|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
56742075|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742076|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56742077|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742078|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742079|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
56742080|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742081|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
56742082|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742083|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56742084|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742085|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56742086|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
56742087|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56742088|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56742089|NCT04876781|Tofacitinib|tofacitinib|mesh-list
56742090|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742091|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742092|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742093|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
56742094|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56742095|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56742096|NCT04873583|Prednisolone|prednisolone|mesh-list
56742097|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
56742098|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56742099|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
56742100|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56742107|NCT04873583|Hormones|hormones|mesh-ancestor
56742120|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56742121|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742122|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56742123|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56742124|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56742125|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742126|NCT04802590|Venetoclax|venetoclax|mesh-list
56742127|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742194|NCT04729114|Dexamethasone|dexamethasone|mesh-list
56742195|NCT04729114|Prednisone|prednisone|mesh-list
56742196|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56742197|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
56742198|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
56742199|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742200|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742201|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56742202|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
56742203|NCT04729114|Hormones|hormones|mesh-ancestor
56742254|NCT04660344|Atezolizumab|atezolizumab|mesh-list
56742255|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742256|NCT04652544|Vitamin D|vitamin d|mesh-list
56453372|NCT04507412|Hormones|hormones|mesh-ancestor
56742257|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
56742258|NCT04652544|Vitamins|vitamins|mesh-ancestor
56742259|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
56742260|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742261|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56742262|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56742263|NCT04652076|Paclitaxel|paclitaxel|mesh-list
56742264|NCT04652076|Carboplatin|carboplatin|mesh-list
56742265|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
56742266|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56742267|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742268|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742269|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742270|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742271|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742272|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742273|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
56742274|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742275|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
56742308|NCT04599634|Venetoclax|venetoclax|mesh-list
56742309|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
56742310|NCT04599634|Magrolimab|magrolimab|mesh-list
56742311|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742312|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742313|NCT04592913|Durvalumab|durvalumab|mesh-list
56742314|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742315|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742321|NCT04585815|Axitinib|axitinib|mesh-list
56742322|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742323|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742324|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742325|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742326|NCT04547907|Paclitaxel|paclitaxel|mesh-list
56742327|NCT04547907|Docetaxel|docetaxel|mesh-list
56742328|NCT04547907|Carboplatin|carboplatin|mesh-list
56742329|NCT04547907|Trastuzumab|trastuzumab|mesh-list
56742330|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56742331|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742332|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742333|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742334|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742335|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742336|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742337|NCT04545944|Midazolam|midazolam|mesh-list
56742338|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56742339|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56742340|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56742341|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742342|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56742343|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56742344|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56742345|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56742346|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
56742347|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
56015049|NCT01427881|Busulfan|busulfan|mesh-list
56742348|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
56742349|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
56742350|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56742351|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742352|NCT04533451|Carboplatin|carboplatin|mesh-list
56742353|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
56742354|NCT04533451|Pemetrexed|pemetrexed|mesh-list
56742355|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742356|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742357|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742358|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742359|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56742360|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56742361|NCT04522804|Psilocybin|psilocybin|mesh-list
56742362|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
56742363|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742364|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56742365|NCT04460937|Adavosertib|adavosertib|mesh-list
56742366|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742367|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742368|NCT04454203|Anesthetics|anesthetics|mesh-list
56742369|NCT04454203|Mepivacaine|mepivacaine|mesh-list
56742370|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
56742371|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56742372|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742373|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
56742374|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742375|NCT04442022|Gemcitabine|gemcitabine|mesh-list
56742376|NCT04442022|Dexamethasone|dexamethasone|mesh-list
56742377|NCT04442022|Rituximab|rituximab|mesh-list
56742378|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742379|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742380|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
56742381|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742382|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742383|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56031670|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56031671|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
56031674|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031675|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56742384|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
56742385|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
56742386|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742387|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56742388|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
56742389|NCT04442022|Hormones|hormones|mesh-ancestor
56742390|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742391|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56742392|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742393|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
56742394|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742395|NCT04442022|Antiviral Agents|antiviral agents|mesh-ancestor
56742396|NCT04442022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742397|NCT04442022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742398|NCT04442022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742399|NCT04439149|GSK2636771|gsk2636771|mesh-list
56742400|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742401|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742402|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742403|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742404|NCT04439110|Trastuzumab|trastuzumab|mesh-list
56742405|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56742406|NCT04439110|Maytansine|maytansine|mesh-list
56742407|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
56742408|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742409|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742410|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56453532|NCT04716569|Ivermectin|ivermectin|mesh-list
56742411|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742412|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742413|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742415|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
56742425|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742426|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742427|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56742428|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
56742429|NCT04424303|Tofacitinib|tofacitinib|mesh-list
56742430|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742431|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742432|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742433|NCT04393285|Letrozole|letrozole|mesh-list
56742434|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742435|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56742436|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56742437|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742438|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742439|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56742440|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
56742441|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742442|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742443|NCT04391283|Osimertinib|osimertinib|mesh-list
56742444|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742445|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742446|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742447|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742448|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
56742449|NCT04379596|Fluorouracil|fluorouracil|mesh-list
56742473|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742474|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742475|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742476|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56742477|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56742478|NCT04338204|Tofacitinib|tofacitinib|mesh-list
56742479|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742480|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742481|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742482|NCT04308785|Atezolizumab|atezolizumab|mesh-list
56742483|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742484|NCT04301076|Prednisone|prednisone|mesh-list
56742485|NCT04301076|Cortisone|cortisone|mesh-list
56742486|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
56742487|NCT04301076|Doxorubicin|doxorubicin|mesh-list
56742488|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56742489|NCT04301076|Etoposide|etoposide|mesh-list
56742490|NCT04301076|Vincristine|vincristine|mesh-list
56742491|NCT04301076|Lenalidomide|lenalidomide|mesh-list
56742492|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
56742493|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
56742494|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742495|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
56742496|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742497|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742498|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56742499|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
56742500|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742501|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742502|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56742503|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56742504|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56742505|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56742506|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742507|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56742508|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
56742509|NCT04301076|Hormones|hormones|mesh-ancestor
56031676|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56031677|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742510|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742511|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56742512|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56742513|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742514|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742515|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742516|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56742517|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56742518|NCT04301076|Growth Substances|growth substances|mesh-ancestor
56742519|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
56742520|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
56742521|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
56742522|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
56742523|NCT04284787|Azacitidine|azacitidine|mesh-list
56742524|NCT04284787|Venetoclax|venetoclax|mesh-list
56742525|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742526|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742527|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742528|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
56742529|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742530|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742531|NCT04266275|Curcumin|curcumin|mesh-list
56742532|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56742533|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56742534|NCT04266275|Analgesics|analgesics|mesh-ancestor
56742535|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
56742536|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742537|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742543|NCT04252742|Erenumab|erenumab|mesh-list
56742555|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742556|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742557|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
56742558|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742559|NCT04241185|Antiviral Agents|antiviral agents|mesh-ancestor
56742560|NCT04241185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742561|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742562|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742563|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
56742564|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742565|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742566|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56742567|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
56742568|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56742569|NCT04216329|Temozolomide|temozolomide|mesh-list
56742570|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56742571|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
56742572|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742573|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742574|NCT04212013|Rituximab|rituximab|mesh-list
56742575|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742576|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742577|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
56742578|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742579|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742580|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
56742581|NCT04210115|Leucovorin|leucovorin|mesh-list
56742582|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
56742583|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
56742584|NCT04210115|Calcium|calcium|mesh-list
56742585|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
56742586|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742587|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742597|NCT04207086|Lenvatinib|lenvatinib|mesh-list
56742598|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742599|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742600|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742601|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742602|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742603|NCT04206319|Listerine|listerine|mesh-list
56742604|NCT04206319|Fluorides|fluorides|mesh-list
56742605|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
56742606|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
56742607|NCT04206319|Protective Agents|protective agents|mesh-ancestor
56742608|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742609|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56742610|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742611|NCT04194359|Bevacizumab|bevacizumab|mesh-list
56742612|NCT04194359|Capecitabine|capecitabine|mesh-list
56742656|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742657|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56742658|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56742659|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742660|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742661|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56742662|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
56742663|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742664|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742665|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
56742666|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
56742667|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56742668|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742669|NCT04053491|Anesthetics|anesthetics|mesh-list
56742670|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56742671|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742672|NCT04041232|Glycerol|glycerol|mesh-list
56742673|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56742674|NCT04041232|Protective Agents|protective agents|mesh-ancestor
56742675|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742676|NCT04030000|Paclitaxel|paclitaxel|mesh-list
56742677|NCT04030000|Carboplatin|carboplatin|mesh-list
56742678|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56742679|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742680|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742681|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742682|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742683|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742684|NCT04010539|Azithromycin|azithromycin|mesh-list
56742685|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
56742686|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56742687|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742697|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742698|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56742699|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742700|NCT03957590|Paclitaxel|paclitaxel|mesh-list
56742701|NCT03957590|Cisplatin|cisplatin|mesh-list
56742702|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56742703|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742704|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
56742705|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
56742706|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
56742707|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742708|NCT03952637|Sirolimus|sirolimus|mesh-list
56453818|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
56742709|NCT03952637|Prednisone|prednisone|mesh-list
56742710|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
56742711|NCT03952637|Rituximab|rituximab|mesh-list
56742712|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742713|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742714|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
56742715|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742716|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742717|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56742751|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56742752|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56742753|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742754|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
56742755|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56742756|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742757|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
56742758|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
56742759|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742760|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56742761|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56742762|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
56742763|NCT03919955|Urological Agents|urological agents|mesh-ancestor
56742764|NCT03919799|Belumosudil|belumosudil|mesh-list
56742765|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56742766|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742767|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742768|NCT03919071|Trametinib|trametinib|mesh-list
56742810|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56742811|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56742812|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
56742813|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56742814|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56742815|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742816|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56742817|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56742818|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56742819|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56742820|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56742821|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56742822|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56742823|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56742824|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
56742825|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56742826|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56742827|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56742828|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56742829|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
56742830|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56742831|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56742832|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56742833|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
56742834|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56742835|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56742836|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56742837|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56742839|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
56742851|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56742852|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742853|NCT03760588|Valsartan|valsartan|mesh-list
56742854|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56742855|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56742856|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56742857|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56742858|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742859|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56742860|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
56742861|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742863|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742864|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742865|NCT03710343|Metformin|metformin|mesh-list
56742866|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56742867|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742868|NCT03682068|Gemcitabine|gemcitabine|mesh-list
56742869|NCT03682068|Carboplatin|carboplatin|mesh-list
56742870|NCT03682068|Durvalumab|durvalumab|mesh-list
56742871|NCT03682068|Tremelimumab|tremelimumab|mesh-list
56742872|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742873|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742874|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
56742875|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742876|NCT03682068|Antiviral Agents|antiviral agents|mesh-ancestor
56742877|NCT03682068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742878|NCT03682068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742879|NCT03682068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742880|NCT03682068|Immunologic Factors|immunologic factors|mesh-ancestor
56742881|NCT03682068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742882|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742883|NCT03681561|Nivolumab|nivolumab|mesh-list
56742884|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742885|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015572|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
56031709|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56742886|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56742887|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742888|NCT03656081|Itraconazole|itraconazole|mesh-list
56742889|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56742890|NCT03656081|Amphotericin B|amphotericin b|mesh-list
56742891|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
56742892|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742893|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56742894|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56742895|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742896|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742897|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56742898|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
56742899|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56742900|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742901|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56742902|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56742903|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56742904|NCT03656081|Amebicides|amebicides|mesh-ancestor
56742905|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56742906|NCT03649048|Cisplatin|cisplatin|mesh-list
56742907|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742908|NCT03642626|Vidarabine|vidarabine|mesh-list
56742909|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
56742910|NCT03642626|Fludarabine|fludarabine|mesh-list
56742911|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
56742912|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742932|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
56742933|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56742934|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742935|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
56742936|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56742937|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742939|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742940|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742941|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
56742942|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742943|NCT03609216|Antiviral Agents|antiviral agents|mesh-ancestor
56742944|NCT03609216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56742945|NCT03609216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742946|NCT03609216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742947|NCT03609216|Immunologic Factors|immunologic factors|mesh-ancestor
56742948|NCT03609216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742949|NCT03608163|Diazoxide|diazoxide|mesh-list
56742950|NCT03608163|Naloxone|naloxone|mesh-list
56742951|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56742952|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742953|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
56742954|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742955|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56742956|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
56742957|NCT03604406|Vaccines|vaccines|mesh-list
56742958|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
56742959|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742960|NCT03599635|Bupivacaine|bupivacaine|mesh-list
56742961|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
56742962|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
56742963|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56742964|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742965|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
56742966|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56742974|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56742975|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
56742976|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742977|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742978|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56742979|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742980|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
56742981|NCT03573700|Fludarabine|fludarabine|mesh-list
56742982|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56742983|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
56742984|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56742985|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56742986|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56742987|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
56742988|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742989|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742990|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56742991|NCT03573024|Azacitidine|azacitidine|mesh-list
56742992|NCT03573024|Venetoclax|venetoclax|mesh-list
56742993|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56742994|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
56742995|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56742996|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56742997|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56742998|NCT03534947|Imiquimod|imiquimod|mesh-list
56742999|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56743000|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
56743001|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743002|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743003|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
56743004|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
56743005|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56743006|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56743007|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743012|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56743013|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56743014|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56743015|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56743016|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56743017|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743019|NCT03521830|Ipilimumab|ipilimumab|mesh-list
56743020|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743021|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743022|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56743023|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743024|NCT03496610|Bupivacaine|bupivacaine|mesh-list
56743025|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
56743026|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
56743027|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56743028|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743029|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
56743030|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743034|NCT03467958|Ozanimod|ozanimod|mesh-list
56743037|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743065|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56743066|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743067|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743068|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
56743069|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743070|NCT03434730|Cyclosporine|cyclosporine|mesh-list
56743071|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
56743072|NCT03434730|Lenograstim|lenograstim|mesh-list
56743073|NCT03434730|Cyclosporins|cyclosporins|mesh-list
56743074|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56743075|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
56743076|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743077|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743078|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743079|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743080|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
56743081|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454188|NCT00330824|BB 1101|bb 1101|mesh-list
56743082|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
56743083|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743084|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56743133|NCT03406897|Vitamin D|vitamin d|mesh-list
56743134|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
56743135|NCT03406897|Vitamins|vitamins|mesh-ancestor
56743136|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
56743137|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743138|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56743139|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56743140|NCT03387423|Tofacitinib|tofacitinib|mesh-list
56743141|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56743142|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743143|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743144|NCT03375307|Olaparib|olaparib|mesh-list
56743182|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56743183|NCT03164616|Tremelimumab|tremelimumab|mesh-list
56743184|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743185|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743186|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
56743187|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743188|NCT03164616|Antiviral Agents|antiviral agents|mesh-ancestor
56743189|NCT03164616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743190|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743191|NCT03164616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743192|NCT03164616|Immunologic Factors|immunologic factors|mesh-ancestor
56743193|NCT03164616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743194|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56743195|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56743196|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743197|NCT03155620|Olaparib|olaparib|mesh-list
56743198|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56743199|NCT03155620|Palbociclib|palbociclib|mesh-list
56743200|NCT03155620|Vemurafenib|vemurafenib|mesh-list
56743201|NCT03155620|Tipifarnib|tipifarnib|mesh-list
56743202|NCT03155620|Ensartinib|ensartinib|mesh-list
56743203|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743204|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743236|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
56743238|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56743239|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56743240|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56743241|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56743242|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56743243|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743244|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56743245|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
56743246|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56743247|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743248|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
56743249|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
56743250|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56743251|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56743252|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
56743253|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743254|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56743255|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
56743256|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
56743257|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
56743258|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
56743259|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56743260|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
56743261|NCT03150693|Protective Agents|protective agents|mesh-ancestor
56743262|NCT03126916|Vitamin A|vitamin a|mesh-list
56743263|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
56743264|NCT03126916|Melphalan|melphalan|mesh-list
56743287|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743288|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
56743289|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743290|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743291|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56743292|NCT03126916|Vitamins|vitamins|mesh-ancestor
56743293|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
56743294|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56743295|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56743296|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56743297|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743298|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56743299|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
56743300|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
56743301|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
56743302|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56743303|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
56743304|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
56743305|NCT03126916|Protective Agents|protective agents|mesh-ancestor
56743306|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56743307|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56743308|NCT03124355|Bromides|bromides|mesh-list
56743309|NCT03124355|Galantamine|galantamine|mesh-list
56454412|NCT00331838|Enoxaparin|enoxaparin|mesh-list
56743310|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56743311|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
56743312|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56743313|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743314|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743332|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
56743333|NCT03011268|Adalimumab|adalimumab|mesh-list
56743334|NCT03011268|Golimumab|golimumab|mesh-list
56743335|NCT03011268|Infliximab|infliximab|mesh-list
56743336|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56743337|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743338|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743339|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
56743340|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56743341|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56743342|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743343|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
56743344|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743345|NCT03004261|Ganciclovir|ganciclovir|mesh-list
56743346|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56743347|NCT03004261|Foscarnet|foscarnet|mesh-list
56743348|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
56743349|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743350|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56743351|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743352|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743353|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56743354|NCT02997228|Leucovorin|leucovorin|mesh-list
56743355|NCT02997228|Bevacizumab|bevacizumab|mesh-list
56743356|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56743357|NCT02997228|Fluorouracil|fluorouracil|mesh-list
56743358|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
56743359|NCT02997228|Atezolizumab|atezolizumab|mesh-list
56743360|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
56743361|NCT02997228|Antibodies|antibodies|mesh-list
56743381|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
56743382|NCT02981628|Leucovorin|leucovorin|mesh-list
56743383|NCT02981628|Folic Acid|folic acid|mesh-list
56743384|NCT02981628|Cytarabine|cytarabine|mesh-list
56743385|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
56743386|NCT02981628|Methotrexate|methotrexate|mesh-list
56743387|NCT02981628|Vincristine|vincristine|mesh-list
56743388|NCT02981628|Asparaginase|asparaginase|mesh-list
56743389|NCT02981628|Pegaspargase|pegaspargase|mesh-list
56743390|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56743391|NCT02981628|Calcium|calcium|mesh-list
56743392|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
56743393|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743394|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
56743395|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743396|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743397|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743398|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
56743399|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743400|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743440|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56743441|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743442|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56743443|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743444|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56743445|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743446|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743447|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
56743448|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56743449|NCT02944578|Curcumin|curcumin|mesh-list
56743450|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56743451|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56743452|NCT02944578|Analgesics|analgesics|mesh-ancestor
56743453|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
56743454|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743455|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743456|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743457|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743458|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743459|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743460|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743461|NCT02889523|Prednisolone|prednisolone|mesh-list
56743462|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
56743463|NCT02889523|Rituximab|rituximab|mesh-list
56743488|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56743489|NCT02784210|Prednisone|prednisone|mesh-list
56743490|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
56743491|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56743492|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56743493|NCT02784210|Prednisolone|prednisolone|mesh-list
56743494|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
56743495|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56743496|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
56743497|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743498|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
56743499|NCT02784210|Hormones|hormones|mesh-ancestor
56743500|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56743501|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743502|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56743503|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743504|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
56743505|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
56743506|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743507|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56743508|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56743509|NCT02784210|Protective Agents|protective agents|mesh-ancestor
56743510|NCT02771626|Nivolumab|nivolumab|mesh-list
56743511|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743512|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743513|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56743514|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743515|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
56743516|NCT02724579|Lomustine|lomustine|mesh-list
56743517|NCT02724579|Cisplatin|cisplatin|mesh-list
56743533|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743534|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743535|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
56743536|NCT02616302|Lansoprazole|lansoprazole|mesh-list
56743537|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56743538|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56743539|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56743540|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743541|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743542|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
56743543|NCT02595879|Cisplatin|cisplatin|mesh-list
56743544|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56743545|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743546|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56743547|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743548|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
56743549|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
56743550|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743551|NCT02546661|Durvalumab|durvalumab|mesh-list
56743552|NCT02546661|Olaparib|olaparib|mesh-list
56743553|NCT02546661|Adavosertib|adavosertib|mesh-list
56743554|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743555|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743556|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56743557|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743558|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743563|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56743564|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56743580|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
56743581|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
56743582|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743583|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56743584|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56743585|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56743586|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56743587|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
56743588|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743589|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743590|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
56743591|NCT02374242|Nivolumab|nivolumab|mesh-list
56743592|NCT02374242|Ipilimumab|ipilimumab|mesh-list
56743593|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743594|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743595|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56743596|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743597|NCT02370329|Interferons|interferons|mesh-list
56743598|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
56743599|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
56743600|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56743601|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56743602|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743603|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
56743604|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743605|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
56743606|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743607|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
56743614|NCT02272790|Paclitaxel|paclitaxel|mesh-list
56743628|NCT02272790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743629|NCT02272790|Immunologic Factors|immunologic factors|mesh-ancestor
56743630|NCT02272790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743631|NCT02113657|Ipilimumab|ipilimumab|mesh-list
56743632|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743633|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743634|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56743635|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743636|NCT02035787|Metformin|metformin|mesh-list
56743637|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56743638|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743639|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
56743640|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56743641|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56743642|NCT01968109|Nivolumab|nivolumab|mesh-list
56743643|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743644|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743645|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56743646|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743647|NCT01850355|Buspirone|buspirone|mesh-list
56743648|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56743685|NCT01464164|Prednisone|prednisone|mesh-list
56743686|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56743687|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
56743688|NCT01464164|Hormones|hormones|mesh-ancestor
56743689|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56743690|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743691|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56743692|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743693|NCT01377389|Ipilimumab|ipilimumab|mesh-list
56743694|NCT01377389|Leuprolide|leuprolide|mesh-list
56743695|NCT01377389|Goserelin|goserelin|mesh-list
56743696|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743697|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743698|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56743699|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743700|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56743701|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
56743702|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56743703|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743704|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56743705|NCT01194271|Ipilimumab|ipilimumab|mesh-list
56743706|NCT01194271|Leuprolide|leuprolide|mesh-list
56743707|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743708|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743709|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56743710|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743711|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56743712|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
56743713|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56743714|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743715|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56743716|NCT01174121|Aldesleukin|aldesleukin|mesh-list
56743717|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
56743718|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
56743719|NCT01174121|Fludarabine|fludarabine|mesh-list
56743720|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743721|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
56743722|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743723|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56743724|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743725|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
56743726|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743727|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743728|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56743729|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743730|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56743731|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56743732|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
56743733|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743734|NCT01119508|Temozolomide|temozolomide|mesh-list
56743735|NCT01119508|Ipilimumab|ipilimumab|mesh-list
56743736|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56743737|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
56743738|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743739|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743740|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743741|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56743742|NCT00977977|Cyclosporine|cyclosporine|mesh-list
56743743|NCT00977977|Rituximab|rituximab|mesh-list
56743744|NCT00977977|Cyclosporins|cyclosporins|mesh-list
56743745|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56743765|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743766|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
56743767|NCT00602459|Rituximab|rituximab|mesh-list
56743768|NCT00602459|Fludarabine|fludarabine|mesh-list
56743769|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
56743770|NCT00602459|Lenalidomide|lenalidomide|mesh-list
56743771|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56743772|NCT00602459|Antibodies|antibodies|mesh-list
56743773|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
56743774|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56743775|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743776|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
56743777|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743831|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743832|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56743833|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
56743834|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
56743835|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
56743836|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56743837|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56743838|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56743839|NCT00199069|Analgesics|analgesics|mesh-ancestor
56743899|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
56743900|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56743901|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743902|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56743903|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
56743904|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56743905|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56743906|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56743907|NCT00568776|Inositol|inositol|mesh-list
56743908|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
56743909|NCT00568776|Vitamins|vitamins|mesh-ancestor
56743910|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
56743911|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743912|NCT01067443|Amphotericin B|amphotericin b|mesh-list
56743913|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56743914|NCT01067443|Miltefosine|miltefosine|mesh-list
56743915|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56743916|NCT01067443|Amebicides|amebicides|mesh-ancestor
56743917|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56743918|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56743919|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56743920|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56743921|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
56743922|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743923|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
56743924|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56743925|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
56743926|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56743927|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56743928|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56743929|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56743942|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743943|NCT00816816|Docetaxel|docetaxel|mesh-list
56743944|NCT00816816|Fluorouracil|fluorouracil|mesh-list
56743945|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56743946|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
56743947|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
56743948|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
56743949|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743950|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
56743951|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56743952|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56743953|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
56743954|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743955|NCT00816894|Olanzapine|olanzapine|mesh-list
56743956|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
56743957|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
56743958|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56743959|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743960|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56743961|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56743962|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56743963|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56743964|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56743965|NCT00816894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56743966|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56743971|NCT00635154|Dexamethasone|dexamethasone|mesh-list
56743991|NCT00822744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56743992|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56743993|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56743994|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56743995|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56743996|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
56743997|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56743998|NCT00822744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56743999|NCT00822744|Antidepressive Agents|antidepressive agents|mesh-ancestor
56744000|NCT00822744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744001|NCT00819468|Teduglutide|teduglutide|mesh-list
56744002|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56744003|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56744004|NCT00819468|Protective Agents|protective agents|mesh-ancestor
56744005|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744006|NCT01067599|Nicotine|nicotine|mesh-list
56744007|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56744008|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
56744009|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744010|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744011|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56744012|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56744013|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
56744014|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744015|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744016|NCT00778817|Mitotane|mitotane|mesh-list
56744017|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56744018|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744019|NCT00293059|Dienogest|dienogest|mesh-list
56744020|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56744021|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56744022|NCT00293059|Estradiol|estradiol|mesh-list
56744023|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56744024|NCT00293059|Estrogens|estrogens|mesh-ancestor
56744025|NCT00293059|Hormones|hormones|mesh-ancestor
56744026|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744028|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56744029|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
56744030|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56744031|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56744032|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56744033|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56744034|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56744035|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
56744036|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56744037|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744038|NCT00756275|Nicotine|nicotine|mesh-list
56744039|NCT00756275|Varenicline|varenicline|mesh-list
56744040|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56744041|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
56744042|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744043|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744044|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56744045|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56744046|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
56744047|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744083|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
56744084|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56744085|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
56744086|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744087|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744088|NCT01067677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56744089|NCT01067677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56744090|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744091|NCT01067677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744092|NCT01067677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56744093|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56744094|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56744095|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
56744096|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
56744097|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
56744098|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56744099|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
56744100|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
56744101|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56744102|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56744103|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56744104|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
56744105|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
56744106|NCT03979651|Trametinib|trametinib|mesh-list
56744107|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
56744108|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56744109|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56744110|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744111|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744112|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744113|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56744114|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744115|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56744116|NCT02600741|Droperidol|droperidol|mesh-list
56744117|NCT02600741|Haloperidol|haloperidol|mesh-list
56744126|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56744127|NCT02600741|Ziprasidone|ziprasidone|mesh-list
56744128|NCT02600741|Clozapine|clozapine|mesh-list
56744129|NCT02600741|Asenapine|asenapine|mesh-list
56744130|NCT02600741|Loxapine|loxapine|mesh-list
56744131|NCT02600741|Iloperidone|iloperidone|mesh-list
56744132|NCT02600741|Perphenazine|perphenazine|mesh-list
56744133|NCT02600741|Fluphenazine|fluphenazine|mesh-list
56744134|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
56744135|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
56744136|NCT02600741|Thioridazine|thioridazine|mesh-list
56744137|NCT02600741|Thiothixene|thiothixene|mesh-list
56744138|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56744139|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
56744140|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744141|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744142|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744143|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56744144|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56744145|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744146|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744147|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56744148|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
56744149|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
56744150|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
56744151|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744152|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56744153|NCT02600741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56744176|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744177|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
56744178|NCT01065727|Natalizumab|natalizumab|mesh-list
56744179|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
56744180|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
56744181|NCT01065727|Analgesics|analgesics|mesh-ancestor
56744182|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
56744183|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744184|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744185|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744186|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56744187|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56744188|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744189|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744190|NCT01065805|Alovudine|alovudine|mesh-list
56744191|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
56744192|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744193|NCT00311623|Sirolimus|sirolimus|mesh-list
56744194|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56744195|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744196|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56744197|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744198|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
56744229|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
56744230|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744231|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56744232|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56744233|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56744234|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56744235|NCT00633594|Rituximab|rituximab|mesh-list
56744236|NCT00633594|Lenalidomide|lenalidomide|mesh-list
56744237|NCT00633594|Bortezomib|bortezomib|mesh-list
56744238|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56744239|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744240|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
56744241|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744242|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56744243|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56744244|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56744245|NCT00633594|Growth Substances|growth substances|mesh-ancestor
56744246|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56744247|NCT04840888|Itraconazole|itraconazole|mesh-list
56744248|NCT04840888|Carbamazepine|carbamazepine|mesh-list
56744249|NCT04840888|Omeprazole|omeprazole|mesh-list
56744250|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56744251|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56744252|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56744253|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744254|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744255|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
56744256|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744257|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56744258|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56744259|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56744260|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
56744261|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744262|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744263|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56744267|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744268|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744269|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56744270|NCT04840888|Analgesics|analgesics|mesh-ancestor
56744271|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
56744272|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744273|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56744274|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744275|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56744276|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56744277|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56744278|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56744279|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56744280|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744281|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744282|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744283|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744284|NCT05396014|Analgesics|analgesics|mesh-ancestor
56744285|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
56744286|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744317|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56744318|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744319|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744320|NCT05301712|Naloxone|naloxone|mesh-list
56744321|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56744322|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744323|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
56744324|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744325|NCT00817284|Bevacizumab|bevacizumab|mesh-list
56744326|NCT00817284|Irinotecan|irinotecan|mesh-list
56744327|NCT00817284|Temozolomide|temozolomide|mesh-list
56744328|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56744329|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744330|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56744377|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744378|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744379|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56744380|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744381|NCT00825864|Dexamethasone|dexamethasone|mesh-list
56744382|NCT00825864|Diclofenac|diclofenac|mesh-list
56744383|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
56744384|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56744385|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56744386|NCT00825864|BB 1101|bb 1101|mesh-list
56744387|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56744388|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
56744389|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
56744390|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744391|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744392|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56744393|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
56744394|NCT00825864|Hormones|hormones|mesh-ancestor
56744395|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744396|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56744397|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744398|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56744399|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56744400|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56744401|NCT00825864|Analgesics|analgesics|mesh-ancestor
56744402|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
56744403|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56744404|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56744405|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744406|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744407|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
56744408|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56744409|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56744410|NCT00527332|Fentanyl|fentanyl|mesh-list
56744411|NCT00527332|Morphine|morphine|mesh-list
56744412|NCT00527332|Bupivacaine|bupivacaine|mesh-list
56744413|NCT00527332|Propofol|propofol|mesh-list
56744414|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
56744416|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744417|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744418|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
56744419|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744420|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56744421|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56744422|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
56744423|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56744424|NCT00527332|Narcotics|narcotics|mesh-ancestor
56744425|NCT00527332|Analgesics|analgesics|mesh-ancestor
56744426|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56744479|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56744480|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744481|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
56744482|NCT00826254|Vitamins|vitamins|mesh-list
56744483|NCT00826254|Vitamin K|vitamin k|mesh-list
56744484|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
56744485|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744486|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56744487|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56744488|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744489|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
56744490|NCT00826254|Coagulants|coagulants|mesh-ancestor
56744491|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56744492|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
56744493|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744494|NCT00820404|BLI-489|bli-489|mesh-list
56744495|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56744496|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744497|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744498|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56744499|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744500|NCT00820482|Menotropins|menotropins|mesh-list
56744501|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56744502|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
56744503|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56744504|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744505|NCT00754793|Dexetimide|dexetimide|mesh-list
56744506|NCT00754793|Citalopram|citalopram|mesh-list
56744507|NCT00754793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56744508|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56017166|NCT01896284|Aflibercept|aflibercept|mesh-list
56017220|NCT00241904|Propranolol|propranolol|mesh-list
56017221|NCT00241904|Metoprolol|metoprolol|mesh-list
56017222|NCT00241904|Atenolol|atenolol|mesh-list
56017223|NCT00241904|Lisinopril|lisinopril|mesh-list
56017224|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56017225|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56017226|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56017227|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56017228|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
56744523|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56744524|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
56744526|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56744527|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744528|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56744529|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744530|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744531|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56744569|NCT05244070|Fludarabine|fludarabine|mesh-list
56744570|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56744571|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
56744572|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744573|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56744574|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56744575|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
56744576|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744577|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744578|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56744579|NCT00826644|Etoposide|etoposide|mesh-list
56744580|NCT00826644|Belotecan|belotecan|mesh-list
56744581|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744582|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56744583|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56744584|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56744585|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744586|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744587|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56744588|NCT00826722|Levetiracetam|levetiracetam|mesh-list
56744589|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
56744590|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
56744591|NCT04922944|Vaccines|vaccines|mesh-list
56744592|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
56744593|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744594|NCT05198050|Letrozole|letrozole|mesh-list
56744595|NCT05198050|Alprostadil|alprostadil|mesh-list
56744596|NCT05198050|Misoprostol|misoprostol|mesh-list
56455676|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
56744597|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744598|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56744599|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56744600|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744601|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744602|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56744603|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
56744604|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56017294|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017301|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56017302|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56017303|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017304|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
56744605|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744606|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56744607|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
56744608|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56744609|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56744610|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56744611|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
56744612|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56744613|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
56744614|NCT05198050|Urological Agents|urological agents|mesh-ancestor
56744615|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
56744616|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
56744617|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744618|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744619|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744620|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
56744621|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56744622|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744623|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744624|NCT04044378|Ifosfamide|ifosfamide|mesh-list
56744625|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56744626|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
56744627|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744628|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744629|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56744630|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
56744631|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56744635|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
56744639|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56744640|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56744641|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56744642|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744643|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744644|NCT00821028|Paclitaxel|paclitaxel|mesh-list
56744645|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56744646|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744647|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56744648|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56744649|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56744650|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744651|NCT00827034|Warfarin|warfarin|mesh-list
56744700|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56744701|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56744702|NCT00524368|Ritonavir|ritonavir|mesh-list
56744703|NCT00524368|Darunavir|darunavir|mesh-list
56744704|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56744705|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56744706|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
56744707|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744708|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744709|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56744710|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56744711|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
56744712|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744713|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56744759|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744760|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56744761|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56744762|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744763|NCT00524134|Carvedilol|carvedilol|mesh-list
56744764|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56744765|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56744766|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
56744767|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744768|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744769|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744770|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56744771|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
56744772|NCT00524134|Protective Agents|protective agents|mesh-ancestor
56744773|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56744774|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744775|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56744776|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
56744777|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56744778|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56744779|NCT00777023|Gabapentin|gabapentin|mesh-list
56744780|NCT00777023|Analgesics|analgesics|mesh-ancestor
56744809|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744810|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744811|NCT00292981|Complement C1s|complement c1s|mesh-list
56744812|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56744813|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56744814|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
56744815|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744816|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56744817|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56744819|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56744820|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56744821|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56744822|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56744823|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
56744824|NCT02598869|Hormones|hormones|mesh-ancestor
56744825|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744826|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031711|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031712|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811371|NCT04192773|Lidocaine|lidocaine|mesh-list
56031719|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031752|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56031753|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
56031754|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031756|NCT03405194|Cobicistat|cobicistat|mesh-list
56031757|NCT03405194|Elvitegravir|elvitegravir|mesh-list
56031793|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56031831|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
56031863|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
56031864|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
56031865|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031866|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56031867|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56031868|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031869|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031870|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56031871|NCT03000413|Narcotics|narcotics|mesh-ancestor
56031872|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56031874|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
56031907|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031908|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031909|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56031910|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
56031911|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56031912|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
56031913|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
56031914|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031949|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031950|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031951|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
56031952|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56031953|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56031954|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56031955|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56032023|NCT03005171|Bupivacaine|bupivacaine|mesh-list
56744827|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56744828|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
56744829|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744830|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744831|NCT04095455|Ketamine|ketamine|mesh-list
56744832|NCT04095455|Analgesics|analgesics|mesh-ancestor
56744833|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
56744834|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744835|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744836|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56744837|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56744838|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
56744839|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
56744840|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56744841|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56744842|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56744843|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744844|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744845|NCT04095299|Capecitabine|capecitabine|mesh-list
56744846|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56744847|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
56744848|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744849|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744850|NCT00296725|Fluoxetine|fluoxetine|mesh-list
56744851|NCT00296725|Imipramine|imipramine|mesh-list
56744852|NCT00296725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56744853|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56744854|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744855|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744856|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744857|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
56744858|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744859|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56744864|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744865|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56744866|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56744867|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
56744868|NCT00523978|Sotalol|sotalol|mesh-list
56744869|NCT00523978|Flecainide|flecainide|mesh-list
56744870|NCT00523978|Propafenone|propafenone|mesh-list
56744871|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56744872|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56744873|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
56744874|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744875|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744876|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744877|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56744878|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
56744879|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
56744880|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744881|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56744882|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56744883|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744884|NCT00296647|Bupropion|bupropion|mesh-list
56744885|NCT00296647|Nicotine|nicotine|mesh-list
56744886|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56744887|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
56744888|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744889|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744890|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56744891|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56744892|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
56744893|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744894|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744895|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56744896|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
56744897|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56744898|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56744902|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56744903|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56744904|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744905|NCT00754013|Donepezil|donepezil|mesh-list
56744906|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56744907|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744908|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744909|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
56744910|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744911|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744912|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
56744913|NCT00523744|Amlodipine|amlodipine|mesh-list
56744914|NCT00523744|Valsartan|valsartan|mesh-list
56744915|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56744916|NCT00523744|Olmesartan|olmesartan|mesh-list
56744917|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56744918|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56744919|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56744920|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56744921|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744922|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56744923|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744924|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
56744925|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56744926|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56744927|NCT00523744|Diuretics|diuretics|mesh-ancestor
56744951|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744952|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744953|NCT02598791|Glucagon|glucagon|mesh-list
56744954|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56744955|NCT02598791|Incretins|incretins|mesh-ancestor
56744956|NCT02598791|Hormones|hormones|mesh-ancestor
56744957|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56744958|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744959|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56744960|NCT00827346|Clopidogrel|clopidogrel|mesh-list
56744961|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56744962|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56744963|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56744964|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56744965|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
56744966|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56744967|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744968|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744970|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56744971|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56744972|NCT00997750|Analgesics|analgesics|mesh-ancestor
56744973|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
56744974|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56744975|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56744976|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56744977|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56744978|NCT00622908|Besifloxacin|besifloxacin|mesh-list
56744979|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56744980|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56744981|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56744982|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56744983|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56744984|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56744985|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744986|NCT00997828|Everolimus|everolimus|mesh-list
56032024|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
56744987|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56744988|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56744989|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
56744990|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745007|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
56745008|NCT02598635|Vitamin D|vitamin d|mesh-list
56745009|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56745010|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745011|NCT02598635|Vitamins|vitamins|mesh-ancestor
56745012|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
56745013|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56745014|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
56745015|NCT04093271|Promethazine|promethazine|mesh-list
56745016|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56745017|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56745018|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56745019|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745020|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
56745021|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
56745022|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
56745023|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745024|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
56745025|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
56745026|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745027|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56745028|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
56745029|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
56745030|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017690|NCT00335504|Analgesics|analgesics|mesh-ancestor
56745032|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56745033|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
56745034|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
56745035|NCT00827580|Eniluracil|eniluracil|mesh-list
56745036|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745037|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745038|NCT04094909|Paclitaxel|paclitaxel|mesh-list
56745039|NCT04094909|Cisplatin|cisplatin|mesh-list
56745040|NCT04094909|Carboplatin|carboplatin|mesh-list
56745041|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
56745042|NCT04094909|Pemetrexed|pemetrexed|mesh-list
56745043|NCT04094909|Endostatins|endostatins|mesh-list
56745044|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56745045|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745046|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
56745047|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
56745048|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
56745049|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745050|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56745051|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745052|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56745053|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56745054|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56745055|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56745056|NCT04094909|Growth Substances|growth substances|mesh-ancestor
56745057|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745058|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
56745059|NCT02599571|Nicotine|nicotine|mesh-list
56745060|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56745061|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
56745062|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745063|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745064|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56745065|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56745066|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
56745069|NCT00296491|Fluticasone|fluticasone|mesh-list
56745073|NCT00296491|Montelukast|montelukast|mesh-list
56745074|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745075|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56745076|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
56745077|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745078|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745079|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56745080|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
56745081|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
56745082|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56745083|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56745084|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56745085|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56745086|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
56745087|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745088|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745089|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56745090|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
56745091|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745092|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56745093|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56745094|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
56745095|NCT00296491|Hormones|hormones|mesh-ancestor
56745096|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
56745097|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56745100|NCT02599493|Rifampin|rifampin|mesh-list
56745121|NCT00296335|Floxuridine|floxuridine|mesh-list
56745122|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745123|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56745124|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
56745125|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745126|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56745127|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745128|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56745129|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
56745130|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745131|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
56745132|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745133|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
56745134|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56745135|NCT04094597|Lactoferrin|lactoferrin|mesh-list
56745136|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745137|NCT01065961|Dexamethasone|dexamethasone|mesh-list
56745138|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
56745139|NCT01065961|BB 1101|bb 1101|mesh-list
56745140|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745141|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
56745142|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
56745143|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745144|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745145|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745146|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
56745147|NCT01065961|Hormones|hormones|mesh-ancestor
56745154|NCT01068223|Cetirizine|cetirizine|mesh-list
56745168|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745169|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56745170|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745171|NCT02600273|Nicotine|nicotine|mesh-list
56745172|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56745173|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
56745174|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745175|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745176|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56745177|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56745178|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
56745179|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745180|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745181|NCT04219774|Aspirin|aspirin|mesh-list
56745182|NCT04219774|Clopidogrel|clopidogrel|mesh-list
56745183|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56745184|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56745185|NCT04219774|Analgesics|analgesics|mesh-ancestor
56745186|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
56745187|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745188|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745189|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745190|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56745191|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56745192|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56745193|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745194|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56745195|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56745196|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745214|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745215|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56745216|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56745217|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56745218|NCT04999228|Analgesics|analgesics|mesh-ancestor
56745219|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
56745220|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745221|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745222|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745223|NCT01564810|Cetuximab|cetuximab|mesh-list
56745224|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56745225|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745226|NCT04092101|Nicotine|nicotine|mesh-list
56745227|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56745228|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
56745229|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745230|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745231|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56745232|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56745233|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
56745234|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745235|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745236|NCT04093895|Taurolidine|taurolidine|mesh-list
56745237|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745238|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56745239|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745240|NCT00624780|Pregabalin|pregabalin|mesh-list
56745241|NCT00624780|Lorazepam|lorazepam|mesh-list
56745242|NCT00624780|Analgesics|analgesics|mesh-ancestor
56745243|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
56745244|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745245|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745246|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
56745254|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56745255|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
56745256|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
56745257|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745258|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56745259|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
56745260|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
56745261|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745262|NCT02599337|Sorafenib|sorafenib|mesh-list
56745263|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745264|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56745265|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745266|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745267|NCT00831636|Cytarabine|cytarabine|mesh-list
56745268|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56745314|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745315|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
56745316|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56745317|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
56745318|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56745319|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
56745320|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745321|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745322|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
56745323|NCT02597699|Lidocaine|lidocaine|mesh-list
56745324|NCT02597699|Sufentanil|sufentanil|mesh-list
56745325|NCT02597699|Remifentanil|remifentanil|mesh-list
56745326|NCT02597699|Dsuvia|dsuvia|mesh-list
56745327|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
56745328|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
56745329|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56745330|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745331|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
56745332|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745333|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56745334|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56745335|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56745336|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745337|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745338|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56745339|NCT02597699|Narcotics|narcotics|mesh-ancestor
56745340|NCT02597699|Analgesics|analgesics|mesh-ancestor
56745341|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56745342|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56745343|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
56745344|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
56745345|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745346|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56745356|NCT00998218|Ranolazine|ranolazine|mesh-list
56745357|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56745358|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745359|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745360|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56745361|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56745362|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
56745363|NCT00311311|Sirolimus|sirolimus|mesh-list
56745364|NCT00311311|Prednisone|prednisone|mesh-list
56745365|NCT00311311|Tacrolimus|tacrolimus|mesh-list
56745366|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745367|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
56745368|NCT00311311|Hormones|hormones|mesh-ancestor
56745369|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745370|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745371|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56745372|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745373|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745374|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
56745375|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56745412|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745413|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745414|NCT00521404|Antiviral Agents|antiviral agents|mesh-ancestor
56745415|NCT00521404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745416|NCT00521404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745417|NCT00521404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745419|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56745420|NCT00311155|Olmesartan|olmesartan|mesh-list
56745421|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56745422|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56745423|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56745424|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745425|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745426|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56745427|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745428|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
56745429|NCT00311155|Diuretics|diuretics|mesh-ancestor
56745430|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
56745431|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56745432|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56745433|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56745434|NCT03981601|Lovastatin|lovastatin|mesh-list
56745435|NCT03981601|L 647318|l 647318|mesh-list
56745436|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
56745437|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56745438|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56745439|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
56745440|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745441|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56745442|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56745443|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745444|NCT00274651|Belinostat|belinostat|mesh-list
56745445|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745447|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745451|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56745452|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745453|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56745454|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
56745455|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56745456|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56745457|NCT02367040|Rituximab|rituximab|mesh-list
56745458|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56745459|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745460|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
56745461|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745462|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56745463|NCT00827814|Dutasteride|dutasteride|mesh-list
56745464|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56745465|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56745466|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745467|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745468|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
56745469|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745470|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745471|NCT01068847|Cycloserine|cycloserine|mesh-list
56745472|NCT01068847|Verapamil|verapamil|mesh-list
56745473|NCT01068847|Nifedipine|nifedipine|mesh-list
56745474|NCT01068847|Tizanidine|tizanidine|mesh-list
56745475|NCT01068847|Naloxone|naloxone|mesh-list
56745476|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56745477|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745478|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
56745479|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745480|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56745481|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745482|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745483|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56456579|NCT00344981|Tenofovir|tenofovir|mesh-list
56745490|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56745491|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
56745492|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56745493|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
56745494|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56745495|NCT01068847|Analgesics|analgesics|mesh-ancestor
56745496|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
56745497|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56745498|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56745499|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
56745500|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
56745501|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56745502|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56745503|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56745504|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
56745505|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745506|NCT00827892|Pioglitazone|pioglitazone|mesh-list
56745507|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56745509|NCT01070875|Heparin|heparin|mesh-list
56018244|NCT04259060|Vitamins|vitamins|mesh-ancestor
56018245|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
56018246|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018252|NCT00318812|Iron|iron|mesh-list
56018253|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56745547|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745548|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56745549|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
56745550|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
56745551|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745552|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745553|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56745554|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
56745555|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56745556|NCT00825552|Risperidone|risperidone|mesh-list
56745558|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
56745600|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745601|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745602|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56745603|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56745604|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56745605|NCT00943839|Sunitinib|sunitinib|mesh-list
56745606|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745607|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56745608|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56745609|NCT00943839|Growth Substances|growth substances|mesh-ancestor
56745610|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745611|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
56745612|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56745613|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745614|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745615|NCT00832182|Insulin|insulin|mesh-list
56745616|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56745617|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
56745618|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
56745619|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
56745620|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
56745621|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56745622|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745623|NCT00952497|Capecitabine|capecitabine|mesh-list
56745624|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745625|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56745626|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
56745627|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745628|NCT00828282|Simvastatin|simvastatin|mesh-list
56745629|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56745630|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56745631|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
56745632|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745633|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56745634|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56032025|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
56745637|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56745638|NCT00952575|Antibodies|antibodies|mesh-list
56745639|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56745640|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
56745641|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
56745642|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745643|NCT03865732|Pregnanolone|pregnanolone|mesh-list
56745644|NCT03865732|Ganaxolone|ganaxolone|mesh-list
56745645|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
56745646|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745647|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745648|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745649|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
56745650|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
56745651|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
56745652|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56745653|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
56745654|NCT00944307|Antacids|antacids|mesh-list
56745655|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
56745656|NCT00944307|TEMPO|tempo|mesh-list
56745657|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56745658|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56745659|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
56745660|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745661|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56745662|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56745663|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745664|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745665|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745666|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
56745667|NCT00944307|Protective Agents|protective agents|mesh-ancestor
56745682|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745683|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745684|NCT00944463|Antiviral Agents|antiviral agents|mesh-ancestor
56745685|NCT00944463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745686|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745687|NCT00944463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745688|NCT00944463|Immunologic Factors|immunologic factors|mesh-ancestor
56745689|NCT00944463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745690|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56745691|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56745692|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56745693|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56745694|NCT00956397|Rifaximin|rifaximin|mesh-list
56745695|NCT00956397|Lactulose|lactulose|mesh-list
56745696|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56745697|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745698|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745699|NCT05300373|Adenosine|adenosine|mesh-list
56745700|NCT05300373|Analgesics|analgesics|mesh-ancestor
56745701|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
56745702|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745704|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56745734|NCT00947895|Hormones|hormones|mesh-ancestor
56745735|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56745736|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745737|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56745738|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
56745739|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
56745740|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745741|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745742|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
56745743|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56745744|NCT00947895|Protective Agents|protective agents|mesh-ancestor
56745745|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56745746|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745747|NCT00623766|Dexamethasone|dexamethasone|mesh-list
56745748|NCT00623766|Prednisone|prednisone|mesh-list
56745794|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
56745795|NCT00954135|Sorafenib|sorafenib|mesh-list
56745796|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745797|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
56745798|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745799|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56745800|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56745801|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
56745802|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745803|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56745804|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56745805|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56745806|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745807|NCT00832806|Varenicline|varenicline|mesh-list
56745808|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56745809|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56745810|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
56745811|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56745812|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745813|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745814|NCT00832884|Lacosamide|lacosamide|mesh-list
56745815|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
56745816|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56745817|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56745818|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745819|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745820|NCT02549118|Tenoxicam|tenoxicam|mesh-list
56745821|NCT02549118|Meperidine|meperidine|mesh-list
56745822|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56745823|NCT02549118|Narcotics|narcotics|mesh-ancestor
56745826|NCT02549118|Analgesics|analgesics|mesh-ancestor
56745837|NCT00957177|Pregabalin|pregabalin|mesh-list
56745838|NCT00957177|Analgesics|analgesics|mesh-ancestor
56745839|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
56745840|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745841|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745842|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
56745843|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56745844|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56745845|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56745846|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56745847|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56745848|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56745849|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56745850|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56745851|NCT04337580|Omeprazole|omeprazole|mesh-list
56745852|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56745853|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745854|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56745857|NCT00828594|Sorafenib|sorafenib|mesh-list
56745892|NCT00954525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56745893|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56745894|NCT00954525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56745895|NCT00954525|Immunologic Factors|immunologic factors|mesh-ancestor
56745896|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56745897|NCT04011345|Folic Acid|folic acid|mesh-list
56745898|NCT04011345|Hematinics|hematinics|mesh-ancestor
56745899|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
56745900|NCT04011345|Vitamins|vitamins|mesh-ancestor
56745901|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
56745902|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745903|NCT00838032|Haloperidol|haloperidol|mesh-list
56745904|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56745905|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
56745906|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
56745907|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56745908|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56745909|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56745910|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56745911|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745912|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
56745913|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
56745915|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56745946|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
56745947|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56745948|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56745949|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56745950|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
56745951|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
56745952|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56745953|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56745954|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56746010|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56746011|NCT04011033|Analgesics|analgesics|mesh-ancestor
56746012|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
56746013|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746014|NCT00998608|Risperidone|risperidone|mesh-list
56746015|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56746016|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
56746017|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746018|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746019|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746020|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56746021|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56746022|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56746023|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56746024|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56746025|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
56746026|NCT04011813|Antioxidants|antioxidants|mesh-list
56746027|NCT04011813|Hypotaurine|hypotaurine|mesh-list
56746034|NCT00998686|Incretins|incretins|mesh-ancestor
56746065|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56746066|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56746067|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746068|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746069|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56746070|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56746071|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
56746072|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746073|NCT00834600|Amlodipine|amlodipine|mesh-list
56746074|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56746075|NCT00834600|Olmesartan|olmesartan|mesh-list
56746076|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56746077|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56746078|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56746079|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56746080|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746081|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56746082|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746083|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
56746084|NCT00834600|Diuretics|diuretics|mesh-ancestor
56746085|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
56746086|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56746087|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56746088|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56746089|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
56746090|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56746091|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
56746092|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746093|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
56746094|NCT00958425|Protective Agents|protective agents|mesh-ancestor
56746096|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56746097|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56746098|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746099|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746105|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746106|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
56746107|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
56746108|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
56746109|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746110|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56746111|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
56746112|NCT00838656|Antiviral Agents|antiviral agents|mesh-ancestor
56746113|NCT00838656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746114|NCT00838656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746115|NCT00838656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746116|NCT00838656|Immunologic Factors|immunologic factors|mesh-ancestor
56746117|NCT00838656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746118|NCT00829608|Vaccines|vaccines|mesh-list
56746119|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
56746120|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746121|NCT00553605|Ketoprofen|ketoprofen|mesh-list
56746122|NCT00553605|Parecoxib|parecoxib|mesh-list
56746123|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56746124|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56746125|NCT00553605|Analgesics|analgesics|mesh-ancestor
56746126|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
56746127|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746128|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746129|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56746130|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746131|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56746132|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746133|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746134|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56746135|NCT00838968|Interferons|interferons|mesh-list
56746148|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746149|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
56746150|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
56746151|NCT05352165|Fluorouracil|fluorouracil|mesh-list
56746152|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56746153|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746154|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
56746155|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746156|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56746157|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746158|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
56746159|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746160|NCT00948987|Aspirin|aspirin|mesh-list
56746161|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56746162|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56746163|NCT00948987|Analgesics|analgesics|mesh-ancestor
56746164|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
56746165|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746166|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746167|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56746168|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746169|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56746170|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56746171|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746172|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56746173|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56746174|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746175|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
56746176|NCT00744497|Prednisone|prednisone|mesh-list
56746177|NCT00744497|Docetaxel|docetaxel|mesh-list
56746191|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746192|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
56746193|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56746194|NCT00949065|Antibodies|antibodies|mesh-list
56746195|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
56746196|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56746197|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
56746198|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746199|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56746200|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746201|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56746202|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746203|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746204|NCT05351385|Dimercaprol|dimercaprol|mesh-list
56746205|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
56746206|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
56746207|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746208|NCT00955227|Ezetimibe|ezetimibe|mesh-list
56746209|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56746210|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56746211|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
56746212|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746213|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56746214|NCT00949299|Buprenorphine|buprenorphine|mesh-list
56746215|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56746216|NCT00949299|Narcotics|narcotics|mesh-ancestor
56746217|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56746218|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746219|NCT00949299|Analgesics|analgesics|mesh-ancestor
56746220|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
56746236|NCT00271609|Growth Substances|growth substances|mesh-ancestor
56746237|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746238|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
56746240|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
56746241|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
56746242|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56746243|NCT00548847|Molgramostim|molgramostim|mesh-list
56746244|NCT00548847|Sargramostim|sargramostim|mesh-list
56746245|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746246|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
56746247|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746248|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
56746249|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746250|NCT00949377|Bromides|bromides|mesh-list
56746251|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
56746252|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
56746253|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56746254|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746255|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
56746256|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746257|NCT00290407|Rituximab|rituximab|mesh-list
56746258|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56746259|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746260|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
56746261|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746262|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746263|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
56746288|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746289|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746290|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
56746291|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
56746292|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746293|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56746294|NCT00955695|Gefitinib|gefitinib|mesh-list
56746295|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746296|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56746297|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746298|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746299|NCT00955773|Everolimus|everolimus|mesh-list
56746300|NCT00955773|Trametinib|trametinib|mesh-list
56746301|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746302|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746303|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
56746304|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746305|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56746308|NCT00549549|Celecoxib|celecoxib|mesh-list
56746343|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746344|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746345|NCT00956007|Cetuximab|cetuximab|mesh-list
56746346|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56746347|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746348|NCT01069159|Propranolol|propranolol|mesh-list
56746349|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56746350|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56746351|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
56746352|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746353|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746354|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746355|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56746356|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56746357|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
56746358|NCT03975205|Doxorubicin|doxorubicin|mesh-list
56746359|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56746360|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746361|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56746362|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56746363|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746364|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746365|NCT01325779|Heparin|heparin|mesh-list
56746366|NCT01325779|Enoxaparin|enoxaparin|mesh-list
56746367|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
56746368|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56746369|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56746370|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746371|NCT00956163|Diphosphonates|diphosphonates|mesh-list
56746372|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
56746373|NCT00956163|Listerine|listerine|mesh-list
56746374|NCT00956163|Fluorides|fluorides|mesh-list
56746386|NCT00956319|Zolpidem|zolpidem|mesh-list
56746387|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56746388|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56746389|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56746390|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746391|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56746392|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
56746393|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
56746394|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746395|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746396|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
56746397|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56746398|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56746399|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56746400|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
56746401|NCT00835848|Exenatide|exenatide|mesh-list
56746402|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56746403|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746404|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56746405|NCT00835848|Incretins|incretins|mesh-ancestor
56746406|NCT00835848|Hormones|hormones|mesh-ancestor
56746407|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746408|NCT00961857|Metformin|metformin|mesh-list
56746409|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56746410|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56746438|NCT00843570|Hormones|hormones|mesh-ancestor
56746439|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746440|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746441|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56746442|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
56746443|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56746444|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56746445|NCT00843570|Progestins|progestins|mesh-ancestor
56746446|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56746447|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
56746448|NCT02547870|Rilpivirine|rilpivirine|mesh-list
56746449|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56746450|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56746451|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746452|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746453|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
56746454|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746455|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56746456|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56746457|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
56746458|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
56746459|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
56746460|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56746461|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746462|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
56746463|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746464|NCT04913805|Niacinamide|niacinamide|mesh-list
56457548|NCT00421538|Nadroparin|nadroparin|mesh-list
56746467|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
56746468|NCT04913805|Vitamins|vitamins|mesh-ancestor
56746469|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
56746470|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746471|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56746481|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56746482|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746483|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746484|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56746485|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56746486|NCT00548145|Ezetimibe|ezetimibe|mesh-list
56746487|NCT00548145|Pitavastatin|pitavastatin|mesh-list
56746488|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56746489|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56746490|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
56746491|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746492|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56746493|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56746494|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746495|NCT00547911|Carbidopa|carbidopa|mesh-list
56746496|NCT00547911|Entacapone|entacapone|mesh-list
56746497|NCT00547911|Droxidopa|droxidopa|mesh-list
56746498|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56746499|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56746500|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
56746501|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746502|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746503|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746504|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56746505|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746506|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56746507|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
56746508|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
56746509|NCT00839280|Vitamins|vitamins|mesh-ancestor
56746510|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
56746511|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746512|NCT00836628|Busulfan|busulfan|mesh-list
56746513|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
56746514|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746515|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746516|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
56032026|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56746517|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746518|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56746519|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746520|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56746521|NCT00962637|Citric Acid|citric acid|mesh-list
56746522|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
56746523|NCT00962637|Enclomiphene|enclomiphene|mesh-list
56746524|NCT00962637|Clomiphene|clomiphene|mesh-list
56746525|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
56746526|NCT00962637|Testosterone|testosterone|mesh-list
56746527|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
56746528|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56746529|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
56746530|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
56746531|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746578|NCT00837174|Vorinostat|vorinostat|mesh-list
56746579|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746580|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56746581|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746582|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746583|NCT04042974|Dinoprostone|dinoprostone|mesh-list
56746584|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
56746585|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56746586|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746587|NCT00844350|Letrozole|letrozole|mesh-list
56746588|NCT00844350|Oxytocin|oxytocin|mesh-list
56746589|NCT00844350|Clomiphene|clomiphene|mesh-list
56746590|NCT00844350|Enclomiphene|enclomiphene|mesh-list
56746591|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
56746592|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746593|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
56746594|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56746595|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746596|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746597|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56746598|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56746599|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746600|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56746601|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
56746602|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746603|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56746604|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
56746625|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
56746626|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56746627|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56746628|NCT00844662|Sevelamer|sevelamer|mesh-list
56746629|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
56746630|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
56746631|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746632|NCT04678089|Bortezomib|bortezomib|mesh-list
56746633|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746634|NCT00963573|Loratadine|loratadine|mesh-list
56746635|NCT00963573|Betamethasone|betamethasone|mesh-list
56746636|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56746637|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
56746638|NCT00963573|Hormones|hormones|mesh-ancestor
56746639|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746640|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746641|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56746642|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
56746643|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
56746682|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
56746683|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
56746684|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
56746685|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56746686|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56746687|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56746688|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457771|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746689|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56746690|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
56746691|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746692|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56746693|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56746694|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56746695|NCT04534023|Idebenone|idebenone|mesh-list
56746696|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
56746697|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746698|NCT04534023|Protective Agents|protective agents|mesh-ancestor
56746699|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746700|NCT00964041|Cycloserine|cycloserine|mesh-list
56746701|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56746702|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746703|NCT00964041|Renal Agents|renal agents|mesh-ancestor
56746704|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56746705|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
56746706|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56746707|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
56746708|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746709|NCT04009317|Crizotinib|crizotinib|mesh-list
56746710|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746711|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56746714|NCT03641547|Capecitabine|capecitabine|mesh-list
56746723|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
56746724|NCT00967629|Calcium|calcium|mesh-list
56746725|NCT00967629|Sevelamer|sevelamer|mesh-list
56746726|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56746727|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746728|NCT00967629|Antacids|antacids|mesh-ancestor
56746729|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746730|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56746731|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
56746732|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
56746733|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56746790|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
56746791|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746792|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746793|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56746794|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56746795|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
56746796|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
56746797|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746798|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56746799|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
56746800|NCT00574080|Hormones|hormones|mesh-ancestor
56746801|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56746802|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56746803|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
56746804|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746805|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56746806|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56746807|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56746808|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56746809|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
56746810|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
56746811|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746812|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56746813|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
56746814|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56746815|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56746837|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
56457923|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
56746838|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746839|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746840|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56746841|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
56746842|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56746843|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56746844|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
56746845|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746846|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
56746847|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746848|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56746849|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56746850|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56746851|NCT00267865|Antidotes|antidotes|mesh-ancestor
56746852|NCT00267865|Protective Agents|protective agents|mesh-ancestor
56746853|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
56746854|NCT00267865|Vitamins|vitamins|mesh-ancestor
56746855|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
56746856|NCT00840918|Lidocaine|lidocaine|mesh-list
56746858|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
56746889|NCT00967707|Gabapentin|gabapentin|mesh-list
56746890|NCT00967707|Donepezil|donepezil|mesh-list
56746891|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56746892|NCT00967707|Analgesics|analgesics|mesh-ancestor
56746893|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
56746894|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746895|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746896|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
56746897|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56746898|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56746899|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56746900|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56746901|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56746902|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56746903|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746904|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746905|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
56746906|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56746907|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746908|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
56746909|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
56746910|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56746911|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56746912|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56457991|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56746937|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56746938|NCT00251719|Lansoprazole|lansoprazole|mesh-list
56746939|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
56746940|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56746941|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56746942|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56746943|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746944|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746945|NCT00845754|Ketorolac|ketorolac|mesh-list
56746946|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56746947|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56746948|NCT00845754|Analgesics|analgesics|mesh-ancestor
56746949|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
56746950|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56746951|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746952|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56746953|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746954|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56746955|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56746956|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56746957|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56746958|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
56746959|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
56746960|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746961|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
56746962|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746963|NCT00841386|Riboflavin|riboflavin|mesh-list
56746964|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
56746965|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
56746966|NCT00841386|Vitamins|vitamins|mesh-ancestor
56746967|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
56746968|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746969|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56746970|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
56746971|NCT03952143|Insulin|insulin|mesh-list
56746978|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56746979|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56746980|NCT00968331|Rituximab|rituximab|mesh-list
56746981|NCT00968331|Lenalidomide|lenalidomide|mesh-list
56746982|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56746983|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56746984|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
56746985|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56746986|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56746987|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56746988|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56746989|NCT00968331|Growth Substances|growth substances|mesh-ancestor
56746990|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
56746991|NCT00852228|Cetuximab|cetuximab|mesh-list
56747042|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56747043|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56747044|NCT02546154|Hematinics|hematinics|mesh-ancestor
56747045|NCT03943095|Fluorides|fluorides|mesh-list
56747046|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
56747047|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
56747048|NCT03943095|Protective Agents|protective agents|mesh-ancestor
56747049|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747050|NCT00848640|Sorafenib|sorafenib|mesh-list
56747051|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747052|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56747053|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747054|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747055|NCT00968565|Citric Acid|citric acid|mesh-list
56747056|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
56747057|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
56747058|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56747059|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
56747060|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
56747061|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747062|NCT00848796|Heparin|heparin|mesh-list
56747063|NCT00848796|Calcium heparin|calcium heparin|mesh-list
56458176|NCT00458913|Bortezomib|bortezomib|mesh-list
56747064|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
56747065|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56747066|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56747067|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747068|NCT00965289|Rituximab|rituximab|mesh-list
56747074|NCT04042506|Nivolumab|nivolumab|mesh-list
56747089|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
56747090|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747091|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56747092|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747093|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
56747094|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747095|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56747096|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56747097|NCT00250705|Aripiprazole|aripiprazole|mesh-list
56747098|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
56747099|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56747100|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56747101|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56747102|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747103|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747149|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747150|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56747151|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56747152|NCT00849264|Growth Substances|growth substances|mesh-ancestor
56747153|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
56747154|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
56747155|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747156|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747157|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56747158|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
56747159|NCT00842556|Glimepiride|glimepiride|mesh-list
56747160|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747161|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747162|NCT00842556|Incretins|incretins|mesh-ancestor
56747163|NCT00842556|Hormones|hormones|mesh-ancestor
56747164|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747165|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56747166|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
56747167|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747168|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747169|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56747170|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56747171|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747172|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
56747173|NCT00849966|Celecoxib|celecoxib|mesh-list
56747174|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56747175|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56747176|NCT00849966|Analgesics|analgesics|mesh-ancestor
56747177|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
56747178|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747179|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747180|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56747186|NCT00853008|Cytarabine|cytarabine|mesh-list
56747190|NCT00853008|Methotrexate|methotrexate|mesh-list
56747191|NCT00853008|Vincristine|vincristine|mesh-list
56747192|NCT00853008|Daunorubicin|daunorubicin|mesh-list
56747193|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
56747194|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
56747195|NCT00853008|Teniposide|teniposide|mesh-list
56747196|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56747197|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
56747198|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
56747199|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747200|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747201|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56747202|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
56747203|NCT00853008|Hormones|hormones|mesh-ancestor
56747204|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747205|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56747206|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747207|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56747208|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
56747209|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56747210|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56747211|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
56747212|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747213|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
56747214|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747215|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56747216|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747217|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
56747218|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747219|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56747220|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
56747221|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747222|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56747233|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
56747234|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747235|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747236|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56747237|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
56747238|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
56747239|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56747240|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56747241|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56747242|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
56747243|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747244|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747245|NCT00853320|Oxycodone|oxycodone|mesh-list
56747246|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56747247|NCT00853320|Narcotics|narcotics|mesh-ancestor
56747248|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747249|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747250|NCT00853320|Analgesics|analgesics|mesh-ancestor
56747251|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
56747252|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747253|NCT00547521|Methotrexate|methotrexate|mesh-list
56747254|NCT00547521|Abatacept|abatacept|mesh-list
56747255|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56747256|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
56747257|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56747258|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747260|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
56747280|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747281|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56747282|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56747283|NCT00266227|Rituximab|rituximab|mesh-list
56747284|NCT00266227|Methotrexate|methotrexate|mesh-list
56747285|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56747286|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747287|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
56747288|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747289|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747290|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56747291|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
56458396|NCT00468351|Hormones|hormones|mesh-ancestor
56747292|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56747293|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56747294|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
56747295|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747296|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
56747297|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747298|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56747299|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747300|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56747301|NCT04233216|Islatravir|islatravir|mesh-list
56747302|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
56747303|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747304|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747305|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747325|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747326|NCT00853554|Hydromorphone|hydromorphone|mesh-list
56747327|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56747328|NCT00853554|Narcotics|narcotics|mesh-ancestor
56747329|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747330|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747331|NCT00853554|Analgesics|analgesics|mesh-ancestor
56747332|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
56747333|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747334|NCT00969033|Irinotecan|irinotecan|mesh-list
56747335|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56747336|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56747337|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747338|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747339|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747340|NCT00573768|Diclofenac|diclofenac|mesh-list
56747341|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56747342|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56747343|NCT00573768|Analgesics|analgesics|mesh-ancestor
56747344|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
56747345|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747346|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747347|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56747348|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747349|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56747350|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747351|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747352|NCT00965913|Nicotine|nicotine|mesh-list
56747353|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56747354|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
56747355|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747356|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747357|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56747358|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56747362|NCT00853866|Reboxetine|reboxetine|mesh-list
56747364|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56747365|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56458444|NCT00426998|Bevacizumab|bevacizumab|mesh-list
56747366|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56747367|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56747368|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747369|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
56747370|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747371|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747372|NCT00855660|Riociguat|riociguat|mesh-list
56747373|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
56747374|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747375|NCT00965991|Metformin|metformin|mesh-list
56747376|NCT00965991|Glyburide|glyburide|mesh-list
56747377|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747378|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747379|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56747380|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56747381|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747382|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747383|NCT00853944|Incretins|incretins|mesh-ancestor
56747384|NCT00853944|Hormones|hormones|mesh-ancestor
56747385|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747386|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56747387|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747388|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747389|NCT02545452|Anastrozole|anastrozole|mesh-list
56747390|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
56747391|NCT02545452|Nonoxynol|nonoxynol|mesh-list
56747392|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56747393|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747394|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56747395|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56747396|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747402|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56747403|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
56747404|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56747405|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56747406|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56747407|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56747408|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56747409|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56747410|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56747411|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
56747412|NCT00547365|Antibodies|antibodies|mesh-list
56747413|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
56747414|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56747415|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56747416|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
56747417|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747418|NCT00854178|Anesthetics|anesthetics|mesh-list
56747419|NCT00854178|Isoflurane|isoflurane|mesh-list
56747420|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747421|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747422|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
56747423|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56747424|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
56747425|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
56747426|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747427|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
56747428|NCT00850746|Z 338|z 338|mesh-list
56747429|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56747430|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747431|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56747432|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56747433|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747434|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747435|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747436|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747437|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56747438|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
56747439|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747440|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56747441|NCT00969813|Tofacitinib|tofacitinib|mesh-list
56747442|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56747443|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747444|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747445|NCT00854256|Mitomycins|mitomycins|mesh-list
56747446|NCT00854256|Mitomycin|mitomycin|mesh-list
56747447|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56747448|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747449|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
56747452|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747502|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56747503|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
56747504|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
56747505|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
56747506|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
56747507|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747508|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747509|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
56747510|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56747511|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747512|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
56747513|NCT00854802|Ribavirin|ribavirin|mesh-list
56747514|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56747515|NCT00854802|Cyclosporine|cyclosporine|mesh-list
56747516|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
56747517|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747518|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
56747519|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747520|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
56747521|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
56747522|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747523|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747524|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
56747525|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747526|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747527|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56747528|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
56747529|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56747530|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747531|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
56747532|NCT04119024|Fludarabine|fludarabine|mesh-list
56747533|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
56747534|NCT04119024|Interleukin-2|interleukin-2|mesh-list
56747535|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747536|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
56747538|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747544|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56747545|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
56747546|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56747547|NCT04119024|Analgesics|analgesics|mesh-ancestor
56747548|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
56747549|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747550|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
56747551|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56747552|NCT00966771|Copper|copper|mesh-list
56747553|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
56747554|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56747555|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
56747556|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56747557|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747558|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56747559|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56747560|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56747561|NCT00966771|Trace Elements|trace elements|mesh-ancestor
56747562|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
56747563|NCT00856596|Sertaconazole|sertaconazole|mesh-list
56747564|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
56747565|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747566|NCT00855114|Everolimus|everolimus|mesh-list
56747567|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747568|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747569|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
56747570|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747571|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
56747572|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56747573|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
56747574|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56747575|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
56747590|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747591|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56747592|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
56747593|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
56747594|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56747595|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
56747596|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747597|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747598|NCT00970905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56747599|NCT00970905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56747600|NCT00970905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747601|NCT00970905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56747602|NCT00970905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56747603|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56747605|NCT00619476|Analgesics|analgesics|mesh-ancestor
56747606|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
56747607|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747608|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747609|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
56747610|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56747611|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56747612|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747613|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56747614|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56747615|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56747616|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747617|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747618|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
56747619|NCT00973713|Everolimus|everolimus|mesh-list
56747620|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747621|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747622|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
56747632|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56747633|NCT00865176|Eplerenone|eplerenone|mesh-list
56747634|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56747635|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
56747636|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747637|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747638|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56747639|NCT00865176|Diuretics|diuretics|mesh-ancestor
56747640|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
56747641|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56747642|NCT00973869|Curcumin|curcumin|mesh-list
56747643|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56747644|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56747645|NCT00973869|Analgesics|analgesics|mesh-ancestor
56747646|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
56747647|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747648|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747649|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56747650|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747651|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747652|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747653|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747654|NCT00959439|Naproxen|naproxen|mesh-list
56747655|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56747681|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
56747682|NCT00618072|Metformin|metformin|mesh-list
56747683|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
56747684|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747685|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747686|NCT00959517|Artesunate|artesunate|mesh-list
56747687|NCT00959517|Chloroquine|chloroquine|mesh-list
56747688|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
56747689|NCT00959517|Primaquine|primaquine|mesh-list
56747690|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
56747691|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56747692|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
56747693|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56747694|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56747695|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747696|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747697|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
56747698|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
56747699|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56747700|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
56747701|NCT00959517|Amebicides|amebicides|mesh-ancestor
56747702|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747703|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56747704|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747705|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747706|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56747707|NCT00959517|Renal Agents|renal agents|mesh-ancestor
56747708|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56747709|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
56747710|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
56747711|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747712|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747726|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747727|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56747728|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56747729|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747730|NCT00974181|Paclitaxel|paclitaxel|mesh-list
56747731|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56747732|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56747733|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747734|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
56747735|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
56747736|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
56747737|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747738|NCT00971607|Sevoflurane|sevoflurane|mesh-list
56747739|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56747740|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56747741|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
56747742|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
56747743|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747744|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56458817|NCT04704245|Petrolatum|petrolatum|mesh-list
56747745|NCT00971685|Dexamethasone|dexamethasone|mesh-list
56747746|NCT00971685|Lenalidomide|lenalidomide|mesh-list
56747747|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56747748|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
56747749|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
56747750|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747751|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747752|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56747753|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
56747771|NCT00971763|Prednisolone|prednisolone|mesh-list
56747772|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
56747773|NCT00971763|Rituximab|rituximab|mesh-list
56747774|NCT00971763|Vincristine|vincristine|mesh-list
56747775|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56747776|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
56747777|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747778|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747779|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56747780|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
56747781|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747782|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747783|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56747786|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
56747833|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56747834|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56747835|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56747836|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747837|NCT05179239|Paclitaxel|paclitaxel|mesh-list
56747838|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56747839|NCT05179239|Cisplatin|cisplatin|mesh-list
56747840|NCT05179239|Carboplatin|carboplatin|mesh-list
56747841|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56747842|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747843|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
56747844|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
56747845|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
56747846|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747847|NCT00972075|Melatonin|melatonin|mesh-list
56747848|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
56747849|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747850|NCT00972075|Protective Agents|protective agents|mesh-ancestor
56747851|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747852|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747853|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56747854|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56747855|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
56747856|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747857|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747880|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747881|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56747882|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56747883|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56747884|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56747885|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747886|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56747887|NCT03897244|Amoxicillin|amoxicillin|mesh-list
56747888|NCT03897244|Metronidazole|metronidazole|mesh-list
56747889|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56747890|NCT03897244|Rabeprazole|rabeprazole|mesh-list
56458970|NCT00430547|Carbimazole|carbimazole|mesh-list
56747891|NCT03897244|Bismuth|bismuth|mesh-list
56747892|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56747893|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747894|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
56747895|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56747896|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56747897|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56747898|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56747899|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747901|NCT03897244|Antacids|antacids|mesh-ancestor
56747931|NCT00974961|Bupivacaine|bupivacaine|mesh-list
56747932|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
56747933|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
56747934|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
56747935|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56747936|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747937|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
56747938|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56747939|NCT00511108|Pioglitazone|pioglitazone|mesh-list
56747940|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56747941|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56747942|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747943|NCT00511108|Incretins|incretins|mesh-ancestor
56747944|NCT00511108|Hormones|hormones|mesh-ancestor
56747945|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56747946|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56747947|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
56747948|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747949|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747950|NCT00781586|Caffeine|caffeine|mesh-list
56747951|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747952|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56747953|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56747954|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747955|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747956|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56747957|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56747958|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
56747959|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56747960|NCT00510952|Insulin|insulin|mesh-list
56747975|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747976|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56747977|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56747978|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56747979|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56747980|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747981|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56747982|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
56747983|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56747984|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56747985|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
56747986|NCT01012570|Adalimumab|adalimumab|mesh-list
56747987|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56747988|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56747989|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56747990|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56747991|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
56747992|NCT00661622|Molgramostim|molgramostim|mesh-list
56747993|NCT00661622|Sargramostim|sargramostim|mesh-list
56747994|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
56747995|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56747996|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56747997|NCT00781820|Bifonazole|bifonazole|mesh-list
56747998|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
56747999|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748000|NCT00786110|Paclitaxel|paclitaxel|mesh-list
56748001|NCT00786110|Sorafenib|sorafenib|mesh-list
56748025|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748026|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748027|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56748028|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56748029|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
56748030|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
56748031|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748032|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748033|NCT00792350|Sorafenib|sorafenib|mesh-list
56748034|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748035|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56748036|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748037|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748038|NCT00792584|Efavirenz|efavirenz|mesh-list
56748039|NCT00792584|Etravirine|etravirine|mesh-list
56748040|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56459111|NCT00431561|Trabedersen|trabedersen|mesh-list
56748041|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56748042|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748043|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748044|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
56748045|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748046|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56020725|NCT01795820|Ticagrelor|ticagrelor|mesh-list
56748072|NCT04093752|Incretins|incretins|mesh-ancestor
56748073|NCT04093752|Hormones|hormones|mesh-ancestor
56748074|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748075|NCT02544282|Acetaminophen|acetaminophen|mesh-list
56748076|NCT02544282|Sufentanil|sufentanil|mesh-list
56748077|NCT02544282|Tramadol|tramadol|mesh-list
56748078|NCT02544282|Pirinitramide|pirinitramide|mesh-list
56748079|NCT02544282|Propofol|propofol|mesh-list
56748080|NCT02544282|Sevoflurane|sevoflurane|mesh-list
56748081|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
56748082|NCT02544282|Atracurium|atracurium|mesh-list
56748083|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56748084|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748085|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748136|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748137|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56748138|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56748139|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
56748140|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
56748141|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748142|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56748143|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56748144|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748145|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748146|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56748147|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56748148|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748149|NCT00960453|Incretins|incretins|mesh-ancestor
56748150|NCT00960453|Hormones|hormones|mesh-ancestor
56748151|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748152|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56748153|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
56748154|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748155|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748156|NCT00265759|Letrozole|letrozole|mesh-list
56748157|NCT00265759|Anastrozole|anastrozole|mesh-list
56748158|NCT00265759|Exemestane|exemestane|mesh-list
56748159|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748184|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56748185|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56748186|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748187|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56748188|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
56748189|NCT00972387|Hormones|hormones|mesh-ancestor
56748190|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748191|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56748192|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56748193|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
56748194|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
56748195|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
56748196|NCT00744263|Vaccines|vaccines|mesh-list
56748197|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56748198|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
56748199|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748200|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
56748201|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56748202|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56748203|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
56748204|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748205|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748207|NCT00866736|Dasatinib|dasatinib|mesh-list
56748234|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
56748235|NCT00975351|Vitamins|vitamins|mesh-ancestor
56748236|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
56748237|NCT01071187|Varenicline|varenicline|mesh-list
56748238|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56748239|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56748240|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
56748241|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748242|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748243|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748244|NCT00618774|Amlodipine|amlodipine|mesh-list
56748245|NCT00618774|Telmisartan|telmisartan|mesh-list
56748246|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56748247|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56748255|NCT00917345|Captopril|captopril|mesh-list
56748298|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
56748299|NCT02555852|Histamine|histamine|mesh-list
56748300|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
56748301|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748302|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56748303|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56748304|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748305|NCT02555852|Antacids|antacids|mesh-ancestor
56748306|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
56748307|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
56748308|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748309|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748310|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
56748311|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56748312|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56748313|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748314|NCT04091009|Buprenorphine|buprenorphine|mesh-list
56748315|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56748316|NCT04091009|Naloxone|naloxone|mesh-list
56748317|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56748318|NCT04091009|Narcotics|narcotics|mesh-ancestor
56748319|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748320|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748321|NCT04091009|Analgesics|analgesics|mesh-ancestor
56748322|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
56748323|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748324|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56748325|NCT02597231|Melatonin|melatonin|mesh-list
56748326|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
56748327|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748328|NCT02597231|Protective Agents|protective agents|mesh-ancestor
56748331|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
56748342|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56748343|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748344|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748345|NCT02597309|Canagliflozin|canagliflozin|mesh-list
56748346|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56748347|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748348|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56748349|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748351|NCT00863148|Clofarabine|clofarabine|mesh-list
56748352|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
56748353|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748354|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748355|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
56748356|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748357|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56748358|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748359|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56748360|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56748361|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
56748362|NCT00786734|Pitavastatin|pitavastatin|mesh-list
56748363|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56748364|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56748365|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56748366|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
56748390|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748391|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
56748392|NCT00661388|Hematinics|hematinics|mesh-ancestor
56748393|NCT00972855|Bicalutamide|bicalutamide|mesh-list
56748394|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
56748395|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
56748396|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748397|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748398|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748399|NCT00972933|Ipilimumab|ipilimumab|mesh-list
56748400|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56748401|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748402|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56748403|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748404|NCT00263575|Fentanyl|fentanyl|mesh-list
56748405|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56748406|NCT00263575|Narcotics|narcotics|mesh-ancestor
56748409|NCT00263575|Analgesics|analgesics|mesh-ancestor
56748451|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748452|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748453|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56748454|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56748455|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
56748456|NCT00863460|Hormones|hormones|mesh-ancestor
56748457|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748458|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56748459|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56748460|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
56748461|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56748462|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56748463|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
56748464|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
56748465|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748466|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56748467|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56748468|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56748469|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56748470|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56748504|NCT00975819|Sirolimus|sirolimus|mesh-list
56748505|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56748506|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748507|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56748508|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748509|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
56748510|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748511|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
56748512|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748513|NCT00859872|Haloperidol|haloperidol|mesh-list
56748514|NCT00859872|Risperidone|risperidone|mesh-list
56748515|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
56748516|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56748517|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
56748518|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748519|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748520|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748521|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56748522|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56748523|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748524|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56748525|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56748526|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
56748527|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
56748528|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
56748529|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748530|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56748531|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56748532|NCT02555696|Paclitaxel|paclitaxel|mesh-list
56748551|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748552|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748553|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56748554|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56748555|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
56748556|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
56748557|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748558|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56748559|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
56748560|NCT05147493|Hormones|hormones|mesh-ancestor
56748561|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748562|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56748563|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56748564|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56748565|NCT05147493|Growth Substances|growth substances|mesh-ancestor
56748566|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
56748567|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56748568|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56748569|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459635|NCT03270969|Tenofovir|tenofovir|mesh-list
56748570|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56748571|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56748572|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56748573|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748574|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
56748575|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748576|NCT03974425|Aflibercept|aflibercept|mesh-list
56748577|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56748578|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56748583|NCT00975897|Leucovorin|leucovorin|mesh-list
56748593|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56748594|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56748595|NCT00975897|Growth Substances|growth substances|mesh-ancestor
56748596|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748597|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
56748598|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56748599|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
56748600|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748601|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56748602|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748603|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
56748604|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56748605|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56748606|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748607|NCT00975897|Antidotes|antidotes|mesh-ancestor
56748608|NCT00975897|Protective Agents|protective agents|mesh-ancestor
56748609|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
56748610|NCT00975897|Vitamins|vitamins|mesh-ancestor
56748611|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
56748612|NCT00867672|Decitabine|decitabine|mesh-list
56748613|NCT00867672|Tretinoin|tretinoin|mesh-list
56748614|NCT00867672|Valproic Acid|valproic acid|mesh-list
56748615|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56748616|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
56748617|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748618|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748619|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748620|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
56748621|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
56748622|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
56748623|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
56748624|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748625|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748626|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
56748627|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56748630|NCT00783926|Vaccines|vaccines|mesh-list
56748633|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748634|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
56748635|NCT01071499|Morphine|morphine|mesh-list
56748636|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56748637|NCT01071499|Narcotics|narcotics|mesh-ancestor
56748638|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748639|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748640|NCT01071499|Analgesics|analgesics|mesh-ancestor
56748641|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
56748642|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748643|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
56748644|NCT00961155|Montelukast|montelukast|mesh-list
56748695|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
56748696|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56748697|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56748698|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
56748699|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56748700|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56748701|NCT02596763|Baclofen|baclofen|mesh-list
56748702|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56748703|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748704|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56748705|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748706|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56748707|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
56748708|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
56748709|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748710|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748711|NCT00973323|Warfarin|warfarin|mesh-list
56748712|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
56748713|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
56748714|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56748715|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
56748716|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56748717|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
56748718|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748719|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748720|NCT00793988|Anesthetics|anesthetics|mesh-list
56748721|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748722|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748723|NCT00973401|Insulin|insulin|mesh-list
56748724|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56748725|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748726|NCT04040322|Iloprost|iloprost|mesh-list
56748727|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56748728|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
56748729|NCT00787436|Thalidomide|thalidomide|mesh-list
56748737|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56748738|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748739|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56748740|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56748741|NCT00787436|Growth Substances|growth substances|mesh-ancestor
56748742|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
56748743|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748744|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56748745|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56748746|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
56748747|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748748|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748749|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56748750|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56748751|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
56748752|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
56748753|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
56748754|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748755|NCT03945981|Lamivudine|lamivudine|mesh-list
56748756|NCT03945981|Dolutegravir|dolutegravir|mesh-list
56748757|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56748758|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56748759|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748760|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748761|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
56748762|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56748763|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56748764|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56748765|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56748766|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56748767|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
56748768|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748769|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
56748778|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748779|NCT00745901|Drospirenone|drospirenone|mesh-list
56748780|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56748781|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56748782|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56748783|NCT00745901|Norgestimate|norgestimate|mesh-list
56748784|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56748785|NCT00745901|Estradiol|estradiol|mesh-list
56748786|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56748787|NCT00745901|Estrogens|estrogens|mesh-ancestor
56748788|NCT00745901|Hormones|hormones|mesh-ancestor
56748789|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748790|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748791|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56748792|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
56748793|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56748794|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56748795|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56748796|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56748797|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56748798|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
56748799|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56748800|NCT00745901|Diuretics|diuretics|mesh-ancestor
56748802|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56748803|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56748804|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56748805|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
56748806|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748807|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748808|NCT00860340|Spironolactone|spironolactone|mesh-list
56748809|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56748810|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
56748811|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748812|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748816|NCT00784316|Metoprolol|metoprolol|mesh-list
56748817|NCT00784316|Amiodarone|amiodarone|mesh-list
56748818|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56748819|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56748820|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
56748821|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
56748822|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748823|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748824|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56748825|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56748826|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56748827|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
56748828|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748829|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748830|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
56748831|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56748832|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56748833|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56748834|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56748835|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56748836|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748837|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56748838|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56748839|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56748840|NCT00286429|Insulin|insulin|mesh-list
56748841|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56748842|NCT00286429|Alogliptin|alogliptin|mesh-list
56748843|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56748844|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748845|NCT00286429|Incretins|incretins|mesh-ancestor
56748846|NCT00286429|Hormones|hormones|mesh-ancestor
56748858|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748859|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
56748860|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
56748861|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748862|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748863|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56748864|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56748865|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
56748866|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56748867|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56748868|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56748869|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56748870|NCT00864006|Valproic Acid|valproic acid|mesh-list
56748871|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
56748872|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748873|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748874|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
56748875|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56748876|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748877|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
56748878|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56748879|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748880|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56748881|NCT00860496|Cyclosporine|cyclosporine|mesh-list
56748882|NCT00860496|Tacrolimus|tacrolimus|mesh-list
56748883|NCT00860496|Cyclosporins|cyclosporins|mesh-list
56748884|NCT00860496|Tofacitinib|tofacitinib|mesh-list
56748885|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748886|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
56748887|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748888|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56748889|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748896|NCT00864162|Ramipril|ramipril|mesh-list
56748900|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748901|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56748902|NCT00787826|Vaccines|vaccines|mesh-list
56748903|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
56748904|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748905|NCT00795314|Fentanyl|fentanyl|mesh-list
56748906|NCT00795314|Butorphanol|butorphanol|mesh-list
56748907|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56748908|NCT00795314|Narcotics|narcotics|mesh-ancestor
56748909|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56748910|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748911|NCT00795314|Analgesics|analgesics|mesh-ancestor
56748912|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
56748913|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56748914|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56748915|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56748916|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
56748917|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
56748918|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
56748919|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
56748920|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56748921|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56748922|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
56748923|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748924|NCT00864240|Clobetasol|clobetasol|mesh-list
56748925|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56748926|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
56748927|NCT00864240|Hormones|hormones|mesh-ancestor
56748928|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748929|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748930|NCT00979641|Docetaxel|docetaxel|mesh-list
56748945|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748946|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56748947|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56748948|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748949|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56748951|NCT00788060|Everolimus|everolimus|mesh-list
56748952|NCT00788060|Sunitinib|sunitinib|mesh-list
56748953|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56748954|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56748955|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
56748956|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748957|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56748958|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56748959|NCT00788060|Growth Substances|growth substances|mesh-ancestor
56748960|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
56748961|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56748962|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748963|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748964|NCT00788138|Vitamin D|vitamin d|mesh-list
56748965|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
56748966|NCT00788138|Vitamins|vitamins|mesh-ancestor
56748967|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
56748968|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748969|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56748970|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56748971|NCT00864396|Lansoprazole|lansoprazole|mesh-list
56748972|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56748973|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56748974|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56748975|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748976|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748977|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
56748978|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56748984|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56748985|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56748986|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56748987|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56748988|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56748989|NCT00961467|Thalidomide|thalidomide|mesh-list
56748990|NCT00961467|Prednisone|prednisone|mesh-list
56748991|NCT00961467|Melphalan|melphalan|mesh-list
56748992|NCT00961467|Lenalidomide|lenalidomide|mesh-list
56748993|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56748994|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
56748995|NCT00961467|Hormones|hormones|mesh-ancestor
56748996|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56748997|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56748998|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56748999|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749000|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56749001|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
56749002|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749003|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56749004|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749005|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
56749006|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749007|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56749032|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749033|NCT04988841|Nivolumab|nivolumab|mesh-list
56749034|NCT04988841|Ipilimumab|ipilimumab|mesh-list
56749035|NCT04988841|Laxatives|laxatives|mesh-list
56749036|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56749037|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56749038|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749039|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56749040|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749041|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749042|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56749043|NCT00980187|Indapamide|indapamide|mesh-list
56749044|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56749045|NCT00980187|Diuretics|diuretics|mesh-ancestor
56749046|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
56749047|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749048|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56749049|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56749050|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749051|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
56749052|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56749053|NCT00284089|Ranibizumab|ranibizumab|mesh-list
56749054|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749055|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56749056|NCT00284089|Growth Substances|growth substances|mesh-ancestor
56749057|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749058|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
56749059|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749060|NCT00984633|Bromides|bromides|mesh-list
56749061|NCT00984633|Propofol|propofol|mesh-list
56749062|NCT00984633|Sevoflurane|sevoflurane|mesh-list
56749063|NCT00984633|Rocuronium|rocuronium|mesh-list
56749064|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56749065|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749066|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749072|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
56749073|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56749074|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56749075|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56749076|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749077|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56749078|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749079|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749080|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749081|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56749082|NCT00976755|Everolimus|everolimus|mesh-list
56749083|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749084|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749085|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
56749086|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749087|NCT00864474|Maraviroc|maraviroc|mesh-list
56749088|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56749089|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56749090|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749091|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56749092|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56749093|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
56749094|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749095|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56749096|NCT00283387|Betaine|betaine|mesh-list
56749121|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
56749122|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749123|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56749124|NCT00984789|Gestodene|gestodene|mesh-list
56749125|NCT00984789|Norelgestromin|norelgestromin|mesh-list
56749126|NCT00984789|Femovan|femovan|mesh-list
56749127|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56749128|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56749129|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56749130|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
56749131|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56749132|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749133|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56749134|NCT00984789|Estrogens|estrogens|mesh-ancestor
56749135|NCT00984789|Hormones|hormones|mesh-ancestor
56749136|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749137|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56749138|NCT00984789|Progestins|progestins|mesh-ancestor
56749139|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56749140|NCT00864552|Factor VIII|factor viii|mesh-list
56749141|NCT00864552|Coagulants|coagulants|mesh-ancestor
56749142|NCT04046822|Liraglutide|liraglutide|mesh-list
56749143|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56749144|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749145|NCT04046822|Incretins|incretins|mesh-ancestor
56749146|NCT04046822|Hormones|hormones|mesh-ancestor
56749147|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749148|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56749149|NCT04007835|Gefitinib|gefitinib|mesh-list
56749150|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749151|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56749152|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749153|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749154|NCT00800930|Butyric Acid|butyric acid|mesh-list
56749155|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
56749156|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
56749157|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749158|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749159|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749160|NCT00868062|Polygeline|polygeline|mesh-list
56749161|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
56749162|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
56749163|NCT00742859|Warfarin|warfarin|mesh-list
56749164|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
56749165|NCT00742859|Betrixaban|betrixaban|mesh-list
56749166|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
56749167|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56749168|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
56749169|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56749170|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
56749171|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460225|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749172|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749173|NCT00742781|Vitamin D|vitamin d|mesh-list
56749174|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
56749175|NCT00742781|Vitamins|vitamins|mesh-ancestor
56749176|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
56749177|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749178|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56749179|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56749180|NCT00280735|Carboplatin|carboplatin|mesh-list
56749181|NCT00280735|Docetaxel|docetaxel|mesh-list
56749182|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749183|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
56749184|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
56749185|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
56749186|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749187|NCT03975283|Bupivacaine|bupivacaine|mesh-list
56749188|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
56749189|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
56749190|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749191|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749202|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
56749203|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749204|NCT00801086|Protective Agents|protective agents|mesh-ancestor
56749205|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56749206|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749207|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56749208|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56749209|NCT00788606|Bevacizumab|bevacizumab|mesh-list
56749210|NCT00788606|Rituximab|rituximab|mesh-list
56749211|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56749212|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749213|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749214|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56749215|NCT00788606|Growth Substances|growth substances|mesh-ancestor
56749216|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749217|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
56749218|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
56749219|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749220|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
56749221|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
56749222|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56749223|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56749224|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749225|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749226|NCT00795938|Urological Agents|urological agents|mesh-ancestor
56749227|NCT00260065|Decitabine|decitabine|mesh-list
56749228|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56749229|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
56749230|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749231|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749232|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749233|NCT01071655|Fluorouracil|fluorouracil|mesh-list
56749234|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
56749235|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749241|NCT02531581|Furosemide|furosemide|mesh-list
56749242|NCT02531581|Diuretics|diuretics|mesh-list
56749243|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
56749244|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749245|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56749246|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56749247|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749248|NCT04046510|Oxytocin|oxytocin|mesh-list
56749249|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
56749250|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56749251|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749253|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
56749254|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749255|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
56749256|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
56749257|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
56749258|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56749259|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749260|NCT00742625|Cytarabine|cytarabine|mesh-list
56749261|NCT00742625|Bortezomib|bortezomib|mesh-list
56749262|NCT00742625|Daunorubicin|daunorubicin|mesh-list
56749263|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56749264|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
56749265|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749266|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749267|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
56749268|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749269|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749270|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
56749271|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749272|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56749273|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56749274|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56749275|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749276|NCT00801788|Oxycodone|oxycodone|mesh-list
56749277|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56749278|NCT00801788|Narcotics|narcotics|mesh-ancestor
56032027|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749279|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749280|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749281|NCT00801788|Analgesics|analgesics|mesh-ancestor
56749282|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
56749283|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749284|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56749285|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749286|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
56749287|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56749288|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749289|NCT00796250|Prednisolone|prednisolone|mesh-list
56749290|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56749291|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
56749292|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56749293|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
56749294|NCT00796250|Azathioprine|azathioprine|mesh-list
56749295|NCT00796250|Infliximab|infliximab|mesh-list
56749296|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56749297|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
56749298|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56749299|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
56749300|NCT00796250|Hormones|hormones|mesh-ancestor
56749301|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749302|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749303|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56749304|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749305|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
56749306|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
56749307|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749308|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749309|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56749324|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749325|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
56749326|NCT02596373|Analgesics|analgesics|mesh-ancestor
56749327|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
56749328|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749329|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749330|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749331|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56749332|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56749333|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749334|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749335|NCT00801866|Bevacizumab|bevacizumab|mesh-list
56749336|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56749337|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749338|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749339|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56749340|NCT00801866|Growth Substances|growth substances|mesh-ancestor
56749341|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749342|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
56749343|NCT03973879|Atezolizumab|atezolizumab|mesh-list
56749344|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749345|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56749346|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56749347|NCT00860964|Estradiol|estradiol|mesh-list
56749348|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56749349|NCT00860964|Estrogens|estrogens|mesh-ancestor
56749350|NCT00860964|Hormones|hormones|mesh-ancestor
56749354|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
56749370|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56749371|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56749372|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749373|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749374|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56749375|NCT00740051|Glimepiride|glimepiride|mesh-list
56749376|NCT00740051|Linagliptin|linagliptin|mesh-list
56749377|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56749378|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56749379|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749380|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749381|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
56749382|NCT00740051|Incretins|incretins|mesh-ancestor
56749383|NCT00740051|Hormones|hormones|mesh-ancestor
56749384|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749385|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56749386|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
56749387|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749388|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749389|NCT00864864|Sunitinib|sunitinib|mesh-list
56749390|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749391|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749392|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56749393|NCT00864864|Growth Substances|growth substances|mesh-ancestor
56749394|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749417|NCT00864942|Rituximab|rituximab|mesh-list
56749418|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56749419|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
56749420|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749421|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749422|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56749423|NCT00864942|Growth Substances|growth substances|mesh-ancestor
56749424|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
56749425|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749426|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56749427|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749428|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56749429|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
56749430|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749431|NCT00870402|Spironolactone|spironolactone|mesh-list
56749432|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56749433|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
56749434|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749435|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749436|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56749437|NCT00870402|Diuretics|diuretics|mesh-ancestor
56749438|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
56749439|NCT00742235|Vitamin D|vitamin d|mesh-list
56749440|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
56749441|NCT00742235|Vitamins|vitamins|mesh-ancestor
56749442|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
56749443|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749444|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56749445|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56749446|NCT00742079|Cycloserine|cycloserine|mesh-list
56749447|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56749448|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749449|NCT00742079|Renal Agents|renal agents|mesh-ancestor
56749450|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56749456|NCT04730362|Sevoflurane|sevoflurane|mesh-list
56749457|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
56749458|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749459|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749460|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56749461|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56749462|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
56749463|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56749464|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56749465|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
56749466|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56749467|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56749468|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
56749469|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749470|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749471|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56749472|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
56749473|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
56749474|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56460528|NCT00474591|PENTA|penta|mesh-list
56749475|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
56749476|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749477|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749478|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56749479|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56749480|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56749482|NCT00870480|Finasteride|finasteride|mesh-list
56749501|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
56749502|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56749503|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
56749504|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56749505|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56749506|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
56749507|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749508|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749509|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749510|NCT00801944|Urological Agents|urological agents|mesh-ancestor
56749511|NCT00870636|Bevacizumab|bevacizumab|mesh-list
56749512|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56749513|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749514|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749515|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56749516|NCT00870636|Growth Substances|growth substances|mesh-ancestor
56749517|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749518|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
56749519|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56749520|NCT00870714|Ketoconazole|ketoconazole|mesh-list
56749521|NCT00870714|Docetaxel|docetaxel|mesh-list
56749522|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749523|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
56749524|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
56749525|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
56749526|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749527|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
56749528|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749529|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56749530|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56749531|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749532|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56749533|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
56749534|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749535|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749537|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56749538|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
56749539|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749540|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
56749541|NCT02598011|Flucytosine|flucytosine|mesh-list
56749542|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
56749543|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749544|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
56749545|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749546|NCT00869310|Dexamethasone|dexamethasone|mesh-list
56749547|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
56749548|NCT00869310|Aprepitant|aprepitant|mesh-list
56749549|NCT00869310|Metoclopramide|metoclopramide|mesh-list
56749550|NCT00869310|BB 1101|bb 1101|mesh-list
56749551|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56749552|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
56749553|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
56749554|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749555|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749556|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749557|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
56749558|NCT00869310|Hormones|hormones|mesh-ancestor
56749559|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749560|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56749561|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749562|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
56749563|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749564|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749565|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56749570|NCT00662558|Celecoxib|celecoxib|mesh-list
56749583|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749584|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56749585|NCT00662558|Narcotics|narcotics|mesh-ancestor
56749586|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749587|NCT00869700|Lumefantrine|lumefantrine|mesh-list
56749588|NCT00869700|Artemether|artemether|mesh-list
56749589|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56749590|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
56749591|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56749592|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56749593|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749594|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
56749595|NCT00869856|Hematinics|hematinics|mesh-ancestor
56749596|NCT00802334|Ritonavir|ritonavir|mesh-list
56749597|NCT00802334|Lopinavir|lopinavir|mesh-list
56749598|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56749599|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56749600|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
56749601|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749602|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749603|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56749604|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56749605|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
56749606|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749607|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56749608|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56749609|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56749610|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56749611|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56749612|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749613|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749614|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56749615|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56749616|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56749624|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56749625|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749626|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56749627|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749628|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
56749629|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749630|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
56749631|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749632|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
56749633|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56749634|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
56749635|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749636|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56749637|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56749638|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
56749639|NCT00739973|Amlodipine|amlodipine|mesh-list
56749640|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56749641|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56749642|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56749643|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749644|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56749645|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749646|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
56749647|NCT00802568|Fludarabine|fludarabine|mesh-list
56749648|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
56749649|NCT00802568|Busulfan|busulfan|mesh-list
56749650|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56749671|NCT00802646|Narcotics|narcotics|mesh-ancestor
56749672|NCT00802646|Analgesics|analgesics|mesh-ancestor
56749673|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56749674|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56749675|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
56749676|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56749677|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56749678|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
56749679|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749680|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749681|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56749682|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56749683|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
56749684|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56749685|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
56749686|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
56749687|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
56749688|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56749689|NCT00802802|Efavirenz|efavirenz|mesh-list
56749690|NCT00802802|Rifampin|rifampin|mesh-list
56749691|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56749692|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56749693|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749694|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749695|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
56749696|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749697|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56749698|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56749699|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56749700|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56749701|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56749702|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56749712|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56749713|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56749714|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
56749715|NCT00802958|Hormones|hormones|mesh-ancestor
56749716|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56749717|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749718|NCT01565512|Bupivacaine|bupivacaine|mesh-list
56749719|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
56749720|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
56749721|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749722|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749723|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
56749724|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749725|NCT04895930|Aflutinib|aflutinib|mesh-list
56749726|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56749727|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749728|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749729|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56749730|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56749731|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
56749732|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749733|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749734|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56749735|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
56749736|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56749737|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56749738|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56749743|NCT00789308|Sirolimus|sirolimus|mesh-list
56749759|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
56749760|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749761|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
56749762|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749763|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56749764|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749765|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56749766|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
56749767|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56749768|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
56749769|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56749770|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56749771|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56749772|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56749773|NCT00789308|Analgesics|analgesics|mesh-ancestor
56749774|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
56749775|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749776|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56749777|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749778|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
56749779|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
56749780|NCT00518284|Paclitaxel|paclitaxel|mesh-list
56749781|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56749782|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56749783|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749784|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
56749785|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
56749786|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
56749787|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749788|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
56749789|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56749790|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749791|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56749792|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56749793|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749794|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022482|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
56749795|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749796|NCT00871104|Vancomycin|vancomycin|mesh-list
56749797|NCT00871104|Imipenem|imipenem|mesh-list
56749798|NCT00871104|Fosfomycin|fosfomycin|mesh-list
56749799|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56749800|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749801|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
56749802|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56749803|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749804|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
56749805|NCT00727415|Fludarabine|fludarabine|mesh-list
56749806|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
56749807|NCT00727415|Lenalidomide|lenalidomide|mesh-list
56749808|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749809|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
56749810|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749811|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749812|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56749813|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
56749814|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749815|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749816|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56749817|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56749818|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
56749819|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56749820|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56749821|NCT00727415|Growth Substances|growth substances|mesh-ancestor
56749822|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
56749823|NCT00803192|Famotidine|famotidine|mesh-list
56749843|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
56749844|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
56749845|NCT00877110|Vincristine|vincristine|mesh-list
56749846|NCT00877110|Topotecan|topotecan|mesh-list
56749847|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749848|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
56749849|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749850|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749851|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56749852|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
56749853|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749854|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749855|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56749856|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56749857|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56749858|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56749859|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56749860|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56749861|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56749862|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749863|NCT00727259|Ribavirin|ribavirin|mesh-list
56749864|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56749865|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
56749866|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749867|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
56749868|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749869|NCT00789386|Midazolam|midazolam|mesh-list
56749870|NCT00789386|Remifentanil|remifentanil|mesh-list
56749871|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56749890|NCT00789464|Trimethoprim|trimethoprim|mesh-list
56749891|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
56749892|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56749893|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749894|NCT00789464|Renal Agents|renal agents|mesh-ancestor
56749895|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
56749896|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56749897|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56749898|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56749899|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749900|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749901|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56749902|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56749903|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56749904|NCT00797030|Cyclosporine|cyclosporine|mesh-list
56749905|NCT00797030|Cyclosporins|cyclosporins|mesh-list
56749906|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56749907|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749908|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749909|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
56749910|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749911|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
56749912|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749913|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
56749914|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749915|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56749916|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
56749917|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
56749918|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56749919|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
56749920|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
56749921|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56749922|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56749930|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749931|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749932|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
56749933|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749934|NCT02553824|Topiramate|topiramate|mesh-list
56749935|NCT02553824|Phentermine|phentermine|mesh-list
56749936|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
56749937|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56749938|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749939|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56749940|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
56749941|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56749942|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
56749943|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
56749944|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749945|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
56749946|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749947|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749948|NCT04039854|Propofol|propofol|mesh-list
56749949|NCT04039854|Sevoflurane|sevoflurane|mesh-list
56749950|NCT04039854|Desflurane|desflurane|mesh-list
56749951|NCT04039854|Isoflurane|isoflurane|mesh-list
56749952|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56749953|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56749954|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749955|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56749956|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
56749957|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
56749958|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56749959|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56749975|NCT04045730|Immunologic Factors|immunologic factors|mesh-ancestor
56749976|NCT04045730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749977|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56749978|NCT00977223|Aprepitant|aprepitant|mesh-list
56749979|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
56749980|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
56749981|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
56749982|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56749983|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749984|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56749985|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56749986|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56749987|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749988|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
56749989|NCT03721068|Fludarabine|fludarabine|mesh-list
56749990|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56749991|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
56749992|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56749993|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56749994|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56749995|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
56749996|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56749997|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56749998|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56749999|NCT00977301|Ritonavir|ritonavir|mesh-list
56750000|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
56750001|NCT00977301|Olanzapine|olanzapine|mesh-list
56750002|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56750003|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56750005|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750006|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750007|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56750018|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56750019|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56750020|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750021|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56750022|NCT00977301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56750023|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56750024|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56750025|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750026|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
56750027|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56750028|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56750029|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750030|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56750031|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56750032|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56750033|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750034|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
56750035|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750036|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
56750037|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56750038|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
56750039|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750040|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750041|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56750042|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
56750043|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750044|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750045|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56750046|NCT00984945|Vaccines|vaccines|mesh-list
56750047|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
56750048|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750049|NCT00879918|Nicotine|nicotine|mesh-list
56750050|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56750056|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
56750057|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750058|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750059|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
56750060|NCT01565590|Propofol|propofol|mesh-list
56750061|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56750062|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750063|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750064|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56750065|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
56750066|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
56750067|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56750068|NCT01565590|Analgesics|analgesics|mesh-ancestor
56750069|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
56750070|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750071|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56750072|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56750073|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56750074|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
56461132|NCT00438828|Hormones|hormones|mesh-ancestor
56750075|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750076|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750077|NCT00877422|Vitamin D|vitamin d|mesh-list
56750078|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
56750079|NCT00877422|Vitamins|vitamins|mesh-ancestor
56750080|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
56750081|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750082|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56750083|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56750084|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
56750085|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56750086|NCT04039698|Velpatasvir|velpatasvir|mesh-list
56750087|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
56750088|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750089|NCT04006821|Apatinib|apatinib|mesh-list
56750096|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750097|NCT00803816|Everolimus|everolimus|mesh-list
56750098|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750099|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56750100|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
56750101|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750102|NCT00797264|Ketamine|ketamine|mesh-list
56750103|NCT00797264|Morphine|morphine|mesh-list
56750104|NCT00797264|Analgesics|analgesics|mesh-ancestor
56750105|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
56750106|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750107|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750108|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56750109|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56750110|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
56750111|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
56750112|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750113|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56750114|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56750115|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750116|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750117|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56750118|NCT00797264|Narcotics|narcotics|mesh-ancestor
56750119|NCT00981201|Celecoxib|celecoxib|mesh-list
56750120|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56750121|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56750122|NCT00981201|Analgesics|analgesics|mesh-ancestor
56750123|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
56750124|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750125|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750126|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750127|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750128|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56750129|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56750135|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56750136|NCT05279391|Tinzaparin|tinzaparin|mesh-list
56750137|NCT05279391|Dalteparin|dalteparin|mesh-list
56750138|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750139|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
56750140|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
56750141|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750142|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750143|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56750144|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
56750145|NCT05279391|Hormones|hormones|mesh-ancestor
56750146|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56750147|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56750148|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750149|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
56461199|NCT00441662|Triamcinolone|triamcinolone|mesh-list
56750150|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56750151|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56750152|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750153|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750154|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56750155|NCT00789620|Lidocaine|lidocaine|mesh-list
56750156|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
56750157|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
56750158|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750159|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750160|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
56750161|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750162|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56750163|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56750164|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56750165|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56750166|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750167|NCT03970265|Meropenem|meropenem|mesh-list
56750168|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56750169|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750171|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750172|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750173|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56750174|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
56750175|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56750176|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
56750177|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750178|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56750179|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56750180|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56750181|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56750182|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750183|NCT00797420|Fluconazole|fluconazole|mesh-list
56750184|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
56750185|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750186|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56750187|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56750188|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750189|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750190|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56750191|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
56750192|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56750193|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750194|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56750195|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56750196|NCT00981513|Vaccines|vaccines|mesh-list
56750197|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
56750214|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56750215|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56750216|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750217|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56750218|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56750219|NCT00726557|Interferons|interferons|mesh-list
56750220|NCT00726557|Ribavirin|ribavirin|mesh-list
56750221|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
56750222|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
56750223|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56750224|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750225|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
56750226|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750227|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
56750228|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750229|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
56750230|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750231|NCT00803972|Insulin|insulin|mesh-list
56750232|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56750233|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
56750234|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56750235|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750236|NCT00880386|Losartan|losartan|mesh-list
56750237|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56750238|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56750239|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56750240|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56750241|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750242|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56750259|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750260|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56750261|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56750262|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750263|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
56750264|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56750265|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56750266|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
56750267|NCT04928391|Nalbuphine|nalbuphine|mesh-list
56750268|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56750269|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750270|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750271|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56750272|NCT04928391|Analgesics|analgesics|mesh-ancestor
56750273|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
56750274|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750275|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56750276|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56750277|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56750278|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
56750279|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750280|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750281|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56750282|NCT04928391|Narcotics|narcotics|mesh-ancestor
56750283|NCT00804050|Vitamins|vitamins|mesh-list
56750284|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
56750285|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750286|NCT00877734|Baclofen|baclofen|mesh-list
56750287|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56750288|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750289|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56750290|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750291|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56750292|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
56750297|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56750298|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
56750299|NCT00978159|Esomeprazole|esomeprazole|mesh-list
56750301|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56750302|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56750303|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56750304|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750305|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750306|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56750307|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
56750308|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
56750309|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750310|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750311|NCT00804206|Bevacizumab|bevacizumab|mesh-list
56750312|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750313|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750314|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56750315|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56750316|NCT00804206|Growth Substances|growth substances|mesh-ancestor
56750317|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750318|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
56750319|NCT00877812|Glycine|glycine|mesh-list
56750320|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
56750321|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750322|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750323|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750324|NCT00981903|Tinzaparin|tinzaparin|mesh-list
56750325|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56750326|NCT00981903|Dalteparin|dalteparin|mesh-list
56750327|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
56750328|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56750329|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56750340|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56750341|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
56750342|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750343|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750344|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56750345|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56750346|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
56750347|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750348|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750349|NCT03921723|Dolutegravir|dolutegravir|mesh-list
56750350|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56750351|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56750352|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750353|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750354|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56750355|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56750356|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
56750357|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750358|NCT00872664|Carotenoids|carotenoids|mesh-list
56750359|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
56750360|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750361|NCT00872664|Protective Agents|protective agents|mesh-ancestor
56750362|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750363|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
56750364|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56750365|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56750366|NCT00878124|Ubiquinone|ubiquinone|mesh-list
56750367|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
56750368|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
56750369|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750370|NCT00878124|Vitamins|vitamins|mesh-ancestor
56750371|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
56750372|NCT00978315|Vitamin D|vitamin d|mesh-list
56750373|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56750374|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750375|NCT00978315|Vitamins|vitamins|mesh-ancestor
56750378|NCT00978393|Liraglutide|liraglutide|mesh-list
56750380|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750381|NCT00978393|Incretins|incretins|mesh-ancestor
56750382|NCT00978393|Hormones|hormones|mesh-ancestor
56750383|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56750384|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
56750385|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750386|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750387|NCT00872976|Dasatinib|dasatinib|mesh-list
56750388|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56750389|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750390|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56750391|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750392|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750393|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56750394|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
56750395|NCT00544167|Paclitaxel|paclitaxel|mesh-list
56750396|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
56750397|NCT00544167|Doxorubicin|doxorubicin|mesh-list
56750398|NCT00544167|Sorafenib|sorafenib|mesh-list
56750399|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56750400|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750401|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
56750402|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
56750403|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
56750404|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750405|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56750406|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
56750407|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750408|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750409|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56750410|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
56750411|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56750412|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56750413|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56750414|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56750418|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
56750419|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
56750420|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56750421|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750422|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750423|NCT05225844|Apatinib|apatinib|mesh-list
56750424|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750425|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56750426|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750427|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750428|NCT00878514|Alprazolam|alprazolam|mesh-list
56750429|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56750430|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750431|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750432|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56750433|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56750434|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56750435|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
56750436|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
56750437|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750438|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750439|NCT00804440|Ibuprofen|ibuprofen|mesh-list
56750440|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56750441|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56750442|NCT00804440|Analgesics|analgesics|mesh-ancestor
56750443|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
56750444|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750445|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750446|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750447|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461519|NCT03278522|Ramosetron|ramosetron|mesh-list
56750448|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56750449|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750450|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750455|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750456|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750457|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
56750458|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750459|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750460|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
56750461|NCT00797810|Cytarabine|cytarabine|mesh-list
56750462|NCT00797810|Dexamethasone|dexamethasone|mesh-list
56750463|NCT00797810|Prednisone|prednisone|mesh-list
56750464|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
56750465|NCT00797810|Ifosfamide|ifosfamide|mesh-list
56750466|NCT00797810|Rituximab|rituximab|mesh-list
56750467|NCT00797810|Vincristine|vincristine|mesh-list
56750468|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56750469|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
56750470|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750471|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750472|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56750473|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
56750474|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750475|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750476|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56750477|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750478|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750479|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
56750480|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
56750504|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750505|NCT00978471|Thiotepa|thiotepa|mesh-list
56750506|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56750507|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
56750508|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750509|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750510|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56750511|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56750512|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
56750513|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750514|NCT00804674|Bupivacaine|bupivacaine|mesh-list
56750515|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
56750516|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
56750517|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750518|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750519|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
56750520|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750521|NCT00881088|PENTA|penta|mesh-list
56750522|NCT00881088|Nadroparin|nadroparin|mesh-list
56750523|NCT00881088|Fondaparinux|fondaparinux|mesh-list
56750524|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56750525|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
56750526|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56750527|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
56750528|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750529|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750530|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
56750531|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56750532|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56750550|NCT00656084|Antiviral Agents|antiviral agents|mesh-ancestor
56750551|NCT00656084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750552|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750553|NCT00656084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56750554|NCT00656084|Analgesics|analgesics|mesh-ancestor
56750555|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
56750556|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750557|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56750558|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56750559|NCT00881166|Paclitaxel|paclitaxel|mesh-list
56750560|NCT00881166|Etoposide|etoposide|mesh-list
56750561|NCT00881166|Docetaxel|docetaxel|mesh-list
56750562|NCT00881166|Carboplatin|carboplatin|mesh-list
56750563|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56750564|NCT00881166|Topotecan|topotecan|mesh-list
56750565|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56750566|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750567|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
56750568|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
56750569|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
56750570|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750571|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56750572|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56750573|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750574|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56750575|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56750576|NCT00804752|Vitamin D|vitamin d|mesh-list
56750577|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
56750578|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
56750579|NCT00804752|Vitamins|vitamins|mesh-list
56750580|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
56750581|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750582|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56750583|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56750584|NCT05225766|Bupivacaine|bupivacaine|mesh-list
56750585|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
56750586|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
56750591|NCT00804830|Bevacizumab|bevacizumab|mesh-list
56750592|NCT00804830|Doxorubicin|doxorubicin|mesh-list
56750593|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750594|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750595|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56750596|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56750597|NCT00804830|Growth Substances|growth substances|mesh-ancestor
56461643|NCT00441207|Vitamins|vitamins|mesh-ancestor
56750598|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750599|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
56750600|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56750601|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56750602|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56750603|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750604|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750605|NCT00982215|Acetaminophen|acetaminophen|mesh-list
56750606|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56750607|NCT00982215|Analgesics|analgesics|mesh-ancestor
56750608|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
56750609|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750610|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750611|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
56750612|NCT00613938|Oxycodone|oxycodone|mesh-list
56750613|NCT00613938|Tapentadol|tapentadol|mesh-list
56750614|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56750615|NCT00613938|Narcotics|narcotics|mesh-ancestor
56750616|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750617|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750618|NCT00613938|Analgesics|analgesics|mesh-ancestor
56750619|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
56750620|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750621|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56750622|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56032028|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
56032029|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032030|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56032031|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56190389|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56190390|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56190391|NCT01468025|Analgesics|analgesics|mesh-ancestor
56190392|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
55804692|NCT02371629|Albuterol|albuterol|mesh-list
56750623|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56750624|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750625|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
56750626|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750627|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56750628|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56750629|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750630|NCT00805064|Triamcinolone|triamcinolone|mesh-list
56750631|NCT00805064|Bevacizumab|bevacizumab|mesh-list
56750632|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750633|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750634|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56750635|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56750636|NCT00805064|Growth Substances|growth substances|mesh-ancestor
56750637|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750638|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
56750639|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750640|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
56750641|NCT00805064|Hormones|hormones|mesh-ancestor
56750642|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56750643|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
56750644|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56750645|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
56750646|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750647|NCT00655928|Expectorants|expectorants|mesh-ancestor
56190393|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190394|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190395|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56190396|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56190397|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
56032064|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032065|NCT05566301|Clopidogrel|clopidogrel|mesh-list
56032066|NCT05566301|Ticagrelor|ticagrelor|mesh-list
56032067|NCT05566301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56032068|NCT05566301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56032069|NCT05566301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56032070|NCT05566301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56032071|NCT05566301|Purinergic Agents|purinergic agents|mesh-ancestor
56032072|NCT05566301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811375|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032076|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
56032077|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032078|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
56032140|NCT05620862|Mitoxantrone|mitoxantrone|mesh-list
56032141|NCT05620862|Analgesics|analgesics|mesh-ancestor
56032142|NCT05620862|Sensory System Agents|sensory system agents|mesh-ancestor
56032143|NCT05620862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032144|NCT05620862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032145|NCT05620862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750648|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
56750649|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56750650|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
56750651|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750652|NCT00655928|Protective Agents|protective agents|mesh-ancestor
56750653|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750654|NCT00655928|Antidotes|antidotes|mesh-ancestor
56750655|NCT00873756|Bevacizumab|bevacizumab|mesh-list
56750656|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750657|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750658|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56750659|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56750660|NCT00873756|Growth Substances|growth substances|mesh-ancestor
56750661|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750662|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
56750663|NCT00873834|Fluoxetine|fluoxetine|mesh-list
56750664|NCT00873834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56750665|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56750666|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56750667|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750668|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750669|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
56750670|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750671|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56750672|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
56461716|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750673|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56750674|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56750675|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56750676|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750678|NCT00655850|Paclitaxel|paclitaxel|mesh-list
56750679|NCT00655850|Bevacizumab|bevacizumab|mesh-list
56750680|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56750686|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56750687|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
56750688|NCT00655850|Antiviral Agents|antiviral agents|mesh-ancestor
56750689|NCT00655850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750690|NCT00655850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750691|NCT00655850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56750692|NCT00655850|Immunologic Factors|immunologic factors|mesh-ancestor
56750693|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750694|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750695|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56750696|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56750697|NCT00655850|Growth Substances|growth substances|mesh-ancestor
56750698|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
56750699|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
56750700|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750701|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750702|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
56750703|NCT00805298|Epinephrine|epinephrine|mesh-list
56750704|NCT00805298|Racepinephrine|racepinephrine|mesh-list
56750705|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
56750706|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750707|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
56750708|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
56750709|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750710|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750711|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56750712|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
56750713|NCT00805298|Hormones|hormones|mesh-ancestor
56750714|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56750715|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56750716|NCT00805298|Protective Agents|protective agents|mesh-ancestor
56750717|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56750718|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56750719|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
56750727|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
56750728|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56750729|NCT00881400|Cefprozil|cefprozil|mesh-list
56750730|NCT00881400|Cephalosporins|cephalosporins|mesh-list
56750731|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56750732|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750733|NCT00246571|Sunitinib|sunitinib|mesh-list
56750734|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750735|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56750736|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56750737|NCT00246571|Growth Substances|growth substances|mesh-ancestor
56750738|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750739|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
56750740|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56750741|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750742|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750743|NCT02553044|Vitamin D|vitamin d|mesh-list
56750744|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
56750745|NCT02553044|Vitamins|vitamins|mesh-ancestor
56750746|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
56750747|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750748|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56750749|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56750750|NCT00545103|Mesalamine|mesalamine|mesh-list
56750751|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56750752|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56750753|NCT00545103|Analgesics|analgesics|mesh-ancestor
56750776|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56750777|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750778|NCT00809744|Vitamins|vitamins|mesh-ancestor
56750779|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
56750780|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56750781|NCT00246337|Rizatriptan|rizatriptan|mesh-list
56750782|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56750783|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
56750784|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750785|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750786|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750787|NCT05012943|Vaccines|vaccines|mesh-list
56750788|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
56750789|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750790|NCT01581853|Ritonavir|ritonavir|mesh-list
56750791|NCT01581853|Lopinavir|lopinavir|mesh-list
56750792|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56750793|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56750794|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
56750795|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750796|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750797|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56750798|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56750799|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
56750800|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750801|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56750803|NCT01070641|Carvedilol|carvedilol|mesh-list
56750823|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750824|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750825|NCT02593721|Ibuprofen|ibuprofen|mesh-list
56750826|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56750827|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56750828|NCT02593721|Analgesics|analgesics|mesh-ancestor
56750829|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
56750830|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750831|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750832|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56750833|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750834|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56750835|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750836|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750837|NCT00985647|Lamivudine|lamivudine|mesh-list
56750838|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56750839|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56750840|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750841|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750842|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
56750843|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750844|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56750845|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56750846|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56750847|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
56750848|NCT00806468|Coagulants|coagulants|mesh-ancestor
56750849|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56750850|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
56750851|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750852|NCT00982527|Fenoldopam|fenoldopam|mesh-list
56750853|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56750854|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
56750855|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
56750856|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
56750862|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
56750863|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56750864|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750865|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56750866|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56750867|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56750868|NCT00725621|Infliximab|infliximab|mesh-list
56750869|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
56750870|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56750871|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750872|NCT00613626|Etoposide|etoposide|mesh-list
56750873|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750874|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56750875|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56750876|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56750877|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750878|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750879|NCT00725543|Infliximab|infliximab|mesh-list
56750880|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
56750881|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56750882|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56750883|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
56750884|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56750885|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750886|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56750887|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
56750888|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56750889|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56750890|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750891|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750892|NCT00616434|Interferons|interferons|mesh-list
56750893|NCT00616434|Interferon-beta|interferon-beta|mesh-list
56750894|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
56750895|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750896|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
56750901|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56750902|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750903|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56750904|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750905|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750906|NCT00257725|Methylphenidate|methylphenidate|mesh-list
56750907|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56750908|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750909|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56750910|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56750911|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56750912|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750913|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
56750914|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750915|NCT00544869|Tolvaptan|tolvaptan|mesh-list
56750916|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56750917|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750918|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
56750919|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750920|NCT02593643|Midazolam|midazolam|mesh-list
56750921|NCT02593643|Ketamine|ketamine|mesh-list
56750922|NCT02593643|Analgesics|analgesics|mesh-ancestor
56750923|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
56750924|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750925|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750926|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56750927|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56750928|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
56750929|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
56750930|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750933|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750941|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
56750942|NCT00881556|Fludarabine|fludarabine|mesh-list
56750943|NCT00881556|Busulfan|busulfan|mesh-list
56750944|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
56750945|NCT00881556|Lorazepam|lorazepam|mesh-list
56750946|NCT00881556|Tacrolimus|tacrolimus|mesh-list
56750947|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56750948|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750949|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56750950|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
56750951|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750952|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56750953|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56750954|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
56750955|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56750956|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56750957|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56750958|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
56750959|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
56750960|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
56750961|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750962|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56750963|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56750964|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56750965|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56750966|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56750967|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56750968|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
56750969|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
56750970|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750971|NCT00881634|Cetirizine|cetirizine|mesh-list
56750972|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
56750973|NCT00881634|Ephedrine|ephedrine|mesh-list
56750974|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56750975|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56032175|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032176|NCT02218463|Estradiol|estradiol|mesh-list
56032177|NCT02218463|Estrogens|estrogens|mesh-ancestor
56032178|NCT02218463|Hormones|hormones|mesh-ancestor
56032179|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56032180|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032181|NCT00919802|Oxytocin|oxytocin|mesh-list
56032182|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
55804693|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
56750976|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56750977|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
56750978|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
56750979|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56750980|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56750981|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750982|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56750983|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
56750984|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750985|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56750986|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
56750987|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
56750988|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56750989|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56750990|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
56750991|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56750992|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
56750993|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56750994|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56750995|NCT00878670|Analgesics|analgesics|mesh-ancestor
56750996|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
56750997|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56750998|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56750999|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56751000|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751001|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56751002|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
56751003|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751004|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56751016|NCT00652028|Fentanyl|fentanyl|mesh-list
56751018|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
56751019|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56751020|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751021|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751022|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56751023|NCT00652028|Analgesics|analgesics|mesh-ancestor
56751024|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
56751025|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751026|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56751027|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56751028|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56751029|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
56751030|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751031|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751032|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56751033|NCT00652028|Narcotics|narcotics|mesh-ancestor
56751034|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56751035|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56751036|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
56751037|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
56751038|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56751039|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56751040|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751041|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
56751042|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
56751043|NCT00799136|Prednisone|prednisone|mesh-list
56751044|NCT00799136|Vincristine|vincristine|mesh-list
56751045|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56751046|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
56751047|NCT00799136|Hormones|hormones|mesh-ancestor
56751048|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56751049|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751050|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56751051|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751059|NCT00799214|Metronidazole|metronidazole|mesh-list
56751060|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751061|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56751062|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56751063|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56751064|NCT00733421|Etoricoxib|etoricoxib|mesh-list
56751065|NCT00733421|Tramadol|tramadol|mesh-list
56751066|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56751067|NCT00733421|Narcotics|narcotics|mesh-ancestor
56751068|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751069|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751070|NCT00733421|Analgesics|analgesics|mesh-ancestor
56751071|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
56751072|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751073|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56751074|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56751075|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56751076|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751077|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56751078|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56751079|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751080|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751081|NCT00613080|Leucovorin|leucovorin|mesh-list
56751082|NCT00613080|Fluorouracil|fluorouracil|mesh-list
56751083|NCT00613080|Capecitabine|capecitabine|mesh-list
56751084|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
56751085|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
56751086|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751087|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56751088|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751089|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56751090|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
56751092|NCT00613080|Antidotes|antidotes|mesh-ancestor
56751104|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56751105|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
56751106|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56751107|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751108|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56751109|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
56751110|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751111|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751112|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
56751113|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751114|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56751115|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56751116|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
56751117|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751118|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56751119|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56751120|NCT00881790|Fluorides|fluorides|mesh-list
56462172|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
56751121|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
56751122|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
56751123|NCT00881790|Protective Agents|protective agents|mesh-ancestor
56751124|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751126|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56751127|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751128|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56751129|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
56751130|NCT00810524|Lamivudine|lamivudine|mesh-list
56751131|NCT00810524|Adefovir|adefovir|mesh-list
56751132|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56751133|NCT00810524|Telbivudine|telbivudine|mesh-list
56751134|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56751135|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56751136|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751137|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751138|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
56751139|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751142|NCT00810680|Valproic Acid|valproic acid|mesh-list
56751143|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
56751144|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751145|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751146|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
56751147|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751148|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751149|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
56751150|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56751151|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751152|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751153|NCT00799448|Insulin|insulin|mesh-list
56751154|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56751155|NCT00799448|Repaglinide|repaglinide|mesh-list
56751156|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
56751157|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
56751158|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
56751159|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56751160|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751161|NCT00806936|Insulin|insulin|mesh-list
56751162|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56751163|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56751164|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751165|NCT00799682|Travoprost|travoprost|mesh-list
56751166|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56751167|NCT00799682|Latanoprost|latanoprost|mesh-list
56751168|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56751169|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56751170|NCT03829020|Metformin|metformin|mesh-list
56751171|NCT03829020|Nelfinavir|nelfinavir|mesh-list
56751192|NCT00810914|Bupivacaine|bupivacaine|mesh-list
56751193|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
56751194|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
56751195|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751196|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751197|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
56751198|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751199|NCT00878904|Epirubicin|epirubicin|mesh-list
56751200|NCT00878904|Panobinostat|panobinostat|mesh-list
56751201|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56751202|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751203|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56751204|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56751205|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751206|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751207|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56751208|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
56751209|NCT00737711|Hematinics|hematinics|mesh-ancestor
56751210|NCT00807326|Simethicone|simethicone|mesh-list
56751211|NCT00807326|Loperamide|loperamide|mesh-list
56751212|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
56751213|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56751214|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
56751215|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751216|NCT00807326|Emollients|emollients|mesh-ancestor
56751217|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
56751218|NCT00875082|Montelukast|montelukast|mesh-list
56751219|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56751220|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
56751221|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56751222|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
56751223|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56751224|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751234|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
56751235|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56751236|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
56751237|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
56751238|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751239|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751240|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56751241|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
56751242|NCT02552342|Hormones|hormones|mesh-ancestor
56751243|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56751244|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56751245|NCT02552342|Protective Agents|protective agents|mesh-ancestor
56751246|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56751247|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751248|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56751249|NCT00811226|Olmesartan|olmesartan|mesh-list
56751250|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56751251|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56751252|NCT00811226|Diuretics|diuretics|mesh-ancestor
56751253|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
56751254|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751255|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56751256|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56751257|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751258|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56751259|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56751260|NCT00238303|Vorinostat|vorinostat|mesh-list
56751261|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751262|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56751263|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751264|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751265|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56751266|NCT00811460|Incretins|incretins|mesh-ancestor
56751267|NCT00811460|Hormones|hormones|mesh-ancestor
56751268|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023977|NCT00651560|Ezetimibe|ezetimibe|mesh-list
56751269|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751270|NCT00875238|Doxorubicin|doxorubicin|mesh-list
56751271|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56751272|NCT00875238|Trastuzumab|trastuzumab|mesh-list
56751273|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56751274|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751275|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56462334|NCT00480675|Hormones|hormones|mesh-ancestor
56751276|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56751277|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751278|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751279|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56751280|NCT00732251|Allopurinol|allopurinol|mesh-list
56751281|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
56751282|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751283|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751284|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
56751285|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751286|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56751287|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
56751288|NCT00732251|Protective Agents|protective agents|mesh-ancestor
56751289|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751290|NCT00882024|Tranilast|tranilast|mesh-list
56751291|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56751292|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56751293|NCT00882024|Analgesics|analgesics|mesh-ancestor
56751294|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
56751295|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751296|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751297|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56751298|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751299|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56751300|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56751301|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751302|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56751306|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751307|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56751308|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56751309|NCT00799760|Oseltamivir|oseltamivir|mesh-list
56751310|NCT00799760|Zanamivir|zanamivir|mesh-list
56751311|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
56751312|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751313|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751314|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751315|NCT00799838|Amoxicillin|amoxicillin|mesh-list
56751316|NCT00799838|Ketoprofen|ketoprofen|mesh-list
56751317|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56751318|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751319|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56751320|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56751321|NCT00799838|Analgesics|analgesics|mesh-ancestor
56751322|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
56751323|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751324|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751325|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56751326|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751327|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56751328|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751329|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751330|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
56751331|NCT00737477|Hematinics|hematinics|mesh-ancestor
56751332|NCT00800150|Fludarabine|fludarabine|mesh-list
56751333|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
56751334|NCT00800150|Melphalan|melphalan|mesh-list
56751335|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751336|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56751337|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
56751338|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751339|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56751340|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
56751341|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032183|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56032184|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032185|NCT02222129|Bupivacaine|bupivacaine|mesh-list
56751342|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56751343|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
56751344|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56751345|NCT00800306|Simendan|simendan|mesh-list
56751346|NCT00800306|Dobutamine|dobutamine|mesh-list
56751347|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56751348|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
56751349|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56751350|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56751351|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751352|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751353|NCT00800306|Protective Agents|protective agents|mesh-ancestor
56751354|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751355|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
56751356|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
56751357|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751358|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56751359|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56751360|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56751361|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
56751362|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751363|NCT01581775|Valproic Acid|valproic acid|mesh-list
56751364|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
56751365|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751366|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751367|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
56751368|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751369|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751370|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
56751371|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56751372|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024099|NCT05671081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56024100|NCT00630734|Ritonavir|ritonavir|mesh-list
56024101|NCT00630734|Darunavir|darunavir|mesh-list
56751385|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751386|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
56751387|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56751388|NCT00731783|Mupirocin|mupirocin|mesh-list
56751389|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56751390|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751391|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
56751392|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
56751393|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56751394|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56751395|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751396|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751397|NCT03691350|Nicotine|nicotine|mesh-list
56751398|NCT03691350|Dimercaprol|dimercaprol|mesh-list
56751399|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56751400|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
56751401|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751402|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751403|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56751404|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56751405|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
56751406|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751407|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751408|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
56751409|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
56751410|NCT02592083|Tamoxifen|tamoxifen|mesh-list
56751411|NCT02592083|Goserelin|goserelin|mesh-list
56751412|NCT02592083|Palbociclib|palbociclib|mesh-list
56751413|NCT02592083|Exemestane|exemestane|mesh-list
56751414|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56751415|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56751426|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751427|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56751429|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56751430|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751431|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
56751432|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751433|NCT00724451|Ribavirin|ribavirin|mesh-list
56751434|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56751435|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56751436|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
56751437|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751438|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
56751439|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751440|NCT00724373|Ribavirin|ribavirin|mesh-list
56751441|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56751442|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
56751443|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751444|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
56751445|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751446|NCT02594579|Vitamin D|vitamin d|mesh-list
56751447|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
56751448|NCT02594579|Vitamins|vitamins|mesh-ancestor
56751449|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
56751450|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751451|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56751452|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56751453|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56751454|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56751455|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56751456|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751457|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751458|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
56751468|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
56751469|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751470|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
56751471|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751472|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
56751473|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56751474|NCT02594423|Bevacizumab|bevacizumab|mesh-list
56751475|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56751476|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751477|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56751478|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56751479|NCT02594423|Growth Substances|growth substances|mesh-ancestor
56751480|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751481|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
56751482|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
56751483|NCT00882414|Hematinics|hematinics|mesh-ancestor
56751484|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56751485|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56751486|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56751487|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
56751488|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751489|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56751490|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56751491|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751492|NCT00875784|Sumatriptan|sumatriptan|mesh-list
56751493|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56751494|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56751495|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56751496|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
56751497|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751498|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751499|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751500|NCT00731549|Aripiprazole|aripiprazole|mesh-list
56462545|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56751501|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
56751505|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751506|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751507|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
56751508|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
56751509|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751510|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751511|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56751512|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56751513|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
56751514|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56751515|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56751516|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56751517|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56751518|NCT00882570|Cefdinir|cefdinir|mesh-list
56751519|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56751520|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751521|NCT00882882|Metformin|metformin|mesh-list
56751522|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56751523|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751524|NCT00882960|Fentanyl|fentanyl|mesh-list
56751525|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56751526|NCT00882960|Narcotics|narcotics|mesh-ancestor
56751527|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751528|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751529|NCT00882960|Analgesics|analgesics|mesh-ancestor
56751530|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
56751531|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751532|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56751533|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56751534|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
56751535|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
56751536|NCT00883194|Ropivacaine|ropivacaine|mesh-list
56751537|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
56751538|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
56751539|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751540|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751544|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56751545|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
56751546|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
56751547|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56751548|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56751549|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751550|NCT00730925|Paclitaxel|paclitaxel|mesh-list
56751551|NCT00730925|Afatinib|afatinib|mesh-list
56751552|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56751553|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751554|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
56751555|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
56751556|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
56751557|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751558|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56751559|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751560|NCT00236899|Gemcitabine|gemcitabine|mesh-list
56751561|NCT00236899|Paclitaxel|paclitaxel|mesh-list
56751562|NCT00236899|Docetaxel|docetaxel|mesh-list
56751563|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56751564|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751565|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
56751566|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
56751567|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
56751568|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751569|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56751570|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
56751571|NCT00236899|Antiviral Agents|antiviral agents|mesh-ancestor
56751572|NCT00236899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751573|NCT00236899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751574|NCT00236899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56751575|NCT00236899|Immunologic Factors|immunologic factors|mesh-ancestor
56751576|NCT00236899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751577|NCT00611130|Vigabatrin|vigabatrin|mesh-list
56751578|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
56751579|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751580|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032186|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
56751581|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
56751582|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751583|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751584|NCT00885690|Olanzapine|olanzapine|mesh-list
56751585|NCT00885690|Sertindole|sertindole|mesh-list
56751586|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
56751587|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
56751588|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751589|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751590|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56751591|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56751592|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56751593|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751594|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751595|NCT00885690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56751596|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56751597|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56751598|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751599|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751600|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
56751601|NCT00888810|Topotecan|topotecan|mesh-list
56751602|NCT00888810|Lapatinib|lapatinib|mesh-list
56751603|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56751604|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56751605|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751606|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751607|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751608|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56751609|NCT00256243|Paclitaxel|paclitaxel|mesh-list
56751610|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
56751611|NCT00256243|Carboplatin|carboplatin|mesh-list
56751612|NCT00256243|Doxorubicin|doxorubicin|mesh-list
56751613|NCT00256243|Trastuzumab|trastuzumab|mesh-list
56751614|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56751615|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751616|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
56751617|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
56751620|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56751621|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
56751622|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751623|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751624|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56751625|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
56751626|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56751627|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56751628|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56751629|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56751630|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751631|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56751632|NCT00236197|Rabeprazole|rabeprazole|mesh-list
56751633|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56751634|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56751635|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56751636|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751637|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751638|NCT02541708|Folic Acid|folic acid|mesh-list
56751639|NCT02541708|Hematinics|hematinics|mesh-ancestor
56751640|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
56751641|NCT02541708|Vitamins|vitamins|mesh-ancestor
56751642|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
56751643|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751644|NCT03973567|Norepinephrine|norepinephrine|mesh-list
56751645|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
56751646|NCT03973567|Serotonin|serotonin|mesh-list
56751647|NCT03973567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56751648|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751649|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56751650|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
56751651|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751652|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751653|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751661|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56751662|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56751663|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56751664|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
56751665|NCT00885924|Coagulants|coagulants|mesh-ancestor
56751666|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56751667|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
56751668|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751669|NCT01071889|Flumazenil|flumazenil|mesh-list
56751670|NCT01071889|Antidotes|antidotes|mesh-ancestor
56751671|NCT01071889|Protective Agents|protective agents|mesh-ancestor
56751672|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751673|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
56751674|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
56751675|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751676|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751677|NCT03973411|Ondansetron|ondansetron|mesh-list
56751678|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
56751679|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
56751680|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751681|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751682|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56751683|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
56751684|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
56751685|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56751686|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
56751687|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751688|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751689|NCT03973411|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56751690|NCT03973411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56751691|NCT03973411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751692|NCT03973411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751693|NCT03973411|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56751694|NCT00883506|Lisinopril|lisinopril|mesh-list
56751696|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
56751701|NCT00883506|Protective Agents|protective agents|mesh-ancestor
56751702|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751703|NCT00278395|Vorinostat|vorinostat|mesh-list
56751704|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751705|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56751706|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751707|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751708|NCT00889044|Clopidogrel|clopidogrel|mesh-list
56751709|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56751710|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56751711|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56751712|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56751713|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
56751714|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751715|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751716|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751717|NCT00886002|Fentanyl|fentanyl|mesh-list
56751718|NCT00886002|Buprenorphine|buprenorphine|mesh-list
56751719|NCT00886002|Naloxone|naloxone|mesh-list
56751720|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56751721|NCT00886002|Narcotics|narcotics|mesh-ancestor
56751722|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751723|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751724|NCT00886002|Analgesics|analgesics|mesh-ancestor
56462769|NCT00459992|Betahistine|betahistine|mesh-list
56751751|NCT00889356|Tetracycline|tetracycline|mesh-list
56751752|NCT00889356|Ketoconazole|ketoconazole|mesh-list
56751753|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56751754|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56751755|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751756|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56751757|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751758|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751759|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
56751760|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56751761|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56751762|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56751763|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
56751764|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56751765|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751771|NCT00889434|Vitamin E|vitamin e|mesh-list
56751810|NCT04179396|Rucaparib|rucaparib|mesh-list
56751811|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56751812|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751813|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751814|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751815|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
56751816|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56751817|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751818|NCT00736853|Acetaminophen|acetaminophen|mesh-list
56751819|NCT00736853|Tramadol|tramadol|mesh-list
56751820|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56751821|NCT00736853|Analgesics|analgesics|mesh-ancestor
56751822|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
56751823|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751824|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751825|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
56751826|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56751827|NCT00736853|Narcotics|narcotics|mesh-ancestor
56751828|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751829|NCT04037514|Acetaminophen|acetaminophen|mesh-list
56751830|NCT04037514|Ibuprofen|ibuprofen|mesh-list
56751831|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56751832|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56751833|NCT04037514|Analgesics|analgesics|mesh-ancestor
56751834|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
56751835|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751836|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751837|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56751838|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751839|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56751840|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751841|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751842|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
56751843|NCT00730847|Vaccines|vaccines|mesh-list
56751851|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
56751852|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56751853|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751854|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751855|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56751856|NCT00573066|Analgesics|analgesics|mesh-ancestor
56751857|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
56751858|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751859|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56751860|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56751861|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56751862|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
56751863|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751864|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751865|NCT02541552|Ropivacaine|ropivacaine|mesh-list
56751866|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
56751867|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
56751868|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751869|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751870|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
56751871|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751872|NCT00886314|Midazolam|midazolam|mesh-list
56751873|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56751874|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56751875|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751876|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751877|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56751899|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
56751900|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56751901|NCT00730691|Vortioxetine|vortioxetine|mesh-list
56751902|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56751903|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56751904|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56751905|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751906|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751907|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751908|NCT00730691|Analgesics|analgesics|mesh-ancestor
56751909|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
56751910|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751911|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
56751912|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56751913|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
56751914|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56751915|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56751916|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751917|NCT00730691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56751918|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
56751919|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56751920|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56751921|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56751922|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56751923|NCT00886860|Misoprostol|misoprostol|mesh-list
56751924|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56751925|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
56751926|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56751927|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751928|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56751929|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56751939|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56751940|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
56751941|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56751942|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
56751943|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
56751944|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
56751945|NCT02543034|Petrolatum|petrolatum|mesh-list
56751946|NCT02543034|Emollients|emollients|mesh-ancestor
56751947|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56751948|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
56751949|NCT00278161|Rituximab|rituximab|mesh-list
56751950|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56751951|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
56751952|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751953|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751954|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56751955|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
56751956|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751957|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56751958|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56751959|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56751960|NCT02541396|Ketamine|ketamine|mesh-list
56751961|NCT02541396|Oxycodone|oxycodone|mesh-list
56751962|NCT02541396|Analgesics|analgesics|mesh-ancestor
56751963|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
56751964|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751965|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751966|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56751967|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56751968|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
56751969|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
56751970|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56751971|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56751972|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56751973|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56751974|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751975|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56751976|NCT02541396|Narcotics|narcotics|mesh-ancestor
56751977|NCT00890604|Acetaminophen|acetaminophen|mesh-list
56751978|NCT00890604|Ibuprofen|ibuprofen|mesh-list
56751979|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56751980|NCT00890604|Analgesics|analgesics|mesh-ancestor
56751981|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
56751982|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56751983|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56751984|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
56751985|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56751986|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56751987|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56751988|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56751989|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751990|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751991|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
56751992|NCT00255151|Lansoprazole|lansoprazole|mesh-list
56751993|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56751994|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56751995|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56751996|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56751997|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56751998|NCT03973957|Fentanyl|fentanyl|mesh-list
56751999|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56752000|NCT03973957|Narcotics|narcotics|mesh-ancestor
56752001|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752002|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752019|NCT00891072|Paclitaxel|paclitaxel|mesh-list
56752025|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752026|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752027|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752028|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752029|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752030|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752031|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752032|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56752033|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
56752034|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752035|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56752036|NCT00891072|Protective Agents|protective agents|mesh-ancestor
56752037|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56752038|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
56752039|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56752040|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56752041|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56752042|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56752043|NCT02591927|Insulin|insulin|mesh-list
56752044|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56752045|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752046|NCT00891150|Oxytocin|oxytocin|mesh-list
56752047|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
56752048|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56752049|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752050|NCT00800462|Bromides|bromides|mesh-list
56752051|NCT00800462|Oxybutynin|oxybutynin|mesh-list
56752052|NCT00800462|Darifenacin|darifenacin|mesh-list
56752053|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
56752054|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
56752071|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752072|NCT00891306|Cyclosporine|cyclosporine|mesh-list
56752073|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
56752074|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
56752075|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56752076|NCT00891306|Cyclosporins|cyclosporins|mesh-list
56752077|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752078|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752079|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752080|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
56752081|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752082|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
56752083|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752084|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
56752085|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56752086|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56752087|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56752088|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752089|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56752090|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
56752091|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752092|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56752093|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
56752094|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
56752095|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752096|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56752097|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
56752098|NCT00891306|Hormones|hormones|mesh-ancestor
56752099|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56752100|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56752101|NCT00891306|Protective Agents|protective agents|mesh-ancestor
56752102|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56752103|NCT00807872|Antibodies|antibodies|mesh-list
56752104|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56752105|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
56752113|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56752114|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56752115|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752116|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56752117|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56752118|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56752119|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752120|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
56752121|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56752122|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56752123|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56752124|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
56752125|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56752126|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56752127|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
56752128|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752129|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
56752130|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
56752131|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752132|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56752133|NCT00812318|Cabotegravir|cabotegravir|mesh-list
56752134|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56752135|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56752136|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752137|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752138|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56752139|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56752140|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
56752142|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
56752156|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56752157|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
56752158|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752159|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56752160|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56752161|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752162|NCT00649220|Memantine|memantine|mesh-list
56752163|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56752164|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56752165|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
56752166|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752167|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752168|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752169|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56752170|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56752171|NCT00812786|Cyclosporine|cyclosporine|mesh-list
56752172|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
56752173|NCT00812786|Everolimus|everolimus|mesh-list
56752174|NCT00812786|Tacrolimus|tacrolimus|mesh-list
56752175|NCT00812786|Cyclosporins|cyclosporins|mesh-list
56752176|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56752177|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
56752178|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752179|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56752180|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752181|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752182|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
56752183|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752184|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
56463221|NCT00463112|Sibutramine|sibutramine|mesh-list
56752185|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56752186|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752187|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56752191|NCT00654368|Etanercept|etanercept|mesh-list
56752196|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752197|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56752198|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
56752199|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752200|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752201|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56752202|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752203|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56752204|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752205|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
56752206|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56752207|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56752208|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56752209|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56752210|NCT00654368|Analgesics|analgesics|mesh-ancestor
56752211|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
56752212|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752213|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56752214|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56752215|NCT00812864|Capecitabine|capecitabine|mesh-list
56752216|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56752217|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
56752218|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752219|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752220|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
56752221|NCT00808184|Midazolam|midazolam|mesh-list
56752222|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56752223|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56752224|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752225|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752226|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56752227|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56752228|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56752229|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56752235|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752236|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56752237|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56752238|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
56752239|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752240|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56752241|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56752242|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752243|NCT00647426|Carboplatin|carboplatin|mesh-list
56752244|NCT00647426|Docetaxel|docetaxel|mesh-list
56752245|NCT00647426|Sorafenib|sorafenib|mesh-list
56752246|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752247|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752248|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752249|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752250|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752251|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56752252|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752253|NCT00647348|Simvastatin|simvastatin|mesh-list
56752254|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56752255|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56752256|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
56752257|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752258|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56752259|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56752260|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752261|NCT00647270|Adalimumab|adalimumab|mesh-list
56752262|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56752263|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56752264|NCT00645944|Eszopiclone|eszopiclone|mesh-list
56752265|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56752266|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752267|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752268|NCT00813332|Docetaxel|docetaxel|mesh-list
56752269|NCT00813332|Endostar protein|endostar protein|mesh-list
56752270|NCT00813332|Endostatins|endostatins|mesh-list
56752271|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752274|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752275|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752276|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56752277|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56752278|NCT00813332|Growth Substances|growth substances|mesh-ancestor
56752279|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752280|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56752281|NCT04708496|Efavirenz|efavirenz|mesh-list
56752282|NCT04708496|Lumefantrine|lumefantrine|mesh-list
56752283|NCT04708496|Dolutegravir|dolutegravir|mesh-list
56752284|NCT04708496|Artemether|artemether|mesh-list
56752285|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56752286|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56752287|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56752288|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752289|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752290|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
56752291|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752292|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56752293|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56752294|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56752295|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56752296|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56752297|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56752298|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
56752299|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56752300|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56752301|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56752305|NCT00646958|Linezolid|linezolid|mesh-list
56752319|NCT00642746|Irinotecan|irinotecan|mesh-list
56752320|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56752321|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
56752322|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752323|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56752324|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752325|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752326|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
56752327|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752328|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56752329|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56752384|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
56752385|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56752386|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752387|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752388|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
56752389|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752390|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752391|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56752392|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56752393|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752394|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752395|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752396|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56752397|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56752398|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
56752399|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
56752400|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56752401|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56752402|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752403|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752404|NCT00814736|Urological Agents|urological agents|mesh-ancestor
56752405|NCT00818090|Paclitaxel|paclitaxel|mesh-list
56752406|NCT00818090|Cisplatin|cisplatin|mesh-list
56752407|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56752408|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752409|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752410|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752411|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752428|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
56752429|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56752430|NCT00642278|Canagliflozin|canagliflozin|mesh-list
56752431|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56752432|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752433|NCT00642278|Incretins|incretins|mesh-ancestor
56752434|NCT00642278|Hormones|hormones|mesh-ancestor
56752435|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56752436|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56752437|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
56752438|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752439|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752440|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56752441|NCT00815048|Atropine|atropine|mesh-list
56752442|NCT00815048|Fentanyl|fentanyl|mesh-list
56752443|NCT00815048|Remifentanil|remifentanil|mesh-list
56752444|NCT00815048|Succinylcholine|succinylcholine|mesh-list
56752445|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56752446|NCT00815048|Narcotics|narcotics|mesh-ancestor
56752447|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752448|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752449|NCT00815048|Analgesics|analgesics|mesh-ancestor
56752450|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
56752451|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752452|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56752453|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56752454|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
56752477|NCT02551796|BB 1101|bb 1101|mesh-list
56752478|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
56752479|NCT02551796|Dipivefrin|dipivefrin|mesh-list
56752480|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56752481|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
56752482|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
56752483|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752484|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752485|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56752486|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
56752487|NCT02551796|Hormones|hormones|mesh-ancestor
56752488|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56752489|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56752490|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752491|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
56752492|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752493|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752494|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56752495|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752497|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752498|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56752499|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56752500|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56752501|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56752502|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56752503|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
56752525|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752526|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
56752527|NCT00640562|Risperidone|risperidone|mesh-list
56752528|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56752529|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56752530|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
56752531|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752532|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752533|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752534|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56752535|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56752536|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752537|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56752538|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56752539|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
56752540|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
56752541|NCT00815204|Dexamethasone|dexamethasone|mesh-list
56752542|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56752543|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
56752544|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
56752545|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752546|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752547|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56752548|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
56752549|NCT00815204|Hormones|hormones|mesh-ancestor
56752550|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56752551|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56752552|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752553|NCT00721955|Loxapine|loxapine|mesh-list
56752554|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56752555|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56752556|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752557|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752558|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56752559|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56752563|NCT00585689|Gemcitabine|gemcitabine|mesh-list
56752564|NCT00585689|Carboplatin|carboplatin|mesh-list
56752565|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56752566|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752567|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56752568|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
56752569|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752570|NCT00585689|Antiviral Agents|antiviral agents|mesh-ancestor
56752571|NCT00585689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752572|NCT00585689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752573|NCT00585689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752574|NCT00585689|Immunologic Factors|immunologic factors|mesh-ancestor
56752575|NCT00585689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752576|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
56752577|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56752578|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
56752579|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752580|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
56752581|NCT00653432|Protective Agents|protective agents|mesh-ancestor
56752582|NCT00815282|Vaccines|vaccines|mesh-list
56752583|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
56752584|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752585|NCT02593019|Adavosertib|adavosertib|mesh-list
56752586|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752587|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752588|NCT00729365|Ramipril|ramipril|mesh-list
56752589|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56752590|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
56752591|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752592|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752593|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56752594|NCT00818870|Omeprazole|omeprazole|mesh-list
56752607|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752608|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56752609|NCT00736385|Metformin|metformin|mesh-list
56752610|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56752611|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752612|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56752613|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
56752614|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752615|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56752616|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752617|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752618|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
56752619|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752620|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
56752621|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56752622|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752623|NCT00253747|Methylphenidate|methylphenidate|mesh-list
56752624|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56752625|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752626|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56752627|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56752628|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56752629|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752630|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
56752631|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752632|NCT00252733|Candesartan|candesartan|mesh-list
56752633|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
56752634|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56752635|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56752636|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56752637|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752638|NCT03974035|Ropivacaine|ropivacaine|mesh-list
56752640|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
56752641|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752645|NCT00275821|Ranibizumab|ranibizumab|mesh-list
56752646|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56752647|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56752648|NCT00275821|Growth Substances|growth substances|mesh-ancestor
56752649|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752650|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
56752651|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752652|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
56752653|NCT00275509|Dexamethasone|dexamethasone|mesh-list
56752654|NCT00275509|Prednisone|prednisone|mesh-list
56752655|NCT00275509|Tacrolimus|tacrolimus|mesh-list
56752656|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
56752657|NCT00275509|Daclizumab|daclizumab|mesh-list
56752658|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56752659|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
56752660|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
56752661|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752662|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752663|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56752664|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
56752665|NCT00275509|Hormones|hormones|mesh-ancestor
56752666|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56752667|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56752668|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752669|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752670|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
56752671|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56752672|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752673|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752674|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56752675|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56752676|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
56752677|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752678|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752679|NCT01072045|Prednisone|prednisone|mesh-list
56752680|NCT01072045|Propranolol|propranolol|mesh-list
56752681|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56752683|NCT01072045|Hormones|hormones|mesh-ancestor
56752684|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56752685|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752686|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56752687|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752688|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56752689|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56752690|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
56752691|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752692|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752693|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56752694|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56752695|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
56752696|NCT01073059|Ertapenem|ertapenem|mesh-list
56752697|NCT01073059|Valproic Acid|valproic acid|mesh-list
56752698|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
56752699|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752700|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752701|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
56752702|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752703|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752704|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
56752705|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56752706|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752707|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56752708|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752709|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752710|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
56752711|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
56752712|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56752713|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752726|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56752727|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56752728|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
56752729|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752730|NCT00163657|Cyclosporine|cyclosporine|mesh-list
56752731|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
56752732|NCT00163657|Tacrolimus|tacrolimus|mesh-list
56752733|NCT00163657|Cyclosporins|cyclosporins|mesh-list
56752734|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752735|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
56752736|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752737|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56752738|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752739|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752740|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
56752741|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752742|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
56752743|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56752744|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56752745|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752746|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56752747|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
56752748|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752749|NCT01073683|Docetaxel|docetaxel|mesh-list
56752750|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752751|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752752|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752753|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752754|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752755|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56752756|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
56752757|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752758|NCT00230971|Metronidazole|metronidazole|mesh-list
56752759|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
56752760|NCT00230971|Tigecycline|tigecycline|mesh-list
56752761|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752762|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752763|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56025461|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752764|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56752765|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56752766|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752767|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752768|NCT00211081|Spironolactone|spironolactone|mesh-list
56752769|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56752770|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
56752771|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56752772|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752773|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56752774|NCT00211081|Diuretics|diuretics|mesh-ancestor
56752775|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
56752776|NCT00884676|Sunitinib|sunitinib|mesh-list
56752777|NCT00884676|Epothilone B|epothilone b|mesh-list
56752778|NCT00884676|Epothilones|epothilones|mesh-list
56752779|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752780|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56752781|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56752782|NCT00884676|Growth Substances|growth substances|mesh-ancestor
56752783|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752784|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
56752785|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56752786|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752787|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463820|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
56752788|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752789|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752790|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752807|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
56752808|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56752809|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
56752810|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752811|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752812|NCT00609336|Antiviral Agents|antiviral agents|mesh-ancestor
56752813|NCT00609336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752814|NCT00609336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752815|NCT00609336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752816|NCT00609336|Immunologic Factors|immunologic factors|mesh-ancestor
56752817|NCT00609336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752818|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752819|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752820|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752821|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
56752822|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56752823|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752824|NCT02541084|Aflibercept|aflibercept|mesh-list
56752825|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56752826|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56752827|NCT02541084|Growth Substances|growth substances|mesh-ancestor
56752828|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752829|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
56752830|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752831|NCT04397406|Fentanyl|fentanyl|mesh-list
56752832|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
56752833|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
56752834|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56752835|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752836|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752837|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56752838|NCT04397406|Analgesics|analgesics|mesh-ancestor
56752839|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
56752840|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752843|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56752847|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56752848|NCT04397406|Narcotics|narcotics|mesh-ancestor
56752849|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56752850|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56752851|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
56752852|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
56752853|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
56752854|NCT00891540|Ropivacaine|ropivacaine|mesh-list
56752855|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
56752856|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
56752857|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752858|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752859|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
56752860|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752861|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56752862|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
56752863|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752864|NCT00891696|Sirolimus|sirolimus|mesh-list
56752865|NCT00891696|Nitroprusside|nitroprusside|mesh-list
56752866|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56752867|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752868|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56752869|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752870|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
56752871|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752872|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
56752896|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56752897|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56752898|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56752899|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56752900|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
56752901|NCT02550782|Bupivacaine|bupivacaine|mesh-list
56752902|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
56752903|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
56752904|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752905|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752906|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
56752907|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752908|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56752909|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56752910|NCT02550782|Analgesics|analgesics|mesh-ancestor
56752911|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56752912|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56752913|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56752914|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
56752915|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752916|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752917|NCT05278728|Irinotecan|irinotecan|mesh-list
56752918|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
56752919|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56752920|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56752921|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752922|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752923|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752924|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56752925|NCT01073761|Ritonavir|ritonavir|mesh-list
56752926|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56752927|NCT01073761|Darunavir|darunavir|mesh-list
56752928|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56752929|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56752930|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
56752934|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56752935|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
56752936|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752937|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56752938|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56752939|NCT00819104|Metoprolol|metoprolol|mesh-list
56752940|NCT00819104|Amlodipine|amlodipine|mesh-list
56752941|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56752942|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56752943|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56752944|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752945|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56752946|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752947|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
56752948|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56752949|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
56752950|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
56752951|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56752952|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56752953|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56752954|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56752955|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
56752956|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56752957|NCT02542098|Hydrocodone|hydrocodone|mesh-list
56752958|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56752959|NCT02542098|Narcotics|narcotics|mesh-ancestor
56752960|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56752979|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752980|NCT00885066|Antiviral Agents|antiviral agents|mesh-ancestor
56752981|NCT00885066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56752982|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56752983|NCT00885066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56752984|NCT00885066|Immunologic Factors|immunologic factors|mesh-ancestor
56752985|NCT00885066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56752986|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56752987|NCT00888108|Docetaxel|docetaxel|mesh-list
56752988|NCT00888108|Navitoclax|navitoclax|mesh-list
56752989|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56752990|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
56752991|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
56752992|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
56752993|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56752994|NCT00885300|Cloxacillin|cloxacillin|mesh-list
56752995|NCT00885300|Heparin|heparin|mesh-list
56752996|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
56752997|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56752998|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56752999|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753000|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56753001|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753002|NCT00888186|Levodopa|levodopa|mesh-list
56753003|NCT00888186|Carbidopa|carbidopa|mesh-list
56753004|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56753005|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56753006|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
56753007|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753008|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753009|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753010|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56753011|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025676|NCT01271582|Leucovorin|leucovorin|mesh-list
56753019|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56753021|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753022|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753023|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56753024|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56753025|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
56753026|NCT00892398|Ranibizumab|ranibizumab|mesh-list
56753027|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56753028|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56753029|NCT00892398|Growth Substances|growth substances|mesh-ancestor
56753030|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753031|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
56753032|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753033|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
56753034|NCT00892476|Calcium|calcium|mesh-list
56753035|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56753036|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753037|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56753038|NCT02541786|Rabeprazole|rabeprazole|mesh-list
56753039|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
56753040|NCT02541786|Lansoprazole|lansoprazole|mesh-list
56753041|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56753042|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56032187|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
56032188|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032189|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032190|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
56032256|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
56032257|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56032258|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
56032259|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56032260|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032261|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
56032262|NCT02248181|Pramipexole|pramipexole|mesh-list
56032263|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
56032264|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032265|NCT02248181|Protective Agents|protective agents|mesh-ancestor
56032295|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56032296|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56032297|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032298|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032299|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56032300|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
56032301|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190398|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56190399|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032302|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032303|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56032304|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56032305|NCT04526951|Aspirin|aspirin|mesh-list
56032306|NCT04526951|Tenecteplase|tenecteplase|mesh-list
56753043|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56753044|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753045|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753046|NCT00888342|Ethanol|ethanol|mesh-list
56753047|NCT00888342|Zopiclone|zopiclone|mesh-list
56753048|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56753049|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753050|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753051|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753052|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56753053|NCT00608868|Gefitinib|gefitinib|mesh-list
56753054|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753055|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753056|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753057|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753058|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56753059|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
56753060|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753061|NCT04036500|Estradiol|estradiol|mesh-list
56753062|NCT04036500|Estrogens|estrogens|mesh-ancestor
56753063|NCT04036500|Hormones|hormones|mesh-ancestor
56753064|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56753065|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753066|NCT00895674|Sorafenib|sorafenib|mesh-list
56753067|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753068|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753069|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753070|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753071|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
56753072|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56753073|NCT04035330|Eusol|eusol|mesh-list
56753074|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
56753075|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753076|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56753077|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753078|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
56753079|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
56753080|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753081|NCT04035096|Protective Agents|protective agents|mesh-ancestor
56753082|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753083|NCT04035096|Vitamins|vitamins|mesh-ancestor
56753084|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
56753085|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
56753086|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56753087|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
56753088|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753089|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753090|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56753091|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
56753092|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56753093|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
56753094|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753095|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753096|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56753097|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
56753098|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
56753099|NCT00608322|Protective Agents|protective agents|mesh-ancestor
56753100|NCT00606294|Misonidazole|misonidazole|mesh-list
56753101|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753102|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56753103|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56753104|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753105|NCT00608244|Tacrolimus|tacrolimus|mesh-list
56753106|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56753107|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
56753108|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753109|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56753112|NCT00893100|Diltiazem|diltiazem|mesh-list
56753124|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753125|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753126|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
56753127|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753128|NCT00896376|Trastuzumab|trastuzumab|mesh-list
56753129|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56753130|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753131|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
56753132|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
56753133|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56753134|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753135|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56753136|NCT00893256|Risperidone|risperidone|mesh-list
56753137|NCT00893256|Citalopram|citalopram|mesh-list
56753138|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56753139|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
56753140|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753141|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753142|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753143|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56753144|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56753145|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753146|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56753147|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56753148|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
56753149|NCT00893256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56753150|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56753151|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56753152|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56753153|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
56753154|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56753155|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56753156|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
56753157|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753161|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
56753162|NCT00901368|Hormones|hormones|mesh-ancestor
56753163|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56753164|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
56753165|NCT00901524|Interferons|interferons|mesh-list
56753166|NCT00901524|Ribavirin|ribavirin|mesh-list
56753167|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
56753168|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
56753169|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56753170|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753171|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
56753172|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753173|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
56753174|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753175|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
56753176|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753177|NCT00893412|Tramadol|tramadol|mesh-list
56753178|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56753179|NCT00893412|Narcotics|narcotics|mesh-ancestor
56753180|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753181|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753182|NCT00893412|Analgesics|analgesics|mesh-ancestor
56753183|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
56753184|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753185|NCT00893490|Mitomycins|mitomycins|mesh-list
56753186|NCT00893490|Mitomycin|mitomycin|mesh-list
56753187|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56753188|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753189|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
56753190|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753191|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56753192|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753193|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
56753194|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
56753195|NCT00638690|Prednisone|prednisone|mesh-list
56753196|NCT00638690|Prednisolone|prednisolone|mesh-list
56753197|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
56753202|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753203|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56753204|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753205|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56753206|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753207|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753208|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
56753209|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56753210|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
56753211|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753212|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753213|NCT00893724|Tocopherols|tocopherols|mesh-list
56753214|NCT00893724|Vitamin E|vitamin e|mesh-list
56753215|NCT00893724|Tocotrienols|tocotrienols|mesh-list
56753216|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
56753217|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
56753218|NCT00893724|Niacinamide|niacinamide|mesh-list
56753219|NCT00893724|Niacin|niacin|mesh-list
56753220|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
56753221|NCT00893724|Ubiquinone|ubiquinone|mesh-list
56753222|NCT00893724|Minocycline|minocycline|mesh-list
56753223|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
56753224|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56753225|NCT00893724|Vitamins|vitamins|mesh-ancestor
56753226|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
56753227|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753228|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
56753229|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753251|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
56753252|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753253|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753254|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56753255|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
56753256|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
56753257|NCT00893880|Protective Agents|protective agents|mesh-ancestor
56753258|NCT00815594|Bevacizumab|bevacizumab|mesh-list
56753259|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56753260|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753261|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56753262|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56753263|NCT00815594|Growth Substances|growth substances|mesh-ancestor
56753264|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753265|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56753266|NCT00897312|Interferons|interferons|mesh-list
56753267|NCT00897312|Ribavirin|ribavirin|mesh-list
56753268|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
56753269|NCT00897312|Tremelimumab|tremelimumab|mesh-list
56753270|NCT00897312|Infliximab|infliximab|mesh-list
56753271|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753272|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
56753273|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753274|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
56753275|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753276|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
56753277|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753278|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56753279|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56753280|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56753281|NCT02540460|Delpazolid|delpazolid|mesh-list
56753282|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
56753283|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56753284|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753285|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56753288|NCT00543387|Docetaxel|docetaxel|mesh-list
56753292|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
56753293|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753294|NCT03455556|Atezolizumab|atezolizumab|mesh-list
56753295|NCT03455556|Maytansine|maytansine|mesh-list
56753296|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56753297|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753298|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
56753299|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753300|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56753301|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56753302|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56753303|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56753304|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753305|NCT04017624|Nicotine|nicotine|mesh-list
56753306|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56753307|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
56753308|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753309|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753310|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56753311|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56753312|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
56753313|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56464333|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56753314|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753315|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
56753316|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753317|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
56753318|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753319|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753320|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56753321|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56753322|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
56753332|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
56753333|NCT00635570|NuvaRing|nuvaring|mesh-list
56753334|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56753335|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56753336|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
56753337|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56753338|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753339|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56753340|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56753341|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56753342|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56753343|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753344|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56753345|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56753346|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753347|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753348|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753349|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
56753350|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56753351|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753352|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56753353|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
56753354|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56753355|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753356|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753357|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753358|NCT00986115|Memantine|memantine|mesh-list
56753359|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56753360|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56753361|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
56753362|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753373|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56753374|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56753375|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56753376|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753377|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753378|NCT00635492|Insulin|insulin|mesh-list
56753379|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56753380|NCT00635492|Exenatide|exenatide|mesh-list
56753381|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56753382|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753383|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56753384|NCT00635492|Incretins|incretins|mesh-ancestor
56753385|NCT00635492|Hormones|hormones|mesh-ancestor
56753386|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56753387|NCT00543309|Milrinone|milrinone|mesh-list
56753388|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56464408|NCT00499668|Ondansetron|ondansetron|mesh-list
56753389|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
56753390|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753391|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56753392|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56753393|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
56753394|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56753395|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56753396|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753397|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753398|NCT00543309|Protective Agents|protective agents|mesh-ancestor
56753399|NCT00569582|Mifepristone|mifepristone|mesh-list
56753400|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56753401|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
56753402|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56753414|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56753415|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
56753416|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56753417|NCT00988845|Protective Agents|protective agents|mesh-ancestor
56753418|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753419|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753420|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56753421|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56753422|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753423|NCT00902460|Midazolam|midazolam|mesh-list
56753424|NCT00902460|Tofacitinib|tofacitinib|mesh-list
56753425|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56753426|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56753427|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753428|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753429|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56753430|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56753431|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56753432|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56753433|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
56753434|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
56753435|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
56753436|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
56753437|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753438|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753439|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753440|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753441|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
56753442|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56753443|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753444|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56753445|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753446|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56753447|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
56753454|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56753455|NCT00986505|Lidocaine|lidocaine|mesh-list
56753456|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
56753457|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
56753458|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753459|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753460|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
56753461|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753462|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56753463|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56753464|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56753465|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56753466|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753467|NCT03667443|Inositol|inositol|mesh-list
56753468|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
56753469|NCT03667443|Vitamins|vitamins|mesh-ancestor
56753470|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
56753471|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753472|NCT00902772|Lorazepam|lorazepam|mesh-list
56753473|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
56753474|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
56753475|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
56753476|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753477|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753478|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56753479|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56753480|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753481|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56753482|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56753483|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56753484|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
56753485|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
56753486|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753487|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753488|NCT00894660|Amodiaquine|amodiaquine|mesh-list
56753495|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753496|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56753497|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56753498|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753499|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753500|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56753501|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
56753502|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56753503|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753504|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753505|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
56753506|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56753507|NCT00542997|Antibodies|antibodies|mesh-list
56753508|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
56753509|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753510|NCT00903084|Tenofovir|tenofovir|mesh-list
56753511|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
56753512|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753513|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56753514|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56753515|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753516|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753517|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56753518|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56753519|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
56753520|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56753540|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56753541|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56753542|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
56753543|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753544|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56753545|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
56753546|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
56753547|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
56753548|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56753549|NCT00986817|Terlipressin|terlipressin|mesh-list
56753550|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56753551|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56753552|NCT00572832|Vaccines|vaccines|mesh-list
56753553|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
56753554|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753555|NCT02591849|Glucagon|glucagon|mesh-list
56753556|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56753557|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56753558|NCT02591849|Hormones|hormones|mesh-ancestor
56753559|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56753560|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753561|NCT02591849|Incretins|incretins|mesh-ancestor
56753562|NCT00898794|Bevacizumab|bevacizumab|mesh-list
56753563|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56753564|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753565|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56753566|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56753567|NCT00898794|Growth Substances|growth substances|mesh-ancestor
56753568|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753569|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
56753570|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
56753571|NCT04086719|BMS-986165|bms-986165|mesh-list
56753572|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
56753573|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56753574|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56753575|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753576|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56753579|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
56753580|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753581|NCT00898950|Aspirin|aspirin|mesh-list
56753582|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
56753583|NCT00898950|Salicylates|salicylates|mesh-list
56753584|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56753585|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56753586|NCT00898950|Analgesics|analgesics|mesh-ancestor
56753587|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
56753588|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753589|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753590|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56753591|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56753592|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56753593|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56753594|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753595|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56753596|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56753597|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753598|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
56753599|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753600|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
56753601|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
56753602|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
56753603|NCT03622515|Anesthetics|anesthetics|mesh-list
56753604|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753605|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753606|NCT05279235|Favipiravir|favipiravir|mesh-list
56753607|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
56026292|NCT00756236|Metoprolol|metoprolol|mesh-list
56032307|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56032308|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56032337|NCT02248571|Everolimus|everolimus|mesh-list
56032338|NCT02248571|Exemestane|exemestane|mesh-list
56032339|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032340|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032341|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56032342|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56032343|NCT02248571|Growth Substances|growth substances|mesh-ancestor
56032344|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032345|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
56032346|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56032347|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
56032348|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032349|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56753608|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753609|NCT00229723|Gefitinib|gefitinib|mesh-list
56753610|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753611|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753612|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464628|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
56923653|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753613|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753615|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56753616|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56753617|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
56753618|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753619|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753620|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753621|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56753622|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56753623|NCT01075477|Rituximab|rituximab|mesh-list
56753624|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56753625|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753626|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
56753627|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753628|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56753629|NCT01075555|Sorafenib|sorafenib|mesh-list
56753630|NCT01075555|Pravastatin|pravastatin|mesh-list
56753631|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753632|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753633|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753634|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753635|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56753636|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56753637|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
56753638|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56753639|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56753647|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753648|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
56753649|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753650|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
56753651|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753652|NCT00228553|Modafinil|modafinil|mesh-list
56753653|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56753654|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753655|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56753656|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56753657|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56753658|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753659|NCT00922506|Doxazosin|doxazosin|mesh-list
56753660|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56753661|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56753662|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56753663|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
56753664|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753665|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753666|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753667|NCT00922506|Urological Agents|urological agents|mesh-ancestor
56753668|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56753669|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56753670|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56753671|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56753672|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
56753673|NCT00816140|Clarithromycin|clarithromycin|mesh-list
56753674|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56753675|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753676|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56753677|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753678|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464702|NCT00469430|Metronidazole|metronidazole|mesh-list
56753685|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753686|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753687|NCT00903942|Paclitaxel|paclitaxel|mesh-list
56753688|NCT00903942|Carboplatin|carboplatin|mesh-list
56753689|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56753690|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56753691|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753692|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
56753693|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
56753694|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
56753695|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753696|NCT00904020|Lidocaine|lidocaine|mesh-list
56753697|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
56753698|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
56753699|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753700|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753701|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
56753702|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753703|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56753704|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56753705|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56753706|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56753707|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753708|NCT00895362|Cetuximab|cetuximab|mesh-list
56753709|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56753710|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56753711|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753712|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753713|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753714|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753715|NCT00904098|Frovatriptan|frovatriptan|mesh-list
56753716|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56753717|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
56753718|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032350|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
56753719|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753720|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753721|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
56753722|NCT00904176|Digoxin|digoxin|mesh-list
56753723|NCT00904176|Warfarin|warfarin|mesh-list
56753724|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56753725|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753726|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56753727|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753728|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
56753729|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56753730|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56753731|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753732|NCT00904176|Protective Agents|protective agents|mesh-ancestor
56753733|NCT02540070|Ketorolac|ketorolac|mesh-list
56753734|NCT02540070|Epinephrine|epinephrine|mesh-list
56753735|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
56753736|NCT02540070|Morphine|morphine|mesh-list
56753737|NCT02540070|Ropivacaine|ropivacaine|mesh-list
56753738|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56753739|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753740|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753741|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56753742|NCT02540070|Analgesics|analgesics|mesh-ancestor
56753743|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
56753744|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753745|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56753746|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56753747|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56753748|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
56753749|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753750|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753751|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56753762|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56753763|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56753764|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56753765|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56753766|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56753767|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753768|NCT00905814|Axitinib|axitinib|mesh-list
56753769|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753770|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56753771|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753772|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753773|NCT00900510|Trimethoprim|trimethoprim|mesh-list
56753774|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56753775|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
56753776|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56753777|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753778|NCT00900510|Renal Agents|renal agents|mesh-ancestor
56753779|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
56753780|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56753781|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56753782|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56753783|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753784|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753785|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56753786|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56753787|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56753788|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56753789|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
56753790|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56753791|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
56753792|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753793|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56753795|NCT00906048|Ofloxacin|ofloxacin|mesh-list
56753803|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753804|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753805|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753806|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56753807|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56753808|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56753809|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
56753810|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
56753811|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56753812|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56753813|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56753814|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56753815|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56753816|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56753817|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56753818|NCT00906126|Misoprostol|misoprostol|mesh-list
56753819|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56753820|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
56753821|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56753822|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753823|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56753824|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56753825|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
56753826|NCT00900744|Tamoxifen|tamoxifen|mesh-list
56753827|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56753828|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
56753829|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56753830|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753831|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56753832|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753833|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56753834|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56753835|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56753836|NCT00643760|Pregabalin|pregabalin|mesh-list
56753839|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
56753840|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753841|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753842|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
56753843|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56753844|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56753845|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753846|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56753847|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56753848|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56753849|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753850|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56753851|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56753852|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56753853|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753854|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
56753855|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
56753856|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56753857|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56753858|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
56753859|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56753860|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56753861|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56753862|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753863|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753864|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56753865|NCT00906360|Cetuximab|cetuximab|mesh-list
56753866|NCT00906360|Sunitinib|sunitinib|mesh-list
56753867|NCT00906360|Antibodies|antibodies|mesh-list
56753868|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
56753869|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56753870|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
56753880|NCT00643604|Treprostinil|treprostinil|mesh-list
56753881|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56753882|NCT00603798|Imiquimod|imiquimod|mesh-list
56753883|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56753884|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
56753885|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753886|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753887|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
56753888|NCT00819572|Antibodies|antibodies|mesh-list
56753889|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
56753890|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
56753891|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753892|NCT00630812|Mannitol|mannitol|mesh-list
56753893|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56753894|NCT00630812|Diuretics|diuretics|mesh-ancestor
56753895|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
56753896|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753897|NCT00906516|Bevacizumab|bevacizumab|mesh-list
56753898|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56753899|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753900|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56753901|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56753902|NCT00906516|Growth Substances|growth substances|mesh-ancestor
56753903|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753904|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
56753905|NCT00629798|Fludarabine|fludarabine|mesh-list
56753906|NCT00629798|Melphalan|melphalan|mesh-list
56753907|NCT00629798|Busulfan|busulfan|mesh-list
56753908|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56753909|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753910|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753911|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56753912|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
56753913|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753914|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56753915|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
56026586|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
56032351|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56032352|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56032353|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753916|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56753917|NCT00160615|Levetiracetam|levetiracetam|mesh-list
56753918|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
56753919|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
56753920|NCT00906594|Latanoprost|latanoprost|mesh-list
56753921|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56753922|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56753923|NCT03970759|Fluorides|fluorides|mesh-list
56753924|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
56753925|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
56753926|NCT03970759|Protective Agents|protective agents|mesh-ancestor
56753927|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753928|NCT00905190|Ondansetron|ondansetron|mesh-list
56753929|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
56753930|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
56753931|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56753932|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753933|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56753934|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
56753935|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
56753936|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56753937|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
56753938|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753939|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753940|NCT00905190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56753941|NCT00905190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56753942|NCT00905190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56753943|NCT00905190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56753944|NCT00905190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56753945|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56753946|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
56753947|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
56753961|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
56753962|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56753963|NCT00627458|Vaccines|vaccines|mesh-list
56753964|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
56753965|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753966|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
56753967|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56753968|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753969|NCT00816218|Pioglitazone|pioglitazone|mesh-list
56753970|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56753971|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753972|NCT00819728|Docetaxel|docetaxel|mesh-list
56753973|NCT00819728|Irinotecan|irinotecan|mesh-list
56753974|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56753975|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
56753976|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
56753977|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
56753978|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753979|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56753980|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56753981|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753982|NCT00906828|Levodopa|levodopa|mesh-list
56753983|NCT00906828|Carbidopa|carbidopa|mesh-list
56753984|NCT00906828|Entacapone|entacapone|mesh-list
56753985|NCT00906828|Tolcapone|tolcapone|mesh-list
56753986|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56753987|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56753988|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
56753989|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56753990|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56753991|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56753992|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56753993|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56753994|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56753995|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
56753997|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
56754002|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
56754003|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754004|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754005|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56754006|NCT00909402|Capecitabine|capecitabine|mesh-list
56754007|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754008|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56754009|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
56754010|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754011|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
56754012|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56754013|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56754014|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754015|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
56754016|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
56754017|NCT00821444|Ziprasidone|ziprasidone|mesh-list
56754018|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56754019|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
56754020|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754021|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754022|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754023|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56754024|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56754025|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754026|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56754027|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56754028|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
56754029|NCT00819962|Bupivacaine|bupivacaine|mesh-list
56754030|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
56754031|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
56754032|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754033|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754034|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
56754035|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754036|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56754038|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56754039|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56754040|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754041|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754042|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
56754043|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754044|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56754045|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56754046|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56754047|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56754048|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
56754049|NCT00927498|Cytarabine|cytarabine|mesh-list
56754050|NCT00927498|Daunorubicin|daunorubicin|mesh-list
56754051|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
56754052|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56754053|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754054|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56754055|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56754056|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754057|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754058|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56754059|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56754060|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
56754062|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754063|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754064|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
56754065|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754066|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
56754067|NCT00159913|Citric Acid|citric acid|mesh-list
56754068|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
56754069|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
56754070|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56754071|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
56754072|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
56754080|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56754081|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754082|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
56754083|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754084|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56754085|NCT00821600|Risperidone|risperidone|mesh-list
56754086|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56754087|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
56754088|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754089|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754090|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754091|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56754092|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56754093|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754094|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56754095|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56754096|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
56754097|NCT00987207|Cyclosporine|cyclosporine|mesh-list
56754098|NCT00987207|Cyclosporins|cyclosporins|mesh-list
56754099|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754100|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754101|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754102|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
56754103|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754104|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
56754105|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754106|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
56754107|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56754108|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56754125|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
56754126|NCT00927732|Quinidine|quinidine|mesh-list
56754127|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
56754128|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56754129|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
56754130|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
56754131|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754132|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754133|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56754134|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56754135|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754136|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754137|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754138|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
56754139|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56754140|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56754141|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754142|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754182|NCT02936622|Paclitaxel|paclitaxel|mesh-list
56754183|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56754184|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56754185|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754186|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
56754187|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
56754188|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
56754189|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754190|NCT00927966|Everolimus|everolimus|mesh-list
56754191|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754192|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754193|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
56754194|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754195|NCT05705505|Letrozole|letrozole|mesh-list
56754196|NCT05705505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754197|NCT05705505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56754198|NCT05705505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56754199|NCT05705505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754200|NCT05705505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754201|NCT05705505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56754202|NCT05705505|Hormone Antagonists|hormone antagonists|mesh-ancestor
56754203|NCT05705505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56754204|NCT05705505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754205|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56754206|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
56754207|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56754230|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56754231|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56754232|NCT01075711|Prednisone|prednisone|mesh-list
56754233|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56754234|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
56754235|NCT01075711|Hormones|hormones|mesh-ancestor
56754236|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56754237|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754238|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56754239|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754240|NCT01073371|Prilocaine|prilocaine|mesh-list
56754241|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
56754242|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
56754243|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754244|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754245|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
56754246|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754247|NCT05470491|Maraviroc|maraviroc|mesh-list
56754248|NCT05470491|Plerixafor|plerixafor|mesh-list
56754249|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56754250|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56754251|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754252|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56754253|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56754254|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
56754255|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754256|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56754257|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
56754258|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56754259|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56754260|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754261|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
56754262|NCT03970213|Coagulants|coagulants|mesh-ancestor
56754263|NCT00821834|Ticlopidine|ticlopidine|mesh-list
56754264|NCT00821834|Clopidogrel|clopidogrel|mesh-list
56754265|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56754268|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56754269|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
56754270|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754271|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754272|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754273|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56754274|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56754275|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56754276|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56754277|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754278|NCT04005417|Fluorides|fluorides|mesh-list
56754279|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
56754280|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
56754281|NCT04005417|Protective Agents|protective agents|mesh-ancestor
56754282|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754283|NCT01073839|Gemcitabine|gemcitabine|mesh-list
56754284|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465294|NCT04325932|Kallikreins|kallikreins|mesh-list
56754285|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56754286|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
56754287|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754288|NCT01073839|Antiviral Agents|antiviral agents|mesh-ancestor
56754289|NCT01073839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754290|NCT01073839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754291|NCT01073839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754292|NCT01073839|Immunologic Factors|immunologic factors|mesh-ancestor
56754293|NCT01073839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754294|NCT05698407|Sufentanil|sufentanil|mesh-list
56754295|NCT05698407|Dexmedetomidine|dexmedetomidine|mesh-list
56754296|NCT05698407|Dsuvia|dsuvia|mesh-list
56754297|NCT05698407|Ropivacaine|ropivacaine|mesh-list
56754310|NCT05698407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754311|NCT05698407|Anesthetics, Local|anesthetics, local|mesh-ancestor
56754312|NCT05698407|Anesthetics|anesthetics|mesh-ancestor
56754313|NCT05698407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56754314|NCT05698407|Narcotics|narcotics|mesh-ancestor
56754315|NCT05698407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56754316|NCT05698407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56754317|NCT05698407|Anesthetics, General|anesthetics, general|mesh-ancestor
56754318|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56754319|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754320|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56754321|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754322|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754323|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
56754324|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56754325|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
56754326|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754327|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754328|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56754329|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
56754330|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56754331|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56754332|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56754333|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754334|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754335|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754336|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56754337|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56754338|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754339|NCT00987441|Sufentanil|sufentanil|mesh-list
56754340|NCT00987441|Dsuvia|dsuvia|mesh-list
56754341|NCT00987441|Ropivacaine|ropivacaine|mesh-list
56754342|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
56754343|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
56754346|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
56754349|NCT00987441|Narcotics|narcotics|mesh-ancestor
56754350|NCT00987441|Analgesics|analgesics|mesh-ancestor
56754351|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56754352|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56754353|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
56754354|NCT00584987|Fluticasone|fluticasone|mesh-list
56754355|NCT00584987|Xhance|xhance|mesh-list
56754356|NCT00584987|Phenylephrine|phenylephrine|mesh-list
56754357|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
56754358|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56754359|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56754360|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
56754361|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754362|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754363|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56754364|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
56754365|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
56754366|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56754367|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56754368|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56754369|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754370|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754371|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754372|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
56754373|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
56754374|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56754375|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56754377|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56754378|NCT00584987|Protective Agents|protective agents|mesh-ancestor
56754379|NCT00727961|Doxorubicin|doxorubicin|mesh-list
56754380|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56754381|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56754382|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754383|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56754384|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56754385|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754386|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754389|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56754390|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754391|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
56754392|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754393|NCT00821912|Docetaxel|docetaxel|mesh-list
56754394|NCT00821912|Capecitabine|capecitabine|mesh-list
56754395|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754396|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
56754397|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
56754398|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
56754399|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754400|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56754401|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
56754402|NCT05689827|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
56754403|NCT05689827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56754404|NCT05689827|Immunologic Factors|immunologic factors|mesh-ancestor
56754405|NCT05689827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754406|NCT00727649|Loperamide|loperamide|mesh-list
56754407|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
56754408|NCT00727649|Psyllium|psyllium|mesh-list
56754409|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56754410|NCT00727649|Cathartics|cathartics|mesh-ancestor
56754411|NCT04006041|Paclitaxel|paclitaxel|mesh-list
56754412|NCT04006041|Cisplatin|cisplatin|mesh-list
56754413|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56754414|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754415|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
56754416|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
56754417|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
56754418|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754419|NCT00225277|Pioglitazone|pioglitazone|mesh-list
56754420|NCT00225277|Glimepiride|glimepiride|mesh-list
56754421|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56754433|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465444|NCT01246362|Etoricoxib|etoricoxib|mesh-list
56754434|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56754435|NCT05354453|Protective Agents|protective agents|mesh-ancestor
56754436|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754437|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754438|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56754439|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56754440|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
56754441|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754442|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754443|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56754444|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
56754445|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56754446|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56754447|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56754448|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754449|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754450|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754451|NCT04388319|Zonisamide|zonisamide|mesh-list
56754452|NCT04388319|Bupropion|bupropion|mesh-list
56754453|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56754454|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
56754455|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56754456|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56754457|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56754477|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754478|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
56754479|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56754480|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56754481|NCT04085393|Granisetron|granisetron|mesh-list
56754482|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
56754483|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
56754484|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754485|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754486|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56754487|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56754488|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
56754489|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754490|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754491|NCT00717275|Temozolomide|temozolomide|mesh-list
56754492|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56754493|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
56754494|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754495|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754496|NCT04006353|Rifampin|rifampin|mesh-list
56754497|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56754498|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
56754499|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56754500|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754501|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
56754502|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56754503|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754504|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754518|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56754519|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56754520|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56754521|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56754522|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754523|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
56754524|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56754525|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
56754526|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754527|NCT00584909|Paclitaxel|paclitaxel|mesh-list
56754528|NCT00584909|Carboplatin|carboplatin|mesh-list
56754529|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56754530|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754531|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
56754532|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
56754533|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
56754534|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754535|NCT03947099|Ketamine|ketamine|mesh-list
56754536|NCT03947099|Analgesics|analgesics|mesh-ancestor
56754537|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
56754538|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754539|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754540|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56754541|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56754542|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
56754543|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
56754544|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754545|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56754549|NCT05361915|Abivertinib|abivertinib|mesh-list
56754562|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56754563|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56754564|NCT00907452|Thalidomide|thalidomide|mesh-list
56754565|NCT00907452|Dexamethasone|dexamethasone|mesh-list
56754566|NCT00907452|Prednisone|prednisone|mesh-list
56754567|NCT00907452|Lenalidomide|lenalidomide|mesh-list
56754568|NCT00907452|Melphalan|melphalan|mesh-list
56754569|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56754570|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
56754571|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
56754572|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754573|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754574|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56754575|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
56754576|NCT00907452|Hormones|hormones|mesh-ancestor
56754577|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56754578|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56754579|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754580|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
56465592|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
56754582|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56754583|NCT00907452|Growth Substances|growth substances|mesh-ancestor
56754584|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
56754585|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56754586|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
56754587|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754588|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56032395|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56032396|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56032397|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032398|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032430|NCT05633381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032431|NCT05633381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032432|NCT05633381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56032433|NCT05633381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032435|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56032436|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56032437|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56032438|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
56032439|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032466|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
56032467|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032468|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56032469|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
56032471|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56032472|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56032473|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56754589|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754590|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
56754591|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56754592|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754593|NCT00717197|Capecitabine|capecitabine|mesh-list
56754594|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56754595|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
56754596|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754597|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754598|NCT00925392|Doripenem|doripenem|mesh-list
56754599|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56754600|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754601|NCT05315271|Ketamine|ketamine|mesh-list
56754602|NCT05315271|Bupivacaine|bupivacaine|mesh-list
56754603|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
56754604|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
56754605|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754606|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754607|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
56754608|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754609|NCT05315271|Analgesics|analgesics|mesh-ancestor
56754610|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56754611|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56754612|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
56754613|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56754614|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56754615|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754616|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754617|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
56754618|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56754633|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754634|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56754635|NCT05313477|Vitamins|vitamins|mesh-ancestor
56754636|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
56754637|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56754638|NCT00224107|Silodosin|silodosin|mesh-list
56754639|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56754640|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56754641|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56754642|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754643|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754644|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754645|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754646|NCT00224107|Urological Agents|urological agents|mesh-ancestor
56754647|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
56754648|NCT04696731|Fludarabine|fludarabine|mesh-list
56754649|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754650|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
56754651|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754652|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56754653|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56754654|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
56754655|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754656|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754657|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56754658|NCT04004871|Paclitaxel|paclitaxel|mesh-list
56754659|NCT04004871|Cisplatin|cisplatin|mesh-list
56754660|NCT04004871|Fluorouracil|fluorouracil|mesh-list
56754661|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56754662|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754667|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
56754675|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
56754676|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754677|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56754678|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56754679|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754680|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
56754681|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754682|NCT00822380|Iron|iron|mesh-list
56754683|NCT00822380|Trace Elements|trace elements|mesh-list
56754684|NCT00822380|Folic Acid|folic acid|mesh-list
56754685|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
56754686|NCT00822380|Micronutrients|micronutrients|mesh-list
56754687|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754688|NCT00822380|Hematinics|hematinics|mesh-ancestor
56754689|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
56754690|NCT00822380|Vitamins|vitamins|mesh-ancestor
56754691|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
56754692|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754693|NCT00822380|Protective Agents|protective agents|mesh-ancestor
56754694|NCT00720083|Cisplatin|cisplatin|mesh-list
56754695|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754696|NCT05621811|ATI 7505|ati 7505|mesh-list
56754697|NCT05621811|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56754698|NCT05621811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56754699|NCT05621811|Serotonin Agents|serotonin agents|mesh-ancestor
56754700|NCT05621811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754701|NCT05621811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754702|NCT05621811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754703|NCT00209131|Tamsulosin|tamsulosin|mesh-list
56754704|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56754705|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56754706|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56754707|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754708|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754709|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754710|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754711|NCT00209131|Urological Agents|urological agents|mesh-ancestor
56032474|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754712|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
56754713|NCT00907608|Hematinics|hematinics|mesh-ancestor
56754714|NCT00224029|Oxybutynin|oxybutynin|mesh-list
56754715|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
56754716|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
56754717|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754718|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754719|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56754720|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56754721|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
56754722|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754723|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754724|NCT00224029|Urological Agents|urological agents|mesh-ancestor
56754725|NCT00929370|Glycine|glycine|mesh-list
56754726|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
56754727|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754728|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754729|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465740|NCT01325428|Vinorelbine|vinorelbine|mesh-list
56754731|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56754732|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56754733|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
56754734|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
56754735|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032476|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56032477|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56032478|NCT04934904|Ropivacaine|ropivacaine|mesh-list
56032479|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
56032480|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
56032481|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032482|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032483|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
56032484|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032485|NCT02219321|Lidocaine|lidocaine|mesh-list
56032486|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
56032487|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
56032488|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032513|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56190400|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032514|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759720|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032515|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032517|NCT02221349|Fluorides|fluorides|mesh-list
56032518|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
56032519|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
56032520|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
56032521|NCT02221349|Protective Agents|protective agents|mesh-ancestor
56032522|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032523|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56032524|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032525|NCT02461758|Vaccines|vaccines|mesh-list
56754736|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754737|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754738|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56754739|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
56754740|NCT02550314|Coagulants|coagulants|mesh-ancestor
56754741|NCT01073527|Adenosine|adenosine|mesh-list
56754742|NCT01073527|Albuterol|albuterol|mesh-list
56754743|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56754744|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
56754745|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754746|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754747|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56754748|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
56754749|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
56754750|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56754751|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56754752|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56754753|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56754754|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754755|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754756|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754757|NCT01073527|Analgesics|analgesics|mesh-ancestor
56754758|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
56754759|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56754760|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
56754761|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56754762|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
56754763|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
56754764|NCT02538432|Gemcitabine|gemcitabine|mesh-list
56754765|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56754766|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
56754767|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754768|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754777|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
56754778|NCT00719849|Fludarabine|fludarabine|mesh-list
56754779|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
56754780|NCT00719849|Cyclosporins|cyclosporins|mesh-list
56754781|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56754782|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754783|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
56754784|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754785|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56754786|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56754787|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
56754788|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754789|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754790|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56754791|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56754792|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
56754793|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754794|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
56754795|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754796|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
56754797|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56754798|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56754799|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56754800|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
56754801|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56754802|NCT00822536|Aspirin|aspirin|mesh-list
56465823|NCT01244217|Fexofenadine|fexofenadine|mesh-list
56754803|NCT00822536|Clopidogrel|clopidogrel|mesh-list
56754804|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56754805|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56754806|NCT00822536|Analgesics|analgesics|mesh-ancestor
56754807|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
56754808|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754809|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027484|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
56032526|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
56032527|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032528|NCT02461290|Rituximab|rituximab|mesh-list
56032529|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032530|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754810|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56754811|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56754812|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56754813|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56754814|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754815|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56754816|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56754817|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754818|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
56754819|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56754820|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56754821|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56754822|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
56754823|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754824|NCT00826826|Amiodarone|amiodarone|mesh-list
56754825|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56754826|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
56754827|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56754828|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56754829|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754830|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56754831|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56754832|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56754860|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56754861|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
56754862|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754863|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754864|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
56754865|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754866|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56754867|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
56754868|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754869|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754870|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56754871|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56754872|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56754873|NCT00926016|Pioglitazone|pioglitazone|mesh-list
56754874|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56754875|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754876|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56754877|NCT04017104|Edotreotide|edotreotide|mesh-list
56754878|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56754879|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754880|NCT00827138|Rebastinib|rebastinib|mesh-list
56754881|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754882|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56754883|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754884|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754885|NCT00817466|Epinephrine|epinephrine|mesh-list
56754886|NCT00817466|Racepinephrine|racepinephrine|mesh-list
56754887|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
56754888|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56754889|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56754890|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754891|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754893|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754901|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
56754902|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56754903|NCT00930072|Clonidine|clonidine|mesh-list
56754904|NCT00930072|Bupivacaine|bupivacaine|mesh-list
56754905|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
56754906|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
56754907|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754908|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754909|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
56754910|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754911|NCT00930072|Analgesics|analgesics|mesh-ancestor
56754912|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56754913|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
56754914|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
56754915|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56754916|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56754917|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56754918|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754919|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754920|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754921|NCT00626522|Bromides|bromides|mesh-list
56754922|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
56754923|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56754924|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
56754925|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754926|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754927|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56754928|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
56754929|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56754930|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56754931|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56754932|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
56754933|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032531|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
56032581|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56032582|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
56032638|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032639|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032641|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
56032642|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56032643|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032644|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
56754934|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754935|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
56754936|NCT00926640|Etoposide|etoposide|mesh-list
56754937|NCT00926640|Belinostat|belinostat|mesh-list
56754938|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754939|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56754940|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56754941|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56754942|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754943|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754944|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56754945|NCT00931398|Methylphenidate|methylphenidate|mesh-list
56754946|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56754947|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754948|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56754949|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56754950|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56754951|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754952|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
56754953|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56754954|NCT00827216|Erythromycin|erythromycin|mesh-list
56754955|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
56754956|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56754957|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
56754958|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56754959|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56754960|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56754961|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56754962|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56754964|NCT00822848|Sorafenib|sorafenib|mesh-list
56754976|NCT04622319|Trastuzumab|trastuzumab|mesh-list
56754977|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56754978|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56754979|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56754980|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
56754981|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
56754982|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
56754983|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56754984|NCT00926718|Remifentanil|remifentanil|mesh-list
56754985|NCT00926718|Rocuronium|rocuronium|mesh-list
56754986|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56754987|NCT00926718|Narcotics|narcotics|mesh-ancestor
56754988|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56754989|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56754990|NCT00926718|Analgesics|analgesics|mesh-ancestor
56754991|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
56754992|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56754993|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56754994|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56754995|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56754996|NCT00823004|Letrozole|letrozole|mesh-list
56754997|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
56754998|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
56754999|NCT00823004|Buserelin|buserelin|mesh-list
56755000|NCT00823004|Ganirelix|ganirelix|mesh-list
56755001|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755025|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56755026|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
56755027|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755028|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755029|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56755030|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56755031|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
56755032|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755033|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755034|NCT00930306|Tolbutamide|tolbutamide|mesh-list
56755035|NCT00930306|Midazolam|midazolam|mesh-list
56755036|NCT00930306|Caffeine|caffeine|mesh-list
56755037|NCT00930306|Omeprazole|omeprazole|mesh-list
56755038|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56755039|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56755040|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755041|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755042|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56755043|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56755044|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56755045|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56755046|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
56755047|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
56755048|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
56755049|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
56755050|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755051|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755052|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56755053|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56755054|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755055|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56755056|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56755057|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
56755062|NCT00830882|Albuterol|albuterol|mesh-list
56755066|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755067|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56755068|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
56755069|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
56755070|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56755071|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56755072|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56755073|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56755074|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
56755075|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755076|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755077|NCT00823238|Tobramycin|tobramycin|mesh-list
56755078|NCT00823238|Ceftazidime|ceftazidime|mesh-list
56755079|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56755080|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755081|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
56755082|NCT00827684|Sirolimus|sirolimus|mesh-list
56755083|NCT00827684|Irinotecan|irinotecan|mesh-list
56755084|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56755085|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56755086|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755087|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755088|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755089|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56755090|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755091|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56755113|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755114|NCT00827840|Risperidone|risperidone|mesh-list
56755115|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56755116|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56755117|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
56755118|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755119|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755120|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755121|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56755122|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56755123|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755124|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56755125|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56755126|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
56755127|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56755128|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56755130|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56755131|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56755132|NCT00936780|Paclitaxel|paclitaxel|mesh-list
56755133|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56755134|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755135|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
56755136|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
56755137|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
56755138|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755139|NCT00823550|Lamivudine|lamivudine|mesh-list
56755140|NCT00823550|Entecavir|entecavir|mesh-list
56755141|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56755142|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56755145|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
56755158|NCT00828230|Budesonide|budesonide|mesh-list
56755159|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56755160|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56755161|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
56755162|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755163|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755164|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56755165|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
56755166|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
56755167|NCT00828230|Hormones|hormones|mesh-ancestor
56755168|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755169|NCT04469556|Leucovorin|leucovorin|mesh-list
56755170|NCT04469556|Gemcitabine|gemcitabine|mesh-list
56755171|NCT04469556|Paclitaxel|paclitaxel|mesh-list
56755172|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
56755173|NCT04469556|Irinotecan|irinotecan|mesh-list
56755174|NCT04469556|Folfirinox|folfirinox|mesh-list
56755175|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56755176|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755177|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56755178|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56755179|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56755180|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755181|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56755182|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
56755183|NCT04469556|Antiviral Agents|antiviral agents|mesh-ancestor
56755184|NCT04469556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755185|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755186|NCT04469556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755187|NCT04469556|Immunologic Factors|immunologic factors|mesh-ancestor
56755188|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755189|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56755191|NCT04469556|Antidotes|antidotes|mesh-ancestor
56755202|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
56755203|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
56755204|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755205|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56755206|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
56755207|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
56755208|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56755209|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
56755210|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755211|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755212|NCT03125811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56755213|NCT03125811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56755214|NCT03125811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56755215|NCT03125811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56755216|NCT00937092|Dopamine|dopamine|mesh-list
56755217|NCT00937092|Furosemide|furosemide|mesh-list
56755218|NCT00937092|Diuretics|diuretics|mesh-ancestor
56755219|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
56755220|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755221|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56755222|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56755223|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755224|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56755225|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
56755226|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
56755227|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755228|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
56755229|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755230|NCT00937092|Protective Agents|protective agents|mesh-ancestor
56755231|NCT04124601|Nivolumab|nivolumab|mesh-list
56755232|NCT04124601|Ipilimumab|ipilimumab|mesh-list
56755246|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56755247|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56755248|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755249|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
56755250|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56755251|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755252|NCT00931008|Docetaxel|docetaxel|mesh-list
56755253|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755254|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56755255|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56755256|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56755257|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755258|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
56755259|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56755260|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56755261|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755262|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56755263|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56755264|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755265|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755266|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755267|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56755268|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
56755269|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56755270|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755292|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
56755293|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56755294|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
56755295|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755296|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755297|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56755298|NCT00931086|Belimumab|belimumab|mesh-list
56755299|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755300|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
56755301|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755302|NCT04482621|Decitabine|decitabine|mesh-list
56755303|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56755304|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
56755305|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755306|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755307|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755308|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
56755309|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56755310|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
56755311|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56755312|NCT04453839|Protective Agents|protective agents|mesh-ancestor
56755313|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755314|NCT03977454|Ropivacaine|ropivacaine|mesh-list
56755315|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
56755316|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
56755317|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755318|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755319|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
56755320|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755321|NCT02549066|Milrinone|milrinone|mesh-list
56755322|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56755323|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56755324|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
56755325|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56755326|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56028005|NCT00806078|Analgesics|analgesics|mesh-ancestor
56755330|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466340|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56755331|NCT00831350|Ranibizumab|ranibizumab|mesh-list
56755332|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56755333|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56755334|NCT00831350|Growth Substances|growth substances|mesh-ancestor
56755335|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755336|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
56755337|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755338|NCT00938184|Paroxetine|paroxetine|mesh-list
56755339|NCT00938184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56755340|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56755341|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56755342|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755343|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755344|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
56755345|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755346|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56755347|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
56755348|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56755349|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56755350|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56755351|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755352|NCT00938262|Rifampin|rifampin|mesh-list
56755353|NCT00938262|Ketoconazole|ketoconazole|mesh-list
56755354|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56755355|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
56755356|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56755357|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755358|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
56755370|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56755371|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56755372|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
56755373|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755374|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755375|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56755376|NCT00933426|Paclitaxel|paclitaxel|mesh-list
56755377|NCT00933426|Lenalidomide|lenalidomide|mesh-list
56755378|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56755379|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755380|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
56755381|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
56755382|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
56755383|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755384|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
56755385|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755386|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56755387|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56755388|NCT00933426|Growth Substances|growth substances|mesh-ancestor
56755389|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
56755390|NCT04013958|Ketamine|ketamine|mesh-list
56755391|NCT04013958|Analgesics|analgesics|mesh-ancestor
56755392|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
56755393|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755394|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755395|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56755396|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56755397|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
56755398|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
56755399|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755400|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56755401|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56755402|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755403|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755406|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56755408|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
56755409|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755410|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755411|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56755412|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56755413|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
56755414|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56755415|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755416|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755417|NCT00938730|Warfarin|warfarin|mesh-list
56755418|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
56755419|NCT00933816|Fluorouracil|fluorouracil|mesh-list
56755420|NCT00933816|Sorafenib|sorafenib|mesh-list
56755421|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755422|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
56755423|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755424|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56755425|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755426|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
56755427|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755428|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56755429|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755430|NCT00538785|Palivizumab|palivizumab|mesh-list
56755431|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
56755432|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755433|NCT03334305|Vaccines|vaccines|mesh-list
56755434|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
56755435|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755436|NCT01563939|Remifentanil|remifentanil|mesh-list
56755437|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56755438|NCT01563939|Narcotics|narcotics|mesh-ancestor
56755453|NCT00990405|Clarithromycin|clarithromycin|mesh-list
56755454|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56755455|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755456|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56755457|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755458|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755459|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56755460|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56755461|NCT00990639|Candesartan|candesartan|mesh-list
56755462|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56755463|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56755464|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56755465|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755466|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
56755467|NCT03025035|Olaparib|olaparib|mesh-list
56755468|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56755469|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755470|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56755471|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755472|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755473|NCT03742947|Hemostatics|hemostatics|mesh-list
56755474|NCT03742947|Coagulants|coagulants|mesh-ancestor
56755475|NCT05359497|Liver Extracts|liver extracts|mesh-list
56755476|NCT05359497|Hematinics|hematinics|mesh-ancestor
56466496|NCT01248117|Ranibizumab|ranibizumab|mesh-list
56755477|NCT00990795|Cyclosporine|cyclosporine|mesh-list
56755478|NCT00990795|Cyclosporins|cyclosporins|mesh-list
56755479|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755480|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755481|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755495|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755496|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56755497|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56755498|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755499|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
56755500|NCT00831506|Digoxin|digoxin|mesh-list
56755501|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56755502|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56755503|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755504|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755505|NCT00831506|Protective Agents|protective agents|mesh-ancestor
56755506|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755507|NCT02842359|Irbesartan|irbesartan|mesh-list
56755508|NCT02842359|Atorvastatin|atorvastatin|mesh-list
56755509|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56755510|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56755511|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
56755512|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755513|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56755514|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56755515|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755516|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56755517|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56755518|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56755519|NCT02783625|Bortezomib|bortezomib|mesh-list
56755520|NCT02783625|Romidepsin|romidepsin|mesh-list
56755521|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755522|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56755523|NCT00828776|Heparin|heparin|mesh-list
56755524|NCT00828776|Calcium heparin|calcium heparin|mesh-list
56755525|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
56755539|NCT04043858|Midodrine|midodrine|mesh-list
56755540|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
56755541|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
56755542|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755543|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755544|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56755545|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56755546|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56755547|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56755548|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
56755549|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56466570|NCT05644717|Ertugliflozin|ertugliflozin|mesh-list
56755550|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755551|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56755552|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56755553|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
56755554|NCT00823862|Ribavirin|ribavirin|mesh-list
56755555|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
56755556|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755557|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
56755558|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755559|NCT00537771|Tamoxifen|tamoxifen|mesh-list
56755560|NCT00537771|Anastrozole|anastrozole|mesh-list
56755561|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56755562|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
56755563|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755564|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755565|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56755566|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755567|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56755568|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56755569|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56755570|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56755571|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56755572|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755573|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032645|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56755574|NCT03826563|Melatonin|melatonin|mesh-list
56755575|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
56755576|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755577|NCT03826563|Protective Agents|protective agents|mesh-ancestor
56755578|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755579|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755580|NCT00823940|Glucagon|glucagon|mesh-list
56755581|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56755582|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56755583|NCT00823940|Hormones|hormones|mesh-ancestor
56755584|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755585|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755586|NCT00823940|Incretins|incretins|mesh-ancestor
56755587|NCT00829322|Modafinil|modafinil|mesh-list
56755588|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56755589|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755590|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56755591|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56755592|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56755593|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755594|NCT00623480|Factor VIII|factor viii|mesh-list
56755595|NCT00623480|Coagulants|coagulants|mesh-ancestor
56755596|NCT02513667|Ceritinib|ceritinib|mesh-list
56755597|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755598|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56755599|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755600|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755601|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
56755603|NCT03823911|Ledipasvir|ledipasvir|mesh-list
56755619|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56755620|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56755621|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56755622|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56755623|NCT04003467|Teriparatide|teriparatide|mesh-list
56755624|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56466644|NCT01315249|Hormones|hormones|mesh-ancestor
56755625|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755626|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56755628|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56755629|NCT00832208|Amebicides|amebicides|mesh-ancestor
56755630|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56755631|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56755632|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755633|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56755634|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
56755635|NCT05361057|Cytarabine|cytarabine|mesh-list
56755636|NCT05361057|Azacitidine|azacitidine|mesh-list
56755637|NCT05361057|Daunorubicin|daunorubicin|mesh-list
56755638|NCT05361057|Venetoclax|venetoclax|mesh-list
56755639|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56755640|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
56755641|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755642|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755643|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
56755644|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755645|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755646|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
56755647|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755648|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755664|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56755665|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56755666|NCT00832364|Analgesics|analgesics|mesh-ancestor
56755667|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
56755668|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755669|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755670|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56755671|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56755672|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56755673|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755674|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
56755675|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
56755676|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
56755677|NCT00832442|Metoprolol|metoprolol|mesh-list
56755678|NCT00832442|Carvedilol|carvedilol|mesh-list
56755679|NCT00832442|Nebivolol|nebivolol|mesh-list
56755680|NCT00832442|Bisoprolol|bisoprolol|mesh-list
56755681|NCT00832442|Bucindolol|bucindolol|mesh-list
56755682|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56755683|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56755684|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56755685|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
56755686|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
56755687|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755688|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755689|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56755690|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56755691|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56755692|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755693|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755694|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
56755695|NCT00832442|Protective Agents|protective agents|mesh-ancestor
56755707|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
56755708|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56755709|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56755710|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56755711|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
56755712|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56755713|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755714|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56755715|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56755716|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56755717|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56755718|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755719|NCT00830492|Clomiphene|clomiphene|mesh-list
56755720|NCT00830492|Enclomiphene|enclomiphene|mesh-list
56755721|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
56755722|NCT00830492|Buserelin|buserelin|mesh-list
56755723|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56755724|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
56755725|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755726|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755727|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56755728|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
56755729|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56755730|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56755731|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56755732|NCT00830570|Warfarin|warfarin|mesh-list
56755733|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
56755734|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
56755735|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56755736|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56755737|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755738|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56755741|NCT04043702|Topiramate|topiramate|mesh-list
56755747|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
56755748|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56755749|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56755750|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56755751|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755752|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755753|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
56755754|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56755755|NCT02547350|Pirarubicin|pirarubicin|mesh-list
56755756|NCT02547350|Epirubicin|epirubicin|mesh-list
56755757|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755758|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56755759|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56755760|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56755761|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755762|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755763|NCT00838214|Prednisone|prednisone|mesh-list
56755764|NCT00838214|Budesonide|budesonide|mesh-list
56755765|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56755766|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
56755767|NCT00838214|Hormones|hormones|mesh-ancestor
56755768|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755769|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755770|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56755771|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755772|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56466791|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
56755773|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
56755774|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755775|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56755776|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
56755777|NCT00621764|Vaccines|vaccines|mesh-list
56755778|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
56755779|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755780|NCT00838370|Fluorouracil|fluorouracil|mesh-list
56755781|NCT00838370|Capecitabine|capecitabine|mesh-list
56755785|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755786|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56755787|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
56755788|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755789|NCT00537381|Prednisone|prednisone|mesh-list
56755790|NCT00537381|Docetaxel|docetaxel|mesh-list
56755791|NCT00537381|Intetumumab|intetumumab|mesh-list
56755792|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755793|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
56755794|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
56755795|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
56755796|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755797|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56755798|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
56755799|NCT00537381|Hormones|hormones|mesh-ancestor
56755800|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755801|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755802|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56755803|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56755804|NCT00833300|Haloperidol|haloperidol|mesh-list
56755805|NCT00833300|Olanzapine|olanzapine|mesh-list
56755806|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
56755807|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
56755808|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
56755809|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56755810|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755811|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56755812|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56755813|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56755814|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755815|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56755816|NCT00833300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56755817|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56755818|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56755819|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755820|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56755822|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56755823|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
56755824|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56755825|NCT00833378|Ritonavir|ritonavir|mesh-list
56755826|NCT00833378|Lopinavir|lopinavir|mesh-list
56755827|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56755828|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56755829|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
56755830|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755831|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755832|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56755833|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56755834|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
56755835|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755836|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56755837|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56755838|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56755845|NCT05359341|Hormones|hormones|mesh-ancestor
56755879|NCT00838838|Hormones|hormones|mesh-ancestor
56755880|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56755881|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755882|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56755883|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755884|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
56755885|NCT05360979|Endostatins|endostatins|mesh-list
56755886|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755887|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56755888|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56755889|NCT05360979|Growth Substances|growth substances|mesh-ancestor
56755890|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755891|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
56755892|NCT00833534|Rituximab|rituximab|mesh-list
56755893|NCT00833534|Lenalidomide|lenalidomide|mesh-list
56755894|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56755895|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755896|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
56755897|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755898|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56755899|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56755900|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56755901|NCT00833534|Growth Substances|growth substances|mesh-ancestor
56755902|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
56755903|NCT05591001|Ketamine|ketamine|mesh-list
56755904|NCT05591001|Propofol|propofol|mesh-list
56755905|NCT05591001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56755906|NCT05591001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56755907|NCT05591001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755908|NCT05591001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56755909|NCT05591001|Anesthetics, General|anesthetics, general|mesh-ancestor
56755910|NCT05591001|Anesthetics|anesthetics|mesh-ancestor
56755911|NCT05591001|Analgesics|analgesics|mesh-ancestor
56755912|NCT05591001|Sensory System Agents|sensory system agents|mesh-ancestor
56755919|NCT00517192|Ritonavir|ritonavir|mesh-list
56755920|NCT00517192|Darunavir|darunavir|mesh-list
56755921|NCT00517192|Tipranavir|tipranavir|mesh-list
56755922|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56755923|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56755924|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
56755925|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755926|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755927|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56755928|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56755929|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
56755930|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755931|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56755932|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56755933|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
56755934|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56755935|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755936|NCT00833768|Sevelamer|sevelamer|mesh-list
56755937|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
56755938|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
56755939|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755940|NCT00510484|Pancrelipase|pancrelipase|mesh-list
56755941|NCT00510484|Pancreatin|pancreatin|mesh-list
56755942|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56755943|NCT00839228|Perhexiline|perhexiline|mesh-list
56755944|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56755945|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56755949|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
56755967|NCT05590221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56755968|NCT05590143|Dapagliflozin|dapagliflozin|mesh-list
56755969|NCT05590143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56755970|NCT05590143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755971|NCT05590143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56755972|NCT05590143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56755973|NCT00622388|Ofatumumab|ofatumumab|mesh-list
56755974|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755975|NCT01156389|Ritonavir|ritonavir|mesh-list
56755976|NCT01156389|Artesunate|artesunate|mesh-list
56755977|NCT01156389|Pyronaridine|pyronaridine|mesh-list
56755978|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56755979|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56755980|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
56755981|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56755982|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56755983|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56755984|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56755985|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
56755986|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56755987|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56755988|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56755989|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
56755990|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56755991|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56755992|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56755993|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
56755994|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56755995|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
56755996|NCT04043624|Lidocaine|lidocaine|mesh-list
56755997|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
56756010|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56756011|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756012|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
56756013|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
56756014|NCT00625742|Ibuprofen|ibuprofen|mesh-list
56756015|NCT00625742|Atenolol|atenolol|mesh-list
56756016|NCT00625742|Melatonin|melatonin|mesh-list
56756017|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56756018|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56756019|NCT00625742|Analgesics|analgesics|mesh-ancestor
56756020|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
56756021|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756022|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756023|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756024|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756025|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56756026|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756027|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756028|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
56756029|NCT00625742|Protective Agents|protective agents|mesh-ancestor
56756030|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756031|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56756032|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56756033|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
56756034|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
56756035|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56756036|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56756037|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56756038|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
56756039|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756040|NCT05589441|Insulin|insulin|mesh-list
56756041|NCT05589441|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56756042|NCT05589441|Albuterol|albuterol|mesh-list
56756052|NCT05589441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56756053|NCT05589441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56756054|NCT05589441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56756055|NCT05589441|Adrenergic Agents|adrenergic agents|mesh-ancestor
56756056|NCT05589441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756057|NCT05589441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756058|NCT00825188|Amlodipine|amlodipine|mesh-list
56756059|NCT00825188|Eplerenone|eplerenone|mesh-list
56756060|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56756061|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56756062|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56756063|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756064|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56756065|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756066|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
56756067|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56756068|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
56756069|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756070|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56756071|NCT00825188|Diuretics|diuretics|mesh-ancestor
56756072|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
56756073|NCT05589363|Bupivacaine|bupivacaine|mesh-list
56756074|NCT05589363|Anesthetics, Local|anesthetics, local|mesh-ancestor
56756075|NCT05589363|Anesthetics|anesthetics|mesh-ancestor
56756076|NCT05589363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756077|NCT05589363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756078|NCT05589363|Sensory System Agents|sensory system agents|mesh-ancestor
56756079|NCT05589363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756080|NCT00834470|Atropine|atropine|mesh-list
56756095|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756096|NCT03997864|Prazosin|prazosin|mesh-list
56756097|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56756098|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56756099|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56756100|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56756101|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
56756102|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756103|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756104|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756105|NCT05407467|Curcumin|curcumin|mesh-list
56756106|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56756107|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56756108|NCT05407467|Analgesics|analgesics|mesh-ancestor
56756109|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
56756110|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756111|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756112|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756113|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756114|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756115|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756116|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756117|NCT01010152|Codeine|codeine|mesh-list
56756118|NCT01010152|Analgesics|analgesics|mesh-ancestor
56756119|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
56756120|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756121|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756122|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56756123|NCT01010152|Narcotics|narcotics|mesh-ancestor
56756124|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756137|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56756138|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56756139|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756140|NCT05407155|Paclitaxel|paclitaxel|mesh-list
56756141|NCT05407155|Bevacizumab|bevacizumab|mesh-list
56756142|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56756143|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756144|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
56756145|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
56756146|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
56756147|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756148|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56756149|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56756150|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56756152|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756153|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
56756154|NCT00840242|Nicotine|nicotine|mesh-list
56756155|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56756156|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
56756157|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756158|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756159|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56756160|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56756161|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
56756162|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756163|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756164|NCT00840398|Buspirone|buspirone|mesh-list
56756165|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56756166|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56756167|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756168|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756169|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56756170|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56756171|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
56756178|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56756179|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
56756180|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56756181|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756182|NCT02548286|Amlodipine|amlodipine|mesh-list
56756183|NCT02548286|Candesartan|candesartan|mesh-list
56756184|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56756185|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56756186|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56756187|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756188|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56756189|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756190|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
56756191|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56756192|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56756193|NCT05360433|Oxycodone|oxycodone|mesh-list
56756194|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56756195|NCT05360433|Narcotics|narcotics|mesh-ancestor
56756196|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756197|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756198|NCT05360433|Analgesics|analgesics|mesh-ancestor
56756199|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
56756200|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756201|NCT00834860|Ribavirin|ribavirin|mesh-list
56756202|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56756203|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
56756204|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756205|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
56756206|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756207|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
56756208|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56756209|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756210|NCT04696575|Lamivudine|lamivudine|mesh-list
56756211|NCT04696575|Carboplatin|carboplatin|mesh-list
56756212|NCT04696575|Etoposide|etoposide|mesh-list
56756218|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56756219|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56756220|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56756221|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756222|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467237|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56756223|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56756224|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56756225|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
56756226|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756227|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56756228|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56756229|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
56756230|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756231|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
56756232|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
56756233|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
56756234|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
56756235|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
56756236|NCT00825422|Ropivacaine|ropivacaine|mesh-list
56756237|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
56756238|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
56756239|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756240|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756241|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
56756242|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756243|NCT05558007|Tadalafil|tadalafil|mesh-list
56756244|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
56756245|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56756246|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56756247|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756248|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756258|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756259|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56756260|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56756261|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56756262|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756263|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
56756264|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756265|NCT02549924|Resveratrol|resveratrol|mesh-list
56756266|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
56756267|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756268|NCT02549924|Protective Agents|protective agents|mesh-ancestor
56756269|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756270|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756271|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56756272|NCT01813227|Dexamethasone|dexamethasone|mesh-list
56756273|NCT01813227|Rituximab|rituximab|mesh-list
56756274|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56756275|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756276|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
56756277|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756278|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756279|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756280|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
56756281|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
56756282|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756283|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56756284|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
56756285|NCT01813227|Hormones|hormones|mesh-ancestor
56756286|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56032646|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56032647|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032648|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032649|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032650|NCT05525273|Trametinib|trametinib|mesh-list
56032651|NCT05525273|Dabrafenib|dabrafenib|mesh-list
56032652|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032653|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56032654|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032655|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032656|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
56032657|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56032658|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032659|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56756287|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56756288|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
56756289|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756290|NCT00989469|Irinotecan|irinotecan|mesh-list
56756291|NCT00989469|Sorafenib|sorafenib|mesh-list
56756292|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56756293|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56756294|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756295|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756296|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756297|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56756299|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56756300|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56756301|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
56756302|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756303|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756304|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756305|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56756306|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56756307|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
56756308|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
56756309|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756310|NCT02548052|Betamethasone|betamethasone|mesh-list
56756311|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
56756312|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56756336|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
56756337|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
56756338|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756339|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56756340|NCT00825656|Capsaicin|capsaicin|mesh-list
56756341|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
56756342|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
56756343|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
56756344|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756345|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756346|NCT00989625|Naproxen|naproxen|mesh-list
56756347|NCT00989625|Sumatriptan|sumatriptan|mesh-list
56756348|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56756349|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56756350|NCT00989625|Analgesics|analgesics|mesh-ancestor
56756351|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
56756352|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756353|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756354|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756355|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756356|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
56756357|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56756358|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756359|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756360|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56756361|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56756362|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56756365|NCT00841256|Glycerol|glycerol|mesh-list
56756383|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756384|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56756385|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
56756386|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56756387|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756388|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
56756389|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756390|NCT00625586|Gemcitabine|gemcitabine|mesh-list
56756391|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56756392|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
56756393|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756394|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756395|NCT00625586|Antiviral Agents|antiviral agents|mesh-ancestor
56756396|NCT00625586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756397|NCT00625586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756398|NCT00625586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756399|NCT00625586|Immunologic Factors|immunologic factors|mesh-ancestor
56756400|NCT00625586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756401|NCT02547116|Rifampin|rifampin|mesh-list
56756402|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56756403|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
56756404|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56756418|NCT02549690|Hormones|hormones|mesh-ancestor
56756433|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756434|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756435|NCT00841724|Fludarabine|fludarabine|mesh-list
56756436|NCT00841724|Busulfan|busulfan|mesh-list
56756437|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
56756438|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756439|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756440|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756441|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
56756442|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756443|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
56756444|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56756445|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56756446|NCT00843362|Dinoprostone|dinoprostone|mesh-list
56756447|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
56756448|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56756449|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756450|NCT00841802|Prednisone|prednisone|mesh-list
56756451|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
56756452|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756453|NCT00841802|Hormones|hormones|mesh-ancestor
56756454|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756455|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756456|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56756457|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756458|NCT04446117|Prednisone|prednisone|mesh-list
56756459|NCT04446117|Atezolizumab|atezolizumab|mesh-list
56756460|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
56756461|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756462|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
56756463|NCT04446117|Hormones|hormones|mesh-ancestor
56756464|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756465|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029156|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56756472|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56756473|NCT00621140|Linagliptin|linagliptin|mesh-list
56756474|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56756475|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756476|NCT00621140|Incretins|incretins|mesh-ancestor
56756477|NCT00621140|Hormones|hormones|mesh-ancestor
56756478|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756479|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56756480|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
56756481|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756482|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756483|NCT00207727|Ustekinumab|ustekinumab|mesh-list
56756484|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
56756485|NCT00841880|Felodipine|felodipine|mesh-list
56756486|NCT00841880|Ramipril|ramipril|mesh-list
56756487|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56756488|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
56756489|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756490|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756491|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56756492|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56756493|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56756494|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56756495|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56756496|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756497|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
56756498|NCT00843440|Bevacizumab|bevacizumab|mesh-list
56756499|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56756500|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756501|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56756502|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56756503|NCT00843440|Growth Substances|growth substances|mesh-ancestor
56756504|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756505|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
56756506|NCT00504556|Warfarin|warfarin|mesh-list
56032693|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
56032694|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756507|NCT00504556|Edoxaban|edoxaban|mesh-list
56756508|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
56756509|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56756510|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
56756511|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56756512|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
56756513|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756514|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756515|NCT00206323|Topiramate|topiramate|mesh-list
56756516|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
56756517|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56756518|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756519|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
56756520|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56756521|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756522|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
56756523|NCT00842114|Interferons|interferons|mesh-list
56756525|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
56756526|NCT00842114|Vincristine|vincristine|mesh-list
56756527|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756528|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
56756529|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756530|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756531|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56756532|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
56756533|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756534|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756535|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56756536|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756537|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
56756538|NCT00842114|Hormones|hormones|mesh-ancestor
56756539|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756540|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56756541|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
56756542|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756543|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56756544|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
56032695|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
56032696|NCT04083755|Hematinics|hematinics|mesh-ancestor
56032697|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
56756545|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
56756546|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
56756547|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
56756548|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56756549|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756550|NCT00536991|Calcitriol|calcitriol|mesh-list
56756551|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56756552|NCT00536991|Ketoconazole|ketoconazole|mesh-list
56756553|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
56756554|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56756555|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56756556|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56756557|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756558|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
56756559|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756560|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56756561|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56756562|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756563|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756564|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56756565|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
56756566|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756567|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756568|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56756569|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56756570|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56756571|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56756572|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56756573|NCT00536991|Vitamins|vitamins|mesh-ancestor
56756574|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
56756575|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56756585|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56756586|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56756587|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56756588|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
56756589|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756590|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756591|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56756592|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56756593|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
56756594|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56756595|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56756596|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
56756597|NCT00504166|Alendronate|alendronate|mesh-list
56756598|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56756599|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756600|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
56756601|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56756602|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56756603|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56756604|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
56756605|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756606|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56756607|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56756608|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756609|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56756610|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56756611|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
56756612|NCT02546648|Coagulants|coagulants|mesh-ancestor
56756613|NCT00842504|Micafungin|micafungin|mesh-list
56756614|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
56756615|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756616|NCT00842582|Azacitidine|azacitidine|mesh-list
56756617|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56756622|NCT00843908|Imidacloprid|imidacloprid|mesh-list
56756625|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756626|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756627|NCT00842660|Gemcitabine|gemcitabine|mesh-list
56756628|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56756629|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
56756630|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756631|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756632|NCT00842660|Antiviral Agents|antiviral agents|mesh-ancestor
56756633|NCT00842660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756634|NCT00842660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756635|NCT00842660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756636|NCT00842660|Immunologic Factors|immunologic factors|mesh-ancestor
56756637|NCT00842660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756638|NCT04249622|Rifaximin|rifaximin|mesh-list
56756639|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56756685|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
56756686|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56756687|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756688|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
56756689|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756690|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756691|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756692|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
56756693|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
56756694|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756695|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56756696|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
56756697|NCT04688788|Hormones|hormones|mesh-ancestor
56756698|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56756699|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56756700|NCT04688788|Protective Agents|protective agents|mesh-ancestor
56756701|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56756702|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56756703|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56756704|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
56756705|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
56756706|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756707|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756708|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
56756709|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
56756710|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56756711|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756712|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756713|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
56756729|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
56756730|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756731|NCT00837044|Naproxen|naproxen|mesh-list
56756732|NCT00837044|Sumatriptan|sumatriptan|mesh-list
56756733|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56756734|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56756735|NCT00837044|Analgesics|analgesics|mesh-ancestor
56756736|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
56756737|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756738|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756739|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56756740|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56756741|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
56756742|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56756743|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756744|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756745|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56756746|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56756747|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56756748|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
56756749|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756750|NCT01013272|Lamivudine|lamivudine|mesh-list
56756751|NCT01013272|Entecavir|entecavir|mesh-list
56756752|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56756753|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56756754|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756755|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756756|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
56756757|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756758|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56756759|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56756760|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
56756761|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
56756762|NCT04232085|Melphalan|melphalan|mesh-list
56756770|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56756771|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
56756772|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756773|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756774|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56756775|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56756776|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756777|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56756778|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56756779|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
56756780|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56756781|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756782|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56756783|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
56756784|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56756785|NCT01010698|Acyclovir|acyclovir|mesh-list
56756786|NCT01010698|Cimetidine|cimetidine|mesh-list
56756787|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
56756788|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756789|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56756790|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56756791|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56756792|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
56756793|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
56756794|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756795|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756796|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756797|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56756798|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56756799|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756800|NCT03541486|Gemcitabine|gemcitabine|mesh-list
56756801|NCT03541486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756802|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56756809|NCT03541486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756810|NCT03541486|Immunologic Factors|immunologic factors|mesh-ancestor
56756811|NCT04893291|Sirolimus|sirolimus|mesh-list
56756812|NCT04893291|Everolimus|everolimus|mesh-list
56756813|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756814|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756815|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
56756816|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756817|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56756818|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756819|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56756820|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
56756821|NCT00620750|Naltrexone|naltrexone|mesh-list
56756822|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56756823|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56756824|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756825|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
56756826|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756827|NCT04867707|Zanamivir|zanamivir|mesh-list
56756828|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
56756829|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756830|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756831|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756832|NCT02547896|Diclofenac|diclofenac|mesh-list
56756833|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56756860|NCT01564251|Immunologic Factors|immunologic factors|mesh-ancestor
56756861|NCT01564251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756862|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56756863|NCT00508144|Pemetrexed|pemetrexed|mesh-list
56756864|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756865|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756866|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756867|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56756868|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56756869|NCT05357547|Buspirone|buspirone|mesh-list
56756870|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56756871|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56756872|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756873|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756874|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56756875|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56756876|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
56756877|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56756878|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756879|NCT00844454|Ethanol|ethanol|mesh-list
56756880|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56756881|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756882|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756883|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756884|NCT02545712|Ethanol|ethanol|mesh-list
56756910|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756911|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56756912|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
56756913|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56756914|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
56756915|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56756916|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
56756917|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756918|NCT00851708|Expectorants|expectorants|mesh-ancestor
56756919|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
56756920|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56756921|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
56756922|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756923|NCT00851708|Protective Agents|protective agents|mesh-ancestor
56756924|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756925|NCT00851708|Antidotes|antidotes|mesh-ancestor
56756926|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
56756927|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56756928|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
56756929|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756930|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
56756931|NCT05018481|Protective Agents|protective agents|mesh-ancestor
56756932|NCT01011166|Ribavirin|ribavirin|mesh-list
56756933|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56756934|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
56756935|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756936|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
56756937|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756938|NCT00621842|Lamotrigine|lamotrigine|mesh-list
56756939|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
56756940|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56756941|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56756942|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756943|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56756944|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756945|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56032698|NCT04372082|Niclosamide|niclosamide|mesh-list
56032699|NCT04372082|Diltiazem|diltiazem|mesh-list
56756946|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56756947|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756948|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56756949|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56756950|NCT04849455|Morphine|morphine|mesh-list
56756951|NCT04849455|Ropivacaine|ropivacaine|mesh-list
56756952|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
56756953|NCT04849455|Anesthetics|anesthetics|mesh-list
56756954|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56756955|NCT04849455|Narcotics|narcotics|mesh-ancestor
56756956|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56756957|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756958|NCT04849455|Analgesics|analgesics|mesh-ancestor
56756959|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
56756960|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56756961|NCT02545010|Paclitaxel|paclitaxel|mesh-list
56756962|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56756963|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756964|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
56756965|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
56756966|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
56756967|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756968|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56756969|NCT01013506|Letrozole|letrozole|mesh-list
56756970|NCT01013506|Goserelin|goserelin|mesh-list
56756971|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756972|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56756973|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756974|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56756975|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56756976|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56756983|NCT00844688|Sorafenib|sorafenib|mesh-list
56756989|NCT00844688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56756990|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756991|NCT00844688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56756992|NCT00844688|Immunologic Factors|immunologic factors|mesh-ancestor
56756993|NCT00844688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56756994|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56756995|NCT04541680|Nintedanib|nintedanib|mesh-list
56756996|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56756997|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56756998|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56756999|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757000|NCT00855530|Amibegron|amibegron|mesh-list
56757001|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56757002|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56757003|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
56757004|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757005|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757006|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757007|NCT00855608|Adalimumab|adalimumab|mesh-list
56757008|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757009|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56757010|NCT00851864|Tinzaparin|tinzaparin|mesh-list
56757011|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56757012|NCT00851864|Dalteparin|dalteparin|mesh-list
56757013|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
56757014|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56757015|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56757018|NCT00851942|Hormones|hormones|mesh-ancestor
56757038|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
56757039|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757040|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757041|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757042|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56757043|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56757044|NCT00619112|Temozolomide|temozolomide|mesh-list
56757045|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56468054|NCT04514094|Fluorides|fluorides|mesh-list
56757046|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
56757047|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757048|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757049|NCT03457701|Iron|iron|mesh-list
56757050|NCT03457701|Trace Elements|trace elements|mesh-ancestor
56757051|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
56757052|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757053|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
56757095|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757096|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
56757097|NCT05246943|Coagulants|coagulants|mesh-ancestor
56757098|NCT00852410|Lidocaine|lidocaine|mesh-list
56757099|NCT00852410|Epinephrine|epinephrine|mesh-list
56757100|NCT00852410|Racepinephrine|racepinephrine|mesh-list
56757101|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
56757102|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
56757103|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
56757104|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757105|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757106|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
56757107|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757108|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56757109|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56757110|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56757111|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56757112|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757113|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56757114|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56757115|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
56757116|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757117|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56757118|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56757119|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
56757144|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757145|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
56757146|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757147|NCT00856310|Fasinumab|fasinumab|mesh-list
56757148|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56757149|NCT00856310|Analgesics|analgesics|mesh-ancestor
56757150|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
56757151|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757152|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757153|NCT02773485|Gemcitabine|gemcitabine|mesh-list
56757154|NCT02773485|Cisplatin|cisplatin|mesh-list
56757155|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757156|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757157|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
56757158|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757159|NCT02773485|Antiviral Agents|antiviral agents|mesh-ancestor
56757160|NCT02773485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757161|NCT02773485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757162|NCT02773485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757163|NCT02773485|Immunologic Factors|immunologic factors|mesh-ancestor
56757164|NCT02773485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757165|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
56757166|NCT04042220|Hormones|hormones|mesh-ancestor
56757167|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757168|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757169|NCT00992355|Tobramycin|tobramycin|mesh-list
56757170|NCT00992355|Dexamethasone|dexamethasone|mesh-list
56757171|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
56757172|NCT00992355|Ketorolac|ketorolac|mesh-list
56757173|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56757174|NCT00992355|BB 1101|bb 1101|mesh-list
56757175|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757176|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
56757188|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757189|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56757190|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56757191|NCT00992355|Analgesics|analgesics|mesh-ancestor
56757192|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
56757193|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56757194|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56757195|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56757196|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757197|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
56757198|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56468205|NCT00485238|Diuretics|diuretics|mesh-ancestor
56757199|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
56757201|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757202|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56757203|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757204|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757205|NCT00856622|Timolol|timolol|mesh-list
56757206|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56757207|NCT00856622|Latanoprost|latanoprost|mesh-list
56757208|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56757209|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56757210|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56757211|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
56757212|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757213|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757214|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757215|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56757216|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56757217|NCT00856700|Incretins|incretins|mesh-list
56757218|NCT00856700|Hormones|hormones|mesh-ancestor
56757221|NCT00618956|Milnacipran|milnacipran|mesh-list
56757229|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56757230|NCT00618956|Analgesics|analgesics|mesh-ancestor
56757231|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
56757232|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757233|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
56757234|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56757235|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56757236|NCT00845546|Loratadine|loratadine|mesh-list
56757237|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
56757238|NCT00845546|Ephedrine|ephedrine|mesh-list
56757239|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
56757240|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
56757241|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56757242|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56757243|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56757244|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
56757245|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
56757246|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757247|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757248|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757249|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56757250|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
56757251|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757252|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56757253|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
56757254|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
56757255|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56757256|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56757257|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
56757258|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56757274|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757275|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56757276|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56757277|NCT02592863|Protective Agents|protective agents|mesh-ancestor
56757278|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757279|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
56757280|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56757281|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
56757282|NCT00719537|Aspirin|aspirin|mesh-list
56757283|NCT00719537|Progesterone|progesterone|mesh-list
56757284|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56757285|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56757286|NCT00719537|Analgesics|analgesics|mesh-ancestor
56757287|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
56757288|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757289|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757290|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757291|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56757292|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56757293|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56757294|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757295|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56757296|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56757297|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757298|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
56757299|NCT00719537|Progestins|progestins|mesh-ancestor
56757300|NCT00719537|Hormones|hormones|mesh-ancestor
56757301|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757302|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
56757303|NCT00853190|Hydrocodone|hydrocodone|mesh-list
56757305|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56757316|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56757317|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
56757318|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
56757319|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757320|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56757321|NCT02590601|Bromocriptine|bromocriptine|mesh-list
56757322|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56757323|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56757324|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
56757325|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757326|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757327|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
56757328|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
56757329|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757330|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757331|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
56757332|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
56757333|NCT00573794|Adalimumab|adalimumab|mesh-list
56757334|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757335|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56757336|NCT00715793|Temozolomide|temozolomide|mesh-list
56757337|NCT00715793|Decitabine|decitabine|mesh-list
56757338|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56757339|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
56757340|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757341|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757342|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757343|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
56757344|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757345|NCT00924014|Furosemide|furosemide|mesh-list
56757346|NCT00924014|Conivaptan|conivaptan|mesh-list
56757347|NCT00924014|Diuretics|diuretics|mesh-ancestor
56757348|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
56757349|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757350|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56757357|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757358|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757359|NCT00853268|Analgesics|analgesics|mesh-ancestor
56757360|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
56757361|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757362|NCT00845780|Amiodarone|amiodarone|mesh-list
56757363|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56757364|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
56757365|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56757366|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56757367|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757368|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56757369|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56757370|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56757371|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757372|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56757373|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56757374|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56757375|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
56757376|NCT00853502|Testosterone|testosterone|mesh-list
56757377|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
56757378|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
56757379|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56757380|NCT00853502|Androgens|androgens|mesh-ancestor
56757381|NCT00853502|Hormones|hormones|mesh-ancestor
56757382|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757383|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757384|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56757385|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757386|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
56757387|NCT00853736|Oxycodone|oxycodone|mesh-list
56032700|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
56032701|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56032762|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032763|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56032764|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032766|NCT02488980|Tafenoquine|tafenoquine|mesh-list
56190401|NCT01468038|Trazodone|trazodone|mesh-list
56190402|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56190403|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56032773|NCT04371224|Capecitabine|capecitabine|mesh-list
56032774|NCT04371224|Irinotecan|irinotecan|mesh-list
56757388|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56757389|NCT00853736|Narcotics|narcotics|mesh-ancestor
56757390|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757391|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757392|NCT00853736|Analgesics|analgesics|mesh-ancestor
56757393|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
56757394|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757395|NCT00857168|Testosterone|testosterone|mesh-list
56757396|NCT00857168|Androgens|androgens|mesh-ancestor
56757397|NCT00857168|Hormones|hormones|mesh-ancestor
56757398|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757399|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757400|NCT00857324|Vorinostat|vorinostat|mesh-list
56757401|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757402|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56757403|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757404|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757405|NCT00853892|Oxycodone|oxycodone|mesh-list
56757406|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56757407|NCT00853892|Narcotics|narcotics|mesh-ancestor
56757408|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757409|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757410|NCT00853892|Analgesics|analgesics|mesh-ancestor
56757411|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
56757412|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757413|NCT04164212|Vaccines|vaccines|mesh-list
56757414|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
56757415|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757416|NCT00857558|Saxagliptin|saxagliptin|mesh-list
56757417|NCT00857558|Incretins|incretins|mesh-ancestor
56757418|NCT00857558|Hormones|hormones|mesh-ancestor
56757419|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56468423|NCT00489983|Antiviral Agents|antiviral agents|mesh-ancestor
56757429|NCT00715559|Cysteamine|cysteamine|mesh-list
56757430|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56757431|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757432|NCT05289869|Oxytocin|oxytocin|mesh-list
56757433|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
56757434|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56757435|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757436|NCT00620282|Liraglutide|liraglutide|mesh-list
56757437|NCT00620282|Glimepiride|glimepiride|mesh-list
56757438|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56757439|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757440|NCT00620282|Incretins|incretins|mesh-ancestor
56757441|NCT00620282|Hormones|hormones|mesh-ancestor
56757442|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757443|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56757444|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757445|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
56757446|NCT05684861|Isotretinoin|isotretinoin|mesh-list
56757447|NCT05684861|Dermatologic Agents|dermatologic agents|mesh-ancestor
56757448|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
56757449|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56757450|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56757451|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757452|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
56757453|NCT04042688|Coagulants|coagulants|mesh-ancestor
56757454|NCT02590133|Fluorouracil|fluorouracil|mesh-list
56757455|NCT02590133|Endostar protein|endostar protein|mesh-list
56757456|NCT02590133|Endostatins|endostatins|mesh-list
56757457|NCT02590133|Nedaplatin|nedaplatin|mesh-list
56757458|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
56757459|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757460|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757461|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757462|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757463|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
56757464|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757467|NCT02590133|Growth Substances|growth substances|mesh-ancestor
56757469|NCT00854204|Darunavir|darunavir|mesh-list
56757470|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56757471|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56757472|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
56757473|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757474|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757475|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56757476|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56757477|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
56757478|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757479|NCT00857870|Metformin|metformin|mesh-list
56757480|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
56757481|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56757482|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757483|NCT00848432|Risperidone|risperidone|mesh-list
56757484|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56757485|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
56757486|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757487|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757488|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757489|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56757490|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56757491|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757492|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56757493|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56757494|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
56757495|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56757496|NCT00854750|Hormones|hormones|mesh-ancestor
56923655|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757497|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757498|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757499|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56757500|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
56757501|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56757502|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030178|NCT01550471|Ciclesonide|ciclesonide|mesh-list
56032775|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
56032776|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757503|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
56757504|NCT00858338|Floxuridine|floxuridine|mesh-list
56757505|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757506|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
56757507|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757508|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757509|NCT00515086|Everolimus|everolimus|mesh-list
56757510|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757511|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757512|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
56757513|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757514|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
56757515|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757516|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56757517|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757518|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757519|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56757520|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56757521|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56757522|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
56757523|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757524|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56757525|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56757526|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757527|NCT00849368|Azathioprine|azathioprine|mesh-list
56757528|NCT00849368|Allopurinol|allopurinol|mesh-list
56757529|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
56757530|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757531|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757532|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
56757533|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56757534|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56757546|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56757547|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
56757548|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757549|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757550|NCT02544854|Propofol|propofol|mesh-list
56757551|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56757552|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757553|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757554|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56757555|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
56757556|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
56757557|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
56757558|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
56757559|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757560|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757561|NCT02544776|Amlodipine|amlodipine|mesh-list
56757562|NCT02544776|Clomiphene|clomiphene|mesh-list
56757563|NCT02544776|Enclomiphene|enclomiphene|mesh-list
56757564|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
56757565|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757566|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56757567|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56757568|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56757569|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56468567|NCT00490412|Vitamin D|vitamin d|mesh-list
56757570|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757571|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
56757572|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56757573|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
56757574|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757575|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56757587|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56757588|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56757589|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757590|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
56757591|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56757592|NCT00859274|Budesonide|budesonide|mesh-list
56757593|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757594|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56757595|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
56757596|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757597|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757598|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56757599|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
56757600|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
56757601|NCT00859274|Hormones|hormones|mesh-ancestor
56757602|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757603|NCT00859352|Midazolam|midazolam|mesh-list
56757604|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56757605|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56757606|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757607|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757608|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56757609|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56757610|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56757611|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56757612|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
56757613|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
56757614|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
56757615|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
56757616|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757617|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757618|NCT00861926|Beclomethasone|beclomethasone|mesh-list
56757619|NCT00861926|Albuterol|albuterol|mesh-list
56757620|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
56757629|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56757630|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
56757631|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757632|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757633|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
56757634|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56757635|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757636|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
56757637|NCT00861926|Hormones|hormones|mesh-ancestor
56757638|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757639|NCT00849992|Imiquimod|imiquimod|mesh-list
56757640|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56757641|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
56757642|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757643|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757644|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
56757645|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
56757646|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56757647|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56757648|NCT02544698|Vaccines|vaccines|mesh-list
56757649|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
56757650|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757651|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
56757652|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56757653|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
56757654|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757655|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757656|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56757657|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
56757658|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56757659|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56757672|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56757673|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56757674|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
56757675|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757676|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757677|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56757678|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56757679|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
56757680|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56757681|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757682|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
56757683|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757684|NCT00850382|Cytarabine|cytarabine|mesh-list
56757685|NCT00850382|Daunorubicin|daunorubicin|mesh-list
56757686|NCT00850382|Dasatinib|dasatinib|mesh-list
56757687|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757688|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
56757689|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757690|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757691|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
56757692|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757693|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757694|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
56757695|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757696|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56757697|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56757698|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56757699|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757700|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56757701|NCT00860366|Uric Acid|uric acid|mesh-list
56757702|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
56757703|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757714|NCT00507442|Dexamethasone|dexamethasone|mesh-list
56757715|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
56757716|NCT00507442|Lenalidomide|lenalidomide|mesh-list
56757717|NCT00507442|Bortezomib|bortezomib|mesh-list
56757718|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757719|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
56757720|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757721|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56468715|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
56757722|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56757723|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
56757724|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757725|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757726|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56757727|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757728|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
56757729|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
56757730|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757731|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56757732|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
56757733|NCT00507442|Hormones|hormones|mesh-ancestor
56757734|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757735|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56757736|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56757737|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56757738|NCT00507442|Growth Substances|growth substances|mesh-ancestor
56757739|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
56757740|NCT00862706|Telbivudine|telbivudine|mesh-list
56757741|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
56757742|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757743|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56757744|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757745|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757746|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56757747|NCT04041362|UB-421|ub-421|mesh-list
56032777|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56032778|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032779|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56032780|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
55804793|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
56757748|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
56757749|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757750|NCT00850850|Physostigmine|physostigmine|mesh-list
56757751|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56757752|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757753|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757754|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
56757755|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757756|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757757|NCT00850850|Miotics|miotics|mesh-ancestor
56757758|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
56757759|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757760|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56757761|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
56757762|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56757763|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56757764|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56757765|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56757766|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757767|NCT00861068|Lacosamide|lacosamide|mesh-list
56757768|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
56757769|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56757770|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56757771|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56757772|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757773|NCT00863096|Vaccines|vaccines|mesh-list
56757776|NCT00870272|Misoprostol|misoprostol|mesh-list
56757795|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56757796|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757797|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
56757798|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757799|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56757800|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56757801|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
56757802|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56757803|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757804|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
56757805|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757806|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
56757807|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757808|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56757809|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757810|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56757811|NCT00865436|Metformin|metformin|mesh-list
56757812|NCT00865436|Glyburide|glyburide|mesh-list
56757813|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56757814|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757815|NCT00715403|Nintedanib|nintedanib|mesh-list
56757816|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757817|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56757818|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757819|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757820|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
56757821|NCT01013584|Vitamin D|vitamin d|mesh-list
56757822|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56757823|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757824|NCT01013584|Vitamins|vitamins|mesh-ancestor
56757825|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
56757826|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56757827|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
56757836|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
56757837|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757838|NCT00864188|Protective Agents|protective agents|mesh-ancestor
56757839|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757840|NCT00864188|Provitamins|provitamins|mesh-ancestor
56757841|NCT00864188|Vitamins|vitamins|mesh-ancestor
56757842|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
56757843|NCT00865670|Azithromycin|azithromycin|mesh-list
56757844|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56757845|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757846|NCT00864344|Sertraline|sertraline|mesh-list
56757847|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
56757848|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56757849|NCT00864344|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56757850|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56757851|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56757852|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757853|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757854|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
56757855|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757856|NCT00864500|Clobetasol|clobetasol|mesh-list
56757857|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56757858|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
56757859|NCT00864500|Hormones|hormones|mesh-ancestor
56757860|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757861|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757862|NCT05179421|Oxytocin|oxytocin|mesh-list
56757863|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
56757864|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56757865|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757866|NCT00864734|Metformin|metformin|mesh-list
56757867|NCT00864734|Glyburide|glyburide|mesh-list
56757868|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56757869|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757870|NCT00864812|Fluticasone|fluticasone|mesh-list
56757878|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757879|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757880|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56757881|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
56757882|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
56757883|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56757884|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
56757885|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56757886|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
56757887|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757888|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757889|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56757890|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56757891|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56757892|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
56757893|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
56757894|NCT00864812|Hormones|hormones|mesh-ancestor
56757895|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56757896|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
56757897|NCT02590055|Gemcitabine|gemcitabine|mesh-list
56757898|NCT02590055|Docetaxel|docetaxel|mesh-list
56757899|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757900|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
56757901|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757902|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757903|NCT02590055|Antiviral Agents|antiviral agents|mesh-ancestor
56757904|NCT02590055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56757905|NCT02590055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757906|NCT02590055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56757907|NCT02590055|Immunologic Factors|immunologic factors|mesh-ancestor
56757908|NCT02590055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757909|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
56757910|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
56757911|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
56757912|NCT00864890|Dexetimide|dexetimide|mesh-list
56757917|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757918|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757919|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
56757920|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757921|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56757922|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
56757923|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56757924|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56757925|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56757926|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
56757927|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
56757928|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56757929|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56757930|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56757931|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
56757932|NCT00919295|Mirtazapine|mirtazapine|mesh-list
56757933|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
56757934|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56757935|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56757936|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
56757937|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
56757938|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757939|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757940|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757941|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56757942|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56757952|NCT00865748|Metformin|metformin|mesh-list
56757962|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56757963|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
56757964|NCT00866060|Memantine|memantine|mesh-list
56757965|NCT00866060|Donepezil|donepezil|mesh-list
56757966|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56757967|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56757968|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56757969|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
56757970|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56757971|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757972|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
56757973|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56757974|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56757975|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
56757976|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56757977|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56757978|NCT00871052|Vitamin D|vitamin d|mesh-list
56757979|NCT00871052|Calcipotriene|calcipotriene|mesh-list
56757980|NCT00871052|Vitamins|vitamins|mesh-ancestor
56757981|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
56757982|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757983|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56757984|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
56757985|NCT00502840|Rituximab|rituximab|mesh-list
56757986|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56757987|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757988|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
56757989|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56757990|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56757991|NCT00514540|Carboplatin|carboplatin|mesh-list
56757992|NCT00514540|Docetaxel|docetaxel|mesh-list
56757993|NCT00514540|Etoposide|etoposide|mesh-list
56757994|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56757995|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
56757996|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
56757997|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
56757998|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804890|NCT03542461|Nivolumab|nivolumab|mesh-list
56758001|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56758002|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758003|NCT00506662|Insulin|insulin|mesh-list
56758004|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56758005|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
56758006|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
56758007|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
56758008|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
56758009|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56758010|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758011|NCT03121534|Dexamethasone|dexamethasone|mesh-list
56758012|NCT03121534|Nivolumab|nivolumab|mesh-list
56758013|NCT03121534|Blinatumomab|blinatumomab|mesh-list
56758014|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56758015|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
56758016|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
56758017|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758018|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758019|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56758020|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
56758021|NCT03121534|Hormones|hormones|mesh-ancestor
56758022|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758023|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56758024|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758025|NCT03121534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56758026|NCT03121534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56758027|NCT03121534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758028|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56758030|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56758031|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
56758032|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758033|NCT04615624|Furosemide|furosemide|mesh-list
56758034|NCT04615624|Diuretics|diuretics|mesh-ancestor
56758045|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758046|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758047|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56758048|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758049|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758050|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
56758051|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
56758052|NCT00513682|Pancrelipase|pancrelipase|mesh-list
56758053|NCT00513682|Pancreatin|pancreatin|mesh-list
56758054|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56758055|NCT05171387|Androgens|androgens|mesh-list
56758056|NCT05171387|Hormones|hormones|mesh-ancestor
56758057|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758058|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758059|NCT00493012|Vitamin D|vitamin d|mesh-list
56758060|NCT00493012|Vitamins|vitamins|mesh-ancestor
56758061|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
56758062|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758063|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56758064|NCT00918593|Bleomycin|bleomycin|mesh-list
56758065|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56758066|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758067|NCT04485130|Disulfiram|disulfiram|mesh-list
56758068|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56758069|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56758070|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758071|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758072|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
56758073|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
56758074|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
56758075|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758090|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56758091|NCT05330429|Growth Substances|growth substances|mesh-ancestor
56758092|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758093|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
56758094|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
56758095|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758096|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56758097|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758098|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
56758099|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56758100|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56758101|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758102|NCT05330429|Antidotes|antidotes|mesh-ancestor
56758103|NCT05330429|Protective Agents|protective agents|mesh-ancestor
56758104|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
56758105|NCT05330429|Vitamins|vitamins|mesh-ancestor
56758106|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
56758107|NCT05684705|Rifabutin|rifabutin|mesh-list
56758108|NCT05684705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758109|NCT05684705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758110|NCT05684705|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56758111|NCT05684705|Antitubercular Agents|antitubercular agents|mesh-ancestor
56758112|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
56758113|NCT05238233|Pilocarpine|pilocarpine|mesh-list
56758114|NCT05238233|Tropicamide|tropicamide|mesh-list
56758115|NCT05238233|Miotics|miotics|mesh-ancestor
56758116|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
56758117|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758118|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758119|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56758120|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56758121|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
56758122|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758123|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758124|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
56758132|NCT05232851|Vaccines|vaccines|mesh-list
56758133|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
56758134|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758135|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56758136|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758137|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
56758138|NCT05311475|Azelastine|azelastine|mesh-list
56758139|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56758140|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
56758141|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56758142|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56758143|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
56758144|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758145|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758146|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56758147|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
56758148|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56758149|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758150|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758151|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56758152|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56758153|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
56758154|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
56758155|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758156|NCT00617708|Gemcitabine|gemcitabine|mesh-list
56758157|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56758158|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56758159|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56758160|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
56758163|NCT00617708|Antiviral Agents|antiviral agents|mesh-ancestor
56758176|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758177|NCT00864968|Nabumetone|nabumetone|mesh-list
56923657|NCT03626064|Nicotine|nicotine|mesh-list
56758178|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56758179|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56758180|NCT00864968|Analgesics|analgesics|mesh-ancestor
56758181|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
56758182|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758183|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758184|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56758185|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56758186|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56758187|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56758188|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758189|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758190|NCT00876044|Aflibercept|aflibercept|mesh-list
56758191|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56758192|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56758193|NCT00876044|Growth Substances|growth substances|mesh-ancestor
56758194|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758195|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
56758196|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758197|NCT00866216|Azithromycin|azithromycin|mesh-list
56758198|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758199|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758200|NCT00871208|Retapamulin|retapamulin|mesh-list
56758201|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
56758220|NCT05113745|Reboxetine|reboxetine|mesh-list
56758221|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
56758222|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56758223|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56758224|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56758225|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758226|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758227|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
56758228|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758229|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758230|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
56758231|NCT00866450|Calcium|calcium|mesh-list
56758232|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56758233|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758234|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56758235|NCT03894969|Vaccines|vaccines|mesh-list
56758236|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
56758237|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758238|NCT00876434|Sirolimus|sirolimus|mesh-list
56758239|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758240|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758241|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56758242|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758243|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
56758244|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758245|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
56758246|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758247|NCT00871442|Fentanyl|fentanyl|mesh-list
56758248|NCT00871442|Bupivacaine|bupivacaine|mesh-list
56758249|NCT00871442|Anesthetics|anesthetics|mesh-list
56758250|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
56758251|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758252|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758253|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
56758254|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758255|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56758256|NCT00871442|Narcotics|narcotics|mesh-ancestor
56032781|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032782|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56758257|NCT00871442|Analgesics|analgesics|mesh-ancestor
56758258|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56758259|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56758260|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
56758261|NCT05355597|Clonidine|clonidine|mesh-list
56758262|NCT05355597|Epinephrine|epinephrine|mesh-list
56758263|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56758264|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56758265|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
56758266|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758267|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758268|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758269|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56758270|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56758271|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
56758272|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758273|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56758274|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
56758275|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
56758276|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
56758277|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56758278|NCT05355597|Analgesics|analgesics|mesh-ancestor
56758279|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
56758280|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56758281|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
56758282|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56758283|NCT00866528|Paclitaxel|paclitaxel|mesh-list
56758284|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56758285|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758286|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
56758287|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
56758288|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
56758290|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56758299|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758300|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56758301|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56758302|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
56758303|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758304|NCT00992667|Protective Agents|protective agents|mesh-ancestor
56758305|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758306|NCT05171972|Ofatumumab|ofatumumab|mesh-list
56758307|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758309|NCT00992823|Trace Elements|trace elements|mesh-ancestor
56758310|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
56758311|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758312|NCT03894813|Metronidazole|metronidazole|mesh-list
56758313|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758314|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758315|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56758316|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56758317|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
56758318|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56758319|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
56758320|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758321|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758322|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56758323|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
56758324|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
56758325|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56469322|NCT01299961|Abatacept|abatacept|mesh-list
56758326|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
56758327|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758328|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758329|NCT00876824|Amphotericin B|amphotericin b|mesh-list
56758330|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56758331|NCT00876824|Amebicides|amebicides|mesh-ancestor
56758332|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56758333|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56758334|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758335|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758339|NCT00866684|Azathioprine|azathioprine|mesh-list
56758340|NCT00866684|Tacrolimus|tacrolimus|mesh-list
56758341|NCT00866684|Cyclosporins|cyclosporins|mesh-list
56758342|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758343|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
56758344|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758345|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56758346|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758347|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758348|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
56758349|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758350|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
56758351|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56758352|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56758353|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758354|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56758355|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
56758356|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56758357|NCT05211947|BI 425809|bi 425809|mesh-list
56758358|NCT05211947|Nootropic Agents|nootropic agents|mesh-ancestor
56758359|NCT00993057|Insulin|insulin|mesh-list
56758360|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56758361|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758362|NCT00866762|Vorinostat|vorinostat|mesh-list
56758363|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56758364|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758365|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758366|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758367|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
56758368|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56758385|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758386|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758387|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
56758388|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758389|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56758390|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758391|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
56758392|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56758393|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56758394|NCT00866996|Methylphenidate|methylphenidate|mesh-list
56758395|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56758396|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56758397|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758398|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56758399|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56758400|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758401|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758402|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
56758403|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758404|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56758405|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56758407|NCT00871910|Ondansetron|ondansetron|mesh-list
56758408|NCT00871910|Aprepitant|aprepitant|mesh-list
56758409|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56758410|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
56758411|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
56758412|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758413|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758414|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56758415|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
56758416|NCT00871910|Hormones|hormones|mesh-ancestor
56758417|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758418|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56758419|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758420|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
56758421|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56758422|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56758423|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
56758424|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758425|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758426|NCT00871910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56758427|NCT00871910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56758428|NCT00871910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758429|NCT00871910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56758430|NCT00871910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56758431|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56758432|NCT05355441|Analgesics|analgesics|mesh-list
56758433|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
56758434|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758435|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758436|NCT05155436|Amlodipine|amlodipine|mesh-list
56758437|NCT05155436|Telmisartan|telmisartan|mesh-list
56758438|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56758439|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56758440|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758441|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758442|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56758443|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758444|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
56758445|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56758446|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56758447|NCT01564329|Endostar protein|endostar protein|mesh-list
56758448|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56758449|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56758450|NCT01564329|Growth Substances|growth substances|mesh-ancestor
56758451|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758452|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
56758453|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758454|NCT05213481|Tepotinib|tepotinib|mesh-list
56758461|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56758462|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56758463|NCT05213481|Analgesics|analgesics|mesh-ancestor
56758464|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
56758465|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758466|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56758467|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758468|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758469|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56758470|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56758471|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758472|NCT00993525|Ranibizumab|ranibizumab|mesh-list
56758473|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56758474|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56758475|NCT00993525|Growth Substances|growth substances|mesh-ancestor
56758476|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758477|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
56758478|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758479|NCT00993681|Vaccines|vaccines|mesh-list
56758480|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
56758481|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758482|NCT03892707|Folic Acid|folic acid|mesh-list
56758483|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
56758484|NCT03892707|Celecoxib|celecoxib|mesh-list
56758485|NCT03892707|Etoricoxib|etoricoxib|mesh-list
56758486|NCT03892707|Meloxicam|meloxicam|mesh-list
56758487|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56758488|NCT03892707|Nimesulide|nimesulide|mesh-list
56758489|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56758490|NCT03892707|Benphothiamine|benphothiamine|mesh-list
56758491|NCT03892707|Vitamins|vitamins|mesh-ancestor
56758492|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
56758493|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758494|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56758495|NCT03892707|Analgesics|analgesics|mesh-ancestor
56758503|NCT03892707|Hematinics|hematinics|mesh-ancestor
56758504|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56758505|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
56758506|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
56758507|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
56758508|NCT00513604|Aldesleukin|aldesleukin|mesh-list
56758509|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
56758510|NCT00513604|Fludarabine|fludarabine|mesh-list
56758511|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
56758512|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758513|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
56758514|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758515|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56758516|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56758517|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
56758518|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758519|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758520|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56758521|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56758522|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
56758523|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56758524|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56758525|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
56758526|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758527|NCT03971409|Doxorubicin|doxorubicin|mesh-list
56758528|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56758529|NCT03971409|Avelumab|avelumab|mesh-list
56758530|NCT03971409|Camptothecin|camptothecin|mesh-list
56758531|NCT03971409|Antibodies|antibodies|mesh-list
56758532|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56758533|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
56758534|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
56758535|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
56758546|NCT00872144|Nabiximols|nabiximols|mesh-list
56758548|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
56758549|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758550|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758551|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
56758552|NCT05018585|Vitamin D|vitamin d|mesh-list
56758553|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56758554|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56758555|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
56758556|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758557|NCT05018585|Antacids|antacids|mesh-ancestor
56758558|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758559|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56758560|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56758561|NCT05018585|Vitamins|vitamins|mesh-ancestor
56758562|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
56758563|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56758564|NCT00867152|Ritonavir|ritonavir|mesh-list
56758565|NCT00867152|Lopinavir|lopinavir|mesh-list
56758566|NCT00867152|Darunavir|darunavir|mesh-list
56758567|NCT00867152|Dolutegravir|dolutegravir|mesh-list
56758568|NCT00867152|Etravirine|etravirine|mesh-list
56758569|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56758570|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56758571|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
56758572|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758573|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758574|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56758576|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
56758597|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56758598|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
56758599|NCT00872378|Exenatide|exenatide|mesh-list
56758600|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56758601|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758602|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56758603|NCT00872378|Incretins|incretins|mesh-ancestor
56758604|NCT00872378|Hormones|hormones|mesh-ancestor
56758605|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758606|NCT00994071|Temozolomide|temozolomide|mesh-list
56758607|NCT00994071|Veliparib|veliparib|mesh-list
56758608|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56758609|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
56758610|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758611|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758612|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56758613|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758614|NCT05226351|Dronabinol|dronabinol|mesh-list
56758615|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
56758616|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758617|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56758618|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56758619|NCT05226351|Analgesics|analgesics|mesh-ancestor
56758620|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
56758621|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758622|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56758623|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56758624|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758625|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758626|NCT05226351|Hormones|hormones|mesh-ancestor
56758627|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758628|NCT00994149|Diazoxide|diazoxide|mesh-list
56758629|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56758636|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56758637|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56758638|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
56758639|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758640|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758641|NCT04039880|Olorofim|olorofim|mesh-list
56758642|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
56758643|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758644|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
56758645|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56758646|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
56758647|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758648|NCT00994305|Expectorants|expectorants|mesh-ancestor
56758649|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
56758650|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56758651|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
56758652|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758653|NCT00994305|Protective Agents|protective agents|mesh-ancestor
56758654|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758655|NCT00994305|Antidotes|antidotes|mesh-ancestor
56758656|NCT00877760|Interferons|interferons|mesh-list
56758657|NCT00877760|Entecavir|entecavir|mesh-list
56758658|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758659|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
56758660|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758661|NCT04083911|Cytarabine|cytarabine|mesh-list
56758662|NCT04083911|Decitabine|decitabine|mesh-list
56758663|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
56758664|NCT04083911|Aclarubicin|aclarubicin|mesh-list
56758665|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56758666|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
56758667|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758668|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758669|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
56758670|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758671|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758677|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56758678|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56758679|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56758680|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
56758681|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
56758682|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758683|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
56758684|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56758685|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56758686|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
56758687|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758688|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56758689|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56758690|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758691|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758692|NCT00994383|Morphine|morphine|mesh-list
56758693|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56758694|NCT00994383|Narcotics|narcotics|mesh-ancestor
56758695|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758696|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758697|NCT00994383|Analgesics|analgesics|mesh-ancestor
56758698|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
56758699|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758700|NCT02588417|Dexamethasone|dexamethasone|mesh-list
56758701|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
56758702|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56758703|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
56758704|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
56758705|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758706|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758707|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56758708|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
56758709|NCT02588417|Hormones|hormones|mesh-ancestor
56758710|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758719|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56758720|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56758721|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758722|NCT00532935|Incretins|incretins|mesh-ancestor
56758723|NCT00532935|Hormones|hormones|mesh-ancestor
56758724|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758725|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56758726|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
56758727|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758728|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758729|NCT00994539|Morphine|morphine|mesh-list
56758730|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56758731|NCT00994539|Narcotics|narcotics|mesh-ancestor
56758732|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758733|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758734|NCT00994539|Analgesics|analgesics|mesh-ancestor
56758735|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
56758736|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758737|NCT00878306|Ritonavir|ritonavir|mesh-list
56758738|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56758739|NCT00878306|Efavirenz|efavirenz|mesh-list
56758740|NCT00878306|Disulfiram|disulfiram|mesh-list
56758741|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56758742|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56758743|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
56758744|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758745|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758746|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56758747|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56758748|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
56758749|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758750|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56758751|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56758752|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56758753|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56758757|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56758758|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56758759|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56758760|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56758761|NCT00994617|Losartan|losartan|mesh-list
56758762|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56758763|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56758764|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56758765|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56758766|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56758767|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758768|NCT00994617|Diuretics|diuretics|mesh-ancestor
56758769|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
56758770|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758771|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56758772|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758773|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
56758774|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56758775|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56758776|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
56758777|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
56758778|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758779|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758780|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758781|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
56758782|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
56758783|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56758784|NCT00919451|Cyclosporine|cyclosporine|mesh-list
56758785|NCT00919451|Cyclosporins|cyclosporins|mesh-list
56758786|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758787|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758788|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758797|NCT05683535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56758798|NCT05683535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56758799|NCT05683535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56758800|NCT05683535|Autonomic Agents|autonomic agents|mesh-ancestor
56758801|NCT05683535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758802|NCT05683535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758803|NCT05683535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56758804|NCT05683535|Respiratory System Agents|respiratory system agents|mesh-ancestor
56758805|NCT05683535|Mydriatics|mydriatics|mesh-ancestor
56758806|NCT05683535|Parasympatholytics|parasympatholytics|mesh-ancestor
56758807|NCT05683535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56758808|NCT05683535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56758809|NCT05683535|Cholinergic Agents|cholinergic agents|mesh-ancestor
56758810|NCT05683535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758811|NCT05683535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758812|NCT03016312|Atezolizumab|atezolizumab|mesh-list
56758813|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758814|NCT05059223|Reboxetine|reboxetine|mesh-list
56758815|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
56758816|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56758817|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56758818|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56758819|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758820|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758821|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
56758822|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758823|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758824|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56758825|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
56758826|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56758827|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56758828|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56758829|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758830|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758831|NCT01014052|Retinol acetate|retinol acetate|mesh-list
56758835|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56758836|NCT01014052|Protective Agents|protective agents|mesh-ancestor
56758837|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758838|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
56758839|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758840|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56758841|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758842|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758843|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
56758844|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56758845|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56758846|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56758847|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56758848|NCT01015300|Bevacizumab|bevacizumab|mesh-list
56758849|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56758850|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758851|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56758852|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56758853|NCT01015300|Growth Substances|growth substances|mesh-ancestor
56758854|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758855|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
56758856|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
56758857|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
56758858|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758859|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
56758860|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758861|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56758862|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56758880|NCT00492232|Zolpidem|zolpidem|mesh-list
56758881|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56758882|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56758883|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758884|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758885|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56758886|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
56758887|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
56758888|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758889|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758890|NCT02587871|Cytarabine|cytarabine|mesh-list
56758891|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56758892|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
56758893|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758894|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758895|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
56758896|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758897|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56758898|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
56758899|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758900|NCT00919919|Progesterone|progesterone|mesh-list
56758901|NCT00919919|Progestins|progestins|mesh-ancestor
56758902|NCT00919919|Hormones|hormones|mesh-ancestor
56758903|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758904|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758905|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
56758906|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56758907|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56758908|NCT00491764|Posaconazole|posaconazole|mesh-list
56758909|NCT00491764|Terbinafine|terbinafine|mesh-list
56758910|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
56758911|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56758912|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56758913|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56758914|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56758917|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56758918|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758919|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56758920|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
56758921|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758922|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758923|NCT02586311|Amlodipine|amlodipine|mesh-list
56758924|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56758925|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56758926|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56758927|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758928|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56758929|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758930|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
56758932|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
56758933|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
56758934|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758935|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758936|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
56758937|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56758938|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56758940|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56758966|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56758967|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
56758968|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758969|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758970|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758971|NCT00878540|Mirtazapine|mirtazapine|mesh-list
56758972|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
56758973|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56758974|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56758975|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
56758976|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
56758977|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56758978|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56758979|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56758980|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56758981|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56758982|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56758983|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56758984|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56758985|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56547672|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547673|NCT04963036|Anesthetics|anesthetics|mesh-list
56547674|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547675|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547676|NCT00973479|Golimumab|golimumab|mesh-list
56547677|NCT00973479|Methotrexate|methotrexate|mesh-list
56547678|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56547679|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
56547680|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56547681|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547683|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
56758989|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
56758990|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56758991|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
56758992|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56758993|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
56758994|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
56758995|NCT04018274|Estradiol|estradiol|mesh-list
56758996|NCT04018274|Estrogens|estrogens|mesh-ancestor
56758997|NCT04018274|Hormones|hormones|mesh-ancestor
56758998|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56758999|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759000|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56759001|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759002|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56759003|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56759004|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56759005|NCT00873002|Sorafenib|sorafenib|mesh-list
56759006|NCT00873002|Panobinostat|panobinostat|mesh-list
56759007|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759008|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56759009|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759010|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759011|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56759012|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
56759013|NCT00491530|Atorvastatin|atorvastatin|mesh-list
56759014|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56759015|NCT00491530|Simvastatin|simvastatin|mesh-list
56759016|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
56759017|NCT00491530|Calcium|calcium|mesh-list
56759018|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56759019|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759020|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56759021|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56759022|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56759023|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
56759029|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56759030|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759031|NCT00615290|Tipranavir|tipranavir|mesh-list
56759032|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56759033|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56759034|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
56759035|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759036|NCT02587169|Doxorubicin|doxorubicin|mesh-list
56759037|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56759038|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56759039|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759040|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56759041|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56759042|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759043|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759044|NCT00873236|Interferons|interferons|mesh-list
56759045|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
56759046|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
56759047|NCT00873236|Bevacizumab|bevacizumab|mesh-list
56759048|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759049|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759050|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56759051|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56759052|NCT00873236|Growth Substances|growth substances|mesh-ancestor
56759053|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759054|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
56759055|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
56759056|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759057|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
56759058|NCT00868010|Donepezil|donepezil|mesh-list
56759059|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56759060|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759061|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759062|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
56759063|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759064|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759065|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
56759068|NCT05683301|Indapamide|indapamide|mesh-list
56759069|NCT05683301|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
56759070|NCT05683301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56759071|NCT05683301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56759072|NCT05683301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56759073|NCT05683301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759074|NCT05683301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56759075|NCT05683301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759076|NCT05683301|Vasodilator Agents|vasodilator agents|mesh-ancestor
56759077|NCT05683301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56759078|NCT05683301|Protease Inhibitors|protease inhibitors|mesh-ancestor
56759079|NCT05683301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759080|NCT05683301|Diuretics|diuretics|mesh-ancestor
56759081|NCT05683301|Natriuretic Agents|natriuretic agents|mesh-ancestor
56759082|NCT05683301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56759083|NCT04770623|Docetaxel|docetaxel|mesh-list
56759084|NCT04770623|Irinotecan|irinotecan|mesh-list
56759085|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759086|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
56759087|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
56759088|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
56759089|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759090|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56759091|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56759092|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759093|NCT05653661|Paclitaxel|paclitaxel|mesh-list
56759094|NCT05653661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56759095|NCT05653661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56759096|NCT05653661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759097|NCT05653661|Tubulin Modulators|tubulin modulators|mesh-ancestor
56759098|NCT05653661|Antimitotic Agents|antimitotic agents|mesh-ancestor
56759099|NCT05653661|Mitosis Modulators|mitosis modulators|mesh-ancestor
56759100|NCT05653661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759101|NCT00873392|Nicotine|nicotine|mesh-list
56759102|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56759103|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
56759104|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759105|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759106|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56759107|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56759108|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
56759109|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759110|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759111|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
56759112|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56759113|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56759114|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759115|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56759116|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56759117|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759118|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759119|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759120|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56759121|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
56759122|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759123|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759124|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56759125|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56759126|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56759127|NCT04658147|Nivolumab|nivolumab|mesh-list
56759128|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759129|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759130|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56759131|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759132|NCT00879164|Bupivacaine|bupivacaine|mesh-list
56759133|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
56759134|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
56759147|NCT04603001|Venetoclax|venetoclax|mesh-list
56759148|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56759149|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
56759150|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759151|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759152|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759153|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
56759154|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759155|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759156|NCT05487599|Sirolimus|sirolimus|mesh-list
56759157|NCT05487599|Prednisone|prednisone|mesh-list
56759158|NCT05487599|Methylprednisolone|methylprednisolone|mesh-list
56759159|NCT05487599|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56759160|NCT05487599|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56759161|NCT05487599|Prednisolone|prednisolone|mesh-list
56759162|NCT05487599|Prednisolone acetate|prednisolone acetate|mesh-list
56759163|NCT05487599|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56759164|NCT05487599|Prednisolone phosphate|prednisolone phosphate|mesh-list
56759165|NCT05487599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759166|NCT05487599|Glucocorticoids|glucocorticoids|mesh-ancestor
56759167|NCT05487599|Hormones|hormones|mesh-ancestor
56759168|NCT05487599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759169|NCT05487599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759170|NCT05487599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56759171|NCT05487599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759172|NCT05487599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56759173|NCT05487599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759174|NCT05487599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56759175|NCT05487599|Antifungal Agents|antifungal agents|mesh-ancestor
56759176|NCT05487599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56759177|NCT05487599|Immunologic Factors|immunologic factors|mesh-ancestor
56759178|NCT05487599|Antiemetics|antiemetics|mesh-ancestor
56759179|NCT05487599|Autonomic Agents|autonomic agents|mesh-ancestor
56759190|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
56759191|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759192|NCT02585765|Pioglitazone|pioglitazone|mesh-list
56759193|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56759194|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759195|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
56759196|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759197|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759198|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
56759199|NCT04634669|Bupropion|bupropion|mesh-list
56759200|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56759201|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
56759202|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56759203|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56759204|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56759205|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56759206|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759207|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
56759208|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759209|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759210|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56759211|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56759212|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759213|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
56759214|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
56759215|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56759216|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56759217|NCT02585531|Dexamethasone|dexamethasone|mesh-list
56759218|NCT02585531|Epinephrine|epinephrine|mesh-list
56759219|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759220|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
56759221|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
56759226|NCT02585531|Hormones|hormones|mesh-ancestor
56759230|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56759231|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56759232|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
56759233|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759234|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759235|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56759236|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56759237|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56759238|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
56759239|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
56759240|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
56759241|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56759242|NCT00920153|Gemcitabine|gemcitabine|mesh-list
56759243|NCT00920153|Cytarabine|cytarabine|mesh-list
56759244|NCT00920153|Dexamethasone|dexamethasone|mesh-list
56759245|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
56759246|NCT00920153|Doxorubicin|doxorubicin|mesh-list
56759247|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56759248|NCT00920153|Etoposide|etoposide|mesh-list
56759249|NCT00920153|Vincristine|vincristine|mesh-list
56759250|NCT00920153|Melphalan|melphalan|mesh-list
56759251|NCT00920153|Vinorelbine|vinorelbine|mesh-list
56759252|NCT00920153|Ifosfamide|ifosfamide|mesh-list
56759253|NCT00920153|Dacarbazine|dacarbazine|mesh-list
56759254|NCT00920153|Carmustine|carmustine|mesh-list
56759255|NCT00920153|Bleomycin|bleomycin|mesh-list
56759256|NCT00920153|Vindesine|vindesine|mesh-list
56759257|NCT00920153|Mitoguazone|mitoguazone|mesh-list
56759258|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759259|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
56759260|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
56759261|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759262|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759263|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759264|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
56759265|NCT00920153|Hormones|hormones|mesh-ancestor
56759266|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759267|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56759268|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031956|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56032783|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56759269|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56759270|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
56759271|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759272|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
56759273|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759274|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759275|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56759276|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
56759277|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56759278|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56759279|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56759280|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56759281|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
56759282|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
56759283|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
56759284|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56759285|NCT00920153|Protective Agents|protective agents|mesh-ancestor
56759286|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56759287|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
56759288|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56759290|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759291|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56759292|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
56759293|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759294|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759295|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56759296|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
56759297|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
56759298|NCT04080713|Hormones|hormones|mesh-ancestor
56759299|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759300|NCT04081805|Estradiol|estradiol|mesh-list
56759301|NCT04081805|Estrogens|estrogens|mesh-ancestor
56759312|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
56759313|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759314|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759315|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
56759316|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759317|NCT04080323|Dinoprostone|dinoprostone|mesh-list
56759318|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
56759319|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759320|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759321|NCT03930017|Vaccines|vaccines|mesh-list
56759322|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
56759323|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759324|NCT00533949|Paclitaxel|paclitaxel|mesh-list
56759325|NCT00533949|Carboplatin|carboplatin|mesh-list
56759326|NCT00533949|Cetuximab|cetuximab|mesh-list
56759327|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56759328|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759329|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
56759330|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
56759331|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
56759332|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759333|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759334|NCT00485134|Vaccines|vaccines|mesh-list
56759335|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
56759336|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759337|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56759338|NCT02585141|Clindamycin|clindamycin|mesh-list
56759339|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
56759340|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
56759341|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759357|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
56759358|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56759359|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759360|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
56759361|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56759362|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759363|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470318|NCT00503126|Bivalirudin|bivalirudin|mesh-list
56759364|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56759365|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56759366|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56759367|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56759368|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56759369|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56759370|NCT00920465|Misoprostol|misoprostol|mesh-list
56759371|NCT00920465|Mifepristone|mifepristone|mesh-list
56759372|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56759373|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
56759374|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759375|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759376|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56759377|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759378|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
56759379|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56759380|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56759381|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56759382|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56759383|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
56032784|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032821|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032822|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032882|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032883|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032884|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56032885|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
56032886|NCT03399539|Hormones|hormones|mesh-ancestor
56032887|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56032888|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56032889|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032890|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032891|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
56032892|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032893|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
56759384|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56759385|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56759386|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
56759387|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759388|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
56759389|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56759390|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56759396|NCT03890367|Vaccines|vaccines|mesh-list
56759397|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
56759398|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759399|NCT00994773|Tenofovir|tenofovir|mesh-list
56759400|NCT00994773|Entecavir|entecavir|mesh-list
56759401|NCT00994773|Simvastatin|simvastatin|mesh-list
56759402|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
56759403|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759404|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56759405|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56759406|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759407|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759408|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56759409|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56759410|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56759411|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56759412|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
56759413|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56759414|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56759415|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
56759416|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56759417|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
56759418|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56759419|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
56759420|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759421|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759424|NCT03084237|Trastuzumab|trastuzumab|mesh-list
56759425|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759426|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56759427|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56759428|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56759429|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759430|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759431|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
56759432|NCT00996021|Dolutegravir|dolutegravir|mesh-list
56759433|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56759434|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56759435|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759436|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56759437|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56759438|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759439|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759440|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759441|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56759442|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
56759443|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759444|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759445|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56759446|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56759447|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56759448|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56759449|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56759450|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56759451|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56759469|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56759470|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56759471|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56759472|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
56759473|NCT02584751|Omeprazole|omeprazole|mesh-list
56759474|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56759475|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759476|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56759477|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759478|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759479|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56759480|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
56759481|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759482|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759483|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56759484|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
56759485|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56759486|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
56759487|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759488|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56759489|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
56759490|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
56759491|NCT02584751|Protective Agents|protective agents|mesh-ancestor
56759492|NCT00999219|Zolpidem|zolpidem|mesh-list
56759493|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56759494|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56759495|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759496|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759497|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56759498|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
56759499|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
56759500|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759501|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759502|NCT00996177|Fentanyl|fentanyl|mesh-list
56032895|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032896|NCT03385655|Carboplatin|carboplatin|mesh-list
56032897|NCT03385655|Durvalumab|durvalumab|mesh-list
56032898|NCT03385655|Tremelimumab|tremelimumab|mesh-list
56032899|NCT03385655|Adavosertib|adavosertib|mesh-list
56032900|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032927|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759503|NCT00996177|Morphine|morphine|mesh-list
56759504|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56759505|NCT00996177|Narcotics|narcotics|mesh-ancestor
56759506|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759507|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759508|NCT00996177|Analgesics|analgesics|mesh-ancestor
56759509|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
56759510|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759511|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56759512|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56759513|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
56759514|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
56759515|NCT04079933|Nicotine|nicotine|mesh-list
56759516|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56759517|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
56759518|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759519|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759520|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56759521|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56759522|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
56759523|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759524|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759525|NCT00999297|Capsaicin|capsaicin|mesh-list
56759526|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
56759527|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
56759528|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
56759529|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759530|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759531|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
56759532|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759533|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56759534|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759535|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759545|NCT05371223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56759546|NCT05371223|Immunologic Factors|immunologic factors|mesh-ancestor
56759547|NCT05371223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759548|NCT00532779|Naltrexone|naltrexone|mesh-list
56759549|NCT00532779|Bupropion|bupropion|mesh-list
56759550|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56759551|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56759552|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759553|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
56759554|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759555|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56759556|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
56759557|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56759558|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56759559|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56759560|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56759561|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759562|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
56759563|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759564|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56759565|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56759566|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759567|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56759568|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
56759569|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759570|NCT00996411|Salvinorin A|salvinorin a|mesh-list
56759571|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
56759572|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759590|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759591|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56759592|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759593|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56759594|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
56759595|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759596|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759597|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56759598|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
56759599|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759600|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759602|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
56759603|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56759604|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56759605|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56759606|NCT04293562|Methotrexate|methotrexate|mesh-list
56759607|NCT04293562|Etoposide|etoposide|mesh-list
56759608|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
56759609|NCT04293562|Daunorubicin|daunorubicin|mesh-list
56759610|NCT04293562|Asparaginase|asparaginase|mesh-list
56759611|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
56759612|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
56759613|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
56759614|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
56759615|NCT04293562|Razoxane|razoxane|mesh-list
56759616|NCT04293562|Calicheamicins|calicheamicins|mesh-list
56759617|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56759618|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
56759622|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
56759639|NCT04293562|Analgesics|analgesics|mesh-ancestor
56759640|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
56759641|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759642|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
56759643|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
56759644|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
56759645|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
56759646|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759647|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56759648|NCT04293562|Protective Agents|protective agents|mesh-ancestor
56759649|NCT05304533|Itraconazole|itraconazole|mesh-list
56759650|NCT05304533|Verapamil|verapamil|mesh-list
56759651|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
56759652|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759653|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56759654|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56759655|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759656|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759657|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56759658|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
56759659|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759660|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759661|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56759662|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56759663|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56759664|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56759665|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56759666|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
56759667|NCT04338269|Atezolizumab|atezolizumab|mesh-list
56759668|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759682|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759683|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759684|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56759685|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
56759686|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
56759687|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56759688|NCT00996723|Dasatinib|dasatinib|mesh-list
56759689|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759690|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56759691|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759692|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759693|NCT04354025|Cytarabine|cytarabine|mesh-list
56759694|NCT04354025|Fludarabine|fludarabine|mesh-list
56759695|NCT04354025|Interleukin-2|interleukin-2|mesh-list
56759696|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759697|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56759698|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
56759699|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759700|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56759701|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
56759702|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759703|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
56759704|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759705|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56759706|NCT04354025|Analgesics|analgesics|mesh-ancestor
56759707|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
56759708|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759709|NCT05332587|Rituximab|rituximab|mesh-list
56759710|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759711|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759712|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
56759713|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759714|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56759724|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
56759725|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
56759726|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
56759727|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
56759728|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56759729|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759730|NCT02582177|Ketoconazole|ketoconazole|mesh-list
56759731|NCT02582177|Clotrimazole|clotrimazole|mesh-list
56759732|NCT02582177|Miconazole|miconazole|mesh-list
56759733|NCT02582177|Dexamethasone|dexamethasone|mesh-list
56759734|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
56759735|NCT02582177|Betamethasone|betamethasone|mesh-list
56759736|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
56759737|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56759738|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
56759739|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56759740|NCT02582177|BB 1101|bb 1101|mesh-list
56759741|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759742|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
56759743|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
56759744|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759745|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759746|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759747|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
56759748|NCT02582177|Hormones|hormones|mesh-ancestor
56759749|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759750|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56759751|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759773|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759774|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759775|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56759776|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
56759777|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759778|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
56759779|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759780|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759781|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56759782|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
56759783|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56759784|NCT05325177|Ibuprofen|ibuprofen|mesh-list
56759785|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56759786|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56759787|NCT05325177|Analgesics|analgesics|mesh-ancestor
56759788|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
56759789|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759790|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759791|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759792|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56759793|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56759794|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759795|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759796|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
56759797|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
56759820|NCT00997191|Hormones|hormones|mesh-ancestor
56759821|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759822|NCT00997269|Ubiquinone|ubiquinone|mesh-list
56759823|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
56759824|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
56759825|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759826|NCT00997269|Vitamins|vitamins|mesh-ancestor
56759827|NCT02582099|Gentamicins|gentamicins|mesh-list
56759828|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56759829|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759830|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56759831|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759832|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759833|NCT00997347|Misoprostol|misoprostol|mesh-list
56759834|NCT00997347|Mifepristone|mifepristone|mesh-list
56759835|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56759836|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
56759837|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759838|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759839|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56759840|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759841|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
56759842|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56759843|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56759844|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56759845|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56759846|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
56759847|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56759848|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56759865|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56759866|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759867|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759868|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
56759869|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
56759870|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56759871|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56759872|NCT02044497|Oxycodone|oxycodone|mesh-list
56759873|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56759874|NCT02044497|Narcotics|narcotics|mesh-ancestor
56759875|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759876|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759877|NCT02044497|Analgesics|analgesics|mesh-ancestor
56759878|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
56759879|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759880|NCT05183139|Dexamethasone|dexamethasone|mesh-list
56759881|NCT05183139|Lenalidomide|lenalidomide|mesh-list
56759882|NCT05183139|Pomalidomide|pomalidomide|mesh-list
56759883|NCT05183139|Ixazomib|ixazomib|mesh-list
56759884|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56759885|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
56759886|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
56759887|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759888|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759889|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759890|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
56759891|NCT05183139|Hormones|hormones|mesh-ancestor
56759892|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56759893|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56759894|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759895|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
56759896|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56759897|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56759898|NCT05183139|Growth Substances|growth substances|mesh-ancestor
56759899|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
56759900|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
56759901|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759903|NCT00999843|Sorafenib|sorafenib|mesh-list
56759904|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759905|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56759906|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759907|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759908|NCT00997659|Chromium|chromium|mesh-list
56759909|NCT00997659|Picolinic acid|picolinic acid|mesh-list
56759910|NCT00997659|Trace Elements|trace elements|mesh-ancestor
56759911|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
56759912|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759913|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56759914|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
56759915|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
56759916|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759917|NCT03828227|Bevacizumab|bevacizumab|mesh-list
56759918|NCT03828227|Capecitabine|capecitabine|mesh-list
56759919|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56759920|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56759921|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56759922|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56759923|NCT03828227|Growth Substances|growth substances|mesh-ancestor
56759924|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759925|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
56759926|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56759927|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
56759928|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759951|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
56759952|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
56759953|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
56759954|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759955|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56759956|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
56759957|NCT04077983|Antiviral Agents|antiviral agents|mesh-ancestor
56759958|NCT04077983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56759959|NCT04077983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56759960|NCT04077983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56759961|NCT04077983|Immunologic Factors|immunologic factors|mesh-ancestor
56759962|NCT04077983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759971|NCT03822845|Edetic Acid|edetic acid|mesh-list
56759972|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56759973|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
56759974|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
56759975|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759976|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
56759977|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56759978|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56759979|NCT01000233|Inositol|inositol|mesh-list
56759980|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
56759981|NCT01000233|Vitamins|vitamins|mesh-ancestor
56759982|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
56759983|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759984|NCT04075955|Olanzapine|olanzapine|mesh-list
56759985|NCT04075955|Aprepitant|aprepitant|mesh-list
56759986|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
56759987|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
56759988|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56759989|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56759990|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56759991|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56759992|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56032661|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
56759993|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56759994|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56759995|NCT04075955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56759996|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56759997|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56759998|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56759999|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760000|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
56760001|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56760002|NCT00484198|Pioglitazone|pioglitazone|mesh-list
56760003|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56760004|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760005|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
56760006|NCT04077905|Doxorubicin|doxorubicin|mesh-list
56760007|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56760008|NCT04077905|Etoposide|etoposide|mesh-list
56760009|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56760010|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760011|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56760012|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56760013|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760014|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760015|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56760016|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56760017|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
56760018|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
56760019|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760020|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760021|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56760022|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
56760023|NCT04077905|Hormones|hormones|mesh-ancestor
56760024|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56760025|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56760026|NCT04077905|Protective Agents|protective agents|mesh-ancestor
56032928|NCT03207347|Niraparib|niraparib|mesh-list
56032929|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56032930|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032931|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760027|NCT04282187|Azacitidine|azacitidine|mesh-list
56760028|NCT04282187|Decitabine|decitabine|mesh-list
56760029|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56760030|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56760031|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
56760032|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760033|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760034|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760035|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56760036|NCT04471246|Cephalexin|cephalexin|mesh-list
56760037|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760038|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760039|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
56760040|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56760041|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56760042|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
56760043|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760044|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760046|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
56760047|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
56760048|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760049|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
56760050|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56760051|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56760052|NCT04276259|Naltrexone|naltrexone|mesh-list
56760053|NCT04276259|Buprenorphine|buprenorphine|mesh-list
56760054|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56760055|NCT04276259|Narcotics|narcotics|mesh-ancestor
56760077|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760078|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
56760079|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760080|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760081|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56760082|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760083|NCT01019278|Cisplatin|cisplatin|mesh-list
56760084|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760085|NCT01014520|Gabapentin|gabapentin|mesh-list
56760086|NCT01014520|Amitriptyline|amitriptyline|mesh-list
56760087|NCT01014520|Analgesics|analgesics|mesh-ancestor
56760088|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
56760089|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760090|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760091|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
56760092|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56760093|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56760094|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56760095|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56760096|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56760097|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56760098|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760099|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760100|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
56760101|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56760102|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
56760103|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56760104|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56760105|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56760106|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56760107|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
56760108|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
56760109|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
56760110|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760111|NCT01016002|Temoporfin|temoporfin|mesh-list
56760115|NCT01019434|Sirolimus|sirolimus|mesh-list
56760116|NCT01019434|Temozolomide|temozolomide|mesh-list
56760117|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56760118|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
56760119|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760120|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760121|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760122|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760123|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56760124|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
56760125|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760126|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
56760127|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760128|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56760129|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56760130|NCT03778229|Osimertinib|osimertinib|mesh-list
56760131|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760132|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56760133|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760134|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760135|NCT00499252|Paclitaxel|paclitaxel|mesh-list
56760136|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56760137|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56760138|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760139|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760140|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760141|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760142|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760143|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56760144|NCT01019590|Olmesartan|olmesartan|mesh-list
56032824|NCT02245256|Analgesics|analgesics|mesh-ancestor
56032932|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032933|NCT03203525|Leucovorin|leucovorin|mesh-list
56032934|NCT03203525|Sirolimus|sirolimus|mesh-list
56032935|NCT03203525|Bevacizumab|bevacizumab|mesh-list
56032936|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56032937|NCT03203525|Doxorubicin|doxorubicin|mesh-list
56032938|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56032939|NCT03203525|Fluorouracil|fluorouracil|mesh-list
56032940|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
56032941|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
56032942|NCT03203525|Antibodies|antibodies|mesh-list
56032943|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
56032944|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56032945|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
56760145|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56760146|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56760147|NCT01019590|Diuretics|diuretics|mesh-ancestor
56760148|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
56760149|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760150|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56760151|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56760152|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760153|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56760154|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56760155|NCT03775421|Macitentan|macitentan|mesh-list
56760156|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56760157|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56760158|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760159|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56760160|NCT00532155|Dexamethasone|dexamethasone|mesh-list
56760161|NCT00532155|Docetaxel|docetaxel|mesh-list
56760162|NCT00532155|Aflibercept|aflibercept|mesh-list
56760163|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56760164|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
56760165|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
56760166|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760167|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760168|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56760169|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
56760170|NCT00532155|Hormones|hormones|mesh-ancestor
56760171|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56760190|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
56760191|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
56760192|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
56760193|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56760194|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56760195|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
56760196|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56760197|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760198|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56760199|NCT03762395|CXA-10|cxa-10|mesh-list
56760200|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56760201|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
56760202|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56760203|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
56760204|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56760205|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56760206|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760207|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56760208|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
56760209|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760210|NCT01014832|Insulin|insulin|mesh-list
56760211|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56760212|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56760213|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760214|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
56760215|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56760237|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56760238|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760239|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760240|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760241|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56760242|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
56760243|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56760244|NCT00998439|Paclitaxel|paclitaxel|mesh-list
56760245|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56760246|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760247|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760248|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760249|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760250|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760251|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
56760252|NCT03996772|Apixaban|apixaban|mesh-list
56760253|NCT03996772|Edoxaban|edoxaban|mesh-list
56760254|NCT03996772|Dabigatran|dabigatran|mesh-list
56760255|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56760256|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
56760257|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56760258|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
56760259|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760260|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760261|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
56760262|NCT01000779|Propranolol|propranolol|mesh-list
56760263|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56760264|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56760265|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56760266|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760267|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760268|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760269|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56760270|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56760271|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
56760273|NCT01000857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56760275|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56760276|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760277|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760278|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
56760279|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760280|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56760281|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
56760282|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56760283|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56760284|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56760285|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760286|NCT01004445|Amikacin|amikacin|mesh-list
56760287|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760288|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760289|NCT03739931|Durvalumab|durvalumab|mesh-list
56760290|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760291|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760292|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
56760293|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56760294|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
56760295|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760296|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
56760297|NCT02580695|Protective Agents|protective agents|mesh-ancestor
56760298|NCT02581553|Allopurinol|allopurinol|mesh-list
56760299|NCT02581553|Lesinurad|lesinurad|mesh-list
56760300|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
56760301|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760324|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760325|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760326|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760327|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760328|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
56760329|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56760330|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760331|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
56760332|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760333|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760334|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56760335|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56760336|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
56760337|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760338|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56760339|NCT00482170|Etanercept|etanercept|mesh-list
56760340|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56760341|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56760342|NCT00482170|Analgesics|analgesics|mesh-ancestor
56760343|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
56760344|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760345|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760346|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56760347|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56760348|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56760349|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760350|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
56760352|NCT05228249|Etoposide|etoposide|mesh-list
56760371|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
56760372|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760373|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56760374|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
56760375|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56760376|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
56760377|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
56760378|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760379|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760380|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760381|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760382|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
56760383|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56760384|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56760385|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760386|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
56760387|NCT02580227|Coagulants|coagulants|mesh-ancestor
56760388|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
56760389|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760390|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760391|NCT04214249|Cytarabine|cytarabine|mesh-list
56760392|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
56760393|NCT04214249|Daunorubicin|daunorubicin|mesh-list
56760394|NCT04214249|Idarubicin|idarubicin|mesh-list
56760395|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760396|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760397|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56032946|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032947|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56032948|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56032949|NCT03203525|Growth Substances|growth substances|mesh-ancestor
56032987|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
56033016|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56033017|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033018|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56033019|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033020|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033021|NCT03102125|Regadenoson|regadenoson|mesh-list
56033022|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56033023|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56190404|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56190408|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56190409|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56190410|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190411|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190413|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56190414|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
56760398|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
56760399|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760400|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
56760401|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760402|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760403|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
56760404|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760405|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56760406|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56760407|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56760408|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760409|NCT01001013|Pioglitazone|pioglitazone|mesh-list
56760410|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56760411|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760412|NCT01004601|Docetaxel|docetaxel|mesh-list
56760413|NCT01004601|Pemetrexed|pemetrexed|mesh-list
56760414|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760415|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760416|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760417|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760418|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760419|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760420|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56760421|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56760422|NCT04460326|Insulin|insulin|mesh-list
56760423|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56760424|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
56760447|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760448|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760449|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56760450|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56760451|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56760452|NCT02580773|Tinzaparin|tinzaparin|mesh-list
56760453|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
56760454|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56760455|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56760456|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760457|NCT01008813|Vaccines|vaccines|mesh-list
56760458|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
56760459|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760460|NCT05674565|Magnesium Sulfate|magnesium sulfate|mesh-list
56760461|NCT05674565|Analgesics|analgesics|mesh-ancestor
56760462|NCT05674565|Sensory System Agents|sensory system agents|mesh-ancestor
56760463|NCT05674565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760464|NCT05674565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760465|NCT05674565|Anesthetics|anesthetics|mesh-ancestor
56760466|NCT05674565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56760467|NCT05674565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56760468|NCT05674565|Anticonvulsants|anticonvulsants|mesh-ancestor
56760469|NCT05674565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56760470|NCT05674565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56760471|NCT05674565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760472|NCT05674565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56760473|NCT05674565|Tocolytic Agents|tocolytic agents|mesh-ancestor
56760474|NCT05674565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56760475|NCT01001637|Curcumin|curcumin|mesh-list
56760476|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56760490|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56760491|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56760492|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56760493|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760494|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56760495|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56760496|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56760497|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
56760498|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760499|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760500|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
56760501|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56760502|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56760503|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760504|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
56760505|NCT01005147|Coagulants|coagulants|mesh-ancestor
56760506|NCT03603899|Xenon|xenon|mesh-list
56760507|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56760508|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
56760509|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
56760510|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56760511|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760512|NCT01001871|Vitamins|vitamins|mesh-list
56760513|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
56760514|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760515|NCT01005303|Vitamin D|vitamin d|mesh-list
56760516|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
56760517|NCT01005303|Vitamins|vitamins|mesh-ancestor
56760518|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
56760519|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760520|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56760521|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56760522|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
56760523|NCT01005381|Vitamin D|vitamin d|mesh-list
56760524|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
56760525|NCT01005381|Calcium|calcium|mesh-list
56760526|NCT01005381|Vitamins|vitamins|mesh-ancestor
56760530|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56760531|NCT01005381|Antacids|antacids|mesh-ancestor
56760532|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760533|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56760534|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
56760535|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760536|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760537|NCT05154279|Terlipressin|terlipressin|mesh-list
56760538|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56760539|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56760540|NCT01005537|Aldesleukin|aldesleukin|mesh-list
56760541|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
56760542|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760543|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
56760544|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760545|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56760546|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56760547|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
56760548|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760549|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760550|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56760551|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56760552|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56760553|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
56760554|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760555|NCT05733741|Benoxinate|benoxinate|mesh-list
56760556|NCT05733741|Hyaluronic Acid|hyaluronic acid|mesh-list
56760557|NCT05733741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56760558|NCT05733741|Immunologic Factors|immunologic factors|mesh-ancestor
56760559|NCT05733741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760560|NCT05733741|Viscosupplements|viscosupplements|mesh-ancestor
56760561|NCT05733741|Protective Agents|protective agents|mesh-ancestor
56760562|NCT05733741|Anesthetics, Local|anesthetics, local|mesh-ancestor
56760563|NCT05733741|Anesthetics|anesthetics|mesh-ancestor
56760564|NCT05733741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56760565|NCT05733741|Sensory System Agents|sensory system agents|mesh-ancestor
56760567|NCT01005927|Calcium|calcium|mesh-list
56760569|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760570|NCT03742713|Docetaxel|docetaxel|mesh-list
56760571|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760572|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760573|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760574|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760575|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760576|NCT01002729|Oseltamivir|oseltamivir|mesh-list
56760577|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
56760578|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760579|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760580|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760581|NCT01002807|Metformin|metformin|mesh-list
56760582|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
56760583|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56760584|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760585|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56760586|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760587|NCT05733351|Docetaxel|docetaxel|mesh-list
56760588|NCT05733351|Antibodies|antibodies|mesh-list
56760589|NCT05733351|Immunoglobulins|immunoglobulins|mesh-list
56760590|NCT05733351|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56760591|NCT05733351|Immunologic Factors|immunologic factors|mesh-ancestor
56760592|NCT05733351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760593|NCT05733351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760594|NCT05733351|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760595|NCT05733351|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760596|NCT05733351|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760597|NCT05733351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760598|NCT05733117|Vitamin D|vitamin d|mesh-list
56760599|NCT05733117|Vitamins|vitamins|mesh-ancestor
56760603|NCT05732961|Luspatercept|luspatercept|mesh-list
56760615|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760616|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760617|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56760618|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56760619|NCT00615056|Growth Substances|growth substances|mesh-ancestor
56760620|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760621|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
56760622|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
56760623|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760624|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56760625|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760626|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
56760627|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56760628|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56760629|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760630|NCT00615056|Antidotes|antidotes|mesh-ancestor
56760631|NCT00615056|Protective Agents|protective agents|mesh-ancestor
56760632|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
56760633|NCT00615056|Vitamins|vitamins|mesh-ancestor
56760634|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
56760635|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56760636|NCT01006551|Ziprasidone|ziprasidone|mesh-list
56760637|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56760638|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
56760639|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760640|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760641|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760642|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56760643|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56760644|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56760659|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760660|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56760661|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56760662|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56760663|NCT00873626|Renal Agents|renal agents|mesh-ancestor
56760664|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56760665|NCT00879242|Deferasirox|deferasirox|mesh-list
56760666|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56760667|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
56760668|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
56760669|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760670|NCT05732493|Capecitabine|capecitabine|mesh-list
56760671|NCT05732493|Oxaliplatin|oxaliplatin|mesh-list
56760672|NCT05732493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56760673|NCT05732493|Antimetabolites|antimetabolites|mesh-ancestor
56760674|NCT05732493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760675|NCT05732493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760676|NCT00868634|Bevacizumab|bevacizumab|mesh-list
56760677|NCT00868634|Capecitabine|capecitabine|mesh-list
56760678|NCT00868634|Vinorelbine|vinorelbine|mesh-list
56760679|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760680|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760681|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56760682|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56760683|NCT00868634|Growth Substances|growth substances|mesh-ancestor
56760684|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760685|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
56760686|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56760687|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
56760690|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760702|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760703|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760704|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
56760705|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
56760706|NCT00879476|Ramipril|ramipril|mesh-list
56760707|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56760708|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
56760709|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760710|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760711|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56760712|NCT00868946|Ribavirin|ribavirin|mesh-list
56760713|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
56760714|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760715|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
56760716|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760717|NCT00482014|Carboplatin|carboplatin|mesh-list
56760718|NCT00482014|Pemetrexed|pemetrexed|mesh-list
56760719|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760720|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760721|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760722|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56760723|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56760724|NCT00879788|Ramipril|ramipril|mesh-list
56471665|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
56760725|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56760726|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
56760727|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760728|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760729|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56760746|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56760747|NCT00614822|Growth Substances|growth substances|mesh-ancestor
56760748|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760749|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
56760750|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760751|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760752|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56760753|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56760754|NCT04861298|Quercetin|quercetin|mesh-list
56760755|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
56760756|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760757|NCT04861298|Protective Agents|protective agents|mesh-ancestor
56760758|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760759|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
56760760|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56760761|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56760762|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760763|NCT03582917|Vitamins|vitamins|mesh-ancestor
56760764|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
56760765|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
56760766|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760767|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760768|NCT00869180|Diclofenac|diclofenac|mesh-list
56760769|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56760770|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56760771|NCT00869180|Analgesics|analgesics|mesh-ancestor
56760772|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
56760773|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760774|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760775|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56760776|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56760780|NCT00874328|Irinotecan|irinotecan|mesh-list
56760788|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
56760789|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
56760790|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760791|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56760792|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760793|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760794|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
56760795|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760796|NCT00874406|Antidotes|antidotes|mesh-ancestor
56760797|NCT00874406|Protective Agents|protective agents|mesh-ancestor
56760798|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
56760799|NCT00874406|Vitamins|vitamins|mesh-ancestor
56471744|NCT00513630|Metformin|metformin|mesh-list
56760800|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
56760801|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
56760802|NCT00880178|Niacin|niacin|mesh-list
56760803|NCT00880178|Niacinamide|niacinamide|mesh-list
56760804|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
56760805|NCT00880178|Simvastatin|simvastatin|mesh-list
56760806|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56760807|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56760808|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
56760809|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760810|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56760811|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56760812|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760813|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
56760814|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
56760815|NCT00880178|Vitamins|vitamins|mesh-ancestor
56760816|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
56760817|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760818|NCT04077125|Rifaximin|rifaximin|mesh-list
56760834|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56760835|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56760836|NCT04194203|Growth Substances|growth substances|mesh-ancestor
56760837|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760838|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
56760839|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760840|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56760841|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56760842|NCT05172401|Triamcinolone|triamcinolone|mesh-list
56760843|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56760844|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56760845|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56760846|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56760847|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
56760848|NCT05172401|Hormones|hormones|mesh-ancestor
56760849|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56760850|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760851|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760852|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
56760853|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760854|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760855|NCT00143455|Cisplatin|cisplatin|mesh-list
56760856|NCT00143455|Irinotecan|irinotecan|mesh-list
56760857|NCT00143455|Etoposide|etoposide|mesh-list
56760858|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760859|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56760860|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56760861|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760862|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760863|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56760864|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56760876|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
56760877|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56760878|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56760879|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56760880|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
56760881|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760882|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760883|NCT01006863|Protective Agents|protective agents|mesh-ancestor
56760884|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56760885|NCT03535727|Gemcitabine|gemcitabine|mesh-list
56760886|NCT03535727|Paclitaxel|paclitaxel|mesh-list
56760887|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56760888|NCT03535727|Cisplatin|cisplatin|mesh-list
56760889|NCT03535727|Capecitabine|capecitabine|mesh-list
56760890|NCT03535727|Irinotecan|irinotecan|mesh-list
56760891|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56760892|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760893|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
56760894|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
56760895|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
56760896|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760897|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56760898|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
56760899|NCT03535727|Antiviral Agents|antiviral agents|mesh-ancestor
56760900|NCT03535727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760901|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760902|NCT03535727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56760903|NCT03535727|Immunologic Factors|immunologic factors|mesh-ancestor
56760907|NCT03529955|Apremilast|apremilast|mesh-list
56760922|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56760923|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760924|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
56760925|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760926|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56760927|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56760928|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56760929|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
56760930|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760931|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760932|NCT01007019|Esomeprazole|esomeprazole|mesh-list
56760933|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56760934|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56760935|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56760936|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760937|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760938|NCT05633979|Trastuzumab|trastuzumab|mesh-list
56760939|NCT05633979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56760940|NCT05633979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56760941|NCT03508739|Valsartan|valsartan|mesh-list
56760942|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56760943|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56760944|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56760945|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56760946|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760947|NCT00205699|Olanzapine|olanzapine|mesh-list
56760948|NCT00205699|Risperidone|risperidone|mesh-list
56760949|NCT00205699|Aripiprazole|aripiprazole|mesh-list
56760950|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56760951|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
56190415|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56190417|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
56190418|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190419|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56190421|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190422|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56190423|NCT01468155|Dabigatran|dabigatran|mesh-list
56190424|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
56190425|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56190426|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
56190427|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051971|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56760952|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56760953|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760954|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760955|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56760956|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56760957|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56760958|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56760959|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56760960|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
56760961|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
56760962|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
56760963|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56760964|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56760965|NCT00205699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56760966|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56760967|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56760968|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
56760969|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
56760970|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56760971|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56760972|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56760973|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56760974|NCT03503513|Gentamicins|gentamicins|mesh-list
56760975|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56760976|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56760977|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56760978|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56760979|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56760980|NCT03498521|Gemcitabine|gemcitabine|mesh-list
56760995|NCT03498521|Growth Substances|growth substances|mesh-ancestor
56760996|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56760997|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
56760998|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56760999|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
56761000|NCT03498521|Antiviral Agents|antiviral agents|mesh-ancestor
56761001|NCT03498521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761002|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761003|NCT03498521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761004|NCT03498521|Immunologic Factors|immunologic factors|mesh-ancestor
56761005|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56761006|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56761007|NCT03850691|Aldesleukin|aldesleukin|mesh-list
56761008|NCT03850691|Nivolumab|nivolumab|mesh-list
56761009|NCT03850691|Ipilimumab|ipilimumab|mesh-list
56761010|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761011|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761012|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56761013|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761014|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56761015|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56761016|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
56761017|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761018|NCT02580149|Clopidogrel|clopidogrel|mesh-list
56761019|NCT02580149|Ticagrelor|ticagrelor|mesh-list
56761020|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56761021|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56761022|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56761023|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56761024|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
56761025|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56471972|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
56761026|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761027|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761028|NCT05618925|Cyclophosphamide|cyclophosphamide|mesh-list
56761029|NCT05618925|Rituximab|rituximab|mesh-list
56761030|NCT05618925|Fludarabine|fludarabine|mesh-list
56761032|NCT05618925|Immunologic Factors|immunologic factors|mesh-ancestor
56761033|NCT05618925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761034|NCT05618925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56761035|NCT05618925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56761036|NCT05618925|Alkylating Agents|alkylating agents|mesh-ancestor
56761037|NCT05618925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761038|NCT05618925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761039|NCT05618925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56761040|NCT05618925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761041|NCT04996017|Atezolizumab|atezolizumab|mesh-list
56761042|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761043|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
56761044|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56761045|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
56761046|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56761047|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
56761048|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761049|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761050|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
56761051|NCT04126031|Ceftazidime|ceftazidime|mesh-list
56761052|NCT04126031|Avibactam|avibactam|mesh-list
56761053|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
56761054|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761055|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761056|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56761057|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761058|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761059|NCT01007565|Anesthetics|anesthetics|mesh-list
56761060|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56761061|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761062|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
56761063|NCT02816021|Azacitidine|azacitidine|mesh-list
56761064|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56190428|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190429|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
56190430|NCT01468259|Droxidopa|droxidopa|mesh-list
56190431|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56190432|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56190433|NCT01468272|Beclomethasone|beclomethasone|mesh-list
56190434|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
56761065|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761066|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56761067|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
56761068|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761069|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761070|NCT05229003|Irinotecan|irinotecan|mesh-list
56761071|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56761072|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56761073|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761074|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761075|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761076|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
56761077|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56761078|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761079|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56761080|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
56761081|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761082|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761083|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761084|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761085|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
56761086|NCT04436926|Narcotics|narcotics|mesh-ancestor
56761087|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56761088|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761089|NCT04436926|Analgesics|analgesics|mesh-ancestor
56761092|NCT02798471|Heparin|heparin|mesh-list
56761114|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
56761115|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
56761116|NCT03441893|Mesalamine|mesalamine|mesh-list
56761117|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56761118|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56761119|NCT03441893|Analgesics|analgesics|mesh-ancestor
56761120|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
56761121|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761122|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761123|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761124|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56761125|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56761126|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761127|NCT03440177|Ramipril|ramipril|mesh-list
56761128|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56761129|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
56761130|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761131|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761132|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56761133|NCT00489736|Amiodarone|amiodarone|mesh-list
56761134|NCT00489736|Dronedarone|dronedarone|mesh-list
56761135|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56761136|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
56761137|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56761138|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56761139|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761143|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761161|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56761162|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56761163|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761164|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761165|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761166|NCT00874484|Enoxaparin|enoxaparin|mesh-list
56761167|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
56761168|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56761169|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56761170|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761171|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56761172|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
56761173|NCT00489424|Acetaminophen|acetaminophen|mesh-list
56761174|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56761175|NCT00489424|Analgesics|analgesics|mesh-ancestor
56761176|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
56761177|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761178|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761179|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
56761180|NCT00869570|Capecitabine|capecitabine|mesh-list
56761181|NCT00869570|Sorafenib|sorafenib|mesh-list
56761182|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56761183|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
56761185|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761213|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761214|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56761215|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761216|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761217|NCT03412643|Paclitaxel|paclitaxel|mesh-list
56761218|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
56761219|NCT03412643|Doxorubicin|doxorubicin|mesh-list
56761220|NCT03412643|Trastuzumab|trastuzumab|mesh-list
56761221|NCT03412643|Pertuzumab|pertuzumab|mesh-list
56761222|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56761223|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761224|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
56761225|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
56761226|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
56761227|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761228|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761229|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
56761230|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761231|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56761232|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56761233|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
56761234|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56761235|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56761236|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56761237|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56761238|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761239|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761259|NCT00933894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56761260|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56761261|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56761262|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761263|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761264|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
56761265|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761266|NCT00933894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56761267|NCT00933894|Antidepressive Agents|antidepressive agents|mesh-ancestor
56761268|NCT00933894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56761269|NCT00564486|Acetaminophen|acetaminophen|mesh-list
56761270|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56761271|NCT00564486|Analgesics|analgesics|mesh-ancestor
56761272|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
56761273|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761274|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761275|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
56761276|NCT00481078|Paclitaxel|paclitaxel|mesh-list
56761277|NCT00481078|Carboplatin|carboplatin|mesh-list
56761278|NCT00481078|Vorinostat|vorinostat|mesh-list
56761279|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56761280|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761281|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
56761282|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
56761283|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
56761284|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761285|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56761286|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761287|NCT00480532|Doxycycline|doxycycline|mesh-list
56761288|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
56761289|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56761290|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56761291|NCT00480532|Estradiol|estradiol|mesh-list
56761292|NCT00480532|Estrogens|estrogens|mesh-ancestor
56761293|NCT00480532|Hormones|hormones|mesh-ancestor
56761294|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56761295|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033024|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
56761296|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56761297|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
56761298|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56761299|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56761300|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761301|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761302|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
56761303|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56761304|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56761305|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56761306|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56761307|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56761308|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56761309|NCT04013880|Decitabine|decitabine|mesh-list
56761310|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56761311|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
56761312|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761313|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761314|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761315|NCT00934518|Cetuximab|cetuximab|mesh-list
56761316|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761317|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761318|NCT00496366|Capecitabine|capecitabine|mesh-list
56761319|NCT00496366|Lapatinib|lapatinib|mesh-list
56761320|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56761321|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
56761322|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761323|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761324|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56034039|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
56034040|NCT02158520|Antibodies|antibodies|mesh-list
56034041|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
56034042|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56034043|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
56034044|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56034045|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034046|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
56761341|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
56761342|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761343|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56761344|NCT00934830|Amoxicillin|amoxicillin|mesh-list
56761345|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761346|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
56761347|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761348|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761349|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
56761350|NCT00564018|Protamines|protamines|mesh-list
56761351|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56761352|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761390|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
56761391|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761392|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56761393|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
56761394|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
56761395|NCT03356483|Vitamins|vitamins|mesh-ancestor
56761396|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
56761397|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761398|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
56761399|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56761400|NCT03093480|Factor VIII|factor viii|mesh-list
56761401|NCT03093480|Coagulants|coagulants|mesh-ancestor
56761402|NCT02578511|Ixazomib|ixazomib|mesh-list
56761403|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761404|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
56761405|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761406|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761407|NCT00563784|Paclitaxel|paclitaxel|mesh-list
56761408|NCT00563784|Carboplatin|carboplatin|mesh-list
56761409|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56761410|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56761411|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761412|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
56761413|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
56761414|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
56761415|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761416|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56761417|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761418|NCT00203047|Prednisone|prednisone|mesh-list
56761419|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
56761420|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
56761421|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761423|NCT00203047|Hormones|hormones|mesh-ancestor
56761434|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761435|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
56761436|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
56761437|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56761438|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761439|NCT04074551|Losartan|losartan|mesh-list
56761440|NCT04074551|Amlodipine|amlodipine|mesh-list
56761441|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56761442|NCT04074551|Ezetimibe|ezetimibe|mesh-list
56761443|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56761444|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56761445|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56761446|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761447|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56761448|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761449|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
56761450|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56761451|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56761452|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
56761453|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56761454|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56761455|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761456|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56761457|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56761458|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56761459|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
56761460|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761461|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761481|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
56761482|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761483|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761484|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56761485|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
56761487|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56761488|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56761489|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761490|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
56761491|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761492|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761493|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
56761494|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56761495|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56761496|NCT03713294|Growth Substances|growth substances|mesh-ancestor
56761497|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
56761498|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
56761499|NCT00141817|Pantoprazole|pantoprazole|mesh-list
56761500|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56761501|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56761502|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56761503|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761504|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761505|NCT03967171|Oxytocin|oxytocin|mesh-list
56761506|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
56761507|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56761508|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761509|NCT03967327|Morphine|morphine|mesh-list
56761510|NCT03967327|Buprenorphine|buprenorphine|mesh-list
56761527|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761528|NCT00874562|Sirolimus|sirolimus|mesh-list
56761529|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761530|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761531|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56761532|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761533|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
56761534|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761535|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
56761536|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761537|NCT00201643|Dexamethasone|dexamethasone|mesh-list
56761538|NCT00201643|Betamethasone|betamethasone|mesh-list
56761539|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761540|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
56761541|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
56761542|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761543|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033025|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
56033026|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033027|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033028|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033029|NCT04369586|Meplazumab|meplazumab|mesh-list
56033030|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
56033031|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033032|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
56033033|NCT02231177|Olodaterol|olodaterol|mesh-list
56033034|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56033063|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56033064|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56033065|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
56033066|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190435|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56190437|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190438|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190439|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56033067|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033068|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56033069|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56033070|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033071|NCT01632215|Gabapentin|gabapentin|mesh-list
56033072|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
56033073|NCT01632215|Analgesics|analgesics|mesh-ancestor
56033074|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
56033075|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033076|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033077|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56033078|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56033079|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033130|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56033131|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033132|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
56033133|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56033134|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56033135|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033136|NCT03060083|Nicotine|nicotine|mesh-list
56033137|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56033138|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
56033139|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033140|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761544|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56761545|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
56761546|NCT00201643|Hormones|hormones|mesh-ancestor
56761547|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56761548|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56761549|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761550|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56761551|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
56761552|NCT03798314|Nivolumab|nivolumab|mesh-list
56761553|NCT03798314|Pomalidomide|pomalidomide|mesh-list
56761554|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761555|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472493|NCT00516438|Topotecan|topotecan|mesh-list
56761556|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56761557|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761558|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
56761559|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761560|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56761561|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56761562|NCT03798314|Growth Substances|growth substances|mesh-ancestor
56761563|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
56761565|NCT01077427|Capecitabine|capecitabine|mesh-list
56761566|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761567|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56761568|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
56761569|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761570|NCT01077427|Antiviral Agents|antiviral agents|mesh-ancestor
56761571|NCT01077427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761572|NCT01077427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761573|NCT01077427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033145|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033147|NCT02244710|Ticagrelor|ticagrelor|mesh-list
56033148|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56033149|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56033150|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56033151|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56033183|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56033184|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56033185|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
56033186|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
56033187|NCT02159495|Fludarabine|fludarabine|mesh-list
56033188|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
56033189|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761574|NCT01077427|Immunologic Factors|immunologic factors|mesh-ancestor
56761575|NCT01077427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761576|NCT00883064|Lisinopril|lisinopril|mesh-list
56761577|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56761578|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
56761579|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761580|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761581|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56761582|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56761583|NCT00883064|Protective Agents|protective agents|mesh-ancestor
56761584|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761585|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
56761586|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
56761587|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
56761588|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
56761589|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56761590|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761591|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56761592|NCT01077505|Incretins|incretins|mesh-ancestor
56761593|NCT01077505|Hormones|hormones|mesh-ancestor
56761594|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56761595|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56761596|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56761597|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56761598|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
56761599|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56761600|NCT01073995|Triamcinolone|triamcinolone|mesh-list
56761601|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56761602|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56761615|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761616|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
56761617|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761618|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761619|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56761620|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56761621|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56761622|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56761623|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761624|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56761625|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56761626|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56761627|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56472616|NCT02949765|Iron|iron|mesh-list
56761628|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
56761629|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761630|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761631|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56761632|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56761633|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
56761634|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56761635|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56761636|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
56761637|NCT00874874|Sorafenib|sorafenib|mesh-list
56761638|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761639|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56761642|NCT04489628|Vitamin D|vitamin d|mesh-list
56761660|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
56761661|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761662|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56761663|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
56761664|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56761665|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56761666|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
56761667|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56761668|NCT00130039|Protective Agents|protective agents|mesh-ancestor
56761669|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56761670|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56761671|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761672|NCT00875030|Artesunate|artesunate|mesh-list
56761673|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
56761674|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56761675|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56761676|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761677|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761678|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
56761679|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
56761680|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56761681|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
56761682|NCT00883298|Bevacizumab|bevacizumab|mesh-list
56761683|NCT00883298|Temozolomide|temozolomide|mesh-list
56761684|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761685|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761686|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56761687|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56761688|NCT00883298|Growth Substances|growth substances|mesh-ancestor
56761689|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761690|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
56761691|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56761692|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
56761693|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761694|NCT00881114|Cetuximab|cetuximab|mesh-list
56761695|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761696|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761698|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
56761699|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761700|NCT00141271|Ziprasidone|ziprasidone|mesh-list
56761701|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56761702|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
56761703|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761704|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761705|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761706|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56761707|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56761708|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56761709|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56761710|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56761711|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
56761712|NCT01017640|Mitomycins|mitomycins|mesh-list
56761713|NCT01017640|Mitomycin|mitomycin|mesh-list
56761714|NCT01017640|Veliparib|veliparib|mesh-list
56761715|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56761716|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761717|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
56761718|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761719|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56761720|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761721|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56761722|NCT00614120|Metformin|metformin|mesh-list
56761723|NCT00614120|Liraglutide|liraglutide|mesh-list
56761724|NCT00614120|Glimepiride|glimepiride|mesh-list
56761725|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56761726|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761727|NCT00614120|Incretins|incretins|mesh-ancestor
56761728|NCT00614120|Hormones|hormones|mesh-ancestor
56761729|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56761730|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56761731|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761739|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761740|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761741|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
56761742|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761743|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56761744|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56761745|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
56761746|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56761747|NCT00495820|Methylphenidate|methylphenidate|mesh-list
56761748|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56761749|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761750|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56761751|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56761752|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56761753|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761754|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
56761755|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761756|NCT04387240|Artesunate|artesunate|mesh-list
56761757|NCT04387240|Artemisinins|artemisinins|mesh-list
56761758|NCT04387240|Artemisinin|artemisinin|mesh-list
56761759|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
56761760|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56761761|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56761762|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761763|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761764|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
56761765|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
56761766|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56761767|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
56761768|NCT00495586|Amoxicillin|amoxicillin|mesh-list
56761769|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
56761770|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
56761771|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761772|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761773|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761779|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
56761780|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761781|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761782|NCT00613730|Antiviral Agents|antiviral agents|mesh-ancestor
56761783|NCT00613730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761784|NCT00613730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761785|NCT00613730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761786|NCT00613730|Immunologic Factors|immunologic factors|mesh-ancestor
56761787|NCT00613730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761788|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56761790|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
56761791|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56761792|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
56761793|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761794|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761795|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56761796|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
56761797|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
56761798|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56761799|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
56761800|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761801|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761802|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
56761803|NCT00881426|Cefprozil|cefprozil|mesh-list
56761804|NCT00881426|Cephalosporins|cephalosporins|mesh-list
56761805|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761806|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761828|NCT00881738|Clarithromycin|clarithromycin|mesh-list
56761829|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761830|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761831|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56761832|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761833|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761834|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56761835|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56761836|NCT00613106|Ibuprofen|ibuprofen|mesh-list
56761837|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56761838|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56761839|NCT00613106|Analgesics|analgesics|mesh-ancestor
56761840|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
56761841|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56761842|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761843|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761844|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56761845|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56761846|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761847|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761848|NCT00881816|Paclitaxel|paclitaxel|mesh-list
56761849|NCT00881816|Capecitabine|capecitabine|mesh-list
56761850|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56761851|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761852|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
56761874|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761875|NCT00875966|Azithromycin|azithromycin|mesh-list
56761876|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761877|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761878|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
56761879|NCT00141037|Trimethoprim|trimethoprim|mesh-list
56761880|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
56761881|NCT00141037|Valganciclovir|valganciclovir|mesh-list
56761882|NCT00141037|Ganciclovir|ganciclovir|mesh-list
56761883|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56761884|NCT00141037|Prednisone|prednisone|mesh-list
56761885|NCT00141037|Tacrolimus|tacrolimus|mesh-list
56761886|NCT00141037|Daclizumab|daclizumab|mesh-list
56761887|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761888|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
56761889|NCT00141037|Hormones|hormones|mesh-ancestor
56761890|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56761891|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761892|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56761893|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761894|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761895|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
56761896|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56761897|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761898|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761899|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56761900|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56761901|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
56761902|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761903|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761904|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56761905|NCT00141037|Renal Agents|renal agents|mesh-ancestor
56761906|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
56761918|NCT01582555|Protective Agents|protective agents|mesh-ancestor
56761919|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761920|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
56761921|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761922|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
56761923|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761924|NCT01582555|Expectorants|expectorants|mesh-ancestor
56761925|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
56761926|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56761927|NCT00139477|Metformin|metformin|mesh-list
56472863|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
56761928|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56761929|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761930|NCT04115774|Diphosphonates|diphosphonates|mesh-list
56761931|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56761932|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761933|NCT00923390|Aldesleukin|aldesleukin|mesh-list
56761934|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
56761935|NCT00923390|Fludarabine|fludarabine|mesh-list
56761936|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761937|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
56761938|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761939|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56761940|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56761941|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
56761942|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761943|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761944|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56761945|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56761946|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56761947|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
56761948|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761949|NCT00885794|Ranibizumab|ranibizumab|mesh-list
56761959|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56761960|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
56761961|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56761962|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56761963|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56761964|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
56761965|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761966|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56761967|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56761968|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56761969|NCT00888758|Sirolimus|sirolimus|mesh-list
56761970|NCT00888758|Umirolimus|umirolimus|mesh-list
56761971|NCT00888758|Everolimus|everolimus|mesh-list
56761972|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56761973|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56761974|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
56761975|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761976|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56761977|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56761978|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761979|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56761980|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
56761981|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56761982|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56761983|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
56761984|NCT04038320|Ledipasvir|ledipasvir|mesh-list
56761985|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
56761986|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56761987|NCT00563706|Risperidone|risperidone|mesh-list
56761988|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56761989|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
56761990|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56761991|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56761992|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762001|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762002|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56762003|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762004|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762005|NCT00939588|Valsartan|valsartan|mesh-list
56762006|NCT00939588|Telmisartan|telmisartan|mesh-list
56762007|NCT00939588|Ramipril|ramipril|mesh-list
56762008|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56762009|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56762010|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56762011|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762012|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56762013|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
56762014|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762015|NCT00889148|Gabapentin|gabapentin|mesh-list
56762016|NCT00889148|Analgesics|analgesics|mesh-ancestor
56762017|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
56762018|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762019|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762020|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
56762021|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56762022|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56762023|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56762024|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56762025|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56762026|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56762027|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762028|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762029|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
56762030|NCT00936156|Carboplatin|carboplatin|mesh-list
56762031|NCT00936156|Etoposide|etoposide|mesh-list
56762032|NCT00936156|Thiotepa|thiotepa|mesh-list
56762033|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762034|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56762035|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56762036|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56033190|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
56033191|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033192|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56034738|NCT05184101|Heparin|heparin|mesh-list
56034739|NCT05184101|Calcium heparin|calcium heparin|mesh-list
56034740|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
56762037|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762038|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762039|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56762040|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
56762041|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56762042|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56762043|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
56762044|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762045|NCT00129961|Cyclosporine|cyclosporine|mesh-list
56762046|NCT00129961|Sirolimus|sirolimus|mesh-list
56762047|NCT00129961|Tacrolimus|tacrolimus|mesh-list
56762048|NCT00129961|Cyclosporins|cyclosporins|mesh-list
56762049|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56762050|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
56762051|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762052|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56762053|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762054|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762055|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
56762056|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762057|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
56762058|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762059|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56762060|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56762061|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762062|NCT00528567|Bevacizumab|bevacizumab|mesh-list
56762063|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762064|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762065|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56762066|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56762075|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762076|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762077|NCT00886028|Doxorubicin|doxorubicin|mesh-list
56762078|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56762079|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762080|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56762081|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56762082|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56762083|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762084|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762085|NCT00936546|Rituximab|rituximab|mesh-list
56762086|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762087|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762088|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
56762089|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762090|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762091|NCT00936624|Montelukast|montelukast|mesh-list
56762092|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56762093|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
56762094|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56762095|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
56762096|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762097|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762098|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56762099|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56762101|NCT00138151|Interferons|interferons|mesh-list
56762121|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762122|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56762123|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56762124|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
56762125|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762126|NCT00889616|Antacids|antacids|mesh-ancestor
56762127|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762128|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762129|NCT02581631|Nivolumab|nivolumab|mesh-list
56762130|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56762131|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762132|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762133|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56762134|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762135|NCT00884546|Dexamethasone|dexamethasone|mesh-list
56762136|NCT00884546|Lenalidomide|lenalidomide|mesh-list
56762137|NCT00884546|Bortezomib|bortezomib|mesh-list
56762138|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762139|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
56762140|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
56762141|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762142|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762143|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762144|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
56762145|NCT00884546|Hormones|hormones|mesh-ancestor
56762146|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762147|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56762148|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762149|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
56762150|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56762151|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56762152|NCT00884546|Growth Substances|growth substances|mesh-ancestor
56762153|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
56762154|NCT00886106|Midazolam|midazolam|mesh-list
56762162|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56762163|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56762164|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
56762166|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
56762167|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
56762168|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762169|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762170|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56762171|NCT00886106|Narcotics|narcotics|mesh-ancestor
56762172|NCT00886106|Analgesics|analgesics|mesh-ancestor
56762173|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
56762174|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762175|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
56762176|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762177|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56762178|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56762179|NCT00889694|Analgesics|analgesics|mesh-ancestor
56762180|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
56762181|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762182|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762183|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762184|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762185|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762186|NCT00529035|Interleukin-2|interleukin-2|mesh-list
56762189|NCT00529035|Analgesics|analgesics|mesh-ancestor
56762215|NCT04895709|Antimitotic Agents|antimitotic agents|mesh-ancestor
56762216|NCT04895709|Mitosis Modulators|mitosis modulators|mesh-ancestor
56762217|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762218|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762219|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56762220|NCT00889850|Esomeprazole|esomeprazole|mesh-list
56762221|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56762222|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762223|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56762224|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762225|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762226|NCT04074317|Insulin|insulin|mesh-list
56762227|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56762228|NCT04074317|Pramlintide|pramlintide|mesh-list
56762229|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56762230|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762231|NCT00941148|Insulin|insulin|mesh-list
56762232|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56762233|NCT00941148|Metformin|metformin|mesh-list
56762234|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
56762235|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
56762236|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
56762237|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
56762238|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56762239|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762240|NCT02541500|Minocycline|minocycline|mesh-list
56762241|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56762242|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762243|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
56762244|NCT04073849|Hematinics|hematinics|mesh-ancestor
56762246|NCT03263429|Panitumumab|panitumumab|mesh-list
56762262|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
56762263|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56762264|NCT00941382|Metformin|metformin|mesh-list
56762265|NCT00941382|Sibutramine|sibutramine|mesh-list
56762266|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56762267|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762268|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
56762269|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56762270|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
56762271|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56762272|NCT03253679|Adavosertib|adavosertib|mesh-list
56762273|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762274|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762275|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56762276|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762277|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56762278|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762279|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762280|NCT00941460|Temozolomide|temozolomide|mesh-list
56762281|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56762282|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
56762283|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762284|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762285|NCT00890318|Ketoconazole|ketoconazole|mesh-list
56762286|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
56762287|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762288|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56762289|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56762290|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762291|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762292|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56762293|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
56762295|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762301|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762302|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762303|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762304|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762305|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
56762306|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56762307|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56762308|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762309|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56762310|NCT04037774|Analgesics|analgesics|mesh-ancestor
56762311|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
56762312|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762313|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56762314|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56762315|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56762316|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
56762317|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762318|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762319|NCT02542748|Norepinephrine|norepinephrine|mesh-list
56762320|NCT02542748|Ephedrine|ephedrine|mesh-list
56762321|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56762322|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56762323|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
56762324|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762327|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
56762349|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762350|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56762351|NCT02542592|Protective Agents|protective agents|mesh-ancestor
56762352|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56762353|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762354|NCT03178487|Upadacitinib|upadacitinib|mesh-list
56762355|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56762356|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56762357|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762358|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762359|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762360|NCT04430036|Gemcitabine|gemcitabine|mesh-list
56762361|NCT04430036|Cisplatin|cisplatin|mesh-list
56762362|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762363|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56762364|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
56762365|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762366|NCT04430036|Antiviral Agents|antiviral agents|mesh-ancestor
56762367|NCT04430036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762368|NCT04430036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762369|NCT04430036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56762370|NCT04430036|Immunologic Factors|immunologic factors|mesh-ancestor
56762371|NCT04430036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762372|NCT00528957|Tenofovir|tenofovir|mesh-list
56762373|NCT00528957|Zidovudine|zidovudine|mesh-list
56762374|NCT00528957|Stavudine|stavudine|mesh-list
56762397|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762398|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762399|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56762400|NCT00890786|Bevacizumab|bevacizumab|mesh-list
56762401|NCT00890786|Irinotecan|irinotecan|mesh-list
56762402|NCT00890786|Temozolomide|temozolomide|mesh-list
56762403|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762404|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762405|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56762406|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56762407|NCT00890786|Growth Substances|growth substances|mesh-ancestor
56762408|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762409|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
56762410|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56762411|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56762412|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762413|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762414|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56762415|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
56762416|NCT00560508|Pramipexole|pramipexole|mesh-list
56762417|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
56762418|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762419|NCT00560508|Protective Agents|protective agents|mesh-ancestor
56762420|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762421|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56762422|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56762423|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
56762424|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
56762425|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762426|NCT00890942|Naloxone|naloxone|mesh-list
56762427|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56762428|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762429|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
56762430|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762431|NCT00942006|Doxycycline|doxycycline|mesh-list
56762435|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
56762436|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56762437|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56762438|NCT02542124|Interleukin-12|interleukin-12|mesh-list
56762439|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56762440|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
56762441|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762442|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56762443|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56762444|NCT02542124|Growth Substances|growth substances|mesh-ancestor
56762445|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
56762446|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762447|NCT00942318|Insulin|insulin|mesh-list
56762448|NCT00942318|Metformin|metformin|mesh-list
56762449|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
56762450|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56762451|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762452|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56762453|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56762454|NCT05280054|Probenecid|probenecid|mesh-list
56762455|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
56762456|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
56762457|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762458|NCT05280054|Renal Agents|renal agents|mesh-ancestor
56762459|NCT03999099|Suvorexant|suvorexant|mesh-list
56473386|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56762460|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56762461|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56762462|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56762465|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762484|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762485|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762486|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
56762487|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
56762488|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762489|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762490|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
56762491|NCT00609518|Hormones|hormones|mesh-ancestor
56762492|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762493|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56762494|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762495|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
56762496|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762497|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762498|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56762499|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56762500|NCT00609518|Hematinics|hematinics|mesh-ancestor
56762501|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56762502|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56762503|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762504|NCT00886496|Lectins|lectins|mesh-list
56762505|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
56762506|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
56762507|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762508|NCT00886496|Coagulants|coagulants|mesh-ancestor
56762534|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762535|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56762536|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
56762537|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762538|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762539|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56762540|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56762541|NCT00886574|Aspirin|aspirin|mesh-list
56762542|NCT00886574|Cilostazol|cilostazol|mesh-list
56762543|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56762544|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56762545|NCT00886574|Analgesics|analgesics|mesh-ancestor
56762546|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
56762547|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762548|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762549|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762550|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762551|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56762552|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56762553|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762554|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56762555|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56762556|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762557|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
56762558|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56762580|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56762581|NCT00137449|Growth Substances|growth substances|mesh-ancestor
56762582|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762583|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
56762584|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56762585|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762586|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762587|NCT00886886|Reboxetine|reboxetine|mesh-list
56762588|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
56762589|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56762590|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56762591|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56762592|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56762593|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762594|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56762595|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762596|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762597|NCT00887042|Fludarabine|fludarabine|mesh-list
56762598|NCT00887042|Busulfan|busulfan|mesh-list
56762599|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
56762600|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762601|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762602|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56762603|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
56762604|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762605|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
56762606|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56762607|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56762608|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
56762609|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
56762610|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56762611|NCT00892112|Antibodies|antibodies|mesh-list
56762612|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
56762613|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56762614|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
56762619|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56762620|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56762621|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
56762622|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762623|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762624|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56762625|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56762626|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
56762627|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762628|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56762629|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56762630|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
56762631|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
56762632|NCT00885326|Bevacizumab|bevacizumab|mesh-list
56762633|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56762634|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
56762635|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762636|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762637|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56762638|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
56762639|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762640|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762641|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56762642|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56762643|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56762644|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56762645|NCT00885326|Growth Substances|growth substances|mesh-ancestor
56762646|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
56762647|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56762648|NCT00892190|Dasatinib|dasatinib|mesh-list
56762649|NCT00892190|Tretinoin|tretinoin|mesh-list
56762650|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762661|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56762662|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56762663|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762664|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762665|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762666|NCT00528879|Metformin|metformin|mesh-list
56762667|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
56762668|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56762669|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762670|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56762671|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762672|NCT00608894|Prednisone|prednisone|mesh-list
56762673|NCT00608894|Azathioprine|azathioprine|mesh-list
56762674|NCT00608894|Tacrolimus|tacrolimus|mesh-list
56762675|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762676|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
56762677|NCT00608894|Hormones|hormones|mesh-ancestor
56762678|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762679|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762680|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56762681|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762682|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56762683|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
56762684|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56762685|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762686|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762687|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
56762688|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56762689|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762690|NCT00892346|Thalidomide|thalidomide|mesh-list
56762704|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56762705|NCT00892346|Growth Substances|growth substances|mesh-ancestor
56762706|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
56762707|NCT00892424|Sorafenib|sorafenib|mesh-list
56762708|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762709|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56762710|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762711|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762712|NCT02541032|Minocycline|minocycline|mesh-list
56762713|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56762714|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762715|NCT00892502|Bismuth|bismuth|mesh-list
56762716|NCT00892502|Antacids|antacids|mesh-ancestor
56762717|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762718|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762719|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56762720|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
56762721|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56762722|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56762723|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56762724|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
56762725|NCT00191113|Estradiol|estradiol|mesh-list
56762726|NCT00191113|Hormones|hormones|mesh-ancestor
56762727|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762728|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762729|NCT00191113|Estrogens|estrogens|mesh-ancestor
56762730|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56762731|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
56762732|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56762733|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56762734|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56762735|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56762736|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56762746|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56762747|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762748|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762749|NCT00892736|Veliparib|veliparib|mesh-list
56762750|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56762751|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762752|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762753|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762754|NCT03966235|Melatonin|melatonin|mesh-list
56762755|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
56762756|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762757|NCT03966235|Protective Agents|protective agents|mesh-ancestor
56762758|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762759|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56762760|NCT01077661|Nebivolol|nebivolol|mesh-list
56762761|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56762762|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
56762763|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56762765|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56762766|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
56762767|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762768|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762769|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762770|NCT00606320|Aripiprazole|aripiprazole|mesh-list
56762771|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
56762772|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56762773|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56762774|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56762775|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56762776|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762777|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
56762778|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
56762779|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762780|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762781|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55760410|NCT04860531|Betamethasone|betamethasone|mesh-list
56033193|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56762782|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56762783|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
56762784|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56762785|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56762786|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56762787|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56762788|NCT03966079|Plasminogen|plasminogen|mesh-list
56762789|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56762790|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56762791|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56762792|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762793|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
56762794|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
56762795|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56762796|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762797|NCT03966859|Atorvastatin|atorvastatin|mesh-list
56762798|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56762799|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56762800|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
56762801|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762802|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56762803|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56762804|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762805|NCT00528411|Aspirin|aspirin|mesh-list
56762806|NCT00528411|Clopidogrel|clopidogrel|mesh-list
56762807|NCT00528411|Ticagrelor|ticagrelor|mesh-list
56762808|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56762809|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56762810|NCT00528411|Analgesics|analgesics|mesh-ancestor
56762826|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
56762827|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762828|NCT00895544|Vaccines|vaccines|mesh-list
56762829|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
56762830|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762831|NCT00895778|Rocuronium|rocuronium|mesh-list
56762832|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56762833|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56762834|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56473756|NCT02276378|Diuretics|diuretics|mesh-ancestor
56762835|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762836|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762838|NCT00187135|Propofol|propofol|mesh-list
56762839|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56762840|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56762841|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762842|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56762843|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
56762844|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
56762845|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56762846|NCT00187135|Narcotics|narcotics|mesh-ancestor
56762847|NCT00187135|Analgesics|analgesics|mesh-ancestor
56762848|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
56762849|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762850|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56762851|NCT00896402|Iodine|iodine|mesh-list
56762852|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
56762853|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56762854|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
56762855|NCT00896402|Povidone|povidone|mesh-list
56762856|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56762857|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762858|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
56762859|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
56762860|NCT00896402|Trace Elements|trace elements|mesh-ancestor
56762861|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
56762862|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762868|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762869|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
56762870|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
56762871|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762872|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762873|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56762874|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
56762875|NCT00560352|Hormones|hormones|mesh-ancestor
56762876|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762877|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56762878|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762879|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56762880|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762881|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762882|NCT00892892|Nitrendipine|nitrendipine|mesh-list
56762883|NCT00892892|Rilmenidine|rilmenidine|mesh-list
56762884|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56762885|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56762886|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56762887|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762888|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56762889|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762890|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
56762891|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
56762892|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
56762893|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56762894|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56762895|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56762896|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56762897|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
56762910|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762911|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762912|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
56762913|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56762914|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762915|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762916|NCT00893048|Prednisone|prednisone|mesh-list
56762917|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56762918|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
56762919|NCT00893048|Hormones|hormones|mesh-ancestor
56762920|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56762921|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762922|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56762923|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762924|NCT00942864|Ranibizumab|ranibizumab|mesh-list
56762925|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56762926|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56762927|NCT00942864|Growth Substances|growth substances|mesh-ancestor
56762928|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762929|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
56762930|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762931|NCT04036448|Lenalidomide|lenalidomide|mesh-list
56762932|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
56762933|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762934|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56762935|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56762936|NCT04036448|Growth Substances|growth substances|mesh-ancestor
56762937|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
56762938|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762939|NCT00896558|Midazolam|midazolam|mesh-list
56762940|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56762941|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56762942|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56762943|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762944|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56762945|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56762946|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56762948|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
56762949|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
56762950|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
56762951|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
56762952|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56762953|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762954|NCT00943176|Modafinil|modafinil|mesh-list
56762955|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56762956|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762957|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56762958|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56762959|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56762960|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762961|NCT00129259|Iron|iron|mesh-list
56762962|NCT00129259|Trace Elements|trace elements|mesh-ancestor
56762963|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
56762964|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762965|NCT00896714|Anesthetics|anesthetics|mesh-list
56762966|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56762967|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762968|NCT00940524|Cytarabine|cytarabine|mesh-list
56762969|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
56762970|NCT00940524|Methotrexate|methotrexate|mesh-list
56762971|NCT00940524|Etoposide|etoposide|mesh-list
56762972|NCT00940524|Asparaginase|asparaginase|mesh-list
56762973|NCT00940524|Dasatinib|dasatinib|mesh-list
56762974|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
56762975|NCT00940524|Pegaspargase|pegaspargase|mesh-list
56762976|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56762977|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
56762978|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56762979|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56762980|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56762981|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
56762982|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56762983|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56762988|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56762989|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
56762990|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
56762991|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56762992|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56762993|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56762994|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56762995|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56762996|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56762997|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
56762998|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56762999|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56763000|NCT00940524|Analgesics|analgesics|mesh-ancestor
56763001|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
56763002|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763003|NCT00186901|Vitamin D|vitamin d|mesh-list
56763004|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
56763005|NCT00186901|Calcium|calcium|mesh-list
56763006|NCT00186901|Vitamins|vitamins|mesh-ancestor
56763007|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
56763008|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763009|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56763010|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56763011|NCT00186901|Antacids|antacids|mesh-ancestor
56763012|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763013|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56763014|NCT00943410|Trastuzumab|trastuzumab|mesh-list
56763015|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56763016|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763017|NCT00896948|Antibodies|antibodies|mesh-list
56763018|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
56763019|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763030|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763031|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763032|NCT00897026|Paclitaxel|paclitaxel|mesh-list
56763033|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
56763034|NCT00897026|Doxorubicin|doxorubicin|mesh-list
56763035|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56763036|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56763037|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763038|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
56763039|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
56763040|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
56763041|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763042|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763043|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
56763044|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763045|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56763046|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56763047|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
56763048|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56763049|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56763050|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56763051|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56763052|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763053|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56763054|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
56763055|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56763056|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56763057|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56763058|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763059|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763060|NCT01076491|Mannitol|mannitol|mesh-list
56763061|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56763062|NCT01076491|Diuretics|diuretics|mesh-ancestor
56763063|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
56763064|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763065|NCT00127933|Capecitabine|capecitabine|mesh-list
56763068|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56763069|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
56763070|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763071|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763072|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
56763073|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
56763074|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
56763075|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56763076|NCT03875313|Talazoparib|talazoparib|mesh-list
56763077|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56763078|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763079|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763080|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763081|NCT01008345|Ezetimibe|ezetimibe|mesh-list
56763082|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56763083|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56763084|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
56763085|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763086|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56763087|NCT05239533|Nivolumab|nivolumab|mesh-list
56763088|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56763089|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56763090|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763091|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56763092|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763093|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
56763094|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763095|NCT04828083|Lidocaine|lidocaine|mesh-list
56763096|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
56763097|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
56763098|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763109|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56763110|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56763111|NCT05225961|Analgesics|analgesics|mesh-ancestor
56763112|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
56763113|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763114|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763115|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763116|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56763117|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56763118|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56763119|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763120|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56763121|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56763122|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763123|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
56763124|NCT00556998|Voriconazole|voriconazole|mesh-list
56763125|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
56763126|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763127|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56763128|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56763129|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763130|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763131|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56763132|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
56763133|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763134|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763135|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56763136|NCT00945360|Letrozole|letrozole|mesh-list
56763137|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56763138|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033194|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
56033229|NCT02224313|Estradiol|estradiol|mesh-list
56033230|NCT02224313|Progesterone|progesterone|mesh-list
56033231|NCT02224313|Estrogens|estrogens|mesh-ancestor
56033232|NCT02224313|Hormones|hormones|mesh-ancestor
56033271|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56033272|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56033305|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
56033306|NCT01635101|Acetaminophen|acetaminophen|mesh-list
56033307|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56033308|NCT01635101|Analgesics|analgesics|mesh-ancestor
56033309|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
56763139|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56763140|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763141|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763142|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56763143|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
56763144|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763145|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763146|NCT00943566|Sufentanil|sufentanil|mesh-list
56763147|NCT00943566|Morphine|morphine|mesh-list
56763148|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56763149|NCT00943566|Narcotics|narcotics|mesh-ancestor
56763150|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763151|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763152|NCT00943566|Analgesics|analgesics|mesh-ancestor
56763153|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
56763154|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763155|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56763156|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56763157|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
56763158|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
56763159|NCT00940680|Losartan|losartan|mesh-list
56763160|NCT00940680|Amlodipine|amlodipine|mesh-list
56763161|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56763162|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56763163|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56763164|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763165|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56763166|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763167|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
56763168|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56763169|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56763170|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56763171|NCT00945438|Vaccines|vaccines|mesh-list
56763172|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
56763178|NCT00943956|Leuprolide|leuprolide|mesh-list
56763179|NCT00943956|Bicalutamide|bicalutamide|mesh-list
56763180|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763181|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763182|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
56763183|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763184|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56763185|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
56763186|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56763187|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763188|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
56763189|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
56763190|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763191|NCT00944346|Metformin|metformin|mesh-list
56763192|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56763193|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763194|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56763195|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763196|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56763197|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
56763198|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56763199|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56763200|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56763201|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763202|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763203|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56763204|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
56763205|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763206|NCT00940836|Acetaminophen|acetaminophen|mesh-list
56763208|NCT00940836|Phenylephrine|phenylephrine|mesh-list
56763222|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56763223|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56763224|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56763225|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
56763226|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763227|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763228|NCT00940836|Protective Agents|protective agents|mesh-ancestor
56763229|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
56763230|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
56763231|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56763232|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
56763233|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
56763234|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56763235|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
56763236|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56763237|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763238|NCT00944424|Vitamin D|vitamin d|mesh-list
56763239|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
56763240|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
56763241|NCT00944424|Vitamins|vitamins|mesh-list
56763242|NCT00944424|Docetaxel|docetaxel|mesh-list
56763243|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
56763244|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763245|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763246|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
56763247|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
56763248|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
56763249|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763250|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56763251|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56763252|NCT04591353|Lidocaine|lidocaine|mesh-list
56763253|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
56763254|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
56763255|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763261|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56763262|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56763263|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763264|NCT00944502|Dexamethasone|dexamethasone|mesh-list
56763265|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763266|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
56763267|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
56763268|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763269|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763270|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56763271|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
56763272|NCT00944502|Hormones|hormones|mesh-ancestor
56763273|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763274|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763275|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763276|NCT00949962|Leuprolide|leuprolide|mesh-list
56763277|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
56763278|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56763279|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
56763280|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56763281|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763282|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763283|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763284|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
56763285|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763287|NCT00946374|Doxorubicin|doxorubicin|mesh-list
56763288|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56763289|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763290|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56763291|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56763303|NCT05068791|Psilocybin|psilocybin|mesh-list
56763304|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
56763305|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
56763306|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56763307|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56763308|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763309|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763310|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763311|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
56763312|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56763313|NCT00950196|Amantadine|amantadine|mesh-list
56763314|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56763315|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56763316|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
56763317|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763318|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
56763319|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763320|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763321|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763322|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56763323|NCT00950196|Analgesics|analgesics|mesh-ancestor
56763324|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
56763325|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763326|NCT01565109|Docetaxel|docetaxel|mesh-list
56763354|NCT00521001|Temozolomide|temozolomide|mesh-list
56763355|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763356|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763357|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
56763358|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763359|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56763360|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
56763361|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763362|NCT00134563|Teriflunomide|teriflunomide|mesh-list
56763363|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56763364|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56763365|NCT00134563|Analgesics|analgesics|mesh-ancestor
56763366|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
56763367|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763368|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763369|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763370|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56763371|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763372|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
56763373|NCT03966547|Anesthetics|anesthetics|mesh-list
56763374|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
56763375|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763376|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763377|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
56763378|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763379|NCT01326325|Ketamine|ketamine|mesh-list
56763380|NCT01326325|Analgesics|analgesics|mesh-ancestor
56763381|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
56763382|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763383|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763384|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56763385|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56763386|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
56763387|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
56036072|NCT03013790|Melatonin|melatonin|mesh-list
56763392|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763393|NCT02408861|Nivolumab|nivolumab|mesh-list
56763394|NCT02408861|Ipilimumab|ipilimumab|mesh-list
56763395|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56763396|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763397|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56763398|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763399|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
56763400|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56763401|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56763402|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763403|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
56763404|NCT01326403|Coagulants|coagulants|mesh-ancestor
56763405|NCT00520845|Celecoxib|celecoxib|mesh-list
56763406|NCT00520845|Docetaxel|docetaxel|mesh-list
56763407|NCT00520845|Pemetrexed|pemetrexed|mesh-list
56763408|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763409|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
56763410|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
56763411|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
56763412|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763413|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763414|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56763415|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56763416|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56763417|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56763418|NCT00520845|Analgesics|analgesics|mesh-ancestor
56763419|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
56763420|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763422|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763435|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56763436|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763437|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56763438|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56763439|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56763440|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763441|NCT00520767|Dexamethasone|dexamethasone|mesh-list
56763442|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
56763443|NCT00520767|Bortezomib|bortezomib|mesh-list
56763444|NCT00520767|Melphalan|melphalan|mesh-list
56763445|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56763446|NCT00520767|BB 1101|bb 1101|mesh-list
56763447|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763448|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
56763449|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
56763450|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763451|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763452|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56763453|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
56763454|NCT00520767|Hormones|hormones|mesh-ancestor
56763455|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763456|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763457|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763458|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
56763459|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763462|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
56763483|NCT01017796|Expectorants|expectorants|mesh-ancestor
56763484|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
56763485|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56763486|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
56763487|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763488|NCT01017796|Protective Agents|protective agents|mesh-ancestor
56763489|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763490|NCT01017796|Antidotes|antidotes|mesh-ancestor
56763491|NCT01017796|Vitamins|vitamins|mesh-ancestor
56763492|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
56763493|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
56763494|NCT01783535|Carboplatin|carboplatin|mesh-list
56763495|NCT01783535|Doxorubicin|doxorubicin|mesh-list
56763496|NCT01783535|Etoposide|etoposide|mesh-list
56763497|NCT01783535|Vincristine|vincristine|mesh-list
56763498|NCT01783535|Topotecan|topotecan|mesh-list
56763499|NCT01783535|Lenograstim|lenograstim|mesh-list
56763500|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763501|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
56763502|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763503|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56763504|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56763505|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
56763506|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763507|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763508|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56763509|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56763510|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56763511|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56763513|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56763514|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56763515|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
56763516|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
56763528|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763529|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56763530|NCT00494026|Carboplatin|carboplatin|mesh-list
56763531|NCT00494026|Pemetrexed|pemetrexed|mesh-list
56763532|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763533|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763534|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763535|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56763536|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56763537|NCT00524589|Calcitriol|calcitriol|mesh-list
56763538|NCT00524589|Dexamethasone|dexamethasone|mesh-list
56763539|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763540|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
56763541|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
56763542|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763543|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763544|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56763545|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
56763546|NCT00524589|Hormones|hormones|mesh-ancestor
56763547|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763548|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763549|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763550|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56763551|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56763552|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56763553|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763554|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56763555|NCT00524589|Vitamins|vitamins|mesh-ancestor
56763556|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
56763557|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56033310|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033311|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033312|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
56033313|NCT02087111|Interferons|interferons|mesh-list
56033314|NCT02087111|Ribavirin|ribavirin|mesh-list
56033315|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
56033316|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
56763577|NCT01015066|Naltrexone|naltrexone|mesh-list
56763578|NCT01015066|Buprenorphine|buprenorphine|mesh-list
56763579|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56763580|NCT01015066|Naloxone|naloxone|mesh-list
56763581|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56763582|NCT01015066|Narcotics|narcotics|mesh-ancestor
56763583|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763584|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763585|NCT01015066|Analgesics|analgesics|mesh-ancestor
56474514|NCT00528177|Analgesics|analgesics|mesh-ancestor
56763586|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
56763587|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763588|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56763589|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56763590|NCT00472030|Omalizumab|omalizumab|mesh-list
56763591|NCT00472030|Prednisone|prednisone|mesh-list
56763592|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763593|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
56763594|NCT00472030|Hormones|hormones|mesh-ancestor
56763595|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763596|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763597|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763598|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763599|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56763600|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56763601|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
56763602|NCT00127855|Vaccines|vaccines|mesh-list
56763603|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56763604|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
56763605|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763606|NCT00493636|Gemcitabine|gemcitabine|mesh-list
56763610|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
56763611|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763612|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763613|NCT00493636|Antiviral Agents|antiviral agents|mesh-ancestor
56763614|NCT00493636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763615|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763616|NCT00493636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763617|NCT00493636|Immunologic Factors|immunologic factors|mesh-ancestor
56763618|NCT00493636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763619|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56763620|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56763621|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763622|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56763623|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763624|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763625|NCT04207060|Indomethacin|indomethacin|mesh-list
56763626|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56763627|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56763628|NCT04207060|Analgesics|analgesics|mesh-ancestor
56763629|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
56763630|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763631|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763632|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763633|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56763634|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
56763635|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
56763636|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56763656|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56763657|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56763658|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56763659|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
56763660|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56763661|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56763662|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
56763663|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763664|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
56763665|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56763666|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56763667|NCT00132769|MK 0873|mk 0873|mesh-list
56763668|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56763669|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56763670|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763671|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763672|NCT02500407|Atezolizumab|atezolizumab|mesh-list
56763673|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763674|NCT02478255|Xenon|xenon|mesh-list
56763675|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56763676|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
56763677|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
56763678|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763679|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763680|NCT00132691|Cyclosporine|cyclosporine|mesh-list
56763681|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
56763682|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56763683|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
56763684|NCT00132691|Chlorambucil|chlorambucil|mesh-list
56763685|NCT00132691|Methotrexate|methotrexate|mesh-list
56763686|NCT00132691|Azathioprine|azathioprine|mesh-list
56763687|NCT00132691|Infliximab|infliximab|mesh-list
56763688|NCT00132691|Tacrolimus|tacrolimus|mesh-list
56763699|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56763700|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56763701|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
56763702|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56763703|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56763704|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
56763705|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
56763706|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763707|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56763708|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56763709|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56763710|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
56763711|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56763712|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56763713|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56763714|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
56763715|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56763716|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56763717|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763718|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
56763719|NCT00132691|Hormones|hormones|mesh-ancestor
56763720|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763721|NCT02390427|Paclitaxel|paclitaxel|mesh-list
56763722|NCT02390427|Maytansine|maytansine|mesh-list
56763723|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56763724|NCT02390427|Trastuzumab|trastuzumab|mesh-list
56763725|NCT02390427|Pertuzumab|pertuzumab|mesh-list
56763726|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56763727|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763728|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
56763729|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
56763730|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
56190440|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
56190441|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56190442|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56190443|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56190444|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
56190445|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190446|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190447|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56190448|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
56190449|NCT01468272|Hormones|hormones|mesh-ancestor
56051972|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
56763731|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763732|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56763733|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56763734|NCT00125359|Bexarotene|bexarotene|mesh-list
56763735|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763736|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56763737|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763738|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763739|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56763740|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56763741|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56763793|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56763794|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763795|NCT00132301|Prednisone|prednisone|mesh-list
56763796|NCT00132301|Docetaxel|docetaxel|mesh-list
56763797|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763798|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
56763799|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
56763800|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
56763801|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763802|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763803|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
56763804|NCT00132301|Hormones|hormones|mesh-ancestor
56763805|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763806|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763807|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763808|NCT00519831|Cetuximab|cetuximab|mesh-list
56763809|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56763810|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763811|NCT04303845|Erenumab|erenumab|mesh-list
56763812|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56763813|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763814|NCT04303845|Analgesics|analgesics|mesh-ancestor
56763815|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
56763816|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763817|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763818|NCT04187703|Azacitidine|azacitidine|mesh-list
56763839|NCT00184093|Immunologic Factors|immunologic factors|mesh-ancestor
56763840|NCT00184093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763841|NCT01074619|Memantine|memantine|mesh-list
56763842|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56763843|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56763844|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
56763845|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763846|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763847|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763848|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56763849|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56763850|NCT00183625|Olanzapine|olanzapine|mesh-list
56763851|NCT00183625|Risperidone|risperidone|mesh-list
56763852|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56763853|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
56763854|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763855|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763856|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763857|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56763858|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56763859|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763860|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56763861|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56763862|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
56763863|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
56763864|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
56763865|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763887|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56763889|NCT02576327|Hormones|hormones|mesh-ancestor
56763890|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56763891|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56763892|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763893|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
56763894|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763895|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763896|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56763897|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763898|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56763899|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56763900|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
56763901|NCT00183391|Methylphenidate|methylphenidate|mesh-list
56763902|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56763903|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56763904|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763905|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56763906|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56763907|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56763908|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763909|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
56763910|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763911|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56763912|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
56763913|NCT00493246|Acetaminophen|acetaminophen|mesh-list
56763914|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56763915|NCT00493246|Analgesics|analgesics|mesh-ancestor
56763916|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
56763919|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
56763930|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763931|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56763932|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
56763933|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
56763934|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
56763935|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56763936|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56763937|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
56763938|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56763939|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763940|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56763941|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763942|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56763943|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56763944|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56763945|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56763946|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56763947|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
56763948|NCT03997006|Protective Agents|protective agents|mesh-ancestor
56763949|NCT02281955|Cisplatin|cisplatin|mesh-list
56763950|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763951|NCT02272049|Xenon|xenon|mesh-list
56763952|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56763953|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
56763954|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
56763955|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56763956|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763957|NCT03996538|Metformin|metformin|mesh-list
56763958|NCT03996538|Vaccines|vaccines|mesh-list
56763959|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
56763960|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474890|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56763961|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56763963|NCT02576015|Ropivacaine|ropivacaine|mesh-list
56763964|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
56763965|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
56763970|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56763971|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56763972|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56763973|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56763974|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763975|NCT02577965|Everolimus|everolimus|mesh-list
56763976|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763977|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56763978|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
56763979|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56763980|NCT00182689|Sorafenib|sorafenib|mesh-list
56763981|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56763982|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56763983|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56763984|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56763985|NCT02578121|Dexamethasone|dexamethasone|mesh-list
56763986|NCT02578121|Pomalidomide|pomalidomide|mesh-list
56763987|NCT02578121|Ixazomib|ixazomib|mesh-list
56763988|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56763989|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
56763990|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
56763991|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56763992|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764023|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56764024|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764025|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
56764026|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764027|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56764028|NCT02577809|Narcotics|narcotics|mesh-ancestor
56764029|NCT02577809|Analgesics|analgesics|mesh-ancestor
56764030|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56764031|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56764032|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
56764033|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56764034|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764035|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764036|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474976|NCT00513266|Vitamins|vitamins|mesh-ancestor
56764037|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
56764038|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
56764039|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56764040|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56764041|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764042|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764043|NCT02224391|Nicotine|nicotine|mesh-list
56764044|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56764045|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
56764046|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764047|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764048|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56764049|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56764050|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
56764067|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56764068|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56764069|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56764070|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56764071|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764072|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56764073|NCT00487084|Narcotics|narcotics|mesh-ancestor
56764074|NCT00487084|Analgesics|analgesics|mesh-ancestor
56764075|NCT03816345|Nivolumab|nivolumab|mesh-list
56764076|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56764077|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764078|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56764079|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764080|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
56764081|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
56764082|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56764083|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
56764084|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764085|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
56764086|NCT04202692|Protective Agents|protective agents|mesh-ancestor
56764087|NCT04202692|Antacids|antacids|mesh-ancestor
56764088|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764089|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56764090|NCT00466726|Sargramostim|sargramostim|mesh-list
56764091|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
56764092|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764093|NCT01721291|Albuterol|albuterol|mesh-list
56764094|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56764095|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
56764096|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764097|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764098|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56764099|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
56764100|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
56764106|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764107|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764108|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56764109|NCT01021540|Hormones|hormones|mesh-ancestor
56764110|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56764111|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764112|NCT04840511|Lidocaine|lidocaine|mesh-list
56764113|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
56764114|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
56764115|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56764116|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764117|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
56764118|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764119|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56764120|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56764121|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56764122|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56764123|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764124|NCT02199665|Dexamethasone|dexamethasone|mesh-list
56764125|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764126|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
56764127|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
56764128|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764129|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764130|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56764131|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
56764132|NCT02199665|Hormones|hormones|mesh-ancestor
56764151|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56764152|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56764153|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56764154|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56764155|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764156|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
56764157|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56764158|NCT02577575|Oxytocin|oxytocin|mesh-list
56764159|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
56764160|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56764161|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764162|NCT00485758|Niacin|niacin|mesh-list
56764163|NCT00485758|Niacinamide|niacinamide|mesh-list
56764164|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
56764165|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56764166|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
56764167|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764168|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56764169|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
56764170|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
56764171|NCT00485758|Vitamins|vitamins|mesh-ancestor
56764172|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
56764173|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764174|NCT02577341|Docetaxel|docetaxel|mesh-list
56764175|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
56764176|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764177|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764178|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764179|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764180|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764181|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56764182|NCT02577497|Fluticasone|fluticasone|mesh-list
56764183|NCT02577497|Beclomethasone|beclomethasone|mesh-list
56764184|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764185|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56764193|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
56764194|NCT02577497|Hormones|hormones|mesh-ancestor
56764195|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56764196|NCT02575859|Cisplatin|cisplatin|mesh-list
56764197|NCT02575859|Mitomycins|mitomycins|mesh-list
56764198|NCT02575859|Mitomycin|mitomycin|mesh-list
56764199|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764200|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56764201|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
56764202|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764203|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56764204|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764205|NCT03850444|Paclitaxel|paclitaxel|mesh-list
56764206|NCT03850444|Carboplatin|carboplatin|mesh-list
56764207|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
56764208|NCT03850444|Pemetrexed|pemetrexed|mesh-list
56764209|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56764210|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764211|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764212|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764213|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764214|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764215|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56764216|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764217|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56764218|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56764219|NCT00469456|Memantine|memantine|mesh-list
56764220|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56190450|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190451|NCT01468285|Betahistine|betahistine|mesh-list
56190452|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
56033317|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56033318|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033351|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56033352|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56033353|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033354|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
56033355|NCT01869413|Coagulants|coagulants|mesh-ancestor
56033356|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
56033357|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56033358|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033359|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033360|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56033361|NCT02982512|Analgesics|analgesics|mesh-ancestor
56033362|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
56033392|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
56033393|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033394|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
56764221|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56764222|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
56764223|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764224|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764225|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764226|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56764227|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56764228|NCT00581555|Etanercept|etanercept|mesh-list
56764229|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56764230|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764231|NCT00581555|Analgesics|analgesics|mesh-ancestor
56764232|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
56764233|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764234|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764235|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764236|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56764237|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56764238|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764239|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
56764240|NCT00469144|Fludarabine|fludarabine|mesh-list
56764241|NCT00469144|Busulfan|busulfan|mesh-list
56764242|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764243|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764244|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764245|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
56764246|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764247|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
56033395|NCT04358120|Protective Agents|protective agents|mesh-ancestor
56033396|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
56033401|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033403|NCT01639157|Buspirone|buspirone|mesh-list
56033404|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56033405|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56033435|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033436|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033438|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
56033439|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
56033440|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56033441|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56033442|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033443|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033444|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033445|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033446|NCT00695279|Vaccines|vaccines|mesh-list
56033447|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
56033448|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033449|NCT04925076|Ethanol|ethanol|mesh-list
56764248|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56764249|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56764250|NCT03987022|Acetaminophen|acetaminophen|mesh-list
56764251|NCT03987022|Ketorolac|ketorolac|mesh-list
56764252|NCT03987022|Oxycodone|oxycodone|mesh-list
56764253|NCT03987022|Hydromorphone|hydromorphone|mesh-list
56764254|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56764255|NCT03987022|Narcotics|narcotics|mesh-ancestor
56764256|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56764257|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764258|NCT03987022|Analgesics|analgesics|mesh-ancestor
56764259|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
56764260|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764261|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56764262|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764263|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764264|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56764265|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56764266|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764267|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764269|NCT01025128|Vitamin D|vitamin d|mesh-list
56764270|NCT01025128|Vitamins|vitamins|mesh-ancestor
56764271|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
56764272|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764273|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56764274|NCT00468910|Aspirin|aspirin|mesh-list
56764275|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56764276|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764277|NCT00468910|Analgesics|analgesics|mesh-ancestor
56764278|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
56764279|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764281|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764292|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
56764293|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
56764294|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764295|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
56764296|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764297|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
56764298|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764299|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56764300|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
56764301|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56764302|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56764303|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56764304|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56764305|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764306|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
56764307|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764308|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764309|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56764310|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764311|NCT00519285|Prednisone|prednisone|mesh-list
56764312|NCT00519285|Prednisolone|prednisolone|mesh-list
56764313|NCT00519285|Docetaxel|docetaxel|mesh-list
56764314|NCT00519285|Aflibercept|aflibercept|mesh-list
56764315|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764316|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764317|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764318|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764319|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764320|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764321|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
56764322|NCT00519285|Hormones|hormones|mesh-ancestor
56764323|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56764324|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764333|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764334|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764335|NCT05212857|Leuprolide|leuprolide|mesh-list
56764336|NCT05212857|Goserelin|goserelin|mesh-list
56764337|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56764338|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
56764339|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56764341|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56764342|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764343|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56764344|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764345|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56764346|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764347|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764348|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
56764349|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56764350|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56764351|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
56764352|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56764353|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
56764354|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56764385|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764386|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764387|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
56764388|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764389|NCT00129389|Paclitaxel|paclitaxel|mesh-list
56764390|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
56764391|NCT00129389|Doxorubicin|doxorubicin|mesh-list
56764392|NCT00129389|Fluorouracil|fluorouracil|mesh-list
56764393|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56764394|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764395|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764396|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764397|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764398|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764399|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764400|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
56764401|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764402|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56764403|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56764404|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
56764405|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56764406|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56764407|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56764408|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56764409|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764410|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
56764411|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56764412|NCT00468052|Fentanyl|fentanyl|mesh-list
56764413|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
56764428|NCT00468052|Narcotics|narcotics|mesh-ancestor
56764431|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
56764432|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
56764433|NCT00453310|Sunitinib|sunitinib|mesh-list
56764434|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764435|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56764436|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56764437|NCT00453310|Growth Substances|growth substances|mesh-ancestor
56764438|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764439|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
56764440|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764441|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764442|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764443|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56764444|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
56764445|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764446|NCT00128843|Anastrozole|anastrozole|mesh-list
56764447|NCT00128843|Exemestane|exemestane|mesh-list
56764448|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56764449|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764450|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56764451|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56764452|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764453|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764454|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56764455|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
56764481|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764482|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56764483|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
56764484|NCT00555906|Hormones|hormones|mesh-ancestor
56764485|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56764486|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56764487|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764488|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764489|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764490|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764491|NCT04071353|Interferons|interferons|mesh-list
56764492|NCT04071353|Ribavirin|ribavirin|mesh-list
56764493|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764494|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
56764495|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764496|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
56764497|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764498|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
56764499|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56764500|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764501|NCT00555672|Fluorouracil|fluorouracil|mesh-list
56764502|NCT00555672|Sunitinib|sunitinib|mesh-list
56764503|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764504|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
56764516|NCT02575547|Docetaxel|docetaxel|mesh-list
56764530|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56764531|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764532|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764533|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56764534|NCT00709553|Midazolam|midazolam|mesh-list
56764535|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56764536|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56764537|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56764538|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764539|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56764540|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56764541|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56764542|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56764543|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
56764544|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
56764545|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
56764546|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
56764547|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764548|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764549|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
56764550|NCT03958656|Fludarabine|fludarabine|mesh-list
56764551|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764552|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
56764582|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764583|NCT00561912|Interferons|interferons|mesh-list
56764584|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
56764585|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
56764586|NCT00561912|Decitabine|decitabine|mesh-list
56764587|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764588|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
56764589|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764590|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
56764591|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764592|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56764593|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
56764594|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764595|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764596|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
56764597|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56764598|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56764599|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764600|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764637|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764638|NCT03961308|Vedolizumab|vedolizumab|mesh-list
56764639|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56764640|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56764641|NCT00956436|Sorafenib|sorafenib|mesh-list
56764642|NCT00956436|Liver Extracts|liver extracts|mesh-list
56764643|NCT00956436|Antibodies|antibodies|mesh-list
56764644|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
56764645|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56764646|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
56764647|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764648|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764649|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764650|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764651|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764652|NCT00956436|Hematinics|hematinics|mesh-ancestor
56764653|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
56764654|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
56764655|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
56764656|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56764657|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56764658|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764659|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764660|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764661|NCT00467896|Iloprost|iloprost|mesh-list
56764662|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56764663|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
56764664|NCT00946686|Leflunomide|leflunomide|mesh-list
56764665|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764666|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764667|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764668|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
56764680|NCT01326559|Cetuximab|cetuximab|mesh-list
56764681|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764682|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764683|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764684|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764685|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764686|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56764687|NCT04069949|Sorafenib|sorafenib|mesh-list
56764688|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764689|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764690|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764691|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764692|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
56764693|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56764694|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764695|NCT00467740|Olodaterol|olodaterol|mesh-list
56764696|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56764697|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
56764698|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764699|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764700|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56764701|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
56764702|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
56764703|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
56764704|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56764705|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56764706|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764707|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764708|NCT00710099|Urological Agents|urological agents|mesh-ancestor
56764709|NCT00001247|Sirolimus|sirolimus|mesh-list
56764710|NCT00001247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56475645|NCT02942706|Cetuximab|cetuximab|mesh-list
56764722|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764723|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764724|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
56764725|NCT00714623|Sirolimus|sirolimus|mesh-list
56764726|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56764727|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764728|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56764729|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764730|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
56764731|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764732|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
56764733|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764734|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
56764735|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56764736|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56764737|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
56764738|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764739|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56764740|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56764741|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764742|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764743|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
56764744|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56764745|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56764746|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56764747|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764748|NCT01021930|Sirolimus|sirolimus|mesh-list
56764749|NCT01021930|Paclitaxel|paclitaxel|mesh-list
56764769|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56764770|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764771|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
56764772|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764773|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764774|NCT00950820|Capecitabine|capecitabine|mesh-list
56764775|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
56764776|NCT00950820|Panitumumab|panitumumab|mesh-list
56764777|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56764778|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
56764779|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764780|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764781|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56764782|NCT00950898|Caffeine|caffeine|mesh-list
56764783|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56764784|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764785|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56764786|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764787|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764788|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56764789|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56764790|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
56764791|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764792|NCT00168805|Enoxaparin|enoxaparin|mesh-list
56764793|NCT00168805|Dabigatran|dabigatran|mesh-list
56764794|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
56764795|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56764796|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56764797|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764798|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
56764799|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56764800|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
56764801|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764802|NCT00467584|Aspirin|aspirin|mesh-list
56764808|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764809|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764810|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56764811|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56764812|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56764813|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764814|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56764815|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56764816|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764817|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
56764818|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
56764819|NCT02574611|Neostigmine|neostigmine|mesh-list
56764820|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56764821|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764822|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764823|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
56764824|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764825|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764826|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56764827|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
56764828|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764829|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56764830|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56764831|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56764832|NCT00714779|Fluoxetine|fluoxetine|mesh-list
56764833|NCT00714779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56764834|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56764835|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037513|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56033450|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56033481|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56033482|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190453|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
56190454|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
56190455|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190456|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190457|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190458|NCT01468389|Capecitabine|capecitabine|mesh-list
56190459|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56190460|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
56190461|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190462|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190463|NCT01468415|Phenol|phenol|mesh-list
56764836|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764837|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764838|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
56764839|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764840|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56764841|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
56764842|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56764843|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56764844|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56764845|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764846|NCT00168103|Complement C1s|complement c1s|mesh-list
56764847|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56764848|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56764849|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
56764850|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764851|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56764852|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56764853|NCT00463060|Sunitinib|sunitinib|mesh-list
56764854|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764855|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56764856|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56764857|NCT00463060|Growth Substances|growth substances|mesh-ancestor
56764858|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764859|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
56764860|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764861|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764862|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764863|NCT03964753|Paclitaxel|paclitaxel|mesh-list
56764864|NCT03964753|Cisplatin|cisplatin|mesh-list
56764865|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56764866|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764867|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
56764868|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
56764869|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
56764870|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190464|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56764871|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
56764872|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
56764873|NCT00956748|Dexamethasone|dexamethasone|mesh-list
56764874|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56764875|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
56764876|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
56764877|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764878|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764879|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56764880|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
56764881|NCT00956748|Hormones|hormones|mesh-ancestor
56764882|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56764883|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56764884|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764885|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764886|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764887|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
56764888|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764889|NCT00956748|Expectorants|expectorants|mesh-ancestor
56764890|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
56764891|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56764892|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
56764893|NCT00956748|Protective Agents|protective agents|mesh-ancestor
56764894|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56764895|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56764896|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56764897|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56764899|NCT01079923|Vitamin D|vitamin d|mesh-list
56764918|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56764919|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56764920|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764921|NCT00462982|Sunitinib|sunitinib|mesh-list
56764922|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56764923|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56764924|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56764925|NCT00462982|Growth Substances|growth substances|mesh-ancestor
56764926|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764927|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
56764928|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56764929|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56764930|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764931|NCT02573597|Sufentanil|sufentanil|mesh-list
56764932|NCT02573597|Bupivacaine|bupivacaine|mesh-list
56764933|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
56764934|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
56764935|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547688|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56764936|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764937|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
56764938|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764939|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56764940|NCT02573597|Narcotics|narcotics|mesh-ancestor
56764941|NCT02573597|Analgesics|analgesics|mesh-ancestor
56764942|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56764943|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56764967|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56764968|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
56764969|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764970|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
56764971|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764972|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
56764973|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56764974|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56764975|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764976|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56764977|NCT00714857|Analgesics|analgesics|mesh-ancestor
56764978|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
56764979|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56764980|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56764981|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56764982|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56764983|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
56764984|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56764985|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56764986|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56764987|NCT00957060|Glimepiride|glimepiride|mesh-list
56764988|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56764989|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56764990|NCT00957060|Incretins|incretins|mesh-ancestor
56764991|NCT00957060|Hormones|hormones|mesh-ancestor
56765000|NCT02573519|Acetylcholine|acetylcholine|mesh-list
56765014|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765015|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765016|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765017|NCT00951444|Gemcitabine|gemcitabine|mesh-list
56765018|NCT00951444|Carboplatin|carboplatin|mesh-list
56765019|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765020|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56765021|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
56765022|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765023|NCT00951444|Antiviral Agents|antiviral agents|mesh-ancestor
56765024|NCT00951444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765025|NCT00951444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765026|NCT00951444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765027|NCT00951444|Immunologic Factors|immunologic factors|mesh-ancestor
56765028|NCT00951444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765029|NCT00462826|Aflibercept|aflibercept|mesh-list
56765030|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
56765031|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56765032|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56765033|NCT00462826|Growth Substances|growth substances|mesh-ancestor
56765034|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765035|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
56765036|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765037|NCT00718601|Imetelstat|imetelstat|mesh-list
56765038|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
56765039|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765040|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765041|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56765042|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56765043|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
56765044|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56765045|NCT00947388|Antibodies|antibodies|mesh-list
56765046|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
56765047|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56765054|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
56765055|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
56765056|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56765057|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56765058|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56765059|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765060|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56765061|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56765062|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
56765063|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56765064|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
56765065|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765066|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765067|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56765068|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
56765069|NCT00957216|Ubiquinone|ubiquinone|mesh-list
56765070|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
56765071|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
56765072|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765073|NCT00957216|Vitamins|vitamins|mesh-ancestor
56765074|NCT00718757|Dexamethasone|dexamethasone|mesh-list
56765075|NCT00718757|Irinotecan|irinotecan|mesh-list
56765076|NCT00718757|Vincristine|vincristine|mesh-list
56765077|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765078|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
56765079|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
56765080|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765081|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765082|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56765083|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
56765084|NCT00718757|Hormones|hormones|mesh-ancestor
56765085|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56765086|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56765094|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
56765095|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
56765096|NCT00947466|Buprenorphine|buprenorphine|mesh-list
56765097|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56765098|NCT00947466|Narcotics|narcotics|mesh-ancestor
56765099|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56765100|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765101|NCT00947466|Analgesics|analgesics|mesh-ancestor
56765102|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
56765103|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765104|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56765105|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56765106|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
56765107|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765108|NCT00951834|Protective Agents|protective agents|mesh-ancestor
56765109|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765110|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56765111|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56765112|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765113|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56765114|NCT00715013|Epothilone B|epothilone b|mesh-list
56765115|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765116|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
56765117|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56765118|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
56765119|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765120|NCT00715091|Diclofenac|diclofenac|mesh-list
56765121|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56765122|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56765123|NCT00715091|Analgesics|analgesics|mesh-ancestor
56765138|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765139|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56765140|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
56765141|NCT04011930|Vitamin D|vitamin d|mesh-list
56765142|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
56765143|NCT04011930|Calcitriol|calcitriol|mesh-list
56765144|NCT04011930|Vitamins|vitamins|mesh-ancestor
56765145|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
56765146|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765147|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56765148|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56765149|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56765150|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56765151|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765152|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56765153|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
56765154|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56765155|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
56765156|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56765157|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765158|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56765159|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56765160|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56765161|NCT02574221|Fluorides|fluorides|mesh-list
56765163|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
56765164|NCT02574221|Protective Agents|protective agents|mesh-ancestor
56765165|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765166|NCT00452530|Enoxaparin|enoxaparin|mesh-list
56765167|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
56765168|NCT00452530|Apixaban|apixaban|mesh-list
56765169|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
56765170|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56765171|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56765172|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765173|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56765179|NCT00549198|Lamivudine|lamivudine|mesh-list
56765180|NCT00549198|Emtricitabine|emtricitabine|mesh-list
56765181|NCT00549198|Efavirenz|efavirenz|mesh-list
56765182|NCT00549198|Abacavir|abacavir|mesh-list
56765183|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
56765184|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765185|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56765186|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56765187|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765188|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765189|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56765190|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56765191|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56765192|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56765193|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56765194|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56765195|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56765196|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56765197|NCT00506415|Rivastigmine|rivastigmine|mesh-list
56765198|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56765199|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765206|NCT04036526|Vaccines|vaccines|mesh-list
56765232|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56765233|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56765234|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56765235|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765236|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56765237|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56765239|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56765240|NCT00952302|Trace Elements|trace elements|mesh-ancestor
56765241|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
56765242|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765243|NCT00952302|Hematinics|hematinics|mesh-ancestor
56765244|NCT03783442|Paclitaxel|paclitaxel|mesh-list
56765245|NCT03783442|Fluorouracil|fluorouracil|mesh-list
56765246|NCT03783442|Capecitabine|capecitabine|mesh-list
56765247|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
56765248|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56765249|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765250|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56765251|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56765252|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56765253|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765254|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
56765255|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56765256|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765257|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
56765258|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765259|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56765260|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
56765261|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56765262|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56765263|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56765264|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56765265|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765266|NCT05300334|Adenosine|adenosine|mesh-list
56190465|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190466|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
56190467|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56190468|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56190469|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56190470|NCT01468441|Cetrorelix|cetrorelix|mesh-list
56765267|NCT05300334|Analgesics|analgesics|mesh-ancestor
56765268|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
56765269|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765270|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765271|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56765272|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
56765273|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56765274|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
56765275|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
56765276|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765277|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765278|NCT00897884|Metformin|metformin|mesh-list
56765279|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765280|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765281|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56765282|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
56765283|NCT01022164|Coagulants|coagulants|mesh-ancestor
56765284|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56765285|NCT01012479|Candesartan|candesartan|mesh-list
56765286|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
56765287|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56765288|NCT01012479|Diuretics|diuretics|mesh-ancestor
56765289|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
56765290|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765291|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56765292|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56765293|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765314|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765315|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765317|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56765318|NCT00719459|Trace Elements|trace elements|mesh-ancestor
56765319|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
56765320|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765321|NCT00719459|Hematinics|hematinics|mesh-ancestor
56765322|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56765323|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56765324|NCT00948168|Exenatide|exenatide|mesh-list
56765325|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765326|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765327|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56765328|NCT00948168|Incretins|incretins|mesh-ancestor
56765329|NCT00948168|Hormones|hormones|mesh-ancestor
56765330|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56765331|NCT00958386|Irinotecan|irinotecan|mesh-list
56765332|NCT00958386|Panitumumab|panitumumab|mesh-list
56765333|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56765334|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56765335|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765336|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765337|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765338|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56765339|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
56765340|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56765341|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
56765342|NCT00719693|Fenofibrate|fenofibrate|mesh-list
56765343|NCT00719693|Calcium|calcium|mesh-list
56765344|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56765345|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765346|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56765347|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56765348|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56765355|NCT00948402|Biguanides|biguanides|mesh-list
56765356|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
56765357|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
56765358|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765359|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765360|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56765361|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56765362|NCT05352126|Disinfectants|disinfectants|mesh-list
56765363|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765364|NCT00948480|Sargramostim|sargramostim|mesh-list
56765365|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
56765366|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765367|NCT03780543|Tenofovir|tenofovir|mesh-list
56765368|NCT03780543|Entecavir|entecavir|mesh-list
56765369|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56765370|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
56765371|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765372|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56765373|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765374|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765375|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56765376|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56765377|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
56765378|NCT03753555|Atorvastatin|atorvastatin|mesh-list
56765379|NCT03753555|Probucol|probucol|mesh-list
56765380|NCT03753555|Calcium|calcium|mesh-list
56765381|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56765382|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765383|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56765384|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56765385|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56765400|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
56765401|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765402|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
56765403|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765404|NCT02573363|Cytarabine|cytarabine|mesh-list
56765405|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
56765406|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56765407|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
56765408|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765409|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765410|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
56765411|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765412|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765413|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
56765414|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765415|NCT02573363|Analgesics|analgesics|mesh-ancestor
56765416|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
56765417|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765418|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56765419|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56765420|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765421|NCT00715637|Cytarabine|cytarabine|mesh-list
56765422|NCT00715637|Amonafide|amonafide|mesh-list
56765423|NCT00715637|Daunorubicin|daunorubicin|mesh-list
56765424|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56765425|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
56765426|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765448|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56765449|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56765450|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
56765451|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765452|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765453|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765454|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56765455|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56765456|NCT00893594|Analgesics|analgesics|mesh-ancestor
56765457|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
56765458|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765459|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765460|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56765461|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
56765462|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56476404|NCT04693910|Hormones|hormones|mesh-list
56765463|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765464|NCT00715715|Prednisone|prednisone|mesh-list
56765465|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765466|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
56765467|NCT00715715|Hormones|hormones|mesh-ancestor
56765468|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56765469|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765470|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56765471|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765472|NCT00953394|Octreotide|octreotide|mesh-list
56765473|NCT00953394|Fluorouracil|fluorouracil|mesh-list
56765474|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56765475|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56765476|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765477|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
56765480|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765489|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765490|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765491|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56765492|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
56765493|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56765494|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
56765495|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765496|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765497|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56765498|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
56765499|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
56765500|NCT05351502|Protective Agents|protective agents|mesh-ancestor
56765501|NCT00898508|Antibodies|antibodies|mesh-list
56765502|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
56765503|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765504|NCT00609986|Insulin|insulin|mesh-list
56765505|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56765506|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
56765507|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
56765508|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
56765509|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
56765510|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765511|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765512|NCT00715871|Nicotine|nicotine|mesh-list
56765513|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56765514|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
56765515|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765516|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765517|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56765518|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56765519|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
56765520|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765521|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765522|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
56765523|NCT00712049|Niacin|niacin|mesh-list
56765530|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56765531|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56765532|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765533|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
56765534|NCT00712049|Vitamins|vitamins|mesh-ancestor
56765535|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
56765536|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476477|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
56765537|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
56765538|NCT00712205|Calcitriol|calcitriol|mesh-list
56765539|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56765540|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765541|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56765542|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56765543|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765544|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56765545|NCT00712205|Vitamins|vitamins|mesh-ancestor
56765546|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
56765547|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56765548|NCT00451906|Bevacizumab|bevacizumab|mesh-list
56765549|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56765550|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190471|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
56190472|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56033483|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56033484|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56033486|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033487|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56033488|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033489|NCT04361474|Budesonide|budesonide|mesh-list
56033490|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033491|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56033492|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
56033522|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033524|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56033526|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56033527|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033528|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56033529|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56033530|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033531|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033532|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56033533|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
56033534|NCT02487108|Acetaminophen|acetaminophen|mesh-list
56033535|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56033536|NCT02487108|Hydrocodone|hydrocodone|mesh-list
56033570|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56033571|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56033608|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56033609|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56033610|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56765551|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56765552|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56765553|NCT00451906|Growth Substances|growth substances|mesh-ancestor
56765554|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765555|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
56765556|NCT04070495|Clarithromycin|clarithromycin|mesh-list
56765557|NCT04070495|Rifampin|rifampin|mesh-list
56765558|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56765559|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765560|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56765561|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765562|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765563|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56765564|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56765565|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56765566|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
56765567|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
56765568|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56765569|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56765570|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56765571|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56765572|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56765573|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56765574|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56765575|NCT00712439|Gabapentin|gabapentin|mesh-list
56765576|NCT00712439|Analgesics|analgesics|mesh-ancestor
56765577|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
56765578|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765579|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765580|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
56765581|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56765582|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56033611|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
56033612|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
56033613|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
56033614|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
56033615|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033616|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033617|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56033618|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765583|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56765584|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56765585|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56765586|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56765587|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765588|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765589|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
56765590|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56765591|NCT00716183|Amoxicillin|amoxicillin|mesh-list
56765592|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
56765593|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
56765594|NCT00716183|Lactams|lactams|mesh-list
56765595|NCT00716183|beta-Lactams|beta-lactams|mesh-list
56765596|NCT00716183|Cloxacillin|cloxacillin|mesh-list
56765597|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765598|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765599|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033619|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033620|NCT01600703|Incretins|incretins|mesh-ancestor
56033622|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033623|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56033686|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033687|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033688|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033689|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
56033690|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56033691|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56033692|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56033693|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56033694|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033695|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
56033696|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033732|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
56033791|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
56033792|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
56033793|NCT04653818|Velpatasvir|velpatasvir|mesh-list
56033794|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56033795|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
56190493|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56190494|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
56190495|NCT01468571|Spironolactone|spironolactone|mesh-list
56190496|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56190497|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
56190498|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190499|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190500|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56190501|NCT01468571|Diuretics|diuretics|mesh-ancestor
56190502|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
56033840|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56033842|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
56033843|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033844|NCT04603898|Protective Agents|protective agents|mesh-ancestor
56033845|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033846|NCT04603898|Vitamins|vitamins|mesh-ancestor
56033847|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
56033848|NCT04356170|Docetaxel|docetaxel|mesh-list
56033849|NCT04356170|Fluorouracil|fluorouracil|mesh-list
56765600|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56765601|NCT00712517|Propofol|propofol|mesh-list
56765602|NCT00712517|Sevoflurane|sevoflurane|mesh-list
56765603|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56765604|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56765605|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765606|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56765607|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
56765608|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
56765609|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56765610|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56765611|NCT00712595|Mifepristone|mifepristone|mesh-list
56476552|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56765612|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56765613|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
56765614|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56765615|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765616|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56765617|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56765618|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56765619|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
56765620|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56765621|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56765622|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
56765623|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56765624|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
56765625|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56765645|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56765646|NCT00606008|Growth Substances|growth substances|mesh-ancestor
56765647|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765648|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
56765649|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56765650|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765651|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765652|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
56765653|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765654|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
56765655|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56765656|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
56765657|NCT00721331|Loratadine|loratadine|mesh-list
56765658|NCT00721331|Nortriptyline|nortriptyline|mesh-list
56765659|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765660|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
56765661|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56765662|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
56765663|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56765664|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56765665|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
56765666|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
56765667|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038340|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56033850|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033851|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
56033852|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
56033853|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
55811469|NCT03560349|Lidocaine|lidocaine|mesh-list
56033886|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033887|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
56033888|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033889|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
56033890|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033891|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56033892|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56033893|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033895|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56033896|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033897|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56033898|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190503|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56190504|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56190505|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56190506|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56190507|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190508|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190509|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190510|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
56190511|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56765668|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765669|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765670|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56765671|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
56765672|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56765673|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56765674|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56765675|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56765676|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
56765677|NCT00123955|Spironolactone|spironolactone|mesh-list
56765678|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56765679|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
56765680|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56765681|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765682|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56765683|NCT00123955|Diuretics|diuretics|mesh-ancestor
56765684|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
56765685|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
56765686|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56190513|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190514|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56190515|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190516|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190517|NCT01468714|Ketoconazole|ketoconazole|mesh-list
56033899|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033900|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56033901|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56033902|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
56033903|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033904|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
56033905|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56033906|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56033907|NCT01652495|Prednisolone|prednisolone|mesh-list
56033908|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
56033909|NCT01652495|Triamcinolone|triamcinolone|mesh-list
56033910|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56033939|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033940|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033941|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033942|NCT01699607|Amphetamine|amphetamine|mesh-list
56033943|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
56033944|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56033945|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033946|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
56033947|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
56033948|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033949|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
56033950|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034027|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56034028|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56034030|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56034031|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765687|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56765688|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765689|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
56765690|NCT01027546|Coagulants|coagulants|mesh-ancestor
56765691|NCT00115063|Orlistat|orlistat|mesh-list
56765692|NCT00115063|Sibutramine|sibutramine|mesh-list
56765693|NCT00115063|Diethylpropion|diethylpropion|mesh-list
56765694|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765695|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765696|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56765697|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56765698|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
56765699|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56765700|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
56765701|NCT01026064|Azithromycin|azithromycin|mesh-list
56765702|NCT01026064|Cantharidin|cantharidin|mesh-list
56765703|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56765704|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765705|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765706|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765707|NCT02571959|Amoxicillin|amoxicillin|mesh-list
56765708|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
56765709|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
56765710|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56765711|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765712|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765713|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765714|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56765715|NCT00461500|Fluticasone|fluticasone|mesh-list
56765716|NCT00461500|Xhance|xhance|mesh-list
56765717|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56765718|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765719|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56765720|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
56765721|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765725|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
56765728|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56765729|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56765730|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
56765731|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765732|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765733|NCT00893906|Vaccines|vaccines|mesh-list
56765734|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
56765735|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765736|NCT00721487|Fluconazole|fluconazole|mesh-list
56765737|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
56765738|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765739|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56765740|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56765741|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765742|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765743|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56034032|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56034033|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190522|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190523|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190524|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56190525|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
56190526|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190527|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190528|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56190530|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
56190531|NCT01468740|Dacarbazine|dacarbazine|mesh-list
56190532|NCT01468740|Doxorubicin|doxorubicin|mesh-list
56190533|NCT01468740|Etoposide|etoposide|mesh-list
56034034|NCT02158520|Paclitaxel|paclitaxel|mesh-list
56034035|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56034036|NCT02158520|Bevacizumab|bevacizumab|mesh-list
56034037|NCT02158520|Ipilimumab|ipilimumab|mesh-list
56034038|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56034070|NCT01704521|Ribavirin|ribavirin|mesh-list
56034071|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
56034072|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034073|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
56034074|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034075|NCT01617083|Azithromycin|azithromycin|mesh-list
56034076|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56034077|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034078|NCT04359524|Vitamin D|vitamin d|mesh-list
56034079|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
56034080|NCT04359524|Vitamins|vitamins|mesh-ancestor
56034081|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
56034082|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034083|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56034084|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56034085|NCT01658657|Metoprolol|metoprolol|mesh-list
56034086|NCT01658657|Amlodipine|amlodipine|mesh-list
56034087|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56034088|NCT01658657|Lisinopril|lisinopril|mesh-list
56034120|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
56034121|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56034122|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56034123|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034124|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56034125|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
56765744|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
56765745|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56765746|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765747|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56765748|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56765749|NCT00167245|Topiramate|topiramate|mesh-list
56765750|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
56765751|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56765752|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765753|NCT00894062|Everolimus|everolimus|mesh-list
56765754|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765755|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765756|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
56765757|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765758|NCT00443560|Fentanyl|fentanyl|mesh-list
56765759|NCT00443560|Bupivacaine|bupivacaine|mesh-list
56476695|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
56765761|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
56765762|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56765763|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765764|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
56765765|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765766|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56765767|NCT00443560|Narcotics|narcotics|mesh-ancestor
56765768|NCT00443560|Analgesics|analgesics|mesh-ancestor
56765769|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56765770|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56765772|NCT01022632|Curcumin|curcumin|mesh-list
56765791|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765792|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765793|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56765794|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765795|NCT01026376|Decitabine|decitabine|mesh-list
56765796|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56765797|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
56765798|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765799|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765800|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765801|NCT00716573|Everolimus|everolimus|mesh-list
56765802|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765803|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765804|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
56765805|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765806|NCT02539706|Rocuronium|rocuronium|mesh-list
56765807|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56765808|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56765809|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56765810|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765811|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765812|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
56765813|NCT00451204|Estrogens|estrogens|mesh-list
56765814|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
56765815|NCT00451204|Hormones|hormones|mesh-ancestor
56765816|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56765817|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765818|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56765819|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
56765820|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765821|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56765822|NCT00721877|Resveratrol|resveratrol|mesh-list
56765823|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
56765824|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765825|NCT00721877|Protective Agents|protective agents|mesh-ancestor
56765826|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765827|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765828|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56765829|NCT03537586|Adenosine|adenosine|mesh-list
56765830|NCT03537586|Heparin|heparin|mesh-list
56765831|NCT03537586|Bivalirudin|bivalirudin|mesh-list
56765832|NCT03537586|Anticoagulants|anticoagulants|mesh-ancestor
56765833|NCT03537586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56765834|NCT03537586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56765835|NCT03537586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765837|NCT03537586|Sensory System Agents|sensory system agents|mesh-ancestor
56765838|NCT03537586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765839|NCT03537586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765840|NCT03537586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56765841|NCT03537586|Vasodilator Agents|vasodilator agents|mesh-ancestor
56765842|NCT03537586|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56765843|NCT03537586|Purinergic Agonists|purinergic agonists|mesh-ancestor
56765844|NCT03537586|Purinergic Agents|purinergic agents|mesh-ancestor
56765845|NCT03537586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765846|NCT03537586|Antithrombins|antithrombins|mesh-ancestor
56765847|NCT03537586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56765848|NCT03537586|Protease Inhibitors|protease inhibitors|mesh-ancestor
56765849|NCT03537586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765850|NCT00722033|Indomethacin|indomethacin|mesh-list
56765851|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56765852|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56765853|NCT00722033|Analgesics|analgesics|mesh-ancestor
56765854|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
56765855|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765856|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765857|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765858|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56765859|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
56765860|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
56765861|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56765862|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56765863|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038527|NCT05457647|Riboflavin|riboflavin|mesh-list
56034126|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56034127|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
56034128|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034129|NCT01620047|Fentanyl|fentanyl|mesh-list
56765864|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765865|NCT00894374|Artesunate|artesunate|mesh-list
56765866|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
56765867|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56765868|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56765869|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765870|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765871|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
56765872|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
56765873|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56765874|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
56765875|NCT04920149|Mesalamine|mesalamine|mesh-list
56765876|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56765877|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56765878|NCT04920149|Analgesics|analgesics|mesh-ancestor
56765879|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
56765880|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765881|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765882|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765883|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56765884|NCT01026610|Entecavir|entecavir|mesh-list
56765885|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
56765886|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765887|NCT00901550|Methotrexate|methotrexate|mesh-list
56765888|NCT00901550|Infliximab|infliximab|mesh-list
56765889|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56765890|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
56765891|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56765892|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765893|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56765894|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
56765895|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765908|NCT02573051|Misoprostol|misoprostol|mesh-list
56765909|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56476848|NCT00525005|Docetaxel|docetaxel|mesh-list
56765910|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
56765911|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56765912|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765913|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56765914|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56765915|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
56765916|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56765917|NCT02573051|Diuretics|diuretics|mesh-ancestor
56765918|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
56765919|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
56765920|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56765921|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765922|NCT02539940|Paclitaxel|paclitaxel|mesh-list
56765923|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56765924|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765925|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
56765926|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
56765927|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
56765928|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765929|NCT01028092|Cyclosporine|cyclosporine|mesh-list
56765930|NCT01028092|Everolimus|everolimus|mesh-list
56765931|NCT01028092|Interleukin-2|interleukin-2|mesh-list
56765932|NCT01028092|Cyclosporins|cyclosporins|mesh-list
56765933|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
56765934|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034130|NCT01620047|Ropivacaine|ropivacaine|mesh-list
56034131|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
56034132|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
56034161|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190545|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190546|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56190547|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56034166|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56034167|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56034168|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56034169|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56034170|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
56034171|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034172|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034173|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034175|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56034176|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
56034177|NCT01661621|Urological Agents|urological agents|mesh-ancestor
56034179|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56034210|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
56034211|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56765935|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765936|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56765937|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
56765938|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765939|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
56765940|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56765941|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
56765942|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56765943|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56765944|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765945|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56765946|NCT01028092|Analgesics|analgesics|mesh-ancestor
56765947|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
56765948|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765949|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
56765950|NCT00605306|Maleic acid|maleic acid|mesh-list
56765951|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765952|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765953|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56765954|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
56765955|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56765956|NCT00905918|Vitamin E|vitamin e|mesh-list
56765957|NCT00905918|Vitamins|vitamins|mesh-ancestor
56765958|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
56765959|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765960|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
56765961|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765962|NCT00905918|Protective Agents|protective agents|mesh-ancestor
56765963|NCT00894608|Letrozole|letrozole|mesh-list
56765964|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56765965|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56765966|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56765967|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56765977|NCT00905996|Propranolol|propranolol|mesh-list
56765978|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56765979|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56765980|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56765981|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56765982|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56765983|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765984|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56765985|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56765986|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
56765987|NCT02539628|Ropivacaine|ropivacaine|mesh-list
56765988|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
56765989|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
56765990|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56765991|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56765992|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
56765993|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56765994|NCT02573987|Lidocaine|lidocaine|mesh-list
56765995|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
56765996|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
56765997|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
56765998|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56765999|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766000|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
56766001|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766002|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56766003|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56766004|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56766005|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56766022|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766023|NCT04069169|Lidocaine|lidocaine|mesh-list
56766024|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
56766025|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
56766026|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766027|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766028|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
56766029|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766030|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56766031|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56766032|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56766033|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56766034|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766035|NCT00713687|Gemcitabine|gemcitabine|mesh-list
56766036|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
56766037|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56766038|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
56766039|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766040|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766041|NCT00713687|Antiviral Agents|antiviral agents|mesh-ancestor
56766042|NCT00713687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766043|NCT00713687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766044|NCT00713687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56766045|NCT00713687|Immunologic Factors|immunologic factors|mesh-ancestor
56766046|NCT00713687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766047|NCT02540876|Ilorasertib|ilorasertib|mesh-list
56766048|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766068|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56766069|NCT00722735|Renal Agents|renal agents|mesh-ancestor
56766070|NCT04067531|Clindamycin|clindamycin|mesh-list
56766071|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
56766072|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
56766073|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56766074|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766075|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56766076|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766077|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766078|NCT00713765|Donepezil|donepezil|mesh-list
56766079|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56766080|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766081|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766082|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
56766083|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766084|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766085|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
56766086|NCT00717587|Sunitinib|sunitinib|mesh-list
56766087|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
56766088|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766089|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56766090|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56034212|NCT04355156|Axitinib|axitinib|mesh-list
56034213|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034214|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56034215|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034216|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034217|NCT03320018|Minocycline|minocycline|mesh-list
56034218|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56034219|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034220|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
56034221|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56034222|NCT03032666|Velpatasvir|velpatasvir|mesh-list
56034223|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
56034302|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034303|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56034304|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56034305|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56034306|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
56034307|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034308|NCT00669734|Protective Agents|protective agents|mesh-ancestor
56034309|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
56034310|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
56034311|NCT00669734|Growth Substances|growth substances|mesh-ancestor
56034312|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56034313|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034352|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56034353|NCT03035084|Vitamin D|vitamin d|mesh-list
56034354|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
56034355|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
56034356|NCT03035084|Vitamins|vitamins|mesh-list
56034357|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
55801411|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
56766091|NCT00717587|Growth Substances|growth substances|mesh-ancestor
56766092|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766093|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
56766094|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56766095|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766096|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766097|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56766098|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
56766099|NCT00894998|Heparin|heparin|mesh-list
56766100|NCT00894998|Calcium heparin|calcium heparin|mesh-list
56766101|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
56766102|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56766103|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56766104|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766105|NCT00713921|Fesoterodine|fesoterodine|mesh-list
56766106|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56766107|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56766108|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
56766109|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766110|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766111|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766112|NCT00713921|Urological Agents|urological agents|mesh-ancestor
56766113|NCT00713999|Praziquantel|praziquantel|mesh-list
56766114|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
56766115|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56766116|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766117|NCT04072601|Atorvastatin|atorvastatin|mesh-list
56766118|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56766119|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56766120|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
56766121|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766122|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56766123|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56766132|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766133|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766134|NCT03476369|Analgesics|analgesics|mesh-ancestor
56766135|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
56477072|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56766136|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766137|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56766138|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56766139|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
56766140|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
56766141|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56766142|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56766143|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56766144|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56766145|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
56766146|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766147|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766148|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56766149|NCT00722969|Sorafenib|sorafenib|mesh-list
56766150|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766151|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56766152|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034362|NCT03034850|Fluorouracil|fluorouracil|mesh-list
56034364|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56034365|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034366|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56034367|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56034368|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034369|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034370|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
56034371|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56034442|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034443|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034444|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56034445|NCT03034382|Narcotics|narcotics|mesh-ancestor
56034446|NCT03034382|Analgesics|analgesics|mesh-ancestor
56034481|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56034482|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56034483|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56034484|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
56034485|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034513|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56034514|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034515|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56034516|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56034517|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56034518|NCT04353362|Renal Agents|renal agents|mesh-ancestor
56034519|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56034520|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56034521|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051973|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
56766153|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766154|NCT03475277|Ketamine|ketamine|mesh-list
56766155|NCT03475277|Analgesics|analgesics|mesh-ancestor
56766156|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
56766157|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766158|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766159|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56766160|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56766161|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
56766162|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
56766163|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766164|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56766165|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56766166|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766167|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766168|NCT04069325|Febuxostat|febuxostat|mesh-list
56766169|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
56766170|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56766171|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56766172|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
56766173|NCT00723047|Coagulants|coagulants|mesh-ancestor
56766174|NCT03451799|Temozolomide|temozolomide|mesh-list
56766175|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56766176|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
56766177|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766178|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766179|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
56766180|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034522|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034523|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034524|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56034525|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56034526|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
56034527|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56034528|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56034529|NCT00946478|Analgesics|analgesics|mesh-ancestor
56034530|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
56034531|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034557|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
56034558|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
56034559|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034560|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034561|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
56034562|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791677|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
56766181|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
56766182|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766183|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56766184|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56766185|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
56766186|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766187|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766188|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56766189|NCT02571491|Ketamine|ketamine|mesh-list
56766190|NCT02571491|Morphine|morphine|mesh-list
56766191|NCT02571491|Remifentanil|remifentanil|mesh-list
56766192|NCT02571491|Analgesics|analgesics|mesh-ancestor
56766193|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
56766194|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766195|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766196|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56766197|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56766198|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
56766199|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
56766200|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766201|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56766202|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56766203|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766204|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766205|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56766206|NCT02571491|Narcotics|narcotics|mesh-ancestor
56766207|NCT00723437|Acitretin|acitretin|mesh-list
56766208|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
56766209|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
56766210|NCT00723515|Listerine|listerine|mesh-list
56766212|NCT00723515|Fluorides|fluorides|mesh-list
56766213|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
56766214|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56766215|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766216|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
56766217|NCT00723515|Protective Agents|protective agents|mesh-ancestor
56766218|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56766220|NCT01028170|Furosemide|furosemide|mesh-list
56766221|NCT01028170|Diuretics|diuretics|mesh-ancestor
56766222|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
56766223|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766224|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56766225|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56766226|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766227|NCT00518115|Exenatide|exenatide|mesh-list
56766228|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
56766229|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56766230|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766231|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56766232|NCT00518115|Incretins|incretins|mesh-ancestor
56766233|NCT00518115|Hormones|hormones|mesh-ancestor
56766234|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56766235|NCT00723983|Sumatriptan|sumatriptan|mesh-list
56766236|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56766237|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56766238|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56766239|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
56766240|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766241|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766242|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766243|NCT00450658|Ibuprofen|ibuprofen|mesh-list
56766244|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56766245|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56766246|NCT00450658|Analgesics|analgesics|mesh-ancestor
56766247|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
56766248|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766249|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766262|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766263|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766264|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56766265|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56766266|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
56766267|NCT00517881|Hematinics|hematinics|mesh-ancestor
56766268|NCT01010139|Codeine|codeine|mesh-list
56766269|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56766270|NCT01010139|Narcotics|narcotics|mesh-ancestor
56766271|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766272|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766273|NCT01010139|Analgesics|analgesics|mesh-ancestor
56766274|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
56766275|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766276|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
56766277|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
56766278|NCT00724295|Ribavirin|ribavirin|mesh-list
56766279|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56766280|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
56766281|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766282|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
56766283|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766284|NCT05366621|Denosumab|denosumab|mesh-list
56766285|NCT05366621|Diphosphonates|diphosphonates|mesh-list
56766286|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766287|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56766288|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
56766289|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56766290|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
56766291|NCT00517413|Hematinics|hematinics|mesh-ancestor
56766292|NCT00724529|Infliximab|infliximab|mesh-list
56766293|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
56766294|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766295|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56766296|NCT01012869|Everolimus|everolimus|mesh-list
56766297|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766298|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56766299|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
56766303|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56766304|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766305|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
56766306|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56766307|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56766308|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56766309|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766310|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766311|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
56766312|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56766313|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
56766314|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766315|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766316|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56766317|NCT01010373|Protective Agents|protective agents|mesh-ancestor
56766318|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56766319|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56766320|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766321|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766322|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
56766323|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766324|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
56766325|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56766326|NCT01010451|Calcium|calcium|mesh-list
56766327|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56766328|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034563|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56034564|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56034565|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56034566|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034567|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034568|NCT03033368|Rilpivirine|rilpivirine|mesh-list
56034569|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56034570|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56034571|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034572|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034573|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
56034574|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034575|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56034576|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56034577|NCT03031262|Cytarabine|cytarabine|mesh-list
56190550|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190551|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56190553|NCT01468740|Hormones|hormones|mesh-ancestor
56034612|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56766329|NCT02570789|Sunitinib|sunitinib|mesh-list
56766330|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766331|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56766332|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56766333|NCT02570789|Growth Substances|growth substances|mesh-ancestor
56766334|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766335|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
56766336|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56766337|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766338|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766339|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56766340|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766341|NCT00450580|Ritonavir|ritonavir|mesh-list
56766342|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
56034613|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56034614|NCT01006538|Growth Substances|growth substances|mesh-ancestor
56034615|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034616|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
56034617|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034618|NCT03017222|Ondansetron|ondansetron|mesh-list
56034619|NCT03017222|Ramosetron|ramosetron|mesh-list
56034620|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
56034655|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034656|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034657|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
56034658|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034659|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
56034660|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034661|NCT03017066|Anesthetics|anesthetics|mesh-list
56034662|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034697|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
55761901|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
56034698|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034699|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034700|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56034701|NCT05218733|Narcotics|narcotics|mesh-ancestor
56034702|NCT05218733|Analgesics|analgesics|mesh-ancestor
56034775|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56034776|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034777|NCT01680653|Incretins|incretins|mesh-ancestor
56034805|NCT05709509|Gout Suppressants|gout suppressants|mesh-ancestor
56034806|NCT05709509|Tubulin Modulators|tubulin modulators|mesh-ancestor
56034807|NCT05709509|Antimitotic Agents|antimitotic agents|mesh-ancestor
56034808|NCT05709509|Mitosis Modulators|mitosis modulators|mesh-ancestor
56034809|NCT05709509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034810|NCT01680887|Varenicline|varenicline|mesh-list
56034811|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56034812|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56034813|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
56034814|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034815|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034816|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034817|NCT01016678|Naproxen|naproxen|mesh-list
56034818|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56034819|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56034820|NCT01016678|Analgesics|analgesics|mesh-ancestor
56034821|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
56034822|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034823|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034824|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56034857|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034858|NCT02447718|Vaccines|vaccines|mesh-list
56766343|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56766344|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56766345|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
56766346|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766347|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766348|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56766349|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56766350|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
56766351|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766352|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56766353|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56766354|NCT00724685|Ropivacaine|ropivacaine|mesh-list
56766355|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
56766356|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
56766357|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766358|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766359|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
56766360|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766361|NCT00123487|Dasatinib|dasatinib|mesh-list
56766362|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766363|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56766364|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766365|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766366|NCT00509925|Insulin|insulin|mesh-list
56766367|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56766368|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
56766369|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
56766370|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
56766371|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
56766372|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
56766373|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56766374|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766375|NCT05277974|Dexamethasone|dexamethasone|mesh-list
56766376|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56766377|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
56766383|NCT05277974|Hormones|hormones|mesh-ancestor
56766384|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56766385|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56766386|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766387|NCT00504777|Rituximab|rituximab|mesh-list
56766388|NCT00504777|Methotrexate|methotrexate|mesh-list
56766389|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56766390|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766391|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
56766392|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766393|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56766394|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56766395|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
56766396|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56766397|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56766398|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
56766399|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766400|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
56766401|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766402|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56766403|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56766404|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56766405|NCT03968263|Hydrocodone|hydrocodone|mesh-list
56766406|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56766407|NCT03968263|Narcotics|narcotics|mesh-ancestor
56766408|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039082|NCT04343001|Analgesics|analgesics|mesh-ancestor
56034859|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56034860|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
56034861|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034862|NCT03016442|Dinoprostone|dinoprostone|mesh-list
56034863|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
56034864|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56034889|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
56034890|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034891|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
56034892|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034893|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
56034894|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56034895|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034896|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56034897|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56034898|NCT00964496|Growth Substances|growth substances|mesh-ancestor
56034899|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
56034900|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034901|NCT00964496|Hematinics|hematinics|mesh-ancestor
56034909|NCT01685411|Lenograstim|lenograstim|mesh-list
56766409|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766410|NCT03968263|Analgesics|analgesics|mesh-ancestor
56766411|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
56766412|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766413|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
56766414|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
56766415|NCT00895076|Dexamethasone|dexamethasone|mesh-list
56766416|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56766417|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
56766418|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
56766419|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766420|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766421|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766422|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
56766423|NCT00895076|Hormones|hormones|mesh-ancestor
56766424|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56766425|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56766426|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766427|NCT03164447|UB-421|ub-421|mesh-list
56766428|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56766429|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
56766430|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766431|NCT01078519|Anesthetics|anesthetics|mesh-list
56766432|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
56766433|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034910|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034911|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
56034912|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034913|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56034914|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56034915|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
56034947|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034948|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034949|NCT03019562|Analgesics|analgesics|mesh-ancestor
56034950|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
56034951|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034952|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56034953|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56034954|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
56034955|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
56034956|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56034957|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56034958|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56034959|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
56034960|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034961|NCT00969878|Antacids|antacids|mesh-ancestor
56034997|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56034998|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
56034999|NCT01688609|Paclitaxel|paclitaxel|mesh-list
55762199|NCT03231215|Dexamethasone|dexamethasone|mesh-list
56035000|NCT01688609|Trastuzumab|trastuzumab|mesh-list
56035001|NCT01688609|Lapatinib|lapatinib|mesh-list
56766434|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766435|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
56766436|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766437|NCT02539316|SMOFlipid|smoflipid|mesh-list
56766438|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56766439|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56766440|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56766441|NCT03968185|Analgesics|analgesics|mesh-list
56766442|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
56766443|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766444|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766445|NCT00509769|Trastuzumab|trastuzumab|mesh-list
56766446|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56766447|NCT00509769|Maytansine|maytansine|mesh-list
56766448|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56766449|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766450|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56766451|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
56766452|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
56766453|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
56766454|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766455|NCT05206877|Insulin|insulin|mesh-list
56766456|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56766457|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56766458|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766459|NCT01074697|Dexamethasone|dexamethasone|mesh-list
56766460|NCT01074697|Palonosetron|palonosetron|mesh-list
56766461|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
56766462|NCT01074697|Aprepitant|aprepitant|mesh-list
56766463|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56766464|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
56766465|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
56766466|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039144|NCT04154787|Rituximab|rituximab|mesh-list
56035002|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56035028|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56035029|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56035030|NCT02485158|Analgesics|analgesics|mesh-ancestor
56035031|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
56035032|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56035033|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56035034|NCT02485158|Hormones|hormones|mesh-ancestor
55805280|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56766467|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766468|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766469|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
56766470|NCT01074697|Hormones|hormones|mesh-ancestor
56766471|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56766472|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56035035|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035036|NCT02455518|Acetaminophen|acetaminophen|mesh-list
56035037|NCT02455518|Ibuprofen|ibuprofen|mesh-list
56035038|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56035039|NCT02455518|Oxycodone|oxycodone|mesh-list
56035040|NCT02455518|Hydrocodone|hydrocodone|mesh-list
56035041|NCT02455518|Codeine|codeine|mesh-list
56035042|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56035043|NCT02455518|Analgesics|analgesics|mesh-ancestor
56035044|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
56035045|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035046|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035047|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
56035048|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56035049|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56035050|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035077|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035079|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035080|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035081|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56035082|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
56035083|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035084|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035085|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56035086|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811501|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035090|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035091|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56035092|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
56190555|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56190556|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56190557|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
56190558|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
56035094|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035095|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56035096|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56035097|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56035098|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56035138|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035139|NCT00979940|Atorvastatin|atorvastatin|mesh-list
56035140|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56035169|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56035170|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56035171|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
56035172|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035173|NCT02873195|Bevacizumab|bevacizumab|mesh-list
56035174|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56035175|NCT02873195|Capecitabine|capecitabine|mesh-list
56035176|NCT02873195|Atezolizumab|atezolizumab|mesh-list
56035177|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
56035178|NCT02873195|Antibodies|antibodies|mesh-list
56035179|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
56035180|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56035181|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
56035182|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035183|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56035184|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56035185|NCT02873195|Growth Substances|growth substances|mesh-ancestor
56035186|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035187|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
56035188|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
56766473|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766474|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766475|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56766476|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56766477|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
56766478|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766479|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56766480|NCT05124275|Pilocarpine|pilocarpine|mesh-list
56766481|NCT05124275|Miotics|miotics|mesh-ancestor
56766482|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
56766483|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766484|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766485|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56766486|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56766487|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
56766488|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766489|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766490|NCT01080079|Terbinafine|terbinafine|mesh-list
56766491|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
56766492|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766493|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766494|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766495|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
56766496|NCT00725231|Doxorubicin|doxorubicin|mesh-list
56766497|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56766498|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56766499|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766500|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56766501|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56766502|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56766503|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766504|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766505|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56766506|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56766509|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766510|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766511|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766512|NCT00114127|Analgesics|analgesics|mesh-ancestor
56766513|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
56766514|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766515|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
56766516|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56766517|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
56766518|NCT00902954|Letrozole|letrozole|mesh-list
56766519|NCT00902954|Anastrozole|anastrozole|mesh-list
56766520|NCT00902954|Exemestane|exemestane|mesh-list
56766521|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766522|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56766523|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56766524|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766525|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766526|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56766527|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
56766528|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56766529|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766530|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56766531|NCT02540720|Dexamethasone|dexamethasone|mesh-list
56766532|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
56766533|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56766534|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56766535|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56766536|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
56766537|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
56766538|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766539|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766552|NCT00122317|Eculizumab|eculizumab|mesh-list
56766553|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56766554|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56766555|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
56766556|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766557|NCT00908336|Docetaxel|docetaxel|mesh-list
56766558|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56766559|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766560|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
56766561|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
56766562|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
56766563|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766564|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56766565|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766566|NCT00908414|TMC-310911|tmc-310911|mesh-list
56766567|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
56766568|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766569|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766570|NCT01074853|Propranolol|propranolol|mesh-list
56766571|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56035213|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035214|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56035215|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035216|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035218|NCT00982592|Antidotes|antidotes|mesh-ancestor
56035219|NCT00982592|Protective Agents|protective agents|mesh-ancestor
56035220|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
56035221|NCT00982592|Vitamins|vitamins|mesh-ancestor
56035222|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
56035223|NCT00983216|Ketoconazole|ketoconazole|mesh-list
56035224|NCT00983216|Colchicine|colchicine|mesh-list
56035225|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
56035226|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035227|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
56035228|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
56035229|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
56035230|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035231|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035232|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
56035233|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035234|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56035235|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56035236|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035237|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56035238|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
56035265|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035266|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56035268|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035270|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56035271|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035272|NCT02249585|Trace Elements|trace elements|mesh-ancestor
56035273|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
56035274|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035275|NCT05478863|Caffeine|caffeine|mesh-list
56190564|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56766572|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56766573|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
56766574|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766575|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766576|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766577|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56766578|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56766579|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
56766580|NCT00725777|Lumefantrine|lumefantrine|mesh-list
56766581|NCT00725777|Artemether|artemether|mesh-list
56766582|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56766583|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
56766584|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56766585|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56766586|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766587|NCT00165841|Rabeprazole|rabeprazole|mesh-list
56766588|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56766589|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766590|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56766591|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766592|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766593|NCT00907166|Gemcitabine|gemcitabine|mesh-list
56766594|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56766595|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
56766596|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766597|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766598|NCT00907166|Antiviral Agents|antiviral agents|mesh-ancestor
56766599|NCT00907166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766600|NCT00907166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766601|NCT00907166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56766615|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766616|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
56766617|NCT03513406|Neostigmine|neostigmine|mesh-list
56766618|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56766619|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766620|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766621|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
56766622|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766623|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766624|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56766625|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
56766626|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766627|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56766628|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56766629|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56766630|NCT00726869|Elotuzumab|elotuzumab|mesh-list
56766631|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766632|NCT01028248|Ranibizumab|ranibizumab|mesh-list
56766633|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56766634|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56766635|NCT01028248|Growth Substances|growth substances|mesh-ancestor
56766636|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035279|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035280|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035281|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56035282|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56035283|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
56035284|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035286|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56035321|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56035322|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035356|NCT02484690|Growth Substances|growth substances|mesh-ancestor
56035357|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035358|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
56035359|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035360|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56035361|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035362|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56035363|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035364|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035396|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
56035397|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035398|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56035399|NCT02447172|Gentamicins|gentamicins|mesh-list
56035400|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56035401|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035402|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56035403|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035404|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035405|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56766637|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
56766638|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766639|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
56766640|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
56766641|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
56766642|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766643|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766644|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
56766645|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766646|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56766647|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56766648|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766649|NCT00603980|Alprazolam|alprazolam|mesh-list
56766650|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56766651|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766652|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035406|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56035407|NCT04200066|Tamoxifen|tamoxifen|mesh-list
56035408|NCT04200066|Temozolomide|temozolomide|mesh-list
56035440|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56035441|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56035443|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035444|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035445|NCT03941288|Cannabidiol|cannabidiol|mesh-list
56035446|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
56035447|NCT00994760|Fentanyl|fentanyl|mesh-list
56035448|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56035515|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
56035516|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035517|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035518|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56035519|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
56035520|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
56035521|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56035522|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
56035523|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035524|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035525|NCT01031498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56035526|NCT01031498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56035527|NCT01031498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56035528|NCT01031498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56035565|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811513|NCT02246673|Febuxostat|febuxostat|mesh-list
56035684|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56035685|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035686|NCT01054742|Ribavirin|ribavirin|mesh-list
56035687|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56035720|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
56035721|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035722|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035723|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56035724|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
56035725|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
56035726|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56035727|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56035728|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56035729|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56035799|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56766653|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56766654|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56766655|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56766656|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
56766657|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
56766658|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766659|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766660|NCT01028404|Insulin|insulin|mesh-list
56766661|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56766662|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
56766663|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
56766664|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56766665|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56766666|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766667|NCT00727103|Varenicline|varenicline|mesh-list
56766668|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56766669|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56766670|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
56766671|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766672|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766673|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766675|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
56766676|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56766677|NCT01028482|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56766678|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56766679|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56766680|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766681|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766682|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
56766683|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766684|NCT00903188|Cyclosporine|cyclosporine|mesh-list
56766685|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
56766686|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
56766687|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56035800|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
56035801|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035802|NCT03014882|Protective Agents|protective agents|mesh-ancestor
56190583|NCT01469351|Incretins|incretins|mesh-ancestor
56190584|NCT01469351|Hormones|hormones|mesh-ancestor
56051975|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56766688|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56766689|NCT00903188|Prednisolone|prednisolone|mesh-list
56766690|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
56766691|NCT00903188|Everolimus|everolimus|mesh-list
56766692|NCT00903188|Cyclosporins|cyclosporins|mesh-list
56766693|NCT00903188|Basiliximab|basiliximab|mesh-list
56766694|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56766695|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
56766696|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766697|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766698|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56766699|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
56766700|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766701|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
56766702|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766703|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
56766704|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56766705|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56766706|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766707|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56766708|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
56766709|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
56766710|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766711|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766712|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
56766713|NCT00903188|Hormones|hormones|mesh-ancestor
56190585|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190586|NCT01469416|Clopidogrel|clopidogrel|mesh-list
56190587|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56190588|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56190589|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56190590|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56190591|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56190592|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
56190593|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190594|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190595|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190596|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56190597|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56190598|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
56190599|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56190600|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56190601|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190602|NCT01469468|Simvastatin|simvastatin|mesh-list
56190603|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56190604|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56190605|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
56035920|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
56035921|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56035922|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766714|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56766715|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56766716|NCT00903188|Protective Agents|protective agents|mesh-ancestor
56766717|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56766718|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56766719|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56035923|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
56035959|NCT05070650|Analgesics|analgesics|mesh-ancestor
56035960|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
56035961|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035962|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035963|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
56035998|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56035999|NCT01076270|Plerixafor|plerixafor|mesh-list
56036000|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56036001|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56036002|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
56036003|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036004|NCT01076504|Carboplatin|carboplatin|mesh-list
56036005|NCT01076504|Amrubicin|amrubicin|mesh-list
56036006|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036007|NCT01076972|Ritonavir|ritonavir|mesh-list
56036008|NCT01076972|Lopinavir|lopinavir|mesh-list
56190606|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190607|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56190608|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56190609|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190610|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
56190611|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036039|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56036041|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56036042|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56036043|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56036044|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036045|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
56036046|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036047|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036048|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56036049|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56036050|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036051|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56036052|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
56036053|NCT02740868|Xenon|xenon|mesh-list
56036054|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56036055|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
56036057|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036058|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036059|NCT02414958|Empagliflozin|empagliflozin|mesh-list
56036060|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56036095|NCT03015818|Fluorides|fluorides|mesh-list
56036096|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56036097|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036127|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56036128|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036130|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036131|NCT02441946|Anastrozole|anastrozole|mesh-list
56036133|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
56036134|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56036135|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036136|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56036137|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56036138|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036139|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036140|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56036141|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
56766720|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
56766721|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56766722|NCT00908726|Propofol|propofol|mesh-list
56766723|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56766724|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766725|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766726|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56766727|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
56766728|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
56766729|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
56766730|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766731|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56766732|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56766733|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
56766734|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766735|NCT03188432|Carboplatin|carboplatin|mesh-list
56477677|NCT02926053|Fludarabine|fludarabine|mesh-list
56766736|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766737|NCT00449956|Timolol|timolol|mesh-list
56766738|NCT00449956|Dorzolamide|dorzolamide|mesh-list
56766739|NCT00449956|Maleic acid|maleic acid|mesh-list
56766740|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766741|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766742|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56766743|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56766744|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
56766745|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036169|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190617|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
56190618|NCT01469507|Protective Agents|protective agents|mesh-ancestor
56036170|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56036171|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036172|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036173|NCT01084148|V0034CR|v0034cr|mesh-list
56036174|NCT01084148|Emollients|emollients|mesh-ancestor
56036175|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
56036176|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
56036177|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56036189|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56036190|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56036191|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036224|NCT02386098|BMS-955176|bms-955176|mesh-list
56036225|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56036226|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56036227|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
56036228|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036229|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036230|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56036231|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56036232|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
56036233|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766746|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766747|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56766748|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56766749|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56766750|NCT00907400|Naproxen|naproxen|mesh-list
56766751|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56036268|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036302|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
56036303|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56036304|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036305|NCT01042496|Lamotrigine|lamotrigine|mesh-list
56036306|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
56036307|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56036308|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56036309|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036310|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56036311|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036312|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56036313|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56036314|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036315|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56036346|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
56036347|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56036348|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56036349|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56036350|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036351|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036352|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56036353|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56036354|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56036355|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56036356|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
56036357|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036358|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036359|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56036360|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56036361|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
56036362|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56036363|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56036395|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036396|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56036397|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56190620|NCT01469520|Zidovudine|zidovudine|mesh-list
56190621|NCT01469520|Nevirapine|nevirapine|mesh-list
56036398|NCT01113398|Growth Substances|growth substances|mesh-ancestor
56036399|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036400|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
56036402|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56036403|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
56036404|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
56036405|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036449|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036450|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036451|NCT01048658|Sevoflurane|sevoflurane|mesh-list
56036452|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56036453|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56036454|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
56036455|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
56036456|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036457|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036458|NCT04341675|Sirolimus|sirolimus|mesh-list
56036459|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036460|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036461|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56036462|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036463|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
56036464|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56766752|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56766753|NCT00907400|Analgesics|analgesics|mesh-ancestor
56766754|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
56766755|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766756|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766757|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56766758|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56766759|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
56766760|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56766761|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766762|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766763|NCT00727493|Alendronate|alendronate|mesh-list
56766764|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56766765|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766766|NCT00727727|Piribedil|piribedil|mesh-list
56766767|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56766768|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56766769|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
56766770|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
56766771|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766772|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766773|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766774|NCT00903656|Lapatinib|lapatinib|mesh-list
56766775|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766776|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56766777|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766778|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766779|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
56766780|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
56766781|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56036465|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
56036466|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036467|NCT02445807|Clobetasol|clobetasol|mesh-list
56036468|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56036469|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
56036470|NCT02445807|Hormones|hormones|mesh-ancestor
56036471|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036472|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036473|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56036474|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56036475|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036476|NCT01116986|Nicotine|nicotine|mesh-list
56036477|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56766782|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56766783|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766784|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766785|NCT00730067|Urological Agents|urological agents|mesh-ancestor
56766786|NCT02538224|Doxycycline|doxycycline|mesh-list
56766787|NCT02538224|Ketoprofen|ketoprofen|mesh-list
56766788|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56766789|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766790|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
56766791|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56766792|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56766793|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56766794|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56766795|NCT02538224|Analgesics|analgesics|mesh-ancestor
56766796|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
56036478|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
56036479|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036480|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036481|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56036482|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56036483|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
56036484|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036485|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036486|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
56036488|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
56036489|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
56036490|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036491|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036492|NCT02415855|Dabigatran|dabigatran|mesh-list
56036493|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
56036494|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56036495|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
56036496|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036497|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036498|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
56036499|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
56036500|NCT00363285|Hormones|hormones|mesh-list
56036501|NCT00363285|Cyproterone|cyproterone|mesh-list
56036529|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036530|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56036531|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56036532|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56036533|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
56036534|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036535|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56036536|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56036537|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036538|NCT02435901|Cyclosporine|cyclosporine|mesh-list
56036539|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
56036540|NCT02435901|Fludarabine|fludarabine|mesh-list
56036541|NCT02435901|Melphalan|melphalan|mesh-list
56036542|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
56036543|NCT02435901|Tacrolimus|tacrolimus|mesh-list
56190622|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56190623|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56118403|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
56036641|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036642|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036644|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
56036645|NCT02819024|Hormones|hormones|mesh-ancestor
56036680|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56190639|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56766797|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766798|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766799|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56766800|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56766801|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56766802|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766803|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766804|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56766805|NCT02538302|Oxybutynin|oxybutynin|mesh-list
56766806|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
56766807|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
56766808|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766809|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766810|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56766812|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
56766813|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766814|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766815|NCT02538302|Urological Agents|urological agents|mesh-ancestor
56766816|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
56766817|NCT02538302|Coagulants|coagulants|mesh-ancestor
56766818|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56766819|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
56766820|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56766821|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190640|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
56190641|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036681|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
56036682|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036705|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036706|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036707|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036708|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
56036709|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56036710|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036711|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036712|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56036713|NCT03013634|Analgesics|analgesics|mesh-ancestor
56036714|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
56036715|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036716|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56036717|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56036718|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56036719|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56036720|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036721|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036723|NCT02980094|Vitamin E|vitamin e|mesh-list
56036724|NCT02980094|Tocopherols|tocopherols|mesh-list
56036725|NCT02980094|Tocotrienols|tocotrienols|mesh-list
56036726|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
56036727|NCT02980094|Selenium|selenium|mesh-list
56766822|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56766823|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766824|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766825|NCT00509067|Olanzapine|olanzapine|mesh-list
56766826|NCT00509067|Risperidone|risperidone|mesh-list
56766827|NCT00509067|Aripiprazole|aripiprazole|mesh-list
56766828|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56766829|NCT00509067|Ziprasidone|ziprasidone|mesh-list
56766830|NCT00509067|Choline|choline|mesh-list
56766831|NCT00509067|Galantamine|galantamine|mesh-list
56766832|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56766833|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56766834|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
56766835|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56766836|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766837|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766838|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56766839|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56766840|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56766841|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56766842|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56766843|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
56766844|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
56766845|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
56766846|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039517|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
56036728|NCT02980094|Antioxidants|antioxidants|mesh-list
56036729|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
56036730|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036731|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036732|NCT02980094|Protective Agents|protective agents|mesh-ancestor
56036733|NCT02980094|Trace Elements|trace elements|mesh-ancestor
56036762|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036763|NCT00363519|Incretins|incretins|mesh-ancestor
56036764|NCT00363519|Hormones|hormones|mesh-ancestor
56036765|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036766|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56036767|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
56036768|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036769|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036773|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036774|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036776|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56036811|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
56036812|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036813|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
56036814|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56036842|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56036843|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56036844|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56766847|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766848|NCT00509067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56766849|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56766850|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56766851|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
56766852|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
56766853|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56766854|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56766855|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56766856|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56766857|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
56766858|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56766859|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
56766860|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56766861|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
56766862|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56766863|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766864|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
56766865|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56766866|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
56766867|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
56766868|NCT02538146|Vitamins|vitamins|mesh-ancestor
56766869|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
56766870|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766871|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
56766872|NCT03194867|Cemiplimab|cemiplimab|mesh-list
56766873|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56766894|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
56766895|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56766896|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56766897|NCT02539394|Prednisolone|prednisolone|mesh-list
56766898|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
56766899|NCT02539394|Hemostatics|hemostatics|mesh-list
56766900|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56766901|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
56766902|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56766903|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
56766904|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
56766905|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56766906|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766907|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56766908|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
56766909|NCT02539394|Hormones|hormones|mesh-ancestor
56766910|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56766911|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56766912|NCT02539394|Protective Agents|protective agents|mesh-ancestor
56766913|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56766914|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766915|NCT02539394|Coagulants|coagulants|mesh-ancestor
56766916|NCT00908180|Cytarabine|cytarabine|mesh-list
56766917|NCT00908180|Cyclosporine|cyclosporine|mesh-list
56766918|NCT00908180|Etoposide|etoposide|mesh-list
56766919|NCT00908180|Melphalan|melphalan|mesh-list
56766920|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
56766921|NCT00908180|Carmustine|carmustine|mesh-list
56766922|NCT00908180|Cyclosporins|cyclosporins|mesh-list
56766923|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56766924|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766925|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56766926|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56766927|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036845|NCT05307458|Buprenorphine|buprenorphine|mesh-list
56766938|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56766939|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56766940|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56766941|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
56766942|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56766943|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56766944|NCT04480463|Aflibercept|aflibercept|mesh-list
56766945|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56766946|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56766947|NCT04480463|Growth Substances|growth substances|mesh-ancestor
56766948|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766949|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
56766950|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766951|NCT00909506|Metformin|metformin|mesh-list
56766952|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56766953|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766954|NCT03997539|Vinorelbine|vinorelbine|mesh-list
56766955|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56766956|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766957|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
56766958|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
56766959|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
56039631|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56036846|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56036847|NCT05307458|Naloxone|naloxone|mesh-list
56036848|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56036849|NCT05307458|Narcotics|narcotics|mesh-ancestor
56036850|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036851|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036852|NCT05307458|Analgesics|analgesics|mesh-ancestor
56036853|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
56036854|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036855|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56036856|NCT02481219|Erythromycin|erythromycin|mesh-list
56036857|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
56036858|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56036859|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
56036860|NCT02481219|Metoclopramide|metoclopramide|mesh-list
56190642|NCT01469572|Hormones|hormones|mesh-ancestor
56190643|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190644|NCT01469598|Gemcitabine|gemcitabine|mesh-list
56190645|NCT01469598|Docetaxel|docetaxel|mesh-list
56190646|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56190647|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
56190648|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190649|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190650|NCT01469598|Antiviral Agents|antiviral agents|mesh-ancestor
56190651|NCT01469598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190652|NCT01469598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190653|NCT01469598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56190654|NCT01469598|Immunologic Factors|immunologic factors|mesh-ancestor
56190655|NCT01469598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190656|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
56766960|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766961|NCT02570243|Heparin|heparin|mesh-list
56766962|NCT02570243|Calcium heparin|calcium heparin|mesh-list
56766963|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
56766964|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56766965|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56766966|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766967|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
56766968|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56766969|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
56766970|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766971|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56766972|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56766973|NCT00927212|Protective Agents|protective agents|mesh-ancestor
56766974|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56766975|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56766976|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56766977|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56766978|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
56766979|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56766980|NCT00927290|Pioglitazone|pioglitazone|mesh-list
56766981|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56766982|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56766983|NCT00728195|Olanzapine|olanzapine|mesh-list
56766984|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
56767005|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56767006|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767007|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
56767008|NCT04390217|Coagulants|coagulants|mesh-ancestor
56767009|NCT00927524|Insulin|insulin|mesh-list
56767010|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56767011|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
56767012|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56767013|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767014|NCT00728273|Micronutrients|micronutrients|mesh-list
56767015|NCT00728273|Trace Elements|trace elements|mesh-list
56767016|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767017|NCT00927602|PENTA|penta|mesh-list
56767018|NCT00927602|Fondaparinux|fondaparinux|mesh-list
56767019|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56767020|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
56767021|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56767022|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
56767023|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767024|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767025|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
56767026|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56767027|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56767028|NCT04286867|Ethanol|ethanol|mesh-list
56767029|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56767030|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767031|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56767032|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767033|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56767034|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56767035|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56767036|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
56767037|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767038|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767039|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190657|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
56190658|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
56036895|NCT01165112|Rituximab|rituximab|mesh-list
56036896|NCT01165112|Carboplatin|carboplatin|mesh-list
56036897|NCT01165112|Etoposide|etoposide|mesh-list
56036898|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55943375|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
56767040|NCT00730535|Urological Agents|urological agents|mesh-ancestor
56767042|NCT00904202|Gabapentin|gabapentin|mesh-list
56767043|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
56767044|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
56767045|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56767046|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767047|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
56767048|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767049|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56767050|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56767051|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56767052|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56767053|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767054|NCT00904202|Analgesics|analgesics|mesh-ancestor
56767055|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
56767056|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56767057|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56767058|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56767059|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56767060|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56767061|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767062|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
56767063|NCT00927836|Lenograstim|lenograstim|mesh-list
56767064|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56767065|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
56767066|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767067|NCT00904280|Oxymorphone|oxymorphone|mesh-list
56767068|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56767069|NCT00904280|Narcotics|narcotics|mesh-ancestor
56767070|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56767085|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
56767086|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767087|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56767088|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767089|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
56767090|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56767091|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56767092|NCT00928148|Amphetamine|amphetamine|mesh-list
56767093|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56767094|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767095|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
56767096|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
56767097|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767098|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
56767099|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767100|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767101|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
56767102|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56767103|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56767104|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56767105|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56767106|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56767107|NCT02430077|Cathartics|cathartics|mesh-ancestor
56767108|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56767109|NCT00904436|Ipratropium|ipratropium|mesh-list
56767110|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56767111|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
56767112|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767113|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767114|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56767128|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56767129|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767130|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767131|NCT00728663|Docetaxel|docetaxel|mesh-list
56767132|NCT00728663|Cetuximab|cetuximab|mesh-list
56767133|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767134|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767135|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767136|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767137|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767138|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56767139|NCT00731003|Tryptophan|tryptophan|mesh-list
56767140|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
56767141|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56767142|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
56767143|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56767144|NCT00729131|Etanercept|etanercept|mesh-list
56767145|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56767146|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56767147|NCT00729131|Analgesics|analgesics|mesh-ancestor
56767148|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
56767149|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767150|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767151|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56767152|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56767153|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56767154|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767155|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
56767156|NCT00729287|Selenium|selenium|mesh-list
56036899|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036900|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036901|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
56036902|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036986|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036987|NCT02486211|Amantadine|amantadine|mesh-list
56036988|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56036989|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56036990|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
56036991|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036992|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
56036993|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036994|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036995|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037029|NCT02384850|Fluorouracil|fluorouracil|mesh-list
56037030|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
56767157|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
56767158|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767159|NCT00729287|Protective Agents|protective agents|mesh-ancestor
56767160|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767161|NCT00729287|Trace Elements|trace elements|mesh-ancestor
56767162|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
56767163|NCT00731393|Vaccines|vaccines|mesh-list
56767164|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
56767165|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767166|NCT02569463|Aldesleukin|aldesleukin|mesh-list
56767167|NCT02569463|Interleukin-2|interleukin-2|mesh-list
56767168|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767169|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56767170|NCT02569463|Analgesics|analgesics|mesh-ancestor
56767171|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
56767172|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767173|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767174|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56767175|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56767176|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
56767177|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767178|NCT00731627|Simvastatin|simvastatin|mesh-list
56767179|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56767180|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56767181|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
56767182|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767183|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56037031|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
56037032|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
56037033|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037034|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56037035|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811612|NCT03967977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56037063|NCT05305508|Calcium|calcium|mesh-list
56037064|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56037065|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037066|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56037067|NCT05305508|Diuretics|diuretics|mesh-ancestor
56037068|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
56037069|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
56037070|NCT05305508|Coagulants|coagulants|mesh-ancestor
56037071|NCT01170884|Timolol|timolol|mesh-list
56037072|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56037073|NCT01170884|Bimatoprost|bimatoprost|mesh-list
56037074|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56037075|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56190659|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
56190660|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56190661|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190662|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767184|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56478115|NCT02917512|Cyclosporins|cyclosporins|mesh-list
56767185|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767186|NCT00568178|Losartan|losartan|mesh-list
56767187|NCT00568178|Amlodipine|amlodipine|mesh-list
56037076|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037077|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56037078|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56037079|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
56037080|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037081|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037082|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56037083|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56037084|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56037085|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56037086|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56037087|NCT01171118|Physostigmine|physostigmine|mesh-list
56037088|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56037089|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037120|NCT01172522|Terfenadine|terfenadine|mesh-list
56037121|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56037122|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56037123|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56037124|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
56037125|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
56037126|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037127|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037128|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037129|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
56037130|NCT01172600|Entonox|entonox|mesh-list
56037131|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56037132|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
56037133|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
56037134|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037135|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037161|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
56037162|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
56037163|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037164|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
56037165|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037166|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56037167|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56037168|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56037169|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
56037170|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037171|NCT05269628|Dronabinol|dronabinol|mesh-list
56037172|NCT05269628|Cannabidiol|cannabidiol|mesh-list
56037173|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
56037174|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
56037175|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037176|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56037177|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56037178|NCT05269628|Analgesics|analgesics|mesh-ancestor
56037179|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
56037180|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037181|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56037182|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55811614|NCT03967977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037223|NCT01173848|Vitamin D|vitamin d|mesh-list
56037224|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
56037225|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56037226|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037227|NCT01173848|Vitamins|vitamins|mesh-ancestor
56037228|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
56037229|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56037230|NCT01174082|Vaccines|vaccines|mesh-list
56037231|NCT01174082|Sargramostim|sargramostim|mesh-list
56037232|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
56037233|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037234|NCT05254418|Dulaglutide|dulaglutide|mesh-list
56037235|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55943868|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
56767188|NCT00568178|Enalapril|enalapril|mesh-list
56767189|NCT00568178|Enalaprilat|enalaprilat|mesh-list
56767190|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56767191|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56767192|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56767193|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767194|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56767195|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767196|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
56767197|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56767198|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56767199|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56767200|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767201|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56039887|NCT01316042|Metformin|metformin|mesh-list
56037258|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037261|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56037262|NCT03011996|Amoxicillin|amoxicillin|mesh-list
56037263|NCT03011996|Clarithromycin|clarithromycin|mesh-list
56037264|NCT03011996|Pantoprazole|pantoprazole|mesh-list
56037265|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56037266|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037267|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56037268|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037269|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037270|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56037271|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56037272|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56037273|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037274|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56037275|NCT01178216|Rituximab|rituximab|mesh-list
56037276|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56037277|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037278|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
56037279|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037280|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56037281|NCT01178528|Carvedilol|carvedilol|mesh-list
56037282|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56037283|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56037284|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
56037317|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037319|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037320|NCT02383758|Laxatives|laxatives|mesh-ancestor
56037321|NCT02492451|Progesterone|progesterone|mesh-list
56037322|NCT02492451|Progestins|progestins|mesh-ancestor
56037323|NCT02492451|Hormones|hormones|mesh-ancestor
56037324|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037325|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037326|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56037327|NCT02410278|Montelukast|montelukast|mesh-list
56037328|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56190666|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190667|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
56190668|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56190669|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
56190670|NCT01469650|Vitamin D|vitamin d|mesh-list
56037329|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
55764553|NCT02576145|Daclizumab|daclizumab|mesh-list
56037330|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56767202|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
56767203|NCT00577889|Gemcitabine|gemcitabine|mesh-list
56767204|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56767205|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
56767206|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767207|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767208|NCT00577889|Antiviral Agents|antiviral agents|mesh-ancestor
56767209|NCT00577889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767210|NCT00577889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767211|NCT00577889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767212|NCT00577889|Immunologic Factors|immunologic factors|mesh-ancestor
56767213|NCT00577889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767214|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
56767215|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56767216|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767217|NCT02538926|Prednisone|prednisone|mesh-list
56767218|NCT02538926|Cortisone|cortisone|mesh-list
56767219|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
56767220|NCT02538926|Rituximab|rituximab|mesh-list
56767221|NCT02538926|Doxorubicin|doxorubicin|mesh-list
56767222|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56767223|NCT02538926|Etoposide|etoposide|mesh-list
56767224|NCT02538926|Vincristine|vincristine|mesh-list
56767225|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
56767226|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
56767227|NCT02538926|Asparaginase|asparaginase|mesh-list
56767228|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
56767229|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56767230|NCT02538926|Antibodies|antibodies|mesh-list
56767231|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
56767232|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56767233|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767234|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
56037331|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
56037332|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037334|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56037335|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56037336|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037337|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
56037338|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56037339|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
56037340|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
56037341|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
56037374|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037377|NCT05042648|Narcotics|narcotics|mesh-ancestor
56037378|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56767235|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767236|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56767237|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56767238|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
56767239|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767240|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767241|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56767242|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56767243|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56767244|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56767245|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767246|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56767247|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
56767248|NCT02538926|Hormones|hormones|mesh-ancestor
56037379|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037380|NCT05042648|Analgesics|analgesics|mesh-ancestor
56037381|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
56037382|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037383|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56037384|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56037385|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56037417|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037418|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
56037419|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037420|NCT02571153|Ketamine|ketamine|mesh-list
56037421|NCT02571153|Analgesics|analgesics|mesh-ancestor
56037422|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
56037453|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56037455|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037456|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
56037457|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56037458|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56037459|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56037460|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037461|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037462|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
56037463|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037464|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037465|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56037466|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037468|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56037469|NCT01650558|Amebicides|amebicides|mesh-ancestor
56037470|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56037471|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56037507|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037509|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037510|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
56037511|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037512|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037606|NCT02581839|Hormones|hormones|mesh-ancestor
56037607|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037608|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037609|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037610|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
56037611|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190671|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
56190672|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
56037612|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767249|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767250|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56767251|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56767252|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767253|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767254|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767255|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56767256|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
56767257|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
56767258|NCT00904904|Ketorolac|ketorolac|mesh-list
56767259|NCT00904904|Indomethacin|indomethacin|mesh-list
56767260|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56767261|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56767262|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56767263|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56767264|NCT00904904|Analgesics|analgesics|mesh-ancestor
56767265|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
56767266|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767267|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767268|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56767269|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56037613|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
56037614|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
56037615|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56037616|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
56037617|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037618|NCT02581839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56037619|NCT02581839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56037620|NCT02581839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037621|NCT02581839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56037622|NCT02581839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56037623|NCT02504775|Acetaminophen|acetaminophen|mesh-list
56037624|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56037625|NCT02504775|Analgesics|analgesics|mesh-ancestor
56037652|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56037653|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037654|NCT01186562|Incretins|incretins|mesh-ancestor
56037655|NCT01186562|Hormones|hormones|mesh-ancestor
56037656|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037657|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56037658|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
56037659|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037660|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037661|NCT01187498|Oxybutynin|oxybutynin|mesh-list
56037662|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
56037663|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
56037664|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037665|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037666|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56037667|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56037668|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
56037669|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037670|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767270|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56767271|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767272|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767273|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
56767274|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
56767275|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56767276|NCT00731861|Paclitaxel|paclitaxel|mesh-list
56767277|NCT00731861|Vatalanib|vatalanib|mesh-list
56767278|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56767279|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767280|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767281|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767282|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767283|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767284|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56767285|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767286|NCT00567476|Omalizumab|omalizumab|mesh-list
56767287|NCT00567476|Terbutaline|terbutaline|mesh-list
56767288|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
56767289|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
56767290|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56767291|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
56037702|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
56037703|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037704|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037705|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037707|NCT01189292|Hormones|hormones|mesh-ancestor
56037708|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037709|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037710|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037711|NCT01189370|Sorafenib|sorafenib|mesh-list
56037712|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037713|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56037714|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037715|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037716|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56037717|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56037718|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56037752|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56037753|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56037754|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
56037755|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037756|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56037757|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037792|NCT01194674|Plasminogen|plasminogen|mesh-list
56037793|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56037794|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56037795|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037796|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56037797|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
56037798|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56190674|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
56037829|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767292|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767293|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767294|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56767295|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
56767296|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
56037830|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037831|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56037832|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56037833|NCT01195922|Sirolimus|sirolimus|mesh-list
56037834|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56037835|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037836|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56037837|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037838|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
56037839|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56037840|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
56037841|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037842|NCT03809780|Dexamethasone|dexamethasone|mesh-list
56037877|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037879|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037880|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
56037881|NCT02512809|Isoflurane|isoflurane|mesh-list
56037903|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56037904|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
56037905|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
56037906|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037907|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037917|NCT01159262|Fentanyl|fentanyl|mesh-list
56037918|NCT01159262|Midazolam|midazolam|mesh-list
56037919|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
56037920|NCT01159262|Morphine|morphine|mesh-list
56037921|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56037922|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037923|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037924|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56037925|NCT01159262|Analgesics|analgesics|mesh-ancestor
56037926|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
56037927|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037928|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55811634|NCT01632891|Lopinavir|lopinavir|mesh-list
56037933|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037995|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037997|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56037998|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56037999|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56038000|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038001|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56038002|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56038003|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038004|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
56038005|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56038006|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56038007|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56038008|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
56038009|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038011|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
56038012|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038013|NCT01203644|Bupivacaine|bupivacaine|mesh-list
56038014|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
56038015|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
56038049|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56038050|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038051|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038052|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
56038053|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038084|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038085|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
56038086|NCT01206452|Hormones|hormones|mesh-ancestor
56110409|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56767297|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56767298|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56767299|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56767300|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767301|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767302|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56767303|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
56767304|NCT00729911|Amiodarone|amiodarone|mesh-list
56767305|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56767306|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
56767307|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56767308|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56767309|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767310|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56767311|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56767312|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56767313|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767314|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56767315|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56767316|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56767317|NCT04018703|Midazolam|midazolam|mesh-list
56767318|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
56767319|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56767320|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56767321|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767343|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767344|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767345|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
56767346|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767347|NCT04065581|Metformin|metformin|mesh-list
56767348|NCT04065581|Acarbose|acarbose|mesh-list
56767349|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56767350|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767351|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56767352|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767353|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767354|NCT00733889|Docetaxel|docetaxel|mesh-list
56767355|NCT00733889|Fluorouracil|fluorouracil|mesh-list
56767356|NCT00733889|Cetuximab|cetuximab|mesh-list
56767357|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767358|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767359|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767360|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767361|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767362|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
56767363|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56767364|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767365|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
56767366|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767367|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56767368|NCT00733967|Varenicline|varenicline|mesh-list
56767391|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767392|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767393|NCT00732407|Losartan|losartan|mesh-list
56767394|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56767395|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56767396|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56767397|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56767398|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767399|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
56767400|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
56767401|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56767402|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56767403|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767404|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767405|NCT00507819|Urological Agents|urological agents|mesh-ancestor
56767406|NCT02569307|Minocycline|minocycline|mesh-list
56767407|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56767408|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767409|NCT01013103|Atorvastatin|atorvastatin|mesh-list
56767410|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56767411|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56767412|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
56767413|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767414|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56767415|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56767437|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56767438|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767439|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
56767440|NCT00734123|Aspirin|aspirin|mesh-list
56767441|NCT00734123|Rimonabant|rimonabant|mesh-list
56767442|NCT00734123|Enalapril|enalapril|mesh-list
56767443|NCT00734123|Clopidogrel|clopidogrel|mesh-list
56767444|NCT00734123|Atorvastatin|atorvastatin|mesh-list
56767445|NCT00734123|Simvastatin|simvastatin|mesh-list
56767446|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56767447|NCT00734123|Diuretics|diuretics|mesh-list
56767448|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56767449|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56767450|NCT00734123|Analgesics|analgesics|mesh-ancestor
56767451|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
56767452|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767453|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767454|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56767455|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56767456|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56767457|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56767458|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767459|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56767460|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56767461|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767462|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
56767463|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56767464|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56767465|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
56767466|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56038087|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190675|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190676|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56190677|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56190678|NCT01469702|Azithromycin|azithromycin|mesh-list
56038088|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038089|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56038090|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038091|NCT01206608|Bupivacaine|bupivacaine|mesh-list
56038092|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
56038093|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
56038094|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56038095|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038096|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
56038097|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943869|NCT02588443|Antiviral Agents|antiviral agents|mesh-ancestor
56767467|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56767468|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56767469|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56767470|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56767471|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
56767472|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767473|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
56767474|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56767475|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
56767476|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56767477|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56767478|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56767479|NCT00734123|Hormones|hormones|mesh-ancestor
56767480|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767481|NCT00734279|Leuprolide|leuprolide|mesh-list
56767482|NCT00734279|Ganirelix|ganirelix|mesh-list
56767483|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56767484|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
56767485|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56767486|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767487|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56767488|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767489|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
56767490|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767491|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
56767492|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
56767493|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56767494|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56767495|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
56767496|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767497|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767498|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038125|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038126|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038127|NCT02431806|Milnacipran|milnacipran|mesh-list
56038129|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
56038130|NCT02431806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56038131|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55944939|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
56767499|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767500|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56767501|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767502|NCT03410043|Osimertinib|osimertinib|mesh-list
56767503|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767504|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56767505|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767506|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767507|NCT00732953|Paclitaxel|paclitaxel|mesh-list
56767508|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56767509|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767510|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767511|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767512|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767513|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767514|NCT03374085|Dexamethasone|dexamethasone|mesh-list
56767515|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56767516|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
56767517|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
56767518|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767519|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767520|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56767521|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
56767522|NCT03374085|Hormones|hormones|mesh-ancestor
56767523|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767524|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56767525|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767526|NCT00577655|Albuterol|albuterol|mesh-list
56767527|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56767528|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
56767529|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767530|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767540|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767541|NCT00733031|Gemcitabine|gemcitabine|mesh-list
56767542|NCT00733031|Pemetrexed|pemetrexed|mesh-list
56767543|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56767544|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
56767545|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767546|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767547|NCT00733031|Antiviral Agents|antiviral agents|mesh-ancestor
56767548|NCT00733031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767549|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767550|NCT00733031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767551|NCT00733031|Immunologic Factors|immunologic factors|mesh-ancestor
56767552|NCT00733031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767553|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56767554|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56767555|NCT01327781|Tamoxifen|tamoxifen|mesh-list
56767556|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56767557|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
56767558|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767559|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767560|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56038132|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56038133|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038134|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038135|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
56038136|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038137|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56038138|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
56038139|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56038140|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56038141|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56038142|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038143|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55811637|NCT01632891|Nevirapine|nevirapine|mesh-list
56038184|NCT05220813|Bupivacaine|bupivacaine|mesh-list
56038185|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
56038186|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
56038187|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56038188|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765430|NCT02426177|Labetalol|labetalol|mesh-list
56038222|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56038223|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56038224|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038321|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038322|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56038323|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038324|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038325|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
56038326|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56038327|NCT03904251|Cytarabine|cytarabine|mesh-list
56767561|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767562|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56767563|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56767564|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56767565|NCT00734669|Glyburide|glyburide|mesh-list
56767566|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56767567|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767568|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
56767569|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
56767570|NCT00113269|Tacrolimus|tacrolimus|mesh-list
56767571|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
56767572|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56038328|NCT03904251|Daunorubicin|daunorubicin|mesh-list
56038329|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
56038330|NCT03904251|Calicheamicins|calicheamicins|mesh-list
56038331|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56038332|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
56038333|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038334|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038335|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
56038336|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038337|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56038338|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
56038339|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190679|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56190680|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190681|NCT01469884|Cyclosporine|cyclosporine|mesh-list
56190682|NCT01469884|Everolimus|everolimus|mesh-list
56190683|NCT01469884|Tacrolimus|tacrolimus|mesh-list
56190684|NCT01469884|Cyclosporins|cyclosporins|mesh-list
56190685|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56190686|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
56190687|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190688|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56190689|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190690|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190691|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
56190692|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190693|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
56190694|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038418|NCT03192345|Cemiplimab|cemiplimab|mesh-list
56038419|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038420|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038421|NCT04246047|Dexamethasone|dexamethasone|mesh-list
56038422|NCT04246047|Bortezomib|bortezomib|mesh-list
56038423|NCT04246047|Daratumumab|daratumumab|mesh-list
56038424|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038465|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038466|NCT02454543|Androgens|androgens|mesh-list
56038467|NCT02454543|Hormones|hormones|mesh-ancestor
56038468|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038469|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038470|NCT05440383|Leuprolide|leuprolide|mesh-list
56038471|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56038472|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
56038473|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56038474|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801444|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56038588|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038589|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038590|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
56038591|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56038592|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038593|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038595|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
56038596|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767573|NCT00113269|Basiliximab|basiliximab|mesh-list
56767574|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767575|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
56767576|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767577|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56767578|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767579|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767580|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56767581|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767582|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56767583|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
56767584|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56767585|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767586|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56767587|NCT04065269|Olaparib|olaparib|mesh-list
56767588|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56767589|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767590|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767591|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767592|NCT00515619|Lacosamide|lacosamide|mesh-list
56767593|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
56767594|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56767595|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56767596|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56767597|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038597|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56038598|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56038600|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56038660|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038661|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038663|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56038664|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56190695|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190697|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
56038665|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56038666|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56038667|NCT01292642|Nicotine|nicotine|mesh-list
56038668|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56038669|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
56038670|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038701|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
56038702|NCT04771481|Metoclopramide|metoclopramide|mesh-list
56038703|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
56038704|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
56038705|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038706|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767598|NCT01815359|Leucovorin|leucovorin|mesh-list
56767599|NCT01815359|Mitomycins|mitomycins|mesh-list
56767600|NCT01815359|Mitomycin|mitomycin|mesh-list
56767601|NCT01815359|Antidotes|antidotes|mesh-ancestor
56767602|NCT01815359|Protective Agents|protective agents|mesh-ancestor
56767603|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767604|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
56767605|NCT01815359|Vitamins|vitamins|mesh-ancestor
56767606|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
56767607|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56767608|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767609|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
56767610|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767611|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56767612|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767613|NCT00449644|Bedaquiline|bedaquiline|mesh-list
56767614|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
56767615|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56767616|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767617|NCT00733265|Ticagrelor|ticagrelor|mesh-list
56767618|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56767619|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56767620|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56767621|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56767622|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
56767623|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767624|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767625|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767626|NCT00112489|Paclitaxel|paclitaxel|mesh-list
56767627|NCT00112489|Carboplatin|carboplatin|mesh-list
56767629|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767642|NCT01082731|Lumefantrine|lumefantrine|mesh-list
56767643|NCT01082731|Artemether|artemether|mesh-list
56767644|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56767645|NCT01082731|Mefloquine|mefloquine|mesh-list
56767646|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
56767647|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56767648|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56767649|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038707|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56038708|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56038709|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56038710|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
56038711|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038712|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038713|NCT01292798|Ranibizumab|ranibizumab|mesh-list
56038714|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56038715|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56038744|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
56038745|NCT03009500|Hormones|hormones|mesh-ancestor
56038746|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038747|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56038748|NCT03009500|Protective Agents|protective agents|mesh-ancestor
56038750|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038752|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56038753|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038754|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038755|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038756|NCT01715207|Atenolol|atenolol|mesh-list
56038757|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56038758|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56038759|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
56038760|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
56038761|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038762|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801461|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
56038949|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038950|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038951|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56038952|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
56038953|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
56038954|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56038955|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
56038956|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
56038957|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038958|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038996|NCT02597907|Aprepitant|aprepitant|mesh-list
56038997|NCT02597907|Palonosetron|palonosetron|mesh-list
56038998|NCT02597907|Ramosetron|ramosetron|mesh-list
56038999|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
56039073|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039074|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039076|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039077|NCT04343001|Aspirin|aspirin|mesh-list
56039078|NCT04343001|Losartan|losartan|mesh-list
56039079|NCT04343001|Simvastatin|simvastatin|mesh-list
56039202|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56039203|NCT01342172|Growth Substances|growth substances|mesh-ancestor
56190698|NCT01469975|Antidotes|antidotes|mesh-ancestor
56190699|NCT01469975|Protective Agents|protective agents|mesh-ancestor
56190700|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190701|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
56190702|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
56190703|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190704|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56190705|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
56190706|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56190707|NCT01469988|Testosterone|testosterone|mesh-list
56190708|NCT01469988|Androgens|androgens|mesh-ancestor
56190710|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767650|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767651|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
56767652|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
56767653|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56767654|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
56767655|NCT00739193|Amiodarone|amiodarone|mesh-list
56767656|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56767657|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
56767658|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56767659|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56767660|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767661|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56767662|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56767663|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56767664|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767665|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56767666|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56767667|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56767668|NCT01011543|Dimercaprol|dimercaprol|mesh-list
56767669|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
56767670|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
56767671|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767672|NCT00733811|Deferiprone|deferiprone|mesh-list
56767673|NCT00733811|Deferoxamine|deferoxamine|mesh-list
56190711|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190712|NCT01470040|Aspirin|aspirin|mesh-list
56190713|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56190714|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56190715|NCT01470040|Analgesics|analgesics|mesh-ancestor
56190716|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
56190717|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190718|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190719|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56190720|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56190721|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56039204|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
56039237|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
56039238|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56039239|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039240|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56039241|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56039242|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039243|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56039244|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56039245|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039296|NCT01246076|Lenalidomide|lenalidomide|mesh-list
56039297|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
56039298|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039299|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56767674|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56767675|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
56767676|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
56767677|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039309|NCT01307462|Fluticasone|fluticasone|mesh-list
56039311|NCT01307462|Azithromycin|azithromycin|mesh-list
56039567|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039568|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
56039569|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56039570|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56190722|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56190723|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190724|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56190725|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56039571|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039572|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56039574|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
56039575|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039576|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56039577|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56039578|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56039579|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
56039580|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039581|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039583|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
56039584|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039585|NCT05561751|Propranolol|propranolol|mesh-list
56039586|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56039587|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56039588|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
56039622|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039623|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039624|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
56039625|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039626|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56039627|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
56039628|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039629|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56039630|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56039682|NCT01248416|Hormones|hormones|mesh-list
56039683|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56039684|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56039685|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039686|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039687|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56039688|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039689|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039690|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56039691|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
56039692|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56039693|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
56039694|NCT01749293|Busulfan|busulfan|mesh-list
56039695|NCT01749293|Fludarabine|fludarabine|mesh-list
56039696|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56039697|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
56039698|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039699|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039700|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56039763|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56039764|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56039769|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039771|NCT04486833|Osimertinib|osimertinib|mesh-list
56039772|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039773|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56039774|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039775|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039805|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767678|NCT00733811|Siderophores|siderophores|mesh-ancestor
56767679|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
56767680|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
56767681|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767682|NCT00507507|Tenofovir|tenofovir|mesh-list
56767683|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
56767684|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767685|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56767686|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56767687|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767688|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767689|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56767690|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56767691|NCT00459706|Etanercept|etanercept|mesh-list
56767692|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56767693|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56767694|NCT00459706|Analgesics|analgesics|mesh-ancestor
56767695|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
56767696|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767697|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767698|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56767699|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56767700|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56767701|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56767702|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
56767703|NCT00735527|Lorazepam|lorazepam|mesh-list
56767704|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
56767705|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
56767706|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
56767707|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767708|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767709|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56767710|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56767711|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56767712|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56767718|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767719|NCT00735761|Acyclovir|acyclovir|mesh-list
56767720|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
56767721|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
56767722|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767723|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56767724|NCT00740285|Lidocaine|lidocaine|mesh-list
56767725|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
56767726|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
56767727|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56767728|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767729|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
56767730|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767731|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56767732|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56767733|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56767734|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56767735|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767736|NCT00507429|Paclitaxel|paclitaxel|mesh-list
56767737|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
56767738|NCT00507429|Combretastatin|combretastatin|mesh-list
56767739|NCT00507429|Carboplatin|carboplatin|mesh-list
56767740|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56767741|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039807|NCT01732445|Danazol|danazol|mesh-list
56039808|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56039809|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56039810|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
56190726|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190727|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
56190728|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
56190729|NCT01470053|Azelastine|azelastine|mesh-list
56190730|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56190731|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
56190732|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56190733|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56190734|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
56190735|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190736|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190737|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56190738|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
56190739|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56190740|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190741|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190742|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56190743|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56190744|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
56190745|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
56190746|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190747|NCT01470092|Tibolone|tibolone|mesh-list
56190748|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
56190749|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
56767742|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767743|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767744|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767745|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767746|NCT01011621|Prednisolone|prednisolone|mesh-list
56767747|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56767748|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
56767749|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56767750|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
56767751|NCT01011621|Betamethasone|betamethasone|mesh-list
56767752|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
56767753|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56767754|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
56767755|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56767756|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
56767757|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56767758|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56767759|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
56767760|NCT01011621|Hormones|hormones|mesh-ancestor
56767761|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767762|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767763|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56767764|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767765|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
56767766|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
56767767|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767768|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56767769|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56767770|NCT01011621|Protective Agents|protective agents|mesh-ancestor
56767771|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56767772|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
56767773|NCT00449176|Oxycodone|oxycodone|mesh-list
56767774|NCT00449176|Tapentadol|tapentadol|mesh-list
56767775|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56767783|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56767784|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56923658|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56767785|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767786|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
56767787|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767788|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
56767789|NCT00515073|Promethazine|promethazine|mesh-list
56767790|NCT00515073|Dexamethasone|dexamethasone|mesh-list
56767791|NCT00515073|Paclitaxel|paclitaxel|mesh-list
56767792|NCT00515073|Cimetidine|cimetidine|mesh-list
56767793|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56767794|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767795|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767796|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767797|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767798|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767799|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56767800|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
56767801|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
56767802|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56767803|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767804|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56767805|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
56767806|NCT00515073|Hormones|hormones|mesh-ancestor
56190750|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190751|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190752|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56190753|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56190754|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190755|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56190756|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
56190757|NCT01470092|Hormones|hormones|mesh-ancestor
56190758|NCT01470157|Ketamine|ketamine|mesh-list
56039811|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56039812|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039813|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56039814|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039815|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039816|NCT01250834|Dulaglutide|dulaglutide|mesh-list
56039817|NCT01250834|Atorvastatin|atorvastatin|mesh-list
56040005|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56190760|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
56190761|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190762|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190763|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56190764|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56190765|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
56190766|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
56767807|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767808|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56767809|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56767810|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56767811|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56767812|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
56767813|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
56767814|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
56767815|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56767816|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
56767817|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
56767818|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767819|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56767820|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
56767821|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
56767822|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56767823|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56767824|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56767825|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56767826|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767827|NCT00710021|Vitamin D|vitamin d|mesh-list
56767828|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
56767829|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
56767830|NCT00710021|Vitamins|vitamins|mesh-list
56767831|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
56767832|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767833|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56767834|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56767835|NCT00504153|Dasatinib|dasatinib|mesh-list
56767836|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767850|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
56767851|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56767852|NCT04065035|Protective Agents|protective agents|mesh-ancestor
56767853|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767854|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
56767855|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
56767856|NCT00442702|Hematinics|hematinics|mesh-ancestor
56767857|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
56767858|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56767859|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767860|NCT00514917|Docetaxel|docetaxel|mesh-list
56767861|NCT00514917|Leuprolide|leuprolide|mesh-list
56767862|NCT00514917|Bicalutamide|bicalutamide|mesh-list
56767863|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767864|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767865|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767866|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767867|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767868|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56767869|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
56767870|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56767871|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190767|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56190768|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56190769|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56190770|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040008|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
56040009|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56040010|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56040011|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56040012|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56040013|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56040014|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56040015|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56040016|NCT01759277|Anesthetics|anesthetics|mesh-list
56040017|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
56040018|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040019|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040020|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
56040021|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040022|NCT02618343|Ondansetron|ondansetron|mesh-list
56040023|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
56040024|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
56040051|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040052|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040053|NCT01251536|Cetuximab|cetuximab|mesh-list
56040054|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56040055|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040056|NCT02620683|Lidocaine|lidocaine|mesh-list
56040057|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
56040058|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
56040059|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040060|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767872|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56767873|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
56767874|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
56767875|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767876|NCT01011699|Niacinamide|niacinamide|mesh-list
56767877|NCT01011699|Niacin|niacin|mesh-list
56767878|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
56767879|NCT01011699|Sevelamer|sevelamer|mesh-list
56767880|NCT01011699|Cinacalcet|cinacalcet|mesh-list
56767881|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
56767882|NCT01011699|Vitamins|vitamins|mesh-ancestor
56767883|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
56767884|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767885|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56767886|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
56767887|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767888|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56767889|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
56767890|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
56767891|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
56767892|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56767893|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56767894|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
56767895|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56767896|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
56767897|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56767898|NCT00504075|Antibodies|antibodies|mesh-list
56767921|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56767922|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56767923|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767924|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
56767925|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56767926|NCT00736541|Cystatins|cystatins|mesh-list
56767927|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
56767928|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56767929|NCT00736541|Expectorants|expectorants|mesh-ancestor
56767930|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
56767931|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56767932|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
56767933|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767934|NCT00736541|Protective Agents|protective agents|mesh-ancestor
56767935|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767936|NCT00736541|Antidotes|antidotes|mesh-ancestor
56767937|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56767938|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
56767939|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767940|NCT00096265|Temozolomide|temozolomide|mesh-list
56767941|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56767942|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56767943|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
56767944|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767945|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767946|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56767947|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767948|NCT01082809|Sunitinib|sunitinib|mesh-list
56767949|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767950|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56767965|NCT01079065|Famotidine|famotidine|mesh-list
56767966|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56767967|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56767968|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56767969|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
56767970|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
56767971|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56767972|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767973|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767974|NCT00711191|Antibodies|antibodies|mesh-list
56767975|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56767976|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
56767977|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56767978|NCT00741221|Bevacizumab|bevacizumab|mesh-list
56767979|NCT00741221|Pemetrexed|pemetrexed|mesh-list
56767980|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56767981|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767982|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56767983|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56767984|NCT00741221|Growth Substances|growth substances|mesh-ancestor
56767985|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040061|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
56040062|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040063|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56040064|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56040065|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56040066|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040067|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040068|NCT01355588|Ketorolac|ketorolac|mesh-list
56040069|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56040070|NCT01355588|Lidocaine|lidocaine|mesh-list
56040071|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
56040098|NCT02621619|Narcotics|narcotics|mesh-ancestor
56190774|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56190775|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
56190776|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190777|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
56190778|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56190779|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56190780|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
56040099|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040101|NCT01253642|Phenelzine|phenelzine|mesh-list
56040102|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040103|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
56040104|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
56040105|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
56040106|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040107|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
56040108|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56040109|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56040110|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040111|NCT01357148|Metformin|metformin|mesh-list
56040112|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56040113|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56767986|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
56767987|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56767988|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56767989|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56767990|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56767991|NCT00736619|Paclitaxel|paclitaxel|mesh-list
56767992|NCT00736619|Cetuximab|cetuximab|mesh-list
56767993|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56767994|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56767995|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56767996|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
56767997|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
56767998|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
56767999|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768000|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768001|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
56768002|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56768003|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768004|NCT05742269|Atezolizumab|atezolizumab|mesh-list
56768005|NCT05742269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768006|NCT00448864|Ecallantide|ecallantide|mesh-list
56768007|NCT00448864|Analgesics|analgesics|mesh-ancestor
56768008|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
56768009|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040678|NCT02865473|Miotics|miotics|mesh-ancestor
56040114|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040115|NCT01357148|Incretins|incretins|mesh-ancestor
56040116|NCT01357148|Hormones|hormones|mesh-ancestor
56040117|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040216|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040218|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040219|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
56040220|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
56040221|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040315|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56040316|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
56040317|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040318|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56040319|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56040320|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56040321|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
56040322|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56040323|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
56040324|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
56040325|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56040326|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56040327|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56040328|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55944981|NCT04891458|Anesthetics|anesthetics|mesh-list
56768010|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478936|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55878759|NCT03424746|Edetic Acid|edetic acid|mesh-list
56040402|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56040403|NCT03823287|Growth Substances|growth substances|mesh-ancestor
56040404|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040405|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
56040463|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56040464|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56040465|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
56040466|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040467|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
56040468|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
56040469|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56040524|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
56040525|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
56040526|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56040527|NCT03162497|Azithromycin|azithromycin|mesh-list
56040528|NCT03162497|Doxycycline|doxycycline|mesh-list
56213188|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213189|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56213190|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
56213191|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213192|NCT02814916|Dalbavancin|dalbavancin|mesh-list
56213193|NCT02814916|Teicoplanin|teicoplanin|mesh-list
56213194|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56040529|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56040530|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040531|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
56040532|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56040533|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56040534|NCT05190315|Temozolomide|temozolomide|mesh-list
56040535|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
56040536|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56040537|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
56040538|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040586|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56040587|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
56040588|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040589|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040590|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040591|NCT01777217|Urological Agents|urological agents|mesh-ancestor
56040593|NCT02251379|Xhance|xhance|mesh-list
56040594|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56040595|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56040596|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
56040602|NCT02251379|Hormones|hormones|mesh-ancestor
56040603|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040604|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
56040605|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56040606|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
56040607|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56040637|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
56040638|NCT01779167|Thalidomide|thalidomide|mesh-list
56040639|NCT01779167|Rituximab|rituximab|mesh-list
56040640|NCT01779167|Lenalidomide|lenalidomide|mesh-list
56040641|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56040642|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040643|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
56040644|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040645|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56040646|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56040647|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56040648|NCT01779167|Growth Substances|growth substances|mesh-ancestor
56040649|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
56040650|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56040780|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040781|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040783|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56040784|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040785|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040786|NCT01786343|Decitabine|decitabine|mesh-list
56040787|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56768011|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56768012|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56768013|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56768014|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768016|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
56768017|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56768018|NCT00448708|Paclitaxel|paclitaxel|mesh-list
55878841|NCT03424356|Fentanyl|fentanyl|mesh-list
56040788|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
56040789|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040790|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040791|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040830|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190781|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190782|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190783|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56190784|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56190785|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56190786|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56190787|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56190788|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190789|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040831|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040832|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56040833|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56040834|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
56040835|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040836|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040837|NCT01091831|Dexamethasone|dexamethasone|mesh-list
56040838|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
56040839|NCT01091831|Melphalan|melphalan|mesh-list
56040840|NCT01091831|Lenalidomide|lenalidomide|mesh-list
56040841|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56040842|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
56040843|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040844|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56040845|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56040846|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
56040847|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040848|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040849|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56040850|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56040851|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
56040888|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56040889|NCT00367185|Growth Substances|growth substances|mesh-ancestor
56040890|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
56040891|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040892|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56040893|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56040894|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041030|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041031|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041032|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041033|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041034|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56041035|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041036|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
56041037|NCT05049525|Itraconazole|itraconazole|mesh-list
56041038|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56041039|NCT05049525|Terbinafine|terbinafine|mesh-list
56041040|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
56041041|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041042|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56041043|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56190790|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768019|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56768020|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56768021|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768022|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768023|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56768024|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56768025|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768026|NCT00925028|Warfarin|warfarin|mesh-list
56768027|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
56768028|NCT00905216|Heparin|heparin|mesh-list
56768029|NCT00905216|Calcium heparin|calcium heparin|mesh-list
56768030|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
56768031|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56768032|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56768033|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768034|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56768035|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
56768036|NCT00929630|Coagulants|coagulants|mesh-ancestor
56768037|NCT00925106|Celecoxib|celecoxib|mesh-list
56768038|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56768039|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56768040|NCT00925106|Analgesics|analgesics|mesh-ancestor
56768041|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
56768042|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768043|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768044|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56768045|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768046|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56768047|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56768048|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768049|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768050|NCT00905528|Telmisartan|telmisartan|mesh-list
56768051|NCT00905528|Ramipril|ramipril|mesh-list
56768052|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56768053|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56768054|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56190791|NCT01470339|Analgesics|analgesics|mesh-ancestor
56768056|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56768057|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
56768058|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768059|NCT00736697|Moxidectin|moxidectin|mesh-list
56768060|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
56768061|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56768062|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768063|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
56768064|NCT02568995|Ketorolac|ketorolac|mesh-list
56768065|NCT02568995|Epinephrine|epinephrine|mesh-list
56768066|NCT02568995|Racepinephrine|racepinephrine|mesh-list
56768067|NCT02568995|Ropivacaine|ropivacaine|mesh-list
56768068|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
56768069|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
56768070|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
56768071|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768072|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768073|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
56768074|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768075|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56768076|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56768077|NCT02568995|Analgesics|analgesics|mesh-ancestor
56768078|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56768079|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768080|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56768081|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768082|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768083|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56768084|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56768085|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
56768086|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768087|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56768101|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768102|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768103|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56768104|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56768105|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768106|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
56768107|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
56768108|NCT00905762|Besifloxacin|besifloxacin|mesh-list
56768109|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56768110|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768111|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56768112|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56768113|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190792|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
56190793|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190794|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
56041044|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041045|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041046|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56041047|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
56041048|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041049|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041050|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56041051|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
56041106|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041145|NCT01333592|Mitiglinide|mitiglinide|mesh-list
56041146|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56041147|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041177|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56041178|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56041179|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041180|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56041181|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56041182|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041183|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
56041184|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
56041185|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041186|NCT01797575|Expectorants|expectorants|mesh-ancestor
56041187|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
56041188|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56041189|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
56041190|NCT01797575|Protective Agents|protective agents|mesh-ancestor
56041191|NCT01797575|Antidotes|antidotes|mesh-ancestor
56041192|NCT02641353|Thalidomide|thalidomide|mesh-list
56041222|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041223|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56041224|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
56041225|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041226|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041264|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
56041265|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
56041266|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041267|NCT02450331|Atezolizumab|atezolizumab|mesh-list
56041268|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041269|NCT01814813|Bevacizumab|bevacizumab|mesh-list
56041270|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56041272|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56041273|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56041274|NCT01814813|Growth Substances|growth substances|mesh-ancestor
56768114|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768115|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768116|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56768117|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56768118|NCT00930332|Methadone|methadone|mesh-list
56768119|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56768120|NCT00930332|Narcotics|narcotics|mesh-ancestor
56768121|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768122|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768123|NCT00930332|Analgesics|analgesics|mesh-ancestor
56768124|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
56768125|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768126|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
56768127|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
56768128|NCT05704985|Paclitaxel|paclitaxel|mesh-list
56768129|NCT05704985|Carboplatin|carboplatin|mesh-list
56768130|NCT05704985|Pembrolizumab|pembrolizumab|mesh-list
56768131|NCT05704985|Fluorouracil|fluorouracil|mesh-list
56768132|NCT05704985|Capecitabine|capecitabine|mesh-list
56768133|NCT05704985|Oxaliplatin|oxaliplatin|mesh-list
56768134|NCT05704985|Nivolumab|nivolumab|mesh-list
56768135|NCT05704985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56768136|NCT05704985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56768137|NCT05704985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768138|NCT05704985|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768139|NCT05704985|Antimitotic Agents|antimitotic agents|mesh-ancestor
56768164|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768165|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768166|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56768167|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
56768168|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56768169|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768170|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56768171|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56768172|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56768173|NCT05694533|Midazolam|midazolam|mesh-list
56768174|NCT05694533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56768175|NCT05694533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56768176|NCT05694533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768177|NCT05694533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768178|NCT05694533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56768179|NCT05694533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56768180|NCT05694533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768181|NCT05694533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56768182|NCT05694533|Anesthetics, General|anesthetics, general|mesh-ancestor
56768183|NCT05694533|Anesthetics|anesthetics|mesh-ancestor
56768184|NCT05694533|GABA Modulators|gaba modulators|mesh-ancestor
56768185|NCT05694533|GABA Agents|gaba agents|mesh-ancestor
56768186|NCT05694533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768187|NCT05694533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768188|NCT00736931|Levetiracetam|levetiracetam|mesh-list
56768189|NCT00736931|Lorazepam|lorazepam|mesh-list
56768190|NCT00736931|Brivaracetam|brivaracetam|mesh-list
56768191|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
56768192|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
56768193|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
56768194|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
56768209|NCT05669339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56768210|NCT05669339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56768211|NCT05669339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768212|NCT05669339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768213|NCT05669339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768214|NCT05669339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56768215|NCT00567164|Drospirenone|drospirenone|mesh-list
56768216|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56768217|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
56768218|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56768219|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768220|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56768221|NCT00567164|Diuretics|diuretics|mesh-ancestor
56768222|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
56768223|NCT00920933|Prednisolone|prednisolone|mesh-list
56768224|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56768225|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
56768226|NCT00920933|Hormones|hormones|mesh-ancestor
56768227|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56768228|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768229|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56768230|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768231|NCT00930566|Methoxsalen|methoxsalen|mesh-list
56040901|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
56041275|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041276|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
56041277|NCT01403246|Lenalidomide|lenalidomide|mesh-list
56041278|NCT01403246|Chlorambucil|chlorambucil|mesh-list
56041279|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
56041313|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041314|NCT01404260|Antiviral Agents|antiviral agents|mesh-ancestor
56041315|NCT01404260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041316|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190795|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56190796|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
56190797|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56190798|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56041317|NCT01404260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041318|NCT01404260|Immunologic Factors|immunologic factors|mesh-ancestor
56041319|NCT01404260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041320|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56041321|NCT02235909|Losartan|losartan|mesh-list
56041322|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56041383|NCT05588037|BB 1101|bb 1101|mesh-list
56041384|NCT05588037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041385|NCT05588037|Antiemetics|antiemetics|mesh-ancestor
56041386|NCT05588037|Autonomic Agents|autonomic agents|mesh-ancestor
56041387|NCT05588037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041388|NCT05588037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768232|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56768233|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
56768234|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
56768235|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56768236|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56768237|NCT00925730|Analgesics|analgesics|mesh-ancestor
56768238|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
56923659|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
56768239|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768240|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768241|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56768242|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768243|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
56768244|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768245|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
56768246|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56768247|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768248|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768249|NCT04063865|Everolimus|everolimus|mesh-list
56768250|NCT04063865|Tacrolimus|tacrolimus|mesh-list
56768251|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768252|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
56768253|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768254|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56768255|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768256|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768257|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768258|NCT00713219|Docetaxel|docetaxel|mesh-list
56768259|NCT00713219|Cetuximab|cetuximab|mesh-list
56768260|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768261|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768262|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
56768263|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
56040919|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
56041389|NCT05588037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56041390|NCT05588037|Glucocorticoids|glucocorticoids|mesh-ancestor
56041391|NCT05588037|Hormones|hormones|mesh-ancestor
56041392|NCT05588037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041393|NCT05588037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56041394|NCT05588037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041395|NCT05588037|Protease Inhibitors|protease inhibitors|mesh-ancestor
56041396|NCT05588037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768264|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768265|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768266|NCT00931580|Vitamin D|vitamin d|mesh-list
56768267|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
56768268|NCT00931580|Vitamins|vitamins|mesh-ancestor
56768269|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
56768270|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768271|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56768272|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56768273|NCT05661461|Sirolimus|sirolimus|mesh-list
56768274|NCT05661461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56768275|NCT05661461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768276|NCT05661461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56768277|NCT05661461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768278|NCT05661461|Antifungal Agents|antifungal agents|mesh-ancestor
56768279|NCT05661461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768280|NCT05661461|Immunologic Factors|immunologic factors|mesh-ancestor
56768281|NCT05661461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768282|NCT00931736|Rifampin|rifampin|mesh-list
56768283|NCT00931736|Isoniazid|isoniazid|mesh-list
56768284|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56768285|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
56768286|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56768287|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768288|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
56768289|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56768290|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768291|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768292|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56041397|NCT05588037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041398|NCT02194088|Diclofenac|diclofenac|mesh-list
56041399|NCT02194088|Atropine|atropine|mesh-list
56041400|NCT02194088|Analgesics|analgesics|mesh-list
56041470|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041471|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56041472|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
56041474|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041475|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56041476|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041477|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
55811673|NCT02208063|Vancomycin|vancomycin|mesh-list
56041482|NCT02685267|Prednisone|prednisone|mesh-list
56041483|NCT02685267|Docetaxel|docetaxel|mesh-list
56041484|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041485|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768293|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56768294|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56768295|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56768296|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56768297|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56768298|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56768299|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56768300|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
56768301|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56768302|NCT05651711|KHK4083|khk4083|mesh-list
56768303|NCT05651711|Dermatologic Agents|dermatologic agents|mesh-ancestor
56768304|NCT02567981|Vitamin A|vitamin a|mesh-list
56768305|NCT02567981|Micronutrients|micronutrients|mesh-list
56768306|NCT02567981|Trace Elements|trace elements|mesh-list
56768307|NCT02567981|Vitamins|vitamins|mesh-ancestor
56768308|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768309|NCT00737555|Tosedostat|tosedostat|mesh-list
56768310|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768311|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768312|NCT00932048|Atorvastatin|atorvastatin|mesh-list
56768313|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56768314|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56768315|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
56768316|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768317|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56041486|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
56041487|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
56041488|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041538|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041539|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
56041540|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
56041541|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041542|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56041543|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
56041544|NCT00367497|Hormones|hormones|mesh-ancestor
56041545|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041546|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56041547|NCT00367497|Protective Agents|protective agents|mesh-ancestor
56041548|NCT01387178|Fluticasone|fluticasone|mesh-list
56041549|NCT01387178|Xhance|xhance|mesh-list
56041550|NCT01387178|Bromides|bromides|mesh-list
56041551|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
56041552|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56041553|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041554|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56041555|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
56041556|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041557|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041558|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56041559|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
56041560|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56768318|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56768319|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768320|NCT04015778|Paclitaxel|paclitaxel|mesh-list
56768321|NCT04015778|Carboplatin|carboplatin|mesh-list
56768322|NCT04015778|Nivolumab|nivolumab|mesh-list
56768323|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56768324|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768325|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768326|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56768327|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56768328|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768329|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768330|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56768331|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
56768332|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56768333|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
56768334|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768335|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768336|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56768337|NCT00926354|Protective Agents|protective agents|mesh-ancestor
56768338|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56768339|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56768340|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768341|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768365|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
56768366|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768367|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768368|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56768369|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768370|NCT00700115|Ritonavir|ritonavir|mesh-list
56768371|NCT00700115|Lopinavir|lopinavir|mesh-list
56768372|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
56768373|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56768374|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56768375|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56768376|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
56768377|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768378|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768379|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56768380|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
56768381|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768382|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56768383|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56768384|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56041561|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56041644|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190799|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56041645|NCT04351490|Vitamins|vitamins|mesh-ancestor
56041646|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
56041679|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56041680|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56041681|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56041683|NCT01391858|Analgesics|analgesics|mesh-ancestor
56041684|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
56041685|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041686|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041747|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041748|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041749|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56041750|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56041752|NCT01829399|Epinephrine|epinephrine|mesh-list
56041753|NCT01829399|Bupivacaine|bupivacaine|mesh-list
56041754|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
56041755|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
56041756|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041757|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041758|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
56041759|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041819|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56041820|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56041821|NCT01412372|Mesalamine|mesalamine|mesh-list
56041822|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56041823|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041824|NCT01412372|Analgesics|analgesics|mesh-ancestor
55769035|NCT05471661|PENTA|penta|mesh-list
56041825|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
56041826|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768385|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56768386|NCT05556473|Tryptophan|tryptophan|mesh-list
56768387|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56768388|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
56768389|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768390|NCT05097599|Trastuzumab|trastuzumab|mesh-list
56768391|NCT05097599|Talazoparib|talazoparib|mesh-list
56768392|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768393|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768394|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56768395|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768396|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768397|NCT05095259|Insulin|insulin|mesh-list
56768398|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56768399|NCT05095259|Epinephrine|epinephrine|mesh-list
56768400|NCT05095259|Glucagon|glucagon|mesh-list
56768401|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56768402|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768403|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56768404|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56768405|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
56768406|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768407|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768408|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56768409|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56768410|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
56768411|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768412|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56768413|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
56768414|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
56768415|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
56768416|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56768417|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56768418|NCT05095259|Hormones|hormones|mesh-ancestor
56768419|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56768420|NCT00566852|Memantine|memantine|mesh-list
56768423|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
56768424|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768425|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768426|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768427|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56768428|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56768429|NCT00936650|Cinacalcet|cinacalcet|mesh-list
56768430|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56768431|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768432|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56768433|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
56768434|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56768435|NCT00442546|Pregabalin|pregabalin|mesh-list
56768436|NCT00442546|Analgesics|analgesics|mesh-ancestor
56768437|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
56768438|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768439|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768440|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
56768441|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56768442|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56768443|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768444|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56768445|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56768446|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56768447|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768448|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768449|NCT00936962|Vaccines|vaccines|mesh-list
56768450|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
56768451|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768452|NCT00514683|Nintedanib|nintedanib|mesh-list
56768453|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768454|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56768455|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768456|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768460|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
56768461|NCT00566696|Thiotepa|thiotepa|mesh-list
56479380|NCT02934035|Analgesics|analgesics|mesh-ancestor
56768463|NCT00566696|Fludarabine|fludarabine|mesh-list
56768464|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
56768465|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
56768466|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56768467|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
56768468|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768469|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
56768470|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768471|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768472|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56768473|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
56768474|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768475|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768476|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56768477|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768478|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56768479|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56768480|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
56768481|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56768482|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768483|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768484|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
56768485|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
56768486|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
56768487|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768488|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768489|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
56768505|NCT00937508|Varenicline|varenicline|mesh-list
56768506|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56768507|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56768508|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
56768509|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768510|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768511|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768512|NCT00937664|Gemcitabine|gemcitabine|mesh-list
56768513|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56768514|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
56768515|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768516|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768517|NCT00937664|Antiviral Agents|antiviral agents|mesh-ancestor
56768518|NCT00937664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768519|NCT00937664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768520|NCT00937664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768521|NCT00937664|Immunologic Factors|immunologic factors|mesh-ancestor
56768522|NCT00937664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768523|NCT00937820|Darexaban|darexaban|mesh-list
56768524|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56768525|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
56768526|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56768527|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
56768528|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768529|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768530|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
56768531|NCT00506883|Colchicine|colchicine|mesh-list
56768532|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
56768533|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768534|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768535|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
56768550|NCT00938132|Warfarin|warfarin|mesh-list
56768551|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
56768552|NCT01023334|Lidocaine|lidocaine|mesh-list
56768553|NCT01023334|Anesthetics|anesthetics|mesh-list
56768554|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
56768555|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768556|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768557|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
56768558|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768559|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56768560|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56768561|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56768562|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56768563|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768564|NCT00938522|Cilostazol|cilostazol|mesh-list
56768565|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56768566|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
56768567|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768568|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768569|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56768570|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
56768571|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56768572|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56768573|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768574|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56768575|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
56768576|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56768600|NCT00503685|Cetuximab|cetuximab|mesh-list
56768601|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768602|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768603|NCT00712673|Metformin|metformin|mesh-list
56768604|NCT00712673|Lixisenatide|lixisenatide|mesh-list
56768605|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56768606|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768607|NCT01562990|Gemcitabine|gemcitabine|mesh-list
56768608|NCT01562990|Rituximab|rituximab|mesh-list
56768609|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56768610|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
56768611|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768612|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768613|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
56768614|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768615|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768616|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56768617|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
56768618|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768619|NCT01562990|Antiviral Agents|antiviral agents|mesh-ancestor
56768620|NCT01562990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768621|NCT01562990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768622|NCT01562990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768623|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56768624|NCT00737867|Gemcitabine|gemcitabine|mesh-list
56768625|NCT00737867|Carboplatin|carboplatin|mesh-list
56768626|NCT00737867|Vinorelbine|vinorelbine|mesh-list
56768627|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768628|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56768629|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
56768630|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768631|NCT00737867|Antiviral Agents|antiviral agents|mesh-ancestor
56768632|NCT00737867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768638|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768639|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
56768640|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
56768641|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56768642|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56768643|NCT03976466|Calcium|calcium|mesh-list
56768644|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56768645|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768646|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768647|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
56768648|NCT02536755|Eliglustat|eliglustat|mesh-list
56768649|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768650|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768651|NCT02567279|Denosumab|denosumab|mesh-list
56768652|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56768653|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768654|NCT00933374|Paclitaxel|paclitaxel|mesh-list
56768655|NCT00933374|Everolimus|everolimus|mesh-list
56768656|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56768657|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768658|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768659|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
56768660|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
56768661|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768662|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768663|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
56768664|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768665|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56768666|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
56768667|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768668|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56768669|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56768670|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56041895|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56041896|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56041897|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56041899|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56041900|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
56041957|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56768671|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56768672|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768673|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768674|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768675|NCT00933452|Analgesics|analgesics|mesh-ancestor
56768676|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
56768677|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768678|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
56768679|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768680|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
56768681|NCT00447694|Deferasirox|deferasirox|mesh-list
56768682|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56768683|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
56768684|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
56768685|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768686|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
56768687|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768688|NCT00447382|Insulin|insulin|mesh-list
56768689|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56768690|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
56768691|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
56768692|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56768693|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768694|NCT00938990|Midazolam|midazolam|mesh-list
56768695|NCT00938990|Etomidate|etomidate|mesh-list
56768696|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56768697|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56768698|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768700|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56768719|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56768720|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768721|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768722|NCT03360916|Atorvastatin|atorvastatin|mesh-list
56768723|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56768724|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56768725|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
56768726|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768727|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56768728|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56768729|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768730|NCT00446992|Olanzapine|olanzapine|mesh-list
56768731|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
56768732|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
56768733|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768734|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768735|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56768736|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56768737|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56041414|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
56041958|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041960|NCT01836029|Carboplatin|carboplatin|mesh-list
56041961|NCT01836029|Fluorouracil|fluorouracil|mesh-list
56041962|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041963|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
56041964|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041965|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56041966|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041967|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
56041968|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041969|NCT02703909|Rocuronium|rocuronium|mesh-list
56041998|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
56041999|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56042000|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
56042001|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042002|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
56042003|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
56042004|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042005|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042006|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56042007|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
56042008|NCT05058287|Hormones|hormones|mesh-ancestor
56042009|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56042010|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56042011|NCT05058287|Protective Agents|protective agents|mesh-ancestor
56042012|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56042013|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042014|NCT02708433|Lidocaine|lidocaine|mesh-list
56042049|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042050|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56190800|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56042051|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
56042053|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56042054|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56768738|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768739|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768740|NCT00446992|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56768741|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56768742|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56768743|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768744|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768745|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
56768746|NCT00503139|Etanercept|etanercept|mesh-list
56768747|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56768748|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56768749|NCT00503139|Analgesics|analgesics|mesh-ancestor
56768750|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
56768751|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768752|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768753|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56768754|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56768755|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56768756|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768757|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
56042055|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042056|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56042057|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56042084|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042086|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042087|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56042089|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042090|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56042091|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56042092|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042093|NCT03206151|Antidotes|antidotes|mesh-ancestor
56042094|NCT03206151|Protective Agents|protective agents|mesh-ancestor
56042095|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
56042096|NCT03206151|Vitamins|vitamins|mesh-ancestor
56042097|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
56042098|NCT03206151|Hematinics|hematinics|mesh-ancestor
56042099|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56042100|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
56042101|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56042102|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042103|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
56042104|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042105|NCT02714283|Azithromycin|azithromycin|mesh-list
56042106|NCT02714283|Erythromycin|erythromycin|mesh-list
56042107|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56042108|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042135|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042136|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56042137|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56042139|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042140|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
56042141|NCT04795583|Hormones|hormones|mesh-ancestor
55811684|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768758|NCT00577031|Bevacizumab|bevacizumab|mesh-list
56768759|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
56768760|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768761|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768762|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56768763|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56768764|NCT00577031|Growth Substances|growth substances|mesh-ancestor
56768765|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768766|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
56768767|NCT00565448|Docetaxel|docetaxel|mesh-list
56768768|NCT00565448|Fluorouracil|fluorouracil|mesh-list
56768769|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768770|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
56768771|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
56768772|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
56768773|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768774|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
56768775|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56768776|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768777|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
56768778|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768779|NCT01012011|Sorafenib|sorafenib|mesh-list
56768780|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768781|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56768782|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768783|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768784|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56768785|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768804|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56768805|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
56768806|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56768807|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768808|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56768809|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56768810|NCT00934154|Growth Substances|growth substances|mesh-ancestor
56768811|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
56768812|NCT00446446|Panitumumab|panitumumab|mesh-list
56768813|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56768814|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768815|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56768816|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56768817|NCT05078255|Incretins|incretins|mesh-ancestor
56768818|NCT05078255|Hormones|hormones|mesh-ancestor
56768819|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56768820|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768821|NCT00939458|Lamotrigine|lamotrigine|mesh-list
56768822|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
56768823|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56768824|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56768825|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768826|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56041491|NCT02685267|Hormones|hormones|mesh-ancestor
56042155|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042183|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042184|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
56042185|NCT05084859|Hormones|hormones|mesh-ancestor
56042186|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56042187|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042188|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56042189|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56042190|NCT02431260|INCB054329|incb054329|mesh-list
56042191|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042192|NCT04630769|Interleukin-2|interleukin-2|mesh-list
56042193|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042194|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56042195|NCT04630769|Analgesics|analgesics|mesh-ancestor
56042196|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
56042197|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042198|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042199|NCT02055963|Minocycline|minocycline|mesh-list
56042200|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56042201|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042202|NCT01848041|Phenylephrine|phenylephrine|mesh-list
56042203|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
56042279|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56190801|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190802|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56768827|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768828|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56768829|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56768830|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56768831|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56768832|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56768833|NCT02566967|Tofacitinib|tofacitinib|mesh-list
56768834|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56479758|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
56768835|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768836|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768837|NCT00939068|Telbivudine|telbivudine|mesh-list
56768838|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
56768839|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768840|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56768841|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768842|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768843|NCT00934232|Busulfan|busulfan|mesh-list
56768844|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
56768845|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768846|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56768847|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
56768848|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768849|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56768852|NCT01013571|Insulin|insulin|mesh-list
56768874|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56768875|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768876|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56768877|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768878|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768879|NCT00502671|Capecitabine|capecitabine|mesh-list
56768880|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56768881|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
56768882|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768883|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768884|NCT00738413|Deferasirox|deferasirox|mesh-list
56768885|NCT00738413|Deferoxamine|deferoxamine|mesh-list
56768886|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56768887|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
56768888|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
56768889|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768890|NCT00738413|Siderophores|siderophores|mesh-ancestor
56768891|NCT00697463|Teriparatide|teriparatide|mesh-list
56768892|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56768893|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768894|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56768895|NCT04409795|Metformin|metformin|mesh-list
56768896|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56768897|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56768898|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768899|NCT04409795|Incretins|incretins|mesh-ancestor
56768900|NCT04409795|Hormones|hormones|mesh-ancestor
56768901|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56768902|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56768903|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
56190803|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042280|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042281|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56042282|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
56042283|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
56042284|NCT05737121|Lidocaine|lidocaine|mesh-list
56042285|NCT05737121|Heparin|heparin|mesh-list
56042286|NCT05737121|Calcium heparin|calcium heparin|mesh-list
56042287|NCT05737121|Anesthetics, Local|anesthetics, local|mesh-ancestor
56042289|NCT05737121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042290|NCT05737121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042291|NCT05737121|Sensory System Agents|sensory system agents|mesh-ancestor
56042292|NCT05737121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56768904|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768905|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768906|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
56768907|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56768908|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
56768909|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56768910|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768911|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768912|NCT00492531|Urological Agents|urological agents|mesh-ancestor
56768913|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
56768914|NCT01015209|Chitosan|chitosan|mesh-list
56768915|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56768916|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56768917|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56768918|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
56041599|NCT01794143|Hormones|hormones|mesh-ancestor
56042293|NCT05737121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56042294|NCT05737121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56042295|NCT05737121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56042296|NCT05737121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56042297|NCT05737121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042298|NCT05737121|Anticoagulants|anticoagulants|mesh-ancestor
56042299|NCT05737121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56042300|NCT05737121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56042301|NCT00796263|Dolutegravir|dolutegravir|mesh-list
56042498|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
56042499|NCT01860287|Buprenorphine|buprenorphine|mesh-list
56042500|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56042501|NCT01860287|Narcotics|narcotics|mesh-ancestor
56042502|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042503|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042504|NCT01860287|Analgesics|analgesics|mesh-ancestor
56042505|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
56042537|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
56042538|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56042539|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
56042540|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56042541|NCT01400906|Fluticasone|fluticasone|mesh-list
56042543|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042544|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56042545|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
56042546|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042547|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042548|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56042549|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
56042550|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56042551|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56042552|NCT00367653|Azithromycin|azithromycin|mesh-list
56042553|NCT00367653|Chloroquine|chloroquine|mesh-list
56042583|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56042584|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56042585|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042586|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56042587|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55769783|NCT01374269|Celecoxib|celecoxib|mesh-list
56042588|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56042589|NCT00556673|Fluticasone|fluticasone|mesh-list
56042590|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
56042591|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56190804|NCT01470352|Analgesics|analgesics|mesh-ancestor
56768919|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768920|NCT01015209|Expectorants|expectorants|mesh-ancestor
56768921|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
56768922|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56768923|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
56768924|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768925|NCT01015209|Protective Agents|protective agents|mesh-ancestor
56768926|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768927|NCT01015209|Antidotes|antidotes|mesh-ancestor
56768928|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56768929|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56768930|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
56768931|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56768932|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
56768933|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
56768934|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
56768935|NCT01015209|Coagulants|coagulants|mesh-ancestor
56768936|NCT04948463|Vancomycin|vancomycin|mesh-list
56768937|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
56768938|NCT04948463|Tazobactam|tazobactam|mesh-list
56768939|NCT04948463|Piperacillin|piperacillin|mesh-list
56768940|NCT04948463|Amikacin|amikacin|mesh-list
56768941|NCT04948463|Ceftazidime|ceftazidime|mesh-list
56768942|NCT04948463|Cefepime|cefepime|mesh-list
56768943|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56768944|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56768945|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56768946|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56768947|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768948|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768949|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768950|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56768951|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56768952|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56768953|NCT01080547|Capecitabine|capecitabine|mesh-list
56768954|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
56768955|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56768959|NCT04930991|Omeprazole|omeprazole|mesh-list
56768960|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56768961|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56768962|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56768963|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768964|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768965|NCT00111241|Letrozole|letrozole|mesh-list
56768966|NCT00111241|Anastrozole|anastrozole|mesh-list
56768967|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56768968|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768969|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56768970|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768971|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768972|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56768973|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
56768974|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56768975|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768976|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56768977|NCT00492297|Sorafenib|sorafenib|mesh-list
56768978|NCT00492297|Dacarbazine|dacarbazine|mesh-list
56768979|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56768980|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56768981|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56768982|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768983|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56768984|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
56479902|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
56768986|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
56768987|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56768988|NCT00697073|Protective Agents|protective agents|mesh-ancestor
56768989|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56768990|NCT04835129|Dexamethasone|dexamethasone|mesh-list
56768991|NCT04835129|Pomalidomide|pomalidomide|mesh-list
56769000|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
56769001|NCT04835129|Hormones|hormones|mesh-ancestor
56769002|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769003|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56769004|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769005|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
56769006|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56769007|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56769008|NCT04835129|Growth Substances|growth substances|mesh-ancestor
56769009|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
56769010|NCT04816643|Vaccines|vaccines|mesh-list
56769011|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
56769012|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769013|NCT00446134|Ribavirin|ribavirin|mesh-list
56769014|NCT00446134|Taribavirin|taribavirin|mesh-list
56769015|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
56769016|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769017|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
56769018|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769019|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
56769020|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
56769021|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
56769022|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56769023|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56769024|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769025|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769026|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769027|NCT00921245|Darifenacin|darifenacin|mesh-list
56769028|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56769029|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56190805|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
56190806|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190807|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
56190808|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56190809|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
56190810|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
56190811|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190812|NCT01470456|Rituximab|rituximab|mesh-list
56190813|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56190814|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190815|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
56042592|NCT00556673|Maleic acid|maleic acid|mesh-list
56042593|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042594|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56042595|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
56769030|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
56769031|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769032|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769033|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769034|NCT00921245|Urological Agents|urological agents|mesh-ancestor
56769035|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
56769036|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56769037|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56769038|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56769039|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769040|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769041|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
56769042|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769043|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769044|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56769045|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769046|NCT00940238|Dexetimide|dexetimide|mesh-list
56769047|NCT00940238|Citalopram|citalopram|mesh-list
56769048|NCT00940238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56769049|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56769050|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769051|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769052|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769053|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
56769054|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769055|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56769056|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
56769057|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56769058|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56769073|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769074|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769075|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56769076|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
56769077|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56769078|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56769079|NCT04013438|Urological Agents|urological agents|mesh-ancestor
56769080|NCT02565719|Interferons|interferons|mesh-list
56769081|NCT02565719|Tenofovir|tenofovir|mesh-list
56769082|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
56769083|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
56769084|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56769085|NCT02565719|REP 2139|rep 2139|mesh-list
56769086|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769087|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
56769088|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769089|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56769090|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56769091|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769092|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769093|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56769094|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56769095|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
56769096|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769097|NCT00111007|Paclitaxel|paclitaxel|mesh-list
56769098|NCT00111007|Carboplatin|carboplatin|mesh-list
56769099|NCT00111007|Sorafenib|sorafenib|mesh-list
56042596|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042597|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042677|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801504|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
56042717|NCT05654363|Analgesics|analgesics|mesh-ancestor
56042718|NCT05654363|Sensory System Agents|sensory system agents|mesh-ancestor
56042719|NCT05654363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042720|NCT02651415|Perindopril|perindopril|mesh-list
56042721|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56042722|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
56042723|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042794|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042795|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56042796|NCT05387811|Diuretics|diuretics|mesh-list
56042797|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
56042798|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042799|NCT05442801|Tropicamide|tropicamide|mesh-list
56042800|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
56042801|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
56042802|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
56042803|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042804|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769100|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56769101|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769102|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
56769103|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
56769104|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
56769105|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769106|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56769107|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769108|NCT00699335|Fentanyl|fentanyl|mesh-list
56769109|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56769110|NCT00699335|Narcotics|narcotics|mesh-ancestor
56769111|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769112|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769113|NCT00699335|Analgesics|analgesics|mesh-ancestor
56769114|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
56769115|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769116|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56769117|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56769118|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
56769119|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
56769120|NCT00939614|Lamotrigine|lamotrigine|mesh-list
56769121|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
56769122|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56769123|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769124|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769125|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56769126|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769127|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56769128|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56769129|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769130|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56769131|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56769141|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769142|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
56769143|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769144|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56769145|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
56769146|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56769147|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56769148|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56769149|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
56769150|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
56769151|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769152|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56769153|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56769154|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
56769155|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
56769156|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56769157|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56769158|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
56769159|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769160|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56769161|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56769162|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769163|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769164|NCT00939848|Gemcitabine|gemcitabine|mesh-list
56769165|NCT00939848|Cisplatin|cisplatin|mesh-list
56769166|NCT00939848|Cediranib|cediranib|mesh-list
56769167|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769168|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56769169|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
56769170|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769171|NCT00939848|Antiviral Agents|antiviral agents|mesh-ancestor
56769172|NCT00939848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769173|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769174|NCT00939848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041833|NCT01415960|Leuprolide|leuprolide|mesh-list
56042899|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042901|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
56042903|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56042904|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56042905|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769175|NCT00939848|Immunologic Factors|immunologic factors|mesh-ancestor
56769176|NCT00939848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769177|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56769178|NCT00935558|Interleukin-2|interleukin-2|mesh-list
56769179|NCT00935558|Exemestane|exemestane|mesh-list
56769180|NCT00935558|Anastrozole|anastrozole|mesh-list
56769181|NCT00935558|Letrozole|letrozole|mesh-list
56769182|NCT00935558|Lactitol|lactitol|mesh-list
56769183|NCT00935558|Vaccines|vaccines|mesh-list
56769184|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56769185|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
56769186|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769187|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769188|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56769189|NCT00935558|Analgesics|analgesics|mesh-ancestor
56769190|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
56769191|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769192|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56769193|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769194|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769195|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56769196|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
56769197|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769198|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56769199|NCT00935558|Cathartics|cathartics|mesh-ancestor
56769200|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56769201|NCT05280236|Propofol|propofol|mesh-list
56769202|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56769203|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769204|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769205|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56769206|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
56769207|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
56480131|NCT01283152|Laxatives|laxatives|mesh-ancestor
56769208|NCT00940472|Metformin|metformin|mesh-list
56769216|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769217|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56769218|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56769219|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769220|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56769221|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56769222|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
56769223|NCT00940550|Melatonin|melatonin|mesh-list
56769224|NCT00940550|Zolpidem|zolpidem|mesh-list
56769225|NCT00940550|Temazepam|temazepam|mesh-list
56769226|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
56769227|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769228|NCT00940550|Protective Agents|protective agents|mesh-ancestor
56769229|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769230|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769231|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56769232|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56769233|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56769234|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
56769235|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
56769236|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769237|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56769238|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56042906|NCT04738773|Naltrexone|naltrexone|mesh-list
56042907|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56043047|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
56043048|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56043050|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56043051|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
56043052|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043053|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043054|NCT02425098|Vaccines|vaccines|mesh-list
56043055|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
56043056|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043057|NCT02424630|Ropivacaine|ropivacaine|mesh-list
56190816|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190817|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56190818|NCT01470495|Sorafenib|sorafenib|mesh-list
56190819|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190820|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56190821|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190822|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190823|NCT01470690|Omeprazole|omeprazole|mesh-list
56190824|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56190825|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56190826|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56190827|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190828|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190829|NCT01470742|Capecitabine|capecitabine|mesh-list
56190830|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56190831|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
56190832|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190833|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769239|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56769240|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
56769241|NCT00940628|Orlistat|orlistat|mesh-list
56769242|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769243|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769244|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56769245|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56769246|NCT00936182|Fluconazole|fluconazole|mesh-list
56769247|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
56769248|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769249|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56769250|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56769251|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769252|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769253|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56769254|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
56769255|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769256|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769257|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56769258|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56769259|NCT00936260|Alendronate|alendronate|mesh-list
56769260|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56769261|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769262|NCT00445978|Verapamil|verapamil|mesh-list
56769263|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56769264|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56769265|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769266|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769268|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769281|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56769282|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
56769283|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769284|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769285|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
56769286|NCT00940784|Aspirin|aspirin|mesh-list
56769287|NCT00940784|Clopidogrel|clopidogrel|mesh-list
56769288|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56769289|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56769290|NCT00940784|Analgesics|analgesics|mesh-ancestor
56769291|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
56769292|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769293|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769294|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56769295|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56769296|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56769297|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56769298|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769299|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56769300|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56769301|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769302|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
56769303|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56769304|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56769305|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56769306|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
56769307|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769308|NCT01023490|Vitamin D|vitamin d|mesh-list
56769326|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56769327|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
56769328|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56769329|NCT00698009|Analgesics|analgesics|mesh-ancestor
56769330|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
56769331|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769332|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56769333|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
56769334|NCT00944606|Vitamin D|vitamin d|mesh-list
56769335|NCT00944606|Vitamins|vitamins|mesh-ancestor
56769336|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
56769337|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769338|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56769339|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
56769340|NCT05257655|Narcotics|narcotics|mesh-ancestor
56769341|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769342|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769343|NCT05257655|Analgesics|analgesics|mesh-ancestor
56769344|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
56769345|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769346|NCT00944684|Ribavirin|ribavirin|mesh-list
56769347|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
56769348|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769349|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
56769350|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769351|NCT04061057|Lidocaine|lidocaine|mesh-list
56769352|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
56769353|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
56769354|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769355|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769356|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
56769357|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769358|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56769367|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56769368|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56769369|NCT00921167|Growth Substances|growth substances|mesh-ancestor
56769370|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769371|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
56769372|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56769373|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56769374|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769375|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769376|NCT04061447|Clarithromycin|clarithromycin|mesh-list
56769377|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56769378|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769379|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56769380|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769381|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769382|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56769383|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56769384|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56769385|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
56769386|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769387|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56769388|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56769389|NCT05472779|Estradiol|estradiol|mesh-list
56769390|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56769391|NCT05472779|Estrogens|estrogens|mesh-ancestor
56769414|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56769415|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769416|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
56769417|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769418|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56769419|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
56769420|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56769421|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769422|NCT02566187|Atorvastatin|atorvastatin|mesh-list
56769423|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56769424|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56769425|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
56769426|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769427|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56769428|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56769429|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769430|NCT05324891|Fentanyl|fentanyl|mesh-list
56769431|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
56769432|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56769433|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769434|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769435|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56769436|NCT05324891|Analgesics|analgesics|mesh-ancestor
56769437|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
56769438|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769439|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56769460|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56769461|NCT00445432|Adalimumab|adalimumab|mesh-list
56769462|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56769463|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56769464|NCT03370133|Ustekinumab|ustekinumab|mesh-list
56769465|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
56769466|NCT00696137|Fentanyl|fentanyl|mesh-list
56769467|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56769468|NCT00696137|Narcotics|narcotics|mesh-ancestor
56769469|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769470|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769471|NCT00696137|Analgesics|analgesics|mesh-ancestor
56769472|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
56769473|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769474|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56769475|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56769476|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
56769477|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
56769478|NCT02565641|Gemcitabine|gemcitabine|mesh-list
56769479|NCT02565641|Capecitabine|capecitabine|mesh-list
56769480|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56769481|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
56769482|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769483|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769484|NCT02565641|Antiviral Agents|antiviral agents|mesh-ancestor
56769485|NCT02565641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769486|NCT02565641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769487|NCT02565641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923660|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769509|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769510|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
56769511|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56769512|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
56769513|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769514|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769515|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56769516|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
56769517|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56769518|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
56769519|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769520|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769521|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56769522|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
56769523|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
56769524|NCT04060979|Protective Agents|protective agents|mesh-ancestor
56769525|NCT00458302|Darunavir|darunavir|mesh-list
56769526|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56769527|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56769528|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
56769529|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769530|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769531|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56043187|NCT02867865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043188|NCT02867865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043189|NCT02867865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043190|NCT02867865|Immunologic Factors|immunologic factors|mesh-ancestor
56043191|NCT02867865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043193|NCT02833233|Ipilimumab|ipilimumab|mesh-list
56043194|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56043195|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043196|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56043338|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56190834|NCT01470794|Flucytosine|flucytosine|mesh-list
56190835|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
56190836|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190837|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
56190838|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190839|NCT01470807|Pancrelipase|pancrelipase|mesh-list
56190840|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56190841|NCT01470937|Acarbose|acarbose|mesh-list
56190842|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56190843|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190844|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811717|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
56190849|NCT01471067|Fludarabine|fludarabine|mesh-list
56043339|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043340|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56769532|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56769533|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
56769534|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769535|NCT00444106|Artesunate|artesunate|mesh-list
56769536|NCT00444106|Lumefantrine|lumefantrine|mesh-list
56769537|NCT00444106|Artemether|artemether|mesh-list
56769538|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56769539|NCT00444106|Mefloquine|mefloquine|mesh-list
56769540|NCT00444106|Atovaquone|atovaquone|mesh-list
56769541|NCT00444106|Proguanil|proguanil|mesh-list
56769542|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56769543|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
56769544|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56769545|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56769546|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769547|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769548|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
56769549|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
56769550|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56769551|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
56769552|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769553|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769554|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
56769555|NCT00561470|Leucovorin|leucovorin|mesh-list
56769556|NCT00561470|Fluorouracil|fluorouracil|mesh-list
56769557|NCT00561470|Irinotecan|irinotecan|mesh-list
56769558|NCT00561470|Aflibercept|aflibercept|mesh-list
56769559|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
56769560|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
56043342|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56043343|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56043344|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
56043345|NCT00368901|Hematinics|hematinics|mesh-ancestor
56043347|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56043348|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56043349|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
56043350|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043351|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043377|NCT00369603|Galantamine|galantamine|mesh-list
56043378|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56043379|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043380|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043381|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
56043382|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043383|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043384|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
56043385|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56043386|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
56043387|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043389|NCT02980016|Rifapentine|rifapentine|mesh-list
56043390|NCT02980016|Rifampin|rifampin|mesh-list
56043391|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
56769561|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769562|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56769563|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769564|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56769565|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
56769566|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769567|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56769568|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56769569|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769570|NCT00561470|Antidotes|antidotes|mesh-ancestor
56769571|NCT00561470|Protective Agents|protective agents|mesh-ancestor
56769572|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
56769573|NCT00561470|Vitamins|vitamins|mesh-ancestor
56769574|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
56769575|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56769576|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56769577|NCT00561470|Growth Substances|growth substances|mesh-ancestor
56769578|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
56769579|NCT00443872|Selegiline|selegiline|mesh-list
56769580|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
56769581|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56769582|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56769583|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56769613|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769614|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
56769615|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769616|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769617|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56769618|NCT00561392|Protective Agents|protective agents|mesh-ancestor
56769619|NCT00694109|Mipomersen|mipomersen|mesh-list
56769620|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56769621|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56769622|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
56769623|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769624|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56769625|NCT03070301|Everolimus|everolimus|mesh-list
56769626|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769627|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56769628|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
56769629|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769630|NCT00940862|Adalimumab|adalimumab|mesh-list
56769631|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56769632|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56769633|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
56769634|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56769635|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769636|NCT00561080|Vaccines|vaccines|mesh-list
56769637|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
56769638|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769639|NCT01307306|Metformin|metformin|mesh-list
56769640|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56769641|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769642|NCT00941096|Timolol|timolol|mesh-list
56769643|NCT00941096|Bimatoprost|bimatoprost|mesh-list
56769644|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56769645|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56769646|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
56769647|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769648|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769653|NCT04012424|Analgesics|analgesics|mesh-list
56769654|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56769655|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56769656|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
56769657|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769658|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769659|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56769660|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56769661|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769662|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769663|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769664|NCT00562094|Pantoprazole|pantoprazole|mesh-list
56769665|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56769666|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043392|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56043393|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043394|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56043395|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56043396|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
56043397|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043398|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56043399|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56043400|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
56043431|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043432|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
56043434|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043435|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56043436|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043437|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
56043438|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043439|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190850|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
56190851|NCT01471067|Melphalan|melphalan|mesh-list
56190852|NCT01471067|Busulfan|busulfan|mesh-list
56190853|NCT01471067|Clofarabine|clofarabine|mesh-list
56190854|NCT01471067|Tacrolimus|tacrolimus|mesh-list
56190855|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
56190856|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56190857|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56190858|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190859|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
56190860|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190861|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56190862|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56190863|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
56190864|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190865|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56190866|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190867|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56190868|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190869|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56190870|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56190871|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
56190872|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55801515|NCT01652469|Docetaxel|docetaxel|mesh-list
56190888|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
56190889|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190890|NCT01471158|Timolol|timolol|mesh-list
56190891|NCT01471158|Dorzolamide|dorzolamide|mesh-list
56190892|NCT01471158|Maleic acid|maleic acid|mesh-list
56769667|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56769668|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769669|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769670|NCT03817853|Prednisone|prednisone|mesh-list
56769671|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
56769672|NCT03817853|Prednisolone|prednisolone|mesh-list
56769673|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
56769674|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56769675|NCT03817853|Doxorubicin|doxorubicin|mesh-list
56769676|NCT03817853|Vincristine|vincristine|mesh-list
56769677|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
56769678|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56769679|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
56769680|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769681|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56769682|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56769683|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
56769684|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769685|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769686|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56769687|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56769688|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56769689|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56769690|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769691|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56769692|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
56769693|NCT03817853|Hormones|hormones|mesh-ancestor
56769694|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769695|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56769696|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56769697|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
56042363|NCT05716763|Tramadol|tramadol|mesh-list
56190893|NCT01471158|Brinzolamide|brinzolamide|mesh-list
56190894|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190895|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190896|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56190897|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56190898|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56190899|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190900|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043489|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043490|NCT05448183|Antiviral Agents|antiviral agents|mesh-ancestor
56043605|NCT03160911|Coagulants|coagulants|mesh-ancestor
56769698|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
56769699|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
56769700|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
56769701|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
56769702|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769703|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56769704|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56769705|NCT03817853|Protective Agents|protective agents|mesh-ancestor
56769706|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56769707|NCT00944840|Amodiaquine|amodiaquine|mesh-list
56769708|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
56769709|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56769710|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56769711|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769712|NCT00439270|Docetaxel|docetaxel|mesh-list
56769713|NCT00439270|Dasatinib|dasatinib|mesh-list
56769714|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769715|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
56769716|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
56769717|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
56769718|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769719|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56769720|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769721|NCT00944918|Fulvestrant|fulvestrant|mesh-list
56769722|NCT00944918|Anastrozole|anastrozole|mesh-list
56769723|NCT00944918|Exemestane|exemestane|mesh-list
56769724|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56769725|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769726|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56769727|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56769728|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
56769729|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769730|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769731|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56769732|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56769733|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043606|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
56043607|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56043608|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043609|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56769734|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769735|NCT04012268|Aspirin|aspirin|mesh-list
56769736|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56769737|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56769738|NCT04012268|Analgesics|analgesics|mesh-ancestor
56769739|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
56769740|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769741|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769742|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56769743|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56769744|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56769745|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56769746|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769747|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56769748|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56769749|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769750|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
56769751|NCT03995134|Remifentanil|remifentanil|mesh-list
56769752|NCT03995134|Propofol|propofol|mesh-list
56769753|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56769754|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769755|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769756|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56769757|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
56769758|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
56769759|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56769760|NCT03995134|Narcotics|narcotics|mesh-ancestor
56769761|NCT03995134|Analgesics|analgesics|mesh-ancestor
56769762|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
56769763|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769764|NCT00553280|Pregabalin|pregabalin|mesh-list
56769765|NCT00553280|Analgesics|analgesics|mesh-ancestor
56769766|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
56769767|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042430|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
56043635|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56043636|NCT04635189|Growth Substances|growth substances|mesh-ancestor
56043637|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
56043639|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56043640|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56043641|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56769768|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769769|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
56769770|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56769771|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56769772|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769773|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56769774|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56769775|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56769776|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769777|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56769778|NCT01024192|Zolpidem|zolpidem|mesh-list
56769779|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56769780|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56769781|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769782|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769783|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56769784|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
56769785|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
56769786|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56769787|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769788|NCT01024270|Misoprostol|misoprostol|mesh-list
56769789|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56769790|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
56769791|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56769792|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769793|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56769794|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56769795|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
56769796|NCT00944996|Citalopram|citalopram|mesh-list
56769797|NCT00944996|Fluoxetine|fluoxetine|mesh-list
56769798|NCT00944996|Paroxetine|paroxetine|mesh-list
56769799|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56769800|NCT00944996|Sertraline|sertraline|mesh-list
56042506|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042507|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56042508|NCT01421498|Lifitegrast|lifitegrast|mesh-list
56042509|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56042510|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56042520|NCT01422200|Vaccines|vaccines|mesh-list
56042521|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
56042522|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769808|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769809|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56769810|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
56769811|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56769812|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56769813|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56769814|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769815|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56769816|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56769817|NCT00950066|Amlodipine|amlodipine|mesh-list
56769818|NCT00950066|Irbesartan|irbesartan|mesh-list
56769819|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56769852|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769853|NCT03994744|Metformin|metformin|mesh-list
56769854|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56769855|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56769856|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769857|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769858|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769859|NCT00950222|Imipenem|imipenem|mesh-list
56769860|NCT00950222|Amikacin|amikacin|mesh-list
56769861|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56769862|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769863|NCT05301530|Docetaxel|docetaxel|mesh-list
56769864|NCT05301530|Trastuzumab|trastuzumab|mesh-list
56769865|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769866|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
56769867|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
56769868|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
56769869|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769870|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56769871|NCT00941174|Leucovorin|leucovorin|mesh-list
56769872|NCT00941174|Calcium|calcium|mesh-list
56769873|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
56769874|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56769875|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769876|NCT00941174|Antidotes|antidotes|mesh-ancestor
56769877|NCT00941174|Protective Agents|protective agents|mesh-ancestor
56769878|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
56769879|NCT00941174|Vitamins|vitamins|mesh-ancestor
56769880|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
56769881|NCT00440518|Lacosamide|lacosamide|mesh-list
56769882|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
56769899|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
56769900|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769901|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769902|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
56769903|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769904|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56769905|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
56769906|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769907|NCT00945308|Eptifibatide|eptifibatide|mesh-list
56769908|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56769909|NCT03172936|Spartalizumab|spartalizumab|mesh-list
56769910|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56769911|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769912|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769913|NCT01030042|Leucovorin|leucovorin|mesh-list
56769914|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
56769915|NCT01030042|Irinotecan|irinotecan|mesh-list
56769916|NCT01030042|Cetuximab|cetuximab|mesh-list
56769917|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769918|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56769919|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56769920|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769921|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769922|NCT01030042|Antidotes|antidotes|mesh-ancestor
56042609|NCT01422434|Calcitriol|calcitriol|mesh-list
56043642|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
56043644|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043645|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190901|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56190902|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56190903|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56190904|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56190905|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56190907|NCT01471262|Hematinics|hematinics|mesh-ancestor
56190908|NCT01471275|Metformin|metformin|mesh-list
56190909|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190910|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190911|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56190912|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56190913|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190914|NCT01471470|Bevacizumab|bevacizumab|mesh-list
56190915|NCT01471470|Docetaxel|docetaxel|mesh-list
56190916|NCT01471470|Capecitabine|capecitabine|mesh-list
56190917|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56190918|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190919|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56190920|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56190921|NCT01471470|Growth Substances|growth substances|mesh-ancestor
56043646|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043647|NCT05227131|Capecitabine|capecitabine|mesh-list
56043648|NCT05227131|Tucatinib|tucatinib|mesh-list
56769923|NCT01030042|Protective Agents|protective agents|mesh-ancestor
56769924|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769925|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
56769926|NCT01030042|Vitamins|vitamins|mesh-ancestor
56769927|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
56769928|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56769929|NCT01024504|Bevacizumab|bevacizumab|mesh-list
56769930|NCT01024504|Capecitabine|capecitabine|mesh-list
56769931|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
56769932|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56769933|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769934|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56769935|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56769936|NCT01024504|Growth Substances|growth substances|mesh-ancestor
56769937|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769938|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
56769939|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56769940|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
56769941|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043649|NCT05227131|Margetuximab|margetuximab|mesh-list
56043650|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56043651|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
56043652|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801566|NCT02410551|Busulfan|busulfan|mesh-list
56043696|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043730|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56043731|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56043758|NCT03022877|Protective Agents|protective agents|mesh-ancestor
56043759|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043760|NCT02572323|Tesamorelin|tesamorelin|mesh-list
56043761|NCT02572323|Growth Substances|growth substances|mesh-ancestor
56043762|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043763|NCT02420262|Insulin|insulin|mesh-list
56043764|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56043765|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
56043766|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
56043767|NCT02420262|Liraglutide|liraglutide|mesh-list
56043768|NCT02420262|Xultophy|xultophy|mesh-list
56043769|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56043770|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043771|NCT02420262|Incretins|incretins|mesh-ancestor
56043772|NCT02420262|Hormones|hormones|mesh-ancestor
56043773|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043774|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56190922|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190923|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
56118710|NCT00003335|Melphalan|melphalan|mesh-list
56190924|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56190925|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56190926|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56190927|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190928|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56190929|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
56190930|NCT01471535|Interferons|interferons|mesh-list
56190931|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
56190932|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
56190933|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56769942|NCT01030120|Etanercept|etanercept|mesh-list
56769943|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56769944|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56769945|NCT01030120|Analgesics|analgesics|mesh-ancestor
56769946|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
56769947|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769948|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769949|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56769950|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56769951|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56769952|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56769953|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
56769954|NCT00951236|Cortisone|cortisone|mesh-list
56769955|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56769956|NCT00945542|Hemostatics|hemostatics|mesh-list
56769957|NCT00945542|Coagulants|coagulants|mesh-ancestor
56769958|NCT00438256|Capecitabine|capecitabine|mesh-list
56769959|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56769960|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
56769961|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769962|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769963|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56769964|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56480881|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
56769965|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
56769966|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769967|NCT00945620|Ropivacaine|ropivacaine|mesh-list
56769968|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
56769969|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
56769970|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56769971|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769972|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
56769973|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769974|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56769975|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56769976|NCT01030510|Rocuronium|rocuronium|mesh-list
56769977|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56769979|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56769980|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56769981|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769982|NCT04813822|Miconazole|miconazole|mesh-list
56769983|NCT04813822|Clotrimazole|clotrimazole|mesh-list
56769984|NCT04813822|Bromides|bromides|mesh-list
56769985|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
56769986|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
56769987|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56769988|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56769989|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56769990|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56769991|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56769992|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56769993|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
56769994|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56769995|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56769996|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56769997|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56769998|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56769999|NCT02917564|Triamcinolone|triamcinolone|mesh-list
56770000|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56770001|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56770002|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56770003|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770004|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
56770005|NCT02917564|Hormones|hormones|mesh-ancestor
56770008|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770023|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56770024|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770025|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
56770026|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770027|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56770028|NCT00952094|Cinacalcet|cinacalcet|mesh-list
56770029|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56770030|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770031|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56770032|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
56770033|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56770034|NCT00942344|Losartan|losartan|mesh-list
56770035|NCT00942344|Amlodipine|amlodipine|mesh-list
56770036|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56770037|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56770038|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56923661|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770039|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770040|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56770041|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770042|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
56770043|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56770044|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56770045|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56770046|NCT00946166|Simvastatin|simvastatin|mesh-list
56770047|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56770048|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56770049|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
56770050|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770051|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56770052|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56770053|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770054|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
56770055|NCT00952562|Vitamin D|vitamin d|mesh-list
56770056|NCT00952562|Vitamins|vitamins|mesh-ancestor
56770058|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770059|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56770060|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56770061|NCT00952640|Vitamin A|vitamin a|mesh-list
56770062|NCT00952640|Vitamins|vitamins|mesh-ancestor
56770063|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
56770064|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770065|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
56770066|NCT00952796|Ampicillin|ampicillin|mesh-list
56770067|NCT00952796|Sulbactam|sulbactam|mesh-list
56770068|NCT00952796|Sultamicillin|sultamicillin|mesh-list
56770069|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56770070|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770071|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56770072|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56770073|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770074|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770075|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770076|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56770077|NCT00952952|Mesalamine|mesalamine|mesh-list
56770078|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56770079|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56770080|NCT00952952|Analgesics|analgesics|mesh-ancestor
56770081|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
56770082|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770083|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770084|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770085|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770086|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56770087|NCT00953108|Citalopram|citalopram|mesh-list
56770088|NCT00953108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56770089|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56770100|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770101|NCT00953498|Pioglitazone|pioglitazone|mesh-list
56770102|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
56770103|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56770104|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770105|NCT00943358|Vaccines|vaccines|mesh-list
56770106|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
56770107|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770108|NCT00120289|Niacin|niacin|mesh-list
56770109|NCT00120289|Simvastatin|simvastatin|mesh-list
56770110|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56770111|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56770112|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
56770113|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770114|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56042805|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56190934|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190935|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
56190936|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043775|NCT02520141|Ramucirumab|ramucirumab|mesh-list
56043776|NCT02520141|Antibodies|antibodies|mesh-list
56043778|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56043779|NCT02520141|Lexatumumab|lexatumumab|mesh-list
56043780|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
56043781|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043820|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56043850|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
56043851|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043852|NCT04168203|Apixaban|apixaban|mesh-list
56043853|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56043854|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
56043855|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56043856|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
56043857|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043858|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043859|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
56043860|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
56043861|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56043890|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56043891|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043892|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56043893|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56043894|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56043895|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043896|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043898|NCT01555281|Dexamethasone|dexamethasone|mesh-list
56043899|NCT01555281|Lenalidomide|lenalidomide|mesh-list
56190947|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190948|NCT01471678|Tamsulosin|tamsulosin|mesh-list
56190949|NCT01471678|Dutasteride|dutasteride|mesh-list
56190950|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56190951|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56043944|NCT00370539|Verteporfin|verteporfin|mesh-list
56043945|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56043946|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56043947|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043948|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56043949|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56043950|NCT00370539|Growth Substances|growth substances|mesh-ancestor
56043951|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043952|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
56770115|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56770116|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770117|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
56770118|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
56770119|NCT00120289|Vitamins|vitamins|mesh-ancestor
56770120|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
56770121|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770122|NCT00946556|Valacyclovir|valacyclovir|mesh-list
56770123|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
56770124|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770125|NCT00943748|Deferiprone|deferiprone|mesh-list
56770126|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56770127|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
56770128|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
56770129|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770130|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
56043953|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56043984|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043985|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
56043986|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
56043987|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
56043988|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043989|NCT00552071|Octreotide|octreotide|mesh-list
56043990|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043991|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56043992|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043993|NCT00673335|Letrozole|letrozole|mesh-list
56043994|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043995|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56043996|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56043997|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044029|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
56044030|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
56044031|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
56044032|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044033|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
56044034|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56044035|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56044036|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
56044037|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044038|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044039|NCT04849377|Cisplatin|cisplatin|mesh-list
56044040|NCT04849377|Carboplatin|carboplatin|mesh-list
56044082|NCT05454345|Rifampin|rifampin|mesh-list
56044083|NCT05454345|Isoniazid|isoniazid|mesh-list
56044113|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
56044114|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044115|NCT03558087|Antiviral Agents|antiviral agents|mesh-ancestor
56044116|NCT03558087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044117|NCT03558087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044118|NCT03558087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56190952|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56190953|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
56190954|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190955|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190956|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190957|NCT01471678|Urological Agents|urological agents|mesh-ancestor
56190958|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56190959|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56190960|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190961|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
56770131|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
56770132|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56770133|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56770134|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770135|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770136|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770137|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770138|NCT00954200|Ibuprofen|ibuprofen|mesh-list
56770139|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56770140|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56770141|NCT00954200|Analgesics|analgesics|mesh-ancestor
56770142|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
56770143|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770144|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770145|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770146|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770147|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56770148|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770149|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770150|NCT00954278|Sorafenib|sorafenib|mesh-list
56770151|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770152|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56770153|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770154|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770155|NCT00550446|Adalimumab|adalimumab|mesh-list
56770156|NCT00550446|Tofacitinib|tofacitinib|mesh-list
56770157|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770158|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770159|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56770160|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770161|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770162|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56770163|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
56190962|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190963|NCT01471704|Verapamil|verapamil|mesh-list
56044119|NCT03558087|Immunologic Factors|immunologic factors|mesh-ancestor
56044120|NCT03558087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044121|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044126|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55944982|NCT04891458|Propofol|propofol|mesh-list
56770164|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770165|NCT00953550|Rocuronium|rocuronium|mesh-list
56770166|NCT00953550|Succinylcholine|succinylcholine|mesh-list
56770167|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56770168|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56770169|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56770170|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770171|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770172|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56770173|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56770174|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56770175|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770176|NCT00949026|Sirolimus|sirolimus|mesh-list
56770177|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56770178|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770179|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56770180|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770181|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
56770182|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770183|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
56770184|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770185|NCT00949182|Doxorubicin|doxorubicin|mesh-list
56770186|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56770187|NCT00949182|Mitomycins|mitomycins|mesh-list
56481111|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
56770188|NCT00949182|Mitomycin|mitomycin|mesh-list
56770189|NCT00949182|Sorafenib|sorafenib|mesh-list
56770190|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56770191|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770192|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56770193|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56770194|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770195|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770196|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56770204|NCT01024660|Donepezil|donepezil|mesh-list
56770205|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56770206|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770207|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770208|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
56770209|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770210|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770211|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
56770212|NCT01751126|Cyclosporine|cyclosporine|mesh-list
56770213|NCT01751126|Cyclosporins|cyclosporins|mesh-list
56770214|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770215|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770216|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770217|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
56770218|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770219|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
56770220|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770221|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
56770222|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770223|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56770224|NCT00943982|Interferons|interferons|mesh-list
56770225|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
56770226|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770227|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
56770228|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770229|NCT00548808|Insulin|insulin|mesh-list
56770230|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56770231|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
56770232|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
56770233|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56770234|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770235|NCT04011878|Mitomycins|mitomycins|mesh-list
56770236|NCT04011878|Mitomycin|mitomycin|mesh-list
56770237|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56770238|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770239|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
56044127|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56044128|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044190|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56044191|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56044192|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56044193|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56770240|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770241|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56770242|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770243|NCT00954096|Nicotine|nicotine|mesh-list
56770244|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56770245|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
56770246|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770247|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770248|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56770249|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56770250|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
56770251|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770252|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770253|NCT00954252|Flurbiprofen|flurbiprofen|mesh-list
56770254|NCT00954252|Analgesics|analgesics|mesh-ancestor
56770255|NCT00954252|Sensory System Agents|sensory system agents|mesh-ancestor
56770256|NCT00954252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770257|NCT00954252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770258|NCT00954252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56770259|NCT00954252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56770260|NCT00954252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770261|NCT00954252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770262|NCT00954252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56770263|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770264|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770265|NCT00110617|Deferasirox|deferasirox|mesh-list
56770266|NCT00110617|Deferoxamine|deferoxamine|mesh-list
56770267|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56770268|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
56770269|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
56042940|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
56044194|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044195|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56044196|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56044197|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56044198|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
56044199|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044200|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56044201|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
56044202|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56044203|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56044204|NCT02347332|Methotrexate|methotrexate|mesh-list
56770270|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770271|NCT00110617|Siderophores|siderophores|mesh-ancestor
56770272|NCT00949494|Hylan|hylan|mesh-list
56770273|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
56770274|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
56770275|NCT00949494|Protective Agents|protective agents|mesh-ancestor
56770276|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770277|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56770278|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
56770279|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
56770280|NCT00954486|Hematinics|hematinics|mesh-ancestor
56770281|NCT00550238|Pimavanserin|pimavanserin|mesh-list
56770282|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56770283|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56770284|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56770285|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56770286|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770287|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770288|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56770289|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56770290|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56770291|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
56770292|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770293|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770294|NCT02903680|Dexamethasone|dexamethasone|mesh-list
56770295|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
56770296|NCT02903680|BB 1101|bb 1101|mesh-list
56770297|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770298|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
56770299|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
56044205|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56044206|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
56044207|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56044208|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044209|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56044210|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
56044211|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044212|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044213|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
56044214|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044243|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56044244|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
56044245|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044246|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
56044247|NCT05451381|Propofol|propofol|mesh-list
56044248|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56044249|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770300|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770301|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770302|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56770303|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
56770304|NCT02903680|Hormones|hormones|mesh-ancestor
56770305|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56770306|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56770307|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770308|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
56770309|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770310|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770311|NCT00946946|Mesalamine|mesalamine|mesh-list
56044250|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044251|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56044252|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
56044253|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
56044254|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56044255|NCT05451381|Analgesics|analgesics|mesh-ancestor
56044256|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
56190964|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56190965|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56190966|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044257|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044258|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56044259|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56044286|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044287|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56044288|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56044289|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
56044290|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044291|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56044292|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
56044293|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
56044294|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
56044295|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56044296|NCT02215070|Pasireotide|pasireotide|mesh-list
56044298|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044299|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044300|NCT04000737|Sorafenib|sorafenib|mesh-list
56044301|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044302|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56044303|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044304|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044305|NCT02347098|Atorvastatin|atorvastatin|mesh-list
56044335|NCT04895592|Ichthammol|ichthammol|mesh-list
56044336|NCT04895592|BB 1101|bb 1101|mesh-list
56044337|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56044338|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
56044339|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
56044340|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044341|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044342|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044343|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
56044344|NCT04895592|Hormones|hormones|mesh-ancestor
56044345|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044346|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56044347|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044348|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
56044349|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044350|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044351|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
56770312|NCT00946946|Azathioprine|azathioprine|mesh-list
56770313|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
56770314|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770315|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56770316|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770317|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770318|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
56770319|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770320|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770321|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56770322|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56770323|NCT00946946|Analgesics|analgesics|mesh-ancestor
56770324|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
56770325|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770326|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770327|NCT00947024|Glipizide|glipizide|mesh-list
56770328|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56770329|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770330|NCT00949572|Vaccines|vaccines|mesh-list
56770331|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
56770332|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
56770333|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770334|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56770335|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
56770336|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56770337|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56770338|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770339|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
56770340|NCT01031992|Coagulants|coagulants|mesh-ancestor
56770341|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56770342|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56770343|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770354|NCT00954902|Protective Agents|protective agents|mesh-ancestor
56770355|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770356|NCT01034020|Nicotine|nicotine|mesh-list
56770357|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56770358|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
56770359|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770360|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770361|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56770362|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56770363|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
56770364|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770365|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770366|NCT01032148|Panobinostat|panobinostat|mesh-list
56770367|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770368|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56770369|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770370|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770371|NCT01032304|Erdosteine|erdosteine|mesh-list
56770372|NCT01032304|Expectorants|expectorants|mesh-ancestor
56770373|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
56770374|NCT00954642|Paclitaxel|paclitaxel|mesh-list
56770375|NCT00954642|Bevacizumab|bevacizumab|mesh-list
56770376|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56770377|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770378|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
56770379|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
56770380|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
56770381|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770382|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56770383|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56770384|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56770385|NCT00954642|Growth Substances|growth substances|mesh-ancestor
56770386|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770387|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
56770388|NCT00954798|Vaccines|vaccines|mesh-list
56770393|NCT00110305|Rilpivirine|rilpivirine|mesh-list
56770394|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56770395|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770396|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770397|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
56770398|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770399|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56770400|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56770401|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56770402|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56770403|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56044352|NCT01556594|Glucagon|glucagon|mesh-list
56044382|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044383|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044384|NCT01440764|Furosemide|furosemide|mesh-list
56044385|NCT01440764|Diuretics|diuretics|mesh-ancestor
56044386|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
56044387|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044388|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56044389|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044390|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044391|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56044392|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56044393|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044394|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044395|NCT05283837|Pertuzumab|pertuzumab|mesh-list
56044396|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044397|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044431|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56044432|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044433|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
56044434|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56044435|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56044436|NCT03289299|Growth Substances|growth substances|mesh-ancestor
56044437|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
56190967|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190968|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56190969|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190970|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
56190971|NCT01471730|Thrombin|thrombin|mesh-list
56190972|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
56190973|NCT01471730|Coagulants|coagulants|mesh-ancestor
56190974|NCT01471808|Metformin|metformin|mesh-list
56190975|NCT01471808|Pioglitazone|pioglitazone|mesh-list
56190976|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56190977|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190978|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190979|NCT01471808|Incretins|incretins|mesh-ancestor
56190980|NCT01471808|Hormones|hormones|mesh-ancestor
56190981|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190982|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56190983|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
56190984|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190985|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190986|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56190987|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
56190988|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190989|NCT01471847|Capecitabine|capecitabine|mesh-list
56190990|NCT01471847|Trastuzumab|trastuzumab|mesh-list
56044439|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55946322|NCT02935361|Azacitidine|azacitidine|mesh-list
56770404|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56770405|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56770406|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56770407|NCT00560066|Vaccines|vaccines|mesh-list
56770408|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
56770409|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770410|NCT00549900|Vaccines|vaccines|mesh-list
56770411|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
56770412|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770413|NCT00435994|Epinephrine|epinephrine|mesh-list
56770414|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56770415|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56770416|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
56770417|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770418|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770419|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770420|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56770421|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56770422|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
56770423|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770424|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56770425|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
56770426|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
56770427|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
56770428|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56770429|NCT01563120|Metformin|metformin|mesh-list
56770430|NCT01563120|Glyburide|glyburide|mesh-list
56770431|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56770432|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770433|NCT00435370|Tropisetron|tropisetron|mesh-list
56770434|NCT00435370|Risperidone|risperidone|mesh-list
56770450|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56770451|NCT05100654|Doxycycline|doxycycline|mesh-list
56770452|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
56770453|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56770454|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56770455|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56770456|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770457|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
56770458|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56770459|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56770460|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56770461|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56770462|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770463|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770464|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770465|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56770466|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56770467|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56770468|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56770469|NCT05100654|Renal Agents|renal agents|mesh-ancestor
56770470|NCT00096031|Cetuximab|cetuximab|mesh-list
56770471|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56770472|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770473|NCT00118417|Clonazepam|clonazepam|mesh-list
56770474|NCT00118417|Sertraline|sertraline|mesh-list
56770475|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
56770476|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56770486|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
56770496|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770497|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56770498|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
56770499|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
56770500|NCT01079455|Protective Agents|protective agents|mesh-ancestor
56770501|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770502|NCT00549848|Cytarabine|cytarabine|mesh-list
56770503|NCT00549848|Dexamethasone|dexamethasone|mesh-list
56770504|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
56770505|NCT00549848|Prednisone|prednisone|mesh-list
56770506|NCT00549848|Prednisolone|prednisolone|mesh-list
56770507|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
56770508|NCT00549848|Doxorubicin|doxorubicin|mesh-list
56770509|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56770510|NCT00549848|Methotrexate|methotrexate|mesh-list
56770511|NCT00549848|Etoposide|etoposide|mesh-list
56770512|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
56770513|NCT00549848|Vincristine|vincristine|mesh-list
56770514|NCT00549848|Daunorubicin|daunorubicin|mesh-list
56770515|NCT00549848|Asparaginase|asparaginase|mesh-list
56770516|NCT00549848|Dasatinib|dasatinib|mesh-list
56770517|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
56770518|NCT00549848|Clofarabine|clofarabine|mesh-list
56770519|NCT00549848|Pegaspargase|pegaspargase|mesh-list
56770520|NCT00549848|Thioguanine|thioguanine|mesh-list
56770521|NCT00549848|BB 1101|bb 1101|mesh-list
56770522|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770523|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
56770524|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770525|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770526|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56770527|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
56770528|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770529|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770530|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56770531|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770532|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
56770533|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
56770541|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770542|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56770543|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56770544|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56770545|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56770546|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
56770547|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56770548|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56770549|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
56770550|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
56770551|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56770552|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56770553|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56770554|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
56770555|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770556|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
56770557|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
56770558|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
56770559|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56770560|NCT01083589|Docetaxel|docetaxel|mesh-list
56770561|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
56770562|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770563|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
56770564|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
56770565|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
56770566|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770567|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56770568|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481534|NCT04885686|Thymol|thymol|mesh-list
56770569|NCT00549770|Valsartan|valsartan|mesh-list
56770570|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56770571|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56770572|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56770573|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56770574|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770575|NCT00548184|Trastuzumab|trastuzumab|mesh-list
56044440|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946323|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56770576|NCT00548184|Lapatinib|lapatinib|mesh-list
56770577|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56770578|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770579|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56770580|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770581|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770582|NCT00454636|Cisplatin|cisplatin|mesh-list
56770583|NCT00454636|Docetaxel|docetaxel|mesh-list
56770584|NCT00454636|Capecitabine|capecitabine|mesh-list
56770585|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
56770586|NCT00454636|Epirubicin|epirubicin|mesh-list
56770587|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770588|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
56770589|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
56770590|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
56770591|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770592|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56770593|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
56770594|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56770595|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56770596|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56770597|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770598|NCT00427960|Atorvastatin|atorvastatin|mesh-list
56770599|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56770600|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56770601|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56770602|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
56770603|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770604|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56770605|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56770606|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770607|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
56770608|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56770609|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770610|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
56770611|NCT00955890|Razoxane|razoxane|mesh-list
56770612|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044441|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55947086|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
56770613|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56770614|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56770615|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56770616|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770617|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770618|NCT00955890|Protective Agents|protective agents|mesh-ancestor
56770619|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770620|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56770621|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56770622|NCT00956046|Vaccines|vaccines|mesh-list
56770623|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
56770624|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770625|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
56770626|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
56770627|NCT00454246|Hematinics|hematinics|mesh-ancestor
56770628|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
56770629|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56770630|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770631|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56770632|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
56770633|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56770634|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770635|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770636|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770637|NCT00956202|Vaccines|vaccines|mesh-list
56770638|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
56770639|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770640|NCT00695903|Vancomycin|vancomycin|mesh-list
56770641|NCT00695903|Daptomycin|daptomycin|mesh-list
56770642|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56770643|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770658|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770659|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770660|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56770661|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
56770662|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56770663|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770664|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56770665|NCT02565173|Timolol|timolol|mesh-list
56770666|NCT02565173|Adenosine|adenosine|mesh-list
56770667|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56770668|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56770669|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
56770670|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770671|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770672|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770673|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56770674|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56770675|NCT02565173|Analgesics|analgesics|mesh-ancestor
56770676|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
56770677|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770678|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
56770679|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56770680|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
56770681|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
56770705|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56770706|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56770707|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56770708|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56770709|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56770710|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770711|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770712|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56770713|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
56770714|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56770715|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770716|NCT00095173|Abatacept|abatacept|mesh-list
56770717|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56923662|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56770718|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770719|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770720|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770721|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
56770722|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770723|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770725|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
56770726|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
56770727|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770728|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770729|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
56770730|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770731|NCT00690443|Atorvastatin|atorvastatin|mesh-list
56770732|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56770748|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56770749|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770750|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56770751|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770752|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
56770753|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56770754|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
56770755|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
56770756|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56770757|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56770758|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770759|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770760|NCT00692237|Urological Agents|urological agents|mesh-ancestor
56770761|NCT00110149|Rituximab|rituximab|mesh-list
56770762|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56770763|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770764|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
56770765|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770766|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770767|NCT01084057|Vorinostat|vorinostat|mesh-list
56770768|NCT01084057|Epothilone B|epothilone b|mesh-list
56770769|NCT01084057|Epothilones|epothilones|mesh-list
56770770|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770771|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56770772|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770773|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770774|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
56770775|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56770776|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56770777|NCT03954444|Phenylephrine|phenylephrine|mesh-list
56770778|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
56770790|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
56481713|NCT01259713|Amebicides|amebicides|mesh-ancestor
56770791|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56770792|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
56770793|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56770794|NCT03954444|Protective Agents|protective agents|mesh-ancestor
56770795|NCT03953820|Diazepam|diazepam|mesh-list
56770796|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56770797|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
56770798|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
56770799|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
56770800|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770801|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770802|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56770803|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56770804|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770805|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56770806|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56770807|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56770808|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56770809|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56770810|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56770811|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
56770812|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
56770813|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
56770814|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
56770815|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770816|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770817|NCT02611037|Gemcitabine|gemcitabine|mesh-list
56770818|NCT02611037|Methotrexate|methotrexate|mesh-list
56770819|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770820|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56770821|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
56770823|NCT02611037|Antiviral Agents|antiviral agents|mesh-ancestor
56770832|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
56770833|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56770834|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56770835|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56770836|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
56770837|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56770838|NCT04492956|Ecopipam|ecopipam|mesh-list
56770839|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56770840|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56770841|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770842|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770843|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56770844|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56770845|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
56770846|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770847|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770848|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56770849|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
56770850|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56770851|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56770852|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770853|NCT00742937|Vitamin A|vitamin a|mesh-list
56770854|NCT00742937|Vitamins|vitamins|mesh-ancestor
56770855|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
56770856|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770857|NCT00692003|Zonisamide|zonisamide|mesh-list
56770858|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
56770859|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56770860|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56770861|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770862|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56770863|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770864|NCT02564315|Nicotine|nicotine|mesh-list
56770865|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56770866|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
56481792|NCT04326868|Albendazole|albendazole|mesh-list
56770867|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770869|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56770870|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56770871|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
56770872|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56770873|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770874|NCT02564237|Vaccines|vaccines|mesh-list
56770875|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
56770876|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770877|NCT00427648|Lidocaine|lidocaine|mesh-list
56770878|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
56770879|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
56770880|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770881|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770882|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
56770883|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770884|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56770885|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56770886|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56770887|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56770888|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770889|NCT02153177|Acetaminophen|acetaminophen|mesh-list
56770890|NCT02153177|Ibuprofen|ibuprofen|mesh-list
56770891|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56770892|NCT02153177|Hydrocodone|hydrocodone|mesh-list
56770893|NCT02153177|Oxycodone|oxycodone|mesh-list
56770894|NCT02153177|Omeprazole|omeprazole|mesh-list
56770895|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56770896|NCT02153177|Analgesics|analgesics|mesh-ancestor
56770897|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
56770898|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56770899|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770900|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
56770911|NCT02153177|Narcotics|narcotics|mesh-ancestor
56770912|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56770913|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
56770914|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
56770915|NCT00743327|Pioglitazone|pioglitazone|mesh-list
56770916|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56770917|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770918|NCT02564861|DS-1971a|ds-1971a|mesh-list
56770919|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56770920|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56770921|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56770922|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770923|NCT00416884|Fludarabine|fludarabine|mesh-list
56770924|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
56770925|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770926|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56770927|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56770928|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56770929|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770930|NCT03502733|Nivolumab|nivolumab|mesh-list
56770931|NCT03502733|Ipilimumab|ipilimumab|mesh-list
56770932|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56770933|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770934|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56770935|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770938|NCT00555620|Sunitinib|sunitinib|mesh-list
56770960|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
56770961|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56770962|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56770963|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
56770964|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56770965|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
56770966|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770967|NCT03463265|Sirolimus|sirolimus|mesh-list
56770968|NCT03463265|Bevacizumab|bevacizumab|mesh-list
56770969|NCT03463265|Temozolomide|temozolomide|mesh-list
56770970|NCT03463265|Lomustine|lomustine|mesh-list
56770971|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56770972|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770973|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56770974|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56770975|NCT03463265|Growth Substances|growth substances|mesh-ancestor
56770976|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56770977|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
56770978|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56770979|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
56770980|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770981|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56770982|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770983|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56770984|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
56770985|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56770986|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
56770987|NCT00947336|Norfloxacin|norfloxacin|mesh-list
56770988|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56770989|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56770990|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56770991|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56770992|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56770993|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56770994|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56770997|NCT00955214|Paclitaxel|paclitaxel|mesh-list
56770998|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56770999|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771000|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
56771001|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
56771002|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
56771003|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771004|NCT00956462|Dexamethasone|dexamethasone|mesh-list
56771005|NCT00956462|Ketorolac|ketorolac|mesh-list
56771006|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56771007|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56771008|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
56771009|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
56771010|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771011|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771012|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56771013|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
56771014|NCT00956462|Hormones|hormones|mesh-ancestor
56771015|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56481940|NCT05468294|Nivolumab|nivolumab|mesh-list
56771016|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56771017|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771018|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56771019|NCT00956462|Analgesics|analgesics|mesh-ancestor
56771020|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
56771021|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56771022|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56771023|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771024|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771025|NCT05300360|Adenosine|adenosine|mesh-list
56771026|NCT05300360|Analgesics|analgesics|mesh-ancestor
56771027|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
56771028|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771029|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771030|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56771031|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
56771032|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56771035|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771036|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771037|NCT00956696|Topiramate|topiramate|mesh-list
56771038|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
56771039|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56771040|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771041|NCT03952650|Chloroquine|chloroquine|mesh-list
56771042|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56771043|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
56771044|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56771045|NCT03952650|Ibuprofen|ibuprofen|mesh-list
56771046|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56771047|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56771048|NCT03952650|Analgesics|analgesics|mesh-ancestor
56771049|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
56771050|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771051|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771052|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56771053|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56771054|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56771055|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771056|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771057|NCT03952650|Amebicides|amebicides|mesh-ancestor
56771058|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56771059|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56771060|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771082|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771083|NCT00962286|Furosemide|furosemide|mesh-list
56771084|NCT00962286|Diuretics|diuretics|mesh-ancestor
56771085|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
56771086|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771087|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56771088|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56771089|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771090|NCT00691301|Pemetrexed|pemetrexed|mesh-list
56771091|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771092|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771093|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771094|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56771095|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56771096|NCT05277480|Apatinib|apatinib|mesh-list
56771097|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771098|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56771099|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771100|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771101|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
56771102|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771103|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56771104|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771105|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771106|NCT02564003|Oxycodone|oxycodone|mesh-list
56771107|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56771108|NCT02564003|Narcotics|narcotics|mesh-ancestor
56771109|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56771110|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771111|NCT02564003|Analgesics|analgesics|mesh-ancestor
56771112|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
56771113|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771114|NCT00956150|Rifaximin|rifaximin|mesh-list
56771115|NCT00956150|Lactulose|lactulose|mesh-list
56771116|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771117|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771118|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56771119|NCT00923663|Lenalidomide|lenalidomide|mesh-list
56771120|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
56771121|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771122|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56771123|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56771124|NCT00923663|Growth Substances|growth substances|mesh-ancestor
56771125|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
56771126|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771127|NCT03284502|Cetuximab|cetuximab|mesh-list
56771128|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56771129|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771130|NCT00743873|Mitogens|mitogens|mesh-list
56771131|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
56771132|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771133|NCT04011098|Fentanyl|fentanyl|mesh-list
56771134|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56771135|NCT04011098|Narcotics|narcotics|mesh-ancestor
56771136|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56771137|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771138|NCT04011098|Analgesics|analgesics|mesh-ancestor
56771139|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
56771140|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771141|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56771142|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56771143|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
56771144|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
56771145|NCT00927563|Tolcapone|tolcapone|mesh-list
56771146|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56771147|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56771148|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56771162|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
56771163|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56771164|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
56771165|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771166|NCT00962442|Expectorants|expectorants|mesh-ancestor
56771167|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56771168|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56771169|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
56771170|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771171|NCT00962442|Protective Agents|protective agents|mesh-ancestor
56771172|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771173|NCT00962442|Antidotes|antidotes|mesh-ancestor
56771174|NCT00957320|Sirolimus|sirolimus|mesh-list
56771175|NCT00957320|Asparaginase|asparaginase|mesh-list
56771176|NCT00957320|Pegaspargase|pegaspargase|mesh-list
56771177|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771178|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771179|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56771180|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771181|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
56771182|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771183|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
56771184|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771185|NCT00653159|Copper|copper|mesh-list
56771186|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
56771187|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56771188|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
56771189|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56771190|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771191|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56771194|NCT00653159|Trace Elements|trace elements|mesh-ancestor
56771208|NCT00948272|Vaccines|vaccines|mesh-list
56771209|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
56771210|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771211|NCT00957554|Amlodipine|amlodipine|mesh-list
56771212|NCT00957554|Irbesartan|irbesartan|mesh-list
56771213|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56771214|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56771215|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56771216|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771217|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56771218|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771219|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
56771220|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56771221|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56771222|NCT03024684|Atorvastatin|atorvastatin|mesh-list
56771223|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56771224|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56771225|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
56771226|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771227|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56771228|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56771229|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771230|NCT00744107|Cobalt|cobalt|mesh-list
56771231|NCT00744107|Trace Elements|trace elements|mesh-ancestor
56771232|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
56771233|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771234|NCT00117637|Interferons|interferons|mesh-list
56771235|NCT00117637|Sorafenib|sorafenib|mesh-list
56771253|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771254|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771255|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56771256|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56771257|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
56771258|NCT02897778|Entinostat|entinostat|mesh-list
56771259|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771260|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56771261|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771262|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771263|NCT01084291|Vaccines|vaccines|mesh-list
56771264|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
56771265|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771266|NCT00741767|Fluticasone|fluticasone|mesh-list
56771267|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56771268|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56771269|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56771270|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56771271|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
56771272|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771273|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771274|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56771275|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
56771276|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
56771277|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56771278|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56771279|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56771280|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56771281|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
56771297|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
56771298|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771299|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
56771300|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771301|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56771302|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771303|NCT00741845|Metronidazole|metronidazole|mesh-list
56771304|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771305|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771306|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56771307|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56771308|NCT00746447|Mesalamine|mesalamine|mesh-list
56771309|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56771310|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56771311|NCT00746447|Analgesics|analgesics|mesh-ancestor
56771312|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
56771313|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771314|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482240|NCT04685642|Aspirin|aspirin|mesh-list
56771315|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56771316|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56771318|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56771319|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56771320|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56771321|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771322|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771323|NCT00742157|Hormones|hormones|mesh-list
56771324|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56771325|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771326|NCT00549302|Tadalafil|tadalafil|mesh-list
56771327|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
56771341|NCT00957866|Ribavirin|ribavirin|mesh-list
56771342|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771343|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
56771344|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771345|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
56771346|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771347|NCT00958022|Carboplatin|carboplatin|mesh-list
56771348|NCT00958022|Etoposide|etoposide|mesh-list
56771349|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
56771350|NCT00958022|Panobinostat|panobinostat|mesh-list
56771351|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
56771352|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771353|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56771354|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56771355|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56771356|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771357|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771358|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56771359|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
56771360|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
56771361|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
56771362|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
56771363|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
56771364|NCT00958100|Tenofovir|tenofovir|mesh-list
56771365|NCT00958100|Lamivudine|lamivudine|mesh-list
56771366|NCT00958100|Emtricitabine|emtricitabine|mesh-list
56771367|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
56771368|NCT00958100|Abacavir|abacavir|mesh-list
56771369|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
56771370|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
56771371|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771372|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56771373|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56771374|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771385|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771386|NCT00948662|Ketoconazole|ketoconazole|mesh-list
56771387|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
56771388|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771389|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56771390|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56771391|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771392|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771393|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56771394|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
56771395|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56771396|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771397|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56771398|NCT00948740|Vitamin D|vitamin d|mesh-list
56771399|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
56771400|NCT00948740|Vitamins|vitamins|mesh-ancestor
56771401|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
56771402|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771403|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56771404|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56771405|NCT00108433|Vancomycin|vancomycin|mesh-list
56771406|NCT00108433|Cefazolin|cefazolin|mesh-list
56771407|NCT00108433|Linezolid|linezolid|mesh-list
56771408|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771409|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771410|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56771411|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771412|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771413|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
56771429|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771430|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771431|NCT01084369|Urological Agents|urological agents|mesh-ancestor
56771432|NCT03040778|Vitamin E|vitamin e|mesh-list
56771433|NCT03040778|Tocopherols|tocopherols|mesh-list
56771434|NCT03040778|Tocotrienols|tocotrienols|mesh-list
56771435|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
56771436|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
56771437|NCT03040778|Vitamins|vitamins|mesh-ancestor
56771438|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
56771439|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771440|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
56771441|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771442|NCT03040778|Protective Agents|protective agents|mesh-ancestor
56771443|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56771444|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771445|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56771446|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56771447|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
56771448|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56771449|NCT00949130|Linezolid|linezolid|mesh-list
56771450|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771451|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771452|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56771453|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771454|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771455|NCT02815592|Carboplatin|carboplatin|mesh-list
56771456|NCT02815592|Etoposide|etoposide|mesh-list
56771457|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771458|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56771459|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56771460|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56771461|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771462|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771463|NCT04010318|Anesthetics|anesthetics|mesh-list
56044160|NCT01554488|Xhance|xhance|mesh-list
56044468|NCT02757105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044469|NCT02757105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56044470|NCT02757105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56044471|NCT05083845|Anesthetics|anesthetics|mesh-list
56044472|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
55948220|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
56771464|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56771465|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771466|NCT00108355|Octreotide|octreotide|mesh-list
56771467|NCT00108355|Midodrine|midodrine|mesh-list
56771468|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56771469|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56771470|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771471|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
56771472|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
56771473|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771474|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771475|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56771476|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56771477|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56771478|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56771479|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
56771480|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771481|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771482|NCT05351606|Bupropion|bupropion|mesh-list
56771483|NCT05351606|Nicotine|nicotine|mesh-list
56771484|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56771485|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
56771486|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771487|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771503|NCT00963222|Vitamin A|vitamin a|mesh-list
56771513|NCT00968760|Cytarabine|cytarabine|mesh-list
56771514|NCT00968760|Etoposide|etoposide|mesh-list
56771515|NCT00968760|Melphalan|melphalan|mesh-list
56771516|NCT00968760|Interleukin-2|interleukin-2|mesh-list
56771517|NCT00968760|Carmustine|carmustine|mesh-list
56771518|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56771519|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771520|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56771521|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56771522|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771523|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771524|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56771525|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
56771526|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
56771527|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771528|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771529|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
56771530|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771531|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56771532|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
56771533|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56771534|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56771535|NCT00968760|Analgesics|analgesics|mesh-ancestor
56771536|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
56771537|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771538|NCT02573324|Temozolomide|temozolomide|mesh-list
56771539|NCT02573324|Immunoconjugates|immunoconjugates|mesh-list
56771540|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56771541|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
56771546|NCT02465138|Ketorolac|ketorolac|mesh-list
56771558|NCT00968994|Petrolatum|petrolatum|mesh-list
56771559|NCT00968994|Emollients|emollients|mesh-ancestor
56771560|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
56771561|NCT00969072|Dutasteride|dutasteride|mesh-list
56771562|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56771563|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56771564|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771565|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771566|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
56771567|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56771568|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771569|NCT00094861|Paclitaxel|paclitaxel|mesh-list
56771570|NCT00094861|Carboplatin|carboplatin|mesh-list
56771571|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56771572|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771573|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
56771574|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
56771575|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
56771576|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771577|NCT00963534|Rituximab|rituximab|mesh-list
56771578|NCT00963534|Lenalidomide|lenalidomide|mesh-list
56771579|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56771580|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56771581|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771582|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
56771583|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771584|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56771605|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56771606|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56771607|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771608|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
56771609|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56771610|NCT00963768|Canagliflozin|canagliflozin|mesh-list
56771611|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56771612|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771613|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56771614|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482538|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56771615|NCT00969462|Doxorubicin|doxorubicin|mesh-list
56771616|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56771617|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771618|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56771619|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56771620|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771621|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771622|NCT00963846|Huperzine A|huperzine a|mesh-list
56771623|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56771624|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771625|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771626|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
56771627|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771628|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771629|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56771630|NCT00963846|Protective Agents|protective agents|mesh-ancestor
56771650|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56771651|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
56771652|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771653|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771654|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56771655|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56771656|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
56771657|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
56771658|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771659|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771660|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56771661|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56771662|NCT00958854|Growth Substances|growth substances|mesh-ancestor
56771663|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
56771664|NCT00964080|Leucovorin|leucovorin|mesh-list
56771665|NCT00964080|Fluorouracil|fluorouracil|mesh-list
56771666|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
56771667|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
56771668|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771669|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56771670|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771671|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771672|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
56771673|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771674|NCT00964080|Antidotes|antidotes|mesh-ancestor
56771675|NCT00964080|Protective Agents|protective agents|mesh-ancestor
56771676|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
56771677|NCT00964080|Vitamins|vitamins|mesh-ancestor
56771678|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
56771679|NCT00969852|Sertraline|sertraline|mesh-list
56771696|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771697|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
56771698|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771699|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771700|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
56771701|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56771702|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56771703|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56771704|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56771705|NCT00426556|Paclitaxel|paclitaxel|mesh-list
56771706|NCT00426556|Trastuzumab|trastuzumab|mesh-list
56771707|NCT00426556|Everolimus|everolimus|mesh-list
56771708|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56771709|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771710|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56771711|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56771712|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56771713|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771714|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56771715|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771716|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
56771717|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771718|NCT00107653|Ribavirin|ribavirin|mesh-list
56771719|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56771720|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
56771721|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
56771722|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771723|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
56771724|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771725|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
56771726|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771737|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
56771738|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
56771739|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56771740|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771741|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
56771742|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771743|NCT00689351|Vaccines|vaccines|mesh-list
56771744|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56771745|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
56771746|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771747|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56771748|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
56771749|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771750|NCT02563847|Erythritol|erythritol|mesh-list
56771751|NCT02563847|Tryptophan|tryptophan|mesh-list
56771752|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56771753|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
56771754|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56771755|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
56771756|NCT00746681|Pregabalin|pregabalin|mesh-list
56771757|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56771758|NCT00746681|Analgesics|analgesics|mesh-ancestor
56771759|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
56771760|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771761|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771762|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
56771763|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56771780|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56771781|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
56771782|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771783|NCT00749099|Pancrelipase|pancrelipase|mesh-list
56771785|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56771786|NCT00959400|Fentanyl|fentanyl|mesh-list
56771787|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56771788|NCT00959400|Narcotics|narcotics|mesh-ancestor
56771789|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56771790|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771791|NCT00959400|Analgesics|analgesics|mesh-ancestor
56771792|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
56771793|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771794|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56771795|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56771796|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
56771797|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
56771798|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
56771799|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
56771800|NCT02563769|Cocaine|cocaine|mesh-list
56771801|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771802|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771803|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771804|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771805|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56771806|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
56771807|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
56771808|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56771809|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771810|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
56771811|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771826|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56771827|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771828|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56771829|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56771830|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56771831|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771832|NCT02562287|Olanzapine|olanzapine|mesh-list
56771833|NCT02562287|Risperidone|risperidone|mesh-list
56771834|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56771835|NCT02562287|Clozapine|clozapine|mesh-list
56771836|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56771837|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
56771838|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56771839|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771840|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771841|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56771842|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56771843|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56771844|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56771845|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56771846|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
56771847|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
56771848|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
56771849|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56771850|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56771851|NCT02562287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56771852|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56771853|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56771854|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
56771855|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
56771856|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
56771857|NCT02562053|Fluoxetine|fluoxetine|mesh-list
56771858|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
56771868|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56771869|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
56771870|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56771871|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56771872|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56771873|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771874|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56771875|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56771876|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
56771877|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56771878|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771879|NCT04060043|Goserelin|goserelin|mesh-list
56771880|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56771881|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771882|NCT00553358|Paclitaxel|paclitaxel|mesh-list
56771883|NCT00553358|Trastuzumab|trastuzumab|mesh-list
56771884|NCT00553358|Lapatinib|lapatinib|mesh-list
56771885|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56771886|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771887|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56771888|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56771889|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56771890|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771916|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56771917|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56771918|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
56771919|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771920|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771921|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56771922|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56771923|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
56771924|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771925|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
56771926|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56771927|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771928|NCT00749567|Bevacizumab|bevacizumab|mesh-list
56771929|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56771930|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56771931|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771932|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56771933|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56771934|NCT00749567|Growth Substances|growth substances|mesh-ancestor
56771935|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771936|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
56771937|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56771938|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771939|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771940|NCT04010942|Metformin|metformin|mesh-list
56771941|NCT04010942|Clomiphene|clomiphene|mesh-list
56771942|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56771943|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771944|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56771945|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
56771946|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56771947|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56771956|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56771957|NCT00949364|Growth Substances|growth substances|mesh-ancestor
56771958|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
56771959|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771960|NCT00689117|Clindamycin|clindamycin|mesh-list
56771961|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
56771962|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
56771963|NCT00689117|Tretinoin|tretinoin|mesh-list
56771964|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56771965|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56771966|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56771967|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56771968|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56771969|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771970|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
56771971|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
56771972|NCT00949442|Insulin|insulin|mesh-list
56771973|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56771974|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
56771975|NCT00949442|Glimepiride|glimepiride|mesh-list
56771976|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56771977|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56771978|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56771979|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56771980|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
56771981|NCT00749723|Carboplatin|carboplatin|mesh-list
56771982|NCT00749723|Etoposide|etoposide|mesh-list
56771983|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
56771984|NCT00749723|Temozolomide|temozolomide|mesh-list
56771985|NCT00749723|Thiotepa|thiotepa|mesh-list
56771986|NCT00749723|Trofosfamide|trofosfamide|mesh-list
56771987|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
56771988|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56771991|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56772002|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56772003|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
56772004|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772005|NCT00688103|Etanercept|etanercept|mesh-list
56772006|NCT00688103|Methotrexate|methotrexate|mesh-list
56772007|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56772008|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
56772009|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56772010|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772011|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56772012|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
56772013|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772014|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772015|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
56772016|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772017|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56772018|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772019|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
56772020|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56772021|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56772022|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56772023|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56772024|NCT00688103|Analgesics|analgesics|mesh-ancestor
56772025|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
56772026|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772027|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772028|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56772029|NCT00949598|Tamoxifen|tamoxifen|mesh-list
56772030|NCT00949598|Letrozole|letrozole|mesh-list
56772031|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772032|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772043|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56772044|NCT00964704|Bevacizumab|bevacizumab|mesh-list
56772045|NCT00964704|Trastuzumab|trastuzumab|mesh-list
56772046|NCT00964704|Docetaxel|docetaxel|mesh-list
56772047|NCT00964704|Capecitabine|capecitabine|mesh-list
56772048|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56772049|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772050|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56772051|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56772052|NCT00964704|Growth Substances|growth substances|mesh-ancestor
56772053|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772054|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
56772055|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
56772056|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
56772057|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
56772058|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772059|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56482996|NCT01256398|Hormones|hormones|mesh-ancestor
56772060|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
56772061|NCT00686855|Dexamethasone|dexamethasone|mesh-list
56772062|NCT00686855|Tacrolimus|tacrolimus|mesh-list
56772063|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772064|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
56772065|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
56772066|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772067|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772093|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56772094|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56772095|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56772096|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
56772097|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772098|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
56772099|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56772100|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
56772101|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772102|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772103|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56772104|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
56772105|NCT00961844|Temozolomide|temozolomide|mesh-list
56772106|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56772107|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
56772108|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772109|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772110|NCT00686777|Interferons|interferons|mesh-list
56772111|NCT00686777|Ribavirin|ribavirin|mesh-list
56772112|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
56772113|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
56772114|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56772115|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772116|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
56772117|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772118|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
56772119|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772141|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56772142|NCT00747305|Growth Substances|growth substances|mesh-ancestor
56772143|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772144|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
56772145|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56772146|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772147|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772148|NCT05254106|Paclitaxel|paclitaxel|mesh-list
56772149|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56772150|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772151|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
56772152|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
56772153|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
56772154|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772155|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56772156|NCT00747383|Glimepiride|glimepiride|mesh-list
56772157|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56772158|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772159|NCT00747383|Incretins|incretins|mesh-ancestor
56772160|NCT00747383|Hormones|hormones|mesh-ancestor
56772161|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772163|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
56772193|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772194|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56772195|NCT00962234|Protective Agents|protective agents|mesh-ancestor
56772196|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772197|NCT00747695|Rabeprazole|rabeprazole|mesh-list
56772198|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56772199|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56772200|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56772201|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772202|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772203|NCT00959972|Nicotine|nicotine|mesh-list
56772204|NCT00959972|Varenicline|varenicline|mesh-list
56772205|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56772206|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
56772207|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772208|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772209|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56483144|NCT01220583|Cisplatin|cisplatin|mesh-list
56772210|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56772211|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
56772212|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772213|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772215|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56772216|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772217|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
56772218|NCT00960284|Gemcitabine|gemcitabine|mesh-list
56772219|NCT00960284|Fluorouracil|fluorouracil|mesh-list
56772220|NCT00960284|Capecitabine|capecitabine|mesh-list
56772221|NCT00960284|Epirubicin|epirubicin|mesh-list
56772222|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772223|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56772224|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
56772225|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772226|NCT00960284|Antiviral Agents|antiviral agents|mesh-ancestor
56772227|NCT00960284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772233|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56772234|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56772235|NCT00105469|Tobramycin|tobramycin|mesh-list
56772236|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56772237|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772238|NCT00962312|Capecitabine|capecitabine|mesh-list
56772239|NCT00962312|Lapatinib|lapatinib|mesh-list
56772240|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56772241|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
56772242|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772243|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772244|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56772245|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772246|NCT00960518|Adefovir|adefovir|mesh-list
56772247|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
56772248|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772249|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56772250|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56772251|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772252|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772253|NCT00960830|Mirtazapine|mirtazapine|mesh-list
56772254|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
56772255|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56772256|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56772257|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
56772258|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
56772259|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772260|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772261|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772262|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56772263|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56772264|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56772265|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56772266|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56772271|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
56772272|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56772273|NCT00962624|Vaccines|vaccines|mesh-list
56772274|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
56772275|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772276|NCT00105235|Cyclosporine|cyclosporine|mesh-list
56772277|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
56772278|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
56772279|NCT00105235|Tacrolimus|tacrolimus|mesh-list
56772280|NCT00105235|Cyclosporins|cyclosporins|mesh-list
56772281|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772282|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
56772283|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772284|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56483211|NCT03757403|Mebendazole|mebendazole|mesh-list
56772285|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772286|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772287|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
56772288|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772289|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
56772290|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56772291|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56772292|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772293|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56772294|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
56772295|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56772296|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56772298|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
56772299|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772300|NCT00547118|Rimonabant|rimonabant|mesh-list
56772301|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56772302|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56772315|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772316|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
56772317|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56772318|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56772319|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
56772320|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
56772321|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
56772322|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772323|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772324|NCT03946124|Fesoterodine|fesoterodine|mesh-list
56772325|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56772326|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56772327|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
56772328|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772329|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772330|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772331|NCT03946124|Urological Agents|urological agents|mesh-ancestor
56772332|NCT00686543|Posaconazole|posaconazole|mesh-list
56772333|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
56772370|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772371|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
56772372|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
56772373|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
56772374|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772375|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56772376|NCT00502203|Paclitaxel|paclitaxel|mesh-list
56772377|NCT00502203|Carboplatin|carboplatin|mesh-list
56772378|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56772379|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772380|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
56772381|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
56772382|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
56772383|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772384|NCT00546078|Vaccines|vaccines|mesh-list
56772385|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
56772386|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772387|NCT00967772|Naftopidil|naftopidil|mesh-list
56772388|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56772389|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56772390|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
56772391|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772392|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772393|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772394|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56772395|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56772418|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56772419|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56772420|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772421|NCT00968006|Incretins|incretins|mesh-ancestor
56772422|NCT00968006|Hormones|hormones|mesh-ancestor
56772423|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772424|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56772425|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
56772426|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772427|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772428|NCT00968162|Fludarabine|fludarabine|mesh-list
56772429|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772430|NCT00968240|Bevacizumab|bevacizumab|mesh-list
56772431|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56772432|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772433|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56772434|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56772435|NCT00968240|Growth Substances|growth substances|mesh-ancestor
56772436|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772437|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
56772438|NCT00501969|Rotigotine|rotigotine|mesh-list
56772439|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
56772440|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
56772441|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772442|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772443|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772444|NCT03942042|Ixekizumab|ixekizumab|mesh-list
56772445|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
56772446|NCT00968396|Melphalan|melphalan|mesh-list
56772447|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56772448|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
56772449|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772450|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772451|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56772452|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772453|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
56772454|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772455|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
56772456|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
56772457|NCT04699604|Levocetirizine|levocetirizine|mesh-list
56772458|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56772459|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56772460|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
56772461|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
56772462|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772463|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772464|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772465|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
56772466|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56772467|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772468|NCT05299580|Trametinib|trametinib|mesh-list
56772469|NCT05299580|Dabrafenib|dabrafenib|mesh-list
56772470|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772471|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56772472|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772473|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772474|NCT01013805|Leucovorin|leucovorin|mesh-list
56772475|NCT01013805|Fluorouracil|fluorouracil|mesh-list
56772476|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
56772477|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
56772478|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772479|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56772480|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772481|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772482|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
56772483|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772484|NCT01013805|Antidotes|antidotes|mesh-ancestor
56772485|NCT01013805|Protective Agents|protective agents|mesh-ancestor
56772486|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
56772487|NCT01013805|Vitamins|vitamins|mesh-ancestor
56772488|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
56772489|NCT00104299|Prednisone|prednisone|mesh-list
56772490|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
56772491|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
56772492|NCT00104299|Rituximab|rituximab|mesh-list
56772493|NCT00104299|Azathioprine|azathioprine|mesh-list
56772494|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
56772495|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772496|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
56772497|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772498|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56772499|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56772500|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
56772501|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772502|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772503|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56772504|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56772506|NCT00104299|Hormones|hormones|mesh-ancestor
56772555|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
56772556|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772557|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772558|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56772559|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56772560|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
56772561|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56772562|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56772563|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772564|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56772565|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56772566|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56772567|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56772568|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
56772569|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56772570|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56772571|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56772572|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56772573|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
56772574|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56772575|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772576|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
56772577|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56772578|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56772579|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56772580|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56772581|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56772582|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56772583|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56772584|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56772585|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
56772593|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56772594|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
56772595|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
56772596|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56772597|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56772598|NCT00964106|Analgesics|analgesics|mesh-ancestor
56772599|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
56772600|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772601|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56772602|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56772603|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772604|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56772605|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56772652|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772653|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56772654|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772655|NCT02976909|Paclitaxel|paclitaxel|mesh-list
56772656|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56772658|NCT02976909|Fluorouracil|fluorouracil|mesh-list
56772659|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56772660|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772661|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
56772662|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
56772663|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
56772664|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772665|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
56772666|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56772667|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772668|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
56772669|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772670|NCT02878083|Adalimumab|adalimumab|mesh-list
56772671|NCT02878083|Vedolizumab|vedolizumab|mesh-list
56772672|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772673|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56772708|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56772709|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56772710|NCT00960960|Growth Substances|growth substances|mesh-ancestor
56772711|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772712|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
56772713|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56772714|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56772715|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772716|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56772717|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
56772718|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772719|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
56772720|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56772721|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56772722|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772723|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
56772724|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772725|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772726|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
56772727|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56772728|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772729|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56772730|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56772731|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772737|NCT00961194|Analgesics|analgesics|mesh-ancestor
56772756|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
56772757|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
56772758|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56772759|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772760|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
56772761|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772762|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56772763|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56772764|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56772765|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56772766|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772767|NCT00415636|Pemetrexed|pemetrexed|mesh-list
56772768|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772769|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772770|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772771|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56772772|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56772773|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
56772774|NCT00965874|Analgesics|analgesics|mesh-ancestor
56772810|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
56772811|NCT00972660|Hormones|hormones|mesh-ancestor
56772812|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772813|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772814|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56772815|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772816|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772817|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772818|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772819|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
56772820|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
56772821|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772822|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
56772823|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56772824|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56772825|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56772826|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56772827|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
56772828|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56772829|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56772830|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56772831|NCT04008966|Cetrorelix|cetrorelix|mesh-list
56772832|NCT04008966|Progesterone|progesterone|mesh-list
56772833|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56772834|NCT04008966|Progestins|progestins|mesh-ancestor
56772835|NCT04008966|Hormones|hormones|mesh-ancestor
56772836|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772837|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772838|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
56772839|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56772840|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
56772841|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56772842|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56772848|NCT00425854|Afatinib|afatinib|mesh-list
56772849|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772850|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56772851|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772852|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772853|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
56772854|NCT00425698|Hematinics|hematinics|mesh-ancestor
56772855|NCT01037530|Ramipril|ramipril|mesh-list
56772856|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56772857|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
56772858|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772859|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772860|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56772861|NCT00973050|Bicalutamide|bicalutamide|mesh-list
56772862|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
56772863|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
56772864|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772865|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772866|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772867|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56772868|NCT00973128|Sargramostim|sargramostim|mesh-list
56772869|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
56772870|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772871|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56772872|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56772873|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772874|NCT00973986|Atorvastatin|atorvastatin|mesh-list
56772875|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56772876|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56772877|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
56772878|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772892|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56772893|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56772894|NCT00425308|Cyclosporine|cyclosporine|mesh-list
56772895|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
56772896|NCT00425308|Everolimus|everolimus|mesh-list
56772897|NCT00425308|Cyclosporins|cyclosporins|mesh-list
56772898|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772899|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772900|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772901|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
56772902|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772903|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
56772904|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56772905|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
56772906|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56772907|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56772908|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772909|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56772910|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56772911|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
56772912|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56772913|NCT04008888|Dexamethasone|dexamethasone|mesh-list
56772914|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
56772915|NCT04008888|Fludarabine|fludarabine|mesh-list
56772916|NCT04008888|Melphalan|melphalan|mesh-list
56772917|NCT04008888|BB 1101|bb 1101|mesh-list
56772918|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56772919|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
56772920|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
56772921|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772922|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772923|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56772924|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
56044473|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044474|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044475|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
56044476|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044477|NCT00371553|Sunitinib|sunitinib|mesh-list
56044478|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044479|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56044480|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56044481|NCT00371553|Growth Substances|growth substances|mesh-ancestor
56044482|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044483|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
56772925|NCT04008888|Hormones|hormones|mesh-ancestor
56772926|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56772927|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56772928|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772929|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
56772930|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772931|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772932|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56772933|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
56772934|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56772935|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
56772936|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56772937|NCT02672098|Carboplatin|carboplatin|mesh-list
56772938|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56772939|NCT01033084|Sertraline|sertraline|mesh-list
56772940|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
56772941|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56772982|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56772983|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772984|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56772985|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56772986|NCT01589068|Nicotine|nicotine|mesh-list
56772987|NCT01589068|Progesterone|progesterone|mesh-list
56772988|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56772989|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
56772990|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56772991|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56772992|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56772993|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56772994|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
56772995|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56772996|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56772997|NCT01589068|Progestins|progestins|mesh-ancestor
56772998|NCT01589068|Hormones|hormones|mesh-ancestor
56772999|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773000|NCT00432562|Vinorelbine|vinorelbine|mesh-list
56773001|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56773002|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773003|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
56773004|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
56773005|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
56773006|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773007|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
56773008|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56773009|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
56773010|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773011|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56773012|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56773013|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56773014|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044484|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56044485|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044486|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044487|NCT05071833|Peppermint oil|peppermint oil|mesh-list
56044488|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
56044520|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
55948221|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
56773015|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
56773016|NCT00974532|Calcium|calcium|mesh-list
56773017|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56773018|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773019|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56773020|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
56773021|NCT00432172|Carboplatin|carboplatin|mesh-list
56773022|NCT00432172|Docetaxel|docetaxel|mesh-list
56773023|NCT00432172|Epirubicin|epirubicin|mesh-list
56773024|NCT00432172|Exemestane|exemestane|mesh-list
56773025|NCT00432172|Goserelin|goserelin|mesh-list
56773026|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773027|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
56773028|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483960|NCT01266460|Vaccines|vaccines|mesh-list
56773077|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
56773078|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
56773079|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56773080|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
56773081|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773082|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773083|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56773084|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
56773085|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
56773086|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56773087|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
56773088|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773089|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773090|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56773091|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56773092|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56773093|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
56773094|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
56773095|NCT00974766|Hormones|hormones|mesh-ancestor
56773096|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773097|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773098|NCT00980382|Docetaxel|docetaxel|mesh-list
56773099|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773100|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
56773101|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
56773102|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
56773103|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773105|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56773106|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56773107|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
56773108|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045829|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045830|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56045831|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
56045832|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56045833|NCT01589510|Bimatoprost|bimatoprost|mesh-list
56045834|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56773119|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773120|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773121|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
56773122|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773123|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56773124|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56773125|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56773126|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773127|NCT04082910|Etanercept|etanercept|mesh-list
56773128|NCT04082910|Infliximab|infliximab|mesh-list
56773129|NCT04082910|Metoprolol|metoprolol|mesh-list
56773130|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56773131|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773170|NCT00414466|Gabapentin|gabapentin|mesh-list
56773171|NCT00414466|Analgesics|analgesics|mesh-ancestor
56773172|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
56773173|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773174|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773175|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
56773176|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56773177|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56773178|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773180|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56773181|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56773182|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773183|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773184|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
56773185|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
56773186|NCT00984750|Simvastatin|simvastatin|mesh-list
56773187|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56773188|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56773189|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
56773190|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773191|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56773192|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56773193|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773194|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
56773195|NCT00984750|Vitamins|vitamins|mesh-ancestor
56773196|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
56773197|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773198|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
56773199|NCT00975312|Tretinoin|tretinoin|mesh-list
56773200|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773201|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
56773202|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56773203|NCT04974996|Prednisone|prednisone|mesh-list
56773204|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
56773205|NCT04974996|Rituximab|rituximab|mesh-list
56773213|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56773214|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
56773215|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773216|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773217|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56773218|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56773219|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56773220|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56773221|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56773222|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773223|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773224|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
56773225|NCT04974996|Hormones|hormones|mesh-ancestor
56773226|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773227|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56773228|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56773229|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
56773230|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
56773231|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
56773232|NCT00981006|Mitogens|mitogens|mesh-list
56773233|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
56773234|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773235|NCT00975390|Caffeine|caffeine|mesh-list
56773236|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56773237|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773238|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56773239|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773240|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773241|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56773242|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56773243|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
56773244|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773245|NCT00981318|Ritonavir|ritonavir|mesh-list
56773246|NCT00981318|Lopinavir|lopinavir|mesh-list
56773247|NCT00981318|Maraviroc|maraviroc|mesh-list
56773248|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56773249|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56773250|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
56773251|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484186|NCT01264081|Lapatinib|lapatinib|mesh-list
56773252|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773253|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56773254|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56773255|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
56773256|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773257|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56773258|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56773259|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56773260|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56773261|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56773262|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
56773263|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56773264|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56773265|NCT00984984|Prednisolone|prednisolone|mesh-list
56773266|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
56773267|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56773268|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
56773269|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773270|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
56773271|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
56773272|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773273|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773274|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773275|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
56773276|NCT00984984|Hormones|hormones|mesh-ancestor
56773277|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773278|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56773279|NCT00984984|Protective Agents|protective agents|mesh-ancestor
56773280|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56773293|NCT00545532|Oseltamivir|oseltamivir|mesh-list
56773294|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
56773295|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773296|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773297|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773298|NCT00544440|Prednisone|prednisone|mesh-list
56773299|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
56773300|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773301|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
56773302|NCT00544440|Hormones|hormones|mesh-ancestor
56773303|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773304|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773305|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56773306|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773307|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56773308|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773309|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773310|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
56773311|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56773312|NCT00981708|Dexamethasone|dexamethasone|mesh-list
56773313|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
56773314|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
56773315|NCT00981708|Lenalidomide|lenalidomide|mesh-list
56773316|NCT00981708|BB 1101|bb 1101|mesh-list
56044521|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044522|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190992|NCT01471847|Dactolisib|dactolisib|mesh-list
56190993|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56190994|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
56190995|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190996|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190997|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56190998|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56118781|NCT00004829|Tobramycin|tobramycin|mesh-list
56190999|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191000|NCT01471886|Ketorolac|ketorolac|mesh-list
56191001|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56044523|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56044524|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56044525|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
56044526|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
56044527|NCT02762331|Vitamins|vitamins|mesh-ancestor
56044528|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
56044529|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044530|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
56773317|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773318|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
56773319|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773320|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773321|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56773322|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
56773323|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773324|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773325|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56773326|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773327|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
56773328|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
56773329|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773330|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773331|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
56773332|NCT00981708|Hormones|hormones|mesh-ancestor
56773333|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773334|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56773335|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
56773336|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773337|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56773338|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56773339|NCT00981708|Growth Substances|growth substances|mesh-ancestor
56773340|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
56773341|NCT00981786|Timolol|timolol|mesh-list
56773342|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56773343|NCT00981786|Travoprost|travoprost|mesh-list
56773344|NCT00981786|Brinzolamide|brinzolamide|mesh-list
56773345|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56773346|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56773347|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
56773348|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773349|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773350|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773351|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56773352|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56046031|NCT02218190|Alvimopan|alvimopan|mesh-list
56773353|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56773354|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56773355|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56773356|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56773357|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773358|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
56773359|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
56773360|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56773361|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56773362|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773363|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773364|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773365|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773366|NCT04928352|Bupivacaine|bupivacaine|mesh-list
56773367|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
56773368|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
56773369|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773370|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773371|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
56773372|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773373|NCT00985374|Everolimus|everolimus|mesh-list
56773374|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773375|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773376|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
56773377|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773378|NCT00975936|Ketoconazole|ketoconazole|mesh-list
56773379|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
56773380|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773381|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56773382|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56773383|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773384|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773393|NCT00976092|Clopidogrel|clopidogrel|mesh-list
56773394|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56773395|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56773396|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56773397|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56773398|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56773399|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
56773400|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773401|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773402|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773403|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
56773404|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56773405|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56773406|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
56773407|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56773408|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
56773409|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773410|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
56773411|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773412|NCT04006470|Fluorides|fluorides|mesh-list
56773413|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
56773414|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
56773415|NCT04006470|Protective Agents|protective agents|mesh-ancestor
56773416|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773417|NCT01323712|Vitamin D|vitamin d|mesh-list
56773418|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
56773419|NCT01323712|Vitamins|vitamins|mesh-ancestor
56773420|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
56773421|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773422|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56773423|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56773424|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
56773425|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773426|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56773427|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773432|NCT03927144|Analgesics|analgesics|mesh-ancestor
56773433|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
56773434|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773435|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773436|NCT00976170|Sorafenib|sorafenib|mesh-list
56773437|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773438|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56773439|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773440|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773441|NCT00982254|Insulin|insulin|mesh-list
56773442|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56773443|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56773444|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773445|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56773446|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56773447|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773448|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
56773449|NCT00976326|Insulin|insulin|mesh-list
56773450|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56773451|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773452|NCT00982332|Betamethasone|betamethasone|mesh-list
56773453|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
56773454|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773455|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
56773456|NCT00982332|Hormones|hormones|mesh-ancestor
56773458|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773478|NCT04007328|Protective Agents|protective agents|mesh-ancestor
56773479|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56773480|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773481|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
56773482|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56773483|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56773484|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773485|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
56773486|NCT00985920|Coagulants|coagulants|mesh-ancestor
56773487|NCT00976794|Carbamazepine|carbamazepine|mesh-list
56773488|NCT00976794|Valproic Acid|valproic acid|mesh-list
56773489|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
56773490|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
56773491|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56773492|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773493|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773494|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
56773495|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56773496|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773497|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773498|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
56773499|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
56773500|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773501|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56773502|NCT00976794|Analgesics|analgesics|mesh-ancestor
56773503|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
56773504|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773505|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56773506|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56773507|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56773508|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56773509|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
56773510|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56773511|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773512|NCT04008186|Metformin|metformin|mesh-list
56773513|NCT04008186|Repaglinide|repaglinide|mesh-list
56773514|NCT04008186|Itraconazole|itraconazole|mesh-list
56773515|NCT04008186|Digoxin|digoxin|mesh-list
56773517|NCT04008186|Midazolam|midazolam|mesh-list
56773518|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56773519|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
56773520|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56773521|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773522|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56773523|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56773524|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773525|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56773526|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56773527|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56773528|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56773529|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
56773530|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
56773531|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
56773532|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
56773533|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773534|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773535|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56773536|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56773537|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
56773538|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56773539|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56773540|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773541|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
56773542|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773543|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56773544|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56773545|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56773546|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
56773547|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773548|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56773558|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773559|NCT00977028|Lidocaine|lidocaine|mesh-list
56773560|NCT00977028|Epinephrine|epinephrine|mesh-list
56773561|NCT00977028|Racepinephrine|racepinephrine|mesh-list
56773562|NCT00977028|Anesthetics|anesthetics|mesh-list
56773563|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
56773564|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
56773565|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773566|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773567|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
56773568|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773569|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56773570|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56773571|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56773572|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56773573|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773574|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56773575|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56773615|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
56773616|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56773617|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56773618|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773619|NCT00984828|Bortezomib|bortezomib|mesh-list
56773620|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773621|NCT00983034|Amoxicillin|amoxicillin|mesh-list
56773622|NCT00983034|Clarithromycin|clarithromycin|mesh-list
56773623|NCT00983034|Lansoprazole|lansoprazole|mesh-list
56773624|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
56773625|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56773626|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773627|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56773628|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773629|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773630|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56773631|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56773632|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56773633|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773634|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56773635|NCT00983112|Thrombin|thrombin|mesh-list
56773636|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
56773637|NCT00983112|Coagulants|coagulants|mesh-ancestor
56773638|NCT00986466|Vitamin D|vitamin d|mesh-list
56773639|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
56773640|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
56773641|NCT00986466|Vitamins|vitamins|mesh-list
56773642|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
56773643|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773644|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56773645|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56773646|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
56773647|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56773648|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
56046339|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56044531|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044532|NCT02762331|Protective Agents|protective agents|mesh-ancestor
56044566|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56044567|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
56044568|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044569|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56044570|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56773649|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773650|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773651|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56773652|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
56773653|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56773654|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
56773655|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773656|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773657|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56773658|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
56773659|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
56773660|NCT00545298|Protective Agents|protective agents|mesh-ancestor
56773661|NCT00983268|Capecitabine|capecitabine|mesh-list
56773662|NCT00983268|Vorinostat|vorinostat|mesh-list
56773663|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56773664|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
56773665|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773666|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773667|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56773668|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773669|NCT00977964|Caseins|caseins|mesh-list
56773670|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
56773671|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
56773672|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773673|NCT00983424|Cyclosporine|cyclosporine|mesh-list
56773674|NCT00983424|Paclitaxel|paclitaxel|mesh-list
56773675|NCT00983424|Cyclosporins|cyclosporins|mesh-list
56773676|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56773677|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773678|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
56773679|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
56773680|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
56773681|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044571|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044572|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044573|NCT01562678|Liraglutide|liraglutide|mesh-list
56044574|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56044575|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044599|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
56044600|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56044601|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56044603|NCT02770521|Treprostinil|treprostinil|mesh-list
56773682|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773683|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773684|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
56773685|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773686|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
56773687|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773688|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
56773689|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773690|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56773691|NCT00983736|Tramadol|tramadol|mesh-list
56773692|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56773693|NCT00983736|Narcotics|narcotics|mesh-ancestor
56773694|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773695|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773696|NCT00983736|Analgesics|analgesics|mesh-ancestor
56773697|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
56773698|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773699|NCT00986778|Lamivudine|lamivudine|mesh-list
56773700|NCT00986778|Adefovir|adefovir|mesh-list
56773701|NCT00986778|Entecavir|entecavir|mesh-list
56773702|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56773703|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56773704|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773705|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773706|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
56773707|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773708|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56773709|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56773730|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56773731|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56773732|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773733|NCT00984360|Naltrexone|naltrexone|mesh-list
56773734|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56773735|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56773736|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773737|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
56773738|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773739|NCT00414388|Sorafenib|sorafenib|mesh-list
56773740|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773741|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56773742|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773743|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773744|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56773745|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
56773746|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
56773747|NCT01037608|Nabiximols|nabiximols|mesh-list
56773748|NCT01037608|Analgesics|analgesics|mesh-ancestor
56773749|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
56773750|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773751|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773780|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56773781|NCT00987168|Octreotide|octreotide|mesh-list
56773782|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773783|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56773784|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773785|NCT00978978|Fentanyl|fentanyl|mesh-list
56773786|NCT00978978|Midazolam|midazolam|mesh-list
56773787|NCT00978978|Propofol|propofol|mesh-list
56773788|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56773789|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773790|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773791|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56773792|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
56773793|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
56773794|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56773795|NCT00978978|Narcotics|narcotics|mesh-ancestor
56773796|NCT00978978|Analgesics|analgesics|mesh-ancestor
56773797|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
56773798|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773799|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56773800|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56773801|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56773802|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56773803|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
56773804|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
56773805|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773806|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773807|NCT00414310|Decitabine|decitabine|mesh-list
56773808|NCT00414310|Valproic Acid|valproic acid|mesh-list
56773809|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56773810|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
56773811|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773812|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773813|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773814|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
56773815|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
56773816|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773817|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773819|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56773820|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773821|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56773822|NCT00542880|Fluticasone|fluticasone|mesh-list
56773823|NCT00542880|Budesonide|budesonide|mesh-list
56773824|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
56773825|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56773826|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56773827|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56773828|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773829|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56773830|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
56773831|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773832|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773833|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56773834|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
56773835|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
56773836|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56773837|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
56773838|NCT00542880|Hormones|hormones|mesh-ancestor
56773839|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56773840|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56773841|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56773842|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56773866|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56773867|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56773868|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
56773869|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
56773870|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773871|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773872|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773873|NCT00979056|Rifaximin|rifaximin|mesh-list
56773874|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56773875|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773876|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773877|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56773878|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56773879|NCT00092677|Simvastatin|simvastatin|mesh-list
56773880|NCT00092677|Ezetimibe|ezetimibe|mesh-list
56773881|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56773882|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56773883|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
56773884|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773885|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56773886|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56773887|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773888|NCT03702270|Penicillins|penicillins|mesh-list
56773889|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56773890|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773891|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56773892|NCT00542178|Simvastatin|simvastatin|mesh-list
56773893|NCT00542178|Fenofibrate|fenofibrate|mesh-list
56773894|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56773895|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56773896|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
56773897|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773898|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56773899|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56773900|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773905|NCT00987636|Treosulfan|treosulfan|mesh-list
56773906|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
56773907|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773908|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773909|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
56773910|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773911|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56773912|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773913|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56773914|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56773915|NCT00424294|Celecoxib|celecoxib|mesh-list
56773916|NCT00424294|Methotrexate|methotrexate|mesh-list
56773917|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56773918|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
56773919|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56773920|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773921|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56773922|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
56773923|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773924|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773925|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
56773926|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773927|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56773928|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56773930|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773931|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56773932|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56773933|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56773934|NCT00424294|Analgesics|analgesics|mesh-ancestor
56773935|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
56044604|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56044605|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044606|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55771811|NCT02354807|Mirabegron|mirabegron|mesh-list
56044607|NCT02346240|Etanercept|etanercept|mesh-list
56044608|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
56044609|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56044610|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56044612|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
56044613|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044614|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044615|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773936|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773937|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56773938|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56773939|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56773940|NCT05587998|Morphine|morphine|mesh-list
56773941|NCT05587998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56773942|NCT05587998|Narcotics|narcotics|mesh-ancestor
56773943|NCT05587998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773944|NCT05587998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773945|NCT05587998|Analgesics|analgesics|mesh-ancestor
56773946|NCT05587998|Sensory System Agents|sensory system agents|mesh-ancestor
56773947|NCT05587998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773948|NCT00988728|Olanzapine|olanzapine|mesh-list
56773949|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
56773950|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
56773951|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56773952|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773953|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56773954|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56773955|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56773956|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56773957|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56773958|NCT00988728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56773959|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56773960|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56773961|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773962|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56773963|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
56773964|NCT00988806|Simendan|simendan|mesh-list
56773965|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56773966|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
56773967|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56773968|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56773969|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773970|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773971|NCT00988806|Protective Agents|protective agents|mesh-ancestor
56773972|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773973|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
56773974|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
56773975|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56773976|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56773977|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773978|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773979|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773980|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56773981|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
56773982|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56773983|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56773984|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56773985|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56773986|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56773987|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56773988|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56773989|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56773990|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56773991|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
56773992|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56773993|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56773994|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56773995|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56773996|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56773997|NCT00987870|Betamethasone|betamethasone|mesh-list
56773998|NCT00987870|Calcipotriene|calcipotriene|mesh-list
56773999|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774000|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
56774001|NCT00987870|Hormones|hormones|mesh-ancestor
56484938|NCT04043494|Ifosfamide|ifosfamide|mesh-list
56774002|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774012|NCT05578170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56774013|NCT05578170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774014|NCT00989274|Vaccines|vaccines|mesh-list
56774015|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
56774016|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774017|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56774018|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56774019|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774020|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56774021|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774022|NCT05712642|Bevacizumab|bevacizumab|mesh-list
56774023|NCT05712642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56774024|NCT05712642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774025|NCT05712642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56774026|NCT05712642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56774027|NCT05712642|Growth Substances|growth substances|mesh-ancestor
56774028|NCT05712642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774029|NCT05712642|Growth Inhibitors|growth inhibitors|mesh-ancestor
56774030|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
56774031|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
56774032|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774033|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
56774034|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774035|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774036|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56774037|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
56774038|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774039|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774040|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56774041|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56774042|NCT01085149|Simvastatin|simvastatin|mesh-list
56774043|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56774044|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56774045|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
56774048|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56774049|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774050|NCT04005612|Vitamin D|vitamin d|mesh-list
56774051|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
56774052|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
56774053|NCT04005612|Vitamins|vitamins|mesh-list
56774054|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
56774055|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774056|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56774057|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56774058|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
56774059|NCT00413920|Prednisone|prednisone|mesh-list
56774060|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774061|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
56774062|NCT00413920|Hormones|hormones|mesh-ancestor
56774063|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774064|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774065|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56774066|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774067|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56774068|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56774069|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
56774070|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56774071|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774072|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485013|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56774073|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774074|NCT00091819|Vancomycin|vancomycin|mesh-list
56774075|NCT00091819|Telavancin|telavancin|mesh-list
56774076|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56774077|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774078|NCT01326871|Gemcitabine|gemcitabine|mesh-list
56774079|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774080|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56774081|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
56774082|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774085|NCT01326871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774086|NCT01326871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774087|NCT01326871|Immunologic Factors|immunologic factors|mesh-ancestor
56774088|NCT01326871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774089|NCT01081561|Riboflavin|riboflavin|mesh-list
56774090|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
56774091|NCT01081561|Vitamins|vitamins|mesh-ancestor
56774092|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
56774093|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774094|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56774095|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
56774096|NCT04004754|Miltefosine|miltefosine|mesh-list
56774097|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
56774098|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774099|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774100|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56774101|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56774102|NCT05711940|Psilocybin|psilocybin|mesh-list
56774103|NCT05711940|Hallucinogens|hallucinogens|mesh-ancestor
56774104|NCT05711940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774105|NCT05711940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56774106|NCT00539994|Retapamulin|retapamulin|mesh-list
56774107|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56774108|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774109|NCT04508790|Dexamethasone|dexamethasone|mesh-list
56774110|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
56774111|NCT04508790|Pomalidomide|pomalidomide|mesh-list
56774112|NCT04508790|Ichthammol|ichthammol|mesh-list
56774113|NCT04508790|BB 1101|bb 1101|mesh-list
56774114|NCT04508790|Leflunomide|leflunomide|mesh-list
56774115|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774116|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
56774117|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
56774132|NCT04508790|Growth Substances|growth substances|mesh-ancestor
56774133|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
56774134|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
56774135|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774136|NCT04005222|Selenium|selenium|mesh-list
56774137|NCT04005222|Melatonin|melatonin|mesh-list
56774138|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
56774139|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774140|NCT04005222|Protective Agents|protective agents|mesh-ancestor
56774141|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774142|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56774143|NCT04005222|Trace Elements|trace elements|mesh-ancestor
56774144|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
56774145|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
56485100|NCT00535509|Cisplatin|cisplatin|mesh-list
56774146|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56774147|NCT00098839|Leucovorin|leucovorin|mesh-list
56774148|NCT00098839|Cytarabine|cytarabine|mesh-list
56774149|NCT00098839|Prednisone|prednisone|mesh-list
56774150|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
56774151|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56774152|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56774153|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56774154|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
56774156|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56774157|NCT00098839|Methotrexate|methotrexate|mesh-list
56774158|NCT00098839|Etoposide|etoposide|mesh-list
56774159|NCT00098839|Vincristine|vincristine|mesh-list
56774160|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
56774161|NCT00098839|Asparaginase|asparaginase|mesh-list
56774162|NCT00098839|Pegaspargase|pegaspargase|mesh-list
56774163|NCT00098839|Epratuzumab|epratuzumab|mesh-list
56774164|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
56774165|NCT00098839|Razoxane|razoxane|mesh-list
56774166|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
56774167|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56046881|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
56044616|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56044617|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044618|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56044619|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
56044620|NCT01511978|Amifampridine|amifampridine|mesh-list
56044621|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56044622|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044623|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044624|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56774168|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
56774169|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774170|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774171|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56774172|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
56774173|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774174|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774175|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56774176|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56774177|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56774178|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56774179|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774180|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774181|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
56774182|NCT00098839|Hormones|hormones|mesh-ancestor
56774183|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774184|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56774185|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56774186|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
56774187|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774188|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56774189|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
56774190|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
56774191|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56774192|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56774193|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56774194|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
56774195|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774196|NCT00098839|Antidotes|antidotes|mesh-ancestor
56774197|NCT00098839|Protective Agents|protective agents|mesh-ancestor
56774198|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
56774199|NCT00098839|Vitamins|vitamins|mesh-ancestor
56774200|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
56774201|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
56774202|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
56774203|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
56046910|NCT03040011|Hormones|hormones|mesh-ancestor
56774204|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56774205|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56774206|NCT05268744|Micronutrients|micronutrients|mesh-list
56774207|NCT05268744|Trace Elements|trace elements|mesh-list
56774208|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774209|NCT02531191|Peficitinib|peficitinib|mesh-list
56774210|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774211|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774212|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774213|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
56774214|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774215|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56774216|NCT01081639|Hormones|hormones|mesh-ancestor
56774217|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774218|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774219|NCT01081717|Golimumab|golimumab|mesh-list
56774220|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56774221|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774222|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774223|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
56774224|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774225|NCT01085383|Aripiprazole|aripiprazole|mesh-list
56774226|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
56774227|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56774228|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56774229|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56774230|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56774231|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774232|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
56774233|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
56774234|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774246|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
56774247|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774248|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774249|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56774250|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
56774251|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774252|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774253|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
56774254|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774255|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56774256|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774257|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
56774258|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774259|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56774260|NCT00490971|Olanzapine|olanzapine|mesh-list
56774304|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774305|NCT00750347|Hormones|hormones|mesh-ancestor
56774306|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774307|NCT00750425|Cediranib|cediranib|mesh-list
56774308|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774309|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56774310|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774311|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774312|NCT00745589|Sevelamer|sevelamer|mesh-list
56774313|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
56774314|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
56774315|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774316|NCT00750581|Indomethacin|indomethacin|mesh-list
56774317|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56774318|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56774319|NCT00750581|Analgesics|analgesics|mesh-ancestor
56774320|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
56774321|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774322|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774323|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774324|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774325|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
56774326|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
56774327|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774328|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56774329|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774330|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774331|NCT00685763|Gemcitabine|gemcitabine|mesh-list
56774332|NCT00685763|Capecitabine|capecitabine|mesh-list
56774333|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56774334|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
56774335|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774336|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774337|NCT00685763|Antiviral Agents|antiviral agents|mesh-ancestor
56774342|NCT00685763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774343|NCT00098293|Lamivudine|lamivudine|mesh-list
56774344|NCT00098293|Zidovudine|zidovudine|mesh-list
56774345|NCT00098293|Efavirenz|efavirenz|mesh-list
56774346|NCT00098293|Maraviroc|maraviroc|mesh-list
56774347|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56774348|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56774349|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774350|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774351|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
56774352|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774353|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56774354|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56774355|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
56774356|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56774357|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56774358|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56774359|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56774360|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56774361|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56774362|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56774363|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56774364|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56774365|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
56774366|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774367|NCT00685685|Lovastatin|lovastatin|mesh-list
56774368|NCT00685685|L 647318|l 647318|mesh-list
56774369|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
56774370|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56774371|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56774372|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
56774373|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774374|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56774375|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56774377|NCT01087567|Insulin|insulin|mesh-list
56774382|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56774383|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774384|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56774385|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774386|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
56774387|NCT00751049|Timolol|timolol|mesh-list
56774388|NCT00751049|Latanoprost|latanoprost|mesh-list
56774389|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56774390|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56774391|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
56774392|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774393|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774394|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774395|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56774396|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56774397|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56774398|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56774399|NCT00500331|Pioglitazone|pioglitazone|mesh-list
56774400|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56774401|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774402|NCT01019109|Cobalt|cobalt|mesh-list
56774403|NCT01019109|Trace Elements|trace elements|mesh-ancestor
56774404|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
56774405|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774406|NCT00499863|Methylphenidate|methylphenidate|mesh-list
56774407|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56774408|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774409|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56774410|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56774411|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56774412|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774413|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
56774424|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774425|NCT01014507|Goserelin|goserelin|mesh-list
56774426|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
56774427|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
56774428|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774429|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774430|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56774431|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774432|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56774433|NCT00097981|Thalidomide|thalidomide|mesh-list
56774434|NCT00097981|Dexamethasone|dexamethasone|mesh-list
56774435|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774436|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
56774437|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
56774438|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774439|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774440|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56774441|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
56774442|NCT00097981|Hormones|hormones|mesh-ancestor
56774443|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774444|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56774445|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774446|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774447|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
56774448|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
56774449|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56485383|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
56774450|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774451|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56774452|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56774453|NCT00097981|Growth Substances|growth substances|mesh-ancestor
56774454|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
56774455|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
56774456|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56774457|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56774458|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56774459|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774461|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774462|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
56774463|NCT01016223|Hormones|hormones|mesh-ancestor
56774464|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774465|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774466|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56774467|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
56774468|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56774469|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
56774470|NCT04151017|Coagulants|coagulants|mesh-ancestor
56774471|NCT01019265|Buprenorphine|buprenorphine|mesh-list
56774472|NCT01019265|Tramadol|tramadol|mesh-list
56774473|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56774474|NCT01019265|Narcotics|narcotics|mesh-ancestor
56774475|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56774476|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774477|NCT01019265|Analgesics|analgesics|mesh-ancestor
56774478|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
56774479|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774480|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56774481|NCT01085617|Cytarabine|cytarabine|mesh-list
56774482|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
56774483|NCT01085617|Melphalan|melphalan|mesh-list
56774484|NCT01085617|Rituximab|rituximab|mesh-list
56774485|NCT01085617|Methotrexate|methotrexate|mesh-list
56774486|NCT01085617|Fludarabine|fludarabine|mesh-list
56774487|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
56774488|NCT01085617|Etoposide|etoposide|mesh-list
56774489|NCT01085617|Vincristine|vincristine|mesh-list
56774490|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
56774491|NCT01085617|Daunorubicin|daunorubicin|mesh-list
56774492|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
56774493|NCT01085617|Pegaspargase|pegaspargase|mesh-list
56774494|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774495|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
56774506|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774507|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56774508|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
56774509|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
56774510|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774511|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56774512|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56774513|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56774514|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56774515|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56774516|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
56774517|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774518|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
56774519|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
56774520|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
56774521|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56774522|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56774523|NCT00499083|Tamoxifen|tamoxifen|mesh-list
56774524|NCT00499083|Paclitaxel|paclitaxel|mesh-list
56774525|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
56774526|NCT00499083|Doxorubicin|doxorubicin|mesh-list
56774527|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56774528|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56774529|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56774530|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774531|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
56774532|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
56774533|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
56774534|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774535|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774536|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
56774537|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774538|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774539|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56047252|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
56774545|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774546|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56774547|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
56774548|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774549|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56774550|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56774551|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56774552|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56774553|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56774554|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56774555|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56774556|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56774557|NCT01087879|Etonogestrel|etonogestrel|mesh-list
56774558|NCT01087879|Desogestrel|desogestrel|mesh-list
56774559|NCT01087879|NuvaRing|nuvaring|mesh-list
56774560|NCT01087879|Norelgestromin|norelgestromin|mesh-list
56774561|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
56774562|NCT01087879|Estradiol|estradiol|mesh-list
56774563|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56774564|NCT01087879|Estrogens|estrogens|mesh-ancestor
56774565|NCT01087879|Hormones|hormones|mesh-ancestor
56774566|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774567|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774568|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56774569|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774570|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56774571|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56774572|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56774573|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56774574|NCT01087879|Progestins|progestins|mesh-ancestor
56774575|NCT01085695|Rabeprazole|rabeprazole|mesh-list
56774576|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56774581|NCT01088035|Carboplatin|carboplatin|mesh-list
56774587|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
56774588|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774589|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774590|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774591|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
56774592|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
56774593|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56774594|NCT00751127|Timolol|timolol|mesh-list
56774595|NCT00751127|Latanoprost|latanoprost|mesh-list
56774596|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56774597|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56774598|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
56774599|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774600|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774601|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774602|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56774603|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56774604|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56774605|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56774606|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
56774607|NCT00751205|Prednisone|prednisone|mesh-list
56774608|NCT00751205|Prednisolone|prednisolone|mesh-list
56774609|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56774610|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
56774611|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56774612|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
56774613|NCT00751205|Sagopilone|sagopilone|mesh-list
56774614|NCT00751205|Epothilones|epothilones|mesh-list
56774615|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56774616|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
56774617|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774618|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
56774632|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
56774633|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
56774634|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
56774635|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
56774636|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
56774637|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774638|NCT00752063|Capecitabine|capecitabine|mesh-list
56774639|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
56774640|NCT00752063|Sorafenib|sorafenib|mesh-list
56774641|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56774642|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
56774643|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774644|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774645|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56774646|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774647|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
56774648|NCT00752141|Oxybutynin|oxybutynin|mesh-list
56774649|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
56774650|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
56774651|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774652|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774653|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56774654|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56774655|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
56774656|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774657|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774658|NCT00752141|Urological Agents|urological agents|mesh-ancestor
56774659|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56774660|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774661|NCT00752141|Renal Agents|renal agents|mesh-ancestor
56774662|NCT00752375|Trimethoprim|trimethoprim|mesh-list
56774663|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56774675|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56774676|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56774677|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56774678|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
56774679|NCT00751517|Methotrexate|methotrexate|mesh-list
56774680|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774681|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
56774682|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774683|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774684|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56774685|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
56774686|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774687|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774688|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56774689|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56774690|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
56774691|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774692|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56774693|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
56774694|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
56774695|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774696|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56774697|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56774698|NCT02561117|Metronidazole|metronidazole|mesh-list
56774699|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774700|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56774701|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56774702|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56774703|NCT00684515|Aspirin|aspirin|mesh-list
56774704|NCT00684515|Vorapaxar|vorapaxar|mesh-list
56774718|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774719|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
56774720|NCT00751751|Losartan|losartan|mesh-list
56774721|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56774722|NCT00751751|Olmesartan|olmesartan|mesh-list
56774723|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56774724|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56774725|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56774726|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56774727|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56774728|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774729|NCT00751751|Diuretics|diuretics|mesh-ancestor
56774730|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
56774731|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774732|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56774733|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56774734|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56774735|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774736|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
56774737|NCT00490815|Hormones|hormones|mesh-ancestor
56774738|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774739|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774740|NCT04453137|Adalimumab|adalimumab|mesh-list
56774741|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774742|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774743|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
56774744|NCT03855189|Beclomethasone|beclomethasone|mesh-list
56774745|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774746|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
56774747|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56774763|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
56774764|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56774765|NCT01019655|Nadroparin|nadroparin|mesh-list
56774766|NCT01019655|Calcium|calcium|mesh-list
56774767|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56774768|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774769|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
56774770|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56774771|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56774772|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774773|NCT00483717|Ketorolac|ketorolac|mesh-list
56774774|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56774775|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56774776|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56774777|NCT00483717|Analgesics|analgesics|mesh-ancestor
56774778|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
56774779|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774780|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774781|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774782|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774783|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56774815|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56774816|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774817|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
56774818|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56774819|NCT00684203|Aspirin|aspirin|mesh-list
56774820|NCT00684203|Clopidogrel|clopidogrel|mesh-list
56774821|NCT00684203|Vorapaxar|vorapaxar|mesh-list
56774822|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56774823|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56774824|NCT00684203|Analgesics|analgesics|mesh-ancestor
56774825|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
56774826|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774827|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774828|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774829|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774830|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56485761|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774831|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56774832|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774833|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56774834|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56774835|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774836|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
56774837|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56774838|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56774839|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56774840|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
56774841|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774842|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56774843|NCT00751829|Olmesartan|olmesartan|mesh-list
56774844|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56774845|NCT00751829|Nitrendipine|nitrendipine|mesh-list
56774846|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56774847|NCT00751829|Diuretics|diuretics|mesh-ancestor
56047562|NCT01691690|Propofol|propofol|mesh-list
56044662|NCT01450826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56044663|NCT01450826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044664|NCT01450826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56044665|NCT01450826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56191003|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56774848|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
56774849|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774850|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56774851|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56774852|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774853|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56774854|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56774855|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56774856|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56774857|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
56774858|NCT00423592|Ambrisentan|ambrisentan|mesh-list
56774859|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56774860|NCT01037998|Gefitinib|gefitinib|mesh-list
56774861|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774862|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56774863|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774864|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774865|NCT00751907|Atorvastatin|atorvastatin|mesh-list
56774866|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56774867|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56774868|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
56774869|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774870|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56774871|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56774872|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774873|NCT00752843|Mifepristone|mifepristone|mesh-list
56774874|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56774875|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
56774876|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774877|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774878|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56774879|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56774880|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56047596|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
56774883|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56774884|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
56774885|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774886|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
56774887|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56774888|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56774889|NCT00752921|Etoricoxib|etoricoxib|mesh-list
56774890|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56774891|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56774892|NCT00752921|Analgesics|analgesics|mesh-ancestor
56774893|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
56774894|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774895|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774896|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56774897|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774898|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56774899|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56774900|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774901|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774902|NCT00683657|Saxagliptin|saxagliptin|mesh-list
56774903|NCT00683657|Incretins|incretins|mesh-ancestor
56774904|NCT00683657|Hormones|hormones|mesh-ancestor
56774905|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774906|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774907|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56774908|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
56774909|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774910|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774911|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56774912|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
56774913|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774914|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56774915|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56774916|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191004|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56191005|NCT01471886|Analgesics|analgesics|mesh-ancestor
56191006|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
56774917|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
56774918|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774919|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774920|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56774921|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56774922|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56774923|NCT00755963|Estradiol|estradiol|mesh-list
56774924|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56774925|NCT00755963|Progesterone|progesterone|mesh-list
56774926|NCT00755963|Estrogens|estrogens|mesh-ancestor
56774927|NCT00755963|Hormones|hormones|mesh-ancestor
56774928|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56774929|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774930|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56774931|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
56774932|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56774933|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56774934|NCT00755963|Progestins|progestins|mesh-ancestor
56774935|NCT00753311|Rizatriptan|rizatriptan|mesh-list
56774936|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56774937|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
56774938|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56774939|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774940|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774941|NCT00753389|Anesthetics|anesthetics|mesh-list
56774942|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56774943|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774944|NCT00753467|Interferons|interferons|mesh-list
56774945|NCT00753467|Adefovir|adefovir|mesh-list
56774961|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
56774962|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
56774963|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56774964|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774965|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
56774966|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56774967|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56774968|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56774969|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56774970|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56774971|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774972|NCT00482391|Paclitaxel|paclitaxel|mesh-list
56774973|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
56774974|NCT00482391|Doxorubicin|doxorubicin|mesh-list
56774975|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56774976|NCT00482391|Trastuzumab|trastuzumab|mesh-list
56774977|NCT00482391|Lapatinib|lapatinib|mesh-list
56774978|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56774979|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56774980|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
56774981|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
56774982|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
56774983|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56774984|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56774985|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
56774986|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56774987|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56774988|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56774989|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
56774990|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56774991|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56775003|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56775004|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56775005|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775006|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56775007|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56775008|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56775009|NCT00757523|Analgesics|analgesics|mesh-ancestor
56775010|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
56775011|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775012|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775013|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775014|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775015|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
56775016|NCT00757679|Milnacipran|milnacipran|mesh-list
56775017|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
56775018|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56775019|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56775020|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56775021|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775022|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775023|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775024|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56775025|NCT00757679|Analgesics|analgesics|mesh-ancestor
56775026|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
56775027|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775028|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
56775029|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56775030|NCT00496587|Gemcitabine|gemcitabine|mesh-list
56775031|NCT00496587|Bevacizumab|bevacizumab|mesh-list
56775032|NCT00496587|Capecitabine|capecitabine|mesh-list
56775033|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56775034|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775035|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56775040|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56775041|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
56775042|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775043|NCT00496587|Antiviral Agents|antiviral agents|mesh-ancestor
56775044|NCT00496587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775045|NCT00496587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485984|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
56775046|NCT00496587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775047|NCT00496587|Immunologic Factors|immunologic factors|mesh-ancestor
56775048|NCT00757835|Timolol|timolol|mesh-list
56775049|NCT00757835|Latanoprost|latanoprost|mesh-list
56775050|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56775051|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56775052|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
56775053|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775054|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775055|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775056|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56775057|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56775058|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56775059|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56775060|NCT01038154|Pravastatin|pravastatin|mesh-list
56775061|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56775062|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56775063|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
56775065|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56775088|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56775089|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
56775090|NCT01324180|Hormones|hormones|mesh-ancestor
56775091|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775092|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56775093|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775094|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775095|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56775096|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56775097|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56775098|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775099|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775100|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56775101|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
56775102|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
56775103|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
56775104|NCT02560649|Tenofovir|tenofovir|mesh-list
56775105|NCT02560649|Lamivudine|lamivudine|mesh-list
56775146|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775147|NCT00682643|Fluticasone|fluticasone|mesh-list
56775149|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775150|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56775151|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
56775152|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775153|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775154|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56775155|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
56775156|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
56775157|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56775158|NCT00758381|Sorafenib|sorafenib|mesh-list
56775159|NCT00758381|Cisplatin|cisplatin|mesh-list
56775160|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775161|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56775162|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775163|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775164|NCT00754871|Dienogest|dienogest|mesh-list
56775165|NCT00754871|Nandrolone|nandrolone|mesh-list
56775204|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56775205|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
56775206|NCT01038388|Hormones|hormones|mesh-ancestor
56775207|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775208|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56775209|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775210|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
56775211|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56775212|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56775213|NCT01038388|Growth Substances|growth substances|mesh-ancestor
56775214|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
56775215|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56775216|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775217|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775218|NCT04050059|Lidocaine|lidocaine|mesh-list
56191007|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191008|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191009|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56191010|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56191011|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56191012|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191013|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191014|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
56191015|NCT01471899|Ketorolac|ketorolac|mesh-list
56191016|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56191017|NCT01471899|Naproxen|naproxen|mesh-list
56191018|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56191019|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56191020|NCT01471899|Analgesics|analgesics|mesh-ancestor
56191021|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
56044666|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56044697|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
56044699|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
56044700|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044701|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
56044702|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56044703|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56044704|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044705|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044706|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044707|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56044708|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
56044709|NCT04334967|Protective Agents|protective agents|mesh-ancestor
56044710|NCT04335123|Losartan|losartan|mesh-list
56044741|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
56044742|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56044743|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56044744|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56044745|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044746|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044747|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
56044748|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56044749|NCT05437965|Hormones|hormones|mesh-ancestor
56044750|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044776|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56044777|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044778|NCT05223231|Antibodies|antibodies|mesh-list
56044779|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
56044780|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
56775219|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56775220|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
56775221|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
56775222|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775223|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775224|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
56775225|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775226|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56775227|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56775228|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56775229|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56775230|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775231|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56775232|NCT02150967|Infigratinib|infigratinib|mesh-list
56775233|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775234|NCT00482001|Donepezil|donepezil|mesh-list
56775235|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56775236|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775237|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775238|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
56775239|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775240|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775241|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
56775242|NCT00490035|Brivaracetam|brivaracetam|mesh-list
56775243|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
56775244|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
56775245|NCT00421174|Etanercept|etanercept|mesh-list
56775246|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775247|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
56775248|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
56775249|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775250|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775253|NCT00421174|Hormones|hormones|mesh-ancestor
56775260|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
56775261|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775262|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775263|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
56775264|NCT00496197|Fluconazole|fluconazole|mesh-list
56775265|NCT00496197|Voriconazole|voriconazole|mesh-list
56775266|NCT00496197|Anidulafungin|anidulafungin|mesh-list
56775267|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
56775268|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775269|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56775270|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56775271|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775272|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775273|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56486211|NCT02964884|Lovastatin|lovastatin|mesh-list
56775274|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
56775275|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775276|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775277|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56775278|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56775279|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56775280|NCT03996993|Bicalutamide|bicalutamide|mesh-list
56775281|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
56775282|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
56775283|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775284|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775285|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775286|NCT01015053|Ropivacaine|ropivacaine|mesh-list
56775287|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
56775302|NCT00489489|Interferon-beta|interferon-beta|mesh-list
56775303|NCT00489489|Teriflunomide|teriflunomide|mesh-list
56775304|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
56775305|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775306|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
56775307|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775308|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56775309|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
56775310|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775311|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56775312|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56775313|NCT00489489|Analgesics|analgesics|mesh-ancestor
56775333|NCT00420784|Ribavirin|ribavirin|mesh-list
56775365|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
56775366|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56775367|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
56775368|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56775369|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
56775370|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775371|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775372|NCT00420238|Etanercept|etanercept|mesh-list
56775373|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56775374|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56775375|NCT00420238|Analgesics|analgesics|mesh-ancestor
56044781|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044782|NCT05013255|Pioglitazone|pioglitazone|mesh-list
56044783|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56044784|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044785|NCT01461668|Retapamulin|retapamulin|mesh-list
56191022|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191023|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191024|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56191025|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56191026|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56191027|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213195|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044786|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56044787|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044788|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
56044789|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
56044790|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044791|NCT05177991|Bupivacaine|bupivacaine|mesh-list
56044794|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044795|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044796|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
55740115|NCT03391427|Lidocaine|lidocaine|mesh-list
56044797|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044798|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56044799|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
56044826|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044827|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56044828|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044829|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044830|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56044832|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
56044833|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56044834|NCT03875235|Durvalumab|durvalumab|mesh-list
56044835|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044836|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044837|NCT05456763|Butyric Acid|butyric acid|mesh-list
56044838|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
56044839|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
56044840|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044841|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044842|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044843|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56044844|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56044845|NCT02369874|Durvalumab|durvalumab|mesh-list
56044870|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56044871|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56044872|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044873|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044874|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56044875|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044877|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56044878|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56775376|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
56775377|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775378|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775379|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775380|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775381|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56775382|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775383|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
56775384|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
56775385|NCT04081545|Analgesics|analgesics|mesh-list
56775386|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56775387|NCT04081545|Anesthetics|anesthetics|mesh-list
56775388|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775389|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775390|NCT04081545|Narcotics|narcotics|mesh-ancestor
56775391|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
56775392|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775393|NCT00420004|Citalopram|citalopram|mesh-list
56775394|NCT00420004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56775395|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56775396|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56775397|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775426|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775427|NCT00419926|Cyclosporine|cyclosporine|mesh-list
56775428|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
56775429|NCT00419926|Prednisone|prednisone|mesh-list
56775430|NCT00419926|Cyclosporins|cyclosporins|mesh-list
56775431|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775432|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
56775433|NCT00419926|Hormones|hormones|mesh-ancestor
56775434|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775435|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775436|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56775437|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775438|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775439|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775440|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775441|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
56775442|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
56775443|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775444|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
56775445|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775446|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56775447|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56775448|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56775449|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
56775450|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775451|NCT00419770|Amphotericin B|amphotericin b|mesh-list
56775452|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56775453|NCT00419770|Deferasirox|deferasirox|mesh-list
56775454|NCT00419770|Amebicides|amebicides|mesh-ancestor
56775455|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56775456|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56775457|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775458|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775459|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
56775460|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56775461|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
56775464|NCT00080119|Isoniazid|isoniazid|mesh-list
56775465|NCT00080119|Trimethoprim|trimethoprim|mesh-list
56775466|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
56775467|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
56775468|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775469|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775470|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56775471|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56775472|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
56775473|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775474|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56775475|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56775476|NCT00080119|Renal Agents|renal agents|mesh-ancestor
56775477|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
56775478|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56775479|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56775480|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56775481|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775482|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56775483|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56775484|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56775485|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56775486|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
56775487|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775488|NCT01034878|Sunitinib|sunitinib|mesh-list
56775489|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044879|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044880|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044881|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56044882|NCT05455359|Famotidine|famotidine|mesh-list
56044883|NCT05455359|Prucalopride|prucalopride|mesh-list
56044884|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56044885|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044886|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56044887|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
56044888|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
56044889|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044890|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044891|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044892|NCT05455359|Laxatives|laxatives|mesh-ancestor
56044893|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56044894|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56044895|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
56044896|NCT00373503|Lofexidine|lofexidine|mesh-list
56191028|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191030|NCT01471925|Esomeprazole|esomeprazole|mesh-list
56191031|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56191032|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191033|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56191034|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110410|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56775490|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56775491|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56775492|NCT01034878|Growth Substances|growth substances|mesh-ancestor
56775493|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775494|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
56486439|NCT02365649|Upadacitinib|upadacitinib|mesh-list
56775495|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56775496|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775497|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775498|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56775499|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56775500|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56775501|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775502|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775503|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56775504|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56775505|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56048251|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
56191035|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191036|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56191037|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191038|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56191039|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044897|NCT00373503|Dronabinol|dronabinol|mesh-list
56044898|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
56044899|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044934|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56044935|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044936|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044937|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56044974|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044975|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045005|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
56045006|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045007|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56045008|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56045009|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56045010|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045011|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045012|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
56045013|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045014|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56045015|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56045017|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56045018|NCT01516268|Narcotics|narcotics|mesh-ancestor
56045038|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56045039|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
56045040|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045041|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045042|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045043|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56045044|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56048265|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56048266|NCT03140631|Protamines|protamines|mesh-list
56048267|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
56048268|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048269|NCT03140631|Coagulants|coagulants|mesh-ancestor
56048270|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
56048271|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
56048272|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048273|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
56048274|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56048275|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
56775506|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56775507|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
56775508|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775509|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775510|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56775511|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56775512|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
56775552|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56775553|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
56775554|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775555|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775556|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
56775557|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775558|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775559|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
56775560|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775561|NCT00493467|Rituximab|rituximab|mesh-list
56775562|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56775563|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775564|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
56775565|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775566|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775567|NCT01088347|Mapatumumab|mapatumumab|mesh-list
56775568|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775569|NCT05257824|Aspirin|aspirin|mesh-list
56775570|NCT05257824|Clopidogrel|clopidogrel|mesh-list
56775571|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56775572|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56775573|NCT05257824|Analgesics|analgesics|mesh-ancestor
56775574|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
56775575|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775576|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775577|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775578|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775579|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56775580|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56775581|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775582|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56775583|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56775584|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775585|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
56775591|NCT04221828|Paclitaxel|paclitaxel|mesh-list
56775592|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56775593|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56775594|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775595|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
56775596|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
56775597|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
56775598|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775599|NCT04221750|Metformin|metformin|mesh-list
56775600|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775601|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775602|NCT04221438|Alovudine|alovudine|mesh-list
56775603|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
56775604|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775605|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
56775606|NCT04198428|Narcotics|narcotics|mesh-ancestor
56775607|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775608|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775609|NCT04198428|Analgesics|analgesics|mesh-ancestor
56775610|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
56775611|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775612|NCT04113018|Dexamethasone|dexamethasone|mesh-list
56775613|NCT04113018|Lenalidomide|lenalidomide|mesh-list
56775614|NCT04113018|Daratumumab|daratumumab|mesh-list
56775615|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775616|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
56775617|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
56775618|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775619|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775620|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56775621|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
56775622|NCT04113018|Hormones|hormones|mesh-ancestor
56775623|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775624|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56775633|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
56775634|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775635|NCT01017393|Ketamine|ketamine|mesh-list
56775636|NCT01017393|Analgesics|analgesics|mesh-ancestor
56775637|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
56775638|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775639|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775640|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56775641|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56775642|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
56775643|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
56775644|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775645|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56775646|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56775647|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775648|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775649|NCT00493311|Acetaminophen|acetaminophen|mesh-list
56775650|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56775651|NCT00493311|Analgesics|analgesics|mesh-ancestor
56775652|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
56775653|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775654|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775655|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
56775656|NCT00571649|Enoxaparin|enoxaparin|mesh-list
56775657|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
56775658|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
56775659|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56775660|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
56775661|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56775662|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
56775663|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775664|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775665|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
56775666|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56775667|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56775668|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56045045|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045046|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56775669|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
56775670|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775671|NCT03917472|Aflibercept|aflibercept|mesh-list
56775672|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56775673|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56775674|NCT03917472|Growth Substances|growth substances|mesh-ancestor
56775675|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775676|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
56775677|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775678|NCT00681863|Pramipexole|pramipexole|mesh-list
56775679|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
56775680|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775681|NCT00681863|Protective Agents|protective agents|mesh-ancestor
56775682|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775683|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56775684|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56775685|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
56775686|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
56775687|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775688|NCT02559791|Reslizumab|reslizumab|mesh-list
56775689|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56775690|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
56775691|NCT05677620|Propofol|propofol|mesh-list
56775692|NCT05677620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56775693|NCT05677620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775694|NCT05677620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775695|NCT05677620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56775696|NCT05677620|Anesthetics, General|anesthetics, general|mesh-ancestor
56775697|NCT05677620|Anesthetics|anesthetics|mesh-ancestor
56775698|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56775699|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
56775700|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56775701|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56775702|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56775703|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045047|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56045048|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
56045049|NCT02368314|Enoxaparin|enoxaparin|mesh-list
56045050|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
56045051|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
56045052|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56775704|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775705|NCT00969176|Acetaminophen|acetaminophen|mesh-list
56775706|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56775707|NCT00969176|Analgesics|analgesics|mesh-ancestor
56775708|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
56775709|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775710|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775711|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
56775712|NCT04503252|Cefazolin|cefazolin|mesh-list
56775713|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775714|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775715|NCT00679367|Dexamethasone|dexamethasone|mesh-list
56775716|NCT00679367|Lenalidomide|lenalidomide|mesh-list
56775717|NCT00679367|Melphalan|melphalan|mesh-list
56045053|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56045054|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772269|NCT02344511|Vancomycin|vancomycin|mesh-list
56045055|NCT01463384|Minocycline|minocycline|mesh-list
56045056|NCT01463384|Tetracycline|tetracycline|mesh-list
56045057|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56045058|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045059|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56045060|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191040|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045061|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045063|NCT02785185|Halobetasol|halobetasol|mesh-list
56045064|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56045065|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045066|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
56045067|NCT02785185|Hormones|hormones|mesh-ancestor
56045068|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56045069|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045070|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
56045071|NCT02787057|Vancomycin|vancomycin|mesh-list
56045072|NCT02787057|Ceftazidime|ceftazidime|mesh-list
56045073|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56045074|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045075|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56045104|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
56045105|NCT05062317|Irinotecan|irinotecan|mesh-list
56045106|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56045107|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045108|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56045109|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56045110|NCT05062317|Growth Substances|growth substances|mesh-ancestor
56045111|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045112|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
56045113|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
56045114|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045115|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56045116|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56045117|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
56045118|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56045119|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56045120|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045121|NCT05062317|Antidotes|antidotes|mesh-ancestor
56045122|NCT05062317|Protective Agents|protective agents|mesh-ancestor
56045123|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
56045125|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
56045126|NCT01469234|Loratadine|loratadine|mesh-list
56045218|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045219|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56045220|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
56110411|NCT02104752|Analgesics|analgesics|mesh-ancestor
56775718|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775719|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
56775720|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
56775721|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775722|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775723|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56775724|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
56775725|NCT00679367|Hormones|hormones|mesh-ancestor
56775726|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775727|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56775728|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775729|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
56775730|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56775731|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56775732|NCT00679367|Growth Substances|growth substances|mesh-ancestor
56775733|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
56775734|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56775735|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
56775736|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775737|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56775738|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775739|NCT00969566|Metformin|metformin|mesh-list
56775740|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56775741|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775742|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775743|NCT00969566|Incretins|incretins|mesh-ancestor
56775744|NCT00969566|Hormones|hormones|mesh-ancestor
56048471|NCT01709474|Vitamin D|vitamin d|mesh-list
56045221|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045222|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045223|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
56045224|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045225|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56045226|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56045227|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
56045228|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045229|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56045230|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56045231|NCT04259775|Insulin|insulin|mesh-list
56045232|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56045233|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045234|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56045235|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045236|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045237|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
56045238|NCT01573052|Gabapentin|gabapentin|mesh-list
56045239|NCT01573052|Analgesics|analgesics|mesh-ancestor
56775745|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775746|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56775747|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
56775748|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775749|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775750|NCT00755495|Doxepin|doxepin|mesh-list
56775751|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56775752|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56775753|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775754|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775755|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56775756|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
56775757|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56775758|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
56045240|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
56045241|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045242|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045243|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
56045244|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56045245|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56045246|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045247|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56045248|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56045249|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56045250|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045251|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045252|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
56191041|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
56191042|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
56191043|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191044|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
56191045|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56191046|NCT01471990|Protective Agents|protective agents|mesh-ancestor
56191047|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191048|NCT01471990|Growth Substances|growth substances|mesh-ancestor
56191049|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191050|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191051|NCT01472016|Docetaxel|docetaxel|mesh-list
56191052|NCT01472016|Cetuximab|cetuximab|mesh-list
56191053|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56191054|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191055|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
56191056|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
56045253|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56045254|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56045255|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
56045256|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
56045257|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
56045258|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56045259|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045260|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
56045261|NCT01523834|Panobinostat|panobinostat|mesh-list
56045262|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045263|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56045264|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045265|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045298|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
56045299|NCT02802111|Albuterol|albuterol|mesh-list
56775759|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
56775760|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775761|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775762|NCT00964184|Metformin|metformin|mesh-list
56775763|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775764|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775765|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
56775766|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
56775767|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
56775768|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775769|NCT00964262|Exenatide|exenatide|mesh-list
56775770|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775771|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775772|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56775773|NCT00964262|Incretins|incretins|mesh-ancestor
56775774|NCT00964262|Hormones|hormones|mesh-ancestor
56775775|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775776|NCT00973778|Capecitabine|capecitabine|mesh-list
56775777|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56775778|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
56775779|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775780|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775781|NCT05623410|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56775782|NCT05623410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56045300|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56045301|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
56045302|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045303|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045304|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56045305|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045321|NCT04164069|Dasatinib|dasatinib|mesh-list
56045322|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
56045323|NCT04164069|Antibodies|antibodies|mesh-list
56045324|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
56045325|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56045326|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
56045327|NCT04164069|Calcium|calcium|mesh-list
56045328|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
56045329|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045330|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56045331|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56045332|NCT04164069|Growth Substances|growth substances|mesh-ancestor
56045333|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045334|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
56045335|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
56045336|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56045337|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56045338|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
56045339|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045340|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56045341|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56045342|NCT04164069|Antidotes|antidotes|mesh-ancestor
56775783|NCT05623410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775784|NCT05623410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775785|NCT05623410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56775786|NCT05623410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56775787|NCT05623410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775788|NCT05623410|Cholinergic Agents|cholinergic agents|mesh-ancestor
56775789|NCT05623410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775790|NCT00964418|Insulin|insulin|mesh-list
56775791|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56775792|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
56775793|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775794|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775795|NCT00974012|Valproic Acid|valproic acid|mesh-list
56775796|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
56775797|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775798|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775799|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
56775800|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56775801|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775802|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
56775803|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56775804|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56775805|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56775806|NCT00964574|Insulin|insulin|mesh-list
56775807|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56775808|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
56775809|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
56775810|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775811|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775812|NCT00970580|Paclitaxel|paclitaxel|mesh-list
56775813|NCT00970580|Carboplatin|carboplatin|mesh-list
56775814|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
56775815|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56775816|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775817|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
56775818|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
56775822|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56775823|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56775824|NCT00974324|Growth Substances|growth substances|mesh-ancestor
56775825|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775826|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
56775827|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775828|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
56775829|NCT00545714|Rituximab|rituximab|mesh-list
56775830|NCT00545714|Fludarabine|fludarabine|mesh-list
56775831|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56775832|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
56775833|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775834|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775835|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56775836|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
56775837|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775838|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775839|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56775840|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56775841|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
56775842|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775843|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775844|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56775845|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56775846|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775847|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775848|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775849|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
56775850|NCT00539838|Prednisone|prednisone|mesh-list
56775851|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
56775852|NCT00539838|Methotrexate|methotrexate|mesh-list
56775853|NCT00539838|Azathioprine|azathioprine|mesh-list
56191057|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
56191058|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191059|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56191060|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56191061|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191062|NCT01472029|Leucovorin|leucovorin|mesh-list
56191063|NCT01472029|Docetaxel|docetaxel|mesh-list
56191064|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
56191065|NCT01472029|Trastuzumab|trastuzumab|mesh-list
56191066|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191067|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
56191068|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
56775854|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56775855|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
56775856|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56775857|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
56775858|NCT00539838|Hormones|hormones|mesh-ancestor
56775859|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56775860|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775861|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56775862|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775863|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56775864|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
56775865|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56775866|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56775867|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
56775868|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775869|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
56775870|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775871|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56775872|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
56775873|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775874|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56775875|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56775876|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56775877|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
56775878|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56775879|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775880|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
56775881|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
56775882|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56775899|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
56775900|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56775901|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775902|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56775903|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56775904|NCT00970970|Growth Substances|growth substances|mesh-ancestor
56775905|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775906|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
56775907|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56775908|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775909|NCT03765450|Infliximab|infliximab|mesh-list
56775910|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
56775911|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56775912|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775913|NCT04004988|Tirzepatide|tirzepatide|mesh-list
56775914|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56775915|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775960|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
56775961|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56775962|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56775963|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56775964|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
56775965|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56775966|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775967|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56775968|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56775969|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56775970|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56775971|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56775972|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56775973|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56775974|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
56775975|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56048707|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191069|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
56191070|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191071|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56045343|NCT04164069|Protective Agents|protective agents|mesh-ancestor
56045344|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
56045345|NCT04164069|Vitamins|vitamins|mesh-ancestor
56045346|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
56045347|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56045348|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045349|NCT04164069|Hematinics|hematinics|mesh-ancestor
56045350|NCT01576874|Oxytocin|oxytocin|mesh-list
56045351|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
56045352|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56045353|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045354|NCT01576952|Bromfenac|bromfenac|mesh-list
56045355|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56045356|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045357|NCT01576952|Analgesics|analgesics|mesh-ancestor
56045358|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
56045359|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045360|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772547|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045361|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045362|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045364|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045365|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56045366|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045367|NCT01577966|Analgesics|analgesics|mesh-ancestor
56045368|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
56045391|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56045392|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045393|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56045395|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
56045396|NCT01578278|Fluticasone|fluticasone|mesh-list
56045398|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
56045399|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045400|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56045401|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
56045402|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048723|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56048724|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56048725|NCT05139563|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56048726|NCT05139563|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56048727|NCT05139563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56048728|NCT05139563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56048740|NCT01646762|Paclitaxel|paclitaxel|mesh-list
56048741|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56048742|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56048743|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56775976|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56775977|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
56775978|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
56775979|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56775980|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56775981|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56775982|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
56775983|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56775984|NCT00974792|Antidotes|antidotes|mesh-ancestor
56775985|NCT00974792|Protective Agents|protective agents|mesh-ancestor
56775986|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
56775988|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
56775989|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
56776019|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776020|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776021|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776022|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56776023|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56776024|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56776025|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
56776026|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
56776027|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
56776028|NCT00755573|Pregabalin|pregabalin|mesh-list
56776029|NCT00755573|Analgesics|analgesics|mesh-ancestor
56776030|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
56776031|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776032|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776033|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
56776034|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56776035|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56776036|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776037|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56776038|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56776039|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56776040|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56776041|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56776042|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56048763|NCT04408313|Naltrexone|naltrexone|mesh-list
56045403|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045404|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56045405|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045407|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56045408|NCT02803749|Buspirone|buspirone|mesh-list
56045409|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56045410|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56045411|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56191072|NCT01472029|Antidotes|antidotes|mesh-ancestor
56118871|NCT00004889|Rituximab|rituximab|mesh-list
56191073|NCT01472029|Protective Agents|protective agents|mesh-ancestor
56191074|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191075|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
56191077|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
56191078|NCT01472055|Fludarabine|fludarabine|mesh-list
56045412|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045413|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56045414|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56045415|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
56045416|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045417|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045418|NCT01578980|Pancrelipase|pancrelipase|mesh-list
56045419|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56776043|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
56776044|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776045|NCT04008290|Liraglutide|liraglutide|mesh-list
56776046|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56776047|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776048|NCT04008290|Incretins|incretins|mesh-ancestor
56776049|NCT04008290|Hormones|hormones|mesh-ancestor
56776050|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776051|NCT02559167|Cannabidiol|cannabidiol|mesh-list
56776052|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
56776053|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56776054|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776055|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56776056|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776057|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776058|NCT05271071|Lidocaine|lidocaine|mesh-list
56776059|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
56776060|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
56776061|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56776062|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776063|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
56776064|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776065|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56776066|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56776067|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56776068|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56776069|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776070|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
56776083|NCT00972218|Adalimumab|adalimumab|mesh-list
56776087|NCT05230901|Spironolactone|spironolactone|mesh-list
56776088|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56776089|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
56776090|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776091|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776092|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56776093|NCT05230901|Diuretics|diuretics|mesh-ancestor
56776094|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
56776095|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56776096|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
56776097|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56776098|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776099|NCT03927950|Citalopram|citalopram|mesh-list
56776100|NCT03927950|Bupropion|bupropion|mesh-list
56776101|NCT03927950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56776102|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56776103|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56487037|NCT04664894|Ribavirin|ribavirin|mesh-list
56776104|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776105|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776106|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
56776107|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776108|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56776109|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
56776110|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56776111|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56776112|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
56048834|NCT04868045|Hormones|hormones|mesh-list
56045420|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56045421|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045422|NCT00372879|Vitamin E|vitamin e|mesh-list
56045423|NCT00372879|Vitamins|vitamins|mesh-ancestor
56045424|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
56045425|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045451|NCT05564858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56045452|NCT05564858|Immunoconjugates|immunoconjugates|mesh-list
56045453|NCT05564858|Immunologic Factors|immunologic factors|mesh-ancestor
56045454|NCT05564858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045455|NCT02814279|Dipyrone|dipyrone|mesh-list
56045456|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
56045457|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56045458|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045459|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
56045460|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56045461|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045462|NCT02814279|Analgesics|analgesics|mesh-ancestor
56045463|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
56776113|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56776114|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56776115|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776116|NCT00972842|Lenalidomide|lenalidomide|mesh-list
56776118|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
56776119|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776120|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56776121|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56776122|NCT00972842|Growth Substances|growth substances|mesh-ancestor
56776123|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
56776124|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776125|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56776126|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776127|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776128|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
56776129|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
56776130|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56776131|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56776132|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776133|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776134|NCT00975494|Urological Agents|urological agents|mesh-ancestor
56776135|NCT00975572|Vaccines|vaccines|mesh-list
56776136|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
56776137|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776138|NCT00965666|Etanercept|etanercept|mesh-list
56776139|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56776140|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56776141|NCT00965666|Analgesics|analgesics|mesh-ancestor
56776142|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
56776158|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776159|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776160|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776161|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56776162|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56776163|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776164|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776165|NCT04049747|Urological Agents|urological agents|mesh-ancestor
56776166|NCT00973154|Prednisone|prednisone|mesh-list
56776167|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776168|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
56776169|NCT00973154|Hormones|hormones|mesh-ancestor
56776170|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776171|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045464|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045465|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045466|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045467|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045468|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
56045469|NCT00373659|Ranibizumab|ranibizumab|mesh-list
56045470|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56045471|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56045472|NCT00373659|Growth Substances|growth substances|mesh-ancestor
56045473|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045494|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
56045495|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56045496|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045497|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56045498|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56045499|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045500|NCT01582490|Bupivacaine|bupivacaine|mesh-list
56045501|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
56045502|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
56045503|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045504|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045505|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
56045506|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045507|NCT01582880|Riboflavin|riboflavin|mesh-list
56045508|NCT01582880|Vitamins|vitamins|mesh-ancestor
56045509|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
56045510|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045511|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
56045512|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56045513|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
56045514|NCT02889393|Teduglutide|teduglutide|mesh-list
56045515|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56045516|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56045517|NCT02889393|Protective Agents|protective agents|mesh-ancestor
56045518|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191079|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045520|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56045521|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045522|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045523|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045525|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
56045526|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045527|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56776172|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56776173|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776174|NCT00965900|Propranolol|propranolol|mesh-list
56776175|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56776176|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56776177|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
56776178|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776179|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776180|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776181|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56776182|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56776183|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
56776184|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
56776185|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776186|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776187|NCT00973232|Acetaminophen|acetaminophen|mesh-list
56776188|NCT00973232|Tramadol|tramadol|mesh-list
56776189|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56776190|NCT00973232|Analgesics|analgesics|mesh-ancestor
56776191|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
56776192|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776193|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776194|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
56776195|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56776196|NCT00973232|Narcotics|narcotics|mesh-ancestor
56776197|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56776198|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56776199|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776200|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56776201|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776202|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776203|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
56776204|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56776205|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776206|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56776210|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776211|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56776212|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56776213|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56776214|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776215|NCT00966056|Mitomycins|mitomycins|mesh-list
56776216|NCT00966056|Mitomycin|mitomycin|mesh-list
56776217|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56776218|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776219|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
56776220|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776221|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56776222|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776223|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56776224|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
56776225|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776226|NCT00979706|Cyclosporine|cyclosporine|mesh-list
56776227|NCT00979706|Interleukin-2|interleukin-2|mesh-list
56776228|NCT00979706|Cyclosporins|cyclosporins|mesh-list
56776229|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776230|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776231|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56776232|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
56776233|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776234|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
56776235|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776236|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
56776237|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56048960|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
56045561|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
56045562|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56045563|NCT03581409|Protective Agents|protective agents|mesh-ancestor
56045564|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56045565|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56045566|NCT03566667|Metoprolol|metoprolol|mesh-list
56045598|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045599|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56045600|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
56045601|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045602|NCT03510741|Protective Agents|protective agents|mesh-ancestor
56045603|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045604|NCT03510741|Antidotes|antidotes|mesh-ancestor
56045605|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
56045606|NCT05556044|Empagliflozin|empagliflozin|mesh-list
56045607|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56045608|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776238|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56776239|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776240|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56776241|NCT00979706|Analgesics|analgesics|mesh-ancestor
56776242|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
56776243|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776244|NCT00979862|Cediranib|cediranib|mesh-list
56776245|NCT00979862|Maleic acid|maleic acid|mesh-list
56776246|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776247|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776248|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776249|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56776250|NCT00966290|Warfarin|warfarin|mesh-list
56776251|NCT00966290|Anticoagulants|anticoagulants|mesh-list
56776252|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
56776253|NCT00966290|Fluindione|fluindione|mesh-list
56776254|NCT00966290|Phenindione|phenindione|mesh-list
56776255|NCT00966368|Insulin|insulin|mesh-list
56776256|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56776257|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
56776258|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56776259|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776260|NCT00980408|Cycloserine|cycloserine|mesh-list
56776261|NCT00980408|Memantine|memantine|mesh-list
56776262|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56776263|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56776264|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
56776265|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776266|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776267|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048987|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
56045609|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56045656|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045657|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56045658|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56045659|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56045660|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045661|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045662|NCT02977299|Aripiprazole|aripiprazole|mesh-list
56045663|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56045664|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
56045665|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56045666|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56045667|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56045668|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045669|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045670|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
56776268|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56776269|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56049013|NCT03000309|Analgesics|analgesics|mesh-ancestor
56045671|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
56045672|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045673|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045674|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56045675|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56045676|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
56045677|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56045678|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56045679|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56045680|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56045681|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56045682|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56045683|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045684|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56045685|NCT02212106|Vaccines|vaccines|mesh-list
56045686|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
56045687|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045689|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56045690|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
56045691|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56045692|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045739|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56045740|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
56045741|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045742|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045743|NCT01535924|Antiviral Agents|antiviral agents|mesh-ancestor
56191080|NCT01472146|Doxorubicin|doxorubicin|mesh-list
56191081|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191085|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191086|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191087|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
56191088|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56191089|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191090|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191091|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56191092|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56191093|NCT01472263|Protective Agents|protective agents|mesh-ancestor
56191094|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191095|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
56191096|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56191097|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
56191098|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56045744|NCT01535924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045745|NCT01535924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045746|NCT01535924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56045747|NCT01535924|Immunologic Factors|immunologic factors|mesh-ancestor
56045748|NCT01535924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045749|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56045750|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
56045752|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56045753|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045754|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045755|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
56045756|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045757|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045758|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56045759|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
56045760|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045762|NCT01536938|Betamethasone|betamethasone|mesh-list
56045763|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
56045764|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56045765|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
56045766|NCT01536938|Calcipotriene|calcipotriene|mesh-list
56045767|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56045768|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045769|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
56776270|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56776271|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776272|NCT00980408|Renal Agents|renal agents|mesh-ancestor
56776273|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56776274|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
56776275|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56776276|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
56776277|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
56776278|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
56776279|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776280|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56776281|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776282|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56776283|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56776284|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776285|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776286|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776287|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56776288|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56776289|NCT05279040|Ivacaftor|ivacaftor|mesh-list
56776290|NCT05279040|Elexacaftor|elexacaftor|mesh-list
56776291|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56776292|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56776293|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776294|NCT03860844|Cytarabine|cytarabine|mesh-list
56776295|NCT03860844|Dexamethasone|dexamethasone|mesh-list
56776296|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
56776297|NCT03860844|Doxorubicin|doxorubicin|mesh-list
56776298|NCT03860844|Methotrexate|methotrexate|mesh-list
56776299|NCT03860844|Fludarabine|fludarabine|mesh-list
56776300|NCT03860844|Etoposide|etoposide|mesh-list
56776301|NCT03860844|Vincristine|vincristine|mesh-list
56776302|NCT03860844|Daunorubicin|daunorubicin|mesh-list
56776303|NCT03860844|Asparaginase|asparaginase|mesh-list
56776304|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
56776305|NCT03860844|Idarubicin|idarubicin|mesh-list
56776306|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
56776307|NCT03860844|Pegaspargase|pegaspargase|mesh-list
56776308|NCT03860844|Montelukast|montelukast|mesh-list
56045770|NCT01536938|Hormones|hormones|mesh-ancestor
56045771|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776309|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56776310|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
56776311|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776312|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776313|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56776314|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
56776315|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776316|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776317|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56776318|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776319|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
56776320|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
56776321|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776322|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56776323|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
56776324|NCT03860844|Hormones|hormones|mesh-ancestor
56776325|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776326|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56776327|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56776328|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56776329|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56776330|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776331|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56776332|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
56776333|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56776334|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56776335|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
56776336|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
56776337|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56776338|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56776351|NCT03860844|Analgesics|analgesics|mesh-ancestor
56776352|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
56776353|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
56776354|NCT05360160|Venetoclax|venetoclax|mesh-list
56776355|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776356|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
56776357|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776358|NCT00989898|Insulin|insulin|mesh-list
56776359|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56776360|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776361|NCT00990054|Plerixafor|plerixafor|mesh-list
56776362|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56776363|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56776364|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
56776365|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776366|NCT03388632|Nivolumab|nivolumab|mesh-list
56776367|NCT03388632|Ipilimumab|ipilimumab|mesh-list
56776368|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776369|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776370|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56049093|NCT03471663|Palbociclib|palbociclib|mesh-list
56045772|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045773|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56045774|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045775|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
56045776|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56045777|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56045778|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045779|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045780|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56045781|NCT01536938|Vitamins|vitamins|mesh-ancestor
56045782|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
56045783|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56045784|NCT02060721|Macitentan|macitentan|mesh-list
56045785|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56045786|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56045787|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045820|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56045821|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56045822|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56045823|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045824|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045825|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56045826|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045827|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045828|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
56045854|NCT02988089|Amoxicillin|amoxicillin|mesh-list
56045863|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56045864|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045865|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56045866|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56045867|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56045868|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045869|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045870|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56776371|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776372|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
56776373|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56776374|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776375|NCT05590572|Etoposide|etoposide|mesh-list
56776376|NCT05590572|Ifosfamide|ifosfamide|mesh-list
56776377|NCT05590572|Isophosphamide mustard|isophosphamide mustard|mesh-list
56776378|NCT05590572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56776379|NCT05590572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776380|NCT05590572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56776381|NCT05590572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56776382|NCT05590572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776383|NCT05590572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776384|NCT05590572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56776385|NCT05590572|Alkylating Agents|alkylating agents|mesh-ancestor
56776386|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
56776387|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56776388|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776389|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776390|NCT05590416|Adalimumab|adalimumab|mesh-list
56776391|NCT05590416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776392|NCT05590416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776393|NCT02910414|Ethanol|ethanol|mesh-list
56776394|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56776395|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776396|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56776397|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776398|NCT00990444|Insulin|insulin|mesh-list
56776399|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56776400|NCT00990444|Dextrans|dextrans|mesh-list
56776401|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56776415|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56776416|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56776417|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56776418|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56776419|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56776420|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56776421|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56776422|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56776424|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
56776425|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56776426|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
56776427|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56776428|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776429|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
56776430|NCT02897076|Hormones|hormones|mesh-ancestor
56776431|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776432|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776433|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56776434|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045871|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56045872|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56045873|NCT02988089|Renal Agents|renal agents|mesh-ancestor
56045874|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56045875|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56045876|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045877|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56045878|NCT02988089|Antacids|antacids|mesh-ancestor
56045879|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56045880|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56045881|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56045916|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045917|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
56045918|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
56045919|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56045920|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56045921|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56045923|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56045959|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045994|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56045995|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045996|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045997|NCT01595516|Metoprolol|metoprolol|mesh-list
56045998|NCT01595516|Nebivolol|nebivolol|mesh-list
56045999|NCT01595516|Bradykinin|bradykinin|mesh-list
56046000|NCT01595516|Kininogens|kininogens|mesh-list
56046001|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046069|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773298|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56046108|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
56046109|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56046145|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
56191100|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56776435|NCT05590260|Iron|iron|mesh-list
56776436|NCT05590260|Trace Elements|trace elements|mesh-ancestor
56776437|NCT05590260|Micronutrients|micronutrients|mesh-ancestor
56776438|NCT05590260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776439|NCT02797548|Aspirin|aspirin|mesh-list
56776440|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56776441|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56776442|NCT02797548|Analgesics|analgesics|mesh-ancestor
56776443|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
56776444|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776445|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776446|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776447|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776448|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56776449|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56776450|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776451|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56776452|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56776453|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776454|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
56776455|NCT00990678|Vitamin D|vitamin d|mesh-list
56776456|NCT00990678|Calcitriol|calcitriol|mesh-list
56776457|NCT00990678|Calcium|calcium|mesh-list
56776458|NCT00990678|Vitamins|vitamins|mesh-ancestor
56191101|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56191102|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56191103|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
56191104|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56191105|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191106|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56191107|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56191108|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56191109|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56191110|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191112|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191113|NCT01472497|Pioglitazone|pioglitazone|mesh-list
56191114|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56191115|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191116|NCT01472510|Ranibizumab|ranibizumab|mesh-list
56191117|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56191118|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56191119|NCT01472510|Growth Substances|growth substances|mesh-ancestor
56191120|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191121|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
56191122|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191125|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191126|NCT01472640|Incretins|incretins|mesh-ancestor
56191127|NCT01472640|Hormones|hormones|mesh-ancestor
56213196|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
56046146|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56046148|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046149|NCT03008889|Protective Agents|protective agents|mesh-ancestor
56046177|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
56776459|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
56776460|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776461|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56776462|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56776463|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56776464|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56776465|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776466|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56776467|NCT00538590|Mitomycins|mitomycins|mesh-list
56776468|NCT00538590|Mitomycin|mitomycin|mesh-list
56776469|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56776470|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776471|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
56776472|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776473|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56776474|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776475|NCT00990834|Simvastatin|simvastatin|mesh-list
56776476|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56776477|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56776478|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
56776479|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776480|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56776481|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56776507|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
56776508|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56776509|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
56776510|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56776511|NCT01829568|Rituximab|rituximab|mesh-list
56776512|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56776513|NCT01829568|Lenalidomide|lenalidomide|mesh-list
56776514|NCT01829568|Antibodies|antibodies|mesh-list
56776515|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
56776516|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56776517|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
56776518|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776519|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776520|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776521|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56776522|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56776523|NCT01829568|Growth Substances|growth substances|mesh-ancestor
56776524|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
56776525|NCT00848328|Rituximab|rituximab|mesh-list
56776526|NCT00848328|Lenalidomide|lenalidomide|mesh-list
56776527|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776528|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776529|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
56776530|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046178|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56046179|NCT02918097|Risperidone|risperidone|mesh-list
56046180|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
56046182|NCT02918097|Nortriptyline|nortriptyline|mesh-list
56046183|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56046184|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
56046185|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046186|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046187|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046188|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56046189|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56046190|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046191|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56191128|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56191129|NCT01472653|Cetuximab|cetuximab|mesh-list
56191130|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191131|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56191132|NCT01472666|Caseins|caseins|mesh-list
56191133|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
56191134|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
56191135|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191136|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56191137|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
56191138|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191139|NCT01472770|Gemcitabine|gemcitabine|mesh-list
56191140|NCT01472770|Capecitabine|capecitabine|mesh-list
56191141|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56191142|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
56046192|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56776531|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776532|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56776533|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56776534|NCT00848328|Growth Substances|growth substances|mesh-ancestor
56776535|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
56776536|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56776537|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
56776538|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776539|NCT00989352|Rituximab|rituximab|mesh-list
56776540|NCT00989352|Methotrexate|methotrexate|mesh-list
56776541|NCT00989352|Lomustine|lomustine|mesh-list
56776542|NCT00989352|Procarbazine|procarbazine|mesh-list
56776543|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776544|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776545|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
56776546|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776547|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776548|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56776549|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
56776550|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56776551|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56776552|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
56776553|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776554|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
56776555|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776556|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56049272|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
56046193|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
56046194|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
56046195|NCT02918097|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56046196|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56046197|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56046198|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046199|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
56046237|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56046271|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56046273|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
56046274|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56046275|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56046276|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56046277|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56046278|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56046279|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56046280|NCT03019887|Analgesics|analgesics|mesh-ancestor
56046300|NCT02920749|Propofol|propofol|mesh-list
56046301|NCT02920749|Sevoflurane|sevoflurane|mesh-list
56046302|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046303|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776557|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56776558|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56776559|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56776560|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
56776561|NCT05566626|Tropicamide|tropicamide|mesh-list
56776562|NCT05566626|Mydriatics|mydriatics|mesh-ancestor
56776563|NCT05566626|Autonomic Agents|autonomic agents|mesh-ancestor
56776564|NCT05566626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776565|NCT05566626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776566|NCT05566626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56776567|NCT05566626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56776568|NCT05566626|Cholinergic Agents|cholinergic agents|mesh-ancestor
56776569|NCT05566626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776570|NCT05566626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776571|NCT00989508|Perhexiline|perhexiline|mesh-list
56776572|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56776573|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56776574|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776575|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56776576|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776577|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
56776578|NCT05360394|Paclitaxel|paclitaxel|mesh-list
56776579|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56776580|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56776581|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776582|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
56776583|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
56776584|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
56776585|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776586|NCT00090259|Losartan|losartan|mesh-list
56776587|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56776588|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56776589|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56776590|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56776591|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776592|NCT00079183|Sirolimus|sirolimus|mesh-list
56776593|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56776594|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776595|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56776596|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776597|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
56776598|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56776599|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
56776600|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776601|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56776602|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
56776603|NCT01086085|Adefovir|adefovir|mesh-list
56776604|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
56776605|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776606|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
56776607|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776608|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56049331|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56046304|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56046305|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56046306|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
56046307|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56046308|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56046309|NCT02248142|Pramipexole|pramipexole|mesh-list
56046310|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
56046311|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046312|NCT02248142|Protective Agents|protective agents|mesh-ancestor
56046313|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046314|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56046315|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56046316|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
56046317|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
56046318|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046319|NCT04667780|Colchicine|colchicine|mesh-list
56046320|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
56046321|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56046322|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
56046323|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
56046324|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
56046325|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191143|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191144|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191145|NCT01472770|Antiviral Agents|antiviral agents|mesh-ancestor
56191146|NCT01472770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191147|NCT01472770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191148|NCT01472770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191149|NCT01472770|Immunologic Factors|immunologic factors|mesh-ancestor
56191150|NCT01472770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191152|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56191153|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213197|NCT02811263|Hematinics|hematinics|mesh-ancestor
56046326|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046327|NCT02248220|Pramipexole|pramipexole|mesh-list
56046328|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
56046329|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046330|NCT02248220|Protective Agents|protective agents|mesh-ancestor
56046331|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046332|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56776609|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56776610|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776611|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776612|NCT01589419|Capecitabine|capecitabine|mesh-list
56776613|NCT01589419|Veliparib|veliparib|mesh-list
56776614|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56776615|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
56776616|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776617|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776618|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56776619|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776620|NCT00676403|Pregabalin|pregabalin|mesh-list
56776621|NCT00676403|Analgesics|analgesics|mesh-ancestor
56776622|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
56776623|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776624|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776625|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
56776626|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56776627|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56776628|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776629|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56046333|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56046334|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
56046335|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
56046336|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046337|NCT02921061|Cytarabine|cytarabine|mesh-list
56046338|NCT02921061|Decitabine|decitabine|mesh-list
56046431|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56046432|NCT03003884|Propofol|propofol|mesh-list
56046433|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56046434|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046435|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046436|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56046437|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
56046438|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
56046439|NCT01880723|Albuterol|albuterol|mesh-list
56046440|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56046441|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
56046442|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046443|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046444|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56046445|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
56046446|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
56046447|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56046448|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56046449|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56046450|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56046451|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
56046489|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046490|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046491|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776630|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56776632|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56776633|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56776634|NCT00078949|Gemcitabine|gemcitabine|mesh-list
56776635|NCT00078949|Cytarabine|cytarabine|mesh-list
56776636|NCT00078949|Dexamethasone|dexamethasone|mesh-list
56776637|NCT00078949|Rituximab|rituximab|mesh-list
56776638|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776639|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776640|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
56776641|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776642|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776643|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776644|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
56776645|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
56776646|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776647|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56776648|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
56776649|NCT00078949|Hormones|hormones|mesh-ancestor
56776650|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776651|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56776652|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56776653|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
56776654|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776655|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
56776656|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776657|NCT00078949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776658|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56776659|NCT00078325|Modafinil|modafinil|mesh-list
56776660|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56776661|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776662|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56776663|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56776664|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56046493|NCT05140694|Dulaglutide|dulaglutide|mesh-list
56046494|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56046495|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56046496|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046497|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56776665|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776666|NCT03963193|Cisplatin|cisplatin|mesh-list
56776667|NCT03963193|Irinotecan|irinotecan|mesh-list
56776668|NCT03963193|Etoposide|etoposide|mesh-list
56776669|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776670|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56776671|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56776672|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776673|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776674|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56776675|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56776676|NCT03961867|Docetaxel|docetaxel|mesh-list
56776677|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
56776678|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776679|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
56776680|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
56776681|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
56776682|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046498|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046499|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
56046500|NCT02987699|Leucovorin|leucovorin|mesh-list
56046501|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
56046502|NCT02987699|Fluorouracil|fluorouracil|mesh-list
56046503|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
56046504|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046505|NCT02987699|Antidotes|antidotes|mesh-ancestor
56046506|NCT02987699|Protective Agents|protective agents|mesh-ancestor
56046507|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191154|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191155|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046508|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
56046509|NCT02987699|Vitamins|vitamins|mesh-ancestor
56046510|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
56046513|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56046515|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
56046516|NCT03003728|Melphalan|melphalan|mesh-list
56046517|NCT03003728|Elotuzumab|elotuzumab|mesh-list
56046518|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56046519|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
56046580|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56046581|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56046583|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
56046584|NCT03028467|Vitamins|vitamins|mesh-ancestor
56046585|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
56046586|NCT04327310|Meplazumab|meplazumab|mesh-list
56046587|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
56046588|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046589|NCT02222870|Vaccines|vaccines|mesh-list
56046590|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
56046591|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046592|NCT02223260|Dabigatran|dabigatran|mesh-list
56046593|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
56046594|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56046595|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
56046596|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046597|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046598|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
56046599|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
56046600|NCT02863263|Povidone|povidone|mesh-list
56046601|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
56776683|NCT00077857|Docetaxel|docetaxel|mesh-list
56776684|NCT00077857|Capecitabine|capecitabine|mesh-list
56776685|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776686|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
56776687|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
56776688|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
56776689|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776690|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56776691|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
56776692|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
56776693|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56776694|NCT00545402|Tacrolimus|tacrolimus|mesh-list
56776695|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56776696|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
56776697|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776698|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56776699|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776700|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776701|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56776702|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776703|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56776704|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
56487642|NCT00541281|Hormones|hormones|mesh-ancestor
56776705|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56776706|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776707|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776708|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
56776709|NCT00545402|Hormones|hormones|mesh-ancestor
56776710|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776711|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56776712|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56776713|NCT00545402|Protective Agents|protective agents|mesh-ancestor
56776714|NCT03963115|Epinephrine|epinephrine|mesh-list
56776715|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56049434|NCT04645667|Tacrolimus|tacrolimus|mesh-list
56776721|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56776722|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56776723|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
56776724|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776725|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56776726|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
56776727|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
56776728|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
56776729|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56776730|NCT01583023|Bupropion|bupropion|mesh-list
56776731|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56776732|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
56776733|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56776734|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56776735|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56776736|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56776737|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776738|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
56776739|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776740|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776741|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56776742|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56776743|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776744|NCT00976976|Cisplatin|cisplatin|mesh-list
56776745|NCT00976976|Docetaxel|docetaxel|mesh-list
56776746|NCT00976976|Capecitabine|capecitabine|mesh-list
56776747|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776748|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
56776749|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
56776750|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
56776751|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776752|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56776753|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
56776754|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56776761|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
56776762|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776763|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
56776764|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776765|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776766|NCT00977132|Lenalidomide|lenalidomide|mesh-list
56776767|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
56776768|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776769|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56776770|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56776771|NCT00977132|Growth Substances|growth substances|mesh-ancestor
56776772|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
56776773|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776774|NCT00545792|Bevacizumab|bevacizumab|mesh-list
56776775|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776776|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776777|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56776778|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56776779|NCT00545792|Growth Substances|growth substances|mesh-ancestor
56776780|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776781|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
56776782|NCT00977288|Atorvastatin|atorvastatin|mesh-list
56776783|NCT00977288|Anacetrapib|anacetrapib|mesh-list
56776784|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56776785|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56776786|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
56776787|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776788|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56776789|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56776790|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776791|NCT00966602|Ivacaftor|ivacaftor|mesh-list
56776792|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56776793|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56776794|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046602|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
56046603|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56046604|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046605|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
56776795|NCT00966680|Anesthetics|anesthetics|mesh-list
56776796|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56776797|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776798|NCT00977444|Prednisolone|prednisolone|mesh-list
56776799|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56776800|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
56776801|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56776802|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
56776803|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56776804|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
56776805|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776806|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
56776807|NCT00977444|Hormones|hormones|mesh-ancestor
56776808|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776809|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776810|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56776811|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776812|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
56776813|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
56776814|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776815|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56776816|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56776817|NCT00977444|Protective Agents|protective agents|mesh-ancestor
56776818|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55880682|NCT05565664|Ketamine|ketamine|mesh-list
56046606|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56046607|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046643|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56046644|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56046750|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046752|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046753|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046754|NCT05672108|Mitomycins|mitomycins|mesh-list
56046755|NCT05672108|Mitomycin|mitomycin|mesh-list
56046756|NCT05672108|Ethiodized Oil|ethiodized oil|mesh-list
56046757|NCT05672108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56046758|NCT05672108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046792|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046793|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046794|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
56046829|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046831|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
56046861|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046863|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
56046864|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046865|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56046866|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56046867|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
56046868|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55949082|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
56776819|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776820|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
56776821|NCT00966836|Valganciclovir|valganciclovir|mesh-list
56776822|NCT00966836|Everolimus|everolimus|mesh-list
56776823|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776824|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56776825|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
56776826|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776827|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56776828|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56776829|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
56776830|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56776831|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776832|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776833|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776834|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
56776835|NCT00967070|Nicotine|nicotine|mesh-list
56776836|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56776837|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
56776838|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776839|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776840|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56776841|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56776842|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
56776843|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049565|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046869|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56046870|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56046871|NCT02870283|Carbamazepine|carbamazepine|mesh-list
56046872|NCT02870283|Valproic Acid|valproic acid|mesh-list
56046873|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56046874|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046875|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046974|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
56191156|NCT01472796|Vitamin D|vitamin d|mesh-list
56191157|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
56191158|NCT01472796|Vitamins|vitamins|mesh-ancestor
56191159|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
56191160|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191161|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56191162|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56191163|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56191164|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
56191165|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56191166|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
56191167|NCT01472913|Coagulants|coagulants|mesh-ancestor
56191168|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56191169|NCT01472926|Plasminogen|plasminogen|mesh-list
56191170|NCT01472926|Tenecteplase|tenecteplase|mesh-list
56191171|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56191172|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56776844|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776845|NCT00977756|Ritonavir|ritonavir|mesh-list
56776846|NCT00977756|Lopinavir|lopinavir|mesh-list
56776847|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56776848|NCT00977756|Darunavir|darunavir|mesh-list
56776849|NCT00977756|Tenofovir|tenofovir|mesh-list
56776850|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
56776851|NCT00977756|Maraviroc|maraviroc|mesh-list
56776852|NCT00977756|Etravirine|etravirine|mesh-list
56776853|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56776854|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56776855|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
56776856|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776857|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776858|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56776859|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56776860|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
56776861|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776862|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56776863|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56776864|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56776865|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56776866|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56776867|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56776868|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56776869|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56046975|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046976|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
56046977|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046978|NCT04350671|Interferons|interferons|mesh-list
56046979|NCT04350671|Ritonavir|ritonavir|mesh-list
56046980|NCT04350671|Lopinavir|lopinavir|mesh-list
56046981|NCT04350671|Interferon-beta|interferon-beta|mesh-list
56046982|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
56046983|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
56046984|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046985|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
56046986|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047002|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56047003|NCT04850846|Metformin|metformin|mesh-list
56047004|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56047005|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047007|NCT05166083|Androgens|androgens|mesh-ancestor
56047008|NCT05166083|Hormones|hormones|mesh-ancestor
56047009|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047010|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047011|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56047012|NCT04826354|Ezetimibe|ezetimibe|mesh-list
56047013|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56047014|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56047015|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
55950390|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
56776870|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56776871|NCT00967148|Tinzaparin|tinzaparin|mesh-list
56776872|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56776873|NCT00967148|Dalteparin|dalteparin|mesh-list
56776874|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
56776875|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56776876|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56776877|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776878|NCT04007588|Nivolumab|nivolumab|mesh-list
56776879|NCT04007588|Ipilimumab|ipilimumab|mesh-list
56776880|NCT04007588|Linrodostat|linrodostat|mesh-list
56776881|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56776882|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776883|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56776884|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776885|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776886|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
56776887|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776888|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
56049624|NCT02314169|Nivolumab|nivolumab|mesh-list
56047016|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047017|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56047018|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56047019|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047020|NCT04707794|Sevoflurane|sevoflurane|mesh-list
56047021|NCT04707794|Desflurane|desflurane|mesh-list
56047022|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56047023|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56047024|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
56047025|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
56047026|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047027|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047028|NCT04667312|Durvalumab|durvalumab|mesh-list
56047029|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56047030|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047031|NCT02759588|Bevacizumab|bevacizumab|mesh-list
56047032|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56047033|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047034|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56047035|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56191173|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191174|NCT01472978|Metronidazole|metronidazole|mesh-list
56191175|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191176|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56191177|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56191178|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56191179|NCT01473043|Axitinib|axitinib|mesh-list
56191180|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191181|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56191182|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191183|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191184|NCT01473069|Ketoconazole|ketoconazole|mesh-list
56191185|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
56191186|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191187|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56047036|NCT02759588|Growth Substances|growth substances|mesh-ancestor
56776889|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776890|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776891|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56776892|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
56776893|NCT04928300|Ketamine|ketamine|mesh-list
56776894|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56776895|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56776896|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776897|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56776898|NCT04928300|Analgesics|analgesics|mesh-ancestor
56776899|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
56776900|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776901|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56776902|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56776903|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56776904|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
56776905|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776906|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776907|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56776908|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56776909|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
56776910|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
56776911|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56776912|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56047037|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047038|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
56047039|NCT03045861|Cobicistat|cobicistat|mesh-list
56047040|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
56047041|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56047042|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56047043|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
56047044|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047046|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56047083|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56047084|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
56047085|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56047121|NCT02247596|Resveratrol|resveratrol|mesh-list
56047122|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
56047123|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047124|NCT02247596|Protective Agents|protective agents|mesh-ancestor
56047158|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
56047159|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56047160|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56047161|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
56047162|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
56047163|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047164|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047165|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56776913|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
56776914|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56776915|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776916|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56776917|NCT00967382|Dalteparin|dalteparin|mesh-list
56776918|NCT00967382|Tinzaparin|tinzaparin|mesh-list
56776919|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56776920|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
56776921|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56776922|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56776923|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776924|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
56776925|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56776926|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776927|NCT00982202|Pioglitazone|pioglitazone|mesh-list
56776928|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56776929|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047166|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
56047167|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
56047206|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56047238|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
56047239|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047240|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047241|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
56047242|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56047243|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047244|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047245|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56047246|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047247|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047248|NCT00555971|Omalizumab|omalizumab|mesh-list
56047284|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047285|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047286|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
56047287|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
56047288|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
56191188|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56191189|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191190|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191191|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56191192|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
56191193|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56191194|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191195|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56191196|NCT01473147|Exenatide|exenatide|mesh-list
56191197|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56191198|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191199|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56191200|NCT01473147|Incretins|incretins|mesh-ancestor
56191201|NCT01473147|Hormones|hormones|mesh-ancestor
56191202|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56191203|NCT01473173|Esomeprazole|esomeprazole|mesh-list
56191204|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56191205|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191206|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56191207|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950735|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776930|NCT00967538|Etanercept|etanercept|mesh-list
56776931|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56776932|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56776933|NCT00967538|Analgesics|analgesics|mesh-ancestor
56776934|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
56776935|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56776936|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776937|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56776938|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56776939|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56776940|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56776941|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
56776942|NCT00982358|Valsartan|valsartan|mesh-list
56776943|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56776944|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56776945|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56776946|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776947|NCT00982436|Carboplatin|carboplatin|mesh-list
56776948|NCT00982436|Docetaxel|docetaxel|mesh-list
56776949|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191208|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047320|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
56047321|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56047322|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56047323|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56047324|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047325|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047326|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
56047327|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56047328|NCT05376722|Prednisone|prednisone|mesh-list
56047329|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047359|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
56047361|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047362|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56047363|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56047364|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047366|NCT02949921|Lidocaine|lidocaine|mesh-list
56047367|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
56047368|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
56047369|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047370|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047371|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
56047405|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56047406|NCT01930487|Antioxidants|antioxidants|mesh-list
56047407|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047408|NCT01930487|Protective Agents|protective agents|mesh-ancestor
56047409|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047410|NCT03864068|Inositol|inositol|mesh-list
56191210|NCT01473251|Ranibizumab|ranibizumab|mesh-list
56191211|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56191212|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191213|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56191214|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56191215|NCT01473251|Growth Substances|growth substances|mesh-ancestor
55957187|NCT02250807|Simeprevir|simeprevir|mesh-list
56776950|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
56776951|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
56776952|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
56776953|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776954|NCT00545168|Permethrin|permethrin|mesh-list
56776955|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776956|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776957|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56776958|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56776959|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56776960|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
56776961|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776962|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56776963|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56776964|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776965|NCT00983138|Asparaginase|asparaginase|mesh-list
56776966|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776967|NCT00544544|Riluzole|riluzole|mesh-list
56776968|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
56776969|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56776970|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56049697|NCT02175173|Rufinamide|rufinamide|mesh-list
56191216|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191217|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
56191218|NCT01473277|Triamcinolone|triamcinolone|mesh-list
56191219|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56191220|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56191221|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56191222|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56191223|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56191224|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
56191225|NCT01473277|Hormones|hormones|mesh-ancestor
56191226|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56191227|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191228|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191229|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
56191230|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191231|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191232|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56191233|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56191234|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
56191235|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191236|NCT01473303|Leucovorin|leucovorin|mesh-list
56191237|NCT01473303|Fluorouracil|fluorouracil|mesh-list
56191238|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
56191239|NCT01473303|Irinotecan|irinotecan|mesh-list
56047411|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
56047412|NCT03864068|Vitamins|vitamins|mesh-ancestor
56047413|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
56047414|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047415|NCT03063255|Anesthetics|anesthetics|mesh-list
56047445|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56047447|NCT01915823|Fluticasone|fluticasone|mesh-list
56776971|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776972|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776973|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776974|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56776975|NCT00544544|Protective Agents|protective agents|mesh-ancestor
56776976|NCT00979160|Dasatinib|dasatinib|mesh-list
56776977|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56776978|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56776979|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776980|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776981|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
56776982|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56776983|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56776984|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56776985|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56776986|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56776987|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776988|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049715|NCT04121403|Rituximab|rituximab|mesh-list
56047448|NCT01915823|Xhance|xhance|mesh-list
56047449|NCT01915823|Azelastine|azelastine|mesh-list
56047450|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047451|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56047452|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
56047453|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047454|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047455|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56191240|NCT01473303|Calcium|calcium|mesh-list
56191241|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
56191242|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56191243|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191244|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
56191245|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191246|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56191247|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191248|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191249|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
56191250|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56191251|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56191252|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191253|NCT01473303|Antidotes|antidotes|mesh-ancestor
56191254|NCT01473303|Protective Agents|protective agents|mesh-ancestor
56191255|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
56191256|NCT01473303|Vitamins|vitamins|mesh-ancestor
56191259|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
56191260|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191261|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56191262|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56191263|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191264|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191265|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56191266|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
56191267|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213198|NCT02650271|Tenofovir|tenofovir|mesh-list
56776989|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56776990|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56776991|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
56776992|NCT00983450|Hormones|hormones|mesh-ancestor
56776993|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56776994|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56776995|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56776996|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56776997|NCT00983996|Alendronate|alendronate|mesh-list
56776998|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56776999|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777000|NCT00985244|Azithromycin|azithromycin|mesh-list
56777001|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777002|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777003|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
56777004|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56777005|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56777006|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
56777007|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777008|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777009|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777010|NCT00979472|Urological Agents|urological agents|mesh-ancestor
56777011|NCT00984152|Efavirenz|efavirenz|mesh-list
56777012|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56777013|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
56777014|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56777015|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56777016|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777017|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777018|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
56777019|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777020|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56777021|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56777024|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56777025|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56777026|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56777027|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56777028|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56777029|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56777030|NCT00985322|Ramipril|ramipril|mesh-list
56777031|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
56777032|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56777033|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
56777034|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777035|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777036|NCT00984230|Lactoferrin|lactoferrin|mesh-list
56777037|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047456|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
56047457|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
56047458|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56047459|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56047490|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047491|NCT01934231|Amoxicillin|amoxicillin|mesh-list
56047492|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
56047493|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
56047494|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56047495|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56047496|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047497|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56047498|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047499|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047500|NCT01935791|Glucagon|glucagon|mesh-list
56047501|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56047502|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56047503|NCT01935791|Hormones|hormones|mesh-ancestor
56047504|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047528|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047529|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047530|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
56047531|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047532|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56047533|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56047534|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56047535|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56047536|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047537|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56047538|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56047539|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
56047540|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047541|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56047542|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56047543|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
56047544|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56047545|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
56047546|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
56047547|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
56047548|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56047549|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
56047550|NCT01691534|Clofazimine|clofazimine|mesh-list
56047551|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
56047552|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56047553|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047554|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777038|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56777039|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56777040|NCT00984386|Estradiol|estradiol|mesh-list
56777041|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56777042|NCT00984386|Estrogens|estrogens|mesh-ancestor
56777043|NCT00984386|Hormones|hormones|mesh-ancestor
56049783|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
56047555|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
56047556|NCT01691690|Acetaminophen|acetaminophen|mesh-list
56047557|NCT01691690|Dexamethasone|dexamethasone|mesh-list
56047558|NCT01691690|Midazolam|midazolam|mesh-list
56047559|NCT01691690|Morphine|morphine|mesh-list
56047632|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
56047633|NCT01626092|Melphalan|melphalan|mesh-list
56047700|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56047701|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
56047702|NCT01921751|Antiviral Agents|antiviral agents|mesh-ancestor
56047703|NCT01921751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047704|NCT01921751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047705|NCT01921751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56047706|NCT01921751|Immunologic Factors|immunologic factors|mesh-ancestor
56047707|NCT01921751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047708|NCT02958345|Vaccines|vaccines|mesh-list
56047710|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047711|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
56047712|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56047713|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
56047714|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047715|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
56047747|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
56047748|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047750|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56047751|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
56047752|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56047753|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
56047754|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047755|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047756|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
56047757|NCT01924871|Remifentanil|remifentanil|mesh-list
56047758|NCT01924871|Desflurane|desflurane|mesh-list
56047759|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56047760|NCT01924871|Narcotics|narcotics|mesh-ancestor
56047796|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56047797|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56047798|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56047799|NCT01938989|Hormones|hormones|mesh-ancestor
56047825|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56047826|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56047827|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56047828|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56191268|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191269|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56191271|NCT01473472|Emtricitabine|emtricitabine|mesh-list
56191272|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56191273|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
56191274|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191275|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56191276|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56191277|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191278|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191279|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56191280|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56191281|NCT01473537|Calcium|calcium|mesh-list
56191282|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56191283|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191284|NCT01473797|Cladribine|cladribine|mesh-list
56047829|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047830|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
56047831|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047832|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56047833|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56777044|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777045|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777046|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56777047|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
56777048|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56777049|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56777050|NCT00984464|Paclitaxel|paclitaxel|mesh-list
56777051|NCT00984464|Carboplatin|carboplatin|mesh-list
56777052|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56777053|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777054|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
56777055|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
56777056|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
56777057|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777058|NCT00985556|Capecitabine|capecitabine|mesh-list
56777059|NCT00985556|Tegafur|tegafur|mesh-list
56777060|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
56777061|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56777062|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
56777063|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777064|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047834|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047835|NCT01926977|Ranibizumab|ranibizumab|mesh-list
56047836|NCT01926977|Aflibercept|aflibercept|mesh-list
56047837|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56047838|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56047839|NCT01926977|Growth Substances|growth substances|mesh-ancestor
56047840|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047841|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
56047842|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047843|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
56047844|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
56047845|NCT01928693|Besifloxacin|besifloxacin|mesh-list
56047846|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56047864|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
56047865|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047866|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047867|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
56047868|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047869|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047870|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
56047871|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56047872|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047873|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56047875|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56047876|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047879|NCT01944293|Analgesics|analgesics|mesh-ancestor
56047880|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
56047881|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047882|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047883|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56047884|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56047885|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
56777065|NCT05537402|Bevacizumab|bevacizumab|mesh-list
56777066|NCT05537402|Atezolizumab|atezolizumab|mesh-list
56777067|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56049808|NCT01769027|Sertraline|sertraline|mesh-list
56047886|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
56191285|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191286|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191288|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047887|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047888|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56047889|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56047890|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047891|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047892|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56047893|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56047894|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56047895|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56047896|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56047897|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
56047898|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
56047899|NCT01944371|Disulfiram|disulfiram|mesh-list
56047900|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56047901|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56047902|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047921|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047922|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56047924|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047925|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047926|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56047927|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56047928|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56047929|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56047930|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
56047931|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
56047932|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047933|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56047934|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
56047935|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56047936|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047937|NCT03076112|Incretins|incretins|mesh-ancestor
56047938|NCT03076112|Hormones|hormones|mesh-ancestor
56047939|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047940|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56047941|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
56047942|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047943|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047944|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56047945|NCT03129945|Indomethacin|indomethacin|mesh-list
56047946|NCT03129945|Nifedipine|nifedipine|mesh-list
56047947|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56047948|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56047949|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047950|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56047951|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047952|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
56047953|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
56047954|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56047955|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56047956|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56047957|NCT03129945|Analgesics|analgesics|mesh-ancestor
56048005|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56048006|NCT05482451|Nivolumab|nivolumab|mesh-list
56048007|NCT05482451|Tretinoin|tretinoin|mesh-list
56048008|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56048009|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048010|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56048011|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048012|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
56048046|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
56048047|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56191289|NCT01473810|Endocine|endocine|mesh-list
56777068|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777069|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56777070|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56777071|NCT05537402|Growth Substances|growth substances|mesh-ancestor
56777072|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777073|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
56777074|NCT04445246|Iloprost|iloprost|mesh-list
56777075|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56777076|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
56777077|NCT00541346|Methylphenidate|methylphenidate|mesh-list
56777078|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56777079|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777080|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56777081|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56777082|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56049811|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
56191290|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56191291|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
56191292|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191293|NCT01473901|Temozolomide|temozolomide|mesh-list
56191294|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56191295|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
56191296|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191297|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191298|NCT01473914|Vitamins|vitamins|mesh-list
56191299|NCT01473914|Vitamin E|vitamin e|mesh-list
56191300|NCT01473914|Tocopherols|tocopherols|mesh-list
56191301|NCT01473914|Tocotrienols|tocotrienols|mesh-list
56191302|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
56191303|NCT01473914|Zinc|zinc|mesh-list
56191304|NCT01473914|Selenium|selenium|mesh-list
56191305|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
56191306|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048048|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56048049|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56048050|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56048051|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56048052|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56048053|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56048054|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56048055|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56048056|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
56048057|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56048071|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
56048072|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048073|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56048074|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
55775249|NCT03175705|Interleukin-2|interleukin-2|mesh-list
56048075|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56048076|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56048077|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56048078|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
56048079|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048080|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048081|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56048082|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
56048083|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
56048084|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
56777083|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777084|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
56777085|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777086|NCT00988520|Bromides|bromides|mesh-list
56777087|NCT00988520|Propofol|propofol|mesh-list
56777088|NCT00988520|Sevoflurane|sevoflurane|mesh-list
56777089|NCT00988520|Rocuronium|rocuronium|mesh-list
56777090|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56777091|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777092|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777093|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56777094|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
56777095|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
56777096|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56049826|NCT04706949|Carboplatin|carboplatin|mesh-list
56048085|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56048086|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56048087|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
56048088|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048089|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048090|NCT02389764|Nintedanib|nintedanib|mesh-list
56048091|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048092|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56048093|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048094|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048095|NCT04903470|Bisacodyl|bisacodyl|mesh-list
56048096|NCT04903470|Cathartics|cathartics|mesh-ancestor
56048097|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048098|NCT04903470|Laxatives|laxatives|mesh-ancestor
56048099|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56048100|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56191307|NCT01473914|Trace Elements|trace elements|mesh-ancestor
56191308|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
56191309|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191310|NCT01473914|Protective Agents|protective agents|mesh-ancestor
56191311|NCT01474174|Vaccines|vaccines|mesh-list
56191312|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
56191313|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191314|NCT01474187|Capecitabine|capecitabine|mesh-list
56191315|NCT01474187|Irinotecan|irinotecan|mesh-list
56191316|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56191317|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
56191318|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048101|NCT01647932|Diuretics|diuretics|mesh-ancestor
56048102|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
56048108|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
56048109|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56048110|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048111|NCT02366130|Denosumab|denosumab|mesh-list
56048112|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56048113|NCT02366130|Hormones|hormones|mesh-list
56048114|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048115|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048116|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56048117|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048118|NCT01635062|Calcitriol|calcitriol|mesh-list
56048119|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56048120|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56048156|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56048157|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048158|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
56777097|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56777098|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
56777099|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56777100|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56777101|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56777102|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777103|NCT05498090|Fenofibrate|fenofibrate|mesh-list
56777104|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56777105|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
56777106|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777107|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56777108|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
56777109|NCT00077623|Hematinics|hematinics|mesh-ancestor
56777110|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
56777111|NCT00541034|Rituximab|rituximab|mesh-list
56777112|NCT00541034|Pentostatin|pentostatin|mesh-list
56777113|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777114|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
56777115|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048159|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048160|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048162|NCT01639352|Hormones|hormones|mesh-ancestor
56048163|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048164|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048165|NCT01705496|Fialuridine|fialuridine|mesh-list
56048166|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
56048167|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048168|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56048169|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048170|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048171|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56048172|NCT02287415|Warfarin|warfarin|mesh-list
56048173|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
56048174|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
56048175|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56048176|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56048177|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56048178|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048179|NCT02312934|Nicotine|nicotine|mesh-list
56048180|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56048181|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
56048182|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048183|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048221|NCT02978157|Bismuth|bismuth|mesh-list
56191319|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191320|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56048222|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56048223|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048295|NCT01706588|Analgesics|analgesics|mesh-ancestor
56048296|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
56048297|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048298|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048299|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56048300|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56048301|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56048302|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777116|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777117|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56777118|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
56777119|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777120|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777121|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56777122|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56777123|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56777124|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777125|NCT00540644|Prednisone|prednisone|mesh-list
56777126|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
56777127|NCT00540644|Lenalidomide|lenalidomide|mesh-list
56777128|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777129|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
56777130|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777131|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777132|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56777133|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
56777134|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777135|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777136|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56777137|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777138|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
56777139|NCT00540644|Hormones|hormones|mesh-ancestor
56777140|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777141|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56777142|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56049857|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
56048303|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048304|NCT05405439|Prednisone|prednisone|mesh-list
56048305|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
56048306|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56048307|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
56048308|NCT05405439|Hormones|hormones|mesh-ancestor
56048309|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048345|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56048346|NCT01603940|Losartan|losartan|mesh-list
56048347|NCT01603940|Benazepril|benazepril|mesh-list
56048385|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
56048386|NCT01706666|Hormones|hormones|mesh-ancestor
56048387|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048388|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56048571|NCT01642238|Clopidogrel|clopidogrel|mesh-list
56048572|NCT01642238|Ticagrelor|ticagrelor|mesh-list
56048635|NCT05736419|Fludarabine|fludarabine|mesh-list
56048636|NCT05736419|Bortezomib|bortezomib|mesh-list
56777143|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56777144|NCT00540644|Growth Substances|growth substances|mesh-ancestor
56777145|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
56777146|NCT05470400|Vaccines|vaccines|mesh-list
56777147|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
56777148|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777149|NCT05450900|Biotin|biotin|mesh-list
56777150|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56777151|NCT05450900|Vitamins|vitamins|mesh-ancestor
56488094|NCT02352558|Dexamethasone|dexamethasone|mesh-list
56777152|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
56777153|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777154|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
56777155|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56777156|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
56777157|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
56777158|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56777159|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56777160|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777161|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56777162|NCT00986336|Topiramate|topiramate|mesh-list
56777163|NCT00986336|Risperidone|risperidone|mesh-list
56777164|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56777165|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
56777166|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777167|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777168|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777169|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56777170|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56777171|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777172|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56777173|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56777187|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
56777188|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777189|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777190|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
56777191|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777192|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777193|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
56777194|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777195|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56777196|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
56777197|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56777198|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777199|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
56777200|NCT00543296|Hormones|hormones|mesh-ancestor
56777201|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777202|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777203|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
56777204|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
56777205|NCT00543062|Loxapine|loxapine|mesh-list
56777206|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777207|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777208|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56777209|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56777210|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777211|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777212|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777213|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777214|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
56777232|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777233|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777234|NCT00676091|Vaccines|vaccines|mesh-list
56777235|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56777236|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
56777237|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777238|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56777239|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
56777240|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777241|NCT02558933|Protective Agents|protective agents|mesh-ancestor
56777242|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777243|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56777244|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56777245|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777246|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56777247|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
56777248|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56777249|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777250|NCT00678041|Renal Agents|renal agents|mesh-ancestor
56777251|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777252|NCT03903822|PF-06700841|pf-06700841|mesh-list
56777253|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56777254|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777255|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777256|NCT04249427|Erenumab|erenumab|mesh-list
56777257|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56777258|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777259|NCT04249427|Analgesics|analgesics|mesh-ancestor
56777260|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
56777261|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777262|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777263|NCT04003350|Acetaminophen|acetaminophen|mesh-list
56777264|NCT04003350|Meloxicam|meloxicam|mesh-list
56777265|NCT04003350|Oxycodone|oxycodone|mesh-list
56777266|NCT04003350|Tramadol|tramadol|mesh-list
56777267|NCT04003350|Gabapentin|gabapentin|mesh-list
56777268|NCT04003350|Esomeprazole|esomeprazole|mesh-list
56777270|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56777271|NCT04003350|Narcotics|narcotics|mesh-ancestor
56777272|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777273|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048637|NCT05736419|Tacrolimus|tacrolimus|mesh-list
56048638|NCT05736419|Thymoglobulin|thymoglobulin|mesh-list
56048639|NCT05736419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56048640|NCT05736419|Immunologic Factors|immunologic factors|mesh-ancestor
56048641|NCT05736419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048642|NCT05736419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56048643|NCT05736419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56048644|NCT05736419|Alkylating Agents|alkylating agents|mesh-ancestor
56048645|NCT05736419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048646|NCT05736419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048647|NCT05736419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56048648|NCT05736419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56048666|NCT02986685|Trimebutine|trimebutine|mesh-list
56048667|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048668|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048669|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56048670|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048671|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56048672|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
56048673|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
56048674|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048675|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048676|NCT05227001|Camphor|camphor|mesh-list
56048677|NCT05227001|Menthol|menthol|mesh-list
56048678|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56048679|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048680|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
56048681|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
56048682|NCT01610570|Plicamycin|plicamycin|mesh-list
56048683|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56048684|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048685|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56048686|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048687|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56048688|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048689|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048690|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56048691|NCT05736341|Midazolam|midazolam|mesh-list
56048692|NCT05736341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56048693|NCT05736341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56048694|NCT05736341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048695|NCT05736341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048696|NCT05736341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56048697|NCT05736341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56048698|NCT05736341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56048699|NCT05736341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56048700|NCT05736341|Anesthetics, General|anesthetics, general|mesh-ancestor
56048701|NCT05736341|Anesthetics|anesthetics|mesh-ancestor
56048702|NCT05736341|GABA Modulators|gaba modulators|mesh-ancestor
56048703|NCT05736341|GABA Agents|gaba agents|mesh-ancestor
56048704|NCT05736341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048705|NCT05736341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048706|NCT01611662|Gemcitabine|gemcitabine|mesh-list
56048756|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56048758|NCT01649180|Axitinib|axitinib|mesh-list
56048759|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048760|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56048761|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048762|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801585|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
56048818|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56048820|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
56048821|NCT05421416|Loratadine|loratadine|mesh-list
56048822|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
56048823|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
56048824|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56048825|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56777274|NCT04003350|Analgesics|analgesics|mesh-ancestor
56777275|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
56777276|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777277|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
56777278|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56777279|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56777280|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56050020|NCT01688336|Folfirinox|folfirinox|mesh-list
56048826|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56048827|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
56048828|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
56048829|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776001|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
56048830|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048889|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56048890|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56048891|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56048892|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56048893|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
56048894|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56048895|NCT01658228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56048896|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
56048897|NCT05709938|Insulin|insulin|mesh-list
56048898|NCT05709938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56048899|NCT05709938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56048900|NCT05709938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048901|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
56048902|NCT01659866|Gentamicins|gentamicins|mesh-list
55776078|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
56048955|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
56048956|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
56048957|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049081|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56049082|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049083|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049084|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56049085|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
56049086|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56049087|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049088|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
56049089|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56049090|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049139|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56049141|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56049142|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049143|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
56049144|NCT01665950|Simvastatin|simvastatin|mesh-list
56049145|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56049146|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56049147|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
56191321|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56191322|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049148|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049149|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56049150|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56049151|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049219|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56049221|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56049222|NCT03744663|Narcotics|narcotics|mesh-ancestor
56049223|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049224|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049225|NCT03744663|Analgesics|analgesics|mesh-ancestor
56049226|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
56049227|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049228|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56049229|NCT01669538|Galantamine|galantamine|mesh-list
56777281|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56777282|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56777283|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049230|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56049231|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049232|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049233|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
56049237|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
56049238|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049239|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
56049240|NCT00375375|Lactulose|lactulose|mesh-list
56049241|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56049242|NCT05667662|Itraconazole|itraconazole|mesh-list
56049243|NCT05667662|Antifungal Agents|antifungal agents|mesh-ancestor
56049244|NCT05667662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049329|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56049461|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56049462|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
56049463|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049464|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049500|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56049501|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56049502|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
56049503|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049504|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049768|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
56049920|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049921|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56049922|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56049923|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56049924|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56049925|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049926|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
56049927|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56049928|NCT01992185|Protective Agents|protective agents|mesh-ancestor
56049929|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049930|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
56049959|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56049960|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049961|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049963|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049964|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
56049965|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56049966|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56049967|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
56049968|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
56049969|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049970|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049971|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56049972|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
56049973|NCT03232749|Hormones|hormones|mesh-ancestor
56049974|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56049975|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56050015|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050973|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050974|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
56050975|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56050976|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56050977|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56050978|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56050979|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050980|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
56051545|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051546|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051548|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051549|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051550|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56051551|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56777284|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777285|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
56777286|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56777287|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56051552|NCT01777412|Growth Substances|growth substances|mesh-ancestor
56051553|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051554|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
56051555|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56051556|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56051559|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051560|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
56051561|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
56051562|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
56051563|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051565|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051566|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56051567|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
56051568|NCT01780454|Rituximab|rituximab|mesh-list
56051569|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051570|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051682|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56051683|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56051700|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56051701|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051702|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
56051703|NCT03656783|Tenofovir|tenofovir|mesh-list
56051704|NCT03656783|Emtricitabine|emtricitabine|mesh-list
56051705|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56051706|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
56051707|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051708|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56051709|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56051710|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051711|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051712|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56051713|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56051714|NCT01784666|Isradipine|isradipine|mesh-list
56051715|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56051716|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56051717|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051718|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051719|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56051720|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051721|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
56051722|NCT03618641|Nivolumab|nivolumab|mesh-list
56051723|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051724|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051725|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56051726|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051727|NCT04362293|Sirolimus|sirolimus|mesh-list
56051728|NCT04362293|Plerixafor|plerixafor|mesh-list
56051729|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
56051730|NCT04362293|Thiotepa|thiotepa|mesh-list
56051731|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
56051732|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
56051733|NCT04362293|Azathioprine|azathioprine|mesh-list
56051734|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56051735|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
56051736|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051737|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051738|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56051739|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
56051740|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051852|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
56051853|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
56051854|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
56051855|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051856|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
56051857|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56051858|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777288|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56777289|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777290|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56777291|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
56777292|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56777293|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051859|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
56051860|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051861|NCT04903652|Vinorelbine|vinorelbine|mesh-list
56051862|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56051863|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051864|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
56051865|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
56051866|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
56051963|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051964|NCT03500289|Midazolam|midazolam|mesh-list
56052104|NCT01801124|Bupivacaine|bupivacaine|mesh-list
56052105|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
56052106|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
56052107|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052108|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052109|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
56052110|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052111|NCT00357461|Ipilimumab|ipilimumab|mesh-list
56052112|NCT00357461|Vaccines|vaccines|mesh-list
56052113|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
56052114|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
56052115|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052116|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56052117|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052118|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56052119|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052645|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56052646|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
56052647|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052648|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56052649|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56052650|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56052651|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052682|NCT00377091|PENTA|penta|mesh-list
56052683|NCT00377091|Fondaparinux|fondaparinux|mesh-list
56052684|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56052685|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
56052686|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56052687|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
56052688|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052689|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052690|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
56052691|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56052692|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56052693|NCT01835912|Citric Acid|citric acid|mesh-list
56052694|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
56052695|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
56052696|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56052697|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
56052955|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56052956|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56052957|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
56052958|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
56052959|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052960|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56052961|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56191324|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56052962|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052963|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052964|NCT00558896|Dexamethasone|dexamethasone|mesh-list
56052965|NCT00558896|Pomalidomide|pomalidomide|mesh-list
56052966|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56052967|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
56052968|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
56777294|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777295|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56777296|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56777297|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56777298|NCT00748007|Rivastigmine|rivastigmine|mesh-list
56777299|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
56777300|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777301|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777302|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
56777303|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777304|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052969|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052970|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052971|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56052972|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
56052973|NCT00558896|Hormones|hormones|mesh-ancestor
56052974|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052975|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56052976|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052977|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
56053115|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56053116|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
56053117|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053118|NCT00557492|Antiviral Agents|antiviral agents|mesh-ancestor
56053119|NCT00557492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053121|NCT00557492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053122|NCT00557492|Immunologic Factors|immunologic factors|mesh-ancestor
56053123|NCT01865708|Ethanol|ethanol|mesh-list
56053124|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56053125|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053126|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053127|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053128|NCT04203225|Lidocaine|lidocaine|mesh-list
56053129|NCT04203225|Epinephrine|epinephrine|mesh-list
56053130|NCT04203225|Tetracaine|tetracaine|mesh-list
56053157|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053158|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053159|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56053160|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56053161|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
56053162|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053163|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053165|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56053166|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053167|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053168|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053169|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56053170|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053171|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56053172|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053173|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053174|NCT00377325|Cyclosporine|cyclosporine|mesh-list
56053175|NCT00377325|Cyclosporins|cyclosporins|mesh-list
56053377|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56053378|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56053380|NCT03054038|Necitumumab|necitumumab|mesh-list
56053546|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053547|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
56053548|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053549|NCT04041219|Tacrolimus|tacrolimus|mesh-list
56053550|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053551|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
56053552|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777305|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56777306|NCT00748007|Protective Agents|protective agents|mesh-ancestor
56777307|NCT00748163|Paclitaxel|paclitaxel|mesh-list
56777308|NCT00748163|Sunitinib|sunitinib|mesh-list
56777309|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56777310|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56777311|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777312|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
56777313|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
56777314|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
56777315|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777316|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56777317|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56777318|NCT00748163|Growth Substances|growth substances|mesh-ancestor
56777319|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050049|NCT04436744|Palbociclib|palbociclib|mesh-list
56053553|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56053554|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053590|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053591|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053592|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56053593|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
56054241|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56054242|NCT01379469|Analgesics|analgesics|mesh-ancestor
56054243|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
56054244|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191325|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56191326|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
56191327|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191328|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191329|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191330|NCT01474304|Acetaminophen|acetaminophen|mesh-list
56191331|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56191332|NCT01474304|Analgesics|analgesics|mesh-ancestor
56191333|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
56191334|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191335|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191336|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
56191337|NCT01474330|Pomalidomide|pomalidomide|mesh-list
56191338|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
56191339|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191340|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56054245|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56054246|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054247|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054248|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56054249|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56054250|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
56054251|NCT04889118|Lenvatinib|lenvatinib|mesh-list
56054252|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56054253|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054509|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054510|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054511|NCT01189071|Urological Agents|urological agents|mesh-ancestor
56054728|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56054729|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054730|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56054731|NCT03756818|Paclitaxel|paclitaxel|mesh-list
56777320|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
56777321|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56777322|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777323|NCT00687401|Infliximab|infliximab|mesh-list
56777324|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
56777325|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56777326|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777327|NCT00485693|Epinephrine|epinephrine|mesh-list
56777328|NCT00485693|Bupivacaine|bupivacaine|mesh-list
56777329|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
56777330|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
56777331|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777332|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777333|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
56777334|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777335|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56050062|NCT01963793|Aprepitant|aprepitant|mesh-list
56054732|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56054733|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56054734|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054735|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
56054736|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
56054737|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
56054738|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054739|NCT01065051|Riociguat|riociguat|mesh-list
56054740|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
56054741|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054742|NCT01048125|Nitroprusside|nitroprusside|mesh-list
56054743|NCT01048125|Phenylephrine|phenylephrine|mesh-list
56054744|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
56054745|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56054746|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
56054747|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
56054748|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054749|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054750|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
56054751|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56054752|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
56054753|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
56054754|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56054755|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56054756|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56054757|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
56191341|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56055131|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055134|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56055135|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56055136|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055137|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055138|NCT00688935|Melatonin|melatonin|mesh-list
56055139|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
56055140|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055141|NCT00688935|Protective Agents|protective agents|mesh-ancestor
56055142|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055143|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055144|NCT00684255|Fludarabine|fludarabine|mesh-list
56055145|NCT00684255|Busulfan|busulfan|mesh-list
56055146|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
56055147|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957188|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
56777336|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56777337|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
56777338|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777339|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777340|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56777341|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56777342|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
56777343|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56777344|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
56777345|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
56777346|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
56777347|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56923665|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56923666|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923667|NCT03613532|Fludarabine|fludarabine|mesh-list
56923668|NCT03613532|Azacitidine|azacitidine|mesh-list
56923669|NCT03613532|Busulfan|busulfan|mesh-list
56923670|NCT03613532|Decitabine|decitabine|mesh-list
56923671|NCT03613532|Venetoclax|venetoclax|mesh-list
56923672|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923673|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56923674|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
56923675|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923676|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923677|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
56923678|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923679|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923680|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
56923681|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56055148|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055301|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
56055302|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055303|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56055343|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055344|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
56055345|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055346|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055347|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56055348|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
56055349|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055350|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055897|NCT05663801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56055898|NCT05663801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56055899|NCT05663801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055900|NCT05663801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923682|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56923683|NCT03606967|Gemcitabine|gemcitabine|mesh-list
56923684|NCT03606967|Poly I-C|poly i-c|mesh-list
56923685|NCT03606967|Paclitaxel|paclitaxel|mesh-list
56923686|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56923687|NCT03606967|Carboplatin|carboplatin|mesh-list
56055901|NCT05663801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56055962|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055964|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56055965|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055966|NCT02959229|Lactoferrin|lactoferrin|mesh-list
56055967|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055972|NCT02953665|Hormones|hormones|mesh-ancestor
56055973|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783174|NCT03078257|Aspirin|aspirin|mesh-list
56055974|NCT00000189|Gepirone|gepirone|mesh-list
56055975|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
56056118|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56056119|NCT00355277|Amitriptyline|amitriptyline|mesh-list
56056261|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
56056263|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
56056264|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
56056265|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56056383|NCT00000801|Doxorubicin|doxorubicin|mesh-list
56056384|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56056385|NCT00000801|Vincristine|vincristine|mesh-list
56056386|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056387|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
56056388|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056389|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056390|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56056391|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
56056392|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056393|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056394|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56056395|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056396|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
56056397|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
56056398|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191342|NCT01474330|Growth Substances|growth substances|mesh-ancestor
56191343|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
56191344|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191345|NCT01474382|Phentolamine|phentolamine|mesh-list
56191346|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56191347|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56191348|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
56191349|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191350|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191351|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191352|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56191353|NCT01474460|Vitamin K|vitamin k|mesh-list
56191354|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
56191355|NCT01474460|Vitamins|vitamins|mesh-ancestor
56191356|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
56191357|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191358|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56191359|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56191360|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191361|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
56191362|NCT01474460|Coagulants|coagulants|mesh-ancestor
56191363|NCT01474473|Calpastatin|calpastatin|mesh-list
56191364|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56056399|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56056400|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
56056401|NCT00000801|Hormones|hormones|mesh-ancestor
56056402|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56056403|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56056404|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56056405|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56056406|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56056407|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056408|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56923688|NCT03606967|Durvalumab|durvalumab|mesh-list
56923689|NCT03606967|Tremelimumab|tremelimumab|mesh-list
56923690|NCT03606967|Ipilimumab|ipilimumab|mesh-list
56923691|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56923692|NCT03606967|Vaccines|vaccines|mesh-list
55881901|NCT01900002|Sorafenib|sorafenib|mesh-list
56056409|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
56056410|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
56056411|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056412|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56056413|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
56056444|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056445|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
56056446|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056447|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56056448|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056449|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
56056450|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056451|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56056453|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56056454|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056481|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
56056483|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56191365|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
56191366|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191367|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056484|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
56056485|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
56056486|NCT00000819|Prednisone|prednisone|mesh-list
56056487|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056488|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
56056489|NCT00000819|Hormones|hormones|mesh-ancestor
56056490|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56056491|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056492|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56056493|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056494|NCT00000279|Clonidine|clonidine|mesh-list
56056495|NCT00000279|Analgesics|analgesics|mesh-ancestor
56056496|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
56056497|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056498|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056499|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56056500|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
56056501|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
56056502|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56056503|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56056504|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56056505|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
56056506|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056517|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56056518|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56056519|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056520|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56056521|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56056522|NCT00001737|Cyclosporine|cyclosporine|mesh-list
56056523|NCT00001737|Cyclosporins|cyclosporins|mesh-list
56056524|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056525|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056526|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056527|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
56056528|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056529|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
56056530|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056531|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
56056532|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056533|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56056534|NCT00000843|Adefovir|adefovir|mesh-list
56056535|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56056536|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
56056537|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056538|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55957410|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
56923693|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
56923694|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56923695|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
56923696|NCT03606967|Poly ICLC|poly iclc|mesh-list
56923697|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
56923698|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923699|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56777349|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777350|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777351|NCT00541970|Vaccines|vaccines|mesh-list
56777352|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
56777353|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056539|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56056540|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056541|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056542|NCT05362487|Bromides|bromides|mesh-list
56056543|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
56056544|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56056545|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
56056546|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056547|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056548|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56056549|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
56056550|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
56056551|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56056552|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
56056553|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056554|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056555|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
56056590|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56056591|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56056592|NCT00359879|Exenatide|exenatide|mesh-list
56056593|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56056594|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056619|NCT00001827|Sargramostim|sargramostim|mesh-list
56191368|NCT01474499|Sorbitol|sorbitol|mesh-list
56191369|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56191370|NCT01474499|Glycerol|glycerol|mesh-list
56191371|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56191372|NCT01474499|Protective Agents|protective agents|mesh-ancestor
56191373|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191374|NCT01474499|Cathartics|cathartics|mesh-ancestor
56191375|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191376|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
56191377|NCT01474642|Capecitabine|capecitabine|mesh-list
56191378|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191379|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56191380|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
56191381|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191383|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
56191384|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56191385|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56191386|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191387|NCT01474967|Metformin|metformin|mesh-list
56191388|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56191389|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191390|NCT01475019|Orlistat|orlistat|mesh-list
56191391|NCT01475019|Sibutramine|sibutramine|mesh-list
56191392|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191393|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056620|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
56056621|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
56056622|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056623|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056624|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56777354|NCT00687323|Temozolomide|temozolomide|mesh-list
56777355|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56777356|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
56050120|NCT01997411|Hormones|hormones|mesh-ancestor
56056625|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056626|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
56056627|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056628|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56056629|NCT01647516|Ozanimod|ozanimod|mesh-list
56056630|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56056631|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056632|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056633|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
56056634|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056635|NCT00001839|Cyclosporine|cyclosporine|mesh-list
56056636|NCT00001839|Cyclosporins|cyclosporins|mesh-list
56056637|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56056638|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056639|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056640|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056641|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
56056642|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056643|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
56056657|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
56056658|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056659|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56191394|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56056660|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
56056661|NCT05536349|Protective Agents|protective agents|mesh-ancestor
56056662|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056663|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
56056664|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056665|NCT00000885|Lamivudine|lamivudine|mesh-list
56056666|NCT00000885|Zidovudine|zidovudine|mesh-list
56056667|NCT00000885|Efavirenz|efavirenz|mesh-list
56056668|NCT00000885|Abacavir|abacavir|mesh-list
56056669|NCT00000885|Didanosine|didanosine|mesh-list
56056670|NCT00000885|Stavudine|stavudine|mesh-list
56056671|NCT00000885|Adefovir|adefovir|mesh-list
56056672|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56056673|NCT00000885|Nelfinavir|nelfinavir|mesh-list
56056674|NCT00000885|Indinavir|indinavir|mesh-list
56056675|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56056676|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56056677|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056678|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056679|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
56056683|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
56056684|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56056685|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56056686|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56056687|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56056688|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56056689|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56056690|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56056691|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56056692|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
56056693|NCT01647282|Minocycline|minocycline|mesh-list
56056694|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56056695|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056697|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
56056698|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056731|NCT05444699|Hormones|hormones|mesh-ancestor
56056732|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56056733|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056734|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56056735|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056736|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
56056737|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
56056738|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056739|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56056740|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56056741|NCT05444699|Protective Agents|protective agents|mesh-ancestor
56777357|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777358|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777359|NCT00989742|Doxycycline|doxycycline|mesh-list
56777360|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777361|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777362|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
56777363|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56777364|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56777365|NCT05408208|Triamcinolone|triamcinolone|mesh-list
56777366|NCT05408208|Methotrexate|methotrexate|mesh-list
56777367|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56777368|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
56777369|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56777370|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777371|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56777372|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
56050129|NCT04153760|Aspirin|aspirin|mesh-list
56056788|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056789|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56056790|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56056791|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56056792|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56056793|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56056794|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56056795|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056796|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
56056797|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
56056798|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056799|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056800|NCT00000945|Cidofovir|cidofovir|mesh-list
56056801|NCT00000945|Probenecid|probenecid|mesh-list
56056802|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
56056803|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
56056804|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056805|NCT00000945|Renal Agents|renal agents|mesh-ancestor
56056806|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
56056807|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056808|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056809|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056810|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
56056811|NCT04344041|Vitamin D|vitamin d|mesh-list
56056812|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56191395|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56191396|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
56191397|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56191398|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
56191399|NCT01475032|Beclomethasone|beclomethasone|mesh-list
56191400|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
56191401|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56191402|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
56191403|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191404|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191405|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56191406|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
56213200|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
56056813|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056815|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
56056816|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56056817|NCT00000963|Didanosine|didanosine|mesh-list
56777373|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777374|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777375|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
56777376|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777377|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56777378|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777379|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
56777380|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777381|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56777382|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777383|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
56777384|NCT05408208|Hormones|hormones|mesh-ancestor
56777385|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777386|NCT00758693|Rituximab|rituximab|mesh-list
56777387|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56777388|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56777389|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777390|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
56050136|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056818|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
56056829|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56056830|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056831|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56056832|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
56056860|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56056861|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056862|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
56056863|NCT00000981|Fiacitabine|fiacitabine|mesh-list
56056864|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056865|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
56056866|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056867|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
56056868|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56056869|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56056870|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056871|NCT00001905|Interferons|interferons|mesh-list
56056872|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
56056873|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056874|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
56056875|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056876|NCT00000987|Zidovudine|zidovudine|mesh-list
56056883|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56056884|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56056885|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056886|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056887|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56056888|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
56056889|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
56056890|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
56056891|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
56056892|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56056893|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56056894|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
56191407|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55957714|NCT05535036|Dexamethasone|dexamethasone|mesh-list
56777391|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777392|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777393|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56777394|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
56777395|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777396|NCT00989820|Coal Tar|coal tar|mesh-list
56777397|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
56777398|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
56191408|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56191409|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56191410|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
56191411|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191412|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191413|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56191414|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
56191416|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56191417|NCT01475227|Zinc|zinc|mesh-list
56191418|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
56056895|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056896|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056897|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056898|NCT00001911|Interleukin-12|interleukin-12|mesh-list
56056899|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56056900|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
56056901|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784079|NCT03551743|Edoxaban|edoxaban|mesh-list
56056902|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56056903|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56056906|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056907|NCT00001929|Eliprodil|eliprodil|mesh-list
56056908|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56056909|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56056910|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056911|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056912|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056913|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56056914|NCT00001929|Protective Agents|protective agents|mesh-ancestor
56056915|NCT00358553|Insulin|insulin|mesh-list
56056916|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56056917|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056918|NCT00000993|Zidovudine|zidovudine|mesh-list
56056919|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
56056920|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056921|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56056922|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56056923|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056924|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
56056925|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056926|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056927|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056928|NCT00359177|Casopitant|casopitant|mesh-list
56056929|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
56056930|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
56056931|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056932|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056933|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56056964|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056965|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056966|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
56056967|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056968|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
56056969|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056970|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
56056971|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056972|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56056973|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56057011|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
56777399|NCT05357820|Itraconazole|itraconazole|mesh-list
56777400|NCT05357820|Rifampin|rifampin|mesh-list
56777401|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
56777402|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777403|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56777404|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56057012|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191419|NCT01475227|Trace Elements|trace elements|mesh-ancestor
56191420|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
56191421|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191422|NCT01475227|Astringents|astringents|mesh-ancestor
56191423|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
56191424|NCT01475266|Apaziquone|apaziquone|mesh-list
56191425|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191426|NCT01475279|Warfarin|warfarin|mesh-list
56191427|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
56191428|NCT01475318|Letrozole|letrozole|mesh-list
56191429|NCT01475318|Misoprostol|misoprostol|mesh-list
56191430|NCT01475318|Mifepristone|mifepristone|mesh-list
56191431|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191432|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56191433|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56191434|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191435|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191436|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56057054|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
56057055|NCT00001065|Amphotericin B|amphotericin b|mesh-list
56057056|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56057057|NCT00001065|Amebicides|amebicides|mesh-ancestor
56057058|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56057059|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56057060|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057061|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057062|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
56057063|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56057064|NCT02977637|Hematinics|hematinics|mesh-ancestor
56057065|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56057066|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56057068|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057069|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057070|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56057071|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
56057072|NCT05501483|Pioglitazone|pioglitazone|mesh-list
56057076|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56057077|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057078|NCT00002001|Zidovudine|zidovudine|mesh-list
56057079|NCT00002001|Didanosine|didanosine|mesh-list
56057080|NCT00002001|Zalcitabine|zalcitabine|mesh-list
56057081|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
56057082|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057083|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057084|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057085|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057086|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
56057087|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057088|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057089|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057114|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057115|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057116|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057117|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
56057118|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56057119|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56057120|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56057121|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56191438|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56057122|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
56057123|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56057124|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
56057125|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55784310|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56057126|NCT02294058|Interferons|interferons|mesh-list
56777405|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777406|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777407|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56777408|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
56050166|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
56057127|NCT02294058|Interferon-beta|interferon-beta|mesh-list
56057128|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
56057129|NCT02294058|Ozanimod|ozanimod|mesh-list
56057130|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057131|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
56057132|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057133|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
56057134|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057135|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56057136|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56057137|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057138|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057139|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
56057140|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057141|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56057142|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057166|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
56057167|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
56057168|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
56057169|NCT00001101|Doxycycline|doxycycline|mesh-list
56057170|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
56057171|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057172|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057173|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
56057174|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56057175|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56057176|NCT00001107|Fluconazole|fluconazole|mesh-list
56057177|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56057178|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
56057179|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057180|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56057200|NCT00002025|Ganciclovir|ganciclovir|mesh-list
56057201|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56057203|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057204|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057205|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057206|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057207|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56057208|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56057209|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
56057210|NCT00001131|Aldesleukin|aldesleukin|mesh-list
56057219|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057220|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56057221|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56057222|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
56057223|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057234|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057235|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057236|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56191439|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191440|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56057238|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
56057240|NCT05270057|Doxorubicin|doxorubicin|mesh-list
56057241|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56057242|NCT05270057|Etoposide|etoposide|mesh-list
56057243|NCT05270057|Vincristine|vincristine|mesh-list
56057244|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56057245|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057246|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
56057247|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057248|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56057249|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56057250|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
56057251|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057252|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777409|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777410|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777411|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56777412|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56777413|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
56777414|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777415|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
56777416|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56777417|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56777418|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56777419|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56777420|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56777421|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56777422|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56777423|NCT00748787|Psyllium|psyllium|mesh-list
56777424|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
56777425|NCT00748787|Cathartics|cathartics|mesh-ancestor
56777426|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56777427|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
56777428|NCT05712044|Folic Acid|folic acid|mesh-list
56777429|NCT05712044|Vitamin B Complex|vitamin b complex|mesh-list
56777430|NCT05712044|Hematinics|hematinics|mesh-ancestor
56777431|NCT05712044|Vitamins|vitamins|mesh-ancestor
56777432|NCT05712044|Micronutrients|micronutrients|mesh-ancestor
56777433|NCT05712044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777434|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56777435|NCT00986960|Hormones|hormones|mesh-ancestor
56777436|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777437|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777438|NCT05711966|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56777439|NCT05711966|Respiratory System Agents|respiratory system agents|mesh-ancestor
56777440|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
56777441|NCT00759005|Propranolol|propranolol|mesh-list
56777442|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56777443|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56777444|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
56777445|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777446|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777447|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777448|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56777449|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56777450|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
56777451|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777452|NCT04360070|Ketamine|ketamine|mesh-list
56777453|NCT04360070|Analgesics|analgesics|mesh-ancestor
56777454|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
56777455|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777456|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777457|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56777458|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56777459|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
56777460|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
56777461|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777462|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56777463|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56777464|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777465|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777466|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
56777467|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
56777468|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
56777469|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777470|NCT00749021|Ranibizumab|ranibizumab|mesh-list
56777471|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56777472|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56777473|NCT00749021|Growth Substances|growth substances|mesh-ancestor
56777474|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057253|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56057254|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56057255|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56057256|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56057257|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56057258|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057259|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56057260|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
56057261|NCT05270057|Hormones|hormones|mesh-ancestor
56057262|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56057263|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56057264|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56057265|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
56057266|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56777475|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
56050235|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56050243|NCT01974245|Vitamin D|vitamin d|mesh-list
56777476|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777477|NCT04048889|Ropivacaine|ropivacaine|mesh-list
56777478|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56777479|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
56777480|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
56777481|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777482|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777483|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
56777484|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777485|NCT00987038|Midazolam|midazolam|mesh-list
56777486|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56777487|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56777488|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777489|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777490|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56777491|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56777492|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56777493|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56777494|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
56777495|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
56488471|NCT02908698|Prednisone|prednisone|mesh-list
56777496|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
56777497|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
56777498|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777499|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777500|NCT05711810|Ubiquinone|ubiquinone|mesh-list
56777501|NCT05711810|Coenzyme Q10|coenzyme q10|mesh-list
56777502|NCT05711810|Tocopherols|tocopherols|mesh-list
56777503|NCT05711810|Vitamin E|vitamin e|mesh-list
56777504|NCT05711810|alpha-Tocopherol|alpha-tocopherol|mesh-list
56777505|NCT05711810|Metoprolol|metoprolol|mesh-list
56777506|NCT05711810|Enalapril|enalapril|mesh-list
56057267|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56057268|NCT00002043|Dapsone|dapsone|mesh-list
56057269|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057270|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
56057271|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56057272|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56057273|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56057274|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057275|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777507|NCT05711810|Enalaprilat|enalaprilat|mesh-list
56777508|NCT05711810|Nifedipine|nifedipine|mesh-list
56777509|NCT05711810|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56777510|NCT05711810|Lansoprazole|lansoprazole|mesh-list
56777511|NCT05711810|Superoxide Dismutase|superoxide dismutase|mesh-list
56777512|NCT05711810|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56777513|NCT05711810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56777514|NCT05711810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56777515|NCT05711810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777516|NCT05711810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777517|NCT05711810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057276|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
56057277|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057278|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
56057279|NCT00001209|Ifosfamide|ifosfamide|mesh-list
56057280|NCT00001209|Vincristine|vincristine|mesh-list
56057305|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
56057306|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56057307|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56057308|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057309|NCT05043077|Phenylephrine|phenylephrine|mesh-list
56057310|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
56057311|NCT05043077|Tropicamide|tropicamide|mesh-list
56057314|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
56057315|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56057316|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057317|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
56057318|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56057319|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
56057320|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
56057321|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56057323|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56057324|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
56057325|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56057326|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057327|NCT05043077|Protective Agents|protective agents|mesh-ancestor
56057328|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56057329|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56191441|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
56057361|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
56057362|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56057363|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
56057364|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057365|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
56057366|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057368|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
56057369|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56057370|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56057371|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56057404|NCT05016713|Protective Agents|protective agents|mesh-ancestor
56057405|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057406|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56057407|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057408|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
56057409|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
56057410|NCT00002073|Hematinics|hematinics|mesh-ancestor
56057411|NCT00001317|Interferons|interferons|mesh-list
56057440|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56057441|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057443|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
56057444|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
56057445|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057446|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
56057447|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56057448|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777518|NCT05711810|Analgesics|analgesics|mesh-ancestor
56777519|NCT05711810|Sensory System Agents|sensory system agents|mesh-ancestor
56777520|NCT05711810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777521|NCT05711810|Antidepressive Agents|antidepressive agents|mesh-ancestor
56777522|NCT05711810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56777523|NCT05711810|Dopamine Agents|dopamine agents|mesh-ancestor
56777524|NCT05711810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777525|NCT05711810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56777526|NCT05711810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56777527|NCT05711810|Sympatholytics|sympatholytics|mesh-ancestor
56777528|NCT05711810|Autonomic Agents|autonomic agents|mesh-ancestor
56777529|NCT05711810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56777530|NCT05711810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56777531|NCT05711810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56777532|NCT05711810|Adrenergic Agents|adrenergic agents|mesh-ancestor
56777533|NCT05711810|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56050272|NCT02007863|Fludarabine|fludarabine|mesh-list
56057449|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057450|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56057451|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56057452|NCT00002091|Protective Agents|protective agents|mesh-ancestor
56057453|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057454|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
56057455|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56057456|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
56057478|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057479|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56057480|NCT00001431|Gemcitabine|gemcitabine|mesh-list
56057481|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56057482|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
56057483|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057484|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057485|NCT00001431|Antiviral Agents|antiviral agents|mesh-ancestor
56057486|NCT00001431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057487|NCT00001431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057488|NCT00001431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057489|NCT00001431|Immunologic Factors|immunologic factors|mesh-ancestor
56057490|NCT00001431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057491|NCT05428007|Nivolumab|nivolumab|mesh-list
56057492|NCT05428007|Ipilimumab|ipilimumab|mesh-list
56057493|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56057494|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057495|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56057496|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057497|NCT00002103|Leucovorin|leucovorin|mesh-list
56057498|NCT00002103|Trimetrexate|trimetrexate|mesh-list
56057499|NCT00002103|Calcium|calcium|mesh-list
56057502|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057503|NCT00002103|Antidotes|antidotes|mesh-ancestor
56057504|NCT00002103|Protective Agents|protective agents|mesh-ancestor
56057505|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
56057506|NCT00002103|Vitamins|vitamins|mesh-ancestor
56057507|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
56057508|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
56057509|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057510|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56057542|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057543|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55740331|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
55963792|NCT01395758|Antiviral Agents|antiviral agents|mesh-ancestor
56777534|NCT05711810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56777535|NCT05711810|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56777536|NCT05711810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56777537|NCT05711810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56777538|NCT05711810|Vasodilator Agents|vasodilator agents|mesh-ancestor
56777539|NCT05711810|Tocolytic Agents|tocolytic agents|mesh-ancestor
56777540|NCT05711810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56777541|NCT05711810|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56777542|NCT05711810|Protease Inhibitors|protease inhibitors|mesh-ancestor
56777543|NCT05711810|Micronutrients|micronutrients|mesh-ancestor
56777544|NCT05711810|Vitamins|vitamins|mesh-ancestor
56057544|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56191442|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56191443|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56191444|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191445|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
56191446|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56191447|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56191448|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56191449|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56191450|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
56191451|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56191453|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
56191454|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56191455|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56191456|NCT01475552|Abciximab|abciximab|mesh-list
56191457|NCT01475552|Clopidogrel|clopidogrel|mesh-list
56191458|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191459|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191460|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56191461|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56191462|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56191463|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56191464|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
56191465|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191466|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
56191467|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
56191468|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
56191469|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56191470|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56057545|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
56057546|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057547|NCT00001449|Leucovorin|leucovorin|mesh-list
56057548|NCT00001449|Gemcitabine|gemcitabine|mesh-list
56057549|NCT00001449|Floxuridine|floxuridine|mesh-list
56057550|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56057551|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
56057552|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057590|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56057591|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
56057592|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56057593|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057594|NCT00381147|Clarithromycin|clarithromycin|mesh-list
56057595|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057630|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56057631|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
56057632|NCT04983407|Antiviral Agents|antiviral agents|mesh-ancestor
56191471|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
56191472|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191473|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191474|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191475|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
56191476|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
56191477|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
56777545|NCT05711810|Antioxidants|antioxidants|mesh-ancestor
56777546|NCT05711810|Protective Agents|protective agents|mesh-ancestor
56777547|NCT05711810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56777548|NCT00759083|Bivalirudin|bivalirudin|mesh-list
56777549|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
56777550|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56777551|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
56777552|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050295|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191478|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
56191479|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
56191480|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
56191481|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
56191482|NCT01475617|Calcium|calcium|mesh-list
56057633|NCT04983407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057658|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057660|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057661|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057662|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56057663|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56057664|NCT00002127|Growth Substances|growth substances|mesh-ancestor
56057665|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
56057666|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057667|NCT00001599|Thalidomide|thalidomide|mesh-list
56057668|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057669|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
56057670|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057671|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
56057672|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057673|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057674|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56057675|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56057676|NCT00001599|Growth Substances|growth substances|mesh-ancestor
56057677|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
56057678|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057679|NCT00380913|Nabilone|nabilone|mesh-list
56057680|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
56057681|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
56057704|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
56057705|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56057706|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56057707|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
56057708|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057709|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057710|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56057711|NCT00002139|Azithromycin|azithromycin|mesh-list
56057712|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057713|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057714|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
56057715|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56057716|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
56057717|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057718|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
56057719|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057720|NCT00002145|Foscarnet|foscarnet|mesh-list
56057721|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56057722|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
56057723|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057724|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057725|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057726|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057727|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784915|NCT04262479|Vitamin D|vitamin d|mesh-list
56057728|NCT00002301|Foscarnet|foscarnet|mesh-list
56057729|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56057730|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
56057731|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191483|NCT01475617|Vitamins|vitamins|mesh-ancestor
56191484|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
56191485|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777553|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777554|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
56777555|NCT00759239|Timolol|timolol|mesh-list
56777556|NCT00759239|Travoprost|travoprost|mesh-list
56777557|NCT00759239|Maleic acid|maleic acid|mesh-list
56777558|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777559|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777560|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56777561|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56777562|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
56191486|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56191487|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56191488|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
56191489|NCT01475617|Hematinics|hematinics|mesh-ancestor
56191490|NCT01475656|Levetiracetam|levetiracetam|mesh-list
56191491|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
56191492|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
56191493|NCT01475708|Doxycycline|doxycycline|mesh-list
56191494|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56191495|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191496|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
56191497|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56191498|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56191499|NCT01475760|Chitosan|chitosan|mesh-list
56191500|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56191501|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56057732|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057762|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
56057764|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56057765|NCT00002157|Thalidomide|thalidomide|mesh-list
56057766|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057767|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
56057770|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057771|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057772|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56057773|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56057774|NCT00002157|Growth Substances|growth substances|mesh-ancestor
56057775|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
56057776|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057777|NCT04685421|Bupivacaine|bupivacaine|mesh-list
56057826|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56057827|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56057828|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
56057829|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56057830|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
56057832|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56057833|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
56057834|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057835|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057836|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
56057837|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057838|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56057861|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057862|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057863|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
56057864|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057865|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56057866|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057867|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
56057868|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56057869|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56191502|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
56191503|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191504|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56191505|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
56191506|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
56777563|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777564|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777565|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56777566|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56777567|NCT03742908|Clindamycin|clindamycin|mesh-list
56777568|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
56777569|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
56777570|NCT03742908|Cefazolin|cefazolin|mesh-list
56777571|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777572|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057870|NCT02293902|Hematinics|hematinics|mesh-ancestor
56057871|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
56057872|NCT02293902|Vitamins|vitamins|mesh-ancestor
56057873|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
56057874|NCT00002343|Ethambutol|ethambutol|mesh-list
56057875|NCT00002343|Rifabutin|rifabutin|mesh-list
56057876|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
56057877|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057878|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057879|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55785059|NCT03067883|Ritonavir|ritonavir|mesh-list
56057880|NCT05168735|Ketamine|ketamine|mesh-list
56057881|NCT05168735|Analgesics|analgesics|mesh-ancestor
56057882|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
56057883|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56057884|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057885|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56057886|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56057887|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
56057888|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
56057889|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56057890|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56057891|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56057920|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56057921|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057922|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057923|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56057924|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56057925|NCT00002361|Ritonavir|ritonavir|mesh-list
56057926|NCT00002361|Indinavir|indinavir|mesh-list
56057927|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56057928|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56057929|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
56057930|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057931|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057932|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057933|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057934|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
56057936|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56057937|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56057939|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
56057940|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057970|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56057971|NCT00002379|Indinavir|indinavir|mesh-list
56057972|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057973|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057974|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057975|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057976|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
56057977|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057978|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057979|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057980|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
56057981|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56057982|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56057983|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
56057984|NCT00359723|Methylphenidate|methylphenidate|mesh-list
56777573|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56777574|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777575|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777576|NCT05357196|Gemcitabine|gemcitabine|mesh-list
56777577|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56777578|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
56777579|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777580|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777581|NCT05357196|Antiviral Agents|antiviral agents|mesh-ancestor
56777582|NCT05357196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777583|NCT05357196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777584|NCT05357196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777585|NCT05357196|Immunologic Factors|immunologic factors|mesh-ancestor
56777586|NCT05357196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777587|NCT05232630|Fenfluramine|fenfluramine|mesh-list
55777522|NCT03416855|Insulin|insulin|mesh-list
56057985|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56057986|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057987|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56057988|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56058022|NCT00002199|Indinavir|indinavir|mesh-list
56058023|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56191507|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
56191508|NCT01475760|Coagulants|coagulants|mesh-ancestor
56191509|NCT01475877|Bromfenac|bromfenac|mesh-list
56058024|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058025|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058026|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058027|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
56058028|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058029|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058030|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058031|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
56058069|NCT02977169|Cisplatin|cisplatin|mesh-list
56058070|NCT02977169|Carboplatin|carboplatin|mesh-list
56058071|NCT02977169|Pemetrexed|pemetrexed|mesh-list
56058072|NCT02977169|Vinorelbine|vinorelbine|mesh-list
56058103|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058104|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058105|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058106|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
56058107|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058108|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
56058109|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058110|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058111|NCT00002415|Tenofovir|tenofovir|mesh-list
56058112|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
56058113|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058114|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058115|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058116|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058117|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058143|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56058145|NCT00002427|Stavudine|stavudine|mesh-list
56058146|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
56058147|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058148|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
56058149|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058150|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965533|NCT04026074|Remifentanil|remifentanil|mesh-list
56777588|NCT05232630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56777589|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56777590|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56058151|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058152|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
56058153|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058154|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
56058155|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058156|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058157|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058158|NCT00002217|Lamivudine|lamivudine|mesh-list
56058159|NCT00002217|Zidovudine|zidovudine|mesh-list
56058160|NCT00002217|Abacavir|abacavir|mesh-list
56058161|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56058163|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058164|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058165|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058166|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058187|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
56058188|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058189|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56058190|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058191|NCT00002433|Interferons|interferons|mesh-list
56058192|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
56058193|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058194|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
56058195|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058196|NCT00002439|Alitretinoin|alitretinoin|mesh-list
56058197|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058198|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
56058200|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56058201|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058202|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058203|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058204|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058205|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058206|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058207|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
56191510|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56058209|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56058210|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058211|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56058212|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058213|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058214|NCT05381909|Paclitaxel|paclitaxel|mesh-list
56058215|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058216|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058217|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058218|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
56058219|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058220|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058221|NCT00002451|Ritonavir|ritonavir|mesh-list
56058222|NCT00002451|Indinavir|indinavir|mesh-list
56058247|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058248|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56058249|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058250|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56058251|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56058252|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56058253|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56058254|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56058255|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058256|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058257|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058258|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058259|NCT00002241|Ritonavir|ritonavir|mesh-list
55785434|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
56058260|NCT00002241|Indinavir|indinavir|mesh-list
56058261|NCT00002241|Lamivudine|lamivudine|mesh-list
56058262|NCT00002241|Stavudine|stavudine|mesh-list
56058263|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56777591|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777592|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777593|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
56777594|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777595|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
56777596|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
56777597|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777598|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777599|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777600|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
56777601|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
56777602|NCT01004874|Bevacizumab|bevacizumab|mesh-list
56777603|NCT01004874|Temozolomide|temozolomide|mesh-list
56777604|NCT01004874|Topotecan|topotecan|mesh-list
56058264|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058265|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058266|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058267|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058268|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058269|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058270|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
56058271|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058297|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
56058298|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058299|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
56058300|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058301|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56058302|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058303|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
56058304|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058306|NCT00002463|Antidotes|antidotes|mesh-ancestor
56058307|NCT00002463|Protective Agents|protective agents|mesh-ancestor
56058308|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
56058309|NCT00002463|Vitamins|vitamins|mesh-ancestor
56058310|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
56058311|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058312|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058313|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
56058314|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058315|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
56058316|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058317|NCT04500899|Phenylephrine|phenylephrine|mesh-list
56058318|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56058319|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
56058320|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
56058321|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058349|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058350|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058351|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058352|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
56058353|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191511|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56191512|NCT01475877|Analgesics|analgesics|mesh-ancestor
56191513|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
56191514|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191515|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191516|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56191517|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56191518|NCT01475890|Vitamin D|vitamin d|mesh-list
56191519|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
56191520|NCT01475890|Vitamins|vitamins|mesh-ancestor
56191521|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
56191522|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777605|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56777606|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777607|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56777608|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56777609|NCT01004874|Growth Substances|growth substances|mesh-ancestor
56777610|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777611|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
56777612|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56777613|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
56777614|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777615|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56777616|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56777617|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777618|NCT00987116|Prednisone|prednisone|mesh-list
56191523|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56191524|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56191525|NCT01476007|Vitamins|vitamins|mesh-list
56191526|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
56191527|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
56191528|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
56191529|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
56191530|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191531|NCT01476007|Hematinics|hematinics|mesh-ancestor
56058354|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058355|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56058356|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
56058357|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058358|NCT00002481|Cytarabine|cytarabine|mesh-list
56058359|NCT00002481|Dexamethasone|dexamethasone|mesh-list
56058360|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
56058361|NCT00002481|Etoposide|etoposide|mesh-list
56058362|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058363|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
56058364|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058365|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058366|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058367|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
56058368|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058403|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058404|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058405|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
56058406|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058407|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058408|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058409|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
56058410|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
55785621|NCT03136705|Niacin|niacin|mesh-list
56058411|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058440|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
56058441|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56058442|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058443|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058444|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
56058445|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058446|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058447|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
56058449|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56058450|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191532|NCT01476124|Morphine|morphine|mesh-list
56058451|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
56058452|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777619|NCT00987116|Azathioprine|azathioprine|mesh-list
56777620|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777621|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
56777622|NCT00987116|Hormones|hormones|mesh-ancestor
56777623|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058453|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058454|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56058455|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56058456|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
56058457|NCT00002493|Doxorubicin|doxorubicin|mesh-list
56058458|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56058489|NCT00002499|Hormones|hormones|mesh-ancestor
56058490|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058491|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058492|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058493|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56058494|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
56058495|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56058496|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058498|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058499|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
56058500|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058501|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56058502|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058503|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
56058504|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058531|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058532|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058533|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058534|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
56058535|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058536|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058537|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058538|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
56058540|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
56058541|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
56058542|NCT04933331|Protective Agents|protective agents|mesh-ancestor
56058543|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058544|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56058545|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058546|NCT00002271|Alovudine|alovudine|mesh-list
56058547|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
56058548|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058549|NCT00002517|Cytarabine|cytarabine|mesh-list
56058550|NCT00002517|Dexamethasone|dexamethasone|mesh-list
56058551|NCT00002517|Etoposide|etoposide|mesh-list
56058552|NCT00002517|Daunorubicin|daunorubicin|mesh-list
56058553|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
56058554|NCT00002517|Idarubicin|idarubicin|mesh-list
56058575|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058576|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058577|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
56058578|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56058579|NCT00002517|Analgesics|analgesics|mesh-ancestor
56058580|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
56058581|NCT00002277|Fluconazole|fluconazole|mesh-list
56058582|NCT00002277|Amphotericin B|amphotericin b|mesh-list
56058583|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56058584|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
56058585|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058586|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56058587|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058588|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058589|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058590|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56058591|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
56058592|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058593|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058594|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56058595|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56777624|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777625|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56777626|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777627|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
56777628|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777629|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56777630|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777631|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
56777632|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777633|NCT05711732|Busulfan|busulfan|mesh-list
56777634|NCT05711732|Alkylating Agents|alkylating agents|mesh-ancestor
56058596|NCT00002277|Amebicides|amebicides|mesh-ancestor
56058597|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56058598|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56058599|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56058600|NCT04469075|Clindamycin|clindamycin|mesh-list
56058601|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
56191534|NCT01476124|Narcotics|narcotics|mesh-ancestor
56191535|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56191536|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191537|NCT01476124|Analgesics|analgesics|mesh-ancestor
56191538|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
56191539|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191540|NCT01476137|Trametinib|trametinib|mesh-list
56191541|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191542|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56058602|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
56058603|NCT04469075|Triamcinolone|triamcinolone|mesh-list
56058604|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56058605|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56058606|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56058607|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058633|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
56058634|NCT00002523|Vitamins|vitamins|mesh-ancestor
56058635|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
56058636|NCT00002529|Tamoxifen|tamoxifen|mesh-list
56058637|NCT00002529|Toremifene|toremifene|mesh-list
56058638|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
56058639|NCT00002529|Doxorubicin|doxorubicin|mesh-list
56058640|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56058641|NCT00002529|Epirubicin|epirubicin|mesh-list
56058642|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058643|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
56058644|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058645|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058646|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058647|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
56058648|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058649|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058650|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56058651|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56058652|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56058653|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56058654|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058655|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56058656|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
56058657|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058690|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56058691|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56058692|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
56058693|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058694|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
56058695|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
56058696|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058697|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777635|NCT05711732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777636|NCT05711732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058698|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56058699|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
56058700|NCT04826237|Hormones|hormones|mesh-ancestor
56058724|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058725|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058726|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
56058727|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058728|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56058729|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56058730|NCT00002535|Analgesics|analgesics|mesh-ancestor
56058731|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
56058732|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058733|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058734|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
56058735|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
56058736|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56058737|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56058738|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191543|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191544|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191545|NCT01476176|Acetaminophen|acetaminophen|mesh-list
56191546|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56191547|NCT01476176|Analgesics|analgesics|mesh-ancestor
56191548|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
56191549|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191550|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191551|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
56191553|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56191555|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
56191556|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058740|NCT00002547|Cyclosporine|cyclosporine|mesh-list
56058741|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
56058742|NCT00002547|Busulfan|busulfan|mesh-list
56058743|NCT00002547|Methotrexate|methotrexate|mesh-list
56058744|NCT00002547|Cyclosporins|cyclosporins|mesh-list
56058745|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058746|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
56058747|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058748|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058749|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058769|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
56058770|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058771|NCT00002553|Cobalt|cobalt|mesh-list
56058772|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
56058773|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058774|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
56058775|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058776|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058777|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058778|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
56058779|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058780|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058781|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56058782|NCT00002553|Trace Elements|trace elements|mesh-ancestor
56058783|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
56058784|NCT00002559|Paclitaxel|paclitaxel|mesh-list
56058785|NCT00002559|Ifosfamide|ifosfamide|mesh-list
56058786|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058787|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058788|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058789|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
56058790|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058791|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058792|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058793|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
56058795|NCT00002565|Prednisone|prednisone|mesh-list
56058796|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
56058797|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
56058798|NCT00002565|Ifosfamide|ifosfamide|mesh-list
56058799|NCT00002565|Doxorubicin|doxorubicin|mesh-list
56058800|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56058801|NCT00002565|Etoposide|etoposide|mesh-list
56058802|NCT00002565|Vincristine|vincristine|mesh-list
56058803|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
56777637|NCT05711732|Immunologic Factors|immunologic factors|mesh-ancestor
56777638|NCT05711732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777639|NCT05711732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058804|NCT00002565|Idarubicin|idarubicin|mesh-list
56058805|NCT00002565|Bleomycin|bleomycin|mesh-list
56058806|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058807|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
56058830|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
56058831|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058832|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
56191557|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191559|NCT01476215|Acetaminophen|acetaminophen|mesh-list
56191560|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56191561|NCT01476215|Analgesics|analgesics|mesh-ancestor
56191562|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
56191563|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191564|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191565|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
56191566|NCT01476280|Palonosetron|palonosetron|mesh-list
56191567|NCT01476280|Ramosetron|ramosetron|mesh-list
56191568|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
56191569|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
56191570|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191571|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191572|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191573|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56191574|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56191575|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
56058833|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
56058834|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058835|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56058836|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56058837|NCT00002565|Protective Agents|protective agents|mesh-ancestor
56058840|NCT00002571|Leucovorin|leucovorin|mesh-list
56058841|NCT00002571|Cytarabine|cytarabine|mesh-list
56058842|NCT00002571|Trimethoprim|trimethoprim|mesh-list
56058843|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
56058844|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56058845|NCT00002571|Prednisone|prednisone|mesh-list
56058846|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
56058847|NCT00002571|Doxorubicin|doxorubicin|mesh-list
56058848|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56058849|NCT00002571|Methotrexate|methotrexate|mesh-list
56058850|NCT00002571|Etoposide|etoposide|mesh-list
56058851|NCT00002571|Vincristine|vincristine|mesh-list
56058852|NCT00002571|Bleomycin|bleomycin|mesh-list
56058853|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
56058854|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058855|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
56058856|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058857|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058858|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058859|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
56058860|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058888|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058889|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
56058890|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058891|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56058892|NCT00002571|Renal Agents|renal agents|mesh-ancestor
56058893|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
56058894|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56058895|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56058896|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56058897|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56058898|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058899|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56058900|NCT04897217|Megestrol|megestrol|mesh-list
56058901|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
56191576|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213201|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058902|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
56058903|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56058904|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
56058905|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56058906|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058907|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56777640|NCT05711732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777641|NCT05711732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56777642|NCT04004702|Levetiracetam|levetiracetam|mesh-list
56777643|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
56777644|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
56777645|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
56777646|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
56777647|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56777648|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
56777649|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777650|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777651|NCT04731974|Melatonin|melatonin|mesh-list
56777652|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
56058908|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56058909|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56058946|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56058947|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058948|NCT00002583|Vinorelbine|vinorelbine|mesh-list
56058949|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058950|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058951|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058952|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
56058953|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058983|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56058984|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
56058985|NCT03004339|Calcipotriene|calcipotriene|mesh-list
56058986|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56058987|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058988|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
56058989|NCT03004339|Hormones|hormones|mesh-ancestor
56058990|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058991|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058992|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56058993|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
56058994|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
56058995|NCT00002619|Carboplatin|carboplatin|mesh-list
56058996|NCT00002619|Thiotepa|thiotepa|mesh-list
56058997|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058998|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
56058999|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059025|NCT05752305|Autonomic Agents|autonomic agents|mesh-ancestor
56059026|NCT05752305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059027|NCT05752305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059028|NCT05752305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059031|NCT05752305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059032|NCT05752305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56059033|NCT05752305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059034|NCT05752305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56059035|NCT05752305|Protective Agents|protective agents|mesh-ancestor
56059036|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
56059037|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56059038|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56059039|NCT04343729|Prednisolone|prednisolone|mesh-list
56059040|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
56059041|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56059042|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
56059043|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56059044|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
56059045|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
56059046|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059047|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059048|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059049|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
56059050|NCT04343729|Hormones|hormones|mesh-ancestor
56059070|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777653|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777654|NCT04731974|Protective Agents|protective agents|mesh-ancestor
56777655|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777656|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777657|NCT00987662|Amlodipine|amlodipine|mesh-list
56777658|NCT00987662|Irbesartan|irbesartan|mesh-list
56777659|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56777660|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56777661|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56777662|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777663|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56777664|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777665|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
56777666|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56777667|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56777668|NCT04430426|Glycolic acid|glycolic acid|mesh-list
56777669|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
56777670|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
56777671|NCT00090103|Tamsulosin|tamsulosin|mesh-list
56059071|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059073|NCT00002637|Aldesleukin|aldesleukin|mesh-list
56059074|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
56059075|NCT00002637|Vaccines|vaccines|mesh-list
56059076|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059077|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
56059078|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059079|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56059080|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56059081|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
56059082|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740390|NCT03387631|Artemether|artemether|mesh-list
56191577|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191578|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56191579|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56191580|NCT01476358|Vitamin A|vitamin a|mesh-list
56059083|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56059085|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
56059086|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56059087|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56059088|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059089|NCT04416737|Insulin|insulin|mesh-list
56059090|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059091|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059092|NCT04401995|Nivolumab|nivolumab|mesh-list
56059093|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059094|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059095|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56059096|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059097|NCT00002643|Cobalt|cobalt|mesh-list
56059098|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
56059099|NCT00002643|Ifosfamide|ifosfamide|mesh-list
56059100|NCT00002643|Doxorubicin|doxorubicin|mesh-list
55786257|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
56059101|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56059103|NCT00002643|Vincristine|vincristine|mesh-list
56059104|NCT00002643|Topotecan|topotecan|mesh-list
56059105|NCT00002643|Amifostine|amifostine|mesh-list
56777672|NCT00090103|Dutasteride|dutasteride|mesh-list
56777673|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56777674|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56777675|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56777676|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
56777677|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777678|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777679|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777680|NCT00090103|Urological Agents|urological agents|mesh-ancestor
56777681|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56777682|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56777683|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777684|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
56059106|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059107|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
56059133|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059134|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
56059135|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059136|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56059137|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059138|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
56059139|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059140|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059141|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56059142|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56059143|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56059144|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56059145|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059146|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56059147|NCT00002649|Analgesics|analgesics|mesh-ancestor
56059148|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
56059149|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059150|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56059151|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56059152|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
56059153|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059154|NCT01151605|Insulin|insulin|mesh-list
56059155|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56059156|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059157|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059178|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56059179|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059180|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56059181|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
56059182|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059183|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
56059184|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56059186|NCT02249299|Analgesics|analgesics|mesh-ancestor
56059187|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
56059188|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059189|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059190|NCT00002679|Tamoxifen|tamoxifen|mesh-list
56059191|NCT00002679|Paclitaxel|paclitaxel|mesh-list
56059192|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
56059193|NCT00002679|Doxorubicin|doxorubicin|mesh-list
56059194|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56059195|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56059196|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059197|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
56059198|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
56191582|NCT01476358|Vitamins|vitamins|mesh-ancestor
56191583|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
56777685|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777686|NCT01088659|Tenofovir|tenofovir|mesh-list
56191584|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059199|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
56059200|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059201|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059202|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
56059203|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059204|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56059205|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059206|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
56059207|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56059208|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56059209|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56059210|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56059211|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059212|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56059213|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
56059214|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059238|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56059240|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
56059241|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059242|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059243|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
56059244|NCT00002691|Hormones|hormones|mesh-ancestor
56059245|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059246|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56059247|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56059248|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
56059249|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56059250|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56059251|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
56059252|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
55786411|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
56059254|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56059255|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56059256|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56059257|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56059258|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56059259|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
56059260|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059261|NCT00002691|Antidotes|antidotes|mesh-ancestor
56059262|NCT00002691|Protective Agents|protective agents|mesh-ancestor
56059263|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
56059264|NCT00002691|Vitamins|vitamins|mesh-ancestor
56059265|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
56059267|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
56059268|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
56059269|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56059270|NCT03003637|Nivolumab|nivolumab|mesh-list
56059308|NCT00002715|Bleomycin|bleomycin|mesh-list
56059309|NCT00002715|Etoposide|etoposide|mesh-list
56059310|NCT00002715|Vincristine|vincristine|mesh-list
56059311|NCT00002715|Vinblastine|vinblastine|mesh-list
56059312|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
56059345|NCT04972513|Protective Agents|protective agents|mesh-ancestor
56059347|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059348|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059349|NCT02981095|Bupivacaine|bupivacaine|mesh-list
56059350|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
56059351|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
56059380|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56059381|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56059382|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56059383|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059384|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
56059385|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059386|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059388|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
56059389|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
56191585|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
56191586|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191587|NCT01476358|Protective Agents|protective agents|mesh-ancestor
56777687|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56777688|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
56777689|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777690|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56777691|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56191588|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56191589|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191590|NCT01476410|Doxorubicin|doxorubicin|mesh-list
56191591|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56191592|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56191593|NCT01476410|Dacarbazine|dacarbazine|mesh-list
56191594|NCT01476410|Vinblastine|vinblastine|mesh-list
56191595|NCT01476410|Antibodies|antibodies|mesh-list
56191596|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
56191597|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56191598|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
56191599|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56191600|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
56191601|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191602|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56191603|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059390|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059391|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059392|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059393|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56059394|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059425|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
56059427|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059428|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059429|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56059430|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56059431|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059432|NCT04311671|Ivermectin|ivermectin|mesh-list
56059433|NCT04311671|Albendazole|albendazole|mesh-list
56059434|NCT04311671|Moxidectin|moxidectin|mesh-list
56059435|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56059436|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059437|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
56059438|NCT04311671|Anticestodal Agents|anticestodal agents|mesh-ancestor
56059439|NCT04311671|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56059440|NCT04311671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56059441|NCT04311671|Tubulin Modulators|tubulin modulators|mesh-ancestor
56059442|NCT04311671|Antimitotic Agents|antimitotic agents|mesh-ancestor
56059443|NCT04311671|Mitosis Modulators|mitosis modulators|mesh-ancestor
56059471|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56059472|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56059473|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56059474|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
56059475|NCT00002757|Doxorubicin|doxorubicin|mesh-list
56059476|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56059477|NCT00002757|Methotrexate|methotrexate|mesh-list
56059478|NCT00002757|Etoposide|etoposide|mesh-list
56059479|NCT00002757|Vincristine|vincristine|mesh-list
56059480|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059481|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
56059483|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56059484|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059485|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
56059486|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191605|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56191606|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191607|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191608|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56191609|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56191610|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56191611|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
56191612|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56191613|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
56191614|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
56191615|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
56059487|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777692|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777693|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777694|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56777695|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56777696|NCT00087607|Ribavirin|ribavirin|mesh-list
56777697|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56777698|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56777699|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
56777700|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777701|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
56777702|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777703|NCT01088737|Imiquimod|imiquimod|mesh-list
56777704|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56777705|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
56777706|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777707|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777708|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
56777709|NCT00069823|Esomeprazole|esomeprazole|mesh-list
56777710|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56777711|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56777712|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56777713|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777714|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777715|NCT01088815|Gemcitabine|gemcitabine|mesh-list
56777716|NCT01088815|Paclitaxel|paclitaxel|mesh-list
56059488|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56059489|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56059490|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56059491|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56059518|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059519|NCT00002775|Docetaxel|docetaxel|mesh-list
56059520|NCT00002775|Estramustine|estramustine|mesh-list
56059521|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059522|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
56059523|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
56059524|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
56059525|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059526|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059527|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
56059528|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56059529|NCT04023227|Valsartan|valsartan|mesh-list
56059530|NCT04023227|Enalapril|enalapril|mesh-list
56059531|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56059532|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56059533|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56059534|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56059535|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059536|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56059537|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
56059538|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777717|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56777718|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777719|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
56777720|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
56777721|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
56777722|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777723|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56777724|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
56777725|NCT01088815|Antiviral Agents|antiviral agents|mesh-ancestor
56777726|NCT01088815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777727|NCT01088815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777728|NCT01088815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059539|NCT01631149|Rocuronium|rocuronium|mesh-list
56059540|NCT01631149|Atracurium|atracurium|mesh-list
56059541|NCT01631149|Mivacurium|mivacurium|mesh-list
56059566|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
56059567|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059569|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56059570|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
56059571|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059572|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56059573|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
56059574|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56059575|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
56059576|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56059577|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
56059578|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059579|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059580|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
56059581|NCT00002793|Leucovorin|leucovorin|mesh-list
56059582|NCT00002793|Fluorouracil|fluorouracil|mesh-list
56059583|NCT00002793|Calcium|calcium|mesh-list
56059584|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
56059585|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56191617|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191618|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
56191619|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191620|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56191621|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191622|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191623|NCT01476592|Resveratrol|resveratrol|mesh-list
56191624|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
56191625|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191626|NCT01476592|Protective Agents|protective agents|mesh-ancestor
56191627|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191628|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191629|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56191630|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
56191631|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56059586|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059587|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
56059588|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059589|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56059590|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059591|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059641|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059642|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56059643|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059644|NCT04003649|Nivolumab|nivolumab|mesh-list
56059645|NCT04003649|Ipilimumab|ipilimumab|mesh-list
56059646|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059647|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059648|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56777729|NCT01088815|Immunologic Factors|immunologic factors|mesh-ancestor
56777730|NCT01088815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777732|NCT00086515|Pioglitazone|pioglitazone|mesh-list
56777733|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56777734|NCT00086515|Glipizide|glipizide|mesh-list
56777735|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56777736|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777737|NCT00086515|Incretins|incretins|mesh-ancestor
56777738|NCT00086515|Hormones|hormones|mesh-ancestor
56777739|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777740|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56777741|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
56777742|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777743|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777744|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
56777745|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
56777746|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56777747|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56777748|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777749|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56777750|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777751|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56777752|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56777753|NCT04378868|Metronidazole|metronidazole|mesh-list
56777754|NCT04378868|Cefuroxime|cefuroxime|mesh-list
56777755|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
56777756|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56777757|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059649|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059650|NCT05713851|Dapagliflozin|dapagliflozin|mesh-list
56059651|NCT05713851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56059652|NCT05713851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059653|NCT05713851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059654|NCT05713851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059655|NCT00361907|Insulin|insulin|mesh-list
56059656|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56059657|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059658|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059659|NCT05688735|Isosorbide|isosorbide|mesh-list
56059660|NCT05688735|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56059661|NCT05688735|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56059662|NCT05688735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56059663|NCT05688735|Diuretics|diuretics|mesh-ancestor
56059664|NCT05688735|Natriuretic Agents|natriuretic agents|mesh-ancestor
56059665|NCT05688735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059666|NCT05688735|Vasodilator Agents|vasodilator agents|mesh-ancestor
56059667|NCT05688735|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56777758|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
56777759|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56777760|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56777761|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56777762|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56777763|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059693|NCT05670795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56059694|NCT05670795|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56059695|NCT05670795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56059696|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56059697|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
56059698|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56059699|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56059700|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059701|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191632|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56191633|NCT01476683|Racecadotril|racecadotril|mesh-list
56191634|NCT01476683|Thiorphan|thiorphan|mesh-list
56191635|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
56191636|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191637|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
56191638|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191639|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191640|NCT01476774|Buprenorphine|buprenorphine|mesh-list
56191641|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56191642|NCT01476774|Narcotics|narcotics|mesh-ancestor
56191643|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56191644|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191645|NCT01476774|Analgesics|analgesics|mesh-ancestor
56191646|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
56059702|NCT04266197|Urological Agents|urological agents|mesh-ancestor
56059703|NCT03942419|Atropine|atropine|mesh-list
56059704|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56059705|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55786866|NCT03079999|Aspirin|aspirin|mesh-list
56059706|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56059707|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56059708|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56059709|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
56059710|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059713|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
56059715|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
56059716|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56059717|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56059718|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
56059750|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56059751|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
56059752|NCT00361517|Amphotericin B|amphotericin b|mesh-list
56059753|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56059754|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56059755|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
56059756|NCT00361517|Amebicides|amebicides|mesh-ancestor
56059757|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56059758|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56059759|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059760|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56059761|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
56059830|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059831|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059832|NCT04178005|Cladribine|cladribine|mesh-list
56059833|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059834|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059835|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
56059836|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059837|NCT05623761|Fluorides|fluorides|mesh-list
56059872|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56059873|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
56059874|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56059875|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059876|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
55965535|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56777764|NCT04333706|Capecitabine|capecitabine|mesh-list
56777765|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56777766|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
56777767|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777768|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777769|NCT00987974|Atorvastatin|atorvastatin|mesh-list
56777770|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56777771|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56777772|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56777773|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
56777774|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777775|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56777776|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56777777|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777778|NCT03519074|Cisplatin|cisplatin|mesh-list
56777779|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777780|NCT03767582|Nivolumab|nivolumab|mesh-list
56777781|NCT03767582|Vaccines|vaccines|mesh-list
56777782|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
56059877|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059909|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56059910|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56191647|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191648|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56191650|NCT01476787|Lenalidomide|lenalidomide|mesh-list
56191651|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56191652|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56191653|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191654|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
56191655|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191656|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56191657|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56059911|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56059912|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059913|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56059914|NCT00382083|Analgesics|analgesics|mesh-ancestor
56059915|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
56059916|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56059917|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56059918|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56059919|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56059920|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059921|NCT01640197|Resveratrol|resveratrol|mesh-list
56059950|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059951|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56059952|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059954|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56059955|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56059956|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56059957|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
56059958|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059959|NCT01642147|Anesthetics|anesthetics|mesh-list
56059960|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059961|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059962|NCT04584749|Lidocaine|lidocaine|mesh-list
56777783|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777784|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56777785|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777786|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56777787|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777788|NCT03905642|Amikacin|amikacin|mesh-list
56777789|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777790|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777791|NCT04126538|Pirfenidone|pirfenidone|mesh-list
56777792|NCT04126538|Analgesics|analgesics|mesh-ancestor
56777793|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
56777794|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777795|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777796|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56488773|NCT04645745|Folic Acid|folic acid|mesh-list
56777797|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56777798|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777799|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56059963|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
56059964|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
56059965|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059966|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059967|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
56059997|NCT05733897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56060000|NCT05493501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56060001|NCT05493501|Carboplatin|carboplatin|mesh-list
56060002|NCT05493501|Pemetrexed|pemetrexed|mesh-list
56060003|NCT05493501|Osimertinib|osimertinib|mesh-list
56060004|NCT05493501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56060005|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060006|NCT05493501|Tubulin Modulators|tubulin modulators|mesh-ancestor
56060007|NCT05493501|Antimitotic Agents|antimitotic agents|mesh-ancestor
56060008|NCT05493501|Mitosis Modulators|mitosis modulators|mesh-ancestor
56060009|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060010|NCT05493501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56060069|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56060070|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060071|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
56060072|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56060073|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060074|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060075|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56060076|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56060077|NCT03767075|Atezolizumab|atezolizumab|mesh-list
56060078|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191658|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56191659|NCT01476787|Growth Substances|growth substances|mesh-ancestor
56191660|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
56191661|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56191662|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
56191663|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191664|NCT01476800|Ketoconazole|ketoconazole|mesh-list
56191665|NCT01476800|Mirabegron|mirabegron|mesh-list
56191666|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
56191667|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777800|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777802|NCT04004234|Gemcitabine|gemcitabine|mesh-list
56777803|NCT04004234|Paclitaxel|paclitaxel|mesh-list
56191668|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56060079|NCT03762317|Clonidine|clonidine|mesh-list
56060080|NCT03762317|Analgesics|analgesics|mesh-ancestor
55787245|NCT04432259|Dexamethasone|dexamethasone|mesh-list
56060081|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
56060082|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060083|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060084|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56060085|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
56060086|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
56060087|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56060088|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56060089|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56060090|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
56060091|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060092|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060093|NCT03122197|Letrozole|letrozole|mesh-list
56060094|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060106|NCT03083431|Propranolol|propranolol|mesh-list
56060107|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56060108|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56060109|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
56060110|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060111|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060112|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060113|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56060114|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56060115|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
56060116|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
56060117|NCT02975921|Povidone|povidone|mesh-list
56060118|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
56060119|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
56060120|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56060121|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060122|NCT05452785|Minocycline|minocycline|mesh-list
56060123|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56060124|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060125|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
56060126|NCT03002545|Cathartics|cathartics|mesh-ancestor
56060127|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060128|NCT04517747|Ramucirumab|ramucirumab|mesh-list
56060129|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060131|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
56060132|NCT02219581|BB 1101|bb 1101|mesh-list
56060133|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56060134|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
56060135|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
56060136|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060137|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060138|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060139|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
56060140|NCT02219581|Hormones|hormones|mesh-ancestor
56060141|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060142|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56060143|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191669|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56191670|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191671|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191672|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56060144|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
56060145|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060165|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
56060166|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
56060167|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060168|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56060169|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56060170|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56060171|NCT03740165|Growth Substances|growth substances|mesh-ancestor
56060172|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060173|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
56777804|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56777805|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56777806|NCT04004234|Antibodies|antibodies|mesh-list
56060174|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56060175|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060177|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56060178|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
56060179|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060180|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060181|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060182|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
56060183|NCT01654861|Gemcitabine|gemcitabine|mesh-list
56060184|NCT01654861|Vitamins|vitamins|mesh-ancestor
56060185|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
56060186|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060187|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56060188|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
56060189|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060190|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060191|NCT01654861|Antiviral Agents|antiviral agents|mesh-ancestor
56060192|NCT01654861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060193|NCT01654861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060194|NCT01654861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56060195|NCT01654861|Immunologic Factors|immunologic factors|mesh-ancestor
56060196|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
56060202|NCT05735834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56060203|NCT05735834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060204|NCT05735834|Immunologic Factors|immunologic factors|mesh-ancestor
56060205|NCT05735834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060206|NCT05735834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56060299|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060300|NCT01656187|Memantine|memantine|mesh-list
56060301|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56060302|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56060303|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
56060304|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060305|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060306|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060307|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56060308|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56060309|NCT01658839|Travoprost|travoprost|mesh-list
56060310|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56060311|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56060312|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56060313|NCT01658995|Doxycycline|doxycycline|mesh-list
56060314|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56060315|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060318|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56060319|NCT01350141|Bococizumab|bococizumab|mesh-list
56060320|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56060321|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56060322|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
56060323|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060354|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56191673|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
56191674|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56191675|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191676|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56191677|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56191678|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56191679|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56191680|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
56191681|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191682|NCT01476800|Urological Agents|urological agents|mesh-ancestor
56191683|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
56191684|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56191685|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56060355|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
56060356|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060357|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060358|NCT05141721|Leucovorin|leucovorin|mesh-list
56060359|NCT05141721|Bevacizumab|bevacizumab|mesh-list
56060360|NCT05141721|Ipilimumab|ipilimumab|mesh-list
56777807|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
56777808|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56777809|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777810|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
56060361|NCT05141721|Atezolizumab|atezolizumab|mesh-list
56060362|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56060363|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060364|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56060365|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56060366|NCT05141721|Growth Substances|growth substances|mesh-ancestor
56060367|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060368|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
56060369|NCT05141721|Antidotes|antidotes|mesh-ancestor
56060370|NCT05141721|Protective Agents|protective agents|mesh-ancestor
56060371|NCT05141721|Vitamin B Complex|vitamin b complex|mesh-ancestor
56060372|NCT05141721|Vitamins|vitamins|mesh-ancestor
56060373|NCT05141721|Micronutrients|micronutrients|mesh-ancestor
56060374|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56060375|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060376|NCT01598545|Hydromorphone|hydromorphone|mesh-list
56060412|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56060413|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060414|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060415|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
56060443|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56060444|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060445|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56060446|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060447|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060448|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
56060449|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56060451|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56060452|NCT00000327|Narcotics|narcotics|mesh-ancestor
56060453|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060454|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060455|NCT00000327|Analgesics|analgesics|mesh-ancestor
55787616|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060456|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
56060457|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060458|NCT01919216|Citalopram|citalopram|mesh-list
56060459|NCT01919216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56060485|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56060486|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
56191686|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56191687|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
56191688|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060487|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060488|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060489|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060490|NCT05364645|Carboplatin|carboplatin|mesh-list
56060491|NCT05364645|Pemetrexed|pemetrexed|mesh-list
56060492|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060493|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060494|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060495|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56060496|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56060497|NCT01919450|Regadenoson|regadenoson|mesh-list
56060498|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56060499|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56060500|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
56060501|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
56060502|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060524|NCT05735132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060525|NCT05735132|Sensory System Agents|sensory system agents|mesh-ancestor
56060526|NCT05735132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787763|NCT04426591|Biotin|biotin|mesh-list
56060527|NCT05735132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56060528|NCT05735132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56060529|NCT05735132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56777811|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
56777812|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
56777813|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777814|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
56777815|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777816|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56777817|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
56777818|NCT04004234|Antiviral Agents|antiviral agents|mesh-ancestor
56777819|NCT04004234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777820|NCT04004234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777821|NCT04004234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777822|NCT04004234|Trace Elements|trace elements|mesh-ancestor
56777823|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
56060530|NCT05735132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060531|NCT05735132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060533|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060534|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56060535|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56060536|NCT01667029|Analgesics|analgesics|mesh-ancestor
56060537|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
56060538|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060539|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060540|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56060541|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56060542|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060543|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
56060544|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
56060545|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56060546|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56060547|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
56060548|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060549|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060550|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060551|NCT05106153|Zolpidem|zolpidem|mesh-list
56060552|NCT05106153|Suvorexant|suvorexant|mesh-list
56060553|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56060554|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56060606|NCT00000345|Lofexidine|lofexidine|mesh-list
56060607|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56060608|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56060609|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060610|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
56060611|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060612|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56060613|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56060614|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56060615|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
56060616|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060617|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060618|NCT00000357|Buprenorphine|buprenorphine|mesh-list
56060619|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56060620|NCT00000357|Narcotics|narcotics|mesh-ancestor
56060621|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060622|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060623|NCT00000357|Analgesics|analgesics|mesh-ancestor
56060624|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
56191689|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191690|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191691|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
56191692|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191693|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
56777824|NCT00990158|Vitamin K|vitamin k|mesh-list
56777825|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
56777826|NCT00990158|Vitamins|vitamins|mesh-ancestor
56777827|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
56777828|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777829|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56777830|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56777831|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777832|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
56777833|NCT00990158|Coagulants|coagulants|mesh-ancestor
56777834|NCT00412984|Warfarin|warfarin|mesh-list
56777835|NCT00412984|Apixaban|apixaban|mesh-list
56050566|NCT01717898|Prednisone|prednisone|mesh-list
56191694|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191695|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56191696|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56191697|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
56191698|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191700|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56060658|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56060659|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060660|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060661|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56060662|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
56060663|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56060664|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56060665|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
56060666|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56060696|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56060697|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
56060699|NCT01610011|Glycine|glycine|mesh-list
56060700|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
56060701|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060702|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060703|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060704|NCT00000399|Hormones|hormones|mesh-list
56060705|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060706|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060707|NCT02237989|Acetaminophen|acetaminophen|mesh-list
56060708|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56060709|NCT02237989|Analgesics|analgesics|mesh-ancestor
56060710|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
56060734|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060735|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56060737|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56060738|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
56060739|NCT01925144|Omeprazole|omeprazole|mesh-list
56060740|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56060741|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060742|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56060743|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060744|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060745|NCT00000441|Carbamazepine|carbamazepine|mesh-list
56060746|NCT00000441|Lorazepam|lorazepam|mesh-list
56060747|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
56060748|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
56060749|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
56060750|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060751|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060752|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060753|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56060754|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060755|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56060756|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56777836|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
56777837|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56777838|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
56777839|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56777840|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
56060757|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56060758|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
56060759|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
56060760|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191702|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
56191703|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
56191704|NCT01477034|Vitamins|vitamins|mesh-list
56191705|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
56191706|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060818|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060819|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56060820|NCT01948388|Hormones|hormones|mesh-ancestor
56060821|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060822|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060823|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
56060824|NCT01675297|Vitamin D|vitamin d|mesh-list
56060825|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
56060826|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
56060827|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56060828|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060829|NCT01675297|Vitamins|vitamins|mesh-ancestor
56060830|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
56060831|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56060832|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56060833|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060868|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060871|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
56060872|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56060873|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56060874|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
56060905|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56060906|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060908|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56060909|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060910|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56060911|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
56060912|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060913|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740434|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060915|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060916|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060917|NCT01676311|Huperzine A|huperzine a|mesh-list
56060949|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
56060950|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56060951|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060952|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56060953|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56060954|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740438|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
56060955|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060956|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060957|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56060958|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56060991|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060992|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060993|NCT01617577|Lenograstim|lenograstim|mesh-list
56060994|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56060995|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
56060996|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060997|NCT01701037|Trametinib|trametinib|mesh-list
56060998|NCT01701037|Dabrafenib|dabrafenib|mesh-list
56060999|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061000|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56061001|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777841|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777842|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777843|NCT03471182|Cocaine|cocaine|mesh-list
56777844|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
56777845|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
56061053|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56061054|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061055|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
56061056|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061057|NCT01683331|Insulin|insulin|mesh-list
56061058|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56191707|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56191708|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56191709|NCT01477060|Metformin|metformin|mesh-list
56191710|NCT01477060|Lapatinib|lapatinib|mesh-list
56191711|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56191712|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191713|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191714|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56191715|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191716|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191717|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56191718|NCT01477073|Hormones|hormones|mesh-ancestor
56191719|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56191720|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191721|NCT01477112|Beta Carotene|beta carotene|mesh-list
56191722|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191723|NCT01477112|Provitamins|provitamins|mesh-ancestor
56191724|NCT01477112|Vitamins|vitamins|mesh-ancestor
56191725|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
56191726|NCT01477151|Anesthetics|anesthetics|mesh-list
56191727|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56191728|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191729|NCT01477190|Morphine|morphine|mesh-list
56191730|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56191731|NCT01477190|Narcotics|narcotics|mesh-ancestor
56191732|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56191733|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191734|NCT01477190|Analgesics|analgesics|mesh-ancestor
56191735|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
56191737|NCT01477203|Citalopram|citalopram|mesh-list
56191738|NCT01477203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56191739|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56191740|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56213202|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56061059|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061060|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
56061061|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56061062|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56061063|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56191741|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191742|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191743|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
56191744|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061064|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56061065|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061066|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
56061067|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061068|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061069|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56061070|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061071|NCT02290106|Pitavastatin|pitavastatin|mesh-list
56061072|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56061073|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56061074|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56061075|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
56061076|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061078|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56061079|NCT00000621|Tretinoin|tretinoin|mesh-list
56061080|NCT00000621|Isotretinoin|isotretinoin|mesh-list
56777846|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777847|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777848|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
56777849|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777850|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56050577|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061081|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061082|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
56061083|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061084|NCT04818957|Vitamin D|vitamin d|mesh-list
56061085|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
56061086|NCT04818957|Vitamins|vitamins|mesh-ancestor
56061087|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
56061088|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061089|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56061117|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
56061118|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56061120|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56061121|NCT00000627|Fluconazole|fluconazole|mesh-list
56061122|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
56061123|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061124|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56061125|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56061126|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061127|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061128|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56061129|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
56061130|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061131|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061132|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56061133|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56061134|NCT00000633|Vaccines|vaccines|mesh-list
56061135|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
56061136|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061171|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56061172|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56061173|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56061174|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56061175|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56061176|NCT01701505|Phenylephrine|phenylephrine|mesh-list
56061177|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
56061178|NCT01701505|Tetracaine|tetracaine|mesh-list
56061211|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56061212|NCT01622257|Metformin|metformin|mesh-list
56061213|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56061214|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061215|NCT04942899|Capecitabine|capecitabine|mesh-list
56061216|NCT04942899|Letrozole|letrozole|mesh-list
56061219|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061221|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56061251|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56191745|NCT01477203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56191747|NCT01477203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56191748|NCT01477242|Ondansetron|ondansetron|mesh-list
56191749|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
56191750|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
56191751|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191752|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191753|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191754|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
56191755|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
56191756|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56191757|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
56061252|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56061253|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061255|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
56061256|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
56061257|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061258|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
56777851|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56777852|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55884349|NCT01620190|Paclitaxel|paclitaxel|mesh-list
56061259|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061260|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56061261|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
56061262|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061263|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
56061264|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56061265|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061266|NCT00000723|Leucovorin|leucovorin|mesh-list
56061267|NCT00000723|Zidovudine|zidovudine|mesh-list
56061268|NCT00000723|Dexamethasone|dexamethasone|mesh-list
56061288|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
56061289|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061290|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061291|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061292|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56061293|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061294|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
56061295|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061296|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56061297|NCT00000723|Antidotes|antidotes|mesh-ancestor
56061298|NCT00000723|Protective Agents|protective agents|mesh-ancestor
56061299|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
56061300|NCT00000723|Vitamins|vitamins|mesh-ancestor
56061301|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
56061302|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56061303|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
56061304|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061305|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56061306|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56061307|NCT02329964|Neostigmine|neostigmine|mesh-list
56061308|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56061309|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56061310|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061311|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061312|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
56061313|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061314|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061315|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56061316|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
56061317|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061318|NCT04750395|Haloperidol|haloperidol|mesh-list
56061319|NCT04750395|Olanzapine|olanzapine|mesh-list
56061320|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
56061321|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
56191765|NCT01477268|Sertraline|sertraline|mesh-list
56191766|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
56191767|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56191768|NCT01477268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56191769|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56191770|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55812087|NCT01649869|Valganciclovir|valganciclovir|mesh-list
56191773|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
56191774|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191775|NCT01477294|Caffeine|caffeine|mesh-list
56191776|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56191777|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061322|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
56061350|NCT00000729|Foscarnet|foscarnet|mesh-list
56061351|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56061352|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
56061353|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061354|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56061355|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56061356|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740509|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
56061357|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061359|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061360|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
56061361|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061362|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56061363|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971788|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
55884437|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
56061364|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061365|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
56061366|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56061367|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
56061368|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061369|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
56061370|NCT02974985|Protective Agents|protective agents|mesh-ancestor
56061371|NCT01704781|Lenalidomide|lenalidomide|mesh-list
56191778|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56191779|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061372|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
56061373|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061374|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56061375|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56061376|NCT01704781|Growth Substances|growth substances|mesh-ancestor
56061400|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56061401|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
56061402|NCT05700266|Aspirin|aspirin|mesh-list
56061403|NCT05700266|Rivaroxaban|rivaroxaban|mesh-list
56061404|NCT05700266|Clopidogrel|clopidogrel|mesh-list
56061405|NCT05700266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56061406|NCT05700266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56061407|NCT05700266|Analgesics|analgesics|mesh-ancestor
56061408|NCT05700266|Sensory System Agents|sensory system agents|mesh-ancestor
56061409|NCT05700266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061410|NCT05700266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061411|NCT05700266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56061412|NCT05700266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061413|NCT05700266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56061414|NCT05700266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56061415|NCT05700266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061416|NCT05700266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56061417|NCT05700266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56061418|NCT05700266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061419|NCT05700266|Antipyretics|antipyretics|mesh-ancestor
56061420|NCT05700266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56061421|NCT05700266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56061422|NCT05700266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56061423|NCT05700266|Purinergic Agents|purinergic agents|mesh-ancestor
56061424|NCT05700266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061425|NCT05700266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56061426|NCT05700266|Antithrombins|antithrombins|mesh-ancestor
56061427|NCT05700266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56061428|NCT05700266|Protease Inhibitors|protease inhibitors|mesh-ancestor
56061429|NCT05700266|Anticoagulants|anticoagulants|mesh-ancestor
56061430|NCT04340193|Nivolumab|nivolumab|mesh-list
56061462|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061463|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
56061464|NCT04683939|Antiviral Agents|antiviral agents|mesh-ancestor
56061465|NCT04683939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061466|NCT04683939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061470|NCT01686451|Simvastatin|simvastatin|mesh-list
56061471|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56061472|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56061473|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
56061500|NCT05681702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061501|NCT05681702|Antipyretics|antipyretics|mesh-ancestor
56061502|NCT05681702|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56061503|NCT05681702|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56061504|NCT05681702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56061505|NCT05681702|Purinergic Agents|purinergic agents|mesh-ancestor
56061506|NCT05681702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061508|NCT04675983|Capecitabine|capecitabine|mesh-list
56061509|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
56061510|NCT04675983|Ramucirumab|ramucirumab|mesh-list
56061511|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061512|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
56061513|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061514|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061515|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061516|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
56061517|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061518|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
56061519|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56061520|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777853|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56777854|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777855|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
56777856|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56777857|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
56777858|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
56777859|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
56777860|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777861|NCT04003376|Vitamin D|vitamin d|mesh-list
56777862|NCT04003376|Triamcinolone|triamcinolone|mesh-list
56777863|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56061584|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
56061585|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56191780|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191781|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56191782|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56191783|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
56061586|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061587|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061588|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061589|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
56061590|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061591|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061592|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
56061593|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061594|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061597|NCT04659603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061598|NCT04659603|Antimetabolites|antimetabolites|mesh-ancestor
56061599|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061600|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061601|NCT04659603|Antiviral Agents|antiviral agents|mesh-ancestor
56061602|NCT04659603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061603|NCT04659603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061604|NCT04659603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061605|NCT04659603|Immunologic Factors|immunologic factors|mesh-ancestor
56061606|NCT04659603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061632|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56061634|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
56061635|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061636|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061637|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56061638|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061639|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56061640|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061641|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061642|NCT05641298|Fusidic Acid|fusidic acid|mesh-list
56061643|NCT05641298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55740525|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
56061644|NCT05641298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061645|NCT05641298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56061646|NCT05641298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061647|NCT05641298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061648|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
56061649|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56061650|NCT04342247|Testosterone|testosterone|mesh-list
56061655|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
56061656|NCT04342247|Hormones|hormones|mesh-ancestor
56061689|NCT01690663|Hormones|hormones|mesh-ancestor
56061690|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061691|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56061692|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061693|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
56061694|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
56777864|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56777865|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56777866|NCT04003376|Vitamins|vitamins|mesh-ancestor
56777867|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
56777868|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777869|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56777870|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777871|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
56488848|NCT02899182|Analgesics|analgesics|mesh-ancestor
56777872|NCT04003376|Hormones|hormones|mesh-ancestor
56777873|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777874|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777875|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
56050598|NCT01740206|Amphetamine|amphetamine|mesh-list
56061695|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061696|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
56061697|NCT05738564|Lidocaine|lidocaine|mesh-list
56061698|NCT05738564|Epinephrine|epinephrine|mesh-list
56061727|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
56061728|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061729|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
56061730|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56061731|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061732|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061733|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56191784|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191786|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
56061735|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
56061736|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061737|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56061738|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56061739|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56061740|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
56061741|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061742|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061743|NCT05738408|Nicotine|nicotine|mesh-list
56061744|NCT05738408|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56061745|NCT05738408|Autonomic Agents|autonomic agents|mesh-ancestor
56061746|NCT05738408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061773|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56061774|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56061775|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56061776|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56061777|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56061778|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56061779|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56061780|NCT03379207|Dimercaprol|dimercaprol|mesh-list
56061781|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
56061782|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
56061783|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061784|NCT03369223|Nivolumab|nivolumab|mesh-list
56061785|NCT03369223|Ipilimumab|ipilimumab|mesh-list
56061786|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56061787|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061788|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56061789|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061791|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56061810|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061811|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56061812|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56777876|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777877|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777878|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56777879|NCT04086212|Icodextrin|icodextrin|mesh-list
56777880|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
56777881|NCT05404490|Bupivacaine|bupivacaine|mesh-list
56777882|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
56777883|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
56777884|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56777885|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777886|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
56777887|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56777888|NCT05359874|Bevacizumab|bevacizumab|mesh-list
56777889|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56777890|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777891|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56777892|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56777893|NCT05359874|Growth Substances|growth substances|mesh-ancestor
56777894|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777895|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
56777896|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
56777897|NCT03391466|Fludarabine|fludarabine|mesh-list
56777898|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777899|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
56777900|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777901|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56050617|NCT02068157|Trioxsalen|trioxsalen|mesh-list
56061813|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
56061814|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061815|NCT04612179|Sirolimus|sirolimus|mesh-list
56061816|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56061817|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061818|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56061819|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061820|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
56061821|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061822|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
56061823|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061824|NCT05578820|Ganciclovir|ganciclovir|mesh-list
56061827|NCT05578820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061828|NCT05578820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56061829|NCT05578820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061830|NCT05578820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061831|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
56061832|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
56061833|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061834|NCT01707043|Calcitriol|calcitriol|mesh-list
56061835|NCT01707043|Betamethasone|betamethasone|mesh-list
56061836|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
56777902|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56777903|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
56777904|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777905|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777906|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56777907|NCT00990392|Polymyxins|polymyxins|mesh-list
56777908|NCT00990392|Bacitracin|bacitracin|mesh-list
56777909|NCT00990392|Polymyxin B|polymyxin b|mesh-list
56777910|NCT00990392|Gramicidin|gramicidin|mesh-list
56777911|NCT00990392|Petrolatum|petrolatum|mesh-list
56777912|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777913|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777914|NCT00990392|Emollients|emollients|mesh-ancestor
56777915|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
56777916|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56777917|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
56777918|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56777919|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777920|NCT03335072|Azithromycin|azithromycin|mesh-list
56777921|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777922|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777923|NCT01034956|Calcium|calcium|mesh-list
56777924|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
56777925|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56777926|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777927|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56777928|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
56777929|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
56777930|NCT01034956|Protective Agents|protective agents|mesh-ancestor
56777931|NCT01580878|Butenafine|butenafine|mesh-list
56777932|NCT01580878|Clotrimazole|clotrimazole|mesh-list
56777933|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
56777934|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061837|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56061838|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
56061839|NCT01707043|Calcipotriene|calcipotriene|mesh-list
56061840|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56061841|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56061842|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
56061843|NCT01707043|Hormones|hormones|mesh-ancestor
56061844|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061870|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191787|NCT01477385|Protective Agents|protective agents|mesh-ancestor
56191788|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191789|NCT01477411|Digoxin|digoxin|mesh-list
55972175|NCT00081770|Ribavirin|ribavirin|mesh-list
56777935|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56777936|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56777937|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56777938|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777939|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777940|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56777941|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
56777942|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56777943|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777944|NCT05589974|Verteporfin|verteporfin|mesh-list
56777945|NCT05589974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56488920|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777946|NCT05589974|Dermatologic Agents|dermatologic agents|mesh-ancestor
56777947|NCT05589896|Mycophenolic Acid|mycophenolic acid|mesh-list
56777948|NCT05589896|Cyclophosphamide|cyclophosphamide|mesh-list
56777949|NCT05589896|Busulfan|busulfan|mesh-list
56777951|NCT05589896|Tacrolimus|tacrolimus|mesh-list
56777952|NCT05589896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56777953|NCT05589896|Immunologic Factors|immunologic factors|mesh-ancestor
56777954|NCT05589896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56777955|NCT05589896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777956|NCT05589896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56777957|NCT05589896|Alkylating Agents|alkylating agents|mesh-ancestor
56777958|NCT05589896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777959|NCT05589896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191790|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56191791|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56191792|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191793|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191794|NCT01477411|Protective Agents|protective agents|mesh-ancestor
56191795|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191796|NCT01477424|Warfarin|warfarin|mesh-list
56191797|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
56191798|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56191799|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56191800|NCT01477489|Veliparib|veliparib|mesh-list
56191801|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56191802|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191803|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191804|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191805|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56191806|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56191807|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
56061871|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061872|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061873|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
56061874|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
56061875|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
56777960|NCT05589896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56777961|NCT05589896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56777962|NCT05589896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777963|NCT05589896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56777964|NCT05589896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56777965|NCT05589896|Antitubercular Agents|antitubercular agents|mesh-ancestor
56777966|NCT05589896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56777967|NCT05589896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050684|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
56061876|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061877|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56061878|NCT01708525|Protective Agents|protective agents|mesh-ancestor
56061879|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061880|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
56061881|NCT03634917|Acamprosate|acamprosate|mesh-list
56061882|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
56061883|NCT03634917|Calcium|calcium|mesh-list
56061884|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56061885|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061886|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56061887|NCT03634917|Antacids|antacids|mesh-ancestor
56061888|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061889|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56061890|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56061891|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
56061892|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56061893|NCT05058872|Estradiol|estradiol|mesh-list
56061913|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56061914|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56061915|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56061916|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061917|NCT03614949|Atezolizumab|atezolizumab|mesh-list
56061918|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061919|NCT03538899|Busulfan|busulfan|mesh-list
56061920|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
55812111|NCT02428699|Vitamins|vitamins|mesh-ancestor
56061922|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191808|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191809|NCT01477580|Antacids|antacids|mesh-ancestor
56191810|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061923|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
56061924|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061925|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56061926|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061927|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56061928|NCT04230681|Fentanyl|fentanyl|mesh-list
56061929|NCT04230681|Hydromorphone|hydromorphone|mesh-list
56061930|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56061931|NCT04230681|Narcotics|narcotics|mesh-ancestor
56061932|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061933|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061934|NCT04230681|Analgesics|analgesics|mesh-ancestor
56061935|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
56061936|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061937|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56061938|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56061939|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
56061940|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
56061941|NCT02324543|Gemcitabine|gemcitabine|mesh-list
56061942|NCT02324543|Docetaxel|docetaxel|mesh-list
56061943|NCT02324543|Capecitabine|capecitabine|mesh-list
56061944|NCT02324543|Irinotecan|irinotecan|mesh-list
56061945|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061946|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061947|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
55789119|NCT02651155|Lubiprostone|lubiprostone|mesh-list
56061984|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56061985|NCT03590171|Bortezomib|bortezomib|mesh-list
55972176|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56777968|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56777969|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56777970|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56777971|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777972|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777973|NCT04003844|Aspirin|aspirin|mesh-list
56777974|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
56777975|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56777976|NCT04003844|Antibodies|antibodies|mesh-list
56777977|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
56777978|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
56777979|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050692|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061986|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061987|NCT03467373|Prednisone|prednisone|mesh-list
56061988|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
56062007|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56062008|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
56062010|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062011|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56062012|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062013|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062014|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062015|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062016|NCT00362765|Metformin|metformin|mesh-list
56062017|NCT00362765|Fenofibrate|fenofibrate|mesh-list
56062018|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56062019|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062020|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56062021|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
56062022|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062023|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56062024|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56062025|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56062026|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
56062027|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
56062028|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062029|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062030|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062031|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
56062032|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
56062033|NCT03300947|Lorazepam|lorazepam|mesh-list
56062034|NCT03300947|Psilocybin|psilocybin|mesh-list
56062035|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
56062036|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062037|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56062038|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
56062039|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
56062040|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
56062041|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062042|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56062043|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56062044|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062080|NCT03522077|Hemostatics|hemostatics|mesh-list
56062081|NCT03522077|Coagulants|coagulants|mesh-ancestor
56191811|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191815|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56191816|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
56191817|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191818|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191819|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
56191820|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191821|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191822|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
56777980|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56777981|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56777982|NCT04003844|Analgesics|analgesics|mesh-ancestor
56777983|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
56777984|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191823|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191824|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56191825|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56191826|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56191827|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191828|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56191829|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56191830|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56191832|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
56191833|NCT01477632|Estradiol|estradiol|mesh-list
56191834|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56191835|NCT01477632|Estrogens|estrogens|mesh-ancestor
56191836|NCT01477632|Hormones|hormones|mesh-ancestor
56062082|NCT02980562|Bisacodyl|bisacodyl|mesh-list
56062112|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062113|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
56062114|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062115|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56062116|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56062118|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56062119|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56062120|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56062121|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062122|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062123|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56062124|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56062125|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
56062126|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062127|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56062128|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56062129|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
56062162|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062163|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56062164|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062165|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062167|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56062168|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191837|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56191838|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191839|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56191840|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
56191841|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56062169|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062170|NCT04990388|Acetaminophen|acetaminophen|mesh-list
56062171|NCT04990388|Antipyretics|antipyretics|mesh-list
56062199|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
56062200|NCT04330677|Oxytocin|oxytocin|mesh-list
56062201|NCT04330677|Estrogens|estrogens|mesh-list
56062202|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
56062203|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56062204|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062205|NCT04330677|Hormones|hormones|mesh-ancestor
56062206|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062207|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
56062208|NCT04965116|Progestins|progestins|mesh-list
56062209|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56062210|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062211|NCT04965116|Hormones|hormones|mesh-ancestor
56062212|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062213|NCT02422615|Fulvestrant|fulvestrant|mesh-list
56062214|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56062215|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062247|NCT03200847|Tretinoin|tretinoin|mesh-list
56062248|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56777985|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56777986|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56777987|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56777988|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56050710|NCT02032433|Naltrexone|naltrexone|mesh-list
56062249|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062250|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
56062251|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
56062252|NCT02259517|Guanfacine|guanfacine|mesh-list
55789427|NCT05057845|Lenvatinib|lenvatinib|mesh-list
56062253|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56062254|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56062255|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062256|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56062257|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56062258|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062259|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062260|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
56062261|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062296|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
56062297|NCT03166761|Hormones|hormones|mesh-ancestor
56062298|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062299|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56062300|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062301|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062336|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
56062337|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
56062338|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56062339|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56062340|NCT00002901|Docetaxel|docetaxel|mesh-list
56062341|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062342|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062377|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56062378|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
56062379|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56062380|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
56062381|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56062410|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062411|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
56062412|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56191843|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56062413|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56062414|NCT04826588|Prednisolone|prednisolone|mesh-list
56062415|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
56062416|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56062417|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
56062418|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
56062419|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56062420|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
56062421|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
56062422|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062423|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062424|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56062425|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
56062427|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062428|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56062429|NCT04826588|Protective Agents|protective agents|mesh-ancestor
56062430|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56062465|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
56062466|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062467|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062468|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56062501|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
56062502|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56062503|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
56062504|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56062505|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062506|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56062507|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56062509|NCT02275338|Lanreotide|lanreotide|mesh-list
56777989|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56777990|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56777991|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56777992|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56777993|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
56777994|NCT05589584|Acetylcysteine|acetylcysteine|mesh-list
56777995|NCT05589584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56777996|NCT05589584|Antiviral Agents|antiviral agents|mesh-ancestor
56777997|NCT05589584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56777998|NCT05589584|Expectorants|expectorants|mesh-ancestor
56777999|NCT05589584|Respiratory System Agents|respiratory system agents|mesh-ancestor
56778000|NCT05589584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56778001|NCT05589584|Antioxidants|antioxidants|mesh-ancestor
56778002|NCT05589584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778003|NCT05589584|Protective Agents|protective agents|mesh-ancestor
56778004|NCT05589584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062510|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062511|NCT01646268|Rotigotine|rotigotine|mesh-list
56062512|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
56062548|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062550|NCT02795858|Octreotide|octreotide|mesh-list
56062551|NCT02795858|Ramucirumab|ramucirumab|mesh-list
56062552|NCT02795858|Lanreotide|lanreotide|mesh-list
56062553|NCT02795858|Somatostatin|somatostatin|mesh-list
56062554|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56062584|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56062585|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062586|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
56062587|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
56062588|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062589|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56062590|NCT01726621|Insulin|insulin|mesh-list
56062591|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56062592|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062594|NCT03836066|Atezolizumab|atezolizumab|mesh-list
56062595|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062596|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062597|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56062598|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56062599|NCT03836066|Growth Substances|growth substances|mesh-ancestor
56062600|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062632|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062633|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062634|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062635|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56062636|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56062637|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
56062638|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062639|NCT02307812|Paclitaxel|paclitaxel|mesh-list
56062640|NCT02307812|Ramucirumab|ramucirumab|mesh-list
56062641|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062675|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
56062676|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56191844|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56191845|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56191846|NCT01477736|Oxybutynin|oxybutynin|mesh-list
56191847|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
56191848|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56191849|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56191850|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56778005|NCT05589584|Antidotes|antidotes|mesh-ancestor
56778006|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56778007|NCT00412750|Telbivudine|telbivudine|mesh-list
56778008|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
56778009|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778010|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56778011|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778012|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778013|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
56778014|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56778015|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56778016|NCT05361278|Eusol|eusol|mesh-list
56778017|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56778018|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56778019|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778020|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
56050731|NCT02342327|Menthol|menthol|mesh-list
56062677|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56062678|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56062679|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062680|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062681|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
56062709|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56062711|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
56062712|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56062713|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56062714|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062715|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062716|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062717|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062718|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062719|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
56062720|NCT03174275|Paclitaxel|paclitaxel|mesh-list
56062721|NCT03174275|Carboplatin|carboplatin|mesh-list
56062722|NCT03174275|Durvalumab|durvalumab|mesh-list
56062723|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062724|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062725|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062726|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062727|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062792|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
56062793|NCT05316649|Chrysarobin|chrysarobin|mesh-list
56062794|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56062795|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56062796|NCT05316649|Analgesics|analgesics|mesh-ancestor
56062797|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
56062798|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062801|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56062802|NCT03990363|Allopurinol|allopurinol|mesh-list
56062829|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56062830|NCT00002919|Methotrexate|methotrexate|mesh-list
56062831|NCT00002919|Vinblastine|vinblastine|mesh-list
56062832|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062833|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56062834|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56062835|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56062836|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062837|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062838|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56062839|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
55972177|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
56778021|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
56778022|NCT00764855|Propofol|propofol|mesh-list
56778023|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56778024|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489003|NCT04640324|Vitamin D|vitamin d|mesh-list
56778025|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778026|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56778027|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
56778028|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
56778029|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56778030|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56778031|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55752342|NCT03321773|Antacids|antacids|mesh-ancestor
56062840|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56062841|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062842|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56062843|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
56062844|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
56062845|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56062846|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062847|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
56062848|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56062849|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56062850|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062851|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062852|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062877|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56062878|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56062879|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56062881|NCT04635241|Calcium heparin|calcium heparin|mesh-list
56062882|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
56191851|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062883|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56062884|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56062885|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062886|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56062887|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56062888|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062889|NCT03954483|Triazolam|triazolam|mesh-list
56062890|NCT03954483|Buspirone|buspirone|mesh-list
56062891|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56062892|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56062893|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062894|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062895|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56062896|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56062897|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
56062898|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062899|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062920|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56062921|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
56062922|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56062923|NCT04526899|Cemiplimab|cemiplimab|mesh-list
56062924|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062925|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062926|NCT00002937|Paclitaxel|paclitaxel|mesh-list
56062927|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062928|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062929|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062930|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062931|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
56778032|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56778033|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778034|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778035|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778036|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56778037|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
56778038|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56778039|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
56050759|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
56062932|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062933|NCT02922777|Docetaxel|docetaxel|mesh-list
56062934|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062935|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062936|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062937|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062938|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062939|NCT02918955|Cisplatin|cisplatin|mesh-list
56062940|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062941|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
56062942|NCT00002943|Carboplatin|carboplatin|mesh-list
56062943|NCT00002943|Etoposide|etoposide|mesh-list
56062944|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062945|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
56062946|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062947|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56062948|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56062949|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
56062950|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062951|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062952|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56062953|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062954|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56062955|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56062985|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062986|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062987|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
56062989|NCT00002955|Protective Agents|protective agents|mesh-ancestor
56062990|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
56062991|NCT00002955|Vitamins|vitamins|mesh-ancestor
56062992|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
56062993|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
56062994|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56062995|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56062996|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062997|NCT02877303|Cytarabine|cytarabine|mesh-list
56062998|NCT02877303|Dexamethasone|dexamethasone|mesh-list
56062999|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
56063000|NCT02877303|Prednisone|prednisone|mesh-list
56063001|NCT02877303|Cortisone|cortisone|mesh-list
56063002|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
56063003|NCT02877303|Rituximab|rituximab|mesh-list
56063004|NCT02877303|Doxorubicin|doxorubicin|mesh-list
56063005|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56063006|NCT02877303|Methotrexate|methotrexate|mesh-list
56191852|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191853|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
56191854|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191855|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191856|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56191857|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191858|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
56191859|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
56191860|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56191861|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56191862|NCT01477736|Urological Agents|urological agents|mesh-ancestor
56191863|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
56191864|NCT01477801|Vitamin D|vitamin d|mesh-list
55972231|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56778040|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56778041|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
56778042|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778043|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56778044|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
56778045|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56778046|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778047|NCT00765011|Cetuximab|cetuximab|mesh-list
56778048|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56778049|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778050|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
56778051|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56778052|NCT00765167|Triclosan|triclosan|mesh-list
56191865|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56191866|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063038|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063039|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063040|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063041|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063042|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56063043|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
56063044|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56063045|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063046|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
56063047|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
56063048|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56063049|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56063050|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
56063051|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063052|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063053|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063054|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063055|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063088|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
56063089|NCT00002967|Doxorubicin|doxorubicin|mesh-list
56063090|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56063091|NCT00002967|Octreotide|octreotide|mesh-list
56063092|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063093|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
56063094|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063095|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063096|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063097|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
56063098|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063099|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063100|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063132|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063133|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063134|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063135|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063136|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063137|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063138|NCT02767557|Gemcitabine|gemcitabine|mesh-list
56063139|NCT02767557|Paclitaxel|paclitaxel|mesh-list
56063140|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063141|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063175|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191867|NCT01477801|Vitamins|vitamins|mesh-ancestor
56191868|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
56191869|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56191870|NCT01477840|Misoprostol|misoprostol|mesh-list
56191871|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56778053|NCT00765167|Fluorides|fluorides|mesh-list
56778054|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
56778055|NCT00765167|Protective Agents|protective agents|mesh-ancestor
56778056|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778057|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56778058|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778059|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
56778060|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
56778061|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56778062|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56778063|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
56778064|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778065|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56778066|NCT00759551|Olmesartan|olmesartan|mesh-list
56778067|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56778068|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56778069|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56778070|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56778071|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778072|NCT03905096|Donepezil|donepezil|mesh-list
56778073|NCT03905096|BI 425809|bi 425809|mesh-list
56778074|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56778075|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778076|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778077|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
56778078|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778079|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778080|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
56778081|NCT00412360|Cyclosporine|cyclosporine|mesh-list
56778082|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
56778083|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
56778084|NCT00412360|Fludarabine|fludarabine|mesh-list
56778085|NCT00412360|Cyclosporins|cyclosporins|mesh-list
56778086|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778087|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
56778089|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778092|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778093|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778094|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56778095|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778096|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
56778097|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778098|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
56778099|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56778100|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56778101|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56778102|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
56778103|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56778104|NCT00761501|Naproxen|naproxen|mesh-list
56778105|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56778106|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56778107|NCT00761501|Analgesics|analgesics|mesh-ancestor
56778108|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
56778109|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778110|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778111|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778112|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778113|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
56778114|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56778115|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778116|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778117|NCT01088893|Everolimus|everolimus|mesh-list
56778118|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778119|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778120|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
56778121|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191872|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
56191873|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56191874|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191875|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56191876|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191877|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
56191878|NCT01477931|Bupropion|bupropion|mesh-list
56191879|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56191880|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
56191881|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56191882|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56191883|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56191884|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56778122|NCT03026036|Raclopride|raclopride|mesh-list
56778123|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56778124|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56778125|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56778126|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778127|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56778128|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56778129|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
56778130|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778131|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778132|NCT00990860|Doxorubicin|doxorubicin|mesh-list
56778133|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063176|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063178|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
56063179|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063180|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063181|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063182|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063208|NCT00003021|Bizelesin|bizelesin|mesh-list
56063209|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063210|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063211|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063212|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
56063213|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063214|NCT03839823|Gemcitabine|gemcitabine|mesh-list
56063215|NCT03839823|Paclitaxel|paclitaxel|mesh-list
56063216|NCT03839823|Vinorelbine|vinorelbine|mesh-list
56063217|NCT03839823|Docetaxel|docetaxel|mesh-list
56063218|NCT03839823|Capecitabine|capecitabine|mesh-list
56063219|NCT03839823|Letrozole|letrozole|mesh-list
56063220|NCT03839823|Anastrozole|anastrozole|mesh-list
56063221|NCT03839823|Goserelin|goserelin|mesh-list
56063222|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063223|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063224|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063225|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063226|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063227|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063228|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063229|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
56063230|NCT03839823|Antiviral Agents|antiviral agents|mesh-ancestor
56063231|NCT03839823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063232|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063265|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063266|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56063267|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063268|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063270|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56063271|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
56063272|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
56063273|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
56063274|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
56191885|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191886|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
56191888|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191889|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56191890|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56191891|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191892|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56191893|NCT01477983|Flecainide|flecainide|mesh-list
56191894|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56191895|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55972232|NCT01927887|Hematinics|hematinics|mesh-ancestor
56778134|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778135|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56778136|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56778137|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778138|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778139|NCT01035190|Budesonide|budesonide|mesh-list
56778140|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778141|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56778142|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
56778143|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778144|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778145|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56778146|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
56778147|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
56778148|NCT01035190|Hormones|hormones|mesh-ancestor
56050826|NCT02041325|Growth Substances|growth substances|mesh-ancestor
56191896|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56063275|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56063276|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063314|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063315|NCT00003081|Melphalan|melphalan|mesh-list
56063316|NCT00003081|Busulfan|busulfan|mesh-list
56063317|NCT00003081|Thiotepa|thiotepa|mesh-list
56063318|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
56063319|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063320|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063350|NCT00003093|Carboplatin|carboplatin|mesh-list
56063351|NCT00003093|Doxorubicin|doxorubicin|mesh-list
56063352|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56063353|NCT00003093|Etoposide|etoposide|mesh-list
56063354|NCT00003093|Molgramostim|molgramostim|mesh-list
56063355|NCT00003093|Lenograstim|lenograstim|mesh-list
56063356|NCT00003093|Sargramostim|sargramostim|mesh-list
56063357|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063358|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
56063359|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063360|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063361|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063362|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
56063363|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063364|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063365|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063383|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56063384|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56063385|NCT00003099|Protective Agents|protective agents|mesh-ancestor
56063386|NCT00003105|Gemcitabine|gemcitabine|mesh-list
56063387|NCT00003105|Paclitaxel|paclitaxel|mesh-list
56063388|NCT00003105|Doxorubicin|doxorubicin|mesh-list
56063389|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56063390|NCT00003105|Ifosfamide|ifosfamide|mesh-list
56063391|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063392|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063393|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063394|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063395|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063396|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063397|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063398|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
56063399|NCT00003105|Antiviral Agents|antiviral agents|mesh-ancestor
56063400|NCT00003105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063401|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778149|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778169|NCT00571103|Acamprosate|acamprosate|mesh-list
56778170|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56778171|NCT00084799|Antibodies|antibodies|mesh-list
56778172|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56050843|NCT01745822|Tenofovir|tenofovir|mesh-list
56063402|NCT00003105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063403|NCT00003105|Immunologic Factors|immunologic factors|mesh-ancestor
56063404|NCT00003105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063405|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063406|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063407|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063408|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56191897|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191898|NCT01478022|Ibuprofen|ibuprofen|mesh-list
56191899|NCT01478022|Isosorbide|isosorbide|mesh-list
56191900|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56191901|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56191902|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56191903|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56191904|NCT01478022|Analgesics|analgesics|mesh-ancestor
56191905|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
56191906|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191907|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191908|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56191909|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56191910|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56063410|NCT00003111|Paclitaxel|paclitaxel|mesh-list
56063411|NCT00003111|Carboplatin|carboplatin|mesh-list
56063412|NCT00003111|Irinotecan|irinotecan|mesh-list
56063413|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063414|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063415|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063416|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063417|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063418|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063419|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56063420|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063421|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063422|NCT05709301|Donepezil|donepezil|mesh-list
56063466|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56063468|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
56063469|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063470|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56063471|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56063472|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063473|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740581|NCT03381599|Lenograstim|lenograstim|mesh-list
56063474|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55973603|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
56778173|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
56778174|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778175|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56778176|NCT00765557|Laxatives|laxatives|mesh-ancestor
56778177|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778178|NCT01086553|Budesonide|budesonide|mesh-list
56778179|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778180|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56778181|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
56778182|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778183|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778184|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56063475|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56063476|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
56063478|NCT03962725|Propofol|propofol|mesh-list
56063479|NCT03962725|Anesthetics|anesthetics|mesh-list
56063480|NCT03962725|Rocuronium|rocuronium|mesh-list
56063481|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
56063482|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56063483|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56063484|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063485|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56063486|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
56063487|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56063488|NCT03962725|Analgesics|analgesics|mesh-ancestor
56063489|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
56063490|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063491|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56063492|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56063493|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56063494|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
56063495|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063496|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063497|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56191911|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191912|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191913|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56191915|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
56191916|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
56191917|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56191918|NCT01478074|Cytarabine|cytarabine|mesh-list
56191919|NCT01478074|Fludarabine|fludarabine|mesh-list
56191920|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191921|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56191922|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
56191923|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191924|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56191925|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
56191926|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191927|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
56191928|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56191929|NCT01478165|Palonosetron|palonosetron|mesh-list
56191930|NCT01478165|Anesthetics|anesthetics|mesh-list
56191931|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56063498|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56063499|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56063500|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56063527|NCT02210559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063528|NCT02210559|Immunologic Factors|immunologic factors|mesh-ancestor
56063529|NCT02210559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063530|NCT00003129|Valrubicin|valrubicin|mesh-list
56063531|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063532|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56778185|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
56778186|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
56778187|NCT01086553|Hormones|hormones|mesh-ancestor
56778188|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778189|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
56778190|NCT04049513|Fludarabine|fludarabine|mesh-list
56778191|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778192|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
56778193|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778194|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778195|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56778196|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
56778197|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778198|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778199|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56778200|NCT01041508|Cyclosporine|cyclosporine|mesh-list
56778201|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
56063535|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063537|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56063538|NCT00003135|Fluorouracil|fluorouracil|mesh-list
56063539|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063540|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063541|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063542|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063543|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063544|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063545|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
56063546|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063547|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063548|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
56063549|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063550|NCT03699631|Methotrexate|methotrexate|mesh-list
56063587|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
56063588|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063589|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063658|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063659|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063660|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
56191932|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191934|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
56191935|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191936|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56191937|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56191938|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56191939|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
56191940|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191941|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191942|NCT01478230|Nicotine|nicotine|mesh-list
56191943|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56063661|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063662|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063663|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063664|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
56063665|NCT04581343|Antiviral Agents|antiviral agents|mesh-ancestor
56063666|NCT04581343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063667|NCT04581343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778202|NCT01041508|Clofarabine|clofarabine|mesh-list
56778203|NCT01041508|Cyclosporins|cyclosporins|mesh-list
56778204|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778205|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778206|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778207|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
56778208|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778209|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
56778210|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778211|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
56778212|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778213|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56063668|NCT04581343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063693|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56063694|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063696|NCT05635903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56063697|NCT05635903|Anticonvulsants|anticonvulsants|mesh-ancestor
56063698|NCT05635903|Antiemetics|antiemetics|mesh-ancestor
56063699|NCT05635903|Autonomic Agents|autonomic agents|mesh-ancestor
56063700|NCT05635903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063701|NCT05635903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063702|NCT05635903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56063703|NCT05635903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56063704|NCT05635903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56063705|NCT05635903|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56063706|NCT05635903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56063707|NCT05635903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56063708|NCT05635903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56063709|NCT05635903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56063710|NCT05635903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56063711|NCT05635903|Anesthetics, General|anesthetics, general|mesh-ancestor
56063712|NCT05635903|Anesthetics|anesthetics|mesh-ancestor
56063713|NCT05635903|GABA Modulators|gaba modulators|mesh-ancestor
56063714|NCT05635903|GABA Agents|gaba agents|mesh-ancestor
56063715|NCT05635903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063716|NCT05635903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063717|NCT01746511|Glycerol|glycerol|mesh-list
56063718|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56063739|NCT05619913|Pembrolizumab|pembrolizumab|mesh-list
56063740|NCT05619913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56063741|NCT05619913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063742|NCT05585125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56063745|NCT05585125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063746|NCT05585125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063747|NCT05585125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063749|NCT01754389|Methotrexate|methotrexate|mesh-list
56063750|NCT01754389|Bortezomib|bortezomib|mesh-list
56063751|NCT01754389|Tacrolimus|tacrolimus|mesh-list
56063752|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56063753|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
56063754|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56063755|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063756|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063757|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
56191944|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
56191945|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191946|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191947|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56191948|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56191949|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
56191950|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191951|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191952|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
56778214|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56778215|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778216|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56778217|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
56778218|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56778219|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56778220|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
56778221|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56778222|NCT00766025|Calcium|calcium|mesh-list
56778223|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56778224|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778225|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56778226|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56778227|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
56778228|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191953|NCT01478282|Dabigatran|dabigatran|mesh-list
56191954|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56191955|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
56191956|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56191957|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
56191958|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063758|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063759|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063760|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
56063761|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063762|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56063763|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063764|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
56063765|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063766|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56063767|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56063768|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56063769|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063770|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063771|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
56063810|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063844|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063846|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56063847|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56063848|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56063878|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063879|NCT04005079|Miotics|miotics|mesh-ancestor
56063880|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56063881|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56063882|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
56063883|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063884|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063885|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56063886|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063887|NCT04005079|Renal Agents|renal agents|mesh-ancestor
56063888|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56063889|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063890|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063891|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063892|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56063893|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56063894|NCT01762501|Amlodipine|amlodipine|mesh-list
56063895|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56063896|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56778229|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56778230|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56778231|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778232|NCT00766181|Lidocaine|lidocaine|mesh-list
56778233|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
56778234|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
56778235|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56778236|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778237|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
56778238|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778239|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56778240|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56778241|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56778242|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56778243|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778244|NCT04048577|Natalizumab|natalizumab|mesh-list
56778245|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
56778246|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778247|NCT00991250|Temozolomide|temozolomide|mesh-list
56778248|NCT00991250|Dacarbazine|dacarbazine|mesh-list
56489218|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56778249|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56778250|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
56778251|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778252|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778253|NCT00418522|Insulin|insulin|mesh-list
56778254|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56063897|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56063898|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56063928|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
56063929|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
56191959|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191960|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
56191961|NCT01478308|Metformin|metformin|mesh-list
56191962|NCT01478308|Prednisone|prednisone|mesh-list
56191963|NCT01478308|Docetaxel|docetaxel|mesh-list
56191964|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56191965|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191966|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191967|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
56191968|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
56191969|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
56191970|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191971|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56191972|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
56191973|NCT01478308|Hormones|hormones|mesh-ancestor
56191974|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778255|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
56778256|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56778257|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778258|NCT00760175|Vaccines|vaccines|mesh-list
56778259|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
56778260|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778261|NCT00766337|Sirolimus|sirolimus|mesh-list
56778262|NCT00766337|Ranibizumab|ranibizumab|mesh-list
56778263|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56778264|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778265|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56778266|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778267|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
56778268|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778269|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
56778270|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778271|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56778272|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56778273|NCT00766337|Growth Substances|growth substances|mesh-ancestor
56778274|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
56778275|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
56778276|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56778277|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56778278|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778279|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56778280|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
56778281|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
56778282|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
56778283|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778284|NCT00762671|Ebselen|ebselen|mesh-list
56778285|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56778286|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56778287|NCT00762671|Analgesics|analgesics|mesh-ancestor
56778296|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778297|NCT00762671|Protective Agents|protective agents|mesh-ancestor
56778298|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56778299|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778300|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56778301|NCT02558387|Nintedanib|nintedanib|mesh-list
56778302|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778303|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56778304|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778305|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778306|NCT00766805|Propranolol|propranolol|mesh-list
56778307|NCT00766805|Isosorbide|isosorbide|mesh-list
56778308|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56778309|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56778310|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56778311|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56778312|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
56778313|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778314|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778315|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778316|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56778317|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56778318|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
56778319|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56778320|NCT00766805|Diuretics|diuretics|mesh-ancestor
56778321|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
56063930|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063931|NCT01769209|Cytarabine|cytarabine|mesh-list
56063932|NCT01769209|Dexamethasone|dexamethasone|mesh-list
56063933|NCT01769209|Doxorubicin|doxorubicin|mesh-list
56063934|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56063935|NCT01769209|Methotrexate|methotrexate|mesh-list
56063936|NCT01769209|Vincristine|vincristine|mesh-list
56063937|NCT01769209|Bortezomib|bortezomib|mesh-list
56063938|NCT01769209|Asparaginase|asparaginase|mesh-list
56063939|NCT01769209|Pegaspargase|pegaspargase|mesh-list
56063940|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56063941|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
56063942|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
56063943|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063971|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063972|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063973|NCT01769365|Amoxicillin|amoxicillin|mesh-list
56063974|NCT01769365|Metronidazole|metronidazole|mesh-list
56063975|NCT01769365|Clarithromycin|clarithromycin|mesh-list
56063976|NCT01769365|Pantoprazole|pantoprazole|mesh-list
56063977|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56063978|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063979|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56063980|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56063981|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56778322|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56778323|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
56778324|NCT00762749|Promethazine|promethazine|mesh-list
56778325|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56778326|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56778327|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56778328|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778329|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
56778331|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
56778332|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778333|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
56778334|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
56778335|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778336|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56778337|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
56778338|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
56778339|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778340|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778341|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56778342|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
56778343|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
56778344|NCT00403546|Ziprasidone|ziprasidone|mesh-list
56778345|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56778346|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
56778347|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778348|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778349|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778350|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56063982|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063983|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063984|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56063985|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56063986|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56063987|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56063988|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56064007|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064008|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
56064009|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064010|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56064011|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064012|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
56064013|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
56064014|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064015|NCT03499483|Tenofovir|tenofovir|mesh-list
56064016|NCT03499483|Emtricitabine|emtricitabine|mesh-list
56064017|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56778351|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56778352|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56778353|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56778354|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56778355|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
56778356|NCT00767117|Ritonavir|ritonavir|mesh-list
56778357|NCT00767117|Lopinavir|lopinavir|mesh-list
56778358|NCT00767117|Etravirine|etravirine|mesh-list
56778359|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56778360|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56778361|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
56778362|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064018|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
56064019|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064020|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56191975|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56191976|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
56064021|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56064022|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064023|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064024|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56064025|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56064026|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
56064027|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56064028|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
56064029|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064031|NCT01673867|Nivolumab|nivolumab|mesh-list
56064032|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064033|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
56064034|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
56064035|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
56064036|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064037|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064038|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56064040|NCT01777945|Capecitabine|capecitabine|mesh-list
56064041|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064042|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
56064043|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
56064044|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
56064073|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064074|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
56064075|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
56064076|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
56064077|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064078|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56064079|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
56064080|NCT05451043|Antiviral Agents|antiviral agents|mesh-ancestor
56064081|NCT05451043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064082|NCT05451043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064083|NCT05451043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56064084|NCT05451043|Immunologic Factors|immunologic factors|mesh-ancestor
56064085|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064086|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064087|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56064088|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56064089|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064090|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064091|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56064128|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064129|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064130|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
56064167|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
56064168|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064205|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778363|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778364|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56778365|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56778366|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
56778367|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778368|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56064206|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56064208|NCT01641055|Caseins|caseins|mesh-list
56064243|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
56064244|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064245|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56064246|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56064247|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
56064248|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064277|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56064279|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56064280|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56064281|NCT00568997|Analgesics|analgesics|mesh-ancestor
56064282|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
56064283|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064284|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064285|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064286|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064287|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064288|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56064289|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
56064290|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56191977|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56191978|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
56191979|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119759|NCT00003827|Topotecan|topotecan|mesh-list
56191980|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
56191981|NCT01478386|Protective Agents|protective agents|mesh-ancestor
56191982|NCT01478490|Metoprolol|metoprolol|mesh-list
56191983|NCT01478490|Mirabegron|mirabegron|mesh-list
56191984|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56191985|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56191986|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
56191987|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
56191988|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56191989|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191990|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56191991|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56191992|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56191993|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
56191994|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56191995|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191996|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56191998|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56191999|NCT01478490|Urological Agents|urological agents|mesh-ancestor
56192000|NCT01478503|Mirabegron|mirabegron|mesh-list
56192001|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56064291|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064292|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064329|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064330|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064331|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56064362|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56064363|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064364|NCT00362921|Carmustine|carmustine|mesh-list
56064365|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56064366|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56064367|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
56064368|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064369|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064370|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064372|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778369|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56778370|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56778371|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56778372|NCT00762983|Loratadine|loratadine|mesh-list
56778373|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
56778374|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
56778375|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56778376|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56778377|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56778378|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
56778379|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
56778380|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051052|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
56064373|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064394|NCT02581085|Tocotrienols|tocotrienols|mesh-list
56064395|NCT02581085|Vitamin E|vitamin e|mesh-list
56064396|NCT02581085|Tocopherols|tocopherols|mesh-list
56064397|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
56064398|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064399|NCT02581085|Protective Agents|protective agents|mesh-ancestor
56192002|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56192003|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56192004|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
56192005|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192006|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192007|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192008|NCT01478503|Urological Agents|urological agents|mesh-ancestor
56192009|NCT01478529|Mirabegron|mirabegron|mesh-list
56192010|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56192011|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56192012|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56192013|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
56192014|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192015|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192016|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192017|NCT01478529|Urological Agents|urological agents|mesh-ancestor
56192018|NCT01478568|Desipramine|desipramine|mesh-list
56192019|NCT01478568|Mirabegron|mirabegron|mesh-list
56192020|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56192021|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56192022|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56192023|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
56192024|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064400|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064401|NCT02581085|Vitamins|vitamins|mesh-ancestor
56064402|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
56064403|NCT01800877|Phenylephrine|phenylephrine|mesh-list
56064404|NCT01800877|Dopamine|dopamine|mesh-list
56064405|NCT01800877|Vasopressins|vasopressins|mesh-list
56064406|NCT01800877|Epinephrine|epinephrine|mesh-list
56064407|NCT01800877|Norepinephrine|norepinephrine|mesh-list
56064408|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56064409|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56064410|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56064411|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064412|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064413|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064414|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064415|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56064416|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56064417|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
56064418|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064419|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56778381|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778382|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778383|NCT00403234|Buprenorphine|buprenorphine|mesh-list
56778384|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56778385|NCT00403234|Narcotics|narcotics|mesh-ancestor
56778386|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56778387|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064420|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
56064421|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
56064422|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
56064423|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56064424|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
56064425|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56064427|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
56064428|NCT01800877|Coagulants|coagulants|mesh-ancestor
56064429|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56064430|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
56192025|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192026|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192027|NCT01478568|Urological Agents|urological agents|mesh-ancestor
56192028|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56192029|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
56192030|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56192031|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192032|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56192033|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56192034|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192035|NCT01478607|Capsaicin|capsaicin|mesh-list
56192036|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
56064431|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
56064432|NCT02471651|Dexamethasone|dexamethasone|mesh-list
56064433|NCT02471651|Ranibizumab|ranibizumab|mesh-list
56064468|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56064469|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56064470|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56064471|NCT04744571|Analgesics|analgesics|mesh-ancestor
56064472|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
56064473|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064474|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064475|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064510|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064511|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064512|NCT02519387|Analgesics|analgesics|mesh-ancestor
56064513|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
56064514|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064552|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064554|NCT01804075|Methadone|methadone|mesh-list
56064587|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064588|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064589|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064590|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
56064591|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56064592|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56064593|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064594|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
56064595|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064596|NCT01804465|Ipilimumab|ipilimumab|mesh-list
56064597|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064598|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064625|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064626|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
56064627|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064628|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064629|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
56064630|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56064631|NCT02417831|Tamsulosin|tamsulosin|mesh-list
56064632|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56778388|NCT00403234|Analgesics|analgesics|mesh-ancestor
56778389|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
56778390|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778391|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56778392|NCT01039090|Dopamine|dopamine|mesh-list
56778393|NCT01039090|Apomorphine|apomorphine|mesh-list
56778394|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
56778395|NCT01039090|Emetics|emetics|mesh-ancestor
56064633|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56064634|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56064635|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064636|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064637|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064638|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064639|NCT02417831|Urological Agents|urological agents|mesh-ancestor
56064640|NCT02419547|Fentanyl|fentanyl|mesh-list
56064641|NCT02419547|Midazolam|midazolam|mesh-list
56064642|NCT02419547|Propofol|propofol|mesh-list
56064643|NCT02419547|Sevoflurane|sevoflurane|mesh-list
56064644|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56192037|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
56192038|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
56192039|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192040|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192041|NCT01478633|Galantamine|galantamine|mesh-list
56192042|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56192043|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192045|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
56192046|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192047|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192048|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56192049|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
56192050|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192051|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
56192052|NCT01478685|Paclitaxel|paclitaxel|mesh-list
56192053|NCT01478685|Carboplatin|carboplatin|mesh-list
56192054|NCT01478685|Azacitidine|azacitidine|mesh-list
56192055|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56064676|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56064677|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56064678|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56064679|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56064680|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56064681|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56064682|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56064683|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064684|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
56064685|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
56064712|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064713|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56064714|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
56064715|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064716|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064717|NCT02420015|Bupropion|bupropion|mesh-list
56064718|NCT02420015|Nicotine|nicotine|mesh-list
56064719|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56064720|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
56064721|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064722|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064723|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56064724|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56064725|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
56064726|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064727|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064728|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56064729|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
56064730|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56064731|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56064764|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
56064765|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
56778396|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778397|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
56778398|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778399|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778400|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
56778401|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778402|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778403|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56778404|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
56064766|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56064767|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56064768|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56064769|NCT05324995|Analgesics|analgesics|mesh-ancestor
56192057|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56064770|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
56064796|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064797|NCT02534129|Petrolatum|petrolatum|mesh-list
56064798|NCT02534129|Emollients|emollients|mesh-ancestor
56064799|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064800|NCT02420951|Bupivacaine|bupivacaine|mesh-list
56064801|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
56064802|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
56064803|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064804|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064805|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
56064806|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064807|NCT02267083|Doxorubicin|doxorubicin|mesh-list
56064808|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56064809|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064810|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56064811|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56064812|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064813|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064814|NCT05748145|Metronidazole|metronidazole|mesh-list
56064815|NCT05748145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064816|NCT05748145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064817|NCT05748145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56064818|NCT05748145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56064819|NCT02535611|Memantine|memantine|mesh-list
56064842|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
56064843|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064844|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56064845|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56064846|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56064847|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064848|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064849|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064850|NCT05747521|Doxorubicin|doxorubicin|mesh-list
56064851|NCT05747521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56064852|NCT05747521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56064853|NCT05747521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064854|NCT05747521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56064855|NCT05747521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56064856|NCT05747521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064857|NCT05747521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064859|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
56064860|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
56064861|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064862|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064863|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
56064864|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064865|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56064866|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56064867|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56778405|NCT01039090|Protective Agents|protective agents|mesh-ancestor
56778407|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56778408|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56778409|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064868|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56064901|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56064902|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56064903|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064904|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064905|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064906|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064907|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56064908|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064909|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
56064910|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56064911|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
56064933|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56064934|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
56064935|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
56064936|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56192058|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192059|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
56192060|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
56192061|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
56192062|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192063|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56192064|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
56192065|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192067|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
56192068|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
56192069|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192070|NCT01478737|Dexamethasone|dexamethasone|mesh-list
56192071|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
56192072|NCT01478737|BB 1101|bb 1101|mesh-list
56192073|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56192074|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
56192075|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
56192076|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192077|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192078|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192079|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
56192080|NCT01478737|Hormones|hormones|mesh-ancestor
56192081|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192082|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56192083|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064937|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56064938|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56064939|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064940|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064942|NCT02493257|Capsaicin|capsaicin|mesh-list
56064943|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56064944|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064945|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064946|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064947|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
56064948|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064949|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
56064950|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064951|NCT02430389|Remifentanil|remifentanil|mesh-list
56064952|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56064954|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064955|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064956|NCT02430389|Analgesics|analgesics|mesh-ancestor
56064957|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
56064958|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064959|NCT02431637|Piperaquine|piperaquine|mesh-list
56064960|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
56064961|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56192084|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
56192085|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778410|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778411|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56778412|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56778413|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56778414|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56778415|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
56778416|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
56778417|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
56778418|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
56778419|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778420|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778421|NCT00767663|Dipyridamole|dipyridamole|mesh-list
56778422|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56778423|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778424|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778425|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56778426|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
56778427|NCT00402688|Levofloxacin|levofloxacin|mesh-list
56778428|NCT00402688|Ofloxacin|ofloxacin|mesh-list
56778429|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56778430|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778431|NCT00402688|Renal Agents|renal agents|mesh-ancestor
56192086|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192087|NCT01478997|Acetaminophen|acetaminophen|mesh-list
56192088|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56192089|NCT01478997|Analgesics|analgesics|mesh-ancestor
56192090|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
56192091|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192092|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192093|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
56192094|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56192095|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
56192096|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192097|NCT01479036|Docetaxel|docetaxel|mesh-list
56192098|NCT01479036|Epirubicin|epirubicin|mesh-list
56192099|NCT01479036|Endostatins|endostatins|mesh-list
56192100|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192101|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
56192102|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
56192103|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
56192104|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064962|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56064963|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064983|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56064984|NCT02545907|Growth Substances|growth substances|mesh-ancestor
56064985|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
56064986|NCT02495831|Diclofenac|diclofenac|mesh-list
56064987|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56064988|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56064989|NCT02495831|Analgesics|analgesics|mesh-ancestor
56064990|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
56064991|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064992|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064993|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778432|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56778433|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56778434|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56778435|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778436|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064994|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064995|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56064996|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064997|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064998|NCT02498483|Acetaminophen|acetaminophen|mesh-list
56064999|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065000|NCT02498483|Analgesics|analgesics|mesh-ancestor
56065001|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
56065002|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065003|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065004|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
56065005|NCT02547623|Dexamethasone|dexamethasone|mesh-list
56065006|NCT02547623|Prednisolone|prednisolone|mesh-list
56065007|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065008|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
56065009|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
56065010|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065011|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065012|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56065013|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
56065014|NCT02547623|Hormones|hormones|mesh-ancestor
56065015|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192106|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56192107|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56192109|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56192110|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56192111|NCT01479036|Growth Substances|growth substances|mesh-ancestor
56192112|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192113|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
56192114|NCT01479075|Insulin|insulin|mesh-list
56192115|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56192116|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56065016|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56065017|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065018|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
56065019|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56065050|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065052|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
56065053|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
56065054|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065055|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065056|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
56065057|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065058|NCT05746897|Pembrolizumab|pembrolizumab|mesh-list
56065059|NCT05746897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56065060|NCT05746897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065061|NCT02499497|Androgens|androgens|mesh-list
56065062|NCT02499497|Hormones|hormones|mesh-ancestor
56065063|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065086|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065087|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065088|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56065089|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56065090|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56065091|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065092|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
56065093|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065094|NCT02501135|Bupivacaine|bupivacaine|mesh-list
56065095|NCT02501135|Ropivacaine|ropivacaine|mesh-list
56065096|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
56065097|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
56065098|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065099|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065100|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
56778437|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778438|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56778439|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56778440|NCT04049045|Empagliflozin|empagliflozin|mesh-list
56778441|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56778442|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778443|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56778444|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778445|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55886295|NCT03315000|Xhance|xhance|mesh-list
56065101|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065102|NCT02550743|Capecitabine|capecitabine|mesh-list
56065103|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56065104|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
56065105|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065106|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065108|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065109|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065110|NCT01829503|Cytarabine|cytarabine|mesh-list
56065111|NCT01829503|Decitabine|decitabine|mesh-list
56065112|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56065113|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
56065114|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065145|NCT05742763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56065146|NCT05742763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065147|NCT05742763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065148|NCT02504723|Carvedilol|carvedilol|mesh-list
56192117|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065149|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56065150|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56065151|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
56065152|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065153|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065154|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065155|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56065156|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
56065157|NCT02504723|Protective Agents|protective agents|mesh-ancestor
56065158|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56065195|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56065196|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56065197|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
56065198|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56065199|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56065200|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56065238|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
56065239|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065240|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56065241|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56065242|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56065243|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56065274|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
56065275|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
56065276|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
56065277|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065278|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065281|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
56065282|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56065283|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
56065284|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56065285|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
56065286|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065287|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778446|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56778447|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778448|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
56778449|NCT01035580|Curcumin|curcumin|mesh-list
56778450|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56778451|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56778452|NCT01035580|Analgesics|analgesics|mesh-ancestor
56778453|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
56051118|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
56065288|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
56065289|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56065290|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
56065318|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
56065319|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
56065320|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
56065321|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065322|NCT00363857|Ropinirole|ropinirole|mesh-list
56065323|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56065324|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56065325|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
56065326|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
56065327|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065328|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065329|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065331|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065332|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
56065333|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065334|NCT00558103|Lapatinib|lapatinib|mesh-list
56065335|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065336|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56065337|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065359|NCT05690815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065361|NCT05690815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56065362|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
56065363|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56065364|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065365|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56065366|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065367|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065368|NCT04477733|Butorphanol|butorphanol|mesh-list
56065369|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56065370|NCT04477733|Narcotics|narcotics|mesh-ancestor
56192118|NCT01479088|Cinacalcet|cinacalcet|mesh-list
56192119|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56192120|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192121|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56192122|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
56192123|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192124|NCT01479114|Lenograstim|lenograstim|mesh-list
56192125|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56192126|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
56192127|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192128|NCT01479179|Trastuzumab|trastuzumab|mesh-list
56065380|NCT05688943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065381|NCT05688943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065382|NCT04218773|Phenylephrine|phenylephrine|mesh-list
56065383|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
56065384|NCT04218773|Norepinephrine|norepinephrine|mesh-list
56065386|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56065387|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
56065388|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
56065389|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065420|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
56065421|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
55792607|NCT05038657|Atezolizumab|atezolizumab|mesh-list
56065422|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065423|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778454|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778455|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778456|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778457|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778458|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778459|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778460|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778461|NCT00671879|Carisoprodol|carisoprodol|mesh-list
56778462|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56778463|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778464|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56778465|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778466|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56778467|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
56065424|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
56065425|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065426|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065427|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
56065428|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
56065429|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56065430|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
56065431|NCT02576249|Hormones|hormones|mesh-ancestor
56065432|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065433|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56065434|NCT02576249|Protective Agents|protective agents|mesh-ancestor
56065462|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065464|NCT00557245|Emtricitabine|emtricitabine|mesh-list
56065465|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56065466|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
56192135|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192136|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
56065467|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065468|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56065469|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56065470|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740617|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
56065471|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065472|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56065473|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56065474|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56065475|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56065476|NCT04743011|Heparin|heparin|mesh-list
56065477|NCT04743011|Calcium heparin|calcium heparin|mesh-list
56065478|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56065479|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
56065509|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065510|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065511|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56065512|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56065513|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56065514|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065515|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56065517|NCT01837069|Lisinopril|lisinopril|mesh-list
56065518|NCT01837069|Atorvastatin|atorvastatin|mesh-list
56065519|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56065520|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56065521|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56065522|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
56065523|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778468|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778469|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56778470|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
56065560|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065591|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56065592|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56065593|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56065594|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
56065595|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065596|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065597|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56065599|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56065600|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56065601|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
56065602|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
56065603|NCT02961257|Prednisone|prednisone|mesh-list
56065604|NCT02961257|Lenograstim|lenograstim|mesh-list
56065605|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065606|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
56065607|NCT02961257|Hormones|hormones|mesh-ancestor
56065638|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065639|NCT02589977|Regadenoson|regadenoson|mesh-list
56065640|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56065641|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56065642|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
56065643|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
56065644|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065645|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065646|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065647|NCT02274948|Metformin|metformin|mesh-list
56065648|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56065686|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55792915|NCT05009017|Bevacizumab|bevacizumab|mesh-list
56065720|NCT05627557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56065721|NCT05627557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56065722|NCT05627557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56065723|NCT05627557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065724|NCT05627557|Anesthetics, Local|anesthetics, local|mesh-ancestor
56065725|NCT05627557|Anesthetics|anesthetics|mesh-ancestor
56065726|NCT05627557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56065727|NCT05627557|Histamine Antagonists|histamine antagonists|mesh-ancestor
56065728|NCT05627557|Histamine Agents|histamine agents|mesh-ancestor
56065729|NCT05627557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065835|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56065836|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56192137|NCT01479231|Lansoprazole|lansoprazole|mesh-list
56192138|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56192139|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192140|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56192141|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065837|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56065838|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56065839|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065840|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56065841|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065842|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
56065843|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56065844|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56065845|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56065846|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56065880|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
56065881|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065882|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065884|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56065885|NCT00365339|Tenofovir|tenofovir|mesh-list
56065886|NCT00365339|Aripiprazole|aripiprazole|mesh-list
56065887|NCT00365339|Famotidine|famotidine|mesh-list
56065888|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56065913|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56065914|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56065915|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56065916|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56778471|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778472|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489442|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
56778473|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56778474|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56778475|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56778476|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
56778477|NCT00767975|Rifampin|rifampin|mesh-list
56778478|NCT00767975|Isoniazid|isoniazid|mesh-list
56778479|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56778480|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
56778481|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56778482|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778483|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
56778484|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56778485|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778486|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778487|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56778488|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56778489|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56778490|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56778491|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56778492|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56778493|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56778494|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56778495|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
56065917|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56065918|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56065919|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56065920|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
56065921|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
56065922|NCT02815033|Choline|choline|mesh-list
56065923|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
56065924|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56065925|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
56065926|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065927|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56065928|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56065929|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
56065930|NCT05589181|Buprenorphine|buprenorphine|mesh-list
56065931|NCT05589181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56065932|NCT05589181|Narcotics|narcotics|mesh-ancestor
56065933|NCT05589181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065934|NCT05589181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065935|NCT05589181|Analgesics|analgesics|mesh-ancestor
56065968|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065969|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
56778496|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56778497|NCT00768131|Paclitaxel|paclitaxel|mesh-list
56778498|NCT00768131|Carboplatin|carboplatin|mesh-list
56778499|NCT00768131|Cetuximab|cetuximab|mesh-list
56778500|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56778501|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778502|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
56778503|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
56778504|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
56778505|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778506|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56778507|NCT00401830|Lacosamide|lacosamide|mesh-list
56778508|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
56778509|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56778510|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56778511|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56778512|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778513|NCT00768209|Topiramate|topiramate|mesh-list
56778514|NCT00768209|Phentermine|phentermine|mesh-list
56051183|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
56065970|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56065971|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065972|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065973|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56065974|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065975|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065976|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
56066009|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56066010|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56066011|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066012|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
56066013|NCT01843621|Vaccines|vaccines|mesh-list
56066014|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
56066015|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066016|NCT02608229|Gemcitabine|gemcitabine|mesh-list
56066047|NCT05649618|Immunologic Factors|immunologic factors|mesh-ancestor
56066048|NCT05649618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066049|NCT05649618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066050|NCT05649618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56066051|NCT05649618|Alkylating Agents|alkylating agents|mesh-ancestor
56192142|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192143|NCT01479244|Molgramostim|molgramostim|mesh-list
56192144|NCT01479244|Sargramostim|sargramostim|mesh-list
56192145|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
56192146|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192147|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192148|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56192149|NCT01479283|Cefazolin|cefazolin|mesh-list
56192150|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56192151|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192152|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
56192153|NCT01479296|Vaccines|vaccines|mesh-list
56192154|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
56192155|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192156|NCT01479361|Atovaquone|atovaquone|mesh-list
56192157|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778515|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
56778516|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56778517|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778518|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56778519|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
56778520|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56778521|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
56778522|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
56778523|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778524|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
56778525|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778526|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778527|NCT02471144|Etanercept|etanercept|mesh-list
56778528|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56778529|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56778530|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56778531|NCT02471144|Analgesics|analgesics|mesh-ancestor
56778532|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
56778533|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778534|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778535|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778536|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778537|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778538|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778539|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
56778540|NCT00401752|Esomeprazole|esomeprazole|mesh-list
56778541|NCT00401752|Ranitidine|ranitidine|mesh-list
56778542|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56778543|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56778544|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778545|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56778546|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489520|NCT04635293|Protective Agents|protective agents|mesh-ancestor
56192158|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
56192159|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56192160|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56192161|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192162|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192163|NCT01479504|Cisplatin|cisplatin|mesh-list
56066052|NCT05649618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066054|NCT05649618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56066055|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56778547|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778548|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56778549|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
56778550|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
56778551|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778552|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778553|NCT00770471|Temozolomide|temozolomide|mesh-list
56778554|NCT00770471|Veliparib|veliparib|mesh-list
56778555|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56066056|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56066057|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56066058|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56066059|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066084|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56066085|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066086|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
56066087|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066088|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066089|NCT01847131|Phenylephrine|phenylephrine|mesh-list
56066090|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
56066091|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56066092|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56066093|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
56066094|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066095|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066096|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066097|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
56066098|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
56066099|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066100|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
56066101|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56066102|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
56066103|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56066104|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
56066105|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56066106|NCT01847131|Protective Agents|protective agents|mesh-ancestor
56192164|NCT01479504|Docetaxel|docetaxel|mesh-list
56192165|NCT01479504|Nedaplatin|nedaplatin|mesh-list
56066107|NCT02285010|Pregabalin|pregabalin|mesh-list
56066108|NCT02285010|Analgesics|analgesics|mesh-ancestor
56066109|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
56066110|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066145|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56066146|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
56066147|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56066148|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
56066149|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066150|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066151|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56066174|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066175|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56066176|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066177|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56066179|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066180|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
56066181|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56066182|NCT05731973|Sufentanil|sufentanil|mesh-list
56066183|NCT05731973|Oxycodone|oxycodone|mesh-list
56066184|NCT05731973|Analgesics, Opioid|analgesics, opioid|mesh-list
56066185|NCT05731973|Bupivacaine|bupivacaine|mesh-list
56066186|NCT05731973|Anesthetics, Local|anesthetics, local|mesh-ancestor
56066187|NCT05731973|Anesthetics|anesthetics|mesh-ancestor
56066188|NCT05731973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066189|NCT05731973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778556|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
56778557|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778558|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778559|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56778560|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778561|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
56778562|NCT00539240|Nortriptyline|nortriptyline|mesh-list
56778563|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
56778564|NCT00539240|Rabeprazole|rabeprazole|mesh-list
56778565|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56778566|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778567|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56778568|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778569|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778570|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56051236|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
56066190|NCT05731973|Sensory System Agents|sensory system agents|mesh-ancestor
56066191|NCT05731973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066192|NCT05731973|Narcotics|narcotics|mesh-ancestor
56066193|NCT05731973|Analgesics|analgesics|mesh-ancestor
56066194|NCT05731973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56066195|NCT05731973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56066196|NCT05731973|Anesthetics, General|anesthetics, general|mesh-ancestor
56066197|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
56066198|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56066199|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56066200|NCT05068349|Protective Agents|protective agents|mesh-ancestor
56066201|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066202|NCT04740931|Aflibercept|aflibercept|mesh-list
56066203|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56066239|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56066240|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56066241|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066242|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
56066243|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066244|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56066246|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56066247|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56066248|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56066262|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066263|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56066264|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56066266|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56066267|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
56066268|NCT00550771|Doxorubicin|doxorubicin|mesh-list
56066269|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56066270|NCT00550771|Trastuzumab|trastuzumab|mesh-list
56066271|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56066272|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066273|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
56066274|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
56066275|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
56066276|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066277|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066278|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
56066279|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192166|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192167|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
56778571|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56778572|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56778573|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56778574|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
56778575|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778576|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778577|NCT00417976|Gemcitabine|gemcitabine|mesh-list
56778578|NCT00417976|Bevacizumab|bevacizumab|mesh-list
56778579|NCT00417976|Fluorouracil|fluorouracil|mesh-list
56778580|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56192168|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
56192169|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
56192170|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192171|NCT01479556|Pregabalin|pregabalin|mesh-list
56192172|NCT01479556|Analgesics|analgesics|mesh-ancestor
56192173|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
56192174|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192175|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192176|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
56192177|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56192178|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192179|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192180|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56192181|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56192182|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56192183|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56192184|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56066280|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066281|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56066282|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
56066283|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56066284|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56066285|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56066286|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56066287|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066288|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066289|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56066290|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56066291|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56066292|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066314|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066315|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56066316|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
56066317|NCT05259839|Hormones|hormones|mesh-ancestor
56066318|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56066319|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56066320|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066321|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
56066322|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56066323|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56066325|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
56066327|NCT04484623|Bortezomib|bortezomib|mesh-list
56066328|NCT04484623|Pomalidomide|pomalidomide|mesh-list
56066329|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066330|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
56066331|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
56066332|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066333|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066334|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192185|NCT01479634|Efavirenz|efavirenz|mesh-list
56192186|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56192187|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56066335|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
56066336|NCT04484623|Hormones|hormones|mesh-ancestor
56778581|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778582|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56778583|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56778584|NCT00417976|Growth Substances|growth substances|mesh-ancestor
56778585|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066337|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56066338|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56066339|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066340|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
56066341|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56066342|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56066343|NCT04484623|Growth Substances|growth substances|mesh-ancestor
56066344|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
56066381|NCT05706701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066382|NCT05706701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066383|NCT05706701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56066384|NCT05706701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56066410|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
56066411|NCT04734197|Hormones|hormones|mesh-ancestor
56066412|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56066413|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56066414|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
56066415|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56066416|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066417|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56066418|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
56066419|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56066420|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56066421|NCT00550147|Methylphenidate|methylphenidate|mesh-list
56066422|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56066423|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066424|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56066425|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56066426|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56066427|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066428|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
56066429|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066430|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
56066431|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56066432|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56066433|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56066464|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066465|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56066466|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066467|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56066468|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
55793662|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
56066469|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
56066470|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066471|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066473|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56066474|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066475|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066476|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
56066477|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066478|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066479|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
56066480|NCT02265913|Acyclovir|acyclovir|mesh-list
56066481|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
56066482|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066483|NCT04191499|Fulvestrant|fulvestrant|mesh-list
56066514|NCT02279641|Protective Agents|protective agents|mesh-ancestor
56066517|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
56066518|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56066519|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066520|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56066521|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56066522|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56778586|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
56778587|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56778588|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
56778589|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886830|NCT02477514|Tedizolid|tedizolid|mesh-list
56066523|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
56192189|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192190|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
56192191|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192192|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56192193|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56192194|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56192195|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56192196|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56192197|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56192198|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
56192200|NCT01479751|Rocuronium|rocuronium|mesh-list
56192201|NCT01479751|Analgesics|analgesics|mesh-ancestor
56192202|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
56192203|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066524|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066525|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066526|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066527|NCT00553657|Urological Agents|urological agents|mesh-ancestor
56066560|NCT01866943|Coagulants|coagulants|mesh-ancestor
56066561|NCT01868425|Acetaminophen|acetaminophen|mesh-list
56066562|NCT01868425|Ketamine|ketamine|mesh-list
56066563|NCT01868425|Gabapentin|gabapentin|mesh-list
56066564|NCT01868425|Bupivacaine|bupivacaine|mesh-list
56066565|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
56066566|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
56066567|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066568|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066569|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
56066570|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066631|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
56066632|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
56066633|NCT01874119|Aprepitant|aprepitant|mesh-list
56066634|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
56066635|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
56066636|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066637|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066638|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56066639|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56066640|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066641|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066642|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
56066643|NCT03123913|Testosterone|testosterone|mesh-list
56066644|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
56066645|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
56066646|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56066647|NCT03123913|Androgens|androgens|mesh-ancestor
56066648|NCT03123913|Hormones|hormones|mesh-ancestor
56066649|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56066650|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066651|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56066652|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066653|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
56066654|NCT02823145|Fenfluramine|fenfluramine|mesh-list
56066655|NCT02823145|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56066687|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56066688|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56066689|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56192207|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
56192208|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
56192209|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56192210|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56192211|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56192212|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778590|NCT00417976|Antiviral Agents|antiviral agents|mesh-ancestor
56778591|NCT00417976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778592|NCT00417976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192213|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066690|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066691|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56066694|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
56066695|NCT01931527|Rasburicase|rasburicase|mesh-list
56066696|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
56066697|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066698|NCT02639429|Misoprostol|misoprostol|mesh-list
56066699|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56066731|NCT01936519|Cyclosporine|cyclosporine|mesh-list
56066732|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
56066733|NCT01936519|Everolimus|everolimus|mesh-list
56066734|NCT01936519|Tacrolimus|tacrolimus|mesh-list
56066735|NCT01936519|Cyclosporins|cyclosporins|mesh-list
56066736|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56066737|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066738|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
56066739|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066740|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066741|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066742|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
56066743|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066744|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
56066807|NCT05588999|Dermatologic Agents|dermatologic agents|mesh-ancestor
56066808|NCT05588999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56066809|NCT05588999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56066810|NCT05588999|Analgesics|analgesics|mesh-ancestor
56066811|NCT05588999|Sensory System Agents|sensory system agents|mesh-ancestor
56066812|NCT05588999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066813|NCT05588999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066814|NCT05588999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066815|NCT05588999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066816|NCT05588999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56066817|NCT05588999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066818|NCT05588999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066820|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
56066821|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56066822|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56066823|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066824|NCT01643928|Rituximab|rituximab|mesh-list
56066825|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066826|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066827|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
56066863|NCT05588531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066896|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56066897|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56066898|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066899|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066900|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066901|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066902|NCT02164955|Pomalidomide|pomalidomide|mesh-list
56066903|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
56066904|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066905|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56066906|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56066907|NCT02164955|Growth Substances|growth substances|mesh-ancestor
56066908|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
56066909|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066910|NCT05587361|Propranolol|propranolol|mesh-list
56066911|NCT05587361|Nicotine|nicotine|mesh-list
56066912|NCT05587361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56066976|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56066977|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066978|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066979|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56066980|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56066981|NCT00367211|Analgesics|analgesics|mesh-ancestor
56066982|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
56066983|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778593|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778594|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
56778595|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
56778596|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56778597|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56066984|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066985|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066986|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066987|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
56066988|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56066989|NCT02646449|Mirtazapine|mirtazapine|mesh-list
56066990|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
56066991|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56066992|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55794185|NCT04785755|Furosemide|furosemide|mesh-list
56066993|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
56066994|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
56066995|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066996|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066997|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066998|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56066999|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56067025|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56067027|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56067028|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
56067029|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067030|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067031|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067032|NCT05369351|Urological Agents|urological agents|mesh-ancestor
56067041|NCT03299309|Vaccines|vaccines|mesh-list
56067042|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
56067043|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067044|NCT05318573|Gemcitabine|gemcitabine|mesh-list
56067045|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
56067046|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56067047|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
56067048|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067049|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067050|NCT05318573|Antiviral Agents|antiviral agents|mesh-ancestor
56067051|NCT05318573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067052|NCT05318573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067053|NCT05318573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067054|NCT05318573|Immunologic Factors|immunologic factors|mesh-ancestor
56067055|NCT05318573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067083|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
56067084|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56067085|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56067086|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067087|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
56067088|NCT02655653|Coagulants|coagulants|mesh-ancestor
56067090|NCT05167487|Carboplatin|carboplatin|mesh-list
56067091|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067092|NCT03081143|Paclitaxel|paclitaxel|mesh-list
56067093|NCT03081143|Ramucirumab|ramucirumab|mesh-list
56067094|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56067095|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067096|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
56067097|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
56067098|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
56067099|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192215|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
56192216|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56067101|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067102|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067103|NCT00367913|Clarithromycin|clarithromycin|mesh-list
56067136|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067138|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
56067139|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56067140|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067141|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56778598|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
56778599|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778600|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778601|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778602|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56778603|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
56778604|NCT00991796|Paclitaxel|paclitaxel|mesh-list
56778605|NCT00991796|Carboplatin|carboplatin|mesh-list
56778606|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56051273|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067142|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56067170|NCT04931693|Analgesics|analgesics|mesh-ancestor
56067171|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
56067172|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067173|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067174|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
56067175|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
56067176|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067177|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067178|NCT02271594|Insulin|insulin|mesh-list
56067179|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56067180|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067181|NCT04817969|Cimetidine|cimetidine|mesh-list
56067182|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56067185|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
56067186|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
56067187|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067188|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067189|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067190|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56067223|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067224|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56067225|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067226|NCT02205047|Fluorouracil|fluorouracil|mesh-list
56067227|NCT02205047|Capecitabine|capecitabine|mesh-list
56067228|NCT02205047|Trastuzumab|trastuzumab|mesh-list
56067229|NCT02205047|Pertuzumab|pertuzumab|mesh-list
56067230|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067231|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
56067232|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067233|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56067270|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067299|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56067300|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56067301|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067302|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56067303|NCT05411471|Vaccines|vaccines|mesh-list
56067304|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
56067305|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067306|NCT02677493|Vaccines|vaccines|mesh-list
56067307|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
56067308|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067309|NCT02679911|Ciclopirox|ciclopirox|mesh-list
56067310|NCT02679911|Amorolfine|amorolfine|mesh-list
56067311|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
56067312|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067313|NCT02680301|Triamcinolone|triamcinolone|mesh-list
56067314|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56067315|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56067316|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56067346|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56067347|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067348|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067349|NCT05407961|Dulaglutide|dulaglutide|mesh-list
56067350|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56067351|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778607|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778608|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
56778609|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
56778610|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
56778611|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778612|NCT00673673|Bevacizumab|bevacizumab|mesh-list
56778613|NCT00673673|Fluorouracil|fluorouracil|mesh-list
56778614|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56778615|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778616|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56778617|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56778618|NCT00673673|Growth Substances|growth substances|mesh-ancestor
56778619|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778620|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56778621|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
56778622|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778623|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56778624|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778625|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
56778626|NCT05357768|Formaldehyde|formaldehyde|mesh-list
56778627|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
56778628|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778629|NCT00763685|Etoricoxib|etoricoxib|mesh-list
56778630|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56778631|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56067352|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56067353|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
56067354|NCT02682563|Gliclazide|gliclazide|mesh-list
56067355|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56192217|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192218|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56067356|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067357|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56067358|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067360|NCT02697071|Analgesics|analgesics|mesh-ancestor
56067361|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
56067394|NCT05648994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067395|NCT05648994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56067396|NCT05648994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56067397|NCT05648994|Alkylating Agents|alkylating agents|mesh-ancestor
56067398|NCT05648994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56067399|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
56067400|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56067401|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
56067436|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
56067437|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067438|NCT04738955|Micafungin|micafungin|mesh-list
56067439|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
56067440|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778632|NCT00763685|Analgesics|analgesics|mesh-ancestor
56778633|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
56778634|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778635|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778636|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778637|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778638|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56778639|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56778640|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067441|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
55794638|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
56067442|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
56067443|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56067444|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
56067474|NCT02705807|Tezosentan|tezosentan|mesh-list
56067475|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56067479|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56067480|NCT01643772|Narcotics|narcotics|mesh-ancestor
56067481|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067482|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067483|NCT01643772|Analgesics|analgesics|mesh-ancestor
56067484|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
56067485|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067486|NCT02707523|Azithromycin|azithromycin|mesh-list
56067487|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56067488|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067524|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067525|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067526|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56067527|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56067560|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56067561|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067562|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
56067563|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067564|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067565|NCT02721017|Fentanyl|fentanyl|mesh-list
56067566|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56067567|NCT02721017|Narcotics|narcotics|mesh-ancestor
56067591|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067592|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
56067593|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067594|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067596|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
56067597|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067598|NCT05109143|Indomethacin|indomethacin|mesh-list
56067599|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56067600|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56067601|NCT05109143|Analgesics|analgesics|mesh-ancestor
56067602|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
56067603|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067604|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067605|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067606|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56067607|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
56067608|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
56067609|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56192219|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
56192220|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56192221|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56192222|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56192223|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56192224|NCT01479881|Cyclosporine|cyclosporine|mesh-list
56192226|NCT01479881|Tacrolimus|tacrolimus|mesh-list
56192227|NCT01479881|Cyclosporins|cyclosporins|mesh-list
56192228|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56192229|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
56192230|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778641|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778642|NCT04048655|Neostigmine|neostigmine|mesh-list
56778643|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56778644|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778645|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778646|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
56778647|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778648|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778649|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56778650|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
56778651|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778652|NCT00768677|Topiramate|topiramate|mesh-list
56778653|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
56778654|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56192231|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56067610|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56067611|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067612|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067613|NCT03614663|Cannabidiol|cannabidiol|mesh-list
56067614|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
56067615|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
56067617|NCT00085735|Cisplatin|cisplatin|mesh-list
56067618|NCT00085735|Vincristine|vincristine|mesh-list
56067619|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067620|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
56067621|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067645|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067647|NCT05544786|Ritonavir|ritonavir|mesh-list
56067648|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56067649|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56067650|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
56067651|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067652|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067654|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56067655|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
56067656|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067657|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56067658|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56067659|NCT02726789|Interferons|interferons|mesh-list
56067660|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
56067661|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
56067662|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56067663|NCT02726789|Entecavir|entecavir|mesh-list
56067664|NCT02726789|REP 2139|rep 2139|mesh-list
56067665|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067666|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
56067667|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067668|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
56067669|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067670|NCT02731313|Trastuzumab|trastuzumab|mesh-list
56067671|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067696|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56067697|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
56067699|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56067700|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56067701|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067702|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
56067703|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067704|NCT05020145|Vaccines|vaccines|mesh-list
56067705|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
56067706|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067707|NCT02734355|Amlodipine|amlodipine|mesh-list
56778655|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778656|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56778657|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56778658|NCT02557451|Growth Substances|growth substances|mesh-ancestor
56778659|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778660|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
56778661|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778662|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56778663|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778664|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56778665|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778666|NCT02558153|Paclitaxel|paclitaxel|mesh-list
56778667|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56051327|NCT02376257|Renal Agents|renal agents|mesh-ancestor
56067708|NCT02734355|Telmisartan|telmisartan|mesh-list
56067709|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56067710|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56192232|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192233|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192234|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
56192235|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192236|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
56192237|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56192238|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
56192239|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
56192240|NCT01479920|Fluoxetine|fluoxetine|mesh-list
56192241|NCT01479920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56192242|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56192243|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192244|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192245|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192246|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
56192247|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192248|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56192249|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
56192250|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56192251|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56192252|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56192253|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192254|NCT01479933|Vitamin D|vitamin d|mesh-list
56192255|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
56067711|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56067712|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56067713|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067714|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56067715|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067716|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
56067717|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56067718|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56067742|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067743|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067744|NCT05446493|Urological Agents|urological agents|mesh-ancestor
56067745|NCT02863055|Nintedanib|nintedanib|mesh-list
56067746|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067747|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56067748|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110412|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
56778668|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778669|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
56778670|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
56778671|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
56778672|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778673|NCT00763763|Interferons|interferons|mesh-list
56778674|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56778675|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
56778676|NCT00763763|Dexamethasone|dexamethasone|mesh-list
56778677|NCT00763763|Vincristine|vincristine|mesh-list
56067749|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067750|NCT05445479|Doxycycline|doxycycline|mesh-list
56067751|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56067752|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067753|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
56067754|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56067755|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56067756|NCT02711735|Vaccines|vaccines|mesh-list
56067757|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
56067758|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192257|NCT01479933|Vitamins|vitamins|mesh-list
56192258|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
56192259|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192260|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56192261|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56192262|NCT01480050|Temozolomide|temozolomide|mesh-list
56192263|NCT01480050|Mibefradil|mibefradil|mesh-list
56192264|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56192265|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
56192266|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192267|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192268|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56192269|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56192270|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192271|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56192272|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192273|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
56192274|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56192275|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56192276|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192277|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
56192278|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56192279|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192280|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192281|NCT01480141|Afatinib|afatinib|mesh-list
56192282|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067759|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
56067760|NCT05445011|Fludarabine|fludarabine|mesh-list
56067761|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
56067762|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067763|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
56067764|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067765|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56067766|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56067767|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
56067768|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067769|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067787|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56067788|NCT04744181|Folic Acid|folic acid|mesh-list
56067789|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
56067790|NCT04744181|Vitamins|vitamins|mesh-ancestor
56067791|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
56067792|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067793|NCT04744181|Hematinics|hematinics|mesh-ancestor
56067794|NCT05444543|Fluticasone|fluticasone|mesh-list
56192283|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56778678|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
56778679|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778680|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
56778681|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
56778682|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778683|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778684|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778685|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
56778686|NCT00763763|Hormones|hormones|mesh-ancestor
56778687|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778688|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56778689|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778690|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
56778691|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778692|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56778693|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
56778694|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
56489679|NCT05427747|Meropenem|meropenem|mesh-list
56778695|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
56778696|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778697|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56192284|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192285|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192286|NCT01480323|Aldesleukin|aldesleukin|mesh-list
56192287|NCT01480323|Ipilimumab|ipilimumab|mesh-list
56192288|NCT01480323|Interleukin-2|interleukin-2|mesh-list
56192289|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56192290|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192291|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56192292|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192293|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56192294|NCT01480323|Analgesics|analgesics|mesh-ancestor
56192295|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
56192296|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192297|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192298|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56192299|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56192300|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
56192301|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192302|NCT01480336|Amiodarone|amiodarone|mesh-list
56192303|NCT01480336|Ranolazine|ranolazine|mesh-list
56192306|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56192307|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192308|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192309|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56192310|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56192327|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192328|NCT01480609|Ezogabine|ezogabine|mesh-list
56192329|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
56067796|NCT05444543|Budesonide|budesonide|mesh-list
56067797|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067798|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56067799|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
56067800|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778698|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778699|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
56778701|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
56778702|NCT01037140|Vitamins|vitamins|mesh-ancestor
56778703|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
56778704|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778705|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56778706|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56778707|NCT05357456|Epinephrine|epinephrine|mesh-list
56778708|NCT05357456|Racepinephrine|racepinephrine|mesh-list
56778709|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
56067801|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067802|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56067803|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
56067804|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
56067805|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56067806|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
56067807|NCT05444543|Hormones|hormones|mesh-ancestor
56067808|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56067809|NCT01970345|Mecasermin|mecasermin|mesh-list
56067810|NCT01970345|Growth Substances|growth substances|mesh-ancestor
56067811|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067812|NCT04635839|Heparin|heparin|mesh-list
56067813|NCT04635839|Calcium heparin|calcium heparin|mesh-list
56067814|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
56067815|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56067816|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56067817|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067818|NCT00619931|APD791|apd791|mesh-list
56067819|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56067820|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56067821|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
56067822|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067823|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067824|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067825|NCT04739111|Antibodies|antibodies|mesh-list
56067826|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
56067827|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56067860|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
56067861|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56067862|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56067863|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067865|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
56067866|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
56067867|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067868|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56067906|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56067907|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
56067908|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067938|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
56067939|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
56067940|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067941|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067942|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
56067943|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067944|NCT05446415|Glucagon|glucagon|mesh-list
56067945|NCT05446415|Incretins|incretins|mesh-list
56067946|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56067947|NCT05446415|Hormones|hormones|mesh-ancestor
56067948|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56067949|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067950|NCT05448365|Vitamin D|vitamin d|mesh-list
56067951|NCT05448365|Vitamins|vitamins|mesh-list
56067952|NCT05448365|Inositol|inositol|mesh-list
56067953|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
56067954|NCT05448365|Pyridoxal|pyridoxal|mesh-list
56067990|NCT00370799|Betamethasone|betamethasone|mesh-list
56778710|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56778711|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56778712|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
56778713|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56778714|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778715|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778716|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56778717|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56778718|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
56778719|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778720|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56778721|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
56778722|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
56778723|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
56778724|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56778725|NCT00069121|Leucovorin|leucovorin|mesh-list
56778726|NCT00069121|Fluorouracil|fluorouracil|mesh-list
56778727|NCT00069121|Capecitabine|capecitabine|mesh-list
56778728|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
56778729|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
56778730|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778731|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56778732|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778733|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067991|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
56067992|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56067993|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
56067994|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56068065|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068066|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56068068|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192330|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192331|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192332|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
56192333|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56192334|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
56192335|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192336|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56192337|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
56192338|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56192339|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56192340|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
56192341|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192342|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56068069|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068070|NCT02656511|Tenofovir|tenofovir|mesh-list
56068071|NCT02656511|Emtricitabine|emtricitabine|mesh-list
56068072|NCT02656511|Dolutegravir|dolutegravir|mesh-list
56068073|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
56068074|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068105|NCT05735431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56778734|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
56778735|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778736|NCT00069121|Antidotes|antidotes|mesh-ancestor
56778737|NCT00069121|Protective Agents|protective agents|mesh-ancestor
56778738|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
56778739|NCT00069121|Vitamins|vitamins|mesh-ancestor
56778740|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
56778741|NCT00768911|Temozolomide|temozolomide|mesh-list
56778742|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56778743|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
56778744|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778745|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778746|NCT00771017|Leuprolide|leuprolide|mesh-list
56778747|NCT00771017|Goserelin|goserelin|mesh-list
56778748|NCT00771017|Bicalutamide|bicalutamide|mesh-list
56778749|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56778750|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
56778751|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56068106|NCT05735431|Respiratory System Agents|respiratory system agents|mesh-ancestor
56068107|NCT05735431|Dermatologic Agents|dermatologic agents|mesh-ancestor
56068108|NCT05735431|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56068109|NCT05735431|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56068110|NCT05735431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56068111|NCT05735431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56068112|NCT05735431|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068113|NCT05735431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068114|NCT05735431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068115|NCT04483583|Clopidogrel|clopidogrel|mesh-list
56068116|NCT04483583|Ticagrelor|ticagrelor|mesh-list
56068152|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56068153|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56068154|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56068155|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068188|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
56068189|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068190|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
56068191|NCT02466581|Hormones|hormones|mesh-ancestor
56068192|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068193|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068194|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56068195|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068196|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
56068269|NCT05735353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068295|NCT00370097|Fluticasone|fluticasone|mesh-list
56068296|NCT00370097|Xhance|xhance|mesh-list
56068297|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068298|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56068299|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
56068300|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068301|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068302|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56068303|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
56068304|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
56068305|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56068306|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56068308|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56068309|NCT00370253|Terlipressin|terlipressin|mesh-list
56068310|NCT00370253|Norepinephrine|norepinephrine|mesh-list
56192343|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56192344|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778752|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778753|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56778754|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778755|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
56778756|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
56192345|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192346|NCT01480752|Lornoxicam|lornoxicam|mesh-list
56192347|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56192348|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56192349|NCT01480752|Analgesics|analgesics|mesh-ancestor
56192350|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
56192351|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192353|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068311|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56068312|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56068313|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56068314|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56068315|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068342|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56068344|NCT05364515|Clobetasol|clobetasol|mesh-list
56068345|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55795540|NCT05054361|Mannitol|mannitol|mesh-list
56068346|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
56068347|NCT05364515|Hormones|hormones|mesh-ancestor
56068348|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068349|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068350|NCT01438073|Hormones|hormones|mesh-list
56068351|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068352|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068353|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56068354|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
56068355|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068356|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56068357|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
56068358|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068389|NCT00371033|Pregabalin|pregabalin|mesh-list
56068390|NCT00371033|Analgesics|analgesics|mesh-ancestor
56068391|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
56068392|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068393|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068394|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
56068395|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56068396|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56068397|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068398|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56068399|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56068400|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56068401|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068402|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56068403|NCT00371111|Triamcinolone|triamcinolone|mesh-list
56068404|NCT00371111|Bevacizumab|bevacizumab|mesh-list
56068429|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068430|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068431|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56068432|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56068433|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56068434|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068435|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56068436|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56068437|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068438|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
56068439|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56192354|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56192356|NCT01480765|Ketamine|ketamine|mesh-list
56192357|NCT01480765|Analgesics|analgesics|mesh-ancestor
56192358|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
56192359|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192360|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110437|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
56778757|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778758|NCT00769145|Ranibizumab|ranibizumab|mesh-list
56778759|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56778760|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56778761|NCT00769145|Growth Substances|growth substances|mesh-ancestor
55887632|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
56192361|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56192362|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56192363|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
56192364|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
56192365|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068440|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56068441|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56068442|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
56068443|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068444|NCT05180825|Trametinib|trametinib|mesh-list
56068445|NCT05180825|Vinblastine|vinblastine|mesh-list
56068446|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068447|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56068448|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068449|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740706|NCT03380689|Bevacizumab|bevacizumab|mesh-list
56068450|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56068452|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
56068481|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56068482|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
56068483|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068484|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068485|NCT01955629|Capecitabine|capecitabine|mesh-list
56068486|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
56068487|NCT01955629|Aflibercept|aflibercept|mesh-list
56068488|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56068489|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
56068490|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068491|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068492|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56068493|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56068494|NCT01955629|Growth Substances|growth substances|mesh-ancestor
56068495|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068496|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
56068497|NCT01898689|Ropivacaine|ropivacaine|mesh-list
56068498|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
56068499|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
56068534|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
56068535|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
56068536|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
56068537|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56068538|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56068539|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
56068575|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068576|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
56068577|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
56068578|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068615|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56068644|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068645|NCT01901809|Dopamine|dopamine|mesh-list
56068646|NCT01901809|Furosemide|furosemide|mesh-list
56068647|NCT01901809|Diuretics|diuretics|mesh-ancestor
56068648|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
56068649|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068650|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56068651|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56068652|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192366|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56192367|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56192368|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192369|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778762|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778763|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
56778764|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778765|NCT00763997|Acetaminophen|acetaminophen|mesh-list
56778766|NCT00763997|Dipyrone|dipyrone|mesh-list
56778767|NCT00763997|Ibuprofen|ibuprofen|mesh-list
56778768|NCT00763997|Parecoxib|parecoxib|mesh-list
56778769|NCT00763997|Valdecoxib|valdecoxib|mesh-list
56778770|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489749|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
56051427|NCT00355589|Ramipril|ramipril|mesh-list
56051428|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56051429|NCT00355589|Diuretics|diuretics|mesh-ancestor
56051430|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
56051431|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051432|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56051433|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051434|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887702|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55887703|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887731|NCT03832894|Estradiol|estradiol|mesh-list
56192370|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
56068653|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56068654|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
56068655|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
56068656|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068657|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
56068658|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068659|NCT01901809|Protective Agents|protective agents|mesh-ancestor
56068660|NCT04947527|Fluorides|fluorides|mesh-list
56068661|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
56068662|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
56068663|NCT04947527|Protective Agents|protective agents|mesh-ancestor
56068700|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
56068701|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068730|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56068732|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56068733|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068734|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56068735|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56068736|NCT00370721|Growth Substances|growth substances|mesh-ancestor
56068737|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068738|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
56068739|NCT01909141|Metformin|metformin|mesh-list
56068740|NCT01909141|Pioglitazone|pioglitazone|mesh-list
56068741|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
56068742|NCT01909141|Letrozole|letrozole|mesh-list
56068743|NCT01909141|Clomiphene|clomiphene|mesh-list
56068744|NCT01909141|Enclomiphene|enclomiphene|mesh-list
56068745|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
56068748|NCT01909141|Testosterone|testosterone|mesh-list
56068749|NCT01909141|Progesterone|progesterone|mesh-list
56068782|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068783|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
56068784|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56068785|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
56778771|NCT00763997|Analgesics|analgesics|mesh-ancestor
56778772|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
56778773|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778774|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778775|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
56778776|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56778777|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778778|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778779|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56778780|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778781|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778782|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56778789|NCT00771251|Golimumab|golimumab|mesh-list
56778790|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56051436|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
56068786|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56068787|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
56068788|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068789|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068790|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
56068820|NCT04403711|Analgesics|analgesics|mesh-ancestor
56068821|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
56068822|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068823|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56068824|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56068825|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56068826|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068827|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068828|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068829|NCT01911169|Vitamin D|vitamin d|mesh-list
56068830|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
56068831|NCT01911169|Vitamins|vitamins|mesh-list
56068849|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068850|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
56068851|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56068852|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
56068853|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068854|NCT04748887|Protective Agents|protective agents|mesh-ancestor
56068855|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068856|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
56068857|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56068858|NCT01916629|Protective Agents|protective agents|mesh-ancestor
56068859|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068860|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
56068861|NCT03298451|Sorafenib|sorafenib|mesh-list
56192371|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56192372|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56068862|NCT03298451|Durvalumab|durvalumab|mesh-list
56068863|NCT03298451|Tremelimumab|tremelimumab|mesh-list
56068864|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56068865|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068866|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56068867|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068868|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778791|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778792|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778793|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
56778794|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778795|NCT01420250|Bicalutamide|bicalutamide|mesh-list
56778796|NCT01420250|Hormones|hormones|mesh-list
56778797|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56778798|NCT01420250|Androgens|androgens|mesh-list
56778799|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
56778800|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778801|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778802|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
56068869|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56068870|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
56068871|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068872|NCT01916941|Prazosin|prazosin|mesh-list
56068873|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56068874|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56068875|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56068876|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56068877|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068878|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068879|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068880|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068882|NCT05732701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56068883|NCT05732701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56068884|NCT05732701|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068885|NCT05732701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068886|NCT05732701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068887|NCT05732701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068918|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068919|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068920|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068921|NCT04184609|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56068922|NCT04184609|Cholinergic Agents|cholinergic agents|mesh-ancestor
56068923|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56068924|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
56068925|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56068926|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
56068929|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068930|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56068932|NCT03273023|Everolimus|everolimus|mesh-list
56068933|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069002|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56069003|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069004|NCT01929889|Iloperidone|iloperidone|mesh-list
56069005|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56069006|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56069007|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56069008|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069009|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56069010|NCT05738473|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56069011|NCT05738473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069012|NCT04335461|Anesthetics|anesthetics|mesh-list
56069013|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
56069046|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069047|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56069048|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069049|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069052|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
56069053|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56778803|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778804|NCT00399568|Acetaminophen|acetaminophen|mesh-list
56778805|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56778806|NCT00399568|Analgesics|analgesics|mesh-ancestor
56778807|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
56778808|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778809|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778810|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
56778811|NCT05088356|Plerixafor|plerixafor|mesh-list
56778812|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
56778813|NCT05088356|Melphalan|melphalan|mesh-list
56778814|NCT05088356|Fludarabine|fludarabine|mesh-list
56778815|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
56778816|NCT05088356|Tacrolimus|tacrolimus|mesh-list
56778817|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
56778818|NCT05088356|Lenograstim|lenograstim|mesh-list
56069054|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56069055|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
56069056|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069057|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56069058|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56069059|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069094|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069095|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796296|NCT05551247|Growth Substances|growth substances|mesh-ancestor
56069096|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56192373|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56192374|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56192375|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56069097|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56069120|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069121|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069122|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56069123|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
56069124|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069125|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069126|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56069127|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56069128|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56069129|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56069130|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56069131|NCT04768465|Prednisone|prednisone|mesh-list
56069132|NCT04768465|Bromides|bromides|mesh-list
56069133|NCT04768465|Tacrolimus|tacrolimus|mesh-list
56069134|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56069135|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56069136|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
56069137|NCT04768465|Hormones|hormones|mesh-ancestor
56069138|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069139|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069140|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56069141|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069142|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56069143|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
56069144|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56069145|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069146|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069147|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
56069148|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56069203|NCT05688475|Autonomic Agents|autonomic agents|mesh-ancestor
56069204|NCT05688475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778819|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778820|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
56778821|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778822|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051481|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
56069235|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069236|NCT05668585|Trametinib|trametinib|mesh-list
56069237|NCT05668585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069239|NCT05668585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069240|NCT05668585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069241|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
56069242|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56069243|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
56069244|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069245|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
56069246|NCT02958761|Protective Agents|protective agents|mesh-ancestor
56069247|NCT05215535|Liver Extracts|liver extracts|mesh-list
56069248|NCT05215535|Hematinics|hematinics|mesh-ancestor
56069279|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069281|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069282|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56069283|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069284|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56069285|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56069286|NCT05630677|Rabeprazole|rabeprazole|mesh-list
56069287|NCT05630677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56069288|NCT05630677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56069289|NCT05630677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56069290|NCT05630677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069291|NCT05630677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069326|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069327|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56192376|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56192377|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56192378|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56192379|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56192380|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56192381|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
56192382|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56192383|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192384|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56192385|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56192386|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56192387|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56192388|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56069328|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
56069329|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069330|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069332|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069333|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
56069334|NCT04337879|Irinotecan|irinotecan|mesh-list
56069335|NCT04337879|Calcium|calcium|mesh-list
56069336|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56069337|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069338|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069339|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56069340|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56069341|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069377|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56069378|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
56069412|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
56069413|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069414|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069415|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56069416|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069417|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56069418|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56069419|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
56778823|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56778824|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887995|NCT02466984|Metoclopramide|metoclopramide|mesh-list
56069420|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56069450|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069451|NCT04334993|Blinatumomab|blinatumomab|mesh-list
56069452|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069453|NCT05349929|Ibuprofen|ibuprofen|mesh-list
56069454|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56069455|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56069456|NCT05349929|Analgesics|analgesics|mesh-ancestor
56069457|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
56069458|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069459|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069466|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56069502|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56069503|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56069504|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56069505|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56069506|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069507|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
56192389|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56192390|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56192391|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56192392|NCT01480791|Diuretics|diuretics|mesh-ancestor
56192393|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
56192394|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192395|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56192396|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192397|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192399|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192400|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56192401|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213203|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56069534|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56069535|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56069536|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
56069537|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
56069538|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56069539|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56069540|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
56069541|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56069542|NCT04611529|Ibuprofen|ibuprofen|mesh-list
56069543|NCT04611529|Diclofenac|diclofenac|mesh-list
56069544|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56069545|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56069546|NCT04611529|Analgesics|analgesics|mesh-ancestor
56069547|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
56069548|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069549|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069550|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56069551|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56069552|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56069553|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069582|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069583|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069584|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069585|NCT05288075|Antidotes|antidotes|mesh-ancestor
56069586|NCT05288075|Protective Agents|protective agents|mesh-ancestor
56069587|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
56069588|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56069589|NCT05272787|Protective Agents|protective agents|mesh-ancestor
56069590|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069591|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
56069592|NCT05145569|Paclitaxel|paclitaxel|mesh-list
56069593|NCT05145569|Carboplatin|carboplatin|mesh-list
56069594|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56069595|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069596|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
56069597|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
56069598|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
56778825|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778826|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56778827|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56778828|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
56778829|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
56778830|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778831|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56778832|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778833|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56778834|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56778835|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56778836|NCT01039558|Ecabet|ecabet|mesh-list
56778837|NCT01039558|Lansoprazole|lansoprazole|mesh-list
56778838|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
56778839|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56069599|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069600|NCT04566991|Deferoxamine|deferoxamine|mesh-list
56069633|NCT04665089|Erythromycin|erythromycin|mesh-list
56069634|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
56069638|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069639|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56069640|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56069641|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069642|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069643|NCT04645823|Lidocaine|lidocaine|mesh-list
56069644|NCT04645823|Fentanyl|fentanyl|mesh-list
56069645|NCT04645823|Citric Acid|citric acid|mesh-list
56069646|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
56069647|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
56069682|NCT03763175|Lovastatin|lovastatin|mesh-list
56069683|NCT03763175|L 647318|l 647318|mesh-list
56069684|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
56069685|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56069686|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56069687|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
56069688|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069689|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56069690|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56069691|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069692|NCT04396873|11C-PS13|11c-ps13|mesh-list
56069693|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56069694|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069695|NCT04365049|Gemcitabine|gemcitabine|mesh-list
56069696|NCT04365049|Paclitaxel|paclitaxel|mesh-list
56069730|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069731|NCT03092011|Analgesics|analgesics|mesh-ancestor
56069732|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
56069733|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069734|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56069735|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
56069736|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
56069737|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56069738|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56069775|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069776|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56069811|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069812|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069814|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
56069815|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
56069849|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56069850|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069851|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069852|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
56778840|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56778841|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56778842|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778843|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778844|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778845|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
56778846|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56778847|NCT01039558|Protective Agents|protective agents|mesh-ancestor
56778848|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778849|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778850|NCT01324258|Gemcitabine|gemcitabine|mesh-list
56778851|NCT01324258|Trametinib|trametinib|mesh-list
56778852|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56778853|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
56778854|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778855|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778856|NCT01324258|Antiviral Agents|antiviral agents|mesh-ancestor
56778857|NCT01324258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778858|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069853|NCT04332497|Ibuprofen|ibuprofen|mesh-list
56069854|NCT04332497|Fentanyl|fentanyl|mesh-list
56069855|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56069856|NCT04332497|Narcotics|narcotics|mesh-ancestor
56069887|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
56069888|NCT04258397|Pirfenidone|pirfenidone|mesh-list
56069889|NCT04258397|Analgesics|analgesics|mesh-ancestor
56069890|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
56069891|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069892|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069893|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56069894|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56069895|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56069896|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56069897|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069927|NCT04186247|Azithromycin|azithromycin|mesh-list
56069928|NCT04186247|Metronidazole|metronidazole|mesh-list
56069929|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56192406|NCT01480869|Calcium|calcium|mesh-list
56192407|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56192408|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192409|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56192415|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56192416|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56192417|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192418|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192419|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56069930|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069931|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56069932|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56069933|NCT04181255|Poractant alfa|poractant alfa|mesh-list
56069934|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56069935|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
56069936|NCT00373373|Sorafenib|sorafenib|mesh-list
56069937|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069938|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56069939|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069940|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778859|NCT01324258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778860|NCT01324258|Immunologic Factors|immunologic factors|mesh-ancestor
56778861|NCT01324258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778862|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56778863|NCT01415882|Dexamethasone|dexamethasone|mesh-list
56778864|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
56778865|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
56778866|NCT01415882|Daratumumab|daratumumab|mesh-list
56778867|NCT01415882|Ixazomib|ixazomib|mesh-list
56778868|NCT01415882|Ichthammol|ichthammol|mesh-list
56778869|NCT01415882|BB 1101|bb 1101|mesh-list
56778870|NCT01415882|Glycine|glycine|mesh-list
56778871|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778872|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
56778873|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778874|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778875|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56778876|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
56778877|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778878|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778879|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56778880|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778881|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
56778882|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
56778883|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778909|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
56778910|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778911|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778912|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778913|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56778914|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778915|NCT02557373|Vitamins|vitamins|mesh-list
56778916|NCT02557373|Vitamin A|vitamin a|mesh-list
56778917|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
56778918|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
56778919|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778920|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
56778921|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778922|NCT02557373|Protective Agents|protective agents|mesh-ancestor
56778923|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56778924|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778926|NCT01757626|Sargramostim|sargramostim|mesh-list
56778927|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
56778928|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778929|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778930|NCT04048811|Propofol|propofol|mesh-list
56778931|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56778932|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051586|NCT01420874|Leucovorin|leucovorin|mesh-list
56069941|NCT00373451|Heparin|heparin|mesh-list
56069942|NCT00373451|Calcium heparin|calcium heparin|mesh-list
56069943|NCT00373451|Bivalirudin|bivalirudin|mesh-list
56069944|NCT00373451|Abciximab|abciximab|mesh-list
56069945|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
56069946|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56069981|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069982|NCT01993849|Expectorants|expectorants|mesh-ancestor
56069983|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
56069984|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56069985|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
56069986|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069987|NCT01993849|Protective Agents|protective agents|mesh-ancestor
56070024|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070025|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070026|NCT02303977|Gemcitabine|gemcitabine|mesh-list
56070027|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56070048|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56070049|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56070050|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070051|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070052|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
56070053|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56070054|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070055|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56070056|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070057|NCT01997905|Protein S|protein s|mesh-list
56070058|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
56070059|NCT02788019|Ropivacaine|ropivacaine|mesh-list
56778933|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778934|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56778935|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
56778936|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
56778937|NCT01086631|Rituximab|rituximab|mesh-list
56778938|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56778939|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778940|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
56778941|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778942|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56778943|NCT00399490|Tanezumab|tanezumab|mesh-list
56778944|NCT00399490|Analgesics|analgesics|mesh-ancestor
56778945|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
56051592|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070060|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
56070061|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
56070062|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070063|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070064|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
56070065|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192420|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56192422|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
56192423|NCT01481194|Doxorubicin|doxorubicin|mesh-list
56192424|NCT01481194|Lenalidomide|lenalidomide|mesh-list
56192425|NCT01481194|Bortezomib|bortezomib|mesh-list
56192426|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56192427|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
56192428|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192429|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56192430|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56192431|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
56192432|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192433|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192434|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56192435|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56192436|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
56192437|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
56192442|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192443|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56192444|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56192445|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56192446|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56192447|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070067|NCT02788097|Progestins|progestins|mesh-ancestor
56070068|NCT02788097|Hormones|hormones|mesh-ancestor
56070069|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56070070|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070071|NCT02789033|Isosorbide|isosorbide|mesh-list
56070072|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56070073|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56070074|NCT02789033|Chitosan|chitosan|mesh-list
56070075|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56070076|NCT02789033|Diuretics|diuretics|mesh-ancestor
56070077|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
56070078|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070079|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
56070080|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56070081|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070112|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070113|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56070114|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070115|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778946|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778947|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778948|NCT00716066|Cytarabine|cytarabine|mesh-list
56778949|NCT00716066|Prednisone|prednisone|mesh-list
56778950|NCT00716066|Cortisone|cortisone|mesh-list
56778951|NCT00716066|Etoposide|etoposide|mesh-list
56778952|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
56778953|NCT00716066|Melphalan|melphalan|mesh-list
56778954|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
56778955|NCT00716066|Carmustine|carmustine|mesh-list
56778956|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
56778957|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56778958|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
56778959|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56778960|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56192448|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56192449|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56192450|NCT01481194|Growth Substances|growth substances|mesh-ancestor
56192451|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
56192452|NCT01481233|Colchicine|colchicine|mesh-list
56192453|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
56192454|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56192455|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
56192456|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
56192457|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
56192458|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192459|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192460|NCT01481259|Pemetrexed|pemetrexed|mesh-list
56192461|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192462|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192463|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192464|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56192465|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56192466|NCT01481311|Bromides|bromides|mesh-list
56192467|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
56192468|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
56192469|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
56070116|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
56070117|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56070118|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070119|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56070120|NCT02882633|Bupivacaine|bupivacaine|mesh-list
56070121|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
56070122|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
56070123|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070124|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070125|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
56070126|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070127|NCT02065765|Ramucirumab|ramucirumab|mesh-list
56070128|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070129|NCT00373607|Artesunate|artesunate|mesh-list
56070159|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070160|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
56070161|NCT02590523|Vancomycin|vancomycin|mesh-list
56070162|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56070163|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070164|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56070166|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070167|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070168|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070169|NCT02895035|Ketorolac|ketorolac|mesh-list
56070170|NCT02895035|Phenylephrine|phenylephrine|mesh-list
56070171|NCT02895035|Epinephrine|epinephrine|mesh-list
56070172|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
56070173|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56778961|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
56778962|NCT00716066|Hormones|hormones|mesh-ancestor
56778963|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56778964|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778965|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56778966|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56778967|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56778968|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56778969|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56778970|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56778971|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56778972|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56778973|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
56778974|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
56778975|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56778976|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56778977|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
56778978|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56778979|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
56778980|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56778981|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
56778982|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
56778983|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56778984|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56778985|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56778986|NCT00398866|Triamcinolone|triamcinolone|mesh-list
56778987|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56070174|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56070204|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56070206|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
56192470|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56192471|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56192472|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192473|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192474|NCT01481350|Urological Agents|urological agents|mesh-ancestor
56192475|NCT01481389|Theobromine|theobromine|mesh-list
56192476|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56192477|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
56192478|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192479|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192480|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56192481|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
56192482|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
56192484|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
56192485|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192486|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
56192487|NCT01481519|Dexamethasone|dexamethasone|mesh-list
56778988|NCT00398866|Bupivacaine|bupivacaine|mesh-list
56778989|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
56778990|NCT00398866|Hylan|hylan|mesh-list
56778991|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
56778992|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
56778993|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56778994|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56778995|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
56778996|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56778997|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56778998|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
56778999|NCT00398866|Hormones|hormones|mesh-ancestor
56779000|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56779001|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779002|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
56779003|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56779004|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
56779005|NCT00398866|Protective Agents|protective agents|mesh-ancestor
56779006|NCT00771563|Cisplatin|cisplatin|mesh-list
56779007|NCT00771563|Docetaxel|docetaxel|mesh-list
56779008|NCT00771563|Enoxaparin|enoxaparin|mesh-list
56192488|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
56192489|NCT01481519|Povidone|povidone|mesh-list
56192490|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
56192491|NCT01481519|BB 1101|bb 1101|mesh-list
56192492|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56192493|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
56192494|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
56192495|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192496|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192497|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192498|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
56192499|NCT01481519|Hormones|hormones|mesh-ancestor
56192500|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192501|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56120283|NCT01885182|Naloxone|naloxone|mesh-list
56192502|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192503|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
56192504|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192505|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192509|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192510|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56192511|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56192512|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
56192514|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192515|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192516|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192517|NCT01481610|Diclofenac|diclofenac|mesh-list
56192518|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
56192519|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56192520|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56192521|NCT01481610|Analgesics|analgesics|mesh-ancestor
56192522|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
56192523|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192524|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192525|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56070207|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779009|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779010|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
56779011|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
56779012|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
56779013|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779014|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
56779015|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56779016|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56779017|NCT00775073|Bevacizumab|bevacizumab|mesh-list
56779018|NCT00775073|Everolimus|everolimus|mesh-list
56779019|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779020|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779021|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56779022|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56779023|NCT00775073|Growth Substances|growth substances|mesh-ancestor
56779024|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779025|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
56779026|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779027|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
56779028|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56779029|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56779030|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56779031|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56779032|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779033|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779034|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779035|NCT00398632|Analgesics|analgesics|mesh-ancestor
56779036|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
56779037|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779038|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
56779039|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56779040|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
56779041|NCT01589146|Heparin|heparin|mesh-list
56779042|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56779043|NCT01589146|Tinzaparin|tinzaparin|mesh-list
56779048|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779049|NCT00775151|Amlodipine|amlodipine|mesh-list
56779050|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56779051|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56779052|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56779053|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779054|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56779055|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779056|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
56779057|NCT04694300|Acetaminophen|acetaminophen|mesh-list
56779058|NCT04694300|Naproxen|naproxen|mesh-list
56779059|NCT04694300|Tramadol|tramadol|mesh-list
56779060|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56779061|NCT04694300|Analgesics|analgesics|mesh-ancestor
56779062|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
56779063|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779107|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56779108|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
56779109|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779110|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779111|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56779112|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779113|NCT00393718|Liraglutide|liraglutide|mesh-list
56779114|NCT00393718|Glyburide|glyburide|mesh-list
56779115|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56779116|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779117|NCT00393718|Incretins|incretins|mesh-ancestor
56779118|NCT00393718|Hormones|hormones|mesh-ancestor
56779119|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56779120|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56779121|NCT00669071|Tretinoin|tretinoin|mesh-list
56779122|NCT00669071|Hydroquinone|hydroquinone|mesh-list
56779123|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779124|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
56779125|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
56779126|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56779127|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
56779128|NCT00669071|Hormones|hormones|mesh-ancestor
56779129|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56779130|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779131|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
56779132|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779133|NCT00669071|Protective Agents|protective agents|mesh-ancestor
56779134|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56070208|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56070209|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56070210|NCT02803229|Amphetamine|amphetamine|mesh-list
56070211|NCT02803229|Adderall|adderall|mesh-list
56070212|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56070213|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070214|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
56070215|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
56070216|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070218|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070219|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070220|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
56070243|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070244|NCT02003911|Azithromycin|azithromycin|mesh-list
56070245|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56070246|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070247|NCT04147351|Bevacizumab|bevacizumab|mesh-list
56070248|NCT04147351|Atezolizumab|atezolizumab|mesh-list
56070249|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779135|NCT01196936|Tamoxifen|tamoxifen|mesh-list
56779136|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56779137|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
56779138|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56779139|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070250|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070251|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56070252|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56070253|NCT04147351|Growth Substances|growth substances|mesh-ancestor
56070254|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070255|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
56070256|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
56070257|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56070258|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070259|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070260|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56070261|NCT02004613|Analgesics|analgesics|mesh-ancestor
56070262|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
56070263|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070264|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56070265|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56070266|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56070267|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
56070268|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070269|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192526|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56192527|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56192528|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192529|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192530|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56192531|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
56192532|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192533|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
56192534|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
56192535|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
56192536|NCT01481714|Citric Acid|citric acid|mesh-list
56070270|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
56070271|NCT01754779|Citric Acid|citric acid|mesh-list
56070311|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56070349|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070350|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
56070351|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
56070377|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070379|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
56070380|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
56070381|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070382|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070383|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
56070384|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070385|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56070386|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56070387|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56070388|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56070389|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070391|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56070392|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
56070393|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56070394|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
56070395|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070396|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070397|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
56070398|NCT01081951|Paclitaxel|paclitaxel|mesh-list
56070399|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56070400|NCT01081951|Carboplatin|carboplatin|mesh-list
56070433|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56070434|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56070438|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070439|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779140|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56051772|NCT03310541|Fulvestrant|fulvestrant|mesh-list
56070440|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
56070473|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070475|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
56070476|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
56070477|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070478|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070505|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070506|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070508|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56070509|NCT02815709|Narcotics|narcotics|mesh-ancestor
56070510|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070511|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070512|NCT02815709|Analgesics|analgesics|mesh-ancestor
56070513|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
56070514|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070515|NCT02912195|Lidocaine|lidocaine|mesh-list
56192538|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56192539|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
56192540|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
56192541|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192542|NCT01481714|Cathartics|cathartics|mesh-ancestor
56192543|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192544|NCT01481714|Antacids|antacids|mesh-ancestor
56192545|NCT01481831|Palonosetron|palonosetron|mesh-list
56192546|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
56192547|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
56192548|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192549|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192550|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192551|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56192552|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56192553|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
56192554|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192555|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192556|NCT01481844|Amoxicillin|amoxicillin|mesh-list
56192557|NCT01481844|Metronidazole|metronidazole|mesh-list
56192558|NCT01481844|Clarithromycin|clarithromycin|mesh-list
56192559|NCT01481844|Tetracycline|tetracycline|mesh-list
56192560|NCT01481844|Tinidazole|tinidazole|mesh-list
56192561|NCT01481844|Lansoprazole|lansoprazole|mesh-list
56192562|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
56192563|NCT01481844|Bismuth|bismuth|mesh-list
56192564|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56192565|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56070516|NCT02912195|Morphine|morphine|mesh-list
56070517|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
56070518|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
56070519|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070520|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070521|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
56070522|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070523|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56070524|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56070525|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56070526|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56070547|NCT01988246|Aflibercept|aflibercept|mesh-list
56070548|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56070549|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56070550|NCT01988246|Growth Substances|growth substances|mesh-ancestor
56070551|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070552|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
56070553|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070554|NCT01990898|Cyclosporine|cyclosporine|mesh-list
56070555|NCT01990898|Cyclosporins|cyclosporins|mesh-list
56070556|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192566|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192567|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56070557|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070558|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56070559|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
56070561|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
56070562|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070563|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
56779141|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779142|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56779143|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56779144|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56779145|NCT00398320|Bevacizumab|bevacizumab|mesh-list
56779146|NCT00398320|Capecitabine|capecitabine|mesh-list
56779147|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
56779148|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779149|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779150|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56779151|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56490122|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
56779152|NCT00398320|Growth Substances|growth substances|mesh-ancestor
56070564|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070565|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56070567|NCT01960387|Clofarabine|clofarabine|mesh-list
56070568|NCT01960387|Antimetabolites|antimetabolites|mesh-list
56070569|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56070570|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070571|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070572|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
56070573|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070574|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56070575|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
56070576|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070577|NCT02823431|Lidocaine|lidocaine|mesh-list
56070578|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
56070579|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
56070580|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070600|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070601|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070602|NCT02059070|Bupivacaine|bupivacaine|mesh-list
56070603|NCT02059070|Ropivacaine|ropivacaine|mesh-list
56070604|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
56070605|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
56070606|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070607|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070608|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
56070609|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070610|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
55797818|NCT05587673|Hormones|hormones|mesh-ancestor
56070612|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
56070613|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070614|NCT01962961|Expectorants|expectorants|mesh-ancestor
56070615|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
56070616|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56070617|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
56070618|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070619|NCT01962961|Protective Agents|protective agents|mesh-ancestor
56070620|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070621|NCT01962961|Antidotes|antidotes|mesh-ancestor
56070622|NCT03010631|Lubiprostone|lubiprostone|mesh-list
56070623|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56070624|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56070625|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070626|NCT00374621|Isosorbide|isosorbide|mesh-list
56070627|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56070628|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56070629|NCT00374621|Misoprostol|misoprostol|mesh-list
56070630|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56070631|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
56070632|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55975174|NCT04399226|Ketamine|ketamine|mesh-list
56779153|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779154|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
56779155|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56779156|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
56779157|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779158|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
56779159|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56779160|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779161|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779162|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56779163|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56779164|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
56070633|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070634|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56070664|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56070665|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
56070666|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070667|NCT02913521|Diclofenac|diclofenac|mesh-list
56070668|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56070669|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56070670|NCT02913521|Analgesics|analgesics|mesh-ancestor
56070671|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
56070672|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070673|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070674|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56192568|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56192569|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56192570|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192571|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192572|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56192573|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56192574|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56192575|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56070677|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070678|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070705|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56070706|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070707|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56070708|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56070709|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070710|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070711|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56070712|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
56070713|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
56070714|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070715|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56070716|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
56070717|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070718|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56070719|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
56070720|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56070721|NCT01965002|Aspirin|aspirin|mesh-list
56070722|NCT01965002|Enoxaparin|enoxaparin|mesh-list
56070723|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56070724|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56070725|NCT01965002|Analgesics|analgesics|mesh-ancestor
56070726|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
56070757|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070758|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56070759|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56779165|NCT04003688|Analgesics|analgesics|mesh-ancestor
56779166|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
56779167|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779168|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779169|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
56779170|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779171|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56779172|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
56779173|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56779174|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56779175|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779176|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56779177|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
56779178|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56779179|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
56779180|NCT00779129|Doxorubicin|doxorubicin|mesh-list
56779181|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779182|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
56779183|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779184|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779185|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56779186|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
56779187|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779188|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779189|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56779190|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56070760|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
56070761|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56070762|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56070763|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56070764|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
56070765|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56070766|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56070799|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56070801|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56070802|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070803|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56070804|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56070805|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56070806|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56070807|NCT02008682|Liraglutide|liraglutide|mesh-list
56070840|NCT02916407|Sevoflurane|sevoflurane|mesh-list
56070841|NCT02916407|Desflurane|desflurane|mesh-list
56070842|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56070843|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56779191|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56779192|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56779193|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779194|NCT00772187|Fentanyl|fentanyl|mesh-list
56779195|NCT00772187|Morphine|morphine|mesh-list
56779196|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
56779197|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779198|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779199|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56779200|NCT00772187|Narcotics|narcotics|mesh-ancestor
56779201|NCT00772187|Analgesics|analgesics|mesh-ancestor
56779202|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
56779203|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779204|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56779205|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56779206|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
56779207|NCT00772265|Insulin|insulin|mesh-list
56779208|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
56779209|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56779210|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779211|NCT00779441|Zolpidem|zolpidem|mesh-list
56779212|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56779213|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56779214|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779215|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779216|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56779217|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
56779218|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
56779219|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779221|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
56779240|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779241|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56779242|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56779243|NCT01837862|Growth Substances|growth substances|mesh-ancestor
56779244|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779245|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
56779246|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56779247|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56779248|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779249|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779250|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56779251|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
56779252|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
56779253|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
56779254|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56779255|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
56779256|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
56779257|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
56779258|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56070844|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
56070845|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
55740778|NCT04420741|Iloprost|iloprost|mesh-list
56070846|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070847|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070880|NCT02922959|Naloxone|naloxone|mesh-list
56192576|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56120375|NCT01862328|Paclitaxel|paclitaxel|mesh-list
56192577|NCT01481844|Antacids|antacids|mesh-ancestor
56192578|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
56070881|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070882|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
56070883|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070884|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56070885|NCT02014363|Amitriptyline|amitriptyline|mesh-list
56070886|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56070887|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
56070922|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56070923|NCT02834663|Growth Substances|growth substances|mesh-ancestor
56070924|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070925|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
56070926|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070951|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070953|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
56070955|NCT02018653|Calcium|calcium|mesh-list
56070956|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56070957|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070958|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56070959|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56070960|NCT02923895|Fluorides|fluorides|mesh-list
56070961|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
56070962|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
56070963|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
56070964|NCT02923895|Protective Agents|protective agents|mesh-ancestor
56070965|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070966|NCT01973348|Methamphetamine|methamphetamine|mesh-list
56070967|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56779259|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779260|NCT00775619|Carvedilol|carvedilol|mesh-list
56779261|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56779262|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56779263|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
56779264|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779265|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779266|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779267|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56779268|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
56779269|NCT00775619|Protective Agents|protective agents|mesh-ancestor
56779270|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56051886|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
56070968|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070969|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
56070970|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
56070971|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070972|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
56070973|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070974|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070975|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
56070976|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56070977|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56071006|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071008|NCT01973335|Spironolactone|spironolactone|mesh-list
56071009|NCT01973335|Acetazolamide|acetazolamide|mesh-list
56071010|NCT01973335|Bumetanide|bumetanide|mesh-list
56071011|NCT01973335|Diuretics|diuretics|mesh-list
56071012|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56071013|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56071014|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
56071015|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071016|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071017|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56071018|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
56071019|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
56071020|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56071021|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071022|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071057|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071089|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
56071090|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56071091|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56071092|NCT01977781|Prednisolone|prednisolone|mesh-list
56071093|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
56071094|NCT01977781|Tacrolimus|tacrolimus|mesh-list
56071095|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56071096|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
56071097|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56071098|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
56071099|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192579|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56192581|NCT01481870|Sorafenib|sorafenib|mesh-list
56192582|NCT01481870|Sunitinib|sunitinib|mesh-list
56071100|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56071101|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071130|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071132|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071133|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071134|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975175|NCT04399226|Propofol|propofol|mesh-list
56779271|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56779272|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56779273|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
56779274|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56779275|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56779276|NCT00775697|Montelukast|montelukast|mesh-list
56779277|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
56779278|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56779279|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
56779280|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
56779281|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56779282|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779283|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56779284|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56779285|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779286|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
56779287|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56779288|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
56779289|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
56779290|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779291|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779292|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56779293|NCT05357066|Analgesics|analgesics|mesh-ancestor
56779294|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
56779295|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779296|NCT02556905|Dexamethasone|dexamethasone|mesh-list
56779297|NCT02556905|Lenalidomide|lenalidomide|mesh-list
56071135|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56071136|NCT02025439|Analgesics|analgesics|mesh-ancestor
56071137|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
56071138|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071139|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
56071140|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56071141|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071142|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
56071172|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071173|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071175|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56071176|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
56071178|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071179|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56071180|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
56071181|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55977761|NCT00765661|Tacrolimus|tacrolimus|mesh-list
56779298|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56779299|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
56779300|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
56779301|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490339|NCT05456932|Iron|iron|mesh-list
56779302|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779303|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56779304|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
56779305|NCT02556905|Hormones|hormones|mesh-ancestor
56779306|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56779307|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56779308|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779309|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
56779310|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56779311|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56779312|NCT02556905|Growth Substances|growth substances|mesh-ancestor
56779313|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
56779314|NCT00539006|Fluticasone|fluticasone|mesh-list
56779315|NCT00539006|Xhance|xhance|mesh-list
56779316|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56779317|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56779318|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
56779319|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779320|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779321|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56779322|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
56779323|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
56779324|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56779325|NCT04047329|Anesthetics|anesthetics|mesh-list
56779326|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779327|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779328|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
56779329|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56779330|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56779331|NCT00537056|Sunitinib|sunitinib|mesh-list
56779332|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56779336|NCT00537056|Growth Substances|growth substances|mesh-ancestor
56779337|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779338|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
56779339|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56051965|NCT03500289|Ketamine|ketamine|mesh-list
56071182|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56071183|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56071184|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071199|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55798403|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071202|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071204|NCT01979276|Pomalidomide|pomalidomide|mesh-list
56071205|NCT01979276|Romidepsin|romidepsin|mesh-list
56071206|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071207|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
56071208|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
56071209|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071210|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071211|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071212|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
56071213|NCT01979276|Hormones|hormones|mesh-ancestor
56071214|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071215|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56071216|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071217|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
56071218|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56071219|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56071220|NCT01979276|Growth Substances|growth substances|mesh-ancestor
56071221|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
56071222|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56071223|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
56071224|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56071225|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
56071226|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071227|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071228|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56071229|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
56071230|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56071231|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
56071232|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071247|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071249|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071250|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071251|NCT02344628|Azithromycin|azithromycin|mesh-list
56071252|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56071253|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071254|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
56071255|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56192583|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192584|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56192585|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192586|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071256|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56071257|NCT02019758|Fluticasone|fluticasone|mesh-list
56071258|NCT02019758|Budesonide|budesonide|mesh-list
56071259|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071260|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56071261|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
56071262|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071263|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071264|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56071265|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
56071266|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
56071267|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56071268|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
56071269|NCT02019758|Hormones|hormones|mesh-ancestor
56071270|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071271|NCT01980589|Dexamethasone|dexamethasone|mesh-list
56071272|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
56779340|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779341|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779342|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56779343|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
56779344|NCT00779831|Ephedrine|ephedrine|mesh-list
56779345|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56779346|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
56779347|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779348|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779349|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56779350|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
56779351|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
56779352|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56779353|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56071273|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56071274|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
56071275|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071277|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56071278|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
56071279|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071280|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071281|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56071282|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071284|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
56071285|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071286|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071287|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
56071288|NCT01980589|Hormones|hormones|mesh-ancestor
56071289|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071290|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56071291|NCT02021942|Pasireotide|pasireotide|mesh-list
56071292|NCT02021942|Hormones|hormones|mesh-ancestor
56071293|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071294|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071295|NCT01981759|Cycloserine|cycloserine|mesh-list
56071320|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071321|NCT01982695|Losartan|losartan|mesh-list
56071322|NCT01982695|Lisinopril|lisinopril|mesh-list
56071323|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56071324|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56071325|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56071326|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56071327|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071328|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56071329|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
56071330|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071331|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56071332|NCT01982695|Protective Agents|protective agents|mesh-ancestor
56071333|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071334|NCT01981772|Lidocaine|lidocaine|mesh-list
56071335|NCT01981772|Epinephrine|epinephrine|mesh-list
56071336|NCT01981772|Racepinephrine|racepinephrine|mesh-list
56071337|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
56071338|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
56071339|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
56071340|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071341|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071342|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
56071343|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779354|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
56779355|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
56779356|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779357|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779358|NCT04857398|Insulin|insulin|mesh-list
56779359|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56779360|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779361|NCT00535262|Selegiline|selegiline|mesh-list
56779362|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
56779363|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56779364|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56779365|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56779366|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56071344|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56071365|NCT01982240|Laxatives|laxatives|mesh-ancestor
56192587|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56192588|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56071366|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56071367|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
56071368|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071369|NCT02029495|Brodalumab|brodalumab|mesh-list
56071370|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56071371|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
56071372|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
56071373|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071374|NCT01985425|Colchicine|colchicine|mesh-list
56071375|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
56071376|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56071377|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
56071378|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
56071379|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
56071380|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071381|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071382|NCT02348918|Bevacizumab|bevacizumab|mesh-list
56071383|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56071384|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071385|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56071386|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56071387|NCT02348918|Growth Substances|growth substances|mesh-ancestor
56071388|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071389|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
56071390|NCT01985581|Guanfacine|guanfacine|mesh-list
56071391|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56071392|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56071395|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
56071396|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071397|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798627|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071424|NCT02034019|Dexamethasone|dexamethasone|mesh-list
56071425|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071426|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
56071427|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
56071428|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071429|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071430|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071431|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
56071433|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071434|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56071435|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071436|NCT02349152|Fentanyl|fentanyl|mesh-list
56071437|NCT02349152|Remifentanil|remifentanil|mesh-list
56071438|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56071439|NCT02349152|Narcotics|narcotics|mesh-ancestor
56779367|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779368|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779369|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56779370|NCT00535262|Protective Agents|protective agents|mesh-ancestor
56779371|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779372|NCT00772499|Atenolol|atenolol|mesh-list
56779373|NCT00772499|Amlodipine|amlodipine|mesh-list
56779374|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56490349|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
56779375|NCT00772499|Olmesartan|olmesartan|mesh-list
56779376|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56779377|NCT00772499|Hydralazine|hydralazine|mesh-list
56779378|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56779379|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56779380|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56779381|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779382|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56071440|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071441|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071442|NCT02349152|Analgesics|analgesics|mesh-ancestor
56071443|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
56071444|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071445|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56071481|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56071482|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071483|NCT02058511|Anesthetics|anesthetics|mesh-list
56071521|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071522|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071547|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55740820|NCT03385057|Analgesics|analgesics|mesh-ancestor
56071549|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071550|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56071551|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
56071552|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56071553|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071554|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56192590|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192591|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
56192592|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56192593|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56071555|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
56071556|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
56071557|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071558|NCT02037061|Bupivacaine|bupivacaine|mesh-list
56071559|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
56071560|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
56071561|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071562|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071563|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
56071564|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071566|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
56071567|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56071568|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56071569|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071570|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071571|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
56071572|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
56779383|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779384|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
56779385|NCT00772499|Diuretics|diuretics|mesh-ancestor
56779386|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
56779387|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56779388|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56779389|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56071599|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56071600|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071601|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56071602|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
56071603|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56071604|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56071605|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
56071606|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071607|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56071608|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56071609|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071611|NCT02062177|Propofol|propofol|mesh-list
56071612|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56071613|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071614|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071615|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56071616|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
56071617|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
56071618|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56071619|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56071620|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56071621|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56071622|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
56071652|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56071653|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071655|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56071656|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071657|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071658|NCT02037230|Gemcitabine|gemcitabine|mesh-list
56071659|NCT02037230|Adavosertib|adavosertib|mesh-list
56071660|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56071661|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
56071662|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071663|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071664|NCT02037230|Antiviral Agents|antiviral agents|mesh-ancestor
56071665|NCT02037230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071666|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071667|NCT02037230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56071668|NCT02037230|Immunologic Factors|immunologic factors|mesh-ancestor
56071694|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
56071695|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
56071696|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
56071697|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071698|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071699|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
56071700|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071701|NCT00374387|NuvaRing|nuvaring|mesh-list
56071702|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56192595|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192596|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192597|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56192598|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56192599|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56192600|NCT01482052|Vaccines|vaccines|mesh-list
56192601|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
56192602|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192603|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56192604|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56071703|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
56779390|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56779391|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
56779392|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
56779393|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779394|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56779395|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56779396|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56779397|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
56779398|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779399|NCT00989690|Docetaxel|docetaxel|mesh-list
56779400|NCT00989690|Pemetrexed|pemetrexed|mesh-list
56779401|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56779402|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779403|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56779404|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56779405|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56071704|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56071705|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071706|NCT03023891|Prednisone|prednisone|mesh-list
56071707|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071708|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
56071709|NCT03023891|Hormones|hormones|mesh-ancestor
56071710|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071711|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071712|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56071713|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071714|NCT03028025|Hemostatics|hemostatics|mesh-list
56071741|NCT03028103|Fluconazole|fluconazole|mesh-list
56071742|NCT03028103|Omeprazole|omeprazole|mesh-list
56071743|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56071744|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071745|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56071746|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071747|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071748|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
56071749|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071750|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56071751|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56071752|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56071753|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
56137537|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071756|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56071757|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56071758|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56071759|NCT03110003|Bupivacaine|bupivacaine|mesh-list
56071760|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
56071761|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
56071762|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071793|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56071794|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071795|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56071796|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
56071797|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56071798|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56071799|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55799004|NCT02492763|Hormones|hormones|mesh-ancestor
56071801|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56071802|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779406|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779407|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779408|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56071834|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071835|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56071836|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56192605|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56192606|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
56192608|NCT01482117|Clopidogrel|clopidogrel|mesh-list
56192609|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56192610|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56192611|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56192612|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56192613|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
56192614|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192615|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192616|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192617|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56071837|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071838|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071839|NCT02042534|Warfarin|warfarin|mesh-list
56071840|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
56071841|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
56071842|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56071843|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
56071844|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56071845|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
56071846|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071876|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071877|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
56071878|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56071879|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
56071880|NCT03119831|Ethanol|ethanol|mesh-list
56071881|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
56071882|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56071883|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56071884|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071885|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071886|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071887|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
56071888|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
56071889|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
56071922|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56071923|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
56071924|NCT02044796|Cladribine|cladribine|mesh-list
56071925|NCT02044796|Lenograstim|lenograstim|mesh-list
56071926|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56071927|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
56071928|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071929|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071930|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
56071931|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071932|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56071933|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
56071964|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071965|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071966|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
56071967|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071968|NCT02045264|Icatibant|icatibant|mesh-list
56071969|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56071970|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56071971|NCT02045264|Analgesics|analgesics|mesh-ancestor
56071972|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
56071973|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072001|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56192618|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
56192619|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192620|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56192621|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
56192622|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56192623|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56779409|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56779410|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56779411|NCT00074581|Ritonavir|ritonavir|mesh-list
56779412|NCT00074581|Lopinavir|lopinavir|mesh-list
56779413|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56192624|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
56192625|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56192626|NCT01482117|Protective Agents|protective agents|mesh-ancestor
56192627|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56192628|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56192629|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192630|NCT01482156|Everolimus|everolimus|mesh-list
56192631|NCT01482156|Dactolisib|dactolisib|mesh-list
56192632|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192633|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56072002|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072003|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072004|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072005|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56072007|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56072008|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56072009|NCT02978339|Analgesics|analgesics|mesh-ancestor
56072010|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
56072011|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072012|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072013|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072014|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56072015|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072016|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072017|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072018|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
56072019|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072035|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072036|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072037|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56072038|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56072039|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56072040|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072041|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072042|NCT02413034|Vancomycin|vancomycin|mesh-list
56072043|NCT02413034|Cefazolin|cefazolin|mesh-list
56072044|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56072045|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072046|NCT04737473|Anesthetics|anesthetics|mesh-list
56072047|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072048|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072049|NCT02369900|Esmolol|esmolol|mesh-list
56072050|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56072051|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56072052|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072053|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072054|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072055|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072056|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56072057|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
56072058|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56072059|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56192634|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
56192635|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072060|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072061|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56072062|NCT03054857|Analgesics|analgesics|mesh-ancestor
56072063|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
56072064|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072065|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56072066|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56072067|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56072068|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072069|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779414|NCT00074581|Tenofovir|tenofovir|mesh-list
56779415|NCT00074581|Lamivudine|lamivudine|mesh-list
56779416|NCT00074581|Zidovudine|zidovudine|mesh-list
56779417|NCT00074581|Emtricitabine|emtricitabine|mesh-list
56779418|NCT00074581|Nevirapine|nevirapine|mesh-list
56779419|NCT00074581|Stavudine|stavudine|mesh-list
56779420|NCT00074581|Didanosine|didanosine|mesh-list
56779421|NCT00074581|Efavirenz|efavirenz|mesh-list
56779422|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56779423|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56779424|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
56779425|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779426|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779427|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56779428|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56779429|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
56779430|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779431|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56779432|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56779433|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56779434|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56779435|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
56779436|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56779437|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56779438|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56779439|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56779440|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56779441|NCT00776477|Aspirin|aspirin|mesh-list
56779442|NCT00776477|Clopidogrel|clopidogrel|mesh-list
56779443|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56072070|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072071|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
56072072|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
56072073|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56072074|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56072108|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072109|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56072110|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56072111|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
56072112|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072113|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072114|NCT03144635|Grazoprevir|grazoprevir|mesh-list
56072115|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
56072116|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072145|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56072147|NCT02039947|Dabrafenib|dabrafenib|mesh-list
56779444|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56779445|NCT00776477|Analgesics|analgesics|mesh-ancestor
56779446|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
56779447|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779448|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072148|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072149|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56072150|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072151|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072152|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56072153|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
56072154|NCT02996591|Dexamethasone|dexamethasone|mesh-list
56072155|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
56072156|NCT02996591|Midazolam|midazolam|mesh-list
56072157|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
56072158|NCT02996591|Ketamine|ketamine|mesh-list
56072159|NCT02996591|Bupivacaine|bupivacaine|mesh-list
56072160|NCT02996591|Mepivacaine|mepivacaine|mesh-list
56072161|NCT02996591|Anesthetics|anesthetics|mesh-list
56072162|NCT02996591|Propofol|propofol|mesh-list
56072163|NCT02996591|Sevoflurane|sevoflurane|mesh-list
56072164|NCT02996591|BB 1101|bb 1101|mesh-list
56072165|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072199|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56072200|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
56072201|NCT03066947|Interferons|interferons|mesh-list
56072202|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
56072203|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
56072204|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
56072237|NCT03152591|Licogliflozin|licogliflozin|mesh-list
56072238|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56072239|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072240|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56072241|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072242|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
56072243|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56072280|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072282|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56072283|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56072284|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072310|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56072311|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56072312|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
56072314|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
56072315|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
56072316|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072317|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072318|NCT02055638|SRX246|srx246|mesh-list
56192637|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192638|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56192639|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
56192640|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192641|NCT01482338|Drospirenone|drospirenone|mesh-list
56192642|NCT01482338|Desogestrel|desogestrel|mesh-list
56192643|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56192644|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
56072320|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072322|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072323|NCT02044393|Itraconazole|itraconazole|mesh-list
56072324|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
56072325|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072326|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56072327|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56072328|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072329|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072330|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56072331|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
56072361|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56072363|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072364|NCT00375557|Valproic Acid|valproic acid|mesh-list
56072365|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56779449|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56779450|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779451|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56779452|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56779453|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779454|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56779455|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56779456|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779457|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
56779458|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56779459|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56779460|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56779461|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
56779462|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779463|NCT00772655|Rituximab|rituximab|mesh-list
56779464|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779465|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779466|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
56779467|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779468|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779469|NCT04272086|Bupivacaine|bupivacaine|mesh-list
56779470|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
56779471|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
56779472|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779473|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779474|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
56779475|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779476|NCT00776633|Aspirin|aspirin|mesh-list
56779477|NCT00776633|Clopidogrel|clopidogrel|mesh-list
56779493|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56779494|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56779495|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56779496|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
56779497|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779498|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56779499|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56779500|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779501|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56779502|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56779503|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56779504|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779505|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
56779506|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779507|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
56779508|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779509|NCT03961087|Ubiquinone|ubiquinone|mesh-list
56779510|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
56779511|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
56779512|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
56779513|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779514|NCT03961087|Vitamins|vitamins|mesh-ancestor
56779515|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56779516|NCT03961087|Protective Agents|protective agents|mesh-ancestor
56779517|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
56779518|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
56779519|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56779520|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052121|NCT00357539|Azithromycin|azithromycin|mesh-list
56072366|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
56072367|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56072368|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56072369|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56072370|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072371|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072372|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
56072401|NCT03179345|Gabapentin|gabapentin|mesh-list
56072402|NCT03179345|Analgesics|analgesics|mesh-ancestor
56072403|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
56072404|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072405|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072406|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
56072407|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56072408|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072409|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779521|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779522|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56779523|NCT03960775|Analgesics|analgesics|mesh-ancestor
56779524|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
56779525|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56547689|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56052156|NCT03279237|Antidotes|antidotes|mesh-ancestor
56072410|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56072411|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56072412|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56072413|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072414|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56072415|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56072416|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56072417|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072445|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072446|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56072447|NCT03086213|Narcotics|narcotics|mesh-ancestor
56072448|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56072449|NCT02378714|Varenicline|varenicline|mesh-list
56072450|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56072451|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56072452|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
56072453|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072454|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072455|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072456|NCT03091673|Glucagon|glucagon|mesh-list
56072457|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56072458|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56072459|NCT03091673|Hormones|hormones|mesh-ancestor
56192645|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192646|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192647|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56192648|NCT01482338|Diuretics|diuretics|mesh-ancestor
56192649|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
56192650|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56192651|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56192652|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56192653|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
56192654|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56192655|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56192656|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56192657|NCT01482338|Progestins|progestins|mesh-ancestor
56192658|NCT01482338|Hormones|hormones|mesh-ancestor
56192659|NCT01482377|Cetuximab|cetuximab|mesh-list
56192661|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56192662|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213204|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072460|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072461|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072462|NCT03091673|Incretins|incretins|mesh-ancestor
56072463|NCT02382848|Prazosin|prazosin|mesh-list
56072464|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56072465|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56072466|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56072500|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072501|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072502|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56072503|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56072504|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56072505|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56072506|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
56072507|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
56072508|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
56072509|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
56072541|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072542|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56072543|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56779526|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56779527|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56779529|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
56779530|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779531|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779532|NCT00536978|Cytarabine|cytarabine|mesh-list
56779533|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
56779534|NCT00536978|Melphalan|melphalan|mesh-list
56779535|NCT00536978|Carmustine|carmustine|mesh-list
56779536|NCT00536978|Rituximab|rituximab|mesh-list
56779537|NCT00536978|Methotrexate|methotrexate|mesh-list
56779538|NCT00536978|Fludarabine|fludarabine|mesh-list
56779539|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
56779540|NCT00536978|Etoposide|etoposide|mesh-list
56779541|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
56779542|NCT00536978|Tacrolimus|tacrolimus|mesh-list
55799755|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
56072544|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
56072546|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072547|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56072548|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56072549|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072550|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072551|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56072552|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
56072588|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56072619|NCT05717738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56072620|NCT05717738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56072621|NCT05717738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072622|NCT05717738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56072623|NCT05717738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56192663|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56192664|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192665|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192667|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56192668|NCT01482416|Hormones|hormones|mesh-ancestor
56192669|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192670|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192671|NCT01482442|Sorafenib|sorafenib|mesh-list
56192672|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192673|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56192674|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072624|NCT05717738|Growth Substances|growth substances|mesh-ancestor
56072625|NCT05717738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072626|NCT05717738|Growth Inhibitors|growth inhibitors|mesh-ancestor
56072627|NCT05717738|Immunologic Factors|immunologic factors|mesh-ancestor
56072628|NCT05717738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56072629|NCT05717738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072630|NCT05717738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072631|NCT02393378|Folic Acid|folic acid|mesh-list
56072632|NCT02393378|Adalimumab|adalimumab|mesh-list
56072633|NCT02393378|Methotrexate|methotrexate|mesh-list
56072634|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56072635|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
56072668|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072669|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
56072670|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56072671|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072672|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072673|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
56072675|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
56072676|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56779543|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779544|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
56779545|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779546|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779547|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56779548|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
56779549|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779550|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779551|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56779552|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779553|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56779554|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
56779555|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56779556|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56779557|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
56779558|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56779559|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779560|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56779561|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56779562|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
56779563|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779564|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56779565|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56779566|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56779567|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56779568|NCT03809611|Choline|choline|mesh-list
56072677|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56072710|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072711|NCT02069041|Antidotes|antidotes|mesh-ancestor
56072712|NCT02069041|Protective Agents|protective agents|mesh-ancestor
56072713|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
56072715|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
56072716|NCT04920344|Cisplatin|cisplatin|mesh-list
56072717|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072718|NCT03101111|Vaccines|vaccines|mesh-list
56072719|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
56072720|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072754|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56072755|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
56072756|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072757|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56072758|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072759|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072760|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
56072761|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072762|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
56072763|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779569|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
56779570|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56779571|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
56779572|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779573|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56779574|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56779575|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
56779576|NCT05360342|Vitamins|vitamins|mesh-list
56779577|NCT05360342|Vitamin K|vitamin k|mesh-list
56779578|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
56779579|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
56779580|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779581|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56779582|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56779583|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779584|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
56779585|NCT05360342|Coagulants|coagulants|mesh-ancestor
56779586|NCT05290220|Lenvatinib|lenvatinib|mesh-list
56779587|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052198|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56072764|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56072765|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56072766|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072767|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072768|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
56072769|NCT00355862|Hormones|hormones|mesh-ancestor
56072770|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072801|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56072802|NCT00355628|Narcotics|narcotics|mesh-ancestor
56192675|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192677|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
56192678|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
56192679|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192680|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192681|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192682|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56072803|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072804|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072805|NCT00355628|Analgesics|analgesics|mesh-ancestor
56072806|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
56072807|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072808|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56072809|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56072810|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
56072811|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
56072812|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
56072813|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56072814|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
56072815|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
56072816|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072852|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56072853|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
56072854|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
56072855|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072856|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072888|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56072889|NCT02300077|Narcotics|narcotics|mesh-ancestor
56779588|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56779589|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779590|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779591|NCT04026230|Atorvastatin|atorvastatin|mesh-list
56052217|NCT00376077|Hormones|hormones|mesh-ancestor
56072890|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072891|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072892|NCT02300077|Analgesics|analgesics|mesh-ancestor
56072893|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
56072894|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072895|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56072896|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56072897|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
56072898|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
56072899|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
56072900|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
56072901|NCT05272826|Dexamethasone|dexamethasone|mesh-list
56072902|NCT05272826|Bortezomib|bortezomib|mesh-list
56072927|NCT05638880|Levocetirizine|levocetirizine|mesh-list
56072928|NCT05638880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56072929|NCT05638880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56072930|NCT05638880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56072931|NCT05638880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072932|NCT05638880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56072934|NCT05638880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072935|NCT05638880|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56072936|NCT05638880|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56072937|NCT05638880|Histamine Antagonists|histamine antagonists|mesh-ancestor
56072938|NCT05638880|Histamine Agents|histamine agents|mesh-ancestor
56072939|NCT05638880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072940|NCT00356096|Pramipexole|pramipexole|mesh-list
56072941|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
56072942|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072943|NCT00356096|Protective Agents|protective agents|mesh-ancestor
56072944|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072945|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56072946|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56072978|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072979|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
56072980|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56192683|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56192684|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
56192685|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192686|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192687|NCT01482559|Dopamine|dopamine|mesh-list
56192688|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56192689|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
56192690|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
56192691|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192692|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192693|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
56192694|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192695|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192696|NCT01482559|Protective Agents|protective agents|mesh-ancestor
56192697|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
56192698|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56192699|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
56192700|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192701|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
56192702|NCT01482624|Protective Agents|protective agents|mesh-ancestor
56192703|NCT01482728|Dasatinib|dasatinib|mesh-list
56192704|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192705|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56192706|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192707|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192708|NCT01482754|Rituximab|rituximab|mesh-list
56072981|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072982|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56072983|NCT03296345|Ketamine|ketamine|mesh-list
56072984|NCT03296345|Analgesics|analgesics|mesh-ancestor
56779592|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56779593|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56779594|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
56779595|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779596|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56052220|NCT00376077|Protective Agents|protective agents|mesh-ancestor
56072985|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
56072986|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072987|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072988|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56072989|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56073017|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
56073018|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073019|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56073020|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56073021|NCT04652414|Prednisone|prednisone|mesh-list
56073022|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56073023|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
56073024|NCT04652414|Hormones|hormones|mesh-ancestor
56073025|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073026|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073027|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56073028|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073030|NCT04630964|Psilocybin|psilocybin|mesh-list
56073031|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56192709|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56192710|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192711|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
56192712|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192713|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56192714|NCT01482897|Prednisolone|prednisolone|mesh-list
56192715|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56192716|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
56073095|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073096|NCT04525820|Vitamin D|vitamin d|mesh-list
56073097|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
56073098|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
56073099|NCT04525820|Vitamins|vitamins|mesh-list
56073100|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56073101|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
56073102|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073103|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56073104|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56073105|NCT05570708|Psilocybin|psilocybin|mesh-list
56073106|NCT05570708|Hallucinogens|hallucinogens|mesh-ancestor
56073107|NCT05570708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073108|NCT05570708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56073109|NCT05117450|Heparin|heparin|mesh-list
56073110|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
56073111|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56073112|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56073113|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073114|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
56073115|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56073116|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
56073117|NCT03305159|Povidone|povidone|mesh-list
56073118|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56073154|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56073155|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56073156|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073157|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56073158|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56073159|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073160|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073162|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
56073163|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
56073190|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56073192|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
56073193|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779597|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56779598|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490576|NCT00450164|Nadolol|nadolol|mesh-list
56779599|NCT00536510|Niacin|niacin|mesh-list
56779600|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56779601|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
56779602|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779603|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56779604|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
56779605|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
56779606|NCT00536510|Vitamins|vitamins|mesh-ancestor
56779607|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
56779608|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779609|NCT04424264|Tenofovir|tenofovir|mesh-list
56779610|NCT04424264|Lamivudine|lamivudine|mesh-list
56779611|NCT04424264|Emtricitabine|emtricitabine|mesh-list
56779612|NCT04424264|Efavirenz|efavirenz|mesh-list
56073194|NCT04776395|Dexamethasone|dexamethasone|mesh-list
56073195|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
56073196|NCT04776395|Ichthammol|ichthammol|mesh-list
56073197|NCT04776395|BB 1101|bb 1101|mesh-list
56073198|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56073199|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
56073200|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
56073201|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073202|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073203|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56073204|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
56073205|NCT04776395|Hormones|hormones|mesh-ancestor
56073206|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073207|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56073208|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073209|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
56073210|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073211|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073212|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073242|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073243|NCT04319588|Anesthetics|anesthetics|mesh-list
56073244|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
56192717|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56192718|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
56192719|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56073245|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073246|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073247|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
56073248|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073250|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56073251|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
56073252|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073253|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073255|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56073256|NCT04298606|Mitogens|mitogens|mesh-list
56073286|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073287|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
56073288|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
56073289|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56073292|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073293|NCT03319277|Analgesics|analgesics|mesh-ancestor
56073294|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
56073295|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073296|NCT03768440|Ropivacaine|ropivacaine|mesh-list
56073297|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
56779613|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56779614|NCT04424264|Rifampin|rifampin|mesh-list
56779615|NCT04424264|Isoniazid|isoniazid|mesh-list
56779616|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
56779617|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779618|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56779619|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56779620|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779621|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779622|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56779623|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56779624|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56779625|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56779626|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56779627|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56779628|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56779629|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56779630|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56779631|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
56779632|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56779633|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
56779634|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56779635|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56073298|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
56073299|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073300|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073301|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
56073334|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073336|NCT00375869|Hematinics|hematinics|mesh-ancestor
56073337|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
56073338|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
56073339|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56073340|NCT03198221|Citric Acid|citric acid|mesh-list
56073341|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
56073342|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56073343|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
56073344|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
56073345|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073346|NCT03198221|Cathartics|cathartics|mesh-ancestor
56073380|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56073381|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073382|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
56073383|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
56073384|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
56073385|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073386|NCT03994874|Furosemide|furosemide|mesh-list
56073387|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
56073388|NCT03994874|Diuretics|diuretics|mesh-list
55978820|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56779636|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56779637|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56779638|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56779639|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
56779640|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56779641|NCT03790670|Sargramostim|sargramostim|mesh-list
56779642|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
56779643|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779644|NCT00398086|Gemcitabine|gemcitabine|mesh-list
56779645|NCT00398086|Paclitaxel|paclitaxel|mesh-list
56073389|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56073390|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
56073391|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073418|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56073419|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
56073420|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
56073421|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56073422|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56073423|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56073424|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
56073425|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073426|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073427|NCT02354833|Protective Agents|protective agents|mesh-ancestor
56073429|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56073430|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073432|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
56073433|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
56073434|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073435|NCT03838484|Nicotine|nicotine|mesh-list
56073436|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56192720|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
56192721|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56192722|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
56192723|NCT01482897|Hormones|hormones|mesh-ancestor
56073437|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
56073438|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073439|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073440|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56073469|NCT03220022|Doxorubicin|doxorubicin|mesh-list
56073470|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56073471|NCT03220022|Etoposide|etoposide|mesh-list
56073472|NCT03220022|Vincristine|vincristine|mesh-list
56073473|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
56073474|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
56073475|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56073476|NCT03220022|Antibodies|antibodies|mesh-list
56073477|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
56073478|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56073479|NCT03220022|Lenograstim|lenograstim|mesh-list
56073480|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56073481|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
56073482|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073484|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56073485|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
56073486|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073524|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073557|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073558|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073561|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56073562|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073563|NCT02802566|Vitamins|vitamins|mesh-list
56073564|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
56073565|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073566|NCT02770040|Infliximab|infliximab|mesh-list
56073567|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073568|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56073601|NCT00357188|Efavirenz|efavirenz|mesh-list
56779646|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56779647|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56779648|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779649|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
56779650|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
56779651|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
56779652|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779653|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56779654|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
56779655|NCT00398086|Antiviral Agents|antiviral agents|mesh-ancestor
56779656|NCT00398086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779657|NCT00398086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779658|NCT00398086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779659|NCT00398086|Immunologic Factors|immunologic factors|mesh-ancestor
56779660|NCT00398086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779661|NCT04364360|Sulforaphane|sulforaphane|mesh-list
56779662|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56779663|NCT04364360|Protective Agents|protective agents|mesh-ancestor
56779664|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779665|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779666|NCT00536198|Sertraline|sertraline|mesh-list
56779667|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
56779668|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56779669|NCT00536198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56779670|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56779671|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56073602|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56073603|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55800811|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
56073604|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
56073605|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073606|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073607|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56073608|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56073609|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
56073610|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073611|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56073612|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56073645|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073646|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073647|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56073648|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56073649|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56073650|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56073651|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56073652|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56779672|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779673|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779674|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
56547690|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
56779675|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779677|NCT00393484|Entecavir|entecavir|mesh-list
56779678|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56779679|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56779680|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779681|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779682|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
56779683|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779684|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56052299|NCT03352323|Phenylephrine|phenylephrine|mesh-list
56073653|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56073654|NCT01349192|Renal Agents|renal agents|mesh-ancestor
56073684|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073685|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56073686|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56073688|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073689|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073690|NCT02112578|Meclizine|meclizine|mesh-list
56073691|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
56073692|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
56073693|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
56192724|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192725|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192726|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56192728|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
56192729|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
56192730|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073694|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073695|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073696|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56073697|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56073698|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
56073725|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56073726|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073727|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
56073728|NCT03417193|Anesthetics|anesthetics|mesh-list
56073729|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073730|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073731|NCT03417193|Narcotics|narcotics|mesh-ancestor
56073732|NCT03417193|Analgesics|analgesics|mesh-ancestor
56073733|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
56073734|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073735|NCT02367859|Trametinib|trametinib|mesh-list
56073736|NCT02367859|Dabrafenib|dabrafenib|mesh-list
56073737|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073738|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56073739|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073740|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073741|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
56073742|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
56073743|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
56073744|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56073745|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56073746|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073811|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
56073812|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
56779685|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56779686|NCT00667823|Macitentan|macitentan|mesh-list
56779687|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56779688|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56779689|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779690|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56779691|NCT00536120|Natalizumab|natalizumab|mesh-list
56779692|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56779693|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
56779694|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779695|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56779696|NCT00057811|Leucovorin|leucovorin|mesh-list
56779697|NCT00057811|Cytarabine|cytarabine|mesh-list
56779698|NCT00057811|Prednisone|prednisone|mesh-list
56779699|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
56779700|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56779701|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56073813|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073814|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073815|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
56073816|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073817|NCT02387359|Plecanatide|plecanatide|mesh-list
56073818|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56073819|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
56073820|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073821|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56073822|NCT00355459|Doxycycline|doxycycline|mesh-list
56073823|NCT00355459|Tetracycline|tetracycline|mesh-list
56073824|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56073825|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073826|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
56073827|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56073828|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56073829|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56073830|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073831|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073867|NCT05664139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073901|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56073903|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56073904|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
56073905|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073906|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073907|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
56073908|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073909|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56192731|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192732|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56073910|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
56073911|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073948|NCT05620771|Bevacizumab|bevacizumab|mesh-list
56073949|NCT05620771|Atezolizumab|atezolizumab|mesh-list
56073984|NCT00003159|Vinblastine|vinblastine|mesh-list
56073985|NCT00003159|Docetaxel|docetaxel|mesh-list
56073986|NCT00003159|Carboplatin|carboplatin|mesh-list
56073987|NCT00003159|Ifosfamide|ifosfamide|mesh-list
56073988|NCT00003159|Mitomycins|mitomycins|mesh-list
56073989|NCT00003159|Mitomycin|mitomycin|mesh-list
56073990|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55770755|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779702|NCT00057811|Prednisolone|prednisolone|mesh-list
56779703|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
56779704|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
56779705|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56779706|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56779707|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56779708|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
56779709|NCT00057811|Rituximab|rituximab|mesh-list
56779710|NCT00057811|Doxorubicin|doxorubicin|mesh-list
56779711|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56779712|NCT00057811|Methotrexate|methotrexate|mesh-list
56779713|NCT00057811|Etoposide|etoposide|mesh-list
56779714|NCT00057811|Vincristine|vincristine|mesh-list
56779715|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
56779716|NCT00057811|Rasburicase|rasburicase|mesh-list
56779717|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56779718|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
56779719|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
56779720|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779721|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
56073991|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073992|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
56074020|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074021|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56074022|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56074023|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074025|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56074026|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56074027|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
56074028|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56074029|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56074030|NCT00355927|Propofol|propofol|mesh-list
56074031|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56074032|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074033|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074034|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56074035|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
56074036|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
56074037|NCT00357422|Ethanol|ethanol|mesh-list
56074038|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56074066|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
56074067|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
56074068|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56074070|NCT00376337|Micafungin|micafungin|mesh-list
56074071|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
56074072|NCT00376337|Clotrimazole|clotrimazole|mesh-list
56074073|NCT00376337|Miconazole|miconazole|mesh-list
56074074|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074075|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56074076|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56074077|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56074078|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074079|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074080|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56074081|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
56074082|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074083|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074119|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779722|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779723|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779724|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56779725|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
56779726|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779727|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779728|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56779729|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779730|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56779731|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56779732|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56779733|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779734|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56779735|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
56779736|NCT00057811|Hormones|hormones|mesh-ancestor
56779737|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56779738|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56779739|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56779740|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
56779741|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56779742|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56779743|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
56074120|NCT00376493|Metronidazole|metronidazole|mesh-list
56074121|NCT00376493|Doxycycline|doxycycline|mesh-list
56074122|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074123|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56074124|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56074153|NCT05640674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074155|NCT05640674|Narcotics|narcotics|mesh-ancestor
56074156|NCT05640674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074157|NCT05640674|Antitussive Agents|antitussive agents|mesh-ancestor
56074158|NCT05640674|Respiratory System Agents|respiratory system agents|mesh-ancestor
56074159|NCT01805271|Everolimus|everolimus|mesh-list
56074160|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074161|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56074162|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
56074163|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074164|NCT05723276|Psilocybin|psilocybin|mesh-list
56074165|NCT05723276|Hallucinogens|hallucinogens|mesh-ancestor
56074166|NCT05723276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074167|NCT05723276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56074168|NCT01768767|Ketamine|ketamine|mesh-list
56074169|NCT01768767|Analgesics|analgesics|mesh-ancestor
56074170|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
56074171|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192733|NCT01482897|Protective Agents|protective agents|mesh-ancestor
56192734|NCT01482936|Oxycodone|oxycodone|mesh-list
56192735|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56192736|NCT01482936|Narcotics|narcotics|mesh-ancestor
56192737|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56192738|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779744|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
56779745|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56779746|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56779747|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56779748|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
56779749|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779750|NCT00057811|Antidotes|antidotes|mesh-ancestor
56779751|NCT00057811|Protective Agents|protective agents|mesh-ancestor
56779752|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
56779753|NCT00057811|Vitamins|vitamins|mesh-ancestor
56779754|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
56779755|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
56779756|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
56779757|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
56779758|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
56779759|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
56779760|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192739|NCT01482936|Analgesics|analgesics|mesh-ancestor
56192740|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
56192741|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192742|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
56192743|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192744|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56192745|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192746|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074172|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074173|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56074174|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56074209|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074210|NCT00356083|Methadone|methadone|mesh-list
56074211|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56074212|NCT00356083|Narcotics|narcotics|mesh-ancestor
56074213|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074214|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074215|NCT00356083|Analgesics|analgesics|mesh-ancestor
56074247|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56074248|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741065|NCT04445857|Calcitonin|calcitonin|mesh-list
56074249|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074251|NCT00003387|Carboplatin|carboplatin|mesh-list
56074252|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56074253|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074254|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
56074255|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
56074256|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
56074257|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074258|NCT05552443|Hydromorphone|hydromorphone|mesh-list
56074288|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56074290|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
56074291|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074292|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56074293|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56074294|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
56074295|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56074296|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56074297|NCT00003213|Dexamethasone|dexamethasone|mesh-list
56074298|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
56074299|NCT00003213|Metoclopramide|metoclopramide|mesh-list
56074300|NCT00003213|Granisetron|granisetron|mesh-list
56074301|NCT00003213|BB 1101|bb 1101|mesh-list
56779761|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56779762|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56779763|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
56779764|NCT03502148|Cisplatin|cisplatin|mesh-list
56779765|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779766|NCT02530801|Bevacizumab|bevacizumab|mesh-list
56779767|NCT02530801|Fluorouracil|fluorouracil|mesh-list
56779768|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779769|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779770|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56074302|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56074303|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
56074336|NCT00003399|Melphalan|melphalan|mesh-list
56074337|NCT00003399|Carmustine|carmustine|mesh-list
56074338|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56074339|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074340|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
56074341|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
56074342|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
56074343|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074344|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56192747|NCT01483053|S 20098|s 20098|mesh-list
56192748|NCT01483053|Citalopram|citalopram|mesh-list
56192749|NCT01483053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56192750|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56192751|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192752|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192753|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192754|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
56192755|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192756|NCT01483053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56192757|NCT01483053|Antidepressive Agents|antidepressive agents|mesh-ancestor
56192758|NCT01483053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56074345|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
56074346|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074347|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56074380|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074381|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
56074382|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56074383|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56074384|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074385|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
56074386|NCT03822793|Coagulants|coagulants|mesh-ancestor
56074387|NCT04735523|Warfarin|warfarin|mesh-list
56074388|NCT04735523|Dabigatran|dabigatran|mesh-list
56074418|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074419|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074420|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074421|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56074422|NCT00003225|Protective Agents|protective agents|mesh-ancestor
56074423|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074424|NCT05372588|Vaccines|vaccines|mesh-list
56074425|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
56074426|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074427|NCT03838094|Calcium|calcium|mesh-list
56074428|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56074429|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074431|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56074432|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56074433|NCT03441269|Analgesics|analgesics|mesh-ancestor
56074434|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
56074435|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074466|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074467|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074468|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
56074469|NCT00358358|Hormones|hormones|mesh-ancestor
56779771|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56779772|NCT02530801|Growth Substances|growth substances|mesh-ancestor
56779773|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779774|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
56779775|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
56779776|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779777|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56779778|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779779|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
56779780|NCT01091077|Naringenin|naringenin|mesh-list
56779781|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56779782|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56779783|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56074470|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074471|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
56074472|NCT05349188|Melatonin|melatonin|mesh-list
56074473|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
56074474|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074475|NCT05349188|Protective Agents|protective agents|mesh-ancestor
56074476|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074477|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074509|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
56074510|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56074511|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56074512|NCT02265510|Growth Substances|growth substances|mesh-ancestor
56074513|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
56074514|NCT03254147|Warfarin|warfarin|mesh-list
56074515|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
56074516|NCT03254147|Dabigatran|dabigatran|mesh-list
56192759|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56074517|NCT03254147|Apixaban|apixaban|mesh-list
56074518|NCT03254147|Edoxaban|edoxaban|mesh-list
56074519|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
56074520|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56074521|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
56074522|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56074523|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
56074524|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074548|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
56074549|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074550|NCT03256253|Pregabalin|pregabalin|mesh-list
56074551|NCT03256253|Analgesics|analgesics|mesh-ancestor
56074552|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
56074553|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074554|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074555|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
56074556|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56074557|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56074558|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074559|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56074560|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56074561|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56074562|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074563|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56074564|NCT03256799|Ivacaftor|ivacaftor|mesh-list
56074565|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56074566|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56074567|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074568|NCT01238211|Cytarabine|cytarabine|mesh-list
56074569|NCT01238211|Daunorubicin|daunorubicin|mesh-list
56074570|NCT01238211|Dasatinib|dasatinib|mesh-list
56074571|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56074577|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779784|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
56779785|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56779786|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779787|NCT01094275|Omeprazole|omeprazole|mesh-list
56779788|NCT01094275|Clopidogrel|clopidogrel|mesh-list
56779789|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56779790|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56779791|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56779792|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56779793|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
56779794|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779795|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779796|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779797|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56779798|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56052403|NCT02310672|Macitentan|macitentan|mesh-list
56074578|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
56074579|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074580|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56074581|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56074582|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56074583|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074584|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56074585|NCT04735445|Liver Extracts|liver extracts|mesh-list
56074586|NCT04735445|Hematinics|hematinics|mesh-ancestor
56074587|NCT00003231|Docetaxel|docetaxel|mesh-list
56074588|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074589|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
56074590|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
56074591|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
56074592|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074593|NCT00003405|Interferons|interferons|mesh-list
56074594|NCT00003405|Cytarabine|cytarabine|mesh-list
56074595|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
56074596|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
56074597|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
56074598|NCT00003405|Idoxuridine|idoxuridine|mesh-list
56074599|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
56074600|NCT00003405|Idarubicin|idarubicin|mesh-list
56074601|NCT00003405|Isotretinoin|isotretinoin|mesh-list
56074602|NCT00003405|Amifostine|amifostine|mesh-list
56074603|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074604|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
56074605|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074606|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56074607|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
56074608|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074609|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56074610|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
56074612|NCT00003405|Analgesics|analgesics|mesh-ancestor
56074613|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
56074614|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074615|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56074616|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56074617|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074618|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56074619|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
56074620|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56192760|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779799|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56779800|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779801|NCT01089205|Metformin|metformin|mesh-list
56779802|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56779803|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779804|NCT02866682|Tacrolimus|tacrolimus|mesh-list
56779805|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779806|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
56779807|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779808|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56779809|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779810|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779811|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
56779812|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56779813|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
56779814|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779815|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779816|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56779817|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
56779818|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56779819|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
56779820|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779821|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779822|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56779823|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
56779824|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
56547691|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779825|NCT01089439|Protective Agents|protective agents|mesh-ancestor
56192761|NCT01483248|Interferons|interferons|mesh-list
56192762|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56192763|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192764|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
56192765|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192766|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56192767|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192768|NCT01483274|Vaccines|vaccines|mesh-list
56192769|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
56192770|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192771|NCT01483300|Cisplatin|cisplatin|mesh-list
56192772|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192773|NCT01483365|Progesterone|progesterone|mesh-list
56192774|NCT01483365|Progestins|progestins|mesh-ancestor
56192775|NCT01483365|Hormones|hormones|mesh-ancestor
56074621|NCT00003405|Protective Agents|protective agents|mesh-ancestor
56074622|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56074623|NCT05131646|Axitinib|axitinib|mesh-list
56074624|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074625|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56074626|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779826|NCT00992030|Rituximab|rituximab|mesh-list
56779827|NCT00992030|Doxorubicin|doxorubicin|mesh-list
56779828|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56779829|NCT00992030|Dacarbazine|dacarbazine|mesh-list
56779830|NCT00992030|Bleomycin|bleomycin|mesh-list
56779831|NCT00992030|Vinblastine|vinblastine|mesh-list
56779832|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779833|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779834|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
56779835|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779836|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56779837|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56779838|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56779839|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56779840|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779841|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779842|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56779843|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
56779844|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56779845|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
56074627|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074659|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56074660|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56074661|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
56074662|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074664|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074665|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56074666|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074667|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074668|NCT00003249|Ketoconazole|ketoconazole|mesh-list
56074669|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
56074670|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
56074671|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074702|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074703|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56074704|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56074705|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
56074706|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074707|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074708|NCT00003261|Zidovudine|zidovudine|mesh-list
56074709|NCT00003261|Methotrexate|methotrexate|mesh-list
56074710|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56074711|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
56074712|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56074713|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074747|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56074748|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074749|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56074750|NCT04530409|Protective Agents|protective agents|mesh-ancestor
56074751|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
56074753|NCT04477837|Edoxaban|edoxaban|mesh-list
56074754|NCT04477837|Dabigatran|dabigatran|mesh-list
56074755|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56074796|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56074831|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
55770756|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
56779846|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
56779847|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
56779848|NCT01976390|Sirolimus|sirolimus|mesh-list
56779849|NCT01976390|Everolimus|everolimus|mesh-list
56779850|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779851|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56074832|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074833|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56074834|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56074835|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192776|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192777|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192779|NCT01483508|Procyanidin|procyanidin|mesh-list
56192780|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
56192783|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192784|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56192785|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56192786|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192787|NCT01483638|Axitinib|axitinib|mesh-list
56192788|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192789|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56074836|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074867|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074868|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074869|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074870|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56074871|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
56074872|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56074873|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
56074874|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074875|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074876|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56074877|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
56074878|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56074879|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
56074880|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074909|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074911|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56074912|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
56074913|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56074914|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56074915|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
56074916|NCT05071352|Nefopam|nefopam|mesh-list
56074917|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56074918|NCT05071352|Analgesics|analgesics|mesh-ancestor
56074919|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
56074920|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074921|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074922|NCT00376025|Antioxidants|antioxidants|mesh-list
56074923|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074924|NCT00376025|Protective Agents|protective agents|mesh-ancestor
56074925|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074926|NCT00376103|Temozolomide|temozolomide|mesh-list
56074927|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56074960|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074961|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074962|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074963|NCT02263326|Lamivudine|lamivudine|mesh-list
56074964|NCT02263326|Dolutegravir|dolutegravir|mesh-list
56074965|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56074966|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56074967|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56074968|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074969|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192790|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192791|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192792|NCT01483729|Ritonavir|ritonavir|mesh-list
56192793|NCT01483729|Lactams|lactams|mesh-list
56779852|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
56779853|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779854|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56779855|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779856|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56779857|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
56779858|NCT00570713|Gemcitabine|gemcitabine|mesh-list
56779859|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56779860|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
56779861|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779862|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779863|NCT00570713|Antiviral Agents|antiviral agents|mesh-ancestor
56779864|NCT00570713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779865|NCT00570713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779866|NCT00570713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56779867|NCT00570713|Immunologic Factors|immunologic factors|mesh-ancestor
56779868|NCT00570713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779869|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
56779870|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56779871|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56779872|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56192794|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56192795|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56192796|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
56192797|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192798|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074970|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
56074991|NCT05647512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074992|NCT05647512|Glucocorticoids|glucocorticoids|mesh-ancestor
56074993|NCT05647512|Hormones|hormones|mesh-ancestor
56074994|NCT05647512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074995|NCT05647512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56074996|NCT05647512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074997|NCT00356395|Candesartan|candesartan|mesh-list
56074998|NCT00356395|Ramipril|ramipril|mesh-list
56074999|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56075000|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56075002|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075003|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56075004|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
56075005|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075006|NCT00356473|Atorvastatin|atorvastatin|mesh-list
56075007|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56075008|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56075009|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
56075010|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075011|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56075012|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56075013|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075014|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
56075015|NCT03410875|Vemurafenib|vemurafenib|mesh-list
56075016|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56779873|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779874|NCT00780377|Bradykinin|bradykinin|mesh-list
56779875|NCT00780377|Kininogens|kininogens|mesh-list
56779876|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
56779877|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56779878|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
56779879|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779880|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779881|NCT05219942|Insulin|insulin|mesh-list
56779882|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
56779883|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56779884|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779885|NCT00669617|Fluticasone|fluticasone|mesh-list
56779886|NCT00669617|Xhance|xhance|mesh-list
56779887|NCT00669617|Albuterol|albuterol|mesh-list
56779888|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56779889|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56779890|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56779891|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
56779892|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779893|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779894|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56779895|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
56490871|NCT02930057|Betamethasone|betamethasone|mesh-list
56779896|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
56779897|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56779898|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56779899|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56779900|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56779901|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
56779902|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779903|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779904|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
56779905|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56779906|NCT03979352|Empagliflozin|empagliflozin|mesh-list
56052499|NCT01803074|Ritonavir|ritonavir|mesh-list
56075017|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075018|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56075019|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075020|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779907|NCT03979352|Pancrelipase|pancrelipase|mesh-list
56779908|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56779909|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779910|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56779911|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779912|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56779913|NCT00773201|Sotalol|sotalol|mesh-list
56779914|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56779915|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56779916|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
56779917|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779918|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779919|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779920|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56779921|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
56779922|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
56779923|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779924|NCT00777413|Minocycline|minocycline|mesh-list
56075021|NCT05461508|Amoxicillin|amoxicillin|mesh-list
56075022|NCT05461508|Fucoidan|fucoidan|mesh-list
56075023|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56075024|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075054|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56075056|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075057|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075058|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
56075059|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075060|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56075061|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075062|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
56075063|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075064|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56075065|NCT05445440|Antidotes|antidotes|mesh-ancestor
56075066|NCT05445440|Protective Agents|protective agents|mesh-ancestor
56075067|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
56075068|NCT05445440|Vitamins|vitamins|mesh-ancestor
56075069|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
56075070|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075071|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56075072|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56075073|NCT05445440|Analgesics|analgesics|mesh-ancestor
56075105|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56075106|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56192799|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56192800|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56192801|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
56192802|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192803|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56192804|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56192805|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56192806|NCT01483781|Canagliflozin|canagliflozin|mesh-list
56192807|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56192808|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192809|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56075107|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56075109|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779925|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56779926|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779927|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
56779928|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56779929|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779930|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56779931|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779932|NCT00992576|Hydromorphone|hydromorphone|mesh-list
56779933|NCT00992576|Naloxone|naloxone|mesh-list
56779934|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56779935|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779936|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
56779937|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779938|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56075110|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56075111|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56075112|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075113|NCT05210582|Afamelanotide|afamelanotide|mesh-list
56075114|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
56075115|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
56075144|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075145|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075146|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56075147|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56075148|NCT00360386|Clopidogrel|clopidogrel|mesh-list
56075149|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56075150|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56075152|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56075153|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
56075154|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075155|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075156|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075157|NCT02977208|Gabapentin|gabapentin|mesh-list
56075158|NCT02977208|Analgesics|analgesics|mesh-ancestor
56075159|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
56075160|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075191|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075192|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56075193|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56075194|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56075195|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56075196|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
56075197|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56075198|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56075199|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075200|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
56075201|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075202|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56075203|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56075204|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56075205|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
56075206|NCT02259348|Aldesleukin|aldesleukin|mesh-list
56075238|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075239|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075240|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
56075241|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56075242|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
56075243|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075244|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779939|NCT00992576|Narcotics|narcotics|mesh-ancestor
56779940|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56779941|NCT00992576|Analgesics|analgesics|mesh-ancestor
56779942|NCT00777569|Nicotine|nicotine|mesh-list
56779943|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56779944|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
56779945|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779946|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192811|NCT01483859|Liver Extracts|liver extracts|mesh-list
56192812|NCT01483859|Hematinics|hematinics|mesh-ancestor
56192813|NCT01483911|Gontivimab|gontivimab|mesh-list
56192814|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
56075245|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56075246|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
56075247|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56075248|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
56075249|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
56075250|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075251|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075280|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56075281|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56075282|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
56075283|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075284|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075285|NCT03592121|Protective Agents|protective agents|mesh-ancestor
56075286|NCT04332809|Gentamicins|gentamicins|mesh-list
56075287|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56075288|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075289|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56075290|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075291|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075292|NCT03596723|Prednisolone|prednisolone|mesh-list
56075293|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56075294|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
56075295|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56075296|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
56075297|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56075298|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
56075335|NCT03472469|Analgesics|analgesics|mesh-ancestor
56075336|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
56075337|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
56075338|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56075370|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
56075371|NCT04943159|Afamelanotide|afamelanotide|mesh-list
56075372|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
56075373|NCT04525157|Afamelanotide|afamelanotide|mesh-list
56075374|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
56075375|NCT04734665|Bevacizumab|bevacizumab|mesh-list
56075376|NCT04734665|Niraparib|niraparib|mesh-list
56075377|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56075379|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56075380|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56075381|NCT04734665|Growth Substances|growth substances|mesh-ancestor
56075406|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
56075407|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075408|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56075409|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075410|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56075411|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56075412|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56075413|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
56075414|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56075415|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075416|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
56075417|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56075418|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56075419|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56075421|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
56075422|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779947|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56779948|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56779949|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
56779950|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779951|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779952|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56779953|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56779954|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56779955|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56779956|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779957|NCT00535730|Vaccines|vaccines|mesh-list
56779958|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56779959|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
56075424|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
56075425|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
56075426|NCT03478163|Cefazolin|cefazolin|mesh-list
56075427|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56075428|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075429|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56075430|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192815|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192816|NCT01484015|Cefepime|cefepime|mesh-list
56192817|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56192818|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075431|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075432|NCT05646810|Lidocaine|lidocaine|mesh-list
56075458|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56075459|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56075460|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
56075461|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075462|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075463|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075464|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56075465|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56075466|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
56075467|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075468|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56075469|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
56075470|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
56075471|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
56075472|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56075473|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56075474|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56075475|NCT02959112|Analgesics|analgesics|mesh-ancestor
56075476|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
56075477|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56075478|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075479|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
56075514|NCT04932434|Psilocybin|psilocybin|mesh-list
56075515|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56075516|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
56075517|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075518|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56075519|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56075520|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
56075521|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075522|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075559|NCT04486352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56075560|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075561|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775480|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56779960|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779961|NCT00992654|Maraviroc|maraviroc|mesh-list
56779962|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56779963|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56779964|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779965|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56779966|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56779967|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
56779968|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56779969|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56779970|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56779971|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
56779972|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56779973|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56779974|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779975|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779976|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56052578|NCT02271698|BB 1101|bb 1101|mesh-list
56075593|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075594|NCT05646264|S 20098|s 20098|mesh-list
56075595|NCT05646264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56075596|NCT05646264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56075597|NCT05646264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075638|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075639|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075640|NCT02973659|Urological Agents|urological agents|mesh-ancestor
56075641|NCT04439396|Ketorolac|ketorolac|mesh-list
56075642|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56075673|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075674|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
56075675|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075676|NCT05651256|Botulinum Toxins|botulinum toxins|mesh-list
56075677|NCT05651256|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56075678|NCT05651256|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56075679|NCT05651256|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56075680|NCT05651256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56075681|NCT05651256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075682|NCT05651256|Cholinergic Agents|cholinergic agents|mesh-ancestor
56075683|NCT05651256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075684|NCT05651256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075716|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075717|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
56075718|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075719|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56075720|NCT04812470|Analgesics|analgesics|mesh-ancestor
56075721|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
56192819|NCT01484080|Paclitaxel|paclitaxel|mesh-list
56075722|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075723|NCT02976194|Ranibizumab|ranibizumab|mesh-list
56075724|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56075725|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56075726|NCT02976194|Growth Substances|growth substances|mesh-ancestor
56075756|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56075757|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075758|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56779977|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56779978|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779979|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
56779980|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779982|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
56779983|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
56779984|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
56779985|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779986|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779987|NCT00666965|Rotigotine|rotigotine|mesh-list
56779988|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
56779989|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
56779990|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56779991|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56779992|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56779993|NCT00781157|Phenylephrine|phenylephrine|mesh-list
56779994|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
56779995|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56779996|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
56779997|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
56052593|NCT02328404|Vitamin D|vitamin d|mesh-list
56075760|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56075761|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075762|NCT01641822|Tobramycin|tobramycin|mesh-list
56075763|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56075764|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075765|NCT04398368|Gemcitabine|gemcitabine|mesh-list
56075766|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56075767|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
56075768|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075769|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075770|NCT04398368|Antiviral Agents|antiviral agents|mesh-ancestor
56075808|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075836|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075837|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
56075838|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075839|NCT05334108|Ecopipam|ecopipam|mesh-list
56075840|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56075841|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56075842|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56075843|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075844|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56075845|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56075846|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
56075847|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075848|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075849|NCT03984656|Lidocaine|lidocaine|mesh-list
56075850|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
56075851|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
56075852|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56075853|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075854|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
56075884|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56075885|NCT04329494|Antidotes|antidotes|mesh-ancestor
56075886|NCT04329494|Protective Agents|protective agents|mesh-ancestor
56779998|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56779999|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780000|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
56780001|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56780002|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
56780003|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
56780004|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56780005|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56780006|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56780007|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
56780008|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780009|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780010|NCT00781157|Protective Agents|protective agents|mesh-ancestor
56780011|NCT00777959|Sirolimus|sirolimus|mesh-list
56780012|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56780013|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780014|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56780015|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780016|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
56780017|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780018|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
56780019|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780020|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
56780021|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56780022|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
56780023|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56780024|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56780025|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780026|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56780027|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780028|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56780029|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780030|NCT00778115|Simethicone|simethicone|mesh-list
56780031|NCT00778115|Loperamide|loperamide|mesh-list
56780038|NCT00993122|Ribavirin|ribavirin|mesh-list
56780039|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
56780040|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780041|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
56780042|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780043|NCT00778193|Aspirin|aspirin|mesh-list
56780044|NCT00778193|Celecoxib|celecoxib|mesh-list
56780045|NCT00778193|Naproxen|naproxen|mesh-list
56780046|NCT00778193|Clopidogrel|clopidogrel|mesh-list
56780047|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56780048|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56780049|NCT00778193|Analgesics|analgesics|mesh-ancestor
56780050|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
56780051|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780052|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780053|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56780054|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780055|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56780056|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56780057|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780058|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56780059|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56780060|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780061|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
56780062|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56780063|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56780064|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56780065|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
56780066|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780069|NCT00778271|Gabapentin|gabapentin|mesh-list
56780083|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
56780084|NCT00778349|Metformin|metformin|mesh-list
56780085|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56780086|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780087|NCT00995618|Tranilast|tranilast|mesh-list
56780088|NCT00995618|Febuxostat|febuxostat|mesh-list
56780089|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
56052700|NCT05747768|Midazolam|midazolam|mesh-list
56075887|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
56075888|NCT04329494|Vitamins|vitamins|mesh-ancestor
56075889|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
56075890|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
56075891|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56075892|NCT03655301|Metformin|metformin|mesh-list
56075893|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55803224|NCT05696977|Cyclosporine|cyclosporine|mesh-list
56076015|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076046|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56076047|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076048|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076049|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192820|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56192821|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56192822|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192823|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
56192824|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
56192825|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
56192826|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192827|NCT01484145|Terbinafine|terbinafine|mesh-list
56192828|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
56192829|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192830|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192831|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076050|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56076051|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56076052|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56076053|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
56076055|NCT04184999|Prednisolone|prednisolone|mesh-list
56076056|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56076057|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
56076058|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56076059|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
56076060|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56076061|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
56076062|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076093|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076094|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076095|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076096|NCT03524339|Urological Agents|urological agents|mesh-ancestor
56076097|NCT05427474|Propranolol|propranolol|mesh-list
56076098|NCT05427474|Gabapentin|gabapentin|mesh-list
56076099|NCT05427474|Analgesics|analgesics|mesh-ancestor
56076100|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
56076101|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076102|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076103|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
56076104|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56076105|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56076175|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076176|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076226|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56076227|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56076228|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56192832|NCT01484171|Idarubicin|idarubicin|mesh-list
56076229|NCT05142228|Erenumab|erenumab|mesh-list
56076230|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56076231|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076232|NCT05142228|Analgesics|analgesics|mesh-ancestor
56780090|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780091|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56780092|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56780093|NCT00995618|Analgesics|analgesics|mesh-ancestor
56780094|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
56076233|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
56076234|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076235|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803440|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076237|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076238|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076239|NCT05122026|Isoniazid|isoniazid|mesh-list
56076240|NCT05122026|Rifapentine|rifapentine|mesh-list
56076241|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
56076242|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56076243|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076244|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56076245|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56076246|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
56076247|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076248|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56076249|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56076250|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
56076251|NCT02958878|Tamsulosin|tamsulosin|mesh-list
56076252|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56076253|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56076254|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56076255|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
56076256|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076257|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076258|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076259|NCT02958878|Urological Agents|urological agents|mesh-ancestor
56076260|NCT02976116|Gefitinib|gefitinib|mesh-list
56076261|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076262|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56076263|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076264|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076265|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
56076266|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56076267|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56076268|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56076296|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56076297|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
56076299|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56076300|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076301|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
56076302|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076303|NCT04844814|Prednisone|prednisone|mesh-list
56076304|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56076305|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076306|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
56076307|NCT04844814|Hormones|hormones|mesh-ancestor
56076308|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56076309|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076310|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56076311|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076312|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56076313|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56076332|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56076333|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076335|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076336|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076337|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56076338|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56076339|NCT05314673|Growth Substances|growth substances|mesh-ancestor
56076340|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076341|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56076342|NCT04190550|Cytarabine|cytarabine|mesh-list
56076343|NCT04190550|Idarubicin|idarubicin|mesh-list
56780095|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780096|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780097|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56780098|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56780099|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780100|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780101|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56780102|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56780103|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
56780104|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
56780105|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780106|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56780107|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56780108|NCT00778427|Metformin|metformin|mesh-list
56780109|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56780110|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780111|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56780112|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56780113|NCT00667355|Adalimumab|adalimumab|mesh-list
56780114|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076344|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56192833|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56192834|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192835|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56192836|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56192837|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192838|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192840|NCT01484184|Buspirone|buspirone|mesh-list
56192841|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56192842|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56192843|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
56076345|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
56076346|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076347|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076348|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
56076349|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076350|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56076351|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
56076352|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076353|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56076354|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56076355|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56076356|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076357|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
56076358|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
56076359|NCT04112069|Pancrelipase|pancrelipase|mesh-list
56076360|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56076361|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076362|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56076363|NCT03785210|Vancomycin|vancomycin|mesh-list
56076364|NCT03785210|Nivolumab|nivolumab|mesh-list
56076365|NCT03785210|Tadalafil|tadalafil|mesh-list
56076366|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076367|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780115|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780116|NCT00778505|Remifentanil|remifentanil|mesh-list
56780117|NCT00778505|Propofol|propofol|mesh-list
56780118|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56780119|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780120|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780121|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56780122|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
56076368|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56076369|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076370|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56076385|NCT04832100|Pregabalin|pregabalin|mesh-list
56076387|NCT04832100|Analgesics|analgesics|mesh-ancestor
56076388|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
56076389|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076390|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076391|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
56076392|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56076393|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56076394|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076395|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56076396|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56076397|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56076398|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076399|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56076400|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56076401|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
56076402|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56076403|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56076404|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
56076405|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076406|NCT02976272|Bortezomib|bortezomib|mesh-list
56076407|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076408|NCT00361790|Aripiprazole|aripiprazole|mesh-list
56076409|NCT00361790|Citalopram|citalopram|mesh-list
56076410|NCT00361790|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56076411|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56076412|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192844|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192847|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56192848|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56192849|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56192850|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56192851|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56192852|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
56192853|NCT01484262|Liraglutide|liraglutide|mesh-list
56192854|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56192855|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192856|NCT01484262|Incretins|incretins|mesh-ancestor
56192857|NCT01484262|Hormones|hormones|mesh-ancestor
56192858|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56192859|NCT01484327|Carvedilol|carvedilol|mesh-list
56076413|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076434|NCT00361868|Metformin|metformin|mesh-list
56076435|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
56076436|NCT00361868|Fenofibrate|fenofibrate|mesh-list
56076437|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56076438|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076439|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56076440|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
56076441|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076442|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56076443|NCT04564872|Linagliptin|linagliptin|mesh-list
56076444|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56076445|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076446|NCT04564872|Incretins|incretins|mesh-ancestor
56076447|NCT04564872|Hormones|hormones|mesh-ancestor
55775543|NCT01678313|Celecoxib|celecoxib|mesh-list
56780123|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
56780124|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56780125|NCT00778505|Narcotics|narcotics|mesh-ancestor
56780126|NCT00778505|Analgesics|analgesics|mesh-ancestor
56491096|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
56076448|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56076449|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56076450|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
56076451|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076452|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076453|NCT04343144|Nivolumab|nivolumab|mesh-list
56076454|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076455|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076456|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56076457|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076458|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
56076459|NCT03743246|Fludarabine|fludarabine|mesh-list
56076460|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56076461|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
56076462|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076463|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56076464|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56076465|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
56076493|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56076494|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56076495|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56076496|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
56076497|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
56076498|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
56076499|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
56076500|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192860|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56192861|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56192862|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
56192863|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192864|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192865|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192866|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56192867|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
56192868|NCT01484327|Protective Agents|protective agents|mesh-ancestor
56192869|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56192870|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56192871|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56192872|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
56192873|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56192874|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56192875|NCT01484457|Pancrelipase|pancrelipase|mesh-list
56192878|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
56192879|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076501|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076503|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56076504|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56076505|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56076506|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56076507|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56076508|NCT00361166|Pimavanserin|pimavanserin|mesh-list
56076509|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56076510|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56076511|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56076512|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56076538|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56076539|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56076540|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
56076542|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
56076543|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076544|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56076545|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076546|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56076547|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
56780127|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
56780128|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780129|NCT00532844|Vitamins|vitamins|mesh-list
56780130|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
56780131|NCT00532844|Verapamil|verapamil|mesh-list
56780132|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
56780133|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780134|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
56780135|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780136|NCT00532844|Protective Agents|protective agents|mesh-ancestor
56780137|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56780138|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56780139|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780140|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56780141|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
56780142|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
56780143|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56780144|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780145|NCT00778583|Renal Agents|renal agents|mesh-ancestor
56780146|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56780147|NCT00778661|Amoxicillin|amoxicillin|mesh-list
56780148|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56780149|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780150|NCT00993356|Lanreotide|lanreotide|mesh-list
56780151|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780152|NCT00781547|Hormones|hormones|mesh-list
56780153|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56780154|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780155|NCT00778739|Cefprozil|cefprozil|mesh-list
56780156|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56076548|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076549|NCT03706313|Bupivacaine|bupivacaine|mesh-list
56076550|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
56076551|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
56076552|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076553|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076554|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
56076555|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076556|NCT05369364|Dexamethasone|dexamethasone|mesh-list
56076557|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
56076586|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56076587|NCT03390686|Paclitaxel|paclitaxel|mesh-list
56076588|NCT03390686|Bevacizumab|bevacizumab|mesh-list
56076589|NCT03390686|Carboplatin|carboplatin|mesh-list
56076590|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56076591|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076592|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
56076593|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
56780157|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780158|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
56780159|NCT00781625|Methenamine|methenamine|mesh-list
56780160|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
56780161|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56780162|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780163|NCT00781625|Renal Agents|renal agents|mesh-ancestor
56780164|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56780165|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
56780166|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56780167|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780168|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56780169|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
56780170|NCT00666263|Antibodies|antibodies|mesh-list
56780171|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
56780172|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56780173|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56780174|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
56780175|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780176|NCT00667277|Bevacizumab|bevacizumab|mesh-list
56780177|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56780178|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076594|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
56076595|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076596|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076597|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56076598|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56076599|NCT03390686|Growth Substances|growth substances|mesh-ancestor
56076600|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076601|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
56076628|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076630|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
56076631|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
56076632|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56076633|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56076634|NCT00361322|Analgesics|analgesics|mesh-ancestor
56076635|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
56076636|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076637|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076638|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076639|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56076640|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56076641|NCT02974712|Fentanyl|fentanyl|mesh-list
56076642|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56076643|NCT02974712|Narcotics|narcotics|mesh-ancestor
56076644|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076645|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076646|NCT02974712|Analgesics|analgesics|mesh-ancestor
56076647|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
56076648|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076675|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56076676|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
56076678|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
56076679|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56780179|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56780180|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56780181|NCT00667277|Growth Substances|growth substances|mesh-ancestor
56780182|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780183|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
56780184|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
56780185|NCT00774527|Fludarabine|fludarabine|mesh-list
56780186|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56780187|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780188|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
56780189|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780190|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780191|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56052788|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
56052789|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052790|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052791|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56076680|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56076681|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076682|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076683|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56076684|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56076685|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56076686|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56076687|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
56076688|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
56076689|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
56076690|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
56076691|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076692|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076693|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56076694|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56076695|NCT04957368|Analgesics|analgesics|mesh-ancestor
56076696|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
56076697|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076698|NCT04818450|Gabapentin|gabapentin|mesh-list
56076699|NCT04818450|Analgesics|analgesics|mesh-ancestor
56076730|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56076731|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076732|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
56076733|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56076734|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076735|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076736|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56076737|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56076738|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56192880|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56192881|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56076739|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56076740|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56076772|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076773|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56076775|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
56076776|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
56076777|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780192|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
56780193|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780194|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780195|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56780196|NCT00778973|Sertraline|sertraline|mesh-list
56780197|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
56780198|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56780199|NCT00778973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56780200|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56780201|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780202|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780203|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780204|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
56780205|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780206|NCT00774605|Varenicline|varenicline|mesh-list
56780207|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56780208|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56780209|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
56780210|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780211|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780212|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780213|NCT00779051|Zolpidem|zolpidem|mesh-list
56780214|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56780215|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56780216|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780217|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780218|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56780219|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
56780220|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
56780221|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780222|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076778|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076779|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
56076780|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076781|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56076782|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56076783|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56076784|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56076806|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56780223|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
56780224|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56780225|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56780226|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
56780227|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780228|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56780229|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56780230|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780231|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780232|NCT00782093|Volociximab|volociximab|mesh-list
56780233|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56780234|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56780235|NCT00782093|Growth Substances|growth substances|mesh-ancestor
56780236|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780237|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
56780238|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780239|NCT00784511|Vitamin D|vitamin d|mesh-list
56780240|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
56780241|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
56780242|NCT00784511|Vitamins|vitamins|mesh-list
56052838|NCT05745038|Zaleplon|zaleplon|mesh-list
56076807|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
56076808|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076809|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076810|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56076811|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56076819|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076820|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076828|NCT05330754|Caffeine|caffeine|mesh-list
56076829|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56076830|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076831|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56076832|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076833|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076834|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56076835|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56076836|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
56076837|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076838|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56076839|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076840|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
56076841|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56076842|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56076843|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076845|NCT04448184|Coagulants|coagulants|mesh-ancestor
56076846|NCT04426968|Interferons|interferons|mesh-list
56076847|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076848|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
56076878|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076879|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076881|NCT04031885|Docetaxel|docetaxel|mesh-list
56076882|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56076883|NCT04031885|Capecitabine|capecitabine|mesh-list
56076884|NCT04031885|Fulvestrant|fulvestrant|mesh-list
56076885|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56076886|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780243|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
56780244|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780245|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56780246|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56780247|NCT00784589|Rituximab|rituximab|mesh-list
56780248|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56780249|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780250|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
56780251|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780252|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780253|NCT00784667|Cetuximab|cetuximab|mesh-list
56780254|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56780255|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076887|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
56076888|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
56076889|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
56076890|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076891|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56076892|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
56076914|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
56076915|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
56076916|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076917|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076918|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
56076919|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076920|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56076921|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56192883|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56192884|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192885|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56192886|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56192887|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56192888|NCT01484717|Nicotine|nicotine|mesh-list
56192889|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56192890|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
56192891|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192892|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192893|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56076922|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56076923|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56076924|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076925|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56076926|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56076927|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
56076928|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076929|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56076930|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56076931|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
56076932|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56076933|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
56076934|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
56076935|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
56076936|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56076937|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
56076938|NCT04211909|Velpatasvir|velpatasvir|mesh-list
56076939|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
56076940|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076941|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
56076942|NCT04223843|Olodaterol|olodaterol|mesh-list
56076943|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56076965|NCT05722795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56780256|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780257|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56780258|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780259|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780260|NCT00784745|Dexamethasone|dexamethasone|mesh-list
56780261|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076966|NCT05722795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076967|NCT05722795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076968|NCT03778554|Metoprolol|metoprolol|mesh-list
56076969|NCT03778554|Carvedilol|carvedilol|mesh-list
56076970|NCT03778554|Nebivolol|nebivolol|mesh-list
56076971|NCT03778554|Bisoprolol|bisoprolol|mesh-list
56076972|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56076973|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56076974|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
56076975|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
56076976|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076977|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137538|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076978|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56076979|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56076980|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56076981|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
56076982|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076983|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076984|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
56076985|NCT03778554|Protective Agents|protective agents|mesh-ancestor
56076986|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56076987|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56076988|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56076989|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
56076990|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56076991|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56076992|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56076993|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56076994|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56192894|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56192895|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
56192896|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56192897|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192898|NCT01484756|Micronutrients|micronutrients|mesh-list
56192899|NCT01484756|Trace Elements|trace elements|mesh-list
56192900|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192901|NCT01484964|Peficitinib|peficitinib|mesh-list
56192902|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192903|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192904|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56192905|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
56192906|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076995|NCT04810494|Lidocaine|lidocaine|mesh-list
56076996|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
56076997|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
56077033|NCT05722405|Growth Substances|growth substances|mesh-ancestor
56077034|NCT05722405|Growth Inhibitors|growth inhibitors|mesh-ancestor
56077061|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077062|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
56077063|NCT04419246|Coagulants|coagulants|mesh-ancestor
56077064|NCT04837014|Acetaminophen|acetaminophen|mesh-list
56077065|NCT04837014|Naproxen|naproxen|mesh-list
56077066|NCT04837014|Hydromorphone|hydromorphone|mesh-list
56077067|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56077068|NCT04837014|Analgesics|analgesics|mesh-ancestor
56077069|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
56077070|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077071|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077072|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
56077073|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56077074|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077075|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780262|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
56780263|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
56780264|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780265|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780266|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56780267|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
56780268|NCT00784745|Hormones|hormones|mesh-ancestor
56780269|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56780270|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56780271|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780272|NCT00993512|Bleomycin|bleomycin|mesh-list
56780273|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56780274|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077076|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
56077077|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56077078|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077079|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077080|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56077081|NCT04837014|Narcotics|narcotics|mesh-ancestor
56077114|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077115|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077116|NCT04232358|Anesthetics|anesthetics|mesh-list
56077117|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077118|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077119|NCT05395494|Cycloserine|cycloserine|mesh-list
56077120|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56077121|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077122|NCT05395494|Renal Agents|renal agents|mesh-ancestor
56077123|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56077148|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077149|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56077150|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56077151|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56077153|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
56077154|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077156|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
56077159|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56077160|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
56077161|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56192908|NCT01484990|Carbidopa|carbidopa|mesh-list
56192909|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56192910|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56192911|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56192912|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
56077162|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
56077163|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077164|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077165|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
56077166|NCT05392530|Macitentan|macitentan|mesh-list
56077167|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56077168|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56077169|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077170|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56077171|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
56077172|NCT03498014|Narcotics|narcotics|mesh-ancestor
56077173|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077200|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
56077201|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56077202|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56077203|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780275|NCT00662129|Gemcitabine|gemcitabine|mesh-list
56780276|NCT00662129|Paclitaxel|paclitaxel|mesh-list
56780277|NCT00662129|Bevacizumab|bevacizumab|mesh-list
56780278|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56780279|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56780281|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
56780282|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
56780283|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
56780284|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780285|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56780286|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56780287|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56077204|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56077205|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55804416|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56077206|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56077207|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077208|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077209|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
56077211|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56077212|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56077213|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077214|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
56077215|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077216|NCT05721079|Methoxsalen|methoxsalen|mesh-list
56077217|NCT05721079|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56077218|NCT05721079|Dermatologic Agents|dermatologic agents|mesh-ancestor
56077219|NCT00362570|Temozolomide|temozolomide|mesh-list
56077220|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56077221|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
56077250|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
56077251|NCT02068430|Vitamins|vitamins|mesh-ancestor
56077252|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
56077253|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077254|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56077255|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
56077256|NCT03138512|Nivolumab|nivolumab|mesh-list
56077257|NCT03138512|Ipilimumab|ipilimumab|mesh-list
56077258|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077259|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077260|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56077261|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077262|NCT03137888|Temozolomide|temozolomide|mesh-list
56077263|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56077264|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
56077265|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077290|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56077291|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077292|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56077293|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077294|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077295|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
56077296|NCT02306161|Ifosfamide|ifosfamide|mesh-list
56077297|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
56077298|NCT02306161|Doxorubicin|doxorubicin|mesh-list
56077299|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56077300|NCT02306161|Etoposide|etoposide|mesh-list
56077301|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
56077302|NCT02306161|Vincristine|vincristine|mesh-list
56077303|NCT02306161|Daunorubicin|daunorubicin|mesh-list
56077307|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
56077308|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077309|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775610|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780288|NCT00662129|Growth Substances|growth substances|mesh-ancestor
56780289|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780290|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
56780291|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56780292|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
56780293|NCT00662129|Antiviral Agents|antiviral agents|mesh-ancestor
56780294|NCT00662129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780295|NCT00662129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780296|NCT00662129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780297|NCT00662129|Immunologic Factors|immunologic factors|mesh-ancestor
56780298|NCT05346224|Pertuzumab|pertuzumab|mesh-list
56077310|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56077311|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
56077312|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077313|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077314|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56077315|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56077316|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56077352|NCT04344457|Analgesics|analgesics|mesh-ancestor
56077353|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
56077354|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077355|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077356|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077394|NCT05720455|Autonomic Agents|autonomic agents|mesh-ancestor
56077430|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
56077431|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
56077432|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144725|NCT00810576|Bortezomib|bortezomib|mesh-list
56077460|NCT05720065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077462|NCT05720065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077463|NCT05720065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077464|NCT05720065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56077465|NCT05720065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077466|NCT05719831|Amoxicillin|amoxicillin|mesh-list
56077467|NCT05719831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56077468|NCT05719831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077469|NCT01152541|Riboflavin|riboflavin|mesh-list
56077470|NCT01152541|Dextrans|dextrans|mesh-list
56077471|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56077472|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
56077473|NCT01152541|Vitamins|vitamins|mesh-ancestor
56077474|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
56077475|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077476|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56077477|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
56077478|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
56077479|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
56077513|NCT05723341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56077515|NCT05723341|Analgesics|analgesics|mesh-ancestor
56077516|NCT05718583|Butyric Acid|butyric acid|mesh-list
56077517|NCT05718583|Histamine Antagonists|histamine antagonists|mesh-ancestor
56077518|NCT05718583|Histamine Agents|histamine agents|mesh-ancestor
56077519|NCT05718583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077545|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56077546|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56077547|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56077548|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077549|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
56077550|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077551|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077552|NCT02451488|Sargramostim|sargramostim|mesh-list
56077553|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
56077554|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077555|NCT03172494|Insulin|insulin|mesh-list
56077556|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56077557|NCT03172494|Liraglutide|liraglutide|mesh-list
56780299|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56780300|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780301|NCT00993746|Lidocaine|lidocaine|mesh-list
56780302|NCT00993746|Bupivacaine|bupivacaine|mesh-list
56780303|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
56780304|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
56780305|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780306|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780307|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
56077558|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
56077559|NCT03172494|Xultophy|xultophy|mesh-list
56077560|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56077561|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077562|NCT03172494|Incretins|incretins|mesh-ancestor
56077563|NCT03172494|Hormones|hormones|mesh-ancestor
56077564|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077565|NCT02452346|Tosedostat|tosedostat|mesh-list
56077566|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077567|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077568|NCT02959255|Esomeprazole|esomeprazole|mesh-list
56077610|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077612|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
56077613|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
56077614|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077615|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077616|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
56077648|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077649|NCT05712343|Valacyclovir|valacyclovir|mesh-list
56077650|NCT05712343|Antiviral Agents|antiviral agents|mesh-ancestor
56077651|NCT05712343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077652|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
56077653|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56077654|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077655|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077656|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56077657|NCT05215158|Analgesics|analgesics|mesh-ancestor
55804871|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
56077658|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
56077691|NCT03101748|Trastuzumab|trastuzumab|mesh-list
56077692|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56077693|NCT03101748|Daunorubicin|daunorubicin|mesh-list
56077694|NCT03101748|Pertuzumab|pertuzumab|mesh-list
56077695|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56077696|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56077697|NCT03101748|Antibodies|antibodies|mesh-list
56077725|NCT05710471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56077726|NCT05710471|Growth Substances|growth substances|mesh-ancestor
56077727|NCT05710471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077728|NCT05710471|Growth Inhibitors|growth inhibitors|mesh-ancestor
56077729|NCT05710471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077731|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56077732|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56077733|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56077734|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56077735|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
56077736|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077737|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077738|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077739|NCT02896712|Modafinil|modafinil|mesh-list
56077740|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56077741|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077742|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56077743|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56077779|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
56077811|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780308|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780309|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56780310|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56780311|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56077813|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
56077814|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077815|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
56077816|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077817|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
56077818|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077819|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56077820|NCT02977741|Olanzapine|olanzapine|mesh-list
56077859|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077931|NCT00608972|Growth Substances|growth substances|mesh-ancestor
56192914|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192915|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192916|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56192917|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192918|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56192919|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
56192920|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
56192921|NCT01485003|Natalizumab|natalizumab|mesh-list
56192922|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
56192923|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192924|NCT01485068|Paclitaxel|paclitaxel|mesh-list
56192925|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56192926|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192927|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
56192928|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
56192929|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
56192930|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192931|NCT01485081|Paclitaxel|paclitaxel|mesh-list
56192932|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56192933|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192934|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
56192935|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
56077932|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077933|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
56077934|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56077935|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56077936|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077937|NCT02729714|Suvorexant|suvorexant|mesh-list
56077938|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56077939|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56077940|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077941|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077942|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56077943|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077970|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077971|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56077972|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077973|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077974|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56077975|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56077976|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077977|NCT05648058|Diphenhydramine|diphenhydramine|mesh-list
56077979|NCT05648058|Nefopam|nefopam|mesh-list
56077980|NCT05648058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56077981|NCT05648058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56077982|NCT05648058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077983|NCT05648058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077984|NCT05648058|Anesthetics, Local|anesthetics, local|mesh-ancestor
56077985|NCT05648058|Anesthetics|anesthetics|mesh-ancestor
56077986|NCT05648058|Sensory System Agents|sensory system agents|mesh-ancestor
56077987|NCT05648058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077988|NCT05648058|Antiemetics|antiemetics|mesh-ancestor
56077989|NCT05648058|Autonomic Agents|autonomic agents|mesh-ancestor
56077990|NCT05648058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56110438|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56780312|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780313|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780314|NCT00789971|Triamcinolone|triamcinolone|mesh-list
56780315|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56780316|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56780317|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56780318|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56780319|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
56780320|NCT00789971|Hormones|hormones|mesh-ancestor
56780321|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56780322|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780323|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780324|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
56780325|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780326|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780327|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56780328|NCT05345522|Antibodies|antibodies|mesh-list
56780329|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
56078025|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078027|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56078028|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56078029|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56078030|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56078031|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078032|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
55741172|NCT03372109|Calcium|calcium|mesh-list
56078033|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078070|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56078071|NCT05114941|Antibodies|antibodies|mesh-list
56078072|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
56078073|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56078074|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
56078105|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078106|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078107|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078109|NCT04871191|Abatacept|abatacept|mesh-list
56078110|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078111|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078112|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
56078113|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078114|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078115|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56078116|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078117|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078118|NCT02976805|Bisacodyl|bisacodyl|mesh-list
56078119|NCT02976805|Cathartics|cathartics|mesh-ancestor
56078153|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078154|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
56078156|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078157|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
56078158|NCT04833907|Prednisone|prednisone|mesh-list
56078159|NCT04833907|Levetiracetam|levetiracetam|mesh-list
56078160|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56078161|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
56078162|NCT04833907|Hormones|hormones|mesh-ancestor
56780330|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56780331|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
56780332|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780333|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780334|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56780335|NCT00782405|Mirtazapine|mirtazapine|mesh-list
56780336|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
56780337|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56780338|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56780339|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56780340|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780341|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780342|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56780343|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
56780344|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
56780345|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780346|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780347|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56780348|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56780349|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56780350|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56780351|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
56780352|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56780353|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56780354|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
56780379|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780380|NCT00996788|Protective Agents|protective agents|mesh-ancestor
56780381|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780382|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780383|NCT01564550|Insulin|insulin|mesh-list
56780384|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56780385|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56780386|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780387|NCT00996866|Vitamin D|vitamin d|mesh-list
56780388|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
56780389|NCT00996866|Vitamins|vitamins|mesh-ancestor
56780390|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
56780391|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780392|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56780393|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56780394|NCT00790439|Cyclosporine|cyclosporine|mesh-list
56780395|NCT00790439|Sirolimus|sirolimus|mesh-list
56780396|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
56780397|NCT00790439|Heparin|heparin|mesh-list
56780398|NCT00790439|Calcium heparin|calcium heparin|mesh-list
56780399|NCT00790439|Dextrans|dextrans|mesh-list
56780400|NCT00790439|Tacrolimus|tacrolimus|mesh-list
56780401|NCT00790439|Cyclosporins|cyclosporins|mesh-list
56780402|NCT00790439|Basiliximab|basiliximab|mesh-list
56780403|NCT00790439|Daclizumab|daclizumab|mesh-list
56780404|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780405|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
56780406|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780407|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56052982|NCT01857362|Nitisinone|nitisinone|mesh-list
56078198|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56078199|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56078200|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56078201|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56078202|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078203|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56078204|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
56078239|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56078240|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56078241|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078242|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078243|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
56078244|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56078245|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078267|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078268|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
56078269|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078271|NCT04731025|Gentamicins|gentamicins|mesh-list
56780408|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780409|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780410|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
56780411|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780412|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
56780413|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078272|NCT04731025|Cefazolin|cefazolin|mesh-list
56078273|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56078274|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078275|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56078276|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078277|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078278|NCT04730635|Donepezil|donepezil|mesh-list
56078279|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56078280|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078281|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192936|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
56078282|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
56078283|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078284|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078285|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
56078286|NCT04686799|Doxycycline|doxycycline|mesh-list
56078287|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56078288|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078289|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
56078290|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56078291|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56078292|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
56078293|NCT04676035|Vitamin K|vitamin k|mesh-list
56078294|NCT04676035|Midazolam|midazolam|mesh-list
56078295|NCT04676035|Omeprazole|omeprazole|mesh-list
56078296|NCT04676035|Warfarin|warfarin|mesh-list
56078297|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56078298|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56078299|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078300|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078327|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078329|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
56078330|NCT04359199|Nivolumab|nivolumab|mesh-list
56078331|NCT04359199|Cetuximab|cetuximab|mesh-list
56078332|NCT04359199|Durvalumab|durvalumab|mesh-list
56078333|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078334|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078335|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56078336|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078337|NCT03875911|Mitomycins|mitomycins|mesh-list
56078338|NCT03875911|Mitomycin|mitomycin|mesh-list
56078339|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56078340|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078341|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
56078342|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078343|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56078344|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078345|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56078346|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56078347|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56078348|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078349|NCT00361075|Estradiol|estradiol|mesh-list
56078421|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078422|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56078423|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56078424|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
56078425|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078458|NCT05616468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078459|NCT05616468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078460|NCT05197842|Prednisone|prednisone|mesh-list
56078461|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
56078462|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
56078463|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078464|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
56078465|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780414|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56780415|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780416|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56780417|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
56780418|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56780419|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
56780420|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56780421|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56780422|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
56780423|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
56780424|NCT00785603|Tramadol|tramadol|mesh-list
56780425|NCT00785603|Paroxetine|paroxetine|mesh-list
56491390|NCT02116998|Antacids|antacids|mesh-ancestor
56780426|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56780427|NCT00785603|Narcotics|narcotics|mesh-ancestor
56780428|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780429|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780430|NCT00785603|Analgesics|analgesics|mesh-ancestor
56780431|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
56780432|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780433|NCT00785603|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56780434|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56078466|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078501|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56078502|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56078503|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078504|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078505|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56078506|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
56078507|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078539|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078540|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
56078541|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
56078542|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
56078543|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078544|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078545|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
56078546|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078547|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078548|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56192937|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192938|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56192939|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56192940|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
56078549|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
56078550|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078551|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56078552|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56078553|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56078554|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078555|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
56078583|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780435|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780436|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780437|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780438|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
56780439|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56780440|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
56780441|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56780442|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56780443|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56780444|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780445|NCT00570401|Dasatinib|dasatinib|mesh-list
56780446|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780447|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56780448|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780449|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780450|NCT00532298|Vaccines|vaccines|mesh-list
56780451|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
56780452|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780453|NCT04047017|Apatinib|apatinib|mesh-list
56780454|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780455|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56780456|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780457|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780458|NCT00997022|Sorafenib|sorafenib|mesh-list
56780459|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780460|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56053031|NCT04310085|Artemether|artemether|mesh-list
56078584|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078585|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078586|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
56078587|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078593|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078594|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078595|NCT03518034|Testosterone|testosterone|mesh-list
56078596|NCT03518034|Androgens|androgens|mesh-ancestor
56078597|NCT03518034|Hormones|hormones|mesh-ancestor
56078598|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078599|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078600|NCT04789668|Atezolizumab|atezolizumab|mesh-list
56078633|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078635|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078636|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56078637|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
56078638|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56078639|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780461|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780462|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780463|NCT00786149|Varenicline|varenicline|mesh-list
56780464|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56780465|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56780466|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
56780467|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780468|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780469|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780470|NCT00410410|Abatacept|abatacept|mesh-list
56780471|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56780472|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780473|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780474|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780475|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
56780476|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780477|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780478|NCT00782951|Morphine|morphine|mesh-list
56780479|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56780480|NCT00782951|Narcotics|narcotics|mesh-ancestor
56780481|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780482|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780483|NCT00782951|Analgesics|analgesics|mesh-ancestor
56780484|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
56780485|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780486|NCT02555813|Gemcitabine|gemcitabine|mesh-list
56780487|NCT02555813|Paclitaxel|paclitaxel|mesh-list
56078640|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
56078669|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56078670|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
56078671|NCT03661645|Hormones|hormones|mesh-ancestor
56078672|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078673|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56078674|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078675|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
56078676|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078677|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078678|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56078679|NCT03661645|Protective Agents|protective agents|mesh-ancestor
56078680|NCT01633944|Buprenorphine|buprenorphine|mesh-list
56078681|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56078682|NCT01633944|Narcotics|narcotics|mesh-ancestor
56078683|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078684|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078685|NCT01633944|Analgesics|analgesics|mesh-ancestor
56078717|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
56078718|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56078719|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110439|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
56780488|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56780489|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56780490|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780491|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
56780492|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
56780493|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
56780494|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780495|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56780496|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
56780497|NCT02555813|Antiviral Agents|antiviral agents|mesh-ancestor
56780498|NCT02555813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780499|NCT02555813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780500|NCT02555813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780501|NCT02555813|Immunologic Factors|immunologic factors|mesh-ancestor
56780502|NCT02555813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491479|NCT04688723|Dabigatran|dabigatran|mesh-list
56780503|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
56780504|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56780505|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780506|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56780507|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
56780508|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56780509|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780510|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780511|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780513|NCT00783107|Cyclosporins|cyclosporins|mesh-list
56780514|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780515|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780516|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780533|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780534|NCT00393094|Bevacizumab|bevacizumab|mesh-list
56780535|NCT00393094|Irinotecan|irinotecan|mesh-list
56780536|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56780537|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780538|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56780539|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56780540|NCT00393094|Growth Substances|growth substances|mesh-ancestor
56780541|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780542|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
56780543|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56780544|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56780545|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780546|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780547|NCT00783653|Sunitinib|sunitinib|mesh-list
56780548|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780549|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56780550|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56780551|NCT00783653|Growth Substances|growth substances|mesh-ancestor
56780552|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780553|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
56780554|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56780555|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780556|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780557|NCT00786305|Amikacin|amikacin|mesh-list
56780558|NCT00786305|Ceftazidime|ceftazidime|mesh-list
56780559|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56780577|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56780578|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780579|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780580|NCT00783731|Midazolam|midazolam|mesh-list
56780581|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56780582|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56780583|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780584|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780585|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56780586|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56780587|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56780588|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56780589|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
56780590|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
56078720|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56078721|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56078722|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
56078723|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56078724|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078725|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56078726|NCT00589316|Trace Elements|trace elements|mesh-ancestor
56078727|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
56078728|NCT00544466|Fludarabine|fludarabine|mesh-list
56078729|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
56078730|NCT00544466|Melphalan|melphalan|mesh-list
56192941|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192943|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192944|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56078761|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078762|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56078763|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56078764|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56078765|NCT00565851|Gemcitabine|gemcitabine|mesh-list
56078766|NCT00565851|Paclitaxel|paclitaxel|mesh-list
56078767|NCT00565851|Docetaxel|docetaxel|mesh-list
56078768|NCT00565851|Bevacizumab|bevacizumab|mesh-list
56078769|NCT00565851|Carboplatin|carboplatin|mesh-list
56078770|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56078805|NCT00003423|Prednisolone|prednisolone|mesh-list
56078806|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
56078807|NCT00003423|Methotrexate|methotrexate|mesh-list
56078809|NCT00003423|Vincristine|vincristine|mesh-list
56078810|NCT00003423|Daunorubicin|daunorubicin|mesh-list
56078811|NCT00003423|Asparaginase|asparaginase|mesh-list
56078812|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
56078843|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56078899|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
56078900|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078933|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
56078934|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078935|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078936|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078937|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078938|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
56078939|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078940|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078941|NCT00003441|Irofulven|irofulven|mesh-list
56078942|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078943|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
56078979|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078980|NCT00002805|Trace Elements|trace elements|mesh-ancestor
56078981|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
56078982|NCT00003297|Topotecan|topotecan|mesh-list
56780591|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
56780592|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
56780593|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780594|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780595|NCT00409708|Methylphenidate|methylphenidate|mesh-list
56780596|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56780597|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780598|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56780599|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56780600|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780601|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780602|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
56780603|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780604|NCT00790985|Naproxen|naproxen|mesh-list
56780605|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56780606|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56780607|NCT00790985|Analgesics|analgesics|mesh-ancestor
56780608|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
56780609|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780610|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780611|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56780612|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780613|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
56780614|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56780615|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780616|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780617|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
56780618|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
56078983|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
56078984|NCT00003297|Thiotepa|thiotepa|mesh-list
56079016|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079017|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079018|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079019|NCT00003447|Gemcitabine|gemcitabine|mesh-list
56079020|NCT00003447|Vinorelbine|vinorelbine|mesh-list
56079021|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079022|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
56079023|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079024|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192945|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192946|NCT01485185|Gabapentin|gabapentin|mesh-list
56192947|NCT01485185|Donepezil|donepezil|mesh-list
56192948|NCT01485185|Analgesics|analgesics|mesh-ancestor
56079025|NCT00003447|Antiviral Agents|antiviral agents|mesh-ancestor
56079063|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137539|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56780619|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780620|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56780621|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780622|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780623|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
56780624|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780625|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56780626|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780627|NCT01324492|Everolimus|everolimus|mesh-list
56780628|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780629|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780630|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
56780631|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780632|NCT01039948|Gefitinib|gefitinib|mesh-list
56780633|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780634|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56780635|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780636|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780637|NCT00391846|Metoprolol|metoprolol|mesh-list
56780638|NCT00391846|Valsartan|valsartan|mesh-list
56780639|NCT00391846|Carvedilol|carvedilol|mesh-list
56780640|NCT00391846|Candesartan|candesartan|mesh-list
56780641|NCT00391846|Ramipril|ramipril|mesh-list
56780642|NCT00391846|Enalapril|enalapril|mesh-list
56780643|NCT00391846|Lisinopril|lisinopril|mesh-list
56780644|NCT00391846|Eplerenone|eplerenone|mesh-list
56780645|NCT00391846|Bisoprolol|bisoprolol|mesh-list
56780646|NCT00391846|Captopril|captopril|mesh-list
56053218|NCT03705273|BB 1101|bb 1101|mesh-list
56079182|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56079218|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56079219|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56079220|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56079221|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079222|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56079258|NCT03576001|Hormones|hormones|mesh-ancestor
56079259|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56079260|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079261|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56079262|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079263|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
56079296|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079298|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079299|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56079300|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56079301|NCT00002865|Leucovorin|leucovorin|mesh-list
56079302|NCT00002865|Cobalt|cobalt|mesh-list
56079303|NCT00002865|Cytarabine|cytarabine|mesh-list
56079337|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56780647|NCT00391846|Trandolapril|trandolapril|mesh-list
56780648|NCT00391846|Spironolactone|spironolactone|mesh-list
56780649|NCT00391846|Diuretics|diuretics|mesh-list
56780650|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56780651|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56780652|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56079338|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079339|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56079340|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
56079341|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56079342|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079343|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
56079344|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
56079375|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56079376|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56079377|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56079378|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079380|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56079381|NCT04530487|Cyclosporine|cyclosporine|mesh-list
56079382|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
56079383|NCT04530487|Fludarabine|fludarabine|mesh-list
56079384|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
56079385|NCT04530487|Etoposide|etoposide|mesh-list
56079386|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
56079387|NCT04530487|Melphalan|melphalan|mesh-list
56079388|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
56079389|NCT04530487|Thiotepa|thiotepa|mesh-list
56079390|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
56079391|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56079425|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079426|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079427|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079428|NCT00003369|Tirapazamine|tirapazamine|mesh-list
56079429|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079431|NCT04342351|Perindopril|perindopril|mesh-list
56079432|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56079461|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56079462|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
56079463|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56079464|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079465|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079466|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192949|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
56192950|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192951|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192952|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
56192953|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56192954|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56079467|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
56079477|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079508|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56079510|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56079511|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079512|NCT00003939|Trabectedin|trabectedin|mesh-list
56079513|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079514|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
56079515|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079516|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079517|NCT00003543|Fluorouracil|fluorouracil|mesh-list
56079518|NCT00003543|Vincristine|vincristine|mesh-list
56079520|NCT00003543|Streptozocin|streptozocin|mesh-list
56079521|NCT00003543|Antibodies|antibodies|mesh-list
56079522|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56079558|NCT00002883|Fluorouracil|fluorouracil|mesh-list
56079592|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079593|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079594|NCT00003951|Exatecan|exatecan|mesh-list
56079595|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56079596|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079597|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780653|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780654|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56079598|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079599|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079600|NCT00003957|Cytarabine|cytarabine|mesh-list
56079637|NCT00003555|Amifostine|amifostine|mesh-list
56079638|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079639|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079640|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079641|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079642|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079668|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079669|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
56079670|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56079671|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079672|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079673|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56079674|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56079675|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079676|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56079677|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079678|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079679|NCT00003993|Aldesleukin|aldesleukin|mesh-list
56079680|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
56079681|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079682|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56079683|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56079684|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
56079685|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079686|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56079687|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
56079688|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079689|NCT00004857|Fludarabine|fludarabine|mesh-list
56192955|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56192956|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56192957|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55801689|NCT04835233|Methyldopa|methyldopa|mesh-list
56192960|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192961|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
56192962|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56192963|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56192964|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
56192965|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
56079719|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
56079720|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079721|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
56079722|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079724|NCT00003567|Carmustine|carmustine|mesh-list
56079725|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56079726|NCT00003567|Sargramostim|sargramostim|mesh-list
56079727|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
56079728|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079729|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079730|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
56079731|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079732|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079733|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079734|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
56079735|NCT00003573|Cisplatin|cisplatin|mesh-list
56079736|NCT00003573|Etoposide|etoposide|mesh-list
56079769|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079770|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079771|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079772|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
56079773|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079774|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
56079775|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079776|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56079777|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56079778|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
56079779|NCT00003591|Paclitaxel|paclitaxel|mesh-list
56079811|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777509|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
56780655|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
56780656|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
56780657|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780658|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780659|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56780660|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56780661|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56780662|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
56780663|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780664|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56780665|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
56780666|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56780667|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56780668|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
56780669|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
56780670|NCT00391846|Protective Agents|protective agents|mesh-ancestor
56780671|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56780672|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780673|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56780674|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
56780675|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56780676|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56780677|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56780678|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
56780679|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780680|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56780681|NCT00391768|Oseltamivir|oseltamivir|mesh-list
56780682|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
56053249|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
56079812|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079813|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
56079814|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56079815|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
56079816|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079818|NCT00004005|Fluorouracil|fluorouracil|mesh-list
56079819|NCT00004005|Irinotecan|irinotecan|mesh-list
56079820|NCT00004005|Calcium|calcium|mesh-list
56079821|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
56079822|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56079855|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
56079856|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56079857|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56079858|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
56079859|NCT00003603|Hormones|hormones|mesh-ancestor
56780683|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780684|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780685|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780686|NCT00391222|Olanzapine|olanzapine|mesh-list
56780687|NCT00391222|Risperidone|risperidone|mesh-list
56780688|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56780689|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
56780690|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780691|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780692|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780693|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56780694|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56780695|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780696|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56780697|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56780698|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
56780699|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
56780700|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
56780701|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780702|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56780703|NCT00391222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56079860|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56079861|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56079862|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079863|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079864|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079865|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079900|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192966|NCT01485198|Acetaminophen|acetaminophen|mesh-list
56192967|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56192968|NCT01485198|Analgesics|analgesics|mesh-ancestor
56192969|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
56192970|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192971|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192972|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
56192973|NCT01485211|Riboflavin|riboflavin|mesh-list
56192974|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
56192975|NCT01485211|Vitamins|vitamins|mesh-ancestor
56192976|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
56192977|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192978|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56192979|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
56192980|NCT01485224|Thalidomide|thalidomide|mesh-list
56192981|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079903|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079904|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
56079905|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079906|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56079907|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079908|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079909|NCT04513951|Antidotes|antidotes|mesh-ancestor
56079979|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56079980|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56079982|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
56780704|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56780705|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780706|NCT00409006|Pemetrexed|pemetrexed|mesh-list
56780707|NCT00409006|Gefitinib|gefitinib|mesh-list
56780708|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780709|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079983|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56079984|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079985|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56079986|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079987|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56079988|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079989|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
56080021|NCT00003633|Docetaxel|docetaxel|mesh-list
56080022|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
56080023|NCT00003633|Estramustine|estramustine|mesh-list
56080024|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080025|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080026|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080027|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080028|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080029|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080030|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
56080031|NCT00003633|Hormones|hormones|mesh-ancestor
56080067|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080068|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080069|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
56080102|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080103|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080104|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080105|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080106|NCT00004071|Analgesics|analgesics|mesh-ancestor
56080107|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
56080108|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080109|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080110|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080111|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080112|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080113|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56192982|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
56192983|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192984|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
56080145|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080146|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080147|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
56080148|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56080149|NCT00003657|Protective Agents|protective agents|mesh-ancestor
56080151|NCT00004089|Fluorouracil|fluorouracil|mesh-list
56080152|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
56080153|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080154|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080155|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080156|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080157|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080158|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080159|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
56080185|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
56080186|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080187|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080188|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080189|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
56080190|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
56080191|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080192|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56080193|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
56080194|NCT00003663|Hormones|hormones|mesh-ancestor
56080195|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080196|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080197|NCT00004107|Epratuzumab|epratuzumab|mesh-list
56780710|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780711|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56780712|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56780713|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56780714|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
56780715|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56780716|NCT00997880|Calcium|calcium|mesh-list
56780717|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56780718|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780719|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56780720|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56780721|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56780722|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
56780723|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780724|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56923700|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780725|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56780726|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780727|NCT00408928|Bortezomib|bortezomib|mesh-list
56780728|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780729|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
56053305|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080199|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56080200|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
56080201|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080202|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56080203|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080204|NCT00004113|Temozolomide|temozolomide|mesh-list
56080205|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080206|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
56080207|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080208|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080210|NCT00004125|Paclitaxel|paclitaxel|mesh-list
56080211|NCT00004125|Docetaxel|docetaxel|mesh-list
56080236|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56080237|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56080238|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56080239|NCT00003675|Topotecan|topotecan|mesh-list
56080240|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080241|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080242|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080243|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080244|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080245|NCT00004137|Paclitaxel|paclitaxel|mesh-list
56080246|NCT00004137|Carboplatin|carboplatin|mesh-list
56080247|NCT00004137|Topotecan|topotecan|mesh-list
56080248|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080249|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080250|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080251|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080252|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
56780730|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56780731|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780732|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56780733|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
56780734|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56780735|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780736|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780737|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780738|NCT00998036|Sirolimus|sirolimus|mesh-list
56780739|NCT00998036|Cisplatin|cisplatin|mesh-list
56780740|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56053327|NCT01869686|Denosumab|denosumab|mesh-list
56080253|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080254|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080255|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080256|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080257|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
56080258|NCT00003681|Amifostine|amifostine|mesh-list
56080259|NCT00003681|Hematinics|hematinics|mesh-ancestor
56080281|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080282|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
56080283|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080284|NCT00384657|Iron|iron|mesh-list
56080285|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56192985|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56192986|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56192987|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56192988|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56192989|NCT01485224|Growth Substances|growth substances|mesh-ancestor
56192990|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
56192991|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192992|NCT01485315|Mannitol|mannitol|mesh-list
56192993|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56192994|NCT01485315|Diuretics|diuretics|mesh-ancestor
56192995|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
56192996|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192997|NCT01485367|Adapalene|adapalene|mesh-list
56192998|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56192999|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56193000|NCT01485367|Analgesics|analgesics|mesh-ancestor
56193001|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
56193002|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193003|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193004|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193005|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56193006|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
56080286|NCT00384657|Trace Elements|trace elements|mesh-ancestor
56080287|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
56080288|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080289|NCT00384657|Hematinics|hematinics|mesh-ancestor
56080290|NCT00005013|Sertraline|sertraline|mesh-list
56080291|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
56080292|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56080293|NCT00005013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56080294|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56080295|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56080296|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080297|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56080298|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
56080299|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080300|NCT00004161|Fenretinide|fenretinide|mesh-list
56080301|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080302|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56080303|NCT00004161|Protective Agents|protective agents|mesh-ancestor
56080304|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780741|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780742|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56780743|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780744|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780745|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56080305|NCT00004173|Paclitaxel|paclitaxel|mesh-list
56080306|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
56080307|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080308|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080309|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080310|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080311|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080312|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080345|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080346|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080347|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080348|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080349|NCT00003687|Morphine|morphine|mesh-list
56080350|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
56193007|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56193008|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
56193009|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193010|NCT01485445|Fluticasone|fluticasone|mesh-list
56193012|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193013|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56193014|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
56193015|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193016|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193017|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56193018|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
56193019|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
56193020|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56193021|NCT01485562|Misoprostol|misoprostol|mesh-list
56193022|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56193023|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
56193024|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56193025|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193026|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56193027|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193028|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
56193029|NCT01485653|Mepivacaine|mepivacaine|mesh-list
56193030|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
56193031|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
56193032|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193033|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193034|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
56080351|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56080352|NCT00003687|Narcotics|narcotics|mesh-ancestor
56080353|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56080354|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080382|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56080383|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080384|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080385|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080386|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080387|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
56080388|NCT00004197|Hormones|hormones|mesh-ancestor
56080389|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080390|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080391|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080392|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080393|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080394|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080395|NCT00004197|Analgesics|analgesics|mesh-ancestor
56080396|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
56080397|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080398|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56080399|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
56080400|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080401|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
56780746|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780747|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56780748|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
56780749|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780750|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
56780751|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780752|NCT05254808|Fosfomycin|fosfomycin|mesh-list
56780753|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
56780754|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56780755|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780756|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56780757|NCT05254808|Renal Agents|renal agents|mesh-ancestor
56780758|NCT02275286|Trabectedin|trabectedin|mesh-list
56780759|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56780760|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
56780761|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780762|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780763|NCT00998192|Paclitaxel|paclitaxel|mesh-list
56780764|NCT00998192|Carboplatin|carboplatin|mesh-list
56780765|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56780766|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780767|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
56780768|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
56780769|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
56780770|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780771|NCT00994526|Vitamin E|vitamin e|mesh-list
56780772|NCT00994526|Calcium|calcium|mesh-list
56780773|NCT00994526|Vitamins|vitamins|mesh-ancestor
56780774|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
56780775|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780776|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56780777|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
56780778|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780779|NCT00994526|Protective Agents|protective agents|mesh-ancestor
56780780|NCT00998504|Resveratrol|resveratrol|mesh-list
56780781|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
56780783|NCT00998504|Protective Agents|protective agents|mesh-ancestor
56780785|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780786|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56780787|NCT00788684|Rituximab|rituximab|mesh-list
56780788|NCT00788684|Navitoclax|navitoclax|mesh-list
56780789|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56780790|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780791|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
56780792|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780793|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780794|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
56780795|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56780796|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
56780797|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780798|NCT00998972|Expectorants|expectorants|mesh-ancestor
56780799|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
56780800|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56780801|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
56053389|NCT03958071|Nintedanib|nintedanib|mesh-list
56080402|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080428|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080429|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080432|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080433|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080434|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
56080435|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080436|NCT00004215|Cytarabine|cytarabine|mesh-list
56080437|NCT00004215|Daunorubicin|daunorubicin|mesh-list
56080438|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080439|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
56080440|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080441|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080442|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
56080443|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080444|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080445|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
56080446|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080447|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56080448|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080449|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080450|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080483|NCT00004227|Cetuximab|cetuximab|mesh-list
56080484|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56080485|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080486|NCT00003621|Etoposide|etoposide|mesh-list
56080487|NCT00003621|Carmustine|carmustine|mesh-list
56080488|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080489|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080490|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080491|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080492|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080493|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080494|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080527|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
56080528|NCT00003717|Paclitaxel|paclitaxel|mesh-list
56080529|NCT00003717|Estramustine|estramustine|mesh-list
56080530|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080531|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080532|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080533|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080534|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
56780802|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780803|NCT00998972|Protective Agents|protective agents|mesh-ancestor
56780804|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780805|NCT00998972|Antidotes|antidotes|mesh-ancestor
56780806|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56780807|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
56780808|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780809|NCT00998816|Pregabalin|pregabalin|mesh-list
56080535|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080536|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080571|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080573|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080574|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56080575|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56080576|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080606|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080607|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56080608|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080609|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080610|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080612|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56080613|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080614|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
56080615|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080616|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080617|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
56080618|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080619|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080620|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
56080653|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56080654|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
56080655|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56080656|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080657|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56193035|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193037|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
56193038|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193039|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
56193040|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193041|NCT01485692|Promethazine|promethazine|mesh-list
56193044|NCT01485692|Haloperidol|haloperidol|mesh-list
56193045|NCT01485692|Olanzapine|olanzapine|mesh-list
56193046|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
56193047|NCT01485692|Ziprasidone|ziprasidone|mesh-list
56193048|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56193049|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56193050|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193051|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193052|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56193053|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56193054|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193055|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56193056|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
56193057|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
56080658|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080659|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56080660|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
56080661|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080692|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080694|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
56080695|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
56080697|NCT00004323|Cyclosporins|cyclosporins|mesh-list
56080698|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56080699|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080700|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
55777510|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
56780810|NCT00998816|Analgesics|analgesics|mesh-ancestor
56780811|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
56780812|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780813|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780814|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
56080701|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080702|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080703|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080704|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
56080705|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080706|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080707|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56080708|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56080709|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
56080710|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56080711|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080712|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
56080747|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080748|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080749|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
56080750|NCT00003759|Valrubicin|valrubicin|mesh-list
56080751|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
56080752|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56080753|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
56193058|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
56193059|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
56193060|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193061|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193062|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
56193063|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
56193064|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193065|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193066|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56193067|NCT01485692|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56193068|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56080789|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
56080790|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56080791|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56080792|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
56080829|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
56080830|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
56080831|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080832|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56080833|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56080834|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080871|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080872|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56080873|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
56080874|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
56080875|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56080902|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080904|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56080905|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56080906|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56080907|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56080909|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
56080910|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56080911|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56080912|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
56080913|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56080914|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
56080915|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56080916|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
56080917|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080919|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
56080920|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56080921|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
56080922|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080923|NCT00004467|Protective Agents|protective agents|mesh-ancestor
56780815|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56780816|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780817|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780818|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56780819|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56780820|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56780821|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780822|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56780823|NCT00533702|Dacarbazine|dacarbazine|mesh-list
56780824|NCT00533702|Ramucirumab|ramucirumab|mesh-list
56780825|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56080951|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080952|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56080953|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56080954|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56080955|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
56080956|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56080957|NCT00385125|Rituximab|rituximab|mesh-list
56080958|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56080959|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56080960|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080961|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
56080962|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080963|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080964|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080965|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
56080966|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080967|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56193069|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56193070|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
56193071|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56080968|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56080994|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080996|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080997|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080998|NCT00003849|Rituximab|rituximab|mesh-list
56080999|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56081000|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081001|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
56081002|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081003|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081004|NCT00004575|Miconazole|miconazole|mesh-list
56081005|NCT00004575|Bradykinin|bradykinin|mesh-list
56081006|NCT00004575|Kininogens|kininogens|mesh-list
56081007|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081008|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081009|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
56081010|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081011|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56081037|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56081038|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56081039|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56081040|NCT00004647|Mexiletine|mexiletine|mesh-list
56081041|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56081042|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56081043|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56081044|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56081045|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081046|NCT02469116|Carboplatin|carboplatin|mesh-list
56081047|NCT02469116|Docetaxel|docetaxel|mesh-list
56081048|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081049|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
56780826|NCT00533702|Imidazole|imidazole|mesh-list
56780827|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56780828|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
56780829|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780830|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780831|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
56780832|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780833|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780834|NCT00408694|Bevacizumab|bevacizumab|mesh-list
56780835|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56780836|NCT00408694|Cisplatin|cisplatin|mesh-list
56081050|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
56081051|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
56081052|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081053|NCT00362960|Losartan|losartan|mesh-list
56081055|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56081056|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56081057|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56081087|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081088|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081090|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081091|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
56081092|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081093|NCT00004689|Clarithromycin|clarithromycin|mesh-list
56081094|NCT00004689|Rifampin|rifampin|mesh-list
56081095|NCT00004689|Ethambutol|ethambutol|mesh-list
56081096|NCT00004689|Streptomycin|streptomycin|mesh-list
56081097|NCT00004689|Thioacetazone|thioacetazone|mesh-list
56081098|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56081099|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081100|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56081101|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081102|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081103|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56081140|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
56081141|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081142|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56081176|NCT00004785|Prednisolone|prednisolone|mesh-list
56081177|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
56081178|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56081179|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
56081180|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56081181|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
56081182|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
56081183|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081184|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081185|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193073|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56193074|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56193075|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
56193076|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
56193077|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56193078|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
56193079|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
56193080|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56193081|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56081186|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
56081215|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081216|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
56081217|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081218|NCT00005577|Gemcitabine|gemcitabine|mesh-list
56081219|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081220|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
56081221|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081222|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780837|NCT00408694|Fluorouracil|fluorouracil|mesh-list
56780838|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
56780839|NCT00408694|Antibodies|antibodies|mesh-list
56780840|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
56780841|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56780842|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
56780843|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780844|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56780845|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56780846|NCT00408694|Growth Substances|growth substances|mesh-ancestor
56780847|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780848|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
56780849|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
56780850|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
56780851|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780852|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56780853|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780854|NCT00999128|Rabeprazole|rabeprazole|mesh-list
56780855|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56780856|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56780857|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56780858|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780859|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780860|NCT00999206|Vaccines|vaccines|mesh-list
56780861|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
56780862|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780863|NCT01043224|Clobetasol|clobetasol|mesh-list
56780864|NCT01043224|Calcipotriene|calcipotriene|mesh-list
56780865|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56780866|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
56780867|NCT01043224|Hormones|hormones|mesh-ancestor
56053430|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081223|NCT00005577|Antiviral Agents|antiviral agents|mesh-ancestor
56081224|NCT00005577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081225|NCT00005577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081226|NCT00005577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081227|NCT00005577|Immunologic Factors|immunologic factors|mesh-ancestor
56081228|NCT00005577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081229|NCT00005583|Doxorubicin|doxorubicin|mesh-list
56081230|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56081267|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081268|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
56081269|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081270|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081271|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56780868|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56780869|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780870|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
56780871|NCT01044238|Methylphenidate|methylphenidate|mesh-list
55893133|NCT03289728|Dobutamine|dobutamine|mesh-list
56081272|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
56081301|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081302|NCT00005607|Antidotes|antidotes|mesh-ancestor
56081303|NCT00005607|Protective Agents|protective agents|mesh-ancestor
56081304|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
56081305|NCT00005607|Vitamins|vitamins|mesh-ancestor
56081306|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
56081307|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
56081308|NCT00005613|Carmustine|carmustine|mesh-list
56081309|NCT00005613|Etoposide|etoposide|mesh-list
56081310|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081311|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
56081312|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081433|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
56081434|NCT00005799|Fludarabine|fludarabine|mesh-list
56081435|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
56081436|NCT00005799|Cyclosporins|cyclosporins|mesh-list
56081437|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081467|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081468|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193082|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
56193083|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
56193084|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56193085|NCT01485718|Cathartics|cathartics|mesh-ancestor
56193086|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193087|NCT01485731|Nelfinavir|nelfinavir|mesh-list
56193088|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56193089|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56193090|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
56193091|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193092|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193093|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56193094|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56193095|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
56193096|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193097|NCT01485744|Leucovorin|leucovorin|mesh-list
56193098|NCT01485744|Fluorouracil|fluorouracil|mesh-list
56193099|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
56193100|NCT01485744|Irinotecan|irinotecan|mesh-list
56193101|NCT01485744|Folfirinox|folfirinox|mesh-list
56193102|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
56193103|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193104|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56193105|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193106|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193107|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
56081469|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081470|NCT01689987|Sirolimus|sirolimus|mesh-list
56081471|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
56081472|NCT01689987|Dexamethasone|dexamethasone|mesh-list
56081473|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
56081474|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
56081475|NCT01689987|Ichthammol|ichthammol|mesh-list
56081476|NCT01689987|BB 1101|bb 1101|mesh-list
56081477|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081478|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
56081479|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081480|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801702|NCT03035695|Coagulants|coagulants|mesh-ancestor
56081481|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56081513|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081514|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56081516|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56081517|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081518|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56081519|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081520|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081521|NCT01689597|Morphine|morphine|mesh-list
56081522|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56780872|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56780873|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491842|NCT00555399|Isotretinoin|isotretinoin|mesh-list
56780874|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56780875|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56780876|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56780877|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780878|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
56780879|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780880|NCT01043380|Atorvastatin|atorvastatin|mesh-list
56780881|NCT01043380|Ezetimibe|ezetimibe|mesh-list
56780882|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56780883|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56780884|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
56780885|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780886|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56780887|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56780888|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780889|NCT01044394|Bisacodyl|bisacodyl|mesh-list
56780890|NCT01044394|Cathartics|cathartics|mesh-ancestor
56780891|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56081523|NCT01689597|Narcotics|narcotics|mesh-ancestor
56193108|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193109|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56193110|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56193111|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193113|NCT01485744|Protective Agents|protective agents|mesh-ancestor
56193114|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
56193115|NCT01485744|Vitamins|vitamins|mesh-ancestor
56193116|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
56193117|NCT01485809|Gefitinib|gefitinib|mesh-list
56193118|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193119|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56193120|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193121|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193122|NCT01485822|Travoprost|travoprost|mesh-list
56193123|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56193124|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56193125|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56193126|NCT01485835|Dexamethasone|dexamethasone|mesh-list
56193127|NCT01485835|Bortezomib|bortezomib|mesh-list
56193128|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193129|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
56193130|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
56081524|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56081525|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081551|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56081553|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081554|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081555|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081556|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081557|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081558|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
56780892|NCT01044394|Laxatives|laxatives|mesh-ancestor
56780893|NCT03474094|Atezolizumab|atezolizumab|mesh-list
56780894|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56780895|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780896|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
56780897|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780898|NCT01043536|Temozolomide|temozolomide|mesh-list
56780899|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56780900|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
56780901|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780902|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780903|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56780904|NCT00056407|Dutasteride|dutasteride|mesh-list
56780905|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56780906|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56780907|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780908|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780909|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
56780910|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56780911|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780912|NCT00110110|Cyclosporine|cyclosporine|mesh-list
56780913|NCT00110110|Carboplatin|carboplatin|mesh-list
56780914|NCT00110110|Etoposide|etoposide|mesh-list
56780915|NCT00110110|Vincristine|vincristine|mesh-list
56780916|NCT00110110|Cyclosporins|cyclosporins|mesh-list
56780917|NCT00110110|Lenograstim|lenograstim|mesh-list
56780918|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081559|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
56081560|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081561|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081562|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
56081563|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081564|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56081565|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
56081566|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56081567|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
56081568|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
56081569|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
56081570|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
56081571|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
56081572|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
56081573|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
56081574|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
56081575|NCT02483000|Vitamins|vitamins|mesh-ancestor
56081576|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
56081577|NCT02420210|Dexamethasone|dexamethasone|mesh-list
56081578|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56081611|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56081612|NCT04829799|Analgesics|analgesics|mesh-ancestor
56081613|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56780919|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56780920|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56780921|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56780922|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56780923|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780924|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56780925|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
56780926|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780927|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56780928|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56780929|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56780930|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56780931|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
56780932|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56780933|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
56780934|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780935|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56780936|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
56780937|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56780938|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56780939|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
56780940|NCT00073021|Mesalamine|mesalamine|mesh-list
56780941|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56780942|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56780943|NCT00073021|Analgesics|analgesics|mesh-ancestor
56780944|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
56780945|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780946|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780947|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56780948|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56780949|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
56780950|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56780961|NCT01004900|Travoprost|travoprost|mesh-list
56780962|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56780963|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56780964|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
56780965|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780966|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780967|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780968|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56780969|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56780970|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56780971|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56780972|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56780973|NCT04001348|Diazepam|diazepam|mesh-list
56780974|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56780975|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
56780976|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
56780977|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
56780978|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56780979|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56780980|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56780981|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56780982|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56780983|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56780984|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56780985|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56780986|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56780987|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56780988|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56780989|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
56780990|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
56780991|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
56780992|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
56780993|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56780994|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56780995|NCT00395512|Pioglitazone|pioglitazone|mesh-list
56781001|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781002|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56781003|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
56781004|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781005|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781006|NCT03956017|Ubiquinone|ubiquinone|mesh-list
56081614|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56193131|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193132|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193133|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193134|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
56193135|NCT01485835|Hormones|hormones|mesh-ancestor
56193136|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56193137|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56193138|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193139|NCT01485848|Paclitaxel|paclitaxel|mesh-list
56193142|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
56193143|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
56081615|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56081616|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081617|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56081618|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
56081619|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
56081620|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
56081653|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56081654|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56081655|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
56081656|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081657|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56081658|NCT01761877|Sulindac|sulindac|mesh-list
56081659|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56081660|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56081662|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
56081693|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081694|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081695|NCT04822467|Ethanol|ethanol|mesh-list
56081696|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56081697|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081698|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56081699|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081700|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
56081701|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56081702|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
56081703|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081704|NCT03306979|Expectorants|expectorants|mesh-ancestor
56081705|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
56081706|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56081740|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56081742|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081743|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081744|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081745|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
56081746|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081747|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56081748|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56081783|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081784|NCT00363025|Daunorubicin|daunorubicin|mesh-list
56081785|NCT00363025|Idarubicin|idarubicin|mesh-list
56081786|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56081787|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081788|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081789|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081790|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081816|NCT04744753|Ionophores|ionophores|mesh-list
56081817|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
56193144|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
56081818|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56781007|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
56781008|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
56781009|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781010|NCT03956017|Vitamins|vitamins|mesh-ancestor
56781011|NCT00994916|Amifampridine|amifampridine|mesh-list
56781012|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56781013|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781014|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781015|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56781016|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56053601|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
56081819|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081820|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56081821|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081822|NCT02420041|Triamcinolone|triamcinolone|mesh-list
56081823|NCT02420041|Lidocaine|lidocaine|mesh-list
56081824|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
56081825|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
56081826|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56081827|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081828|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
56081829|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081830|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56081831|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56081832|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56081833|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56081834|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081835|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56081836|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
56081837|NCT02420041|Hormones|hormones|mesh-ancestor
56081840|NCT02421211|Ledipasvir|ledipasvir|mesh-list
56081874|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081875|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56081877|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
56081878|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
56081879|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56081880|NCT03089905|Narcotics|narcotics|mesh-ancestor
56081881|NCT02424968|Cyclosporine|cyclosporine|mesh-list
56081882|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
56081908|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56081909|NCT02492750|Ichthammol|ichthammol|mesh-list
56081910|NCT02492750|BB 1101|bb 1101|mesh-list
56081911|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56081912|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
56081913|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
56081914|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081915|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081916|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56081917|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
56081918|NCT02492750|Hormones|hormones|mesh-ancestor
56081919|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081920|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56081921|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081922|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
56081923|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56081924|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56081925|NCT02492750|Growth Substances|growth substances|mesh-ancestor
56081926|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
56081927|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
56081928|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081929|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081930|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081931|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
56081957|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781017|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781018|NCT00999440|Methadone|methadone|mesh-list
56781019|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56781020|NCT00999440|Narcotics|narcotics|mesh-ancestor
56781021|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781022|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781023|NCT00999440|Analgesics|analgesics|mesh-ancestor
56781024|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
56053613|NCT00553202|Cyclosporins|cyclosporins|mesh-list
56081958|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
56081959|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081961|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56081962|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
56081963|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56081964|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081965|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081966|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56081967|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56081968|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56081969|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
56081970|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56081971|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081972|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
56081973|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
56081974|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
56193145|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193147|NCT01485926|Docetaxel|docetaxel|mesh-list
56081975|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56081976|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56081977|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081978|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082005|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
56082006|NCT02533466|Protective Agents|protective agents|mesh-ancestor
56082007|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082008|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56082009|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082010|NCT02974244|Exenatide|exenatide|mesh-list
56082011|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56082012|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082013|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56082014|NCT02974244|Incretins|incretins|mesh-ancestor
56082015|NCT02974244|Hormones|hormones|mesh-ancestor
56082016|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082017|NCT02436031|Desipramine|desipramine|mesh-list
56082018|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56082019|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
56082020|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56082021|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082022|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082023|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56082024|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56082025|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56082026|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
56082027|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082028|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082059|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082060|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56082061|NCT02430818|Narcotics|narcotics|mesh-ancestor
56082063|NCT02455453|Estrogens|estrogens|mesh-ancestor
56082064|NCT02455453|Hormones|hormones|mesh-ancestor
56082065|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082066|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082067|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56082068|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
56082069|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781025|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781026|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
56781027|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
56781028|NCT00054691|Gefitinib|gefitinib|mesh-list
56781029|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781030|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56781031|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082070|NCT02519023|Acetaminophen|acetaminophen|mesh-list
56082071|NCT02519023|Ibuprofen|ibuprofen|mesh-list
56082072|NCT02519023|Epinephrine|epinephrine|mesh-list
56082103|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56082104|NCT02497040|Bupivacaine|bupivacaine|mesh-list
56082105|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
56082106|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
56082107|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
56082108|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082109|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082110|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
56082111|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082112|NCT02523235|Ropivacaine|ropivacaine|mesh-list
56082113|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
56082114|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
56082115|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082116|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082117|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
56082118|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082150|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082151|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082153|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56082154|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
56082155|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
56082156|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082157|NCT04743739|Cyclosporine|cyclosporine|mesh-list
56082158|NCT04743739|Rituximab|rituximab|mesh-list
56082159|NCT04743739|Cyclosporins|cyclosporins|mesh-list
56082160|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56193148|NCT01485926|Trastuzumab|trastuzumab|mesh-list
56193149|NCT01485926|Lapatinib|lapatinib|mesh-list
56193150|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193151|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
56193152|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
56193153|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
56193154|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193155|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56193156|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56193157|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193158|NCT01485939|Lidocaine|lidocaine|mesh-list
56193159|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
56193160|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
56082161|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082162|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
56082163|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082164|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082195|NCT02525653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082196|NCT02525653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56082197|NCT02525653|Immunologic Factors|immunologic factors|mesh-ancestor
56082198|NCT02525653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082200|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
56082201|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56082202|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56082203|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082204|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082239|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082240|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
56082241|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082242|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56082243|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56082244|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
56781032|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781033|NCT02530879|Esomeprazole|esomeprazole|mesh-list
56781034|NCT02530879|Omeprazole|omeprazole|mesh-list
56781035|NCT02530879|Lansoprazole|lansoprazole|mesh-list
56781036|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
56781037|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56053628|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
56082245|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082246|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56082247|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
56082248|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082249|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56082250|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
56082287|NCT02432456|Methocarbamol|methocarbamol|mesh-list
56082288|NCT02432456|Pantoprazole|pantoprazole|mesh-list
56082289|NCT02432456|Analgesics|analgesics|mesh-ancestor
56082290|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
56082291|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082292|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082318|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082319|NCT02531971|Analgesics|analgesics|mesh-ancestor
56082320|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
56082321|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082322|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56082323|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56082324|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
56082325|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
56082327|NCT02464657|Dexamethasone|dexamethasone|mesh-list
56082328|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
56082329|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56082330|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56082332|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
56082333|NCT02464657|Nivolumab|nivolumab|mesh-list
56082334|NCT02464657|Idarubicin|idarubicin|mesh-list
56082335|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56082336|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
56193161|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193162|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193163|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
56082337|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082338|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
56082339|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
56082340|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082341|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082342|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082343|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
56082344|NCT02464657|Hormones|hormones|mesh-ancestor
56082409|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
56082410|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082411|NCT02438540|Metformin|metformin|mesh-list
56082412|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56082413|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082414|NCT02506634|Esomeprazole|esomeprazole|mesh-list
56082415|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56082416|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082417|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56082418|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082419|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082420|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
56082421|NCT02506868|Hematinics|hematinics|mesh-ancestor
56082422|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
56082423|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56082424|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
56082425|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082426|NCT02541422|Expectorants|expectorants|mesh-ancestor
56082427|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56082428|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56082429|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
56082430|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082431|NCT02541422|Protective Agents|protective agents|mesh-ancestor
56082432|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082433|NCT02541422|Antidotes|antidotes|mesh-ancestor
56781038|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56781039|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56781040|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781041|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781042|NCT03957499|Dexamethasone|dexamethasone|mesh-list
56781043|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
56781044|NCT03957499|Bupivacaine|bupivacaine|mesh-list
56781045|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56781046|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
56781047|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
56053631|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
56082466|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
56082467|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56082468|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56082469|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082470|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
56082471|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
56082472|NCT02538679|Epinephrine|epinephrine|mesh-list
56082473|NCT02538679|Racepinephrine|racepinephrine|mesh-list
56082474|NCT02538679|Bupivacaine|bupivacaine|mesh-list
56082475|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
56082476|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
56082477|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
56082478|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082479|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082516|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082517|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
56082518|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082519|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
56082540|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082541|NCT02555228|Emollients|emollients|mesh-ancestor
56082542|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56082543|NCT02556788|Trifarotene|trifarotene|mesh-list
56082544|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
56082545|NCT02516150|Ethanol|ethanol|mesh-list
56082546|NCT02516150|Glucagon|glucagon|mesh-list
56082547|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56082548|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082549|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082550|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082551|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082552|NCT02516150|Hormones|hormones|mesh-ancestor
56082553|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082554|NCT04025060|Caffeine|caffeine|mesh-list
56082555|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56082556|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082557|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56082558|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193165|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56193166|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56193167|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56193168|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56193169|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193170|NCT01485978|Ramipril|ramipril|mesh-list
56193171|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56193172|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
56193173|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193174|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193175|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56193176|NCT01486004|Simeprevir|simeprevir|mesh-list
56193177|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
56193178|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193179|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
56193180|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193181|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193182|NCT01486017|Peficitinib|peficitinib|mesh-list
56781048|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781049|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781050|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56781051|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
56781052|NCT03957499|Hormones|hormones|mesh-ancestor
56053639|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193183|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193184|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193185|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193186|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
56193187|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193189|NCT01486082|Clarithromycin|clarithromycin|mesh-list
56193190|NCT01486082|Omeprazole|omeprazole|mesh-list
56193191|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56193192|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193193|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56193194|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193195|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56193196|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193197|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193201|NCT01486251|Axitinib|axitinib|mesh-list
56193204|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193205|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193206|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
56193207|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
56193208|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56193209|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193210|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193213|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56193214|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56193215|NCT01486433|Analgesics|analgesics|mesh-ancestor
56082559|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082560|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56082561|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56082562|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
56082563|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082564|NCT04631510|Gabapentin|gabapentin|mesh-list
56082565|NCT04631510|Analgesics|analgesics|mesh-ancestor
56082566|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
56082567|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082568|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082569|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
56082570|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56082571|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56082572|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082596|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
56082597|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56082598|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56082599|NCT04341038|Prednisolone|prednisolone|mesh-list
56082600|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
56082601|NCT04341038|Tacrolimus|tacrolimus|mesh-list
56082602|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56082603|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
56082604|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56082605|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
56082606|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082607|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56082608|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082609|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082610|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082611|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
56082612|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
56082613|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082614|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082615|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
56082616|NCT04341038|Hormones|hormones|mesh-ancestor
56082617|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082618|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56781053|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781054|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56781055|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781056|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
56781057|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
56781058|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781059|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
56781060|NCT03957499|Analgesics|analgesics|mesh-ancestor
56781061|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56781062|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
56781063|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56781064|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56781065|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781066|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56781067|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
56781068|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56781069|NCT01040338|Nicotine|nicotine|mesh-list
56053645|NCT00553202|Hormones|hormones|mesh-ancestor
56082619|NCT04341038|Protective Agents|protective agents|mesh-ancestor
56082620|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56082621|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082622|NCT02561702|Mexiletine|mexiletine|mesh-list
56082656|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
56082657|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082658|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
56082659|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082660|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
56082661|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082662|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
56082663|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193216|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
56193217|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193218|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193219|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193220|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56193221|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56193222|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56193223|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193224|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56193225|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56193226|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193227|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
56193228|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56193229|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56193230|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
56082664|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
56082699|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56082700|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56082701|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
56082702|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
56082704|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
56082706|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
56082707|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56082708|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082737|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781070|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56781071|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
56781072|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781073|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781074|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56781075|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56781076|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
56781077|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781078|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781079|NCT00066703|Tamoxifen|tamoxifen|mesh-list
56781080|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56781081|NCT00066703|Exemestane|exemestane|mesh-list
56781082|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56781083|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
56781084|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781085|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781086|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56781087|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053665|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
56082738|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56082739|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56082740|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
56082741|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082742|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
56082743|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082744|NCT00364052|Valganciclovir|valganciclovir|mesh-list
56082745|NCT00364052|Ganciclovir|ganciclovir|mesh-list
56082746|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56082747|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
56082748|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082749|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56082750|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082751|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082752|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56082753|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
56082754|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56082755|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
56082756|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56082790|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082791|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56082792|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56082805|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
56082806|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56082807|NCT02791568|Hematinics|hematinics|mesh-ancestor
56082808|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56082809|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56082810|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56082811|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082812|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082813|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
56082814|NCT05247554|Prednisone|prednisone|mesh-list
56193231|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56193232|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56193233|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
56193234|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
56781088|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56781089|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56781090|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56781091|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56781092|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56781093|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781094|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781095|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
56781096|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56193235|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193236|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193238|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
56193300|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
56193301|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193302|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
56193303|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
56193304|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56193305|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193306|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193307|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
56193308|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
56193309|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56193310|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193311|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193312|NCT01486888|Insulin|insulin|mesh-list
56193313|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56193314|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193315|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193316|NCT01486901|Insulin|insulin|mesh-list
56193317|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56193318|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
56193319|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
56193320|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
56193321|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193322|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193323|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
56193324|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193325|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193326|NCT01486940|Insulin|insulin|mesh-list
56193327|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56193348|NCT01486979|Hormones|hormones|mesh-ancestor
56193349|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56193351|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56193352|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
56193353|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56193354|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56193355|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
56082815|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082816|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
56082817|NCT05247554|Hormones|hormones|mesh-ancestor
56082818|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082819|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082820|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56082821|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082822|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
56082823|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56082824|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56082825|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082826|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082827|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082828|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082829|NCT02596022|Ketamine|ketamine|mesh-list
56082830|NCT02596022|Analgesics|analgesics|mesh-ancestor
56082831|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
56781097|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
56781098|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56781099|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56781100|NCT03955939|Midazolam|midazolam|mesh-list
56781101|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56781102|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56781103|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781104|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082832|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082833|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082834|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56082835|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56082836|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
56082837|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
56082838|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082839|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56082840|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56082841|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082842|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082843|NCT00364442|Fluticasone|fluticasone|mesh-list
56082844|NCT00364442|Xhance|xhance|mesh-list
56082845|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56082846|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082847|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56082848|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
56082849|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082850|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082851|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56082852|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56082853|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
56082884|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
56082885|NCT02601170|Protective Agents|protective agents|mesh-ancestor
56082886|NCT00366002|Darifenacin|darifenacin|mesh-list
56082887|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56082888|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56082889|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
56082890|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082891|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082892|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082893|NCT00366002|Urological Agents|urological agents|mesh-ancestor
56082894|NCT00422240|Adapalene|adapalene|mesh-list
56082895|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56082896|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56082926|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56082927|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56082928|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082930|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56193356|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56193357|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193358|NCT01487096|Teriflunomide|teriflunomide|mesh-list
56193359|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56193360|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56193361|NCT01487096|Analgesics|analgesics|mesh-ancestor
56082931|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082932|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56082933|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082934|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
56082935|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56082977|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
56082978|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56082979|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082980|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082981|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56082982|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
56082983|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
56781105|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56781106|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56781107|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56781108|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56781109|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
56781110|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
56781111|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
56781112|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
56781113|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781114|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781115|NCT01094821|ATI 7505|ati 7505|mesh-list
56781116|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56781117|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56781118|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
56781119|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053698|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
56083018|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56083019|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
56083020|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56083056|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
56083057|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083058|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083090|NCT04158362|Capecitabine|capecitabine|mesh-list
56083092|NCT04158362|Fulvestrant|fulvestrant|mesh-list
56083093|NCT04158362|Anastrozole|anastrozole|mesh-list
56083094|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56083095|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083096|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
56083097|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
56083098|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
56083099|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083135|NCT04604132|Paclitaxel|paclitaxel|mesh-list
56083136|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56083137|NCT04604132|Atezolizumab|atezolizumab|mesh-list
56083138|NCT04604132|Ramucirumab|ramucirumab|mesh-list
56083139|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56083140|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56083173|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083174|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083175|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56083177|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
55810350|NCT01638533|Romidepsin|romidepsin|mesh-list
56083178|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083210|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56083211|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
56083212|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083213|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
56083215|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56083216|NCT00300768|Ivermectin|ivermectin|mesh-list
56083217|NCT00300768|Moxidectin|moxidectin|mesh-list
56083218|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56083219|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083220|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
56083253|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56083254|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083255|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083256|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56193362|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
56193363|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193364|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781120|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781121|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781122|NCT00072475|Vatalanib|vatalanib|mesh-list
56781123|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56781124|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781125|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781126|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
56781127|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56193365|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193366|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56193367|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193368|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
56193369|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
56193372|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56193373|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56193374|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193375|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193376|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193377|NCT01487226|Paclitaxel|paclitaxel|mesh-list
56193378|NCT01487226|Cisplatin|cisplatin|mesh-list
56193379|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56083258|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083259|NCT04326764|Panobinostat|panobinostat|mesh-list
56083260|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083261|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56083262|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083263|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083299|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56083329|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083331|NCT02470741|Letrozole|letrozole|mesh-list
56083332|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083333|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56083334|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56083335|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083336|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083337|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56083338|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
56083339|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083340|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083341|NCT02544607|Ketamine|ketamine|mesh-list
56083342|NCT02544607|Analgesics|analgesics|mesh-ancestor
56083343|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
56083344|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083375|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083376|NCT02471521|Rocuronium|rocuronium|mesh-list
56083377|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56083378|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56083379|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56083380|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083381|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083382|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
56083383|NCT02624479|Antidotes|antidotes|mesh-ancestor
56083384|NCT02624479|Protective Agents|protective agents|mesh-ancestor
56083385|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083386|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
56083387|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083417|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56193380|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193381|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
56083418|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083420|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
56083421|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083423|NCT02247804|Bimatoprost|bimatoprost|mesh-list
56083424|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56781128|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56781129|NCT00066469|Prednisone|prednisone|mesh-list
56781130|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
56781131|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56781132|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56781133|NCT00066469|Prednisolone|prednisolone|mesh-list
56781134|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
56781135|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
56781136|NCT00066469|Rituximab|rituximab|mesh-list
56781137|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56781138|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
56781139|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781140|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
56781141|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781142|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781143|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56781144|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
56781145|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781146|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781147|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56781148|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56781149|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56781150|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
56781151|NCT00066469|Hormones|hormones|mesh-ancestor
56781152|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781153|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56083425|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56083426|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
56083427|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083428|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083429|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083430|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56083431|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083432|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
56083461|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56083462|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083463|NCT04058756|Spartalizumab|spartalizumab|mesh-list
56083464|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56083465|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083466|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083467|NCT02243202|Canagliflozin|canagliflozin|mesh-list
56083468|NCT02243202|Phentermine|phentermine|mesh-list
56083469|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56083471|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56083472|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083473|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56083474|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
56781154|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
56781155|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
56781156|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781157|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56781158|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56781159|NCT00066469|Protective Agents|protective agents|mesh-ancestor
56781160|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
56781161|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56781162|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56083475|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56083476|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
56083514|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083544|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56083545|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56083546|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56083547|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083548|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
56083549|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083550|NCT00367718|Bortezomib|bortezomib|mesh-list
56083551|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083552|NCT02474407|Diazepam|diazepam|mesh-list
56083553|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56083554|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
56083585|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
56083586|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
56083587|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
56083588|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083589|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083590|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
56083591|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083592|NCT02563093|Vaccines|vaccines|mesh-list
56083593|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
56083594|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083595|NCT02564029|Lorazepam|lorazepam|mesh-list
56083596|NCT02564029|PF-06372865|pf-06372865|mesh-list
56083597|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
56083598|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
56083599|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
56083600|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083601|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083602|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56083633|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56083634|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56083635|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083636|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083637|NCT03678428|Antidotes|antidotes|mesh-ancestor
56083638|NCT03678428|Protective Agents|protective agents|mesh-ancestor
56083639|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083640|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
56083641|NCT03678428|Vitamins|vitamins|mesh-ancestor
56193382|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
56193383|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
56193384|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193385|NCT01487278|Misoprostol|misoprostol|mesh-list
56193386|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56193387|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
56193388|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56193389|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193390|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56193391|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193392|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
56193393|NCT01487304|Hormones|hormones|mesh-list
56193394|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56193395|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193396|NCT01487317|Rivastigmine|rivastigmine|mesh-list
56193397|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56193398|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781163|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781164|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
56781165|NCT01094977|Coagulants|coagulants|mesh-ancestor
56781166|NCT01095133|Amiloride|amiloride|mesh-list
56781167|NCT01095133|Diuretics|diuretics|mesh-ancestor
56781168|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
56781169|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781170|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56781171|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56781172|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56781173|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781174|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56781175|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56781176|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
56492141|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
56781177|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56781178|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
56781179|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083643|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56083644|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
56083645|NCT02565901|Sirolimus|sirolimus|mesh-list
56083646|NCT02565901|Carboplatin|carboplatin|mesh-list
56083647|NCT02565901|Docetaxel|docetaxel|mesh-list
56083648|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083649|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
56083650|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
56083651|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
56083678|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56083679|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083680|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
56083682|NCT03926624|Analgesics|analgesics|mesh-ancestor
56083683|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
56083684|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083685|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56083686|NCT05588102|Fluvoxamine|fluvoxamine|mesh-list
56083687|NCT05588102|Citalopram|citalopram|mesh-list
56083688|NCT05588102|Fluoxetine|fluoxetine|mesh-list
56083689|NCT05588102|Paroxetine|paroxetine|mesh-list
56083690|NCT05588102|Sertraline|sertraline|mesh-list
56083691|NCT05588102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56083692|NCT05588102|Serotonin|serotonin|mesh-list
56083693|NCT05588102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56083694|NCT05588102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55810875|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083695|NCT05588102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083696|NCT05588102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083697|NCT05588102|Serotonin Agents|serotonin agents|mesh-ancestor
56083698|NCT05588102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083699|NCT05588102|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56083700|NCT05588102|Antidepressive Agents|antidepressive agents|mesh-ancestor
56083701|NCT05588102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56083734|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
56083736|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083737|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083738|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083739|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56083766|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56781180|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781181|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56781182|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
56781183|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
56781184|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56781185|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
56781186|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053774|NCT03193190|Leucovorin|leucovorin|mesh-list
56083767|NCT02577601|Estradiol|estradiol|mesh-list
56193399|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193400|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
56193401|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193402|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193403|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56193404|NCT01487317|Protective Agents|protective agents|mesh-ancestor
56193405|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
56193406|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193407|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193409|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193410|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193411|NCT01487395|Donepezil|donepezil|mesh-list
56193412|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56193413|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193414|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193415|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
56193416|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193417|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193418|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
56193419|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
56193420|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56083768|NCT02577601|Estrogens|estrogens|mesh-ancestor
56083769|NCT02577601|Hormones|hormones|mesh-ancestor
56083770|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083771|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083772|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56083773|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
56083774|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144729|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810952|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56083775|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56083776|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56083777|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56083778|NCT02577991|Triamcinolone|triamcinolone|mesh-list
56083779|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56083780|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083781|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
56083782|NCT02577991|Hormones|hormones|mesh-ancestor
56083783|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083784|NCT02207634|Evolocumab|evolocumab|mesh-list
56083785|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56083786|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56083787|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
55741374|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083817|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083824|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56083825|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
56083826|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193421|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193422|NCT01487421|Insulin|insulin|mesh-list
56193423|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56193424|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
56193425|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
56193426|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193427|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193428|NCT01487512|Hydromorphone|hydromorphone|mesh-list
56193429|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56193430|NCT01487512|Narcotics|narcotics|mesh-ancestor
56193431|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781187|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781188|NCT00070291|Cyclosporine|cyclosporine|mesh-list
56781189|NCT00070291|Cyclosporins|cyclosporins|mesh-list
56781190|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781191|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781192|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781193|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
56781194|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781195|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
56781196|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781197|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
56781198|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781199|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56781200|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
56781202|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
56781203|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781204|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56781205|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56781206|NCT00053365|Irofulven|irofulven|mesh-list
56193432|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083827|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083828|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56083829|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
56083830|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
56083831|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
56083832|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56083833|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
56083834|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
56083835|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56083906|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
56083907|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083908|NCT00367250|Trastuzumab|trastuzumab|mesh-list
56083909|NCT00367250|Cetuximab|cetuximab|mesh-list
56083910|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56083911|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083912|NCT02489227|Adalimumab|adalimumab|mesh-list
56083913|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56083914|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083915|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
56083948|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56083950|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56083951|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
56083952|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083953|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083954|NCT05553314|Carvedilol|carvedilol|mesh-list
56083955|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56083956|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56083957|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
56083958|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083959|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083989|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
56083990|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083991|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56083992|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56083993|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56083994|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
56781207|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56781208|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
56781209|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781210|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781211|NCT00387010|Fentanyl|fentanyl|mesh-list
56781212|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56781213|NCT00387010|Narcotics|narcotics|mesh-ancestor
56781214|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781215|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781216|NCT00387010|Analgesics|analgesics|mesh-ancestor
56781217|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
56781218|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781219|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56781220|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56781221|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
56781222|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
56781223|NCT01092091|BCT-100|bct-100|mesh-list
56781224|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781225|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
56781226|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56781227|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781228|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
56781229|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56781230|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56781231|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083995|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083996|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083997|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56083998|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
56083999|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56084000|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56084001|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56084002|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
56084003|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084004|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084006|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
56084039|NCT03238196|Fulvestrant|fulvestrant|mesh-list
56084040|NCT03238196|Palbociclib|palbociclib|mesh-list
56084041|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56193433|NCT01487512|Analgesics|analgesics|mesh-ancestor
56193434|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
56193435|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193436|NCT01487564|Hydromorphone|hydromorphone|mesh-list
56193437|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56193438|NCT01487564|Narcotics|narcotics|mesh-ancestor
56193439|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193440|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193441|NCT01487564|Analgesics|analgesics|mesh-ancestor
56193502|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55777511|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781232|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
56781233|NCT00386308|Coagulants|coagulants|mesh-ancestor
56781234|NCT00064987|Hormones|hormones|mesh-list
56781235|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56781236|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781237|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781238|NCT00374140|Everolimus|everolimus|mesh-list
56781239|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781240|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781241|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
56781242|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781243|NCT00665561|Maraviroc|maraviroc|mesh-list
56781244|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56781245|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56781246|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56084042|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084043|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56084044|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56084045|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
56084046|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56084047|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084048|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56084079|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56084080|NCT03019640|Lenograstim|lenograstim|mesh-list
56084081|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
56084082|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084083|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084084|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56084085|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56084086|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56084087|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56084088|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084089|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084090|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56084091|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
56084109|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56084110|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
56084111|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084112|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
56084113|NCT02136901|Protective Agents|protective agents|mesh-ancestor
56084114|NCT02507011|Carvedilol|carvedilol|mesh-list
56084115|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56084116|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56084117|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
56084118|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084119|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084120|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084121|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56084122|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
56084123|NCT02507011|Protective Agents|protective agents|mesh-ancestor
56084124|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56084125|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56084126|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56084127|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
56084128|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56084129|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56084130|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
56084131|NCT02977286|Naloxegol|naloxegol|mesh-list
56084158|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56781247|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781248|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56781249|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
56781250|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781251|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56781252|NCT03955705|Nefopam|nefopam|mesh-list
56781253|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56781254|NCT03955705|Analgesics|analgesics|mesh-ancestor
56781255|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
56781256|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781257|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781258|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
56781259|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56781260|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053837|NCT03026348|Antacids|antacids|mesh-ancestor
56084159|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56084160|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56084161|NCT05335148|Colchicine|colchicine|mesh-list
56084162|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
56084163|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56084164|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
56084165|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
56084166|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
56084167|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084168|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084169|NCT02976896|Apatinib|apatinib|mesh-list
56084170|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084171|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56084172|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084173|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084174|NCT01810705|Asparaginase|asparaginase|mesh-list
56084175|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084176|NCT02508103|Oxytocin|oxytocin|mesh-list
56084177|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
56084178|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56084179|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084218|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56084219|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56084220|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56193503|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
56193504|NCT01488201|Brodalumab|brodalumab|mesh-list
56193505|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
56193506|NCT01488227|Vitamin D|vitamin d|mesh-list
56193507|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
56193508|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
56193509|NCT01488227|Vitamins|vitamins|mesh-list
56193510|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
56193511|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193512|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56193513|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56193514|NCT01488253|Sirolimus|sirolimus|mesh-list
56193515|NCT01488253|Tacrolimus|tacrolimus|mesh-list
56193516|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193517|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
56084221|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56084222|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56084223|NCT02240628|Lidocaine|lidocaine|mesh-list
56084251|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084252|NCT02511535|Vaccines|vaccines|mesh-list
56084253|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
56084254|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084255|NCT03545035|Rituximab|rituximab|mesh-list
56084256|NCT03545035|Idelalisib|idelalisib|mesh-list
55777514|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
56781261|NCT00786695|Esomeprazole|esomeprazole|mesh-list
56781262|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56781263|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56781264|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56781265|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781266|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781267|NCT00786851|Lenalidomide|lenalidomide|mesh-list
56781268|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
56781269|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781270|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56781271|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56781272|NCT00786851|Growth Substances|growth substances|mesh-ancestor
56781273|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
56781274|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781275|NCT00787007|Equol|equol|mesh-list
56781276|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
56781277|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56781278|NCT00787007|Estrogens|estrogens|mesh-ancestor
56781279|NCT00787007|Hormones|hormones|mesh-ancestor
56781280|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781281|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781282|NCT00791141|Cetuximab|cetuximab|mesh-list
56781283|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56781284|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781285|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
56781286|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
56781287|NCT00386152|Hematinics|hematinics|mesh-ancestor
56781288|NCT00787553|Cefazolin|cefazolin|mesh-list
56781289|NCT00787553|Tinidazole|tinidazole|mesh-list
56781290|NCT00787553|Imidazole|imidazole|mesh-list
56781291|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56781292|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781293|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781294|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781295|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
56781296|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56781297|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56781298|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56781299|NCT00795353|Alefacept|alefacept|mesh-list
56781300|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
56781301|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
56781302|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781303|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
56781304|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56781305|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
56781306|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56781307|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781308|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56781309|NCT01045876|Dexamethasone|dexamethasone|mesh-list
56781310|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56781311|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
56781312|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
56781313|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781314|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781315|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56781316|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
56781317|NCT01045876|Hormones|hormones|mesh-ancestor
56781318|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781319|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56781320|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084257|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56084258|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084259|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
56084260|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084261|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56084262|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084263|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084264|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56084265|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56084266|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084267|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
56084268|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
56084269|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56084270|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084271|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56084305|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084306|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084309|NCT05673811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56084310|NCT05673811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084311|NCT05673811|Tubulin Modulators|tubulin modulators|mesh-ancestor
56084379|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084381|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56084382|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56084383|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56084384|NCT02596867|Propranolol|propranolol|mesh-list
56084385|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56084386|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56084387|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
56084388|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084389|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781321|NCT00385762|Paroxetine|paroxetine|mesh-list
56781322|NCT00385762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56781323|NCT00385762|Serotonin|serotonin|mesh-list
56781324|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56781325|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56781326|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781327|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781328|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
56781329|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781330|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56781331|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
56781332|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56781333|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56781334|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56781335|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781336|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56781337|NCT00385684|Acetaminophen|acetaminophen|mesh-list
56781338|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56781339|NCT00385684|Hydrocodone|hydrocodone|mesh-list
56781340|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56781341|NCT00385684|Narcotics|narcotics|mesh-ancestor
56781342|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781343|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781344|NCT00385684|Analgesics|analgesics|mesh-ancestor
56781345|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
56781346|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781347|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
56781348|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
56781349|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56781350|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
56781351|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56084390|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084391|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56084430|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56084460|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084462|NCT02608177|Hormones|hormones|mesh-ancestor
56193518|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084463|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56084464|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56084465|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
56781352|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56781353|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781354|NCT00661661|Tofacitinib|tofacitinib|mesh-list
56781355|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56781356|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781357|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781359|NCT00038467|Exemestane|exemestane|mesh-list
56781360|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56781361|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
56781362|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781363|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053944|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56084466|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084467|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084470|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
56084471|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084472|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
56084473|NCT02608489|Protective Agents|protective agents|mesh-ancestor
56084474|NCT02611765|Penicillins|penicillins|mesh-list
56084475|NCT02611765|Penicillin G|penicillin g|mesh-list
56084509|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56084510|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
56084511|NCT05732155|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56084512|NCT05732155|Hallucinogens|hallucinogens|mesh-ancestor
56084513|NCT05732155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084514|NCT05732155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56084515|NCT05732155|Serotonin Agents|serotonin agents|mesh-ancestor
56084516|NCT05732155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084517|NCT05732155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084553|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56084554|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
56084555|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084586|NCT05730907|Protective Agents|protective agents|mesh-ancestor
56084587|NCT05730907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084589|NCT05384665|Remifentanil|remifentanil|mesh-list
56084590|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56084591|NCT05384665|Narcotics|narcotics|mesh-ancestor
56084592|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084593|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084594|NCT05384665|Analgesics|analgesics|mesh-ancestor
56084595|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
56084596|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084597|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56084598|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56084599|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
56084627|NCT05281471|Taxane|taxane|mesh-list
56084628|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56084629|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084630|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
56084631|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
56084632|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
56084633|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084634|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56084635|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56084636|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56084637|NCT05281471|Growth Substances|growth substances|mesh-ancestor
56084638|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084639|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
56084640|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56084641|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
56084642|NCT05281471|Antiviral Agents|antiviral agents|mesh-ancestor
56084643|NCT05281471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781364|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56781365|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781366|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56781367|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56781368|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56781369|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56781370|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56781371|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053953|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56084644|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084645|NCT05281471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56084646|NCT05281471|Immunologic Factors|immunologic factors|mesh-ancestor
56084647|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56084648|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56084677|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56084679|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084680|NCT04802863|Imipenem|imipenem|mesh-list
56084681|NCT04802863|Cilastatin|cilastatin|mesh-list
56084682|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56084683|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084684|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
56084685|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193519|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56193520|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193521|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193522|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56193523|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193524|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56193525|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193526|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
56193527|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56193528|NCT01488266|Milnacipran|milnacipran|mesh-list
56193529|NCT01488266|Aripiprazole|aripiprazole|mesh-list
56193534|NCT01488266|Paroxetine|paroxetine|mesh-list
56193535|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56193536|NCT01488266|Sertraline|sertraline|mesh-list
56084686|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084687|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
56084688|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56084689|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084690|NCT04622839|Acetaminophen|acetaminophen|mesh-list
56084691|NCT04622839|Ibuprofen|ibuprofen|mesh-list
56084692|NCT04622839|Diclofenac|diclofenac|mesh-list
56084724|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
56084725|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
56084726|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084727|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084728|NCT02619799|Analgesics|analgesics|mesh-ancestor
56084729|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
56084730|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084731|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56084732|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
56084733|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56084734|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56084735|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56084768|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
56084769|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56084770|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084771|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084772|NCT02625181|Promethazine|promethazine|mesh-list
56084773|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
56084774|NCT02625181|Meclizine|meclizine|mesh-list
56084775|NCT02625181|Dexamethasone|dexamethasone|mesh-list
56084776|NCT02625181|Fentanyl|fentanyl|mesh-list
56084777|NCT02625181|Sufentanil|sufentanil|mesh-list
56084778|NCT02625181|Scopolamine|scopolamine|mesh-list
56084779|NCT02625181|Oxymorphone|oxymorphone|mesh-list
56781372|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781373|NCT01095445|Ribavirin|ribavirin|mesh-list
56781374|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56781375|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
56053963|NCT02988362|Amlodipine|amlodipine|mesh-list
56084780|NCT02625181|Meperidine|meperidine|mesh-list
56084781|NCT02625181|Droperidol|droperidol|mesh-list
56084782|NCT02625181|Ketamine|ketamine|mesh-list
56084813|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56084814|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56084815|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084816|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084817|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56084818|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56084819|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
56084821|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
56084822|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56084823|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56084824|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56084825|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084826|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084827|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56084828|NCT02625181|Narcotics|narcotics|mesh-ancestor
56084829|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56084830|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56084831|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56084832|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
56084833|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
56084834|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56084835|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
56084836|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56084837|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56084869|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56084870|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084871|NCT04363801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56084872|NCT04363801|Immunologic Factors|immunologic factors|mesh-ancestor
56084873|NCT04363801|Antidotes|antidotes|mesh-ancestor
56084874|NCT04363801|Protective Agents|protective agents|mesh-ancestor
56084875|NCT04363801|Vitamin B Complex|vitamin b complex|mesh-ancestor
56084876|NCT04363801|Vitamins|vitamins|mesh-ancestor
56084877|NCT04363801|Micronutrients|micronutrients|mesh-ancestor
56084878|NCT02630017|Methylphenidate|methylphenidate|mesh-list
56084879|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56084918|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084919|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084920|NCT02633371|Urological Agents|urological agents|mesh-ancestor
56084922|NCT04159519|Albuterol|albuterol|mesh-list
56084923|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
56084924|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56084925|NCT04159519|Benralizumab|benralizumab|mesh-list
56084926|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56084927|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56084960|NCT02634073|Sorbitol|sorbitol|mesh-list
56084961|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56084962|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56084963|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084964|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084965|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
56084966|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084967|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56084968|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56084995|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
56084996|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
56084997|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084998|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56084999|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56085000|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085001|NCT02207244|Adalimumab|adalimumab|mesh-list
56085002|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56085003|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56085004|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781376|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781377|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
56781378|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781379|NCT00660179|Macitentan|macitentan|mesh-list
56781380|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56781381|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56781382|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781383|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56781384|NCT00050167|Paclitaxel|paclitaxel|mesh-list
56781385|NCT00050167|Docetaxel|docetaxel|mesh-list
56085005|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
56085006|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085007|NCT02207088|Ritonavir|ritonavir|mesh-list
56085008|NCT02207088|Ribavirin|ribavirin|mesh-list
56085009|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56085010|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56085011|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
56085012|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193538|NCT01488266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56193539|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56193540|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56193541|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193542|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193544|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193545|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56193546|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193547|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193548|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56193549|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
56193550|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56085013|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085014|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56085015|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56085016|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
56085017|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085018|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56085019|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56085020|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
56085021|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
56085022|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55801734|NCT04360135|Acetaminophen|acetaminophen|mesh-list
56085050|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085052|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085053|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
56085054|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
56085055|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56085056|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56085057|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085058|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085060|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56085061|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
56085062|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085063|NCT02206152|Expectorants|expectorants|mesh-ancestor
56085064|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
56085065|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56085067|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085068|NCT02206152|Protective Agents|protective agents|mesh-ancestor
56085069|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085070|NCT02206152|Antidotes|antidotes|mesh-ancestor
56085096|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56085097|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
56085098|NCT04146571|Ensartinib|ensartinib|mesh-list
56085099|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781386|NCT00050167|Capecitabine|capecitabine|mesh-list
56781387|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56781388|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781389|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
56781390|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
56781391|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
56781392|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781393|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56781394|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
56781395|NCT01096927|Amoxicillin|amoxicillin|mesh-list
56781396|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
56781397|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
56781398|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56781399|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781400|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781401|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492367|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781402|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56781403|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
56781404|NCT00660023|Hematinics|hematinics|mesh-ancestor
56781405|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
56085100|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56085101|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085102|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085103|NCT02204982|Rituximab|rituximab|mesh-list
56085104|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085105|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085106|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
56085107|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085108|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085109|NCT04074265|Ketorolac|ketorolac|mesh-list
56085110|NCT04074265|Epinephrine|epinephrine|mesh-list
56085111|NCT04074265|Ropivacaine|ropivacaine|mesh-list
56193551|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56193552|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193553|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56193554|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56193555|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085112|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
56085113|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
56085114|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085115|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085116|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
56085117|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085118|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56085119|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56085120|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
56085154|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56085155|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085156|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085157|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085158|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
56085159|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777562|NCT02893241|Ephedrine|ephedrine|mesh-list
56781406|NCT02554955|Daclizumab|daclizumab|mesh-list
56781407|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56781408|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781409|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56781410|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
56781411|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56781412|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781413|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781414|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781415|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781416|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
56781417|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781418|NCT00062647|Vancomycin|vancomycin|mesh-list
56781419|NCT00062647|Cloxacillin|cloxacillin|mesh-list
56781420|NCT00062647|Oxacillin|oxacillin|mesh-list
56781421|NCT00062647|Telavancin|telavancin|mesh-list
56781422|NCT00062647|Nafcillin|nafcillin|mesh-list
56781423|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56781424|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085176|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085178|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085179|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085180|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56085181|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085182|NCT04684212|Warfarin|warfarin|mesh-list
56085183|NCT04684212|Rivaroxaban|rivaroxaban|mesh-list
56085184|NCT04684212|Dabigatran|dabigatran|mesh-list
56085185|NCT04684212|Edoxaban|edoxaban|mesh-list
56085186|NCT04684212|Apixaban|apixaban|mesh-list
56085187|NCT04684212|Betrixaban|betrixaban|mesh-list
56085188|NCT04684212|Anticoagulants|anticoagulants|mesh-ancestor
56085189|NCT04684212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56085190|NCT04684212|Antithrombins|antithrombins|mesh-ancestor
56085191|NCT04684212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56085192|NCT04684212|Protease Inhibitors|protease inhibitors|mesh-ancestor
56085193|NCT04684212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085194|NCT04684212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085195|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
56085197|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085198|NCT03250273|Nivolumab|nivolumab|mesh-list
56085199|NCT03250273|Entinostat|entinostat|mesh-list
56085200|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085201|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085202|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56085203|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085204|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56085205|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085206|NCT02203032|Ustekinumab|ustekinumab|mesh-list
56085207|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56085208|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
56085209|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
56085210|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085211|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56085212|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085213|NCT02169414|Levodopa|levodopa|mesh-list
56085214|NCT02169414|Carbidopa|carbidopa|mesh-list
56085216|NCT02169414|Benserazide|benserazide|mesh-list
56085217|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56085218|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56781425|NCT00570323|Fulvestrant|fulvestrant|mesh-list
56781426|NCT00570323|Anastrozole|anastrozole|mesh-list
56781427|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56781428|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781429|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56085219|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
56085254|NCT05588869|Dermatologic Agents|dermatologic agents|mesh-ancestor
56085255|NCT05588869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085256|NCT05588869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56085257|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
56085258|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56085287|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
56085288|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56193556|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
56193557|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56193558|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56193559|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56193560|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56193561|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56193562|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56193563|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56193564|NCT01488266|Analgesics|analgesics|mesh-ancestor
56193565|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
56193566|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56193567|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
56193568|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
56193569|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56085289|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56085290|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
56085291|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
56085292|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085293|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085294|NCT02609828|Tanezumab|tanezumab|mesh-list
56085295|NCT02609828|Analgesics|analgesics|mesh-ancestor
56085296|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
56085297|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085298|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085299|NCT03206047|Poly I-C|poly i-c|mesh-list
56085300|NCT03206047|Atezolizumab|atezolizumab|mesh-list
56085301|NCT03206047|Guadecitabine|guadecitabine|mesh-list
56085302|NCT03206047|Azacitidine|azacitidine|mesh-list
56085303|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56085337|NCT02672917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085338|NCT02672917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085339|NCT02672917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085340|NCT02672917|Immunologic Factors|immunologic factors|mesh-ancestor
56085341|NCT02672917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085342|NCT01632306|Leucovorin|leucovorin|mesh-list
56085343|NCT01632306|Gemcitabine|gemcitabine|mesh-list
56085344|NCT01632306|Paclitaxel|paclitaxel|mesh-list
56085345|NCT01632306|Fluorouracil|fluorouracil|mesh-list
56085346|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
56085347|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56085369|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
56085370|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085371|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085372|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
56085373|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085374|NCT05587933|Parasympatholytics|parasympatholytics|mesh-list
56085376|NCT05587933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085377|NCT05587933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085378|NCT02018263|Cocaine|cocaine|mesh-list
56085379|NCT02018263|Nicotine|nicotine|mesh-list
56085380|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56085381|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
56085382|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085383|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085384|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56085385|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56085386|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
56085387|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110440|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781430|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56781431|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
56781432|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781433|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781434|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56781435|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56781436|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781437|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781438|NCT00791531|Methotrexate|methotrexate|mesh-list
56781439|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56781440|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
56781441|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56781442|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085388|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085389|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
56085390|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
56193570|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56193571|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56193572|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56193573|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
56193574|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56193575|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56193576|NCT01488305|Micronutrients|micronutrients|mesh-list
56193577|NCT01488305|Trace Elements|trace elements|mesh-list
56193578|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193579|NCT01488344|Nintedanib|nintedanib|mesh-list
56193580|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193581|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56193582|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193583|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193584|NCT01488396|Cyclosporine|cyclosporine|mesh-list
56193585|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56193586|NCT01488396|Cyclosporins|cyclosporins|mesh-list
56193587|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193588|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193589|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085391|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085392|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
56085393|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56085394|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56085395|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56085396|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56085397|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
56085398|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56085399|NCT02168946|Meropenem|meropenem|mesh-list
56085400|NCT02168946|Vaborbactam|vaborbactam|mesh-list
56085401|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56085402|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
56085403|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085404|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
56085405|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085433|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085434|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
56085435|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56085436|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56085437|NCT00367562|Valsartan|valsartan|mesh-list
56085438|NCT00367562|Enalapril|enalapril|mesh-list
56085439|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56085440|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56085441|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56054032|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054033|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054034|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56054035|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56054042|NCT00558038|Lactulose|lactulose|mesh-list
56781443|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56781444|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
56781445|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781446|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781447|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
56781448|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781449|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56781450|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781451|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
56781452|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781453|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56781454|NCT00788099|Gemcitabine|gemcitabine|mesh-list
56781455|NCT00788099|Sorafenib|sorafenib|mesh-list
56781456|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56781457|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
56781458|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781459|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781460|NCT00788099|Antiviral Agents|antiviral agents|mesh-ancestor
56781461|NCT00788099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781462|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781463|NCT00788099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781464|NCT00788099|Immunologic Factors|immunologic factors|mesh-ancestor
56781465|NCT00788099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781466|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56781467|NCT00795587|Mannitol|mannitol|mesh-list
56781468|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56781469|NCT00795587|Diuretics|diuretics|mesh-ancestor
56781470|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
56781471|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781472|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
56781473|NCT00661505|Hematinics|hematinics|mesh-ancestor
56781474|NCT00788333|Trastuzumab|trastuzumab|mesh-list
56085442|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781475|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56781476|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781477|NCT00795899|Paclitaxel|paclitaxel|mesh-list
56781478|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
56781480|NCT00795899|Epirubicin|epirubicin|mesh-list
56781481|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56781482|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781483|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
56781484|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
56781485|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
56781486|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781487|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781488|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
56781489|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781490|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054064|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56085443|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56085444|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
56085445|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085446|NCT02302976|Exenatide|exenatide|mesh-list
56085447|NCT02302976|Cocaine|cocaine|mesh-list
56085448|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56085449|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085450|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56085451|NCT02302976|Incretins|incretins|mesh-ancestor
56085452|NCT02302976|Hormones|hormones|mesh-ancestor
56193590|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
56193591|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193592|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
56193593|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193594|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
56193596|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56193597|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56193598|NCT01488526|Tenofovir|tenofovir|mesh-list
56193599|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
56193600|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193601|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56193602|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56193603|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193604|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193605|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56193606|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56193607|NCT01488552|Metformin|metformin|mesh-list
56193608|NCT01488552|Gemcitabine|gemcitabine|mesh-list
56193609|NCT01488552|Paclitaxel|paclitaxel|mesh-list
56193610|NCT01488552|Folfirinox|folfirinox|mesh-list
56193611|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56193612|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193613|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
56193614|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
56193615|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
56193616|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193617|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56193618|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
56193619|NCT01488552|Antiviral Agents|antiviral agents|mesh-ancestor
56193620|NCT01488552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193621|NCT01488552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193622|NCT01488552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193623|NCT01488552|Immunologic Factors|immunologic factors|mesh-ancestor
56193624|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193625|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56781491|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56781492|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
56781493|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56781494|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56781495|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56781496|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56781497|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56781498|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781499|NCT00795977|Picibanil|picibanil|mesh-list
56781500|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781501|NCT00796211|Nortriptyline|nortriptyline|mesh-list
56781502|NCT00796211|Calcipotriene|calcipotriene|mesh-list
56781503|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
56781504|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56781505|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
56781506|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56781507|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56781508|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56054085|NCT00378729|Metformin|metformin|mesh-list
56085453|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085454|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
56085455|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
56085489|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085490|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193626|NCT01488565|Azacitidine|azacitidine|mesh-list
56193627|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56193628|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
56193629|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193630|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085491|NCT02244164|Liraglutide|liraglutide|mesh-list
56085492|NCT02244164|Exenatide|exenatide|mesh-list
56085493|NCT02244164|Lixisenatide|lixisenatide|mesh-list
56085494|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56085495|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56085496|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085497|NCT02244164|Incretins|incretins|mesh-ancestor
56085498|NCT02244164|Hormones|hormones|mesh-ancestor
56085524|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085525|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56085526|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56085527|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085528|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085529|NCT02028806|Antidotes|antidotes|mesh-ancestor
56085530|NCT02028806|Protective Agents|protective agents|mesh-ancestor
56085531|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085532|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
56085533|NCT02028806|Vitamins|vitamins|mesh-ancestor
56085534|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
56085535|NCT01756118|Dactolisib|dactolisib|mesh-list
56085536|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085537|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56085538|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085539|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
56085540|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56085541|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56085542|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085543|NCT02657252|Polidocanol|polidocanol|mesh-list
56781509|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56781510|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781511|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
56781512|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781513|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781514|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
56781515|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56781516|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781517|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56781518|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
56781519|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56781520|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781521|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781522|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781523|NCT00662909|Mirabegron|mirabegron|mesh-list
56781524|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56781525|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56781526|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56781527|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
56781528|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781529|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781530|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781531|NCT00662909|Urological Agents|urological agents|mesh-ancestor
56781532|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
56781533|NCT00050011|Letrozole|letrozole|mesh-list
56781534|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054100|NCT03802227|Oxycodone|oxycodone|mesh-list
56085544|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56085545|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56085546|NCT04740086|Calcium|calcium|mesh-list
56085547|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56085583|NCT02660918|Bupivacaine|bupivacaine|mesh-list
56085584|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
56085585|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
56085614|NCT05441761|Dexamethasone|dexamethasone|mesh-list
56085615|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
56085616|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56085617|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
56085618|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
56085619|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085620|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085621|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56085622|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
56085623|NCT05441761|Hormones|hormones|mesh-ancestor
56085624|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085625|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56085626|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781535|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56781536|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56781537|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781538|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781539|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56781540|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
56085627|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56085628|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
56085659|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085660|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
56085661|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085662|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
56085663|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085665|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56085666|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085667|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56085668|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085669|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
56085670|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085671|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
56085702|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085703|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193631|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193632|NCT01488656|Vitamin D|vitamin d|mesh-list
56193633|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56193634|NCT01488656|Antioxidants|antioxidants|mesh-list
56193635|NCT01488656|Vitamins|vitamins|mesh-ancestor
56193636|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
56193637|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193638|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56193639|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193640|NCT01488656|Protective Agents|protective agents|mesh-ancestor
56193641|NCT01488734|Vitamin D|vitamin d|mesh-list
56193642|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
56193643|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
56193644|NCT01488734|Vitamins|vitamins|mesh-list
56193645|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
56193646|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193647|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56193648|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56193649|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56193650|NCT01488773|Montelukast|montelukast|mesh-list
56193651|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56085704|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085705|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56085706|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085707|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085708|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
56085709|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
56085710|NCT02643979|Ketamine|ketamine|mesh-list
56085711|NCT02643979|Propofol|propofol|mesh-list
56085712|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56085713|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085714|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085715|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56085716|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
56085717|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
56085743|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085744|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085745|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085746|NCT02694601|Caffeine|caffeine|mesh-list
56085747|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56085748|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085749|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56085750|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085751|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085758|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085759|NCT02698735|Gentamicins|gentamicins|mesh-list
56085760|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56781541|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781542|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781543|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56781544|NCT00661427|Cetuximab|cetuximab|mesh-list
56781545|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085761|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085762|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56085763|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193652|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
56193653|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193654|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193655|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56085764|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085765|NCT02691416|Propofol|propofol|mesh-list
56085766|NCT02691416|Sevoflurane|sevoflurane|mesh-list
56085798|NCT05502211|Analgesics|analgesics|mesh-ancestor
56085799|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56085800|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56085801|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
56085802|NCT02674412|Buspirone|buspirone|mesh-list
56085803|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56085804|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56085805|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085806|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085807|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56085808|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56085809|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
56085810|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085811|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085812|NCT04708106|Menthol|menthol|mesh-list
56085813|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
56085840|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56085841|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085842|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
56085843|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56085844|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56085845|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085846|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
56085847|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085848|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085849|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
56085850|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56085851|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085852|NCT05470465|Oxycodone|oxycodone|mesh-list
56085853|NCT05470465|Citalopram|citalopram|mesh-list
56085854|NCT05470465|Paroxetine|paroxetine|mesh-list
56085855|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56085856|NCT05470465|Narcotics|narcotics|mesh-ancestor
56085857|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085858|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085859|NCT05470465|Analgesics|analgesics|mesh-ancestor
56085860|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
56085861|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085862|NCT05470465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56085863|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56085894|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085895|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
56085896|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085897|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085898|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
56085899|NCT02710981|Clomiphene|clomiphene|mesh-list
56085900|NCT02710981|Enclomiphene|enclomiphene|mesh-list
56085901|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
56085902|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085903|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
55801740|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
56085904|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56085906|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085934|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56781546|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781547|NCT00049543|Gefitinib|gefitinib|mesh-list
56781548|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781549|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56781550|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492522|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781551|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781552|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56781553|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56781554|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781555|NCT04080427|Dronabinol|dronabinol|mesh-list
56085936|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085937|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085938|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56085939|NCT05303636|Diuretics|diuretics|mesh-ancestor
56085940|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
56085941|NCT02659501|Acetaminophen|acetaminophen|mesh-list
56193656|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
56193657|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56193658|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56193659|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56193660|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
56085942|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56085944|NCT02659501|Diazepam|diazepam|mesh-list
56085945|NCT02659501|Morphine|morphine|mesh-list
56085946|NCT02659501|Hydrocodone|hydrocodone|mesh-list
56085947|NCT02659501|Bupivacaine|bupivacaine|mesh-list
56085948|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
56085949|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
56085950|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085951|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085952|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
56085953|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085992|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56085993|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56085994|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56085995|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086026|NCT02664961|Growth Substances|growth substances|mesh-ancestor
56086027|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086028|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
56086029|NCT02665273|Bupivacaine|bupivacaine|mesh-list
56086030|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
56086031|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
56086032|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086033|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086034|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
56086035|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086036|NCT02713178|Bupivacaine|bupivacaine|mesh-list
56086037|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
56144730|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144732|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56144734|NCT00812604|Petrolatum|petrolatum|mesh-list
56144735|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
56144736|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144737|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144738|NCT00812604|Emollients|emollients|mesh-ancestor
56144739|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
56144740|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
56144741|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56144742|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56144743|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56144744|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56144745|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781556|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
56781557|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781558|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56781559|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56781560|NCT04080427|Analgesics|analgesics|mesh-ancestor
56781561|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
56781562|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781563|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56781564|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56781565|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781566|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781567|NCT04080427|Hormones|hormones|mesh-ancestor
56781568|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781569|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
56781570|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781571|NCT00035815|Mitogens|mitogens|mesh-list
56781572|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
56054143|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
56144746|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
56144747|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144748|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144749|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56144750|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144751|NCT00814788|Everolimus|everolimus|mesh-list
56144752|NCT00814788|Bicalutamide|bicalutamide|mesh-list
56144753|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144754|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144777|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144778|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144779|NCT00821184|Urological Agents|urological agents|mesh-ancestor
56144780|NCT05236842|Sulthiame|sulthiame|mesh-list
56144781|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
56144782|NCT05209620|Pemetrexed|pemetrexed|mesh-list
56144783|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144784|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813228|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
56144785|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086062|NCT05261672|Bupivacaine|bupivacaine|mesh-list
56086063|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
56086064|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
56086065|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193661|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193662|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086066|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086067|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
56086068|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086069|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56086070|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56086071|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56086072|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56086073|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56086075|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
56086076|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
56086077|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
56086078|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086079|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086080|NCT02714504|Voriconazole|voriconazole|mesh-list
56781573|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781574|NCT00662831|Dalteparin|dalteparin|mesh-list
56086081|NCT02714504|Posaconazole|posaconazole|mesh-list
56086082|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
56086083|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086084|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56086105|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
56086106|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
56086107|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
56086108|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086110|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
56086111|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086112|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
56086113|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086114|NCT00368329|Carboplatin|carboplatin|mesh-list
56086115|NCT00368329|Fluorouracil|fluorouracil|mesh-list
56086116|NCT00368329|Capecitabine|capecitabine|mesh-list
56086117|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56086118|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086119|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
56086120|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086121|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56086122|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56086123|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
56086124|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086125|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56086126|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
56086127|NCT02670343|Testosterone|testosterone|mesh-list
56086128|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
56086129|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
56086130|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56086131|NCT02670343|Androgens|androgens|mesh-ancestor
56086132|NCT02670343|Hormones|hormones|mesh-ancestor
56086133|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086134|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086135|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56086136|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086137|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
56086175|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086176|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56086177|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56086215|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086241|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56086242|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
56086243|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
56086244|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
56086246|NCT02734238|Testosterone|testosterone|mesh-list
56086247|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
56086248|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
56086249|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56086250|NCT02734238|Androgens|androgens|mesh-ancestor
56086251|NCT02734238|Hormones|hormones|mesh-ancestor
56086252|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086253|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086255|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193663|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56193664|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
56086256|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
56086257|NCT04707547|Nivolumab|nivolumab|mesh-list
56086258|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56086259|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086260|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56086261|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086262|NCT03535376|Valsartan|valsartan|mesh-list
56086263|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56086264|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56086265|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56086266|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086285|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56086286|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086288|NCT04947085|Analgesics|analgesics|mesh-ancestor
55783427|NCT05178823|Protective Agents|protective agents|mesh-ancestor
56781575|NCT00662831|Tinzaparin|tinzaparin|mesh-list
56781576|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56781577|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
56781578|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56781579|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56781580|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781581|NCT02555423|Anesthetics|anesthetics|mesh-list
56781582|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
56781583|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
56781584|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781585|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781586|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
56781587|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781588|NCT00792779|Propofol|propofol|mesh-list
55895310|NCT00984399|Estradiol|estradiol|mesh-list
56086289|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
56086290|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086291|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086292|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56086293|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56086294|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
56086295|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
56086296|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086297|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56086298|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56086299|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086300|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086301|NCT03357224|Atezolizumab|atezolizumab|mesh-list
56086302|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086303|NCT04947020|Metformin|metformin|mesh-list
56086304|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56086305|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086306|NCT02679469|Nalmefene|nalmefene|mesh-list
56086307|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56086308|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086309|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
56086310|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086311|NCT04915508|Hormones|hormones|mesh-list
56086312|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086313|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086314|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
56086315|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56086316|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56086317|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086318|NCT05445661|Mannitol|mannitol|mesh-list
56086319|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56086320|NCT05445661|Diuretics|diuretics|mesh-ancestor
56086321|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
56086322|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086357|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086358|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086359|NCT05424523|Omalizumab|omalizumab|mesh-list
56086360|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56086361|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56086362|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
56086363|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
56086364|NCT05442931|Pregabalin|pregabalin|mesh-list
56086365|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
56086366|NCT05442931|Analgesics|analgesics|mesh-ancestor
56086367|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
56086368|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781589|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56781590|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781591|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781592|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56781593|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
56781594|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
56781595|NCT00662363|Lubiprostone|lubiprostone|mesh-list
56781596|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56781597|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56781598|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781599|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56781600|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56781601|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56781602|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781603|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781604|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56781605|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56781606|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56781607|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
56781608|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086369|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086401|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086402|NCT04003987|Bupivacaine|bupivacaine|mesh-list
56086403|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
56086404|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
56086405|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086406|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086407|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
56086408|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086450|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
56086451|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086452|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56086453|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56086454|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
56086455|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
56086456|NCT03615547|Clomiphene|clomiphene|mesh-list
56086457|NCT03615547|Enclomiphene|enclomiphene|mesh-list
56086458|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
56086459|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56086460|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
56086461|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086462|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086463|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56086495|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086497|NCT03122509|Tremelimumab|tremelimumab|mesh-list
56086498|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56086499|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086500|NCT03113695|Lenalidomide|lenalidomide|mesh-list
56086501|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
56086502|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
56086503|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086504|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55779599|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781609|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781610|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56781611|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56781612|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
56781613|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56781614|NCT00792857|Vitamins|vitamins|mesh-ancestor
56781615|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
56781616|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086505|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56086506|NCT03113695|Growth Substances|growth substances|mesh-ancestor
56086507|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
56086544|NCT05444738|Oxytocin|oxytocin|mesh-list
56086545|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
56086546|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56086547|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086548|NCT05243953|Cromakalim|cromakalim|mesh-list
56086549|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56086550|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56086551|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
56086587|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086588|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086589|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56086626|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56086627|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086628|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
56086629|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56086630|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
56086631|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56086632|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086664|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56086666|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55813879|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
56086696|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56086697|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
56086698|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
56086699|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
56086700|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56086701|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56086702|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
56086703|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086704|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086705|NCT00059930|Leucovorin|leucovorin|mesh-list
56086706|NCT00059930|Dexamethasone|dexamethasone|mesh-list
56086707|NCT00059930|Fluorouracil|fluorouracil|mesh-list
56193665|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56193666|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56193667|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56086708|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
56086709|NCT00059930|Floxuridine|floxuridine|mesh-list
56086710|NCT00059930|Calcium|calcium|mesh-list
56086711|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
56086712|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56086713|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
56086714|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
56086715|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086716|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086717|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56086718|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
56086719|NCT00059930|Hormones|hormones|mesh-ancestor
56086720|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086721|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56086752|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56086753|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56086754|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
56086755|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56086756|NCT05443178|Amebicides|amebicides|mesh-ancestor
56086757|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56781617|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56781618|NCT02554175|Propofol|propofol|mesh-list
56781619|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56781620|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781621|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781622|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56781623|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
56492612|NCT04790045|Venetoclax|venetoclax|mesh-list
56781624|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
56054203|NCT01882868|Antidotes|antidotes|mesh-ancestor
56086758|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56086759|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
56086760|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56086761|NCT05064319|Gabapentin|gabapentin|mesh-list
56086762|NCT05064319|Analgesics|analgesics|mesh-ancestor
56086763|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
56086764|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086765|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086766|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
56086767|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56086768|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56086769|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086770|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56086771|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56086772|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56086773|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086796|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56086797|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086798|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56086799|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56086800|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086801|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
56086802|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56086803|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56086804|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56086805|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
56086806|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086807|NCT05451290|Gemcitabine|gemcitabine|mesh-list
56086808|NCT05451290|Tegafur|tegafur|mesh-list
56086809|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
56086810|NCT05451290|Apatinib|apatinib|mesh-list
56086811|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56086812|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
56086813|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086814|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086815|NCT05451290|Antiviral Agents|antiviral agents|mesh-ancestor
56086816|NCT05451290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086817|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086818|NCT05451290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56086819|NCT05451290|Immunologic Factors|immunologic factors|mesh-ancestor
56086820|NCT05451290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086821|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56086823|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56086824|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56086825|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086826|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
56193668|NCT01488838|Cisplatin|cisplatin|mesh-list
56193669|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193670|NCT01488955|Fosfomycin|fosfomycin|mesh-list
56193671|NCT01488955|Ibuprofen|ibuprofen|mesh-list
56193672|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56086889|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56086890|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
56086891|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814108|NCT01657877|Calcium|calcium|mesh-list
56086892|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086893|NCT04747496|Edoxaban|edoxaban|mesh-list
56781625|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56781626|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56781627|NCT00789503|Vitamin D|vitamin d|mesh-list
56781628|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
56781629|NCT00789503|Calcium|calcium|mesh-list
56781630|NCT00789503|Vitamins|vitamins|mesh-ancestor
56781631|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
56781632|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781633|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56781634|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56781635|NCT00797303|Bevacizumab|bevacizumab|mesh-list
56781636|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56781637|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781638|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56781639|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56781640|NCT00797303|Growth Substances|growth substances|mesh-ancestor
56781641|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781642|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
56781643|NCT00661193|Paclitaxel|paclitaxel|mesh-list
56781644|NCT00661193|Carboplatin|carboplatin|mesh-list
56781645|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56781646|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56781647|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781648|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
56781649|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
56781650|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
56781651|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781652|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56781653|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781654|NCT00801047|Remifentanil|remifentanil|mesh-list
56781655|NCT00801047|Bupivacaine|bupivacaine|mesh-list
56781657|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
56781671|NCT00801281|Doxorubicin|doxorubicin|mesh-list
56781672|NCT00801281|Vincristine|vincristine|mesh-list
56781673|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781674|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
56781675|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781676|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781677|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56781678|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
56781679|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781680|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781681|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56781682|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56781683|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56781684|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56781685|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56781686|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781687|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56781688|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
56086894|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56086895|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
56086896|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56086897|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
56086898|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086899|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086900|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
56086901|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
56086902|NCT05451121|Propofol|propofol|mesh-list
56086904|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086905|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086906|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56086907|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
56086933|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
56086934|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56086935|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56086936|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56086937|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56086938|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086939|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
56086940|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086941|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086942|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56086943|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086944|NCT05450042|Paclitaxel|paclitaxel|mesh-list
56086945|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56086946|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086947|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56086948|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
56086949|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56086950|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086951|NCT05447936|Vitamin D|vitamin d|mesh-list
56086952|NCT05447936|Vitamins|vitamins|mesh-ancestor
56086953|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
56086954|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086955|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56086986|NCT02230332|Alendronate|alendronate|mesh-list
56086987|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55783634|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
56781689|NCT00801281|Hormones|hormones|mesh-ancestor
56781690|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781691|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56781692|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56781693|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
56781694|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
56781695|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
56781696|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56781697|NCT00801515|Maraviroc|maraviroc|mesh-list
56781698|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56492671|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781699|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56781700|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781701|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56781702|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56781703|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
56781704|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781705|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56781707|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56781708|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
56781709|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56781710|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781711|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56781712|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56781713|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
56781714|NCT00797771|Insulin|insulin|mesh-list
56086988|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086989|NCT05447780|Anesthetics|anesthetics|mesh-list
56086990|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086991|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086992|NCT05447702|Paclitaxel|paclitaxel|mesh-list
56086993|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
56086994|NCT05447702|Apatinib|apatinib|mesh-list
56086995|NCT05447702|Epirubicin|epirubicin|mesh-list
56086996|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56086997|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086998|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
56086999|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
56087027|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087028|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
56087029|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56087030|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56087031|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087033|NCT05449483|Cisplatin|cisplatin|mesh-list
56087034|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56087035|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087036|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
56193673|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56781715|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56781716|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781717|NCT00793559|Terlipressin|terlipressin|mesh-list
56781718|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56781719|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56781720|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56781721|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
56781722|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
56781723|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56781724|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56781725|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781726|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781727|NCT00798083|Lidocaine|lidocaine|mesh-list
56781728|NCT00798083|Ketamine|ketamine|mesh-list
56781729|NCT00798083|Amitriptyline|amitriptyline|mesh-list
56781730|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
56193675|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
56193676|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193677|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193678|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193679|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56193680|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56193681|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193682|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193683|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56193684|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193685|NCT01489059|Ipilimumab|ipilimumab|mesh-list
56193686|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56193687|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193688|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56213206|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56087037|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
56087038|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
56087039|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087041|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56087042|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087043|NCT04806919|Progesterone|progesterone|mesh-list
56087046|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087076|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087077|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087078|NCT00370201|Colchicine|colchicine|mesh-list
56087079|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
56087080|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087081|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
56087082|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
56087083|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
56087084|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087085|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087086|NCT05448781|Paclitaxel|paclitaxel|mesh-list
56087087|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56087088|NCT05448781|Carboplatin|carboplatin|mesh-list
56087089|NCT05448781|Pemetrexed|pemetrexed|mesh-list
56087090|NCT05448781|Endostatins|endostatins|mesh-list
56087091|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56087092|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087125|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087127|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56087128|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56087129|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
56087130|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781731|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
56781732|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781733|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781734|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
56781735|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781736|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56781737|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56087131|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56087132|NCT03233347|Nivolumab|nivolumab|mesh-list
56087166|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
56087167|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56087168|NCT03036488|Paclitaxel|paclitaxel|mesh-list
56087169|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
56087170|NCT03036488|Carboplatin|carboplatin|mesh-list
56087171|NCT03036488|Doxorubicin|doxorubicin|mesh-list
56087172|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
56087173|NCT03036488|Epirubicin|epirubicin|mesh-list
56087174|NCT03036488|Lenograstim|lenograstim|mesh-list
56193689|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193690|NCT01489072|Remifentanil|remifentanil|mesh-list
56193691|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56193692|NCT01489072|Narcotics|narcotics|mesh-ancestor
56193693|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56087175|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56087176|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087177|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
56087178|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
56087209|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56087210|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56087211|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087212|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
56087213|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087215|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56087216|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56087217|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56087218|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
56087219|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087220|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087221|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087222|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
56087257|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087258|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56087259|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087260|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56087261|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56087262|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56087263|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087295|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56087296|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
56087297|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087298|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56087299|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
56087300|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087301|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087302|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56087333|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
56087334|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
56087335|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
56087336|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087337|NCT05202158|Gentamicins|gentamicins|mesh-list
56087338|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56087339|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087340|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56087342|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087343|NCT00370370|Triamcinolone|triamcinolone|mesh-list
56087344|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56087345|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56781738|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56781739|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56781740|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781741|NCT00798083|Analgesics|analgesics|mesh-ancestor
56781742|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56781743|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56781744|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
56781745|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56781746|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56781747|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781748|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56781749|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
56781750|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56781751|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56781752|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56781753|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56781754|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
56781755|NCT00798395|Zopiclone|zopiclone|mesh-list
56781756|NCT00798395|Mirtazapine|mirtazapine|mesh-list
56781757|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56087346|NCT00370370|Bevacizumab|bevacizumab|mesh-list
56087379|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
56087380|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56087381|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
56087382|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087383|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087384|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
56087385|NCT00370591|Fluticasone|fluticasone|mesh-list
56087387|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56087388|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087408|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087409|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087410|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56087411|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
56087412|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56193694|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193695|NCT01489072|Analgesics|analgesics|mesh-ancestor
56193696|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
56193697|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193698|NCT01489124|Imipenem|imipenem|mesh-list
56193699|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56193700|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193701|NCT01489137|Remifentanil|remifentanil|mesh-list
56193702|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56193703|NCT01489137|Narcotics|narcotics|mesh-ancestor
56193704|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193705|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193706|NCT01489137|Analgesics|analgesics|mesh-ancestor
56193707|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
56193708|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193709|NCT01489202|Cobalt|cobalt|mesh-list
56193710|NCT01489202|Chromium|chromium|mesh-list
56193711|NCT01489202|Everolimus|everolimus|mesh-list
56193712|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193713|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56781758|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781759|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781760|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
56781761|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56781762|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56781763|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
56781764|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
56193714|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
56193715|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193716|NCT01489202|Trace Elements|trace elements|mesh-ancestor
56193717|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
56193718|NCT01489228|Benzonidazole|benzonidazole|mesh-list
56193719|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193720|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
56193721|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193722|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56087413|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
56087414|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087415|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087416|NCT00392756|Hormones|hormones|mesh-list
56087417|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087418|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087419|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56087420|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56087421|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087422|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087423|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
56087424|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087425|NCT03908593|Pantoprazole|pantoprazole|mesh-list
56087426|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56087427|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087428|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56087429|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087430|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193723|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56193724|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56193725|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087433|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087434|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
56087435|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
56087436|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087437|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087438|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087439|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
56087440|NCT04027322|Hormones|hormones|mesh-ancestor
56087441|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087452|NCT00371072|Mitomycin|mitomycin|mesh-list
56087453|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56087454|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087455|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
56087456|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087457|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56087458|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087459|NCT02582905|Choline|choline|mesh-list
56087460|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56087461|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
56087462|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56087463|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
56087464|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087465|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087466|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56087467|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
56087468|NCT05454332|Caffeine|caffeine|mesh-list
56087469|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56087470|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087471|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56781765|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781766|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781767|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56781768|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56781769|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56781770|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56054342|NCT02988908|Donepezil|donepezil|mesh-list
56087472|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087473|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087474|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56087475|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56087476|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
56087477|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087478|NCT03821857|Corticosterone|corticosterone|mesh-list
56087479|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087480|NCT03924518|Granisetron|granisetron|mesh-list
56087481|NCT03924518|Serotonin|serotonin|mesh-list
56087482|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
56087483|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
56087484|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087485|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087518|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
56087519|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087520|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087521|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56087522|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
56087523|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087524|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087525|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56087526|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56087527|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
56087528|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087529|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56087530|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
56087556|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56087557|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087558|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56087559|NCT04891718|Nivolumab|nivolumab|mesh-list
56087560|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087561|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087562|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56087563|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087564|NCT03770689|Capecitabine|capecitabine|mesh-list
56087565|NCT03770689|Peposertib|peposertib|mesh-list
56087566|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56087567|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
56193726|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56087570|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56087571|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087572|NCT00371306|Metformin|metformin|mesh-list
56087573|NCT00371306|Glyburide|glyburide|mesh-list
56087574|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56087575|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087576|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
56087577|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
56087578|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56087615|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56087650|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087652|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56087653|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087686|NCT05055050|Imiquimod|imiquimod|mesh-list
56087687|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56087688|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
56087689|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087690|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087691|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
56087692|NCT03698461|Leucovorin|leucovorin|mesh-list
56087693|NCT03698461|Bevacizumab|bevacizumab|mesh-list
56781771|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56781772|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
56781773|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56781774|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56781775|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
56781776|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56781777|NCT00801905|Nepafenac|nepafenac|mesh-list
56781778|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56781779|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56781780|NCT00801905|Analgesics|analgesics|mesh-ancestor
56781781|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
56781782|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781783|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781784|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56781785|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781786|NCT00658541|Zolpidem|zolpidem|mesh-list
56781787|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56781788|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56781789|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56781790|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781791|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56781792|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
56781793|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
56781794|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781795|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087721|NCT04852484|Analgesics|analgesics|mesh-ancestor
56087722|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
56087723|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087724|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087725|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56087726|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56087727|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
56087728|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56087729|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56087730|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56087731|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087732|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087733|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56087734|NCT04852484|Narcotics|narcotics|mesh-ancestor
56087735|NCT04809662|Imiquimod|imiquimod|mesh-list
56087736|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56087737|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
56087738|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087739|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087740|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
56087741|NCT02196324|Serlopitant|serlopitant|mesh-list
56087742|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56087743|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781796|NCT00048061|Vitamin D|vitamin d|mesh-list
56781797|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
56781798|NCT00048061|Calcium|calcium|mesh-list
56781799|NCT00048061|Vitamins|vitamins|mesh-ancestor
56087777|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
56087778|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
56087779|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56087780|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087781|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
56087782|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087783|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56087814|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087815|NCT05378971|Pomalidomide|pomalidomide|mesh-list
56087816|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
56087817|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087818|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56087819|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56087820|NCT05378971|Growth Substances|growth substances|mesh-ancestor
56087821|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
56087822|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087823|NCT04337450|Lamivudine|lamivudine|mesh-list
56087824|NCT04337450|Dolutegravir|dolutegravir|mesh-list
56087825|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56193729|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56193730|NCT01489319|Analgesics|analgesics|mesh-ancestor
56193731|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
56087927|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087928|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087929|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56087963|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56087964|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56087965|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56087966|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
56087967|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087968|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087969|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56088006|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56088007|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088008|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
56088009|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
56088010|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088011|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56088012|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
56088013|NCT05032183|Hormones|hormones|mesh-ancestor
56088014|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088015|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56088016|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
56088017|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088050|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56088051|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088052|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
56088053|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
56088054|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088055|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
56088056|NCT03559868|Digoxin|digoxin|mesh-list
56088057|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56088058|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56088059|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088060|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088082|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
56088083|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088084|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088085|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088087|NCT02958800|Risperidone|risperidone|mesh-list
56088088|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56088089|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
56088090|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56088091|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
56088092|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088093|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088094|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088095|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56781800|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
56781801|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781802|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56781803|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56781804|NCT00802139|Iron|iron|mesh-list
56781805|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56781806|NCT00802139|Trace Elements|trace elements|mesh-ancestor
56781807|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
56781808|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781809|NCT00802139|Hematinics|hematinics|mesh-ancestor
56781810|NCT00802217|Capsaicin|capsaicin|mesh-list
56781811|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
56781812|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
56781813|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
56781814|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781815|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781816|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
56781817|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56781818|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56781819|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56781820|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
56781821|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781822|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781823|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781824|NCT00802373|Urological Agents|urological agents|mesh-ancestor
56781825|NCT03957109|Anesthetics|anesthetics|mesh-list
56781826|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088096|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088097|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56088098|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56088099|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
56088100|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
56088101|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
56088102|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088103|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56088104|NCT02958800|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56088105|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56088106|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56088107|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
56088108|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
56088109|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56088110|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088111|NCT04738045|Ritonavir|ritonavir|mesh-list
56088112|NCT04738045|Lopinavir|lopinavir|mesh-list
56088113|NCT04738045|Remdesivir|remdesivir|mesh-list
56088143|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088145|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
56088146|NCT04516915|Oseltamivir|oseltamivir|mesh-list
56088147|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
56781827|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781828|NCT00802451|Mesalamine|mesalamine|mesh-list
56781829|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56781830|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56781831|NCT00802451|Analgesics|analgesics|mesh-ancestor
56193732|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088148|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088149|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088150|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088151|NCT02753881|Doxorubicin|doxorubicin|mesh-list
56088152|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56088181|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
56088182|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088183|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56088184|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
56088185|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
56088186|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088187|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088188|NCT05320718|Ropivacaine|ropivacaine|mesh-list
56088189|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
56088190|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
56088191|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088192|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088193|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
56088194|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088195|NCT02739698|Paclitaxel|paclitaxel|mesh-list
56088196|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56088197|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088198|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
56088199|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
56088201|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088228|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088229|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088231|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
56088232|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
56088233|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56088234|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
56088235|NCT02194062|Hormones|hormones|mesh-ancestor
56088236|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088237|NCT02768558|Nivolumab|nivolumab|mesh-list
56088238|NCT02768558|Etoposide|etoposide|mesh-list
56088239|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088240|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088241|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56088242|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088243|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56088244|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56088245|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56088246|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088247|NCT02192970|Bevacizumab|bevacizumab|mesh-list
56088248|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088249|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088250|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56088251|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56088284|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
56088285|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088286|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
56088287|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56088288|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56088289|NCT04336891|Estradiol|estradiol|mesh-list
56088290|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56088291|NCT04336891|Testosterone|testosterone|mesh-list
56088292|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
56088293|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
56088294|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56088295|NCT04336891|Estrogens|estrogens|mesh-ancestor
56088326|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088327|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088329|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054408|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56054409|NCT02299206|Protective Agents|protective agents|mesh-ancestor
56054410|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054421|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
56054422|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054423|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
55896044|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896045|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
55896046|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896047|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56781832|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
56781833|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781834|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781835|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56781836|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781837|NCT03956953|BMS-986165|bms-986165|mesh-list
56781838|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
56781839|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56781840|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781841|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781842|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
56781843|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56781844|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781845|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
56781846|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56781847|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088330|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56088331|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56088332|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56088333|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56088334|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088335|NCT02766517|Capsaicin|capsaicin|mesh-list
56193733|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193734|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088366|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56088367|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
56088368|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088369|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088370|NCT00372008|Testosterone|testosterone|mesh-list
56088371|NCT00372008|Androgens|androgens|mesh-ancestor
56088378|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088379|NCT04337593|Pegaspargase|pegaspargase|mesh-list
56088380|NCT04337593|Basiliximab|basiliximab|mesh-list
56088409|NCT02192190|Celecoxib|celecoxib|mesh-list
56088410|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56088411|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56088412|NCT02192190|Analgesics|analgesics|mesh-ancestor
56781848|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56781849|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56781850|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781851|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781852|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781853|NCT01097317|Carboplatin|carboplatin|mesh-list
56781854|NCT01097317|Vinorelbine|vinorelbine|mesh-list
56781855|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781856|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56781857|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
56781858|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
56781859|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
56781860|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781861|NCT01095679|Baclofen|baclofen|mesh-list
56781862|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56054427|NCT02298192|Liraglutide|liraglutide|mesh-list
56088413|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
56088414|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088415|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088416|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088417|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55741509|NCT04521751|Acarbose|acarbose|mesh-list
56088418|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56088419|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56088420|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088421|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088422|NCT02748889|Carboplatin|carboplatin|mesh-list
56088423|NCT02748889|Etoposide|etoposide|mesh-list
56088424|NCT02748889|Atezolizumab|atezolizumab|mesh-list
56088457|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
56088458|NCT02973776|Hormones|hormones|mesh-ancestor
56088459|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088460|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088461|NCT02161458|Dexetimide|dexetimide|mesh-list
56088462|NCT02161458|Citalopram|citalopram|mesh-list
56088463|NCT02161458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56088464|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56088465|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56088499|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56088500|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56088501|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56088502|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56088503|NCT04737889|Growth Substances|growth substances|mesh-ancestor
56088504|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
56088540|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
56088567|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
56088569|NCT04334629|Ibuprofen|ibuprofen|mesh-list
56088570|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56088571|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56088572|NCT04334629|Analgesics|analgesics|mesh-ancestor
56088573|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
56088574|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088575|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088576|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088577|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56088578|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56088579|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088580|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781863|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781864|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56781865|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781866|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56781867|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
56781868|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
56781869|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088581|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56088582|NCT05158153|Furosemide|furosemide|mesh-list
56088583|NCT05158153|Diuretics|diuretics|mesh-ancestor
56088614|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56088615|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56088616|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
56088617|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088618|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193735|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56193736|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56193737|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088619|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088620|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
56088621|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56088701|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56088702|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088703|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56088704|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
56088731|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088732|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56088734|NCT00966914|Docetaxel|docetaxel|mesh-list
56088735|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56088736|NCT00966914|Cisplatin|cisplatin|mesh-list
56088737|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
56088738|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56088739|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088740|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
56088741|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
56088742|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
56088743|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088744|NCT00966914|Protective Agents|protective agents|mesh-ancestor
56088745|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088746|NCT03229057|Metformin|metformin|mesh-list
56088747|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56088748|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088749|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
56088750|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56088751|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56088781|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
56088783|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088784|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
56088785|NCT05063396|Anesthetics|anesthetics|mesh-list
56088786|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088787|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088788|NCT05063396|Narcotics|narcotics|mesh-ancestor
56088789|NCT05063396|Analgesics|analgesics|mesh-ancestor
56088790|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
56088791|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088792|NCT05055752|Aspirin|aspirin|mesh-list
56088828|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
56088829|NCT04181515|Yohimbine|yohimbine|mesh-list
56088830|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088831|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
56088832|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
56088854|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088855|NCT04180969|Urological Agents|urological agents|mesh-ancestor
56088856|NCT04101877|Bevacizumab|bevacizumab|mesh-list
56088857|NCT04101877|Aflibercept|aflibercept|mesh-list
56088858|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088859|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088860|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56088861|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56781870|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781871|NCT00794261|Lenograstim|lenograstim|mesh-list
56781872|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56781873|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
56781874|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781875|NCT03953287|Acetaminophen|acetaminophen|mesh-list
56781876|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56781877|NCT03953287|Analgesics|analgesics|mesh-ancestor
56781878|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
56781879|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781880|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781881|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
56781882|NCT01097551|Phenylephrine|phenylephrine|mesh-list
56781883|NCT01097551|Acetylcholine|acetylcholine|mesh-list
56781884|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
56781885|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
56781886|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56781887|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
56781888|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56781889|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781890|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781891|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56781892|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
56781893|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
56781894|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781895|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
56054448|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
56088862|NCT04101877|Growth Substances|growth substances|mesh-ancestor
56088863|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088864|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
56088865|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
56088866|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
56088867|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193743|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193744|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56193745|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56193746|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193747|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193748|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56193749|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
56193750|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193751|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56088868|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088869|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088870|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
56088871|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56088872|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088873|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088874|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
56781896|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56781897|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
56781898|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
56781899|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56781900|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56781901|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56781902|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
56781903|NCT01097551|Protective Agents|protective agents|mesh-ancestor
56781904|NCT00803309|Interferons|interferons|mesh-list
56781905|NCT00803309|Ribavirin|ribavirin|mesh-list
56781906|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
56781907|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
56781908|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56781909|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781910|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
56781911|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781912|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
56781913|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781914|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
56781915|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781916|NCT03953209|Spironolactone|spironolactone|mesh-list
56781917|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56781918|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
56781919|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781920|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781921|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56781922|NCT03953209|Diuretics|diuretics|mesh-ancestor
56781923|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
56781924|NCT01583959|Folic Acid|folic acid|mesh-list
56781925|NCT01583959|Hematinics|hematinics|mesh-ancestor
56781926|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
56781928|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
56781929|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781930|NCT00803387|Travoprost|travoprost|mesh-list
56781931|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56781932|NCT02553551|Vitamins|vitamins|mesh-list
56781936|NCT00803465|Xhance|xhance|mesh-list
56781938|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56781939|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
56781940|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56781941|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781942|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56781943|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
56781944|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
56781945|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56781946|NCT00803699|Selenium|selenium|mesh-list
56781947|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
56781948|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781949|NCT00803699|Protective Agents|protective agents|mesh-ancestor
56781950|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781951|NCT00803699|Trace Elements|trace elements|mesh-ancestor
56781952|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
56781953|NCT00798785|Rituximab|rituximab|mesh-list
56781954|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56781955|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781956|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
56781957|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781958|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56781959|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56781960|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56781961|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781962|NCT01095991|Incretins|incretins|mesh-ancestor
56781963|NCT01095991|Hormones|hormones|mesh-ancestor
56781964|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56781965|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56781966|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
56781967|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56781968|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781969|NCT00794807|Alefacept|alefacept|mesh-list
56088875|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56088876|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088877|NCT04762381|Dexamethasone|dexamethasone|mesh-list
56088878|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
56088879|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56088880|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088881|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
56088911|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
56088913|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088914|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56781970|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
56781971|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
56781972|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781973|NCT00794885|Folic Acid|folic acid|mesh-list
56781974|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
56781975|NCT00794885|Enalapril|enalapril|mesh-list
56781976|NCT00794885|Enalaprilat|enalaprilat|mesh-list
56781977|NCT00794885|Maleic acid|maleic acid|mesh-list
56781978|NCT00794885|Hematinics|hematinics|mesh-ancestor
56781979|NCT00794885|Vitamins|vitamins|mesh-ancestor
56781980|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
56781981|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781982|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088915|NCT04900220|Protective Agents|protective agents|mesh-ancestor
56088916|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56088917|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088918|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56088919|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
56088920|NCT04333628|Chloroquine|chloroquine|mesh-list
56088921|NCT04333628|Amebicides|amebicides|mesh-ancestor
56088922|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56088923|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56088924|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088925|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
56088926|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56088947|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088948|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56088949|NCT02923466|Interferon-beta|interferon-beta|mesh-list
56088950|NCT02923466|Avelumab|avelumab|mesh-list
56088951|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088952|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088953|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
56088954|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088955|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
56088956|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088957|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
56088958|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
56088959|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088960|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
56088961|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088962|NCT00199862|Antibodies|antibodies|mesh-list
56088963|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
56088964|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193752|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56193753|NCT01489371|Growth Substances|growth substances|mesh-ancestor
56193754|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
56193755|NCT01489410|Ethanol|ethanol|mesh-list
56193756|NCT01489410|Doxorubicin|doxorubicin|mesh-list
56088965|NCT05051527|Silymarin|silymarin|mesh-list
56088966|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
56088967|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088968|NCT05051527|Protective Agents|protective agents|mesh-ancestor
56088969|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088971|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56088972|NCT00372853|Tremelimumab|tremelimumab|mesh-list
56088973|NCT00372853|Ipilimumab|ipilimumab|mesh-list
56088974|NCT00372853|Sunitinib|sunitinib|mesh-list
56088975|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088976|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088977|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56088978|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088979|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56088980|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56088981|NCT00372853|Growth Substances|growth substances|mesh-ancestor
56088982|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088983|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
56088984|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56781983|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56781984|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56781985|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
56781986|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56781987|NCT00803933|Pentamidine|pentamidine|mesh-list
56781988|NCT00803933|Pafuramidine|pafuramidine|mesh-list
56781989|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
56054547|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
56089048|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
56089049|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56089050|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089051|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
56089052|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089053|NCT02902172|Acetaminophen|acetaminophen|mesh-list
56089055|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56089056|NCT02902172|Analgesics|analgesics|mesh-ancestor
56089057|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
56089058|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089059|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089060|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
56089061|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56089062|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089063|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56089089|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089091|NCT02582125|Nivolumab|nivolumab|mesh-list
56089092|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56089093|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089094|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56089095|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089096|NCT02785406|Suvorexant|suvorexant|mesh-list
56089097|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56089098|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56089099|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089100|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089101|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56089102|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089103|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089104|NCT02062489|Tamoxifen|tamoxifen|mesh-list
56089105|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56089106|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
56089107|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089108|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089109|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089137|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
56089139|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56089140|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56089141|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
56089142|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089143|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
56089144|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
56089145|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089146|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193757|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56193758|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
56193759|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56193760|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193761|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56089147|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56089148|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
56089149|NCT02790788|Hormones|hormones|mesh-ancestor
56089150|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089151|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56089152|NCT02790788|Protective Agents|protective agents|mesh-ancestor
56089153|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089154|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56781990|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56781991|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56781992|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56781993|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56781994|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
56781995|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56781996|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56781997|NCT00656669|Paclitaxel|paclitaxel|mesh-list
56781998|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
56781999|NCT00656669|Doxorubicin|doxorubicin|mesh-list
56782000|NCT00656669|Sunitinib|sunitinib|mesh-list
56782001|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56782002|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782003|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56089155|NCT02915744|Gemcitabine|gemcitabine|mesh-list
56089187|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
56089188|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56089189|NCT02781571|Velpatasvir|velpatasvir|mesh-list
56089190|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
56089191|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089192|NCT02918630|Nicotine|nicotine|mesh-list
56089193|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56089194|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
56089195|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089196|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089197|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56089198|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56089199|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
56089200|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089201|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089202|NCT02781649|Ribavirin|ribavirin|mesh-list
56089203|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
56089204|NCT02781649|Grazoprevir|grazoprevir|mesh-list
56089205|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56089206|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
56089207|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089208|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
56089209|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089210|NCT01821781|Fludarabine|fludarabine|mesh-list
56089211|NCT01821781|Melphalan|melphalan|mesh-list
56089230|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
56089231|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089232|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089233|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56089234|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56089235|NCT03002012|Fluconazole|fluconazole|mesh-list
56089237|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
56089238|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56089239|NCT03002012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56089240|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56089241|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56089242|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089243|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089244|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
56089245|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089246|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
56089247|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089248|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56089249|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56089250|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089251|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56089252|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
56193762|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55783635|NCT03077009|Protective Agents|protective agents|mesh-ancestor
56782004|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56782005|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56782006|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782007|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782008|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
56782009|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782010|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782011|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56782012|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
56782013|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56782014|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56782015|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56193764|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089253|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089254|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56089255|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56089256|NCT00373646|Thalidomide|thalidomide|mesh-list
56089257|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56089259|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089260|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
56089261|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56089262|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089263|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56089264|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56089265|NCT00373646|Growth Substances|growth substances|mesh-ancestor
56089266|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
56089290|NCT03001843|Narcotics|narcotics|mesh-list
56089291|NCT03001843|Analgesics|analgesics|mesh-ancestor
56089292|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
56089293|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089294|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089295|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56089296|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56089297|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
56089298|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
56089299|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089300|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56089301|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56089302|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089303|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089304|NCT02785159|Tazarotene|tazarotene|mesh-list
56089305|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
56089306|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
56089307|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
56089308|NCT02786719|Doxorubicin|doxorubicin|mesh-list
56089309|NCT02786719|Etoposide|etoposide|mesh-list
56089310|NCT02786719|Vincristine|vincristine|mesh-list
56089311|NCT02786719|Topotecan|topotecan|mesh-list
56089312|NCT02786719|Sargramostim|sargramostim|mesh-list
56089313|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56089314|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
56089315|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089316|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56089317|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56089318|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
56089319|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089320|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089391|NCT00374348|Aripiprazole|aripiprazole|mesh-list
56089462|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56089463|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
56089464|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782016|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56782017|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782018|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56782019|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56782020|NCT00656669|Growth Substances|growth substances|mesh-ancestor
56782021|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
56782022|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56782023|NCT00799175|Ketorolac|ketorolac|mesh-list
56782024|NCT00799175|Epinephrine|epinephrine|mesh-list
56782025|NCT00799175|Ropivacaine|ropivacaine|mesh-list
56782026|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
56782027|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
56782028|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56782029|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782030|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
56782031|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782032|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56782033|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56089465|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56089498|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56089499|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089500|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56089501|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
56089502|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089503|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56089504|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56089505|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56089506|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
56089507|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089508|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089509|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56089540|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089541|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089542|NCT03025945|Nepafenac|nepafenac|mesh-list
56193765|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56193766|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089543|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56089544|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56089545|NCT03025945|Analgesics|analgesics|mesh-ancestor
56089546|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
56089547|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089548|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089549|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089550|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56089551|NCT02937506|Fentanyl|fentanyl|mesh-list
56089552|NCT02937506|Midazolam|midazolam|mesh-list
56089553|NCT02937506|Propofol|propofol|mesh-list
56089554|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56089556|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089584|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
56089585|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089586|NCT03022526|Fentanyl|fentanyl|mesh-list
56089587|NCT03022526|Bupivacaine|bupivacaine|mesh-list
56089588|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
56089589|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
56089590|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089591|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089592|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
56782034|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
56782035|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782036|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782037|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56782038|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56782039|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
56782040|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56782041|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
56782042|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
56782043|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
56782044|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56782045|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56782046|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56782047|NCT00799175|Analgesics|analgesics|mesh-ancestor
56782048|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782049|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782050|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56782051|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782052|NCT00656513|Pilocarpine|pilocarpine|mesh-list
56782053|NCT00656513|Miotics|miotics|mesh-ancestor
56782054|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
56782055|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782056|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782057|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56782058|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56782059|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
56782060|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089593|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089594|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56089595|NCT03022526|Narcotics|narcotics|mesh-ancestor
56089596|NCT03022526|Analgesics|analgesics|mesh-ancestor
56089597|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56089598|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56089599|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
56089600|NCT02794441|Dexamethasone|dexamethasone|mesh-list
56089601|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089602|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
56089603|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
56089604|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089605|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089606|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56089607|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
56089608|NCT02794441|Hormones|hormones|mesh-ancestor
56089631|NCT03031795|Ketorolac|ketorolac|mesh-list
56089632|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56089633|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56089634|NCT03031795|Analgesics|analgesics|mesh-ancestor
56089635|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
56089636|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089637|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782061|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782062|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56782063|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
56782064|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782065|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782066|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56782067|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782068|NCT00804245|Choline|choline|mesh-list
56782069|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
56782070|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56782071|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
56782072|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089638|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089639|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56089640|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56089641|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089642|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089643|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
56089644|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56089645|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089646|NCT02909959|Sulforaphane|sulforaphane|mesh-list
56089647|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56089648|NCT02909959|Protective Agents|protective agents|mesh-ancestor
56089649|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089650|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089651|NCT00373802|Phenylephrine|phenylephrine|mesh-list
56089652|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
56089653|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56089654|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
56089655|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
56089656|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089657|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089658|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
56089693|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
56089694|NCT03032965|Protective Agents|protective agents|mesh-ancestor
56089695|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
56089696|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
56089697|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193767|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193768|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193769|NCT01489488|Riociguat|riociguat|mesh-list
56193770|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
56193771|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193772|NCT01489566|Fluorouracil|fluorouracil|mesh-list
56089698|NCT03030638|Olodaterol|olodaterol|mesh-list
56089699|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56089742|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
56089743|NCT03035929|BB 1101|bb 1101|mesh-list
56089744|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089745|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
56089746|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
56089747|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089748|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089752|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089753|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089754|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089755|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
56089756|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089757|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089759|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56089760|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089761|NCT02831816|Ethanol|ethanol|mesh-list
56782073|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56782074|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56782075|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
56782076|NCT00804401|Naproxen|naproxen|mesh-list
56054633|NCT01085643|Lubiprostone|lubiprostone|mesh-list
56089762|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
56089763|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56089764|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56089765|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089766|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089767|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089768|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
56089769|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
56089770|NCT03036163|Macozinone|macozinone|mesh-list
56089771|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
56089772|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56089773|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089774|NCT02953886|Fluorides|fluorides|mesh-list
56089775|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
56089776|NCT02953886|Protective Agents|protective agents|mesh-ancestor
56089777|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089778|NCT02802241|Peppermint oil|peppermint oil|mesh-list
56089779|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
56089814|NCT02954198|Hormones|hormones|mesh-ancestor
56089815|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089816|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089817|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089818|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089819|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56089820|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
56089821|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56089822|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817029|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56089823|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089824|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56089825|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56089826|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
56089827|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56089828|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089829|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
56089830|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
56089831|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089832|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56089833|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56089834|NCT02954198|Protective Agents|protective agents|mesh-ancestor
56089835|NCT02956070|Dexamethasone|dexamethasone|mesh-list
56089836|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
56089837|NCT02956070|BB 1101|bb 1101|mesh-list
56193774|NCT01489566|Mitomycin|mitomycin|mesh-list
56193775|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
56193776|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193777|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56089838|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089839|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
56089840|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
56089873|NCT02918617|Fluorides|fluorides|mesh-list
56089874|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
56089875|NCT02918617|Protective Agents|protective agents|mesh-ancestor
56089876|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089877|NCT02839772|Glycerol|glycerol|mesh-list
56089878|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56089879|NCT02839772|Protective Agents|protective agents|mesh-ancestor
56089880|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089881|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56089882|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56089922|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089923|NCT02964416|Tramadol|tramadol|mesh-list
56089924|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56089927|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089928|NCT02964416|Analgesics|analgesics|mesh-ancestor
56089929|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
56089930|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089931|NCT02812771|Efinaconazole|efinaconazole|mesh-list
56782077|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56782078|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56782079|NCT00804401|Analgesics|analgesics|mesh-ancestor
56547692|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56782080|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
56782081|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782082|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782083|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782084|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782085|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
56089932|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
56089933|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089934|NCT02969876|Vortioxetine|vortioxetine|mesh-list
56089935|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
56089967|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56089968|NCT02817763|Analgesics|analgesics|mesh-ancestor
56089969|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
56089970|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089971|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817177|NCT04891484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56089972|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089973|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56090042|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56090043|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090044|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
56090045|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56090046|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
56090141|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090142|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
56090143|NCT02935699|Promethazine|promethazine|mesh-list
56090144|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56090145|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56090146|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090147|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090148|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
56090149|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
56090150|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
56090151|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090152|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
56090153|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
56090154|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090155|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56090156|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
56090157|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
56090158|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090180|NCT00374881|Sorbitol|sorbitol|mesh-list
56090181|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56090182|NCT00374881|Narcotics|narcotics|mesh-ancestor
56090183|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090184|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090185|NCT00374881|Analgesics|analgesics|mesh-ancestor
56090186|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
56090187|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193778|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193779|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193780|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
56193781|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090188|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56090189|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
56090190|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
56090191|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
55817397|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56090192|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56090193|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
56090194|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
55783636|NCT04477525|Bupivacaine|bupivacaine|mesh-list
56782086|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56782087|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782088|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782089|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56782090|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
56782091|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56782092|NCT02553083|Amoxicillin|amoxicillin|mesh-list
56782093|NCT02553083|Doxycycline|doxycycline|mesh-list
56782094|NCT02553083|Esomeprazole|esomeprazole|mesh-list
56782095|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56782096|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782097|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
56782098|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56782099|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56782100|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56782101|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56782102|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56782103|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782104|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782105|NCT00804947|Melphalan|melphalan|mesh-list
56782106|NCT00804947|Busulfan|busulfan|mesh-list
56782107|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56782108|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
56782109|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782110|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782111|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56782112|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782113|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
56782114|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782115|NCT00806663|Sunitinib|sunitinib|mesh-list
56782116|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090195|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56090196|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56090197|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56090198|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
56090199|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090200|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090201|NCT00374881|Protective Agents|protective agents|mesh-ancestor
56090203|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090204|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
56090205|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56090206|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090207|NCT02846233|Metformin|metformin|mesh-list
56090239|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782117|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56782118|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56782119|NCT00806663|Growth Substances|growth substances|mesh-ancestor
56782120|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782121|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
56782122|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56782123|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782124|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782125|NCT00806741|Phenylephrine|phenylephrine|mesh-list
56782126|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
56782127|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56782128|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56782129|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
56782130|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
56782131|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782132|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782133|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
56782134|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56782135|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
56782136|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
56782137|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56782138|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56782139|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56782140|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
56782141|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782142|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054689|NCT03020030|Antidotes|antidotes|mesh-ancestor
56090241|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
56090242|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
56090243|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090244|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090245|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
56090246|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090247|NCT02997722|Ketamine|ketamine|mesh-list
56090248|NCT02997722|Analgesics|analgesics|mesh-ancestor
56090249|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
56090250|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090251|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090252|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56090253|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56090254|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
56090255|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
56090256|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090257|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56090283|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090284|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090285|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
56782143|NCT00806741|Protective Agents|protective agents|mesh-ancestor
56782144|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782145|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
56782146|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56782147|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782148|NCT00805649|Dexamethasone|dexamethasone|mesh-list
56782149|NCT00805649|Bevacizumab|bevacizumab|mesh-list
56782150|NCT00805649|Temazepam|temazepam|mesh-list
56782151|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56782152|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782153|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56782154|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56782155|NCT00805649|Growth Substances|growth substances|mesh-ancestor
56782156|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782157|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
56782158|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782159|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
56782160|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
56782161|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782162|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56782163|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
56782164|NCT00805649|Hormones|hormones|mesh-ancestor
56782165|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782196|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56782197|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56782198|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782199|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782200|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
56782201|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782202|NCT00809549|Lenograstim|lenograstim|mesh-list
56782203|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56782204|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
56782205|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782206|NCT00809627|Caffeine|caffeine|mesh-list
56782207|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56782208|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782209|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56090286|NCT02850601|Hormones|hormones|mesh-ancestor
56090287|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090288|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56090289|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090290|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
56090291|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56090292|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090293|NCT03057704|Lidocaine|lidocaine|mesh-list
56090294|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
56090295|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
56090296|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090297|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090298|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
56090299|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090300|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56090301|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56090302|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56090303|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56090304|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193783|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
56121554|NCT01780974|Protective Agents|protective agents|mesh-ancestor
56193784|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56193785|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193787|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
56193788|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193789|NCT01489592|Protective Agents|protective agents|mesh-ancestor
56090305|NCT02874092|Ticagrelor|ticagrelor|mesh-list
56090340|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
56090341|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
56090342|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55817551|NCT02279719|Sorafenib|sorafenib|mesh-list
56090343|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
56090344|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56090366|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56090368|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
56090369|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090370|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56090371|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
56090372|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090373|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56090374|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56090375|NCT03118466|Growth Substances|growth substances|mesh-ancestor
56090376|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
56090377|NCT03118466|Analgesics|analgesics|mesh-ancestor
56090393|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
56090394|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
56782210|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782211|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782212|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56782213|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56782214|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
56782215|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782216|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56782217|NCT00809705|Incretins|incretins|mesh-ancestor
56782218|NCT00809705|Hormones|hormones|mesh-ancestor
56782219|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782220|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782221|NCT00655499|Irinotecan|irinotecan|mesh-list
56782222|NCT00655499|Panitumumab|panitumumab|mesh-list
56782223|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56782224|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56782225|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782226|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090395|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090396|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090397|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56090398|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56090435|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
56090436|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
56090451|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56090453|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090454|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56090455|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56090456|NCT02946073|Buprenorphine|buprenorphine|mesh-list
56090457|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56090458|NCT02946073|Narcotics|narcotics|mesh-ancestor
56090459|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090460|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090461|NCT02946073|Analgesics|analgesics|mesh-ancestor
56090462|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
56090463|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090464|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56090465|NCT03071744|Fentanyl|fentanyl|mesh-list
56090466|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56090467|NCT03071744|Narcotics|narcotics|mesh-ancestor
56090468|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193790|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193792|NCT01489631|Gabapentin|gabapentin|mesh-list
56193793|NCT01489631|Bupivacaine|bupivacaine|mesh-list
56193794|NCT01489631|Ropivacaine|ropivacaine|mesh-list
56193795|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
56193796|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
56193797|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193798|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193799|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
56193800|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193801|NCT01489631|Analgesics|analgesics|mesh-ancestor
56193802|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
56193803|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56193804|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56090469|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090470|NCT03071744|Analgesics|analgesics|mesh-ancestor
56090471|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
56782227|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782228|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56782229|NCT00800267|Timolol|timolol|mesh-list
56493224|NCT00556608|Hylan|hylan|mesh-list
56782231|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56782232|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56782233|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
56782234|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782235|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782236|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782237|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56782238|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56782239|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56782240|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56782241|NCT00809939|Progesterone|progesterone|mesh-list
56782242|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56782243|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56782244|NCT00809939|Progestins|progestins|mesh-ancestor
56782245|NCT00809939|Hormones|hormones|mesh-ancestor
56782246|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782247|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054789|NCT03539744|Venetoclax|venetoclax|mesh-list
56090472|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090473|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56090474|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56090478|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56090479|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56090480|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56090481|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
56090482|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090483|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56090484|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56090485|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090486|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56090487|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56090488|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090490|NCT05404334|Hormones|hormones|mesh-ancestor
56090491|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817697|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
56090492|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090493|NCT00374894|Succimer|succimer|mesh-list
56090494|NCT00374894|Antidotes|antidotes|mesh-ancestor
56090495|NCT00374894|Protective Agents|protective agents|mesh-ancestor
56090496|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090547|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
56090548|NCT02860507|Neostigmine|neostigmine|mesh-list
56090549|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56090550|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090551|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090552|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
56090553|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783637|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
56782248|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56782249|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
56782250|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
56782251|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56782252|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56782253|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
56782254|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782255|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56782256|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56782257|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782258|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782259|NCT00807521|Dexamethasone|dexamethasone|mesh-list
56782260|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782261|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
56782262|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
56782263|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090554|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090555|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56090556|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
56090557|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090558|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56090559|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56090560|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56090561|NCT03082196|Fluorides|fluorides|mesh-list
56090562|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
56090563|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
56090564|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
56193805|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193806|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56193807|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56193808|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193809|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193810|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
56193811|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56193812|NCT01489631|Narcotics|narcotics|mesh-ancestor
56193813|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56193814|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56090565|NCT03082196|Protective Agents|protective agents|mesh-ancestor
56090566|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090567|NCT02861131|Neostigmine|neostigmine|mesh-list
56090568|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56090569|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090570|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090571|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
56090572|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090573|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090574|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56090575|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
56090576|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090577|NCT03136328|Edotreotide|edotreotide|mesh-list
56090578|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56090579|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090580|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56090581|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56090633|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090634|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56090636|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55813795|NCT02161731|Warfarin|warfarin|mesh-list
56090638|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782264|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782265|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56782266|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
56782267|NCT00807521|Hormones|hormones|mesh-ancestor
56054819|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090639|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56090640|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56090641|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
56090642|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56090643|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090644|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
56090645|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
56090646|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090647|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090648|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56090649|NCT02953873|Protective Agents|protective agents|mesh-ancestor
56090650|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
56090689|NCT03100123|Enoxaparin|enoxaparin|mesh-list
56090713|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090714|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56090715|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090716|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
56090717|NCT04611152|Aflibercept|aflibercept|mesh-list
56090718|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56090719|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56090720|NCT04611152|Growth Substances|growth substances|mesh-ancestor
56090721|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090722|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
56090723|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090724|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
56090725|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56090726|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
56090727|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090728|NCT03104725|Expectorants|expectorants|mesh-ancestor
56090729|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
56090730|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56090731|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
56193815|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
56193816|NCT01489644|Metformin|metformin|mesh-list
56090732|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090733|NCT03104725|Protective Agents|protective agents|mesh-ancestor
56090734|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090735|NCT03104725|Antidotes|antidotes|mesh-ancestor
56090736|NCT03154658|Ropivacaine|ropivacaine|mesh-list
56090737|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
56090738|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
56090739|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090740|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090741|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
56090742|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090743|NCT03098420|Dexamethasone|dexamethasone|mesh-list
56090772|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56090773|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090774|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090775|NCT00422617|Alefacept|alefacept|mesh-list
56090776|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
56090778|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090779|NCT03104738|Insulin|insulin|mesh-list
56090780|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56090781|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090782|NCT03163472|Anesthetics|anesthetics|mesh-list
56090783|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
56090784|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090785|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090786|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
56090787|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090788|NCT04468568|Terbutaline|terbutaline|mesh-list
56090789|NCT04468568|Atosiban|atosiban|mesh-list
56090790|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56090791|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
56090792|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090793|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090817|NCT03168308|Neostigmine|neostigmine|mesh-list
56782268|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782269|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56782270|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782271|NCT00800423|Timolol|timolol|mesh-list
56782272|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56782273|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782274|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56782275|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56782276|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
56782277|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782278|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782279|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56782280|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56782281|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56782282|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56782283|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56782284|NCT00651755|Prednisone|prednisone|mesh-list
56782285|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
56782286|NCT00651755|Rituximab|rituximab|mesh-list
56782287|NCT00651755|Doxorubicin|doxorubicin|mesh-list
56782288|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56782289|NCT00651755|Vincristine|vincristine|mesh-list
56782290|NCT00651755|Ondansetron|ondansetron|mesh-list
56782291|NCT00651755|Aprepitant|aprepitant|mesh-list
56782292|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782293|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
56054827|NCT01020903|Aprepitant|aprepitant|mesh-list
56090818|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56090819|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090820|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090821|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
56090822|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090823|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090824|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56090825|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
56090826|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090827|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56090828|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56090829|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56090830|NCT03109015|Sunitinib|sunitinib|mesh-list
56090831|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090832|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56090833|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56090834|NCT03109015|Growth Substances|growth substances|mesh-ancestor
56090835|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090836|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
56090837|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56090838|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110441|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782294|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782295|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782296|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56782297|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
56782298|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782299|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782300|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56782301|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56782302|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56782303|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56782304|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56782305|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782306|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782307|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
56782308|NCT00651755|Hormones|hormones|mesh-ancestor
56782309|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782310|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56782311|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56782312|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
56782313|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
56090839|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090840|NCT03115177|Doxycycline|doxycycline|mesh-list
56090841|NCT03115177|Cefazolin|cefazolin|mesh-list
56090842|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56090843|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090844|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
56090901|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
56090902|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090903|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090904|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090905|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56090906|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56090907|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56090908|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090909|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56193817|NCT01489644|Repaglinide|repaglinide|mesh-list
56193818|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193819|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193820|NCT01489683|Lidocaine|lidocaine|mesh-list
56193821|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
56193822|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
56193823|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193824|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193825|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
56193826|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193827|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56193828|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56193829|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56193830|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56090910|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56090911|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090912|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
56782314|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
56782315|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
56782316|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
56782317|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782318|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56782319|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
56782320|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
56782321|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56782322|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
56782323|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782324|NCT00651755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56782325|NCT00651755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56090913|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56090914|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56090915|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56090916|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
56090917|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090918|NCT03795350|Beclomethasone|beclomethasone|mesh-list
56090919|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
56090920|NCT03795350|Bromides|bromides|mesh-list
56090921|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
56090922|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56090923|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
56090924|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090925|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090926|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56090927|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
56090928|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56090929|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56090930|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56090931|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
56090932|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090966|NCT03503942|Metformin|metformin|mesh-list
56090967|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56090968|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090969|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
56090970|NCT03122587|Vitamins|vitamins|mesh-ancestor
56090971|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
56090972|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090973|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56090974|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56090982|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56090983|NCT02161146|Analgesics|analgesics|mesh-ancestor
56090984|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
56090985|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090986|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090987|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090988|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56090989|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56193831|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193833|NCT01489696|Mirabegron|mirabegron|mesh-list
56193834|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56193835|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56193836|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56193837|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
56193838|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193839|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193840|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193841|NCT01489696|Urological Agents|urological agents|mesh-ancestor
56193842|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56193843|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56193844|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56193845|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
56090990|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56782326|NCT00651755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56782327|NCT00651755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56782328|NCT00651755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56782329|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56782330|NCT00807755|Carboplatin|carboplatin|mesh-list
56782331|NCT00807755|Etoposide|etoposide|mesh-list
56782332|NCT00807755|Everolimus|everolimus|mesh-list
56782333|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782334|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56782335|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56782336|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56782337|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782338|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782339|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782340|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
56782341|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782342|NCT00813527|Fenofibrate|fenofibrate|mesh-list
56782343|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56782344|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
56782345|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782346|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56782347|NCT00810563|Bupivacaine|bupivacaine|mesh-list
56782348|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
56782349|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
56782350|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56782351|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782352|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
56782353|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782354|NCT00808145|Gemcitabine|gemcitabine|mesh-list
56782355|NCT00808145|Cisplatin|cisplatin|mesh-list
56090991|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56090992|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
56090993|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
56091025|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
56091026|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56091028|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
56091029|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
56091030|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56091031|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
56091032|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56091033|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
56091034|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091035|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091036|NCT03087578|Mirabegron|mirabegron|mesh-list
56091037|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56782356|NCT00808145|Sorafenib|sorafenib|mesh-list
56782357|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782358|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56782359|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
56782360|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782361|NCT00808145|Antiviral Agents|antiviral agents|mesh-ancestor
56782362|NCT00808145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782363|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782364|NCT00808145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782365|NCT00808145|Immunologic Factors|immunologic factors|mesh-ancestor
56782366|NCT00808145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782367|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56782368|NCT02552459|Sufentanil|sufentanil|mesh-list
56782369|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
56782371|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56782372|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56782373|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782374|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56782375|NCT02552459|Analgesics|analgesics|mesh-ancestor
56782376|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
56782377|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782378|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56782379|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56782380|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56091063|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56091064|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56091065|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56091067|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
56091068|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091069|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091070|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091071|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56091072|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56091073|NCT04736810|Gemcitabine|gemcitabine|mesh-list
56091074|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091075|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56091076|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
56091077|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091078|NCT04736810|Antiviral Agents|antiviral agents|mesh-ancestor
56091079|NCT04736810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091080|NCT04736810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091081|NCT04736810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56091082|NCT04736810|Immunologic Factors|immunologic factors|mesh-ancestor
56091083|NCT04736810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091132|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
56091133|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091134|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091135|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56193846|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56782381|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
56782382|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782383|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782384|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56782385|NCT02552459|Narcotics|narcotics|mesh-ancestor
56782386|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56193847|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56193848|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
56193849|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193850|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193851|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193852|NCT01489709|Urological Agents|urological agents|mesh-ancestor
56193853|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56193854|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56193855|NCT01489852|Estradiol|estradiol|mesh-list
56193856|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56193857|NCT01489852|Estrogens|estrogens|mesh-ancestor
56193858|NCT01489852|Hormones|hormones|mesh-ancestor
56193859|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56193860|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193861|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56193862|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
56193863|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56193864|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56193865|NCT01489865|Fluorouracil|fluorouracil|mesh-list
56193867|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
56091136|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
56091191|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091192|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
56091193|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56091194|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56091195|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
56091196|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
56091197|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
56091198|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091199|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091201|NCT03143569|Calcium heparin|calcium heparin|mesh-list
56091202|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
56091203|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56091204|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56091205|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091206|NCT05271240|Bevacizumab|bevacizumab|mesh-list
56091207|NCT05271240|Temozolomide|temozolomide|mesh-list
56091208|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091209|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091210|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56091211|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56091212|NCT05271240|Growth Substances|growth substances|mesh-ancestor
56091213|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091214|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
56091215|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56091216|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
56091217|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091218|NCT03149887|Bupivacaine|bupivacaine|mesh-list
56091219|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
56091220|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
56091221|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193868|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193869|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56193870|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193871|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193872|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
56193873|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193874|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56193875|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193876|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
56193877|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56782387|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56782388|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
56782389|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
56782390|NCT00810953|Pentamidine|pentamidine|mesh-list
56782391|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
56782392|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782393|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56782394|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56782395|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56782396|NCT00811031|Prednisone|prednisone|mesh-list
56782397|NCT00811031|Docetaxel|docetaxel|mesh-list
56782398|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782399|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
56782400|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
56193878|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56193879|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56193880|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56193881|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193883|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193884|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193885|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56193886|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56193887|NCT01489917|Heparin|heparin|mesh-list
56193888|NCT01489917|Hemostatics|hemostatics|mesh-list
56193889|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
56193890|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56193891|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56193892|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193893|NCT01489917|Coagulants|coagulants|mesh-ancestor
56193894|NCT01489943|Pioglitazone|pioglitazone|mesh-list
56193895|NCT01489943|Midazolam|midazolam|mesh-list
56193896|NCT01489943|Omeprazole|omeprazole|mesh-list
56193897|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56193898|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56091222|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091258|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56091259|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56091261|NCT02995915|Nicotine|nicotine|mesh-list
56091262|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56091263|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
56091286|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56091287|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56091288|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
56091289|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091290|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091291|NCT03000283|Conivaptan|conivaptan|mesh-list
56193899|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56193900|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193901|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091292|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56091293|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091294|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
56091295|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091296|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
56091297|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56091298|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091299|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56091300|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091301|NCT03168841|Efinaconazole|efinaconazole|mesh-list
56091302|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
56091303|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091304|NCT03865615|Oxytocin|oxytocin|mesh-list
56091305|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
56091306|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56782401|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
56782402|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782403|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782404|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
56782405|NCT00811031|Hormones|hormones|mesh-ancestor
56782406|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782407|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782408|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56782409|NCT02552537|Mannitol|mannitol|mesh-list
56782410|NCT02552537|Omeprazole|omeprazole|mesh-list
56782411|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56782412|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56782413|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56091307|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091308|NCT03185546|Nicotine|nicotine|mesh-list
56091309|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56091310|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
56091311|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091312|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091335|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
56091336|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091337|NCT03187730|Nicotine|nicotine|mesh-list
56091338|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56091339|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
56091340|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091341|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091342|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56091343|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56091344|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
56091345|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091346|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091347|NCT03261193|Bupivacaine|bupivacaine|mesh-list
56091348|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
56091349|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
56091350|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091351|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091352|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
56091353|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091354|NCT00375661|Interferons|interferons|mesh-list
56091355|NCT00375661|Ribavirin|ribavirin|mesh-list
56091356|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
56091357|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
56091397|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56091399|NCT03347929|Analgesics|analgesics|mesh-ancestor
56091400|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
56091401|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091402|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091403|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56091404|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56091405|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
56091406|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56193902|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56193903|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56193904|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193905|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56193906|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
56193907|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
56193908|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
56193909|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
56193910|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193911|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193912|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56782414|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782415|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782416|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56782417|NCT02552537|Diuretics|diuretics|mesh-ancestor
56782418|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
56782419|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782420|NCT00808223|Alefacept|alefacept|mesh-list
56782421|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
56782422|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
56782423|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782424|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
56782425|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
56782426|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56782427|NCT00811421|Mefloquine|mefloquine|mesh-list
56782428|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
56782429|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56782430|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56782431|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782432|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56782433|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782434|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782435|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56782436|NCT00811421|Renal Agents|renal agents|mesh-ancestor
56782437|NCT00569777|Ketotifen|ketotifen|mesh-list
56782438|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
56782439|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
56782440|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56782441|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
56782442|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
56193913|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56193914|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
56193915|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56193916|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56193917|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193918|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193919|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56193920|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193921|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56193922|NCT01489982|Zopiclone|zopiclone|mesh-list
56193923|NCT01489982|Doxepin|doxepin|mesh-list
56091407|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091408|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091409|NCT04823156|Calcium|calcium|mesh-list
56091410|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56091411|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091412|NCT02221674|Tapentadol|tapentadol|mesh-list
56091413|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56091414|NCT02221674|Narcotics|narcotics|mesh-ancestor
56782443|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782444|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782445|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782446|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56782447|NCT00654095|Atorvastatin|atorvastatin|mesh-list
56782448|NCT00654095|Ezetimibe|ezetimibe|mesh-list
56782449|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56782450|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56782451|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
56782452|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782453|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56782454|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56782455|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782456|NCT00811967|Ribavirin|ribavirin|mesh-list
56782457|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56782458|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
56782459|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
56782460|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782461|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
56782462|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782463|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
56091415|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091440|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56091442|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
56091443|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091444|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091445|NCT03324373|Everolimus|everolimus|mesh-list
56091451|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56091452|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091453|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091454|NCT04736108|Prednisolone|prednisolone|mesh-list
56091455|NCT04736108|Goserelin|goserelin|mesh-list
56091456|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
56091457|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56091458|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
56091459|NCT04736108|Hormones|hormones|mesh-ancestor
56091460|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56091461|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091462|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56193924|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56193925|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193926|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091493|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56091494|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56091495|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091496|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091497|NCT04356716|Urological Agents|urological agents|mesh-ancestor
56091499|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091500|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091501|NCT03198884|Dolutegravir|dolutegravir|mesh-list
56091502|NCT03198884|Darunavir|darunavir|mesh-list
56091503|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56782464|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782465|NCT04046159|Tamoxifen|tamoxifen|mesh-list
56782466|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56782467|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
56782468|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782469|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782470|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56782471|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055001|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56091504|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56091505|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091536|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091537|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56091538|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56091539|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091541|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091542|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091543|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56091544|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091545|NCT00716755|Olanzapine|olanzapine|mesh-list
56091546|NCT00716755|Risperidone|risperidone|mesh-list
56091547|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55818756|NCT02412371|Paclitaxel|paclitaxel|mesh-list
56091563|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56091564|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56091565|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
55741576|NCT03357133|Tirofiban|tirofiban|mesh-list
56091567|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56091568|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091570|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
56091571|NCT03202550|Oxycodone|oxycodone|mesh-list
56091572|NCT03202550|Lorazepam|lorazepam|mesh-list
56091573|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56091574|NCT03202550|Narcotics|narcotics|mesh-ancestor
56091575|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091576|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091577|NCT03202550|Analgesics|analgesics|mesh-ancestor
56091578|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
56091579|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091580|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
56091581|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
56091582|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
56091583|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56091584|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56091585|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56091586|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56091587|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56091588|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
56091589|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
56091590|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091604|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56193927|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56193928|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56193929|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
56193930|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56193931|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
56193932|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
56193933|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193934|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193935|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
56193936|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
56193937|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56193938|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193939|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193940|NCT01490047|Etanercept|etanercept|mesh-list
56193941|NCT01490047|Doxorubicin|doxorubicin|mesh-list
56782472|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56782473|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56782474|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56782475|NCT00653939|Paclitaxel|paclitaxel|mesh-list
56782476|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
56782477|NCT00653939|Combretastatin|combretastatin|mesh-list
56782478|NCT00653939|Bevacizumab|bevacizumab|mesh-list
56782479|NCT00653939|Carboplatin|carboplatin|mesh-list
56782480|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56782481|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782482|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
56782483|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
56782484|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
56782485|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193942|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56193943|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56193944|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56193945|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56193946|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56193947|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56193948|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091606|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091607|NCT04708171|Anesthetics|anesthetics|mesh-list
56091608|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091647|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091685|NCT03296072|Fluorides|fluorides|mesh-list
56091686|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
56091711|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56091712|NCT03185065|Analgesics|analgesics|mesh-ancestor
56091713|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
56091714|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091715|NCT02220894|Paclitaxel|paclitaxel|mesh-list
56091716|NCT02220894|Carboplatin|carboplatin|mesh-list
56091717|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
56091718|NCT02220894|Pemetrexed|pemetrexed|mesh-list
56091719|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56091720|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091721|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
56091722|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
56091723|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
56091724|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091725|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091726|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801821|NCT02406261|Donepezil|donepezil|mesh-list
56091729|NCT02159040|Azacitidine|azacitidine|mesh-list
56091730|NCT02159040|Deferasirox|deferasirox|mesh-list
56091731|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56091732|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
56193949|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56193950|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56091733|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091734|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091735|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091736|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56091737|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
56091738|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
56091760|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
56091761|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091762|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091763|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56091764|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782486|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56782487|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56782488|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56782489|NCT00653939|Growth Substances|growth substances|mesh-ancestor
56782490|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782491|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
55897487|NCT01709903|Xhance|xhance|mesh-list
56091766|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
56091767|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091768|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56091769|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
56091770|NCT01632150|Hormones|hormones|mesh-ancestor
56091771|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56091772|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56091773|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
56091774|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091775|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
56091776|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56091777|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091778|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56091779|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56091780|NCT01632150|Growth Substances|growth substances|mesh-ancestor
56091781|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
56091783|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56091784|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56091785|NCT03297944|Zolpidem|zolpidem|mesh-list
56091786|NCT03297944|Alprazolam|alprazolam|mesh-list
56091787|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56091788|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56091789|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091790|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091791|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56091792|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
56091794|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091795|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091821|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091822|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
56091823|NCT03300674|Lidocaine|lidocaine|mesh-list
56091824|NCT03300674|Hydromorphone|hydromorphone|mesh-list
56091825|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
56091826|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
56091827|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091828|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091829|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
56091830|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091831|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56091832|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56091833|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56091834|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56091835|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091836|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56091837|NCT03300674|Narcotics|narcotics|mesh-ancestor
56091838|NCT03300674|Analgesics|analgesics|mesh-ancestor
56091839|NCT02158806|Aspirin|aspirin|mesh-list
56091840|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56091841|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56091842|NCT02158806|Analgesics|analgesics|mesh-ancestor
56091843|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
56091844|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091867|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091870|NCT03220958|Metoclopramide|metoclopramide|mesh-list
56091871|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56091872|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56091873|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56193951|NCT01490047|Analgesics|analgesics|mesh-ancestor
56193952|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
56193953|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782492|NCT00812123|Cyclosporine|cyclosporine|mesh-list
56782493|NCT00812123|Sirolimus|sirolimus|mesh-list
56782494|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
56782495|NCT00812123|Prednisone|prednisone|mesh-list
56782496|NCT00812123|Cyclosporins|cyclosporins|mesh-list
56782497|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782498|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
56782499|NCT00812123|Hormones|hormones|mesh-ancestor
56782500|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782501|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782502|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56782503|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782504|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782505|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782506|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782507|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
56782508|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
56782509|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782510|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
56782511|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055036|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
56193954|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193955|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56193956|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56193957|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56193958|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56193959|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
56193960|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
56193961|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193962|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193963|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
56193964|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56193965|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193966|NCT01490203|Edetic Acid|edetic acid|mesh-list
56193967|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
56193968|NCT01490203|Antidotes|antidotes|mesh-ancestor
56193969|NCT01490203|Protective Agents|protective agents|mesh-ancestor
56193970|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193971|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
56193972|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
56193973|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193974|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56193975|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
56193976|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56193977|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56193978|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56193979|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193980|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56091874|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091875|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
56091876|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
56091877|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
56091878|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091879|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
56091880|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
56091881|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56782512|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56782513|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56782514|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56782515|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
56782516|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56782517|NCT00646451|Pregabalin|pregabalin|mesh-list
56782518|NCT00646451|Analgesics|analgesics|mesh-ancestor
56782519|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
56782520|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782521|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782522|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
56782523|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56782524|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56782525|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055053|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
56091882|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56091883|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
56091884|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
56091885|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091886|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091887|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56193981|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56193982|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56193983|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193985|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56193986|NCT01490229|Ezetimibe|ezetimibe|mesh-list
56193987|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56193988|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56193989|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
56193990|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193991|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56193992|NCT01490255|Amlodipine|amlodipine|mesh-list
56193993|NCT01490255|Ranolazine|ranolazine|mesh-list
56193994|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56193995|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56193996|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56193997|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193998|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56193999|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194000|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
56091888|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
56091889|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
56091890|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56091891|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56091892|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
56091893|NCT02182830|Empagliflozin|empagliflozin|mesh-list
56091957|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091958|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091959|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56091960|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56091961|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
56091962|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091963|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56091964|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
56091966|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
56091967|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56091968|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
56091969|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56782526|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56782527|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56782528|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56782529|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493500|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
56782530|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56782531|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
56782532|NCT00809237|Gefitinib|gefitinib|mesh-list
56782533|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
56782534|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56782535|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56782536|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782537|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782538|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782539|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782540|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782541|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56782542|NCT00817583|Docetaxel|docetaxel|mesh-list
56782543|NCT00817583|Fluorouracil|fluorouracil|mesh-list
56782544|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782545|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
56782546|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
56782547|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
56055068|NCT00803283|Morphine|morphine|mesh-list
56091970|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56194001|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56194002|NCT01490268|Sufentanil|sufentanil|mesh-list
56091971|NCT03228914|Protective Agents|protective agents|mesh-ancestor
56091972|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
56091973|NCT03316976|Lansoprazole|lansoprazole|mesh-list
56091974|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56091975|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56091976|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56091977|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091978|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091979|NCT03234374|Bupivacaine|bupivacaine|mesh-list
56091980|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
56091981|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
56091982|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091983|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091984|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
56091985|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091986|NCT04332536|Codeine|codeine|mesh-list
56091987|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56091988|NCT04332536|Narcotics|narcotics|mesh-ancestor
56091989|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091990|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091991|NCT04332536|Analgesics|analgesics|mesh-ancestor
56091992|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
56091993|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091994|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
56092030|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092031|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782548|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782549|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
56782550|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56782551|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782552|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
56782553|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782554|NCT00817661|Vitamin A|vitamin a|mesh-list
56782555|NCT00817661|Vitamins|vitamins|mesh-ancestor
56782556|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
56782557|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782558|NCT00642707|Leronlimab|leronlimab|mesh-list
56782559|NCT00642707|Antibodies|antibodies|mesh-list
56782560|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56782561|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
56782562|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782563|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56092032|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092076|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092077|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092105|NCT03249272|Adenosine|adenosine|mesh-list
56092106|NCT03249272|Regadenoson|regadenoson|mesh-list
56092107|NCT03249272|Analgesics|analgesics|mesh-ancestor
56092108|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
56092109|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092110|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092111|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56092112|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
56092113|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56092114|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
56092115|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
56092116|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092117|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092118|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56092119|NCT03468920|Acetaminophen|acetaminophen|mesh-list
56092120|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56092121|NCT03468920|Analgesics|analgesics|mesh-ancestor
56092122|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
56092123|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092144|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092145|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56092146|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56092147|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092148|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092149|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56092150|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56092151|NCT03344510|Anesthetics|anesthetics|mesh-list
56092152|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092153|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092155|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56092156|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092157|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092158|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56092159|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56092160|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56092161|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
56092162|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
56092163|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092164|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092165|NCT03270332|Albuterol|albuterol|mesh-list
56782564|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56782565|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782566|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56782567|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56782568|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
56782569|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782570|NCT02551523|Dolutegravir|dolutegravir|mesh-list
56782571|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56782572|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56782573|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56782574|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782575|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782576|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56782577|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
56782578|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782579|NCT00817739|Leuprolide|leuprolide|mesh-list
56782580|NCT00817739|Flutamide|flutamide|mesh-list
56782581|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56782582|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
56782583|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56782584|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782585|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56782586|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782587|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
56782588|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
56782589|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782590|NCT00817895|Cisplatin|cisplatin|mesh-list
56782591|NCT00817895|Fluorouracil|fluorouracil|mesh-list
56782592|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782609|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
56782610|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782611|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782612|NCT00061945|Leucovorin|leucovorin|mesh-list
56782613|NCT00061945|Cytarabine|cytarabine|mesh-list
56782614|NCT00061945|Acyclovir|acyclovir|mesh-list
56782615|NCT00061945|Trimethoprim|trimethoprim|mesh-list
56782616|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
56782617|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56782618|NCT00061945|Dexamethasone|dexamethasone|mesh-list
56782619|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
56782620|NCT00061945|Methotrexate|methotrexate|mesh-list
56782621|NCT00061945|Vincristine|vincristine|mesh-list
56782622|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
56782623|NCT00061945|Daunorubicin|daunorubicin|mesh-list
56782624|NCT00061945|Asparaginase|asparaginase|mesh-list
56782625|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
56782626|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
56782627|NCT00061945|Allopurinol|allopurinol|mesh-list
56782628|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
56782629|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782630|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
56782631|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782632|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782633|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56782634|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
56782635|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782636|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782637|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56782638|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782639|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
56782640|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
56782641|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092166|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56194004|NCT01490268|Hydromorphone|hydromorphone|mesh-list
56194005|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56194006|NCT01490268|Narcotics|narcotics|mesh-ancestor
56194007|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194008|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121779|NCT01755546|Narcotics|narcotics|mesh-ancestor
56194009|NCT01490268|Analgesics|analgesics|mesh-ancestor
56194010|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
56194011|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194012|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56092167|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
56092168|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092169|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782642|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56782643|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
56782644|NCT00061945|Hormones|hormones|mesh-ancestor
56782645|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782646|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56092170|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56092171|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
56092172|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
56092173|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56092174|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56092175|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56092176|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56092207|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56092208|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56092209|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092210|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092211|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092212|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56092213|NCT02216214|Mirabegron|mirabegron|mesh-list
56092214|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56092215|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56092216|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56092217|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
56092218|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092219|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092220|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092221|NCT02216214|Urological Agents|urological agents|mesh-ancestor
56092222|NCT00376376|Levofloxacin|levofloxacin|mesh-list
56092288|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
56092289|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
56092290|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092291|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092292|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092293|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
56092294|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56092295|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
56092296|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092297|NCT03581084|Expectorants|expectorants|mesh-ancestor
56092298|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
56092299|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56092300|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
56092301|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092302|NCT03581084|Protective Agents|protective agents|mesh-ancestor
56092303|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092305|NCT03383588|Epinephrine|epinephrine|mesh-list
56092306|NCT03383588|Fentanyl|fentanyl|mesh-list
56092307|NCT03383588|Morphine|morphine|mesh-list
56092309|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
56092310|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
56092311|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194013|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56194014|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
56194015|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
56194016|NCT01490333|Vitamin D|vitamin d|mesh-list
56194017|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
56194018|NCT01490333|Vitamins|vitamins|mesh-ancestor
56194019|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
56194020|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194021|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56194022|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56194023|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56194024|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
56194025|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194026|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56194027|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56194028|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56194029|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
56194030|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194031|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56194032|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56782647|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56782648|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
56782649|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56782650|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56782651|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
56782652|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
56782653|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782654|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56782655|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56782656|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
56782657|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782658|NCT00061945|Antidotes|antidotes|mesh-ancestor
56782659|NCT00061945|Protective Agents|protective agents|mesh-ancestor
56782660|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
56782661|NCT00061945|Vitamins|vitamins|mesh-ancestor
56782662|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
56782663|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56782664|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
56782665|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
56782666|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
56782667|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56782668|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56782669|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56782670|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56055183|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56194033|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194034|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
56194035|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092312|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092313|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
56092314|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092343|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
56092344|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092345|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092346|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56092347|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56092348|NCT03588806|Oxycodone|oxycodone|mesh-list
56092349|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56092350|NCT03588806|Narcotics|narcotics|mesh-ancestor
56092351|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092352|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092353|NCT03588806|Analgesics|analgesics|mesh-ancestor
56092354|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
56092355|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092360|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56092361|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
56092362|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56092363|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56092398|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092399|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
56782671|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56782672|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
56782673|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56782674|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
56782675|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56782676|NCT00061945|Renal Agents|renal agents|mesh-ancestor
56782677|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
56782678|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56782679|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56782680|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56782681|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56092400|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092402|NCT01599234|Analgesics|analgesics|mesh-ancestor
56194036|NCT01490437|Dexamethasone|dexamethasone|mesh-list
56194037|NCT01490437|Pemetrexed|pemetrexed|mesh-list
56092403|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
56092440|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56092441|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092442|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56092468|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092469|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
56092470|NCT03523988|Acetaminophen|acetaminophen|mesh-list
56092471|NCT03523988|Ibuprofen|ibuprofen|mesh-list
56092472|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56092473|NCT03523988|Analgesics|analgesics|mesh-ancestor
56092474|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
56092475|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092476|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092477|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
56092478|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56092479|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56092480|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56092481|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56092482|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092483|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092484|NCT03525548|Ivacaftor|ivacaftor|mesh-list
56092485|NCT03525548|Elexacaftor|elexacaftor|mesh-list
56092486|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56092487|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56092488|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092489|NCT03528512|Fentanyl|fentanyl|mesh-list
56092490|NCT03528512|Midazolam|midazolam|mesh-list
56092491|NCT03528512|Ketamine|ketamine|mesh-list
56092492|NCT03528512|Analgesics|analgesics|mesh-ancestor
56092522|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56092523|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092524|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
56092525|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
56092526|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092527|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56092528|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56092529|NCT02133924|Protective Agents|protective agents|mesh-ancestor
56092530|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
56092531|NCT03537404|Ritonavir|ritonavir|mesh-list
56092532|NCT03537404|Tenofovir|tenofovir|mesh-list
56092533|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
56092534|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56092535|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56092536|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
56092537|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092556|NCT03538808|Varenicline|varenicline|mesh-list
56092557|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56092558|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56092559|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
56092560|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092561|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783638|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
56782682|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56782683|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56782684|NCT00817973|Caseins|caseins|mesh-list
56782685|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
56782686|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
56923701|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
56782687|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782688|NCT01097941|Vaccines|vaccines|mesh-list
56782689|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
56782690|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782691|NCT00642473|Metronidazole|metronidazole|mesh-list
56782692|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56782693|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782694|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56782695|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782696|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782697|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782698|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56782699|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56782700|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56782701|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56092562|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092563|NCT00377000|Clindamycin|clindamycin|mesh-list
56092564|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
56092565|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
56092566|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56092567|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56092568|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092569|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56092571|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092572|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
56092573|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56092574|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56092575|NCT04501640|Mirabegron|mirabegron|mesh-list
56092576|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56092577|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56092578|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56092579|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
56092580|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194038|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194039|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56194040|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
56194041|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
56194042|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194043|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56194044|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
56194045|NCT01490437|Hormones|hormones|mesh-ancestor
56194046|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56194047|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56194048|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194049|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194050|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194051|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56782702|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56782703|NCT00366340|Vaccines|vaccines|mesh-list
56782704|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56782705|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
56782706|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782707|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
56782708|NCT03992326|Fludarabine|fludarabine|mesh-list
56782709|NCT03992326|Interleukin-2|interleukin-2|mesh-list
56782710|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782711|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
56055239|NCT01784991|Narcotics|narcotics|mesh-ancestor
56194052|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56194053|NCT01490476|Everolimus|everolimus|mesh-list
56194054|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194055|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56092581|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092582|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092583|NCT04501640|Urological Agents|urological agents|mesh-ancestor
56092584|NCT04757610|Ranibizumab|ranibizumab|mesh-list
56092585|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56092586|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56092587|NCT04757610|Growth Substances|growth substances|mesh-ancestor
56092588|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092589|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
56092590|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092591|NCT03633344|Silicon|silicon|mesh-list
56092630|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092662|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
56092663|NCT04392362|Adenosine|adenosine|mesh-list
56092664|NCT04392362|Analgesics|analgesics|mesh-ancestor
56092665|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
56092666|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092667|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092668|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56092669|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
56092670|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56092671|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
56092672|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
56092673|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092674|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092675|NCT04734782|Antibodies|antibodies|mesh-list
56092712|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092713|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56092814|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56092815|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56092816|NCT03329911|Growth Substances|growth substances|mesh-ancestor
56092817|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092818|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
56092820|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
56092821|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56092822|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194056|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
56194057|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194058|NCT01490567|Donepezil|donepezil|mesh-list
56194059|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56194060|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194061|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194062|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
56194063|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194064|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194066|NCT01490658|Metformin|metformin|mesh-list
56194067|NCT01490658|Repaglinide|repaglinide|mesh-list
56194068|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194069|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194070|NCT01490671|Tenofovir|tenofovir|mesh-list
56092823|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
56782712|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782713|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782714|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56782715|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
56782716|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782717|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782718|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56782719|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56782720|NCT03992326|Analgesics|analgesics|mesh-ancestor
56782721|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
56782722|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782723|NCT01045954|Insulin|insulin|mesh-list
56782724|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
56782725|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
56782726|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56782727|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782728|NCT01046032|Metformin|metformin|mesh-list
56782729|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56782730|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782731|NCT00061633|Vancomycin|vancomycin|mesh-list
56782732|NCT00061633|Penicillins|penicillins|mesh-list
56782733|NCT00061633|Telavancin|telavancin|mesh-list
56055254|NCT05600517|Fluorides|fluorides|mesh-list
56092824|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56092825|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56092826|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092827|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092828|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56092829|NCT03330457|Betrixaban|betrixaban|mesh-list
56092830|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56092831|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
56092832|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56092833|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
56092834|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092835|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092836|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
56092837|NCT03961100|Entrectinib|entrectinib|mesh-list
56092838|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56092839|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092840|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092842|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
56092843|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
56092866|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
56092867|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092868|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092869|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
56092870|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092871|NCT03445195|Imipenem|imipenem|mesh-list
56092872|NCT03445195|Sulbactam|sulbactam|mesh-list
56092873|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
56092874|NCT03445195|Cilastatin|cilastatin|mesh-list
56092875|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56092876|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092877|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
56092878|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782734|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56782735|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782736|NCT00645593|Gemcitabine|gemcitabine|mesh-list
56782737|NCT00645593|Cetuximab|cetuximab|mesh-list
56782738|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782739|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56782740|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
56782741|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782742|NCT00645593|Antiviral Agents|antiviral agents|mesh-ancestor
56782743|NCT00645593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782744|NCT00645593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782745|NCT00645593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782746|NCT00645593|Immunologic Factors|immunologic factors|mesh-ancestor
56782747|NCT00645593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782748|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56782749|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
56782750|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
56782751|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782752|NCT02550977|Gestodene|gestodene|mesh-list
56782753|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56782754|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56782755|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56782756|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
56782757|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56782758|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782759|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56782760|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56782761|NCT02550977|Progestins|progestins|mesh-ancestor
56782762|NCT02550977|Hormones|hormones|mesh-ancestor
56782763|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782764|NCT01045018|Mesalamine|mesalamine|mesh-list
56782765|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56782766|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56782767|NCT01045018|Analgesics|analgesics|mesh-ancestor
56782768|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
56782773|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
56782774|NCT01049464|Analgesics|analgesics|mesh-ancestor
56782775|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
56782776|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782777|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782778|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
56782779|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56782780|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56782781|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
56782782|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56782783|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56782784|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782785|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56782786|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
56782787|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56782788|NCT01046266|Cetuximab|cetuximab|mesh-list
56782789|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56782790|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782791|NCT00365794|Testosterone|testosterone|mesh-list
56782792|NCT00365794|Androgens|androgens|mesh-ancestor
56782793|NCT00365794|Hormones|hormones|mesh-ancestor
56782794|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782795|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782796|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
56782797|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56782798|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56782799|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56782800|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56782801|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782802|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
56782803|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782813|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782814|NCT01049620|Capecitabine|capecitabine|mesh-list
56782815|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
56782816|NCT01049620|Everolimus|everolimus|mesh-list
56782817|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56782818|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
56782819|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782820|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782821|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782822|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
56782823|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782824|NCT00059839|Prednisone|prednisone|mesh-list
56782825|NCT00059839|Doxorubicin|doxorubicin|mesh-list
56782826|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56782827|NCT00059839|Methotrexate|methotrexate|mesh-list
56782828|NCT00059839|Vincristine|vincristine|mesh-list
56782829|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
56782830|NCT00059839|Vinblastine|vinblastine|mesh-list
56782831|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56782832|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092879|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092880|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56092881|NCT04277936|Levetiracetam|levetiracetam|mesh-list
56092882|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
56092883|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
56092884|NCT03670160|Clonidine|clonidine|mesh-list
56092885|NCT03670160|Phenobarbital|phenobarbital|mesh-list
56092886|NCT03670160|Analgesics|analgesics|mesh-ancestor
56092887|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
55741620|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
56092888|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092889|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092890|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56092891|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
56194071|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
56194072|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194073|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56092892|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
56092893|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56092894|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56092895|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56092896|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
56092897|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092933|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
56092934|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
56092935|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092936|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56092937|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092938|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56092939|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
56092940|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092941|NCT00422864|Antidotes|antidotes|mesh-ancestor
56092942|NCT00422864|Protective Agents|protective agents|mesh-ancestor
56092943|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
56092944|NCT00422864|Vitamins|vitamins|mesh-ancestor
56092945|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
56092946|NCT00377936|Gemcitabine|gemcitabine|mesh-list
56092947|NCT00377936|Paclitaxel|paclitaxel|mesh-list
56092950|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782833|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56782834|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56782835|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782836|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782837|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56782838|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
56092951|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092952|NCT00377936|Antiviral Agents|antiviral agents|mesh-ancestor
56092953|NCT00377936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092954|NCT00377936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092955|NCT00377936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56092956|NCT00377936|Immunologic Factors|immunologic factors|mesh-ancestor
56092957|NCT00377936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092958|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56092959|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
56092960|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
56092961|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
56092962|NCT03696758|Metoprolol|metoprolol|mesh-list
56092963|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
56092964|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
56092965|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56092966|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56092967|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092988|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092989|NCT03711578|Tenalisib|tenalisib|mesh-list
56092990|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
56092991|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092992|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092993|NCT03463915|Triamcinolone|triamcinolone|mesh-list
56092994|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56092995|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56092996|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56092997|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56092998|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
56092999|NCT03463915|Hormones|hormones|mesh-ancestor
56093000|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56093001|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093002|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56093003|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
56093004|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093005|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093006|NCT03473665|Celecoxib|celecoxib|mesh-list
56093007|NCT03473665|Diclofenac|diclofenac|mesh-list
56093008|NCT03473665|Indomethacin|indomethacin|mesh-list
56093009|NCT03473665|Meloxicam|meloxicam|mesh-list
56093010|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56093011|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093012|NCT03473665|Analgesics|analgesics|mesh-ancestor
56093013|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
56093014|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093015|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194074|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56194075|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194076|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194077|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56194078|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56194079|NCT01490749|Carboplatin|carboplatin|mesh-list
56194080|NCT01490749|Capecitabine|capecitabine|mesh-list
56194081|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
56194082|NCT01490749|Everolimus|everolimus|mesh-list
56194083|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121866|NCT01706328|Xhance|xhance|mesh-list
56194084|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56194086|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093016|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56093017|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56093018|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56093019|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56093020|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493800|NCT00538070|Glycine|glycine|mesh-list
56782839|NCT00059839|Hormones|hormones|mesh-ancestor
56782840|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782841|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782842|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56782843|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56782844|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
56782845|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56782846|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56093055|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56093057|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
56093058|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
56093059|NCT00376519|Fludarabine|fludarabine|mesh-list
56093060|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
56093061|NCT00376519|Cyclosporins|cyclosporins|mesh-list
56093084|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
56093085|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093091|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093093|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093094|NCT03378973|Analgesics|analgesics|mesh-ancestor
56093095|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
56093096|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093097|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56093098|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56093099|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56093100|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
56093101|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093102|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093104|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56093105|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
56093106|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093107|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093108|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
56093109|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56093110|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093111|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093112|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56093113|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56093150|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56093171|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093173|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56093174|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093175|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
56093176|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194087|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56194088|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
56194089|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194091|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56194092|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194093|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194094|NCT01490905|Ibuprofen|ibuprofen|mesh-list
56194095|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56194096|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56194097|NCT01490905|Analgesics|analgesics|mesh-ancestor
56093177|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
56093178|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56093179|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
56093180|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093181|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
56093182|NCT04081610|Protective Agents|protective agents|mesh-ancestor
56093183|NCT03840278|Pancrelipase|pancrelipase|mesh-list
56093185|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56093186|NCT03838874|Bupivacaine|bupivacaine|mesh-list
56093187|NCT03838874|Mepivacaine|mepivacaine|mesh-list
56782847|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
56782848|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
56782849|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56782850|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782851|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
56782852|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782853|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56782854|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56782855|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
56782856|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
56782857|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
56782858|NCT00059215|Clopidogrel|clopidogrel|mesh-list
56782859|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56093188|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
56093189|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
56093190|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093191|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093192|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
56093193|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093194|NCT04045964|Nicotine|nicotine|mesh-list
56093195|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56093196|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
56093197|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093198|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093199|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56093200|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56093201|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
56093202|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093235|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56093236|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093237|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56093239|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093240|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093241|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56093242|NCT03806270|Midazolam|midazolam|mesh-list
56093243|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
56093244|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56093245|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093246|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093247|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093248|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56093249|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093250|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093251|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56093252|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
56093291|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
56093292|NCT03264157|Vaccines|vaccines|mesh-list
56093293|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
56093294|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093295|NCT04029584|Rifampin|rifampin|mesh-list
55820407|NCT04887506|Prednisone|prednisone|mesh-list
56093296|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56194098|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
56194099|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093297|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
56093298|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093299|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093300|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
56093301|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56093302|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093303|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093304|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56093305|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56782860|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56782861|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56782862|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56782863|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56782864|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
56782865|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782866|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782867|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782868|NCT00058825|Cyclosporine|cyclosporine|mesh-list
56782869|NCT00058825|Fludarabine|fludarabine|mesh-list
56782870|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
56782871|NCT00058825|Tacrolimus|tacrolimus|mesh-list
56782872|NCT00058825|Cyclosporins|cyclosporins|mesh-list
56782873|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782874|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782875|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782876|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
56782877|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782878|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56782879|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782880|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
56782881|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782882|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
56782883|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56782884|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56782885|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56782886|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
56782887|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782888|NCT03953989|Ranolazine|ranolazine|mesh-list
56782889|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56782890|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093306|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56093307|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56093308|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56093309|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56093310|NCT04028960|Insulin|insulin|mesh-list
56093311|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56093312|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56093313|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093314|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
56093315|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56093316|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
56093317|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
56782891|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782892|NCT01096225|Vaccines|vaccines|mesh-list
56782893|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
56782894|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782895|NCT02535130|Amikacin|amikacin|mesh-list
56782896|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56782897|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782898|NCT01046500|Inositol|inositol|mesh-list
56782899|NCT01046500|Metformin|metformin|mesh-list
56782900|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56782901|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782902|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
56093318|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093319|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093320|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093321|NCT03502915|Analgesics|analgesics|mesh-ancestor
56093322|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
56093323|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093324|NCT04018664|Nalbuphine|nalbuphine|mesh-list
56093325|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56093387|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093388|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56093389|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56093390|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56093391|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093392|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093394|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56093395|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56093397|NCT04005404|Ropivacaine|ropivacaine|mesh-list
56093398|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
56093399|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
56093400|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093401|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093402|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
56093403|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093404|NCT03232892|Trametinib|trametinib|mesh-list
56093442|NCT03767738|Growth Substances|growth substances|mesh-ancestor
56093443|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093444|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
56093477|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093479|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56093480|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093481|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093482|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093483|NCT03405259|Fluorides|fluorides|mesh-list
56093484|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
56093485|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
56093510|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56093511|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56093512|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56093513|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
56093514|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093515|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56093516|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56093517|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56093518|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56093519|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56093520|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
56093521|NCT05313308|Midazolam|midazolam|mesh-list
56093522|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56093523|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093524|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093525|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093526|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56782903|NCT01046500|Vitamins|vitamins|mesh-ancestor
56782904|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
56782905|NCT01046578|Letrozole|letrozole|mesh-list
56782906|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782907|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56782908|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56782909|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782910|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093527|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093528|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093529|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56093530|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
56093531|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
56093532|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
56093533|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
56093534|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093535|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093536|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
56093537|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56093559|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
56093560|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56093561|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093562|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56093563|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56093564|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56093565|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
56093566|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56093567|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
56093568|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093569|NCT01495988|Bevacizumab|bevacizumab|mesh-list
56093570|NCT01495988|Vemurafenib|vemurafenib|mesh-list
56093571|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56093572|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093573|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56093574|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56093575|NCT01495988|Growth Substances|growth substances|mesh-ancestor
56093576|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093577|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
56093578|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56093579|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093580|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093581|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
56093582|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
56093583|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137540|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56093585|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093587|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
56093588|NCT03415243|Acetaminophen|acetaminophen|mesh-list
56093589|NCT03415243|Phenylephrine|phenylephrine|mesh-list
56093590|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
56093591|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
56093592|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093593|NCT03415243|Analgesics|analgesics|mesh-ancestor
56093594|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
56093628|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
56093630|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56093631|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56093632|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56093633|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
56093634|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56093635|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56093636|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093637|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
56093670|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56093671|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
56093672|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56093673|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56093674|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56782911|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56782912|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
56782913|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782914|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782916|NCT00372424|Trastuzumab|trastuzumab|mesh-list
56782917|NCT00372424|Sunitinib|sunitinib|mesh-list
56782918|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782919|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
56782920|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
56782921|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
56782922|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782923|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56782924|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56782925|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56782926|NCT00372424|Growth Substances|growth substances|mesh-ancestor
56782927|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782928|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
56782929|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56782930|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782931|NCT02530411|Fulvestrant|fulvestrant|mesh-list
56782932|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56782933|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055449|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56093675|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56093676|NCT02734940|Narcotics|narcotics|mesh-ancestor
56093677|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56093678|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093679|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56194101|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56194102|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194103|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56194104|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194105|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194106|NCT01490944|Iron|iron|mesh-list
56194107|NCT01490944|Folic Acid|folic acid|mesh-list
56194108|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
56194109|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
56194110|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
56194111|NCT01490944|Trace Elements|trace elements|mesh-ancestor
56194112|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
56194113|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194114|NCT01490944|Hematinics|hematinics|mesh-ancestor
56194115|NCT01490944|Vitamins|vitamins|mesh-ancestor
56194116|NCT01490996|Curcumin|curcumin|mesh-list
56194117|NCT01490996|Capecitabine|capecitabine|mesh-list
56194118|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56194119|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
56194120|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194121|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194122|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56194123|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56194124|NCT01490996|Analgesics|analgesics|mesh-ancestor
56782934|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56782935|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56782936|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
56782937|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56782938|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782939|NCT01327027|Vasopressins|vasopressins|mesh-list
56782940|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
56782941|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
56782942|NCT01327027|Coagulants|coagulants|mesh-ancestor
56782943|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56782944|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56782945|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
56782946|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782947|NCT01093807|Enalapril|enalapril|mesh-list
56782948|NCT01093807|Enalaprilat|enalaprilat|mesh-list
56782949|NCT01093807|Lercanidipine|lercanidipine|mesh-list
56782950|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56782951|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
56782952|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782953|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782954|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56782955|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56782956|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56782957|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56782958|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782959|NCT00044083|Tolcapone|tolcapone|mesh-list
56782960|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56782961|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56782962|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56782963|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782964|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56782965|NCT00058123|Poly ICLC|poly iclc|mesh-list
56782966|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
56055476|NCT01548651|Saxagliptin|saxagliptin|mesh-list
56194125|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
56194126|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194127|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194128|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56093752|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
56093753|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56782967|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
56782968|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782969|NCT03952273|Sirolimus|sirolimus|mesh-list
56782970|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56782971|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782972|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56782973|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782974|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
56782975|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782976|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
56782977|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782978|NCT00022633|Gemcitabine|gemcitabine|mesh-list
56782979|NCT00022633|Paclitaxel|paclitaxel|mesh-list
56093754|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093755|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56093756|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56093757|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093758|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093759|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
56093760|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093761|NCT03565328|Niacinamide|niacinamide|mesh-list
56093763|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
56093764|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
56093766|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
56093767|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093768|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56093769|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
56093770|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093771|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56093772|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
56194130|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194131|NCT01491009|Midazolam|midazolam|mesh-list
56194132|NCT01491009|Remifentanil|remifentanil|mesh-list
56194133|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56194134|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56194135|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194136|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194137|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56194138|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56194139|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56194140|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56194141|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
56194142|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
56194143|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
56194144|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
56194145|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194146|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194147|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56194148|NCT01491009|Narcotics|narcotics|mesh-ancestor
56194149|NCT01491009|Analgesics|analgesics|mesh-ancestor
56093773|NCT01206296|Gemcitabine|gemcitabine|mesh-list
56093774|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56093775|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
56093776|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093777|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093778|NCT01206296|Antiviral Agents|antiviral agents|mesh-ancestor
56093779|NCT01206296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093780|NCT01206296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093781|NCT01206296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56093782|NCT01206296|Immunologic Factors|immunologic factors|mesh-ancestor
56093783|NCT01206296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093784|NCT02593682|Suvorexant|suvorexant|mesh-list
56093785|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56093810|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
56782980|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56782981|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782982|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
56782983|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
56782984|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
56782985|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493953|NCT00538421|Sevoflurane|sevoflurane|mesh-list
56782986|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56782987|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
56093811|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093812|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093813|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093814|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56093815|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
56093816|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56093817|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093818|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56093819|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56093820|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56093821|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56093822|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56093824|NCT01163084|Goserelin|goserelin|mesh-list
56093825|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56093826|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
56093827|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56093828|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093829|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56093830|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093831|NCT01155518|Clomiphene|clomiphene|mesh-list
56093832|NCT01155518|Testosterone|testosterone|mesh-list
56194150|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
56194151|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093833|NCT01155518|Androgens|androgens|mesh-ancestor
56093897|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093898|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093919|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56093920|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
56093921|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093922|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093923|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093924|NCT02369744|Urological Agents|urological agents|mesh-ancestor
56093926|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
56093927|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093928|NCT02367170|Midazolam|midazolam|mesh-list
56093929|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56093930|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56137541|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
56093932|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093934|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093935|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093936|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56093937|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
56093938|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
56093939|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
56093940|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
56093941|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093942|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093943|NCT01078844|Memantine|memantine|mesh-list
56093944|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56093945|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56093946|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
56093947|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093948|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093949|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56782988|NCT00022633|Antiviral Agents|antiviral agents|mesh-ancestor
56782989|NCT00022633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56782990|NCT00022633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56782991|NCT00022633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56782992|NCT00022633|Immunologic Factors|immunologic factors|mesh-ancestor
56782993|NCT00022633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093950|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56093971|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
55821097|NCT02325401|Metformin|metformin|mesh-list
56093972|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093973|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
56093974|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56093975|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56093976|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56093977|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56093978|NCT05312840|Gemcitabine|gemcitabine|mesh-list
56093979|NCT05312840|Carboplatin|carboplatin|mesh-list
56093980|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093981|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56093982|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
56093983|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093984|NCT05312840|Antiviral Agents|antiviral agents|mesh-ancestor
56093985|NCT05312840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093986|NCT05312840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093987|NCT05312840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56093988|NCT05312840|Immunologic Factors|immunologic factors|mesh-ancestor
56093989|NCT05312840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093990|NCT00376129|Alefacept|alefacept|mesh-list
56093991|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
56093992|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
56093993|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093994|NCT01035944|Chitosan|chitosan|mesh-list
56093995|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56093996|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56093997|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
56093998|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093999|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56094000|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
56094001|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
56094002|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
56094003|NCT01035944|Coagulants|coagulants|mesh-ancestor
56094004|NCT00378638|Bevacizumab|bevacizumab|mesh-list
56094029|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094030|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194152|NCT01491048|Tacrine|tacrine|mesh-list
56194153|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56194154|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194155|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194156|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
56194157|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194158|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121935|NCT04414020|Hormones|hormones|mesh-ancestor
56194159|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56194160|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
56194161|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094031|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094032|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094033|NCT01023620|Pioglitazone|pioglitazone|mesh-list
56094034|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56094035|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094036|NCT03595579|Bupropion|bupropion|mesh-list
56094037|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56094039|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56094040|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56094041|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56094042|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56094043|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094044|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
56094045|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821173|NCT01639729|Sufentanil|sufentanil|mesh-list
55814596|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
56782994|NCT00021541|Tipifarnib|tipifarnib|mesh-list
56782995|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782996|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
56782997|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56782998|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56782999|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783000|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783001|NCT02688790|Dalbavancin|dalbavancin|mesh-list
56783002|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56094046|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094047|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55741664|NCT02848131|Dasatinib|dasatinib|mesh-list
56094048|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56094049|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094050|NCT02200328|Metronidazole|metronidazole|mesh-list
56094074|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094076|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56094077|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
56094078|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094079|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094080|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
56094081|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
56094082|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56094083|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094084|NCT00379730|Prednisolone|prednisolone|mesh-list
56094085|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094086|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
56094087|NCT00379730|Hormones|hormones|mesh-ancestor
56094088|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094089|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094090|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56094091|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094092|NCT02074904|Topiramate|topiramate|mesh-list
56094093|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
56094094|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56094095|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094096|NCT02043860|Melphalan|melphalan|mesh-list
56094097|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
56094098|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094099|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56094100|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
56094101|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094120|NCT03608839|Dexamethasone|dexamethasone|mesh-list
56194162|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
56094121|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
56094123|NCT03608839|BB 1101|bb 1101|mesh-list
56094124|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094125|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
56094126|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
56094127|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094128|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094129|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56094130|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
56094131|NCT03608839|Hormones|hormones|mesh-ancestor
56094132|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094133|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56094134|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094135|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
56094136|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094137|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094148|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56094149|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
56094150|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
56094151|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094152|NCT03610399|Primaquine|primaquine|mesh-list
56783003|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783004|NCT00488475|Etanercept|etanercept|mesh-list
56783005|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56783006|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56783007|NCT00488475|Analgesics|analgesics|mesh-ancestor
56783008|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
56783009|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783010|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783011|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783012|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783013|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56094153|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
56094154|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56094155|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56094156|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094157|NCT03610633|Oxytocin|oxytocin|mesh-list
56094158|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
56094194|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56094195|NCT03545893|Narcotics|narcotics|mesh-ancestor
56137542|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
56094214|NCT01889420|Growth Substances|growth substances|mesh-ancestor
56094215|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
56094216|NCT00379028|Fluticasone|fluticasone|mesh-list
56094217|NCT00379028|Budesonide|budesonide|mesh-list
56094218|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
56094219|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56094220|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094221|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56094222|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
56094223|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094224|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094225|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56094226|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
56094227|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
56094228|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56094229|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
56094230|NCT00379028|Hormones|hormones|mesh-ancestor
56094231|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094232|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56094233|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56094234|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56094235|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
56094236|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094237|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094238|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56094239|NCT05286554|Hormones|hormones|mesh-list
56094240|NCT05286554|Progesterone|progesterone|mesh-list
56094241|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094242|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094243|NCT05286554|Progestins|progestins|mesh-ancestor
56094244|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
56094245|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56094246|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
56094247|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56094248|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56094249|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56094250|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094251|NCT00379262|Fluorouracil|fluorouracil|mesh-list
56094252|NCT00379262|Capecitabine|capecitabine|mesh-list
56094271|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094272|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
56094273|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56094274|NCT03621085|Ketamine|ketamine|mesh-list
56194164|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56194165|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56110442|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56783014|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783015|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
56783016|NCT01020279|Celecoxib|celecoxib|mesh-list
56783017|NCT01020279|Ketoprofen|ketoprofen|mesh-list
56783018|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56783019|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56783020|NCT01020279|Analgesics|analgesics|mesh-ancestor
56783021|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
56783022|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783023|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783024|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783025|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783026|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56783027|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56783028|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783029|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783030|NCT01020357|Caffeine|caffeine|mesh-list
56783031|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
56783032|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783033|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56783034|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783035|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56783036|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783037|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56783038|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56783039|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
56783040|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783041|NCT00042991|Gefitinib|gefitinib|mesh-list
56783042|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194166|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194167|NCT01491100|Interferons|interferons|mesh-list
56194168|NCT01491100|Interferon-beta|interferon-beta|mesh-list
56194169|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
56194170|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194171|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
56194172|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194173|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
56194174|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194175|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56094275|NCT03621085|Analgesics|analgesics|mesh-ancestor
56094276|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
56094277|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094278|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094279|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56783043|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56783044|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783045|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783046|NCT00466167|Pramipexole|pramipexole|mesh-list
56783047|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
56783048|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783049|NCT00466167|Protective Agents|protective agents|mesh-ancestor
56783050|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783051|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56783052|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56783053|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
56783054|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
56783055|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783056|NCT01017939|Prednisone|prednisone|mesh-list
56783057|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
56783058|NCT01017939|Theophylline|theophylline|mesh-list
56783059|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
56783060|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783061|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
56783062|NCT01017939|Hormones|hormones|mesh-ancestor
56783063|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56783064|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783065|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56783066|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783067|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56783068|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055578|NCT05721755|Antimetabolites|antimetabolites|mesh-ancestor
56094280|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56094281|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
56094282|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
56094283|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094284|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56094285|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56094286|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094287|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094288|NCT00795236|Melatonin|melatonin|mesh-list
56094289|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
56094290|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094291|NCT00795236|Protective Agents|protective agents|mesh-ancestor
56094292|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094294|NCT00790478|Melatonin|melatonin|mesh-list
56094295|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
56094296|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094297|NCT00790478|Protective Agents|protective agents|mesh-ancestor
56094298|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094299|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094300|NCT04490239|Heparin|heparin|mesh-list
56094301|NCT04490239|Calcium heparin|calcium heparin|mesh-list
56783069|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783070|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
56783071|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56783072|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
56783073|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
56783074|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56783075|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56783076|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783077|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56783078|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
56783079|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783080|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56783081|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56783082|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
56783083|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56783084|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56783085|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
56783086|NCT00480441|Dronabinol|dronabinol|mesh-list
56783087|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
56783088|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783089|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56783090|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56783091|NCT00480441|Analgesics|analgesics|mesh-ancestor
56783092|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
56783093|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783094|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56783095|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56783096|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783097|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094302|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
56094303|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56094334|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
56094335|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56094336|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
56094337|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094338|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094339|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
56094340|NCT05080556|Carboplatin|carboplatin|mesh-list
56094341|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094342|NCT01797380|Citalopram|citalopram|mesh-list
56094343|NCT01797380|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56094344|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55821466|NCT04907851|Denosumab|denosumab|mesh-list
56783098|NCT00480441|Hormones|hormones|mesh-ancestor
56783099|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56783100|NCT01022463|Atenolol|atenolol|mesh-list
56783101|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56783102|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56783103|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
56783104|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
56783105|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783106|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094345|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56094346|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094347|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094348|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
56094380|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
56094381|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094382|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094383|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56094384|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
56194176|NCT01491139|Olaparib|olaparib|mesh-list
56194177|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194178|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56194179|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194180|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194181|NCT01491191|Palmidrol|palmidrol|mesh-list
56194182|NCT01491191|Analgesics|analgesics|mesh-ancestor
56194183|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
56194184|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194185|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194186|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56094385|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094386|NCT00691574|Melatonin|melatonin|mesh-list
56094387|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
56094388|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094389|NCT00691574|Protective Agents|protective agents|mesh-ancestor
56094390|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094391|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094412|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094413|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
56094414|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56094416|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094417|NCT03633487|Guaifenesin|guaifenesin|mesh-list
55821542|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56094419|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
56094420|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
56094421|NCT00423020|Hematinics|hematinics|mesh-ancestor
56094422|NCT01756586|Dexamethasone|dexamethasone|mesh-list
56094423|NCT01756586|Bupivacaine|bupivacaine|mesh-list
56094424|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094425|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
56094426|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
56094427|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094428|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094429|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56094430|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
56094431|NCT01756586|Hormones|hormones|mesh-ancestor
56094432|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094433|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56094434|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094435|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
56094436|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
56094441|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56094442|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
56094443|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094444|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094475|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56783107|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56783108|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56783109|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56783110|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
56783111|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783112|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783113|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56783114|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56783115|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56783116|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783117|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783118|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56783119|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56783120|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56783121|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
56783122|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055652|NCT00501345|Aspirin|aspirin|mesh-list
56094476|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56094477|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56094478|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56094481|NCT00638222|Carvedilol|carvedilol|mesh-list
56094482|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56094483|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56094484|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
56094485|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094486|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194187|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56194188|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094487|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094519|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56094520|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
56094521|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094522|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094523|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56094524|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56094525|NCT01705106|Analgesics|analgesics|mesh-ancestor
56094526|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
56094527|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094528|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094529|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094530|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094531|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56094532|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56094533|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094534|NCT00624650|Phenylephrine|phenylephrine|mesh-list
56094535|NCT00624650|Dobutamine|dobutamine|mesh-list
56094602|NCT00379418|Abciximab|abciximab|mesh-list
56094603|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
56094604|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56094605|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
56094606|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56094607|NCT00378716|Leucovorin|leucovorin|mesh-list
56094608|NCT00378716|Fluorouracil|fluorouracil|mesh-list
56094609|NCT00378716|Tegafur|tegafur|mesh-list
56094610|NCT00378716|Calcium|calcium|mesh-list
56094611|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
56094612|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56783123|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783124|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56783125|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56783126|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
56783127|NCT01018251|Alovudine|alovudine|mesh-list
56783128|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
56783129|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094613|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094614|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
56094615|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094616|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56094617|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094618|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094619|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
56094620|NCT00378716|Antidotes|antidotes|mesh-ancestor
56094621|NCT00378716|Protective Agents|protective agents|mesh-ancestor
56094622|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
56094623|NCT00378716|Vitamins|vitamins|mesh-ancestor
56094624|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
56094625|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
56094626|NCT03644095|Guaifenesin|guaifenesin|mesh-list
56094644|NCT01633814|Estrogens|estrogens|mesh-ancestor
56094645|NCT01633814|Hormones|hormones|mesh-ancestor
56094646|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094647|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094648|NCT04585490|Paclitaxel|paclitaxel|mesh-list
56094649|NCT04585490|Cisplatin|cisplatin|mesh-list
56094650|NCT04585490|Carboplatin|carboplatin|mesh-list
56094651|NCT04585490|Pemetrexed|pemetrexed|mesh-list
56094652|NCT04585490|Durvalumab|durvalumab|mesh-list
56094655|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094656|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
56094657|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
56094658|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
56094659|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094660|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094661|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56094662|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56094663|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56094664|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
56094665|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094666|NCT04714099|Cyclosporine|cyclosporine|mesh-list
56094667|NCT04714099|Cyclosporins|cyclosporins|mesh-list
56094668|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094669|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094670|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094671|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
56094672|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194189|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194190|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
56094673|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
56094674|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094675|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
56094676|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094677|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56094678|NCT04566770|Vaccines|vaccines|mesh-list
56094679|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
56094680|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094681|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
56094682|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56094683|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56094684|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094704|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094705|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
56094706|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094707|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56094708|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094709|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094710|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
56094711|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783130|NCT00463047|Fentanyl|fentanyl|mesh-list
56783131|NCT00463047|Oxycodone|oxycodone|mesh-list
56783132|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56783133|NCT00463047|Narcotics|narcotics|mesh-ancestor
56783134|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783135|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783136|NCT00463047|Analgesics|analgesics|mesh-ancestor
56494113|NCT00539396|Insulin|insulin|mesh-list
56783137|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
56783138|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783139|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56783140|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56783141|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
56783142|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
56783143|NCT00487539|Golimumab|golimumab|mesh-list
56783144|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56783145|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56783146|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783147|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094712|NCT01636466|Everolimus|everolimus|mesh-list
56094713|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094714|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094715|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
56094716|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094717|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
56094718|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094719|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
56094720|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094721|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094722|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56094724|NCT04499924|Trastuzumab|trastuzumab|mesh-list
56094725|NCT04499924|Ramucirumab|ramucirumab|mesh-list
56094726|NCT04499924|Tucatinib|tucatinib|mesh-list
56094727|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56094728|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094729|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
56094730|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
56094731|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
56094732|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094733|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56094734|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56094735|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094736|NCT03949621|Vedolizumab|vedolizumab|mesh-list
56094737|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56094738|NCT04429880|Oxytocin|oxytocin|mesh-list
56094771|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56094772|NCT01692158|Tinzaparin|tinzaparin|mesh-list
56094773|NCT01692158|Dalteparin|dalteparin|mesh-list
56094774|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
56094775|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56094776|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56094777|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094779|NCT01570634|Loperamide|loperamide|mesh-list
56094780|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
56094781|NCT01570634|Calcium|calcium|mesh-list
56094799|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
56094800|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56094801|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
56094802|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56783148|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
56783149|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783150|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
56783151|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56783152|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783153|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783154|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56783155|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56783156|NCT00486759|Bevacizumab|bevacizumab|mesh-list
56783157|NCT00486759|Rituximab|rituximab|mesh-list
56783158|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783159|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783160|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56783161|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56783162|NCT00486759|Growth Substances|growth substances|mesh-ancestor
56783163|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783164|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
56783165|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
56783166|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783167|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
56783168|NCT00486603|Temozolomide|temozolomide|mesh-list
56783169|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56783170|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
56094803|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56094804|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56094805|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56094806|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56094807|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56094808|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56094810|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
56094812|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
56094813|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
56094814|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56094815|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56194191|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194192|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56194193|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56194194|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194195|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194197|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56194198|NCT01491204|Paclitaxel|paclitaxel|mesh-list
56194199|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56194200|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194201|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
56194202|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
56194203|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
56194204|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194205|NCT01491217|Paclitaxel|paclitaxel|mesh-list
56194206|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56142891|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56783171|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783172|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783173|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
56783174|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56783175|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56783176|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783177|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783178|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094816|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56094817|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
56094818|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
56094819|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094820|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094821|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094822|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56094823|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
56094824|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094825|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56094826|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
56094827|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
56094828|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56094829|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56094830|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
56094831|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
56094832|NCT00652574|Dasatinib|dasatinib|mesh-list
56094864|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56094866|NCT00521924|Chloroquine|chloroquine|mesh-list
56094867|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
56094868|NCT00521924|Methotrexate|methotrexate|mesh-list
56094869|NCT00521924|Infliximab|infliximab|mesh-list
56094870|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
56094871|NCT00521924|Cyclosporins|cyclosporins|mesh-list
56094872|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56094873|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
56094874|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56094875|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094876|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56094908|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094910|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56094911|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56094912|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094913|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56094914|NCT00379964|Caspofungin|caspofungin|mesh-list
56094915|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
56094916|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094917|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194208|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
56194209|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
56194210|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
56194211|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194212|NCT01491256|Atorvastatin|atorvastatin|mesh-list
56194213|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56194214|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56194215|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
56194216|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194217|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56194218|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56194219|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094943|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094944|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
56094945|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094946|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56094947|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56094948|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56094949|NCT00000734|Renal Agents|renal agents|mesh-ancestor
56094950|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
56094951|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56783179|NCT00474045|Insulin|insulin|mesh-list
56783180|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56783181|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
56783182|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
56783183|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
56783184|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
56783185|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
56783186|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56783187|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783188|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56783189|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
56783190|NCT01020825|Coagulants|coagulants|mesh-ancestor
56783191|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
56783192|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56094952|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56094953|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56094954|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56094955|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56094956|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56094957|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56094958|NCT03663283|Bupivacaine|bupivacaine|mesh-list
56094959|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
56094960|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
56094961|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094962|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094963|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
56094964|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094965|NCT00000764|Interferons|interferons|mesh-list
56095004|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
56095005|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095030|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095031|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095032|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095034|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
56095035|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095036|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095037|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095038|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095039|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095040|NCT00368654|Methotrexate|methotrexate|mesh-list
56095041|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56095042|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
56095043|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56095044|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095045|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56095046|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
56095047|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095048|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095049|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
56095050|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095051|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56095052|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56194220|NCT01491295|Tenofovir|tenofovir|mesh-list
56194221|NCT01491295|Lamivudine|lamivudine|mesh-list
56194222|NCT01491295|Adefovir|adefovir|mesh-list
56194223|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
56194224|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194225|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56194226|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56194227|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194228|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194229|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56194230|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56783193|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56783194|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56783195|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56783196|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783197|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
56783198|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783199|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783200|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56783201|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783202|NCT00462501|Leucovorin|leucovorin|mesh-list
56783203|NCT00462501|Bevacizumab|bevacizumab|mesh-list
56783204|NCT00462501|Fluorouracil|fluorouracil|mesh-list
56783205|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
56783206|NCT00462501|Calcium|calcium|mesh-list
56783207|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
56194231|NCT01491321|Loxoprofen|loxoprofen|mesh-list
56194234|NCT01491321|Analgesics|analgesics|mesh-ancestor
56194235|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
56194236|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194237|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194238|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56194239|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194240|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56194241|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56194242|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095053|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
56095054|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56095055|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095056|NCT00000776|Fluconazole|fluconazole|mesh-list
56095070|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56095071|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095072|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
56095073|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095074|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56095075|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56095076|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095077|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095078|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56095079|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
56095080|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56095081|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56095082|NCT00000776|Amebicides|amebicides|mesh-ancestor
56095083|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56095084|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56095085|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56095086|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
56095087|NCT04283773|Antibodies|antibodies|mesh-list
56095088|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
56095089|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56095090|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
56095091|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095092|NCT00329732|Lidocaine|lidocaine|mesh-list
56095093|NCT00329732|Bupivacaine|bupivacaine|mesh-list
56194243|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
56194244|NCT01491503|Cetirizine|cetirizine|mesh-list
56194245|NCT01491503|Montelukast|montelukast|mesh-list
56194246|NCT01491503|Levocetirizine|levocetirizine|mesh-list
56194247|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56194248|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
56194249|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56194250|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
56194251|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56783208|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783209|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783210|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56783211|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56494177|NCT00540098|Paroxetine|paroxetine|mesh-list
56783212|NCT00462501|Growth Substances|growth substances|mesh-ancestor
56783213|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783214|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
56783215|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56783216|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
56783217|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783218|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783219|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783220|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
56783221|NCT00462501|Antidotes|antidotes|mesh-ancestor
56783222|NCT00462501|Protective Agents|protective agents|mesh-ancestor
56095094|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
56095095|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
56095096|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095097|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095098|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
56095099|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095100|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56095101|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56095102|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56095103|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56095104|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095105|NCT00000782|Vaccines|vaccines|mesh-list
56095106|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
56095107|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095108|NCT00000800|Zidovudine|zidovudine|mesh-list
56095109|NCT00000800|Methadone|methadone|mesh-list
56095110|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
56095111|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095112|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095113|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095114|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095115|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
55815301|NCT02507219|Ibuprofen|ibuprofen|mesh-list
56095175|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095176|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095178|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56095179|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095181|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095182|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095183|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095184|NCT02921906|Acetaminophen|acetaminophen|mesh-list
56095185|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095186|NCT02921906|Analgesics|analgesics|mesh-ancestor
56095187|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
56095188|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095189|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095190|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
56095191|NCT00000812|Thalidomide|thalidomide|mesh-list
56095192|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56095193|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
55879442|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
56783223|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
56783224|NCT00462501|Vitamins|vitamins|mesh-ancestor
56783225|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
56783226|NCT03996603|Estrogens|estrogens|mesh-list
56783227|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56783228|NCT03996603|Hormones|hormones|mesh-ancestor
56783229|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56783230|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783231|NCT00462345|Rituximab|rituximab|mesh-list
56095194|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095195|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
56095196|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56095197|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095198|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56095199|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56095200|NCT00000812|Growth Substances|growth substances|mesh-ancestor
56095201|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
56095202|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095203|NCT00000818|Zidovudine|zidovudine|mesh-list
56194252|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194253|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56194254|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56194255|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194256|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56194258|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
56194259|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
56194260|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194261|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56194262|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56194263|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56194264|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56194265|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
56194266|NCT01491867|Travoprost|travoprost|mesh-list
56194267|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56194268|NCT01492062|Pancrelipase|pancrelipase|mesh-list
56194269|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56194270|NCT01492114|Resveratrol|resveratrol|mesh-list
56194271|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
56194272|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194273|NCT01492114|Protective Agents|protective agents|mesh-ancestor
56095204|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
56095205|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095228|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56095230|NCT00089414|Progesterone|progesterone|mesh-list
56095231|NCT00089414|Estrogens|estrogens|mesh-ancestor
56095232|NCT00089414|Hormones|hormones|mesh-ancestor
55741681|NCT02801097|Irinotecan|irinotecan|mesh-list
56095233|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56095234|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095235|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56095236|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
56095237|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56095238|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56095239|NCT00089414|Progestins|progestins|mesh-ancestor
56095240|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56095241|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56095242|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56095243|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
56095244|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56095245|NCT00089414|Diuretics|diuretics|mesh-ancestor
56095246|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
56095248|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
56095249|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095250|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56095251|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
56095252|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783232|NCT00462345|Methotrexate|methotrexate|mesh-list
56783233|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783234|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783235|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
56783236|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783237|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783238|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56783239|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
56783240|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56783241|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783242|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
56783243|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783244|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
56095253|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095254|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56194274|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194275|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095255|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56095266|NCT00000848|Saquinavir|saquinavir|mesh-list
56095267|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56095268|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56095269|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
56095270|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095271|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095272|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095273|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095274|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
56095275|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095276|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56095277|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56095278|NCT01795586|Carboplatin|carboplatin|mesh-list
56095279|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095280|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
56095281|NCT02212574|Lomustine|lomustine|mesh-list
56095282|NCT02212574|Vincristine|vincristine|mesh-list
56095283|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56095284|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
56095285|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095286|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56095287|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56095288|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
56095289|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095290|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095291|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56095292|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56095293|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
56095294|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
56095295|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
56095296|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
56095297|NCT00000854|Nandrolone|nandrolone|mesh-list
56095298|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
56095299|NCT00000854|Androgens|androgens|mesh-ancestor
56095300|NCT00000854|Hormones|hormones|mesh-ancestor
56095301|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56095302|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095303|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
56095304|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56095305|NCT04298918|Trastuzumab|trastuzumab|mesh-list
56095306|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56095307|NCT04298918|Venetoclax|venetoclax|mesh-list
56095308|NCT04298918|Maytansine|maytansine|mesh-list
56783245|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783246|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56783247|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783248|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56783249|NCT01022541|Bevacizumab|bevacizumab|mesh-list
56783250|NCT01022541|Capecitabine|capecitabine|mesh-list
56783251|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
56783252|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783253|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783254|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56783255|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56783256|NCT01022541|Growth Substances|growth substances|mesh-ancestor
56783257|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783258|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
56783259|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783260|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
56783261|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783262|NCT01047202|Vaccines|vaccines|mesh-list
56783263|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
56783264|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783265|NCT01049854|Vidarabine|vidarabine|mesh-list
56783266|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
56783267|NCT01049854|Thiotepa|thiotepa|mesh-list
56783268|NCT01049854|Busulfan|busulfan|mesh-list
56783269|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
56783270|NCT01049854|Fludarabine|fludarabine|mesh-list
56783271|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56783272|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783273|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
56783274|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783275|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56095309|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56095310|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095311|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56095312|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
56095313|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
56095314|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
56095315|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095316|NCT00001676|Fludarabine|fludarabine|mesh-list
56095317|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095318|NCT03714919|Acetaminophen|acetaminophen|mesh-list
55822439|NCT02740699|Atorvastatin|atorvastatin|mesh-list
56095319|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
56095320|NCT03714919|Ketamine|ketamine|mesh-list
56095321|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
56095322|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56783276|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56783277|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
56783278|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783279|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783280|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56783281|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783282|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
56783283|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
56783284|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783285|NCT00453999|Oseltamivir|oseltamivir|mesh-list
56783286|NCT00453999|Peramivir|peramivir|mesh-list
56783287|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
56095342|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
56095343|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
56095344|NCT00000872|Lamivudine|lamivudine|mesh-list
56095345|NCT00000872|Zidovudine|zidovudine|mesh-list
56095346|NCT00000872|Nevirapine|nevirapine|mesh-list
56095347|NCT00000872|Abacavir|abacavir|mesh-list
56095348|NCT00000872|Stavudine|stavudine|mesh-list
56095349|NCT00000872|Nelfinavir|nelfinavir|mesh-list
56095350|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095351|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095352|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095353|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095354|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
56194276|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56194277|NCT01492153|Insulin|insulin|mesh-list
56194278|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56194279|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
56194280|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
56194281|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
56194282|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194283|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194284|NCT01492166|Insulin|insulin|mesh-list
56194285|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56194286|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194287|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194288|NCT01492179|Lidocaine|lidocaine|mesh-list
56194289|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
56194290|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
56194291|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194292|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194293|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
56194294|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194295|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56095355|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095356|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095357|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095358|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
56095359|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095360|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095361|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56095362|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56095363|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
56095364|NCT00000878|Lamivudine|lamivudine|mesh-list
56095365|NCT00000878|Zidovudine|zidovudine|mesh-list
56095366|NCT00000878|Stavudine|stavudine|mesh-list
56095367|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095368|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095369|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095370|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095371|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
56095372|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095373|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095374|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095375|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
56783288|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783289|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923702|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
56783290|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783291|NCT00453921|Methylphenidate|methylphenidate|mesh-list
56783292|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56783293|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783294|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56095376|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
56095377|NCT04218799|Mupirocin|mupirocin|mesh-list
56095378|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56095502|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56095503|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56095505|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095506|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56095507|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56095508|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56095509|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095510|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095511|NCT00000920|Ritonavir|ritonavir|mesh-list
56095512|NCT00000920|Saquinavir|saquinavir|mesh-list
56095513|NCT00000920|Lamivudine|lamivudine|mesh-list
56095514|NCT00000920|Zidovudine|zidovudine|mesh-list
56095515|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56194296|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56194298|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56194299|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194300|NCT01492205|Insulin|insulin|mesh-list
56194301|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56194302|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194303|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194304|NCT01492218|Insulin|insulin|mesh-list
56194305|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56194306|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194307|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194308|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56194309|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194310|NCT01492504|Asunaprevir|asunaprevir|mesh-list
56095516|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56095517|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
56095518|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095519|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095520|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095521|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095522|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
56095523|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095524|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56095549|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56095550|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095551|NCT00000194|Renal Agents|renal agents|mesh-ancestor
56095552|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56095553|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
56095554|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56095555|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
56095556|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095557|NCT00000200|Methadone|methadone|mesh-list
56095558|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56095559|NCT00000200|Narcotics|narcotics|mesh-ancestor
56095560|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095561|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095562|NCT00000200|Analgesics|analgesics|mesh-ancestor
56095563|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
56095564|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095565|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
56095566|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
56783295|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56783296|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56783297|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783298|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
56783299|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783301|NCT00382720|Capecitabine|capecitabine|mesh-list
56783302|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
56783303|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783304|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
56783305|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
56783306|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
56783307|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783308|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783309|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
56783310|NCT01025349|Bevacizumab|bevacizumab|mesh-list
56095567|NCT00000206|Buprenorphine|buprenorphine|mesh-list
56095568|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56095569|NCT00000206|Narcotics|narcotics|mesh-ancestor
56095570|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095571|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095572|NCT00000206|Analgesics|analgesics|mesh-ancestor
56095573|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
56095574|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095575|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56095576|NCT00000212|Desipramine|desipramine|mesh-list
56095598|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095599|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
56095600|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56095601|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56095602|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56095604|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
56095605|NCT00000950|Rifampin|rifampin|mesh-list
56095606|NCT00000950|Isoniazid|isoniazid|mesh-list
56095607|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
56095608|NCT00000950|Ethambutol|ethambutol|mesh-list
56194311|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
56194312|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194313|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194314|NCT01492543|Tegafur|tegafur|mesh-list
56194315|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56194316|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
56095609|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56095610|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
56095611|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56095612|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095613|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
56095614|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095615|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095616|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095617|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56095618|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095619|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56095620|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56095621|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56095622|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095623|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56095624|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56095664|NCT00000230|Buprenorphine|buprenorphine|mesh-list
56095665|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56095666|NCT00000230|Narcotics|narcotics|mesh-ancestor
56783311|NCT01025349|Docetaxel|docetaxel|mesh-list
56783312|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783313|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783314|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56783315|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56783316|NCT01025349|Growth Substances|growth substances|mesh-ancestor
56783317|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783318|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
56783319|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
56783320|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
56783321|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
56055836|NCT00379977|Vaccines|vaccines|mesh-list
56095667|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095668|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095669|NCT00000230|Analgesics|analgesics|mesh-ancestor
56095670|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
56095671|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095672|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56095673|NCT00000236|Buprenorphine|buprenorphine|mesh-list
56095674|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56095676|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56095677|NCT00000236|Narcotics|narcotics|mesh-ancestor
56095678|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095679|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095680|NCT00000236|Analgesics|analgesics|mesh-ancestor
56095681|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
56095682|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095708|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095709|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
56095710|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56095711|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56095712|NCT00000992|Itraconazole|itraconazole|mesh-list
56095713|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
56095714|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095715|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56095716|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56194317|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194318|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194319|NCT01492556|Etoposide|etoposide|mesh-list
56194320|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56194321|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194322|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56194323|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56095717|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095718|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801877|NCT04819243|Atezolizumab|atezolizumab|mesh-list
56095721|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56095722|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095723|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56095724|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
56095725|NCT00000254|Isoflurane|isoflurane|mesh-list
56095726|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56095727|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
56095728|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
56095729|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095762|NCT00001016|Antidotes|antidotes|mesh-ancestor
56095763|NCT00001016|Protective Agents|protective agents|mesh-ancestor
56095764|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
56095766|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
56095767|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
56095768|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095769|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56095770|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
56783322|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783323|NCT02473276|Morphine|morphine|mesh-list
56783324|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56783325|NCT02473276|Narcotics|narcotics|mesh-ancestor
56783326|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783327|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783328|NCT02473276|Analgesics|analgesics|mesh-ancestor
56095771|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095772|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095773|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56095774|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095807|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095809|NCT00001028|Pentamidine|pentamidine|mesh-list
56095810|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095811|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
56095812|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56095813|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56095814|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56095815|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095816|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095817|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
56095852|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095853|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56095901|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
56095902|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095903|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56095904|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56095905|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56095906|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
56095907|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095908|NCT00001052|Antacids|antacids|mesh-ancestor
56095909|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095910|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56095911|NCT00001058|Ritonavir|ritonavir|mesh-list
56095912|NCT00001058|Indinavir|indinavir|mesh-list
56095913|NCT00001058|Clarithromycin|clarithromycin|mesh-list
56095914|NCT00001058|Ethambutol|ethambutol|mesh-list
56095915|NCT00001058|Rifabutin|rifabutin|mesh-list
56095916|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56095917|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56095918|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
56095919|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095920|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095921|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095922|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095923|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
56095924|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194324|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194325|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194326|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
56194327|NCT01492608|Analgesics|analgesics|mesh-ancestor
56194328|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
56194329|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194330|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194331|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
56194332|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194333|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56194334|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
56194335|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56194336|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56194337|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095925|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56095926|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56095928|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56095929|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
56095930|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56095954|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56783329|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
56783330|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783331|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
56783332|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783333|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
56783334|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56783335|NCT00371566|Lapatinib|lapatinib|mesh-list
56783336|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055855|NCT00357851|Aprotinin|aprotinin|mesh-list
56095955|NCT00000320|Narcotics|narcotics|mesh-ancestor
56095956|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095957|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095958|NCT00000320|Analgesics|analgesics|mesh-ancestor
56095959|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
56095960|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095961|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56095963|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56095964|NCT00000326|Narcotics|narcotics|mesh-ancestor
56095965|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095966|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095967|NCT00000326|Analgesics|analgesics|mesh-ancestor
56095968|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
56095969|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095970|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
56095971|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56095972|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56095973|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
56095974|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56095975|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095976|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095977|NCT00002000|Valacyclovir|valacyclovir|mesh-list
56095978|NCT00002000|Acyclovir|acyclovir|mesh-list
56095979|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
56095980|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095981|NCT03979807|Bromides|bromides|mesh-list
56095982|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
56096019|NCT04169113|Narcotics|narcotics|mesh-ancestor
56096043|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
56096044|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096045|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56096046|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56096047|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56096048|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
56096049|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096050|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096052|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
56096053|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
56096054|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56096055|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096056|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
56096057|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096058|NCT00001094|Lamivudine|lamivudine|mesh-list
56096059|NCT00001094|Zidovudine|zidovudine|mesh-list
56096060|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56096061|NCT00001094|Delavirdine|delavirdine|mesh-list
56096062|NCT00001094|Nelfinavir|nelfinavir|mesh-list
56096063|NCT00001094|Saquinavir|saquinavir|mesh-list
56096064|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096065|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096066|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096088|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56096089|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096090|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56096091|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096092|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
56096093|NCT00000338|Lisuride|lisuride|mesh-list
56096094|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56783337|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56783338|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783339|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783340|NCT00371254|Dasatinib|dasatinib|mesh-list
56783341|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783342|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56783343|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783344|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783345|NCT00452673|Capecitabine|capecitabine|mesh-list
56783346|NCT00452673|Dasatinib|dasatinib|mesh-list
56783347|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783348|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
56783349|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783350|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783351|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56783352|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783353|NCT00461253|Copper|copper|mesh-list
56783354|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
56783355|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56783356|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
56783357|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56783358|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783359|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56783360|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56783361|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56783362|NCT00461253|Trace Elements|trace elements|mesh-ancestor
56783363|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
56783364|NCT00469833|Insulin|insulin|mesh-list
56783365|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56783366|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
56783367|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
56783368|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56783369|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783370|NCT00641537|Cladribine|cladribine|mesh-list
56783371|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783378|NCT00814541|Bortezomib|bortezomib|mesh-list
56783379|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783380|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
56783381|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
56783382|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783383|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783384|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56783385|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
56783386|NCT00814541|Hormones|hormones|mesh-ancestor
56783387|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56783388|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56783389|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783390|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56783391|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56783392|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56783393|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783394|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783395|NCT00814619|Capecitabine|capecitabine|mesh-list
56783396|NCT00814619|Panitumumab|panitumumab|mesh-list
56783397|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783398|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
56783399|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783400|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783401|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783402|NCT00641147|Curcumin|curcumin|mesh-list
56783403|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56783404|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56783405|NCT00641147|Analgesics|analgesics|mesh-ancestor
56783406|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
56783407|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096095|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56096096|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56096097|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
56096098|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096099|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096100|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096104|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096105|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56096106|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56096107|NCT04085341|Growth Substances|growth substances|mesh-ancestor
56096108|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096109|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
56783408|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783409|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783410|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783411|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783412|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783413|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783414|NCT00460239|Morphine|morphine|mesh-list
56783415|NCT00460239|Buprenorphine|buprenorphine|mesh-list
56783416|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56783417|NCT00460239|Narcotics|narcotics|mesh-ancestor
56783418|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783419|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783420|NCT00460239|Analgesics|analgesics|mesh-ancestor
56783421|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
56783422|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783423|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56783424|NCT00640835|Buprenorphine|buprenorphine|mesh-list
56783425|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56783426|NCT00640835|Naloxone|naloxone|mesh-list
56783427|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56783428|NCT00640835|Narcotics|narcotics|mesh-ancestor
56783429|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783430|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783431|NCT00640835|Analgesics|analgesics|mesh-ancestor
56783432|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
56783433|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783434|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56783435|NCT03839355|Warfarin|warfarin|mesh-list
56494403|NCT00541814|Cyclosporins|cyclosporins|mesh-list
56783436|NCT03839355|Apixaban|apixaban|mesh-list
56783437|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
56783452|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783453|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
56783454|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
56783455|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783456|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783457|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56096110|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56096111|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096112|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096113|NCT00002018|Interferons|interferons|mesh-list
56096114|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
56096115|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096116|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
55864534|NCT05039632|Nivolumab|nivolumab|mesh-list
56096140|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56096141|NCT00000344|Narcotics|narcotics|mesh-ancestor
56096142|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56096143|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096144|NCT00000344|Analgesics|analgesics|mesh-ancestor
56096145|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
56096146|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096147|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56096148|NCT04103515|Cimetidine|cimetidine|mesh-list
56096149|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56096150|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56096151|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56096152|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
56096153|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
56096154|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096155|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096156|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096157|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56096158|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096159|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096160|NCT00002030|Pentamidine|pentamidine|mesh-list
56096161|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
56096162|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096163|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56096164|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56096165|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56096166|NCT00001112|Interferons|interferons|mesh-list
56096167|NCT00001112|Zidovudine|zidovudine|mesh-list
56194340|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55864586|NCT01700959|Melatonin|melatonin|mesh-list
56096217|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
56096218|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
56096219|NCT03789175|Vitamins|vitamins|mesh-ancestor
56096220|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
56096221|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096222|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56096223|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
56096224|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096225|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56096226|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
56096227|NCT00002048|Zidovudine|zidovudine|mesh-list
56096228|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
56096229|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096230|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096231|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096232|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096233|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
56096234|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096235|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096259|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096260|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
56096261|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096262|NCT00000440|Naltrexone|naltrexone|mesh-list
56096263|NCT00000440|Sertraline|sertraline|mesh-list
56096264|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56096265|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56096266|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783458|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
56783460|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56783461|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56783462|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783463|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
56783464|NCT00452439|Vitamin D|vitamin d|mesh-list
56783465|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
56783466|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
56783467|NCT00452439|Calcium|calcium|mesh-list
56096267|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
56096271|NCT00000440|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56096272|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56096273|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56096274|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096275|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096276|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
56096277|NCT00002084|Valacyclovir|valacyclovir|mesh-list
56096278|NCT00002084|Acyclovir|acyclovir|mesh-list
56096279|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
56096280|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096281|NCT00000446|Sertraline|sertraline|mesh-list
56096282|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
56096283|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56096284|NCT00000446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56096285|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56096286|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56096287|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096288|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096289|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
56096290|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096326|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096328|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56096329|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56096330|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096331|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
56096332|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096333|NCT00000458|Sertraline|sertraline|mesh-list
56096334|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
56096335|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56096336|NCT00000458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56096337|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55741699|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
56096338|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56096339|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096340|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096342|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096343|NCT03782233|Bromides|bromides|mesh-list
56096344|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56096345|NCT03782233|Rocuronium|rocuronium|mesh-list
56194341|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56194342|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56194343|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56194344|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56194345|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194346|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194347|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194348|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
56194349|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56194350|NCT01492712|Propofol|propofol|mesh-list
56194351|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56194352|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194353|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194354|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56194355|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
56194356|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
56783468|NCT00452439|Vitamins|vitamins|mesh-ancestor
56783469|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
56783470|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783471|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56783472|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56783473|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56783474|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56783475|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194357|NCT01492725|Plasminogen|plasminogen|mesh-list
56194358|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56194359|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56194360|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56194361|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194362|NCT01492881|Doxorubicin|doxorubicin|mesh-list
56194363|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56194364|NCT01492881|Bortezomib|bortezomib|mesh-list
56194365|NCT01492881|Vorinostat|vorinostat|mesh-list
56096372|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56096374|NCT00002102|Antidotes|antidotes|mesh-ancestor
56096375|NCT00002102|Protective Agents|protective agents|mesh-ancestor
56096376|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
56096380|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096381|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56096382|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
56096383|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096384|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096385|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56096386|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096387|NCT00002108|Lamivudine|lamivudine|mesh-list
56096388|NCT00002108|Zidovudine|zidovudine|mesh-list
56096389|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096390|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096391|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096392|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096393|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
56096394|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096395|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096424|NCT00000506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56194366|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56194367|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096425|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56096426|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56096427|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
56096428|NCT00000512|Niacin|niacin|mesh-list
56096429|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
56096430|NCT00000512|Lovastatin|lovastatin|mesh-list
56096431|NCT00000512|L 647318|l 647318|mesh-list
56096432|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
56096433|NCT00000512|Colestipol|colestipol|mesh-list
56096434|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56096435|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
56096436|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096437|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56096438|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
56096439|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
56096440|NCT00000512|Vitamins|vitamins|mesh-ancestor
56096441|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
56096460|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56096461|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56096462|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096463|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56096464|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096465|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
56096466|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56096467|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56096468|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
56096469|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56783476|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56783477|NCT01023087|Colistin|colistin|mesh-list
56783478|NCT01023087|Polymyxins|polymyxins|mesh-list
56783479|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56783480|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783481|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
56783482|NCT00381940|Bortezomib|bortezomib|mesh-list
56783483|NCT00381940|Vinorelbine|vinorelbine|mesh-list
56783484|NCT00381940|Ifosfamide|ifosfamide|mesh-list
56783485|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783486|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56783487|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
56783488|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
56783489|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
56783490|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783491|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56783492|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
56783493|NCT00818675|Sirolimus|sirolimus|mesh-list
56783494|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56783495|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783496|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56783497|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096470|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56096471|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096472|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
56096473|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56096474|NCT00000542|Protective Agents|protective agents|mesh-ancestor
56096475|NCT00000542|Diuretics|diuretics|mesh-ancestor
56096476|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
56096477|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56096478|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56096479|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56096480|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56096481|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
56096482|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096483|NCT00002120|Leucovorin|leucovorin|mesh-list
56096484|NCT00002120|Trimethoprim|trimethoprim|mesh-list
56096485|NCT00002120|Dapsone|dapsone|mesh-list
56096486|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
56096487|NCT00002120|Trimetrexate|trimetrexate|mesh-list
56096488|NCT00002120|Calcium|calcium|mesh-list
56096489|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
56096490|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56096491|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096492|NCT00002120|Antidotes|antidotes|mesh-ancestor
56096493|NCT00002120|Protective Agents|protective agents|mesh-ancestor
56096494|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
56096495|NCT00002120|Vitamins|vitamins|mesh-ancestor
56096496|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
56096497|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56096498|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096499|NCT00002120|Renal Agents|renal agents|mesh-ancestor
56096535|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096536|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56096537|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56096538|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
56783498|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
56783499|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783500|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
56783501|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783502|NCT00364156|Nicotine|nicotine|mesh-list
56783503|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56783504|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
56783505|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783506|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783507|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56783508|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56783509|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
56783510|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783511|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783512|NCT00452361|Cyclosporine|cyclosporine|mesh-list
56783513|NCT00452361|Sirolimus|sirolimus|mesh-list
56783514|NCT00452361|Tacrolimus|tacrolimus|mesh-list
56783515|NCT00452361|Cyclosporins|cyclosporins|mesh-list
56783516|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56783517|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783518|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
56783519|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783520|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783521|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783522|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
56783523|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783524|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
56783525|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783526|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56783527|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56783528|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783529|NCT03334318|Allopurinol|allopurinol|mesh-list
56783530|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
56783531|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056024|NCT05716607|Hydrocortisone|hydrocortisone|mesh-list
55864952|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
56096565|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56096566|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56096567|NCT00002144|Foscarnet|foscarnet|mesh-list
56096568|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56096569|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
56783532|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783533|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
56783534|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783535|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56783536|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
56783537|NCT03334318|Protective Agents|protective agents|mesh-ancestor
56783538|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783539|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
56783540|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56783541|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56783542|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783543|NCT03877809|Sirolimus|sirolimus|mesh-list
56783544|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56783545|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783546|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56783547|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783548|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
56783549|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783550|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
56783551|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783552|NCT01049932|Rilpivirine|rilpivirine|mesh-list
56783553|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56783554|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56783555|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783556|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783557|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
56783558|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783559|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56783560|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56783561|NCT03875391|Oxytocin|oxytocin|mesh-list
56783562|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
56096570|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096571|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096572|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096573|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194369|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56194370|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194371|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194372|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56194373|NCT01492894|Cyclosporine|cyclosporine|mesh-list
56194374|NCT01492894|Sirolimus|sirolimus|mesh-list
56194375|NCT01492894|Tacrolimus|tacrolimus|mesh-list
56194376|NCT01492894|Cyclosporins|cyclosporins|mesh-list
56194377|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56194378|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
56783563|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56783564|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783565|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
56783566|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783567|NCT04903353|Risperidone|risperidone|mesh-list
56783568|NCT04903353|Aripiprazole|aripiprazole|mesh-list
56783569|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56783570|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
56783571|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783572|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783573|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783574|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56783575|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56783576|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783577|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56783578|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56783579|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
56783580|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
56783581|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
56783582|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56783583|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56783584|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56783585|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56783586|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
56783587|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56783588|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56783589|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56494551|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
56783590|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56783591|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783592|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
56783593|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783594|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783595|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56783596|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783600|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783601|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783602|NCT01047748|Protective Agents|protective agents|mesh-ancestor
56783603|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783604|NCT00568451|Paclitaxel|paclitaxel|mesh-list
56783605|NCT00568451|Carboplatin|carboplatin|mesh-list
56783606|NCT00568451|Temozolomide|temozolomide|mesh-list
56783607|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56783608|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783609|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
56783610|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
56783611|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
56096574|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096575|NCT00000578|Beclomethasone|beclomethasone|mesh-list
56096576|NCT00000578|Theophylline|theophylline|mesh-list
56096577|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56096578|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
56096579|NCT00000578|Hormones|hormones|mesh-ancestor
56096580|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56096581|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096582|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56096583|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
56096584|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56096618|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096620|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56096621|NCT00000590|Antibodies|antibodies|mesh-list
56096622|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
56096623|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096624|NCT00000614|Warfarin|warfarin|mesh-list
56096625|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
56096626|NCT02973464|Valganciclovir|valganciclovir|mesh-list
56096648|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56096649|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56096650|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56096651|NCT03109873|Metformin|metformin|mesh-list
56096652|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56096653|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096654|NCT04948892|Anesthetics|anesthetics|mesh-list
56096655|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56096656|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096657|NCT04713254|Metoprolol|metoprolol|mesh-list
56096658|NCT04713254|Midazolam|midazolam|mesh-list
56096659|NCT04713254|Bupropion|bupropion|mesh-list
56096660|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56096661|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56096662|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56096663|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096664|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56096665|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56096666|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56096667|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56096668|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
56096669|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
56096670|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
56096671|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
56096672|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096673|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096674|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56096675|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
56096676|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56096677|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56096678|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56096679|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
56096680|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56783612|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783613|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56783614|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
56783615|NCT00459537|Terbinafine|terbinafine|mesh-list
56783616|NCT00459537|Amorolfine|amorolfine|mesh-list
56783617|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
56783618|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783619|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783620|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783621|NCT03866421|Liver Extracts|liver extracts|mesh-list
56783622|NCT03866421|Hematinics|hematinics|mesh-ancestor
56783623|NCT00819377|Milrinone|milrinone|mesh-list
56783624|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56056132|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
56096696|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096697|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56194379|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194380|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56096699|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096701|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56096702|NCT00002162|Lamivudine|lamivudine|mesh-list
56096703|NCT00002162|Zidovudine|zidovudine|mesh-list
56096704|NCT00002162|Didanosine|didanosine|mesh-list
56096705|NCT00002162|Stavudine|stavudine|mesh-list
56096706|NCT00002162|Zalcitabine|zalcitabine|mesh-list
56096707|NCT00002162|Saquinavir|saquinavir|mesh-list
56096708|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096709|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096710|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096711|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096712|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
56096713|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096714|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096715|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096716|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
56096717|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56096718|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56096719|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
56096720|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56096721|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096722|NCT00000638|Pyridoxine|pyridoxine|mesh-list
56096723|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
56096724|NCT00000638|Rifampin|rifampin|mesh-list
56096725|NCT00000638|Isoniazid|isoniazid|mesh-list
56096726|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
56096727|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56096728|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
56096729|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56096730|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096731|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
56096732|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096733|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096734|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096735|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56096736|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56096737|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56096738|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56096739|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56096740|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56096741|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56096742|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56096743|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
56783625|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56783626|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
56783627|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56783628|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56783629|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783630|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783631|NCT00819377|Protective Agents|protective agents|mesh-ancestor
56783632|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783633|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
56783634|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
56783635|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56783636|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783637|NCT01023243|Aspirin|aspirin|mesh-list
56783638|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56096771|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096772|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096773|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096774|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096776|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096777|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096778|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096779|NCT00002168|Lamivudine|lamivudine|mesh-list
56096780|NCT00002168|Zidovudine|zidovudine|mesh-list
56096781|NCT00002168|Didanosine|didanosine|mesh-list
56096782|NCT00002168|Stavudine|stavudine|mesh-list
56096783|NCT00002168|Indinavir|indinavir|mesh-list
56096784|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096785|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096786|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096787|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096788|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
56096789|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096790|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55865197|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56096816|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56096817|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
56096818|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096819|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096820|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096821|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096822|NCT00000680|Zidovudine|zidovudine|mesh-list
56194382|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194383|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
56194384|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194386|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194387|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56194388|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56194389|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194390|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
56194391|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
56194392|NCT01492920|Vitamins|vitamins|mesh-ancestor
56096823|NCT00000680|Aldesleukin|aldesleukin|mesh-list
56096824|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
56096825|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096826|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096827|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096828|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096829|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
55823937|NCT04620759|Psilocybin|psilocybin|mesh-list
56096830|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096831|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56783639|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56783640|NCT01023243|Analgesics|analgesics|mesh-ancestor
56783641|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
56783642|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783643|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783644|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783645|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783646|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56783647|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56783648|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783649|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56783650|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56783651|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783652|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
56783653|NCT03762915|Minocycline|minocycline|mesh-list
56783654|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56783655|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096832|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096833|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096834|NCT00000692|Miglustat|miglustat|mesh-list
56096835|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096836|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096837|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096838|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096839|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
55865239|NCT00860938|Budesonide|budesonide|mesh-list
56096870|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096871|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56096873|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096874|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56096875|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096876|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
56096877|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56096878|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
56096879|NCT00002198|Abacavir|abacavir|mesh-list
56096880|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096912|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096913|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096914|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
56096915|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096916|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096917|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56096918|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
56096919|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096920|NCT00001526|Daclizumab|daclizumab|mesh-list
56096921|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56096922|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
56096923|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096948|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56096949|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56096950|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56096951|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
56096952|NCT03758365|Hormones|hormones|mesh-ancestor
56096953|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56096954|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096955|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56096956|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
56783656|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
56783657|NCT00469209|Bortezomib|bortezomib|mesh-list
56783658|NCT00469209|Melphalan|melphalan|mesh-list
56783659|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
56783660|NCT00469209|Vitamins|vitamins|mesh-ancestor
56783661|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
56783662|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783663|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783664|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56783665|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
56783666|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783667|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56783668|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783669|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
56783670|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
56783671|NCT00469209|Protective Agents|protective agents|mesh-ancestor
56783672|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56783673|NCT00635219|Vortioxetine|vortioxetine|mesh-list
56783674|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56783675|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56783676|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56096957|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096958|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096959|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56194393|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
56194394|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096960|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
56096961|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
56096962|NCT00002300|Megestrol|megestrol|mesh-list
56096963|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
56096964|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56096965|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56096966|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56096967|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
56096968|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56096969|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096970|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56096971|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56096972|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56096993|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096994|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
56096995|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096996|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096997|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096998|NCT00002216|Lamivudine|lamivudine|mesh-list
56096999|NCT00002216|Zidovudine|zidovudine|mesh-list
56097000|NCT00002216|Abacavir|abacavir|mesh-list
56097001|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56097002|NCT00002216|Nelfinavir|nelfinavir|mesh-list
56097003|NCT00002216|Amprenavir|amprenavir|mesh-list
56097004|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097005|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097006|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097007|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783677|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783678|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783679|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783680|NCT00635219|Analgesics|analgesics|mesh-ancestor
56783681|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
56783682|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783683|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
55900210|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
56097008|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
56097009|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097010|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097011|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097012|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
56097013|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56097014|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56097015|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
56097016|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56097017|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
56097018|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56097019|NCT00002222|Valganciclovir|valganciclovir|mesh-list
56097020|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
56097021|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097022|NCT00002312|Zidovudine|zidovudine|mesh-list
56097051|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097052|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097053|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
56097054|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097056|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56097057|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
56097058|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097059|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56097060|NCT04714177|Protective Agents|protective agents|mesh-ancestor
56097061|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097062|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
56097063|NCT00001628|Giapreza|giapreza|mesh-list
56097064|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
56097065|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
56097066|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56097067|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56097068|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
56097069|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097100|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097101|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097103|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
56097104|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097105|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097106|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097107|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56097108|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56097109|NCT00002330|Ganciclovir|ganciclovir|mesh-list
56097110|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56097111|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
56097112|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194396|NCT01492959|Insulin|insulin|mesh-list
56194397|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56194398|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194399|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194400|NCT01492972|Leuprolide|leuprolide|mesh-list
56194401|NCT01492972|Goserelin|goserelin|mesh-list
56194402|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56194403|NCT01492972|Buserelin|buserelin|mesh-list
56194404|NCT01492972|Androgens|androgens|mesh-list
56194405|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56194406|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
56194407|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56194408|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097113|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097162|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881969|NCT03004612|Incretins|incretins|mesh-ancestor
56783684|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56783685|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
56783686|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56783687|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56783688|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783689|NCT00635219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56783690|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
56783691|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56783692|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56056202|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097164|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56097166|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56097167|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56097168|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56097169|NCT00001658|Amoxicillin|amoxicillin|mesh-list
56097170|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56097171|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097172|NCT00002252|Octreotide|octreotide|mesh-list
56097173|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097174|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56097175|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097176|NCT00002348|Mitoguazone|mitoguazone|mesh-list
56097177|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097178|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097179|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097180|NCT02721277|SMOFlipid|smoflipid|mesh-list
56097181|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56097182|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56097183|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56097184|NCT05752526|Diclofenac|diclofenac|mesh-list
56097185|NCT05752526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56097186|NCT05752526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56097187|NCT05752526|Analgesics|analgesics|mesh-ancestor
56097188|NCT05752526|Sensory System Agents|sensory system agents|mesh-ancestor
56097189|NCT05752526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097190|NCT05752526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097191|NCT05752526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097192|NCT05752526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097193|NCT05752526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56097194|NCT05752526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097195|NCT05752526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097196|NCT00002270|Interferons|interferons|mesh-list
56097197|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
56097198|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
56097199|NCT00002270|Zidovudine|zidovudine|mesh-list
56097200|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097201|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
56097202|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097241|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097242|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097243|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097244|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
56097245|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097246|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097247|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097248|NCT00002276|Zidovudine|zidovudine|mesh-list
56194409|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56194410|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097249|NCT00002276|Ibuprofen|ibuprofen|mesh-list
56097250|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56097251|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56097252|NCT00002276|Analgesics|analgesics|mesh-ancestor
56097253|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
56097254|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097313|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56783693|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56783694|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56783695|NCT01026129|Lidocaine|lidocaine|mesh-list
56783696|NCT01026129|Remifentanil|remifentanil|mesh-list
56783697|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
56783698|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
56783699|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783700|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783701|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
56783702|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783703|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56783704|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56783705|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56783706|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56097314|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56097315|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56097317|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56097318|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56097319|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
56097320|NCT00002288|Zidovudine|zidovudine|mesh-list
56097321|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
56097322|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097323|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097324|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097325|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097326|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
55801896|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
56097332|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56097334|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097335|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097336|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097337|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097338|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
56097339|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097340|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55865731|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56097369|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097370|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097372|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097373|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
56097374|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097375|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56097376|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56097377|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56097378|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
56097379|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56097380|NCT00002378|Ritonavir|ritonavir|mesh-list
56097381|NCT00002378|Nelfinavir|nelfinavir|mesh-list
56097382|NCT00002378|Saquinavir|saquinavir|mesh-list
56097383|NCT00002378|Lamivudine|lamivudine|mesh-list
56097384|NCT00002378|Zidovudine|zidovudine|mesh-list
56097385|NCT00002378|Stavudine|stavudine|mesh-list
56097386|NCT00002378|Delavirdine|delavirdine|mesh-list
56097387|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56097388|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56097389|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
56097390|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097409|NCT02589145|Enoxaparin|enoxaparin|mesh-list
56097410|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56097411|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783707|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783708|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56783709|NCT01026129|Narcotics|narcotics|mesh-ancestor
56783710|NCT01026129|Analgesics|analgesics|mesh-ancestor
56783711|NCT01026285|Risperidone|risperidone|mesh-list
56783712|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
56783713|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56783714|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
56783715|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783716|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783717|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783718|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56783719|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783720|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56783721|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56783722|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
56783723|NCT01026363|Vitamin D|vitamin d|mesh-list
56783724|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
56783725|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
56783726|NCT01026363|Calcitriol|calcitriol|mesh-list
56783727|NCT01026363|Vitamins|vitamins|mesh-list
56783728|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
56783729|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783730|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56783731|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56783732|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56783733|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56783734|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783735|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56783736|NCT01023399|Artesunate|artesunate|mesh-list
56783737|NCT01023399|Amodiaquine|amodiaquine|mesh-list
56783738|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
56783739|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56783740|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56783741|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783742|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783748|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56783749|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56783750|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56783751|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56783752|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783753|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
56783754|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783755|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783756|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56783757|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783758|NCT00451035|Panobinostat|panobinostat|mesh-list
56783759|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783760|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56783761|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783762|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783763|NCT00468585|Bevacizumab|bevacizumab|mesh-list
56783764|NCT00468585|Capecitabine|capecitabine|mesh-list
56783765|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783766|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783767|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56783768|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56783769|NCT00468585|Growth Substances|growth substances|mesh-ancestor
56783770|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783771|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
56783772|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097412|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
56097413|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097414|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097415|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097416|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
56097417|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
56097418|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097419|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097420|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
56097421|NCT02589145|Hormones|hormones|mesh-ancestor
56097422|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56097423|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56097424|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097425|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
56194411|NCT01492972|Hormones|hormones|mesh-ancestor
56194412|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56194413|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
56194414|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56194415|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
56194416|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56194417|NCT01492985|Vaccines|vaccines|mesh-list
56194418|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
56783773|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
56783774|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783775|NCT00450801|Leucovorin|leucovorin|mesh-list
56783776|NCT00450801|Cytarabine|cytarabine|mesh-list
56783777|NCT00450801|Thalidomide|thalidomide|mesh-list
56783778|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
56783779|NCT00450801|Ifosfamide|ifosfamide|mesh-list
56783780|NCT00450801|Rituximab|rituximab|mesh-list
56783781|NCT00450801|Doxorubicin|doxorubicin|mesh-list
56783782|NCT00450801|Methotrexate|methotrexate|mesh-list
56783783|NCT00450801|Etoposide|etoposide|mesh-list
56783784|NCT00450801|Vincristine|vincristine|mesh-list
56783785|NCT00450801|Granisetron|granisetron|mesh-list
56783786|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56783787|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
56783788|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783789|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783790|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56783791|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
56783792|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783793|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783794|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56783795|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783796|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56783797|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56783798|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56783799|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783800|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56783801|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
56783802|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56783803|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783804|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
56783805|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
56194419|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194420|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
56194421|NCT01493050|Calcium|calcium|mesh-list
56194422|NCT01493050|Sevelamer|sevelamer|mesh-list
56213207|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097426|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097427|NCT02589145|Antiviral Agents|antiviral agents|mesh-ancestor
56097428|NCT02589145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097429|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097430|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097431|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56783806|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56783807|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56783808|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56783809|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
56783810|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56783811|NCT00450801|Antidotes|antidotes|mesh-ancestor
56783812|NCT00450801|Protective Agents|protective agents|mesh-ancestor
56783813|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
56783814|NCT00450801|Vitamins|vitamins|mesh-ancestor
56783815|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
56783816|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
56783817|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
56494775|NCT00544349|Leucovorin|leucovorin|mesh-list
56783818|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
56783819|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
56783820|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
56783821|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56783822|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097432|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56097433|NCT02589145|Growth Substances|growth substances|mesh-ancestor
56097434|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
56097435|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097436|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
56097437|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56097439|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55741728|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097440|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56097441|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56097442|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
56097461|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
56097462|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56097464|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097465|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097466|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097467|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097468|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
56097469|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097470|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097471|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097472|NCT00002396|Tenofovir|tenofovir|mesh-list
56097473|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
56097474|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097475|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097476|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097477|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097478|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097479|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097480|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097481|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56097482|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56097483|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
56097484|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097485|NCT00002402|Antacids|antacids|mesh-ancestor
56097486|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097487|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097488|NCT00002420|Didanosine|didanosine|mesh-list
56097489|NCT00002420|Stavudine|stavudine|mesh-list
56097490|NCT00002420|Delavirdine|delavirdine|mesh-list
56097491|NCT00002420|Emivirine|emivirine|mesh-list
56097492|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
56783823|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
56783824|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56783825|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56783826|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56783827|NCT00450801|Growth Substances|growth substances|mesh-ancestor
56783828|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
56783829|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56783830|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
56783831|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783832|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
56783833|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783834|NCT00458211|Ziprasidone|ziprasidone|mesh-list
56783835|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56783836|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
56783837|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783838|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783839|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097493|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097494|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
56194423|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56194424|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194426|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097495|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097496|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097497|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097498|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
56097499|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55865864|NCT01928615|Trastuzumab|trastuzumab|mesh-list
56097508|NCT05722418|Fludarabine|fludarabine|mesh-list
56097509|NCT05722418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097510|NCT05722418|Immunologic Factors|immunologic factors|mesh-ancestor
56097511|NCT05722418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097512|NCT05722418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097513|NCT05722418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097514|NCT05722418|Alkylating Agents|alkylating agents|mesh-ancestor
56097515|NCT05722418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097516|NCT05722418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097517|NCT05722418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56097518|NCT04024501|Verinurad|verinurad|mesh-list
56097519|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
56097520|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097521|NCT05722262|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
56097522|NCT05722262|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56097523|NCT05722262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097524|NCT05722262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56097525|NCT05722262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097527|NCT05709626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56097528|NCT05709626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56097529|NCT05709626|Analgesics|analgesics|mesh-ancestor
56097530|NCT05709626|Sensory System Agents|sensory system agents|mesh-ancestor
56097531|NCT05709626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097532|NCT05709626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097533|NCT05709626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097534|NCT05709626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783840|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56783841|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56783842|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56783843|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56783844|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56783845|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
56783846|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
56783847|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56783848|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783849|NCT00457821|Ivacaftor|ivacaftor|mesh-list
56783850|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56783851|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56783852|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783853|NCT00633893|Apixaban|apixaban|mesh-list
56783854|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56783855|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
56783856|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56783857|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
56783858|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783859|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783860|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
56783861|NCT02550665|Donepezil|donepezil|mesh-list
56783862|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56783863|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097535|NCT05709626|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56097536|NCT05709626|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56097537|NCT05709626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097538|NCT05709626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56097539|NCT05709626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56097540|NCT05709626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097541|NCT05709626|Antipyretics|antipyretics|mesh-ancestor
56097543|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56097544|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56097545|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
56097546|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56097547|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097548|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097549|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56097550|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
56097551|NCT03538015|Protective Agents|protective agents|mesh-ancestor
56097552|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56097553|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56097554|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56097555|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
56097556|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56097557|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56097558|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56097559|NCT03342157|Sennosides|sennosides|mesh-list
56097560|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
56783864|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783865|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
56783866|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783867|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783868|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
56783869|NCT00819845|Carvedilol|carvedilol|mesh-list
56783870|NCT00819845|Ramipril|ramipril|mesh-list
56783871|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56097561|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097562|NCT03342157|Laxatives|laxatives|mesh-ancestor
56194427|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56194428|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
56194429|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
56194430|NCT01493102|Vasopressins|vasopressins|mesh-list
56194431|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
56194432|NCT01493102|Norepinephrine|norepinephrine|mesh-list
56194433|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56194434|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56194435|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
56194436|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194437|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194438|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194439|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
56194440|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
56194441|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194442|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56194443|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
56194444|NCT01493102|Coagulants|coagulants|mesh-ancestor
56097563|NCT04331210|Diclofenac|diclofenac|mesh-list
55865918|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
56097581|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097582|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097584|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56097585|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
56097586|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097587|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097588|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097589|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097590|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097592|NCT05701436|Doxorubicin|doxorubicin|mesh-list
56097593|NCT05701436|Fluorouracil|fluorouracil|mesh-list
56097594|NCT05701436|Oxaliplatin|oxaliplatin|mesh-list
56097595|NCT05701436|Raltitrexed|raltitrexed|mesh-list
56097596|NCT05701436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097597|NCT05701436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56097598|NCT05701436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097599|NCT05701436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097600|NCT05701436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097601|NCT05701436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097603|NCT05701436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097604|NCT05701436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097605|NCT05701436|Immunologic Factors|immunologic factors|mesh-ancestor
56097606|NCT05701436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097607|NCT05701436|Antidotes|antidotes|mesh-ancestor
56097608|NCT05701436|Protective Agents|protective agents|mesh-ancestor
56097609|NCT05701436|Vitamin B Complex|vitamin b complex|mesh-ancestor
56097610|NCT05701436|Vitamins|vitamins|mesh-ancestor
56097611|NCT05701436|Micronutrients|micronutrients|mesh-ancestor
56097612|NCT05701436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56097613|NCT02487277|Gemcitabine|gemcitabine|mesh-list
56097614|NCT02487277|Paclitaxel|paclitaxel|mesh-list
56097615|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56097616|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097617|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
56097618|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
56097619|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
56097620|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881970|NCT03004612|Hormones|hormones|mesh-ancestor
56783872|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56783873|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56783874|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
56783875|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783876|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783877|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783878|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56783879|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
56783880|NCT00819845|Protective Agents|protective agents|mesh-ancestor
56783881|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56097621|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097622|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
56194445|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56194446|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
56194448|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56194449|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
56194450|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194451|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194452|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
56194453|NCT01493154|Vaccines|vaccines|mesh-list
56194454|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
56194455|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194456|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56194457|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194458|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56194459|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
56194460|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194461|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194462|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56194463|NCT01493310|Paclitaxel|paclitaxel|mesh-list
56194464|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56194465|NCT01493310|Mifepristone|mifepristone|mesh-list
56194466|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56194467|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194468|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
56194469|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
56194470|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
56194471|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194472|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56194473|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
56194474|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56194475|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097640|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56097641|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
56097642|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56097643|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097644|NCT02436265|Dexamethasone|dexamethasone|mesh-list
56097645|NCT02436265|Ropivacaine|ropivacaine|mesh-list
56097646|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097647|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
56097648|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
56097649|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097650|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097651|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097652|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
56097653|NCT02436265|Hormones|hormones|mesh-ancestor
56194476|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56194477|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56194478|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56194479|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
56194480|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56194481|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56194482|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
56194483|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56783882|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56783883|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56783884|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
56194484|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
56194485|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56194486|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56194488|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56194489|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
56097654|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56097655|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56097656|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097657|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
56097658|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
56097659|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56097660|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
56097661|NCT05751746|Magnesium Sulfate|magnesium sulfate|mesh-list
56097662|NCT05751746|Analgesics|analgesics|mesh-ancestor
56097663|NCT05751746|Sensory System Agents|sensory system agents|mesh-ancestor
56097664|NCT05751746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097665|NCT05751746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097666|NCT05751746|Anesthetics|anesthetics|mesh-ancestor
56097667|NCT05751746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56097668|NCT05751746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56097669|NCT05751746|Anticonvulsants|anticonvulsants|mesh-ancestor
56097670|NCT05751746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56097671|NCT05751746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56097672|NCT05751746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097673|NCT05751746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56097674|NCT05751746|Tocolytic Agents|tocolytic agents|mesh-ancestor
56097675|NCT05751746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56097676|NCT00002450|Tenofovir|tenofovir|mesh-list
56097677|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
55866049|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
56097687|NCT00002456|Cyclosporine|cyclosporine|mesh-list
56097688|NCT00002456|Methotrexate|methotrexate|mesh-list
56097689|NCT00002456|Cyclosporins|cyclosporins|mesh-list
56097690|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56097691|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
56097692|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56097693|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097694|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097695|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
56097696|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097697|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097698|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
56097699|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097700|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56097701|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097702|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
56097703|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097704|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097705|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
56097706|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194490|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194491|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194492|NCT01493388|Insulin|insulin|mesh-list
56194493|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56194494|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194495|NCT01493440|Atosiban|atosiban|mesh-list
56194496|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
56194497|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56194498|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194499|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
56194500|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56194501|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
56194502|NCT01493453|Fludarabine|fludarabine|mesh-list
56194503|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56194504|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
56194505|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783885|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56783886|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56783887|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
56783888|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783889|NCT00457743|Sunitinib|sunitinib|mesh-list
56783890|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783891|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56783892|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56783893|NCT00457743|Growth Substances|growth substances|mesh-ancestor
56783894|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783895|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
56194506|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194507|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56194508|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
56213208|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
56097707|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56097708|NCT01525927|Cisplatin|cisplatin|mesh-list
56097709|NCT01525927|Carboplatin|carboplatin|mesh-list
56097710|NCT01525927|Etoposide|etoposide|mesh-list
56097711|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097712|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56097714|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097715|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097716|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097717|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
56097718|NCT00002474|Carboplatin|carboplatin|mesh-list
56097719|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
56097720|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097721|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
56097722|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097723|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097724|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097725|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
56097726|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097727|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097728|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56097729|NCT00002474|Analgesics|analgesics|mesh-ancestor
56097730|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
56097731|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097732|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097733|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097734|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097735|NCT05751668|Paclitaxel|paclitaxel|mesh-list
56097736|NCT05751668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56097737|NCT05751668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097738|NCT05751668|Tubulin Modulators|tubulin modulators|mesh-ancestor
56097739|NCT05751668|Antimitotic Agents|antimitotic agents|mesh-ancestor
56097740|NCT05751668|Mitosis Modulators|mitosis modulators|mesh-ancestor
56097741|NCT05751668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194509|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194510|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194511|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56194512|NCT01493479|Rituximab|rituximab|mesh-list
56194513|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56194514|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194515|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
56194516|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194517|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194518|NCT01493570|BI 409306|bi 409306|mesh-list
56194519|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56194520|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194521|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194522|NCT01493622|Minocycline|minocycline|mesh-list
55882040|NCT03000634|Dexamethasone|dexamethasone|mesh-list
56783896|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56783897|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783898|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783899|NCT03705585|Vaccines|vaccines|mesh-list
56783900|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
56783901|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783902|NCT01023867|Donepezil|donepezil|mesh-list
56783903|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56783904|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783905|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783906|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
56783907|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783908|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783909|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
56783910|NCT00820469|Rituximab|rituximab|mesh-list
56194523|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56194524|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194525|NCT01493635|Analgesics|analgesics|mesh-list
56194526|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
56194527|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097742|NCT00002492|Doxorubicin|doxorubicin|mesh-list
56097743|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56097765|NCT05751512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097766|NCT05751512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097767|NCT05751512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56097768|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56097769|NCT02373865|Glimepiride|glimepiride|mesh-list
56097770|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56097771|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097772|NCT02373865|Incretins|incretins|mesh-ancestor
56097773|NCT02373865|Hormones|hormones|mesh-ancestor
56097774|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56097775|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56097776|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
56097777|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097778|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097779|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56097780|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097781|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
56097782|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
56097783|NCT00002498|Fluorouracil|fluorouracil|mesh-list
56097784|NCT00002498|Methotrexate|methotrexate|mesh-list
56097785|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
56097786|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097787|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
56097788|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097790|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097791|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
56097792|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097793|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097794|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55866174|NCT00879034|Lonafarnib|lonafarnib|mesh-list
56097803|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097804|NCT00002498|Analgesics|analgesics|mesh-ancestor
56097805|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
56097806|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194528|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194530|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
56194531|NCT01493648|Vitamins|vitamins|mesh-ancestor
56194532|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
56783911|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783912|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783913|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
56783914|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783915|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56783916|NCT00815399|Metformin|metformin|mesh-list
56783917|NCT00815399|Pioglitazone|pioglitazone|mesh-list
56783918|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56783919|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783920|NCT00644969|Varenicline|varenicline|mesh-list
56783921|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56783922|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56783923|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
56783924|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56783925|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783926|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56783927|NCT00812435|Eptifibatide|eptifibatide|mesh-list
56783928|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56783929|NCT00812513|Becaplermin|becaplermin|mesh-list
56783930|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
56783931|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56783933|NCT00812513|Growth Substances|growth substances|mesh-ancestor
56783965|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56783966|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56783967|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56494929|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
56783968|NCT00820547|Growth Substances|growth substances|mesh-ancestor
56783969|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
56783970|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
56783971|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
56783972|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
56783973|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
56783974|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56783975|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56783976|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56783977|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56783978|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783979|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
56783980|NCT00815867|Hematinics|hematinics|mesh-ancestor
56783981|NCT00815945|Carboplatin|carboplatin|mesh-list
56783982|NCT00815945|Doxorubicin|doxorubicin|mesh-list
56783983|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56783984|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56783985|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56783986|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56783987|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56783988|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56783989|NCT00812825|Prednisolone|prednisolone|mesh-list
56783990|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56783991|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
56783992|NCT00812825|Hormones|hormones|mesh-ancestor
56783993|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56783996|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784007|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56784008|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784009|NCT00647699|Riboflavin|riboflavin|mesh-list
56784010|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56784011|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56784012|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
56784013|NCT00647699|Vitamins|vitamins|mesh-ancestor
56784014|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
56784015|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784016|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56784017|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
56784018|NCT00813059|Bevacizumab|bevacizumab|mesh-list
56784019|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784020|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784021|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56784022|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56784023|NCT00813059|Growth Substances|growth substances|mesh-ancestor
56784024|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784025|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784026|NCT00467649|Insulin|insulin|mesh-list
56784027|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56784028|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
56784029|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
56784030|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
56784031|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
56784032|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
56784057|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784058|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784059|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784060|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56784061|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56784062|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784063|NCT00816413|Cyclosporine|cyclosporine|mesh-list
56784064|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
56784065|NCT00816413|Pentostatin|pentostatin|mesh-list
56784066|NCT00816413|Cyclosporins|cyclosporins|mesh-list
56784067|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784068|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784069|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56784070|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
56784071|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784072|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
56784073|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784114|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784115|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56784116|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56784117|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784118|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56784119|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
56784120|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56784121|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
56784122|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56784123|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56784124|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56784125|NCT00813449|Dacarbazine|dacarbazine|mesh-list
56784126|NCT00813449|Endostar protein|endostar protein|mesh-list
56784127|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56784128|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
56784129|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784130|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784131|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56784132|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56784133|NCT00813449|Growth Substances|growth substances|mesh-ancestor
56784134|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784135|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784136|NCT00822029|Alendronate|alendronate|mesh-list
56784137|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56784138|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784139|NCT00467259|Testosterone|testosterone|mesh-list
56784140|NCT00467259|Androgens|androgens|mesh-ancestor
56784141|NCT00467259|Hormones|hormones|mesh-ancestor
56784142|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56784143|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784144|NCT01022151|Aminophylline|aminophylline|mesh-list
56784145|NCT01022151|Doxapram|doxapram|mesh-list
56784146|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56784147|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
56784153|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56784154|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784155|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784156|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56784157|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56784158|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
56784159|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784160|NCT01022151|Protective Agents|protective agents|mesh-ancestor
56784161|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56784162|NCT01022229|Vitamins|vitamins|mesh-list
56784163|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
56784164|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
56784165|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784166|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
56784167|NCT00449787|Naproxen|naproxen|mesh-list
56784168|NCT00449787|Sumatriptan|sumatriptan|mesh-list
56784169|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56784170|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56784171|NCT00449787|Analgesics|analgesics|mesh-ancestor
56784172|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
56784173|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784174|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784175|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56784176|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784203|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784204|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784205|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56784206|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56784207|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784208|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784209|NCT00449163|Antidotes|antidotes|mesh-ancestor
56784210|NCT00449163|Protective Agents|protective agents|mesh-ancestor
56784211|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
56784212|NCT00449163|Vitamins|vitamins|mesh-ancestor
56784213|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
56784214|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56784215|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
56784216|NCT01026987|Plerixafor|plerixafor|mesh-list
56784217|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56784218|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56784219|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
56784220|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784259|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56784260|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784261|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784262|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784263|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56784264|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56784265|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56784266|NCT01027611|Lidocaine|lidocaine|mesh-list
56495224|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
56784267|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
56784268|NCT01027611|Propoxycaine|propoxycaine|mesh-list
56784269|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
56784270|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
56784271|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784272|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784273|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
56784274|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784275|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56784276|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56784277|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56784278|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56784279|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784280|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56784281|NCT01024413|Gefitinib|gefitinib|mesh-list
56784282|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784283|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56784284|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784285|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784286|NCT00446511|Valsartan|valsartan|mesh-list
56784287|NCT00446511|Enalapril|enalapril|mesh-list
56784288|NCT00446511|Enalaprilat|enalaprilat|mesh-list
56784296|NCT01024491|Paroxetine|paroxetine|mesh-list
56784299|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56784300|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784301|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784302|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
56784303|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784304|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56784305|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
56784306|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56784307|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56784308|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56784309|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784310|NCT00446199|Drospirenone|drospirenone|mesh-list
56784311|NCT00446199|Estradiol|estradiol|mesh-list
56784312|NCT00446199|Estrogens|estrogens|mesh-ancestor
56784313|NCT00446199|Hormones|hormones|mesh-ancestor
56784314|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56784315|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784316|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56784317|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
56784318|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56784319|NCT00446199|Diuretics|diuretics|mesh-ancestor
56784320|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
56784321|NCT01027689|Alprazolam|alprazolam|mesh-list
56784322|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56784323|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784324|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784325|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56784326|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56784327|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56784328|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
56784329|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
56784330|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194533|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194534|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56194535|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56194536|NCT01493674|Folic Acid|folic acid|mesh-list
56194537|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
56097807|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097808|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097810|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
56097811|NCT00002504|Aldesleukin|aldesleukin|mesh-list
56784331|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784332|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
56784333|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56784334|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
56784335|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784336|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784337|NCT01027923|Cytarabine|cytarabine|mesh-list
56784338|NCT01027923|Plerixafor|plerixafor|mesh-list
56784339|NCT01027923|Etoposide|etoposide|mesh-list
56784340|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
56784341|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56784342|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784343|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56784344|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56784345|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784348|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
56784392|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
56784393|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784394|NCT00444795|Sunitinib|sunitinib|mesh-list
56784395|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784396|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56784397|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56784398|NCT00444795|Growth Substances|growth substances|mesh-ancestor
56784399|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784400|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784401|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56784402|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784403|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784404|NCT03527043|Citalopram|citalopram|mesh-list
56784405|NCT03527043|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56784406|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56784407|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56784408|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784409|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784410|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
56784411|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784412|NCT03527043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56784413|NCT03527043|Antidepressive Agents|antidepressive agents|mesh-ancestor
56784414|NCT03527043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56784415|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
56784416|NCT03846219|Calcium|calcium|mesh-list
56495370|NCT00550199|Immunologic Factors|immunologic factors|mesh-ancestor
56784417|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56784420|NCT00455325|Chloroquine|chloroquine|mesh-list
56784435|NCT00455325|Filaricides|filaricides|mesh-ancestor
56784436|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
56784437|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
56784438|NCT01028079|Aspirin|aspirin|mesh-list
56784439|NCT01028079|Ibuprofen|ibuprofen|mesh-list
56784440|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56784441|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56784442|NCT01028079|Analgesics|analgesics|mesh-ancestor
56784443|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
56784444|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784445|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784446|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56784501|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56784502|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56784503|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784504|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784505|NCT05357430|Propofol|propofol|mesh-list
56784506|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56784507|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784508|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784509|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56784510|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
56784511|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
56784512|NCT00370552|Paclitaxel|paclitaxel|mesh-list
56784513|NCT00370552|Epothilones|epothilones|mesh-list
56784514|NCT00370552|Bevacizumab|bevacizumab|mesh-list
56784515|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56784516|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784517|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
56784518|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
56784519|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
56784520|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784521|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56784522|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56784523|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56784524|NCT00370552|Growth Substances|growth substances|mesh-ancestor
56784525|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784526|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
56784527|NCT00537030|Asparaginase|asparaginase|mesh-list
56784528|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784529|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
56784530|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56784531|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784532|NCT04400994|Rituximab|rituximab|mesh-list
56784544|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56784545|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56784546|NCT04429152|Tenofovir|tenofovir|mesh-list
56784547|NCT04429152|Lamivudine|lamivudine|mesh-list
56784548|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
56784549|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784550|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56784551|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56784552|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784553|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784554|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56784555|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56784556|NCT04262154|Prednisone|prednisone|mesh-list
56784557|NCT04262154|Atezolizumab|atezolizumab|mesh-list
56784558|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56784559|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
56784560|NCT04262154|Hormones|hormones|mesh-ancestor
56784561|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56784562|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784563|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56784564|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784565|NCT04001400|Rabeprazole|rabeprazole|mesh-list
56784566|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56784567|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56784568|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56784569|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784570|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784571|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56784572|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56784573|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56784574|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56784575|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784576|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
56784577|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784579|NCT04285866|Durvalumab|durvalumab|mesh-list
56784582|NCT01047982|Folic Acid|folic acid|mesh-list
56784583|NCT01047982|Inositol|inositol|mesh-list
56784584|NCT01047982|Hematinics|hematinics|mesh-ancestor
56784585|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
56784586|NCT01047982|Vitamins|vitamins|mesh-ancestor
56784587|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
56784588|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784589|NCT00536874|Gemcitabine|gemcitabine|mesh-list
56784590|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
56784591|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56784592|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
56784593|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784594|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784595|NCT00536874|Antiviral Agents|antiviral agents|mesh-ancestor
56784596|NCT00536874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784597|NCT00536874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784598|NCT00536874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56784599|NCT00536874|Immunologic Factors|immunologic factors|mesh-ancestor
56784600|NCT00536874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784601|NCT00991848|Lidocaine|lidocaine|mesh-list
56784602|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
56784603|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
56784604|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784605|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784606|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
56097812|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097813|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
56097814|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097815|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
56097816|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097817|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097818|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097820|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56097821|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097822|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
56097823|NCT00002510|Etoposide|etoposide|mesh-list
56097824|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097825|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
56097826|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097827|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097828|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097829|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
56097830|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097831|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097832|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56097833|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56097834|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097835|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097836|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097837|NCT01500109|Acetaminophen|acetaminophen|mesh-list
56097838|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56097839|NCT01500109|Analgesics|analgesics|mesh-ancestor
56097840|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
56784607|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784608|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56784609|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56784610|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56784611|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56784612|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784613|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
56784614|NCT00268476|Metformin|metformin|mesh-list
56784615|NCT00268476|Prednisone|prednisone|mesh-list
56784616|NCT00268476|Prednisolone|prednisolone|mesh-list
56784617|NCT00268476|Celecoxib|celecoxib|mesh-list
56784618|NCT00268476|Docetaxel|docetaxel|mesh-list
56784619|NCT00268476|Estradiol|estradiol|mesh-list
56784620|NCT00268476|Androgens|androgens|mesh-list
56784621|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56784622|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784623|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784624|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
56784625|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
56784626|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
56784627|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784661|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56784662|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
56784663|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784664|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784665|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784666|NCT00536484|Urological Agents|urological agents|mesh-ancestor
56784667|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56784668|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
56784669|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784670|NCT00992004|Turmeric extract|turmeric extract|mesh-list
56784671|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
56784672|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784673|NCT00992004|Protective Agents|protective agents|mesh-ancestor
56784674|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784675|NCT03862716|Insulin|insulin|mesh-list
56784676|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56784677|NCT03862716|Metformin|metformin|mesh-list
56784678|NCT03862716|Liraglutide|liraglutide|mesh-list
56784679|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
56784680|NCT03862716|Xultophy|xultophy|mesh-list
56784681|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56784682|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784715|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784716|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56784717|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784718|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
56784719|NCT00455013|Sirolimus|sirolimus|mesh-list
56784720|NCT00455013|Abatacept|abatacept|mesh-list
56784721|NCT00455013|Tacrolimus|tacrolimus|mesh-list
56784722|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
56784723|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56784724|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
56784725|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784726|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56784727|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784728|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784729|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56784730|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784731|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56784732|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
56784733|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56784734|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784735|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
56784736|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56784737|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784738|NCT00363298|Caffeine|caffeine|mesh-list
56784739|NCT00363298|Amphetamine|amphetamine|mesh-list
56784740|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
56784741|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56784742|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784743|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56784750|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
56784762|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56784763|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56784764|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784765|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784766|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56784767|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56784768|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56784769|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56784770|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
56784771|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
56784772|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
56784773|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
56784774|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784775|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784776|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56784777|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56784778|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56784779|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784780|NCT05254548|Analgesics|analgesics|mesh-ancestor
56784781|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
56784782|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784783|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56784784|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56784785|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56784786|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784812|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
56784813|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56784814|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56784815|NCT04002024|Analgesics|analgesics|mesh-ancestor
56784816|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
56784817|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784818|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784819|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56784820|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56784821|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56784876|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
56784877|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784878|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784879|NCT00992238|Urological Agents|urological agents|mesh-ancestor
56784880|NCT00379834|Timolol|timolol|mesh-list
56784881|NCT00379834|Dorzolamide|dorzolamide|mesh-list
56784882|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56784883|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56784884|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
56784885|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784886|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784887|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784888|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56784889|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56784890|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56784891|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784892|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
56784893|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
56784894|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56784895|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
56784896|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
56784897|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
56784898|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56784899|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784900|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56784909|NCT03453840|Lumefantrine|lumefantrine|mesh-list
56784926|NCT03709446|Leflunomide|leflunomide|mesh-list
56784927|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784928|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784929|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56784930|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
56784931|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784932|NCT05354700|Carboplatin|carboplatin|mesh-list
56784933|NCT05354700|Etoposide|etoposide|mesh-list
56784934|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784935|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56784936|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56784937|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56784938|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784939|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784940|NCT03339258|Doxazosin|doxazosin|mesh-list
56784941|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56784942|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56784943|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56784944|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56784945|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
56784946|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56784947|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784948|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784949|NCT00992706|Doxorubicin|doxorubicin|mesh-list
56784950|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56784951|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56784952|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784953|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56784954|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56784955|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784956|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784967|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56784968|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
56784969|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784970|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784971|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56784972|NCT00993096|Insulin|insulin|mesh-list
56784973|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56784974|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
56784975|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
56784976|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56784977|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
56784978|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56784979|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
56784980|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56784981|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784982|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56784983|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56784984|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
56784985|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
56784986|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56784987|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56784988|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784989|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
56784990|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56784991|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56784992|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56784993|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56784994|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56784995|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56784996|NCT00993408|Selexipag|selexipag|mesh-list
56784997|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56784998|NCT03994107|Paclitaxel|paclitaxel|mesh-list
56784999|NCT03994107|Doxorubicin|doxorubicin|mesh-list
56785007|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56785008|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785009|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56785010|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56785011|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56785012|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785013|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785014|NCT03469713|Nivolumab|nivolumab|mesh-list
56785015|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785016|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785017|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56785018|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785019|NCT00427635|Esomeprazole|esomeprazole|mesh-list
56785020|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56785021|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56785022|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56785023|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785024|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785025|NCT00993642|Panobinostat|panobinostat|mesh-list
56785026|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785027|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56785028|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785029|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785030|NCT01028547|Dexamethasone|dexamethasone|mesh-list
56785031|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785032|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
56785033|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
56785034|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785051|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56785052|NCT01031355|Estrogens|estrogens|mesh-ancestor
56785053|NCT01031355|Hormones|hormones|mesh-ancestor
56785054|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785055|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56785056|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
56785057|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56785058|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56785059|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
56785060|NCT01031355|Vitamins|vitamins|mesh-ancestor
56785061|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
56785062|NCT00993720|Liraglutide|liraglutide|mesh-list
56785063|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56785064|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785065|NCT00993720|Incretins|incretins|mesh-ancestor
56785066|NCT00993720|Hormones|hormones|mesh-ancestor
56785067|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785068|NCT03891264|Cannabidiol|cannabidiol|mesh-list
56785069|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
56785070|NCT00425607|Lonafarnib|lonafarnib|mesh-list
56785071|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785106|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56785107|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785108|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785109|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
56785110|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
56785111|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785112|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785113|NCT00993876|Citalopram|citalopram|mesh-list
56785114|NCT00993876|Reboxetine|reboxetine|mesh-list
56785115|NCT00993876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56785116|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56785117|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56785118|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785119|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785120|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
56785121|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785122|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56785123|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
56785124|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56785125|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56785126|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
56785127|NCT05129358|Furosemide|furosemide|mesh-list
56785128|NCT05129358|Diuretics|diuretics|mesh-ancestor
56785129|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
56785130|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785131|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56785132|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56785133|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785134|NCT01646814|Aspirin|aspirin|mesh-list
56785137|NCT01646814|Analgesics|analgesics|mesh-ancestor
56785146|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56785147|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56785148|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785149|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
56785150|NCT00994344|Ritonavir|ritonavir|mesh-list
56785151|NCT00994344|Lopinavir|lopinavir|mesh-list
56785152|NCT00994344|Darunavir|darunavir|mesh-list
56785153|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56785154|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56785155|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
56785156|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785157|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785158|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56785159|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56785160|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
56785161|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785162|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56785163|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56785164|NCT00994500|Bortezomib|bortezomib|mesh-list
56785165|NCT00994500|Vorinostat|vorinostat|mesh-list
56785166|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785167|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56785168|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785169|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785170|NCT01416636|Treprostinil|treprostinil|mesh-list
56785171|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56785172|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
56785173|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56785174|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56785175|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56785176|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56785177|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785178|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
56785179|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785183|NCT05213208|Propofol|propofol|mesh-list
56785186|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785187|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56785188|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
56785189|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
56785190|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56785191|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56785192|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785193|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
56785194|NCT00999258|Sirolimus|sirolimus|mesh-list
56785195|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56785196|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785197|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56785198|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785199|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
56785200|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785201|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
56785202|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785203|NCT00994734|Mifepristone|mifepristone|mesh-list
56785204|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56785205|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
56785206|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56785207|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785208|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56785209|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56785210|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56785211|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
56785212|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56785213|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56785214|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
56785215|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785216|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
56785217|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56785218|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56785219|NCT00999336|Betrixaban|betrixaban|mesh-list
56785221|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
56785224|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785225|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785226|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
56785227|NCT00995826|Laninamivir|laninamivir|mesh-list
56785228|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
56785229|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785230|NCT00994812|Metformin|metformin|mesh-list
56785231|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56785232|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785233|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
56785234|NCT00994968|Docetaxel|docetaxel|mesh-list
56785235|NCT00994968|Doxorubicin|doxorubicin|mesh-list
56785236|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56785237|NCT00994968|Tegafur|tegafur|mesh-list
56785238|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785239|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
56785240|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785241|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785242|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56785243|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
56785244|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785245|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785246|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56496205|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
56785247|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785248|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
56785249|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
56785273|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785274|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
56785275|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56785276|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56785277|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56785278|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56785279|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
56785280|NCT00995046|Factor VIII|factor viii|mesh-list
56785281|NCT00995046|Coagulants|coagulants|mesh-ancestor
56785282|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56785283|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
56785284|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785285|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
56785286|NCT04000932|Hormones|hormones|mesh-ancestor
56785287|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785288|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785289|NCT05170230|Terlipressin|terlipressin|mesh-list
56785290|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56785291|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56785292|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56785293|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
56785294|NCT01000116|Coagulants|coagulants|mesh-ancestor
56785324|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785325|NCT01000896|Paclitaxel|paclitaxel|mesh-list
56785326|NCT01000896|Carboplatin|carboplatin|mesh-list
56785327|NCT01000896|Saracatinib|saracatinib|mesh-list
56785328|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56785329|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785330|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785331|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
56785332|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
56785333|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785334|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785335|NCT00997542|Allopurinol|allopurinol|mesh-list
56785336|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
56785337|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785338|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785339|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
56785340|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785341|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56785342|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
56785343|NCT00997542|Protective Agents|protective agents|mesh-ancestor
56785344|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785345|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56785346|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
56785347|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785348|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785349|NCT01001130|Fluticasone|fluticasone|mesh-list
56785351|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785352|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56785353|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
56785354|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785371|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
56785372|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785373|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785374|NCT01001364|Budesonide|budesonide|mesh-list
56785375|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
56785376|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785377|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56785378|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
56785379|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785380|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785381|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56785382|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
56785383|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
56785384|NCT01001364|Hormones|hormones|mesh-ancestor
56785385|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785386|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56785387|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56785388|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56785389|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
56785390|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785391|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097841|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097842|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097843|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
56097845|NCT00002516|Dactinomycin|dactinomycin|mesh-list
56097846|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
56097847|NCT00002516|Ifosfamide|ifosfamide|mesh-list
56097848|NCT00002516|Doxorubicin|doxorubicin|mesh-list
56097849|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56097850|NCT00002516|Etoposide|etoposide|mesh-list
56097851|NCT00002516|Vincristine|vincristine|mesh-list
56097852|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097853|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
56097854|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097855|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097856|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097857|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
56097858|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097859|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097860|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56097861|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56097862|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097863|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097864|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097875|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
56097878|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
56194539|NCT01493674|Vitamins|vitamins|mesh-ancestor
56194540|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
56194541|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194542|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
56194543|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56194544|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
56194545|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56785392|NCT01031667|Cilostazol|cilostazol|mesh-list
56785393|NCT01031667|Probucol|probucol|mesh-list
56785394|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56785395|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
56496360|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
56785396|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785397|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785399|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
56785400|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56785401|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56785402|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785403|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56785404|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
56785405|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56785406|NCT01031667|Protective Agents|protective agents|mesh-ancestor
56785407|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56785408|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56785409|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785410|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56785411|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56785412|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
56785413|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56785414|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
56785415|NCT03995277|Biotin|biotin|mesh-list
56785416|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
56785417|NCT03995277|Vitamins|vitamins|mesh-ancestor
56785418|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
56785419|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785420|NCT01323465|Rifampin|rifampin|mesh-list
56785421|NCT01323465|Ketoconazole|ketoconazole|mesh-list
56785422|NCT01323465|Nabiximols|nabiximols|mesh-list
56785423|NCT01323465|Omeprazole|omeprazole|mesh-list
56785424|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56785437|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56785438|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56785439|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56785440|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56785441|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
56785442|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56785443|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56785444|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56785445|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
56785446|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785447|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785448|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56785449|NCT01323465|Analgesics|analgesics|mesh-ancestor
56785450|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
56785451|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785452|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
56785453|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
56785454|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
56785455|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56785456|NCT04000386|Protective Agents|protective agents|mesh-ancestor
56785458|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
56785489|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
56785490|NCT00424749|Hormones|hormones|mesh-ancestor
56785491|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785492|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56785493|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56785494|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56785495|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56785496|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56785497|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785498|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785499|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785500|NCT00424593|Analgesics|analgesics|mesh-ancestor
56785501|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
56785502|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785503|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
56785504|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56785505|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
56785506|NCT00369382|Cyclosporine|cyclosporine|mesh-list
56785507|NCT00369382|Sirolimus|sirolimus|mesh-list
56785508|NCT00369382|Tacrolimus|tacrolimus|mesh-list
56785509|NCT00369382|Cyclosporins|cyclosporins|mesh-list
56785510|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785511|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
56785512|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785513|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56785514|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785523|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
56785536|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
56785537|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56785538|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56785539|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785540|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56785541|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785542|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785543|NCT00441441|Fluticasone|fluticasone|mesh-list
56785544|NCT00441441|Xhance|xhance|mesh-list
56785545|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56785546|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785547|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56785548|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
56785549|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785550|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785551|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56785552|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
56785553|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
56785554|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56785555|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56785556|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56785557|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56785558|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
56785559|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785560|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785561|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
56785573|NCT00436605|Dasatinib|dasatinib|mesh-list
56785583|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785584|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
56785585|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56785586|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785587|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56785588|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56785589|NCT01028781|Growth Substances|growth substances|mesh-ancestor
56785590|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
56785591|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785592|NCT01031901|Sirolimus|sirolimus|mesh-list
56785593|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56785594|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785595|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56785596|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785597|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
56785598|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56785599|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
56785600|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785601|NCT00368992|Paclitaxel|paclitaxel|mesh-list
56785602|NCT00368992|Bevacizumab|bevacizumab|mesh-list
56785603|NCT00368992|Cetuximab|cetuximab|mesh-list
56785604|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56785605|NCT00368992|Antibodies|antibodies|mesh-list
56785606|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
56785607|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56785608|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56785609|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785610|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785611|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56785612|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56785613|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785614|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56785616|NCT00368992|Growth Substances|growth substances|mesh-ancestor
56785627|NCT00375934|Diclofenac|diclofenac|mesh-list
56785628|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56785629|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56785630|NCT00375934|Analgesics|analgesics|mesh-ancestor
56785631|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
56785632|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785633|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785634|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785635|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785636|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56785637|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785638|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785639|NCT01052584|Chloroquine|chloroquine|mesh-list
56785640|NCT01052584|Lumefantrine|lumefantrine|mesh-list
56785641|NCT01052584|Artemether|artemether|mesh-list
56785642|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56785643|NCT01052584|Amebicides|amebicides|mesh-ancestor
56785644|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56785645|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56785646|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785647|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
56785648|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785649|NCT02534506|Nivolumab|nivolumab|mesh-list
56785650|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785651|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785652|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56785653|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785654|NCT01050322|Gemcitabine|gemcitabine|mesh-list
56785655|NCT01050322|Capecitabine|capecitabine|mesh-list
56785656|NCT01050322|Vinorelbine|vinorelbine|mesh-list
56785657|NCT01050322|Lapatinib|lapatinib|mesh-list
56785658|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56785659|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
56785660|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785661|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785662|NCT01050322|Antiviral Agents|antiviral agents|mesh-ancestor
56785663|NCT01050322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785666|NCT01050322|Immunologic Factors|immunologic factors|mesh-ancestor
56785667|NCT01050322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785668|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56785669|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785670|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
56785671|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
56785672|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56785673|NCT00531960|Bevacizumab|bevacizumab|mesh-list
56785674|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56785675|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56785676|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785677|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56785678|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56785679|NCT00531960|Growth Substances|growth substances|mesh-ancestor
56785680|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785681|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
56785682|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56785683|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785684|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785685|NCT01001676|Paclitaxel|paclitaxel|mesh-list
56785686|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56785687|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785688|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
56785689|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
56785690|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
56785691|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785692|NCT00816959|Bleomycin|bleomycin|mesh-list
56785693|NCT00816959|Dacarbazine|dacarbazine|mesh-list
56785694|NCT00816959|Vinblastine|vinblastine|mesh-list
56785711|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56785712|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
56785713|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785714|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785715|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56785716|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56785717|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
56785718|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785719|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785720|NCT00361504|Oxycodone|oxycodone|mesh-list
56785721|NCT00361504|Tapentadol|tapentadol|mesh-list
56785722|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56785723|NCT00361504|Narcotics|narcotics|mesh-ancestor
56785724|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56785725|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785726|NCT00361504|Analgesics|analgesics|mesh-ancestor
56785727|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
56785728|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785729|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56785730|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56785731|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56785732|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785733|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
56785734|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785735|NCT00361270|Complement Factor H|complement factor h|mesh-list
56785759|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
56785760|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785761|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785762|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56785763|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56785764|NCT03990922|Morphine|morphine|mesh-list
56785765|NCT03990922|Ropivacaine|ropivacaine|mesh-list
56785766|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56785767|NCT03990922|Narcotics|narcotics|mesh-ancestor
56785768|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56785769|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496733|NCT00562419|Irinotecan|irinotecan|mesh-list
56785770|NCT03990922|Analgesics|analgesics|mesh-ancestor
56785771|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
56785772|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785773|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
56785774|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
56785775|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
56785776|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56785777|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
56785778|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56785813|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785814|NCT01002300|Oxytocin|oxytocin|mesh-list
56785815|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
56785816|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56785817|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785818|NCT00822419|Lidocaine|lidocaine|mesh-list
56785819|NCT00822419|Ketamine|ketamine|mesh-list
56785820|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
56785821|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
56785822|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56785823|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785824|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
56785825|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785826|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56785827|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56785828|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56785829|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56785830|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785831|NCT00822419|Analgesics|analgesics|mesh-ancestor
56785832|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56785833|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56785834|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
56785835|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56785862|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785863|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785864|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
56785865|NCT01002690|Etoricoxib|etoricoxib|mesh-list
56785866|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56785867|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56785868|NCT01002690|Analgesics|analgesics|mesh-ancestor
56785869|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
56785870|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785871|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785872|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785873|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56785874|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56785875|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56785876|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785877|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785878|NCT01048684|Mannitol|mannitol|mesh-list
56785879|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56785880|NCT01048684|Diuretics|diuretics|mesh-ancestor
56785881|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
56785882|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785883|NCT01002768|Insulin|insulin|mesh-list
56785884|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56785885|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
56785886|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56785911|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785912|NCT01052974|Ropivacaine|ropivacaine|mesh-list
56785913|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
56785914|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
56785915|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56785916|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785917|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
56785918|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785919|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
56785920|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
56785921|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56785922|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785923|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785924|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
56785925|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56785926|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56785927|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785928|NCT01003002|Levodopa|levodopa|mesh-list
56785929|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56785930|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56785931|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
56785932|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56785933|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785934|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785935|NCT01003158|Paclitaxel|paclitaxel|mesh-list
56785936|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56785958|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785959|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56785960|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56785961|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785962|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56785963|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56785964|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56785965|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56785966|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785967|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
56785968|NCT00424047|Dexamethasone|dexamethasone|mesh-list
56785969|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
56785970|NCT00424047|Lenalidomide|lenalidomide|mesh-list
56785971|NCT00424047|BB 1101|bb 1101|mesh-list
56785972|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56785973|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
56785974|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
56785975|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56785976|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785977|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56785978|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
56785979|NCT00424047|Hormones|hormones|mesh-ancestor
56785980|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56785981|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56785982|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56785983|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
56785984|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56785985|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56785986|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
56785987|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56785989|NCT00424047|Growth Substances|growth substances|mesh-ancestor
56785998|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56785999|NCT01032057|Gemcitabine|gemcitabine|mesh-list
56786000|NCT01032057|Capecitabine|capecitabine|mesh-list
56786001|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56786002|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
56786003|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786004|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786005|NCT01032057|Antiviral Agents|antiviral agents|mesh-ancestor
56786006|NCT01032057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786007|NCT01032057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786008|NCT01032057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56786009|NCT01032057|Immunologic Factors|immunologic factors|mesh-ancestor
56786010|NCT01032057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786011|NCT01003314|Vaccines|vaccines|mesh-list
56786012|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
56786013|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786014|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56786015|NCT00530088|Trioxsalen|trioxsalen|mesh-list
56786016|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786017|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
56786018|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56786019|NCT01006668|Propofol|propofol|mesh-list
56786020|NCT01006668|Sevoflurane|sevoflurane|mesh-list
56786021|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56786022|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786023|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786024|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56786025|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
56786046|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786047|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56786048|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56786049|NCT00436215|Growth Substances|growth substances|mesh-ancestor
56786050|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786051|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
56786052|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56786053|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786054|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786055|NCT05734248|Hyaluronic Acid|hyaluronic acid|mesh-list
56786056|NCT05734248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56786057|NCT05734248|Immunologic Factors|immunologic factors|mesh-ancestor
56786058|NCT05734248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786059|NCT05734248|Viscosupplements|viscosupplements|mesh-ancestor
56786060|NCT05734248|Protective Agents|protective agents|mesh-ancestor
56786061|NCT00441363|Bromocriptine|bromocriptine|mesh-list
56786062|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56786063|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56786064|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
56786065|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56786066|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786067|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
56786068|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
56786069|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786070|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786071|NCT05586360|Simvastatin|simvastatin|mesh-list
56786072|NCT05586360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56786073|NCT05586360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56786079|NCT00626795|Mupirocin|mupirocin|mesh-list
56786091|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786092|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786093|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56786094|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
56786095|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
56786096|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56786097|NCT00826553|Analgesics|analgesics|mesh-ancestor
56786098|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
56786099|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786100|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56786101|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56786102|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56786103|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
56786104|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786105|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786106|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56786107|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56786108|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56786109|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786110|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
56786111|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
56786112|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
56786113|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
56786114|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
56786115|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786116|NCT00626639|Cisplatin|cisplatin|mesh-list
56786117|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786118|NCT00626561|Paclitaxel|paclitaxel|mesh-list
56786139|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786140|NCT00423891|Entecavir|entecavir|mesh-list
56786141|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
56786142|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786143|NCT00830609|Ribavirin|ribavirin|mesh-list
56786144|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56786145|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
56786146|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
56786147|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786148|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
56786149|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786150|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
56786151|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786152|NCT00822809|Prednisolone|prednisolone|mesh-list
56786153|NCT00822809|Catumaxomab|catumaxomab|mesh-list
56786154|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56786155|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
56786156|NCT00822809|Hormones|hormones|mesh-ancestor
56786157|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56786158|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786159|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56786162|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
56786195|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
56786196|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56786197|NCT00823121|Buserelin|buserelin|mesh-list
56786198|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56786199|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786200|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56786201|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
56786202|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56786203|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56786204|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786205|NCT00626405|Paclitaxel|paclitaxel|mesh-list
56786206|NCT00626405|Bevacizumab|bevacizumab|mesh-list
56786207|NCT00626405|Carboplatin|carboplatin|mesh-list
56786208|NCT00626405|Temozolomide|temozolomide|mesh-list
56786209|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56786210|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56786211|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786212|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
56786213|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
56786214|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
56786215|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786216|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786217|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56786218|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56786219|NCT00626405|Growth Substances|growth substances|mesh-ancestor
56786221|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
56786245|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
56786246|NCT01050556|Hematinics|hematinics|mesh-ancestor
56786247|NCT01050556|Vitamins|vitamins|mesh-ancestor
56786248|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
56786249|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786250|NCT00423735|Dasatinib|dasatinib|mesh-list
56786251|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786252|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56786253|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786254|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786255|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
56786256|NCT01032213|Analgesics|analgesics|mesh-ancestor
56786257|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
56786258|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786259|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786260|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
56786261|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786262|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56786263|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
56786264|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56786265|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56786266|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786267|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56786268|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
56786269|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56786270|NCT00357994|Levodopa|levodopa|mesh-list
56786271|NCT00357994|Carbidopa|carbidopa|mesh-list
56786272|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56786273|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56786274|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56786275|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
56786276|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786287|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786288|NCT00423657|Vancomycin|vancomycin|mesh-list
56786289|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56786290|NCT00423657|Aztreonam|aztreonam|mesh-list
56786291|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56786292|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786293|NCT00831155|Nicotine|nicotine|mesh-list
56786294|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56786295|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
56786296|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786297|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786298|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56786299|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56786300|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
56786301|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786302|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786303|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
56786304|NCT00827021|Hematinics|hematinics|mesh-list
56786305|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
56786306|NCT04491617|Narcotics|narcotics|mesh-ancestor
56786307|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786308|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786309|NCT04491617|Analgesics|analgesics|mesh-ancestor
56786310|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
56786311|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786312|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
56786318|NCT02407509|Everolimus|everolimus|mesh-list
56786338|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56786339|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786340|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
56786341|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786342|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786343|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56786344|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786345|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
56786346|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56786347|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
56786348|NCT02548403|Simethicone|simethicone|mesh-list
56786349|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
56786350|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786351|NCT02548403|Emollients|emollients|mesh-ancestor
56786352|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
56786353|NCT00367432|Levetiracetam|levetiracetam|mesh-list
56786354|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
56786355|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
56786356|NCT00623363|Piclozotan|piclozotan|mesh-list
56786359|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
56786392|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786393|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786394|NCT00357760|Aflibercept|aflibercept|mesh-list
56786395|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
56786396|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56786397|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56786398|NCT00357760|Growth Substances|growth substances|mesh-ancestor
56786399|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786400|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
56786401|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786402|NCT04396535|Docetaxel|docetaxel|mesh-list
56786403|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786404|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
56786405|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
56786406|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
56786407|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786408|NCT00622739|Ziprasidone|ziprasidone|mesh-list
56786409|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56786410|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
56786411|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786412|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786413|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786419|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
56786444|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
56786445|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
56786446|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786447|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786448|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56786449|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56786450|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497399|NCT00563160|Gemcitabine|gemcitabine|mesh-list
56786451|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56786452|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56786453|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
56786454|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
56786455|NCT01053208|Promethazine|promethazine|mesh-list
56786456|NCT01053208|Ibuprofen|ibuprofen|mesh-list
56786457|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786458|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56786459|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56786460|NCT01053208|Analgesics|analgesics|mesh-ancestor
56786461|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
56786462|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786463|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786464|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56786465|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56786466|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56786467|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786471|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
56786492|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
56786493|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786494|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786495|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
56786496|NCT00824135|Rituximab|rituximab|mesh-list
56786497|NCT00824135|Melphalan|melphalan|mesh-list
56786498|NCT00824135|Thiotepa|thiotepa|mesh-list
56786499|NCT00824135|Clofarabine|clofarabine|mesh-list
56786500|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
56786501|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786502|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786503|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
56786504|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786505|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56786506|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56786507|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56786508|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
56786509|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56786510|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786511|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786512|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786513|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56786514|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
56786515|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56786516|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56786517|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56786518|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
56786519|NCT00422799|Rituximab|rituximab|mesh-list
56786520|NCT00422799|Bortezomib|bortezomib|mesh-list
56786521|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786522|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786523|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
56786525|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56786534|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786535|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56786536|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56786537|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56786538|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56786539|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786540|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56786541|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56786542|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786543|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
56786544|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56786545|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56786546|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56786547|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
56786548|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786549|NCT00435045|Atorvastatin|atorvastatin|mesh-list
56786550|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56786551|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56786552|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
56786553|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786554|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56786555|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56786556|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786557|NCT00441129|Insulin|insulin|mesh-list
56786558|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56786559|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786560|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
56786561|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56786578|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56786579|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
56786580|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
56786581|NCT00832481|Metformin|metformin|mesh-list
56786582|NCT00832481|Repaglinide|repaglinide|mesh-list
56786583|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56786584|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786585|NCT00350272|Tenofovir|tenofovir|mesh-list
56786586|NCT00350272|Lamivudine|lamivudine|mesh-list
56786587|NCT00350272|Efavirenz|efavirenz|mesh-list
56786588|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
56786589|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
56786590|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786591|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56786592|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56786593|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786594|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786595|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56786596|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56786597|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56786598|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56786599|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56786600|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56786601|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56786603|NCT04044287|Misoprostol|misoprostol|mesh-list
56786628|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786629|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
56786630|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
56786631|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56786632|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
56786633|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786634|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786635|NCT00825071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56786636|NCT00825071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56786637|NCT00825071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786638|NCT00825071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786639|NCT00825071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56786640|NCT00574847|Citalopram|citalopram|mesh-list
56786641|NCT00574847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56786642|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56786643|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56786644|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786645|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786646|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
56786650|NCT00574847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786681|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
56786682|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
56786683|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
56786684|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786685|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56786686|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
56786687|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
56786688|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56786689|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
56786690|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56786691|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786692|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56786693|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56786694|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56786695|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56786696|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56786697|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56786698|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786699|NCT02549105|Lidocaine|lidocaine|mesh-list
56786700|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56786701|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
56786702|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
56786703|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786705|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
56786729|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56786730|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
56786731|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786732|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786733|NCT00624065|Carvedilol|carvedilol|mesh-list
56786734|NCT00624065|Lisinopril|lisinopril|mesh-list
56786735|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56786736|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56786737|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
56786738|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786739|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786740|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786741|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56786742|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
56786743|NCT00624065|Protective Agents|protective agents|mesh-ancestor
56786744|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56786745|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56786746|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56786747|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
56786782|NCT00422097|Famotidine|famotidine|mesh-list
56786783|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
56786784|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
56786785|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
56786786|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786787|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786788|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56786789|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786790|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56786791|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
56786792|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
56786793|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786794|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786795|NCT01051102|Insulin|insulin|mesh-list
56786796|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56786797|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
56786798|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
56786799|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56786800|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
56786801|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56786802|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56786808|NCT00434967|Candesartan|candesartan|mesh-list
56786833|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
56786834|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786835|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786836|NCT00837239|Antiviral Agents|antiviral agents|mesh-ancestor
56786837|NCT00837239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786838|NCT00837239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786839|NCT00837239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56786840|NCT00837239|Immunologic Factors|immunologic factors|mesh-ancestor
56786841|NCT00837239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786843|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56786844|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56786845|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786846|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
56786847|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
56786848|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
56786849|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786850|NCT00833963|Trastuzumab|trastuzumab|mesh-list
56786851|NCT00833963|Pertuzumab|pertuzumab|mesh-list
56786852|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56786853|NCT00833963|Maytansine|maytansine|mesh-list
56786854|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56786855|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786856|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56786857|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
56786858|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
56786859|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
56786860|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786861|NCT00837317|Phenol|phenol|mesh-list
56786862|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56786863|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786864|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
56786865|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56786866|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56786867|NCT04043897|Rifaximin|rifaximin|mesh-list
56786868|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56786869|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786873|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56786874|NCT00356590|Analgesics|analgesics|mesh-ancestor
56786875|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
56786876|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56786877|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786878|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56786879|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56786880|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786881|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56786882|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
56786883|NCT00828503|Valganciclovir|valganciclovir|mesh-list
56786884|NCT00828503|Everolimus|everolimus|mesh-list
56786885|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786886|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56786887|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
56786888|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786889|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
56786890|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786891|NCT00834665|Molgramostim|molgramostim|mesh-list
56786892|NCT00834665|Sargramostim|sargramostim|mesh-list
56786893|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
56786894|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786895|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56786896|NCT00837707|Aripiprazole|aripiprazole|mesh-list
56786897|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
56786898|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786899|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56786900|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56786901|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786902|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786903|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
56786904|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
56786905|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786906|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786907|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56786913|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56786915|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
56786916|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56786917|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786918|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
56786919|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786920|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786921|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
56786922|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56786923|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786924|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786925|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56786926|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56786927|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56786928|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
56786929|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786930|NCT00356278|Cycloserine|cycloserine|mesh-list
56786931|NCT00356278|Alprazolam|alprazolam|mesh-list
56786932|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56786933|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56786934|NCT00356278|Renal Agents|renal agents|mesh-ancestor
56786935|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56786936|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
56786937|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56786938|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
56786939|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786940|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56786941|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786942|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56786947|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
56786960|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56786961|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56786962|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56786963|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56786964|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56786965|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56786966|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56786967|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56786968|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56786969|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
56786970|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
56786971|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56786972|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56786973|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
56786975|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
56786976|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
56786977|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56786978|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56786979|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
56786980|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
56786981|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56786982|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
56786983|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
56786984|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
56786985|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56786986|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
56786987|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
56786988|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787007|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56787008|NCT00356122|Growth Substances|growth substances|mesh-ancestor
56787009|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787010|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
56787011|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
56787012|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
56787013|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
56787014|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787015|NCT00828815|Etravirine|etravirine|mesh-list
56787016|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56787017|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56787018|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787019|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787020|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
56787021|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787022|NCT01053520|Navitoclax|navitoclax|mesh-list
56787023|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787024|NCT00347932|Besifloxacin|besifloxacin|mesh-list
56787025|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56787026|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787027|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56787028|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56787029|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787030|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787031|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787032|NCT00828971|Amoxicillin|amoxicillin|mesh-list
56787053|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787054|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787055|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56787056|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
56787057|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
56787058|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56787059|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
56787060|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787061|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787062|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
56787063|NCT00359788|Albuterol|albuterol|mesh-list
56787064|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
56787065|NCT00359788|Ipratropium|ipratropium|mesh-list
56787066|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56787067|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
56787068|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787069|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787070|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56787071|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
56787072|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
56787073|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56787074|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
56787075|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787076|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787083|NCT05416476|Anisodine|anisodine|mesh-list
56787102|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56787103|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
56787104|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787105|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56787106|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56787107|NCT01056172|Ribavirin|ribavirin|mesh-list
56787108|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56787109|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
56787110|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
56787111|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787112|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
56787113|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787114|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
56787115|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787116|NCT00838955|Sirolimus|sirolimus|mesh-list
56787117|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56787118|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787119|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56787120|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498080|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
56787121|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
56787122|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56787123|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
56787124|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787125|NCT00347776|Azithromycin|azithromycin|mesh-list
56787126|NCT00347776|Tetracycline|tetracycline|mesh-list
56787150|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56787151|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
56787152|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56787153|NCT00829205|Protective Agents|protective agents|mesh-ancestor
56787154|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56787155|NCT04944888|Eliglustat|eliglustat|mesh-list
56787156|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787157|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787158|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787159|NCT00839111|Irinotecan|irinotecan|mesh-list
56787160|NCT00839111|Sorafenib|sorafenib|mesh-list
56787161|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56787162|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56787163|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787164|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787165|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787166|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56787167|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56787168|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56787169|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56787170|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
56787171|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787172|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787173|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787174|NCT00836381|Urological Agents|urological agents|mesh-ancestor
56787175|NCT02533336|Abamectin|abamectin|mesh-list
56194546|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194547|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56194548|NCT01493843|Paclitaxel|paclitaxel|mesh-list
56194549|NCT01493843|Bevacizumab|bevacizumab|mesh-list
56097879|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097880|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097881|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097882|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
56097883|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097884|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097885|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56097886|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56097887|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097888|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097889|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097890|NCT00002528|Tamoxifen|tamoxifen|mesh-list
56097891|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56097892|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
56097893|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56097894|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097895|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56787176|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
56787177|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56787178|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787179|NCT00836537|Benazepril|benazepril|mesh-list
56787180|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56787181|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
56787182|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787183|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787184|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56787185|NCT01053910|Ramipril|ramipril|mesh-list
56787186|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56787187|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
56787188|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787189|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787190|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56787191|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56787192|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
56787193|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787194|NCT01008384|Vitamin D|vitamin d|mesh-list
56787195|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
56787197|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
56787198|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787199|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56787226|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787227|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787228|NCT00839501|Diuretics|diuretics|mesh-ancestor
56787229|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
56787230|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787231|NCT00529542|Atorvastatin|atorvastatin|mesh-list
56787232|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56787233|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56787234|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
56787235|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787236|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56787237|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56787238|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787239|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
56787240|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787241|NCT00621959|Levocetirizine|levocetirizine|mesh-list
56787242|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56787243|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56787244|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
56787245|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
56787246|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787247|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787248|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787277|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56787278|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787279|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
56787280|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
56787281|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
56787282|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787283|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56787284|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787285|NCT00830531|Bumetanide|bumetanide|mesh-list
56787286|NCT00830531|Diuretics|diuretics|mesh-ancestor
56787287|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
56787288|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787289|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56787290|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787291|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787292|NCT05014542|Analgesics|analgesics|mesh-list
56787293|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
56787294|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787295|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787296|NCT04926324|Niraparib|niraparib|mesh-list
56787297|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56787298|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787299|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787300|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787301|NCT00621257|Vitamin D|vitamin d|mesh-list
56787302|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
56787303|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
56787304|NCT00621257|Vitamins|vitamins|mesh-list
56787305|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
56787306|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787320|NCT02546531|Antiviral Agents|antiviral agents|mesh-ancestor
56787321|NCT02546531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787322|NCT02546531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787323|NCT02546531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56787324|NCT02546531|Immunologic Factors|immunologic factors|mesh-ancestor
56787325|NCT02546531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787326|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56787327|NCT05205720|Ropivacaine|ropivacaine|mesh-list
56787328|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
56787329|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
56787330|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56787331|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787332|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
56787333|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787334|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
56787335|NCT04043195|Nivolumab|nivolumab|mesh-list
56787336|NCT04043195|Ipilimumab|ipilimumab|mesh-list
56787337|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787338|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56787339|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56787340|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787341|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
56787342|NCT00841061|Trace Elements|trace elements|mesh-ancestor
56787343|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
56787344|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787345|NCT04042805|Lenvatinib|lenvatinib|mesh-list
56787346|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787347|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56787348|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787349|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787350|NCT05643846|Bupivacaine|bupivacaine|mesh-list
56787351|NCT05643846|Anesthetics, Local|anesthetics, local|mesh-list
56787352|NCT05643846|Anesthetics|anesthetics|mesh-list
56787353|NCT05643846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56787354|NCT05643846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787355|NCT05643846|Sensory System Agents|sensory system agents|mesh-ancestor
56787356|NCT05643846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882041|NCT03000634|Lenalidomide|lenalidomide|mesh-list
56787357|NCT00841139|Perhexiline|perhexiline|mesh-list
56787358|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56787359|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787360|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787361|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56787362|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787363|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
56787364|NCT00844337|Amoxicillin|amoxicillin|mesh-list
56787365|NCT00844337|Gentamicins|gentamicins|mesh-list
56787366|NCT00844337|Penicillins|penicillins|mesh-list
56787367|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56787368|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787369|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56787370|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787371|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787372|NCT00841373|Ranibizumab|ranibizumab|mesh-list
56787373|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56787374|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56787375|NCT00841373|Growth Substances|growth substances|mesh-ancestor
56787376|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787377|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
56787378|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787379|NCT00851513|Lidocaine|lidocaine|mesh-list
56787380|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
56787381|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
56787382|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56787383|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787384|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
56787385|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787386|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56787387|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56787388|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56787397|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787398|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
56787399|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56787400|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787401|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56787402|NCT02545751|Thymalfasin|thymalfasin|mesh-list
56787403|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56787404|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
56787405|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787406|NCT00841919|Insulin|insulin|mesh-list
56787407|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56787408|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
56787409|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
56787410|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
56787411|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
56787412|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
56787413|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56787414|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787415|NCT00852059|Methylphenidate|methylphenidate|mesh-list
56787416|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56787417|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787418|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56787419|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56787420|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787421|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787422|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
56787423|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787424|NCT00844727|Rofecoxib|rofecoxib|mesh-list
56787425|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56787426|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56787427|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787428|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787429|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56787436|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56787437|NCT00528528|Ribavirin|ribavirin|mesh-list
56787438|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
56787439|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
56787440|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56787441|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56787442|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56787443|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
56787444|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787445|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
56787446|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787447|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
56787448|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787449|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787450|NCT00620555|Gabapentin|gabapentin|mesh-list
56787451|NCT00620555|Analgesics|analgesics|mesh-ancestor
56787452|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
56787453|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787454|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787455|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
56787456|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56787457|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56787458|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56787459|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56787460|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56787461|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56787462|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787463|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787464|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
56787465|NCT00845351|Bexarotene|bexarotene|mesh-list
56787466|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787482|NCT00845819|Trace Elements|trace elements|mesh-ancestor
56787483|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
56787484|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787485|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
56787486|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
56787487|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56787488|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
56787489|NCT00845819|Ionophores|ionophores|mesh-ancestor
56787490|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56787491|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787492|NCT02546843|Rocuronium|rocuronium|mesh-list
56787493|NCT02546843|Atracurium|atracurium|mesh-list
56787494|NCT02546843|Cisatracurium|cisatracurium|mesh-list
56787495|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56787496|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56787497|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56787498|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787499|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787500|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56787501|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56787502|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
56787503|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787504|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787505|NCT03998982|Dexamethasone|dexamethasone|mesh-list
56787506|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
56787507|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787508|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
56787509|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
56787510|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787527|NCT00620321|Cytarabine|cytarabine|mesh-list
56787528|NCT00620321|Idarubicin|idarubicin|mesh-list
56787529|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56787530|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
56787531|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787532|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787533|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
56787534|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787535|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56787536|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
56787537|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787538|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56787539|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56787540|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56787541|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787542|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
56787543|NCT00621023|Decitabine|decitabine|mesh-list
56787544|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
56787545|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56787546|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
56787547|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787548|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787549|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787550|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
56787551|NCT00621023|Protective Agents|protective agents|mesh-ancestor
56787552|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787553|NCT00621023|Vitamins|vitamins|mesh-ancestor
56787554|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
56787555|NCT00848861|Midazolam|midazolam|mesh-list
56787556|NCT00848861|Meperidine|meperidine|mesh-list
56787557|NCT00848861|Propofol|propofol|mesh-list
56787558|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56787559|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56787572|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56787573|NCT00848861|Narcotics|narcotics|mesh-ancestor
56787574|NCT00848861|Analgesics|analgesics|mesh-ancestor
56787575|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
56787576|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787577|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
56787578|NCT00852371|Piperaquine|piperaquine|mesh-list
56787579|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
56787580|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56787581|NCT00852371|Amodiaquine|amodiaquine|mesh-list
56787582|NCT00852371|Artenimol|artenimol|mesh-list
56787583|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
56787584|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56787585|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56787586|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787587|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56787588|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787589|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787590|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56787591|NCT00852371|Renal Agents|renal agents|mesh-ancestor
56787592|NCT00528372|Metformin|metformin|mesh-list
56787593|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
56787594|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56787595|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787596|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56787597|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787598|NCT01564680|Acetaminophen|acetaminophen|mesh-list
56787599|NCT01564680|Lornoxicam|lornoxicam|mesh-list
56787600|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787601|NCT01564680|Analgesics|analgesics|mesh-ancestor
56787602|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
56787603|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787604|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787605|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
56060024|NCT03561259|Vorinostat|vorinostat|mesh-list
56097896|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097897|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56097898|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56097899|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56097900|NCT02341495|Vitamin D|vitamin d|mesh-list
56097901|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
56097902|NCT02341495|Azacitidine|azacitidine|mesh-list
56097903|NCT02341495|Deferasirox|deferasirox|mesh-list
56097904|NCT02341495|Vitamins|vitamins|mesh-ancestor
56787606|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56787607|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787608|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56787609|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
56787610|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787611|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56787612|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787613|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787614|NCT00527982|Celecoxib|celecoxib|mesh-list
56787615|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56787616|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787617|NCT00527982|Analgesics|analgesics|mesh-ancestor
56787618|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
56787619|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787620|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787621|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787622|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56787623|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56787624|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56787625|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787626|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787627|NCT00527904|Naproxen|naproxen|mesh-list
56787628|NCT00527904|Esomeprazole|esomeprazole|mesh-list
56787654|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56787655|NCT00842933|Prednisone|prednisone|mesh-list
56787656|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
56787657|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
56787658|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56787659|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56787660|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56787661|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787662|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
56787663|NCT00842933|Hormones|hormones|mesh-ancestor
56787664|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56787665|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787666|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56787667|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787668|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
56787669|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
56787670|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787671|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56787674|NCT00849095|Budesonide|budesonide|mesh-list
56787711|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56787712|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
56787713|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787714|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787715|NCT00849329|Lapatinib|lapatinib|mesh-list
56787716|NCT00849329|Esomeprazole|esomeprazole|mesh-list
56787717|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56787718|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56787719|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56787720|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787721|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498673|NCT01691846|Metformin|metformin|mesh-list
56787722|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787723|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56787725|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56787726|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787727|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
56787728|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
56787730|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
56787765|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56787766|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787767|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787768|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56787769|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
56787770|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787771|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
56787772|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787773|NCT00855881|Tegafur|tegafur|mesh-list
56787774|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56787775|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
56787776|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787777|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787778|NCT00619229|Alprostadil|alprostadil|mesh-list
56787779|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56787780|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
56787781|NCT00619229|Urological Agents|urological agents|mesh-ancestor
56787782|NCT02546297|Budesonide|budesonide|mesh-list
56787783|NCT02546297|Bromides|bromides|mesh-list
56787784|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
56787785|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
56787786|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56787787|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787788|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56787789|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
56097905|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
56097906|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097907|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56097908|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097909|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
56097910|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097911|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097912|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097913|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56097914|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56097915|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
56097916|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
56097917|NCT00002534|Cytarabine|cytarabine|mesh-list
56097918|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
56097919|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
56097920|NCT00002534|Thiotepa|thiotepa|mesh-list
56097921|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56097922|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097923|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
56097924|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097925|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097926|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097927|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
56097928|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097939|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56787790|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787791|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787792|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56787793|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
56787794|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
56787795|NCT02546297|Hormones|hormones|mesh-ancestor
56787796|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56787797|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56787798|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56787800|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
56787801|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56787802|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787803|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
56787804|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56787805|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
56787806|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
56787807|NCT00618995|Niacin|niacin|mesh-list
56787808|NCT00618995|Niacinamide|niacinamide|mesh-list
56787809|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
56787810|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56787811|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
56787812|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787813|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56787814|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
56787815|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
56787816|NCT00618995|Vitamins|vitamins|mesh-ancestor
56097940|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
56194550|NCT01493843|Carboplatin|carboplatin|mesh-list
56194551|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56194552|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194553|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
56194554|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
56194555|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
56194556|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194557|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56194558|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56194559|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56194560|NCT01493843|Growth Substances|growth substances|mesh-ancestor
56194561|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194562|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
56194563|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56194564|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56194565|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56194566|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56194567|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194569|NCT01493973|Hematinics|hematinics|mesh-ancestor
56097942|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56787817|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
56787818|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787819|NCT03685344|Durvalumab|durvalumab|mesh-list
56787820|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56787821|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56787822|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56787823|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787824|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
56787825|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787826|NCT00856037|Doxorubicin|doxorubicin|mesh-list
56787827|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56787828|NCT00856037|Topotecan|topotecan|mesh-list
56787829|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56787830|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787831|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56787832|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56787833|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060260|NCT01655719|Pioglitazone|pioglitazone|mesh-list
56097943|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56097944|NCT00002534|Protective Agents|protective agents|mesh-ancestor
56097945|NCT00002546|Ifosfamide|ifosfamide|mesh-list
56097946|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097947|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097948|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
56097949|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097950|NCT00378781|Minocycline|minocycline|mesh-list
56097951|NCT00378781|Heparin|heparin|mesh-list
56097952|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
56097953|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56097954|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55741737|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
56097955|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097956|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56097957|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097958|NCT05751044|Cytarabine|cytarabine|mesh-list
56097959|NCT05751044|Dexamethasone|dexamethasone|mesh-list
56097960|NCT05751044|Cyclophosphamide|cyclophosphamide|mesh-list
56097961|NCT05751044|Venetoclax|venetoclax|mesh-list
56097962|NCT05751044|Dasatinib|dasatinib|mesh-list
56097963|NCT05751044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097964|NCT05751044|Immunologic Factors|immunologic factors|mesh-ancestor
56097965|NCT05751044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097966|NCT05751044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097967|NCT05751044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56097968|NCT05751044|Alkylating Agents|alkylating agents|mesh-ancestor
56097969|NCT05751044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097970|NCT05751044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097971|NCT05751044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56097972|NCT05751044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097973|NCT05751044|Antiemetics|antiemetics|mesh-ancestor
56097974|NCT05751044|Autonomic Agents|autonomic agents|mesh-ancestor
56194571|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
56194572|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
56194573|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194574|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194575|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
56194576|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194577|NCT01493999|Clopidogrel|clopidogrel|mesh-list
56194578|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55882042|NCT03000634|Bortezomib|bortezomib|mesh-list
56787834|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787835|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56787836|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
56787837|NCT02615184|Lansoprazole|lansoprazole|mesh-list
56787838|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56787839|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56787840|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56787841|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787842|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787843|NCT00856271|Losartan|losartan|mesh-list
56787844|NCT00856271|Olmesartan|olmesartan|mesh-list
56787845|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56787846|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56787847|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56787848|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56787849|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56787850|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787851|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
56787852|NCT00856505|Everolimus|everolimus|mesh-list
56787853|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787854|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56787855|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
56787856|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787857|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56787882|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56787883|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787884|NCT00520572|Analgesics|analgesics|mesh-ancestor
56787885|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
56787886|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787887|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787888|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787889|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56787890|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56787891|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56787892|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
56787893|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
56787894|NCT00853697|Testosterone|testosterone|mesh-list
56787895|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
56787896|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
56787897|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56787898|NCT00853697|Dutasteride|dutasteride|mesh-list
56787899|NCT00853697|Androgens|androgens|mesh-ancestor
56787900|NCT00853697|Hormones|hormones|mesh-ancestor
56787901|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56787902|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787937|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787938|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56787939|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787940|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
56787941|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56787942|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56787943|NCT03998826|Piroxicam|piroxicam|mesh-list
56787944|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56787945|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56787946|NCT03998826|Analgesics|analgesics|mesh-ancestor
56787947|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
56787948|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56787949|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787950|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56787951|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56787952|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56787953|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787954|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787955|NCT04035486|Carboplatin|carboplatin|mesh-list
56787956|NCT04035486|Pemetrexed|pemetrexed|mesh-list
56787957|NCT04035486|Osimertinib|osimertinib|mesh-list
56787958|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787959|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787960|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787961|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56787962|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56787963|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56787964|NCT00853931|Panitumumab|panitumumab|mesh-list
56787965|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56787966|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787967|NCT00854009|BLI-489|bli-489|mesh-list
56787968|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56787969|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787975|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787976|NCT00861731|Simvastatin|simvastatin|mesh-list
56787977|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56787978|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56787979|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
56787980|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787981|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56787982|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56787983|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56787984|NCT02544659|Pamidronate|pamidronate|mesh-list
56787985|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56787986|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56787987|NCT00861887|Vancomycin|vancomycin|mesh-list
56787988|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56787989|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56787990|NCT00857519|Carboplatin|carboplatin|mesh-list
56787991|NCT00857519|Melphalan|melphalan|mesh-list
56787992|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56787993|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56787994|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
56787995|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56787996|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56787997|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56787998|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
56787999|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788000|NCT00618449|Azithromycin|azithromycin|mesh-list
56788001|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56788002|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788022|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
56788023|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
56788024|NCT00854321|Rituximab|rituximab|mesh-list
56788025|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56788026|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788027|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
56788028|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788029|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56788030|NCT03684642|Metformin|metformin|mesh-list
56788031|NCT03684642|Dulaglutide|dulaglutide|mesh-list
56788032|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
56788033|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56788034|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788035|NCT00857831|Vitamin D|vitamin d|mesh-list
56788036|NCT00857831|Calcium|calcium|mesh-list
56788037|NCT00857831|Vitamins|vitamins|mesh-ancestor
56788038|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
56788039|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788040|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56788041|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56788042|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
56788043|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788044|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
56788045|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56788046|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56788047|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788048|NCT00862043|Urological Agents|urological agents|mesh-ancestor
56788049|NCT00519636|Fluticasone|fluticasone|mesh-list
56788050|NCT00519636|Xhance|xhance|mesh-list
56788053|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
56788070|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56788071|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788072|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788073|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56788074|NCT00857987|Expectorants|expectorants|mesh-list
56788075|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
56788076|NCT00854477|Capecitabine|capecitabine|mesh-list
56788077|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56788078|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
56788079|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788080|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788081|NCT00854633|Lactoferrin|lactoferrin|mesh-list
56788082|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
56788083|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788084|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788085|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
56788086|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56788087|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56788088|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
56788089|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788090|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56788123|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56788124|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
56788125|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788126|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
56788127|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56788128|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
56788129|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788130|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788131|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56788132|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
56788133|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56788134|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
56788135|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788136|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788137|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56788138|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
56788139|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
56788140|NCT00854711|Protective Agents|protective agents|mesh-ancestor
56788141|NCT00858455|Dolutegravir|dolutegravir|mesh-list
56788142|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56788143|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56788144|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788145|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788146|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56788147|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56194579|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56194580|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56194581|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56194582|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56194583|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
56194584|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194585|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097975|NCT05751044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097976|NCT05751044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097977|NCT05751044|Glucocorticoids|glucocorticoids|mesh-ancestor
56097978|NCT05751044|Hormones|hormones|mesh-ancestor
56097979|NCT05751044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56097980|NCT05751044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56097981|NCT05751044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097982|NCT05751044|Antimetabolites|antimetabolites|mesh-ancestor
56097983|NCT05751044|Antiviral Agents|antiviral agents|mesh-ancestor
56097984|NCT05751044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097985|NCT05751044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56097986|NCT05751044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097987|NCT00378625|Artesunate|artesunate|mesh-list
56097988|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
56097989|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56097990|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56788148|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
56788149|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788150|NCT02544737|Apatinib|apatinib|mesh-list
56788151|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788152|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56788153|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788154|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788155|NCT00526656|Sunitinib|sunitinib|mesh-list
56788156|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788157|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56788158|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56788159|NCT00526656|Growth Substances|growth substances|mesh-ancestor
56788160|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788161|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
56788162|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56788163|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788164|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788165|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
56788166|NCT00858767|Vitamin K|vitamin k|mesh-list
56788167|NCT00858767|Vitamin MK 7|vitamin mk 7|mesh-list
56788168|NCT00858767|Caseins|caseins|mesh-list
56788169|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
56788170|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
56788171|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788172|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56788173|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56788174|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
56788175|NCT00858767|Coagulants|coagulants|mesh-ancestor
56788176|NCT00858767|Vitamins|vitamins|mesh-ancestor
56788196|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788197|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788198|NCT00859079|Insulin|insulin|mesh-list
56788199|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56788200|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56788201|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56788202|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788203|NCT00859079|Incretins|incretins|mesh-ancestor
56788204|NCT00859079|Hormones|hormones|mesh-ancestor
56788205|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56788206|NCT02544425|Dexamethasone|dexamethasone|mesh-list
56788207|NCT02544425|Etoposide|etoposide|mesh-list
56788208|NCT02544425|Melphalan|melphalan|mesh-list
56788209|NCT02544425|Busulfan|busulfan|mesh-list
56788210|NCT02544425|Asparaginase|asparaginase|mesh-list
56788211|NCT02544425|Ifosfamide|ifosfamide|mesh-list
56788212|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56788213|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
56788214|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
56788215|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788216|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788217|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56788218|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
56788219|NCT02544425|Hormones|hormones|mesh-ancestor
56788220|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56788221|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56788222|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788223|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56788224|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56788225|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56788226|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788227|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788233|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
56788239|NCT04523688|Temozolomide|temozolomide|mesh-list
56788240|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56788241|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
56788242|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788243|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788244|NCT00511836|Naltrexone|naltrexone|mesh-list
56788245|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56788246|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56788247|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499197|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
56788248|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
56788249|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788250|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
56788251|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56788252|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788253|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788254|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56788255|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788256|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56788258|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56788259|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56788260|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56788261|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788262|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788263|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788264|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788265|NCT00855101|Voriconazole|voriconazole|mesh-list
56788266|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
56788277|NCT00573755|Sorafenib|sorafenib|mesh-list
56788281|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788282|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56788283|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788284|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788285|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56788286|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56788287|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56788288|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
56788289|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56788290|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788291|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56788292|NCT02544191|Goserelin|goserelin|mesh-list
56788293|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56788294|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788295|NCT00524316|Doxorubicin|doxorubicin|mesh-list
56788296|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56788297|NCT00524316|Sunitinib|sunitinib|mesh-list
56788298|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56788299|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788300|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56788301|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56788302|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788303|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788304|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56788329|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788330|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56788331|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788332|NCT02544269|Bupivacaine|bupivacaine|mesh-list
56788333|NCT02544269|Ropivacaine|ropivacaine|mesh-list
56788334|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
56788335|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
56788336|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788337|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788338|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
56788339|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788340|NCT00434577|Vaccines|vaccines|mesh-list
56788341|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
56788342|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788343|NCT00865085|Dexetimide|dexetimide|mesh-list
56788344|NCT00865085|Citalopram|citalopram|mesh-list
56788345|NCT00865085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56788346|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56788347|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788348|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788349|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788350|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
56788351|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788352|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56788353|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
56788354|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56788355|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56788356|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56097991|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097992|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097993|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
56097994|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
56098030|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098031|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098032|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56098033|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
56098044|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
56098045|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098046|NCT00002552|Antidotes|antidotes|mesh-ancestor
56098047|NCT00002552|Protective Agents|protective agents|mesh-ancestor
56098048|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
56098050|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
56098051|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098052|NCT05750966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56098053|NCT05750966|Ciprofloxacin|ciprofloxacin|mesh-list
56098054|NCT05750966|Gentamicins|gentamicins|mesh-list
56098055|NCT05750966|Ceftriaxone|ceftriaxone|mesh-list
56098056|NCT05750966|Cefuroxime|cefuroxime|mesh-list
56098057|NCT05750966|Cefuroxime axetil|cefuroxime axetil|mesh-list
56788357|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
56788358|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
56788359|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788360|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56788361|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56788362|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
56788363|NCT00796068|Cyclosporine|cyclosporine|mesh-list
56788364|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
56788365|NCT00796068|Fludarabine|fludarabine|mesh-list
56788366|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
56788367|NCT00796068|Treosulfan|treosulfan|mesh-list
56788368|NCT00796068|Busulfan|busulfan|mesh-list
56788369|NCT00796068|Cyclosporins|cyclosporins|mesh-list
56788370|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788371|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56788372|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
56788373|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788374|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56788375|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
56788376|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788377|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788378|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
56788379|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788380|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
56788381|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56788382|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56788383|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56788384|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56788385|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
56788386|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56788404|NCT01009476|Nicergoline|nicergoline|mesh-list
56788405|NCT01009476|Piracetam|piracetam|mesh-list
56788406|NCT01009476|Galantamine|galantamine|mesh-list
56788407|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
56788408|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56788409|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788410|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788411|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
56788412|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788413|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788414|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56788415|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
56788416|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788417|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56788418|NCT01009476|Protective Agents|protective agents|mesh-ancestor
56788419|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56788420|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56788421|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788422|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
56788423|NCT00517296|Adalimumab|adalimumab|mesh-list
56788424|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56788425|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56788426|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
56788427|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56788428|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56788429|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788430|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
56788431|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56788432|NCT00523848|Thalidomide|thalidomide|mesh-list
56788433|NCT00523848|Doxorubicin|doxorubicin|mesh-list
56788434|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56788435|NCT00523848|Bortezomib|bortezomib|mesh-list
56788436|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56788437|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788438|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56788439|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56788446|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56788447|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788448|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56788449|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56788450|NCT00523848|Growth Substances|growth substances|mesh-ancestor
56788451|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
56788452|NCT04414722|Amoxicillin|amoxicillin|mesh-list
56788453|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
56788454|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
56788455|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56788456|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56788457|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788458|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56788459|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788460|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788461|NCT00617669|Docetaxel|docetaxel|mesh-list
56788462|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788463|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56788464|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56788465|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56788466|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788467|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
56788468|NCT04018157|Ketamine|ketamine|mesh-list
56788469|NCT04018157|Propofol|propofol|mesh-list
56499419|NCT01156792|Montelukast|montelukast|mesh-list
56788470|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56788471|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788472|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788473|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56788474|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
56788477|NCT04018157|Analgesics|analgesics|mesh-ancestor
56788490|NCT00865241|Glyburide|glyburide|mesh-list
56788491|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56788492|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788493|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56788494|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
56788495|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56788496|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788497|NCT00863291|Buprenorphine|buprenorphine|mesh-list
56788498|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56788499|NCT00863291|Narcotics|narcotics|mesh-ancestor
56788500|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788501|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788502|NCT00863291|Analgesics|analgesics|mesh-ancestor
56788503|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
56788504|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788505|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56788506|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
56788507|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56788508|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56788509|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788510|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
56788511|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
56788512|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788513|NCT03639714|Nivolumab|nivolumab|mesh-list
56788514|NCT03639714|Ipilimumab|ipilimumab|mesh-list
56788515|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56788516|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788517|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56788518|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788519|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
56788520|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56788521|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56788532|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56788533|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56788534|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56788535|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
56788536|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56788537|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788538|NCT00861107|Vaccines|vaccines|mesh-list
56788539|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
56788540|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788541|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
56788542|NCT00510510|Bromides|bromides|mesh-list
56788543|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
56788544|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56788545|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56499494|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
56788546|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56788547|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
56788548|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788549|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788550|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788551|NCT04685694|Misoprostol|misoprostol|mesh-list
56788552|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56788553|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
56788554|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56788555|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788556|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56788557|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56788558|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
56788559|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
56788560|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
56788561|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56788562|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788564|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
56788574|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56788575|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56788576|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788577|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56788578|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56788579|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56788580|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788581|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788582|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
56788583|NCT00863837|Terlipressin|terlipressin|mesh-list
56788584|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56788585|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56788586|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56788587|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788588|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788589|NCT00863915|Ramipril|ramipril|mesh-list
56788590|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56788591|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
56788592|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788593|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788594|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56788595|NCT01009944|Atenolol|atenolol|mesh-list
56788596|NCT01009944|Lisinopril|lisinopril|mesh-list
56788597|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56788598|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56788599|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788600|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788601|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56788602|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56788603|NCT01009944|Protective Agents|protective agents|mesh-ancestor
56788604|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788605|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56788606|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
56788607|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
56788608|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098058|NCT05750966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56788609|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56788610|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56788611|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56788612|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788613|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788614|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56788615|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
56788616|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
56788617|NCT00864071|Griseofulvin|griseofulvin|mesh-list
56788618|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
56788619|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788620|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56788621|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
56788622|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788623|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56788624|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
56788625|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788626|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788627|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56788662|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
56788663|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56788664|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788665|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788666|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
56788667|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56788668|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56788669|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
56788670|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788671|NCT00617591|Dexamethasone|dexamethasone|mesh-list
56788672|NCT00617591|Doxorubicin|doxorubicin|mesh-list
56788673|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56788674|NCT00617591|Lenalidomide|lenalidomide|mesh-list
56788675|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56788676|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
56788677|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
56788678|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788679|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788680|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56788681|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
56788682|NCT00617591|Hormones|hormones|mesh-ancestor
56788683|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56788684|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56788685|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788686|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56788687|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56788696|NCT00864305|Gabapentin|gabapentin|mesh-list
56788709|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788710|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
56788711|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56788712|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56788713|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56788714|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788715|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788716|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788717|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788718|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788719|NCT04018313|Omalizumab|omalizumab|mesh-list
56788720|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56788721|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56788722|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56788723|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
56788724|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
56788725|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788726|NCT00864617|Nifedipine|nifedipine|mesh-list
56788727|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56788728|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788729|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788730|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56788731|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788732|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
56788733|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
56788734|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56788735|NCT00865943|Dexetimide|dexetimide|mesh-list
56788736|NCT00865943|Citalopram|citalopram|mesh-list
56788737|NCT00865943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56788738|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56788739|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788742|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
56788748|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56788749|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
56788750|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
56788751|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788752|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56788753|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56788754|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
56788755|NCT00866021|Ritonavir|ritonavir|mesh-list
56788756|NCT00866021|Lopinavir|lopinavir|mesh-list
56788757|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56788758|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56788759|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
56788760|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788761|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788762|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56788763|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56788764|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
56788765|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788766|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56788767|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56788768|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
56788769|NCT04545762|Fludarabine|fludarabine|mesh-list
56788770|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
56788771|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56788772|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
56788773|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788774|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56788775|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56788776|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
56788777|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788778|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788790|NCT00871247|Urological Agents|urological agents|mesh-ancestor
56788791|NCT02543879|Azacitidine|azacitidine|mesh-list
56788792|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56788793|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
56788794|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788795|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788796|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788797|NCT04137120|Aflibercept|aflibercept|mesh-list
56788798|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56788799|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56788800|NCT04137120|Growth Substances|growth substances|mesh-ancestor
56788801|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788802|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
56788803|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788804|NCT00616655|Eszopiclone|eszopiclone|mesh-list
56788805|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56788806|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56788807|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788808|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
56788809|NCT00864773|Growth Substances|growth substances|mesh-ancestor
56788810|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788811|NCT01010490|Dipivefrin|dipivefrin|mesh-list
56788812|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56788813|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788814|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788815|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788816|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788817|NCT00516048|Exenatide|exenatide|mesh-list
56788821|NCT00516048|Incretins|incretins|mesh-ancestor
56788835|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788836|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56788837|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56788838|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
56788839|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788840|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56788841|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56788842|NCT00872417|Lamivudine|lamivudine|mesh-list
56788843|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56788844|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56788845|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56788846|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788847|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
56788848|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56788849|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56788850|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56788851|NCT00876317|Etoricoxib|etoricoxib|mesh-list
56788852|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56788853|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56788866|NCT00866645|Sulpiride|sulpiride|mesh-list
56061323|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061324|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788889|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788890|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788891|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788892|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788893|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56788894|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56788895|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56788896|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56788897|NCT00872963|Vaccines|vaccines|mesh-list
56788898|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
56788899|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788900|NCT00873197|Granisetron|granisetron|mesh-list
56788901|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
56788902|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
56788903|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56788945|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
56788946|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56788947|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56788948|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56788949|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
56788950|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56788951|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788952|NCT00877175|Protective Agents|protective agents|mesh-ancestor
56788953|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56788954|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56788955|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
56788956|NCT00420927|Adalimumab|adalimumab|mesh-list
56788957|NCT00420927|Methotrexate|methotrexate|mesh-list
56788958|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56788959|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
56788960|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56788961|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56788962|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56788963|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
56788964|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56788965|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56788996|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56788997|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56788998|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56788999|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56789000|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56789001|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
56789002|NCT05225831|Fludarabine|fludarabine|mesh-list
56789003|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789004|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
56789005|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789006|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789007|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56789008|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
56789009|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789010|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789011|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56789012|NCT00873509|Buspirone|buspirone|mesh-list
56789013|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56789014|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56789015|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789016|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789017|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56789018|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56789019|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
56789020|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789021|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789022|NCT00877253|Carboplatin|carboplatin|mesh-list
56789023|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789024|NCT05225753|Chrysarobin|chrysarobin|mesh-list
56789025|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56789038|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789039|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789040|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789041|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56789042|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
56789043|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789044|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789045|NCT00867737|Fluticasone|fluticasone|mesh-list
56789046|NCT00867737|Budesonide|budesonide|mesh-list
56789047|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
56789048|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56789049|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56789050|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56789051|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789052|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56789053|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
56789054|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789055|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789056|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56789057|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
56789058|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
56789059|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56789060|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
56789061|NCT00867737|Hormones|hormones|mesh-ancestor
56789062|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789063|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56789085|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56789086|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56789087|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789088|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
56789089|NCT00420849|Dexamethasone|dexamethasone|mesh-list
56789090|NCT00420849|Lenalidomide|lenalidomide|mesh-list
56789091|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789092|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
56789093|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
56789094|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789095|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789096|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789097|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
56789098|NCT00420849|Hormones|hormones|mesh-ancestor
56789099|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789100|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56789101|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789102|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
56789103|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56789104|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56789105|NCT00420849|Growth Substances|growth substances|mesh-ancestor
56789106|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
56789107|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
56789108|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56789109|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56789110|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56789111|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
56789112|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789113|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56789114|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56789115|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789116|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789117|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56789118|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56061523|NCT03668951|Analgesics|analgesics|mesh-ancestor
56098059|NCT05750966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098060|NCT05750966|Antitubercular Agents|antitubercular agents|mesh-ancestor
56098061|NCT05750966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098062|NCT05750966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098063|NCT05750966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194586|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789119|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
56789120|NCT00874601|Valsartan|valsartan|mesh-list
56789121|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56789122|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56789123|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56789124|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789125|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56789126|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
56789127|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56789128|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56789129|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789130|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789131|NCT00874679|Urological Agents|urological agents|mesh-ancestor
56789132|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56789133|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56789134|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56789135|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56789136|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061607|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56061608|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
56061614|NCT04312659|Infliximab|infliximab|mesh-list
56789172|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789173|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56789174|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
56789175|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
56789176|NCT00419757|Hormones|hormones|mesh-ancestor
56789177|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789178|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56789179|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56789180|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56789181|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
56789182|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789183|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789184|NCT00434109|Sunitinib|sunitinib|mesh-list
56789185|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789186|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56789187|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56789188|NCT00434109|Growth Substances|growth substances|mesh-ancestor
56789190|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
56789222|NCT01035021|Rocuronium|rocuronium|mesh-list
56789223|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56789224|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56789225|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56789226|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789227|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789228|NCT00878345|Pentobarbital|pentobarbital|mesh-list
56789229|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
56789230|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56789231|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789232|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789233|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789234|NCT00878345|Analgesics|analgesics|mesh-ancestor
56789235|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
56789236|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789237|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56789238|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56789239|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56789240|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
56789241|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789242|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789243|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56789244|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
56789245|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
56789246|NCT00433017|Ranibizumab|ranibizumab|mesh-list
56789247|NCT00433017|Verteporfin|verteporfin|mesh-list
56789248|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56789249|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56789250|NCT00433017|Growth Substances|growth substances|mesh-ancestor
56789251|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789252|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
56789256|NCT03726671|Choline|choline|mesh-list
56789265|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56789266|NCT00868283|Protective Agents|protective agents|mesh-ancestor
56789267|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789268|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
56789269|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
56789270|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56789271|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789272|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56789273|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
56789274|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56789275|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789276|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789277|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789278|NCT00875537|Capsaicin|capsaicin|mesh-list
56789279|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
56789280|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
56789281|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
56789282|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789283|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789284|NCT00875771|Bevacizumab|bevacizumab|mesh-list
56789285|NCT00875771|Capecitabine|capecitabine|mesh-list
56789286|NCT00875771|Irinotecan|irinotecan|mesh-list
56789287|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56789288|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789289|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56789290|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56789291|NCT00875771|Growth Substances|growth substances|mesh-ancestor
56789313|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789314|NCT00878657|Antiviral Agents|antiviral agents|mesh-ancestor
56789315|NCT00878657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789316|NCT00878657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789317|NCT00878657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789318|NCT00878657|Immunologic Factors|immunologic factors|mesh-ancestor
56789319|NCT00878657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789320|NCT00868829|Chromium|chromium|mesh-list
56789321|NCT00868829|Sirolimus|sirolimus|mesh-list
56789322|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56789323|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789324|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56789325|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789326|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
56789327|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789328|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
56789329|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789330|NCT00868829|Trace Elements|trace elements|mesh-ancestor
56789331|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
56789332|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
56789333|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
56789334|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56789335|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56789336|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789337|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56789338|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789339|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56789340|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56789360|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789361|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789362|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789363|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789364|NCT03994965|Pimavanserin|pimavanserin|mesh-list
56789365|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56789366|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56789367|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56789368|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56789369|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789370|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789371|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56789372|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56789373|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56789374|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
56789375|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789376|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789377|NCT00531284|Dexamethasone|dexamethasone|mesh-list
56789378|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789415|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789416|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789417|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56789418|NCT00999752|Nebivolol|nebivolol|mesh-list
56789419|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56789420|NCT00999752|Diuretics|diuretics|mesh-ancestor
56789421|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
56789422|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789423|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56789424|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56789425|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789426|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
56789427|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56789428|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56789429|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56789430|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
56789431|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789432|NCT01005758|Cytarabine|cytarabine|mesh-list
56789433|NCT01005758|Dexamethasone|dexamethasone|mesh-list
56789434|NCT01005758|Prednisone|prednisone|mesh-list
56789435|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
56789436|NCT01005758|Prednisolone|prednisolone|mesh-list
56789437|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
56789438|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56789439|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56789440|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56789466|NCT01005758|Hormones|hormones|mesh-ancestor
56789467|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789468|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56789469|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56789470|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56789471|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56789472|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789473|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56789474|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
56789475|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56789476|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56789477|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
56789478|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
56789479|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56789480|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56789481|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56789482|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
56789483|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789519|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56789520|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789521|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56789522|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789523|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789524|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
56789525|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56789526|NCT01000298|Amoxicillin|amoxicillin|mesh-list
56789527|NCT01000298|Cefdinir|cefdinir|mesh-list
56789528|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56789529|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789530|NCT00614939|Saxagliptin|saxagliptin|mesh-list
56789531|NCT00614939|Incretins|incretins|mesh-ancestor
56789532|NCT00614939|Hormones|hormones|mesh-ancestor
56789533|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789534|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789535|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56789536|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
56789537|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789538|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789539|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56789540|NCT01009190|Carboplatin|carboplatin|mesh-list
56789541|NCT01009190|Rucaparib|rucaparib|mesh-list
56789542|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789543|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56789544|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789545|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789546|NCT05176964|Capecitabine|capecitabine|mesh-list
56789547|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
56789548|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56789549|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
56789550|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789551|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789552|NCT00879827|PENTA|penta|mesh-list
56789553|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
56789558|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56789559|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56789560|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
56789561|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789562|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789563|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789564|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56789565|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56789566|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
56789567|NCT04040309|Lidocaine|lidocaine|mesh-list
56789568|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
56789569|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
56789570|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789571|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789572|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
56789573|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789574|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56789575|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56789614|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56789615|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789616|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789617|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56789618|NCT05076110|Narcotics|narcotics|mesh-ancestor
56789619|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789620|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
56789621|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56789622|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56789623|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56789624|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56789625|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56789626|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789627|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
56789628|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56789629|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56789630|NCT00880373|Ibuprofen|ibuprofen|mesh-list
56789631|NCT00880373|Morphine|morphine|mesh-list
56789632|NCT00880373|Heroin|heroin|mesh-list
56789633|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56789634|NCT00880373|Narcotics|narcotics|mesh-ancestor
56789635|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789636|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789637|NCT00880373|Analgesics|analgesics|mesh-ancestor
56789638|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
56789639|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789640|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56789641|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789642|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789643|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789644|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56789645|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789646|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789647|NCT01007630|Rasagiline|rasagiline|mesh-list
56789648|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56789649|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789652|NCT01007630|Protective Agents|protective agents|mesh-ancestor
56789653|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789654|NCT00885443|Propofol|propofol|mesh-list
56789655|NCT00885443|Sevoflurane|sevoflurane|mesh-list
56789656|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56789657|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789658|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789659|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56789660|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
56789661|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
56789662|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56789663|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56789664|NCT00882869|Sorafenib|sorafenib|mesh-list
56789665|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789666|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56789667|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789668|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789669|NCT00882947|Iloprost|iloprost|mesh-list
56789670|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56789671|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
56789672|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56789673|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56789674|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
56789675|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789676|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789677|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56789678|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56789679|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56789699|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
56789700|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789701|NCT01007864|Protective Agents|protective agents|mesh-ancestor
56789702|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789703|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56789704|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56789705|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
56789706|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
56789707|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789708|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56789709|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
56789710|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789711|NCT01008020|Protective Agents|protective agents|mesh-ancestor
56789712|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789713|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56789714|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56789715|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789716|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56789717|NCT01008098|Citalopram|citalopram|mesh-list
56789718|NCT01008098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56789719|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56789720|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56789721|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789722|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789723|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
56789724|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789725|NCT01008098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56789726|NCT01008098|Antidepressive Agents|antidepressive agents|mesh-ancestor
56789727|NCT01008098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56789728|NCT00530270|Dexamethasone|dexamethasone|mesh-list
56789729|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789736|NCT00530270|Hormones|hormones|mesh-ancestor
56789739|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789740|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56789741|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789742|NCT01001624|Hydroquinone|hydroquinone|mesh-list
56789743|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
56789744|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789745|NCT01001624|Protective Agents|protective agents|mesh-ancestor
56789746|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789747|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56789748|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
56789749|NCT01001780|Rituximab|rituximab|mesh-list
56789750|NCT01001780|Pentostatin|pentostatin|mesh-list
56789751|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789752|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
56789753|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789754|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789755|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56789756|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
56789757|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789758|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789759|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56789760|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56789761|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56789762|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789763|NCT01008566|Sorafenib|sorafenib|mesh-list
56789764|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56789765|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789787|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789788|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56789789|NCT03885596|Narcotics|narcotics|mesh-ancestor
56789790|NCT03885596|Analgesics|analgesics|mesh-ancestor
56789791|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56789792|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56789793|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
56789794|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789795|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
56789796|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56789797|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789798|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56789799|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56789800|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56789801|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789802|NCT01002092|Endostar protein|endostar protein|mesh-list
56789803|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56789804|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56789805|NCT01002092|Growth Substances|growth substances|mesh-ancestor
56789806|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789807|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
56789808|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789809|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
56789810|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
56789811|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
56789812|NCT05547386|Edetic Acid|edetic acid|mesh-list
56789813|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56789814|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
56789815|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
56789834|NCT05732948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789835|NCT05732948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789836|NCT05732948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56789837|NCT00529802|Everolimus|everolimus|mesh-list
56789838|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789839|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56789840|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
56789841|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789842|NCT05021900|Tenalisib|tenalisib|mesh-list
56789843|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
56789844|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789845|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789846|NCT00528866|Docetaxel|docetaxel|mesh-list
56789847|NCT00528866|Bicalutamide|bicalutamide|mesh-list
56789848|NCT00528866|Flutamide|flutamide|mesh-list
56789849|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789850|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
56789851|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
56789852|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
56789853|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789854|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
56789855|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
56789856|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789857|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789858|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56789859|NCT05730920|Methadone|methadone|mesh-list
56789860|NCT05730920|Bupivacaine|bupivacaine|mesh-list
56789861|NCT05730920|Anesthetics, Local|anesthetics, local|mesh-ancestor
56789862|NCT05730920|Anesthetics|anesthetics|mesh-ancestor
56789863|NCT05730920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789864|NCT05730920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789865|NCT05730920|Sensory System Agents|sensory system agents|mesh-ancestor
56789866|NCT05730920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789875|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
56789876|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789877|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789878|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56789879|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
56789880|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
56789881|NCT03999008|Hormones|hormones|mesh-ancestor
56789882|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789883|NCT05140148|Amantadine|amantadine|mesh-list
56789884|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56789885|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56789886|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
56789887|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56789888|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
56789889|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56789890|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789891|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500842|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
56789893|NCT05140148|Analgesics|analgesics|mesh-ancestor
56789894|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
56789895|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789896|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
56789897|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56789898|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789899|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789900|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56789901|NCT04932746|Analgesics|analgesics|mesh-ancestor
56789902|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
56789903|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789904|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56789905|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56789906|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56789907|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
56789910|NCT00614393|Irinotecan|irinotecan|mesh-list
56789915|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789916|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789917|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789918|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56789919|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
56789920|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789921|NCT00880529|Morphine|morphine|mesh-list
56789922|NCT00880529|Bupivacaine|bupivacaine|mesh-list
56789923|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
56789924|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
56789925|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789926|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789927|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
56789928|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789929|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56789930|NCT00880529|Narcotics|narcotics|mesh-ancestor
56789931|NCT00880529|Analgesics|analgesics|mesh-ancestor
56789932|NCT04731779|Cannabidiol|cannabidiol|mesh-list
56789933|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
56789934|NCT00880841|Buprenorphine|buprenorphine|mesh-list
56789935|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56789936|NCT00880841|Naloxone|naloxone|mesh-list
56789937|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56789938|NCT00880841|Narcotics|narcotics|mesh-ancestor
56789939|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56789940|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789941|NCT00880841|Analgesics|analgesics|mesh-ancestor
56789942|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
56789943|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789944|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56789945|NCT00883259|Metformin|metformin|mesh-list
56789946|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56789947|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789948|NCT00885599|Listerine|listerine|mesh-list
56789949|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56789957|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
56789958|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789959|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789960|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789961|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
56789962|NCT04366115|Hormones|hormones|mesh-ancestor
56789963|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789964|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56789965|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789966|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
56789967|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56789968|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56789969|NCT04038125|Dexamethasone|dexamethasone|mesh-list
56789970|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56789971|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
56789972|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
56789973|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56789974|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56789975|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56789976|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
56789977|NCT04038125|Hormones|hormones|mesh-ancestor
56789978|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56789979|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56789980|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56789981|NCT00881153|Cefprozil|cefprozil|mesh-list
56789982|NCT00881153|Cephalosporins|cephalosporins|mesh-list
56789983|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56790004|NCT04038749|Bromocriptine|bromocriptine|mesh-list
56790005|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56790006|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56790007|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
56790008|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
56790009|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790010|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790011|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790012|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
56790013|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56790014|NCT00881231|Cilostazol|cilostazol|mesh-list
56790015|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56790016|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
56790017|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790018|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790019|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56790020|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
56790021|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56790022|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56790023|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790024|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56790025|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
56790026|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56790027|NCT00881231|Protective Agents|protective agents|mesh-ancestor
56790028|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56790029|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56790030|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790031|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
56790032|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56790033|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56790034|NCT00881387|Gemcitabine|gemcitabine|mesh-list
56790035|NCT00881387|Rituximab|rituximab|mesh-list
56790036|NCT00881387|Vinorelbine|vinorelbine|mesh-list
56790037|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56790043|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
56790044|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790045|NCT00881387|Antiviral Agents|antiviral agents|mesh-ancestor
56790046|NCT00881387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790047|NCT00881387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790048|NCT00881387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790049|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56790050|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
56790051|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
56790052|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
56790054|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56790055|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790056|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56790057|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56790058|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56790059|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790060|NCT00881543|Incretins|incretins|mesh-ancestor
56790061|NCT00881543|Hormones|hormones|mesh-ancestor
56790062|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56790063|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
56790064|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790065|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790066|NCT00881855|Cefprozil|cefprozil|mesh-list
56790067|NCT00881855|Cephalosporins|cephalosporins|mesh-list
56790068|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56790069|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790070|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
56790071|NCT04015115|Narcotics|narcotics|mesh-ancestor
56790072|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790073|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790074|NCT04015115|Analgesics|analgesics|mesh-ancestor
56790087|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56790088|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56790089|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56790090|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790091|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
56790092|NCT00882323|Fludarabine|fludarabine|mesh-list
56790093|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
56790094|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790095|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
56790096|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790097|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790098|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56790099|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
56790100|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790101|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790102|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56790103|NCT00882401|Vitamin D|vitamin d|mesh-list
56790104|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
56790105|NCT00882401|Vitamins|vitamins|mesh-ancestor
56790106|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
56790107|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790108|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56790109|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56790110|NCT00886457|Interferons|interferons|mesh-list
56790111|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
56790112|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
56790113|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56790114|NCT00886457|Decitabine|decitabine|mesh-list
56790115|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790116|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
56790117|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501064|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
56790130|NCT02543099|Policosanol|policosanol|mesh-list
56790131|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56790132|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56790133|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
56790134|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790135|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56790136|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56790137|NCT00882635|Heparin|heparin|mesh-list
56790138|NCT00882635|Enoxaparin|enoxaparin|mesh-list
56790139|NCT00882635|Calcium heparin|calcium heparin|mesh-list
56790140|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
56790141|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56790142|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56790143|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790144|NCT00609869|Rituximab|rituximab|mesh-list
56790145|NCT00609869|Lenalidomide|lenalidomide|mesh-list
56790146|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56790147|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790148|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
56790149|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790150|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790151|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56790152|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56790153|NCT00609869|Growth Substances|growth substances|mesh-ancestor
56790154|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
56790155|NCT00888797|Etodolac|etodolac|mesh-list
56790156|NCT00888797|Propranolol|propranolol|mesh-list
56790157|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56790158|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56790159|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
56790176|NCT00884663|Propranolol|propranolol|mesh-list
56790177|NCT00884663|Candesartan|candesartan|mesh-list
56790178|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56790179|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56790180|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
56790181|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790182|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790183|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790184|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56790185|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56790186|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
56790187|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56790188|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56790189|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
56790190|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56790191|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56790192|NCT00887003|Prednisolone|prednisolone|mesh-list
56790193|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
56790195|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56790196|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
56790197|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
56790198|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
56790199|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790200|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790201|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
56790202|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790203|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790204|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
56790205|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
56790206|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56790207|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
56790208|NCT00887003|Hormones|hormones|mesh-ancestor
56790220|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
56790221|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790222|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
56790223|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790224|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
56790225|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790226|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790227|NCT03998696|Cisplatin|cisplatin|mesh-list
56790228|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790229|NCT00611975|Bupropion|bupropion|mesh-list
56790230|NCT00611975|Fluoxetine|fluoxetine|mesh-list
56790231|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56790232|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
56790233|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56790234|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56790235|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56790236|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56790237|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790238|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
56790239|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790240|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790241|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56790242|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56790243|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790244|NCT00611975|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56790245|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
56790246|NCT05695352|Meloxicam|meloxicam|mesh-list
56790247|NCT05695352|Levonorgestrel|levonorgestrel|mesh-list
56790248|NCT05695352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56790249|NCT05695352|Contraceptive Agents|contraceptive agents|mesh-ancestor
56790250|NCT05695352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56790251|NCT05695352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790254|NCT05695352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56790260|NCT05695352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790261|NCT05695352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790262|NCT05695352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56790263|NCT05695352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56790264|NCT05695352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790265|NCT05695352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790266|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
56790267|NCT04895306|Testosterone|testosterone|mesh-list
56790268|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
56790269|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
56790270|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56790271|NCT04895306|Androgens|androgens|mesh-ancestor
56790272|NCT04895306|Hormones|hormones|mesh-ancestor
56790273|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56790274|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790275|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56790276|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790277|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
56790278|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56790279|NCT00889343|Leucovorin|leucovorin|mesh-list
56790280|NCT00889343|Fluorouracil|fluorouracil|mesh-list
56790281|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
56790282|NCT00889343|Irinotecan|irinotecan|mesh-list
56790283|NCT00889343|Sorafenib|sorafenib|mesh-list
56790284|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
56790285|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790286|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56790287|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790288|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790307|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790308|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56790309|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
56790310|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790311|NCT04974398|Antiviral Agents|antiviral agents|mesh-ancestor
56790312|NCT04974398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790313|NCT04974398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790314|NCT04974398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790315|NCT04974398|Immunologic Factors|immunologic factors|mesh-ancestor
56790316|NCT04974398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790317|NCT00573131|Paclitaxel|paclitaxel|mesh-list
56790318|NCT00573131|Cisplatin|cisplatin|mesh-list
56790319|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56790320|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790321|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
56790322|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
56790323|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
56790324|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790325|NCT01565018|Rotigotine|rotigotine|mesh-list
56790326|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
56790327|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
56790328|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790329|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790330|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790331|NCT01565096|Metformin|metformin|mesh-list
56790332|NCT01565096|Glimepiride|glimepiride|mesh-list
56790333|NCT01565096|Vildagliptin|vildagliptin|mesh-list
56790334|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56790335|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790336|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56790337|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790338|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
56790339|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56790340|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
56790341|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062742|NCT02975141|Paclitaxel|paclitaxel|mesh-list
56194587|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56194588|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56194589|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194590|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56790342|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790343|NCT04702880|Carboplatin|carboplatin|mesh-list
56790344|NCT04702880|Nivolumab|nivolumab|mesh-list
56790345|NCT04702880|Etoposide|etoposide|mesh-list
56790346|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790347|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56790348|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56790349|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790350|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56790351|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56790352|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56790353|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790354|NCT00889499|Tropisetron|tropisetron|mesh-list
56790355|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
56790356|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
56790357|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790358|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790359|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56790360|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56790361|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56790362|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
56790363|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790364|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790365|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56790366|NCT00889655|Laxatives|laxatives|mesh-ancestor
56790367|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56790368|NCT05002946|Naltrexone|naltrexone|mesh-list
56790369|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56790370|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56790371|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790372|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
56790373|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790384|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
56790385|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56790386|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56790387|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790388|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790389|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
56790390|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
56790391|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56790392|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790393|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790394|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56790395|NCT04635098|Analgesics|analgesics|mesh-ancestor
56790396|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
56790397|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790398|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56790399|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56790400|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56790401|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
56790402|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790403|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790404|NCT00521144|Topotecan|topotecan|mesh-list
56790405|NCT00521144|Obatoclax|obatoclax|mesh-list
56790406|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56790407|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56790408|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790433|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56790434|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56790435|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790436|NCT02542007|Sirolimus|sirolimus|mesh-list
56790437|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56790438|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790439|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56790440|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790441|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
56790442|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790443|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
56790444|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790445|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56790446|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56790447|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56790448|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790449|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790450|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56790451|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56790452|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56790453|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
56790454|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790455|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790456|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56790457|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56790481|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56790482|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56790483|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
56790484|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56790485|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56790486|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56790487|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56790488|NCT02541383|Thalidomide|thalidomide|mesh-list
56790489|NCT02541383|Dexamethasone|dexamethasone|mesh-list
56790490|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
56790491|NCT02541383|Bortezomib|bortezomib|mesh-list
56790492|NCT02541383|Daratumumab|daratumumab|mesh-list
56790493|NCT02541383|BB 1101|bb 1101|mesh-list
56790494|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56790495|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790496|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
56501443|NCT04597424|Doxycycline|doxycycline|mesh-list
56790498|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790499|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790500|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56790502|NCT02541383|Hormones|hormones|mesh-ancestor
56790538|NCT00893009|Theophylline|theophylline|mesh-list
56790539|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56790540|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
56790541|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790542|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790543|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56790544|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
56790545|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56790546|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790547|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790548|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
56790549|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56790550|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56790551|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
56790552|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790553|NCT00890747|Sunitinib|sunitinib|mesh-list
56790554|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790555|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56790556|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56790557|NCT00890747|Growth Substances|growth substances|mesh-ancestor
56790558|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790559|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
56790560|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56790561|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790562|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790563|NCT04017845|Tribenoside|tribenoside|mesh-list
56790564|NCT04017845|Lidocaine|lidocaine|mesh-list
56790583|NCT04017845|Cathartics|cathartics|mesh-ancestor
56790584|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56790585|NCT04017845|Laxatives|laxatives|mesh-ancestor
56790586|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56790587|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56790588|NCT04017845|Analgesics|analgesics|mesh-ancestor
56790589|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790590|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790591|NCT00520130|Cytarabine|cytarabine|mesh-list
56790592|NCT00520130|Cyclosporine|cyclosporine|mesh-list
56790593|NCT00520130|Rituximab|rituximab|mesh-list
56790594|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
56790595|NCT00520130|Fludarabine|fludarabine|mesh-list
56790596|NCT00520130|Cyclosporins|cyclosporins|mesh-list
56790597|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56790598|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790599|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
56790600|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790601|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790602|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56790603|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
56790604|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790605|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790606|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
56790607|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790608|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790609|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
56790610|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
56790611|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56790612|NCT00519896|Sunitinib|sunitinib|mesh-list
56790632|NCT00519428|Bupropion|bupropion|mesh-list
56790633|NCT00519428|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56790634|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56790635|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56790636|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790637|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790638|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
56790639|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790640|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56790641|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
56790642|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56790643|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56790644|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56790645|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
56790646|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
56790647|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790649|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56790650|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
56790651|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56790652|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
56790653|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56790654|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56790655|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790656|NCT00431847|Anesthetics|anesthetics|mesh-list
56790657|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56790658|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790659|NCT00431067|Afatinib|afatinib|mesh-list
56790660|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790661|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56790662|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790676|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56790677|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790678|NCT00518882|Incretins|incretins|mesh-ancestor
56790679|NCT00518882|Hormones|hormones|mesh-ancestor
56790680|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56790681|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56790682|NCT00518180|Lactitol|lactitol|mesh-list
56790683|NCT00518180|Vaccines|vaccines|mesh-list
56790684|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
56790685|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790686|NCT00518180|Cathartics|cathartics|mesh-ancestor
56790687|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56790688|NCT00525902|Adalimumab|adalimumab|mesh-list
56790689|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790690|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790691|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56790692|NCT00525824|Simvastatin|simvastatin|mesh-list
56790693|NCT00525824|Ezetimibe|ezetimibe|mesh-list
56790694|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56790695|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56790696|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
56790697|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790698|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56790699|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56790700|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790701|NCT00525590|Carmustine|carmustine|mesh-list
56790702|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56790703|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
56790704|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790705|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790706|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
56790707|NCT00430677|Prednisone|prednisone|mesh-list
56790708|NCT00430677|Prednisolone|prednisolone|mesh-list
56790720|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56790721|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501663|NCT01147393|Epratuzumab|epratuzumab|mesh-list
56790722|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790723|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790724|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56790725|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790727|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790728|NCT02631759|Levetiracetam|levetiracetam|mesh-list
56790729|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
56790730|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
56790731|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
56790732|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56790733|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790734|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
56790735|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56790736|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
56790737|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790738|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790739|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56790740|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
56790741|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
56790742|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56790743|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
56790744|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790745|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790746|NCT05199662|Tenecteplase|tenecteplase|mesh-list
56790747|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56790748|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56790749|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790750|NCT04501406|Pioglitazone|pioglitazone|mesh-list
56790751|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56790752|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790753|NCT03656666|Thalidomide|thalidomide|mesh-list
56063183|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790761|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790762|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790763|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56790764|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56790765|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790766|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790767|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790768|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
56790769|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
56790770|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56790771|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790772|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56790773|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56790774|NCT03656666|Growth Substances|growth substances|mesh-ancestor
56790775|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
56790776|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790777|NCT00430521|Vaccines|vaccines|mesh-list
56790778|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
56790779|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790780|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56790781|NCT01036035|Pilocarpine|pilocarpine|mesh-list
56790782|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56790812|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56790813|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
56790814|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56790815|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
56790816|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56790817|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
56790818|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790819|NCT01033149|Expectorants|expectorants|mesh-ancestor
56790820|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
56790821|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56790822|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
56790823|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790824|NCT01033149|Protective Agents|protective agents|mesh-ancestor
56790825|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790826|NCT01033149|Antidotes|antidotes|mesh-ancestor
56790827|NCT00440271|Ritonavir|ritonavir|mesh-list
56790828|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
56790829|NCT00440271|Maraviroc|maraviroc|mesh-list
56790830|NCT00440271|Tipranavir|tipranavir|mesh-list
56790831|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
56790832|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56790833|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56790834|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56790835|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
56790836|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790837|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790838|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56790839|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56790840|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
56790841|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790842|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56790843|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56790844|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56790856|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
56790857|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790858|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790859|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790860|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56790861|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56790862|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790863|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790864|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56790865|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
56790866|NCT01051648|Triamcinolone|triamcinolone|mesh-list
56790867|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56790868|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56790869|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56790870|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790871|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
56790872|NCT01051648|Hormones|hormones|mesh-ancestor
56790873|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56790874|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790875|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56790876|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
56790877|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790878|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790879|NCT00429273|Guanfacine|guanfacine|mesh-list
56790880|NCT00429273|Methylphenidate|methylphenidate|mesh-list
56790881|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56790882|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56790883|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790884|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56790885|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56790886|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56790888|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
56790894|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
56790895|NCT00359632|Linezolid|linezolid|mesh-list
56790896|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56790897|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790898|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56790899|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790900|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790901|NCT01324960|Aldesleukin|aldesleukin|mesh-list
56790902|NCT01324960|Azacitidine|azacitidine|mesh-list
56790903|NCT01324960|Histamine|histamine|mesh-list
56790904|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56790905|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
56790906|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790907|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790908|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56790909|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790910|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56790911|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56790912|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
56790913|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56790914|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
56790915|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
56790916|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790917|NCT00417885|Sunitinib|sunitinib|mesh-list
56790918|NCT00417885|Exemestane|exemestane|mesh-list
56790919|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56790920|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56790921|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56790922|NCT00417885|Growth Substances|growth substances|mesh-ancestor
56790923|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790924|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
56790939|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56790940|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790941|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790942|NCT00525044|Ambroxol|ambroxol|mesh-list
56790943|NCT00525044|Expectorants|expectorants|mesh-ancestor
56790944|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
56790945|NCT00355342|Fluticasone|fluticasone|mesh-list
56790946|NCT00355342|Xhance|xhance|mesh-list
56790947|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56790948|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56790949|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56790950|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
56790951|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56790952|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56790953|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56790954|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
56790955|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
56790956|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56790997|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56790998|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56790999|NCT01056874|Maraviroc|maraviroc|mesh-list
56791000|NCT01056874|Digoxin|digoxin|mesh-list
56791001|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56791002|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56791003|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791004|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791005|NCT01056874|Protective Agents|protective agents|mesh-ancestor
56791006|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791007|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56791008|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56791009|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56791010|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56791011|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
56791012|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791013|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56791014|NCT00355030|Leuprolide|leuprolide|mesh-list
56791015|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56791016|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
56791017|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56791018|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791019|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56791020|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791021|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
56791022|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56791023|NCT01057186|Sevelamer|sevelamer|mesh-list
56501966|NCT00567554|Growth Substances|growth substances|mesh-ancestor
56791024|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
56791025|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
56791026|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791027|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56791028|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791029|NCT01057186|Vitamins|vitamins|mesh-ancestor
56791030|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
56791031|NCT01057264|Gemcitabine|gemcitabine|mesh-list
56791032|NCT01057264|Paclitaxel|paclitaxel|mesh-list
56791033|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56791034|NCT01057264|Bevacizumab|bevacizumab|mesh-list
56791035|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791036|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791037|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
56791038|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
56791039|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
56791040|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791041|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56791042|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56791043|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56791044|NCT01057264|Growth Substances|growth substances|mesh-ancestor
56791045|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791046|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
56791047|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56791048|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
56791049|NCT01057264|Antiviral Agents|antiviral agents|mesh-ancestor
56791050|NCT01057264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791051|NCT01057264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791052|NCT01057264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791087|NCT01057498|RNS60|rns60|mesh-list
56791088|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56791089|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56791090|NCT01057498|Analgesics|analgesics|mesh-ancestor
56791091|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
56791092|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791093|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791094|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791095|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791096|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56791097|NCT03742258|Prednisone|prednisone|mesh-list
56791098|NCT03742258|Cortisone|cortisone|mesh-list
56791099|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
56791100|NCT03742258|Rituximab|rituximab|mesh-list
56791101|NCT03742258|Doxorubicin|doxorubicin|mesh-list
56791102|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56791103|NCT03742258|Vincristine|vincristine|mesh-list
56791104|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56791105|NCT03742258|Antibodies|antibodies|mesh-list
56791106|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
56791107|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56791108|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791109|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
56791110|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791111|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791112|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56791113|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
56791138|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
56791139|NCT00354172|Fludarabine|fludarabine|mesh-list
56791140|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
56791141|NCT00354172|Interleukin-2|interleukin-2|mesh-list
56791142|NCT00354172|Cyclosporins|cyclosporins|mesh-list
56791143|NCT00354172|Lenograstim|lenograstim|mesh-list
56791144|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56791145|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
56791146|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791147|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
56791148|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791149|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791150|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56791151|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
56791152|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791153|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791154|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56791155|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56791156|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
56791157|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56791158|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791159|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
56791160|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791161|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
56791162|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56791163|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56791164|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56791165|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
56791166|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56791167|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791168|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
56791169|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
56791170|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791171|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56791172|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
56791173|NCT00354172|Hormones|hormones|mesh-ancestor
56502117|NCT04586543|Docetaxel|docetaxel|mesh-list
56791177|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56791178|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56791179|NCT00354172|Analgesics|analgesics|mesh-ancestor
56791180|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
56791181|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56791182|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56791183|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
56791184|NCT00353704|Pregabalin|pregabalin|mesh-list
56791185|NCT00353704|Morphine|morphine|mesh-list
56791186|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56791187|NCT00353704|Narcotics|narcotics|mesh-ancestor
56791188|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56791189|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791190|NCT00353704|Analgesics|analgesics|mesh-ancestor
56791191|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
56791192|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791193|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
56791194|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56791195|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56791196|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791197|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56791198|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56791199|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56791200|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56791201|NCT03742180|Ketorolac|ketorolac|mesh-list
56791202|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
56791203|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56791204|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56791205|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791206|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56791207|NCT03742180|Analgesics|analgesics|mesh-ancestor
56791208|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
56791209|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791210|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56791211|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56791212|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56063607|NCT03439891|Nivolumab|nivolumab|mesh-list
56194591|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56194592|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56194593|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
56791213|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
56791214|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791215|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791216|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56791217|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791218|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791219|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56791220|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791221|NCT00512252|Cytarabine|cytarabine|mesh-list
56791222|NCT00512252|Plerixafor|plerixafor|mesh-list
56791223|NCT00512252|Etoposide|etoposide|mesh-list
56791224|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
56791225|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791226|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791227|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56791228|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56791229|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791230|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791231|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56791232|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
56791233|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
56791234|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791235|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791236|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
56791237|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791238|NCT00512252|Analgesics|analgesics|mesh-ancestor
56791239|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
56791240|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791241|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56791242|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56791243|NCT00516386|Mecasermin|mecasermin|mesh-list
56791244|NCT00516386|Growth Substances|growth substances|mesh-ancestor
56791255|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56791256|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
56791257|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
56791258|NCT04462796|Cathartics|cathartics|mesh-ancestor
56791259|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56791260|NCT00524030|Pregabalin|pregabalin|mesh-list
56791261|NCT00524030|Analgesics|analgesics|mesh-ancestor
56791262|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
56791263|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791264|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791265|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
56791266|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56791267|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56791268|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791269|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56791270|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56791271|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56791272|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56791273|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56791274|NCT00523718|Riluzole|riluzole|mesh-list
56791275|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
56791276|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56791277|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56791278|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791306|NCT03457142|BB 1101|bb 1101|mesh-list
56791307|NCT03457142|Glycine|glycine|mesh-list
56791308|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791309|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
56791310|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
56791311|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791312|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791313|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56791314|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
56791315|NCT03457142|Hormones|hormones|mesh-ancestor
56791316|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791317|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56791318|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791319|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791320|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
56502287|NCT04584515|Rifampin|rifampin|mesh-list
56791321|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791322|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56791323|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791324|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
56791325|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791358|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
56791359|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
56791360|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791361|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
56791362|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
56791363|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56791364|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56791365|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56791366|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56791367|NCT00345046|Prednisolone|prednisolone|mesh-list
56791368|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56791369|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
56791370|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56791371|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
56791372|NCT00345046|Prednisone|prednisone|mesh-list
56791373|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56791374|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
56791375|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791376|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
56791377|NCT00345046|Hormones|hormones|mesh-ancestor
56791378|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791379|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791380|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56791381|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791382|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
56791383|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
56791384|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791385|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56791386|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56791387|NCT00345046|Protective Agents|protective agents|mesh-ancestor
56791388|NCT00515216|Leucovorin|leucovorin|mesh-list
56791389|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
56791390|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56791391|NCT00515216|Fluorouracil|fluorouracil|mesh-list
56791392|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
56791393|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
56791394|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
56063773|NCT01754623|Fluorouracil|fluorouracil|mesh-list
56791396|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56791397|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791398|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791399|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
56791400|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791401|NCT00515216|Antidotes|antidotes|mesh-ancestor
56791402|NCT00515216|Protective Agents|protective agents|mesh-ancestor
56791403|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
56791405|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
56791406|NCT01004978|Cisplatin|cisplatin|mesh-list
56791407|NCT01004978|Doxorubicin|doxorubicin|mesh-list
56791408|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56791409|NCT01004978|Sorafenib|sorafenib|mesh-list
56791410|NCT01004978|Mitomycins|mitomycins|mesh-list
56791411|NCT01004978|Mitomycin|mitomycin|mesh-list
56791412|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791413|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56791414|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56791415|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56791416|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791417|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791418|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56791419|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
56791420|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56791421|NCT00440193|Enoxaparin|enoxaparin|mesh-list
56791422|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
56791423|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56791424|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
56791425|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56791426|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
56791427|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791428|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791429|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
56791430|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56791431|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56791432|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
56791433|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56791438|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791439|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791440|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
56791441|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791442|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
56791443|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791444|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
56791445|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791446|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56791447|NCT00514904|Vaccines|vaccines|mesh-list
56791448|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
56791449|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791450|NCT00440115|Bupropion|bupropion|mesh-list
56791451|NCT00440115|Nicotine|nicotine|mesh-list
56791452|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56791453|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
56791454|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791455|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791456|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56791457|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56791458|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
56791459|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791460|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791461|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56791462|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
56791463|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56791467|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
56791486|NCT00416715|Vitamins|vitamins|mesh-ancestor
56791487|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
56791488|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791489|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56791490|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56791491|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
56791492|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56791493|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
56791494|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
56791495|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791496|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791497|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56791498|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56791499|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791500|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56791501|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
56791502|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791503|NCT00416715|Antacids|antacids|mesh-ancestor
56791504|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56791505|NCT01037517|Plerixafor|plerixafor|mesh-list
56791506|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56791507|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56791508|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
56791509|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791510|NCT00406029|Levodopa|levodopa|mesh-list
56791511|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56791512|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56791513|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
56791514|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791515|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791517|NCT00514514|Cyclosporine|cyclosporine|mesh-list
56791531|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56791532|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791533|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56791534|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56791535|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
56791536|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56791537|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56791538|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
56791539|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791540|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
56791541|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56791542|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
56791543|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56791544|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
56791545|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791546|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791547|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
56791548|NCT00521586|Vaccines|vaccines|mesh-list
56791549|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56791550|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
56791551|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791552|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
56791553|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56791554|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
56791555|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791556|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791557|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56791558|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
56791578|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
56791579|NCT03336216|Antiviral Agents|antiviral agents|mesh-ancestor
56791580|NCT03336216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791581|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791582|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791583|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
56791584|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791585|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56791586|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56791587|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56791588|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56791589|NCT03336216|Antidotes|antidotes|mesh-ancestor
56791590|NCT03336216|Protective Agents|protective agents|mesh-ancestor
56791591|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
56791592|NCT03336216|Vitamins|vitamins|mesh-ancestor
56791593|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
56791594|NCT01010646|Ribavirin|ribavirin|mesh-list
56791595|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
56791596|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
56791597|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56791610|NCT00515112|Hormones|hormones|mesh-ancestor
56791634|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56791635|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56791636|NCT00404547|Ciclesonide|ciclesonide|mesh-list
56791637|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
56791638|NCT00404547|Hormones|hormones|mesh-ancestor
56791639|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791640|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791641|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56791642|NCT00515034|Imipenem|imipenem|mesh-list
56791643|NCT00515034|Doripenem|doripenem|mesh-list
56791644|NCT00515034|Cilastatin|cilastatin|mesh-list
56791645|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56791646|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791647|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
56791648|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791649|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791650|NCT04635774|Insulin|insulin|mesh-list
56791651|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56791652|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791653|NCT00404235|Paclitaxel|paclitaxel|mesh-list
56791654|NCT00404235|Carboplatin|carboplatin|mesh-list
56791655|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56791656|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791657|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791658|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
56791659|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
56791660|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
56791661|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791681|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791682|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
56791683|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791684|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791685|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56791686|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791687|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
56791688|NCT00344968|Hormones|hormones|mesh-ancestor
56791689|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791690|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791691|NCT00509028|Budesonide|budesonide|mesh-list
56791692|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791693|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56791694|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
56791695|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791696|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791697|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56791698|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
56791699|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
56791700|NCT00509028|Hormones|hormones|mesh-ancestor
56791701|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791702|NCT00352846|Vitamin D|vitamin d|mesh-list
56791703|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
56791704|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
56791705|NCT00352846|Calcium|calcium|mesh-list
56791706|NCT00352846|Vitamins|vitamins|mesh-ancestor
56791707|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
56791708|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791709|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56791710|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56791711|NCT00352846|Antacids|antacids|mesh-ancestor
56791712|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791713|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56791714|NCT00508872|Leucovorin|leucovorin|mesh-list
56791715|NCT00508872|Bevacizumab|bevacizumab|mesh-list
56791716|NCT00508872|Fluorouracil|fluorouracil|mesh-list
56791720|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56791721|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56791722|NCT00508872|Growth Substances|growth substances|mesh-ancestor
56791723|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791724|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
56791725|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
56791726|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791727|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56791728|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791729|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
56791730|NCT00508872|Antidotes|antidotes|mesh-ancestor
56791731|NCT00508872|Protective Agents|protective agents|mesh-ancestor
56791732|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
56791733|NCT00508872|Vitamins|vitamins|mesh-ancestor
56791734|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
56791735|NCT00508482|Lactulose|lactulose|mesh-list
56791736|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56791737|NCT00344032|Vaccines|vaccines|mesh-list
56791738|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
56791739|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791740|NCT00607373|Mipomersen|mipomersen|mesh-list
56791741|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56791742|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56791743|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
56791744|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791745|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56791746|NCT00508404|Panitumumab|panitumumab|mesh-list
56791747|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56791748|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791749|NCT00352690|Paclitaxel|paclitaxel|mesh-list
56791750|NCT00352690|Carboplatin|carboplatin|mesh-list
56791751|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56791752|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791753|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791754|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56791755|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56791756|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56791759|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
56791760|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
56791761|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
56791762|NCT03502577|Fludarabine|fludarabine|mesh-list
56791763|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791764|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
56791765|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791766|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791767|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56791768|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
56791769|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791770|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791771|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56791772|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
56791773|NCT03249012|Calcitriol|calcitriol|mesh-list
56791774|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
56791775|NCT03249012|Calcium|calcium|mesh-list
56791776|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56791777|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791778|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56791779|NCT03249012|Antacids|antacids|mesh-ancestor
56791780|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791781|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56791782|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56791783|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56791784|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56791786|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
56791787|NCT03477539|Lenalidomide|lenalidomide|mesh-list
56791788|NCT03477539|Daratumumab|daratumumab|mesh-list
56791789|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
56791790|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791791|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56791792|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56791793|NCT03477539|Growth Substances|growth substances|mesh-ancestor
56791794|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
56791795|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791799|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56791800|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791801|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56791802|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
56791803|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791804|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791805|NCT00893477|Rituximab|rituximab|mesh-list
56791806|NCT00893477|Sargramostim|sargramostim|mesh-list
56791807|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56791808|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791809|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
56791810|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791811|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791812|NCT00609245|Valproic Acid|valproic acid|mesh-list
56791813|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
56791814|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791815|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791816|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
56791817|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791818|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791819|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
56791820|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56791821|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56791822|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56791823|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
56791824|NCT01010802|Hematinics|hematinics|mesh-ancestor
56791825|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
56791826|NCT04036253|Hematinics|hematinics|mesh-ancestor
56791827|NCT00893555|Voriconazole|voriconazole|mesh-list
56791828|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
56791829|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791830|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56791831|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56791832|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064212|NCT01788631|Regadenoson|regadenoson|mesh-list
56791838|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56791839|NCT02541071|Clonidine|clonidine|mesh-list
56791840|NCT02541071|Yohimbine|yohimbine|mesh-list
56791841|NCT02541071|Analgesics|analgesics|mesh-ancestor
56791842|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
56791843|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791844|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791845|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56791846|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
56791847|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
56791848|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56791849|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56791850|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56791851|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
56791852|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791853|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791854|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
56791855|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56791856|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56791857|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56791858|NCT02541071|Urological Agents|urological agents|mesh-ancestor
56791859|NCT01058824|Lincomycin|lincomycin|mesh-list
56791860|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56791861|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56791862|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56791863|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791864|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791865|NCT00895739|Cyclosporine|cyclosporine|mesh-list
56791866|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
56791867|NCT00895739|Cyclosporins|cyclosporins|mesh-list
56791883|NCT01058902|Analgesics|analgesics|mesh-ancestor
56791884|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
56791885|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791886|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791887|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791888|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791889|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56791890|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56791891|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791892|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56791893|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56791894|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56791895|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
56791896|NCT00609167|Dexamethasone|dexamethasone|mesh-list
56791897|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
56791898|NCT00609167|Bortezomib|bortezomib|mesh-list
56791899|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791900|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
56791901|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791902|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56791903|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56791904|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
56791905|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791906|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791907|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56791908|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56791909|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
56791910|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
56791911|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56791912|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56791913|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
56791914|NCT00609167|Hormones|hormones|mesh-ancestor
56791915|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56791916|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56791917|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
56791922|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
56791923|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791924|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791925|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791926|NCT00606281|Aripiprazole|aripiprazole|mesh-list
56791927|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
56791928|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56791929|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56791930|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56791931|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56791932|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791933|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
56791934|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
56791935|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56791936|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791937|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56791938|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56791939|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
56791940|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56791941|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56791942|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56791943|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56791944|NCT00506142|Vincristine|vincristine|mesh-list
56791945|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56791946|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791947|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
56791948|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
56791949|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
56791950|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791951|NCT00891605|Paclitaxel|paclitaxel|mesh-list
56791965|NCT00514020|Fluorouracil|fluorouracil|mesh-list
56791966|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
56791967|NCT00514020|Calcium|calcium|mesh-list
56791968|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
56791969|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56791970|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56791971|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
56791972|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56791973|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56791974|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56791975|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56791976|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
56791977|NCT00514020|Antidotes|antidotes|mesh-ancestor
56791978|NCT00514020|Protective Agents|protective agents|mesh-ancestor
56791979|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
56791980|NCT00514020|Vitamins|vitamins|mesh-ancestor
56791981|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
56791982|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
56791983|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
56791984|NCT03570827|Androgens|androgens|mesh-list
56791985|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56792023|NCT00891761|Ondansetron|ondansetron|mesh-list
56792024|NCT00891761|Casopitant|casopitant|mesh-list
56792025|NCT00891761|BB 1101|bb 1101|mesh-list
56792026|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792027|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
56792028|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
56792029|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792030|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792031|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56792032|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
56792033|NCT00891761|Hormones|hormones|mesh-ancestor
56792034|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792035|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56792036|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792037|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
56792038|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792039|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792040|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
56792041|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
56792042|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56792043|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
56792044|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792045|NCT00891761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56792046|NCT00891761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56792047|NCT00891761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792048|NCT00891761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792049|NCT00891761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56792050|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56792051|NCT01012830|Huperzine A|huperzine a|mesh-list
56792052|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56792053|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792054|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792055|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
56792066|NCT00513474|Etoposide|etoposide|mesh-list
56792067|NCT00513474|Allopurinol|allopurinol|mesh-list
56792068|NCT00513474|Rasburicase|rasburicase|mesh-list
56792069|NCT00513474|Tacrolimus|tacrolimus|mesh-list
56792070|NCT00513474|Cyclosporins|cyclosporins|mesh-list
56792071|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56792072|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
56792073|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792074|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792075|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56792076|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
56792077|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792078|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792079|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56792080|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56792081|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
56792082|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56792083|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56792084|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
56792085|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
56792086|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792087|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56792088|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56792089|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56792090|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56792091|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56792092|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56792093|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
56792094|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56792095|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56792096|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56792097|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
56792098|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56792099|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
56792106|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792107|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792108|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
56792109|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56792110|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792111|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792112|NCT00896519|Prednisone|prednisone|mesh-list
56792113|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
56792114|NCT00896519|Rituximab|rituximab|mesh-list
56792115|NCT00896519|Doxorubicin|doxorubicin|mesh-list
56792116|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56792117|NCT00896519|Vincristine|vincristine|mesh-list
56792118|NCT00896519|Sargramostim|sargramostim|mesh-list
56792119|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56792120|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
56792121|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792122|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792123|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56792124|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
56792125|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792126|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792127|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56792128|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792129|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56792130|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56792131|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56792132|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792133|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792134|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
56792135|NCT00896519|Hormones|hormones|mesh-ancestor
56792136|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792137|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56792138|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56792139|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
56792140|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
56792141|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
56792144|NCT00505752|Hormones|hormones|mesh-ancestor
56792145|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792146|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792147|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56792148|NCT01011036|Clonazepam|clonazepam|mesh-list
56792149|NCT01011036|Clobazam|clobazam|mesh-list
56792150|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56792151|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56792152|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56792153|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
56792154|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792155|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792156|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792157|NCT01011036|Urological Agents|urological agents|mesh-ancestor
56792158|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
56792159|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
56792160|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
56792161|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56792162|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56503077|NCT04312750|Lidocaine|lidocaine|mesh-list
56792163|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792164|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792165|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56792166|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
56792168|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56792169|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792170|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792171|NCT00894023|Abciximab|abciximab|mesh-list
56792172|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
56792173|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56792174|NCT00892073|Metformin|metformin|mesh-list
56792188|NCT02541227|Protective Agents|protective agents|mesh-ancestor
56792189|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792190|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
56792191|NCT00896987|Lamotrigine|lamotrigine|mesh-list
56792192|NCT00896987|Carbamazepine|carbamazepine|mesh-list
56792193|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
56792194|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56792195|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792196|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792197|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56792198|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792199|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56792200|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56792201|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792202|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792203|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56792204|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
56792205|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56792206|NCT00896987|Analgesics|analgesics|mesh-ancestor
56792207|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
56792208|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792209|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56792210|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56792211|NCT00897065|Antibodies|antibodies|mesh-list
56792212|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
56792213|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792214|NCT00343252|Teriparatide|teriparatide|mesh-list
56792235|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
56792236|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792237|NCT00892307|Adenosine|adenosine|mesh-list
56503156|NCT01138657|Prednisone|prednisone|mesh-list
56792238|NCT00892307|Analgesics|analgesics|mesh-ancestor
56792239|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
56792240|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792241|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792242|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56792243|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
56792244|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56792245|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
56792246|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
56792247|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792248|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792249|NCT00342628|Vaccines|vaccines|mesh-list
56792250|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
56792251|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792252|NCT00897377|Temozolomide|temozolomide|mesh-list
56792253|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56792254|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
56792255|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792256|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792257|NCT00894569|Paclitaxel|paclitaxel|mesh-list
56792258|NCT00894569|Carboplatin|carboplatin|mesh-list
56792259|NCT00894569|Cetuximab|cetuximab|mesh-list
56792260|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56792261|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792262|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
56792263|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
56792264|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
56792265|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792276|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
56792277|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792278|NCT00892385|Temozolomide|temozolomide|mesh-list
56792279|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56792280|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
56792281|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792282|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792283|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56792284|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
56792285|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792286|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56792287|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56792288|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792289|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792290|NCT01011114|Cinacalcet|cinacalcet|mesh-list
56792291|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56792292|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792293|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56792294|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
56792295|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792296|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
56792297|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
56792298|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56792299|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56792300|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
56792323|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56792324|NCT05278637|Analgesics|analgesics|mesh-ancestor
56792325|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
56792326|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792327|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792328|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792329|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792330|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56792331|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56792332|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792333|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56792334|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56792335|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792336|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
56792337|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56792338|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56792339|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56792340|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
56792341|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792342|NCT04017377|Paclitaxel|paclitaxel|mesh-list
56792343|NCT04017377|Cisplatin|cisplatin|mesh-list
56792344|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56792345|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792346|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
56792347|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
56792348|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
56792349|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792350|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56792351|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56792352|NCT04931615|Thrombin|thrombin|mesh-list
56792353|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
56792354|NCT04931615|Coagulants|coagulants|mesh-ancestor
56792355|NCT04035707|Rocuronium|rocuronium|mesh-list
56792356|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792364|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
56792365|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792366|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56792367|NCT00901511|Molgramostim|molgramostim|mesh-list
56792368|NCT00901511|Sargramostim|sargramostim|mesh-list
56792369|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
56792370|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792371|NCT00901511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792372|NCT00894959|Heparin|heparin|mesh-list
56792373|NCT00894959|Calcium heparin|calcium heparin|mesh-list
56792374|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
56792375|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56792376|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56792377|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792378|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
56792379|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
56792380|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792381|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792382|NCT00895115|Vitamin E|vitamin e|mesh-list
56792383|NCT00895115|Vitamins|vitamins|mesh-ancestor
56792384|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
56792385|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503303|NCT03450057|Daratumumab|daratumumab|mesh-list
56792386|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
56792387|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792388|NCT00895115|Protective Agents|protective agents|mesh-ancestor
56792389|NCT00901745|Norepinephrine|norepinephrine|mesh-list
56792414|NCT00901823|Choline|choline|mesh-list
56792415|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
56792416|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56792417|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
56792418|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792419|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56792420|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56792421|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
56792422|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56792423|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
56792424|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56792425|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
56792426|NCT00902057|Coagulants|coagulants|mesh-ancestor
56792427|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56792428|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
56792429|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792430|NCT00902135|Interferons|interferons|mesh-list
56792431|NCT00902135|Interferon-beta|interferon-beta|mesh-list
56792432|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
56792433|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792434|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
56792435|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56792436|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
56792438|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56792467|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
56792468|NCT00902681|Fesoterodine|fesoterodine|mesh-list
56792469|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56792470|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56792471|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
56792472|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792473|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792474|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792475|NCT00902681|Urological Agents|urological agents|mesh-ancestor
56792476|NCT00906113|Melphalan|melphalan|mesh-list
56792477|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56792478|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
56792479|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792480|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792481|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56792482|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56792483|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
56792484|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792485|NCT00902837|Oxycodone|oxycodone|mesh-list
56792486|NCT00902837|Naloxone|naloxone|mesh-list
56792487|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56792488|NCT00902837|Narcotics|narcotics|mesh-ancestor
56792489|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792490|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792491|NCT00902837|Analgesics|analgesics|mesh-ancestor
56792492|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
56792493|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792494|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56792495|NCT00605813|Sertraline|sertraline|mesh-list
56792496|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
56792497|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792510|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792511|NCT00906269|Urological Agents|urological agents|mesh-ancestor
56792512|NCT00902915|Dexamethasone|dexamethasone|mesh-list
56792513|NCT00902915|Lenalidomide|lenalidomide|mesh-list
56792514|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792515|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
56792516|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
56792517|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792518|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792519|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56792520|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
56792521|NCT00902915|Hormones|hormones|mesh-ancestor
56792522|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792523|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56792524|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792525|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
56792526|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56792527|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56792528|NCT00902915|Growth Substances|growth substances|mesh-ancestor
56792529|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
56792530|NCT04034771|Propofol|propofol|mesh-list
56792531|NCT04034771|Melatonin|melatonin|mesh-list
56792532|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56792563|NCT00605657|Valproic Acid|valproic acid|mesh-list
56792564|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
56792565|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792566|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792567|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
56792568|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792569|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792570|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
56792571|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56792572|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792573|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792574|NCT00899951|Fentanyl|fentanyl|mesh-list
56792575|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56792576|NCT00899951|Narcotics|narcotics|mesh-ancestor
56792577|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792578|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792579|NCT00899951|Analgesics|analgesics|mesh-ancestor
56792580|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
56792581|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792620|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792621|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56792622|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792623|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792624|NCT00904085|Oxymorphone|oxymorphone|mesh-list
56792625|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56792626|NCT00904085|Narcotics|narcotics|mesh-ancestor
56792627|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792628|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792629|NCT00904085|Analgesics|analgesics|mesh-ancestor
56792630|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
56792631|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792632|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56792633|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
56792634|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
56792635|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56792636|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792637|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792638|NCT00908531|Letrozole|letrozole|mesh-list
56792639|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792640|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56792641|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56792642|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792643|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792644|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56792645|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
56792646|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792647|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792648|NCT00904397|Celecoxib|celecoxib|mesh-list
56792649|NCT00904397|Lidocaine|lidocaine|mesh-list
56792662|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56792663|NCT00904397|Analgesics|analgesics|mesh-ancestor
56792664|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792665|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792666|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56792667|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56792668|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792669|NCT00904475|Lidocaine|lidocaine|mesh-list
56792670|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
56792671|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
56792672|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792673|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792674|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
56792675|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792676|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56792677|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56792678|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56792679|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792680|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792681|NCT00908921|Glimepiride|glimepiride|mesh-list
56792682|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56792683|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56792706|NCT00909077|Rituximab|rituximab|mesh-list
56792714|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
56792715|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
56792716|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792717|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56792718|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
56792719|NCT00909077|Hormones|hormones|mesh-ancestor
56792720|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792721|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56792722|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
56792723|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792724|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792725|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
56792726|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56792727|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56792728|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792729|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
56792730|NCT00904709|Coagulants|coagulants|mesh-ancestor
56792731|NCT00340834|Interferons|interferons|mesh-list
56792732|NCT00340834|Interferon-beta|interferon-beta|mesh-list
56792733|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
56792734|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56792735|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792736|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
56792737|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56792738|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56792739|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792740|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56792741|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
56792743|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56792759|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56792760|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792761|NCT01055470|Diclofenac|diclofenac|mesh-list
56792762|NCT01055470|Lornoxicam|lornoxicam|mesh-list
56792763|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56792764|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56792765|NCT01055470|Analgesics|analgesics|mesh-ancestor
56792766|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
56792767|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792768|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792769|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56792770|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792771|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56792772|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792773|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792774|NCT03986008|Liraglutide|liraglutide|mesh-list
56792775|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56792776|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792777|NCT03986008|Incretins|incretins|mesh-ancestor
56792778|NCT03986008|Hormones|hormones|mesh-ancestor
56792779|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56792780|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56792781|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
56792782|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56792783|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56792784|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792785|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792786|NCT00909233|Urological Agents|urological agents|mesh-ancestor
56792787|NCT00909311|Ritonavir|ritonavir|mesh-list
56792788|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56792789|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56792790|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
56792798|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56792799|NCT00907751|Rituximab|rituximab|mesh-list
56792800|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792801|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792802|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
56792803|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792804|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792805|NCT00336856|Irinotecan|irinotecan|mesh-list
56792806|NCT00336856|Cetuximab|cetuximab|mesh-list
56792807|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56792808|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56792809|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792810|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792811|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792812|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792813|NCT00905333|Felodipine|felodipine|mesh-list
56792814|NCT00905333|Candesartan|candesartan|mesh-list
56792815|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
56792816|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56792817|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56792818|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56792819|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792820|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56792821|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56792822|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792823|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56792824|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792825|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
56792826|NCT00907829|Lidocaine|lidocaine|mesh-list
56792827|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
56792828|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
56792829|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792830|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792836|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56503760|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
56792837|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792838|NCT00336544|Clarithromycin|clarithromycin|mesh-list
56792839|NCT00336544|Cethromycin|cethromycin|mesh-list
56792840|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56792841|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56792842|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56792843|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792844|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792845|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56792846|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56792847|NCT01059058|Fluorides|fluorides|mesh-list
56792848|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
56792849|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
56792850|NCT01059058|Protective Agents|protective agents|mesh-ancestor
56792851|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792852|NCT00605033|Buprenorphine|buprenorphine|mesh-list
56792853|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56792854|NCT00605033|Naloxone|naloxone|mesh-list
56792855|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56792856|NCT00605033|Narcotics|narcotics|mesh-ancestor
56792857|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792858|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792859|NCT00605033|Analgesics|analgesics|mesh-ancestor
56792860|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
56792861|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792862|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56792863|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56792879|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56792880|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56792881|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792882|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56792883|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792884|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56792885|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56792886|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56792887|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56792888|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56792889|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
56792890|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
56792891|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792892|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56792893|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56792894|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792895|NCT01325194|Cytarabine|cytarabine|mesh-list
56792896|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56792897|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
56792898|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792899|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792900|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
56792901|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56792902|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56792903|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
56792904|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792905|NCT00908219|Bevacizumab|bevacizumab|mesh-list
56792925|NCT00931697|Mefloquine|mefloquine|mesh-list
56792926|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
56792927|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56792928|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56792929|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56792930|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
56792931|NCT00927797|Rituximab|rituximab|mesh-list
56792932|NCT00927797|Pentostatin|pentostatin|mesh-list
56792933|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56792934|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
56792935|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792936|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56792937|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56792938|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
56792939|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792940|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792941|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56792942|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56792943|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56792944|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56792945|NCT00338962|Naltrexone|naltrexone|mesh-list
56792946|NCT00338962|Paroxetine|paroxetine|mesh-list
56792947|NCT00338962|Desipramine|desipramine|mesh-list
56792948|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56792976|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56792977|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
56792978|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
56792979|NCT00927875|Carboplatin|carboplatin|mesh-list
56792980|NCT00927875|Etoposide|etoposide|mesh-list
56792981|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56792982|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56792983|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56792984|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56792985|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503911|NCT00191139|Gemcitabine|gemcitabine|mesh-list
56792986|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792988|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56792989|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
56792990|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56792991|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56792992|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56792993|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
56792994|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56792995|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
56792996|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56792997|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56792998|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56792999|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
56793000|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
56793001|NCT00568061|Protective Agents|protective agents|mesh-ancestor
56793002|NCT03547427|Acetaminophen|acetaminophen|mesh-list
56793003|NCT03547427|Insulin|insulin|mesh-list
56793004|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56793005|NCT03547427|Pramlintide|pramlintide|mesh-list
56793022|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793023|NCT03038100|Paclitaxel|paclitaxel|mesh-list
56793024|NCT03038100|Bevacizumab|bevacizumab|mesh-list
56793025|NCT03038100|Carboplatin|carboplatin|mesh-list
56793026|NCT03038100|Atezolizumab|atezolizumab|mesh-list
56793027|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56793028|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56793029|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793030|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
56793031|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
56793032|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
56793033|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793034|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56793035|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56793036|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56793037|NCT03038100|Growth Substances|growth substances|mesh-ancestor
56793038|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793039|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
56793040|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
56793041|NCT00338728|Letrozole|letrozole|mesh-list
56793042|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
56793043|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793044|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56793045|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56793046|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793047|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793048|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56793053|NCT01059136|Spironolactone|spironolactone|mesh-list
56793068|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
56793069|NCT00504894|Thiopental|thiopental|mesh-list
56793070|NCT00504894|Propofol|propofol|mesh-list
56793071|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56793072|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56793073|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793074|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56793075|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
56793076|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
56793077|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
56793078|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
56793079|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
56793080|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793081|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793082|NCT00924755|Caffeine|caffeine|mesh-list
56793083|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56793084|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793085|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56793086|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793087|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793088|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56793089|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56793090|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
56793091|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793092|NCT01011348|Ubiquinone|ubiquinone|mesh-list
56793093|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
56793094|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
56793095|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793096|NCT01011348|Vitamins|vitamins|mesh-ancestor
56793097|NCT00928655|Acetazolamide|acetazolamide|mesh-list
56793108|NCT01011426|Bisacodyl|bisacodyl|mesh-list
56793116|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793117|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56793118|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793119|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793120|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
56793121|NCT00513240|Hematinics|hematinics|mesh-ancestor
56793122|NCT00928811|Basiliximab|basiliximab|mesh-list
56793123|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793124|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
56793125|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793126|NCT00932867|Telmisartan|telmisartan|mesh-list
56793127|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56793128|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56793129|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56793130|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793131|NCT00928967|Interferons|interferons|mesh-list
56793132|NCT00928967|Interferon-beta|interferon-beta|mesh-list
56793133|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
56793134|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793135|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
56793136|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793137|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
56793138|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793139|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56793140|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
56793141|NCT00933023|Betamethasone|betamethasone|mesh-list
56793142|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56793143|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
56793144|NCT00933023|Hormones|hormones|mesh-ancestor
56793145|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793146|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793147|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56793148|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
56793149|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
56793150|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56793151|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56793152|NCT00933179|Gestodene|gestodene|mesh-list
56793153|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56793154|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
56793155|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56793156|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793157|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56793158|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56793159|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56793160|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56793161|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56793162|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56793163|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56793164|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56793165|NCT00933179|Progestins|progestins|mesh-ancestor
56793166|NCT00933179|Hormones|hormones|mesh-ancestor
56793167|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793168|NCT00504348|Tacrolimus|tacrolimus|mesh-list
56793169|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793170|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
56793171|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793172|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56793173|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793174|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793175|NCT00929045|Hormones|hormones|mesh-list
56793176|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793177|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793178|NCT00925457|Domperidone|domperidone|mesh-list
56793179|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56793182|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
56793196|NCT00335764|Sirolimus|sirolimus|mesh-list
56793197|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56793198|NCT00335764|Sorafenib|sorafenib|mesh-list
56793199|NCT00335764|Tipifarnib|tipifarnib|mesh-list
56793200|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793201|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56793202|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793203|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793204|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56793205|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793206|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56793207|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
56793208|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793209|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
56793210|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504134|NCT00590070|Nitroprusside|nitroprusside|mesh-list
56793211|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
56793212|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56793213|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793214|NCT03981484|Thrombin|thrombin|mesh-list
56793215|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
56793216|NCT03981484|Coagulants|coagulants|mesh-ancestor
56793217|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56793218|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793219|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56793220|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793221|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793222|NCT01063660|Treosulfan|treosulfan|mesh-list
56793223|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56793224|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
56793225|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793236|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
56793239|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56793240|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793241|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56793242|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56793243|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793244|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793245|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793246|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56793247|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
56793248|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56793249|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793250|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56793251|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56793252|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56793253|NCT00309946|Cediranib|cediranib|mesh-list
56793254|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793255|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793256|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793257|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56793258|NCT00929591|Tamoxifen|tamoxifen|mesh-list
56793259|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
56793260|NCT00929591|Doxorubicin|doxorubicin|mesh-list
56793261|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56793262|NCT00929591|Fluorouracil|fluorouracil|mesh-list
56793263|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793264|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
56793265|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793266|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56793267|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56793268|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
56793269|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793270|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793271|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56793272|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56793273|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56793274|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56793275|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793276|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
56793277|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56793278|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56793279|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
56793280|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793281|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56793282|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56504211|NCT00477165|Citalopram|citalopram|mesh-list
56793283|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56793284|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56793285|NCT03997500|Norepinephrine|norepinephrine|mesh-list
56793286|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56793287|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56793288|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
56793289|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793290|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793291|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793292|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
56793293|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
56793294|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793295|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56793296|NCT01011660|Amlodipine|amlodipine|mesh-list
56793297|NCT01011660|Telmisartan|telmisartan|mesh-list
56793298|NCT01011660|Amiloride|amiloride|mesh-list
56793299|NCT01011660|Simvastatin|simvastatin|mesh-list
56793300|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56793301|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56793302|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56793303|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793304|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56793315|NCT01011660|Diuretics|diuretics|mesh-ancestor
56793316|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
56793317|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56793318|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56793319|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56793320|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56793321|NCT01015248|Rituximab|rituximab|mesh-list
56793322|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56793323|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56793324|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793325|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
56793326|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793327|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56793328|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56793329|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
56793330|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793331|NCT00506922|Methotrexate|methotrexate|mesh-list
56793332|NCT00506922|Pentostatin|pentostatin|mesh-list
56793333|NCT00506922|Tacrolimus|tacrolimus|mesh-list
56793334|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56793335|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
56793336|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56793337|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793338|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56793339|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
56793340|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793341|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793342|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
56793343|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793344|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56793345|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793346|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
56793347|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56793348|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56793349|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56793350|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56793351|NCT00934193|Gabapentin|gabapentin|mesh-list
56793352|NCT00934193|Analgesics|analgesics|mesh-ancestor
56793353|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
56793354|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793355|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793356|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
56504282|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56793357|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56793358|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56793359|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56793360|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56793361|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56793362|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56793363|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793364|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793365|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
56793367|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56793368|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56793369|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793370|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56793371|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56793372|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793373|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793374|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793375|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56793376|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
56793377|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56793378|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793379|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56793380|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56793381|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56793382|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
56793383|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
56793384|NCT00926315|Calcitriol|calcitriol|mesh-list
56793385|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56793386|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793387|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56793388|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56793389|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793390|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56793391|NCT00926315|Vitamins|vitamins|mesh-ancestor
56793392|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
56793393|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56793394|NCT01013454|Varenicline|varenicline|mesh-list
56793395|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56793396|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56793397|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
56793398|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793399|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793400|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793401|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56793402|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
56793403|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793404|NCT00926627|Bosentan|bosentan|mesh-list
56793405|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56793406|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56793407|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793408|NCT00934739|Thalidomide|thalidomide|mesh-list
56793409|NCT00934739|Dexamethasone|dexamethasone|mesh-list
56793410|NCT00934739|Celecoxib|celecoxib|mesh-list
56793411|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
56793412|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793413|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
56793414|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793415|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56793429|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56793430|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
56793431|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56793432|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793433|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56793434|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56793435|NCT00934739|Growth Substances|growth substances|mesh-ancestor
56793436|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
56793437|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56793438|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56793439|NCT00934739|Analgesics|analgesics|mesh-ancestor
56793440|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
56793441|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56793442|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56793443|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793444|NCT01015482|Midazolam|midazolam|mesh-list
56793445|NCT01015482|Remifentanil|remifentanil|mesh-list
56793446|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56793447|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56793448|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56793449|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793450|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56793451|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56793452|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56793453|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56793454|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
56793455|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
56793456|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
56793457|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
56793458|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793459|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793460|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56793461|NCT01015482|Narcotics|narcotics|mesh-ancestor
56793462|NCT01015482|Analgesics|analgesics|mesh-ancestor
56793472|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793473|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56793474|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793475|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
56793476|NCT01013532|Aspirin|aspirin|mesh-list
56793477|NCT01013532|Cilostazol|cilostazol|mesh-list
56793478|NCT01013532|Probucol|probucol|mesh-list
56793479|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56793480|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56793481|NCT01013532|Analgesics|analgesics|mesh-ancestor
56793482|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
56793483|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793484|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793485|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56793486|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56793487|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56793488|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56793489|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793490|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56793491|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56793492|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793493|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
56793494|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56793495|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
56793496|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56793497|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
56793522|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56793523|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56793524|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793525|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56793526|NCT00926705|Analgesics|analgesics|mesh-ancestor
56793527|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
56793528|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793529|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56793530|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56793531|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56793532|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
56793533|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793534|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793535|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56793536|NCT00926705|Narcotics|narcotics|mesh-ancestor
56793537|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56793538|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56793539|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
56793540|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
56793541|NCT01012284|Bedaquiline|bedaquiline|mesh-list
56793542|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
56793543|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56793544|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793545|NCT00934973|Mebeverine|mebeverine|mesh-list
56793546|NCT00934973|Alverine|alverine|mesh-list
56793547|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
56793548|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
56793549|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
56793550|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793551|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793552|NCT00485472|Lacosamide|lacosamide|mesh-list
56793553|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
56793554|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56793564|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56793565|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793566|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793567|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793568|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56793569|NCT01018836|Protective Agents|protective agents|mesh-ancestor
56793570|NCT04015661|Paclitaxel|paclitaxel|mesh-list
56793571|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56793572|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56793573|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793574|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
56793575|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
56793576|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
56793577|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793578|NCT00491400|Atorvastatin|atorvastatin|mesh-list
56793579|NCT00491400|Fenofibrate|fenofibrate|mesh-list
56793580|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56504512|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
56793581|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56793582|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
56793583|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793584|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56793585|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56793586|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793587|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
56793588|NCT00491322|Vitamin D|vitamin d|mesh-list
56793589|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56793590|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793591|NCT00491322|Vitamins|vitamins|mesh-ancestor
56793592|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
56793593|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56793594|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56793597|NCT04314570|Ropivacaine|ropivacaine|mesh-list
56793603|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793604|NCT04297332|Nicotine|nicotine|mesh-list
56793605|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56793606|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
56793607|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793608|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793609|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56793610|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56793611|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
56793612|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793613|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793614|NCT00930839|Aspirin|aspirin|mesh-list
56793616|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
56793617|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56793618|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56793619|NCT00930839|Analgesics|analgesics|mesh-ancestor
56793620|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
56793621|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793622|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793623|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56793624|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56793625|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56793626|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56793627|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793628|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56793629|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56793630|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793631|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
56793632|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56793633|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
56793649|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793650|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56793651|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56793652|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
56793653|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
56793654|NCT00935363|Glyburide|glyburide|mesh-list
56793655|NCT00935363|Rifampin|rifampin|mesh-list
56793656|NCT00935363|Fluconazole|fluconazole|mesh-list
56793657|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56793658|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
56793659|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56793660|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793661|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
56793662|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56793663|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793664|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793665|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56793666|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56793667|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56793668|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56793669|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56793670|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56793681|NCT00930995|Candesartan|candesartan|mesh-list
56066111|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066112|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
56066113|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56066114|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56066115|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066117|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56793697|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56793698|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
56793699|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793700|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793701|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56793702|NCT04179864|Prednisone|prednisone|mesh-list
56793703|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56793704|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
56793705|NCT04179864|Hormones|hormones|mesh-ancestor
56793706|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793707|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793708|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56793709|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793710|NCT00936689|Doxorubicin|doxorubicin|mesh-list
56793711|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
56793712|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56793713|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793714|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56793715|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56793736|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56793737|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793738|NCT01019070|Asunaprevir|asunaprevir|mesh-list
56793739|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
56793740|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793741|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793742|NCT00936767|Artesunate|artesunate|mesh-list
56793743|NCT00936767|Mefloquine|mefloquine|mesh-list
56793744|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
56793745|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56793746|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56793747|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793748|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793749|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
56793750|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
56793751|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56793752|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
56793753|NCT00931229|Entecavir|entecavir|mesh-list
56793754|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
56793755|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793756|NCT00936923|Furosemide|furosemide|mesh-list
56793757|NCT00936923|Diuretics|diuretics|mesh-list
56793758|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
56793759|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793763|NCT01019382|Gemcitabine|gemcitabine|mesh-list
56793789|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56793790|NCT02567825|Amoxicillin|amoxicillin|mesh-list
56793791|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
56793792|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
56793793|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
56793794|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56793795|NCT02567825|Ofloxacin|ofloxacin|mesh-list
56793796|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56793797|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793798|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56793799|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793800|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793801|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56793802|NCT02567825|Renal Agents|renal agents|mesh-ancestor
56793803|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56793804|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56793805|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793806|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56793807|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56793808|NCT00490776|Panobinostat|panobinostat|mesh-list
56793809|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793810|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56793811|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793812|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793813|NCT00566735|Galantamine|galantamine|mesh-list
56793814|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56793815|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793816|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793817|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
56793818|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793819|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793832|NCT00937079|Incretins|incretins|mesh-ancestor
56793833|NCT00937079|Hormones|hormones|mesh-ancestor
56793834|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793835|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
56793836|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56793837|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56793838|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
56793839|NCT00937625|Fludarabine|fludarabine|mesh-list
56793840|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
56793841|NCT00937625|Interleukin-2|interleukin-2|mesh-list
56793842|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56793843|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
56793844|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793845|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56793846|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56793847|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
56793848|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793849|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793850|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56793851|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56793885|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793886|NCT00564629|Acetaminophen|acetaminophen|mesh-list
56793887|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56793888|NCT00564629|Analgesics|analgesics|mesh-ancestor
56793889|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
56793890|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793891|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793892|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
56793893|NCT00564395|Insulin|insulin|mesh-list
56793894|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56793895|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
56793896|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56793897|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793898|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
56793899|NCT04013243|Analgesics|analgesics|mesh-ancestor
56793900|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
56793901|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56793902|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793903|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
56793904|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56793905|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56793906|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
56793907|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56793938|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793939|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793940|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793941|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56793942|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56793943|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56793944|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56793945|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56793946|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
56793947|NCT00502242|Ramipril|ramipril|mesh-list
56793948|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56793949|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
56793950|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793951|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793952|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56793953|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56793954|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56793955|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56793956|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
56793957|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793958|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56793959|NCT03045653|Tamoxifen|tamoxifen|mesh-list
56793960|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56793961|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
56793962|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56793963|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793964|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56793965|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56793966|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56793967|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56793968|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56793969|NCT02991365|Insulin|insulin|mesh-list
56793970|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56793976|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793977|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56793978|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56793979|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
56793980|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56793981|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793982|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
56793983|NCT00490698|Atorvastatin|atorvastatin|mesh-list
56793984|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56793985|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56793986|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
56793987|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793988|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56793989|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56793990|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56793991|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56793992|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56793993|NCT04492254|Enoxaparin|enoxaparin|mesh-list
56793994|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
56793995|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56793996|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56793997|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56793998|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
56793999|NCT03855228|Loratadine|loratadine|mesh-list
56794025|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56794026|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794028|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56794029|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56794030|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56794031|NCT01019772|Vaccines|vaccines|mesh-list
56794032|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
56794033|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794034|NCT00513500|Amoxicillin|amoxicillin|mesh-list
56794035|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56794036|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56794037|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794038|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
56794039|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56794040|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56794041|NCT00511004|Albendazole|albendazole|mesh-list
56794042|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
56794043|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
56794044|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56794045|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794046|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
56794047|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56794048|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56794049|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56794050|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56794051|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56794052|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794074|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
56794075|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
56794076|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56794077|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
56794078|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794079|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794080|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56794081|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56794082|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56794083|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
56794084|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
56794085|NCT00512798|Temozolomide|temozolomide|mesh-list
56794086|NCT00512798|Bortezomib|bortezomib|mesh-list
56794087|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56794088|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
56794089|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794090|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794091|NCT00940121|Mirabegron|mirabegron|mesh-list
56794092|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56794093|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56794094|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56794095|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
56794096|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794097|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794098|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794099|NCT00940121|Urological Agents|urological agents|mesh-ancestor
56505029|NCT04312204|Gemcitabine|gemcitabine|mesh-list
56794100|NCT04012619|Cisplatin|cisplatin|mesh-list
56794101|NCT04012619|Carboplatin|carboplatin|mesh-list
56794102|NCT04012619|Pemetrexed|pemetrexed|mesh-list
56794118|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56794119|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56794120|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56794121|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56794122|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56794123|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
56794124|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794125|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794126|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794127|NCT00941057|Androgens|androgens|mesh-ancestor
56794128|NCT00941057|Hormones|hormones|mesh-ancestor
56794129|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
56794130|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
56794131|NCT00941057|Vitamins|vitamins|mesh-ancestor
56794132|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
56794133|NCT00561821|Mirtazapine|mirtazapine|mesh-list
56794134|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
56794135|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56794136|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56794137|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
56794138|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
56794139|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794140|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794141|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794142|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56794143|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56794144|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56794145|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56794146|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56794147|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56794148|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
56794151|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
56794160|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794161|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56794162|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56794163|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56794164|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794165|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
56794166|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56794167|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
56794168|NCT00335452|Clopidogrel|clopidogrel|mesh-list
56794169|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56794170|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56794171|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56794172|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56794173|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
56794174|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794175|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794176|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794177|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
56794178|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56794179|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794180|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56794181|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
56794182|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56794183|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794184|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794185|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794186|NCT00522392|Dexamethasone|dexamethasone|mesh-list
56794187|NCT00522392|Lenalidomide|lenalidomide|mesh-list
56794189|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794190|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
56794191|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
56794192|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794193|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794194|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56794195|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
56794196|NCT00522392|Hormones|hormones|mesh-ancestor
56066571|NCT01868425|Analgesics|analgesics|mesh-ancestor
56794197|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794198|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794199|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794200|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
56794201|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56794202|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56794203|NCT00522392|Growth Substances|growth substances|mesh-ancestor
56794204|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
56794205|NCT00335140|Leucovorin|leucovorin|mesh-list
56794206|NCT00335140|Cytarabine|cytarabine|mesh-list
56794207|NCT00335140|Dexamethasone|dexamethasone|mesh-list
56794208|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
56794209|NCT00335140|Rituximab|rituximab|mesh-list
56794210|NCT00335140|Methotrexate|methotrexate|mesh-list
56794211|NCT00335140|Vincristine|vincristine|mesh-list
56794212|NCT00335140|Procarbazine|procarbazine|mesh-list
56794213|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56794214|NCT00335140|BB 1101|bb 1101|mesh-list
56794215|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
56794216|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794217|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794218|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
56794219|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794220|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794221|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794222|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
56794223|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
56794248|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
56794249|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56794250|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
56794251|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
56794252|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
56794253|NCT01061320|Tocopherols|tocopherols|mesh-list
56794254|NCT01061320|Vitamin E|vitamin e|mesh-list
56794255|NCT01061320|Tocotrienols|tocotrienols|mesh-list
56794256|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
56794257|NCT01061320|Vitamins|vitamins|mesh-ancestor
56794258|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
56794259|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794260|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
56794261|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794262|NCT01061320|Protective Agents|protective agents|mesh-ancestor
56794263|NCT01012544|Clopidogrel|clopidogrel|mesh-list
56794264|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56794265|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56794266|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56794267|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56794268|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
56794269|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794270|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794271|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794272|NCT01012700|Poly ICLC|poly iclc|mesh-list
56794273|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
56794274|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
56794275|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794276|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
56794277|NCT01565720|Isavuconazole|isavuconazole|mesh-list
56794278|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56794279|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794281|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56794292|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
56794293|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794294|NCT00309244|Coagulants|coagulants|mesh-ancestor
56794295|NCT00483756|Cyclosporine|cyclosporine|mesh-list
56794296|NCT00483756|Cyclosporins|cyclosporins|mesh-list
56794297|NCT00483756|Tofacitinib|tofacitinib|mesh-list
56794298|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794299|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794300|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794301|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
56794302|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794303|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
56794304|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794305|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
56794306|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794307|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56794308|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56794309|NCT00309166|Vaccines|vaccines|mesh-list
56794310|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
56794311|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794312|NCT01063816|Gemcitabine|gemcitabine|mesh-list
56794313|NCT01063816|Carboplatin|carboplatin|mesh-list
56794314|NCT01063816|Veliparib|veliparib|mesh-list
56794315|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794316|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56794317|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
56794318|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794319|NCT01063816|Antiviral Agents|antiviral agents|mesh-ancestor
56794320|NCT01063816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794321|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794322|NCT01063816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794323|NCT01063816|Immunologic Factors|immunologic factors|mesh-ancestor
56794336|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
56794337|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794338|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794339|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56794340|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56794341|NCT00482274|Docetaxel|docetaxel|mesh-list
56794342|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794343|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
56794344|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
56794345|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
56794346|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794347|NCT00490542|Ziprasidone|ziprasidone|mesh-list
56794348|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56794349|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
56794350|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794351|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794352|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794353|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56794354|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56794355|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56794356|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56794357|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56794358|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
56794359|NCT01059604|Naproxen|naproxen|mesh-list
56794360|NCT01059604|Sumatriptan|sumatriptan|mesh-list
56794361|NCT01059604|Naratriptan|naratriptan|mesh-list
56794362|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56794363|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56794364|NCT01059604|Analgesics|analgesics|mesh-ancestor
56794365|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
56794366|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794367|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794368|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794369|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794370|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
56794371|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56194594|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194595|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56794372|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794373|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794374|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56794375|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56794376|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56794377|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
56794378|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794379|NCT02532634|Dexamethasone|dexamethasone|mesh-list
56794380|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
56794381|NCT02532634|Aprepitant|aprepitant|mesh-list
56794382|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
56794383|NCT02532634|Palonosetron|palonosetron|mesh-list
56794384|NCT02532634|Ramosetron|ramosetron|mesh-list
56794385|NCT02532634|BB 1101|bb 1101|mesh-list
56794386|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794387|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
56794388|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
56794389|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794390|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794391|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56794392|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
56794393|NCT02532634|Hormones|hormones|mesh-ancestor
56794394|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794395|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794396|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794397|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
56794398|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794401|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794421|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794422|NCT01014234|Cyclosporine|cyclosporine|mesh-list
56794423|NCT01014234|Sirolimus|sirolimus|mesh-list
56794424|NCT01014234|Cyclosporins|cyclosporins|mesh-list
56794425|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794426|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794427|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794428|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
56794429|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794430|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
56794431|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794432|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
56794433|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794434|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56794435|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56794436|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56794437|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794438|NCT00501228|Lenograstim|lenograstim|mesh-list
56794439|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56794440|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
56794441|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794442|NCT00308620|Chloroquine|chloroquine|mesh-list
56794443|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56794444|NCT00308620|Amebicides|amebicides|mesh-ancestor
56794445|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56794446|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56794447|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794448|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
56794449|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794450|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56794451|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56794452|NCT00308620|Analgesics|analgesics|mesh-ancestor
56794453|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
56794454|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794455|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794456|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066873|NCT05588297|Nivolumab|nivolumab|mesh-list
56066874|NCT05588297|Capecitabine|capecitabine|mesh-list
56066875|NCT05588297|Oxaliplatin|oxaliplatin|mesh-list
56066876|NCT05588297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066877|NCT05588297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794462|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56794463|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794464|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794465|NCT01019850|Vorinostat|vorinostat|mesh-list
56794466|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56794467|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794468|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56794469|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794470|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794471|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56794472|NCT00308308|Insulin|insulin|mesh-list
56794473|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56794474|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794475|NCT00505934|Levetiracetam|levetiracetam|mesh-list
56794476|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
56794477|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
56794478|NCT02532790|Prednisone|prednisone|mesh-list
56794479|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794480|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
56794507|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56794508|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
56794509|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56794510|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56794511|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56794512|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56794513|NCT03997058|Estazolam|estazolam|mesh-list
56794514|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
56794515|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56794516|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56794517|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56794518|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794519|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56794520|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
56794521|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
56794522|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794523|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794524|NCT00500760|Panitumumab|panitumumab|mesh-list
56794525|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794526|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794527|NCT01016730|Bortezomib|bortezomib|mesh-list
56794528|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794529|NCT01012934|Alendronate|alendronate|mesh-list
56794530|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56794531|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794532|NCT04334330|Trastuzumab|trastuzumab|mesh-list
56794533|NCT04334330|Fulvestrant|fulvestrant|mesh-list
56794534|NCT04334330|Palbociclib|palbociclib|mesh-list
56794535|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794536|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794537|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794538|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56794539|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56794540|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
56794541|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56066913|NCT05587361|Autonomic Agents|autonomic agents|mesh-ancestor
56194596|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56194597|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794542|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794543|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56794544|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794545|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794546|NCT01015196|Daunorubicin|daunorubicin|mesh-list
56794547|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56794548|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794549|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56794550|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56794551|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794552|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794553|NCT01009892|Codeine|codeine|mesh-list
56794554|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56794555|NCT01009892|Narcotics|narcotics|mesh-ancestor
56794556|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56794557|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794558|NCT01009892|Analgesics|analgesics|mesh-ancestor
56794559|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
56794560|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794561|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
56794562|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
56794563|NCT00307684|Methylphenidate|methylphenidate|mesh-list
56794564|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56794570|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
56794590|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794591|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794592|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
56794593|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794594|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
56794595|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56794596|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56794597|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56794598|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56794599|NCT00307294|Growth Substances|growth substances|mesh-ancestor
56794600|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
56794601|NCT03981094|Pirfenidone|pirfenidone|mesh-list
56794602|NCT03981094|Analgesics|analgesics|mesh-ancestor
56794603|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
56794604|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794605|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794606|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56794607|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56794608|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794609|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794610|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794611|NCT03963401|PF-06700841|pf-06700841|mesh-list
56794612|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56794613|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794614|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794615|NCT04410965|Teriflunomide|teriflunomide|mesh-list
56794640|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56794641|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56794642|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794643|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56794644|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56794645|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794646|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794647|NCT01060228|Valproic Acid|valproic acid|mesh-list
56794648|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56794649|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56794650|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56794651|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56794652|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794653|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56794654|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56794655|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56794656|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
56794657|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794658|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794659|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56794660|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56794661|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
56794662|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
56794663|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794664|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
56794665|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
56794666|NCT00306670|Prednisone|prednisone|mesh-list
56794667|NCT00306670|Rituximab|rituximab|mesh-list
56794687|NCT00321646|Growth Substances|growth substances|mesh-ancestor
56794688|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794689|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
56794690|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
56794691|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
56794692|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
56794693|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794694|NCT00403767|Warfarin|warfarin|mesh-list
56794695|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
56794696|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
56794697|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56794698|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
56794699|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56794700|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
56794701|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794702|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794703|NCT00492284|Dexamethasone|dexamethasone|mesh-list
56794704|NCT00492284|Ranibizumab|ranibizumab|mesh-list
56794705|NCT00492284|Verteporfin|verteporfin|mesh-list
56794706|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794707|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
56794708|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
56794709|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794710|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794711|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56794712|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
56794713|NCT00492284|Hormones|hormones|mesh-ancestor
56794714|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794715|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794716|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794717|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56794718|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56794719|NCT00492284|Growth Substances|growth substances|mesh-ancestor
56794720|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
56794723|NCT01013012|Dexamethasone|dexamethasone|mesh-list
56794729|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794730|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56794731|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
56794732|NCT01013012|Hormones|hormones|mesh-ancestor
56794733|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794734|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794735|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794736|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56794737|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
56794738|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794739|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794740|NCT01009970|Prednisone|prednisone|mesh-list
56794741|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
56794742|NCT01009970|Rituximab|rituximab|mesh-list
56794743|NCT01009970|Doxorubicin|doxorubicin|mesh-list
56794744|NCT01009970|Vincristine|vincristine|mesh-list
56794745|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794746|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
56794747|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794748|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794749|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56794750|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
56794751|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794752|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794753|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56794754|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794777|NCT05102162|Tazobactam|tazobactam|mesh-list
56794778|NCT05102162|Piperacillin|piperacillin|mesh-list
56794779|NCT05102162|Cefepime|cefepime|mesh-list
56794780|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56794781|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56794782|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505699|NCT03450161|Fentanyl|fentanyl|mesh-list
56794783|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56794784|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794785|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794786|NCT03563157|Leucovorin|leucovorin|mesh-list
56794787|NCT03563157|Paclitaxel|paclitaxel|mesh-list
56794788|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
56794789|NCT03563157|Fluorouracil|fluorouracil|mesh-list
56794790|NCT03563157|Capecitabine|capecitabine|mesh-list
56794791|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
56794792|NCT03563157|Cetuximab|cetuximab|mesh-list
56794793|NCT03563157|Avelumab|avelumab|mesh-list
56794794|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56794795|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794796|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
56794797|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
56794798|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
56794799|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794800|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56794801|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
56794802|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794803|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56794804|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56794805|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
56794806|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56794807|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
56794808|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56794809|NCT03563157|Antidotes|antidotes|mesh-ancestor
56794822|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794823|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794824|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
56794825|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56794826|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56794827|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56794828|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56794829|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794830|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794831|NCT01010048|Urological Agents|urological agents|mesh-ancestor
56794832|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56794833|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56794834|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56794835|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
56794836|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
56794837|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56794838|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56794839|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56794840|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56794841|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56794842|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
56794843|NCT01589055|Nicotine|nicotine|mesh-list
56794844|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56794845|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
56794846|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794847|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794848|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56794849|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56794850|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
56794851|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794852|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794853|NCT00414765|Aldesleukin|aldesleukin|mesh-list
56794854|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794855|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56794856|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56794859|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56794860|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56505782|NCT04564326|Fentanyl|fentanyl|mesh-list
56794861|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56794862|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794864|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56794865|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56794866|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794867|NCT01013480|Baclofen|baclofen|mesh-list
56794868|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56794869|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794870|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56794871|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794872|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56794873|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
56794874|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
56794875|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794876|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794877|NCT00500370|Exenatide|exenatide|mesh-list
56794878|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56794879|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794880|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56794881|NCT00500370|Incretins|incretins|mesh-ancestor
56794882|NCT00500370|Hormones|hormones|mesh-ancestor
56794883|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794884|NCT00320788|Aflibercept|aflibercept|mesh-list
56794885|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56794886|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56794896|NCT03996486|Paraproteins|paraproteins|mesh-list
56794905|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794906|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56794907|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
56794908|NCT01014468|Bevacizumab|bevacizumab|mesh-list
56794909|NCT01014468|Ranibizumab|ranibizumab|mesh-list
56794910|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56794911|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794912|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56794913|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56794914|NCT01014468|Growth Substances|growth substances|mesh-ancestor
56794915|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794916|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
56794917|NCT00503984|Prednisone|prednisone|mesh-list
56794918|NCT00503984|Docetaxel|docetaxel|mesh-list
56794919|NCT00503984|Azacitidine|azacitidine|mesh-list
56794920|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794921|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
56794922|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
56794923|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
56794924|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794925|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794926|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
56794927|NCT00503984|Hormones|hormones|mesh-ancestor
56794928|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56794929|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794930|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56794931|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56794932|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
56794933|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794934|NCT03996564|Acetaminophen|acetaminophen|mesh-list
56794951|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56794952|NCT03996564|Narcotics|narcotics|mesh-ancestor
56794953|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56794954|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
56794955|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
56794956|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56794957|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
56794958|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
56794959|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
56794960|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56794961|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56794962|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56794963|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56794964|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56794965|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56794966|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56794967|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56794968|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
56794969|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
56794970|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
56794971|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
56794972|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56794974|NCT00565409|Methotrexate|methotrexate|mesh-list
56794975|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56794976|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
56794977|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56794978|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56794979|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56794980|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
56794981|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56794982|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56794983|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56794984|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56794985|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56794994|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56794995|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56794996|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56794997|NCT00394251|Paclitaxel|paclitaxel|mesh-list
56794998|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
56794999|NCT00394251|Bevacizumab|bevacizumab|mesh-list
56795000|NCT00394251|Doxorubicin|doxorubicin|mesh-list
56795001|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56795002|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56795003|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56795004|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795005|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
56795006|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
56795007|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
56795008|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795009|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795010|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
56505946|NCT02486367|Ticagrelor|ticagrelor|mesh-list
56795011|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795012|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56795013|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56795014|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
56795015|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56795016|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795017|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795018|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795019|NCT00394251|Growth Substances|growth substances|mesh-ancestor
56795020|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
56795021|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56795022|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56795023|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56795024|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795036|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56795037|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795038|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
56795039|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
56795040|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
56795041|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795042|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795043|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795044|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795045|NCT00503906|Growth Substances|growth substances|mesh-ancestor
56795046|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795047|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
56795048|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56795049|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
56795050|NCT00503906|Antiviral Agents|antiviral agents|mesh-ancestor
56795051|NCT00503906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795052|NCT00503906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795053|NCT00503906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795054|NCT00503906|Immunologic Factors|immunologic factors|mesh-ancestor
56795055|NCT00305110|Hydromorphone|hydromorphone|mesh-list
56795056|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56795057|NCT00305110|Narcotics|narcotics|mesh-ancestor
56795058|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56795059|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795060|NCT00305110|Analgesics|analgesics|mesh-ancestor
56795061|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
56795062|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795063|NCT03984760|Sevelamer|sevelamer|mesh-list
56795064|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
56795065|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
56795067|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
56795079|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56795080|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56795081|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
56795082|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795083|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56795084|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
56795085|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56795086|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
56795087|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56506000|NCT04560816|Choline|choline|mesh-list
56795088|NCT00500292|Leucovorin|leucovorin|mesh-list
56795089|NCT00500292|Folic Acid|folic acid|mesh-list
56795090|NCT00500292|Fluorouracil|fluorouracil|mesh-list
56795091|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
56795092|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
56795093|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
56795094|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795095|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56795096|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795097|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795098|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
56795099|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795100|NCT00500292|Antidotes|antidotes|mesh-ancestor
56795101|NCT00500292|Protective Agents|protective agents|mesh-ancestor
56795102|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
56795103|NCT00500292|Vitamins|vitamins|mesh-ancestor
56795104|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
56795105|NCT00500292|Hematinics|hematinics|mesh-ancestor
56795106|NCT01013558|Remifentanil|remifentanil|mesh-list
56795107|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56795108|NCT01013558|Narcotics|narcotics|mesh-ancestor
56795109|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56795110|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795111|NCT01013558|Analgesics|analgesics|mesh-ancestor
56795112|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
56795113|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795114|NCT00499746|Tramadol|tramadol|mesh-list
56795120|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56795121|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56795122|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795123|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
56795124|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795125|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56795126|NCT00499746|Narcotics|narcotics|mesh-ancestor
56795127|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56795128|NCT00499746|Analgesics|analgesics|mesh-ancestor
56795129|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
56795130|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795131|NCT01010516|Niacin|niacin|mesh-list
56795132|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56795133|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56795134|NCT01010516|Fenofibrate|fenofibrate|mesh-list
56795135|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56795136|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56795137|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
56795138|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795139|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56795140|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795141|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
56795142|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
56795143|NCT01010516|Vitamins|vitamins|mesh-ancestor
56795144|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
56795145|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795146|NCT01020162|Gabapentin|gabapentin|mesh-list
56795147|NCT01020162|Amitriptyline|amitriptyline|mesh-list
56795148|NCT01020162|Analgesics|analgesics|mesh-ancestor
56795149|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
56795150|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795151|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795152|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
56795162|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56795163|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
56795164|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56795165|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56547694|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56795166|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56795167|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56795168|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
56795169|NCT01016886|Bisoprolol|bisoprolol|mesh-list
56795170|NCT01016886|Perindopril|perindopril|mesh-list
56795171|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56795172|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
56795173|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
56795174|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795175|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795176|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56795177|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56795178|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56795179|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56795180|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795181|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795183|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
56795211|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795212|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795213|NCT04250064|Growth Substances|growth substances|mesh-ancestor
56795214|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795215|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
56795216|NCT00480636|Dalteparin|dalteparin|mesh-list
56795217|NCT00480636|Tinzaparin|tinzaparin|mesh-list
56795218|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56795219|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
56795220|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56795221|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56795222|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795223|NCT01017198|Antacids|antacids|mesh-list
56795224|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795225|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56795226|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
56795227|NCT00499122|Docetaxel|docetaxel|mesh-list
56795228|NCT00499122|Doxorubicin|doxorubicin|mesh-list
56795229|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795230|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
56795231|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795232|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56795233|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56795234|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
56795236|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795262|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
56795263|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
56795264|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795265|NCT00488826|Vaccines|vaccines|mesh-list
56795266|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56795267|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
56795268|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795269|NCT01017354|Calcifediol|calcifediol|mesh-list
56795270|NCT01017354|Vitamins|vitamins|mesh-ancestor
56795271|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
56795272|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795273|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56795274|NCT00393861|Bevacizumab|bevacizumab|mesh-list
56795275|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
56795276|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795277|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795278|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795279|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795280|NCT00393861|Growth Substances|growth substances|mesh-ancestor
56795281|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795282|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
56795283|NCT01040559|Idarubicin|idarubicin|mesh-list
56795284|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56795285|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795286|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56795288|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795311|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56795312|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
56795313|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56795314|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795315|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795316|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56795317|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56795318|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56795319|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
56795320|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795321|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
56795322|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56795323|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795324|NCT00320398|PENTA|penta|mesh-list
56795325|NCT00320398|Fondaparinux|fondaparinux|mesh-list
56795326|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56795327|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
56795328|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56795329|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
56795330|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795331|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795332|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
56795333|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56795362|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
56795363|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56795364|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56795365|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56795366|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
56795367|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795368|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795369|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795370|NCT01017744|Anesthetics|anesthetics|mesh-list
56795371|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56795372|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795373|NCT00477594|Mipomersen|mipomersen|mesh-list
56795374|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56795375|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56795376|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
56795378|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56795420|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
56795421|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795422|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56795423|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795424|NCT00303628|Antidotes|antidotes|mesh-ancestor
56795425|NCT00303628|Protective Agents|protective agents|mesh-ancestor
56795426|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
56795427|NCT00303628|Vitamins|vitamins|mesh-ancestor
56795428|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
56795429|NCT00414453|Lidocaine|lidocaine|mesh-list
56795430|NCT00414453|Oxycodone|oxycodone|mesh-list
56795431|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
56795432|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
56795433|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56795434|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795435|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
56795436|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795437|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56795438|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56795439|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56795440|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56795441|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795442|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56795443|NCT00414453|Narcotics|narcotics|mesh-ancestor
56795444|NCT00414453|Analgesics|analgesics|mesh-ancestor
56795445|NCT01037595|Turmeric extract|turmeric extract|mesh-list
56795446|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
56795447|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795448|NCT01037595|Protective Agents|protective agents|mesh-ancestor
56795449|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795450|NCT01041027|Paclitaxel|paclitaxel|mesh-list
56795451|NCT01041027|Carboplatin|carboplatin|mesh-list
56795452|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56795463|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795464|NCT00332332|Etanercept|etanercept|mesh-list
56795465|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56795466|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56795467|NCT00332332|Analgesics|analgesics|mesh-ancestor
56795468|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
56795469|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795470|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795471|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56795472|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56795473|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56795474|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795475|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
56795476|NCT00392925|Pramlintide|pramlintide|mesh-list
56795477|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
56795478|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56795479|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795480|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
56795481|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56795482|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
56795483|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795484|NCT00474786|Sirolimus|sirolimus|mesh-list
56795485|NCT00474786|Sorafenib|sorafenib|mesh-list
56795486|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795487|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56795488|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795489|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795490|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56795491|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795492|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56795493|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
56795494|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795495|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
56795496|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795497|NCT00392769|Cetuximab|cetuximab|mesh-list
56795500|NCT01041183|Ramosetron|ramosetron|mesh-list
56795502|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
56795503|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795504|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795505|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56795506|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56795507|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
56795508|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795509|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795510|NCT00319696|Bosentan|bosentan|mesh-list
56795511|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56795512|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56795513|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795514|NCT00474630|Naltrexone|naltrexone|mesh-list
56795515|NCT00474630|Bupropion|bupropion|mesh-list
56795516|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56795517|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56795518|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795519|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
56795520|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795521|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56795522|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
56795523|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56795524|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56795525|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56795526|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56795527|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795528|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
56795529|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795545|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795546|NCT01038063|Lumefantrine|lumefantrine|mesh-list
56795547|NCT01038063|Artemether|artemether|mesh-list
56795548|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56795549|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
56795550|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56795551|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56795552|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795553|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
56795554|NCT01043991|Hematinics|hematinics|mesh-ancestor
56795555|NCT01020630|Sunitinib|sunitinib|mesh-list
56795556|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795557|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795558|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795559|NCT01020630|Growth Substances|growth substances|mesh-ancestor
56795560|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795561|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
56795562|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56795563|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795564|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795565|NCT00403455|Paroxetine|paroxetine|mesh-list
56795566|NCT00403455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56795567|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56795568|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56795569|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795570|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795571|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
56795572|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795573|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56795574|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
56795575|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56795576|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56795577|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56795584|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
56795585|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795586|NCT00509600|Etanercept|etanercept|mesh-list
56795587|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56795588|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56795589|NCT00509600|Analgesics|analgesics|mesh-ancestor
56795590|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
56795591|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795592|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795593|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56795594|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56795595|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56795596|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795597|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
56795598|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
56795599|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56795600|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56795601|NCT01014104|Prednisolone|prednisolone|mesh-list
56795602|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
56795603|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56795604|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
56795605|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56795606|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
56795607|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
56795608|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795609|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795610|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56795611|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
56795612|NCT01014104|Hormones|hormones|mesh-ancestor
56795613|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56795614|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56795615|NCT01014104|Protective Agents|protective agents|mesh-ancestor
56795616|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56795617|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795618|NCT00402987|Celecoxib|celecoxib|mesh-list
56795619|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56795622|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
56795623|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795624|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795625|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56795626|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56795627|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56795628|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56795629|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795630|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795631|NCT01015664|Sirolimus|sirolimus|mesh-list
56795632|NCT01015664|Cetuximab|cetuximab|mesh-list
56795633|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795634|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795635|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56795636|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795637|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56795638|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
56795639|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795640|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
56795641|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795642|NCT00501644|Interferons|interferons|mesh-list
56795643|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
56795644|NCT00501644|Carboplatin|carboplatin|mesh-list
56795645|NCT00501644|Molgramostim|molgramostim|mesh-list
56795646|NCT00501644|Sargramostim|sargramostim|mesh-list
56795647|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795648|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
56795649|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795650|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
56795651|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795652|NCT01014260|Doxycycline|doxycycline|mesh-list
56795653|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56795654|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795658|NCT01010672|Sirolimus|sirolimus|mesh-list
56795665|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
56795666|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795667|NCT01014338|Fosinopril|fosinopril|mesh-list
56795668|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56795669|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
56795670|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795671|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795672|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56795673|NCT01014416|Tolvaptan|tolvaptan|mesh-list
56795674|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56795675|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795676|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
56795677|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795678|NCT00497796|Ganciclovir|ganciclovir|mesh-list
56795679|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56795680|NCT00497796|Maribavir|maribavir|mesh-list
56795681|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
56795682|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795683|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56795684|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795685|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795686|NCT01017822|Gemcitabine|gemcitabine|mesh-list
56795687|NCT01017822|Capecitabine|capecitabine|mesh-list
56795688|NCT01017822|Conatumumab|conatumumab|mesh-list
56795689|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56795690|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
56795691|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795692|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795693|NCT01017822|Antiviral Agents|antiviral agents|mesh-ancestor
56795694|NCT01017822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795695|NCT01017822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795707|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795708|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56795709|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
56795710|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56795711|NCT01020708|Mesalamine|mesalamine|mesh-list
56795712|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56795713|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
56795714|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795715|NCT01020708|Expectorants|expectorants|mesh-ancestor
56795716|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
56795717|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56795718|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
56795719|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795720|NCT01020708|Protective Agents|protective agents|mesh-ancestor
56795721|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795722|NCT01020708|Antidotes|antidotes|mesh-ancestor
56795723|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56795724|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56795725|NCT01020708|Analgesics|analgesics|mesh-ancestor
56795726|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
56795727|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795728|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56795729|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56795730|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
56795731|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56795732|NCT01020864|Carboplatin|carboplatin|mesh-list
56795733|NCT01020864|Cetuximab|cetuximab|mesh-list
56795734|NCT01020864|Vinorelbine|vinorelbine|mesh-list
56795735|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795736|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795737|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56795738|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
56795739|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
56795740|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
56795741|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795742|NCT04428372|Mannitol|mannitol|mesh-list
56795747|NCT04056624|Carotenoids|carotenoids|mesh-list
56795748|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
56795749|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795750|NCT04056624|Protective Agents|protective agents|mesh-ancestor
56795751|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795752|NCT01014858|Donepezil|donepezil|mesh-list
56795753|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56795754|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795755|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795756|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
56795757|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795758|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795759|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
56795760|NCT00471276|Sunitinib|sunitinib|mesh-list
56795761|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795762|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795763|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795764|NCT00471276|Growth Substances|growth substances|mesh-ancestor
56795765|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795766|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
56506671|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
56795767|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56795768|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795769|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795771|NCT00470262|Fenofibrate|fenofibrate|mesh-list
56795772|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56795773|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795774|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56795775|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
56795776|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795777|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56795778|NCT04034862|Lamivudine|lamivudine|mesh-list
56795779|NCT04034862|Dolutegravir|dolutegravir|mesh-list
56795788|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56795789|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56795790|NCT00496470|Budesonide|budesonide|mesh-list
56795791|NCT00496470|Bromides|bromides|mesh-list
56795792|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
56795793|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
56795794|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56795795|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56795796|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56795797|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
56795798|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795799|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795800|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56795801|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
56795802|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
56795803|NCT00496470|Hormones|hormones|mesh-ancestor
56795804|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56795805|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56795806|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56795807|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56795808|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
56795809|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795810|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795811|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
56795812|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56795813|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
56795814|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
56795815|NCT01021176|Diltiazem|diltiazem|mesh-list
56795816|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56795817|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56795818|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56795819|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795820|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56795821|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795822|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
56795823|NCT01018368|Rifampin|rifampin|mesh-list
56795824|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56795825|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
56795826|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56795827|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795828|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
56795829|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56795830|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795831|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795832|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56795833|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56795834|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56795835|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56795836|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56795837|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56795838|NCT00487578|Naratriptan|naratriptan|mesh-list
56795839|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56795840|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56795841|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56795842|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
56795843|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795844|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795845|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795846|NCT00495612|Omalizumab|omalizumab|mesh-list
56795847|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56795848|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56795849|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
56795850|NCT01021488|Enoxaparin|enoxaparin|mesh-list
56795851|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56795852|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56795853|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56795854|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
56795855|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795856|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56795857|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56795860|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56795861|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56795862|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56795863|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
56795864|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
56795865|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795866|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56795867|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56795868|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795869|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56795870|NCT00509366|Gemcitabine|gemcitabine|mesh-list
56795871|NCT00509366|Cisplatin|cisplatin|mesh-list
56795872|NCT00509366|Docetaxel|docetaxel|mesh-list
56795873|NCT00509366|Pemetrexed|pemetrexed|mesh-list
56795874|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795875|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56795876|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
56795877|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795878|NCT00509366|Antiviral Agents|antiviral agents|mesh-ancestor
56795879|NCT00509366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795880|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795881|NCT00509366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56795882|NCT00509366|Immunologic Factors|immunologic factors|mesh-ancestor
56795883|NCT00509366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795884|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
56795885|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
56795886|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
56795887|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56795906|NCT00500318|Bromides|bromides|mesh-list
56795909|NCT00499694|Satraplatin|satraplatin|mesh-list
56795910|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56795911|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795912|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56795913|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56795914|NCT00499694|Growth Substances|growth substances|mesh-ancestor
56795915|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795916|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
56795917|NCT00486954|Paclitaxel|paclitaxel|mesh-list
56795918|NCT00486954|Lapatinib|lapatinib|mesh-list
56795919|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56795920|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795921|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
56795922|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
56795923|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
56795924|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795925|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56795926|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795927|NCT00494676|Methamphetamine|methamphetamine|mesh-list
56795928|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56795929|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795930|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
56795931|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
56795932|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795933|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
56795934|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56795935|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795946|NCT00486330|Ritonavir|ritonavir|mesh-list
56795955|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56795956|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
56795957|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56795958|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56795959|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56795960|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56795961|NCT00486330|Narcotics|narcotics|mesh-ancestor
56795962|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56795963|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795964|NCT00486330|Analgesics|analgesics|mesh-ancestor
56795965|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
56795966|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795967|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56795968|NCT01021566|Methadone|methadone|mesh-list
56795969|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56795970|NCT01021566|Narcotics|narcotics|mesh-ancestor
56795971|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56795972|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56795973|NCT01021566|Analgesics|analgesics|mesh-ancestor
56795974|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
56795975|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56795976|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
56795977|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
56795978|NCT00494442|Olaparib|olaparib|mesh-list
56795979|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56795980|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56795981|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56795982|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56795983|NCT00493974|Zileuton|zileuton|mesh-list
56795999|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
56796000|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796001|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796002|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
56796003|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796004|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56796005|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796006|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56796007|NCT01018602|Vildagliptin|vildagliptin|mesh-list
56796008|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56796009|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796010|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56796011|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
56796012|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796013|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796014|NCT01018758|Palonosetron|palonosetron|mesh-list
56796015|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
56796016|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
56796017|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796018|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796019|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56796020|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56796021|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56796051|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796052|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796053|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56796054|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56796055|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56796056|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56796057|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796058|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56796059|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56796060|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56796061|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
56796062|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
56796063|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56796064|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
56796065|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56796066|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
56796067|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796068|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506968|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
56796069|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
56796070|NCT00469014|Fludarabine|fludarabine|mesh-list
56796071|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
56796072|NCT00469014|Busulfan|busulfan|mesh-list
56796073|NCT00469014|Clofarabine|clofarabine|mesh-list
56796074|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
56796075|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56796076|NCT00469014|Lenograstim|lenograstim|mesh-list
56796077|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796079|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
56796097|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56796098|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796099|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796100|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796101|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56796102|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
56796103|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56796104|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796105|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56796106|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56796107|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56796108|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56796109|NCT00392223|Azithromycin|azithromycin|mesh-list
56796110|NCT00392223|Minocycline|minocycline|mesh-list
56796111|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56796112|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796113|NCT00402285|Lycopene|lycopene|mesh-list
56796114|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56796115|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
56796116|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796117|NCT00402285|Protective Agents|protective agents|mesh-ancestor
56796118|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796119|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56796120|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56796121|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796122|NCT03747159|Belimumab|belimumab|mesh-list
56796123|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796124|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
56796125|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796126|NCT00413283|Gemcitabine|gemcitabine|mesh-list
56796127|NCT00413283|Carboplatin|carboplatin|mesh-list
56796128|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796129|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796130|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
56796137|NCT00413283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796138|NCT00402051|Carboplatin|carboplatin|mesh-list
56796139|NCT00402051|Pemetrexed|pemetrexed|mesh-list
56796140|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796141|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796142|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507054|NCT02213913|Prednisone|prednisone|mesh-list
56796143|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56796144|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56796146|NCT00401973|Amantadine|amantadine|mesh-list
56796147|NCT00401973|Zonisamide|zonisamide|mesh-list
56796148|NCT00401973|Olanzapine|olanzapine|mesh-list
56796149|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56796150|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796151|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
56796152|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
56796153|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796154|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56796155|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56796156|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56796157|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56796158|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56796159|NCT00401973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56796160|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56796161|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796162|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796163|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796164|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
56796165|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56796166|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56796167|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
56796168|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796169|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
56796170|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56796171|NCT00401973|Analgesics|analgesics|mesh-ancestor
56796176|NCT01038453|Vitamin D|vitamin d|mesh-list
56796177|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
56796178|NCT01038453|Vitamins|vitamins|mesh-ancestor
56796179|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
56796180|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796181|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56796182|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56796183|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
56796184|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56796185|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56796186|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796187|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
56796188|NCT00401193|Coagulants|coagulants|mesh-ancestor
56796189|NCT00400569|Sunitinib|sunitinib|mesh-list
56796190|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796191|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56796192|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56796193|NCT00400569|Growth Substances|growth substances|mesh-ancestor
56796194|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796195|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
56796196|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56796197|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796198|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796199|NCT00413049|Amlodipine|amlodipine|mesh-list
56796200|NCT00413049|Valsartan|valsartan|mesh-list
56796201|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56796202|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56796203|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796204|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796205|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56796206|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796207|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
56796208|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56796209|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56796210|NCT03732495|Denosumab|denosumab|mesh-list
56796211|NCT03732495|Lenvatinib|lenvatinib|mesh-list
56796212|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796214|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796215|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796216|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56796217|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796218|NCT01041729|Atorvastatin|atorvastatin|mesh-list
56796219|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56796220|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56796221|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
56796222|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796223|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56796224|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56796225|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796226|NCT01324245|Fenoldopam|fenoldopam|mesh-list
56796227|NCT01324245|Enalaprilat|enalaprilat|mesh-list
56796228|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56796229|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
56796230|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
56796231|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
56796232|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796233|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796234|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796235|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56796236|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
56796237|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796238|NCT00454194|Pemetrexed|pemetrexed|mesh-list
56796239|NCT00454194|Sorafenib|sorafenib|mesh-list
56796240|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796260|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
56796261|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796262|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56796263|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56796264|NCT00303316|Vaccines|vaccines|mesh-list
56796265|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
56796266|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796267|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
56796268|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56796269|NCT01064986|Epinephrine|epinephrine|mesh-list
56796270|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56796271|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56796272|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
56796273|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796274|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796275|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796276|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56796277|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56796278|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
56796279|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796280|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56796281|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
56796282|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
56796283|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
56796284|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56796285|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56796286|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
56796287|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56796288|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56796289|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56796290|NCT03980002|Thalidomide|thalidomide|mesh-list
56796291|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796292|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
56796293|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796294|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
56796295|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56796298|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56796299|NCT03980002|Growth Substances|growth substances|mesh-ancestor
56796300|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
56796301|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796302|NCT00331864|Ranibizumab|ranibizumab|mesh-list
56796303|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56796304|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56796305|NCT00331864|Growth Substances|growth substances|mesh-ancestor
56796306|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796307|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
56796308|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796310|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56796311|NCT00331630|Lapatinib|lapatinib|mesh-list
56796312|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56796313|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796314|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
56796315|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
56796316|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
56796317|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796318|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56796319|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796320|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
56796321|NCT00331552|Doxorubicin|doxorubicin|mesh-list
56796322|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56796323|NCT00331552|Trastuzumab|trastuzumab|mesh-list
56796324|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56796325|NCT00331552|Antibodies|antibodies|mesh-list
56796326|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
56796327|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56796345|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796346|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
56796347|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796348|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796349|NCT00302458|Methylphenidate|methylphenidate|mesh-list
56796350|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56796351|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796352|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56796353|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56796354|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796355|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796356|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
56796357|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796358|NCT00391053|Vaccines|vaccines|mesh-list
56796359|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
56796360|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796361|NCT00317044|Esomeprazole|esomeprazole|mesh-list
56796362|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56796363|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56796364|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56796365|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796366|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507267|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
56796367|NCT00301834|Cyclosporine|cyclosporine|mesh-list
56796368|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
56796369|NCT00301834|Methotrexate|methotrexate|mesh-list
56796370|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
56796371|NCT00301834|Fludarabine|fludarabine|mesh-list
56796372|NCT00301834|Busulfan|busulfan|mesh-list
56796373|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
56796374|NCT00301834|Cyclosporins|cyclosporins|mesh-list
56796375|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56796376|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
56796386|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796387|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
56796388|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796389|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56796390|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
56796391|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796392|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56796393|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56796394|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
56796395|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
56796396|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796397|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56796398|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
56796399|NCT00301834|Hormones|hormones|mesh-ancestor
56796400|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56796401|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56796402|NCT00301834|Protective Agents|protective agents|mesh-ancestor
56796403|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
56796404|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56796405|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56796406|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56796407|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
56796408|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56796409|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796410|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796411|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56796412|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56796413|NCT00466440|Prednisone|prednisone|mesh-list
56796414|NCT00466440|Docetaxel|docetaxel|mesh-list
56796415|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796416|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
56796429|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56796430|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56796431|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796432|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56796433|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
56796434|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56796435|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
56796436|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
56796437|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796438|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796439|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56796440|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56796441|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
56796442|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
56796443|NCT03926754|Mirabegron|mirabegron|mesh-list
56796444|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56796445|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56796485|NCT00400179|Cisplatin|cisplatin|mesh-list
56796486|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796487|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
56796488|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56796489|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56796490|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796491|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796492|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
56796493|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56796494|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56796495|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796496|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56796497|NCT00464490|Analgesics|analgesics|mesh-ancestor
56796498|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
56796499|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796500|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56796501|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56796502|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56796503|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
56796504|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796505|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796506|NCT00412893|Voriconazole|voriconazole|mesh-list
56796507|NCT00412893|Isavuconazole|isavuconazole|mesh-list
56796508|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
56796509|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796510|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56796511|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56796525|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56796526|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
56796527|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796528|NCT01041963|Losartan|losartan|mesh-list
56796529|NCT01041963|Enalapril|enalapril|mesh-list
56796530|NCT01041963|Enalaprilat|enalaprilat|mesh-list
56796531|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56796532|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56796533|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56796534|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56796535|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796536|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56796537|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
56796538|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796539|NCT01044225|Cetuximab|cetuximab|mesh-list
56796540|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56796541|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796542|NCT00508274|Capecitabine|capecitabine|mesh-list
56796543|NCT00508274|Lapatinib|lapatinib|mesh-list
56796544|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796545|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
56796546|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796547|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796548|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56796549|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796550|NCT01042041|Doxorubicin|doxorubicin|mesh-list
56796551|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56796552|NCT01042041|Sorafenib|sorafenib|mesh-list
56796553|NCT01042041|Mitomycins|mitomycins|mesh-list
56796554|NCT01042041|Mitomycin|mitomycin|mesh-list
56796555|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796556|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56796557|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56796558|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56796559|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796560|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068934|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796561|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56796562|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
56796563|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56796564|NCT00499460|Oxycodone|oxycodone|mesh-list
56796565|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56796566|NCT00499460|Narcotics|narcotics|mesh-ancestor
56796567|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56796568|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796569|NCT00499460|Analgesics|analgesics|mesh-ancestor
56796570|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
56796571|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796572|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
56796573|NCT00412113|Amlodipine|amlodipine|mesh-list
56796574|NCT00412113|Atorvastatin|atorvastatin|mesh-list
56796575|NCT00412113|Calcium|calcium|mesh-list
56796576|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56796577|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796578|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56796579|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56796580|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56796581|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
56796582|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796583|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56796584|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56796585|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796586|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56796587|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56507501|NCT00477672|Pimavanserin|pimavanserin|mesh-list
56796588|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796589|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
56796590|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
56796603|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796604|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
56796605|NCT01039155|Azacitidine|azacitidine|mesh-list
56796606|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796607|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796608|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
56796609|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796610|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796611|NCT01039233|Bicalutamide|bicalutamide|mesh-list
56796612|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
56796613|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
56796614|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56796615|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796616|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796617|NCT00490646|Docetaxel|docetaxel|mesh-list
56796618|NCT00490646|Trastuzumab|trastuzumab|mesh-list
56796619|NCT00490646|Epothilones|epothilones|mesh-list
56796620|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796621|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
56796622|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
56796623|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
56796624|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796625|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56796626|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
56796627|NCT03992937|Progesterone|progesterone|mesh-list
56796628|NCT03992937|Progestins|progestins|mesh-ancestor
56796629|NCT03992937|Hormones|hormones|mesh-ancestor
56796630|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56796631|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796632|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56796646|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56796647|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796648|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56796649|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796650|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796651|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56796652|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796653|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56796654|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56796655|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796656|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56796657|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56796658|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
56796659|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56796660|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796661|NCT00561353|Ribavirin|ribavirin|mesh-list
56796662|NCT00561353|Simeprevir|simeprevir|mesh-list
56796663|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
56796664|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796666|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796667|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
56796668|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796669|NCT00859781|Ketoconazole|ketoconazole|mesh-list
56796670|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
56796671|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56796672|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
56796673|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796674|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56796675|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56796676|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796677|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796678|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56796679|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
56796683|NCT00944957|Efavirenz|efavirenz|mesh-list
56796685|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56796686|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56796687|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796688|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796689|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
56796690|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796691|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56796692|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56796693|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56796694|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56796695|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56796696|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56796697|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56796698|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56796699|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56796700|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56796701|NCT00945347|Miglustat|miglustat|mesh-list
56796702|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796703|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796704|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56796736|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796737|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
56796738|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796739|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796740|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796741|NCT01042665|Latanoprost|latanoprost|mesh-list
56796742|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56796743|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56796744|NCT00949949|Gemcitabine|gemcitabine|mesh-list
56796746|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796747|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796748|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
56796749|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796750|NCT00949949|Antiviral Agents|antiviral agents|mesh-ancestor
56796751|NCT00949949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796752|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796753|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796754|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
56796755|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796756|NCT00941369|Insulin|insulin|mesh-list
56796757|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
56796758|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
56796759|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
56796760|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
56796761|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56796762|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796763|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
56796764|NCT00950027|Povidone|povidone|mesh-list
56796765|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
56796766|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
56796767|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56796768|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796769|NCT00941525|Latanoprost|latanoprost|mesh-list
56796770|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56796771|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56796772|NCT00456261|Gemcitabine|gemcitabine|mesh-list
56796773|NCT00456261|Bevacizumab|bevacizumab|mesh-list
56796777|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796778|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56796779|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56796780|NCT00456261|Growth Substances|growth substances|mesh-ancestor
56796781|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796782|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
56796783|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56796784|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
56796785|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796786|NCT00456261|Antiviral Agents|antiviral agents|mesh-ancestor
56796787|NCT00456261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796788|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796789|NCT00456261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796790|NCT00456261|Immunologic Factors|immunologic factors|mesh-ancestor
56796791|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56796792|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56796793|NCT00386607|Valsartan|valsartan|mesh-list
56796794|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56796795|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56796796|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56796797|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56796798|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796799|NCT00386607|Diuretics|diuretics|mesh-ancestor
56796800|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
56796801|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796802|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56796803|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796804|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
56796806|NCT00410163|Ofatumumab|ofatumumab|mesh-list
56796820|NCT00409617|Adalimumab|adalimumab|mesh-list
56796821|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56796822|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796823|NCT00300274|Cyclosporine|cyclosporine|mesh-list
56796824|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
56796825|NCT00300274|Everolimus|everolimus|mesh-list
56796826|NCT00300274|Cyclosporins|cyclosporins|mesh-list
56796827|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796828|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796829|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56796830|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
56796831|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796832|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
56796833|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796834|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
56796835|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796836|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56796837|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796838|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56796839|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56796840|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
56796841|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56796842|NCT01043211|Lidocaine|lidocaine|mesh-list
56796843|NCT01043211|Epinephrine|epinephrine|mesh-list
56796844|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
56796845|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
56796846|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56796847|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796848|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
56069297|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
56796867|NCT01043445|Glycerol|glycerol|mesh-list
56796868|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56796869|NCT01043445|Protective Agents|protective agents|mesh-ancestor
56796870|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796871|NCT00396591|Aflibercept|aflibercept|mesh-list
56796872|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56796873|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56796874|NCT00396591|Growth Substances|growth substances|mesh-ancestor
56796875|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796876|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
56796877|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796878|NCT00316264|Palivizumab|palivizumab|mesh-list
56796879|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
56796880|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56796881|NCT00385827|Prednisone|prednisone|mesh-list
56796882|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
56796883|NCT00385827|Siltuximab|siltuximab|mesh-list
56796884|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56796885|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
56796886|NCT00385827|Hormones|hormones|mesh-ancestor
56796887|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56796888|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796889|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56796890|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796892|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
56796893|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796894|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56796913|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796914|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56796915|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56796916|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56796917|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56796918|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56796919|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
56796920|NCT00498368|Rituximab|rituximab|mesh-list
56796921|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
56796922|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56796923|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796924|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
56796925|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796926|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56796927|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56796928|NCT04460066|Paclitaxel|paclitaxel|mesh-list
56796929|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56796930|NCT04460066|Antibodies|antibodies|mesh-list
56796931|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56796932|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56796933|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56796934|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56796935|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56796936|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796937|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
56796938|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796939|NCT00385671|Pregabalin|pregabalin|mesh-list
56796940|NCT00385671|Gabapentin|gabapentin|mesh-list
56796941|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56796942|NCT00385671|Analgesics|analgesics|mesh-ancestor
56796943|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
56796944|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796945|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796946|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
56796947|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56796948|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796951|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56796952|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56796953|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56796954|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56796955|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56796956|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56796957|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796958|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
56796959|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56796960|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56796961|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
56796963|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
56796964|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56796965|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
56796966|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56796967|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56796968|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56796969|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56796970|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796971|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
56796972|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56796973|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796974|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56796975|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56796976|NCT01011062|Losartan|losartan|mesh-list
56796977|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56796978|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56796979|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56796980|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56796981|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56796982|NCT00490490|Iodine|iodine|mesh-list
56796993|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56796994|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
56796995|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56796996|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56796997|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56796998|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56796999|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56797000|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
56797001|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56797002|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56797003|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
56797004|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797005|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
56797006|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56797007|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56797008|NCT05176418|Nicotine|nicotine|mesh-list
56797009|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56797010|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
56797011|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797012|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797013|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56797014|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56797015|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
56797016|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797017|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797018|NCT00385593|Budesonide|budesonide|mesh-list
56797019|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
56797036|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797037|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
56797038|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56797039|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56797040|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
56797041|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797042|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797043|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797044|NCT01015040|Urological Agents|urological agents|mesh-ancestor
56797045|NCT00495170|Paclitaxel|paclitaxel|mesh-list
56797046|NCT00495170|Carboplatin|carboplatin|mesh-list
56797047|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56797048|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797049|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
56797050|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
56797051|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
56797052|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797053|NCT01011374|Ranibizumab|ranibizumab|mesh-list
56797054|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56797055|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56797056|NCT01011374|Growth Substances|growth substances|mesh-ancestor
56797057|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797058|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
56797059|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797060|NCT00385203|Cediranib|cediranib|mesh-list
56797061|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797062|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56797063|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797064|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797065|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
56797066|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56797067|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
56797068|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797075|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
56797076|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797077|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797078|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56797079|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
56797080|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797081|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56797082|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56797083|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797084|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797085|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56797086|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56797087|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56797088|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56797089|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797090|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797091|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797092|NCT00408993|Analgesics|analgesics|mesh-ancestor
56797093|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
56797094|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797095|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
56797096|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797097|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
56797098|NCT00395967|Plerixafor|plerixafor|mesh-list
56797099|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56797100|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56797120|NCT00560573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797121|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797122|NCT00560573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56797123|NCT00560573|Immunologic Factors|immunologic factors|mesh-ancestor
56797124|NCT00560573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797125|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56797126|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56797127|NCT00950105|Semapimod|semapimod|mesh-list
56797128|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56797129|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56797130|NCT00950105|Analgesics|analgesics|mesh-ancestor
56797131|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
56797132|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797133|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797134|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797135|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797136|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56797137|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
56797138|NCT00950261|Cisplatin|cisplatin|mesh-list
56797139|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797140|NCT05280197|Bupivacaine|bupivacaine|mesh-list
56797141|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
56797142|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
56797143|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797144|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797145|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
56797146|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797147|NCT00946595|Ritonavir|ritonavir|mesh-list
56797166|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56797167|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56797168|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56797169|NCT00494780|Prednisone|prednisone|mesh-list
56797170|NCT00494780|Prednisolone|prednisolone|mesh-list
56797171|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
56797172|NCT00494780|Doxorubicin|doxorubicin|mesh-list
56797173|NCT00494780|Vincristine|vincristine|mesh-list
56797174|NCT00494780|Ofatumumab|ofatumumab|mesh-list
56797175|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56797176|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
56797177|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797178|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797179|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56797180|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
56797181|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797182|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797183|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56797184|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56797185|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56797186|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56797187|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797188|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797189|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
56797190|NCT00494780|Hormones|hormones|mesh-ancestor
56797191|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797192|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56797193|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56797194|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
56797195|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
56069648|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
56069649|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797209|NCT00490022|Hormones|hormones|mesh-ancestor
56797210|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797211|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797212|NCT01011530|Pevonedistat|pevonedistat|mesh-list
56797213|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797214|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797215|NCT00493454|Rituximab|rituximab|mesh-list
56797216|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56797217|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797218|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797219|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
56797220|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797221|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797222|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
56797223|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56797224|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797225|NCT00950339|Omeprazole|omeprazole|mesh-list
56797226|NCT00950339|Pantoprazole|pantoprazole|mesh-list
56797227|NCT00950339|Famotidine|famotidine|mesh-list
56797228|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56797229|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797230|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56797231|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797238|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
56797258|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797259|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56797260|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
56797261|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797262|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
56797263|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
56797264|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797265|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797266|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797267|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
56797268|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56797269|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797270|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797271|NCT00560417|Insulin|insulin|mesh-list
56797272|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56797273|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
56797274|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
56797275|NCT00560417|Protamines|protamines|mesh-list
56797276|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56797277|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797278|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
56797279|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797280|NCT00560417|Coagulants|coagulants|mesh-ancestor
56797281|NCT01040091|Tenofovir|tenofovir|mesh-list
56797282|NCT01040091|Emtricitabine|emtricitabine|mesh-list
56797283|NCT01040091|Efavirenz|efavirenz|mesh-list
56797284|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56797285|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
56797286|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797287|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56797288|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56797289|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797298|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56797299|NCT00946907|Aspirin|aspirin|mesh-list
56797300|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56797301|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56797302|NCT00946907|Analgesics|analgesics|mesh-ancestor
56797303|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
56797304|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797305|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797306|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797307|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797308|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56797309|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56797310|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797311|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56797312|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56797313|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797314|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
56797315|NCT00942539|Midazolam|midazolam|mesh-list
56797316|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56797317|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56797318|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797319|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797320|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56797321|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56797322|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797323|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56797324|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
56797325|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
56797326|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
56797327|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
56797328|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508246|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56797329|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797330|NCT00947063|Promethazine|promethazine|mesh-list
56797331|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
56797332|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
56797335|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
56797336|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
56797337|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797338|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797339|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797340|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56797341|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56797342|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56797343|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797344|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
56797345|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
56797346|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
56797347|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797348|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
56797349|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
56797350|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797351|NCT00942617|Aspirin|aspirin|mesh-list
56797352|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56797353|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56797354|NCT00942617|Analgesics|analgesics|mesh-ancestor
56797355|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
56797356|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797357|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797358|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797359|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797360|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56797361|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56797362|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797363|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56797364|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56797365|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797366|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
56797367|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
56797368|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797370|NCT03968159|Pimavanserin|pimavanserin|mesh-list
56797374|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56797375|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797376|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797377|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797378|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56797379|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56797380|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
56797381|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797382|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797383|NCT00947141|Valganciclovir|valganciclovir|mesh-list
56797384|NCT00947141|Ganciclovir|ganciclovir|mesh-list
56797385|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56797386|NCT00947141|Foscarnet|foscarnet|mesh-list
56797387|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56797388|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
56797389|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797390|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56797391|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797392|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797393|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56797394|NCT03966365|Timolol|timolol|mesh-list
56797395|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56797396|NCT03966365|Dorzolamide|dorzolamide|mesh-list
56797397|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56797398|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56797399|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
56797400|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797401|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797402|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508325|NCT00577109|Leucovorin|leucovorin|mesh-list
56797403|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56797404|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56797405|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56797413|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56797414|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797415|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797416|NCT03965351|Probenecid|probenecid|mesh-list
56797417|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
56797418|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
56797419|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797420|NCT03965351|Renal Agents|renal agents|mesh-ancestor
56797421|NCT00947375|Lamotrigine|lamotrigine|mesh-list
56797422|NCT00947375|Haloperidol|haloperidol|mesh-list
56797423|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
56797424|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
56797425|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
56797426|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797427|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797428|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797429|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56797430|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56797431|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797432|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797433|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56797434|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
56797435|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797436|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797437|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56797438|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
56797439|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56797440|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56797441|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56797442|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56797443|NCT00947453|Montelukast|montelukast|mesh-list
56797444|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56797455|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797456|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56797457|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56797458|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797459|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797460|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56797461|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
56797462|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797463|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797464|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56797465|NCT04364555|Clobetasol|clobetasol|mesh-list
56797466|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797467|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
56797468|NCT04364555|Hormones|hormones|mesh-ancestor
56797469|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797470|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797471|NCT00374907|Metformin|metformin|mesh-list
56797472|NCT00374907|Saxagliptin|saxagliptin|mesh-list
56797473|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56797474|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797475|NCT00374907|Incretins|incretins|mesh-ancestor
56797477|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797478|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56797479|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
56797480|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797482|NCT01045083|Methylphenidate|methylphenidate|mesh-list
56797499|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797500|NCT00947843|Aspirin|aspirin|mesh-list
56797501|NCT00947843|Clopidogrel|clopidogrel|mesh-list
56797502|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56797503|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56797504|NCT00947843|Analgesics|analgesics|mesh-ancestor
56797505|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
56797506|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797507|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797508|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797509|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797510|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56797511|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56797512|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797513|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56797514|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56797515|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797516|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
56797517|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56797518|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56797519|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56797520|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
56797521|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797522|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
56797523|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
56797524|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56797525|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797526|NCT00407745|Pregabalin|pregabalin|mesh-list
56797527|NCT00407745|Analgesics|analgesics|mesh-ancestor
56797528|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
56797529|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797530|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797538|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797539|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797540|NCT00951431|Esomeprazole|esomeprazole|mesh-list
56797541|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56797542|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797543|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56797544|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797545|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797546|NCT00299494|Rituximab|rituximab|mesh-list
56797547|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56797548|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797549|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797551|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797552|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797553|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56797554|NCT00943553|Decitabine|decitabine|mesh-list
56797555|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56797556|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
56797557|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797558|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797559|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797560|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
56797561|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56797562|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
56797563|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56797564|NCT00453180|Expectorants|expectorants|mesh-ancestor
56797565|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
56797566|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56797567|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
56797568|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797569|NCT00453180|Protective Agents|protective agents|mesh-ancestor
56797570|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797571|NCT00453180|Antidotes|antidotes|mesh-ancestor
56797572|NCT00943709|Insulin|insulin|mesh-list
56797573|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56797577|NCT00464178|Bortezomib|bortezomib|mesh-list
56797579|NCT00316186|Carboplatin|carboplatin|mesh-list
56797580|NCT00316186|Topotecan|topotecan|mesh-list
56797581|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797582|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56797583|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56797584|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797585|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797586|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
56797587|NCT01065220|Testolactone|testolactone|mesh-list
56797588|NCT01065220|Lynestrenol|lynestrenol|mesh-list
56797589|NCT01065220|Estradiol|estradiol|mesh-list
56797590|NCT01065220|Cyproterone|cyproterone|mesh-list
56797591|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
56797592|NCT01065220|Estrogens|estrogens|mesh-ancestor
56797593|NCT01065220|Hormones|hormones|mesh-ancestor
56797594|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797595|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797596|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56797597|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
56797598|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56797600|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
56797634|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797635|NCT00299182|Cytarabine|cytarabine|mesh-list
56797636|NCT00299182|Dexamethasone|dexamethasone|mesh-list
56797637|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
56797638|NCT00299182|Rituximab|rituximab|mesh-list
56797639|NCT00299182|Doxorubicin|doxorubicin|mesh-list
56797640|NCT00299182|Methotrexate|methotrexate|mesh-list
56797641|NCT00299182|Vincristine|vincristine|mesh-list
56797642|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56797643|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
56797644|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797645|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797646|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56797647|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
56797648|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797649|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797650|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56797651|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797652|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797653|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
56797654|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
56797655|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797656|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797657|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
56797658|NCT00299182|Hormones|hormones|mesh-ancestor
56797659|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797660|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56797661|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56797682|NCT00467142|Irinotecan|irinotecan|mesh-list
56797683|NCT00467142|Calcium|calcium|mesh-list
56797684|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
56797685|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797686|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797687|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56797688|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56797689|NCT00467142|Growth Substances|growth substances|mesh-ancestor
56797690|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797691|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
56797692|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56797693|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
56797694|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797695|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56797696|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56797697|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
56797698|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56797699|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56797700|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797701|NCT00467142|Antidotes|antidotes|mesh-ancestor
56797702|NCT00467142|Protective Agents|protective agents|mesh-ancestor
56797703|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
56797704|NCT00467142|Vitamins|vitamins|mesh-ancestor
56797705|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
56797706|NCT01065376|Cabergoline|cabergoline|mesh-list
56797707|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56797708|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56797709|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
56797710|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
56797711|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797727|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56797728|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56797729|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797730|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797731|NCT00329602|Ropinirole|ropinirole|mesh-list
56797732|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56797733|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56797734|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
56797735|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
56797736|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797737|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797738|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797739|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
56797740|NCT01060696|Scopolamine|scopolamine|mesh-list
56797741|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56797742|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56797743|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
56797744|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
56797745|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797746|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797747|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797748|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
56797749|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56797750|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
56797751|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797752|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797753|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56797754|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
56797755|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56797773|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797774|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56797775|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
56797776|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
56797778|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797779|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56797780|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56797781|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56797782|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
56797783|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797784|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797785|NCT00313846|Buprenorphine|buprenorphine|mesh-list
56797786|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56797787|NCT00313846|Narcotics|narcotics|mesh-ancestor
56797788|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797789|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797790|NCT00313846|Analgesics|analgesics|mesh-ancestor
56797791|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
56797792|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797793|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56797794|NCT00949247|Bevacizumab|bevacizumab|mesh-list
56797795|NCT00949247|Trastuzumab|trastuzumab|mesh-list
56797825|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56797826|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56797827|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56797828|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
56797829|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797830|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797831|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797832|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
56797833|NCT00299104|Rituximab|rituximab|mesh-list
56797834|NCT00299104|Methotrexate|methotrexate|mesh-list
56797835|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797836|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797837|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
56797838|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797839|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797840|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56797841|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
56797842|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56797843|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56797844|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
56797845|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797846|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
56797847|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797848|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56797849|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56797850|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56797851|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797852|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
56797853|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
56797854|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797855|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797856|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
56797858|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797859|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56797860|NCT00299104|Protective Agents|protective agents|mesh-ancestor
56797862|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797863|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797864|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
56797865|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797866|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56797867|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
56797868|NCT00313612|Topotecan|topotecan|mesh-list
56797869|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797870|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56797871|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56797872|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797873|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797874|NCT00507416|Thalidomide|thalidomide|mesh-list
56797875|NCT00507416|Dexamethasone|dexamethasone|mesh-list
56797876|NCT00507416|Prednisone|prednisone|mesh-list
56797877|NCT00507416|Bortezomib|bortezomib|mesh-list
56797878|NCT00507416|Melphalan|melphalan|mesh-list
56797879|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797880|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
56797881|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
56797882|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797883|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797884|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797885|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
56797886|NCT00507416|Hormones|hormones|mesh-ancestor
56797887|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797888|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56797889|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797890|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56797891|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
56797892|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797893|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56797894|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56797895|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
56797896|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
56797897|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56797900|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56797901|NCT00507416|Growth Substances|growth substances|mesh-ancestor
56797902|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
56797903|NCT00489476|Loxapine|loxapine|mesh-list
56797904|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56797905|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56797906|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56797907|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797908|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56797909|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56797910|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
56797911|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797912|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797913|NCT04216043|Caseins|caseins|mesh-list
56797914|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
56797915|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
56797916|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797917|NCT00957125|Bevacizumab|bevacizumab|mesh-list
56797918|NCT00957125|Docetaxel|docetaxel|mesh-list
56797919|NCT00957125|Epirubicin|epirubicin|mesh-list
56797920|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56797921|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797922|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56797923|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56797924|NCT00957125|Growth Substances|growth substances|mesh-ancestor
56797926|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
56797949|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797950|NCT00952991|Vildagliptin|vildagliptin|mesh-list
56797951|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56797952|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797953|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56797954|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
56797955|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797956|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797957|NCT00953303|Dexamethasone|dexamethasone|mesh-list
56797958|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
56797959|NCT00953303|Prednisone|prednisone|mesh-list
56797960|NCT00953303|Torsemide|torsemide|mesh-list
56797961|NCT00953303|Dobutamine|dobutamine|mesh-list
56797962|NCT00953303|Dopamine|dopamine|mesh-list
56797963|NCT00953303|Furosemide|furosemide|mesh-list
56797964|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
56797965|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
56797966|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56797967|NCT00953303|BB 1101|bb 1101|mesh-list
56797968|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56797969|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
56797970|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
56797971|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56797972|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56797973|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56797974|NCT00953303|Hormones|hormones|mesh-ancestor
56797975|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56797976|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56797977|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56797978|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
56797979|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56797980|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56797981|NCT00953303|Diuretics|diuretics|mesh-ancestor
56797982|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
56070401|NCT01081951|Olaparib|olaparib|mesh-list
56797990|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56797991|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
56797992|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56797993|NCT00953303|Protective Agents|protective agents|mesh-ancestor
56797994|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
56797995|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56797996|NCT05300555|Warfarin|warfarin|mesh-list
56797997|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
56797998|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
56797999|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56798000|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
56798001|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56798002|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
56798003|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798004|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798005|NCT04010669|Somatostatin|somatostatin|mesh-list
56798006|NCT04010669|Hormones|hormones|mesh-ancestor
56798007|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798008|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798009|NCT00452790|Vaccines|vaccines|mesh-list
56798010|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56798011|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
56798012|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798013|NCT00953381|Omeprazole|omeprazole|mesh-list
56798014|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56798015|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798016|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56798017|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798018|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798019|NCT05300477|Acetazolamide|acetazolamide|mesh-list
56798020|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
56798021|NCT05300477|Hematinics|hematinics|mesh-ancestor
56798022|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
56798023|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56798024|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798026|NCT05300477|Diuretics|diuretics|mesh-ancestor
56798031|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798032|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56798033|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56798034|NCT00953459|Growth Substances|growth substances|mesh-ancestor
56798035|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798036|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
56798037|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56798038|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798039|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798040|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56798041|NCT00953537|Capecitabine|capecitabine|mesh-list
56798042|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798043|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
56798044|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798045|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798046|NCT00463788|Cisplatin|cisplatin|mesh-list
56798047|NCT00463788|Cetuximab|cetuximab|mesh-list
56798048|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798049|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56798050|NCT00548249|Iron|iron|mesh-list
56798051|NCT00548249|Trace Elements|trace elements|mesh-ancestor
56798052|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
56798053|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798054|NCT01025466|Memantine|memantine|mesh-list
56798055|NCT01025466|Rivastigmine|rivastigmine|mesh-list
56798056|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56798058|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
56798079|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798080|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
56798081|NCT03839940|Hormones|hormones|mesh-ancestor
56798082|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798083|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56798084|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798085|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798086|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
56798087|NCT03905928|Nicotine|nicotine|mesh-list
56798088|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56798089|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
56798090|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798091|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798092|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56798093|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56798094|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
56798095|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798096|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798097|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
56798098|NCT01027494|Dexamethasone|dexamethasone|mesh-list
56798099|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798132|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798133|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
56798134|NCT00462384|Hematinics|hematinics|mesh-ancestor
56798135|NCT00452400|Olodaterol|olodaterol|mesh-list
56798136|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56798137|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
56798138|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798139|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798140|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56798141|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
56798142|NCT03576690|Atoltivimab|atoltivimab|mesh-list
56798143|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
56798144|NCT03576690|Odesivimab|odesivimab|mesh-list
56798145|NCT03576690|Maftivimab|maftivimab|mesh-list
56798146|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
56798147|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798148|NCT01566474|Melatonin|melatonin|mesh-list
56798149|NCT01566474|Omeprazole|omeprazole|mesh-list
56798150|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
56798151|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798152|NCT01566474|Protective Agents|protective agents|mesh-ancestor
56798188|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798189|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
56798190|NCT00443430|Hormones|hormones|mesh-ancestor
56798191|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798192|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798193|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56798194|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798195|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56798196|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
56798197|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56798198|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798199|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
56798200|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798201|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
56798202|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798203|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56798204|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798205|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
56798206|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798207|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56798208|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
56798209|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
56798210|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798211|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798212|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56798213|NCT00443430|Protective Agents|protective agents|mesh-ancestor
56798214|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56798216|NCT00443430|Analgesics|analgesics|mesh-ancestor
56798234|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56798235|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56798236|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56798237|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56798238|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56798239|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56798240|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798241|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798242|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
56798243|NCT01025934|Bevacizumab|bevacizumab|mesh-list
56798244|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56798245|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798246|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56798247|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56798248|NCT01025934|Growth Substances|growth substances|mesh-ancestor
56798249|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798250|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
56798251|NCT01026090|Dronedarone|dronedarone|mesh-list
56798252|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56798253|NCT00460746|Ritonavir|ritonavir|mesh-list
56798254|NCT00460746|Darunavir|darunavir|mesh-list
56798255|NCT00460746|Etravirine|etravirine|mesh-list
56798256|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56798257|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56798258|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
56798259|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798278|NCT00459342|Dasatinib|dasatinib|mesh-list
56798282|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798283|NCT00442962|Tenofovir|tenofovir|mesh-list
56798284|NCT00442962|Emtricitabine|emtricitabine|mesh-list
56798285|NCT00442962|Efavirenz|efavirenz|mesh-list
56798286|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56798287|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
56798288|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798289|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56798290|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56798291|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798292|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798293|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56798294|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56798295|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56798296|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56798297|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56798298|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56798299|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56798300|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56798301|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56798302|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
56509215|NCT02218671|Brotizolam|brotizolam|mesh-list
56798303|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56798304|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798305|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798306|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56798307|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56798308|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56798322|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798323|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
56798324|NCT00459186|Prednisone|prednisone|mesh-list
56798325|NCT00459186|Docetaxel|docetaxel|mesh-list
56798326|NCT00459186|Everolimus|everolimus|mesh-list
56798327|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798328|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
56798329|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
56798330|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
56798331|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798332|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798333|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
56798334|NCT00459186|Hormones|hormones|mesh-ancestor
56798335|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798336|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798337|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56798338|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798339|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
56798340|NCT01026714|Fluconazole|fluconazole|mesh-list
56798341|NCT01026714|Rifampin|rifampin|mesh-list
56798342|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
56798343|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
56798344|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798345|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56798346|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56798347|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798348|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798349|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56798350|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
56798351|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798352|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798355|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56798362|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56798363|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56798364|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56798365|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56798366|NCT01026714|Analgesics|analgesics|mesh-ancestor
56798367|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
56798368|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798369|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56798370|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56798371|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798372|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798373|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56798374|NCT03996252|Calcitriol|calcitriol|mesh-list
56509291|NCT00581165|Etanercept|etanercept|mesh-list
56798376|NCT03996252|Calcipotriene|calcipotriene|mesh-list
56798377|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
56798378|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798379|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798380|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798381|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798382|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
56798383|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798384|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
56798385|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56798386|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56798387|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56798388|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56798389|NCT03996252|Vitamins|vitamins|mesh-ancestor
56798390|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
56798391|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56798392|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
56798393|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56798402|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798403|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56798404|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
56798405|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56798406|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798407|NCT00450450|Lenograstim|lenograstim|mesh-list
56798408|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56798409|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
56798410|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798411|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
56798412|NCT03440892|Methotrexate|methotrexate|mesh-list
56798413|NCT03440892|Abatacept|abatacept|mesh-list
56798414|NCT03440892|Tofacitinib|tofacitinib|mesh-list
56798415|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56798416|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
56798417|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56798418|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798419|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798420|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
56798421|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798422|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798423|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
56798424|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798425|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56798426|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798427|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
56798428|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798429|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56798430|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56798431|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56798432|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798434|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56798443|NCT01023360|Esomeprazole|esomeprazole|mesh-list
56798444|NCT01023360|Rabeprazole|rabeprazole|mesh-list
56798445|NCT01023360|Pantoprazole|pantoprazole|mesh-list
56798446|NCT01023360|Clopidogrel|clopidogrel|mesh-list
56798447|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56798448|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56798449|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56798450|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56798451|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56798452|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
56798453|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798454|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798455|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798456|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56798457|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798458|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798459|NCT03685890|Nivolumab|nivolumab|mesh-list
56798460|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56798461|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798462|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56798463|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798464|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
56798465|NCT00442416|Hematinics|hematinics|mesh-ancestor
56798466|NCT03674424|Avelumab|avelumab|mesh-list
56798467|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56798468|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798469|NCT00441792|Midazolam|midazolam|mesh-list
56798470|NCT00441792|Etomidate|etomidate|mesh-list
56798471|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56798472|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56798473|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56798474|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798475|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56798476|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56798477|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56798484|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798485|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
56798486|NCT00312208|Docetaxel|docetaxel|mesh-list
56798487|NCT00312208|Doxorubicin|doxorubicin|mesh-list
56798488|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56798489|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798490|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
56798491|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798492|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798493|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56798494|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
56798495|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798496|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798497|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56798498|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
56798499|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
56798500|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
56798501|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56798502|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56798503|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56798504|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798505|NCT00297778|Pramipexole|pramipexole|mesh-list
56798506|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
56798507|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798536|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798537|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56798538|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798539|NCT00958139|Permethrin|permethrin|mesh-list
56798540|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798541|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798542|NCT00450216|Ibuprofen|ibuprofen|mesh-list
56798543|NCT00450216|Famotidine|famotidine|mesh-list
56798544|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56798545|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56798546|NCT00450216|Analgesics|analgesics|mesh-ancestor
56798547|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
56798548|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798549|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798550|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798551|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798552|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56798553|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798554|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798555|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56798556|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56798557|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56798558|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
56798559|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
56798560|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798561|NCT00953771|Danazol|danazol|mesh-list
56798562|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56798563|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
56798580|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798581|NCT00958451|Vitamins|vitamins|mesh-ancestor
56798582|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
56798583|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56798584|NCT05352191|Beclomethasone|beclomethasone|mesh-list
56798585|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798586|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
56798587|NCT05352191|Hormones|hormones|mesh-ancestor
56798588|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798589|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798590|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56798591|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
56798592|NCT00954005|Gemcitabine|gemcitabine|mesh-list
56798593|NCT00954005|Rituximab|rituximab|mesh-list
56798594|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
56798595|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56798596|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798597|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
56798598|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798599|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798600|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56798601|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
56798602|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798603|NCT00954005|Antiviral Agents|antiviral agents|mesh-ancestor
56798604|NCT00954005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798605|NCT00954005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798606|NCT00954005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798607|NCT01023750|Fenofibrate|fenofibrate|mesh-list
56798608|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56798609|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
56798610|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798611|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56798612|NCT05300009|Methotrexate|methotrexate|mesh-list
56798613|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56798614|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
56798615|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56798618|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
56798619|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798620|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798621|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
56798622|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798623|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56798624|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798625|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
56798626|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798627|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56798628|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
56798629|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56798630|NCT00547703|Nortriptyline|nortriptyline|mesh-list
56798631|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56798632|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
56798633|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56798634|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56798635|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56798636|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56798637|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798638|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
56798639|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798640|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798641|NCT00297232|Natalizumab|natalizumab|mesh-list
56798642|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
56798643|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798644|NCT01062802|Atorvastatin|atorvastatin|mesh-list
56798645|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56798646|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56798647|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
56798661|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56798662|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56798663|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798664|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
56798665|NCT00954395|Coagulants|coagulants|mesh-ancestor
56798666|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
56798667|NCT03741101|Trametinib|trametinib|mesh-list
56798668|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798669|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56798670|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798671|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798672|NCT00449670|Vaccines|vaccines|mesh-list
56798673|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
56257786|NCT01917045|Dsuvia|dsuvia|mesh-list
56798674|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798675|NCT04010903|Insulin|insulin|mesh-list
56798676|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56798677|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798678|NCT05299931|Ustekinumab|ustekinumab|mesh-list
56798679|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
56798680|NCT00296374|Atorvastatin|atorvastatin|mesh-list
56798681|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56798682|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56798683|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56798684|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
56798685|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798686|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56798687|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56798688|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798689|NCT03387761|Nivolumab|nivolumab|mesh-list
56798690|NCT03387761|Ipilimumab|ipilimumab|mesh-list
56798692|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798704|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56798705|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56798706|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56798707|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798708|NCT00954785|Diclofenac|diclofenac|mesh-list
56798709|NCT00954785|Etoricoxib|etoricoxib|mesh-list
56798710|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56798711|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56798712|NCT00954785|Analgesics|analgesics|mesh-ancestor
56798713|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
56798714|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798715|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798716|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798717|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798718|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56798719|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798720|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798721|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56798722|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
56798723|NCT00548717|Sirolimus|sirolimus|mesh-list
56798724|NCT00548717|Bortezomib|bortezomib|mesh-list
56798725|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56798726|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798727|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56798728|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
56798729|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56798730|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56798731|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798732|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798737|NCT00441168|Dexamethasone|dexamethasone|mesh-list
56798748|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
56798749|NCT00441168|Hormones|hormones|mesh-ancestor
56798750|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798751|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56798752|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798753|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56798754|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
56798755|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
56798756|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
56798757|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798758|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56798759|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56798760|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56798761|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798762|NCT01062958|Vitamins|vitamins|mesh-list
56798763|NCT01062958|Folic Acid|folic acid|mesh-list
56798764|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
56798765|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
56798766|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
56798767|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798768|NCT01062958|Hematinics|hematinics|mesh-ancestor
56798801|NCT02748707|Analgesics|analgesics|mesh-ancestor
56798802|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
56798803|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798804|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798805|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798806|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798807|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56798808|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56798809|NCT05014061|Adenosine|adenosine|mesh-list
56798810|NCT05014061|Analgesics|analgesics|mesh-ancestor
56798811|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
56798812|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798813|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798862|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
56798863|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798864|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798865|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56798866|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
56798867|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
56798868|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56798869|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56798870|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56798871|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56798872|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
56798873|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56798874|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798875|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
56798876|NCT00384189|Hormones|hormones|mesh-ancestor
56798877|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56798878|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56798879|NCT00326716|Ritonavir|ritonavir|mesh-list
56798880|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56798881|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56798882|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56798883|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56798884|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
56798912|NCT01063192|Vitamins|vitamins|mesh-ancestor
56798913|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
56798914|NCT03978988|Aspirin|aspirin|mesh-list
56798915|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56798916|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56798917|NCT03978988|Analgesics|analgesics|mesh-ancestor
56798918|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
56798919|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56798920|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798921|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56798922|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798923|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56798924|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56798925|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56798926|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56798927|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56798928|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56798929|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
56798930|NCT01063426|Enoxaparin|enoxaparin|mesh-list
56798931|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
56798932|NCT01063426|Atorvastatin|atorvastatin|mesh-list
56798968|NCT04919369|Protective Agents|protective agents|mesh-ancestor
56798969|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56798970|NCT00959075|Thiamine|thiamine|mesh-list
56798971|NCT00959075|Vitamins|vitamins|mesh-ancestor
56798972|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
56798973|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798974|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
56798975|NCT00295750|Leuprolide|leuprolide|mesh-list
56798976|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56798977|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
56798978|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56798979|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798980|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56798981|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56798982|NCT00959231|Cyclosporine|cyclosporine|mesh-list
56798983|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
56798984|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
56798985|NCT00959231|Fludarabine|fludarabine|mesh-list
56798986|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
56798987|NCT00959231|Cyclosporins|cyclosporins|mesh-list
56798988|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56798989|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
56798990|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56798991|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56798992|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56798993|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
56798994|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799017|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799018|NCT04720547|Zolpidem|zolpidem|mesh-list
56799019|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56799020|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56799021|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56799022|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799023|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56799024|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
56799025|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
56799026|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799027|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799028|NCT00959387|Paclitaxel|paclitaxel|mesh-list
56799029|NCT00959387|Cisplatin|cisplatin|mesh-list
56799030|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56799031|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799032|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
56799033|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
56799034|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
56799035|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799036|NCT04718285|Favipiravir|favipiravir|mesh-list
56799037|NCT04718285|Montelukast|montelukast|mesh-list
56799038|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56799039|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
56799040|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56799041|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
56799042|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799043|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799044|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56799045|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56799046|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799047|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
56799048|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799049|NCT00959621|Aspirin|aspirin|mesh-list
56799050|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56194598|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
56799055|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799056|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799057|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799058|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56799059|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56799060|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799061|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56799062|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56799063|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799064|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
56799065|NCT00959777|Lenograstim|lenograstim|mesh-list
56799066|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56799067|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
56799068|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799069|NCT00959933|Ribavirin|ribavirin|mesh-list
56799070|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
56799071|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799072|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
56799073|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799074|NCT00960245|Nadolol|nadolol|mesh-list
56799075|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56799076|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56799077|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
56799078|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799079|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799080|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799081|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56799082|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56799083|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
56799084|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
56799085|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799086|NCT00406653|Abatacept|abatacept|mesh-list
56799087|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56799088|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799089|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799093|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799094|NCT00547157|Cisplatin|cisplatin|mesh-list
56799095|NCT00547157|Panitumumab|panitumumab|mesh-list
56799096|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799097|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799098|NCT00960479|Ribavirin|ribavirin|mesh-list
56799099|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
56799100|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799101|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
56799102|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799103|NCT00960557|Combretastatin|combretastatin|mesh-list
56799104|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56799105|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799106|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
56799107|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
56799108|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
56799109|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799110|NCT00960635|Vitamin D|vitamin d|mesh-list
56799111|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
56799112|NCT00960635|Calcitriol|calcitriol|mesh-list
56799113|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56799114|NCT00960635|Vitamins|vitamins|mesh-ancestor
56799115|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
56799116|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799117|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56799123|NCT00960713|Rituximab|rituximab|mesh-list
56799143|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56799144|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56799145|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56799146|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56799147|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799148|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799149|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799150|NCT00384033|Analgesics|analgesics|mesh-ancestor
56799151|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
56799152|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799153|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
56799154|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56799155|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
56799156|NCT00962663|Ibuprofen|ibuprofen|mesh-list
56799157|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56799158|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56799159|NCT00962663|Analgesics|analgesics|mesh-ancestor
56799160|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
56799161|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799162|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799163|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799164|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799165|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56799166|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799191|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
56799192|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
56799193|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56799194|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799195|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
56799196|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
56799197|NCT00963131|Antioxidants|antioxidants|mesh-list
56799198|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799199|NCT00963131|Protective Agents|protective agents|mesh-ancestor
56799200|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799201|NCT00963209|Tamoxifen|tamoxifen|mesh-list
56799202|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56799203|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
56799204|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799205|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799206|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56799207|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799208|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56799209|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56799210|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56799211|NCT00963443|Aspirin|aspirin|mesh-list
56799212|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
56799213|NCT00963443|Ephedrine|ephedrine|mesh-list
56799214|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56799215|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56799216|NCT00963443|Analgesics|analgesics|mesh-ancestor
56799217|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
56799218|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799221|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799235|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56799236|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
56799237|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
56799238|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799239|NCT00963833|Interferons|interferons|mesh-list
56799240|NCT00963833|Interferon-beta|interferon-beta|mesh-list
56799241|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
56799242|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799243|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
56799244|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799245|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
56799246|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799247|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56799248|NCT00967655|Capecitabine|capecitabine|mesh-list
56799249|NCT00967655|Irinotecan|irinotecan|mesh-list
56799250|NCT00967655|Panitumumab|panitumumab|mesh-list
56799251|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56799252|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
56799253|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799254|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799255|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56799256|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56799257|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799258|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799259|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
56799260|NCT00546377|Rituximab|rituximab|mesh-list
56799261|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
56799262|NCT00546377|Pentostatin|pentostatin|mesh-list
56799284|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
56799285|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56799286|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56799287|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
56799288|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799289|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799290|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799291|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56799292|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56799293|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
56799294|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
56799295|NCT00964457|Cetuximab|cetuximab|mesh-list
56799296|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799297|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799298|NCT00964535|Budesonide|budesonide|mesh-list
56799299|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
56799300|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56799301|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799302|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56799303|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
56799304|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799305|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799306|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56799307|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
56799332|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56799333|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
56799334|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799335|NCT00968435|Bevacizumab|bevacizumab|mesh-list
56799336|NCT00968435|Cetuximab|cetuximab|mesh-list
56799337|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799338|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799339|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56799340|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56799341|NCT00968435|Growth Substances|growth substances|mesh-ancestor
56799342|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799343|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
56799344|NCT05253287|Hormones|hormones|mesh-list
56799345|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799346|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799347|NCT00968591|Everolimus|everolimus|mesh-list
56799348|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799349|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799350|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
56799351|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799352|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
56799353|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56799354|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56799356|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
56799357|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56799358|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
56799359|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799360|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
56799361|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
56799362|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799363|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799376|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799377|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56799378|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56799379|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
56799380|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799381|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799382|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56799383|NCT00965315|Fenofibrate|fenofibrate|mesh-list
56799384|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56799385|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56799386|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
56799387|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799388|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56799389|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56799390|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799391|NCT00969293|Ecallantide|ecallantide|mesh-list
56799392|NCT00969293|Analgesics|analgesics|mesh-ancestor
56799393|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
56799394|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799395|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799396|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56799397|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56799398|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799399|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799400|NCT00969449|Naproxen|naproxen|mesh-list
56799401|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56799402|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56799403|NCT00969449|Analgesics|analgesics|mesh-ancestor
56799404|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
56799405|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799419|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799420|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799421|NCT00965549|Insulin|insulin|mesh-list
56799422|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56799423|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
56799424|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
56799426|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56799427|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799428|NCT00966251|Pidilizumab|pidilizumab|mesh-list
56799429|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799430|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799431|NCT00966329|Maraviroc|maraviroc|mesh-list
56799432|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56799433|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56799434|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799435|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56799436|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56799437|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
56799438|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799439|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56799440|NCT00970697|Becaplermin|becaplermin|mesh-list
56799441|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
56799442|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56799443|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56799444|NCT00970697|Growth Substances|growth substances|mesh-ancestor
56799445|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799446|NCT00967031|Capecitabine|capecitabine|mesh-list
56799447|NCT00967031|Lapatinib|lapatinib|mesh-list
56799448|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56799449|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
56799451|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799464|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799465|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799466|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
56799467|NCT00970931|Amiloride|amiloride|mesh-list
56799468|NCT00970931|Diuretics|diuretics|mesh-list
56799469|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
56799470|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799471|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56799472|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56799473|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56799474|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799475|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56799476|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56799477|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56799478|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56799479|NCT00406419|Methotrexate|methotrexate|mesh-list
56799480|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
56799481|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56799482|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
56799483|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56799484|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799485|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56799486|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
56799487|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799488|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799489|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
56799490|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799491|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56799492|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799496|NCT00967421|Ethanol|ethanol|mesh-list
56799507|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56799508|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56799509|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799510|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
56799511|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799512|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56799513|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56799514|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56799515|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56799516|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56799517|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56799518|NCT00971399|Ondansetron|ondansetron|mesh-list
56799519|NCT00971399|Ramosetron|ramosetron|mesh-list
56799520|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
56799521|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
56799522|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799523|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799524|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56799525|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
56799526|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
56799527|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56799528|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
56799529|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799530|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799531|NCT00971399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56799532|NCT00971399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56799533|NCT00971399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56799534|NCT00971399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56799535|NCT00971399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56799536|NCT00973505|Anastrozole|anastrozole|mesh-list
56799548|NCT00973583|Vitamins|vitamins|mesh-ancestor
56799549|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
56799550|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799551|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56799552|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
56799553|NCT00972101|Rituximab|rituximab|mesh-list
56799554|NCT00972101|Fludarabine|fludarabine|mesh-list
56799555|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
56799556|NCT00972101|Etoposide|etoposide|mesh-list
56799557|NCT00972101|Melphalan|melphalan|mesh-list
56799558|NCT00972101|Thiotepa|thiotepa|mesh-list
56799559|NCT00972101|Tacrolimus|tacrolimus|mesh-list
56799560|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56799561|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799562|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799563|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
56799564|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799565|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799566|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56799567|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
56799568|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799569|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799570|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799571|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56799572|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56799573|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56799575|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56799576|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56799581|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
56799596|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56799597|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56799598|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56799599|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56799600|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56799601|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799602|NCT00311584|Irinotecan|irinotecan|mesh-list
56799603|NCT00311584|Temozolomide|temozolomide|mesh-list
56799604|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56799605|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56799606|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799607|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799608|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799609|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56799610|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
56799611|NCT00383331|Gemcitabine|gemcitabine|mesh-list
56799612|NCT00383331|Pemetrexed|pemetrexed|mesh-list
56799655|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799656|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56799657|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799658|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799659|NCT03927911|Bupivacaine|bupivacaine|mesh-list
56799660|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
56799661|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
56799662|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56799663|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799664|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
56799665|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799666|NCT00383019|Latanoprost|latanoprost|mesh-list
56799667|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56799668|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56799669|NCT00310804|Vaccines|vaccines|mesh-list
56799670|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
56799671|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799672|NCT00590187|Sapacitabine|sapacitabine|mesh-list
56799673|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799674|NCT03978364|Azacitidine|azacitidine|mesh-list
56799675|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56799676|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
56799677|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799678|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799679|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799680|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
56799681|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
56799682|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56799683|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
56799684|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799685|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799686|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56799687|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
56799697|NCT03978286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56799698|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56799699|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56799700|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799701|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799702|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
56799703|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799704|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56799705|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56799706|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56799707|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56799708|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56799709|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56799710|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56799711|NCT03933449|Paclitaxel|paclitaxel|mesh-list
56799712|NCT03933449|Docetaxel|docetaxel|mesh-list
56799713|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
56799714|NCT03933449|Irinotecan|irinotecan|mesh-list
56799715|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56799716|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799717|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
56799718|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
56799719|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
56799720|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799721|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799722|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56799723|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56799742|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
56799743|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799744|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
56799745|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
56799746|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799747|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799748|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56799749|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
56799750|NCT01049451|Hormones|hormones|mesh-ancestor
56799751|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799752|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56799753|NCT01049451|Protective Agents|protective agents|mesh-ancestor
56799754|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56799755|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799756|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56799757|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
56799758|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799759|NCT00974753|Ketorolac|ketorolac|mesh-list
56799760|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56799761|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56799762|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56799763|NCT00974753|Analgesics|analgesics|mesh-ancestor
56799764|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
56799765|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799766|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799767|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799768|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799769|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56799770|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799771|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799772|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
56799773|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56799774|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56799775|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
56799782|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799783|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799784|NCT00975065|Metformin|metformin|mesh-list
56799785|NCT00975065|Vildagliptin|vildagliptin|mesh-list
56799786|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56799787|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799788|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56799789|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
56799790|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799791|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799792|NCT00972881|Capecitabine|capecitabine|mesh-list
56799793|NCT00972881|Irinotecan|irinotecan|mesh-list
56799794|NCT00972881|Cetuximab|cetuximab|mesh-list
56799795|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56799796|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
56799797|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799798|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799799|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56799800|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56799801|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799802|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56799803|NCT00290758|Genistein|genistein|mesh-list
56799804|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56799805|NCT00290758|Protective Agents|protective agents|mesh-ancestor
56799806|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799807|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799808|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56799809|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799810|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799811|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
56799812|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56799813|NCT00290758|Estrogens|estrogens|mesh-ancestor
56799814|NCT00290758|Hormones|hormones|mesh-ancestor
56799822|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56799823|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56799824|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56799825|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
56799826|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799827|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799828|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799829|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56799830|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56799831|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
56799832|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799833|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56799834|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
56799835|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
56799836|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
56799837|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56799838|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799839|NCT00973037|Tamoxifen|tamoxifen|mesh-list
56799840|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56799841|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
56799842|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799843|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799844|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56799845|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799846|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56799847|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56799848|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56799849|NCT00973115|Simvastatin|simvastatin|mesh-list
56799850|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56799851|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56799852|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
56799853|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799854|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56799856|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799859|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799860|NCT00975533|Insulin|insulin|mesh-list
56799861|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56799862|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799863|NCT00372567|Sunitinib|sunitinib|mesh-list
56799864|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
56799865|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799866|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56799867|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56799868|NCT00372567|Growth Substances|growth substances|mesh-ancestor
56799869|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799870|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
56799871|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56799872|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799873|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799874|NCT00973271|Atorvastatin|atorvastatin|mesh-list
56799875|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
56799876|NCT00973271|Fenofibrate|fenofibrate|mesh-list
56799877|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56799878|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56799879|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
56799880|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799881|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56799882|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56799883|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799893|NCT00365547|Bevacizumab|bevacizumab|mesh-list
56799908|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56799909|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56799910|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56799911|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56799912|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
56799913|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56799914|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799915|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799916|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56799917|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56799918|NCT00979589|Analgesics|analgesics|mesh-ancestor
56799919|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
56799920|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56799921|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799922|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56799923|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56799924|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56799925|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56799926|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799927|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
56799928|NCT00294658|Prednisone|prednisone|mesh-list
56799929|NCT00294658|Prednisolone|prednisolone|mesh-list
56799930|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799931|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
56799932|NCT00294658|Hormones|hormones|mesh-ancestor
56799933|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56799934|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799935|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56799936|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799937|NCT00979667|Oseltamivir|oseltamivir|mesh-list
56799938|NCT00979667|Zanamivir|zanamivir|mesh-list
56799950|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799951|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56799952|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
56799953|NCT03923933|Bumetanide|bumetanide|mesh-list
56799954|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56799955|NCT03923933|Diuretics|diuretics|mesh-ancestor
56799956|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
56799957|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799958|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56799959|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56799960|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799961|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56799962|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
56799963|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799964|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56799965|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56799966|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799967|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
56799968|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56799969|NCT00980213|Sunitinib|sunitinib|mesh-list
56799970|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56799971|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56799972|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56799973|NCT00980213|Growth Substances|growth substances|mesh-ancestor
56799974|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56799975|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
56799976|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56799979|NCT00976469|Vaccines|vaccines|mesh-list
56799996|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56799997|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
56799998|NCT05061017|Nivolumab|nivolumab|mesh-list
56799999|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800000|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
56800001|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800002|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800003|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56800004|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
56800005|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800006|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800007|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56800008|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56800009|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56800010|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
56800011|NCT00977093|Antidotes|antidotes|mesh-ancestor
56800012|NCT00977093|Protective Agents|protective agents|mesh-ancestor
56800013|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800014|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
56800015|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
56800016|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800017|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56800018|NCT00977249|Varenicline|varenicline|mesh-list
56800019|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56800020|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56800021|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
56800044|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800045|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800046|NCT00273052|Metoprolol|metoprolol|mesh-list
56800047|NCT00273052|Carvedilol|carvedilol|mesh-list
56800048|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56800049|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56800050|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
56800051|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
56800052|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800053|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800054|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56800055|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56800056|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56800057|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
56800058|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800059|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800060|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
56800061|NCT00273052|Protective Agents|protective agents|mesh-ancestor
56800062|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56800063|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56800064|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56800065|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
56800066|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56800067|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56800068|NCT01046721|Exenatide|exenatide|mesh-list
56800069|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56800070|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800071|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56800072|NCT01046721|Incretins|incretins|mesh-ancestor
56800073|NCT01046721|Hormones|hormones|mesh-ancestor
56800074|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56800075|NCT01046799|Entecavir|entecavir|mesh-list
56800086|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56800087|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
56800088|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800089|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
56800090|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56800091|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56800092|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800093|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
56800094|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
56800095|NCT02534961|Cefazolin|cefazolin|mesh-list
56800096|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800097|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800098|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
56800099|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
56800100|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56800101|NCT01046955|Daclizumab|daclizumab|mesh-list
56800102|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
56800103|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800104|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800105|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56800106|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800107|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56800108|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800109|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56800110|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800111|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800112|NCT00271024|Naltrexone|naltrexone|mesh-list
56800113|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56800114|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56800115|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800116|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
56800118|NCT00381693|Azacitidine|azacitidine|mesh-list
56800130|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56800131|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800132|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800133|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56800134|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56800135|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
56800136|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
56800137|NCT00977873|Vitamin D|vitamin d|mesh-list
56800138|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56800139|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800140|NCT00977873|Vitamins|vitamins|mesh-ancestor
56800141|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
56800142|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56800143|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56800144|NCT00457392|Sunitinib|sunitinib|mesh-list
56800145|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800146|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56800147|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800148|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800149|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56800150|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56800151|NCT00457392|Growth Substances|growth substances|mesh-ancestor
56800152|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800153|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
56800154|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
56800155|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56800156|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800157|NCT00381615|Vaccines|vaccines|mesh-list
56800158|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
56800159|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800160|NCT00978107|Flucytosine|flucytosine|mesh-list
56800161|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
56800162|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800163|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
56800164|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800165|NCT01029132|Galantamine|galantamine|mesh-list
56800167|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800168|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800169|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
56800170|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800171|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800172|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56800173|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
56800174|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800176|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
56800177|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
56800178|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800179|NCT01049763|Oseltamivir|oseltamivir|mesh-list
56800180|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
56800181|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800182|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800183|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800184|NCT00981773|Maraviroc|maraviroc|mesh-list
56800185|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56800186|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56800187|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800188|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56800189|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56800190|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
56800191|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800192|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56800193|NCT01049841|Sirolimus|sirolimus|mesh-list
56800194|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800195|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800214|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56800215|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
56800216|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800217|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800218|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
56800219|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56800220|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56800221|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56800222|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56800223|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
56800224|NCT00981929|Losartan|losartan|mesh-list
56800225|NCT00981929|Tramadol|tramadol|mesh-list
56800226|NCT00981929|Caffeine|caffeine|mesh-list
56800227|NCT00981929|Omeprazole|omeprazole|mesh-list
56800228|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56800229|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56800230|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56800231|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56800232|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800233|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56800234|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800235|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56800236|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800237|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56800238|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56800239|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
56800240|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800241|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56800242|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56800243|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56800244|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56800245|NCT00981929|Narcotics|narcotics|mesh-ancestor
56800255|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800256|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
56800257|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800258|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56800259|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
56800260|NCT00978653|Protective Agents|protective agents|mesh-ancestor
56800261|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800262|NCT00293722|Etanercept|etanercept|mesh-list
56800263|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56800264|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56800265|NCT00293722|Analgesics|analgesics|mesh-ancestor
56800266|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
56800267|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800268|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800269|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56800270|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800271|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56800272|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800273|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
56800274|NCT00381303|Ritonavir|ritonavir|mesh-list
56800275|NCT00381303|Darunavir|darunavir|mesh-list
56800276|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56800277|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56800278|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
56800279|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800280|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800281|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56800282|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56800283|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
56800284|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800285|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56800286|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56800287|NCT00364689|Rifaximin|rifaximin|mesh-list
56800298|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
56800299|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800300|NCT00982631|Sirolimus|sirolimus|mesh-list
56800301|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800302|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800303|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56800304|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800305|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
56800306|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800307|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
56800308|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800309|NCT00364611|Bevacizumab|bevacizumab|mesh-list
56800310|NCT00364611|Trastuzumab|trastuzumab|mesh-list
56800311|NCT00364611|Docetaxel|docetaxel|mesh-list
56800312|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56800313|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800314|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56800315|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56800316|NCT00364611|Growth Substances|growth substances|mesh-ancestor
56800317|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800318|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
56800319|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
56800320|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
56800321|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
56800322|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800323|NCT00956189|Aripiprazole|aripiprazole|mesh-list
56800346|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56800347|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800348|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800349|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56800350|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
56800351|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56800352|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800353|NCT04007003|Insulin|insulin|mesh-list
56800354|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56800355|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800356|NCT00364533|Oxycodone|oxycodone|mesh-list
56800357|NCT00364533|Tapentadol|tapentadol|mesh-list
56800358|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56800359|NCT00364533|Narcotics|narcotics|mesh-ancestor
56800360|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56800361|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800362|NCT00364533|Analgesics|analgesics|mesh-ancestor
56800363|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
56800364|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800365|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56800366|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56800367|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56800368|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800369|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
56800370|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800371|NCT01047423|Simvastatin|simvastatin|mesh-list
56800372|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56800373|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56800389|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56800390|NCT01047579|Protective Agents|protective agents|mesh-ancestor
56800391|NCT04006847|Dasatinib|dasatinib|mesh-list
56800392|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800393|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56800394|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800395|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800396|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
56800397|NCT00984893|Diphosphonates|diphosphonates|mesh-list
56800398|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56800399|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800400|NCT00983021|Insulin|insulin|mesh-list
56800401|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56800402|NCT00983021|Liraglutide|liraglutide|mesh-list
56800403|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
56800404|NCT00983021|Xultophy|xultophy|mesh-list
56800405|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56800406|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800407|NCT00983021|Incretins|incretins|mesh-ancestor
56800408|NCT00983021|Hormones|hormones|mesh-ancestor
56800409|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56800410|NCT00984971|Tenofovir|tenofovir|mesh-list
56800411|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
56800412|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800413|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56800414|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56800415|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800416|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800417|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56800418|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56800419|NCT00544817|Temozolomide|temozolomide|mesh-list
56800420|NCT00544817|Sorafenib|sorafenib|mesh-list
56800421|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56800422|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
56800423|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800429|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800430|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800431|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
56800432|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800433|NCT00983177|Colchicine|colchicine|mesh-list
56800434|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
56800435|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800436|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
56800437|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
56800438|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
56800439|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800440|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800441|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
56800442|NCT00983255|Tedizolid|tedizolid|mesh-list
56800443|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
56800444|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800445|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800446|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56800447|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800448|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800449|NCT00988403|Levan|levan|mesh-list
56800450|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800451|NCT00988481|Topiramate|topiramate|mesh-list
56800452|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
56800453|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56800454|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800455|NCT00289900|Atorvastatin|atorvastatin|mesh-list
56800456|NCT00289900|Simvastatin|simvastatin|mesh-list
56800457|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56800458|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56800459|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
56800473|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56800474|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56800475|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56800476|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56800477|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56800478|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56800479|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56800480|NCT00985361|Vitamin D|vitamin d|mesh-list
56800481|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
56800482|NCT00985361|Vitamins|vitamins|mesh-list
56800483|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
56800484|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800485|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56800486|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56800487|NCT00269152|Carboplatin|carboplatin|mesh-list
56800488|NCT00269152|Pemetrexed|pemetrexed|mesh-list
56800489|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800490|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800491|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800492|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56800493|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56800494|NCT00988715|Cyclosporine|cyclosporine|mesh-list
56800495|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
56800496|NCT00988715|Fludarabine|fludarabine|mesh-list
56800497|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
56800498|NCT00988715|Cyclosporins|cyclosporins|mesh-list
56800499|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800521|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56800522|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
56800523|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800524|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800525|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56800526|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
56800527|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
56800528|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56800529|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56800530|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56800531|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56800532|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
56800533|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800534|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800535|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
56800536|NCT03975166|Hormones|hormones|mesh-ancestor
56800537|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56800538|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
56800539|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56800540|NCT01325818|Pravastatin|pravastatin|mesh-list
56800541|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56800542|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56800543|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
56800544|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800545|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56800546|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56800547|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800548|NCT00379899|Vitamin D|vitamin d|mesh-list
56800549|NCT00379899|Cinacalcet|cinacalcet|mesh-list
56800550|NCT00379899|Vitamins|vitamins|mesh-ancestor
56800551|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
56194599|NCT01494155|Capecitabine|capecitabine|mesh-list
56800564|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
56800565|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56800566|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
56800567|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
56800568|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800569|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800570|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56800571|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
56800572|NCT02535039|Hormones|hormones|mesh-ancestor
56800573|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56800574|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56800575|NCT02535039|Protective Agents|protective agents|mesh-ancestor
56800576|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56800577|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800578|NCT00363129|Vitamin E|vitamin e|mesh-list
56800579|NCT00363129|Vitamins|vitamins|mesh-ancestor
56800580|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
56800581|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800582|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
56800583|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800584|NCT00363129|Protective Agents|protective agents|mesh-ancestor
56800585|NCT00379587|Rituximab|rituximab|mesh-list
56800586|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56800587|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800588|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
56800589|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800590|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800591|NCT00363051|Everolimus|everolimus|mesh-list
56800592|NCT00363051|Octreotide|octreotide|mesh-list
56800593|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800594|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800609|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
56800610|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800611|NCT01047657|Orlistat|orlistat|mesh-list
56800612|NCT01047657|Sibutramine|sibutramine|mesh-list
56800613|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800614|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800615|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56800616|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56800617|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
56800618|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56800619|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
56800620|NCT00378573|Gemcitabine|gemcitabine|mesh-list
56800621|NCT00378573|Bevacizumab|bevacizumab|mesh-list
56800622|NCT00378573|Docetaxel|docetaxel|mesh-list
56800623|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56800624|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800625|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56800626|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56800627|NCT00378573|Growth Substances|growth substances|mesh-ancestor
56800628|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800629|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
56800630|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56800631|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
56800632|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800633|NCT00378573|Antiviral Agents|antiviral agents|mesh-ancestor
56800634|NCT00378573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800635|NCT00378573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800636|NCT00378573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800637|NCT00378573|Immunologic Factors|immunologic factors|mesh-ancestor
56800638|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
56800639|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
56800640|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
56800641|NCT02346747|Immunologic Factors|immunologic factors|mesh-list
56800642|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800644|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800645|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56800646|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800648|NCT02534571|Epinephrine|epinephrine|mesh-list
56800649|NCT02534571|Hemostatics|hemostatics|mesh-list
56800650|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56800651|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56800652|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
56800653|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800654|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800655|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800656|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56800657|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56800658|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
56800659|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800660|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56800661|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
56800662|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
56800663|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
56800664|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56800665|NCT02534571|Coagulants|coagulants|mesh-ancestor
56800666|NCT00378105|Dexamethasone|dexamethasone|mesh-list
56800667|NCT00378105|Lenalidomide|lenalidomide|mesh-list
56800668|NCT00378105|Bortezomib|bortezomib|mesh-list
56800669|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56800670|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
56800671|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
56800672|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800673|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800674|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56800699|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56800700|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56800701|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800702|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
56800703|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56800704|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56800705|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
56800706|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800707|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56800708|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56800709|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800710|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800711|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
56800712|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56800713|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56800714|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
56800715|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800716|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56800717|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56800718|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800719|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800720|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
56800721|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56800722|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
56800723|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800724|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56800725|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800726|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
56800727|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800728|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
56800729|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56800730|NCT04535882|Protective Agents|protective agents|mesh-ancestor
56800740|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56800741|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56800742|NCT01016990|Valproic Acid|valproic acid|mesh-list
56800743|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
56800744|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800745|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800746|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
56800747|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800748|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800749|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
56800750|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56800751|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56800752|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56800753|NCT01048047|Amlodipine|amlodipine|mesh-list
56800754|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56800755|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56800756|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56800757|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800758|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56800759|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800760|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
56800761|NCT01324635|Panobinostat|panobinostat|mesh-list
56800762|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56800763|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800764|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800766|NCT00456846|Paclitaxel|paclitaxel|mesh-list
56800774|NCT03324282|Avelumab|avelumab|mesh-list
56800787|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800788|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
56800789|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56800790|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800791|NCT01029522|Atorvastatin|atorvastatin|mesh-list
56800792|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56800793|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56800794|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
56800795|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800796|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56800797|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56800798|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800799|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
56800800|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56800801|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56800802|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56800803|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56800804|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800805|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
56800806|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56800807|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800808|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56800809|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800810|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
56800811|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56800812|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56800813|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56800814|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56800816|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
56800829|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56800830|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800831|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56800832|NCT00456300|Incretins|incretins|mesh-ancestor
56800833|NCT00456300|Hormones|hormones|mesh-ancestor
56800834|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56800835|NCT00267748|Sunitinib|sunitinib|mesh-list
56800836|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800837|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56800838|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56800839|NCT00267748|Growth Substances|growth substances|mesh-ancestor
56800840|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800841|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
56800842|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56800843|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800844|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800845|NCT00267202|Omalizumab|omalizumab|mesh-list
56800846|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
56800847|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800848|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56800849|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56800850|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
56800851|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
56800852|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56800853|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56800854|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800855|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
56800856|NCT01067638|Coagulants|coagulants|mesh-ancestor
56800857|NCT00267046|Doxorubicin|doxorubicin|mesh-list
56800874|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800875|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56800876|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
56800877|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
56800878|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
56800879|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800880|NCT00286468|Alogliptin|alogliptin|mesh-list
56800881|NCT00286468|Glyburide|glyburide|mesh-list
56800882|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56800883|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800884|NCT00286468|Incretins|incretins|mesh-ancestor
56800885|NCT00286468|Hormones|hormones|mesh-ancestor
56800886|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56800887|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56800888|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
56800889|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800890|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800891|NCT00507026|Ketorolac|ketorolac|mesh-list
56800892|NCT00507026|Diclofenac|diclofenac|mesh-list
56800893|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56800894|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56800895|NCT00507026|Analgesics|analgesics|mesh-ancestor
56800896|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
56800897|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56800898|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800899|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56800900|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800901|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56800902|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800903|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800904|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
56800915|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56800916|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56800917|NCT01019174|Growth Substances|growth substances|mesh-ancestor
56800918|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
56800919|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56800920|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56800921|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800922|NCT01011920|Cytarabine|cytarabine|mesh-list
56800923|NCT01011920|Rituximab|rituximab|mesh-list
56800924|NCT01011920|Methotrexate|methotrexate|mesh-list
56800925|NCT01011920|Thiotepa|thiotepa|mesh-list
56800926|NCT01011920|Carmustine|carmustine|mesh-list
56800927|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56511874|NCT01195090|Hormones|hormones|mesh-ancestor
56800928|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800929|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
56800930|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56800931|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56800932|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56800933|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
56800934|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56800935|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56800936|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
56800937|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56800938|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
56800939|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800940|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56800941|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56800942|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56800943|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
56800944|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073392|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56073393|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073394|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56073395|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56073406|NCT05722340|Anesthetics|anesthetics|mesh-list
56073407|NCT05722340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073408|NCT05722340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073409|NCT02354833|Phenylephrine|phenylephrine|mesh-list
56073410|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
56800959|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56800960|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56800961|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
56800962|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56800963|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56800964|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56800965|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801009|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
56801010|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801011|NCT00455520|Tapentadol|tapentadol|mesh-list
56801012|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56801013|NCT00455520|Narcotics|narcotics|mesh-ancestor
56801014|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801015|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801016|NCT00455520|Analgesics|analgesics|mesh-ancestor
56801017|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
56801018|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801019|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56801020|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56801021|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56801022|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801023|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
56801024|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801025|NCT00284050|Ranibizumab|ranibizumab|mesh-list
56801026|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56801027|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56801028|NCT00284050|Growth Substances|growth substances|mesh-ancestor
56801029|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801030|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
56801031|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801032|NCT00293020|Fentanyl|fentanyl|mesh-list
56801033|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56801034|NCT00293020|Narcotics|narcotics|mesh-ancestor
56801035|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801036|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801055|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56801056|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56801057|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56801058|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
56801059|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56801060|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801061|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801062|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
56801063|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56801064|NCT00377403|Acetaminophen|acetaminophen|mesh-list
56801065|NCT00377403|Amoxicillin|amoxicillin|mesh-list
56801066|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
56801067|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
56801068|NCT00377403|Ephedrine|ephedrine|mesh-list
56801069|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
56801070|NCT00377403|Guaifenesin|guaifenesin|mesh-list
56801071|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56801072|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56801073|NCT00377403|Analgesics|analgesics|mesh-ancestor
56801074|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
56801075|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801076|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801077|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
56801078|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56801079|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801080|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
56801081|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
56801082|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56801083|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56801084|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801085|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801086|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56801087|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
56801088|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56801089|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
56801090|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56801091|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56801093|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
56801094|NCT00377403|Expectorants|expectorants|mesh-ancestor
56801095|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56801096|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56801097|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
56801098|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56801099|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56801100|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801101|NCT00292942|Artesunate|artesunate|mesh-list
56801102|NCT00292942|Mannitol|mannitol|mesh-list
56801103|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
56801104|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56801105|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56801106|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801107|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801108|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
56801109|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
56801110|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56801111|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
56801112|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56801113|NCT00292942|Diuretics|diuretics|mesh-ancestor
56801114|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
56801115|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801116|NCT00483938|Interferons|interferons|mesh-list
56801117|NCT00483938|Ribavirin|ribavirin|mesh-list
56801118|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
56801119|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
56801120|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56801121|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801122|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
56801123|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801124|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
56801125|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801126|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
56801128|NCT00370071|Interferons|interferons|mesh-list
56801138|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56801139|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56801140|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
56801141|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
56801142|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801143|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801144|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801145|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
56801146|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56801147|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
56801148|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801149|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801150|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56801151|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
56801152|NCT03991845|Levocetirizine|levocetirizine|mesh-list
56801153|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56801154|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56801155|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
56801156|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
56801157|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801158|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801159|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801161|NCT01017380|Etoricoxib|etoricoxib|mesh-list
56801162|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56801163|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56801164|NCT01017380|Analgesics|analgesics|mesh-ancestor
56801165|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
56801166|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801169|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801184|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56801185|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56801186|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56801187|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801188|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801189|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56801190|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
56801191|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56801192|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
56801193|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
56801194|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
56801195|NCT00266812|Temozolomide|temozolomide|mesh-list
56801196|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56801197|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
56801198|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801199|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801200|NCT04249544|Pramipexole|pramipexole|mesh-list
56801201|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
56801202|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801203|NCT04249544|Protective Agents|protective agents|mesh-ancestor
56801204|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801205|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56801206|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56801207|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
56801208|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
56801209|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801210|NCT03218085|Tenofovir|tenofovir|mesh-list
56801211|NCT03218085|Emtricitabine|emtricitabine|mesh-list
56801212|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
56801213|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801214|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56801220|NCT00488774|Golimumab|golimumab|mesh-list
56801226|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801227|NCT00361569|Estrogens|estrogens|mesh-list
56801228|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56801229|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
56801230|NCT00361569|Hormones|hormones|mesh-ancestor
56801231|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801232|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801234|NCT01011998|Valproic Acid|valproic acid|mesh-list
56801235|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801236|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56801237|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801238|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801239|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
56801240|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
56801241|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801242|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801243|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
56801244|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56801245|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801246|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56801247|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
56801248|NCT01017458|Testosterone|testosterone|mesh-list
56801249|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
56801250|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
56801251|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56801252|NCT01017458|Androgens|androgens|mesh-ancestor
56801253|NCT01017458|Hormones|hormones|mesh-ancestor
56801254|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801255|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801256|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56801271|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
56801272|NCT01019642|Vitamin D|vitamin d|mesh-list
56801273|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56801274|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801275|NCT01019642|Vitamins|vitamins|mesh-ancestor
56801276|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
56801277|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56801278|NCT00266656|Hormones|hormones|mesh-list
56801279|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801280|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801281|NCT00483548|Ziprasidone|ziprasidone|mesh-list
56801282|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56801283|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
56801284|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801285|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801286|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801287|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56801288|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56801289|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801290|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56801291|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56801292|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
56801293|NCT00445770|Etanercept|etanercept|mesh-list
56801294|NCT00445770|Methotrexate|methotrexate|mesh-list
56801295|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56801296|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
56801318|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56801319|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
56801320|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801321|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801322|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56801323|NCT00266032|Diuretics|diuretics|mesh-ancestor
56801324|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
56801325|NCT01019798|Docetaxel|docetaxel|mesh-list
56801326|NCT01019798|Sunitinib|sunitinib|mesh-list
56801327|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801328|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
56801329|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
56801330|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
56801331|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801332|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56801333|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56801334|NCT01019798|Growth Substances|growth substances|mesh-ancestor
56801335|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801336|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
56801337|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56801338|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801339|NCT00483002|Varenicline|varenicline|mesh-list
56801340|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56801341|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56801342|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
56801343|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801344|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801345|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801346|NCT00482612|Mirtazapine|mirtazapine|mesh-list
56801347|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
56801348|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56801349|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56801350|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
56801351|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
56801352|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073749|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
56194600|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56194601|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
56801353|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801354|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801355|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56801356|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56801357|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801358|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56801359|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56801360|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56801361|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
56801362|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56801363|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56801364|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
56801365|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56801366|NCT00282568|Tacrolimus|tacrolimus|mesh-list
56801367|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801368|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
56801369|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801370|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56801371|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801372|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801373|NCT02532322|Acetaminophen|acetaminophen|mesh-list
56801374|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56801375|NCT02532322|Analgesics|analgesics|mesh-ancestor
56801376|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
56801377|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801400|NCT00445692|Growth Substances|growth substances|mesh-ancestor
56801401|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
56801402|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56801403|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801404|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56801405|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801406|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801407|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56801408|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56801409|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
56801410|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801411|NCT00282412|Cyclosporine|cyclosporine|mesh-list
56801412|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
56801413|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
56801414|NCT00282412|Fludarabine|fludarabine|mesh-list
56801415|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
56801416|NCT00282412|Cyclosporins|cyclosporins|mesh-list
56801417|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801418|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
56801419|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801420|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801421|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56801422|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
56801423|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801424|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801425|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56801426|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801427|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
56801428|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801429|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801430|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56801431|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56801432|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56801433|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
56801434|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56801435|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56801436|NCT03974932|Acetaminophen|acetaminophen|mesh-list
56801437|NCT03974932|Ibuprofen|ibuprofen|mesh-list
56801438|NCT03974932|Celecoxib|celecoxib|mesh-list
56801439|NCT03974932|Bupivacaine|bupivacaine|mesh-list
56801440|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
56801441|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
56801442|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801443|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801444|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
56801445|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801446|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56801447|NCT03974932|Analgesics|analgesics|mesh-ancestor
56801448|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
56801449|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56801450|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801451|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801452|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56801453|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801454|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801455|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56801457|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801458|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
56801459|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801460|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56801461|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801462|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801463|NCT00265330|Ziprasidone|ziprasidone|mesh-list
56801464|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56801465|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
56801466|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801467|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801468|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801469|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56801476|NCT00543569|Alefacept|alefacept|mesh-list
56801481|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801482|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56801483|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801484|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801485|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56801486|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801487|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56801488|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
56801489|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56801490|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801491|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801492|NCT00984347|Oxytocin|oxytocin|mesh-list
56801493|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
56801494|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56801495|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801496|NCT00984425|Sorafenib|sorafenib|mesh-list
56801497|NCT00984425|Lapatinib|lapatinib|mesh-list
56801498|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801499|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56801500|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801501|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801502|NCT05596955|Naltrexone|naltrexone|mesh-list
56801503|NCT05596955|Buprenorphine|buprenorphine|mesh-list
56801504|NCT05596955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56801505|NCT05596955|Narcotics|narcotics|mesh-ancestor
56801506|NCT05596955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801507|NCT05596955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801508|NCT05596955|Analgesics|analgesics|mesh-ancestor
56801509|NCT05596955|Sensory System Agents|sensory system agents|mesh-ancestor
56801510|NCT05596955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801511|NCT05596955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56801512|NCT05596955|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56801513|NCT00445458|Paclitaxel|paclitaxel|mesh-list
56801514|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56801515|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801516|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
56801517|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
56801519|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801520|NCT03914417|Imiquimod|imiquimod|mesh-list
56801521|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56801522|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
56801523|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801524|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801525|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
56801526|NCT05586113|Bismuth|bismuth|mesh-list
56801527|NCT05586113|Antacids|antacids|mesh-ancestor
56801528|NCT05586113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801529|NCT05586113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801530|NCT05581901|Methadone|methadone|mesh-list
56801531|NCT05581901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56801532|NCT05581901|Narcotics|narcotics|mesh-ancestor
56801533|NCT05581901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801534|NCT05581901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801535|NCT05581901|Analgesics|analgesics|mesh-ancestor
56801536|NCT05581901|Sensory System Agents|sensory system agents|mesh-ancestor
56801537|NCT05581901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801538|NCT05581901|Antitussive Agents|antitussive agents|mesh-ancestor
56801539|NCT05581901|Respiratory System Agents|respiratory system agents|mesh-ancestor
56801540|NCT00541385|Artesunate|artesunate|mesh-list
56801541|NCT00541385|Lumefantrine|lumefantrine|mesh-list
56801542|NCT00541385|Pyronaridine|pyronaridine|mesh-list
56801543|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
56801544|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56801545|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56801546|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801547|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801548|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
56801549|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
56801550|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56801551|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
56801552|NCT00988949|Spiradoline|spiradoline|mesh-list
56801553|NCT00988949|Analgesics|analgesics|mesh-ancestor
56801562|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
56801563|NCT00989027|Ergonovine|ergonovine|mesh-list
56801564|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
56801565|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56801566|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801567|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56801568|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
56801569|NCT00265096|Golimumab|golimumab|mesh-list
56801570|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56801571|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56801572|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801573|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801574|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
56801575|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801576|NCT02201108|Teriflunomide|teriflunomide|mesh-list
56801577|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56801578|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56801579|NCT02201108|Analgesics|analgesics|mesh-ancestor
56801580|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
56801581|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801582|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801583|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801584|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801585|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801586|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
56801587|NCT00986609|Poly I-C|poly i-c|mesh-list
56801588|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56801589|NCT00986609|Vaccines|vaccines|mesh-list
56801590|NCT00986609|Poly ICLC|poly iclc|mesh-list
56801594|NCT00986609|Laxatives|laxatives|mesh-ancestor
56801609|NCT05003258|Dexamethasone|dexamethasone|mesh-list
56801610|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801611|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
56801613|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801614|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801615|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801616|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
56801617|NCT05003258|Hormones|hormones|mesh-ancestor
56801618|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801619|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56801620|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801621|NCT05499689|Bupivacaine|bupivacaine|mesh-list
56801622|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
56801623|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
56801624|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801625|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801626|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
56801627|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801628|NCT01012232|Ropivacaine|ropivacaine|mesh-list
56801629|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
56801630|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
56801631|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801632|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801633|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
56801634|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801635|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56801636|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56801656|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56801657|NCT00986765|Analgesics|analgesics|mesh-ancestor
56801658|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
56801659|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801660|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801661|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801662|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801663|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56801664|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56801665|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801666|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56801667|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56801668|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801669|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
56801670|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
56801671|NCT00986843|Irinotecan|irinotecan|mesh-list
56801672|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56801673|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56801674|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801675|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801676|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801677|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
56801678|NCT01019876|Fludarabine|fludarabine|mesh-list
56801679|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801680|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
56801681|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801682|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801683|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56801684|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
56512605|NCT01646684|Pasireotide|pasireotide|mesh-list
56801685|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801686|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801687|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56801688|NCT05463419|Vaccines|vaccines|mesh-list
56801691|NCT01017770|Artesunate|artesunate|mesh-list
56801695|NCT01017770|Amodiaquine|amodiaquine|mesh-list
56801696|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
56801697|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56801698|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56801699|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801700|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801701|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
56801702|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
56801703|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56801704|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
56801705|NCT05712707|Lofexidine|lofexidine|mesh-list
56801706|NCT05712707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56801707|NCT05712707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56801708|NCT05712707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801709|NCT05712707|Sensory System Agents|sensory system agents|mesh-ancestor
56801710|NCT05712707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801711|NCT05712707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56801712|NCT05712707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56801713|NCT05712707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56801714|NCT05712707|Adrenergic Agents|adrenergic agents|mesh-ancestor
56801715|NCT05712707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801716|NCT05712707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801717|NCT01017926|Triazolam|triazolam|mesh-list
56801718|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56801719|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56801720|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56801721|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56801723|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56801745|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
56801746|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801747|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801748|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56801749|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
56801750|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801751|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801752|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56801753|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56801754|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56801755|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56512670|NCT01682408|Diuretics|diuretics|mesh-ancestor
56801756|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56801757|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801758|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56801759|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
56801760|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801761|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801762|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56801763|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56801764|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56801765|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
56801766|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56801767|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801768|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
56801769|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
56801770|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801771|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801772|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
56801773|NCT00481832|Hormones|hormones|mesh-ancestor
56801774|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801775|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56801776|NCT00481832|Protective Agents|protective agents|mesh-ancestor
56801784|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
56801785|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
56801786|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801787|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
56801788|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801789|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56801790|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56801791|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
56801792|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
56801793|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56801794|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801795|NCT05318105|Diuretics|diuretics|mesh-list
56801796|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56801797|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
56801798|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801799|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56801800|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801801|NCT00987233|Triamcinolone|triamcinolone|mesh-list
56801802|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56801803|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56801804|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56801805|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801806|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
56801807|NCT00987233|Hormones|hormones|mesh-ancestor
56801808|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801809|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801810|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801811|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
56801812|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801814|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
56801826|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801827|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
56801828|NCT04377503|Hormones|hormones|mesh-ancestor
56801829|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801830|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56801831|NCT04377503|Protective Agents|protective agents|mesh-ancestor
56801832|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56801833|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801834|NCT00542789|Esomeprazole|esomeprazole|mesh-list
56801835|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56801836|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801837|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56801838|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801839|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801840|NCT00464672|Vaccines|vaccines|mesh-list
56801841|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
56801842|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801843|NCT03996434|Cetrorelix|cetrorelix|mesh-list
56801844|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56801845|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
56801846|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56801847|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801848|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
56801849|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801850|NCT00987779|Gabapentin|gabapentin|mesh-list
56801851|NCT00987779|Analgesics|analgesics|mesh-ancestor
56801852|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
56801853|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801854|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801870|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801871|NCT00473876|Metformin|metformin|mesh-list
56801872|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56801873|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801874|NCT00463580|Infliximab|infliximab|mesh-list
56801875|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801876|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801877|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801878|NCT01020734|Cyclosporine|cyclosporine|mesh-list
56801879|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
56801880|NCT01020734|Busulfan|busulfan|mesh-list
56801881|NCT01020734|Methotrexate|methotrexate|mesh-list
56801882|NCT01020734|Fludarabine|fludarabine|mesh-list
56801883|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
56801884|NCT01020734|Cyclosporins|cyclosporins|mesh-list
56801885|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56801886|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801887|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
56801888|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801889|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801890|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56801891|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
56801892|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801893|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801894|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56801895|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56801896|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
56801897|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56801898|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56801899|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
56801900|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801901|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801914|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801915|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56801916|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56801917|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56801918|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56801919|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56801920|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56801921|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56801922|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56801923|NCT04891289|Gemcitabine|gemcitabine|mesh-list
56801924|NCT04891289|Dexamethasone|dexamethasone|mesh-list
56801925|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
56801926|NCT04891289|Floxuridine|floxuridine|mesh-list
56801927|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801928|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
56801929|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
56801930|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56801931|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801932|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56801933|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
56801934|NCT04891289|Hormones|hormones|mesh-ancestor
56801935|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56801936|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56801937|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801938|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56801939|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
56801940|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801941|NCT04891289|Antiviral Agents|antiviral agents|mesh-ancestor
56801942|NCT04891289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56801943|NCT04891289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801944|NCT04891289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801945|NCT04891289|Immunologic Factors|immunologic factors|mesh-ancestor
56801956|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801957|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56801958|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
56801959|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801960|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801961|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801962|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56801963|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56801964|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56801965|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
56801966|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56801967|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56801968|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56801969|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56801970|NCT00264550|Golimumab|golimumab|mesh-list
56801971|NCT00264550|Methotrexate|methotrexate|mesh-list
56801972|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56801973|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56801974|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
56801975|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56801976|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56801977|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56801978|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
56801979|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56801980|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56801981|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56801982|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802000|NCT01070290|Capecitabine|capecitabine|mesh-list
56802002|NCT01070290|Irinotecan|irinotecan|mesh-list
56802003|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56802004|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
56802005|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802006|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802007|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56802008|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56802009|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802010|NCT01070446|Choline|choline|mesh-list
56802011|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
56802012|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56802013|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
56802014|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802015|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802016|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56802017|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
56802018|NCT01050387|Vitamin D|vitamin d|mesh-list
56802019|NCT01050387|Vitamins|vitamins|mesh-ancestor
56802020|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
56802021|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802022|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56802023|NCT01070524|Budesonide|budesonide|mesh-list
56802024|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56802025|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802026|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56802027|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
56802028|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802029|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802030|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56802031|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
56802032|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
56802046|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
56802047|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
56802048|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
56802049|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802050|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802051|NCT01069042|Enalapril|enalapril|mesh-list
56802052|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56802053|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
56802054|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802055|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802056|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56802057|NCT00368979|Dutasteride|dutasteride|mesh-list
56802058|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56802059|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56802060|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802061|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802062|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
56802063|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802064|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802065|NCT00264238|Memantine|memantine|mesh-list
56802066|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56802067|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56802068|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
56802069|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802070|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802071|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802072|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56802073|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56802088|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56802089|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
56802090|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56802091|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
56802092|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802093|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
56802094|NCT01050621|Vitamins|vitamins|mesh-ancestor
56802095|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
56802096|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802097|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
56802098|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802099|NCT01050621|Protective Agents|protective agents|mesh-ancestor
56802100|NCT00359073|Montelukast|montelukast|mesh-list
56802101|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56802102|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
56802103|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56802104|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
56802105|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802106|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802107|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56802108|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56802109|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802110|NCT04674683|Nivolumab|nivolumab|mesh-list
56802111|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56802112|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802136|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802137|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56802138|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802139|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802143|NCT01050699|Fentanyl|fentanyl|mesh-list
56802144|NCT01050699|Midazolam|midazolam|mesh-list
56802145|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
56802146|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56802147|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802148|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802149|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56802150|NCT01050699|Analgesics|analgesics|mesh-ancestor
56802198|NCT05711615|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56802199|NCT05711615|Peposertib|peposertib|mesh-list
56802200|NCT05711615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56802201|NCT05711615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802202|NCT05711615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56802203|NCT05711615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56802204|NCT05711615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802205|NCT05711615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802206|NCT05711615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56802207|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
56802208|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56802209|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56513130|NCT01649336|Paclitaxel|paclitaxel|mesh-list
56802210|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
56802211|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802212|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56802213|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56802214|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802215|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802217|NCT00358917|Lopinavir|lopinavir|mesh-list
56802218|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56802219|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56802220|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56802221|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
56802222|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802223|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802224|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56802225|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56802226|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
56802227|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802228|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56802240|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802241|NCT01050777|Paromomycin|paromomycin|mesh-list
56802242|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56802243|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56802244|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802245|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56802246|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56802247|NCT00264004|Cediranib|cediranib|mesh-list
56802248|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802249|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56802250|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802251|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802252|NCT01069198|Vitamin A|vitamin a|mesh-list
56802253|NCT01069198|Albendazole|albendazole|mesh-list
56802254|NCT01069198|Vitamins|vitamins|mesh-ancestor
56802255|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
56802256|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802257|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802258|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802259|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
56802260|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56802261|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802262|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
56802263|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56802264|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56802265|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
56802266|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
56802267|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
56802268|NCT00368355|Cytarabine|cytarabine|mesh-list
56802269|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
56802270|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
56802271|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802284|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56802285|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
56802286|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56802287|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802288|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802289|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56802290|NCT01070680|Analgesics|analgesics|mesh-ancestor
56802291|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
56802292|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802293|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56802294|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56802295|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56802296|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
56802297|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802298|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802299|NCT00445146|Elvitegravir|elvitegravir|mesh-list
56802300|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56802301|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56802302|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
56802303|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802304|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56802305|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802306|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802307|NCT01581736|Insulin|insulin|mesh-list
56802308|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56802309|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56802310|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802311|NCT01030302|Bortezomib|bortezomib|mesh-list
56802312|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802313|NCT00368277|Amlodipine|amlodipine|mesh-list
56802314|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56802315|NCT00368277|Ramipril|ramipril|mesh-list
56802316|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56802317|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56802324|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
56802325|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56802326|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56802327|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
56802328|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802329|NCT00280150|Paclitaxel|paclitaxel|mesh-list
56802330|NCT00280150|Bevacizumab|bevacizumab|mesh-list
56802331|NCT00280150|Carboplatin|carboplatin|mesh-list
56802332|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56802333|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56802334|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802335|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
56802336|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
56802337|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
56802338|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802339|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56802340|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56802341|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56802342|NCT00280150|Growth Substances|growth substances|mesh-ancestor
56802343|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802344|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
56802345|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56802346|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802347|NCT00279916|Triamcinolone|triamcinolone|mesh-list
56802348|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56802349|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56802350|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56802351|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802352|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
56802353|NCT00279916|Hormones|hormones|mesh-ancestor
56802354|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802355|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802356|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802364|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56802365|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
56802366|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802367|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802368|NCT02534337|Antiviral Agents|antiviral agents|mesh-ancestor
56802369|NCT02534337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802370|NCT02534337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802371|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802372|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
56802373|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802374|NCT02534337|Antidotes|antidotes|mesh-ancestor
56802375|NCT02534337|Protective Agents|protective agents|mesh-ancestor
56802376|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
56802377|NCT02534337|Vitamins|vitamins|mesh-ancestor
56802378|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
56802379|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56802380|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
56802381|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802382|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
56802383|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
56802384|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802385|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
56802386|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802387|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802388|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
56802389|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802390|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
56802391|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56802392|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
56802393|NCT00251758|Lansoprazole|lansoprazole|mesh-list
56802394|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56802395|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802396|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56802397|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802399|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56802405|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802406|NCT00539591|Interferons|interferons|mesh-list
56802407|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
56802408|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
56802409|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56802410|NCT00539591|Temozolomide|temozolomide|mesh-list
56802411|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802412|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
56802413|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802414|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56802415|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
56802416|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802417|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
56802418|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802419|NCT04417361|Erenumab|erenumab|mesh-list
56802420|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56802421|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802422|NCT04417361|Analgesics|analgesics|mesh-ancestor
56802423|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
56802424|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802425|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802426|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
56802427|NCT03396575|Fludarabine|fludarabine|mesh-list
56802428|NCT03396575|Vaccines|vaccines|mesh-list
56802429|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
56802430|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802431|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802432|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56802433|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56802450|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
56802451|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56802452|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802453|NCT00541775|Incretins|incretins|mesh-ancestor
56802454|NCT00541775|Hormones|hormones|mesh-ancestor
56802455|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802456|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56802457|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
56802458|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802459|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802460|NCT04004117|Fentanyl|fentanyl|mesh-list
56802461|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56802462|NCT04004117|Narcotics|narcotics|mesh-ancestor
56802463|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802464|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802465|NCT04004117|Analgesics|analgesics|mesh-ancestor
56802466|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
56802467|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802468|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56802469|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56802470|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
56802471|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
56802472|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
56802473|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56802474|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
56802475|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802476|NCT00539513|Expectorants|expectorants|mesh-ancestor
56802477|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
56802479|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
56074928|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
56074929|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074930|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074931|NCT03836287|Bromides|bromides|mesh-list
56802498|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802499|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56802500|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56802501|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802502|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
56802503|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56802504|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802505|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56802506|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802507|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56802508|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56802509|NCT02997761|Blinatumomab|blinatumomab|mesh-list
56802510|NCT02997761|Antibodies|antibodies|mesh-list
56802511|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
56802512|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56802513|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
56802514|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56802515|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
56802516|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802517|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802518|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802519|NCT00454584|Etanercept|etanercept|mesh-list
56802520|NCT00454584|Ustekinumab|ustekinumab|mesh-list
56802521|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56802542|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802543|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802544|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56802545|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
56802546|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
56802547|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802548|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802549|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
56802550|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802551|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56802552|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56802553|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
56802554|NCT02583893|Analgesics|analgesics|mesh-ancestor
56802555|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
56802556|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802557|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56802558|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
56802559|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802560|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
56802561|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802598|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56802599|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802600|NCT05360147|Incretins|incretins|mesh-ancestor
56802601|NCT05360147|Hormones|hormones|mesh-ancestor
56802602|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802603|NCT00444912|Plerixafor|plerixafor|mesh-list
56802604|NCT00444912|Rituximab|rituximab|mesh-list
56802605|NCT00444912|Lenograstim|lenograstim|mesh-list
56802606|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56802607|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802608|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
56802609|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802610|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56802611|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56802612|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56802613|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56802614|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
56802615|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802616|NCT00538733|Clarithromycin|clarithromycin|mesh-list
56802617|NCT00538733|Thalidomide|thalidomide|mesh-list
56802618|NCT00538733|Dexamethasone|dexamethasone|mesh-list
56802619|NCT00538733|Lenalidomide|lenalidomide|mesh-list
56802620|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802621|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
56802622|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
56802623|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802624|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802625|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802626|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
56802627|NCT00538733|Hormones|hormones|mesh-ancestor
56802645|NCT00444678|Capecitabine|capecitabine|mesh-list
56802646|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
56802647|NCT00444678|Cetuximab|cetuximab|mesh-list
56802648|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56802649|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
56802650|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802651|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802652|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56802653|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
56802654|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
56802655|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802656|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
56802657|NCT00990197|Nicotine|nicotine|mesh-list
56802658|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56802659|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
56802660|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802661|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802662|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56802663|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56802664|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
56802665|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802666|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802667|NCT01051011|Metformin|metformin|mesh-list
56802668|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
56802669|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56802670|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56802671|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802672|NCT01051011|Incretins|incretins|mesh-ancestor
56802673|NCT01051011|Hormones|hormones|mesh-ancestor
56802674|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802675|NCT01048827|Busulfan|busulfan|mesh-list
56802676|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
56802684|NCT02023463|Leuprolide|leuprolide|mesh-list
56802688|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56802689|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802690|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56802691|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802692|NCT01302327|Exenatide|exenatide|mesh-list
56802693|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56802694|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802695|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56802696|NCT01302327|Incretins|incretins|mesh-ancestor
56802697|NCT01302327|Hormones|hormones|mesh-ancestor
56802698|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802699|NCT01048983|Minocycline|minocycline|mesh-list
56802700|NCT01048983|Curcumin|curcumin|mesh-list
56802701|NCT01048983|Modafinil|modafinil|mesh-list
56802702|NCT01048983|Bupropion|bupropion|mesh-list
56802703|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56802704|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
56802705|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56802706|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56802707|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56802708|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56802709|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802710|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
56802711|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802712|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802713|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56802714|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56802733|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802734|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802735|NCT01340417|Melatonin|melatonin|mesh-list
56802736|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
56513642|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802737|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802738|NCT01340417|Protective Agents|protective agents|mesh-ancestor
56802739|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802740|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802741|NCT01049061|Farletuzumab|farletuzumab|mesh-list
56802742|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802744|NCT00367341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56802745|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56802746|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56802747|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802748|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802749|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
56802750|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802751|NCT00367341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56802752|NCT00367341|Antidepressive Agents|antidepressive agents|mesh-ancestor
56802753|NCT00367341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56802754|NCT01052961|Oseltamivir|oseltamivir|mesh-list
56802755|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
56802756|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802757|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802758|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802759|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
56802760|NCT00440466|Hematinics|hematinics|mesh-ancestor
56802777|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
56802778|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
56802779|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
56802780|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802781|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56802782|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802783|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
56802784|NCT05360537|Liraglutide|liraglutide|mesh-list
56802785|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56802786|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802787|NCT05360537|Incretins|incretins|mesh-ancestor
56802788|NCT05360537|Hormones|hormones|mesh-ancestor
56802789|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56802790|NCT05590637|Pimavanserin|pimavanserin|mesh-list
56802791|NCT05590637|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56802792|NCT05590637|Antidepressive Agents|antidepressive agents|mesh-ancestor
56802793|NCT05590637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56802794|NCT05590637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56802795|NCT05590637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56802796|NCT05590637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802797|NCT05590637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802798|NCT05590637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56802799|NCT05590637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56802800|NCT05590637|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56802801|NCT05590637|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56802802|NCT05590637|Serotonin Agents|serotonin agents|mesh-ancestor
56802803|NCT05590637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56802804|NCT05590637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802805|NCT00989651|Paclitaxel|paclitaxel|mesh-list
56802806|NCT00989651|Bevacizumab|bevacizumab|mesh-list
56802822|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802823|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56802824|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56802825|NCT00989651|Growth Substances|growth substances|mesh-ancestor
56802826|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802827|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
56802828|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
56802829|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56802830|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802831|NCT05590559|Morphine|morphine|mesh-list
56802832|NCT05590559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56802833|NCT05590559|Narcotics|narcotics|mesh-ancestor
56802834|NCT05590559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802835|NCT05590559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802836|NCT05590559|Analgesics|analgesics|mesh-ancestor
56802837|NCT05590559|Sensory System Agents|sensory system agents|mesh-ancestor
56802838|NCT05590559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802839|NCT05590325|Dolutegravir|dolutegravir|mesh-list
56802840|NCT05590325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56802841|NCT05590325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56802842|NCT05590325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802843|NCT05590325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802844|NCT05590325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56802845|NCT05590325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56802846|NCT05590325|Antiviral Agents|antiviral agents|mesh-ancestor
56802847|NCT05590325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802848|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
56802851|NCT00989729|Prednisolone|prednisolone|mesh-list
56802869|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56802870|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802871|NCT00990587|Ciclopirox|ciclopirox|mesh-list
56802872|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
56802873|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802874|NCT00537329|Anidulafungin|anidulafungin|mesh-list
56802875|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
56802876|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56802877|NCT03905135|Avelumab|avelumab|mesh-list
56802878|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56802879|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802880|NCT00991055|Pioglitazone|pioglitazone|mesh-list
56802881|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56802882|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802883|NCT00991133|Clofarabine|clofarabine|mesh-list
56802884|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802885|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802886|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56802887|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
56802888|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
56802889|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56802890|NCT00991211|Doxorubicin|doxorubicin|mesh-list
56802891|NCT00991211|Vincristine|vincristine|mesh-list
56802892|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802893|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
56802894|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802895|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56802896|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56802897|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
56802898|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802899|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56802900|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56802901|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56802902|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56802903|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56802904|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802908|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
56802909|NCT00357903|Etanercept|etanercept|mesh-list
56802910|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56802911|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56802912|NCT00357903|Analgesics|analgesics|mesh-ancestor
56802913|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
56802914|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802915|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802916|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56802917|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56802918|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802919|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56802920|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
56802921|NCT01053039|Morphine|morphine|mesh-list
56802922|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56802923|NCT01053039|Narcotics|narcotics|mesh-ancestor
56802924|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56802925|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802926|NCT01053039|Analgesics|analgesics|mesh-ancestor
56802927|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
56802928|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56802929|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56802930|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56802931|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56802932|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
56802933|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802934|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56802935|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56802936|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56802937|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
56802938|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
56802952|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
56802953|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56802954|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
56802955|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56802956|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56802957|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56802958|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
56802959|NCT01055691|Metformin|metformin|mesh-list
56802960|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
56802961|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56802962|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802963|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56802964|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513863|NCT03558854|Analgesics|analgesics|mesh-ancestor
56802965|NCT03896477|Vaccines|vaccines|mesh-list
56802966|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56802967|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
56802968|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56802969|NCT00444600|Triamcinolone|triamcinolone|mesh-list
56802970|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56802971|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56802972|NCT00444600|Ranibizumab|ranibizumab|mesh-list
56802973|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56802974|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56802982|NCT00444600|Hormones|hormones|mesh-ancestor
56803001|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803002|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803003|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803004|NCT00537017|Levodopa|levodopa|mesh-list
56803005|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56803006|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56803007|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
56803008|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803009|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803010|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803011|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
56803012|NCT00348309|Donepezil|donepezil|mesh-list
56803013|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56803014|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803015|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803016|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
56803017|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803018|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803019|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
56803020|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803021|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
56803022|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56803023|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803024|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803025|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803048|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
56803049|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803050|NCT05426681|Glyburide|glyburide|mesh-list
56803051|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803052|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803053|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56803054|NCT01055925|Laxatives|laxatives|mesh-ancestor
56803055|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56803056|NCT00440232|Frovatriptan|frovatriptan|mesh-list
56803057|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56803058|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
56803059|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803060|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803061|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803062|NCT01564199|Fluticasone|fluticasone|mesh-list
56803063|NCT01564199|Xhance|xhance|mesh-list
56803064|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56803065|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56803066|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56803067|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
56803068|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803069|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803070|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56803071|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
56803072|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
56803073|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56803074|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56803075|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56803076|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56803077|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
56803078|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803079|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803080|NCT02533323|Gemcitabine|gemcitabine|mesh-list
56803090|NCT02533323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56803091|NCT02533323|Immunologic Factors|immunologic factors|mesh-ancestor
56803092|NCT02533323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803093|NCT05379959|Methamphetamine|methamphetamine|mesh-list
56803094|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56803095|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803096|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
56803097|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
56803098|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803099|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
56803100|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803101|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803102|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
56803103|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56803104|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56803105|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56803106|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56803107|NCT03158064|Durvalumab|durvalumab|mesh-list
56803108|NCT03158064|Tremelimumab|tremelimumab|mesh-list
56803109|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56803110|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803111|NCT04791228|Doxorubicin|doxorubicin|mesh-list
56803112|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56803113|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56803114|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803115|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56803116|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56803117|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803118|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803119|NCT05357885|Antibodies|antibodies|mesh-list
56803120|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
56803121|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803122|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56803123|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
56803128|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56803129|NCT00356889|Antibodies|antibodies|mesh-list
56803130|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
56803131|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56803132|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803133|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56803134|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56803135|NCT00356889|Growth Substances|growth substances|mesh-ancestor
56803136|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803137|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
56803138|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
56803139|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56803140|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803141|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803142|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
56803143|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
56803144|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56803145|NCT05186363|Amodiaquine|amodiaquine|mesh-list
56803146|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
56803147|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56803148|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56803149|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803150|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56803151|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803152|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803153|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56803154|NCT05186363|Renal Agents|renal agents|mesh-ancestor
56803155|NCT03742323|Idelalisib|idelalisib|mesh-list
56803156|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803157|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803158|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803159|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
56803160|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
56803171|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
56803172|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
56803173|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803174|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56803175|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803176|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56803177|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803178|NCT01030614|Dexamethasone|dexamethasone|mesh-list
56803179|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56803180|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
56803181|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
56803182|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803183|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803184|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56803185|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
56803186|NCT01030614|Hormones|hormones|mesh-ancestor
56803187|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56803188|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56803189|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803190|NCT01030692|Rivastigmine|rivastigmine|mesh-list
56803191|NCT01030692|Huperzine A|huperzine a|mesh-list
56803192|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56803193|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803194|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803195|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
56803196|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803197|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803198|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56803199|NCT01030692|Protective Agents|protective agents|mesh-ancestor
56803200|NCT03138252|Oxytocin|oxytocin|mesh-list
56803201|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
56803202|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56803204|NCT04994561|Niacinamide|niacinamide|mesh-list
56803214|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803215|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
56803216|NCT04994561|Protective Agents|protective agents|mesh-ancestor
56803217|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56803218|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
56803219|NCT04994561|Vitamins|vitamins|mesh-ancestor
56803220|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
56803221|NCT01030770|Ranibizumab|ranibizumab|mesh-list
56803222|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56803223|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56803224|NCT01030770|Growth Substances|growth substances|mesh-ancestor
56803225|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803226|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
56803227|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803228|NCT04941443|Ibuprofen|ibuprofen|mesh-list
56803229|NCT04941443|Methadone|methadone|mesh-list
56803230|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56803231|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56803232|NCT04941443|Analgesics|analgesics|mesh-ancestor
56803233|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
56803234|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803235|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803236|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56803237|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56803238|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56803239|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803240|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803241|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56803242|NCT04941443|Narcotics|narcotics|mesh-ancestor
56803243|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803244|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
56803259|NCT04198805|Tocopherols|tocopherols|mesh-list
56803260|NCT04198805|Tocotrienols|tocotrienols|mesh-list
56803261|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
56803262|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
56803263|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803264|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
56803265|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803266|NCT04198805|Protective Agents|protective agents|mesh-ancestor
56803267|NCT00536939|Paclitaxel|paclitaxel|mesh-list
56803268|NCT00536939|Bevacizumab|bevacizumab|mesh-list
56803269|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56803270|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803271|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
56803272|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
56803273|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
56803274|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803275|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56803276|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56803277|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56803278|NCT00536939|Growth Substances|growth substances|mesh-ancestor
56803279|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803280|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
56803282|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56803283|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803284|NCT04597697|Insulin|insulin|mesh-list
56803285|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803286|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803287|NCT00347919|Lapatinib|lapatinib|mesh-list
56803288|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803289|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56803290|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803292|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
56803302|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803303|NCT00356421|Insulin|insulin|mesh-list
56803304|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56803305|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
56803306|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803307|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803308|NCT03990129|Dipyrone|dipyrone|mesh-list
56803309|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56803310|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56803311|NCT03990129|Analgesics|analgesics|mesh-ancestor
56803312|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
56803313|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803314|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803315|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56803316|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56803317|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
56803318|NCT01051947|Metoprolol|metoprolol|mesh-list
56803319|NCT01051947|Nebivolol|nebivolol|mesh-list
56803320|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56803321|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56803322|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
56803323|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
56803324|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803325|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803326|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56803327|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56803328|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56803329|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
56803330|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803331|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803346|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803347|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803348|NCT00443820|Terbinafine|terbinafine|mesh-list
56803349|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
56803350|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803351|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803352|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803353|NCT00438672|Dexamethasone|dexamethasone|mesh-list
56803354|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56803355|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
56803356|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
56803357|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803358|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803359|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56803360|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
56803361|NCT00438672|Hormones|hormones|mesh-ancestor
56803362|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56803363|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56803364|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803365|NCT00438360|Cyclosporine|cyclosporine|mesh-list
56803366|NCT00438360|Cyclosporins|cyclosporins|mesh-list
56803367|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803368|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803369|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56803370|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
56803371|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803372|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
56803373|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803374|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
56803375|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56803376|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56803377|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56803378|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56803379|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56803380|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56803382|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803383|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803384|NCT00536471|Analgesics|analgesics|mesh-ancestor
56803385|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
56803386|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803387|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
56803388|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56803389|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
56803390|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56803391|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
56803392|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56803393|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56803394|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56803395|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
56803396|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56803397|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803398|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56803399|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56803400|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56803401|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56803402|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803403|NCT04002635|Letrozole|letrozole|mesh-list
56803404|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56803405|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56803406|NCT04002635|Estradiol|estradiol|mesh-list
56803407|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56803408|NCT04002635|Progesterone|progesterone|mesh-list
56803428|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803429|NCT01052181|Vitamins|vitamins|mesh-ancestor
56803430|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
56803431|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56803432|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
56803433|NCT01056237|Azathioprine|azathioprine|mesh-list
56803434|NCT01056237|Tacrolimus|tacrolimus|mesh-list
56803435|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56803436|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
56803437|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803438|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56803439|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803440|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803441|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56803442|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803443|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56803444|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
56803445|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56803446|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803447|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
56803448|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56803449|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56803450|NCT02533557|Lidocaine|lidocaine|mesh-list
56803451|NCT02533557|Epinephrine|epinephrine|mesh-list
56803452|NCT02533557|Racepinephrine|racepinephrine|mesh-list
56803453|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
56803454|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
56803455|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
56803476|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56803477|NCT00356265|Phenylephrine|phenylephrine|mesh-list
56803478|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
56803479|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56803480|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
56803481|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
56803482|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803483|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803484|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
56803485|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56803486|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
56803487|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
56803488|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56803489|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56803490|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56803491|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
56803492|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803493|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803494|NCT00356265|Protective Agents|protective agents|mesh-ancestor
56803495|NCT01052259|Gusperimus|gusperimus|mesh-list
56803496|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56803497|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803498|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803499|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803500|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56803501|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
56803502|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56803503|NCT01052259|Protective Agents|protective agents|mesh-ancestor
56803504|NCT01056549|Exenatide|exenatide|mesh-list
56803505|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803506|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803507|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56803508|NCT01056549|Incretins|incretins|mesh-ancestor
56803509|NCT01056549|Hormones|hormones|mesh-ancestor
56803510|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56803511|NCT01052337|Anesthetics|anesthetics|mesh-list
56075907|NCT04870866|Niacin|niacin|mesh-list
56075944|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075945|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56075946|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
56075947|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56075948|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56075949|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56075950|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56075951|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075952|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56075953|NCT05650476|Talazoparib|talazoparib|mesh-list
56075954|NCT05650476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56075958|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
56803514|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56803515|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56803516|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56803517|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803518|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803519|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56803520|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56803521|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56803522|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
56803523|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803524|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803552|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56803553|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
56803554|NCT01564355|Hormones|hormones|mesh-ancestor
56803555|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56803556|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803557|NCT01056705|Vaccines|vaccines|mesh-list
56803558|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
56803559|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803560|NCT00437268|Irinotecan|irinotecan|mesh-list
56803561|NCT00437268|Cetuximab|cetuximab|mesh-list
56803562|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56803563|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56803564|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803565|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56514460|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
56803566|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803567|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56803568|NCT04002089|Bupivacaine|bupivacaine|mesh-list
56803569|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
56803570|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
56803571|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803572|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803573|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
56803574|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803575|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56803576|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803577|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
56803578|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56803579|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56803580|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56803581|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56803582|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803583|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
56803584|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803590|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803591|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56803592|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56803593|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803594|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803595|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56803596|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56803597|NCT04139525|Heparin|heparin|mesh-list
56803598|NCT04139525|Calcium heparin|calcium heparin|mesh-list
56803599|NCT04139525|Citric Acid|citric acid|mesh-list
56803600|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
56803601|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
56803602|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56803603|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
56803604|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
56803605|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803606|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56803607|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56803608|NCT00437034|Aflibercept|aflibercept|mesh-list
56803609|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
56803610|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56803611|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56803612|NCT00437034|Growth Substances|growth substances|mesh-ancestor
56803613|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803614|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
56803615|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803616|NCT00337467|Ritonavir|ritonavir|mesh-list
56803617|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56803618|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56803623|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56803635|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803636|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56803637|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
56803638|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56803639|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803641|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803642|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56803643|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56803644|NCT00428220|Growth Substances|growth substances|mesh-ancestor
56803645|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803646|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
56803647|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56803648|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803649|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803650|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56803651|NCT01057329|Olanzapine|olanzapine|mesh-list
56803652|NCT01057329|Aripiprazole|aripiprazole|mesh-list
56803653|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56803654|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
56803655|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
56803656|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803657|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803658|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56803659|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56803660|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56803661|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803662|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56803663|NCT01057329|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56803664|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56803668|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
56803677|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56803678|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56803679|NCT01057329|Analgesics|analgesics|mesh-ancestor
56803680|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
56803681|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56803682|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
56803683|NCT01057407|Sevelamer|sevelamer|mesh-list
56803684|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
56803685|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
56803686|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803687|NCT01057563|Paclitaxel|paclitaxel|mesh-list
56803688|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56803689|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56803690|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803691|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
56803692|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
56803693|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
56803694|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803695|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
56803696|NCT02176967|Carboplatin|carboplatin|mesh-list
56803697|NCT02176967|Doxorubicin|doxorubicin|mesh-list
56803698|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56803699|NCT02176967|Etoposide|etoposide|mesh-list
56803700|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
56803701|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
56803702|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56803703|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
56803704|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803705|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56803706|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56803707|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
56803708|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803709|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803718|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
56803719|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
56803720|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
56803721|NCT00345579|PENTA|penta|mesh-list
56803722|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
56803723|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56803724|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56803725|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803726|NCT04002323|Lamivudine|lamivudine|mesh-list
56803727|NCT04002323|Dolutegravir|dolutegravir|mesh-list
56803728|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56803729|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56803730|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803731|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803732|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
56803733|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803734|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56803735|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56803736|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56803737|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56803738|NCT04001855|Acetic Acid|acetic acid|mesh-list
56803739|NCT04001855|Retinol acetate|retinol acetate|mesh-list
56803740|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56803741|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803742|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56803743|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
56803744|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803767|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
56803768|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56803769|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
56803770|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56803771|NCT03989817|Protective Agents|protective agents|mesh-ancestor
56803772|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803773|NCT01059123|Amoxicillin|amoxicillin|mesh-list
56803774|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56803775|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803776|NCT03986385|Capecitabine|capecitabine|mesh-list
56803777|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
56803778|NCT03986385|Apatinib|apatinib|mesh-list
56803779|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56803780|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
56803781|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803782|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803783|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56803784|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803785|NCT00344019|Atorvastatin|atorvastatin|mesh-list
56803786|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56803787|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56803788|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
56514690|NCT01601093|Sulbactam|sulbactam|mesh-list
56803789|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803790|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56803791|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56803792|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803793|NCT00535847|Interferons|interferons|mesh-list
56803794|NCT00535847|Ribavirin|ribavirin|mesh-list
56803795|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
56803796|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
56803797|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56803799|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
56803810|NCT03606785|Coagulants|coagulants|mesh-ancestor
56803811|NCT05356169|Venetoclax|venetoclax|mesh-list
56803812|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803813|NCT05072093|Tenofovir|tenofovir|mesh-list
56803814|NCT05072093|Emtricitabine|emtricitabine|mesh-list
56803815|NCT05072093|Cabotegravir|cabotegravir|mesh-list
56803816|NCT05072093|Doxycycline|doxycycline|mesh-list
56803817|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
56803818|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803819|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56803820|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56803821|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803822|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803823|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56803824|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56803825|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56803826|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
56803827|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56803868|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
56803869|NCT01060137|Fentanyl|fentanyl|mesh-list
56803870|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56803871|NCT01060137|Narcotics|narcotics|mesh-ancestor
56803872|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56803873|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803874|NCT01060137|Analgesics|analgesics|mesh-ancestor
56803875|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
56803876|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803877|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56803878|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56803879|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
56803880|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
56803881|NCT03989271|Quercetin|quercetin|mesh-list
56803882|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
56803883|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803884|NCT03989271|Protective Agents|protective agents|mesh-ancestor
56803885|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803886|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
56803887|NCT01058109|Calcium|calcium|mesh-list
56803888|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56803889|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803890|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56803891|NCT00992069|Efavirenz|efavirenz|mesh-list
56803892|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56803893|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56803894|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56803895|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803913|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
56803914|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
56803915|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803916|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
56803917|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803918|NCT01060293|Protective Agents|protective agents|mesh-ancestor
56803919|NCT05343767|Metformin|metformin|mesh-list
56803920|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56803921|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803922|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56803923|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56803924|NCT03989037|Carboplatin|carboplatin|mesh-list
56803925|NCT03989037|Docetaxel|docetaxel|mesh-list
56803926|NCT03989037|Trastuzumab|trastuzumab|mesh-list
56803927|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56803928|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
56803929|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
56803930|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
56803931|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803933|NCT00416598|Cytarabine|cytarabine|mesh-list
56803973|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
56803974|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803975|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803976|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56803977|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56803978|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
56803979|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56803980|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56803981|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
56803982|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56803983|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56803984|NCT00992381|Naproxen|naproxen|mesh-list
56803985|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56803986|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56803987|NCT00992381|Analgesics|analgesics|mesh-ancestor
56803988|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
56803989|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56803990|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56803991|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56803992|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56803993|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
56803997|NCT00992537|Insulin|insulin|mesh-list
56804025|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56804026|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804027|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56804028|NCT04001231|Incretins|incretins|mesh-ancestor
56804029|NCT04001231|Hormones|hormones|mesh-ancestor
56804030|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804031|NCT03892889|Aripiprazole|aripiprazole|mesh-list
56804032|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
56804033|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56804034|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56804035|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56804036|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56804037|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804038|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
56804039|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
56804040|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804041|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804042|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56804043|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56804044|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
56804079|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56804080|NCT01034124|Vitamin K|vitamin k|mesh-list
56804081|NCT01034124|Midazolam|midazolam|mesh-list
56804082|NCT01034124|Warfarin|warfarin|mesh-list
56804083|NCT01034124|Vitamins|vitamins|mesh-ancestor
56804084|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
56804085|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804086|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56804087|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56804088|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56804089|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56804090|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56804091|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56804092|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56804093|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
56804094|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
56804095|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
56804096|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
56804097|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804098|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804099|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
56804100|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56804101|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56804102|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
56804103|NCT01034124|Coagulants|coagulants|mesh-ancestor
56804104|NCT00339183|Panitumumab|panitumumab|mesh-list
56804105|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56804106|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804107|NCT01060605|Sirolimus|sirolimus|mesh-list
56804128|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804129|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56804130|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56804131|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56804132|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804133|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804134|NCT00995423|Paclitaxel|paclitaxel|mesh-list
56804135|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56804136|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804137|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
56804138|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
56804139|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
56804140|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804141|NCT00995657|Fluticasone|fluticasone|mesh-list
56804143|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56804144|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56804145|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
56804146|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804147|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804148|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56804149|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
56804150|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
56804151|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56804152|NCT00994097|Gemcitabine|gemcitabine|mesh-list
56804153|NCT00994097|Pemetrexed|pemetrexed|mesh-list
56804154|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804155|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56804175|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56804176|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56804178|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
56804179|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804180|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56804181|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56804182|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804183|NCT00338949|Olanzapine|olanzapine|mesh-list
56804184|NCT00338949|Risperidone|risperidone|mesh-list
56804185|NCT00338949|Ziprasidone|ziprasidone|mesh-list
56804186|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56804187|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
56804188|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804189|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804190|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804191|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56804192|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56804193|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56804194|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56804195|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56804196|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
56804197|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
56804198|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
56804199|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804200|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56804201|NCT00338949|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56804202|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56804203|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56804221|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
56804222|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804223|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
56804224|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804225|NCT03988725|Protective Agents|protective agents|mesh-ancestor
56804226|NCT00332241|Aripiprazole|aripiprazole|mesh-list
56804227|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
56804228|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56804229|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56804230|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56804231|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56804232|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804233|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
56804234|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
56804235|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804236|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804237|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56804238|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56515141|NCT00592917|Vitamin D|vitamin d|mesh-list
56804239|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
56804240|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56804241|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56804242|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56804243|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56804244|NCT01058577|Somatostatin|somatostatin|mesh-list
56804245|NCT01058577|Hormones|hormones|mesh-ancestor
56804247|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804268|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804269|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56804270|NCT03983889|Narcotics|narcotics|mesh-ancestor
56804271|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56804272|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56804273|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56804274|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56804275|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
56804276|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
56804277|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
56804278|NCT00337935|Hematinics|hematinics|mesh-ancestor
56804279|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
56804280|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
56804281|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56804282|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
56804283|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804284|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804285|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56804286|NCT00352755|Leucovorin|leucovorin|mesh-list
56804287|NCT00352755|Fluorouracil|fluorouracil|mesh-list
56804288|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
56804289|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
56804290|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804291|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56804292|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804293|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804294|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
56804317|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56804318|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
56804319|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
56804320|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804321|NCT00330681|Edaravone|edaravone|mesh-list
56804322|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56804323|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
56804324|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804325|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56804326|NCT00330681|Protective Agents|protective agents|mesh-ancestor
56804327|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804328|NCT00329901|Vaccines|vaccines|mesh-list
56804329|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
56804330|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804331|NCT00436956|Prednisone|prednisone|mesh-list
56804332|NCT00436956|Cediranib|cediranib|mesh-list
56804333|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56804334|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
56804335|NCT00436956|Hormones|hormones|mesh-ancestor
56804336|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804337|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804338|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56804339|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804340|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804341|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804342|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804343|NCT00436644|Topotecan|topotecan|mesh-list
56804344|NCT00436644|Lapatinib|lapatinib|mesh-list
56804345|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56804346|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56804347|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804351|NCT00324987|Bevacizumab|bevacizumab|mesh-list
56804361|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56804362|NCT00324987|Growth Substances|growth substances|mesh-ancestor
56804363|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804364|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
56804365|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
56804366|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804367|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804368|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804369|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
56804370|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56804371|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804372|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
56804373|NCT01055145|Levofloxacin|levofloxacin|mesh-list
56804374|NCT01055145|Ofloxacin|ofloxacin|mesh-list
56804375|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56804376|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804377|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56804378|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56804379|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804380|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804381|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804382|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56804383|NCT01055145|Renal Agents|renal agents|mesh-ancestor
56804384|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56804385|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56804386|NCT00436566|Paclitaxel|paclitaxel|mesh-list
56804387|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
56804388|NCT00436566|Doxorubicin|doxorubicin|mesh-list
56804389|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56804390|NCT00436566|Trastuzumab|trastuzumab|mesh-list
56804391|NCT00436566|Lapatinib|lapatinib|mesh-list
56804405|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56804406|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56804407|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56804408|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804409|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56804410|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804412|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56804413|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56804414|NCT01060683|Analgesics|analgesics|mesh-ancestor
56804415|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
56804416|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804417|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804418|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56804419|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56804420|NCT01055301|Thalidomide|thalidomide|mesh-list
56804421|NCT01055301|Dexamethasone|dexamethasone|mesh-list
56804422|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
56804423|NCT01055301|Melphalan|melphalan|mesh-list
56804424|NCT01055301|Doxorubicin|doxorubicin|mesh-list
56804425|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56804426|NCT01055301|Etoposide|etoposide|mesh-list
56804427|NCT01055301|Lenalidomide|lenalidomide|mesh-list
56804428|NCT01055301|Bortezomib|bortezomib|mesh-list
56804444|NCT01055301|Hormones|hormones|mesh-ancestor
56804459|NCT01055379|Rasagiline|rasagiline|mesh-list
56804460|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56804461|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804462|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804463|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56804464|NCT01055379|Protective Agents|protective agents|mesh-ancestor
56804465|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804466|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56804467|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56804468|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56804469|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
56804470|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804471|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56804472|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56804473|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804474|NCT00352365|Lenalidomide|lenalidomide|mesh-list
56804475|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
56804476|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804477|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56804478|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56804479|NCT00352365|Growth Substances|growth substances|mesh-ancestor
56804480|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
56804481|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804482|NCT01055535|Plasminogen|plasminogen|mesh-list
56804483|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56804484|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56804485|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804486|NCT03987867|Paclitaxel|paclitaxel|mesh-list
56804487|NCT03987867|Carboplatin|carboplatin|mesh-list
56804488|NCT03987867|Pemetrexed|pemetrexed|mesh-list
56804502|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56804503|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56804504|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
56804505|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804506|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804507|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804508|NCT00996515|Azacitidine|azacitidine|mesh-list
56804509|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56804510|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56804511|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
56804512|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804513|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804514|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804515|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804516|NCT00994799|Ranibizumab|ranibizumab|mesh-list
56804517|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56804518|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56804519|NCT00994799|Growth Substances|growth substances|mesh-ancestor
56804520|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804521|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
56804522|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804523|NCT00533507|Vaccines|vaccines|mesh-list
56804553|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804554|NCT00998933|Testosterone|testosterone|mesh-list
56804555|NCT00998933|Androgens|androgens|mesh-ancestor
56804556|NCT00998933|Hormones|hormones|mesh-ancestor
56804557|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804558|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804559|NCT00323115|Temozolomide|temozolomide|mesh-list
56804560|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56804561|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
56804562|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804563|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804564|NCT00322881|Paclitaxel|paclitaxel|mesh-list
56804565|NCT00322881|Carboplatin|carboplatin|mesh-list
56804566|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56804567|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804568|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
56804569|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
56804570|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
56804571|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804572|NCT00415194|Pemetrexed|pemetrexed|mesh-list
56804573|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804606|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56804607|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
56804608|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804609|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804610|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56804611|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
56804612|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804613|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
56804614|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56804615|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56804616|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804617|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56804618|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56804619|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804620|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804621|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804622|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56804623|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
56804624|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56804625|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804626|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56804627|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56804628|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56804629|NCT00998075|Esomeprazole|esomeprazole|mesh-list
56804630|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804631|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804632|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56804633|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56804634|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56804635|NCT00531947|Selegiline|selegiline|mesh-list
56804636|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
56804637|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56804638|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56804639|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56804642|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804643|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56804644|NCT00531947|Protective Agents|protective agents|mesh-ancestor
56804645|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804646|NCT01003847|Fenofibrate|fenofibrate|mesh-list
56804647|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56804648|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
56804649|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804650|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56804651|NCT00530855|Lacosamide|lacosamide|mesh-list
56804652|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
56804653|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56804654|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56804655|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56804656|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804657|NCT01004237|Valsartan|valsartan|mesh-list
56804658|NCT01004237|Pravastatin|pravastatin|mesh-list
56804659|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56804660|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56804661|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56804662|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804663|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56804664|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56804665|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
56804666|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56804677|NCT05239637|Heparin|heparin|mesh-list
56804689|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56804690|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56804692|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56804693|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56804694|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56804695|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56804696|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56804697|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
56804698|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804699|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804700|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804701|NCT01005641|Lapatinib|lapatinib|mesh-list
56804702|NCT01005641|Exemestane|exemestane|mesh-list
56804703|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804704|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804705|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804706|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804707|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56804708|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56804709|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56804710|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
56804711|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804712|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804713|NCT01005797|Sorafenib|sorafenib|mesh-list
56804714|NCT01005797|Panobinostat|panobinostat|mesh-list
56804715|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804716|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804717|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804718|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804719|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56804731|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804732|NCT01006187|Lidocaine|lidocaine|mesh-list
56804733|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
56804734|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
56804735|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56804736|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804737|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
56804738|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804739|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56804740|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56804741|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56804742|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56804743|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804744|NCT00530777|Valacyclovir|valacyclovir|mesh-list
56804745|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
56804746|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804747|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
56804748|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56804749|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804750|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804751|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56804752|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56804753|NCT01006499|Protective Agents|protective agents|mesh-ancestor
56804780|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804781|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804782|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56804783|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56804784|NCT00531479|Voriconazole|voriconazole|mesh-list
56804785|NCT00531479|Anidulafungin|anidulafungin|mesh-list
56804786|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
56804787|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804788|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56804789|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56804790|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804791|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804792|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56804793|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
56804794|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804795|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804796|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56804797|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
56804798|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56804799|NCT00999479|Norethindrone|norethindrone|mesh-list
56804800|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
56804801|NCT00999479|Estradiol|estradiol|mesh-list
56804802|NCT00999479|Estrogens|estrogens|mesh-ancestor
56804803|NCT00999479|Hormones|hormones|mesh-ancestor
56804804|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56804828|NCT00999791|Growth Substances|growth substances|mesh-ancestor
56804829|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804830|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
56804831|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56804832|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56804833|NCT00999791|Analgesics|analgesics|mesh-ancestor
56804834|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
56804835|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804836|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56804837|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56804838|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56804839|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804840|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804841|NCT00999869|Triamcinolone|triamcinolone|mesh-list
56804842|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56804843|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56804844|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
56804845|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56804846|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56804847|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56804848|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56804849|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56804850|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804851|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
56804852|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804853|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804854|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56804856|NCT00999869|Hormones|hormones|mesh-ancestor
56804874|NCT01008917|Sirolimus|sirolimus|mesh-list
56804875|NCT01008917|Sorafenib|sorafenib|mesh-list
56804876|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804877|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804878|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804879|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804880|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56804881|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804882|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56804883|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
56804884|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804885|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
56804886|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804887|NCT01009073|Irinotecan|irinotecan|mesh-list
56804888|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56804889|NCT01009073|Navitoclax|navitoclax|mesh-list
56804890|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56804891|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56804892|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804893|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804894|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804895|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804896|NCT00530075|Gusperimus|gusperimus|mesh-list
56804897|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56804923|NCT05733923|Eusol|eusol|mesh-list
56804926|NCT01002911|Cefazolin|cefazolin|mesh-list
56804927|NCT01002911|Cephalexin|cephalexin|mesh-list
56804928|NCT01002911|Bacitracin|bacitracin|mesh-list
56804929|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56804930|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804931|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56804932|NCT05059535|Acetaminophen|acetaminophen|mesh-list
56804933|NCT05059535|Analgesics|analgesics|mesh-list
56804934|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56804935|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
56804936|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804937|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804938|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
56804939|NCT00531011|Paclitaxel|paclitaxel|mesh-list
56804940|NCT00531011|Everolimus|everolimus|mesh-list
56804941|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56804942|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804943|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
56804944|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
56804945|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
56804946|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804947|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804948|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
56804949|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804950|NCT04000295|Paclitaxel|paclitaxel|mesh-list
56804951|NCT04000295|Etoposide|etoposide|mesh-list
56804952|NCT04000295|Apatinib|apatinib|mesh-list
56804953|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56804954|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804955|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
56804956|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
56804957|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
56804958|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804959|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56804960|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56804961|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804968|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
56804969|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56804970|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804971|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56804972|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56804973|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56804974|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56804975|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804976|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56804977|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56804978|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
56804979|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
56804980|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56804981|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56804982|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56804983|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
56804984|NCT01003613|Coagulants|coagulants|mesh-ancestor
56804985|NCT00471146|Gemcitabine|gemcitabine|mesh-list
56804986|NCT00471146|Axitinib|axitinib|mesh-list
56804987|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56804988|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
56804989|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56804990|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56804991|NCT00471146|Antiviral Agents|antiviral agents|mesh-ancestor
56804992|NCT00471146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56804993|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56804994|NCT00471146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56804995|NCT00471146|Immunologic Factors|immunologic factors|mesh-ancestor
56804996|NCT00471146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56804997|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56804998|NCT01021358|Ketoconazole|ketoconazole|mesh-list
56804999|NCT01021358|Navitoclax|navitoclax|mesh-list
56805000|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
56805001|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805002|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56805004|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805005|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805006|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56805007|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
56805008|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805009|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805010|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56805011|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805012|NCT00469898|Carboplatin|carboplatin|mesh-list
56805013|NCT00469898|Irinotecan|irinotecan|mesh-list
56805014|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805015|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56805016|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56805017|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805018|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805019|NCT01021436|Amikacin|amikacin|mesh-list
56805020|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56805021|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805022|NCT00529763|Dasatinib|dasatinib|mesh-list
56805023|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805024|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56805025|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805026|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805027|NCT00486902|Ketamine|ketamine|mesh-list
56805028|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
56805029|NCT00486902|Analgesics|analgesics|mesh-ancestor
56805030|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
56805031|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805032|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805033|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56805034|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56805035|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
56805036|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
56805037|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56805039|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56805042|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56805043|NCT05538767|Albendazole|albendazole|mesh-list
56805044|NCT05538767|Emodepside|emodepside|mesh-list
56805045|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
56805046|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56805047|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805048|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
56805049|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56805050|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56805051|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
56805052|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
56805053|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
56805054|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805055|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805056|NCT03687827|Insulin|insulin|mesh-list
56805057|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56805058|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
56805059|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56805060|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805061|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56805062|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56805063|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
56805064|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56515969|NCT00107120|Citalopram|citalopram|mesh-list
56805065|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805066|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56805067|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
56805068|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56805069|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56805088|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805089|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805090|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56805091|NCT05641259|Azacitidine|azacitidine|mesh-list
56805092|NCT05641259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56805093|NCT05641259|Antimetabolites|antimetabolites|mesh-ancestor
56805094|NCT05641259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805095|NCT05641259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805096|NCT05641259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805097|NCT05405387|Budesonide|budesonide|mesh-list
56805098|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805099|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56805100|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
56805101|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805102|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805103|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56805104|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
56805105|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
56805106|NCT05405387|Hormones|hormones|mesh-ancestor
56805107|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805108|NCT03999437|Terbinafine|terbinafine|mesh-list
56805109|NCT03999437|Butenafine|butenafine|mesh-list
56805110|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
56805111|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805112|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805113|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805114|NCT05638217|Listerine|listerine|mesh-list
56805115|NCT05638217|Fluorides|fluorides|mesh-list
56805116|NCT05638217|Sodium Fluoride|sodium fluoride|mesh-list
56805117|NCT05638217|Fluorides, Topical|fluorides, topical|mesh-list
56805118|NCT05638217|Cariostatic Agents|cariostatic agents|mesh-ancestor
56805119|NCT05638217|Protective Agents|protective agents|mesh-ancestor
56805120|NCT05638217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805121|NCT05638217|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56805128|NCT05637281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805129|NCT05637281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805130|NCT05637281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805131|NCT05637281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56805132|NCT05637281|Gout Suppressants|gout suppressants|mesh-ancestor
56805133|NCT05637281|Tocolytic Agents|tocolytic agents|mesh-ancestor
56805134|NCT05637281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56805135|NCT05637281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56805136|NCT05637281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805137|NCT05637281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805138|NCT00321711|Azacitidine|azacitidine|mesh-list
56805139|NCT00321711|Decitabine|decitabine|mesh-list
56805140|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56805141|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
56805142|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805143|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805144|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805145|NCT00486044|Simvastatin|simvastatin|mesh-list
56805146|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56805147|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56805148|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
56805149|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805150|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56805177|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805178|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56805179|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805180|NCT00463346|Acamprosate|acamprosate|mesh-list
56805181|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56805182|NCT01022528|Dexamethasone|dexamethasone|mesh-list
56805183|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
56805184|NCT01022528|BB 1101|bb 1101|mesh-list
56805185|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805186|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
56805187|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
56805188|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805189|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805190|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56805191|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
56805192|NCT01022528|Hormones|hormones|mesh-ancestor
56805193|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805194|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56805195|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805196|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
56805197|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805198|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805199|NCT01025102|Sufentanil|sufentanil|mesh-list
56805200|NCT01025102|Ropivacaine|ropivacaine|mesh-list
56805201|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56805202|NCT01025102|Narcotics|narcotics|mesh-ancestor
56805203|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56805204|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805205|NCT01025102|Analgesics|analgesics|mesh-ancestor
56805206|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
56805222|NCT01037712|Valacyclovir|valacyclovir|mesh-list
56805223|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
56805224|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805225|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56805226|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805227|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56805228|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805229|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805230|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
56805231|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56805232|NCT00461786|Pemetrexed|pemetrexed|mesh-list
56805233|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805234|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805235|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805236|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56805237|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56805238|NCT01021592|Bortezomib|bortezomib|mesh-list
56805239|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805240|NCT00435162|Valsartan|valsartan|mesh-list
56805241|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56805242|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56805243|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56805244|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805245|NCT03836664|Timolol|timolol|mesh-list
56805246|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56805247|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56805248|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56805249|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56805250|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
56805251|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805256|NCT00350727|Lapatinib|lapatinib|mesh-list
56805264|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805265|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56805266|NCT01032486|Protective Agents|protective agents|mesh-ancestor
56805267|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805268|NCT01061697|Pregabalin|pregabalin|mesh-list
56805269|NCT01061697|Analgesics|analgesics|mesh-ancestor
56805270|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
56805271|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805272|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805273|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
56805274|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56805275|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56805276|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805277|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56805278|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56805279|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56805280|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56805281|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56805282|NCT00434304|Ropinirole|ropinirole|mesh-list
56805283|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56805284|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56805285|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
56805286|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
56805287|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805288|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805289|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805290|NCT00424008|Fluticasone|fluticasone|mesh-list
56805291|NCT00424008|Xhance|xhance|mesh-list
56805292|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
56805293|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
56805294|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56805295|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56805296|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805303|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
56805304|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56805305|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56805306|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56805307|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56805308|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
56805309|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805310|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805311|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
56805312|NCT00424008|Hormones|hormones|mesh-ancestor
56805313|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805314|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
56805315|NCT00423930|Bevacizumab|bevacizumab|mesh-list
56805316|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56805317|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805318|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56805319|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56805320|NCT00423930|Growth Substances|growth substances|mesh-ancestor
56805321|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805322|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
56805323|NCT00423852|Paclitaxel|paclitaxel|mesh-list
56805324|NCT00423852|Carboplatin|carboplatin|mesh-list
56805325|NCT00423852|Ifosfamide|ifosfamide|mesh-list
56805326|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56805327|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805328|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
56805329|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
56805334|NCT00461708|Gemcitabine|gemcitabine|mesh-list
56805349|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56805350|NCT00327171|Growth Substances|growth substances|mesh-ancestor
56805351|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805352|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
56805353|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805354|NCT01038024|Antioxidants|antioxidants|mesh-list
56805355|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805356|NCT01038024|Protective Agents|protective agents|mesh-ancestor
56805357|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805358|NCT00461630|Niacin|niacin|mesh-list
56805359|NCT00461630|Simvastatin|simvastatin|mesh-list
56805360|NCT00461630|Ezetimibe|ezetimibe|mesh-list
56805361|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56805362|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56805363|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56805364|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
56805365|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805367|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56805368|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805369|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
56805370|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
56805371|NCT00461630|Vitamins|vitamins|mesh-ancestor
56805372|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
56805373|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805374|NCT01061853|Sirolimus|sirolimus|mesh-list
56805375|NCT01061853|Betamethasone|betamethasone|mesh-list
56805376|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56805377|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805378|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56805379|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805380|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
56805381|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56805382|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
56805383|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805384|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805385|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
56805386|NCT01061853|Hormones|hormones|mesh-ancestor
56110443|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
56805387|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805388|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56805389|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
56805390|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
56805391|NCT01325415|Naloxegol|naloxegol|mesh-list
56805392|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56805393|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805394|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56805395|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56805396|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805397|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805398|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805399|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805400|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56805401|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
56805402|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805403|NCT01022840|Ketamine|ketamine|mesh-list
56805404|NCT01022840|Esketamine|esketamine|mesh-list
56805405|NCT01022840|Analgesics|analgesics|mesh-ancestor
56805406|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
56805407|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805408|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805409|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56805410|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56805411|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
56805412|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
56805413|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56805414|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56805415|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56805416|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805417|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805428|NCT01025570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56805429|NCT01025570|Immunologic Factors|immunologic factors|mesh-ancestor
56805430|NCT01025570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805431|NCT03983876|Adalimumab|adalimumab|mesh-list
56805432|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805433|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56805434|NCT00327015|Metformin|metformin|mesh-list
56805435|NCT00327015|Pioglitazone|pioglitazone|mesh-list
56805436|NCT00327015|Saxagliptin|saxagliptin|mesh-list
56805437|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56805438|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516348|NCT01342211|Bococizumab|bococizumab|mesh-list
56805439|NCT00327015|Incretins|incretins|mesh-ancestor
56805440|NCT00327015|Hormones|hormones|mesh-ancestor
56805441|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805442|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56805443|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
56805444|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805445|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805446|NCT00434148|Pasireotide|pasireotide|mesh-list
56805447|NCT00434148|Hormones|hormones|mesh-ancestor
56805448|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805449|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805450|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
56805451|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56805452|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56805453|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56805454|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805455|NCT01063647|Treosulfan|treosulfan|mesh-list
56805456|NCT01063647|Busulfan|busulfan|mesh-list
56805457|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56805458|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
56805459|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805460|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805461|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56805467|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805468|NCT03982082|Coal Tar|coal tar|mesh-list
56805469|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
56805470|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
56805471|NCT00433914|Vaccines|vaccines|mesh-list
56805472|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
56805473|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805474|NCT00321555|Immunotoxins|immunotoxins|mesh-list
56805475|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
56805476|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805477|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
56805478|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805479|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
56805480|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56805481|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56805482|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805483|NCT00468650|Urological Agents|urological agents|mesh-ancestor
56805484|NCT00423150|Temozolomide|temozolomide|mesh-list
56805485|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56805486|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
56805487|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805488|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805489|NCT00433836|Valsartan|valsartan|mesh-list
56805490|NCT00433836|Enalapril|enalapril|mesh-list
56805491|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56805492|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56805493|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56805494|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805495|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56805496|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
56805497|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805498|NCT01022918|Bevacizumab|bevacizumab|mesh-list
56805499|NCT01022918|Temozolomide|temozolomide|mesh-list
56805507|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56805508|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
56805509|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805510|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
56805511|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56805512|NCT00433446|Siltuximab|siltuximab|mesh-list
56805513|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805514|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56805515|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56805516|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56805517|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805518|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
56805519|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
56805520|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56805521|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
56805522|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805523|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56805524|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56805525|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56805526|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56805527|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56805528|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56805529|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805530|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805531|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805532|NCT00433290|Analgesics|analgesics|mesh-ancestor
56805533|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
56805534|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805536|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56805550|NCT00467558|Naltrexone|naltrexone|mesh-list
56805551|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56805552|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56805553|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805554|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
56805555|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805556|NCT00422292|Vaccines|vaccines|mesh-list
56805557|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
56805558|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805559|NCT00452348|Fluticasone|fluticasone|mesh-list
56805560|NCT00452348|Xhance|xhance|mesh-list
56805561|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56805562|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56805563|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805564|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56805565|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
56805566|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805567|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805568|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56805569|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
56805570|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
56805571|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56805572|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56805573|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56805574|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56805575|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
56805576|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805598|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805599|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
56805600|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56805601|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
56805602|NCT00320541|Antiviral Agents|antiviral agents|mesh-ancestor
56805603|NCT00320541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805604|NCT00320541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805605|NCT00320541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56805606|NCT00320541|Immunologic Factors|immunologic factors|mesh-ancestor
56805607|NCT00320385|Trastuzumab|trastuzumab|mesh-list
56805608|NCT00320385|Lapatinib|lapatinib|mesh-list
56805609|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56805610|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805611|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56805612|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805613|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805614|NCT00309777|Simvastatin|simvastatin|mesh-list
56805615|NCT00309777|Pitavastatin|pitavastatin|mesh-list
56805616|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56805617|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56805618|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
56805619|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805620|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56805621|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56805622|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805623|NCT00325143|Edetic Acid|edetic acid|mesh-list
56805624|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
56805625|NCT00325143|Antidotes|antidotes|mesh-ancestor
56805626|NCT00325143|Protective Agents|protective agents|mesh-ancestor
56805627|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805628|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
56805629|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
56805631|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56805641|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
56805642|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805643|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56805644|NCT01062087|Lidocaine|lidocaine|mesh-list
56805645|NCT01062087|Bupivacaine|bupivacaine|mesh-list
56805646|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
56805647|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
56805648|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56805649|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805650|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
56805651|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805652|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56805653|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56805654|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56805655|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56805656|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805657|NCT00319449|Atorvastatin|atorvastatin|mesh-list
56805658|NCT00319449|Ezetimibe|ezetimibe|mesh-list
56805659|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56805660|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56805661|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
56805662|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805663|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56805664|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56805665|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805666|NCT00308685|Albuterol|albuterol|mesh-list
56805667|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56805668|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
56805669|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805670|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805671|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56805672|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
56805673|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
56805680|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805681|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56805682|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805683|NCT03981081|Prednisone|prednisone|mesh-list
56805684|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805685|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
56805686|NCT03981081|Hormones|hormones|mesh-ancestor
56805687|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805688|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805689|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56805690|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805691|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
56805692|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805693|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
56805694|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56805695|NCT00316719|Lamivudine|lamivudine|mesh-list
56805696|NCT00316719|Adefovir|adefovir|mesh-list
56805697|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56805698|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56805699|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56805700|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805701|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805702|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
56805703|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805704|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56805705|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56805706|NCT01065987|Tizanidine|tizanidine|mesh-list
56805707|NCT01065987|Analgesics|analgesics|mesh-ancestor
56805708|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
56805709|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805724|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56805725|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56805726|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
56805727|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
56805728|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805729|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805730|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805731|NCT00422058|Liraglutide|liraglutide|mesh-list
56805732|NCT00422058|Orlistat|orlistat|mesh-list
56805733|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56805734|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805735|NCT00422058|Incretins|incretins|mesh-ancestor
56805736|NCT00422058|Hormones|hormones|mesh-ancestor
56516634|NCT04309357|Plasminogen|plasminogen|mesh-list
56805737|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805738|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805739|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805740|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56805741|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56805742|NCT01032798|Mepivacaine|mepivacaine|mesh-list
56805743|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
56805744|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
56805745|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56805746|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805747|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
56805748|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56805749|NCT00413244|Testosterone|testosterone|mesh-list
56805750|NCT00413244|Androgens|androgens|mesh-ancestor
56805751|NCT00413244|Hormones|hormones|mesh-ancestor
56805752|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805753|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805754|NCT01033032|Amrubicin|amrubicin|mesh-list
56805765|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56805766|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56805767|NCT00420342|Estradiol|estradiol|mesh-list
56805768|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56805769|NCT00420342|Estrogens|estrogens|mesh-ancestor
56805770|NCT00420342|Hormones|hormones|mesh-ancestor
56805771|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805772|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805773|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56805774|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
56805775|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56805776|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56805777|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56805778|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56805779|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56805780|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56805781|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56805782|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805783|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56805784|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
56805785|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56805786|NCT00420342|Diuretics|diuretics|mesh-ancestor
56805787|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
56805788|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56805789|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56805790|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805791|NCT01038648|Incretins|incretins|mesh-ancestor
56805792|NCT01038648|Hormones|hormones|mesh-ancestor
56805793|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805794|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56805795|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
56805796|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805804|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805805|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
56805806|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805807|NCT00451958|Leuprolide|leuprolide|mesh-list
56805808|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56805809|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
56805810|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56805811|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805812|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56805813|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805815|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56805816|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
56805817|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805818|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805819|NCT01025882|Antiviral Agents|antiviral agents|mesh-ancestor
56805820|NCT01025882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805821|NCT01025882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805822|NCT01025882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56805823|NCT01025882|Immunologic Factors|immunologic factors|mesh-ancestor
56805824|NCT01025882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805825|NCT01026116|Paclitaxel|paclitaxel|mesh-list
56805826|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
56805827|NCT01026116|Epirubicin|epirubicin|mesh-list
56805828|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56805829|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805830|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
56805831|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
56805832|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
56805833|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805834|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56805835|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
56805836|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805845|NCT00432276|Metformin|metformin|mesh-list
56805846|NCT00432276|Pioglitazone|pioglitazone|mesh-list
56805847|NCT00432276|Alogliptin|alogliptin|mesh-list
56805848|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56805849|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805850|NCT00432276|Incretins|incretins|mesh-ancestor
56805851|NCT00432276|Hormones|hormones|mesh-ancestor
56805852|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805853|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56805854|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
56805855|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805856|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805857|NCT01027520|Monensin|monensin|mesh-list
56805858|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
56805859|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56805860|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56805861|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56805862|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
56805863|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
56805864|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
56805865|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805866|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805867|NCT01027520|Ionophores|ionophores|mesh-ancestor
56805899|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805900|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56805901|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56805902|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56805903|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
56805904|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56805905|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56805906|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
56805907|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805908|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
56805909|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56805910|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56805911|NCT00443534|Sunitinib|sunitinib|mesh-list
56805912|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56805913|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56805914|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56805915|NCT00443534|Growth Substances|growth substances|mesh-ancestor
56805916|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805917|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
56805918|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56805919|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805920|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805921|NCT00419952|Budesonide|budesonide|mesh-list
56805922|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
56805924|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56805944|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805945|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56805946|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805947|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
56805948|NCT00419562|Insulin|insulin|mesh-list
56805949|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56805950|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805951|NCT03557294|Varenicline|varenicline|mesh-list
56805952|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56805953|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56805954|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
56805955|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805956|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805957|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805958|NCT01026350|Antibodies|antibodies|mesh-list
56805959|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
56805960|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805962|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56805963|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56805964|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
56805965|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805966|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805967|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805968|NCT00308139|Exenatide|exenatide|mesh-list
56805969|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56805970|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805971|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56805972|NCT00308139|Incretins|incretins|mesh-ancestor
56805973|NCT00308139|Hormones|hormones|mesh-ancestor
56805974|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56805975|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56805976|NCT00459056|Carvedilol|carvedilol|mesh-list
56805977|NCT00459056|Lisinopril|lisinopril|mesh-list
56805978|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56805979|NCT00459056|Diuretics|diuretics|mesh-ancestor
56805980|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
56805981|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56805982|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56805983|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56805984|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56805985|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56805986|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56805987|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
56805988|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56805989|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
56805990|NCT00459056|Protective Agents|protective agents|mesh-ancestor
56805991|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56805992|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56805993|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
56805994|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56805995|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56805996|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56805997|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
56805998|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56805999|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56806000|NCT01062477|Vaccines|vaccines|mesh-list
56806001|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
56806002|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806003|NCT01323374|Carbidopa|carbidopa|mesh-list
56806004|NCT01323374|Droxidopa|droxidopa|mesh-list
56806005|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56806006|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56806007|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
56806008|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806009|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806010|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806011|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56806012|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806013|NCT00431964|Azithromycin|azithromycin|mesh-list
56806014|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56806021|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806022|NCT00316173|Carboplatin|carboplatin|mesh-list
56806023|NCT00316173|Topotecan|topotecan|mesh-list
56806024|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806025|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56806026|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56806027|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806028|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806029|NCT00412542|Thalidomide|thalidomide|mesh-list
56806030|NCT00412542|Irinotecan|irinotecan|mesh-list
56806031|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56806032|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56806033|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516949|NCT00596804|Veltuzumab|veltuzumab|mesh-list
56806034|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806035|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806036|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806037|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
56806038|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806039|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
56806040|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56806041|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806042|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56806043|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56806044|NCT00412542|Growth Substances|growth substances|mesh-ancestor
56806045|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
56806046|NCT00316017|Dextrans|dextrans|mesh-list
56806047|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
56806048|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
56806049|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
56806050|NCT00451178|Prednisone|prednisone|mesh-list
56806051|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
56806052|NCT00451178|Rituximab|rituximab|mesh-list
56806053|NCT00451178|Doxorubicin|doxorubicin|mesh-list
56806054|NCT00451178|Vincristine|vincristine|mesh-list
56806062|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806063|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56806064|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56806065|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56806066|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56806067|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56806068|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806069|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56806070|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
56806071|NCT00451178|Hormones|hormones|mesh-ancestor
56806072|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806073|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56806074|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56806075|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
56806076|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
56806077|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
56806078|NCT00450866|Epothilones|epothilones|mesh-list
56806079|NCT00450866|Epothilone B|epothilone b|mesh-list
56806080|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
56806081|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
56806082|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
56806083|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806084|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806085|NCT01026584|Aripiprazole|aripiprazole|mesh-list
56806086|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
56806087|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56806088|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56806089|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56806090|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56806091|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806105|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56806106|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
56806107|NCT01023542|Everolimus|everolimus|mesh-list
56806108|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806109|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806110|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
56806111|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806112|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
56806113|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56806114|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56806115|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806116|NCT01028534|Olmesartan|olmesartan|mesh-list
56806117|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56806118|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
56806119|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
56806120|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56806121|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56806122|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806123|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56806124|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56806125|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806126|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56806127|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56806128|NCT00441974|Adefovir|adefovir|mesh-list
56806129|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56806130|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
56806131|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806132|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56806151|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
56806152|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806153|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
56806154|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56806155|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56806156|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806157|NCT00430716|Urological Agents|urological agents|mesh-ancestor
56806158|NCT01028768|Teduglutide|teduglutide|mesh-list
56806159|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56806160|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56806161|NCT01028768|Protective Agents|protective agents|mesh-ancestor
56806162|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806163|NCT00441272|Pioglitazone|pioglitazone|mesh-list
56806164|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56806165|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806166|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56806167|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
56806168|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806169|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56806170|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56806171|NCT01028924|Teduglutide|teduglutide|mesh-list
56806172|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56806173|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56806174|NCT01028924|Protective Agents|protective agents|mesh-ancestor
56806175|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806176|NCT01029002|Vitamin D|vitamin d|mesh-list
56806177|NCT01029002|Vitamins|vitamins|mesh-ancestor
56806178|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
56806179|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806198|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56806199|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806200|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806201|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56806202|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
56806203|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806204|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806205|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56806206|NCT01038882|Midazolam|midazolam|mesh-list
56806207|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56806208|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56806209|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56806210|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806211|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56806212|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56806213|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56806214|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56806215|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
56806216|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
56806217|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
56806218|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
56806219|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806220|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806221|NCT00449930|Metformin|metformin|mesh-list
56806222|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56806223|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56806224|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806225|NCT00449930|Incretins|incretins|mesh-ancestor
56806226|NCT00449930|Hormones|hormones|mesh-ancestor
56806227|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806228|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56806229|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
56806238|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806239|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806240|NCT01024322|Diclofenac|diclofenac|mesh-list
56806241|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
56806242|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56806243|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
56806244|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56806245|NCT01024322|Prednisolone|prednisolone|mesh-list
56806246|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56806247|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
56806248|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56806249|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56806250|NCT01024322|Analgesics|analgesics|mesh-ancestor
56806251|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
56806252|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806253|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806254|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56806255|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806256|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56806257|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806258|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806259|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
56806260|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
56806261|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56806262|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
56806263|NCT01024322|Hormones|hormones|mesh-ancestor
56806264|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806272|NCT01566266|Amoxicillin|amoxicillin|mesh-list
56806284|NCT00430248|Protective Agents|protective agents|mesh-ancestor
56806285|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806286|NCT00411762|Capecitabine|capecitabine|mesh-list
56806287|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56806288|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
56806289|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806290|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806291|NCT00429858|Gemcitabine|gemcitabine|mesh-list
56806292|NCT00429858|Tegafur|tegafur|mesh-list
56806293|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56806294|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
56806295|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806296|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806297|NCT00429858|Antiviral Agents|antiviral agents|mesh-ancestor
56806298|NCT00429858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806299|NCT00429858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806300|NCT00429858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806301|NCT00429858|Immunologic Factors|immunologic factors|mesh-ancestor
56806302|NCT00429858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806303|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
56806304|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56806305|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
56806306|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806307|NCT00449150|Cetrorelix|cetrorelix|mesh-list
56806308|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56806309|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
56806310|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56806311|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806312|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
56806314|NCT00428844|Vancomycin|vancomycin|mesh-list
56806329|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
56806330|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806331|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806332|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56806333|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
56806334|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806335|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
56517256|NCT02891967|Z 350|z 350|mesh-list
56806336|NCT00449072|Loratadine|loratadine|mesh-list
56806337|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
56806338|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
56806339|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56806340|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56806341|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56806342|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
56806343|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
56806344|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806345|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806346|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806347|NCT00419094|Levetiracetam|levetiracetam|mesh-list
56806348|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
56806349|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
56806350|NCT00448916|Pregabalin|pregabalin|mesh-list
56806351|NCT00448916|Analgesics|analgesics|mesh-ancestor
56806352|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
56806353|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806354|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806355|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
56806356|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56806357|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56806358|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806359|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56806372|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56806373|NCT00418938|Growth Substances|growth substances|mesh-ancestor
56806374|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806375|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
56806376|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
56806377|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806378|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56806379|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806380|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
56806381|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56806382|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56806383|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806384|NCT00418938|Antidotes|antidotes|mesh-ancestor
56806385|NCT00418938|Protective Agents|protective agents|mesh-ancestor
56806386|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
56806387|NCT00418938|Vitamins|vitamins|mesh-ancestor
56806388|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
56806389|NCT00448760|Leucovorin|leucovorin|mesh-list
56806390|NCT00448760|Docetaxel|docetaxel|mesh-list
56806391|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
56806392|NCT00448760|Floxuridine|floxuridine|mesh-list
56806393|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806394|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
56806395|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
56806396|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
56806397|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806398|NCT00448760|Antidotes|antidotes|mesh-ancestor
56806399|NCT00448760|Protective Agents|protective agents|mesh-ancestor
56806400|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806401|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
56806402|NCT00448760|Vitamins|vitamins|mesh-ancestor
56806403|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
56806404|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56806405|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
56806406|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
56806407|NCT01039350|Hematinics|hematinics|mesh-ancestor
56806414|NCT01033500|Abatacept|abatacept|mesh-list
56806415|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56806416|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806417|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806418|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806419|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
56806420|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806421|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806422|NCT01035450|Sirolimus|sirolimus|mesh-list
56806423|NCT01035450|Everolimus|everolimus|mesh-list
56806424|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806425|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806426|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
56806427|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806428|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56806429|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806430|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56806431|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
56806432|NCT01035528|Metformin|metformin|mesh-list
56806433|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
56806434|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56806435|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806436|NCT01033656|Methotrexate|methotrexate|mesh-list
56806437|NCT01033656|Azathioprine|azathioprine|mesh-list
56806438|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56806439|NCT01033656|Leflunomide|leflunomide|mesh-list
56806440|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56806441|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
56806442|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56806443|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806444|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56806458|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56806459|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
56806460|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
56806461|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806462|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806463|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806464|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56806465|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56806466|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56806467|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56806468|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56806469|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56806470|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56806471|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56806472|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56806473|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
56806474|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56806475|NCT00448136|Bevacizumab|bevacizumab|mesh-list
56806476|NCT00448136|Streptozocin|streptozocin|mesh-list
56806477|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56806478|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806479|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56806480|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56806481|NCT00448136|Growth Substances|growth substances|mesh-ancestor
56806482|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806483|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
56806484|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56806485|NCT00447902|Ritonavir|ritonavir|mesh-list
56806486|NCT00447902|Tipranavir|tipranavir|mesh-list
56806487|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56806488|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56806500|NCT00440726|Cytarabine|cytarabine|mesh-list
56806501|NCT00440726|Dexamethasone|dexamethasone|mesh-list
56806502|NCT00440726|Doxorubicin|doxorubicin|mesh-list
56806503|NCT00440726|Methotrexate|methotrexate|mesh-list
56806504|NCT00440726|Vincristine|vincristine|mesh-list
56806505|NCT00440726|Bortezomib|bortezomib|mesh-list
56806506|NCT00440726|Asparaginase|asparaginase|mesh-list
56806507|NCT00440726|Pegaspargase|pegaspargase|mesh-list
56806508|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56806509|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
56806510|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
56806511|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806512|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806513|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56806514|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
56806515|NCT00440726|Hormones|hormones|mesh-ancestor
56806516|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806517|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56806518|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806519|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56806520|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56806521|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56806522|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806523|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806524|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56806525|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
56806526|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56806527|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56806528|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
56806529|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
56806530|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56806531|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806535|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
56806544|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
56806545|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806546|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806547|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806548|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56806549|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56806550|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
56806551|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
56806552|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806553|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56806554|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
56806555|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
56806556|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806557|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806558|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56806559|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56806560|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56806561|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56806562|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806563|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
56806564|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806565|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806567|NCT01030094|Carbamazepine|carbamazepine|mesh-list
56806568|NCT01030094|Valproic Acid|valproic acid|mesh-list
56806569|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
56806570|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56806571|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806572|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806573|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806574|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
56806575|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806576|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
56806577|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56806583|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806584|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56806585|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56806586|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56806587|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56806588|NCT01565798|Copper|copper|mesh-list
56806589|NCT01565798|Trace Elements|trace elements|mesh-ancestor
56806590|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
56806591|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806592|NCT01030328|Fenofibrate|fenofibrate|mesh-list
56806593|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56806594|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
56806595|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806596|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56806597|NCT03168464|Nivolumab|nivolumab|mesh-list
56806598|NCT03168464|Ipilimumab|ipilimumab|mesh-list
56806599|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56806600|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806601|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56806602|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806603|NCT00405756|Aspirin|aspirin|mesh-list
56806604|NCT00405756|Prednisone|prednisone|mesh-list
56806605|NCT00405756|Lenalidomide|lenalidomide|mesh-list
56806606|NCT00405756|Melphalan|melphalan|mesh-list
56806607|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56806608|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
56806609|NCT00405756|Hormones|hormones|mesh-ancestor
56806610|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806611|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806612|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56806613|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806614|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56806625|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806626|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
56806627|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
56806628|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56806629|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56806630|NCT00405756|Growth Substances|growth substances|mesh-ancestor
56806631|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
56806632|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56806633|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
56806634|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56806635|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806636|NCT00456092|Apremilast|apremilast|mesh-list
56806637|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56806638|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56806639|NCT00456092|Analgesics|analgesics|mesh-ancestor
56517547|NCT01317615|Paclitaxel|paclitaxel|mesh-list
56806640|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
56806641|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806642|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806643|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56806644|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806645|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56806646|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56806647|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806648|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806649|NCT01030640|Tanezumab|tanezumab|mesh-list
56806650|NCT01030640|Analgesics|analgesics|mesh-ancestor
56806651|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
56806652|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806653|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806654|NCT00411450|Panitumumab|panitumumab|mesh-list
56806655|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56806656|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806657|NCT00404820|Vitamin D|vitamin d|mesh-list
56806658|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
56806659|NCT00404820|Alendronate|alendronate|mesh-list
56806660|NCT00404820|Calcium|calcium|mesh-list
56806661|NCT00404820|Vitamins|vitamins|mesh-ancestor
56806663|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806664|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56806665|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56806666|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
56806667|NCT00446030|Bevacizumab|bevacizumab|mesh-list
56806668|NCT00446030|Carboplatin|carboplatin|mesh-list
56806669|NCT00446030|Docetaxel|docetaxel|mesh-list
56806670|NCT00446030|Doxorubicin|doxorubicin|mesh-list
56806671|NCT00446030|Trastuzumab|trastuzumab|mesh-list
56806672|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806673|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
56806674|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806675|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806676|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56806677|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
56806678|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806679|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806680|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56806681|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56806682|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56806683|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56806684|NCT00446030|Growth Substances|growth substances|mesh-ancestor
56806685|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
56806686|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
56806687|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
56806688|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
56806689|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56806690|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56806691|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56806692|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806693|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
56806694|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56806695|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806696|NCT00410514|Mirabegron|mirabegron|mesh-list
56806697|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56806698|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56806701|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806702|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806703|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806704|NCT00410514|Urological Agents|urological agents|mesh-ancestor
56806705|NCT03847610|Penicillins|penicillins|mesh-list
56806706|NCT03847610|Penicillin V|penicillin v|mesh-list
56806707|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56806708|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806709|NCT01036854|Ondansetron|ondansetron|mesh-list
56806710|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
56806711|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
56806712|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806713|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806714|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56806715|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
56517617|NCT01321008|Prednisone|prednisone|mesh-list
56806716|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
56806717|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56806718|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
56806719|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806720|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806721|NCT01036854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56806722|NCT01036854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56806723|NCT01036854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56806724|NCT01036854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56806725|NCT01036854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56806727|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56806728|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806729|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56806730|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806731|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806732|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56806733|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56806734|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
56806735|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56806736|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
56806738|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806739|NCT00439556|Cytarabine|cytarabine|mesh-list
56806740|NCT00439556|Rituximab|rituximab|mesh-list
56806741|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56806742|NCT00439556|Methotrexate|methotrexate|mesh-list
56806743|NCT00439556|Etoposide|etoposide|mesh-list
56806744|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
56806745|NCT00439556|Bortezomib|bortezomib|mesh-list
56806746|NCT00439556|Melphalan|melphalan|mesh-list
56806747|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
56806748|NCT00439556|Carmustine|carmustine|mesh-list
56806749|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
56806750|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56806751|NCT00439556|Antibodies|antibodies|mesh-list
56806752|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
56806753|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56806754|NCT00439556|Tacrolimus|tacrolimus|mesh-list
56806755|NCT00439556|Lenograstim|lenograstim|mesh-list
56806756|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
56806757|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56806758|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
56806759|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806760|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806761|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806762|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56806763|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
56806764|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56806765|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56806766|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
56806767|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806768|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56806769|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806770|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56806771|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806772|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56806773|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56806774|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56806776|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
56806779|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56806780|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56806781|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
56806782|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56806783|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
56806784|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56806785|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56806786|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56806787|NCT00410202|Tenofovir|tenofovir|mesh-list
56806788|NCT00410202|Lamivudine|lamivudine|mesh-list
56806789|NCT00410202|Entecavir|entecavir|mesh-list
56806790|NCT00410202|Adefovir|adefovir|mesh-list
56806791|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
56806792|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806793|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56806794|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56806795|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806796|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806797|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56806798|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56806800|NCT03011684|Letrozole|letrozole|mesh-list
56806801|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806802|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56806803|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56806804|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806805|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806806|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56806807|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
56806808|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806809|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806810|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56806811|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56806812|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56806821|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806822|NCT00445328|Heparin|heparin|mesh-list
56806823|NCT00445328|Calcium heparin|calcium heparin|mesh-list
56806824|NCT00445328|Dalteparin|dalteparin|mesh-list
56806825|NCT00445328|Tinzaparin|tinzaparin|mesh-list
56806826|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56806827|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
56806828|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56806829|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56806830|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806831|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
56806832|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
56806833|NCT00455312|Fludarabine|fludarabine|mesh-list
56806834|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
56806835|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
56806836|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56806837|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56806838|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
56806839|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806840|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56806841|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56806842|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
56806843|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806844|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806845|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56806846|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56806847|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
56806848|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
56806849|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806850|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56806851|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
56806852|NCT00455312|Hormones|hormones|mesh-ancestor
56806853|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806854|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56806860|NCT01031030|Epirubicin|epirubicin|mesh-list
56806863|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806864|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56517758|NCT01170364|Sibutramine|sibutramine|mesh-list
56806865|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56806866|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
56806867|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806868|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806869|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56806870|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
56806871|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56806872|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56806873|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
56806874|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56806875|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
56806876|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806877|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56806878|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56806879|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56806880|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56806881|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56806883|NCT01024712|Carboplatin|carboplatin|mesh-list
56806884|NCT01024712|Gefitinib|gefitinib|mesh-list
56806885|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56806886|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806887|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
56806888|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
56806889|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
56806890|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806891|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56806892|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806893|NCT01323452|Entecavir|entecavir|mesh-list
56806894|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
56806895|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806904|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
56806905|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806906|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56806907|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56806908|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56806909|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56806910|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806911|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56806912|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
56806913|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
56806914|NCT00444626|Protective Agents|protective agents|mesh-ancestor
56806915|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56806916|NCT01024868|Ropivacaine|ropivacaine|mesh-list
56806917|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
56806918|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
56806919|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56806920|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806921|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
56806922|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56806923|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
56806924|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56806925|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
56806926|NCT03795194|Ampicillin|ampicillin|mesh-list
56806927|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56806928|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806929|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806930|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56806931|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56806932|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
56806933|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56806934|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
56806935|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806944|NCT04844762|Menthol|menthol|mesh-list
56806945|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
56806946|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
56806947|NCT01323218|Vitamin D|vitamin d|mesh-list
56806948|NCT01323218|Vitamins|vitamins|mesh-ancestor
56806949|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
56806950|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806951|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56806952|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56806953|NCT01323296|Hematinics|hematinics|mesh-ancestor
56806954|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56806955|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56806956|NCT00438464|Finasteride|finasteride|mesh-list
56806957|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56806958|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56806959|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806960|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806961|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
56806962|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56806963|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56806964|NCT00438464|Urological Agents|urological agents|mesh-ancestor
56806965|NCT00437294|Capecitabine|capecitabine|mesh-list
56806966|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56806967|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
56806968|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806969|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56806970|NCT01033760|Ritonavir|ritonavir|mesh-list
56806971|NCT01033760|Darunavir|darunavir|mesh-list
56806972|NCT01033760|Tenofovir|tenofovir|mesh-list
56806973|NCT01033760|Emtricitabine|emtricitabine|mesh-list
56806974|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
56806989|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56806990|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56806991|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56806992|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56806993|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56806994|NCT01031732|Tacrine|tacrine|mesh-list
56806995|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56806996|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56806997|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56806998|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
56806999|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807000|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807001|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56807002|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
56807003|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807004|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
56807005|NCT01033994|Mitogens|mitogens|mesh-list
56807006|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
56807007|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807008|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56807009|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56807010|NCT00436826|Interferons|interferons|mesh-list
56807011|NCT00436826|Interferon-beta|interferon-beta|mesh-list
56807012|NCT00436826|Cladribine|cladribine|mesh-list
56807013|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
56807014|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807015|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
56807016|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807017|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
56807018|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807019|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807020|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56807022|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807026|NCT01036932|Lenograstim|lenograstim|mesh-list
56807032|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56807033|NCT00410046|Analgesics|analgesics|mesh-ancestor
56807034|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
56807035|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807036|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807037|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56807038|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807039|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56807040|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807041|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
56807042|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
56807043|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
56807044|NCT00416624|Hematinics|hematinics|mesh-ancestor
56807045|NCT02501954|Paclitaxel|paclitaxel|mesh-list
56807046|NCT02501954|Carboplatin|carboplatin|mesh-list
56807047|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56807048|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807049|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
56807050|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
56807051|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
56807052|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807053|NCT00262600|Warfarin|warfarin|mesh-list
56807054|NCT00262600|Dabigatran|dabigatran|mesh-list
56807055|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
56807056|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
56807057|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56807058|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
56807059|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807060|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807061|NCT00409578|Valsartan|valsartan|mesh-list
56807079|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56807080|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
56807081|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807082|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807083|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807084|NCT00262522|Ritonavir|ritonavir|mesh-list
56807085|NCT00262522|Lopinavir|lopinavir|mesh-list
56807086|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56807087|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56807088|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56807089|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
56807090|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807091|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807092|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56807093|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56807094|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
56807095|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807096|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56807097|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56807098|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56807099|NCT00436280|Gemcitabine|gemcitabine|mesh-list
56807100|NCT00436280|Rituximab|rituximab|mesh-list
56807101|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
56807102|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807103|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807104|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
56807105|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807106|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807107|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56807108|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
56807123|NCT01039974|Ketoconazole|ketoconazole|mesh-list
56807124|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
56807125|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807126|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56807127|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56807128|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807129|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807130|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56807131|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
56807132|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807133|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807134|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56807135|NCT01032122|Rituximab|rituximab|mesh-list
56807136|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807137|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807138|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
56807139|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807140|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807141|NCT03819660|Amifampridine|amifampridine|mesh-list
56807142|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56807143|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807144|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807145|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56807146|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807147|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807148|NCT00394524|Insulin|insulin|mesh-list
56807149|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56807150|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807151|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
56807152|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56807153|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56807154|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807155|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56807156|NCT00409344|Analgesics|analgesics|mesh-ancestor
56807159|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56807160|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56807161|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56807162|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
56807163|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807164|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807165|NCT00415610|Nicardipine|nicardipine|mesh-list
56807166|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56807167|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56807168|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807169|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807170|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56807171|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807172|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
56807173|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
56807174|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56807175|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
56807176|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807177|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56807178|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56807179|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
56807180|NCT00250432|Caspofungin|caspofungin|mesh-list
56807181|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
56807182|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807183|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807184|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807185|NCT03741478|Insulin|insulin|mesh-list
56807186|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56807187|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
56807188|NCT03741478|Olanzapine|olanzapine|mesh-list
56807189|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56807190|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807200|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56807201|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807202|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807203|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807204|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
56807205|NCT00249808|Antibodies|antibodies|mesh-list
56807206|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56807207|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
56807208|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807209|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
56807210|NCT00278512|Fludarabine|fludarabine|mesh-list
56807211|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
56807212|NCT00278512|Tacrolimus|tacrolimus|mesh-list
56807213|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
56807214|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807215|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
56807216|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807217|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807218|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56807219|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
56807220|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807221|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807222|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56807223|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56807224|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807225|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807226|NCT01072240|Rituximab|rituximab|mesh-list
56807227|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807228|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807229|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
56807230|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807231|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807232|NCT00427934|Maraviroc|maraviroc|mesh-list
56807233|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56807240|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56807241|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56807242|NCT00427700|Clomiphene|clomiphene|mesh-list
56807243|NCT00427700|Enclomiphene|enclomiphene|mesh-list
56807244|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
56807245|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56807246|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
56807247|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807248|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807249|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56807250|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
56807251|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56807252|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56807253|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56807254|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56807255|NCT01324076|Doxorubicin|doxorubicin|mesh-list
56807256|NCT01324076|Sorafenib|sorafenib|mesh-list
56807257|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56807258|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807259|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56807260|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56807261|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807262|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807263|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56807264|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
56807289|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56807290|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807291|NCT00426842|Midodrine|midodrine|mesh-list
56807292|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
56807293|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
56807294|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807295|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807296|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56807297|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56807298|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56807299|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56807300|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
56807301|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807302|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807303|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56807304|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
56807305|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56807306|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56807307|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56807308|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56807309|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807310|NCT01072318|Letrozole|letrozole|mesh-list
56807311|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807312|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56807313|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56807314|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807315|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807316|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56518208|NCT01072357|Bevacizumab|bevacizumab|mesh-list
56807331|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56807332|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56807333|NCT03975088|Growth Substances|growth substances|mesh-ancestor
56807334|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807335|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
56807336|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807337|NCT00276016|Phenylephrine|phenylephrine|mesh-list
56807338|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
56807339|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
56807340|NCT00276016|Ephedrine|ephedrine|mesh-list
56807341|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56807342|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
56807343|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
56807344|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807345|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807346|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
56807347|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56807348|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
56807349|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
56807350|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56807351|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56807352|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56807353|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
56807354|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807355|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807356|NCT00276016|Protective Agents|protective agents|mesh-ancestor
56807357|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56807358|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56807359|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56807360|NCT00434642|Gemcitabine|gemcitabine|mesh-list
56807361|NCT00434642|Bevacizumab|bevacizumab|mesh-list
56807362|NCT00434642|Carboplatin|carboplatin|mesh-list
56807374|NCT00434642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807375|NCT00434642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807376|NCT00434642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807377|NCT00434642|Immunologic Factors|immunologic factors|mesh-ancestor
56807378|NCT01032434|Sertraline|sertraline|mesh-list
56807379|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
56807380|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56807381|NCT01032434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56807382|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56807383|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807384|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807385|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807386|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
56807387|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807388|NCT00426764|Romidepsin|romidepsin|mesh-list
56807389|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56807390|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807391|NCT01032668|Clopidogrel|clopidogrel|mesh-list
56807392|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56807393|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56807394|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56807395|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56807396|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
56807397|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807398|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807399|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807400|NCT00434252|Paclitaxel|paclitaxel|mesh-list
56807401|NCT00434252|Bevacizumab|bevacizumab|mesh-list
56807402|NCT00434252|Carboplatin|carboplatin|mesh-list
56807403|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56807404|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807416|NCT00425750|Bortezomib|bortezomib|mesh-list
56807417|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807418|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
56807419|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
56807420|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
56807421|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807422|NCT00414908|Pancrelipase|pancrelipase|mesh-list
56807423|NCT00414908|Pancreatin|pancreatin|mesh-list
56807424|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56807425|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
56807426|NCT00242710|Estrogens|estrogens|mesh-list
56807427|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56807428|NCT00242710|Hormones|hormones|mesh-ancestor
56807429|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807430|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807431|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56807432|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56807433|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
56807434|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56807435|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56807436|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56807437|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56807438|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807439|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807440|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807441|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807442|NCT00408876|Analgesics|analgesics|mesh-ancestor
56807443|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
56807444|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807445|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
56807458|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56807459|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807460|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56807461|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
56807462|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56807463|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807464|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
56518357|NCT04296253|Mitogens|mitogens|mesh-list
56807465|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807466|NCT01070836|Natalizumab|natalizumab|mesh-list
56807467|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
56807468|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807469|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
56807470|NCT00239590|Testosterone|testosterone|mesh-list
56807471|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
56807472|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
56807473|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56807474|NCT00239590|Androgens|androgens|mesh-ancestor
56807475|NCT00239590|Hormones|hormones|mesh-ancestor
56807476|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807477|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807478|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56807479|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807480|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
56807481|NCT00433160|Teriparatide|teriparatide|mesh-list
56807482|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56807483|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807484|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56807485|NCT00239356|Aripiprazole|aripiprazole|mesh-list
56807486|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
56807487|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56807488|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56807489|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56807498|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
56807499|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56807500|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56807501|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56807502|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56807503|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
56807504|NCT00425438|Prednisolone|prednisolone|mesh-list
56807505|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
56807506|NCT00425438|Azathioprine|azathioprine|mesh-list
56807507|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807508|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
56807509|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807510|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807511|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56807512|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
56807513|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807514|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807515|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56807516|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56807517|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56807518|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
56807519|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56807520|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807521|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807522|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56807523|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
56807524|NCT00425438|Hormones|hormones|mesh-ancestor
56807525|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807526|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56807527|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
56807528|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56807529|NCT01041066|Labetalol|labetalol|mesh-list
56807530|NCT01041066|Nicardipine|nicardipine|mesh-list
56807531|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56807532|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56807533|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
56194602|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110444|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
56807534|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807535|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807536|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807537|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56807538|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
56807539|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
56807540|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807541|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56807542|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56807543|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56807544|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807545|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56807546|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
56807547|NCT01323608|Vitamin D|vitamin d|mesh-list
56807548|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
56807549|NCT01323608|Vitamins|vitamins|mesh-ancestor
56807550|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
56807551|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807552|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56807553|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56807554|NCT00275002|Temozolomide|temozolomide|mesh-list
56807555|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56807556|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56807557|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
56807558|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807559|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807560|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807561|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
56807562|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56807563|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
56807568|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56807575|NCT00393042|Amphetamine|amphetamine|mesh-list
56807576|NCT00393042|Adderall|adderall|mesh-list
56807577|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56807578|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56807579|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807580|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
56807581|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
56807582|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807583|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
56807584|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807585|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807586|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
56807587|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56807588|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56807589|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807590|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56807591|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
56807592|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
56807593|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56807594|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807595|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
56807596|NCT01040286|Analgesics|analgesics|mesh-ancestor
56807597|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
56807598|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807599|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807600|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56807601|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56807602|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56807603|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807604|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56807605|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807617|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56807618|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807619|NCT03546192|Vaccines|vaccines|mesh-list
56807620|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
56807621|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807622|NCT01043952|Remifentanil|remifentanil|mesh-list
56807623|NCT01043952|Propofol|propofol|mesh-list
56807624|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56807625|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56807626|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807627|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56807628|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
56807629|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
56807630|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56807631|NCT01043952|Narcotics|narcotics|mesh-ancestor
56807632|NCT01043952|Analgesics|analgesics|mesh-ancestor
56807633|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
56807634|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56807635|NCT00274924|Prednisone|prednisone|mesh-list
56807636|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
56807637|NCT00274924|Ifosfamide|ifosfamide|mesh-list
56807638|NCT00274924|Rituximab|rituximab|mesh-list
56807639|NCT00274924|Carboplatin|carboplatin|mesh-list
56807640|NCT00274924|Doxorubicin|doxorubicin|mesh-list
56807641|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56807642|NCT00274924|Etoposide|etoposide|mesh-list
56807643|NCT00274924|Vincristine|vincristine|mesh-list
56807644|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
56807645|NCT00274924|Lenograstim|lenograstim|mesh-list
56807646|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807647|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
56807648|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807649|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807650|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56807651|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
56807652|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807653|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807654|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56807658|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56807659|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807660|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56807661|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
56807662|NCT00274924|Hormones|hormones|mesh-ancestor
56807663|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807664|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56807665|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56807666|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56807667|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
56807668|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
56807669|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
56807670|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
56807671|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
56807672|NCT00274846|Aldesleukin|aldesleukin|mesh-list
56807673|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
56807674|NCT00274846|Fludarabine|fludarabine|mesh-list
56807675|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
56807676|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807677|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
56807678|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807679|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807680|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56807681|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
56807682|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807683|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807684|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56807685|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56807686|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
56807687|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56807688|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56807703|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56807704|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56807705|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
56807706|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
56807707|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
56807708|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
56807709|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807710|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807711|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56807712|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56807713|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
56807714|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56807715|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56807716|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807717|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56807718|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56807719|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56807720|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56807721|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
56807722|NCT00414440|Everolimus|everolimus|mesh-list
56807723|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807724|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807725|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
56807726|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807727|NCT00209560|Fospropofol|fospropofol|mesh-list
56807728|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56807729|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56807730|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807731|NCT01073800|Atorvastatin|atorvastatin|mesh-list
56807732|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56807746|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56807747|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56807748|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807749|NCT01033058|Atorvastatin|atorvastatin|mesh-list
56807750|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56807751|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56807752|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
56807753|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807754|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56807755|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56807756|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807757|NCT03973138|Ranibizumab|ranibizumab|mesh-list
56807758|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56807759|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56807760|NCT03973138|Growth Substances|growth substances|mesh-ancestor
56807761|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807762|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
56807763|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807764|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
56807765|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56807766|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807767|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56807768|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56807796|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
56807797|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807798|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807799|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56807800|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
56807801|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807802|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807803|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56807804|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56807805|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56807806|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56807807|NCT00408408|Growth Substances|growth substances|mesh-ancestor
56807808|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
56807809|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56807810|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
56807811|NCT00408408|Antiviral Agents|antiviral agents|mesh-ancestor
56807812|NCT00408408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807813|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807814|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56807815|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56807816|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56807817|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56807818|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56807819|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56807820|NCT00414050|Vaccines|vaccines|mesh-list
56807845|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807846|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56807847|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56807848|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807849|NCT00259012|Pantoprazole|pantoprazole|mesh-list
56807850|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56807851|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56807852|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56807853|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807854|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807855|NCT01044186|Deferasirox|deferasirox|mesh-list
56807856|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56807857|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
56807858|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
56807859|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807860|NCT00209170|Citalopram|citalopram|mesh-list
56807861|NCT00209170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56807862|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56807863|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807864|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807896|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56807897|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56807898|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807899|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56807900|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56807901|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56807902|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56807903|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
56807904|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56807905|NCT01581814|Estrogens|estrogens|mesh-ancestor
56807906|NCT01581814|Hormones|hormones|mesh-ancestor
56807907|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56807908|NCT00407550|Gemcitabine|gemcitabine|mesh-list
56807909|NCT00407550|Pemetrexed|pemetrexed|mesh-list
56807910|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56807911|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
56807912|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807913|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807914|NCT00407550|Antiviral Agents|antiviral agents|mesh-ancestor
56807915|NCT00407550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807916|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56807917|NCT00407550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807918|NCT00407550|Immunologic Factors|immunologic factors|mesh-ancestor
56807919|NCT00407550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807920|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56807921|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56807922|NCT00209092|Docetaxel|docetaxel|mesh-list
56807923|NCT00209092|Capecitabine|capecitabine|mesh-list
56807924|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807925|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
56807926|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
56807927|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
56807938|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807939|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807940|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56807941|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807942|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
56807943|NCT00403260|Artesunate|artesunate|mesh-list
56807944|NCT00403260|Mefloquine|mefloquine|mesh-list
56807945|NCT00403260|Pyronaridine|pyronaridine|mesh-list
56807946|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
56807947|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56807948|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56807949|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56807950|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807951|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
56807952|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
56807953|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56807954|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
56807958|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56807959|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56807960|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56807961|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56807962|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807963|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56807964|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807965|NCT00406848|Analgesics|analgesics|mesh-ancestor
56807966|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
56807984|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
56807985|NCT00315705|Etoposide|etoposide|mesh-list
56807986|NCT00315705|Clofarabine|clofarabine|mesh-list
56518884|NCT01048099|Pertuzumab|pertuzumab|mesh-list
56807987|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56807988|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
56807989|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56807990|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56807991|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56807992|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
56807993|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56807994|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56807995|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56807996|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56807997|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56807998|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56807999|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808000|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56808001|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
56808003|NCT03982173|Tremelimumab|tremelimumab|mesh-list
56808004|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808005|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808006|NCT01062633|Erythritol|erythritol|mesh-list
56808007|NCT01062633|Sorbitol|sorbitol|mesh-list
56808008|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
56808009|NCT01062633|Cathartics|cathartics|mesh-ancestor
56808011|NCT00307125|Rituximab|rituximab|mesh-list
56808034|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808035|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56808036|NCT01066377|Renal Agents|renal agents|mesh-ancestor
56808037|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
56808038|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56808039|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56808040|NCT00306891|Cediranib|cediranib|mesh-list
56808041|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808042|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56808043|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808044|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808045|NCT03980847|Alendronate|alendronate|mesh-list
56808046|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56808047|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808048|NCT00391872|Clopidogrel|clopidogrel|mesh-list
56808049|NCT00391872|Ticagrelor|ticagrelor|mesh-list
56808050|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56808051|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56808052|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56808053|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56808054|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
56808055|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808056|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808057|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808058|NCT00391170|Dexamethasone|dexamethasone|mesh-list
56808059|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56518958|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808060|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
56808061|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
56808062|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808076|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56808077|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56808078|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56808079|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56808080|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56808081|NCT00402324|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56808082|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56808083|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56808084|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808085|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808086|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
56808087|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
56808088|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808089|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
56808090|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
56808091|NCT00294723|Liraglutide|liraglutide|mesh-list
56808092|NCT00294723|Glimepiride|glimepiride|mesh-list
56808093|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56808094|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808095|NCT00294723|Incretins|incretins|mesh-ancestor
56808096|NCT00294723|Hormones|hormones|mesh-ancestor
56808097|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808098|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56808099|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808100|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
56808101|NCT00375492|Exenatide|exenatide|mesh-list
56808102|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56808103|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808104|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56808105|NCT00375492|Incretins|incretins|mesh-ancestor
56808106|NCT00375492|Hormones|hormones|mesh-ancestor
56808107|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808120|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56808121|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56808122|NCT00305877|Growth Substances|growth substances|mesh-ancestor
56808123|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808124|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
56808125|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
56808126|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56808127|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
56808128|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808129|NCT00305877|Antiviral Agents|antiviral agents|mesh-ancestor
56808130|NCT00305877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808131|NCT00305877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808132|NCT00305877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808133|NCT00312195|Buprenorphine|buprenorphine|mesh-list
56808134|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56808135|NCT00312195|Narcotics|narcotics|mesh-ancestor
56808136|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56519033|NCT05643651|Aspirin|aspirin|mesh-list
56808137|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808138|NCT00312195|Analgesics|analgesics|mesh-ancestor
56808139|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
56808140|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808141|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56808142|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
56808143|NCT02532777|Prednisone|prednisone|mesh-list
56808144|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
56808145|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
56808146|NCT02532777|Leflunomide|leflunomide|mesh-list
56808147|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56808148|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56808149|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808150|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
56808151|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808152|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808154|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
56808160|NCT02532777|Hormones|hormones|mesh-ancestor
56808161|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808162|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808163|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56808164|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56808165|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
56808166|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56808167|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808168|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
56808169|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
56808170|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808171|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56808172|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56808173|NCT02532777|Protective Agents|protective agents|mesh-ancestor
56808174|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
56808175|NCT01062945|Doxazosin|doxazosin|mesh-list
56808176|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56808177|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56808178|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56808179|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56808180|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
56808181|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808182|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808183|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808184|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
56808185|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56808186|NCT01063023|Asunaprevir|asunaprevir|mesh-list
56808187|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
56808188|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808203|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56808204|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56808205|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
56808206|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808207|NCT01066689|Rituximab|rituximab|mesh-list
56808208|NCT01066689|Citric Acid|citric acid|mesh-list
56808209|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
56808210|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808211|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56519107|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56808212|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
56808213|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808214|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808216|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56808217|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
56808218|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
56808219|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808220|NCT01063179|Thalidomide|thalidomide|mesh-list
56808221|NCT01063179|Prednisone|prednisone|mesh-list
56808222|NCT01063179|Bortezomib|bortezomib|mesh-list
56808223|NCT01063179|Melphalan|melphalan|mesh-list
56808224|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56808225|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
56808226|NCT01063179|Hormones|hormones|mesh-ancestor
56808227|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808228|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808229|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808230|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808231|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56808232|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
56808233|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808234|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56808236|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
56808246|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56808247|NCT00293709|Analgesics|analgesics|mesh-ancestor
56808248|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
56808249|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808250|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808251|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56808252|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808253|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56808254|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808255|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
56808256|NCT01063257|Clofarabine|clofarabine|mesh-list
56808257|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56808258|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
56808259|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808260|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808261|NCT03977649|Erenumab|erenumab|mesh-list
56808262|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56808263|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808264|NCT03977649|Analgesics|analgesics|mesh-ancestor
56808265|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
56808266|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808267|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808268|NCT01066767|Fexofenadine|fexofenadine|mesh-list
56808269|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56808270|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56808271|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56808272|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
56808291|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56808292|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56808293|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56808294|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
56808295|NCT01066845|Tadalafil|tadalafil|mesh-list
56808296|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
56808297|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56808298|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56808299|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808300|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808301|NCT01066845|Urological Agents|urological agents|mesh-ancestor
56808302|NCT01064349|Trastuzumab|trastuzumab|mesh-list
56808303|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808304|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808305|NCT00293397|Doxorubicin|doxorubicin|mesh-list
56808306|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56808307|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56808308|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808309|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56808310|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56808311|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808312|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808313|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
56808314|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56808315|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808316|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56808317|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56808318|NCT01069263|Protective Agents|protective agents|mesh-ancestor
56808319|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808320|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56808321|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
56808322|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080721|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
56808332|NCT01067235|Modafinil|modafinil|mesh-list
56808333|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56808334|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808335|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56808336|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56808337|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56808338|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808339|NCT00290745|Tamoxifen|tamoxifen|mesh-list
56808340|NCT00290745|Letrozole|letrozole|mesh-list
56808341|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808342|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808343|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56808344|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56808345|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808346|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56808347|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
56808348|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808349|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808350|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808351|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56808352|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56808353|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56808354|NCT03980223|Doxycycline|doxycycline|mesh-list
56808355|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56808356|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808357|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
56808359|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56808360|NCT01067391|Tadalafil|tadalafil|mesh-list
56808361|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
56808362|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56808363|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56808364|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808365|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808369|NCT00402168|Tacrolimus|tacrolimus|mesh-list
56808370|NCT00402168|Cyclosporins|cyclosporins|mesh-list
56808371|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808372|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
56808373|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808374|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56808375|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808376|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808377|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
56808378|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808379|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
56808380|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808381|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56808382|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808383|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
56808384|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56808385|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56808386|NCT00290589|Prednisolone|prednisolone|mesh-list
56808387|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
56808388|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56808389|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
56808390|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56808391|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
56808392|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
56808393|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808394|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808395|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56808396|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
56808397|NCT00290589|Hormones|hormones|mesh-ancestor
56808398|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808399|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56808400|NCT00290589|Protective Agents|protective agents|mesh-ancestor
56808401|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808402|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808411|NCT00290511|Fludarabine|fludarabine|mesh-list
56808412|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
56808413|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
56808414|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808415|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808416|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
56808417|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808418|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808419|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56808420|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
56808421|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
56808422|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808423|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56808424|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
56808425|NCT00290511|Hormones|hormones|mesh-ancestor
56808426|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808427|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808428|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56808429|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
56808430|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808431|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808432|NCT00290511|Analgesics|analgesics|mesh-ancestor
56519337|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
56808433|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
56808434|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56808435|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56808436|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808437|NCT00290433|Cytarabine|cytarabine|mesh-list
56808438|NCT00290433|Dexamethasone|dexamethasone|mesh-list
56808439|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
56808440|NCT00290433|Doxorubicin|doxorubicin|mesh-list
56808441|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56808442|NCT00290433|Methotrexate|methotrexate|mesh-list
56808443|NCT00290433|Vincristine|vincristine|mesh-list
56808444|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808445|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
56808450|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808451|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808452|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56808453|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56808454|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
56808455|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
56808456|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808457|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56808458|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
56808459|NCT00290433|Hormones|hormones|mesh-ancestor
56808460|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808461|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808462|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56808463|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56808464|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56808465|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808466|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56808467|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
56808468|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56808469|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56808470|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
56808471|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
56808472|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56808473|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56808474|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
56808475|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808497|NCT00391092|Trastuzumab|trastuzumab|mesh-list
56808498|NCT00391092|Docetaxel|docetaxel|mesh-list
56808499|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808500|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808501|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56808502|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56808503|NCT00391092|Growth Substances|growth substances|mesh-ancestor
56808504|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808505|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
56808506|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
56808507|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
56808508|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
56808509|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808510|NCT00374868|Pemetrexed|pemetrexed|mesh-list
56808511|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808512|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808513|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808514|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56808515|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56808516|NCT01044342|Donepezil|donepezil|mesh-list
56808517|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56808518|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808519|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808520|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
56808521|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808522|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808523|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
56808543|NCT00303459|Bosentan|bosentan|mesh-list
56808544|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56808545|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56808546|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808547|NCT00289887|Losartan|losartan|mesh-list
56808548|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56808549|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56808550|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56808551|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56808552|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808553|NCT01068093|Ezetimibe|ezetimibe|mesh-list
56808554|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56808555|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56808556|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
56808557|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808558|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56808559|NCT00401544|Dextrans|dextrans|mesh-list
56808560|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
56808561|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
56808562|NCT00401544|Hematinics|hematinics|mesh-ancestor
56808563|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
56808564|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
56808565|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
56808566|NCT00292461|Lamotrigine|lamotrigine|mesh-list
56808567|NCT00292461|Zonisamide|zonisamide|mesh-list
56808568|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
56808569|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56808570|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56808574|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56808588|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56808589|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56808590|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56808591|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56808592|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56808593|NCT00390858|Deferasirox|deferasirox|mesh-list
56808594|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56808595|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
56808596|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
56808597|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808598|NCT00390780|Clotrimazole|clotrimazole|mesh-list
56808599|NCT00390780|Miconazole|miconazole|mesh-list
56808600|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56808601|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808602|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
56808603|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56808604|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56808605|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808606|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808607|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56808608|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
56808609|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808610|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808611|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56808612|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56808635|NCT00302211|Iloprost|iloprost|mesh-list
56808636|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
56808637|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56808638|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56808639|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808640|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808641|NCT00302211|Urological Agents|urological agents|mesh-ancestor
56808642|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56808643|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56808644|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56808645|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
56808646|NCT01045902|Ampicillin|ampicillin|mesh-list
56808647|NCT01045902|Sulbactam|sulbactam|mesh-list
56808648|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56808649|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56808650|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808651|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56808652|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56808653|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808654|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808655|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808656|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56808657|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
56808658|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56808659|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808660|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56808661|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56808662|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56808679|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
56808680|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56808681|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
56808682|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56808683|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56808684|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56808685|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56808686|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808687|NCT01068327|Leucovorin|leucovorin|mesh-list
56808688|NCT01068327|Gemcitabine|gemcitabine|mesh-list
56808689|NCT01068327|Nelfinavir|nelfinavir|mesh-list
56808690|NCT01068327|Fluorouracil|fluorouracil|mesh-list
56808691|NCT01068327|Calcium|calcium|mesh-list
56808692|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
56808693|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56808694|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
56808695|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808696|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808697|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
56808698|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808699|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808700|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808701|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
56808702|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808703|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56808704|NCT01068327|Antidotes|antidotes|mesh-ancestor
56808705|NCT01068327|Protective Agents|protective agents|mesh-ancestor
56808706|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
56808707|NCT01068327|Vitamins|vitamins|mesh-ancestor
56808708|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
56808709|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56808710|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56808711|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
56808712|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56808713|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56808714|NCT01045980|Vitamin D|vitamin d|mesh-list
56808715|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
56808716|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
56808717|NCT01045980|Vitamins|vitamins|mesh-list
56808720|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56808721|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56808722|NCT00388674|Entecavir|entecavir|mesh-list
56808723|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
56808724|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808725|NCT00388362|Sirolimus|sirolimus|mesh-list
56808726|NCT00388362|Prednisone|prednisone|mesh-list
56808727|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56808728|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
56808729|NCT00388362|Hormones|hormones|mesh-ancestor
56519639|NCT01309841|Naloxegol|naloxegol|mesh-list
56808730|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808731|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808732|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808733|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808734|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56808735|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808736|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56808737|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
56808738|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808739|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
56808741|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
56808742|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808743|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
56808744|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808745|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808746|NCT01046214|Bupropion|bupropion|mesh-list
56808747|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56808748|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
56808749|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56808750|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56808751|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56808761|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56808762|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56808763|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808764|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56808765|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808766|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56808767|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808768|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808769|NCT00387426|Sunitinib|sunitinib|mesh-list
56808770|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808771|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56808772|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56808773|NCT00387426|Growth Substances|growth substances|mesh-ancestor
56808774|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808775|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
56808776|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56808777|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808778|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808779|NCT00387348|Dexetimide|dexetimide|mesh-list
56808780|NCT00387348|Citalopram|citalopram|mesh-list
56808781|NCT00387348|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56808782|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56808783|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56808784|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808785|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808786|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
56808787|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808804|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
56808805|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808806|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56808808|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56808809|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808810|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808811|NCT01234532|Anastrozole|anastrozole|mesh-list
56808812|NCT01234532|Entinostat|entinostat|mesh-list
56808813|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808814|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808815|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56808816|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56808817|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808818|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808819|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56808820|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
56808821|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808822|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808823|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56808824|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
56808825|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56808826|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56808827|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808828|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56808829|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
56808830|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808831|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56808832|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56808833|NCT02594384|Rituximab|rituximab|mesh-list
56808834|NCT02594384|Atezolizumab|atezolizumab|mesh-list
56808835|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808836|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808843|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
56808844|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808845|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808846|NCT01068405|Methotrexate|methotrexate|mesh-list
56808847|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56808848|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
56808849|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56808850|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808851|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56808852|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
56808853|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808854|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808855|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
56808856|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808857|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56808858|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808859|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
56808860|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808861|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56808862|NCT00429572|Fludarabine|fludarabine|mesh-list
56808863|NCT00429572|Melphalan|melphalan|mesh-list
56808864|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808865|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808866|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808867|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
56808868|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808869|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56808890|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808891|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56808892|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
56808893|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808894|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808895|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56808896|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56808897|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
56808898|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
56808899|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56808900|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56808901|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808902|NCT00429416|Protective Agents|protective agents|mesh-ancestor
56808903|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
56808904|NCT00429182|Thiotepa|thiotepa|mesh-list
56808905|NCT00429182|Carboplatin|carboplatin|mesh-list
56808906|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808907|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
56808908|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808909|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808910|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56808911|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
56808912|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808913|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808914|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56808915|NCT00429104|Trastuzumab|trastuzumab|mesh-list
56808916|NCT00429104|Sargramostim|sargramostim|mesh-list
56808917|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808918|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808919|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
56808920|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808921|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
56808922|NCT00429026|Melphalan|melphalan|mesh-list
56808923|NCT00429026|Fludarabine|fludarabine|mesh-list
56808924|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081328|NCT00005631|Rituximab|rituximab|mesh-list
56808929|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
56808930|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808931|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808932|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56808933|NCT00301821|Prednisone|prednisone|mesh-list
56808934|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
56808935|NCT00301821|Rituximab|rituximab|mesh-list
56808936|NCT00301821|Doxorubicin|doxorubicin|mesh-list
56808937|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56808938|NCT00301821|Vincristine|vincristine|mesh-list
56808939|NCT00301821|Epratuzumab|epratuzumab|mesh-list
56808940|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56808941|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
56808942|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808943|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56808944|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56808945|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
56808946|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808947|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808948|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56808949|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56808950|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56808951|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56808952|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56808953|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519922|NCT01294683|Niacin|niacin|mesh-list
56808954|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56808955|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
56808956|NCT00301821|Hormones|hormones|mesh-ancestor
56808957|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808958|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808959|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56808960|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
56808961|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
56808962|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
56808964|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
56808967|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56808968|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808969|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56808970|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
56808971|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
56808972|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56808973|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
56808974|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56808975|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808976|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
56808977|NCT00372996|Fulvestrant|fulvestrant|mesh-list
56808978|NCT00372996|Exemestane|exemestane|mesh-list
56808979|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56808980|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56808981|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56808982|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56808983|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
56808984|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56808985|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808986|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56808987|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56808988|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56808989|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808990|NCT00399360|Metformin|metformin|mesh-list
56808991|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56808992|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808993|NCT00428948|Tolvaptan|tolvaptan|mesh-list
56808994|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56808995|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56808996|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
56808997|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56808998|NCT00428792|Methylphenidate|methylphenidate|mesh-list
56809004|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809005|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
56809006|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809007|NCT00300885|Paclitaxel|paclitaxel|mesh-list
56809008|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56809009|NCT00300885|Carboplatin|carboplatin|mesh-list
56809010|NCT00300885|Sorafenib|sorafenib|mesh-list
56809011|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56809012|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809013|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
56809014|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
56809015|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
56809016|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809017|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809018|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809019|NCT00386334|Eszopiclone|eszopiclone|mesh-list
56809020|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56809021|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56809022|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809023|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
56809024|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56809025|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809026|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
56809027|NCT00292227|Rotigotine|rotigotine|mesh-list
56809028|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56519928|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
56809029|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809030|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56809031|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56809039|NCT00386100|Metformin|metformin|mesh-list
56809048|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56809049|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56809050|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56809051|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809052|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56809053|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56809054|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56809055|NCT03979989|Tapentadol|tapentadol|mesh-list
56809056|NCT03979989|Omeprazole|omeprazole|mesh-list
56809057|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56809058|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56809059|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56809060|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809061|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809062|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56809063|NCT03979989|Narcotics|narcotics|mesh-ancestor
56809064|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56809065|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809066|NCT03979989|Analgesics|analgesics|mesh-ancestor
56809067|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
56809068|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809069|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56809070|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56809071|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56809072|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
56809073|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809074|NCT01325571|Tacrolimus|tacrolimus|mesh-list
56809075|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809076|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
56809077|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809089|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
56809090|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56809091|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56809092|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809093|NCT00286455|Alogliptin|alogliptin|mesh-list
56809094|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56809095|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809096|NCT00286455|Incretins|incretins|mesh-ancestor
56809097|NCT00286455|Hormones|hormones|mesh-ancestor
56809098|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809099|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56809100|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
56520012|NCT01291017|Palbociclib|palbociclib|mesh-list
56809101|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809102|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809103|NCT00385944|Clopidogrel|clopidogrel|mesh-list
56809104|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56809105|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56809106|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56809107|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56809108|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56809109|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
56809110|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809138|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
56809139|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809140|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809141|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809142|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56809143|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56809144|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
56809145|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809146|NCT01042314|Donepezil|donepezil|mesh-list
56809147|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56809148|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809149|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809150|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
56809151|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809152|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809153|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
56809154|NCT00372528|Pregabalin|pregabalin|mesh-list
56809155|NCT00372528|Analgesics|analgesics|mesh-ancestor
56809156|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
56809157|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809158|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809159|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
56809160|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56809161|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56809162|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809163|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56809164|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56809165|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56809166|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56809167|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56809168|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
56809169|NCT00283803|Hormones|hormones|mesh-list
56809180|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809181|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56809182|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56809183|NCT00283803|Analgesics|analgesics|mesh-ancestor
56809184|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
56809185|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809186|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56809187|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56809188|NCT01044810|Efavirenz|efavirenz|mesh-list
56809189|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56809190|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56809191|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809192|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809193|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
56809194|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809195|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56809196|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56809197|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56809198|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56809199|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56809200|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56809201|NCT01033370|Clevidipine|clevidipine|mesh-list
56809202|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56809203|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56809204|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809205|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56809206|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809207|NCT01044888|Heparin|heparin|mesh-list
56809208|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
56809215|NCT03742466|Prednisolone|prednisolone|mesh-list
56809219|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56809220|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
56809221|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
56809222|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809223|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809224|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56809225|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
56809226|NCT03742466|Hormones|hormones|mesh-ancestor
56809227|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809228|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56809229|NCT03742466|Protective Agents|protective agents|mesh-ancestor
56809230|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56809231|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809232|NCT01065285|Vaccines|vaccines|mesh-list
56809233|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
56809234|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809235|NCT01033526|Aspirin|aspirin|mesh-list
56809236|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56809237|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56809238|NCT01033526|Analgesics|analgesics|mesh-ancestor
56809239|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
56809240|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809241|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809242|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56809243|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56809244|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56809245|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56809246|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809247|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56809251|NCT00397488|Sunitinib|sunitinib|mesh-list
56809262|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56809263|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56809264|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56809265|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809266|NCT02900664|Trametinib|trametinib|mesh-list
56809267|NCT02900664|Spartalizumab|spartalizumab|mesh-list
56809268|NCT02900664|Nazartinib|nazartinib|mesh-list
56809269|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809270|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809271|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809272|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809273|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56809274|NCT01324596|Prednisolone|prednisolone|mesh-list
56809275|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56809276|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
56809277|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56809278|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
56809279|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
56809280|NCT01324596|Rituximab|rituximab|mesh-list
56809281|NCT01324596|Doxorubicin|doxorubicin|mesh-list
56809282|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56809283|NCT01324596|Vincristine|vincristine|mesh-list
56809284|NCT01324596|Bortezomib|bortezomib|mesh-list
56809285|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56809286|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
56809287|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809288|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
56809289|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809290|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56809291|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56809292|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
56809293|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809294|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809304|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
56809305|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56809306|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
56809307|NCT01324596|Hormones|hormones|mesh-ancestor
56809308|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809309|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56809310|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
56809311|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
56809312|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809313|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56809314|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56809315|NCT01324596|Protective Agents|protective agents|mesh-ancestor
56809316|NCT00424190|Vancomycin|vancomycin|mesh-list
56809317|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56809318|NCT00424190|Aztreonam|aztreonam|mesh-list
56809319|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56809320|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809321|NCT02859012|Axitinib|axitinib|mesh-list
56809322|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56520232|NCT01287117|Omalizumab|omalizumab|mesh-list
56809323|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809324|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809325|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809326|NCT00274287|Sargramostim|sargramostim|mesh-list
56809327|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
56809328|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809329|NCT01045278|Interferons|interferons|mesh-list
56809330|NCT01045278|Ribavirin|ribavirin|mesh-list
56809331|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
56809332|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
56809333|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56809334|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809335|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
56809336|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809337|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
56809347|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
56809348|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809349|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
56809350|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809351|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
56809352|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809353|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56809354|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
56809355|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809356|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
56809357|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56809358|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809359|NCT00282243|Tacrolimus|tacrolimus|mesh-list
56809360|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809361|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
56809362|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809363|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56809364|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809365|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809366|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
56809367|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56809368|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56809395|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809396|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
56809397|NCT00232180|Eplerenone|eplerenone|mesh-list
56809398|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56809399|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
56809400|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809401|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809402|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56809403|NCT00232180|Diuretics|diuretics|mesh-ancestor
56809404|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
56809405|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56809406|NCT01070277|Albendazole|albendazole|mesh-list
56809407|NCT01070277|Tinidazole|tinidazole|mesh-list
56809408|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
56809409|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56809410|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809411|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
56809412|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56809413|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56809414|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
56809415|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
56809416|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
56809417|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809418|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809419|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
56809420|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56809421|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56809422|NCT00270231|Naltrexone|naltrexone|mesh-list
56809423|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56809424|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56809425|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809426|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
56809427|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809435|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809436|NCT00258856|Vaccines|vaccines|mesh-list
56809437|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
56809438|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809439|NCT00269919|Risperidone|risperidone|mesh-list
56809440|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56809441|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
56809442|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809443|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809444|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809445|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56809446|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56809447|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56809448|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56809449|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56809450|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
56809451|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56809452|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809453|NCT00257920|Vitamins|vitamins|mesh-ancestor
56809454|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
56809455|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56809456|NCT00268983|Iodine|iodine|mesh-list
56809457|NCT00268983|Rituximab|rituximab|mesh-list
56809458|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
56809459|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56809460|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809484|NCT00257608|Growth Substances|growth substances|mesh-ancestor
56809485|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809486|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
56809487|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809488|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809489|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809490|NCT00231478|Granisetron|granisetron|mesh-list
56809491|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
56809492|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
56809493|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809494|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809495|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56809496|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56809497|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
56809498|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809499|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809501|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56809502|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56809503|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56809504|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
56809505|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809506|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809507|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56809508|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56809509|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
56809513|NCT00268905|Carboplatin|carboplatin|mesh-list
56809533|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
56809534|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56809535|NCT00206440|Esomeprazole|esomeprazole|mesh-list
56809536|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56809537|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56809538|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56809539|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809540|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809541|NCT00268437|Carboplatin|carboplatin|mesh-list
56809542|NCT00268437|Pemetrexed|pemetrexed|mesh-list
56809543|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809544|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809545|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809546|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56520461|NCT00623376|Analgesics|analgesics|mesh-ancestor
56809547|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56809548|NCT00423488|Simvastatin|simvastatin|mesh-list
56809549|NCT00423488|Ezetimibe|ezetimibe|mesh-list
56809550|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56809551|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56809552|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
56809553|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809554|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56809555|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56809556|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809583|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
56809584|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
56809585|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809586|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56809587|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
56809588|NCT00404066|Hormones|hormones|mesh-ancestor
56809589|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809590|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56809591|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56809592|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56809593|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56809594|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56809595|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56809596|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56809597|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809598|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809599|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56809600|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809601|NCT00423332|Cediranib|cediranib|mesh-list
56809602|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809603|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809604|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809605|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809606|NCT00413036|Lenalidomide|lenalidomide|mesh-list
56809607|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
56809608|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809609|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56809610|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56809611|NCT00413036|Growth Substances|growth substances|mesh-ancestor
56809612|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
56809614|NCT00412958|Plasminogen|plasminogen|mesh-list
56809626|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56809627|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56809628|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56809629|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809630|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
56809631|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809632|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
56809633|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809634|NCT00384930|Tadalafil|tadalafil|mesh-list
56809635|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
56809636|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56809637|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56809638|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809639|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809640|NCT00384930|Urological Agents|urological agents|mesh-ancestor
56809641|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
56809642|NCT00423098|Prednisone|prednisone|mesh-list
56809643|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
56809644|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56809645|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56809646|NCT00423098|Prednisolone|prednisolone|mesh-list
56809647|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
56809648|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56809649|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
56809650|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56809651|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
56809652|NCT00423098|Hormones|hormones|mesh-ancestor
56809653|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809656|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809671|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56809672|NCT01042704|Dexamethasone|dexamethasone|mesh-list
56809673|NCT01042704|Lenalidomide|lenalidomide|mesh-list
56809674|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56809675|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56809676|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
56809677|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
56809678|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809679|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809680|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56809681|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
56809682|NCT01042704|Hormones|hormones|mesh-ancestor
56809683|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809684|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56809685|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809686|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56809687|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56809688|NCT01042704|Analgesics|analgesics|mesh-ancestor
56809689|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
56809690|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56809691|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56809692|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56809693|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809694|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56809695|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56809696|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809697|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
56809698|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
56809699|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56809715|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56809716|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56809717|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809718|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809719|NCT01046838|Urological Agents|urological agents|mesh-ancestor
56809720|NCT01042782|Everolimus|everolimus|mesh-list
56809721|NCT01042782|Mitomycin|mitomycin|mesh-list
56809722|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809723|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809724|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
56809725|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809726|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
56809727|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809728|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56809729|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56809730|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809731|NCT00411788|Sirolimus|sirolimus|mesh-list
56809732|NCT00411788|Trastuzumab|trastuzumab|mesh-list
56809733|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809734|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809735|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56809736|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809737|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56809738|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
56809739|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809740|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
56809741|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809742|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56809743|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809744|NCT01040936|Atorvastatin|atorvastatin|mesh-list
56809745|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56809746|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56809755|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809756|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809757|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56809758|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56809759|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56809760|NCT01041170|Rimonabant|rimonabant|mesh-list
56809761|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56809762|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56809763|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56809764|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809765|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809766|NCT01041170|Hormones|hormones|mesh-ancestor
56809767|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56809768|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809769|NCT01041482|Sorafenib|sorafenib|mesh-list
56809770|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809771|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809772|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809773|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809775|NCT00422942|Methotrexate|methotrexate|mesh-list
56809776|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809777|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809778|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
56809779|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809780|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56809781|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56809782|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
56809785|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
56809797|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56809798|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56809799|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809800|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809801|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809802|NCT00422162|Analgesics|analgesics|mesh-ancestor
56809803|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
56809804|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809805|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
56809806|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56809807|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
56809808|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56809809|NCT00411632|Bexarotene|bexarotene|mesh-list
56809810|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809811|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56809812|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809813|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809814|NCT00422084|Artesunate|artesunate|mesh-list
56809815|NCT00422084|Lumefantrine|lumefantrine|mesh-list
56809816|NCT00422084|Artemether|artemether|mesh-list
56809817|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56809818|NCT00422084|Pyronaridine|pyronaridine|mesh-list
56809819|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
56809820|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56809821|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56809822|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809823|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809824|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
56809825|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
56809826|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56809827|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
56809828|NCT00421928|Oxycodone|oxycodone|mesh-list
56809829|NCT00421928|Tapentadol|tapentadol|mesh-list
56809830|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56809831|NCT00421928|Narcotics|narcotics|mesh-ancestor
56809838|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56809839|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56809840|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809841|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
56809842|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56809843|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
56809844|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
56809845|NCT01047072|Rituximab|rituximab|mesh-list
56809847|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
56809848|NCT01047072|Tacrolimus|tacrolimus|mesh-list
56809849|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809850|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
56809851|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809852|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56809853|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56809854|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
56809855|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809856|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809857|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56809858|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809859|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56809860|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
56809861|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56809862|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809863|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56809887|NCT01043172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809888|NCT01043172|Immunologic Factors|immunologic factors|mesh-ancestor
56809889|NCT01043172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809890|NCT01045434|Omeprazole|omeprazole|mesh-list
56809891|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56809892|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56809893|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56809894|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809895|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809896|NCT01043484|Bevacizumab|bevacizumab|mesh-list
56809897|NCT01043484|Capecitabine|capecitabine|mesh-list
56809898|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809899|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809900|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56809901|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56809902|NCT01043484|Growth Substances|growth substances|mesh-ancestor
56809903|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809904|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
56809905|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56809906|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
56809907|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809908|NCT00396318|Tenecteplase|tenecteplase|mesh-list
56809909|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56809910|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56809911|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809912|NCT00381888|PENTA|penta|mesh-list
56809913|NCT00381888|Fondaparinux|fondaparinux|mesh-list
56809914|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56809915|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
56809916|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56809917|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
56809918|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809919|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809920|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
56809921|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56809927|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56809928|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56809929|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809930|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56809931|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809932|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56809933|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56809934|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56809935|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56809936|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56809937|NCT00421148|Bromides|bromides|mesh-list
56809938|NCT00421148|Rocuronium|rocuronium|mesh-list
56809939|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
56809940|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56809941|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56809942|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56809943|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809944|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809945|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56809946|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56809947|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
56809948|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56809949|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809976|NCT00403130|Paclitaxel|paclitaxel|mesh-list
56809977|NCT00403130|Bevacizumab|bevacizumab|mesh-list
56809978|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56809979|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56809980|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
56809981|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
56809982|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
56809983|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56809984|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56809985|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56809986|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56809987|NCT00403130|Growth Substances|growth substances|mesh-ancestor
56809988|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56809989|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
56809990|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56809991|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
56809992|NCT00403130|Antiviral Agents|antiviral agents|mesh-ancestor
56809993|NCT00403130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56809994|NCT00403130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56809995|NCT00403130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56809996|NCT00403130|Immunologic Factors|immunologic factors|mesh-ancestor
56809997|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
56809998|NCT01039610|Linezolid|linezolid|mesh-list
56809999|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56810000|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810001|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56810002|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56810003|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810004|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810005|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810009|NCT00267189|Cyclosporine|cyclosporine|mesh-list
56810020|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810021|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810022|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
56810023|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56810024|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810025|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
56810026|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810027|NCT00402116|Temozolomide|temozolomide|mesh-list
56810028|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56810029|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
56810030|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810031|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810032|NCT00401960|Daptomycin|daptomycin|mesh-list
56810033|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56810034|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810035|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56810036|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56810037|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56810038|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810039|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810040|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810041|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810042|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56810043|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
56810044|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810045|NCT00371826|Cyclosporine|cyclosporine|mesh-list
56810046|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
56810047|NCT00371826|Prednisone|prednisone|mesh-list
56810048|NCT00371826|Everolimus|everolimus|mesh-list
56810049|NCT00371826|Cyclosporins|cyclosporins|mesh-list
56810050|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56810051|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56810052|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
56810053|NCT00371826|Hormones|hormones|mesh-ancestor
56810057|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810058|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810059|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810060|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810061|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
56810062|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
56810063|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810064|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810065|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810066|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56810067|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56810068|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
56810069|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56810070|NCT03993366|Pramlintide|pramlintide|mesh-list
56810071|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
56810072|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56810073|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810074|NCT02457702|Glycerol|glycerol|mesh-list
56810075|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56810076|NCT02457702|Protective Agents|protective agents|mesh-ancestor
56810077|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810078|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
56810113|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56810114|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56810115|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56810116|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810117|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810118|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810119|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810120|NCT00401258|Analgesics|analgesics|mesh-ancestor
56810121|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
56810122|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810123|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
56810124|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810125|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
56810126|NCT00380874|Pregabalin|pregabalin|mesh-list
56810127|NCT00380874|Analgesics|analgesics|mesh-ancestor
56810128|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
56810129|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810130|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810131|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
56810132|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56810133|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810134|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810136|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56810162|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810163|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810164|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810165|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56810166|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56810167|NCT00380250|Lubiprostone|lubiprostone|mesh-list
56810168|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56810169|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810170|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810171|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
56810172|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56810173|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810174|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56810175|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
56810176|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56810177|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810178|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810179|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810180|NCT00395694|Lamotrigine|lamotrigine|mesh-list
56810181|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
56810182|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56810183|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810184|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810185|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56810186|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810187|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56810188|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56810189|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810190|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810191|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56810201|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
56810202|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
56810203|NCT00419744|Hormones|hormones|mesh-ancestor
56810204|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56810205|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56810206|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56810207|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56810208|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
56810209|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810210|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810211|NCT01047774|Caseins|caseins|mesh-list
56810212|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
56810213|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
56810214|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810215|NCT00395304|Fluticasone|fluticasone|mesh-list
56810216|NCT00395304|Xhance|xhance|mesh-list
56810217|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56810218|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56810219|NCT00395304|Montelukast|montelukast|mesh-list
56810220|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56810221|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56810222|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
56810223|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810224|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810225|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56810226|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
56810227|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810228|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56810229|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56810230|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56810231|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56810232|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
56810241|NCT00395304|Hormones|hormones|mesh-ancestor
56810242|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
56810243|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
56810244|NCT00395226|Astringents|astringents|mesh-ancestor
56810245|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810246|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810247|NCT00394914|Pleconaril|pleconaril|mesh-list
56810248|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
56810249|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810250|NCT00366444|Diclofenac|diclofenac|mesh-list
56810251|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56810252|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56810253|NCT00366444|Analgesics|analgesics|mesh-ancestor
56810254|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
56810255|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810256|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810257|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56810258|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810259|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56810260|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810261|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810262|NCT00365976|Eszopiclone|eszopiclone|mesh-list
56810263|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56810264|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810265|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810266|NCT00378534|Cyclosporine|cyclosporine|mesh-list
56810267|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
56810268|NCT00378534|Fludarabine|fludarabine|mesh-list
56810289|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810290|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
56810291|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
56810292|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810293|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810294|NCT00377520|Pemetrexed|pemetrexed|mesh-list
56810295|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810296|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810297|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810298|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56810299|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56810300|NCT00377364|Acetaminophen|acetaminophen|mesh-list
56810301|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56810302|NCT00377364|Analgesics|analgesics|mesh-ancestor
56810303|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
56810304|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810305|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810306|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
56810307|NCT00365508|Nicotine|nicotine|mesh-list
56810308|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56810309|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
56810310|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810311|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810312|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56810313|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56810314|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
56810315|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810316|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810317|NCT00365352|Gabapentin|gabapentin|mesh-list
56810318|NCT00365352|Analgesics|analgesics|mesh-ancestor
56810319|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
56810320|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810321|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810322|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
56810323|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56810327|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56810328|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56810329|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810330|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810331|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
56810332|NCT00410384|Belimumab|belimumab|mesh-list
56810333|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810334|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
56810335|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810336|NCT00370032|Alosetron|alosetron|mesh-list
56810337|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56810338|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56810339|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
56810388|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56810389|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810390|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810391|NCT01039766|Oxytocin|oxytocin|mesh-list
56810392|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
56810393|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56810394|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810395|NCT00409682|Adalimumab|adalimumab|mesh-list
56810396|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56810397|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810398|NCT01039844|Paclitaxel|paclitaxel|mesh-list
56810399|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56810400|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810401|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
56810402|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
56810403|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
56810404|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810405|NCT01042028|Capecitabine|capecitabine|mesh-list
56810406|NCT01042028|Irinotecan|irinotecan|mesh-list
56810407|NCT01042028|Cetuximab|cetuximab|mesh-list
56810408|NCT01042028|Everolimus|everolimus|mesh-list
56810409|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
56810410|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56810411|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
56810412|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810413|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810414|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56810415|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56810416|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810417|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56810418|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810432|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810433|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
56810434|NCT00398138|Sargramostim|sargramostim|mesh-list
56810435|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
56810436|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
56810437|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810438|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56810439|NCT04566380|Capecitabine|capecitabine|mesh-list
56810440|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
56810441|NCT04566380|Nivolumab|nivolumab|mesh-list
56810442|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56810444|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810445|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810446|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56810447|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56810448|NCT02095184|Letrozole|letrozole|mesh-list
56810449|NCT02095184|Anastrozole|anastrozole|mesh-list
56810450|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810451|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56810452|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56810453|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810454|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810455|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56810456|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
56810457|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56810458|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810459|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56810460|NCT00397982|Sirolimus|sirolimus|mesh-list
56810461|NCT00397982|Bevacizumab|bevacizumab|mesh-list
56810478|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
56810479|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810480|NCT03715166|Bumetanide|bumetanide|mesh-list
56810481|NCT03715166|Diuretics|diuretics|mesh-ancestor
56810482|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
56810483|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810484|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56810485|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810486|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810487|NCT01042574|Clevidipine|clevidipine|mesh-list
56810488|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56810489|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810490|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810491|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56810492|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810493|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
56810494|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56810495|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56810496|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
56810497|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810498|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56810499|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56810500|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810501|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810502|NCT01040078|Vaccines|vaccines|mesh-list
56810503|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
56810504|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810505|NCT01035320|Simvastatin|simvastatin|mesh-list
56810506|NCT01035320|Ezetimibe|ezetimibe|mesh-list
56810507|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56810509|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
56810519|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810520|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810521|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56810522|NCT00396812|Rituximab|rituximab|mesh-list
56810523|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56810524|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810525|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
56810526|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810527|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810528|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
56810529|NCT03636152|Chloroquine|chloroquine|mesh-list
56810530|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
56810531|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56810532|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56810533|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810534|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810535|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810536|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810537|NCT03636152|Amebicides|amebicides|mesh-ancestor
56810538|NCT01566578|Mitogens|mitogens|mesh-list
56810539|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56810540|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810541|NCT01040234|Bupivacaine|bupivacaine|mesh-list
56810542|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
56810543|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
56810544|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810545|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810546|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
56810547|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810548|NCT00396656|Atenolol|atenolol|mesh-list
56810549|NCT00396656|Valsartan|valsartan|mesh-list
56810550|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56810551|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56810552|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56810553|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56810555|NCT00396656|Diuretics|diuretics|mesh-ancestor
56810558|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56810559|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810560|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56810561|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
56810562|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
56810563|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810564|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56810565|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56810566|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56810567|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
56810568|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810569|NCT00408434|Efatutazone|efatutazone|mesh-list
56810570|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810571|NCT00418886|Pemetrexed|pemetrexed|mesh-list
56810572|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810573|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810574|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810575|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56810576|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56810577|NCT01040312|Cisplatin|cisplatin|mesh-list
56810578|NCT01040312|Carboplatin|carboplatin|mesh-list
56810579|NCT01040312|Nedaplatin|nedaplatin|mesh-list
56810580|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810581|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56810582|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56810583|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56810584|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810585|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810586|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56810587|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810588|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810589|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
56521515|NCT01297062|Incretins|incretins|mesh-ancestor
56810590|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810591|NCT00406640|Citalopram|citalopram|mesh-list
56810595|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810596|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810597|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810598|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
56810599|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810600|NCT00406640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56810601|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
56810602|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810603|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56810604|NCT01043510|Insulin|insulin|mesh-list
56810605|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56810606|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
56810607|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56810608|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810609|NCT01043666|Mirabegron|mirabegron|mesh-list
56810610|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56810611|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56810612|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56810613|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56810614|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
56810615|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810616|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810617|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810618|NCT01043666|Urological Agents|urological agents|mesh-ancestor
56810619|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56810620|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56810621|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
56810622|NCT00394472|Lesogaberan|lesogaberan|mesh-list
56810623|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56810624|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56810625|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
56810626|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
56810635|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810636|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56810637|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56810638|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810639|NCT01043744|Lumefantrine|lumefantrine|mesh-list
56810640|NCT01043744|Artemether|artemether|mesh-list
56810641|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56810642|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
56810643|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56810644|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56810645|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810646|NCT00395018|Entecavir|entecavir|mesh-list
56810647|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
56810648|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810649|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
56810650|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56810651|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56810652|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810653|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
56810654|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810655|NCT00375518|Atorvastatin|atorvastatin|mesh-list
56810656|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56810657|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56810658|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
56810659|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810660|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56810661|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56810662|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810663|NCT01045772|Rilonacept|rilonacept|mesh-list
56810664|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56810665|NCT01045928|Rituximab|rituximab|mesh-list
56810666|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56810667|NCT01045928|Lenalidomide|lenalidomide|mesh-list
56810668|NCT01045928|Antibodies|antibodies|mesh-list
56810669|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
56810676|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56810677|NCT01045928|Growth Substances|growth substances|mesh-ancestor
56810678|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
56810679|NCT00256750|Cyclosporine|cyclosporine|mesh-list
56810680|NCT00256750|Abatacept|abatacept|mesh-list
56810681|NCT00256750|Cyclosporins|cyclosporins|mesh-list
56810682|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810683|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810684|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810685|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
56810686|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810687|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
56810688|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810689|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
56810690|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810691|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56810692|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56810693|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810694|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
56810695|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
56810696|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
56810697|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
56810698|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
56810699|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56810700|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810702|NCT00203476|Ezetimibe|ezetimibe|mesh-list
56810703|NCT00203476|Colestipol|colestipol|mesh-list
56810704|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56810705|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56810706|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
56810707|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810708|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56810709|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
56810710|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
56810711|NCT00203476|Vitamins|vitamins|mesh-ancestor
56810718|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810719|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
56810720|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810721|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810722|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
56810723|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56810724|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810725|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810726|NCT00200356|Ozagrel|ozagrel|mesh-list
56810727|NCT00200356|Edaravone|edaravone|mesh-list
56810728|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56810729|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
56810730|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810731|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56810732|NCT00200356|Protective Agents|protective agents|mesh-ancestor
56810733|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810734|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810735|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56810736|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56810737|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
56521666|NCT01075048|Irinotecan|irinotecan|mesh-list
56810738|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
56810739|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810740|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56810741|NCT00227266|Valproic Acid|valproic acid|mesh-list
56810742|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
56810743|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810744|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810745|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
56810746|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810747|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810748|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
56810749|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56810761|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
56810762|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810763|NCT00256204|Rasagiline|rasagiline|mesh-list
56810764|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56810765|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810766|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810767|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56810768|NCT00256204|Protective Agents|protective agents|mesh-ancestor
56810769|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810770|NCT03972358|Misoprostol|misoprostol|mesh-list
56810771|NCT03972358|Mifepristone|mifepristone|mesh-list
56810772|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56810773|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
56810774|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56810775|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810776|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56810777|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56810778|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
56810779|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56810780|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56810781|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56810782|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56810783|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
56810784|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56810785|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56810786|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
56810787|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56810788|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
56810789|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56810790|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56810791|NCT01073332|Antioxidants|antioxidants|mesh-list
56810802|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56810803|NCT01071772|Insulin|insulin|mesh-list
56810804|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56810805|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810806|NCT01074346|Interferons|interferons|mesh-list
56810807|NCT01074346|Interferon-beta|interferon-beta|mesh-list
56810808|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
56810809|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810810|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
56810811|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810812|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
56810813|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810814|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56810815|NCT00278889|Leucovorin|leucovorin|mesh-list
56810816|NCT00278889|Bevacizumab|bevacizumab|mesh-list
56810817|NCT00278889|Fluorouracil|fluorouracil|mesh-list
56810818|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
56810820|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56810821|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810822|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56810823|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56810824|NCT00278889|Growth Substances|growth substances|mesh-ancestor
56810825|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810826|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
56810827|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
56810828|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810829|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56810830|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810831|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
56810832|NCT00278889|Antidotes|antidotes|mesh-ancestor
56810833|NCT00278889|Protective Agents|protective agents|mesh-ancestor
56810834|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
56810835|NCT00278889|Vitamins|vitamins|mesh-ancestor
56810836|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
56810837|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56810838|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810839|NCT01070745|Ibuprofen|ibuprofen|mesh-list
56810840|NCT01070745|Indomethacin|indomethacin|mesh-list
56810842|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56810843|NCT01070745|Analgesics|analgesics|mesh-ancestor
56810844|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
56810845|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810846|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810847|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56810848|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810849|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56810850|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810851|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810852|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
56810853|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
56810854|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56810855|NCT01071057|Morphine|morphine|mesh-list
56810856|NCT01071057|Naloxone|naloxone|mesh-list
56810857|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56810858|NCT01071057|Narcotics|narcotics|mesh-ancestor
56810859|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810860|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810861|NCT01071057|Analgesics|analgesics|mesh-ancestor
56810862|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
56810863|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56810864|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56810865|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
56810866|NCT00278109|Doxorubicin|doxorubicin|mesh-list
56810867|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56810868|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
56810869|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810870|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56810871|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56810886|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56810887|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810888|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
56810889|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810890|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810891|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56521810|NCT02874820|Idazoxan|idazoxan|mesh-list
56810892|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56810893|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810894|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56810895|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56810896|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56810897|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810898|NCT00266409|Alprazolam|alprazolam|mesh-list
56810899|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56810900|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810901|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810902|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56810903|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56810904|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810905|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
56810906|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
56810907|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56810908|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810909|NCT00265785|Pemetrexed|pemetrexed|mesh-list
56810910|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810911|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810912|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810913|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56810928|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810929|NCT00265395|Interferons|interferons|mesh-list
56810930|NCT00265395|Ribavirin|ribavirin|mesh-list
56810931|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
56810932|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
56810933|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56810934|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810935|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
56810936|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56810937|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
56810938|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810939|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
56810940|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810941|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56810942|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
56810943|NCT00195442|Factor VIII|factor viii|mesh-list
56810944|NCT00195442|Coagulants|coagulants|mesh-ancestor
56810945|NCT01070823|Natalizumab|natalizumab|mesh-list
56810946|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
56810947|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810948|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56810949|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
56810950|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56810951|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56810952|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56810953|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56810954|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810955|NCT00275301|Olanzapine|olanzapine|mesh-list
56810956|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
56810957|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
56810973|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56810974|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
56810976|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56810977|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56810978|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56810979|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810980|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810981|NCT00255346|Dasatinib|dasatinib|mesh-list
56810982|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56810983|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56810984|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810985|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810986|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
56810987|NCT00255190|Lansoprazole|lansoprazole|mesh-list
56810988|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56810989|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56810990|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56810991|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56810992|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810993|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56810994|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56810995|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56810996|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56810997|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
56810998|NCT01049646|Giapreza|giapreza|mesh-list
56810999|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
56811000|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56811001|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56811021|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811022|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56811023|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56811024|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
56811025|NCT02286414|Coagulants|coagulants|mesh-ancestor
56811026|NCT00255034|Ribavirin|ribavirin|mesh-list
56811027|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56811028|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
56811029|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
56811030|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811031|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
56811032|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811033|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
56811034|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811035|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
56811036|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811037|NCT00254566|Azithromycin|azithromycin|mesh-list
56811038|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
56811039|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56811040|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56811041|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811042|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56811043|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56811044|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811045|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811046|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811047|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56811048|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
56811049|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56811050|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811051|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56811052|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56811053|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56811054|NCT02531854|Pemetrexed|pemetrexed|mesh-list
56811055|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811056|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811058|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56811059|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56811060|NCT01048086|Tretinoin|tretinoin|mesh-list
56811061|NCT01048086|Isotretinoin|isotretinoin|mesh-list
56811062|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811063|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
56811064|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
56811065|NCT03830892|Nicotine|nicotine|mesh-list
56811066|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56811067|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
56811068|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811069|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811070|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56811071|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56811072|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
56811073|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811074|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811075|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
56811076|NCT01049880|Gemcitabine|gemcitabine|mesh-list
56811077|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56811078|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
56811079|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811080|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811081|NCT01049880|Antiviral Agents|antiviral agents|mesh-ancestor
56811082|NCT01049880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811083|NCT01049880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811084|NCT01049880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811085|NCT01049880|Immunologic Factors|immunologic factors|mesh-ancestor
56811086|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811087|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
56811088|NCT01049880|Protective Agents|protective agents|mesh-ancestor
56811089|NCT01049880|Vitamins|vitamins|mesh-ancestor
56811091|NCT00253630|Vorinostat|vorinostat|mesh-list
56811101|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811102|NCT01048320|Gemcitabine|gemcitabine|mesh-list
56811103|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
56811104|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
56811105|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56811106|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
56811107|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811108|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811109|NCT01048320|Antiviral Agents|antiviral agents|mesh-ancestor
56811110|NCT01048320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811111|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811112|NCT01048320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811113|NCT01048320|Immunologic Factors|immunologic factors|mesh-ancestor
56811114|NCT01048320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811115|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56811116|NCT03990480|Amlodipine|amlodipine|mesh-list
56811117|NCT03990480|Valsartan|valsartan|mesh-list
56811118|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56811119|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56811120|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56811121|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811122|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56811123|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811124|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
56811125|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56811126|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56811127|NCT00369486|Triamcinolone|triamcinolone|mesh-list
56811128|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56811146|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811147|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811148|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56811149|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
56811150|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
56811151|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56811152|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56811153|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56811154|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56811155|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
56811156|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811157|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811158|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
56811159|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56811160|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56811161|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56811162|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56811163|NCT01048398|Acetaminophen|acetaminophen|mesh-list
56811164|NCT01048398|Remifentanil|remifentanil|mesh-list
56811165|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56811166|NCT01048398|Analgesics|analgesics|mesh-ancestor
56811167|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
56811168|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811169|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811170|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
56811171|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56811172|NCT01048398|Narcotics|narcotics|mesh-ancestor
56811173|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56811192|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522104|NCT01029886|Hormones|hormones|mesh-ancestor
56811193|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
56811194|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56811195|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56811196|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56811197|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56811198|NCT00221104|Pravastatin|pravastatin|mesh-list
56811199|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56811200|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56811201|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
56811202|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811203|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56811204|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56811205|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811206|NCT00189202|Sirolimus|sirolimus|mesh-list
56811207|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56811208|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811209|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56811210|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811211|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
56811212|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811213|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
56811214|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811240|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811241|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56811242|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56811243|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
56811244|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56811245|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56811246|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56811247|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56811248|NCT00362232|Enoxaparin|enoxaparin|mesh-list
56811249|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
56811250|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
56811251|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56811252|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
56811253|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56811254|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
56811255|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811256|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811257|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
56811258|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56811259|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56811260|NCT01048554|Bevacizumab|bevacizumab|mesh-list
56811261|NCT01048554|Temozolomide|temozolomide|mesh-list
56811262|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56811263|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811264|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56811265|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56811266|NCT01048554|Growth Substances|growth substances|mesh-ancestor
56522180|NCT01061710|Varenicline|varenicline|mesh-list
56811267|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811268|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
56811269|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56811270|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
56811271|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811272|NCT00219544|Pregabalin|pregabalin|mesh-list
56811279|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56811280|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811281|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56811282|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56811283|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56811284|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56811285|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56811286|NCT00357552|Ritonavir|ritonavir|mesh-list
56811287|NCT00357552|Lopinavir|lopinavir|mesh-list
56811288|NCT00357552|Tenofovir|tenofovir|mesh-list
56811289|NCT00357552|Emtricitabine|emtricitabine|mesh-list
56811290|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56811291|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56811292|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56811293|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
56811294|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811295|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811296|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56811297|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56811298|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
56811299|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811300|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56811301|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56811328|NCT00357396|Melphalan|melphalan|mesh-list
56811329|NCT00357396|Busulfan|busulfan|mesh-list
56811330|NCT00357396|Thiotepa|thiotepa|mesh-list
56811331|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56811332|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
56811333|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811334|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811335|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56811336|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811337|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
56811338|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811339|NCT00186628|Acetaminophen|acetaminophen|mesh-list
56811340|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
56811341|NCT00186628|Promethazine|promethazine|mesh-list
56811342|NCT00186628|Cyclosporine|cyclosporine|mesh-list
56811343|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
56811344|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
56811345|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56811346|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56811347|NCT00186628|Prednisolone|prednisolone|mesh-list
56811348|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
56811349|NCT00186628|Rituximab|rituximab|mesh-list
56811350|NCT00186628|Granisetron|granisetron|mesh-list
56811351|NCT00186628|Lenograstim|lenograstim|mesh-list
56811352|NCT00186628|Cyclosporins|cyclosporins|mesh-list
56811353|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
56811354|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56811355|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56811356|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
56811357|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56811358|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811377|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
56811378|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56811379|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
56811380|NCT00186628|Hormones|hormones|mesh-ancestor
56811381|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56811382|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56811383|NCT00186628|Protective Agents|protective agents|mesh-ancestor
56811384|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56811385|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56811386|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56811387|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56811388|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
56811389|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
56811390|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56811391|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
56811392|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
56811393|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811394|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56811395|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
56811396|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56811397|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
56811398|NCT00368550|Sertraline|sertraline|mesh-list
56811399|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
56811400|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56811401|NCT00368550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56811402|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56811403|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56811404|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811405|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811406|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
56811407|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811408|NCT01050036|Busulfan|busulfan|mesh-list
56811409|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
56811410|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811411|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811412|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
56194603|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194604|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
56811413|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811414|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56811415|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811416|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56811417|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56811418|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56811419|NCT00357006|Estradiol|estradiol|mesh-list
56811420|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56811421|NCT00357006|Estrogens|estrogens|mesh-ancestor
56811422|NCT00357006|Hormones|hormones|mesh-ancestor
56811423|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56811424|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811425|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56811426|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
56811427|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56811428|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56811429|NCT01050114|Oxybutynin|oxybutynin|mesh-list
56811430|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56811431|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56811432|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811433|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811434|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56811435|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56811436|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811437|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
56811438|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811439|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
56811440|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
56811441|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56811442|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56811443|NCT01050114|Urological Agents|urological agents|mesh-ancestor
56811454|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811455|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811456|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
56811457|NCT01050270|Ondansetron|ondansetron|mesh-list
56811458|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56811459|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
56811460|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
56811461|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811462|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811463|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56811464|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
56811465|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
56811466|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56811467|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
56811468|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811469|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811470|NCT01050270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56811471|NCT01050270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56811472|NCT01050270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56811473|NCT01050270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56811474|NCT01050270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56811475|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
56811476|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811477|NCT01050270|Expectorants|expectorants|mesh-ancestor
56811478|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
56811479|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56811480|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
56811481|NCT01050270|Protective Agents|protective agents|mesh-ancestor
56811482|NCT01050270|Antidotes|antidotes|mesh-ancestor
56811483|NCT00367770|Bosentan|bosentan|mesh-list
56811484|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56811485|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56811499|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811500|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811501|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56811502|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56811503|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811504|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
56811505|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811506|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
56811507|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56811508|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56811509|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56811510|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
56811511|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56811513|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56811514|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
56811515|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811516|NCT00361842|Irinotecan|irinotecan|mesh-list
56811517|NCT00361842|Floxuridine|floxuridine|mesh-list
56811518|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56811519|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56811520|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811521|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811522|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811523|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56811524|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
56811525|NCT01324752|Losartan|losartan|mesh-list
56811526|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56811527|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56811545|NCT01053390|Somatostatin|somatostatin|mesh-list
56811546|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811547|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
56811548|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811549|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56811550|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811551|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
56811552|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811553|NCT01053390|Antidotes|antidotes|mesh-ancestor
56811554|NCT01053390|Protective Agents|protective agents|mesh-ancestor
56811555|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
56811556|NCT01053390|Vitamins|vitamins|mesh-ancestor
56811557|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
56811558|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56811559|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56811560|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56811561|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811562|NCT01053390|Hormones|hormones|mesh-ancestor
56811563|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56811564|NCT00356148|Ampicillin|ampicillin|mesh-list
56811565|NCT00356148|Sulbactam|sulbactam|mesh-list
56811566|NCT00356148|Sultamicillin|sultamicillin|mesh-list
56811567|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56811568|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811569|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56811570|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811571|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811572|NCT00361218|Citalopram|citalopram|mesh-list
56811573|NCT00361218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56811574|NCT00361218|Serotonin|serotonin|mesh-list
56811575|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56811576|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56811585|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
56811587|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56811588|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811589|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56811590|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56811591|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811592|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811593|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811594|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56811595|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
56811596|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56811597|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811598|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56811599|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56811600|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56811601|NCT02534610|Etoricoxib|etoricoxib|mesh-list
56811602|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56811603|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56811604|NCT02534610|Analgesics|analgesics|mesh-ancestor
56811605|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
56811606|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811607|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811608|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56811609|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56811610|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56811611|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56811612|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811613|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811614|NCT01050426|Leucovorin|leucovorin|mesh-list
56811615|NCT01050426|Cetuximab|cetuximab|mesh-list
56811630|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56811631|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56811632|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811633|NCT00252694|Candesartan|candesartan|mesh-list
56811634|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56811635|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56811636|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56811637|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811638|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
56811639|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56811640|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
56811641|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56811642|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811643|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56811644|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56811645|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56811646|NCT01077466|Natalizumab|natalizumab|mesh-list
56811647|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
56811648|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811649|NCT00160654|Levetiracetam|levetiracetam|mesh-list
56811650|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
56811651|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
56811652|NCT01582672|Sunitinib|sunitinib|mesh-list
56811653|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811662|NCT00366678|Vaccines|vaccines|mesh-list
56811679|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811680|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811681|NCT00355368|Rocuronium|rocuronium|mesh-list
56811682|NCT00355368|Succinylcholine|succinylcholine|mesh-list
56811683|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56811684|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56811685|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56811686|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811687|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811688|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56811689|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
56811690|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56811691|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811692|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56811693|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811694|NCT00360282|Rizatriptan|rizatriptan|mesh-list
56811695|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56811696|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
56811697|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811698|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811699|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811700|NCT00373958|Vaccines|vaccines|mesh-list
56811701|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56811702|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
56811726|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811727|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56811728|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56811729|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56811730|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56811731|NCT00184600|Insulin|insulin|mesh-list
56811732|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56811733|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
56811734|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
56811735|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56811736|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
56811737|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
56811738|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56811739|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811740|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56811741|NCT00265317|Sunitinib|sunitinib|mesh-list
56811742|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811743|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56811744|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811745|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811746|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56811747|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56811748|NCT00265317|Growth Substances|growth substances|mesh-ancestor
56811749|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811750|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
56811751|NCT00373490|Vorinostat|vorinostat|mesh-list
56811752|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811753|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56811754|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811755|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811756|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56811757|NCT00251589|Vorinostat|vorinostat|mesh-list
56811758|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811766|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811767|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56811768|NCT00265239|Protective Agents|protective agents|mesh-ancestor
56811769|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811770|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
56811771|NCT00159874|Citric Acid|citric acid|mesh-list
56811772|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
56811773|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
56811774|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56811775|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
56811776|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
56811777|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811778|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
56811779|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56811780|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56811781|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811782|NCT00159874|Urological Agents|urological agents|mesh-ancestor
56811783|NCT03989778|Vitamin D|vitamin d|mesh-list
56811784|NCT03989778|Vitamins|vitamins|mesh-ancestor
56811785|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
56811786|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811787|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56811788|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
56811789|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
56811790|NCT00184054|Vitamins|vitamins|mesh-ancestor
56811791|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
56811792|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811793|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
56811815|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811816|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811817|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811818|NCT00183274|Norepinephrine|norepinephrine|mesh-list
56811819|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56811820|NCT00183274|Serotonin|serotonin|mesh-list
56811821|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
56811822|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56811823|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56811824|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
56811825|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811826|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811827|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811828|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
56811829|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
56811830|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811831|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56811832|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56811833|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56811834|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56811835|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
56811836|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56811837|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56811838|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
56811839|NCT00183196|Naltrexone|naltrexone|mesh-list
56811840|NCT00183196|Gabapentin|gabapentin|mesh-list
56811841|NCT00183196|Analgesics|analgesics|mesh-ancestor
56811842|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
56811843|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811844|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811845|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
56811846|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56811847|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56811853|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811854|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
56811855|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56811856|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56811857|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
56811858|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811859|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
56811860|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811861|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56811862|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
56811863|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56811864|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811865|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56811866|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811867|NCT00348816|Prednisone|prednisone|mesh-list
56811868|NCT00348816|Docetaxel|docetaxel|mesh-list
56811869|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811870|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
56811871|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
56811872|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
56811873|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811874|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56811875|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
56811876|NCT00348816|Hormones|hormones|mesh-ancestor
56811877|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56811878|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811879|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56811880|NCT03989310|Manganese|manganese|mesh-list
56811881|NCT03989310|Gemcitabine|gemcitabine|mesh-list
56811882|NCT03989310|Paclitaxel|paclitaxel|mesh-list
56811883|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56811884|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56811885|NCT03989310|Antibodies|antibodies|mesh-list
56811886|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
56811887|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56811888|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811889|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
56811891|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
56811892|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811893|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
56811894|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811895|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56811896|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
56811897|NCT03989310|Antiviral Agents|antiviral agents|mesh-ancestor
56811898|NCT03989310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811899|NCT03989310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811900|NCT03989310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811901|NCT03989310|Trace Elements|trace elements|mesh-ancestor
56811902|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
56811903|NCT03966898|Letrozole|letrozole|mesh-list
56811904|NCT03966898|Anastrozole|anastrozole|mesh-list
56811905|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56811906|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56811907|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56811908|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811909|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811910|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56811911|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
56811912|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56811913|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811914|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56811915|NCT03989700|Thiamine|thiamine|mesh-list
56811916|NCT03989700|Vitamins|vitamins|mesh-ancestor
56811917|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
56811918|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811919|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
56811920|NCT01051284|Gemcitabine|gemcitabine|mesh-list
56811933|NCT01055808|Insulin|insulin|mesh-list
56811935|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811936|NCT00265083|Golimumab|golimumab|mesh-list
56811937|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56811938|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56811939|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56811940|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811941|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
56811942|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811943|NCT00264849|Omalizumab|omalizumab|mesh-list
56811944|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56811945|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56811946|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
56811947|NCT01073709|Acetaminophen|acetaminophen|mesh-list
56811948|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56811949|NCT01073709|Analgesics|analgesics|mesh-ancestor
56811950|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
56811951|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56811952|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811953|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
56811954|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56811955|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56811956|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56811957|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56811958|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811959|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811960|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811961|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56811962|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
56811963|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56811964|NCT01071291|Niacin|niacin|mesh-list
56811965|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
56811966|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56811967|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
56811968|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811969|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56811970|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
56811972|NCT01071291|Vitamins|vitamins|mesh-ancestor
56811973|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
56811974|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811975|NCT00129766|Palivizumab|palivizumab|mesh-list
56811976|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
56811977|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811978|NCT00150592|Guanfacine|guanfacine|mesh-list
56811979|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56811980|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56811981|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56811982|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56811983|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
56811984|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56811985|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811986|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811987|NCT00149890|Cyclosporine|cyclosporine|mesh-list
56811988|NCT00149890|Cyclosporins|cyclosporins|mesh-list
56811989|NCT00149890|Basiliximab|basiliximab|mesh-list
56811990|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56811991|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56811992|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56811993|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
56811994|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56811995|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
56811996|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56811997|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
56811998|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56811999|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56812000|NCT00174382|Donepezil|donepezil|mesh-list
56812001|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56812016|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812017|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812018|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
56812019|NCT00348348|Besifloxacin|besifloxacin|mesh-list
56812020|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56812021|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812022|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56812023|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56812024|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812025|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812026|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812027|NCT00354744|Dactinomycin|dactinomycin|mesh-list
56812028|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
56812029|NCT00354744|Ifosfamide|ifosfamide|mesh-list
56812030|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
56812031|NCT00354744|Doxorubicin|doxorubicin|mesh-list
56812032|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56812033|NCT00354744|Irinotecan|irinotecan|mesh-list
56812034|NCT00354744|Etoposide|etoposide|mesh-list
56812035|NCT00354744|Vincristine|vincristine|mesh-list
56812036|NCT00354744|Camptothecin|camptothecin|mesh-list
56812037|NCT00354744|Lenograstim|lenograstim|mesh-list
56812038|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56812039|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
56812040|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812041|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56812042|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56812043|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
56812044|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812045|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812046|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56812047|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56812048|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56084518|NCT05732155|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56084519|NCT05732155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56084520|NCT05732155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56084521|NCT05732155|Adrenergic Agents|adrenergic agents|mesh-ancestor
55741398|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56084532|NCT05528419|Valsartan|valsartan|mesh-list
56084533|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56084534|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56084536|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56812058|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812059|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56812060|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56812061|NCT01055964|Tacrolimus|tacrolimus|mesh-list
56812062|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56812063|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
56812064|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812065|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56812066|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812067|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812068|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56812069|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56812070|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
56812071|NCT01056042|Gestodene|gestodene|mesh-list
56812072|NCT01056042|Estradiol|estradiol|mesh-list
56812073|NCT01056042|Estrogens|estrogens|mesh-ancestor
56812074|NCT01056042|Hormones|hormones|mesh-ancestor
56812097|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812098|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56812099|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56812100|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56812101|NCT00373256|Growth Substances|growth substances|mesh-ancestor
56812102|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812103|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
56812104|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56812105|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812106|NCT01324544|Buprenorphine|buprenorphine|mesh-list
56812107|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56812108|NCT01324544|Narcotics|narcotics|mesh-ancestor
56812109|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812110|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812111|NCT01324544|Analgesics|analgesics|mesh-ancestor
56812112|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
56812113|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812114|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56812115|NCT00394082|Paclitaxel|paclitaxel|mesh-list
56812116|NCT00394082|Bevacizumab|bevacizumab|mesh-list
56812117|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56812118|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56812119|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812120|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812121|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
56812122|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
56812123|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812124|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56812125|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56812130|NCT00393848|Ketoconazole|ketoconazole|mesh-list
56812139|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812140|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812141|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56812142|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
56812143|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56812144|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
56812145|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812146|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812147|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56812148|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
56812149|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56812150|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56812151|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56812152|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
56812153|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812154|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812155|NCT00392990|Cytarabine|cytarabine|mesh-list
56812156|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
56812157|NCT00392990|Ifosfamide|ifosfamide|mesh-list
56812158|NCT00392990|Rituximab|rituximab|mesh-list
56812159|NCT00392990|Doxorubicin|doxorubicin|mesh-list
56812160|NCT00392990|Methotrexate|methotrexate|mesh-list
56812161|NCT00392990|Etoposide|etoposide|mesh-list
56812162|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
56812163|NCT00392990|Vincristine|vincristine|mesh-list
56812164|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56812165|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
56812186|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56812187|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56812188|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56812189|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
56812190|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812191|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812192|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
56812193|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
56812194|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
56812195|NCT01046006|Dexamethasone|dexamethasone|mesh-list
56812196|NCT01046006|Rituximab|rituximab|mesh-list
56812197|NCT01046006|Bortezomib|bortezomib|mesh-list
56812198|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56812199|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812200|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
56812201|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812202|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56812203|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56812204|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
56812205|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
56812206|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812207|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56812208|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
56812209|NCT01046006|Hormones|hormones|mesh-ancestor
56812210|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812211|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56812212|NCT01046162|Alprazolam|alprazolam|mesh-list
56812213|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56812214|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812215|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812231|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812232|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56812233|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56812234|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
56812235|NCT00417248|Etoposide|etoposide|mesh-list
56812236|NCT00417248|Sorafenib|sorafenib|mesh-list
56812237|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812238|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56812239|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56812240|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56812241|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812242|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812243|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56812245|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
56812246|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
56812247|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812248|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812249|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56812250|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56812251|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56812252|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
56812253|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812254|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812255|NCT00392288|Ciclesonide|ciclesonide|mesh-list
56812256|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
56812257|NCT00392288|Hormones|hormones|mesh-ancestor
56812258|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812259|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812260|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56812261|NCT00417170|Amlodipine|amlodipine|mesh-list
56812270|NCT01840592|Sorafenib|sorafenib|mesh-list
56812274|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56812275|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812276|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812277|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56812278|NCT00249873|Clopidogrel|clopidogrel|mesh-list
56812279|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56812280|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56812281|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56812282|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56812283|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
56812284|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812285|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812286|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812287|NCT01037348|Ranibizumab|ranibizumab|mesh-list
56812288|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56812289|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56812290|NCT01037348|Growth Substances|growth substances|mesh-ancestor
56812291|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812292|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
56812293|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812294|NCT03490292|Paclitaxel|paclitaxel|mesh-list
56812295|NCT03490292|Carboplatin|carboplatin|mesh-list
56812296|NCT03490292|Avelumab|avelumab|mesh-list
56812297|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56812298|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812299|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812300|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
56812301|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
56812302|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812303|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56812316|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812317|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812319|NCT01046708|Progestins|progestins|mesh-ancestor
56812320|NCT01046708|Hormones|hormones|mesh-ancestor
56812321|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812322|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812323|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
56812324|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56812325|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56812326|NCT01046786|Prednisolone|prednisolone|mesh-list
56812327|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
56812328|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56812329|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
56812330|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56812331|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
56812332|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
56812333|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812334|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812335|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56812336|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
56812337|NCT01046786|Hormones|hormones|mesh-ancestor
56812338|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812339|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56812340|NCT01046786|Protective Agents|protective agents|mesh-ancestor
56812343|NCT00391976|Tobramycin|tobramycin|mesh-list
56812367|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56812368|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812369|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56812370|NCT01046864|Leucovorin|leucovorin|mesh-list
56812371|NCT01046864|Fluorouracil|fluorouracil|mesh-list
56812372|NCT01046864|Irinotecan|irinotecan|mesh-list
56812373|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
56812374|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812375|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56812376|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812377|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56812378|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
56812379|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812380|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56812381|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56812382|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812383|NCT01046864|Antidotes|antidotes|mesh-ancestor
56812384|NCT01046864|Protective Agents|protective agents|mesh-ancestor
56812385|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
56812386|NCT01046864|Vitamins|vitamins|mesh-ancestor
56812387|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
56812388|NCT01046942|Aspirin|aspirin|mesh-list
56812389|NCT01046942|Clopidogrel|clopidogrel|mesh-list
56812390|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56812391|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56812392|NCT01046942|Analgesics|analgesics|mesh-ancestor
56812393|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
56812394|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812395|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812413|NCT01049438|Mupirocin|mupirocin|mesh-list
56812414|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56812415|NCT01049438|Trimethoprim|trimethoprim|mesh-list
56812416|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
56812417|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
56812418|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812419|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
56812420|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56812421|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56812422|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56812423|NCT01049438|Renal Agents|renal agents|mesh-ancestor
56812424|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56812425|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812426|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812427|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56812428|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56812429|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56812430|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56812431|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56812433|NCT01047098|Trace Elements|trace elements|mesh-ancestor
56812434|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
56812435|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812436|NCT00391586|Gemcitabine|gemcitabine|mesh-list
56812437|NCT00391586|Paclitaxel|paclitaxel|mesh-list
56812438|NCT00391586|Etoposide|etoposide|mesh-list
56812439|NCT00391586|Vinorelbine|vinorelbine|mesh-list
56812440|NCT00391586|Docetaxel|docetaxel|mesh-list
56812441|NCT00391586|Irinotecan|irinotecan|mesh-list
56812442|NCT00391586|Pemetrexed|pemetrexed|mesh-list
56812443|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56812444|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56812445|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812459|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56812460|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56812461|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56812462|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56812463|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56812464|NCT00391430|Sertraline|sertraline|mesh-list
56812465|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
56812466|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56812467|NCT00391430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56812468|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56812469|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56812470|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812472|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
56812473|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812474|NCT00391274|Docetaxel|docetaxel|mesh-list
56812475|NCT00391274|Pemetrexed|pemetrexed|mesh-list
56812476|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812477|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812478|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
56812479|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
56812480|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812481|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812482|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56812483|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56812484|NCT00391118|Paclitaxel|paclitaxel|mesh-list
56812485|NCT00391118|Carboplatin|carboplatin|mesh-list
56812486|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56812487|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812488|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812489|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56812490|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56812491|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812502|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56812503|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56812504|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812505|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56812506|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56812507|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56812508|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812509|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56812510|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56812511|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
56812512|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56812513|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56812514|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
56812515|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812516|NCT01047566|Digoxin|digoxin|mesh-list
56812517|NCT01047566|Dronedarone|dronedarone|mesh-list
56812518|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
56812519|NCT01047566|Calcium|calcium|mesh-list
56812520|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56812521|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56812522|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812523|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56812552|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56812553|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56812554|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56812555|NCT00371150|Entecavir|entecavir|mesh-list
56812556|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
56812557|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812558|NCT00264303|Levocetirizine|levocetirizine|mesh-list
56812559|NCT00264303|Desloratadine|desloratadine|mesh-list
56812560|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56812561|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56812562|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
56812563|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
56812564|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812565|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812566|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812567|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56812568|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
56812569|NCT01071369|Betamethasone|betamethasone|mesh-list
56812570|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
56812571|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56812572|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
56812573|NCT01071369|Lidocaine|lidocaine|mesh-list
56812574|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56812575|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
56812576|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
56812577|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812578|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812579|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
56812598|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56812599|NCT00264147|Analgesics|analgesics|mesh-ancestor
56812600|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
56812601|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812602|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812603|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56812604|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56812605|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56812606|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812607|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812608|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56812609|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
56812610|NCT01044446|Icodextrin|icodextrin|mesh-list
56812611|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56812612|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
56812613|NCT03971019|Atorvastatin|atorvastatin|mesh-list
56812614|NCT03971019|Simvastatin|simvastatin|mesh-list
56812615|NCT03971019|Calcium|calcium|mesh-list
56812616|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56812617|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812618|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56812619|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56812620|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56812621|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
56812622|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812648|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56812649|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56812650|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56812651|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56812652|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812653|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56812654|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56812655|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812656|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
56812657|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56812658|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56812659|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56812660|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
56812661|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812662|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
56812663|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56812664|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
56812665|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812666|NCT00248625|Expectorants|expectorants|mesh-ancestor
56812667|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
56812668|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56812669|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
56812670|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812671|NCT00248625|Protective Agents|protective agents|mesh-ancestor
56812672|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812673|NCT00248625|Antidotes|antidotes|mesh-ancestor
56812674|NCT00262821|Tirapazamine|tirapazamine|mesh-list
56812675|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812676|NCT01326117|Tadalafil|tadalafil|mesh-list
56812677|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
56812678|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56812679|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56812680|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812690|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
56812691|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812692|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812693|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56812694|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56812696|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56812697|NCT00170950|Benazepril|benazepril|mesh-list
56812698|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56812699|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56812700|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56812701|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812702|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56812703|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812704|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
56812705|NCT00170950|Diuretics|diuretics|mesh-ancestor
56812706|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
56812749|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56812750|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812751|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812752|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812753|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
56812754|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812755|NCT01047722|Aspirin|aspirin|mesh-list
56812756|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56812757|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56812758|NCT01047722|Analgesics|analgesics|mesh-ancestor
56812759|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
56812760|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812761|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812762|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56812763|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56812764|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56812765|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56812766|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812767|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56812768|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56523680|NCT02868931|Insulin|insulin|mesh-list
56812770|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
56812771|NCT00390416|Leucovorin|leucovorin|mesh-list
56812772|NCT00390416|Bevacizumab|bevacizumab|mesh-list
56812773|NCT00390416|Docetaxel|docetaxel|mesh-list
56812774|NCT00390416|Fluorouracil|fluorouracil|mesh-list
56812775|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56812776|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812777|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56812778|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56812779|NCT00390416|Growth Substances|growth substances|mesh-ancestor
56812780|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812781|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
56812782|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
56812783|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
56812788|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56812789|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
56812790|NCT00390416|Antidotes|antidotes|mesh-ancestor
56812791|NCT00390416|Protective Agents|protective agents|mesh-ancestor
56812792|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
56812793|NCT00390416|Vitamins|vitamins|mesh-ancestor
56812794|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
56812795|NCT00261495|Oxycodone|oxycodone|mesh-list
56812796|NCT00261495|Hydromorphone|hydromorphone|mesh-list
56812797|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56812798|NCT00261495|Narcotics|narcotics|mesh-ancestor
56812799|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812800|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812801|NCT00261495|Analgesics|analgesics|mesh-ancestor
56812802|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
56812803|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812804|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
56812805|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56812806|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
56812807|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812808|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812809|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56812810|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
56812811|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
56812812|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56812813|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
56812814|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56812815|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812816|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
56812817|NCT00365456|Hormones|hormones|mesh-list
56812834|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
56812835|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
56812836|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
56812837|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56812838|NCT03480698|Protective Agents|protective agents|mesh-ancestor
56812839|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812840|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
56812841|NCT00206427|Lapatinib|lapatinib|mesh-list
56812842|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812843|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56812844|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812845|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812847|NCT00389324|Antibodies|antibodies|mesh-list
56812848|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
56812849|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56812850|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56812851|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
56812852|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
56812853|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812854|NCT00365300|Pantoprazole|pantoprazole|mesh-list
56812855|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56812856|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56812857|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56812858|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812859|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812860|NCT01048034|Azacitidine|azacitidine|mesh-list
56812861|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
56812862|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56812863|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
56812864|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812865|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56812866|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812867|NCT01048034|Hematinics|hematinics|mesh-ancestor
56812878|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812879|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812880|NCT01049672|Analgesics|analgesics|mesh-ancestor
56812881|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
56812882|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812883|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56812884|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
56812885|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
56812886|NCT01048190|Vaccines|vaccines|mesh-list
56812887|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
56812888|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812889|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
56812890|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56812891|NCT01048268|Incretins|incretins|mesh-ancestor
56812892|NCT01048268|Hormones|hormones|mesh-ancestor
56812893|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56812894|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812895|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56812896|NCT03993236|Ezetimibe|ezetimibe|mesh-list
56812931|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56812932|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
56812933|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56812934|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56812935|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56812936|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812937|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
56812938|NCT00529373|Vitamin D|vitamin d|mesh-list
56812939|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
56812940|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
56812941|NCT00529373|Calcium|calcium|mesh-list
56812942|NCT00529373|Vitamins|vitamins|mesh-ancestor
56812943|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
56812944|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812945|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56812946|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56812947|NCT00529373|Antacids|antacids|mesh-ancestor
56812948|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56812949|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56812950|NCT00369122|Bevacizumab|bevacizumab|mesh-list
56812951|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56812952|NCT00369122|Cisplatin|cisplatin|mesh-list
56812953|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
56812954|NCT00369122|Antibodies|antibodies|mesh-list
56812955|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
56812956|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56812957|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
56812980|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
56812981|NCT03999203|Protective Agents|protective agents|mesh-ancestor
56812982|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
56812983|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56812984|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
56812985|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
56812986|NCT04854395|Bupivacaine|bupivacaine|mesh-list
56812987|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
56812988|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
56812989|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56812990|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56812991|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
56812992|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56812993|NCT05173493|Amoxicillin|amoxicillin|mesh-list
56812994|NCT05173493|Levofloxacin|levofloxacin|mesh-list
56523912|NCT01009840|Bortezomib|bortezomib|mesh-list
56812995|NCT05173493|Ofloxacin|ofloxacin|mesh-list
56812996|NCT05173493|Tetracycline|tetracycline|mesh-list
56812997|NCT05173493|Furazolidone|furazolidone|mesh-list
56812998|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56812999|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813000|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56813001|NCT05173493|Renal Agents|renal agents|mesh-ancestor
56813002|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56813003|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813004|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813005|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813006|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813007|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56813008|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56813009|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56813010|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56813011|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56813012|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56813021|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813022|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813023|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813024|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56813025|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813026|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813027|NCT05117489|Cortisone|cortisone|mesh-list
56813028|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813029|NCT03966040|Vaccines|vaccines|mesh-list
56813030|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
56813031|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813032|NCT03999125|Dexamethasone|dexamethasone|mesh-list
56813033|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
56813034|NCT03999125|Ranibizumab|ranibizumab|mesh-list
56813035|NCT03999125|Aflibercept|aflibercept|mesh-list
56813036|NCT03999125|BB 1101|bb 1101|mesh-list
56813037|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813038|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
56813039|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
56813040|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813041|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813042|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813043|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
56813044|NCT03999125|Hormones|hormones|mesh-ancestor
56813045|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56813061|NCT00166114|Citalopram|citalopram|mesh-list
56813070|NCT00166114|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56813071|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
56813072|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56813073|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56813074|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813075|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56813076|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
56813077|NCT05032781|Minocycline|minocycline|mesh-list
56813078|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56813079|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813080|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
56813081|NCT00129376|Docetaxel|docetaxel|mesh-list
56813082|NCT00129376|Doxorubicin|doxorubicin|mesh-list
56813083|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56813084|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
56813085|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813086|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813087|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56813088|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
56813089|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813090|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813091|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56813092|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813093|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
56813094|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813095|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56813096|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56813097|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813098|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813099|NCT04878107|Docetaxel|docetaxel|mesh-list
56813100|NCT04878107|Apatinib|apatinib|mesh-list
56813101|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813102|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813103|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56813104|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813106|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56813109|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56813110|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813111|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56813112|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813113|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813114|NCT00129220|Haloperidol|haloperidol|mesh-list
56813115|NCT00129220|Olanzapine|olanzapine|mesh-list
56813116|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
56813117|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
56813118|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
56813119|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813120|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813121|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813122|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56813123|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56813124|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56813125|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56813126|NCT00129220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56813127|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56813128|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56813129|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813130|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813131|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
56813132|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56813133|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
56813134|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56813135|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
56813136|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813155|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813156|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813157|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56813158|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813159|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
56813160|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
56813161|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813162|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813163|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
56813164|NCT04754945|Hormones|hormones|mesh-ancestor
56813165|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56813166|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56813167|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
56813168|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813169|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
56813170|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56813171|NCT00128830|Etravirine|etravirine|mesh-list
56813172|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
56813173|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56813174|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
56813175|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56813176|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813177|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813178|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
56813179|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813180|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56813181|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56813182|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56813183|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56813184|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56813186|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
56813197|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56813198|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56813199|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813200|NCT01074892|Hormones|hormones|mesh-ancestor
56813201|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56813202|NCT00128206|Rifampin|rifampin|mesh-list
56813203|NCT00128206|Isoniazid|isoniazid|mesh-list
56813204|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56813205|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
56813206|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56813207|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813208|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
56813209|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56813210|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813211|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813212|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56813213|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56813214|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56813215|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56813216|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56813217|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56524128|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813218|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56813219|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56813220|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
56813221|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56813222|NCT01075828|Cetuximab|cetuximab|mesh-list
56813223|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813241|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
56813242|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813243|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56813244|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56813245|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
56813246|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
56813247|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56813248|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
56813249|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56813250|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813251|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813252|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56813253|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813254|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813255|NCT03966118|Paclitaxel|paclitaxel|mesh-list
56813256|NCT03966118|Avelumab|avelumab|mesh-list
56813257|NCT03966118|Ramucirumab|ramucirumab|mesh-list
56813258|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56813259|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813260|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813261|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56813262|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813263|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813264|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813265|NCT03968224|Metformin|metformin|mesh-list
56813290|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56813291|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56813292|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56813293|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
56813294|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
56813295|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56813296|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813297|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56813298|NCT00141778|Diuretics|diuretics|mesh-ancestor
56813299|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
56813300|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
56813301|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813302|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56813303|NCT00141778|Hormones|hormones|mesh-ancestor
56813304|NCT01079884|Esomeprazole|esomeprazole|mesh-list
56813305|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56813306|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813307|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56813308|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813309|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813310|NCT01075906|Colchicine|colchicine|mesh-list
56813311|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
56813312|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813313|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813314|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
56813315|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813338|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813339|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813340|NCT01076140|Lisinopril|lisinopril|mesh-list
56813341|NCT01076140|Nebivolol|nebivolol|mesh-list
56813342|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56813343|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
56813344|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813345|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813346|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56813347|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56813348|NCT01076140|Protective Agents|protective agents|mesh-ancestor
56813349|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813350|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
56813351|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56813352|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56813353|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56813354|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
56813355|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813356|NCT00205803|Vaccines|vaccines|mesh-list
56813357|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56813358|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
56813359|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813360|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56813361|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56813386|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813387|NCT00259857|Alendronate|alendronate|mesh-list
56813388|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56813389|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813390|NCT01071681|Telmisartan|telmisartan|mesh-list
56813391|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56813392|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56813393|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56813394|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813395|NCT00203307|Olanzapine|olanzapine|mesh-list
56813396|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
56813397|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
56813398|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813399|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813400|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813401|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56813402|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56813403|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56813404|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56813405|NCT00203307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56813406|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56813407|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56813408|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813409|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813410|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
56813411|NCT00126568|Sorafenib|sorafenib|mesh-list
56813412|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813413|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56813414|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813416|NCT00202839|Ribavirin|ribavirin|mesh-list
56813429|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
56813430|NCT00126490|Antibodies|antibodies|mesh-list
56813431|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
56813432|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56813433|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
56813434|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813435|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56813436|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56813437|NCT00126490|Growth Substances|growth substances|mesh-ancestor
56813438|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813439|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
56813440|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
56813441|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56813442|NCT00126490|Analgesics|analgesics|mesh-ancestor
56813443|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
56813444|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813445|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56813446|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56813447|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
56813448|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813449|NCT00200967|Beclomethasone|beclomethasone|mesh-list
56813450|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56813451|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56813452|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
56813453|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813454|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813455|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56813456|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
56813465|NCT00200967|Hormones|hormones|mesh-ancestor
56813476|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56813477|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56813478|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813479|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813480|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813481|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56813482|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
56813483|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56813484|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
56813485|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
56813486|NCT00140140|Paclitaxel|paclitaxel|mesh-list
56813487|NCT00140140|Vinorelbine|vinorelbine|mesh-list
56813488|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56813489|NCT00140140|Trastuzumab|trastuzumab|mesh-list
56813490|NCT00140140|Lenograstim|lenograstim|mesh-list
56813491|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56813492|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813493|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813494|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
56813495|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813496|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813497|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813498|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56813499|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
56813500|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813501|NCT00346164|Doxorubicin|doxorubicin|mesh-list
56813502|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56813503|NCT00346164|Ifosfamide|ifosfamide|mesh-list
56813504|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56813505|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813506|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56813507|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813508|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813510|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56813515|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56813516|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56524431|NCT01208181|Etoricoxib|etoricoxib|mesh-list
56813517|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813518|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813519|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813520|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56813521|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56813522|NCT00114244|Gemcitabine|gemcitabine|mesh-list
56813523|NCT00114244|Sorafenib|sorafenib|mesh-list
56813524|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56813525|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
56813526|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813527|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813528|NCT00114244|Antiviral Agents|antiviral agents|mesh-ancestor
56813529|NCT00114244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813530|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813531|NCT00114244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56813532|NCT00114244|Immunologic Factors|immunologic factors|mesh-ancestor
56813533|NCT00114244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813534|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56813535|NCT01054872|Vaccines|vaccines|mesh-list
56813536|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
56813537|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813538|NCT00337662|Olanzapine|olanzapine|mesh-list
56813539|NCT00337662|Risperidone|risperidone|mesh-list
56813540|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56813541|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
56813542|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813543|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813544|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813557|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56813558|NCT00138424|Cidofovir|cidofovir|mesh-list
56813559|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
56813560|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813561|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813562|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813563|NCT00368966|Vaccines|vaccines|mesh-list
56813564|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56813565|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
56813566|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813567|NCT00114166|Topotecan|topotecan|mesh-list
56813568|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56813569|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813570|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813571|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813572|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813573|NCT00337428|Vaccines|vaccines|mesh-list
56813574|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
56813575|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813576|NCT00235989|Interferons|interferons|mesh-list
56813577|NCT00235989|Interferon-beta|interferon-beta|mesh-list
56813578|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
56813579|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813580|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
56813581|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813582|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
56813606|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813607|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
56813608|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56813609|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813610|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56813611|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813612|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813613|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813614|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813615|NCT03988530|Scopolamine|scopolamine|mesh-list
56813616|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56813617|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56813618|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
56813619|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
56813620|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813621|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813622|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813623|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
56813624|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56813625|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
56813626|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813627|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813661|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
56813662|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56813663|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
56813664|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813665|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524574|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
56813666|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56813667|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
56813668|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813669|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813670|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56813671|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813672|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
56813673|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
56813674|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813675|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56813676|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
56813678|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56813679|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56813680|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56813713|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56813714|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56813715|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56813716|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56813717|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56813718|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
56813719|NCT00337194|Gemcitabine|gemcitabine|mesh-list
56813720|NCT00337194|Doxorubicin|doxorubicin|mesh-list
56813721|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56813722|NCT00337194|Vinorelbine|vinorelbine|mesh-list
56813723|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56813724|NCT00337194|Antibodies|antibodies|mesh-list
56813725|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56813726|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
56813727|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813728|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56813729|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
56813730|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813731|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813732|NCT00337194|Antiviral Agents|antiviral agents|mesh-ancestor
56813733|NCT00337194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813734|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813735|NCT00337194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56813736|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56813737|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56813738|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56813739|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56813740|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
56813741|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
56547697|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56813742|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
56813743|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813744|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
56813745|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813746|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813747|NCT01074333|Cetuximab|cetuximab|mesh-list
56813751|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56813752|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813753|NCT01057212|Bevacizumab|bevacizumab|mesh-list
56813754|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813755|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813756|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56813757|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56813758|NCT01057212|Growth Substances|growth substances|mesh-ancestor
56813759|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813760|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
56813761|NCT03988452|Ritonavir|ritonavir|mesh-list
56813762|NCT03988452|Darunavir|darunavir|mesh-list
56813763|NCT03988452|Tenofovir|tenofovir|mesh-list
56813764|NCT03988452|Lamivudine|lamivudine|mesh-list
56813765|NCT03988452|Zidovudine|zidovudine|mesh-list
56813766|NCT03988452|Dolutegravir|dolutegravir|mesh-list
56813767|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56813768|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56813769|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
56813770|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813771|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813772|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56813773|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56813774|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
56813775|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813776|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56813777|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56813778|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56813779|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56813780|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
56813781|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56813782|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56813783|NCT01048580|Capecitabine|capecitabine|mesh-list
56813784|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56813785|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
56813786|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813788|NCT00195819|Adalimumab|adalimumab|mesh-list
56086216|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56086217|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56086218|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56086235|NCT03609008|Cromakalim|cromakalim|mesh-list
56086236|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56086237|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56086238|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
56086239|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086240|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086245|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
56813790|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813791|NCT00527735|Paclitaxel|paclitaxel|mesh-list
56813792|NCT00527735|Carboplatin|carboplatin|mesh-list
56813793|NCT00527735|Ipilimumab|ipilimumab|mesh-list
56813794|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56813840|NCT00527423|Growth Substances|growth substances|mesh-ancestor
56813841|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813842|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
56813843|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813844|NCT00527111|Fluorouracil|fluorouracil|mesh-list
56813845|NCT00527111|Cetuximab|cetuximab|mesh-list
56813846|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
56813847|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813848|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56813849|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813850|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56813851|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
56813852|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813853|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56813854|NCT00336024|Leucovorin|leucovorin|mesh-list
56813855|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
56813856|NCT00336024|Thiotepa|thiotepa|mesh-list
56813857|NCT00336024|Carboplatin|carboplatin|mesh-list
56813858|NCT00336024|Methotrexate|methotrexate|mesh-list
56813859|NCT00336024|Etoposide|etoposide|mesh-list
56813896|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813897|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813898|NCT04090697|Oxandrolone|oxandrolone|mesh-list
56813899|NCT04090697|Androgens|androgens|mesh-ancestor
56813900|NCT04090697|Hormones|hormones|mesh-ancestor
56813901|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56813902|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813903|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
56813904|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
56813905|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813906|NCT01325220|Baclofen|baclofen|mesh-list
56813907|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56813908|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813909|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56813910|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56813911|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56813912|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
56813913|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
56813914|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813915|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813916|NCT00367484|Interferons|interferons|mesh-list
56813917|NCT00367484|Interferon-beta|interferon-beta|mesh-list
56813918|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
56813919|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813920|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
56813921|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813922|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
56813923|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813924|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56813925|NCT00526799|Sorafenib|sorafenib|mesh-list
56813943|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56813944|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56813945|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
56813946|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56813947|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813948|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56813949|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56813950|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
56813951|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56813952|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56813953|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56813954|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
56813955|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
56813956|NCT03992066|Hematinics|hematinics|mesh-ancestor
56813957|NCT03986268|Vitamin D|vitamin d|mesh-list
56813958|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
56813959|NCT03986268|Vitamins|vitamins|mesh-ancestor
56813960|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
56813961|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813962|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56813963|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56813964|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
56813965|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56813966|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
56813967|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813968|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56813969|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56813970|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
56813971|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813972|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56813973|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56813974|NCT01259648|Remifentanil|remifentanil|mesh-list
56813986|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813987|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56813988|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56813989|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56813990|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
56813991|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813992|NCT01044992|Levodopa|levodopa|mesh-list
56813993|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56813994|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56813995|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
56813996|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56813997|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56813998|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56813999|NCT00520403|Interferons|interferons|mesh-list
56814000|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
56814001|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
56814002|NCT00520403|Bevacizumab|bevacizumab|mesh-list
56814003|NCT00520403|Vinblastine|vinblastine|mesh-list
56814004|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814005|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814006|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56814007|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56814008|NCT00520403|Growth Substances|growth substances|mesh-ancestor
56814009|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814010|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
56814011|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
56814012|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814013|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
56814014|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814015|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814030|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56814031|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56814032|NCT00520013|Growth Substances|growth substances|mesh-ancestor
56814033|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814034|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
56814035|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56814036|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814037|NCT00526097|Bisacodyl|bisacodyl|mesh-list
56814038|NCT00526097|Cathartics|cathartics|mesh-ancestor
56814039|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56814040|NCT00526097|Laxatives|laxatives|mesh-ancestor
56814041|NCT00525785|Leucovorin|leucovorin|mesh-list
56814042|NCT00525785|Folic Acid|folic acid|mesh-list
56814043|NCT00525785|Fluorouracil|fluorouracil|mesh-list
56814044|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
56814045|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
56814046|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
56814047|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56547698|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814048|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56814049|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814050|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814051|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
56814052|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814053|NCT00525785|Antidotes|antidotes|mesh-ancestor
56814054|NCT00525785|Protective Agents|protective agents|mesh-ancestor
56814055|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
56814056|NCT00525785|Vitamins|vitamins|mesh-ancestor
56814057|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
56814058|NCT00525785|Hematinics|hematinics|mesh-ancestor
56814059|NCT00525161|Sorafenib|sorafenib|mesh-list
56814060|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814061|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56814062|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086508|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086509|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56086510|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56086511|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56086512|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56814074|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814075|NCT00524459|Docetaxel|docetaxel|mesh-list
56814076|NCT00524459|Doxorubicin|doxorubicin|mesh-list
56814077|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56814078|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814079|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814080|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814081|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814082|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814083|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56814084|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56814085|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56814086|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814087|NCT00519623|Insulin|insulin|mesh-list
56814088|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56814089|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814090|NCT01076530|Temozolomide|temozolomide|mesh-list
56814091|NCT01076530|Vorinostat|vorinostat|mesh-list
56814092|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56814093|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
56814118|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56814119|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814120|NCT00124072|Hematinics|hematinics|mesh-ancestor
56814121|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
56814122|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
56814123|NCT01080352|Vitamins|vitamins|mesh-ancestor
56814124|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
56814125|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814126|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
56814127|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814128|NCT01080352|Protective Agents|protective agents|mesh-ancestor
56814130|NCT00524303|Trastuzumab|trastuzumab|mesh-list
56814131|NCT00524303|Lapatinib|lapatinib|mesh-list
56814132|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814133|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814134|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814135|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814136|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814137|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814138|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814139|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56814140|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814141|NCT04461041|Empagliflozin|empagliflozin|mesh-list
56814142|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56814143|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814144|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56814145|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814146|NCT00335556|Dactinomycin|dactinomycin|mesh-list
56814147|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
56814148|NCT00335556|Carboplatin|carboplatin|mesh-list
56814149|NCT00335556|Doxorubicin|doxorubicin|mesh-list
56814150|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56814151|NCT00335556|Irinotecan|irinotecan|mesh-list
56814152|NCT00335556|Etoposide|etoposide|mesh-list
56814153|NCT00335556|Vincristine|vincristine|mesh-list
56814154|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814159|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
56814160|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814161|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814162|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56814163|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56814164|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56814165|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56814166|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814167|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56814168|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814169|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814170|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814171|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814172|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56814173|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814174|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56814175|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56814176|NCT00518687|Vaccines|vaccines|mesh-list
56814177|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
56814178|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814179|NCT00134056|Prednisone|prednisone|mesh-list
56814180|NCT00134056|Docetaxel|docetaxel|mesh-list
56814181|NCT00134056|Atrasentan|atrasentan|mesh-list
56814182|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814183|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814184|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814185|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814186|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814187|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56814188|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
56814189|NCT00134056|Hormones|hormones|mesh-ancestor
56814190|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814191|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814199|NCT01326442|Vitamin D|vitamin d|mesh-list
56814200|NCT01326442|Vitamins|vitamins|mesh-ancestor
56814201|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
56814202|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814203|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56814205|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56814206|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
56814207|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814208|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814209|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56814210|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
56814211|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
56814212|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56814213|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
56814214|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56814215|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814216|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
56814217|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814218|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
56814219|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814220|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814221|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56814222|NCT00345540|Carboplatin|carboplatin|mesh-list
56814223|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814224|NCT00335322|Ritonavir|ritonavir|mesh-list
56814225|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56814226|NCT00335322|Tenofovir|tenofovir|mesh-list
56814227|NCT00335322|Zidovudine|zidovudine|mesh-list
56814228|NCT00335322|Emtricitabine|emtricitabine|mesh-list
56814229|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56814230|NCT00335322|Abacavir|abacavir|mesh-list
56814231|NCT00335322|Efavirenz|efavirenz|mesh-list
56814232|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56814233|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56086678|NCT04562792|Daunorubicin|daunorubicin|mesh-list
56086679|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56086680|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086681|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56086682|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56086683|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086685|NCT04523701|SMOFlipid|smoflipid|mesh-list
56814242|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56814243|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56814244|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56814245|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
56814246|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56814247|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56814248|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56814249|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56814250|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56814251|NCT01059396|Propranolol|propranolol|mesh-list
56814290|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
56814291|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
56814292|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814293|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56814294|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56814295|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814296|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814297|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56814298|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
56814299|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814300|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814301|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56814302|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56814303|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56814304|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56814305|NCT01061112|Analgesics|analgesics|mesh-ancestor
56814306|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
56814307|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814308|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56814309|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56814310|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56814311|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56814312|NCT01061190|Propranolol|propranolol|mesh-list
56814324|NCT00517829|Docetaxel|docetaxel|mesh-list
56814338|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814339|NCT00334542|Simvastatin|simvastatin|mesh-list
56814340|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56814341|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56814342|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
56814343|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814344|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56814345|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56814346|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814347|NCT00112294|Paclitaxel|paclitaxel|mesh-list
56814348|NCT00112294|Docetaxel|docetaxel|mesh-list
56814349|NCT00112294|Carboplatin|carboplatin|mesh-list
56814351|NCT00112294|Taxane|taxane|mesh-list
56814352|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814353|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814354|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814355|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814356|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814357|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814358|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814359|NCT00235443|Lacosamide|lacosamide|mesh-list
56814360|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
56814390|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56814391|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56814392|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
56814393|NCT03973203|Niacin|niacin|mesh-list
56814394|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
56814395|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56814396|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
56814397|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814398|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56814399|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
56814400|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
56814401|NCT03973203|Vitamins|vitamins|mesh-ancestor
56814402|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
56814403|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814404|NCT01073007|Simvastatin|simvastatin|mesh-list
56814405|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56814406|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56814407|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
56814408|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814409|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56814410|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56814411|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814412|NCT03741621|Psyllium|psyllium|mesh-list
56814413|NCT03741621|Cathartics|cathartics|mesh-ancestor
56814414|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56814415|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
56814416|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
56814417|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56814418|NCT00323622|Amodiaquine|amodiaquine|mesh-list
56814419|NCT00323622|Vaccines|vaccines|mesh-list
56814420|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
56814421|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814422|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
56814423|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56814424|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56814425|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814426|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56814427|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086827|NCT04344860|Coagulants|coagulants|mesh-ancestor
56814428|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814429|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56814430|NCT00323622|Renal Agents|renal agents|mesh-ancestor
56814431|NCT01326039|Bupivacaine|bupivacaine|mesh-list
56814432|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
56814433|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
56814434|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56814435|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814436|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
56814437|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814438|NCT01057758|Simvastatin|simvastatin|mesh-list
56814439|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56814440|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56814441|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
56814442|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814443|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56814444|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56814445|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814446|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
56814447|NCT00186537|Fenofibrate|fenofibrate|mesh-list
56814448|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56814449|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814450|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56814451|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
56814452|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814453|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56814475|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814476|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
56814477|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
56814478|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56814479|NCT00255723|Carboplatin|carboplatin|mesh-list
56814480|NCT00255723|Etoposide|etoposide|mesh-list
56814481|NCT00255723|Ifosfamide|ifosfamide|mesh-list
56814482|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814483|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814484|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56814485|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56814486|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814487|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814488|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56814489|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
56814490|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
56814491|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56814492|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56814493|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814494|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
56814495|NCT01060176|Coagulants|coagulants|mesh-ancestor
56814496|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
56814497|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56814498|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814499|NCT03982992|Blinatumomab|blinatumomab|mesh-list
56814501|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
56814525|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814526|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56814527|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56814528|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
56814529|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814530|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814531|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56814532|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56814533|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56814534|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56814535|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814536|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56814537|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
56814538|NCT03677141|Hormones|hormones|mesh-ancestor
56814539|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814540|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56814541|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814542|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814543|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814544|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814545|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
56814546|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814547|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814548|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
56814549|NCT03649841|Prednisone|prednisone|mesh-list
56814550|NCT03649841|Cortisone|cortisone|mesh-list
56814551|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
56814552|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
56814553|NCT03649841|Hormones|hormones|mesh-list
56814554|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56814555|NCT03649841|Androgens|androgens|mesh-list
56814568|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
56814569|NCT03649841|Protective Agents|protective agents|mesh-ancestor
56814570|NCT03649841|Vitamins|vitamins|mesh-ancestor
56814571|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
56814572|NCT03649841|Estrogens|estrogens|mesh-ancestor
56814573|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
56814574|NCT00522431|Testosterone|testosterone|mesh-list
56814575|NCT00522431|Androgens|androgens|mesh-ancestor
56814576|NCT00522431|Hormones|hormones|mesh-ancestor
56814577|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814578|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814579|NCT00185211|Interferons|interferons|mesh-list
56814580|NCT00185211|Interferon-beta|interferon-beta|mesh-list
56814581|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
56814582|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814583|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
56814584|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814585|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
56814586|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814587|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56814588|NCT00516737|Rizatriptan|rizatriptan|mesh-list
56814589|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56814590|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
56814591|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56814592|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814593|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814595|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
56814596|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814600|NCT00132730|MK 0873|mk 0873|mesh-list
56814619|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814620|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56814621|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
56814622|NCT02531841|Hormones|hormones|mesh-ancestor
56814623|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814624|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56814625|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814626|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
56814627|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814628|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814629|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814630|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56814631|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56814632|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56814633|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
56814634|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56814635|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814636|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
56814637|NCT01074411|Carboplatin|carboplatin|mesh-list
56814638|NCT01074411|Bortezomib|bortezomib|mesh-list
56814639|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814640|NCT03973047|Ondansetron|ondansetron|mesh-list
56814641|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
56814642|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
56814643|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814644|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814645|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56814646|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
56814647|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
56814663|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56814664|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56814665|NCT01074567|Protective Agents|protective agents|mesh-ancestor
56814666|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814667|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56814668|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
56814669|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814670|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
56814671|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
56814672|NCT03519971|Paclitaxel|paclitaxel|mesh-list
56814673|NCT03519971|Etoposide|etoposide|mesh-list
56814674|NCT03519971|Cisplatin|cisplatin|mesh-list
56814675|NCT03519971|Carboplatin|carboplatin|mesh-list
56814676|NCT03519971|Pemetrexed|pemetrexed|mesh-list
56814677|NCT03519971|Durvalumab|durvalumab|mesh-list
56814678|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814679|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814680|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814681|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814682|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814683|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814684|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56814685|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56814686|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814687|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56814688|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56814689|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814690|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
56814691|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814692|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
56814693|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814694|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814695|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56814696|NCT00340704|Tamsulosin|tamsulosin|mesh-list
56814703|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814704|NCT00340704|Urological Agents|urological agents|mesh-ancestor
56814705|NCT00132496|Rabeprazole|rabeprazole|mesh-list
56814706|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56814707|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56814708|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56814709|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814710|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814711|NCT01080586|Cyclosporine|cyclosporine|mesh-list
56814712|NCT01080586|Cyclosporins|cyclosporins|mesh-list
56814713|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814714|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814715|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814716|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
56814717|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814718|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
56814719|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814720|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
56814721|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56814722|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56814723|NCT00231777|Ondansetron|ondansetron|mesh-list
56814724|NCT00231777|Aprepitant|aprepitant|mesh-list
56814725|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
56814726|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
56814727|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814728|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814729|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56525614|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56814730|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
56814731|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
56814732|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56814733|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
56814742|NCT01076842|Insulin|insulin|mesh-list
56814746|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56814747|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814748|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56814749|NCT01076842|Incretins|incretins|mesh-ancestor
56814750|NCT01076842|Hormones|hormones|mesh-ancestor
56814751|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814752|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
56814753|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814754|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
56814755|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814756|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56814757|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56814758|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
56814759|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814760|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814761|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56814762|NCT00231465|Docetaxel|docetaxel|mesh-list
56814763|NCT00231465|Gefitinib|gefitinib|mesh-list
56814764|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814765|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814766|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814767|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814768|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814769|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56814770|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814771|NCT00254397|Leuprolide|leuprolide|mesh-list
56814772|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56814773|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
56814774|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56814775|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814778|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
56814790|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56814791|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814792|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56814793|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814794|NCT00110890|Cinacalcet|cinacalcet|mesh-list
56814795|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56814796|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814797|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56814798|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
56814799|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814800|NCT00182637|Bortezomib|bortezomib|mesh-list
56814801|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814802|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56814803|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
56814804|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56814805|NCT00122278|Dexamethasone|dexamethasone|mesh-list
56814806|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56814808|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
56814809|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814810|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814811|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56814812|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
56814813|NCT00122278|Hormones|hormones|mesh-ancestor
56814814|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814815|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56814816|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814817|NCT00182091|Hormones|hormones|mesh-list
56814818|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814819|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814820|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56814821|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
56814822|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814830|NCT00181155|Allopurinol|allopurinol|mesh-list
56814831|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
56814832|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814833|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814834|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
56814835|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56814836|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56814837|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
56814838|NCT00181155|Protective Agents|protective agents|mesh-ancestor
56814839|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814840|NCT00322452|Paclitaxel|paclitaxel|mesh-list
56814841|NCT00322452|Carboplatin|carboplatin|mesh-list
56814842|NCT00322452|Gefitinib|gefitinib|mesh-list
56814843|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56814844|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814845|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814846|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814847|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814848|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814849|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56814850|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814851|NCT00110812|Aldesleukin|aldesleukin|mesh-list
56814852|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814853|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56814854|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56814855|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
56814856|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814857|NCT00516269|Methylphenidate|methylphenidate|mesh-list
56814858|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56814859|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814860|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56814861|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56814862|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56814873|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814874|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814875|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814876|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814877|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56814878|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56814879|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56814881|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814882|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
56814883|NCT00228813|Lenograstim|lenograstim|mesh-list
56814884|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56814885|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
56814886|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814887|NCT00322374|Epirubicin|epirubicin|mesh-list
56814888|NCT00322374|Epothilones|epothilones|mesh-list
56814889|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56814890|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814891|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56814892|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56814893|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814894|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814895|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
56814896|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
56814897|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
56814898|NCT00174447|Ziprasidone|ziprasidone|mesh-list
56814899|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56814900|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
56814901|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56814902|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814911|NCT00321984|Lansoprazole|lansoprazole|mesh-list
56814918|NCT01060488|Hormones|hormones|mesh-ancestor
56814919|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56814920|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814921|NCT01060566|Ivacaftor|ivacaftor|mesh-list
56814922|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56814923|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56814924|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814925|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
56814926|NCT02533284|Analgesics|analgesics|mesh-ancestor
56814927|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
56814928|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56814929|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814930|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
56814931|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56814932|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56814933|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
56814934|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56814935|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56814936|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814937|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56814938|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
56814939|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56814940|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
56814941|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56814942|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
56814943|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56814944|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56814945|NCT00110266|Deferasirox|deferasirox|mesh-list
56814946|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56814947|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
56814948|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
56814959|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814960|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814961|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56814962|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56814963|NCT00132028|Vorinostat|vorinostat|mesh-list
56814964|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814965|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56814966|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56814967|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814968|NCT01045304|Gemcitabine|gemcitabine|mesh-list
56814969|NCT01045304|Carboplatin|carboplatin|mesh-list
56814970|NCT01045304|Iniparib|iniparib|mesh-list
56814971|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56814972|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56814973|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
56814974|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56814975|NCT01045304|Antiviral Agents|antiviral agents|mesh-ancestor
56814976|NCT01045304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56814977|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815014|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
56815015|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
56815016|NCT00362414|Mitogens|mitogens|mesh-list
56815017|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
56815018|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815019|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
56815020|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
56815021|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815022|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56815023|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56815024|NCT01049204|Maraviroc|maraviroc|mesh-list
56815025|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56815026|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56815027|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815029|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56815030|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
56815031|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815032|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56815033|NCT00096382|Aldesleukin|aldesleukin|mesh-list
56815034|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
56815069|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56815070|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815071|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815072|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
56815073|NCT00096226|Paclitaxel|paclitaxel|mesh-list
56815074|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56815075|NCT00096226|Carboplatin|carboplatin|mesh-list
56815076|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56815077|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815078|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
56815079|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
56815080|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
56815081|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815082|NCT01078714|Bumetanide|bumetanide|mesh-list
56815083|NCT01078714|Diuretics|diuretics|mesh-ancestor
56815084|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
56815085|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815086|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56815087|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56815088|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815089|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
56815090|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56815091|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
56815092|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815093|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815094|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56815095|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
56815096|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56815097|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
56525986|NCT05605535|Paclitaxel|paclitaxel|mesh-list
56815111|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
56815112|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
56815113|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815114|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815115|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56815116|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56815117|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
56815118|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56815119|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56815120|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56815121|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56815122|NCT01082926|Aldesleukin|aldesleukin|mesh-list
56815123|NCT01082926|Interleukin-2|interleukin-2|mesh-list
56815124|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815125|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56815126|NCT01082926|Analgesics|analgesics|mesh-ancestor
56815127|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
56815128|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815129|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815130|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56815131|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56815132|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
56815133|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815134|NCT03962920|Tigecycline|tigecycline|mesh-list
56815135|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56815141|NCT01078870|Citalopram|citalopram|mesh-list
56815159|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56815160|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56815161|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56815162|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815163|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815164|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
56815165|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
56815166|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815167|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815168|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56815169|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56815170|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
56815171|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56815172|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56526060|NCT01170663|Paclitaxel|paclitaxel|mesh-list
56815173|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56815174|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56815175|NCT00104572|Vitamin D|vitamin d|mesh-list
56815176|NCT00104572|Anastrozole|anastrozole|mesh-list
56815177|NCT00104572|Calcium|calcium|mesh-list
56815178|NCT00104572|Testosterone|testosterone|mesh-list
56815179|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56815180|NCT00104572|Vitamins|vitamins|mesh-ancestor
56815181|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
56815182|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815183|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56815184|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56815185|NCT00104572|Androgens|androgens|mesh-ancestor
56815186|NCT00104572|Hormones|hormones|mesh-ancestor
56815187|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815188|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56815189|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815190|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56815191|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815192|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815197|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56815198|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815199|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56815200|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815201|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815202|NCT00103402|Alfuzosin|alfuzosin|mesh-list
56815203|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56815204|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56815205|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56815206|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56815207|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815208|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815209|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815210|NCT00103402|Urological Agents|urological agents|mesh-ancestor
56815211|NCT00095836|Gefitinib|gefitinib|mesh-list
56815212|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815213|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56815214|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815215|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815216|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
56815217|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56815218|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
56815219|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815220|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815221|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56815222|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
56815223|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
56815224|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56815225|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
56815226|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815227|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815228|NCT03330821|Cytarabine|cytarabine|mesh-list
56815229|NCT03330821|Idarubicin|idarubicin|mesh-list
56815230|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56815234|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815235|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815236|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
56815237|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815238|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815239|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
56815240|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815241|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56815242|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56815243|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56815244|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
56815245|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56815246|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56526148|NCT00963547|Lapatinib|lapatinib|mesh-list
56815247|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56815248|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56815249|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56815250|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815251|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
56815252|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815253|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815254|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56815255|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815256|NCT03235505|Nicotine|nicotine|mesh-list
56815257|NCT03235505|Varenicline|varenicline|mesh-list
56815258|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56815259|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
56815260|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815261|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815262|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56815263|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56815264|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
56815265|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815273|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
56815274|NCT00511901|Hematinics|hematinics|mesh-ancestor
56815275|NCT04580147|Aflibercept|aflibercept|mesh-list
56815276|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56815277|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56815278|NCT04580147|Growth Substances|growth substances|mesh-ancestor
56815279|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815280|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
56815281|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815282|NCT03147287|Fulvestrant|fulvestrant|mesh-list
56815283|NCT03147287|Palbociclib|palbociclib|mesh-list
56815284|NCT03147287|Avelumab|avelumab|mesh-list
56815285|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56815286|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815287|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56815288|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56815289|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
56815290|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815291|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815292|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56815293|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815294|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815295|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56815296|NCT00228423|Clopidogrel|clopidogrel|mesh-list
56815305|NCT00513695|Paclitaxel|paclitaxel|mesh-list
56815322|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56815323|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56815324|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56815325|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56815326|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815327|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56815328|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56815329|NCT00513695|Growth Substances|growth substances|mesh-ancestor
56815330|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
56815331|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56815332|NCT00162981|Clobazam|clobazam|mesh-list
56815333|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
56815334|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56815335|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56815336|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815337|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815338|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56815339|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56815340|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
56815341|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
56815342|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815343|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815344|NCT00099268|Levodopa|levodopa|mesh-list
56815345|NCT00099268|Carbidopa|carbidopa|mesh-list
56815346|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56815347|NCT00099268|Entacapone|entacapone|mesh-list
56815348|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56815349|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56815350|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
56815351|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815352|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815353|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815354|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56815363|NCT00511355|Estradiol|estradiol|mesh-list
56815364|NCT00511355|Estrogens|estrogens|mesh-ancestor
56815365|NCT00511355|Hormones|hormones|mesh-ancestor
56815366|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815367|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815368|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56815369|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
56815370|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56815371|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56815372|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56815373|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56815374|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56815375|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56815376|NCT01083784|Valproic Acid|valproic acid|mesh-list
56815377|NCT01083784|Clonazepam|clonazepam|mesh-list
56815378|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
56815379|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815380|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815381|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
56815382|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815383|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815384|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
56815385|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56815386|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815387|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56815388|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
56815389|NCT00095212|Testosterone|testosterone|mesh-list
56815390|NCT00095212|Androgens|androgens|mesh-ancestor
56815391|NCT00095212|Hormones|hormones|mesh-ancestor
56815392|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815393|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815407|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
56815408|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815409|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815410|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815411|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56815412|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56815413|NCT00120250|Eszopiclone|eszopiclone|mesh-list
56815414|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56815415|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815416|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815417|NCT01081600|Trastuzumab|trastuzumab|mesh-list
56815418|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56815419|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815420|NCT01079338|Caffeine|caffeine|mesh-list
56815421|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56815422|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815423|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56815424|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815425|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815426|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56815427|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56815428|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
56815429|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815430|NCT00384176|Leucovorin|leucovorin|mesh-list
56815431|NCT00384176|Bevacizumab|bevacizumab|mesh-list
56815432|NCT00384176|Fluorouracil|fluorouracil|mesh-list
56815433|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
56815434|NCT00384176|Cediranib|cediranib|mesh-list
56815435|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56815436|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815437|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56815438|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56815439|NCT00384176|Growth Substances|growth substances|mesh-ancestor
56815440|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194605|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56194606|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56194607|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194608|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122385|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
56815441|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
56815442|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
56815443|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815444|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56815445|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815446|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
56815447|NCT00384176|Antidotes|antidotes|mesh-ancestor
56815448|NCT00384176|Protective Agents|protective agents|mesh-ancestor
56815449|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
56815450|NCT00384176|Vitamins|vitamins|mesh-ancestor
56815451|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
56815452|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56815453|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815454|NCT00513305|Cytarabine|cytarabine|mesh-list
56815455|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
56815456|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56815457|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
56815458|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815459|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815460|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
56815461|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815462|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815463|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
56815464|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815465|NCT00513071|Saracatinib|saracatinib|mesh-list
56815466|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815467|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815468|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815469|NCT00510887|Dexamethasone|dexamethasone|mesh-list
56815470|NCT00510887|Rituximab|rituximab|mesh-list
56815471|NCT00510887|Fludarabine|fludarabine|mesh-list
56815472|NCT00510887|Bortezomib|bortezomib|mesh-list
56815473|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
56815474|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56815475|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815476|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
56815477|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194609|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194610|NCT01494259|Epinephrine|epinephrine|mesh-list
56194611|NCT01494259|Bupivacaine|bupivacaine|mesh-list
56194612|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
56194613|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
56815478|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815479|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815480|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
56815481|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
56815482|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815483|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815484|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
56815485|NCT00510887|Hormones|hormones|mesh-ancestor
56815486|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815487|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56815488|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815489|NCT00510887|Analgesics|analgesics|mesh-ancestor
56815490|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
56815491|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56815492|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56815493|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815494|NCT01012349|Aspirin|aspirin|mesh-list
56815495|NCT01012349|Citric Acid|citric acid|mesh-list
56815496|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
56815497|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56815498|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56815499|NCT01012349|Analgesics|analgesics|mesh-ancestor
56815500|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
56815501|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815502|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815503|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815504|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815505|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56815506|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56815507|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815508|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56815509|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56815510|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815511|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
56815512|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
56815518|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815519|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815520|NCT01009541|Pregabalin|pregabalin|mesh-list
56815521|NCT01009541|Analgesics|analgesics|mesh-ancestor
56815522|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
56815523|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815524|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815525|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
56815526|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56815527|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56815528|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815529|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56815530|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56815531|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56815532|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815533|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56815534|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
56815535|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815536|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56815537|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815538|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815539|NCT01009697|Codeine|codeine|mesh-list
56815540|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56815541|NCT01009697|Narcotics|narcotics|mesh-ancestor
56815542|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815543|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815544|NCT01009697|Analgesics|analgesics|mesh-ancestor
56815545|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
56815546|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815547|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
56815548|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
56815549|NCT01009853|Codeine|codeine|mesh-list
56815558|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
56815559|NCT00506285|Methylphenidate|methylphenidate|mesh-list
56815560|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56815561|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815562|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56815563|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56815564|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56815565|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815566|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
56815567|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815568|NCT00506129|Fludarabine|fludarabine|mesh-list
56815569|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
56815570|NCT00506129|Melphalan|melphalan|mesh-list
56815571|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
56815572|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56815573|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815574|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56815575|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
56815576|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815577|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815578|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
56815579|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815580|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56815581|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
56815582|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56815583|NCT00358670|Infliximab|infliximab|mesh-list
56815584|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56815585|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815586|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815587|NCT01010087|Oseltamivir|oseltamivir|mesh-list
56815588|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
56815600|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815601|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815602|NCT00383786|Vofopitant|vofopitant|mesh-list
56815603|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
56815604|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
56815605|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815606|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815607|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815608|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56815609|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815610|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815611|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56815612|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
56815613|NCT05358977|Coagulants|coagulants|mesh-ancestor
56815614|NCT01010243|Pioglitazone|pioglitazone|mesh-list
56815615|NCT01010243|Dexamethasone|dexamethasone|mesh-list
56815616|NCT01010243|Lenalidomide|lenalidomide|mesh-list
56815617|NCT01010243|Treosulfan|treosulfan|mesh-list
56815618|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815619|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
56815620|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
56815621|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815622|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815623|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815624|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
56815626|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815627|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56815628|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815629|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
56815630|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56815631|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56815638|NCT00383708|Lanreotide|lanreotide|mesh-list
56815644|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
56815645|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815646|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815647|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56815648|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56815649|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
56815650|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
56815651|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815652|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56815653|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56815654|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815655|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815656|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
56815657|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
56815658|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56815659|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
56815660|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815661|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815662|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56815663|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
56815696|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815697|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815698|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815699|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
56815700|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56815701|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815702|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815703|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56815704|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56815705|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56815706|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
56815707|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56815708|NCT01052792|Naproxen|naproxen|mesh-list
56815709|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56815710|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56815711|NCT01052792|Analgesics|analgesics|mesh-ancestor
56815712|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
56815713|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815714|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815715|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815716|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815717|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
56815718|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56815719|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815720|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815721|NCT01052870|Finasteride|finasteride|mesh-list
56815722|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56815723|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56815724|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815725|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815737|NCT01045538|Capecitabine|capecitabine|mesh-list
56815738|NCT01045538|Vorinostat|vorinostat|mesh-list
56815739|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815740|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56815741|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
56815742|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815743|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56815744|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815745|NCT00361634|Etanercept|etanercept|mesh-list
56815746|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56815747|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56815748|NCT00361634|Analgesics|analgesics|mesh-ancestor
56815749|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
56815750|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815751|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815752|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815753|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815754|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815755|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815756|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
56815757|NCT00357968|Clopidogrel|clopidogrel|mesh-list
56815758|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56815759|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56815760|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56815761|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56815762|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56815763|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
56815784|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56815785|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56815786|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815787|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56815788|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56815789|NCT00357500|Analgesics|analgesics|mesh-ancestor
56815790|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
56815791|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815792|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815793|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56815794|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56815795|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
56815796|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56815797|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815798|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56815799|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56815800|NCT00357500|Growth Substances|growth substances|mesh-ancestor
56815801|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
56815802|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56815803|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
56815804|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56815805|NCT00357110|Fulvestrant|fulvestrant|mesh-list
56815806|NCT00357110|Anastrozole|anastrozole|mesh-list
56815807|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56815808|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815810|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56815830|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815831|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56815832|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56815833|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
56815834|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815835|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56815836|NCT02531152|Latanoprost|latanoprost|mesh-list
56815837|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56815838|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56815839|NCT01084408|Paclitaxel|paclitaxel|mesh-list
56815840|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56815841|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56815842|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815843|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
56815844|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
56815845|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56815846|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815848|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815849|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56815850|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815851|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815852|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56815853|NCT00095056|Glipizide|glipizide|mesh-list
56815854|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56815855|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815856|NCT00095056|Incretins|incretins|mesh-ancestor
56815857|NCT00095056|Hormones|hormones|mesh-ancestor
56815858|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815859|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56815860|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
56815861|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815863|NCT00098020|Isotretinoin|isotretinoin|mesh-list
56815875|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
56815876|NCT00381680|Asparaginase|asparaginase|mesh-list
56815877|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
56815878|NCT00381680|Pegaspargase|pegaspargase|mesh-list
56815879|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
56815880|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815881|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
56815882|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815883|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815884|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56815885|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
56815886|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815887|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815888|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56815889|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815890|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
56815891|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
56815892|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815893|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56815894|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
56815895|NCT00381680|Hormones|hormones|mesh-ancestor
56815896|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56815897|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56815898|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56815899|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56815900|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56815901|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815902|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56815903|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
56815904|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56815905|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56815906|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
56815918|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
56815919|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
56815920|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
56815921|NCT03292250|Durvalumab|durvalumab|mesh-list
56815922|NCT03292250|Tremelimumab|tremelimumab|mesh-list
56815923|NCT03292250|Nintedanib|nintedanib|mesh-list
56815924|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56815925|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815926|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56815927|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815928|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815930|NCT01053338|Promethazine|promethazine|mesh-list
56815931|NCT01053338|Ibuprofen|ibuprofen|mesh-list
56815932|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815933|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56815934|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56815935|NCT01053338|Analgesics|analgesics|mesh-ancestor
56815936|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
56815937|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56815938|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815939|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56815940|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56815941|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56815942|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815943|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56815944|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56815945|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56815946|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
56815947|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
56815966|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56815967|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
56815968|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56815969|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56815970|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
56815971|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
56815972|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
56815973|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56815974|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815975|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
56815976|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56815977|NCT00360698|Insulin|insulin|mesh-list
56815978|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56815979|NCT00360698|Metformin|metformin|mesh-list
56815980|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
56815981|NCT00360698|Glimepiride|glimepiride|mesh-list
56815982|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
56815983|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56815984|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815985|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56815986|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56815987|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
56815988|NCT03990194|Leuprolide|leuprolide|mesh-list
56815989|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56815990|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
56815991|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56815992|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56815993|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56815994|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56815995|NCT00380978|Narcotics|narcotics|mesh-list
56815998|NCT00380978|Analgesics|analgesics|mesh-ancestor
56816013|NCT00227721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816014|NCT00227721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816015|NCT00227721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816016|NCT00227721|Immunologic Factors|immunologic factors|mesh-ancestor
56816017|NCT00227721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816018|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
56816019|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
56816020|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
56816021|NCT01074723|Carotenoids|carotenoids|mesh-list
56816022|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
56816023|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816024|NCT01074723|Protective Agents|protective agents|mesh-ancestor
56816025|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816026|NCT01074801|Insulin|insulin|mesh-list
56816027|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56816028|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56816029|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816030|NCT01074879|Caseins|caseins|mesh-list
56816031|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
56816032|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
56816033|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816034|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
56816035|NCT00226941|Promethazine|promethazine|mesh-list
56816036|NCT00226941|Capecitabine|capecitabine|mesh-list
56816037|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
56816038|NCT00226941|Cetuximab|cetuximab|mesh-list
56816039|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816040|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
56816041|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816042|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816043|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56816044|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56816045|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56816055|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56816056|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
56816057|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
56816058|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816059|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56816060|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
56816061|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
56816062|NCT01075503|Ropivacaine|ropivacaine|mesh-list
56816063|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
56816064|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
56816065|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56816066|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816067|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
56816068|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816069|NCT01075581|Epinephrine|epinephrine|mesh-list
56816070|NCT01075581|Racepinephrine|racepinephrine|mesh-list
56816071|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
56816072|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56816073|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56816074|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
56816075|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526955|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816076|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816077|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816078|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56816079|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56816081|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816082|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56816083|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
56816084|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
56816085|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
56816086|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56816087|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
56816088|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816097|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816098|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
56816099|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816100|NCT00504257|Bevacizumab|bevacizumab|mesh-list
56816101|NCT00504257|Docetaxel|docetaxel|mesh-list
56816102|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56816103|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816104|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56816105|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56816106|NCT00504257|Growth Substances|growth substances|mesh-ancestor
56816107|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816108|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
56816109|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
56816110|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
56816111|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
56816112|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816113|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
56816114|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816115|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816116|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816117|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816118|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56816119|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
56816120|NCT05358509|Hematinics|hematinics|mesh-ancestor
56816121|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
56816122|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816123|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
56816124|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816125|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816126|NCT00493025|Paclitaxel|paclitaxel|mesh-list
56816127|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56816128|NCT00493025|Cisplatin|cisplatin|mesh-list
56816129|NCT00493025|Gefitinib|gefitinib|mesh-list
56816130|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56816131|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816132|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
56816133|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
56816135|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816136|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816137|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816138|NCT01075113|Sorafenib|sorafenib|mesh-list
56816139|NCT01075113|Vorinostat|vorinostat|mesh-list
56816140|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816141|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816142|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816143|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816144|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56816145|NCT01073319|Rivastigmine|rivastigmine|mesh-list
56816146|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56816147|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816148|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816149|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
56816150|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816151|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56527042|NCT00946153|Lenvatinib|lenvatinib|mesh-list
56816152|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56816153|NCT01073319|Protective Agents|protective agents|mesh-ancestor
56816154|NCT00160563|Levocetirizine|levocetirizine|mesh-list
56816155|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56816156|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56816157|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
56816158|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
56816159|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816160|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816161|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816180|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816181|NCT00380588|Gemcitabine|gemcitabine|mesh-list
56816182|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816183|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816184|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
56816185|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816186|NCT00380588|Antiviral Agents|antiviral agents|mesh-ancestor
56816187|NCT00380588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816188|NCT00380588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816189|NCT00380588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816190|NCT00380588|Immunologic Factors|immunologic factors|mesh-ancestor
56816191|NCT00380588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816192|NCT00379808|Montelukast|montelukast|mesh-list
56816193|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56816194|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
56816195|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56816196|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
56816197|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816198|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816199|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56816200|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56816201|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816202|NCT03990038|Ropivacaine|ropivacaine|mesh-list
56816203|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
56816204|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
56816205|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56816206|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816207|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
56816208|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816223|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56816224|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56816225|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
56816226|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
56816227|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816228|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816229|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56816230|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816231|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816232|NCT01053650|Acetaminophen|acetaminophen|mesh-list
56816233|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56816234|NCT01053650|Analgesics|analgesics|mesh-ancestor
56816235|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
56816236|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816237|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816238|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
56816239|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
56816240|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56816241|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816242|NCT01050608|Ethanol|ethanol|mesh-list
56816243|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56816244|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816245|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56816246|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816247|NCT01053806|Lenalidomide|lenalidomide|mesh-list
56816248|NCT01053806|Azacitidine|azacitidine|mesh-list
56816249|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
56816250|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816251|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56816252|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56816253|NCT01053806|Growth Substances|growth substances|mesh-ancestor
56816254|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
56816255|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816256|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816257|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
56816263|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
56816264|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816265|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56816266|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
56816267|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816268|NCT01010789|Modafinil|modafinil|mesh-list
56816269|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56816270|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816271|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56816272|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56816273|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56816274|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816275|NCT01015235|Ketorolac|ketorolac|mesh-list
56816276|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56816277|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56816278|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56816279|NCT01015235|Analgesics|analgesics|mesh-ancestor
56816280|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
56816281|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816282|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816283|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56816284|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816285|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56816286|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816287|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816288|NCT00508157|Olanzapine|olanzapine|mesh-list
56816289|NCT00508157|Risperidone|risperidone|mesh-list
56816290|NCT00508157|Aripiprazole|aripiprazole|mesh-list
56816291|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56816292|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
56816293|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56816294|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
56816295|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816302|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
56816304|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
56816305|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816306|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56816307|NCT00508157|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56816308|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56816309|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56816310|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
56816311|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
56816312|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56816313|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56816314|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56816315|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56816316|NCT04331717|Leuprolide|leuprolide|mesh-list
56816317|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56816318|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
56816319|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56816320|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816321|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56816322|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816323|NCT01015391|Azathioprine|azathioprine|mesh-list
56816324|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
56816325|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816326|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816327|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816350|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
56816351|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56816352|NCT00507689|Antibodies|antibodies|mesh-list
56816353|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
56816354|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816355|NCT00491387|Metoprolol|metoprolol|mesh-list
56816356|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56816357|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56816358|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
56816359|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
56816360|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816361|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816362|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56816363|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56816364|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56816365|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
56816366|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816367|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816368|NCT01011257|Clopidogrel|clopidogrel|mesh-list
56816369|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56816370|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56816371|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56816372|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56816373|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
56816374|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816375|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816376|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816377|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
56816378|NCT01015547|Methotrexate|methotrexate|mesh-list
56816379|NCT01015547|Infliximab|infliximab|mesh-list
56816380|NCT01015547|Naltrexone|naltrexone|mesh-list
56816386|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
56816392|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816393|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
56816394|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816395|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56816396|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56816397|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816398|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56816399|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56816400|NCT01015547|Analgesics|analgesics|mesh-ancestor
56816401|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
56816402|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816403|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56816404|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56816405|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56816406|NCT00491075|Gemcitabine|gemcitabine|mesh-list
56816407|NCT00491075|Pemetrexed|pemetrexed|mesh-list
56816408|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816409|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
56816410|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816411|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816412|NCT00491075|Antiviral Agents|antiviral agents|mesh-ancestor
56816413|NCT00491075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816414|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816415|NCT00491075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816416|NCT00491075|Immunologic Factors|immunologic factors|mesh-ancestor
56816417|NCT00491075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816418|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56816419|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56816420|NCT00507455|Tamsulosin|tamsulosin|mesh-list
56816421|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
56816422|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56816423|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56816424|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56816425|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
56088795|NCT05055752|Analgesics|analgesics|mesh-ancestor
56816430|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56816431|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56816432|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
56816433|NCT04275713|Metformin|metformin|mesh-list
56816434|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56816435|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816436|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
56816437|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816438|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816439|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816440|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816441|NCT00490919|Buprenorphine|buprenorphine|mesh-list
56816442|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56816443|NCT00490919|Narcotics|narcotics|mesh-ancestor
56816444|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56816445|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816446|NCT00490919|Analgesics|analgesics|mesh-ancestor
56816447|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
56816448|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816449|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56816450|NCT01015937|Losartan|losartan|mesh-list
56816451|NCT01015937|Enalapril|enalapril|mesh-list
56816452|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
56816453|NCT01015937|Giapreza|giapreza|mesh-list
56816455|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
56816481|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56816482|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
56816483|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816484|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816485|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816486|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56816487|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
56816488|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816489|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56816490|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
56816491|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56816492|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56816493|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
56816494|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56816495|NCT01012193|Protective Agents|protective agents|mesh-ancestor
56816496|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56816497|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56816498|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816499|NCT00503399|Teriparatide|teriparatide|mesh-list
56816500|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
56816501|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56816502|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816503|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56816504|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56816505|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56816506|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816507|NCT00506519|Antithrombins|antithrombins|mesh-list
56816508|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
56816526|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56816527|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56816528|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56816529|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
56816530|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816531|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816532|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
56816533|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56816534|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816535|NCT00160251|Ribavirin|ribavirin|mesh-list
56816536|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56816537|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
56816538|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816539|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
56816540|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816541|NCT01075425|Bortezomib|bortezomib|mesh-list
56816542|NCT01075425|Belinostat|belinostat|mesh-list
56816543|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816581|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56816582|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56816583|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
56816584|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816585|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56816586|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
56816587|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
56816588|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
56816589|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56816590|NCT00377858|Insulin|insulin|mesh-list
56816591|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56816592|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
56816593|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
56816594|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56816595|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816596|NCT00502775|Fluticasone|fluticasone|mesh-list
56816597|NCT00502775|Xhance|xhance|mesh-list
56816598|NCT00502775|Fexofenadine|fexofenadine|mesh-list
56816599|NCT00502775|Terfenadine|terfenadine|mesh-list
56816600|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56816601|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56816602|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
56816603|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56816604|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816605|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56816606|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
56816607|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
56816608|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56816609|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56816610|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56816611|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
56816612|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
56194614|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194615|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194616|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
56194617|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194618|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56194625|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
56194626|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56194627|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
56098064|NCT05750966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098065|NCT05750966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098066|NCT05750966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56098067|NCT05750966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56816613|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816614|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816616|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
56816617|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816618|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56816619|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56816620|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816621|NCT01054118|Incretins|incretins|mesh-ancestor
56816622|NCT01054118|Hormones|hormones|mesh-ancestor
56816623|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816624|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56816625|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
56816626|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089012|NCT02892110|Varenicline|varenicline|mesh-list
56098068|NCT05750966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56098069|NCT05314153|Brexanolone|brexanolone|mesh-list
56098070|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
56098071|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56098072|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098074|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
56098075|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
56098076|NCT00377923|Progesterone|progesterone|mesh-list
56098077|NCT00377923|Progestins|progestins|mesh-ancestor
56098078|NCT00377923|Hormones|hormones|mesh-ancestor
56098079|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098080|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098081|NCT00002570|Leucovorin|leucovorin|mesh-list
56098082|NCT00002570|Fluorouracil|fluorouracil|mesh-list
56098083|NCT00002570|Calcium|calcium|mesh-list
56098084|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
56098085|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56098086|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098087|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
56098088|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098089|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098090|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098091|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098092|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
56098093|NCT00002570|Antidotes|antidotes|mesh-ancestor
56098094|NCT00002570|Protective Agents|protective agents|mesh-ancestor
56098095|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
56098096|NCT00002570|Vitamins|vitamins|mesh-ancestor
56098097|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
56098098|NCT00002576|Prednisolone|prednisolone|mesh-list
56098099|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
56098100|NCT00002576|Doxorubicin|doxorubicin|mesh-list
56098113|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56098114|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098115|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098116|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098117|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098118|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098119|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
56098120|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56098121|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098122|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
56098123|NCT00002576|Hormones|hormones|mesh-ancestor
56098124|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098125|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098126|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098127|NCT00002576|Analgesics|analgesics|mesh-ancestor
56098128|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
56816627|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816628|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56816629|NCT01050842|Bicalutamide|bicalutamide|mesh-list
56816630|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
56816631|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
56816632|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816633|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816634|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816635|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56816636|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56816637|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56816638|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56816639|NCT00485069|Levodopa|levodopa|mesh-list
56816640|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56816641|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56816642|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
56816643|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56816644|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816645|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816646|NCT03989336|Manganese|manganese|mesh-list
56816647|NCT03989336|Paclitaxel|paclitaxel|mesh-list
56816648|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56816649|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56816650|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56816651|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816652|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
56816653|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
56816654|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
56816656|NCT03989336|Trace Elements|trace elements|mesh-ancestor
56816670|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56816671|NCT00484679|Triamcinolone|triamcinolone|mesh-list
56816672|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56816673|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56527558|NCT00950755|Antibodies|antibodies|mesh-list
56816674|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56816675|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56816676|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
56816678|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816679|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816680|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816681|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
56816682|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816683|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816684|NCT00377312|Hormones|hormones|mesh-list
56816685|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
56816686|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816687|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816688|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56816689|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
56816690|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
56816691|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56816692|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56816693|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816697|NCT00376688|Sirolimus|sirolimus|mesh-list
56816716|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816717|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56816718|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56816719|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816720|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816721|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56816722|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
56816723|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816724|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816725|NCT00484289|Abatacept|abatacept|mesh-list
56816726|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56816727|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816728|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816729|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816730|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
56816731|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816732|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816733|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56816734|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816735|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816736|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816737|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816738|NCT01013909|Terbinafine|terbinafine|mesh-list
56816739|NCT01013909|Bifonazole|bifonazole|mesh-list
56816740|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
56816741|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816742|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816762|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56816763|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56816764|NCT01019291|Formaldehyde|formaldehyde|mesh-list
56816765|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
56816766|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816767|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
56816768|NCT01019447|Triclosan|triclosan|mesh-list
56816769|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56816770|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56816771|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56816772|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56816773|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
56816774|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816775|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56816776|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
56816777|NCT00490529|Rituximab|rituximab|mesh-list
56816778|NCT00490529|Vaccines|vaccines|mesh-list
56816779|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
56816780|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816781|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816782|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816789|NCT00333840|Interferons|interferons|mesh-list
56816818|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56527702|NCT00950599|Incretins|incretins|mesh-ancestor
56816819|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
56816820|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56816821|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
56816822|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816823|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
56816824|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816825|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56816826|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816827|NCT00339144|Dasatinib|dasatinib|mesh-list
56816828|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816829|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816830|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816831|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816832|NCT00321828|Leucovorin|leucovorin|mesh-list
56816833|NCT00321828|Bevacizumab|bevacizumab|mesh-list
56816834|NCT00321828|Fluorouracil|fluorouracil|mesh-list
56816835|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
56816873|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56816874|NCT00331422|Paclitaxel|paclitaxel|mesh-list
56816875|NCT00331422|Carboplatin|carboplatin|mesh-list
56816876|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56816877|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816878|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
56816879|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
56816880|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
56816881|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816882|NCT00331344|Prednisone|prednisone|mesh-list
56816883|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
56816884|NCT00331344|Epothilone B|epothilone b|mesh-list
56816885|NCT00331344|Epothilones|epothilones|mesh-list
56816886|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56816887|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
56816888|NCT00331344|Hormones|hormones|mesh-ancestor
56816889|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816890|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816891|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56527777|NCT05367063|Incretins|incretins|mesh-ancestor
56816892|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816893|NCT00331344|Analgesics|analgesics|mesh-ancestor
56816894|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
56816927|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816928|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56816929|NCT00375674|Sunitinib|sunitinib|mesh-list
56816930|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816931|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56816932|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56816933|NCT00375674|Growth Substances|growth substances|mesh-ancestor
56816934|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816935|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
56816936|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816937|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816938|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816939|NCT03991910|Ramipril|ramipril|mesh-list
56816940|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56816941|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
56816942|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816943|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816944|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56816945|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
56816946|NCT00320190|Dasatinib|dasatinib|mesh-list
56816947|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816948|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56816949|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816950|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816951|NCT02534402|Prednisone|prednisone|mesh-list
56816952|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56816953|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
56816954|NCT02534402|Hormones|hormones|mesh-ancestor
56816955|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816956|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816957|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56816958|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816959|NCT00319956|Azithromycin|azithromycin|mesh-list
56816960|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56816961|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816962|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56816964|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816965|NCT01062048|Incretins|incretins|mesh-ancestor
56816966|NCT01062048|Hormones|hormones|mesh-ancestor
56816967|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56816968|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56816969|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
56816970|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56816971|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56527847|NCT01279850|Pregabalin|pregabalin|mesh-list
56816972|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
56816973|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56816974|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56816975|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56816976|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816977|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56816978|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
56816980|NCT01054508|Niacinamide|niacinamide|mesh-list
56816981|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
56816982|NCT01054508|Vitamins|vitamins|mesh-ancestor
56816983|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
56816984|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56816985|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56816986|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
56816987|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816988|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56816989|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
56816990|NCT00348686|Felodipine|felodipine|mesh-list
56816991|NCT00348686|Candesartan|candesartan|mesh-list
56816992|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
56816993|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56816994|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56816995|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56816996|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56816997|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56816998|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56098129|NCT00002582|Tamoxifen|tamoxifen|mesh-list
56817001|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817002|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
56817003|NCT03742310|Vitamin D|vitamin d|mesh-list
56817004|NCT03742310|Calcitriol|calcitriol|mesh-list
56817005|NCT03742310|Vitamins|vitamins|mesh-ancestor
56817006|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
56817007|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817008|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56817009|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56817010|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56817011|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817012|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817013|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56817014|NCT00360230|Vaccines|vaccines|mesh-list
56817015|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
56817016|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817017|NCT03989024|Clomiphene|clomiphene|mesh-list
56817018|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56817019|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56817020|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
56817021|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817022|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817023|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56817024|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
56817025|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56089392|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
56098130|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
56098131|NCT00002582|Doxorubicin|doxorubicin|mesh-list
56098132|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56098133|NCT00002582|Fluorouracil|fluorouracil|mesh-list
56098134|NCT00002582|Methotrexate|methotrexate|mesh-list
56098135|NCT00002582|Leuprolide|leuprolide|mesh-list
56098136|NCT00002582|Goserelin|goserelin|mesh-list
56098137|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098138|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
56098139|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098140|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098141|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098142|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
56098143|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098144|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098145|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56194628|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
56194629|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
56194630|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56194631|NCT01494311|Lidocaine|lidocaine|mesh-list
56194632|NCT01494311|Tetracaine|tetracaine|mesh-list
56194633|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
56194634|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
55882043|NCT03000634|Elotuzumab|elotuzumab|mesh-list
56817026|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56817027|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56817028|NCT03989024|Hormones|hormones|mesh-ancestor
56817029|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
56817030|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56817031|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817032|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
56817033|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56817034|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817035|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56817036|NCT03742232|Laxatives|laxatives|mesh-ancestor
56817037|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56817038|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
56817039|NCT00352664|Donepezil|donepezil|mesh-list
56817040|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56817041|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817042|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817043|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
56817044|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817045|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817046|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
56817047|NCT03991442|Amlodipine|amlodipine|mesh-list
56817048|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56817049|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56817050|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817051|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194635|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194636|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194637|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
56194638|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194639|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56194640|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56194641|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56194642|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56194643|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194644|NCT01494363|Leucovorin|leucovorin|mesh-list
56194645|NCT01494363|Fluorouracil|fluorouracil|mesh-list
56098146|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56098147|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098148|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098149|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098150|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
56098151|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098152|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56098153|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
56098154|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56098155|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098156|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56817052|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56817053|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817054|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
56817055|NCT00490139|Trastuzumab|trastuzumab|mesh-list
56817056|NCT00490139|Lapatinib|lapatinib|mesh-list
56817057|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56817058|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817059|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56817060|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817061|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817062|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
56817063|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56817064|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817065|NCT01051388|Rabeprazole|rabeprazole|mesh-list
56817066|NCT01051388|Gefarnate|gefarnate|mesh-list
56817067|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56817068|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56817069|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56817070|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817071|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817072|NCT00490061|Lapatinib|lapatinib|mesh-list
56817073|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817074|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56817075|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817076|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817077|NCT04265105|Fluticasone|fluticasone|mesh-list
56817078|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817079|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56817080|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
56817081|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817082|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817083|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56817084|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
56817085|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
56817091|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
56817092|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56817093|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817094|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
56817095|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817096|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817097|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56817098|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
56817099|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817100|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817101|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56817102|NCT01016639|Capecitabine|capecitabine|mesh-list
56817103|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
56817104|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56817105|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
56817106|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817107|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817108|NCT00501293|Methylphenidate|methylphenidate|mesh-list
56817109|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56817110|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817111|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56817112|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56817113|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817114|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817115|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
56817116|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817117|NCT01014221|Prednisolone|prednisolone|mesh-list
56817118|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817119|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
56817120|NCT01014221|Hormones|hormones|mesh-ancestor
56817132|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56817133|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
56817134|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817135|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817136|NCT00359762|Exenatide|exenatide|mesh-list
56817137|NCT00359762|Glimepiride|glimepiride|mesh-list
56817138|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56817139|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817140|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56817141|NCT00359762|Incretins|incretins|mesh-ancestor
56817142|NCT00359762|Hormones|hormones|mesh-ancestor
56817143|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817144|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56817145|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817146|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
56817147|NCT03988010|Amantadine|amantadine|mesh-list
56817148|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56817149|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56817150|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
56817151|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817152|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
56817153|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817154|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817155|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817156|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56817157|NCT03988010|Analgesics|analgesics|mesh-ancestor
56817158|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
56817159|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817160|NCT01055522|Interleukin-2|interleukin-2|mesh-list
56817178|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
56817179|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817180|NCT00347438|Capecitabine|capecitabine|mesh-list
56817181|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56817182|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
56817183|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817184|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817185|NCT00329238|Warfarin|warfarin|mesh-list
56817186|NCT00329238|Dabigatran|dabigatran|mesh-list
56817187|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
56817188|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
56817189|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56817190|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
56817191|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817192|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817193|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56817194|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56817195|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56817196|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
56817197|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817198|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56817199|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56817200|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817201|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56817202|NCT00328926|Hormones|hormones|mesh-list
56817226|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817227|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56817228|NCT00319020|Bosentan|bosentan|mesh-list
56817229|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56817230|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56817231|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817232|NCT01056224|Remifentanil|remifentanil|mesh-list
56817233|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56817234|NCT01056224|Narcotics|narcotics|mesh-ancestor
56817235|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817236|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817237|NCT01056224|Analgesics|analgesics|mesh-ancestor
56817238|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
56817239|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817240|NCT03982680|Gemcitabine|gemcitabine|mesh-list
56817241|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56817242|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
56817243|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817244|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817245|NCT03982680|Antiviral Agents|antiviral agents|mesh-ancestor
56817246|NCT03982680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817247|NCT03982680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817248|NCT03982680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817249|NCT03982680|Immunologic Factors|immunologic factors|mesh-ancestor
56817276|NCT00350870|Disulfiram|disulfiram|mesh-list
56817277|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56817278|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56817279|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817280|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817281|NCT00350792|Carboplatin|carboplatin|mesh-list
56817282|NCT00350792|Pemetrexed|pemetrexed|mesh-list
56817283|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817284|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817285|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817286|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56817287|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56817288|NCT00317772|Topotecan|topotecan|mesh-list
56817289|NCT00317772|Gefitinib|gefitinib|mesh-list
56817290|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56817291|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56817292|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817293|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817294|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817295|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56817296|NCT01325298|Riboflavin|riboflavin|mesh-list
56817297|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
56817298|NCT01325298|Vitamins|vitamins|mesh-ancestor
56817299|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
56817300|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817301|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56817302|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
56817303|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
56817304|NCT00350636|Oxybutynin|oxybutynin|mesh-list
56817305|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
56817306|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
56817307|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817308|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817309|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56817317|NCT00350636|Renal Agents|renal agents|mesh-ancestor
56817318|NCT01051544|Factor VIII|factor viii|mesh-list
56817319|NCT01051544|Coagulants|coagulants|mesh-ancestor
56817320|NCT01058720|Vitamin D|vitamin d|mesh-list
56817321|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
56817322|NCT01058720|Vitamins|vitamins|mesh-ancestor
56817323|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
56817324|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817325|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56817326|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56817327|NCT00346268|Parecoxib|parecoxib|mesh-list
56817328|NCT00346268|Morphine|morphine|mesh-list
56817329|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56817330|NCT00346268|Narcotics|narcotics|mesh-ancestor
56817331|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817332|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817333|NCT00346268|Analgesics|analgesics|mesh-ancestor
56817334|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
56817335|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817336|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56817337|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56817338|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817339|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817340|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56817341|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56098157|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56098158|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56098159|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
56098160|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098161|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098162|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56098179|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098180|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098182|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
56098183|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
56098184|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56098185|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56098186|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56098187|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
56098188|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56098189|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098190|NCT05750576|Chlorhexidine|chlorhexidine|mesh-list
56098191|NCT05750576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56098192|NCT05750576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098193|NCT05750576|Disinfectants|disinfectants|mesh-ancestor
56098194|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
56098195|NCT00002594|Melphalan|melphalan|mesh-list
56098196|NCT00002594|Molgramostim|molgramostim|mesh-list
56098197|NCT00002594|Sargramostim|sargramostim|mesh-list
56098198|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817342|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817343|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817344|NCT00327444|Aflibercept|aflibercept|mesh-list
56817345|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56817346|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56817348|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817349|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
56817350|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817351|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
56817352|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56817353|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817354|NCT03982134|Panobinostat|panobinostat|mesh-list
56817355|NCT03982134|Spartalizumab|spartalizumab|mesh-list
56817356|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817357|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56817358|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817359|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817360|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56817361|NCT00337610|Metformin|metformin|mesh-list
56817397|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817398|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817399|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817400|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56817401|NCT01051934|Paclitaxel|paclitaxel|mesh-list
56817402|NCT01051934|Bevacizumab|bevacizumab|mesh-list
56817403|NCT01051934|Carboplatin|carboplatin|mesh-list
56817404|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56817405|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817406|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
56817407|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
56817408|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
56817409|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817410|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56817411|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56098199|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
56098200|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098201|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194646|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
56194647|NCT01494363|Irinotecan|irinotecan|mesh-list
56194648|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
56194649|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194650|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56194651|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194652|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56194653|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
56194654|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194655|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56194656|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56194657|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194658|NCT01494363|Antidotes|antidotes|mesh-ancestor
56194659|NCT01494363|Protective Agents|protective agents|mesh-ancestor
56194660|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
56194661|NCT01494363|Vitamins|vitamins|mesh-ancestor
56194662|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
56194663|NCT01494402|Aspirin|aspirin|mesh-list
56194664|NCT01494402|Esomeprazole|esomeprazole|mesh-list
56194665|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56194666|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56194667|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56194668|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194669|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194670|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56194671|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56194672|NCT01494402|Analgesics|analgesics|mesh-ancestor
56194673|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
56194674|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098202|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098203|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
56098204|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098205|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098206|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098208|NCT02234011|Analgesics|analgesics|mesh-ancestor
56098209|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
56098210|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098211|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098212|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56098213|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56098214|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
56817412|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56817413|NCT01051934|Growth Substances|growth substances|mesh-ancestor
56817414|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817415|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
56817416|NCT01325168|Oxytocin|oxytocin|mesh-list
56817417|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
56817418|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56817419|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817420|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
56817421|NCT00316914|Calcium|calcium|mesh-list
56817422|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56817423|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817424|NCT00316914|Analgesics|analgesics|mesh-ancestor
56817425|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
56817426|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817427|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
56817428|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817429|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56817430|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
56817431|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56817432|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817433|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817434|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
56817463|NCT01056614|Methotrexate|methotrexate|mesh-list
56817464|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
56817465|NCT01056614|Fludarabine|fludarabine|mesh-list
56817466|NCT01056614|Busulfan|busulfan|mesh-list
56817467|NCT01056614|Tacrolimus|tacrolimus|mesh-list
56817468|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
56817469|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56817470|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
56817471|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56817472|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
56817473|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56817474|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817475|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56817476|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
56817477|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817478|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817479|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
56817480|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817481|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56817482|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817483|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
56817484|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817485|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56817486|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56817487|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
56817488|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56817489|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56817490|NCT00346034|Pregabalin|pregabalin|mesh-list
56817491|NCT00346034|Analgesics|analgesics|mesh-ancestor
56817492|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
56817493|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817494|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817495|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
56817500|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56817505|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
56817506|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817507|NCT01059110|Salicylates|salicylates|mesh-list
56817508|NCT01059110|Imiquimod|imiquimod|mesh-list
56817509|NCT01059110|Fluorouracil|fluorouracil|mesh-list
56817510|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56817511|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
56817512|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817513|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817514|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
56817515|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
56817516|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817517|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56817518|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817519|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56817520|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56098215|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
56098216|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56098217|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56098218|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56098219|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194675|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098220|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098221|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
56098222|NCT00002600|Carboplatin|carboplatin|mesh-list
56098234|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56098235|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098236|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098237|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56098238|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098239|NCT02144155|Oxytocin|oxytocin|mesh-list
56098240|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
56098241|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56098242|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098243|NCT00002618|Leucovorin|leucovorin|mesh-list
56098245|NCT00002618|Cytarabine|cytarabine|mesh-list
56098246|NCT00002618|Prednisone|prednisone|mesh-list
56098247|NCT00002618|Doxorubicin|doxorubicin|mesh-list
56098248|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56098249|NCT00002618|Methotrexate|methotrexate|mesh-list
56098250|NCT00002618|Vincristine|vincristine|mesh-list
56098251|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
56098252|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
56098253|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56098254|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098255|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098256|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098257|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098258|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098259|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098260|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098261|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
56098262|NCT00002618|Hormones|hormones|mesh-ancestor
56098263|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098264|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098265|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56098266|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
56098267|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55883184|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
56817521|NCT01059110|Analgesics|analgesics|mesh-ancestor
56817522|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
56817523|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817524|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817525|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817526|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56817527|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817528|NCT03991364|Methamphetamine|methamphetamine|mesh-list
56817529|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56817530|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817531|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
56817532|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
56817533|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817534|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
56817535|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817536|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817537|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
56817538|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56817539|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56817540|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817541|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56817542|NCT00335738|Carboplatin|carboplatin|mesh-list
56817543|NCT00335738|Etoposide|etoposide|mesh-list
56817544|NCT00335738|Vincristine|vincristine|mesh-list
56817545|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
56817546|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817547|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56817548|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56817549|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56817550|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817565|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
56817566|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817567|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817568|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56817569|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56817570|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
56817571|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817572|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817573|NCT01059422|Lamivudine|lamivudine|mesh-list
56817574|NCT01059422|Abacavir|abacavir|mesh-list
56817575|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
56817576|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56817577|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56817578|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817579|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817580|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
56817581|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817582|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56817583|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56817584|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56817585|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56817586|NCT01052246|Clindamycin|clindamycin|mesh-list
56817587|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
56817588|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
56817589|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56817590|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56817591|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817592|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56817593|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817594|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817595|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
56817596|NCT00334958|Rufinamide|rufinamide|mesh-list
56817597|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
56817606|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817607|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817608|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56817609|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56817610|NCT00326898|Growth Substances|growth substances|mesh-ancestor
56817611|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817612|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
56817613|NCT01062360|Aspirin|aspirin|mesh-list
56817614|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
56817615|NCT01062360|Ephedrine|ephedrine|mesh-list
56817616|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56817617|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56817618|NCT01062360|Analgesics|analgesics|mesh-ancestor
56817619|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
56817620|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817621|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817622|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817623|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817624|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56817625|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56817626|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817627|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56817628|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56817629|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817630|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
56817631|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56817632|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
56817633|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56817634|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
56817635|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
56817636|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56817637|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56817638|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
56098268|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098269|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
56098270|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098271|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56098272|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098273|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
56098274|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55886707|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56817639|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
56817640|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817641|NCT01063842|Acetaminophen|acetaminophen|mesh-list
56817642|NCT01063842|Tramadol|tramadol|mesh-list
56817643|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56528521|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
56817644|NCT01063842|Analgesics|analgesics|mesh-ancestor
56817645|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
56817646|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817647|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817648|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
56817649|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56817650|NCT01063842|Narcotics|narcotics|mesh-ancestor
56817651|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817653|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56817654|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56817655|NCT01063920|Analgesics|analgesics|mesh-ancestor
56817656|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
56817657|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817658|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817659|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817660|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817661|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
56817662|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56817663|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817664|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817665|NCT01062516|Esomeprazole|esomeprazole|mesh-list
56817666|NCT01062516|Famotidine|famotidine|mesh-list
56817667|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56817668|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56817669|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56817670|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817671|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817672|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56817673|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
56817674|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
56817679|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56817680|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817681|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
56817682|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
56817683|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
56817684|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817685|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56817686|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
56817687|NCT00334802|Antiviral Agents|antiviral agents|mesh-ancestor
56817688|NCT00334802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817689|NCT00334802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817690|NCT00334802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817691|NCT00334802|Immunologic Factors|immunologic factors|mesh-ancestor
56817692|NCT00334802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817693|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
56817694|NCT03985358|Narcotics|narcotics|mesh-ancestor
56817695|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817696|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817697|NCT03985358|Analgesics|analgesics|mesh-ancestor
56817698|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
56817699|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817700|NCT01052324|Remifentanil|remifentanil|mesh-list
56817701|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56817702|NCT01052324|Narcotics|narcotics|mesh-ancestor
56817703|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817704|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817705|NCT01052324|Analgesics|analgesics|mesh-ancestor
56817706|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
56817707|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817708|NCT01059890|Metronidazole|metronidazole|mesh-list
56817709|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
56817710|NCT01059890|Cefotaxime|cefotaxime|mesh-list
56817711|NCT01059890|Cefoxitin|cefoxitin|mesh-list
56817712|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817713|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56817714|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56817715|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56817716|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56817717|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56817718|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817719|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817720|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817721|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56817722|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56817723|NCT01057160|Rizatriptan|rizatriptan|mesh-list
56817724|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56817725|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
56817726|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817727|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817728|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817729|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
56817730|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56817731|NCT00307086|Bortezomib|bortezomib|mesh-list
56817732|NCT00307086|Melphalan|melphalan|mesh-list
56817733|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817734|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56817735|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
56817736|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817737|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56817738|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817739|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
56817740|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817741|NCT02533544|Tenofovir|tenofovir|mesh-list
56817742|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
56817743|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817744|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56817745|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56817746|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817747|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098275|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56098276|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
56098277|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098279|NCT00002618|Protective Agents|protective agents|mesh-ancestor
56098280|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
56098281|NCT00002618|Vitamins|vitamins|mesh-ancestor
56098282|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
56098283|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098284|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098285|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
56817748|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56817749|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56817750|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56817751|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
56817752|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56817753|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56817754|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56817755|NCT00325416|Melphalan|melphalan|mesh-list
56817756|NCT00325416|Topotecan|topotecan|mesh-list
56817757|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56817758|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
56817759|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817760|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817761|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56817762|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817763|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
56817764|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817765|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56817766|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56817767|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817768|NCT00314808|Dronabinol|dronabinol|mesh-list
56817769|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
56817770|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817771|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56817772|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56817773|NCT00314808|Analgesics|analgesics|mesh-ancestor
56817774|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
56817775|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817776|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56817794|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56817796|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
56817797|NCT01064154|Carvedilol|carvedilol|mesh-list
56817798|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56817799|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56817800|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
56817801|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56817802|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817803|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817804|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56817805|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
56817806|NCT01064154|Protective Agents|protective agents|mesh-ancestor
56817807|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56817808|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56817809|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56817810|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
56817811|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56817812|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56817813|NCT00314340|Acetaminophen|acetaminophen|mesh-list
56817814|NCT00314340|Morphine|morphine|mesh-list
56817815|NCT00314340|Hydrocodone|hydrocodone|mesh-list
56817816|NCT00314340|Phenobarbital|phenobarbital|mesh-list
56817848|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56817849|NCT00306852|Mitomycins|mitomycins|mesh-list
56817850|NCT00306852|Mitomycin|mitomycin|mesh-list
56817851|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56817852|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817853|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
56817854|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817855|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56817856|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817857|NCT00314262|Celecoxib|celecoxib|mesh-list
56817858|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56817859|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817860|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56817861|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817862|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817863|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56817864|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56817865|NCT00314262|Analgesics|analgesics|mesh-ancestor
56817866|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
56528743|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
56817867|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817868|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817869|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817870|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817871|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56817872|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56817873|NCT00333866|Pregabalin|pregabalin|mesh-list
56817893|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
56817894|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
56817895|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817896|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
56817897|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817898|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56817899|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
56817900|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56817901|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56817902|NCT00332696|Prednisolone|prednisolone|mesh-list
56817903|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
56817904|NCT00332696|Octreotide|octreotide|mesh-list
56817905|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56817906|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
56817907|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817908|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
56817909|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
56817910|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817911|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817912|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56817913|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
56817914|NCT00332696|Hormones|hormones|mesh-ancestor
56817915|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817916|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56817917|NCT00332696|Protective Agents|protective agents|mesh-ancestor
56817918|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56817943|NCT00324038|Buprenorphine|buprenorphine|mesh-list
56817944|NCT00324038|Codeine|codeine|mesh-list
56817945|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56817946|NCT00324038|Analgesics|analgesics|mesh-ancestor
56817947|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
56817948|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817949|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817950|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
56817951|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56817952|NCT00324038|Narcotics|narcotics|mesh-ancestor
56817953|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817954|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56817955|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
56817956|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
56817957|NCT03984110|Dexamethasone|dexamethasone|mesh-list
56817958|NCT03984110|Aflibercept|aflibercept|mesh-list
56817959|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56817960|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
56817961|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
56817962|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56817963|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817964|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56817965|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
56817966|NCT03984110|Hormones|hormones|mesh-ancestor
56817967|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56817968|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56817969|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817970|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56817971|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56817972|NCT03984110|Growth Substances|growth substances|mesh-ancestor
56817973|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
56817974|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
56817975|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817976|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
56817979|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56817983|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56817984|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56817985|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817986|NCT00331760|Cisplatin|cisplatin|mesh-list
56817987|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56817988|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56817989|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56817990|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56817991|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
56817992|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817993|NCT00313014|Oxycodone|oxycodone|mesh-list
56817994|NCT00313014|Buprenorphine|buprenorphine|mesh-list
56817995|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56817996|NCT00313014|Narcotics|narcotics|mesh-ancestor
56817997|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56817998|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56817999|NCT00313014|Analgesics|analgesics|mesh-ancestor
56818000|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
56818001|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818002|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56818003|NCT01075659|Nicotine|nicotine|mesh-list
56818005|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
56818036|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818037|NCT00130533|Capecitabine|capecitabine|mesh-list
56818038|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56818039|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
56818040|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818041|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818042|NCT00156819|Fluticasone|fluticasone|mesh-list
56818043|NCT00156819|Xhance|xhance|mesh-list
56818044|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56818045|NCT00156819|Montelukast|montelukast|mesh-list
56818046|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56818047|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56818048|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
56818049|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818050|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818051|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56818052|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
56818053|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
56818054|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56818055|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56818056|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56818057|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56818058|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
56818059|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818060|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818061|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56818062|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
56818063|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818064|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56818065|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56818066|NCT00224133|Silodosin|silodosin|mesh-list
56818067|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56818068|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56818069|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56818070|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
56818073|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818074|NCT00224133|Urological Agents|urological agents|mesh-ancestor
56818075|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
56818076|NCT00224055|Hematinics|hematinics|mesh-ancestor
56818077|NCT00150969|Vitamin K|vitamin k|mesh-list
56818078|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
56818079|NCT00150969|Vitamins|vitamins|mesh-ancestor
56818080|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
56818081|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818082|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56818083|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56818084|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818085|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
56818086|NCT00150969|Coagulants|coagulants|mesh-ancestor
56818087|NCT00150345|Voriconazole|voriconazole|mesh-list
56818088|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
56818136|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56818137|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
56818138|NCT00148317|Hormones|hormones|mesh-ancestor
56818139|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818140|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56818141|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818142|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56818143|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56818144|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56818145|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818146|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818147|NCT00323882|Ipilimumab|ipilimumab|mesh-list
56818148|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56818149|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818150|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56818151|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818152|NCT00331682|Docetaxel|docetaxel|mesh-list
56818153|NCT00331682|Alvocidib|alvocidib|mesh-list
56818154|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818155|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
56818156|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
56818157|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
56818158|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818159|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
56818160|NCT00331682|Growth Substances|growth substances|mesh-ancestor
56818161|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818162|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56818163|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818164|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56818165|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56529037|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
56098286|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
56098287|NCT00002618|Trace Elements|trace elements|mesh-ancestor
56098288|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
56098289|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56098300|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098301|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098302|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098303|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
56098304|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
56818166|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56818167|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818168|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818169|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
56818170|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818171|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56818172|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56818173|NCT00331136|Artesunate|artesunate|mesh-list
56818174|NCT00331136|Pyronaridine|pyronaridine|mesh-list
56818175|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
56818176|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56818177|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56818178|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818179|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818180|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
56818181|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
56818182|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56818183|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
56818184|NCT00330668|Mecasermin|mecasermin|mesh-list
56818185|NCT00330668|Growth Substances|growth substances|mesh-ancestor
56818187|NCT00306384|Alogliptin|alogliptin|mesh-list
56818222|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56818223|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
56818224|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818225|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818226|NCT01064232|Risperidone|risperidone|mesh-list
56818227|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56818228|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
56818229|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818230|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818231|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818232|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56818233|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56818234|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818235|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56818236|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56818237|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
56818238|NCT00501059|Aspirin|aspirin|mesh-list
56818239|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56818240|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56818241|NCT00501059|Analgesics|analgesics|mesh-ancestor
56818242|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
56818243|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818244|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818245|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56818246|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818247|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56818248|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56818249|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818250|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56090592|NCT02953561|Avelumab|avelumab|mesh-list
56098305|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098306|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56098307|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098308|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56098309|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
56098310|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098311|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
56098312|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098313|NCT00002630|Cobalt|cobalt|mesh-list
56098314|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
56098315|NCT00002630|Melphalan|melphalan|mesh-list
56194676|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56194677|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818251|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56818252|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818253|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
56818254|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56818255|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
56818256|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818257|NCT00322868|Pioglitazone|pioglitazone|mesh-list
56818258|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56818259|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818260|NCT01016717|Omeprazole|omeprazole|mesh-list
56818261|NCT01016717|Pantoprazole|pantoprazole|mesh-list
56818262|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56818263|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56818264|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56818265|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818266|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818267|NCT01016795|Lenograstim|lenograstim|mesh-list
56818268|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56818269|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
56818270|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818271|NCT00343382|Pilocarpine|pilocarpine|mesh-list
56818272|NCT00343382|Miotics|miotics|mesh-ancestor
56818273|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
56818274|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818275|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818276|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56818277|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56818278|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
56818279|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818281|NCT00481871|Vitamins|vitamins|mesh-list
56818298|NCT00481871|Immunologic Factors|immunologic factors|mesh-ancestor
56818299|NCT00481871|Hematinics|hematinics|mesh-ancestor
56818300|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56818301|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
56818302|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818303|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
56818304|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818305|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818306|NCT00329108|Olanzapine|olanzapine|mesh-list
56818307|NCT00329108|Ziprasidone|ziprasidone|mesh-list
56818308|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
56818309|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
56818310|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818311|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818312|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56818313|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56818314|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56818315|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818316|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56818317|NCT00329108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56818318|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56818319|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818320|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818321|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818322|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
56818323|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56818324|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56818325|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
56818326|NCT00329030|Rituximab|rituximab|mesh-list
56818327|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
56818328|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56818329|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818330|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
56818331|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818332|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818333|NCT00328562|Gefitinib|gefitinib|mesh-list
56818334|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818335|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56818336|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818337|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818338|NCT00328172|Metformin|metformin|mesh-list
56818339|NCT00328172|Linagliptin|linagliptin|mesh-list
56818340|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56818341|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818342|NCT00328172|Incretins|incretins|mesh-ancestor
56818343|NCT00328172|Hormones|hormones|mesh-ancestor
56818344|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818345|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56818346|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
56818347|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818348|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818349|NCT01061372|Pregabalin|pregabalin|mesh-list
56818350|NCT01061372|Analgesics|analgesics|mesh-ancestor
56818351|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
56818352|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818353|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818354|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
56818355|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56818356|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818359|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56818388|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818389|NCT00305448|Fulvestrant|fulvestrant|mesh-list
56818390|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56818391|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818392|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56818393|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56818394|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
56818395|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818396|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818397|NCT01063218|Emollients|emollients|mesh-list
56818398|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
56818399|NCT00305058|Morphine|morphine|mesh-list
56818400|NCT00305058|Hydromorphone|hydromorphone|mesh-list
56818401|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56818402|NCT00305058|Narcotics|narcotics|mesh-ancestor
56818403|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818404|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818405|NCT00305058|Analgesics|analgesics|mesh-ancestor
56818406|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
56818407|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818408|NCT01061450|Simvastatin|simvastatin|mesh-list
56818409|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56818410|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56818411|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
56818412|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818413|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56818415|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818436|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818437|NCT00321932|Vitamins|vitamins|mesh-ancestor
56818438|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
56818439|NCT00321932|Antacids|antacids|mesh-ancestor
56818440|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56818441|NCT00326612|Midazolam|midazolam|mesh-list
56818442|NCT00326612|Diazepam|diazepam|mesh-list
56818443|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56818444|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56818445|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818446|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818447|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56818448|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56818449|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56818450|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56818451|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
56818452|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
56818453|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
56818454|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
56818455|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818456|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818457|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
56818458|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
56818459|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
56818460|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818488|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818489|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56818490|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56818491|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56818492|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818493|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818494|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56818495|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
56818496|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818497|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56818498|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
56818499|NCT03982862|Hormones|hormones|mesh-ancestor
56818500|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818501|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56818502|NCT01060904|Doxorubicin|doxorubicin|mesh-list
56818503|NCT01060904|Bleomycin|bleomycin|mesh-list
56818504|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56818505|NCT01060904|Dacarbazine|dacarbazine|mesh-list
56818506|NCT01060904|Vinblastine|vinblastine|mesh-list
56818507|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56818508|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56818509|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818510|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56818511|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56818512|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818513|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818514|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56818515|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
56818516|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818517|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56818518|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
56090845|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56194678|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56194679|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56194680|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56194681|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56194682|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
56122458|NCT01691508|Prednisone|prednisone|mesh-list
56194683|NCT01494415|Paclitaxel|paclitaxel|mesh-list
56194684|NCT01494415|Carboplatin|carboplatin|mesh-list
55886708|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
56818519|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56818520|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
56818521|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
56818522|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
56818523|NCT01058174|Fluconazole|fluconazole|mesh-list
56818524|NCT01058174|Amphotericin B|amphotericin b|mesh-list
56818525|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56818526|NCT01058174|Caspofungin|caspofungin|mesh-list
56818527|NCT01058174|Micafungin|micafungin|mesh-list
56818528|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
56818529|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818530|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56818531|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56818532|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818533|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818534|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56818535|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
56818536|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818537|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818538|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56818571|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818572|NCT01061060|Epoprostenol|epoprostenol|mesh-list
56818573|NCT01061060|Beraprost|beraprost|mesh-list
56818574|NCT01061060|Tezosentan|tezosentan|mesh-list
56818575|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56818576|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
56818577|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56818578|NCT00310388|Ezogabine|ezogabine|mesh-list
56818579|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
56818580|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818581|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818582|NCT03981770|Anesthetics|anesthetics|mesh-list
56818583|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818584|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818585|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56818586|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
56818587|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194685|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56194686|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194687|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
56194688|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
56194689|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
56194690|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194691|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
56194692|NCT01494441|Calcium|calcium|mesh-list
56194693|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56194694|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194695|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56194696|NCT01494597|Cyclosporine|cyclosporine|mesh-list
56194697|NCT01494597|Isavuconazole|isavuconazole|mesh-list
56194698|NCT01494597|Cyclosporins|cyclosporins|mesh-list
56194699|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194700|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194701|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56194724|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098316|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098317|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
56098318|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098319|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098320|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098321|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
56098322|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098323|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098324|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098325|NCT00002630|Trace Elements|trace elements|mesh-ancestor
56098326|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
56098328|NCT00002642|Etoposide|etoposide|mesh-list
56098329|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098330|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098331|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098332|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098333|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098334|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098335|NCT00002642|Trace Elements|trace elements|mesh-ancestor
56098336|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
56098337|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098338|NCT03983941|Ropivacaine|ropivacaine|mesh-list
56818588|NCT01063556|Donepezil|donepezil|mesh-list
56818589|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56818590|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818591|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818592|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
56818593|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818594|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818595|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
56818596|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
56818597|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56818598|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
56818599|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818600|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
56818601|NCT03981458|Protective Agents|protective agents|mesh-ancestor
56818602|NCT00309842|Cyclosporine|cyclosporine|mesh-list
56818603|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
56818604|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
56818605|NCT00309842|Fludarabine|fludarabine|mesh-list
56818606|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
56818607|NCT00309842|Cyclosporins|cyclosporins|mesh-list
56818608|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818609|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
56818610|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818611|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818638|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818639|NCT00499889|Vidarabine|vidarabine|mesh-list
56818640|NCT00499889|Methotrexate|methotrexate|mesh-list
56818641|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
56818642|NCT00499889|Fludarabine|fludarabine|mesh-list
56818643|NCT00499889|Busulfan|busulfan|mesh-list
56818644|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
56818645|NCT00499889|Tacrolimus|tacrolimus|mesh-list
56818646|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
56818647|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56818648|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56818649|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
56818650|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56818651|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818652|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56818653|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
56818654|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818655|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818656|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
56818657|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818658|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56818659|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818660|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
56818661|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56818662|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56818663|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
56818664|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818665|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56818666|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
56818667|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56818668|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56818670|NCT00309608|Glimepiride|glimepiride|mesh-list
56818682|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818683|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818684|NCT00308750|Carboplatin|carboplatin|mesh-list
56818685|NCT00308750|Docetaxel|docetaxel|mesh-list
56818686|NCT00308750|Pemetrexed|pemetrexed|mesh-list
56818687|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818688|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
56818689|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
56818690|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
56818691|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818692|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818693|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56818694|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56818695|NCT00489359|Carboplatin|carboplatin|mesh-list
56818696|NCT00489359|Pemetrexed|pemetrexed|mesh-list
56818697|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818698|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818699|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818700|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56818701|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56818702|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
56818703|NCT00481247|Dasatinib|dasatinib|mesh-list
56818704|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818705|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56818706|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818707|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818732|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
56818733|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818734|NCT01020383|Abciximab|abciximab|mesh-list
56818735|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
56818736|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56818737|NCT00499031|Cetuximab|cetuximab|mesh-list
56818738|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56818739|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818740|NCT00498797|Prednisolone|prednisolone|mesh-list
56818741|NCT00498797|Docetaxel|docetaxel|mesh-list
56818742|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818743|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
56818744|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
56818745|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
56818746|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818747|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56818748|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
56818749|NCT00498797|Hormones|hormones|mesh-ancestor
56818750|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098339|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
56098340|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
56098341|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56098342|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098343|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
56098344|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098345|NCT05750030|Bevacizumab|bevacizumab|mesh-list
56098346|NCT05750030|Atezolizumab|atezolizumab|mesh-list
56098347|NCT05750030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56098348|NCT05750030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098349|NCT05750030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56098350|NCT05750030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56098351|NCT05750030|Growth Substances|growth substances|mesh-ancestor
56098352|NCT05750030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098353|NCT05750030|Growth Inhibitors|growth inhibitors|mesh-ancestor
56098354|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56098355|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56098366|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56098367|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
56098368|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098369|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56098370|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56098371|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098373|NCT01401049|Propofol|propofol|mesh-list
56098374|NCT01401049|Fospropofol|fospropofol|mesh-list
56098375|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
56098376|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
56098377|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56098378|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098379|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
56098380|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098381|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56098382|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56098383|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56098384|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55886709|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
56818751|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818752|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56818753|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
56818754|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56818755|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56818756|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
56818757|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
56818758|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56818759|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818760|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56818761|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56818762|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56818763|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818764|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818765|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
56818766|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818767|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818768|NCT00295620|Anastrozole|anastrozole|mesh-list
56818769|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56529635|NCT01281917|Bortezomib|bortezomib|mesh-list
56818770|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818771|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56818772|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56818773|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818774|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818775|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56818776|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
56818777|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56818778|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818779|NCT03980496|Omeprazole|omeprazole|mesh-list
56818780|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56818781|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56818785|NCT01063530|Fluorides|fluorides|mesh-list
56818788|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818789|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
56818790|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56818791|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818792|NCT01069302|Clopidogrel|clopidogrel|mesh-list
56818793|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56818794|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56818795|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56818796|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56818797|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
56818798|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818799|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818800|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818801|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
56818802|NCT00321620|Denosumab|denosumab|mesh-list
56818803|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56818804|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818805|NCT00304278|Cisplatin|cisplatin|mesh-list
56818806|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56818807|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818808|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56818809|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818810|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818811|NCT03981068|Nimorazole|nimorazole|mesh-list
56818812|NCT03981068|Cisplatin|cisplatin|mesh-list
56818813|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818814|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56818815|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56818816|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56818817|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818818|NCT01064102|Cetirizine|cetirizine|mesh-list
56818819|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56818820|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56818821|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56818822|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
56098385|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098386|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56098387|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56098388|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
56818823|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
56818824|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818825|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818826|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818827|NCT02532114|Niclosamide|niclosamide|mesh-list
56818828|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
56818829|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56818830|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
56818831|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56818832|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818833|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
56818834|NCT00307736|Bevacizumab|bevacizumab|mesh-list
56818835|NCT00307736|Fluorouracil|fluorouracil|mesh-list
56818836|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56818837|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56098389|NCT00381758|Methylphenidate|methylphenidate|mesh-list
56098390|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56098391|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098392|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55741749|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098393|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56098394|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56098395|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098396|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
56098397|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56098399|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56098400|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098401|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56098402|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56098403|NCT01402531|Growth Substances|growth substances|mesh-ancestor
56098404|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098405|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
56098406|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
56098407|NCT00381836|Hematinics|hematinics|mesh-ancestor
56098408|NCT01971853|Analgesics|analgesics|mesh-list
56098409|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
56098410|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098411|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098412|NCT00002678|Dexamethasone|dexamethasone|mesh-list
56098413|NCT00002678|Prednisone|prednisone|mesh-list
56098414|NCT00002678|Melphalan|melphalan|mesh-list
56098415|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098416|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
56098417|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
56098418|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098419|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866768|NCT01830478|Rituximab|rituximab|mesh-list
56098433|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56098434|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098435|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56098436|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56098438|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098439|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
56098440|NCT00002684|Paclitaxel|paclitaxel|mesh-list
56098441|NCT00002684|Ifosfamide|ifosfamide|mesh-list
56098442|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098443|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098444|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098445|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
56098446|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
56098447|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818838|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818839|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56818840|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56818841|NCT00307736|Growth Substances|growth substances|mesh-ancestor
56818842|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818843|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
56818844|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
56818845|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818846|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56818847|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818848|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
56818849|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56818850|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818851|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56818852|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56818853|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56818854|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818855|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818856|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
56818857|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818890|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818891|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56818892|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
56818893|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818894|NCT01061996|Basiliximab|basiliximab|mesh-list
56818895|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818896|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
56818897|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818898|NCT01064180|Carvedilol|carvedilol|mesh-list
56818899|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56818900|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56818901|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
56818902|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818903|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818904|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818905|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56818906|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
56818907|NCT01064180|Protective Agents|protective agents|mesh-ancestor
56818908|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56818909|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56818910|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56818911|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
56818912|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56818913|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56818914|NCT01069536|Metoclopramide|metoclopramide|mesh-list
56818915|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
56818916|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
56818917|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56529789|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
56818918|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818919|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56818920|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56818921|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56818923|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818929|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56818930|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
56818931|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818932|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818933|NCT00290706|Antiviral Agents|antiviral agents|mesh-ancestor
56818934|NCT00290706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56818935|NCT00290706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818936|NCT00290706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56818937|NCT00290706|Immunologic Factors|immunologic factors|mesh-ancestor
56818938|NCT00290706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818939|NCT03978156|Dronabinol|dronabinol|mesh-list
56818940|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
56818941|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818942|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56818943|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56818944|NCT03978156|Analgesics|analgesics|mesh-ancestor
56818945|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
56818946|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56818947|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56818948|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56818949|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56818950|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818951|NCT03978156|Hormones|hormones|mesh-ancestor
56818979|NCT01069770|Growth Substances|growth substances|mesh-ancestor
56818980|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56818981|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
56818982|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56818983|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818984|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818985|NCT00303108|Carboplatin|carboplatin|mesh-list
56818986|NCT00303108|Doxorubicin|doxorubicin|mesh-list
56818987|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56818988|NCT00303108|Trastuzumab|trastuzumab|mesh-list
56818989|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56818990|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56818991|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56818992|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56818993|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56818994|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56818995|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56818997|NCT00302952|L 647318|l 647318|mesh-list
56818998|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
56818999|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56819000|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56819032|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56819033|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
56819034|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819035|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
56819036|NCT01325610|Vitamin D|vitamin d|mesh-list
56819037|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56819038|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819039|NCT01325610|Vitamins|vitamins|mesh-ancestor
56819040|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
56819041|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56819042|NCT00301080|Cycloserine|cycloserine|mesh-list
56819043|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56819044|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819045|NCT00301080|Renal Agents|renal agents|mesh-ancestor
56819046|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56819047|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
56819048|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56819049|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
56819050|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819051|NCT01066806|Calcium|calcium|mesh-list
56819052|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56819053|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819054|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56819055|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56819056|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819081|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56819082|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
56819083|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
56819084|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56819085|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819086|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56819087|NCT01581450|Analgesics|analgesics|mesh-ancestor
56819088|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
56819089|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819090|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56819091|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56819092|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819093|NCT00289848|Incretins|incretins|mesh-ancestor
56819095|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819096|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56819097|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
56819098|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819099|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819100|NCT00289536|Factor VIII|factor viii|mesh-list
56819101|NCT00289536|Coagulants|coagulants|mesh-ancestor
56819102|NCT01066962|Ritonavir|ritonavir|mesh-list
56819103|NCT01066962|Darunavir|darunavir|mesh-list
56819104|NCT01066962|Tenofovir|tenofovir|mesh-list
56819105|NCT01066962|Emtricitabine|emtricitabine|mesh-list
56819106|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
56819107|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56819122|NCT01067118|Insulin|insulin|mesh-list
56819132|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819133|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819134|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
56819135|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819136|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819137|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
56819138|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819139|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819140|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
56819141|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819142|NCT01065246|Catumaxomab|catumaxomab|mesh-list
56819143|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819144|NCT01325844|Anesthetics|anesthetics|mesh-list
56819145|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56819146|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819147|NCT01067430|Diclofenac|diclofenac|mesh-list
56819148|NCT01067430|Etoricoxib|etoricoxib|mesh-list
56819149|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56819150|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56819151|NCT01067430|Analgesics|analgesics|mesh-ancestor
56819152|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
56819153|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819154|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819155|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819156|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819157|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56819158|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819159|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819160|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56819161|NCT00305864|Temozolomide|temozolomide|mesh-list
56819162|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
56819175|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
56819176|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819177|NCT03978884|Losartan|losartan|mesh-list
56819178|NCT03978884|Amlodipine|amlodipine|mesh-list
56819179|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56819180|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56819181|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56819182|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56819183|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819184|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56819185|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819186|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
56819187|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56819188|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56819189|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56819190|NCT03978884|Diuretics|diuretics|mesh-ancestor
56819191|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
56819192|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56819193|NCT00319982|Diltiazem|diltiazem|mesh-list
56819194|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56819195|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56819196|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56819197|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819198|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56819199|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819200|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
56819201|NCT00319592|Vaccines|vaccines|mesh-list
56819202|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
56819203|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819217|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56819218|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819219|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819220|NCT01064570|Tretinoin|tretinoin|mesh-list
56819221|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819222|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
56819223|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819224|NCT01581164|Vaccines|vaccines|mesh-list
56819225|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
56819226|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819227|NCT00319046|Miglustat|miglustat|mesh-list
56819228|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819229|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819230|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56819231|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56819232|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
56819276|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819277|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56819278|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819279|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
56819280|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
56819281|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819282|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819283|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
56819284|NCT00299130|Hormones|hormones|mesh-ancestor
56819285|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819286|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56819287|NCT00299130|Protective Agents|protective agents|mesh-ancestor
56819288|NCT00288054|Docetaxel|docetaxel|mesh-list
56819289|NCT00288054|Cetuximab|cetuximab|mesh-list
56819290|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819291|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
56819292|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
56819293|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
56819294|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819295|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56819296|NCT00287586|Testosterone|testosterone|mesh-list
56819297|NCT00287586|Androgens|androgens|mesh-ancestor
56819299|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819300|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819301|NCT01070160|Metformin|metformin|mesh-list
56819302|NCT01070160|Progesterone|progesterone|mesh-list
56819303|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56819304|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819305|NCT01070160|Progestins|progestins|mesh-ancestor
56819306|NCT01070160|Hormones|hormones|mesh-ancestor
56819307|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819308|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
56819309|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56819310|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819311|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
56819312|NCT03977220|Paclitaxel|paclitaxel|mesh-list
56819313|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56819315|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
56819316|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
56819317|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
56819318|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819319|NCT00293202|Etanercept|etanercept|mesh-list
56819320|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56819321|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56819322|NCT00293202|Analgesics|analgesics|mesh-ancestor
56819323|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
56819324|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819325|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819326|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819327|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819328|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819329|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819330|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
56819331|NCT00286494|Pioglitazone|pioglitazone|mesh-list
56819332|NCT00286494|Alogliptin|alogliptin|mesh-list
56819333|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56819334|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819335|NCT00286494|Incretins|incretins|mesh-ancestor
56819336|NCT00286494|Hormones|hormones|mesh-ancestor
56819337|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819338|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56819339|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
56819340|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819341|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819342|NCT00298740|Insulin|insulin|mesh-list
56819343|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56819344|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819345|NCT01067898|Vitamin D|vitamin d|mesh-list
56819346|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
56819347|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
56819348|NCT01067898|Vitamins|vitamins|mesh-list
56819349|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
56819350|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
56819351|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819353|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56819354|NCT01067898|Antacids|antacids|mesh-ancestor
56819355|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819356|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819357|NCT03979248|BMS-986165|bms-986165|mesh-list
56819358|NCT03979248|Rabeprazole|rabeprazole|mesh-list
56819359|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56819360|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819361|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56819362|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819363|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819364|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819365|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56819366|NCT00285012|Varenicline|varenicline|mesh-list
56819367|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56819368|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56819369|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
56819370|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819371|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819372|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819373|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
56819374|NCT00284934|Prednisone|prednisone|mesh-list
56819375|NCT00284934|Tacrolimus|tacrolimus|mesh-list
56819376|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819404|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56819405|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
56819406|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819407|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56819408|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56819409|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819410|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
56819411|NCT00298272|Adalimumab|adalimumab|mesh-list
56819412|NCT00298272|Etanercept|etanercept|mesh-list
56819413|NCT00298272|Rituximab|rituximab|mesh-list
56819414|NCT00298272|Methotrexate|methotrexate|mesh-list
56819415|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56819416|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819417|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
56819418|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819419|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819420|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56819421|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
56819422|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56819423|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56819456|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819457|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819458|NCT00298038|Rifaximin|rifaximin|mesh-list
56819459|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56819460|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819461|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819462|NCT00283686|Telmisartan|telmisartan|mesh-list
56819463|NCT00283686|Lisinopril|lisinopril|mesh-list
56819464|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56819465|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56819466|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56819467|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56819468|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819469|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
56819470|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819471|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56819472|NCT00283686|Protective Agents|protective agents|mesh-ancestor
56819473|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819474|NCT00297882|Artesunate|artesunate|mesh-list
56819475|NCT00297882|Lumefantrine|lumefantrine|mesh-list
56819476|NCT00297882|Artemether|artemether|mesh-list
56819477|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56819478|NCT00297882|Amodiaquine|amodiaquine|mesh-list
56819479|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
56819480|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56819508|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819509|NCT01068132|Cetuximab|cetuximab|mesh-list
56819510|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56819511|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819512|NCT00297492|Nicotine|nicotine|mesh-list
56530387|NCT01254305|Analgesics|analgesics|mesh-ancestor
56819513|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56819514|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
56819515|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819516|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819517|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56819518|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56819519|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
56819520|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819521|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819522|NCT00496769|Aspirin|aspirin|mesh-list
56819523|NCT00496769|Apixaban|apixaban|mesh-list
56819524|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56819525|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56819526|NCT00496769|Analgesics|analgesics|mesh-ancestor
56819527|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
56819528|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819544|NCT01014845|Vaccines|vaccines|mesh-list
56819560|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56819561|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
56819562|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56819563|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819564|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56819565|NCT00282984|Varenicline|varenicline|mesh-list
56819566|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56819567|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56819568|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
56819569|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819570|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819571|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819572|NCT00296400|Atorvastatin|atorvastatin|mesh-list
56819573|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56819574|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56819575|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56819576|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
56819577|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819578|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56819579|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56819580|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819581|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
56819582|NCT00296244|Prednisone|prednisone|mesh-list
56819583|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
56819584|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56819585|NCT00296244|Tacrolimus|tacrolimus|mesh-list
56819586|NCT00296244|Basiliximab|basiliximab|mesh-list
56819587|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819588|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
56819589|NCT00296244|Hormones|hormones|mesh-ancestor
56819590|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56530454|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819591|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819592|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56819598|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819599|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
56819600|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
56819601|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819602|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819603|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56819604|NCT00296244|Protective Agents|protective agents|mesh-ancestor
56819605|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56819606|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56819607|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
56819608|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56819609|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819610|NCT01068444|Pioglitazone|pioglitazone|mesh-list
56819611|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56819612|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819613|NCT00282048|Axitinib|axitinib|mesh-list
56819614|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819655|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
56819656|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56819657|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56819658|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
56819659|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56819660|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819661|NCT01070862|Thalidomide|thalidomide|mesh-list
56819662|NCT01070862|Dexamethasone|dexamethasone|mesh-list
56819663|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
56819664|NCT01070862|Doxorubicin|doxorubicin|mesh-list
56819665|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56530529|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56819666|NCT01070862|Melphalan|melphalan|mesh-list
56819667|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
56819668|NCT01070862|Vincristine|vincristine|mesh-list
56819669|NCT01070862|BB 1101|bb 1101|mesh-list
56819670|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819671|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
56819672|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
56819673|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819674|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819675|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56819676|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
56819677|NCT01070862|Hormones|hormones|mesh-ancestor
56819678|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819679|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56819680|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819681|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
56819682|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819683|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819684|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56819685|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56819686|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56819687|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56819688|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
56819694|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819695|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56819696|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56819697|NCT01070862|Growth Substances|growth substances|mesh-ancestor
56819698|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
56819699|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819700|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56819701|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
56819702|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
56819703|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
56819704|NCT00495677|PF 232798|pf 232798|mesh-list
56098448|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098449|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
56098450|NCT05586776|Chlorhexidine|chlorhexidine|mesh-list
56098451|NCT05586776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56098452|NCT05586776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56098453|NCT05586776|Mupirocin|mupirocin|mesh-list
56098454|NCT05586776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098455|NCT05586776|Disinfectants|disinfectants|mesh-ancestor
56098456|NCT05586776|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098457|NCT05586776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56098458|NCT05586776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56098459|NCT05586776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098460|NCT05586776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098461|NCT02972918|Simendan|simendan|mesh-list
56098462|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56098463|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
56098464|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56098465|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56098467|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098468|NCT02972918|Protective Agents|protective agents|mesh-ancestor
56098469|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098470|NCT05600491|Temozolomide|temozolomide|mesh-list
56098471|NCT05600491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098472|NCT05600491|Alkylating Agents|alkylating agents|mesh-ancestor
56098473|NCT05600491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098474|NCT05600491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098475|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
56098476|NCT00002696|Doxorubicin|doxorubicin|mesh-list
56098477|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56098478|NCT00002696|Fluorouracil|fluorouracil|mesh-list
56098479|NCT00002696|Methotrexate|methotrexate|mesh-list
56098480|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098492|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098493|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
56098494|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098495|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56098496|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
56194726|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
56194727|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
56194728|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194729|NCT01494714|Petrolatum|petrolatum|mesh-list
56194730|NCT01494714|Emollients|emollients|mesh-ancestor
56194731|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
56194732|NCT01494727|Amlodipine|amlodipine|mesh-list
56194733|NCT01494727|Valsartan|valsartan|mesh-list
56098497|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56098498|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098499|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56098500|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56098501|NCT00002702|Aldesleukin|aldesleukin|mesh-list
56098502|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098503|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56098504|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56098505|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
56098506|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819705|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56819706|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819707|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56819708|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56819709|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
56819710|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819711|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56819712|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
56819713|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56819714|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819715|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
56819716|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56819717|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819718|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819719|NCT00292188|Pregabalin|pregabalin|mesh-list
56819720|NCT00292188|Analgesics|analgesics|mesh-ancestor
56819721|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
56819722|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819723|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819724|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
56819725|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56819726|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56819727|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819728|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56819729|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56819730|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56819731|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56819732|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56819733|NCT00271596|Citalopram|citalopram|mesh-list
56819734|NCT00271596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56819735|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56819736|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56819737|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819738|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819741|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56819742|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
56819743|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56819744|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
56819745|NCT01068756|Rifampin|rifampin|mesh-list
56819746|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56819747|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819748|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56819749|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819750|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56819751|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
56819752|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56819753|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819754|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
56819755|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56819756|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819757|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56819758|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56819759|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56819760|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56819761|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56819762|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56819763|NCT00291642|Cetirizine|cetirizine|mesh-list
56819764|NCT00291642|Levocetirizine|levocetirizine|mesh-list
56819765|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56819766|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56819785|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819786|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819787|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56819788|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56819789|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56819790|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56819791|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56819792|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
56819793|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
56819794|NCT00270894|Docetaxel|docetaxel|mesh-list
56819795|NCT00270894|Trastuzumab|trastuzumab|mesh-list
56819796|NCT00270894|Epirubicin|epirubicin|mesh-list
56819797|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819798|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
56819799|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819800|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819801|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56819802|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
56819803|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819804|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819838|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819839|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
56819840|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56819841|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56819842|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
56819843|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819844|NCT01064726|Fluticasone|fluticasone|mesh-list
56819846|NCT01064726|Ibuprofen|ibuprofen|mesh-list
56819847|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819848|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56819849|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
56819850|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819851|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819852|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56819853|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
56819854|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819855|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56819856|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56819857|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56819858|NCT01064726|Analgesics|analgesics|mesh-ancestor
56819859|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
56819860|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56819861|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56819862|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819863|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819864|NCT00295022|Montelukast|montelukast|mesh-list
56819865|NCT00295022|Levocetirizine|levocetirizine|mesh-list
56819866|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56819867|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
56819869|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
56819883|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56819884|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56819885|NCT01062152|Growth Substances|growth substances|mesh-ancestor
56819886|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
56819887|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819889|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56819890|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56819891|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819892|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819893|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
56819894|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56819895|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819896|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
56819897|NCT01065038|Anagrelide|anagrelide|mesh-list
56819898|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819899|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
56819900|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819901|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819902|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56819903|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56819904|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56819905|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56819906|NCT00291486|Capecitabine|capecitabine|mesh-list
56819907|NCT00291486|Antibodies|antibodies|mesh-list
56819908|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56819909|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
56819910|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819911|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56819912|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
56819913|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819914|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819915|NCT00301964|Bevacizumab|bevacizumab|mesh-list
56819916|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56819917|NCT00301964|Antibodies|antibodies|mesh-list
56819918|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
56092223|NCT00376376|Ofloxacin|ofloxacin|mesh-list
56098507|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
56819919|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56819920|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819921|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56819922|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56819923|NCT00301964|Growth Substances|growth substances|mesh-ancestor
56819924|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819925|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
56819926|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
56819927|NCT00301808|Docetaxel|docetaxel|mesh-list
56819928|NCT00301808|Pemetrexed|pemetrexed|mesh-list
56819929|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56819930|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
56819931|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
56819932|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
56819933|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819934|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56819935|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56819936|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56819937|NCT01070706|Gemcitabine|gemcitabine|mesh-list
56819938|NCT01070706|Paclitaxel|paclitaxel|mesh-list
56819939|NCT01070706|Sunitinib|sunitinib|mesh-list
56819940|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56819973|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819974|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56819975|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56819976|NCT00294554|Memantine|memantine|mesh-list
56819977|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56819978|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56819979|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
56819980|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56819981|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56819982|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819983|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56819984|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56819985|NCT00294398|Fluticasone|fluticasone|mesh-list
56819986|NCT00294398|Xhance|xhance|mesh-list
56819987|NCT00294398|Budesonide|budesonide|mesh-list
56819988|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56819989|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56819990|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
56819991|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56819992|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56819993|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56819994|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
56819995|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
56819996|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56819997|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
56819998|NCT00294398|Hormones|hormones|mesh-ancestor
56819999|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820021|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820022|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56820023|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56820024|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
56820025|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56820026|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56820027|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56820028|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56820029|NCT00291330|Warfarin|warfarin|mesh-list
56820030|NCT00291330|Dabigatran|dabigatran|mesh-list
56820031|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
56820032|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
56820033|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56820034|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
56530910|NCT04207112|Linezolid|linezolid|mesh-list
56820035|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820036|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820037|NCT03975036|Antibodies|antibodies|mesh-list
56820038|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
56820039|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820040|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
56820041|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56820042|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820043|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56820044|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
56820045|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56820046|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820047|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820048|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820049|NCT01582230|Vildagliptin|vildagliptin|mesh-list
56820050|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56820051|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820052|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56820060|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820061|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
56820062|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
56820063|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
56820064|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820065|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56820066|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820067|NCT00299546|Golimumab|golimumab|mesh-list
56820068|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56820069|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56820070|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56820071|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820072|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
56820073|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820074|NCT03975270|Paclitaxel|paclitaxel|mesh-list
56820075|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56820076|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820077|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
56820078|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
56820079|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
56820080|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820081|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56820082|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
56820083|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56820084|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56820085|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820086|NCT03977792|Docosanol|docosanol|mesh-list
56820087|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
56820088|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820089|NCT01066598|Rituximab|rituximab|mesh-list
56820090|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56820091|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820092|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
56820093|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820094|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820099|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
56820100|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820101|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820102|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56820103|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820104|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56820105|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820106|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820107|NCT01065194|Simendan|simendan|mesh-list
56820108|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56820109|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
56820110|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56820111|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56530985|NCT04952402|Vaccines|vaccines|mesh-list
56820112|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820113|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820114|NCT01065194|Protective Agents|protective agents|mesh-ancestor
56820115|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820116|NCT01065272|Dexamethasone|dexamethasone|mesh-list
56820117|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56820118|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
56820119|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
56820120|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820121|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820147|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56820148|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
56820149|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56820150|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56820151|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56820152|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56820153|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56820154|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56820155|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56820156|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56820157|NCT01066754|Fexofenadine|fexofenadine|mesh-list
56820158|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56820159|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56820160|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56820161|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
56820162|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
56820163|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820164|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820165|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820166|NCT00276744|Gemcitabine|gemcitabine|mesh-list
56820167|NCT00276744|Sirolimus|sirolimus|mesh-list
56820168|NCT00276744|Capecitabine|capecitabine|mesh-list
56820169|NCT00276744|Docetaxel|docetaxel|mesh-list
56820170|NCT00276744|Irinotecan|irinotecan|mesh-list
56820171|NCT00276744|Cetuximab|cetuximab|mesh-list
56820172|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56820173|NCT00276744|Mitomycins|mitomycins|mesh-list
56820174|NCT00276744|Mitomycin|mitomycin|mesh-list
56820175|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56820176|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
56820192|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56820193|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56820194|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
56820195|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
56820196|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56820197|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
56820198|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
56820199|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56820200|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820201|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820202|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
56820203|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56820204|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56820205|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820206|NCT02532192|Cytarabine|cytarabine|mesh-list
56820207|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
56820208|NCT02532192|Fluconazole|fluconazole|mesh-list
56820209|NCT02532192|Dexamethasone|dexamethasone|mesh-list
56820210|NCT02532192|Rituximab|rituximab|mesh-list
56820211|NCT02532192|Cisplatin|cisplatin|mesh-list
56820247|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
56820248|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820249|NCT00316082|Metformin|metformin|mesh-list
56820250|NCT00316082|Saxagliptin|saxagliptin|mesh-list
56820251|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56820252|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820253|NCT00316082|Incretins|incretins|mesh-ancestor
56820254|NCT00316082|Hormones|hormones|mesh-ancestor
56820255|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820256|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56820257|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
56820258|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820259|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820260|NCT00316004|Dextrans|dextrans|mesh-list
56531132|NCT00624182|Immunologic Factors|immunologic factors|mesh-ancestor
56820261|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
56820262|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
56820263|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
56820264|NCT01066832|Paclitaxel|paclitaxel|mesh-list
56820265|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56820266|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820267|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
56820268|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
56820269|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
56820270|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820271|NCT00298766|Bortezomib|bortezomib|mesh-list
56820272|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820273|NCT03979664|Dexamethasone|dexamethasone|mesh-list
56820274|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56820275|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
56820276|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
56820277|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820278|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820279|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56820280|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
56820281|NCT03979664|Hormones|hormones|mesh-ancestor
56820282|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098508|NCT01890577|Hematinics|hematinics|mesh-ancestor
56820284|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820285|NCT01325558|Gemcitabine|gemcitabine|mesh-list
56820286|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56820287|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
56820288|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820289|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820290|NCT01325558|Antiviral Agents|antiviral agents|mesh-ancestor
56820291|NCT01325558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820292|NCT01325558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820293|NCT01325558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820294|NCT01325558|Immunologic Factors|immunologic factors|mesh-ancestor
56820295|NCT01325558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820296|NCT00315458|Buprenorphine|buprenorphine|mesh-list
56820297|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56820298|NCT00315458|Narcotics|narcotics|mesh-ancestor
56820299|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56820300|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820301|NCT00315458|Analgesics|analgesics|mesh-ancestor
56820302|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
56820303|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820304|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56820305|NCT01065662|Sirolimus|sirolimus|mesh-list
56820306|NCT01065662|Cediranib|cediranib|mesh-list
56820307|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56820308|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820309|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56820310|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820311|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
56820312|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820313|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
56820314|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820329|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56820330|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820331|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56820332|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820333|NCT00293384|Dexamethasone|dexamethasone|mesh-list
56820334|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
56820335|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
56820336|NCT00293384|Aprepitant|aprepitant|mesh-list
56820337|NCT00293384|Granisetron|granisetron|mesh-list
56820338|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56820339|NCT00293384|BB 1101|bb 1101|mesh-list
56820340|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820341|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
56820342|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820343|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820344|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56820345|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
56820346|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820347|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820348|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56820349|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56820350|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
56820351|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
56820352|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820353|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56820354|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
56820355|NCT00293384|Hormones|hormones|mesh-ancestor
56820356|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820357|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56820358|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
56820359|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820360|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56820361|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820362|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56820363|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
56820364|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
56820367|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820368|NCT00296816|Bevacizumab|bevacizumab|mesh-list
56820369|NCT00296816|Docetaxel|docetaxel|mesh-list
56820370|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
56820371|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56820372|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820373|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56820374|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56820375|NCT00296816|Growth Substances|growth substances|mesh-ancestor
56820376|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820377|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
56820378|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
56820379|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
56820380|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
56820381|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820382|NCT01066988|Emollients|emollients|mesh-list
56820383|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56820384|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56820385|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
56820386|NCT00097786|Nateglinide|nateglinide|mesh-list
56820387|NCT00097786|Valsartan|valsartan|mesh-list
56820388|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56820389|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56820390|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56820391|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820392|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56820393|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820394|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56820395|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56820396|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820397|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
56098509|NCT01315873|Bortezomib|bortezomib|mesh-list
56098510|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56098511|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098512|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098513|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
56098514|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098515|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
56098516|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56098517|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
56098518|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098519|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
56098520|NCT01895959|Protective Agents|protective agents|mesh-ancestor
56820398|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56820399|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
56820400|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56820401|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56820402|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820403|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56820404|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820405|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56820406|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56820407|NCT01084486|Metformin|metformin|mesh-list
56820408|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56820409|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820410|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56820411|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56531284|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56820412|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56820413|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56820414|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820415|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56820416|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56098521|NCT01303003|Dexamethasone|dexamethasone|mesh-list
56098522|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098523|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
56098524|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
56098525|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098526|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098527|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56098528|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
56098529|NCT01303003|Hormones|hormones|mesh-ancestor
56098530|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098531|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098532|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098534|NCT00002714|Doxorubicin|doxorubicin|mesh-list
56098535|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56098536|NCT00002714|Bleomycin|bleomycin|mesh-list
56098537|NCT00002714|Etoposide|etoposide|mesh-list
56098538|NCT00002714|Vincristine|vincristine|mesh-list
56098539|NCT00002714|Vinblastine|vinblastine|mesh-list
56098540|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
56098541|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56098542|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098543|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098544|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098545|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098565|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098566|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56098567|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56098568|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56098569|NCT01821859|Bevacizumab|bevacizumab|mesh-list
56098570|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56098571|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56098572|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098573|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56098574|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56820417|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56820418|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56820419|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
56820420|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820421|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820422|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56820423|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56820424|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
56820425|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56820426|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56820427|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
56820428|NCT01084720|V0034CR|v0034cr|mesh-list
56820429|NCT01084720|Emollients|emollients|mesh-ancestor
56820430|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
56820431|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
56820432|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56820433|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56820434|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820435|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
56820436|NCT03963466|Coagulants|coagulants|mesh-ancestor
56820437|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
56820438|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820439|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56820440|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
56820441|NCT01084876|Paclitaxel|paclitaxel|mesh-list
56820442|NCT01084876|Trastuzumab|trastuzumab|mesh-list
56820443|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56820444|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820445|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
56820446|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
56820447|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
56820448|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820449|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56098575|NCT01821859|Growth Substances|growth substances|mesh-ancestor
56098576|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098577|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
56098578|NCT05600023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56194734|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56194735|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56194736|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56194737|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56820450|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56820451|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56820452|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56820453|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56820454|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820455|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820456|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
56820457|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820458|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56820459|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56820460|NCT00251004|Cyclosporine|cyclosporine|mesh-list
56820461|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
56820462|NCT00251004|Everolimus|everolimus|mesh-list
56820463|NCT00251004|Cyclosporins|cyclosporins|mesh-list
56820464|NCT00251004|Basiliximab|basiliximab|mesh-list
56820465|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820466|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820467|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820468|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
56820469|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820470|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
56820471|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820472|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
56820501|NCT00493649|Trastuzumab|trastuzumab|mesh-list
56820502|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820503|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
56820504|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820505|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820506|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56820507|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
56820508|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820509|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820510|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56820511|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
56820512|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
56820513|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
56820514|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56820515|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
56820516|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56820517|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
56820518|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820519|NCT01021163|Expectorants|expectorants|mesh-ancestor
56820520|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
56820521|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56820522|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
56820554|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56820555|NCT01082458|Narcotics|narcotics|mesh-ancestor
56820556|NCT01082458|Analgesics|analgesics|mesh-ancestor
56820557|NCT00469859|Cytarabine|cytarabine|mesh-list
56820558|NCT00469859|Idarubicin|idarubicin|mesh-list
56820559|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56820560|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
56820561|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820562|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820563|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
56820564|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820565|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820566|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
56820567|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820568|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56820569|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56820570|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56820571|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820573|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
56820574|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
56820575|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820576|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820577|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56194738|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194739|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56194740|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194741|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
56194742|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56098579|NCT05600023|Nitrofurantoin|nitrofurantoin|mesh-list
56098580|NCT05600023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098581|NCT05600023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56098582|NCT05600023|Renal Agents|renal agents|mesh-ancestor
56098583|NCT01194427|Tamoxifen|tamoxifen|mesh-list
56098584|NCT01194427|Vorinostat|vorinostat|mesh-list
56098585|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56098586|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
56098587|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098588|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098589|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098590|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098591|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56098592|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56098593|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56098594|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56098595|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098596|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098597|NCT05599789|Docetaxel|docetaxel|mesh-list
56098598|NCT05599789|Pembrolizumab|pembrolizumab|mesh-list
56098634|NCT00002744|Cytarabine|cytarabine|mesh-list
56098635|NCT00002744|Dexamethasone|dexamethasone|mesh-list
56098636|NCT00002744|Prednisone|prednisone|mesh-list
56098637|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
55889480|NCT04124913|Progestins|progestins|mesh-ancestor
56820578|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56820579|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
56820580|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820581|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820582|NCT01085032|Nicotine|nicotine|mesh-list
56820583|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56820584|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
56820585|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820586|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820587|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56820588|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56820589|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
56820590|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820591|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820592|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
56820593|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
56820594|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56820595|NCT01021787|Protective Agents|protective agents|mesh-ancestor
56820596|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820634|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
56531523|NCT01111539|Aripiprazole|aripiprazole|mesh-list
56820635|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
56820636|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56820637|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
56820638|NCT00093496|Gemcitabine|gemcitabine|mesh-list
56820639|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56820640|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
56820641|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820642|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820643|NCT00093496|Antiviral Agents|antiviral agents|mesh-ancestor
56820644|NCT00093496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820645|NCT00093496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820646|NCT00093496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820647|NCT00093496|Immunologic Factors|immunologic factors|mesh-ancestor
56820648|NCT00093496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820649|NCT00265122|Ustekinumab|ustekinumab|mesh-list
56820650|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
56820651|NCT00096538|Valganciclovir|valganciclovir|mesh-list
56820652|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
56820653|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820688|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56820689|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56820690|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56820691|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56820692|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
56820693|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56820694|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56820695|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
56820696|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820697|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
56820698|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56820699|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56820700|NCT01021865|Glucagon|glucagon|mesh-list
56820701|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56820702|NCT01021865|Regadenoson|regadenoson|mesh-list
56820703|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56820704|NCT01021865|Hormones|hormones|mesh-ancestor
56820705|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820706|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820707|NCT01021865|Incretins|incretins|mesh-ancestor
56820708|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56820709|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56820710|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
56820711|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
56820712|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820713|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820714|NCT00468143|Adderall|adderall|mesh-list
56820715|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56820716|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820717|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
56820718|NCT00467831|Erythromycin|erythromycin|mesh-list
56820719|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
56820720|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56820727|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56820728|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56820729|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56820730|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820731|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
56820732|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820733|NCT00467831|Expectorants|expectorants|mesh-ancestor
56820734|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
56820735|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56820736|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
56820737|NCT00467831|Protective Agents|protective agents|mesh-ancestor
56820738|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820739|NCT00467831|Antidotes|antidotes|mesh-ancestor
56820740|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56820741|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56820742|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
56820743|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56820744|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56820745|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820746|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56820747|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56820778|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56820779|NCT00116272|Analgesics|analgesics|mesh-ancestor
56820780|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
56820781|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820782|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820783|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56531655|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
56820784|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820785|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56820787|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
56820788|NCT01022021|Rituximab|rituximab|mesh-list
56820789|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56820790|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56820791|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820792|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
56820793|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820794|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820795|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56820796|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
56820797|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820798|NCT00467597|Levodopa|levodopa|mesh-list
56820799|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56820800|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56820801|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
56820802|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820803|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820804|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820805|NCT00115804|Fluoxetine|fluoxetine|mesh-list
56820806|NCT00115804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56820807|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56820808|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56820809|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820810|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820811|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
56820812|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820814|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
56820815|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56820816|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56820817|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56820818|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820819|NCT00467363|Aspirin|aspirin|mesh-list
56820820|NCT00467363|Folic Acid|folic acid|mesh-list
56820821|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56820822|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56820823|NCT00467363|Analgesics|analgesics|mesh-ancestor
56820824|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
56820825|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56820826|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820827|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56820828|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56820829|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56820830|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56820831|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820832|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56820833|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56820870|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820871|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
56820872|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
56820873|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
56820874|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820875|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56820876|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
56820877|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820878|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56820879|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
56820880|NCT00264498|Gemcitabine|gemcitabine|mesh-list
56820881|NCT00264498|Carboplatin|carboplatin|mesh-list
56820882|NCT00264498|Gefitinib|gefitinib|mesh-list
56820883|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820884|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56820885|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
56820886|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820887|NCT00264498|Antiviral Agents|antiviral agents|mesh-ancestor
56820888|NCT00264498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820889|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820890|NCT00264498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56820891|NCT00264498|Immunologic Factors|immunologic factors|mesh-ancestor
56820892|NCT00264498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820893|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56820894|NCT00466193|Zolpidem|zolpidem|mesh-list
56820895|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56820896|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56820917|NCT03970668|Incretins|incretins|mesh-ancestor
56820918|NCT03970668|Hormones|hormones|mesh-ancestor
56820919|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820920|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56820921|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
56820922|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820923|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820924|NCT00454181|Interferons|interferons|mesh-list
56820925|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
56820926|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56820927|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
56820928|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820929|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
56820930|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820931|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56820932|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56820933|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820934|NCT01073826|Incretins|incretins|mesh-ancestor
56820935|NCT01073826|Hormones|hormones|mesh-ancestor
56820936|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820937|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56820938|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
56820939|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098638|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56098639|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56098640|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56098641|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
56098642|NCT00002744|Doxorubicin|doxorubicin|mesh-list
56098643|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56098644|NCT00002744|Methotrexate|methotrexate|mesh-list
56098674|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
56098675|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56098676|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098677|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
56098678|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098679|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56098680|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56098681|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
56098682|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098683|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098684|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098685|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
56098686|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
56098687|NCT00002744|Trace Elements|trace elements|mesh-ancestor
56098688|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
56098690|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
56098701|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098702|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098703|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
56098704|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889481|NCT04124913|Hormones|hormones|mesh-ancestor
56820940|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820942|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56820943|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56820944|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56820945|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
56820946|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56820947|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820948|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
56820949|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56820950|NCT00237042|Estradiol|estradiol|mesh-list
56820951|NCT00237042|Estrogens|estrogens|mesh-ancestor
56820952|NCT00237042|Hormones|hormones|mesh-ancestor
56820953|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56820954|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56820955|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56820956|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
56820957|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56820958|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56820962|NCT00465647|Hydromorphone|hydromorphone|mesh-list
56820997|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
56820998|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56820999|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56821000|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56821001|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56821002|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56821003|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56821004|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56821005|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
56821006|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56821007|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56821008|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56821009|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56923721|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923722|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923723|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923725|NCT03593018|Azacitidine|azacitidine|mesh-list
56923726|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56923727|NCT03593018|Romidepsin|romidepsin|mesh-list
56923728|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56923729|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
56923730|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923731|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923732|NCT03593018|Antiviral Agents|antiviral agents|mesh-ancestor
56923733|NCT03593018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923734|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923735|NCT03593018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56923736|NCT03593018|Immunologic Factors|immunologic factors|mesh-ancestor
56923737|NCT03593018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923738|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56923739|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
56923740|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56923741|NCT03570099|Naloxone|naloxone|mesh-list
56923742|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56923743|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923745|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923746|NCT03550391|Memantine|memantine|mesh-list
56923747|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56923748|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56923749|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
56923750|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56923751|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923752|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923753|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56923754|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56923755|NCT03529396|Chloroquine|chloroquine|mesh-list
56923756|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56923757|NCT03529396|Primaquine|primaquine|mesh-list
56923758|NCT03529396|Amebicides|amebicides|mesh-ancestor
56923759|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56923760|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56923761|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923762|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
56923763|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56923764|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56923765|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56923766|NCT03529396|Analgesics|analgesics|mesh-ancestor
56923767|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
56923768|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923769|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923770|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923771|NCT03529396|Filaricides|filaricides|mesh-ancestor
56923772|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
56923773|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
56923790|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923791|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923792|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923793|NCT03436563|Atezolizumab|atezolizumab|mesh-list
56334926|NCT00396968|Plerixafor|plerixafor|mesh-list
56923794|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923796|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56923797|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923798|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923799|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923800|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56923801|NCT03422536|Cetuximab|cetuximab|mesh-list
56923802|NCT03422536|Antibodies|antibodies|mesh-list
56923803|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
56923804|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56923805|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
56923806|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923807|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923808|NCT03411031|Thalidomide|thalidomide|mesh-list
56923809|NCT03411031|Dexamethasone|dexamethasone|mesh-list
56923810|NCT03411031|Lenalidomide|lenalidomide|mesh-list
56923811|NCT03411031|Elotuzumab|elotuzumab|mesh-list
56923812|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923813|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
56923814|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
56923815|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923816|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923817|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56923818|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
56923819|NCT03411031|Hormones|hormones|mesh-ancestor
56923820|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923821|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56923822|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923823|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
56923824|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56923825|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56923829|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
56923830|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56923831|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923832|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
56923833|NCT03358017|Atorvastatin|atorvastatin|mesh-list
56923834|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56923835|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56923836|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
56923837|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923838|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56923839|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56923840|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923841|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56923842|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923843|NCT03289351|Tazobactam|tazobactam|mesh-list
56923844|NCT03289351|Piperacillin|piperacillin|mesh-list
56923845|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56923846|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56923847|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923848|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56923849|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923850|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923851|NCT03280667|Denosumab|denosumab|mesh-list
56923852|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
56923853|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56923854|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923855|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56923856|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923857|NCT03272347|Tenofovir|tenofovir|mesh-list
56923858|NCT03272347|Lamivudine|lamivudine|mesh-list
56923859|NCT03272347|Islatravir|islatravir|mesh-list
56923860|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
56923861|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56923862|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56923869|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56923870|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56923871|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56923872|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
56923873|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56923874|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923875|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923876|NCT03251300|Urological Agents|urological agents|mesh-ancestor
56923877|NCT03228693|Triamcinolone|triamcinolone|mesh-list
56923878|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923879|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
56923880|NCT03228693|Hormones|hormones|mesh-ancestor
56923881|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923882|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923883|NCT03201458|Atezolizumab|atezolizumab|mesh-list
56923884|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56923885|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923886|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
56923887|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923888|NCT03191149|Osimertinib|osimertinib|mesh-list
56923889|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923890|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56923891|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923894|NCT03108690|Meropenem|meropenem|mesh-list
56923921|NCT03103152|Analgesics|analgesics|mesh-ancestor
56923922|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
56923923|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923924|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923925|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56923926|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56923927|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56923928|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56923929|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56923930|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56923931|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56923932|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
56923933|NCT03037385|Pralsetinib|pralsetinib|mesh-list
56923934|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923935|NCT02988297|RNS60|rns60|mesh-list
56923936|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56923937|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56923938|NCT02988297|Analgesics|analgesics|mesh-ancestor
56923939|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
56557556|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
56923975|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56923976|NCT02861573|Dexamethasone|dexamethasone|mesh-list
56923977|NCT02861573|Prednisone|prednisone|mesh-list
56923978|NCT02861573|Carboplatin|carboplatin|mesh-list
56923979|NCT02861573|Docetaxel|docetaxel|mesh-list
56923980|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
56923981|NCT02861573|Etoposide|etoposide|mesh-list
56923982|NCT02861573|Olaparib|olaparib|mesh-list
56923983|NCT02861573|Lenvatinib|lenvatinib|mesh-list
56923984|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
56923985|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56923986|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
56923987|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
56923988|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56923989|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56923990|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56923991|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
56923992|NCT02861573|Hormones|hormones|mesh-ancestor
56923993|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56923994|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56923995|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56923996|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
56923997|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
56923998|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
56923999|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924000|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924001|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56924002|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56924003|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56924004|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924005|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56924006|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56924007|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56924017|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924018|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56335152|NCT00038597|Lonafarnib|lonafarnib|mesh-list
56924019|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
56924020|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924021|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56924022|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56924023|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56924024|NCT02719613|Dexamethasone|dexamethasone|mesh-list
56924025|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
56924026|NCT02719613|Nivolumab|nivolumab|mesh-list
56924027|NCT02719613|Lenalidomide|lenalidomide|mesh-list
56924028|NCT02719613|Bortezomib|bortezomib|mesh-list
56924029|NCT02719613|Pomalidomide|pomalidomide|mesh-list
56924030|NCT02719613|Elotuzumab|elotuzumab|mesh-list
56924031|NCT02719613|BB 1101|bb 1101|mesh-list
56924032|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924033|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
56924034|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
56924035|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924036|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924037|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56924038|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
56924039|NCT02719613|Hormones|hormones|mesh-ancestor
56924040|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924041|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56924042|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924043|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
56924044|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924045|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924046|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924047|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56924048|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
56924060|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924061|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56924062|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56924063|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924064|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924065|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
56924066|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924067|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56924068|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56924069|NCT02659930|Growth Substances|growth substances|mesh-ancestor
56924070|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
56924071|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
56924072|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924073|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098705|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194743|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56194744|NCT01494740|Vaccines|vaccines|mesh-list
56194745|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
56194746|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194747|NCT01494805|Ranibizumab|ranibizumab|mesh-list
56194748|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56194749|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56098707|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
56098708|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
56098709|NCT00381914|Vitamins|vitamins|mesh-list
56098710|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
56098711|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098712|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56098713|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56098714|NCT00423007|Bromfenac|bromfenac|mesh-list
56098715|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56098716|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56098717|NCT00423007|Analgesics|analgesics|mesh-ancestor
56098718|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
56098719|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098720|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098721|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098722|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098724|NCT04713787|Oxfendazole|oxfendazole|mesh-list
56098725|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
56098726|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56098727|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098728|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
56098729|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56098730|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56098731|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098732|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
56098733|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
56098734|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098735|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098736|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
56098737|NCT00002750|Melphalan|melphalan|mesh-list
56098738|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098739|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
56098740|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098741|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098742|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098743|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098744|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
55890541|NCT05021913|Protective Agents|protective agents|mesh-ancestor
56924074|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
56924075|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924076|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924077|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
56924078|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
56924079|NCT02475681|Chlorambucil|chlorambucil|mesh-list
56924080|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924081|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924082|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56924083|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
56924084|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924085|NCT02315196|Paclitaxel|paclitaxel|mesh-list
56924086|NCT02315196|Carboplatin|carboplatin|mesh-list
56924087|NCT02315196|Doxorubicin|doxorubicin|mesh-list
56924088|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56924089|NCT02315196|Epirubicin|epirubicin|mesh-list
56924090|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56924091|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924092|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
56557557|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56924093|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
56924094|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
56924095|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924096|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56924097|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56924098|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56924099|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924101|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924102|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924103|NCT02207712|Ranibizumab|ranibizumab|mesh-list
56924104|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56924105|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56924106|NCT02207712|Growth Substances|growth substances|mesh-ancestor
56924107|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924108|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
56924109|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924138|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56924139|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56924140|NCT02133573|Progesterone|progesterone|mesh-list
56924141|NCT02133573|Progestins|progestins|mesh-ancestor
56924142|NCT02133573|Hormones|hormones|mesh-ancestor
56924143|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924144|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924145|NCT02016924|Cobicistat|cobicistat|mesh-list
56924146|NCT02016924|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56924147|NCT02016924|Emtricitabine|emtricitabine|mesh-list
56924148|NCT02016924|Tenofovir|tenofovir|mesh-list
56924149|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924150|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924151|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56924152|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56924153|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
56924154|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56924155|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56924156|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56924157|NCT02016924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56924159|NCT01917877|Dexamethasone|dexamethasone|mesh-list
56924166|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924167|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
56924168|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56924169|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
56924170|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
56924171|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56924172|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56924173|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
56924174|NCT01917877|Hormones|hormones|mesh-ancestor
56924175|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56924176|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56924190|NCT01698840|Vitamin D|vitamin d|mesh-list
56924191|NCT01698840|Vitamins|vitamins|mesh-ancestor
56924192|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
56924193|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924194|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56924195|NCT01570296|Gefitinib|gefitinib|mesh-list
56924196|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924197|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56924198|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924199|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924200|NCT01199575|Rituximab|rituximab|mesh-list
56924201|NCT01199575|Lenalidomide|lenalidomide|mesh-list
56924202|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924203|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924204|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
56924216|NCT00496873|Pentostatin|pentostatin|mesh-list
56924217|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56924218|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
56924219|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56924220|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56924221|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56924222|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
56924223|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56924224|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56924225|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56924226|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56924227|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56924228|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56924229|NCT00492778|Cisplatin|cisplatin|mesh-list
56924230|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335379|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
56557558|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557559|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
56557560|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557561|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56557562|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56557564|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56557565|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56557566|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56557567|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
56557568|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480197|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56557569|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557573|NCT02801032|Tadalafil|tadalafil|mesh-list
56557574|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
56098745|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098746|NCT00002756|Leucovorin|leucovorin|mesh-list
56098747|NCT00002756|Cytarabine|cytarabine|mesh-list
56098748|NCT00002756|Prednisone|prednisone|mesh-list
56098749|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
56098750|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56098751|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56098752|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56098753|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
56098754|NCT00002756|Methotrexate|methotrexate|mesh-list
56098755|NCT00002756|Etoposide|etoposide|mesh-list
56098756|NCT00002756|Vincristine|vincristine|mesh-list
56098757|NCT00002756|Daunorubicin|daunorubicin|mesh-list
56098758|NCT00002756|Asparaginase|asparaginase|mesh-list
56557575|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56557576|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56557577|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557578|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337027|NCT00213694|Analgesics|analgesics|mesh-ancestor
56557579|NCT02801032|Urological Agents|urological agents|mesh-ancestor
56557580|NCT05442190|Hypericin|hypericin|mesh-list
56557581|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
56557583|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557585|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557586|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337688|NCT00218530|Lofexidine|lofexidine|mesh-list
56337759|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
56557587|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557588|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56337945|NCT00042653|Cinacalcet|cinacalcet|mesh-list
56557589|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
56338055|NCT00402259|Esomeprazole|esomeprazole|mesh-list
56557590|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557591|NCT02689960|Prednisone|prednisone|mesh-list
56557592|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56557593|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
56557595|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56557596|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338491|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56338561|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338635|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56557597|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56557598|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557599|NCT01150097|Everolimus|everolimus|mesh-list
56557600|NCT01150097|Tacrolimus|tacrolimus|mesh-list
56557601|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557602|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
56339236|NCT00397358|Icodextrin|icodextrin|mesh-list
56339309|NCT00044564|IDN 5109|idn 5109|mesh-list
56339382|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093864|NCT01139996|Clonidine|clonidine|mesh-list
56557605|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557606|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339826|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
56339900|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
56339978|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557607|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340062|NCT00079638|Vitamins|vitamins|mesh-ancestor
56557608|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56557609|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56557610|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
56557611|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340660|NCT00133627|Ketotifen|ketotifen|mesh-list
56340724|NCT00133822|Risperidone|risperidone|mesh-list
56557613|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56341179|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
56557614|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56557615|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
56557616|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557617|NCT02794792|Metformin|metformin|mesh-list
56557618|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
56341485|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
56341556|NCT00147355|Narcotics|narcotics|mesh-ancestor
56557619|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56344990|NCT00165217|Growth Substances|growth substances|mesh-ancestor
56345138|NCT00045396|Tipifarnib|tipifarnib|mesh-list
56480198|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56345285|NCT00167479|Risperidone|risperidone|mesh-list
56480199|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
56557640|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557642|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56480200|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56480201|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
56557643|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56345740|NCT00169819|Abciximab|abciximab|mesh-list
56557644|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56345816|NCT00170755|Darifenacin|darifenacin|mesh-list
56345966|NCT00171574|Valsartan|valsartan|mesh-list
56346106|NCT00399867|Simvastatin|simvastatin|mesh-list
56346181|NCT00055913|Antibodies|antibodies|mesh-list
56480202|NCT02920502|Vitamin D|vitamin d|mesh-list
56346327|NCT00174343|Exemestane|exemestane|mesh-list
56346477|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557645|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557646|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557648|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56557650|NCT01148693|Gentamicins|gentamicins|mesh-list
56349898|NCT00198172|Epirubicin|epirubicin|mesh-list
56349956|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56350032|NCT00198601|Gentamicins|gentamicins|mesh-list
56557674|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557675|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56557676|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557678|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
56557679|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350724|NCT00061802|Risperidone|risperidone|mesh-list
56557680|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
56557681|NCT05414422|Ketamine|ketamine|mesh-list
56557682|NCT05414422|Analgesics|analgesics|mesh-ancestor
56557683|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
56557684|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557685|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351003|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
56351076|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
56557686|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56557687|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56351311|NCT00095667|Lapatinib|lapatinib|mesh-list
56557688|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
56351530|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
56557689|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
56557690|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56557691|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56557692|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56557714|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557715|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56557716|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56557717|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
56353536|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56353609|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353682|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353904|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
56557718|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557719|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56354127|NCT00241501|Esomeprazole|esomeprazole|mesh-list
56354203|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354279|NCT00242359|Omalizumab|omalizumab|mesh-list
56354353|NCT00242788|Capecitabine|capecitabine|mesh-list
56557720|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56557721|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354578|NCT00067262|Valproic Acid|valproic acid|mesh-list
56557722|NCT00693589|Hematinics|hematinics|mesh-ancestor
56557723|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
56557724|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
56557725|NCT01148537|Buprenorphine|buprenorphine|mesh-list
56354802|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
56557726|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56354949|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56356139|NCT00255502|Metoprolol|metoprolol|mesh-list
56557745|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
56357397|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
56557746|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56557747|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56557750|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
56557751|NCT02793544|Busulfan|busulfan|mesh-list
56557752|NCT02793544|Fludarabine|fludarabine|mesh-list
56557753|NCT02793544|Mesna|mesna|mesh-list
56557754|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557755|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
56557756|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557757|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56557758|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56557759|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
56557760|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557761|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557762|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56557763|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56557765|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
56557804|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557805|NCT01148459|Vaccines|vaccines|mesh-list
56557806|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
56557807|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557808|NCT03913234|Trastuzumab|trastuzumab|mesh-list
56557809|NCT03913234|Letrozole|letrozole|mesh-list
56557810|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557811|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557812|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56557813|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56557814|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557815|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557816|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56557817|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
56557818|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56557819|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557820|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
56557821|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
56557822|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56557823|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557824|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56557825|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557826|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56557827|NCT03854500|Tenecteplase|tenecteplase|mesh-list
56557828|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56557829|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56557830|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557831|NCT02789332|Paclitaxel|paclitaxel|mesh-list
56557832|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56557833|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
56557834|NCT02789332|Carboplatin|carboplatin|mesh-list
56557835|NCT02789332|Epirubicin|epirubicin|mesh-list
56557836|NCT02789332|Olaparib|olaparib|mesh-list
56557837|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56557838|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557839|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
56557842|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557843|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557844|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
56557845|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557846|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56557847|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56557848|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
56557849|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56557850|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56557851|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56557852|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56557853|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557854|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56557855|NCT02792140|Naltrexone|naltrexone|mesh-list
56557856|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56557857|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56557861|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
56557900|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56557901|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
56557902|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56557903|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
56557904|NCT02620345|Progestins|progestins|mesh-ancestor
56557905|NCT02620345|Hormones|hormones|mesh-ancestor
56557906|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56557907|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557908|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
56557909|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
56358127|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56557910|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56557911|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56557912|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557913|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
56557914|NCT02790580|Doxorubicin|doxorubicin|mesh-list
56557915|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56557916|NCT02790580|Sunitinib|sunitinib|mesh-list
56557917|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56557918|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
56557954|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56557955|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56557956|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56557957|NCT04232800|Riboflavin|riboflavin|mesh-list
56557958|NCT04232800|Vitamins|vitamins|mesh-ancestor
56557959|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
56557960|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557961|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
56557962|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56557963|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
56557964|NCT01148225|Adalimumab|adalimumab|mesh-list
56557965|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56557966|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56557967|NCT02788240|Meropenem|meropenem|mesh-list
56557968|NCT02788240|Terlipressin|terlipressin|mesh-list
56557969|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56557970|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557971|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56557972|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56557973|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
56557974|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
56557975|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56557976|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557977|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56557978|NCT02884115|Penicillins|penicillins|mesh-list
56557979|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56557980|NCT02884115|Penicillin G|penicillin g|mesh-list
56557981|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
56557982|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56557983|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557984|NCT01190813|Levodopa|levodopa|mesh-list
56558001|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56558002|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558003|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558004|NCT00870727|Aripiprazole|aripiprazole|mesh-list
56558005|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
56558006|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56558007|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56558008|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56558009|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558010|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558011|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
56558012|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
56558013|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558014|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558015|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56558016|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56558017|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
56558018|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56558019|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56558020|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56558021|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56558022|NCT02787928|Hydromorphone|hydromorphone|mesh-list
56558023|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56558024|NCT02787928|Narcotics|narcotics|mesh-ancestor
56558025|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558026|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558027|NCT02787928|Analgesics|analgesics|mesh-ancestor
56558028|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
56558029|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558030|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
56558043|NCT01147055|Crizotinib|crizotinib|mesh-list
56558044|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56558045|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
56558046|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558047|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558048|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
56558049|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56558050|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558051|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558052|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56558053|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56558054|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56558055|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56558056|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56558057|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56558058|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558059|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56558060|NCT02623231|Citalopram|citalopram|mesh-list
56558061|NCT02623231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56558062|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56558095|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
56558096|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558097|NCT04233502|Protective Agents|protective agents|mesh-ancestor
56558098|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558099|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558100|NCT00696475|Diazoxide|diazoxide|mesh-list
56558101|NCT00696475|Choline|choline|mesh-list
56558102|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
56558103|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56558104|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
56306446|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56558105|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558106|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558107|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56558109|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56558110|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
56558111|NCT03628066|Letrozole|letrozole|mesh-list
56558112|NCT03628066|Palbociclib|palbociclib|mesh-list
56558113|NCT03628066|Goserelin|goserelin|mesh-list
56558114|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558115|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56558116|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56558117|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558118|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558119|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56558120|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
56558121|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56558122|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558123|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56558124|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56558125|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
56558138|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56558139|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
56558140|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56558141|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558142|NCT04232644|Amphetamine|amphetamine|mesh-list
56558143|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
56558144|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56558145|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558146|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
56558147|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
56558148|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558149|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
56558150|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558151|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558152|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
56558153|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56558154|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56558155|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558156|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56558157|NCT03557788|Rifaximin|rifaximin|mesh-list
56558158|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558159|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558160|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558161|NCT04133155|Gemcitabine|gemcitabine|mesh-list
56558162|NCT04133155|Paclitaxel|paclitaxel|mesh-list
56558163|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56558164|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558165|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
56558177|NCT01190267|Asenapine|asenapine|mesh-list
56558184|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56558185|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56558186|NCT00869089|Analgesics|analgesics|mesh-ancestor
56558187|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
56558188|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558189|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558190|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56558191|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56558192|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56558193|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56558194|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558195|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558196|NCT02616367|Bupivacaine|bupivacaine|mesh-list
56558197|NCT02616367|Ropivacaine|ropivacaine|mesh-list
56558198|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
56558199|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
56558200|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558201|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558202|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
56558203|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558204|NCT04200040|Dacarbazine|dacarbazine|mesh-list
56558205|NCT04200040|Molgramostim|molgramostim|mesh-list
56558206|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56558207|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
56558208|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558209|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558210|NCT04232722|Sorafenib|sorafenib|mesh-list
56558211|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558212|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56558213|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094536|NCT00624650|Furosemide|furosemide|mesh-list
56098759|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
56098760|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
56098777|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56098778|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098779|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
55816917|NCT01855750|Doxorubicin|doxorubicin|mesh-list
56098781|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098782|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56098783|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56098784|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098785|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098786|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56558214|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558215|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56558216|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56558217|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558218|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
56558219|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56558220|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558221|NCT02787226|Bupivacaine|bupivacaine|mesh-list
56558222|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
56558223|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
56558224|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558225|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558226|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
56558227|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558228|NCT00697567|Vaccines|vaccines|mesh-list
56558229|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
56558230|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558231|NCT02616289|Emollients|emollients|mesh-list
56558232|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
56558233|NCT01145495|Rituximab|rituximab|mesh-list
56558234|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56558235|NCT01145495|Lenalidomide|lenalidomide|mesh-list
56558236|NCT01145495|Antibodies|antibodies|mesh-list
56558237|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
56558238|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56558239|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
56558240|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558241|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558242|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56558243|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56558244|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56558245|NCT01145495|Growth Substances|growth substances|mesh-ancestor
56558246|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
56558247|NCT03421756|Sirolimus|sirolimus|mesh-list
56098787|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
56194750|NCT01494805|Growth Substances|growth substances|mesh-ancestor
56194751|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194752|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
56194753|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194754|NCT01494857|Adalimumab|adalimumab|mesh-list
56194755|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56194756|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194757|NCT01495026|Tamsulosin|tamsulosin|mesh-list
56558249|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558250|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558251|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56558252|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558253|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
56558254|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56558255|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
56558256|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558257|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56558259|NCT00870103|Dexamethasone|dexamethasone|mesh-list
56558260|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56558261|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56558262|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
56558263|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
56558264|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558265|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558266|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56558267|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
56558268|NCT00870103|Hormones|hormones|mesh-ancestor
56558269|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56558270|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56558271|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558272|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56558273|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558279|NCT03365752|Anesthetics|anesthetics|mesh-list
56558299|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558300|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
56558301|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56558302|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558303|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558304|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56558305|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56558306|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56558307|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558308|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56558309|NCT04232332|Mitogens|mitogens|mesh-list
56558310|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
56558311|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558312|NCT02785276|Ropivacaine|ropivacaine|mesh-list
56558313|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
56558314|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
56558315|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558354|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
56558355|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
56558356|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
56558357|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558358|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
56558359|NCT01144403|Rituximab|rituximab|mesh-list
56558360|NCT01144403|Fludarabine|fludarabine|mesh-list
56558361|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
56558362|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56558363|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
56558364|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558365|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56558366|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56558367|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
56558368|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558369|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558370|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56558371|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56558372|NCT01144403|Analgesics|analgesics|mesh-ancestor
56558373|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
56558411|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
56558412|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558413|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558414|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56558415|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
56558416|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
56558417|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56558418|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
56558419|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558420|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558421|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
56558422|NCT04231864|Durvalumab|durvalumab|mesh-list
56558423|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
56558424|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56558425|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
56558426|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56558427|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558428|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
56558429|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558430|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
56558431|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
56558432|NCT01101438|Metformin|metformin|mesh-list
56558433|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56558434|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558435|NCT02992522|Lenalidomide|lenalidomide|mesh-list
56558436|NCT02992522|Venetoclax|venetoclax|mesh-list
56558437|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
56558438|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
56558439|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558440|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56558441|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56558442|NCT02992522|Growth Substances|growth substances|mesh-ancestor
56558453|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56558454|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56558455|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
56558456|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558457|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558458|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56558459|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56558460|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
56558461|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56558462|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56558463|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
56558464|NCT02786446|Naproxen|naproxen|mesh-list
56558465|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56558466|NCT02786446|Lidocaine|lidocaine|mesh-list
56558467|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
56558468|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
56558469|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558470|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558471|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
56558472|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558506|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
56558507|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558508|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558509|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
56558510|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558511|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56558512|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
56558513|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558515|NCT02947516|Hematinics|hematinics|mesh-ancestor
56558516|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56558517|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
56558518|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56558519|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56558520|NCT00864721|Sunitinib|sunitinib|mesh-list
56558521|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558522|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56558523|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56558524|NCT00864721|Growth Substances|growth substances|mesh-ancestor
56558525|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558526|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
56558527|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56558528|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558529|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558530|NCT05308420|Morphine|morphine|mesh-list
56558531|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558532|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558533|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56558534|NCT05308420|Narcotics|narcotics|mesh-ancestor
56558535|NCT05308420|Analgesics|analgesics|mesh-ancestor
56558536|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
56558537|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558550|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558551|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56306907|NCT00397501|Antidotes|antidotes|mesh-ancestor
56558552|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
56558553|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
56558554|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
56558555|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
56558556|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56558557|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56558558|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56558559|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56558560|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558561|NCT01095666|Metformin|metformin|mesh-list
56558562|NCT01095666|Pioglitazone|pioglitazone|mesh-list
56558563|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
56558564|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56558565|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558566|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56558567|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558568|NCT01100658|Methylphenidate|methylphenidate|mesh-list
56558569|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56558570|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558571|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56558572|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56558573|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558574|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558575|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
56558576|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558577|NCT05276908|Bupivacaine|bupivacaine|mesh-list
56558578|NCT05276908|Anesthetics|anesthetics|mesh-list
56558579|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
56558584|NCT02785978|Levodopa|levodopa|mesh-list
56558590|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558591|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
56558592|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56558593|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558594|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558595|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56558596|NCT02786212|Analgesics|analgesics|mesh-ancestor
56558597|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
56558598|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558599|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56558600|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56558601|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56558602|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56558603|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558604|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558605|NCT05273710|Folic Acid|folic acid|mesh-list
56558606|NCT05273710|Hematinics|hematinics|mesh-ancestor
56558607|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
56558608|NCT05273710|Vitamins|vitamins|mesh-ancestor
56558609|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
56558610|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558611|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
56558612|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
56558613|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56558614|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558639|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558640|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
56558641|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56558642|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
56558643|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
56558644|NCT02389036|Tobramycin|tobramycin|mesh-list
56558645|NCT02389036|Colistin|colistin|mesh-list
56558646|NCT02389036|Nystatin|nystatin|mesh-list
56558647|NCT02389036|Cefotaxime|cefotaxime|mesh-list
56558648|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56558649|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56558650|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56558651|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558652|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558653|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558654|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56558655|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56558656|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
56558657|NCT02389036|Ionophores|ionophores|mesh-ancestor
56558658|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558659|NCT02878512|Anesthetics|anesthetics|mesh-list
56558660|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558661|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558662|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
56558663|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56558664|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
56558665|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56558666|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
56558667|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558668|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558669|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
56558670|NCT01094808|Pregabalin|pregabalin|mesh-list
56558671|NCT01094808|Analgesics|analgesics|mesh-ancestor
56558672|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
56558673|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558674|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558675|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
56558678|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558679|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56558680|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56558681|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56558682|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558683|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56558684|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56558685|NCT00864253|Dacarbazine|dacarbazine|mesh-list
56558686|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558687|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56558688|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
56558689|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558690|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56558691|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56558692|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
56558693|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558694|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558695|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56558696|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
56558697|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
56558698|NCT02782312|Hormones|hormones|mesh-ancestor
56558700|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
56558728|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558729|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
56558730|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56558731|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558732|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558733|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56558734|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56558735|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56558736|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558737|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56558738|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56558743|NCT04230070|Estradiol|estradiol|mesh-list
56558787|NCT00864097|Tanezumab|tanezumab|mesh-list
56558788|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56558789|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56558790|NCT00864097|Analgesics|analgesics|mesh-ancestor
56558791|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
56558792|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558793|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558794|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56558795|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56558796|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56558797|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558798|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558799|NCT02782624|Empagliflozin|empagliflozin|mesh-list
56558800|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56558801|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558802|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56558803|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558804|NCT02781766|Thrombin|thrombin|mesh-list
56558805|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
56558806|NCT02781766|Coagulants|coagulants|mesh-ancestor
56558807|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
56558808|NCT00887536|Bevacizumab|bevacizumab|mesh-list
56558809|NCT00887536|Docetaxel|docetaxel|mesh-list
56558810|NCT00887536|Doxorubicin|doxorubicin|mesh-list
56558811|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56558812|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
56558813|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558814|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56558815|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56558816|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
56558817|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558818|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558819|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56558820|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56558821|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56194758|NCT01495026|Dutasteride|dutasteride|mesh-list
56194759|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56194760|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56194761|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56194762|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
56558822|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56558823|NCT00887536|Growth Substances|growth substances|mesh-ancestor
56558824|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
56558825|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
56558826|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
56558827|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
56558828|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56558829|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56558830|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56558831|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56558832|NCT02614339|Metformin|metformin|mesh-list
56558833|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56558834|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558835|NCT02618395|Hydrocodone|hydrocodone|mesh-list
56558836|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56558837|NCT02618395|Narcotics|narcotics|mesh-ancestor
56558838|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558839|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558840|NCT02618395|Analgesics|analgesics|mesh-ancestor
56558841|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
56558842|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56558875|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558876|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56558877|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558878|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56558879|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
56558880|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56558881|NCT05298163|Calcitriol|calcitriol|mesh-list
56558882|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56558883|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558884|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56558885|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56558886|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558887|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56558888|NCT05298163|Vitamins|vitamins|mesh-ancestor
56558889|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
56558890|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56558891|NCT01141283|Buprenorphine|buprenorphine|mesh-list
56558892|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56558893|NCT01141283|Narcotics|narcotics|mesh-ancestor
56558894|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56558895|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558896|NCT01141283|Analgesics|analgesics|mesh-ancestor
56558925|NCT01094184|Docetaxel|docetaxel|mesh-list
56558926|NCT01094184|Bevacizumab|bevacizumab|mesh-list
56558927|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56558928|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56558929|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
56558930|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
56558931|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
56558932|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558933|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56558990|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
56558991|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56558992|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56558993|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56558994|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56558995|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56558996|NCT02744092|Enoxaparin|enoxaparin|mesh-list
56558997|NCT02744092|Dalteparin|dalteparin|mesh-list
56558998|NCT02744092|PENTA|penta|mesh-list
56558999|NCT02744092|Warfarin|warfarin|mesh-list
56559000|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
56559001|NCT02744092|Dabigatran|dabigatran|mesh-list
56559002|NCT02744092|Apixaban|apixaban|mesh-list
56559003|NCT02744092|Edoxaban|edoxaban|mesh-list
56559004|NCT02744092|Fondaparinux|fondaparinux|mesh-list
56559005|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
56559006|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56559007|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
56559008|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56559009|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
56559010|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559014|NCT01200368|Vaccines|vaccines|mesh-list
56559047|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559048|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559049|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559050|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
56559051|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
56559052|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559053|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56559054|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
56559055|NCT01078974|Hormones|hormones|mesh-ancestor
56559056|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559057|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56559058|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56559059|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56559060|NCT01078974|Growth Substances|growth substances|mesh-ancestor
56559061|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
56559062|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
56559063|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
56559064|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559065|NCT02878200|Piperaquine|piperaquine|mesh-list
56559066|NCT02878200|Artenimol|artenimol|mesh-list
56559067|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
56559068|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56559069|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56559070|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559071|NCT04302012|Mydriatics|mydriatics|mesh-list
56559072|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
56559073|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559074|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559075|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56559076|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56559077|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56194763|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213209|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56098788|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098789|NCT00002756|Antidotes|antidotes|mesh-ancestor
56098790|NCT00002756|Protective Agents|protective agents|mesh-ancestor
56098791|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
56098792|NCT00002756|Vitamins|vitamins|mesh-ancestor
56098793|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
56098794|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098795|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
56098796|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
56559078|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56559079|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559080|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559081|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
56559082|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559083|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56559084|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56559085|NCT02781064|Atorvastatin|atorvastatin|mesh-list
56559086|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56559087|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56559088|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
56559089|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559090|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56559091|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56559092|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559093|NCT04205682|Cannabidiol|cannabidiol|mesh-list
56559094|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
56559095|NCT05398484|Psilocybin|psilocybin|mesh-list
56559096|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
56559097|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559099|NCT01134263|Vaccines|vaccines|mesh-list
56559100|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
56559101|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559102|NCT01199822|Olaratumab|olaratumab|mesh-list
56559103|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559104|NCT01096056|Vaccines|vaccines|mesh-list
56559105|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
56559106|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559107|NCT00866359|Apremilast|apremilast|mesh-list
56559108|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559109|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559110|NCT00866359|Analgesics|analgesics|mesh-ancestor
56559111|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
56095408|NCT00000896|Indinavir|indinavir|mesh-list
56098797|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56098798|NCT01183429|Tretinoin|tretinoin|mesh-list
56098799|NCT01183429|Isotretinoin|isotretinoin|mesh-list
56098800|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098801|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
56098802|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098803|NCT01157533|Vancomycin|vancomycin|mesh-list
56098804|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56098805|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098806|NCT05558150|Aceclofenac|aceclofenac|mesh-list
56559112|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559113|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559114|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559115|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559116|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56559117|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56559118|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559119|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559120|NCT01199198|Tolvaptan|tolvaptan|mesh-list
56559121|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56559122|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559123|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
56559124|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559125|NCT05089708|Trifarotene|trifarotene|mesh-list
56559126|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
56559127|NCT01095978|Clarithromycin|clarithromycin|mesh-list
56559128|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56559129|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559130|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56559131|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559132|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559133|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56559134|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56559135|NCT01134107|Insulin|insulin|mesh-list
56559136|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56559137|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
56559138|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
56559139|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56559140|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559141|NCT01198574|Vitamins|vitamins|mesh-list
56559142|NCT01198574|Folic Acid|folic acid|mesh-list
56559143|NCT01198574|Vitamin A|vitamin a|mesh-list
56559144|NCT01198574|Iron|iron|mesh-list
56559145|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
56559146|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
56559147|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098807|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56098808|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559148|NCT01198574|Trace Elements|trace elements|mesh-ancestor
56559149|NCT01198574|Hematinics|hematinics|mesh-ancestor
56559150|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
56559151|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
56559152|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559153|NCT01198574|Protective Agents|protective agents|mesh-ancestor
56559154|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56559155|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559156|NCT02580994|Carboplatin|carboplatin|mesh-list
56559157|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
56559158|NCT02580994|Etoposide|etoposide|mesh-list
56559159|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559160|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56559161|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56559162|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56559163|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56559164|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559165|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559166|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56559167|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559168|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56559169|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559170|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559172|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56559173|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559196|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559197|NCT04878432|Azacitidine|azacitidine|mesh-list
56559198|NCT04878432|Decitabine|decitabine|mesh-list
56559199|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56559200|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
56559201|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559202|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559203|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559204|NCT00634894|Letrozole|letrozole|mesh-list
56559205|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559206|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56559207|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56559208|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559209|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559210|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56559211|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
56559212|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559213|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559214|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
56559215|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56559216|NCT02779270|Protective Agents|protective agents|mesh-ancestor
56559217|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559218|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
56559246|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559247|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56559248|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559249|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56559250|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559251|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
56559252|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559253|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56559254|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
56559255|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559256|NCT02200978|Analgesics|analgesics|mesh-ancestor
56559257|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
56559258|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559259|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56559260|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56559261|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
56559262|NCT02779192|Ebselen|ebselen|mesh-list
56559263|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559264|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559265|NCT02779192|Analgesics|analgesics|mesh-ancestor
56559266|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
56559267|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559273|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
56559299|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56559300|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56559301|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56559302|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559304|NCT05017246|Narcotics|narcotics|mesh-ancestor
56559305|NCT05017246|Analgesics|analgesics|mesh-ancestor
56559306|NCT01091454|Cisplatin|cisplatin|mesh-list
56559307|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559308|NCT01140347|Ramucirumab|ramucirumab|mesh-list
56559309|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559310|NCT04227652|Ibuprofen|ibuprofen|mesh-list
56559311|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559312|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559313|NCT04227652|Analgesics|analgesics|mesh-ancestor
56559314|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
56559315|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559316|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559317|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559318|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559319|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56559320|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559322|NCT02883569|Ibuprofen|ibuprofen|mesh-list
56559354|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559355|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559356|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559357|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56559358|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559359|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559360|NCT01197560|Gemcitabine|gemcitabine|mesh-list
56559361|NCT01197560|Rituximab|rituximab|mesh-list
56559362|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
56559363|NCT01197560|Etoposide|etoposide|mesh-list
56559364|NCT01197560|Lenalidomide|lenalidomide|mesh-list
56559365|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56559366|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559367|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
56559368|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559369|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559370|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56559371|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
56559372|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559373|NCT01197560|Antiviral Agents|antiviral agents|mesh-ancestor
56559374|NCT01197560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307718|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56559375|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559376|NCT01197560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559377|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56559378|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56559401|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56559402|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
56559403|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
56559404|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
56559405|NCT05314660|Fluorides|fluorides|mesh-list
56559406|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
56559407|NCT05314660|Protective Agents|protective agents|mesh-ancestor
56559408|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559409|NCT04920292|Oxfendazole|oxfendazole|mesh-list
56559410|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
56559411|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56559412|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559413|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
56559414|NCT04317872|Dexamethasone|dexamethasone|mesh-list
56559415|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
56559416|NCT04317872|BB 1101|bb 1101|mesh-list
56559417|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559418|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
56559419|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
56559420|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559421|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559422|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56559423|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
56559424|NCT04317872|Hormones|hormones|mesh-ancestor
56559425|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559426|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56559427|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559428|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
56559429|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559430|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559431|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
56559432|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
56559433|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
56559445|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56559446|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559447|NCT01194830|Incretins|incretins|mesh-ancestor
56559448|NCT01194830|Hormones|hormones|mesh-ancestor
56559449|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559450|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56559451|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
56559452|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559453|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559455|NCT02778178|Ropivacaine|ropivacaine|mesh-list
56559456|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
56559457|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
56559458|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559459|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559460|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
56559461|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559462|NCT02778178|Analgesics|analgesics|mesh-ancestor
56559463|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56559464|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
56559465|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
56559466|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56559467|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56559468|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56559469|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
56559470|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559471|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559472|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
56559473|NCT01194440|Letrozole|letrozole|mesh-list
56559474|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559475|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56559476|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56559484|NCT04823052|Sulindac|sulindac|mesh-list
56559487|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559488|NCT04823052|Analgesics|analgesics|mesh-ancestor
56559489|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
56559490|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559491|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559492|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559493|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559494|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559495|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56559496|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559497|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559498|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
56559499|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
56559500|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
56559501|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559502|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
56559503|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56559504|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559505|NCT00951015|Efavirenz|efavirenz|mesh-list
56559506|NCT00951015|Dolutegravir|dolutegravir|mesh-list
56559507|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56559508|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56559509|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559510|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559511|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
56559512|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559513|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56559514|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56559515|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56559516|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56559517|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56559518|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56559519|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56559520|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56559521|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56559523|NCT02777866|Bupivacaine|bupivacaine|mesh-list
56559524|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
56559525|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
56559526|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559527|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559528|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
56559529|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559530|NCT00626262|Esomeprazole|esomeprazole|mesh-list
56559531|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56559532|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56559533|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56559534|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559535|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559536|NCT02876796|Firsocostat|firsocostat|mesh-list
56559537|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559538|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559539|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
56559540|NCT01193660|Hematinics|hematinics|mesh-ancestor
56559541|NCT02777788|Gemcitabine|gemcitabine|mesh-list
56559543|NCT02777788|Vinorelbine|vinorelbine|mesh-list
56559544|NCT02777788|Docetaxel|docetaxel|mesh-list
56559545|NCT02777788|Carboplatin|carboplatin|mesh-list
56559546|NCT02777788|Pemetrexed|pemetrexed|mesh-list
56559547|NCT02777788|Cisplatin|cisplatin|mesh-list
56559548|NCT02777788|Nedaplatin|nedaplatin|mesh-list
56559549|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56559550|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559551|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
56559552|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
56559553|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
56559554|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559555|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56559556|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
56559557|NCT02777788|Antiviral Agents|antiviral agents|mesh-ancestor
56098809|NCT05558150|Analgesics|analgesics|mesh-ancestor
56098810|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
56098811|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098812|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098813|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098814|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098815|NCT05749016|Paclitaxel|paclitaxel|mesh-list
56098816|NCT05749016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56098817|NCT05749016|Carboplatin|carboplatin|mesh-list
56098818|NCT05749016|Pertuzumab|pertuzumab|mesh-list
56098819|NCT05749016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098833|NCT01126801|Estradiol|estradiol|mesh-list
56559558|NCT02777788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559559|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559560|NCT02777788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559561|NCT02777788|Immunologic Factors|immunologic factors|mesh-ancestor
56559562|NCT02777788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559563|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56559564|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56559565|NCT01076166|Clarithromycin|clarithromycin|mesh-list
56559566|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56559567|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559568|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56559569|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559570|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559571|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56559572|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56559573|NCT02777710|Durvalumab|durvalumab|mesh-list
56559574|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56559575|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559576|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56559577|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
56559578|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559609|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559610|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559611|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559612|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559613|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56559614|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559615|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559616|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
56559617|NCT01193348|Eculizumab|eculizumab|mesh-list
56559618|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56559619|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559620|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
56559621|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559622|NCT00945321|Aprepitant|aprepitant|mesh-list
56559623|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
56559624|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
56559625|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
56559626|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559627|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559628|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56559629|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56559630|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559632|NCT02776228|Brotizolam|brotizolam|mesh-list
56559661|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
56559662|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559663|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56559664|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559665|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56559666|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56559667|NCT05382728|Osimertinib|osimertinib|mesh-list
56559668|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559669|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56559670|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559671|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559672|NCT00944697|Oxycodone|oxycodone|mesh-list
56559673|NCT00944697|Naloxone|naloxone|mesh-list
56308020|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559674|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56559675|NCT00944697|Narcotics|narcotics|mesh-ancestor
56559676|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559677|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559679|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
56559680|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559681|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56559682|NCT01192178|Fluticasone|fluticasone|mesh-list
56559683|NCT01192178|Xhance|xhance|mesh-list
56559684|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56559685|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56559686|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559687|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56559688|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
56559689|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559690|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559691|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56559692|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
56559693|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56559694|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56559695|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56559696|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55864452|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
56559698|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
56559699|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559700|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559701|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
56559702|NCT01192178|Hormones|hormones|mesh-ancestor
56559703|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559704|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
56559705|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
56559706|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56559707|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559708|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56559709|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559710|NCT00869401|Temozolomide|temozolomide|mesh-list
56559711|NCT00869401|Dasatinib|dasatinib|mesh-list
56559712|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56559713|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
56559714|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559715|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559716|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56559717|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559718|NCT01076010|Sorafenib|sorafenib|mesh-list
56559719|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559720|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56559721|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559723|NCT04225780|Ganciclovir|ganciclovir|mesh-list
56559746|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559747|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56559748|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56559749|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
56559750|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56559751|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56559752|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56559753|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56559754|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56559755|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56559756|NCT04134637|Bupivacaine|bupivacaine|mesh-list
56559757|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
56559758|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
56559759|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559760|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559761|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
56559762|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559763|NCT02617849|Paclitaxel|paclitaxel|mesh-list
56559765|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
56559766|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56559767|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559768|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
56559799|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56559800|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56559801|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
56559802|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559803|NCT02775292|Analgesics|analgesics|mesh-ancestor
56559804|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
56559805|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559806|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56559807|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56559808|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
56559809|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559810|NCT00862849|Insulin|insulin|mesh-list
56559811|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56559812|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
56559813|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56559814|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559815|NCT01090050|Naproxen|naproxen|mesh-list
56559816|NCT01090050|Sumatriptan|sumatriptan|mesh-list
56559817|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559818|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559819|NCT01090050|Analgesics|analgesics|mesh-ancestor
56559820|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
56559821|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559822|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559852|NCT01077960|Hormones|hormones|mesh-list
56559853|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56559854|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559855|NCT04269369|Fluorouracil|fluorouracil|mesh-list
56559856|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
56559857|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559858|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56559859|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559860|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559861|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
56559862|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559863|NCT02776540|Aspirin|aspirin|mesh-list
56559864|NCT02776540|Clopidogrel|clopidogrel|mesh-list
56559865|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56559866|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56559867|NCT02776540|Analgesics|analgesics|mesh-ancestor
56559868|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
56559869|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559870|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559871|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56559872|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559873|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56559874|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56559875|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559876|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56098834|NCT01126801|Estrogens|estrogens|mesh-ancestor
56098835|NCT01126801|Hormones|hormones|mesh-ancestor
56098836|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098837|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098838|NCT01702909|Interleukin-2|interleukin-2|mesh-list
56098839|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098840|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56098841|NCT01702909|Analgesics|analgesics|mesh-ancestor
56098842|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
56098843|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098844|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098845|NCT00002768|Cytarabine|cytarabine|mesh-list
56098846|NCT00002768|Methotrexate|methotrexate|mesh-list
56098847|NCT00002768|Etoposide|etoposide|mesh-list
56098848|NCT00002768|Busulfan|busulfan|mesh-list
56098849|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56194764|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194765|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194766|NCT01495026|Urological Agents|urological agents|mesh-ancestor
56194767|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56194768|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56098850|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
56559877|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56559878|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56559879|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
56559880|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56559881|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56559882|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56559883|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
56559884|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56559885|NCT02878122|Carboplatin|carboplatin|mesh-list
56559886|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559887|NCT04807348|Metformin|metformin|mesh-list
56559888|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56559889|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559890|NCT04224922|Paclitaxel|paclitaxel|mesh-list
56559891|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
56559892|NCT04224922|Epirubicin|epirubicin|mesh-list
56559893|NCT04224922|Carboplatin|carboplatin|mesh-list
56559894|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56559895|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56559896|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
56559897|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
56559898|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308246|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
56559899|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559900|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559901|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
56559902|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559903|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56559924|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56559925|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
56559926|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
56559927|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56559928|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56559929|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
56559930|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559931|NCT04778410|Analgesics|analgesics|mesh-ancestor
56559932|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
56559933|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559934|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56559935|NCT02877888|Fluorides|fluorides|mesh-list
56559936|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
56559937|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
56559938|NCT02877888|Protective Agents|protective agents|mesh-ancestor
56559939|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559940|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56559941|NCT02772640|Ezetimibe|ezetimibe|mesh-list
56559942|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56559943|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56559944|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
56559945|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56559978|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56559979|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559980|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56559981|NCT02771782|Vaccines|vaccines|mesh-list
56559982|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
56559983|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
56559984|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559985|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56559986|NCT02771392|Tetracaine|tetracaine|mesh-list
56559987|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56559988|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
56559989|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
56559990|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56559991|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56559992|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
56559993|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56559994|NCT02771704|Iodine|iodine|mesh-list
56559995|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
56559996|NCT02771704|Fluorides|fluorides|mesh-list
56559997|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
56559998|NCT02771704|Protective Agents|protective agents|mesh-ancestor
56098852|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098853|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098854|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
56098855|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098856|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098857|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098858|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098859|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56098860|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098861|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
56098862|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098863|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56098864|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098865|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098866|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098867|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
56098868|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098869|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
56098870|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55825966|NCT03651128|Hormones|hormones|mesh-ancestor
56098871|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098872|NCT05599243|Dutasteride|dutasteride|mesh-list
56098873|NCT05599243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56098874|NCT05599243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56098875|NCT05599243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098876|NCT05599243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098877|NCT05599243|Hormone Antagonists|hormone antagonists|mesh-ancestor
56098878|NCT05599243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098892|NCT01126957|Propofol|propofol|mesh-list
56098893|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56098894|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56098895|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098896|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56559999|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560000|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56560001|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560002|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
56560003|NCT02771704|Trace Elements|trace elements|mesh-ancestor
56560004|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
56560005|NCT02771314|Osimertinib|osimertinib|mesh-list
56560006|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560007|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56560008|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560009|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560010|NCT02771158|Midodrine|midodrine|mesh-list
56560011|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
56560012|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
56560013|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560014|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560015|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56560016|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56560017|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56560019|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56560020|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560021|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560022|NCT02770690|Lidocaine|lidocaine|mesh-list
56560023|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
56560024|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
56560025|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
56560026|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560035|NCT02770378|Ritonavir|ritonavir|mesh-list
56308414|NCT00053287|Topotecan|topotecan|mesh-list
56560049|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560050|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56560051|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56560052|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
56560053|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560054|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56560055|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56560056|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56560057|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
56560058|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560059|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56560060|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56560061|NCT02770378|Analgesics|analgesics|mesh-ancestor
56560062|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
56560063|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560064|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560065|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560066|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560067|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56560068|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56560069|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
56560070|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56560071|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56560072|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
56560094|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
56560095|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56560096|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560097|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
56560098|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56560099|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560100|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560101|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56560102|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56560103|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56560104|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56560105|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56560106|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56560107|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56560108|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
56560109|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56560110|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56560111|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56560112|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56560113|NCT00943917|Exenatide|exenatide|mesh-list
56560114|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56560115|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560116|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56560117|NCT00943917|Incretins|incretins|mesh-ancestor
56560118|NCT00943917|Hormones|hormones|mesh-ancestor
56560119|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560120|NCT02769832|Gemcitabine|gemcitabine|mesh-list
56560121|NCT02769832|Paclitaxel|paclitaxel|mesh-list
56560138|NCT02876250|Cyclosporins|cyclosporins|mesh-list
56560139|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560140|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560141|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560142|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
56560143|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560144|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
56560145|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560146|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56560147|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560148|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56560149|NCT02769910|Capsaicin|capsaicin|mesh-list
56560150|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
56560151|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56560152|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
56560153|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560154|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560155|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56560195|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56560196|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560197|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
56358454|NCT00107523|Cytarabine|cytarabine|mesh-list
56560198|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56560199|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56560200|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56560201|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560202|NCT02851095|Metformin|metformin|mesh-list
56560203|NCT02851095|Canagliflozin|canagliflozin|mesh-list
56560204|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56560205|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560206|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56560207|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560208|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
56560209|NCT00580047|Vitamin D|vitamin d|mesh-list
56560210|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
56560211|NCT00580047|Alendronate|alendronate|mesh-list
56560212|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
56560213|NCT00580047|Calcium|calcium|mesh-list
56560214|NCT00580047|Vitamins|vitamins|mesh-ancestor
56560215|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
56560216|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560217|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56560218|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56560219|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560220|NCT00580047|Antacids|antacids|mesh-ancestor
56560221|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56560222|NCT01074450|Pramipexole|pramipexole|mesh-list
56560223|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
56560224|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560225|NCT01074450|Protective Agents|protective agents|mesh-ancestor
56560226|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560227|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56560228|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56560234|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560235|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56560236|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560237|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
56560238|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560239|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
56560240|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560241|NCT00635284|Sirolimus|sirolimus|mesh-list
56560242|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56560243|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560244|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56560245|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560246|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
56560247|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560248|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
56560249|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560250|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
56560251|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56560252|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56560253|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56560254|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
56560255|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560256|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560257|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560258|NCT00699049|Urological Agents|urological agents|mesh-ancestor
56560259|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56560261|NCT04131283|Epinephrine|epinephrine|mesh-list
56560282|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
56560283|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560284|NCT02617771|Vitamin D|vitamin d|mesh-list
56560285|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
56560286|NCT02617771|Vitamins|vitamins|mesh-ancestor
56560287|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
56560288|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560289|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56560290|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56560291|NCT02696590|Vitamin D|vitamin d|mesh-list
56560292|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
56560293|NCT02696590|Vitamins|vitamins|mesh-ancestor
56560294|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
56560295|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560296|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56560297|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56560298|NCT02617459|Betaxolol|betaxolol|mesh-list
56560299|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56560300|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56560301|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56560302|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
56560303|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
56560304|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560305|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560306|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56560307|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56560308|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56560309|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
56560310|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560311|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560312|NCT02854995|Triamcinolone|triamcinolone|mesh-list
56560313|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560314|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
56560315|NCT02854995|Hormones|hormones|mesh-ancestor
56560324|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
56560325|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56560326|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560327|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560328|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56560329|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560330|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56560331|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56560332|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560333|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56560334|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56560335|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
56560336|NCT02696512|Protective Agents|protective agents|mesh-ancestor
56560337|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
56560338|NCT02696512|Vitamins|vitamins|mesh-ancestor
56560339|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
56560340|NCT02696512|Antidotes|antidotes|mesh-ancestor
56560341|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
56560342|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
56560343|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560344|NCT00949533|Oseltamivir|oseltamivir|mesh-list
56560352|NCT02854761|Vitamin D|vitamin d|mesh-list
56560380|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560381|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56560382|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
56560383|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560384|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56560385|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560386|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56560387|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56560388|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56560390|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
56560391|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560392|NCT00869323|Rituximab|rituximab|mesh-list
56560393|NCT00869323|Bortezomib|bortezomib|mesh-list
56560396|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
56560441|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358514|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56560442|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560443|NCT02766634|Lenograstim|lenograstim|mesh-list
56560444|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56560445|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
56560446|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560447|NCT02774044|Beractant|beractant|mesh-list
56560448|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
56560449|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56560450|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
56560451|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
56560452|NCT02766556|Ropivacaine|ropivacaine|mesh-list
56560453|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56560454|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560455|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560456|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56560457|NCT02766556|Analgesics|analgesics|mesh-ancestor
56560458|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
56560459|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560460|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56560461|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56560462|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56560463|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
56560464|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560465|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560467|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
56560486|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560487|NCT00940875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560488|NCT00940875|Immunologic Factors|immunologic factors|mesh-ancestor
56560489|NCT00940875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560490|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56560491|NCT02766322|Ethanol|ethanol|mesh-list
56560492|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56560493|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560494|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560495|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560496|NCT05656742|Vitamin D|vitamin d|mesh-list
56560497|NCT05656742|Vitamins|vitamins|mesh-ancestor
56560498|NCT05656742|Micronutrients|micronutrients|mesh-ancestor
56560499|NCT05656742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560500|NCT05656742|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56560501|NCT05655728|Metformin|metformin|mesh-list
56560502|NCT05655728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56560503|NCT05655728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560504|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56560505|NCT00940485|Entecavir|entecavir|mesh-list
56560506|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
56560507|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560508|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
56560509|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560510|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
56560512|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560538|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
56560539|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560540|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56560541|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560542|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56560543|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
56560544|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560545|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
56560546|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560547|NCT04316936|Dexamethasone|dexamethasone|mesh-list
56560548|NCT04316936|Prednisolone|prednisolone|mesh-list
56560549|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56560550|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
56560551|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56560552|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
56560553|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56560554|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
56560555|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560556|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
56560557|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
56560558|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560559|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560560|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56560561|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
56560562|NCT04316936|Hormones|hormones|mesh-ancestor
56560563|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560564|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56560565|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560566|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56560567|NCT04316936|Protective Agents|protective agents|mesh-ancestor
56560568|NCT00861757|Tadalafil|tadalafil|mesh-list
56560569|NCT00861757|Tamsulosin|tamsulosin|mesh-list
56560580|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560581|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560583|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
56560584|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56560585|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560586|NCT02762890|Iodine|iodine|mesh-list
56560587|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56560588|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560589|NCT02762890|Trace Elements|trace elements|mesh-ancestor
56560590|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
56560591|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560592|NCT02613715|Ethanol|ethanol|mesh-list
56560593|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56560594|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560595|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560596|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560597|NCT02762656|Lidocaine|lidocaine|mesh-list
56560598|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
56560599|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
56560600|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560601|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560602|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
56560603|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560604|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56560605|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56560606|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56560607|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560608|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560609|NCT00637325|Trastuzumab|trastuzumab|mesh-list
56560610|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56560623|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560624|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560625|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56560626|NCT01130597|Diuretics|diuretics|mesh-ancestor
56560627|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
56560628|NCT00939003|Adalimumab|adalimumab|mesh-list
56560629|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560630|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560631|NCT01188668|Aripiprazole|aripiprazole|mesh-list
56560632|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56560633|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
56560634|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56560635|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56560636|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56560637|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560638|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560639|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
56560640|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
56560641|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560642|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560643|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56560644|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56560645|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
56560661|NCT00865189|Leucovorin|leucovorin|mesh-list
56560674|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
56560675|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560676|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56560677|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56560678|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
56560679|NCT00865189|Antidotes|antidotes|mesh-ancestor
56560680|NCT00865189|Protective Agents|protective agents|mesh-ancestor
56560681|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
56560682|NCT00865189|Vitamins|vitamins|mesh-ancestor
56560683|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
56560684|NCT00865189|Hematinics|hematinics|mesh-ancestor
56560685|NCT00329043|Sunitinib|sunitinib|mesh-list
56560686|NCT00329043|Leuprolide|leuprolide|mesh-list
56560687|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560688|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56560689|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56560690|NCT00329043|Growth Substances|growth substances|mesh-ancestor
56560691|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560692|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
56560693|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56560694|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560695|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560696|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56560697|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
56560726|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56560727|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56560728|NCT01182194|Estradiol|estradiol|mesh-list
56560729|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56560730|NCT01182194|Estrogens|estrogens|mesh-ancestor
56560731|NCT01182194|Hormones|hormones|mesh-ancestor
56560732|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560733|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560734|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56560735|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
56560736|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56560737|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56560738|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56560739|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56560740|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56560741|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
56560742|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56560744|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
56560745|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56560746|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56560747|NCT01181726|Norethindrone|norethindrone|mesh-list
56560748|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
56560749|NCT01181726|Estradiol|estradiol|mesh-list
56560750|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56560751|NCT01181726|Estrogens|estrogens|mesh-ancestor
56560752|NCT01181726|Hormones|hormones|mesh-ancestor
56560753|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560754|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560772|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560773|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560774|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560775|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56560776|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56560777|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560778|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560779|NCT04130815|Furosemide|furosemide|mesh-list
56560780|NCT04130815|Diuretics|diuretics|mesh-ancestor
56560781|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
56560782|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560783|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56560784|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560785|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560786|NCT04256265|Risdiplam|risdiplam|mesh-list
56560787|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56560788|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560789|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560790|NCT04312061|Tramadol|tramadol|mesh-list
56560791|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56560792|NCT04312061|Narcotics|narcotics|mesh-ancestor
56560793|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560794|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560795|NCT04312061|Analgesics|analgesics|mesh-ancestor
56560796|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
56560797|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560798|NCT00860743|Antioxidants|antioxidants|mesh-list
56560799|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560800|NCT00860743|Protective Agents|protective agents|mesh-ancestor
56560815|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560816|NCT05383131|Analgesics|analgesics|mesh-ancestor
56560817|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
56560818|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560819|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560820|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56560821|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56560822|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560823|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560824|NCT02761486|Aspirin|aspirin|mesh-list
56560825|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56560826|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56560827|NCT02761486|Analgesics|analgesics|mesh-ancestor
56560828|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
56560829|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560830|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560831|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56560832|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560833|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56560834|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56560835|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560836|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56560837|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56560838|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560839|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
56560840|NCT02882789|Delpazolid|delpazolid|mesh-list
56560841|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
56560842|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56560843|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560844|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56560845|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560846|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098897|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
56098898|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
56098899|NCT01126957|Analgesics|analgesics|mesh-ancestor
56098900|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
56098901|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098902|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56098903|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56098904|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56098905|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56560847|NCT00940017|Voriconazole|voriconazole|mesh-list
56560848|NCT00940017|Anidulafungin|anidulafungin|mesh-list
56560849|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
56560850|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560851|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56560852|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56560853|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560854|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560855|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56560856|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
56560857|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560858|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560859|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56560860|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
56560861|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56560862|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56560903|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
56560904|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56560905|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56560906|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
56560907|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56560908|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56560909|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
56560910|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
56560911|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
56560912|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
56560913|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
56560914|NCT00848497|Testosterone|testosterone|mesh-list
56560915|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
56560916|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
56560917|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56560918|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560919|NCT00848497|Androgens|androgens|mesh-ancestor
56098906|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098907|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56098908|NCT01126957|Narcotics|narcotics|mesh-ancestor
56098909|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56098910|NCT00002780|Aldesleukin|aldesleukin|mesh-list
56098911|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
56098912|NCT00002780|Thiotepa|thiotepa|mesh-list
56098913|NCT00002780|Carboplatin|carboplatin|mesh-list
56098914|NCT00002780|Sargramostim|sargramostim|mesh-list
56098915|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098916|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
56098917|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098918|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098919|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098920|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
56098921|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098922|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194769|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194770|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
56194771|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56194773|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56194774|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194775|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
56194776|NCT01495039|Ionophores|ionophores|mesh-ancestor
56098923|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098924|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56098925|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56098926|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
56098927|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098928|NCT01692691|Dacarbazine|dacarbazine|mesh-list
56098929|NCT01692691|Carmustine|carmustine|mesh-list
56098931|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
56098932|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098933|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098934|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
56098935|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098936|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098938|NCT01122511|Ranibizumab|ranibizumab|mesh-list
56098939|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098940|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
56098941|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
56098942|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890542|NCT05025423|Venetoclax|venetoclax|mesh-list
56560920|NCT00848497|Hormones|hormones|mesh-ancestor
56560921|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560922|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560923|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56560924|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560925|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
56560926|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
56560927|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56560928|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56560929|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560930|NCT00848497|Urological Agents|urological agents|mesh-ancestor
56560931|NCT02763592|Lidocaine|lidocaine|mesh-list
56560932|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
56560933|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
56560934|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560935|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560936|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
56560937|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560938|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56560939|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56560940|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56560941|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560942|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560943|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
56560944|NCT01185782|Hormones|hormones|mesh-list
56560945|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56560946|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560947|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560963|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
56560964|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
56560965|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560966|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560967|NCT00699361|Pantoprazole|pantoprazole|mesh-list
56560968|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56560969|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56560970|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56560971|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56560972|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560973|NCT01185704|Cetrorelix|cetrorelix|mesh-list
56560974|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56560975|NCT01185704|Hormones|hormones|mesh-list
56560976|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56560977|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56560978|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560979|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56560980|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
56560981|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56560982|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
56560983|NCT01128959|Carbamazepine|carbamazepine|mesh-list
56560984|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
56560985|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
56560986|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56560987|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56560988|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56560989|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56560990|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56560991|NCT01128959|Analgesics|analgesics|mesh-ancestor
56560992|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
56560993|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56560994|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56560995|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56560996|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56560997|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56098965|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098966|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56560998|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56560999|NCT04119739|Ibuprofen|ibuprofen|mesh-list
56561000|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56561001|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56561002|NCT04119739|Analgesics|analgesics|mesh-ancestor
56561003|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
56561004|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561005|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561006|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56561007|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561008|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56561009|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561010|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561011|NCT00859573|Modafinil|modafinil|mesh-list
56561012|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56561013|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561014|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56561015|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56561016|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56561017|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561018|NCT02758444|Micronutrients|micronutrients|mesh-list
56561019|NCT02758444|Trace Elements|trace elements|mesh-list
56561048|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56561049|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56561050|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561051|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56561052|NCT02758366|Doxorubicin|doxorubicin|mesh-list
56561053|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56561054|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561055|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56561056|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56561057|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561058|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561059|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
56561060|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56561061|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
56561062|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561063|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561064|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56358653|NCT00272935|Estrogens|estrogens|mesh-list
56561065|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
56561066|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561067|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561068|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56561069|NCT00637403|Megestrol|megestrol|mesh-list
56561070|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
56561071|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56561072|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56561083|NCT01185080|Adenosine|adenosine|mesh-list
56561092|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
56561093|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561094|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561095|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
56309455|NCT00398515|Sirolimus|sirolimus|mesh-list
56561096|NCT05114837|Fludarabine|fludarabine|mesh-list
56561097|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56561098|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
56561099|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561100|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561101|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56561102|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
56561103|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561104|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561105|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56561106|NCT01181102|Enoxaparin|enoxaparin|mesh-list
56561107|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
56561108|NCT01181102|Edoxaban|edoxaban|mesh-list
56561109|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
56561147|NCT02760316|Protective Agents|protective agents|mesh-ancestor
56561148|NCT00858403|Dasatinib|dasatinib|mesh-list
56561149|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561150|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56561151|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561152|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561153|NCT02760472|SMOFlipid|smoflipid|mesh-list
56561154|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56561155|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56561156|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56561157|NCT00858247|Vitamin D|vitamin d|mesh-list
56561158|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
56561159|NCT00858247|Vitamins|vitamins|mesh-ancestor
56561160|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
56561161|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561162|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56561163|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56561164|NCT04480918|Ketamine|ketamine|mesh-list
56561165|NCT04480918|Esketamine|esketamine|mesh-list
56561204|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
56561205|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56561206|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56561207|NCT02757196|Prednisolone|prednisolone|mesh-list
56561208|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
56561209|NCT02757196|Rituximab|rituximab|mesh-list
56561210|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56561211|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
56561223|NCT02757196|Hormones|hormones|mesh-ancestor
56561270|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
56561271|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56561272|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56561273|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56561274|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56561275|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
56561276|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561277|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561278|NCT02759614|Bevacizumab|bevacizumab|mesh-list
56561279|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56561280|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56561281|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561282|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56561283|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56561284|NCT02759614|Growth Substances|growth substances|mesh-ancestor
56561285|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561290|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
56561327|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
56561328|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
56561329|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561330|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561331|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
56561332|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561333|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56561334|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56561335|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561336|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56561337|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
56561338|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56561339|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56561340|NCT02758990|Vitamin D|vitamin d|mesh-list
56561341|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
56561342|NCT02758990|Vitamins|vitamins|mesh-list
56561343|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
56561344|NCT02758990|Vitamin E|vitamin e|mesh-list
56561387|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561388|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56561389|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
56561390|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56561391|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
56561392|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561393|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309758|NCT00398554|Prednisone|prednisone|mesh-list
56561394|NCT02758522|Insulin|insulin|mesh-list
56561453|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
56561454|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
56561455|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561456|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56561457|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56561458|NCT04220632|Protective Agents|protective agents|mesh-ancestor
56561459|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56561460|NCT00939627|Cetuximab|cetuximab|mesh-list
56561461|NCT00939627|Sorafenib|sorafenib|mesh-list
56561462|NCT00939627|Antibodies|antibodies|mesh-list
56561463|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
56561464|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56561465|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
56561466|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561467|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561468|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56561469|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561470|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561471|NCT05382741|Durvalumab|durvalumab|mesh-list
56561472|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56561473|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561474|NCT04220476|Letrozole|letrozole|mesh-list
56561475|NCT04220476|Palbociclib|palbociclib|mesh-list
56561506|NCT02695654|Analgesics|analgesics|mesh-ancestor
56358741|NCT00273520|Telithromycin|telithromycin|mesh-list
56561508|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561509|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561510|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56561511|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
56561512|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
56561513|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56561520|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
56561572|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
56561573|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
56561574|NCT05168566|Maleic acid|maleic acid|mesh-list
56561575|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561576|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561577|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
56561578|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56561579|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56561580|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561581|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
56561636|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56561637|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56561638|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56561639|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56561640|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561641|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
56561642|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561643|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561644|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56561647|NCT01086384|Xhance|xhance|mesh-list
56561703|NCT04799626|Renal Agents|renal agents|mesh-ancestor
56561704|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56561705|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56561706|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56561707|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561708|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561709|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56561710|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56561711|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56561712|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56561713|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56561714|NCT00636064|Parecoxib|parecoxib|mesh-list
56561715|NCT00636064|Valdecoxib|valdecoxib|mesh-list
56561716|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56561717|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56561718|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561719|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561720|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56561721|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56561722|NCT00636064|Analgesics|analgesics|mesh-ancestor
56561723|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
56561724|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561725|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561726|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56561727|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56561728|NCT02751034|Lidocaine|lidocaine|mesh-list
56561729|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
56561730|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
56561731|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561732|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561733|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
56561734|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561735|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56561736|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56561740|NCT04217668|Isosorbide|isosorbide|mesh-list
56561741|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56561742|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56561743|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56561744|NCT04217668|Diuretics|diuretics|mesh-ancestor
56561745|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
56561746|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561747|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
56561748|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56561749|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561750|NCT01127165|Zonisamide|zonisamide|mesh-list
56561806|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56561807|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56561808|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
56561809|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56561810|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56561811|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56561812|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56561813|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
56561814|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561815|NCT00941655|Leucovorin|leucovorin|mesh-list
56561816|NCT00941655|Fluorouracil|fluorouracil|mesh-list
56561817|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
56561818|NCT00941655|Irinotecan|irinotecan|mesh-list
56561832|NCT00941655|Vitamins|vitamins|mesh-ancestor
56561870|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
56561871|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56561872|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56561873|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56561874|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
56561875|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561876|NCT04801368|Anesthetics|anesthetics|mesh-list
56561877|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
56561878|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56561879|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561880|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
56561881|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561882|NCT00607503|Terbutaline|terbutaline|mesh-list
56561883|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56561884|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
56561887|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56561927|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56561928|NCT03974152|Nicotine|nicotine|mesh-list
56561929|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56561930|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
56561931|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56561932|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561933|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56561934|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56561935|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
56561936|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56561937|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56561992|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
56561993|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56561994|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
56561995|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56561996|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56561997|NCT04745910|Rasburicase|rasburicase|mesh-list
56561998|NCT04745910|Uric Acid|uric acid|mesh-list
56561999|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
56562000|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562001|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
56562003|NCT04745910|Protective Agents|protective agents|mesh-ancestor
56562059|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562060|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562061|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56562062|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
56562063|NCT02695732|Protective Agents|protective agents|mesh-ancestor
56562064|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56562065|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56562066|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56562067|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
56562070|NCT02751268|Ropivacaine|ropivacaine|mesh-list
56562124|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56562125|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56562126|NCT02748304|Analgesics|analgesics|mesh-ancestor
56562127|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
56562128|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562129|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562130|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56562131|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562132|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56562133|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56562134|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562135|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56562136|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56562194|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562195|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56562196|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562197|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
56562198|NCT02744638|Metronidazole|metronidazole|mesh-list
56562199|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562200|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56562201|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56562202|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56562203|NCT02740894|Gefitinib|gefitinib|mesh-list
56562204|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562209|NCT00857389|Busulfan|busulfan|mesh-list
56562257|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
56562258|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
56562259|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56562260|NCT02874768|Analgesics|analgesics|mesh-ancestor
56562261|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
56562262|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562263|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56562264|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56562265|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56562266|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
56562267|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562268|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562269|NCT00857233|Memantine|memantine|mesh-list
56562270|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56562271|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56562272|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
56562273|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562274|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562275|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562313|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562314|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562315|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56562316|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
56562317|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
56562318|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56562319|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
56562320|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56562321|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
56562322|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562323|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
56562324|NCT02739880|Protective Agents|protective agents|mesh-ancestor
56562325|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
56562326|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56562327|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56562328|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56562329|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56562330|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562331|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
56562332|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562333|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562334|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56562335|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56562336|NCT00856375|Irinotecan|irinotecan|mesh-list
56562337|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
56562338|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56562339|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56562340|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562341|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562342|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562343|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56562354|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
56562355|NCT01070784|Hormones|hormones|mesh-ancestor
56562356|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562357|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56562358|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56562359|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56562360|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
56562361|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562362|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562363|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
56562364|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56562365|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562366|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56562367|NCT00837577|Voglibose|voglibose|mesh-list
56562368|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56562369|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562370|NCT00837577|Incretins|incretins|mesh-ancestor
56562371|NCT00837577|Hormones|hormones|mesh-ancestor
56562372|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562373|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56562374|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
56562375|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562376|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310743|NCT00070057|Celecoxib|celecoxib|mesh-list
56562377|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56562379|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
56562380|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562381|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56562390|NCT00848107|Treprostinil|treprostinil|mesh-list
56562398|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562399|NCT04030741|Metronidazole|metronidazole|mesh-list
56562400|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562401|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56562402|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56562403|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56562404|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56562405|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56562406|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
56562464|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
56562465|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562466|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562468|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
56562469|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562470|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
56562471|NCT01046136|Guaifenesin|guaifenesin|mesh-list
56562472|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56562473|NCT01046136|Expectorants|expectorants|mesh-ancestor
56562474|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
56562475|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56562476|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56562477|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
56562478|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562479|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562480|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562521|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56562522|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
56562523|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
56562524|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
56562525|NCT02738632|Amlodipine|amlodipine|mesh-list
56310928|NCT00071266|Niacin|niacin|mesh-list
56562526|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56562527|NCT02738632|Telmisartan|telmisartan|mesh-list
56562528|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56562529|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56562530|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56562531|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56562532|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562536|NCT02738632|Diuretics|diuretics|mesh-ancestor
56562580|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
56562581|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562582|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56562583|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56562584|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562585|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562586|NCT01070316|Everolimus|everolimus|mesh-list
56562587|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562588|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562589|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
56562590|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562591|NCT02737774|Carboplatin|carboplatin|mesh-list
56562643|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56562644|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
56562645|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562646|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562647|NCT02737228|Antiviral Agents|antiviral agents|mesh-ancestor
56562648|NCT02737228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562649|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562650|NCT02737228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56562651|NCT02737228|Immunologic Factors|immunologic factors|mesh-ancestor
56562652|NCT02737228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562653|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56562654|NCT01126541|Rituximab|rituximab|mesh-list
56562655|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56562656|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562657|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
56562658|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562659|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562660|NCT02737150|Anesthetics|anesthetics|mesh-list
56562661|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56562662|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562663|NCT02735356|Itraconazole|itraconazole|mesh-list
56562664|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
56562692|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
56562693|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56562694|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
56562695|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56562696|NCT04278898|Expectorants|expectorants|mesh-ancestor
56562697|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
56562698|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56562699|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
56562700|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562701|NCT04278898|Protective Agents|protective agents|mesh-ancestor
56562702|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562703|NCT04278898|Antidotes|antidotes|mesh-ancestor
56562704|NCT00637559|Esomeprazole|esomeprazole|mesh-list
56562705|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56562706|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56562707|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56562708|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562709|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562749|NCT00847405|Sumatriptan|sumatriptan|mesh-list
56562750|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56562751|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56562752|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56562753|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
56562754|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56562755|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562756|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562757|NCT02731846|Fluticasone|fluticasone|mesh-list
56562758|NCT02731846|Xhance|xhance|mesh-list
56562759|NCT02731846|Albuterol|albuterol|mesh-list
56562760|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56562777|NCT04248712|Loratadine|loratadine|mesh-list
56562811|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56562812|NCT02731378|Iron|iron|mesh-list
56562813|NCT02731378|Dextrans|dextrans|mesh-list
56562814|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
56562815|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
56562816|NCT02731378|Trace Elements|trace elements|mesh-ancestor
56562817|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
56562818|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562819|NCT02731378|Hematinics|hematinics|mesh-ancestor
56562820|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
56562821|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
56562822|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
56562823|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56562824|NCT02731534|Hematinics|hematinics|mesh-ancestor
56562825|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
56562826|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
56562827|NCT02734420|Coagulants|coagulants|mesh-ancestor
56562828|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
56562829|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562830|NCT00704275|Cyclosporine|cyclosporine|mesh-list
56562870|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56562871|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56562872|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56562873|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56562874|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56562875|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562876|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56562877|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
56562878|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
56562879|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
56562937|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56562938|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56562939|NCT00855439|Exenatide|exenatide|mesh-list
56562940|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56562941|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56562942|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56562943|NCT00855439|Incretins|incretins|mesh-ancestor
56562944|NCT00855439|Hormones|hormones|mesh-ancestor
56562945|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56562946|NCT01064856|Adalimumab|adalimumab|mesh-list
56562947|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56562948|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56562949|NCT02730442|Fluconazole|fluconazole|mesh-list
56562950|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
56562951|NCT02730442|Clotrimazole|clotrimazole|mesh-list
56562952|NCT02730442|Miconazole|miconazole|mesh-list
56562997|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56562998|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56562999|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56563000|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
56563001|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563002|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
56563003|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
56563004|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56563005|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
56563006|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
56563007|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56563008|NCT01042392|Ramipril|ramipril|mesh-list
56563009|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56563010|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
56563011|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563012|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563013|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56563014|NCT00704665|Methocarbamol|methocarbamol|mesh-list
56563015|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56563016|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563017|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56563018|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563019|NCT00913315|Tamsulosin|tamsulosin|mesh-list
56563020|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56563021|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56563022|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56563023|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56563024|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
56563025|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563026|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563032|NCT00701857|Pemetrexed|pemetrexed|mesh-list
56563039|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56563040|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563041|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
56563042|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563043|NCT02733250|Paclitaxel|paclitaxel|mesh-list
56563044|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
56563045|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56563046|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563047|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
56563048|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
56563049|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
56563050|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563051|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56563052|NCT03188068|Sirolimus|sirolimus|mesh-list
56563053|NCT03188068|Prednisolone|prednisolone|mesh-list
56358974|NCT00108420|Prazosin|prazosin|mesh-list
56563054|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56563055|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563056|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56563057|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563058|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
56563059|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563060|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
56563061|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563062|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56563063|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
56563064|NCT03188068|Hormones|hormones|mesh-ancestor
56563065|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563066|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56563067|NCT01064310|Sunitinib|sunitinib|mesh-list
56563068|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563080|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563081|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563082|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56563083|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56563084|NCT02726854|Apatinib|apatinib|mesh-list
56563085|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563086|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56563087|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563088|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563089|NCT02728492|Gemcitabine|gemcitabine|mesh-list
56563090|NCT02728492|Paclitaxel|paclitaxel|mesh-list
56563091|NCT02728492|Carboplatin|carboplatin|mesh-list
56563142|NCT00627432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563143|NCT00627432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563144|NCT00627432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563145|NCT00627432|Immunologic Factors|immunologic factors|mesh-ancestor
56563146|NCT00627432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563147|NCT02727712|Anesthetics|anesthetics|mesh-list
56563148|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563149|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563150|NCT01042236|Fesoterodine|fesoterodine|mesh-list
56563151|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56563152|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56563153|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
56563154|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563204|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563205|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56563206|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56563207|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563208|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56563209|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56563210|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
56563211|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
56563212|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563213|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
56563214|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56563216|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56563267|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563268|NCT02719132|Metformin|metformin|mesh-list
56563269|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
56563270|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56563271|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563272|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56563273|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563274|NCT02718820|Docetaxel|docetaxel|mesh-list
56311648|NCT00075595|Vitamins|vitamins|mesh-ancestor
56563275|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
56563276|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563277|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
56563278|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
56563279|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
56563280|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563281|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56563282|NCT02718976|Lidocaine|lidocaine|mesh-list
56563283|NCT02718976|Epinephrine|epinephrine|mesh-list
56563284|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56563321|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56563322|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
56563323|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563324|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563325|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
56563326|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563327|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563328|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
56563329|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563330|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
56563331|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
56563332|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
56563383|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563384|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563385|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
56563386|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56563387|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563388|NCT04964284|Hormones|hormones|mesh-list
56563390|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563450|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563451|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56563452|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
56563453|NCT02715232|Lynestrenol|lynestrenol|mesh-list
56563454|NCT02715232|Estradiol|estradiol|mesh-list
56563455|NCT02715232|Testosterone|testosterone|mesh-list
56563456|NCT02715232|Cyproterone|cyproterone|mesh-list
56563457|NCT02715232|Estrogens|estrogens|mesh-ancestor
56563458|NCT02715232|Hormones|hormones|mesh-ancestor
56563459|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563460|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563461|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56563462|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
56563463|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56563513|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56563514|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563515|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56563516|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56563517|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
56563518|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563519|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56563520|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56563521|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563522|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56563523|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56563524|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56563525|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563526|NCT00636766|Hormones|hormones|mesh-ancestor
56563527|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563528|NCT03998176|Tenofovir|tenofovir|mesh-list
56563529|NCT03998176|Emtricitabine|emtricitabine|mesh-list
56563530|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56563531|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
56563532|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563533|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56563534|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56563535|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563536|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563559|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563560|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56563561|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56563562|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
56563563|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563564|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
56563565|NCT00611416|Protective Agents|protective agents|mesh-ancestor
56563566|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56563567|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56563568|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563569|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56563570|NCT02712658|Terbutaline|terbutaline|mesh-list
56563571|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56563572|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
56563573|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563574|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563575|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56563576|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
56563578|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
56563579|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56563580|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56563581|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56563611|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56563612|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56563613|NCT02712346|Ambrisentan|ambrisentan|mesh-list
56563614|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56563615|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
56563616|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563617|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
56563618|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563619|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563676|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
56563677|NCT02710396|Pemetrexed|pemetrexed|mesh-list
56563678|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56563679|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563680|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
56563681|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
56563682|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
56563683|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563684|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56563685|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563686|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56563687|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56563688|NCT02710162|Capsaicin|capsaicin|mesh-list
56563689|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
56563690|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
56563691|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
56563692|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563693|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563694|NCT00611728|Irinotecan|irinotecan|mesh-list
56563695|NCT00611728|Sunitinib|sunitinib|mesh-list
56563696|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56563697|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56563698|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563699|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563700|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563701|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56563703|NCT00611728|Growth Substances|growth substances|mesh-ancestor
56563723|NCT04189666|Protective Agents|protective agents|mesh-ancestor
56563724|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563725|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563726|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56563727|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563728|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
56563729|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56563730|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56563731|NCT03944512|Pravastatin|pravastatin|mesh-list
56563732|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56563733|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56563734|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
56563735|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563736|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56563737|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56563738|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563739|NCT00937521|Antipyretics|antipyretics|mesh-list
56563740|NCT00937521|Vaccines|vaccines|mesh-list
56563741|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
56563742|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563743|NCT02709382|Tazobactam|tazobactam|mesh-list
56563744|NCT02709382|Cefepime|cefepime|mesh-list
56563745|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56563746|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563747|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56563748|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563749|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563771|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563772|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563773|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56563774|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56563775|NCT00606099|Adefovir|adefovir|mesh-list
56563776|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56563777|NCT00606099|Telbivudine|telbivudine|mesh-list
56563778|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
56563779|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56563780|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56563781|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56563782|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56563783|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563784|NCT00935883|Eculizumab|eculizumab|mesh-list
56563785|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56563786|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56563787|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
56563788|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563789|NCT02708446|Misoprostol|misoprostol|mesh-list
56563790|NCT02708446|Mifepristone|mifepristone|mesh-list
56563791|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56563792|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
56563793|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56563794|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312170|NCT00079105|Hormones|hormones|mesh-ancestor
56563795|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56563796|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56563798|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56563799|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56563800|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56563801|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56563802|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
56563803|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56563804|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56563805|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
56098967|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098968|NCT01663285|Gemcitabine|gemcitabine|mesh-list
56098969|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56563806|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56563807|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
56563808|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56563809|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56563810|NCT05378919|Folic Acid|folic acid|mesh-list
56563811|NCT05378919|Leucovorin|leucovorin|mesh-list
56563812|NCT05378919|Fluorouracil|fluorouracil|mesh-list
56563813|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
56563814|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
56563815|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
56563816|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56563871|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563872|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56563873|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56563874|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56563875|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
56563876|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56563877|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56563881|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56563938|NCT05265442|Methadone|methadone|mesh-list
56563939|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56563940|NCT05265442|Narcotics|narcotics|mesh-ancestor
56563941|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56563942|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563943|NCT05265442|Analgesics|analgesics|mesh-ancestor
56563944|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
56312317|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
56563945|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56563946|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
56563947|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56563949|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
56563950|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56563951|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56563952|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
56563953|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56563997|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56563998|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
56563999|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564000|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564001|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
56564002|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564003|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56564004|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56564005|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
56564006|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564007|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564008|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56564009|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564010|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564011|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56564012|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
56564013|NCT05263882|Gemcitabine|gemcitabine|mesh-list
56564014|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56564015|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
56564052|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564053|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564054|NCT05380245|Clarithromycin|clarithromycin|mesh-list
56564055|NCT05380245|Voriconazole|voriconazole|mesh-list
56564056|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564057|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564058|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56564059|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564060|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564115|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564116|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564117|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564118|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564119|NCT00605397|Trastuzumab|trastuzumab|mesh-list
56564120|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56564121|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564122|NCT00625547|Levodopa|levodopa|mesh-list
56564123|NCT00625547|Cabergoline|cabergoline|mesh-list
56564124|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56564125|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56564126|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
56564127|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480205|NCT02920502|Vitamins|vitamins|mesh-ancestor
56564174|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
56564175|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564176|NCT01123889|Lidocaine|lidocaine|mesh-list
56564177|NCT01123889|Ropivacaine|ropivacaine|mesh-list
56564178|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
56564179|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
56480206|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
56564180|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564181|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564182|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
56564183|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564184|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56564185|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56564186|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56564187|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56564188|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564189|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56564190|NCT00606957|Vitamin D|vitamin d|mesh-list
56564191|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
56564192|NCT00606957|Vitamins|vitamins|mesh-ancestor
56564193|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
56564194|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564195|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56564196|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56564197|NCT00934947|Propranolol|propranolol|mesh-list
56564198|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56564199|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56564200|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
56564201|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564202|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564203|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564204|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56564213|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56564214|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564215|NCT04189198|Bupivacaine|bupivacaine|mesh-list
56564216|NCT04189198|Carticaine|carticaine|mesh-list
56564217|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
56564218|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
56564219|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564220|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564221|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
56564222|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564223|NCT00608361|Dasatinib|dasatinib|mesh-list
56564224|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564225|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564274|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564275|NCT00625859|Bupropion|bupropion|mesh-list
56564276|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56564277|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
56564278|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56564279|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56564280|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56564281|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56564282|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564283|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
56564284|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564285|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564286|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56564287|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56564288|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564289|NCT02691195|Ropivacaine|ropivacaine|mesh-list
56564290|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
56564291|NCT02691195|Anesthetics|anesthetics|mesh-list
56564292|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564293|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564294|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
56564323|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564324|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56564325|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56564326|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56564327|NCT01119287|Analgesics|analgesics|mesh-ancestor
56564328|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
56564329|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564330|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56564331|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56564332|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56564333|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
56564337|NCT01110707|Hormones|hormones|mesh-list
56564385|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56564386|NCT04862962|Ezetimibe|ezetimibe|mesh-list
56564387|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56564388|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56312766|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
56564389|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
56564390|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564391|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56564392|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56564393|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564394|NCT01118975|Lapatinib|lapatinib|mesh-list
56564455|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56564456|NCT02693392|Metformin|metformin|mesh-list
56564457|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56564458|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564459|NCT04175626|Sirolimus|sirolimus|mesh-list
56564460|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564461|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564462|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56312876|NCT00083785|Talaporfin|talaporfin|mesh-list
56564463|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564513|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56564514|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56564515|NCT04120870|Ketamine|ketamine|mesh-list
56564516|NCT04120870|Etomidate|etomidate|mesh-list
56564517|NCT04120870|Analgesics|analgesics|mesh-ancestor
56564518|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
56564519|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564520|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564521|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56564522|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56564523|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
56564524|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
56564525|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564526|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56564527|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56564528|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564529|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564530|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56564531|NCT03747562|Gabapentin|gabapentin|mesh-list
56564532|NCT03747562|Analgesics|analgesics|mesh-ancestor
56564533|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
56359284|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56564534|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564535|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564536|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
56564537|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56564538|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56564539|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564540|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56564541|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56564542|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56564543|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564544|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564545|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
56564552|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56564553|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56564554|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564555|NCT03747484|Antiviral Agents|antiviral agents|mesh-ancestor
56564556|NCT03747484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564557|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
56564558|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564559|NCT01109849|Methylphenidate|methylphenidate|mesh-list
56564560|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
56564561|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564562|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56564563|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56564564|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56564565|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564566|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
56564567|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564607|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56564608|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56564609|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564610|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
56564611|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564613|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56564614|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56564615|NCT02881619|Analgesics|analgesics|mesh-ancestor
56564616|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
56564617|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564618|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564619|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56564620|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564633|NCT02882087|Methotrexate|methotrexate|mesh-list
56564665|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
56564666|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564667|NCT05297682|Propofol|propofol|mesh-list
56564668|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
56564669|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564670|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564671|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56564672|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56564673|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
56564674|NCT01108055|Paclitaxel|paclitaxel|mesh-list
56564675|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56564676|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564677|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
56564678|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
56564679|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
56564680|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564681|NCT00609375|Cefepime|cefepime|mesh-list
56564682|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56564683|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313068|NCT03151239|Niacinamide|niacinamide|mesh-list
56564684|NCT01107899|Clopidogrel|clopidogrel|mesh-list
56564685|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56564686|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56564687|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56564688|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56564689|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56564712|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56564713|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56564714|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
56564715|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564716|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56564717|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56359318|NCT00109161|Antibodies|antibodies|mesh-list
56564718|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564779|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56564780|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56564781|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56564782|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56564783|NCT00613288|Testosterone|testosterone|mesh-list
56564784|NCT00613288|Androgens|androgens|mesh-ancestor
56564786|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56564787|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564788|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
56564789|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56564790|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
56564791|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564792|NCT03711838|Expectorants|expectorants|mesh-ancestor
56564793|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
56564794|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56564795|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
56564796|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564797|NCT03711838|Protective Agents|protective agents|mesh-ancestor
56564798|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564799|NCT03711838|Antidotes|antidotes|mesh-ancestor
56564800|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
56564801|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
56564802|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56564803|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56564804|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564805|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564806|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564807|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564827|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
56564828|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56564829|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56564830|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56564831|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
56564832|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564833|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564834|NCT03615508|Protective Agents|protective agents|mesh-ancestor
56564835|NCT02880995|Amisulpride|amisulpride|mesh-list
56564836|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56564837|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56564891|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56564892|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56564893|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564894|NCT05244538|Remifentanil|remifentanil|mesh-list
56564895|NCT05244538|Propofol|propofol|mesh-list
56564896|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56564897|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56564898|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564899|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56564900|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
56564901|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
56564902|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56564903|NCT05244538|Narcotics|narcotics|mesh-ancestor
56564904|NCT05244538|Analgesics|analgesics|mesh-ancestor
56564905|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
56564906|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56564907|NCT03638128|Denosumab|denosumab|mesh-list
56564908|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56564909|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564910|NCT05042440|Factor VIII|factor viii|mesh-list
56564911|NCT05042440|BAX 855|bax 855|mesh-list
56564912|NCT05042440|Coagulants|coagulants|mesh-ancestor
56564913|NCT03481660|Aflibercept|aflibercept|mesh-list
56564914|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56564915|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56564916|NCT03481660|Growth Substances|growth substances|mesh-ancestor
56564917|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564918|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
56564919|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564920|NCT05345236|Aflibercept|aflibercept|mesh-list
56564921|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56564922|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56564923|NCT05345236|Growth Substances|growth substances|mesh-ancestor
56101253|NCT00001135|Nevirapine|nevirapine|mesh-list
56098970|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098971|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
56098972|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098973|NCT01663285|Antiviral Agents|antiviral agents|mesh-ancestor
56098974|NCT01663285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098975|NCT01663285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098976|NCT01663285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098977|NCT01663285|Immunologic Factors|immunologic factors|mesh-ancestor
56098978|NCT01663285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564924|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564925|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
56564926|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564927|NCT03017872|Ritonavir|ritonavir|mesh-list
56564928|NCT03017872|Darunavir|darunavir|mesh-list
56564929|NCT03017872|Dolutegravir|dolutegravir|mesh-list
56564930|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56564931|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56564932|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
56564933|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56564934|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564935|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56564936|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56564937|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
56564938|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56564939|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56564940|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56564941|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56564942|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56564943|NCT02692534|Cocaine|cocaine|mesh-list
56564944|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
56564957|NCT04409860|Paclitaxel|paclitaxel|mesh-list
56564977|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564978|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56564979|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56564980|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
56564981|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56564982|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
56564983|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564984|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56564985|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56564986|NCT04142086|Vaccines|vaccines|mesh-list
56564987|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
56564988|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56564989|NCT03664882|Fexofenadine|fexofenadine|mesh-list
56564990|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56564991|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56564992|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56564993|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
56564994|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
56564995|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56564996|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56564998|NCT03951142|Losartan|losartan|mesh-list
56565028|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565029|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565030|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56565031|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
56565032|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565033|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565034|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56565035|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56565036|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
56565037|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56565038|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56565039|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
56565040|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
56565041|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565042|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56565043|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56565044|NCT00932373|Trastuzumab|trastuzumab|mesh-list
56565045|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56565046|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56565047|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565048|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
56565049|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
56565050|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
56565051|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565052|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
56565053|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56565054|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
56565055|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565056|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
56565057|NCT04265001|Protective Agents|protective agents|mesh-ancestor
56565058|NCT00608595|Celecoxib|celecoxib|mesh-list
56565059|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56565060|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565061|NCT00608595|Analgesics|analgesics|mesh-ancestor
56565066|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565067|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56565068|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56565069|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565070|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565072|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56565073|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56565074|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565075|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56565076|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565077|NCT01055496|Gemcitabine|gemcitabine|mesh-list
56565078|NCT01055496|Dexamethasone|dexamethasone|mesh-list
56565079|NCT01055496|Prednisone|prednisone|mesh-list
56565080|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
56565081|NCT01055496|Rituximab|rituximab|mesh-list
56565123|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56565124|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565125|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56565126|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565127|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
56565128|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56565129|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56565130|NCT04262193|Suvorexant|suvorexant|mesh-list
56565131|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56565132|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56565133|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565134|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565138|NCT00609531|Citalopram|citalopram|mesh-list
56565185|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565186|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56565187|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56565188|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
56565189|NCT02704546|Methylphenidate|methylphenidate|mesh-list
56565190|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56565191|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565192|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56565193|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56565194|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565195|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565196|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
56565197|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56565198|NCT01032018|Bupropion|bupropion|mesh-list
56565244|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
56565245|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
56565246|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56565247|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565248|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
56565249|NCT00608673|Hormones|hormones|mesh-ancestor
56565250|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565251|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565252|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56565253|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
56565254|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56565256|NCT00608673|Analgesics|analgesics|mesh-ancestor
56565305|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565306|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565307|NCT00627250|Analgesics|analgesics|mesh-ancestor
56565308|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
56565309|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565310|NCT04300374|Anesthetics|anesthetics|mesh-list
56565311|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565312|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565313|NCT02703376|Prednisone|prednisone|mesh-list
56565314|NCT02703376|Prednisolone|prednisolone|mesh-list
56565315|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565316|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
56565317|NCT02703376|Hormones|hormones|mesh-ancestor
56565318|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565319|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565322|NCT00610077|Letrozole|letrozole|mesh-list
56565363|NCT03172780|Analgesics|analgesics|mesh-ancestor
56565364|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
56565365|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565366|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565367|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565368|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565369|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56565370|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565371|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565372|NCT05011617|Anesthetics|anesthetics|mesh-list
56565373|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565374|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565375|NCT03169972|Factor VIII|factor viii|mesh-list
56565376|NCT03169972|BAX 855|bax 855|mesh-list
56565377|NCT03169972|Coagulants|coagulants|mesh-ancestor
56565378|NCT00926367|Clindamycin|clindamycin|mesh-list
56565379|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
56565380|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
56565381|NCT00926367|Adapalene|adapalene|mesh-list
56565382|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56565383|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56565397|NCT04261023|Abatacept|abatacept|mesh-list
56565418|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565419|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565420|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56565421|NCT00926289|Telmisartan|telmisartan|mesh-list
56565422|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56565423|NCT00926289|Diuretics|diuretics|mesh-ancestor
56565424|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
56565425|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565426|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56565427|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56313818|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565428|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565476|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565477|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56565478|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56565479|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565480|NCT01114373|Melatonin|melatonin|mesh-list
56565481|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
56565482|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565483|NCT01114373|Protective Agents|protective agents|mesh-ancestor
56565484|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565485|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565486|NCT00925899|Melatonin|melatonin|mesh-list
56565487|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
56565488|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565489|NCT00925899|Protective Agents|protective agents|mesh-ancestor
56565490|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565533|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
56565534|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56565535|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56565536|NCT01030458|Diuretics|diuretics|mesh-ancestor
56565537|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
56565538|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56565539|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
56565540|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
56565541|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565542|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56565548|NCT02702674|Oxytocin|oxytocin|mesh-list
56565597|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565598|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56565599|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565600|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
56565601|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565602|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56565603|NCT00627666|Antidotes|antidotes|mesh-ancestor
56565604|NCT00627666|Protective Agents|protective agents|mesh-ancestor
56565605|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
56565664|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56565665|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565666|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565667|NCT04214938|Lidocaine|lidocaine|mesh-list
56565668|NCT04214938|Xylometazoline|xylometazoline|mesh-list
56565669|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
56565670|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
56565671|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565672|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565673|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
56565683|NCT00615160|Dacarbazine|dacarbazine|mesh-list
56565728|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
56565729|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565730|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565731|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
56565732|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565733|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56565734|NCT02698228|Narcotics|narcotics|mesh-ancestor
56565735|NCT02698228|Analgesics|analgesics|mesh-ancestor
56565736|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
56565737|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56565738|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56565739|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565740|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
56565741|NCT02702128|Coagulants|coagulants|mesh-ancestor
56565742|NCT00610545|Atorvastatin|atorvastatin|mesh-list
56565743|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56565744|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56565745|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
56565746|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565747|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56565748|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56565749|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565750|NCT00193414|Gemcitabine|gemcitabine|mesh-list
56565751|NCT00193414|Pemetrexed|pemetrexed|mesh-list
56565752|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56565753|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
56565777|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56565778|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56565779|NCT04260711|Analgesics|analgesics|mesh-ancestor
56565780|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
56565781|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565782|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565783|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
56565784|NCT00610623|Azithromycin|azithromycin|mesh-list
56565785|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56565786|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56565787|NCT02697838|Paclitaxel|paclitaxel|mesh-list
56565788|NCT02697838|Apatinib|apatinib|mesh-list
56565789|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56565790|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565791|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
56565792|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
56565793|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
56565794|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565795|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56565796|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565797|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
56565798|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56565799|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565800|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
56565801|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565802|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565803|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56565824|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565825|NCT02705872|Sufentanil|sufentanil|mesh-list
56565826|NCT02705872|Dsuvia|dsuvia|mesh-list
56565827|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
56565828|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56565829|NCT02705872|Narcotics|narcotics|mesh-ancestor
56565830|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565831|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565832|NCT02705872|Analgesics|analgesics|mesh-ancestor
56565833|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
56565834|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565835|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56565836|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56565888|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
56565889|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
56565890|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56565891|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565892|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
56565893|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56565894|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56565895|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56565896|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56565897|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56565954|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56565955|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56565956|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56565957|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56565958|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565959|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56565960|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
56565961|NCT02700022|Hormones|hormones|mesh-ancestor
56565962|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56565963|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56565964|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56565965|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
56565966|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
56565967|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
56565968|NCT02699710|Folic Acid|folic acid|mesh-list
56565969|NCT02699710|Methotrexate|methotrexate|mesh-list
56565970|NCT02699710|Rabeprazole|rabeprazole|mesh-list
56565971|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56565972|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
56565973|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56565974|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56565975|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56565976|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
56565977|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56565978|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56565979|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56565980|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56565981|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56565982|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56565983|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
56565984|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56565985|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56565986|NCT02699710|Hematinics|hematinics|mesh-ancestor
56565987|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
56565988|NCT02699710|Vitamins|vitamins|mesh-ancestor
56565994|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
56565995|NCT04214626|Rituximab|rituximab|mesh-list
56565996|NCT04214626|Methotrexate|methotrexate|mesh-list
56565997|NCT04214626|Vincristine|vincristine|mesh-list
56565998|NCT04214626|Lenalidomide|lenalidomide|mesh-list
56565999|NCT04214626|Epirubicin|epirubicin|mesh-list
56566000|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56566001|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
56566002|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566003|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566004|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56566005|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
56566006|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566007|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566008|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56566009|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56566010|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566011|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
56566012|NCT04214626|Hormones|hormones|mesh-ancestor
56566013|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566014|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56566015|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56566016|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
56566017|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56566018|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56566019|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
56566020|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
56566021|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566022|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56566023|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56566024|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56566025|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56566026|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56566035|NCT03140488|Oxytocin|oxytocin|mesh-list
56566036|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
56566037|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56566038|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566039|NCT00616408|Octreotide|octreotide|mesh-list
56566040|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56566041|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56566042|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566043|NCT05323786|Anesthetics|anesthetics|mesh-list
56566100|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56566101|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
56566102|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566103|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566104|NCT01027650|Dexamethasone|dexamethasone|mesh-list
56566105|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566106|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
56566107|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
56566108|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566109|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566110|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56566112|NCT01027650|Hormones|hormones|mesh-ancestor
56566113|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566114|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56566115|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566160|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
56566161|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
56566162|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56566163|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56566164|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566165|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56566166|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566167|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566168|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
56566169|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56566170|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566171|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566172|NCT00627744|Incretins|incretins|mesh-ancestor
56566173|NCT00627744|Hormones|hormones|mesh-ancestor
56566174|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566175|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56566176|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
56566177|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566178|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566179|NCT01105091|Epoprostenol|epoprostenol|mesh-list
56566180|NCT01105091|Tezosentan|tezosentan|mesh-list
56566181|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56566183|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
56566184|NCT00628056|Perhexiline|perhexiline|mesh-list
56566211|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56566212|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56566213|NCT04907721|Hormones|hormones|mesh-ancestor
56566214|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566215|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566216|NCT04907721|Incretins|incretins|mesh-ancestor
56566217|NCT04907019|Rifampin|rifampin|mesh-list
56566218|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56566219|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
56566220|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56566221|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566222|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
56566223|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56566224|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566225|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566226|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56566227|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56566228|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56566229|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56566230|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56566231|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56566232|NCT01022424|Tolvaptan|tolvaptan|mesh-list
56566235|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
56566259|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566260|NCT01104779|Cariprazine|cariprazine|mesh-list
56566261|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56566262|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56566263|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566264|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566265|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56566266|NCT00918957|Tobramycin|tobramycin|mesh-list
56566267|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56566268|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566269|NCT04308161|Vitamin D|vitamin d|mesh-list
56566270|NCT04308161|Miconazole|miconazole|mesh-list
56566271|NCT04308161|Vitamins|vitamins|mesh-ancestor
56566272|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
56566273|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566274|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56566275|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
56566276|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566277|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56566278|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56566279|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566280|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566281|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56566282|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
56566283|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566286|NCT04939467|Pirfenidone|pirfenidone|mesh-list
56566307|NCT00918879|Saxagliptin|saxagliptin|mesh-list
56566308|NCT00918879|Incretins|incretins|mesh-ancestor
56566309|NCT00918879|Hormones|hormones|mesh-ancestor
56566310|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566311|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566312|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56566313|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
56566314|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566315|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566316|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566317|NCT01026792|Sirolimus|sirolimus|mesh-list
56566318|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56566319|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566320|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56566321|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566322|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
56566323|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56566324|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
56566325|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566326|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
56566327|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56566328|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566329|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566330|NCT04300686|Adalimumab|adalimumab|mesh-list
56566331|NCT04300686|Antibodies|antibodies|mesh-list
56566332|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
56566333|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
56566334|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566336|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566351|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56566352|NCT01098461|Incretins|incretins|mesh-ancestor
56566353|NCT01098461|Hormones|hormones|mesh-ancestor
56566354|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566355|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566356|NCT01098305|Varenicline|varenicline|mesh-list
56566357|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56566358|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56566359|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
56566360|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566361|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566362|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566363|NCT00833833|Aspirin|aspirin|mesh-list
56566364|NCT00833833|Dexamethasone|dexamethasone|mesh-list
56566365|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
56566366|NCT00833833|Pomalidomide|pomalidomide|mesh-list
56566367|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56566368|NCT00833833|BB 1101|bb 1101|mesh-list
56566369|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566370|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
56566371|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
56566372|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566373|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566405|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
56566406|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56566407|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56566408|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566409|NCT00704743|Calpastatin|calpastatin|mesh-list
56566410|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56566411|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
56566412|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566413|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566414|NCT01097057|Plerixafor|plerixafor|mesh-list
56566415|NCT01097057|Rituximab|rituximab|mesh-list
56566416|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56566417|NCT01097057|Carboplatin|carboplatin|mesh-list
56566418|NCT01097057|Etoposide|etoposide|mesh-list
56566419|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
56566420|NCT01097057|Ifosfamide|ifosfamide|mesh-list
56566421|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
56566422|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
56566423|NCT01097057|Antibodies|antibodies|mesh-list
56566424|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
56566464|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56566465|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56566466|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566467|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56566468|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566469|NCT01014624|Clopidogrel|clopidogrel|mesh-list
56566470|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56566471|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56566472|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56566473|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56566474|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56566475|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
56566476|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566477|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566478|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566481|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56566482|NCT02872428|Valproic Acid|valproic acid|mesh-list
56566483|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
56566484|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566485|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566486|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
56566487|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566488|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566489|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
56566490|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56566491|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566492|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56566493|NCT02873364|Vitamin D|vitamin d|mesh-list
56566494|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
56566495|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
56566496|NCT02873364|Vitamins|vitamins|mesh-list
56098979|NCT00002786|Aldesleukin|aldesleukin|mesh-list
56098980|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098981|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56098982|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56098983|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
56098984|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098985|NCT00378937|Acetaminophen|acetaminophen|mesh-list
56098986|NCT00378937|Morphine|morphine|mesh-list
56098987|NCT00378937|Oxycodone|oxycodone|mesh-list
56098988|NCT00378937|Codeine|codeine|mesh-list
56098989|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
56098990|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
56566497|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
56566498|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566499|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56566500|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56566501|NCT00628290|Cannabidiol|cannabidiol|mesh-list
56566502|NCT00628290|Amisulpride|amisulpride|mesh-list
56566503|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
56566504|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56566505|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56566506|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566507|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566508|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56566509|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56566510|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
56566511|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359688|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
56566512|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566513|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56566514|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
56566515|NCT04559412|Etanercept|etanercept|mesh-list
56566516|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56566517|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56566518|NCT04559412|Analgesics|analgesics|mesh-ancestor
56566533|NCT02872584|Prednisone|prednisone|mesh-list
56566546|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566547|NCT00704899|Amitriptyline|amitriptyline|mesh-list
56566548|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56566549|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
56566550|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56566551|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56566552|NCT00704899|Analgesics|analgesics|mesh-ancestor
56566553|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
56314938|NCT02762981|Paclitaxel|paclitaxel|mesh-list
56566554|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566555|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566556|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56566557|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56566558|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56566559|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566560|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
56566561|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566563|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56566564|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566565|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56566567|NCT01104701|Hormones|hormones|mesh-ancestor
56566568|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566569|NCT00833755|Ketamine|ketamine|mesh-list
56566570|NCT00833755|Analgesics|analgesics|mesh-ancestor
56566571|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
56566572|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566573|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566574|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56566575|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56566576|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
56566577|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
56566583|NCT01021332|Tamsulosin|tamsulosin|mesh-list
56566587|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56566588|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
56566589|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566590|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566591|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566592|NCT01021332|Urological Agents|urological agents|mesh-ancestor
56566593|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56566594|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56566595|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
56566596|NCT00923091|Amlodipine|amlodipine|mesh-list
56566597|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56566598|NCT00923091|Olmesartan|olmesartan|mesh-list
56566599|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56566600|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
56566601|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56566602|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56566603|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56566604|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566605|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56566606|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566607|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
56566608|NCT00923091|Diuretics|diuretics|mesh-ancestor
56566609|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
56566610|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56566611|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56566612|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56566613|NCT00853957|Amlodipine|amlodipine|mesh-list
56566614|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56566615|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56566616|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56566617|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566620|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
56566626|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
56566627|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
56566628|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566629|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566630|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
56566631|NCT01021020|Renal Agents|renal agents|mesh-ancestor
56566632|NCT00833053|Methotrexate|methotrexate|mesh-list
56566633|NCT00833053|Infliximab|infliximab|mesh-list
56566634|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56566635|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
56566636|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56566637|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566638|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56566639|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
56566640|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566641|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566650|NCT01020786|Carboplatin|carboplatin|mesh-list
56566684|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566685|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
56566686|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56566687|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56566688|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566689|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56566690|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56566691|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56566692|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566693|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56566694|NCT02872818|Metformin|metformin|mesh-list
56566695|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56566696|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56566745|NCT04203771|Analgesics|analgesics|mesh-ancestor
56566746|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
56566747|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566748|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566749|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566750|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566751|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56566752|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566753|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566754|NCT04256733|Capsaicin|capsaicin|mesh-list
56566755|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
56566756|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
56566757|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
56566758|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566759|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566760|NCT01025232|Ranibizumab|ranibizumab|mesh-list
56566761|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56566762|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56566763|NCT01025232|Growth Substances|growth substances|mesh-ancestor
56566801|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566802|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
56566803|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566804|NCT00832819|Paclitaxel|paclitaxel|mesh-list
56566805|NCT00832819|Carboplatin|carboplatin|mesh-list
56566807|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56566808|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566809|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
56566810|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
56566811|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
56566812|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566813|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56566814|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566815|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
56566816|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
56566817|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566818|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566819|NCT05527483|Listerine|listerine|mesh-list
56566820|NCT05527483|Fluorides|fluorides|mesh-list
56566821|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
56566822|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
56566823|NCT05527483|Protective Agents|protective agents|mesh-ancestor
56566824|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566825|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56566826|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566827|NCT00853723|Teriparatide|teriparatide|mesh-list
56566828|NCT00853723|Hormones|hormones|mesh-list
56566829|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
56566830|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
56566831|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56566832|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566833|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56566834|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56566835|NCT00918255|Adalimumab|adalimumab|mesh-list
56566836|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56566837|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56566840|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566841|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56566842|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56566843|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
56566844|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
56566845|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
56566846|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566847|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566848|NCT01096589|Ionophores|ionophores|mesh-ancestor
56566849|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56566850|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
56566851|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56566852|NCT04252521|Ketoprofen|ketoprofen|mesh-list
56566853|NCT04252521|Metoclopramide|metoclopramide|mesh-list
56566854|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
56566855|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
56566856|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566857|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566858|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56566859|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56566860|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56566861|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
56566862|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566872|NCT00845065|Ribavirin|ribavirin|mesh-list
56566893|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56566894|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56566895|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566896|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
56566897|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566898|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566899|NCT05252325|Lidocaine|lidocaine|mesh-list
56566900|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
56566901|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
56566902|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
56566903|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56566904|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566905|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
56566906|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56566907|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56566908|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56566909|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56566910|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56566911|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566912|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56566913|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
56566914|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
56566915|NCT05252325|Protective Agents|protective agents|mesh-ancestor
56566916|NCT01024920|Sunitinib|sunitinib|mesh-list
56566943|NCT00705445|Trace Elements|trace elements|mesh-list
56566944|NCT00705445|Micronutrients|micronutrients|mesh-list
56566945|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566946|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56566947|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56566948|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56566949|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566950|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566951|NCT02879981|Trimethoprim|trimethoprim|mesh-list
56566952|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
56566953|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
56566954|NCT02879981|Guaifenesin|guaifenesin|mesh-list
56566955|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56566956|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56566957|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566958|NCT02879981|Renal Agents|renal agents|mesh-ancestor
56566959|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
56566960|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56566961|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56566962|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56566963|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566964|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566965|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56566966|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56566967|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56566968|NCT02879981|Expectorants|expectorants|mesh-ancestor
56566969|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
56566970|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56566971|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56566972|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
56566973|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56566974|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56566975|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
56566976|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56566977|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
56566978|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
56566981|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56566982|NCT04307693|Ritonavir|ritonavir|mesh-list
56566983|NCT04307693|Lopinavir|lopinavir|mesh-list
56566984|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
56566985|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56566986|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56566987|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
56566988|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56566989|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56566990|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56566991|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56566992|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
56566993|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56566994|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56566995|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56566996|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
56566997|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56566998|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56566999|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567000|NCT02878421|Nicotine|nicotine|mesh-list
56567001|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56567002|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
56567003|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567004|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567005|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56359802|NCT00282061|Melatonin|melatonin|mesh-list
56567006|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56567007|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
56567008|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567009|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098991|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56098992|NCT00378937|Narcotics|narcotics|mesh-ancestor
56098993|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56098994|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098995|NCT00378937|Analgesics|analgesics|mesh-ancestor
56099014|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099016|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56099017|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56099018|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
56099019|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56099020|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56099021|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
55826166|NCT02154529|XL647|xl647|mesh-list
56099022|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
56099023|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194777|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567010|NCT01019694|Albuterol|albuterol|mesh-list
56567011|NCT01019694|Ipratropium|ipratropium|mesh-list
56567012|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56567013|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
56567014|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567015|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567016|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56567017|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
56567018|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
56567019|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56567020|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56567021|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56567022|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56567023|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
56567024|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567025|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567026|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56567027|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
56567028|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56567029|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56567030|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56567031|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567032|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567033|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567034|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567035|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
56103395|NCT00003944|Paclitaxel|paclitaxel|mesh-list
56194778|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194779|NCT01495104|Valproic Acid|valproic acid|mesh-list
56194780|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
56194781|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194782|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194783|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
56194784|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194785|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194786|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
56194787|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56194788|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194789|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56194791|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
56194792|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56194793|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
56194794|NCT01495117|Povidone|povidone|mesh-list
56194795|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56194796|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56567036|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56567037|NCT01095653|Metformin|metformin|mesh-list
56567038|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
56567039|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56567040|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567041|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56567042|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567043|NCT00920907|Ipilimumab|ipilimumab|mesh-list
56567044|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56567045|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567046|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56567047|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567048|NCT00700297|Colchicine|colchicine|mesh-list
56567049|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
56567050|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567051|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567052|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567053|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567054|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567055|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567056|NCT04307147|Capecitabine|capecitabine|mesh-list
56567057|NCT04307147|Vinorelbine|vinorelbine|mesh-list
56567058|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56567059|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
56567060|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567061|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567062|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56567063|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567064|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567065|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567066|NCT00844831|Lubiprostone|lubiprostone|mesh-list
56567067|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56315479|NCT00405496|Difluprednate|difluprednate|mesh-list
56567077|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56567078|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56567079|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56567080|NCT05010876|Analgesics|analgesics|mesh-ancestor
56567081|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
56567082|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567083|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567084|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56567085|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567086|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56567087|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56567088|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567089|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56567090|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567091|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
56567092|NCT04307069|Oxytocin|oxytocin|mesh-list
56567093|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
56567094|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56567095|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567096|NCT04251741|Adalimumab|adalimumab|mesh-list
56567097|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56567098|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567099|NCT02878265|Vitamins|vitamins|mesh-list
56567100|NCT02878265|Vitamin A|vitamin a|mesh-list
56567101|NCT02878265|Zinc|zinc|mesh-list
56567106|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
56567126|NCT01023672|Modafinil|modafinil|mesh-list
56567127|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56567128|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567129|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56567130|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56567131|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56567132|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567133|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56567134|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56567135|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
56567136|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567137|NCT00705835|Antacids|antacids|mesh-ancestor
56567138|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567139|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56567140|NCT00702637|Modafinil|modafinil|mesh-list
56567141|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56567142|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567143|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56567144|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56567145|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56567146|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567147|NCT04786275|Fentanyl|fentanyl|mesh-list
56567148|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56567149|NCT04786275|Narcotics|narcotics|mesh-ancestor
56567150|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567151|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567153|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
56567154|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567155|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56567156|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56567167|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
56567168|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56567169|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56567170|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567171|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
56567172|NCT04785651|Coagulants|coagulants|mesh-ancestor
56567173|NCT05525611|Cabergoline|cabergoline|mesh-list
56567174|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56567175|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56567176|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
56567177|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
56567178|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359855|NCT00282217|Sirolimus|sirolimus|mesh-list
56567179|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567180|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567184|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
56567226|NCT02872038|Cefazolin|cefazolin|mesh-list
56567227|NCT02872038|Ceftazidime|ceftazidime|mesh-list
56567228|NCT02872038|Cefepime|cefepime|mesh-list
56567229|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56567230|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567231|NCT00627900|Sirolimus|sirolimus|mesh-list
56567232|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56567233|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567234|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56567235|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567236|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
56567237|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567238|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
56567239|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567240|NCT02996110|Nivolumab|nivolumab|mesh-list
56567241|NCT02996110|Ipilimumab|ipilimumab|mesh-list
56567242|NCT02996110|Linrodostat|linrodostat|mesh-list
56567243|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56567244|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567245|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56567246|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567247|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567248|NCT01103063|Azithromycin|azithromycin|mesh-list
56567249|NCT01103063|Chloroquine|chloroquine|mesh-list
56567250|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
56567251|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
56567252|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56567253|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56567254|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567255|NCT01103063|Amebicides|amebicides|mesh-ancestor
56567274|NCT04213378|Paclitaxel|paclitaxel|mesh-list
56567275|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56567276|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56567277|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567278|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567279|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567280|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567281|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567282|NCT04213924|Ibuprofen|ibuprofen|mesh-list
56567283|NCT04213924|Lidocaine|lidocaine|mesh-list
56567284|NCT04213924|Bupivacaine|bupivacaine|mesh-list
56567285|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
56567286|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
56567287|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567288|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567289|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
56567290|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567291|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56567292|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56567298|NCT04213924|Analgesics|analgesics|mesh-ancestor
56567329|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
56567330|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567331|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567332|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56567333|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56567334|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
56567335|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567336|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
56567337|NCT04213612|Doxorubicin|doxorubicin|mesh-list
56567338|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56567339|NCT04213612|Vincristine|vincristine|mesh-list
56567340|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567341|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
56567342|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567343|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567344|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56567345|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
56567346|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567347|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567348|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56567349|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56567350|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56567351|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56567352|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567353|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56567354|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567355|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567356|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567375|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56567376|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
56567377|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56567378|NCT02703220|Urological Agents|urological agents|mesh-ancestor
56567379|NCT02878031|Amoxicillin|amoxicillin|mesh-list
56567380|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56567381|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567382|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
56567383|NCT02879669|Carboplatin|carboplatin|mesh-list
56567384|NCT02879669|Pemetrexed|pemetrexed|mesh-list
56567385|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567386|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
56567387|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567388|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567389|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56567390|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
56567391|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567392|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567393|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56567394|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567395|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56567396|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56567397|NCT00516724|Paclitaxel|paclitaxel|mesh-list
56567398|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56567399|NCT00516724|Carboplatin|carboplatin|mesh-list
56567400|NCT00516724|Olaparib|olaparib|mesh-list
56567401|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56567402|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56567403|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567419|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567420|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567421|NCT01090973|Panobinostat|panobinostat|mesh-list
56567422|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56567423|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567424|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567425|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567426|NCT02607904|Cannabidiol|cannabidiol|mesh-list
56567427|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
56567428|NCT05295394|Lamivudine|lamivudine|mesh-list
56567429|NCT05295394|Dolutegravir|dolutegravir|mesh-list
56567430|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56567431|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56567432|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567433|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567434|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
56567435|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567436|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56567437|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56567438|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56567439|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56567440|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
56567442|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56567443|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
56567470|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
56567471|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56567472|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56567473|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567474|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567475|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56567476|NCT04254471|Carboplatin|carboplatin|mesh-list
56567477|NCT04254471|Etoposide|etoposide|mesh-list
56567478|NCT04254471|Rabeprazole|rabeprazole|mesh-list
56567479|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567480|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56567481|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56567482|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56567483|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567484|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567485|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56567486|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56567487|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56567488|NCT00631527|Sunitinib|sunitinib|mesh-list
56567489|NCT00631527|Leuprolide|leuprolide|mesh-list
56567490|NCT00631527|Goserelin|goserelin|mesh-list
56567491|NCT00631527|Bicalutamide|bicalutamide|mesh-list
56567492|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567493|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56567494|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56567495|NCT00631527|Growth Substances|growth substances|mesh-ancestor
56567496|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567497|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
56567498|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56567499|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567500|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567501|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56567511|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567512|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567513|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
56567514|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
56567515|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567516|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567517|NCT00916383|Donepezil|donepezil|mesh-list
56567518|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56567519|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567520|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567521|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
56567522|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567523|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567524|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
56567525|NCT00617500|Hormones|hormones|mesh-list
56567526|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56567527|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567528|NCT04254081|Lidocaine|lidocaine|mesh-list
56567529|NCT04254081|Buprenorphine|buprenorphine|mesh-list
56567545|NCT04209478|Morphine|morphine|mesh-list
56567565|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56567566|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567567|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359912|NCT00283036|Irbesartan|irbesartan|mesh-list
56567568|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56567569|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56567570|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
56567571|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567572|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567573|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
56567574|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
56567575|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567576|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56567577|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56567578|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
56567579|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56567580|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567581|NCT04766008|Metformin|metformin|mesh-list
56567582|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56567583|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567584|NCT00916149|Lamotrigine|lamotrigine|mesh-list
56567585|NCT00916149|Levetiracetam|levetiracetam|mesh-list
56567586|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
56567587|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
56567588|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56567589|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567590|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567591|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56567592|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567593|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56567594|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56567595|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567596|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56567597|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56194797|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194798|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
56194800|NCT01495117|Trace Elements|trace elements|mesh-ancestor
56194801|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
56099024|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56567598|NCT04713969|Pantoprazole|pantoprazole|mesh-list
56567599|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56567600|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56567601|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56567602|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567603|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567604|NCT00617656|Gemcitabine|gemcitabine|mesh-list
56567605|NCT00617656|Cisplatin|cisplatin|mesh-list
56567606|NCT00617656|Docetaxel|docetaxel|mesh-list
56567607|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567608|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56567609|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
56567610|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567611|NCT00617656|Antiviral Agents|antiviral agents|mesh-ancestor
56567612|NCT00617656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567613|NCT00617656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567614|NCT00617656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567615|NCT00617656|Immunologic Factors|immunologic factors|mesh-ancestor
56567616|NCT00617656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567617|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567618|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567619|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567620|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56567621|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
56567622|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56567623|NCT00175162|Protective Agents|protective agents|mesh-ancestor
56567624|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567625|NCT04648540|Acetaminophen|acetaminophen|mesh-list
56567626|NCT04648540|Celecoxib|celecoxib|mesh-list
56567627|NCT04648540|Ketorolac|ketorolac|mesh-list
56567628|NCT04648540|Lidocaine|lidocaine|mesh-list
56567629|NCT04648540|Pregabalin|pregabalin|mesh-list
56567630|NCT04648540|Fentanyl|fentanyl|mesh-list
56567631|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
56567632|NCT04648540|Morphine|morphine|mesh-list
56567633|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
56567634|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
56567635|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567637|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
56567638|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567639|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56567640|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56567641|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56567642|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567643|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567644|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56567645|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56567647|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56567648|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56567649|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56567650|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
56567651|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567652|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56567653|NCT04648540|Narcotics|narcotics|mesh-ancestor
56567654|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56567655|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56567656|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
56567657|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
56567658|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
56567670|NCT04213222|Bevacizumab|bevacizumab|mesh-list
56567692|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56567693|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567694|NCT00617968|Docetaxel|docetaxel|mesh-list
56567695|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567696|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567697|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567698|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567699|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567700|NCT00621400|Dexamethasone|dexamethasone|mesh-list
56567701|NCT00621400|Lenalidomide|lenalidomide|mesh-list
56567702|NCT00621400|Melphalan|melphalan|mesh-list
56567703|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56567704|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
56567705|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
56567706|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567707|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567708|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56567709|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
56567710|NCT00621400|Hormones|hormones|mesh-ancestor
56567711|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56567712|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56567713|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567714|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
56567715|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56567743|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
56567744|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
56567745|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
56567746|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567747|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56567748|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56567749|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56567750|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56567751|NCT02879435|Bupivacaine|bupivacaine|mesh-list
56567752|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
56316150|NCT00011960|Paclitaxel|paclitaxel|mesh-list
56567753|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
56567754|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567755|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567756|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
56567757|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567758|NCT02879513|Paclitaxel|paclitaxel|mesh-list
56567759|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
56567760|NCT02879513|Epirubicin|epirubicin|mesh-list
56567761|NCT02879513|Fluorouracil|fluorouracil|mesh-list
56567762|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56567763|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567764|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567765|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567766|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567767|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567768|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567769|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
56567770|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567771|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567772|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56567773|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
56567774|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56567785|NCT00621478|Lorazepam|lorazepam|mesh-list
56567786|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
56567787|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
56567788|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
56567789|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567790|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567791|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56567792|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56567793|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567794|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56567795|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56567796|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56567797|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
56567798|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
56567799|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567800|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567801|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56567802|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56567803|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56567804|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56567806|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
56567839|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56567840|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56567841|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56567842|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
56567843|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567844|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567845|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567846|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56567847|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
56567848|NCT02299414|Nifedipine|nifedipine|mesh-list
56567849|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56567850|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567851|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567852|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56567853|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567854|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
56567855|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
56567856|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56567857|NCT01016262|Mesalamine|mesalamine|mesh-list
56567858|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56567859|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56567860|NCT01016262|Analgesics|analgesics|mesh-ancestor
56567861|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
56567862|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567863|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567864|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56567865|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56567866|NCT00625937|Docetaxel|docetaxel|mesh-list
56567867|NCT00625937|Tegafur|tegafur|mesh-list
56567868|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567869|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
56567870|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
56567871|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
56567872|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104127|NCT00003596|Fluorouracil|fluorouracil|mesh-list
56099025|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56099026|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56567873|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56567874|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
56567875|NCT01001910|Carboplatin|carboplatin|mesh-list
56567876|NCT01001910|Pemetrexed|pemetrexed|mesh-list
56567877|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567878|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567879|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567880|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56567881|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56567882|NCT04308317|Tetrandrine|tetrandrine|mesh-list
56567883|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
56567884|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56567885|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56567886|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567887|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56567888|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567889|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
56567890|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56567891|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56567892|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567893|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56567894|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099027|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
56099028|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099029|NCT05521880|Oritavancin|oritavancin|mesh-list
56099030|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56099031|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099032|NCT01090141|Micafungin|micafungin|mesh-list
56099033|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
56099034|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099035|NCT01048723|Everolimus|everolimus|mesh-list
56099036|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099037|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099038|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
56099039|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099040|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
56099041|NCT05513612|Fludarabine|fludarabine|mesh-list
56099042|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099043|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
56099044|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099045|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56099046|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56099047|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
56099048|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099049|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099050|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56099051|NCT05594407|Lidocaine|lidocaine|mesh-list
56194802|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194803|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
56194804|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
56194805|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
56194806|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56194807|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56567895|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56567896|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
56567897|NCT01009554|Listerine|listerine|mesh-list
56567898|NCT01009554|Fluorides|fluorides|mesh-list
56567899|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
56567900|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
56567901|NCT01009554|Protective Agents|protective agents|mesh-ancestor
56567902|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567903|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56567904|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56567905|NCT04211896|Nivolumab|nivolumab|mesh-list
56567906|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56567907|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567908|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56567909|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567910|NCT04188184|Epinephrine|epinephrine|mesh-list
56567911|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
56567912|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56567913|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56567914|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567951|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567952|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567953|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
56567954|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567955|NCT00621790|Fenoldopam|fenoldopam|mesh-list
56567956|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56567957|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
56567958|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
56567959|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
56567960|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567961|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567962|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567963|NCT00618124|Capecitabine|capecitabine|mesh-list
56567964|NCT00618124|Sunitinib|sunitinib|mesh-list
56567965|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359960|NCT00283543|Carmustine|carmustine|mesh-list
56567966|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
56567967|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567968|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56567969|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56567970|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56567971|NCT00618124|Growth Substances|growth substances|mesh-ancestor
56567972|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567973|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
56194808|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194809|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194810|NCT01495169|Iloperidone|iloperidone|mesh-list
56194811|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56194812|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56194813|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194814|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099052|NCT05594407|Dexmedetomidine|dexmedetomidine|mesh-list
56099053|NCT05594407|Ketamine|ketamine|mesh-list
56099054|NCT05594407|Remifentanil|remifentanil|mesh-list
56099066|NCT05594407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56099067|NCT05594407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56099068|NCT05594407|Analgesics|analgesics|mesh-ancestor
56099069|NCT05594407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56099070|NCT05594407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56099071|NCT05594407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56099072|NCT05594407|Adrenergic Agents|adrenergic agents|mesh-ancestor
56099073|NCT05594407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099074|NCT05594407|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56099075|NCT05594407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56099076|NCT05594407|Anesthetics, General|anesthetics, general|mesh-ancestor
56099077|NCT05594407|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56099078|NCT05594407|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56099079|NCT05594407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56099080|NCT05594407|Narcotics|narcotics|mesh-ancestor
56099081|NCT00379717|Docetaxel|docetaxel|mesh-list
56099082|NCT00379717|Cisplatin|cisplatin|mesh-list
56567974|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56567975|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56567976|NCT05063656|Gabapentin|gabapentin|mesh-list
56567977|NCT05063656|Analgesics|analgesics|mesh-ancestor
56567978|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
56567979|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56567980|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567982|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56567983|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56567984|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56567985|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56567986|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56567987|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56567988|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56567989|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567990|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
56567991|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
56567992|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56567993|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56567994|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56567995|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56567996|NCT01882660|Decitabine|decitabine|mesh-list
56567997|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56567998|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
56567999|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568000|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568001|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568002|NCT01001832|Abatacept|abatacept|mesh-list
56568003|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56568004|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568005|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568006|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568007|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
56568008|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568013|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56568014|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568015|NCT01006356|Hydromorphone|hydromorphone|mesh-list
56568016|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56568017|NCT01006356|Narcotics|narcotics|mesh-ancestor
56568018|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56568019|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568020|NCT01006356|Analgesics|analgesics|mesh-ancestor
56568021|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
56568022|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568023|NCT01089725|Tanezumab|tanezumab|mesh-list
56568024|NCT01089725|Analgesics|analgesics|mesh-ancestor
56568025|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
56568026|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568027|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568028|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
56568029|NCT01190930|Leucovorin|leucovorin|mesh-list
56568030|NCT01190930|Folic Acid|folic acid|mesh-list
56568031|NCT01190930|Cytarabine|cytarabine|mesh-list
56568032|NCT01190930|Dexamethasone|dexamethasone|mesh-list
56568033|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
56360056|NCT04718701|Paclitaxel|paclitaxel|mesh-list
56568034|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
56568035|NCT01190930|Doxorubicin|doxorubicin|mesh-list
56568036|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56099083|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099084|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
56099085|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
56099086|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
56099087|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099088|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
56099089|NCT04706377|Vitamins|vitamins|mesh-ancestor
56099090|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
56099091|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099092|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
56099093|NCT01583647|Niacin|niacin|mesh-list
56099094|NCT01583647|Niacinamide|niacinamide|mesh-list
56099095|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
56099096|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56099097|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
56099098|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099099|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56099100|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
56099101|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
56099103|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
56099104|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099105|NCT04403516|Dexamethasone|dexamethasone|mesh-list
56099106|NCT04403516|Prednisolone|prednisolone|mesh-list
56099107|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56099108|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
56099109|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56099110|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
56099111|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56099112|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
56099113|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568037|NCT01190930|Methotrexate|methotrexate|mesh-list
56360437|NCT00077753|Enoxaparin|enoxaparin|mesh-list
56568038|NCT01190930|Vincristine|vincristine|mesh-list
56568039|NCT01190930|Asparaginase|asparaginase|mesh-list
56568040|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
56568041|NCT01190930|Pegaspargase|pegaspargase|mesh-list
56568042|NCT01190930|Thioguanine|thioguanine|mesh-list
56568044|NCT01190930|Calcium|calcium|mesh-list
56568045|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
56360797|NCT00289588|Mupirocin|mupirocin|mesh-list
56568047|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56360917|NCT00290680|Celecoxib|celecoxib|mesh-list
56568048|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
56568049|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361283|NCT00130234|Omalizumab|omalizumab|mesh-list
56568050|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56361325|NCT00130195|Cytarabine|cytarabine|mesh-list
56568051|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56361620|NCT00079508|Bivalirudin|bivalirudin|mesh-list
56361692|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
56568053|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316460|NCT00845910|Bevacizumab|bevacizumab|mesh-list
56361842|NCT00079820|Vaccines|vaccines|mesh-list
56568054|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568055|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56568056|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568068|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56364669|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56568069|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56568070|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56364971|NCT00297466|Nicotine|nicotine|mesh-list
56365041|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365274|NCT04717531|Trastuzumab|trastuzumab|mesh-list
56365360|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
56568071|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56568072|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56568073|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
56568074|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56365875|NCT00091377|Paclitaxel|paclitaxel|mesh-list
56365950|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568075|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56568076|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
56568077|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
56568078|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56568079|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56366324|NCT03883919|Vitamin D|vitamin d|mesh-list
56568080|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
56366549|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568081|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568082|NCT01190930|Antidotes|antidotes|mesh-ancestor
56480218|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56480219|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369212|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
56369285|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
56568106|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56369359|NCT04715269|Alprazolam|alprazolam|mesh-list
56369444|NCT00089453|Dexamethasone|dexamethasone|mesh-list
56568107|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56568108|NCT00618202|Analgesics|analgesics|mesh-ancestor
56568109|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
56568110|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568111|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568112|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369966|NCT00420589|Hormones|hormones|mesh-ancestor
56568113|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56568114|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56568115|NCT00626015|Temozolomide|temozolomide|mesh-list
56568116|NCT00626015|Daclizumab|daclizumab|mesh-list
56370258|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
56568117|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568118|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
56568119|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370944|NCT00092339|Valdecoxib|valdecoxib|mesh-list
56371086|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568120|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568121|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568122|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
56371463|NCT01054573|Interferons|interferons|mesh-list
56568123|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568124|NCT05662306|Aripiprazole|aripiprazole|mesh-list
56568125|NCT05662306|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
56371766|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
56568135|NCT05662306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568136|NCT05662306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56568137|NCT05662306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56568138|NCT05662306|Serotonin Agents|serotonin agents|mesh-ancestor
56568139|NCT05662306|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56568140|NCT05662306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56568141|NCT05662306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56568142|NCT05662306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56568143|NCT00618280|Nicotine|nicotine|mesh-list
56568144|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56568145|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
56568146|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568147|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568148|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56568149|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56568150|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
56568151|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568152|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568154|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56568155|NCT01101191|Narcotics|narcotics|mesh-ancestor
56568184|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568185|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
56568186|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56375691|NCT00108602|Diuretics|diuretics|mesh-ancestor
56568188|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568189|NCT01178762|Azithromycin|azithromycin|mesh-list
56568190|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56568191|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568192|NCT03563560|Cytarabine|cytarabine|mesh-list
56568193|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
56568194|NCT03563560|Alvocidib|alvocidib|mesh-list
56568195|NCT03563560|Daunorubicin|daunorubicin|mesh-list
56375834|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375909|NCT00143169|Parecoxib|parecoxib|mesh-list
56568196|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56376056|NCT00109382|Aspirin|aspirin|mesh-list
56376124|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568198|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568199|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568200|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
56568201|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568202|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568203|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
56568204|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568205|NCT03563560|Analgesics|analgesics|mesh-ancestor
56568206|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
56376867|NCT00347971|Rituximab|rituximab|mesh-list
56377018|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56568207|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568208|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56377325|NCT00350857|Analgesics|analgesics|mesh-ancestor
56568209|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56568210|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568211|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
56568212|NCT03563560|Growth Substances|growth substances|mesh-ancestor
56568213|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56568215|NCT01178138|Prazosin|prazosin|mesh-list
56568218|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56568219|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56568220|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
56568221|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568222|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568223|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568224|NCT01190228|Vaccines|vaccines|mesh-list
56568225|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
56568226|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568227|NCT01009086|Ustekinumab|ustekinumab|mesh-list
56568228|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
56568229|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
56568230|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56568231|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56568232|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099114|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
56099115|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
56194815|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56194817|NCT01495195|Donepezil|donepezil|mesh-list
56194818|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56194819|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194820|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194821|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
56194822|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194823|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194824|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
56194825|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
56194826|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56194827|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56194828|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56194829|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56194830|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56099116|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099117|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099118|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56099119|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
56099138|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56099139|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56099140|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099141|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099142|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099143|NCT01035073|Analgesics|analgesics|mesh-ancestor
56099144|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
56099145|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099146|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
56099147|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099148|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
56099149|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
56099150|NCT04331743|Analgesics|analgesics|mesh-ancestor
56099151|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
56099152|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099153|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099154|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099155|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56099156|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56099157|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099158|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099159|NCT05296759|Gabapentin|gabapentin|mesh-list
56099160|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56568233|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
56568234|NCT01190150|Coagulants|coagulants|mesh-ancestor
56568236|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56378486|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56568237|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568238|NCT05210062|Succinylcholine|succinylcholine|mesh-list
56568239|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56568240|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56568241|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56568242|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568243|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568244|NCT01001520|Tolcapone|tolcapone|mesh-list
56378567|NCT05553678|Midazolam|midazolam|mesh-list
56568245|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56568246|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56378783|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568247|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56568248|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56379083|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568249|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568250|NCT00619840|Methylphenidate|methylphenidate|mesh-list
56568251|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56379535|NCT00464347|Triamcinolone|triamcinolone|mesh-list
56568252|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568253|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56099161|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
56099162|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56099163|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56099164|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56099165|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56099166|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099167|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
56099168|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099169|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099170|NCT05296759|Analgesics|analgesics|mesh-ancestor
56099171|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
56099172|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099173|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
56099174|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56099185|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56194834|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56194835|NCT01495208|Growth Substances|growth substances|mesh-ancestor
56194836|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194837|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
56194838|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194840|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
56194841|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
56194842|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56194843|NCT01495260|Vitamins|vitamins|mesh-ancestor
56194844|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
56568254|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56568255|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56001728|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
56379907|NCT00475072|Ribavirin|ribavirin|mesh-list
56379981|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56380129|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
56380217|NCT00117728|Nevirapine|nevirapine|mesh-list
56568256|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568257|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
56380284|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
56568258|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568260|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56568261|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56568262|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380570|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
56568263|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56568264|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
56568265|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
56568266|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
56568268|NCT02697058|Fluorouracil|fluorouracil|mesh-list
56568269|NCT02697058|Calcium|calcium|mesh-list
56568270|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
56568271|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56104545|NCT00003662|Cyclosporine|cyclosporine|mesh-list
56194845|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194846|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
56194847|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194848|NCT01495260|Expectorants|expectorants|mesh-ancestor
56194849|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
56194850|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56194851|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
56194852|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194853|NCT01495260|Protective Agents|protective agents|mesh-ancestor
56194854|NCT01495260|Antidotes|antidotes|mesh-ancestor
56194855|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
56194856|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56194857|NCT01495338|Cetirizine|cetirizine|mesh-list
56194858|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56194859|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56099187|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099188|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
56099189|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099190|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56099191|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099192|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099193|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
56099194|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
56099195|NCT01532635|Tacrolimus|tacrolimus|mesh-list
56099196|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099197|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
56099198|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099199|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56099200|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568272|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568273|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56568274|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
56381233|NCT00484237|Analgesics|analgesics|mesh-ancestor
56568275|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381311|NCT00120809|Renal Agents|renal agents|mesh-ancestor
56568276|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56568277|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568278|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568279|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
56568280|NCT02697058|Antidotes|antidotes|mesh-ancestor
56568281|NCT02697058|Protective Agents|protective agents|mesh-ancestor
56568282|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
56568284|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
56568285|NCT00622414|Aflibercept|aflibercept|mesh-list
56568286|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
56568287|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56568288|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56568289|NCT00622414|Growth Substances|growth substances|mesh-ancestor
56568290|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568323|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
56568324|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
56568325|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56568326|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56568327|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
56568328|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568329|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568330|NCT04296162|Capecitabine|capecitabine|mesh-list
56568331|NCT04296162|Trastuzumab|trastuzumab|mesh-list
56568332|NCT04296162|Vinorelbine|vinorelbine|mesh-list
56568333|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56568334|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
56568335|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568336|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568337|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56568338|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56568339|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
56568340|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
56005062|NCT00002494|Etoposide|etoposide|mesh-list
56568341|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
56383342|NCT04710914|Midazolam|midazolam|mesh-list
56383415|NCT00146913|Interferons|interferons|mesh-list
56568343|NCT00619996|Sorafenib|sorafenib|mesh-list
56568344|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568345|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
56568346|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
56568347|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
56568348|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568349|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383490|NCT00501787|Metformin|metformin|mesh-list
56104621|NCT00003368|Irinotecan|irinotecan|mesh-list
56099201|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
56099202|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099203|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099204|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56099205|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56099206|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099207|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56194860|NCT01495338|Analgesics|analgesics|mesh-ancestor
56194861|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
56194862|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194863|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194864|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56099208|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56099209|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
56568350|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383562|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
56383857|NCT01248091|Nitroprusside|nitroprusside|mesh-list
56480220|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384158|NCT03890952|Nivolumab|nivolumab|mesh-list
56480221|NCT02920658|Betamethasone|betamethasone|mesh-list
56480222|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
56480223|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56480224|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
56480225|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56568351|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56384828|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
56568352|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56384902|NCT00132548|Renal Agents|renal agents|mesh-ancestor
56568353|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56568354|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384973|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568355|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568356|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
56568390|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56568391|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568392|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568393|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
56568394|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568395|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568396|NCT01176968|Eplerenone|eplerenone|mesh-list
56568397|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56568398|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
56568399|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56568400|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568401|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56568402|NCT01176968|Diuretics|diuretics|mesh-ancestor
56568403|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
56385900|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
56568404|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56568405|NCT02697370|Factor VIII|factor viii|mesh-list
56568406|NCT02697370|Coagulants|coagulants|mesh-ancestor
56568407|NCT02691442|Epinephrine|epinephrine|mesh-list
56568408|NCT02691442|Ropivacaine|ropivacaine|mesh-list
56568409|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
56568410|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
56568411|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
56385974|NCT00159471|Antiviral Agents|antiviral agents|mesh-ancestor
56568412|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56568413|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568414|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
56568415|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568416|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56568417|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56568418|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56568419|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568420|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568421|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56568422|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56099210|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56099211|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099212|NCT00986947|Rituximab|rituximab|mesh-list
56099213|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56568423|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
56568424|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56568425|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56568426|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
56568427|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
56568428|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56568430|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
56568431|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56568432|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56568433|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568434|NCT02687854|Vitamin K|vitamin k|mesh-list
56568435|NCT02687854|Apixaban|apixaban|mesh-list
56568436|NCT02687854|Vitamins|vitamins|mesh-ancestor
56568437|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
56104740|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
56099214|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099215|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
56099216|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099217|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56099218|NCT05736224|Sunscreening Agents|sunscreening agents|mesh-list
56099219|NCT05736224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56099220|NCT05736224|Protective Agents|protective agents|mesh-ancestor
56099221|NCT05736224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099222|NCT05736224|Dermatologic Agents|dermatologic agents|mesh-ancestor
56099223|NCT05203172|Cetuximab|cetuximab|mesh-list
56099224|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56099225|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099226|NCT04829318|Esketamine|esketamine|mesh-list
55801903|NCT04817527|Edaravone|edaravone|mesh-list
56099227|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
56099228|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099229|NCT00539617|Leucovorin|leucovorin|mesh-list
56099230|NCT00539617|Fluorouracil|fluorouracil|mesh-list
56099231|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
56099232|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56099233|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
56099234|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099235|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56099236|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099237|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099238|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
56099256|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
56099257|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099258|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56099259|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56099260|NCT04579640|Vitamin D|vitamin d|mesh-list
56099261|NCT04579640|Vitamins|vitamins|mesh-ancestor
56099262|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
56099263|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099264|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56099265|NCT00523939|Cytarabine|cytarabine|mesh-list
56099266|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56099267|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
56099268|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099269|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099270|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
56099271|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099272|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099273|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
56099274|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099275|NCT00382538|Mifepristone|mifepristone|mesh-list
56099276|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56099277|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
56099278|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56568438|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568439|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56568440|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
56568441|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56568442|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
56568443|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568444|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568445|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
56568446|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56568447|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56568448|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
56568449|NCT02687854|Coagulants|coagulants|mesh-ancestor
56568451|NCT01005966|Fluorides|fluorides|mesh-list
56568452|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
56568453|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
56568456|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386522|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56568457|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56568458|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568460|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
56568461|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56568462|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56568463|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568464|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
56568465|NCT00603304|Urological Agents|urological agents|mesh-ancestor
56568466|NCT01176032|Losartan|losartan|mesh-list
56568467|NCT01176032|Amlodipine|amlodipine|mesh-list
56568468|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56568475|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
56568486|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568487|NCT01008618|Analgesics|analgesics|mesh-ancestor
56568488|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
56568489|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568490|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56568491|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56568492|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
56568493|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
56568494|NCT01001208|Etanercept|etanercept|mesh-list
56568495|NCT01001208|Methotrexate|methotrexate|mesh-list
56568496|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56568497|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
56568498|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56568499|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387016|NCT00154791|Gemcitabine|gemcitabine|mesh-list
56568500|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56568501|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
56568502|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568503|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568504|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
56568505|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387214|NCT00141206|Varenicline|varenicline|mesh-list
56099279|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099280|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56099281|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56099282|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56099283|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
56099284|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56099285|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56099286|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
56099287|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56194865|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194866|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56194867|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56194868|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56194869|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
56194870|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
56194871|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194872|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194873|NCT01495351|Bortezomib|bortezomib|mesh-list
56194874|NCT01495351|Veliparib|veliparib|mesh-list
56194875|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194876|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56194877|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194878|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099288|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
56099289|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56099290|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56099291|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56099292|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56099293|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099294|NCT00954187|Pregabalin|pregabalin|mesh-list
56099295|NCT00954187|Gabapentin|gabapentin|mesh-list
56568506|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56568507|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568508|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
56316897|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56568509|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56568510|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56568511|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56568512|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56568513|NCT01001208|Analgesics|analgesics|mesh-ancestor
56568514|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
56568515|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568516|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568517|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56568518|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56568519|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
56387359|NCT00162396|Albuterol|albuterol|mesh-list
56568520|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568523|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
56568524|NCT01193842|Rituximab|rituximab|mesh-list
56568559|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
56568560|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
56389117|NCT00467467|Urological Agents|urological agents|mesh-ancestor
56389270|NCT00469690|Analgesics|analgesics|mesh-ancestor
56568562|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011490|NCT05355701|Cetuximab|cetuximab|mesh-list
56568563|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568564|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56568565|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390175|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390248|NCT00420901|Urological Agents|urological agents|mesh-ancestor
56390398|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568567|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56390547|NCT00165633|Vitamins|vitamins|mesh-ancestor
56568568|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56568569|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56568570|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
56568571|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568572|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56568573|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568574|NCT01093612|Copper|copper|mesh-list
56568575|NCT01093612|Trastuzumab|trastuzumab|mesh-list
56390695|NCT00512980|Antiviral Agents|antiviral agents|mesh-ancestor
55719234|NCT02319499|Iron|iron|mesh-list
56391067|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56568576|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56391222|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56391516|NCT00166881|Irinotecan|irinotecan|mesh-list
56568577|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391604|NCT00520000|Paclitaxel|paclitaxel|mesh-list
56568578|NCT01093612|Trace Elements|trace elements|mesh-ancestor
56391739|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
56391892|NCT00523120|Diclofenac|diclofenac|mesh-list
56391967|NCT02952157|Lidocaine|lidocaine|mesh-list
56392034|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392191|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
56568580|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392634|NCT00525772|Hormones|hormones|mesh-ancestor
56099296|NCT00954187|Analgesics|analgesics|mesh-ancestor
56099297|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
56099298|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392723|NCT03016871|Nivolumab|nivolumab|mesh-list
56392787|NCT02945527|Dexamethasone|dexamethasone|mesh-list
56568583|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56392933|NCT04692376|Hormones|hormones|mesh-ancestor
56393008|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393090|NCT02945020|Simeprevir|simeprevir|mesh-list
56568584|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56568585|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568586|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56568587|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56393385|NCT00168909|Vitamins|vitamins|mesh-ancestor
56568588|NCT01182350|Growth Substances|growth substances|mesh-ancestor
56393607|NCT02942758|Pioglitazone|pioglitazone|mesh-list
56568589|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568590|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
56568591|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568592|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
56568593|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568594|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56568595|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568596|NCT00603538|Paclitaxel|paclitaxel|mesh-list
56568597|NCT00603538|Carboplatin|carboplatin|mesh-list
56099299|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099331|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
56099332|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099333|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099334|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56099335|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56099336|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
56099337|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
56099338|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099339|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56099340|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56099341|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867701|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099373|NCT00379015|Epirubicin|epirubicin|mesh-list
56099374|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099375|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
56099376|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099377|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56099378|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56099379|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
56099380|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099381|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099382|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56099383|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
55867750|NCT01047436|Artemether|artemether|mesh-list
56099396|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099397|NCT04713176|Remdesivir|remdesivir|mesh-list
56099398|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
56099399|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099400|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
56099401|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099402|NCT04725656|Nicotine|nicotine|mesh-list
56099403|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56568598|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56568599|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568600|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
56568601|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
56568602|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
56393816|NCT02940925|Cisplatin|cisplatin|mesh-list
56568603|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393893|NCT00146471|Levetiracetam|levetiracetam|mesh-list
56394112|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
56568604|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56568605|NCT02537860|Fentanyl|fentanyl|mesh-list
56568606|NCT02537860|Bupivacaine|bupivacaine|mesh-list
56394407|NCT05273671|Analgesics|analgesics|mesh-ancestor
56394558|NCT02930434|Vitamin D|vitamin d|mesh-list
56568607|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
56568608|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
56394783|NCT02928679|Liraglutide|liraglutide|mesh-list
56568609|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56568610|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395008|NCT02917525|Vitamin K|vitamin k|mesh-list
56395078|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395150|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
56568625|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
56395437|NCT05784987|Mitoxantrone|mitoxantrone|mesh-list
56395509|NCT05782894|Anesthetics, General|anesthetics, general|mesh-ancestor
56395510|NCT05782894|Anesthetics|anesthetics|mesh-ancestor
56395511|NCT05782894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56395512|NCT05782894|Narcotics|narcotics|mesh-ancestor
56395513|NCT05782894|Analgesics|analgesics|mesh-ancestor
56395514|NCT05782894|Sensory System Agents|sensory system agents|mesh-ancestor
56395515|NCT05782894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395516|NCT05782712|Adenosine|adenosine|mesh-list
56395517|NCT05782712|Analgesics|analgesics|mesh-ancestor
56395660|NCT05724316|Vitamin D|vitamin d|mesh-list
56395661|NCT05724316|Cholecalciferol|cholecalciferol|mesh-list
56395662|NCT05724316|Vitamins|vitamins|mesh-ancestor
56395663|NCT05724316|Micronutrients|micronutrients|mesh-ancestor
56395664|NCT05724316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395665|NCT05724316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56395666|NCT05724316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56395667|NCT05723705|Liver Extracts|liver extracts|mesh-list
56395668|NCT05723705|Hematinics|hematinics|mesh-ancestor
56395684|NCT05700422|Varenicline|varenicline|mesh-list
56395691|NCT05691712|Tirzepatide|tirzepatide|mesh-list
56396043|NCT05415215|Maytansine|maytansine|mesh-list
56396051|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
56396116|NCT05368558|Cariprazine|cariprazine|mesh-list
56396117|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56396118|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56396119|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56396120|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396121|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56396122|NCT05364424|Rituximab|rituximab|mesh-list
56396123|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
56396124|NCT05364424|Carboplatin|carboplatin|mesh-list
56396125|NCT05364424|Etoposide|etoposide|mesh-list
56396126|NCT05364424|Ifosfamide|ifosfamide|mesh-list
56396127|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396128|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396129|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
56396130|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396131|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56396132|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56396133|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56396134|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56396135|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396136|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568649|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56396262|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396263|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
56396264|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396265|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396266|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56568650|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56568651|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396562|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56396565|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
56480226|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480227|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
56480228|NCT02920658|Hormones|hormones|mesh-ancestor
56480229|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480230|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480231|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56480232|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
56480233|NCT01281202|Vigabatrin|vigabatrin|mesh-list
56480234|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
56480235|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480236|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480237|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
56480238|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480239|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397020|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
56397021|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56397022|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
56397023|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397024|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397043|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
56568654|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397172|NCT04246086|Lenalidomide|lenalidomide|mesh-list
56568655|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568656|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
56568657|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568658|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56568659|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56568660|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56568661|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105078|NCT00003728|Leucovorin|leucovorin|mesh-list
56099404|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
56099405|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194879|NCT01495377|Remifentanil|remifentanil|mesh-list
56194880|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56194881|NCT01495377|Narcotics|narcotics|mesh-ancestor
56194882|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194883|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194884|NCT01495377|Analgesics|analgesics|mesh-ancestor
56194885|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
56194886|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194887|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
56194888|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
56194889|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56194890|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56194891|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568662|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56568663|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56568664|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56568666|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56568667|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568668|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568669|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
56568670|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56568671|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
56568672|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56568673|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
56568674|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
56568675|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
56568676|NCT01162304|Oxycodone|oxycodone|mesh-list
56568677|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56568678|NCT01162304|Narcotics|narcotics|mesh-ancestor
56568679|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56568680|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568681|NCT01162304|Analgesics|analgesics|mesh-ancestor
56397583|NCT03762096|Resveratrol|resveratrol|mesh-list
56397584|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
56397585|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397586|NCT03762096|Protective Agents|protective agents|mesh-ancestor
56397587|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397588|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397589|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56397590|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56397591|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56397592|NCT03739814|Blinatumomab|blinatumomab|mesh-list
56194892|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194893|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194894|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56194895|NCT01495468|Hormones|hormones|mesh-list
55891068|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
56397639|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
56397640|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56397641|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56397643|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
56568682|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
56480240|NCT01281124|Azacitidine|azacitidine|mesh-list
56568683|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568685|NCT04515394|Tepotinib|tepotinib|mesh-list
56568686|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56568687|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568688|NCT04206176|Ticagrelor|ticagrelor|mesh-list
56397778|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
56568689|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56568690|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56568691|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56568692|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56568693|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
56398302|NCT01711554|Tretinoin|tretinoin|mesh-list
56398380|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56568694|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56568695|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568699|NCT00638326|Clopidogrel|clopidogrel|mesh-list
56568723|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56568724|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56568725|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568726|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56568727|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568728|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
56568729|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
56568730|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56568731|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56568732|NCT02885558|Diuretics|diuretics|mesh-ancestor
56568733|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
56568734|NCT04186702|Ranibizumab|ranibizumab|mesh-list
56568735|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56147143|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
56147528|NCT01210560|Tolvaptan|tolvaptan|mesh-list
56568737|NCT04186702|Growth Substances|growth substances|mesh-ancestor
56568738|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568739|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
56568740|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568741|NCT01008150|Paclitaxel|paclitaxel|mesh-list
56568742|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
56568743|NCT01008150|Doxorubicin|doxorubicin|mesh-list
56568744|NCT01008150|Trastuzumab|trastuzumab|mesh-list
56568745|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56568746|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568748|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
56568749|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
56147951|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
56568750|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568751|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56148177|NCT01315158|Fentanyl|fentanyl|mesh-list
56568752|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
56148333|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
56148433|NCT01347060|Xhance|xhance|mesh-list
56568753|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56148546|NCT01365624|Ketorolac|ketorolac|mesh-list
56568754|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105199|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
56194896|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56568755|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56568756|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
56568757|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56568758|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56568759|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56568763|NCT04186936|Simethicone|simethicone|mesh-list
56568818|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568819|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56568820|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56568821|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
56568822|NCT02689024|Acetaminophen|acetaminophen|mesh-list
56568823|NCT02689024|Dipyrone|dipyrone|mesh-list
56152160|NCT01907334|Xhance|xhance|mesh-list
56568824|NCT02689024|Ibuprofen|ibuprofen|mesh-list
56568826|NCT02689024|Naproxen|naproxen|mesh-list
56568827|NCT02689024|Fentanyl|fentanyl|mesh-list
56568828|NCT02689024|Morphine|morphine|mesh-list
56568829|NCT02689024|Bupivacaine|bupivacaine|mesh-list
56568830|NCT02689024|Ropivacaine|ropivacaine|mesh-list
56568831|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
56568832|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
56568833|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
56568834|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56568835|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152759|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568839|NCT02689024|Narcotics|narcotics|mesh-ancestor
56568866|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568867|NCT00638560|Protective Agents|protective agents|mesh-ancestor
56568868|NCT00638638|Abciximab|abciximab|mesh-list
56568869|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
56156791|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56568870|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56157016|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
56568871|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
56157090|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
56568872|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56568873|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56157312|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
56568874|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568875|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
56157533|NCT05150652|Exemestane|exemestane|mesh-list
56568877|NCT04203160|Gemcitabine|gemcitabine|mesh-list
56568878|NCT04203160|Cisplatin|cisplatin|mesh-list
56568879|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568880|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56568881|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
56568882|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568883|NCT04203160|Antiviral Agents|antiviral agents|mesh-ancestor
56568884|NCT04203160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568885|NCT04203160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568886|NCT04203160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56568887|NCT04203160|Immunologic Factors|immunologic factors|mesh-ancestor
56568888|NCT04203160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568890|NCT01004250|Pemetrexed|pemetrexed|mesh-list
56568891|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56568892|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568893|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56568894|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56568895|NCT01004250|Growth Substances|growth substances|mesh-ancestor
56568896|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568897|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
56568898|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194897|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194898|NCT01495520|Ranolazine|ranolazine|mesh-list
56194899|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56568899|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568900|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56568901|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56568902|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56568903|NCT02688634|Amoxicillin|amoxicillin|mesh-list
56568904|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568905|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
56568906|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56568907|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
56568908|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568909|NCT00639496|Expectorants|expectorants|mesh-ancestor
56568910|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
56568911|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56568912|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
56568913|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568914|NCT00639496|Protective Agents|protective agents|mesh-ancestor
56568915|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568916|NCT00639496|Antidotes|antidotes|mesh-ancestor
56568918|NCT02688400|Diacetylrhein|diacetylrhein|mesh-list
56568919|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56568920|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56568921|NCT02688400|Analgesics|analgesics|mesh-ancestor
56568922|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
56568923|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568924|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568925|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568926|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56568927|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56568928|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56568929|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568930|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568931|NCT00639574|Nefopam|nefopam|mesh-list
56194900|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56194901|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194902|NCT01495624|Dexamethasone|dexamethasone|mesh-list
56194903|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
56194904|NCT01495624|Ropivacaine|ropivacaine|mesh-list
56194905|NCT01495624|Anesthetics|anesthetics|mesh-list
56194906|NCT01495624|BB 1101|bb 1101|mesh-list
56194907|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56194908|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
56122678|NCT01592292|Adalimumab|adalimumab|mesh-list
56194909|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
56568932|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56568933|NCT00639574|Analgesics|analgesics|mesh-ancestor
56568934|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
56568935|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568936|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568937|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
56568938|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568939|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56568940|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568941|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568942|NCT01004172|Bevacizumab|bevacizumab|mesh-list
56568943|NCT01004172|Trastuzumab|trastuzumab|mesh-list
56568944|NCT01004172|Carboplatin|carboplatin|mesh-list
56568945|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56568946|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56568947|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56568948|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56568949|NCT01004172|Growth Substances|growth substances|mesh-ancestor
56568950|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568951|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
56568952|NCT02688322|Sulbactam|sulbactam|mesh-list
56568953|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56099406|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099407|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56099408|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56099409|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
56099410|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099411|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099412|NCT04713410|Prednisolone|prednisolone|mesh-list
56099413|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56099414|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
56099415|NCT04713410|Hormones|hormones|mesh-ancestor
56099416|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56099417|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099418|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56194910|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194911|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194912|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56194913|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
56194914|NCT01495624|Hormones|hormones|mesh-ancestor
56194915|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56194916|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56194917|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194918|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
56194919|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194920|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194921|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
56194922|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194923|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
56194924|NCT01495715|Idebenone|idebenone|mesh-list
56194925|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
56194926|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568954|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56568955|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56568956|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568957|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568958|NCT02685748|Aspirin|aspirin|mesh-list
56568959|NCT02685748|Pantoprazole|pantoprazole|mesh-list
56568960|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56568961|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56568962|NCT02685748|Analgesics|analgesics|mesh-ancestor
56568963|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
56568964|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56568965|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56568966|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56568967|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56568969|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56568970|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56568971|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56568972|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56568973|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56568974|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
56568975|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56568976|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56569006|NCT05663944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569007|NCT05663944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56569008|NCT05663944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569009|NCT05663944|Antifungal Agents|antifungal agents|mesh-ancestor
56569010|NCT05663944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569011|NCT05663944|Immunologic Factors|immunologic factors|mesh-ancestor
56569012|NCT05663944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569013|NCT05663944|Hematinics|hematinics|mesh-ancestor
56569014|NCT02682862|Bromides|bromides|mesh-list
56569015|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
56569016|NCT02682862|Olodaterol|olodaterol|mesh-list
56569017|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56569018|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
56569019|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569020|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569021|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56569022|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
56569023|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
56569024|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56569025|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
56569026|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569027|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569028|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
56569029|NCT02073838|Ribavirin|ribavirin|mesh-list
56569030|NCT02073838|Decitabine|decitabine|mesh-list
56569031|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
56569032|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569033|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
56569034|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569035|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56569036|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569037|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569038|NCT00640198|Memantine|memantine|mesh-list
56569049|NCT04293822|Cetirizine|cetirizine|mesh-list
56569050|NCT04293822|Minoxidil|minoxidil|mesh-list
56569051|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56569052|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56569053|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56569054|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
56569055|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
56569056|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569057|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569058|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569059|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56569060|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
56569061|NCT02680600|Cefepime|cefepime|mesh-list
56569062|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56569063|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569064|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56569065|NCT04182724|Paclitaxel|paclitaxel|mesh-list
56569066|NCT04182724|Apatinib|apatinib|mesh-list
56569067|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56569068|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569069|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
56569070|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
56569071|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
56569072|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569073|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56569074|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569075|NCT04184518|Durvalumab|durvalumab|mesh-list
56569076|NCT04184518|Cediranib|cediranib|mesh-list
56569077|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569078|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569079|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569094|NCT05663710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569095|NCT05663710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569096|NCT05663710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56569097|NCT05663710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569098|NCT02928406|Atezolizumab|atezolizumab|mesh-list
56569099|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569100|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
56569101|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
56569102|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
56569103|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569104|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569105|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
56569106|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569107|NCT01161446|Antibodies|antibodies|mesh-list
56569108|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
56569109|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
56569110|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569111|NCT00641680|Fluticasone|fluticasone|mesh-list
56569113|NCT00641680|Budesonide|budesonide|mesh-list
56569114|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569115|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56569116|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
56569117|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569118|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569119|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56569120|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
56569121|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56569122|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56569124|NCT00641680|Hormones|hormones|mesh-ancestor
56569126|NCT01174004|Pimavanserin|pimavanserin|mesh-list
56569141|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569142|NCT00641758|Pycnogenols|pycnogenols|mesh-list
56569143|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56569144|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
56569145|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569146|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
56569147|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569148|NCT00641758|Protective Agents|protective agents|mesh-ancestor
56569149|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56569150|NCT00640276|Pitavastatin|pitavastatin|mesh-list
56569151|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56569152|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56569153|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56569154|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
56569155|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569156|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569157|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56569158|NCT02680132|Esomeprazole|esomeprazole|mesh-list
56569159|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56569160|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56569161|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56569162|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569163|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569164|NCT02683564|Infliximab|infliximab|mesh-list
56569165|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
56569166|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56569167|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569168|NCT01101035|Allopurinol|allopurinol|mesh-list
56569169|NCT01101035|Febuxostat|febuxostat|mesh-list
56569170|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
56569171|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569172|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569173|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
56569174|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569175|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56569181|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56569182|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56569184|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
56569185|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569186|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569187|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569188|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569189|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
56569190|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56569191|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569192|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317591|NCT00129246|Naltrexone|naltrexone|mesh-list
56569194|NCT01006980|Dacarbazine|dacarbazine|mesh-list
56569195|NCT01006980|Vemurafenib|vemurafenib|mesh-list
56569196|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56569197|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
56569198|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569199|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569200|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56569201|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569202|NCT04296240|Capecitabine|capecitabine|mesh-list
56569203|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
56569204|NCT04296240|Antiemetics|antiemetics|mesh-list
56569205|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56569206|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
56569207|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569208|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569209|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
56569210|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569211|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569212|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56194927|NCT01495715|Protective Agents|protective agents|mesh-ancestor
56194928|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194929|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56194930|NCT01495806|Cathartics|cathartics|mesh-ancestor
56194931|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56194932|NCT01495845|Clopidogrel|clopidogrel|mesh-list
56194933|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56194934|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56194935|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56194936|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56194937|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
56569213|NCT04205058|Caffeine|caffeine|mesh-list
56569214|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56569215|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569216|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56569217|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569218|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569219|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56194938|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194939|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194940|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099419|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099420|NCT04713332|Vitamin E|vitamin e|mesh-list
56099421|NCT04713332|Tocopherols|tocopherols|mesh-list
56099422|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
56099423|NCT04713332|Vitamins|vitamins|mesh-ancestor
56099424|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
56099425|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099426|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
56099427|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099428|NCT04713332|Protective Agents|protective agents|mesh-ancestor
56099429|NCT00476827|Gemcitabine|gemcitabine|mesh-list
56194941|NCT01495884|Lapatinib|lapatinib|mesh-list
56194942|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194943|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56194944|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194945|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194946|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
56194947|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194948|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56194949|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194950|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194951|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
56194952|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56194953|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194954|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56194955|NCT01495949|Thiopental|thiopental|mesh-list
56194956|NCT01495949|Etomidate|etomidate|mesh-list
56194957|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56194958|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56194959|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194960|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56194961|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
56194962|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
56194963|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
56194964|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
56194965|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
56194966|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194967|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194968|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
56194969|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56194970|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56099430|NCT00476827|Paclitaxel|paclitaxel|mesh-list
56099431|NCT00476827|Vinorelbine|vinorelbine|mesh-list
56099432|NCT00476827|Docetaxel|docetaxel|mesh-list
56099433|NCT00476827|Bevacizumab|bevacizumab|mesh-list
56099434|NCT00476827|Irinotecan|irinotecan|mesh-list
56099435|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56099436|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099437|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
56099438|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
56099439|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
56099440|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099441|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56099442|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56099443|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56099444|NCT00476827|Growth Substances|growth substances|mesh-ancestor
56194971|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56569220|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56569221|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
56569222|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569223|NCT04183738|Ritonavir|ritonavir|mesh-list
56569224|NCT04183738|Darunavir|darunavir|mesh-list
56569225|NCT04183738|Dolutegravir|dolutegravir|mesh-list
56569226|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56569227|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56569228|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
56569229|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569230|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569231|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56569232|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56569233|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
56569234|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569235|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56569236|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56569237|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56569238|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56569239|NCT04204980|Daratumumab|daratumumab|mesh-list
56569240|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56569241|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569242|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
56569243|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569244|NCT05664568|Amoxicillin|amoxicillin|mesh-list
56569245|NCT05664568|Clavulanic Acid|clavulanic acid|mesh-list
56569246|NCT05664568|Clavulanic Acids|clavulanic acids|mesh-list
56569247|NCT05664568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56569248|NCT05664568|Cephalexin|cephalexin|mesh-list
56569249|NCT05664568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56569250|NCT05664568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569265|NCT00640432|Analgesics|analgesics|mesh-ancestor
56569266|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
56569267|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569268|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569269|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569270|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569271|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56105692|NCT00004436|Prednisone|prednisone|mesh-list
56194972|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56194973|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194974|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
56194975|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56194976|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194977|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56194978|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194980|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
56194981|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
56194982|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56122754|NCT01589094|Immunologic Factors|immunologic factors|mesh-ancestor
56194983|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56194984|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
56194985|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56194986|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56194987|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56194988|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56194989|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56194990|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194991|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
56194992|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56194993|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56099445|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099446|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
55867791|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56099461|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
56099462|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
56099463|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099464|NCT00904423|Vitamin D|vitamin d|mesh-list
56099465|NCT00904423|Vitamins|vitamins|mesh-ancestor
56099466|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
56099467|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099468|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56099469|NCT05328895|Betahistine|betahistine|mesh-list
56099470|NCT05328895|Vasodilator Agents|vasodilator agents|mesh-ancestor
56099471|NCT05328895|Histamine Agonists|histamine agonists|mesh-ancestor
56099472|NCT05328895|Histamine Agents|histamine agents|mesh-ancestor
56099473|NCT05328895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099474|NCT05328895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099475|NCT05328895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099476|NCT00879619|Prednisone|prednisone|mesh-list
56099477|NCT00879619|Cortisone|cortisone|mesh-list
56099478|NCT00879619|Docetaxel|docetaxel|mesh-list
56099480|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099481|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
56099482|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
56099483|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
56194994|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194996|NCT01496196|Coagulants|coagulants|mesh-ancestor
56194997|NCT01496261|Aspirin|aspirin|mesh-list
56194998|NCT01496261|Clopidogrel|clopidogrel|mesh-list
56194999|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56195000|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56195001|NCT01496261|Analgesics|analgesics|mesh-ancestor
56195002|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
56195003|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195004|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195005|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195006|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569272|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56569273|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569274|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569275|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56569276|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56569277|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56569278|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
56569279|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569280|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56569281|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56569282|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569284|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569285|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56569286|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
56569287|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569288|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569289|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56569290|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
56569291|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
56569292|NCT00641212|Hormones|hormones|mesh-ancestor
56569293|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56569294|NCT04183192|Reslizumab|reslizumab|mesh-list
56569295|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56569296|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
56569297|NCT02681848|Nicotine|nicotine|mesh-list
56569298|NCT02681848|Varenicline|varenicline|mesh-list
56569299|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56569300|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
56569301|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569302|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569303|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56569304|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56569305|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
56569306|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569308|NCT00997386|Melphalan|melphalan|mesh-list
56569311|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56569312|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
56569313|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569314|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569315|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56569316|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569317|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
56569318|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569319|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569320|NCT02679820|Copper|copper|mesh-list
56569321|NCT02679820|Trace Elements|trace elements|mesh-ancestor
56569322|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
56569323|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569324|NCT00641914|Budesonide|budesonide|mesh-list
56569325|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569326|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56569327|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
56569328|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569329|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569330|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56569331|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
56569332|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
56569333|NCT00641914|Hormones|hormones|mesh-ancestor
56569334|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56569335|NCT00640588|Adefovir|adefovir|mesh-list
56569336|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56569337|NCT00640588|Telbivudine|telbivudine|mesh-list
56569338|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
56569339|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569340|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56569341|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56569342|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569343|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569344|NCT05663398|Ibuprofen|ibuprofen|mesh-list
56569345|NCT05663398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56569346|NCT05663398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56195007|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56195008|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56569347|NCT05663398|Analgesics|analgesics|mesh-ancestor
56569348|NCT05663398|Sensory System Agents|sensory system agents|mesh-ancestor
56569349|NCT05663398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569350|NCT05663398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569351|NCT05663398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569352|NCT05663398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569353|NCT05663398|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56569354|NCT05663398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569355|NCT05663398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569356|NCT00640744|Atorvastatin|atorvastatin|mesh-list
56569357|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56569358|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56569359|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
56569360|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569361|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56569362|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56569363|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569364|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
56569365|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56569366|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56569367|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569368|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
56569400|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
56569401|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
56569402|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
56569403|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569404|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569405|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
56569406|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569407|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569408|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56569409|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
56569410|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56569411|NCT00641446|Budesonide|budesonide|mesh-list
56569412|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569413|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56569414|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
56569415|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569416|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569417|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56317805|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
56569418|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
56569419|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
56569420|NCT00641446|Hormones|hormones|mesh-ancestor
56569421|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56569422|NCT02678182|Capecitabine|capecitabine|mesh-list
56569423|NCT02678182|Trastuzumab|trastuzumab|mesh-list
56569424|NCT02678182|Durvalumab|durvalumab|mesh-list
56569425|NCT02678182|Ramucirumab|ramucirumab|mesh-list
56569426|NCT02678182|Rucaparib|rucaparib|mesh-list
56569428|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
56569446|NCT05663242|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56569447|NCT05663164|Thiamine|thiamine|mesh-list
56569448|NCT05663164|Vitamins|vitamins|mesh-ancestor
56569449|NCT05663164|Micronutrients|micronutrients|mesh-ancestor
56569450|NCT05663164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569451|NCT05663164|Vitamin B Complex|vitamin b complex|mesh-ancestor
56569452|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
56569453|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56569454|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569455|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56569456|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569457|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
56569458|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56569459|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569460|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569461|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56569462|NCT02678728|Analgesics|analgesics|mesh-ancestor
56569463|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
56569464|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569465|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56569466|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56569499|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56569500|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569501|NCT05511610|Sevoflurane|sevoflurane|mesh-list
56569502|NCT05511610|Desflurane|desflurane|mesh-list
56569503|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56569504|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56569505|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
56569506|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
56569507|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569508|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569509|NCT02675530|Ketamine|ketamine|mesh-list
56569510|NCT02675530|Analgesics|analgesics|mesh-ancestor
56569511|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
56569512|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569513|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569514|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56569515|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56569516|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
56569517|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
56569518|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569519|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56569520|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56569521|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569522|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569547|NCT02675140|Vitamin A|vitamin a|mesh-list
56569548|NCT02675140|Albendazole|albendazole|mesh-list
56569549|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
56569550|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
56569551|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569552|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
56569553|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569554|NCT02675140|Protective Agents|protective agents|mesh-ancestor
56569555|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56569556|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569557|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
56569558|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56569559|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569560|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
56569561|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56569562|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56569563|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
56569564|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
56569565|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
56569566|NCT02674906|Heparin|heparin|mesh-list
56569567|NCT02674906|Calcium heparin|calcium heparin|mesh-list
56569568|NCT02674906|Anticoagulants|anticoagulants|mesh-list
56569570|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56569603|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
56569604|NCT04178512|Fentanyl|fentanyl|mesh-list
56569605|NCT04178512|BB 1101|bb 1101|mesh-list
56569606|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569607|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
56569608|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
56569609|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569610|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569611|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56569612|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
56569613|NCT04178512|Hormones|hormones|mesh-ancestor
56569614|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56569615|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56569616|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569617|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
56569618|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569619|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569620|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56569621|NCT04178512|Narcotics|narcotics|mesh-ancestor
56569622|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569623|NCT04178512|Analgesics|analgesics|mesh-ancestor
56569624|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
56569625|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56569626|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56569627|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
56569628|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
56569629|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
56569630|NCT01160198|Chelating Agents|chelating agents|mesh-list
56569631|NCT01160198|Glycine|glycine|mesh-list
56195009|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195011|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56195012|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195013|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
56195014|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56099484|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099485|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56099486|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
56099487|NCT00879619|Hormones|hormones|mesh-ancestor
56099488|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56099489|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099490|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56099491|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56099492|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56099493|NCT00879619|Growth Substances|growth substances|mesh-ancestor
56099494|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
56099495|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56099496|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569632|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
56569633|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569634|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
56569635|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569636|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569637|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
56569638|NCT01160198|Protective Agents|protective agents|mesh-ancestor
56569639|NCT01160198|Vitamins|vitamins|mesh-ancestor
56569640|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
56569641|NCT02676934|Anesthetics|anesthetics|mesh-list
56569642|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569643|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569644|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
56569645|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56318026|NCT00018954|Cytarabine|cytarabine|mesh-list
56569646|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
56569647|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
56569648|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569649|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569650|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569651|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56569652|NCT05351086|Analgesics|analgesics|mesh-ancestor
56569653|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
56569654|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569655|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56569656|NCT02885168|Phenylephrine|phenylephrine|mesh-list
56569657|NCT02885168|Protein C|protein c|mesh-list
56569658|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
56569680|NCT01159574|Dexamethasone|dexamethasone|mesh-list
56569681|NCT01159574|Pomalidomide|pomalidomide|mesh-list
56569682|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569683|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
56569684|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
56569685|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569686|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569687|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56569688|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
56569689|NCT01159574|Hormones|hormones|mesh-ancestor
56569690|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56569691|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56569692|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569693|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56569694|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569695|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56569696|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569697|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569698|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56569699|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56569700|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
56569701|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56569702|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56569703|NCT01159574|Growth Substances|growth substances|mesh-ancestor
56569704|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
56099497|NCT00822679|Eszopiclone|eszopiclone|mesh-list
56099498|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56099499|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099500|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099501|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56099502|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56099503|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56099504|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
56099505|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099506|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099507|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099508|NCT00323635|Urological Agents|urological agents|mesh-ancestor
56099509|NCT05033522|Sorafenib|sorafenib|mesh-list
56099522|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56099523|NCT00314353|Growth Substances|growth substances|mesh-ancestor
56099524|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099525|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
56099526|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56099527|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
56195015|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56195016|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56195017|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
56195018|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569705|NCT01158950|Tolcapone|tolcapone|mesh-list
56569706|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56569707|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56569708|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56569709|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569710|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569711|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
56569712|NCT00910234|Hematinics|hematinics|mesh-ancestor
56569713|NCT05652322|Furosemide|furosemide|mesh-list
56569714|NCT05652322|Diuretics|diuretics|mesh-ancestor
56569715|NCT05652322|Natriuretic Agents|natriuretic agents|mesh-ancestor
56569716|NCT05652322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569717|NCT05652322|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56569718|NCT05652322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56569719|NCT05652322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569720|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
56569721|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56569722|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
56569723|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569724|NCT01172288|Expectorants|expectorants|mesh-ancestor
56569727|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
56569760|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56569761|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569762|NCT04178980|Simvastatin|simvastatin|mesh-list
56569763|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56569764|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56569765|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
56569766|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569767|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56569768|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56569769|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569770|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56569771|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56569772|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
56569773|NCT02672566|Enoxaparin|enoxaparin|mesh-list
56569774|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
56569775|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56569776|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56569777|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569778|NCT02672488|Metformin|metformin|mesh-list
56569779|NCT02672488|Sorafenib|sorafenib|mesh-list
56569780|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56569781|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569783|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56569784|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569785|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569786|NCT02537392|Folic Acid|folic acid|mesh-list
56569787|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
56569788|NCT02537392|Vitamins|vitamins|mesh-ancestor
56569789|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
56569790|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569791|NCT02537392|Hematinics|hematinics|mesh-ancestor
56569792|NCT02673814|Durvalumab|durvalumab|mesh-list
56569793|NCT02673814|Bavituximab|bavituximab|mesh-list
56569805|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569806|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
56569807|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56569808|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56569809|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56569810|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56569811|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56569812|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569813|NCT02537158|Sorafenib|sorafenib|mesh-list
56569814|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569815|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56569816|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569817|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569818|NCT02676154|Fesoterodine|fesoterodine|mesh-list
56569819|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56569820|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56569821|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
56569822|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569823|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569824|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569825|NCT02676154|Urological Agents|urological agents|mesh-ancestor
56569826|NCT02676310|Bimatoprost|bimatoprost|mesh-list
56569827|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56569828|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
56569829|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56569830|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56569831|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569832|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
56569833|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569834|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569835|NCT04180384|Paclitaxel|paclitaxel|mesh-list
56569836|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56569837|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56569838|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569841|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
56569842|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569843|NCT00643240|Antibodies|antibodies|mesh-list
56569844|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56569845|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
56569846|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569847|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
56569848|NCT02671708|Busulfan|busulfan|mesh-list
56569849|NCT02671708|Idarubicin|idarubicin|mesh-list
56569850|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569851|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
56569852|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569853|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569854|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56569856|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569857|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569858|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56569859|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56569860|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56569861|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56569862|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569864|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569895|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56569896|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56569897|NCT04175158|Growth Substances|growth substances|mesh-ancestor
56569898|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569899|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
56569900|NCT02671318|Sirolimus|sirolimus|mesh-list
56569901|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56569902|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569903|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56569904|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569905|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
56569906|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56569907|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
56569908|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569909|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
56569910|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
56569911|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
56569912|NCT02668588|Octreotide|octreotide|mesh-list
56569913|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56569914|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56569915|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569916|NCT02671084|Sevoflurane|sevoflurane|mesh-list
56569917|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56569918|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56569919|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
56569920|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
56569921|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56569922|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569942|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569943|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56569944|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56569945|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
56569946|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569947|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56569948|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56569949|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56569950|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56569951|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56569952|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56569953|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569954|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56569955|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
56569956|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
56569957|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
56569958|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56569959|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
56569960|NCT02670616|Hormones|hormones|mesh-ancestor
56569961|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56569962|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56569963|NCT00645502|Risperidone|risperidone|mesh-list
56569964|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56569965|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
56569966|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56569967|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569968|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569969|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56569986|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56569987|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56569988|NCT02670772|Tenofovir|tenofovir|mesh-list
56569989|NCT02670772|Stavudine|stavudine|mesh-list
56569990|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
56569991|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56569992|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56569993|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56569994|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56569995|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56569996|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56569997|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56569998|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
56569999|NCT02667730|Acetaminophen|acetaminophen|mesh-list
56570000|NCT02667730|Celecoxib|celecoxib|mesh-list
56570001|NCT02667730|Naproxen|naproxen|mesh-list
56570002|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56570003|NCT02667730|Analgesics|analgesics|mesh-ancestor
56570004|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
56570005|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570040|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570041|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
56570042|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570043|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56570044|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
56570045|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56570046|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56570047|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56570048|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
56570049|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
56570050|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570051|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56570052|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56570053|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
56570054|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56570055|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570056|NCT02870634|Copper|copper|mesh-list
56570057|NCT02870634|Trace Elements|trace elements|mesh-ancestor
56570058|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
56570059|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570060|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
56570061|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56570062|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56570063|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570064|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570065|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56570066|NCT00645580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56570087|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570088|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56570089|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56570090|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570091|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56570092|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56570093|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570094|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
56570095|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570096|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56570097|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56570098|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56570099|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
56318490|NCT05574179|Midazolam|midazolam|mesh-list
56570100|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570101|NCT05033080|Ivacaftor|ivacaftor|mesh-list
56570102|NCT05033080|Elexacaftor|elexacaftor|mesh-list
56570103|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56570104|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570105|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570106|NCT00998946|Vitamins|vitamins|mesh-list
56570107|NCT00998946|Folic Acid|folic acid|mesh-list
56570108|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
56570109|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
56570110|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
56570111|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
56570112|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570113|NCT00998946|Hematinics|hematinics|mesh-ancestor
56570114|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570115|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56570116|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570117|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570118|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56570119|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56570120|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56570121|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
56570123|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56570124|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56570125|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570126|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
56570127|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
56570128|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56570129|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56570130|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570131|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570132|NCT00645034|Urological Agents|urological agents|mesh-ancestor
56570133|NCT04173832|Amantadine|amantadine|mesh-list
56570134|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56570135|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56570136|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
56570137|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570138|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
56570139|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570140|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570141|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570142|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56570143|NCT04173832|Analgesics|analgesics|mesh-ancestor
56570144|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
56570145|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570176|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56570177|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
56570178|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56570179|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570180|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570181|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56570182|NCT00646126|Renal Agents|renal agents|mesh-ancestor
56570183|NCT02537080|Nimodipine|nimodipine|mesh-list
56570184|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56570185|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56570186|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570187|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570188|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56570189|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570190|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
56570191|NCT02667496|Sargramostim|sargramostim|mesh-list
56570192|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
56570193|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570194|NCT00645112|Azithromycin|azithromycin|mesh-list
56570195|NCT00645112|Cefdinir|cefdinir|mesh-list
56570196|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56570197|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570198|NCT02666092|Antibodies|antibodies|mesh-list
56570199|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
56570200|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570201|NCT00645814|Adalimumab|adalimumab|mesh-list
56570202|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570203|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570204|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56570205|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
56570206|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56570219|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570220|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
56570221|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570222|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570223|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56570224|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
56570225|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570226|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
56570227|NCT00910390|Ethylene|ethylene|mesh-list
56570228|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56570229|NCT00910390|Growth Substances|growth substances|mesh-ancestor
56570230|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570231|NCT02665936|Dexamethasone|dexamethasone|mesh-list
56570232|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
56570233|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
56570234|NCT02665936|BB 1101|bb 1101|mesh-list
56570235|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570236|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
56570237|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
56570238|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570239|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570240|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56570241|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
56570242|NCT02665936|Hormones|hormones|mesh-ancestor
56570243|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570244|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56570245|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570246|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
56570247|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570248|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570249|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
56570262|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570263|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56570264|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56570265|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56570266|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
56570268|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56570269|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
56570270|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570271|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56570272|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570273|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570274|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56570275|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570276|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56570277|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
56570278|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56570279|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570280|NCT02666716|Fluconazole|fluconazole|mesh-list
56570281|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
56570282|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570283|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56570284|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56570285|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570311|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570312|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570313|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
56570314|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570315|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56570316|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
56570317|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56570318|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570319|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570320|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56570321|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
56570322|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56318709|NCT00022308|Irinotecan|irinotecan|mesh-list
56570323|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56570324|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56570325|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56570326|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
56570327|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
56570328|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56570333|NCT02666014|Neostigmine|neostigmine|mesh-list
56570363|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570364|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56570365|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
56570366|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570367|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56570368|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56570369|NCT00646516|Budesonide|budesonide|mesh-list
56570370|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
56570371|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56570372|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570373|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56570374|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
56570375|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570376|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570377|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56570378|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
56570379|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
56570380|NCT00646516|Hormones|hormones|mesh-ancestor
56570381|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570382|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56570383|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56570384|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56570385|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
56570386|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570387|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570409|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570410|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56570411|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
56570412|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
56570413|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56570414|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
56570415|NCT00646594|Hormones|hormones|mesh-ancestor
56570416|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570417|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56570418|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56570419|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56570420|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
56570421|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570422|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570423|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
56570424|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56570425|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
56570426|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570427|NCT04773184|Capsaicin|capsaicin|mesh-list
56570428|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
56570429|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
56570430|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
56570431|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570432|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570433|NCT00647140|Levodopa|levodopa|mesh-list
56570434|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
56570435|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570436|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570437|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570438|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56570439|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56570452|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
56570453|NCT02663830|Clomiphene|clomiphene|mesh-list
56570454|NCT02663830|Enclomiphene|enclomiphene|mesh-list
56570455|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
56570456|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003885|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
56570457|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
56570458|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56570459|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56570460|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570461|NCT02663830|Urological Agents|urological agents|mesh-ancestor
56570462|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56570463|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
56570464|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570465|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570466|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56570467|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
56570468|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56570469|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56570470|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56570471|NCT00648544|Pravastatin|pravastatin|mesh-list
56570472|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56570473|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56570474|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
56570475|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570476|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56570477|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56570478|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570480|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56570481|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56570482|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
56570483|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570484|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106774|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
56195019|NCT01496326|Ibuprofen|ibuprofen|mesh-list
56195020|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56195021|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56195022|NCT01496326|Analgesics|analgesics|mesh-ancestor
56195023|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
56570485|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570486|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56570487|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
56570488|NCT00648622|Protective Agents|protective agents|mesh-ancestor
56570489|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56570490|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570491|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56570492|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
56570493|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56570494|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56570495|NCT00994422|Ivermectin|ivermectin|mesh-list
56570496|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56570497|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570498|NCT00648778|Loxapine|loxapine|mesh-list
56570499|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56570500|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56570501|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570502|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570503|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56570504|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56570508|NCT00645424|Atorvastatin|atorvastatin|mesh-list
56570539|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570540|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570541|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56570542|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56570543|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
56318942|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
56570544|NCT02663440|Temozolomide|temozolomide|mesh-list
56570545|NCT02663440|Molgramostim|molgramostim|mesh-list
56570546|NCT02663440|Sargramostim|sargramostim|mesh-list
56570547|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56570548|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
56570549|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570550|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570551|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
56570552|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570554|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
56570555|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570556|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56570557|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
56570558|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570559|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570560|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56570561|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
56570562|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
56570563|NCT04171180|Hormones|hormones|mesh-ancestor
56570571|NCT02660008|Glucagon|glucagon|mesh-list
56570586|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570587|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570588|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
56570589|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56570590|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570591|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570592|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
56570593|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570595|NCT02663284|Ropivacaine|ropivacaine|mesh-list
56570650|NCT00647842|Analgesics|analgesics|mesh-ancestor
56570651|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
56570652|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570653|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56570654|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56570655|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
56570656|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
56570657|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
56570658|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56570659|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56570660|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56570661|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570662|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570663|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
56570664|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570665|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570666|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56570667|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570668|NCT02662894|Valsartan|valsartan|mesh-list
56004117|NCT00002368|Lamivudine|lamivudine|mesh-list
56570669|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56570670|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56570671|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56570672|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
56570673|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570674|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56570675|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56570676|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570677|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56570678|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56570679|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56570680|NCT04291794|Propofol|propofol|mesh-list
56570681|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56570682|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570683|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570684|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56570686|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
56570687|NCT02662660|Acetaminophen|acetaminophen|mesh-list
56570688|NCT02662660|Dipyrone|dipyrone|mesh-list
56570689|NCT02662660|Bupivacaine|bupivacaine|mesh-list
56570690|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
56319100|NCT05268185|Vaccines|vaccines|mesh-list
56570691|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
56570692|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
56570693|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570694|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570695|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
56570696|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570697|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56570698|NCT02662660|Analgesics|analgesics|mesh-ancestor
56570699|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
56570700|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56570701|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570702|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570703|NCT02868606|Insulin|insulin|mesh-list
56570704|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56570705|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56570706|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570707|NCT00647920|Adalimumab|adalimumab|mesh-list
56570708|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570709|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570710|NCT00830869|Ixazomib|ixazomib|mesh-list
56570711|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570715|NCT02662504|Cisplatin|cisplatin|mesh-list
56570737|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570738|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56570739|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56570740|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
56570741|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570742|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56570743|NCT00702793|Varenicline|varenicline|mesh-list
56570744|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56570745|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56570746|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
56570747|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570748|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570749|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570751|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
56570752|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56570753|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570754|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570755|NCT00994110|Pasireotide|pasireotide|mesh-list
56570756|NCT00994110|Hormones|hormones|mesh-ancestor
56570757|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570759|NCT02662348|Aldesleukin|aldesleukin|mesh-list
56570792|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
56570793|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570794|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570795|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56570796|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56570797|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56570798|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
56570799|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570800|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570801|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
56570802|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56570803|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56570804|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56570805|NCT04170790|Saxagliptin|saxagliptin|mesh-list
56570806|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
56570807|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
56570808|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56570848|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56570849|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56570850|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56570851|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
56570852|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570853|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570854|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
56570855|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56570856|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
56570857|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
56570858|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570859|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570860|NCT00648076|Valproic Acid|valproic acid|mesh-list
56570861|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
56570862|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570863|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570864|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
56570865|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570866|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570867|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
56195024|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195025|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195026|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195027|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56195028|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56195029|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195030|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195031|NCT01496417|Abatacept|abatacept|mesh-list
56099528|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099529|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56099530|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56099531|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099532|NCT00279409|Aripiprazole|aripiprazole|mesh-list
56099533|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
56099534|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099535|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56099536|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56099537|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099538|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099539|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
56099540|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
56099541|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099542|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099543|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56099544|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56099545|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
56099546|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56099547|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56099548|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56099549|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56099551|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
56099552|NCT05278975|Thiostrepton|thiostrepton|mesh-list
56099553|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56570868|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56570869|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570870|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56570871|NCT00649012|Pioglitazone|pioglitazone|mesh-list
56570872|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56570873|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570874|NCT04685590|Dasatinib|dasatinib|mesh-list
56570875|NCT04685590|Quercetin|quercetin|mesh-list
56570876|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570877|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56570878|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570879|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570880|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
56570881|NCT04685590|Protective Agents|protective agents|mesh-ancestor
56570882|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570883|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
56570884|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56570885|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56570886|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570887|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
56570888|NCT04170088|Coagulants|coagulants|mesh-ancestor
56570889|NCT00648154|Letrozole|letrozole|mesh-list
56570890|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570891|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56570892|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56570893|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570894|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570914|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
56570915|NCT02661100|Poly ICLC|poly iclc|mesh-list
56570916|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56570917|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56570918|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
56570919|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
56570920|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570922|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56570923|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570924|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56570925|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56570926|NCT02660866|Vorapaxar|vorapaxar|mesh-list
56570927|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56570928|NCT00853099|Adalimumab|adalimumab|mesh-list
56570929|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56570930|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56570931|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56570932|NCT00648310|Estrogens|estrogens|mesh-list
56570933|NCT00648310|Hormones|hormones|mesh-ancestor
56570934|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56570935|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570936|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56570937|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56570938|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
56570939|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56570940|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570941|NCT00648310|Urological Agents|urological agents|mesh-ancestor
56570942|NCT00702871|Ranitidine|ranitidine|mesh-list
56570943|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56570944|NCT00702871|Sucralfate|sucralfate|mesh-list
56570945|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56570946|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56570947|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56570948|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
56570949|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
56570950|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099554|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099555|NCT05011058|Valganciclovir|valganciclovir|mesh-list
56099556|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
56099557|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099559|NCT05007392|Dotinurad|dotinurad|mesh-list
56158070|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
56570951|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570952|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570953|NCT00830167|Pregabalin|pregabalin|mesh-list
56570954|NCT00830167|Analgesics|analgesics|mesh-ancestor
56570955|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
56570956|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56570957|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56570958|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
56570959|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56570960|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56570961|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570962|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56570963|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56570964|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56570965|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56570966|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56570967|NCT04160052|Azacitidine|azacitidine|mesh-list
56570968|NCT04160052|Venetoclax|venetoclax|mesh-list
56570969|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56570970|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
56570971|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56570972|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571001|NCT00843193|Fluticasone|fluticasone|mesh-list
56571002|NCT00843193|Xhance|xhance|mesh-list
56571003|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571004|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56571005|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
56571006|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571007|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571008|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56571009|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
56571010|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
56571011|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56571012|NCT00853021|Aldesleukin|aldesleukin|mesh-list
56571013|NCT00853021|Bevacizumab|bevacizumab|mesh-list
56571014|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56571015|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571016|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56571017|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56571018|NCT00853021|Growth Substances|growth substances|mesh-ancestor
56571019|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571020|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
56571021|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56571022|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56571023|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
56571024|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571025|NCT00913237|Desipramine|desipramine|mesh-list
56571026|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56571027|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
56571028|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56571029|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571030|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571031|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56107185|NCT00002941|Carmustine|carmustine|mesh-list
56099560|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
56099561|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56099562|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
56099563|NCT05007392|Renal Agents|renal agents|mesh-ancestor
56099564|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
56099565|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
56099566|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099567|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56099568|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56099569|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56099570|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
56099571|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099572|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56571032|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56571033|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571034|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
56571035|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571036|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571037|NCT05367284|Testosterone|testosterone|mesh-list
56571038|NCT05367284|Androgens|androgens|mesh-ancestor
56571039|NCT05367284|Hormones|hormones|mesh-ancestor
56571040|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571041|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571042|NCT00843115|Donepezil|donepezil|mesh-list
56571043|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56571044|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571045|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571046|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
56571047|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571048|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571049|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
56571050|NCT01156376|Listerine|listerine|mesh-list
56571051|NCT01156376|Fluorides|fluorides|mesh-list
56571052|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
56571053|NCT01156376|Protective Agents|protective agents|mesh-ancestor
56571054|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571055|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56571056|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571057|NCT01156142|Doxepin|doxepin|mesh-list
56571058|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56571059|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56571060|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571061|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571062|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56571063|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
56571064|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099573|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56099596|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56099597|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
56099598|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099599|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099600|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56099601|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56571065|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
56571066|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
56319476|NCT00026091|Fenretinide|fenretinide|mesh-list
56571067|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571068|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571069|NCT00842257|Panitumumab|panitumumab|mesh-list
56571070|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56571071|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571072|NCT00706069|Capecitabine|capecitabine|mesh-list
56571073|NCT00706069|Vinorelbine|vinorelbine|mesh-list
56571074|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56571075|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
56571076|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571077|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571078|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56571079|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
56571080|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
56571081|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
56571082|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56571083|NCT01155284|Lansoprazole|lansoprazole|mesh-list
56571084|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
56571085|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571086|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571087|NCT01155284|Incretins|incretins|mesh-ancestor
56571089|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56099602|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
56099603|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56099604|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56099605|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56099606|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56099607|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56099608|NCT00780481|Bradykinin|bradykinin|mesh-list
56099609|NCT00780481|Kininogens|kininogens|mesh-list
56099610|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
56099611|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56099612|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
56099613|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099614|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099615|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
56099616|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56099617|NCT05345990|Antibodies|antibodies|mesh-list
56099618|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
56099619|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099620|NCT00019747|Thalidomide|thalidomide|mesh-list
56099621|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099622|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
56099623|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099624|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
56099625|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56099626|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571090|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56571091|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
56571092|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571093|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571094|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56571095|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571096|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56571097|NCT00852397|Apixaban|apixaban|mesh-list
56571098|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56571099|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
56571100|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56571101|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
56571102|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571103|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571104|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
56571105|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
56571106|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56571107|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
56571108|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571109|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
56571110|NCT00852241|Protective Agents|protective agents|mesh-ancestor
56571111|NCT02612233|Pregabalin|pregabalin|mesh-list
56571112|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56571113|NCT02612233|Analgesics|analgesics|mesh-ancestor
56571114|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
56571115|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571116|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571117|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
56571118|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56571119|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571120|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571121|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56571122|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56571123|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56107236|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099627|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56099628|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56099629|NCT00019747|Growth Substances|growth substances|mesh-ancestor
56099630|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
56099645|NCT00746239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56571124|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571125|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56571126|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56571127|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56571128|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571129|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
56571130|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
56571131|NCT01169636|Carboplatin|carboplatin|mesh-list
56571132|NCT01169636|Etoposide|etoposide|mesh-list
56571133|NCT01169636|Ifosfamide|ifosfamide|mesh-list
56571134|NCT01169636|Panobinostat|panobinostat|mesh-list
56571135|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571136|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56571137|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56571138|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56571139|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571140|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571141|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56571142|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
56571143|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56571144|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
56571145|NCT00706225|Estrogens|estrogens|mesh-list
56571146|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56571174|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
56571175|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56571176|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571177|NCT01169558|Bevacizumab|bevacizumab|mesh-list
56571178|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56571179|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571180|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56571181|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56571182|NCT01169558|Growth Substances|growth substances|mesh-ancestor
56571183|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571184|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
56571186|NCT00700687|Celecoxib|celecoxib|mesh-list
56571187|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56571188|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56571189|NCT00700687|Analgesics|analgesics|mesh-ancestor
56571190|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
56571191|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571192|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571193|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571194|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56571231|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56571232|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56571233|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56571234|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56571235|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56571236|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56571237|NCT00707083|Dexamethasone|dexamethasone|mesh-list
56571238|NCT00707083|Methotrexate|methotrexate|mesh-list
56571239|NCT00707083|Vincristine|vincristine|mesh-list
56571240|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
56571241|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571242|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
56571243|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
56571244|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571245|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571246|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571247|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
56571249|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571250|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56571251|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571252|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56571253|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
56571254|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56571255|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56571256|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
56571257|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571258|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
56571259|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571277|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56571278|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56571279|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56571280|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
56571281|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571282|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571283|NCT04116931|Clopidogrel|clopidogrel|mesh-list
56571284|NCT04116931|Ticagrelor|ticagrelor|mesh-list
56571285|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56571286|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56571287|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56571288|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56571289|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
56571290|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571291|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571292|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571294|NCT00600886|Pasireotide|pasireotide|mesh-list
56571295|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571296|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56571297|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571298|NCT00600886|Hormones|hormones|mesh-ancestor
56571299|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571300|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571301|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56571302|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56571303|NCT00649324|Diuretics|diuretics|mesh-ancestor
56571304|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
56571305|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571306|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56571307|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571308|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571309|NCT00648388|Cilostazol|cilostazol|mesh-list
56107403|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
56099646|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56099647|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56099648|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571310|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56571311|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
56571312|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571313|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571314|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56571315|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
56571316|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56571317|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56571318|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571319|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56571320|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
56571321|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56571322|NCT00648388|Protective Agents|protective agents|mesh-ancestor
56571323|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56571324|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56571325|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571326|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
56571327|NCT02658760|Bupivacaine|bupivacaine|mesh-list
56571328|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
56571329|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
56571330|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571331|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571332|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
56571333|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571334|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56571335|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56571336|NCT02658760|Analgesics|analgesics|mesh-ancestor
56571337|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56571338|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56099649|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099650|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
56099651|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099652|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56099653|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
56099654|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099655|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56099656|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56099657|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
56099658|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
56099659|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099660|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56099661|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56099662|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
56099663|NCT04977674|Naltrexone|naltrexone|mesh-list
56099664|NCT04977674|Ketamine|ketamine|mesh-list
56099665|NCT04977674|Analgesics|analgesics|mesh-ancestor
56571339|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56571340|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
56571341|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571342|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571344|NCT02536690|Remifentanil|remifentanil|mesh-list
56571345|NCT02536690|Propofol|propofol|mesh-list
56571346|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56571347|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571348|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571349|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56571350|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
56571351|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
56571352|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56571353|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56571354|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56571355|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56571356|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
56571357|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
56571358|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571359|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571360|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56571361|NCT02536690|Narcotics|narcotics|mesh-ancestor
56571362|NCT02536690|Analgesics|analgesics|mesh-ancestor
56571363|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
56571364|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571365|NCT00649090|Exemestane|exemestane|mesh-list
56571366|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571367|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56571368|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56571383|NCT00838903|Hormones|hormones|mesh-ancestor
56571387|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571388|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571389|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56571390|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56571391|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
56571392|NCT00648466|Sumatriptan|sumatriptan|mesh-list
56571393|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56571394|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56571395|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56571397|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571398|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571399|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571400|NCT00649402|Amlodipine|amlodipine|mesh-list
56571401|NCT00649402|Benazepril|benazepril|mesh-list
56571402|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56571403|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56571404|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571405|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571406|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56571407|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571408|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
56571409|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56571410|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
56571411|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571412|NCT04477486|Venetoclax|venetoclax|mesh-list
56571413|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571414|NCT00649480|Balsalazide|balsalazide|mesh-list
56571415|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56571416|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56571417|NCT00649480|Analgesics|analgesics|mesh-ancestor
56571418|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
56571419|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571420|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571421|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571425|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56571426|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571427|NCT02656342|Renal Agents|renal agents|mesh-ancestor
56571428|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56571429|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
56571430|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56571431|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
56571432|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571433|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
56571434|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
56571435|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571436|NCT00650416|Carvedilol|carvedilol|mesh-list
56571437|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56571438|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56571439|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
56571440|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571441|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571442|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571443|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56571445|NCT00650416|Protective Agents|protective agents|mesh-ancestor
56571446|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56571447|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571448|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56571449|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
56571450|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56571451|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56571452|NCT00649948|Metformin|metformin|mesh-list
56571453|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571454|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571455|NCT04167982|Isotretinoin|isotretinoin|mesh-list
56571456|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56571457|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
56571458|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56571467|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571469|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
56571470|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571471|NCT00828139|Aflibercept|aflibercept|mesh-list
56571472|NCT00828139|Topotecan|topotecan|mesh-list
56571473|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
56571474|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56571475|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56571476|NCT00828139|Growth Substances|growth substances|mesh-ancestor
56571477|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571478|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
56571479|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571480|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56571481|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56571482|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571483|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571484|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
56571485|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56571486|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
56571487|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571488|NCT02658214|Leucovorin|leucovorin|mesh-list
56571489|NCT02658214|Folic Acid|folic acid|mesh-list
56571490|NCT02658214|Gemcitabine|gemcitabine|mesh-list
56571491|NCT02658214|Paclitaxel|paclitaxel|mesh-list
56571492|NCT02658214|Etoposide|etoposide|mesh-list
56571493|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56571494|NCT02658214|Carboplatin|carboplatin|mesh-list
56571495|NCT02658214|Fluorouracil|fluorouracil|mesh-list
56571496|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
56571497|NCT02658214|Durvalumab|durvalumab|mesh-list
56571498|NCT02658214|Tremelimumab|tremelimumab|mesh-list
56571515|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56571516|NCT02658214|Antidotes|antidotes|mesh-ancestor
56571517|NCT02658214|Protective Agents|protective agents|mesh-ancestor
56571518|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
56571519|NCT02658214|Vitamins|vitamins|mesh-ancestor
56571520|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
56571521|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56571522|NCT02658214|Hematinics|hematinics|mesh-ancestor
56571523|NCT04169230|Citalopram|citalopram|mesh-list
56571524|NCT04169230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56571525|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56571526|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571527|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571528|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571529|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
56571530|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571531|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56571532|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
56571533|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56571534|NCT04201756|Afatinib|afatinib|mesh-list
56571535|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571536|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56571537|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571538|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571539|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
56571540|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56571541|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56571542|NCT02651350|Prednisolone|prednisolone|mesh-list
56571543|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
56571544|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56571545|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
56571546|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571547|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
56571548|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
56571549|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571552|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
56571554|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571555|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56571556|NCT02651350|Protective Agents|protective agents|mesh-ancestor
56571557|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56571558|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571559|NCT02658292|Naftifine|naftifine|mesh-list
56571560|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
56571561|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571562|NCT02651038|Micafungin|micafungin|mesh-list
56571563|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
56571564|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571565|NCT00650026|Adalimumab|adalimumab|mesh-list
56571566|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571567|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56571568|NCT00838513|Eculizumab|eculizumab|mesh-list
56571569|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56571570|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56571571|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
56571572|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571573|NCT00649636|Fluoxetine|fluoxetine|mesh-list
56571574|NCT00649636|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56571578|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571607|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
56571608|NCT02657512|Charcoal|charcoal|mesh-list
56571609|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56571610|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
56571611|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56571612|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
56571613|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571614|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571615|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
56571617|NCT02657512|Protective Agents|protective agents|mesh-ancestor
56571618|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571619|NCT00818779|Amlodipine|amlodipine|mesh-list
56571620|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56571621|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56571622|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571623|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571624|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56571625|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571626|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
56571663|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56571664|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571665|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56571666|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56571667|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
56571668|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
56571669|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
56571670|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571671|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571672|NCT02650102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56571673|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56571674|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571675|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
56571676|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
56571677|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56571678|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56571679|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56571680|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56571682|NCT00650182|Naltrexone|naltrexone|mesh-list
56571683|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56571684|NCT00650182|Narcotics|narcotics|mesh-ancestor
56571685|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571686|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571687|NCT00650182|Analgesics|analgesics|mesh-ancestor
56571688|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
56571689|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571690|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56571691|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56571692|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
56571709|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56571710|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
56571711|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56571712|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56571713|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56571714|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56571715|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
56571716|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
56571717|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571718|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56571719|NCT00910780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56571720|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56571721|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56571722|NCT02656810|Teriparatide|teriparatide|mesh-list
56571723|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56571724|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571725|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56571726|NCT02649478|Fluticasone|fluticasone|mesh-list
56571727|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56571728|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56571729|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571730|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56571731|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
56571732|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571733|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571734|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56571735|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
56320151|NCT00392717|Atorvastatin|atorvastatin|mesh-list
56571752|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571753|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571754|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56571755|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
56571756|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
56571757|NCT04168138|Cytarabine|cytarabine|mesh-list
56571758|NCT04168138|Decitabine|decitabine|mesh-list
56571759|NCT04168138|Aclarubicin|aclarubicin|mesh-list
56571760|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56571761|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
56571762|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571763|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571764|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
56571765|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571766|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56571767|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
56571768|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571769|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571770|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56571771|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56571772|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56571773|NCT04059562|Irinotecan|irinotecan|mesh-list
56571774|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56571775|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56571776|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571777|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571778|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571779|NCT00649870|Valacyclovir|valacyclovir|mesh-list
56571780|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
56571781|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571797|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56571798|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571799|NCT03978520|Upadacitinib|upadacitinib|mesh-list
56571800|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56571801|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56571802|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571803|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571804|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56571805|NCT02652598|Tolcapone|tolcapone|mesh-list
56571806|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56571807|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56571808|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56571809|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571810|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571811|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56571812|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571813|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571814|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
56571815|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
56571816|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56320231|NCT00030069|Vitamins|vitamins|mesh-ancestor
56571817|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56571818|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571849|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56571850|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
56571851|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571852|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571853|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571854|NCT00652600|Propranolol|propranolol|mesh-list
56571855|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56571856|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56571857|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
56571858|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56571859|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571860|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571861|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56571862|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56571863|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
56571864|NCT03201250|Dexamethasone|dexamethasone|mesh-list
56571865|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56571866|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
56571903|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56571904|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56571905|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
56571906|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56571907|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56571908|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
56571909|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
56571910|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
56571911|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571912|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571913|NCT02644408|Megestrol|megestrol|mesh-list
56571914|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56571915|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56571916|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56571917|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
56571918|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56571919|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571920|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56571921|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56571922|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56571923|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571924|NCT05758597|Midazolam|midazolam|mesh-list
56571925|NCT05758597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56571926|NCT05758597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56571927|NCT05758597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571928|NCT05758597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571929|NCT05758597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56571930|NCT05758597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56571948|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571949|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56571950|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
56571951|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571952|NCT02641288|Ropivacaine|ropivacaine|mesh-list
56571953|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
56571954|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
56571955|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56571956|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571957|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
56571958|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56571959|NCT04165174|Apatinib|apatinib|mesh-list
56571960|NCT04165174|Antibodies|antibodies|mesh-list
56571961|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56571962|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
56571963|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571964|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571965|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56571966|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320389|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
56571967|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571968|NCT02613247|Hylan|hylan|mesh-list
56571969|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
56108069|NCT00003613|Carmustine|carmustine|mesh-list
56099666|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
56099667|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099668|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099669|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56099670|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56099671|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
56099672|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
56099673|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099674|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56099675|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56195033|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195034|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195035|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195036|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
56195037|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195038|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56195039|NCT01496443|Glimepiride|glimepiride|mesh-list
56195040|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56195041|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195042|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195043|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195044|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
56099676|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099677|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099678|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56099679|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56099680|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56099681|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56571970|NCT02613247|Protective Agents|protective agents|mesh-ancestor
56571971|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571972|NCT02641132|Mitomycins|mitomycins|mesh-list
56571973|NCT02641132|Mitomycin|mitomycin|mesh-list
56571974|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56571975|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571976|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
56571977|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56571978|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56571979|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56571980|NCT00653614|Drospirenone|drospirenone|mesh-list
56571981|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56571982|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
56571983|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56571984|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56571985|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56571986|NCT00653614|Diuretics|diuretics|mesh-ancestor
56571987|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
56571988|NCT02644252|Tocotrienols|tocotrienols|mesh-list
56571989|NCT02644252|Vitamin E|vitamin e|mesh-list
56571990|NCT02644252|Tocopherols|tocopherols|mesh-list
56571991|NCT02644252|Carboplatin|carboplatin|mesh-list
56571992|NCT02644252|Vinorelbine|vinorelbine|mesh-list
56571993|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56571994|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56572020|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56572021|NCT02640976|Cetrorelix|cetrorelix|mesh-list
56572022|NCT02640976|Menotropins|menotropins|mesh-list
56572023|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56572024|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572025|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56572026|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
56572027|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
56572028|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572029|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
56572030|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
56572031|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572032|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56572033|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56572034|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572035|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56572036|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572037|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56572038|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56572039|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572040|NCT02535988|Thymalfasin|thymalfasin|mesh-list
56320452|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572041|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56572042|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
56572043|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572045|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572046|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
56572047|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
56572048|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
56572049|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099682|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56099683|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099684|NCT00402883|Folic Acid|folic acid|mesh-list
56099685|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
56099686|NCT00402883|Bevacizumab|bevacizumab|mesh-list
56099687|NCT00402883|Carboplatin|carboplatin|mesh-list
56099688|NCT00402883|Pemetrexed|pemetrexed|mesh-list
56099689|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56099690|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099691|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56572050|NCT02535910|Vitamin D|vitamin d|mesh-list
56572051|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
56572052|NCT02535910|Calcifediol|calcifediol|mesh-list
56572053|NCT02535910|Vitamins|vitamins|mesh-ancestor
56572054|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
56572055|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572056|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56572057|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56572058|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56572060|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56572061|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56572062|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572063|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572064|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572065|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572066|NCT00849901|Analgesics|analgesics|mesh-ancestor
56572078|NCT02641054|Levodopa|levodopa|mesh-list
56572106|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
56572107|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
56572108|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
56572109|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56572110|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
56572111|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
56572112|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572113|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
56572114|NCT00652912|Clonazepam|clonazepam|mesh-list
56572116|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
56572117|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
56572118|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572119|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572120|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572121|NCT00707473|Cisplatin|cisplatin|mesh-list
56572122|NCT00707473|Carboplatin|carboplatin|mesh-list
56572123|NCT00707473|Docetaxel|docetaxel|mesh-list
56572124|NCT00707473|Fluorouracil|fluorouracil|mesh-list
56572125|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572126|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
56572127|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
56572128|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
56005581|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
56572129|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572130|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
56572131|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56572132|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56572156|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572157|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572158|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56572159|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56572160|NCT02640508|Lenvatinib|lenvatinib|mesh-list
56572161|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572162|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56572163|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572164|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572165|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
56572166|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56572167|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56572168|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572169|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
56572170|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
56572171|NCT05259566|Menthol|menthol|mesh-list
56572172|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
56572173|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
56572174|NCT02643550|Cetuximab|cetuximab|mesh-list
56572175|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56572176|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572177|NCT00817063|Alitretinoin|alitretinoin|mesh-list
56572178|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572179|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
56572180|NCT04313270|Evolocumab|evolocumab|mesh-list
56572181|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56572182|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56572183|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
56572184|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572185|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56572202|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572203|NCT00707551|Ketoconazole|ketoconazole|mesh-list
56572204|NCT00707551|Verapamil|verapamil|mesh-list
56572206|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572207|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56572208|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56572209|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572210|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572211|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56572212|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
56572213|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572214|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572215|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56572216|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56572217|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56572218|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572219|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56572220|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
56572221|NCT00986154|Heparin|heparin|mesh-list
56572222|NCT00986154|Calcium heparin|calcium heparin|mesh-list
56572223|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56572224|NCT00986154|Tinzaparin|tinzaparin|mesh-list
56572225|NCT00986154|Dalteparin|dalteparin|mesh-list
56572226|NCT00986154|Warfarin|warfarin|mesh-list
56572227|NCT00986154|Edoxaban|edoxaban|mesh-list
56572228|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
56572229|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56572230|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56572232|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56572248|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572249|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572250|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56572251|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56572252|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
56572253|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56572254|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
56572255|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
56572256|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
56572257|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56572258|NCT02613091|Clemastine|clemastine|mesh-list
56572259|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
56572260|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
56572261|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56572262|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
56572263|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
56572264|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572265|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320687|NCT00031746|Caseins|caseins|mesh-list
56572266|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572267|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56572268|NCT02639806|Lidocaine|lidocaine|mesh-list
56572269|NCT02639806|Sevoflurane|sevoflurane|mesh-list
56572270|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
56572293|NCT00848965|Xhance|xhance|mesh-list
56572299|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56572300|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
56572301|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
56572302|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56572303|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
56572304|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
56572305|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56572306|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56572307|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572308|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572309|NCT00654082|Urological Agents|urological agents|mesh-ancestor
56572310|NCT00654160|Leucovorin|leucovorin|mesh-list
56572311|NCT00654160|Fluorouracil|fluorouracil|mesh-list
56572312|NCT00654160|Irinotecan|irinotecan|mesh-list
56572313|NCT00654160|Calcium|calcium|mesh-list
56572314|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
56572315|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56572316|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572317|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
56572318|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572319|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56572320|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572326|NCT00654160|Antidotes|antidotes|mesh-ancestor
56572352|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56572353|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
56572354|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572355|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56572356|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56572357|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572358|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
56572359|NCT00816595|Bevacizumab|bevacizumab|mesh-list
56572360|NCT00816595|Rituximab|rituximab|mesh-list
56572361|NCT00816595|Pentostatin|pentostatin|mesh-list
56572362|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56572363|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
56572364|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572365|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56572366|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56572367|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
56572368|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572369|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572370|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56572371|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56572372|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56572373|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56572374|NCT00816595|Growth Substances|growth substances|mesh-ancestor
56572375|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
56572379|NCT01166438|Trospium chloride|trospium chloride|mesh-list
56572401|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
56572402|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
56572403|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572404|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56572405|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572406|NCT01153958|Metronidazole|metronidazole|mesh-list
56572407|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
56572408|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572409|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56572410|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56572411|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56572412|NCT00707785|Vitamin A|vitamin a|mesh-list
56572413|NCT00707785|Vitamins|vitamins|mesh-ancestor
56572414|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
56572415|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572416|NCT00599638|Pregabalin|pregabalin|mesh-list
56572417|NCT00599638|Analgesics|analgesics|mesh-ancestor
56572418|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
56572419|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572420|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572421|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
56572422|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56572423|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572424|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572425|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56572426|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56572449|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56572450|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572451|NCT02638870|Amitriptyline|amitriptyline|mesh-list
56572452|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56572453|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
56572454|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56572455|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56572456|NCT02638870|Analgesics|analgesics|mesh-ancestor
56572457|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
56572458|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572459|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572460|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56572461|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56572462|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572463|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572464|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
56572465|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572466|NCT02641990|Exenatide|exenatide|mesh-list
56572467|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56572468|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572469|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56572470|NCT02641990|Incretins|incretins|mesh-ancestor
56572471|NCT02641990|Hormones|hormones|mesh-ancestor
56572472|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572473|NCT00653380|Doxycycline|doxycycline|mesh-list
56572474|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56572475|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572476|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
56572477|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56572479|NCT02646592|Alfentanil|alfentanil|mesh-list
56572493|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
56572494|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572495|NCT02646670|Ranibizumab|ranibizumab|mesh-list
56572496|NCT02646670|Aflibercept|aflibercept|mesh-list
56572497|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56572498|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56572499|NCT02646670|Growth Substances|growth substances|mesh-ancestor
56572500|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572501|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
56572502|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572503|NCT00651976|Letrozole|letrozole|mesh-list
56572504|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572505|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56572506|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56572507|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572508|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572509|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56572510|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
56572511|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572512|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572513|NCT01166282|Adalimumab|adalimumab|mesh-list
56572514|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56572515|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56572516|NCT01153724|Fluconazole|fluconazole|mesh-list
56572517|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
56572521|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572540|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572541|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572542|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
56572543|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56572544|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
56572545|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56572546|NCT00598702|Acetaminophen|acetaminophen|mesh-list
56572547|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56572548|NCT00598702|Analgesics|analgesics|mesh-ancestor
56572549|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
56572550|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572551|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572552|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
56572553|NCT01148810|Siponimod|siponimod|mesh-list
56572554|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56572555|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572556|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56572557|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
56572558|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572559|NCT02884310|Remifentanil|remifentanil|mesh-list
56572560|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56572561|NCT02884310|Narcotics|narcotics|mesh-ancestor
56572562|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572563|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572564|NCT02884310|Analgesics|analgesics|mesh-ancestor
56572565|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
56572566|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572567|NCT01164956|Methylphenidate|methylphenidate|mesh-list
56572568|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56572569|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572570|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56572571|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56572572|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572573|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572574|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
56099692|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56099693|NCT00402883|Growth Substances|growth substances|mesh-ancestor
56572575|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572576|NCT01151540|Rufinamide|rufinamide|mesh-list
56572577|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
56572578|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56572579|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56572580|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572581|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572582|NCT01163786|Bortezomib|bortezomib|mesh-list
56572583|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572584|NCT05367362|Minocycline|minocycline|mesh-list
56572585|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56572586|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572587|NCT00984282|Sorafenib|sorafenib|mesh-list
56572588|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572589|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56572590|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572591|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572592|NCT04187196|Propofol|propofol|mesh-list
56572593|NCT04187196|Methohexital|methohexital|mesh-list
56572594|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56572595|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572596|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572597|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56572598|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
56572627|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572628|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572629|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56572630|NCT01121900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56572631|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56572632|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56572633|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572634|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572635|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
56572636|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56572637|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
56572638|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56321046|NCT00033267|Sirolimus|sirolimus|mesh-list
56572639|NCT01121666|Hormones|hormones|mesh-ancestor
56572640|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572641|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572642|NCT00984126|Factor VIII|factor viii|mesh-list
56572643|NCT00984126|Coagulants|coagulants|mesh-ancestor
56572644|NCT02868996|Kallikreins|kallikreins|mesh-list
56572645|NCT02868996|Coagulants|coagulants|mesh-ancestor
56572646|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56572647|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
56572648|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56572649|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572674|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572675|NCT00982644|Insulin|insulin|mesh-list
56572676|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56572677|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
56572678|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56572679|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572680|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56572681|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56572682|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56572683|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
56572684|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572685|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56572686|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56572687|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572688|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
56572689|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56572690|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56572691|NCT02867904|Prednisolone|prednisolone|mesh-list
56572692|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
56572693|NCT02867904|Bupivacaine|bupivacaine|mesh-list
56572694|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56572695|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
56572696|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56572697|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
56572698|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
56572699|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572700|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572701|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56572702|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
56572703|NCT02867904|Hormones|hormones|mesh-ancestor
56572704|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572705|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56572717|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56572718|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572719|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572720|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56572721|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56572722|NCT00707941|Oseltamivir|oseltamivir|mesh-list
56572723|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
56572724|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572725|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572726|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572727|NCT00824473|Azelastine|azelastine|mesh-list
56572728|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56572729|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
56572730|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572731|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572732|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56572733|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
56572734|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56572735|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572736|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572737|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56099701|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56099702|NCT00402883|Hematinics|hematinics|mesh-ancestor
56099703|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
56099704|NCT04573478|Atrasentan|atrasentan|mesh-list
55826788|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56099705|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099706|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56099707|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56099708|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099709|NCT04939844|Lenalidomide|lenalidomide|mesh-list
56099710|NCT04939844|Bortezomib|bortezomib|mesh-list
56099711|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
56099712|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099713|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56099714|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56099715|NCT04939844|Growth Substances|growth substances|mesh-ancestor
56099716|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
56099717|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099718|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56099719|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099720|NCT05295212|Atezolizumab|atezolizumab|mesh-list
56099721|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099722|NCT04313972|Naltrexone|naltrexone|mesh-list
56099723|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56099724|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56099725|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817677|NCT01850524|Ixazomib|ixazomib|mesh-list
56099726|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
56099727|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099728|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
56099729|NCT05286320|Lenvatinib|lenvatinib|mesh-list
56099730|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56099731|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572738|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56572739|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56572740|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
56572741|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
56572742|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572743|NCT02867280|Sorafenib|sorafenib|mesh-list
56572744|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56572745|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56572746|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572747|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572748|NCT04290390|Itraconazole|itraconazole|mesh-list
56572749|NCT04290390|Rifampin|rifampin|mesh-list
56572750|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56572751|NCT04290390|Estradiol|estradiol|mesh-list
56572752|NCT04290390|Estrogens|estrogens|mesh-ancestor
56572753|NCT04290390|Hormones|hormones|mesh-ancestor
56572754|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572755|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572756|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56572757|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
56572758|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56572759|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56572760|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
56572761|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572762|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56572763|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56572764|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572767|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
56572783|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56572784|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
56572785|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321197|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56572786|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572787|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56572788|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
56572789|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56572790|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
56572791|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572792|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572793|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56572794|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
56572795|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
56572796|NCT04290858|Protective Agents|protective agents|mesh-ancestor
56572797|NCT05326555|Imidacloprid|imidacloprid|mesh-list
56572798|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
56572799|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572800|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572801|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572802|NCT02610829|Vitamin E|vitamin e|mesh-list
56572803|NCT02610829|Tocopherols|tocopherols|mesh-list
56572804|NCT02610829|Tocotrienols|tocotrienols|mesh-list
56572805|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
56572806|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
56572807|NCT02610829|Vitamins|vitamins|mesh-ancestor
56572810|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
56572831|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56572832|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572833|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56572834|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572835|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572836|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
56572837|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56572838|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56572839|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56572840|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
56572841|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56572842|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56572843|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56572844|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572845|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572846|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56572847|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56572848|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
56572849|NCT00814801|Galantamine|galantamine|mesh-list
56572850|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56572851|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56572852|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572853|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
56572854|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572855|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572856|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56321281|NCT00034359|Lamivudine|lamivudine|mesh-list
56572857|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
56572858|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572859|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
56572860|NCT00653458|Ondansetron|ondansetron|mesh-list
56572862|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
56572863|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572864|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572865|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56099732|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56099733|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195045|NCT01496521|Aspirin|aspirin|mesh-list
56195046|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56572866|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
56572867|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
56572868|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56572869|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
56572870|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572871|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572872|NCT00653458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56572873|NCT00653458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56572874|NCT00653458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572875|NCT00653458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56572876|NCT00653458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56572878|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56572879|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572880|NCT00708565|Iloprost|iloprost|mesh-list
56572881|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56572882|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
56572883|NCT03315910|Nicotine|nicotine|mesh-list
56572884|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56572885|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
56572886|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572887|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572888|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56572889|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56572890|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
56572917|NCT05756569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572918|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
56572919|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56572920|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
56572921|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572922|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572923|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56572924|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
56572925|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56572926|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
56572927|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56572928|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56572929|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56572930|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
56572931|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
56572932|NCT04166812|Protective Agents|protective agents|mesh-ancestor
56572933|NCT02435212|Deferasirox|deferasirox|mesh-list
56572935|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
56572976|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
56572977|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56572978|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56572979|NCT00709189|Folic Acid|folic acid|mesh-list
56572980|NCT00709189|Norgestimate|norgestimate|mesh-list
56572981|NCT00709189|Estradiol|estradiol|mesh-list
56572982|NCT00709189|Estrogens|estrogens|mesh-ancestor
56572983|NCT00709189|Hormones|hormones|mesh-ancestor
56572984|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56572985|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56572986|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56572987|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
56572988|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56572989|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56572990|NCT00709189|Hematinics|hematinics|mesh-ancestor
56572991|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
56572992|NCT00709189|Vitamins|vitamins|mesh-ancestor
56572993|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
56572994|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56572995|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56572996|NCT00709267|Folic Acid|folic acid|mesh-list
56572997|NCT00709267|Hematinics|hematinics|mesh-ancestor
56572998|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
56572999|NCT00709267|Vitamins|vitamins|mesh-ancestor
56573000|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
56573001|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573002|NCT04082442|Evolocumab|evolocumab|mesh-list
56573003|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56573004|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56573005|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
56573006|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573007|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56573008|NCT00591565|Acamprosate|acamprosate|mesh-list
56573022|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573023|NCT01133756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573024|NCT01133756|Immunologic Factors|immunologic factors|mesh-ancestor
56573025|NCT01133756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573026|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56573027|NCT01133678|Paclitaxel|paclitaxel|mesh-list
56573028|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56573029|NCT01133678|Cisplatin|cisplatin|mesh-list
56573030|NCT01133678|Cetuximab|cetuximab|mesh-list
56573031|NCT01133678|Everolimus|everolimus|mesh-list
56573032|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56573033|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573034|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
56573035|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
56573036|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
56573037|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573038|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573039|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573040|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
56573041|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573042|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
56573043|NCT00652132|Antidotes|antidotes|mesh-ancestor
56573044|NCT00652132|Protective Agents|protective agents|mesh-ancestor
56573045|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573046|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
56573072|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
56573073|NCT00655018|Tocopherols|tocopherols|mesh-list
56573074|NCT00655018|Vitamin E|vitamin e|mesh-list
56573075|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
56573076|NCT00655018|Vitamins|vitamins|mesh-ancestor
56573077|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
56573078|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573079|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
56573080|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573081|NCT00655018|Protective Agents|protective agents|mesh-ancestor
56573082|NCT02635750|Donepezil|donepezil|mesh-list
56573083|NCT02635750|BI 409306|bi 409306|mesh-list
56573084|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56573085|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573086|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573087|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
56006550|NCT00002716|Antidotes|antidotes|mesh-ancestor
56573089|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573090|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
56573091|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56573092|NCT04164238|Paclitaxel|paclitaxel|mesh-list
56573093|NCT04164238|Carboplatin|carboplatin|mesh-list
56573094|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56573100|NCT02645734|Bevacizumab|bevacizumab|mesh-list
56573126|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573127|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
56573128|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56573129|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56573130|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573131|NCT02645656|Curcumin|curcumin|mesh-list
56573132|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56573133|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56573134|NCT02645656|Analgesics|analgesics|mesh-ancestor
56573135|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
56573136|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573137|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573138|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56573139|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56573140|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573141|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573142|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573143|NCT01132820|Cediranib|cediranib|mesh-list
56573144|NCT01132820|Maleic acid|maleic acid|mesh-list
56573145|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573146|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573147|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573148|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56573149|NCT00655330|Valsartan|valsartan|mesh-list
56573150|NCT00655330|Probucol|probucol|mesh-list
56573151|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56573152|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56573153|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56573154|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573155|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56573156|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56573157|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
56195047|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56195048|NCT01496521|Analgesics|analgesics|mesh-ancestor
56195049|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
56195050|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195051|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195052|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195053|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56195054|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56195055|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56573158|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56573159|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
56573160|NCT00655330|Protective Agents|protective agents|mesh-ancestor
56573161|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573162|NCT00655408|Iron|iron|mesh-list
56573163|NCT00655408|Trace Elements|trace elements|mesh-ancestor
56573164|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
56573165|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573166|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
56321584|NCT01805726|Alfentanil|alfentanil|mesh-list
56573167|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56573168|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56573169|NCT04163536|Prednisolone|prednisolone|mesh-list
56573170|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
56573171|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56573172|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
56573173|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56573174|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
56573175|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
56573176|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573177|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573178|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56573179|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
56573180|NCT04163536|Hormones|hormones|mesh-ancestor
56573181|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573182|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56573183|NCT04163536|Protective Agents|protective agents|mesh-ancestor
56573184|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56573185|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573186|NCT00652288|Insulin|insulin|mesh-list
56573187|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56573188|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
56573189|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
56573190|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
56573191|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56573199|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573200|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56573201|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573202|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
56573203|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573204|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
56573205|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573206|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573207|NCT02635282|Fentanyl|fentanyl|mesh-list
56573208|NCT02635282|Midazolam|midazolam|mesh-list
56573209|NCT02635282|Ketamine|ketamine|mesh-list
56573210|NCT02635282|Analgesics|analgesics|mesh-ancestor
56573211|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
56573212|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573213|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573214|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56573215|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56573216|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
56573217|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
56573218|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573219|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56573220|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56573221|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573222|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573223|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56573224|NCT02635282|Narcotics|narcotics|mesh-ancestor
56573225|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56573226|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56573227|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56573228|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56573229|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56573230|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
56573231|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
56195056|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195057|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56195058|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56195059|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195060|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
56195061|NCT01496534|Carboplatin|carboplatin|mesh-list
56099734|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099735|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
56099736|NCT00728845|Paclitaxel|paclitaxel|mesh-list
56573232|NCT00655798|Antioxidants|antioxidants|mesh-list
56573233|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573234|NCT00655798|Protective Agents|protective agents|mesh-ancestor
56573235|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573236|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
56573237|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56321642|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573238|NCT02637700|Antibodies|antibodies|mesh-list
56573239|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
56573240|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56573241|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
56573242|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573243|NCT02637466|Vortioxetine|vortioxetine|mesh-list
56573244|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
56573246|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56573247|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56573248|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573249|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573250|NCT02637466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56573251|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56573252|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56573253|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573254|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573255|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
56573256|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56573257|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56573258|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56573278|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573279|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573280|NCT00656032|Cinacalcet|cinacalcet|mesh-list
56573281|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56573282|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573283|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56573284|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
56573285|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573286|NCT00885118|Empagliflozin|empagliflozin|mesh-list
56573287|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56573288|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573289|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56573290|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573291|NCT00656812|Rituximab|rituximab|mesh-list
56573292|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573293|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573294|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
56573295|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573296|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56573297|NCT00656110|Ethanol|ethanol|mesh-list
56573298|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
56573299|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56573300|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56573301|NCT00656110|Prednisolone|prednisolone|mesh-list
56573302|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
56573303|NCT00656110|Lidocaine|lidocaine|mesh-list
56573304|NCT00656110|Bupivacaine|bupivacaine|mesh-list
56573305|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56573306|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
56573307|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
56573308|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
56573309|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573310|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573311|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
56573312|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573313|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56099737|NCT00728845|Bevacizumab|bevacizumab|mesh-list
56573314|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56573315|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56573316|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56573317|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573318|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56573319|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
56573320|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
56573321|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56573322|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
56573323|NCT00656110|Hormones|hormones|mesh-ancestor
56573324|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573325|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56573326|NCT00656110|Protective Agents|protective agents|mesh-ancestor
56573327|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56573328|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573329|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56573330|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573331|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56573332|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
56573333|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56573334|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56573335|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573336|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573337|NCT00656188|Urological Agents|urological agents|mesh-ancestor
56573338|NCT00880906|Fluticasone|fluticasone|mesh-list
56573339|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56573340|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56573341|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56573342|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
56573343|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573344|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573345|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56573346|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
56573352|NCT04160026|Piperaquine|piperaquine|mesh-list
56573353|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
56573354|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56573355|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
56573356|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56573357|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56573358|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573359|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56573360|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573361|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573362|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56573363|NCT04160026|Renal Agents|renal agents|mesh-ancestor
56573364|NCT04159870|Rifaximin|rifaximin|mesh-list
56573365|NCT04159870|Norfloxacin|norfloxacin|mesh-list
56573366|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56573367|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573368|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56573369|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56573370|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56573371|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573372|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573373|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573374|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56573375|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56573376|NCT00657514|Ranolazine|ranolazine|mesh-list
56573377|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56573378|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56573380|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
56573397|NCT00882310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573398|NCT00882310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573399|NCT00882310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573400|NCT00882310|Immunologic Factors|immunologic factors|mesh-ancestor
56573401|NCT00882310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573402|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
56573403|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
56573404|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
56573405|NCT00884650|Analgesics|analgesics|mesh-list
56573406|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
56573407|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573408|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573409|NCT02636842|Aripiprazole|aripiprazole|mesh-list
56573410|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
56573411|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
56573412|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56573413|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56573414|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56573415|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573416|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573417|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
56573418|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
56573419|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573420|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573421|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56573422|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56573445|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
56573446|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
56573447|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56573448|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573449|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573450|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
56573451|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56573452|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573453|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573454|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
56573455|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573456|NCT04161586|Prilocaine|prilocaine|mesh-list
56573457|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
56573458|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
56573459|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573460|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573461|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
56573462|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573463|NCT02636218|Ketamine|ketamine|mesh-list
56573502|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56573503|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573504|NCT04162834|Papaverine|papaverine|mesh-list
56573505|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56573506|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573507|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573508|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
56573509|NCT04162834|Urological Agents|urological agents|mesh-ancestor
56573510|NCT00657904|Bicalutamide|bicalutamide|mesh-list
56573511|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
56573512|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
56573513|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573514|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573515|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573516|NCT02633878|Progesterone|progesterone|mesh-list
56573517|NCT02633878|Progestins|progestins|mesh-ancestor
56573518|NCT02633878|Hormones|hormones|mesh-ancestor
56573519|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573520|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573521|NCT00597766|Triamcinolone|triamcinolone|mesh-list
56573522|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56573523|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56573524|NCT00597766|Lidocaine|lidocaine|mesh-list
56573525|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56573526|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
56573527|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
56573528|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573549|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573550|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
56573551|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573552|NCT00977574|Sirolimus|sirolimus|mesh-list
56573553|NCT00977574|Paclitaxel|paclitaxel|mesh-list
56573554|NCT00977574|Epothilones|epothilones|mesh-list
56573555|NCT00977574|Epothilone B|epothilone b|mesh-list
56573556|NCT00977574|Bevacizumab|bevacizumab|mesh-list
56573557|NCT00977574|Carboplatin|carboplatin|mesh-list
56573558|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56573559|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56573560|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
56573561|NCT00977574|Antibodies|antibodies|mesh-list
56573562|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
56573563|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56573564|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
56573565|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56573566|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573567|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
56573568|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
56573569|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
56573570|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573571|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56573572|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56573573|NCT00977574|Growth Substances|growth substances|mesh-ancestor
56573574|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573575|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
56573600|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
56158126|NCT03770130|Analgesics|analgesics|mesh-ancestor
56573602|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
56573603|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573604|NCT01079741|Laxatives|laxatives|mesh-ancestor
56573605|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56573606|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
56573607|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573608|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56573609|NCT01079741|Emollients|emollients|mesh-ancestor
56573610|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
56573611|NCT02877641|Vitamin D|vitamin d|mesh-list
56573612|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
56573613|NCT02877641|Vitamins|vitamins|mesh-list
56573614|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
56573615|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573616|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56573617|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56573618|NCT04074330|Rituximab|rituximab|mesh-list
56573619|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573621|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
56573622|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573623|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56573624|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
56573625|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56573626|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573654|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573655|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56573656|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
56573657|NCT02865174|Coagulants|coagulants|mesh-ancestor
56573658|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
56573659|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56573660|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56573661|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573662|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56573663|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56573664|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573665|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573666|NCT00879814|Vaccines|vaccines|mesh-list
56573667|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
56573668|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573669|NCT02633176|Docetaxel|docetaxel|mesh-list
56573670|NCT02633176|Capecitabine|capecitabine|mesh-list
56573671|NCT02633176|Cetuximab|cetuximab|mesh-list
56573672|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573673|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
56573674|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
56573675|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
56573676|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573677|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56573678|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
56573679|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573680|NCT04156984|Golimumab|golimumab|mesh-list
56573681|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56099738|NCT00728845|Carboplatin|carboplatin|mesh-list
56099739|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56099740|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099741|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
56099742|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
56099743|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
56099744|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099745|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56099746|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56099747|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56099748|NCT00728845|Growth Substances|growth substances|mesh-ancestor
56099749|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099750|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
56099751|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
56099752|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56099753|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56099754|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099755|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099756|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56573682|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56573683|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573684|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
56573685|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573686|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56573687|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
56573688|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573689|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56573690|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
56573691|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573692|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322093|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
56573693|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56573694|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56573695|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56573696|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
56573697|NCT01132664|Capecitabine|capecitabine|mesh-list
56573698|NCT01132664|Trastuzumab|trastuzumab|mesh-list
56573699|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56573700|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
56573701|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573702|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573703|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573704|NCT01078805|Teriparatide|teriparatide|mesh-list
56573731|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56573732|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573733|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
56573734|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56573735|NCT00913549|Clemastine|clemastine|mesh-list
56573736|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
56573737|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
56573738|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56573739|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
56573740|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
56573741|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573742|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573743|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573744|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56573745|NCT01076153|Clarithromycin|clarithromycin|mesh-list
56573746|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56573747|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573748|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56573749|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573750|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573751|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56573752|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56573753|NCT01076075|Metformin|metformin|mesh-list
56573754|NCT01076075|Pioglitazone|pioglitazone|mesh-list
56573755|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56573756|NCT01076075|Glimepiride|glimepiride|mesh-list
56573757|NCT01076075|Gliclazide|gliclazide|mesh-list
56573758|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56573759|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573778|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56573779|NCT00881530|Metformin|metformin|mesh-list
56573780|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56573781|NCT00881530|Empagliflozin|empagliflozin|mesh-list
56573782|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56573783|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573784|NCT00881530|Incretins|incretins|mesh-ancestor
56573785|NCT00881530|Hormones|hormones|mesh-ancestor
56573786|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56573787|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56573788|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
56573789|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573790|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573791|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56573792|NCT02632474|Tenofovir|tenofovir|mesh-list
56573793|NCT02632474|Lamivudine|lamivudine|mesh-list
56573794|NCT02632474|Efavirenz|efavirenz|mesh-list
56573795|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
56573796|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56573797|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56573798|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56573799|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573800|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573801|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56573802|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56573803|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56573804|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56573805|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56573806|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56573807|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56573808|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56573809|NCT04156750|Metformin|metformin|mesh-list
56573810|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56109867|NCT00005575|Imipramine|imipramine|mesh-list
56099757|NCT04531982|Pimavanserin|pimavanserin|mesh-list
56099758|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56099759|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56099760|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56099761|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56099774|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
56573811|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573812|NCT02877173|Alprostadil|alprostadil|mesh-list
56573813|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56573814|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
56573815|NCT02877173|Urological Agents|urological agents|mesh-ancestor
56573816|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56573817|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56573818|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56573819|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56573820|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573821|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56573822|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56573823|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573824|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
56573825|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573826|NCT00661180|Sorafenib|sorafenib|mesh-list
56573827|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573828|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56573829|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573830|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573831|NCT01078571|Adalimumab|adalimumab|mesh-list
56573832|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56573833|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56573834|NCT04160416|Capecitabine|capecitabine|mesh-list
56573835|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
56573836|NCT04160416|Irinotecan|irinotecan|mesh-list
56573837|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56573838|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
56573839|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573840|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573841|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56573842|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56573843|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573844|NCT00661336|Melphalan|melphalan|mesh-list
56573851|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573852|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
56573853|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573854|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
56573855|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56573856|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573857|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56573858|NCT00661336|Protective Agents|protective agents|mesh-ancestor
56573859|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
56573860|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573861|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573862|NCT00657202|Ranibizumab|ranibizumab|mesh-list
56573863|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56573864|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56573865|NCT00657202|Growth Substances|growth substances|mesh-ancestor
56573866|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573867|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
56573868|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573869|NCT00626483|Basiliximab|basiliximab|mesh-list
56573870|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573871|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
56573872|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573873|NCT00626717|Riboflavin|riboflavin|mesh-list
56573874|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
56573875|NCT00626717|Vitamins|vitamins|mesh-ancestor
56573876|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
56573877|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573878|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56573879|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
56573880|NCT04156204|Tacrolimus|tacrolimus|mesh-list
56573881|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56573882|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
56573883|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573884|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56573885|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56573886|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099775|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56099776|NCT05278676|Renal Agents|renal agents|mesh-ancestor
56099778|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56099779|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573887|NCT02631694|Propranolol|propranolol|mesh-list
56573888|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56573889|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56573890|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
56573891|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573892|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573893|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573894|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56573895|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56573896|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
56573897|NCT04305587|Clopidogrel|clopidogrel|mesh-list
56573898|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56573899|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56573900|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56573902|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
56573903|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573904|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573905|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573906|NCT00658840|Capecitabine|capecitabine|mesh-list
56573907|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56573908|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
56573909|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573910|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573911|NCT00658918|Ciclesonide|ciclesonide|mesh-list
56573912|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
56573913|NCT00658918|Hormones|hormones|mesh-ancestor
56573934|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
56573935|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
56573936|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56573937|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
56573938|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573939|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573940|NCT00659074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56573941|NCT00659074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56573942|NCT00659074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56573943|NCT00659074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56573944|NCT00659074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56573945|NCT01077713|Gemcitabine|gemcitabine|mesh-list
56573946|NCT01077713|Bevacizumab|bevacizumab|mesh-list
56573947|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573948|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573949|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56573950|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56573951|NCT01077713|Growth Substances|growth substances|mesh-ancestor
56573952|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56573953|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
56573954|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56573955|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
56573956|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573986|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56573987|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56573988|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56573989|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
56573990|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
56573991|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56573992|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56573993|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322396|NCT00276848|Vidarabine|vidarabine|mesh-list
56573994|NCT05758831|Rituximab|rituximab|mesh-list
56573995|NCT05758831|Ocrelizumab|ocrelizumab|mesh-list
56573996|NCT05758831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56573997|NCT05758831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56573998|NCT05758831|Immunologic Factors|immunologic factors|mesh-ancestor
56573999|NCT05758831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574000|NCT05758831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574001|NCT04287894|Pemetrexed|pemetrexed|mesh-list
56574002|NCT04287894|Durvalumab|durvalumab|mesh-list
56574003|NCT04287894|Tremelimumab|tremelimumab|mesh-list
56574004|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574005|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574006|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574007|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56574008|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56574009|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574010|NCT04287426|Remifentanil|remifentanil|mesh-list
56574011|NCT04287426|Rocuronium|rocuronium|mesh-list
56574012|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56574013|NCT04287426|Narcotics|narcotics|mesh-ancestor
56574014|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574015|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574016|NCT04287426|Analgesics|analgesics|mesh-ancestor
56574017|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
56574018|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574019|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56574025|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
56574026|NCT04047576|Hormones|hormones|mesh-ancestor
56574027|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574028|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574029|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56574030|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574031|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56574032|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574033|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56574034|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
56574035|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56574036|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
56574037|NCT00976950|Ritonavir|ritonavir|mesh-list
56574038|NCT00976950|Tipranavir|tipranavir|mesh-list
56574039|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56574040|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56574041|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
56574042|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574081|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56574082|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
56574083|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574084|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574085|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
56574086|NCT02864784|Calcium|calcium|mesh-list
56574087|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56574088|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574089|NCT02864784|Antacids|antacids|mesh-ancestor
56574090|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574091|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56574092|NCT03829254|Pembrolizumab|pembrolizumab|mesh-list
56574093|NCT03829254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574094|NCT03829254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574095|NCT00819013|Vaccines|vaccines|mesh-list
56574096|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
56574097|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574098|NCT04868773|Trifluridine|trifluridine|mesh-list
56574099|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
56574100|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574101|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
56574102|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574103|NCT04868461|Caseins|caseins|mesh-list
56574104|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
56574105|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
56574106|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574107|NCT02865642|Citalopram|citalopram|mesh-list
56574108|NCT02865642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56574109|NCT02865642|Serotonin|serotonin|mesh-list
56574110|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56574111|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56574123|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574124|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
56574125|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
56574126|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
56574127|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574128|NCT00629616|Fulvestrant|fulvestrant|mesh-list
56574129|NCT00629616|Anastrozole|anastrozole|mesh-list
56574130|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56574131|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574132|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56574133|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56574134|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
56574135|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574136|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574137|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56574138|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56574139|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574140|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574141|NCT01120184|Paclitaxel|paclitaxel|mesh-list
56574142|NCT01120184|Maytansine|maytansine|mesh-list
56574143|NCT01120184|Docetaxel|docetaxel|mesh-list
56574144|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56574146|NCT01120184|Pertuzumab|pertuzumab|mesh-list
56574147|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56574148|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574149|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
56574150|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
56574151|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
56574152|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574153|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574154|NCT01120028|Sirolimus|sirolimus|mesh-list
56574155|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
56574156|NCT01120028|Tacrolimus|tacrolimus|mesh-list
56574157|NCT01120028|Basiliximab|basiliximab|mesh-list
56099780|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099781|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56099782|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56099783|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099784|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
56099785|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
56099786|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574158|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56574159|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
56574160|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574161|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56574162|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574163|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574164|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56574165|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574166|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56574167|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574168|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
56574169|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574170|NCT00878800|Doxorubicin|doxorubicin|mesh-list
56574171|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56574172|NCT00878800|Belinostat|belinostat|mesh-list
56574173|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56574174|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574175|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56574176|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56574177|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574178|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574179|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56574180|NCT00662272|Vaccines|vaccines|mesh-list
56574181|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
56574182|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574183|NCT04158856|Trastuzumab|trastuzumab|mesh-list
56574184|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574185|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574203|NCT01145222|Midazolam|midazolam|mesh-list
56574204|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56574205|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56574206|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574207|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574208|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56574209|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56574210|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56574211|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56574212|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
56574213|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
56574214|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
56574215|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
56574216|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574217|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574218|NCT01145066|Borage oil|borage oil|mesh-list
56322614|NCT00275834|Zonisamide|zonisamide|mesh-list
56574219|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574220|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
56574221|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
56574222|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56574223|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56574224|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574228|NCT00637442|Galantamine|galantamine|mesh-list
56574255|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56574256|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574257|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56574258|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
56574259|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574260|NCT02863614|Ibuprofen|ibuprofen|mesh-list
56574261|NCT02863614|Lorazepam|lorazepam|mesh-list
56574262|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56574263|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574264|NCT02863614|Analgesics|analgesics|mesh-ancestor
56574265|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
56574266|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574267|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574268|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56574269|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574270|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56574271|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574272|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574274|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
56574275|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
56574276|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56574277|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56574278|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574279|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56574280|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56574281|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56574282|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
56574283|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
56574284|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574285|NCT02864550|Doxycycline|doxycycline|mesh-list
56574286|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56574287|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574288|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
56574289|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56574290|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56574291|NCT00974922|Vitamin D|vitamin d|mesh-list
56110323|NCT00005797|Busulfan|busulfan|mesh-list
56099787|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574292|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
56574293|NCT00974922|Vitamins|vitamins|mesh-ancestor
56574294|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
56574295|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574296|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56574297|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56574299|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56574300|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56574301|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56574302|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
56574303|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
56574304|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574305|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574306|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574307|NCT00969150|Milnacipran|milnacipran|mesh-list
56574308|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
56574309|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56574310|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56574311|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56574312|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574313|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574323|NCT00974220|Fentanyl|fentanyl|mesh-list
56574344|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56574345|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56574346|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
56574347|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574348|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574349|NCT00970944|Amantadine|amantadine|mesh-list
56574350|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56574351|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56574352|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
56574353|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574354|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
56574355|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574356|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574357|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574358|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574359|NCT00970944|Analgesics|analgesics|mesh-ancestor
56574360|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
56574361|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574362|NCT05780723|Mesalamine|mesalamine|mesh-list
56574363|NCT05780723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56574364|NCT05780723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574365|NCT05780723|Analgesics|analgesics|mesh-ancestor
56574366|NCT05780723|Sensory System Agents|sensory system agents|mesh-ancestor
56322759|NCT00275093|Sirolimus|sirolimus|mesh-list
56574394|NCT05780489|Estrogens|estrogens|mesh-ancestor
56574395|NCT05780489|Hormones|hormones|mesh-ancestor
56574396|NCT05780489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574397|NCT05780489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574398|NCT05780489|Progestins|progestins|mesh-ancestor
56574399|NCT05780320|Amiodarone|amiodarone|mesh-list
56574400|NCT05780320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56574401|NCT05780320|Vasodilator Agents|vasodilator agents|mesh-ancestor
56574402|NCT05780320|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56574403|NCT05780320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56574404|NCT05780320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574405|NCT05780320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56574406|NCT05780320|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56574407|NCT05780320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56574408|NCT05780320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574409|NCT05780320|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56574410|NCT05780320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56574411|NCT05780320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56574412|NCT05780307|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56574413|NCT05780307|Immunologic Factors|immunologic factors|mesh-ancestor
56574414|NCT05780307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574415|NCT05780294|Asparaginase|asparaginase|mesh-list
56574445|NCT05779943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56574446|NCT05779943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574448|NCT05779943|Protective Agents|protective agents|mesh-ancestor
56574449|NCT05779644|Metformin|metformin|mesh-list
56574450|NCT05779644|Liraglutide|liraglutide|mesh-list
56574451|NCT05779644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56574452|NCT05779644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574453|NCT05779644|Incretins|incretins|mesh-ancestor
56574454|NCT05779644|Hormones|hormones|mesh-ancestor
56574455|NCT05779644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574456|NCT05779514|Mirabegron|mirabegron|mesh-list
56574457|NCT05779514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56574458|NCT05779514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56574459|NCT05779514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56574460|NCT05779514|Adrenergic Agents|adrenergic agents|mesh-ancestor
56574461|NCT05779514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574462|NCT05779514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574463|NCT05779514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574464|NCT05779514|Urological Agents|urological agents|mesh-ancestor
56574465|NCT05779423|Nivolumab|nivolumab|mesh-list
56574466|NCT05779423|Ipilimumab|ipilimumab|mesh-list
56574467|NCT05779423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574468|NCT05779423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574469|NCT05779423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56574470|NCT05779423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574471|NCT05779410|Vitamin D|vitamin d|mesh-list
56574472|NCT05779410|Ergocalciferols|ergocalciferols|mesh-list
56574473|NCT05779410|Cholecalciferol|cholecalciferol|mesh-list
56574474|NCT05779410|Vitamins|vitamins|mesh-list
56574475|NCT05779410|Micronutrients|micronutrients|mesh-ancestor
56574476|NCT05779410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574477|NCT05779410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56574478|NCT05779410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56574479|NCT05779254|Metronidazole|metronidazole|mesh-list
56574480|NCT05779254|Neomycin|neomycin|mesh-list
56574481|NCT05779254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574484|NCT05779254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56574485|NCT05779254|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56574486|NCT05779254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574487|NCT05779254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574489|NCT05779241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56574490|NCT05779241|Serotonin Agents|serotonin agents|mesh-ancestor
56574491|NCT05779241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574492|NCT05779241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574493|NCT05779241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574494|NCT05779241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56574495|NCT05779241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56574496|NCT05779241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574497|NCT05779241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56574498|NCT05779241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56574499|NCT05779241|Dopamine Agents|dopamine agents|mesh-ancestor
56574500|NCT05779059|Ticagrelor|ticagrelor|mesh-list
56574501|NCT05779059|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56574502|NCT05779059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56574503|NCT05779059|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56574504|NCT05779059|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56574505|NCT05779059|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56574506|NCT05779059|Purinergic Agents|purinergic agents|mesh-ancestor
56574535|NCT05775237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56574536|NCT05775237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574537|NCT05775237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574538|NCT05775237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574539|NCT05774366|Desflurane|desflurane|mesh-list
56574540|NCT05774366|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56574541|NCT05774366|Anesthetics, General|anesthetics, general|mesh-ancestor
56574542|NCT05774366|Anesthetics|anesthetics|mesh-ancestor
56574543|NCT05774366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574544|NCT05774366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574545|NCT05774067|Terlipressin|terlipressin|mesh-list
56574546|NCT05774067|Vasopressins|vasopressins|mesh-list
56574547|NCT05774067|Norepinephrine|norepinephrine|mesh-list
56574548|NCT05774067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56574549|NCT05774067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56574550|NCT05774067|Adrenergic Agents|adrenergic agents|mesh-ancestor
56574551|NCT05774067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574554|NCT05774067|Sympathomimetics|sympathomimetics|mesh-ancestor
56574596|NCT05755997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574597|NCT05755997|Nootropic Agents|nootropic agents|mesh-ancestor
56574598|NCT05747794|Paclitaxel|paclitaxel|mesh-list
56574599|NCT05747794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56574600|NCT05747794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574601|NCT05747794|Tubulin Modulators|tubulin modulators|mesh-ancestor
56574602|NCT05747794|Antimitotic Agents|antimitotic agents|mesh-ancestor
56574603|NCT05747794|Mitosis Modulators|mitosis modulators|mesh-ancestor
56574604|NCT05747794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574605|NCT05746273|Nicotine|nicotine|mesh-list
56574606|NCT05746273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56574607|NCT05746273|Autonomic Agents|autonomic agents|mesh-ancestor
56574608|NCT05746273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574609|NCT05746273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574610|NCT05746273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56574611|NCT05746273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56574612|NCT05746273|Cholinergic Agents|cholinergic agents|mesh-ancestor
56574613|NCT05746273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574614|NCT05746273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574615|NCT05739929|Colchicine|colchicine|mesh-list
56574616|NCT05739929|Gout Suppressants|gout suppressants|mesh-ancestor
56574617|NCT05739929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574618|NCT05739929|Tubulin Modulators|tubulin modulators|mesh-ancestor
56574619|NCT05739929|Antimitotic Agents|antimitotic agents|mesh-ancestor
56574620|NCT05739929|Mitosis Modulators|mitosis modulators|mesh-ancestor
56574621|NCT05739929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574622|NCT05739929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574623|NCT05731895|BI 425809|bi 425809|mesh-list
56574642|NCT05712265|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56574643|NCT05709093|Azacitidine|azacitidine|mesh-list
56574644|NCT05709093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56574645|NCT05709093|Antimetabolites|antimetabolites|mesh-ancestor
56574646|NCT05709093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574647|NCT05709093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574648|NCT05709093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574649|NCT05699252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56574650|NCT05699252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56574651|NCT05699252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574652|NCT05695261|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56574653|NCT05695261|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56574654|NCT05695261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574655|NCT05695261|Antitubercular Agents|antitubercular agents|mesh-ancestor
56574656|NCT05687266|Paclitaxel|paclitaxel|mesh-list
56574657|NCT05687266|Carboplatin|carboplatin|mesh-list
56574658|NCT05687266|Pembrolizumab|pembrolizumab|mesh-list
56574659|NCT05687266|Pemetrexed|pemetrexed|mesh-list
56574660|NCT05687266|Durvalumab|durvalumab|mesh-list
56574661|NCT05687266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56574662|NCT05687266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574663|NCT05687266|Tubulin Modulators|tubulin modulators|mesh-ancestor
56574664|NCT05687266|Antimitotic Agents|antimitotic agents|mesh-ancestor
56574665|NCT05687266|Mitosis Modulators|mitosis modulators|mesh-ancestor
56574666|NCT05687266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574692|NCT05637060|Antimetabolites|antimetabolites|mesh-ancestor
56574693|NCT05637060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574694|NCT05637060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56574695|NCT05637060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56574696|NCT05637060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574697|NCT05635604|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
56574698|NCT05635604|Growth Substances|growth substances|mesh-ancestor
56574699|NCT05635604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574700|NCT05635604|Vasodilator Agents|vasodilator agents|mesh-ancestor
56574701|NCT05635604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574702|NCT05635604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574703|NCT05620784|Furosemide|furosemide|mesh-list
56574704|NCT05620784|Diuretics|diuretics|mesh-list
56574705|NCT05620784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56574707|NCT05620784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574708|NCT05620784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56574709|NCT05620784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574710|NCT05617859|Lenvatinib|lenvatinib|mesh-list
56574711|NCT05617859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574712|NCT05617859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56574742|NCT05600426|Cyclosporine|cyclosporine|mesh-list
56574743|NCT05600426|Cyclophosphamide|cyclophosphamide|mesh-list
56574744|NCT05600426|Methotrexate|methotrexate|mesh-list
56574745|NCT05600426|Fludarabine|fludarabine|mesh-list
56574746|NCT05600426|Cyclosporins|cyclosporins|mesh-list
56574747|NCT05600426|Thymoglobulin|thymoglobulin|mesh-list
56574748|NCT05600426|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56574749|NCT05600426|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56574750|NCT05600426|Immunologic Factors|immunologic factors|mesh-ancestor
56574751|NCT05600426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574752|NCT05600426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574753|NCT05600426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56574754|NCT05600426|Alkylating Agents|alkylating agents|mesh-ancestor
56574755|NCT05600426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574756|NCT05600426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574757|NCT05600426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56574758|NCT05600426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56574759|NCT05600426|Abortifacient Agents|abortifacient agents|mesh-ancestor
56574760|NCT05600426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56574761|NCT05600426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56574762|NCT05600426|Antimetabolites|antimetabolites|mesh-ancestor
56574763|NCT05600426|Dermatologic Agents|dermatologic agents|mesh-ancestor
56574764|NCT05600426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574765|NCT05600426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56574766|NCT05600426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56574767|NCT05600426|Antifungal Agents|antifungal agents|mesh-ancestor
56574768|NCT05600426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574769|NCT05600426|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56574770|NCT05598957|Vitamin D|vitamin d|mesh-list
56574790|NCT05567068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56574791|NCT05567068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56574792|NCT05567068|Analgesics|analgesics|mesh-ancestor
56574793|NCT05567068|Sensory System Agents|sensory system agents|mesh-ancestor
56574794|NCT05567068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574795|NCT05567068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574796|NCT05567068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56574797|NCT05567068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56574798|NCT05565001|Cromakalim|cromakalim|mesh-list
56574799|NCT05565001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56574800|NCT05565001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56574801|NCT05565001|Autonomic Agents|autonomic agents|mesh-ancestor
56574802|NCT05565001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574803|NCT05565001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574804|NCT05565001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56574805|NCT05565001|Respiratory System Agents|respiratory system agents|mesh-ancestor
56574806|NCT05565001|Parasympatholytics|parasympatholytics|mesh-ancestor
56574807|NCT05565001|Vasodilator Agents|vasodilator agents|mesh-ancestor
56574808|NCT05561062|Atorvastatin|atorvastatin|mesh-list
56574809|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56574810|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56574811|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
56574812|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574813|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56574814|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56574815|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574838|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56574839|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574840|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56574841|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
56574842|NCT05548296|Gemcitabine|gemcitabine|mesh-list
56574843|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56574844|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
56574845|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574846|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574847|NCT05548296|Antiviral Agents|antiviral agents|mesh-ancestor
56574848|NCT05548296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574849|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574850|NCT05548296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56574851|NCT05548296|Immunologic Factors|immunologic factors|mesh-ancestor
56574852|NCT05548296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574853|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
56008334|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56574854|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574856|NCT05536791|Dabigatran|dabigatran|mesh-list
56574857|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
56574858|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56574859|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
56574860|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574861|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574862|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
56574863|NCT05518149|Aticaprant|aticaprant|mesh-list
56574864|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56574865|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574866|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
56574867|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56574868|NCT05500508|Eflornithine|eflornithine|mesh-list
56574869|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574877|NCT05480384|Nivolumab|nivolumab|mesh-list
56574880|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574881|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56574882|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574883|NCT05476926|Ranibizumab|ranibizumab|mesh-list
56574884|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56574885|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56574886|NCT05476926|Growth Substances|growth substances|mesh-ancestor
56574887|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574888|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
56574889|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574890|NCT05472623|Nivolumab|nivolumab|mesh-list
56574891|NCT05472623|Adagrasib|adagrasib|mesh-list
56574892|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56574893|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56574894|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56574895|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574896|NCT05458102|Voriconazole|voriconazole|mesh-list
56574897|NCT05458102|Cobicistat|cobicistat|mesh-list
56574898|NCT05458102|Rifabutin|rifabutin|mesh-list
56574899|NCT05458102|Vesatolimod|vesatolimod|mesh-list
56574900|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
56574901|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574902|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56574903|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56574904|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574905|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574927|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
56574928|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56574929|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56574930|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56574931|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56574932|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574933|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56574934|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
56574935|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56574936|NCT05412004|Tirzepatide|tirzepatide|mesh-list
56574937|NCT05412004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56574938|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574939|NCT05412004|Incretins|incretins|mesh-ancestor
56574940|NCT05412004|Hormones|hormones|mesh-ancestor
56574941|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56574942|NCT05409157|Bisacodyl|bisacodyl|mesh-list
56574943|NCT05409157|Cathartics|cathartics|mesh-ancestor
56574944|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56574945|NCT05409157|Laxatives|laxatives|mesh-ancestor
56574982|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574983|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
56574984|NCT05350202|Empagliflozin|empagliflozin|mesh-list
56574985|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56574986|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574987|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56574988|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574989|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
56574990|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56574991|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56574992|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56574993|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
56574994|NCT05311033|Coagulants|coagulants|mesh-ancestor
56574995|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
56574996|NCT05281562|Vitamins|vitamins|mesh-ancestor
56574997|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
56574998|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56574999|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
56575000|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575001|NCT05281562|Protective Agents|protective agents|mesh-ancestor
56575002|NCT05281510|Vesatolimod|vesatolimod|mesh-list
56575003|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
56575004|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575005|NCT05276596|Norepinephrine|norepinephrine|mesh-list
56575006|NCT05276596|Ephedrine|ephedrine|mesh-list
56575007|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56575008|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56575009|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56575010|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56575012|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575028|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
56575029|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575030|NCT05241262|Expectorants|expectorants|mesh-ancestor
56575031|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
56575032|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56575033|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
56575034|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575035|NCT05241262|Protective Agents|protective agents|mesh-ancestor
56575036|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575037|NCT05241262|Antidotes|antidotes|mesh-ancestor
56575038|NCT05218499|Doxorubicin|doxorubicin|mesh-list
56575039|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56575040|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575041|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56575059|NCT05185089|Maleic acid|maleic acid|mesh-list
56575089|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575090|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575091|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
56575092|NCT05172908|Hormones|hormones|mesh-ancestor
56575093|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575094|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575095|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575096|NCT05162937|Antibodies|antibodies|mesh-list
56575097|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
56575098|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575099|NCT05161936|Lumasiran|lumasiran|mesh-list
56575100|NCT05161936|Renal Agents|renal agents|mesh-ancestor
56575101|NCT05144009|Rituximab|rituximab|mesh-list
56575102|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56575103|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575104|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575105|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
56575106|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575107|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56575108|NCT05143424|Morphine|morphine|mesh-list
56575109|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56575110|NCT05143424|Narcotics|narcotics|mesh-ancestor
56575111|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575112|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575113|NCT05143424|Analgesics|analgesics|mesh-ancestor
56575115|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575116|NCT05142696|Carboplatin|carboplatin|mesh-list
56575118|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56575119|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56575120|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575121|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56575122|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56111116|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
56099792|NCT00703339|Treprostinil|treprostinil|mesh-list
56195062|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195063|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
56195064|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56195065|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195066|NCT01496690|Pregabalin|pregabalin|mesh-list
56195067|NCT01496690|Analgesics|analgesics|mesh-ancestor
56195068|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
56195069|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099793|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56099794|NCT04330586|Ciclesonide|ciclesonide|mesh-list
56575123|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56575124|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575125|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575126|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
56575127|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
56575128|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56575129|NCT05137067|Cisplatin|cisplatin|mesh-list
56575130|NCT05137067|Docetaxel|docetaxel|mesh-list
56575131|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
56575132|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
56575133|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
56575134|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
56575135|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575136|NCT05130463|Empagliflozin|empagliflozin|mesh-list
56575137|NCT05130463|Linagliptin|linagliptin|mesh-list
56575138|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56575139|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575140|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56575141|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575142|NCT05130463|Incretins|incretins|mesh-ancestor
56575143|NCT05130463|Hormones|hormones|mesh-ancestor
56575144|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575145|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56575146|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
56575173|NCT05027945|Sirolimus|sirolimus|mesh-list
56575174|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
56575175|NCT05027945|Busulfan|busulfan|mesh-list
56575176|NCT05027945|Fludarabine|fludarabine|mesh-list
56575177|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575178|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
56575179|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575180|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56575181|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56575182|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
56575183|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575184|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575185|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56575186|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56575234|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56575235|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575236|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575237|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56575238|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
56575239|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575240|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575241|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575299|NCT04847557|Tirzepatide|tirzepatide|mesh-list
56575300|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56575301|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575302|NCT04847557|Incretins|incretins|mesh-ancestor
56575303|NCT04847557|Hormones|hormones|mesh-ancestor
56575308|NCT04834557|Digoxin|digoxin|mesh-list
56575369|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56575370|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575371|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575372|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575373|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56575374|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56575375|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56575376|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
56575377|NCT04680975|Belumosudil|belumosudil|mesh-list
56575378|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56575379|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575381|NCT04663555|Dexamethasone|dexamethasone|mesh-list
56575432|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575433|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56575434|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
56575435|NCT04501861|Coagulants|coagulants|mesh-ancestor
56575436|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56575437|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
56575438|NCT04496024|Ofloxacin|ofloxacin|mesh-list
56575439|NCT04496024|Levofloxacin|levofloxacin|mesh-list
56575440|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56575441|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575501|NCT04200651|Dexamethasone|dexamethasone|mesh-list
56575502|NCT04200651|Prednisolone|prednisolone|mesh-list
56575503|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56575504|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
56575505|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56575506|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
56575507|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56575508|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
56575509|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575510|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
56575511|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
56575512|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575513|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575514|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575515|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
56575516|NCT04200651|Hormones|hormones|mesh-ancestor
56575517|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575518|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575519|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575520|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56575521|NCT04200651|Protective Agents|protective agents|mesh-ancestor
56575522|NCT04152200|Lumasiran|lumasiran|mesh-list
56575523|NCT04152200|Renal Agents|renal agents|mesh-ancestor
56575524|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
56575525|NCT04150900|Bavituximab|bavituximab|mesh-list
56575526|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575527|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575528|NCT04145700|Gemcitabine|gemcitabine|mesh-list
56575550|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
56575551|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575552|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575553|NCT04098081|Antiviral Agents|antiviral agents|mesh-ancestor
56575554|NCT04098081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575555|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575556|NCT04098081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575557|NCT04098081|Immunologic Factors|immunologic factors|mesh-ancestor
56575558|NCT04098081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575559|NCT04084171|Insulin|insulin|mesh-list
56575560|NCT04084171|Pancrelipase|pancrelipase|mesh-list
56575561|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56575562|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575563|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575567|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56575568|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56575571|NCT04047706|Temozolomide|temozolomide|mesh-list
56575612|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56575613|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575614|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575615|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56575616|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
56575617|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
56575618|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575619|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575620|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
56575621|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575681|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
56575682|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56575683|NCT03871621|Meglitinide|meglitinide|mesh-list
56575684|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56575685|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575686|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56575687|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575688|NCT03867188|Bupivacaine|bupivacaine|mesh-list
56575689|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
56575690|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
56575691|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56575692|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575693|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
56575694|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56575695|NCT03796884|Linaclotide|linaclotide|mesh-list
56575696|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56575697|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
56575698|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575699|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56575700|NCT03794999|Benralizumab|benralizumab|mesh-list
56575701|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56575702|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
56575703|NCT03753074|Tenofovir|tenofovir|mesh-list
56575704|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
56575705|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56575706|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56575707|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56575708|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575709|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575710|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56575712|NCT03745040|Bupivacaine|bupivacaine|mesh-list
56575723|NCT03686345|Midostaurin|midostaurin|mesh-list
56575724|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575725|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56575726|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575727|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575728|NCT03681184|Lumasiran|lumasiran|mesh-list
56575729|NCT03681184|Renal Agents|renal agents|mesh-ancestor
56575730|NCT03671967|Meropenem|meropenem|mesh-list
56575731|NCT03671967|Tazobactam|tazobactam|mesh-list
56575732|NCT03671967|Piperacillin|piperacillin|mesh-list
56575739|NCT03657810|Acetaminophen|acetaminophen|mesh-list
56575788|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575789|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56575790|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575791|NCT03544736|Paclitaxel|paclitaxel|mesh-list
56575792|NCT03544736|Carboplatin|carboplatin|mesh-list
56575793|NCT03544736|Nivolumab|nivolumab|mesh-list
56575794|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56575795|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575796|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
56575797|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
56575798|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
56575799|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575800|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575801|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56575802|NCT03533010|Vitamin D|vitamin d|mesh-list
56575803|NCT03533010|Vitamins|vitamins|mesh-ancestor
56575804|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
56575805|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575806|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56575807|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
56575808|NCT03409198|Doxorubicin|doxorubicin|mesh-list
56575809|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56575810|NCT03409198|Nivolumab|nivolumab|mesh-list
56575811|NCT03409198|Ipilimumab|ipilimumab|mesh-list
56575812|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575813|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
56575814|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575815|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56575816|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56575817|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
56575818|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575832|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56575833|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575834|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56575835|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56575836|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56575837|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575838|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
56575839|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56575840|NCT03321656|Tacrolimus|tacrolimus|mesh-list
56575841|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56575842|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
56575843|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575844|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56575845|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575846|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575891|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575892|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56575893|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56575894|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56575895|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
56575896|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
56575897|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56575898|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56575899|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56575900|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56575901|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56575902|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56575903|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56575904|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
56575905|NCT03094637|Azacitidine|azacitidine|mesh-list
56575906|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56575907|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575908|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56575909|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
56575910|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575911|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575941|NCT03009981|Hormones|hormones|mesh-ancestor
56575942|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575943|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575944|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56575945|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575946|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56575947|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
56575948|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56575949|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56575950|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56575951|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575952|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
56575953|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56575954|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
56575955|NCT02960659|Metformin|metformin|mesh-list
56575956|NCT02960659|Liraglutide|liraglutide|mesh-list
56575957|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56575958|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575959|NCT02960659|Incretins|incretins|mesh-ancestor
56575960|NCT02960659|Hormones|hormones|mesh-ancestor
56575961|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56575962|NCT02927301|Atezolizumab|atezolizumab|mesh-list
56575963|NCT02927301|Antibodies|antibodies|mesh-list
56575964|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56575965|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
56575966|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56575967|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575968|NCT02870738|Triamcinolone|triamcinolone|mesh-list
56575969|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56575970|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
56575971|NCT02870738|Hormones|hormones|mesh-ancestor
56575985|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56575986|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56575987|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
56575988|NCT02684058|Carboplatin|carboplatin|mesh-list
56575989|NCT02684058|Vincristine|vincristine|mesh-list
56575990|NCT02684058|Trametinib|trametinib|mesh-list
56575991|NCT02684058|Dabrafenib|dabrafenib|mesh-list
56575992|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56575993|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56575994|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
56575995|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
56575996|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
56575997|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56575998|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56575999|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576000|NCT02667886|Axitinib|axitinib|mesh-list
56576001|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576002|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56576003|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576004|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576005|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
56576006|NCT02623972|Doxorubicin|doxorubicin|mesh-list
56576007|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56576008|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576009|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
56576010|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576011|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576012|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56576013|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
56576014|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576015|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099797|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56099798|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099799|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56099800|NCT00382694|Fludarabine|fludarabine|mesh-list
56099801|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099802|NCT00673309|Insulin|insulin|mesh-list
56099803|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56099804|NCT00673309|Itraconazole|itraconazole|mesh-list
56099805|NCT00673309|Propranolol|propranolol|mesh-list
56099806|NCT00673309|Hormones|hormones|mesh-list
56099807|NCT00673309|Oxandrolone|oxandrolone|mesh-list
56099808|NCT00673309|Nandrolone|nandrolone|mesh-list
56099809|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56099810|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576016|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56576017|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56576018|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56576019|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56324448|NCT04634838|Copper|copper|mesh-list
56576020|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576021|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
56576022|NCT02614066|Fludarabine|fludarabine|mesh-list
56576023|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576024|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
56576025|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576026|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576027|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56576028|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
56576029|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576030|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576031|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56576032|NCT02587195|Teriflunomide|teriflunomide|mesh-list
56576033|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56576034|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56576035|NCT02587195|Analgesics|analgesics|mesh-ancestor
56576036|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
56576037|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111837|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099811|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56099812|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099813|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
56099814|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099815|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56099816|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56099817|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099818|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56099819|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
56099820|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56099821|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56099822|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56099823|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
56099824|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099852|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
56099853|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099854|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099855|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
56099856|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099857|NCT04849364|Capecitabine|capecitabine|mesh-list
56099858|NCT04849364|Atezolizumab|atezolizumab|mesh-list
56099859|NCT04849364|Talazoparib|talazoparib|mesh-list
56099860|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56099861|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
56099862|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099863|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576038|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576039|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576040|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576041|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576042|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
56576044|NCT02582008|Nicotine|nicotine|mesh-list
56576045|NCT02582008|Varenicline|varenicline|mesh-list
56576046|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56576047|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
56576048|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576049|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576050|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56576051|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56576052|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
56576053|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576054|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576055|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56576056|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
56576057|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56576058|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56576059|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56576060|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56576061|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
56576062|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56576063|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56576064|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576065|NCT02502799|Methylphenidate|methylphenidate|mesh-list
56576066|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56576067|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576068|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56576069|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56576072|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
56576080|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
56576081|NCT02081378|Dasatinib|dasatinib|mesh-list
56576082|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576083|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56576153|NCT01107717|Pioglitazone|pioglitazone|mesh-list
56576154|NCT01107717|Exenatide|exenatide|mesh-list
56576155|NCT01107717|Glyburide|glyburide|mesh-list
56576156|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56576157|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158272|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
56576158|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56576159|NCT01107717|Incretins|incretins|mesh-ancestor
56576160|NCT01107717|Hormones|hormones|mesh-ancestor
56576161|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56576162|NCT00782574|Olaparib|olaparib|mesh-list
56576163|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576164|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56576165|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576166|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576167|NCT00753545|Olaparib|olaparib|mesh-list
56576168|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56576169|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576170|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576171|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576172|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
56576173|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56576174|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
56576175|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56576176|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576177|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56576178|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56576179|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56576180|NCT00408447|Fludarabine|fludarabine|mesh-list
56576181|NCT00408447|Busulfan|busulfan|mesh-list
56576182|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
56576183|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576195|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56576196|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56576197|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
56576198|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56576199|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576200|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
56576201|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576202|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56576203|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576204|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576205|NCT00025935|Lithium Carbonate|lithium carbonate|mesh-list
56576206|NCT00025935|Antidepressive Agents|antidepressive agents|mesh-ancestor
56576207|NCT00025935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56576208|NCT00025935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576209|NCT00025935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576210|NCT00025935|Antimanic Agents|antimanic agents|mesh-ancestor
56576211|NCT00025935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56576212|NCT00025935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56576213|NCT00025935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576214|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56576215|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56576216|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576218|NCT00970632|Tadalafil|tadalafil|mesh-list
56576244|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576245|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56576246|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576247|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576248|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576249|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56576250|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56576251|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
56576252|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56576253|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576255|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56576256|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56576257|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576258|NCT01131182|Incretins|incretins|mesh-ancestor
56576259|NCT01131182|Hormones|hormones|mesh-ancestor
56576260|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56576261|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56576262|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
56576263|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576298|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56576299|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576300|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576301|NCT00964782|Urological Agents|urological agents|mesh-ancestor
56576302|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56576303|NCT02882984|Gefitinib|gefitinib|mesh-list
56576304|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576305|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56576307|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576308|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56576309|NCT00966654|Incretins|incretins|mesh-ancestor
56576310|NCT00966654|Hormones|hormones|mesh-ancestor
56576311|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56576312|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576313|NCT00625196|Fluticasone|fluticasone|mesh-list
56576314|NCT00625196|Xhance|xhance|mesh-list
56576315|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576316|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56576317|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
56576318|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576319|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576320|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56576351|NCT01144052|Interferons|interferons|mesh-list
56576352|NCT01144052|Interferon-beta|interferon-beta|mesh-list
56576353|NCT01144052|Natalizumab|natalizumab|mesh-list
56576354|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
56576355|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576356|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
56576357|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576358|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
56576359|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576360|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56576361|NCT04283526|Decitabine|decitabine|mesh-list
56576362|NCT04283526|Spartalizumab|spartalizumab|mesh-list
56576363|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56576364|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
56576365|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576366|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576367|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576368|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56576369|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
56576370|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576371|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56576372|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56576373|NCT01117766|Pregabalin|pregabalin|mesh-list
56576374|NCT01117766|Analgesics|analgesics|mesh-ancestor
56576375|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
56099864|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56099865|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099867|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56099868|NCT00000199|Protective Agents|protective agents|mesh-ancestor
56099869|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099870|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
56099871|NCT04485104|Cannabidiol|cannabidiol|mesh-list
56099872|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
56099873|NCT00668785|Ranibizumab|ranibizumab|mesh-list
56099874|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56099875|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56099898|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099899|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56099900|NCT04358432|Ezetimibe|ezetimibe|mesh-list
56099901|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56099902|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56099903|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
56195070|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195071|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
56195072|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56195073|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56195074|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195075|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56195076|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56099904|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099905|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56099907|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
56099908|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56576376|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576377|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576378|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
56576379|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56576380|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56576381|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576382|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56576383|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56576384|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56576385|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56576386|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56576387|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
56576388|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56576389|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56576390|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576391|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
56324804|NCT04238819|Dinutuximab|dinutuximab|mesh-list
56576392|NCT04312880|Coagulants|coagulants|mesh-ancestor
56576393|NCT01117454|Flecainide|flecainide|mesh-list
56576394|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56576395|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56576396|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56576397|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576398|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576400|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56576422|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
56576423|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56576424|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56576425|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56576426|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576427|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576428|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
56576429|NCT03624036|Fludarabine|fludarabine|mesh-list
56576430|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576431|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
56576432|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576433|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576434|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56576435|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
56576436|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576437|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576438|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56576439|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
56576440|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56576441|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56576442|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56576443|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56576444|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576445|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
56576446|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576447|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576448|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56576449|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576450|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56576451|NCT04669041|Ezetimibe|ezetimibe|mesh-list
56576452|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56324882|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56576465|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
56576466|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576467|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576468|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576469|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576470|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56576471|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576472|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576473|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
56576527|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576528|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576529|NCT01128296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576530|NCT01128296|Immunologic Factors|immunologic factors|mesh-ancestor
56576531|NCT01128296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576532|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
56576533|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56576534|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56576535|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576536|NCT05082909|Probenecid|probenecid|mesh-list
56576537|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
56324958|NCT04091386|Factor VIII|factor viii|mesh-list
56576538|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
56576539|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576540|NCT05082909|Renal Agents|renal agents|mesh-ancestor
56576541|NCT04253145|Atezolizumab|atezolizumab|mesh-list
56576542|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576543|NCT04240509|Tenofovir|tenofovir|mesh-list
56576585|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576586|NCT00625352|Antiviral Agents|antiviral agents|mesh-ancestor
56576587|NCT00625352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576588|NCT00625352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576589|NCT00625352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576590|NCT00625352|Immunologic Factors|immunologic factors|mesh-ancestor
56576591|NCT00625352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576592|NCT04539873|Colchicine|colchicine|mesh-list
56576593|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
56576594|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576595|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
56576596|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
56576597|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
56576598|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576599|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576600|NCT02861040|Vincristine|vincristine|mesh-list
56576601|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56576602|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576603|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
56576604|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
56576605|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
56576606|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576607|NCT04646187|Adalimumab|adalimumab|mesh-list
56576608|NCT04646187|Infliximab|infliximab|mesh-list
56576635|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576636|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
56576637|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576638|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576639|NCT04177953|Carboplatin|carboplatin|mesh-list
56576640|NCT04177953|Nivolumab|nivolumab|mesh-list
56576641|NCT04177953|Pemetrexed|pemetrexed|mesh-list
56576642|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576643|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56576644|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56576645|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576646|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576647|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56576648|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56576649|NCT00878722|Idarubicin|idarubicin|mesh-list
56576650|NCT00878722|Belinostat|belinostat|mesh-list
56576651|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56576652|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576653|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56576654|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56576687|NCT04158076|Amlodipine|amlodipine|mesh-list
56576688|NCT04158076|Telmisartan|telmisartan|mesh-list
56576689|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56576690|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56576691|NCT04158076|Ezetimibe|ezetimibe|mesh-list
56576692|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56576693|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56576694|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56576695|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576696|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56576697|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576698|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
56576699|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56576700|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56576701|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
56576702|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56576703|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56576704|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576705|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56576706|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56576707|NCT04413201|Osimertinib|osimertinib|mesh-list
56576708|NCT04413201|Afatinib|afatinib|mesh-list
56576709|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576710|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56576711|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576712|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576713|NCT00961350|Aspirin|aspirin|mesh-list
56576714|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56576715|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56576716|NCT00961350|Analgesics|analgesics|mesh-ancestor
56576717|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
56576718|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099909|NCT00000217|Carbamazepine|carbamazepine|mesh-list
56099910|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
56099911|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
56099912|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56099913|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099914|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099915|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099916|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56099917|NCT00000217|Analgesics|analgesics|mesh-ancestor
56099918|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
56576719|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576720|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576721|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576722|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56576723|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56576724|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576725|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56576726|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56576727|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576728|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
56576729|NCT03537690|Paclitaxel|paclitaxel|mesh-list
56576730|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56576731|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56576732|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576733|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56576734|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56576735|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56576736|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576737|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
56576738|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56576739|NCT04032184|Fluorides|fluorides|mesh-list
56576740|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
56576741|NCT04032184|Protective Agents|protective agents|mesh-ancestor
56576742|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576743|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56576744|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576745|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
56576746|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
56576747|NCT04246437|Carbidopa|carbidopa|mesh-list
56576748|NCT04246437|Entacapone|entacapone|mesh-list
56576749|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56576750|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56576751|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
56576752|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576753|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576754|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576755|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55892212|NCT02057133|Trastuzumab|trastuzumab|mesh-list
56576756|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576757|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56325187|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
56576758|NCT00662896|Ibuprofen|ibuprofen|mesh-list
56576759|NCT00662896|Naproxen|naproxen|mesh-list
56576760|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56576761|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56576762|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56576763|NCT00662896|Analgesics|analgesics|mesh-ancestor
56576764|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
56576765|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576766|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576767|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576768|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56576769|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56576770|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576771|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576772|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
56576773|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56576774|NCT00963924|Cycloserine|cycloserine|mesh-list
56576775|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56576776|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576777|NCT00963924|Renal Agents|renal agents|mesh-ancestor
56576778|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56576779|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
56576806|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
56576807|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576808|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576809|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56576810|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56576811|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56576812|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56576813|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576814|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56576815|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
56576816|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
56576817|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
56576818|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576819|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
56576820|NCT00666484|Hormones|hormones|mesh-ancestor
56576821|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56576822|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56576861|NCT00666796|Analgesics|analgesics|mesh-ancestor
56576862|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
56576863|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576864|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576865|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
56576866|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56576867|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56576868|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56576869|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56576870|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56576871|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56576872|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576873|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576874|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
56576875|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56576876|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576877|NCT00912093|Icatibant|icatibant|mesh-list
56576878|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56576879|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56576880|NCT00912093|Analgesics|analgesics|mesh-ancestor
56576881|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
56576882|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576912|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56576913|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576914|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56576915|NCT02631460|Carboplatin|carboplatin|mesh-list
56576916|NCT02631460|Pemetrexed|pemetrexed|mesh-list
56576917|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56576918|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576919|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576920|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56576921|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56576922|NCT04094961|Dexamethasone|dexamethasone|mesh-list
56576923|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
56576924|NCT04094961|Pomalidomide|pomalidomide|mesh-list
56576925|NCT04094961|Ixazomib|ixazomib|mesh-list
56576926|NCT04094961|BB 1101|bb 1101|mesh-list
56576927|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56576928|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
56576929|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
56576930|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56576931|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576932|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56576933|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
56576934|NCT04094961|Hormones|hormones|mesh-ancestor
56576935|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56576936|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56576938|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
56576962|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576963|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
56576965|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
56576966|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
56576967|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
56576968|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56576969|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56576970|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56576971|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56576972|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56576973|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56576974|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56576975|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
56576976|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56576977|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
56576978|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56576979|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56576980|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56576981|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56576982|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56576983|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56576984|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
56576985|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56577011|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56577012|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577013|NCT00961116|Fenofibrate|fenofibrate|mesh-list
56577084|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577085|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577086|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
56577087|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577088|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56577089|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56577090|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56577091|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56577092|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56577093|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56577094|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56577095|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56577096|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
56577097|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56577098|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
56577099|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56577100|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
56577101|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577102|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
56577103|NCT04204278|Protective Agents|protective agents|mesh-ancestor
56577104|NCT02859792|Riluzole|riluzole|mesh-list
56577105|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
56577106|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56577107|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56577108|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577109|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577110|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577111|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56577112|NCT02859792|Protective Agents|protective agents|mesh-ancestor
56577113|NCT00625430|Fludarabine|fludarabine|mesh-list
56577114|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
56577115|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577116|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577117|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
56099919|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099920|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56099921|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56099922|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577118|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577119|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577120|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
56577121|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577122|NCT04282746|Ketamine|ketamine|mesh-list
56577123|NCT04282746|Analgesics|analgesics|mesh-ancestor
56577124|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
56577125|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577126|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577127|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56577128|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56577129|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
56577130|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
56577131|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577132|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56577133|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56577134|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577135|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577136|NCT03328026|Interferons|interferons|mesh-list
56577149|NCT03773445|Golimumab|golimumab|mesh-list
56577172|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56577173|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
56577177|NCT01126424|Urological Agents|urological agents|mesh-ancestor
56577244|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577245|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577246|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56577247|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
56577248|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56577249|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577250|NCT04282200|Ketorolac|ketorolac|mesh-list
56577251|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56577252|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56577254|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
56577255|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577256|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577257|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577301|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577302|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
56577303|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577304|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56577305|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
56577306|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56577307|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56577308|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577309|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56577310|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
56577311|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56577312|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56577313|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56577314|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56577315|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
56577316|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577317|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56577318|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56577319|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577320|NCT03188796|Vitamin D|vitamin d|mesh-list
56577321|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
56577322|NCT03188796|Vitamins|vitamins|mesh-ancestor
56577323|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
56577324|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577325|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56577326|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56577327|NCT03164928|Denosumab|denosumab|mesh-list
56577328|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56577329|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577330|NCT01076543|Sirolimus|sirolimus|mesh-list
56577331|NCT01076543|Lenalidomide|lenalidomide|mesh-list
56577332|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
56577333|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577334|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56577335|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56099923|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56099924|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56577336|NCT01076543|Growth Substances|growth substances|mesh-ancestor
56577337|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
56577338|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577339|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56577340|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577341|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56577342|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
56577343|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577344|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
56577345|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56577346|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577347|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56577348|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56577349|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577350|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577351|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577352|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56577353|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56577354|NCT02860494|Everolimus|everolimus|mesh-list
56325796|NCT02451943|Olaratumab|olaratumab|mesh-list
56577355|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577356|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577357|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
56577358|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577359|NCT00663832|Panobinostat|panobinostat|mesh-list
56577360|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577361|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56577362|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577363|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577364|NCT04281576|Capecitabine|capecitabine|mesh-list
56577365|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
56577366|NCT04281576|Trastuzumab|trastuzumab|mesh-list
56577367|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577368|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
56577369|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577370|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577371|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56577372|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
56577373|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56577374|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577375|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56577376|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56577377|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577378|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577379|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577380|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56577381|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56577382|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56577383|NCT04304807|Melatonin|melatonin|mesh-list
56577384|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577385|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
56577386|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577387|NCT04304807|Protective Agents|protective agents|mesh-ancestor
56577388|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577389|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577390|NCT04280874|Dinoprostone|dinoprostone|mesh-list
56577391|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
56577392|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56577393|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577394|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56577395|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56577396|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56577397|NCT04157998|Metoclopramide|metoclopramide|mesh-list
56577398|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
56577399|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
56577400|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577401|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099925|NCT00000223|Buprenorphine|buprenorphine|mesh-list
56099926|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56099927|NCT00000223|Narcotics|narcotics|mesh-ancestor
56099937|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099938|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099940|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
56099941|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099942|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56099943|NCT00000235|Buprenorphine|buprenorphine|mesh-list
56099944|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56099945|NCT00000235|Narcotics|narcotics|mesh-ancestor
56099946|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099947|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099948|NCT00000235|Analgesics|analgesics|mesh-ancestor
56099949|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
56577402|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56577403|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56577404|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56577405|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
56577406|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577407|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577408|NCT01072877|Polidocanol|polidocanol|mesh-list
56577409|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56577410|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56577411|NCT00630474|Xylometazoline|xylometazoline|mesh-list
56577412|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
56577413|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56577414|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
56577415|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
56577416|NCT00957528|Testosterone|testosterone|mesh-list
56577417|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
56577418|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
56577419|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56577420|NCT00957528|Androgens|androgens|mesh-ancestor
56577421|NCT00957528|Hormones|hormones|mesh-ancestor
56577422|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56577423|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577424|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56577425|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577426|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
56577427|NCT02857062|Emollients|emollients|mesh-list
56577428|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
56577429|NCT00958776|Peramivir|peramivir|mesh-list
56577430|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
56577431|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577432|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577433|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577434|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
56577435|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577436|NCT02858856|Mitogens|mitogens|mesh-ancestor
56577437|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
56577438|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577443|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
56577444|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577445|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577446|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
56577447|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577448|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56577449|NCT02858622|Narcotics|narcotics|mesh-ancestor
56577450|NCT02858622|Analgesics|analgesics|mesh-ancestor
56577451|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56577452|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56577453|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
56577454|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
56577455|NCT02191566|Tegafur|tegafur|mesh-list
56577456|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577457|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577458|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
56577459|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577460|NCT00596830|Paclitaxel|paclitaxel|mesh-list
56577461|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56577462|NCT00596830|Carboplatin|carboplatin|mesh-list
56577463|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56577464|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577465|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
56577466|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
56577467|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
56577493|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56577494|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56577495|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56577496|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
56577497|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577498|NCT02819856|Protective Agents|protective agents|mesh-ancestor
56577499|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56577500|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577501|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56577502|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
56577503|NCT02630290|Ropivacaine|ropivacaine|mesh-list
56577504|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56577505|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56577506|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577507|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56577508|NCT02630290|Analgesics|analgesics|mesh-ancestor
56577509|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
56577510|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577511|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56577512|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56577513|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56577514|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
56577515|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577516|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577517|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
56577518|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
56577519|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
56577520|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56577521|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
56099950|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099951|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56099952|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
56099953|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099954|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
56099955|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
56099956|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56099957|NCT00000241|Flupenthixol|flupenthixol|mesh-list
56099958|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
56099959|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56099960|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56099961|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099962|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099963|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099964|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56099965|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
56099966|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099967|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577522|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577523|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
56577524|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
56577525|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56577526|NCT00668356|Didanosine|didanosine|mesh-list
56577527|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
56577528|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577529|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56577530|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56577531|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577532|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
56577533|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577534|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56577535|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56577536|NCT00664222|Furosemide|furosemide|mesh-list
56577537|NCT00664222|Spironolactone|spironolactone|mesh-list
56577538|NCT00664222|Diuretics|diuretics|mesh-ancestor
56577539|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
56577540|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577541|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56577542|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56099968|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
56099969|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56099970|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
56099971|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
56099972|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099973|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195077|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56195078|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56195079|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56195080|NCT01496742|Paclitaxel|paclitaxel|mesh-list
56195081|NCT01496742|Bevacizumab|bevacizumab|mesh-list
56195082|NCT01496742|Carboplatin|carboplatin|mesh-list
56195083|NCT01496742|Pemetrexed|pemetrexed|mesh-list
56195084|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56195085|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099974|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56099975|NCT00000253|Analgesics|analgesics|mesh-ancestor
56099976|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
56099977|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099978|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
56099979|NCT00000259|Sevoflurane|sevoflurane|mesh-list
56099980|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56099981|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56099982|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
56099983|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
56099984|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099985|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099986|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56099987|NCT00000259|Analgesics|analgesics|mesh-ancestor
56099988|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
56099989|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099991|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099992|NCT00379405|Ritonavir|ritonavir|mesh-list
56099993|NCT00379405|Saquinavir|saquinavir|mesh-list
56099994|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55868330|NCT04878315|Captopril|captopril|mesh-list
56577543|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577544|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56577545|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
56577546|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56577547|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56577549|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56577550|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577551|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56577552|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577553|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
56577554|NCT00952614|Hormones|hormones|mesh-ancestor
56577555|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56577556|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577557|NCT00911859|Prednisone|prednisone|mesh-list
56577558|NCT00911859|Bortezomib|bortezomib|mesh-list
56577559|NCT00911859|Melphalan|melphalan|mesh-list
56577560|NCT00911859|Siltuximab|siltuximab|mesh-list
56577561|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56577562|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577563|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
56577564|NCT00911859|Hormones|hormones|mesh-ancestor
56577565|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56577566|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577567|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56577568|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577569|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56577570|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
56577571|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577578|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
56577587|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56577588|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577589|NCT00596752|Alprostadil|alprostadil|mesh-list
56577590|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56577591|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
56577592|NCT00596752|Urological Agents|urological agents|mesh-ancestor
56577593|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56577594|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577595|NCT00958074|Vorinostat|vorinostat|mesh-list
56577596|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577597|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56577598|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577599|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577600|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
56577601|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56577602|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577603|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577604|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56577605|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56577643|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56577644|NCT00664846|Analgesics|analgesics|mesh-ancestor
56577645|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
56577646|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56577647|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577648|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56577649|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56577650|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56577708|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56577709|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
56577710|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56577711|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577712|NCT00632385|Eletriptan|eletriptan|mesh-list
56577713|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56577714|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
56577715|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577716|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577717|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577718|NCT00910689|Propranolol|propranolol|mesh-list
56577719|NCT00910689|Nadolol|nadolol|mesh-list
56577720|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56577768|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56577769|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56577770|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
56577771|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
56577772|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
56577773|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
56577774|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577775|NCT00811135|Bevacizumab|bevacizumab|mesh-list
56577776|NCT00811135|Trastuzumab|trastuzumab|mesh-list
56577777|NCT00811135|Capecitabine|capecitabine|mesh-list
56577778|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56577779|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577780|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56577781|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56577782|NCT00811135|Growth Substances|growth substances|mesh-ancestor
56577783|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577784|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
56577785|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577786|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
56577787|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577788|NCT00811057|Indomethacin|indomethacin|mesh-list
56577789|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
56577790|NCT00811057|Nifedipine|nifedipine|mesh-list
56577820|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56577821|NCT00808639|Doxorubicin|doxorubicin|mesh-list
56577822|NCT00808639|Methotrexate|methotrexate|mesh-list
56577823|NCT00808639|Vinblastine|vinblastine|mesh-list
56577824|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577825|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56577826|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56577827|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56577828|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577829|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577830|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56577831|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
56577832|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56577833|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577834|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56577835|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
56577836|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
56577837|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56577838|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56577839|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
56577840|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56577841|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56577842|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56577843|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
56577844|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
56577845|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
56577846|NCT00910299|Clopidogrel|clopidogrel|mesh-list
56577847|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56577848|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56100022|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100023|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56100024|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56100025|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56100026|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
56100027|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100028|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100030|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56100031|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100032|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56100033|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56100034|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56100035|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100036|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
56577849|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56577850|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56577851|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56577852|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
56577853|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56577854|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577855|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577856|NCT05754853|Gemcitabine|gemcitabine|mesh-list
56577857|NCT05754853|Paclitaxel|paclitaxel|mesh-list
56577858|NCT05754853|Docetaxel|docetaxel|mesh-list
56577859|NCT05754853|Pemetrexed|pemetrexed|mesh-list
56577860|NCT05754853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56577861|NCT05754853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577862|NCT05754853|Tubulin Modulators|tubulin modulators|mesh-ancestor
56577863|NCT05754853|Antimitotic Agents|antimitotic agents|mesh-ancestor
56577864|NCT05754853|Mitosis Modulators|mitosis modulators|mesh-ancestor
56577865|NCT05754853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577867|NCT05754853|Antimetabolites|antimetabolites|mesh-ancestor
56577906|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56577907|NCT00596362|Bevacizumab|bevacizumab|mesh-list
56577908|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56577909|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577910|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56577911|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56577912|NCT00596362|Growth Substances|growth substances|mesh-ancestor
56577913|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577914|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
56577915|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
56577916|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56577917|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56577918|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56577919|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56577920|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577921|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577922|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577923|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56577924|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56577925|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56577926|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56577927|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
56577928|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
56577955|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56577956|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577957|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577958|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56577959|NCT00676468|Montelukast|montelukast|mesh-list
56577960|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56577961|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
56577962|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56577963|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
56577964|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56577965|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577966|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56577967|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56577968|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577969|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56577970|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56577971|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56577972|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577973|NCT00676702|Vitamin K|vitamin k|mesh-list
56577974|NCT00676702|Pancrelipase|pancrelipase|mesh-list
56577975|NCT00676702|Pancreatin|pancreatin|mesh-list
56577976|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56577977|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56577978|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56577979|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577980|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
56577981|NCT00676702|Coagulants|coagulants|mesh-ancestor
56577982|NCT00676702|Vitamins|vitamins|mesh-ancestor
56577983|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
56577984|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577985|NCT05753371|Metformin|metformin|mesh-list
56577986|NCT05753371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56100037|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100038|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56100039|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
56100040|NCT00599131|Docetaxel|docetaxel|mesh-list
56100041|NCT00599131|Fluorouracil|fluorouracil|mesh-list
56100042|NCT00599131|Cetuximab|cetuximab|mesh-list
56100070|NCT04295486|Aspirin|aspirin|mesh-list
56100071|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56100072|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56577987|NCT05753371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56577988|NCT00671476|Doxorubicin|doxorubicin|mesh-list
56577989|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56577990|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56577991|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56577992|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56577993|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56577994|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56577995|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56577996|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
56577997|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56577998|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56577999|NCT00908583|Prednisolone|prednisolone|mesh-list
56578000|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
56578001|NCT00908583|Rituximab|rituximab|mesh-list
56578002|NCT00908583|Bortezomib|bortezomib|mesh-list
56578003|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56578011|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
56578047|NCT04973605|Hormones|hormones|mesh-ancestor
56578048|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578049|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56578050|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578051|NCT04153708|Antibodies|antibodies|mesh-list
56578052|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
56578053|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
56578054|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
56578055|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578056|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
56578057|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56578058|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56578059|NCT00676936|Prednisolone|prednisolone|mesh-list
56578060|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
56578061|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56578062|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
56578063|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578064|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
56578065|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
56578066|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578067|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578068|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578069|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
56578070|NCT00676936|Hormones|hormones|mesh-ancestor
56578071|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578072|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56578073|NCT00676936|Protective Agents|protective agents|mesh-ancestor
56578074|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56578075|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578076|NCT02629744|Etrolizumab|etrolizumab|mesh-list
56578077|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578078|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
56113481|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56100073|NCT04295486|Analgesics|analgesics|mesh-ancestor
56100074|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
56100075|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100076|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100077|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56100078|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56100079|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56100080|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56100081|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578079|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578080|NCT00670618|Fluorides|fluorides|mesh-list
56578081|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
56578082|NCT00670618|Protective Agents|protective agents|mesh-ancestor
56578083|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578084|NCT00677170|Pevonedistat|pevonedistat|mesh-list
56578085|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578086|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578087|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
56578088|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
56578089|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56578090|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56578091|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56158332|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
56578092|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578093|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56578094|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56578095|NCT01125566|Trastuzumab|trastuzumab|mesh-list
56578096|NCT01125566|Vinorelbine|vinorelbine|mesh-list
56578097|NCT01125566|Afatinib|afatinib|mesh-list
56578098|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56578099|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578100|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56578101|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578102|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578103|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578104|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578124|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56578125|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56578126|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56578127|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56578128|NCT00671008|Insulin|insulin|mesh-list
56578129|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56578130|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
56578131|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
56578132|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
56578133|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56578134|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56578135|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578136|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
56578137|NCT00911716|Bevacizumab|bevacizumab|mesh-list
56578138|NCT00911716|Docetaxel|docetaxel|mesh-list
56578139|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578140|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
56578141|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578142|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56578143|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56578144|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
56113555|NCT00281879|Cyclosporine|cyclosporine|mesh-list
56100082|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56100083|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56100084|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100085|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
56195086|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
56195087|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
56195088|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
56195089|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195090|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56195091|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56195092|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56195093|NCT01496742|Growth Substances|growth substances|mesh-ancestor
56195094|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195095|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
56195096|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195097|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56195098|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56195100|NCT01496911|Levocetirizine|levocetirizine|mesh-list
56195101|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56195102|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56195103|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
56195104|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
56195105|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56195106|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195107|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195108|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
56195109|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
56195110|NCT01496989|Interleukin-12|interleukin-12|mesh-list
56195111|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56195112|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
56195113|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195114|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56578145|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578146|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578147|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56578148|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56578149|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56578150|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56578151|NCT00911716|Growth Substances|growth substances|mesh-ancestor
56578152|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
56578153|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578154|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578155|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578156|NCT00595582|Curcumin|curcumin|mesh-list
56578157|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56578158|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56578159|NCT00595582|Analgesics|analgesics|mesh-ancestor
56578160|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
56578161|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578162|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578163|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578164|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56578165|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578166|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578167|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578168|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
56578169|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56578170|NCT00680446|Antibodies|antibodies|mesh-list
56578171|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
56578172|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
56578173|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578174|NCT00672022|Miglustat|miglustat|mesh-list
56578175|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578176|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578187|NCT00680602|Citalopram|citalopram|mesh-list
56578188|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
56578189|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56578190|NCT00680602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56578191|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56578192|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56578193|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578194|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578195|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
56578196|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578197|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56578198|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56578199|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56578200|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578201|NCT00680680|Dutasteride|dutasteride|mesh-list
56578202|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56578242|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578243|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
56578244|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56578245|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56578246|NCT00877006|Prednisone|prednisone|mesh-list
56578247|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
56578248|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56578249|NCT00877006|Rituximab|rituximab|mesh-list
56578250|NCT00877006|Doxorubicin|doxorubicin|mesh-list
56578251|NCT00877006|Vincristine|vincristine|mesh-list
56578252|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578253|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
56578254|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578255|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56578256|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56578257|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
56578258|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578259|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578260|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56578261|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56578262|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56578263|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56578264|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56578265|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578266|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578267|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
56578291|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56578292|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56578293|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56578294|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
56578295|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578296|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578297|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578298|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
56578299|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
56578300|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578301|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578302|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56578303|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56578304|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
56578305|NCT00807937|Lorazepam|lorazepam|mesh-list
56578306|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
56578307|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
56578308|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
56578309|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578310|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578311|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578312|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56578313|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56578314|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56578315|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56578339|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578340|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578341|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56578342|NCT00678964|Carboplatin|carboplatin|mesh-list
56578343|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56578344|NCT00678964|Vinorelbine|vinorelbine|mesh-list
56578345|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578346|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56578347|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578348|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578349|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56578350|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578351|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578352|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578353|NCT05753059|Bendroflumethiazide|bendroflumethiazide|mesh-list
56578354|NCT05753059|Amiloride|amiloride|mesh-list
56578355|NCT05753059|Diuretics|diuretics|mesh-ancestor
56578356|NCT05753059|Natriuretic Agents|natriuretic agents|mesh-ancestor
56578357|NCT05753059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578358|NCT05753059|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56578359|NCT05753059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56578360|NCT05753059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56578361|NCT05753059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578362|NCT05753059|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56578363|NCT05753059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56578364|NCT05753059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56578365|NCT05753059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56578366|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
56578367|NCT02627248|Docetaxel|docetaxel|mesh-list
56578368|NCT02627248|Epirubicin|epirubicin|mesh-list
56195115|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56195116|NCT01496989|Growth Substances|growth substances|mesh-ancestor
56195129|NCT01497041|Docetaxel|docetaxel|mesh-list
56195130|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
56195131|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195132|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
56195133|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
56195134|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
56195135|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195136|NCT01497093|Thalidomide|thalidomide|mesh-list
56195137|NCT01497093|Dexamethasone|dexamethasone|mesh-list
56195138|NCT01497093|Bortezomib|bortezomib|mesh-list
56195139|NCT01497093|Pomalidomide|pomalidomide|mesh-list
56195140|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195141|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
56578369|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578370|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
56578371|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578372|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56578373|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56578374|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
56578375|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578376|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578377|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56578378|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578379|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578380|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578381|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56578382|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56578383|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56578384|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578385|NCT03993535|Serotonin|serotonin|mesh-list
56578386|NCT03993535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56578387|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56578388|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
56578389|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578390|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578391|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578392|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56578393|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56578394|NCT02626936|Insulin|insulin|mesh-list
56578395|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56578396|NCT02626936|Glucagon|glucagon|mesh-list
56578397|NCT02626936|Hormones|hormones|mesh-list
56578402|NCT00912262|Capsaicin|capsaicin|mesh-list
56578413|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578414|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56578415|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56578416|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578417|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578418|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56578419|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
56578420|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
56578421|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578422|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578423|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
56578424|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578425|NCT00906945|Analgesics|analgesics|mesh-ancestor
56578426|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
56578427|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578428|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56578429|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56578430|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56578431|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
56578432|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
56578433|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56578434|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56578435|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578436|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
56578437|NCT02627560|Coagulants|coagulants|mesh-ancestor
56578438|NCT00681460|Metformin|metformin|mesh-list
56578455|NCT05752903|Ketamine|ketamine|mesh-list
56578461|NCT05752903|Anesthetics, General|anesthetics, general|mesh-ancestor
56578462|NCT05752903|Anesthetics|anesthetics|mesh-ancestor
56578463|NCT05752903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56578464|NCT05752903|Analgesics|analgesics|mesh-ancestor
56578465|NCT05752903|Sensory System Agents|sensory system agents|mesh-ancestor
56578466|NCT05752903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578467|NCT05752903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56578468|NCT05752903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56578469|NCT05752903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56578470|NCT05752903|Adrenergic Agents|adrenergic agents|mesh-ancestor
56578471|NCT05752903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578472|NCT05752903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578473|NCT05752903|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56578474|NCT05752903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56578475|NCT05752903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56578476|NCT00590317|Ondansetron|ondansetron|mesh-list
56578477|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
56578478|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
56578479|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
56578480|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578481|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578514|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578515|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578516|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56578517|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
56578518|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
56578519|NCT00805285|Hormones|hormones|mesh-ancestor
56578520|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578521|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
56578522|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
56578523|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578524|NCT02606773|Protective Agents|protective agents|mesh-ancestor
56578525|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578526|NCT02606773|Vitamins|vitamins|mesh-ancestor
56578527|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
56578528|NCT04310774|Tegafur|tegafur|mesh-list
56578529|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56578530|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
56578531|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578532|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578533|NCT05715229|Paclitaxel|paclitaxel|mesh-list
56578534|NCT05715229|Carboplatin|carboplatin|mesh-list
56578535|NCT05715229|Nivolumab|nivolumab|mesh-list
56578536|NCT05715229|Pemetrexed|pemetrexed|mesh-list
56578537|NCT05715229|Ipilimumab|ipilimumab|mesh-list
56578538|NCT05715229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56578539|NCT05715229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578540|NCT05715229|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578541|NCT05715229|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578542|NCT05715229|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578543|NCT05715229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578544|NCT05715229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56578558|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
56578559|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578560|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
56578561|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578562|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56578563|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56578564|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
56578565|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578566|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578567|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56578568|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56578569|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
56578570|NCT00805207|Estradiol|estradiol|mesh-list
56578571|NCT00805207|Estrogens|estrogens|mesh-list
56578572|NCT00805207|Testosterone|testosterone|mesh-list
56578573|NCT00805207|Progesterone|progesterone|mesh-list
56578574|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
56578575|NCT00805207|Hormones|hormones|mesh-ancestor
56578576|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578577|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578578|NCT00805207|Androgens|androgens|mesh-ancestor
56578579|NCT00805207|Progestins|progestins|mesh-ancestor
56578580|NCT00805675|Tenofovir|tenofovir|mesh-list
56578581|NCT00805675|Telbivudine|telbivudine|mesh-list
56578582|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
56578583|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578609|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
56578610|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
56578611|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578612|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578613|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56578614|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56578615|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56578616|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
56578617|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578618|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578619|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
56578620|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56578621|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56578622|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56578623|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56578624|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56578625|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578626|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56578627|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56578628|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56578629|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56578630|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56578632|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56578657|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56578658|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56578659|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578660|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
56578661|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
56578662|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578663|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578664|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578665|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
56578666|NCT03903835|Hormones|hormones|mesh-ancestor
56578667|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578668|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578669|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56578670|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56578671|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578672|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
56578673|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56578674|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56578675|NCT05745337|Metoprolol|metoprolol|mesh-list
56578676|NCT05745337|Verapamil|verapamil|mesh-list
56578677|NCT05745337|Diltiazem|diltiazem|mesh-list
56578678|NCT05745337|Calcium Channel Blockers|calcium channel blockers|mesh-list
56578679|NCT05745337|Calcium|calcium|mesh-list
56578680|NCT05745337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56578681|NCT05745337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56578705|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56578707|NCT02856750|Gabapentin|gabapentin|mesh-list
56578708|NCT02856750|Analgesics|analgesics|mesh-ancestor
56578709|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
56578710|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578711|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578712|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
56578713|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56578714|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56578715|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56578716|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56578717|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56578718|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56578719|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578720|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578721|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
56578722|NCT05751967|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56578723|NCT05751967|Fenofibrate|fenofibrate|mesh-list
56578724|NCT05751967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56578725|NCT05751967|Antimetabolites|antimetabolites|mesh-ancestor
56578726|NCT05751967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578727|NCT05751967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56578728|NCT05751967|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56578729|NCT05751967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578730|NCT02857920|Bevacizumab|bevacizumab|mesh-list
56578731|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56578732|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578733|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56578734|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56578735|NCT02857920|Growth Substances|growth substances|mesh-ancestor
56578736|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578747|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56578748|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578749|NCT03641209|Acetaminophen|acetaminophen|mesh-list
56578750|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56578751|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56578752|NCT03641209|Analgesics|analgesics|mesh-ancestor
56578753|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
56578754|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578755|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578756|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
56578757|NCT05704543|Buprenorphine|buprenorphine|mesh-list
56578758|NCT05704543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56578759|NCT05704543|Narcotics|narcotics|mesh-ancestor
56578760|NCT05704543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56578761|NCT05704543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578762|NCT05704543|Analgesics|analgesics|mesh-ancestor
56578763|NCT05704543|Sensory System Agents|sensory system agents|mesh-ancestor
56578764|NCT05704543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578765|NCT05704543|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56578805|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56578806|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578807|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
56578808|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56578809|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56578810|NCT02606539|Antidotes|antidotes|mesh-ancestor
56578811|NCT02606539|Protective Agents|protective agents|mesh-ancestor
56578812|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
56578813|NCT02606539|Vitamins|vitamins|mesh-ancestor
56578814|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
56578815|NCT02606539|Hematinics|hematinics|mesh-ancestor
56578816|NCT00589693|Imipenem|imipenem|mesh-list
56578817|NCT00589693|Doripenem|doripenem|mesh-list
56578818|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
56578819|NCT00589693|Cilastatin|cilastatin|mesh-list
56578820|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56578821|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578822|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
56578823|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578824|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578825|NCT02606383|Ketoconazole|ketoconazole|mesh-list
56578826|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
56578827|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578828|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56578829|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56578830|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578831|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578855|NCT05660473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56578856|NCT05660473|Alkylating Agents|alkylating agents|mesh-ancestor
56578857|NCT05660473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578858|NCT05660473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56578859|NCT05660473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56578860|NCT05660473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578861|NCT05660473|Antiemetics|antiemetics|mesh-ancestor
56578862|NCT05660473|Autonomic Agents|autonomic agents|mesh-ancestor
56578863|NCT05660473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56578864|NCT05660473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56578865|NCT05660473|Glucocorticoids|glucocorticoids|mesh-ancestor
56578866|NCT05660473|Hormones|hormones|mesh-ancestor
56578867|NCT05660473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158368|NCT04715646|Brivaracetam|brivaracetam|mesh-list
56578868|NCT05660473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56578869|NCT05660473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56578870|NCT05660473|Abortifacient Agents|abortifacient agents|mesh-ancestor
56578871|NCT05660473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56578873|NCT05660473|Antimetabolites|antimetabolites|mesh-ancestor
56578908|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
56578909|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578910|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56578911|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
56578912|NCT01964430|Antiviral Agents|antiviral agents|mesh-ancestor
56578913|NCT01964430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56578914|NCT01964430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578915|NCT01964430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56578916|NCT01964430|Immunologic Factors|immunologic factors|mesh-ancestor
56578917|NCT01964430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578918|NCT04269954|Heparin|heparin|mesh-list
56578919|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56578920|NCT04269954|Tinzaparin|tinzaparin|mesh-list
56578921|NCT04269954|Dalteparin|dalteparin|mesh-list
56578922|NCT04269954|Batroxobin|batroxobin|mesh-list
56578923|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
56578924|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56578925|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56578926|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578927|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
56578928|NCT04269954|Coagulants|coagulants|mesh-ancestor
56578929|NCT00630630|Levetiracetam|levetiracetam|mesh-list
56578930|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
56578931|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
56327398|NCT04735926|Vitamins|vitamins|mesh-ancestor
56578932|NCT01254864|Prednisone|prednisone|mesh-list
56578933|NCT01254864|Sunitinib|sunitinib|mesh-list
56578934|NCT01254864|Dasatinib|dasatinib|mesh-list
56578935|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
56578936|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56578957|NCT02854722|Vitamins|vitamins|mesh-list
56578958|NCT02854722|Calcium|calcium|mesh-list
56578959|NCT02854722|Deferasirox|deferasirox|mesh-list
56578960|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
56578961|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578962|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56578963|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56578964|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56578965|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
56578966|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
56578967|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578968|NCT00800683|Linagliptin|linagliptin|mesh-list
56578969|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56578970|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578971|NCT00800683|Incretins|incretins|mesh-ancestor
56578972|NCT00800683|Hormones|hormones|mesh-ancestor
56578973|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56114372|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
56195142|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
56195147|NCT01497093|Hormones|hormones|mesh-ancestor
56195195|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195196|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56195197|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195198|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195199|NCT01497470|Paclitaxel|paclitaxel|mesh-list
56195200|NCT01497470|Carboplatin|carboplatin|mesh-list
56195201|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56195202|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195203|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
56195204|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56122975|NCT01582152|Growth Substances|growth substances|mesh-ancestor
56195205|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56195206|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100086|NCT00000289|Ondansetron|ondansetron|mesh-list
56100087|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
56100088|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
55868438|NCT01676571|Vortioxetine|vortioxetine|mesh-list
56100136|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56100137|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56100138|NCT04423718|Aflibercept|aflibercept|mesh-list
56100139|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56100140|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56100141|NCT04423718|Growth Substances|growth substances|mesh-ancestor
56100142|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100143|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
56100144|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100145|NCT00000301|Amantadine|amantadine|mesh-list
56100146|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56100147|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56100148|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
56100149|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100150|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
56100151|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100152|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100153|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100154|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56100155|NCT00000301|Analgesics|analgesics|mesh-ancestor
56100156|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
55892213|NCT02057133|Pertuzumab|pertuzumab|mesh-list
56578974|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56578975|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
56578976|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56578977|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578978|NCT01113710|Rotigotine|rotigotine|mesh-list
56578979|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
56578980|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
56578981|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56578982|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578983|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578984|NCT01124162|Losartan|losartan|mesh-list
56578985|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56578986|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56578987|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56578988|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56578989|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56578990|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56578991|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56578992|NCT00923533|Diuretics|diuretics|mesh-ancestor
56578993|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
56578994|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56578995|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56578996|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56578997|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579023|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579024|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
56579025|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
56579026|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579027|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579028|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56579029|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56579030|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
56579031|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56579032|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56579033|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56579034|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56579035|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
56579036|NCT00952068|Tramadol|tramadol|mesh-list
56579037|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56579038|NCT00952068|Narcotics|narcotics|mesh-ancestor
56579039|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579040|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579041|NCT00952068|Analgesics|analgesics|mesh-ancestor
56579042|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
56579043|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579044|NCT00951912|Genistein|genistein|mesh-list
56579045|NCT00951912|Daidzein|daidzein|mesh-list
56579055|NCT00951912|Estrogens|estrogens|mesh-ancestor
56579074|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579075|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579076|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579077|NCT01123070|Rituximab|rituximab|mesh-list
56579078|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56579079|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579080|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
56579081|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579083|NCT02857686|Anesthetics|anesthetics|mesh-list
56579084|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579085|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579086|NCT03198741|Aspirin|aspirin|mesh-list
56579088|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56579089|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56579090|NCT03198741|Analgesics|analgesics|mesh-ancestor
56579091|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
56579092|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579093|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579094|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56579095|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56579096|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56100157|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100158|NCT00000307|Naltrexone|naltrexone|mesh-list
56100159|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56100160|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56100161|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100162|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
56100163|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100164|NCT00000313|Fenfluramine|fenfluramine|mesh-list
56100165|NCT00000313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56100166|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56100167|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56100168|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100169|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100171|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100172|NCT00000319|Buprenorphine|buprenorphine|mesh-list
56100173|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56100174|NCT00000319|Narcotics|narcotics|mesh-ancestor
56100175|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100176|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100177|NCT00000319|Analgesics|analgesics|mesh-ancestor
56100178|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
56100179|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100180|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56100181|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56195208|NCT01497483|Pravastatin|pravastatin|mesh-list
56195209|NCT01497483|Cyclosporins|cyclosporins|mesh-list
56195210|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213210|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56100183|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56100184|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100185|NCT04181203|Leuprolide|leuprolide|mesh-list
56100186|NCT04181203|Goserelin|goserelin|mesh-list
56579097|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56579098|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579099|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56579100|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56579101|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579102|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
56579103|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56579104|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56579105|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56579106|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
56579107|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579108|NCT01122680|Bromides|bromides|mesh-list
56579109|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
56579110|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56579111|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
56579112|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579113|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579114|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56579115|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
56579116|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
56579117|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56579118|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
56579119|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579120|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579121|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
56579122|NCT00946998|Sertraline|sertraline|mesh-list
56579123|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
56579124|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100187|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56100188|NCT04181203|Hormones|hormones|mesh-list
56100189|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56100190|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100199|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56100201|NCT03521102|Hydromorphone|hydromorphone|mesh-list
56100202|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56100203|NCT03521102|Analgesics|analgesics|mesh-ancestor
56100204|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
56100205|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100206|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100207|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
56100208|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56100209|NCT03521102|Narcotics|narcotics|mesh-ancestor
56100210|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100211|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
56100212|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56579125|NCT00946998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56579126|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56579127|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579128|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579129|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579130|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
56579131|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579132|NCT01138826|Amlodipine|amlodipine|mesh-list
56579133|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56579134|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56579135|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579136|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579137|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56579138|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579139|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
56579140|NCT00906087|Timolol|timolol|mesh-list
56579141|NCT00906087|Dorzolamide|dorzolamide|mesh-list
56579142|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56579143|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56579174|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579175|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579176|NCT03504501|Lamotrigine|lamotrigine|mesh-list
56579177|NCT03504501|Lovastatin|lovastatin|mesh-list
56579178|NCT03504501|L 647318|l 647318|mesh-list
56579179|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
56579180|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
56579181|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56579182|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579183|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579184|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56579185|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579186|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56579187|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56579188|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579189|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56579190|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56579191|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56579192|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56579193|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
56579194|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56579195|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56579196|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579197|NCT02420574|Albendazole|albendazole|mesh-list
56579198|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
56579199|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56579221|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579222|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56579223|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
56579224|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
56579225|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56579226|NCT02853864|Analgesics|analgesics|mesh-ancestor
56579227|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
56579228|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579229|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56579230|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56579231|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56579232|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
56579233|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579234|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579235|NCT00907257|Tretinoin|tretinoin|mesh-list
56579236|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56579237|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
56579238|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579239|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
56579240|NCT01138046|Paclitaxel|paclitaxel|mesh-list
56579241|NCT01138046|Lapatinib|lapatinib|mesh-list
56579242|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56579243|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579244|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
56579273|NCT01137812|Hormones|hormones|mesh-ancestor
56579274|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579275|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56579276|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
56579277|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579278|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579279|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56579280|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56579281|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56579282|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56579283|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
56579284|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579285|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56579286|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56579287|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579288|NCT04146220|Prednisolone|prednisolone|mesh-list
56579289|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56579290|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
56579291|NCT04146220|Hormones|hormones|mesh-ancestor
56579292|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579293|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579294|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56579295|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579296|NCT00679666|Riboflavin|riboflavin|mesh-list
56579297|NCT00679666|Vitamins|vitamins|mesh-ancestor
56579298|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
56579299|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579300|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
56579301|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56579302|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
56579303|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
56579304|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
56579305|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56579306|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56579307|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579308|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56100213|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100214|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56579309|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579310|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579311|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56579312|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
56579313|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56579314|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56579315|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579316|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579317|NCT00681772|Urological Agents|urological agents|mesh-ancestor
56579318|NCT00946920|Goserelin|goserelin|mesh-list
56579319|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56579320|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579321|NCT00679900|SR 46349B|sr 46349b|mesh-list
56579322|NCT00679900|Lormetazepam|lormetazepam|mesh-list
56579323|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56579324|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56579325|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579326|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56579327|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56579362|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56579363|NCT00680134|Tavaborole|tavaborole|mesh-list
56579364|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
56579365|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579366|NCT00680212|Beta Carotene|beta carotene|mesh-list
56579367|NCT00680212|Carotenoids|carotenoids|mesh-list
56579368|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
56579369|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579370|NCT00680212|Protective Agents|protective agents|mesh-ancestor
56579371|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579372|NCT00680212|Provitamins|provitamins|mesh-ancestor
56579373|NCT00680212|Vitamins|vitamins|mesh-ancestor
56579374|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
56579376|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56579377|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56579378|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579379|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
56579380|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
56579381|NCT02855346|Dapivirine|dapivirine|mesh-list
56579382|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
56579383|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56579384|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
56579385|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56579386|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579387|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56579388|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56579389|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56579390|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56579391|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56579392|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
56579393|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579394|NCT01111604|Ramucirumab|ramucirumab|mesh-list
56579395|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579396|NCT00950742|Trastuzumab|trastuzumab|mesh-list
56579397|NCT00950742|Afatinib|afatinib|mesh-list
56579398|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56579399|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579400|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56579402|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579403|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
56579404|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579405|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
56579406|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56579407|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56579408|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579409|NCT05061368|Urological Agents|urological agents|mesh-ancestor
56579410|NCT04310228|Favipiravir|favipiravir|mesh-list
56579411|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
56579412|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579413|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
56579414|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56579415|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
56579416|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579417|NCT00955110|Oxymorphone|oxymorphone|mesh-list
56579418|NCT00955110|Oxycodone|oxycodone|mesh-list
56579419|NCT00955110|Hydromorphone|hydromorphone|mesh-list
56579420|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56579421|NCT00955110|Narcotics|narcotics|mesh-ancestor
56579422|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579423|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579424|NCT00955110|Analgesics|analgesics|mesh-ancestor
56579425|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
56579426|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579427|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56579428|NCT05056142|Anesthetics|anesthetics|mesh-list
56579429|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579430|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579431|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56579432|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56579433|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56579434|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579435|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579436|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56579437|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56114781|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56579438|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579439|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
56579440|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579441|NCT01111526|Panobinostat|panobinostat|mesh-list
56579442|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579443|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56579444|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579445|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579446|NCT02881346|Betamethasone|betamethasone|mesh-list
56579447|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
56579448|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56579450|NCT02881346|Calcipotriene|calcipotriene|mesh-list
56579451|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56100215|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56100216|NCT00000763|Growth Substances|growth substances|mesh-ancestor
56100217|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100218|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
56100219|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
56100220|NCT00380263|Growth Substances|growth substances|mesh-ancestor
56100221|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100222|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
56100223|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100224|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100225|NCT00000769|Interleukin-4|interleukin-4|mesh-list
56100226|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56100227|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
56100228|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100229|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100230|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56100231|NCT05440591|Metformin|metformin|mesh-list
56100232|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
56100233|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56100234|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827316|NCT04857203|Vitamin D|vitamin d|mesh-list
56100235|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55741799|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100236|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100238|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
56100239|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100240|NCT00379951|Ertapenem|ertapenem|mesh-list
56100241|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56100242|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100243|NCT00000337|Selegiline|selegiline|mesh-list
56100244|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
56100245|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100246|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56100247|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56100248|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56100249|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100250|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100251|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56100252|NCT00000337|Protective Agents|protective agents|mesh-ancestor
56100253|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100254|NCT00000781|Zidovudine|zidovudine|mesh-list
56100255|NCT00000781|Nevirapine|nevirapine|mesh-list
56100256|NCT00000781|Didanosine|didanosine|mesh-list
56195211|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195213|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
56195214|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195215|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
56195216|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579452|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56579453|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
56579454|NCT02881346|Hormones|hormones|mesh-ancestor
56579455|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579456|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579457|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56579458|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
56579459|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
56579460|NCT00630708|Losartan|losartan|mesh-list
56579461|NCT00630708|Benazepril|benazepril|mesh-list
56579462|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56579463|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56579464|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56579465|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56579466|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579467|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56579468|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
56579469|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579470|NCT01111292|Inositol|inositol|mesh-list
56579508|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
56579509|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56579510|NCT05367206|Paclitaxel|paclitaxel|mesh-list
56579511|NCT05367206|Carboplatin|carboplatin|mesh-list
56579512|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56579513|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56579514|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579515|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56579516|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56579517|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56579518|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579519|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
56579520|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56579521|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56579522|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
56579523|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579524|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579525|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579526|NCT00944658|Apremilast|apremilast|mesh-list
56579527|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56579528|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56579529|NCT00944658|Analgesics|analgesics|mesh-ancestor
56579530|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
56579531|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579532|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579533|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56579534|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56195217|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
56195218|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56195219|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56195220|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56195221|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56100272|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56100273|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100274|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100275|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100276|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56100277|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
56100278|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100279|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100280|NCT00000805|Ganciclovir|ganciclovir|mesh-list
56100281|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56100282|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
56100283|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100284|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100285|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579535|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56579536|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56579537|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579538|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579539|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56579540|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56579541|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56579542|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
56579543|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579544|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114913|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
56100286|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100287|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56100288|NCT04270682|Cathartics|cathartics|mesh-ancestor
56100289|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100290|NCT00000355|Buprenorphine|buprenorphine|mesh-list
56100291|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56100292|NCT00000355|Narcotics|narcotics|mesh-ancestor
56100293|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100294|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100295|NCT00000355|Analgesics|analgesics|mesh-ancestor
56100296|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
56100297|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100298|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56100299|NCT04022785|Azacitidine|azacitidine|mesh-list
56100300|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56100301|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
56100302|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100303|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100304|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100305|NCT00000361|Methotrexate|methotrexate|mesh-list
56100306|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56100307|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
56100308|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56100309|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100310|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56100312|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100313|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100314|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
56100315|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868646|NCT01674855|Lenograstim|lenograstim|mesh-list
56100336|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56100337|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56100338|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56100339|NCT00000373|Olanzapine|olanzapine|mesh-list
56100340|NCT00000373|Fluoxetine|fluoxetine|mesh-list
56100341|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
56100342|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
56100343|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195222|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
56195223|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56195224|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56195225|NCT01497522|Vildagliptin|vildagliptin|mesh-list
56195226|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195227|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195228|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56195229|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
56195230|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195231|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195232|NCT01497535|Insulin|insulin|mesh-list
56195233|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56195234|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
56579545|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56579546|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
56579547|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56579548|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56579549|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56579550|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
56579551|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579552|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579553|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
56579554|NCT01110200|Hormones|hormones|mesh-ancestor
56579555|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579556|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
56579557|NCT05182112|Gemcitabine|gemcitabine|mesh-list
56579558|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579559|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56579560|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
56579561|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579562|NCT05182112|Antiviral Agents|antiviral agents|mesh-ancestor
56579563|NCT05182112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579564|NCT05182112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579565|NCT05182112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56579566|NCT05182112|Immunologic Factors|immunologic factors|mesh-ancestor
56579567|NCT05182112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579568|NCT01136954|Zonisamide|zonisamide|mesh-list
56579592|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56579593|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579594|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
56579595|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
56579596|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
56579597|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579598|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56579599|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
56579600|NCT01107626|Paclitaxel|paclitaxel|mesh-list
56579601|NCT01107626|Bevacizumab|bevacizumab|mesh-list
56579602|NCT01107626|Carboplatin|carboplatin|mesh-list
56579603|NCT01107626|Pemetrexed|pemetrexed|mesh-list
56579604|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56579605|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579606|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56579607|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56579608|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56579609|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579610|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56579611|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56579612|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56579613|NCT01107626|Growth Substances|growth substances|mesh-ancestor
56579614|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579615|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
56579616|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579617|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56579618|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56579619|NCT04309058|Vitamin D|vitamin d|mesh-list
56579620|NCT04309058|Vitamins|vitamins|mesh-ancestor
56579621|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
56579636|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579637|NCT01135394|Pioglitazone|pioglitazone|mesh-list
56579638|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56579639|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579640|NCT00949884|Losartan|losartan|mesh-list
56579641|NCT00949884|Olmesartan|olmesartan|mesh-list
56579642|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56579643|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56579644|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56579645|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56579646|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56579647|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579648|NCT00949650|Pemetrexed|pemetrexed|mesh-list
56579649|NCT00949650|Afatinib|afatinib|mesh-list
56579650|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579651|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579652|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579653|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56579654|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56579655|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56579656|NCT03082755|Gabapentin|gabapentin|mesh-list
56579657|NCT03082755|Analgesics|analgesics|mesh-ancestor
56579658|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
56579659|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480245|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579660|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579662|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56579663|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56579664|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579665|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56579679|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
56579680|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579681|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56579682|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579683|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579684|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56579685|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56579686|NCT05317689|Psilocybin|psilocybin|mesh-list
56579687|NCT05317689|Psilocin|psilocin|mesh-list
56579688|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
56579689|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579690|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56579691|NCT05293665|Vaccines|vaccines|mesh-list
56579692|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
56579693|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579694|NCT00905307|Aripiprazole|aripiprazole|mesh-list
56579695|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
56579696|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56579697|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56579698|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56579700|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579732|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56579733|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
56579734|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56579735|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
56579736|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579737|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579738|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56579739|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56579740|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579741|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
56579742|NCT00903357|Protective Agents|protective agents|mesh-ancestor
56579743|NCT00903357|Vitamins|vitamins|mesh-ancestor
56579744|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
56579745|NCT02776917|Paclitaxel|paclitaxel|mesh-list
56579746|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56579747|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579748|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
56579749|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
56579750|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
56195235|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
56195236|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195237|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195238|NCT01497548|Methylphenidate|methylphenidate|mesh-list
56195239|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56195240|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195241|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56195243|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56195244|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195245|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
56195246|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56195248|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56195249|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
56100344|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100345|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100346|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56100347|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56100348|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100349|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100350|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56100351|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56100352|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56100353|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100354|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100355|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
56100356|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56100357|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
56100358|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56195250|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
56195251|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
56195252|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
56195253|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195254|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195255|NCT01497574|Insulin|insulin|mesh-list
56195256|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56579751|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579752|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
56579753|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56579754|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56579755|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579756|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579757|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56579758|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
56579759|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
56579760|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579761|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579762|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
56579763|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56579764|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56579765|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579766|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56579767|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56579768|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
56579769|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56579770|NCT02122185|Metformin|metformin|mesh-list
56579771|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56579772|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579773|NCT02087865|Donepezil|donepezil|mesh-list
56579774|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56579775|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579776|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579777|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
56579778|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579779|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579795|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
56579796|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
56579797|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579798|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579799|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
56579800|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579801|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
56579802|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56579803|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579804|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56480246|NCT00623857|Vitamins|vitamins|mesh-list
56579805|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56579806|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56579807|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579808|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56579809|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56579810|NCT01104662|Vancomycin|vancomycin|mesh-list
56579811|NCT01104662|Daptomycin|daptomycin|mesh-list
56579812|NCT01104662|Penicillins|penicillins|mesh-list
56579813|NCT01104662|Cloxacillin|cloxacillin|mesh-list
56579814|NCT01104662|Oxacillin|oxacillin|mesh-list
56579815|NCT01104662|Nafcillin|nafcillin|mesh-list
56579816|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56579817|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579818|NCT05062785|Insulin|insulin|mesh-list
56579845|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579846|NCT02880800|Morphine|morphine|mesh-list
56579847|NCT02880800|Hydromorphone|hydromorphone|mesh-list
56579848|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56579849|NCT02880800|Narcotics|narcotics|mesh-ancestor
56579850|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579851|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579852|NCT02880800|Analgesics|analgesics|mesh-ancestor
56579853|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
56579854|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579855|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
56579856|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56579857|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56579858|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56579859|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579860|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579861|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
56579862|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579863|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579864|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56579865|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579866|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
56579867|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56579868|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
56579869|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579870|NCT01106846|Ketamine|ketamine|mesh-list
56579871|NCT01106846|Analgesics|analgesics|mesh-ancestor
56579872|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
56579873|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579874|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579875|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56579876|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56579877|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
56579878|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
56195257|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
56195258|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
56195259|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195260|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195261|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
56100359|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56100360|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579879|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579880|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56579881|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56579882|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579883|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579884|NCT05034783|Exenatide|exenatide|mesh-list
56579885|NCT05034783|Edetic Acid|edetic acid|mesh-list
56579886|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
56579887|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
56579888|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579889|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
56579890|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56579891|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56579892|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579893|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56579894|NCT05034783|Incretins|incretins|mesh-ancestor
56579895|NCT05034783|Hormones|hormones|mesh-ancestor
56579896|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579897|NCT00902577|Misonidazole|misonidazole|mesh-list
56579898|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579899|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56579900|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56328367|NCT03007147|Etoposide|etoposide|mesh-list
56579901|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56579902|NCT04202367|Bupivacaine|bupivacaine|mesh-list
56579903|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
56579904|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
56579905|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56579906|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579907|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
56579908|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579909|NCT02846493|Dexamethasone|dexamethasone|mesh-list
56579910|NCT02846493|Bromocriptine|bromocriptine|mesh-list
56579911|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56579912|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
56579913|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
56579917|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
56579918|NCT02846493|Hormones|hormones|mesh-ancestor
56579919|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579920|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56579921|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579922|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56579923|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56579924|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
56579925|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
56579926|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
56579927|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579928|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579929|NCT01106690|Metformin|metformin|mesh-list
56579930|NCT01106690|Pioglitazone|pioglitazone|mesh-list
56579931|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56579932|NCT01106690|Canagliflozin|canagliflozin|mesh-list
56579933|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56579934|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579935|NCT01106690|Incretins|incretins|mesh-ancestor
56579936|NCT01106690|Hormones|hormones|mesh-ancestor
56579937|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56579938|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56579939|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
56579940|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56579941|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579942|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56579943|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
56579944|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56579945|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
56579946|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56579947|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480247|NCT00623857|Zinc|zinc|mesh-list
56579958|NCT04286529|Calcitriol|calcitriol|mesh-list
56579959|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56579960|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579961|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56579962|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579963|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579964|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56579965|NCT04286529|Vitamins|vitamins|mesh-ancestor
56579966|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
56579967|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56579968|NCT01103180|Citalopram|citalopram|mesh-list
56579969|NCT01103180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56579970|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56579971|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56579972|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579973|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56579974|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
56579975|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579976|NCT01103180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56579977|NCT01103180|Antidepressive Agents|antidepressive agents|mesh-ancestor
56579978|NCT01103180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56579979|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
56579980|NCT00625898|Bevacizumab|bevacizumab|mesh-list
56579981|NCT00625898|Carboplatin|carboplatin|mesh-list
56100361|NCT00000823|Zidovudine|zidovudine|mesh-list
56100362|NCT00000823|Didanosine|didanosine|mesh-list
56100363|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
56100364|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100365|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100366|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100367|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100368|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
56100369|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100370|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100371|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100380|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56100382|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100383|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56100384|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56100385|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100386|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
56100387|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
56100388|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100389|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100390|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100391|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
56100392|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56100393|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892214|NCT02057133|Everolimus|everolimus|mesh-list
56579982|NCT00625898|Docetaxel|docetaxel|mesh-list
56579983|NCT00625898|Fluorouracil|fluorouracil|mesh-list
56579984|NCT00625898|Trastuzumab|trastuzumab|mesh-list
56579985|NCT00625898|Epirubicin|epirubicin|mesh-list
56579986|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56579987|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
56579988|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56579989|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56579990|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56579991|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
56579992|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579993|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56579994|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56579995|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56579996|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56100394|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100396|NCT00002894|Carboplatin|carboplatin|mesh-list
56100397|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56100398|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100399|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
56100400|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
56100401|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
56100402|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100403|NCT00000829|Vaccines|vaccines|mesh-list
56100404|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56100405|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
56100407|NCT03282344|Nivolumab|nivolumab|mesh-list
56100408|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56100409|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100410|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56100411|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100412|NCT00000403|Doxycycline|doxycycline|mesh-list
56100413|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56100414|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100415|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
56100416|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56100417|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56100418|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
56100419|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56100420|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56195262|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195263|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195264|NCT01497600|Insulin|insulin|mesh-list
56195265|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56195266|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
56195267|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
56195268|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
56195269|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
56195270|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195271|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195272|NCT01497626|Bortezomib|bortezomib|mesh-list
56195273|NCT01497626|Lapatinib|lapatinib|mesh-list
56195274|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195275|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56195276|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195277|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195278|NCT01497652|Rasagiline|rasagiline|mesh-list
56195279|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56195280|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195281|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56579997|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56579998|NCT00625898|Growth Substances|growth substances|mesh-ancestor
56579999|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
56580000|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
56580001|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
56580002|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
56580003|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
56580004|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56580005|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56580006|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56580007|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56580008|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580009|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
56580010|NCT04527549|Trametinib|trametinib|mesh-list
56580011|NCT04527549|Dabrafenib|dabrafenib|mesh-list
56580012|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56580013|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
56580014|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56580015|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56580016|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580017|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580018|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580019|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580020|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580021|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56580022|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56580023|NCT04527549|Protective Agents|protective agents|mesh-ancestor
56580024|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580025|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56580026|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
56580027|NCT02853552|Misoprostol|misoprostol|mesh-list
56580028|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56580029|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
56580030|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56580031|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580032|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56580034|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
56580037|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56580038|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
56580039|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580040|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580041|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56580042|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56580043|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
56580044|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580045|NCT02844621|Omeprazole|omeprazole|mesh-list
56580046|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56580047|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56580048|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56195282|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56195283|NCT01497652|Protective Agents|protective agents|mesh-ancestor
56195284|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195285|NCT01497717|Adalimumab|adalimumab|mesh-list
56195286|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195287|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56195288|NCT01497873|Topotecan|topotecan|mesh-list
56195289|NCT01497873|Belotecan|belotecan|mesh-list
56100421|NCT04233164|Prednisolone|prednisolone|mesh-list
56100422|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
56100423|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56100424|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
56100425|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56100426|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
56100427|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
56100428|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100429|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100430|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100431|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
56100432|NCT04233164|Hormones|hormones|mesh-ancestor
56100433|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56100434|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56100435|NCT04233164|Protective Agents|protective agents|mesh-ancestor
56100436|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56100451|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56100452|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56100453|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
56100454|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
56100455|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56100456|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
56100457|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195290|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56195291|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56195292|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195293|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195294|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195295|NCT01497912|Atorvastatin|atorvastatin|mesh-list
56195296|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56195297|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56195298|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
56195299|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195301|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56195302|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195304|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56195305|NCT01497977|Estrogens|estrogens|mesh-ancestor
56195307|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195308|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195309|NCT01497990|Ertapenem|ertapenem|mesh-list
56195310|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56195311|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195312|NCT01498003|Tirofiban|tirofiban|mesh-list
56195313|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56580049|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580050|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580051|NCT01106534|Aspirin|aspirin|mesh-list
56328523|NCT02632409|Nivolumab|nivolumab|mesh-list
56580052|NCT01106534|Everolimus|everolimus|mesh-list
56580053|NCT01106534|Clopidogrel|clopidogrel|mesh-list
56580054|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56580055|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56580056|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56580057|NCT01106534|Analgesics|analgesics|mesh-ancestor
56580058|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
56580059|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580060|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580061|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56580062|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580063|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56580064|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56580065|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580066|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56580067|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56580068|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580069|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
56580078|NCT00941304|Oxycodone|oxycodone|mesh-list
56580101|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580102|NCT02879006|Omalizumab|omalizumab|mesh-list
56580103|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56580104|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56580105|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
56580106|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56580107|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56580108|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580109|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56580110|NCT02857218|Hematinics|hematinics|mesh-ancestor
56580111|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56580112|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56580113|NCT00602316|Chelating Agents|chelating agents|mesh-list
56580114|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
56580115|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580116|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
56580117|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
56580118|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56580119|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580120|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580121|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
56580122|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56580123|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56580124|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580125|NCT04956302|Dexamethasone|dexamethasone|mesh-list
56580126|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
56580127|NCT04956302|Bortezomib|bortezomib|mesh-list
56580129|NCT04956302|Panobinostat|panobinostat|mesh-list
56580130|NCT04956302|Ichthammol|ichthammol|mesh-list
56580131|NCT04956302|BB 1101|bb 1101|mesh-list
56580132|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56580133|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56580134|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
56580135|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
56580139|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
56580143|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580144|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
56580145|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580146|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580147|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
56580148|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56580149|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
56580150|NCT02848443|Trifluridine|trifluridine|mesh-list
56580151|NCT02848443|Bevacizumab|bevacizumab|mesh-list
56580152|NCT02848443|Nivolumab|nivolumab|mesh-list
56580153|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
56580154|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56580155|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580156|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56580157|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56580158|NCT02848443|Growth Substances|growth substances|mesh-ancestor
56580159|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580160|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
56580161|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56580162|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580163|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
56580164|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
56580165|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580166|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
56580167|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56580168|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580169|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580170|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56580171|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56580172|NCT00632697|Protective Agents|protective agents|mesh-ancestor
56195314|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56195315|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100458|NCT04226456|Expectorants|expectorants|mesh-ancestor
56100459|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
56100460|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56100461|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
56100462|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100463|NCT04226456|Protective Agents|protective agents|mesh-ancestor
56100464|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100465|NCT04226456|Antidotes|antidotes|mesh-ancestor
56100466|NCT00000415|Calcium|calcium|mesh-list
56100467|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56100468|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580173|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580174|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
56580175|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56580176|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
56580177|NCT02848209|Phenol|phenol|mesh-list
56580178|NCT02848209|Croton Oil|croton oil|mesh-list
56580179|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56580180|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580181|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
56580182|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56580183|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56580184|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
56580185|NCT05337969|Metformin|metformin|mesh-list
56580186|NCT05337969|Vildagliptin|vildagliptin|mesh-list
56580187|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580188|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580189|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56580190|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
56580191|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580192|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580193|NCT02844153|Metformin|metformin|mesh-list
56580194|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580195|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580196|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56580197|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
56580198|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56580199|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580200|NCT02844309|Thalidomide|thalidomide|mesh-list
56580212|NCT02845713|Ivermectin|ivermectin|mesh-list
56580223|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
56580224|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580225|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580226|NCT02845713|Filaricides|filaricides|mesh-ancestor
56580227|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
56580228|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56580229|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580230|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56580231|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
56580232|NCT00902265|Coagulants|coagulants|mesh-ancestor
56580233|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56580234|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
56580235|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580236|NCT02848287|Ropivacaine|ropivacaine|mesh-list
56580237|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
56580238|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
56580239|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56580240|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580241|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
56580242|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580243|NCT05337657|Letrozole|letrozole|mesh-list
56580244|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580245|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56580246|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56580247|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580248|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580249|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56580250|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
56580251|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56580262|NCT02690883|Exenatide|exenatide|mesh-list
56580268|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56580269|NCT02844933|Cannabidiol|cannabidiol|mesh-list
56580270|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
56580271|NCT05104047|Lobeline|lobeline|mesh-list
56580272|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56580273|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
56580274|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580275|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580276|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56580277|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56580278|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
56580279|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580280|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580281|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
56580283|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56580284|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580285|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580286|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580287|NCT02847429|Crenolanib|crenolanib|mesh-list
56580288|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580289|NCT04750005|Listerine|listerine|mesh-list
56580290|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56580291|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580292|NCT05336721|Capecitabine|capecitabine|mesh-list
56580293|NCT05336721|Chiauranib|chiauranib|mesh-list
56580294|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56580295|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
56580296|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580297|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580298|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56580299|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580300|NCT04646655|Enoxaparin|enoxaparin|mesh-list
56580310|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580311|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56580312|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56580313|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580314|NCT00652431|Niacin|niacin|mesh-list
56580315|NCT00652431|Niacinamide|niacinamide|mesh-list
56580316|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
56580317|NCT00652431|Simvastatin|simvastatin|mesh-list
56580318|NCT00652431|Ezetimibe|ezetimibe|mesh-list
56580319|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56580320|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56580321|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56580322|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
56580323|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580324|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56580325|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56580326|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580327|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
56580366|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580367|NCT04599075|Insulin|insulin|mesh-list
56580368|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56580369|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580370|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580371|NCT02842281|Levan|levan|mesh-list
56580372|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580373|NCT03721341|Hormones|hormones|mesh-list
56580374|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56580375|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580376|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
56580377|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56580378|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56580379|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580380|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56580381|NCT02842437|Analgesics|analgesics|mesh-ancestor
56580382|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
56580383|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580384|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56580385|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56580386|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56580387|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
56580388|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580390|NCT00157911|Simvastatin|simvastatin|mesh-list
56580416|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
56580417|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
56580418|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580419|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580420|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56580421|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56580422|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56580423|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56580424|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56580425|NCT00156117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56580426|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56580427|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56580428|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115783|NCT00002531|Vitamins|vitamins|mesh-ancestor
56100469|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
56100470|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56100471|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
56100472|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100473|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56100474|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100475|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
56100476|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100477|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
56195316|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56195317|NCT01498016|Busulfan|busulfan|mesh-list
56195318|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
56195319|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195320|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195321|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
56195322|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195323|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56195324|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195325|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56195326|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
56195327|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56195328|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
56195329|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195330|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195331|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56195332|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
56195333|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
56195334|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56195335|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
56195336|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56195337|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195338|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
56195339|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56100478|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56100479|NCT00000847|Protective Agents|protective agents|mesh-ancestor
56100480|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
56100481|NCT04195568|Antacids|antacids|mesh-ancestor
56100482|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100483|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100484|NCT00000439|Valproic Acid|valproic acid|mesh-list
56100485|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
56100486|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100487|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100488|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
56100489|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100490|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580429|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580430|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
56580431|NCT00140985|Losartan|losartan|mesh-list
56580432|NCT00140985|Amlodipine|amlodipine|mesh-list
56580433|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56580434|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56580435|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56580436|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580437|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56580438|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580439|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
56580440|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56580441|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56580442|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56580443|NCT00140907|Losartan|losartan|mesh-list
56580444|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56580445|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56580446|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56580447|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56580448|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580449|NCT00132717|Atorvastatin|atorvastatin|mesh-list
56580451|NCT00132717|Simvastatin|simvastatin|mesh-list
56580479|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
56580480|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
56580481|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56580482|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580483|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
56580484|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580485|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56580486|NCT02852382|Narcotics|narcotics|mesh-ancestor
56580487|NCT02852382|Analgesics|analgesics|mesh-ancestor
56580488|NCT00630942|Minocycline|minocycline|mesh-list
56580489|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56580490|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580491|NCT00602550|Zidovudine|zidovudine|mesh-list
56580492|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
56580493|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580494|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100491|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
56100492|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56100493|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100494|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100496|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
56100497|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56100498|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100499|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55868829|NCT02083107|Misoprostol|misoprostol|mesh-list
56100532|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
56100534|NCT00000865|Zidovudine|zidovudine|mesh-list
56100535|NCT00000865|Abacavir|abacavir|mesh-list
56100536|NCT00000865|Didanosine|didanosine|mesh-list
56100537|NCT00000865|Stavudine|stavudine|mesh-list
56195340|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56195341|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195342|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56195343|NCT01498380|Analgesics|analgesics|mesh-ancestor
56195344|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
56195345|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195346|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56100538|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100539|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100540|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100541|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100556|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
56100557|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100558|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100559|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56100561|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56100562|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56100563|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100564|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56100565|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56100566|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100567|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
56100568|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56100569|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56100570|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
56100571|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56100572|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56100573|NCT00000889|Aldesleukin|aldesleukin|mesh-list
56100574|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100575|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56580495|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56580496|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580497|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
56580498|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580499|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56580500|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56580501|NCT00602706|Melphalan|melphalan|mesh-list
56328975|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
56580503|NCT00602706|Sargramostim|sargramostim|mesh-list
56580504|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56580505|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
56580506|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580507|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580508|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56580509|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56580510|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
56580511|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580512|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56580513|NCT00602706|Analgesics|analgesics|mesh-ancestor
56580514|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
56580515|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580516|NCT00604344|Insulin|insulin|mesh-list
56580517|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56580518|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
56580519|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
56580520|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
56580521|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
56580522|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580523|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580524|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
56580525|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
56580526|NCT02851914|Serotonin|serotonin|mesh-list
56580527|NCT02851914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56580528|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56580529|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56100576|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100577|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
56100578|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100579|NCT00000505|Plasminogen|plasminogen|mesh-list
56100580|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56100581|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55892215|NCT02057133|Letrozole|letrozole|mesh-list
56580530|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
56580531|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580532|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580533|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580534|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56580535|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56580536|NCT00938964|Lidocaine|lidocaine|mesh-list
56580537|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
56580538|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
56580539|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014128|NCT01341301|Tacrolimus|tacrolimus|mesh-list
56580540|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580541|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
56580542|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580543|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56580544|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56580545|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56580582|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56580583|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580584|NCT00942084|Acyclovir|acyclovir|mesh-list
56580585|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
56580586|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56580587|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
56580588|NCT00941928|Fludarabine|fludarabine|mesh-list
56580589|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
56580590|NCT00941928|Interleukin-2|interleukin-2|mesh-list
56580591|NCT00941928|Epratuzumab|epratuzumab|mesh-list
56580592|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56580593|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
56580594|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580595|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580596|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56580597|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
56580598|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580599|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580640|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56580641|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56580642|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56580643|NCT00937560|Growth Substances|growth substances|mesh-ancestor
56580644|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580645|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
56580646|NCT04268394|Metformin|metformin|mesh-list
56580647|NCT04268394|Itraconazole|itraconazole|mesh-list
56580648|NCT04268394|Rifampin|rifampin|mesh-list
56580649|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
56580651|NCT04268394|Digoxin|digoxin|mesh-list
56580652|NCT04268394|Midazolam|midazolam|mesh-list
56580653|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56580654|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56580655|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580656|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56580657|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
56580658|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56580659|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56580660|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
56580661|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580662|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580663|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
56580664|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580692|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56580693|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56580694|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56580695|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
56580696|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56580697|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
56580698|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56580699|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56580700|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56580701|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56580702|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56580703|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56580704|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56580705|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56580706|NCT04268394|Protective Agents|protective agents|mesh-ancestor
56580707|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56580714|NCT02851212|Metformin|metformin|mesh-list
56580746|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
56580747|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
56580748|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56580749|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
56580750|NCT00875056|Vorinostat|vorinostat|mesh-list
56580751|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580752|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56580753|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580754|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580755|NCT00685594|Vitamin D|vitamin d|mesh-list
56580756|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
56580757|NCT00685594|Vitamins|vitamins|mesh-ancestor
56580758|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
56580759|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580760|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56580761|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56580806|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580807|NCT00685906|Ticagrelor|ticagrelor|mesh-list
56580808|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
56580809|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56580810|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56580811|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56580812|NCT00685906|Estradiol|estradiol|mesh-list
56580813|NCT00685906|Estrogens|estrogens|mesh-ancestor
56580814|NCT00685906|Hormones|hormones|mesh-ancestor
56580815|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56580816|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580817|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56580818|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
56580819|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56580820|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56580821|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56580822|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56580823|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56580824|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56580825|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56580826|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56580827|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56580828|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
56580829|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014366|NCT01410409|Acetaminophen|acetaminophen|mesh-list
56580852|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580853|NCT00686140|Celecoxib|celecoxib|mesh-list
56580854|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56580855|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56580856|NCT00686140|Analgesics|analgesics|mesh-ancestor
56580857|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
56580858|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580859|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580860|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56580861|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56580862|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56580863|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56580864|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100582|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56100583|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100584|NCT03181100|Paclitaxel|paclitaxel|mesh-list
56100585|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56100586|NCT03181100|Bevacizumab|bevacizumab|mesh-list
56100587|NCT03181100|Atezolizumab|atezolizumab|mesh-list
56100588|NCT03181100|Vemurafenib|vemurafenib|mesh-list
56100589|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56100590|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
56100591|NCT03181100|Antibodies|antibodies|mesh-list
56100592|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
56100593|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56100594|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
56100595|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56100596|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100597|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
56100598|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
56100599|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
56100600|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100601|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56100602|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56100603|NCT03181100|Growth Substances|growth substances|mesh-ancestor
56100604|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100605|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
56100627|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818163|NCT02034435|Amlodipine|amlodipine|mesh-list
56100628|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100630|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100631|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100632|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100633|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
56195347|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56195348|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56195349|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
56195350|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56195351|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195352|NCT01498406|Vitamin D|vitamin d|mesh-list
56195353|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
56195354|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
56195355|NCT01498406|Vitamins|vitamins|mesh-list
56123127|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
56195356|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
56195357|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100634|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56100635|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56100636|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
56100638|NCT00000541|Folic Acid|folic acid|mesh-list
56100639|NCT00000541|Vitamin E|vitamin e|mesh-list
56100640|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
56100641|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
56580865|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580866|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
56580867|NCT00686218|Panobinostat|panobinostat|mesh-list
56580868|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56580869|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580870|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56580871|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580872|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580873|NCT00683956|Propofol|propofol|mesh-list
56580874|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
56580875|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56580876|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580877|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56580878|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56580879|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
56580880|NCT02850744|Temozolomide|temozolomide|mesh-list
56580881|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56580882|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
56580883|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580884|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580885|NCT04139668|Naltrexone|naltrexone|mesh-list
56580886|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56580887|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56580888|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580889|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
56580890|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580891|NCT04266756|Selexipag|selexipag|mesh-list
56580892|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56580893|NCT00606060|Factor VIII|factor viii|mesh-list
56580894|NCT00606060|Coagulants|coagulants|mesh-ancestor
56580910|NCT00684112|Analgesics|analgesics|mesh-ancestor
56580911|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
56580912|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56580913|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580914|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
56580915|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56580916|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56580917|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56580918|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56580919|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56580920|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56580921|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580922|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580923|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
56580924|NCT00684190|Esomeprazole|esomeprazole|mesh-list
56580925|NCT00684190|Lesogaberan|lesogaberan|mesh-list
56580926|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56580927|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56580928|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56580929|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56580930|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580931|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56580932|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
56580933|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
56580934|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580935|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580936|NCT00684268|Silybin|silybin|mesh-list
56580937|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56580938|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56580939|NCT00684268|Protective Agents|protective agents|mesh-ancestor
56580940|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100642|NCT00000541|Pyridoxal|pyridoxal|mesh-list
56580953|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56580954|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
56580955|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56580956|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
56580957|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
56580958|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56580959|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56580960|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56580961|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
56580962|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56580963|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580964|NCT00874120|Protective Agents|protective agents|mesh-ancestor
56580965|NCT00939822|Simvastatin|simvastatin|mesh-list
56580966|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56580967|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56580968|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
56580969|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56580970|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56580972|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581009|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
56581010|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581011|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56581012|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581013|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56581014|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56581015|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56581016|NCT00939510|Lenalidomide|lenalidomide|mesh-list
56581017|NCT00939510|Sargramostim|sargramostim|mesh-list
56581018|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
56581019|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581020|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56581021|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56581022|NCT00939510|Growth Substances|growth substances|mesh-ancestor
56329509|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
56581069|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581070|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56581071|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56581072|NCT04138420|Growth Substances|growth substances|mesh-ancestor
56581073|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581074|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
56581075|NCT05378646|Interferons|interferons|mesh-list
56581076|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
56581077|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581078|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
56581079|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581080|NCT01093586|Cyclosporine|cyclosporine|mesh-list
56581081|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
56581082|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
56581083|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56581084|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56581085|NCT01093586|Prednisolone|prednisolone|mesh-list
56581086|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
56581087|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
56581088|NCT01093586|Busulfan|busulfan|mesh-list
56581089|NCT01093586|Cyclosporins|cyclosporins|mesh-list
56581090|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
56581091|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56581092|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56581093|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
56581094|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581095|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
56581096|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581097|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329588|NCT00021320|Paclitaxel|paclitaxel|mesh-list
56581118|NCT01093586|Hormones|hormones|mesh-ancestor
56581119|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581120|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56581121|NCT01093586|Protective Agents|protective agents|mesh-ancestor
56581122|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56581123|NCT04266132|Bupivacaine|bupivacaine|mesh-list
56581124|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
56581125|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
56581126|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56581127|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581128|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
56581129|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581130|NCT02625454|Acetaminophen|acetaminophen|mesh-list
56581131|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56581132|NCT02625454|Analgesics|analgesics|mesh-ancestor
56581133|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
56581134|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581135|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581136|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
56581137|NCT00606450|Thalidomide|thalidomide|mesh-list
56581138|NCT00606450|Apremilast|apremilast|mesh-list
56581139|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56581140|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56581141|NCT00606450|Analgesics|analgesics|mesh-ancestor
56581142|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
56581146|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581167|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581168|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56581169|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56581170|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581171|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56329662|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56581172|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56581174|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56581175|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56581176|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56581177|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581178|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56581179|NCT00688402|Lesogaberan|lesogaberan|mesh-list
56581180|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56581181|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56581182|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
56581183|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
56581184|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581185|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581186|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581187|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
56581188|NCT04138264|Narcotics|narcotics|mesh-ancestor
56581189|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56581190|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581191|NCT04138264|Analgesics|analgesics|mesh-ancestor
56581214|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581215|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56581216|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56581217|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581218|NCT02625376|Resveratrol|resveratrol|mesh-list
56581219|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
56581220|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581221|NCT02625376|Protective Agents|protective agents|mesh-ancestor
56581222|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581223|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581224|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56581225|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
56581226|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56581227|NCT04153084|Cathartics|cathartics|mesh-ancestor
56581228|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100643|NCT00000541|Pyridoxine|pyridoxine|mesh-list
56100644|NCT00000541|Beta Carotene|beta carotene|mesh-list
56100645|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
56100646|NCT00000541|Carotenoids|carotenoids|mesh-list
56100647|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
56100648|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100649|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
56100650|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100651|NCT00000541|Protective Agents|protective agents|mesh-ancestor
56100652|NCT00000541|Hematinics|hematinics|mesh-ancestor
56100653|NCT00000541|Provitamins|provitamins|mesh-ancestor
56100654|NCT00000913|Ritonavir|ritonavir|mesh-list
56100655|NCT00000913|Nelfinavir|nelfinavir|mesh-list
56100656|NCT00000913|Saquinavir|saquinavir|mesh-list
56100657|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56100658|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56100659|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
56100660|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868994|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
56100672|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100673|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56100674|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56100675|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56100676|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100677|NCT00000577|Colchicine|colchicine|mesh-list
56100678|NCT00000577|Albuterol|albuterol|mesh-list
56100679|NCT00000577|Hormones|hormones|mesh-list
56100680|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
56100681|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
56100682|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56100683|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100684|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56100685|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
56100686|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100687|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56100688|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
56100689|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
56100690|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56100691|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56100692|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56100693|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100694|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100695|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
56100696|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56100697|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
56581229|NCT04153084|Laxatives|laxatives|mesh-ancestor
56581230|NCT00688948|Alfuzosin|alfuzosin|mesh-list
56581231|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56581232|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56581233|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56581234|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
56581235|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581236|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581237|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581238|NCT00688948|Urological Agents|urological agents|mesh-ancestor
56581239|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56581240|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56581241|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581242|NCT00873730|Etanercept|etanercept|mesh-list
56581243|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56581244|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56581245|NCT00873730|Analgesics|analgesics|mesh-ancestor
56581246|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
56581247|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581248|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581249|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581250|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581251|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56581252|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581253|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
56581254|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56581255|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56581256|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56581258|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581259|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56581260|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56581261|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581262|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
56581263|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56581264|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
56581267|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56581268|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56581269|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56581270|NCT00672568|Capsaicin|capsaicin|mesh-list
56581271|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
56581272|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
56581273|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
56581274|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581275|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581277|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581278|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
56581279|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
56581280|NCT00874432|Lisinopril|lisinopril|mesh-list
56581281|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56581282|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56581283|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
56581284|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581285|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56581286|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56581287|NCT00874432|Protective Agents|protective agents|mesh-ancestor
56116639|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
56100698|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
56100699|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
56195358|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56195359|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56195360|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56195362|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
56195363|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195364|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56195365|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195366|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195367|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56195368|NCT01498718|Vaccines|vaccines|mesh-list
56195369|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
56195370|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195371|NCT01498783|Fluorouracil|fluorouracil|mesh-list
56195372|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
56195373|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195374|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56195375|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100700|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100701|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
56100702|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56100703|NCT03015896|Nivolumab|nivolumab|mesh-list
56100704|NCT03015896|Lenalidomide|lenalidomide|mesh-list
56100705|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56100706|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100707|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56100708|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100709|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
56100710|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100711|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56100712|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56581288|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581289|NCT00935220|Linagliptin|linagliptin|mesh-list
56581290|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56581291|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581292|NCT00935220|Incretins|incretins|mesh-ancestor
56581293|NCT00935220|Hormones|hormones|mesh-ancestor
56581294|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581295|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56581296|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
56581297|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581298|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581299|NCT00691912|Paclitaxel|paclitaxel|mesh-list
56581300|NCT00691912|Doxorubicin|doxorubicin|mesh-list
56581301|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56581302|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56581303|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581304|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
56581305|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
56581306|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
56581307|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581308|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56581309|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56581310|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56581311|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581312|NCT00689806|Lovastatin|lovastatin|mesh-list
56581339|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581340|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581341|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581342|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581343|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56581344|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581345|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
56581346|NCT00594880|Interferons|interferons|mesh-list
56581347|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
56581348|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
56581349|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56581350|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581351|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
56581352|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581353|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
56581354|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581355|NCT00690118|Pioglitazone|pioglitazone|mesh-list
56581356|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56581397|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
56581398|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
56581399|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581400|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581402|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
56581403|NCT00694408|Hormones|hormones|mesh-ancestor
56581404|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581405|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56581406|NCT00694408|Protective Agents|protective agents|mesh-ancestor
56581407|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56581408|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581409|NCT04136782|Paclitaxel|paclitaxel|mesh-list
56581410|NCT04136782|Docetaxel|docetaxel|mesh-list
56581411|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56581412|NCT04136782|Carboplatin|carboplatin|mesh-list
56581413|NCT04136782|Epirubicin|epirubicin|mesh-list
56581414|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56581415|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581416|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
56581417|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
56581418|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
56581419|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581420|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56581421|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56581422|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56581423|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581424|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
56581425|NCT04137640|Docetaxel|docetaxel|mesh-list
56581446|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581447|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56581448|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56581449|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56581450|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56581451|NCT02624830|Glyburide|glyburide|mesh-list
56581452|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56581453|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581454|NCT02629042|Prednisolone|prednisolone|mesh-list
56581455|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581456|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581457|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
56581458|NCT02629042|Hormones|hormones|mesh-ancestor
56581459|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581460|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56581461|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581462|NCT00692614|Triamcinolone|triamcinolone|mesh-list
56581463|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56581464|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56581465|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56581466|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581467|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
56581468|NCT00692614|Hormones|hormones|mesh-ancestor
56581469|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581470|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581471|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581472|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
56581473|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581474|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581476|NCT04136470|Ipilimumab|ipilimumab|mesh-list
56581477|NCT04136470|Atezolizumab|atezolizumab|mesh-list
56116814|NCT04332107|Azithromycin|azithromycin|mesh-list
56100713|NCT03015896|Growth Substances|growth substances|mesh-ancestor
56100714|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56100715|NCT02994836|Adalimumab|adalimumab|mesh-list
56100716|NCT02994836|Infliximab|infliximab|mesh-list
56100717|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56100718|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56100719|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56100720|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
56100721|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100722|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56581478|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56581479|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581480|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56581481|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581482|NCT00673426|Enoxaparin|enoxaparin|mesh-list
56581483|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
56581484|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56581485|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56581486|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581487|NCT00673504|Gemcitabine|gemcitabine|mesh-list
56581488|NCT00673504|Sunitinib|sunitinib|mesh-list
56581489|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56581490|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
56581491|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581492|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581493|NCT00673504|Antiviral Agents|antiviral agents|mesh-ancestor
56581494|NCT00673504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581495|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581496|NCT00673504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581497|NCT00673504|Immunologic Factors|immunologic factors|mesh-ancestor
56581498|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581499|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56581530|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581531|NCT00693004|Donepezil|donepezil|mesh-list
56581532|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56581533|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581534|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581535|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
56581536|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581537|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581538|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
56581539|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
56581540|NCT00695344|Everolimus|everolimus|mesh-list
56581541|NCT00695344|Azathioprine|azathioprine|mesh-list
56581542|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581543|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581544|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
56581545|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581546|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56581547|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56330040|NCT00022724|Sirolimus|sirolimus|mesh-list
56581548|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
56581549|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56581550|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581551|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581552|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581553|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
56581554|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56581555|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581576|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56581577|NCT02624440|Trimethoprim|trimethoprim|mesh-list
56581578|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
56581579|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56581580|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581581|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56581582|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581583|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581584|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56581585|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56581586|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56581587|NCT02624440|Renal Agents|renal agents|mesh-ancestor
56581588|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
56581589|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56581590|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56581591|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56581592|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55869047|NCT03629613|Antioxidants|antioxidants|mesh-list
56100733|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56100735|NCT00000613|Hormones|hormones|mesh-ancestor
56100736|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56100737|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
56100738|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56100739|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100740|NCT00000949|Aldesleukin|aldesleukin|mesh-list
56100741|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100742|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100743|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100744|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
56100745|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100746|NCT00002936|Etoposide|etoposide|mesh-list
56100747|NCT00002936|Altretamine|altretamine|mesh-list
56100748|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56195376|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195377|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
56195378|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195379|NCT01498796|Ketorolac|ketorolac|mesh-list
56195380|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56195381|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56195382|NCT01498796|Analgesics|analgesics|mesh-ancestor
56195383|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
56195384|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195385|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195386|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195387|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56195388|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56195389|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195390|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195391|NCT01498809|Midodrine|midodrine|mesh-list
56195392|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
56100749|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100750|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56100751|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56100752|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100753|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100754|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56100755|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
56581593|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56581594|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56581595|NCT00693862|Levodopa|levodopa|mesh-list
56581596|NCT00693862|Carbidopa|carbidopa|mesh-list
56581597|NCT00693862|Entacapone|entacapone|mesh-list
56581598|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56581599|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56581600|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
56581601|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581602|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581603|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581604|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56581605|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581606|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56581607|NCT05377788|Lazertinib|lazertinib|mesh-list
56581608|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56581609|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581610|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581611|NCT00674050|Fluticasone|fluticasone|mesh-list
56581612|NCT00674050|Albuterol|albuterol|mesh-list
56581613|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581614|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581615|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56581616|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
56581617|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581618|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56581619|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56581620|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
56581621|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56581638|NCT00936702|Carboplatin|carboplatin|mesh-list
56581639|NCT00936702|Everolimus|everolimus|mesh-list
56581640|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56581641|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581642|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
56581643|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
56581644|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
56581645|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581646|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581647|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
56581648|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581649|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56581650|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
56581651|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56581652|NCT00607932|Protective Agents|protective agents|mesh-ancestor
56581653|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581654|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581656|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56581657|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
56581658|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581659|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581660|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56581691|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56581692|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
56581693|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581694|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56330191|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56581695|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56581696|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
56581697|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581698|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581699|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56581700|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
56581701|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56581702|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
56581703|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56581704|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581705|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56581706|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56581707|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56581708|NCT00674752|Gabapentin|gabapentin|mesh-list
56581709|NCT00674752|Analgesics|analgesics|mesh-ancestor
56581710|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
56581711|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581712|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581713|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
56581714|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56581715|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56581716|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56581717|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100756|NCT00000649|Zidovudine|zidovudine|mesh-list
56100758|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
56100759|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100760|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100761|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100762|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100763|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
56100764|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100765|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100766|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100767|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56100768|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56100769|NCT00000961|Zidovudine|zidovudine|mesh-list
56100770|NCT00000961|Immune Sera|immune sera|mesh-list
56100771|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
56100772|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100773|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56581718|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56581719|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56581720|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581721|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581722|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
56581724|NCT04265274|Disulfiram|disulfiram|mesh-list
56581725|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581726|NCT04265274|Trace Elements|trace elements|mesh-ancestor
56581727|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
56581728|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581729|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56581730|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56581731|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581732|NCT00607152|Allopurinol|allopurinol|mesh-list
56581733|NCT00607152|Rasburicase|rasburicase|mesh-list
56581734|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
56581735|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581736|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581737|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
56581738|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581739|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56581740|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
56581741|NCT00607152|Protective Agents|protective agents|mesh-ancestor
56581742|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581743|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
56581744|NCT00696748|Testosterone|testosterone|mesh-list
56581745|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
56581746|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
56581747|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56581748|NCT00696748|Androgens|androgens|mesh-ancestor
56581749|NCT00696748|Hormones|hormones|mesh-ancestor
56581750|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56581751|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581752|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56581753|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117100|NCT03058289|Ipilimumab|ipilimumab|mesh-list
56100774|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100775|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581754|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
56581755|NCT02621554|Resveratrol|resveratrol|mesh-list
56581756|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
56581757|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581758|NCT02621554|Protective Agents|protective agents|mesh-ancestor
56581759|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581760|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581761|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56581762|NCT02623036|Enalapril|enalapril|mesh-list
56581763|NCT02623036|Lisinopril|lisinopril|mesh-list
56581764|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56581765|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
56581766|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581767|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581768|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56581769|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56581775|NCT00696826|Incretins|incretins|mesh-ancestor
56581812|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
56581813|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
56581814|NCT04135378|Vitamins|vitamins|mesh-ancestor
56581815|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
56581816|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581817|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
56581818|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581819|NCT04135378|Protective Agents|protective agents|mesh-ancestor
56581820|NCT04135690|Sorafenib|sorafenib|mesh-list
56581821|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581822|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56581823|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581824|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581825|NCT02878772|Aspirin|aspirin|mesh-list
56581826|NCT02878772|Vinpocetine|vinpocetine|mesh-list
56581827|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56581828|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56581829|NCT02878772|Analgesics|analgesics|mesh-ancestor
56581830|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
56581831|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581832|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581833|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581834|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581863|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581864|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581865|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56581866|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
56581867|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56581868|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56581869|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56581870|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
56581871|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56581872|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581873|NCT00871234|Etravirine|etravirine|mesh-list
56581874|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56581875|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56581876|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581877|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581878|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
56581879|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581880|NCT04267224|Ticagrelor|ticagrelor|mesh-list
56581881|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56581882|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56581883|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56581884|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56581911|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581912|NCT02621320|Vitamin D|vitamin d|mesh-list
56581913|NCT02621320|Vitamins|vitamins|mesh-ancestor
56581914|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
56581915|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581916|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56581917|NCT01097330|Amiodarone|amiodarone|mesh-list
56581918|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56581919|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
56581920|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56581921|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56581922|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581923|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56581924|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56581925|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56581926|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581927|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56581928|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56581929|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56581930|NCT00934440|Bevacizumab|bevacizumab|mesh-list
56581931|NCT00934440|Azacitidine|azacitidine|mesh-list
56581932|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56581933|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56581934|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56581935|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56581936|NCT00934440|Growth Substances|growth substances|mesh-ancestor
56581937|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581938|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
56581939|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56581940|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
56581941|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581942|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581943|NCT02622802|Acetaminophen|acetaminophen|mesh-list
56581944|NCT02622802|Azithromycin|azithromycin|mesh-list
56581945|NCT02622802|Erythromycin|erythromycin|mesh-list
56581949|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56581950|NCT02622802|Analgesics|analgesics|mesh-ancestor
56581951|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
56581952|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581953|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581954|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
56581955|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56581956|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56581957|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56581958|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56581959|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56581960|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56581962|NCT05158374|Metformin|metformin|mesh-list
56581963|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56581964|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56581965|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56581966|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56581967|NCT05158374|Analgesics|analgesics|mesh-ancestor
56581968|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
56581969|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56581970|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56581971|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56581972|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56581973|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56582002|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
56582003|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582004|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56582005|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56582006|NCT00696514|Hematinics|hematinics|mesh-ancestor
56582007|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
56582008|NCT04263870|Capecitabine|capecitabine|mesh-list
56582009|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
56582010|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56582011|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
56582012|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582013|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582014|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
56582015|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582016|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
56582017|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
56582018|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
56582019|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
56582020|NCT00871000|Antidotes|antidotes|mesh-ancestor
56582021|NCT00871000|Protective Agents|protective agents|mesh-ancestor
56582022|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582023|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
56582024|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
56582025|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582026|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56582027|NCT01096784|Mecasermin|mecasermin|mesh-list
56582028|NCT01096784|Growth Substances|growth substances|mesh-ancestor
56582029|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582030|NCT00696592|Bevacizumab|bevacizumab|mesh-list
56582031|NCT00696592|Verteporfin|verteporfin|mesh-list
56582032|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56582033|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582046|NCT02622022|Analgesics|analgesics|mesh-ancestor
56582047|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
56582048|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582049|NCT00934050|Inositol|inositol|mesh-list
56582050|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
56582051|NCT00934050|Vitamins|vitamins|mesh-ancestor
56582052|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
56582053|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582054|NCT02620618|Infliximab|infliximab|mesh-list
56582055|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
56582056|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56582057|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582058|NCT04135456|Mannitol|mannitol|mesh-list
56582059|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56582060|NCT04135456|Diuretics|diuretics|mesh-ancestor
56582061|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
56582062|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582063|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
56100776|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
56100777|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100778|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100779|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100780|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
56100781|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100782|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56100783|NCT04048304|Vancomycin|vancomycin|mesh-list
56100784|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100785|NCT00000655|Trimethoprim|trimethoprim|mesh-list
56100786|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56100797|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100798|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56195393|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
56195394|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195395|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195396|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56195397|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56195398|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56195399|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56195400|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
56195401|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56195402|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195403|NCT01498835|Sunitinib|sunitinib|mesh-list
56195404|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195405|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56195406|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56195407|NCT01498835|Growth Substances|growth substances|mesh-ancestor
56195408|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195409|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
56195410|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56195411|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195412|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195413|NCT01498861|Dolutegravir|dolutegravir|mesh-list
56195414|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
56195415|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56195416|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56195417|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56195418|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195419|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195420|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56582064|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582065|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
56582066|NCT05321576|Narcotics|narcotics|mesh-ancestor
56582067|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582068|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582069|NCT05321576|Analgesics|analgesics|mesh-ancestor
56582070|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
56582071|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582072|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56582073|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
56582074|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56582075|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582076|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582077|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56582078|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56582079|NCT00864916|Protective Agents|protective agents|mesh-ancestor
56582080|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582081|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
56582082|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56582084|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
56582085|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582086|NCT00864682|Lidocaine|lidocaine|mesh-list
56582087|NCT00864682|Propofol|propofol|mesh-list
56582088|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
56582089|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
56582090|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158441|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56582091|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582092|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
56582093|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582106|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582107|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56582108|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56582109|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
56582110|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
56582111|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56582112|NCT02614456|Interferons|interferons|mesh-list
56582113|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
56582114|NCT02614456|Nivolumab|nivolumab|mesh-list
56582115|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56582116|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582117|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56582118|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582119|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
56582120|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582121|NCT04130230|Choline|choline|mesh-list
56582122|NCT04130230|Neostigmine|neostigmine|mesh-list
56582123|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56582124|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582125|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582126|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
56582127|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56582128|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582129|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56582130|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
56582131|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582132|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
56582133|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56582134|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
56582135|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56582136|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56582149|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56582150|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582152|NCT00869050|Temozolomide|temozolomide|mesh-list
56582153|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56582154|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
56582155|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582156|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582157|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56582158|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
56582159|NCT04133506|Aspirin|aspirin|mesh-list
56582160|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56582161|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56582162|NCT04133506|Analgesics|analgesics|mesh-ancestor
56582163|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
56582164|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582165|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582166|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56582167|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582168|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56582169|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56582170|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582171|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56582172|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56582173|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582174|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
56582175|NCT04872218|Abatacept|abatacept|mesh-list
56582195|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582196|NCT04933682|Rifampin|rifampin|mesh-list
56582197|NCT04933682|Fluconazole|fluconazole|mesh-list
56582198|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56582199|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
56582200|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56582201|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582202|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
56582203|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56582204|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582205|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582206|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56582207|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56582208|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56582209|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56582210|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56582211|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56582212|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
56582213|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56582214|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56582215|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56582216|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
56582217|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56582218|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582219|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56582220|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56582221|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
56582236|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
56582237|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582238|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56582239|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
56582240|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56582241|NCT01101308|Oxycodone|oxycodone|mesh-list
56582242|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56582243|NCT01101308|Narcotics|narcotics|mesh-ancestor
56582244|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582245|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582246|NCT01101308|Analgesics|analgesics|mesh-ancestor
56582247|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
56582248|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582249|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56582250|NCT00926796|Azithromycin|azithromycin|mesh-list
56582251|NCT00926796|Gentamicins|gentamicins|mesh-list
56582252|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
56582253|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56582254|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582255|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56582256|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582257|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582258|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56582262|NCT00696982|Glyburide|glyburide|mesh-list
56582288|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582289|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56582290|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56582291|NCT01079936|Growth Substances|growth substances|mesh-ancestor
56582292|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
56582293|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330798|NCT00025064|Chlorambucil|chlorambucil|mesh-list
56582294|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56582295|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
56582296|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582297|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56582298|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56582299|NCT00931710|Losartan|losartan|mesh-list
56582300|NCT00931710|Amlodipine|amlodipine|mesh-list
56582301|NCT00931710|Valsartan|valsartan|mesh-list
56195421|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56195422|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
56195423|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195424|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56195425|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56195426|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56195427|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195430|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56100799|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56100800|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56100801|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56100802|NCT00002948|Topotecan|topotecan|mesh-list
56100803|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56100804|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56100805|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100806|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100807|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100808|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56100809|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
56100810|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100811|NCT02769962|Olaparib|olaparib|mesh-list
56100812|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56100813|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100814|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100815|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100816|NCT00000967|Interferons|interferons|mesh-list
56100817|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
56100818|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
56100819|NCT00000967|Zidovudine|zidovudine|mesh-list
56100820|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100821|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
56100822|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100823|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
56100824|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100825|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
56100826|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100827|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100828|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100829|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100830|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100831|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100832|NCT00000661|Zidovudine|zidovudine|mesh-list
56100833|NCT00000661|Oxazepam|oxazepam|mesh-list
55741806|NCT05124951|Etoposide|etoposide|mesh-list
56100834|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
56100835|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582302|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56582303|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56582304|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56582305|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56582306|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582307|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56582308|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582309|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
56582310|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56582311|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56582312|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56582313|NCT00931710|Diuretics|diuretics|mesh-ancestor
56582314|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
56582315|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56582316|NCT01100528|Interferons|interferons|mesh-list
56582317|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
56582318|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
56582319|NCT01100528|Dacarbazine|dacarbazine|mesh-list
56582320|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582321|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
56582322|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582323|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
56582324|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582325|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56582328|NCT01079234|Insulin|insulin|mesh-list
56582351|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
56582352|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582353|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582354|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56582355|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56582356|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
56582357|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56582358|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56582359|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56582360|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56582361|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
56582362|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56582363|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582364|NCT01078922|Ofatumumab|ofatumumab|mesh-list
56582365|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582366|NCT00609570|Calcium|calcium|mesh-list
56582367|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56330876|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
56582368|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582369|NCT00863746|Sorafenib|sorafenib|mesh-list
56582370|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582371|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56582372|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582373|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582374|NCT04992156|Palbociclib|palbociclib|mesh-list
56582399|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56582400|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
56582401|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582402|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56582403|NCT04203732|Anesthetics|anesthetics|mesh-list
56582404|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582405|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582406|NCT00863512|Gemcitabine|gemcitabine|mesh-list
56582407|NCT00863512|Docetaxel|docetaxel|mesh-list
56582408|NCT00863512|Pemetrexed|pemetrexed|mesh-list
56582409|NCT00863512|Vinorelbine|vinorelbine|mesh-list
56582410|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582411|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56582412|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
56582413|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582414|NCT00863512|Antiviral Agents|antiviral agents|mesh-ancestor
56582415|NCT00863512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582416|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582417|NCT00863512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56582418|NCT00863512|Immunologic Factors|immunologic factors|mesh-ancestor
56582419|NCT00863512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582420|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
56582421|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
56582422|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
56582423|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56582426|NCT02619994|Levofloxacin|levofloxacin|mesh-list
56582448|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56582449|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
56582450|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56582451|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
56582452|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
56582453|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158450|NCT04129554|Tenofovir|tenofovir|mesh-list
56582454|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582455|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56582457|NCT04263402|Hormones|hormones|mesh-ancestor
56582458|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56582459|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56582460|NCT04263402|Protective Agents|protective agents|mesh-ancestor
56582461|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56582462|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582463|NCT00868192|Bevacizumab|bevacizumab|mesh-list
56582464|NCT00868192|Pemetrexed|pemetrexed|mesh-list
56582465|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56582466|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582467|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56582468|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56582469|NCT00868192|Growth Substances|growth substances|mesh-ancestor
56582470|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582471|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
56582472|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582473|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582474|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56582475|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56582476|NCT02615782|Tadalafil|tadalafil|mesh-list
56582477|NCT02615782|Tamsulosin|tamsulosin|mesh-list
56582478|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
56582479|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56582480|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56582481|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100836|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100837|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100838|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100839|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
56100840|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100841|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56582482|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582483|NCT02615782|Urological Agents|urological agents|mesh-ancestor
56582484|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56582485|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56582486|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56582487|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
56582488|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56582489|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582490|NCT00930930|Paclitaxel|paclitaxel|mesh-list
56582491|NCT00930930|Everolimus|everolimus|mesh-list
56582492|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56582493|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582494|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
56582495|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
56582496|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
56582497|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582498|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56582499|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
56582500|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582501|NCT00698776|Lenalidomide|lenalidomide|mesh-list
56582502|NCT00698776|KRN 7000|krn 7000|mesh-list
56582503|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
56582504|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582505|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56100842|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100843|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56100844|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100845|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100846|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56100847|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56100848|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100849|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
56100850|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
56100851|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100852|NCT00000979|Zidovudine|zidovudine|mesh-list
56100888|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56100889|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
56100890|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56100891|NCT00000673|Ganciclovir|ganciclovir|mesh-list
56100892|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56100911|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
56100912|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
56100913|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
56100914|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100915|NCT00000691|Foscarnet|foscarnet|mesh-list
55828009|NCT05651633|Lidocaine|lidocaine|mesh-list
56100916|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56100917|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
56100918|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100919|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100920|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56582506|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56582507|NCT00698776|Growth Substances|growth substances|mesh-ancestor
56582508|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
56582509|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582510|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56582511|NCT04122040|Roxithromycin|roxithromycin|mesh-list
56582512|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56582513|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582514|NCT04258956|Avelumab|avelumab|mesh-list
56582515|NCT04258956|Axitinib|axitinib|mesh-list
56582516|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56582517|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582518|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56582519|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582520|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582521|NCT00862654|Ketoconazole|ketoconazole|mesh-list
56582522|NCT00862654|Clobetasol|clobetasol|mesh-list
56582523|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
56582524|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582525|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56582526|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56582527|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582528|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582529|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56582530|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
56582531|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56582532|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117888|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
56100921|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100922|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100923|NCT00002984|Paclitaxel|paclitaxel|mesh-list
56100924|NCT00002984|Fluorouracil|fluorouracil|mesh-list
56195431|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195432|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56195433|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56195434|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56195435|NCT01498900|Repaglinide|repaglinide|mesh-list
56195436|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195437|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195438|NCT01498913|Repaglinide|repaglinide|mesh-list
56195439|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195440|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195441|NCT01498926|Insulin|insulin|mesh-list
56100925|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56100926|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582533|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56582534|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56582535|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
56582536|NCT00862654|Hormones|hormones|mesh-ancestor
56582537|NCT00609180|Antioxidants|antioxidants|mesh-list
56582538|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582539|NCT00609180|Protective Agents|protective agents|mesh-ancestor
56582540|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582541|NCT05190432|Taxifolin|taxifolin|mesh-list
56582542|NCT05190432|Ergothioneine|ergothioneine|mesh-list
56582543|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
56582544|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582545|NCT05190432|Protective Agents|protective agents|mesh-ancestor
56582546|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582547|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56582548|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56582549|NCT05190432|Analgesics|analgesics|mesh-ancestor
56582550|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
56582551|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582552|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56582553|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582554|NCT00867490|Amlodipine|amlodipine|mesh-list
56582555|NCT00867490|Candesartan|candesartan|mesh-list
56582556|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56582557|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56582558|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56582559|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56582563|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
56582579|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582580|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582581|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56582582|NCT00925704|Calcitriol|calcitriol|mesh-list
56582583|NCT00925704|Sevelamer|sevelamer|mesh-list
56582584|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56582585|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582586|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56582587|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56100927|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
56100928|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
56100929|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
56100930|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100931|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
56100932|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56100933|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56100934|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
56100935|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100936|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
56100937|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56100938|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100939|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
56100940|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56100941|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
56100942|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100943|NCT00000997|Zalcitabine|zalcitabine|mesh-list
56100944|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
56100945|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100946|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100947|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100948|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100963|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56100964|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100965|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100967|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
56100968|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100970|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
56100971|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
56100972|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
56100973|NCT00000703|Leucovorin|leucovorin|mesh-list
56100974|NCT00000703|Cytarabine|cytarabine|mesh-list
56100975|NCT00000703|Zidovudine|zidovudine|mesh-list
56100976|NCT00000703|Dexamethasone|dexamethasone|mesh-list
56100977|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
56100978|NCT00000703|Doxorubicin|doxorubicin|mesh-list
56100979|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56100980|NCT00000703|Methotrexate|methotrexate|mesh-list
56100981|NCT00000703|Vincristine|vincristine|mesh-list
56100982|NCT00000703|Bleomycin|bleomycin|mesh-list
56100983|NCT00000703|Allopurinol|allopurinol|mesh-list
56100984|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
56100985|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56100986|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
56100987|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100988|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56100989|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56100990|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
56100991|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100992|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100993|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56100994|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56100995|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
56195442|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56195443|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
56195444|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195445|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195446|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
56582588|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582589|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56582590|NCT00925704|Vitamins|vitamins|mesh-ancestor
56582591|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
56331130|NCT00053976|Daclizumab|daclizumab|mesh-list
56582592|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56582593|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
56582594|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
56582595|NCT00697138|Amphetamine|amphetamine|mesh-list
56582596|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
56582597|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56582598|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56582599|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56582600|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56582601|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582602|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
56582603|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56582604|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582605|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56582606|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
56582607|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
56582608|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582609|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
56582639|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
56582640|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56582641|NCT04134130|Androgens|androgens|mesh-ancestor
56582642|NCT04134130|Hormones|hormones|mesh-ancestor
56582643|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56582644|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582645|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56582646|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582647|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
56582648|NCT04258644|Paclitaxel|paclitaxel|mesh-list
56582649|NCT04258644|Apatinib|apatinib|mesh-list
56582650|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56582651|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582652|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
56582653|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
56582654|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
56582655|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582656|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56582657|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582694|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582695|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
56582696|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56582697|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
56582698|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582699|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582700|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56582701|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
56582702|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582703|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582704|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56582705|NCT00866788|Omalizumab|omalizumab|mesh-list
56582706|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
56582707|NCT00866788|Promethazine|promethazine|mesh-list
56582708|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56582709|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
56582710|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56582711|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56582712|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
56582713|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56582714|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56582715|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582716|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582717|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
56582718|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
56582719|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
56582720|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582721|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
56582722|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
56582723|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100996|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
56100997|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100998|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100999|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
56101000|NCT00000703|Hormones|hormones|mesh-ancestor
56101001|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101002|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56101003|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56101004|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56101005|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56101006|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101007|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56101008|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
56101097|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
56101098|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582724|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
56582725|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56582726|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582727|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
56582728|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
56582729|NCT04132570|Budesonide|budesonide|mesh-list
56582730|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56582731|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56582732|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
56582733|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582734|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582735|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56582736|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
56582737|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
56582738|NCT04132570|Hormones|hormones|mesh-ancestor
56582739|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56582740|NCT00699244|Anesthetics|anesthetics|mesh-list
56582741|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56331258|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
56582742|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582743|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56582744|NCT00699322|Glimepiride|glimepiride|mesh-list
56582745|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56582746|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582747|NCT00699322|Incretins|incretins|mesh-ancestor
56582748|NCT00699322|Hormones|hormones|mesh-ancestor
56582749|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56582750|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56101099|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56195447|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195448|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195449|NCT01499004|Tofacitinib|tofacitinib|mesh-list
56101100|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101101|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101102|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
56101103|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101104|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101105|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101106|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
56101107|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56101108|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56101109|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56101110|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56101111|NCT00000727|Renal Agents|renal agents|mesh-ancestor
56101112|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56101113|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56582751|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
56582752|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582753|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582754|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56582755|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56582756|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
56582757|NCT00860470|Iron|iron|mesh-list
56582758|NCT00860470|Trace Elements|trace elements|mesh-list
56582759|NCT00860470|Folic Acid|folic acid|mesh-list
56582760|NCT00860470|Micronutrients|micronutrients|mesh-list
56582761|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582762|NCT00860470|Hematinics|hematinics|mesh-ancestor
56582763|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
56582764|NCT00860470|Vitamins|vitamins|mesh-ancestor
56582765|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
56582766|NCT00923364|Fludarabine|fludarabine|mesh-list
56582767|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
56582768|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56582769|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56582770|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
56582771|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582772|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56582773|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56582774|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
56582775|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582776|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582777|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56582778|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56582779|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
56582799|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
56582800|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582801|NCT04134598|Tamoxifen|tamoxifen|mesh-list
56582802|NCT04134598|Letrozole|letrozole|mesh-list
56582803|NCT04134598|Anastrozole|anastrozole|mesh-list
56582804|NCT04134598|Exemestane|exemestane|mesh-list
56582805|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582806|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56582807|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56582808|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582809|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582810|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56582811|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
56582812|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56582813|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582814|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56158460|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56582815|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56582816|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56582817|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56582819|NCT04134052|Ketamine|ketamine|mesh-list
56582820|NCT04134052|Analgesics|analgesics|mesh-ancestor
56582821|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
56582822|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582823|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582824|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56582825|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56582844|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582845|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582846|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56582847|NCT05001750|Doxycycline|doxycycline|mesh-list
56582848|NCT05001750|Nafcillin|nafcillin|mesh-list
56582849|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56582850|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582851|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
56582852|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
56582853|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56582854|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56582855|NCT00859456|Sunitinib|sunitinib|mesh-list
56582856|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582857|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56582858|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56582859|NCT00859456|Growth Substances|growth substances|mesh-ancestor
56582860|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582861|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
56582862|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56582863|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582864|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582865|NCT01075646|Ropivacaine|ropivacaine|mesh-list
56582866|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56582867|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
56582868|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
56582869|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56582870|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582891|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56582892|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582893|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582894|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
56582895|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56582896|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
56582897|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582898|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
56582899|NCT02876276|Protective Agents|protective agents|mesh-ancestor
56582900|NCT00923130|Bevacizumab|bevacizumab|mesh-list
56582901|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56582902|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582903|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56101114|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101115|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
56101116|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56101117|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56101118|NCT00001039|Clarithromycin|clarithromycin|mesh-list
56101119|NCT00001039|Ethambutol|ethambutol|mesh-list
56101120|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56101121|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101122|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55741825|NCT04139655|Colchicine|colchicine|mesh-list
56101123|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101124|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101125|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56101126|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101127|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
56101129|NCT00001057|Didanosine|didanosine|mesh-list
56101130|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
56101131|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101132|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101133|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101134|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101164|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101165|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101166|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101167|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101168|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
56101169|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101170|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101171|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101172|NCT00002305|Fluconazole|fluconazole|mesh-list
56101173|NCT00002305|Amphotericin B|amphotericin b|mesh-list
56101174|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56101175|NCT00002305|Flucytosine|flucytosine|mesh-list
56101176|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
56101177|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101178|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56101179|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101180|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101181|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101182|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56101194|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56101195|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101196|NCT00002311|Wobenzym|wobenzym|mesh-list
56101197|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56101198|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
56101199|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101201|NCT00002317|Trimetrexate|trimetrexate|mesh-list
56101202|NCT00002317|Calcium|calcium|mesh-list
56101203|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
56582904|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56582905|NCT00923130|Growth Substances|growth substances|mesh-ancestor
56582906|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582907|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
56582908|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56582909|NCT04258098|Metronidazole|metronidazole|mesh-list
56582910|NCT04258098|Streptomycin|streptomycin|mesh-list
56582911|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56582912|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56582913|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56582914|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56582915|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56582916|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582917|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
56582918|NCT02605915|Carboplatin|carboplatin|mesh-list
56582919|NCT02605915|Docetaxel|docetaxel|mesh-list
56582920|NCT02605915|Doxorubicin|doxorubicin|mesh-list
56582921|NCT02605915|Trastuzumab|trastuzumab|mesh-list
56582922|NCT02605915|Atezolizumab|atezolizumab|mesh-list
56582923|NCT02605915|Pertuzumab|pertuzumab|mesh-list
56582924|NCT02605915|Maytansine|maytansine|mesh-list
56582925|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56582926|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56582927|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
56582944|NCT04028323|Octreotide|octreotide|mesh-list
56582957|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
56582958|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56582959|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56582960|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56582961|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56582962|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
56582963|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158463|NCT04128540|Narcotics|narcotics|mesh-ancestor
56582964|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582965|NCT01075100|Carboplatin|carboplatin|mesh-list
56582966|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56582967|NCT02876354|Vitamin K|vitamin k|mesh-list
56582968|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
56582969|NCT02876354|Vitamins|vitamins|mesh-ancestor
56582970|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
56582971|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56582972|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56582973|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56582974|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56582975|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
56582976|NCT02876354|Coagulants|coagulants|mesh-ancestor
56582977|NCT00626678|Prednisone|prednisone|mesh-list
56582978|NCT00626678|Azathioprine|azathioprine|mesh-list
56582979|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56582980|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
56582981|NCT00626678|Hormones|hormones|mesh-ancestor
56582982|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583004|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56583005|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583006|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583007|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583008|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
56583009|NCT00859222|Bevacizumab|bevacizumab|mesh-list
56583010|NCT00859222|Panobinostat|panobinostat|mesh-list
56583011|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583012|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583013|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56583014|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56583015|NCT00859222|Growth Substances|growth substances|mesh-ancestor
56583016|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583017|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56583018|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56583019|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583020|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583021|NCT00858988|Rifaximin|rifaximin|mesh-list
56583022|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56583023|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583024|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583025|NCT00858832|Methylergonovine|methylergonovine|mesh-list
56583057|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583058|NCT00610350|Protective Agents|protective agents|mesh-ancestor
56583059|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583060|NCT01071200|Hormones|hormones|mesh-list
56583061|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56583062|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583063|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583064|NCT04255836|Durvalumab|durvalumab|mesh-list
56583065|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583066|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583067|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
56583068|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
56583069|NCT00699478|Vitamins|vitamins|mesh-ancestor
56583070|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
56583071|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583072|NCT01070888|Budesonide|budesonide|mesh-list
56583073|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
56583074|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583075|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56583076|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
56583077|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583078|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583079|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56583080|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
56583081|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
56583082|NCT01070888|Hormones|hormones|mesh-ancestor
56583083|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583085|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56583101|NCT05652673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56583102|NCT05652673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583103|NCT00857818|Risperidone|risperidone|mesh-list
56583104|NCT00857818|Aripiprazole|aripiprazole|mesh-list
56583105|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56583106|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56583107|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
56583108|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583109|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158466|NCT04128540|Analgesics|analgesics|mesh-ancestor
56583110|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583111|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56583112|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56583113|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583114|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583115|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56583116|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
56583117|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
56583118|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
56331642|NCT00027833|Leucovorin|leucovorin|mesh-list
56583119|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56583120|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56583121|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56583122|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56583148|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56583149|NCT01074554|Azithromycin|azithromycin|mesh-list
56583150|NCT01074554|Levofloxacin|levofloxacin|mesh-list
56583151|NCT01074554|Rifampin|rifampin|mesh-list
56583152|NCT01074554|Ethambutol|ethambutol|mesh-list
56583153|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583154|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56583155|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
56583156|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56583157|NCT01074554|Renal Agents|renal agents|mesh-ancestor
56583158|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56583159|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56583160|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583161|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583162|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583163|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56583164|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56583165|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
56583166|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56583167|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56583168|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56583200|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583201|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583202|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56583203|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583204|NCT00697996|Rituximab|rituximab|mesh-list
56583205|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583206|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583207|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
56583208|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583209|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583210|NCT04118842|Rifampin|rifampin|mesh-list
56583211|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56583212|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
56583213|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56583214|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583215|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
56583216|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56583217|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583218|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583219|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56583220|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56583221|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56583222|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56583223|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56583224|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56583225|NCT00699634|Nabilone|nabilone|mesh-list
56583226|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
56583227|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
56583228|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583229|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583230|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583231|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56583232|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56583239|NCT00798889|Growth Substances|growth substances|mesh-ancestor
56583240|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583241|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
56583242|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583243|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158472|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
56583244|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583245|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
56583246|NCT04113889|Metformin|metformin|mesh-list
56583247|NCT04113889|Pioglitazone|pioglitazone|mesh-list
56583248|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56583249|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583250|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
56583251|NCT04113889|Vitamins|vitamins|mesh-ancestor
56583252|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
56583253|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
56583254|NCT00796861|Sunitinib|sunitinib|mesh-list
56583255|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583256|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56583257|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56583258|NCT00796861|Growth Substances|growth substances|mesh-ancestor
56583293|NCT00914641|Apixaban|apixaban|mesh-list
56583294|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56583295|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
56583296|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56583297|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
56583298|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583299|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583300|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
56583301|NCT00796549|Afatinib|afatinib|mesh-list
56583302|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583303|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583304|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583305|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583306|NCT00856492|Paclitaxel|paclitaxel|mesh-list
56583307|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
56583308|NCT00856492|Bevacizumab|bevacizumab|mesh-list
56583309|NCT00856492|Doxorubicin|doxorubicin|mesh-list
56583310|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56583311|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56583312|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56583313|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583314|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
56583315|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
56583316|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
56583317|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583318|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56583343|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583344|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56583345|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
56583346|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583347|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56583348|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583349|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56583350|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
56583351|NCT04111003|Anesthetics|anesthetics|mesh-list
56583352|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583353|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583354|NCT05673577|Cetuximab|cetuximab|mesh-list
56583355|NCT05673577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583356|NCT05673577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583357|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
56583358|NCT00856180|Bevacizumab|bevacizumab|mesh-list
56583359|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56583360|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
56583361|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583362|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583363|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56583373|NCT02605213|Vancomycin|vancomycin|mesh-list
56583394|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583395|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583396|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583397|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56583398|NCT04115449|Analgesics|analgesics|mesh-ancestor
56583399|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
56583400|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583401|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56583402|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56583403|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56583404|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
56583405|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583406|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583407|NCT04133974|Methadone|methadone|mesh-list
56583408|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56583409|NCT04133974|Narcotics|narcotics|mesh-ancestor
56583410|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583411|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583412|NCT04133974|Analgesics|analgesics|mesh-ancestor
56583413|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
56583414|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583415|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
56583416|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
56583418|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56583419|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583420|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583421|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
56583441|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56583442|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583443|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583444|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56583445|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56583446|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56583447|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56583448|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56583449|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
56583450|NCT00834093|Vaccines|vaccines|mesh-list
56583451|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
56583452|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583453|NCT00869440|Midazolam|midazolam|mesh-list
56583454|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56583455|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583456|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583457|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583458|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56583459|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56583460|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583461|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56583462|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
56583463|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
56583464|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
56583465|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
56583466|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583467|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583468|NCT00895947|Interferons|interferons|mesh-list
56583469|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
56583470|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583486|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583487|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583488|NCT00092781|Celecoxib|celecoxib|mesh-list
56583489|NCT00092781|Etoricoxib|etoricoxib|mesh-list
56583490|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56583491|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56583492|NCT00092781|Analgesics|analgesics|mesh-ancestor
56583493|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
56583494|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583495|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583496|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583497|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583498|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56583499|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56583500|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583501|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583502|NCT00092703|Diclofenac|diclofenac|mesh-list
56583503|NCT00092703|Etoricoxib|etoricoxib|mesh-list
56583504|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56583505|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56583506|NCT00092703|Analgesics|analgesics|mesh-ancestor
56583507|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
56583508|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583509|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583510|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583511|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583512|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56583513|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583516|NCT00699946|Olanzapine|olanzapine|mesh-list
56583530|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583531|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
56583532|NCT00796315|Doxylamine|doxylamine|mesh-list
56583533|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
56583534|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
56583535|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
56583536|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583537|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583538|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583539|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56583540|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
56583541|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
56583542|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583543|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583544|NCT00855166|Metformin|metformin|mesh-list
56583545|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56583546|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
56583547|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56583548|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583549|NCT00855166|Incretins|incretins|mesh-ancestor
56583550|NCT00855166|Hormones|hormones|mesh-ancestor
56583551|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583552|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56583553|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
56583554|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583580|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583581|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583582|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56583583|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56583584|NCT02617810|Midazolam|midazolam|mesh-list
56583585|NCT02617810|Warfarin|warfarin|mesh-list
56583586|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56583587|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583588|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583589|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583590|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56583591|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56583592|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583593|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56583594|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
56583595|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
56583596|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
56583597|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
56583598|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583599|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583600|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
56583601|NCT00898443|Anesthetics|anesthetics|mesh-list
56583602|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583603|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583631|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583632|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583633|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583634|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56583635|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
56583636|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
56583637|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583638|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583639|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56583640|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583641|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56583642|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583643|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583644|NCT00592852|Fluoxetine|fluoxetine|mesh-list
56583645|NCT00592852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56583646|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56583647|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56583648|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583649|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583650|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
56583651|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583681|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583682|NCT02617654|Liraglutide|liraglutide|mesh-list
56583683|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56583684|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583685|NCT02617654|Incretins|incretins|mesh-ancestor
56583687|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583688|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
56583689|NCT00700024|Testosterone|testosterone|mesh-list
56583690|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
56583691|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
56583692|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56583693|NCT00700024|Androgens|androgens|mesh-ancestor
56583694|NCT00700024|Hormones|hormones|mesh-ancestor
56583695|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583696|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583697|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56583698|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583699|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
56583700|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
56583701|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56583702|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583703|NCT00796003|Decitabine|decitabine|mesh-list
56583709|NCT02973789|Docetaxel|docetaxel|mesh-list
56583734|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56583735|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56583736|NCT04025203|Analgesics|analgesics|mesh-ancestor
56583737|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
56583738|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583739|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583740|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583741|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56583742|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56583743|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583744|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583745|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
56583746|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56583747|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56583748|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583749|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583750|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56583751|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56583752|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583753|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
56583754|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56583755|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583756|NCT00915577|Interferons|interferons|mesh-list
56583757|NCT00915577|Interferon-beta|interferon-beta|mesh-list
56583758|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
56583785|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583786|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583787|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56583788|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56583789|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583790|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
56583791|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583792|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
56583793|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56583795|NCT00899847|Analgesics|analgesics|mesh-ancestor
56583796|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
56583797|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583798|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
56583799|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56583800|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56583801|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
56583802|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56583803|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56583804|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56583805|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56583806|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56583807|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
56583808|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
56583809|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
56583810|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
56583811|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583812|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56583813|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
56583814|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
56583815|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583816|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56583830|NCT00529113|Antiviral Agents|antiviral agents|mesh-ancestor
56583831|NCT00529113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583832|NCT00529113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583833|NCT00529113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56583834|NCT00529113|Immunologic Factors|immunologic factors|mesh-ancestor
56583835|NCT00529113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583836|NCT04106557|Gaboxadol|gaboxadol|mesh-list
56583837|NCT04106557|Analgesics|analgesics|mesh-ancestor
56583838|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
56583839|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583840|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583842|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
56583843|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
56583844|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583845|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583846|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
56583847|NCT04117750|Vitamin D|vitamin d|mesh-list
56583848|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
56583849|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56583850|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583851|NCT04117750|Vitamins|vitamins|mesh-ancestor
56583852|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
56583886|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56583887|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56583888|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56583889|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56583890|NCT02840409|Growth Substances|growth substances|mesh-ancestor
56583891|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583892|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
56583893|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56583894|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
56583895|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
56583896|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
56583897|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583898|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
56583899|NCT02839941|Tacrolimus|tacrolimus|mesh-list
56583900|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
56583901|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56583903|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583904|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56583905|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56583906|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583907|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56583908|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119283|NCT00005585|Dexamethasone|dexamethasone|mesh-list
56101204|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56101205|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101206|NCT00002317|Antidotes|antidotes|mesh-ancestor
56101207|NCT00002317|Protective Agents|protective agents|mesh-ancestor
56101208|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
56101209|NCT00002317|Vitamins|vitamins|mesh-ancestor
56101210|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
56195450|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56195451|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195452|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195453|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
56195455|NCT01499069|Propiverine|propiverine|mesh-list
56195456|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56195457|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56195458|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
56101211|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
56101212|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101213|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56101214|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
56101215|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101216|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101217|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56101218|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101219|NCT00001123|Ribavirin|ribavirin|mesh-list
56101220|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
56101221|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101222|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
56583909|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56583910|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
56583911|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56583912|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56583913|NCT02839941|Hormones|hormones|mesh-ancestor
56583914|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56583915|NCT02842983|Esmolol|esmolol|mesh-list
56583916|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56583917|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56583918|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
56583919|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583920|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583921|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583922|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56583966|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56583967|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56583968|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
56583969|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583970|NCT02839161|Antacids|antacids|mesh-ancestor
56583971|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56583972|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56583973|NCT04249713|Brodalumab|brodalumab|mesh-list
56583974|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
56583975|NCT00610506|Dexetimide|dexetimide|mesh-list
56583976|NCT00610506|Citalopram|citalopram|mesh-list
56583977|NCT00610506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56583978|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56583979|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56583980|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101223|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101224|NCT00002323|Zidovudine|zidovudine|mesh-list
56101225|NCT00002323|Nevirapine|nevirapine|mesh-list
56101226|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
56101227|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101228|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101231|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
56101232|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101233|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101234|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101235|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56101236|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56101237|NCT00380965|Nabilone|nabilone|mesh-list
56101238|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
56101239|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
56101240|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101241|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101242|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56101243|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56101244|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56101245|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56101246|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56101247|NCT00002996|Flecainide|flecainide|mesh-list
56101248|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56101300|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
56101301|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101302|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101303|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101305|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101306|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56101307|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101308|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
56101309|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56101310|NCT00001903|Antibodies|antibodies|mesh-list
56101311|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
56101312|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101313|NCT00002335|Emtricitabine|emtricitabine|mesh-list
56101314|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
56101315|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101316|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101317|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101318|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101319|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101320|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56195459|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583981|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56583982|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
56583983|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56583984|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56583985|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
56583986|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56583987|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56583988|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56583989|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
56583990|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
56583991|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56583992|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56583993|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56583994|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
56583995|NCT04260828|Aspirin|aspirin|mesh-list
56583996|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56583997|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56195460|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101321|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101323|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
56101324|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101325|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56101326|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101327|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101328|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101329|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56101330|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
56101331|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101353|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101355|NCT00001237|Sargramostim|sargramostim|mesh-list
56101356|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
56101357|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101358|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101359|NCT00001933|Nefiracetam|nefiracetam|mesh-list
56101360|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56101361|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56101362|NCT00001933|Protective Agents|protective agents|mesh-ancestor
56101363|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101364|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
56101365|NCT00001249|Antibodies|antibodies|mesh-list
56101366|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
56101367|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101368|NCT00380575|Conivaptan|conivaptan|mesh-list
56101369|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56101370|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101371|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
56101372|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101373|NCT00001963|Chrysarobin|chrysarobin|mesh-list
56101378|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101381|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56101382|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
56101383|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101384|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869706|NCT04361188|Anesthetics|anesthetics|mesh-list
56101421|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892216|NCT02057133|Fulvestrant|fulvestrant|mesh-list
56583998|NCT04260828|Analgesics|analgesics|mesh-ancestor
56583999|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
56584000|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584001|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584002|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56584003|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584004|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56584005|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56584006|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584007|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56584008|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56584009|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584010|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
56584011|NCT00928746|Bromides|bromides|mesh-list
56584012|NCT00928746|Ipratropium|ipratropium|mesh-list
56584013|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
56584014|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56584015|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
56584016|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584017|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584018|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56584019|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
56584020|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56584021|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
56584022|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584024|NCT04468815|Esomeprazole|esomeprazole|mesh-list
56584046|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584047|NCT00894543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56584048|NCT00894543|Antidepressive Agents|antidepressive agents|mesh-ancestor
56584049|NCT00894543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56584050|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56584051|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56584052|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584053|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56584054|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56584055|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56584056|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584057|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
56584058|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584059|NCT00853372|Sunitinib|sunitinib|mesh-list
56584060|NCT00853372|Trebananib|trebananib|mesh-list
56584061|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56584062|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584063|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56584064|NCT00853372|Growth Substances|growth substances|mesh-ancestor
56584065|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584066|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
56584067|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56584068|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584069|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584070|NCT02836977|Tegafur|tegafur|mesh-list
56584071|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56584072|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
56584073|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584074|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584075|NCT04988256|Cyclosporine|cyclosporine|mesh-list
56584076|NCT04988256|Prednisone|prednisone|mesh-list
56584077|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
56584078|NCT04988256|Cyclosporins|cyclosporins|mesh-list
56584079|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56584083|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584084|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56584085|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584086|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584087|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584088|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584089|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
56101422|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101423|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55869783|NCT03663543|Estrogens|estrogens|mesh-list
56101443|NCT00002383|Saquinavir|saquinavir|mesh-list
56101444|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56101445|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56101446|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
56101447|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101448|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101449|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101450|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101451|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
56101452|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101453|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56101454|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101455|NCT00002389|Lamivudine|lamivudine|mesh-list
56101456|NCT00002389|Zidovudine|zidovudine|mesh-list
56101457|NCT00002389|Abacavir|abacavir|mesh-list
56101458|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101459|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101460|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101461|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101462|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
56101463|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101464|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101465|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56195461|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195463|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
56195464|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
56195465|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195466|NCT01499108|Liraglutide|liraglutide|mesh-list
56195467|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195468|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195469|NCT01499108|Incretins|incretins|mesh-ancestor
56195470|NCT01499108|Hormones|hormones|mesh-ancestor
56195471|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195472|NCT01499121|Sunitinib|sunitinib|mesh-list
56195473|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195474|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56195475|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56195476|NCT01499121|Growth Substances|growth substances|mesh-ancestor
56101466|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
56101467|NCT00001357|Interleukin-2|interleukin-2|mesh-list
56101468|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101469|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56101470|NCT00001357|Analgesics|analgesics|mesh-ancestor
56101471|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
56101472|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101473|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101474|NCT00001381|Suramin|suramin|mesh-list
56101475|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
56101476|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
56101477|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56101478|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101479|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101480|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56101481|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56101482|NCT00002011|Methoxsalen|methoxsalen|mesh-list
56101483|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56101484|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
56101497|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101498|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
56332617|NCT00031733|Sargramostim|sargramostim|mesh-list
56584090|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
56584091|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584092|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
56584093|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584094|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56584095|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
56584096|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
56584097|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584098|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584099|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56584100|NCT04988256|Protective Agents|protective agents|mesh-ancestor
56584101|NCT00848536|Travoprost|travoprost|mesh-list
56584102|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56584103|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56584104|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56584105|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
56584106|NCT00922116|Hematinics|hematinics|mesh-ancestor
56584107|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
56584108|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56584109|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
56584110|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584147|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584148|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584149|NCT00703378|Docetaxel|docetaxel|mesh-list
56584150|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584151|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
56584152|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
56584153|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
56584154|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584155|NCT00852202|Cariprazine|cariprazine|mesh-list
56584156|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56584157|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56584158|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56584159|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584160|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56584161|NCT01074008|Ritonavir|ritonavir|mesh-list
56584162|NCT01074008|Ribavirin|ribavirin|mesh-list
56584163|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56584164|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56584165|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56584166|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
56584167|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584168|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584169|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56584170|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56584197|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584198|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584199|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56584200|NCT00789373|Pemetrexed|pemetrexed|mesh-list
56584201|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584202|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584203|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584204|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56584205|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56584206|NCT00851890|Interferons|interferons|mesh-list
56584207|NCT00851890|Ribavirin|ribavirin|mesh-list
56584208|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584209|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
56584210|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584211|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
56584212|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584213|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56584214|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56584215|NCT00837616|Estradiol|estradiol|mesh-list
56584216|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56584217|NCT00837616|Estrogens|estrogens|mesh-ancestor
56584218|NCT00837616|Hormones|hormones|mesh-ancestor
56584219|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584220|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584221|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56584222|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
56584228|NCT00626288|Mesalamine|mesalamine|mesh-list
56584244|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56584245|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
56584246|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584247|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584248|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584250|NCT01067144|Lorazepam|lorazepam|mesh-list
56584251|NCT01067144|Analgesics|analgesics|mesh-ancestor
56584252|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
56584253|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584254|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584255|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
56584256|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56584257|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56584258|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56584259|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56584260|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56584261|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56584262|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584263|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584265|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
56584266|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
56584267|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584268|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56584269|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
56584270|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
56584271|NCT01078298|Varenicline|varenicline|mesh-list
56584272|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56584273|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56584274|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
56584275|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584276|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584277|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584278|NCT00788593|Pancreatin|pancreatin|mesh-list
56584279|NCT00788593|Pancrelipase|pancrelipase|mesh-list
56584280|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584281|NCT04106011|Gabapentin|gabapentin|mesh-list
56101499|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101500|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101501|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56584282|NCT04106011|Analgesics|analgesics|mesh-ancestor
56584283|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
56584284|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584285|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584286|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
56584287|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56584288|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56584289|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56584290|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56584291|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56584292|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56584293|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584294|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584295|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
56584296|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56584297|NCT02875886|Amiloride|amiloride|mesh-list
56584298|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56584299|NCT02875886|Diuretics|diuretics|mesh-ancestor
56584300|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
56584301|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584302|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56584303|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56584304|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584332|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56584333|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56584334|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56584335|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56584336|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56584337|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56584338|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56584339|NCT02836743|Melatonin|melatonin|mesh-list
56584340|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
56584341|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584342|NCT02836743|Protective Agents|protective agents|mesh-ancestor
56584343|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584344|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56584345|NCT04255368|Choline|choline|mesh-list
56584346|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
56584347|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56584348|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
56584349|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584350|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584351|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56584352|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
56584353|NCT00610818|Mitogens|mitogens|mesh-list
56584354|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
56584355|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584356|NCT00787891|Rabeprazole|rabeprazole|mesh-list
56584357|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56584358|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584359|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56584360|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584361|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584362|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56584371|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56584372|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56584373|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56584374|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56584375|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
56584376|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56584377|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56584378|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
56584379|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56584380|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
56584381|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584382|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584383|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584384|NCT02836509|Acetaminophen|acetaminophen|mesh-list
56584385|NCT02836509|Ibuprofen|ibuprofen|mesh-list
56101502|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56101503|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56101504|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56101505|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56101507|NCT00002035|Didanosine|didanosine|mesh-list
56101508|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
56101509|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101510|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101511|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101512|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101513|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
56101514|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101515|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101516|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101517|NCT00002041|Amphotericin B|amphotericin b|mesh-list
56101518|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56101519|NCT00002041|Amebicides|amebicides|mesh-ancestor
56101520|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56101521|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56101522|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195477|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195478|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
56195479|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56195480|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195481|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195482|NCT01499225|Doxycycline|doxycycline|mesh-list
56195483|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56195484|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195485|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
56195486|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56195487|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56195488|NCT01499251|Temozolomide|temozolomide|mesh-list
56101523|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55828599|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
56101524|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
56101525|NCT00002047|Zidovudine|zidovudine|mesh-list
56101526|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
56101527|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101528|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101529|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101530|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101531|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
56101532|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101533|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101534|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56584386|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56584387|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56584388|NCT02836509|Analgesics|analgesics|mesh-ancestor
56584389|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
56584390|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56332919|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
56584391|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584392|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56584393|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584394|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56584395|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584396|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584398|NCT05306379|Simvastatin|simvastatin|mesh-list
56584399|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56584400|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56584401|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
56584402|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584403|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56584404|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56584440|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584441|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584442|NCT02836353|Hormones|hormones|mesh-ancestor
56584443|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584444|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584445|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
56584446|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56584447|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56584448|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584449|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56584450|NCT02836431|Analgesics|analgesics|mesh-ancestor
56584451|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
56584452|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584453|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56584454|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56584455|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56584456|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
56584457|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584459|NCT05326425|Lazertinib|lazertinib|mesh-list
56584494|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
56584495|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56584496|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56584497|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56584498|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56584499|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56584500|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56584501|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56584502|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56584504|NCT02835729|Idarubicin|idarubicin|mesh-list
56584505|NCT02835729|Tryptophan|tryptophan|mesh-list
56584506|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56584507|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
56584508|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584509|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584510|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
56584511|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584512|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584513|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
56584514|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584515|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56584516|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56584517|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56584518|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584519|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56584520|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
56584521|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56584522|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
56584523|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584525|NCT00787267|Dasatinib|dasatinib|mesh-list
56584536|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56584537|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
56584538|NCT02838615|Hormones|hormones|mesh-ancestor
56584539|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584540|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56584541|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584542|NCT02833701|Vitamins|vitamins|mesh-list
56584543|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
56584544|NCT02833701|Bevacizumab|bevacizumab|mesh-list
56584545|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56584546|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
56584547|NCT02833701|Antibodies|antibodies|mesh-list
56584548|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
56584549|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56584550|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
56584551|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158514|NCT03689244|Selexipag|selexipag|mesh-list
56584553|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56584554|NCT02833701|Growth Substances|growth substances|mesh-ancestor
56584555|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584556|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
56584557|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
56584558|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
56584559|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
56584560|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584561|NCT02833701|Protective Agents|protective agents|mesh-ancestor
56584562|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
56584563|NCT02838225|Docetaxel|docetaxel|mesh-list
56584564|NCT02838225|Doxorubicin|doxorubicin|mesh-list
56584565|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56584566|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584567|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
56101535|NCT00002053|Pentamidine|pentamidine|mesh-list
56584581|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584582|NCT00928434|Leuprolide|leuprolide|mesh-list
56584583|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56584584|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
56584585|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56584586|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584587|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56584588|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584589|NCT04248621|Goserelin|goserelin|mesh-list
56584590|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56584591|NCT04248621|Leuprolide|leuprolide|mesh-list
56584592|NCT04248621|Flutamide|flutamide|mesh-list
56584593|NCT04248621|Bicalutamide|bicalutamide|mesh-list
56584594|NCT04248621|Androgens|androgens|mesh-list
56584595|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
56584596|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56584597|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584598|NCT04248621|Hormones|hormones|mesh-ancestor
56584599|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584600|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584601|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
56584602|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
56584603|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56584604|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
56584605|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56584632|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56584633|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56584634|NCT02602483|Analgesics|analgesics|mesh-ancestor
56584635|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
56584636|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584637|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584638|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56584639|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584640|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56584641|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584642|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584643|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
56584644|NCT02602483|Protective Agents|protective agents|mesh-ancestor
56584645|NCT02602483|Vitamins|vitamins|mesh-ancestor
56584646|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
56584647|NCT00784147|Ibalizumab|ibalizumab|mesh-list
56584648|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56584649|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56584650|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56584651|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
56584652|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584653|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
56584654|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584655|NCT04260360|Docetaxel|docetaxel|mesh-list
56584656|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584657|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
56584658|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
56584659|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
56584660|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584661|NCT04254822|Carvedilol|carvedilol|mesh-list
56584677|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
56584678|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56584679|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584680|NCT00891813|Vitamins|vitamins|mesh-ancestor
56584681|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
56584682|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56584683|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
56584684|NCT04255056|Epirubicin|epirubicin|mesh-list
56584685|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584686|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
56584687|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584688|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584689|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56584690|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
56584691|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584693|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56584694|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56584695|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56584696|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56584697|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584698|NCT00783835|Methylphenidate|methylphenidate|mesh-list
56584699|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56158517|NCT03443856|Ipilimumab|ipilimumab|mesh-list
56584700|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584701|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56584702|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56584705|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
56584724|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584725|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584726|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
56584727|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584728|NCT02831205|Trace Elements|trace elements|mesh-ancestor
56584729|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
56584730|NCT00783289|Benralizumab|benralizumab|mesh-list
56584731|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56584732|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
56584733|NCT02828163|Triamcinolone|triamcinolone|mesh-list
56584734|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56584735|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56584736|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56584737|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56584738|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
56584739|NCT02828163|Hormones|hormones|mesh-ancestor
56584740|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584741|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584742|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584743|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
56584744|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584745|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584746|NCT04107805|Midazolam|midazolam|mesh-list
56584747|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56584748|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56584749|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56584750|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584770|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584772|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56584773|NCT04672460|Talazoparib|talazoparib|mesh-list
56584774|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56584775|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584776|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584777|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584778|NCT00847912|Fluorouracil|fluorouracil|mesh-list
56584779|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
56584780|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584781|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56584782|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584783|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56584784|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
56584785|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584786|NCT00850564|Hormones|hormones|mesh-list
56584787|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56584788|NCT00850564|Tesamorelin|tesamorelin|mesh-list
56584792|NCT00837148|Sorafenib|sorafenib|mesh-list
56584825|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
56584826|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584827|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56584828|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56584829|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
56584830|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56584831|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56584832|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56584833|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56584834|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584835|NCT00782509|Olodaterol|olodaterol|mesh-list
56584836|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56584837|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
56584838|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584839|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584840|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56584841|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
56584842|NCT00701428|Losartan|losartan|mesh-list
56584843|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56584844|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56584845|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56584846|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56584847|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584848|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56584849|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56584850|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584851|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
56584852|NCT00706888|Pyridoxal|pyridoxal|mesh-list
56584853|NCT00706888|Pyridoxine|pyridoxine|mesh-list
56584871|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56584872|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
56584873|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584874|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584875|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56584876|NCT00918138|Metformin|metformin|mesh-list
56584877|NCT00918138|Saxagliptin|saxagliptin|mesh-list
56584878|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56584879|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584880|NCT00918138|Incretins|incretins|mesh-ancestor
56584881|NCT00918138|Hormones|hormones|mesh-ancestor
56584882|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56584883|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56584884|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
56584885|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56584886|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584887|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56584888|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56584889|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584890|NCT00782275|Sirolimus|sirolimus|mesh-list
56584891|NCT00782275|Bevacizumab|bevacizumab|mesh-list
56584892|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56584893|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56584894|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56584921|NCT00781885|Beraprost|beraprost|mesh-list
56584922|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56584923|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
56584924|NCT04901676|Leronlimab|leronlimab|mesh-list
56584925|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56584926|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56584927|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584928|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56584929|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56584930|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
56584931|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56584932|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
56584933|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56584934|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584935|NCT02603965|Copper|copper|mesh-list
56584936|NCT02603965|Trace Elements|trace elements|mesh-ancestor
56584937|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
56584938|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584939|NCT00918684|Citalopram|citalopram|mesh-list
56584940|NCT00918684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56584941|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56584942|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56584943|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584944|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56584945|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
56584946|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584947|NCT00918684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56584948|NCT00918684|Antidepressive Agents|antidepressive agents|mesh-ancestor
56584949|NCT00918684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56584950|NCT00919854|Ritonavir|ritonavir|mesh-list
56584951|NCT00919854|Darunavir|darunavir|mesh-list
56584965|NCT04669782|Vitamins|vitamins|mesh-ancestor
56584966|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
56584967|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584968|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56584969|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56584970|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56584971|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
56584972|NCT04669782|Coagulants|coagulants|mesh-ancestor
56584973|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56584974|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56584975|NCT04871412|Vitamin D|vitamin d|mesh-list
56584976|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
56584977|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
56584978|NCT04871412|Vitamins|vitamins|mesh-list
56584979|NCT04871412|Curcumin|curcumin|mesh-list
56584980|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
56584981|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56584982|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56584983|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56584984|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56584985|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56584986|NCT04871412|Analgesics|analgesics|mesh-ancestor
56584987|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
56584988|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56584989|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56584990|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56585015|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585016|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
56585017|NCT04247373|Ropivacaine|ropivacaine|mesh-list
56585018|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
56585019|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
56585020|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585021|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585022|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
56585023|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585024|NCT02832999|Liraglutide|liraglutide|mesh-list
56585025|NCT02832999|Vildagliptin|vildagliptin|mesh-list
56585026|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56585027|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585028|NCT02832999|Incretins|incretins|mesh-ancestor
56585029|NCT02832999|Hormones|hormones|mesh-ancestor
56585030|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56585031|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56585032|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
56585033|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585034|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585035|NCT04245033|Piperaquine|piperaquine|mesh-list
56585036|NCT04245033|Artenimol|artenimol|mesh-list
56585067|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585068|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
56585069|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
56585070|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
56585071|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585073|NCT02829879|Fluorides|fluorides|mesh-list
56585074|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
56585075|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
56585076|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
56585077|NCT02829879|Protective Agents|protective agents|mesh-ancestor
56585078|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585079|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56585080|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585081|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
56585082|NCT02829957|Apixaban|apixaban|mesh-list
56585083|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56585084|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
56585085|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56585086|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
56585087|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585088|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585089|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
56585090|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
56585091|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56585092|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585093|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585094|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56585095|NCT05246007|Analgesics|analgesics|mesh-ancestor
56585096|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
56585097|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585100|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56585112|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56585113|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
56585114|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585115|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56585116|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585117|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56585118|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
56585119|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56585120|NCT00835978|Axitinib|axitinib|mesh-list
56585121|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101536|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
56101537|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101538|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56101539|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56101540|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56101541|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
56101542|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56101543|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
56101544|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101545|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
56101546|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101547|NCT00002065|Disulfiram|disulfiram|mesh-list
56101563|NCT00002401|Indinavir|indinavir|mesh-list
56101564|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101565|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101566|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101567|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101568|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
56101569|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101570|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101571|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101572|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
56101573|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56101574|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56101575|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
56101576|NCT00002407|Lamivudine|lamivudine|mesh-list
56101577|NCT00002407|Nevirapine|nevirapine|mesh-list
56101578|NCT00002407|Didanosine|didanosine|mesh-list
56101579|NCT00002407|Stavudine|stavudine|mesh-list
56101580|NCT00002407|Indinavir|indinavir|mesh-list
56101581|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101582|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101583|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101584|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101586|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101587|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101588|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101589|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56101590|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56101591|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
56195489|NCT01499251|Macitentan|macitentan|mesh-list
56195490|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56195491|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
56195492|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195493|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195494|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56101592|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56101593|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56101594|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
56101595|NCT00002413|Emivirine|emivirine|mesh-list
56101596|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101597|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101598|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101599|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101600|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
56101601|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585122|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56585123|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585124|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585125|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56585126|NCT01077518|Ofatumumab|ofatumumab|mesh-list
56585127|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56585128|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56585129|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
56585130|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585131|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585132|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
56585133|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585134|NCT04203186|Lumefantrine|lumefantrine|mesh-list
56585135|NCT04203186|Artemether|artemether|mesh-list
56585136|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56585137|NCT04203186|Atovaquone|atovaquone|mesh-list
56585138|NCT04203186|Proguanil|proguanil|mesh-list
56585139|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56585140|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
56585141|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56585142|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56585143|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585144|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101602|NCT00002419|Efavirenz|efavirenz|mesh-list
56101603|NCT00002419|Abacavir|abacavir|mesh-list
55828671|NCT04963283|Nivolumab|nivolumab|mesh-list
56101604|NCT00002419|Adefovir|adefovir|mesh-list
56101605|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56101606|NCT00002419|Amprenavir|amprenavir|mesh-list
56101607|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101608|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101610|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101622|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
56101623|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56101624|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56101625|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56101626|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
56101627|NCT00381511|Heparin|heparin|mesh-list
56101628|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56101629|NCT00381511|Tinzaparin|tinzaparin|mesh-list
56101630|NCT00381511|Dalteparin|dalteparin|mesh-list
56101631|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
56101632|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56101633|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56101634|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101635|NCT00002425|Saquinavir|saquinavir|mesh-list
56101636|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56101637|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56101638|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
56101639|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101640|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101641|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101642|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101643|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
56585145|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585146|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
56585148|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56585149|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585150|NCT00914316|Ranolazine|ranolazine|mesh-list
56585151|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56585152|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56585153|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585154|NCT00701740|Isotretinoin|isotretinoin|mesh-list
56585155|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
56585156|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
56585157|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
56585158|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56585159|NCT00701740|Protective Agents|protective agents|mesh-ancestor
56585160|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585161|NCT04938882|Lidocaine|lidocaine|mesh-list
56585162|NCT04938882|Ropivacaine|ropivacaine|mesh-list
56585163|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
56585210|NCT04303598|Tenofovir|tenofovir|mesh-list
56585211|NCT04303598|Lamivudine|lamivudine|mesh-list
56585212|NCT04303598|Efavirenz|efavirenz|mesh-list
56585213|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
56585214|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585215|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56585216|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56333739|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56585217|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585218|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585219|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56585220|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56585221|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56585222|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56585223|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56585224|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56585225|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56585226|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56585227|NCT04607460|Coal Tar|coal tar|mesh-list
56585228|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
56585229|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
56585230|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
56585231|NCT04636086|Vitamin D|vitamin d|mesh-list
56585252|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
56585253|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
56585254|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56585255|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
56585256|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585257|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585258|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
56585259|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585260|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56585261|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585262|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585263|NCT00707278|Capecitabine|capecitabine|mesh-list
56585264|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
56585265|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56585266|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
56585267|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585268|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585269|NCT01077284|Allopurinol|allopurinol|mesh-list
56585270|NCT01077284|Febuxostat|febuxostat|mesh-list
56585271|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
56585272|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585273|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585274|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
56585275|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56585276|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56585277|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
56585278|NCT01077284|Protective Agents|protective agents|mesh-ancestor
56585279|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585298|NCT04103125|Protective Agents|protective agents|mesh-ancestor
56585299|NCT00826618|Ranibizumab|ranibizumab|mesh-list
56585300|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56585301|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56585302|NCT00826618|Growth Substances|growth substances|mesh-ancestor
56585303|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585305|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585306|NCT02876822|Vitamin D|vitamin d|mesh-list
56585307|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
56585308|NCT02876822|Vitamins|vitamins|mesh-ancestor
56585309|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
56585310|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585311|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56585312|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56585313|NCT00826540|Bevacizumab|bevacizumab|mesh-list
56585314|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56585315|NCT00826540|Sorafenib|sorafenib|mesh-list
56585316|NCT00826540|Antibodies|antibodies|mesh-list
56585317|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
56585318|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56585319|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585320|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56585321|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56585322|NCT00826540|Growth Substances|growth substances|mesh-ancestor
56585323|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585324|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
56585325|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
56585326|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56585327|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585328|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585329|NCT04303130|Endostar protein|endostar protein|mesh-list
56585330|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56585343|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56585344|NCT00626600|Narcotics|narcotics|mesh-ancestor
56585345|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585346|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585347|NCT00626600|Analgesics|analgesics|mesh-ancestor
56585348|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
56585349|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585350|NCT00707512|Natalizumab|natalizumab|mesh-list
56585351|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
56585352|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585353|NCT00704548|Simvastatin|simvastatin|mesh-list
56585354|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56585355|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56585356|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
56585357|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585358|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56585359|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56585360|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585371|NCT00846040|Fallypride|fallypride|mesh-list
56585397|NCT00707824|Nalbuphine|nalbuphine|mesh-list
56585398|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56585399|NCT00707824|Narcotics|narcotics|mesh-ancestor
56585400|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585401|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585402|NCT00707824|Analgesics|analgesics|mesh-ancestor
56585403|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
56585404|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585405|NCT00826228|Teriparatide|teriparatide|mesh-list
56585406|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56585407|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585408|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56120773|NCT01803282|Bevacizumab|bevacizumab|mesh-list
56120774|NCT01803282|Carboplatin|carboplatin|mesh-list
56120775|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
56120776|NCT01803282|Irinotecan|irinotecan|mesh-list
56120777|NCT01803282|Pemetrexed|pemetrexed|mesh-list
56120778|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56101644|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101645|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56101646|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101647|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
56101648|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56101649|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56101650|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101651|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
56101652|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
56101653|NCT00002077|Fluconazole|fluconazole|mesh-list
56101654|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
56101655|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101656|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56101657|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101658|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101659|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101660|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56101661|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
56101662|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101663|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101664|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56195495|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56195496|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56195498|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
56195499|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56195501|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
56195502|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195503|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195504|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195505|NCT01499446|Fluticasone|fluticasone|mesh-list
56195506|NCT01499446|Xhance|xhance|mesh-list
56195507|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195508|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56195509|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
56195510|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101665|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56101666|NCT00002089|Azithromycin|azithromycin|mesh-list
56101667|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56101668|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585409|NCT00791479|Dulaglutide|dulaglutide|mesh-list
56585410|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56585411|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585412|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56585413|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56585414|NCT02831751|Vaccines|vaccines|mesh-list
56585415|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
56585416|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585417|NCT00913458|Etanercept|etanercept|mesh-list
56585418|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56585419|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56585420|NCT00913458|Analgesics|analgesics|mesh-ancestor
56585421|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
56101669|NCT00002095|Ganciclovir|ganciclovir|mesh-list
56101670|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56101671|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
56101672|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101688|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
56101689|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56101690|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101691|NCT00002107|Aldesleukin|aldesleukin|mesh-list
56101692|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101693|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101694|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101695|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
56101696|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101697|NCT00002113|Fluconazole|fluconazole|mesh-list
56101698|NCT00002113|Flucytosine|flucytosine|mesh-list
56101699|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
56101700|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101701|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56101702|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101703|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101704|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101705|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56101706|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
56101707|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101708|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101709|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56101710|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56101711|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
56101712|NCT00002437|Cidofovir|cidofovir|mesh-list
56101713|NCT00002437|Probenecid|probenecid|mesh-list
56101714|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
56101715|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
56101716|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56101717|NCT00002437|Renal Agents|renal agents|mesh-ancestor
56101718|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
56101719|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101720|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101721|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101722|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
56101723|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56195511|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195512|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56195513|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
56195514|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
56195515|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56195517|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
56195518|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56101724|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56101725|NCT04329650|Prednisolone|prednisolone|mesh-list
56101726|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
56101727|NCT04329650|Siltuximab|siltuximab|mesh-list
56585422|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585423|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585424|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56585425|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56585426|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56585427|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56585428|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
56585429|NCT05208333|Albendazole|albendazole|mesh-list
56585430|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
56585431|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56585432|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585433|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
56585434|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56585435|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56585436|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
56585437|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
56585438|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
56585439|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585440|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333975|NCT00064428|PENTA|penta|mesh-list
56585441|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56585475|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585476|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
56585477|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585478|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585479|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56585480|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585481|NCT04244097|Bupivacaine|bupivacaine|mesh-list
56585482|NCT04244097|Neostigmine|neostigmine|mesh-list
56585483|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
56585484|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
56585485|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585486|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585487|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
56585488|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585489|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56585490|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585491|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585492|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
56585493|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585494|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56585495|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
56585496|NCT04619316|Trametinib|trametinib|mesh-list
56585497|NCT04619316|Dabrafenib|dabrafenib|mesh-list
56585498|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585499|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56585500|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585501|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585502|NCT00785629|Calcium|calcium|mesh-list
56585503|NCT00785629|Sevelamer|sevelamer|mesh-list
56585504|NCT00785629|Calcium acetate|calcium acetate|mesh-list
56585506|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585518|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585519|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56585520|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56585521|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56585522|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56480251|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56585523|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585524|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56585525|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56585526|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585527|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
56585528|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56101729|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
56101730|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56101731|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
56101753|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101754|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56101755|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56101756|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
56101757|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
56101758|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56101760|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56101761|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
56101762|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101763|NCT00002449|Aldesleukin|aldesleukin|mesh-list
56101764|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101765|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101766|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101767|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
56101768|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101769|NCT00003014|Carboplatin|carboplatin|mesh-list
56101770|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101772|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56101773|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
56101774|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101775|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101776|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101777|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101778|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101779|NCT00001579|Leucovorin|leucovorin|mesh-list
56101780|NCT00001579|Fluorouracil|fluorouracil|mesh-list
56101781|NCT00001579|Eniluracil|eniluracil|mesh-list
56101782|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
56101783|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101784|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56101785|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101786|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56101787|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
55870098|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101801|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101802|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741905|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101804|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101805|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56101806|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56101807|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101808|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101809|NCT00002131|Protective Agents|protective agents|mesh-ancestor
56101810|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56101811|NCT00380887|Estrogens|estrogens|mesh-ancestor
56101812|NCT00380887|Hormones|hormones|mesh-ancestor
56101813|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56585529|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56585530|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56585531|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
56585532|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585533|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56585534|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
56585535|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56585536|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
56585537|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
56585538|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56585539|NCT00915733|Protective Agents|protective agents|mesh-ancestor
56585540|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56585541|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56585542|NCT00913770|Buprenorphine|buprenorphine|mesh-list
56585543|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56585544|NCT00913770|Narcotics|narcotics|mesh-ancestor
56585545|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585546|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585547|NCT00913770|Analgesics|analgesics|mesh-ancestor
56585548|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
56585549|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585550|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56585551|NCT00912912|Sunitinib|sunitinib|mesh-list
56585552|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585553|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56585554|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56585578|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56585579|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56585580|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56585581|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
56585582|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
56585583|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585584|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56585585|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
56585586|NCT00784927|Hormones|hormones|mesh-ancestor
56585587|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56585588|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56585589|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56585590|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56585591|NCT00784927|Growth Substances|growth substances|mesh-ancestor
56585592|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
56585593|NCT00637884|Fexofenadine|fexofenadine|mesh-list
56585594|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56585595|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56585596|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56585597|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
56585598|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
56585599|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585629|NCT04834206|Fluorouracil|fluorouracil|mesh-list
56585630|NCT04834206|Nedaplatin|nedaplatin|mesh-list
56585631|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585632|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56585633|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56585634|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56585635|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585636|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
56585637|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56585638|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56585639|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
56585640|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585641|NCT00631722|Haloperidol|haloperidol|mesh-list
56585642|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
56585643|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
56585644|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
56585645|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585646|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585647|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56585648|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56585649|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56585650|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585651|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56585652|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56585653|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
56585654|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585655|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585656|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56585657|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
56585658|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56585659|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
56585660|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585661|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585662|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56585668|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585669|NCT00779467|Fentanyl|fentanyl|mesh-list
56585670|NCT00779467|Bupivacaine|bupivacaine|mesh-list
56585671|NCT00779467|Neostigmine|neostigmine|mesh-list
56585672|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
56585673|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
56585674|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585675|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585676|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
56585677|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585678|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56585679|NCT00779467|Narcotics|narcotics|mesh-ancestor
56585680|NCT00779467|Analgesics|analgesics|mesh-ancestor
56585681|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56585682|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56585683|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
56585684|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56585685|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585686|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585687|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
56585688|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585689|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56585690|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
56585691|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
56585692|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
56585693|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585694|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
56585695|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56585696|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585697|NCT00778921|Amlodipine|amlodipine|mesh-list
56585698|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56585699|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56585700|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56585701|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585702|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56585705|NCT04173312|Bupivacaine|bupivacaine|mesh-list
56585706|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
56585707|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
56585708|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585709|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585710|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
56585711|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585712|NCT00587431|Docetaxel|docetaxel|mesh-list
56585713|NCT00587431|Leuprolide|leuprolide|mesh-list
56585714|NCT00587431|Testosterone|testosterone|mesh-list
56585715|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585716|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
56585717|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
56585718|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
56585719|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585720|NCT00587431|Androgens|androgens|mesh-ancestor
56585721|NCT00587431|Hormones|hormones|mesh-ancestor
56585722|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56585723|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585724|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56585725|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56585763|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56585764|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56585765|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
56585766|NCT00707902|Lidocaine|lidocaine|mesh-list
56585767|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
56585768|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
56585769|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585770|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585771|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
56585772|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585773|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56585774|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56585775|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56585776|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56585777|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585778|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56585779|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585780|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
56585781|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
56585782|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56585783|NCT05511337|Citric Acid|citric acid|mesh-list
56585784|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
56585785|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
56585786|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56585787|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
56585788|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
56585789|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585790|NCT00833794|Tramadol|tramadol|mesh-list
56585791|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56585792|NCT00833794|Narcotics|narcotics|mesh-ancestor
56585793|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56101814|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101815|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
56101816|NCT00002461|Carmustine|carmustine|mesh-list
56101817|NCT00002461|Etoposide|etoposide|mesh-list
56101818|NCT00002461|Sargramostim|sargramostim|mesh-list
56101819|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195519|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195520|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195521|NCT01499485|Diuretics|diuretics|mesh-ancestor
56195522|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
56195523|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195524|NCT01499589|Anesthetics|anesthetics|mesh-list
56195525|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585794|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585795|NCT00833794|Analgesics|analgesics|mesh-ancestor
56585796|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
56585797|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585798|NCT00778375|Cytarabine|cytarabine|mesh-list
56585799|NCT00778375|Decitabine|decitabine|mesh-list
56585800|NCT00778375|Clofarabine|clofarabine|mesh-list
56585801|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56585802|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
56585803|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585804|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585805|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
56585806|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585807|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56585808|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
56585809|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585810|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585811|NCT04102267|Epinephrine|epinephrine|mesh-list
56585812|NCT04102267|Bupivacaine|bupivacaine|mesh-list
56585813|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
56585814|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
56585815|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56585816|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585817|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
56585818|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585819|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56585845|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
56585846|NCT00916045|Melphalan|melphalan|mesh-list
56585847|NCT00916045|Busulfan|busulfan|mesh-list
56585848|NCT00916045|Thiotepa|thiotepa|mesh-list
56585849|NCT00916045|Fludarabine|fludarabine|mesh-list
56585850|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
56585851|NCT00916045|Cyclosporins|cyclosporins|mesh-list
56585852|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
56585853|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56585854|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56585855|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
56585856|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585857|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56585858|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56585859|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
56195526|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195527|NCT01499602|Norethindrone|norethindrone|mesh-list
56195528|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
56195529|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56195530|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
56195531|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56195532|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195533|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56195534|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56195535|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56101820|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
56101821|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101822|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56101823|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56101824|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
56101825|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101826|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101827|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56101828|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55828890|NCT03918850|Analgesics|analgesics|mesh-ancestor
56101829|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56101830|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56101831|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101832|NCT00003026|Bicalutamide|bicalutamide|mesh-list
56101833|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56101834|NCT00003026|Flutamide|flutamide|mesh-list
56101835|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
56101836|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
56101837|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101838|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101839|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101840|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
56101841|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56101842|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
56101843|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56101844|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56101845|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56101846|NCT00002143|Acitretin|acitretin|mesh-list
56101847|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
56101848|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
56101849|NCT00002149|Amoxicillin|amoxicillin|mesh-list
56101866|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56101867|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56101868|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
56101869|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
56101870|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56101871|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55892217|NCT02057133|Anastrozole|anastrozole|mesh-list
56585860|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585861|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585862|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56585863|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56585864|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
56585865|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
56585866|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585867|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585868|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
56585869|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
56585870|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56585871|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56585872|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56585873|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
56585874|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56585875|NCT00916123|Prednisone|prednisone|mesh-list
56585876|NCT00916123|Docetaxel|docetaxel|mesh-list
56585877|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585878|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
56585879|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
56585880|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
56585881|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585913|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585914|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56585915|NCT00777049|Panobinostat|panobinostat|mesh-list
56585916|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585917|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56585918|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585919|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585920|NCT00774787|Imiquimod|imiquimod|mesh-list
56585921|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56585922|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
56585923|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585924|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585925|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
56585926|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
56585927|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585928|NCT01040780|Gefitinib|gefitinib|mesh-list
56585929|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585930|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56585931|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56585932|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585933|NCT04303988|Bevacizumab|bevacizumab|mesh-list
56585934|NCT04303988|Carboplatin|carboplatin|mesh-list
56585935|NCT04303988|Temozolomide|temozolomide|mesh-list
56585936|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56585937|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585938|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56585939|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56585940|NCT04303988|Growth Substances|growth substances|mesh-ancestor
56585941|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585942|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
56585943|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56585956|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
56585957|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
56585958|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56585959|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
56585960|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56585961|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56585962|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585964|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56585965|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56585966|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585967|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
56585968|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
56585969|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
56585970|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56585971|NCT04241601|Aldesleukin|aldesleukin|mesh-list
56585972|NCT04241601|Interleukin-2|interleukin-2|mesh-list
56585973|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56585974|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56585975|NCT04241601|Analgesics|analgesics|mesh-ancestor
56585976|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
56585977|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56585978|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56585979|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56585980|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56585981|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
56585982|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56585983|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
56585984|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
56585985|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56585986|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56586001|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586002|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586003|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56586004|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56586005|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
56586006|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
56586007|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586008|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56586009|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
56586010|NCT00833560|Hormones|hormones|mesh-ancestor
56586011|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586012|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56586013|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
56586014|NCT04242927|Niacin|niacin|mesh-list
56586015|NCT04242927|Niacinamide|niacinamide|mesh-list
56586016|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
56586017|NCT04242927|Vitamins|vitamins|mesh-ancestor
56586018|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
56586019|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586020|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56586021|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
56586022|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586023|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56586024|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
56586025|NCT00887679|Citalopram|citalopram|mesh-list
56586026|NCT00887679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56586027|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56586028|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586047|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586048|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586049|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56586050|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56586051|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
56586052|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586053|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56586054|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56586055|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
56586056|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56586057|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56586058|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
56586059|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586060|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586061|NCT00845182|Pioglitazone|pioglitazone|mesh-list
56586062|NCT00845182|Exenatide|exenatide|mesh-list
56586063|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56586064|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586065|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56586101|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586102|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56586103|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56586104|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56586105|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
56586106|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586107|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586109|NCT02612272|Betamethasone|betamethasone|mesh-list
56586110|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56586111|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56586112|NCT02612272|Analgesics|analgesics|mesh-ancestor
56586113|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
56586114|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586115|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586116|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56586117|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586118|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56586119|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586156|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56586157|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586158|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56586159|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
56586160|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56586161|NCT00822172|Protective Agents|protective agents|mesh-ancestor
56586162|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56586163|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56586164|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586165|NCT00832000|Mexiletine|mexiletine|mesh-list
56586166|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56586167|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56586168|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56586169|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586170|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586213|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56586214|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586215|NCT02825121|Trace Elements|trace elements|mesh-ancestor
56586216|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
56586217|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586218|NCT02825199|Caffeine|caffeine|mesh-list
56586219|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56586220|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586221|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56586222|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586223|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586224|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56586225|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56586226|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
56586227|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56101872|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101873|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101876|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101877|NCT02973295|Protective Agents|protective agents|mesh-ancestor
56101878|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101879|NCT00003032|Tamoxifen|tamoxifen|mesh-list
56101880|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
56101881|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
56101882|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56101883|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
56101884|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101885|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56101886|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56101887|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
56101888|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101889|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101890|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56101891|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56101892|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
56101893|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101894|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56101895|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56101896|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56101897|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56101898|NCT00003032|Analgesics|analgesics|mesh-ancestor
56101899|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
56101900|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101901|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56101902|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56101903|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101904|NCT00002155|Lamivudine|lamivudine|mesh-list
55828969|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
56101906|NCT00002155|Indinavir|indinavir|mesh-list
55870210|NCT03032614|Carboplatin|carboplatin|mesh-list
56101917|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56101918|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
56101920|NCT00003038|Doxorubicin|doxorubicin|mesh-list
56101921|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56101922|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56101923|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101924|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56101925|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56101926|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586228|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
56586229|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56586230|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586231|NCT00886743|Oprelvekin|oprelvekin|mesh-list
56586232|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586233|NCT02826759|Insulin|insulin|mesh-list
56586234|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56586235|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586236|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56586237|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121607|NCT01762800|Hormones|hormones|mesh-ancestor
56101927|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101928|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
56101929|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
56101930|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56101931|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101932|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56101933|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56101934|NCT02176148|Fluocinonide|fluocinonide|mesh-list
56101935|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56101936|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
56101938|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101939|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101940|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56101941|NCT00003044|Cisplatin|cisplatin|mesh-list
56101942|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101943|NCT00002161|Adefovir|adefovir|mesh-list
56101944|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56101945|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
56101946|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101947|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101948|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101949|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101950|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101951|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
56195538|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56101952|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56101953|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
56101954|NCT03805022|Doxorubicin|doxorubicin|mesh-list
56101955|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56101956|NCT03805022|Ifosfamide|ifosfamide|mesh-list
56101957|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
56101958|NCT03805022|Dacarbazine|dacarbazine|mesh-list
56101959|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56101960|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101961|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56101962|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56101963|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101964|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101965|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56101966|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
56101967|NCT05752435|Bleomycin|bleomycin|mesh-list
56101968|NCT05752435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56101969|NCT05752435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101970|NCT00003050|Tamoxifen|tamoxifen|mesh-list
56101971|NCT00003050|Paclitaxel|paclitaxel|mesh-list
56101981|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56101982|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
56101983|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101984|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56101985|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56101986|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
56101987|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56101988|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56101989|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56101990|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56101991|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586238|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56586239|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
56586240|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586241|NCT02826837|Bevacizumab|bevacizumab|mesh-list
56586242|NCT02826837|Cetuximab|cetuximab|mesh-list
56586243|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56586244|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586245|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56586246|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56586247|NCT02826837|Growth Substances|growth substances|mesh-ancestor
56586248|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586249|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
56586250|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56586251|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
56586252|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586253|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
56586254|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56586255|NCT02823483|Protective Agents|protective agents|mesh-ancestor
56586257|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
56586295|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586296|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56586297|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
56586298|NCT02603575|Hormones|hormones|mesh-ancestor
56586299|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586300|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56586301|NCT02603575|Protective Agents|protective agents|mesh-ancestor
56586302|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
56586303|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586304|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586305|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586306|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56586307|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
56586308|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
56586309|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56586310|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586311|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586316|NCT02822157|Gemcitabine|gemcitabine|mesh-list
56586350|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
56586351|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586352|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56586353|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56586354|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56586355|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586356|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56586357|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
56586359|NCT04200885|Dexamethasone|dexamethasone|mesh-list
56586360|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56586361|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56586362|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56586363|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
56586364|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
56586413|NCT05659407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56586414|NCT00766675|Acetaminophen|acetaminophen|mesh-list
56586415|NCT00766675|Tramadol|tramadol|mesh-list
56586416|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56586417|NCT00766675|Analgesics|analgesics|mesh-ancestor
56586418|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
56334955|NCT01331018|Plerixafor|plerixafor|mesh-list
56586419|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586420|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586421|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
56586422|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56586423|NCT00766675|Narcotics|narcotics|mesh-ancestor
56586424|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586425|NCT02820441|Zopiclone|zopiclone|mesh-list
56121791|NCT04413864|Analgesics|analgesics|mesh-ancestor
56101992|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56101993|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
56101994|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101995|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56101996|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56101997|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56101998|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56102000|NCT00002179|Zidovudine|zidovudine|mesh-list
56102001|NCT00002179|Indinavir|indinavir|mesh-list
56102002|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102003|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102004|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102005|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102006|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
56102007|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102008|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102009|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102010|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
56102011|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56102012|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56102013|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
56102014|NCT00003056|Cyclosporine|cyclosporine|mesh-list
56102015|NCT00003056|Methotrexate|methotrexate|mesh-list
56102016|NCT00003056|Cyclosporins|cyclosporins|mesh-list
56102017|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56102018|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
56102019|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56102020|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102021|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56102022|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
56102023|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102024|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102025|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
56102026|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102027|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56102028|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102029|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
56102030|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102031|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102032|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
56102033|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195539|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56195540|NCT01499641|Prednisolone|prednisolone|mesh-list
56195541|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
56195542|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56195543|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
56195544|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56586426|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56586427|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586428|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586429|NCT02821377|Furosemide|furosemide|mesh-list
56586430|NCT02821377|Diuretics|diuretics|mesh-ancestor
56586431|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
56586432|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586433|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56586434|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586435|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586436|NCT02820987|Meropenem|meropenem|mesh-list
56586437|NCT02820987|Tazobactam|tazobactam|mesh-list
56586438|NCT02820987|Piperacillin|piperacillin|mesh-list
56586439|NCT02820987|Cefepime|cefepime|mesh-list
56586440|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56586441|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56586442|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586443|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56586444|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586445|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586446|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
56586447|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586448|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
56586449|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
56586450|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
56586451|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56586452|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586453|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56586454|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586455|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586456|NCT03245892|Paclitaxel|paclitaxel|mesh-list
56586457|NCT03245892|Carboplatin|carboplatin|mesh-list
56586458|NCT03245892|Nivolumab|nivolumab|mesh-list
56586459|NCT03245892|Ipilimumab|ipilimumab|mesh-list
56586466|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56586467|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56586468|NCT02818881|Methamphetamine|methamphetamine|mesh-list
56586469|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56586470|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586471|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
56586472|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
56586473|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586474|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
56586475|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586476|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586482|NCT02818725|Cisplatin|cisplatin|mesh-list
56586526|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
56586527|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
56586528|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586529|NCT03539952|Antidotes|antidotes|mesh-ancestor
56586530|NCT03539952|Protective Agents|protective agents|mesh-ancestor
56586531|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586532|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586533|NCT02820051|Lidocaine|lidocaine|mesh-list
56586596|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586597|NCT00765817|Exenatide|exenatide|mesh-list
56586598|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56586599|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586600|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56586601|NCT00765817|Incretins|incretins|mesh-ancestor
56586602|NCT00765817|Hormones|hormones|mesh-ancestor
56586603|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586604|NCT02818491|Dexamethasone|dexamethasone|mesh-list
56586605|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
56586606|NCT02818491|Ropivacaine|ropivacaine|mesh-list
56586607|NCT02818491|BB 1101|bb 1101|mesh-list
56586608|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56586609|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
56586610|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
56586611|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586612|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586613|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56586614|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
56586615|NCT02818491|Hormones|hormones|mesh-ancestor
56121974|NCT01703286|Hormones|hormones|mesh-ancestor
56195545|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
56195546|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
56195547|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195548|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195549|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56195550|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
56195552|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195553|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56195554|NCT01499641|Protective Agents|protective agents|mesh-ancestor
56195555|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56195556|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195557|NCT01499693|Pantoprazole|pantoprazole|mesh-list
56102034|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56102036|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56102037|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55870340|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
56102049|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102050|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
56102051|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102052|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102053|NCT00002191|Albendazole|albendazole|mesh-list
56102054|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
55829131|NCT02178956|Paclitaxel|paclitaxel|mesh-list
56102055|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56102056|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102057|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
56102058|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56102059|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56102060|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102061|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102062|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102063|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102064|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102066|NCT00383396|Cyclosporins|cyclosporins|mesh-list
56102067|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102068|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586616|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586617|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56586618|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586619|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
56586620|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586621|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586622|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
56586623|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
56586624|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586625|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
56586626|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
56586627|NCT02816853|Domperidone|domperidone|mesh-list
56586628|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56586629|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586630|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56586631|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56586632|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586633|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586634|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586635|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586636|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
56586637|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
56586638|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586639|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56586640|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56586641|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
56586663|NCT05656443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586664|NCT05656443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586665|NCT05656443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56586666|NCT05656443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56586667|NCT05656443|Antiviral Agents|antiviral agents|mesh-ancestor
56586668|NCT05656443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586669|NCT05656443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56586670|NCT05656443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56586671|NCT04238169|Bevacizumab|bevacizumab|mesh-list
56586672|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56586673|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586674|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56586675|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56586676|NCT04238169|Growth Substances|growth substances|mesh-ancestor
56586677|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586719|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56586720|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56586721|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
56586722|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
56586723|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586724|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56586725|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56586726|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586727|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586728|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56586729|NCT02817477|Narcotics|narcotics|mesh-ancestor
56586730|NCT02819115|Vaccines|vaccines|mesh-list
56586731|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
56586732|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586733|NCT05382208|Doxycycline|doxycycline|mesh-list
56586734|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56586735|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586736|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
56586737|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56586738|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56586739|NCT04099069|Anesthetics|anesthetics|mesh-list
56586740|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586742|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56586770|NCT02817321|Analgesics|analgesics|mesh-ancestor
56586771|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
56586772|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586773|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
56586774|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
56586775|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
56586776|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56586777|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586778|NCT04605861|Liraglutide|liraglutide|mesh-list
56586779|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56586780|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586781|NCT04605861|Incretins|incretins|mesh-ancestor
56586782|NCT04605861|Hormones|hormones|mesh-ancestor
56586783|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586784|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56586785|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56586786|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586787|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
56586788|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586789|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56335327|NCT00203788|Risperidone|risperidone|mesh-list
56586790|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56586791|NCT00705562|Caseins|caseins|mesh-list
56586792|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
56586793|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
56158667|NCT04978584|Prednisone|prednisone|mesh-list
56586794|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586796|NCT00843856|Tacrolimus|tacrolimus|mesh-list
56586818|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586819|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
56586820|NCT00705796|Testosterone|testosterone|mesh-list
56586821|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
56586822|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
56586823|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56586824|NCT00705796|Androgens|androgens|mesh-ancestor
56586825|NCT00705796|Hormones|hormones|mesh-ancestor
56586826|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586827|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586828|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56586829|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586830|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
56586831|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
56586832|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56586833|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
56586834|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586835|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56586836|NCT04432935|Lactoferrin|lactoferrin|mesh-list
56586837|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586838|NCT00591370|Temozolomide|temozolomide|mesh-list
56586840|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
56586872|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
56586873|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
56586874|NCT02237508|Hormones|hormones|mesh-ancestor
56586875|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56586876|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56586877|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56586878|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56586879|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
56586880|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586881|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586882|NCT02237508|Antidotes|antidotes|mesh-ancestor
56586883|NCT02237508|Protective Agents|protective agents|mesh-ancestor
56586884|NCT04237935|Clopidogrel|clopidogrel|mesh-list
56586885|NCT04237935|Ticagrelor|ticagrelor|mesh-list
56586886|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56586887|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56586888|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56586889|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56586890|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
56586891|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586892|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586893|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586894|NCT05579574|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
56586895|NCT05579574|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56586896|NCT05579574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56586897|NCT05579574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56586898|NCT05579574|Contraceptive Agents|contraceptive agents|mesh-ancestor
56586899|NCT05579574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56586913|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56586914|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56586915|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56586916|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56586917|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586918|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56586919|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56586920|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586921|NCT02809755|Lidocaine|lidocaine|mesh-list
56586922|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
56586923|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
56586924|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56586925|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586926|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
56586927|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56586928|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56586929|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56586930|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56586931|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56586932|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586933|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
56586934|NCT02812719|Salicylates|salicylates|mesh-list
56586935|NCT02812719|Glycolic acid|glycolic acid|mesh-list
56586936|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56586937|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
56586961|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56586962|NCT00909480|Insulin|insulin|mesh-list
56586963|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56586964|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
56586965|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
56586966|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56586967|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586968|NCT05642715|Varenicline|varenicline|mesh-list
56586969|NCT05642715|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56586970|NCT05642715|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56586971|NCT05642715|Cholinergic Agents|cholinergic agents|mesh-ancestor
56586972|NCT05642715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56586973|NCT05642715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56586974|NCT05642715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56586975|NCT02874326|Octreotide|octreotide|mesh-list
56586976|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56586977|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56586978|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586979|NCT02812641|Bevacizumab|bevacizumab|mesh-list
56586980|NCT02812641|Cisplatin|cisplatin|mesh-list
56586981|NCT02812641|Fluorouracil|fluorouracil|mesh-list
56586982|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56586983|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56586984|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56587000|NCT01058096|Cariprazine|cariprazine|mesh-list
56587013|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56587014|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587015|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
56587016|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587018|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56587019|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56587080|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56587081|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56587082|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480255|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587083|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587084|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
56587085|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56587087|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
56587088|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587089|NCT02815059|Prednisone|prednisone|mesh-list
56587090|NCT02815059|Dasatinib|dasatinib|mesh-list
56587092|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
56587141|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56587142|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56587143|NCT00634491|Acetazolamide|acetazolamide|mesh-list
56587144|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
56587145|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56587146|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587147|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587148|NCT00634491|Diuretics|diuretics|mesh-ancestor
56587149|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
56587150|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587151|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
56587152|NCT02807103|Rituximab|rituximab|mesh-list
56587153|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587154|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
56587155|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587156|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587157|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56587158|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
56335701|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
56122512|NCT01687296|Xhance|xhance|mesh-list
56102069|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102072|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
56102073|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102074|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
56102075|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102076|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56102077|NCT00002197|Abacavir|abacavir|mesh-list
56102078|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102079|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102080|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102081|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102082|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
56195558|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56195559|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56195560|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56195561|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195562|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102083|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102084|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102085|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102086|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
56102087|NCT00003068|Thiotepa|thiotepa|mesh-list
56102088|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
56102089|NCT00003068|Amifostine|amifostine|mesh-list
56102090|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102091|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
56102092|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102093|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102094|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102095|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
56102096|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102097|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102098|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102099|NCT00003068|Analgesics|analgesics|mesh-ancestor
56102100|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
55892218|NCT02057133|Exemestane|exemestane|mesh-list
56587159|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587160|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587161|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56587162|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56587163|NCT02806791|Lenograstim|lenograstim|mesh-list
56587164|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56587165|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
56587166|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587167|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
56587168|NCT02800785|Metronidazole|metronidazole|mesh-list
56587169|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
56587170|NCT02800785|Levofloxacin|levofloxacin|mesh-list
56587171|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
56587173|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
56587174|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
56587176|NCT02800785|Ertapenem|ertapenem|mesh-list
56587177|NCT02800785|Tigecycline|tigecycline|mesh-list
56587178|NCT02800785|Cefotaxime|cefotaxime|mesh-list
56587179|NCT02800785|Cefoxitin|cefoxitin|mesh-list
56587180|NCT02800785|Ticarcillin|ticarcillin|mesh-list
56587181|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
56587182|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56587183|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587184|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56587185|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56587186|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587187|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587188|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587189|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56587190|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56587191|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56587206|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56587207|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56587208|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56587209|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587210|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56587211|NCT05498103|Methazolamide|methazolamide|mesh-list
56587212|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56587213|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587214|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587215|NCT05498103|Diuretics|diuretics|mesh-ancestor
56587216|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
56587217|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587218|NCT00771667|Ustekinumab|ustekinumab|mesh-list
56587219|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
56587220|NCT05579964|Dexmedetomidine|dexmedetomidine|mesh-list
56587221|NCT05579964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56587222|NCT05579964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587223|NCT05579964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587224|NCT05579964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56587225|NCT05579964|Analgesics|analgesics|mesh-ancestor
56587226|NCT05579964|Sensory System Agents|sensory system agents|mesh-ancestor
56587227|NCT05579964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587228|NCT05579964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56587229|NCT05579964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56587230|NCT05579964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56587231|NCT05579964|Adrenergic Agents|adrenergic agents|mesh-ancestor
56587232|NCT05579964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587233|NCT05579964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587251|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587252|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56587253|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587254|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587255|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56587256|NCT03893175|Narcotics|narcotics|mesh-ancestor
56587257|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587258|NCT04236453|Tenofovir|tenofovir|mesh-list
56587259|NCT04236453|Emtricitabine|emtricitabine|mesh-list
56587260|NCT04236453|Darunavir|darunavir|mesh-list
56587261|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56587262|NCT04236453|Cobicistat|cobicistat|mesh-list
56587263|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56587264|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56587265|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
56587266|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587267|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56587268|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56587269|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587270|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587271|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56587272|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56587273|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56587274|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56587275|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
56587299|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56587300|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56587301|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587302|NCT05461339|Ranibizumab|ranibizumab|mesh-list
56587303|NCT05461339|Antibodies|antibodies|mesh-list
56587304|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56587305|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
56587306|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587307|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56587308|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56587309|NCT05461339|Growth Substances|growth substances|mesh-ancestor
56587310|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
56587311|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587312|NCT03409848|Nivolumab|nivolumab|mesh-list
56587313|NCT03409848|Ipilimumab|ipilimumab|mesh-list
56587314|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56587315|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587316|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56587317|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587318|NCT00763555|Calcitriol|calcitriol|mesh-list
56587319|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56587320|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587321|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56587322|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56587349|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
56587350|NCT02799927|Calcium|calcium|mesh-list
56587351|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56587352|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587353|NCT00770653|Metformin|metformin|mesh-list
56587354|NCT00770653|Pioglitazone|pioglitazone|mesh-list
56587355|NCT00770653|Glimepiride|glimepiride|mesh-list
56587356|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56587357|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587358|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56587359|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587360|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
56587361|NCT02799615|Infliximab|infliximab|mesh-list
56587362|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
56587363|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56587364|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587365|NCT00819052|Nevirapine|nevirapine|mesh-list
56587366|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56587367|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56587368|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587369|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587370|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
56587371|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587372|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102101|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102102|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102129|NCT00003080|Analgesics|analgesics|mesh-ancestor
56102130|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
56102131|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102132|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102133|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102134|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102135|NCT00002203|Lamivudine|lamivudine|mesh-list
56102136|NCT00002203|Zidovudine|zidovudine|mesh-list
56102137|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56102138|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102139|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102140|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102141|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102142|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
56102143|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102144|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102145|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102146|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
56102147|NCT01568918|Tamsulosin|tamsulosin|mesh-list
56102148|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56102149|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56102150|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56102151|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
56102180|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56102181|NCT00003086|Analgesics|analgesics|mesh-ancestor
56102182|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
56102183|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587373|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56587374|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56587375|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56587376|NCT00763009|Dipyridamole|dipyridamole|mesh-list
56587377|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56587378|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587379|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587380|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56587381|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
56587382|NCT02799459|Anesthetics|anesthetics|mesh-list
56587383|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587384|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335929|NCT00206986|Clonidine|clonidine|mesh-list
56587385|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
56102184|NCT00003092|Paclitaxel|paclitaxel|mesh-list
56102185|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102186|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102187|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102188|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102189|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102190|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102191|NCT00381199|Amitriptyline|amitriptyline|mesh-list
56102192|NCT00381199|Nabilone|nabilone|mesh-list
56102194|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
56102195|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56102196|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56102197|NCT00381199|Analgesics|analgesics|mesh-ancestor
56102198|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
55870514|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56102211|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56102212|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56102213|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
56195563|NCT01499758|Atorvastatin|atorvastatin|mesh-list
56195564|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56195565|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56102214|NCT00002509|Carboplatin|carboplatin|mesh-list
56102215|NCT00002509|Etoposide|etoposide|mesh-list
56102216|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102217|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
56102218|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102219|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102220|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102221|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
56102222|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102223|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102224|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102225|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102226|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102227|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102228|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102229|NCT00002515|Carboplatin|carboplatin|mesh-list
56102230|NCT00002515|Topotecan|topotecan|mesh-list
56102231|NCT00002515|Thiotepa|thiotepa|mesh-list
56102232|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102233|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
56102234|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102235|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56102236|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102237|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102238|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102239|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56587387|NCT05477589|Busulfan|busulfan|mesh-list
56587388|NCT05477589|Fludarabine|fludarabine|mesh-list
56587389|NCT05477589|Clofarabine|clofarabine|mesh-list
56587390|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587391|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
56587392|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587393|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587394|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56587395|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
56587396|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587397|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587398|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56587399|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56587400|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
56587401|NCT00841672|Amlodipine|amlodipine|mesh-list
56587402|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56587403|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56587404|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56587405|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587406|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56587407|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587408|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
56587409|NCT05549115|Amoxicillin|amoxicillin|mesh-list
56587410|NCT05549115|Clarithromycin|clarithromycin|mesh-list
56587438|NCT00908232|Dexamethasone|dexamethasone|mesh-list
56587439|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
56587440|NCT00908232|Lenalidomide|lenalidomide|mesh-list
56587441|NCT00908232|Bortezomib|bortezomib|mesh-list
56587442|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587443|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
56587444|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587445|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587446|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56587447|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
56587448|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587449|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587450|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56122802|NCT01562028|Bevacizumab|bevacizumab|mesh-list
56102240|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
56102241|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102242|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102243|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
56102244|NCT00002521|Etoposide|etoposide|mesh-list
56102245|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102246|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
56102247|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102248|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102249|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102250|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
56102251|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102252|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102253|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102254|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102255|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102256|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102257|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102258|NCT00003110|Bleomycin|bleomycin|mesh-list
56102259|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56102260|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102261|NCT00002215|Nelfinavir|nelfinavir|mesh-list
56102273|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102274|NCT00003116|Cyclosporine|cyclosporine|mesh-list
56102275|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
56102276|NCT00003116|Busulfan|busulfan|mesh-list
56102277|NCT00003116|Cyclosporins|cyclosporins|mesh-list
56102278|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102279|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
56102280|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102281|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102282|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102284|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102285|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102286|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102287|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102289|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102290|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
56102291|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56102292|NCT00002227|Lamivudine|lamivudine|mesh-list
56102293|NCT00002227|Efavirenz|efavirenz|mesh-list
56102294|NCT00002227|Stavudine|stavudine|mesh-list
56102295|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56195566|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
56102296|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102297|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102298|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102299|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
55892219|NCT02057133|Loperamide|loperamide|mesh-list
56587451|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56587452|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
56587453|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
56587454|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587455|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56587456|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
56587457|NCT00908232|Hormones|hormones|mesh-ancestor
56587458|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56587459|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56587460|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56587461|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56587462|NCT00908232|Growth Substances|growth substances|mesh-ancestor
56587463|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
56587464|NCT00770341|Vancomycin|vancomycin|mesh-list
56587465|NCT00770341|Daptomycin|daptomycin|mesh-list
56587466|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56587467|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587468|NCT05472753|Selenium|selenium|mesh-list
56587469|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
56587470|NCT05472753|Curcumin|curcumin|mesh-list
56587471|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56587472|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56587473|NCT05472753|Analgesics|analgesics|mesh-ancestor
56587474|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
56587475|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587476|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587477|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56587478|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102300|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102301|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102302|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102303|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56102304|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56102305|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56102306|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56102307|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56102308|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56102309|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
56102310|NCT03689972|Natalizumab|natalizumab|mesh-list
56102311|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
56102312|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102313|NCT00002233|Lamivudine|lamivudine|mesh-list
56102314|NCT00002233|Abacavir|abacavir|mesh-list
56102315|NCT00002233|Indinavir|indinavir|mesh-list
56102316|NCT00002233|Amprenavir|amprenavir|mesh-list
56102317|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102318|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56587479|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587480|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587481|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587482|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
56587483|NCT05472753|Protective Agents|protective agents|mesh-ancestor
56587484|NCT05472753|Trace Elements|trace elements|mesh-ancestor
56587485|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
56587486|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587487|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56587488|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56587489|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56587490|NCT03396276|Narcotics|narcotics|mesh-ancestor
56587491|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587492|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587493|NCT03396276|Analgesics|analgesics|mesh-ancestor
56587494|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
56587495|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587496|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56587497|NCT02799147|Fludarabine|fludarabine|mesh-list
56587498|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
56587499|NCT02799147|Busulfan|busulfan|mesh-list
56587500|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56587532|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587533|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587534|NCT03326310|Azacitidine|azacitidine|mesh-list
56587535|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56587536|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
56587537|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587538|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587539|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587541|NCT05511909|Buspirone|buspirone|mesh-list
56587542|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56587543|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56587544|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587545|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587546|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56587547|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56587591|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
56587592|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587593|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56587594|NCT03230604|Z 350|z 350|mesh-list
56587595|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56587596|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56587597|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587598|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587599|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
56587600|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56587601|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587602|NCT02798055|Bosentan|bosentan|mesh-list
56587603|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56587604|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56587605|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587606|NCT05331768|Terlipressin|terlipressin|mesh-list
56587607|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56587608|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56587609|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
56587610|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56587612|NCT02640222|Vitamin K|vitamin k|mesh-list
56587646|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587647|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56587648|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
56587649|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587650|NCT02797977|Antiviral Agents|antiviral agents|mesh-ancestor
56587651|NCT02797977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587652|NCT02797977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587653|NCT02797977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587654|NCT02797977|Immunologic Factors|immunologic factors|mesh-ancestor
56587655|NCT02797977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587657|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
56587658|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587659|NCT00762073|Budesonide|budesonide|mesh-list
56587660|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56587661|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56587662|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
56587663|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123001|NCT01534182|Interferons|interferons|mesh-list
56102319|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102320|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102321|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
56102322|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102323|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102324|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102325|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56102326|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55870626|NCT03017248|Ketamine|ketamine|mesh-list
56102360|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
56102361|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870687|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102395|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102398|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
56102399|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102400|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56102401|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56102402|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102403|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102411|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56102412|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56102413|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56102415|NCT00383474|Tipifarnib|tipifarnib|mesh-list
56102416|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102417|NCT00002245|Lamivudine|lamivudine|mesh-list
56102418|NCT00002245|Abacavir|abacavir|mesh-list
56102419|NCT00002245|Amprenavir|amprenavir|mesh-list
56102420|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102421|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102422|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102423|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102424|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
56102425|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829495|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56102426|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102427|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102428|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56102429|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
56587664|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587665|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56587666|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
56587667|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
56587668|NCT00762073|Hormones|hormones|mesh-ancestor
56587669|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56587670|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56587671|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
56587672|NCT03847857|Coagulants|coagulants|mesh-ancestor
56587673|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
56587674|NCT02630628|Tacrolimus|tacrolimus|mesh-list
56587675|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587676|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
56587677|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587678|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56587679|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587680|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587681|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56587682|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587683|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56336236|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
56587684|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
56587685|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56587714|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
56587715|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587716|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587717|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56587718|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56587719|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56587720|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587721|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587722|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56587723|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56587724|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56587725|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
56587726|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158709|NCT04241562|Mitogens|mitogens|mesh-list
56587727|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587728|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56587729|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56587731|NCT00761527|Desloratadine|desloratadine|mesh-list
56587732|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56587733|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
56587734|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587738|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56587765|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
56587766|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
56587767|NCT02797041|Bortezomib|bortezomib|mesh-list
56587768|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587769|NCT02794779|Oxytocin|oxytocin|mesh-list
56587770|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
56587771|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56587772|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587773|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
56587774|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56587775|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587776|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56587777|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56587778|NCT00816556|Estradiol|estradiol|mesh-list
56587779|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56587780|NCT00816556|Estrogens|estrogens|mesh-ancestor
56587781|NCT00816556|Hormones|hormones|mesh-ancestor
56587782|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56587783|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587784|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56587785|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
56587786|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56587787|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56587788|NCT04100473|Insulin|insulin|mesh-list
56587789|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56587790|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
56587791|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56587792|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587793|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56587794|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56587795|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587796|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56587801|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
56587808|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56587809|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587810|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56587811|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
56587812|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587813|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587814|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
56587815|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587816|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56587817|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587818|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
56587819|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56587820|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56587821|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56587822|NCT02796183|Bevacizumab|bevacizumab|mesh-list
56587823|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56587824|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56587825|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56587826|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56587827|NCT02796183|Growth Substances|growth substances|mesh-ancestor
56587828|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587829|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
56102430|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56102431|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56102432|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56102433|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
56102434|NCT00003128|Paclitaxel|paclitaxel|mesh-list
56102435|NCT00003128|Ifosfamide|ifosfamide|mesh-list
56102436|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102437|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102438|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102439|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
56195567|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195568|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56195569|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56195570|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195571|NCT01499771|Atorvastatin|atorvastatin|mesh-list
56195572|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56195573|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56195574|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
56195575|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195576|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56195577|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56195578|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195579|NCT01499875|Penicillin V|penicillin v|mesh-list
56195580|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56195581|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195583|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
56195584|NCT01499953|Fondaparinux|fondaparinux|mesh-list
56195585|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56195586|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
56587830|NCT02796105|Ganirelix|ganirelix|mesh-list
56587831|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
56587832|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56587833|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587834|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56587836|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
56587837|NCT02795949|Meropenem|meropenem|mesh-list
56587838|NCT02795949|Tazobactam|tazobactam|mesh-list
56587839|NCT02795949|Piperacillin|piperacillin|mesh-list
56587840|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
56587841|NCT02795949|Imipenem|imipenem|mesh-list
56587842|NCT02795949|Ceftazidime|ceftazidime|mesh-list
56587843|NCT02795949|Ampicillin|ampicillin|mesh-list
56587844|NCT02795949|Cefuroxime|cefuroxime|mesh-list
56587845|NCT02795949|Ertapenem|ertapenem|mesh-list
56587846|NCT02795949|Cefepime|cefepime|mesh-list
56587847|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56587848|NCT02795949|Lactams|lactams|mesh-list
56587849|NCT02795949|Aztreonam|aztreonam|mesh-list
56587850|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56587851|NCT02795949|beta-Lactams|beta-lactams|mesh-list
56587852|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56587888|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
56587889|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587890|NCT02794389|Expectorants|expectorants|mesh-ancestor
56587891|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
56587892|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56587893|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
56587894|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587895|NCT02794389|Protective Agents|protective agents|mesh-ancestor
56587896|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587897|NCT02794389|Antidotes|antidotes|mesh-ancestor
56587898|NCT02601703|Tacrolimus|tacrolimus|mesh-list
56587899|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587900|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
56587901|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587902|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56587903|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56587904|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587905|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
56587906|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56587907|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
56587908|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587909|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56336457|NCT00209755|Ribavirin|ribavirin|mesh-list
56587910|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56587938|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56587939|NCT02790099|Morphine|morphine|mesh-list
56587940|NCT02790099|Bupivacaine|bupivacaine|mesh-list
56587941|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
56587942|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
56587943|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56587944|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587945|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
56587946|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56587947|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56587948|NCT02790099|Narcotics|narcotics|mesh-ancestor
56587949|NCT02790099|Analgesics|analgesics|mesh-ancestor
56587950|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
56587951|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56587952|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
56587953|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587954|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
56587955|NCT02790177|Protective Agents|protective agents|mesh-ancestor
56587956|NCT04100083|Spironolactone|spironolactone|mesh-list
56587957|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56587958|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
56587959|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56587960|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587961|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56587962|NCT04100083|Diuretics|diuretics|mesh-ancestor
56587963|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
56587964|NCT02794155|Insulin|insulin|mesh-list
56587965|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56587966|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
56587967|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56587984|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
56587985|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
56587986|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56336535|NCT00209872|Analgesics|analgesics|mesh-ancestor
56587987|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
56587988|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56587989|NCT02793843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56587990|NCT02793843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56587991|NCT02793843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56587992|NCT02793843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56587993|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
56587994|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
56587995|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56587996|NCT02793687|Protective Agents|protective agents|mesh-ancestor
56587997|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56587998|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56587999|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56588000|NCT02801487|Cisplatin|cisplatin|mesh-list
56588001|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588002|NCT02793765|Docetaxel|docetaxel|mesh-list
56588003|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588004|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
56588005|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
56588006|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
56588007|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588008|NCT02793219|Docetaxel|docetaxel|mesh-list
56588009|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588010|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
56588011|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
56588012|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
56588014|NCT02801409|Anesthetics|anesthetics|mesh-list
56588030|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56588031|NCT02789865|Renal Agents|renal agents|mesh-ancestor
56588032|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56588033|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56588034|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588035|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588036|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588037|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56588038|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56588039|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
56588040|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56588041|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
56588042|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588043|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
56588044|NCT02792673|Protective Agents|protective agents|mesh-ancestor
56588045|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
56588046|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56588047|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
56588048|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588049|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56588050|NCT02791737|Coal Tar|coal tar|mesh-list
56588085|NCT02389374|Primaquine|primaquine|mesh-list
56588086|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56588087|NCT02389374|Amebicides|amebicides|mesh-ancestor
56588088|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56588089|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56588090|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588091|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
56588092|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588093|NCT02789475|Amlodipine|amlodipine|mesh-list
56588094|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56588095|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56588096|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56588097|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56588098|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588099|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56588100|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588101|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
56588102|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56588103|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56588104|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
56588105|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56588106|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56588107|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588135|NCT03068910|Diuretics|diuretics|mesh-ancestor
56588136|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
56588137|NCT02790957|Plerixafor|plerixafor|mesh-list
56588138|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56336685|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56588139|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56588140|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
56588141|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588142|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56588143|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
56588144|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56588145|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56588146|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588147|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56588148|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56588149|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56588150|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588151|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
56588152|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588153|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
56588154|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56588155|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102440|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102441|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102442|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102443|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
56102444|NCT04331197|Letrozole|letrozole|mesh-list
56102445|NCT04331197|Clomiphene|clomiphene|mesh-list
56102446|NCT04331197|Enclomiphene|enclomiphene|mesh-list
56102447|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
56102448|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102449|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102450|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56102451|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56102452|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102453|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56102454|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
56102455|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56102456|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102457|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56102458|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
56102459|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56102460|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56102461|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56102462|NCT05751733|Sunitinib|sunitinib|mesh-list
56102463|NCT05751733|Imatinib Mesylate|imatinib mesylate|mesh-list
56102464|NCT05751733|Apatinib|apatinib|mesh-list
56102465|NCT05751733|Dasatinib|dasatinib|mesh-list
56102466|NCT05751733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102467|NCT05751733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56102468|NCT05751733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56102469|NCT05751733|Growth Substances|growth substances|mesh-ancestor
56588156|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56588157|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588158|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
56588159|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588160|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588161|NCT02339532|Carboplatin|carboplatin|mesh-list
56588162|NCT02339532|Docetaxel|docetaxel|mesh-list
56588163|NCT02339532|Trastuzumab|trastuzumab|mesh-list
56588164|NCT02339532|Pertuzumab|pertuzumab|mesh-list
56588165|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123506|NCT04672512|Prednisone|prednisone|mesh-list
56102481|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56102482|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
56102483|NCT00002798|Busulfan|busulfan|mesh-list
56102484|NCT00002798|Methotrexate|methotrexate|mesh-list
56102485|NCT00002798|Fludarabine|fludarabine|mesh-list
56102486|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
56102487|NCT00002798|Etoposide|etoposide|mesh-list
56195587|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56195588|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
56195589|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195590|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195591|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
56195592|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56195593|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56195594|NCT01500005|Vitamin D|vitamin d|mesh-list
56195595|NCT01500005|Vitamins|vitamins|mesh-ancestor
56195596|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
56195597|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195598|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56195599|NCT01500018|Phentermine|phentermine|mesh-list
56195600|NCT01500018|Ketamine|ketamine|mesh-list
56195601|NCT01500018|Analgesics|analgesics|mesh-ancestor
56195604|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195605|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56195606|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56195607|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
56195608|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
56195609|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56102488|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
56102489|NCT00002798|Daunorubicin|daunorubicin|mesh-list
56102490|NCT00002798|Asparaginase|asparaginase|mesh-list
56102491|NCT00002798|Interleukin-2|interleukin-2|mesh-list
56102492|NCT00002798|Idarubicin|idarubicin|mesh-list
56102493|NCT00002798|Thioguanine|thioguanine|mesh-list
56102494|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102495|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
56102496|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102497|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102498|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102499|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
56102500|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102501|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102502|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55829565|NCT01510912|Diclofenac|diclofenac|mesh-list
56102503|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56102504|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
56102505|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
56102506|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102507|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56102508|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
56102509|NCT00002798|Hormones|hormones|mesh-ancestor
56102510|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56102511|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56102512|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56102513|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
56102514|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56102515|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56102516|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
56588166|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
56588167|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
56588168|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
56588169|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588170|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588171|NCT00632580|Ropivacaine|ropivacaine|mesh-list
56588172|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
56588173|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
56588174|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588175|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588176|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
56588177|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588178|NCT03494322|Cetuximab|cetuximab|mesh-list
56588179|NCT03494322|Avelumab|avelumab|mesh-list
56588180|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588181|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588182|NCT02789397|Rituximab|rituximab|mesh-list
56588183|NCT02789397|Azathioprine|azathioprine|mesh-list
56588184|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588185|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588186|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
56588187|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588188|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588189|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
56588190|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588191|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56588192|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56588193|NCT03485274|Vortioxetine|vortioxetine|mesh-list
56588194|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
56588195|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56588196|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56588207|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56588208|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56588209|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56588210|NCT00816166|Aspirin|aspirin|mesh-list
56588211|NCT00816166|Clopidogrel|clopidogrel|mesh-list
56588212|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56588213|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56588214|NCT00816166|Analgesics|analgesics|mesh-ancestor
56588215|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
56588216|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588217|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588218|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588219|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588220|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56588221|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56588222|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588223|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56588224|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56588225|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588226|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
56588229|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56588260|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56588261|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588262|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588263|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56588264|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
56588265|NCT02786823|Folic Acid|folic acid|mesh-list
56588266|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
56588267|NCT02786823|Metformin|metformin|mesh-list
56588268|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56588269|NCT02786823|Vitamins|vitamins|mesh-ancestor
56588270|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
56102517|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
56195610|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56195611|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56195612|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56195613|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195614|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56195615|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
56195616|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56195617|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
56195618|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
56195619|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
56195620|NCT01500070|Everolimus|everolimus|mesh-list
56195621|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195622|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195623|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
56102518|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102519|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56102520|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102521|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102522|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102523|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102524|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
56102525|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102549|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102550|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102551|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102552|NCT00002545|Carmustine|carmustine|mesh-list
56102553|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102554|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
56102555|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102556|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102557|NCT00002804|Cobalt|cobalt|mesh-list
56102558|NCT00002804|Doxorubicin|doxorubicin|mesh-list
56102559|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56102560|NCT00002804|Vincristine|vincristine|mesh-list
56102561|NCT00002804|Ifosfamide|ifosfamide|mesh-list
56102566|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102568|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102569|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102570|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56102571|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
56102572|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102573|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102574|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102575|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102599|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56102601|NCT00003392|Paclitaxel|paclitaxel|mesh-list
56102602|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
56102603|NCT00003392|Carboplatin|carboplatin|mesh-list
56102604|NCT00003392|Melphalan|melphalan|mesh-list
56102605|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102606|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102607|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102608|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102609|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
56588271|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588272|NCT02786823|Hematinics|hematinics|mesh-ancestor
56588273|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
56588274|NCT05332314|Ibuprofen|ibuprofen|mesh-list
56588275|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56588276|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56588277|NCT05332314|Analgesics|analgesics|mesh-ancestor
56588278|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
56588279|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588280|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588281|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588282|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588283|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56588284|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588285|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336836|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
56588286|NCT00815308|Paclitaxel|paclitaxel|mesh-list
56588287|NCT00815308|Cetuximab|cetuximab|mesh-list
56588288|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56588289|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588290|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
56588291|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
56588292|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
56588293|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588294|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588295|NCT01039376|Ofatumumab|ofatumumab|mesh-list
56588296|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588297|NCT02610712|Ketamine|ketamine|mesh-list
56588298|NCT02610712|Analgesics|analgesics|mesh-ancestor
56588299|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
56588300|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588314|NCT00905034|Vincristine|vincristine|mesh-list
56588315|NCT00905034|Asparaginase|asparaginase|mesh-list
56588316|NCT00905034|Pegaspargase|pegaspargase|mesh-list
56588317|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588318|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588319|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
56588320|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588321|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588322|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588323|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
56588324|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
56588325|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588326|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56588327|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
56588328|NCT00905034|Hormones|hormones|mesh-ancestor
56588329|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588330|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56588331|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56588332|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
56588333|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56588334|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56588335|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
56588336|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588337|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56588338|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588339|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56588340|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56588346|NCT02611804|Diclofenac|diclofenac|mesh-list
56588360|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56336913|NCT00212173|Sibutramine|sibutramine|mesh-list
56588361|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
56588363|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588364|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588365|NCT02611492|Cytarabine|cytarabine|mesh-list
56588366|NCT02611492|Dexamethasone|dexamethasone|mesh-list
56588367|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56588368|NCT02611492|Methotrexate|methotrexate|mesh-list
56588369|NCT02611492|Vincristine|vincristine|mesh-list
56588370|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
56195624|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195626|NCT01500161|Fludarabine|fludarabine|mesh-list
56195627|NCT01500161|Etoposide|etoposide|mesh-list
56195628|NCT01500161|Melphalan|melphalan|mesh-list
56195629|NCT01500161|Busulfan|busulfan|mesh-list
56195630|NCT01500161|Carmustine|carmustine|mesh-list
56195631|NCT01500161|Clofarabine|clofarabine|mesh-list
56195632|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195633|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56195634|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
56195635|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195636|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195637|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
56195638|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102610|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102611|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102612|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
56102613|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102614|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102615|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102616|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
56102617|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102618|NCT00002551|Leucovorin|leucovorin|mesh-list
56102619|NCT00002551|Levamisole|levamisole|mesh-list
56102620|NCT00002551|Fluorouracil|fluorouracil|mesh-list
56102621|NCT00002551|Calcium|calcium|mesh-list
56102622|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
56102623|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56102624|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102625|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
56102652|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102653|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
56102655|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56102656|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102657|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
56102658|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102659|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102660|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102661|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
56102662|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102663|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102664|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102665|NCT00002263|Zidovudine|zidovudine|mesh-list
56102666|NCT00002263|Sargramostim|sargramostim|mesh-list
56102667|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
56102668|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102669|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102670|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102672|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
56102673|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102674|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102675|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102709|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56102710|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
56102711|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102712|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
56588371|NCT02611492|Lenograstim|lenograstim|mesh-list
56588372|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588373|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
56588374|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
56588375|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588376|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588377|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56588378|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
56588379|NCT02611492|Hormones|hormones|mesh-ancestor
56588380|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588381|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56588382|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588383|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56588384|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
56588385|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56588386|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56588387|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
56588388|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588389|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
56588390|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588391|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56588392|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56588393|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
56588394|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588395|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56588396|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56588397|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
56588398|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
56588399|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
56588416|NCT01038752|Carboplatin|carboplatin|mesh-list
56588417|NCT01038752|Docetaxel|docetaxel|mesh-list
56588418|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588419|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
56588420|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
56588421|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
56588422|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588423|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
56588424|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
56588425|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56588426|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588427|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56588428|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56588429|NCT04233021|Osimertinib|osimertinib|mesh-list
56588430|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588431|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56588432|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588433|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588434|NCT00903630|Doxorubicin|doxorubicin|mesh-list
56588435|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56588436|NCT00903630|Lenalidomide|lenalidomide|mesh-list
56588437|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56588438|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588439|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56588440|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56588442|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588443|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
56102713|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102714|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56195639|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56195640|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56195641|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56195642|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195643|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
56195644|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195645|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56195646|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
56102715|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102716|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
56102717|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102718|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102719|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102720|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102721|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102722|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
56102723|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102746|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102747|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56588444|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588445|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56588446|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56588447|NCT00903630|Growth Substances|growth substances|mesh-ancestor
56588448|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
56588450|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
56588451|NCT04302584|Norepinephrine|norepinephrine|mesh-list
56588452|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56588453|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56588454|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
56588455|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588456|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102748|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56102749|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56102750|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56102751|NCT00003152|Interferons|interferons|mesh-list
56102752|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
56102754|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
56102755|NCT00003152|Vincristine|vincristine|mesh-list
56102756|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102757|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
56102758|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102759|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102760|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102761|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
56102762|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102763|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102764|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102765|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56102766|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
56102767|NCT00003152|Hormones|hormones|mesh-ancestor
56102768|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56102769|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56102770|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
56102771|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102772|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102773|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102774|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102775|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102776|NCT05751421|Meloxicam|meloxicam|mesh-list
56102777|NCT05751421|Bupivacaine|bupivacaine|mesh-list
55871076|NCT01006252|Paclitaxel|paclitaxel|mesh-list
56102794|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
56102796|NCT00002822|Carboplatin|carboplatin|mesh-list
56102797|NCT00002822|Doxorubicin|doxorubicin|mesh-list
56102798|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56102799|NCT00002822|Etoposide|etoposide|mesh-list
56102800|NCT00002822|Vincristine|vincristine|mesh-list
56102801|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102802|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
56102803|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102804|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102805|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102806|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
56102807|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102808|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102809|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102810|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56195647|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102811|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102813|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102814|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102815|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102816|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
56588457|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588458|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
56588459|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
56588460|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588461|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56588462|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
56588463|NCT04302584|Coagulants|coagulants|mesh-ancestor
56588464|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56588465|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
56588466|NCT00703144|Tazobactam|tazobactam|mesh-list
56588467|NCT00703144|Piperacillin|piperacillin|mesh-list
56588468|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56588469|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56588470|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588471|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56588472|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588473|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588474|NCT01054820|Diclofenac|diclofenac|mesh-list
56588475|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
56588476|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56588477|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56588478|NCT01054820|Analgesics|analgesics|mesh-ancestor
56588479|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
56588480|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588481|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588482|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588483|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588484|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56588485|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588486|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588487|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
56588488|NCT03105843|Miotics|miotics|mesh-ancestor
56588489|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
56588498|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588499|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588500|NCT02874248|Drospirenone|drospirenone|mesh-list
56588501|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56588502|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
56588503|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588504|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588505|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56588506|NCT02874248|Diuretics|diuretics|mesh-ancestor
56588507|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
56588508|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56588509|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588510|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
56588511|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
56588512|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
56588513|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588514|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588515|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
56588516|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588517|NCT02788305|Misoprostol|misoprostol|mesh-list
56588518|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56588519|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
56588550|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
56588551|NCT04302116|Vigabatrin|vigabatrin|mesh-list
56588552|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56588553|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
56588554|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588555|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
56588556|NCT04302116|Hormones|hormones|mesh-ancestor
56588557|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588558|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588559|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56588560|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588561|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
56588562|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
56588563|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588564|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56588565|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56588566|NCT04302116|Protective Agents|protective agents|mesh-ancestor
56588567|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
56588568|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588569|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588570|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
56588571|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588576|NCT02890212|Selenium|selenium|mesh-list
56588603|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588604|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588605|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56588606|NCT01372254|Nicotine|nicotine|mesh-list
56588607|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56588608|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
56588609|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588610|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588611|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56588612|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56588613|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
56588614|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588615|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588616|NCT02785653|Sevoflurane|sevoflurane|mesh-list
56588617|NCT02785653|Rocuronium|rocuronium|mesh-list
56588618|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56588619|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56588620|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
56588621|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
56588622|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588623|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588624|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56588625|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56588626|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56588627|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588628|NCT02787447|Gefitinib|gefitinib|mesh-list
56588629|NCT02787447|Thymalfasin|thymalfasin|mesh-list
56588630|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588631|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56588632|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588633|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588634|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56588643|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588644|NCT02909361|Fulvestrant|fulvestrant|mesh-list
56588645|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56588646|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588647|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56588648|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56588649|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
56588650|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588651|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588652|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
56588653|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56588654|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
56588655|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
56588656|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588657|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588658|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56588659|NCT04301024|Analgesics|analgesics|mesh-ancestor
56588660|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
56588661|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337204|NCT00215176|Modafinil|modafinil|mesh-list
56588662|NCT01340430|Trastuzumab|trastuzumab|mesh-list
56588663|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588664|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588665|NCT01029782|Cefazolin|cefazolin|mesh-list
56588666|NCT01029782|Cephalexin|cephalexin|mesh-list
56588667|NCT01029782|Probenecid|probenecid|mesh-list
56588694|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56588695|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56588696|NCT03936192|Analgesics|analgesics|mesh-ancestor
56588697|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
56588698|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588699|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588700|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588701|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588702|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56588703|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56588704|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588705|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588754|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
56588755|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588756|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588757|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
56588758|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
56588759|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56588760|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588761|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56588762|NCT00221988|Levetiracetam|levetiracetam|mesh-list
56588763|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
56588764|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
56588765|NCT02341911|Gemcitabine|gemcitabine|mesh-list
56588766|NCT02341911|Carboplatin|carboplatin|mesh-list
56588767|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588768|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56588769|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
56124093|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56102817|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102818|NCT00002281|Zidovudine|zidovudine|mesh-list
56102819|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
56102820|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
56102821|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102822|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102823|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102824|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102825|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
56102826|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102827|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102828|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102829|NCT00002281|Hematinics|hematinics|mesh-ancestor
56102830|NCT00002287|Zidovudine|zidovudine|mesh-list
56102831|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
56102832|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102833|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55871131|NCT00960778|Nicotine|nicotine|mesh-list
56102890|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102891|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102892|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102893|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102894|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56102895|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102896|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56102897|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
56102898|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56102899|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56102900|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
56102901|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
56102902|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56102903|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102904|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
56102905|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102906|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102907|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102908|NCT00002557|Antidotes|antidotes|mesh-ancestor
56102909|NCT00002557|Protective Agents|protective agents|mesh-ancestor
56102910|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
56102911|NCT00002557|Vitamins|vitamins|mesh-ancestor
56102912|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
56102913|NCT00003158|Paclitaxel|paclitaxel|mesh-list
56102914|NCT00003158|Etoposide|etoposide|mesh-list
56588770|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588771|NCT02341911|Antiviral Agents|antiviral agents|mesh-ancestor
56588772|NCT02341911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588773|NCT02341911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588774|NCT02341911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56588775|NCT02341911|Immunologic Factors|immunologic factors|mesh-ancestor
56588776|NCT02341911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588777|NCT02847000|Decitabine|decitabine|mesh-list
56588778|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
56588779|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56588780|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
56588781|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588782|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588783|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588784|NCT02784327|Ropivacaine|ropivacaine|mesh-list
56588785|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
56588786|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
56588787|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588788|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588789|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
56588791|NCT02845050|Cisplatin|cisplatin|mesh-list
56588825|NCT04202406|Acetaminophen|acetaminophen|mesh-list
56588826|NCT04202406|Codeine|codeine|mesh-list
56588827|NCT04202406|Caffeine|caffeine|mesh-list
56588828|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56588829|NCT04202406|Analgesics|analgesics|mesh-ancestor
56588830|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
56588831|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588832|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588833|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
56588834|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56588835|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56588836|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588837|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588838|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56588839|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56588840|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
56588841|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56588842|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56588843|NCT04202406|Narcotics|narcotics|mesh-ancestor
56588844|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588845|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
56588846|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
56588847|NCT02846766|Lenvatinib|lenvatinib|mesh-list
56588848|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588849|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56588874|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588875|NCT00867321|Bevacizumab|bevacizumab|mesh-list
56588876|NCT00867321|Sorafenib|sorafenib|mesh-list
56588877|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56588878|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588879|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56588880|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56588881|NCT00867321|Growth Substances|growth substances|mesh-ancestor
56588882|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588883|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
56588884|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56588885|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588886|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588888|NCT00913666|Interferon-beta|interferon-beta|mesh-list
56588889|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
56588890|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56588891|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
56588892|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588893|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
56588894|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588895|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56588896|NCT05756764|Liraglutide|liraglutide|mesh-list
56588897|NCT05756764|Topiramate|topiramate|mesh-list
56588898|NCT05756764|Phentermine|phentermine|mesh-list
56588899|NCT05756764|Glucagon|glucagon|mesh-list
56588900|NCT05756764|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56588903|NCT05756764|Incretins|incretins|mesh-ancestor
56588924|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56588925|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588926|NCT02601157|Aspirin|aspirin|mesh-list
56588927|NCT02601157|Clopidogrel|clopidogrel|mesh-list
56588928|NCT02601157|Ticagrelor|ticagrelor|mesh-list
56588929|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56588930|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56588931|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56588932|NCT02601157|Analgesics|analgesics|mesh-ancestor
56588933|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
56588934|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56588935|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588936|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56588937|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56588938|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56588939|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56588940|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588941|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56588958|NCT00902304|Amlodipine|amlodipine|mesh-list
56588979|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56588980|NCT02784795|Antiviral Agents|antiviral agents|mesh-ancestor
56588981|NCT02784795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56588982|NCT02784795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56588983|NCT02784795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56588984|NCT02784795|Immunologic Factors|immunologic factors|mesh-ancestor
56588985|NCT02784795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588986|NCT05282277|Raclopride|raclopride|mesh-list
56588987|NCT05282277|Estradiol|estradiol|mesh-list
56588988|NCT05282277|Progesterone|progesterone|mesh-list
56588989|NCT05282277|Estrogens|estrogens|mesh-ancestor
56588990|NCT05282277|Hormones|hormones|mesh-ancestor
56588991|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56588992|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56588993|NCT05282277|Progestins|progestins|mesh-ancestor
56588994|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56588995|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56588996|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56588997|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56588998|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56588999|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
56102915|NCT00003158|Carboplatin|carboplatin|mesh-list
56102916|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55871213|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
56102951|NCT05751187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102952|NCT05751187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56102953|NCT05751187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102954|NCT05751187|Hematinics|hematinics|mesh-ancestor
56102955|NCT05751187|Vitamin B Complex|vitamin b complex|mesh-ancestor
56102956|NCT00003416|Interferons|interferons|mesh-list
56102957|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
56102958|NCT00003416|Dexamethasone|dexamethasone|mesh-list
56102959|NCT00003416|Melphalan|melphalan|mesh-list
56102960|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56102994|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102995|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102996|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102997|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102998|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102999|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103016|NCT05720767|Hormone Antagonists|hormone antagonists|mesh-ancestor
56103017|NCT05720767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103018|NCT05720767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103019|NCT05720767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56103020|NCT05720767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56103021|NCT05720767|Antitubercular Agents|antitubercular agents|mesh-ancestor
56195649|NCT01500408|Interferon-beta|interferon-beta|mesh-list
56195650|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
56195651|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195652|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
56195653|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195654|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
56195655|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195656|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56123429|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
56195657|NCT01500473|Desogestrel|desogestrel|mesh-list
56589000|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589001|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589002|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56589003|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
56589004|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589005|NCT02848794|Irinotecan|irinotecan|mesh-list
56589006|NCT02848794|Apatinib|apatinib|mesh-list
56589007|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56589008|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56589009|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589010|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589011|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589012|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56589013|NCT04096027|Cabergoline|cabergoline|mesh-list
56589014|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56589015|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56589016|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
56589017|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
56589018|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589019|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589020|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589021|NCT04216134|Edetic Acid|edetic acid|mesh-list
56589022|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56589023|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
56589024|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
56589025|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589026|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
56589027|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56589048|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
56589049|NCT00759031|Protective Agents|protective agents|mesh-ancestor
56589050|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589051|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56589052|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589053|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56589054|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56589055|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
56589056|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589057|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56589058|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
56589059|NCT04197219|Axitinib|axitinib|mesh-list
56589060|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56589061|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589062|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56589063|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589064|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589065|NCT04834908|Immune Sera|immune sera|mesh-list
56589066|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
56589067|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589068|NCT02512497|Fludarabine|fludarabine|mesh-list
56589103|NCT02784015|Etoposide|etoposide|mesh-list
56589104|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589105|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
56589106|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589107|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589108|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56589109|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
56589110|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589111|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589112|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56589113|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56589114|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56589115|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56589116|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589117|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56589118|NCT02601235|Pyrilamine|pyrilamine|mesh-list
56589119|NCT02601235|Phenylephrine|phenylephrine|mesh-list
56589120|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
56589121|NCT02601235|Naphazoline|naphazoline|mesh-list
56589122|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589123|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56589124|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56589125|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
56589126|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589127|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589128|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
56589129|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
56589131|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
56589150|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56589151|NCT02846142|Estradiol|estradiol|mesh-list
56589152|NCT02846142|Estrogens|estrogens|mesh-ancestor
56589153|NCT02846142|Hormones|hormones|mesh-ancestor
56589154|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589155|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589156|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56589157|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
56589158|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56589159|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56589160|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56589161|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56589162|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56589163|NCT00757783|Ritonavir|ritonavir|mesh-list
56589164|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56589165|NCT00757783|Darunavir|darunavir|mesh-list
56589166|NCT00757783|Tenofovir|tenofovir|mesh-list
56589167|NCT00757783|Emtricitabine|emtricitabine|mesh-list
56589209|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
56589210|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
56589211|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589212|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56589213|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589214|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589215|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
56589216|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589217|NCT02845908|Antidotes|antidotes|mesh-ancestor
56589218|NCT02845908|Protective Agents|protective agents|mesh-ancestor
56589219|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
56589220|NCT02845908|Vitamins|vitamins|mesh-ancestor
56589221|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
56589222|NCT02784483|Atezolizumab|atezolizumab|mesh-list
56589223|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589224|NCT02784561|Cytarabine|cytarabine|mesh-list
56589225|NCT02784561|Fludarabine|fludarabine|mesh-list
56589226|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
56589227|NCT02784561|Busulfan|busulfan|mesh-list
56589228|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
56589229|NCT02784561|Lenograstim|lenograstim|mesh-list
56589230|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589231|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56589232|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
56589233|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589234|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589235|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
56589236|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589237|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
56124557|NCT01391130|Sunitinib|sunitinib|mesh-list
56195658|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56195660|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56195661|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
56195662|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56195663|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195664|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56195665|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56195666|NCT01500473|Progestins|progestins|mesh-ancestor
56195667|NCT01500473|Hormones|hormones|mesh-ancestor
56103022|NCT05720767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56103023|NCT05720767|Leprostatic Agents|leprostatic agents|mesh-ancestor
56103024|NCT05720767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56103025|NCT05720767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56103026|NCT05720767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56103027|NCT05720767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56103028|NCT05720767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56103029|NCT05720767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56589238|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589239|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
56589240|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56589241|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56589242|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56589243|NCT00757627|Etoricoxib|etoricoxib|mesh-list
56589244|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56589245|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589246|NCT00757627|Analgesics|analgesics|mesh-ancestor
56589247|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
56589248|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589249|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589250|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56589251|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589252|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56589253|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56589254|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589255|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589256|NCT02600455|Abatacept|abatacept|mesh-list
56589257|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56589258|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589259|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589260|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589261|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
56589263|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589286|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589287|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589288|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56589289|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589290|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56589291|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589292|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589293|NCT01022996|Everolimus|everolimus|mesh-list
56589294|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589295|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589296|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
56589297|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589298|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
56589299|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56589347|NCT00839332|Antiviral Agents|antiviral agents|mesh-ancestor
56589348|NCT00839332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589349|NCT00839332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589350|NCT00839332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589351|NCT00839332|Immunologic Factors|immunologic factors|mesh-ancestor
56589352|NCT00839332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589353|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
56589354|NCT04095169|Complement C3|complement c3|mesh-list
56589355|NCT04095169|Complement C3d|complement c3d|mesh-list
56589356|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
56589357|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589358|NCT05241912|Dobutamine|dobutamine|mesh-list
56589359|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56589360|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
56589361|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
56589362|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589363|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589364|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56589365|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56589366|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56589367|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
56589368|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589369|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589370|NCT05241912|Protective Agents|protective agents|mesh-ancestor
56589371|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
56589372|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56589373|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589374|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56589375|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589376|NCT04229355|Sorafenib|sorafenib|mesh-list
56589377|NCT04229355|Lenvatinib|lenvatinib|mesh-list
56589378|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
56589389|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56589390|NCT02848170|Olmesartan|olmesartan|mesh-list
56589391|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56589392|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56589393|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56589394|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56589395|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589396|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
56589397|NCT04420884|Fluorouracil|fluorouracil|mesh-list
56589398|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56589399|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589400|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
56589401|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589402|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56589403|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589404|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
56589405|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589406|NCT05341401|Prednisolone|prednisolone|mesh-list
56589407|NCT05341401|Budesonide|budesonide|mesh-list
56589408|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56589409|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
56589444|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589445|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56589446|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56589447|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56589448|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
56589449|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589450|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589451|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56589452|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56589453|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56589454|NCT04778904|Nivolumab|nivolumab|mesh-list
56589455|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56589456|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589457|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56589458|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589459|NCT02339922|Rituximab|rituximab|mesh-list
56589461|NCT02339922|Ixazomib|ixazomib|mesh-list
56589500|NCT00902538|Amlodipine|amlodipine|mesh-list
56589501|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56589502|NCT00902538|Olmesartan|olmesartan|mesh-list
56589503|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56589504|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56589505|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56589506|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56589507|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589508|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56589509|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589510|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
56589511|NCT00902538|Diuretics|diuretics|mesh-ancestor
56589512|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
56589513|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56589514|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56589515|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56589516|NCT04019964|Nivolumab|nivolumab|mesh-list
56589517|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56589518|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589555|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
56589556|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56589557|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
56589558|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589559|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589560|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56589561|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
56589562|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56589563|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56589564|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56589565|NCT04793568|Interferons|interferons|mesh-list
56589566|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
56589567|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589568|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
56589569|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589570|NCT01979211|Cetuximab|cetuximab|mesh-list
56589571|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56589572|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589573|NCT05339217|Aldesleukin|aldesleukin|mesh-list
56589574|NCT05339217|Interleukin-2|interleukin-2|mesh-list
56589575|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589576|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589577|NCT05339217|Analgesics|analgesics|mesh-ancestor
56589578|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
56589579|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589605|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56589606|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56589607|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56589608|NCT05319093|Ozanimod|ozanimod|mesh-list
56589609|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56589610|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589611|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56589612|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
56589613|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589614|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
56589615|NCT00752557|Vitamin D|vitamin d|mesh-list
56589616|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
56589617|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
56589618|NCT00752557|Diphosphonates|diphosphonates|mesh-list
56589619|NCT00752557|Vitamins|vitamins|mesh-list
56589620|NCT00752557|Calcium|calcium|mesh-list
56589621|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
56589622|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589623|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56589624|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56589625|NCT04570176|Epinephrine|epinephrine|mesh-list
56589626|NCT04570176|Racepinephrine|racepinephrine|mesh-list
56589627|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
56589628|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56589629|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56589630|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
56589631|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589653|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56589654|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
56589655|NCT02779569|Decitabine|decitabine|mesh-list
56589656|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56589657|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
56589658|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589659|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589660|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589661|NCT04095013|Fentanyl|fentanyl|mesh-list
56589662|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
56589663|NCT04095013|Bupivacaine|bupivacaine|mesh-list
56589664|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
56589665|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
56589666|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56589667|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589668|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
56589669|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589670|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56589711|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56589712|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589713|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589714|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
56589715|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56589716|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589717|NCT04301882|Interferons|interferons|mesh-list
56589718|NCT04301882|Ribavirin|ribavirin|mesh-list
56589719|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
56589720|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589721|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589723|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589724|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56589725|NCT03896880|Clotrimazole|clotrimazole|mesh-list
56589726|NCT03896880|Miconazole|miconazole|mesh-list
56589727|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
56589728|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589729|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56589730|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56589731|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56589732|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589733|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589734|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56589735|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
56589736|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589759|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589760|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589761|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56589762|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56589763|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
56589764|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
56589765|NCT02599675|Vitamin D|vitamin d|mesh-list
56589766|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
56589767|NCT02599675|Vitamins|vitamins|mesh-ancestor
56589768|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
56589769|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589770|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56589771|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56589772|NCT02778789|Adalimumab|adalimumab|mesh-list
56589773|NCT02778789|Etanercept|etanercept|mesh-list
56589774|NCT02778789|Golimumab|golimumab|mesh-list
56589775|NCT02778789|Infliximab|infliximab|mesh-list
56589776|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
56589777|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56589778|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589779|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
56589780|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56589781|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56589782|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589783|NCT02778789|Analgesics|analgesics|mesh-ancestor
56589809|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589855|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
56589856|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
56589857|NCT05293041|Coagulants|coagulants|mesh-ancestor
56589858|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56589859|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56589860|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
56589861|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589862|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
56589863|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
56589864|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103030|NCT05720767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56103031|NCT05751031|Raltegravir Potassium|raltegravir potassium|mesh-list
56103032|NCT05751031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56103033|NCT05751031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56103034|NCT05751031|Antiviral Agents|antiviral agents|mesh-ancestor
56103035|NCT05751031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103036|NCT05751031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56103037|NCT05751031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56103038|NCT05751031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103039|NCT05751031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589865|NCT02778945|Rocuronium|rocuronium|mesh-list
56589866|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56589867|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56589868|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56589869|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589870|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589871|NCT02721342|Ramipril|ramipril|mesh-list
56589872|NCT02721342|Irbesartan|irbesartan|mesh-list
56589873|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56589874|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
56589875|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589876|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589877|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56589878|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56589879|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56589880|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
56589881|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56589882|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589883|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
56589884|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
56589885|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
56589886|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589917|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589918|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56589919|NCT00092820|Ezetimibe|ezetimibe|mesh-list
56589920|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56589921|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56589922|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
56589923|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589924|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56589925|NCT04228263|Aspirin|aspirin|mesh-list
56589926|NCT04228263|Folic Acid|folic acid|mesh-list
56589927|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
56589928|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56589929|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589930|NCT04228263|Analgesics|analgesics|mesh-ancestor
56589931|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
56103040|NCT00002852|Paclitaxel|paclitaxel|mesh-list
56103041|NCT00002852|Carboplatin|carboplatin|mesh-list
56103042|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103043|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103044|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103045|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103046|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103047|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103048|NCT00003422|Leucovorin|leucovorin|mesh-list
56103049|NCT00003422|Fluorouracil|fluorouracil|mesh-list
56103050|NCT00003422|Calcium|calcium|mesh-list
56103051|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
56103052|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56103053|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103054|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
56103063|NCT00003422|Vitamins|vitamins|mesh-ancestor
56103064|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
56103065|NCT00003176|Temozolomide|temozolomide|mesh-list
56103066|NCT00003176|Carmustine|carmustine|mesh-list
56103067|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56195668|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195670|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103068|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
56103069|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103070|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103071|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
56103072|NCT00002858|Doxorubicin|doxorubicin|mesh-list
56103073|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103074|NCT00002858|Etoposide|etoposide|mesh-list
56103075|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103076|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
56103077|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103078|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103079|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103080|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
56103081|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103082|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103083|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103084|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103085|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103086|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103088|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103089|NCT00002864|Tamoxifen|tamoxifen|mesh-list
56103090|NCT00002864|Octreotide|octreotide|mesh-list
56103091|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56103092|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
56589932|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589933|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589934|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56589935|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589936|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56589937|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56589938|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589939|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56589940|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56589941|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589942|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
56589943|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
56589944|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56589945|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56589946|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589947|NCT04228263|Hematinics|hematinics|mesh-ancestor
56589948|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
56589949|NCT04228263|Vitamins|vitamins|mesh-ancestor
56589950|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
56589951|NCT00092742|Diclofenac|diclofenac|mesh-list
56589952|NCT00092742|Etoricoxib|etoricoxib|mesh-list
56589953|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56589954|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56589955|NCT00092742|Analgesics|analgesics|mesh-ancestor
56589956|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
56589957|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56589958|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589959|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56589960|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56589961|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56589962|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56589963|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589975|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56589976|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56589977|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589978|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56589979|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56589980|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
56589981|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56589982|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56589983|NCT02598427|Trastuzumab|trastuzumab|mesh-list
56589984|NCT02598427|Pertuzumab|pertuzumab|mesh-list
56589985|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56589986|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56589987|NCT05128071|Progesterone|progesterone|mesh-list
56589988|NCT05128071|Progestins|progestins|mesh-ancestor
55902968|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55902969|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55902970|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55902971|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55902974|NCT02397486|Vitamin E|vitamin e|mesh-list
56103093|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103094|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103095|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103096|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103097|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56103098|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56103099|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56103100|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56103101|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
56103102|NCT00002870|Thiotepa|thiotepa|mesh-list
56103103|NCT00002870|Fluorouracil|fluorouracil|mesh-list
56103104|NCT00002870|Epirubicin|epirubicin|mesh-list
56103105|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103106|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
56103107|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103108|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103109|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103110|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
56103130|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103131|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103132|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103133|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
56103134|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103135|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56103136|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
56103137|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56103138|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
56103139|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103140|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56103141|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56103142|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56103143|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
56103144|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103145|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103146|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56589989|NCT05128071|Hormones|hormones|mesh-ancestor
56589990|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56589991|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56589992|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56589993|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56589994|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56589995|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
56589996|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56589997|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56589998|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56103147|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56103148|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56103149|NCT00003182|Gemcitabine|gemcitabine|mesh-list
56103150|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103151|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103152|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
56195671|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56195672|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195673|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195675|NCT01500577|Simvastatin|simvastatin|mesh-list
56195676|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56195677|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56195678|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
56195679|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195680|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56195681|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56195682|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195683|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56103153|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103154|NCT00003182|Antiviral Agents|antiviral agents|mesh-ancestor
56103155|NCT00003182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103156|NCT00003182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103157|NCT00003182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103158|NCT00003182|Immunologic Factors|immunologic factors|mesh-ancestor
56103159|NCT00003182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103160|NCT00002587|Paclitaxel|paclitaxel|mesh-list
56103161|NCT00002587|Topotecan|topotecan|mesh-list
56103163|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103200|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103201|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103202|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
56103226|NCT00002882|Interleukin-2|interleukin-2|mesh-list
56103227|NCT00002882|Dacarbazine|dacarbazine|mesh-list
56103228|NCT00002882|Vinblastine|vinblastine|mesh-list
56103229|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103230|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
56103231|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103232|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
56103233|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103234|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56103235|NCT00002882|Analgesics|analgesics|mesh-ancestor
56103236|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
56103237|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103238|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56103239|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56103240|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103241|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
56103242|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103243|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103244|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103245|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103246|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103247|NCT00002888|Paclitaxel|paclitaxel|mesh-list
56589999|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590000|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
56590001|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
56590002|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
56590003|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590004|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
56590005|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56590006|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590007|NCT01028222|Dacarbazine|dacarbazine|mesh-list
56590008|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56590009|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
56590010|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590011|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590012|NCT04833855|Omalizumab|omalizumab|mesh-list
56590013|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56103248|NCT00002888|Fluorouracil|fluorouracil|mesh-list
56103249|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103250|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103251|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103252|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103253|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103254|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103255|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
56103282|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103284|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103285|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195684|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56195685|NCT01500577|Analgesics|analgesics|mesh-ancestor
56195686|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
56195687|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195688|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195689|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195690|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56195691|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56195692|NCT01500590|Ramipril|ramipril|mesh-list
56195693|NCT01500590|Irbesartan|irbesartan|mesh-list
56195694|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56195695|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
56195696|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195697|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195698|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56195699|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56195700|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56195701|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
56103286|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
56103287|NCT00002599|Hormones|hormones|mesh-ancestor
56103288|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103289|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103291|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103292|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103293|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103294|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103295|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103296|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
56103297|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
56103298|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103299|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56103300|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56590014|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56590015|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56590016|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
56590017|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
56590018|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590019|NCT00586495|Sorafenib|sorafenib|mesh-list
56590020|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590021|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56590022|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903007|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56103301|NCT00002599|Protective Agents|protective agents|mesh-ancestor
56103302|NCT00002599|Trace Elements|trace elements|mesh-ancestor
56103303|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
56103304|NCT00003440|Paclitaxel|paclitaxel|mesh-list
56103305|NCT00003440|Trastuzumab|trastuzumab|mesh-list
56103435|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103436|NCT00003230|Paclitaxel|paclitaxel|mesh-list
56103464|NCT00003962|Aldesleukin|aldesleukin|mesh-list
56103465|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103466|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56103467|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56103468|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
56103469|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103470|NCT00003236|ISIS 5132|isis 5132|mesh-list
56103471|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103472|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103473|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195702|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
56195703|NCT01500785|Simendan|simendan|mesh-list
56103474|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
56103475|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56103476|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
56103477|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103478|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103482|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
56103483|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103484|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
56103485|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103486|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103487|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103488|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
56103522|NCT05664061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56103523|NCT05664061|Autonomic Agents|autonomic agents|mesh-ancestor
56103524|NCT05664061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103525|NCT05664061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103526|NCT05664061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56103527|NCT05664061|Respiratory System Agents|respiratory system agents|mesh-ancestor
56103528|NCT05664061|Dermatologic Agents|dermatologic agents|mesh-ancestor
56103529|NCT05664061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56103530|NCT05664061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56103531|NCT05664061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56103587|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103588|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103589|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56103590|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56103591|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
56103592|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103593|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103594|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56103595|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56103596|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56103598|NCT00003518|Paclitaxel|paclitaxel|mesh-list
56103599|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103600|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103601|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103602|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
56590023|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590025|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590026|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
56590027|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
56590028|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
56590029|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590030|NCT01027754|Varenicline|varenicline|mesh-list
56590031|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56590032|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56590033|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
56590034|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590035|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590036|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590037|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
56590038|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56590039|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590040|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590041|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56590042|NCT02773017|Analgesics|analgesics|mesh-ancestor
56590043|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
56590044|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590045|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56590046|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56590047|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56590048|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
56590070|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590071|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56590072|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56590073|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590074|NCT02772237|Riboflavin|riboflavin|mesh-list
56590075|NCT02772237|Vitamins|vitamins|mesh-ancestor
56590076|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
56590077|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590078|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
56590079|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56590080|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
56590081|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56590082|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56590083|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590084|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
56590085|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590086|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56590087|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590088|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590089|NCT02771925|Gabapentin|gabapentin|mesh-list
56590090|NCT02771925|Analgesics|analgesics|mesh-ancestor
56590091|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
56590092|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590093|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590094|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
56590095|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56590096|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56590097|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590098|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590116|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56590117|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590118|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56590119|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590120|NCT02771457|Infliximab|infliximab|mesh-list
56590121|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
56590122|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590123|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56590124|NCT02771379|Idebenone|idebenone|mesh-list
56590125|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
56590126|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590127|NCT02771379|Protective Agents|protective agents|mesh-ancestor
56590128|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590129|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
55903124|NCT00367276|Drospirenone|drospirenone|mesh-list
56103603|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103604|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103605|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103606|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
56103607|NCT00003518|Antiviral Agents|antiviral agents|mesh-ancestor
56103608|NCT00003518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103609|NCT00003518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103610|NCT00003518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103611|NCT00003518|Immunologic Factors|immunologic factors|mesh-ancestor
56103618|NCT00002653|Melphalan|melphalan|mesh-list
56103619|NCT00002653|Carmustine|carmustine|mesh-list
56103620|NCT00002653|Doxorubicin|doxorubicin|mesh-list
56103621|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103622|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103623|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
56103624|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103679|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103680|NCT00003260|Antidotes|antidotes|mesh-ancestor
56103681|NCT00003260|Protective Agents|protective agents|mesh-ancestor
56103682|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
56103683|NCT00003260|Vitamins|vitamins|mesh-ancestor
56103684|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
56103685|NCT00002665|Leucovorin|leucovorin|mesh-list
56103686|NCT00002665|Cytarabine|cytarabine|mesh-list
56103687|NCT00002665|Dexamethasone|dexamethasone|mesh-list
56103688|NCT00002665|Prednisone|prednisone|mesh-list
56103689|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
56103690|NCT00002665|Doxorubicin|doxorubicin|mesh-list
56103691|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103692|NCT00002665|Methotrexate|methotrexate|mesh-list
56195704|NCT01500785|Vitamins|vitamins|mesh-ancestor
56195705|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
56195706|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195707|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
56195708|NCT01500785|Hematinics|hematinics|mesh-ancestor
56195709|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56195710|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
56195711|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56195712|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56195713|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195714|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195715|NCT01500785|Protective Agents|protective agents|mesh-ancestor
56195716|NCT01500824|Crizotinib|crizotinib|mesh-list
56103693|NCT00002665|Etoposide|etoposide|mesh-list
56103694|NCT00002665|Vincristine|vincristine|mesh-list
56103719|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103720|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103721|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103722|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56590130|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590131|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
56590132|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56590133|NCT02844114|Gemcitabine|gemcitabine|mesh-list
56590134|NCT02844114|Cisplatin|cisplatin|mesh-list
56590135|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590136|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56590137|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
56590138|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590139|NCT02844114|Antiviral Agents|antiviral agents|mesh-ancestor
56590140|NCT02844114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590141|NCT02844114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590142|NCT02844114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56590143|NCT02844114|Immunologic Factors|immunologic factors|mesh-ancestor
56590144|NCT02844114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590145|NCT02696733|Cephalosporins|cephalosporins|mesh-list
56590146|NCT02696733|Lidocaine|lidocaine|mesh-list
56590147|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
56590148|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
55903134|NCT02546986|Cc-486|cc-486|mesh-list
56103723|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
56103724|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56103725|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103726|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
56103727|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
56103728|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56103729|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56103730|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103731|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
56103732|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103733|NCT00002665|Antidotes|antidotes|mesh-ancestor
56103734|NCT00002665|Protective Agents|protective agents|mesh-ancestor
56103735|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
56103736|NCT00002665|Vitamins|vitamins|mesh-ancestor
56103737|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
56103738|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103739|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103740|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103741|NCT00003536|Methotrexate|methotrexate|mesh-list
56103742|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56103743|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
56103744|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56103745|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103778|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103780|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
56103781|NCT00004010|Dacarbazine|dacarbazine|mesh-list
56103782|NCT00004010|Doxorubicin|doxorubicin|mesh-list
56103783|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103784|NCT00004010|Etoposide|etoposide|mesh-list
56103785|NCT00004010|Vincristine|vincristine|mesh-list
56103786|NCT00004010|Bleomycin|bleomycin|mesh-list
56103788|NCT00004010|Procarbazine|procarbazine|mesh-list
56103789|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103809|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103810|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103811|NCT00004016|Interferons|interferons|mesh-list
56103812|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
56103813|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103814|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
56103815|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103816|NCT00004022|Aldesleukin|aldesleukin|mesh-list
56590149|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590150|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590151|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
56590152|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590153|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56590154|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56590155|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56590156|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56590157|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590158|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56590159|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590160|NCT05335122|Bimatoprost|bimatoprost|mesh-list
56590161|NCT05335122|Travoprost|travoprost|mesh-list
56590162|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56590163|NCT00897390|Metformin|metformin|mesh-list
56590164|NCT00897390|Saxagliptin|saxagliptin|mesh-list
56590165|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56590166|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590167|NCT00897390|Incretins|incretins|mesh-ancestor
56590168|NCT00897390|Hormones|hormones|mesh-ancestor
56590169|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590170|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56590171|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
56590172|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590173|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590174|NCT01034462|Milnacipran|milnacipran|mesh-list
56590175|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
56590177|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56590193|NCT02774811|Bimatoprost|bimatoprost|mesh-list
56590194|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56590195|NCT00817050|Fluticasone|fluticasone|mesh-list
56590196|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
56590197|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590198|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56590199|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
56590200|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590201|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590202|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56590203|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56590204|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
56590205|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56590206|NCT04224831|Mitogens|mitogens|mesh-list
56590207|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
56590208|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590209|NCT00816972|Loratadine|loratadine|mesh-list
56590210|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
56590211|NCT00816972|Oxybutynin|oxybutynin|mesh-list
56590212|NCT00816972|Desloratadine|desloratadine|mesh-list
56590213|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
56590214|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
56590215|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590216|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103817|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
56103818|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103819|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56103820|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56195717|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195718|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56195719|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195720|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195721|NCT01500837|Levofloxacin|levofloxacin|mesh-list
56195723|NCT01500837|Rifampin|rifampin|mesh-list
56195724|NCT01500837|Clindamycin|clindamycin|mesh-list
56103821|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
56103823|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
56103824|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103825|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103826|NCT00381901|Trastuzumab|trastuzumab|mesh-list
56103827|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56103828|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103829|NCT00003278|Dexamethasone|dexamethasone|mesh-list
56103830|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56103831|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
56103832|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
56103833|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103834|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103835|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56103836|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
56103837|NCT00003278|Hormones|hormones|mesh-ancestor
56103838|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103839|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103840|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103841|NCT00004028|Carmustine|carmustine|mesh-list
56590217|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56590218|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56590219|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
56590220|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590221|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590222|NCT00816972|Urological Agents|urological agents|mesh-ancestor
56590223|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56590224|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590226|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56590227|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56590228|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
56590229|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
56590230|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
56590231|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
56103842|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103843|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
56103912|NCT00003290|Hormones|hormones|mesh-list
56103913|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103933|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103934|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103936|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56103937|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
56103938|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56103939|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103940|NCT05627479|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56103941|NCT00002689|Dexamethasone|dexamethasone|mesh-list
56103942|NCT00002689|Fluorouracil|fluorouracil|mesh-list
56103943|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56103944|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
56103945|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
56103946|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103947|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103948|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56103949|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
56103950|NCT00002689|Hormones|hormones|mesh-ancestor
56103951|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103952|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103953|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103954|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
55831002|NCT01483690|Decitabine|decitabine|mesh-list
56103955|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103956|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103957|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103959|NCT00003296|Doxorubicin|doxorubicin|mesh-list
56103960|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103961|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103962|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103963|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103964|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103965|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195725|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
56195726|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
56195727|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56195728|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195729|NCT01500837|Renal Agents|renal agents|mesh-ancestor
56195730|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56195731|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56195732|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56195733|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590232|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56590233|NCT02774499|Methadone|methadone|mesh-list
56590234|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56590235|NCT02774499|Narcotics|narcotics|mesh-ancestor
56590236|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590237|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590238|NCT02774499|Analgesics|analgesics|mesh-ancestor
56590239|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
56590240|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590241|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
56590242|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
56590243|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56590244|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56590245|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
56590246|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56338769|NCT00399399|Azathioprine|azathioprine|mesh-list
56590247|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590248|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590249|NCT02774187|Leucovorin|leucovorin|mesh-list
56590250|NCT02774187|Fluorouracil|fluorouracil|mesh-list
56590251|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
56590252|NCT02774187|Sorafenib|sorafenib|mesh-list
56590253|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
56590254|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590255|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56590256|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590257|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56590280|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590281|NCT02773875|Pancrelipase|pancrelipase|mesh-list
56590282|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590283|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
56590284|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56590285|NCT02768961|Ledipasvir|ledipasvir|mesh-list
56590286|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
56590287|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590288|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
56590289|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56195734|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195735|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195736|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56195737|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56195738|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56195739|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
56195740|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
56195741|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56103991|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103992|NCT00003578|Etoposide|etoposide|mesh-list
56103993|NCT00003578|Vincristine|vincristine|mesh-list
56103994|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103995|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
56103996|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103997|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103998|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103999|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
56104000|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104001|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104002|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104003|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104004|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104005|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104006|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104007|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56104008|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
56104009|NCT00003578|Hormones|hormones|mesh-ancestor
56104010|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104011|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104012|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104013|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104014|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
56104015|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
56104016|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104017|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104051|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104053|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104054|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104055|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104056|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56104057|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
56104058|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56104059|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104060|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
56104081|NCT00004070|Growth Substances|growth substances|mesh-ancestor
56104082|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
56195742|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56195743|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56195744|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56195745|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56195746|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56195747|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56590290|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56590291|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56590292|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480257|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
56590293|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590294|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
56590295|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590296|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590297|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56590298|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590299|NCT02768805|Vaccines|vaccines|mesh-list
56590300|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
56590301|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590302|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56590303|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
56590304|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56590305|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
56590306|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590307|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
56590308|NCT02773251|Protective Agents|protective agents|mesh-ancestor
56590309|NCT02773251|Laxatives|laxatives|mesh-ancestor
56590310|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590311|NCT02768649|Risperidone|risperidone|mesh-list
56590312|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56590340|NCT04224675|Captopril|captopril|mesh-list
56590341|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56590342|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56590343|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
56590344|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
56590345|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590346|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590347|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56590348|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56590349|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56590350|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
56590351|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590352|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590353|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56590354|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
56590355|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590356|NCT02768493|Ropivacaine|ropivacaine|mesh-list
56590357|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
56590358|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
56590359|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590360|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590361|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
56590362|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590363|NCT02768415|Apatinib|apatinib|mesh-list
56590364|NCT02768415|Vinorelbine|vinorelbine|mesh-list
56590365|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590366|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56590367|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590368|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590369|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56590370|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
56590371|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
56590372|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
56590373|NCT02773095|Lactitol|lactitol|mesh-list
56195748|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56195749|NCT01500850|Insulin|insulin|mesh-list
56195750|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56195751|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
56195752|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
56195753|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
56590374|NCT02773095|Cathartics|cathartics|mesh-ancestor
56590375|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590376|NCT02768337|Afatinib|afatinib|mesh-list
56590377|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590378|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56590379|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590380|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590381|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
56590382|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56590383|NCT02768571|Protective Agents|protective agents|mesh-ancestor
56590384|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590385|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
56590386|NCT02767713|Dexamethasone|dexamethasone|mesh-list
56590387|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590388|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
56590389|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
56590390|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590391|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590392|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590393|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
56590394|NCT02767713|Hormones|hormones|mesh-ancestor
56590395|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590428|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56590429|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56590430|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56590431|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56590432|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
56590433|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590434|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56590435|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56590436|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
56590437|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
56590492|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590493|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590494|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56590495|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590496|NCT02766855|Cysteamine|cysteamine|mesh-list
56590497|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56590498|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590499|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56590500|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56590501|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
56590502|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590503|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590504|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56590505|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56590506|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56590507|NCT04224051|Metformin|metformin|mesh-list
56590508|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56590509|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590510|NCT02762253|Riboflavin|riboflavin|mesh-list
56590511|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
56590512|NCT02762253|Vitamins|vitamins|mesh-ancestor
56590513|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
56590514|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590516|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
56590517|NCT00746941|Mefloquine|mefloquine|mesh-list
56590518|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
56590539|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56590540|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56590541|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56590542|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
56590543|NCT04091971|Ketamine|ketamine|mesh-list
56590544|NCT04091971|Analgesics|analgesics|mesh-ancestor
56590545|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
56590546|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590547|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590548|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56590549|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56590550|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
56195754|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
56195755|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
56104083|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104091|NCT00004082|Antiviral Agents|antiviral agents|mesh-ancestor
56104092|NCT00004082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104093|NCT00004082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104094|NCT00004082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104095|NCT00004082|Immunologic Factors|immunologic factors|mesh-ancestor
56104096|NCT00004082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104097|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104098|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104099|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104100|NCT00002707|Tamoxifen|tamoxifen|mesh-list
56104101|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
56104102|NCT00002707|Docetaxel|docetaxel|mesh-list
56104103|NCT00002707|Doxorubicin|doxorubicin|mesh-list
56104104|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104105|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
56104106|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104107|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104108|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104109|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
56104110|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104111|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104112|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104113|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104114|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104115|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104179|NCT00003602|Etoposide|etoposide|mesh-list
56104180|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
56104181|NCT00003602|Idarubicin|idarubicin|mesh-list
56104182|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104183|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104184|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104185|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104186|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104187|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104188|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104189|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
56104190|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
56104191|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104192|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104193|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
56195756|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195757|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195758|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56195759|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56195760|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56195761|NCT01500863|Estradiol|estradiol|mesh-list
56195762|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56195763|NCT01500863|Progesterone|progesterone|mesh-list
56195764|NCT01500863|Estrogens|estrogens|mesh-ancestor
56195765|NCT01500863|Hormones|hormones|mesh-ancestor
56195766|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590551|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
56590552|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590553|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56590554|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56590555|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590556|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590557|NCT04091815|Anesthetics|anesthetics|mesh-list
56590558|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590559|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590560|NCT00746785|Olanzapine|olanzapine|mesh-list
56590561|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
56590562|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
56590563|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590564|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590565|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590566|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56590567|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56590568|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590569|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590570|NCT00746785|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56590571|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56590603|NCT04223973|Insulin|insulin|mesh-list
56590604|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56590605|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590606|NCT00750919|Mirtazapine|mirtazapine|mesh-list
56590607|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
56590608|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590609|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56590610|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
56590611|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
56590612|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590613|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590614|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590615|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56590616|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56590617|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590618|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56590619|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56590620|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56590621|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
56590622|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56590623|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56590624|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
56590625|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56590626|NCT02761161|Mianserin|mianserin|mesh-list
56590627|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56590628|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56590629|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
56590650|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56590651|NCT00746551|Hematinics|hematinics|mesh-ancestor
56590652|NCT04091503|Temozolomide|temozolomide|mesh-list
56590653|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56590654|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
56590655|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590656|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590657|NCT02696577|Aspirin|aspirin|mesh-list
56590658|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56590659|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56590660|NCT02696577|Analgesics|analgesics|mesh-ancestor
56590661|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
55903653|NCT00121251|Sorafenib|sorafenib|mesh-list
56195767|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195768|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56195769|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
56195770|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56104194|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104195|NCT00003602|Analgesics|analgesics|mesh-ancestor
56104197|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104198|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104199|NCT04609423|Vitamin D|vitamin d|mesh-list
56104200|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
56104201|NCT04609423|Vitamins|vitamins|mesh-ancestor
56104202|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
56104203|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104206|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104207|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104208|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
56104209|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104210|NCT00003332|Antiviral Agents|antiviral agents|mesh-ancestor
56104211|NCT00003332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104212|NCT00003332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104213|NCT00003332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104214|NCT00003332|Immunologic Factors|immunologic factors|mesh-ancestor
56104263|NCT00002737|Isotretinoin|isotretinoin|mesh-list
56104264|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104265|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
56104266|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104302|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104304|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104305|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104306|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
56104307|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104308|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56104309|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104310|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
56195771|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56195772|NCT01500863|Progestins|progestins|mesh-ancestor
56195773|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
56104311|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104312|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104313|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104314|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104315|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104316|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
56104317|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104318|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104319|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
56104320|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104321|NCT00004112|Prednisone|prednisone|mesh-list
56104322|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
56104323|NCT00004112|Rituximab|rituximab|mesh-list
56590662|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590663|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590664|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590665|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56590666|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56590667|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56590668|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590669|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56590670|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56590671|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590672|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
56590673|NCT04688931|Mitomycins|mitomycins|mesh-list
56590674|NCT04688931|Mitomycin|mitomycin|mesh-list
56590675|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56590676|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590677|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
56590678|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590679|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56590680|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590681|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
56590682|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
56590683|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590684|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590685|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590710|NCT02765373|Anastrozole|anastrozole|mesh-list
56590711|NCT02765373|Exemestane|exemestane|mesh-list
56590712|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590713|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56590714|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56590715|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590716|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590717|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56590718|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
56590719|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590720|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590721|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56590722|NCT02760615|Losartan|losartan|mesh-list
56590723|NCT02760615|Midazolam|midazolam|mesh-list
56590724|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
56590725|NCT02760615|Caffeine|caffeine|mesh-list
56590726|NCT02760615|Omeprazole|omeprazole|mesh-list
56590727|NCT02760615|Vedolizumab|vedolizumab|mesh-list
56590728|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56590729|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56590730|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590731|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590732|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56590733|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56590734|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56590735|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56590736|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
56590737|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
56590738|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
56590757|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56590758|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56590759|NCT02760459|Dexamethasone|dexamethasone|mesh-list
56590760|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590761|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
56590762|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
56590763|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590764|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590765|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590766|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
56590767|NCT02760459|Hormones|hormones|mesh-ancestor
56590768|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590769|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56590770|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590771|NCT02765217|Amoxicillin|amoxicillin|mesh-list
56590772|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
56590774|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56590775|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56590776|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590777|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590778|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590779|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56590780|NCT02760381|Acetic Acid|acetic acid|mesh-list
56590781|NCT02760381|Retinol acetate|retinol acetate|mesh-list
56590806|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590807|NCT00745849|Esomeprazole|esomeprazole|mesh-list
56590809|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590810|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56590811|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590812|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590813|NCT02759991|Vaccines|vaccines|mesh-list
56590814|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
56590815|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590816|NCT04112277|Morphine|morphine|mesh-list
56590817|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56590818|NCT04112277|Narcotics|narcotics|mesh-ancestor
56590819|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590820|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590821|NCT04112277|Analgesics|analgesics|mesh-ancestor
56590822|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
56590823|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590824|NCT00749203|Midazolam|midazolam|mesh-list
56590825|NCT00749203|Ketamine|ketamine|mesh-list
56590826|NCT00749203|Analgesics|analgesics|mesh-ancestor
56590827|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
56590828|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590829|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590830|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56590831|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56590832|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
56590833|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
56590834|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56590853|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590854|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590855|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
56590856|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590857|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56590858|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56590859|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
56590860|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56590861|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56590862|NCT02764749|Phenol|phenol|mesh-list
56590863|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56590864|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590865|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
56590866|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56590867|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56104324|NCT00004112|Doxorubicin|doxorubicin|mesh-list
56104325|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56104326|NCT00004112|Vincristine|vincristine|mesh-list
56104327|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104328|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
56104329|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104330|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104331|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104332|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
56104356|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104357|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104358|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104359|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104360|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104361|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104362|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104363|NCT05586373|Dipyrone|dipyrone|mesh-list
56104364|NCT05586373|Ibuprofen|ibuprofen|mesh-list
56104365|NCT05586373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56104366|NCT05586373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56104367|NCT05586373|Analgesics|analgesics|mesh-ancestor
56104368|NCT05586373|Sensory System Agents|sensory system agents|mesh-ancestor
56104369|NCT05586373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104370|NCT05586373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104371|NCT05586373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56104372|NCT05586373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104373|NCT05586373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56104374|NCT05586373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104375|NCT05586373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104376|NCT05586373|Antipyretics|antipyretics|mesh-ancestor
56104377|NCT00003356|Aldesleukin|aldesleukin|mesh-list
56104378|NCT00003356|Rituximab|rituximab|mesh-list
56104379|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56104380|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104381|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
56104414|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104415|NCT00003362|Sargramostim|sargramostim|mesh-list
56104416|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
56104417|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
56104418|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104419|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56104420|NCT00003650|Cytarabine|cytarabine|mesh-list
56104421|NCT00003650|Dexamethasone|dexamethasone|mesh-list
56104422|NCT00003650|Prednisone|prednisone|mesh-list
56104423|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
56104424|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
56104447|NCT00003650|Hormones|hormones|mesh-ancestor
56590868|NCT02764359|Vancomycin|vancomycin|mesh-list
56590869|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56590870|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590871|NCT02764125|Levodopa|levodopa|mesh-list
56590872|NCT02764125|Carbidopa|carbidopa|mesh-list
56590873|NCT02764125|Entacapone|entacapone|mesh-list
56590874|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56590875|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56590876|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
56590877|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590878|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590879|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590880|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56590881|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56590882|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56590883|NCT02764281|Dexamethasone|dexamethasone|mesh-list
56590884|NCT02764281|Methotrexate|methotrexate|mesh-list
56590885|NCT02764281|Etoposide|etoposide|mesh-list
56590886|NCT02764281|Pegaspargase|pegaspargase|mesh-list
56590887|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590888|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
56590889|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
56590890|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56590891|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590892|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590893|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
56590894|NCT02764281|Hormones|hormones|mesh-ancestor
56590895|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56590896|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56590897|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590913|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56590914|NCT02763969|Interferons|interferons|mesh-list
56590915|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
56590916|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
56590917|NCT02763969|Ustekinumab|ustekinumab|mesh-list
56590918|NCT02763969|Famotidine|famotidine|mesh-list
56590919|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339441|NCT00044798|Citalopram|citalopram|mesh-list
56590920|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
56590921|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590922|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
56590923|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590924|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
56590925|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56590926|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56590927|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56590928|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
56590930|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56590931|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590932|NCT04660929|Pembrolizumab|pembrolizumab|mesh-list
56590933|NCT04660929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56590934|NCT04660929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590935|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
56590936|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56590937|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56590938|NCT02758509|Interferons|interferons|mesh-list
56590939|NCT02758509|Ritonavir|ritonavir|mesh-list
56590940|NCT02758509|Ribavirin|ribavirin|mesh-list
56590941|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
56590942|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
56590943|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
56590962|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56590963|NCT02762955|Adalimumab|adalimumab|mesh-list
56590964|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56590965|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56590966|NCT04191681|Valsartan|valsartan|mesh-list
56590967|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56590968|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56590969|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56590970|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56590971|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56590972|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56590973|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56590974|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56590975|NCT02752503|Nalmefene|nalmefene|mesh-list
56590976|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56590977|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591019|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591020|NCT02756715|Propofol|propofol|mesh-list
56591021|NCT02756715|Desflurane|desflurane|mesh-list
56591022|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56591023|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591024|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591025|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56591026|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
56591027|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
56591028|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56591029|NCT04221321|Atorvastatin|atorvastatin|mesh-list
56591030|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56591031|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56591032|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
56591033|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591034|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56591036|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591077|NCT02695797|Hormones|hormones|mesh-ancestor
56591078|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591079|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591080|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56591081|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591082|NCT02755311|Cisplatin|cisplatin|mesh-list
56591083|NCT02755311|Carboplatin|carboplatin|mesh-list
56591084|NCT02755311|Fluorouracil|fluorouracil|mesh-list
56591085|NCT02755311|Epirubicin|epirubicin|mesh-list
56591086|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
56591087|NCT02755311|Pirarubicin|pirarubicin|mesh-list
56591088|NCT02755311|Doxorubicin|doxorubicin|mesh-list
56591089|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56591090|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591091|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
56591092|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591093|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56591094|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104448|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104449|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104450|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56104451|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
56104452|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56104453|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104454|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
56195774|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56195775|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195776|NCT01500915|Ranibizumab|ranibizumab|mesh-list
56195777|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56195778|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56195779|NCT01500915|Growth Substances|growth substances|mesh-ancestor
56195780|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195781|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
56195782|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195783|NCT01500928|Insulin|insulin|mesh-list
56195784|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195785|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195786|NCT01500980|Chloroquine|chloroquine|mesh-list
56195787|NCT01500980|Primaquine|primaquine|mesh-list
56195788|NCT01500980|Amebicides|amebicides|mesh-ancestor
56195789|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56195790|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56195791|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195792|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
56195793|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56195794|NCT01500993|Fluorouracil|fluorouracil|mesh-list
56195795|NCT01500993|Capecitabine|capecitabine|mesh-list
56195796|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
56195797|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195798|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56195799|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195800|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195801|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
56195802|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195803|NCT01501032|Pancrelipase|pancrelipase|mesh-list
56195804|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56195805|NCT01501084|Exenatide|exenatide|mesh-list
56123569|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56591095|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
56591096|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591097|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56591098|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56591099|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56591100|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591101|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
56591102|NCT02755311|Coagulants|coagulants|mesh-ancestor
56591103|NCT04554771|Paclitaxel|paclitaxel|mesh-list
56591104|NCT04554771|Carboplatin|carboplatin|mesh-list
56591105|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56591106|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591107|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
56591108|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
56591109|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
56591110|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591111|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
56591112|NCT02754765|Levofloxacin|levofloxacin|mesh-list
56591113|NCT02754765|Ofloxacin|ofloxacin|mesh-list
56591114|NCT02754765|Linezolid|linezolid|mesh-list
56591115|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
56591116|NCT02754765|Bedaquiline|bedaquiline|mesh-list
56591117|NCT02754765|Clofazimine|clofazimine|mesh-list
56591118|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56591119|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591120|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56339661|NCT00045227|Docetaxel|docetaxel|mesh-list
56591147|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591148|NCT00917059|Citalopram|citalopram|mesh-list
56591149|NCT00917059|Bupropion|bupropion|mesh-list
56591150|NCT00917059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56591151|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56591152|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56591153|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591154|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591155|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
56591156|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591157|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56591158|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
56591159|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56591160|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56591161|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
56591162|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56591163|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56591164|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591165|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
56591166|NCT02754687|Nandrolone|nandrolone|mesh-list
56591167|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
56591168|NCT02754687|Androgens|androgens|mesh-ancestor
56591170|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591171|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591172|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
56591173|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56591174|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56591175|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56591176|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591177|NCT05429775|Budesonide|budesonide|mesh-list
56591178|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591179|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56591180|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
56591183|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56591184|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
56591185|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
56591186|NCT05429775|Hormones|hormones|mesh-ancestor
56591187|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591188|NCT04220073|Antibodies|antibodies|mesh-list
56591189|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56591190|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
56591191|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591192|NCT05429151|Acyclovir|acyclovir|mesh-list
56591193|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
56591194|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591195|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
56591196|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56591197|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56591198|NCT04219995|Prednisolone|prednisolone|mesh-list
56591199|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
56591200|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56591201|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
56591202|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591203|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
56591204|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
56591205|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591206|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591209|NCT04219995|Hormones|hormones|mesh-ancestor
56591237|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56591238|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56591239|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56591240|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
56591241|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591242|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591243|NCT02752971|Diclofenac|diclofenac|mesh-list
56591244|NCT02752971|Bupivacaine|bupivacaine|mesh-list
56591245|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
56591246|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
56591247|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591248|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591249|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
56591297|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56591298|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56591299|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56591300|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
56591301|NCT00635973|Gefitinib|gefitinib|mesh-list
56591302|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591303|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56591304|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591305|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591306|NCT02750163|Acetaminophen|acetaminophen|mesh-list
56591307|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591308|NCT02750163|Analgesics|analgesics|mesh-ancestor
56591309|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
56591310|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591311|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591312|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
56591313|NCT04217421|Allopurinol|allopurinol|mesh-list
56591314|NCT04217421|Mannitol|mannitol|mesh-list
56591315|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
56591316|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591317|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591318|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
56591319|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591320|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56591321|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
56591322|NCT04217421|Protective Agents|protective agents|mesh-ancestor
56591323|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591324|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56591325|NCT04217421|Diuretics|diuretics|mesh-ancestor
56591328|NCT04036929|Estrogens|estrogens|mesh-list
56591343|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591344|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591345|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
56591346|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591347|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56591348|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
56591349|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56591350|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56591351|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56591352|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591353|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56591354|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591355|NCT04218513|Edaravone|edaravone|mesh-list
56591356|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56591357|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
56591358|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591359|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56591360|NCT04218513|Protective Agents|protective agents|mesh-ancestor
56591361|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591362|NCT04218435|Valsartan|valsartan|mesh-list
56591363|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56591364|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56591365|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56591366|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56591367|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591368|NCT04138875|Rituximab|rituximab|mesh-list
56591369|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56591385|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56591386|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591388|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
56591389|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
56591390|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591391|NCT02695563|Lactoferrin|lactoferrin|mesh-list
56591392|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591393|NCT02747823|Bevacizumab|bevacizumab|mesh-list
56591394|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56591395|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591396|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56591397|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56591398|NCT02747823|Growth Substances|growth substances|mesh-ancestor
56591399|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591400|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
56591401|NCT02747511|Haloperidol|haloperidol|mesh-list
56591402|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
56591403|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
56591404|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
56591405|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591406|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591407|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56591408|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56591409|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56591410|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591411|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56591412|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56591413|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
56591414|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591431|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591432|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591433|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56591434|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
56591435|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591436|NCT02746185|Heparin|heparin|mesh-list
56591437|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56591438|NCT02746185|Tinzaparin|tinzaparin|mesh-list
56591439|NCT02746185|Dalteparin|dalteparin|mesh-list
56591440|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
56591441|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
56591442|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56591443|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56591444|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591445|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56339966|NCT00079443|Rituximab|rituximab|mesh-list
56591446|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
56591447|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56591448|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
56591449|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591450|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
56591451|NCT02742051|Fluorouracil|fluorouracil|mesh-list
56591452|NCT02742051|Everolimus|everolimus|mesh-list
56591453|NCT02742051|Letrozole|letrozole|mesh-list
56591454|NCT02742051|Epirubicin|epirubicin|mesh-list
56591455|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56591456|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
56591482|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591483|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591484|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591485|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591486|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56591487|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56591488|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591489|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56591490|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56591491|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591492|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
56591493|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
56591494|NCT02745873|Vitamins|vitamins|mesh-ancestor
56591495|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
56591496|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591497|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
56591498|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591500|NCT02745639|Capecitabine|capecitabine|mesh-list
56591539|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
56591540|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56591541|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56591542|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56591543|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56591544|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
56591545|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56591546|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56591547|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
56591548|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591549|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
56591550|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56591551|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56591552|NCT00839254|Vaccines|vaccines|mesh-list
56591553|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56591554|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
56591555|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591556|NCT02741115|Udenafil|udenafil|mesh-list
56591557|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56591558|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56591559|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591561|NCT02740803|Listerine|listerine|mesh-list
56591590|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591591|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56591592|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56591593|NCT00812968|Growth Substances|growth substances|mesh-ancestor
56591594|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
56591595|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591596|NCT02744703|Capecitabine|capecitabine|mesh-list
56591597|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56591598|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56591599|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
56591600|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591601|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591602|NCT02744937|Aspirin|aspirin|mesh-list
56591603|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56591604|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591605|NCT02744937|Analgesics|analgesics|mesh-ancestor
56591606|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
56591607|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591608|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591609|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591610|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591611|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56591642|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56591643|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56591644|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
56591645|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591646|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591647|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591652|NCT00813748|Omalizumab|omalizumab|mesh-list
56591653|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56591654|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56591655|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
56591656|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
56591657|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56591658|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
56591659|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591660|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56591661|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591662|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
56591663|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56591664|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
56591665|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56591666|NCT02739711|Protective Agents|protective agents|mesh-ancestor
56591667|NCT00813592|Pasireotide|pasireotide|mesh-list
56591668|NCT00813592|Hormones|hormones|mesh-ancestor
56591669|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591670|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591671|NCT02739633|Gemcitabine|gemcitabine|mesh-list
56591672|NCT02739633|Paclitaxel|paclitaxel|mesh-list
56591673|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56591675|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
56591676|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
56591680|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
56591691|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
56591692|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56591693|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
56591694|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
56591695|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591696|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591697|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
56591698|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56591699|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
56591700|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
56591701|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56591702|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56591703|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56591704|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
56591705|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591706|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591707|NCT02739399|Protective Agents|protective agents|mesh-ancestor
56591708|NCT02743065|Doxorubicin|doxorubicin|mesh-list
56591709|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56591710|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591711|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56591712|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56591713|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591714|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195806|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56195807|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195808|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56195809|NCT01501084|Incretins|incretins|mesh-ancestor
56195810|NCT01501084|Hormones|hormones|mesh-ancestor
56104455|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
56195811|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195812|NCT01501123|Midazolam|midazolam|mesh-list
56195813|NCT01501123|Haloperidol|haloperidol|mesh-list
56195814|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
56195815|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56195816|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56195817|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56195818|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195819|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56195820|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56195821|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56195822|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56195823|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
56195824|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
56195825|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
56195826|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
56195827|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56104457|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56104458|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104459|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104460|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56591715|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56591716|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
56591717|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591718|NCT02742675|Leuprolide|leuprolide|mesh-list
56591719|NCT02742675|Goserelin|goserelin|mesh-list
56591720|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56591721|NCT02742675|Flutamide|flutamide|mesh-list
56591722|NCT02742675|Bicalutamide|bicalutamide|mesh-list
56591723|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56591724|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
56591725|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56591726|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591727|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56591728|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591729|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
56591730|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
56591731|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904707|NCT01582009|Everolimus|everolimus|mesh-list
56104461|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104462|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
56104463|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104464|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104465|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104466|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104467|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56104468|NCT00003650|Protective Agents|protective agents|mesh-ancestor
56104469|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104470|NCT00003650|Analgesics|analgesics|mesh-ancestor
56104471|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
56104472|NCT00002755|Tamoxifen|tamoxifen|mesh-list
56104474|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
56104475|NCT00002755|Thiotepa|thiotepa|mesh-list
56104476|NCT00002755|Doxorubicin|doxorubicin|mesh-list
56104477|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56104478|NCT00002755|Fluorouracil|fluorouracil|mesh-list
56104479|NCT00002755|Methotrexate|methotrexate|mesh-list
56104480|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104481|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
56104517|NCT00002761|Cyclosporins|cyclosporins|mesh-list
56104518|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104519|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
56104520|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104521|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104579|NCT00004154|Protective Agents|protective agents|mesh-ancestor
56104580|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104581|NCT00002767|Interferons|interferons|mesh-list
56104582|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
56104583|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
56104584|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104585|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
56104586|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104587|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
56104588|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104589|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56104590|NCT00002773|Interferons|interferons|mesh-list
56104591|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
56104592|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
56104593|NCT00002773|Sargramostim|sargramostim|mesh-list
56195828|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195829|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
56195830|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
56195831|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591732|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
56591733|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56591734|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
56591735|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56591736|NCT00812812|Paroxetine|paroxetine|mesh-list
56591737|NCT00812812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56591738|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56591739|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56591740|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591741|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591742|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
56591795|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56591796|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
56591797|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591798|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591799|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56591800|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
56591801|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591802|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591803|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56591804|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
56591805|NCT02609386|Trace Elements|trace elements|mesh-ancestor
56591806|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56591807|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56591808|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591809|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56591810|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591811|NCT02609386|Analgesics|analgesics|mesh-ancestor
56591812|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
56591813|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591814|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591815|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
56591816|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
56591817|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56591819|NCT02738619|Vitamin D|vitamin d|mesh-list
56591843|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591844|NCT02736435|Leuprolide|leuprolide|mesh-list
56591845|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56591846|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
56591847|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56591848|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591849|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56591850|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591851|NCT05757388|Acetaminophen|acetaminophen|mesh-list
56591852|NCT05757388|Parecoxib|parecoxib|mesh-list
56591853|NCT05757388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591854|NCT05757388|Analgesics|analgesics|mesh-ancestor
56591855|NCT05757388|Sensory System Agents|sensory system agents|mesh-ancestor
56591856|NCT05757388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591857|NCT05757388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591858|NCT05757388|Antipyretics|antipyretics|mesh-ancestor
56591859|NCT05757388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56591860|NCT05757388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56591861|NCT05757388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591897|NCT00744055|Prazosin|prazosin|mesh-list
56591898|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56591899|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56591900|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56591901|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56591902|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
56591903|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591904|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591905|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591906|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
56591907|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56591908|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56591909|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591910|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
56591911|NCT02738073|Coagulants|coagulants|mesh-ancestor
56591912|NCT03967483|Indomethacin|indomethacin|mesh-list
56591913|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56591914|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56591915|NCT03967483|Analgesics|analgesics|mesh-ancestor
56591916|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
56591917|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591918|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591919|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591920|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56591921|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
56591922|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
56591923|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56591924|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56591925|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195832|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56195833|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56195834|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56195835|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
56195836|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56195837|NCT01501136|Gemcitabine|gemcitabine|mesh-list
56195838|NCT01501136|Dexamethasone|dexamethasone|mesh-list
56195839|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
56104594|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104595|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
56104596|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104597|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104598|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104599|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
56104600|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104601|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591926|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591927|NCT00740779|Silodosin|silodosin|mesh-list
56591928|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56591929|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56591930|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56591931|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56591932|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591933|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591934|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591935|NCT00740779|Urological Agents|urological agents|mesh-ancestor
56591936|NCT00735475|Vaccines|vaccines|mesh-list
56591937|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
56591938|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591939|NCT01026818|Tadalafil|tadalafil|mesh-list
56591940|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
56591941|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56591942|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56591943|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591944|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591945|NCT01026818|Urological Agents|urological agents|mesh-ancestor
56591946|NCT02593747|Loratadine|loratadine|mesh-list
56591947|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
56591948|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
56591949|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56591950|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56591974|NCT00734929|Ondansetron|ondansetron|mesh-list
56591975|NCT00734929|Aprepitant|aprepitant|mesh-list
56591976|NCT00734929|BB 1101|bb 1101|mesh-list
56591977|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56591978|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
56591979|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
56591980|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56591981|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56591982|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56591983|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
56591984|NCT00734929|Hormones|hormones|mesh-ancestor
56591985|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56591986|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56591987|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56591988|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
55904972|NCT01534637|Antiviral Agents|antiviral agents|mesh-ancestor
56104602|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104603|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
56104604|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104605|NCT00004160|Gemcitabine|gemcitabine|mesh-list
56104606|NCT00004160|Paclitaxel|paclitaxel|mesh-list
56104607|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104608|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104609|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104610|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104611|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104612|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104613|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104614|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
56104664|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104665|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
56104666|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104667|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104668|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104669|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
56104670|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104671|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104672|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104673|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
56104674|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104675|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56104676|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
56104677|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56104678|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56104679|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104680|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56104681|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104682|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56104683|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
56104684|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104685|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104686|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56104687|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56104688|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56104689|NCT00002785|Leucovorin|leucovorin|mesh-list
56104691|NCT00002785|Cytarabine|cytarabine|mesh-list
56104692|NCT00002785|Cyclosporine|cyclosporine|mesh-list
56104693|NCT00002785|Dexamethasone|dexamethasone|mesh-list
56195840|NCT01501136|Cisplatin|cisplatin|mesh-list
56195841|NCT01501136|Etoposide|etoposide|mesh-list
56591989|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56591990|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56591991|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
56591992|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
56591993|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56591994|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
56591995|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56591996|NCT00734929|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56591997|NCT00734929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56591998|NCT00734929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56591999|NCT00734929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56592000|NCT00734929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56592001|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56592002|NCT00734851|Docetaxel|docetaxel|mesh-list
56592003|NCT00734851|Sunitinib|sunitinib|mesh-list
56592004|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592005|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
56592047|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
56592048|NCT02737605|Esketamine|esketamine|mesh-list
56592049|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56592050|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592051|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56592052|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56592053|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592054|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592055|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592056|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
56592057|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56592058|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
56592059|NCT02737371|Clotrimazole|clotrimazole|mesh-list
56592060|NCT02737371|Miconazole|miconazole|mesh-list
56592061|NCT02737371|Olorofim|olorofim|mesh-list
56592062|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158883|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
56592063|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56592064|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56592065|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56592099|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592100|NCT02737059|Analgesics|analgesics|mesh-ancestor
56592101|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
56592102|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592103|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
56592104|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
56592105|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56592106|NCT02731911|Dexamethasone|dexamethasone|mesh-list
56592107|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56592108|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
56592109|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
56592110|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592111|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592112|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56592113|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
56592114|NCT02731911|Hormones|hormones|mesh-ancestor
56592115|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592116|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56592117|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592154|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56592155|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592156|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
56592157|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56592158|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56592159|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
56592160|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56592161|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56592162|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56592163|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
56592164|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56592165|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56592166|NCT00743197|Protective Agents|protective agents|mesh-ancestor
56592167|NCT02731287|Timolol|timolol|mesh-list
56592168|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592169|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56592170|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56195842|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
56195843|NCT01501136|Ifosfamide|ifosfamide|mesh-list
56195844|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
56195845|NCT01501136|Pegaspargase|pegaspargase|mesh-list
56195846|NCT01501136|Asparaginase|asparaginase|mesh-list
56104694|NCT00002785|Prednisone|prednisone|mesh-list
56104695|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
56104696|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
56104697|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56104773|NCT00003386|Carboplatin|carboplatin|mesh-list
56104774|NCT00003386|Vaccines|vaccines|mesh-list
56104775|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
56104776|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
56104777|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104778|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104779|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104780|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104781|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104782|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104783|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104784|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104785|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104786|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104787|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
56104788|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104789|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56104790|NCT00384566|Metoprolol|metoprolol|mesh-list
56104791|NCT00384566|Carvedilol|carvedilol|mesh-list
56104792|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56104832|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104834|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56104835|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104836|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104837|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56104838|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56104839|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104840|NCT00002791|Doxorubicin|doxorubicin|mesh-list
56104841|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56104842|NCT00002791|Ifosfamide|ifosfamide|mesh-list
56104843|NCT00002791|Dacarbazine|dacarbazine|mesh-list
56104844|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104845|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592171|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
56592172|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592173|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592174|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56592175|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56592176|NCT02735343|Ketamine|ketamine|mesh-list
56592177|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
56592178|NCT02735343|Analgesics|analgesics|mesh-ancestor
56592179|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
56158914|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
56592180|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592181|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592182|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56592183|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56592184|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
56592185|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
56592186|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592187|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56592188|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56592189|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592190|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592191|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
56592222|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56592223|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56592224|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56592226|NCT03255915|Emtricitabine|emtricitabine|mesh-list
56592227|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
56592228|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592229|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56592230|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56592231|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592232|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592233|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56592234|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56592235|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
56592236|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56592237|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592238|NCT00739297|Montelukast|montelukast|mesh-list
56592239|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56592240|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
56592241|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56592242|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
56592243|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592244|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592245|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56592246|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56592249|NCT05430243|Diuretics|diuretics|mesh-list
56592270|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592271|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56592272|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56592273|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56592274|NCT02730117|Protective Agents|protective agents|mesh-ancestor
56592275|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
56592276|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56592277|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
56592278|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56592279|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56592280|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592281|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592282|NCT02595463|Lidocaine|lidocaine|mesh-list
56592283|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592284|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
56592285|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592286|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592287|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
56592288|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592324|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
56592325|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
56592326|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592327|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592328|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56592329|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592330|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592331|NCT02735031|Exenatide|exenatide|mesh-list
56592332|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56592333|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592334|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56592335|NCT02735031|Incretins|incretins|mesh-ancestor
56592336|NCT02735031|Hormones|hormones|mesh-ancestor
56592337|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592338|NCT02595541|Milrinone|milrinone|mesh-list
56592339|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
56592340|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
56592341|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56592342|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56592343|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592344|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592345|NCT02595541|Urological Agents|urological agents|mesh-ancestor
56592346|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56592347|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56592348|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56592349|NCT02595541|Protective Agents|protective agents|mesh-ancestor
56592350|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905352|NCT02388516|Vitamin D|vitamin d|mesh-list
56104846|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104847|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104848|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104849|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104850|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104851|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
56104852|NCT00004190|Gemcitabine|gemcitabine|mesh-list
56104853|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
56104854|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104855|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
56104856|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104857|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104858|NCT00004190|Antiviral Agents|antiviral agents|mesh-ancestor
56104859|NCT00004190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104860|NCT00004190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104861|NCT00004190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104862|NCT00004190|Immunologic Factors|immunologic factors|mesh-ancestor
56104863|NCT00004190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592351|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56592352|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592353|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56592354|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592355|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592356|NCT01026194|Pioglitazone|pioglitazone|mesh-list
56592357|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56592358|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592359|NCT02734875|Anticoagulants|anticoagulants|mesh-list
56592360|NCT04088461|Metformin|metformin|mesh-list
56592361|NCT04088461|Linagliptin|linagliptin|mesh-list
56592362|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56592363|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592364|NCT04088461|Incretins|incretins|mesh-ancestor
56592365|NCT04088461|Hormones|hormones|mesh-ancestor
56592366|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592367|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56592368|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
56592369|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592370|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592371|NCT00636519|Antitoxins|antitoxins|mesh-list
56592372|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
56592373|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
56592374|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592375|NCT02729805|Ketamine|ketamine|mesh-list
56592376|NCT02729805|Analgesics|analgesics|mesh-ancestor
56592400|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56592401|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
56592402|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592403|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592404|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56592405|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56592406|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
56592407|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592408|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56592409|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56592410|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56592411|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56592412|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56592413|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56592414|NCT00917839|Lamotrigine|lamotrigine|mesh-list
56592457|NCT05757310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56592458|NCT05757310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56592459|NCT05757310|Alkylating Agents|alkylating agents|mesh-ancestor
56592460|NCT05757310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592461|NCT05757310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592462|NCT05757310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56592463|NCT05757310|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56592464|NCT05757310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592465|NCT05757310|Antimetabolites|antimetabolites|mesh-ancestor
56592466|NCT05757310|Antiviral Agents|antiviral agents|mesh-ancestor
56592467|NCT05757310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592468|NCT00743119|Dronabinol|dronabinol|mesh-list
56592469|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
56592470|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592471|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56592472|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56592473|NCT00743119|Analgesics|analgesics|mesh-ancestor
56592474|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
56592475|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104864|NCT00004196|Interferons|interferons|mesh-list
56104865|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
56104866|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104867|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
56104868|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104869|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
56104870|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104940|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104941|NCT00004220|Antiviral Agents|antiviral agents|mesh-ancestor
56104942|NCT00004220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195847|NCT01501136|BB 1101|bb 1101|mesh-list
56195849|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195850|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
56195851|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
56195852|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195853|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195854|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56195855|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
56195856|NCT01501136|Hormones|hormones|mesh-ancestor
56195857|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195858|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56195859|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195860|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
56195861|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195862|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195863|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56195864|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
56195865|NCT01501136|Antiviral Agents|antiviral agents|mesh-ancestor
56195866|NCT01501136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56195867|NCT01501136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195868|NCT01501136|Immunologic Factors|immunologic factors|mesh-ancestor
56195869|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56195870|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56195871|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56195872|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56195873|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
56195874|NCT01501136|Protective Agents|protective agents|mesh-ancestor
56592476|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56592477|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56592478|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592479|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592480|NCT00743119|Hormones|hormones|mesh-ancestor
56592481|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592482|NCT02610010|Cisplatin|cisplatin|mesh-list
56592483|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592484|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
56592485|NCT02610088|Gliclazide|gliclazide|mesh-list
56592486|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56592487|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592488|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56592489|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592490|NCT02734407|Aflibercept|aflibercept|mesh-list
56592491|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56592492|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56592493|NCT02734407|Growth Substances|growth substances|mesh-ancestor
56592494|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592495|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
56592496|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592497|NCT02734173|Ritonavir|ritonavir|mesh-list
56592498|NCT02734173|Ribavirin|ribavirin|mesh-list
56592499|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56592500|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56592501|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
56592502|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592503|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592504|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56592505|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56592506|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
55905490|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
56195875|NCT01501149|Gemcitabine|gemcitabine|mesh-list
56195876|NCT01501149|Dexamethasone|dexamethasone|mesh-list
56195877|NCT01501149|Etoposide|etoposide|mesh-list
56195878|NCT01501149|Pegaspargase|pegaspargase|mesh-list
56195879|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195880|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
56104943|NCT00004220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104944|NCT00004220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104945|NCT00004220|Immunologic Factors|immunologic factors|mesh-ancestor
56104946|NCT00004220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104947|NCT00003704|Capecitabine|capecitabine|mesh-list
56104948|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56592507|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592508|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56592509|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56592510|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
56592511|NCT05297422|Ketamine|ketamine|mesh-list
56592512|NCT05297422|Ropivacaine|ropivacaine|mesh-list
56592513|NCT05297422|Analgesics|analgesics|mesh-ancestor
56592514|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
56592515|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592516|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592517|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56592518|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56592519|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
56592520|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
56592521|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592522|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56592523|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56592524|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592525|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592526|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592527|NCT00813124|Fludarabine|fludarabine|mesh-list
56592528|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
56592559|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
56592560|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592561|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592562|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592563|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56592564|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592565|NCT02733705|Fentanyl|fentanyl|mesh-list
56592566|NCT02733705|Propofol|propofol|mesh-list
56592567|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56592568|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592569|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592570|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56592571|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
56592572|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
56592573|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56592574|NCT02733705|Narcotics|narcotics|mesh-ancestor
56592575|NCT02733705|Analgesics|analgesics|mesh-ancestor
56592576|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
56592577|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592578|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56592579|NCT02596555|Dabigatran|dabigatran|mesh-list
56592580|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
56592581|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56592582|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
56592583|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592584|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592608|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592609|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592610|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
56592611|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592612|NCT00811720|Nalmefene|nalmefene|mesh-list
56592613|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56592614|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592615|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
56592616|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592617|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55905625|NCT01524887|Antibodies|antibodies|mesh-list
56104949|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
56104950|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104951|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104952|NCT00004868|Semaxinib|semaxinib|mesh-list
56104953|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56195881|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
56195882|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104954|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56104955|NCT00004868|Growth Substances|growth substances|mesh-ancestor
56104956|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104957|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
56104958|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104959|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56104960|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104961|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104962|NCT05487235|Atezolizumab|atezolizumab|mesh-list
56104964|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104965|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56104966|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56104967|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56104968|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104969|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104970|NCT00003710|Irinotecan|irinotecan|mesh-list
56104971|NCT00003710|Mitomycins|mitomycins|mesh-list
56104972|NCT00003710|Mitomycin|mitomycin|mesh-list
56104973|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56104993|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104994|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104995|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104996|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
56104997|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104998|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
56104999|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105000|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56105001|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
56105002|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
56105003|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105004|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56105005|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56105006|NCT00004232|Protective Agents|protective agents|mesh-ancestor
56105007|NCT05231629|Dexamethasone|dexamethasone|mesh-list
56105008|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
56105009|NCT05231629|Melphalan|melphalan|mesh-list
56105010|NCT05231629|Lenalidomide|lenalidomide|mesh-list
56105011|NCT05231629|Bortezomib|bortezomib|mesh-list
56105012|NCT05231629|Daratumumab|daratumumab|mesh-list
56105013|NCT05231629|BB 1101|bb 1101|mesh-list
56105014|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56105015|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56105016|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
56105017|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
56105018|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105019|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105020|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56105021|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
56105022|NCT05231629|Hormones|hormones|mesh-ancestor
56592618|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592619|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592620|NCT00811642|Posaconazole|posaconazole|mesh-list
56592621|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
56592622|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592623|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56592624|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56592625|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56592626|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56592627|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56592628|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592630|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56592674|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56592675|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56592676|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592677|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
56592679|NCT05753722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56592680|NCT05753722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592681|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
56592682|NCT02727621|Propofol|propofol|mesh-list
56592683|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56592684|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592685|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592686|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56592687|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
56592688|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
56592689|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56592690|NCT02727621|Analgesics|analgesics|mesh-ancestor
56592691|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
56592692|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592693|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56592694|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56592695|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56105023|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105024|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56105025|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105026|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
56105027|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105028|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105029|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105064|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105066|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105067|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105068|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56105069|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105070|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
56105071|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105072|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56105138|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105139|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105140|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105141|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56105142|NCT00003728|Analgesics|analgesics|mesh-ancestor
56105143|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
56105144|NCT00004886|Docetaxel|docetaxel|mesh-list
56195883|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195884|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56195885|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
56195886|NCT01501149|Hormones|hormones|mesh-ancestor
56195887|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195888|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56195889|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195890|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56195891|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
56592696|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
56592697|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592698|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592699|NCT02608606|Tacrolimus|tacrolimus|mesh-list
56592700|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56592701|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
56592702|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592703|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56592704|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592705|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592706|NCT02608918|BMS-955176|bms-955176|mesh-list
56592707|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56592708|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56592709|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
56341270|NCT00146146|Letrozole|letrozole|mesh-list
56592710|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592711|NCT05755204|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56592712|NCT05755204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56592713|NCT05755204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56592714|NCT05755204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592749|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592750|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56592751|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592752|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592753|NCT05753566|Androgens|androgens|mesh-list
56592754|NCT05753566|Hormones|hormones|mesh-ancestor
56592755|NCT05753566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592756|NCT05753566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592757|NCT05154747|Rilpivirine|rilpivirine|mesh-list
56592758|NCT05154747|Cabotegravir|cabotegravir|mesh-list
56592759|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
56592760|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56592761|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56592762|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592763|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592764|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
56592765|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592766|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56592767|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56592768|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56592769|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56592770|NCT00590824|Interleukin-2|interleukin-2|mesh-list
56592771|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592772|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56592773|NCT00590824|Analgesics|analgesics|mesh-ancestor
56592774|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
56592775|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592792|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56592793|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
56592794|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592795|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
56592796|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56592797|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56592798|NCT02720601|Capecitabine|capecitabine|mesh-list
56592800|NCT02720601|Camptothecin|camptothecin|mesh-list
56592801|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56592802|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
56592803|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592804|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592805|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56592806|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56592807|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592808|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56195892|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105145|NCT00004886|Dofequidar|dofequidar|mesh-list
56105167|NCT05477875|Acetaminophen|acetaminophen|mesh-list
56105168|NCT05477875|Dronabinol|dronabinol|mesh-list
56105169|NCT05477875|Codeine|codeine|mesh-list
56105170|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56105171|NCT05477875|Analgesics|analgesics|mesh-ancestor
56105172|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
56105173|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105174|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105175|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
56105176|NCT05477875|Hallucinogens|hallucinogens|mesh-ancestor
56105177|NCT05477875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56105178|NCT05477875|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56105179|NCT05477875|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56105180|NCT05477875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105181|NCT05477875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105183|NCT05477875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105184|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56105185|NCT05477875|Narcotics|narcotics|mesh-ancestor
56105186|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56105187|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
56105188|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
56105189|NCT00004256|Sargramostim|sargramostim|mesh-list
56105190|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
56105191|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105192|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
56105193|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105194|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56105195|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
56105196|NCT00004892|Carmustine|carmustine|mesh-list
56105197|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56105198|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105240|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105241|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
56105242|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105243|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105244|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105245|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
56105246|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592809|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
56592810|NCT00590590|Promethazine|promethazine|mesh-list
56592811|NCT00590590|Lidocaine|lidocaine|mesh-list
56592812|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592813|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
56592814|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592815|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592816|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
56592817|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592818|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56592819|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56592820|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56592821|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56592822|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592823|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56592824|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56592825|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
56592826|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
56592827|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56592828|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56592829|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
56592830|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
56592831|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105247|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105248|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55741955|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56105249|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56105250|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56105251|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55832264|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56105252|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105253|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56105254|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56105255|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
56105256|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
56105257|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105258|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56105259|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
56195893|NCT01501149|Antiviral Agents|antiviral agents|mesh-ancestor
56195894|NCT01501149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105260|NCT00004904|Hormones|hormones|mesh-ancestor
56105261|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105262|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56105263|NCT00004904|Protective Agents|protective agents|mesh-ancestor
56105264|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
56105265|NCT00004286|Antibodies|antibodies|mesh-list
56105266|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
56105267|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56105268|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56105269|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
56105270|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105271|NCT00003746|Cladribine|cladribine|mesh-list
56592832|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56592833|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
56592834|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
56592835|NCT02720367|Gemcitabine|gemcitabine|mesh-list
56592836|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56592837|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
56592838|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592839|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592840|NCT02720367|Antiviral Agents|antiviral agents|mesh-ancestor
56592841|NCT02720367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56592842|NCT02720367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592843|NCT02720367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56592844|NCT02720367|Immunologic Factors|immunologic factors|mesh-ancestor
56592845|NCT02720367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592846|NCT02693769|Fluticasone|fluticasone|mesh-list
56592847|NCT02693769|Xhance|xhance|mesh-list
56592848|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
56105272|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105273|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105274|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
56105275|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105276|NCT00003752|Bexarotene|bexarotene|mesh-list
56105277|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105280|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56105281|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
56105282|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105283|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105284|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
56105285|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105286|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105287|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
56105288|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105289|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56105305|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56105307|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105308|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105309|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105310|NCT00004316|Capsaicin|capsaicin|mesh-list
56105311|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
56105312|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
56105313|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
56105314|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105315|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105316|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
56105317|NCT00003764|Fludarabine|fludarabine|mesh-list
56105318|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
56105319|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105320|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
56105321|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105322|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105323|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105324|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
56105325|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105326|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105327|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56105328|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56105330|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
56105331|NCT00004928|Calcitriol|calcitriol|mesh-list
56105332|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56105333|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592849|NCT02693769|Bromides|bromides|mesh-list
56592850|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
56592851|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56592852|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56592853|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
56592854|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592855|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592856|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56592857|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
56592858|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
56592859|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56592860|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56592861|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55905866|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
56105334|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56105335|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56105336|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56105337|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105338|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56105339|NCT00004928|Vitamins|vitamins|mesh-ancestor
56105340|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
56105341|NCT00004328|Enalapril|enalapril|mesh-list
56105342|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
56105343|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56105437|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105438|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
56105439|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195895|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195896|NCT01501149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56195897|NCT01501149|Immunologic Factors|immunologic factors|mesh-ancestor
56105440|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
56105441|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56105442|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105443|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56105444|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56105445|NCT00384800|Growth Substances|growth substances|mesh-ancestor
56105446|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
56105447|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105448|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56105449|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
56105450|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105451|NCT00384878|Leucovorin|leucovorin|mesh-list
56105452|NCT00384878|Fluorouracil|fluorouracil|mesh-list
56105453|NCT00384878|Cetuximab|cetuximab|mesh-list
56105454|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105455|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
56105456|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105457|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56105459|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
56105460|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105461|NCT00384878|Antidotes|antidotes|mesh-ancestor
56105462|NCT00384878|Protective Agents|protective agents|mesh-ancestor
56105463|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
56105464|NCT00384878|Vitamins|vitamins|mesh-ancestor
56105465|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
56105498|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105500|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105501|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56105502|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56105503|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
56105504|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55892970|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
56592862|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56592863|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
56592864|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592865|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592866|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
56592867|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56592868|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56592869|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56592870|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
56592871|NCT05335941|Pemetrexed|pemetrexed|mesh-list
56592872|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592873|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56592874|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592875|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56592876|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56592877|NCT02725359|Tizanidine|tizanidine|mesh-list
56592878|NCT02725359|Bupivacaine|bupivacaine|mesh-list
56592920|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
56592921|NCT00806494|Fesoterodine|fesoterodine|mesh-list
56592922|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56592923|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56592924|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
56592925|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592926|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592927|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592928|NCT00806494|Urological Agents|urological agents|mesh-ancestor
56592929|NCT00806416|Vitamin D|vitamin d|mesh-list
56592930|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
56592931|NCT00806416|Alendronate|alendronate|mesh-list
56592932|NCT00806416|Vitamins|vitamins|mesh-ancestor
56592933|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
56592934|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592935|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56592936|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56592937|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56592938|NCT00811252|Vortioxetine|vortioxetine|mesh-list
56592939|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56592940|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56592941|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56592942|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56592943|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56592944|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592945|NCT00811252|Analgesics|analgesics|mesh-ancestor
56592946|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
56592947|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592964|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56592965|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
56592966|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592967|NCT00736957|Acetaminophen|acetaminophen|mesh-list
56592968|NCT00736957|Tramadol|tramadol|mesh-list
56592969|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56592970|NCT00736957|Analgesics|analgesics|mesh-ancestor
56592971|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
56592972|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592973|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592974|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
56592975|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56592976|NCT00736957|Narcotics|narcotics|mesh-ancestor
56592977|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56592978|NCT05024344|Dexamethasone|dexamethasone|mesh-list
56592979|NCT05024344|Ropivacaine|ropivacaine|mesh-list
56592980|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56592981|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
56592982|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
56592983|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56592984|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56592985|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56592986|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
56592987|NCT05024344|Hormones|hormones|mesh-ancestor
56592988|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56592989|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56592990|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56592991|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
56592992|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
56593011|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593013|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56593014|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593015|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593016|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593017|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56593018|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
56593019|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56593020|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593021|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
56593022|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56593023|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56593024|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
56593025|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593026|NCT02723487|Bupivacaine|bupivacaine|mesh-list
56593027|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
56593028|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
56593029|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593030|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593031|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
56593032|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593033|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
56593034|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
56593035|NCT02717871|Levofloxacin|levofloxacin|mesh-list
56593036|NCT02717871|Ofloxacin|ofloxacin|mesh-list
56593037|NCT02717871|Gentamicins|gentamicins|mesh-list
56593038|NCT02717871|Cefazolin|cefazolin|mesh-list
56593039|NCT02717871|Tobramycin|tobramycin|mesh-list
56593040|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
56593041|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
56593060|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
56593061|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
56593062|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593063|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593064|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56593065|NCT02717871|Protective Agents|protective agents|mesh-ancestor
56593066|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56593067|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593068|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56593069|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56593070|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593071|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593072|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56593073|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56593074|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56593120|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56593121|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593122|NCT00736645|Urological Agents|urological agents|mesh-ancestor
56593123|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
56593124|NCT00736645|Protective Agents|protective agents|mesh-ancestor
56593125|NCT00736645|Trace Elements|trace elements|mesh-ancestor
56593126|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
56593127|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
56593128|NCT02326311|Dasatinib|dasatinib|mesh-list
56593129|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593130|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56593131|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105505|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56105506|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56105507|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56105508|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56105538|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105539|NCT00004400|Testosterone|testosterone|mesh-list
56105540|NCT00004400|Androgens|androgens|mesh-ancestor
56105541|NCT00004400|Hormones|hormones|mesh-ancestor
56105542|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105543|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105544|NCT00003812|Paclitaxel|paclitaxel|mesh-list
56105545|NCT00003812|Etoposide|etoposide|mesh-list
56105546|NCT00003812|Carboplatin|carboplatin|mesh-list
56105547|NCT00003812|Topotecan|topotecan|mesh-list
56105548|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56105549|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105550|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105551|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105580|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
56105581|NCT00003824|Cephalexin|cephalexin|mesh-list
56105582|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105583|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56105584|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105585|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105586|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105587|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105588|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56105589|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56105590|NCT00004406|Hormones|hormones|mesh-list
56105591|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
56105592|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105593|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105594|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56105631|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
56195898|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56195899|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56195900|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56195902|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
56195903|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195904|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195905|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
56195906|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56195907|NCT01501253|Amlodipine|amlodipine|mesh-list
56195908|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56195909|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56195910|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56195911|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195912|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56195913|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593132|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593133|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
56593134|NCT00736489|AZD-3199|azd-3199|mesh-list
56593135|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56593136|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
56593137|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593138|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593139|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56593140|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
56593141|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56195914|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
56195915|NCT01501344|Calcium|calcium|mesh-list
56195916|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56195917|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195918|NCT01501370|Dexamethasone|dexamethasone|mesh-list
56195919|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
56195920|NCT01501370|Lenalidomide|lenalidomide|mesh-list
56195921|NCT01501370|Vorinostat|vorinostat|mesh-list
56105632|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56105633|NCT00004424|Narcotics|narcotics|mesh-ancestor
56105634|NCT00004424|Analgesics|analgesics|mesh-ancestor
56105679|NCT00005036|Vitamins|vitamins|mesh-ancestor
56105680|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
56105681|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56105682|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
56105683|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105684|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56105685|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
56105686|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105687|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105688|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56105689|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56105690|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56105691|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
56105748|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105749|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56105751|NCT00005048|Estramustine|estramustine|mesh-list
56105752|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56105753|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105754|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105755|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105756|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
56195923|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56195924|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
56105757|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105758|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105759|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
56105760|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56105761|NCT04756765|Talazoparib|talazoparib|mesh-list
56105762|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56105763|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105764|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105765|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105766|NCT00004466|Atorvastatin|atorvastatin|mesh-list
56105767|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56105768|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56105769|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
56105770|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105771|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56105772|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56105773|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105774|NCT00005054|Temozolomide|temozolomide|mesh-list
56105775|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56593142|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56593143|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56593144|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
56593145|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593146|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593147|NCT02716233|Pegaspargase|pegaspargase|mesh-list
56593148|NCT02716233|Asparaginase|asparaginase|mesh-list
56593149|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593150|NCT01999569|Letrozole|letrozole|mesh-list
56593151|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593152|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56593153|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56593154|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593155|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593156|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56593157|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
56593158|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56593159|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593160|NCT04087915|Evolocumab|evolocumab|mesh-list
56593161|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56593163|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
56593195|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
56593196|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
56593197|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
56593198|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593199|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56593200|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56593201|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56593202|NCT02715531|Growth Substances|growth substances|mesh-ancestor
56593203|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593204|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
56593205|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56593206|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
56593207|NCT02715531|Antiviral Agents|antiviral agents|mesh-ancestor
56593208|NCT02715531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593209|NCT02715531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593210|NCT02715531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56593211|NCT02715531|Immunologic Factors|immunologic factors|mesh-ancestor
56593212|NCT02715531|Antidotes|antidotes|mesh-ancestor
56593213|NCT02715531|Protective Agents|protective agents|mesh-ancestor
56593214|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
56593215|NCT02715531|Vitamins|vitamins|mesh-ancestor
56593216|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
56593217|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
56593218|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56593219|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593220|NCT04037085|Ketamine|ketamine|mesh-list
56593221|NCT04037085|Analgesics|analgesics|mesh-ancestor
56593222|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
56593223|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593239|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593240|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593241|NCT04787835|Anesthetics|anesthetics|mesh-list
56593242|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
56593243|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593244|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593245|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
56593246|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593247|NCT00730015|Linaclotide|linaclotide|mesh-list
56593248|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56105776|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
56105804|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105805|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
56105806|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105807|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105808|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105809|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56105810|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
56105811|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105812|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56105813|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56105814|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
56105815|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105816|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105817|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56105818|NCT00005072|Interleukin-2|interleukin-2|mesh-list
56105840|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56105841|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105842|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105843|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105844|NCT04700527|Butyric Acid|butyric acid|mesh-list
56105845|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
56105846|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
56105847|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105848|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105849|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105850|NCT00003908|Carboplatin|carboplatin|mesh-list
56105851|NCT00003908|Docetaxel|docetaxel|mesh-list
56105852|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105854|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105855|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105856|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105857|NCT00382837|Epratuzumab|epratuzumab|mesh-list
56105858|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56105859|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105860|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
56105861|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105862|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105863|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105864|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105865|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105866|NCT00005078|Paclitaxel|paclitaxel|mesh-list
56105867|NCT00005078|Carboplatin|carboplatin|mesh-list
56105868|NCT00005078|Tirapazamine|tirapazamine|mesh-list
56105869|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56105870|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105895|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
56105896|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56195925|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
56195926|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56195927|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195928|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56195929|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
56195930|NCT01501370|Hormones|hormones|mesh-ancestor
56593249|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
56593250|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593251|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593252|NCT00806026|Pregabalin|pregabalin|mesh-list
56593253|NCT00806026|Pramipexole|pramipexole|mesh-list
56593254|NCT00806026|Analgesics|analgesics|mesh-ancestor
56593255|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
56593256|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593257|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593258|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
56593259|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56593260|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56593261|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593262|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56593263|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56593264|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56593265|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593266|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56593267|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
56593268|NCT00806026|Protective Agents|protective agents|mesh-ancestor
56593269|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56593302|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56593303|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
56593304|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
56593305|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56593306|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593307|NCT02714361|Vitamin D|vitamin d|mesh-list
56593308|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
56593309|NCT02714361|Vitamins|vitamins|mesh-ancestor
56593310|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
56593311|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593312|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56593313|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56593315|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593316|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
56593317|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
56593318|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
56593319|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593320|NCT02713893|Econazole|econazole|mesh-list
56593321|NCT02713893|Benzydamine|benzydamine|mesh-list
56593322|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56593323|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
56593324|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593325|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56593326|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56593327|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593328|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593329|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56593333|NCT00729937|Clindamycin|clindamycin|mesh-list
56593349|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56593350|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56593351|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56593352|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56593353|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56593354|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
56593355|NCT00729859|Anastrozole|anastrozole|mesh-list
56593356|NCT00729859|Testosterone|testosterone|mesh-list
56593357|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
56593358|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
56593359|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56593360|NCT00729859|Acyline|acyline|mesh-list
56593361|NCT00729859|Androgens|androgens|mesh-ancestor
56593362|NCT00729859|Hormones|hormones|mesh-ancestor
56593363|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56593364|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593365|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56593366|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593374|NCT00810394|Sorafenib|sorafenib|mesh-list
56593405|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56593406|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593407|NCT00808444|Vaccines|vaccines|mesh-list
56593408|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56593409|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
56593410|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593411|NCT00914134|Levodopa|levodopa|mesh-list
56593412|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56593413|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56195931|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195932|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56195933|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195934|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
56195935|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195936|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195937|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
56195938|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56195939|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56195940|NCT01501370|Growth Substances|growth substances|mesh-ancestor
56195941|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56195942|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56195943|NCT01501396|Megestrol|megestrol|mesh-list
56195944|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
56195945|NCT01501396|Mirtazapine|mirtazapine|mesh-list
56195946|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
56105897|NCT00003920|Cyclosporine|cyclosporine|mesh-list
56105898|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56105899|NCT00003920|Antibodies|antibodies|mesh-list
56105900|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
56105901|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56105902|NCT00003920|Cyclosporins|cyclosporins|mesh-list
56105903|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
56105904|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105905|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105906|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105907|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105908|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105909|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
56105910|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105911|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
56105912|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105913|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56105914|NCT00003926|Melphalan|melphalan|mesh-list
56105915|NCT00003926|Busulfan|busulfan|mesh-list
56105916|NCT00003926|Thiotepa|thiotepa|mesh-list
56105917|NCT00003926|Lenograstim|lenograstim|mesh-list
56105918|NCT00003926|Amifostine|amifostine|mesh-list
56105919|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56105920|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
56105921|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105943|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105945|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105946|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
56105947|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105948|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105949|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56105950|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56195947|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56195948|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56195949|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
56105951|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56105952|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105953|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105954|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56105955|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105956|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105957|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
56593414|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
56593415|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593416|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593417|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593418|NCT05754736|Bevacizumab|bevacizumab|mesh-list
56593419|NCT05754736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56593420|NCT05754736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593421|NCT05754736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56593422|NCT05754736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56593423|NCT05754736|Growth Substances|growth substances|mesh-ancestor
56593424|NCT05754736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593425|NCT05754736|Growth Inhibitors|growth inhibitors|mesh-ancestor
56593426|NCT00742027|Panobinostat|panobinostat|mesh-list
56593427|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593428|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56593429|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593430|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593431|NCT02609698|Aspirin|aspirin|mesh-list
56593432|NCT02609698|Clopidogrel|clopidogrel|mesh-list
56593433|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56593434|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56593435|NCT02609698|Analgesics|analgesics|mesh-ancestor
56593440|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56593464|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593465|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593466|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56593467|NCT02713191|Analgesics|analgesics|mesh-ancestor
56593468|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
56593469|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593470|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56593471|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56593472|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56593473|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
56593474|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593475|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593476|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56593477|NCT02713191|Narcotics|narcotics|mesh-ancestor
56593478|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56105958|NCT00004580|Ritonavir|ritonavir|mesh-list
56105959|NCT00004580|Lopinavir|lopinavir|mesh-list
56105960|NCT00004580|Nevirapine|nevirapine|mesh-list
56105961|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56105962|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56105963|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
56105964|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105965|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105966|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56105967|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56105968|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
56105969|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105970|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56105971|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56105972|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56105973|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56105974|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56105975|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56106022|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106023|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106024|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56106025|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
56106026|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56106027|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56106028|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56106029|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56106030|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106031|NCT00005120|Calanolide A|calanolide a|mesh-list
56106032|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56106033|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56106034|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
56106035|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106036|NCT00004664|Megestrol|megestrol|mesh-list
56106037|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56106038|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56106039|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56106040|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
56106041|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56106074|NCT04608409|Paclitaxel|paclitaxel|mesh-list
56106075|NCT04608409|Lapatinib|lapatinib|mesh-list
56106076|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56106077|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106078|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
56106079|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
56593479|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56593480|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
56593481|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
56593482|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56593483|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56593484|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56593485|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
56593486|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
56593487|NCT00611169|Tirofiban|tirofiban|mesh-list
56593488|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56593489|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56593490|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593491|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56593492|NCT05754502|Trastuzumab|trastuzumab|mesh-list
56593493|NCT05754502|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56593494|NCT05754502|Maytansine|maytansine|mesh-list
56593495|NCT05754502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56593496|NCT05754502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593497|NCT05754502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56593536|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56593537|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56593538|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56593539|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
56593540|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593541|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593542|NCT05754424|Insulin Aspart|insulin aspart|mesh-list
56593543|NCT05754424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56593544|NCT05754424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593545|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56593546|NCT00636831|Cefazolin|cefazolin|mesh-list
56593547|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593548|NCT04193631|Cannabidiol|cannabidiol|mesh-list
56593549|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
56593550|NCT04856631|Cetuximab|cetuximab|mesh-list
56593551|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56593552|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593553|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
56593554|NCT00808210|Methotrexate|methotrexate|mesh-list
56593555|NCT00808210|Infliximab|infliximab|mesh-list
56593556|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
56593557|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56593558|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
56593559|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56593560|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593561|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56593562|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
56593563|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593564|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593565|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
56593566|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593567|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56593568|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56593569|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
56593570|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56593571|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56593573|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
56593575|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593576|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593577|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
56593578|NCT00808210|Hormones|hormones|mesh-ancestor
56593579|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56593580|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56593581|NCT00808210|Protective Agents|protective agents|mesh-ancestor
56593582|NCT02777229|Tenofovir|tenofovir|mesh-list
56593583|NCT02777229|Lamivudine|lamivudine|mesh-list
56593584|NCT02777229|Efavirenz|efavirenz|mesh-list
56593585|NCT02777229|Dolutegravir|dolutegravir|mesh-list
56593586|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
56593587|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593588|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56593589|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56593590|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593591|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593592|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56593593|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56593594|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56593595|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56593596|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56593597|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56593598|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56593599|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56593600|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56593601|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56593602|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56593603|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
56593618|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56593619|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593620|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56593621|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593622|NCT02777073|Incretins|incretins|mesh-ancestor
56593623|NCT02777073|Hormones|hormones|mesh-ancestor
56593624|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56593625|NCT02711865|Antibodies|antibodies|mesh-list
56593626|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
56593627|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593628|NCT02711943|Levofloxacin|levofloxacin|mesh-list
56593629|NCT02711943|Ofloxacin|ofloxacin|mesh-list
56593630|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56593631|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593632|NCT02711943|Renal Agents|renal agents|mesh-ancestor
56593633|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56593634|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56593676|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56593677|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
56593678|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56593679|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593680|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593681|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
56593682|NCT02711241|Urological Agents|urological agents|mesh-ancestor
56593683|NCT02711007|Apatinib|apatinib|mesh-list
56593684|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593685|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56593686|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593687|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593688|NCT02710539|Amlodipine|amlodipine|mesh-list
56593689|NCT02710539|Perindopril|perindopril|mesh-list
56593690|NCT02710539|Indapamide|indapamide|mesh-list
56593691|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56593692|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56593693|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56593694|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593695|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56593696|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593697|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
56593728|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
56593729|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
56593730|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593731|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
56593732|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593733|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56593734|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56593735|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
56593736|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593737|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593738|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56593739|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593740|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
56593741|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56593742|NCT04843761|Protective Agents|protective agents|mesh-ancestor
56593743|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
56593744|NCT00729157|Aflibercept|aflibercept|mesh-list
56593745|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
56593746|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56593747|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56593748|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56593749|NCT00729157|Growth Substances|growth substances|mesh-ancestor
56593750|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593751|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
56593752|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593753|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593775|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
56593776|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
56593777|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56593778|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
56593779|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56593780|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
56593781|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593782|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56593783|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
56593784|NCT02708511|Copper|copper|mesh-list
56593785|NCT02708511|Trace Elements|trace elements|mesh-ancestor
56593786|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
56593787|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593788|NCT02596243|Vaccines|vaccines|mesh-list
56593789|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
56106080|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
56106081|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106082|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56106083|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106085|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56106086|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106087|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
56106088|NCT00004730|Analgesics|analgesics|mesh-ancestor
56106089|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
56106090|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106091|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106092|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
56106093|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56106094|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56106095|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
56106096|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56106097|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56195950|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
56195951|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56195952|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195953|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195954|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56195955|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56195956|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56195957|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56195958|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56195959|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56195960|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
56106098|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106099|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56106100|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
56106101|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56106102|NCT04606381|Lazertinib|lazertinib|mesh-list
56106103|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56106104|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106105|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106106|NCT00004736|Lamivudine|lamivudine|mesh-list
56106107|NCT00004736|Zidovudine|zidovudine|mesh-list
56106108|NCT00004736|Stavudine|stavudine|mesh-list
56106180|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
56106181|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106205|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106206|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56106207|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56106208|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106209|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593790|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593791|NCT02717091|Gemcitabine|gemcitabine|mesh-list
56593792|NCT02717091|Paclitaxel|paclitaxel|mesh-list
56593793|NCT02717091|Folfirinox|folfirinox|mesh-list
56593794|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56593795|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593796|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
56593797|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
56593798|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
56593799|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593800|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56593801|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
56593802|NCT02717091|Antiviral Agents|antiviral agents|mesh-ancestor
56593803|NCT02717091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593804|NCT02717091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593805|NCT02717091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56593806|NCT02717091|Immunologic Factors|immunologic factors|mesh-ancestor
56593807|NCT02717091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593808|NCT03911973|Talazoparib|talazoparib|mesh-list
56593809|NCT03911973|Gedatolisib|gedatolisib|mesh-list
56593810|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56593811|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593812|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593843|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56593844|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
56593845|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593846|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593847|NCT00585325|Lidocaine|lidocaine|mesh-list
56593848|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
56593849|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
56593850|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56593851|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593852|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
56593853|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593854|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56593855|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56593856|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56593857|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56593858|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593859|NCT02716857|Oxycodone|oxycodone|mesh-list
56593860|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56593899|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56593900|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
56593901|NCT00611793|Bevacizumab|bevacizumab|mesh-list
56593902|NCT00611793|Vatalanib|vatalanib|mesh-list
56593903|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56593904|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56593905|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56593906|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56593907|NCT00611793|Growth Substances|growth substances|mesh-ancestor
56593908|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593909|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
56593910|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56593911|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593912|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593913|NCT00611871|Propranolol|propranolol|mesh-list
56593914|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56593915|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56593916|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
56593917|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593918|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593919|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593920|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56593921|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56593922|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
56593923|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
56593924|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56593946|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56593947|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
56593948|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56593949|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593950|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593951|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56593952|NCT00741013|Protein C|protein c|mesh-list
56593953|NCT00741013|Lovastatin|lovastatin|mesh-list
56593954|NCT00741013|L 647318|l 647318|mesh-list
56593955|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
56593956|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56593957|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56593958|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
56593959|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56593960|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56593961|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56593962|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56593963|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
56593964|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56593965|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56593966|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593967|NCT04087759|Bedaquiline|bedaquiline|mesh-list
56593968|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
56593969|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
56593970|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56593971|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56593972|NCT00740857|Ibuprofen|ibuprofen|mesh-list
56593973|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56593974|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56593975|NCT00740857|Analgesics|analgesics|mesh-ancestor
56593976|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
56593977|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56593978|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593988|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56593989|NCT00808132|Hormones|hormones|mesh-ancestor
56593990|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56593991|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56593992|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56593993|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56593994|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56593995|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
56593996|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56593997|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56593998|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56593999|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56594000|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56594001|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594002|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56027626|NCT01321541|Rituximab|rituximab|mesh-list
56594003|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56594004|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
56594005|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56594006|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
56594007|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56594008|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
56594009|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594010|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56594011|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56594032|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594033|NCT02692989|Anesthetics|anesthetics|mesh-list
56594034|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56594035|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594036|NCT04126473|Ivacaftor|ivacaftor|mesh-list
56594037|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56594038|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56594039|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594040|NCT03643276|Cytarabine|cytarabine|mesh-list
56594041|NCT03643276|Dexamethasone|dexamethasone|mesh-list
56594042|NCT03643276|Prednisone|prednisone|mesh-list
56594043|NCT03643276|Prednisolone|prednisolone|mesh-list
56594044|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
56594045|NCT03643276|Ifosfamide|ifosfamide|mesh-list
56594046|NCT03643276|Doxorubicin|doxorubicin|mesh-list
56594047|NCT03643276|Methotrexate|methotrexate|mesh-list
56594048|NCT03643276|Fludarabine|fludarabine|mesh-list
56594049|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
56594050|NCT03643276|Etoposide|etoposide|mesh-list
56594051|NCT03643276|Vincristine|vincristine|mesh-list
56594052|NCT03643276|Bortezomib|bortezomib|mesh-list
56594053|NCT03643276|Daunorubicin|daunorubicin|mesh-list
56594054|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
56594055|NCT03643276|Pegaspargase|pegaspargase|mesh-list
56594056|NCT03643276|Blinatumomab|blinatumomab|mesh-list
56594057|NCT03643276|Vindesine|vindesine|mesh-list
56594058|NCT03643276|Asparaginase|asparaginase|mesh-list
56594069|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
56594084|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56594085|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
56594086|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
56594087|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56594088|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56594089|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56594090|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
56594091|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594092|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
56594093|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
56594094|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
56594095|NCT04882293|Atorvastatin|atorvastatin|mesh-list
56594096|NCT04882293|Fenofibrate|fenofibrate|mesh-list
56594097|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56594098|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56594099|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
56594100|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594101|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56594140|NCT00803452|Doxycycline|doxycycline|mesh-list
56594141|NCT00803452|Minocycline|minocycline|mesh-list
56594142|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56594143|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594144|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
56594145|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56594146|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56594147|NCT04546113|Ropivacaine|ropivacaine|mesh-list
56594148|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
56594149|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
56594150|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56594151|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594152|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
56594153|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594154|NCT05737342|Red yeast rice|red yeast rice|mesh-list
56594155|NCT05737342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56594156|NCT05737342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56594157|NCT05737342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56594158|NCT05737342|Antimetabolites|antimetabolites|mesh-ancestor
56594160|NCT05737342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594196|NCT05753956|Serotonin Agents|serotonin agents|mesh-ancestor
56594197|NCT05753956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594198|NCT05753956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594199|NCT05753956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56594200|NCT05705050|Aminophylline|aminophylline|mesh-list
56594201|NCT05705050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56594202|NCT05705050|Autonomic Agents|autonomic agents|mesh-ancestor
56594203|NCT05705050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594204|NCT05705050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594205|NCT05705050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56594206|NCT05705050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56594207|NCT05705050|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56594208|NCT05705050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56594209|NCT05705050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56342744|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
56594210|NCT05705050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594211|NCT05705050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56106210|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56106211|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
56106212|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106213|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106214|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56106215|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56106216|NCT00004778|Dexamethasone|dexamethasone|mesh-list
56106217|NCT00004778|Betamethasone|betamethasone|mesh-list
56106218|NCT00004778|Hormones|hormones|mesh-list
56106219|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
56106220|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106221|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
56106222|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
56106223|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106224|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106225|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56106226|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
56106227|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106228|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56106229|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106230|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56106231|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
56106232|NCT00004784|Methotrexate|methotrexate|mesh-list
56106260|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56106261|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56106263|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106264|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56106265|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
56195961|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56195962|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56195963|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
56195964|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56195965|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56195966|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56195967|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56195968|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
56195969|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594212|NCT05705050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56594213|NCT05705050|Purinergic Agents|purinergic agents|mesh-ancestor
56594214|NCT05705050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594215|NCT05705050|Protective Agents|protective agents|mesh-ancestor
56594216|NCT04188483|Selenium|selenium|mesh-list
56594217|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
56594218|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594219|NCT04188483|Protective Agents|protective agents|mesh-ancestor
56594220|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594221|NCT04188483|Trace Elements|trace elements|mesh-ancestor
56594222|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
56594223|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56594224|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
56594225|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594226|NCT00717067|Ritonavir|ritonavir|mesh-list
56594227|NCT00717067|Saquinavir|saquinavir|mesh-list
56594228|NCT00717067|Maraviroc|maraviroc|mesh-list
56594229|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56594230|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56594231|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
56594232|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594233|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594234|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56594235|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56594236|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
56594237|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594240|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56594262|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56594263|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56594264|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
56594265|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594266|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594267|NCT02607436|Aspirin|aspirin|mesh-list
56594268|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
56594269|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56594270|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56594271|NCT02607436|Analgesics|analgesics|mesh-ancestor
56594272|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
56594273|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594274|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195970|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56195971|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56195972|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56195973|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56195974|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
56195975|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56195978|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195979|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195980|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
56195981|NCT01501435|Fenofibrate|fenofibrate|mesh-list
56195985|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56195987|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56195988|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56106266|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106267|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106268|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56106269|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56106270|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
56106271|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
56106272|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56106273|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
56106274|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106275|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106276|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106277|NCT00004826|Clozapine|clozapine|mesh-list
56106278|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56106308|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106310|NCT00005612|Etoposide|etoposide|mesh-list
56106311|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
56106312|NCT00005612|Carboplatin|carboplatin|mesh-list
56106313|NCT00005612|Topotecan|topotecan|mesh-list
56195989|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
56195990|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56195991|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56195992|NCT01501448|Estradiol|estradiol|mesh-list
56195993|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56106314|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56106315|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106316|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
56106317|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56106318|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56106319|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106320|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106321|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
56106322|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106344|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594275|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56594276|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56594277|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56594278|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56594279|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594280|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56594281|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56594282|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594283|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
56342816|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56594284|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56594285|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
56594286|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594287|NCT02607592|Pemetrexed|pemetrexed|mesh-list
56594288|NCT02607592|Nedaplatin|nedaplatin|mesh-list
56594289|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594290|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594291|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594292|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56594293|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56594294|NCT04356339|Interferons|interferons|mesh-list
56594295|NCT04356339|Interferon-beta|interferon-beta|mesh-list
56594296|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
56594297|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594298|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
56594299|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594300|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
56594323|NCT02605720|Artenimol|artenimol|mesh-list
56594324|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
56594325|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56594326|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56594327|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594328|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
56594329|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56594330|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
56594331|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594332|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
56594333|NCT04188561|Protective Agents|protective agents|mesh-ancestor
56594334|NCT00588952|Ketamine|ketamine|mesh-list
56594335|NCT00588952|Analgesics|analgesics|mesh-ancestor
56594336|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
56594337|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594338|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907334|NCT01524289|Anacetrapib|anacetrapib|mesh-list
56106345|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106346|NCT00005624|Tacedinaline|tacedinaline|mesh-list
56106347|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56106348|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106349|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106350|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106351|NCT00385502|Econazole|econazole|mesh-list
56106352|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
56106353|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106354|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56106355|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56106356|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106357|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106358|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56106359|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
56106360|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106361|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106362|NCT00005630|Sargramostim|sargramostim|mesh-list
56106363|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
56106364|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106365|NCT00005636|Pemetrexed|pemetrexed|mesh-list
56106366|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106367|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106368|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106369|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56106370|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56106371|NCT00005642|Semaxinib|semaxinib|mesh-list
56106372|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56106373|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56106413|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56106415|NCT00005654|Clomiphene|clomiphene|mesh-list
56106416|NCT00005654|Enclomiphene|enclomiphene|mesh-list
56106417|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
56106418|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56106419|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106420|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56106421|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
56106422|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56195994|NCT01501448|Estrogens|estrogens|mesh-ancestor
56195995|NCT01501448|Hormones|hormones|mesh-ancestor
56195996|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892971|NCT02005354|Anesthetics|anesthetics|mesh-list
56594339|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56594340|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56594341|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
56594342|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
56594343|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56594344|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56594345|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56594346|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594347|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594348|NCT04885257|Methylphenidate|methylphenidate|mesh-list
56594349|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56594350|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594351|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56594352|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56594353|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56594354|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594355|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
56594356|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594357|NCT05073003|Vaccines|vaccines|mesh-list
56594358|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
56594359|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594360|NCT03484923|Spartalizumab|spartalizumab|mesh-list
56594361|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56594362|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594363|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594364|NCT00802360|Menotropins|menotropins|mesh-list
56594365|NCT00802360|Progesterone|progesterone|mesh-list
56594366|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56594382|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594383|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
56594384|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594385|NCT04811625|Aspirin|aspirin|mesh-list
56594386|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56594387|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56594388|NCT04811625|Analgesics|analgesics|mesh-ancestor
56594389|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
56594390|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594391|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594392|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56594393|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56594394|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56594395|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56594396|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594397|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56594398|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56594399|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594400|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
56594436|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594437|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594439|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
56594440|NCT03292666|Dabigatran|dabigatran|mesh-list
56594441|NCT03292666|Apixaban|apixaban|mesh-list
56594442|NCT03292666|Anticoagulants|anticoagulants|mesh-list
56594443|NCT03292666|Edoxaban|edoxaban|mesh-list
56594444|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56594445|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
56594446|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56594447|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
56594448|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594449|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594450|NCT02707653|Misoprostol|misoprostol|mesh-list
56594451|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56594452|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
56594453|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594454|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594455|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56594456|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56594457|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
56594458|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55907453|NCT02367924|Trabectedin|trabectedin|mesh-list
56195997|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195998|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56195999|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
56196000|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56196001|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56196002|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56196003|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56196004|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56196005|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56196006|NCT01501487|Paclitaxel|paclitaxel|mesh-list
56196007|NCT01501487|Docetaxel|docetaxel|mesh-list
56196008|NCT01501487|Trastuzumab|trastuzumab|mesh-list
56196009|NCT01501487|Pertuzumab|pertuzumab|mesh-list
56196010|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56196011|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196012|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
56196013|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
56196014|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
56196015|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196016|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56196017|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56106460|NCT04456699|Capecitabine|capecitabine|mesh-list
56106461|NCT04456699|Olaparib|olaparib|mesh-list
56106486|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56106487|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
56106488|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106489|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56106490|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56106491|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106492|NCT00005762|Ritonavir|ritonavir|mesh-list
56106493|NCT00005762|Nelfinavir|nelfinavir|mesh-list
56106494|NCT00005762|Indinavir|indinavir|mesh-list
56594459|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56594460|NCT03901131|Norethindrone|norethindrone|mesh-list
56594461|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
56594462|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
56594463|NCT03901131|Estradiol|estradiol|mesh-list
56594464|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56594465|NCT03901131|Estrogens|estrogens|mesh-ancestor
56594466|NCT03901131|Hormones|hormones|mesh-ancestor
56594467|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56594468|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594469|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56594470|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
56594471|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594472|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56594473|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56594474|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56594475|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56594476|NCT02607202|Gemcitabine|gemcitabine|mesh-list
56594477|NCT02607202|Paclitaxel|paclitaxel|mesh-list
56594478|NCT02607202|Carboplatin|carboplatin|mesh-list
56594479|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56594480|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594481|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
56594482|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
56594483|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
56594486|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
56594509|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343040|NCT00153634|Azithromycin|azithromycin|mesh-list
56594510|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56594511|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56594512|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56594513|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
56594514|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594515|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594516|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56594517|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56594518|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
56594519|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56594520|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56594521|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
56594522|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
56594523|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56594524|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
56594525|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594526|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
56594527|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56594528|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594529|NCT03868839|Telmisartan|telmisartan|mesh-list
56594530|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56594531|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56594534|NCT00589420|Docetaxel|docetaxel|mesh-list
56594557|NCT04114630|Erenumab|erenumab|mesh-list
56594558|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56594559|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594560|NCT04114630|Analgesics|analgesics|mesh-ancestor
56594561|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
56594562|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594563|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594564|NCT04112212|Vedolizumab|vedolizumab|mesh-list
56594565|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56594566|NCT00914524|Olmesartan|olmesartan|mesh-list
56594567|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56594568|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56594569|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56594570|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56594571|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594572|NCT03787095|Cemiplimab|cemiplimab|mesh-list
56594574|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594611|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
56594612|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56594613|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
56594614|NCT04007991|Ecopipam|ecopipam|mesh-list
56594615|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56594616|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56594617|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56594618|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594619|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56594620|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56594621|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
56594622|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594623|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594624|NCT03822507|Cinacalcet|cinacalcet|mesh-list
56594625|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56594626|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594627|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56594628|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
56594665|NCT00627536|Mitogens|mitogens|mesh-list
56594666|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
56594667|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594668|NCT00724711|Tenofovir|tenofovir|mesh-list
56594669|NCT00724711|Lamivudine|lamivudine|mesh-list
56594670|NCT00724711|Emtricitabine|emtricitabine|mesh-list
56594671|NCT00724711|Abacavir|abacavir|mesh-list
56594672|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
56594673|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594674|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56594675|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56594676|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594677|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594678|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56594679|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56594680|NCT00721279|Pramipexole|pramipexole|mesh-list
56594681|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
56594682|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594683|NCT00721279|Protective Agents|protective agents|mesh-ancestor
56594684|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594685|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56594686|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56106495|NCT00005762|Saquinavir|saquinavir|mesh-list
56106496|NCT00005762|Amprenavir|amprenavir|mesh-list
56106497|NCT00005762|Efavirenz|efavirenz|mesh-list
56106498|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56106499|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56106500|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
56106502|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106504|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56106505|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
56106506|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106507|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56106508|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56106509|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56106510|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56196018|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56196019|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196020|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196021|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56196022|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196023|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196024|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196025|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196026|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
56196027|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
56106511|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56106512|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56106513|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56106546|NCT00005798|Carboplatin|carboplatin|mesh-list
56106547|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106548|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
56594687|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
56594688|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
56594689|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594690|NCT01030952|Acarbose|acarbose|mesh-list
56594691|NCT01030952|Nateglinide|nateglinide|mesh-list
56594692|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56594693|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594694|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106549|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106550|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106551|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56106552|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
56106553|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106554|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106555|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56106556|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
56106615|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56106616|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106617|NCT05296603|Lenvatinib|lenvatinib|mesh-list
56106618|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106619|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56106620|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106621|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106622|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
56106623|NCT04569890|Prednisone|prednisone|mesh-list
56106624|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
56106625|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106626|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
56106627|NCT04569890|Hormones|hormones|mesh-ancestor
56106628|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106629|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106630|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56106631|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106632|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
56106633|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56106634|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56106635|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106636|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106637|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106638|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106639|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106640|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
56106641|NCT00423163|Voriconazole|voriconazole|mesh-list
56106661|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
56106662|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106663|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106664|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56196036|NCT01501669|Irinotecan|irinotecan|mesh-list
56196037|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56196038|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
56196039|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196040|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196041|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56196046|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56106665|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56106667|NCT04568876|Analgesics|analgesics|mesh-ancestor
56106668|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
56106669|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106670|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106671|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56106672|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56106673|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106674|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106675|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
56106676|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106677|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56594695|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56594696|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594697|NCT03611751|Apremilast|apremilast|mesh-list
56594698|NCT03611751|BMS-986165|bms-986165|mesh-list
56594699|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56594700|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56594701|NCT03611751|Analgesics|analgesics|mesh-ancestor
56594702|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
56594703|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594704|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594705|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56594706|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56594707|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56594708|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56594709|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594710|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594711|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
56594712|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56594713|NCT00613743|Morphine|morphine|mesh-list
56594714|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56594715|NCT00613743|Narcotics|narcotics|mesh-ancestor
56594716|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56594717|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594718|NCT00613743|Analgesics|analgesics|mesh-ancestor
56594719|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
56594720|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594721|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
56594722|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56594723|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
56594724|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594725|NCT00614757|Expectorants|expectorants|mesh-ancestor
56594726|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
56594727|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56594728|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
55907718|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106678|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56106679|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106680|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106681|NCT04568876|Hormones|hormones|mesh-ancestor
56106682|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56594729|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594730|NCT00614757|Protective Agents|protective agents|mesh-ancestor
56594731|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594733|NCT02692365|Manganese|manganese|mesh-list
56594734|NCT02692365|Trace Elements|trace elements|mesh-ancestor
56594735|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
56594736|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594737|NCT03492099|Buprenorphine|buprenorphine|mesh-list
56594738|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56594739|NCT03492099|Narcotics|narcotics|mesh-ancestor
56594740|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56594741|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594742|NCT03492099|Analgesics|analgesics|mesh-ancestor
56594743|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
56594744|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594745|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56594746|NCT03481959|Methylphenidate|methylphenidate|mesh-list
56594747|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56594748|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594749|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56594750|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56594751|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56594752|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594753|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
56594754|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594755|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56594756|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56594757|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56594771|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56594772|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
56594773|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594774|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594775|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56594776|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56594777|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56594778|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594779|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56594780|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56594781|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56594782|NCT03387657|Diuretics|diuretics|mesh-ancestor
56594783|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
56594784|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594789|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56594826|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56594827|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56594828|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
56594829|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
56594830|NCT00720109|Leucovorin|leucovorin|mesh-list
56594831|NCT00720109|Folic Acid|folic acid|mesh-list
56594832|NCT00720109|Cytarabine|cytarabine|mesh-list
56594833|NCT00720109|Dexamethasone|dexamethasone|mesh-list
56594834|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
56594835|NCT00720109|Prednisone|prednisone|mesh-list
56594836|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
56594837|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56594838|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56594839|NCT00720109|Prednisolone|prednisolone|mesh-list
56594840|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
56594841|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
56594843|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56594891|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
56594892|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
56594893|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56594894|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56594895|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56594896|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56594897|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56594898|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
56594899|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594900|NCT00720109|Antidotes|antidotes|mesh-ancestor
56594901|NCT00720109|Protective Agents|protective agents|mesh-ancestor
56594902|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
56594903|NCT00720109|Vitamins|vitamins|mesh-ancestor
56594904|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
56594905|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56594906|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
56594907|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
56594908|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
56594909|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56594910|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56594911|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56594912|NCT00720109|Hematinics|hematinics|mesh-ancestor
56594913|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
56594914|NCT01705977|Belimumab|belimumab|mesh-list
56594915|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56594916|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
56594917|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594918|NCT02590627|Lumefantrine|lumefantrine|mesh-list
56594919|NCT02590627|Artemether|artemether|mesh-list
56594920|NCT02590627|Piperaquine|piperaquine|mesh-list
56594940|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
56594941|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594942|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56594943|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56594944|NCT02415153|Growth Substances|growth substances|mesh-ancestor
56594945|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
56594946|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594947|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
56594948|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56594949|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56159056|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
56594950|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594951|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
56594952|NCT04111822|Coagulants|coagulants|mesh-ancestor
56594953|NCT00628160|Terlipressin|terlipressin|mesh-list
56594954|NCT00628160|Dopamine|dopamine|mesh-list
56594955|NCT00628160|Norepinephrine|norepinephrine|mesh-list
56594956|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
56594957|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56594958|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56594959|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56594960|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594961|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594962|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
56594963|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
56594964|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56594965|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56594966|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56594967|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56594968|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
56594969|NCT00628160|Protective Agents|protective agents|mesh-ancestor
56594970|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56594971|NCT02324608|Cetuximab|cetuximab|mesh-list
56594972|NCT02324608|Antibodies|antibodies|mesh-list
56594973|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
56594974|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56594975|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
55907957|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106684|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56594976|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594977|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594978|NCT02274285|Vaccines|vaccines|mesh-list
56594979|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
56594980|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594981|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
56594982|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56594983|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
56594984|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
56594985|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
56594986|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56594987|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56594988|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56594989|NCT00614835|Gemcitabine|gemcitabine|mesh-list
56594990|NCT00614835|Docetaxel|docetaxel|mesh-list
56594991|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56594992|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
56594993|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56594994|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56594995|NCT00614835|Antiviral Agents|antiviral agents|mesh-ancestor
56594996|NCT00614835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56594997|NCT00614835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56594998|NCT00614835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56594999|NCT00614835|Immunologic Factors|immunologic factors|mesh-ancestor
56595000|NCT00614835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595001|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
56595002|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
56595003|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
56595004|NCT00715429|Vitamin D|vitamin d|mesh-list
56595005|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
56595006|NCT00715429|Vitamins|vitamins|mesh-ancestor
56595007|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
56595008|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595009|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56595010|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56595011|NCT02606032|Metronidazole|metronidazole|mesh-list
56595017|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56595018|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
56595019|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
56595020|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595021|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595022|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56595023|NCT01743651|Baclofen|baclofen|mesh-list
56595024|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56595025|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595026|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56595027|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595028|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56595029|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
56595030|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
56595031|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595032|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595034|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56595035|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56595039|NCT00723229|Acyclovir|acyclovir|mesh-list
56595074|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
56595075|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595076|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56595077|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56595078|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56595079|NCT00628238|Growth Substances|growth substances|mesh-ancestor
56595080|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
56595081|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56595082|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56595083|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
56595084|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595095|NCT01019486|Regadenoson|regadenoson|mesh-list
56595096|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56595097|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56595098|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56595099|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
56595100|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
56595101|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595102|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595103|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595104|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56595105|NCT02803203|Bevacizumab|bevacizumab|mesh-list
56595136|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595137|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595138|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56595139|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56595140|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595141|NCT00628316|Caffeine|caffeine|mesh-list
56595142|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56595143|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595144|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56595145|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595146|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595147|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56595148|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56595149|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
56595150|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595151|NCT01018862|Azelastine|azelastine|mesh-list
56595152|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56595153|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
56595154|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595190|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595191|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56595192|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56595193|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
56595194|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595195|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56595196|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56595197|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595198|NCT04301336|Trace Elements|trace elements|mesh-ancestor
56595199|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
56595200|NCT04301336|Hematinics|hematinics|mesh-ancestor
56595201|NCT04301336|Vitamins|vitamins|mesh-ancestor
56595202|NCT04301336|Astringents|astringents|mesh-ancestor
56595203|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
56595204|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595205|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
56595206|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56595207|NCT00627848|Rivastigmine|rivastigmine|mesh-list
56595208|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56595209|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595247|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
56595248|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56595249|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595250|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
56595251|NCT04505774|Empagliflozin|empagliflozin|mesh-list
56595252|NCT04505774|Canagliflozin|canagliflozin|mesh-list
56595253|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
56595254|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56595256|NCT04505774|Calcium heparin|calcium heparin|mesh-list
56595257|NCT04505774|Enoxaparin|enoxaparin|mesh-list
56595258|NCT04505774|Dalteparin|dalteparin|mesh-list
56595259|NCT04505774|Tinzaparin|tinzaparin|mesh-list
56595260|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56595261|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
56595262|NCT04505774|Clopidogrel|clopidogrel|mesh-list
56595310|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595311|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595312|NCT02871986|Estrogens|estrogens|mesh-list
56595313|NCT02871986|Hormones|hormones|mesh-ancestor
56595314|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595315|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595316|NCT00722137|Prednisone|prednisone|mesh-list
56595317|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
56595318|NCT00722137|Rituximab|rituximab|mesh-list
56595319|NCT00722137|Doxorubicin|doxorubicin|mesh-list
56595320|NCT00722137|Vincristine|vincristine|mesh-list
56595321|NCT00722137|Bortezomib|bortezomib|mesh-list
56595322|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595373|NCT00799708|Estrogens|estrogens|mesh-ancestor
56595374|NCT00799708|Hormones|hormones|mesh-ancestor
56595375|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595376|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595377|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56595378|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
56595379|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56595380|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56595381|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
56595382|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
56595383|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
56595384|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56595385|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56595386|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595387|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595388|NCT00796510|Urological Agents|urological agents|mesh-ancestor
56595389|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56595390|NCT04111432|Vaccines|vaccines|mesh-list
56595391|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
56595392|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595393|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56595394|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56595395|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56595396|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595397|NCT00588640|Methadone|methadone|mesh-list
56595420|NCT02604940|Analgesics|analgesics|mesh-ancestor
56595421|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
56595422|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595423|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56595424|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56595425|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56595426|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
56595427|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595428|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595429|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
56595430|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
56595431|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595432|NCT00802672|Ciclopirox|ciclopirox|mesh-list
56595433|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
56595434|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595435|NCT04113772|Nitisinone|nitisinone|mesh-list
56595436|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595481|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56595482|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56595483|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56595484|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56595485|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
56595486|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56595487|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595488|NCT02604784|Cisplatin|cisplatin|mesh-list
56595489|NCT02604784|Doxorubicin|doxorubicin|mesh-list
56595490|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56595491|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
56595547|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595548|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56595549|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
56595550|NCT05294263|Varenicline|varenicline|mesh-list
56595551|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56595552|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56595553|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
56595554|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595555|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595556|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595557|NCT02589457|Tenofovir|tenofovir|mesh-list
56595558|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
56595559|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595560|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56595561|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56595562|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595563|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595564|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56595565|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56595566|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
56595567|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56595568|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595599|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56595600|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
56595601|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595602|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595603|NCT05175235|Pembrolizumab|pembrolizumab|mesh-list
56595604|NCT05175235|Nivolumab|nivolumab|mesh-list
56595605|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595606|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595607|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56595608|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595609|NCT05236777|Natalizumab|natalizumab|mesh-list
56595610|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
56595611|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595612|NCT04298684|Metformin|metformin|mesh-list
56595613|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56595614|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56595615|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595616|NCT04298684|Incretins|incretins|mesh-ancestor
56595617|NCT04298684|Hormones|hormones|mesh-ancestor
56595620|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
56595662|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
56595663|NCT00793624|Olodaterol|olodaterol|mesh-list
56595664|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56595665|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
56595666|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595667|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595668|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56595669|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
56595670|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56595671|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56595672|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56595673|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
56595674|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595675|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595676|NCT00919243|Prednisone|prednisone|mesh-list
56595677|NCT00919243|Allopurinol|allopurinol|mesh-list
56595678|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56595679|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
56595680|NCT00919243|Hormones|hormones|mesh-ancestor
56595681|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595682|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595683|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56595684|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595685|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
56595686|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595687|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595688|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
56595689|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56595690|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56106685|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106693|NCT04338061|Teriflunomide|teriflunomide|mesh-list
56106721|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56106722|NCT04568096|Tamoxifen|tamoxifen|mesh-list
56106723|NCT04568096|Tretinoin|tretinoin|mesh-list
56106724|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56106725|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
56110445|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56595691|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
56595692|NCT00919243|Protective Agents|protective agents|mesh-ancestor
56595708|NCT05224141|Carboplatin|carboplatin|mesh-list
56595709|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
56595710|NCT05224141|Etoposide|etoposide|mesh-list
56595711|NCT05224141|Atezolizumab|atezolizumab|mesh-list
56595712|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595713|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595714|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56595715|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56595716|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56595718|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595719|NCT00794950|Sunitinib|sunitinib|mesh-list
56595720|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595753|NCT00798694|Travoprost|travoprost|mesh-list
56595754|NCT00798694|Latanoprost|latanoprost|mesh-list
56595755|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56595756|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56595757|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56595758|NCT00718315|Erythromycin|erythromycin|mesh-list
56595759|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
56595760|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56595761|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
56595762|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
56595763|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56595764|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595765|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56595766|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595767|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595768|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56595769|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595770|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56595771|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56595772|NCT00798304|Vaccines|vaccines|mesh-list
56595775|NCT04109872|Lenalidomide|lenalidomide|mesh-list
56595809|NCT04107220|Valsartan|valsartan|mesh-list
56595810|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56595811|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56595812|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56595813|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56595814|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595815|NCT05649748|Treprostinil|treprostinil|mesh-list
56595816|NCT05649748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56595817|NCT02591017|Ketamine|ketamine|mesh-list
56595818|NCT02591017|Morphine|morphine|mesh-list
56595819|NCT02591017|Chitosan|chitosan|mesh-list
56595820|NCT02591017|Analgesics|analgesics|mesh-ancestor
56595821|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
56595822|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56595823|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595824|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56595825|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56595826|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
56595827|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
56595828|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56595829|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56595830|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56595831|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595832|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595833|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56595834|NCT02591017|Narcotics|narcotics|mesh-ancestor
56595835|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56595836|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56595854|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56595855|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
56595856|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595857|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56595858|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
56595859|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595860|NCT05137717|Maribavir|maribavir|mesh-list
56595861|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
56595862|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595863|NCT02643303|Durvalumab|durvalumab|mesh-list
56595864|NCT02643303|Tremelimumab|tremelimumab|mesh-list
56595865|NCT02643303|Poly ICLC|poly iclc|mesh-list
56595866|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595867|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595868|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
56595869|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
56595870|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595871|NCT01939275|Copper|copper|mesh-list
56595872|NCT01939275|Trastuzumab|trastuzumab|mesh-list
56595873|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56595874|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595875|NCT01939275|Trace Elements|trace elements|mesh-ancestor
56595876|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
56595877|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595878|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
56595879|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56106726|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106727|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106728|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56106729|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196047|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196048|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196049|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196050|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56196051|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
56196052|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196053|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196054|NCT01501708|Voriconazole|voriconazole|mesh-list
56196055|NCT01501708|Amphotericin B|amphotericin b|mesh-list
56196056|NCT01501708|Caspofungin|caspofungin|mesh-list
56196057|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
56106730|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56106731|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56106732|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56106734|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106735|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56106736|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
56106737|NCT02278172|Vitamin D|vitamin d|mesh-list
56106738|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
56106739|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
56595880|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56595881|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595882|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
56595883|NCT00615147|Coagulants|coagulants|mesh-ancestor
56595884|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56595885|NCT01029717|Minocycline|minocycline|mesh-list
56595886|NCT01029717|Rifampin|rifampin|mesh-list
56595887|NCT01029717|Heparin|heparin|mesh-list
56595888|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56595889|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56595890|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
56595891|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
56595892|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56595893|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56595894|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595895|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
56595896|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56595938|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
56595939|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595940|NCT00915616|Protective Agents|protective agents|mesh-ancestor
56344470|NCT00162604|Cefuroxime|cefuroxime|mesh-list
56595941|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595942|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56595943|NCT00914836|Betamethasone|betamethasone|mesh-list
56595944|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
56595945|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56595946|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
56595947|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
56595948|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56595949|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56595950|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
56595951|NCT00914836|Hormones|hormones|mesh-ancestor
56595952|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56595953|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595954|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56595955|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
56595956|NCT04106752|Caffeine|caffeine|mesh-list
56595957|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56595958|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595959|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56595960|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595961|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595962|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56595963|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56595964|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
56595965|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56595966|NCT00792298|Suvorexant|suvorexant|mesh-list
56595977|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
56595978|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56595979|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56595980|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56595981|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
56595982|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56595983|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56595984|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
56595985|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56595986|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56595987|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56595988|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
56595989|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56595990|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56595991|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56595992|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56595993|NCT04106362|Cisplatin|cisplatin|mesh-list
56595994|NCT04106362|Cetuximab|cetuximab|mesh-list
56595995|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56595996|NCT04106362|Antibodies|antibodies|mesh-list
56595997|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
56595998|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56595999|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
56596029|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56596030|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
56596031|NCT04083625|Carbetocin|carbetocin|mesh-list
56596032|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
56596033|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56596034|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596035|NCT00787930|Valproic Acid|valproic acid|mesh-list
56596036|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
56596037|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596038|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596039|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
56596040|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596041|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596042|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
56596043|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56596044|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596045|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56596046|NCT04106050|Lidocaine|lidocaine|mesh-list
56596047|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
56596048|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
56596049|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596050|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596058|NCT00588094|Rituximab|rituximab|mesh-list
56596082|NCT05590624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596083|NCT05590624|Appetite Depressants|appetite depressants|mesh-ancestor
56596084|NCT05590624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56596085|NCT05590624|Sympathomimetics|sympathomimetics|mesh-ancestor
56596086|NCT05590624|Autonomic Agents|autonomic agents|mesh-ancestor
56596087|NCT05590624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596088|NCT05590624|Adrenergic Agents|adrenergic agents|mesh-ancestor
56596089|NCT05590624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344624|NCT00163345|Hormones|hormones|mesh-ancestor
56596090|NCT05590624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596091|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56596092|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
56596093|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596095|NCT00482157|Calcitriol|calcitriol|mesh-list
56596096|NCT00482157|Vitamins|vitamins|mesh-ancestor
56596097|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
56596098|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596099|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56596100|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56596101|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56596102|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56596103|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596104|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56596105|NCT02706015|Dipyrone|dipyrone|mesh-list
56596106|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
56596107|NCT02706015|Caffeine|caffeine|mesh-list
56596108|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56596109|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596110|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56596111|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596112|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596113|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56596114|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56596115|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
56596116|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596120|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
56596121|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596122|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56596123|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56596124|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
56596125|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56596126|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
56596127|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
56596128|NCT02707575|Ranibizumab|ranibizumab|mesh-list
56596129|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56596130|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56596131|NCT02707575|Growth Substances|growth substances|mesh-ancestor
56596132|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596133|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
56596134|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596135|NCT00919399|Tamoxifen|tamoxifen|mesh-list
56596136|NCT00919399|Exemestane|exemestane|mesh-list
56596137|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56596138|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
56480258|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596139|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56596171|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56596172|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56596173|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596174|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56596175|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56596176|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56596177|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
56596178|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596179|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56596180|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56596181|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596182|NCT04853251|Ranibizumab|ranibizumab|mesh-list
56596183|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56596184|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56596185|NCT04853251|Growth Substances|growth substances|mesh-ancestor
56596186|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596228|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596229|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596230|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
56596231|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596232|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56596233|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56596234|NCT05095207|Bicalutamide|bicalutamide|mesh-list
56596235|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
56596236|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
56596237|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56596238|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596239|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596240|NCT03354039|Tamoxifen|tamoxifen|mesh-list
56596241|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56596242|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
56596243|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56596244|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596245|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56596246|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596247|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56596248|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56596249|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56596250|NCT04105426|Antioxidants|antioxidants|mesh-list
56596251|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596252|NCT04105426|Protective Agents|protective agents|mesh-ancestor
56596253|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596254|NCT02704923|Atropine|atropine|mesh-list
56596255|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56596256|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56596257|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56596258|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56596259|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56596260|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
56596265|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
56596266|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
56596267|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56596268|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56596269|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
56596270|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596271|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596272|NCT05546554|Suvorexant|suvorexant|mesh-list
56596273|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56596274|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56596275|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596276|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596277|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56596278|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596279|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596280|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
56596281|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
56596282|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56596284|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56596285|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56596286|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596287|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
56596288|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596289|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596290|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56596291|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596292|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56596293|NCT02704767|Apatinib|apatinib|mesh-list
56596294|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56596299|NCT02587273|Fentanyl|fentanyl|mesh-list
56596310|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
56596312|NCT02587741|Acarbose|acarbose|mesh-list
56596313|NCT02587741|Gliclazide|gliclazide|mesh-list
56596314|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56596315|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56596316|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596317|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56596318|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596319|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596320|NCT02703363|Minocycline|minocycline|mesh-list
56596321|NCT02703363|Celecoxib|celecoxib|mesh-list
56596322|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56596323|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56596324|NCT02703363|Analgesics|analgesics|mesh-ancestor
56596325|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
56596326|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596327|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596328|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56596329|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56596330|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56596331|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56596332|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106740|NCT02278172|Vitamins|vitamins|mesh-list
56106741|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
56106842|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106843|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56106845|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56106846|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
56106847|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106848|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56106849|NCT04561856|Dexamethasone|dexamethasone|mesh-list
56106850|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
56106851|NCT04561856|BB 1101|bb 1101|mesh-list
56106852|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106853|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
56106854|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
56106855|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106856|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106857|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56106858|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
56106860|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106861|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56106862|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106863|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
56106864|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106969|NCT04068103|Antidotes|antidotes|mesh-ancestor
56106970|NCT04068103|Protective Agents|protective agents|mesh-ancestor
56196065|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56196066|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196067|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56596333|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596334|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56596335|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596336|NCT05018221|Vitamins|vitamins|mesh-list
56596337|NCT05018221|Vitamin K|vitamin k|mesh-list
56596338|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
56596339|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
56596340|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
56596341|NCT05018221|Citric Acid|citric acid|mesh-list
56596342|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
56596343|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
56596345|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
56596399|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56596400|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596401|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
56596402|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
56596403|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
56596404|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596405|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
56596406|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
56596407|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56596408|NCT00915694|Nelfinavir|nelfinavir|mesh-list
56596409|NCT00915694|Temozolomide|temozolomide|mesh-list
56596410|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56596411|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
56596412|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596413|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596414|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56596415|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56596416|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
56596422|NCT04799431|Poly I-C|poly i-c|mesh-list
56596456|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56596457|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596458|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596459|NCT02702739|Ribavirin|ribavirin|mesh-list
56596460|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
56596461|NCT02702739|Simeprevir|simeprevir|mesh-list
56596462|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
56596463|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596465|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596466|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
56596467|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596468|NCT02602444|Ticagrelor|ticagrelor|mesh-list
56596469|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56596472|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56596519|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56596520|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596521|NCT02602600|Incretins|incretins|mesh-ancestor
56596522|NCT02602600|Hormones|hormones|mesh-ancestor
56596523|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56596524|NCT00615615|Levetiracetam|levetiracetam|mesh-list
56596525|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
56596526|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
56596527|NCT00784810|Acetaminophen|acetaminophen|mesh-list
56596528|NCT00784810|Oxycodone|oxycodone|mesh-list
56596529|NCT00784810|Codeine|codeine|mesh-list
56596530|NCT00784810|Naloxone|naloxone|mesh-list
56596531|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56596532|NCT00784810|Analgesics|analgesics|mesh-ancestor
56596533|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
56596534|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596535|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596536|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
56596537|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56596538|NCT00784810|Narcotics|narcotics|mesh-ancestor
56345067|NCT00165685|Sibutramine|sibutramine|mesh-list
56596540|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56596576|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56596577|NCT04081909|Narcotics|narcotics|mesh-ancestor
56596578|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56596579|NCT03272217|Bevacizumab|bevacizumab|mesh-list
56596580|NCT03272217|Atezolizumab|atezolizumab|mesh-list
56596581|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56596582|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596583|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56596584|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56596585|NCT03272217|Growth Substances|growth substances|mesh-ancestor
56596586|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596587|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
56596588|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56596589|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56596590|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596591|NCT00915382|Cisplatin|cisplatin|mesh-list
56596592|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596593|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56596632|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56596633|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56596634|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596635|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596636|NCT00919555|Pioglitazone|pioglitazone|mesh-list
56596637|NCT00919555|Tretinoin|tretinoin|mesh-list
56596638|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56596639|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596640|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596641|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
56196069|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56196070|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56196071|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56196072|NCT01501747|Acetaminophen|acetaminophen|mesh-list
56196073|NCT01501747|Cephalexin|cephalexin|mesh-list
56196074|NCT01501747|Ibuprofen|ibuprofen|mesh-list
56196075|NCT01501747|Caffeine|caffeine|mesh-list
56106971|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
56106972|NCT04068103|Vitamins|vitamins|mesh-ancestor
56106973|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
56106974|NCT04068103|Hematinics|hematinics|mesh-ancestor
56106975|NCT03351361|Nivolumab|nivolumab|mesh-list
56106976|NCT03351361|Ipilimumab|ipilimumab|mesh-list
56106977|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56106978|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106979|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56106980|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106996|NCT03234907|Vedolizumab|vedolizumab|mesh-list
56106997|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56106998|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
56106999|NCT03228667|Nivolumab|nivolumab|mesh-list
56107000|NCT03228667|Durvalumab|durvalumab|mesh-list
56107001|NCT03228667|Avelumab|avelumab|mesh-list
56107002|NCT03228667|Atezolizumab|atezolizumab|mesh-list
56107021|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107022|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107023|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107024|NCT03968653|Carboplatin|carboplatin|mesh-list
56107025|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107026|NCT04330027|Mitogens|mitogens|mesh-list
56107027|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107028|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107029|NCT00002893|Leucovorin|leucovorin|mesh-list
56107030|NCT00002893|Fluorouracil|fluorouracil|mesh-list
56107031|NCT00002893|Raltitrexed|raltitrexed|mesh-list
56107032|NCT00002893|Calcium|calcium|mesh-list
56107033|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
55741977|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56107034|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56107035|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196076|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56196077|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56196078|NCT01501747|Analgesics|analgesics|mesh-ancestor
56196079|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
56107037|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107038|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107039|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107040|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107041|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
56107042|NCT00002893|Antidotes|antidotes|mesh-ancestor
56107043|NCT00002893|Protective Agents|protective agents|mesh-ancestor
56107044|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
56107045|NCT00002893|Vitamins|vitamins|mesh-ancestor
56107046|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
56107047|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56107048|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107049|NCT03905941|Metformin|metformin|mesh-list
56107050|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
56107051|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56107052|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596642|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
56596643|NCT02979093|Oxytocin|oxytocin|mesh-list
56596644|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
56596645|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56596646|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596647|NCT05567029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56596648|NCT05567029|Immunologic Factors|immunologic factors|mesh-ancestor
56596649|NCT05567029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596650|NCT02588131|Durvalumab|durvalumab|mesh-list
56596651|NCT02588131|Tremelimumab|tremelimumab|mesh-list
56596652|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56596653|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596654|NCT04766983|Dimercaprol|dimercaprol|mesh-list
56596655|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
56596656|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
56596657|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596658|NCT04766437|Ticagrelor|ticagrelor|mesh-list
56596659|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56596660|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56596661|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56596662|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56596663|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56596664|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
56596665|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596666|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596692|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56596693|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56596694|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
56596695|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596696|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56596697|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56596698|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56596699|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56596700|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56596701|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56596702|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56596703|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56596704|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56596705|NCT04761601|Gemcitabine|gemcitabine|mesh-list
56596706|NCT04761601|Paclitaxel|paclitaxel|mesh-list
56596707|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56596708|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596709|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
56596710|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
56596711|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
56596712|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596713|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56596714|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
56596715|NCT04761601|Antiviral Agents|antiviral agents|mesh-ancestor
56596716|NCT04761601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596717|NCT04761601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909688|NCT02332512|Apatinib|apatinib|mesh-list
56107053|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56107054|NCT03900715|Luspatercept|luspatercept|mesh-list
56107055|NCT03900715|Hematinics|hematinics|mesh-ancestor
56107056|NCT03818581|Suvorexant|suvorexant|mesh-list
56107057|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56107058|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56107059|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56107099|NCT00002917|Paclitaxel|paclitaxel|mesh-list
56107100|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107101|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107102|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107103|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107104|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107105|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107106|NCT00383695|Capecitabine|capecitabine|mesh-list
56107107|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
56107108|NCT00383695|Cetuximab|cetuximab|mesh-list
56107109|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107110|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
56596718|NCT04761601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56596719|NCT04761601|Immunologic Factors|immunologic factors|mesh-ancestor
56596720|NCT04761601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596721|NCT02960763|Aripiprazole|aripiprazole|mesh-list
56596722|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
56596723|NCT02960763|Bupropion|bupropion|mesh-list
56596724|NCT02960763|Nortriptyline|nortriptyline|mesh-list
56596725|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56596726|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
56596727|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56596728|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56480260|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56596729|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56596730|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56596731|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596732|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
56596733|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596734|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596735|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56596736|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56596769|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
56596770|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596771|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596772|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
56596773|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596774|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56596775|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56596776|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56596777|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56596778|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596779|NCT02586961|Betamethasone|betamethasone|mesh-list
56596780|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
56596781|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56596782|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
56596783|NCT02586961|Epinephrine|epinephrine|mesh-list
56596784|NCT02586961|Racepinephrine|racepinephrine|mesh-list
56596785|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56596786|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
56596787|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56596788|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
56596789|NCT02586961|Hormones|hormones|mesh-ancestor
56596790|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56596791|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596792|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56596793|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
56596815|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596816|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56596817|NCT02700711|Analgesics|analgesics|mesh-ancestor
56596818|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
56596819|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596820|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
56596821|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56596822|NCT04215159|Gemcitabine|gemcitabine|mesh-list
56596823|NCT04215159|Trastuzumab|trastuzumab|mesh-list
56596824|NCT04215159|Irinotecan|irinotecan|mesh-list
56596825|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56596826|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
56596827|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596828|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596829|NCT04215159|Antiviral Agents|antiviral agents|mesh-ancestor
56596830|NCT04215159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596831|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596832|NCT04215159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56596833|NCT04215159|Immunologic Factors|immunologic factors|mesh-ancestor
56596834|NCT04215159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596871|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596872|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
56596873|NCT02586181|Vitamin D|vitamin d|mesh-list
56596874|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
56596875|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
56596876|NCT02586181|Vitamins|vitamins|mesh-list
56596877|NCT02586181|Folic Acid|folic acid|mesh-list
56596878|NCT02586181|Calcium|calcium|mesh-list
56596879|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
56596880|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596881|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56596882|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56596883|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
56596884|NCT02586181|Hematinics|hematinics|mesh-ancestor
56596885|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56596886|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56596887|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596888|NCT04958785|Paclitaxel|paclitaxel|mesh-list
56596889|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56596890|NCT04958785|Magrolimab|magrolimab|mesh-list
56596891|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56596892|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596893|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
56596894|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
56596895|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
56596896|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596897|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56596898|NCT00775138|Amikacin|amikacin|mesh-list
56596899|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56596900|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56596901|NCT03236805|Ketamine|ketamine|mesh-list
56596902|NCT03236805|Morphine|morphine|mesh-list
56596903|NCT03236805|Analgesics|analgesics|mesh-ancestor
56596904|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
56596905|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596906|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596907|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56596909|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
56596911|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596913|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56596914|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56596915|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596916|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56596917|NCT03236805|Narcotics|narcotics|mesh-ancestor
56596918|NCT02698995|Acetaminophen|acetaminophen|mesh-list
56596919|NCT02698995|Dexamethasone|dexamethasone|mesh-list
56596920|NCT02698995|Lidocaine|lidocaine|mesh-list
56596921|NCT02698995|Morphine|morphine|mesh-list
56596922|NCT02698995|Ropivacaine|ropivacaine|mesh-list
56596923|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56596924|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
56596925|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
56596926|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56596927|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56596928|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56596929|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
56596930|NCT02698995|Hormones|hormones|mesh-ancestor
56596931|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56596932|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56596933|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596934|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
56596935|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
56086745|NCT05443178|Isoniazid|isoniazid|mesh-list
56596936|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56596937|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
56596938|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56596939|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56596940|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56596941|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55909908|NCT01794351|Protective Agents|protective agents|mesh-ancestor
56107111|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107112|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107113|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56107114|NCT00383851|Temozolomide|temozolomide|mesh-list
56107115|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56107116|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107117|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
56107118|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107156|NCT02461927|Ketamine|ketamine|mesh-list
56107157|NCT02461927|Analgesics|analgesics|mesh-ancestor
56107158|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
56596942|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596943|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56596944|NCT02698995|Narcotics|narcotics|mesh-ancestor
56596945|NCT02698995|Analgesics|analgesics|mesh-ancestor
56596946|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56596947|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
56596948|NCT00920101|Atorvastatin|atorvastatin|mesh-list
56596949|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56596950|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56596951|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
56596952|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596953|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56596954|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56596955|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596956|NCT00616785|Irinotecan|irinotecan|mesh-list
56596957|NCT00616785|Etoposide|etoposide|mesh-list
56596958|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56596959|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56596960|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56596961|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596962|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596963|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56596964|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56596965|NCT00616005|Irinotecan|irinotecan|mesh-list
56596966|NCT00616005|Temozolomide|temozolomide|mesh-list
56596967|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56596968|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56596969|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596973|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
56596987|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56596988|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56596989|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
56596990|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56596991|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56596992|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56596993|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56596994|NCT02586649|Bromides|bromides|mesh-list
56596995|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
56596996|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56596997|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56596998|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
56596999|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597000|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597001|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56597002|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
56597003|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
56597004|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
56597005|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597006|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597007|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
56597008|NCT04213833|Lidocaine|lidocaine|mesh-list
56597009|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
56597010|NCT04213833|Propofol|propofol|mesh-list
56597011|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
56597012|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
56597013|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597014|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597015|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
56597032|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
56597033|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56597034|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597035|NCT00783796|Everolimus|everolimus|mesh-list
56597036|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597037|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597038|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
56597039|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597040|NCT00637065|Bosentan|bosentan|mesh-list
56597041|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56597042|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56597043|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597044|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
56597045|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
56597046|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56597047|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56597048|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56597049|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597050|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56597051|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56597052|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
56597053|NCT04947553|Bupropion|bupropion|mesh-list
56597054|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56597055|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
56597056|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56597057|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56597058|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56597059|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56597060|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597061|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
56597062|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597063|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597070|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56597072|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56597073|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
56597074|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597075|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597076|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56597077|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597078|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56597079|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56597080|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56597081|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
56597082|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
56597143|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597144|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597145|NCT04079725|Mitomycins|mitomycins|mesh-list
56597146|NCT04079725|Mitomycin|mitomycin|mesh-list
56597147|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56597148|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597149|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
56107159|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56107160|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107161|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56107162|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56107163|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
56107164|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
56107165|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56107166|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56107167|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56107168|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56107169|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107170|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56107171|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56107172|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56107173|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56107174|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56107175|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
56107176|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
56107177|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56107178|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56107179|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56196080|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196081|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196082|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56196083|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196084|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56196085|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196086|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196088|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56196089|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56196090|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56196091|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56196092|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
56196093|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56107180|NCT00002935|Trioxsalen|trioxsalen|mesh-list
56107181|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107275|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107276|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107277|NCT00002977|Melphalan|melphalan|mesh-list
56107278|NCT00002977|Thiotepa|thiotepa|mesh-list
56107279|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
56107280|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107281|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107282|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
56107283|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107284|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107285|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107286|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107287|NCT00003391|Antibodies|antibodies|mesh-list
56107289|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
56107290|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107291|NCT00003397|Gemcitabine|gemcitabine|mesh-list
56107292|NCT00003397|Dexamethasone|dexamethasone|mesh-list
56107294|NCT00003397|Etoposide|etoposide|mesh-list
56107295|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
56107296|NCT00003397|Rituximab|rituximab|mesh-list
56107297|NCT00003397|Melphalan|melphalan|mesh-list
56107298|NCT00003397|Carmustine|carmustine|mesh-list
56107299|NCT00003397|Sargramostim|sargramostim|mesh-list
56107300|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107301|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107302|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
56597150|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597151|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56597152|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597153|NCT00783718|Vedolizumab|vedolizumab|mesh-list
56597154|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56597155|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56597156|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597157|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56597158|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56597159|NCT04213287|Analgesics|analgesics|mesh-ancestor
56597160|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
56597161|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597162|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56597163|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597164|NCT02585791|Glycerol|glycerol|mesh-list
56597165|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56597166|NCT02585791|Protective Agents|protective agents|mesh-ancestor
56597167|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597168|NCT04913389|Acetazolamide|acetazolamide|mesh-list
56597169|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
56597170|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56597171|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597172|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597173|NCT04913389|Diuretics|diuretics|mesh-ancestor
56597174|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
56597175|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597176|NCT04904965|Propofol|propofol|mesh-list
56597177|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56597178|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597179|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597180|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56597192|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56597193|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56597194|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597195|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597196|NCT00617565|Insulin|insulin|mesh-list
56597197|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56597198|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
56597199|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
56597200|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56597201|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597202|NCT04079413|Insulin|insulin|mesh-list
56597203|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56597204|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
56597205|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
56345750|NCT00170053|Sirolimus|sirolimus|mesh-list
56597206|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56597255|NCT04559581|Nintedanib|nintedanib|mesh-list
56597256|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597257|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56597258|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597259|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597260|NCT00583453|Celecoxib|celecoxib|mesh-list
56597261|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56597262|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56597263|NCT00583453|Analgesics|analgesics|mesh-ancestor
56597264|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
56597265|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597266|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597267|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56597268|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597269|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56597270|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56597271|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597272|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597273|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56597274|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
56597275|NCT02584231|Coagulants|coagulants|mesh-ancestor
56597276|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56597277|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
56597278|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597279|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
56597280|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56597281|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56597282|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597283|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
56597299|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56597300|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56597301|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597302|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597304|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
56597305|NCT04080349|Misoprostol|misoprostol|mesh-list
56597306|NCT04080349|Dinoprostone|dinoprostone|mesh-list
56597307|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56597308|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
56597309|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56597310|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597311|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56597312|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56597313|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
56597314|NCT04624243|Risperidone|risperidone|mesh-list
56597315|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56597316|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
56597317|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597318|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597319|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597320|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56597321|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56597322|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597323|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56597324|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56597325|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
56597326|NCT02585011|Epinephrine|epinephrine|mesh-list
56597327|NCT02585011|Ropivacaine|ropivacaine|mesh-list
56597328|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
56597329|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
56597330|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597331|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597332|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
56597333|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597334|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56597335|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56597338|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597339|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56597340|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56597341|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
56597342|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56597343|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
56597344|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
56597345|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
56597346|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56597347|NCT04858009|Paclitaxel|paclitaxel|mesh-list
56597348|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56597349|NCT04858009|Cisplatin|cisplatin|mesh-list
56597350|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56597351|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597352|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
56597353|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
56597354|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
56597355|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597364|NCT04610671|Nivolumab|nivolumab|mesh-list
56597365|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56597366|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597367|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56597368|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597369|NCT00920725|Insulin|insulin|mesh-list
56597397|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56597398|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
56597399|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
56597400|NCT05435911|Antidotes|antidotes|mesh-ancestor
56597401|NCT05435911|Protective Agents|protective agents|mesh-ancestor
56597402|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
56597403|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
56597404|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597405|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597406|NCT04472299|Ropivacaine|ropivacaine|mesh-list
56597407|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
56597408|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
56597409|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597410|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597411|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
56597412|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597413|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56597414|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
56597415|NCT02583685|Ribavirin|ribavirin|mesh-list
56597416|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56597417|NCT02583685|Simeprevir|simeprevir|mesh-list
56597418|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
56597419|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597420|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
56597421|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597422|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
56597423|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597424|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
56597425|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597426|NCT04606771|Osimertinib|osimertinib|mesh-list
56597427|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597428|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56597429|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597430|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597431|NCT04504825|Dexamethasone|dexamethasone|mesh-list
55910366|NCT00383565|Romidepsin|romidepsin|mesh-list
56107303|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107304|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107324|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
56107325|NCT00003397|Antiviral Agents|antiviral agents|mesh-ancestor
56107326|NCT00003397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345970|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56597432|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
56597433|NCT04504825|Bortezomib|bortezomib|mesh-list
56597434|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597435|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
56597436|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597437|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597438|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56597439|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
56597440|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597441|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597442|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56597443|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56597444|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
56597445|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
56597446|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597447|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56597448|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
56597488|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56597489|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597490|NCT04501939|Venetoclax|venetoclax|mesh-list
56597491|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597492|NCT05674669|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
56597493|NCT05674669|Hallucinogens|hallucinogens|mesh-ancestor
56597494|NCT05674669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597495|NCT05674669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56597496|NCT05674669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56597497|NCT05674669|Serotonin Agents|serotonin agents|mesh-ancestor
56597498|NCT05674669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597499|NCT05674669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597500|NCT05674669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56597501|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
56597502|NCT04332211|Ephedrine|ephedrine|mesh-list
56597503|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56597504|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
56597505|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597506|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597507|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56597508|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
56597509|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
56597510|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56597511|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56597512|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
56597513|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
56597537|NCT04078711|Losartan|losartan|mesh-list
56597538|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56597539|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56597540|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56597541|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56597542|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597543|NCT04086745|Adalimumab|adalimumab|mesh-list
56597544|NCT04086745|Etanercept|etanercept|mesh-list
56597545|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56597546|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56597547|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597548|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56597549|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56597550|NCT04086745|Analgesics|analgesics|mesh-ancestor
56597551|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
56597552|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597553|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597554|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56597555|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56597556|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
56597557|NCT05290129|Oxytocin|oxytocin|mesh-list
56597558|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
56597559|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56597560|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597561|NCT04304573|Calcium|calcium|mesh-list
56597562|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56597563|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597564|NCT04667117|Ofatumumab|ofatumumab|mesh-list
56597565|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597566|NCT04426669|Aldesleukin|aldesleukin|mesh-list
56597567|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
56597568|NCT04426669|Fludarabine|fludarabine|mesh-list
56597580|NCT04426669|Analgesics|analgesics|mesh-ancestor
56597581|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
56597582|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597583|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56597584|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56597585|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
56597586|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56597587|NCT02874989|Dasatinib|dasatinib|mesh-list
56597588|NCT02874989|Quercetin|quercetin|mesh-list
56597589|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597590|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56597591|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597592|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597593|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
56597594|NCT02874989|Protective Agents|protective agents|mesh-ancestor
56597595|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597596|NCT01071317|Naproxen|naproxen|mesh-list
56597639|NCT05568550|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56597640|NCT05568550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597641|NCT05568550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597642|NCT05568550|Hormones|hormones|mesh-ancestor
56597643|NCT05568550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597644|NCT05568550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597645|NCT02583217|Ketamine|ketamine|mesh-list
56597646|NCT02583217|Remifentanil|remifentanil|mesh-list
56597647|NCT02583217|Propofol|propofol|mesh-list
56597648|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56597649|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597653|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
56597703|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56597704|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
56597705|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597706|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597707|NCT04102072|Protective Agents|protective agents|mesh-ancestor
56597708|NCT02875457|Cisplatin|cisplatin|mesh-list
56597709|NCT02875457|Etoposide|etoposide|mesh-list
56597710|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
56597711|NCT02875457|Apatinib|apatinib|mesh-list
56597712|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597713|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56597714|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56597715|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56597716|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597717|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597719|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
56597765|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597766|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56597767|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56597768|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597769|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56597770|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56597771|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
56597772|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
56597773|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
56597774|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597775|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56597776|NCT04076371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56597830|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597831|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597832|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56597833|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56597834|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
56597835|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597837|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56597838|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56597839|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56597840|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597841|NCT03897751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56597842|NCT01010126|Sirolimus|sirolimus|mesh-list
56597843|NCT01010126|Bevacizumab|bevacizumab|mesh-list
56597844|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56597845|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
56597846|NCT01010126|Antibodies|antibodies|mesh-list
56597847|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
56597848|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56597849|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
56597850|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597851|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56597852|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56597853|NCT01010126|Growth Substances|growth substances|mesh-ancestor
56597882|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56597883|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
56597884|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597885|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597886|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597887|NCT03879577|Tamoxifen|tamoxifen|mesh-list
56597888|NCT03879577|Docetaxel|docetaxel|mesh-list
56597889|NCT03879577|Trastuzumab|trastuzumab|mesh-list
56597890|NCT03879577|Letrozole|letrozole|mesh-list
56597891|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56597892|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
56597893|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
56597894|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
56597895|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597896|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56597897|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56597898|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56597899|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597900|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56597901|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
56597902|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597903|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597904|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56597934|NCT00617877|Losartan|losartan|mesh-list
56597935|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56597936|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56597937|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56597938|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56597939|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56597940|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597941|NCT00617877|Diuretics|diuretics|mesh-ancestor
56597942|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
56597943|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597944|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56597945|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56597946|NCT00617955|Aprotinin|aprotinin|mesh-list
56597947|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597948|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
56597949|NCT00617955|Coagulants|coagulants|mesh-ancestor
56597950|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56597951|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56597952|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
56597953|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56597954|NCT03834883|Ibutilide|ibutilide|mesh-list
56597955|NCT03834883|Progesterone|progesterone|mesh-list
56597956|NCT03834883|Progestins|progestins|mesh-ancestor
56597957|NCT03834883|Hormones|hormones|mesh-ancestor
56597958|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56597959|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597960|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56597961|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
56597962|NCT02582437|Narcotics|narcotics|mesh-ancestor
56597963|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56597965|NCT02582437|Analgesics|analgesics|mesh-ancestor
56597977|NCT05674201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56597978|NCT05674201|Analgesics|analgesics|mesh-ancestor
56597979|NCT05674201|Sensory System Agents|sensory system agents|mesh-ancestor
56597980|NCT05674201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597981|NCT05674201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56597982|NCT05674201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56597983|NCT05674201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56597984|NCT05674201|Adrenergic Agents|adrenergic agents|mesh-ancestor
56597985|NCT05674201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56597986|NCT05674201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56597987|NCT05674201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56597988|NCT05674201|Narcotics|narcotics|mesh-ancestor
56597989|NCT01070303|Adalimumab|adalimumab|mesh-list
56597990|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56597991|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56597992|NCT00618111|Granisetron|granisetron|mesh-list
56597993|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
56597994|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
56597995|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56597996|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56597997|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56597998|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56597999|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
56598000|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598001|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598002|NCT01009814|Ritonavir|ritonavir|mesh-list
56598003|NCT01009814|Fostemsavir|fostemsavir|mesh-list
56598004|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56598005|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56598006|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
56598007|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598008|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598009|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56598010|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56598011|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
56598012|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598013|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56598014|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56598015|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56598016|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56598017|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
56598018|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
56598019|NCT03824587|Calcium|calcium|mesh-list
56598020|NCT03824587|Sevelamer|sevelamer|mesh-list
56598021|NCT03824587|Calcium acetate|calcium acetate|mesh-list
56598022|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56598023|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598024|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56598025|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
56598026|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
56598027|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598028|NCT03824587|Antacids|antacids|mesh-ancestor
56598029|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56598030|NCT00773734|Thalidomide|thalidomide|mesh-list
56598031|NCT00773734|Apremilast|apremilast|mesh-list
56598032|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56598033|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56598034|NCT00773734|Analgesics|analgesics|mesh-ancestor
56598035|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
56598036|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598037|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598038|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598039|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598040|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56598041|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56598055|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
56598061|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
56598062|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598063|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598064|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56598065|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
56598066|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598067|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598068|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56598069|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598070|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598071|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
56598072|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
56598073|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598074|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56598075|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56598076|NCT02280525|Growth Substances|growth substances|mesh-ancestor
56598077|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
56598078|NCT04297202|Apatinib|apatinib|mesh-list
56598079|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598117|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598118|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598119|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
56598120|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598121|NCT01001702|Aripiprazole|aripiprazole|mesh-list
56598122|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
56598123|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56598124|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56598125|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56598126|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598127|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598128|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
56598129|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
56598130|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598131|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598132|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56598133|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56598134|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
56598135|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56598136|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56598137|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56598138|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56598139|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
56598140|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56598141|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598142|NCT00618345|Everolimus|everolimus|mesh-list
56598143|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598144|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598145|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
56598146|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598147|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
56598148|NCT02601898|Progesterone|progesterone|mesh-list
56598149|NCT02601898|Progestins|progestins|mesh-ancestor
56598150|NCT02601898|Hormones|hormones|mesh-ancestor
55911070|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107327|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107328|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107329|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107330|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
56107331|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107332|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56598151|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56598152|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598153|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
56598154|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598155|NCT02601898|Protective Agents|protective agents|mesh-ancestor
56598156|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
56598157|NCT02601898|Vitamins|vitamins|mesh-ancestor
56598158|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
56598159|NCT00618423|Ketamine|ketamine|mesh-list
56598160|NCT00618423|Analgesics|analgesics|mesh-ancestor
56598161|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
56598162|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598163|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598164|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56598165|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56598166|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
56598167|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
56598168|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598169|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56598170|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56598171|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598205|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56598206|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56598207|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
56598208|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598209|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598210|NCT04214145|Protective Agents|protective agents|mesh-ancestor
56598211|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
56598212|NCT04214145|Coagulants|coagulants|mesh-ancestor
56598213|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56598214|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
56598215|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
56598216|NCT04212429|Levofloxacin|levofloxacin|mesh-list
56598217|NCT04212429|Ofloxacin|ofloxacin|mesh-list
56598218|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56598219|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56598220|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56598221|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598222|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56598223|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56598224|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598225|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598226|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598227|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56598228|NCT04212429|Renal Agents|renal agents|mesh-ancestor
56598229|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56598230|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56598255|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598256|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598257|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
56598258|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598259|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56598260|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598261|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
56598262|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598263|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56598264|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56598265|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56598266|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56598267|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
56598268|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598269|NCT00618501|Antidotes|antidotes|mesh-ancestor
56598315|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598316|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598317|NCT00618579|Warfarin|warfarin|mesh-list
56598318|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
56598319|NCT00781768|Ondansetron|ondansetron|mesh-list
56598320|NCT00781768|Aprepitant|aprepitant|mesh-list
56598321|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
56598322|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
56598323|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598324|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598325|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56107333|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107334|NCT00003415|Topotecan|topotecan|mesh-list
56107335|NCT00003415|Amifostine|amifostine|mesh-list
55741980|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
56107336|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56196094|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56196095|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107337|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107338|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107339|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107340|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107341|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56107342|NCT00003415|Protective Agents|protective agents|mesh-ancestor
56107343|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107344|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
56107346|NCT00002989|Busulfan|busulfan|mesh-list
56107347|NCT00002989|Idarubicin|idarubicin|mesh-list
56107348|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107349|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
56107350|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107351|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107352|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107353|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
56107354|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107355|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107356|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107357|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107358|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107388|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107389|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
56107390|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107391|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107392|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107393|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
56107394|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107395|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107396|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107397|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56107398|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
56107399|NCT01925131|Hormones|hormones|mesh-ancestor
56107400|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107401|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56107402|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107488|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56107489|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
56107490|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
56107491|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56107492|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56107493|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
56107494|NCT00003007|Hormones|hormones|mesh-ancestor
56107496|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56107497|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
56107498|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107499|NCT01478035|Phenytoin|phenytoin|mesh-list
56598326|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
56598327|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
56598328|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56598329|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
56598330|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598331|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598332|NCT00781768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56598333|NCT00781768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56598334|NCT00781768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598335|NCT00781768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56598336|NCT00781768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56598337|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56598338|NCT01005680|Gemcitabine|gemcitabine|mesh-list
56598339|NCT01005680|Pemetrexed|pemetrexed|mesh-list
56598340|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598341|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598342|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
56598344|NCT01005680|Antiviral Agents|antiviral agents|mesh-ancestor
56598384|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56598385|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56598386|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598387|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598388|NCT01005602|Protective Agents|protective agents|mesh-ancestor
56598389|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598390|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56598391|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
56598392|NCT05490940|Coagulants|coagulants|mesh-ancestor
56598393|NCT04304261|Metformin|metformin|mesh-list
56598394|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
56598395|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56598396|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598448|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56598449|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598450|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56598451|NCT01064297|Lamotrigine|lamotrigine|mesh-list
56598452|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
56598453|NCT01064297|Valproic Acid|valproic acid|mesh-list
56598454|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56598455|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56598456|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598457|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56598458|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598459|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56598460|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56598461|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598462|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56598463|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56598464|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598465|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
56598466|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598467|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
56598468|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
56598469|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
56598470|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
56598499|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
56598500|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598502|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
56598503|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598505|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598506|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
56598507|NCT02580331|Metformin|metformin|mesh-list
56598508|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56598509|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598510|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56598511|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56598512|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56598513|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56598514|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598515|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598516|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598517|NCT00767806|Analgesics|analgesics|mesh-ancestor
56598518|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
56598519|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598520|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
56598521|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56598522|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
56598523|NCT00780910|Ribavirin|ribavirin|mesh-list
56598524|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56598525|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
56598526|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598527|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
56598528|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598547|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598548|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
56598549|NCT00770770|Hormones|hormones|mesh-ancestor
56598550|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56598551|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598552|NCT00766636|Gemcitabine|gemcitabine|mesh-list
56598553|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56598554|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598555|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
56598556|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598557|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598558|NCT00766636|Antiviral Agents|antiviral agents|mesh-ancestor
56598559|NCT00766636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598560|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598561|NCT00766636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598562|NCT00766636|Immunologic Factors|immunologic factors|mesh-ancestor
56598563|NCT00766636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598564|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56598565|NCT04348045|Durvalumab|durvalumab|mesh-list
56598566|NCT04348045|Olaparib|olaparib|mesh-list
56598567|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598568|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598569|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56598572|NCT03337009|Naloxone|naloxone|mesh-list
56598597|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598598|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56598599|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
56598600|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598601|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598602|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56598603|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
56598604|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
56598605|NCT04952389|Hormones|hormones|mesh-ancestor
56598606|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56598607|NCT02581969|Factor VIII|factor viii|mesh-list
56598608|NCT02581969|Coagulants|coagulants|mesh-ancestor
56598609|NCT00770692|Eszopiclone|eszopiclone|mesh-list
56598610|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56598611|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56598612|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598618|NCT04099732|Dabigatran|dabigatran|mesh-list
56598656|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
56598657|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598658|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
56598659|NCT02743819|Ipilimumab|ipilimumab|mesh-list
56598660|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56598661|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598662|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56598663|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598664|NCT04074421|Rifaximin|rifaximin|mesh-list
56598665|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56598668|NCT02579707|Ivosidenib|ivosidenib|mesh-list
56598721|NCT03011671|Acetazolamide|acetazolamide|mesh-list
55911665|NCT00475215|Rocuronium|rocuronium|mesh-list
56107500|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
56107501|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56107502|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56107503|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56107539|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56107572|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107574|NCT00003019|Methotrexate|methotrexate|mesh-list
56107575|NCT00003019|Vinblastine|vinblastine|mesh-list
56107576|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56107577|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
56107578|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56107579|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107609|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56107610|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
56107611|NCT00003493|Hormones|hormones|mesh-ancestor
56107612|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107613|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56107614|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196097|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56107615|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107616|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107617|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107618|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107619|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107620|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107621|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107622|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107623|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107624|NCT00788125|Carboplatin|carboplatin|mesh-list
56107625|NCT00788125|Etoposide|etoposide|mesh-list
56107659|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56107661|NCT00003517|Flutamide|flutamide|mesh-list
56107662|NCT00003517|Bicalutamide|bicalutamide|mesh-list
56107663|NCT00003517|Hormones|hormones|mesh-list
56107664|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
56107685|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107686|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107687|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107688|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
56107690|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56107691|NCT00002803|Vincristine|vincristine|mesh-list
56107692|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107693|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
56107694|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107695|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107696|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107697|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
56107698|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107699|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107700|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107701|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55741992|NCT02649231|Analgesics|analgesics|mesh-ancestor
56107702|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107703|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107704|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107705|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107706|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107707|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107708|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107709|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56107710|NCT00383929|Candesartan|candesartan|mesh-list
56107711|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
56107712|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56107713|NCT00383929|Diuretics|diuretics|mesh-ancestor
56107714|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
56107715|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107716|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56107737|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107738|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107740|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107741|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107742|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56107743|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
56598722|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56598723|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
56598724|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598725|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598727|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56598728|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598729|NCT03011671|Diuretics|diuretics|mesh-ancestor
56598730|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
56598731|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598732|NCT00628706|Dronabinol|dronabinol|mesh-list
56598733|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
56598734|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598785|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
56598786|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598787|NCT02589691|Rocuronium|rocuronium|mesh-list
56598788|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56598789|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56598790|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56598791|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598792|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598793|NCT01004432|Golimumab|golimumab|mesh-list
56598794|NCT01004432|Methotrexate|methotrexate|mesh-list
56598795|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56347337|NCT00408538|UC-781|uc-781|mesh-list
56598796|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56598797|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
56598798|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56598799|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598800|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598802|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598803|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598804|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
56598805|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598806|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56598807|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598808|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
56598809|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598810|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56598811|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56598812|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598814|NCT02539537|Folic Acid|folic acid|mesh-list
55834746|NCT02038790|Buprenorphine|buprenorphine|mesh-list
56107744|NCT00003541|Hormones|hormones|mesh-ancestor
56107745|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107746|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56107747|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107748|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107749|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107750|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107751|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
56107752|NCT00002809|Methotrexate|methotrexate|mesh-list
56107753|NCT00002809|Tacrolimus|tacrolimus|mesh-list
56107754|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56107755|NCT00002809|Sargramostim|sargramostim|mesh-list
56107756|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
56107757|NCT00002809|Antibodies|antibodies|mesh-list
56107758|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
56107759|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56598815|NCT02539537|Gemcitabine|gemcitabine|mesh-list
56598816|NCT02539537|Fluorouracil|fluorouracil|mesh-list
56598817|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
56598818|NCT02539537|Irinotecan|irinotecan|mesh-list
56598819|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
56598820|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598821|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
56598822|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598823|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598824|NCT02539537|Antiviral Agents|antiviral agents|mesh-ancestor
56598825|NCT02539537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598826|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598827|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598828|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
56598829|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598830|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56598831|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56598832|NCT02539537|Antidotes|antidotes|mesh-ancestor
56598833|NCT02539537|Protective Agents|protective agents|mesh-ancestor
56598834|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
56598835|NCT02539537|Vitamins|vitamins|mesh-ancestor
56598836|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
56598837|NCT02539537|Hematinics|hematinics|mesh-ancestor
56598838|NCT02576275|Rituximab|rituximab|mesh-list
56598839|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56598868|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
56598869|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598870|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56598871|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56598872|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56598873|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56598874|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
56598875|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
56598876|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598877|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56598878|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
56598879|NCT01000610|Hormones|hormones|mesh-ancestor
56598880|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56598881|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56598884|NCT02523469|Nivolumab|nivolumab|mesh-list
56598927|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56598928|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
56598929|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598930|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598931|NCT00619203|Acetaminophen|acetaminophen|mesh-list
56598932|NCT00619203|Glycerol|glycerol|mesh-list
56598933|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56598934|NCT00619203|Analgesics|analgesics|mesh-ancestor
56598935|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
56598936|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598937|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598938|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
56598939|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56598940|NCT00619203|Protective Agents|protective agents|mesh-ancestor
56598941|NCT04072471|Lesinurad|lesinurad|mesh-list
56598942|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
56598943|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598944|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
56598945|NCT04072471|Renal Agents|renal agents|mesh-ancestor
56347474|NCT00057512|Masoprocol|masoprocol|mesh-list
56598946|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56598947|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56107760|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56196098|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196099|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56196100|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56196101|NCT01501760|Growth Substances|growth substances|mesh-ancestor
56196102|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196103|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
56196105|NCT01501786|Propofol|propofol|mesh-list
56196106|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56123867|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56107761|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107762|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
56107763|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107764|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107765|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107766|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
56107767|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107768|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107769|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107770|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56107771|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
56107803|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107804|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107805|NCT00002827|Trace Elements|trace elements|mesh-ancestor
56107806|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
56107807|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56107808|NCT00002827|Protective Agents|protective agents|mesh-ancestor
56107809|NCT00384475|Ciclesonide|ciclesonide|mesh-list
56107810|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
56107811|NCT00384475|Hormones|hormones|mesh-ancestor
56107812|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107813|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107814|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56107815|NCT00003565|Docetaxel|docetaxel|mesh-list
56598948|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598949|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56598950|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56598951|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56598952|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598954|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56598955|NCT01812603|Nabiximols|nabiximols|mesh-list
56598956|NCT01812603|Analgesics|analgesics|mesh-ancestor
56598957|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
56598958|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56598959|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598960|NCT04211805|Tenofovir|tenofovir|mesh-list
56598961|NCT04211805|Vaccines|vaccines|mesh-list
56598962|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
56598963|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56598964|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
56598965|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598966|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56598967|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56598968|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598969|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598970|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56598971|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56598972|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
56598973|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
56598974|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56598975|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56598976|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598977|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56598978|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598979|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56598980|NCT04100824|Nimodipine|nimodipine|mesh-list
56598981|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56598989|NCT00580801|Ribavirin|ribavirin|mesh-list
56598990|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
56598991|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
56598992|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56598993|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56598994|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
56598995|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56598996|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
56598997|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56598998|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
56598999|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599000|NCT00619671|Rituximab|rituximab|mesh-list
56599001|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56599002|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599003|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
56599004|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599005|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599006|NCT00628550|Vasopressins|vasopressins|mesh-list
56599007|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
56599008|NCT00628550|Epinephrine|epinephrine|mesh-list
56599009|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56599010|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56599011|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
56599012|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599042|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56599043|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
56599044|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599045|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599046|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
56599047|NCT02576119|BMS-955176|bms-955176|mesh-list
56599048|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56599049|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599050|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56599051|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56599052|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599053|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599054|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599055|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56599056|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56599057|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
56599102|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56599103|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56599104|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56599105|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56599106|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56599107|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599108|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599109|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
56599111|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599112|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56599113|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56599114|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
56599115|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
56599116|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
56599163|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599164|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599165|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599166|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599167|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56599168|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56599169|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347687|NCT00058292|Lenograstim|lenograstim|mesh-list
56599170|NCT01057589|Hematinics|hematinics|mesh-ancestor
56599171|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
56599173|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56599174|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
56599175|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599176|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599177|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56599178|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56107816|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107817|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107818|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107848|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56107849|NCT00002833|Prednisolone|prednisolone|mesh-list
56107850|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
56107851|NCT00002833|Fludarabine|fludarabine|mesh-list
56107852|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
56107853|NCT00002833|Idarubicin|idarubicin|mesh-list
56107854|NCT00002833|Cladribine|cladribine|mesh-list
56107855|NCT00002833|Cyclosporins|cyclosporins|mesh-list
56107856|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56107857|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
56107858|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107859|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107860|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
56107861|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107862|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107863|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
56107864|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107865|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
56107896|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107897|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107898|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56107899|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107900|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
56107901|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107902|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56107903|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
56107904|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107905|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
56107906|NCT00003577|Fluorouracil|fluorouracil|mesh-list
56196107|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196108|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107909|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107910|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
56107933|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107934|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107935|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107936|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
56107937|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107938|NCT00003583|Etoposide|etoposide|mesh-list
56107939|NCT00003583|Amifostine|amifostine|mesh-list
56599179|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
56599180|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599181|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599182|NCT02575729|Betamethasone|betamethasone|mesh-list
56599183|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
56599184|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599185|NCT02575729|Hormones|hormones|mesh-ancestor
56599186|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599187|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599188|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56599189|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
56599190|NCT01835041|Leucovorin|leucovorin|mesh-list
56599191|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
56599192|NCT01835041|Fluorouracil|fluorouracil|mesh-list
56599193|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
56599194|NCT01835041|Irinotecan|irinotecan|mesh-list
56599195|NCT01835041|Calcium|calcium|mesh-list
56599196|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
56599197|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56599198|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599199|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
56599200|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599201|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56599202|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599203|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599204|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
56599205|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56599206|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56599207|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599208|NCT01835041|Antidotes|antidotes|mesh-ancestor
56599209|NCT01835041|Protective Agents|protective agents|mesh-ancestor
56599210|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
56599211|NCT01835041|Vitamins|vitamins|mesh-ancestor
56599212|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
56599213|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
56599221|NCT00579553|Progestins|progestins|mesh-ancestor
56599222|NCT00579553|Hormones|hormones|mesh-ancestor
56599223|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599224|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599225|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56599226|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
56599227|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
56599228|NCT04209933|Bismuth|bismuth|mesh-list
56599229|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599230|NCT04209933|Antacids|antacids|mesh-ancestor
56599231|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599232|NCT04209933|Diuretics|diuretics|mesh-ancestor
56599233|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
56599234|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599235|NCT04209933|Expectorants|expectorants|mesh-ancestor
56599236|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
56599237|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56599238|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
56599239|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599240|NCT04209699|BMS-986165|bms-986165|mesh-list
56599241|NCT04209699|Famotidine|famotidine|mesh-list
56599242|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56599243|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599244|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56599245|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
56599246|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
56599247|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56159139|NCT04527900|Carboplatin|carboplatin|mesh-list
56599248|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599249|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599250|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
56599251|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56599252|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599254|NCT00620295|Bortezomib|bortezomib|mesh-list
56599255|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56599256|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
55912149|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
56107940|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107941|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107942|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56599257|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599258|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599259|NCT00620295|Antiviral Agents|antiviral agents|mesh-ancestor
56599260|NCT00620295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599261|NCT00620295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599262|NCT00620295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599263|NCT00620295|Immunologic Factors|immunologic factors|mesh-ancestor
56599264|NCT00620295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599265|NCT00581893|Phenytoin|phenytoin|mesh-list
56599266|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
56599267|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56599268|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56599269|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56599270|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599271|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56599272|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56599273|NCT00006421|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56599274|NCT00006421|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56599275|NCT00006421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599276|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
56599277|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56599278|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599279|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56599280|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599281|NCT04664023|Vaccines|vaccines|mesh-list
56599282|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
56599283|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599284|NCT02334865|Lenalidomide|lenalidomide|mesh-list
56599285|NCT02334865|Sargramostim|sargramostim|mesh-list
56599286|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56599287|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
56599288|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
56599289|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599290|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55912205|NCT01687478|Fluoxetine|fluoxetine|mesh-list
56599295|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56599296|NCT04073719|Acetic Acid|acetic acid|mesh-list
56599297|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56599298|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599299|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
56599300|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56599301|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56599302|NCT00379431|Prednisolone|prednisolone|mesh-list
56599303|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
56599304|NCT00379431|Rituximab|rituximab|mesh-list
56599305|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56599306|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
56599307|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56599308|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599309|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
56599310|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599311|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599312|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599313|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
56599314|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
56599315|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599316|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599317|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
56599318|NCT00379431|Hormones|hormones|mesh-ancestor
56599319|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599320|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56599321|NCT00379431|Protective Agents|protective agents|mesh-ancestor
56599322|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56599324|NCT03892785|Methotrexate|methotrexate|mesh-list
56599325|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599326|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
56599327|NCT03892785|Hormones|hormones|mesh-ancestor
56599328|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599329|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599331|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599336|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
56599337|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599338|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56599339|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599340|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56599341|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599342|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
56599343|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599344|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56107943|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107944|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107945|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107946|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56107947|NCT00003583|Protective Agents|protective agents|mesh-ancestor
56107948|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107949|NCT00002845|Aldesleukin|aldesleukin|mesh-list
56107950|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107951|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56107952|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56107953|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
56107954|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107955|NCT00003067|Aldesleukin|aldesleukin|mesh-list
56107956|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107957|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56107958|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56107959|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
56107981|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56107982|NCT00003595|Vincristine|vincristine|mesh-list
56107983|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107984|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
56107985|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107986|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107987|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107988|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
56107989|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107990|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107991|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107992|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56107993|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107994|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107995|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107996|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107997|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56107998|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
56107999|NCT00003595|Hormones|hormones|mesh-ancestor
56108000|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56108001|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56108002|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108003|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108004|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108005|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108006|NCT00003073|Cytarabine|cytarabine|mesh-list
56108007|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108008|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
56108009|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108010|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108011|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
56108014|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
56108015|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108046|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108047|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
56108048|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196109|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56108050|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108051|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56599345|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
56599346|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
56599347|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599348|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
56599349|NCT04954989|Hematinics|hematinics|mesh-ancestor
56599350|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
56599351|NCT03890289|Idelalisib|idelalisib|mesh-list
56599352|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56599353|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599354|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599355|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599356|NCT00621699|Ezetimibe|ezetimibe|mesh-list
56599357|NCT00621699|Tacrolimus|tacrolimus|mesh-list
56599373|NCT00770146|Mipomersen|mipomersen|mesh-list
56599409|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56599410|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56599411|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
56599412|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
56599413|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
56599414|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599415|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599416|NCT04188171|Polidocanol|polidocanol|mesh-list
56599417|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56599418|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56599419|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
56599420|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
56599421|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
56599422|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56599423|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599424|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
56599425|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599426|NCT00622011|Risperidone|risperidone|mesh-list
56599427|NCT00622011|Zotepine|zotepine|mesh-list
56599428|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56599429|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
56599430|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599431|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599432|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599433|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56599434|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56108052|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
56108053|NCT00002875|Lomustine|lomustine|mesh-list
56108054|NCT00002875|Cisplatin|cisplatin|mesh-list
56108055|NCT00002875|Vincristine|vincristine|mesh-list
56108056|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108057|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
56108058|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108059|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108060|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108061|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
56108062|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108104|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
56108105|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108106|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
56108107|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108108|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56108109|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56108110|NCT00003619|Vitamin E|vitamin e|mesh-list
56108111|NCT00003619|Cytarabine|cytarabine|mesh-list
56108112|NCT00003619|Fludarabine|fludarabine|mesh-list
56108113|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
56108114|NCT00003619|Etoposide|etoposide|mesh-list
56108115|NCT00003619|Busulfan|busulfan|mesh-list
56108116|NCT00003619|Topotecan|topotecan|mesh-list
56108117|NCT00003619|Isotretinoin|isotretinoin|mesh-list
56108118|NCT00003619|Vitamins|vitamins|mesh-ancestor
56599435|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56599436|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56599437|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56599438|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
56599439|NCT03936309|Lidocaine|lidocaine|mesh-list
56599440|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
56599441|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
56599442|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56599443|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599444|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
56599445|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599446|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56599447|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56599448|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56599449|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56599450|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599451|NCT03838263|Cisplatin|cisplatin|mesh-list
56599452|NCT03838263|Nivolumab|nivolumab|mesh-list
56599453|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599454|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56599455|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56108119|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
56108120|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108121|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108122|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108123|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
56108124|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108125|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108126|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
55835111|NCT04691804|Prednisone|prednisone|mesh-list
56108127|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108128|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108177|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56108178|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108179|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
56108180|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108181|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56108182|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108183|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108184|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
56108185|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56108186|NCT00003937|Protective Agents|protective agents|mesh-ancestor
56108187|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108188|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108189|NCT00003625|Cyclosporine|cyclosporine|mesh-list
56108190|NCT00003625|Etoposide|etoposide|mesh-list
56108191|NCT00003625|Vincristine|vincristine|mesh-list
56108192|NCT00003625|Cyclosporins|cyclosporins|mesh-list
56108193|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108194|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108195|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108196|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108197|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599456|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599457|NCT04208373|Itraconazole|itraconazole|mesh-list
56599458|NCT04208373|Etravirine|etravirine|mesh-list
56599459|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
56599460|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599461|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56599462|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56599463|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599464|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599465|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56599466|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
56599467|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599468|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599469|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56599470|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56599471|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56599472|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
56108198|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108199|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108200|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108201|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108202|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108203|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
56108204|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108205|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
56108207|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
56108208|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108209|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56108210|NCT00003637|Fluorouracil|fluorouracil|mesh-list
56108211|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108212|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
56196110|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
56196111|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
56196112|NCT01501786|Analgesics|analgesics|mesh-ancestor
56196113|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
56196114|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196115|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56196116|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56196117|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56196118|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56108213|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108214|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108242|NCT00003955|Sargramostim|sargramostim|mesh-list
56108243|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108244|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
56108245|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108246|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108247|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108248|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
56108249|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108250|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108251|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108252|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56347986|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56599474|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56599475|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56599476|NCT03771651|Analgesics|analgesics|mesh-ancestor
56599477|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
56599478|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599479|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599480|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599481|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599482|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56599483|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56599484|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599485|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56599486|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56599487|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599531|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
56599532|NCT02873273|Hormones|hormones|mesh-ancestor
56599533|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599534|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56599535|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599536|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
56599537|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599538|NCT01056263|Axitinib|axitinib|mesh-list
56599539|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599540|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56599541|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599542|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599543|NCT00637143|Cyclosporine|cyclosporine|mesh-list
56599544|NCT00637143|Tacrolimus|tacrolimus|mesh-list
56599545|NCT00637143|Cyclosporins|cyclosporins|mesh-list
56599547|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
56599548|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599549|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56108253|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108254|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108255|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108256|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108257|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108258|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108259|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56108260|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108261|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108262|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56108263|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56108294|NCT00003961|Sargramostim|sargramostim|mesh-list
56108295|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
56108296|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108297|NCT00003661|Cyclosporine|cyclosporine|mesh-list
56108298|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
56108299|NCT00003661|Melphalan|melphalan|mesh-list
56108300|NCT00003661|Busulfan|busulfan|mesh-list
56108301|NCT00003661|Cyclosporins|cyclosporins|mesh-list
56108302|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56108303|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108304|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108305|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108306|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
56108307|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108308|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
56108309|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108339|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56108340|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108341|NCT00003115|Analgesics|analgesics|mesh-ancestor
56108342|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
56108343|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56108344|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
56108345|NCT00003667|Doxorubicin|doxorubicin|mesh-list
56108346|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56108347|NCT00003667|Vincristine|vincristine|mesh-list
56108348|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
56108350|NCT00003667|Glycerol|glycerol|mesh-list
56108351|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108352|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
56108353|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599550|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599551|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599552|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
56599553|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599554|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
56599555|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599557|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56599558|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599559|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56599560|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599561|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599562|NCT01056107|Glucagon|glucagon|mesh-list
56599563|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56599565|NCT01056107|Hormones|hormones|mesh-ancestor
56599611|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599612|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599613|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56599614|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
56599615|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599616|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599617|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56599618|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56599619|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
56599620|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56348138|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599621|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56599622|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
56599623|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
56599624|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599625|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56599626|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56599627|NCT02407119|Amoxicillin|amoxicillin|mesh-list
56599628|NCT02407119|Clarithromycin|clarithromycin|mesh-list
56599629|NCT02407119|Omeprazole|omeprazole|mesh-list
56599630|NCT02407119|Rabeprazole|rabeprazole|mesh-list
56599631|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56599632|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56599633|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599634|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56599635|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599636|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599637|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599638|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55912527|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196119|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196121|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56196122|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
56196123|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56196124|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56196126|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
56196127|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196128|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108354|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108355|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108356|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
56108381|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599639|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56599640|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56599641|NCT01008410|Budesonide|budesonide|mesh-list
56599642|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599643|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56599644|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
56599645|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599646|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108382|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108383|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108384|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
56108385|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108386|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108387|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108388|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108389|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108390|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108391|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108392|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108393|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108394|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108395|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56108396|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
56108397|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56108398|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56108399|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56108400|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56108401|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56108402|NCT00003985|KRN 7000|krn 7000|mesh-list
56108403|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56108404|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
56108405|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108406|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108407|NCT00384553|Rituximab|rituximab|mesh-list
56108430|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108431|NCT00384631|Bevacizumab|bevacizumab|mesh-list
56108432|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56108433|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108434|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55835439|NCT01984424|Ezetimibe|ezetimibe|mesh-list
56108435|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56108436|NCT00384631|Growth Substances|growth substances|mesh-ancestor
56108437|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108438|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
56108439|NCT00003127|Paclitaxel|paclitaxel|mesh-list
56108440|NCT00003127|Carboplatin|carboplatin|mesh-list
56108441|NCT00003127|Amifostine|amifostine|mesh-list
56108442|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108443|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108444|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108445|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108446|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108447|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742007|NCT03364075|Serotonin|serotonin|mesh-list
56108448|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56108449|NCT00003127|Protective Agents|protective agents|mesh-ancestor
56108450|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108451|NCT00004003|Gemcitabine|gemcitabine|mesh-list
56196129|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56196130|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196131|NCT01501890|Algestone|algestone|mesh-list
56196132|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56196133|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56196134|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56196135|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
56196136|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599647|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56599648|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
56599649|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
56599650|NCT01008410|Hormones|hormones|mesh-ancestor
56599651|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599652|NCT00627653|Fenofibrate|fenofibrate|mesh-list
56599653|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56599654|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
56599655|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599656|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56599657|NCT02347917|Pemetrexed|pemetrexed|mesh-list
56599658|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599659|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599660|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599661|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56599662|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56599663|NCT01972035|Valacyclovir|valacyclovir|mesh-list
56599706|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599707|NCT05264493|Naloxone|naloxone|mesh-list
56599708|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56599709|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599710|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
56599711|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599712|NCT00612261|Triamcinolone|triamcinolone|mesh-list
56599713|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56599714|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56599715|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56599716|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599717|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
56599718|NCT00612261|Hormones|hormones|mesh-ancestor
56599719|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599720|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196137|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196138|NCT01501890|Progestins|progestins|mesh-ancestor
56196139|NCT01501890|Hormones|hormones|mesh-ancestor
56196140|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56196141|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56196142|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56196143|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
56196144|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56196145|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56196146|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56196147|NCT01501916|Vitamin D|vitamin d|mesh-list
56196148|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
56196149|NCT01501916|Vitamins|vitamins|mesh-ancestor
56108452|NCT00004003|Fluorouracil|fluorouracil|mesh-list
56108453|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108454|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108455|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
56108456|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108457|NCT00004003|Antiviral Agents|antiviral agents|mesh-ancestor
56108458|NCT00004003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108485|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108486|NCT00003691|Paclitaxel|paclitaxel|mesh-list
56108487|NCT00003691|Doxorubicin|doxorubicin|mesh-list
56108488|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56108489|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108490|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108491|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108492|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108493|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108494|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108495|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108496|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108497|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108498|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108499|NCT00003139|Pilocarpine|pilocarpine|mesh-list
56108500|NCT00003139|Miotics|miotics|mesh-ancestor
56108501|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
56108502|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56108503|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108504|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56108505|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56108506|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
56108507|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56108508|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108537|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56599721|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599722|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
56599723|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599724|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599725|NCT00636909|Cyclosporine|cyclosporine|mesh-list
56599726|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
56599727|NCT00636909|Methotrexate|methotrexate|mesh-list
56599728|NCT00636909|Fludarabine|fludarabine|mesh-list
56599729|NCT00636909|Cyclosporins|cyclosporins|mesh-list
56599730|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599743|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
56599785|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
56599786|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
56599787|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
56599788|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599789|NCT05661669|Ketamine|ketamine|mesh-list
56599790|NCT05661669|Analgesics|analgesics|mesh-ancestor
56599791|NCT05661669|Sensory System Agents|sensory system agents|mesh-ancestor
56599792|NCT05661669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599793|NCT05661669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599794|NCT05661669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56599795|NCT05661669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56599796|NCT05661669|Anesthetics, General|anesthetics, general|mesh-ancestor
56599797|NCT05661669|Anesthetics|anesthetics|mesh-ancestor
56599798|NCT05661669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56599799|NCT05661669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55912706|NCT01491841|Pixantrone|pixantrone|mesh-list
56108538|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56108539|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
56196150|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
56108540|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56108542|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
56108544|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
56108545|NCT00004039|Rituximab|rituximab|mesh-list
56108546|NCT00004039|Doxorubicin|doxorubicin|mesh-list
56108547|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56108548|NCT00004039|Vincristine|vincristine|mesh-list
56108549|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108550|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
56108551|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108552|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108553|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108554|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
56108555|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108556|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108557|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108558|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56108559|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108591|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56108592|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56108593|NCT00003151|Antacids|antacids|mesh-ancestor
56108594|NCT00004045|Exatecan|exatecan|mesh-list
56108595|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56108596|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108597|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108598|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108599|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108600|NCT00003715|Interferons|interferons|mesh-list
56108601|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
56108602|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
56108603|NCT00003715|Vaccines|vaccines|mesh-list
56108604|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
56108632|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
56108633|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108634|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108635|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108636|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
56108645|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108647|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108648|NCT00003157|Gemcitabine|gemcitabine|mesh-list
56108649|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599800|NCT05661669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56599801|NCT05661669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599802|NCT05661669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599803|NCT01023035|Ribavirin|ribavirin|mesh-list
56599804|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56599805|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
56599806|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
56599807|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599808|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
56599809|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599810|NCT01023035|Hematinics|hematinics|mesh-ancestor
56599811|NCT01028651|Treprostinil|treprostinil|mesh-list
56599812|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56599813|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
56599814|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56599815|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56599816|NCT00627731|Prednisolone|prednisolone|mesh-list
56599817|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
56599818|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56599819|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
56599820|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56599821|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
56599822|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
56599823|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599824|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599825|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56599826|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
56599827|NCT00627731|Hormones|hormones|mesh-ancestor
56599828|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56599847|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56599848|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599849|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56599851|NCT01007552|Bevacizumab|bevacizumab|mesh-list
56599852|NCT01007552|Capecitabine|capecitabine|mesh-list
56599853|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56599854|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599855|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56599856|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56599857|NCT01007552|Growth Substances|growth substances|mesh-ancestor
56599858|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599859|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
56599860|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56599861|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
56599862|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599863|NCT01007552|Antiviral Agents|antiviral agents|mesh-ancestor
56599864|NCT01007552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599865|NCT01007552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599866|NCT01007552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599867|NCT01007552|Immunologic Factors|immunologic factors|mesh-ancestor
56599868|NCT02870036|Leucovorin|leucovorin|mesh-list
56599869|NCT02870036|Thalidomide|thalidomide|mesh-list
56599870|NCT02870036|Fluorouracil|fluorouracil|mesh-list
56599871|NCT02870036|Calcium|calcium|mesh-list
56599872|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
56599873|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56599874|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599875|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
56599876|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599877|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55912774|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
56108650|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108651|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
56108652|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108653|NCT00003157|Antiviral Agents|antiviral agents|mesh-ancestor
56108713|NCT00004081|Docetaxel|docetaxel|mesh-list
56108714|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108715|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108716|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108717|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108718|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108719|NCT00003751|Penicillamine|penicillamine|mesh-list
56108720|NCT00003751|Antidotes|antidotes|mesh-ancestor
56108721|NCT00003751|Protective Agents|protective agents|mesh-ancestor
56108722|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599878|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56599879|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56599880|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
56599881|NCT02870036|Antidotes|antidotes|mesh-ancestor
56599882|NCT02870036|Protective Agents|protective agents|mesh-ancestor
56599883|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
56599884|NCT02870036|Vitamins|vitamins|mesh-ancestor
56599885|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
56599886|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
56599887|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56599888|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56599889|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56599890|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56599891|NCT02870036|Growth Substances|growth substances|mesh-ancestor
56599892|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
56599893|NCT04296422|Ibuprofen|ibuprofen|mesh-list
56599894|NCT04296422|Diclofenac|diclofenac|mesh-list
56599895|NCT04296422|Naproxen|naproxen|mesh-list
56599896|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56599897|NCT04296422|Piroxicam|piroxicam|mesh-list
56599898|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
56599899|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
56599900|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56599901|NCT04296422|Analgesics|analgesics|mesh-ancestor
56599902|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
56599903|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56599904|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599905|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55912795|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
56108723|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
56108724|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
56108725|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108726|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108727|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56108728|NCT00004087|Antibodies|antibodies|mesh-list
56108729|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
56108730|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56196151|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196152|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56196153|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56196154|NCT01501942|Glycine|glycine|mesh-list
56196155|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
56196156|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196157|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196158|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196159|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
56196160|NCT01501968|Colistin|colistin|mesh-list
56196161|NCT01501968|Vitamins|vitamins|mesh-ancestor
56196162|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
56196163|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599906|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56599907|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56599908|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56599909|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599910|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
56599911|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56599912|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56599913|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
56599914|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
56599915|NCT00998738|Calcium|calcium|mesh-list
56033525|NCT04356872|Ifosfamide|ifosfamide|mesh-list
56599916|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56599917|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599918|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56599965|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56599966|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56599967|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
56599968|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
56599969|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599970|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599971|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56599972|NCT01027949|Treprostinil|treprostinil|mesh-list
56599973|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56599974|NCT01038323|Milnacipran|milnacipran|mesh-list
56599975|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
56599976|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56599977|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56599978|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56599979|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56599980|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56599981|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600018|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56600019|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
56600020|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196164|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
56196165|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196166|NCT01501968|Protective Agents|protective agents|mesh-ancestor
56196167|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56196168|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196169|NCT01502020|Imiquimod|imiquimod|mesh-list
56196170|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56108731|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
56108732|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108733|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108734|NCT00003757|Rituximab|rituximab|mesh-list
56108735|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56108736|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108737|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
56108738|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108739|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108766|NCT00003763|Hematinics|hematinics|mesh-ancestor
56108767|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
56108768|NCT00003763|Vitamins|vitamins|mesh-ancestor
56108770|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108771|NCT00003181|Aldesleukin|aldesleukin|mesh-list
56108772|NCT00003181|Vinblastine|vinblastine|mesh-list
56108773|NCT00003181|Sargramostim|sargramostim|mesh-list
56108774|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
56108775|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108776|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108777|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56108778|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56108779|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
56108780|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108781|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108782|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108783|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108784|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108785|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108786|NCT00004105|Paclitaxel|paclitaxel|mesh-list
56108787|NCT00004105|Vinorelbine|vinorelbine|mesh-list
56108788|NCT00004105|Estramustine|estramustine|mesh-list
56108789|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108790|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108791|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108864|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108865|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
56196171|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
56196172|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196173|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196174|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
56196175|NCT01502046|Dronabinol|dronabinol|mesh-list
56196176|NCT01502046|Cannabidiol|cannabidiol|mesh-list
56196177|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
56196178|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
56196179|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196180|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196181|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56196182|NCT01502046|Analgesics|analgesics|mesh-ancestor
56196183|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
56196184|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196185|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56108866|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108867|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108868|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56108869|NCT00003193|Protective Agents|protective agents|mesh-ancestor
56108870|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108871|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
56108872|NCT00004135|Fludarabine|fludarabine|mesh-list
56108873|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
56108874|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108875|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
56108876|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108877|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108878|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108879|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
56600021|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600022|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600023|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56600024|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600025|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56600026|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
56600027|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
56600028|NCT04299971|Methotrexate|methotrexate|mesh-list
56600029|NCT04299971|Tofacitinib|tofacitinib|mesh-list
56600030|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56600031|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
56600032|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56600033|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600034|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56600035|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
56600036|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600037|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600038|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
56600039|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600040|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56600041|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600042|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
56600071|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56600072|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56600073|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600074|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56600075|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56600076|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600077|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56600078|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56600079|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56600080|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56108880|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108881|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108882|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108910|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
56108911|NCT00003799|Antidotes|antidotes|mesh-ancestor
56108912|NCT00003799|Protective Agents|protective agents|mesh-ancestor
56108913|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
56108914|NCT00003799|Vitamins|vitamins|mesh-ancestor
56108915|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
56108916|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
56108917|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56108918|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
56108919|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108920|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108921|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
56108922|NCT00003211|Vincristine|vincristine|mesh-list
56108923|NCT00003211|Amifostine|amifostine|mesh-list
56108924|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108925|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
56108926|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108927|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108928|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108929|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
56108930|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108932|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108992|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56108994|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
56108995|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56108996|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
56108997|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196186|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56196187|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56108998|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108999|NCT00003817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56109000|NCT00003817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56109001|NCT00003817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56109002|NCT00003817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56109003|NCT00003817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56109004|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56109005|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
56109006|NCT00003829|Fludarabine|fludarabine|mesh-list
56109007|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
56109008|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109009|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
56109010|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109011|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109012|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109013|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
56109014|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109015|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109016|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109017|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109018|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
56600081|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56600082|NCT00627809|Streptokinase|streptokinase|mesh-list
56600083|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56600084|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56600085|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600086|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56600087|NCT02872649|Warfarin|warfarin|mesh-list
56600088|NCT02872649|Dabigatran|dabigatran|mesh-list
56600089|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
56600090|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
56600091|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
56600092|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56600093|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
56600094|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600095|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600096|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56600097|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
56600098|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56600099|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56600100|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56600101|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
56600102|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56600103|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600104|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56600105|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56600106|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56600107|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56600108|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600109|NCT01018511|Tamsulosin|tamsulosin|mesh-list
56600110|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
56600111|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56600112|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56600122|NCT00996476|Simeprevir|simeprevir|mesh-list
56600123|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
56600124|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600125|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
56600126|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600127|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600128|NCT02269267|Imatinib Mesylate|imatinib mesylate|mesh-list
56600129|NCT02269267|Dasatinib|dasatinib|mesh-list
56600130|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
56600131|NCT02269267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159153|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56600132|NCT02269267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56600133|NCT02269267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600134|NCT02269267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600135|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
56600136|NCT02269267|Protective Agents|protective agents|mesh-ancestor
56600137|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600138|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56600139|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56600140|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600141|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
56600142|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
56348668|NCT02969252|Rifamycins|rifamycins|mesh-list
56600143|NCT01017731|Promethazine|promethazine|mesh-list
56600144|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
56109038|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
56109039|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109040|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109041|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109042|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
56109043|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109044|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109045|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109046|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56109047|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
56109048|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
56109049|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109050|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109051|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
56109052|NCT00003217|Hormones|hormones|mesh-ancestor
56109053|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109054|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56109055|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56109056|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109057|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109058|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109059|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56109060|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
56109061|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56109062|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109063|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
56109064|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
56600145|NCT01017731|Ramucirumab|ramucirumab|mesh-list
56600146|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56600147|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600148|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56600149|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56600150|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600151|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600152|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600153|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600154|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56600155|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56600156|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600157|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
55913117|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913126|NCT04742751|Metformin|metformin|mesh-list
55913127|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55913128|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913129|NCT04479813|Moxonidine|moxonidine|mesh-list
55913130|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55913131|NCT04474899|Amlodipine|amlodipine|mesh-list
55913132|NCT04474899|Moxonidine|moxonidine|mesh-list
56600206|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
56600207|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600208|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600209|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56600210|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
56600211|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
56600212|NCT04231760|Protective Agents|protective agents|mesh-ancestor
56600213|NCT01385059|Axitinib|axitinib|mesh-list
56600214|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600215|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56600216|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600217|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600218|NCT00769132|Niacin|niacin|mesh-list
56600219|NCT00769132|Niacinamide|niacinamide|mesh-list
56600220|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
56600221|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56600222|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
56600223|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600224|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56600225|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
56600226|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
56600227|NCT00769132|Vitamins|vitamins|mesh-ancestor
56600228|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
56600229|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600230|NCT04070755|Minocycline|minocycline|mesh-list
56600231|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56600232|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600241|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56600242|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56600243|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600244|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600245|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600246|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
56600247|NCT00991952|Growth Substances|growth substances|mesh-ancestor
56600248|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600249|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56600250|NCT00779038|Fentanyl|fentanyl|mesh-list
56600307|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600308|NCT01017575|Ribavirin|ribavirin|mesh-list
56600309|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56600310|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
56600311|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600312|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
56600313|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600314|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56600315|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
56600316|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56600317|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600318|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56600319|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56600320|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56600321|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913218|NCT00522795|Cisplatin|cisplatin|mesh-list
56109065|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56109066|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56109067|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
56109068|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109069|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56109070|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109071|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109072|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109073|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109074|NCT00004183|Capecitabine|capecitabine|mesh-list
56109075|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109108|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109109|NCT00003835|Antidotes|antidotes|mesh-ancestor
56109110|NCT00003835|Protective Agents|protective agents|mesh-ancestor
56109111|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
56109113|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
56109114|NCT00003847|Doxorubicin|doxorubicin|mesh-list
56109115|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56109116|NCT00003847|Vincristine|vincristine|mesh-list
56109117|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56196188|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196190|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56196191|NCT01502202|Pemetrexed|pemetrexed|mesh-list
56196192|NCT01502202|Gefitinib|gefitinib|mesh-list
56196193|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196194|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196195|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196196|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56196197|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56196198|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56196199|NCT01502241|Temozolomide|temozolomide|mesh-list
56196200|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56196201|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
56196202|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196203|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109118|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109119|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109120|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109121|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109146|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56600322|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
56600323|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600324|NCT05673187|Adagrasib|adagrasib|mesh-list
56600325|NCT05673187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600326|NCT01253161|Pasireotide|pasireotide|mesh-list
56600327|NCT01253161|Hormones|hormones|mesh-ancestor
56600328|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600329|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600330|NCT00709423|Moxaverine|moxaverine|mesh-list
56600331|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
56600332|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
56600333|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600334|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600335|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
56600336|NCT01017029|Everolimus|everolimus|mesh-list
56600337|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600338|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600339|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
56600340|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600341|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56600342|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56600343|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
56600344|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56600345|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600346|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600347|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600348|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56600349|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
56600365|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
56600366|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56600367|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56109147|NCT00385021|Growth Substances|growth substances|mesh-ancestor
56109148|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
56109149|NCT00385021|Antidotes|antidotes|mesh-ancestor
56109150|NCT00385021|Protective Agents|protective agents|mesh-ancestor
56109151|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
56109152|NCT00385021|Vitamins|vitamins|mesh-ancestor
56109153|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
56109154|NCT00003235|Paclitaxel|paclitaxel|mesh-list
56109155|NCT00003235|Carboplatin|carboplatin|mesh-list
56109156|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109157|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109158|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109159|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109160|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109161|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109162|NCT00004201|Gemcitabine|gemcitabine|mesh-list
56109163|NCT00004201|Carboplatin|carboplatin|mesh-list
56109164|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109165|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109166|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
56109167|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109168|NCT00004201|Antiviral Agents|antiviral agents|mesh-ancestor
56109169|NCT00004201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109170|NCT00004201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109171|NCT00004201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109172|NCT00004201|Immunologic Factors|immunologic factors|mesh-ancestor
56109194|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109195|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109196|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109197|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109198|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109200|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55836167|NCT01445548|Sirolimus|sirolimus|mesh-list
56109201|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109202|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56109203|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56196205|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56196206|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56196207|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109204|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
56109205|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109206|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109207|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56109209|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109210|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56109211|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109212|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109213|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109214|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109215|NCT00003871|Vaccines|vaccines|mesh-list
56109216|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
56109217|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109218|NCT00004219|Granisetron|granisetron|mesh-list
56109219|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
56109220|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
56109221|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109222|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109223|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109275|NCT00004237|Doxorubicin|doxorubicin|mesh-list
56109276|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56109277|NCT00004237|Vinorelbine|vinorelbine|mesh-list
56109278|NCT00004237|Epirubicin|epirubicin|mesh-list
56109279|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
56109280|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109281|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
56109282|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109338|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56109339|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
56109340|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109341|NCT00003925|Leucovorin|leucovorin|mesh-list
56600368|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600369|NCT00627965|Urological Agents|urological agents|mesh-ancestor
56600370|NCT02576353|Fentanyl|fentanyl|mesh-list
56600371|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56600372|NCT02576353|Narcotics|narcotics|mesh-ancestor
56600373|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600374|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600375|NCT02576353|Analgesics|analgesics|mesh-ancestor
56600376|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
56600377|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600378|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56600379|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56600380|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
56600381|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
56600382|NCT01016015|Sirolimus|sirolimus|mesh-list
56600383|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56600384|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56109342|NCT00003925|Gemcitabine|gemcitabine|mesh-list
56109343|NCT00003925|Tegafur|tegafur|mesh-list
56109344|NCT00003925|Calcium|calcium|mesh-list
56109345|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
56109346|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109347|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
56109348|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109349|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109350|NCT00003925|Antiviral Agents|antiviral agents|mesh-ancestor
56109351|NCT00003925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109352|NCT00003925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109353|NCT00003925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109354|NCT00003925|Immunologic Factors|immunologic factors|mesh-ancestor
56109355|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109356|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56109430|NCT00004855|Nevirapine|nevirapine|mesh-list
56109431|NCT00004855|Abacavir|abacavir|mesh-list
56109432|NCT00004855|Stavudine|stavudine|mesh-list
56109433|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56109461|NCT00004861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109462|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109463|NCT00004861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109464|NCT00004861|Immunologic Factors|immunologic factors|mesh-ancestor
56109465|NCT00004861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109466|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56109467|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56109468|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56109469|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109470|NCT04074343|Irinotecan|irinotecan|mesh-list
56109471|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56109472|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109473|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109474|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109475|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109476|NCT00003301|Irinotecan|irinotecan|mesh-list
56109477|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56196208|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
56196209|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196210|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196211|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
56196212|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56196213|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
56196214|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196215|NCT01502280|Protective Agents|protective agents|mesh-ancestor
56600385|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600386|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56600387|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600388|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
56600389|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600390|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
56600391|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600392|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
56600393|NCT00628043|Hematinics|hematinics|mesh-ancestor
56600394|NCT00709657|Bevacizumab|bevacizumab|mesh-list
56600395|NCT00709657|Ranibizumab|ranibizumab|mesh-list
56600396|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600397|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600398|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56600399|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56600400|NCT00709657|Growth Substances|growth substances|mesh-ancestor
56600401|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600402|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
56600403|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
56600404|NCT04073173|Analgesics|analgesics|mesh-list
56600405|NCT04073173|Narcotics|narcotics|mesh-ancestor
56600406|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600407|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600408|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
56600409|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600410|NCT00628121|Cetrorelix|cetrorelix|mesh-list
56600411|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56600412|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
55913297|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196216|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109478|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109506|NCT00004873|Fluorouracil|fluorouracil|mesh-list
56109508|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109509|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109510|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109511|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109512|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109513|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
56109514|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109515|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109516|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
56109517|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109518|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56109519|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109520|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109521|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109523|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600413|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56600414|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600415|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
56600416|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600417|NCT00709969|Lumefantrine|lumefantrine|mesh-list
56600418|NCT00709969|Artemether|artemether|mesh-list
56600419|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56600420|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
56600421|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56600422|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56600423|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600424|NCT00710125|Doxorubicin|doxorubicin|mesh-list
56600425|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56600426|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600427|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56600428|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56600429|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109524|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109525|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56109526|NCT00004339|Trientine|trientine|mesh-list
56109546|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109547|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109548|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109549|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
56109550|NCT00003331|Antidotes|antidotes|mesh-ancestor
56109551|NCT00003331|Protective Agents|protective agents|mesh-ancestor
56109552|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
56109553|NCT00003331|Vitamins|vitamins|mesh-ancestor
56109554|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
56109555|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56109556|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109557|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109558|NCT00004885|Leucovorin|leucovorin|mesh-list
56109559|NCT00004885|Fluorouracil|fluorouracil|mesh-list
56109560|NCT00004885|Irinotecan|irinotecan|mesh-list
56109561|NCT00004885|Calcium|calcium|mesh-list
56109562|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
56109563|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56109564|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109565|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
56109566|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109567|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109568|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109569|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109570|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
56109571|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56109572|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109573|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109575|NCT00004885|Protective Agents|protective agents|mesh-ancestor
56109576|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
56109577|NCT00004885|Vitamins|vitamins|mesh-ancestor
56109578|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
56109579|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55836538|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
56109581|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109582|NCT00003337|Epratuzumab|epratuzumab|mesh-list
56109583|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56196218|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
56196219|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56600430|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600431|NCT02573701|Risperidone|risperidone|mesh-list
56600432|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
56600433|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56600434|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
56600435|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600436|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600437|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600438|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56600439|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600440|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56600441|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56600442|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
56600443|NCT00714649|Cetuximab|cetuximab|mesh-list
56600444|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600445|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600446|NCT00710359|Vitamins|vitamins|mesh-list
56348954|NCT00192049|Gemcitabine|gemcitabine|mesh-list
56600447|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
56600449|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
56600450|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
56600451|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600452|NCT00710359|Hematinics|hematinics|mesh-ancestor
56600453|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56600454|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56600455|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
56600456|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600457|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56600458|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56600459|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
56196220|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
56196221|NCT01502358|Vaccines|vaccines|mesh-list
56196222|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
56109612|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109613|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109614|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109615|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
56109616|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109617|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109618|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109619|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109620|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109621|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109622|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109623|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
56109624|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600460|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
56600461|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600462|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600463|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
56600464|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56600465|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600466|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600467|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56600468|NCT00710437|Analgesics|analgesics|mesh-ancestor
56600469|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
56600470|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600471|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56600472|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56600473|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56600474|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
56600475|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600476|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600477|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
56600478|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56600479|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
56600480|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56600481|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600482|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56600483|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56600484|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56109625|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109626|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
56109627|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
56109628|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56109629|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56109630|NCT00004357|Prednisolone|prednisolone|mesh-list
56109631|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
56109659|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109660|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109661|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56109662|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
56109663|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109664|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109666|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
56109667|NCT00004921|Carboplatin|carboplatin|mesh-list
56109668|NCT00004921|Melphalan|melphalan|mesh-list
56109669|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109670|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109671|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109672|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109673|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
56110446|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
56600485|NCT00714883|Sirolimus|sirolimus|mesh-list
56600486|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56600487|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600488|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56600489|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600490|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
56600491|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600492|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
56600493|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600494|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
56600495|NCT00710827|Androgens|androgens|mesh-ancestor
56600496|NCT00710827|Hormones|hormones|mesh-ancestor
56600497|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600498|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600500|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
56600549|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600550|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56600551|NCT01014689|Lymecycline|lymecycline|mesh-list
56600552|NCT01014689|Adapalene|adapalene|mesh-list
56600553|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56600554|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56600555|NCT01014689|Analgesics|analgesics|mesh-ancestor
56600556|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
56600557|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600558|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600559|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56600560|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56600561|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
56600562|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56600563|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600564|NCT01014533|Gabapentin|gabapentin|mesh-list
56600565|NCT01014533|Analgesics|analgesics|mesh-ancestor
56600566|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
56600607|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56600608|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56600609|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
56600610|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600611|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56600612|NCT00714961|Clopidogrel|clopidogrel|mesh-list
56600613|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56600614|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56600615|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56600616|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56600617|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
56600618|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600619|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600620|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600621|NCT02574403|Eculizumab|eculizumab|mesh-list
56600622|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56600623|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600624|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
56600625|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600626|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
56600627|NCT01013753|Olodaterol|olodaterol|mesh-list
56600628|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56600629|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
56600630|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600631|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600632|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56600633|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
55913504|NCT01446809|Doxorubicin|doxorubicin|mesh-list
56109674|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109675|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109676|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
56109677|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109678|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109679|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109680|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
56109706|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
56109707|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109708|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109709|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56109710|NCT00004999|Lamivudine|lamivudine|mesh-list
56109711|NCT00004999|Zidovudine|zidovudine|mesh-list
56109712|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56109713|NCT00004999|Capravirine|capravirine|mesh-list
56109714|NCT00004999|Nelfinavir|nelfinavir|mesh-list
56600634|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56600635|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56600636|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56600637|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
56600638|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600639|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600640|NCT00715039|Lorazepam|lorazepam|mesh-list
56600641|NCT00715039|Paroxetine|paroxetine|mesh-list
56600642|NCT00715039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56600643|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56600644|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56600645|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600646|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56600647|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
56600648|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600649|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56600650|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
56600651|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56600652|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56600653|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56600654|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600655|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
56600656|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
56600657|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
56600658|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600659|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56600660|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56600661|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600662|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56600663|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56600664|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
56600665|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
56600666|NCT00711295|Vaccines|vaccines|mesh-list
56600667|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
56600668|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600669|NCT02871869|Buformin|buformin|mesh-list
56600670|NCT02871869|Prednisone|prednisone|mesh-list
55897666|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
56600671|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
56600672|NCT02871869|Rituximab|rituximab|mesh-list
56600673|NCT02871869|Epirubicin|epirubicin|mesh-list
56600674|NCT02871869|Vindesine|vindesine|mesh-list
56600675|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600676|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
56600677|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600678|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56600679|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56600680|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
56600681|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600682|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600683|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56600684|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600685|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56600686|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
56600688|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600689|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56600690|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56600691|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56600692|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56600693|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600694|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56600695|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
56600696|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
56600697|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
56600698|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56600699|NCT01013597|Panobinostat|panobinostat|mesh-list
56600700|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600701|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56600702|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600703|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600704|NCT00715273|Niacin|niacin|mesh-list
56600713|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56600714|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56600715|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600716|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
56600717|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
56600718|NCT00715273|Vitamins|vitamins|mesh-ancestor
56600719|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
56600720|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600721|NCT01013285|Bevacizumab|bevacizumab|mesh-list
56600722|NCT01013285|Temozolomide|temozolomide|mesh-list
56600723|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600777|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600778|NCT00711919|Pitavastatin|pitavastatin|mesh-list
56600779|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56600780|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56600781|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56600782|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
56600783|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600784|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600785|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56600786|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
56600787|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
56600788|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56600789|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56600790|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600791|NCT00712465|Digoxin|digoxin|mesh-list
56600834|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56600835|NCT00603447|Growth Substances|growth substances|mesh-ancestor
56600836|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
56600837|NCT00718705|Josamycin|josamycin|mesh-list
56600838|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56600839|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600840|NCT00639015|Phenylephrine|phenylephrine|mesh-list
56600841|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
56600842|NCT00639015|Norepinephrine|norepinephrine|mesh-list
56600843|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56600844|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
56600845|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
56600846|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600847|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600848|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
56600849|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56600850|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
56600851|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
56600852|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56600853|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56600859|NCT00712855|Sorafenib|sorafenib|mesh-list
56600889|NCT04185675|Anesthetics|anesthetics|mesh-list
56600890|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600891|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600892|NCT04208061|Ritonavir|ritonavir|mesh-list
56600893|NCT04208061|Darunavir|darunavir|mesh-list
56600894|NCT04208061|Dabigatran|dabigatran|mesh-list
56600895|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56600896|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56600897|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
56600898|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600899|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600900|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56600901|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56600902|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
56600903|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56600904|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56600905|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56600906|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
56600907|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56600908|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
56600909|NCT00988208|Prednisone|prednisone|mesh-list
56600910|NCT00988208|Docetaxel|docetaxel|mesh-list
56600911|NCT00988208|Lenalidomide|lenalidomide|mesh-list
56600912|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600913|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
56600914|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
56600915|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
56600916|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600917|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56600918|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
56600919|NCT00988208|Hormones|hormones|mesh-ancestor
56600920|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600921|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600922|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56600923|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
56600926|NCT00988208|Growth Substances|growth substances|mesh-ancestor
56600929|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
56600930|NCT04185831|Everolimus|everolimus|mesh-list
56600931|NCT04185831|Atezolizumab|atezolizumab|mesh-list
56600932|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600933|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56600934|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
56600935|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600936|NCT02686983|Betamethasone|betamethasone|mesh-list
56600937|NCT02686983|Anesthetics|anesthetics|mesh-list
56600938|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
56600939|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56600940|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600941|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
56600942|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56600943|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56600944|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
56600945|NCT02686983|Hormones|hormones|mesh-ancestor
56600946|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56600947|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56600948|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
56600949|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
56600950|NCT02686905|Vitamin D|vitamin d|mesh-list
56600951|NCT02686905|Vitamins|vitamins|mesh-list
56600952|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
56600953|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
56600954|NCT02686905|Calcium|calcium|mesh-list
56600955|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
56600956|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600957|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56600958|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56600959|NCT02686905|Hematinics|hematinics|mesh-ancestor
56600960|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
56600961|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
56600962|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600963|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
56600964|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56600965|NCT00990704|Protective Agents|protective agents|mesh-ancestor
56109715|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56109716|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56109717|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109718|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600966|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56600967|NCT00639327|Irinotecan|irinotecan|mesh-list
56600968|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56600969|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56600970|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600971|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600972|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600973|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56600974|NCT04089553|Durvalumab|durvalumab|mesh-list
56600975|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56600977|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
56600978|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56600979|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56600980|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56600981|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56600982|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
56600983|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56601022|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601023|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56601024|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56601025|NCT00778102|Growth Substances|growth substances|mesh-ancestor
56601026|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601027|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
56601028|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56601029|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56601030|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601031|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601032|NCT00778102|Antidotes|antidotes|mesh-ancestor
56601033|NCT00778102|Protective Agents|protective agents|mesh-ancestor
56601034|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
56601035|NCT00778102|Vitamins|vitamins|mesh-ancestor
56601036|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
56601037|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
56601038|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56601039|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601040|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
56601041|NCT00713557|Tirofiban|tirofiban|mesh-list
56601042|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56601043|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56601044|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601045|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56601046|NCT00719095|Naltrexone|naltrexone|mesh-list
56601047|NCT00719095|Buprenorphine|buprenorphine|mesh-list
56601048|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56109719|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
56109720|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109721|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56109722|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56109723|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
56109724|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56109725|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56109726|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
56196223|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196224|NCT01502592|Ipilimumab|ipilimumab|mesh-list
56196225|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56196226|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196227|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56196228|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196229|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56196230|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56196231|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
56196232|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
56196233|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56109727|NCT00003361|Decitabine|decitabine|mesh-list
56109728|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109729|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
56601049|NCT00719095|Narcotics|narcotics|mesh-ancestor
56601050|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601051|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601052|NCT00719095|Analgesics|analgesics|mesh-ancestor
56601054|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601055|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56601056|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56601057|NCT00916630|Pemetrexed|pemetrexed|mesh-list
56601058|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601059|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601060|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601061|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56601062|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56601063|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
56601064|NCT02572375|Codeine|codeine|mesh-list
56601065|NCT02572375|Guaifenesin|guaifenesin|mesh-list
56601066|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56601067|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56601068|NCT02572375|Narcotics|narcotics|mesh-ancestor
56601069|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601070|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601071|NCT02572375|Analgesics|analgesics|mesh-ancestor
56601072|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
56601073|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601076|NCT02572375|Expectorants|expectorants|mesh-ancestor
56601099|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56601100|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601101|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601102|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
56601103|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601104|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
56601105|NCT00719173|Aprepitant|aprepitant|mesh-list
56601106|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601107|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
56601108|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601109|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601110|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56601111|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
56601112|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601113|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601114|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56601115|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
56601116|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
56601117|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601118|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56601119|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56601120|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601121|NCT00756886|Atorvastatin|atorvastatin|mesh-list
56601122|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56601149|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
56601150|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601151|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
56601152|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601153|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
56601154|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601155|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
56601156|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601157|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
56601158|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
56601159|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56601160|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56601161|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601162|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56601163|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601165|NCT00639483|Celecoxib|celecoxib|mesh-list
56601206|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56601207|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56601208|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56601209|NCT00990314|Epoprostenol|epoprostenol|mesh-list
56601210|NCT00990314|Beraprost|beraprost|mesh-list
56601211|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56601212|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
56601213|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56601214|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
56601215|NCT00909831|Sirolimus|sirolimus|mesh-list
56601216|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
56601217|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56601218|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56601219|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601220|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601221|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601222|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601223|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56601224|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56601225|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601226|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
56601227|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601228|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
56601229|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601230|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
56601231|NCT00717379|Prednisone|prednisone|mesh-list
56601256|NCT00717379|Protective Agents|protective agents|mesh-ancestor
56601257|NCT02867306|Methotrexate|methotrexate|mesh-list
56601258|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56601259|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
56601260|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56601261|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601262|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56601263|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
56601264|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601265|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601266|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
56601267|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601268|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56601269|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601270|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
56601271|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601272|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56601326|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56601327|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601328|NCT02869100|Listerine|listerine|mesh-list
56601329|NCT02869100|Fluorides|fluorides|mesh-list
56601330|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
56109780|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
56109781|NCT00004399|Nimodipine|nimodipine|mesh-list
56109782|NCT00004399|Analgesics|analgesics|mesh-ancestor
56109783|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
56109784|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109785|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109786|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
56109787|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56109788|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56109789|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
56109790|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56109791|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56109792|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109793|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56109794|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
56109795|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56109796|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56109797|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
56109798|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56109799|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
56109800|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56109801|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109803|NCT00005017|Amprenavir|amprenavir|mesh-list
56109804|NCT00005017|Lamivudine|lamivudine|mesh-list
56109834|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56109835|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109836|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109837|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109838|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109839|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
56109840|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109841|NCT00004429|Hormones|hormones|mesh-list
56109842|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109843|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109844|NCT00005041|Tipifarnib|tipifarnib|mesh-list
56109845|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109846|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56109847|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56109848|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56109849|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109850|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
56109851|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109912|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
56109913|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109914|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
56109915|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
56109916|NCT00005581|Paclitaxel|paclitaxel|mesh-list
56109917|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
56109918|NCT00005581|Fluorouracil|fluorouracil|mesh-list
56196234|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
56196235|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196236|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196237|NCT01502774|Cyclosporine|cyclosporine|mesh-list
56196238|NCT01502774|Cyclosporins|cyclosporins|mesh-list
56196239|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196240|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196241|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56196242|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
56196243|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196244|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
56196245|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196246|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
56196247|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196248|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56196249|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
56196250|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196251|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56196252|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56601331|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
56601332|NCT02869100|Protective Agents|protective agents|mesh-ancestor
56601333|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601334|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56601335|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601336|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
56601337|NCT04096768|Ketamine|ketamine|mesh-list
56601338|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56601339|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601340|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601341|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601342|NCT04096768|Analgesics|analgesics|mesh-ancestor
56601343|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
56601344|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601345|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56601346|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56601347|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56601348|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
56601349|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601350|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601351|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56601352|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56601353|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
56601354|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
56601355|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56601356|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56601358|NCT00714103|Analgesics|analgesics|mesh-ancestor
56601359|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
56601360|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601361|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601375|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56601376|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56601377|NCT00993044|Growth Substances|growth substances|mesh-ancestor
56601378|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601379|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
56601380|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56601381|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56601382|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601383|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601384|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56601385|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
56601386|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
56601387|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
56601388|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56601389|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
56601390|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
56601391|NCT00714181|Temozolomide|temozolomide|mesh-list
56601392|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56601393|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
56601394|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601395|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601396|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
56601404|NCT02600806|Ofloxacin|ofloxacin|mesh-list
56601427|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56601428|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
56601429|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56601430|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601431|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56601432|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601433|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601435|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
56601436|NCT04291118|Budesonide|budesonide|mesh-list
56601437|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56601438|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56601439|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
56601440|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601441|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601442|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56601443|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
56601444|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
56601445|NCT04291118|Hormones|hormones|mesh-ancestor
56601446|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56601447|NCT02868944|Sufentanil|sufentanil|mesh-list
56601448|NCT02868944|Morphine|morphine|mesh-list
56601449|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
56601450|NCT02868944|Anesthetics|anesthetics|mesh-list
56601451|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
56601452|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56601453|NCT02868944|Narcotics|narcotics|mesh-ancestor
56601454|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601455|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762379|NCT03120221|Iodine|iodine|mesh-list
56601476|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601477|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601479|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56601480|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601481|NCT00719797|Leucovorin|leucovorin|mesh-list
56601482|NCT00719797|Bevacizumab|bevacizumab|mesh-list
56601483|NCT00719797|Fluorouracil|fluorouracil|mesh-list
56601484|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
56601485|NCT00719797|Irinotecan|irinotecan|mesh-list
56601486|NCT00719797|Calcium|calcium|mesh-list
56601487|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
56601488|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56601489|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601490|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56601491|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56601492|NCT00719797|Growth Substances|growth substances|mesh-ancestor
56601493|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601494|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
56601495|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56601496|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
56601497|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601498|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56601499|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601500|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
56601501|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56601528|NCT03258723|Metformin|metformin|mesh-list
56601529|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56601530|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601531|NCT00640029|Meloxicam|meloxicam|mesh-list
56601532|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56601533|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601534|NCT00640029|Analgesics|analgesics|mesh-ancestor
56601535|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
56601536|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601537|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601538|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56601539|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601540|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56601541|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56601542|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601543|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601550|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
56601551|NCT02684799|Omeprazole|omeprazole|mesh-list
56601552|NCT02684799|Famotidine|famotidine|mesh-list
56601553|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56601554|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56601555|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56601556|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601557|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601558|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56601559|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
56601560|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
56601561|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601581|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56601582|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601583|NCT00752986|Fulvestrant|fulvestrant|mesh-list
56601584|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56601585|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601586|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56601587|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56601588|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
56601589|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56601590|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601591|NCT02684487|Vitamin D|vitamin d|mesh-list
56601592|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
56601593|NCT02684487|Vitamins|vitamins|mesh-ancestor
56601594|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
56601595|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601596|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56601597|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56601598|NCT02684409|Sumatriptan|sumatriptan|mesh-list
56601599|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56601600|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56601601|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56601602|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
56601603|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601604|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601605|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601606|NCT00762892|Tenofovir|tenofovir|mesh-list
56601607|NCT00762892|Emtricitabine|emtricitabine|mesh-list
56601608|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
56601624|NCT04290572|Isotretinoin|isotretinoin|mesh-list
56601625|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
56601626|NCT04069429|Heparin|heparin|mesh-list
56601627|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
56601628|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56601629|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56601630|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601631|NCT00755716|Topiramate|topiramate|mesh-list
56601632|NCT00755716|Nicotine|nicotine|mesh-list
56601633|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56601634|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
56601635|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601636|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601637|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56601638|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56601639|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
56601640|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601682|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601683|NCT02600650|Testosterone|testosterone|mesh-list
56601684|NCT02600650|Androgens|androgens|mesh-ancestor
56601685|NCT02600650|Hormones|hormones|mesh-ancestor
56601686|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56601687|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601688|NCT03084471|Durvalumab|durvalumab|mesh-list
56601689|NCT03084471|Tremelimumab|tremelimumab|mesh-list
56601690|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56601691|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56601692|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601693|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
56601694|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601696|NCT00718471|Enoxaparin|enoxaparin|mesh-list
56601697|NCT00718471|Calcium heparin|calcium heparin|mesh-list
56601698|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
56601699|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56601700|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56601701|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601702|NCT00723307|Metformin|metformin|mesh-list
56601703|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56601704|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601705|NCT00723385|Vitamin D|vitamin d|mesh-list
56601706|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
56601707|NCT00723385|Vitamins|vitamins|mesh-ancestor
56601708|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
56601709|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601710|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56601711|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56601712|NCT00754936|Citalopram|citalopram|mesh-list
56601713|NCT00754936|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56601714|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56601715|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56601716|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601717|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601722|NCT00754936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56601723|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
56601724|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
56601725|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56601726|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601727|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601728|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601729|NCT02684019|Analgesics|analgesics|mesh-ancestor
56601730|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
56601731|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56350236|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
56601732|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56601733|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56601734|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56601735|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
56601736|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601737|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601738|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
56601739|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56601740|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
56601741|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56601742|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56601743|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56601744|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
56601745|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56601746|NCT00720421|Lorazepam|lorazepam|mesh-list
56601769|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56601770|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
56601771|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56601772|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601773|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56601774|NCT02601508|Rocuronium|rocuronium|mesh-list
56601775|NCT02601508|Atracurium|atracurium|mesh-list
56601776|NCT02601508|Cisatracurium|cisatracurium|mesh-list
56601777|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56601778|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56601779|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56601780|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601781|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601782|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56601783|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56601784|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
56601785|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601786|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601787|NCT02570581|Acetaminophen|acetaminophen|mesh-list
56601788|NCT02570581|Ramipril|ramipril|mesh-list
56601789|NCT02570581|Furosemide|furosemide|mesh-list
56601790|NCT02570581|Memantine|memantine|mesh-list
56601791|NCT02570581|Alprazolam|alprazolam|mesh-list
56601792|NCT02570581|Zopiclone|zopiclone|mesh-list
56601793|NCT02570581|Oxazepam|oxazepam|mesh-list
56601794|NCT02570581|Donepezil|donepezil|mesh-list
56601795|NCT02570581|Clopidogrel|clopidogrel|mesh-list
56601796|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56601797|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55914621|NCT00651963|Ezetimibe|ezetimibe|mesh-list
56196253|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196254|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124017|NCT01473732|Tacrolimus|tacrolimus|mesh-list
56196255|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
56196256|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
56196257|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
56196258|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56109919|NCT00005581|Epirubicin|epirubicin|mesh-list
56109980|NCT00005089|Doxorubicin|doxorubicin|mesh-list
56109981|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56109982|NCT00005089|Vincristine|vincristine|mesh-list
56109983|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109984|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
56109985|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109986|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109987|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109988|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
56109989|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601798|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56601799|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56601800|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
56601801|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601802|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601803|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601804|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601805|NCT02570581|Analgesics|analgesics|mesh-ancestor
56350302|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601806|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
56601807|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601808|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
56601809|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56601810|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601811|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
56601812|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
56601813|NCT02570581|Diuretics|diuretics|mesh-ancestor
56601814|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
56601815|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56601816|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56601817|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56601818|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56601819|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
56601820|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56601821|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56601822|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56601823|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
56601824|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56601825|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56601826|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56601827|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56601828|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56109990|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109991|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109992|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56109993|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56109994|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109995|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109996|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109997|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56601829|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56601830|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
56601831|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
56601833|NCT00640263|Lopinavir|lopinavir|mesh-list
56601834|NCT00640263|Lamivudine|lamivudine|mesh-list
56601835|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56601836|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56601837|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
56601838|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601839|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601840|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56601841|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56601842|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
56601843|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601844|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56601845|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56601846|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56601847|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56601848|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56601849|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
56601850|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56601851|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
56601852|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601853|NCT04019288|Durvalumab|durvalumab|mesh-list
56601854|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
56601855|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56601856|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
56601857|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56601858|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601859|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
56601876|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601877|NCT02867930|Analgesics|analgesics|mesh-ancestor
56601878|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
56601879|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601880|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56350379|NCT00201682|Etanercept|etanercept|mesh-list
56601881|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56601882|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56601883|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
56601884|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56601885|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601886|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56601887|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56601888|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56601889|NCT02570893|Paclitaxel|paclitaxel|mesh-list
56601890|NCT02570893|Carboplatin|carboplatin|mesh-list
56601891|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56601892|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56601893|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
56601894|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
56601895|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
56601896|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601897|NCT02538081|Risperidone|risperidone|mesh-list
56601898|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56601899|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
56601924|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56601925|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56601926|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56601927|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56601928|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601929|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56601930|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56601931|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601932|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
56601933|NCT00578227|Vaccines|vaccines|mesh-list
56601934|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
56601935|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601936|NCT00720577|Pioglitazone|pioglitazone|mesh-list
56601937|NCT00720577|Losartan|losartan|mesh-list
56601938|NCT00720577|Simvastatin|simvastatin|mesh-list
56601939|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56601940|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56601941|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
56601942|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56601943|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56601944|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56601945|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56601946|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56601947|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601948|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56601949|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56601950|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56601951|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56601969|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56601970|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
56601971|NCT00720811|Acetaminophen|acetaminophen|mesh-list
56601972|NCT00720811|Amoxicillin|amoxicillin|mesh-list
56601973|NCT00720811|Lumefantrine|lumefantrine|mesh-list
56601974|NCT00720811|Artemether|artemether|mesh-list
56601975|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56601976|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56601977|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56601978|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56601979|NCT00720811|Analgesics|analgesics|mesh-ancestor
56601980|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
56601981|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56601982|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56601983|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
56601984|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
56601985|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56601986|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56601988|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56601989|NCT00577993|Interferons|interferons|mesh-list
56601990|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
56601991|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
56601992|NCT00577993|Dexamethasone|dexamethasone|mesh-list
56601993|NCT00577993|Prednisone|prednisone|mesh-list
56601994|NCT00577993|Prednisolone|prednisolone|mesh-list
56601995|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56601996|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
56601997|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56601998|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
56601999|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
56602000|NCT00577993|Rituximab|rituximab|mesh-list
56602001|NCT00577993|Doxorubicin|doxorubicin|mesh-list
56602002|NCT00577993|Fludarabine|fludarabine|mesh-list
56602003|NCT00577993|Etoposide|etoposide|mesh-list
56602004|NCT00577993|Vincristine|vincristine|mesh-list
56602005|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
56602016|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602017|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602018|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56602019|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56602020|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602021|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
56602022|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
56602023|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602024|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602025|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
56602026|NCT00577993|Hormones|hormones|mesh-ancestor
56602027|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56602028|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56602029|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350529|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
56602030|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56602031|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56602032|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602033|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56602044|NCT00975806|Sunitinib|sunitinib|mesh-list
56602068|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
56602069|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56602070|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56602071|NCT02866370|Paclitaxel|paclitaxel|mesh-list
56602072|NCT02866370|Carboplatin|carboplatin|mesh-list
56602073|NCT02866370|Doxorubicin|doxorubicin|mesh-list
56602074|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56602075|NCT02866370|Topotecan|topotecan|mesh-list
56602076|NCT02866370|Nintedanib|nintedanib|mesh-list
56602077|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56602078|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602079|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
56602080|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
56602081|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
56602082|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602083|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56602084|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56602085|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602086|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602087|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56602088|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56602089|NCT00978068|Ritonavir|ritonavir|mesh-list
56602090|NCT00978068|Lopinavir|lopinavir|mesh-list
56602091|NCT00978068|Nevirapine|nevirapine|mesh-list
56602092|NCT00978068|Efavirenz|efavirenz|mesh-list
56602093|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56602094|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56602095|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56602096|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
56602097|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602098|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602099|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56602100|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56602111|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
56602112|NCT00629642|Oxybutynin|oxybutynin|mesh-list
56602113|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56602114|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56602115|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
56602116|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602117|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602118|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602119|NCT00629642|Urological Agents|urological agents|mesh-ancestor
56602120|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
56602121|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
56602122|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602123|NCT02865356|Cyclosporine|cyclosporine|mesh-list
56602124|NCT02865356|Cyclosporins|cyclosporins|mesh-list
56602125|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602126|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602127|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602128|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
56602129|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602130|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
56602131|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602132|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
56602133|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109998|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
56109999|NCT00005089|Hormones|hormones|mesh-ancestor
56110023|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110024|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196259|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196260|NCT01502904|Sirolimus|sirolimus|mesh-list
56196261|NCT01502904|Pravastatin|pravastatin|mesh-list
56196262|NCT01502904|Pitavastatin|pitavastatin|mesh-list
56196263|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56196264|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196265|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56196266|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196267|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
56196268|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56196269|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
56196270|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196271|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56196272|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56196273|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
56196274|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110025|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110026|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56110027|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110028|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110029|NCT00005113|Cyclosporine|cyclosporine|mesh-list
56110032|NCT00005113|Cyclosporins|cyclosporins|mesh-list
56110033|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110034|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
56110035|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110036|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56602134|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56602135|NCT04287842|Sevoflurane|sevoflurane|mesh-list
56602136|NCT04287842|Desflurane|desflurane|mesh-list
56602137|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56602138|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56602139|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
56602140|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
56602141|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56602142|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602143|NCT04068194|Avelumab|avelumab|mesh-list
56602144|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56602145|NCT04068194|Peposertib|peposertib|mesh-list
56602146|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56602147|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602148|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
56602149|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602150|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56602151|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602152|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602153|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
56602154|NCT00721747|Docetaxel|docetaxel|mesh-list
56602155|NCT00721747|Doxorubicin|doxorubicin|mesh-list
56602156|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56602157|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602158|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
56602159|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602160|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602161|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56602162|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
56602163|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602164|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602165|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56602166|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
56602167|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
56602168|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
56602169|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56602170|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56602172|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602173|NCT00603525|Ofatumumab|ofatumumab|mesh-list
56602174|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602175|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56602176|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
56602177|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602178|NCT03715933|Carboplatin|carboplatin|mesh-list
56602179|NCT03715933|Fluorouracil|fluorouracil|mesh-list
56602180|NCT03715933|Irinotecan|irinotecan|mesh-list
56602181|NCT03715933|Pemetrexed|pemetrexed|mesh-list
56602182|NCT03715933|Temozolomide|temozolomide|mesh-list
56602183|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350677|NCT00222976|Analgesics|analgesics|mesh-ancestor
56602184|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
56602185|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602186|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56602187|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602188|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
56602189|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602190|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56602191|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602192|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602193|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56602194|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56602224|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602225|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602226|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
56602227|NCT00640575|Hormones|hormones|mesh-ancestor
56602228|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56602229|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602230|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
56602231|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602232|NCT04067791|Melatonin|melatonin|mesh-list
56602233|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
56602234|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602235|NCT04067791|Protective Agents|protective agents|mesh-ancestor
56602236|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602237|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56602238|NCT00762034|Paclitaxel|paclitaxel|mesh-list
56602239|NCT00762034|Bevacizumab|bevacizumab|mesh-list
56602240|NCT00762034|Carboplatin|carboplatin|mesh-list
56602241|NCT00762034|Pemetrexed|pemetrexed|mesh-list
56602242|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56602243|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602244|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
56602245|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
56602246|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
56602247|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602248|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56602249|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56602250|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56602251|NCT00762034|Growth Substances|growth substances|mesh-ancestor
56602252|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602253|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
56602254|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602255|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56602256|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56602257|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
56602258|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56602259|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
56110037|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110038|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602260|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56602261|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
56602262|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602263|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602264|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
56602265|NCT04183881|Brodalumab|brodalumab|mesh-list
56602266|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
56602267|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
56602268|NCT04093648|Fludarabine|fludarabine|mesh-list
56602269|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602270|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
56602271|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602272|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602273|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56602274|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
56602275|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602276|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602277|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56602278|NCT04184115|Scopolamine|scopolamine|mesh-list
56602279|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56602280|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
56602281|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
56602282|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602283|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602284|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602285|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
56602286|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56602287|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
56602307|NCT00640809|Analgesics|analgesics|mesh-ancestor
56602308|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
56602309|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602310|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602311|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602312|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602313|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56602314|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602315|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602316|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56602317|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56602318|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602319|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56602320|NCT00754624|Insulin|insulin|mesh-list
56602321|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56602322|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602323|NCT05630209|Doxorubicin|doxorubicin|mesh-list
56602324|NCT05630209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56602325|NCT05630209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602326|NCT05630209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56602327|NCT05630209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602359|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
56602360|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56602361|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602362|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56602363|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602364|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
56602365|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56602366|NCT02683005|Ledipasvir|ledipasvir|mesh-list
56602367|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
56602368|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602369|NCT03583957|Caffeine|caffeine|mesh-list
56602370|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56602371|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602372|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56602385|NCT02571283|Epinephrine|epinephrine|mesh-list
56602420|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
56602421|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602422|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602423|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56602424|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
56602425|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56602426|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56602427|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56602428|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56602429|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602430|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602431|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56602432|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
56602433|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56602434|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56602435|NCT02571517|Prednisolone|prednisolone|mesh-list
56602436|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
56602437|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56602476|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
56602477|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
56602478|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602479|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602480|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
56602481|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56350980|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602482|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
56602483|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
56602484|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56602485|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56602486|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56602487|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
56602488|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602489|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602490|NCT04144465|Protective Agents|protective agents|mesh-ancestor
56602491|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
56602493|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56602496|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
56602530|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602531|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56602532|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56602533|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602534|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
56602535|NCT02570035|Mirabegron|mirabegron|mesh-list
56602536|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56602537|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56602538|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56602539|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
56602540|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602542|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602593|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602594|NCT02571205|Testosterone|testosterone|mesh-list
56602595|NCT02571205|Androgens|androgens|mesh-ancestor
56602596|NCT02571205|Hormones|hormones|mesh-ancestor
56602597|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56602598|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602599|NCT04290026|Metoclopramide|metoclopramide|mesh-list
56602600|NCT04290026|Granisetron|granisetron|mesh-list
56602601|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
56602602|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
56602603|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602604|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602605|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56602606|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56602607|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56602608|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
56602609|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602610|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602611|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56602612|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
56602613|NCT00640887|Ritonavir|ritonavir|mesh-list
56602614|NCT00640887|Lopinavir|lopinavir|mesh-list
56602615|NCT00640887|Nevirapine|nevirapine|mesh-list
56602616|NCT00640887|Efavirenz|efavirenz|mesh-list
56602617|NCT00640887|Rifabutin|rifabutin|mesh-list
56602618|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56602619|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56602620|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
56602621|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602622|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602623|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56110039|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
56110040|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110041|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
56110042|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56110043|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56110044|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56110045|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110046|NCT00004573|Ganciclovir|ganciclovir|mesh-list
56110047|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56110048|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
56110049|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110050|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56110085|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56110086|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56110087|NCT00005635|Paclitaxel|paclitaxel|mesh-list
56602624|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56602625|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
56602626|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602627|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56602628|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56602629|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56602630|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56602631|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56602632|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56602633|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56602634|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56602635|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56602636|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56602637|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56602638|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
56602639|NCT05615623|Doxorubicin|doxorubicin|mesh-list
56602640|NCT05615623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56602641|NCT05615623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602642|NCT05615623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56602643|NCT05615623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56602644|NCT05615623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602645|NCT05615623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602646|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
56602647|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
56602648|NCT00730093|Vitamins|vitamins|mesh-ancestor
56602649|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
56602650|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602651|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
56602652|NCT00730093|Hematinics|hematinics|mesh-ancestor
56602653|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56602654|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56602655|NCT00727129|Estradiol|estradiol|mesh-list
56602656|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56602657|NCT00727129|Estrogens|estrogens|mesh-ancestor
56602658|NCT00727129|Hormones|hormones|mesh-ancestor
56602659|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110088|NCT00005635|Trastuzumab|trastuzumab|mesh-list
56602660|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602661|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56602662|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
56602663|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56602664|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56602665|NCT04183725|Oseltamivir|oseltamivir|mesh-list
56602666|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
56602667|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602668|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602669|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602670|NCT00730249|Methylphenidate|methylphenidate|mesh-list
56602671|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56602672|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602673|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56602674|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56602675|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56602676|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602677|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
56602678|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602685|NCT01632657|Sumatriptan|sumatriptan|mesh-list
56602712|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602713|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602714|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56602715|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56602716|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
56602717|NCT02682225|Ketamine|ketamine|mesh-list
56602718|NCT02682225|Esketamine|esketamine|mesh-list
56602719|NCT02682225|Analgesics|analgesics|mesh-ancestor
56602720|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
56602721|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602722|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602723|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56602724|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56602725|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
56602727|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56602728|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56602770|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
56602771|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602772|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
56602773|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602774|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56602775|NCT03702283|Penicillins|penicillins|mesh-list
56602776|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56602777|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602778|NCT00727753|Bevacizumab|bevacizumab|mesh-list
56602779|NCT00727753|Ranibizumab|ranibizumab|mesh-list
56351281|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
56602780|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56602781|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602782|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56602783|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56602784|NCT00727753|Growth Substances|growth substances|mesh-ancestor
56602785|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602786|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
56602787|NCT00727831|Leucovorin|leucovorin|mesh-list
56602788|NCT00727831|Methotrexate|methotrexate|mesh-list
56602825|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602826|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
56602827|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602828|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56602829|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56602830|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56602831|NCT02681913|Adenosine|adenosine|mesh-list
56602832|NCT02681913|Analgesics|analgesics|mesh-ancestor
56602833|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
56602834|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602835|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602836|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56602837|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
56602838|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56602839|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
56602840|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
56602841|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56602842|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602843|NCT02681679|Bromfenac|bromfenac|mesh-list
56602844|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56602845|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56602878|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56602879|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602880|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56602881|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56602882|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
56602883|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56602884|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
56602885|NCT00641589|Hematinics|hematinics|mesh-ancestor
56602886|NCT00734383|Propofol|propofol|mesh-list
56602887|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56602888|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56602889|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602890|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56602891|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
56602892|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
56602893|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56602894|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
56602895|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602896|NCT02680977|Levodopa|levodopa|mesh-list
56602897|NCT02680977|Benserazide|benserazide|mesh-list
56602898|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56602934|NCT00909987|Bevacizumab|bevacizumab|mesh-list
56602935|NCT00909987|Capecitabine|capecitabine|mesh-list
56602936|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
56602937|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56602938|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56602939|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56602940|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56602941|NCT00909987|Growth Substances|growth substances|mesh-ancestor
56602942|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602943|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
56602944|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56602945|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
56602946|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602947|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56602948|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
56602949|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602950|NCT00760474|Pregabalin|pregabalin|mesh-list
56602951|NCT00760474|Analgesics|analgesics|mesh-ancestor
56602952|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
56602953|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56602954|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56602955|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
56602956|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56602957|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56602958|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602959|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56602960|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56602980|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56602981|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56602982|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
56602983|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56602984|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56602985|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
56602986|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56602987|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
56602988|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56602989|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56602990|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56602991|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56602992|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
56602993|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56602994|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56602995|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
56602996|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
56603037|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
56603038|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603039|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56603040|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603041|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
56603042|NCT00735241|Antidotes|antidotes|mesh-ancestor
56603043|NCT00735241|Protective Agents|protective agents|mesh-ancestor
56603044|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
56603045|NCT00735241|Vitamins|vitamins|mesh-ancestor
56603046|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
56603047|NCT00735241|Hematinics|hematinics|mesh-ancestor
56603048|NCT00729313|Lanreotide|lanreotide|mesh-list
56603049|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603050|NCT00641979|Budesonide|budesonide|mesh-list
56603051|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603052|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56603053|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
56603054|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603055|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603056|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56603057|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
56603058|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
56603059|NCT00641979|Hormones|hormones|mesh-ancestor
56603060|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603061|NCT02679339|Lidocaine|lidocaine|mesh-list
56603062|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603063|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
56603064|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603065|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603066|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
56603067|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603068|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55915873|NCT04051957|Isosorbide|isosorbide|mesh-list
56603079|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56603080|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603081|NCT00752206|Saracatinib|saracatinib|mesh-list
56351575|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603082|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603083|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603084|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603085|NCT02678949|Fluticasone|fluticasone|mesh-list
56603087|NCT02678949|Albuterol|albuterol|mesh-list
56603088|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603089|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56603090|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
56036722|NCT02980094|Vitamins|vitamins|mesh-list
56603091|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603092|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603093|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56603094|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
56603095|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
56603096|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56603097|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
56603105|NCT00642135|Phenylephrine|phenylephrine|mesh-list
56603133|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56603134|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603135|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603136|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56603137|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56603138|NCT02600260|Enoxaparin|enoxaparin|mesh-list
56603139|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
56603140|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
56603141|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56603142|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56603143|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603144|NCT05446870|Paclitaxel|paclitaxel|mesh-list
56603145|NCT05446870|Docetaxel|docetaxel|mesh-list
56603146|NCT05446870|Bevacizumab|bevacizumab|mesh-list
56603147|NCT05446870|Carboplatin|carboplatin|mesh-list
56603148|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
56603149|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56603150|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603151|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
56603152|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
56603153|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
56603161|NCT02537379|Ribavirin|ribavirin|mesh-list
56603188|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603189|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603190|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603191|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56603192|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56603193|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603194|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56603195|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56603196|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603197|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
56603198|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56603199|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56603200|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56603201|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
56603202|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603203|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
56603204|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603205|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
56603206|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603207|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603208|NCT00643539|Azithromycin|azithromycin|mesh-list
56603209|NCT00643539|Amoxicillin|amoxicillin|mesh-list
56603210|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56603211|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603237|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603238|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603239|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603240|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56603241|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56603242|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603243|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56603244|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56603245|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603246|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
56603248|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
56603249|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603250|NCT04179513|Methotrexate|methotrexate|mesh-list
56603251|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56603252|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
56603253|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56603254|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603255|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56603292|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56603293|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
56603294|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603295|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603296|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56603297|NCT02674737|Narcotics|narcotics|mesh-ancestor
56603298|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56603299|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603300|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603301|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56603302|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603303|NCT02674893|Liraglutide|liraglutide|mesh-list
56603304|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56603305|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56351801|NCT00228319|Carotenoids|carotenoids|mesh-list
56603306|NCT02674893|Incretins|incretins|mesh-ancestor
56603307|NCT02674893|Hormones|hormones|mesh-ancestor
56603308|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603309|NCT02717455|Panobinostat|panobinostat|mesh-list
56603310|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603311|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56036929|NCT02411448|Gefitinib|gefitinib|mesh-list
56603312|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603313|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603314|NCT02674581|Fostemsavir|fostemsavir|mesh-list
56603315|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56603316|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56603317|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
56603318|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603319|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56603334|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603335|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56603336|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56603337|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
56603338|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56603339|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
56603340|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
56603341|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
56603342|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56603343|NCT04065529|Zinc|zinc|mesh-list
56603344|NCT04065529|Trace Elements|trace elements|mesh-ancestor
56603345|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
56603346|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603347|NCT04179045|Sirolimus|sirolimus|mesh-list
56603348|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56603349|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603350|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56603351|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603352|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
56603353|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603354|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
56603355|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603356|NCT00970268|Bromides|bromides|mesh-list
56603357|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
56603358|NCT02674113|Bupivacaine|bupivacaine|mesh-list
56603359|NCT02674113|Anesthetics|anesthetics|mesh-list
56603360|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603361|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603362|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603365|NCT03698552|Epratuzumab|epratuzumab|mesh-list
56603380|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56603381|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56603382|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603383|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
56603384|NCT00731575|Prednisolone|prednisolone|mesh-list
56603385|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56603386|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
56603387|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56603388|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
56603389|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56603390|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
56603391|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603392|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
56603393|NCT00731575|Hormones|hormones|mesh-ancestor
56603394|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603395|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603396|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56603397|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603398|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
56603399|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
56603400|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603401|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56603402|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56603403|NCT00731575|Protective Agents|protective agents|mesh-ancestor
56603404|NCT02674191|Clindamycin|clindamycin|mesh-list
56603405|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
56603406|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
56603407|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
56603408|NCT02674191|Mepivacaine|mepivacaine|mesh-list
56603409|NCT02674191|Benzocaine|benzocaine|mesh-list
56603410|NCT02674191|Povidone|povidone|mesh-list
56603426|NCT00736021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56603427|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56603428|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56603429|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603430|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603431|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
56603432|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603433|NCT00736021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56603434|NCT00736021|Antidepressive Agents|antidepressive agents|mesh-ancestor
56603435|NCT00736021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56603436|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
56603437|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56603438|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56603439|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603487|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56603488|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56603489|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603490|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
56603491|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56603492|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56603493|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56603494|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56603495|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56603496|NCT05273775|Protective Agents|protective agents|mesh-ancestor
56603497|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56603498|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56603553|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56603554|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603555|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56603556|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603557|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
56603558|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
56603559|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
56603560|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56603561|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56603562|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603563|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603564|NCT00644631|Urological Agents|urological agents|mesh-ancestor
56603565|NCT02671383|Lopinavir|lopinavir|mesh-list
56603566|NCT02671383|Darunavir|darunavir|mesh-list
56603567|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56603568|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56603569|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
56603570|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603571|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603572|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56603573|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56603574|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
56603575|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603576|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56603577|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56603578|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56603579|NCT00738751|Panobinostat|panobinostat|mesh-list
56603580|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56603581|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603582|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56603583|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603584|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603585|NCT05243823|Estradiol|estradiol|mesh-list
56603586|NCT05243823|Estrogens|estrogens|mesh-ancestor
56110107|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110108|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56110109|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56110110|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
56603587|NCT05243823|Hormones|hormones|mesh-ancestor
56603588|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603589|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603590|NCT00736801|Fluticasone|fluticasone|mesh-list
56603591|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56603592|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603593|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56603594|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
56603595|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603596|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603597|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56603598|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
56603599|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
56603600|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56603601|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56603602|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56603603|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56603604|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
56603605|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603606|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603607|NCT00738829|Rituximab|rituximab|mesh-list
56603608|NCT00738829|Fludarabine|fludarabine|mesh-list
56159283|NCT02820324|Morphine|morphine|mesh-list
56603609|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
56603611|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56603612|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603613|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
56603614|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603615|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603616|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55916434|NCT03140982|Propofol|propofol|mesh-list
56110111|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110112|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110113|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56110114|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56110115|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
56110116|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56110117|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56110119|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
56110120|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110121|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56196275|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55898950|NCT05625802|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603617|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
56603618|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603619|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603620|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56603621|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56603622|NCT00738829|Growth Substances|growth substances|mesh-ancestor
56603623|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
56603624|NCT02671227|Bupivacaine|bupivacaine|mesh-list
56603625|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603626|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
56603627|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603628|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603629|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
56603630|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603631|NCT00644709|Atorvastatin|atorvastatin|mesh-list
56603632|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56603633|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56603634|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
56603635|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603636|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56603637|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56603638|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603639|NCT00738985|Simvastatin|simvastatin|mesh-list
56603640|NCT00738985|Ezetimibe|ezetimibe|mesh-list
56603641|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56603642|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56603643|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56603644|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
56603645|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603646|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56603647|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56603648|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603649|NCT05216211|Bupivacaine|bupivacaine|mesh-list
56603650|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603651|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
56603652|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916463|NCT03110640|Fludarabine|fludarabine|mesh-list
56603653|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603654|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
56603655|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603656|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56603657|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56603658|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603659|NCT00732121|Incretins|incretins|mesh-ancestor
56603660|NCT00732121|Hormones|hormones|mesh-ancestor
56603661|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56603662|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56603663|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
56603664|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603666|NCT02537223|Cisplatin|cisplatin|mesh-list
56603712|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603713|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
56603714|NCT04175067|Antioxidants|antioxidants|mesh-list
56603715|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603716|NCT04175067|Protective Agents|protective agents|mesh-ancestor
56603717|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603718|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
56603719|NCT00758602|Tacrolimus|tacrolimus|mesh-list
56603720|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603721|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
56603722|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603723|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56603724|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603725|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603726|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56603727|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603728|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56603729|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
56603730|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56603731|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603732|NCT00713323|Nabiximols|nabiximols|mesh-list
56603733|NCT00713323|Analgesics|analgesics|mesh-ancestor
56603734|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
56603735|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603763|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
56603764|NCT00732511|Protective Agents|protective agents|mesh-ancestor
56603765|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56603766|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56603767|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56603768|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
56603769|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56603770|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56603771|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
56603772|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56603773|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
56603774|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603775|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603776|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56603777|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
56603778|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56603779|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
56603780|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603781|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603782|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56603783|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
56603784|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
56603785|NCT00739531|Protective Agents|protective agents|mesh-ancestor
56603786|NCT00739609|Tryptophan|tryptophan|mesh-list
56603787|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56603788|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
56603810|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603811|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
56603812|NCT00732589|Lidocaine|lidocaine|mesh-list
56603813|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603814|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
56603815|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603816|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603817|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
56603818|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603819|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56603820|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56603821|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56603822|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56603823|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603824|NCT00645879|Citric Acid|citric acid|mesh-list
56603825|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
56603826|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
56603827|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56603828|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
56603829|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
56603863|NCT05560009|Protective Agents|protective agents|mesh-ancestor
56603864|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603865|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
56603866|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56603867|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603868|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56603869|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56603870|NCT04174131|Lidocaine|lidocaine|mesh-list
56603871|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
56603872|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
56603873|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
56603874|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603875|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603876|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
56603877|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603878|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56603879|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56603880|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56603883|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56603920|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56603921|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
56603922|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603923|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56603924|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56603925|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603926|NCT02665845|Mesalamine|mesalamine|mesh-list
56603927|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56603928|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56603929|NCT02665845|Analgesics|analgesics|mesh-ancestor
56603930|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
56603931|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56603932|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603933|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56603934|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56603935|NCT00646425|Basiliximab|basiliximab|mesh-list
56603936|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603937|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
56603938|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603939|NCT04837209|Niraparib|niraparib|mesh-list
56603940|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56603941|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603942|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603943|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603970|NCT02665533|Narcotics|narcotics|mesh-ancestor
56603971|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56603972|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
56603973|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
56603974|NCT00646503|Telbivudine|telbivudine|mesh-list
56603975|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
56603976|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56603977|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56603978|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56603979|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603981|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
56603982|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603983|NCT00646659|Carboplatin|carboplatin|mesh-list
56603984|NCT00646659|Docetaxel|docetaxel|mesh-list
56352506|NCT00232648|Budesonide|budesonide|mesh-list
56603985|NCT00646659|Fluorouracil|fluorouracil|mesh-list
56603986|NCT00646659|Cetuximab|cetuximab|mesh-list
56603987|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56603988|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
56603989|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
56603990|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
56603991|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56603992|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
56603993|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56603994|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56603995|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
56603996|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56603997|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56603998|NCT00648531|Balsalazide|balsalazide|mesh-list
56603999|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56604000|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56604001|NCT00648531|Analgesics|analgesics|mesh-ancestor
56604002|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
56604003|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604004|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604005|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56604006|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604014|NCT00648765|Anagrelide|anagrelide|mesh-list
56604015|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56604016|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56604017|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604018|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56604019|NCT00648843|Oxybutynin|oxybutynin|mesh-list
56604020|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
56604021|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
56604022|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604023|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604024|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56604025|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56604077|NCT02662491|Calcium|calcium|mesh-list
56604078|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
56604079|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604080|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56604081|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56604082|NCT00648999|Ritonavir|ritonavir|mesh-list
56604083|NCT00648999|Lopinavir|lopinavir|mesh-list
56604084|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56604085|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56604086|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
56604087|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604088|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604089|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56604090|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56604091|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
56604092|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604093|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56604094|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56604095|NCT02661711|Aflibercept|aflibercept|mesh-list
56604096|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56604097|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56604098|NCT02661711|Growth Substances|growth substances|mesh-ancestor
56604099|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604100|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
56604101|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604102|NCT02661789|Goserelin|goserelin|mesh-list
56604103|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56604104|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604105|NCT02661477|Interferons|interferons|mesh-list
56604106|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
56604113|NCT00649077|Meloxicam|meloxicam|mesh-list
56604122|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56604123|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56604124|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604125|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604126|NCT02656251|Ethanol|ethanol|mesh-list
56604127|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
56604128|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56604129|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56604130|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604131|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56604132|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604133|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
56604134|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
56604135|NCT02656095|Heparin|heparin|mesh-list
56604136|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
56604137|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56604181|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604182|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56604183|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56604184|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56604185|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56604186|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
56604187|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604188|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604189|NCT00712933|Belimumab|belimumab|mesh-list
56604190|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604191|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
56604192|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604193|NCT02654847|Norepinephrine|norepinephrine|mesh-list
56604194|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56604195|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56604196|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
56604200|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
56604238|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56604239|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
56604240|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604241|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604242|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604243|NCT04064125|Minocycline|minocycline|mesh-list
56604244|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56604245|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604246|NCT00740389|Etravirine|etravirine|mesh-list
56604247|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56604248|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56604249|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604250|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604251|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
56604252|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604253|NCT00740467|Cyclosporine|cyclosporine|mesh-list
56604254|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
56604255|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
56604256|NCT00740467|Busulfan|busulfan|mesh-list
56604257|NCT00740467|Fludarabine|fludarabine|mesh-list
56604258|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
56604293|NCT00733057|Minocycline|minocycline|mesh-list
56604294|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56604295|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604296|NCT00737971|Triamcinolone|triamcinolone|mesh-list
56604297|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56604298|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56604299|NCT00737971|Bevacizumab|bevacizumab|mesh-list
56604300|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56604301|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56604302|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604303|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56604304|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56604305|NCT00737971|Growth Substances|growth substances|mesh-ancestor
56604306|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604307|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
56604308|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56604309|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
56604310|NCT00737971|Hormones|hormones|mesh-ancestor
56604311|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604312|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604313|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
56604314|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604315|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604316|NCT00650247|Sumatriptan|sumatriptan|mesh-list
56604317|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56604318|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56604319|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56604339|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604340|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604341|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
56604342|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56604343|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56604344|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604345|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604346|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56604347|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56604348|NCT02653209|Pioglitazone|pioglitazone|mesh-list
56604349|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56604350|NCT02653209|Canagliflozin|canagliflozin|mesh-list
56604351|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56604352|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604353|NCT02653209|Incretins|incretins|mesh-ancestor
56604354|NCT02653209|Hormones|hormones|mesh-ancestor
56604355|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604356|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56604357|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
56604393|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56604394|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
56604395|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56604396|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604397|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
56604398|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56604399|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604400|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604401|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56604402|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56604403|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56604404|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56604405|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56604406|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56604407|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
56604408|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
56604409|NCT00741325|Plerixafor|plerixafor|mesh-list
56604410|NCT00741325|Lenograstim|lenograstim|mesh-list
56604411|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56604412|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
56604445|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56604447|NCT05742295|Vitamins|vitamins|mesh-ancestor
56604448|NCT05742295|Micronutrients|micronutrients|mesh-ancestor
56604449|NCT05742295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604450|NCT05742295|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56604451|NCT05742295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56604452|NCT05742295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604453|NCT05742295|Hemostatics|hemostatics|mesh-ancestor
56604454|NCT05742295|Coagulants|coagulants|mesh-ancestor
56604455|NCT02652273|Abatacept|abatacept|mesh-list
56604456|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56604457|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604458|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604459|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604460|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
56604461|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604462|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604463|NCT00650325|Sertraline|sertraline|mesh-list
56604464|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
56604465|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56604466|NCT00650325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56604467|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56604468|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56604469|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604470|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604471|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
56604472|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604473|NCT00650403|Paroxetine|paroxetine|mesh-list
56604474|NCT00650403|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56604475|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56604476|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56604477|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604478|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604484|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56604485|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56604486|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604487|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56604488|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56604489|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
56604490|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604491|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604492|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56604493|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
56604494|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56604495|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56604496|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56604497|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
56604498|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56604499|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604501|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
56604503|NCT00920803|Protective Agents|protective agents|mesh-ancestor
56604541|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
56604542|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
56604543|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604544|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
56604545|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604546|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
56604547|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604548|NCT05551897|Itraconazole|itraconazole|mesh-list
56604549|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
56604550|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604551|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56604552|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56604553|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604554|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604555|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56604556|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
56604557|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604558|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604559|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56604560|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
56604562|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56604563|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604592|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56604593|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604594|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
56604595|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604596|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56604597|NCT02647047|Analgesics|analgesics|mesh-ancestor
56604598|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
56604599|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56604600|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56604601|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604602|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56604603|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604604|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604605|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56604606|NCT02647047|Narcotics|narcotics|mesh-ancestor
56604650|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56604651|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604652|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56604653|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56604654|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
56604655|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56604656|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604657|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56604658|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56604659|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604660|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604661|NCT05741905|Levofloxacin|levofloxacin|mesh-list
56604662|NCT05741905|Ofloxacin|ofloxacin|mesh-list
56604663|NCT05741905|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56604664|NCT05741905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604665|NCT05741905|Renal Agents|renal agents|mesh-ancestor
56604666|NCT05741905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56604707|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56604708|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56604709|NCT00652119|Growth Substances|growth substances|mesh-ancestor
56604710|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604711|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
56604712|NCT05740657|Fentanyl|fentanyl|mesh-list
56604713|NCT05740657|Sufentanil|sufentanil|mesh-list
56604714|NCT05740657|Morphine|morphine|mesh-list
56604715|NCT05740657|Remifentanil|remifentanil|mesh-list
56604716|NCT05740657|Oxycodone|oxycodone|mesh-list
56604717|NCT05740657|Hydromorphone|hydromorphone|mesh-list
56604718|NCT05740657|Alfentanil|alfentanil|mesh-list
56604719|NCT05740657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56604720|NCT05740657|Narcotics|narcotics|mesh-ancestor
56604721|NCT05740657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56604722|NCT05740657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604723|NCT05740657|Analgesics|analgesics|mesh-ancestor
56604724|NCT05740657|Sensory System Agents|sensory system agents|mesh-ancestor
56604725|NCT05740657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604726|NCT05740657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56604730|NCT02646267|Warfarin|warfarin|mesh-list
56604766|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
56604767|NCT02645565|Azathioprine|azathioprine|mesh-list
56604768|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56604769|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
56604770|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604771|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
56604772|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604773|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56604774|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56604775|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
56604776|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604777|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604778|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56604828|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604829|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56604830|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56604831|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604832|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604833|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56604834|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
56604835|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56604836|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
56604837|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
56604838|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
56604839|NCT00708175|Pioglitazone|pioglitazone|mesh-list
56604840|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56604841|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604842|NCT05740345|Metformin|metformin|mesh-list
56604843|NCT05740345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56604845|NCT02641431|Ajmaline|ajmaline|mesh-list
56604885|NCT04062565|Riociguat|riociguat|mesh-list
56604886|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56604887|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
56604888|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56604889|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
56604890|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56604891|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
56604892|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
56604893|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56604894|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604895|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56604896|NCT00967694|Analgesics|analgesics|mesh-ancestor
56604897|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
56604898|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56604899|NCT04288700|Timolol|timolol|mesh-list
56604900|NCT04288700|Propranolol|propranolol|mesh-list
56604901|NCT04288700|Captopril|captopril|mesh-list
56604902|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56604903|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56604904|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604941|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56604942|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
56604943|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604944|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56604945|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56604946|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604947|NCT00967616|Antidotes|antidotes|mesh-ancestor
56604948|NCT00967616|Protective Agents|protective agents|mesh-ancestor
56604949|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
56604950|NCT00967616|Vitamins|vitamins|mesh-ancestor
56604951|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
56604952|NCT04288232|Aflibercept|aflibercept|mesh-list
56604953|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56604954|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56604955|NCT04288232|Growth Substances|growth substances|mesh-ancestor
56604956|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56604957|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
56353464|NCT00237913|Olanzapine|olanzapine|mesh-list
56604958|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604959|NCT02864264|Interferons|interferons|mesh-list
56604960|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
56604961|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56604962|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
56604963|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56604995|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56604996|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56604997|NCT00974090|Glimepiride|glimepiride|mesh-list
56604998|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56604999|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56605000|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605001|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56605002|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
56605003|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56605004|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56605005|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56605006|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
56605007|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605008|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56605009|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56605010|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605011|NCT02639091|Pemetrexed|pemetrexed|mesh-list
56605051|NCT03887702|Entecavir|entecavir|mesh-list
56605052|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
56605053|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605054|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56605055|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56605056|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605057|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605058|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56605059|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56605060|NCT02638857|Epirubicin|epirubicin|mesh-list
56605061|NCT02638857|Mitomycins|mitomycins|mesh-list
56605062|NCT02638857|Mitomycin|mitomycin|mesh-list
56605063|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
56605064|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56605065|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605066|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56605067|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56605068|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605069|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605070|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
56605071|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56605072|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
56605077|NCT02638545|Analgesics|analgesics|mesh-ancestor
56605105|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605106|NCT01842399|Protective Agents|protective agents|mesh-ancestor
56605107|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605108|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605109|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56605110|NCT00970502|Celecoxib|celecoxib|mesh-list
56605111|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56605112|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605113|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56605114|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605115|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605116|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56605117|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56605118|NCT00970502|Analgesics|analgesics|mesh-ancestor
56605119|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
56605120|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605121|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605122|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56605157|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605158|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605159|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56605160|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
56605161|NCT02567773|Hormones|hormones|mesh-ancestor
56605162|NCT00967226|Prednisolone|prednisolone|mesh-list
56605163|NCT00967226|Propranolol|propranolol|mesh-list
56605164|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
56605165|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56605166|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
56605167|NCT00967226|Hormones|hormones|mesh-ancestor
56605168|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605169|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605170|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56605171|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605172|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56605173|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56605174|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
56605175|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605176|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605177|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56605178|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56605179|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
56605180|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56605181|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56605182|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56605183|NCT00964886|Benztropine|benztropine|mesh-list
56605184|NCT00964886|Desipramine|desipramine|mesh-list
56605185|NCT00964886|Clomipramine|clomipramine|mesh-list
56605201|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605202|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56605203|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56605204|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
56605205|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56605206|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
56605207|NCT00964886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56605208|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
56605209|NCT02861222|Doxorubicin|doxorubicin|mesh-list
56605210|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56605211|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605212|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56605213|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56605214|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605215|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605216|NCT04062019|Aldesleukin|aldesleukin|mesh-list
56605217|NCT04062019|Interleukin-2|interleukin-2|mesh-list
56605218|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605219|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56605220|NCT04062019|Analgesics|analgesics|mesh-ancestor
56605221|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
56605222|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605223|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605224|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56605225|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56605226|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
56605227|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605228|NCT04061863|Nivolumab|nivolumab|mesh-list
56605229|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56605230|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605231|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56605232|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605243|NCT05332561|Atezolizumab|atezolizumab|mesh-list
56605244|NCT05332561|Olaparib|olaparib|mesh-list
56605245|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56605246|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605247|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56605248|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605249|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605250|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
56605251|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56605252|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56605253|NCT00705757|Bimatoprost|bimatoprost|mesh-list
56605254|NCT00705757|Travoprost|travoprost|mesh-list
56605255|NCT00705757|Latanoprost|latanoprost|mesh-list
56605256|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56605257|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56605258|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56605259|NCT04284644|Propofol|propofol|mesh-list
56605260|NCT04284644|Sevoflurane|sevoflurane|mesh-list
56605261|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56605301|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56605302|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56605303|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605304|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
56605305|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
56605306|NCT04283162|Calcium|calcium|mesh-list
56605307|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56605308|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605309|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56605310|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
56605311|NCT04283162|Coagulants|coagulants|mesh-ancestor
56605312|NCT00758524|Eplerenone|eplerenone|mesh-list
56605313|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56605314|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
56605315|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605316|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605317|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56605318|NCT00758524|Diuretics|diuretics|mesh-ancestor
56605319|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
56605320|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56605321|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
56605322|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56605352|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605353|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56605354|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56605355|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605356|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605357|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56605358|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56605360|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
56605361|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605362|NCT04092868|Coagulants|coagulants|mesh-ancestor
56605363|NCT05695573|Cystatins|cystatins|mesh-list
56605364|NCT05695573|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56605365|NCT05695573|Protease Inhibitors|protease inhibitors|mesh-ancestor
56605366|NCT05695573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605367|NCT05695573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605368|NCT05674513|Ulipristal acetate|ulipristal acetate|mesh-list
56605369|NCT05674513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56605370|NCT05674513|Contraceptive Agents|contraceptive agents|mesh-ancestor
56605371|NCT05674513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56605372|NCT05674513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605374|NCT00916942|Lidocaine|lidocaine|mesh-list
56605404|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605405|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605406|NCT04092478|Anesthetics|anesthetics|mesh-list
56605407|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605408|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605409|NCT02598466|Abatacept|abatacept|mesh-list
56605410|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56353910|NCT00240214|Sirolimus|sirolimus|mesh-list
56605411|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605412|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605413|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56605414|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
56605415|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605416|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605417|NCT04089592|Fentanyl|fentanyl|mesh-list
56605418|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
56605419|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56605420|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605421|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605422|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56605423|NCT04089592|Analgesics|analgesics|mesh-ancestor
56605424|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
56605425|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605426|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56605427|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56605428|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56605429|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
56605449|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605450|NCT00961298|Analgesics|analgesics|mesh-ancestor
56605451|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
56605452|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605453|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
56605454|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56605455|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
56605456|NCT00744328|Sertraline|sertraline|mesh-list
56605457|NCT00744328|Estradiol|estradiol|mesh-list
56605458|NCT00744328|Estrogens|estrogens|mesh-ancestor
56605459|NCT00744328|Hormones|hormones|mesh-ancestor
56605460|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56605461|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605462|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
56605463|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56605464|NCT00744328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56605465|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56605466|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56605467|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605468|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605469|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
56605470|NCT04019782|Hylan|hylan|mesh-list
56605471|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
56605502|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
56605503|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56605504|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56605505|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605506|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605507|NCT00959894|Tenofovir|tenofovir|mesh-list
56605508|NCT00959894|Emtricitabine|emtricitabine|mesh-list
56605509|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56605510|NCT00959894|Etravirine|etravirine|mesh-list
56605511|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
56605512|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605513|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56605514|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56605515|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605516|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605517|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56605518|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56605519|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
56605520|NCT02599168|Propofol|propofol|mesh-list
56605521|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56605537|NCT00746590|Tretazicar|tretazicar|mesh-list
56605554|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56605555|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56605556|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
56605557|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605558|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605559|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605560|NCT02597140|Lidocaine|lidocaine|mesh-list
56605561|NCT02597140|Propofol|propofol|mesh-list
56605562|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
56605563|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
56605564|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605565|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605566|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
56605567|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605568|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56605569|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56605570|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56605571|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56605572|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605573|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56605574|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56605575|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
56605576|NCT02598310|Paclitaxel|paclitaxel|mesh-list
56605577|NCT02598310|Trastuzumab|trastuzumab|mesh-list
56605578|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56605579|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605580|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
56605581|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
56605582|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
56605583|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605584|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56605585|NCT04091074|Clopidogrel|clopidogrel|mesh-list
56605586|NCT04091074|Ticagrelor|ticagrelor|mesh-list
56605587|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56605588|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55918435|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605589|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56605590|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56605591|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
56605592|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605593|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605594|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605595|NCT00749398|Infliximab|infliximab|mesh-list
56605596|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
56605597|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56605598|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605599|NCT01012973|Aflibercept|aflibercept|mesh-list
56605600|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56605601|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56605602|NCT01012973|Growth Substances|growth substances|mesh-ancestor
56605603|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605604|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
56605605|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605606|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
56605607|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
56605608|NCT03974464|Coagulants|coagulants|mesh-ancestor
56605609|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56605610|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56605611|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
56605612|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605613|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
56605614|NCT00742924|Leucovorin|leucovorin|mesh-list
56605615|NCT00742924|Cisplatin|cisplatin|mesh-list
56605616|NCT00742924|Doxorubicin|doxorubicin|mesh-list
56605641|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56605642|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56605643|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
56605644|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605645|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56605646|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56605647|NCT00742924|Antidotes|antidotes|mesh-ancestor
56605648|NCT00742924|Protective Agents|protective agents|mesh-ancestor
56605649|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
56605650|NCT00742924|Vitamins|vitamins|mesh-ancestor
56605651|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
56605652|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56605653|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56605654|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
56605655|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56605656|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56605657|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
56605658|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
56605659|NCT02596984|Caspofungin|caspofungin|mesh-list
56605660|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
56605661|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605662|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605663|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605664|NCT00698815|Pemetrexed|pemetrexed|mesh-list
56605665|NCT00698815|Sunitinib|sunitinib|mesh-list
56605666|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605667|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605668|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605669|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56605670|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56605671|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56605672|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56605673|NCT00698815|Growth Substances|growth substances|mesh-ancestor
55918517|NCT04406779|Hormones|hormones|mesh-list
56196276|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56196277|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196278|NCT01502943|Atorvastatin|atorvastatin|mesh-list
56196279|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196280|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196281|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56196282|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56605674|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605675|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
56605676|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56605677|NCT02599090|Temozolomide|temozolomide|mesh-list
56605678|NCT02599090|Sorafenib|sorafenib|mesh-list
56605679|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56605680|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
56605681|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605682|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605683|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56605684|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605685|NCT00745498|Bevacizumab|bevacizumab|mesh-list
56605686|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56605735|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605736|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56605737|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
56605738|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56605739|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56605740|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56605741|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56605742|NCT04827979|Daratumumab|daratumumab|mesh-list
56605743|NCT04827979|Abatacept|abatacept|mesh-list
56605744|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
56605745|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
56605746|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
56605747|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605748|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605749|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56605750|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605751|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56605752|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56605753|NCT02597998|BI 409306|bi 409306|mesh-list
56605754|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56605755|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605756|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605757|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
56605758|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56605759|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605760|NCT00576901|Bevacizumab|bevacizumab|mesh-list
56605761|NCT00576901|Docetaxel|docetaxel|mesh-list
56605762|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56605763|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605764|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56605765|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56605766|NCT00576901|Growth Substances|growth substances|mesh-ancestor
56605767|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605768|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
56605769|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
56605770|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
56605771|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
56605772|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605773|NCT00699283|Brivaracetam|brivaracetam|mesh-list
56605774|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
56605775|NCT01023815|Cyclosporine|cyclosporine|mesh-list
56605776|NCT01023815|Everolimus|everolimus|mesh-list
56605777|NCT01023815|Cyclosporins|cyclosporins|mesh-list
56605778|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605779|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605780|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56605781|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
56605782|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605783|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
56605784|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605785|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56605833|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56605834|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56605835|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605836|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
56605837|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56605838|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56605839|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56605840|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
56605841|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56605842|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56605843|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
56605897|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605898|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56605899|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56605900|NCT02567929|Propofol|propofol|mesh-list
56605901|NCT02567929|Sevoflurane|sevoflurane|mesh-list
56605902|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56605903|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56605904|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605905|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56605906|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
56605907|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
56605908|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56605909|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56605910|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56605911|NCT05188417|Tirofiban|tirofiban|mesh-list
56605912|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56605913|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56605914|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605915|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56605916|NCT00962780|Vaccines|vaccines|mesh-list
56605917|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56605918|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
56605919|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605920|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56605921|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56196283|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
56196284|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56196285|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56196286|NCT01503008|Metformin|metformin|mesh-list
56196287|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
56196288|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56196289|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
56196290|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56110122|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56110123|NCT00005641|Antidotes|antidotes|mesh-ancestor
56110124|NCT00005641|Protective Agents|protective agents|mesh-ancestor
56110125|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
56110126|NCT00005641|Vitamins|vitamins|mesh-ancestor
56110127|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
56110128|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
56110129|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110130|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56110131|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110132|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
56110133|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
56110134|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110135|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56110136|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
56605922|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605923|NCT00739882|Antibodies|antibodies|mesh-list
56605924|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56605925|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
56605926|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56605927|NCT00961220|Carmustine|carmustine|mesh-list
56605928|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56605929|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56605930|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
56605931|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605932|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605933|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605934|NCT00734656|Ethanol|ethanol|mesh-list
56605983|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56605984|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56605985|NCT00739648|Renal Agents|renal agents|mesh-ancestor
56605986|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56605987|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56605988|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56605989|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56605990|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56605991|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56605992|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56605993|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56605994|NCT05465941|Irinotecan|irinotecan|mesh-list
56605995|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56606000|NCT01032239|Baclofen|baclofen|mesh-list
56606046|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56606047|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56606048|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56606049|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
56606050|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606051|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606052|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606053|NCT00637715|Urological Agents|urological agents|mesh-ancestor
56606054|NCT02596282|Anesthetics|anesthetics|mesh-list
56606055|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606056|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606057|NCT04557085|Cenobamate|cenobamate|mesh-list
56606106|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606107|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606108|NCT00734032|Darapladib|darapladib|mesh-list
56606109|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56606110|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606111|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606112|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
56606113|NCT04284098|Bupivacaine|bupivacaine|mesh-list
56606114|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
56606115|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
56606116|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606117|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606118|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
56606119|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606120|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56606121|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56606122|NCT04284098|Analgesics|analgesics|mesh-ancestor
56606123|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56606124|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56606125|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56606126|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
56606127|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606128|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606129|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56606130|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56606131|NCT00733954|Clobetasol|clobetasol|mesh-list
56606132|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56606133|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
56606134|NCT00733954|Hormones|hormones|mesh-ancestor
56606135|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606136|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606137|NCT02595268|Pitavastatin|pitavastatin|mesh-list
56606138|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56606139|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56606140|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56606141|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
56110137|NCT00005641|Hormones|hormones|mesh-ancestor
56606142|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606143|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606144|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56606145|NCT00921505|Acetaminophen|acetaminophen|mesh-list
56606146|NCT00921505|Ibuprofen|ibuprofen|mesh-list
56606147|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56606148|NCT00921505|Analgesics|analgesics|mesh-ancestor
56606149|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
56606150|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606151|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606152|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
56606153|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56606154|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56606155|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56606156|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56606157|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354665|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56606158|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606159|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56606160|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56606161|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606162|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56606164|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606165|NCT04298021|Durvalumab|durvalumab|mesh-list
56606166|NCT04298021|Olaparib|olaparib|mesh-list
56606188|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56606189|NCT02595190|Narcotics|narcotics|mesh-ancestor
56606190|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56606191|NCT04061473|Empagliflozin|empagliflozin|mesh-list
56606192|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56606193|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606194|NCT04061473|Incretins|incretins|mesh-ancestor
56606195|NCT04061473|Hormones|hormones|mesh-ancestor
56606196|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606197|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56606198|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
56606199|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606200|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606201|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56606202|NCT04502693|Vaccines|vaccines|mesh-list
56606203|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
56606249|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606250|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56606251|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606252|NCT00742807|Alfentanil|alfentanil|mesh-list
56606253|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56606254|NCT00742807|Narcotics|narcotics|mesh-ancestor
56606255|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606256|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606257|NCT00742807|Analgesics|analgesics|mesh-ancestor
56606258|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
56606259|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606260|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56606261|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
56606262|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
56606308|NCT02595034|Clindamycin|clindamycin|mesh-list
56606309|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
56606310|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
56606311|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56606312|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56606313|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56606314|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56606315|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606316|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606317|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
56606318|NCT00958724|Vinorelbine|vinorelbine|mesh-list
56606319|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56606320|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606321|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606322|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
56606323|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606324|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606325|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56606326|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
56606327|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56606328|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56606329|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606330|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606331|NCT00738400|Urological Agents|urological agents|mesh-ancestor
56606332|NCT00958568|Olanzapine|olanzapine|mesh-list
56606333|NCT00958568|Fluoxetine|fluoxetine|mesh-list
56606334|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
56606335|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
56606336|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606337|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606338|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606339|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56606340|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56110138|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110139|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56110140|NCT00005647|Paclitaxel|paclitaxel|mesh-list
56110141|NCT00005647|Semaxinib|semaxinib|mesh-list
56110142|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56110143|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110144|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
56110145|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
56110146|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606341|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606342|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56606343|NCT00958568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56606344|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56606345|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56606346|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606347|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606348|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
56606349|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56606350|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
56606351|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56606352|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56606353|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606354|NCT00630500|Memantine|memantine|mesh-list
56606355|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56606356|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56606357|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
56606358|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606360|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606394|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606395|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56606396|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56606397|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
56606398|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
56606399|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56606400|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606401|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
56606402|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606403|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
56606404|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56606405|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56606406|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56606407|NCT02858804|Growth Substances|growth substances|mesh-ancestor
56606408|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
56606409|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
56606410|NCT00958256|Rituximab|rituximab|mesh-list
56606411|NCT00958256|Bortezomib|bortezomib|mesh-list
56606412|NCT00958256|Lenograstim|lenograstim|mesh-list
56606413|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56606414|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
56606415|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606416|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56606417|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56606418|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
56606419|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606420|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606421|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56606422|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56606423|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56110147|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110181|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110182|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56110183|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56110184|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56110185|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110186|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56110187|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56110188|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
56110189|NCT00004747|Antibodies|antibodies|mesh-list
56110190|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
56196293|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196295|NCT01503060|Lidocaine|lidocaine|mesh-list
56196296|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
56606424|NCT01006265|Ponesimod|ponesimod|mesh-list
56606425|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56606426|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606427|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56606428|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
56606429|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606430|NCT02861690|Paclitaxel|paclitaxel|mesh-list
56606431|NCT02861690|Nedaplatin|nedaplatin|mesh-list
56606432|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56606433|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606434|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606435|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56606436|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606437|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606438|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
56606439|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56606440|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606441|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56606442|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606443|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
56606444|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56606445|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606446|NCT00628667|Esomeprazole|esomeprazole|mesh-list
56606447|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56606448|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606458|NCT01008995|Ustekinumab|ustekinumab|mesh-list
56606471|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56606472|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606473|NCT00743587|Naproxen|naproxen|mesh-list
56606474|NCT00743587|Oxycodone|oxycodone|mesh-list
56606475|NCT00743587|Tramadol|tramadol|mesh-list
56606476|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56606477|NCT00743587|Narcotics|narcotics|mesh-ancestor
56606478|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56606479|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606480|NCT00743587|Analgesics|analgesics|mesh-ancestor
56606481|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
56606482|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606483|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56606534|NCT04279106|Protective Agents|protective agents|mesh-ancestor
56606535|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606536|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56606537|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56606538|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
56606539|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56606540|NCT00743743|Resveratrol|resveratrol|mesh-list
56606541|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
56606542|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606543|NCT00743743|Protective Agents|protective agents|mesh-ancestor
56606544|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606545|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606546|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56606547|NCT03881917|Cystatins|cystatins|mesh-list
56606548|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56606549|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
56606550|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606551|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606552|NCT01005719|Omeprazole|omeprazole|mesh-list
56606553|NCT01005719|Lansoprazole|lansoprazole|mesh-list
56606563|NCT02856854|Cocaine|cocaine|mesh-list
56606588|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56606589|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
56606590|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606591|NCT02856932|Methamphetamine|methamphetamine|mesh-list
56606592|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56606593|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606594|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
56606595|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
56606596|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56606597|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
56606600|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
56606652|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56606653|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
56606654|NCT01005329|Antibodies|antibodies|mesh-list
56606655|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
56606656|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56606657|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
56606658|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56606659|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606660|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606661|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
56606662|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606663|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606664|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56606665|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56606666|NCT01005329|Growth Substances|growth substances|mesh-ancestor
56606667|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606668|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
56606669|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
56606670|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
56606671|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56606672|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606673|NCT00921349|Nadolol|nadolol|mesh-list
56606674|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56606675|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56606676|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
56606677|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355186|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
56606678|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606697|NCT03048578|Hormones|hormones|mesh-ancestor
56606698|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606699|NCT02856776|Vitamin D|vitamin d|mesh-list
56606700|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
56606701|NCT02856776|Vitamins|vitamins|mesh-ancestor
56606702|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
56606703|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606704|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56606705|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56606706|NCT04296851|Niclosamide|niclosamide|mesh-list
56606707|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
56606708|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56606709|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
56606710|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56606711|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56606712|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
56606713|NCT02858024|Dapivirine|dapivirine|mesh-list
56606714|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56606715|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56606716|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
56606717|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56606718|NCT02857946|Linagliptin|linagliptin|mesh-list
56606719|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56606720|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606721|NCT02857946|Incretins|incretins|mesh-ancestor
56606722|NCT02857946|Hormones|hormones|mesh-ancestor
56606723|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606724|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56606745|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
56606746|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606747|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606748|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56606749|NCT00630968|Levetiracetam|levetiracetam|mesh-list
56606750|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
56606751|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
56606752|NCT02513563|Paclitaxel|paclitaxel|mesh-list
56606753|NCT02513563|Carboplatin|carboplatin|mesh-list
56355261|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
56606754|NCT02513563|Adavosertib|adavosertib|mesh-list
56606755|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56606756|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606757|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
56606758|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
56606759|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
56606760|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606761|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56606762|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
56606763|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
56606764|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606765|NCT00689611|Bupropion|bupropion|mesh-list
56606779|NCT02563795|Fentanyl|fentanyl|mesh-list
56606799|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606800|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606801|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
56606802|NCT00744445|Hematinics|hematinics|mesh-ancestor
56606803|NCT02854748|Empagliflozin|empagliflozin|mesh-list
56606804|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56606805|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606806|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56606807|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606808|NCT00744679|Natalizumab|natalizumab|mesh-list
56606861|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606862|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56606863|NCT00948818|Linaclotide|linaclotide|mesh-list
56606864|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56606865|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
56606866|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606867|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606868|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56606869|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56606870|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56606871|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606924|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56606925|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56606926|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56606927|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
56606928|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56606929|NCT00745147|Laxatives|laxatives|mesh-list
56606930|NCT00745147|Lactulose|lactulose|mesh-list
56606931|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56606932|NCT00688909|Letrozole|letrozole|mesh-list
56606933|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56606934|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56606987|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56606988|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
56606989|NCT02856542|Calcipotriene|calcipotriene|mesh-list
56606990|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56606991|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56606992|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
56606993|NCT02856542|Hormones|hormones|mesh-ancestor
56606994|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56606995|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56606996|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56606997|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
56606998|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
56606999|NCT00688753|Everolimus|everolimus|mesh-list
56607049|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56607050|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56607051|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607052|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607053|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
56607054|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607055|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56607056|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
56607057|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56607058|NCT04274270|Endostar protein|endostar protein|mesh-list
56607059|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56607060|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56607061|NCT04274270|Growth Substances|growth substances|mesh-ancestor
56607062|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607063|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
56607064|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607065|NCT02855294|Drospirenone|drospirenone|mesh-list
56607066|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56607067|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
56607068|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607069|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607070|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56607071|NCT02855294|Diuretics|diuretics|mesh-ancestor
56607072|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
56607073|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56607096|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56607097|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607098|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607099|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56607100|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56607101|NCT00694369|Narcotics|narcotics|mesh-ancestor
56607102|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56607103|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
56607104|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
56607105|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56607106|NCT00745693|BQ 788|bq 788|mesh-list
56607107|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56607108|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56607109|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607111|NCT02563405|Doxazosin|doxazosin|mesh-list
56607157|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
56607158|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607159|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607160|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56607161|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
56607162|NCT00954512|Antiviral Agents|antiviral agents|mesh-ancestor
56607163|NCT00954512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607164|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607165|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607166|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
56607167|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607168|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607169|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56607221|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56607222|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
56607223|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
56607224|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
56607225|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
56607226|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56607227|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607228|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56607229|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56607230|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56607231|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607232|NCT00949988|Rituximab|rituximab|mesh-list
56607233|NCT00949988|Dasatinib|dasatinib|mesh-list
56607234|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607235|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607236|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
56607237|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607238|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56607239|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56607240|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607241|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607242|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56607243|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56607244|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607245|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607246|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
56607247|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607248|NCT02593474|Naltrexone|naltrexone|mesh-list
56607249|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56607250|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56607251|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607252|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
56607253|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607254|NCT00687193|Tofacitinib|tofacitinib|mesh-list
56607258|NCT00917878|Calcium|calcium|mesh-list
56607259|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56607260|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607261|NCT00730912|Loratadine|loratadine|mesh-list
56607262|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
56607263|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
56607264|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56607265|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56607266|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56607267|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
56607268|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
56607269|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607270|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607271|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607272|NCT00730756|Fluticasone|fluticasone|mesh-list
56607273|NCT00730756|Xhance|xhance|mesh-list
56607274|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56607275|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56607276|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
56607277|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607278|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607279|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56607280|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
56607281|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
56607282|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56607283|NCT00730132|Ezetimibe|ezetimibe|mesh-list
56607284|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56607308|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56607309|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56607310|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56607311|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56607312|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56607313|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
56607314|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56607315|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56607316|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56607317|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
56607318|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56607319|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56607320|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607321|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56607322|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607323|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607324|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56607325|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56607362|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607363|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56607364|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
56607365|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607366|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607367|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56607368|NCT04088266|Buprenorphine|buprenorphine|mesh-list
56607369|NCT04088266|Naloxone|naloxone|mesh-list
56607370|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56607371|NCT04088266|Narcotics|narcotics|mesh-ancestor
56607372|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56607373|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607374|NCT04088266|Analgesics|analgesics|mesh-ancestor
56607375|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
56607376|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607377|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56607378|NCT00749359|Paroxetine|paroxetine|mesh-list
56607379|NCT00749359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56607380|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56607381|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56607383|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607413|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
56607415|NCT01410344|Vidarabine|vidarabine|mesh-list
56607416|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
56607417|NCT01410344|Melphalan|melphalan|mesh-list
56607418|NCT01410344|Busulfan|busulfan|mesh-list
56607419|NCT01410344|Fludarabine|fludarabine|mesh-list
56607420|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
56607421|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607422|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
56607423|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607424|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56607425|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56607426|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
56607427|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607428|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607429|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56607430|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56607431|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
56607432|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
56607433|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607434|NCT02594410|Lercanidipine|lercanidipine|mesh-list
56607435|NCT02594410|Clopidogrel|clopidogrel|mesh-list
56607436|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56607437|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56607438|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56607439|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56607440|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
56607441|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607442|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196297|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
56196298|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196299|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196300|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
56196301|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196302|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56196303|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56196304|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56196305|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196306|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196307|NCT01503216|Vitamin D|vitamin d|mesh-list
56110253|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56110254|NCT00004825|Mitogens|mitogens|mesh-list
56110255|NCT00004825|Mecasermin|mecasermin|mesh-list
56110256|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56110257|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110258|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56607443|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607444|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56607445|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56607446|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56607447|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56607448|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56607449|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
56607450|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56607451|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56607452|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56607453|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56607454|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607455|NCT00586066|Memantine|memantine|mesh-list
56607456|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56607457|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56607458|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
56607459|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607460|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607461|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607462|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56607463|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56607464|NCT00630890|Capecitabine|capecitabine|mesh-list
56607465|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56607466|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
56607469|NCT00728494|Ribavirin|ribavirin|mesh-list
56607490|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607491|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607492|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
56607493|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56607494|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
56607495|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56607496|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
56607498|NCT00941330|Exemestane|exemestane|mesh-list
56607499|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56607500|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
56607501|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607502|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56607503|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56607504|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
56607505|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607506|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607507|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56607508|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
56607509|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
56607510|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
56607511|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56607512|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56607513|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607543|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607544|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607545|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56607546|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607547|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56607548|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56607549|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56607550|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607551|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56607552|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
56607553|NCT00736450|Hormones|hormones|mesh-ancestor
56607554|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607555|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56607556|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56607601|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607602|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
56607603|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607604|NCT05096468|Pregabalin|pregabalin|mesh-list
56607605|NCT05096468|Ketamine|ketamine|mesh-list
56607606|NCT05096468|Esketamine|esketamine|mesh-list
56607607|NCT05096468|Analgesics|analgesics|mesh-ancestor
56607608|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
56607609|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607610|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607611|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56607612|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56607613|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
56607614|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
56607615|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56607616|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56607617|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56607618|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607628|NCT04088032|Durvalumab|durvalumab|mesh-list
56607655|NCT00735904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607656|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56607657|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
56607658|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
56607659|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56607660|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56607661|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607662|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
56607663|NCT02561923|Coagulants|coagulants|mesh-ancestor
56607664|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56607665|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
56607666|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56607667|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
56607668|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607669|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
56607670|NCT00918190|Dexamethasone|dexamethasone|mesh-list
56607671|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
56607672|NCT00918190|Midazolam|midazolam|mesh-list
56607673|NCT00918190|Ondansetron|ondansetron|mesh-list
56607674|NCT00918190|BB 1101|bb 1101|mesh-list
56607675|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56607676|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
56607677|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
56607678|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607679|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607680|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56607681|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
56607682|NCT00918190|Hormones|hormones|mesh-ancestor
56607683|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607684|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56607685|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607686|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
56607687|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607688|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607689|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56607697|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
56607698|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
56607699|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
56607700|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607701|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
56607702|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
56607703|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56607704|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
56607705|NCT00918190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56607706|NCT02563327|Pyridoxine|pyridoxine|mesh-list
56607707|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
56607708|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
56607709|NCT02563327|Rifampin|rifampin|mesh-list
56607710|NCT02563327|Isoniazid|isoniazid|mesh-list
56607711|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
56607712|NCT02563327|Ethambutol|ethambutol|mesh-list
56607713|NCT02563327|Rifapentine|rifapentine|mesh-list
56607714|NCT02563327|Vitamins|vitamins|mesh-ancestor
56607715|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
56607716|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607717|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56607718|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56607719|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56607720|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56607721|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607722|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607723|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607724|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
56607725|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56607747|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607748|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56607749|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
56607750|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
56607751|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56607752|NCT02593942|Narcotics|narcotics|mesh-ancestor
56607753|NCT02593942|Analgesics|analgesics|mesh-ancestor
56607754|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
56607755|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607756|NCT00742339|Octreotide|octreotide|mesh-list
56607757|NCT00742339|Terlipressin|terlipressin|mesh-list
56607758|NCT00742339|Midodrine|midodrine|mesh-list
56607759|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56607760|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56607761|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607762|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
56607763|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
56607764|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607765|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607766|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56607767|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56607768|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56607769|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56607770|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
56607771|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607772|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607773|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56607774|NCT02592772|Menthol|menthol|mesh-list
56607775|NCT02592772|Nicotine|nicotine|mesh-list
56607776|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56607777|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
56607778|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920663|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
56110259|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110260|NCT00004825|Growth Substances|growth substances|mesh-ancestor
56110261|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56110262|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56110263|NCT00385645|Zidovudine|zidovudine|mesh-list
56110264|NCT00385645|Lamivudine|lamivudine|mesh-list
56110265|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56110266|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56110267|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
56110268|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110269|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607779|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607780|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56607781|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56607782|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
56607783|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607784|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607785|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
56607786|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
56607787|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
56607788|NCT00631202|Hematinics|hematinics|mesh-ancestor
56607789|NCT00721630|Capecitabine|capecitabine|mesh-list
56607790|NCT00721630|Lapatinib|lapatinib|mesh-list
56607791|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56607792|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
56607793|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607794|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607795|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56607796|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607797|NCT00686725|Temozolomide|temozolomide|mesh-list
56607798|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56607799|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
56607800|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607801|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607802|NCT04055623|Aldesleukin|aldesleukin|mesh-list
56607803|NCT04055623|Interleukin-2|interleukin-2|mesh-list
56607804|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607805|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56607806|NCT04055623|Analgesics|analgesics|mesh-ancestor
56607807|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
56607808|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607809|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607810|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56607811|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56607812|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
56607814|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56607819|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56607820|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56607821|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607822|NCT00727246|Choline|choline|mesh-list
56607823|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56607824|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
56607825|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56607826|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
56607827|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607828|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56607829|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56607830|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
56607831|NCT05381558|Triamcinolone|triamcinolone|mesh-list
56607880|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607881|NCT02592694|Tenecteplase|tenecteplase|mesh-list
56607882|NCT02592694|Tirofiban|tirofiban|mesh-list
56607883|NCT02592694|Bivalirudin|bivalirudin|mesh-list
56607884|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
56607885|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56607886|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
56607887|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607888|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607889|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
56607890|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56607891|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56607892|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56607893|NCT02591836|Atorvastatin|atorvastatin|mesh-list
56607894|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56607895|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56607896|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
56607897|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607898|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56607899|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56607900|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56607901|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
56607902|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56607903|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
56607904|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607905|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607906|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56607907|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
56607908|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56607909|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
56607910|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607911|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56607912|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56607913|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
56607914|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
56607915|NCT02851472|Protective Agents|protective agents|mesh-ancestor
56110292|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
56607916|NCT00687973|Atenolol|atenolol|mesh-list
56607917|NCT00687973|Amlodipine|amlodipine|mesh-list
56607918|NCT00687973|Valsartan|valsartan|mesh-list
56607919|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56607920|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56607921|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56607922|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607923|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56607924|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607925|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
56607926|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56607927|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56607928|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56607929|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
56607930|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
56607931|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56607932|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56607933|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56607934|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56607935|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
56607937|NCT00747097|Gemcitabine|gemcitabine|mesh-list
56607969|NCT00752011|Carboplatin|carboplatin|mesh-list
56607970|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607971|NCT00721396|Vaccines|vaccines|mesh-list
56607972|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56607973|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
56607974|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607975|NCT00943826|Bevacizumab|bevacizumab|mesh-list
56607976|NCT00943826|Temozolomide|temozolomide|mesh-list
56607977|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607978|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607979|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56607980|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56607981|NCT00943826|Growth Substances|growth substances|mesh-ancestor
56607982|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56607983|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
56607984|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56607985|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
56607986|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607987|NCT04268888|Nivolumab|nivolumab|mesh-list
56607988|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
56607989|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56607990|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56607991|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56607992|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56607993|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56607994|NCT04268888|Estrogens|estrogens|mesh-ancestor
56607995|NCT04268888|Hormones|hormones|mesh-ancestor
56607996|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56607997|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608004|NCT02851394|Tramadol|tramadol|mesh-list
56608012|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608013|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
56608014|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
56608015|NCT00603434|Methylphenidate|methylphenidate|mesh-list
56608016|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56608017|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608018|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56608019|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56608020|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56608021|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608022|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
56608023|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608024|NCT01004003|Sorafenib|sorafenib|mesh-list
56608025|NCT01004003|Nintedanib|nintedanib|mesh-list
56608026|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608027|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56608028|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608029|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608030|NCT00943670|Trastuzumab|trastuzumab|mesh-list
56608031|NCT00943670|Pertuzumab|pertuzumab|mesh-list
56608032|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56608033|NCT00943670|Maytansine|maytansine|mesh-list
56608034|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608035|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608061|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608062|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56608063|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608064|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
56608065|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608066|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608067|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56608068|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
56608069|NCT00943124|Niacin|niacin|mesh-list
56608070|NCT00943124|Niacinamide|niacinamide|mesh-list
56608071|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
56608072|NCT00943124|Simvastatin|simvastatin|mesh-list
56608073|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56608074|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56608075|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
56608076|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608077|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56608078|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56608079|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608080|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
56608081|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
56608117|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608118|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608119|NCT00726388|Diclofenac|diclofenac|mesh-list
56608120|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56608121|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56608122|NCT00726388|Analgesics|analgesics|mesh-ancestor
56608123|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
56608124|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608185|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56608186|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56608188|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56608189|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608190|NCT00752401|Vitamin D|vitamin d|mesh-list
56608191|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
56608192|NCT00752401|Vitamins|vitamins|mesh-ancestor
56608193|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
56608194|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608195|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56608196|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56608197|NCT00750451|Heparin|heparin|mesh-list
56608198|NCT00750451|Enoxaparin|enoxaparin|mesh-list
56608199|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56608200|NCT00750451|Tinzaparin|tinzaparin|mesh-list
56608201|NCT00750451|Dalteparin|dalteparin|mesh-list
56608202|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
56608203|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
56608204|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56608205|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56608243|NCT00747799|Fluorouracil|fluorouracil|mesh-list
56608244|NCT00747799|Sorafenib|sorafenib|mesh-list
56608245|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608246|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
56608247|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608248|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56608249|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608250|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
56608251|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608252|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56608253|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608254|NCT04294823|Esomeprazole|esomeprazole|mesh-list
56608255|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56608256|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608257|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56608302|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
56608303|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56608304|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56608305|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608306|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
56608307|NCT00684307|Coagulants|coagulants|mesh-ancestor
56608308|NCT00683917|Leuprolide|leuprolide|mesh-list
56608309|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56608310|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
56608311|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56608312|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608313|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56608314|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608315|NCT00750529|Donepezil|donepezil|mesh-list
56608316|NCT00750529|Galantamine|galantamine|mesh-list
56608317|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56608318|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608319|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608320|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
56608321|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608322|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608323|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
56608324|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56608325|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
56608326|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608327|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
56608328|NCT00747877|Melphalan|melphalan|mesh-list
56608329|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608330|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
56608331|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608339|NCT00750763|Cathartics|cathartics|mesh-ancestor
56608348|NCT00752479|Cyclosporins|cyclosporins|mesh-list
56608349|NCT00752479|Basiliximab|basiliximab|mesh-list
56608350|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
56608351|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56608352|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
56608353|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608354|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608355|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608356|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
56608357|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608358|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
56608359|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608360|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
56608361|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608362|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56608363|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56608364|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608365|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56608366|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
56608367|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56608368|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608369|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
56608370|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
56608371|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608400|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
56608401|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608402|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56608403|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56608404|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56608405|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608406|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56608407|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56608408|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608409|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608410|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56608411|NCT00750997|Dextrans|dextrans|mesh-list
56608412|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
56608413|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
56608414|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
56608415|NCT00748345|Caspofungin|caspofungin|mesh-list
56608416|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
56608417|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608418|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608419|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608420|NCT00752869|Dutasteride|dutasteride|mesh-list
56608421|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56608422|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56608450|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608451|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608452|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56608453|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
56608454|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
56608455|NCT00748423|Protective Agents|protective agents|mesh-ancestor
56608456|NCT00687271|Atorvastatin|atorvastatin|mesh-list
56608458|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56608459|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608460|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56608461|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56608462|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
56608463|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608464|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56608465|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56608466|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608467|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
56608468|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56608469|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608470|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
56608503|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56608504|NCT01031381|Growth Substances|growth substances|mesh-ancestor
56608505|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608506|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
56608507|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608508|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
56608509|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56608510|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
56608511|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608512|NCT00751699|Mesalamine|mesalamine|mesh-list
56608513|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56608514|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56608515|NCT00751699|Analgesics|analgesics|mesh-ancestor
56608516|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
56608517|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608518|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608519|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608520|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608521|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
56608559|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608560|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608561|NCT00685165|Primidone|primidone|mesh-list
56608562|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
56608563|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
56608564|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
56608565|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608566|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608567|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608568|NCT00749047|Pioglitazone|pioglitazone|mesh-list
56608569|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56608570|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608571|NCT05393713|Antibodies|antibodies|mesh-list
56608572|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56608573|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
56608574|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608575|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
56608576|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608577|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
56608578|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
56608579|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56608580|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608581|NCT00753493|Topiramate|topiramate|mesh-list
56608582|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
56608583|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56608610|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56608611|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
56608612|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608613|NCT05388877|Dabrafenib|dabrafenib|mesh-list
56608614|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608615|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56608616|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608617|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608618|NCT04053205|Paclitaxel|paclitaxel|mesh-list
56608619|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56608620|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608621|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
56608622|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
56608623|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
56608624|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608625|NCT02559973|Buprenorphine|buprenorphine|mesh-list
56608626|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56608627|NCT02559973|Naloxone|naloxone|mesh-list
56608628|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56608629|NCT02559973|Narcotics|narcotics|mesh-ancestor
56608630|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608631|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608632|NCT02559973|Analgesics|analgesics|mesh-ancestor
56608633|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
56608634|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608635|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56608636|NCT00753883|Simvastatin|simvastatin|mesh-list
56608637|NCT00753883|Ezetimibe|ezetimibe|mesh-list
56608638|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56357135|NCT00072098|Growth Substances|growth substances|mesh-ancestor
56608639|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56608640|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
56608641|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608642|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56608644|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608648|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56608649|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56608650|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56608651|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
56608652|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608653|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608654|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56608655|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
56608656|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56608657|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608658|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608659|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56608660|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56608661|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
56608662|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
56608663|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608664|NCT00754039|Fenofibrate|fenofibrate|mesh-list
56608665|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56608666|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56608667|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
56608668|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608669|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56608670|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56608671|NCT02560909|Vaccines|vaccines|mesh-list
55921575|NCT03154645|Ibuprofen|ibuprofen|mesh-list
56110293|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56110294|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
56137543|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110295|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110297|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56110298|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
56110299|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
56110300|NCT00005773|Protective Agents|protective agents|mesh-ancestor
56110301|NCT00005779|Interleukin-12|interleukin-12|mesh-list
56110302|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56110303|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
56110304|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110305|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56110306|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56110307|NCT00005779|Growth Substances|growth substances|mesh-ancestor
56110308|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
56110309|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110310|NCT00005791|Fluorouracil|fluorouracil|mesh-list
56110311|NCT00005791|Irinotecan|irinotecan|mesh-list
56110312|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110313|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
56110314|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110315|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56110316|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608672|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
56608673|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608674|NCT02592226|Anesthetics|anesthetics|mesh-list
56608675|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608676|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608677|NCT02970448|Temozolomide|temozolomide|mesh-list
56608678|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56608679|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
56608680|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608681|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608682|NCT00756301|Lidocaine|lidocaine|mesh-list
56608683|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
56608684|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
56608685|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608686|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608687|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
56608688|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608689|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56608690|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56608691|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56608692|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56608693|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608694|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
56608695|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56608696|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608697|NCT00720226|Losartan|losartan|mesh-list
56608698|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56608699|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56608700|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56608701|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56608703|NCT00725920|Topiramate|topiramate|mesh-list
56608707|NCT00725842|Ribavirin|ribavirin|mesh-list
56608711|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608712|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
56608713|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608714|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608715|NCT04051723|Dexamethasone|dexamethasone|mesh-list
56608716|NCT04051723|Ropivacaine|ropivacaine|mesh-list
56608717|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608718|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
56608719|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
56608720|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608721|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608722|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608723|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
56608724|NCT04051723|Hormones|hormones|mesh-ancestor
56608725|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608726|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56608727|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608728|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
56608729|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
56608731|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
56608765|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56608766|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608767|NCT00757315|Triamcinolone|triamcinolone|mesh-list
56608768|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56608769|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56608770|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56608771|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608772|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
56608773|NCT00757315|Hormones|hormones|mesh-ancestor
56608774|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608775|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608776|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56608777|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
56608778|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608779|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608780|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
56608781|NCT00757393|Vitamin D|vitamin d|mesh-list
56608782|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
56608783|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
56608784|NCT00757393|Vitamins|vitamins|mesh-list
56608785|NCT00757393|Calcium|calcium|mesh-list
56608786|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
56608787|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608788|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56608789|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56608790|NCT00754351|Gemcitabine|gemcitabine|mesh-list
56608791|NCT00754351|Bevacizumab|bevacizumab|mesh-list
56608815|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56608816|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608817|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56608818|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608819|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
56159386|NCT02880228|Lenalidomide|lenalidomide|mesh-list
56608820|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56608821|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56608822|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56608823|NCT00754507|Atorvastatin|atorvastatin|mesh-list
56608824|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56608825|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56608826|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56608827|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
56608828|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608829|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56608830|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56608831|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608832|NCT00725608|Buprenorphine|buprenorphine|mesh-list
56608833|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56608834|NCT00725608|Naloxone|naloxone|mesh-list
56608866|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608867|NCT00724282|Eszopiclone|eszopiclone|mesh-list
56608868|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56608869|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56608870|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608871|NCT04086238|Decitabine|decitabine|mesh-list
56608872|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
56608873|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56608874|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
56608875|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608876|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56608877|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608878|NCT00724126|Rifaximin|rifaximin|mesh-list
56608879|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56608880|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608881|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56608882|NCT00723892|Ribavirin|ribavirin|mesh-list
56608883|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56608884|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
56608885|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
56608886|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608887|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
56608888|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56608889|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
56608890|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608891|NCT04086940|Esmolol|esmolol|mesh-list
56608917|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
56608918|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608919|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608920|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56608921|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
56608922|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
56608923|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56608924|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56608925|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56608926|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
56608927|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608928|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608929|NCT00722800|Drospirenone|drospirenone|mesh-list
56608930|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56608931|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56608932|NCT00722800|Estradiol|estradiol|mesh-list
56608933|NCT00722800|Estrogens|estrogens|mesh-ancestor
56608934|NCT00722800|Hormones|hormones|mesh-ancestor
56608935|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56608936|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608937|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56357436|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
56608938|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
56608939|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56608940|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56608941|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56608942|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55921839|NCT02081443|Ticagrelor|ticagrelor|mesh-list
56110317|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
56196308|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
56196309|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
56196310|NCT01503216|Vitamins|vitamins|mesh-ancestor
56110318|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110319|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56110320|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56110321|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110382|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56110383|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110385|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56110386|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
56110387|NCT02149836|Ezogabine|ezogabine|mesh-list
56110388|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
56110389|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56110390|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110391|NCT02130024|Ranibizumab|ranibizumab|mesh-list
56110392|NCT02130024|Aflibercept|aflibercept|mesh-list
56608943|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56608944|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
56608945|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56608946|NCT00722800|Diuretics|diuretics|mesh-ancestor
56608947|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
56608948|NCT00741598|Galantamine|galantamine|mesh-list
56608949|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56608950|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56608951|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56608952|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
56608953|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56608954|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608955|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56608956|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
56608957|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608958|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
56608959|NCT03947632|Chrysarobin|chrysarobin|mesh-list
56608960|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56608961|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56608962|NCT03947632|Analgesics|analgesics|mesh-ancestor
56608963|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
56608964|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56608965|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56608966|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56608967|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56608969|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56608972|NCT04085770|Vitamins|vitamins|mesh-ancestor
56608991|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56608992|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
56608993|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56608994|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
56608995|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
56608996|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56608997|NCT00741286|Protective Agents|protective agents|mesh-ancestor
56608998|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56608999|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56609000|NCT05283304|Buprenorphine|buprenorphine|mesh-list
56609001|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56609002|NCT05283304|Narcotics|narcotics|mesh-ancestor
56609003|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609004|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609005|NCT05283304|Analgesics|analgesics|mesh-ancestor
56609006|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
56609007|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609008|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56609009|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56609010|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56357523|NCT00265291|Fluoxetine|fluoxetine|mesh-list
56609011|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56609012|NCT00716092|Linagliptin|linagliptin|mesh-list
56609042|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609043|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56609044|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609045|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609046|NCT00715624|Metformin|metformin|mesh-list
56609047|NCT00715624|Lixisenatide|lixisenatide|mesh-list
56609048|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56609049|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609050|NCT00919282|Leucovorin|leucovorin|mesh-list
56609051|NCT00919282|Folic Acid|folic acid|mesh-list
56609052|NCT00919282|Gemcitabine|gemcitabine|mesh-list
56609053|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
56609054|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56609055|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
56609056|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609057|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609058|NCT00919282|Antiviral Agents|antiviral agents|mesh-ancestor
56609059|NCT00919282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609060|NCT00919282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609061|NCT00919282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609062|NCT00919282|Immunologic Factors|immunologic factors|mesh-ancestor
56609063|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609064|NCT00919282|Antidotes|antidotes|mesh-ancestor
56609065|NCT00919282|Protective Agents|protective agents|mesh-ancestor
56609066|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
56609067|NCT00919282|Vitamins|vitamins|mesh-ancestor
56609093|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609094|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609095|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56609096|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609097|NCT00576199|Bevacizumab|bevacizumab|mesh-list
56609098|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609099|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609100|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56609101|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56609102|NCT00576199|Growth Substances|growth substances|mesh-ancestor
56609103|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609155|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609156|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56609157|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
56609158|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609159|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
56609160|NCT00714688|Methylphenidate|methylphenidate|mesh-list
56609161|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56609162|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609163|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56609164|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56609165|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56609166|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609167|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
56609168|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609169|NCT05165212|Amoxicillin|amoxicillin|mesh-list
56609170|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56609171|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609172|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
56609173|NCT04051099|Bupivacaine|bupivacaine|mesh-list
56609174|NCT04051099|Propofol|propofol|mesh-list
56609175|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
56609176|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
56609177|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609178|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609179|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
56609180|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609181|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56609182|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56609183|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
56609184|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56609185|NCT04051099|Analgesics|analgesics|mesh-ancestor
56110393|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56110394|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56110395|NCT02130024|Growth Substances|growth substances|mesh-ancestor
56110396|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110397|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
56110398|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110399|NCT02105688|Grazoprevir|grazoprevir|mesh-list
56110400|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
56110401|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110402|NCT02105454|Ribavirin|ribavirin|mesh-list
56110403|NCT02105454|Grazoprevir|grazoprevir|mesh-list
56110404|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
56110405|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609186|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56159395|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
56609187|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56609188|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56609189|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
56609190|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609191|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609192|NCT01031069|Vaccines|vaccines|mesh-list
56609193|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
56609194|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609195|NCT04084912|Dexamethasone|dexamethasone|mesh-list
56609196|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
56609197|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56609198|NCT04084912|BB 1101|bb 1101|mesh-list
56609199|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56609200|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
56609201|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
56609202|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609203|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609204|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56609205|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
56609238|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609239|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56609240|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56609241|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
56609242|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609243|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609245|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56609246|NCT00682435|Narcotics|narcotics|mesh-ancestor
56609247|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609248|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609249|NCT00682435|Analgesics|analgesics|mesh-ancestor
56609250|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
56609251|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609252|NCT05340205|Misoprostol|misoprostol|mesh-list
56609253|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
56609254|NCT05340205|Oxytocin|oxytocin|mesh-list
56609255|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
56609256|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56609257|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609258|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56609267|NCT00713830|Metformin|metformin|mesh-list
56609294|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609295|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609296|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56609297|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609298|NCT00755521|Etoricoxib|etoricoxib|mesh-list
56609299|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56609300|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56609301|NCT00755521|Analgesics|analgesics|mesh-ancestor
56609302|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
56609303|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609304|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609305|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56609306|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56609354|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609355|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609356|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56609357|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56609358|NCT05039944|Irinotecan|irinotecan|mesh-list
56609359|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56609360|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56609361|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609362|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609363|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609364|NCT05038462|Lactoferrin|lactoferrin|mesh-list
56609365|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609366|NCT03719131|Rituximab|rituximab|mesh-list
56609367|NCT03719131|Nivolumab|nivolumab|mesh-list
56609368|NCT03719131|Ipilimumab|ipilimumab|mesh-list
56609369|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609370|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609371|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
56609372|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609373|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56609374|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56609375|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609376|NCT04984759|Primaquine|primaquine|mesh-list
56609377|NCT04984759|Tafenoquine|tafenoquine|mesh-list
56609378|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
56609379|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56609380|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56609382|NCT05190094|Letrozole|letrozole|mesh-list
56609399|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609400|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56609401|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
56609402|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56609403|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56609404|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
56609405|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609406|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56609407|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56609408|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609409|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56609410|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56609411|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
56609412|NCT05109442|Atezolizumab|atezolizumab|mesh-list
56609413|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609414|NCT00676663|Exemestane|exemestane|mesh-list
56609415|NCT00676663|Entinostat|entinostat|mesh-list
56609416|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609417|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56609418|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56609419|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609420|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609421|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56609422|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
56609423|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609424|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609447|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
56609448|NCT05007106|Antiviral Agents|antiviral agents|mesh-ancestor
56609449|NCT05007106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609450|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609451|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609452|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
56609453|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56609454|NCT02560207|Cefotaxime|cefotaxime|mesh-list
56609455|NCT02560207|Cefoxitin|cefoxitin|mesh-list
56609456|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56609457|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609458|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
56609459|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609460|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609461|NCT00678691|Modafinil|modafinil|mesh-list
56609462|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56609463|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609464|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56609465|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56609466|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56609467|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609468|NCT05003752|Goserelin|goserelin|mesh-list
56609469|NCT05003752|Androgens|androgens|mesh-list
56609470|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56609472|NCT05003752|Hormones|hormones|mesh-ancestor
56609495|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609496|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56609497|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56609498|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
56609499|NCT05683912|Aflibercept|aflibercept|mesh-list
56609500|NCT05683912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56609501|NCT05683912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56609502|NCT05683912|Growth Substances|growth substances|mesh-ancestor
56609503|NCT05683912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609504|NCT05683912|Growth Inhibitors|growth inhibitors|mesh-ancestor
56609505|NCT05683912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609506|NCT00679939|Metformin|metformin|mesh-list
56609507|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
56609508|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56609509|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609510|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
56609511|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609512|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609513|NCT02587390|Simvastatin|simvastatin|mesh-list
56609514|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56609515|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56609516|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
56609548|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609549|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56609550|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
56609555|NCT00919438|Diuretics|diuretics|mesh-list
56609556|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
56609557|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609558|NCT00571519|Metformin|metformin|mesh-list
56609559|NCT00571519|Pioglitazone|pioglitazone|mesh-list
56609560|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56609561|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609562|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56609563|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56609564|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609565|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
56609566|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56609567|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
56609568|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56609569|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609570|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56609571|NCT04935034|Vitamin D|vitamin d|mesh-list
56609572|NCT04935034|Vitamins|vitamins|mesh-ancestor
56609573|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
56609574|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609575|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56609576|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
56609588|NCT04809220|Biguanides|biguanides|mesh-list
56609597|NCT04807816|Gemcitabine|gemcitabine|mesh-list
56609598|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56609599|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
56609600|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609601|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609602|NCT04807816|Antiviral Agents|antiviral agents|mesh-ancestor
56609603|NCT04807816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609604|NCT04807816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609605|NCT04807816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609606|NCT04807816|Immunologic Factors|immunologic factors|mesh-ancestor
56609607|NCT04807816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609608|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56609609|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609610|NCT00921973|Vaccines|vaccines|mesh-list
56609611|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
56358109|NCT00073970|Celecoxib|celecoxib|mesh-list
56609612|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609613|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
56609614|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56609615|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
56609653|NCT05681650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609654|NCT05681650|Tubulin Modulators|tubulin modulators|mesh-ancestor
56609655|NCT05681650|Antimitotic Agents|antimitotic agents|mesh-ancestor
56609656|NCT05681650|Mitosis Modulators|mitosis modulators|mesh-ancestor
56609657|NCT05681650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609658|NCT05681650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609659|NCT05681650|Immunologic Factors|immunologic factors|mesh-ancestor
56609660|NCT05681650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609661|NCT05681650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56609662|NCT05681650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56609663|NCT05681650|Alkylating Agents|alkylating agents|mesh-ancestor
56609664|NCT05681650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56609665|NCT02476279|Indomethacin|indomethacin|mesh-list
56609666|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56609667|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56609668|NCT02476279|Analgesics|analgesics|mesh-ancestor
56609669|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
56609670|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609671|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609672|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56609673|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56609674|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
56609675|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
56609704|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609705|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56609706|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
56609707|NCT04895410|Hormones|hormones|mesh-ancestor
56609708|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609709|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56609710|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609711|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
56609712|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56609713|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56609714|NCT04895410|Growth Substances|growth substances|mesh-ancestor
56609715|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
56609716|NCT00675025|Donepezil|donepezil|mesh-list
56609717|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56609718|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609719|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609720|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
56609721|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609722|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609723|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
56609724|NCT02312245|Gemcitabine|gemcitabine|mesh-list
56609725|NCT02312245|Paclitaxel|paclitaxel|mesh-list
56609726|NCT02312245|Bevacizumab|bevacizumab|mesh-list
56609727|NCT02312245|Doxorubicin|doxorubicin|mesh-list
56609728|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56609729|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56609730|NCT02312245|Topotecan|topotecan|mesh-list
56609731|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56609732|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
56609733|NCT02312245|Antibodies|antibodies|mesh-list
56609734|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
56609749|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56609750|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
56609751|NCT02312245|Antiviral Agents|antiviral agents|mesh-ancestor
56609752|NCT02312245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609753|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609754|NCT02312245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609755|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56609756|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56609757|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56609758|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56609759|NCT00758407|Methylphenidate|methylphenidate|mesh-list
56609760|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56609761|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609762|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56609763|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56609764|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56609765|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609766|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
56609767|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609768|NCT04767061|Propranolol|propranolol|mesh-list
56609769|NCT04767061|Metoprolol|metoprolol|mesh-list
56609770|NCT04767061|Atenolol|atenolol|mesh-list
56609771|NCT04767061|Sotalol|sotalol|mesh-list
56609772|NCT04767061|Nadolol|nadolol|mesh-list
56609773|NCT04767061|Acebutolol|acebutolol|mesh-list
56609774|NCT04767061|Carvedilol|carvedilol|mesh-list
56609775|NCT04767061|Nebivolol|nebivolol|mesh-list
56609776|NCT04767061|Bisoprolol|bisoprolol|mesh-list
56609777|NCT04767061|Labetalol|labetalol|mesh-list
56609798|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56609799|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56609800|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56609801|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56609802|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56609803|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56609804|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
56609805|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56609806|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
56609807|NCT05322577|Nivolumab|nivolumab|mesh-list
56609808|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
56609809|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609810|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609811|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56609812|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609813|NCT04785820|Nivolumab|nivolumab|mesh-list
56609814|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56609815|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609816|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56609817|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609818|NCT00759421|Olanzapine|olanzapine|mesh-list
56609819|NCT00759421|Sertindole|sertindole|mesh-list
56609820|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
56609821|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
56609822|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609846|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
56609847|NCT00763165|Protective Agents|protective agents|mesh-ancestor
56609848|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609849|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56609850|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609851|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56609852|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56609853|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
56609854|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609855|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56609856|NCT04049227|Letrozole|letrozole|mesh-list
56609857|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609858|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56609859|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56609860|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609861|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609862|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56609863|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
56609864|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609865|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609866|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56609867|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
56609896|NCT00678379|Analgesics|analgesics|mesh-ancestor
56609897|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56609898|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
56609899|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
56609900|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56609901|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56609902|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56609903|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
56609904|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56609905|NCT00760279|Azithromycin|azithromycin|mesh-list
56609906|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56609907|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609908|NCT00674323|Ranibizumab|ranibizumab|mesh-list
56609909|NCT00674323|Verteporfin|verteporfin|mesh-list
56609910|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56609911|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56609912|NCT00674323|Growth Substances|growth substances|mesh-ancestor
56609913|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358419|NCT00270751|Minocycline|minocycline|mesh-list
56609914|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
56609915|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609916|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56609917|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
56609918|NCT00763633|Vitamins|vitamins|mesh-list
56609919|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
56609920|NCT00763633|Pyridoxal|pyridoxal|mesh-list
56609921|NCT00763633|Pyridoxine|pyridoxine|mesh-list
56609922|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
56609923|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
56609924|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609925|NCT00763789|Remifentanil|remifentanil|mesh-list
56609926|NCT00763789|Anesthetics|anesthetics|mesh-list
56609927|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56609928|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609929|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56609930|NCT00763789|Narcotics|narcotics|mesh-ancestor
56609931|NCT00763789|Analgesics|analgesics|mesh-ancestor
56609932|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
56609933|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609936|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56609937|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
56609938|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
56609939|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56609940|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609941|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56609942|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
56609943|NCT04115956|Hormones|hormones|mesh-ancestor
56609944|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56609945|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56609946|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609947|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56609948|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
56609949|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609950|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56609951|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609952|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
56609953|NCT04081480|Valacyclovir|valacyclovir|mesh-list
56609954|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
56609955|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56609990|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56609991|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56609992|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
56609993|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56609994|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56609995|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
56609996|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56609997|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56609998|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56609999|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
56610000|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56610001|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56610002|NCT04674514|Dexamethasone|dexamethasone|mesh-list
56610003|NCT04674514|Lenalidomide|lenalidomide|mesh-list
56610004|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610005|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
56610006|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
56610007|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610008|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610009|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56610010|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
56610011|NCT04674514|Hormones|hormones|mesh-ancestor
56610012|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610013|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56610014|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610015|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
56610016|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56610022|NCT04669678|Etonogestrel|etonogestrel|mesh-list
56610036|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
56610037|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610038|NCT04081012|Expectorants|expectorants|mesh-ancestor
56610039|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
56610040|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56610041|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
56610042|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610043|NCT04081012|Protective Agents|protective agents|mesh-ancestor
56610044|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610045|NCT04081012|Antidotes|antidotes|mesh-ancestor
56610046|NCT04551040|Terazosin|terazosin|mesh-list
56610047|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56610048|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56610049|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56610050|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
56610051|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610052|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610053|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610054|NCT04551040|Urological Agents|urological agents|mesh-ancestor
56610055|NCT00942968|Dalteparin|dalteparin|mesh-list
56610089|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610090|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56610091|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
56610092|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610093|NCT00942422|Protective Agents|protective agents|mesh-ancestor
56610094|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610095|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56610096|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56610097|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610098|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56610099|NCT05380934|Methotrexate|methotrexate|mesh-list
56610100|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56610101|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
56610102|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56610103|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610104|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56610105|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
56610106|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610107|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610115|NCT00603824|PENTA|penta|mesh-list
56610145|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610146|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
56610147|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56610148|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610149|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
56610150|NCT00942266|Leucovorin|leucovorin|mesh-list
56610151|NCT00942266|Fluorouracil|fluorouracil|mesh-list
56610152|NCT00942266|Vorinostat|vorinostat|mesh-list
56610153|NCT00942266|Calcium|calcium|mesh-list
56610154|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
56610155|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56610156|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610157|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56610158|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
56610159|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610160|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56610161|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610162|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610163|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
56610164|NCT00942266|Antidotes|antidotes|mesh-ancestor
56610165|NCT00942266|Protective Agents|protective agents|mesh-ancestor
56610200|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
56610201|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610202|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610203|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610204|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56610205|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56610206|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610207|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
56610208|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
56610209|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56610210|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610211|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56610212|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610213|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56610215|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56610216|NCT00604058|Vaccines|vaccines|mesh-list
56610217|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
56610218|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610220|NCT02852798|Apatinib|apatinib|mesh-list
56610221|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610222|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
56610223|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
56610224|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
56610225|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610226|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56610227|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610228|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
56610247|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610248|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
56610249|NCT00672841|Clotrimazole|clotrimazole|mesh-list
56610250|NCT00672841|Miconazole|miconazole|mesh-list
56610251|NCT00672841|Anidulafungin|anidulafungin|mesh-list
56610252|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610253|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56610254|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56610255|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56610256|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610257|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610258|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56610259|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
56610260|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610261|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610262|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56610263|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56610264|NCT00920296|Cabotegravir|cabotegravir|mesh-list
56610265|NCT00920296|Etravirine|etravirine|mesh-list
56610266|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56610267|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56610268|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610269|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610297|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610298|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610299|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56610300|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610301|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610302|NCT00673465|Metformin|metformin|mesh-list
56610303|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56610304|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610305|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
56610306|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56610307|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56610308|NCT00764413|Prednisolone|prednisolone|mesh-list
56610309|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
56610310|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56610311|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
56610312|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610313|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
56610314|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
56610315|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610316|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610317|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56610318|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
56610319|NCT00764413|Hormones|hormones|mesh-ancestor
56610325|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
56610347|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
56610348|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
56610349|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610350|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56610351|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56610352|NCT00605930|Niacinamide|niacinamide|mesh-list
56610353|NCT00605930|Niacin|niacin|mesh-list
56610354|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
56610355|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
56610356|NCT00605930|Vitamins|vitamins|mesh-ancestor
56610357|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
56610358|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610359|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56610360|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
56480262|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610361|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610362|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56610363|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
56610364|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
56610365|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56610366|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610367|NCT00602186|Prazosin|prazosin|mesh-list
56610369|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56610398|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56610399|NCT02583568|Bevacizumab|bevacizumab|mesh-list
56610400|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56610401|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610402|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56610403|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56610404|NCT02583568|Growth Substances|growth substances|mesh-ancestor
56610405|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610406|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
56610407|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
56610408|NCT02852564|Diuretics|diuretics|mesh-ancestor
56610409|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
56610410|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610411|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610412|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610413|NCT05593042|Vaccines|vaccines|mesh-list
56610414|NCT05593042|Immunologic Factors|immunologic factors|mesh-ancestor
56610415|NCT05593042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610416|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56610417|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610418|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610419|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610420|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56610421|NCT05509816|Midazolam|midazolam|mesh-list
56610422|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56610423|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56610424|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610425|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610426|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56610444|NCT04078048|Vitamins|vitamins|mesh-list
56610445|NCT04078048|Vitamin E|vitamin e|mesh-list
56610446|NCT04078048|Antioxidants|antioxidants|mesh-list
56610447|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
56610448|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610449|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610450|NCT04078048|Protective Agents|protective agents|mesh-ancestor
56610451|NCT00673387|Pramlintide|pramlintide|mesh-list
56610452|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
56610453|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56610454|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610455|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
56610456|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56610457|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
56610458|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610459|NCT00933608|Memantine|memantine|mesh-list
56610460|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56610461|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56610462|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
56610463|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610464|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610465|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610466|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56610467|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56610468|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
56610469|NCT04613596|Pemetrexed|pemetrexed|mesh-list
56610470|NCT04613596|Adagrasib|adagrasib|mesh-list
56610471|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56610472|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610473|NCT04613596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610474|NCT04613596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610475|NCT04613596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56610476|NCT04613596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56610477|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56610478|NCT02558023|Nicardipine|nicardipine|mesh-list
56610479|NCT02558023|Urapidil|urapidil|mesh-list
56610483|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610484|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56610485|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610486|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
56610487|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56610488|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
56610489|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610490|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56610491|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56610492|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56610493|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
56610494|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56610495|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56610496|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56610497|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56610498|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610499|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
56610500|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610501|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610502|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
56610503|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56610504|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
56610505|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610506|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610507|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
56610508|NCT00574951|Imetelstat|imetelstat|mesh-list
56610509|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56610510|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610511|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610512|NCT02584816|Vaccines|vaccines|mesh-list
56610513|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
56269011|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269012|NCT01986322|Vaccines|vaccines|mesh-list
56269013|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
56269014|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269015|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
56269016|NCT01986426|Ipilimumab|ipilimumab|mesh-list
56269017|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56269018|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269020|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610514|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610515|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
56610516|NCT02584738|Prednisolone|prednisolone|mesh-list
56610517|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
56610518|NCT02584738|Bromides|bromides|mesh-list
56610519|NCT02584738|Albuterol|albuterol|mesh-list
56610520|NCT02584738|Ipratropium|ipratropium|mesh-list
56610521|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610522|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
56610523|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
56610524|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610525|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610526|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56610527|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
56610528|NCT02584738|Hormones|hormones|mesh-ancestor
56610529|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610530|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56610531|NCT02584738|Protective Agents|protective agents|mesh-ancestor
56610532|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56610533|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610534|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
56610570|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56610571|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56610572|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56610573|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56610574|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56610575|NCT04416568|Nivolumab|nivolumab|mesh-list
56610576|NCT04416568|Ipilimumab|ipilimumab|mesh-list
56610577|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56610578|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610579|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56610580|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610582|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
56610583|NCT05269381|Sargramostim|sargramostim|mesh-list
56610584|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610585|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
56610586|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610587|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56610588|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56610589|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
56610590|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610591|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610592|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56610593|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56610594|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
56610595|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56610596|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56610597|NCT02583022|Analgesics|analgesics|mesh-ancestor
56610598|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
56610615|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610616|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56610617|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
56610618|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610619|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610620|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
56610621|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610622|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56610623|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610624|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
56610625|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56610626|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56610627|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56610628|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610629|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56610630|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56610631|NCT00764725|Analgesics|analgesics|mesh-ancestor
56610632|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
56610633|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610634|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610635|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
56610636|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56610637|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610638|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
56610639|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610640|NCT04077892|Budesonide|budesonide|mesh-list
56610641|NCT04077892|Montelukast|montelukast|mesh-list
56610642|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610643|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56610644|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
56610647|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56610657|NCT00606242|Fluticasone|fluticasone|mesh-list
56610658|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610659|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56610660|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
56610661|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610662|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359166|NCT00108771|Fentanyl|fentanyl|mesh-list
56610663|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56610664|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
56610665|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
56610666|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56610667|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56610668|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56610669|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
56610670|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610671|NCT00770263|Sirolimus|sirolimus|mesh-list
56610672|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56610673|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610674|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56610675|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610676|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610677|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56610678|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610679|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56610680|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
56610681|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56610682|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
56610705|NCT02584582|Incretins|incretins|mesh-ancestor
56610706|NCT02584582|Hormones|hormones|mesh-ancestor
56610707|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610708|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56610709|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56610710|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
56610711|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610712|NCT00765973|Topotecan|topotecan|mesh-list
56610713|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56610714|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56610715|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610716|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610717|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610718|NCT00775177|Doxycycline|doxycycline|mesh-list
56610719|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56610720|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610721|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
56610763|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56610764|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56610765|NCT00770575|Pioglitazone|pioglitazone|mesh-list
56610766|NCT00770575|Atorvastatin|atorvastatin|mesh-list
56610767|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56610768|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56610769|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
56610770|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610771|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56610772|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56610773|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610774|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56610775|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610776|NCT00770731|Sirolimus|sirolimus|mesh-list
56610777|NCT00770731|Bortezomib|bortezomib|mesh-list
56610778|NCT00770731|Topotecan|topotecan|mesh-list
56610779|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610780|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56610781|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56610782|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610818|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610819|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56610820|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56610821|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56610822|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610823|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56610824|NCT04379518|Interferons|interferons|mesh-list
56610825|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
56610826|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
56610827|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56610828|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56610829|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
56610830|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56610831|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
56610832|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610833|NCT04378426|Midazolam|midazolam|mesh-list
56610834|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
56610835|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56610836|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56610837|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610838|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610839|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56610840|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56610841|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56610842|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56610869|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610870|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56610871|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56610872|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610873|NCT00668863|Antidotes|antidotes|mesh-ancestor
56610874|NCT00668863|Protective Agents|protective agents|mesh-ancestor
56610875|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
56610876|NCT00668863|Vitamins|vitamins|mesh-ancestor
56610877|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
56610878|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56610879|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56610880|NCT00668863|Growth Substances|growth substances|mesh-ancestor
56610881|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
56610882|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56610883|NCT04077736|Aldesleukin|aldesleukin|mesh-list
56610884|NCT04077736|Interleukin-2|interleukin-2|mesh-list
56610885|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359389|NCT00109278|Vaccines|vaccines|mesh-list
56610886|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56610887|NCT04077736|Analgesics|analgesics|mesh-ancestor
56610888|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
56610889|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610890|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610891|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56610892|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56610921|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610922|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610923|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56610924|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
56610925|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56610926|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56610927|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56610928|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56610929|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56610930|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56610931|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610932|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610933|NCT00775489|Beclomethasone|beclomethasone|mesh-list
56610934|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56610935|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
56610936|NCT00775489|Hormones|hormones|mesh-ancestor
56610937|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56610938|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610939|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56610940|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
56610941|NCT05261594|Caffeine|caffeine|mesh-list
56610942|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56610943|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610944|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56610945|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56610946|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56610947|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56610948|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56610949|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
56610950|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56610951|NCT00771199|Fentanyl|fentanyl|mesh-list
56610952|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56610953|NCT00771199|Narcotics|narcotics|mesh-ancestor
56269021|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56269022|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
56269023|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56269024|NCT01986465|Prednisolone|prednisolone|mesh-list
56269025|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
56610954|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56610955|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56610956|NCT00771199|Analgesics|analgesics|mesh-ancestor
56610957|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
56610958|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56610959|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56610960|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56610961|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
56610962|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
56610963|NCT04264130|Artesunate|artesunate|mesh-list
56610964|NCT04264130|Lumefantrine|lumefantrine|mesh-list
56610965|NCT04264130|Artemether|artemether|mesh-list
56359460|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
56610966|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56610968|NCT04264130|Artefenomel|artefenomel|mesh-list
56610969|NCT04264130|Ferroquine|ferroquine|mesh-list
56610970|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
56610971|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56610984|NCT02557867|Analgesics|analgesics|mesh-ancestor
56611013|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56611014|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56611015|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
56611016|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611017|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611018|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611020|NCT02582476|Diuretics|diuretics|mesh-ancestor
56611021|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
56611022|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611023|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56611024|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56611025|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611026|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
56611027|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56611028|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56611029|NCT04078204|Protective Agents|protective agents|mesh-ancestor
56611030|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611037|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
56611038|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56611039|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
56611040|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611041|NCT04067518|Pegaspargase|pegaspargase|mesh-list
56611042|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611043|NCT04077580|Methenamine|methenamine|mesh-list
56611044|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
56611045|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
56611046|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56611047|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269026|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56269027|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
56186417|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56186418|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186419|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
56186420|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186421|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56186422|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56186423|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56186424|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
56186425|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186426|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186427|NCT01437371|Ramipril|ramipril|mesh-list
56186428|NCT01437371|Enalapril|enalapril|mesh-list
56186429|NCT01437371|Lisinopril|lisinopril|mesh-list
56186430|NCT01437371|Captopril|captopril|mesh-list
56611048|NCT04077580|Renal Agents|renal agents|mesh-ancestor
56611049|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56611050|NCT05334004|Ritonavir|ritonavir|mesh-list
56611051|NCT05334004|Lopinavir|lopinavir|mesh-list
56611052|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56611053|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56611054|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
56611055|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611056|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611057|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56611058|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56611059|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
56611060|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611061|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56611062|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56611063|NCT04240054|Dexamethasone|dexamethasone|mesh-list
56611064|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
56611065|NCT04240054|Bortezomib|bortezomib|mesh-list
56611066|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611067|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
56611068|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611069|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611103|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
56611104|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611105|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
56611106|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611107|NCT00771433|Lenograstim|lenograstim|mesh-list
56611108|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56611109|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
56611110|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611111|NCT00668395|Efavirenz|efavirenz|mesh-list
56611112|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56611113|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56611114|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611115|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611116|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
56611117|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611118|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56611119|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56611120|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56611121|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56611122|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56611123|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56611155|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56611156|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56611157|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
56611158|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611159|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611160|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56611161|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
56611162|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
56611163|NCT00767221|Hormones|hormones|mesh-ancestor
56611164|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56611165|NCT04024072|Brinzolamide|brinzolamide|mesh-list
56611166|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56611167|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611168|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611169|NCT00771511|Capsaicin|capsaicin|mesh-list
56611170|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
56611171|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
56611172|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
56611173|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611174|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611175|NCT00776113|Carvedilol|carvedilol|mesh-list
56611176|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56611177|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56611178|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
56611179|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611180|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611181|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611182|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56611183|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
56269028|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269029|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
56269030|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
56269031|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269032|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269033|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56269034|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
56269035|NCT01986465|Hormones|hormones|mesh-ancestor
56269036|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269037|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56269038|NCT01986465|Protective Agents|protective agents|mesh-ancestor
56269039|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56269040|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269041|NCT01986556|Lesinurad|lesinurad|mesh-list
56269042|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
56611184|NCT00776113|Protective Agents|protective agents|mesh-ancestor
56611185|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56611186|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56611187|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56611188|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
56611189|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56611190|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56611192|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611193|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56611194|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611195|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611196|NCT04008238|Trabectedin|trabectedin|mesh-list
56611197|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56611198|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
56611199|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611200|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611201|NCT00672139|Bromides|bromides|mesh-list
56611202|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
56611203|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
56611204|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56611205|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611206|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
56611207|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611208|NCT04222972|Gemcitabine|gemcitabine|mesh-list
56611209|NCT04222972|Paclitaxel|paclitaxel|mesh-list
56611210|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56611211|NCT04222972|Carboplatin|carboplatin|mesh-list
56611212|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
56611213|NCT04222972|Pemetrexed|pemetrexed|mesh-list
56269043|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56269044|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
56269045|NCT01986556|Renal Agents|renal agents|mesh-ancestor
56269046|NCT01986582|Phenylephrine|phenylephrine|mesh-list
56269047|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
56269048|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56269049|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56269050|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
56269051|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269052|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269053|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269054|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
56269055|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
56269056|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269090|NCT01986764|Estradiol|estradiol|mesh-list
56269091|NCT01986764|Estrogens|estrogens|mesh-list
56269092|NCT01986764|Hormones|hormones|mesh-ancestor
55891090|NCT02766465|Sirolimus|sirolimus|mesh-list
56611214|NCT04222972|Pralsetinib|pralsetinib|mesh-list
56611215|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56611216|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611217|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
56611218|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
56611219|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
56611220|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611221|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56611222|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
56611223|NCT04222972|Antiviral Agents|antiviral agents|mesh-ancestor
56611224|NCT04222972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611225|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611226|NCT04222972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611227|NCT04222972|Immunologic Factors|immunologic factors|mesh-ancestor
56611228|NCT04222972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611229|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611230|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56611231|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56611232|NCT02557789|Lefamulin|lefamulin|mesh-list
56611233|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56611234|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611235|NCT00771823|Maraviroc|maraviroc|mesh-list
56611236|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56611238|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611239|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56611240|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56611241|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
56611242|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622938|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56269093|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55844193|NCT03447808|Daratumumab|daratumumab|mesh-list
56269122|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
56269123|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56269124|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56269125|NCT01986894|Growth Substances|growth substances|mesh-ancestor
56269126|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
56269127|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56269128|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
56269129|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
56269130|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56269131|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56269132|NCT01986998|Prednisolone|prednisolone|mesh-list
56269133|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
56269134|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56269135|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
56269150|NCT01987076|Clobetasol|clobetasol|mesh-list
56611243|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56611244|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
56611245|NCT03766126|Fludarabine|fludarabine|mesh-list
56611246|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611247|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
56611248|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611249|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611250|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56611251|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
56611252|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611253|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611254|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56611255|NCT04219540|Buprenorphine|buprenorphine|mesh-list
56611256|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56611257|NCT04219540|Narcotics|narcotics|mesh-ancestor
56611258|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611259|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611260|NCT04219540|Analgesics|analgesics|mesh-ancestor
56611261|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
56611262|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611263|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56611264|NCT03955042|Pemetrexed|pemetrexed|mesh-list
56611265|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56359763|NCT00281944|Vitamins|vitamins|mesh-ancestor
56611266|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611267|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611268|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56611269|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56611270|NCT03742414|Fluticasone|fluticasone|mesh-list
56611289|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611290|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611291|NCT03711058|Nivolumab|nivolumab|mesh-list
56611292|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611293|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611294|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56611295|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611296|NCT03710824|Nintedanib|nintedanib|mesh-list
56611297|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611298|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56611299|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611300|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611301|NCT00570739|Metformin|metformin|mesh-list
56611302|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56611303|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56611304|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611305|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56611306|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56611307|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
56611308|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611309|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56611310|NCT04076098|Minocycline|minocycline|mesh-list
56611311|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56611312|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611313|NCT00771979|Saracatinib|saracatinib|mesh-list
56611317|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
56611337|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611338|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
56611339|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611340|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611341|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
56611343|NCT00776425|Hematinics|hematinics|mesh-ancestor
56611344|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
56611345|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56611346|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56611347|NCT03913702|Prednisolone|prednisolone|mesh-list
56611348|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
56611349|NCT03913702|Ketorolac|ketorolac|mesh-list
56611350|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56611351|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56611352|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
56611353|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56611354|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
56611355|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
56611356|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611357|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611358|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611359|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
56611360|NCT03913702|Hormones|hormones|mesh-ancestor
56611361|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56611362|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56611363|NCT03913702|Protective Agents|protective agents|mesh-ancestor
56186431|NCT01437371|Trandolapril|trandolapril|mesh-list
56186432|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56186433|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56186434|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
56186435|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186436|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56186437|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56186438|NCT01437371|Protective Agents|protective agents|mesh-ancestor
56186439|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186440|NCT01437462|Propofol|propofol|mesh-list
56186441|NCT01437462|Sevoflurane|sevoflurane|mesh-list
56186442|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56186443|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56186444|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186445|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56186446|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
56186447|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
56186448|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56186449|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56186450|NCT01437566|Fulvestrant|fulvestrant|mesh-list
56186451|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56186452|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186453|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56186454|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56611364|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56611365|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611366|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56611367|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56611368|NCT03913702|Analgesics|analgesics|mesh-ancestor
56611369|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
56611370|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611371|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56611372|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611373|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611374|NCT03909412|Dexamethasone|dexamethasone|mesh-list
56611375|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
56611376|NCT03909412|Lenograstim|lenograstim|mesh-list
56611377|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611378|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
56611379|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611380|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611381|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56611382|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
56611383|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611384|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611385|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56611386|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56611387|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
56611389|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611390|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611391|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
56611392|NCT03909412|Hormones|hormones|mesh-ancestor
56611393|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56611394|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56611395|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56611396|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
56611398|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
56611405|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56611406|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611407|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611408|NCT04075006|Ketamine|ketamine|mesh-list
56611409|NCT04075006|Analgesics|analgesics|mesh-ancestor
56611410|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
56611411|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611412|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611413|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56611414|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56611415|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
56611416|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
56611417|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611418|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56611419|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56611420|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611421|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611422|NCT04191304|Benralizumab|benralizumab|mesh-list
56611423|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56611424|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
56611425|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
56611426|NCT04188106|Varenicline|varenicline|mesh-list
56611427|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56611428|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56611455|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56611456|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56611457|NCT00669955|Antacids|antacids|mesh-ancestor
56611458|NCT00772291|Pregabalin|pregabalin|mesh-list
56611459|NCT00772291|Analgesics|analgesics|mesh-ancestor
56611460|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
56611461|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611462|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611463|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
56611464|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56611465|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56611466|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611467|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56611468|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56611469|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56611470|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611471|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56611472|NCT04013854|Nivolumab|nivolumab|mesh-list
56611473|NCT04013854|Ipilimumab|ipilimumab|mesh-list
56611474|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611475|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611476|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56611477|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611478|NCT05673928|Trastuzumab|trastuzumab|mesh-list
56611479|NCT05673928|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56611480|NCT05673928|Maytansine|maytansine|mesh-list
56611481|NCT05673928|Tucatinib|tucatinib|mesh-list
56611482|NCT05673928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611491|NCT03595150|Diclofenac|diclofenac|mesh-list
56611499|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611500|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56611501|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611502|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611503|NCT00768157|Lamivudine|lamivudine|mesh-list
56611504|NCT00768157|Entecavir|entecavir|mesh-list
56611505|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
56611506|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56611507|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56611508|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611509|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611510|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611511|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56611512|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56611513|NCT00671749|Clindamycin|clindamycin|mesh-list
56611514|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
56611515|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
56611516|NCT00671749|Adapalene|adapalene|mesh-list
56611517|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56611518|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56611519|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611520|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56611521|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611522|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611523|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
56611524|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56611525|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56611526|NCT00671749|Analgesics|analgesics|mesh-ancestor
56611527|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
56611528|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611529|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611530|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56186455|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
56186456|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186457|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186458|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
56269151|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269152|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
56269153|NCT01987076|Hormones|hormones|mesh-ancestor
56269154|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269155|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611531|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611532|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
56611534|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56611535|NCT04149106|Amodiaquine|amodiaquine|mesh-list
56611536|NCT04149106|Artenimol|artenimol|mesh-list
56611537|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
56611538|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56611539|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56611540|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611541|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56611542|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611543|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611544|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56611545|NCT04149106|Renal Agents|renal agents|mesh-ancestor
56611546|NCT02580604|Calcium|calcium|mesh-list
56611547|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56611548|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611549|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
56611550|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
56611551|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611552|NCT00768391|Olaratumab|olaratumab|mesh-list
56611553|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611554|NCT00669877|Cytarabine|cytarabine|mesh-list
56611555|NCT00669877|Dexamethasone|dexamethasone|mesh-list
56611556|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
56611557|NCT00669877|Rituximab|rituximab|mesh-list
56611558|NCT00669877|Doxorubicin|doxorubicin|mesh-list
56611559|NCT00669877|Methotrexate|methotrexate|mesh-list
56611560|NCT00669877|Vincristine|vincristine|mesh-list
56611561|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611562|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
56611563|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611564|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611565|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56611566|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
56611567|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611575|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611576|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
56611577|NCT00669877|Hormones|hormones|mesh-ancestor
56611578|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56611579|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56611580|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56611581|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56611582|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56611583|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611584|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56611585|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
56611586|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56611587|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56611588|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
56611589|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
56611590|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56611591|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56611592|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
56611593|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611594|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56611595|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
56611596|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
56611597|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
56611598|NCT00772681|Docetaxel|docetaxel|mesh-list
56611599|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611600|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
56611601|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
56611602|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
56611603|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611604|NCT00772759|AZD-3199|azd-3199|mesh-list
56611605|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56611617|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611618|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56611619|NCT00772837|Amoxicillin|amoxicillin|mesh-list
56611620|NCT00772837|Clarithromycin|clarithromycin|mesh-list
56611621|NCT00772837|Omeprazole|omeprazole|mesh-list
56611622|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611623|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56611624|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611625|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56611626|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611627|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611628|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56611629|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56611630|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56611631|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
56611632|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611633|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611634|NCT03475186|Ramipril|ramipril|mesh-list
56611635|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56611636|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
56611637|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611638|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611639|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56611640|NCT00768859|Paclitaxel|paclitaxel|mesh-list
56611641|NCT00768859|Carboplatin|carboplatin|mesh-list
56611642|NCT00768859|Trastuzumab|trastuzumab|mesh-list
56611643|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56611644|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611645|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
56611661|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
56611662|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611663|NCT00777439|Domperidone|domperidone|mesh-list
56611664|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611665|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
56611666|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
56611667|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611668|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611669|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611670|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56611671|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
56611672|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611673|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56611674|NCT00769093|Hematinics|hematinics|mesh-ancestor
56611675|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56611676|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56611677|NCT00671437|Cetuximab|cetuximab|mesh-list
56611678|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611679|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611680|NCT00777517|Atorvastatin|atorvastatin|mesh-list
56611681|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56611682|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56611683|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
56611684|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611685|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56611686|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56611687|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611688|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
56611689|NCT00769171|Metronidazole|metronidazole|mesh-list
56611690|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
56611691|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56611692|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56611702|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611703|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56611704|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56611705|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56611706|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56611707|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56611708|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
56611709|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56611710|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611711|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56611712|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56611713|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611714|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611715|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611716|NCT00769405|Leucovorin|leucovorin|mesh-list
56611718|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
56611719|NCT00769405|Calcium|calcium|mesh-list
56611720|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
56611721|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56611722|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611723|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
56611724|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611725|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56611726|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611727|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611728|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
56611729|NCT00769405|Antidotes|antidotes|mesh-ancestor
56611730|NCT00769405|Protective Agents|protective agents|mesh-ancestor
56611731|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
56611732|NCT00769405|Vitamins|vitamins|mesh-ancestor
56611733|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
56611734|NCT02829502|Exenatide|exenatide|mesh-list
56611735|NCT02829502|Glucagon|glucagon|mesh-list
56611747|NCT02635191|Esomeprazole|esomeprazole|mesh-list
56611748|NCT02635191|Omeprazole|omeprazole|mesh-list
56611749|NCT02635191|Rabeprazole|rabeprazole|mesh-list
56611750|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56611751|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611752|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56611753|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56611754|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56611755|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611756|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56611757|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611758|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611759|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56611760|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56611761|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56611762|NCT00777673|Paclitaxel|paclitaxel|mesh-list
56611763|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
56611764|NCT00777673|Bevacizumab|bevacizumab|mesh-list
56611765|NCT00777673|Carboplatin|carboplatin|mesh-list
56611766|NCT00777673|Doxorubicin|doxorubicin|mesh-list
56611767|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56611768|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56611769|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611770|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
56611771|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
56611772|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
56611773|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611774|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611775|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
56611776|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611777|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611778|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56611779|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
56611780|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56611781|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611782|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56611786|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56611787|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56611788|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56611789|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611790|NCT02579902|Vitamin D|vitamin d|mesh-list
56611791|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
56611792|NCT02579902|Vitamins|vitamins|mesh-ancestor
56611793|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
56611794|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611795|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56611796|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56611797|NCT02557087|Meperidine|meperidine|mesh-list
56611798|NCT02557087|Scopolamine|scopolamine|mesh-list
56611799|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56611800|NCT02557087|Narcotics|narcotics|mesh-ancestor
56611801|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611802|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611803|NCT02557087|Analgesics|analgesics|mesh-ancestor
56611804|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
56611805|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611806|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56611807|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
56611808|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
56611809|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56611810|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
56611811|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56611812|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
56611813|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611814|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611815|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56611816|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56611831|NCT02579590|Progestins|progestins|mesh-ancestor
56611832|NCT02579590|Hormones|hormones|mesh-ancestor
56611833|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56611834|NCT02634723|Factor VIII|factor viii|mesh-list
56611835|NCT02634723|Coagulants|coagulants|mesh-ancestor
56611836|NCT02634489|Tamsulosin|tamsulosin|mesh-list
56611837|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
56611838|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56611839|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56611840|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56611841|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
56611842|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611843|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611844|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611845|NCT02634489|Urological Agents|urological agents|mesh-ancestor
56611846|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56611847|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56611848|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
56611849|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
56611850|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
56611851|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56611852|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611853|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611854|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
56611855|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56611856|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611857|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611858|NCT02756962|Cytarabine|cytarabine|mesh-list
56611859|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56611860|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
56611861|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611862|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611863|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
56611864|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56611869|NCT03920566|Dalteparin|dalteparin|mesh-list
56611871|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56611872|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56611873|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611874|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
56611875|NCT00582790|Interleukin-2|interleukin-2|mesh-list
56611876|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611877|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56611878|NCT00582790|Analgesics|analgesics|mesh-ancestor
56611879|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
56611880|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611881|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611882|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56611883|NCT02678572|Melphalan|melphalan|mesh-list
56611884|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56611885|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
56611886|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611887|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611888|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56611889|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56611890|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
56611891|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611892|NCT00774007|Mesalamine|mesalamine|mesh-list
56611893|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56611894|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56611895|NCT00774007|Analgesics|analgesics|mesh-ancestor
56611896|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
56611897|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611898|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611899|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56611900|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56611901|NCT00769873|Heparin|heparin|mesh-list
56611902|NCT00769873|Enoxaparin|enoxaparin|mesh-list
56611903|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56611904|NCT00769873|Tinzaparin|tinzaparin|mesh-list
56611905|NCT00769873|Dalteparin|dalteparin|mesh-list
56611906|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
56611907|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56611908|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56110406|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
56611909|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611910|NCT00777985|Bosentan|bosentan|mesh-list
56611911|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56611912|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56611913|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611914|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
56611915|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56611916|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611917|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611918|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56611919|NCT00778063|Analgesics|analgesics|mesh-ancestor
56611920|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
56611921|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611922|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56611923|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56611924|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56611925|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
56611926|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611927|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611928|NCT00770107|Thiamine|thiamine|mesh-list
56611929|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
56611930|NCT00770107|Vitamins|vitamins|mesh-ancestor
56611931|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
56611932|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611933|NCT00774241|Bevacizumab|bevacizumab|mesh-list
56611934|NCT00774241|Docetaxel|docetaxel|mesh-list
56611935|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611936|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611937|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56611938|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56611939|NCT00774241|Growth Substances|growth substances|mesh-ancestor
56611940|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611941|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
56269156|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56269157|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269158|NCT01987128|Ropivacaine|ropivacaine|mesh-list
56269159|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
56269160|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
56269161|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269162|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611942|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
56611943|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
56611944|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
56611945|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611946|NCT00774319|Cisplatin|cisplatin|mesh-list
56611947|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611948|NCT00881751|Bevacizumab|bevacizumab|mesh-list
56611949|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56611950|NCT00881751|Sorafenib|sorafenib|mesh-list
56611951|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56611952|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56611953|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56611954|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56611955|NCT00881751|Growth Substances|growth substances|mesh-ancestor
56611956|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611957|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
56611958|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56611959|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56611960|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611961|NCT02634255|Fentanyl|fentanyl|mesh-list
56611962|NCT02634255|Propofol|propofol|mesh-list
56611963|NCT02634255|Rocuronium|rocuronium|mesh-list
56611964|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56611965|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611966|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611967|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56611968|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
56611969|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
56611970|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56611971|NCT02634255|Narcotics|narcotics|mesh-ancestor
56611972|NCT02634255|Analgesics|analgesics|mesh-ancestor
56611973|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
56611974|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611975|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55924865|NCT05135442|Bortezomib|bortezomib|mesh-list
56269163|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
56269164|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269165|NCT01987154|Caseins|caseins|mesh-list
56269166|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
56269167|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
56269168|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611976|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56611977|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56611978|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56611979|NCT02634021|Midazolam|midazolam|mesh-list
56611980|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
56611981|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56611982|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56611983|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56611984|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56611985|NCT02634021|Analgesics|analgesics|mesh-ancestor
56611986|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
56611987|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56611988|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56611989|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56611990|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56611991|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
56611992|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56611993|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56611994|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56611995|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56611996|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56611997|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56611998|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56611999|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
56612000|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
56612001|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
56612002|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
56612003|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
56612004|NCT04161729|Analgesics|analgesics|mesh-ancestor
56612005|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
56612006|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612007|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612017|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56612018|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
56612019|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
56612020|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56612021|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56612022|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612023|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612024|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612025|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612027|NCT00934856|Trastuzumab|trastuzumab|mesh-list
56612029|NCT00934856|Maytansine|maytansine|mesh-list
56612030|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56612031|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612032|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
56612033|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
56612034|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
56612035|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612036|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56612037|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56612038|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56612039|NCT04265612|Laxatives|laxatives|mesh-ancestor
56612040|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56612041|NCT00934700|Xenon|xenon|mesh-list
56612042|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56612043|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
56612044|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
56612045|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612046|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612066|NCT00669331|Diuretics|diuretics|mesh-ancestor
56612067|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
56612068|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612069|NCT00778297|Vaccines|vaccines|mesh-list
56612070|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
56612071|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612072|NCT00779233|Zidovudine|zidovudine|mesh-list
56612073|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
56612074|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612075|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56612076|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56612077|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612078|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
56612079|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612080|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56612081|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56612082|NCT00607178|Vaccines|vaccines|mesh-list
56612083|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
56612084|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612085|NCT02556463|Durvalumab|durvalumab|mesh-list
56612086|NCT02556463|MEDI9197|medi9197|mesh-list
56612087|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56612088|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612089|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56612090|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
56612091|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612092|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56612093|NCT00779389|Dasatinib|dasatinib|mesh-list
56612094|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612095|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56612096|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360584|NCT00287521|Timolol|timolol|mesh-list
56612097|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612098|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56612105|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56612106|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56612107|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56612108|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56612109|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56612110|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56612111|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56612113|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56612114|NCT05153174|Protective Agents|protective agents|mesh-ancestor
56612115|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612116|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612117|NCT00778765|Gabapentin|gabapentin|mesh-list
56612118|NCT00778765|Analgesics|analgesics|mesh-ancestor
56612119|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
56612120|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612121|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612122|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
56612123|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56612124|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56612125|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612126|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612127|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56612128|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56612129|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612130|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612131|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
56612132|NCT00779935|Infliximab|infliximab|mesh-list
56612133|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
56612134|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56612135|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612136|NCT00780013|Metformin|metformin|mesh-list
56612137|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56612138|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612139|NCT00667225|Cantharidin|cantharidin|mesh-list
56612140|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612141|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612142|NCT00780169|Sorafenib|sorafenib|mesh-list
56612143|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612144|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56612145|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612146|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612147|NCT00780325|Celecoxib|celecoxib|mesh-list
56612148|NCT00780325|Naproxen|naproxen|mesh-list
56612149|NCT00780325|Acetazolamide|acetazolamide|mesh-list
56612150|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56612151|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56612152|NCT00780325|Analgesics|analgesics|mesh-ancestor
56612153|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
56612154|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612155|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612156|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612157|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612158|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56612159|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56612160|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612161|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612162|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
56612163|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
56612164|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56612165|NCT00780325|Diuretics|diuretics|mesh-ancestor
56612166|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
56612167|NCT02556229|Aflibercept|aflibercept|mesh-list
56612168|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56612192|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
56612193|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612194|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612195|NCT04262804|Antiviral Agents|antiviral agents|mesh-ancestor
56612196|NCT04262804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612197|NCT04262804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612198|NCT04262804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56612199|NCT04262804|Immunologic Factors|immunologic factors|mesh-ancestor
56612200|NCT04262804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612201|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56612202|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56612203|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
56612204|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
56612205|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56612207|NCT00665431|Antacids|antacids|mesh-list
56612208|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56612209|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56612210|NCT00665431|Analgesics|analgesics|mesh-ancestor
56612211|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
56612212|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612213|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612214|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612215|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612216|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56612241|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
56612242|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56612243|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56360738|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
56612244|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612245|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612246|NCT00657033|Urological Agents|urological agents|mesh-ancestor
56612247|NCT04161027|Pregabalin|pregabalin|mesh-list
56612248|NCT04161027|Analgesics|analgesics|mesh-ancestor
56612249|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
56612250|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612251|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612252|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
56612253|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56612254|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56612255|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612256|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56612257|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56612258|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56612259|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612260|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612261|NCT02633007|Levodopa|levodopa|mesh-list
56612262|NCT02633007|Carbidopa|carbidopa|mesh-list
56612263|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56612264|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56612265|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
56612266|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612267|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612268|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612269|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56612270|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612271|NCT01000727|Darapladib|darapladib|mesh-list
56612272|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56612273|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186459|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56186460|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56186461|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186462|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
56612274|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612275|NCT00881205|Rivastigmine|rivastigmine|mesh-list
56612276|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56612277|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612278|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612279|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
56612280|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612281|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612282|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56612283|NCT00881205|Protective Agents|protective agents|mesh-ancestor
56612284|NCT00879879|Losartan|losartan|mesh-list
56612285|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56612286|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56612287|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56612288|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56612289|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612290|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
56612291|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
56612292|NCT00661999|Hematinics|hematinics|mesh-ancestor
56612293|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56612294|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612295|NCT04156815|Isotretinoin|isotretinoin|mesh-list
56612296|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56612297|NCT04156425|Golimumab|golimumab|mesh-list
56612298|NCT04156425|Dexetimide|dexetimide|mesh-list
56612299|NCT04156425|Citalopram|citalopram|mesh-list
56612300|NCT04156425|Calcium|calcium|mesh-list
56612301|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56612302|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612303|NCT04156425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56612304|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56186463|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186464|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186465|NCT01437592|Insulin|insulin|mesh-list
56186466|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56186467|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186468|NCT01437618|Bevacizumab|bevacizumab|mesh-list
56269169|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56269171|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269172|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269173|NCT01987297|Cytarabine|cytarabine|mesh-list
56269174|NCT01987297|Daunorubicin|daunorubicin|mesh-list
56269175|NCT01987297|Idarubicin|idarubicin|mesh-list
56269176|NCT01987297|Tretinoin|tretinoin|mesh-list
56612305|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56612306|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612307|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612308|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
56612309|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56612310|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
56612311|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612312|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56612313|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56612314|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
56612315|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
56612316|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612317|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56612318|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56612319|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
56612320|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56612321|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612322|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56612323|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
56612324|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
56612325|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56612326|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612327|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56612328|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56612329|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612331|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612351|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612352|NCT00780637|Bradykinin|bradykinin|mesh-list
56612353|NCT00780637|Kininogens|kininogens|mesh-list
56612354|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
56612355|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56612356|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
56612357|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612358|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612359|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
56612360|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
56612361|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612362|NCT00790153|Insulin|insulin|mesh-list
56612363|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56612364|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612365|NCT00661635|Valdecoxib|valdecoxib|mesh-list
56612366|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56612367|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56612368|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612369|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612370|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56612371|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56612372|NCT00661635|Analgesics|analgesics|mesh-ancestor
56612373|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
56612374|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612375|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612376|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612377|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612378|NCT02631603|Prednisolone|prednisolone|mesh-list
56612379|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612380|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
56612381|NCT02631603|Hormones|hormones|mesh-ancestor
56612382|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56612383|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612384|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56612385|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612386|NCT00790387|Heparin|heparin|mesh-list
56612389|NCT00790387|Tirofiban|tirofiban|mesh-list
56612390|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
56612391|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56360885|NCT00290602|Hormones|hormones|mesh-ancestor
56612392|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56612393|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612394|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56612395|NCT04156035|Lamotrigine|lamotrigine|mesh-list
56612396|NCT04156035|Ketamine|ketamine|mesh-list
56612397|NCT04156035|Analgesics|analgesics|mesh-ancestor
56612398|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
56612399|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612400|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612401|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56612402|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56612403|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
56612404|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
56612405|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612406|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56612407|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56612408|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612409|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612410|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
56612411|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56612412|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56612413|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56612414|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56159473|NCT02911818|Phentermine|phentermine|mesh-list
55925290|NCT04460352|Antidotes|antidotes|mesh-ancestor
56269177|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
56269178|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56269179|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
56269180|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269181|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269182|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
56269183|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269184|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56269185|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
56269186|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269187|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56269188|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56269189|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56269190|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269191|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
56269192|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
56612415|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56612416|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612417|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56612418|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
56612419|NCT00662337|Promethazine|promethazine|mesh-list
56612420|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56612421|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56612422|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612423|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612424|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
56612425|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
56612426|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
56612427|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612428|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
56612429|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
56612430|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56612431|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56612432|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
56612433|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
56612434|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612435|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612436|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56612437|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
56612438|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
56612466|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612468|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
56612469|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
56612470|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612471|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612472|NCT00662805|Fluticasone|fluticasone|mesh-list
56612474|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56612475|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612476|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56612477|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
56612478|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612479|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612480|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56612481|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
56612482|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
56612483|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56612484|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56612485|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56612486|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56612487|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
56612488|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612489|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612490|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
56612491|NCT00662883|Ketamine|ketamine|mesh-list
56612492|NCT00662883|Analgesics|analgesics|mesh-ancestor
56612493|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
56612494|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612495|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612496|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56612509|NCT00785473|Vitamin D|vitamin d|mesh-list
56612512|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56612513|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612514|NCT00785473|Vitamins|vitamins|mesh-ancestor
56612515|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
56612516|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56612517|NCT00785473|Antacids|antacids|mesh-ancestor
56612518|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612519|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56612520|NCT00785551|Quinine|quinine|mesh-list
56612521|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
56612522|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56612523|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56612524|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612525|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56612526|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612527|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56612528|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612529|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56612530|NCT00785551|Analgesics|analgesics|mesh-ancestor
56612531|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
56612532|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56612533|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56612534|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56612535|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612536|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612537|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612538|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56612539|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56612540|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
56612546|NCT00663195|Furosemide|furosemide|mesh-list
56612556|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56612557|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56612558|NCT00791011|Bortezomib|bortezomib|mesh-list
56612559|NCT00791011|Vorinostat|vorinostat|mesh-list
56612560|NCT00791011|Conatumumab|conatumumab|mesh-list
56612561|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612562|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56612563|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159474|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56612564|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612565|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56612566|NCT00781105|Telbivudine|telbivudine|mesh-list
56612567|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
56612568|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612569|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56612570|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612571|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612572|NCT00785863|Ketorolac|ketorolac|mesh-list
56612573|NCT00785863|Parecoxib|parecoxib|mesh-list
56612574|NCT00785863|Remifentanil|remifentanil|mesh-list
56612575|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56612576|NCT00785863|Narcotics|narcotics|mesh-ancestor
56612577|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612578|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612579|NCT00785863|Analgesics|analgesics|mesh-ancestor
56612580|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
56612581|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612582|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56612583|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55925463|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
56269193|NCT01987310|Atorvastatin|atorvastatin|mesh-list
56269194|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56269195|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56269196|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
56269197|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269221|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269222|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56269223|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
56269224|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
56269225|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269226|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269227|NCT01987804|Oxytocin|oxytocin|mesh-list
56269228|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
56269229|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55898951|NCT05625802|Anesthetics|anesthetics|mesh-ancestor
56612584|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612585|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612586|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56612587|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612588|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612589|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56612590|NCT00664105|Carboplatin|carboplatin|mesh-list
56612591|NCT00664105|Docetaxel|docetaxel|mesh-list
56612592|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612593|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
56612594|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
56612595|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
56612596|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612597|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56612598|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
56612599|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612600|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
56612601|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56612602|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612603|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612604|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56612605|NCT02555605|Analgesics|analgesics|mesh-ancestor
56612606|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
56612607|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612608|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56612609|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56612610|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56612611|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
56612612|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612613|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361113|NCT00078689|Daclizumab|daclizumab|mesh-list
56612614|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56612615|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56612616|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56612619|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612621|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56612622|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
56612623|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612624|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612625|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56612626|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56612627|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
56612628|NCT00663741|Sorafenib|sorafenib|mesh-list
56612629|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612630|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56612631|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612632|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612633|NCT00663897|Lansoprazole|lansoprazole|mesh-list
56612634|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
56612636|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56612637|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56612638|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56612639|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612640|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612641|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56612642|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
56612643|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612644|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612645|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56612646|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56612647|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
56612648|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612649|NCT04031859|Aspirin|aspirin|mesh-list
56612650|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56612651|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56612652|NCT04031859|Analgesics|analgesics|mesh-ancestor
56612653|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
56269230|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269231|NCT01988077|Ipilimumab|ipilimumab|mesh-list
56269232|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56269233|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269234|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56269235|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269236|NCT01988116|Calcitriol|calcitriol|mesh-list
56269237|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56269238|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612654|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612655|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612656|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612657|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612658|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56612659|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56612660|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612661|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56612662|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56612663|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612664|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
56612665|NCT00664287|Niacin|niacin|mesh-list
56612666|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56612667|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
56612668|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612669|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56612670|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
56612671|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
56612672|NCT00664287|Vitamins|vitamins|mesh-ancestor
56612673|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
56612674|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612675|NCT00664599|Rituximab|rituximab|mesh-list
56612676|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56612677|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612678|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
56612679|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612680|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612681|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
56612682|NCT02631135|Remifentanil|remifentanil|mesh-list
56612683|NCT02631135|Propofol|propofol|mesh-list
56612684|NCT02631135|Rocuronium|rocuronium|mesh-list
56612685|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56361190|NCT00078962|Gemcitabine|gemcitabine|mesh-list
56612696|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56612697|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56612698|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
56612699|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612700|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612701|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56612702|NCT02631135|Narcotics|narcotics|mesh-ancestor
56612703|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56612704|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56612705|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56612706|NCT00664677|Masoprocol|masoprocol|mesh-list
56612707|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
56612708|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612709|NCT00664677|Protective Agents|protective agents|mesh-ancestor
56612710|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612711|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56612712|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612713|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56333936|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333937|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333938|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
56333939|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333940|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56333941|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333953|NCT00037115|Hormones|hormones|mesh-ancestor
56333967|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
56333968|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56333969|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56333970|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56333971|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56333972|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
56333973|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333974|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333976|NCT00064428|Fondaparinux|fondaparinux|mesh-list
56333977|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56333978|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
56333979|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56333980|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
56333981|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333982|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333983|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
56333984|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56333985|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56612714|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56612715|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56612717|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
56612718|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612719|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612720|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612721|NCT00596817|Vortioxetine|vortioxetine|mesh-list
56612722|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
56612723|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612724|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56612725|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56612726|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612727|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612728|NCT00596817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56612729|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56612730|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925647|NCT04198506|Tacrolimus|tacrolimus|mesh-list
56269239|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55891239|NCT05739682|Autonomic Agents|autonomic agents|mesh-ancestor
56269240|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56612731|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612732|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612733|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
56612734|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56612735|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56612736|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56612737|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56612738|NCT01000649|Vasopressins|vasopressins|mesh-list
56612739|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
56612740|NCT01000649|Coagulants|coagulants|mesh-ancestor
56612741|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56612742|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56612743|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
56612744|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612745|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56612746|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
56612747|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56612748|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56612749|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612750|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612751|NCT00664833|Urological Agents|urological agents|mesh-ancestor
56612752|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
56612753|NCT00666835|Hematinics|hematinics|mesh-ancestor
56612775|NCT00666757|Sertraline|sertraline|mesh-list
56612781|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56612782|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612783|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612784|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612785|NCT00666757|Analgesics|analgesics|mesh-ancestor
56612786|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
56612787|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612789|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612790|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
56612791|NCT00666757|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56612792|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
56612793|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56612794|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56612795|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56612796|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612797|NCT01000337|Propofol|propofol|mesh-list
56612798|NCT01000337|Sevoflurane|sevoflurane|mesh-list
56612799|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56612800|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612801|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612802|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56612803|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
56612804|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
56612805|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56612806|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56612807|NCT02869763|Ethanol|ethanol|mesh-list
56612808|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56612809|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612810|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612811|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612812|NCT04153383|Milrinone|milrinone|mesh-list
56612813|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55925730|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
56269241|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269242|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56269243|NCT01988116|Vitamins|vitamins|mesh-ancestor
56269244|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
56269245|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56186469|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56186471|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56612814|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56612815|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
56612816|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56612817|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56612818|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612819|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612820|NCT04153383|Protective Agents|protective agents|mesh-ancestor
56612821|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612822|NCT00671541|Gentamicins|gentamicins|mesh-list
56612823|NCT00671541|Bacitracin|bacitracin|mesh-list
56612824|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56612825|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612826|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56612827|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612828|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612829|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56612830|NCT00671697|Decitabine|decitabine|mesh-list
56612831|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
56612832|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56612833|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
56612835|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612866|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
56612867|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56612868|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56612869|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612870|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612871|NCT00786253|Urological Agents|urological agents|mesh-ancestor
56612872|NCT00595413|Adalimumab|adalimumab|mesh-list
56612873|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612874|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612875|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
56612876|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56612877|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612878|NCT00786331|Carboplatin|carboplatin|mesh-list
56612879|NCT00786331|Pemetrexed|pemetrexed|mesh-list
56612880|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612881|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612882|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612883|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56612884|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56612885|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56612886|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56612887|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56612888|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56612889|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612890|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56612891|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56612892|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56612893|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
56612894|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612895|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612896|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56186472|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56186473|NCT01437618|Growth Substances|growth substances|mesh-ancestor
56186474|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186475|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
56186476|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
56186477|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56186478|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56186479|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269246|NCT01988298|Acetaminophen|acetaminophen|mesh-list
56612897|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56612898|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
56612899|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
56612900|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56612901|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56612902|NCT00595335|Prednisolone|prednisolone|mesh-list
56612903|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
56612904|NCT00595335|Rituximab|rituximab|mesh-list
56612905|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56612906|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
56612907|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56612908|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612909|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
56612910|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612911|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56612912|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56612913|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
56612914|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
56612915|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612916|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56612917|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
56612918|NCT00595335|Hormones|hormones|mesh-ancestor
56612919|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56612920|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56612921|NCT00595335|Protective Agents|protective agents|mesh-ancestor
56612922|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56612923|NCT00781417|Vitamin D|vitamin d|mesh-list
56612924|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
56612925|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
56612926|NCT00781417|Vitamins|vitamins|mesh-list
56612927|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
56612928|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612929|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56612930|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56612931|NCT00672165|Antibodies|antibodies|mesh-list
56612939|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612940|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
56612941|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56612943|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
56612944|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56612945|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56612946|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56612947|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56612948|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612949|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612950|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612951|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612952|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56612953|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56612954|NCT00672399|Incretins|incretins|mesh-ancestor
56612955|NCT00672399|Hormones|hormones|mesh-ancestor
56612956|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56612957|NCT00661531|Anastrozole|anastrozole|mesh-list
56612958|NCT00661531|Estradiol|estradiol|mesh-list
56612959|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56612960|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612961|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56612962|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56612963|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612964|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612965|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56612966|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
56612967|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56612968|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612969|NCT00661531|Estrogens|estrogens|mesh-ancestor
56612970|NCT00661531|Hormones|hormones|mesh-ancestor
56612974|NCT02629575|Sirolimus|sirolimus|mesh-list
56612982|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612983|NCT00781573|Clopidogrel|clopidogrel|mesh-list
56612984|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56612985|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56612986|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56612987|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56612988|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
56612989|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56612990|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612991|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56612992|NCT04152681|Apatinib|apatinib|mesh-list
56612993|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56612994|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56612995|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56612996|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56612997|NCT00999713|Calfactant|calfactant|mesh-list
56612998|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56612999|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613036|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56613037|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613038|NCT02870231|Incretins|incretins|mesh-ancestor
56613039|NCT02870231|Hormones|hormones|mesh-ancestor
56613040|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56613041|NCT00782041|Leucovorin|leucovorin|mesh-list
56613042|NCT00782041|Folic Acid|folic acid|mesh-list
56613043|NCT00782041|Fluorouracil|fluorouracil|mesh-list
56613044|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
56613045|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
56613046|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
56613047|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613048|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56613049|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613050|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613051|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
56613052|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613053|NCT00782041|Antidotes|antidotes|mesh-ancestor
56613054|NCT00782041|Protective Agents|protective agents|mesh-ancestor
56613055|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
56613056|NCT00782041|Vitamins|vitamins|mesh-ancestor
56613057|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
56613058|NCT00782041|Hematinics|hematinics|mesh-ancestor
56613059|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56613060|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613061|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56613062|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613063|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613064|NCT00792181|Midazolam|midazolam|mesh-list
56613065|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56613066|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56613067|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613068|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613069|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56613074|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
56613078|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613079|NCT00792337|Simvastatin|simvastatin|mesh-list
56613080|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56613081|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56613082|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
56613083|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361592|NCT00079469|Bupropion|bupropion|mesh-list
56613085|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56613086|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613087|NCT00787111|Fluoxetine|fluoxetine|mesh-list
56613088|NCT00787111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56613089|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56613090|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56613091|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613092|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613093|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
56613094|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613095|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56613096|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
56613097|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56613098|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56613099|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56613100|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613101|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
56613102|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56613103|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
56613104|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613105|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
56613106|NCT00782197|Protective Agents|protective agents|mesh-ancestor
56613121|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56613122|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56613123|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613124|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613125|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
56613126|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613127|NCT00787501|Citalopram|citalopram|mesh-list
56613128|NCT00787501|Fluoxetine|fluoxetine|mesh-list
56613129|NCT00787501|Sertraline|sertraline|mesh-list
56613130|NCT00787501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56613131|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56613132|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56613133|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613134|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613135|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
56613136|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613137|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56613138|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
56613139|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56613140|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56613141|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56613142|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613144|NCT00787657|Interferon-beta|interferon-beta|mesh-list
56613145|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
56613146|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613147|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
56613148|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613149|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
56613150|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613151|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56333986|NCT00064467|Bupropion|bupropion|mesh-list
56613152|NCT04264676|Metronidazole|metronidazole|mesh-list
56613153|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613154|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56613155|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56613156|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56613160|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
56613161|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613162|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613163|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613164|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56613165|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56613166|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
56613167|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
56613168|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
56613169|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
56613170|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613171|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613172|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
56613173|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613174|NCT00637637|Ritonavir|ritonavir|mesh-list
56613175|NCT00637637|Indinavir|indinavir|mesh-list
56613176|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56613177|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56613178|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
56613179|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613180|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613181|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56613182|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56613183|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
56613184|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613185|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56613186|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56613187|NCT00927758|Fluticasone|fluticasone|mesh-list
56613188|NCT00927758|Xhance|xhance|mesh-list
56613189|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56613190|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56613191|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56613192|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56613193|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
56613194|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926108|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
56269247|NCT01988298|Ibuprofen|ibuprofen|mesh-list
56269248|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56613195|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613196|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613197|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613198|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
56613199|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56613200|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56613201|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56613202|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56613203|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56613204|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613205|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613206|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
56613207|NCT00927758|Hormones|hormones|mesh-ancestor
56613208|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56613209|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
56613210|NCT00783523|Doxycycline|doxycycline|mesh-list
56613211|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56613212|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613213|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
56613214|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56613215|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56613216|NCT00783601|Montelukast|montelukast|mesh-list
56613217|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613218|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613219|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56613220|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
56613221|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56613222|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613223|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56613224|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56269280|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269281|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56269282|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56269283|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56269284|NCT01988610|Mifepristone|mifepristone|mesh-list
56269285|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56269286|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
56269287|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56269288|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269289|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56269290|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56269291|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56361744|NCT04727853|Irinotecan|irinotecan|mesh-list
56613225|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613226|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
56613227|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56613228|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
56613229|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613230|NCT00787813|Expectorants|expectorants|mesh-ancestor
56613231|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613232|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56613233|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
56613234|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613235|NCT00787813|Protective Agents|protective agents|mesh-ancestor
56613236|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613237|NCT00787813|Antidotes|antidotes|mesh-ancestor
56613238|NCT04261634|Mitogens|mitogens|mesh-list
56613239|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
56613240|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613241|NCT00787969|Sirolimus|sirolimus|mesh-list
56613242|NCT00787969|Rituximab|rituximab|mesh-list
56613243|NCT00787969|Cladribine|cladribine|mesh-list
56613244|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56613245|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613246|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
56613247|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613248|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56613249|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56613250|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613251|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55926175|NCT00814671|Rifampin|rifampin|mesh-list
56269292|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
55844393|NCT03084328|Vitamin D|vitamin d|mesh-list
56269363|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
56269364|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269365|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56269366|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56269367|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56269368|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269430|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56269431|NCT01989676|Trastuzumab|trastuzumab|mesh-list
56269432|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56269433|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269434|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
56269435|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
56269436|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
56269437|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269438|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56269439|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
56269440|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56613252|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
56613253|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613254|NCT00609596|Dutasteride|dutasteride|mesh-list
56613255|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56613256|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56613257|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613258|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613259|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
56613260|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56613261|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613262|NCT00608816|Epinephrine|epinephrine|mesh-list
56613263|NCT00608816|Racepinephrine|racepinephrine|mesh-list
56613264|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
56613265|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56613266|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56613267|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
56613268|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613269|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613270|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613271|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56613272|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56613273|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
56613274|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613275|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613276|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613277|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
56613278|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
56613279|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56613280|NCT02535273|Lidocaine|lidocaine|mesh-list
56613281|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
56613282|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
56613283|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
56613286|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
56613292|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613293|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56613294|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56613295|NCT02535273|Analgesics|analgesics|mesh-ancestor
56613296|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56613297|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56613298|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56613299|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
56613300|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613301|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
56613302|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
56613303|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613304|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56613305|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56613306|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613307|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613308|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613309|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
56613310|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56613311|NCT05001152|Ozanimod|ozanimod|mesh-list
56613312|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56613313|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613314|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613315|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
56613316|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613317|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
56613319|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
56613336|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613337|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56613338|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
56613339|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613340|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613341|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
56613342|NCT04259606|Antacids|antacids|mesh-ancestor
56613343|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613344|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56613345|NCT00788749|Fluticasone|fluticasone|mesh-list
56613346|NCT00788749|Xhance|xhance|mesh-list
56613347|NCT00788749|Prednisolone|prednisolone|mesh-list
56613348|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56613349|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56613350|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
56613351|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613352|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613353|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613354|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613355|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
56613356|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56613357|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
56613358|NCT00788749|Hormones|hormones|mesh-ancestor
56613359|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56159520|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613360|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56613361|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613362|NCT00609752|Prednisolone|prednisolone|mesh-list
56613382|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613383|NCT05220020|Lenvatinib|lenvatinib|mesh-list
56613384|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613385|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56613386|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613387|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613388|NCT00789061|Lansoprazole|lansoprazole|mesh-list
56613389|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56613390|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56613391|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56613392|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613393|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613394|NCT00996437|Ranibizumab|ranibizumab|mesh-list
56613395|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56613396|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56613397|NCT00996437|Growth Substances|growth substances|mesh-ancestor
56613398|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613399|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
56613400|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613401|NCT02628951|Paclitaxel|paclitaxel|mesh-list
56613402|NCT02628951|Ramucirumab|ramucirumab|mesh-list
56613403|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56613404|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613405|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
56613406|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
56613407|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
56613408|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613409|NCT00662311|Paclitaxel|paclitaxel|mesh-list
56613410|NCT00662311|Vorinostat|vorinostat|mesh-list
56613411|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56613412|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613413|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
56613414|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
56613415|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
56613422|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
56613423|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613424|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613425|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613426|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613427|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56613428|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56613429|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56613430|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
56613431|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613432|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613433|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56613434|NCT00996281|Olmesartan|olmesartan|mesh-list
56613435|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56613436|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
56613437|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56613438|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56613439|NCT00996281|Diuretics|diuretics|mesh-ancestor
56613440|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
56613441|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613442|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56613443|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56613474|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613475|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
56613476|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613477|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56613478|NCT00795223|Narcotics|narcotics|mesh-ancestor
56613479|NCT00795223|Analgesics|analgesics|mesh-ancestor
56613480|NCT00795301|Capecitabine|capecitabine|mesh-list
56613481|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
56613482|NCT00795301|Cetuximab|cetuximab|mesh-list
56613483|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56613484|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
56613485|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613486|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613487|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56613488|NCT00675285|Montelukast|montelukast|mesh-list
56613489|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613490|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613491|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56613492|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
56613493|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56613494|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613495|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56613496|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56613497|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613498|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
56613499|NCT00789763|Gemcitabine|gemcitabine|mesh-list
56613521|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56613522|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56613523|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56613524|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613525|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56613526|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613527|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
56613528|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56613529|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56613530|NCT00795457|Poly I-C|poly i-c|mesh-list
56613531|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56613532|NCT00795457|Vaccines|vaccines|mesh-list
56613533|NCT00795457|Poly ICLC|poly iclc|mesh-list
56613534|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
56613535|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613536|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
56613537|NCT00795457|Laxatives|laxatives|mesh-ancestor
56613538|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56613539|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
56613540|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613541|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56613542|NCT00793195|SMOFlipid|smoflipid|mesh-list
56613543|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56613544|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56613545|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56613546|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
56613547|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56613569|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56613570|NCT00795613|Vincristine|vincristine|mesh-list
56613571|NCT00795613|Procarbazine|procarbazine|mesh-list
56613572|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56613573|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613574|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56613575|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56613576|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613577|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613578|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56613579|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
56613580|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
56613581|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
56613582|NCT00800761|Deferiprone|deferiprone|mesh-list
56613583|NCT00800761|Deferoxamine|deferoxamine|mesh-list
56613584|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56613585|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
56613586|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
56613587|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613589|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
56613590|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56613591|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613592|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56613593|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
56613594|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56613595|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613596|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613597|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613598|NCT00800917|Sirolimus|sirolimus|mesh-list
56613599|NCT00800917|Bevacizumab|bevacizumab|mesh-list
56613600|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56613601|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613602|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56613611|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613612|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
56613613|NCT05003102|Fentanyl|fentanyl|mesh-list
56613614|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
56613615|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56613616|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613617|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613618|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56613619|NCT05003102|Analgesics|analgesics|mesh-ancestor
56613620|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
56613621|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613622|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56613623|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56613624|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56613625|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
56613626|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613627|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613628|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56613629|NCT05003102|Narcotics|narcotics|mesh-ancestor
56613630|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56613631|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56613632|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
56613633|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
56613634|NCT00676377|Neostigmine|neostigmine|mesh-list
56613635|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56613636|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613637|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613638|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
56613639|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613640|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613641|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56613642|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
56613643|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613644|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
55926551|NCT05237115|Amoxicillin|amoxicillin|mesh-list
56269441|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
56269442|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56269443|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
56269444|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269445|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613645|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56613646|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613647|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56613648|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56613649|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613650|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613651|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613652|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56613653|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56613654|NCT00676845|Olmesartan|olmesartan|mesh-list
56613655|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56613656|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56613657|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56613658|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56613659|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613660|NCT04152057|Paclitaxel|paclitaxel|mesh-list
56613661|NCT04152057|Trastuzumab|trastuzumab|mesh-list
56613662|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56613663|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613664|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
56613665|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56613666|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56613667|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613668|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56613669|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
56613670|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
56613671|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56613689|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613690|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56613691|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56613692|NCT05199038|Octreotide|octreotide|mesh-list
56613693|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56613694|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56613695|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613696|NCT00660907|Metformin|metformin|mesh-list
56613697|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
56613698|NCT00660907|Glipizide|glipizide|mesh-list
56613699|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56613700|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613701|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56613702|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613703|NCT00677001|R 306465|r 306465|mesh-list
56613704|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56613705|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613706|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613707|NCT04992572|Lidocaine|lidocaine|mesh-list
56613708|NCT04992572|Propofol|propofol|mesh-list
56613709|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
56613710|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
56613711|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613712|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613713|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
56613714|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613715|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56613716|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56613717|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56613718|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56613719|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269446|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
56269447|NCT01989884|IDN 5109|idn 5109|mesh-list
56269448|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269449|NCT01989897|Phenol|phenol|mesh-list
56269450|NCT01989897|Histamine|histamine|mesh-list
56269451|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
56269452|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
56269453|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269454|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269455|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844552|NCT03081442|Misoprostol|misoprostol|mesh-list
56613720|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56613721|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56613722|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
56613723|NCT05083052|Propolis|propolis|mesh-list
56613724|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613725|NCT04031703|Paclitaxel|paclitaxel|mesh-list
56613726|NCT04031703|Docetaxel|docetaxel|mesh-list
56613727|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
56613728|NCT04031703|Carboplatin|carboplatin|mesh-list
56613729|NCT04031703|Fluorouracil|fluorouracil|mesh-list
56613730|NCT04031703|Epirubicin|epirubicin|mesh-list
56613731|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56613732|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613733|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
56613734|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
56613735|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
56613736|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613737|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613738|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
56613739|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613740|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56613741|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56613742|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
56613743|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56613744|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
56613745|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56613746|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56613747|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56613748|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56613749|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613751|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56613752|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56613753|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56613754|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56613762|NCT00877773|Sirolimus|sirolimus|mesh-list
56613763|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56613764|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613765|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56613766|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613767|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
56613768|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56613769|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
56613770|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613771|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56613772|NCT00994643|Aldesleukin|aldesleukin|mesh-list
56613773|NCT00994643|Rituximab|rituximab|mesh-list
56613774|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56613775|NCT00994643|Interleukin-2|interleukin-2|mesh-list
56613776|NCT00994643|Antibodies|antibodies|mesh-list
56613777|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
56613778|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56613779|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
56613780|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613781|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613782|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56613783|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56613784|NCT00994643|Analgesics|analgesics|mesh-ancestor
56613785|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
56613786|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613787|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56613788|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56613789|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
56613790|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56613791|NCT00912171|Budesonide|budesonide|mesh-list
56613792|NCT00912171|Montelukast|montelukast|mesh-list
56613793|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56613794|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56613795|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
56613796|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613804|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
56613805|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56613806|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56613807|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613808|NCT00677391|Sibutramine|sibutramine|mesh-list
56613809|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
56613810|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56613811|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
56613812|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56613813|NCT00660829|Azelastine|azelastine|mesh-list
56613814|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56613815|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
56613816|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613817|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613818|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613819|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613820|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56613821|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613822|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613823|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56613824|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56613825|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56613826|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
56613827|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
56613828|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613829|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
56613830|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56613831|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56613835|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
56613848|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56613849|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56613850|NCT00795925|Propiverine|propiverine|mesh-list
56613851|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
56613852|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
56613853|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613854|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613855|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56613856|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56613857|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
56613858|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613859|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613860|NCT00795925|Urological Agents|urological agents|mesh-ancestor
56613861|NCT04293419|Durvalumab|durvalumab|mesh-list
56613862|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56613863|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613864|NCT00793429|Prucalopride|prucalopride|mesh-list
56613865|NCT00793429|Laxatives|laxatives|mesh-ancestor
56613866|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56613867|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56613868|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56613869|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
56613870|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613871|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613872|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613873|NCT00801151|Vinorelbine|vinorelbine|mesh-list
56613874|NCT00801151|Vorinostat|vorinostat|mesh-list
56613875|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56613876|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613877|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
56613878|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
56613879|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
56613880|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613881|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56269488|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56186480|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
56186481|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186482|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186483|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
56186484|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56613882|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613883|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56613884|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56613885|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56613886|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613887|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613888|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56613889|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56613890|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56613891|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
56613892|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613893|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613894|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56613895|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56613896|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
56613897|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
56613898|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56186485|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56186486|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
56186487|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269489|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
56269490|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56269491|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56269492|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56269493|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269494|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
56269495|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56269496|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56269523|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56269524|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269525|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269526|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
56269527|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56269528|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
56269529|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
56269530|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269531|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269532|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56269533|NCT01990404|Analgesics|analgesics|mesh-ancestor
56269534|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
56269535|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269536|NCT01990443|Reslizumab|reslizumab|mesh-list
56269537|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56269538|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
56269539|NCT01990586|Rabeprazole|rabeprazole|mesh-list
56269540|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56269541|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56269542|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56269543|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269544|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269576|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56269578|NCT01990781|Hormones|hormones|mesh-ancestor
56269579|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269580|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56269581|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613899|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
56613900|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613901|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613902|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56613903|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
56613904|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
56613905|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56613906|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
56613907|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613908|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613910|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56613911|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56613912|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56613913|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56613914|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613915|NCT00993473|Insulin|insulin|mesh-list
56613916|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56613917|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
56613918|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
56613919|NCT00993473|Protamines|protamines|mesh-list
56613920|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56613921|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613922|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
56613923|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613924|NCT00993473|Coagulants|coagulants|mesh-ancestor
56613925|NCT00660595|Risperidone|risperidone|mesh-list
56613926|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56613927|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56613928|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
56613929|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269582|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
56269583|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269584|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269585|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
56269586|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
56269587|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269619|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
56269620|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269621|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269622|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56269623|NCT01991054|Vitamin D|vitamin d|mesh-list
56269624|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
56269625|NCT01991054|Vitamins|vitamins|mesh-ancestor
56269626|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
56269627|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613930|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613931|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613932|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56613933|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56613934|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613935|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56613936|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56613937|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
56613938|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
56613939|NCT00929240|Bevacizumab|bevacizumab|mesh-list
56613940|NCT00929240|Capecitabine|capecitabine|mesh-list
56613941|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56613942|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613943|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56613944|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56613945|NCT00929240|Growth Substances|growth substances|mesh-ancestor
56613946|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613947|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
56613948|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55926869|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55926870|NCT05246371|Analgesics|analgesics|mesh-ancestor
55926871|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
55926872|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926873|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55926874|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55926875|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55926876|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
55926877|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926880|NCT00863265|Ezetimibe|ezetimibe|mesh-list
56269628|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56269629|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56269630|NCT01991119|Dronedarone|dronedarone|mesh-list
56269631|NCT01991119|Propafenone|propafenone|mesh-list
56269667|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56269668|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56269669|NCT01991275|Morphine|morphine|mesh-list
56269670|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56269697|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56114245|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
56186488|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186489|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186490|NCT01437670|Urological Agents|urological agents|mesh-ancestor
56269699|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
56269700|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56269701|NCT01991327|Enclomiphene|enclomiphene|mesh-list
56613950|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613951|NCT00793663|Dexamethasone|dexamethasone|mesh-list
56613952|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
56613953|NCT00793663|Ondansetron|ondansetron|mesh-list
56613954|NCT00793663|Sevoflurane|sevoflurane|mesh-list
56613955|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56613956|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
56613957|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
56613958|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56613959|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613960|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56613961|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
56613962|NCT00793663|Hormones|hormones|mesh-ancestor
56613963|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56613964|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56613965|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56613966|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56613967|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56613968|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
56613969|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
56613970|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56613971|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
56613972|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
56613973|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56613974|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
56613975|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56613976|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613977|NCT00793663|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56613978|NCT00793663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56613979|NCT00793663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56613980|NCT00793663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56613981|NCT04932980|Aflibercept|aflibercept|mesh-list
56613982|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56613983|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56613984|NCT04932980|Growth Substances|growth substances|mesh-ancestor
56613985|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56613990|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56613991|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56613992|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56613993|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56613994|NCT02554045|Urological Agents|urological agents|mesh-ancestor
56613995|NCT05330390|Levetiracetam|levetiracetam|mesh-list
56613996|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
56613997|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
56613998|NCT00993317|Methotrexate|methotrexate|mesh-list
56613999|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
56614000|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56614001|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
56614002|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56614003|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614004|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56614005|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
56614006|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614007|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614008|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
56614009|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614010|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56614011|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56614012|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
56614013|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56614014|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56614015|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56614016|NCT00801385|Sorafenib|sorafenib|mesh-list
56614017|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614018|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56614019|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614020|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614021|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
56614022|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56614023|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56614024|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56614025|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269702|NCT01991327|Clomiphene|clomiphene|mesh-list
56269703|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
56269704|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56614026|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614027|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
56614028|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614029|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614030|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56614031|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614032|NCT00877071|Doxorubicin|doxorubicin|mesh-list
56614033|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56614034|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614035|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56614036|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56614037|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614038|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614039|NCT05191862|Cilostazol|cilostazol|mesh-list
55926964|NCT00835185|Folic Acid|folic acid|mesh-list
55926965|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
55926966|NCT00835185|Necitumumab|necitumumab|mesh-list
56269705|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
56269706|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269707|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269708|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56269709|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
56269710|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56269711|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56269712|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56269713|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56269714|NCT01991561|Vaccines|vaccines|mesh-list
56269715|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
56269716|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269717|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56269718|NCT01991561|Antacids|antacids|mesh-ancestor
56269719|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269742|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56269743|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269744|NCT01991873|Leucovorin|leucovorin|mesh-list
56269745|NCT01991873|Folic Acid|folic acid|mesh-list
56269746|NCT01991873|Fluorouracil|fluorouracil|mesh-list
56269747|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
56269748|NCT01991873|Panitumumab|panitumumab|mesh-list
56269749|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
56269750|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
56269751|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269752|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56269753|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269754|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56269755|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
56269756|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269757|NCT01991873|Antidotes|antidotes|mesh-ancestor
56269758|NCT01991873|Protective Agents|protective agents|mesh-ancestor
56269759|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
56269760|NCT01991873|Vitamins|vitamins|mesh-ancestor
56269761|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
56269762|NCT01991873|Hematinics|hematinics|mesh-ancestor
56269763|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56269764|NCT01991951|Warfarin|warfarin|mesh-list
55891759|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56269765|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
56269766|NCT01992133|Vitamin D|vitamin d|mesh-list
56269767|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
56269768|NCT01992133|Vitamins|vitamins|mesh-ancestor
56614040|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56614041|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
56614042|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614043|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614044|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56614045|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
56614046|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56614047|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56614048|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614049|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56614050|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
56614051|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56614052|NCT05191862|Protective Agents|protective agents|mesh-ancestor
56614053|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56614054|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56614055|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614056|NCT02868827|Vitamin D|vitamin d|mesh-list
56614057|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
56614058|NCT02868827|Vitamins|vitamins|mesh-ancestor
56614059|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
56614060|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614061|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56614062|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56614063|NCT00678327|Prednisolone|prednisolone|mesh-list
56614064|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
56614065|NCT00678327|Dacarbazine|dacarbazine|mesh-list
56614066|NCT00678327|Doxorubicin|doxorubicin|mesh-list
56614067|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56614088|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
56614089|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
56614090|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56614091|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
56614092|NCT00678327|Hormones|hormones|mesh-ancestor
56614093|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614094|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56614095|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
56614096|NCT00987389|Hormones|hormones|mesh-ancestor
56614097|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614098|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614099|NCT00929162|Paclitaxel|paclitaxel|mesh-list
56614100|NCT00929162|Carboplatin|carboplatin|mesh-list
56614101|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56614102|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614103|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
56614104|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
56614105|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
56614106|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614107|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
56614108|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56614109|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
56614110|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614111|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614112|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56614113|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
56614114|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
56614115|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56614116|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
56614117|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614118|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269769|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
56269770|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269771|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56269772|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56269774|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55844872|NCT01970371|Meropenem|meropenem|mesh-list
56269801|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56269802|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56269803|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
56269804|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269805|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56614119|NCT00678483|Rimonabant|rimonabant|mesh-list
56614120|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56614121|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56614122|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56614123|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614124|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614125|NCT00678483|Hormones|hormones|mesh-ancestor
56614126|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614127|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614128|NCT00610454|Levetiracetam|levetiracetam|mesh-list
56614129|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
56614130|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
56614131|NCT04151355|Atorvastatin|atorvastatin|mesh-list
56614132|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56614133|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56614134|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
56614135|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614136|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56614137|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56614138|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614139|NCT00609284|Carboplatin|carboplatin|mesh-list
56614171|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56614172|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614173|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56614174|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614175|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614176|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56614177|NCT04257812|Renal Agents|renal agents|mesh-ancestor
56614178|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
56614179|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56614180|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
56614181|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269806|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56269807|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269808|NCT01992263|Vitamin D|vitamin d|mesh-list
56269809|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
56269810|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
56269811|NCT01992263|Vitamins|vitamins|mesh-list
56269812|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
56269813|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269814|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56186492|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
56269815|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56269816|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
56269817|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56269818|NCT01992328|Antibodies|antibodies|mesh-list
56269819|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
56269820|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
56269821|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56269822|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
56269823|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269824|NCT01992341|Paclitaxel|paclitaxel|mesh-list
56269825|NCT01992341|Trebananib|trebananib|mesh-list
56269826|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56269858|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56269860|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
56269861|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269862|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56269863|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56269864|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269865|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56269866|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56269867|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56269868|NCT01992705|Fluorouracil|fluorouracil|mesh-list
56269899|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269900|NCT01993173|Vaccines|vaccines|mesh-list
56269901|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
56269902|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269903|NCT01993212|Enclomiphene|enclomiphene|mesh-list
56269904|NCT01993212|Testosterone|testosterone|mesh-list
56269905|NCT01993212|Androgens|androgens|mesh-ancestor
56269906|NCT01993212|Hormones|hormones|mesh-ancestor
56269907|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269908|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269909|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56269910|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
56269911|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56269912|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
56269913|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56269914|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56269915|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56269916|NCT01993225|Enclomiphene|enclomiphene|mesh-list
56269917|NCT01993225|Testosterone|testosterone|mesh-list
56269942|NCT01993459|Midazolam|midazolam|mesh-list
56269943|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56269944|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56614182|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
56614183|NCT02868749|Protective Agents|protective agents|mesh-ancestor
56614184|NCT00659581|Telmisartan|telmisartan|mesh-list
56614185|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56614186|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56614187|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56614188|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614189|NCT00793741|Somatostatin|somatostatin|mesh-list
56614190|NCT00793741|Hormones|hormones|mesh-ancestor
56614191|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614192|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614193|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56614194|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56614195|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56614196|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614197|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614198|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56614199|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56614200|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56614201|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
56614202|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614203|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614204|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56614205|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56614206|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
56614207|NCT00991289|Interferons|interferons|mesh-list
56614208|NCT00991289|Ribavirin|ribavirin|mesh-list
56614209|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
56614210|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
56614211|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56614212|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
56614213|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614214|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
56614215|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614216|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
55927033|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
56269945|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56269946|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269947|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269948|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56614217|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614218|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
56614219|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614220|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56614221|NCT04046029|Heparin|heparin|mesh-list
56614222|NCT04046029|Bivalirudin|bivalirudin|mesh-list
56614223|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
56614224|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56614225|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56614226|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614227|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
56614228|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56614229|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
56614230|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614231|NCT00679653|Sibutramine|sibutramine|mesh-list
56614232|NCT00679653|Metoprolol|metoprolol|mesh-list
56614233|NCT00679653|Verapamil|verapamil|mesh-list
56614234|NCT00679653|Felodipine|felodipine|mesh-list
56614235|NCT00679653|Ramipril|ramipril|mesh-list
56614236|NCT00679653|Trandolapril|trandolapril|mesh-list
56614237|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56614238|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56614239|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
56614240|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
56614241|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614242|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614243|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56614244|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56614246|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
56614247|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614248|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927074|NCT01396265|Rifampin|rifampin|mesh-list
56269949|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56269950|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56269951|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56269952|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
56269953|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
56269954|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
56269955|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
56269956|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269957|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269962|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269963|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269964|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269965|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56614249|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56614250|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
56614251|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614252|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56614253|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56614254|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56614255|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
56614256|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
56614257|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56614258|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
56614259|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56614260|NCT00793897|Paclitaxel|paclitaxel|mesh-list
56614261|NCT00793897|Carboplatin|carboplatin|mesh-list
56614262|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56614263|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614264|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
56614265|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
56614266|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
56614267|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614268|NCT00793975|Ramucirumab|ramucirumab|mesh-list
56614269|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614270|NCT00679965|Tavaborole|tavaborole|mesh-list
56614271|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
56614272|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614273|NCT00930644|Teduglutide|teduglutide|mesh-list
56614274|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56614275|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56614276|NCT00930644|Protective Agents|protective agents|mesh-ancestor
56614277|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614279|NCT02627469|Fluorides|fluorides|mesh-list
56614280|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
56614281|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
56614282|NCT02627469|Protective Agents|protective agents|mesh-ancestor
56614286|NCT00680277|Carotenoids|carotenoids|mesh-list
56614293|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614294|NCT00680355|Protective Agents|protective agents|mesh-ancestor
56614295|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614296|NCT00801697|Vaccines|vaccines|mesh-list
56614297|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
56614298|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614299|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
56614300|NCT00684489|Coal Tar|coal tar|mesh-list
56614301|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
56614302|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
56614303|NCT00990821|Midazolam|midazolam|mesh-list
56614304|NCT00990821|Aprepitant|aprepitant|mesh-list
56614305|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
56614306|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56614307|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56614308|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614309|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614310|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56614311|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56614312|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56614313|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56614314|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
56614315|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
56614316|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
56614317|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
56614318|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614319|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614320|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
56614321|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
56048058|NCT04350281|Interferons|interferons|mesh-list
56614322|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614323|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56614336|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56614337|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56614338|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56614339|NCT00658567|Pimavanserin|pimavanserin|mesh-list
56614340|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56614341|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56614342|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56614343|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56614344|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614345|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614346|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56614347|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56614348|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56614349|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
56362864|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56614350|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614351|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614352|NCT00875433|Afatinib|afatinib|mesh-list
56614353|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614354|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56614390|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
56614391|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614392|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614393|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56614394|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56614395|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
56614396|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614397|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614398|NCT00685347|Albuterol|albuterol|mesh-list
56614399|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56614400|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
56614401|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614402|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614403|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56614404|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
56614405|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
56614406|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56614407|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56614408|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56614409|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56614410|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
56614411|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614412|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614413|NCT00685425|Albuterol|albuterol|mesh-list
56614414|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56614415|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
56614416|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614417|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614418|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56614419|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
56614420|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
56614421|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56614422|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56614423|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56362940|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56614427|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614428|NCT04290455|Castor Oil|castor oil|mesh-list
56614429|NCT04290455|Cathartics|cathartics|mesh-ancestor
56614430|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56614431|NCT00685503|Ranibizumab|ranibizumab|mesh-list
56614432|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56614433|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56614434|NCT00685503|Growth Substances|growth substances|mesh-ancestor
56614435|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614436|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
56614437|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614438|NCT00802009|Dexamethasone|dexamethasone|mesh-list
56614439|NCT00802009|Mepivacaine|mepivacaine|mesh-list
56614440|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56614441|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
56614442|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
56614443|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614444|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614445|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56614446|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
56614484|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56614485|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56614486|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56614487|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614488|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614490|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56614491|NCT00797017|Narcotics|narcotics|mesh-ancestor
56614492|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614493|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614494|NCT00797017|Analgesics|analgesics|mesh-ancestor
56614495|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
56614496|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614497|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56614498|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56614499|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
56614500|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
56614501|NCT05330000|Voriconazole|voriconazole|mesh-list
56614503|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614504|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56614505|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56614506|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614507|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614508|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56614509|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
56614510|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614511|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614513|NCT00794443|Diphosphonates|diphosphonates|mesh-list
56614531|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
56614532|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56614533|NCT02866955|Tamoxifen|tamoxifen|mesh-list
56614534|NCT02866955|Estramustine|estramustine|mesh-list
56614535|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56614536|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
56614537|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614538|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614539|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56614540|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614541|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56614542|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56614543|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56614544|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56614545|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
56614546|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614547|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
56614548|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
56614549|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614550|NCT02626065|Nivolumab|nivolumab|mesh-list
56614551|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56614552|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614553|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56614554|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614555|NCT00794755|Vitamin K|vitamin k|mesh-list
56614556|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
56614557|NCT00794755|Vitamins|vitamins|mesh-ancestor
56614558|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
56614559|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614560|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56614561|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56614562|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614563|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
56614564|NCT00794755|Coagulants|coagulants|mesh-ancestor
56614569|NCT00685971|Vitamins|vitamins|mesh-ancestor
56614570|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
56614571|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56614572|NCT00802243|Leflunomide|leflunomide|mesh-list
56614573|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614574|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614575|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56614576|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
56614577|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614579|NCT00988637|Clobetasol|clobetasol|mesh-list
56622940|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
56269966|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56269968|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
56270002|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270003|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
56270004|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56270005|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270006|NCT01993979|Gemcitabine|gemcitabine|mesh-list
56270007|NCT01993979|Cisplatin|cisplatin|mesh-list
56270008|NCT01993979|Carboplatin|carboplatin|mesh-list
56186493|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
56186494|NCT01437696|Vitamins|vitamins|mesh-list
56270009|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270010|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56270030|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56270031|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56270032|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270034|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
56270035|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270036|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270037|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270038|NCT01994265|Warfarin|warfarin|mesh-list
56270039|NCT01994265|Dabigatran|dabigatran|mesh-list
56270040|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
56270041|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
56270042|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56270043|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
56270044|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270045|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270046|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56270047|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
56270048|NCT01994330|Coagulants|coagulants|mesh-ancestor
56270049|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56270050|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
56270051|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270052|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
56270053|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56270054|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270055|NCT01994460|Linezolid|linezolid|mesh-list
56270056|NCT01994460|Ethambutol|ethambutol|mesh-list
56270057|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56270058|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270059|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56270060|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270061|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270062|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
56270063|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
56270064|NCT01994642|Dexamethasone|dexamethasone|mesh-list
56270065|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
56270083|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56270084|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56270085|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56270086|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56270088|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
56270089|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
56270090|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
56614580|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56614581|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614582|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56614583|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56614584|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614585|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56614586|NCT00988637|Vitamins|vitamins|mesh-ancestor
56614587|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
56614588|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56614589|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56614590|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
56614591|NCT00988637|Hormones|hormones|mesh-ancestor
56614592|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614593|NCT00802321|Dutasteride|dutasteride|mesh-list
56614594|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56614595|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56270091|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270092|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270093|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270094|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56270095|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270096|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56270097|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56270098|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56270101|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270102|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270103|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
56270104|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
56270105|NCT01994733|Calcium|calcium|mesh-list
56270106|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56270107|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270108|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56270109|NCT01994733|Antacids|antacids|mesh-ancestor
56270110|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270111|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270112|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
56270113|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56270114|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270115|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
56270116|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
56270117|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270118|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901461|NCT00707304|Lactoferrin|lactoferrin|mesh-list
56270119|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270120|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
56270121|NCT01994759|Hormones|hormones|mesh-ancestor
56000894|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270150|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56270151|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56270152|NCT01995006|Analgesics|analgesics|mesh-ancestor
56270153|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
56270154|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270155|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270156|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270157|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56270158|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
56270159|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56614596|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614597|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614598|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
56614599|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614600|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614601|NCT00686361|Choline|choline|mesh-list
56614602|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
56614603|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56614604|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
56614605|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614606|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56614607|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56614608|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
56614609|NCT00686439|Adalimumab|adalimumab|mesh-list
56614610|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56614611|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56614612|NCT04161755|Atezolizumab|atezolizumab|mesh-list
56614613|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614614|NCT00797485|Leucovorin|leucovorin|mesh-list
56614615|NCT00797485|Bevacizumab|bevacizumab|mesh-list
56270160|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270161|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270162|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
56270163|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
56270164|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56270165|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56270166|NCT01995019|Prednisolone|prednisolone|mesh-list
56270167|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
56270168|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56270202|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270203|NCT01995188|Bevacizumab|bevacizumab|mesh-list
56270204|NCT01995188|Carboplatin|carboplatin|mesh-list
56270205|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56270206|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270207|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56270208|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56270244|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56270245|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
56270246|NCT01995344|Fludarabine|fludarabine|mesh-list
56270247|NCT01995344|Interleukin-2|interleukin-2|mesh-list
56270248|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270249|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
56270250|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270273|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56270274|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270275|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56270276|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56270277|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270278|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
56270279|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56270280|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56270281|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56270282|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
56270283|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270284|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56614616|NCT00797485|Fluorouracil|fluorouracil|mesh-list
56614617|NCT00797485|Capecitabine|capecitabine|mesh-list
56614618|NCT00797485|Irinotecan|irinotecan|mesh-list
56614619|NCT00797485|Calcium|calcium|mesh-list
56614620|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
56614621|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56614622|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614623|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56614624|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56614625|NCT00797485|Growth Substances|growth substances|mesh-ancestor
56614626|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614627|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
56614628|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56614629|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
56614630|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614631|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56614632|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56614633|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
56614634|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56614635|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56614636|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614637|NCT00797485|Antidotes|antidotes|mesh-ancestor
56614638|NCT00797485|Protective Agents|protective agents|mesh-ancestor
56614639|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
56614640|NCT00797485|Vitamins|vitamins|mesh-ancestor
56614641|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
56614668|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
56614669|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614670|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614671|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56614672|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
56614673|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614674|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56614675|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
56614676|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614677|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
56614678|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56614679|NCT00687843|Protective Agents|protective agents|mesh-ancestor
56614680|NCT04257656|Remdesivir|remdesivir|mesh-list
56614681|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
56270285|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
56270286|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56270287|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
56270288|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
56270289|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56270290|NCT01995370|Protective Agents|protective agents|mesh-ancestor
56270291|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56270292|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56270293|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56270294|NCT01995695|Vaccines|vaccines|mesh-list
56270295|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
55892290|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
56270296|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270297|NCT01995734|Pasireotide|pasireotide|mesh-list
56270298|NCT01995734|Hormones|hormones|mesh-ancestor
56270299|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56270300|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270301|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56270338|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55845445|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
56270369|NCT01996306|Antidotes|antidotes|mesh-ancestor
56270370|NCT01996306|Protective Agents|protective agents|mesh-ancestor
56270371|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
55892369|NCT01903473|Sirolimus|sirolimus|mesh-list
56186496|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901527|NCT02703636|Rivastigmine|rivastigmine|mesh-list
56270373|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
56270374|NCT01996358|Rocuronium|rocuronium|mesh-list
56270375|NCT01996358|Succinylcholine|succinylcholine|mesh-list
56270376|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56270377|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56270378|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56270379|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270380|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270381|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56270382|NCT01996384|Lidocaine|lidocaine|mesh-list
56270383|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
56270384|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
56270385|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270386|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270418|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56270419|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56270420|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
56270421|NCT01996475|Dexetimide|dexetimide|mesh-list
56270422|NCT01996475|Citalopram|citalopram|mesh-list
56270423|NCT01996475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56270424|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56270425|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56614682|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614683|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
56614684|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614685|NCT05329844|Vildagliptin|vildagliptin|mesh-list
56614686|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56614687|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614688|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56614689|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
56614690|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614691|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614692|NCT00687999|Interferons|interferons|mesh-list
56614693|NCT00687999|Ribavirin|ribavirin|mesh-list
56614694|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
56614695|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270426|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845526|NCT01808144|Febuxostat|febuxostat|mesh-list
56270454|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270455|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270456|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
56270457|NCT01996501|Olanzapine|olanzapine|mesh-list
56270458|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
56270459|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
56270460|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270461|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270462|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270463|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56270464|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56270465|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270466|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56270467|NCT01996501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56270468|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56270469|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56270470|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270471|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270472|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
55845580|NCT04305106|Hormones|hormones|mesh-ancestor
56270509|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
56270511|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
56270546|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
56270547|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270548|NCT01997203|Vitamin D|vitamin d|mesh-list
56270549|NCT01997203|Interferons|interferons|mesh-list
56270550|NCT01997203|Ribavirin|ribavirin|mesh-list
56270551|NCT01997203|Vitamins|vitamins|mesh-ancestor
56270552|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
56270553|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270587|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270588|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270589|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
56270590|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270592|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
56270622|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56270623|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270624|NCT01997788|Morphine|morphine|mesh-list
56270625|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56270626|NCT01997788|Narcotics|narcotics|mesh-ancestor
56270627|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270628|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270629|NCT01997788|Analgesics|analgesics|mesh-ancestor
56270630|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
56270631|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270632|NCT01997801|Ketamine|ketamine|mesh-list
56614696|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
56614697|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614698|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
56614699|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614700|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
56614701|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614702|NCT00688077|Calcitonin|calcitonin|mesh-list
56614703|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
56614704|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56614705|NCT00688077|Katacalcin|katacalcin|mesh-list
56614706|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56270633|NCT01997801|Analgesics|analgesics|mesh-ancestor
56270634|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
56270635|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186497|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56186498|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56186499|NCT01437748|Bromides|bromides|mesh-list
56186500|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
56186501|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56186502|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
56186503|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186504|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186505|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56186506|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
56186507|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
56186508|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56186509|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
56186510|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186511|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186512|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
56186513|NCT01437800|Metformin|metformin|mesh-list
55901598|NCT02418702|Ketamine|ketamine|mesh-list
56270636|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270637|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56270638|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56270705|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270706|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270707|NCT01998295|Lumefantrine|lumefantrine|mesh-list
56270708|NCT01998295|Artemether|artemether|mesh-list
56270709|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56270710|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
56270711|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56270712|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56270713|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270714|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
56270715|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56270716|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
56270717|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270718|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
56270719|NCT01998308|Protective Agents|protective agents|mesh-ancestor
56270720|NCT01998347|Paclitaxel|paclitaxel|mesh-list
56270721|NCT01998347|Fluorouracil|fluorouracil|mesh-list
56270722|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56270748|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270749|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270750|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
56270751|NCT01998503|Hormones|hormones|mesh-ancestor
56270752|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56270753|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56270754|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270755|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
56270756|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56270757|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
56270758|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614707|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614708|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56614709|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
56614710|NCT00923156|Ramipril|ramipril|mesh-list
56614711|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56614712|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
56614713|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614714|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614715|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56614716|NCT00688857|Diazoxide|diazoxide|mesh-list
56614717|NCT00688857|Choline|choline|mesh-list
56614718|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
56270759|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56270760|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270761|NCT01998685|Fentanyl|fentanyl|mesh-list
56270762|NCT01998685|Midazolam|midazolam|mesh-list
56270763|NCT01998685|Remifentanil|remifentanil|mesh-list
56270764|NCT01998685|Propofol|propofol|mesh-list
56270765|NCT01998685|Sevoflurane|sevoflurane|mesh-list
56270766|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56186514|NCT01437800|Glimepiride|glimepiride|mesh-list
56186515|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55901657|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56270793|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270794|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270795|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56270797|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
56270798|NCT01998698|Protective Agents|protective agents|mesh-ancestor
56270799|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
56270800|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
56270801|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270802|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
56270803|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270804|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56270805|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56270806|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56270807|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56270809|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
56270810|NCT01998763|Vitamins|vitamins|mesh-ancestor
56270811|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
56270812|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270813|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56270814|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56270815|NCT01998776|Misoprostol|misoprostol|mesh-list
55845897|NCT03091192|Growth Substances|growth substances|mesh-ancestor
56270847|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
56270848|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56270849|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56270850|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270851|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270852|NCT01999309|Simvastatin|simvastatin|mesh-list
56270853|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56270854|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56270855|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
56270856|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845941|NCT04397770|Temozolomide|temozolomide|mesh-list
56270873|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56270874|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270875|NCT01999647|Ropivacaine|ropivacaine|mesh-list
56270876|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
56270877|NCT01999647|Anesthetics|anesthetics|mesh-list
56270878|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270879|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270880|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
55902071|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
56614719|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56614720|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
56614721|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614722|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56614723|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56614724|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
56614725|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56363238|NCT00306748|Linaclotide|linaclotide|mesh-list
56614726|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
56614727|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
56614728|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56614729|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614730|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
56614731|NCT00689169|Cytarabine|cytarabine|mesh-list
56614732|NCT00689169|Rituximab|rituximab|mesh-list
56614733|NCT00689169|Etoposide|etoposide|mesh-list
56614734|NCT00689169|Melphalan|melphalan|mesh-list
56614735|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56614736|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614737|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
56614738|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614739|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56614740|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56614741|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55927403|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
56270881|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270882|NCT01999673|Docetaxel|docetaxel|mesh-list
56270883|NCT01999673|Bavituximab|bavituximab|mesh-list
56270884|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56270885|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270886|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
56270887|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
56270888|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
56270889|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270890|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56270891|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
56270892|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270893|NCT01999686|Metformin|metformin|mesh-list
56270894|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56270895|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270896|NCT01999738|Folic Acid|folic acid|mesh-list
56270897|NCT01999738|Hematinics|hematinics|mesh-ancestor
56270898|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
56270899|NCT01999738|Vitamins|vitamins|mesh-ancestor
56270900|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
56270901|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270903|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270904|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56270905|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270906|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56270907|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270908|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56614742|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56614743|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614744|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614745|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56614746|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
56614747|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56614748|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56614749|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56614750|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
56614751|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
56614752|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614753|NCT04203914|Empagliflozin|empagliflozin|mesh-list
56614754|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56614755|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614756|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56614757|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614758|NCT00874731|Sirolimus|sirolimus|mesh-list
56614759|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56614760|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614761|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56614762|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614763|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
56614764|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56614765|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
56614766|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614767|NCT02625519|Hormones|hormones|mesh-list
56614768|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56614769|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614770|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614771|NCT00912483|Heparin|heparin|mesh-list
56614772|NCT00912483|Calcium heparin|calcium heparin|mesh-list
56614773|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
56614774|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56614775|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56614776|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614777|NCT04257032|Dabigatran|dabigatran|mesh-list
56270909|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56614778|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56614779|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56614780|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56614781|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
56614782|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614783|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56614784|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56614785|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614786|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
56614787|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56614788|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
56614789|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
56186516|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186518|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56186519|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
56186520|NCT01437813|Metformin|metformin|mesh-list
56186521|NCT01437813|Glimepiride|glimepiride|mesh-list
56186522|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55901734|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
56270910|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
56270911|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270912|NCT01999842|Vaccines|vaccines|mesh-list
56270913|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
56270914|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270915|NCT01999907|Vitamin D|vitamin d|mesh-list
56270916|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
56270948|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56270949|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270950|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270951|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56270952|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
56270953|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
56270954|NCT02000206|Analgesics|analgesics|mesh-ancestor
56270955|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
56270956|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270957|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56270958|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56270959|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56270960|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270993|NCT02000401|Analgesics|analgesics|mesh-ancestor
56270994|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
56270995|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270996|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270997|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270998|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56270999|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56271000|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271001|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271002|NCT02000414|Daptomycin|daptomycin|mesh-list
56271031|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271032|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271033|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56271034|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271035|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271037|NCT02000947|Tremelimumab|tremelimumab|mesh-list
56271038|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56271039|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56271040|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271041|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
56271042|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271043|NCT02001012|Chloroquine|chloroquine|mesh-list
56271044|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56271045|NCT02001012|Lumefantrine|lumefantrine|mesh-list
56614790|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56614791|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56614792|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
56614793|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56614794|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
56614795|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
56614796|NCT00924560|Estradiol|estradiol|mesh-list
56614797|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56614798|NCT00924560|Estrogens|estrogens|mesh-ancestor
56614799|NCT00924560|Hormones|hormones|mesh-ancestor
55927469|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271070|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271071|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56271072|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56271073|NCT02001168|Docetaxel|docetaxel|mesh-list
56271074|NCT02001168|Pemetrexed|pemetrexed|mesh-list
56271075|NCT02001168|Cisplatin|cisplatin|mesh-list
56271076|NCT02001168|Endostatins|endostatins|mesh-list
56271077|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271078|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271079|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
56271080|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
56271081|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271082|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271083|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56271084|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56271085|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56271086|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56186523|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186524|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56186525|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56186526|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
56186528|NCT01437826|Antioxidants|antioxidants|mesh-list
56186529|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186530|NCT01437826|Protective Agents|protective agents|mesh-ancestor
56186531|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186532|NCT01437826|Trace Elements|trace elements|mesh-ancestor
56186533|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
56186534|NCT01437839|Apixaban|apixaban|mesh-list
56186535|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56186536|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
55901807|NCT02411604|Tacrolimus|tacrolimus|mesh-list
56271087|NCT02001168|Growth Substances|growth substances|mesh-ancestor
56271088|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271089|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
56271090|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
56271091|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271092|NCT02001259|Lidocaine|lidocaine|mesh-list
56271093|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
56271094|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
56271095|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271096|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271097|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
56271098|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271099|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56271132|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56271133|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271134|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
56271135|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56271136|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56271137|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271138|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
56271139|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
56271140|NCT02001363|Liraglutide|liraglutide|mesh-list
56271174|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56271175|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56271176|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
56271177|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614800|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614801|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614802|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56614803|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56614804|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56614805|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56614806|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56614807|NCT00689559|Aripiprazole|aripiprazole|mesh-list
56614808|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
56614809|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56614810|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56614811|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56614812|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614813|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614814|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
56614815|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
56271178|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271179|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271180|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56271181|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56271182|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56271208|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
56271209|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271210|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56271211|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271212|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271213|NCT02001857|Hemostatics|hemostatics|mesh-list
56271214|NCT02001857|Coagulants|coagulants|mesh-ancestor
56271215|NCT02001883|Policosanol|policosanol|mesh-list
56271216|NCT02001883|Atorvastatin|atorvastatin|mesh-list
56271217|NCT02001883|Simvastatin|simvastatin|mesh-list
56271218|NCT02001883|Red yeast rice|red yeast rice|mesh-list
56271219|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56271220|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56271221|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
56271222|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271223|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56186537|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56186538|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
56186539|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186540|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186541|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
56186542|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56186543|NCT01437982|Prednisolone|prednisolone|mesh-list
56186544|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56186545|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
56186546|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56186547|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
56186548|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56186549|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
56186550|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56186551|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
56186552|NCT01437982|Hormones|hormones|mesh-ancestor
56186553|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55901860|NCT02410746|Ibuprofen|ibuprofen|mesh-list
56271224|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56271225|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927494|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55927495|NCT04623216|Azacitidine|azacitidine|mesh-list
56614816|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614817|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614818|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56614819|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56614820|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
56614821|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56614822|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56614823|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56614824|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56614825|NCT00689637|Warfarin|warfarin|mesh-list
56614826|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
56614827|NCT00689715|Ethanol|ethanol|mesh-list
56614828|NCT00689715|Paclitaxel|paclitaxel|mesh-list
56614829|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56614830|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56614831|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614832|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271226|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56271227|NCT02001896|Gemcitabine|gemcitabine|mesh-list
56271228|NCT02001896|Carboplatin|carboplatin|mesh-list
56271229|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56271230|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271231|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56271250|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271251|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271252|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56271253|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
56271254|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56271255|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271256|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271257|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
56271258|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56271259|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56271260|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
56271261|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271262|NCT02001948|Morphine|morphine|mesh-list
56271263|NCT02001948|Bupivacaine|bupivacaine|mesh-list
56271264|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
56271265|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
56271266|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271267|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271268|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
56271269|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271270|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56271271|NCT02001948|Narcotics|narcotics|mesh-ancestor
55893279|NCT02460510|Mannitol|mannitol|mesh-list
56271273|NCT02001974|Paclitaxel|paclitaxel|mesh-list
56271274|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56271275|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271276|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271277|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
56271278|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
56271279|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271280|NCT02002000|Vitamin D|vitamin d|mesh-list
56614833|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
56614834|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
56614835|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614836|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56614837|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087197|NCT02966756|Venetoclax|venetoclax|mesh-list
56614838|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614839|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614841|NCT00689949|Hematinics|hematinics|mesh-ancestor
56614842|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
56614843|NCT00689949|Vitamins|vitamins|mesh-ancestor
56614844|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
56614845|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614846|NCT04256642|Morphine|morphine|mesh-list
56614847|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56271281|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
56186554|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186555|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56186556|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186557|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
56271282|NCT02002000|Vitamins|vitamins|mesh-ancestor
56271283|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
56271284|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271285|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56271286|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56271287|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
56271288|NCT02002039|Hematinics|hematinics|mesh-ancestor
56271321|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
56271322|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
56271323|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271324|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56271325|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271326|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271327|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
56271328|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271329|NCT02002195|Antidotes|antidotes|mesh-ancestor
56271330|NCT02002195|Protective Agents|protective agents|mesh-ancestor
56271331|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
56271332|NCT02002195|Vitamins|vitamins|mesh-ancestor
56271333|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
56271334|NCT02002247|Selenium|selenium|mesh-list
56271368|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271369|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271370|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56271371|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
56271372|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
56271373|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927531|NCT02912988|Letrozole|letrozole|mesh-list
55927532|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927533|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55927534|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55927535|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614848|NCT04256642|Narcotics|narcotics|mesh-ancestor
56614849|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614850|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614851|NCT04256642|Analgesics|analgesics|mesh-ancestor
56614852|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
56614853|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614854|NCT00611000|Folic Acid|folic acid|mesh-list
56614855|NCT00611000|Hematinics|hematinics|mesh-ancestor
56614856|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
56614857|NCT00611000|Vitamins|vitamins|mesh-ancestor
56614858|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
56271374|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56271400|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271401|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
56271402|NCT02002598|Dexamethasone|dexamethasone|mesh-list
56271403|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
56271404|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56271405|NCT02002598|BB 1101|bb 1101|mesh-list
56271406|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271407|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
56271408|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
56271409|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271410|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271411|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56271412|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
56271413|NCT02002598|Hormones|hormones|mesh-ancestor
56271414|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271415|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56271416|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271417|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
56271418|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271419|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271420|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56271421|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
56271458|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271459|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56271460|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
56271461|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
55846548|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56271487|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271488|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56271489|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56271490|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
56271491|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271492|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271493|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
56271494|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56271495|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56271496|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186558|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
56186559|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186560|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56186561|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56614859|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614860|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
56614861|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56614862|NCT00690105|Fluticasone|fluticasone|mesh-list
56614863|NCT00690105|Tacrolimus|tacrolimus|mesh-list
56614864|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56614865|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
56614866|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614867|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56614868|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614869|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614870|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56614871|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56614872|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
56614873|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614874|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56614875|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
56614876|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
56614877|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56614878|NCT00694317|Zaleplon|zaleplon|mesh-list
56614879|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
56614880|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56614881|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614882|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614883|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
56614885|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614886|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614887|NCT04136613|Copper|copper|mesh-list
56614888|NCT04136613|Trace Elements|trace elements|mesh-ancestor
56614889|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
56614890|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614891|NCT00978731|Dasatinib|dasatinib|mesh-list
55927549|NCT00876915|Dalteparin|dalteparin|mesh-list
56186562|NCT01437982|Protective Agents|protective agents|mesh-ancestor
56186563|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56186564|NCT01438021|Methotrexate|methotrexate|mesh-list
56186565|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56186566|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
56186567|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56186568|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186569|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56186570|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
56186571|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614892|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614893|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56614894|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614895|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614896|NCT04136535|Carboplatin|carboplatin|mesh-list
56614897|NCT04136535|Pemetrexed|pemetrexed|mesh-list
56614898|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614899|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186572|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186573|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
56186574|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186575|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56186576|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271497|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
56271498|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271499|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271500|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
56271501|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56271502|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56271503|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56271504|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56271505|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271506|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
56271507|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271508|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271509|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55846586|NCT01929031|Ibuprofen|ibuprofen|mesh-list
56271511|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
56271512|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56271513|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56271514|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271515|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
56271516|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271517|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271519|NCT02003209|Docetaxel|docetaxel|mesh-list
56271520|NCT02003209|Trastuzumab|trastuzumab|mesh-list
56271521|NCT02003209|Pertuzumab|pertuzumab|mesh-list
56271522|NCT02003209|Goserelin|goserelin|mesh-list
56271523|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56271524|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56271525|NCT02003209|Antibodies|antibodies|mesh-list
56271526|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
56271527|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56271528|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56271529|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
56271530|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271531|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271532|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271533|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
56271534|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
56186577|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
56186578|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56186579|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56186581|NCT01438086|Growth Substances|growth substances|mesh-ancestor
56186582|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186583|NCT01438112|Gemcitabine|gemcitabine|mesh-list
56186584|NCT01438112|Interferons|interferons|mesh-list
56186585|NCT01438112|Mitomycins|mitomycins|mesh-list
56186586|NCT01438112|Mitomycin|mitomycin|mesh-list
56186587|NCT01438112|Valrubicin|valrubicin|mesh-list
56186588|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56186589|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
56186590|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186591|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271535|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271536|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56271537|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56271538|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614900|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614901|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56614902|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56614903|NCT00694629|Rifampin|rifampin|mesh-list
56614904|NCT00694629|Rifapentine|rifapentine|mesh-list
56614905|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56614906|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
56614907|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56614908|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614909|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
56614910|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56614911|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614912|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614913|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56614914|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56614915|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56614916|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56614917|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56614918|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56614919|NCT00912639|Paclitaxel|paclitaxel|mesh-list
56614920|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56614921|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56614922|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
56614923|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
56614924|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
56614925|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614926|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
56614927|NCT02866409|Bupivacaine|bupivacaine|mesh-list
56614928|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
56614929|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
56614930|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614931|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614932|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
56271539|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56271540|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
56271541|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271542|NCT02003313|Vaccines|vaccines|mesh-list
56271543|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
56271544|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614933|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614934|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56614935|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56614936|NCT02866409|Analgesics|analgesics|mesh-ancestor
56614937|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56614938|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56614939|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56614940|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
56614941|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56614942|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614943|NCT00694863|Cosyntropin|cosyntropin|mesh-list
56614944|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
56614945|NCT00694863|Hormones|hormones|mesh-ancestor
56614946|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271545|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56271546|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56271547|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271548|NCT02003495|Vaccines|vaccines|mesh-list
56271549|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
56271550|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271551|NCT02003664|Baclofen|baclofen|mesh-list
56271552|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56271553|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271554|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56271555|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271556|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56271557|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
56271558|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
56271559|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271560|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271561|NCT02003677|Insulin|insulin|mesh-list
56271562|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56271563|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
56271564|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
56271565|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56271566|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56271567|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271568|NCT02003768|Propofol|propofol|mesh-list
56271569|NCT02003768|Desflurane|desflurane|mesh-list
56271570|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56271571|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271572|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271573|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56271574|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
56271576|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56271577|NCT02003885|Desflurane|desflurane|mesh-list
56271578|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56271579|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
56271580|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
56271581|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271582|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186592|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
56186593|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186594|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271583|NCT02004067|Cyclosporine|cyclosporine|mesh-list
56271584|NCT02004067|Castor Oil|castor oil|mesh-list
56271585|NCT02004067|Cyclosporins|cyclosporins|mesh-list
56271617|NCT02004197|Ranitidine|ranitidine|mesh-list
56271618|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56271619|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271620|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56614947|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614948|NCT00629213|Acarbose|acarbose|mesh-list
56614949|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56614950|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614951|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614953|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614954|NCT00978341|Pregabalin|pregabalin|mesh-list
56614955|NCT00978341|Analgesics|analgesics|mesh-ancestor
56614956|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
56614957|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614958|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614959|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
56614960|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56614961|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56614962|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56614963|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56614964|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56614965|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56614966|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56614967|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56614968|NCT00695331|Misoprostol|misoprostol|mesh-list
56614969|NCT00695331|Oxytocin|oxytocin|mesh-list
56614970|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
56614971|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56614972|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614973|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56614974|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
56614975|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56614976|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56614977|NCT00695643|Mesalamine|mesalamine|mesh-list
56614978|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55927626|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
56271621|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271622|NCT02004197|Antacids|antacids|mesh-ancestor
56271623|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56271624|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56271625|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56271626|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
56271627|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
56271628|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846712|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
56271651|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56271652|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
56614979|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56614980|NCT00695643|Analgesics|analgesics|mesh-ancestor
56614981|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
56614982|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56614983|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614984|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56614985|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56614986|NCT02623881|Progesterone|progesterone|mesh-list
56614987|NCT02623881|Progestins|progestins|mesh-ancestor
56614988|NCT02623881|Hormones|hormones|mesh-ancestor
56614989|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56614990|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56614991|NCT04135833|Itraconazole|itraconazole|mesh-list
56614992|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56614993|NCT04135833|Rifampin|rifampin|mesh-list
56614994|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
56614995|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56614996|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56614997|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56614998|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56614999|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615000|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56615001|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
56615002|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615003|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615004|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56615005|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56615006|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
56615007|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56615008|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
56615009|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56615010|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56271653|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271654|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56271655|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56271656|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
56271658|NCT02004574|Betamethasone|betamethasone|mesh-list
56271659|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
56271660|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56615011|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56615012|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56615013|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56615014|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56615015|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56615016|NCT00696033|Diazepam|diazepam|mesh-list
56615017|NCT00696033|Lorazepam|lorazepam|mesh-list
56615018|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
56615019|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
56615020|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
56615021|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615022|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615023|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56615024|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56615025|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615026|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56615027|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56615028|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56615029|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
56615030|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
56615031|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615032|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615033|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56615034|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56615035|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56615036|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56615037|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
56615038|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
56615039|NCT00696111|Leuprolide|leuprolide|mesh-list
56615040|NCT00696111|Progesterone|progesterone|mesh-list
56615041|NCT00696111|Estrogens|estrogens|mesh-list
56615056|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615057|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615058|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56615059|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56615060|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56615061|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615062|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615063|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615064|NCT00977561|Cisplatin|cisplatin|mesh-list
56615065|NCT00977561|Carboplatin|carboplatin|mesh-list
56615066|NCT00977561|Etoposide|etoposide|mesh-list
56615067|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
56615068|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615069|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56615070|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56615071|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56615072|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615073|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615074|NCT04291313|Vitamin D|vitamin d|mesh-list
56615075|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
56615076|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
56615077|NCT04291313|Vitamins|vitamins|mesh-list
56615078|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
56615079|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615080|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56615081|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56615082|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56615083|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56615084|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
56615085|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271661|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
56271662|NCT02004574|Calcipotriene|calcipotriene|mesh-list
56271663|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56271664|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271665|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
56271666|NCT02004574|Hormones|hormones|mesh-ancestor
56271667|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271668|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271669|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56271670|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
56271671|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
56271672|NCT02004652|Prucalopride|prucalopride|mesh-list
56271673|NCT02004652|Laxatives|laxatives|mesh-ancestor
56271674|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800127|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
56615086|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56615087|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56615088|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56615089|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56615090|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
56615091|NCT04049669|Temozolomide|temozolomide|mesh-list
56615092|NCT04049669|Lomustine|lomustine|mesh-list
56615093|NCT04049669|Etoposide|etoposide|mesh-list
56615094|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615095|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
56615096|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615097|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615098|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56615099|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
56615100|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615102|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56615103|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56615104|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56615105|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56615106|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615107|NCT00594165|Rotigotine|rotigotine|mesh-list
56615108|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
56615109|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
56615110|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615111|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615112|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615113|NCT00928070|Fesoterodine|fesoterodine|mesh-list
56615114|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56615115|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56615116|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
56615117|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615118|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615119|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615120|NCT00928070|Urological Agents|urological agents|mesh-ancestor
56615121|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
56271675|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56271676|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56271677|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
56271678|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615122|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56615123|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615124|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615125|NCT04001621|Capecitabine|capecitabine|mesh-list
56615126|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56615127|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
56615128|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615129|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615130|NCT00976937|Metformin|metformin|mesh-list
56615132|NCT00976937|Lixisenatide|lixisenatide|mesh-list
56615133|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56615134|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615135|NCT00976937|Incretins|incretins|mesh-ancestor
56615136|NCT00976937|Hormones|hormones|mesh-ancestor
56615137|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271679|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271680|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271681|NCT02004769|Docetaxel|docetaxel|mesh-list
56271682|NCT02004769|Capecitabine|capecitabine|mesh-list
56271683|NCT02004769|Trastuzumab|trastuzumab|mesh-list
56271706|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271707|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271708|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
56271709|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271710|NCT02004899|Fentanyl|fentanyl|mesh-list
56271711|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56271712|NCT02004899|Narcotics|narcotics|mesh-ancestor
56271713|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271714|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271715|NCT02004899|Analgesics|analgesics|mesh-ancestor
56271716|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
56271717|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271718|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56271719|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56271720|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
56271721|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
56271722|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56271723|NCT02005068|Cephalosporins|cephalosporins|mesh-list
56271724|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56271725|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271726|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56271727|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56271728|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56186595|NCT01438112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56186596|NCT01438112|Immunologic Factors|immunologic factors|mesh-ancestor
56186597|NCT01438112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271729|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56271730|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271731|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271732|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271733|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56271734|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
56271760|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56271762|NCT02005315|Paclitaxel|paclitaxel|mesh-list
56271763|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56271764|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271765|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271766|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
56271767|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56615138|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56615139|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
56615140|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615141|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615142|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
56615143|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56615144|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56615145|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615146|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615147|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615148|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615149|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56615150|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56615151|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56615152|NCT04256252|Rituximab|rituximab|mesh-list
56615153|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56615154|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615155|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
56615156|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615157|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615158|NCT02622555|Mirabegron|mirabegron|mesh-list
56615159|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56615160|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56615161|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56615162|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615163|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615164|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615165|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615166|NCT02622555|Urological Agents|urological agents|mesh-ancestor
56615167|NCT05329454|Ibuprofen|ibuprofen|mesh-list
56615168|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56615169|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56615170|NCT05329454|Analgesics|analgesics|mesh-ancestor
56615176|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56615177|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615178|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615179|NCT00629447|Tinzaparin|tinzaparin|mesh-list
56615180|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
56615181|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56615182|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56615183|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615184|NCT02622477|Pirfenidone|pirfenidone|mesh-list
56615185|NCT02622477|Analgesics|analgesics|mesh-ancestor
56615186|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
56615187|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615188|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615189|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56615190|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56615191|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56615192|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615193|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615194|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
56615195|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
56615196|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56615197|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
56615198|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615199|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615200|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56271768|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271769|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56271770|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
56271771|NCT02005315|Antiviral Agents|antiviral agents|mesh-ancestor
56271772|NCT02005315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271773|NCT02005315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271774|NCT02005315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271775|NCT02005315|Immunologic Factors|immunologic factors|mesh-ancestor
56271776|NCT02005315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271777|NCT02005419|Metformin|metformin|mesh-list
56271778|NCT02005419|Gemcitabine|gemcitabine|mesh-list
56271779|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56271780|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
56271781|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271782|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271783|NCT02005419|Antiviral Agents|antiviral agents|mesh-ancestor
56271784|NCT02005419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271785|NCT02005419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271800|NCT02005575|Dexamethasone|dexamethasone|mesh-list
56271802|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271803|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
56271804|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
56271805|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271806|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615201|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
56615202|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
56615203|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56615204|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
56615205|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615206|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615207|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56615208|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56615209|NCT04289675|Interferons|interferons|mesh-list
56615210|NCT04289675|Interferon-beta|interferon-beta|mesh-list
56615211|NCT04289675|Teriflunomide|teriflunomide|mesh-list
56615212|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56615213|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615214|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
56615215|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615216|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
56615217|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615218|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
56615219|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615220|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56615221|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56615222|NCT04289675|Analgesics|analgesics|mesh-ancestor
56615223|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
56615224|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615225|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56615226|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615227|NCT00696579|Gemcitabine|gemcitabine|mesh-list
56615228|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56615229|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
56271807|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56271808|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
56271809|NCT02005575|Hormones|hormones|mesh-ancestor
56271810|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271811|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56271812|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271813|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
56271814|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
56271815|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271816|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
56271817|NCT02005588|Iron|iron|mesh-list
56271818|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
56271819|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
56271820|NCT02005588|Trace Elements|trace elements|mesh-ancestor
56271821|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
56271822|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271823|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
56271824|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
56615230|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615231|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615232|NCT00696579|Antiviral Agents|antiviral agents|mesh-ancestor
56615233|NCT00696579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615234|NCT00696579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615235|NCT00696579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615236|NCT00696579|Immunologic Factors|immunologic factors|mesh-ancestor
56615237|NCT00696579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615238|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
56615239|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56615240|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
56615241|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615242|NCT02865629|Expectorants|expectorants|mesh-ancestor
56615243|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
56615244|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56271825|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271826|NCT02005653|Doxycycline|doxycycline|mesh-list
56271827|NCT02005653|Albendazole|albendazole|mesh-list
56271828|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
56271829|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56271830|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271831|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
56271832|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56271833|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56271834|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
56271835|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
56271836|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56271837|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271838|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
56271839|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
56186598|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56186599|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
56186600|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56186601|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56186602|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56186603|NCT01438190|Metformin|metformin|mesh-list
56271840|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271841|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271842|NCT02005653|Filaricides|filaricides|mesh-ancestor
56271843|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
56271844|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56271845|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271846|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
56271847|NCT02005718|Vitamin D|vitamin d|mesh-list
56271848|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56271849|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271880|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
56271881|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56271882|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56271883|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
56271884|NCT02005783|Docetaxel|docetaxel|mesh-list
56271885|NCT02005783|Epirubicin|epirubicin|mesh-list
56271886|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271887|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
56271888|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271889|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56271890|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56271891|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
56271892|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271893|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271894|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56615245|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
56615246|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615247|NCT02865629|Protective Agents|protective agents|mesh-ancestor
56615248|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615249|NCT02865629|Antidotes|antidotes|mesh-ancestor
56615250|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
56615251|NCT02867345|Interleukin-2|interleukin-2|mesh-list
56615252|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615253|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
56615254|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615255|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615256|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56615257|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
56271895|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271896|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
56271927|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56271928|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271929|NCT02006225|Plerixafor|plerixafor|mesh-list
56271930|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56271931|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56271932|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
56271933|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271934|NCT02006277|Crizotinib|crizotinib|mesh-list
56271935|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56271936|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271937|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56271938|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271939|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271971|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271972|NCT02006745|Ribavirin|ribavirin|mesh-list
56271973|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
56271974|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271975|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
56271976|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271977|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56271978|NCT02006849|Hormones|hormones|mesh-ancestor
56271979|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56272014|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272015|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56272017|NCT02007161|Diclofenac|diclofenac|mesh-list
56272018|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56272019|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56272052|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272053|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272054|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
56272055|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272056|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56272057|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56272058|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56186604|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56186605|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186606|NCT01438320|Quercetin|quercetin|mesh-list
56186607|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
56272081|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
56272082|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56272083|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272084|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272085|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56272086|NCT02007798|Analgesics|analgesics|mesh-ancestor
56272087|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
56615258|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615259|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615260|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56615261|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56615262|NCT02867345|Analgesics|analgesics|mesh-ancestor
56615263|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
56615264|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615265|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
56615266|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56615267|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
56615268|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615269|NCT00975689|Expectorants|expectorants|mesh-ancestor
56615270|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
56615271|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56615272|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
56615273|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615274|NCT00975689|Protective Agents|protective agents|mesh-ancestor
56272088|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272089|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56272090|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56272091|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56272092|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
56272093|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272094|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272095|NCT02007837|Aspirin|aspirin|mesh-list
56272096|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56272097|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56272099|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
56272100|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272101|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272102|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56272103|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56272104|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56272105|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56272106|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272107|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56272108|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56272109|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272110|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
56272111|NCT02007850|Ropivacaine|ropivacaine|mesh-list
56272112|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
56272147|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56272148|NCT02008006|Cytarabine|cytarabine|mesh-list
56272149|NCT02008006|Etoposide|etoposide|mesh-list
56272150|NCT02008006|Melphalan|melphalan|mesh-list
56272151|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55847239|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
56272187|NCT02008162|Bromides|bromides|mesh-list
56272188|NCT02008162|Albuterol|albuterol|mesh-list
56272189|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
56272211|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272212|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56272213|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
56272214|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56272215|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272216|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272217|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56272218|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56615275|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615276|NCT00975689|Antidotes|antidotes|mesh-ancestor
56615277|NCT02621385|Midazolam|midazolam|mesh-list
56615278|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56615279|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56615280|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615281|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615282|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56615283|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56615284|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56615285|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56615286|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
56272219|NCT02008214|Protective Agents|protective agents|mesh-ancestor
56272220|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272221|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
56272222|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56272223|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
56272224|NCT02008383|Panitumumab|panitumumab|mesh-list
56272225|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272226|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272227|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
56272228|NCT02008422|Tegafur|tegafur|mesh-list
56272229|NCT02008422|Endostar protein|endostar protein|mesh-list
56272230|NCT02008422|Endostatins|endostatins|mesh-list
56272231|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272232|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56272233|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
56272234|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272235|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56272236|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56272237|NCT02008422|Growth Substances|growth substances|mesh-ancestor
56272238|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186608|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186609|NCT01438320|Protective Agents|protective agents|mesh-ancestor
56186610|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186611|NCT05597085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56186612|NCT05597085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56186613|NCT05597085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186614|NCT05597085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56186615|NCT05563389|Atorvastatin|atorvastatin|mesh-list
56186616|NCT05563389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56186617|NCT05563389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56186618|NCT05563389|Antimetabolites|antimetabolites|mesh-ancestor
56186619|NCT05563389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186620|NCT05563389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56186621|NCT05563389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56186622|NCT05563389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186623|NCT05554393|Cytarabine|cytarabine|mesh-list
56272239|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
56272240|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
56272241|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56272242|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847314|NCT03825328|Gemcitabine|gemcitabine|mesh-list
56272266|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272267|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56272268|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
56272269|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56272270|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272271|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272272|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56272273|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
56272274|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56272276|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56615287|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
56615288|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
56615289|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
56615290|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615291|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615292|NCT00922766|Dalteparin|dalteparin|mesh-list
56615293|NCT00922766|Tinzaparin|tinzaparin|mesh-list
56615294|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56615295|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
56615296|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56615297|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56615298|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615299|NCT04134897|Capecitabine|capecitabine|mesh-list
56615300|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
56615301|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56272277|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56272278|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56272279|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
56272280|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272281|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56272282|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56272283|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272284|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56272285|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
56272286|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56272287|NCT02008968|Allopurinol|allopurinol|mesh-list
56272288|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
56272289|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272290|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272320|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
56272321|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
56272322|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272323|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272324|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
56272325|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56272326|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
56272327|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
56272328|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56272329|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56186625|NCT05554393|Daunorubicin|daunorubicin|mesh-list
56186626|NCT05554393|Venetoclax|venetoclax|mesh-list
56186627|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56186628|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
56272330|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56272331|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
56272332|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272333|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272334|NCT02009007|Protective Agents|protective agents|mesh-ancestor
56272335|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
56272336|NCT02009098|Cefuroxime|cefuroxime|mesh-list
56272337|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
55847418|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56272363|NCT05778838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272364|NCT05778838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272365|NCT05778825|Minoxidil|minoxidil|mesh-list
56272366|NCT05778825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56272367|NCT05778825|Vasodilator Agents|vasodilator agents|mesh-ancestor
56272368|NCT05778760|Vitamin A|vitamin a|mesh-list
56272369|NCT05778760|Vitamins|vitamins|mesh-ancestor
56272370|NCT05778760|Micronutrients|micronutrients|mesh-ancestor
56272371|NCT05778760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272372|NCT05778617|Ambroxol|ambroxol|mesh-list
56615302|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
56615303|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615304|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615305|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
56615306|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615307|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
56615308|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56615309|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56615310|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615311|NCT02620995|Urological Agents|urological agents|mesh-ancestor
56615312|NCT02620839|Cisplatin|cisplatin|mesh-list
56272373|NCT05778617|Expectorants|expectorants|mesh-ancestor
56272374|NCT05778617|Respiratory System Agents|respiratory system agents|mesh-ancestor
56272375|NCT05778591|Buprenorphine|buprenorphine|mesh-list
56272376|NCT05778591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56272377|NCT05778591|Narcotics|narcotics|mesh-ancestor
56272378|NCT05778591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272379|NCT05778591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272380|NCT05778591|Analgesics|analgesics|mesh-ancestor
56272381|NCT05778591|Sensory System Agents|sensory system agents|mesh-ancestor
56272382|NCT05778591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272383|NCT05778591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56272384|NCT05778461|N-Methylaspartate|n-methylaspartate|mesh-list
56272385|NCT05778461|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56272386|NCT05778461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56272387|NCT05778461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272388|NCT05778461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272389|NCT05778461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272425|NCT05778097|Androgens|androgens|mesh-list
56272426|NCT05778097|Hormones|hormones|mesh-ancestor
56272427|NCT05778097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56272428|NCT05778097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272429|NCT05778084|Empagliflozin|empagliflozin|mesh-list
56272463|NCT05777707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272464|NCT05777694|Anesthetics|anesthetics|mesh-list
56272465|NCT05777694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272466|NCT05777694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272467|NCT05777369|Prednisone|prednisone|mesh-list
56272468|NCT05777369|Cyclophosphamide|cyclophosphamide|mesh-list
56272469|NCT05777369|Rituximab|rituximab|mesh-list
56272470|NCT05777369|Vincristine|vincristine|mesh-list
56272471|NCT05777369|Mitoxantrone|mitoxantrone|mesh-list
56272492|NCT05777369|Analgesics|analgesics|mesh-ancestor
56272493|NCT05777369|Sensory System Agents|sensory system agents|mesh-ancestor
56272494|NCT05777369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272495|NCT05777369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56272496|NCT05777369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56272497|NCT05777369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272498|NCT05777278|Docetaxel|docetaxel|mesh-list
56272499|NCT05777278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272500|NCT05777278|Tubulin Modulators|tubulin modulators|mesh-ancestor
56272501|NCT05777278|Antimitotic Agents|antimitotic agents|mesh-ancestor
56272502|NCT05777278|Mitosis Modulators|mitosis modulators|mesh-ancestor
56272503|NCT05777278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272504|NCT05777122|Lidocaine|lidocaine|mesh-list
56272505|NCT05777122|Anesthetics, Local|anesthetics, local|mesh-ancestor
56272506|NCT05777122|Anesthetics|anesthetics|mesh-ancestor
56272507|NCT05777122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272508|NCT05777122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272509|NCT05777122|Sensory System Agents|sensory system agents|mesh-ancestor
56186629|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186630|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272510|NCT05777122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800132|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
56615313|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615314|NCT02620605|Cabergoline|cabergoline|mesh-list
56615315|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56615316|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56615317|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
56615318|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
56615319|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615320|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615321|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615322|NCT00976391|Insulin|insulin|mesh-list
56615323|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56615324|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
56615326|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
56615327|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56272511|NCT05777122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56272512|NCT05777122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56272513|NCT05777122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56272514|NCT05777122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272515|NCT05777122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272516|NCT05777109|Denosumab|denosumab|mesh-list
56272517|NCT05777109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56272518|NCT05777109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272519|NCT05753306|Cisplatin|cisplatin|mesh-list
56272520|NCT05753306|Docetaxel|docetaxel|mesh-list
56272521|NCT05753306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272522|NCT05753306|Tubulin Modulators|tubulin modulators|mesh-ancestor
56272523|NCT05753306|Antimitotic Agents|antimitotic agents|mesh-ancestor
56272524|NCT05753306|Mitosis Modulators|mitosis modulators|mesh-ancestor
56272550|NCT05717140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272551|NCT05717140|Immunologic Factors|immunologic factors|mesh-ancestor
56272552|NCT05717140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272553|NCT05708950|Pembrolizumab|pembrolizumab|mesh-list
56272554|NCT05708950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272555|NCT05708950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272556|NCT05707273|Cyclophosphamide|cyclophosphamide|mesh-list
56272557|NCT05707273|Fludarabine|fludarabine|mesh-list
56272558|NCT05707273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56272559|NCT05707273|Immunologic Factors|immunologic factors|mesh-ancestor
56272560|NCT05707273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272561|NCT05707273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56272562|NCT05707273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56272563|NCT05707273|Alkylating Agents|alkylating agents|mesh-ancestor
56272564|NCT05707273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272565|NCT05707273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272566|NCT05707273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56272567|NCT05706259|Vitamin D|vitamin d|mesh-list
56272568|NCT05706259|Ergocalciferols|ergocalciferols|mesh-list
56272569|NCT05706259|Cholecalciferol|cholecalciferol|mesh-list
56272570|NCT05706259|Vitamins|vitamins|mesh-list
56272571|NCT05706259|Micronutrients|micronutrients|mesh-ancestor
56272572|NCT05706259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272573|NCT05706259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55847659|NCT04390984|Gefitinib|gefitinib|mesh-list
56272602|NCT05632133|Lacosamide|lacosamide|mesh-list
56272604|NCT05632133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56272605|NCT05632133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56272606|NCT05632133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272607|NCT05632133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272609|NCT05624151|Dexmedetomidine|dexmedetomidine|mesh-list
56272610|NCT05624151|Bupivacaine|bupivacaine|mesh-list
56272611|NCT05624151|Anesthetics, Local|anesthetics, local|mesh-ancestor
56272612|NCT05624151|Anesthetics|anesthetics|mesh-ancestor
55800500|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
56615328|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615329|NCT00976391|Incretins|incretins|mesh-ancestor
56615330|NCT00976391|Hormones|hormones|mesh-ancestor
56615331|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615332|NCT04252664|Remdesivir|remdesivir|mesh-list
56615333|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
56615334|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615335|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
56615336|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615337|NCT00696969|Amphotericin B|amphotericin b|mesh-list
56615338|NCT00696969|Paromomycin|paromomycin|mesh-list
56615339|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56615340|NCT00696969|Miltefosine|miltefosine|mesh-list
56615341|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56615342|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
56615343|NCT00696969|Amebicides|amebicides|mesh-ancestor
56615344|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56615345|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56615346|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615347|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56615348|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
56615349|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615350|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56615351|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56615352|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
56615353|NCT04203680|Tryptophan|tryptophan|mesh-list
56615354|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56615355|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56615356|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
56615357|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56615359|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
56615360|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56615361|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615362|NCT02620293|Emollients|emollients|mesh-list
56615363|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
56615364|NCT02619981|Lidocaine|lidocaine|mesh-list
56615365|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
56615368|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615369|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
56615370|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615371|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56615372|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56615373|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56615374|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56615375|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615376|NCT04859660|Tamsulosin|tamsulosin|mesh-list
56615377|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56615378|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56615379|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56615380|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615381|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615382|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615383|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615384|NCT04859660|Urological Agents|urological agents|mesh-ancestor
56615385|NCT02619669|Letrozole|letrozole|mesh-list
56615386|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928024|NCT05360615|Empagliflozin|empagliflozin|mesh-list
56272613|NCT05624151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272614|NCT05624151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272615|NCT05624151|Sensory System Agents|sensory system agents|mesh-ancestor
56272616|NCT05624151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272617|NCT05624151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56272618|NCT05624151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56272619|NCT05624151|Analgesics|analgesics|mesh-ancestor
56272620|NCT05624151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55847712|NCT01891708|Bevacizumab|bevacizumab|mesh-list
56272646|NCT05597150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56272647|NCT05595460|Carboplatin|carboplatin|mesh-list
56272648|NCT05595460|Etoposide|etoposide|mesh-list
56272649|NCT05595460|Atezolizumab|atezolizumab|mesh-list
56272650|NCT05595460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272651|NCT05595460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56272652|NCT05595460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56272653|NCT05595460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56272654|NCT05595460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272655|NCT05595460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272656|NCT05592418|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56186631|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
56186632|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186633|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56272657|NCT05592418|Poly I-C|poly i-c|mesh-list
56272658|NCT05592418|Antiviral Agents|antiviral agents|mesh-ancestor
56272659|NCT05592418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272660|NCT05592418|Interferon Inducers|interferon inducers|mesh-ancestor
56272661|NCT05592418|Immunologic Factors|immunologic factors|mesh-ancestor
56272662|NCT05592418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272663|NCT05590468|Niacinamide|niacinamide|mesh-list
56272665|NCT05590468|Nicotinic Acids|nicotinic acids|mesh-list
56272666|NCT05590468|Vitamin B Complex|vitamin b complex|mesh-ancestor
56272667|NCT05590468|Vitamins|vitamins|mesh-ancestor
56272668|NCT05590468|Micronutrients|micronutrients|mesh-ancestor
56615387|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56615388|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56615389|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615390|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615391|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56615392|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
56615393|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615394|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615395|NCT03965117|Norepinephrine|norepinephrine|mesh-list
56615396|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56272669|NCT05590468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272670|NCT05590468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56272755|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
56272756|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
56272757|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272758|NCT05514197|Protective Agents|protective agents|mesh-ancestor
56272759|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272760|NCT05514197|Vitamins|vitamins|mesh-ancestor
56272761|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
56272762|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56272862|NCT05282121|Empagliflozin|empagliflozin|mesh-list
56272863|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56272864|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272865|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56272898|NCT05198830|Cisplatin|cisplatin|mesh-list
56272899|NCT05198830|Pemetrexed|pemetrexed|mesh-list
56272900|NCT05198830|Durvalumab|durvalumab|mesh-list
56272901|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
56272902|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56272903|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
56272904|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272905|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272906|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272907|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56272938|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
56272939|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
56272940|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56272941|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56272942|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56272943|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
56272944|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272945|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56272972|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56272973|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56272974|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272975|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272976|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56272977|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272978|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
56272979|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56272980|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56272981|NCT05103332|Diuretics|diuretics|mesh-ancestor
56272982|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
56272983|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56272984|NCT05091905|Ropivacaine|ropivacaine|mesh-list
56272985|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
56272986|NCT05091905|Anesthetics|anesthetics|mesh-list
56272987|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272988|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272989|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
56272990|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272991|NCT05087992|Bevacizumab|bevacizumab|mesh-list
56272992|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56615397|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56363917|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615398|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615399|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615400|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615401|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615402|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
56615403|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
56615404|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615405|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56615406|NCT00917462|Sorafenib|sorafenib|mesh-list
56615407|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615408|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56615409|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615410|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615411|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
56615412|NCT02619513|Ropivacaine|ropivacaine|mesh-list
56615413|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56615414|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615415|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615416|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56615417|NCT02619513|Analgesics|analgesics|mesh-ancestor
56615418|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
56615419|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615420|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56615421|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56615422|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56615423|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615424|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615425|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615427|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
56615428|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56615429|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56615430|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615431|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
56615433|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615434|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56615435|NCT00697125|Vaccines|vaccines|mesh-list
56615436|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
56615437|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615438|NCT03859427|Dexamethasone|dexamethasone|mesh-list
56615439|NCT03859427|Lenalidomide|lenalidomide|mesh-list
56615440|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56615441|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
56615442|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
56615443|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615444|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615445|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56615446|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
56615447|NCT03859427|Hormones|hormones|mesh-ancestor
56615448|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615449|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56615450|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615451|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
56615452|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56615453|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56615454|NCT03859427|Growth Substances|growth substances|mesh-ancestor
56615455|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
56615456|NCT04134273|Clindamycin|clindamycin|mesh-list
56615457|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
56615458|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
56615459|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56615460|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615461|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56615462|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615463|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615464|NCT03853187|Durvalumab|durvalumab|mesh-list
56615465|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56615466|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56615473|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615475|NCT03849443|Coagulants|coagulants|mesh-ancestor
56615476|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
56615477|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56615478|NCT00697281|Growth Substances|growth substances|mesh-ancestor
56615479|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615480|NCT00979901|Loratadine|loratadine|mesh-list
56615481|NCT00979901|Montelukast|montelukast|mesh-list
56615482|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56615483|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
56615484|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56615485|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
56615486|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615487|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615488|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56615489|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56615490|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615491|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
56615492|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56615493|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56615494|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56615495|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56615496|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
56615497|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
56615498|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615499|NCT02619201|Ondansetron|ondansetron|mesh-list
56615500|NCT02619201|Metoclopramide|metoclopramide|mesh-list
56615501|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
56615519|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
56615520|NCT00975611|Amantadine|amantadine|mesh-list
56615521|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56615522|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56615523|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
56615524|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615525|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
56615526|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615527|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615528|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615529|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56615530|NCT00975611|Analgesics|analgesics|mesh-ancestor
56615531|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
56615532|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615533|NCT02865005|Dapsone|dapsone|mesh-list
56615534|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615535|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
56615536|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56615537|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56615538|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56615539|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615540|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615541|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
56615542|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56615543|NCT02862977|Ketoprofen|ketoprofen|mesh-list
56615544|NCT02862977|Amitriptyline|amitriptyline|mesh-list
56615545|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
56615546|NCT02862977|Caffeine|caffeine|mesh-list
56615565|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
56615566|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56615567|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56615568|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56615569|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56615570|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615571|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56615572|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56615573|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56615574|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615575|NCT02864927|Vaccines|vaccines|mesh-list
56615576|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
56615577|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615578|NCT02618499|Oxytocin|oxytocin|mesh-list
56615579|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
56615580|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56615581|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615582|NCT04133961|Phenylephrine|phenylephrine|mesh-list
56615583|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
56615584|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56615585|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
56615586|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
56615587|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615588|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615589|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
56615590|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56615591|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
56615592|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
56615593|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56272993|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272994|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56273017|NCT05083169|Daratumumab|daratumumab|mesh-list
56186634|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
56186635|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186636|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186637|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56186638|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56186639|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56186640|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56186641|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
56186642|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56186643|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56186644|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186645|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186646|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186647|NCT05525013|Simvastatin|simvastatin|mesh-list
56615594|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56615595|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56615596|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615597|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615598|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615599|NCT04133961|Protective Agents|protective agents|mesh-ancestor
56615600|NCT02618733|Clopidogrel|clopidogrel|mesh-list
56615601|NCT02618733|Ticagrelor|ticagrelor|mesh-list
56615602|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56615603|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56615604|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56615605|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56615606|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
56615607|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186649|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56186650|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186651|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56186652|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56186653|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
56186654|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186655|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56186656|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56186657|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186658|NCT05511766|Allopurinol|allopurinol|mesh-list
56186659|NCT05511766|Atorvastatin|atorvastatin|mesh-list
56186660|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56186661|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56273018|NCT05083169|Pomalidomide|pomalidomide|mesh-list
56273019|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273020|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
56273021|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
56273022|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273023|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273024|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56273025|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
56273026|NCT05083169|Hormones|hormones|mesh-ancestor
56273027|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56273028|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56273029|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273030|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
56273031|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56273032|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56273033|NCT05083169|Growth Substances|growth substances|mesh-ancestor
56186665|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56186667|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
56186668|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56186670|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
56186671|NCT05511766|Protective Agents|protective agents|mesh-ancestor
56186672|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186673|NCT05465174|Nivolumab|nivolumab|mesh-list
56186674|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56186675|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186676|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56186677|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273034|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
56273035|NCT04983589|Pilocarpine|pilocarpine|mesh-list
56273036|NCT04983589|Miotics|miotics|mesh-ancestor
56273037|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
56273038|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273039|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615608|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615609|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615610|NCT00970307|Vaccines|vaccines|mesh-list
56615611|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56615612|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
56615613|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615614|NCT00917384|Ramucirumab|ramucirumab|mesh-list
56615615|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615616|NCT04133571|Lidocaine|lidocaine|mesh-list
56615617|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
56615618|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
56615619|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615620|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615621|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
56615622|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615623|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56615624|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56615625|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56615626|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56615627|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615628|NCT00629681|Pregabalin|pregabalin|mesh-list
56615629|NCT00629681|Analgesics|analgesics|mesh-ancestor
56615630|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
56615631|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615632|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615633|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
56615634|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56615635|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56615636|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615637|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56615644|NCT02617485|Rituximab|rituximab|mesh-list
56615650|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615651|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56615652|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
56615653|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615654|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615655|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56615656|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56615657|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56273040|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56273041|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56273042|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
56273043|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273044|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273045|NCT04978493|Ustekinumab|ustekinumab|mesh-list
56273046|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
56273047|NCT04975334|Naloxone|naloxone|mesh-list
56273048|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56273084|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273086|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273087|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273088|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
56273089|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56273125|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56273126|NCT04777357|Cariprazine|cariprazine|mesh-list
56273160|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
56273161|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
56273162|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273163|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273164|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273205|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273206|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273207|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56273208|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56273209|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55895219|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
56273225|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56273226|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273227|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186682|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
56186683|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186684|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56186685|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56186686|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
56186687|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186688|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186689|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56186690|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56186691|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
56186692|NCT05387525|Diclofenac|diclofenac|mesh-list
56186693|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
56186694|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56186695|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56186696|NCT05387525|Analgesics|analgesics|mesh-ancestor
56186697|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
56186698|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186699|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186700|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56186701|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56186702|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56186703|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186704|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186705|NCT05382312|Bedaquiline|bedaquiline|mesh-list
56186706|NCT05382312|GSK656|gsk656|mesh-list
56615658|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56615659|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56615660|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615661|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56615662|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
56615663|NCT02617485|Hormones|hormones|mesh-ancestor
56615664|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615665|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56615666|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56615667|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
56615668|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
56615669|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
56615670|NCT04289207|Danazol|danazol|mesh-list
56615671|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56615672|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
56615673|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615674|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615675|NCT02863835|Albuterol|albuterol|mesh-list
56615676|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56615677|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
56615678|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615679|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615680|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56615681|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
56615682|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
56615683|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56615684|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56615685|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56615686|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56615687|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615688|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615689|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615690|NCT00697437|Ketoconazole|ketoconazole|mesh-list
56615691|NCT00697437|Docetaxel|docetaxel|mesh-list
56615696|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615697|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
56615698|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615699|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56615700|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56615701|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615702|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56615703|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
56615704|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615705|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615706|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56615707|NCT04252274|Darunavir|darunavir|mesh-list
56615708|NCT04252274|Cobicistat|cobicistat|mesh-list
56615709|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56615710|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56615711|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56615712|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
56615713|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615714|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615715|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56615716|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56615717|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
56615718|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615719|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56615720|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56615721|NCT04833140|Estradiol|estradiol|mesh-list
56615722|NCT04833140|Estrogens|estrogens|mesh-ancestor
56615723|NCT04833140|Hormones|hormones|mesh-ancestor
56615724|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56615725|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615726|NCT00864513|Pemetrexed|pemetrexed|mesh-list
56615727|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615728|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186707|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
56186708|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56273229|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56273230|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
56273231|NCT04558281|Ropivacaine|ropivacaine|mesh-list
56273232|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
56615729|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615730|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56615731|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56615732|NCT04128891|Valsartan|valsartan|mesh-list
56615733|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56615734|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56615735|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56615736|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56615737|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615738|NCT04251962|Fentanyl|fentanyl|mesh-list
56615739|NCT04251962|Bupivacaine|bupivacaine|mesh-list
56615740|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
56615741|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
56615742|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615743|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615744|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
56615745|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615746|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56615747|NCT04251962|Narcotics|narcotics|mesh-ancestor
56615748|NCT04251962|Analgesics|analgesics|mesh-ancestor
56273233|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
56273234|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56273235|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273236|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
56273237|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186741|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186742|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56186743|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186744|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186745|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
56186746|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56186748|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56186749|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
56186750|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
56186751|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56186752|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273298|NCT04522973|Ethanol|ethanol|mesh-list
56273299|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56273300|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273301|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895301|NCT03248544|Vitamin D|vitamin d|mesh-list
56273302|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273303|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56273304|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
56273305|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56273306|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56273307|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56273308|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56273309|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273310|NCT04495855|Dienogest|dienogest|mesh-list
56273311|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56273312|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
56615749|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56615750|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56615751|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
56615752|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
56615753|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56615754|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615755|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56615756|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615757|NCT04250948|Capecitabine|capecitabine|mesh-list
56615758|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
56615759|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56615760|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
56615761|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615762|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615763|NCT05251766|Paclitaxel|paclitaxel|mesh-list
56615764|NCT05251766|Docetaxel|docetaxel|mesh-list
56615765|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56615766|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615767|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
56615768|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
56615769|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
56615770|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615771|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
56615772|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56615773|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615774|NCT00631514|Acetaminophen|acetaminophen|mesh-list
56615775|NCT00631514|Ibuprofen|ibuprofen|mesh-list
56615776|NCT00631514|Piroxicam|piroxicam|mesh-list
56615777|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56615778|NCT00631514|Analgesics|analgesics|mesh-ancestor
56615779|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
56615780|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615781|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273313|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56273314|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273315|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56186753|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
56186754|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56186755|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56186756|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273316|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56273317|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55801014|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56615782|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
56615783|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56615784|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56615785|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615786|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56615787|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615788|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615789|NCT04623944|Cytarabine|cytarabine|mesh-list
56615790|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
56615791|NCT04623944|Fludarabine|fludarabine|mesh-list
56615792|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615793|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
56615794|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615795|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615796|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56615797|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
56615798|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615799|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615800|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56615801|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56615802|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
56615803|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
56615804|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615805|NCT05253014|Acetaminophen|acetaminophen|mesh-list
56615806|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56615807|NCT05253014|Analgesics|analgesics|mesh-ancestor
56615808|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
56615809|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615810|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615811|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
56615812|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
56615813|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615814|NCT00656851|Pioglitazone|pioglitazone|mesh-list
56615824|NCT00656617|Vorinostat|vorinostat|mesh-list
56615825|NCT00656617|Idarubicin|idarubicin|mesh-list
56615826|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56615827|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
56615828|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615829|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615830|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
56615831|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615832|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615833|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
56615834|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273318|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56273319|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
56273320|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56273321|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56273322|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273323|NCT04468984|Navitoclax|navitoclax|mesh-list
56273324|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273325|NCT04461587|Pirfenidone|pirfenidone|mesh-list
56273326|NCT04461587|Analgesics|analgesics|mesh-ancestor
56273327|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
56273328|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273354|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56273355|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
56273356|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273357|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273358|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
56273359|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56273360|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56273361|NCT04298567|Analgesics|analgesics|mesh-ancestor
56273362|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
56273363|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273364|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273365|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273366|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273367|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56273368|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56273369|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56273370|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56273371|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
56273372|NCT04278833|Dexamethasone|dexamethasone|mesh-list
56273373|NCT04278833|Triamcinolone|triamcinolone|mesh-list
55895375|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56273374|NCT04278833|Betamethasone|betamethasone|mesh-list
56273375|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273376|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
56273407|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56273408|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56273409|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56273410|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273411|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56273412|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
56273413|NCT04229004|Antiviral Agents|antiviral agents|mesh-ancestor
56273414|NCT04229004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273415|NCT04229004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273416|NCT04229004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273417|NCT04229004|Immunologic Factors|immunologic factors|mesh-ancestor
56273418|NCT04229004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273419|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56273420|NCT04226690|Dronabinol|dronabinol|mesh-list
56273421|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
56273454|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56273455|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273456|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
56273457|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615835|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56615836|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615837|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56615838|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56615839|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56615840|NCT00798343|Vaccines|vaccines|mesh-list
56615841|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
56615842|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615843|NCT00803725|Fentanyl|fentanyl|mesh-list
56615844|NCT00803725|Mepivacaine|mepivacaine|mesh-list
56615845|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56615846|NCT00803725|Narcotics|narcotics|mesh-ancestor
56615847|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615848|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615849|NCT00803725|Analgesics|analgesics|mesh-ancestor
56615850|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
56615851|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615853|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56615854|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
56273458|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
56273459|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273460|NCT04170348|Vitamin D|vitamin d|mesh-list
56273461|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
56273462|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
56273463|NCT04170348|Vitamins|vitamins|mesh-list
56273494|NCT04086485|Olaparib|olaparib|mesh-list
56273495|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56273496|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273497|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273498|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273499|NCT04062591|Piroxicam|piroxicam|mesh-list
56186757|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56186759|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
56186760|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186761|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56186762|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56186763|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56186764|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
56186765|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186766|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186767|NCT05164159|Propofol|propofol|mesh-list
56186768|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56186769|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56186770|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186771|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56186772|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
56186773|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
56186774|NCT05164146|Propofol|propofol|mesh-list
56186775|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56186776|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56186777|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186778|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56186779|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
56186780|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
56186781|NCT05153070|Cyclosporine|cyclosporine|mesh-list
56186782|NCT05153070|Cyclosporins|cyclosporins|mesh-list
56186783|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801015|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56615855|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
56615856|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
56615857|NCT00803803|Pilocarpine|pilocarpine|mesh-list
56615858|NCT00803803|Miotics|miotics|mesh-ancestor
56615859|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
56615860|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615861|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615862|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56615863|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56615864|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
56615865|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615866|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615867|NCT04775329|Rifaximin|rifaximin|mesh-list
56615868|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56615869|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615870|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56615871|NCT00659269|Vitamins|vitamins|mesh-list
56615872|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
56615873|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
56615874|NCT00659269|Pyridoxal|pyridoxal|mesh-list
56615875|NCT00659269|Pyridoxine|pyridoxine|mesh-list
56615876|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
56615877|NCT00659269|Vincristine|vincristine|mesh-list
56615878|NCT00659269|Vinorelbine|vinorelbine|mesh-list
56615879|NCT00659269|Docetaxel|docetaxel|mesh-list
56615880|NCT00659269|Cisplatin|cisplatin|mesh-list
56615881|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
56615882|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56615883|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615884|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
56615885|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
56615886|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
56615887|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615888|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
56615889|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615890|NCT00922129|Cyclosporine|cyclosporine|mesh-list
56615891|NCT00922129|Sirolimus|sirolimus|mesh-list
56615892|NCT00922129|Tacrolimus|tacrolimus|mesh-list
56615893|NCT00922129|Cyclosporins|cyclosporins|mesh-list
56615894|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615895|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
56615896|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615897|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56615898|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56615899|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615900|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
56615901|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615902|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
56615903|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56615904|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56615905|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56615906|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615907|NCT00806299|Loperamide|loperamide|mesh-list
56615908|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
56615909|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56186784|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186785|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273500|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56273501|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56273502|NCT04062591|Analgesics|analgesics|mesh-ancestor
56273503|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
56273504|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273505|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273506|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273507|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273508|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56273509|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273545|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273546|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56273577|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
56273578|NCT03994731|Hormones|hormones|mesh-ancestor
56273579|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186786|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
56186787|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114537|NCT00000605|Hormones|hormones|mesh-list
56186788|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
56186789|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186790|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
56273580|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56273581|NCT03994731|Protective Agents|protective agents|mesh-ancestor
56273582|NCT03994731|Hematinics|hematinics|mesh-ancestor
56273583|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
56273584|NCT03994731|Vitamins|vitamins|mesh-ancestor
56273585|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
56273586|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56273587|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56273588|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56273589|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
56273590|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
56273591|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273592|NCT03984357|Gemcitabine|gemcitabine|mesh-list
56273593|NCT03984357|Antibodies|antibodies|mesh-list
56273594|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
56273595|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
56273596|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273597|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273633|NCT03824522|BAX 855|bax 855|mesh-list
56273634|NCT03824522|Coagulants|coagulants|mesh-ancestor
56273635|NCT03812991|Calcitonin|calcitonin|mesh-list
56273636|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
56273637|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56273638|NCT03812991|Katacalcin|katacalcin|mesh-list
56273639|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56615910|NCT00804115|Timolol|timolol|mesh-list
56615911|NCT00804115|Latanoprost|latanoprost|mesh-list
56615912|NCT00804115|Pilocarpine|pilocarpine|mesh-list
56615913|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56615914|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56615915|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
56615916|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615917|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615918|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615919|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56615920|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56615921|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56273640|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273664|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
56273665|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56273666|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
56273667|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273668|NCT03652753|Protective Agents|protective agents|mesh-ancestor
56273669|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273670|NCT03652753|Antidotes|antidotes|mesh-ancestor
56273672|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56273673|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273674|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56273675|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56273676|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56273677|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273678|NCT03556202|Mirikizumab|mirikizumab|mesh-list
56273679|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56273680|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56273681|NCT03556202|Analgesics|analgesics|mesh-ancestor
56273682|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
56273683|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273684|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273685|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273686|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273687|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56273688|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56273689|NCT03480438|Blinatumomab|blinatumomab|mesh-list
56273690|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273691|NCT03463876|Apatinib|apatinib|mesh-list
56273692|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848783|NCT01452334|BMS-936559|bms-936559|mesh-list
56273726|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273727|NCT03429543|Incretins|incretins|mesh-ancestor
56273728|NCT03429543|Hormones|hormones|mesh-ancestor
56273729|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56273730|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56273763|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56273765|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273766|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56273767|NCT03350451|Lumasiran|lumasiran|mesh-list
56273768|NCT03350451|Renal Agents|renal agents|mesh-ancestor
56273769|NCT03329508|Pramipexole|pramipexole|mesh-list
56186791|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56186797|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
56186798|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186799|NCT05129748|Antidotes|antidotes|mesh-ancestor
56186800|NCT05129748|Protective Agents|protective agents|mesh-ancestor
56186801|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
56186802|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186803|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
56186804|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56273770|NCT03329508|Rasagiline|rasagiline|mesh-list
56615922|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56615923|NCT00804115|Miotics|miotics|mesh-ancestor
56615924|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
56615925|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615927|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56615928|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
56615929|NCT02554123|Vitamin E|vitamin e|mesh-list
56615930|NCT02554123|Petrolatum|petrolatum|mesh-list
56615931|NCT02554123|Vitamins|vitamins|mesh-ancestor
56615932|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
56615933|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615934|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
56615935|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615936|NCT02554123|Protective Agents|protective agents|mesh-ancestor
56615937|NCT02554123|Emollients|emollients|mesh-ancestor
56615938|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
56615939|NCT00799045|Clopidogrel|clopidogrel|mesh-list
56615940|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56615941|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56615942|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56615943|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56615944|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
56615945|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56615946|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615947|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615948|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
56615949|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56615950|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615951|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56615952|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
56615953|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56615957|NCT00804271|Memantine|memantine|mesh-list
56615966|NCT00799201|Naloxone|naloxone|mesh-list
56615967|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56615968|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615969|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
56615970|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56615971|NCT00806611|Ethanol|ethanol|mesh-list
56615972|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56615973|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56615974|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56615975|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615976|NCT00799513|Lenalidomide|lenalidomide|mesh-list
56615977|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
56615978|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615979|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56615980|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56615981|NCT00799513|Growth Substances|growth substances|mesh-ancestor
56615982|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
56615983|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615984|NCT00806767|Fludarabine|fludarabine|mesh-list
56615985|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
56615986|NCT00806767|Busulfan|busulfan|mesh-list
56615987|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
56615988|NCT00806767|Antibodies|antibodies|mesh-list
56615989|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
56615990|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56615991|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56615992|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56615993|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56615994|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
56273771|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
56273772|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273773|NCT03329508|Protective Agents|protective agents|mesh-ancestor
56273774|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273804|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56273805|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
56273806|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56273807|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273808|NCT03281304|Tofacitinib|tofacitinib|mesh-list
56273809|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56273810|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273811|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273812|NCT03233711|Nivolumab|nivolumab|mesh-list
56273813|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273814|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273815|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56273816|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615995|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56615996|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56615997|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
56615998|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56615999|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
56616000|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56616001|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56616002|NCT00863655|Everolimus|everolimus|mesh-list
56616003|NCT00863655|Exemestane|exemestane|mesh-list
56616004|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616005|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616006|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
56616007|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616008|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56616009|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56616010|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616011|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616012|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56616013|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
56616014|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616015|NCT00806923|Gemcitabine|gemcitabine|mesh-list
56616016|NCT00806923|Bevacizumab|bevacizumab|mesh-list
56616017|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56616018|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616019|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56616020|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56616021|NCT00806923|Growth Substances|growth substances|mesh-ancestor
56616022|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616023|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
56616024|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56616025|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
56616026|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616027|NCT00806923|Antiviral Agents|antiviral agents|mesh-ancestor
56616028|NCT00806923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616034|NCT00698607|Clopidogrel|clopidogrel|mesh-list
56616035|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616036|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616037|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
56616038|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616039|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56616040|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56616041|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56616042|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56616043|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
56616044|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616045|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616046|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56616047|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616048|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56616049|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
56616050|NCT04124757|Rocuronium|rocuronium|mesh-list
56616051|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56616052|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56616053|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56616054|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616055|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616056|NCT04123041|Nicotine|nicotine|mesh-list
56616057|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56616058|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
56616059|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616060|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616061|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56616062|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56616063|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
56616064|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616066|NCT00698763|Simendan|simendan|mesh-list
56616074|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616075|NCT00804895|Cortivazol|cortivazol|mesh-list
56616076|NCT00804895|Verapamil|verapamil|mesh-list
56616077|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56616078|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56616079|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616080|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616081|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56616082|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616083|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
56616084|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56616085|NCT00800137|Heparin|heparin|mesh-list
56616086|NCT00800137|Calcium heparin|calcium heparin|mesh-list
56616087|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56616088|NCT00800137|Tinzaparin|tinzaparin|mesh-list
56616089|NCT00800137|Dalteparin|dalteparin|mesh-list
56616090|NCT00800137|Warfarin|warfarin|mesh-list
56616091|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
56616092|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56616093|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56616094|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616095|NCT00807079|Carboplatin|carboplatin|mesh-list
56616096|NCT00807079|Topotecan|topotecan|mesh-list
56616097|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616098|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56616099|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56616100|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616101|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616102|NCT00800215|Lacosamide|lacosamide|mesh-list
56616103|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
56616104|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56616105|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56616106|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616107|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616108|NCT00800293|Betamethasone|betamethasone|mesh-list
56616109|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
56616113|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56616114|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
56616115|NCT00800293|Hormones|hormones|mesh-ancestor
56616116|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616117|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616118|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56616119|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
56616120|NCT00658021|Exenatide|exenatide|mesh-list
56616121|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56616122|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616123|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56616124|NCT00658021|Incretins|incretins|mesh-ancestor
56616125|NCT00658021|Hormones|hormones|mesh-ancestor
56616126|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616127|NCT00920816|Sorafenib|sorafenib|mesh-list
56616128|NCT00920816|Axitinib|axitinib|mesh-list
56616129|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616130|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56616131|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616132|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616133|NCT00631592|Dolutegravir|dolutegravir|mesh-list
56616134|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56616135|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56616136|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616137|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616138|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56616139|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56616140|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
56616141|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616142|NCT05251610|Propranolol|propranolol|mesh-list
56616143|NCT05251610|Oxytocin|oxytocin|mesh-list
56616144|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
56616145|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56616146|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616147|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56616148|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56616152|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56616153|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56616154|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
56616156|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56616157|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
56616158|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616159|NCT00657553|Bortezomib|bortezomib|mesh-list
56616160|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616161|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
56616162|NCT04253912|Povidone|povidone|mesh-list
56616163|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
56616164|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
56616165|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56616166|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616167|NCT00800527|Diclofenac|diclofenac|mesh-list
56616168|NCT00800527|Gabapentin|gabapentin|mesh-list
56616169|NCT00800527|Analgesics|analgesics|mesh-ancestor
56616170|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
55928792|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
56273894|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
56273895|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273896|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55848994|NCT04390594|Analgesics|analgesics|mesh-ancestor
56273924|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273926|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56273927|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
56273928|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
56273929|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56273930|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56273931|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56273932|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
56273933|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273934|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273935|NCT02725060|Protective Agents|protective agents|mesh-ancestor
56273936|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56273937|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56273938|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56273939|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
56273940|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
56273941|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273942|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273967|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186805|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186806|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
56273969|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56273970|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56273971|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273972|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56273973|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56273974|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56273975|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273976|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
56273977|NCT02432963|Vaccines|vaccines|mesh-list
56273978|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
56273979|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273980|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273981|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273982|NCT02358538|Ganaxolone|ganaxolone|mesh-list
56616171|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616172|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616173|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
56616174|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56616175|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56616176|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616177|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56616178|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56616179|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56616180|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616181|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616182|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
56616183|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56616184|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616185|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56616186|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616187|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56616188|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616189|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56616190|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55895970|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
56273983|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
56273984|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273985|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273986|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273987|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
56273988|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
56273989|NCT02349906|Treosulfan|treosulfan|mesh-list
56273990|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56273991|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
56273992|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274024|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274026|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56274027|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274028|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274029|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56274030|NCT02157883|Itraconazole|itraconazole|mesh-list
56274031|NCT02157883|Osimertinib|osimertinib|mesh-list
56274032|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
56274033|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274034|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56274035|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56274036|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274037|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274038|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56274040|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274041|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274042|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56274043|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274044|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56274045|NCT02087826|Metformin|metformin|mesh-list
56616191|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616192|NCT00862719|Incretins|incretins|mesh-ancestor
56616193|NCT00862719|Hormones|hormones|mesh-ancestor
56616194|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616195|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56616196|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
56616197|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616198|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616199|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
56616200|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616201|NCT00862641|Regadenoson|regadenoson|mesh-list
56616202|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56616203|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56274046|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56274047|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274048|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
56274049|NCT02048813|Rituximab|rituximab|mesh-list
56274050|NCT02048813|Fludarabine|fludarabine|mesh-list
56274051|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
56274052|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56274053|NCT02048813|Antibodies|antibodies|mesh-list
56274054|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
56274055|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56274056|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274057|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
56274058|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274059|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56274060|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56274061|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
56274062|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274063|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274064|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56274065|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56274066|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
56274067|NCT02048150|Antibodies|antibodies|mesh-list
56274068|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56274069|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
56186808|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
56186809|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56186810|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274070|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274071|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56274072|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
56274073|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56274074|NCT02038452|Prednisolone|prednisolone|mesh-list
56274075|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
56274076|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56274077|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
56274078|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56274079|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
56274080|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
56274081|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274082|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274083|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274084|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
56274085|NCT02038452|Hormones|hormones|mesh-ancestor
56274086|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274088|NCT02038452|Protective Agents|protective agents|mesh-ancestor
56274089|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56274090|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274091|NCT01933932|Docetaxel|docetaxel|mesh-list
56274092|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616204|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
56616205|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
56616206|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616207|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616208|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616209|NCT04119921|Ketorolac|ketorolac|mesh-list
56616210|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56616211|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
56616212|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56616213|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616214|NCT04119921|Analgesics|analgesics|mesh-ancestor
56616215|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
56616216|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616217|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616218|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56616219|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616220|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56616221|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616222|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616223|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56616224|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56616225|NCT00861471|Docetaxel|docetaxel|mesh-list
56616226|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
56616227|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616228|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
56274093|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
56274094|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
56274095|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
56274096|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274097|NCT01898494|Cisplatin|cisplatin|mesh-list
56274098|NCT01898494|Carboplatin|carboplatin|mesh-list
56274099|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274100|NCT01748448|Vitamin D|vitamin d|mesh-list
56274101|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
56274102|NCT01748448|Vitamins|vitamins|mesh-ancestor
56274103|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
56274104|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274105|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56274106|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56274107|NCT01476839|Cytarabine|cytarabine|mesh-list
56274108|NCT01476839|Etoposide|etoposide|mesh-list
56274109|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
56274110|NCT01476839|Melphalan|melphalan|mesh-list
56274111|NCT01476839|Carmustine|carmustine|mesh-list
56274112|NCT01476839|Basiliximab|basiliximab|mesh-list
55849172|NCT02543944|Clonidine|clonidine|mesh-list
56274145|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
56274146|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274147|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274148|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
56274149|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616229|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
56616230|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
56616231|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616232|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56616233|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616234|NCT02613585|Permethrin|permethrin|mesh-list
56616235|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616236|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616237|NCT04119297|Heparinoids|heparinoids|mesh-list
56616238|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56616239|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
56616240|NCT00699387|Benzonidazole|benzonidazole|mesh-list
56616241|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616242|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
56616243|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616244|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56616245|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56616246|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56616247|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616248|NCT00699465|Enoxaparin|enoxaparin|mesh-list
56616249|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
56616250|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
56616251|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56616252|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56616253|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616254|NCT00858117|Rituximab|rituximab|mesh-list
56616255|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
56616256|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56616257|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616258|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
56616259|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274150|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56274151|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274152|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56274153|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274154|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56274155|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
56274156|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56274182|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56274184|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
56274185|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274186|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56274187|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56274188|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
56616260|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616261|NCT00700947|Metoprolol|metoprolol|mesh-list
56616262|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56616263|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56616264|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
56616265|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616266|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616267|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616268|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56616269|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56616270|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
56616271|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
56616272|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616273|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56616274|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56616275|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
56616276|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616277|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
56616278|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616279|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
56616280|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
56616281|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
56616282|NCT00805519|Chloroquine|chloroquine|mesh-list
56616283|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56616284|NCT00805519|Prednisolone|prednisolone|mesh-list
56616285|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56616286|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
56616287|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56616288|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
56616289|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56616290|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
56616291|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56616293|NCT00805519|Hormones|hormones|mesh-ancestor
56616301|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56616302|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56616303|NCT00805519|Protective Agents|protective agents|mesh-ancestor
56616304|NCT00805519|Amebicides|amebicides|mesh-ancestor
56616305|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56616306|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56616307|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616308|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
56616309|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616310|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56616311|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616312|NCT00805519|Analgesics|analgesics|mesh-ancestor
56616313|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
56616314|NCT00805519|Filaricides|filaricides|mesh-ancestor
55928943|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
56274189|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274190|NCT00863369|Antiviral Agents|antiviral agents|mesh-ancestor
56274191|NCT00863369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274192|NCT00863369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274193|NCT00863369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274194|NCT00862433|Vitamins|vitamins|mesh-list
56274195|NCT00862433|Vitamin E|vitamin e|mesh-list
56274196|NCT00862433|Tocopherols|tocopherols|mesh-list
56186811|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186812|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56186813|NCT05111431|Analgesics|analgesics|mesh-ancestor
56186814|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
56186815|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186816|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56186817|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56186818|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56186819|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
56186820|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186821|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186823|NCT05060731|Trace Elements|trace elements|mesh-ancestor
56186824|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
56186825|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186826|NCT04965298|Lansoprazole|lansoprazole|mesh-list
56186827|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
56186828|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56186829|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274197|NCT00862433|Tocotrienols|tocotrienols|mesh-list
56274198|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
56274199|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
56274200|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274201|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
56274202|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274203|NCT00862433|Protective Agents|protective agents|mesh-ancestor
56274204|NCT00600496|Sirolimus|sirolimus|mesh-list
56274205|NCT00600496|Docetaxel|docetaxel|mesh-list
56274206|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56274207|NCT00600496|Dacarbazine|dacarbazine|mesh-list
56274208|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849301|NCT02514382|Bortezomib|bortezomib|mesh-list
56274239|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274240|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56274241|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56274242|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56274243|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274244|NCT00203996|Pioglitazone|pioglitazone|mesh-list
56274245|NCT00203996|Leuprolide|leuprolide|mesh-list
56274246|NCT00203996|Estrogens|estrogens|mesh-list
56274247|NCT00203996|Progestins|progestins|mesh-list
56274248|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55807369|NCT02532283|Oseltamivir|oseltamivir|mesh-list
56616315|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
56616316|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
56616317|NCT00592683|Aripiprazole|aripiprazole|mesh-list
56616318|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
56616319|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56616320|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56616321|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56616322|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616323|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616324|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
56616325|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
56274249|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274250|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56274251|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
56274252|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56274277|NCT00092222|Bortezomib|bortezomib|mesh-list
56274278|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274279|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
56274280|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274281|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56274282|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56274283|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
56274284|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274285|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274286|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56274287|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56186830|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56186831|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186832|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274288|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56274289|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56274290|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56274291|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274292|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56274295|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274296|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56274297|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56274298|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
56274299|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274300|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
56274301|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
56274302|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
56274303|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56274304|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
56274305|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
56274306|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56274334|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56274335|NCT02009306|Fentanyl|fentanyl|mesh-list
56274336|NCT02009306|Midazolam|midazolam|mesh-list
56274337|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56274338|NCT02009306|Narcotics|narcotics|mesh-ancestor
56274339|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274340|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274341|NCT02009306|Analgesics|analgesics|mesh-ancestor
56274342|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
56274343|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274344|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56274345|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56274346|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
56274347|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
56274348|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56274349|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56274350|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56274351|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56616326|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616327|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616328|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56616329|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56616330|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
56616331|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56616332|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56616333|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56616334|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56616335|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
56616336|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
56616337|NCT02613039|Estrogens|estrogens|mesh-list
56616338|NCT02613039|Progestins|progestins|mesh-list
56616339|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56616340|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616341|NCT02613039|Hormones|hormones|mesh-ancestor
56616342|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616343|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56616344|NCT00813475|Insulin|insulin|mesh-list
56616345|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56616346|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56616347|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616348|NCT00701259|Lansoprazole|lansoprazole|mesh-list
56616349|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
56616350|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56616351|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56616352|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56616353|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616354|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616355|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56616356|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56616357|NCT00701337|Estradiol|estradiol|mesh-list
56616358|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56616359|NCT00701337|Estrogens|estrogens|mesh-ancestor
56616366|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56616367|NCT00654901|Vaccines|vaccines|mesh-list
56616368|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
56616369|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616370|NCT00701493|Topiramate|topiramate|mesh-list
56616371|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
56616372|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56616373|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616374|NCT04253678|Vortioxetine|vortioxetine|mesh-list
56616375|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
56616376|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56616377|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56616379|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616380|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616381|NCT04253678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56616382|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56616383|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616384|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616385|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616386|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
56274352|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
56274353|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
56274354|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274355|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274356|NCT02009410|Pancrelipase|pancrelipase|mesh-list
56274383|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274384|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
56274385|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274386|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274387|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56274388|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274389|NCT02009592|Rifaximin|rifaximin|mesh-list
56274390|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56274391|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274392|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274393|NCT02009618|Rifaximin|rifaximin|mesh-list
56274394|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56274395|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274396|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274397|NCT02009631|Veliparib|veliparib|mesh-list
56274398|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56274399|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274400|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274401|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274402|NCT02009709|Riboflavin|riboflavin|mesh-list
56274403|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55849495|NCT02363374|Antidotes|antidotes|mesh-ancestor
56274441|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56274443|NCT02010762|Vitamins|vitamins|mesh-ancestor
56274444|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
56274445|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274467|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56274468|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186833|NCT04956939|Levodopa|levodopa|mesh-list
56186834|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56616387|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56616388|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56616389|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56616390|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56616391|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56616392|NCT00813631|Laxatives|laxatives|mesh-ancestor
56616393|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56616394|NCT02551861|Ribavirin|ribavirin|mesh-list
56616395|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
56616396|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
56616397|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616398|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
56616399|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616400|NCT00846495|Topiramate|topiramate|mesh-list
56616401|NCT00846495|Frovatriptan|frovatriptan|mesh-list
56616402|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
56616403|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56616404|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616405|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56616406|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
56616407|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616408|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616409|NCT00654745|Amlodipine|amlodipine|mesh-list
56616410|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56616411|NCT00654745|Olmesartan|olmesartan|mesh-list
56616412|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56616413|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56616414|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56616415|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616416|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616417|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56616418|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616419|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
56616428|NCT00846027|Gemcitabine|gemcitabine|mesh-list
56616429|NCT00846027|Paclitaxel|paclitaxel|mesh-list
56616430|NCT00846027|Bevacizumab|bevacizumab|mesh-list
56616431|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56616432|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616433|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
56616434|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
56616435|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
56616436|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616437|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56616438|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56616439|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56616440|NCT00846027|Growth Substances|growth substances|mesh-ancestor
56616441|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616442|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
56616443|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56616444|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
56616445|NCT00846027|Antiviral Agents|antiviral agents|mesh-ancestor
56616446|NCT00846027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616447|NCT00846027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616448|NCT00846027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616449|NCT00846027|Immunologic Factors|immunologic factors|mesh-ancestor
56616450|NCT00807625|Copper|copper|mesh-list
56159582|NCT02956044|Hormones|hormones|mesh-ancestor
56616451|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56616453|NCT00807625|Trace Elements|trace elements|mesh-ancestor
56616454|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
56616455|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616456|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56616457|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
56616458|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56616464|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56616472|NCT00810121|Analgesics|analgesics|mesh-ancestor
56616473|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
56616474|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616475|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616476|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56616477|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616478|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56616479|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616480|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616481|NCT00652327|Atorvastatin|atorvastatin|mesh-list
56616482|NCT00652327|Simvastatin|simvastatin|mesh-list
56616483|NCT00652327|Ezetimibe|ezetimibe|mesh-list
56616484|NCT00652327|Pravastatin|pravastatin|mesh-list
56616485|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56616486|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56616487|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56616488|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
56616489|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186835|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56186836|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
56186837|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186838|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186839|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186840|NCT04955470|Midazolam|midazolam|mesh-list
56186841|NCT04955470|Ketamine|ketamine|mesh-list
56186842|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56186843|NCT04955470|Analgesics|analgesics|mesh-ancestor
56186844|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
56186845|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186846|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274469|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
56274471|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56274472|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56274473|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
56274474|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274475|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274476|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274477|NCT02010944|Urological Agents|urological agents|mesh-ancestor
56274478|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56274479|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56274480|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56274481|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
56274482|NCT02010957|Etomidate|etomidate|mesh-list
56274483|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56274484|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274485|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274486|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56274487|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
56274488|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
56274489|NCT02010970|Itraconazole|itraconazole|mesh-list
56274490|NCT02010970|Diltiazem|diltiazem|mesh-list
56274491|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
56274492|NCT02010970|Midazolam|midazolam|mesh-list
56274493|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56274494|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274495|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56274496|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56616490|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56616491|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616492|NCT00814021|Sunitinib|sunitinib|mesh-list
56616493|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616494|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56616495|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56616496|NCT00814021|Growth Substances|growth substances|mesh-ancestor
56616497|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616498|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
56616499|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56616500|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616501|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616502|NCT00645853|Warfarin|warfarin|mesh-list
56616503|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
56616504|NCT00652093|Acetaminophen|acetaminophen|mesh-list
56616505|NCT00652093|Oxymorphone|oxymorphone|mesh-list
56616506|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
56616507|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
56616508|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
56616509|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616510|NCT00652093|Analgesics|analgesics|mesh-ancestor
56616511|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
56616512|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616513|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616514|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
56616515|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56616516|NCT00652093|Narcotics|narcotics|mesh-ancestor
56616517|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616518|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56616519|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
56616520|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
56616521|NCT00651937|Melphalan|melphalan|mesh-list
56616522|NCT00651937|Lenograstim|lenograstim|mesh-list
56616523|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56616524|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
56616530|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616531|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56616533|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616534|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
56616535|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616536|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56616537|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616538|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616539|NCT00651313|Lidocaine|lidocaine|mesh-list
56616540|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
56616541|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
56616542|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616543|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616544|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
56274525|NCT02011191|Biotin|biotin|mesh-list
56274526|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
56274527|NCT02011191|Vitamins|vitamins|mesh-ancestor
56274528|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
56274529|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274530|NCT02011347|Ketamine|ketamine|mesh-list
56274531|NCT02011347|Analgesics|analgesics|mesh-ancestor
56274532|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
56274533|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274534|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274535|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56274536|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56274537|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
56274538|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
56274539|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274540|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55849627|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
56274573|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274574|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56274575|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
56274576|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274577|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186847|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56186848|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56186849|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
56186850|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
56186851|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56186852|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56186853|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56186854|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186855|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186856|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56186857|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56274578|NCT02011737|Naftopidil|naftopidil|mesh-list
56274579|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56274580|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56274581|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
56274582|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274617|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56274618|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56274619|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274620|NCT02011880|Corylifolin|corylifolin|mesh-list
56274621|NCT02011880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55849713|NCT02223208|Prednisone|prednisone|mesh-list
56274657|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56274658|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616545|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616546|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56616547|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56616548|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56616549|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616550|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616551|NCT00808171|Lidocaine|lidocaine|mesh-list
56616552|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
56616553|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
56616554|NCT00808171|Prilocaine|prilocaine|mesh-list
56616555|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56616556|NCT00808171|Anesthetics|anesthetics|mesh-list
56616557|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616558|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616559|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
56616560|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616561|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56616562|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56616563|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56616564|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616565|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274659|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56274660|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56274661|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
56274662|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
56274663|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274690|NCT02012088|Doxorubicin|doxorubicin|mesh-list
56274691|NCT02012088|Vincristine|vincristine|mesh-list
56274692|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274693|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
56274694|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274695|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56274696|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56274697|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
56274698|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274699|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274700|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56274701|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56274702|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56274703|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56274704|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56274705|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274706|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56274707|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
56274708|NCT02012088|Hormones|hormones|mesh-ancestor
56274709|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274710|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849791|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56274741|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274742|NCT02012244|Analgesics|analgesics|mesh-ancestor
56616566|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56616567|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
56616568|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616569|NCT00808171|Analgesics|analgesics|mesh-ancestor
56616570|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56616571|NCT04703257|Dipyrone|dipyrone|mesh-list
56616572|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56616573|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616574|NCT04703257|Analgesics|analgesics|mesh-ancestor
56616575|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
56616576|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616577|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929189|NCT00783354|Loratadine|loratadine|mesh-list
56274743|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
56274744|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274745|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56274746|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56274748|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56274749|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
56274750|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274751|NCT02012322|Ubiquinone|ubiquinone|mesh-list
56274752|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
56186858|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56186859|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56186860|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56186861|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
56186862|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
56186863|NCT04938557|Insulin|insulin|mesh-list
56274754|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274755|NCT02012322|Vitamins|vitamins|mesh-ancestor
56274756|NCT02012335|Ketamine|ketamine|mesh-list
56274757|NCT02012335|Analgesics|analgesics|mesh-ancestor
56274790|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274791|NCT02012569|Hemostatics|hemostatics|mesh-list
56274792|NCT02012569|Coagulants|coagulants|mesh-ancestor
56274793|NCT02012595|Donepezil|donepezil|mesh-list
56274794|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56274795|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274796|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274797|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
56274798|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274799|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274800|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
56274801|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
56274834|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274836|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274837|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
56274838|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
56274839|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274840|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56274860|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274862|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56274863|NCT02013089|Growth Substances|growth substances|mesh-ancestor
56274864|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
56274865|NCT02013102|Decitabine|decitabine|mesh-list
56274866|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56274867|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
56274868|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274869|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274870|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274871|NCT02013115|Budesonide|budesonide|mesh-list
56274872|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56274873|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56274874|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
56616578|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56616579|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616580|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
56616581|NCT00808327|Fentanyl|fentanyl|mesh-list
56616582|NCT00808327|Bupivacaine|bupivacaine|mesh-list
56616583|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
56616584|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
56616585|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616586|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616587|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
56616588|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616589|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56616590|NCT00808327|Narcotics|narcotics|mesh-ancestor
56616591|NCT00808327|Analgesics|analgesics|mesh-ancestor
56616592|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56616593|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56616594|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
56616595|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56616596|NCT00814723|Ezetimibe|ezetimibe|mesh-list
56616597|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56616598|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56274875|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274876|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274877|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56274878|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
56274879|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
56274880|NCT02013115|Hormones|hormones|mesh-ancestor
56274881|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274882|NCT02013154|Paclitaxel|paclitaxel|mesh-list
56274883|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
56274884|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56274885|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274886|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
56274887|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
56274888|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
56274889|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274890|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56274891|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56274892|NCT02013219|Atezolizumab|atezolizumab|mesh-list
55896865|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
56274893|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274894|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56274895|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274896|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274930|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
56274931|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274933|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
56274934|NCT02013453|Paclitaxel|paclitaxel|mesh-list
56274935|NCT02013453|Carboplatin|carboplatin|mesh-list
56274936|NCT02013453|Fluorouracil|fluorouracil|mesh-list
56274937|NCT02013453|Pemetrexed|pemetrexed|mesh-list
56274938|NCT02013453|Omeprazole|omeprazole|mesh-list
56274939|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56274954|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274955|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56274957|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56274958|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616599|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
56616600|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616601|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56616602|NCT00845871|Deferasirox|deferasirox|mesh-list
56616603|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56616604|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
56616605|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
56616606|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616607|NCT02864849|Capecitabine|capecitabine|mesh-list
56616608|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
56616609|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56616610|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
56616611|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616612|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616613|NCT00701961|Artesunate|artesunate|mesh-list
56616614|NCT00701961|Mefloquine|mefloquine|mesh-list
56616615|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
56616616|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56616617|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56616618|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616619|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616620|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
56616621|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
56616622|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56616623|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
56616624|NCT04286711|Paclitaxel|paclitaxel|mesh-list
56616625|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56616626|NCT04286711|Apatinib|apatinib|mesh-list
56616627|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56616628|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616629|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
56616630|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
56616631|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
56616632|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616633|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56616636|NCT02863913|Interleukin-2|interleukin-2|mesh-list
56616640|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616641|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56616642|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
56616643|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616644|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616645|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56616646|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616647|NCT02863913|Analgesics|analgesics|mesh-ancestor
56616648|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
56616649|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616650|NCT02612649|Ramosetron|ramosetron|mesh-list
56616651|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
56616652|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
56616653|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616654|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616655|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56616656|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56616657|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
56616658|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616659|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616660|NCT04908800|Itraconazole|itraconazole|mesh-list
56616661|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
56616662|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616663|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56616664|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56616665|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616666|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616667|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56616668|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
56616669|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616670|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616671|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56616672|NCT00844857|Olanzapine|olanzapine|mesh-list
56616673|NCT00844857|Fluoxetine|fluoxetine|mesh-list
56616675|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
55801283|NCT04852081|Fulvestrant|fulvestrant|mesh-list
56616677|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365193|NCT00090480|Vaccines|vaccines|mesh-list
56616678|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56616679|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56616680|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56616681|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616682|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56616683|NCT00844857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56616684|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56616685|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616686|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616687|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616688|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
56616689|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56616690|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
56616691|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56616692|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56616693|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616694|NCT00702117|Flecainide|flecainide|mesh-list
56616695|NCT00702117|Procainamide|procainamide|mesh-list
56616696|NCT00702117|Ajmaline|ajmaline|mesh-list
56274959|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274960|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56274961|NCT02013570|Analgesics|analgesics|mesh-ancestor
56274962|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
56274963|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274964|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56274965|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55896944|NCT00186069|Analgesics|analgesics|mesh-ancestor
56274966|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56274967|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
56274968|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274969|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274970|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
56274971|NCT02013856|Procyanidin|procyanidin|mesh-list
56274972|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
56274973|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274974|NCT02013856|Protective Agents|protective agents|mesh-ancestor
56274975|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274976|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56274977|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56274978|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274979|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
56274980|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56274981|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274982|NCT02013960|Misoprostol|misoprostol|mesh-list
56274983|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56274984|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
56274985|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56274986|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274987|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56616697|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56616698|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56616699|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56616700|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616701|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616702|NCT00913107|Lamotrigine|lamotrigine|mesh-list
56616703|NCT00913107|Carbamazepine|carbamazepine|mesh-list
56616704|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
56616705|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56616706|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616707|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616708|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56274988|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274989|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
56274990|NCT02013986|Midazolam|midazolam|mesh-list
56274991|NCT02013986|Propofol|propofol|mesh-list
56274992|NCT02013986|Etomidate|etomidate|mesh-list
56274993|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56274994|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274995|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274996|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56274997|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
55850070|NCT01895998|Albuterol|albuterol|mesh-list
56275031|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56275032|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56275033|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
56275034|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56275035|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
55850125|NCT01659658|Ixazomib|ixazomib|mesh-list
56275072|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
56275073|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850165|NCT01615510|Tapentadol|tapentadol|mesh-list
56275100|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275101|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
56275102|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275103|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56275104|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56275105|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275106|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56275107|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
56275108|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56275109|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56275110|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56275111|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
56275112|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
56275113|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897112|NCT00097695|Icatibant|icatibant|mesh-list
56186864|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56186865|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56186866|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186867|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
56186869|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186870|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56186871|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
56186872|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56275114|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275115|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275116|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
56275117|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56616709|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616710|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56616711|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56616712|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616713|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56616714|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56616715|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
56616716|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616717|NCT00913107|Analgesics|analgesics|mesh-ancestor
56616718|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
56616719|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616720|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56616721|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56616722|NCT00569803|Abatacept|abatacept|mesh-list
56616723|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56616724|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616725|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616726|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616727|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
56616728|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616729|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616730|NCT00920426|Cabotegravir|cabotegravir|mesh-list
56616731|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56616732|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56616733|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616734|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616735|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56616736|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56616737|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
56616738|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616739|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56616740|NCT04046185|Progesterone|progesterone|mesh-list
56616741|NCT04046185|Progestins|progestins|mesh-ancestor
56616742|NCT04046185|Hormones|hormones|mesh-ancestor
56616749|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
56616750|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
56365273|NCT04717531|Docetaxel|docetaxel|mesh-list
56616751|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56616752|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616753|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
56616754|NCT04253132|Analgesics|analgesics|mesh-ancestor
56616755|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
56616756|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616757|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616758|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56616759|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616760|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56616761|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616762|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56616763|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56616764|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616765|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56616766|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
56616767|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
56616768|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616769|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56616770|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
56616771|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616772|NCT00914966|Complement C1s|complement c1s|mesh-list
56616773|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56275118|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275119|NCT02014714|Fentanyl|fentanyl|mesh-list
56275120|NCT02014714|Morphine|morphine|mesh-list
56275121|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56275122|NCT02014714|Narcotics|narcotics|mesh-ancestor
56275160|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
56275161|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275162|NCT02014922|Protective Agents|protective agents|mesh-ancestor
55850251|NCT00479128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275199|NCT02015312|Mannitol|mannitol|mesh-list
56275200|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56275201|NCT02015312|Diuretics|diuretics|mesh-ancestor
56275223|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275225|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
56275226|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
56275227|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275228|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
56275229|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
56275230|NCT02015507|Ivacaftor|ivacaftor|mesh-list
56275231|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56275232|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275233|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56275234|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56275235|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616774|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56616775|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
56616776|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616777|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56616778|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616779|NCT00815269|Sevoflurane|sevoflurane|mesh-list
56616780|NCT00815269|Desflurane|desflurane|mesh-list
56616781|NCT00815269|Isoflurane|isoflurane|mesh-list
56616782|NCT00815269|Halothane|halothane|mesh-list
56616783|NCT00815269|Enflurane|enflurane|mesh-list
56616784|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56616785|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56616786|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
56616787|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
56616788|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616789|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275236|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275237|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275238|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56275239|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56275240|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56275241|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275242|NCT02015559|Protective Agents|protective agents|mesh-list
56275243|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275244|NCT02015598|Carbocysteine|carbocysteine|mesh-list
56275245|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56275246|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275247|NCT02015598|Expectorants|expectorants|mesh-ancestor
56275248|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
56275249|NCT02015650|Fluorouracil|fluorouracil|mesh-list
56275250|NCT02015650|Cetuximab|cetuximab|mesh-list
56275251|NCT02015650|Mitomycins|mitomycins|mesh-list
56275252|NCT02015650|Mitomycin|mitomycin|mesh-list
56275253|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
56275254|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275255|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850331|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56275280|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56275281|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
56275282|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56275283|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56275284|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275285|NCT02015923|Panitumumab|panitumumab|mesh-list
56186873|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186874|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186875|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186877|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
56275286|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56275287|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275288|NCT02015949|Methylphenidate|methylphenidate|mesh-list
56275289|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56275290|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275291|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56275292|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56275293|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275294|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275295|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
56275296|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275298|NCT02015988|Fenofibrate|fenofibrate|mesh-list
56616790|NCT00914810|Vitamin D|vitamin d|mesh-list
56616791|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
56616792|NCT00914810|Vitamins|vitamins|mesh-ancestor
56616793|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
56616794|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616795|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56616796|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56616797|NCT00808717|Atorvastatin|atorvastatin|mesh-list
56616798|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56616799|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56616800|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
56616801|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616802|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56616803|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56616804|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616805|NCT00914732|Vaccines|vaccines|mesh-list
56616806|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
56616807|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616808|NCT00844545|Eculizumab|eculizumab|mesh-list
56616809|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56616810|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616811|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
56616812|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616813|NCT00815503|Ropivacaine|ropivacaine|mesh-list
56616814|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
56616815|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
56616816|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616817|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616818|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
56616819|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616820|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
56616821|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616822|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
56616823|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616824|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56616825|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56275299|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56275300|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56275301|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
56616826|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
56616827|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616828|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616829|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56616830|NCT00702819|Bevacizumab|bevacizumab|mesh-list
56616831|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56616832|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616833|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56616834|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56616835|NCT00702819|Growth Substances|growth substances|mesh-ancestor
56616836|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616837|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
56616838|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56616839|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
56616840|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
56616841|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616842|NCT00842985|Dronabinol|dronabinol|mesh-list
56275302|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275303|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56275304|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56275335|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56275336|NCT02016261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56275337|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56275338|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275339|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275340|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275341|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
56275342|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56275344|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56275345|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56275346|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275347|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56275348|NCT02016274|Paclitaxel|paclitaxel|mesh-list
56275349|NCT02016274|Cisplatin|cisplatin|mesh-list
56275373|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56275374|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275375|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275376|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56275378|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
56275379|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275380|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56275381|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56275382|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56275383|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
56275384|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275385|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275386|NCT02016417|Gemcitabine|gemcitabine|mesh-list
56275387|NCT02016417|Cisplatin|cisplatin|mesh-list
56275388|NCT02016417|Docetaxel|docetaxel|mesh-list
56275389|NCT02016417|Fluorouracil|fluorouracil|mesh-list
56275390|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275391|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56275392|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
56616843|NCT00842985|Modafinil|modafinil|mesh-list
56616844|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56616845|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616846|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56616847|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56616848|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56616849|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275393|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275394|NCT02016417|Antiviral Agents|antiviral agents|mesh-ancestor
56275395|NCT02016417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275396|NCT02016417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275397|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275398|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
56275399|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275400|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
56275429|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56275430|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56186878|NCT04922567|Doxorubicin|doxorubicin|mesh-list
56186879|NCT04922567|Vincristine|vincristine|mesh-list
56186880|NCT04922567|Lenalidomide|lenalidomide|mesh-list
56275431|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275432|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
56275433|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56275434|NCT02016664|Ketamine|ketamine|mesh-list
56275435|NCT02016664|Analgesics|analgesics|mesh-ancestor
56275436|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
56275437|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275438|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275439|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56275440|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56275441|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
56275442|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
56275443|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275444|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56275445|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56275446|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275447|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275476|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56275477|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56275478|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275479|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56275480|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56275481|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56275482|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56275483|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
56275484|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
56275485|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
56275486|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
56275487|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275488|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275489|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56275490|NCT02016976|Narcotics|narcotics|mesh-ancestor
56275491|NCT02017119|Lactulose|lactulose|mesh-list
56275492|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56275493|NCT02017197|Warfarin|warfarin|mesh-list
56275494|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
56275495|NCT02017314|Morphine|morphine|mesh-list
56275496|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56275497|NCT02017314|Narcotics|narcotics|mesh-ancestor
55850577|NCT01479621|Albuterol|albuterol|mesh-list
56275532|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275533|NCT02017561|Metformin|metformin|mesh-list
56275534|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56275552|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275554|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56275555|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275556|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
55801284|NCT04852081|Palbociclib|palbociclib|mesh-list
56616850|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
56616851|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56616852|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616853|NCT00842985|Analgesics|analgesics|mesh-ancestor
56616854|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
56616855|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616856|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56616857|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56616858|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616859|NCT00842985|Hormones|hormones|mesh-ancestor
56616860|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616861|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
56616862|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56616863|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
56616864|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616865|NCT00808795|Expectorants|expectorants|mesh-ancestor
56616866|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
56616867|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56616868|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
56616869|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616870|NCT00808795|Protective Agents|protective agents|mesh-ancestor
56616871|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616872|NCT00808795|Antidotes|antidotes|mesh-ancestor
56616873|NCT00808951|Artesunate|artesunate|mesh-list
56616874|NCT00808951|Lumefantrine|lumefantrine|mesh-list
56616875|NCT00808951|Artemether|artemether|mesh-list
56616876|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56616877|NCT00808951|Amodiaquine|amodiaquine|mesh-list
56616878|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
56616879|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56616880|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56616881|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56616882|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616894|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56616895|NCT00842829|Narcotics|narcotics|mesh-ancestor
56616896|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616897|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616898|NCT00842829|Analgesics|analgesics|mesh-ancestor
56616899|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
56616900|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616901|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56616902|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56616903|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
56616904|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
56616905|NCT04045093|Warfarin|warfarin|mesh-list
56616906|NCT04045093|Dabigatran|dabigatran|mesh-list
56616907|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
56616908|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
56616909|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56616910|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
56616911|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616912|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616913|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
56616914|NCT00811291|Folic Acid|folic acid|mesh-list
56616915|NCT00811291|Calcium|calcium|mesh-list
56616916|NCT00811291|Vitamins|vitamins|mesh-ancestor
56275557|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56275558|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275559|NCT02018055|Aspirin|aspirin|mesh-list
56275560|NCT02018055|Clopidogrel|clopidogrel|mesh-list
56275561|NCT02018055|Ticagrelor|ticagrelor|mesh-list
56275562|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56275563|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56275564|NCT02018055|Analgesics|analgesics|mesh-ancestor
56275565|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
56275566|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275567|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275568|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56275569|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56275570|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56275571|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56275572|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275573|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56275574|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56275575|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275576|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
56275577|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56275578|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56275579|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56186881|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56186882|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
56186883|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186884|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56186885|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56186886|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
56186887|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186888|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616917|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
56616918|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616919|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56616920|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56616921|NCT00811291|Hematinics|hematinics|mesh-ancestor
56616922|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
56616923|NCT00811369|Fulvestrant|fulvestrant|mesh-list
56616924|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56616925|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616926|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56616927|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56616928|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
56616929|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56616930|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616931|NCT00842361|Insulin|insulin|mesh-list
56616932|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56616933|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
56616934|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
56616935|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56616936|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
56616937|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56616938|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56616939|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616940|NCT00811447|Docetaxel|docetaxel|mesh-list
56616941|NCT00811447|Fluorouracil|fluorouracil|mesh-list
56616942|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616943|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
56616944|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
56616945|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622941|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56186889|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56186890|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56186891|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56186892|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56186893|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275580|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
56275581|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275582|NCT02018081|Levofloxacin|levofloxacin|mesh-list
56275583|NCT02018081|Ofloxacin|ofloxacin|mesh-list
56275584|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56275585|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275586|NCT02018081|Renal Agents|renal agents|mesh-ancestor
56275587|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55801285|NCT04852081|Anastrozole|anastrozole|mesh-list
56616946|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616947|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
56616948|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56616949|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56616950|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
56616951|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616952|NCT00702975|Paclitaxel|paclitaxel|mesh-list
56616953|NCT00702975|Bevacizumab|bevacizumab|mesh-list
56616954|NCT00702975|Carboplatin|carboplatin|mesh-list
56616955|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56616956|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56616957|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616958|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
56616959|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
56616960|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
56616961|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616962|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56616963|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56616964|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56275588|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56275589|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56275590|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275607|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56275608|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56275609|NCT02018094|Trace Elements|trace elements|mesh-ancestor
56275610|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
56275611|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275612|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56275613|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275614|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275615|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
56275616|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
56275617|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56275618|NCT02018133|Vitamin D|vitamin d|mesh-list
56275619|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
56275620|NCT02018133|Vitamins|vitamins|mesh-ancestor
56275621|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
56275622|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275623|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56275624|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56275625|NCT02018159|Menotropins|menotropins|mesh-list
56275626|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56275627|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
56275628|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56275629|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275630|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
56275631|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
56275632|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
56275633|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275634|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275635|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
56275636|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275637|NCT02018276|Lidocaine|lidocaine|mesh-list
56275638|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
56275639|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
56275640|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616965|NCT00702975|Growth Substances|growth substances|mesh-ancestor
56616966|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616967|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
56616968|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56616969|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616970|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56616971|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56616972|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616974|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56616975|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56616976|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56616978|NCT02612181|Analgesics|analgesics|mesh-ancestor
56275641|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275642|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
56275643|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275644|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56186894|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56186895|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
56186896|NCT04922567|Hormones|hormones|mesh-ancestor
56186897|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186898|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56186899|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56186900|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
56186901|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
56186902|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
56186903|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56186904|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56186905|NCT04922567|Growth Substances|growth substances|mesh-ancestor
56186906|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
56186907|NCT04906278|Oxytocin|oxytocin|mesh-list
56186908|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
56186909|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56186910|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186911|NCT04850222|Fluoxetine|fluoxetine|mesh-list
56186912|NCT04850222|Calcium|calcium|mesh-list
56186913|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56186914|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186915|NCT04850222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56186916|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56275645|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56275646|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56275647|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275648|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275650|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56275676|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
56275677|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275678|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56275679|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56275680|NCT02018523|Growth Substances|growth substances|mesh-ancestor
56275681|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
56275682|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275684|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
56275685|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275686|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
56275689|NCT02018588|Tryptophan|tryptophan|mesh-list
56275690|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56275691|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
56275692|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56275693|NCT02018601|Acetaminophen|acetaminophen|mesh-list
56275694|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56275695|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56616979|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
56616980|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56616981|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56616982|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56616983|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56616984|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
56616985|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56616986|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616987|NCT02612259|Tryptophan|tryptophan|mesh-list
56616988|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56616989|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
56616990|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56275696|NCT02018601|Analgesics|analgesics|mesh-ancestor
56275697|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
56275698|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275699|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186917|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56186918|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186919|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56186920|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
56186921|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56186922|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
56186923|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56186924|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56275725|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56275727|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56275728|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275729|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56275730|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56275731|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
56275732|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56275733|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56275734|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56275735|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56275736|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
56275737|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56275738|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56275739|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
56275740|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56275741|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
56275742|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56275743|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56275744|NCT02018874|Gemcitabine|gemcitabine|mesh-list
56275745|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56275746|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
56275747|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275748|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275750|NCT02018874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275751|NCT02018874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275752|NCT02018874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275753|NCT02018874|Immunologic Factors|immunologic factors|mesh-ancestor
56275754|NCT02018874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275755|NCT02018965|Vitamins|vitamins|mesh-list
56275757|NCT02018965|Niacinamide|niacinamide|mesh-list
56275758|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
56275759|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
56275760|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
56275761|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275762|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56275763|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
56616991|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56616992|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56616993|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56616994|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56616995|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56616996|NCT00642811|Aspirin|aspirin|mesh-list
56616997|NCT00642811|Clopidogrel|clopidogrel|mesh-list
56616998|NCT00642811|Ticagrelor|ticagrelor|mesh-list
56616999|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56617000|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56275764|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275765|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56275766|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
56275767|NCT02018991|Everolimus|everolimus|mesh-list
56275768|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275769|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275770|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
56275771|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275772|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
56275773|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56275774|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56275775|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56275776|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275777|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275778|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
56275779|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275780|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275781|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56275782|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275784|NCT02019056|Metadoxine|metadoxine|mesh-list
56275785|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56275786|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
56275787|NCT02019056|Vitamins|vitamins|mesh-ancestor
56275788|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
56275789|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275790|NCT02019095|Dimercaprol|dimercaprol|mesh-list
56275791|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
56275792|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
56275793|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275794|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
56275795|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56275796|NCT02019160|Fluorides|fluorides|mesh-list
56275797|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
56275798|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
56275799|NCT02019160|Protective Agents|protective agents|mesh-ancestor
56275800|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275801|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56275802|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275803|NCT02019186|Vitamins|vitamins|mesh-list
56275804|NCT02019186|Vitamin E|vitamin e|mesh-list
56275805|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
56275806|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275807|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
56275808|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275809|NCT02019186|Protective Agents|protective agents|mesh-ancestor
56275810|NCT02019290|Midazolam|midazolam|mesh-list
56275811|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56275812|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56275813|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275814|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275815|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56275816|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56275817|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56275818|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56275819|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
56275820|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
56275821|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
56617001|NCT00642811|Analgesics|analgesics|mesh-ancestor
56617002|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
56617003|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617004|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617005|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56617006|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56617007|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56617008|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56617009|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617010|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56617011|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56617012|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275822|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
56275823|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275824|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275825|NCT02019329|Risperidone|risperidone|mesh-list
56275826|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56275855|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56275856|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56275858|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
56275859|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275860|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275861|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275862|NCT02019459|Nicotine|nicotine|mesh-list
56275863|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56275864|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
56275865|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275866|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275867|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56275868|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56275869|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
56275870|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275871|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275872|NCT02019485|Tapentadol|tapentadol|mesh-list
56275873|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56275874|NCT02019485|Narcotics|narcotics|mesh-ancestor
56275913|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275944|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56275945|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56275946|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56275948|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56275949|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
56275950|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275951|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275952|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56275953|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56186925|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56186926|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186928|NCT04801966|Nivolumab|nivolumab|mesh-list
56186929|NCT04801966|Atezolizumab|atezolizumab|mesh-list
56186930|NCT04801966|Olaparib|olaparib|mesh-list
56186931|NCT04801966|Palbociclib|palbociclib|mesh-list
56186932|NCT04801966|Trametinib|trametinib|mesh-list
56186933|NCT04801966|Vemurafenib|vemurafenib|mesh-list
56186934|NCT04801966|Dabrafenib|dabrafenib|mesh-list
56186935|NCT04801966|Talazoparib|talazoparib|mesh-list
56186936|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56186937|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186938|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56275954|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
56275955|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275970|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617013|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
56617014|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56617015|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56617016|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56617017|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
56617018|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617019|NCT00838929|Vorinostat|vorinostat|mesh-list
56617020|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617021|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56617022|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617023|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617024|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56617025|NCT00811603|Cefazolin|cefazolin|mesh-list
56617026|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617027|NCT00811681|Pioglitazone|pioglitazone|mesh-list
56617028|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56617029|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617030|NCT00811759|Temozolomide|temozolomide|mesh-list
56617031|NCT00811759|Sorafenib|sorafenib|mesh-list
56617032|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56617033|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
56617034|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617035|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617036|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56617037|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617038|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
56617039|NCT00815893|Propofol|propofol|mesh-list
56617040|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56617041|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617042|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617043|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56617056|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
56617057|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
56617058|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617059|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56617060|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617061|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56617062|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
56617063|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617064|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56617065|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617066|NCT04648891|Lidocaine|lidocaine|mesh-list
56617067|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
56617068|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
56617069|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617070|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617071|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
56617072|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617073|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55929673|NCT01922713|Provitamins|provitamins|mesh-ancestor
56275971|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56275972|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56275973|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56275974|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275975|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
56275976|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
56275978|NCT02020161|Idarubicin|idarubicin|mesh-list
56275979|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56275980|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
56275981|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56275982|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275983|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56275984|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
56275985|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275986|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275987|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
56275988|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275989|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56275990|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275991|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
56275992|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56275993|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56275994|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56275995|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56275996|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56275997|NCT02020200|Methylphenidate|methylphenidate|mesh-list
56275998|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56275999|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276000|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56276001|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56276002|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276003|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276004|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
56276005|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276006|NCT02020213|Posaconazole|posaconazole|mesh-list
56617074|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56617075|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56617076|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617077|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617078|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
56617079|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56617080|NCT04648033|Atovaquone|atovaquone|mesh-list
56617081|NCT04648033|Cisplatin|cisplatin|mesh-list
56617082|NCT04648033|Vinorelbine|vinorelbine|mesh-list
56617083|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617084|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56617085|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
56617086|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
56617087|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
56617088|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617089|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617090|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
56617091|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56617092|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56617093|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617094|NCT00811837|Midazolam|midazolam|mesh-list
56617095|NCT00811837|Remifentanil|remifentanil|mesh-list
56617096|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56617097|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56617098|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617099|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617100|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56617101|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56617102|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56617103|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56617104|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
56617105|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
56617106|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
56617107|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
56617117|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617118|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56617119|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617120|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
56617121|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56617122|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
56617123|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617124|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56617125|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
56617126|NCT00816127|Coagulants|coagulants|mesh-ancestor
56617127|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56617128|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
56617129|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276007|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
56276008|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276009|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56276010|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56276011|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56276012|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56276035|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276036|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56276037|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56276038|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56114687|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186939|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186940|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56276039|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276040|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276042|NCT02020603|Racepinephrine|racepinephrine|mesh-list
56276043|NCT02020603|Hemostatics|hemostatics|mesh-list
56276044|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
56276045|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55805283|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
56276046|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56276047|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
56276048|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276049|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276050|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276051|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56276052|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56276054|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276055|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56276056|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
56276057|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
56276058|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
56276059|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56276060|NCT02020603|Coagulants|coagulants|mesh-ancestor
56276061|NCT02020629|Lixisenatide|lixisenatide|mesh-list
56276062|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56276063|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276064|NCT02020681|Fluorides|fluorides|mesh-list
56276071|NCT02020694|Vitamins|vitamins|mesh-list
56276072|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
56276073|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276074|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56276075|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56276076|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
56276077|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56276078|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56276079|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56276080|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55811195|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
56617130|NCT00916058|Melphalan|melphalan|mesh-list
56617131|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56276081|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276082|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
56276083|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276084|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276085|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56276086|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276087|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56276088|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56276089|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
56276090|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56276091|NCT02021097|Estradiol|estradiol|mesh-list
56276092|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56276093|NCT02021097|Estrogens|estrogens|mesh-ancestor
56276094|NCT02021097|Hormones|hormones|mesh-ancestor
56276095|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276096|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276097|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56276098|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
56276099|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56276100|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56276101|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56276102|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56276103|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56276104|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56276105|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56276106|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56276108|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
56276109|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276110|NCT02021201|Risperidone|risperidone|mesh-list
56276111|NCT02021201|Sertindole|sertindole|mesh-list
56276112|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56276113|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
56186942|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56186943|NCT04800692|Verapamil|verapamil|mesh-list
56186944|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56186945|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56186946|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56186947|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186948|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56186949|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186950|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
56276114|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276115|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276116|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276117|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56276118|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56276119|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276120|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56276121|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56276123|NCT02021214|Methylphenidate|methylphenidate|mesh-list
56276124|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56276125|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276126|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56276127|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56276128|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276129|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276130|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
56276131|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276132|NCT02021240|Dexamethasone|dexamethasone|mesh-list
56276133|NCT02021240|Ketamine|ketamine|mesh-list
56276134|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56276135|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
56276151|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276152|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56276153|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56276154|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276155|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276156|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
56276157|NCT02021409|Hematinics|hematinics|mesh-ancestor
56276158|NCT02021422|Fluorouracil|fluorouracil|mesh-list
56617132|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56617133|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
56617134|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276159|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
56276160|NCT02021422|Irinotecan|irinotecan|mesh-list
56276161|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56276162|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
56276163|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276164|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276165|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276166|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276167|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
56276168|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276169|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56276170|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55898142|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56276171|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276172|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56276173|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56276174|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276175|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
56276176|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56276177|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276178|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
56276179|NCT02021825|Analgesics|analgesics|mesh-ancestor
56276180|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
56276181|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276182|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186951|NCT04787848|Bromides|bromides|mesh-list
56186952|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
56186953|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
56186954|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56186955|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186956|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
56186957|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186958|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
56186959|NCT04660799|Promethazine|promethazine|mesh-list
56186960|NCT04660799|Prednisone|prednisone|mesh-list
56186961|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
56186962|NCT04660799|Rituximab|rituximab|mesh-list
56186963|NCT04660799|Doxorubicin|doxorubicin|mesh-list
56186964|NCT04660799|Vincristine|vincristine|mesh-list
56186965|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56186966|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
56186967|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56186968|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
56186969|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186970|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56186971|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56276183|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276184|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56276185|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56276186|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276188|NCT02021851|Dexamethasone|dexamethasone|mesh-list
56276189|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
56276190|NCT02021851|Ondansetron|ondansetron|mesh-list
56276191|NCT02021851|Aprepitant|aprepitant|mesh-list
56276192|NCT02021851|BB 1101|bb 1101|mesh-list
56276193|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56276194|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
56276222|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276223|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56276224|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56276225|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56276227|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
56276228|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276229|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56276230|NCT02022163|Antacids|antacids|mesh-ancestor
56276231|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276232|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56276233|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56276234|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56276235|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
56617135|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617136|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56617137|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56617138|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
56617139|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617149|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
56617150|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
56617151|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
56617152|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617153|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617154|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
56276236|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56276237|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
56276238|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56276239|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276240|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56276241|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56276259|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56276260|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
56276261|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276262|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56276263|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56186972|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
56186973|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56186974|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186975|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56186976|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56186977|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56186978|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56186979|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56186980|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56186981|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56186982|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
56186983|NCT04660799|Hormones|hormones|mesh-ancestor
56276264|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276265|NCT02022358|Leucovorin|leucovorin|mesh-list
56276266|NCT02022358|Folic Acid|folic acid|mesh-list
56276267|NCT02022358|Methotrexate|methotrexate|mesh-list
56276268|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
56276269|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56276270|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
56276271|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56276272|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276273|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276274|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
56276275|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276276|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276277|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
56276278|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276279|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56276280|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276281|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
56276282|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56276283|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56276284|NCT02022358|Antidotes|antidotes|mesh-ancestor
56276285|NCT02022358|Protective Agents|protective agents|mesh-ancestor
56276286|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
56276287|NCT02022358|Vitamins|vitamins|mesh-ancestor
56276288|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
56276289|NCT02022358|Hematinics|hematinics|mesh-ancestor
56276290|NCT02022475|Vitamin D|vitamin d|mesh-list
56276291|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
56276292|NCT02022475|Vitamins|vitamins|mesh-ancestor
56276293|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
56276294|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617155|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617156|NCT00912782|Vitamin D|vitamin d|mesh-list
56617157|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
56617158|NCT00912782|Vitamins|vitamins|mesh-ancestor
56617159|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
56617160|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617161|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56617162|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56617163|NCT04202978|Capecitabine|capecitabine|mesh-list
56617164|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
56617165|NCT04202978|Apatinib|apatinib|mesh-list
56617166|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56617167|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
56617168|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617169|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617170|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56617171|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617172|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
56617173|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56617174|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56276295|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56276296|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56276297|NCT02022488|Midazolam|midazolam|mesh-list
56276298|NCT02022488|Ketamine|ketamine|mesh-list
56276299|NCT02022488|Alfentanil|alfentanil|mesh-list
56276300|NCT02022488|Analgesics|analgesics|mesh-ancestor
56276301|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
55851373|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
56276332|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56276333|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56276334|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56276335|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56276336|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276337|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56276338|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56276339|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276340|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
56276341|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
56276342|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276343|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
56276344|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
56186984|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56186985|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56186986|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56186987|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
56186988|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
56186989|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
56186990|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
56186991|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56186992|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56276345|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
56276346|NCT02022540|Ranibizumab|ranibizumab|mesh-list
56276347|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56276382|NCT02022917|Bevacizumab|bevacizumab|mesh-list
56276383|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56276384|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276385|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56617175|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56617176|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276386|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56276418|NCT02023021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276419|NCT02023047|Nifedipine|nifedipine|mesh-list
56276420|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56276421|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276422|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276423|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56276424|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276425|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
56276426|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
56276427|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56276428|NCT02023086|Tropicamide|tropicamide|mesh-list
56276429|NCT02023086|Mydriatics|mydriatics|mesh-list
56276430|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
55851515|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56276455|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276457|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
56276458|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
56276459|NCT02023359|Everolimus|everolimus|mesh-list
56276460|NCT02023359|Exemestane|exemestane|mesh-list
56276461|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276462|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276463|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
56276464|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276465|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56276466|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56276467|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276468|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276469|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56276470|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
56276471|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276472|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
56276473|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
56276474|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55898448|NCT02442648|Rituximab|rituximab|mesh-list
56276475|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
56276476|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276477|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276478|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56276510|NCT02023567|Serotonin|serotonin|mesh-list
56276511|NCT02023567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56276512|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56276513|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
56276514|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276515|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276516|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56186993|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56186994|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276517|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56276518|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276519|NCT02023684|Lidocaine|lidocaine|mesh-list
56276520|NCT02023684|Ropivacaine|ropivacaine|mesh-list
56276521|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
56276522|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
56276523|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851605|NCT00185692|Cyclosporine|cyclosporine|mesh-list
56276552|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56276553|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
56276555|NCT02023853|Erythritol|erythritol|mesh-list
56276556|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276557|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56276558|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56276559|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56276560|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
56276561|NCT02023892|Atorvastatin|atorvastatin|mesh-list
56276562|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56276563|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56276564|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
56276565|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276566|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55851652|NCT01526733|Insulin|insulin|mesh-list
56617177|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617178|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
56617179|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617180|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617181|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56617182|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617183|NCT04203368|Adenosine|adenosine|mesh-list
56617184|NCT04203368|Verapamil|verapamil|mesh-list
56617185|NCT04203368|Analgesics|analgesics|mesh-ancestor
56617186|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
56617187|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617188|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617189|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56617190|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
56617191|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56617192|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
56617193|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
56617194|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617195|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617196|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56617197|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617198|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56617199|NCT04133948|Nivolumab|nivolumab|mesh-list
56617200|NCT04133948|Ipilimumab|ipilimumab|mesh-list
55929782|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56276594|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
56276595|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56276596|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56276597|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
56276598|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
56276599|NCT02024022|Cathartics|cathartics|mesh-ancestor
56276600|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56276601|NCT02024152|Cetirizine|cetirizine|mesh-list
56276602|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56276603|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56276604|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56276605|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
56276606|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
56276607|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276608|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276609|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276610|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
56276611|NCT02024217|Tegafur|tegafur|mesh-list
56276612|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276613|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276614|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
55851697|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276632|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
56276634|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56617201|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617202|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617203|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56617204|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617205|NCT00911534|Rabeprazole|rabeprazole|mesh-list
56617206|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56617207|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56276635|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
56276636|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276637|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56276638|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56276639|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
56276640|NCT02024308|Cytarabine|cytarabine|mesh-list
56276641|NCT02024308|Fludarabine|fludarabine|mesh-list
56276642|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276643|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276644|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
56276645|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276646|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276647|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
56276648|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276649|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
55801025|NCT04856137|Rituximab|rituximab|mesh-list
56276652|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276653|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276654|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276655|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
56276656|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276657|NCT02024373|Atorvastatin|atorvastatin|mesh-list
56276658|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56276659|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56276660|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
56186995|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
56186996|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
56186997|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
56186998|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
56276661|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276662|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56276663|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56276664|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276665|NCT02024425|Antioxidants|antioxidants|mesh-list
56276666|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276667|NCT02024425|Protective Agents|protective agents|mesh-ancestor
56276668|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276669|NCT02024555|Azithromycin|azithromycin|mesh-list
56276670|NCT02024555|Levofloxacin|levofloxacin|mesh-list
56276671|NCT02024555|Ofloxacin|ofloxacin|mesh-list
56276702|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276703|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276704|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56276705|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56276706|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56276707|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276708|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56276709|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
56276710|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56276711|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
56276712|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
56276713|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276714|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851857|NCT01524783|Everolimus|everolimus|mesh-list
56276770|NCT02024984|Clomiphene|clomiphene|mesh-list
56276771|NCT02024984|Enclomiphene|enclomiphene|mesh-list
56276772|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
56276773|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56276774|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
56276775|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811196|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617208|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56617209|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617210|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617211|NCT00911300|Vitamin K|vitamin k|mesh-list
56617212|NCT00911300|Heparin|heparin|mesh-list
56617213|NCT00911300|Calcium heparin|calcium heparin|mesh-list
56617214|NCT00911300|PENTA|penta|mesh-list
56617215|NCT00911300|Fondaparinux|fondaparinux|mesh-list
56617216|NCT00911300|Vitamins|vitamins|mesh-ancestor
56617217|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
56617218|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617219|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
56617220|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56617221|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56617222|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617223|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56617224|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
56617225|NCT00911300|Coagulants|coagulants|mesh-ancestor
56276776|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276777|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56276778|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
56276779|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56276780|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56276781|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56276782|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
56276783|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276784|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56276785|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276786|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276787|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
56276788|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276789|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276790|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56276791|NCT02025023|Triamcinolone|triamcinolone|mesh-list
56276792|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56276793|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56276794|NCT02025023|Fluorouracil|fluorouracil|mesh-list
56276795|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56276796|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
56276797|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276798|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276799|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276800|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276801|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
56276834|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56276835|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276836|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276837|NCT02025348|Metoprolol|metoprolol|mesh-list
56276838|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56276839|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56186999|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56187000|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
56187001|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276840|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
56276841|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
56276842|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276843|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276844|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56617226|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56617227|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
56617228|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56617229|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
56617230|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898825|NCT05720260|Durvalumab|durvalumab|mesh-list
56276845|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56276846|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56276847|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
56276848|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276849|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276850|NCT02025361|Lidocaine|lidocaine|mesh-list
56276884|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56276885|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276886|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56276887|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
56276888|NCT02025491|Amphotericin B|amphotericin b|mesh-list
55851991|NCT00107536|Lapatinib|lapatinib|mesh-list
56276912|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56276913|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56276914|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276915|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276916|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56276917|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
56276918|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276919|NCT02025803|Capecitabine|capecitabine|mesh-list
56276920|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276921|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
56276922|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276923|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276924|NCT02025855|Methadone|methadone|mesh-list
56276925|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56276926|NCT02025855|Narcotics|narcotics|mesh-ancestor
56276927|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276928|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276929|NCT02025855|Analgesics|analgesics|mesh-ancestor
56276930|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
56276931|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276932|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
56276933|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
56276934|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
56276935|NCT02025868|Darunavir|darunavir|mesh-list
56276936|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56276937|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56276938|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
56276939|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276940|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56276941|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56276942|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276943|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276945|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56276946|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
56276947|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
56276948|NCT02025881|Thiotepa|thiotepa|mesh-list
56276949|NCT02025881|Carboplatin|carboplatin|mesh-list
56276950|NCT02025881|Etoposide|etoposide|mesh-list
56276951|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276952|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
56276953|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276954|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801029|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
56276958|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276959|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56276960|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56276961|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56276962|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56276963|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276964|NCT02025998|Ibudilast|ibudilast|mesh-list
56187002|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56187003|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
56187004|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
56187005|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
56617231|NCT00911144|Vaccines|vaccines|mesh-list
56617232|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56617233|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
56187006|NCT04636632|Aprepitant|aprepitant|mesh-list
56187007|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
56187008|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
56187009|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187010|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187011|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56187012|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56187013|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187014|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187015|NCT04597372|Tamsulosin|tamsulosin|mesh-list
56187016|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56187017|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56187018|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56187019|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
56187020|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187021|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187022|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187023|NCT04597372|Urological Agents|urological agents|mesh-ancestor
56187024|NCT04588688|Mifepristone|mifepristone|mesh-list
56276965|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56276966|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
56276967|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276968|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276969|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56276970|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
56276971|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56276972|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276973|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276974|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56276975|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
56276976|NCT02026050|Dexamethasone|dexamethasone|mesh-list
56276977|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
56276978|NCT02026050|BB 1101|bb 1101|mesh-list
56276979|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56276980|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
56276981|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
56276982|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276983|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276984|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56276985|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
56276986|NCT02026050|Hormones|hormones|mesh-ancestor
56276987|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276988|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56276989|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276990|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
56276991|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187025|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56187026|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
56187027|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56187028|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187096|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187097|NCT04322305|Pregabalin|pregabalin|mesh-list
56187098|NCT04322305|Analgesics|analgesics|mesh-ancestor
56276992|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276993|NCT02026219|Clopidogrel|clopidogrel|mesh-list
56276994|NCT02026219|Ticagrelor|ticagrelor|mesh-list
56276995|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56277006|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277007|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56277008|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277009|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
56277011|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
56277012|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56277013|NCT02026479|BB 1101|bb 1101|mesh-list
56277014|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56277015|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
56277016|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
56277017|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617234|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617235|NCT04285580|Bimatoprost|bimatoprost|mesh-list
56617236|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56277043|NCT02026518|Vitamin D|vitamin d|mesh-list
56277044|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
56277045|NCT02026518|Vitamins|vitamins|mesh-ancestor
56277046|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
56277047|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277048|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56277049|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56277050|NCT02026583|Simvastatin|simvastatin|mesh-list
56277051|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56277052|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56277053|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
56277054|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277055|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56277056|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56277057|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277058|NCT02026765|Heparin|heparin|mesh-list
56277059|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
56277060|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56277061|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56277062|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277063|NCT02026778|Betahistine|betahistine|mesh-list
56277064|NCT02026778|Ondansetron|ondansetron|mesh-list
56277065|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
56277066|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
56277099|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277101|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277102|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277103|NCT02026921|Carboplatin|carboplatin|mesh-list
56277104|NCT02026921|Docetaxel|docetaxel|mesh-list
56277105|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277106|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
56277107|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
56277108|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
56277109|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277136|NCT02027103|Pioglitazone|pioglitazone|mesh-list
56277137|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277138|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277139|NCT02027220|Dexamethasone|dexamethasone|mesh-list
56277140|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
56277141|NCT02027220|Bortezomib|bortezomib|mesh-list
56277142|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277143|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
56277144|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277145|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56277146|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55801036|NCT04855279|Listerine|listerine|mesh-list
56187101|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187102|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
56187103|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56187104|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56187105|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187106|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56187107|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56187108|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56187109|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277148|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277149|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277150|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56277151|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56277152|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
56277153|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
56277154|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277155|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277156|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
56277157|NCT02027220|Hormones|hormones|mesh-ancestor
56277158|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277159|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56277191|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277192|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56617237|NCT04395248|Anesthetics|anesthetics|mesh-list
56617238|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617239|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617240|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
56617241|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56617242|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617243|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617244|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56617245|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617246|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56617247|NCT04276298|Metronidazole|metronidazole|mesh-list
56617248|NCT04276298|Lidocaine|lidocaine|mesh-list
56617249|NCT04276298|Diltiazem|diltiazem|mesh-list
56617250|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
56617251|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
56617252|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617253|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617254|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
56617255|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277194|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56277195|NCT02027337|Diuretics|diuretics|mesh-ancestor
56277196|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
56277197|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
56277198|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277199|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56277200|NCT02027363|Capecitabine|capecitabine|mesh-list
56277201|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852291|NCT00118378|Modafinil|modafinil|mesh-list
56277228|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277229|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
56277230|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277231|NCT02027532|Vancomycin|vancomycin|mesh-list
56277232|NCT02027532|Cefazolin|cefazolin|mesh-list
56277233|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56277234|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277235|NCT02027675|Micronutrients|micronutrients|mesh-list
56277236|NCT02027675|Trace Elements|trace elements|mesh-list
56277237|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277238|NCT02027753|Metformin|metformin|mesh-list
56277239|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
56277240|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56277241|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277242|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277243|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
56277244|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277245|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277246|NCT02027792|Diclofenac|diclofenac|mesh-list
56277247|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56277248|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56277249|NCT02027792|Analgesics|analgesics|mesh-ancestor
56277250|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
56277251|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277252|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277253|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56277254|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187110|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56617256|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56617257|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56617258|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56617259|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617260|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617261|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617262|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56617263|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56617264|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56617265|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56617266|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56617267|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56617268|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
56617269|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
56617270|NCT04273880|Methylphenidate|methylphenidate|mesh-list
56617271|NCT04273880|Vitamins|vitamins|mesh-ancestor
56617272|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
56617273|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617274|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
56617275|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187111|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56187112|NCT04318405|Hematinics|hematinics|mesh-ancestor
56187113|NCT04189848|Dulaglutide|dulaglutide|mesh-list
56187114|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187115|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187116|NCT04156334|Anesthetics|anesthetics|mesh-list
56187117|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187118|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187121|NCT04083170|Thiotepa|thiotepa|mesh-list
56187122|NCT04083170|Fludarabine|fludarabine|mesh-list
56277270|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277271|NCT02027961|Durvalumab|durvalumab|mesh-list
56277272|NCT02027961|Trametinib|trametinib|mesh-list
56277273|NCT02027961|Dabrafenib|dabrafenib|mesh-list
56277274|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56277275|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277276|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56277277|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277278|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277279|NCT02027987|Valproic Acid|valproic acid|mesh-list
56277280|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
56277281|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277282|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277283|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
56277284|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277285|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277286|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
56277287|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56277288|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277289|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56277290|NCT02028026|Citalopram|citalopram|mesh-list
56277291|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56277292|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56277293|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56617276|NCT04273880|Protective Agents|protective agents|mesh-ancestor
56617277|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56617278|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56617279|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56277294|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56277295|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277296|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277298|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277299|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56277300|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
56277301|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56277302|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56277303|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56277304|NCT02028078|Insulin|insulin|mesh-list
56277305|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56277306|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277307|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277308|NCT02028234|Omeprazole|omeprazole|mesh-list
56277309|NCT02028234|Pantoprazole|pantoprazole|mesh-list
56277310|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56277311|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277312|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56277313|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852386|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
56277327|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56277328|NCT02028403|BMS-936559|bms-936559|mesh-list
56277329|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56277330|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56277331|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277332|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
56277333|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277334|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
56187123|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
56187124|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56187125|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
56187126|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187127|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187128|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56187129|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
56187130|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187131|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187132|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56187133|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56187134|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
56187135|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
56187136|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277335|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
56277336|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277337|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277338|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
56277339|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
56277341|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56277342|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277343|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277344|NCT02028429|Urological Agents|urological agents|mesh-ancestor
56277346|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56277347|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
56277348|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277349|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277350|NCT02028507|Capecitabine|capecitabine|mesh-list
56277351|NCT02028507|Fulvestrant|fulvestrant|mesh-list
56277352|NCT02028507|Palbociclib|palbociclib|mesh-list
56277353|NCT02028507|Exemestane|exemestane|mesh-list
56277354|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56277355|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
56277356|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277357|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277358|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56277359|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56277360|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56617280|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56277361|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
56277362|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277363|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277364|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56277365|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277366|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56277367|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56277368|NCT02028533|Oxytocin|oxytocin|mesh-list
56277369|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
56277370|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56277371|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277372|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
56277398|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56277399|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277400|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277401|NCT02028689|Metformin|metformin|mesh-list
56277402|NCT02028689|Lesinurad|lesinurad|mesh-list
56277403|NCT02028689|Furosemide|furosemide|mesh-list
56277404|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277405|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277406|NCT02028689|Diuretics|diuretics|mesh-ancestor
56187137|NCT04078906|SMOFlipid|smoflipid|mesh-list
56187138|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
56187139|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56187140|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56187141|NCT03980171|Lenalidomide|lenalidomide|mesh-list
56187142|NCT03980171|Venetoclax|venetoclax|mesh-list
56187143|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
56187144|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
56187145|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187146|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56187147|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56187148|NCT03980171|Growth Substances|growth substances|mesh-ancestor
56277407|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
56277408|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56277409|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56277410|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277411|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
56277412|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56277413|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
56277414|NCT02028689|Renal Agents|renal agents|mesh-ancestor
56277415|NCT02028819|Dolutegravir|dolutegravir|mesh-list
56277416|NCT02028819|Ibalizumab|ibalizumab|mesh-list
56277417|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56277418|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56277419|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277420|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277421|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56277422|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55852504|NCT00130780|Docetaxel|docetaxel|mesh-list
56277481|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
56277482|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56277483|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56277484|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
56277492|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56277494|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
56277495|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277496|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56277497|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
56277498|NCT02029313|Montelukast|montelukast|mesh-list
56277499|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56277500|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
56277501|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56277502|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
55852582|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277509|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56277510|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277511|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
56277512|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277513|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56277514|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56277515|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56277516|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277518|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56617282|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617283|NCT00910988|Olanzapine|olanzapine|mesh-list
56617284|NCT00910988|Ziprasidone|ziprasidone|mesh-list
56617285|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
56617286|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
56617287|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617288|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617289|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56617290|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56617291|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56617292|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617293|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56617294|NCT00910988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56617295|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56617296|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55929879|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56277519|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187149|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
56187150|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277520|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277521|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
56277522|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277523|NCT02029534|Atorvastatin|atorvastatin|mesh-list
56277524|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56277525|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56277526|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
56277527|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277528|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56277529|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56277530|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277531|NCT02029573|Temozolomide|temozolomide|mesh-list
56277532|NCT02029573|Atorvastatin|atorvastatin|mesh-list
56277533|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56277534|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56277535|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
56277536|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277537|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56277538|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56277539|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277540|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56277541|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
56277542|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277543|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
56277544|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277545|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56277546|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56277547|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277548|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277549|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
56277550|NCT02029599|Acetaminophen|acetaminophen|mesh-list
56277551|NCT02029599|Methotrexate|methotrexate|mesh-list
55801056|NCT04848259|Hormones|hormones|mesh-ancestor
56277555|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277556|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56277557|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
56277558|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277559|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277560|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
56617297|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277561|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277562|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56277563|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277564|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
56277565|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852635|NCT01766336|Inositol|inositol|mesh-list
56277591|NCT02029794|Acetic Acid|acetic acid|mesh-list
56277592|NCT02029794|Retinol acetate|retinol acetate|mesh-list
56277593|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56277594|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277595|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56277596|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
56277597|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277598|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56277599|NCT02029794|Protective Agents|protective agents|mesh-ancestor
56277600|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277601|NCT02029898|Remifentanil|remifentanil|mesh-list
56277602|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56277603|NCT02029898|Narcotics|narcotics|mesh-ancestor
56277604|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277605|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277606|NCT02029898|Analgesics|analgesics|mesh-ancestor
56277607|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
56277608|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277609|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
56277610|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277611|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277612|NCT02029937|Proflavine|proflavine|mesh-list
56187151|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187152|NCT03979365|Tacrolimus|tacrolimus|mesh-list
56187153|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56187154|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
56187155|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187156|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56187157|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187158|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187159|NCT03901339|Gemcitabine|gemcitabine|mesh-list
56187160|NCT03901339|Capecitabine|capecitabine|mesh-list
56187161|NCT03901339|Vinorelbine|vinorelbine|mesh-list
56187162|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56187163|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
56187164|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187165|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187166|NCT03901339|Antiviral Agents|antiviral agents|mesh-ancestor
56187167|NCT03901339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56187168|NCT03901339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187169|NCT03901339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56187170|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
56187171|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187172|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56187173|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
56187174|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
56187175|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
56187176|NCT03860077|Nicotine|nicotine|mesh-list
56187177|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56187178|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
56187179|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187180|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187181|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56187182|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56187183|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
56187184|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187185|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187186|NCT03697512|Rituximab|rituximab|mesh-list
56187187|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187190|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277613|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56277614|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277615|NCT02029950|Cytarabine|cytarabine|mesh-list
56277642|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
56277643|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
56277644|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
56277646|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56277647|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617298|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617299|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
56617300|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56617301|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56617302|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
56617303|NCT00644059|Vaccines|vaccines|mesh-list
56617304|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
56617305|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277648|NCT02031367|Triamcinolone|triamcinolone|mesh-list
56277649|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56277650|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56277651|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56277652|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56277653|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
56277654|NCT02031367|Hormones|hormones|mesh-ancestor
56277655|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277656|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277657|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277658|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
56277659|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277660|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277661|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
56277662|NCT02031692|Vitamin D|vitamin d|mesh-list
56277663|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
56277664|NCT02031692|Calcium|calcium|mesh-list
55852748|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56277666|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277667|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56277669|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
56277670|NCT02031692|Antacids|antacids|mesh-ancestor
56277671|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277672|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277673|NCT02031991|Bevacizumab|bevacizumab|mesh-list
56277674|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56277675|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277676|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56277677|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56277678|NCT02031991|Growth Substances|growth substances|mesh-ancestor
56277679|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277680|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
56277681|NCT02032043|Ivermectin|ivermectin|mesh-list
56277682|NCT02032043|Albendazole|albendazole|mesh-list
56277683|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56277684|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277685|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
56277686|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
56277687|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56277688|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56277689|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
56277690|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
56277691|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
56277692|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277693|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277694|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56277695|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56277696|NCT02032134|Protective Agents|protective agents|mesh-ancestor
56277697|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277698|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56277699|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
56277700|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277701|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
56277702|NCT02032186|Cathartics|cathartics|mesh-ancestor
56277703|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277704|NCT02033356|Lidocaine|lidocaine|mesh-list
56277705|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
56277706|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
56277707|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277708|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277709|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
56617306|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
56617307|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56617308|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617309|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56617310|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
56617311|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56617312|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617313|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617314|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617315|NCT00811993|Gemcitabine|gemcitabine|mesh-list
56617316|NCT00811993|Etoposide|etoposide|mesh-list
56277710|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277711|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56277712|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56187194|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56187195|NCT03671746|Analgesics|analgesics|mesh-ancestor
56187196|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
56187197|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187198|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187199|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56187200|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187201|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56187202|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277713|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56277714|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56277715|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277716|NCT02033733|Cisatracurium|cisatracurium|mesh-list
56277717|NCT02033733|Atracurium|atracurium|mesh-list
56277718|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
56277719|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56277720|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277721|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277722|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56277723|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56277724|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56277725|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
56277726|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277727|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277728|NCT02034253|Risperidone|risperidone|mesh-list
56277729|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56277730|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
56277731|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277732|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277733|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277734|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56277735|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56277736|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277771|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
56277772|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56277773|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56277774|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277775|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277776|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56277777|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277778|NCT02038062|Sevoflurane|sevoflurane|mesh-list
56277779|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56277780|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56277781|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
56277810|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277811|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277812|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277813|NCT02040064|Gefitinib|gefitinib|mesh-list
56617317|NCT00811993|Docetaxel|docetaxel|mesh-list
56617318|NCT00811993|Bevacizumab|bevacizumab|mesh-list
56617319|NCT00811993|Carboplatin|carboplatin|mesh-list
56617320|NCT00811993|Capecitabine|capecitabine|mesh-list
56617321|NCT00811993|Trastuzumab|trastuzumab|mesh-list
56617322|NCT00811993|Irinotecan|irinotecan|mesh-list
56617323|NCT00811993|Cetuximab|cetuximab|mesh-list
56617324|NCT00811993|Temozolomide|temozolomide|mesh-list
56617325|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56617326|NCT00811993|Sorafenib|sorafenib|mesh-list
56617327|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56617328|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617329|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56617330|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
56277814|NCT02040064|Tremelimumab|tremelimumab|mesh-list
56277815|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277816|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56277817|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277818|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277819|NCT02040142|Mitomycins|mitomycins|mesh-list
56277820|NCT02040142|Mitomycin|mitomycin|mesh-list
56277821|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56277822|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187203|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187204|NCT03558724|Bevacizumab|bevacizumab|mesh-list
56187205|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187206|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187207|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56187208|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56277823|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
56277824|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277825|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56277826|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277853|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
56277854|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277855|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277856|NCT02040350|Pralidoxime|pralidoxime|mesh-list
56277857|NCT02040350|Antidotes|antidotes|mesh-ancestor
56277858|NCT02040350|Protective Agents|protective agents|mesh-ancestor
56277859|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277860|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
56277861|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
56277862|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277863|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
56277864|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277865|NCT02040402|Vaccines|vaccines|mesh-list
56277866|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
56277867|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277868|NCT02040415|Eperisone|eperisone|mesh-list
56277869|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
56277870|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56277871|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56277872|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277873|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56277874|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277875|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56277876|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56277877|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277878|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
56277879|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
56277880|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
56277881|NCT02040441|Spironolactone|spironolactone|mesh-list
56277909|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56277910|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56277911|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
56617331|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56617332|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617333|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617334|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56617335|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56159594|NCT02956122|Prednisolone|prednisolone|mesh-list
56617336|NCT00811993|Growth Substances|growth substances|mesh-ancestor
56617337|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617338|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
56617339|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56617340|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
56617341|NCT00811993|Antiviral Agents|antiviral agents|mesh-ancestor
56617342|NCT00811993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617343|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617344|NCT00811993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56617345|NCT00811993|Immunologic Factors|immunologic factors|mesh-ancestor
56617346|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56617347|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56617348|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56617349|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56277912|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277913|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277914|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56277915|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56277916|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56277917|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
56277918|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56277919|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
56277920|NCT02040597|Hormones|hormones|mesh-ancestor
56277921|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277922|NCT02040636|Vaccines|vaccines|mesh-list
56277923|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
56277924|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277925|NCT02040649|Midazolam|midazolam|mesh-list
56277926|NCT02040649|Propofol|propofol|mesh-list
56277927|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56277960|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
56277961|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56277962|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
56277963|NCT02040818|Protective Agents|protective agents|mesh-ancestor
56277964|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277965|NCT02040818|Antidotes|antidotes|mesh-ancestor
56277966|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56277967|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56187209|NCT03558724|Growth Substances|growth substances|mesh-ancestor
56187210|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187211|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
56277968|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277969|NCT02040831|Vaccines|vaccines|mesh-list
56277970|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
56277971|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277972|NCT02040883|Olanzapine|olanzapine|mesh-list
56277973|NCT02040883|Risperidone|risperidone|mesh-list
56277994|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56617350|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
56617351|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56277995|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56277996|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
56277997|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
56277998|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56277999|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56278002|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56278003|NCT02040909|Propofol|propofol|mesh-list
56278004|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56278005|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278006|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278007|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56278008|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
56278009|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
56278010|NCT02040935|Trastuzumab|trastuzumab|mesh-list
56278011|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56278012|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278013|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
56278014|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56278015|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278016|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56278017|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56278018|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278019|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278020|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278021|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56278022|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56278023|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56278024|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
56278025|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278026|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56278027|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55853116|NCT01790464|Lidocaine|lidocaine|mesh-list
56278054|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
56278055|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
56278056|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
56278057|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278058|NCT02041455|Amitriptyline|amitriptyline|mesh-list
56278059|NCT02041455|Melatonin|melatonin|mesh-list
56278060|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
56278061|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278062|NCT02041455|Protective Agents|protective agents|mesh-ancestor
56278063|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278064|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278065|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56278066|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
56278067|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56278068|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56278069|NCT02041455|Analgesics|analgesics|mesh-ancestor
56278070|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
56278071|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278072|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56278073|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56278074|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56278075|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
56278076|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278108|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56278109|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278110|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
56187213|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56187214|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187215|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56278111|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56278112|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278113|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56278114|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
56278115|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278117|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278118|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278119|NCT02042196|Cetrorelix|cetrorelix|mesh-list
56617352|NCT00817765|Ritonavir|ritonavir|mesh-list
56617353|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
56617354|NCT00817765|Posaconazole|posaconazole|mesh-list
56617355|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56617356|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56617357|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
56617358|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617359|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617360|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56617361|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56617362|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
56617363|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617364|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56617365|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56617366|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
56617367|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56617368|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56617369|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56617370|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56617371|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56617372|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
56617373|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56617374|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617375|NCT00816205|Nifedipine|nifedipine|mesh-list
56617376|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56617377|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617378|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617379|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56617380|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617381|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
56617382|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
56617383|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56617392|NCT00910910|Chlorambucil|chlorambucil|mesh-list
56617393|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
56617394|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617395|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56617396|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56617397|NCT00910910|Growth Substances|growth substances|mesh-ancestor
56617398|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929986|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278120|NCT02042196|Estradiol|estradiol|mesh-list
56278121|NCT02042196|Estrogens|estrogens|mesh-ancestor
56278140|NCT02042495|Metformin|metformin|mesh-list
56278141|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56278142|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278143|NCT02042573|Sertraline|sertraline|mesh-list
56278146|NCT02042573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56278147|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56278148|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56278149|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278150|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278151|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
56278152|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278153|NCT02042599|Sevoflurane|sevoflurane|mesh-list
56278154|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56278155|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56278156|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
56278157|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
56278158|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278159|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278160|NCT02042612|Sevoflurane|sevoflurane|mesh-list
56278161|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56278162|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56278163|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
56278164|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
56278165|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278166|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278167|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56278168|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278169|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278171|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56278172|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278173|NCT02042690|Dexamethasone|dexamethasone|mesh-list
56278174|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
56278175|NCT02042690|Methotrexate|methotrexate|mesh-list
56278176|NCT02042690|Epirubicin|epirubicin|mesh-list
56278177|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
56278178|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278179|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
56278204|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56278205|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56278206|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56278207|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56278208|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
56278209|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
56278210|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278211|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
56278212|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278213|NCT02042742|Protective Agents|protective agents|mesh-ancestor
56278214|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278215|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56278216|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56278217|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
56278218|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56278219|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56187216|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187217|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278220|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278221|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56617399|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617400|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56617401|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
56617402|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617403|NCT04522544|Durvalumab|durvalumab|mesh-list
56617404|NCT04522544|Tremelimumab|tremelimumab|mesh-list
56617405|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617406|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617407|NCT04384562|Methylphenidate|methylphenidate|mesh-list
56617408|NCT04384562|Reboxetine|reboxetine|mesh-list
56617409|NCT04384562|Nicotine|nicotine|mesh-list
56617410|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56617411|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
56617412|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617413|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617414|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56617415|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56617416|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
56617417|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617418|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617419|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56617420|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56278222|NCT02043054|Liraglutide|liraglutide|mesh-list
56278223|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56278224|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278225|NCT02043054|Incretins|incretins|mesh-ancestor
56278226|NCT02043054|Hormones|hormones|mesh-ancestor
56278227|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278261|NCT02043314|Isoniazid|isoniazid|mesh-list
56278262|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
56278263|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56278264|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278265|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56278266|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56278267|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
56278268|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278269|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56278299|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278302|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56278303|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56278304|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278305|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278307|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278308|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
56278309|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278310|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278311|NCT02043886|Acarbose|acarbose|mesh-list
56278312|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56278313|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278314|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278315|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56617421|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56617422|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56278346|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278347|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278348|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56278349|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
56278350|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56278351|NCT02044133|Vitamin D|vitamin d|mesh-list
55900334|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56278352|NCT02044133|Vitamins|vitamins|mesh-ancestor
56278353|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
56278354|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278355|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56278356|NCT02044146|Clopidogrel|clopidogrel|mesh-list
56278357|NCT02044146|Ticagrelor|ticagrelor|mesh-list
56278358|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56278359|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56278360|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56278389|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56278390|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278391|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56278392|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56278393|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278394|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56278395|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56278396|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278397|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
56278398|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56278399|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56278400|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56278401|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
56278402|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278403|NCT02044354|Docetaxel|docetaxel|mesh-list
56278467|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56278468|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56278469|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56278470|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187218|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56187219|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56187220|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
56278471|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278472|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56278473|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56278474|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56278475|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
56278476|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56278477|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278478|NCT02045017|Dexamethasone|dexamethasone|mesh-list
56278479|NCT02045017|Pomalidomide|pomalidomide|mesh-list
56278480|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56278481|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
56278482|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
56278483|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278484|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278485|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56278486|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
56278487|NCT02045017|Hormones|hormones|mesh-ancestor
56278516|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278517|NCT02045368|Methotrexate|methotrexate|mesh-list
56278518|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56278519|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
56278520|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278521|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278522|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278523|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
56278524|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278525|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278526|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56278527|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278528|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56278529|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56617423|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
56617424|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
56617425|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56617426|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56617427|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
56617428|NCT04515134|Ubiquinone|ubiquinone|mesh-list
56617430|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
56617431|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617432|NCT04515134|Vitamins|vitamins|mesh-ancestor
56617433|NCT04238390|Meropenem|meropenem|mesh-list
56617434|NCT04238390|Tazobactam|tazobactam|mesh-list
56617435|NCT04238390|Ceftolozane|ceftolozane|mesh-list
56278530|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
56278531|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278532|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56278556|NCT02045602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278557|NCT02045667|Mexiletine|mexiletine|mesh-list
56278558|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56278559|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56278560|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56278561|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56278562|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278563|NCT02045693|Buprenorphine|buprenorphine|mesh-list
56278564|NCT02045693|Methadone|methadone|mesh-list
56278565|NCT02045693|Naloxone|naloxone|mesh-list
56278566|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56278567|NCT02045693|Narcotics|narcotics|mesh-ancestor
56278568|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278569|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278570|NCT02045693|Analgesics|analgesics|mesh-ancestor
56278571|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
56278572|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278573|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55900563|NCT01682213|Dabrafenib|dabrafenib|mesh-list
56278574|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
56278575|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
56278576|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
56278577|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
56278578|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
56278579|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278580|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278581|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
56278582|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278583|NCT02045849|Itraconazole|itraconazole|mesh-list
56278615|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
56278616|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278617|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56278618|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56278619|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56278620|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
56187221|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187222|NCT03495960|Rituximab|rituximab|mesh-list
56187223|NCT03495960|Methotrexate|methotrexate|mesh-list
56187224|NCT03495960|Lenalidomide|lenalidomide|mesh-list
56187225|NCT03495960|Temozolomide|temozolomide|mesh-list
56187226|NCT03495960|Procarbazine|procarbazine|mesh-list
56187227|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187228|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187229|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
56187230|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187231|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187232|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56187233|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
56187234|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56187235|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56187236|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
56187237|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617436|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56617437|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56617438|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617439|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56617440|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617441|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617442|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56617443|NCT04238390|Renal Agents|renal agents|mesh-ancestor
56617444|NCT04236830|Fluorides|fluorides|mesh-list
56617445|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
56617446|NCT04236830|Protective Agents|protective agents|mesh-ancestor
56617447|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617448|NCT04203212|Goserelin|goserelin|mesh-list
56617449|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56617450|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617451|NCT00637910|Docetaxel|docetaxel|mesh-list
56617452|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56187238|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
56278621|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278622|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278623|NCT02045992|Caffeine|caffeine|mesh-list
56278651|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
56278652|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278653|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278654|NCT02046304|Antiviral Agents|antiviral agents|mesh-ancestor
56278655|NCT02046304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278656|NCT02046304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278657|NCT02046304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278658|NCT02046304|Immunologic Factors|immunologic factors|mesh-ancestor
56278659|NCT02046304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278660|NCT02046421|Gemcitabine|gemcitabine|mesh-list
56278661|NCT02046421|Carboplatin|carboplatin|mesh-list
56278662|NCT02046421|Mifepristone|mifepristone|mesh-list
56278663|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278664|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278665|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
56278666|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853767|NCT01782872|Ropivacaine|ropivacaine|mesh-list
56278686|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56278687|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
56278688|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56278689|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56278690|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56278691|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56278692|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
56278693|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278694|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278695|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278697|NCT02046460|Vitamin K|vitamin k|mesh-list
56278698|NCT02046460|Warfarin|warfarin|mesh-list
56278699|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
56278700|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
56278701|NCT02046460|Vitamins|vitamins|mesh-ancestor
56278702|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
56278703|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278704|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
56278705|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56278706|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56114994|NCT00002111|Saquinavir|saquinavir|mesh-list
56617453|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617454|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
56617455|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
56617456|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
56617457|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617458|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56617459|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617460|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
56617461|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56617462|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56617463|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56617464|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617465|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617466|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
56617467|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617468|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617469|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56617470|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617471|NCT04449536|Mesna|mesna|mesh-list
56617472|NCT04449536|Protective Agents|protective agents|mesh-ancestor
56617473|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617474|NCT03960554|Denosumab|denosumab|mesh-list
56617475|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56617476|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617477|NCT04084106|Amoxicillin|amoxicillin|mesh-list
56617478|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
56187239|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187240|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56187241|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56187242|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56187243|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56187244|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56187245|NCT03495960|Growth Substances|growth substances|mesh-ancestor
56187246|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
56187247|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56187248|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
56278707|NCT02046460|Analgesics|analgesics|mesh-ancestor
56278708|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
56278709|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278710|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56278711|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278712|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56278713|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56278714|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278715|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56278716|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56278717|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617479|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
56617480|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56617481|NCT04084106|Penicillin V|penicillin v|mesh-list
56617482|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56617483|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617484|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617485|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617486|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56617487|NCT02977052|Nivolumab|nivolumab|mesh-list
56617488|NCT02977052|Ipilimumab|ipilimumab|mesh-list
56617489|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617490|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617491|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56617492|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617493|NCT02973542|Ethosuximide|ethosuximide|mesh-list
56617494|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
56617495|NCT02973386|Cisplatin|cisplatin|mesh-list
56617496|NCT02973386|Capecitabine|capecitabine|mesh-list
56617497|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278718|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
56278719|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56278720|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
56278721|NCT02046460|Coagulants|coagulants|mesh-ancestor
56278759|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853859|NCT01753856|Demeclocycline|demeclocycline|mesh-list
56278796|NCT02046720|Propofol|propofol|mesh-list
56278797|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56278831|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278832|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56278833|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
56278834|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278835|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278864|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278866|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56278867|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56278868|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278869|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
55900860|NCT03106740|Minocycline|minocycline|mesh-list
56278871|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278872|NCT02047136|Histamine|histamine|mesh-list
56278873|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
56278874|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
56278875|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278876|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278877|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278878|NCT02047149|Zileuton|zileuton|mesh-list
56278879|NCT02047149|Dasatinib|dasatinib|mesh-list
56278880|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
56278913|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56278914|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278915|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
56278916|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56278917|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56278918|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
56278919|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56278920|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56617498|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56617499|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
56617500|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617501|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
56617502|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56617503|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56617504|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
56617505|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617506|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617507|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617508|NCT00909428|Urological Agents|urological agents|mesh-ancestor
56617509|NCT03718130|Vaccines|vaccines|mesh-list
56617510|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
56617511|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617512|NCT00908960|Enoxaparin|enoxaparin|mesh-list
56617513|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
56617514|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56617515|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56617516|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617517|NCT05470244|Analgesics|analgesics|mesh-list
56617518|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
56617519|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617520|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617521|NCT05332106|Dienogest|dienogest|mesh-list
56617522|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56617523|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56617524|NCT05332106|Estradiol|estradiol|mesh-list
56617525|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56617526|NCT05332106|Nandrolone|nandrolone|mesh-list
56617527|NCT05332106|Estrogens|estrogens|mesh-ancestor
56617528|NCT05332106|Hormones|hormones|mesh-ancestor
56617529|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278957|NCT00005823|Thioguanine|thioguanine|mesh-list
56278958|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56278959|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278960|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56187249|NCT03416127|Metformin|metformin|mesh-list
56187250|NCT03416127|Propolis|propolis|mesh-list
56187251|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187252|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187253|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56187254|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
56187255|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617530|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617531|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56617532|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
56617533|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56617534|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56617535|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56617536|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56617537|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56617538|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
56617539|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56617540|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617541|NCT05332106|Androgens|androgens|mesh-ancestor
56187256|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187257|NCT03293069|Deferiprone|deferiprone|mesh-list
56187258|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56187259|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
56187260|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
56187261|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187262|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
56187263|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
56187264|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187265|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
56187266|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187267|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187268|NCT03250975|Azithromycin|azithromycin|mesh-list
56187269|NCT03250975|Budesonide|budesonide|mesh-list
56187270|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56187271|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56278961|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56278962|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854063|NCT01519167|Analgesics|analgesics|mesh-ancestor
56278994|NCT00005829|Immunologic Factors|immunologic factors|mesh-ancestor
56278995|NCT00005829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278997|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278998|NCT00005835|Melphalan|melphalan|mesh-list
56278999|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
56279000|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
56279001|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279002|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279003|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
55854101|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
56279041|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
56279042|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279043|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
56279044|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279045|NCT00005847|Analgesics|analgesics|mesh-ancestor
56279069|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56279070|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56279071|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
56279072|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56279073|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
56279074|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56279075|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56279076|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56279077|NCT00005853|Etanercept|etanercept|mesh-list
56279078|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56279079|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56279080|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56279082|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
56187272|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
56187273|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187274|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187275|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56617542|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
56617543|NCT05332028|Fentanyl|fentanyl|mesh-list
56617544|NCT05332028|Bupivacaine|bupivacaine|mesh-list
56617545|NCT05332028|Propofol|propofol|mesh-list
56617546|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
56617547|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
56617548|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617549|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617550|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
56617551|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617552|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56187276|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
56187277|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
56187278|NCT03250975|Hormones|hormones|mesh-ancestor
56187279|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187280|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56279083|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279084|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279085|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279086|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279087|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56279088|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279089|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
56279090|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
56279091|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279092|NCT00005859|Tipifarnib|tipifarnib|mesh-list
56279093|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279094|NCT00005862|Semaxinib|semaxinib|mesh-list
56279095|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56279096|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56279132|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279133|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279134|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279160|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56279161|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
56279162|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279163|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279164|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56279165|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279166|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56279167|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56279168|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56279169|NCT00005889|Glucagon|glucagon|mesh-list
56279170|NCT00005889|Glycerol|glycerol|mesh-list
55901181|NCT01697345|Hormones|hormones|mesh-ancestor
56279171|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279172|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56279173|NCT00005889|Hormones|hormones|mesh-ancestor
56279174|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279175|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56279176|NCT00005889|Protective Agents|protective agents|mesh-ancestor
56279177|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
56279178|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279179|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
56279180|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279181|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279214|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279215|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56279216|NCT00005898|Protective Agents|protective agents|mesh-ancestor
56279217|NCT00386412|Valganciclovir|valganciclovir|mesh-list
56279218|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
56279219|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279220|NCT00386529|Aspirin|aspirin|mesh-list
56279221|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56279222|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56617553|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56617554|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
56617555|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56279223|NCT00386529|Analgesics|analgesics|mesh-ancestor
56279224|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
55854319|NCT00393874|Prazosin|prazosin|mesh-list
56279259|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279260|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279261|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56279262|NCT00005931|Semaxinib|semaxinib|mesh-list
56187281|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279263|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854359|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56279293|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
56279294|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279295|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279296|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279297|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56279298|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
56279299|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56279300|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279301|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
56279302|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
56279303|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279304|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56279305|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56279306|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
56279307|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279308|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56279309|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56279343|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
56279344|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279345|NCT00005952|Temozolomide|temozolomide|mesh-list
56279346|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279347|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
56279348|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279349|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279350|NCT00005955|Temozolomide|temozolomide|mesh-list
56279351|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279352|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
56279353|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279376|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279377|NCT00005964|Prednisone|prednisone|mesh-list
56279378|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
56279379|NCT00005964|Doxorubicin|doxorubicin|mesh-list
56279380|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56279381|NCT00005964|Etoposide|etoposide|mesh-list
56279382|NCT00005964|Vincristine|vincristine|mesh-list
56279383|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279384|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
56279385|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279386|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279387|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279388|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
56279389|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279390|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279391|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279392|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56279393|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56279394|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279395|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901387|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
56279396|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279397|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
56279398|NCT00005964|Hormones|hormones|mesh-ancestor
56279399|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279400|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56279401|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279402|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279403|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279404|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279405|NCT00005967|Tipifarnib|tipifarnib|mesh-list
56617556|NCT05332028|Narcotics|narcotics|mesh-ancestor
56617557|NCT05332028|Analgesics|analgesics|mesh-ancestor
56617558|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56279406|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279437|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56279438|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
56279439|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279440|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56279441|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56279442|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56279443|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56279444|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56279445|NCT00005976|Carboplatin|carboplatin|mesh-list
56279446|NCT00005976|NSC 366140|nsc 366140|mesh-list
56187282|NCT03232346|Buprenorphine|buprenorphine|mesh-list
56187283|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56187284|NCT03232346|Narcotics|narcotics|mesh-ancestor
56279447|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279448|NCT00005979|Leucovorin|leucovorin|mesh-list
56279478|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279479|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279480|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
56279481|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279482|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279483|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279484|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279485|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
56279486|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
56279487|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279488|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56279489|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
56279490|NCT00005985|Hormones|hormones|mesh-ancestor
56279491|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279492|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56279493|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279494|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56279495|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279496|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854581|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
56279534|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279535|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56279536|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279604|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56279605|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56279606|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56279607|NCT00006006|Growth Substances|growth substances|mesh-ancestor
56279608|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
56279609|NCT00006009|Visilizumab|visilizumab|mesh-list
56279610|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
56279611|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279612|NCT00006012|Paclitaxel|paclitaxel|mesh-list
56279613|NCT00006012|Etoposide|etoposide|mesh-list
56279614|NCT00006012|Topotecan|topotecan|mesh-list
56279615|NCT00006012|Amifostine|amifostine|mesh-list
56279616|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279617|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279645|NCT00006015|Protective Agents|protective agents|mesh-ancestor
56279646|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
56279648|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
56279649|NCT00006018|Paclitaxel|paclitaxel|mesh-list
56279650|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279651|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279652|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279653|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279654|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279655|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279656|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
56279657|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
56279658|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
56279659|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279660|NCT00006021|Protective Agents|protective agents|mesh-ancestor
56279661|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279662|NCT00006021|Vitamins|vitamins|mesh-ancestor
56617559|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
56617560|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56617561|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56617562|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56617563|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617564|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617565|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
56617566|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617567|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617568|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56617569|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617571|NCT00643201|Warfarin|warfarin|mesh-list
56617572|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
56617573|NCT00643201|Apixaban|apixaban|mesh-list
56617574|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
56617575|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56617576|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56617577|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617578|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56617579|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
56279663|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
56279664|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279665|NCT00006024|Temozolomide|temozolomide|mesh-list
56279666|NCT00006024|Lomustine|lomustine|mesh-list
56279667|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55901692|NCT02412150|Desflurane|desflurane|mesh-list
56279700|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279701|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279702|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
56279703|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279704|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279705|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
56279706|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279727|NCT00006042|Fludarabine|fludarabine|mesh-list
56279728|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
56279729|NCT00006042|Tacrolimus|tacrolimus|mesh-list
56279730|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279731|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
56279732|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279733|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279734|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279735|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
56279736|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279737|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279738|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279739|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279740|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
56279741|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56279742|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279743|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56279744|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56279745|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
56279746|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56279747|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279748|NCT05680974|Antibodies|antibodies|mesh-list
56279749|NCT05680974|Immunologic Factors|immunologic factors|mesh-ancestor
56617580|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56617581|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
56617582|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617583|NCT00643123|Allopurinol|allopurinol|mesh-list
56279750|NCT05680974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279751|NCT05680857|Ubiquinone|ubiquinone|mesh-list
56279752|NCT05680857|Coenzyme Q10|coenzyme q10|mesh-list
56279753|NCT05680857|Micronutrients|micronutrients|mesh-ancestor
56279754|NCT05680857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279755|NCT05680857|Vitamins|vitamins|mesh-ancestor
56279756|NCT00386763|Lumefantrine|lumefantrine|mesh-list
56279757|NCT00386763|Artemether|artemether|mesh-list
56279758|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56279759|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
56279760|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56279761|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56279762|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279763|NCT05680662|Metformin|metformin|mesh-list
56279764|NCT05680662|Quercetin|quercetin|mesh-list
56279765|NCT05680662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56279799|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56279800|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56279802|NCT00386841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56279803|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56279835|NCT05679375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56279836|NCT05679375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56279837|NCT05679375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56279838|NCT05679375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56279839|NCT05679375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279840|NCT05679336|Cyclophosphamide|cyclophosphamide|mesh-list
56279841|NCT05679336|Rituximab|rituximab|mesh-list
56279842|NCT05679336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279843|NCT05679336|Immunologic Factors|immunologic factors|mesh-ancestor
56279844|NCT05679336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279878|NCT05605509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279879|NCT05605509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279880|NCT05605509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279881|NCT05605509|Immunologic Factors|immunologic factors|mesh-ancestor
56279882|NCT05605509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279883|NCT05605509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56279885|NCT05597163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55854976|NCT00455962|Hormones|hormones|mesh-ancestor
56279917|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
56279918|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
56279919|NCT05423535|Coagulants|coagulants|mesh-ancestor
56279920|NCT03940131|Panitumumab|panitumumab|mesh-list
56279921|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56279922|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279923|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
56279924|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56279925|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279926|NCT05160597|Edetic Acid|edetic acid|mesh-list
56279927|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56279928|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
56279929|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
56279930|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279931|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
56279956|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56279957|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
56279959|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187285|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187286|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279960|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56279961|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279962|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
56279963|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56279964|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56279965|NCT04910568|Growth Substances|growth substances|mesh-ancestor
56279966|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
56279968|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
56279969|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279971|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
55811282|NCT05190705|BB 1101|bb 1101|mesh-list
56617584|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
56617585|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617586|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617587|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
56617588|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56617589|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56617590|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
56617591|NCT00643123|Protective Agents|protective agents|mesh-ancestor
56617592|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617593|NCT00816673|Melatonin|melatonin|mesh-list
56617594|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
56617595|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617596|NCT00816673|Protective Agents|protective agents|mesh-ancestor
56617597|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001041|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
56279972|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279973|NCT04803084|Protective Agents|protective agents|mesh-ancestor
56279974|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279975|NCT04793685|Prazosin|prazosin|mesh-list
56279976|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56279977|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56279978|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56279979|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56279980|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
56279981|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56279982|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855052|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56280011|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280012|NCT03834909|Tenofovir|tenofovir|mesh-list
56280013|NCT03834909|Emtricitabine|emtricitabine|mesh-list
56280014|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56280015|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
56280016|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280017|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56280018|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56280019|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280020|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280021|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56280022|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56280023|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
56280024|NCT04360473|Ketamine|ketamine|mesh-list
56280025|NCT04360473|Anesthetics|anesthetics|mesh-list
56280026|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56280027|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280028|NCT04360473|Analgesics|analgesics|mesh-ancestor
55855105|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
56280037|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280038|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56280039|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
56280040|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56280041|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56280042|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56280043|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
56280044|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56280045|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56280046|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
56280047|NCT04329975|Coagulants|coagulants|mesh-ancestor
56280048|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56280049|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
56617598|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617599|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56617600|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56617601|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56617602|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56280050|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280051|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
56280052|NCT04305795|Cemiplimab|cemiplimab|mesh-list
56280053|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280054|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280055|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
56280056|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56280057|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280058|NCT04175613|Apremilast|apremilast|mesh-list
56280059|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56280060|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56280061|NCT04175613|Analgesics|analgesics|mesh-ancestor
56280062|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
56280063|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280064|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187287|NCT03232346|Analgesics|analgesics|mesh-ancestor
56187288|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
56187289|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187290|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56187291|NCT03227731|Tenofovir|tenofovir|mesh-list
56187292|NCT03227731|Emtricitabine|emtricitabine|mesh-list
56187293|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56187294|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
56187295|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56187296|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56187297|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56280065|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56280066|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280067|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56280068|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56280069|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280070|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280072|NCT03945357|Clindamycin|clindamycin|mesh-list
56280073|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
56280074|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
56280075|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280076|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
56280077|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902061|NCT02408172|Metoprolol|metoprolol|mesh-list
56280078|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280079|NCT03945357|Antiviral Agents|antiviral agents|mesh-ancestor
56280080|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280081|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280082|NCT03945357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280083|NCT03945357|Immunologic Factors|immunologic factors|mesh-ancestor
56280084|NCT03945357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280085|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56280086|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56280087|NCT03913221|Caffeine|caffeine|mesh-list
56280088|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
56280089|NCT03913221|Citric Acid|citric acid|mesh-list
56280090|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
56280091|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
56280092|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56280093|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
56280094|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
56280120|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56280121|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56280122|NCT03786081|Growth Substances|growth substances|mesh-ancestor
56280123|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280124|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
56280125|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
56280126|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56617603|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617604|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617605|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617606|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
56617607|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56617608|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56617609|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56617610|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56617611|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617612|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617613|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617614|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617615|NCT00641719|Analgesics|analgesics|mesh-ancestor
56617616|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
56617617|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617618|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
56617619|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56617620|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
56617621|NCT02863367|Gemcitabine|gemcitabine|mesh-list
56280127|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280128|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56280129|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280130|NCT03741933|Apremilast|apremilast|mesh-list
56280131|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56280132|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56280133|NCT03741933|Analgesics|analgesics|mesh-ancestor
56280134|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
56280135|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280136|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280137|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56280138|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280139|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56280140|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56280141|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187298|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187299|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187300|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55855221|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280174|NCT03084939|Trastuzumab|trastuzumab|mesh-list
56280175|NCT03084939|Lapatinib|lapatinib|mesh-list
56280176|NCT03084939|Maytansine|maytansine|mesh-list
56280177|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56280178|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280179|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
55855269|NCT00383266|Pemetrexed|pemetrexed|mesh-list
56280206|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56280207|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56280208|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
56280209|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56280210|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280211|NCT00387504|Fenretinide|fenretinide|mesh-list
56280212|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280213|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56617622|NCT02863367|Apatinib|apatinib|mesh-list
56617623|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56617624|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
56617625|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617626|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617627|NCT02863367|Antiviral Agents|antiviral agents|mesh-ancestor
56617628|NCT02863367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617629|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617630|NCT02863367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56617631|NCT02863367|Immunologic Factors|immunologic factors|mesh-ancestor
56617632|NCT02863367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617633|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56617635|NCT00648895|Nebivolol|nebivolol|mesh-list
56617636|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56617637|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56617638|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
56617639|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
56617640|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617641|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617642|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56617643|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56617644|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56617645|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
56617646|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617647|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617648|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
56617649|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56280214|NCT00387504|Protective Agents|protective agents|mesh-ancestor
56280215|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280216|NCT02936505|Cyclosporine|cyclosporine|mesh-list
56280217|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
56280218|NCT02936505|Tacrolimus|tacrolimus|mesh-list
56280219|NCT02936505|Cyclosporins|cyclosporins|mesh-list
56280220|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
56280221|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55991238|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991239|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55991240|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55991241|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55991242|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
55991265|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991266|NCT04807504|Ropivacaine|ropivacaine|mesh-list
55991267|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
55991269|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991270|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991272|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617650|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56617651|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56617652|NCT00975221|Cinacalcet|cinacalcet|mesh-list
56617653|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56617654|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617655|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56617656|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
56617657|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56617658|NCT02863679|Tetracaine|tetracaine|mesh-list
56617659|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
56617660|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
56617661|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617662|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617663|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
56617664|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617665|NCT00906698|Vinorelbine|vinorelbine|mesh-list
56617666|NCT00906698|Afatinib|afatinib|mesh-list
56617667|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56617668|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617669|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
56617670|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
56617671|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
56617672|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001110|NCT00000778|Vitamins|vitamins|mesh-ancestor
55991292|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991315|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991316|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991318|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55991319|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
55991320|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55991321|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991322|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55991323|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991324|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55991325|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55991326|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55991327|NCT03087604|Lidocaine|lidocaine|mesh-list
55991328|NCT03087604|Epinephrine|epinephrine|mesh-list
55855483|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
55991343|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991344|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55991345|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55991346|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
55991347|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56187301|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56187302|NCT03200015|Metformin|metformin|mesh-list
56187303|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187304|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187305|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
56187306|NCT03193281|Dasatinib|dasatinib|mesh-list
56617673|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56617674|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617675|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56617676|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56617677|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
56617678|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617679|NCT03396926|Bevacizumab|bevacizumab|mesh-list
56617680|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56617681|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
56617682|NCT03396926|Capecitabine|capecitabine|mesh-list
56187307|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187308|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56187309|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187310|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187311|NCT03149640|Amikacin|amikacin|mesh-list
56187312|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56187313|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115066|NCT05752409|Anesthetics|anesthetics|mesh-ancestor
56187314|NCT03098355|Interleukin-2|interleukin-2|mesh-list
56187315|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187316|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56187317|NCT03098355|Analgesics|analgesics|mesh-ancestor
56187318|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
56187319|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187320|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187322|NCT02986334|Omeprazole|omeprazole|mesh-list
55991348|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
55991349|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
55991350|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
55991352|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55991354|NCT00987727|Glycerol|glycerol|mesh-list
55991355|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55991356|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
55991384|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991386|NCT04557189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55991387|NCT04557189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991388|NCT04557189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55991389|NCT04557189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55991390|NCT05388487|Complement Factor H|complement factor h|mesh-list
55991391|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55991392|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991393|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
55991425|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991426|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55991428|NCT03018535|Hormones|hormones|mesh-ancestor
55991429|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55991430|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55991431|NCT03018535|Protective Agents|protective agents|mesh-ancestor
55991432|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55991433|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55991434|NCT04890873|Antacids|antacids|mesh-ancestor
55991435|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991436|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55991437|NCT04889547|Dexamethasone|dexamethasone|mesh-list
55991460|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991461|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56187323|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56187324|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55991462|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55991463|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991465|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55991466|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55991467|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55991468|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
55991469|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991470|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56617683|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
56617684|NCT03396926|Antibodies|antibodies|mesh-list
55991471|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55991472|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991473|NCT03146806|Ketamine|ketamine|mesh-list
55991474|NCT03146806|Analgesics|analgesics|mesh-ancestor
55991475|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
55991476|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991477|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991478|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55991479|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55991480|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
55991481|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
55991482|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991483|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55991484|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55991485|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991486|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991487|NCT03439293|Dexamethasone|dexamethasone|mesh-list
55991488|NCT03439293|Daratumumab|daratumumab|mesh-list
55991489|NCT03439293|Ixazomib|ixazomib|mesh-list
55991522|NCT03424005|Growth Substances|growth substances|mesh-ancestor
55991523|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991525|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55991526|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
55991527|NCT03424005|Antiviral Agents|antiviral agents|mesh-ancestor
55991528|NCT03424005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991529|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991530|NCT03424005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991531|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
55991532|NCT02975583|Vorapaxar|vorapaxar|mesh-list
55991533|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55991568|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
55991569|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
55991570|NCT04450108|Protective Agents|protective agents|mesh-ancestor
55991571|NCT03891849|Octreotide|octreotide|mesh-list
55991572|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55991573|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55991574|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991611|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991613|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55991614|NCT03096730|Analgesics|analgesics|mesh-ancestor
55991615|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
55991616|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991617|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55991618|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55991648|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55991649|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991650|NCT03321045|Trastuzumab|trastuzumab|mesh-list
55991651|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991652|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991653|NCT00989989|Ranibizumab|ranibizumab|mesh-list
55991654|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55991655|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55991656|NCT00989989|Growth Substances|growth substances|mesh-ancestor
55991657|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991658|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
55991659|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991660|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
55991661|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991662|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
55991690|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
55991691|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991692|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187325|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56187326|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187327|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187328|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56187329|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56187330|NCT02986334|Analgesics|analgesics|mesh-ancestor
56187331|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
56187332|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187333|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617685|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
56617686|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56617687|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
56617688|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617689|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56617690|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56617691|NCT03396926|Growth Substances|growth substances|mesh-ancestor
56617692|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617693|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
56617694|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
56617695|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56617696|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
56617697|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617698|NCT00971945|Paclitaxel|paclitaxel|mesh-list
56617699|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56617700|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617701|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
56187334|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56187335|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187336|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
56187337|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56187338|NCT02820857|Bevacizumab|bevacizumab|mesh-list
56187339|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187340|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187341|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56187342|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56187343|NCT02820857|Growth Substances|growth substances|mesh-ancestor
56187344|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991693|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55991694|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55991696|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991697|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991698|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55991699|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
55991700|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55991701|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55991702|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55991703|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991704|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
55991705|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55991706|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55991707|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991708|NCT03168022|Amitriptyline|amitriptyline|mesh-list
55991741|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
55991742|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991743|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991744|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55991745|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55991746|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
55991747|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
55991748|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855920|NCT01431963|Lamotrigine|lamotrigine|mesh-list
55991781|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991783|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
55991784|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991786|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56617702|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
56617703|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
56617704|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617705|NCT03672500|Epinephrine|epinephrine|mesh-list
56617706|NCT03672500|Bupivacaine|bupivacaine|mesh-list
55991787|NCT00993187|Glimepiride|glimepiride|mesh-list
55991788|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187345|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
56187346|NCT02668289|Anesthetics|anesthetics|mesh-list
56187347|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187348|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187349|NCT02655315|Deferiprone|deferiprone|mesh-list
56187350|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56187351|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
56187352|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
56187353|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187354|NCT02572843|Durvalumab|durvalumab|mesh-list
56187355|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187356|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187357|NCT02436733|Pemetrexed|pemetrexed|mesh-list
56187358|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187359|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187360|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187361|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55991789|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991790|NCT00993187|Incretins|incretins|mesh-ancestor
55991849|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991851|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991852|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55991853|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991854|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991855|NCT00993655|Paclitaxel|paclitaxel|mesh-list
55991856|NCT00993655|Carboplatin|carboplatin|mesh-list
55991857|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55991858|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991859|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
55991860|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
55991861|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
55991862|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991863|NCT00362583|Fentanyl|fentanyl|mesh-list
55991864|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55991865|NCT00362583|Narcotics|narcotics|mesh-ancestor
55991866|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991867|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991868|NCT00362583|Analgesics|analgesics|mesh-ancestor
55991869|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
55991870|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991871|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55991872|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55991901|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55991902|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991903|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991904|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55991905|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55991906|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55991907|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991908|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55991909|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55991910|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55991911|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55991912|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55991913|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55991914|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56187362|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56187363|NCT02426502|Cyclosporine|cyclosporine|mesh-list
56187364|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
55991915|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991916|NCT03179410|Avelumab|avelumab|mesh-list
55991917|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617707|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
56617708|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
56617709|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617710|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617711|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
56617712|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617713|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56617714|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56617715|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
56617716|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617717|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617718|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56617719|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56617720|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
56617721|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56617722|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56617723|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
56617724|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
56617725|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56617726|NCT00971867|Paclitaxel|paclitaxel|mesh-list
56001163|NCT00000796|Pyridoxine|pyridoxine|mesh-list
55991950|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
55991951|NCT03653338|Rituximab|rituximab|mesh-list
55991952|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
55991953|NCT03653338|Fludarabine|fludarabine|mesh-list
55991954|NCT03653338|Thiotepa|thiotepa|mesh-list
55991955|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
55991956|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991957|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991958|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
55991959|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991960|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856131|NCT00545662|Choline|choline|mesh-list
55992007|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992010|NCT00421863|Clonidine|clonidine|mesh-list
55992011|NCT00421863|Ramipril|ramipril|mesh-list
55992012|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55992013|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55992014|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55992015|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992016|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55992017|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992018|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
55992019|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55992020|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55992021|NCT00421863|Analgesics|analgesics|mesh-ancestor
55992022|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
55992023|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992024|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
55992025|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
55992026|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55992027|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55992028|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55992029|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
55992030|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617727|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56617728|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617729|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
56617730|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
56617731|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
56617732|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617733|NCT03667820|Osimertinib|osimertinib|mesh-list
56617734|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617735|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56617736|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617737|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617738|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
56617739|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617740|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617741|NCT03221036|Vedolizumab|vedolizumab|mesh-list
56617742|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56617743|NCT00812851|Dronabinol|dronabinol|mesh-list
56617744|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
56617745|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617746|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56617747|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56617748|NCT00812851|Analgesics|analgesics|mesh-ancestor
56617749|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
56617750|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617751|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56617752|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56617753|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622942|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55992031|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55992032|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
55992033|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992034|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55992035|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55992036|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55992037|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55992038|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992039|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
55992040|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992041|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992042|NCT05363722|Bevacizumab|bevacizumab|mesh-list
55992043|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55992044|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992045|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55992046|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55992047|NCT05363722|Growth Substances|growth substances|mesh-ancestor
56617754|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617755|NCT00812851|Hormones|hormones|mesh-ancestor
56617756|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56617757|NCT00648037|Rituximab|rituximab|mesh-list
56617758|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617759|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617760|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
56617761|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617762|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56617763|NCT00817375|Milnacipran|milnacipran|mesh-list
56617764|NCT00817375|Mirtazapine|mirtazapine|mesh-list
56617765|NCT00817375|Sertraline|sertraline|mesh-list
56617766|NCT00817375|Fluoxetine|fluoxetine|mesh-list
56617767|NCT00817375|Paroxetine|paroxetine|mesh-list
56617768|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56617769|NCT00817375|Nortriptyline|nortriptyline|mesh-list
56617770|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
56617771|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56617772|NCT00817375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55992048|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992049|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
55992050|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55992051|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992052|NCT04736524|Antibodies|antibodies|mesh-list
55992053|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
55992054|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992055|NCT03127137|Triamcinolone|triamcinolone|mesh-list
55992056|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55992057|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55992058|NCT03127137|Lidocaine|lidocaine|mesh-list
55992059|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55992060|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
55992061|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
55992062|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187365|NCT02426502|Prednisone|prednisone|mesh-list
56187366|NCT02426502|Azathioprine|azathioprine|mesh-list
56187367|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
56187368|NCT02426502|Cyclosporins|cyclosporins|mesh-list
55992093|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992094|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55992095|NCT03122847|Protective Agents|protective agents|mesh-ancestor
55992096|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55992097|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992098|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
55992099|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
55992100|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55992101|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55992102|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992103|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856268|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
55992166|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55992167|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992169|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992171|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55992172|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55992173|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55992174|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992175|NCT03618537|Dexamethasone|dexamethasone|mesh-list
55992176|NCT03618537|Ixazomib|ixazomib|mesh-list
56617773|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56617774|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617775|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159601|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
56617776|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617778|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617779|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56617780|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56617781|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56617782|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617783|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56617784|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56617785|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
56617786|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
56617787|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56617788|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56617789|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617790|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55992177|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992178|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
55992179|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
55992180|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992181|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992182|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55992183|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
55992184|NCT03618537|Hormones|hormones|mesh-ancestor
55992185|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992240|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
55992241|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
55992242|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992243|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992244|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
55992245|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992246|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
55992247|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55992248|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992249|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
55992250|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992251|NCT03087903|Protective Agents|protective agents|mesh-ancestor
55992252|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992253|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
55992254|NCT03577431|Everolimus|everolimus|mesh-list
55992255|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992256|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
55992257|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856426|NCT00520468|Cyclosporine|cyclosporine|mesh-list
55992292|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992294|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
55992295|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992328|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
55992329|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55992330|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
55992331|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617791|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56617792|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56617793|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
56617794|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56617795|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56617796|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56617797|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56617798|NCT00817375|Analgesics|analgesics|mesh-ancestor
56617799|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
56617800|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617801|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56617802|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56617803|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56617804|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
56617805|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
55992332|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992333|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992334|NCT05240456|Urological Agents|urological agents|mesh-ancestor
55992335|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55992337|NCT03574779|Bevacizumab|bevacizumab|mesh-list
55992338|NCT03574779|Carboplatin|carboplatin|mesh-list
55992339|NCT03574779|Niraparib|niraparib|mesh-list
55992372|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55992373|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55992374|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56187369|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56187370|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
56187371|NCT02426502|Hormones|hormones|mesh-ancestor
55992375|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992376|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992377|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
55856554|NCT01426347|Vitamin D|vitamin d|mesh-list
55992393|NCT00635102|Glycine|glycine|mesh-list
55992394|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55992395|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992396|NCT00635102|Renal Agents|renal agents|mesh-ancestor
55992397|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55992398|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
55992399|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55992400|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
55992401|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992402|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
55992403|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992404|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992405|NCT03041883|Riboflavin|riboflavin|mesh-list
55992406|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
55992407|NCT03041883|Vitamins|vitamins|mesh-ancestor
55992408|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
55992409|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992410|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55992411|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
55992412|NCT03034005|Budesonide|budesonide|mesh-list
55992413|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992414|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55992415|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
55992416|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992417|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992418|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55992419|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
55992420|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
55992421|NCT03034005|Hormones|hormones|mesh-ancestor
55811424|NCT01600053|Lenalidomide|lenalidomide|mesh-list
56617806|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56617807|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56617808|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617809|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617810|NCT00818701|Urological Agents|urological agents|mesh-ancestor
56617811|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
56617812|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617814|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56617815|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56617816|NCT00813241|Analgesics|analgesics|mesh-ancestor
56617817|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
56617818|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617819|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617820|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56617821|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56617822|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56617823|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56617824|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617825|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617826|NCT00640393|Etanercept|etanercept|mesh-list
56617827|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56617828|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56617829|NCT00640393|Analgesics|analgesics|mesh-ancestor
56617830|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
56617831|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617832|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617833|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56617834|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56617835|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56617836|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56617837|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
56617838|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56617839|NCT05315024|Imiquimod|imiquimod|mesh-list
56617840|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56617841|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
56617842|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617844|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
56617845|NCT00627445|Insulin|insulin|mesh-list
56617846|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56617847|NCT00627445|Metformin|metformin|mesh-list
55992422|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992423|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55992424|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55992425|NCT00635024|Melphalan|melphalan|mesh-list
55992426|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55992427|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55992428|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
55992429|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992430|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992431|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55992432|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992433|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
55992434|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992435|NCT03544281|Dexamethasone|dexamethasone|mesh-list
55992436|NCT03544281|Lenalidomide|lenalidomide|mesh-list
55992468|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992470|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
55992471|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992472|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55992473|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55992474|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
55992475|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
55992476|NCT04165330|Nivolumab|nivolumab|mesh-list
55992477|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55992478|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992479|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55992480|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992515|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992516|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55992518|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992519|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55992520|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55992521|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55856700|NCT01402947|Mesalamine|mesalamine|mesh-list
55992542|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
55992543|NCT03287674|Nivolumab|nivolumab|mesh-list
55992544|NCT03287674|Fludarabine|fludarabine|mesh-list
55992545|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
56187372|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187373|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187374|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56187375|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187376|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187377|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187378|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56187379|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
56187380|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
56187381|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56187382|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
56187383|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187384|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56187385|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56187386|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56187387|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
56187388|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56187389|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
56187390|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56187391|NCT02275156|Evolocumab|evolocumab|mesh-list
56187392|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56187393|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56187394|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
56187395|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187397|NCT02124902|Carboplatin|carboplatin|mesh-list
56187398|NCT02124902|Docetaxel|docetaxel|mesh-list
56187399|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992546|NCT03287674|Ipilimumab|ipilimumab|mesh-list
55992547|NCT03287674|Interleukin-2|interleukin-2|mesh-list
55992548|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56617848|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
56617849|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
56617850|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56617851|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
56617852|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56617853|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56617854|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617855|NCT02030990|Fluorometholone|fluorometholone|mesh-list
56617856|NCT02030990|Mitomycins|mitomycins|mesh-list
55992549|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
55992550|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992551|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992552|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55992553|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
55992554|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992555|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992556|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55992557|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55992558|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55992559|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55992560|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
55992561|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55992562|NCT03287674|Analgesics|analgesics|mesh-ancestor
55992563|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
56187400|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
56187401|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
56187402|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
56187403|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187404|NCT02067182|Dabigatran|dabigatran|mesh-list
56187405|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
56187406|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56187407|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
56187408|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187409|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187410|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
56187411|NCT01877837|Fludarabine|fludarabine|mesh-list
56187412|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
56187413|NCT01877837|Melphalan|melphalan|mesh-list
56187414|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
56187415|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187416|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56187417|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
56187418|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992564|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992565|NCT03289234|Edaravone|edaravone|mesh-list
55992566|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55992567|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
55992568|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992569|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55992570|NCT03289234|Protective Agents|protective agents|mesh-ancestor
55992571|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992572|NCT00634244|Cytarabine|cytarabine|mesh-list
55992573|NCT00634244|Sirolimus|sirolimus|mesh-list
55992574|NCT00634244|Carboplatin|carboplatin|mesh-list
55992575|NCT00634244|Etoposide|etoposide|mesh-list
55992576|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
55992609|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992610|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992611|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
55992612|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992613|NCT03418714|Salvinorin A|salvinorin a|mesh-list
55992614|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
55992615|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992616|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55992617|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
55992618|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617857|NCT02030990|Mitomycin|mitomycin|mesh-list
56617858|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56617859|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617860|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
56617861|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617862|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56617863|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617864|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56617865|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
55992619|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992656|NCT03428230|Analgesics|analgesics|mesh-ancestor
55992657|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
55992658|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992659|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856838|NCT01402011|Lidocaine|lidocaine|mesh-list
55992688|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
55992689|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
55992690|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992691|NCT03296800|Renal Agents|renal agents|mesh-ancestor
55992692|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55992693|NCT00999037|Sevelamer|sevelamer|mesh-list
55992694|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
55992695|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
55992696|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187419|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56187420|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
56187421|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187422|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56187423|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
56187424|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56187425|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187427|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56187428|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187429|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56187430|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56187431|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56187432|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187433|NCT01624142|Evolocumab|evolocumab|mesh-list
56187434|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55992697|NCT00634010|Morphine|morphine|mesh-list
55992698|NCT00634010|Methadone|methadone|mesh-list
55992699|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55992700|NCT00634010|Narcotics|narcotics|mesh-ancestor
55992701|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992702|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992703|NCT00634010|Analgesics|analgesics|mesh-ancestor
55856869|NCT01891357|Paclitaxel|paclitaxel|mesh-list
55992770|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992771|NCT03437044|Clopidogrel|clopidogrel|mesh-list
55992772|NCT03437044|Ticagrelor|ticagrelor|mesh-list
55992802|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
55992803|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992804|NCT03304054|Amifampridine|amifampridine|mesh-list
55992805|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55992806|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992807|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992808|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55992809|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55992810|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992811|NCT01929278|Clindamycin|clindamycin|mesh-list
55992812|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
55992813|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
55992814|NCT01929278|Tretinoin|tretinoin|mesh-list
55992815|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55992816|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992817|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56617866|NCT02030990|Hormones|hormones|mesh-ancestor
56617867|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56617868|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617869|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56617870|NCT00822055|Timolol|timolol|mesh-list
56617871|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56617872|NCT00822055|Dorzolamide|dorzolamide|mesh-list
56617873|NCT00822055|Maleic acid|maleic acid|mesh-list
56617874|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
56617875|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617876|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617877|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56617878|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56617879|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
56617880|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617881|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617882|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56617883|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56617884|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56001295|NCT02658890|Nivolumab|nivolumab|mesh-list
55992832|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992834|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55992835|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55992836|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992837|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55992838|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55992839|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
55992840|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992841|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55992842|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55992843|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992844|NCT03211234|Ranibizumab|ranibizumab|mesh-list
55992845|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55992846|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56187435|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56187436|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
56187437|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187438|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56187439|NCT01375764|Ezetimibe|ezetimibe|mesh-list
56187440|NCT01375764|Evolocumab|evolocumab|mesh-list
56187441|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56187442|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56187443|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56187444|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
56187445|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187446|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56187447|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
56187448|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187449|NCT00523341|Denosumab|denosumab|mesh-list
56187450|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56187451|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187452|NCT00364013|Panitumumab|panitumumab|mesh-list
56187453|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56617885|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56617886|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56617887|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56617888|NCT00822133|Lidocaine|lidocaine|mesh-list
56617889|NCT00822133|Ketamine|ketamine|mesh-list
56617890|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
56617891|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
56617892|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617893|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617894|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
56617895|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617896|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56617897|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56617898|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56617899|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617900|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617901|NCT00822133|Analgesics|analgesics|mesh-ancestor
56617902|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56187454|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187455|NCT00345839|Cinacalcet|cinacalcet|mesh-list
56187456|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56187457|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187458|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56187459|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
56187460|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187461|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
56187462|NCT00330759|Denosumab|denosumab|mesh-list
56115214|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56187463|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55992847|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55992848|NCT03211234|Growth Substances|growth substances|mesh-ancestor
55992849|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992850|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
55992851|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992852|NCT03105518|Acetaminophen|acetaminophen|mesh-list
55992853|NCT03105518|Fentanyl|fentanyl|mesh-list
55992854|NCT03105518|Oxycodone|oxycodone|mesh-list
55992855|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55992856|NCT03105518|Narcotics|narcotics|mesh-ancestor
55992857|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992858|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992859|NCT03105518|Analgesics|analgesics|mesh-ancestor
55992860|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
55992861|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992862|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56187464|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187466|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187467|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187469|NCT01438359|Diuretics|diuretics|mesh-ancestor
56187470|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
56187471|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187472|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56187473|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56187474|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187475|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55758119|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
56187476|NCT01438372|Hematinics|hematinics|mesh-ancestor
56187477|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
56187478|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56187479|NCT01438515|Doxycycline|doxycycline|mesh-list
56187480|NCT01438515|Rifampin|rifampin|mesh-list
56187481|NCT01438515|Mupirocin|mupirocin|mesh-list
56187482|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56187483|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992863|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55992864|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
55992865|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
55992866|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55992867|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
55992868|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
55992869|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
55992870|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992871|NCT01929668|Protective Agents|protective agents|mesh-ancestor
55992872|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992873|NCT01929668|Vitamins|vitamins|mesh-ancestor
55992874|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
55992875|NCT01929746|Daclizumab|daclizumab|mesh-list
55992876|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992877|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
55857032|NCT01724528|Febuxostat|febuxostat|mesh-list
55992950|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55992951|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55992952|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992953|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55993000|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55993001|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55993002|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55993003|NCT02847559|Bevacizumab|bevacizumab|mesh-list
55993004|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55993005|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
55993007|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
55993008|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55993009|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
55993010|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993011|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55993012|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55857182|NCT01748162|Hormones|hormones|mesh-ancestor
55993037|NCT02393859|Daunorubicin|daunorubicin|mesh-list
55993038|NCT02393859|Asparaginase|asparaginase|mesh-list
55993039|NCT02393859|Ifosfamide|ifosfamide|mesh-list
55993040|NCT02393859|Blinatumomab|blinatumomab|mesh-list
55993041|NCT02393859|Pegaspargase|pegaspargase|mesh-list
55993042|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993043|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
55993044|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
56187484|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
56187485|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
56187486|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56187487|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
56187488|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56187489|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56187490|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56187491|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
56187492|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
56187493|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56187494|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187495|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187496|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56187497|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56187498|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56187499|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56187500|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56187501|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56187502|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56187503|NCT01438554|Trametinib|trametinib|mesh-list
56187504|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187505|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55993045|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993046|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993047|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55993048|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
55993049|NCT02393859|Hormones|hormones|mesh-ancestor
56110407|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617903|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56617904|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
56617905|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56617906|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56617907|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617908|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56617909|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
56617910|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56617911|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
56617912|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617913|NCT00822211|Vildagliptin|vildagliptin|mesh-list
56617914|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56617915|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617916|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56617917|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
56617918|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617919|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993050|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993051|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55993053|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55993054|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
55993055|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55993056|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55993057|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
55993058|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993059|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
55993060|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993061|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55993062|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993063|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
55993064|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993065|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55993066|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55993101|NCT03122444|Imipramine|imipramine|mesh-list
55993102|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55993103|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
55993104|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55857276|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
55993168|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55993170|NCT01924286|Prednisone|prednisone|mesh-list
55993171|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56187506|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187507|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187509|NCT01438567|Naloxone|naloxone|mesh-list
56187510|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56187511|NCT01438567|Narcotics|narcotics|mesh-ancestor
56187512|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187513|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187514|NCT01438567|Analgesics|analgesics|mesh-ancestor
56187515|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
56187516|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187517|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56187518|NCT01438580|Aspirin|aspirin|mesh-list
55993174|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993175|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617920|NCT04018417|Amphotericin B|amphotericin b|mesh-list
56617921|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56617923|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56617924|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56617925|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56617926|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56617927|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
56617928|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
56617929|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56617930|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56617931|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56617932|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617933|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617934|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
56617935|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617936|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617937|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56617938|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993176|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55993177|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993178|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
55993179|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55993180|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
55993181|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857347|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993197|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55993198|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55993199|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55993200|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
55993201|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55993202|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55993203|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55993204|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993205|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993207|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
55993208|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993209|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55993210|NCT01920386|Acetaminophen|acetaminophen|mesh-list
55993212|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993213|NCT01920386|Analgesics|analgesics|mesh-ancestor
55993214|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
55993215|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993216|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993217|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
55993218|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55993219|NCT01920386|Narcotics|narcotics|mesh-ancestor
55993220|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993221|NCT03460990|Ivacaftor|ivacaftor|mesh-list
55993222|NCT03460990|VX-659|vx-659|mesh-list
55993223|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55993224|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55993225|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993226|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55993227|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
55993228|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993229|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
55993230|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617939|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
56617940|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
56617941|NCT00826657|Vitamins|vitamins|mesh-ancestor
56617942|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
56617943|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617944|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
56617945|NCT00826657|Hematinics|hematinics|mesh-ancestor
56617946|NCT02992964|Nivolumab|nivolumab|mesh-list
56617947|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55993231|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
55993232|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55993233|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993234|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993235|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993236|NCT01920542|Analgesics|analgesics|mesh-ancestor
55993237|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
55993238|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993239|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55993240|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55857405|NCT01857583|PENTA|penta|mesh-list
55993264|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
55993265|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993266|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55993267|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
55993268|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
55993269|NCT01921010|Vitamins|vitamins|mesh-ancestor
55993270|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
55993271|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993272|NCT03115424|Liraglutide|liraglutide|mesh-list
55993273|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55993274|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993275|NCT03115424|Incretins|incretins|mesh-ancestor
55993277|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993278|NCT03325816|Nivolumab|nivolumab|mesh-list
55993279|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55993280|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55993281|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993282|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55993283|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993284|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55993285|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
55993286|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55993287|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55993288|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55993289|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55993290|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993291|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
55993292|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993326|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55993327|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
55993328|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
55993329|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993330|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993331|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
55993332|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993360|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993361|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993362|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55993363|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993364|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
55993365|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
55993366|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993367|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55993368|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
55993369|NCT01057225|Hormones|hormones|mesh-ancestor
55993370|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993371|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56617948|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617949|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56617950|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617951|NCT03597776|Lidocaine|lidocaine|mesh-list
56366490|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56617952|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
56617954|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56617955|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617956|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
56617957|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56617958|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56617959|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56617960|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56617961|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56617962|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617963|NCT00625183|Selenium|selenium|mesh-list
56617964|NCT00625183|Capecitabine|capecitabine|mesh-list
56617965|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
56617966|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56617967|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
56617968|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617969|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617970|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
56617971|NCT00625183|Protective Agents|protective agents|mesh-ancestor
56617972|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993372|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
55993373|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55993374|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993375|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55993376|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55993377|NCT01057225|Growth Substances|growth substances|mesh-ancestor
55993378|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
55993379|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
55993380|NCT01057381|Morphine|morphine|mesh-list
55993381|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55993465|NCT01921790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993466|NCT01921790|Immunologic Factors|immunologic factors|mesh-ancestor
55993467|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187523|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
56187524|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187525|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187526|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56187527|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187528|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56187529|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56187530|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187531|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56187532|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56617973|NCT00625183|Trace Elements|trace elements|mesh-ancestor
56617974|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
56617975|NCT00826891|Topotecan|topotecan|mesh-list
56617976|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56617977|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56617978|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56617979|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617980|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617981|NCT00826969|Ciclesonide|ciclesonide|mesh-list
56617982|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
56617983|NCT00826969|Hormones|hormones|mesh-ancestor
56617984|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56617985|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56617986|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56617987|NCT03560882|Atorvastatin|atorvastatin|mesh-list
56617988|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56617989|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56617990|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
56617991|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56617992|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56187533|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187534|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
56187535|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
56187536|NCT01438632|Insulin|insulin|mesh-list
56187537|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187538|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187539|NCT01438723|Metformin|metformin|mesh-list
56187540|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187541|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187542|NCT01438736|Etonogestrel|etonogestrel|mesh-list
56187543|NCT01438736|Desogestrel|desogestrel|mesh-list
56187544|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55993468|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55993469|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55993470|NCT01921790|Growth Substances|growth substances|mesh-ancestor
55993472|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
55993474|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993475|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
55993476|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
55993477|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993478|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993479|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55993480|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
55993481|NCT04347980|Hormones|hormones|mesh-ancestor
55993482|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993483|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55993484|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993485|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
55993522|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55993523|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55993553|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993554|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
55993555|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993556|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993557|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
55993558|NCT02226159|Dexamethasone|dexamethasone|mesh-list
56617993|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56617994|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56617996|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
56617997|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
56617998|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56617999|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618000|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618001|NCT03553004|Niraparib|niraparib|mesh-list
56618002|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56618003|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618004|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618005|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618006|NCT05242874|Dexamethasone|dexamethasone|mesh-list
56618007|NCT05242874|Olanzapine|olanzapine|mesh-list
56618008|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
56618009|NCT05242874|Aprepitant|aprepitant|mesh-list
55993559|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
55993560|NCT02226159|Lidocaine|lidocaine|mesh-list
55993561|NCT02226159|BB 1101|bb 1101|mesh-list
55993562|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993563|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
55993564|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
55993565|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187545|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
56187546|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56187547|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187548|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56187549|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56187550|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56187551|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56187553|NCT01438736|Hormones|hormones|mesh-ancestor
56187554|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187555|NCT01438749|Diazepam|diazepam|mesh-list
56187556|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56187557|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
56187558|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
55993566|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993567|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55993568|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
55993569|NCT02226159|Hormones|hormones|mesh-ancestor
55857737|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
55993598|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993599|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55993600|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55993602|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55993603|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993604|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993605|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993606|NCT02153541|Antipyrine|antipyrine|mesh-list
55993607|NCT02153541|Benzocaine|benzocaine|mesh-list
55993608|NCT02153541|Glycerol|glycerol|mesh-list
55993609|NCT02153541|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55993610|NCT02153541|Protective Agents|protective agents|mesh-ancestor
55993611|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993612|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
55993613|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
55993614|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993615|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
55993637|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618010|NCT05242874|Antiemetics|antiemetics|mesh-list
56618011|NCT05242874|Tropisetron|tropisetron|mesh-list
56618012|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618013|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
56618014|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618015|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618016|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618017|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
56618018|NCT05242874|Hormones|hormones|mesh-ancestor
56618019|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618020|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56618021|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618022|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618023|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56618024|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56618025|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618026|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56618027|NCT05242874|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56618028|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56001441|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55993639|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993640|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993641|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55993642|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55993643|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993644|NCT01885689|Sirolimus|sirolimus|mesh-list
55993645|NCT01885689|Melphalan|melphalan|mesh-list
55993646|NCT01885689|Clofarabine|clofarabine|mesh-list
55993647|NCT01885689|Tacrolimus|tacrolimus|mesh-list
55993648|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993649|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
55993650|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993651|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55993652|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993653|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993654|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55993655|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993656|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55993657|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993658|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
55993659|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55993660|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
55993661|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55993662|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55993663|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
55993694|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55993695|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55993696|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993697|NCT02604537|Ketorolac|ketorolac|mesh-list
55993698|NCT02604537|Betamethasone|betamethasone|mesh-list
55993699|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55993700|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993701|NCT02604537|Analgesics|analgesics|mesh-ancestor
55993702|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
56618029|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618030|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618031|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
56618032|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56618033|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56618034|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56618036|NCT02768948|Telmisartan|telmisartan|mesh-list
56618037|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56618038|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56618039|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56618040|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56618041|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618042|NCT00640315|Riociguat|riociguat|mesh-list
56618043|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
56618044|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618045|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
56618046|NCT00904748|Citric Acid|citric acid|mesh-list
56618047|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
56618048|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
56618049|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56618050|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
55993703|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993737|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993738|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993740|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993741|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55993742|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55993771|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993772|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993773|NCT03490942|Incretins|incretins|mesh-ancestor
55993774|NCT00376870|Pioglitazone|pioglitazone|mesh-list
55993775|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55993776|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993777|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
55993778|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
55993779|NCT03256162|Midazolam|midazolam|mesh-list
55993780|NCT03256162|Ketamine|ketamine|mesh-list
55993781|NCT03256162|Analgesics|analgesics|mesh-ancestor
55993782|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
55993783|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993784|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993785|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55993786|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55993787|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
55993788|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
55993789|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993817|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55993818|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993819|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993820|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
55993821|NCT03354598|Probenecid|probenecid|mesh-list
55993822|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55993823|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993824|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56618051|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
56618052|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618053|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
56618054|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56618055|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56618056|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618057|NCT00904748|Urological Agents|urological agents|mesh-ancestor
56618058|NCT00574405|Insulin|insulin|mesh-list
56618059|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56618060|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
56618061|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
56618062|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
56618063|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
56618064|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
56618065|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56618066|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618067|NCT00971243|Metformin|metformin|mesh-list
56618068|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56618069|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618070|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55993825|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55993826|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993827|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993828|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993829|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55993830|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55993831|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
55993832|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
55993833|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993834|NCT03354598|Renal Agents|renal agents|mesh-ancestor
55993835|NCT02169895|Opicapone|opicapone|mesh-list
55993836|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
55993867|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993868|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55993869|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993870|NCT01074463|Pramipexole|pramipexole|mesh-list
55993871|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
55993872|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993874|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993876|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55993877|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
55993878|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
55993879|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993880|NCT01075087|Ropivacaine|ropivacaine|mesh-list
55993936|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993937|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993938|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993940|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993941|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
56187560|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187561|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187562|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56187563|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56187564|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187565|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56618071|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56618072|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56618073|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618074|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618075|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56618076|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618077|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618078|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
56618079|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618080|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56618081|NCT04400383|Antibodies|antibodies|mesh-list
56618082|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
56618083|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56618084|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
56618085|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618086|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618087|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
56187566|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56187567|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56187568|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56187569|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56187570|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56187571|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
56187573|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
55993942|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993943|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
55993944|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993945|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55993946|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
55721280|NCT04248452|Vitamins|vitamins|mesh-ancestor
55993947|NCT00376480|Fludarabine|fludarabine|mesh-list
55993948|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
55993949|NCT00376480|Thiotepa|thiotepa|mesh-list
55993950|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55993951|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993952|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55993953|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
55993954|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993955|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993956|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
55993957|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993958|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993989|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993990|NCT03500302|Evolocumab|evolocumab|mesh-list
55993991|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55993992|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55993993|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
55993994|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993995|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55993996|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55993997|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
55993998|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993999|NCT03503578|Ketamine|ketamine|mesh-list
55994000|NCT03503578|Sevoflurane|sevoflurane|mesh-list
55994001|NCT03503578|Analgesics|analgesics|mesh-ancestor
55994002|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
55994034|NCT02178241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994035|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
55994036|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
56618088|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
56618089|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56618090|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56618091|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618092|NCT00568555|Naltrexone|naltrexone|mesh-list
56618093|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56618094|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56618095|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618096|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
56618097|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618098|NCT00819325|Pioglitazone|pioglitazone|mesh-list
56618099|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56618100|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618101|NCT00904670|Methylphenidate|methylphenidate|mesh-list
56001510|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55994037|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
55994039|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994040|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
55994041|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
55994042|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
55994043|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994074|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
55994075|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994076|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994077|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55994079|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
56187574|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
56187575|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187576|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187577|NCT01438866|Fluorides|fluorides|mesh-list
56187578|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
56187579|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
55994080|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55994081|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55994082|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994083|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994084|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55994085|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55994086|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
55994087|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
55858254|NCT01873729|Naltrexone|naltrexone|mesh-list
55994123|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
55994124|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
55994125|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994126|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994164|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994165|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994166|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994200|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994201|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994202|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994203|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
55994204|NCT04735042|Empagliflozin|empagliflozin|mesh-list
55994205|NCT04735042|Linagliptin|linagliptin|mesh-list
55994206|NCT04735042|Saxagliptin|saxagliptin|mesh-list
55994207|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55858369|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994274|NCT01084759|Hormones|hormones|mesh-ancestor
55994275|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618102|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56618103|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618104|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56618105|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56618106|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618107|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618108|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
56618109|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618110|NCT00827281|Cycloserine|cycloserine|mesh-list
56618111|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56618112|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618113|NCT00827281|Renal Agents|renal agents|mesh-ancestor
56618114|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56618115|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
56618116|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994276|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994277|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55994278|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
55994279|NCT01110187|Lacosamide|lacosamide|mesh-list
55994280|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
55994281|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
55994282|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55994283|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55994284|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55994285|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994286|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55994287|NCT01110421|Amoxicillin|amoxicillin|mesh-list
55994314|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994316|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994317|NCT04356833|Plasminogen|plasminogen|mesh-list
55994318|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55994319|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55994320|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55994321|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994322|NCT05620277|Tocopherols|tocopherols|mesh-list
55994323|NCT05620277|Vitamin E|vitamin e|mesh-list
55994324|NCT05620277|alpha-Tocopherol|alpha-tocopherol|mesh-list
55994325|NCT05620277|Antioxidants|antioxidants|mesh-ancestor
55994326|NCT05620277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994327|NCT05620277|Protective Agents|protective agents|mesh-ancestor
55994328|NCT05620277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994329|NCT05620277|Vitamins|vitamins|mesh-ancestor
55994330|NCT05620277|Micronutrients|micronutrients|mesh-ancestor
55994331|NCT01110499|Bimatoprost|bimatoprost|mesh-list
55994332|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55994333|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55994334|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55994335|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
55994362|NCT02174419|Narcotics|narcotics|mesh-ancestor
55994363|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187580|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
56187581|NCT01438866|Protective Agents|protective agents|mesh-ancestor
56187582|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994364|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994366|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
55994367|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994368|NCT05620589|Amoxicillin|amoxicillin|mesh-list
55994369|NCT05620589|Tetracycline|tetracycline|mesh-list
55994370|NCT05620589|Esomeprazole|esomeprazole|mesh-list
55994371|NCT05620589|Bismuth|bismuth|mesh-list
56618117|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
56618118|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618119|NCT00823381|Resveratrol|resveratrol|mesh-list
56618120|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
56618121|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618122|NCT00823381|Protective Agents|protective agents|mesh-ancestor
56618123|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618124|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618125|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56618126|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
56618127|NCT00638443|Promethazine|promethazine|mesh-list
56618128|NCT00638443|Pregabalin|pregabalin|mesh-list
56618129|NCT00638443|Analgesics|analgesics|mesh-ancestor
56618130|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
56618131|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618132|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618133|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
56618134|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56618135|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618136|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618137|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56618138|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56618139|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56618140|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618141|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56618142|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56618143|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56618144|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
56618145|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
56618146|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
55994372|NCT05620589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994373|NCT05620589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994374|NCT05620589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55994375|NCT05620589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994376|NCT05620589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55994377|NCT05620589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994378|NCT05620589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994379|NCT05620589|Antacids|antacids|mesh-ancestor
55994380|NCT05620589|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55994381|NCT01086475|Cycloserine|cycloserine|mesh-list
55994382|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55994383|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994384|NCT01086475|Renal Agents|renal agents|mesh-ancestor
55994385|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56618147|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
56618148|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618149|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55994386|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
55994453|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55994454|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
55994455|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994456|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994457|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994458|NCT02245529|Urological Agents|urological agents|mesh-ancestor
55994459|NCT04341779|Tenofovir|tenofovir|mesh-list
55994460|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
55994461|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994462|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55994463|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55994464|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858624|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994490|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55994491|NCT01089517|Growth Substances|growth substances|mesh-ancestor
55994492|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994493|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
55994494|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994495|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55994496|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55994497|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994498|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
55994499|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994500|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55994501|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994502|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994504|NCT04354961|Carboplatin|carboplatin|mesh-list
55994505|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55994506|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994507|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
55994508|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
55994509|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
55994510|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994511|NCT01089751|Trospium chloride|trospium chloride|mesh-list
55994512|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
55994532|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
55994533|NCT03032315|Diuretics|diuretics|mesh-ancestor
55994534|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
55994535|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55994536|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55994537|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55994538|NCT01090921|Bortezomib|bortezomib|mesh-list
55994539|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994540|NCT03537274|Interferons|interferons|mesh-list
55994541|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
55994542|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
55994543|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56187584|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56187585|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
56187586|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187587|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187588|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56187589|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56187590|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
56187591|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187592|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187593|NCT01439100|Oxycodone|oxycodone|mesh-list
56187594|NCT01439100|Naloxone|naloxone|mesh-list
56187595|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56187596|NCT01439100|Narcotics|narcotics|mesh-ancestor
56187597|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187598|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187600|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
56187601|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187602|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56187603|NCT01439152|Maytansine|maytansine|mesh-list
56187604|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
56187605|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56618150|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
56618151|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
56618152|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618153|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56618154|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
56618155|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
56618156|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
56618157|NCT00568399|Antidotes|antidotes|mesh-ancestor
56618158|NCT00568399|Protective Agents|protective agents|mesh-ancestor
56618159|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618160|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
56618161|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618162|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
56618163|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56618164|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618165|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
56618166|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
56187606|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994544|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994545|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
55994546|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994547|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
55994548|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994549|NCT00939653|Cytarabine|cytarabine|mesh-list
55994550|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
55994551|NCT00939653|Etoposide|etoposide|mesh-list
55994552|NCT00939653|Clofarabine|clofarabine|mesh-list
55994553|NCT00939653|Lenograstim|lenograstim|mesh-list
55994554|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994555|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
55994556|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994557|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994558|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55994559|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
55994560|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994561|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994562|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55994563|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55994564|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55994565|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55994566|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994591|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994592|NCT03014323|Galantamine|galantamine|mesh-list
55994593|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55994594|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187607|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
56187608|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
56187609|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
56187610|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994595|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994596|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
55994597|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994598|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994599|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55994600|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
55994601|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994602|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
55994603|NCT03393208|Metformin|metformin|mesh-list
55994604|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55994605|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618167|NCT00975143|Isotretinoin|isotretinoin|mesh-list
56618168|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
56618169|NCT04286087|Anesthetics|anesthetics|mesh-list
56618170|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618171|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618172|NCT04288349|Epinephrine|epinephrine|mesh-list
56618173|NCT04288349|Racepinephrine|racepinephrine|mesh-list
56618174|NCT04288349|Ropivacaine|ropivacaine|mesh-list
56618175|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
56618176|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
56618177|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
56618178|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618179|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618180|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
55994606|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
55994607|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55994608|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
55994609|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994610|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994611|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55994612|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
55994613|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55994614|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
55994615|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994616|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994617|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55858789|NCT05072236|Lidocaine|lidocaine|mesh-list
55994636|NCT03593902|Prednisolone|prednisolone|mesh-list
55994637|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
55994638|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
55994639|NCT03593902|Rituximab|rituximab|mesh-list
55994640|NCT03593902|Fludarabine|fludarabine|mesh-list
55994641|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
55994642|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55994643|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55994644|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
55994645|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994646|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
55994647|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994648|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994652|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994653|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55994654|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55994655|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994656|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
55994657|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
55994658|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994659|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994660|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
55994661|NCT03593902|Hormones|hormones|mesh-ancestor
55994662|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994663|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55994664|NCT03593902|Protective Agents|protective agents|mesh-ancestor
55994665|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55994666|NCT00948935|Gemcitabine|gemcitabine|mesh-list
55994667|NCT00948935|Irinotecan|irinotecan|mesh-list
55994668|NCT00948935|Panitumumab|panitumumab|mesh-list
55994669|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55994670|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
55994671|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994672|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994673|NCT00948935|Antiviral Agents|antiviral agents|mesh-ancestor
55994674|NCT00948935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994675|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618181|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618182|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56618183|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56618184|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
56618185|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994676|NCT00948935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994677|NCT00948935|Immunologic Factors|immunologic factors|mesh-ancestor
55994678|NCT00948935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187611|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
56187612|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187613|NCT01439178|Bevacizumab|bevacizumab|mesh-list
56187614|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187615|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187616|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56187617|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56187618|NCT01439178|Growth Substances|growth substances|mesh-ancestor
56187619|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187620|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
56187621|NCT01439191|Vinorelbine|vinorelbine|mesh-list
55994679|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55994680|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55994702|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
55994703|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994705|NCT02516241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994706|NCT02516241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994707|NCT02516241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994708|NCT02516241|Immunologic Factors|immunologic factors|mesh-ancestor
55994709|NCT02516241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994710|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55994712|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55994713|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
55994714|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
55994715|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994716|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994717|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994718|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55994719|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55994720|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994721|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55994722|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55994723|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55994724|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
55994725|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994726|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994727|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
55994728|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994729|NCT03031691|Trifluridine|trifluridine|mesh-list
55994730|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
55994731|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858885|NCT03232138|Sulforaphane|sulforaphane|mesh-list
55994761|NCT01093417|Vitamins|vitamins|mesh-ancestor
55994762|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
55994763|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994764|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55994765|NCT04744545|Curcumin|curcumin|mesh-list
55994766|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55994767|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55994768|NCT04744545|Analgesics|analgesics|mesh-ancestor
55994769|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
55994770|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994771|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994772|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56187622|NCT01439191|Antibodies|antibodies|mesh-list
56187623|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
56187624|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994773|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994774|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994775|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618186|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618187|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56618188|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56618189|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
55994776|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994800|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994801|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55994803|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
55994804|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994805|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994806|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994807|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994808|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55994809|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55994810|NCT00923013|Rituximab|rituximab|mesh-list
55994811|NCT00923013|Cladribine|cladribine|mesh-list
55994812|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55994813|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994814|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
55994815|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994816|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994817|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994818|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
55994819|NCT04744623|Dapsone|dapsone|mesh-list
55994820|NCT04744623|Prednisolone|prednisolone|mesh-list
55994821|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55994822|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
55994823|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55994824|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
55994825|NCT04744623|Triamcinolone|triamcinolone|mesh-list
55994826|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55994827|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55994828|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55994856|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55994857|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
55994858|NCT00939731|Crizotinib|crizotinib|mesh-list
55994859|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994860|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55994861|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994862|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994863|NCT00633945|Lenalidomide|lenalidomide|mesh-list
55994864|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
55994865|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994866|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55994867|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55994868|NCT00633945|Growth Substances|growth substances|mesh-ancestor
55994869|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
55994870|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994871|NCT03729245|Nivolumab|nivolumab|mesh-list
55994872|NCT03729245|Sunitinib|sunitinib|mesh-list
55994873|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55994874|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994875|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55994876|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994944|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55994945|NCT03030911|Narcotics|narcotics|mesh-ancestor
55994946|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55994947|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55994948|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
55994950|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55994951|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55994952|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55994953|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
55994954|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
55994955|NCT01120405|Sevoflurane|sevoflurane|mesh-list
55859116|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
55994985|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55994986|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55994987|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994988|NCT02245451|Ritonavir|ritonavir|mesh-list
55994989|NCT02245451|Tipranavir|tipranavir|mesh-list
55994990|NCT02245451|Methadone|methadone|mesh-list
56618190|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56618191|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
56618192|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
56618193|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
56618194|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56618195|NCT03667313|Sirolimus|sirolimus|mesh-list
56618196|NCT03667313|Paclitaxel|paclitaxel|mesh-list
56618197|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56618198|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618199|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
56618200|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
56618201|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
56618202|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618203|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56618204|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618205|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56618206|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
56618207|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56618208|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
56618209|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618210|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56618211|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
56618212|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618213|NCT03657797|Latanoprost|latanoprost|mesh-list
56618214|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56618215|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56618216|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56618217|NCT04925531|Ampicillin|ampicillin|mesh-list
56618218|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618219|NCT00634933|Prednisone|prednisone|mesh-list
56618221|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56618222|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56618223|NCT00634933|Prednisolone|prednisolone|mesh-list
56618224|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
56618225|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56618226|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
56618227|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618228|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
55994991|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56110408|NCT02104752|Curcumin|curcumin|mesh-list
56618229|NCT00634933|Hormones|hormones|mesh-ancestor
56618230|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618231|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618232|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56618233|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618234|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
56618235|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
56618236|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618237|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618238|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56618239|NCT00634933|Protective Agents|protective agents|mesh-ancestor
56618240|NCT00967499|Ondansetron|ondansetron|mesh-list
56618241|NCT00967499|Palonosetron|palonosetron|mesh-list
56618242|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
56618243|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
56618244|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618245|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618246|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618247|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
56618248|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
56618249|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56618250|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
56618251|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618252|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618253|NCT00967499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56618255|NCT00967499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618256|NCT00967499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56618257|NCT00967499|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56618258|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56001642|NCT02279654|Growth Substances|growth substances|mesh-ancestor
56187625|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56187626|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187627|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
56187628|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
56187629|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
56187630|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187631|NCT01439230|Donepezil|donepezil|mesh-list
56187632|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56187633|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187634|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994992|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55994993|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
55994994|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811425|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
56618259|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56618260|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
56618261|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56618262|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56618263|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56618264|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56001669|NCT00001864|Atropine|atropine|mesh-list
55994995|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994996|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55994997|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55994998|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
55994999|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995000|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55995001|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55859159|NCT02958514|Hormones|hormones|mesh-ancestor
55995035|NCT00433589|Docetaxel|docetaxel|mesh-list
55995036|NCT00433589|Capecitabine|capecitabine|mesh-list
55995037|NCT00433589|Letrozole|letrozole|mesh-list
55995038|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995039|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
55995040|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
55995041|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
55995042|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995043|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55995044|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
55995045|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55995072|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995073|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995074|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55995075|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995077|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
55995078|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
55722402|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
55995079|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995080|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995081|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
55995082|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995083|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55995084|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55995085|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55995086|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55995087|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995089|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995090|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995091|NCT01097785|Simvastatin|simvastatin|mesh-list
55995119|NCT02574078|Docetaxel|docetaxel|mesh-list
55995120|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55995121|NCT02574078|Bevacizumab|bevacizumab|mesh-list
55995122|NCT02574078|Carboplatin|carboplatin|mesh-list
55995123|NCT02574078|Nivolumab|nivolumab|mesh-list
55995124|NCT02574078|Pemetrexed|pemetrexed|mesh-list
55995125|NCT02574078|Crizotinib|crizotinib|mesh-list
55995126|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55995127|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995128|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
55995129|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
55995130|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
55995132|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55995133|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55995134|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55995135|NCT02574078|Growth Substances|growth substances|mesh-ancestor
55995136|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995137|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
55859289|NCT00569530|Calfactant|calfactant|mesh-list
55995171|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55995172|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
55995173|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618265|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
56618266|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995174|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995175|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995176|NCT03608488|Vitamin D|vitamin d|mesh-list
55995177|NCT03608488|Vitamins|vitamins|mesh-ancestor
55995178|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
55995179|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995180|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55995181|NCT05507658|Capecitabine|capecitabine|mesh-list
55995248|NCT02565810|Adalimumab|adalimumab|mesh-list
55995249|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995250|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995251|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
55995252|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
55995253|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55995254|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55995255|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995256|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995257|NCT00940901|Urological Agents|urological agents|mesh-ancestor
55995258|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55995259|NCT04353713|Laxatives|laxatives|mesh-ancestor
55995260|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55995262|NCT04900038|Dolutegravir|dolutegravir|mesh-list
55995263|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55995264|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55995302|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
55995303|NCT00952133|Palonosetron|palonosetron|mesh-list
55995375|NCT00942149|Daptomycin|daptomycin|mesh-list
55995376|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55995377|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995378|NCT04570956|Tamoxifen|tamoxifen|mesh-list
55995379|NCT04570956|Afimoxifene|afimoxifene|mesh-list
55722707|NCT00849485|Levetiracetam|levetiracetam|mesh-list
55995412|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995414|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
55995415|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55995416|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55995417|NCT01037881|Analgesics|analgesics|mesh-ancestor
55995418|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
55995419|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995420|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995446|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995448|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55995449|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55995450|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55995451|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55995452|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
55995453|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
55995454|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
55995455|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
55995456|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995457|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995458|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55995459|NCT01039207|Rilotumumab|rilotumumab|mesh-list
55995460|NCT01039207|Antibodies|antibodies|mesh-list
55995461|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
55995462|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55995463|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
55995464|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995465|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995466|NCT02981615|Levofloxacin|levofloxacin|mesh-list
55995467|NCT02981615|Ofloxacin|ofloxacin|mesh-list
55995468|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55806588|NCT05493371|Empagliflozin|empagliflozin|mesh-list
55995469|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995490|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56187636|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187637|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187638|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
56187639|NCT01439243|Donepezil|donepezil|mesh-list
56187640|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56187641|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187642|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187643|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
56618267|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618268|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618269|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56618270|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56618271|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
56618272|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618273|NCT00629837|Factor VIII|factor viii|mesh-list
56618274|NCT00629837|Coagulants|coagulants|mesh-ancestor
56618275|NCT00827671|Cetuximab|cetuximab|mesh-list
56618276|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56618277|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618278|NCT00626275|Naproxen|naproxen|mesh-list
56618279|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56618280|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56618281|NCT00626275|Analgesics|analgesics|mesh-ancestor
56618282|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
56618283|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618284|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618285|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618286|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56618287|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
56618288|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56618289|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995491|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
55995492|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995493|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55995494|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55995495|NCT05307835|Molgramostim|molgramostim|mesh-list
55995496|NCT05307835|Sargramostim|sargramostim|mesh-list
55995497|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
55995498|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995499|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995500|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55995501|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995502|NCT03019835|Neostigmine|neostigmine|mesh-list
55995503|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55995504|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995505|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995506|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
55995507|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995508|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995509|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55995510|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
55995511|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995512|NCT00955877|Morphine|morphine|mesh-list
55995513|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55995514|NCT00955877|Narcotics|narcotics|mesh-ancestor
55995515|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995516|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995517|NCT00955877|Analgesics|analgesics|mesh-ancestor
55995518|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
55995519|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618290|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618291|NCT03451331|Gemcitabine|gemcitabine|mesh-list
56618292|NCT03451331|Carboplatin|carboplatin|mesh-list
56618293|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
56618294|NCT03451331|Nivolumab|nivolumab|mesh-list
56001695|NCT02232152|Protective Agents|protective agents|mesh-ancestor
55995520|NCT03960658|Ketamine|ketamine|mesh-list
55995521|NCT03960658|Analgesics|analgesics|mesh-ancestor
55995522|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
55995523|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859657|NCT00617188|Fulvestrant|fulvestrant|mesh-list
55995545|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995546|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995547|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995548|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
55995549|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55995550|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
55995551|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
55995552|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995553|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
55995554|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55995556|NCT05313958|Sorafenib|sorafenib|mesh-list
55995557|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
55995558|NCT05313958|Idarubicin|idarubicin|mesh-list
55995559|NCT05313958|Cladribine|cladribine|mesh-list
55995560|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55995561|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
55995562|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995563|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995564|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
55995565|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995566|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55995567|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
55995568|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995569|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55995570|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995571|NCT05313958|Analgesics|analgesics|mesh-ancestor
55995572|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
56187644|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187645|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187646|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
56187647|NCT01439399|Lidocaine|lidocaine|mesh-list
56187648|NCT01439399|Ketamine|ketamine|mesh-list
56187649|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
56187650|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
56187652|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187653|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
56187654|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187655|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56187656|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56187657|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55995573|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995574|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55722930|NCT05142254|Tadalafil|tadalafil|mesh-list
55995605|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995606|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995608|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
55995609|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995610|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55995611|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
55995612|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
55995613|NCT01009619|Azithromycin|azithromycin|mesh-list
55995614|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55995615|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995616|NCT01010009|Resveratrol|resveratrol|mesh-list
55995617|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
55995650|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
55995651|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55995652|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
55995653|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995655|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995656|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
56618295|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618296|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56618297|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
56618298|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618299|NCT03451331|Antiviral Agents|antiviral agents|mesh-ancestor
56618300|NCT03451331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618301|NCT03451331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618302|NCT03451331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56618303|NCT03451331|Immunologic Factors|immunologic factors|mesh-ancestor
56618304|NCT03451331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618305|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56618306|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56618307|NCT03643133|Mifamurtide|mifamurtide|mesh-list
56618308|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56618309|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
56618310|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618311|NCT04044313|Lenvatinib|lenvatinib|mesh-list
55995692|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55995693|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55995710|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55995711|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55995712|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55995714|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
55995715|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995716|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995717|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995718|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55995719|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55995720|NCT01010477|Nicotine|nicotine|mesh-list
55995721|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55995722|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
55995723|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995724|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995725|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55995726|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55995727|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
55995728|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995729|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995730|NCT03921190|Anesthetics|anesthetics|mesh-list
55995731|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995732|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995733|NCT00953849|Calcitriol|calcitriol|mesh-list
56187658|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56187659|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187660|NCT01439399|Analgesics|analgesics|mesh-ancestor
56187661|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56187662|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56187663|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
56187664|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56187665|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56187666|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187668|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
56187669|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187670|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187671|NCT01439542|Hormones|hormones|mesh-list
55995734|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56618312|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618313|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56618314|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618315|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618316|NCT00823849|Cilostazol|cilostazol|mesh-list
56618317|NCT00823849|Probucol|probucol|mesh-list
56618318|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56618319|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
56618320|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618321|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618322|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55995735|NCT00953849|Vitamin D|vitamin d|mesh-list
55995736|NCT00953849|Celecoxib|celecoxib|mesh-list
55995737|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55995738|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55995739|NCT00953849|Analgesics|analgesics|mesh-ancestor
55995740|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
55995749|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55995750|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55995751|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55995752|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55995783|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995784|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55995785|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55995786|NCT03906448|Temozolomide|temozolomide|mesh-list
55995787|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55995788|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
55995789|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995790|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995791|NCT01011413|Efavirenz|efavirenz|mesh-list
55995792|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55995793|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55995794|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995795|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995796|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
55995797|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995798|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55995822|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
55995823|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
55995824|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995825|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995826|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55995827|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
55995829|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995830|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55995831|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187672|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55995832|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55995833|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
55995834|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55995835|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55995836|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
55995837|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995839|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995840|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55995841|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55995842|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
55995843|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995844|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55995845|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55995846|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56618323|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
56618324|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55995847|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55995848|NCT03649750|Guaifenesin|guaifenesin|mesh-list
55995849|NCT03649750|Expectorants|expectorants|mesh-ancestor
55859987|NCT00600340|Growth Substances|growth substances|mesh-ancestor
55995895|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995897|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
55995898|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55995899|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55995900|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55801079|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
55995901|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995902|NCT00957359|Niacin|niacin|mesh-list
55995903|NCT00957359|Psilocybin|psilocybin|mesh-list
55995904|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
55995905|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55995906|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
55995907|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995908|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55995909|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
55860056|NCT00602446|Deferasirox|deferasirox|mesh-list
55995938|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55995939|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55995940|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995941|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995942|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55995943|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55995944|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995945|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995946|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55995947|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995948|NCT03018899|Anesthetics|anesthetics|mesh-list
55995949|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995950|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995951|NCT00958919|Naloxone|naloxone|mesh-list
55995952|NCT00958919|Endorphins|endorphins|mesh-list
55995953|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55995954|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995955|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
55995956|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995957|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860090|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995970|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995971|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55995973|NCT04323592|Hormones|hormones|mesh-ancestor
55995974|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995975|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55995976|NCT04323592|Protective Agents|protective agents|mesh-ancestor
55995977|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55995978|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723306|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
55995979|NCT01047241|Sufentanil|sufentanil|mesh-list
55995980|NCT01047241|Ketamine|ketamine|mesh-list
55995981|NCT01047241|Analgesics|analgesics|mesh-ancestor
55995982|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
55995983|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995984|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995985|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55995986|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56187673|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187674|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187675|NCT01439750|Rituximab|rituximab|mesh-list
56187676|NCT01439750|Bortezomib|bortezomib|mesh-list
56187677|NCT01439750|Cladribine|cladribine|mesh-list
56187678|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187679|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187680|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
56187681|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187682|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187683|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56187684|NCT01439984|Clomipramine|clomipramine|mesh-list
56187685|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56618325|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56618326|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366867|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56618327|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56618328|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
56618329|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56187686|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
56187687|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56187688|NCT01439984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56115492|NCT00002165|Nelfinavir|nelfinavir|mesh-list
56187689|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56187690|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56187691|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187692|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187693|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
56187694|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187695|NCT01440062|Vitamin D|vitamin d|mesh-list
55995987|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
55995988|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
55995989|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995994|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55995995|NCT01047241|Narcotics|narcotics|mesh-ancestor
55995996|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55995997|NCT01012661|Lidocaine|lidocaine|mesh-list
55995998|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
55995999|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
55996000|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996001|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996002|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
55996003|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996004|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55996005|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55996006|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55996007|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55996008|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996009|NCT03655444|Nivolumab|nivolumab|mesh-list
55996010|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55996011|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187696|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
56187697|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
55996012|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55996013|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996014|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55996015|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996016|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996017|NCT03018821|Tenofovir|tenofovir|mesh-list
55996053|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55996054|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
55996055|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
55996087|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996089|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55996090|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55996091|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
55996092|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
55996093|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996094|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996095|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55996096|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996097|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55996098|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996118|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996119|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
55996120|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
55996121|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996122|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996123|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618330|NCT00823849|Protective Agents|protective agents|mesh-ancestor
56618331|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56618332|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56618333|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618334|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56618335|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56618336|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
56618337|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56618338|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
56618339|NCT02550067|Copper|copper|mesh-list
56618340|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56618341|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
56618342|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
56618343|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56618344|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
56618345|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56618346|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618347|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56618348|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55996124|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
55996125|NCT04290676|Hormones|hormones|mesh-ancestor
55996126|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996127|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55996128|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996129|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
55996130|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996131|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996132|NCT03112993|Neostigmine|neostigmine|mesh-list
55996133|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55996134|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996135|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996136|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
55996137|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996138|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996139|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55996140|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
55996141|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996187|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996188|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996189|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
55996191|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996192|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996193|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
55996194|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996195|NCT05004025|Nivolumab|nivolumab|mesh-list
55996196|NCT05004025|Ipilimumab|ipilimumab|mesh-list
55996197|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187698|NCT01440062|Vitamins|vitamins|mesh-list
56187699|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
55996198|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996199|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55723525|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55996200|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996222|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
55996223|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996224|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
56618349|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56618350|NCT02550067|Trace Elements|trace elements|mesh-ancestor
56618351|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
56618352|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56618353|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56618354|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56618355|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618356|NCT02862509|Budesonide|budesonide|mesh-list
56618357|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618358|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56618359|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
56618360|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618361|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618362|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55996225|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
55996226|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
55996227|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996228|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
55996229|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55996230|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996231|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
55996232|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996233|NCT01924819|Antidotes|antidotes|mesh-ancestor
55996234|NCT01924819|Protective Agents|protective agents|mesh-ancestor
55996235|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
55996236|NCT01924819|Vitamins|vitamins|mesh-ancestor
55996237|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
55996238|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55996239|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55996240|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55996241|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996242|NCT01168687|Levetiracetam|levetiracetam|mesh-list
55996243|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
55996244|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
55996245|NCT03685396|Hemostatics|hemostatics|mesh-list
55996246|NCT03685396|Coagulants|coagulants|mesh-ancestor
55996247|NCT01126255|Clobetasol|clobetasol|mesh-list
55996248|NCT01126255|Progesterone|progesterone|mesh-list
55996249|NCT01126255|Progestins|progestins|mesh-ancestor
55996250|NCT01126255|Hormones|hormones|mesh-ancestor
55801090|NCT04375813|Sirolimus|sirolimus|mesh-list
55996251|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996252|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996253|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996254|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
55996255|NCT04198948|Gliclazide|gliclazide|mesh-list
55996256|NCT04198948|Omeprazole|omeprazole|mesh-list
55996257|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55996258|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996259|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55996260|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860387|NCT00693160|Ketorolac|ketorolac|mesh-list
55996282|NCT04822363|Analgesics|analgesics|mesh-ancestor
55996283|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
55996284|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996285|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996286|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996287|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55996288|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55996289|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55996290|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996291|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55996292|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55996293|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618363|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
56618364|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
56618365|NCT02862509|Hormones|hormones|mesh-ancestor
56159610|NCT02956122|Protective Agents|protective agents|mesh-ancestor
56618366|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618367|NCT04285775|Chrysarobin|chrysarobin|mesh-list
56618368|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56618369|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56618370|NCT04285775|Analgesics|analgesics|mesh-ancestor
56618371|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
56618372|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618373|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618374|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618375|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56618376|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56618377|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56618378|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55996294|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
55996295|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55996296|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55996297|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55996298|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
55996299|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996300|NCT01170247|Ketamine|ketamine|mesh-list
55996301|NCT01170247|Analgesics|analgesics|mesh-ancestor
55996302|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
55996303|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996304|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996305|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55996306|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55996307|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
55996308|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
55860444|NCT00695500|Varenicline|varenicline|mesh-list
55996329|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996330|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996331|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187700|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996332|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996333|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996334|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
55996335|NCT03809182|Fentanyl|fentanyl|mesh-list
55996336|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
55996337|NCT03809182|Morphine|morphine|mesh-list
55996338|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55996339|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996340|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996341|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996342|NCT03809182|Analgesics|analgesics|mesh-ancestor
55996343|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
55996344|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996345|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55996346|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55996347|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55996348|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
55996349|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996350|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618379|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618380|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618381|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618382|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618383|NCT00965081|Analgesics|analgesics|mesh-ancestor
56618384|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
56618385|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996351|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55996352|NCT03809182|Narcotics|narcotics|mesh-ancestor
55996353|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55996354|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55996355|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
55996356|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
55996357|NCT01170949|Miltefosine|miltefosine|mesh-list
55996358|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
55996359|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860495|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996394|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55996395|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
55996396|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996397|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996399|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996400|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55996401|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996460|NCT02186665|Vitamins|vitamins|mesh-ancestor
55996461|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
55996462|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55996463|NCT01172197|Ropivacaine|ropivacaine|mesh-list
55996464|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
55996465|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
55996466|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
55996467|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996468|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996469|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
55996470|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996521|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996522|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996523|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55996524|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55996525|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
55996526|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996527|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996528|NCT03439046|Letrozole|letrozole|mesh-list
55996529|NCT03439046|Fulvestrant|fulvestrant|mesh-list
55996530|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996531|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55996532|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55996533|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996534|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996535|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55996536|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
55996537|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996538|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996539|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55996540|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55996541|NCT00983918|Propofol|propofol|mesh-list
55996542|NCT00983918|Sevoflurane|sevoflurane|mesh-list
55996543|NCT00983918|Desflurane|desflurane|mesh-list
55996544|NCT00983918|Isoflurane|isoflurane|mesh-list
55996545|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56187701|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56187702|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56187703|NCT01440088|Doxorubicin|doxorubicin|mesh-list
56187704|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56187705|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56187706|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801435|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
56618386|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
56618387|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56618388|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
56618389|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56618390|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56618391|NCT00961649|Brinzolamide|brinzolamide|mesh-list
56618392|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56618393|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56618394|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56618395|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56618396|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56618397|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
56618398|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618399|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618400|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187707|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56187708|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56187709|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187710|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187711|NCT01440114|Fentanyl|fentanyl|mesh-list
56187712|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56187713|NCT01440114|Narcotics|narcotics|mesh-ancestor
56187714|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187715|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187716|NCT01440114|Analgesics|analgesics|mesh-ancestor
56187717|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
56187718|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996546|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996547|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996548|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55996549|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
55996550|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
55996551|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55996552|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55996553|NCT01926236|Leucovorin|leucovorin|mesh-list
55996554|NCT01926236|Folic Acid|folic acid|mesh-list
55996597|NCT00983372|Colchicine|colchicine|mesh-list
55996598|NCT00983372|Diltiazem|diltiazem|mesh-list
55996599|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
55996600|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55996601|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
55996602|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
55996603|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
55996604|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996608|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860748|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
55996792|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55996793|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
55996794|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996795|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996796|NCT01178827|Urological Agents|urological agents|mesh-ancestor
55996797|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55996798|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996799|NCT01178827|Renal Agents|renal agents|mesh-ancestor
55996800|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
55996801|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55996802|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
55996803|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996804|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996805|NCT02181517|Ranibizumab|ranibizumab|mesh-list
56618401|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56618402|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618403|NCT04267601|Anagliptin|anagliptin|mesh-list
56618404|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55996806|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55996807|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55996808|NCT02181517|Growth Substances|growth substances|mesh-ancestor
55996809|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996810|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
55996811|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996812|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55996813|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55996814|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
55996815|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996816|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996817|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55996818|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55996819|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55996821|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
55996822|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996823|NCT03872947|Leucovorin|leucovorin|mesh-list
55996824|NCT03872947|Gemcitabine|gemcitabine|mesh-list
55996825|NCT03872947|Bevacizumab|bevacizumab|mesh-list
55996826|NCT03872947|Carboplatin|carboplatin|mesh-list
55996827|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
55996828|NCT03872947|Nivolumab|nivolumab|mesh-list
55996829|NCT03872947|Irinotecan|irinotecan|mesh-list
55996830|NCT03872947|Topotecan|topotecan|mesh-list
55996831|NCT03872947|Imiquimod|imiquimod|mesh-list
55996848|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55996849|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55996850|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55996852|NCT03872947|Protective Agents|protective agents|mesh-ancestor
55996853|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
55996854|NCT03872947|Vitamins|vitamins|mesh-ancestor
55996855|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
55996856|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55996857|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
55996858|NCT02246881|Factor VIII|factor viii|mesh-list
55996859|NCT02246881|Coagulants|coagulants|mesh-ancestor
55996860|NCT00980330|Ribavirin|ribavirin|mesh-list
55996861|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55996862|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
55996863|NCT00980330|Simeprevir|simeprevir|mesh-list
55996864|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
55996865|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996866|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
55996867|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996868|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996869|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
55996870|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996871|NCT01138735|Adapalene|adapalene|mesh-list
55996872|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
55996873|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55996874|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
55996875|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55996876|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996877|NCT01138735|Analgesics|analgesics|mesh-ancestor
55996878|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
55996879|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996882|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55996884|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55996885|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996886|NCT03064568|Misoprostol|misoprostol|mesh-list
55996887|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55996888|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
55996889|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55996890|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996891|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55996908|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55996909|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55996910|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996911|NCT00987272|Analgesics|analgesics|mesh-ancestor
55996912|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
56618405|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
56618406|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618407|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618408|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56618409|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618410|NCT02861261|Promethazine|promethazine|mesh-list
56618411|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
56618412|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
56618413|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
56618414|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56618415|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
56618416|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
56618417|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618418|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618419|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618420|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56618421|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56618422|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56618423|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618424|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
56618425|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
55996913|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996914|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996915|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996916|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187720|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56187721|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
56187722|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
56187723|NCT01440127|Metformin|metformin|mesh-list
56187724|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187725|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187726|NCT01440140|Insulin|insulin|mesh-list
56187727|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187728|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187729|NCT01440270|Cetuximab|cetuximab|mesh-list
56187730|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187731|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187732|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56187733|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56187734|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56187735|NCT01440335|Fenoterol|fenoterol|mesh-list
56187736|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56187737|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
56187738|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187739|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187740|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56187741|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
56187742|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
56187743|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
56187744|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56187745|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56187746|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56187747|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56187748|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
56618426|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
56618427|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618428|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
56618429|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
56187749|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996917|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55996918|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55996919|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55996920|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
55996921|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
55996922|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996923|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996924|NCT03709459|Doxycycline|doxycycline|mesh-list
55996925|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55996926|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996927|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
55996928|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55996929|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55996930|NCT05600894|Decitabine|decitabine|mesh-list
55996931|NCT05600894|Venetoclax|venetoclax|mesh-list
55996932|NCT05600894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55996933|NCT05600894|Antimetabolites|antimetabolites|mesh-ancestor
55996934|NCT05600894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996935|NCT05600894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996936|NCT05600894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996937|NCT00986882|Ibuprofen|ibuprofen|mesh-list
55996938|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55996939|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996940|NCT00986882|Analgesics|analgesics|mesh-ancestor
55996948|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996950|NCT00981656|Mitomycins|mitomycins|mesh-list
55996983|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55996984|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55996985|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55996986|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55996987|NCT01182493|Insulin|insulin|mesh-list
55996988|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55996989|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996990|NCT01927484|Methotrexate|methotrexate|mesh-list
55996991|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55996992|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
55996993|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55996994|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861128|NCT04386850|Calcifediol|calcifediol|mesh-list
55997089|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55997090|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55997091|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55997092|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
55997093|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
55997094|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861230|NCT01278784|Expectorants|expectorants|mesh-ancestor
55997128|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997129|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997130|NCT05506410|Cytarabine|cytarabine|mesh-list
55997131|NCT05506410|Prednisone|prednisone|mesh-list
55997132|NCT05506410|Rituximab|rituximab|mesh-list
55997133|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55997134|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997135|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997136|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
55997137|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997138|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55997139|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55997140|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
55997187|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997188|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56187750|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187752|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56187753|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
56187754|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187755|NCT01440400|Anesthetics|anesthetics|mesh-list
56187756|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618430|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618431|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
56618432|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56618433|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56618434|NCT04283435|Estradiol|estradiol|mesh-list
56618435|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56618436|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618437|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618439|NCT04283435|Hormones|hormones|mesh-ancestor
56618440|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618441|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56618442|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
56618443|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56618444|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56618445|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
56618446|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56618447|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56618448|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618449|NCT04283435|Urological Agents|urological agents|mesh-ancestor
56187757|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187758|NCT01440439|Insulin|insulin|mesh-list
55997189|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
55997191|NCT03033758|Hormones|hormones|mesh-ancestor
55997192|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997193|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55997194|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55997195|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55997196|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
55997197|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997198|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997199|NCT01016483|Gemcitabine|gemcitabine|mesh-list
55997200|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55997201|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
55997202|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997203|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997207|NCT01016483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55997208|NCT01016483|Immunologic Factors|immunologic factors|mesh-ancestor
55997209|NCT01016483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997210|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
55997211|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
55997212|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997213|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997214|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55997215|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997216|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997218|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55997219|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55997247|NCT05604794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997248|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55997250|NCT04120454|Ramucirumab|ramucirumab|mesh-list
55997251|NCT04120454|Antibodies|antibodies|mesh-list
55997252|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
56618450|NCT04284761|Bicalutamide|bicalutamide|mesh-list
56618451|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
56618452|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
56618453|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618454|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618455|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618456|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
56618457|NCT00632125|Hematinics|hematinics|mesh-ancestor
56618458|NCT00903968|Plerixafor|plerixafor|mesh-list
56618459|NCT00903968|Dexamethasone|dexamethasone|mesh-list
56618460|NCT00903968|Bortezomib|bortezomib|mesh-list
56618461|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618462|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
56618463|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
56618464|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618465|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618466|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618467|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
56618468|NCT00903968|Hormones|hormones|mesh-ancestor
56618469|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618470|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56618471|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618472|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56618473|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56618474|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
56618475|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618476|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
55997253|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55997254|NCT04120454|Lexatumumab|lexatumumab|mesh-list
55997255|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
55997256|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997257|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997258|NCT01017653|Irinotecan|irinotecan|mesh-list
55997259|NCT01017653|Panitumumab|panitumumab|mesh-list
55724558|NCT00649025|Xhance|xhance|mesh-list
55997260|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55997261|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55997262|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997263|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997264|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997265|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997328|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997330|NCT05510778|Antidotes|antidotes|mesh-ancestor
55997331|NCT05510778|Protective Agents|protective agents|mesh-ancestor
55997332|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997333|NCT00972335|Bevacizumab|bevacizumab|mesh-list
55997334|NCT00972335|Everolimus|everolimus|mesh-list
55997335|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997336|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187759|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56618477|NCT00632606|Metoclopramide|metoclopramide|mesh-list
56618478|NCT00632606|Analgesics|analgesics|mesh-ancestor
56618479|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
56618480|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618481|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618482|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
56618483|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618484|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56618485|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
56618486|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56618487|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618488|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618489|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56618490|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
56618491|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56618492|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
56618493|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
56618494|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618495|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56618496|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56618497|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
56618498|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618499|NCT02586038|Thalidomide|thalidomide|mesh-list
56618500|NCT02586038|Dexamethasone|dexamethasone|mesh-list
56618501|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
56618502|NCT02586038|Ixazomib|ixazomib|mesh-list
56187760|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
56187761|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
56187762|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187763|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187764|NCT01440582|Dexamethasone|dexamethasone|mesh-list
56187765|NCT01440582|Lenalidomide|lenalidomide|mesh-list
55997337|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55997338|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55997339|NCT00972335|Growth Substances|growth substances|mesh-ancestor
55997340|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997341|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
55997342|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55997343|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
55997380|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997397|NCT05608070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997399|NCT00972725|Amebicides|amebicides|mesh-ancestor
55997400|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55997401|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55997402|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997403|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
55997404|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55997405|NCT05600660|Rituximab|rituximab|mesh-list
55997406|NCT05600660|Methotrexate|methotrexate|mesh-list
55997407|NCT05600660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997408|NCT05600660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618503|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56618504|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
56618505|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618506|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56618507|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56618508|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
56618509|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618510|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618511|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56618512|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618513|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
56618514|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
56618515|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618516|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618517|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
56618519|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618520|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56618521|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
56618522|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56618523|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618524|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55997409|NCT05600660|Immunologic Factors|immunologic factors|mesh-ancestor
55997410|NCT05600660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997411|NCT05600660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55997412|NCT05600660|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55997413|NCT05600660|Abortifacient Agents|abortifacient agents|mesh-ancestor
55997414|NCT05600660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55997417|NCT05600660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997418|NCT05600660|Dermatologic Agents|dermatologic agents|mesh-ancestor
55997419|NCT05600660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997420|NCT05600660|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55997421|NCT05600660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55997422|NCT05600660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55997424|NCT00972959|Dexamethasone|dexamethasone|mesh-list
55997425|NCT00972959|Bortezomib|bortezomib|mesh-list
55997426|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55997427|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
55997428|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
55997429|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997430|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997431|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55997432|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
55997433|NCT00972959|Hormones|hormones|mesh-ancestor
55997434|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997435|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55997436|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997437|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55997438|NCT05609240|Cefuroxime|cefuroxime|mesh-list
55997439|NCT05609240|Cefuroxime axetil|cefuroxime axetil|mesh-list
55997457|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
55997458|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
55997459|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
56618525|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56618526|NCT02586038|Growth Substances|growth substances|mesh-ancestor
56618527|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
56618528|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
56618529|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618530|NCT00903344|Vitamin D|vitamin d|mesh-list
56618531|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
56618532|NCT00903344|Vitamins|vitamins|mesh-ancestor
56618533|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
56618534|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618535|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56618536|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56618537|NCT02847338|Amlodipine|amlodipine|mesh-list
56618538|NCT02847338|Lisinopril|lisinopril|mesh-list
56618539|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
56618540|NCT02847338|Amiloride|amiloride|mesh-list
55997460|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55997461|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55997462|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55997463|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
55997464|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997465|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997466|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
55997467|NCT03017963|Antidotes|antidotes|mesh-ancestor
55997468|NCT03017963|Protective Agents|protective agents|mesh-ancestor
56187767|NCT01440582|Panobinostat|panobinostat|mesh-list
56187768|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56187769|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
55997469|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997470|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
55997471|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997472|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
55997473|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55997474|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997475|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
55997476|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
55997477|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55997478|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
55997479|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997480|NCT00977171|Droxidopa|droxidopa|mesh-list
55997481|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55997482|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55997483|NCT04129424|Insulin|insulin|mesh-list
55997484|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55997485|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724751|NCT03483415|Narcotics|narcotics|mesh-ancestor
55997487|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55997488|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
55997489|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997490|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997491|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55997492|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
55997493|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55997494|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
55997495|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997496|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997497|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55997555|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
55997556|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997557|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55997559|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997563|NCT04129112|Propofol|propofol|mesh-list
56618541|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56618542|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56618543|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618544|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618545|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56618546|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618547|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
56618548|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56618549|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
56618550|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618551|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56618552|NCT02847338|Protective Agents|protective agents|mesh-ancestor
56618553|NCT02847338|Diuretics|diuretics|mesh-ancestor
56618554|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
56618555|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56618556|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55997564|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
55997565|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997566|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997567|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55997568|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55997569|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
55997570|NCT01608893|Metoprolol|metoprolol|mesh-list
55997571|NCT01608893|Carvedilol|carvedilol|mesh-list
55997572|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55997573|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55997574|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
55997575|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
55997576|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997577|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997578|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55997579|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55997580|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55997581|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
55997582|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997636|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997638|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
55997639|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997640|NCT03827642|Naloxone|naloxone|mesh-list
55997641|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55997642|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997643|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
55997644|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997645|NCT05510310|Oxytocin|oxytocin|mesh-list
55997646|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
55997647|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55997648|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187770|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
56187771|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187772|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187773|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56187774|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
56187775|NCT01440582|Hormones|hormones|mesh-ancestor
56187776|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187777|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56187778|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618557|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56618558|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56618559|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56618560|NCT02847104|Insulin|insulin|mesh-list
56618561|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56618562|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56618563|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618564|NCT02849132|Entecavir|entecavir|mesh-list
56618565|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
56618566|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618567|NCT05091866|Progesterone|progesterone|mesh-list
56618568|NCT05091866|Progestins|progestins|mesh-list
56618569|NCT05091866|Hormones|hormones|mesh-ancestor
56618570|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618571|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618572|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
56618573|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56618574|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618575|NCT02848508|Metformin|metformin|mesh-list
56618576|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56618577|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618578|NCT00902564|Citalopram|citalopram|mesh-list
56618579|NCT00902564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56001878|NCT04390100|Coagulants|coagulants|mesh-ancestor
56187779|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
56187780|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56187781|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56187782|NCT01440582|Growth Substances|growth substances|mesh-ancestor
56187783|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
56187784|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56187785|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187786|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187787|NCT01440608|Albendazole|albendazole|mesh-list
56187788|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
55997649|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55997650|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
55997651|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55997652|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55997653|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55997654|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997656|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55997657|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997658|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
55997659|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55997660|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997661|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55997662|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997663|NCT04411524|Capecitabine|capecitabine|mesh-list
55997664|NCT04411524|Irinotecan|irinotecan|mesh-list
55997665|NCT04411524|Antibodies|antibodies|mesh-list
55997666|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
56187789|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55724981|NCT05150899|Tamsulosin|tamsulosin|mesh-list
56618580|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56618581|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618582|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618583|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618584|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
56618585|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618586|NCT00902564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56618587|NCT00902564|Antidepressive Agents|antidepressive agents|mesh-ancestor
56618588|NCT00902564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56618589|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
56618590|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
56618591|NCT00626197|Azathioprine|azathioprine|mesh-list
56618592|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
56618593|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56618594|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
56618595|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618596|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56618597|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56618598|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
55997709|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55997710|NCT05505006|Folic Acid|folic acid|mesh-list
55997711|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
55997712|NCT05505006|Hematinics|hematinics|mesh-ancestor
55997713|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
55997714|NCT05505006|Vitamins|vitamins|mesh-ancestor
55997715|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
55997716|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997717|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
55997718|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
55997719|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
55997756|NCT04393610|Lidocaine|lidocaine|mesh-list
55997757|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
55997758|NCT04393610|Fentanyl|fentanyl|mesh-list
55997759|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
55997760|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
55997761|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861887|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
55997786|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
55997787|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997788|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997789|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55997790|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55997791|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55997792|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55997793|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997794|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55997795|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55997796|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997798|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55997799|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55997800|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
55997801|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55997802|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55997803|NCT03826004|Clemastine|clemastine|mesh-list
55997804|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
55997805|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
55801666|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56618599|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618600|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618601|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56618602|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56618603|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56618604|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
56618605|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56618606|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618607|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618608|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
56618609|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56618610|NCT02847884|Infliximab|infliximab|mesh-list
56618611|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
56618612|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618613|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56618614|NCT00623935|Fludarabine|fludarabine|mesh-list
56618615|NCT00623935|Busulfan|busulfan|mesh-list
56618616|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618617|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618618|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56618619|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
56618620|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618621|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
56618622|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56618623|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56618624|NCT04029116|Fluconazole|fluconazole|mesh-list
56618625|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
55997806|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55997807|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
55997929|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55997930|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
55997931|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997932|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997933|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997934|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55997935|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
55997936|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997937|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55997938|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
55997939|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55997940|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55997941|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
55997943|NCT02983214|Protective Agents|protective agents|mesh-ancestor
55997944|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55997945|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55997946|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997948|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
56618626|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
56618627|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618628|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56618629|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56618630|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997949|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997950|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997951|NCT03824834|Morphine|morphine|mesh-list
55997952|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55998004|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55998005|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
55998006|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998007|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
55998009|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
56187790|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998010|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998011|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998012|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998013|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55998014|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
55725277|NCT02256982|Cisplatin|cisplatin|mesh-list
55998015|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998016|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998017|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55998018|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998019|NCT04393220|Bevacizumab|bevacizumab|mesh-list
55998020|NCT04393220|Nivolumab|nivolumab|mesh-list
55998021|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998022|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862151|NCT01272934|Diclofenac|diclofenac|mesh-list
55998040|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998041|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
55998042|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998043|NCT05394233|Bevacizumab|bevacizumab|mesh-list
55998044|NCT05394233|Pemetrexed|pemetrexed|mesh-list
55998045|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998046|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998047|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55998048|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55998049|NCT05394233|Growth Substances|growth substances|mesh-ancestor
55998050|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998051|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
55998052|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998053|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998054|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55998055|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55998056|NCT03823976|Anesthetics|anesthetics|mesh-list
55998057|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998058|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998059|NCT00982553|Ribavirin|ribavirin|mesh-list
55998069|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998070|NCT02943590|Atorvastatin|atorvastatin|mesh-list
55998071|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55998072|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55998073|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
55998074|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998075|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55998076|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55998077|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998078|NCT02939300|Nivolumab|nivolumab|mesh-list
55998093|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55998094|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998095|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998096|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998098|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55998099|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998100|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998101|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
55998102|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618631|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618632|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56618633|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
56618634|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618635|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618636|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56618637|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56618639|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56618640|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56618641|NCT00623779|Analgesics|analgesics|mesh-ancestor
56618642|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
56618643|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618644|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618645|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618646|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56618647|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56618648|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56001933|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998103|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998104|NCT02891954|Canagliflozin|canagliflozin|mesh-list
55998105|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55998106|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998107|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55998108|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998109|NCT02565186|Lasmiditan|lasmiditan|mesh-list
56187791|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
56187792|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56187793|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56187794|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
56187795|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
56187796|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
56187797|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187798|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187799|NCT01440621|Pyridoxine|pyridoxine|mesh-list
56187800|NCT01440621|Modafinil|modafinil|mesh-list
56187801|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55998110|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55998111|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
55998112|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998113|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998114|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998115|NCT02883062|Paclitaxel|paclitaxel|mesh-list
55998116|NCT02883062|Carboplatin|carboplatin|mesh-list
55998117|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55998118|NCT02883062|Atezolizumab|atezolizumab|mesh-list
55998119|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55998120|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55998121|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998122|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
55998123|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
55998124|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
55998125|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998126|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
56618649|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618650|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56618651|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56618652|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618653|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
56618654|NCT00828373|Lidocaine|lidocaine|mesh-list
56618655|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
56618656|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
56618657|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001955|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998127|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998128|NCT04694586|Rifampin|rifampin|mesh-list
55998129|NCT04694586|Isoniazid|isoniazid|mesh-list
55998192|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998194|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
55998195|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
55998196|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
55998197|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998198|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998199|NCT02937272|Gemcitabine|gemcitabine|mesh-list
55998200|NCT02937272|Paclitaxel|paclitaxel|mesh-list
55998201|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55998202|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998203|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
55998204|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
55998205|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
55998206|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998207|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55998208|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
55998209|NCT02937272|Antiviral Agents|antiviral agents|mesh-ancestor
55998210|NCT02937272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998211|NCT02937272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998212|NCT02937272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998213|NCT02937272|Immunologic Factors|immunologic factors|mesh-ancestor
55998214|NCT02937272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998215|NCT02936102|Spartalizumab|spartalizumab|mesh-list
55998216|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55998217|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998262|NCT03821168|Bevacizumab|bevacizumab|mesh-list
56187802|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187803|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56187804|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55998263|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
55998264|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998265|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998266|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55998267|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55998268|NCT03821168|Growth Substances|growth substances|mesh-ancestor
55998269|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998270|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
55998271|NCT03821168|Hematinics|hematinics|mesh-ancestor
55998272|NCT01454180|Leucovorin|leucovorin|mesh-list
55998273|NCT01454180|Gemcitabine|gemcitabine|mesh-list
55998274|NCT01454180|Capecitabine|capecitabine|mesh-list
55998275|NCT01454180|Fluorouracil|fluorouracil|mesh-list
55998276|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55998277|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
55998278|NCT01454180|Folfirinox|folfirinox|mesh-list
55998279|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55998280|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
55998281|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998282|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998283|NCT01454180|Antiviral Agents|antiviral agents|mesh-ancestor
55998284|NCT01454180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998285|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998286|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998287|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
56618658|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618659|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
56618660|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618661|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56618662|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56618663|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56618664|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618665|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618666|NCT04789070|Sirolimus|sirolimus|mesh-list
56618667|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56618668|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618669|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56618670|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618671|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
55998288|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998289|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55998290|NCT01454180|Antidotes|antidotes|mesh-ancestor
55998314|NCT05564286|Autonomic Agents|autonomic agents|mesh-ancestor
55998315|NCT05564286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801159|NCT03040531|Vitamin D|vitamin d|mesh-list
55998319|NCT05564286|Hormones|hormones|mesh-ancestor
55998320|NCT05564286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998321|NCT05564286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55998322|NCT05564286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998323|NCT05564286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55998324|NCT05564286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998325|NCT05564286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998326|NCT05564286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55998327|NCT05564286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55998328|NCT05564286|Serotonin Agents|serotonin agents|mesh-ancestor
55998329|NCT01454804|Trastuzumab|trastuzumab|mesh-list
55998330|NCT01454804|Lapatinib|lapatinib|mesh-list
55998331|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998332|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998333|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55998334|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998335|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998336|NCT03820622|Paclitaxel|paclitaxel|mesh-list
55998337|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55998338|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55998339|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998340|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
55998341|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
55998342|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
55998343|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998344|NCT05504382|Naproxen|naproxen|mesh-list
55998345|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55998373|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998374|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998375|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55998376|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55998377|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56187805|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56187806|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187807|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
56187808|NCT01440621|Vitamins|vitamins|mesh-ancestor
56618672|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56618673|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
56618674|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618675|NCT00824239|Fentanyl|fentanyl|mesh-list
56618676|NCT00824239|Midazolam|midazolam|mesh-list
56618677|NCT00824239|Propofol|propofol|mesh-list
56618678|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56187809|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
56187810|NCT01440673|Aprepitant|aprepitant|mesh-list
56187811|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
56187812|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
56187813|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187814|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187815|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56187816|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56187817|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187818|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187819|NCT01440725|Mitogens|mitogens|mesh-list
56187820|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
56187821|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187822|NCT01440751|Mitomycins|mitomycins|mesh-list
56187823|NCT01440751|Mitomycin|mitomycin|mesh-list
56187824|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56187825|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187826|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
56187827|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187828|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56187829|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187830|NCT01440790|Vitamins|vitamins|mesh-list
56187831|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
56187832|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
56187833|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187834|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
56187835|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187836|NCT01440790|Protective Agents|protective agents|mesh-ancestor
56187837|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
56187849|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
55801163|NCT03040531|Calcium|calcium|mesh-list
56187850|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187851|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187852|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
56187853|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187854|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56187855|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
56187856|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56187857|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56187858|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187859|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56187860|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
56187861|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56187862|NCT01440985|Nicotine|nicotine|mesh-list
56187863|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56187864|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
55998378|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55998379|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998380|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998381|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998382|NCT05508516|Analgesics|analgesics|mesh-ancestor
55998383|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
55998384|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998385|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
55998386|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55998387|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
55998388|NCT02902484|Nintedanib|nintedanib|mesh-list
55725648|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
55998389|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862515|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
55998442|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998444|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55998445|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
56618679|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618680|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618681|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56618682|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
56124651|NCT01405950|Clonidine|clonidine|mesh-list
55998446|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55998447|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
55998448|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998449|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998450|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
55998451|NCT01453946|Budesonide|budesonide|mesh-list
55998452|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998453|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55998454|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
55998455|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998456|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998457|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55998458|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
55998459|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
55998460|NCT01453946|Hormones|hormones|mesh-ancestor
55998461|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998462|NCT01455896|Exenatide|exenatide|mesh-list
55998463|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55998464|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998465|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55998466|NCT01455896|Incretins|incretins|mesh-ancestor
55998467|NCT01455896|Hormones|hormones|mesh-ancestor
55998468|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998469|NCT05562882|Daratumumab|daratumumab|mesh-list
56187865|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187866|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187867|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56187868|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56187869|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
56187870|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187871|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187872|NCT01440998|Paclitaxel|paclitaxel|mesh-list
56187873|NCT01440998|Carboplatin|carboplatin|mesh-list
56187874|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56187875|NCT01440998|Dasatinib|dasatinib|mesh-list
56187876|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56187877|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187878|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
56187879|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
56187880|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
55998470|NCT05562882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998471|NCT05560542|Dexamethasone|dexamethasone|mesh-list
55998472|NCT05560542|Atropine|atropine|mesh-list
55862594|NCT01790503|Temozolomide|temozolomide|mesh-list
55998507|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
55998509|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55998510|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998565|NCT03827018|Hormones|hormones|mesh-ancestor
55998566|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998567|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998568|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55998569|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998570|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998571|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
55998572|NCT05325762|Propofol|propofol|mesh-list
55998573|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55998574|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998575|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998576|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55998577|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
55998578|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
55998579|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55998580|NCT05325762|Analgesics|analgesics|mesh-ancestor
55998581|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
55998582|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998583|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56618683|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
56618684|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56618685|NCT00824239|Narcotics|narcotics|mesh-ancestor
56618686|NCT00824239|Analgesics|analgesics|mesh-ancestor
56618687|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
56618688|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618689|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56618690|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56618691|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56618692|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56618693|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
56618694|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
56618695|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618696|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618697|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56618698|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
56618699|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56618700|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56618701|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56618702|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56618703|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
56618704|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618705|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998584|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55998585|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55998586|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
55998587|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998588|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998589|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
55998590|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
55998591|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55998592|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998593|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55998594|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55998727|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55998728|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998729|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998730|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998731|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
55998732|NCT04842422|Imiquimod|imiquimod|mesh-list
55998733|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56187881|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187882|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56187883|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187885|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187886|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56187887|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187888|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187889|NCT01441193|Vaccines|vaccines|mesh-list
56187890|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
56187891|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618706|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56618707|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56187892|NCT01441206|Rifampin|rifampin|mesh-list
56187893|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56187894|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
56187895|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55998734|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
55862860|NCT00765856|Oxymorphone|oxymorphone|mesh-list
55998819|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55998820|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
55998821|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998822|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998823|NCT04051684|Ropivacaine|ropivacaine|mesh-list
55998824|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
55998825|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
55998826|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998827|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998828|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
55998829|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998830|NCT04840862|Rifabutin|rifabutin|mesh-list
55998831|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55998832|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998833|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55998834|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
55998835|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
55998836|NCT04840238|Vitamin D|vitamin d|mesh-list
55998837|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55998839|NCT04840238|Vitamins|vitamins|mesh-ancestor
55998840|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
55998841|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55998842|NCT03829618|Lidocaine|lidocaine|mesh-list
55998843|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
55998844|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
55998869|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998870|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55998871|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55998872|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55998874|NCT01451060|Metaraminol|metaraminol|mesh-list
55998875|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55998876|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998877|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
55998878|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
55998879|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998880|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55998881|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
55998882|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998883|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998884|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55998885|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55998886|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55998887|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
56187896|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56187897|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
55998889|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
55998890|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55998891|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55998892|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
55998893|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998894|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998895|NCT01143181|Brincidofovir|brincidofovir|mesh-list
55998920|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998921|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998922|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
55998923|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55998924|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
55998925|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
55998926|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55998927|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55998928|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55998929|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
55998930|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998931|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998932|NCT01451294|Protective Agents|protective agents|mesh-ancestor
56618708|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
56618709|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618710|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618711|NCT04044703|Vancomycin|vancomycin|mesh-list
56618712|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56618713|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618714|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
56618715|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618716|NCT00824317|Methylphenidate|methylphenidate|mesh-list
56618717|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56618718|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618719|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56618720|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56618721|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618722|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618723|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
56618724|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618725|NCT02847806|Insulin|insulin|mesh-list
55998933|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55998934|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
55998935|NCT01187017|Fludarabine|fludarabine|mesh-list
55998936|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998937|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
55998938|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998939|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998940|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55998941|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
55998942|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998943|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998944|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55999016|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
55999017|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863141|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
55999047|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
55999048|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999049|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999050|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999051|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55999052|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55999054|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55999055|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55999056|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999057|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
55999111|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55999112|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55999113|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55999115|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55999116|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55999118|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
55999119|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999120|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999121|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999122|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999123|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56618726|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56618727|NCT02847806|Estradiol|estradiol|mesh-list
56618728|NCT02847806|Testosterone|testosterone|mesh-list
56618729|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56618730|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618731|NCT02847806|Estrogens|estrogens|mesh-ancestor
56618732|NCT02847806|Hormones|hormones|mesh-ancestor
56618733|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618734|NCT02847806|Androgens|androgens|mesh-ancestor
56618735|NCT00828529|Bedaquiline|bedaquiline|mesh-list
56618736|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
56618737|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56618738|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618739|NCT00632762|Amantadine|amantadine|mesh-list
56618740|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56618741|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56618742|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
56618743|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618744|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
55999124|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999125|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999126|NCT02559414|Aspirin|aspirin|mesh-list
55999127|NCT02559414|Clopidogrel|clopidogrel|mesh-list
55999128|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55999129|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56187898|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56187899|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187900|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187901|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56187902|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56187903|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56187904|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56187905|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56187906|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56187907|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56187908|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56187909|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187910|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187911|NCT01441232|Incretins|incretins|mesh-ancestor
56187912|NCT01441232|Hormones|hormones|mesh-ancestor
56187913|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56187914|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56187915|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
56187916|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187917|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187918|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56187919|NCT01441284|Pramipexole|pramipexole|mesh-list
56187920|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
56187921|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187922|NCT01441284|Protective Agents|protective agents|mesh-ancestor
56187923|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187924|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56187925|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56187926|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
56618745|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618746|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618747|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618748|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56618749|NCT00632762|Analgesics|analgesics|mesh-ancestor
56618750|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
56618751|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618752|NCT01351766|Nicotine|nicotine|mesh-list
56618753|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56618754|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
56618755|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618756|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618757|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56002027|NCT00001954|Etanercept|etanercept|mesh-list
56187927|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
56187928|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187929|NCT01441297|Nintedanib|nintedanib|mesh-list
55999130|NCT02559414|Analgesics|analgesics|mesh-ancestor
55999131|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
55999132|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187930|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187931|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56187932|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187933|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187934|NCT01441388|Bevacizumab|bevacizumab|mesh-list
56187935|NCT01441388|Sunitinib|sunitinib|mesh-list
56187936|NCT01441388|Sorafenib|sorafenib|mesh-list
56187937|NCT01441388|Axitinib|axitinib|mesh-list
56187938|NCT01441388|Crizotinib|crizotinib|mesh-list
56187939|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56187940|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56187941|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56187946|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56187947|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56187948|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187949|NCT01441427|Lenograstim|lenograstim|mesh-list
56187950|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56187951|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
56187952|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999133|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999134|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999135|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999136|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55999137|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55999138|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999139|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55999140|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55999141|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999142|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
55999143|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55999144|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55999145|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55726397|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
55999146|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
55999147|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999181|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999183|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
55999184|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55999185|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55999186|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55999187|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863318|NCT01733329|Folic Acid|folic acid|mesh-list
56618758|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56618759|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
56618760|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618761|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618762|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
55999230|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999232|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55999234|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
55999235|NCT05025644|Dobutamine|dobutamine|mesh-list
55999236|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55999237|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
55999238|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
56187953|NCT01441505|Midazolam|midazolam|mesh-list
56187954|NCT01441505|Ketamine|ketamine|mesh-list
56187955|NCT01441505|Analgesics|analgesics|mesh-ancestor
56187956|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
56187957|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187958|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187959|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56187960|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56187961|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
56187962|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
56187963|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187964|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56187965|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56187966|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187967|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187968|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56187969|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56187970|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56187971|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56187972|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56187973|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
56187974|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
56187975|NCT01441531|Gabapentin|gabapentin|mesh-list
56187976|NCT01441531|Analgesics|analgesics|mesh-ancestor
55999239|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999240|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999241|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55999242|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55999243|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55999244|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
55999245|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999247|NCT05025644|Protective Agents|protective agents|mesh-ancestor
55999249|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55999250|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999251|NCT03810066|Osimertinib|osimertinib|mesh-list
55999252|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999253|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55999254|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999255|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999256|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
55999257|NCT03992482|Antibodies|antibodies|mesh-list
55999258|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
55999259|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55999260|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55999261|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
55999262|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999263|NCT00377494|Vaccines|vaccines|mesh-list
55999264|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
55999265|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999266|NCT01459250|S 20098|s 20098|mesh-list
55999267|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56187977|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
56187978|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187979|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187980|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
56187981|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56187982|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56187983|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187984|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56618763|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56618764|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618765|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618766|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56618767|NCT02846090|Analgesics|analgesics|mesh-ancestor
56618768|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
56618769|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618770|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56618771|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56618772|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56618773|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
56618774|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618775|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618776|NCT00828763|Dolutegravir|dolutegravir|mesh-list
56618777|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56618778|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56618779|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618780|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618781|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56618782|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56618783|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
56618784|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618785|NCT00824707|Entecavir|entecavir|mesh-list
56618786|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
56618787|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618788|NCT00824785|Capecitabine|capecitabine|mesh-list
56618789|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
56618790|NCT00824785|Epirubicin|epirubicin|mesh-list
56187985|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56187986|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56187987|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187988|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187989|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
55999268|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999269|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999270|NCT04303156|Islatravir|islatravir|mesh-list
55999271|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
55999272|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999273|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999274|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999275|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55999276|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55999277|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55999278|NCT04390334|Efavirenz|efavirenz|mesh-list
55999279|NCT04390334|Famotidine|famotidine|mesh-list
55999280|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56618791|NCT00824785|Panitumumab|panitumumab|mesh-list
56618792|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56618793|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
56618794|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618795|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618796|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56618797|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56618798|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56618799|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618800|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56618801|NCT00824863|Ketoconazole|ketoconazole|mesh-list
56618802|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
56618803|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618804|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56618805|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56618806|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159618|NCT02956746|Antibodies|antibodies|mesh-list
56618807|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618808|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55999281|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55863384|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
55999314|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
55999315|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999316|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999317|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999318|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55863454|NCT05567770|Androgens|androgens|mesh-list
55999419|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55999420|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55999422|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55999423|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
55999424|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
55999425|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
55999426|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55999427|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55999428|NCT04423926|Growth Substances|growth substances|mesh-ancestor
55999429|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
55999430|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999431|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
55999475|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999476|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
55999477|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999478|NCT05024552|Cytarabine|cytarabine|mesh-list
55999535|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
55999571|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55999572|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999573|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999574|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
55999576|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
55999577|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999578|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
56187991|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56187992|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801667|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56618809|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
56618810|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618811|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618812|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56618813|NCT02844530|Epratuzumab|epratuzumab|mesh-list
56618814|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56618815|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56618816|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618817|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
56618818|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
56618819|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618820|NCT00820417|Cetuximab|cetuximab|mesh-list
56618821|NCT00820417|Gefitinib|gefitinib|mesh-list
56618822|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56618823|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618824|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56187993|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187994|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56187995|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56187996|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187997|NCT01441700|Anesthetics|anesthetics|mesh-list
56187998|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56187999|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999579|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
55999580|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005881|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
56005882|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005883|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005884|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56005885|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56005886|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
56005887|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56005888|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56005889|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
56005890|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
56005891|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005892|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56005893|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56005929|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005930|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56005931|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56005932|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56005933|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56005934|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005935|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
56005968|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005969|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56005970|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
56005971|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005973|NCT00002578|Protective Agents|protective agents|mesh-ancestor
56005974|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
56005975|NCT00002578|Vitamins|vitamins|mesh-ancestor
56005976|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
56006094|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
56006095|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
56618825|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622943|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56006096|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006097|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56006098|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
56006099|NCT00199082|Hormones|hormones|mesh-ancestor
56006100|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006101|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006102|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56006103|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
56006104|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56006105|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006106|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
56006107|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
56006108|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006109|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56006134|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
56006135|NCT04194554|Niraparib|niraparib|mesh-list
56006136|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56006137|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
56006138|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56006139|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006140|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56188000|NCT01441804|Ribavirin|ribavirin|mesh-list
56188002|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
56188003|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
56188004|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188005|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
56188006|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188007|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
56188008|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188010|NCT01441869|Saxagliptin|saxagliptin|mesh-list
56188011|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56188012|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188013|NCT01441869|Incretins|incretins|mesh-ancestor
56188014|NCT01441869|Hormones|hormones|mesh-ancestor
56188015|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56188016|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56006141|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006142|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56006143|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006144|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006145|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
56006146|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006147|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56006148|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56006149|NCT00002608|Tamoxifen|tamoxifen|mesh-list
56006150|NCT00002608|Doxorubicin|doxorubicin|mesh-list
56006151|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56006152|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006153|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56006154|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006155|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006156|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006157|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738924|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56006175|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006176|NCT00002632|Paclitaxel|paclitaxel|mesh-list
56006177|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006178|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006179|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
56006180|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
56006181|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
56006182|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006183|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56006184|NCT00002638|Cytarabine|cytarabine|mesh-list
56006185|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
56006186|NCT00002638|Carmustine|carmustine|mesh-list
56006187|NCT00002638|Etoposide|etoposide|mesh-list
56006188|NCT00002638|Sargramostim|sargramostim|mesh-list
56006189|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006190|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
56618826|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618827|NCT04923620|Cetuximab|cetuximab|mesh-list
56622944|NCT00855049|Acetaminophen|acetaminophen|mesh-list
56006191|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733373|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
56006192|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006193|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006194|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
56006195|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006196|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188017|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
56188018|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188019|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188021|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56188022|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56188023|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
56188024|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188025|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56188026|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56188027|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188028|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
56188029|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188030|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
56188031|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56188032|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56006198|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006200|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006201|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006202|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006203|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
56006204|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
56006205|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006206|NCT04136366|Methotrexate|methotrexate|mesh-list
56006207|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56006208|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
56006209|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56006210|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006211|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006212|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
56006213|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006241|NCT01896440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56006242|NCT01896440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56006243|NCT00002650|Folic Acid|folic acid|mesh-list
56006244|NCT00002650|Hematinics|hematinics|mesh-ancestor
56006245|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
56006246|NCT00002650|Vitamins|vitamins|mesh-ancestor
56006247|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
56006248|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006250|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006251|NCT05073718|Aspirin|aspirin|mesh-list
56006252|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56006253|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56006254|NCT05073718|Analgesics|analgesics|mesh-ancestor
56006255|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
56006256|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006257|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006258|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56188038|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
56188039|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56188040|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56188041|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188042|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188043|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006259|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006260|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56006261|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56006292|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006293|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006294|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802035|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
56618828|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56618829|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006295|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006296|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
56006297|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
56006298|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006299|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006300|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
56006301|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006302|NCT00002674|Analgesics|analgesics|mesh-ancestor
56006303|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
56006304|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006305|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
56006340|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
56006341|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56006344|NCT00002692|Calcium|calcium|mesh-list
56006345|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
56006382|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
56006383|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006384|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56006419|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
56006420|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56006422|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56006423|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56006424|NCT05266846|Growth Substances|growth substances|mesh-ancestor
56006455|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006456|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006457|NCT01107236|Naproxen|naproxen|mesh-list
56006458|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56006459|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56006460|NCT01107236|Analgesics|analgesics|mesh-ancestor
56006461|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
56006462|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006463|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006464|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006465|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006466|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
56006467|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56006468|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006469|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006504|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56006505|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
56006506|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56006507|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006509|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
56006510|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006511|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56006544|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56006545|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
56006546|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006547|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56188044|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56188045|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56188046|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
56188047|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188048|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
56188049|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56188050|NCT01441986|Analgesics|analgesics|mesh-ancestor
56188051|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
56188052|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188053|NCT01442025|Infliximab|infliximab|mesh-list
56188054|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
56188055|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56188056|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56188057|NCT01442168|Atovaquone|atovaquone|mesh-list
56188058|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188059|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
56188060|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56188061|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56188062|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006548|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006549|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
56006551|NCT00002716|Protective Agents|protective agents|mesh-ancestor
56618830|NCT00828919|Axitinib|axitinib|mesh-list
56618831|NCT00828919|Crizotinib|crizotinib|mesh-list
56618832|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618833|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56618834|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618835|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618836|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56618837|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
56618838|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618839|NCT02548741|Metformin|metformin|mesh-list
56618840|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
56618841|NCT02548741|Calcium|calcium|mesh-list
56006552|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
56006553|NCT00002716|Vitamins|vitamins|mesh-ancestor
56006554|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
56006555|NCT02533674|Gemcitabine|gemcitabine|mesh-list
56006556|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006557|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
56006558|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006592|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006593|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56006594|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56006595|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56006596|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006597|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
56006598|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006600|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006601|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56006602|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006603|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006631|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006632|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56006633|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
56006634|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
56006635|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
56006636|NCT00002740|Protective Agents|protective agents|mesh-ancestor
56006637|NCT00002740|Trace Elements|trace elements|mesh-ancestor
56006638|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
56006639|NCT00002746|Aldesleukin|aldesleukin|mesh-list
56006640|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006641|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56006642|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56006643|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
56006644|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006645|NCT01049945|Dexamethasone|dexamethasone|mesh-list
56006646|NCT01049945|Lenalidomide|lenalidomide|mesh-list
56006647|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56006648|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006649|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
56188063|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188066|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
56188067|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188068|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56188069|NCT01442311|Interferons|interferons|mesh-list
56188070|NCT01442311|Ribavirin|ribavirin|mesh-list
56006650|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
56006651|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006652|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006653|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56006654|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
56006655|NCT01049945|Hormones|hormones|mesh-ancestor
56006689|NCT01050647|Hormones|hormones|mesh-ancestor
56006690|NCT01050647|Cathartics|cathartics|mesh-ancestor
56006691|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56006692|NCT04825678|Erenumab|erenumab|mesh-list
56006693|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56618842|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56618843|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618844|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56618845|NCT02548741|Antacids|antacids|mesh-ancestor
56618846|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618847|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56618848|NCT02845856|Cetuximab|cetuximab|mesh-list
56618849|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56618850|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618852|NCT00825019|Amibegron|amibegron|mesh-list
56618853|NCT00825019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56618854|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56006727|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006728|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006729|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56006730|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
56006731|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56006762|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006763|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006764|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006765|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
56006766|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
56006767|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006768|NCT04783792|Protective Agents|protective agents|mesh-ancestor
56006769|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006770|NCT04783792|Vitamins|vitamins|mesh-ancestor
56006771|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
56006772|NCT05002816|Elotuzumab|elotuzumab|mesh-list
56006773|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006774|NCT01676402|Vaccines|vaccines|mesh-list
56006775|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
56006776|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006819|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56006820|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56006821|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006851|NCT04757584|Nebivolol|nebivolol|mesh-list
56006852|NCT04757584|Bisoprolol|bisoprolol|mesh-list
56006853|NCT04757584|Labetalol|labetalol|mesh-list
56006854|NCT04757584|Pindolol|pindolol|mesh-list
56006855|NCT04757584|Betaxolol|betaxolol|mesh-list
56006856|NCT04757584|Penbutolol|penbutolol|mesh-list
56006857|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56006858|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56006859|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
56006860|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56006861|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006862|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006863|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56006864|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56006865|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
56006866|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
56006867|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
56006868|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006869|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56006870|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
56006871|NCT04757584|Protective Agents|protective agents|mesh-ancestor
56006904|NCT00382642|Ondansetron|ondansetron|mesh-list
56006905|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
56006906|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
56006909|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56006910|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
56188071|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
56188072|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
56188073|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56618855|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618856|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618857|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618858|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
56618859|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618860|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56618861|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
56618862|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56618863|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56618864|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56618865|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618866|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56618867|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56618868|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
56618869|NCT00929006|Progesterone|progesterone|mesh-list
56618870|NCT00929006|Progestins|progestins|mesh-ancestor
56006911|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
56006969|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56006970|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56006971|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56006972|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006973|NCT01620788|Losartan|losartan|mesh-list
56006974|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56006975|NCT01620788|Indapamide|indapamide|mesh-list
56006976|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56006977|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56006978|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56006979|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56006980|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006981|NCT01620788|Diuretics|diuretics|mesh-ancestor
56006982|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
56006983|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006984|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56006985|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56006986|NCT03014843|Bromides|bromides|mesh-list
56006987|NCT03014843|Naloxone|naloxone|mesh-list
56007015|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56007017|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56007018|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007019|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56007020|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
56007021|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007022|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007023|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
56007024|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007025|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56007026|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007027|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
56007028|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007029|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56007030|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
56007031|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734200|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007032|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56007033|NCT03913559|Analgesics|analgesics|mesh-ancestor
56007034|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
56007035|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618871|NCT00929006|Hormones|hormones|mesh-ancestor
56618872|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618873|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618874|NCT00877214|Rituximab|rituximab|mesh-list
56618875|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56618876|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618877|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
56618878|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618880|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
56618881|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56618882|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56618883|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618884|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
56618885|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618886|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618887|NCT05242718|Palmidrol|palmidrol|mesh-list
56618888|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
56618889|NCT05242718|Curcumin|curcumin|mesh-list
56618890|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56618891|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56618892|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56618893|NCT05242718|Analgesics|analgesics|mesh-ancestor
56007036|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
56007073|NCT03852797|Analgesics|analgesics|mesh-ancestor
56007074|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
56007075|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007076|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56007077|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56007142|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
56007143|NCT03850379|Levofloxacin|levofloxacin|mesh-list
56007144|NCT03850379|Ofloxacin|ofloxacin|mesh-list
56007145|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56007146|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007148|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56007149|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007150|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007151|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007152|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56007153|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56007154|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56007155|NCT03850379|Renal Agents|renal agents|mesh-ancestor
56007156|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56007157|NCT03014687|Cefdinir|cefdinir|mesh-list
56007158|NCT03014687|Cephalosporins|cephalosporins|mesh-list
56007159|NCT03014687|Trimethoprim|trimethoprim|mesh-list
56007160|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
56007161|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007192|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
56007193|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56188074|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188075|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
56188076|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188077|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
56618894|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
56618895|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618896|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618897|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618898|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56618899|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618900|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618901|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618902|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
56618903|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618904|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56618905|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56618906|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618907|NCT05242718|Hormones|hormones|mesh-ancestor
56618908|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618909|NCT05242718|Expectorants|expectorants|mesh-ancestor
56618910|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
56618911|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56618912|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
56618913|NCT05242718|Protective Agents|protective agents|mesh-ancestor
56188078|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188079|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
56188080|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188082|NCT01442428|Naproxen|naproxen|mesh-list
56188083|NCT01442428|Atorvastatin|atorvastatin|mesh-list
56188084|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56188085|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
56188086|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
56188087|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188088|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188089|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56188090|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
56188091|NCT01442428|Hormones|hormones|mesh-ancestor
56188092|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56188093|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56007194|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007195|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56007196|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56007197|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56007198|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
56007199|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56007200|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56007201|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
56007202|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007203|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
56007231|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56007232|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007233|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007234|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
56007235|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56007236|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
56007237|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56618914|NCT05242718|Antidotes|antidotes|mesh-ancestor
56618915|NCT02845778|Melatonin|melatonin|mesh-list
56618916|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
56618917|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618918|NCT02845778|Protective Agents|protective agents|mesh-ancestor
56618919|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618920|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618921|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56618922|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56618923|NCT05337332|Triamcinolone|triamcinolone|mesh-list
56618924|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56618925|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56618926|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56618927|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56618928|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
56618930|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56618931|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618932|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56618933|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
56618934|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618935|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618936|NCT03085004|Gemcitabine|gemcitabine|mesh-list
56618937|NCT03085004|Ethanol|ethanol|mesh-list
56618938|NCT03085004|Paclitaxel|paclitaxel|mesh-list
56618939|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56618940|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618941|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56618942|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56618943|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56007238|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007239|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56007240|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56007241|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56007242|NCT01059929|Fentanyl|fentanyl|mesh-list
56007243|NCT01059929|Midazolam|midazolam|mesh-list
56007244|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
56007245|NCT01059929|Propofol|propofol|mesh-list
56007246|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56007247|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007248|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007249|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56007250|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
56007251|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
56007287|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
56007288|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
56007290|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
56618944|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618945|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56618946|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
56618947|NCT03085004|Antiviral Agents|antiviral agents|mesh-ancestor
56618948|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56618949|NCT03085004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618950|NCT03085004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56618951|NCT03085004|Immunologic Factors|immunologic factors|mesh-ancestor
56618952|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618953|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56618954|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618956|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
56618957|NCT00901394|Hematinics|hematinics|mesh-ancestor
56618958|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
56618959|NCT00901394|Vitamins|vitamins|mesh-ancestor
56618960|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
56618961|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618962|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55722048|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
56002192|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56002193|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56002194|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002195|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56002196|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
56002197|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002198|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007291|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188094|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188095|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56007292|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
56007319|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56007320|NCT04156828|Carboplatin|carboplatin|mesh-list
56007321|NCT04156828|Antibodies|antibodies|mesh-list
56007322|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
56007323|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56007324|NCT04156828|Lenograstim|lenograstim|mesh-list
56007325|NCT04156828|BB 1101|bb 1101|mesh-list
56007326|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
56007327|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007328|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007329|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007330|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007331|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
56007332|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
56007333|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007334|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007337|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007338|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55802238|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618963|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
56618964|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
56618965|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56618966|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56618967|NCT00901394|Analgesics|analgesics|mesh-ancestor
56618968|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
56618969|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618970|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
56618971|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56618972|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
56618973|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
56618974|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56618975|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618976|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618977|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56618978|NCT05337254|Analgesics|analgesics|mesh-ancestor
56618979|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
56618980|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618981|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
56618982|NCT00896532|Denosumab|denosumab|mesh-list
56618983|NCT00896532|Alendronate|alendronate|mesh-list
56618984|NCT00896532|Teriparatide|teriparatide|mesh-list
56618985|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56618986|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56007339|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56007340|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
56007449|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
56007450|NCT03998488|Cathartics|cathartics|mesh-ancestor
56007451|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007452|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
56007453|NCT05426304|S 20098|s 20098|mesh-list
56007454|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56007455|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007456|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007457|NCT03955198|Durvalumab|durvalumab|mesh-list
56007491|NCT03342196|Fludarabine|fludarabine|mesh-list
56007492|NCT03342196|Melphalan|melphalan|mesh-list
56007493|NCT03342196|Thiotepa|thiotepa|mesh-list
56007494|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007495|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007496|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007526|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007528|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56007529|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
56007530|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
56007531|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
56007532|NCT01246063|Dexamethasone|dexamethasone|mesh-list
56007533|NCT01246063|Doxorubicin|doxorubicin|mesh-list
56007534|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56007535|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007536|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
56007537|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
56007538|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56618987|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56618988|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56618989|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
56618990|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
56618991|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56618992|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56618993|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56618994|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56618995|NCT02843490|Ranibizumab|ranibizumab|mesh-list
56618996|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56618997|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56618998|NCT02843490|Growth Substances|growth substances|mesh-ancestor
56618999|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56367542|NCT00325858|Analgesics|analgesics|mesh-ancestor
56619000|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
56619001|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619002|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
56619003|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619004|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56619005|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619006|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619008|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
56619009|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619010|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56619011|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56619012|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002224|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
56007539|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007540|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007541|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
56007542|NCT01246063|Hormones|hormones|mesh-ancestor
56007571|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007572|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007573|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
56007574|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56007575|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56007576|NCT03836014|Growth Substances|growth substances|mesh-ancestor
56007577|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
56007578|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
56007579|NCT01205503|Doxorubicin|doxorubicin|mesh-list
56007580|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007581|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
56007582|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007583|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007584|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56007585|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
56619013|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619014|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56619015|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56619016|NCT01341600|Omeprazole|omeprazole|mesh-list
56619017|NCT01341600|Clopidogrel|clopidogrel|mesh-list
56619018|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56619019|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56619020|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56619021|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56619022|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
56619023|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619024|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619025|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619026|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56052783|NCT03402243|Menthol|menthol|mesh-list
56619027|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619028|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56619029|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619030|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
56619031|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56619032|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56619033|NCT02845388|Estradiol|estradiol|mesh-list
56619034|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56619035|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619036|NCT02845388|Estrogens|estrogens|mesh-ancestor
56619037|NCT02845388|Hormones|hormones|mesh-ancestor
56619038|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007586|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007587|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188096|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56188097|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
56188098|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188099|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56188100|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56188101|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188102|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56188103|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56188104|NCT01442428|Analgesics|analgesics|mesh-ancestor
56188105|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
56188106|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56188107|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
56188108|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56188109|NCT01442519|Mitomycins|mitomycins|mesh-list
56007624|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56007625|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750595|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
56619039|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619040|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56619041|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
56619042|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56619043|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56619044|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
56619045|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56619046|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56619047|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619048|NCT02845388|Urological Agents|urological agents|mesh-ancestor
56619049|NCT02845466|Becaplermin|becaplermin|mesh-list
56619050|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
56619051|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56619052|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56619053|NCT02845466|Growth Substances|growth substances|mesh-ancestor
56007653|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007655|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
56007657|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56007658|NCT03091660|Vaccines|vaccines|mesh-list
56007659|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
56007660|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
56007661|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007662|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56007663|NCT04385368|Durvalumab|durvalumab|mesh-list
56007664|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007665|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007666|NCT03786796|Olaparib|olaparib|mesh-list
56007667|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56007668|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007669|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007670|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007671|NCT03779854|Vidarabine|vidarabine|mesh-list
56007700|NCT03089866|Midazolam|midazolam|mesh-list
56007701|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56007702|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56007703|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007704|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007705|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56007706|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56007707|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56007708|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56007709|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
56007710|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
55734890|NCT03130517|Antibodies|antibodies|mesh-list
56007711|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
56007712|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
56007713|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007714|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007715|NCT00002890|Lintuzumab|lintuzumab|mesh-list
56007716|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007717|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007718|NCT00002896|Leucovorin|leucovorin|mesh-list
56007720|NCT00002896|Fluorouracil|fluorouracil|mesh-list
56007751|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56007752|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007753|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56007754|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
56007755|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007756|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
56007757|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802615|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56619054|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619055|NCT04345796|Empagliflozin|empagliflozin|mesh-list
56619056|NCT04345796|Carvedilol|carvedilol|mesh-list
56619057|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56619058|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619059|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56619060|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619061|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56619062|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56007758|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56007759|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56007760|NCT05445232|Midazolam|midazolam|mesh-list
56007761|NCT05445232|Caffeine|caffeine|mesh-list
56007762|NCT05445232|Warfarin|warfarin|mesh-list
56007763|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56007764|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56007765|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007766|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007767|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56007801|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007804|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
56007805|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007806|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56007807|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56007808|NCT01212445|Laxatives|laxatives|mesh-list
56007809|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007840|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56007841|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
56007842|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56007843|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56007844|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56007845|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56007846|NCT01250977|Donepezil|donepezil|mesh-list
56007847|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56007848|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007849|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007850|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
56007851|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007890|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
56007891|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007922|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
56007923|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007924|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007925|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56007926|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56007927|NCT01214161|Lidocaine|lidocaine|mesh-list
56007928|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
56007929|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
56007930|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007931|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007932|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
56007933|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007934|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56007935|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56007936|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56007969|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007970|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007972|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007973|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007974|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56007975|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56007976|NCT00383812|Growth Substances|growth substances|mesh-ancestor
56619063|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
56619064|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619065|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56619066|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
56619067|NCT04345796|Protective Agents|protective agents|mesh-ancestor
56619068|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56619069|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56619070|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56619071|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
56619072|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56619073|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56619075|NCT00623623|Tenecteplase|tenecteplase|mesh-list
56619076|NCT00623623|Clopidogrel|clopidogrel|mesh-list
56619077|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56619078|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56619079|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56619080|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56619081|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
56619082|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619083|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619084|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619085|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
56619086|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56619087|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56619088|NCT00896454|Denosumab|denosumab|mesh-list
56619089|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56619090|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619091|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56619092|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56619093|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56619094|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56008006|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
56008007|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008008|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008009|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008010|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008011|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008012|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008013|NCT01281475|Levodopa|levodopa|mesh-list
56008014|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56619095|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619096|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619097|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619098|NCT04224584|Analgesics|analgesics|mesh-ancestor
56619100|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619101|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
56619102|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56619103|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
56619104|NCT02993198|Carvedilol|carvedilol|mesh-list
56619105|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56619106|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56619107|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
56619108|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002319|NCT02507336|Growth Substances|growth substances|mesh-ancestor
56008015|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56008016|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
56008017|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008018|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008019|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008020|NCT00002932|Cisplatin|cisplatin|mesh-list
56008021|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188111|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
56188112|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56188113|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188114|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
56188115|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188116|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56188117|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008022|NCT01572662|Methotrexate|methotrexate|mesh-list
56008023|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
56008055|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56008056|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56008057|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56008058|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
56008059|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
56008060|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
56008061|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56008062|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56008063|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56008064|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56008065|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56008066|NCT01258153|MEN 11420|men 11420|mesh-list
56008132|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56008133|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008135|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
56008136|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56008137|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56008138|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
56008139|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008140|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008141|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008142|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008143|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008144|NCT00003394|Paclitaxel|paclitaxel|mesh-list
56008145|NCT00003394|Carboplatin|carboplatin|mesh-list
56008148|NCT00003394|Estramustine|estramustine|mesh-list
56008149|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008150|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008184|NCT00002944|Thioguanine|thioguanine|mesh-list
56008185|NCT00002944|Lomustine|lomustine|mesh-list
56008186|NCT00002944|Procarbazine|procarbazine|mesh-list
55802616|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
56619109|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619110|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619111|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56619112|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
56619113|NCT02993198|Protective Agents|protective agents|mesh-ancestor
56619114|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56619115|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002334|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
56008187|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008188|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008189|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008190|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008191|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008192|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008219|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008220|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008221|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008222|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008223|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008224|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008225|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
56008226|NCT00003412|Interleukin-12|interleukin-12|mesh-list
56008227|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56008228|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
56008229|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008230|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56008231|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56008232|NCT00003412|Growth Substances|growth substances|mesh-ancestor
56008233|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
56008234|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008235|NCT04301492|Vortioxetine|vortioxetine|mesh-list
56008236|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
56008237|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56188119|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
56008238|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56008239|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56008240|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56008241|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008242|NCT04301492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56008243|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56008275|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008276|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008277|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56008278|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008279|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008280|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008281|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008282|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
56008284|NCT00754364|Carboplatin|carboplatin|mesh-list
56008285|NCT00754364|Pemetrexed|pemetrexed|mesh-list
56008286|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008287|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008288|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
56008322|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56008323|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008324|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56008325|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008326|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56008327|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56008328|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56008329|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56008355|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56008357|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55802617|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
56619116|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56619117|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
56619118|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56619119|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56619120|NCT00829231|Sorafenib|sorafenib|mesh-list
56619121|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619122|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56619123|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619124|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619125|NCT00901628|Cefuroxime|cefuroxime|mesh-list
56619126|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
56619127|NCT00901628|Ketorolac|ketorolac|mesh-list
56619128|NCT00901628|Epinephrine|epinephrine|mesh-list
56619129|NCT00901628|Morphine|morphine|mesh-list
56619130|NCT00901628|Ropivacaine|ropivacaine|mesh-list
56619131|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56619132|NCT00901628|Narcotics|narcotics|mesh-ancestor
56619133|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56008358|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008359|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56008360|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56008361|NCT04777838|Analgesics|analgesics|mesh-ancestor
56008362|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
56008363|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56008364|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
56008365|NCT00003424|Tamoxifen|tamoxifen|mesh-list
56008366|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56008367|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
56008368|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56008369|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008370|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56008371|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008372|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56008373|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56008374|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56008376|NCT02494258|Cc-486|cc-486|mesh-list
56008377|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008378|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
56008409|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56008410|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008412|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008413|NCT00003010|Marimastat|marimastat|mesh-list
56008414|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008415|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008416|NCT00003436|Cytarabine|cytarabine|mesh-list
56008417|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
56008418|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56008419|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56008420|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56008421|NCT00003436|Methotrexate|methotrexate|mesh-list
56008422|NCT00003436|Etoposide|etoposide|mesh-list
56008448|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56008449|NCT00003436|Analgesics|analgesics|mesh-ancestor
56008450|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
56008451|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008452|NCT02432378|Celecoxib|celecoxib|mesh-list
56188120|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188121|NCT01442532|Midazolam|midazolam|mesh-list
56619134|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619135|NCT00901628|Analgesics|analgesics|mesh-ancestor
56619136|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
56619137|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619138|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
56619139|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
56619140|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56619141|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56619142|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
56619143|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619144|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619145|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56619146|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56619147|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
56619148|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56619149|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
56619150|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
56619151|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
56619152|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56619153|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56619154|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56619155|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56619156|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56619157|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56188122|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56188123|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56188124|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188125|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188126|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56188127|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56188128|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56188129|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56188130|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
56188131|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
56188132|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
56188133|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
56188134|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188135|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188136|NCT01442558|Bupivacaine|bupivacaine|mesh-list
56188137|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
56188138|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
56188139|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188140|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188141|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
56188142|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188143|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
56188144|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56188145|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
56188146|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188147|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
56188148|NCT01442571|Protective Agents|protective agents|mesh-ancestor
56619158|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619159|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56619160|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619161|NCT00623545|Exenatide|exenatide|mesh-list
56619162|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56619163|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619164|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56619165|NCT00623545|Incretins|incretins|mesh-ancestor
56619166|NCT00623545|Hormones|hormones|mesh-ancestor
56619167|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619168|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
56619169|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56619170|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56619171|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619172|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
56619173|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619174|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619175|NCT02839668|Acetaminophen|acetaminophen|mesh-list
56619176|NCT02839668|Lidocaine|lidocaine|mesh-list
56619177|NCT02839668|Atropine|atropine|mesh-list
56619178|NCT02839668|Tramadol|tramadol|mesh-list
56619179|NCT02839668|Sevoflurane|sevoflurane|mesh-list
56619180|NCT02839668|Neostigmine|neostigmine|mesh-list
56619181|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
56188149|NCT01442610|Rasagiline|rasagiline|mesh-list
56188150|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56188151|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008453|NCT02432378|Cisplatin|cisplatin|mesh-list
56008454|NCT02432378|Vaccines|vaccines|mesh-list
56008455|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
56008456|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008457|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008458|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56008459|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56008460|NCT02432378|Analgesics|analgesics|mesh-ancestor
56008461|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
56008462|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008463|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56008464|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008465|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56188152|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188153|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56188155|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188156|NCT01442662|Gemcitabine|gemcitabine|mesh-list
56188157|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55735626|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008466|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56008467|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008468|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008469|NCT00003466|Temozolomide|temozolomide|mesh-list
56008470|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008471|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
56008501|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56619182|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
56619183|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619184|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619185|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
56619186|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619187|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56619188|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56619189|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56619190|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56619191|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619192|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56619193|NCT02839668|Analgesics|analgesics|mesh-ancestor
56619194|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
56619195|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56619196|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56619197|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
56619198|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56008502|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008503|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008504|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008505|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008506|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008507|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
56008508|NCT00003490|Prednisone|prednisone|mesh-list
56008509|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
56008510|NCT00003490|Vincristine|vincristine|mesh-list
56008511|NCT00003490|Sargramostim|sargramostim|mesh-list
56008512|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008513|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
56008514|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008515|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008516|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008544|NCT03584516|Prednisolone|prednisolone|mesh-list
56008545|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
56008546|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56008547|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
56008548|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56008549|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
56008550|NCT03584516|Hormones|hormones|mesh-ancestor
56008551|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56008552|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008553|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56008554|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008555|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
56008556|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
56008557|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008558|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56008559|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56008560|NCT03584516|Protective Agents|protective agents|mesh-ancestor
56008561|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
56008562|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56008563|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56008612|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
56008613|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008614|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008615|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56619199|NCT02839668|Narcotics|narcotics|mesh-ancestor
56619200|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56619201|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56619202|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
56619203|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56619204|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
56619205|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
56619206|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
56619207|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56619208|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56619209|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
56619210|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619211|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56619212|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619213|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56619214|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56619215|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
56619216|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619217|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56619218|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
56619219|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619220|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56619221|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
56619222|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619223|NCT02839356|Epinephrine|epinephrine|mesh-list
56619224|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56619225|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56619226|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
56619227|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619228|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619229|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002398|NCT02734004|Durvalumab|durvalumab|mesh-list
56008616|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56008617|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
56008618|NCT00003064|Paclitaxel|paclitaxel|mesh-list
56008619|NCT00003064|Etoposide|etoposide|mesh-list
56008620|NCT00003064|Carboplatin|carboplatin|mesh-list
56008621|NCT00003064|Topotecan|topotecan|mesh-list
56008622|NCT00003064|Thiotepa|thiotepa|mesh-list
56008623|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
56008624|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008625|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008661|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
56008662|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619230|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56619231|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56619232|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
56619233|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619234|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56619235|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
56619236|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
56619237|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
56619238|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56619239|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56619240|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619241|NCT02840526|Acetaminophen|acetaminophen|mesh-list
56619242|NCT02840526|Fentanyl|fentanyl|mesh-list
56619243|NCT02840526|Bupivacaine|bupivacaine|mesh-list
56619294|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619295|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367836|NCT00400335|Dutasteride|dutasteride|mesh-list
56619296|NCT02834676|Ethanol|ethanol|mesh-list
56619297|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56619298|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619299|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619300|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619301|NCT00632840|Atorvastatin|atorvastatin|mesh-list
56619302|NCT00632840|Fenofibrate|fenofibrate|mesh-list
56619303|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56619304|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56619305|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
56619306|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619307|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56619308|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56619309|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619310|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56619311|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56619312|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56619313|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56619314|NCT00829777|Naloxone|naloxone|mesh-list
56619315|NCT00829777|Lactulose|lactulose|mesh-list
56619316|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56002464|NCT02725424|Docetaxel|docetaxel|mesh-list
56008663|NCT00384436|Citalopram|citalopram|mesh-list
56008700|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56008701|NCT00003076|Eflornithine|eflornithine|mesh-list
56008702|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008703|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56188158|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
56188159|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188160|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188161|NCT01442662|Antiviral Agents|antiviral agents|mesh-ancestor
56188162|NCT01442662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188163|NCT01442662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188164|NCT01442662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188167|NCT01442701|Triclosan|triclosan|mesh-list
56188168|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56188169|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188170|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56008771|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008772|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
56008773|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008774|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008775|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008776|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
56008777|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008778|NCT05358704|Leucovorin|leucovorin|mesh-list
56008779|NCT05358704|Fluorouracil|fluorouracil|mesh-list
56619317|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619318|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
56619319|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619320|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619321|NCT02834754|Vedolizumab|vedolizumab|mesh-list
56619322|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619323|NCT02839122|Tadalafil|tadalafil|mesh-list
56619324|NCT02839122|Dutasteride|dutasteride|mesh-list
56619325|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
56619326|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56619327|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56619328|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619329|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619330|NCT02839122|Urological Agents|urological agents|mesh-ancestor
56619331|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56619332|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56619333|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
56619374|NCT04044079|Dinoprostone|dinoprostone|mesh-list
56619375|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56619376|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
56619377|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56619378|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619379|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56619380|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619381|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
56619382|NCT00830323|Oseltamivir|oseltamivir|mesh-list
56619383|NCT00830323|Amantadine|amantadine|mesh-list
56619384|NCT00830323|Zanamivir|zanamivir|mesh-list
56619385|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
56619386|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619387|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619388|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619389|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56619390|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56619391|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
56619392|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619393|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619394|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56619395|NCT00830323|Analgesics|analgesics|mesh-ancestor
56619396|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
56159624|NCT02967354|Tryptophan|tryptophan|mesh-list
56619397|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619398|NCT00830401|Doxycycline|doxycycline|mesh-list
56619399|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56619400|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619401|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
56619402|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56619403|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56619404|NCT04249908|Maleic acid|maleic acid|mesh-list
56619405|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619406|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008780|NCT05358704|Capecitabine|capecitabine|mesh-list
56008781|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
56008782|NCT05358704|Irinotecan|irinotecan|mesh-list
56008783|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
56008817|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008818|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008819|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56008820|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56008821|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619407|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56619408|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56619409|NCT02837640|Levodopa|levodopa|mesh-list
56619410|NCT02837640|Carbidopa|carbidopa|mesh-list
56619411|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56619412|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56619413|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56619414|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
56619415|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619416|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619417|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619418|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56619419|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619420|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56619421|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
56619422|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
56619423|NCT02834286|Dexamethasone|dexamethasone|mesh-list
56619424|NCT02834286|Rituximab|rituximab|mesh-list
56619425|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56619426|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619427|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
56619428|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619429|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56619430|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56619431|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
56619432|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
56619433|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008822|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56008823|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56008824|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
56008825|NCT00606346|Infliximab|infliximab|mesh-list
56008860|NCT00059228|Estradiol|estradiol|mesh-list
56008861|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56008862|NCT00059228|Estrogens|estrogens|mesh-ancestor
56008863|NCT00059228|Hormones|hormones|mesh-ancestor
56008864|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56008865|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008896|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008897|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008898|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
56008899|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56008900|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56008901|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008902|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
56008903|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56008904|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56008905|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56008906|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56008955|NCT00493870|Docetaxel|docetaxel|mesh-list
56619434|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619435|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
56619436|NCT02834286|Hormones|hormones|mesh-ancestor
56619437|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619438|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56619439|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
56619440|NCT02839044|Vitamin K|vitamin k|mesh-list
56619441|NCT02839044|Vitamin MK 7|vitamin mk 7|mesh-list
56619442|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56619443|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56619444|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619445|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
56619446|NCT02839044|Coagulants|coagulants|mesh-ancestor
56619447|NCT02839044|Vitamins|vitamins|mesh-ancestor
56619448|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
56619449|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619450|NCT02837094|Insulin|insulin|mesh-list
56619451|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56619452|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619453|NCT02833506|Sirolimus|sirolimus|mesh-list
56619454|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56619455|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619456|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56619457|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619458|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
56619459|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56619460|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
56008956|NCT00493870|Doxorubicin|doxorubicin|mesh-list
56008957|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008958|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
56008959|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008960|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008961|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008962|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
56188171|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56188172|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
56188173|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188174|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56008963|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008965|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56008966|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008967|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008968|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008969|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56008970|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56008971|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008972|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008973|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
56008974|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56008975|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56619461|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619462|NCT02838576|Estrogens|estrogens|mesh-list
56619463|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56619464|NCT02838576|Hormones|hormones|mesh-ancestor
56619465|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619466|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619467|NCT00838539|Sirolimus|sirolimus|mesh-list
56619468|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56619469|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619470|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56619471|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619472|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
56619474|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
56619475|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619476|NCT02836548|Vorinostat|vorinostat|mesh-list
56619477|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56619478|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619479|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008976|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009010|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009011|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
56009012|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009043|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009044|NCT01063829|Letermovir|letermovir|mesh-list
56009045|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56009046|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009047|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009048|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009049|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
56009050|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009051|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
56009052|NCT00072566|Bevacizumab|bevacizumab|mesh-list
56009053|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56009054|NCT00072566|Antibodies|antibodies|mesh-list
56009055|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
56009056|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56009057|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
56009058|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
56009059|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009060|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
56009061|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009062|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009063|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009064|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
56009065|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009066|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009068|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56009069|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56009070|NCT00072566|Growth Substances|growth substances|mesh-ancestor
56009071|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
56009072|NCT00003622|Paclitaxel|paclitaxel|mesh-list
56009073|NCT00003622|Vinorelbine|vinorelbine|mesh-list
56009103|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
56009104|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009105|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009106|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
56009107|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802618|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
56619480|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619481|NCT02836704|Metformin|metformin|mesh-list
56619482|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
56619483|NCT02836704|Acarbose|acarbose|mesh-list
56619484|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56619485|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619486|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56619487|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619488|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619489|NCT02833584|Acetaminophen|acetaminophen|mesh-list
56619490|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56619491|NCT02833584|Analgesics|analgesics|mesh-ancestor
56619492|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
56619493|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619494|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619495|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
56619496|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56619497|NCT00837759|Lansoprazole|lansoprazole|mesh-list
56619498|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
56619499|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56619500|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619501|NCT00837759|Incretins|incretins|mesh-ancestor
56619502|NCT00837759|Hormones|hormones|mesh-ancestor
56619503|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619504|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56619505|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
56619506|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622946|NCT00855049|Analgesics|analgesics|mesh-ancestor
56009108|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009109|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56009110|NCT05061992|Lactulose|lactulose|mesh-list
56009111|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56009112|NCT00002806|Vincristine|vincristine|mesh-list
56009113|NCT00002806|Lomustine|lomustine|mesh-list
56009114|NCT00002806|Procarbazine|procarbazine|mesh-list
56009115|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009116|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188175|NCT01442727|Selenium|selenium|mesh-list
56188176|NCT01442727|Selenious Acid|selenious acid|mesh-list
56188177|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
56188178|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
56188179|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188180|NCT01442727|Protective Agents|protective agents|mesh-ancestor
56188181|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188182|NCT01442727|Trace Elements|trace elements|mesh-ancestor
56188183|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
56188184|NCT01442766|Donepezil|donepezil|mesh-list
56188185|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56188186|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619507|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619508|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56619509|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619510|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56619511|NCT00703365|Gemcitabine|gemcitabine|mesh-list
56619512|NCT00703365|Sorafenib|sorafenib|mesh-list
56619513|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56619514|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
56619515|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619516|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619517|NCT00703365|Antiviral Agents|antiviral agents|mesh-ancestor
56619518|NCT00703365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619519|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619520|NCT00703365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56619521|NCT00703365|Immunologic Factors|immunologic factors|mesh-ancestor
56619522|NCT00703365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619523|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56619524|NCT04249284|BMS-986165|bms-986165|mesh-list
56619525|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
56619526|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56619527|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619528|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619529|NCT04474938|Dexamethasone|dexamethasone|mesh-list
56619530|NCT04474938|Bortezomib|bortezomib|mesh-list
56619531|NCT04474938|Daratumumab|daratumumab|mesh-list
56619532|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002657|NCT00000340|Pemoline|pemoline|mesh-list
56188187|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188188|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
56009117|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009118|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009119|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009156|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009157|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56009159|NCT00002812|Hormones|hormones|mesh-ancestor
56009160|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56009161|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56009237|NCT02191033|Nicotine|nicotine|mesh-list
56009238|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56009239|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
56009268|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
56009269|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56009270|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009271|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009272|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
56009273|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
56009274|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56009275|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009276|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
56619533|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
56619534|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
56619535|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619536|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619537|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619538|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
56619539|NCT04474938|Hormones|hormones|mesh-ancestor
56619540|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619541|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56619542|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619543|NCT00837213|Doxycycline|doxycycline|mesh-list
56619544|NCT00837213|Clindamycin|clindamycin|mesh-list
56619545|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
56619546|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
56619547|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56619548|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56619549|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619550|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
56619551|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56619552|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56619553|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56619554|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619555|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619556|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
56619557|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
56619558|NCT02833038|Analgesics|analgesics|mesh-ancestor
56619559|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
56619560|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619561|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619562|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
56619563|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002681|NCT00002032|Rifabutin|rifabutin|mesh-list
56009277|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009278|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009279|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009280|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009281|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009282|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009283|NCT00002824|Ganciclovir|ganciclovir|mesh-list
56009284|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56009319|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56009320|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56009321|NCT01260883|Analgesics|analgesics|mesh-ancestor
56009322|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
56619564|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56619565|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
56619566|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56619567|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56619568|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619569|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56619570|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
56619571|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56619572|NCT00703755|Metformin|metformin|mesh-list
56619573|NCT00703755|Fenofibrate|fenofibrate|mesh-list
56619574|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56009375|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56009376|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56009377|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009378|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
56009379|NCT00003658|Rituximab|rituximab|mesh-list
56009380|NCT00003658|Pentostatin|pentostatin|mesh-list
56009381|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009382|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
56009383|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009384|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009385|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009386|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
56009387|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188189|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188190|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188191|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
56188193|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56188194|NCT01442818|Narcotics|narcotics|mesh-ancestor
56188195|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188196|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188197|NCT01442818|Analgesics|analgesics|mesh-ancestor
56188198|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
56188199|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188200|NCT01442870|Metformin|metformin|mesh-list
56188201|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56188202|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188203|NCT01442909|Docetaxel|docetaxel|mesh-list
56188204|NCT01442909|Pemetrexed|pemetrexed|mesh-list
56188205|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188206|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
56188207|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
56188208|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009388|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009389|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56009390|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56009391|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56009392|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009393|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
56009394|NCT00002836|Thiotepa|thiotepa|mesh-list
56009395|NCT00002836|Carmustine|carmustine|mesh-list
56009396|NCT00002836|Cisplatin|cisplatin|mesh-list
56009397|NCT00002836|Etoposide|etoposide|mesh-list
56009398|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009399|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
56009400|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009401|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009402|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009403|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
56009405|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009437|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009438|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
56009439|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009440|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56009441|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56619575|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619576|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56619577|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
56619578|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619579|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56619580|NCT02838342|Interferons|interferons|mesh-list
56619581|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
56619582|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
56619583|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56619584|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
56619585|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619586|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56619587|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56619588|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
56619589|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619590|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619591|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56619592|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
56619593|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619594|NCT05333640|Sirolimus|sirolimus|mesh-list
56619595|NCT05333640|Paclitaxel|paclitaxel|mesh-list
56619596|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56619597|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619598|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
56619599|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
56619600|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
56619601|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619602|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56619603|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619604|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56619605|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
56009442|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009443|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56009444|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
56009445|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56009446|NCT00003202|Gemcitabine|gemcitabine|mesh-list
56009447|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009448|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009450|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009451|NCT00003202|Antiviral Agents|antiviral agents|mesh-ancestor
56009486|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56009487|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56009488|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
56619606|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56619607|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
56619608|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619610|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
56619611|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619612|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56619613|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56619614|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619615|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619616|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56619617|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
56619618|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619619|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619620|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56619621|NCT00633438|Celecoxib|celecoxib|mesh-list
56619622|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56619623|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56619624|NCT00633438|Analgesics|analgesics|mesh-ancestor
56619625|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
56619626|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619627|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619628|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56619629|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56619630|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56619631|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56619632|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619633|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619634|NCT02833116|Dexamethasone|dexamethasone|mesh-list
56619635|NCT02833116|Betamethasone|betamethasone|mesh-list
56009489|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56009490|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009491|NCT00003214|Paclitaxel|paclitaxel|mesh-list
56188209|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188210|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188211|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56188212|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56188213|NCT01442935|Leucovorin|leucovorin|mesh-list
56188214|NCT01442935|Folic Acid|folic acid|mesh-list
56115976|NCT00002633|Leuprolide|leuprolide|mesh-list
56188215|NCT01442935|Bevacizumab|bevacizumab|mesh-list
56188216|NCT01442935|Cetuximab|cetuximab|mesh-list
56188217|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
56188218|NCT01442935|Irinotecan|irinotecan|mesh-list
56619636|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56619637|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
56619638|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
56619639|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619640|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619641|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619642|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
56619643|NCT02833116|Hormones|hormones|mesh-ancestor
56619644|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619645|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56619646|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619647|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56619648|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
56619649|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
56619650|NCT00703989|Benphothiamine|benphothiamine|mesh-list
56619651|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
56002773|NCT01894334|Edaravone|edaravone|mesh-list
56188219|NCT01442935|Fluorouracil|fluorouracil|mesh-list
56188220|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
56188221|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56188222|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188223|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56188224|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56188225|NCT01442935|Growth Substances|growth substances|mesh-ancestor
56188226|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188227|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
56188228|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56188229|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56188230|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188231|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188232|NCT01442935|Antidotes|antidotes|mesh-ancestor
56009492|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
56009526|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
56009527|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009528|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009530|NCT00002866|Epirubicin|epirubicin|mesh-list
56009531|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009532|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009533|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009534|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009535|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009571|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56009573|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
56009574|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009575|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009605|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56009606|NCT00003682|Prednisolone|prednisolone|mesh-list
56009607|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
56009608|NCT00003682|Doxorubicin|doxorubicin|mesh-list
56009609|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56009610|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56009611|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
56009612|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009613|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009614|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009615|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009616|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188233|NCT01442935|Protective Agents|protective agents|mesh-ancestor
56188234|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
56188237|NCT01442935|Hematinics|hematinics|mesh-ancestor
56619652|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619653|NCT00703989|Protective Agents|protective agents|mesh-ancestor
56619654|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619655|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
56619656|NCT00703989|Vitamins|vitamins|mesh-ancestor
56619657|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
56619658|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56619659|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
56619660|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
56619661|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
56619662|NCT05335460|Capecitabine|capecitabine|mesh-list
56619663|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
56619664|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56619665|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
56619666|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619667|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619668|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
56619669|NCT02836002|Piperaquine|piperaquine|mesh-list
56619670|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
56619671|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56619672|NCT02836002|Atovaquone|atovaquone|mesh-list
56619673|NCT02836002|Proguanil|proguanil|mesh-list
56619674|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56619675|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
56619676|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56619677|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56619678|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188238|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
56188239|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56188240|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188241|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
56188242|NCT01442974|Gemcitabine|gemcitabine|mesh-list
56188243|NCT01442974|Paclitaxel|paclitaxel|mesh-list
56188244|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56188245|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188246|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
56188247|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
56188248|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
56188249|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188250|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56188251|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
56188252|NCT01442974|Antiviral Agents|antiviral agents|mesh-ancestor
56188253|NCT01442974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188254|NCT01442974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009617|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009644|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009647|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56009648|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009649|NCT00003934|Cytarabine|cytarabine|mesh-list
56619679|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56619680|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619681|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619682|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56619683|NCT02836002|Renal Agents|renal agents|mesh-ancestor
56619684|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
56619685|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
56619686|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56619687|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
56619688|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56619689|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56619690|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619691|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
56619692|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619693|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619694|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56619695|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
56619696|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
56619697|NCT02297516|Protective Agents|protective agents|mesh-ancestor
56619698|NCT02842580|Leucovorin|leucovorin|mesh-list
56619699|NCT02842580|Bevacizumab|bevacizumab|mesh-list
56619700|NCT02842580|Capecitabine|capecitabine|mesh-list
56619701|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
56619702|NCT02842580|Irinotecan|irinotecan|mesh-list
56619703|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
56619704|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56619705|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619706|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56619707|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56619708|NCT02842580|Growth Substances|growth substances|mesh-ancestor
56619726|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619727|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619728|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619729|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56009650|NCT00003934|Methotrexate|methotrexate|mesh-list
56009651|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
56009652|NCT00003934|Daunorubicin|daunorubicin|mesh-list
56009653|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
56009654|NCT00003934|Tretinoin|tretinoin|mesh-list
56009655|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56009656|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
56009657|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56009658|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009659|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009660|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
56009661|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009662|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009663|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
56009689|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009690|NCT00003250|Fenretinide|fenretinide|mesh-list
56009691|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009692|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56009693|NCT00003250|Protective Agents|protective agents|mesh-ancestor
56009694|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009695|NCT00003256|Alvocidib|alvocidib|mesh-list
56009696|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009697|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
56009698|NCT00003256|Growth Substances|growth substances|mesh-ancestor
56009699|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009700|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56009701|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188255|NCT01442974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188256|NCT01442974|Immunologic Factors|immunologic factors|mesh-ancestor
56188257|NCT01442974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188258|NCT01442987|Irbesartan|irbesartan|mesh-list
56188259|NCT01442987|Atorvastatin|atorvastatin|mesh-list
56188260|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56188261|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56188262|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
56188263|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188264|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56188265|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56188266|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188267|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56188268|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56188269|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56188270|NCT01443065|Leucovorin|leucovorin|mesh-list
56188271|NCT01443065|Folic Acid|folic acid|mesh-list
56188272|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
56188273|NCT01443065|Panitumumab|panitumumab|mesh-list
56188274|NCT01443065|Fluorouracil|fluorouracil|mesh-list
56188275|NCT01443065|Rilotumumab|rilotumumab|mesh-list
56188276|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
56188277|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188278|NCT01443065|Antidotes|antidotes|mesh-ancestor
56188279|NCT01443065|Protective Agents|protective agents|mesh-ancestor
56009702|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009704|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56009705|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
56009706|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56009707|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009708|NCT04679480|Cemiplimab|cemiplimab|mesh-list
56009709|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56009710|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009711|NCT00003262|Prednisone|prednisone|mesh-list
56009712|NCT00003262|Doxorubicin|doxorubicin|mesh-list
56009713|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56009714|NCT00003262|Epirubicin|epirubicin|mesh-list
56009745|NCT00003700|Asparaginase|asparaginase|mesh-list
56009746|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
56009747|NCT00003700|Allopurinol|allopurinol|mesh-list
56009748|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
56009749|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56619730|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
56619731|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
56619732|NCT00835731|Misoprostol|misoprostol|mesh-list
56619733|NCT00835731|Vitamins|vitamins|mesh-ancestor
56619734|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
56619735|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619736|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56619737|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
56619738|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56619739|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56619740|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619741|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
56619742|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
56619743|NCT00835731|Hematinics|hematinics|mesh-ancestor
56619744|NCT03721406|Ropivacaine|ropivacaine|mesh-list
56619745|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
56619746|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
56619747|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619748|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619749|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
56619750|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619751|NCT00751166|Cetirizine|cetirizine|mesh-list
56619752|NCT00751166|Desloratadine|desloratadine|mesh-list
56619753|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56619754|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56619755|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56619756|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
56619757|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
56619758|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619759|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009751|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009752|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009753|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009754|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
56009755|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009756|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009757|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56009758|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56188281|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
56188283|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
56188284|NCT01443065|Hematinics|hematinics|mesh-ancestor
56188285|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56188286|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
56188287|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188288|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56188289|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56619760|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619761|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56619762|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
56619763|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56619764|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
56619765|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56619766|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56619767|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56619768|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619769|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619770|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
56619771|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56619772|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56619773|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56619775|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56619776|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116061|NCT05673785|Hormones|hormones|mesh-ancestor
56188290|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
56188291|NCT01443104|Sirolimus|sirolimus|mesh-list
56188292|NCT01443104|Everolimus|everolimus|mesh-list
56188293|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188294|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188295|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
56188296|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188297|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56188298|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188299|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56188300|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
56188301|NCT01443117|Vaccines|vaccines|mesh-list
56188302|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
56188303|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188304|NCT01443169|Pregabalin|pregabalin|mesh-list
56188305|NCT01443169|Analgesics|analgesics|mesh-ancestor
56188306|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
56009759|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
56009760|NCT00003700|Hormones|hormones|mesh-ancestor
56009761|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56009762|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56009794|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009796|NCT00003958|Cactinomycin|cactinomycin|mesh-list
56009797|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
56009798|NCT00003958|Vincristine|vincristine|mesh-list
56009799|NCT00003958|Topotecan|topotecan|mesh-list
56009800|NCT00003958|Sargramostim|sargramostim|mesh-list
56009801|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009802|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
56009803|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009804|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009805|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009806|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
56009830|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009831|NCT00003268|Cytarabine|cytarabine|mesh-list
56009832|NCT00003268|Idarubicin|idarubicin|mesh-list
56009833|NCT00003268|Amifostine|amifostine|mesh-list
56009834|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009835|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
56188307|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188308|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188310|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56188311|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56188312|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619777|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
56619778|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
56619779|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
56619780|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619781|NCT03508232|Doxycycline|doxycycline|mesh-list
56619782|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56619783|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619784|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
56619785|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56619786|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56619787|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
56619788|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
56619789|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56619790|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619791|NCT00704301|Rivastigmine|rivastigmine|mesh-list
56619792|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56619793|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619794|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619795|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
56619796|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619797|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619798|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56619799|NCT00704301|Protective Agents|protective agents|mesh-ancestor
56619800|NCT00831103|Valacyclovir|valacyclovir|mesh-list
56188313|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56188314|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56188315|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56188316|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188317|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56188318|NCT01443195|Iron|iron|mesh-list
56188319|NCT01443195|Trace Elements|trace elements|mesh-ancestor
56188320|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
56188321|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188322|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56188323|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56188324|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56188325|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56188326|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188327|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188328|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188329|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
56188330|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56188331|NCT01443221|Metformin|metformin|mesh-list
56188332|NCT01443221|Mitiglinide|mitiglinide|mesh-list
56009836|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009837|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009838|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
56009839|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009840|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009841|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
56009842|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619801|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
56619802|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56619803|NCT00704444|Ezetimibe|ezetimibe|mesh-list
56619804|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56619805|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56619806|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
56619807|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619808|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56619809|NCT00704691|Lenalidomide|lenalidomide|mesh-list
56619810|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
56619811|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619812|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56619813|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56619814|NCT00704691|Growth Substances|growth substances|mesh-ancestor
56619815|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
56619816|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619817|NCT00704925|Amifampridine|amifampridine|mesh-list
56619818|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56619819|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619820|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619821|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56619822|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002887|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56009843|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009844|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009845|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009846|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009847|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56009848|NCT00003268|Protective Agents|protective agents|mesh-ancestor
56009849|NCT00083720|Cetuximab|cetuximab|mesh-list
56009850|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56009851|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009852|NCT00003274|Sargramostim|sargramostim|mesh-list
56009853|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
56009854|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
56188333|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56188334|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188335|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
56188336|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56188337|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56188338|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
56188339|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188340|NCT01443325|Lidocaine|lidocaine|mesh-list
56188341|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
56188342|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
56188343|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188344|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188345|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
56188346|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188347|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56188348|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56188349|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55802683|NCT02197039|Pantoprazole|pantoprazole|mesh-list
56619823|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619824|NCT00574249|Adalimumab|adalimumab|mesh-list
56619825|NCT00574249|Betamethasone|betamethasone|mesh-list
56619826|NCT00574249|Calcipotriene|calcipotriene|mesh-list
56619827|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56619828|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56619829|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
56619830|NCT00574249|Hormones|hormones|mesh-ancestor
56368354|NCT00124644|Cytarabine|cytarabine|mesh-list
56619831|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619832|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619833|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56619834|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
56619835|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
56619836|NCT00891228|ST 1435|st 1435|mesh-list
56619837|NCT00891228|Testosterone|testosterone|mesh-list
56619838|NCT00891228|Androgens|androgens|mesh-ancestor
56619839|NCT00891228|Hormones|hormones|mesh-ancestor
56619840|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56619841|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619842|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56619843|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
56619844|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56619845|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56619846|NCT00896168|Methotrexate|methotrexate|mesh-list
56619847|NCT00896168|Infliximab|infliximab|mesh-list
56619848|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56619849|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
56619850|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56619851|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619852|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56619853|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
56619854|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188350|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56188351|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188352|NCT01443338|Acitretin|acitretin|mesh-list
56188353|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
56188354|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
56188355|NCT01443377|Panitumumab|panitumumab|mesh-list
56188356|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56188357|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188358|NCT01443416|Vaccines|vaccines|mesh-list
56619855|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619856|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
56619857|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619858|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56619859|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56619860|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
56619861|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56619862|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56619863|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56188359|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56188360|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
56009855|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009857|NCT00003280|Rituximab|rituximab|mesh-list
56009891|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009892|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009894|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
56009895|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
56009896|NCT00085436|Aldesleukin|aldesleukin|mesh-list
56009897|NCT00085436|Vaccines|vaccines|mesh-list
56009898|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
56009899|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737055|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009900|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009928|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
56009929|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009931|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56009932|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
56009933|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56188362|NCT01443429|Beraprost|beraprost|mesh-list
56188363|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56188364|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
56188365|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56188366|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56188367|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56188368|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56188369|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56188370|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188371|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188372|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188373|NCT01443520|Analgesics|analgesics|mesh-ancestor
56188374|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
56188375|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188376|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
56188377|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56188378|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
56009934|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009935|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
56009936|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009937|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009938|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009939|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56009940|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56009941|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56009942|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56009943|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56009944|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56009976|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56009977|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56009978|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56009979|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56009980|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56009981|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56010001|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010002|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
56619864|NCT00833703|Clopidogrel|clopidogrel|mesh-list
56619865|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56619866|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56619867|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56619868|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56619869|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
56619870|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619871|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619872|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619873|NCT05243940|Lidocaine|lidocaine|mesh-list
56619874|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
56619875|NCT05243940|Ketamine|ketamine|mesh-list
56619876|NCT05243940|Remifentanil|remifentanil|mesh-list
56619877|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
56619878|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
56619879|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619880|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619881|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
56619882|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619883|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56619884|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56619885|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56619886|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56010003|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010004|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010005|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010006|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010007|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010008|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56010009|NCT00003994|Protective Agents|protective agents|mesh-ancestor
56010010|NCT00003742|Paclitaxel|paclitaxel|mesh-list
56010011|NCT00003742|Irinotecan|irinotecan|mesh-list
56010012|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010013|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010014|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010015|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010016|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010017|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188379|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56188381|NCT01443572|Sevoflurane|sevoflurane|mesh-list
56188383|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188384|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188386|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56188387|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
56188388|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56188389|NCT01443624|Hematinics|hematinics|mesh-ancestor
56188390|NCT01443676|Bevacizumab|bevacizumab|mesh-list
56188391|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56188392|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188393|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56010018|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56619887|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619888|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56619889|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56619890|NCT05243940|Analgesics|analgesics|mesh-ancestor
56619891|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56619892|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56619893|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56619894|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
56619895|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619896|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56619897|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56619898|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
56619899|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56619900|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56619901|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56619902|NCT05243940|Narcotics|narcotics|mesh-ancestor
56619903|NCT00833547|Eszopiclone|eszopiclone|mesh-list
56619904|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56368429|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002945|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
56010019|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010020|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010021|NCT00003304|Temozolomide|temozolomide|mesh-list
56010022|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010023|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
56010024|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010025|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010026|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
56010027|NCT00004006|Carboplatin|carboplatin|mesh-list
56010028|NCT00004006|Doxorubicin|doxorubicin|mesh-list
56010029|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010031|NCT00004006|Topotecan|topotecan|mesh-list
56010032|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010033|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
56010034|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010035|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010036|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010037|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
56010071|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010072|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
56010073|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010074|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56010075|NCT00089024|Antidotes|antidotes|mesh-ancestor
56010076|NCT00089024|Protective Agents|protective agents|mesh-ancestor
56010077|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
56010079|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
56010110|NCT00089102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010111|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56010112|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010113|NCT00004012|Capecitabine|capecitabine|mesh-list
56010114|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010115|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
56010116|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010117|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010118|NCT00003754|Thalidomide|thalidomide|mesh-list
55737283|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
56619905|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619906|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619908|NCT00833469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56619909|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56619910|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56619911|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619912|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619913|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
56619914|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619915|NCT00833469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56619916|NCT00833469|Antidepressive Agents|antidepressive agents|mesh-ancestor
56619917|NCT00833469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56619918|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
56619919|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56619920|NCT02831478|Protective Agents|protective agents|mesh-ancestor
56619921|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619922|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56619923|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
56619924|NCT00837655|Calcium|calcium|mesh-list
56619925|NCT00837655|Sevelamer|sevelamer|mesh-list
56619926|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56619927|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619928|NCT00837655|Antacids|antacids|mesh-ancestor
56619929|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619930|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56619931|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
56619932|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
56619933|NCT00843661|Ezetimibe|ezetimibe|mesh-list
56619934|NCT00843661|Pravastatin|pravastatin|mesh-list
56619935|NCT00843661|Fenofibrate|fenofibrate|mesh-list
56619936|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56619937|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56010119|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
56010120|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010121|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
56010122|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010123|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010173|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010174|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
56010175|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010176|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188394|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56619938|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
56619939|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619940|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56619941|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56619942|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619943|NCT00832377|Timolol|timolol|mesh-list
56619944|NCT00832377|Dorzolamide|dorzolamide|mesh-list
56619945|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56619946|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56619947|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
56619948|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56619949|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619950|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619951|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56619952|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56619953|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56619954|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619955|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56619956|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
56619957|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619958|NCT00705315|Bevacizumab|bevacizumab|mesh-list
56619959|NCT00705315|Docetaxel|docetaxel|mesh-list
56619960|NCT00705315|Epirubicin|epirubicin|mesh-list
56619961|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56619962|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619963|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56619964|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56619965|NCT00705315|Growth Substances|growth substances|mesh-ancestor
56619966|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619967|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
56619968|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
56619969|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
56619970|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622947|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
56188395|NCT01443676|Growth Substances|growth substances|mesh-ancestor
56188396|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188397|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
56188398|NCT01443741|Insulin|insulin|mesh-list
56188399|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56619971|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619972|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56619973|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56619974|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56619975|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56619976|NCT00892008|Pregabalin|pregabalin|mesh-list
56619977|NCT00892008|Analgesics|analgesics|mesh-ancestor
56619978|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
56619979|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56619980|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619981|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
56619982|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56619983|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56619984|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56619985|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56619986|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56188400|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56188401|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188402|NCT01443780|Selenium|selenium|mesh-list
56188403|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
56188404|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188405|NCT01443780|Protective Agents|protective agents|mesh-ancestor
56188406|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188407|NCT01443780|Trace Elements|trace elements|mesh-ancestor
56188408|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
56188409|NCT01443806|Oseltamivir|oseltamivir|mesh-list
56188410|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
56188411|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188412|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188413|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188415|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
56188416|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
56188417|NCT01443897|Vitamins|vitamins|mesh-list
56188418|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
56188419|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188420|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56188421|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56188422|NCT01443988|Travoprost|travoprost|mesh-list
56188423|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56188424|NCT01444001|Vaccines|vaccines|mesh-list
56188425|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56188426|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
56188427|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188428|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
56188429|NCT01444118|Vaccines|vaccines|mesh-list
56188436|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
56188437|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188438|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188439|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56188440|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56188441|NCT01444131|Nicotine|nicotine|mesh-list
56188442|NCT01444131|Varenicline|varenicline|mesh-list
56188443|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56188444|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
56188445|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188446|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188447|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56188448|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56619987|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56619988|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56619989|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56619990|NCT00623233|Gemcitabine|gemcitabine|mesh-list
56619991|NCT00623233|Bevacizumab|bevacizumab|mesh-list
56619992|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56619993|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56619994|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56619995|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56619996|NCT00623233|Growth Substances|growth substances|mesh-ancestor
56619997|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56619998|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
56619999|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56620000|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
56620001|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620002|NCT00623233|Antiviral Agents|antiviral agents|mesh-ancestor
56620003|NCT00623233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620004|NCT00623233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620005|NCT00623233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620006|NCT00623233|Immunologic Factors|immunologic factors|mesh-ancestor
56620007|NCT00837889|Diuretics|diuretics|mesh-list
56620008|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
56620009|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620010|NCT02841488|Fentanyl|fentanyl|mesh-list
56620011|NCT02841488|Ropivacaine|ropivacaine|mesh-list
56620012|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
56620013|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
56620014|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188449|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
56188450|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188451|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188452|NCT01444196|Desloratadine|desloratadine|mesh-list
56010177|NCT04771754|Dolutegravir|dolutegravir|mesh-list
56010178|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56010179|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56010180|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010181|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010182|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56010183|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56010214|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010216|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010217|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56010218|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010219|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010220|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
56010221|NCT00004036|Carboplatin|carboplatin|mesh-list
56010222|NCT00004036|Sargramostim|sargramostim|mesh-list
56010223|NCT00004036|Amifostine|amifostine|mesh-list
56620015|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620016|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
56620017|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620018|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56620019|NCT02841488|Narcotics|narcotics|mesh-ancestor
56620020|NCT02841488|Analgesics|analgesics|mesh-ancestor
56620021|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56620022|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56620023|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
56620024|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
56620025|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
56620026|NCT02832726|Vitamins|vitamins|mesh-ancestor
56620027|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
56620028|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620029|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
56620030|NCT02832726|Hematinics|hematinics|mesh-ancestor
56620031|NCT00202904|Ezetimibe|ezetimibe|mesh-list
56620032|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56620033|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56620034|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
56620035|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620036|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56620037|NCT02690870|Tamoxifen|tamoxifen|mesh-list
56620038|NCT02690870|Clomiphene|clomiphene|mesh-list
56620039|NCT02690870|Enclomiphene|enclomiphene|mesh-list
56620040|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
56620041|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56620042|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
56620043|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56620044|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620045|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56620046|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620047|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56620048|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56620049|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56620050|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56010224|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010225|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
56010226|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010227|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620051|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
56620052|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56620053|NCT00844207|Azithromycin|azithromycin|mesh-list
56368579|NCT00087347|Hematinics|hematinics|mesh-ancestor
56620054|NCT00844207|Chloroquine|chloroquine|mesh-list
56620055|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56620056|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56620057|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620058|NCT00844207|Amebicides|amebicides|mesh-ancestor
56620059|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56620060|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56620061|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
56620062|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620063|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56620065|NCT00844207|Analgesics|analgesics|mesh-ancestor
56620066|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
56620067|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620068|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620069|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620070|NCT00844207|Filaricides|filaricides|mesh-ancestor
56620071|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
56620072|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
56620073|NCT02841722|Lenograstim|lenograstim|mesh-list
56620074|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56620075|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
56620076|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010260|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010261|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
56010262|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010263|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010264|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
56010265|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010266|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010267|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
56010268|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010269|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010270|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010271|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010344|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010345|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010376|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
56010377|NCT00003364|Doxorubicin|doxorubicin|mesh-list
56010378|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010380|NCT00003364|Vincristine|vincristine|mesh-list
56010381|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010382|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
56010383|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188453|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56188455|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188456|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188457|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620077|NCT02548117|Finasteride|finasteride|mesh-list
56620078|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56620079|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56620080|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620081|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620082|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
56620083|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56003112|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
56188458|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56188459|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56188460|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
56188461|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
56188462|NCT01444248|Metformin|metformin|mesh-list
56188463|NCT01444248|Glimepiride|glimepiride|mesh-list
56188464|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56188465|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188466|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56188467|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188468|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
56188469|NCT01444339|Vaccines|vaccines|mesh-list
56188470|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56010384|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010385|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010386|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
56010387|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010388|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010440|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
56010441|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56010442|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010443|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
56010444|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010445|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56010446|NCT00003382|Gemcitabine|gemcitabine|mesh-list
56010447|NCT00003382|Topotecan|topotecan|mesh-list
56010448|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010449|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
56010450|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010451|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010485|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56010486|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
56010487|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56010488|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56010489|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56010490|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56010525|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56010526|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010527|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56010528|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
56010529|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
56010530|NCT02972866|Hormones|hormones|mesh-ancestor
56010531|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56010532|NCT00003808|Theophylline|theophylline|mesh-list
56010568|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
56010569|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56010570|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010571|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56010601|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188471|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
56188472|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010602|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010603|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010604|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010605|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010606|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620084|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620085|NCT02548117|Urological Agents|urological agents|mesh-ancestor
56620086|NCT02841800|Phenobarbital|phenobarbital|mesh-list
56620087|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
56620088|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56620089|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620090|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620091|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56620092|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56620093|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620094|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620095|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
56620096|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
56620097|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56620098|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56620099|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56620100|NCT02832336|Caffeine|caffeine|mesh-list
56620101|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
56620102|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620103|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56620104|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620105|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56620106|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620107|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56620108|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56003128|NCT01151761|Cisplatin|cisplatin|mesh-list
56010607|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
56010608|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010609|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010610|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010611|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
56010612|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010613|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010614|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010615|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010616|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010617|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
56010618|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010619|NCT00014222|Hematinics|hematinics|mesh-ancestor
56010620|NCT00004870|Irinotecan|irinotecan|mesh-list
56010621|NCT00004870|Oblimersen|oblimersen|mesh-list
56010651|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010652|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010653|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010654|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55802684|NCT02197039|Hemostatics|hemostatics|mesh-list
56620109|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
56620110|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620111|NCT00621751|Carbamazepine|carbamazepine|mesh-list
56620112|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
56620113|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
56620114|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56620115|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620116|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620117|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56620118|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56620119|NCT00621751|Analgesics|analgesics|mesh-ancestor
56620120|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
56620121|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620122|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56620123|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56620124|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620125|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56620126|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56620127|NCT02690792|Vitamin E|vitamin e|mesh-list
56620128|NCT02690792|Vitamins|vitamins|mesh-ancestor
56620130|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620131|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
56620132|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620133|NCT02690792|Protective Agents|protective agents|mesh-ancestor
56620134|NCT00831649|Natalizumab|natalizumab|mesh-list
56620135|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
56620136|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620137|NCT02841332|Misonidazole|misonidazole|mesh-list
56620139|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56620140|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620141|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56620142|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55730389|NCT02307305|Acetaminophen|acetaminophen|mesh-list
56010655|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010656|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
56010657|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010658|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010659|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
56010661|NCT00003862|Protective Agents|protective agents|mesh-ancestor
56010662|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
56010663|NCT00003862|Vitamins|vitamins|mesh-ancestor
56010664|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
56620143|NCT02841332|Growth Substances|growth substances|mesh-ancestor
56620144|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620145|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56620146|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56620147|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56620148|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620149|NCT00838357|Plerixafor|plerixafor|mesh-list
56620150|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56620151|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56620152|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
56620153|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620154|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
56620155|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620156|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
56620157|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620158|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620159|NCT00156104|Haloperidol|haloperidol|mesh-list
56620160|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
56620161|NCT00156104|Asenapine|asenapine|mesh-list
56620162|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
56620163|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
56620164|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620165|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620166|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56620167|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56620168|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56620169|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620170|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56620171|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56620172|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
56620173|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620174|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620175|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56620176|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56010665|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
56010666|NCT00003868|Methotrexate|methotrexate|mesh-list
56010667|NCT00003868|Antibodies|antibodies|mesh-list
56010668|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56010669|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010681|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010682|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
56010683|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
56010684|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620177|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56620178|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56620179|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56620180|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620181|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
56620182|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620183|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620184|NCT00891930|Irinotecan|irinotecan|mesh-list
56620185|NCT00891930|Panitumumab|panitumumab|mesh-list
56620186|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56620187|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56620188|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620189|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620190|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620191|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56620192|NCT02831088|Salicylates|salicylates|mesh-list
56620193|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56620194|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56620195|NCT02831088|Analgesics|analgesics|mesh-ancestor
56620196|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
56620197|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620198|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620199|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620200|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620201|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56620202|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003222|NCT00001426|Paclitaxel|paclitaxel|mesh-list
56010685|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56010686|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56010687|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56010689|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
56010690|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56010691|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
56010692|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010693|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010694|NCT00004090|Gemcitabine|gemcitabine|mesh-list
56010695|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010696|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010697|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
56010698|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010699|NCT00004090|Antiviral Agents|antiviral agents|mesh-ancestor
56010700|NCT00004090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010701|NCT00004090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010702|NCT00004090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010703|NCT00004090|Immunologic Factors|immunologic factors|mesh-ancestor
56010704|NCT00004090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368730|NCT00331123|Testosterone|testosterone|mesh-list
56620203|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620204|NCT02841176|Golimumab|golimumab|mesh-list
56620205|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56620206|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620207|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620208|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
56620209|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620210|NCT01615874|Prednisone|prednisone|mesh-list
56620211|NCT01615874|Prednisolone|prednisolone|mesh-list
56620212|NCT01615874|Montelukast|montelukast|mesh-list
56620213|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
56620214|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620215|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
56620216|NCT01615874|Hormones|hormones|mesh-ancestor
56620217|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56620218|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620219|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56620220|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620221|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
56010705|NCT00004102|Leucovorin|leucovorin|mesh-list
56010706|NCT00004102|Fluorouracil|fluorouracil|mesh-list
56010707|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
56010708|NCT00004102|Calcium|calcium|mesh-list
56010709|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
56010710|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56010711|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010712|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
56010713|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010714|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010715|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188473|NCT01444352|Vaccines|vaccines|mesh-list
56010716|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010717|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
56010718|NCT00004102|Antidotes|antidotes|mesh-ancestor
56010719|NCT00004102|Protective Agents|protective agents|mesh-ancestor
56010720|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
56010721|NCT00004102|Vitamins|vitamins|mesh-ancestor
56010722|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
56010723|NCT00003880|Paclitaxel|paclitaxel|mesh-list
56010724|NCT00003880|Carboplatin|carboplatin|mesh-list
56010725|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010726|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010727|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010728|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010729|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010730|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010732|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56010733|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010752|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010753|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010754|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010755|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56010756|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56010757|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56010758|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56620222|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620223|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56620224|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
56620225|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56620226|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
56620227|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56620228|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56620229|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620230|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56620231|NCT00891462|Bromides|bromides|mesh-list
56620232|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
56620233|NCT04248348|Heparin|heparin|mesh-list
56620234|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56620235|NCT04248348|Tinzaparin|tinzaparin|mesh-list
56620236|NCT04248348|Dalteparin|dalteparin|mesh-list
56620237|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
56620282|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620283|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56620284|NCT02830932|Vaccines|vaccines|mesh-list
56620285|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
56620286|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620287|NCT00895310|Ketoconazole|ketoconazole|mesh-list
56620288|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
56620289|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620290|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
56620291|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620292|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56620293|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56620294|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620295|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620296|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56620297|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
56620298|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56620299|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620300|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56620301|NCT04245618|Gemcitabine|gemcitabine|mesh-list
56620302|NCT04245618|Cisplatin|cisplatin|mesh-list
56620303|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620304|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010759|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
56010760|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56010762|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
56010763|NCT00004114|Fludarabine|fludarabine|mesh-list
56010764|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
56010765|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010766|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
56010767|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010768|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010769|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010770|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
56010771|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010772|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010773|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010774|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010775|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
56010776|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
56010777|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010778|NCT00004126|Paclitaxel|paclitaxel|mesh-list
56010779|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
56010780|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010781|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010782|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010783|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010784|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
56110447|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620305|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
56620306|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620307|NCT04245618|Antiviral Agents|antiviral agents|mesh-ancestor
56620308|NCT04245618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620309|NCT04245618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620310|NCT04245618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620311|NCT04245618|Immunologic Factors|immunologic factors|mesh-ancestor
56620312|NCT04245618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620313|NCT00092768|Celecoxib|celecoxib|mesh-list
56620314|NCT00092768|Etoricoxib|etoricoxib|mesh-list
56620315|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56620316|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56620317|NCT00092768|Analgesics|analgesics|mesh-ancestor
56620318|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
56003346|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010785|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010786|NCT00004906|Pamidronate|pamidronate|mesh-list
56010787|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
56010788|NCT00004906|Thiotepa|thiotepa|mesh-list
56010789|NCT00004906|Carboplatin|carboplatin|mesh-list
56010790|NCT00004906|Docetaxel|docetaxel|mesh-list
56010825|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010826|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010827|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010828|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
56010829|NCT00004132|Ifosfamide|ifosfamide|mesh-list
56010830|NCT00004132|Etoposide|etoposide|mesh-list
56010859|NCT05776953|Sensory System Agents|sensory system agents|mesh-ancestor
56010860|NCT05776953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56010861|NCT05776953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010862|NCT05776953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56010863|NCT05776953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010864|NCT05776953|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56010865|NCT05776953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010866|NCT05776953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010867|NCT05776940|Dexamethasone|dexamethasone|mesh-list
56010868|NCT05776940|Dexamethasone acetate|dexamethasone acetate|mesh-list
56010869|NCT05776940|Bortezomib|bortezomib|mesh-list
56010870|NCT05776940|Daratumumab|daratumumab|mesh-list
56010871|NCT05776940|BB 1101|bb 1101|mesh-list
56010872|NCT05776940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56010873|NCT05776940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56188474|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56010907|NCT05776888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010908|NCT05776875|Bevacizumab|bevacizumab|mesh-list
56010909|NCT05776875|Atezolizumab|atezolizumab|mesh-list
56010910|NCT05776875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56010911|NCT05776875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010912|NCT05776875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56010913|NCT05776875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56010915|NCT05776875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010938|NCT05776524|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010939|NCT05776524|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010940|NCT05776524|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010941|NCT05776524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010942|NCT05776524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010943|NCT05776524|Antimetabolites|antimetabolites|mesh-ancestor
56010944|NCT05776524|Antiviral Agents|antiviral agents|mesh-ancestor
56010945|NCT05776524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010946|NCT05776524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010947|NCT05776524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010948|NCT05776524|Immunologic Factors|immunologic factors|mesh-ancestor
56620319|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620320|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620321|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620322|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620323|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56620324|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56620325|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620326|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620327|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
56620328|NCT02831712|Trace Elements|trace elements|mesh-ancestor
56620329|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
56620330|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620331|NCT05104554|Folic Acid|folic acid|mesh-list
56620332|NCT05104554|Micronutrients|micronutrients|mesh-list
56620333|NCT05104554|Trace Elements|trace elements|mesh-list
56620334|NCT05104554|Hematinics|hematinics|mesh-ancestor
56620335|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
56620336|NCT05104554|Vitamins|vitamins|mesh-ancestor
56620337|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620338|NCT02843984|Lactoferrin|lactoferrin|mesh-list
56620339|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620340|NCT02840708|Sargramostim|sargramostim|mesh-list
56620341|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
56620342|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620343|NCT00817076|Desloratadine|desloratadine|mesh-list
56620344|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56010949|NCT05776524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738112|NCT01236521|Analgesics|analgesics|mesh-list
56010958|NCT05776407|Cyclophosphamide|cyclophosphamide|mesh-list
56010963|NCT05776407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010964|NCT05776407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010965|NCT05776407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010966|NCT05776407|Alkylating Agents|alkylating agents|mesh-ancestor
56011003|NCT05776056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56011028|NCT05776030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56011029|NCT05776017|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56011030|NCT05776017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56011031|NCT05776017|Immunologic Factors|immunologic factors|mesh-ancestor
56011032|NCT05776017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011034|NCT05776017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011035|NCT05776017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56011036|NCT05775965|Aspirin|aspirin|mesh-list
56011037|NCT05775965|Rivaroxaban|rivaroxaban|mesh-list
56011038|NCT05775965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56011039|NCT05775965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56011040|NCT05775965|Analgesics|analgesics|mesh-ancestor
56011041|NCT05775965|Sensory System Agents|sensory system agents|mesh-ancestor
56011042|NCT05775965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011043|NCT05775965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011044|NCT05775965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011045|NCT05775965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620345|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
56620346|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011046|NCT05775965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56011047|NCT05775965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56011077|NCT05775874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011079|NCT05775861|Ropivacaine|ropivacaine|mesh-list
56011080|NCT05775861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56011081|NCT05775861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56011082|NCT05775861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011083|NCT05775861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56011084|NCT05775861|Analgesics|analgesics|mesh-ancestor
56011085|NCT05775861|Sensory System Agents|sensory system agents|mesh-ancestor
56011086|NCT05775861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011087|NCT05775861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56011088|NCT05775861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56011089|NCT05775861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56011090|NCT05775861|Adrenergic Agents|adrenergic agents|mesh-ancestor
56011091|NCT05775861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011122|NCT05775692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011123|NCT05775692|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56011124|NCT05775692|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56011125|NCT05775536|Aspirin|aspirin|mesh-list
56011126|NCT05775536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56188479|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188481|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188482|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56188483|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56188484|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188485|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188486|NCT01444547|Paclitaxel|paclitaxel|mesh-list
56188487|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56011127|NCT05775536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56011128|NCT05775536|Analgesics|analgesics|mesh-ancestor
56011129|NCT05775536|Sensory System Agents|sensory system agents|mesh-ancestor
56011130|NCT05775536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011131|NCT05775536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011167|NCT05775159|Growth Substances|growth substances|mesh-ancestor
56011168|NCT05775159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011169|NCT05775159|Growth Inhibitors|growth inhibitors|mesh-ancestor
56011170|NCT05775159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56011211|NCT05774899|Lenvatinib|lenvatinib|mesh-list
56011212|NCT05774899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011213|NCT05774899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56011214|NCT05774899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011252|NCT05773950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011254|NCT05773950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56011384|NCT05519254|Lactoferrin|lactoferrin|mesh-list
56011385|NCT05519254|Muramidase|muramidase|mesh-list
56011517|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56011518|NCT05329740|Prednisolone|prednisolone|mesh-list
56011519|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
56011520|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56011521|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
56011522|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011523|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
56011524|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
56011525|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011526|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011527|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56011528|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
56011529|NCT05329740|Hormones|hormones|mesh-ancestor
56011530|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011531|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56011532|NCT05329740|Protective Agents|protective agents|mesh-ancestor
56011533|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56011534|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011590|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011591|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
56011592|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56011593|NCT05298592|Nivolumab|nivolumab|mesh-list
56011594|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011595|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620347|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620348|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620349|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56620350|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56620351|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
56620352|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
56620353|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
56620354|NCT02844062|Fludarabine|fludarabine|mesh-list
56620355|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620356|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
56620357|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620358|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620359|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56620360|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
56620361|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620362|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003387|NCT00002122|Azithromycin|azithromycin|mesh-list
56011596|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56011597|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011633|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188489|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188490|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
56188491|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
56188492|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
56188493|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188495|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56188496|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
56188497|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56188498|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
56188499|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188500|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188501|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
56188502|NCT01444612|Heparin|heparin|mesh-list
56188503|NCT01444612|Calcium heparin|calcium heparin|mesh-list
56188504|NCT01444612|Enoxaparin|enoxaparin|mesh-list
56188505|NCT01444612|Dalteparin|dalteparin|mesh-list
56188506|NCT01444612|Tinzaparin|tinzaparin|mesh-list
56188507|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56188509|NCT01444612|Fondaparinux|fondaparinux|mesh-list
56188510|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
56188511|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56188512|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56188513|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011667|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011669|NCT05180006|Trastuzumab|trastuzumab|mesh-list
56011670|NCT05180006|Pertuzumab|pertuzumab|mesh-list
56011671|NCT05180006|Atezolizumab|atezolizumab|mesh-list
56011672|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011673|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011674|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56011675|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56011676|NCT05180006|Growth Substances|growth substances|mesh-ancestor
56011677|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011678|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
56011679|NCT05170204|Durvalumab|durvalumab|mesh-list
56011680|NCT05170204|Pralsetinib|pralsetinib|mesh-list
56011681|NCT05170204|Entrectinib|entrectinib|mesh-list
56011682|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56620363|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56620364|NCT02830230|Azithromycin|azithromycin|mesh-list
56620366|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56620367|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620368|NCT02840240|Gabapentin|gabapentin|mesh-list
56620369|NCT02840240|Analgesics|analgesics|mesh-ancestor
56620370|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
56620371|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620372|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620373|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
56620374|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56620375|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56620376|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620377|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56620378|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56620379|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56620380|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620381|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620382|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
56620383|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56620384|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56003408|NCT00001534|Losartan|losartan|mesh-list
56011683|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011684|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56011685|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011686|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011687|NCT05148884|Befiradol|befiradol|mesh-list
56011719|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011720|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56011722|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56011723|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56188514|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56188515|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
56011724|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56011725|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56011726|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011727|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
56011728|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011787|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
56011788|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56011789|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
56011790|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56011791|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011792|NCT05042505|Incretins|incretins|mesh-ancestor
56011793|NCT05042505|Hormones|hormones|mesh-ancestor
56011794|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011795|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56011796|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
56011797|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011798|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011799|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56011800|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
56620385|NCT00888654|Protective Agents|protective agents|mesh-ancestor
56620386|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620387|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620388|NCT03238430|Morphine|morphine|mesh-list
56620389|NCT03238430|Ropivacaine|ropivacaine|mesh-list
56620390|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56620391|NCT03238430|Narcotics|narcotics|mesh-ancestor
56620392|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620393|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620394|NCT03238430|Analgesics|analgesics|mesh-ancestor
56620395|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
56620396|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620397|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
56620398|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
56620399|NCT02829840|Azacitidine|azacitidine|mesh-list
56620400|NCT02829840|Ponatinib|ponatinib|mesh-list
56620401|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56620402|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
56620403|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620404|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620405|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620406|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56620407|NCT03223220|Midazolam|midazolam|mesh-list
56620408|NCT03223220|Ketamine|ketamine|mesh-list
56620409|NCT03223220|Analgesics|analgesics|mesh-ancestor
56620410|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
56620411|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011801|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011802|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011803|NCT04987203|Nivolumab|nivolumab|mesh-list
56011804|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011805|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011806|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56011807|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011808|NCT04939597|Memantine|memantine|mesh-list
56011809|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56011839|NCT04914234|Atenolol|atenolol|mesh-list
56011840|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56011841|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56011842|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
56011843|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
56011844|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011845|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011846|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56011847|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56011848|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56011849|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
56011850|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011851|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739006|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56620412|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620413|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56620414|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56620415|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
56620416|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
56620417|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620418|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56620419|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56620420|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620421|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620422|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56620423|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56620424|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56620425|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56368950|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
56620426|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56620427|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
56620428|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
56003446|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
56011860|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56011861|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
56011891|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56011892|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56011894|NCT04820309|Trospium chloride|trospium chloride|mesh-list
56011895|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
56011896|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
56011897|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011898|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011899|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56011900|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56011901|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
56011902|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011903|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011904|NCT04820309|Urological Agents|urological agents|mesh-ancestor
56011905|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56011906|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56011907|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56011937|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56011938|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011940|NCT04802161|Daunorubicin|daunorubicin|mesh-list
56011941|NCT04802161|Pomalidomide|pomalidomide|mesh-list
56011942|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56011943|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
56011944|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011945|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011946|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
56011947|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188516|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56011948|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56011949|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
56011978|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011979|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011981|NCT04739800|Doxorubicin|doxorubicin|mesh-list
56011982|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56011983|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56011984|NCT04739800|Durvalumab|durvalumab|mesh-list
56620429|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56620430|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56620431|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620433|NCT02827890|Hormones|hormones|mesh-ancestor
56622948|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011985|NCT04739800|Topotecan|topotecan|mesh-list
56011986|NCT04739800|Olaparib|olaparib|mesh-list
56011987|NCT04739800|Cediranib|cediranib|mesh-list
56011988|NCT04739800|Maleic acid|maleic acid|mesh-list
56011989|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
56011990|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56011991|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
56011992|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56011993|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011994|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012002|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012003|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
56012004|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012005|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56012006|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56012040|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
56012041|NCT04677569|Azithromycin|azithromycin|mesh-list
56012042|NCT04677569|Amikacin|amikacin|mesh-list
56012043|NCT04677569|Ethambutol|ethambutol|mesh-list
56012044|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56012045|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012046|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
56012047|NCT04677543|Azithromycin|azithromycin|mesh-list
56012048|NCT04677543|Amikacin|amikacin|mesh-list
56012049|NCT04677543|Ethambutol|ethambutol|mesh-list
56012050|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56012051|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012104|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012105|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012107|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56012108|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
56012109|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56012142|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012143|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012144|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012147|NCT04619797|Carboplatin|carboplatin|mesh-list
56012148|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
56012149|NCT04619797|Pemetrexed|pemetrexed|mesh-list
56012150|NCT04619797|Atezolizumab|atezolizumab|mesh-list
56012151|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012152|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012153|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012181|NCT04543942|Ethanol|ethanol|mesh-list
56012182|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56012183|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012184|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56012185|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012186|NCT04538950|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56012187|NCT04538950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012188|NCT04500158|Lidocaine|lidocaine|mesh-list
56012189|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
56012190|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
56012191|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56012192|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012193|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
56012194|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012195|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56012196|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56012259|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56012260|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
56012261|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
56188517|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
56188518|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012263|NCT04385277|Irinotecan|irinotecan|mesh-list
56012264|NCT04385277|Temozolomide|temozolomide|mesh-list
56012265|NCT04385277|Tretinoin|tretinoin|mesh-list
56012270|NCT04385277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56012271|NCT04385277|Vitamins|vitamins|mesh-ancestor
56012272|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
56620434|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56620435|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56620436|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
56620437|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620438|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620439|NCT04250792|Naltrexone|naltrexone|mesh-list
56620440|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56620441|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56620442|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620443|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
56620444|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620445|NCT02840162|Celecoxib|celecoxib|mesh-list
56620446|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
56620447|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56620448|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56620449|NCT02840162|Analgesics|analgesics|mesh-ancestor
56620450|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
56620451|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620452|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620453|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620454|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620455|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56003469|NCT00002134|Ganciclovir|ganciclovir|mesh-list
56012273|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012274|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56012275|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012276|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012277|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012278|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012304|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012305|NCT04256421|Carboplatin|carboplatin|mesh-list
56012306|NCT04256421|Etoposide|etoposide|mesh-list
56012307|NCT04256421|Atezolizumab|atezolizumab|mesh-list
56012308|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012309|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012310|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012311|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012312|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012313|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012314|NCT04236414|Olaparib|olaparib|mesh-list
56012315|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56012316|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012317|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012318|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012319|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56012320|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56012321|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012322|NCT04157335|Benralizumab|benralizumab|mesh-list
56012323|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56620456|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56620457|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620458|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620459|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56012324|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
56012325|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
56012353|NCT03941964|Venetoclax|venetoclax|mesh-list
56012354|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012355|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
56012356|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012357|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012358|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012359|NCT03939767|Aflibercept|aflibercept|mesh-list
56012360|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56012361|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56012362|NCT03939767|Growth Substances|growth substances|mesh-ancestor
56012363|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012364|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
56012365|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012366|NCT03932201|Factor VIII|factor viii|mesh-list
56012367|NCT03932201|Coagulants|coagulants|mesh-ancestor
56012369|NCT03907423|Glimepiride|glimepiride|mesh-list
56012370|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56012371|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56012372|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012373|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56012374|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56012375|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
56012409|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
56012410|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
56012411|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56012412|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
56012413|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56012414|NCT03859024|Analgesics|analgesics|mesh-ancestor
56012415|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
56012416|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56012417|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56012418|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56188519|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
56188520|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188521|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56188522|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56188523|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188524|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188528|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188529|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56188530|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188531|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188532|NCT01444833|Candesartan|candesartan|mesh-list
56188533|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56188534|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56188535|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56188536|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188537|NCT01444846|Ebselen|ebselen|mesh-list
56188538|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56188539|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56188540|NCT01444846|Analgesics|analgesics|mesh-ancestor
56188541|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
56188542|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188543|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188544|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56188545|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56188546|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56012446|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012447|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012448|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
56012449|NCT03816163|Antiviral Agents|antiviral agents|mesh-ancestor
56012450|NCT03816163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012451|NCT03816163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620460|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56620461|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
56620462|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56620463|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
56620464|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56620465|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620466|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56620467|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56620468|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620469|NCT02827578|Tamsulosin|tamsulosin|mesh-list
56620470|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
56620471|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56620472|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56620473|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56620474|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
56620475|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622949|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012452|NCT03816163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012453|NCT03816163|Immunologic Factors|immunologic factors|mesh-ancestor
56012454|NCT03816163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012455|NCT03808077|Rocuronium|rocuronium|mesh-list
56012456|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56012457|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56012458|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56012459|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012460|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012461|NCT03630705|Vaccines|vaccines|mesh-list
56012462|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
56188547|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56188548|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
56188549|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188550|NCT01444846|Protective Agents|protective agents|mesh-ancestor
56188551|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56188552|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188553|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56188554|NCT01444885|Amlodipine|amlodipine|mesh-list
56188555|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
56188556|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56188557|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56188558|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56012463|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012464|NCT03603184|Paclitaxel|paclitaxel|mesh-list
56012465|NCT03603184|Carboplatin|carboplatin|mesh-list
56012466|NCT03603184|Atezolizumab|atezolizumab|mesh-list
56012467|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012468|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012504|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012594|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56012595|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
56012596|NCT02840539|Hormones|hormones|mesh-ancestor
56012597|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012598|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56012599|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012600|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
56012601|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012602|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802685|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56620476|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620477|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620478|NCT02827578|Urological Agents|urological agents|mesh-ancestor
56620479|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56620480|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56620481|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
56620482|NCT02829372|Antibodies|antibodies|mesh-list
56620483|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56620484|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56620485|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
56620486|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620487|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
56620488|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620489|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
56620490|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620491|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620492|NCT00887484|Clindamycin|clindamycin|mesh-list
56620493|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
56003510|NCT00000658|Bleomycin|bleomycin|mesh-list
56012603|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012604|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
56012605|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
56012606|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012607|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012608|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
56012609|NCT02825160|Iloprost|iloprost|mesh-list
56012610|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56012611|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
56012612|NCT02667587|Nivolumab|nivolumab|mesh-list
56012613|NCT02667587|Temozolomide|temozolomide|mesh-list
56012614|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012646|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
56012647|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012648|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012649|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
56012650|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56012651|NCT02291055|Durvalumab|durvalumab|mesh-list
56012652|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012653|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012654|NCT02118584|Etrolizumab|etrolizumab|mesh-list
56012655|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56012656|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
56012657|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012849|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
56012851|NCT00198978|Methotrexate|methotrexate|mesh-list
56012852|NCT00198978|Vincristine|vincristine|mesh-list
56012853|NCT00198978|Asparaginase|asparaginase|mesh-list
56012854|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
56012855|NCT00198978|Idarubicin|idarubicin|mesh-list
56012856|NCT00198978|Lenograstim|lenograstim|mesh-list
56012857|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012858|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
56012859|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012860|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56012861|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012862|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
56188559|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188560|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56188561|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620494|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
56620495|NCT00887484|Adapalene|adapalene|mesh-list
56620496|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56188562|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
56188563|NCT01444976|Midazolam|midazolam|mesh-list
56188564|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
56188565|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188566|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188567|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56188568|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56012863|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012898|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56012899|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56012900|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012901|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56012902|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56012903|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56012969|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012970|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013001|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013002|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
56013003|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56013004|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56013005|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56013006|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
56013007|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013008|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
56013009|NCT00004984|Insulin|insulin|mesh-list
56013010|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56013011|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56013012|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013013|NCT00004174|Paclitaxel|paclitaxel|mesh-list
56013045|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56013046|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
56013047|NCT00004990|Dexamethasone|dexamethasone|mesh-list
56013048|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013049|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
56013050|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
56013051|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013052|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013053|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56013054|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
56013077|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56013079|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013080|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013081|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013083|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56013084|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
56013086|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
56013087|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56013088|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56013089|NCT00004192|Prednisolone|prednisolone|mesh-list
56013090|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
56013091|NCT00004192|Etoposide|etoposide|mesh-list
56013092|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56013093|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
56013094|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013095|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56013096|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56013097|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013098|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188569|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56188570|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56188571|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56188572|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56188573|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
56188574|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
56188575|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
56188576|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188577|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188578|NCT01445106|Nelfinavir|nelfinavir|mesh-list
56188579|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56188580|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56188581|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
56620497|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56620498|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620499|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56620500|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620501|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369025|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620502|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56620503|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56620504|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56620505|NCT00887484|Analgesics|analgesics|mesh-ancestor
56620506|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
56620507|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620508|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620509|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620510|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620512|NCT00794378|Desloratadine|desloratadine|mesh-list
56620513|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56620514|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56620515|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56003528|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
56188582|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188583|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188584|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56188585|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56188586|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
56188587|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188588|NCT01445119|Carboplatin|carboplatin|mesh-list
56013099|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013100|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013101|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
56013102|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
56013103|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013104|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013105|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
56013106|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013107|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013108|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
56013109|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
56013143|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740281|NCT04448717|Antibodies|antibodies|mesh-list
56013144|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56013145|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013146|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013147|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56013148|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
56013149|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013150|NCT00004204|Temozolomide|temozolomide|mesh-list
56013151|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56013228|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56013229|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56013230|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56013232|NCT00005032|Oblimersen|oblimersen|mesh-list
56013233|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56013234|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620516|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
56620517|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
56620518|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622950|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
56013235|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
56013236|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013237|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
56013238|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013239|NCT00005038|Aldesleukin|aldesleukin|mesh-list
56013240|NCT00005038|Histamine|histamine|mesh-list
56013241|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
56013242|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013243|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56188589|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188591|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
56013299|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013300|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56013301|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56013302|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56013303|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
56013304|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013305|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56013306|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56013307|NCT00005578|Protective Agents|protective agents|mesh-ancestor
56013308|NCT00022490|Cytarabine|cytarabine|mesh-list
56013309|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
56013345|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013346|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
56013347|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
56013348|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013432|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
56013433|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
56013434|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013435|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56013436|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56013437|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
56013438|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013439|NCT00005596|Antidotes|antidotes|mesh-ancestor
56013440|NCT00005596|Protective Agents|protective agents|mesh-ancestor
56013441|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
56013442|NCT00005596|Vitamins|vitamins|mesh-ancestor
56013443|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
56013444|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55740607|NCT03460015|Propofol|propofol|mesh-list
56013445|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
56013446|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013447|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
56013478|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
56013479|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013480|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56013481|NCT00004264|Protective Agents|protective agents|mesh-ancestor
56013482|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013484|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013485|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
56013486|NCT00005074|Growth Substances|growth substances|mesh-ancestor
56013487|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013488|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56013489|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013490|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013491|NCT00005602|Carboplatin|carboplatin|mesh-list
56013492|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013493|NCT00004276|Thalidomide|thalidomide|mesh-list
56013494|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013495|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
56013533|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56013561|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013562|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013563|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
56013564|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013565|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56013566|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56013567|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
56051970|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56620519|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620520|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620521|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56620522|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
56620523|NCT00789152|Levocetirizine|levocetirizine|mesh-list
56620524|NCT00789152|Desloratadine|desloratadine|mesh-list
56620525|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56620526|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56620527|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
56620528|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
56620529|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620530|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620531|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620532|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56620533|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
56013568|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013569|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
56013570|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
56013571|NCT00005626|Irinotecan|irinotecan|mesh-list
56013572|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56013573|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013574|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013575|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013576|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013577|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
56188592|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
56188593|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188594|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013653|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013654|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56013655|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
56013656|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013657|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013658|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56013684|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
56013685|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56013686|NCT00004360|Diuretics|diuretics|mesh-ancestor
56013687|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
56013688|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013689|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56013690|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56013691|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013693|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56013694|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56013695|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
56013696|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013697|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013698|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56013699|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56013700|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
56013701|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013702|NCT00004390|Morphine|morphine|mesh-list
56013703|NCT00004390|Methadone|methadone|mesh-list
56013704|NCT00004390|Nortriptyline|nortriptyline|mesh-list
56013705|NCT00004390|Desipramine|desipramine|mesh-list
56013706|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56013707|NCT00004390|Narcotics|narcotics|mesh-ancestor
56620534|NCT00783458|Fluticasone|fluticasone|mesh-list
56620535|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
56620536|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620537|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56620538|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
56620539|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620540|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620541|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56620542|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
56620543|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
56620544|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56620545|NCT00620659|Modafinil|modafinil|mesh-list
56620546|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56620547|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620548|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56620549|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56620550|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56620551|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620552|NCT03575000|Bromocriptine|bromocriptine|mesh-list
56620553|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56620554|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56620555|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
56620556|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56620557|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620558|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
56013708|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56013709|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013741|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
56013742|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56013743|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
56013744|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56013745|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56013746|NCT00004420|Analgesics|analgesics|mesh-ancestor
56013747|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
56013748|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013749|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013750|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013774|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013775|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56013776|NCT02197273|Epinephrine|epinephrine|mesh-list
56013777|NCT02197273|Fentanyl|fentanyl|mesh-list
56013778|NCT02197273|Morphine|morphine|mesh-list
56013779|NCT02197273|Bupivacaine|bupivacaine|mesh-list
56013780|NCT02197273|Ropivacaine|ropivacaine|mesh-list
56013781|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
56013782|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
56013783|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56013784|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620559|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
56620560|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620561|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620562|NCT02829060|Gentamicins|gentamicins|mesh-list
56620563|NCT02829060|Ampicillin|ampicillin|mesh-list
56620564|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
56620565|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56620566|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620567|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56620568|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620569|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620570|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56620571|NCT02829060|Renal Agents|renal agents|mesh-ancestor
56620572|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56620573|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56620574|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56620575|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56159644|NCT02968368|Hematinics|hematinics|mesh-ancestor
56620576|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620577|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56620578|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56620579|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56620580|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
56620581|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620582|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620583|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56620584|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56620585|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
56620586|NCT00783146|Fexofenadine|fexofenadine|mesh-list
56620587|NCT00783146|Desloratadine|desloratadine|mesh-list
56620588|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56620589|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
56620590|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622951|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56013785|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
56013786|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013787|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56013788|NCT02197273|Narcotics|narcotics|mesh-ancestor
56013792|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
56013793|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56013794|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56620591|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620592|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013795|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
56013796|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013797|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013798|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56013799|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56013800|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
56013831|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013832|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
56013833|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56013834|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55739193|NCT03407027|Hormones|hormones|mesh-ancestor
56013835|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56013836|NCT00004450|Growth Substances|growth substances|mesh-ancestor
56013837|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
56013838|NCT00004468|Calcitriol|calcitriol|mesh-list
56013839|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56013840|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013841|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56013842|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56013843|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013844|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56013845|NCT00004468|Vitamins|vitamins|mesh-ancestor
56013881|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013895|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56013896|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56013897|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56013898|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013899|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
56013900|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013901|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013902|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56013903|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013905|NCT00004486|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56013906|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56013907|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56013908|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013909|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013910|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
56013911|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013912|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56013913|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
56013914|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56013915|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56013916|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56013917|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013918|NCT00004492|Clotrimazole|clotrimazole|mesh-list
56013919|NCT00004492|Miconazole|miconazole|mesh-list
56013920|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
56013921|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013922|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
56013923|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013924|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013925|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56013926|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56013927|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013928|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
56013929|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56013930|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56013931|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56013932|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
56013940|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013971|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56013972|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013973|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013974|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
55802901|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56620593|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56620594|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56620595|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
56620596|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
56620597|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56620598|NCT00844675|Rabeprazole|rabeprazole|mesh-list
56620599|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56620600|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56620601|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56620602|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620603|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620604|NCT02840006|Anesthetics|anesthetics|mesh-list
56620605|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620606|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620607|NCT02826252|Iloprost|iloprost|mesh-list
56620608|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56620609|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
56013975|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56013976|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013977|NCT00005800|Docetaxel|docetaxel|mesh-list
56013978|NCT00005800|Doxorubicin|doxorubicin|mesh-list
56013979|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56013980|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013981|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
56013982|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013983|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
56014019|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56014020|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
56014049|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56014050|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56014051|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56014052|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56014053|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56014054|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56014055|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56014056|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56014057|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56014059|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
56014060|NCT00004690|Protective Agents|protective agents|mesh-ancestor
56014061|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014062|NCT00004696|Morphine|morphine|mesh-list
56014063|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56014086|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56014087|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
56014088|NCT00004762|Cladribine|cladribine|mesh-list
56014089|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014090|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014091|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
56014092|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014093|NCT00004786|Iloprost|iloprost|mesh-list
56014094|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56014095|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
56014096|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56014097|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56014098|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014099|NCT01272583|Incretins|incretins|mesh-ancestor
56014100|NCT01272583|Hormones|hormones|mesh-ancestor
55789626|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56620610|NCT02839928|Ketamine|ketamine|mesh-list
56620611|NCT02839928|Analgesics|analgesics|mesh-list
56620612|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56620613|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
56620614|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620615|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620616|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56620617|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56620618|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
56620619|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
56620620|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620621|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56620622|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56620623|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56003632|NCT02020070|Ipilimumab|ipilimumab|mesh-list
56014101|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56014102|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56014103|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
56014104|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014105|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014106|NCT00004804|Interferons|interferons|mesh-list
56014107|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
56014108|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014109|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
56014110|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014111|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
56014112|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014113|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
56014114|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56014115|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
56014116|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
56014163|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014165|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014166|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014167|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
56014168|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014169|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
56014170|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56188599|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56188601|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56188602|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56014171|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014172|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56014173|NCT01295515|Interferons|interferons|mesh-list
56014174|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
56014175|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
56014176|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56014177|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014178|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
56014179|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014180|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
56014181|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014182|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
56014183|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56014184|NCT00101816|Dasatinib|dasatinib|mesh-list
56014185|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014186|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56014187|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014188|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014189|NCT00102518|Aripiprazole|aripiprazole|mesh-list
56620624|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620625|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
56620626|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56620627|NCT05018520|Prednisone|prednisone|mesh-list
56620628|NCT05018520|Rituximab|rituximab|mesh-list
56620629|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
56620630|NCT05018520|Vincristine|vincristine|mesh-list
56620631|NCT05018520|Doxorubicin|doxorubicin|mesh-list
56620632|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56620633|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620634|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
56620635|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620636|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620637|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620638|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56620639|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
56620640|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620641|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56620642|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620643|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
56620644|NCT05018520|Hormones|hormones|mesh-ancestor
56014190|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
56014191|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56014192|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56014208|NCT00103376|Androgens|androgens|mesh-list
56014209|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
56014210|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014211|NCT00103376|Hormones|hormones|mesh-ancestor
56014212|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56014213|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014214|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
56014215|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
56014216|NCT00042224|Clozapine|clozapine|mesh-list
56014217|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56014218|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
56014219|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014220|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014221|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014222|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56014223|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56014224|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014225|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56014226|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
56014227|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
56014228|NCT01296763|Irinotecan|irinotecan|mesh-list
56014229|NCT01296763|Olaparib|olaparib|mesh-list
56014230|NCT01296763|Mitomycins|mitomycins|mesh-list
56014231|NCT01296763|Mitomycin|mitomycin|mesh-list
56014232|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014233|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56014234|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56014235|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014236|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014237|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56014238|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56620645|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56620646|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56620647|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56620648|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
56620649|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
56014239|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
56014240|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56014241|NCT01349491|Ranolazine|ranolazine|mesh-list
56014242|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56014243|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56014244|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014245|NCT01280695|Pioglitazone|pioglitazone|mesh-list
56014246|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56014247|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014248|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
56014249|NCT00103844|Dasatinib|dasatinib|mesh-list
56014251|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56014271|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014273|NCT01351753|Topiramate|topiramate|mesh-list
56014274|NCT01351753|Orlistat|orlistat|mesh-list
56014275|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56188603|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
56188604|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188605|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188606|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56188607|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56188608|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
56188609|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188610|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56188611|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56188612|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56188613|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56188614|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56014276|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014277|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
56014278|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014279|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014280|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56014281|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56014282|NCT00104858|Cyclosporine|cyclosporine|mesh-list
56014283|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
56014284|NCT00104858|Rituximab|rituximab|mesh-list
56014285|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56014286|NCT00104858|Fludarabine|fludarabine|mesh-list
56014287|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
56014288|NCT00104858|Antibodies|antibodies|mesh-list
56014289|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
56014290|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56014291|NCT00104858|Cyclosporins|cyclosporins|mesh-list
56014292|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
56014293|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014294|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014295|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014296|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56014297|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
56014298|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014299|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014300|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014301|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
56014302|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014303|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
56014304|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56014305|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56014306|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56014307|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
56014308|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56014334|NCT01304641|Simvastatin|simvastatin|mesh-list
56014335|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56014336|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56620651|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56620652|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56620653|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56620654|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620655|NCT04321746|Ketamine|ketamine|mesh-list
56014337|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
56014338|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014339|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56014340|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56014341|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014342|NCT00107744|Caseins|caseins|mesh-list
56014343|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
56014344|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
56014345|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014346|NCT04753112|Valsartan|valsartan|mesh-list
56014347|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56014348|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56188619|NCT01445236|Cyclosporine|cyclosporine|mesh-list
56188690|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188691|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
56188692|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56188693|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188694|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188695|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56188697|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
56188699|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56188700|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56188701|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56188702|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
56188703|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188704|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188705|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56014349|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56014350|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56014351|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014353|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56014354|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56014355|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014356|NCT00108524|Orlistat|orlistat|mesh-list
56014357|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014358|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144686|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144687|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144688|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
56144689|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144690|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
56144691|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144692|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
56144693|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56144694|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56144695|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56144696|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
56144697|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
56144698|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014375|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56014376|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56014377|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014378|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014379|NCT01410565|Apaziquone|apaziquone|mesh-list
56014380|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014381|NCT01357135|Metformin|metformin|mesh-list
56014382|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56014383|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56014384|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014385|NCT01357135|Incretins|incretins|mesh-ancestor
56014386|NCT01357135|Hormones|hormones|mesh-ancestor
56014387|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56014388|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56620656|NCT04321746|Analgesics|analgesics|mesh-ancestor
56620657|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
56620658|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620659|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014389|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
56014390|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188706|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56188707|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
56188708|NCT01445743|Vaccines|vaccines|mesh-list
56188709|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
56188710|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188711|NCT01445756|Lidocaine|lidocaine|mesh-list
56188712|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
56188713|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
56188714|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188715|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188716|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
56188717|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188718|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56014426|NCT01359007|Protective Agents|protective agents|mesh-ancestor
56014427|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014428|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
56014429|NCT01359007|Vitamins|vitamins|mesh-ancestor
56014430|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
56014431|NCT01414153|Bevacizumab|bevacizumab|mesh-list
56014449|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
56014450|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014451|NCT01362127|Cisplatin|cisplatin|mesh-list
56014452|NCT01362127|Carboplatin|carboplatin|mesh-list
56014453|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
56014454|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014455|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
56014456|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56014457|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014458|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014459|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56014460|NCT01362205|Analgesics|analgesics|mesh-ancestor
56014461|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
56014462|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014463|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56014464|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56014465|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56014466|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
56014467|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014468|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014469|NCT00052910|Leucovorin|leucovorin|mesh-list
56014470|NCT00052910|Fluorouracil|fluorouracil|mesh-list
56014471|NCT00052910|Epirubicin|epirubicin|mesh-list
56014472|NCT00052910|Calcium|calcium|mesh-list
56014473|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
56014474|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014475|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56014476|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014477|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
56014478|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014479|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56014480|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014481|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
56014482|NCT00052910|Antidotes|antidotes|mesh-ancestor
56014483|NCT00052910|Protective Agents|protective agents|mesh-ancestor
56014484|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
56014485|NCT00052910|Vitamins|vitamins|mesh-ancestor
56014486|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
56014487|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56014488|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56014489|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56014490|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014491|NCT01363843|Leucovorin|leucovorin|mesh-list
56014492|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
56014493|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014519|NCT02568566|Vaccines|vaccines|mesh-list
56014520|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
56188719|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56188720|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56620660|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56620661|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56620662|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
56620663|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
56620664|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620665|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56620666|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56620667|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620668|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620669|NCT02839694|Celecoxib|celecoxib|mesh-list
56620670|NCT02839694|Decitabine|decitabine|mesh-list
56620671|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
56620672|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56620673|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56620674|NCT02839694|Analgesics|analgesics|mesh-ancestor
56620675|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
56620676|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620677|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620678|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620679|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620680|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56620681|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56620682|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003679|NCT00002164|Nelfinavir|nelfinavir|mesh-list
56188721|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56188722|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188724|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56188725|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56188726|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
56188727|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188728|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56188729|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56188730|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188731|NCT01445938|Lumefantrine|lumefantrine|mesh-list
56188732|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
56188733|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56014521|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014522|NCT00151814|Olmesartan|olmesartan|mesh-list
56014523|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56014524|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56014525|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56014526|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56014527|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014528|NCT00153842|Bexarotene|bexarotene|mesh-list
56014529|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014530|NCT01314001|Nicotine|nicotine|mesh-list
56014531|NCT01314001|Varenicline|varenicline|mesh-list
56014532|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56014533|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
56014534|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620683|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620684|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56620685|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
56620686|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620687|NCT04243434|Prednisone|prednisone|mesh-list
56620688|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
56620689|NCT04243434|Doxorubicin|doxorubicin|mesh-list
56620690|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56620691|NCT04243434|Vincristine|vincristine|mesh-list
56620692|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620693|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
56620694|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620695|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620696|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56620697|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
56620698|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620699|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620700|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56014535|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014536|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56014537|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56014538|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
56014539|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014540|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014541|NCT01363999|Atorvastatin|atorvastatin|mesh-list
56014542|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
56014543|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56014574|NCT01364623|Androgens|androgens|mesh-ancestor
56014575|NCT01364623|Hormones|hormones|mesh-ancestor
56014576|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56014577|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014578|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56014579|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014580|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
56014581|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
56014582|NCT00258206|Rituximab|rituximab|mesh-list
56014583|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014584|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
56014585|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014586|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014587|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56014588|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
56014645|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56014646|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
56014647|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56188734|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56188735|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014648|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
56014649|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56014650|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56014651|NCT03047135|Olaparib|olaparib|mesh-list
56014652|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56014653|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014654|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014655|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014656|NCT04780061|Vitamin D|vitamin d|mesh-list
56620701|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56620702|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56620703|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56620704|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620705|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620706|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
56620707|NCT04243434|Hormones|hormones|mesh-ancestor
56620708|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56620709|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56620710|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56620711|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
56620712|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
56620713|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
56620714|NCT00832039|Selenious Acid|selenious acid|mesh-list
56620715|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
56620716|NCT00832039|Trace Elements|trace elements|mesh-ancestor
56620717|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
56014693|NCT01072643|Analgesics|analgesics|mesh-ancestor
56014712|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
56014713|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
56014714|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
56014715|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
56014716|NCT00117962|Carboplatin|carboplatin|mesh-list
56014717|NCT00117962|Pemetrexed|pemetrexed|mesh-list
56014718|NCT00117962|Cetuximab|cetuximab|mesh-list
56014719|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014720|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014721|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014722|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56014723|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56014724|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56014725|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
56014726|NCT00118274|Vaccines|vaccines|mesh-list
56014727|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
56014728|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
56014729|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014730|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014731|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014732|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56014733|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
56014734|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014735|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014736|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56014737|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56014738|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
56014739|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56014740|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014741|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
56014742|NCT00166166|Fluconazole|fluconazole|mesh-list
56014743|NCT00166166|Nitroprusside|nitroprusside|mesh-list
56014744|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
56014745|NCT00166166|Acetylcholine|acetylcholine|mesh-list
56014746|NCT00166166|Bradykinin|bradykinin|mesh-list
56014747|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56014748|NCT00166166|Kininogens|kininogens|mesh-list
56014749|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
56014772|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
56014773|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56014774|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
56014775|NCT00118352|Fludarabine|fludarabine|mesh-list
56014776|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
56620718|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620719|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
56620720|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56620721|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620722|NCT02837978|Methotrexate|methotrexate|mesh-list
56369250|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
56620723|NCT02837978|Tacrolimus|tacrolimus|mesh-list
56620724|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56620725|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
56620726|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56620727|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620728|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56620729|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
56620730|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620731|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620732|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56620733|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620734|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56014777|NCT00118352|Antibodies|antibodies|mesh-list
56014779|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56014780|NCT00118352|Cyclosporins|cyclosporins|mesh-list
56014781|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
56014782|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014783|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014784|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56014785|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
56014786|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014787|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014788|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014789|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
56014790|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014791|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
56014792|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014793|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56014794|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56188737|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56188738|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56188739|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
56188740|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
56188741|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188742|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116502|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
56188743|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56188744|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56188745|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56188800|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188801|NCT01446276|Protective Agents|protective agents|mesh-ancestor
56188802|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188803|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014795|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56014796|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
56014797|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56014798|NCT01111331|Empagliflozin|empagliflozin|mesh-list
56014799|NCT01111331|Warfarin|warfarin|mesh-list
56014828|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
56014829|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56014830|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56620735|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620736|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
56620737|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620738|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56620739|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56620740|NCT00839059|Lenalidomide|lenalidomide|mesh-list
56620741|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
56620742|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620743|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56620744|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56620745|NCT00839059|Growth Substances|growth substances|mesh-ancestor
56620746|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
56620747|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620748|NCT02839538|Anesthetics|anesthetics|mesh-list
56620749|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014831|NCT02176031|Prednisolone|prednisolone|mesh-list
56014832|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
56014833|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56014834|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
56014835|NCT02176031|Natalizumab|natalizumab|mesh-list
56014836|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56014837|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
56014838|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
56014839|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014840|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014841|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56014842|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
56014843|NCT02176031|Hormones|hormones|mesh-ancestor
56014844|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56014845|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56014854|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014855|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014856|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
56014857|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014858|NCT01077401|Ranibizumab|ranibizumab|mesh-list
56014859|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56014860|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56014861|NCT01077401|Growth Substances|growth substances|mesh-ancestor
56014862|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014863|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
56014864|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014865|NCT01316341|Empagliflozin|empagliflozin|mesh-list
56014866|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56014867|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014868|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56014869|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014870|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56014871|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
56014872|NCT01112735|Coagulants|coagulants|mesh-ancestor
56014873|NCT03014297|Everolimus|everolimus|mesh-list
56014874|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
56014875|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014876|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014877|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
56014878|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014879|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56014880|NCT01034111|Metformin|metformin|mesh-list
56014881|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56014882|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56014883|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014884|NCT01034111|Incretins|incretins|mesh-ancestor
56620750|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620751|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56620752|NCT02826174|Anesthetics|anesthetics|mesh-list
56620753|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620754|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620755|NCT00621517|Bupropion|bupropion|mesh-list
56620756|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56620757|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
56620758|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56620759|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56620760|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56003767|NCT00000730|Leucovorin|leucovorin|mesh-list
56014885|NCT01034111|Hormones|hormones|mesh-ancestor
56014886|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56014887|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56014888|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
56014889|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014890|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014891|NCT01114997|Lidocaine|lidocaine|mesh-list
56014892|NCT01114997|Esmolol|esmolol|mesh-list
56014893|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
56014894|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
56014895|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014896|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188804|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56188806|NCT01446328|Aripiprazole|aripiprazole|mesh-list
56188807|NCT01446328|Amisulpride|amisulpride|mesh-list
56188808|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
56188809|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
56188810|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188811|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188812|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56188813|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56188814|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56188815|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188816|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56014897|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
56014898|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014899|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56014900|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56014901|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56014902|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56014903|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014904|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56014905|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56014906|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56014907|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
56014908|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014909|NCT00118742|Cyclosporine|cyclosporine|mesh-list
56014910|NCT00118742|Sirolimus|sirolimus|mesh-list
56014911|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
56014912|NCT00118742|Tacrolimus|tacrolimus|mesh-list
56014913|NCT00118742|Cyclosporins|cyclosporins|mesh-list
56014923|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014924|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56014925|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014926|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56014927|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
56014928|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56014929|NCT01317667|Vaccines|vaccines|mesh-list
56014930|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
56014931|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620761|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56620762|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620763|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
56620764|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620765|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620766|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56620767|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56620768|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620769|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
56620770|NCT02827266|Hematinics|hematinics|mesh-ancestor
56620771|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
56620772|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620773|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56620774|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620775|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620776|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
56620777|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56620778|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620779|NCT02826876|Ropivacaine|ropivacaine|mesh-list
56620780|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
56620781|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
56620782|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620783|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620784|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
56620785|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620786|NCT04244448|Emtricitabine|emtricitabine|mesh-list
56620787|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
56620788|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620789|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56620790|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56620806|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
56620807|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56620808|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620809|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620810|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56620811|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56620812|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56620813|NCT02547025|Renal Agents|renal agents|mesh-ancestor
56620814|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56620815|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56620816|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620817|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56620818|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56014932|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
56014933|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014934|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
56014935|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014936|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014937|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56014938|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
56014939|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014940|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014941|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56014942|NCT01317901|Rituximab|rituximab|mesh-list
56014943|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56014944|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56014945|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014946|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
56014947|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014948|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014949|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56014950|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
56014951|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014953|NCT03008551|Empagliflozin|empagliflozin|mesh-list
56014954|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56014955|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116578|NCT00382421|Aspirin|aspirin|mesh-list
56188818|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56188819|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56188820|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188821|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188822|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
56188823|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
56188824|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
56188825|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
56014956|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56014957|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014958|NCT01366885|Vitamin D|vitamin d|mesh-list
56014959|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
56014960|NCT01366885|Vitamins|vitamins|mesh-ancestor
56014961|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
56014962|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014963|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56014964|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56014966|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56014967|NCT01899170|Narcotics|narcotics|mesh-ancestor
56014968|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014969|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014970|NCT01899170|Analgesics|analgesics|mesh-ancestor
56620819|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56620820|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56620821|NCT02547025|Antacids|antacids|mesh-ancestor
56620822|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
56620823|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56620824|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56620825|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
56620826|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620827|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56620828|NCT05660382|Miconazole|miconazole|mesh-list
56620829|NCT05660382|Clotrimazole|clotrimazole|mesh-list
56620830|NCT05660382|Mineral Oil|mineral oil|mesh-list
56620831|NCT05660382|Antifungal Agents|antifungal agents|mesh-ancestor
56620832|NCT05660382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014971|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
56014972|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014973|NCT01425229|Bosentan|bosentan|mesh-list
56014974|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56014975|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56014976|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014977|NCT00258362|Carboplatin|carboplatin|mesh-list
56014978|NCT00258362|Docetaxel|docetaxel|mesh-list
56014979|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015002|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56015003|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015004|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56015006|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56015007|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015008|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015009|NCT01425853|Celecoxib|celecoxib|mesh-list
56015010|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56015011|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56015012|NCT01425853|Analgesics|analgesics|mesh-ancestor
56015013|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
56015014|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015015|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015016|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015017|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015018|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56015019|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56015020|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015021|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015022|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56015023|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56015024|NCT01426867|Brinzolamide|brinzolamide|mesh-list
56015025|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56015026|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56015027|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56015028|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56015029|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56015030|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
56015031|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015032|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188826|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56188827|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56188828|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56015067|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015068|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56015070|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
56015071|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
56015072|NCT02112734|Vitamins|vitamins|mesh-list
56015141|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56620833|NCT05660382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56620834|NCT05660382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56620835|NCT05660382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620836|NCT05660382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620837|NCT05660382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56620838|NCT05660382|Hormone Antagonists|hormone antagonists|mesh-ancestor
56620839|NCT05660382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56620840|NCT05660382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620841|NCT05660382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56620842|NCT05660382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56620843|NCT05660382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56620844|NCT05660382|Emollients|emollients|mesh-ancestor
56620845|NCT05660382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56620846|NCT00839371|Midazolam|midazolam|mesh-list
56620847|NCT00839371|Propofol|propofol|mesh-list
56620848|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56620849|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620850|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620851|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56620852|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
56620853|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
56620854|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56015142|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015143|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56015144|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015145|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015146|NCT01899248|Sevoflurane|sevoflurane|mesh-list
56015147|NCT01899248|Desflurane|desflurane|mesh-list
56015148|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56015149|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56015150|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
56015179|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
56015180|NCT00176228|Lamotrigine|lamotrigine|mesh-list
56015181|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
56015182|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56015183|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56015184|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015185|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56015186|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015187|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56015188|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56015189|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56015190|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56015191|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56015192|NCT00176306|Levofloxacin|levofloxacin|mesh-list
56015193|NCT00176306|Ofloxacin|ofloxacin|mesh-list
56015194|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56015195|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015196|NCT00176306|Renal Agents|renal agents|mesh-ancestor
56015197|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56620855|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56620856|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56620857|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56620858|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
56620859|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
56620860|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620861|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620862|NCT02826408|Rabeprazole|rabeprazole|mesh-list
56620864|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56620865|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56620866|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620867|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620868|NCT00573937|Morphine|morphine|mesh-list
56620869|NCT00573937|Methadone|methadone|mesh-list
56620870|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56620871|NCT00573937|Narcotics|narcotics|mesh-ancestor
56620872|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620873|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620874|NCT00573937|Analgesics|analgesics|mesh-ancestor
56620875|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
56620876|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620877|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
56015198|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56015199|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56015265|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015266|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56015268|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56015269|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56015270|NCT01323595|Analgesics|analgesics|mesh-ancestor
56015271|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
56015272|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015273|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015274|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015275|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015276|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56015277|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56015278|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144721|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
56015279|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930011|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015311|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56015312|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015313|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015314|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
56015315|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56015316|NCT01325311|Estrogens|estrogens|mesh-ancestor
56015317|NCT01325311|Hormones|hormones|mesh-ancestor
56015318|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015334|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015335|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015336|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56620878|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
56620879|NCT00845533|Piperaquine|piperaquine|mesh-list
56620880|NCT00845533|Artenimol|artenimol|mesh-list
56620881|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
56620882|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56620883|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56620884|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620885|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56620886|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56620887|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56620888|NCT04958538|Methotrexate|methotrexate|mesh-list
56620889|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56620890|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
56620891|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56620892|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620893|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56620894|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
56620895|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620896|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620897|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015337|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56015338|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
56015339|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188829|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56188830|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56015340|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56015341|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56015342|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
56015343|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56015348|NCT01432405|Pioglitazone|pioglitazone|mesh-list
56015349|NCT01432405|Exenatide|exenatide|mesh-list
56015350|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56015351|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015352|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56015353|NCT01432405|Incretins|incretins|mesh-ancestor
56015354|NCT01432405|Hormones|hormones|mesh-ancestor
56015355|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015356|NCT01432561|Cysteamine|cysteamine|mesh-list
56015357|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56015358|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015359|NCT01116401|Leuprolide|leuprolide|mesh-list
56015360|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56015361|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
56015362|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56015363|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015364|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015365|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015366|NCT03008317|Chromium|chromium|mesh-list
56015367|NCT03008317|Trace Elements|trace elements|mesh-ancestor
56015368|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
56015369|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015370|NCT01433107|Terbinafine|terbinafine|mesh-list
56015371|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
56015372|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015373|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620898|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620899|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56620900|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620901|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
56620902|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56620903|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56620904|NCT02548195|Gemcitabine|gemcitabine|mesh-list
56620905|NCT02548195|Capecitabine|capecitabine|mesh-list
56620906|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
56620907|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56620908|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
56620909|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620910|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620911|NCT02548195|Antiviral Agents|antiviral agents|mesh-ancestor
56620912|NCT02548195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56620913|NCT02548195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620914|NCT02548195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56620915|NCT02548195|Immunologic Factors|immunologic factors|mesh-ancestor
56620916|NCT02548195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620917|NCT00573859|Methylphenidate|methylphenidate|mesh-list
56620918|NCT00573859|Amphetamine|amphetamine|mesh-list
56620919|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56620920|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
56620921|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56620922|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56620923|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620924|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56620925|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56620926|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56003915|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56015374|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015375|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
56015376|NCT01082939|Rituximab|rituximab|mesh-list
56015377|NCT01082939|Fludarabine|fludarabine|mesh-list
56015378|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
56015379|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
56015413|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015414|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56015415|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56015416|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015417|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015418|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56015419|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
56015440|NCT05448378|Vitamins|vitamins|mesh-ancestor
56620927|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620928|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
56620929|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620930|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56620931|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
56620932|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
56620933|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
56620934|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620935|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
56620936|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56620937|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
56620938|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56620939|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56620940|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620941|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56620943|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
56620944|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620945|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56620946|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56620947|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56620948|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
56015441|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
56015442|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015443|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
56015444|NCT01434121|Vitamins|vitamins|mesh-ancestor
56015445|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
56015446|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015447|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
56015448|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015449|NCT01434121|Protective Agents|protective agents|mesh-ancestor
56015450|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56015451|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
56015452|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015453|NCT01040819|Pioglitazone|pioglitazone|mesh-list
56015454|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56015455|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015456|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56015457|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015458|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56015459|NCT01084265|Hormones|hormones|mesh-list
56015460|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56015461|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015462|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015463|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56015464|NCT01084499|Letrozole|letrozole|mesh-list
56015465|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015466|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56188831|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56188832|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56188833|NCT01446445|Valganciclovir|valganciclovir|mesh-list
56188834|NCT01446445|Ganciclovir|ganciclovir|mesh-list
56188835|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56188836|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
56620949|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620950|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620951|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
56620952|NCT00839683|Valsartan|valsartan|mesh-list
56620953|NCT00839683|Simvastatin|simvastatin|mesh-list
56620954|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56620955|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56620956|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
56188837|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188838|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56188840|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188841|NCT01446458|Folfirinox|folfirinox|mesh-list
56188842|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188843|NCT01446484|Cyclosporine|cyclosporine|mesh-list
56188844|NCT01446484|Sirolimus|sirolimus|mesh-list
56188845|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
56188846|NCT01446484|Everolimus|everolimus|mesh-list
56188847|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
56188848|NCT01446484|Tacrolimus|tacrolimus|mesh-list
56188849|NCT01446484|Cyclosporins|cyclosporins|mesh-list
56188850|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015467|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56015468|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015469|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015470|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56015471|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
56015472|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015492|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56015493|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
56015494|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
56015495|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
56015496|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
56015497|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56015498|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56015499|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
56015500|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
56015501|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015502|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56015503|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
56015504|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015505|NCT02397720|Nivolumab|nivolumab|mesh-list
56015506|NCT02397720|Ipilimumab|ipilimumab|mesh-list
56015507|NCT02397720|Azacitidine|azacitidine|mesh-list
56015508|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56015509|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015510|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56015511|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015512|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56015513|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
56015514|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015515|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56015516|NCT01085903|Modafinil|modafinil|mesh-list
56015517|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56015518|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015519|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56015520|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56015521|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56015522|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015523|NCT01118741|Disulfiram|disulfiram|mesh-list
56188851|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
56188852|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188853|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56188854|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188855|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188856|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
56188857|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188858|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56188859|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56188860|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56620957|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620958|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56620959|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56620960|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56620961|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56620962|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56620963|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56620964|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56620965|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56620966|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620967|NCT00839761|Iron|iron|mesh-list
56620968|NCT00839761|Trace Elements|trace elements|mesh-ancestor
56620969|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
56188861|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56188862|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56188863|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
56188864|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56015524|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56015525|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56015526|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015527|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015528|NCT01439815|Fluticasone|fluticasone|mesh-list
56015560|NCT01384591|Losartan|losartan|mesh-list
56015561|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56015562|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56015563|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56015564|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56015565|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56015568|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015569|NCT01384591|Expectorants|expectorants|mesh-ancestor
56015570|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
56015637|NCT01042145|Dexamethasone|dexamethasone|mesh-list
56015638|NCT01042145|Prednisone|prednisone|mesh-list
56015639|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015640|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
56015641|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
56015642|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015643|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015644|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56015645|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
56015646|NCT01042145|Hormones|hormones|mesh-ancestor
56015647|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015648|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015649|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015650|NCT01043393|Desoximetasone|desoximetasone|mesh-list
56015651|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015652|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
56015653|NCT01043393|Hormones|hormones|mesh-ancestor
55742842|NCT04505995|Azacitidine|azacitidine|mesh-list
56015654|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015655|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015691|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
56015692|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015693|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015694|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56015695|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56015696|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
56015697|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
56015732|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55803352|NCT02579629|Ropivacaine|ropivacaine|mesh-list
56620970|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620971|NCT02825394|Ecarin|ecarin|mesh-list
56620972|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56620973|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56620974|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620975|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56620976|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56620977|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
56620978|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620979|NCT00845689|Adenosine|adenosine|mesh-list
56620980|NCT00845689|Analgesics|analgesics|mesh-ancestor
56620981|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
56620982|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56620983|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620984|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56620985|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
56620986|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56620987|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
56620988|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
56620989|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56620990|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56620991|NCT05660694|Vitamin E|vitamin e|mesh-list
56620992|NCT05660694|Triamcinolone|triamcinolone|mesh-list
56620993|NCT05660694|Pentoxifylline|pentoxifylline|mesh-list
56620994|NCT05660694|Vitamins|vitamins|mesh-ancestor
56620995|NCT05660694|Micronutrients|micronutrients|mesh-ancestor
56620996|NCT05660694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56620997|NCT05660694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56620998|NCT05660694|Glucocorticoids|glucocorticoids|mesh-ancestor
56620999|NCT05660694|Hormones|hormones|mesh-ancestor
56621000|NCT05660694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56621001|NCT05660694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621002|NCT05660694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621003|NCT05660694|Antioxidants|antioxidants|mesh-ancestor
56621004|NCT05660694|Protective Agents|protective agents|mesh-ancestor
56621010|NCT05113368|Fulvestrant|fulvestrant|mesh-list
56621011|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56621012|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621013|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56621015|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
56621016|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56621017|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621018|NCT02824614|Erythritol|erythritol|mesh-list
56621019|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
56621020|NCT00840229|Triamcinolone|triamcinolone|mesh-list
56621021|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56621022|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56621023|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56621024|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621025|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
56621026|NCT00840229|Hormones|hormones|mesh-ancestor
56621027|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015733|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188865|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56188866|NCT01446497|Timolol|timolol|mesh-list
56188867|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56188868|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56188869|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56015734|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56015735|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56015736|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56015758|NCT01089569|Hormones|hormones|mesh-ancestor
56015759|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015772|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
56015773|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56015774|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56015775|NCT00128180|Prednisolone|prednisolone|mesh-list
56015776|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
56015777|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56015778|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
56015779|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015780|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
56015781|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
56015782|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015783|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015784|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56015785|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
56015786|NCT00128180|Hormones|hormones|mesh-ancestor
56015787|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015788|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56015809|NCT01897844|Somatostatin|somatostatin|mesh-list
56015810|NCT01897844|Hormones|hormones|mesh-ancestor
56015811|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015812|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015813|NCT00131378|Hormones|hormones|mesh-list
56015814|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015815|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015816|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
56015817|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56015818|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
56015819|NCT01445821|Fludarabine|fludarabine|mesh-list
56015820|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
56621028|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621029|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56621030|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
56621031|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621032|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621033|NCT00831441|Apixaban|apixaban|mesh-list
56621034|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56621035|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
56621036|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56621037|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
56621038|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621039|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621040|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
56621041|NCT00840385|Vidarabine|vidarabine|mesh-list
56621042|NCT00840385|Fludarabine|fludarabine|mesh-list
56621043|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
56621044|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621045|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56621046|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
56622952|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56015822|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
56015823|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015824|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015825|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56015826|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
56015827|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015828|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015829|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56015830|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015831|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
56015832|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
56015833|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015834|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56015835|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
56015836|NCT01445821|Hormones|hormones|mesh-ancestor
56015837|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015838|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56015839|NCT01445821|Protective Agents|protective agents|mesh-ancestor
56015840|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015852|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56015853|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
56015854|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
56015855|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56015856|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015857|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56015858|NCT03013439|Hematinics|hematinics|mesh-ancestor
56015859|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56188870|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
56188871|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188872|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188873|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188874|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56188875|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56188876|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56621047|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621048|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56621049|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
56621050|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621051|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
56621052|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621053|NCT02824458|Apatinib|apatinib|mesh-list
56621054|NCT02824458|Gefitinib|gefitinib|mesh-list
56621055|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621056|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56621057|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621058|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621059|NCT00840931|Lenalidomide|lenalidomide|mesh-list
56621060|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
56621061|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621062|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56621063|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56621064|NCT00840931|Growth Substances|growth substances|mesh-ancestor
56621065|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
56621066|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621067|NCT05659992|Cytarabine|cytarabine|mesh-list
56621068|NCT05659992|Azacitidine|azacitidine|mesh-list
56188877|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56188878|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56188879|NCT01446523|Lactulose|lactulose|mesh-list
56188880|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56188881|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56188882|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
56015860|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56015861|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56015862|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56015863|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015864|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015865|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015866|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56015867|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
56015868|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56015869|NCT01093469|Decanoic acid|decanoic acid|mesh-list
56015870|NCT01093469|Petrolatum|petrolatum|mesh-list
56015871|NCT01093469|Emollients|emollients|mesh-ancestor
56015872|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015873|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
56015874|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015875|NCT02543658|Neostigmine|neostigmine|mesh-list
56015876|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56015877|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015878|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015879|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
56015880|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015881|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015882|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56015883|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
56015884|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621069|NCT05659992|Venetoclax|venetoclax|mesh-list
56621070|NCT05659992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56621071|NCT05659992|Antimetabolites|antimetabolites|mesh-ancestor
56621072|NCT05659992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621073|NCT05659992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621074|NCT05659992|Antiviral Agents|antiviral agents|mesh-ancestor
56621075|NCT05659992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621076|NCT05659992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56621077|NCT05659992|Immunologic Factors|immunologic factors|mesh-ancestor
56621078|NCT05659992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621079|NCT05659992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621080|NCT00834379|Pravastatin|pravastatin|mesh-list
56621081|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56621082|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56621083|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
56621084|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621085|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56015886|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
56015887|NCT02923128|Dsuvia|dsuvia|mesh-list
56015888|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56015889|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56015890|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015891|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56015892|NCT02923128|Analgesics|analgesics|mesh-ancestor
56015894|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015895|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56015896|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56015898|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
56015899|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015900|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015901|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56015902|NCT02923128|Narcotics|narcotics|mesh-ancestor
56015926|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56015927|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
56015928|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188883|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188885|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56188886|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56188887|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
56015929|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015930|NCT00183794|Antiviral Agents|antiviral agents|mesh-ancestor
56015931|NCT00183794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015932|NCT00183794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015933|NCT00183794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015934|NCT00183794|Immunologic Factors|immunologic factors|mesh-ancestor
56015935|NCT00183794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015936|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
56015937|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
56015938|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
56015939|NCT00270296|Ritonavir|ritonavir|mesh-list
56015940|NCT00270296|Lopinavir|lopinavir|mesh-list
56015941|NCT00270296|Lamivudine|lamivudine|mesh-list
56015942|NCT00270296|Zidovudine|zidovudine|mesh-list
56015943|NCT00270296|Nevirapine|nevirapine|mesh-list
56015944|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56015945|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56015946|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56015947|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
56015948|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621086|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56621088|NCT00834457|Ritonavir|ritonavir|mesh-list
56621089|NCT00834457|Lopinavir|lopinavir|mesh-list
56621090|NCT00834457|Zidovudine|zidovudine|mesh-list
56621091|NCT00834457|Lamivudine|lamivudine|mesh-list
56621092|NCT00834457|Abacavir|abacavir|mesh-list
56621093|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
56621094|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56621095|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56621096|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
56621097|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621098|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621099|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56621100|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56621101|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
56621102|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621103|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56621104|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56621105|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
56621106|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56621107|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56621108|NCT03851965|Plasminogen|plasminogen|mesh-list
56621109|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56621110|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56621111|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621112|NCT02611635|Warfarin|warfarin|mesh-list
56621136|NCT00705471|Infliximab|infliximab|mesh-list
56621137|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621138|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621139|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621140|NCT00705549|Gemcitabine|gemcitabine|mesh-list
56621141|NCT00705549|Cisplatin|cisplatin|mesh-list
56621142|NCT00705549|Docetaxel|docetaxel|mesh-list
56621143|NCT00705549|Vinorelbine|vinorelbine|mesh-list
56621144|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621145|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56621146|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
56621147|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621148|NCT00705549|Antiviral Agents|antiviral agents|mesh-ancestor
56621149|NCT00705549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621150|NCT00705549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621151|NCT00705549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56621152|NCT00705549|Immunologic Factors|immunologic factors|mesh-ancestor
56621153|NCT00705549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621154|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
56621155|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
56621156|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56621157|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56621158|NCT02824770|Tramadol|tramadol|mesh-list
56621159|NCT02824770|Bupivacaine|bupivacaine|mesh-list
56621160|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621161|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
56621162|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621163|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621164|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
56621165|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621166|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56621167|NCT02824770|Narcotics|narcotics|mesh-ancestor
56621168|NCT02824770|Analgesics|analgesics|mesh-ancestor
56621169|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56621170|NCT02824536|Antibodies|antibodies|mesh-list
56621171|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
56621172|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56015949|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015950|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56015951|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56015952|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
55743139|NCT03892395|Vitamin D|vitamin d|mesh-list
56621173|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
56621174|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621175|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621176|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
56621177|NCT00831129|Simvastatin|simvastatin|mesh-list
56621178|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56621179|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56621180|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
56621181|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621182|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56015953|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015954|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56015982|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015984|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56015985|NCT03013205|Triamcinolone|triamcinolone|mesh-list
56015986|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56015987|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56015988|NCT03013205|Lidocaine|lidocaine|mesh-list
56015989|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56015990|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015991|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
56015992|NCT03013205|Hormones|hormones|mesh-ancestor
56015993|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015994|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015995|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015996|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
56015997|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015998|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015999|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
56016027|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016028|NCT03110315|Suvorexant|suvorexant|mesh-list
56016029|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56016030|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56016031|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016032|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016033|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56016034|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016035|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016036|NCT05307341|Sufentanil|sufentanil|mesh-list
56016037|NCT05307341|Dsuvia|dsuvia|mesh-list
56016038|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56016039|NCT05307341|Narcotics|narcotics|mesh-ancestor
56016074|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188888|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188889|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56188890|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56188891|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188892|NCT01446731|Docetaxel|docetaxel|mesh-list
56188893|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188894|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
56188895|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
56188896|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
56188897|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188898|NCT01446783|Mecasermin|mecasermin|mesh-list
56188899|NCT01446783|Growth Substances|growth substances|mesh-ancestor
56016075|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56016076|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56016077|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56016078|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016079|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016080|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56016081|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56016082|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
56621183|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56621184|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621185|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56621186|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621187|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
56621188|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56621189|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
56621190|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621191|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56621192|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621193|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
56621194|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621195|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
56016083|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016084|NCT05306405|Misoprostol|misoprostol|mesh-list
56016085|NCT05306405|Estradiol|estradiol|mesh-list
56016086|NCT05306405|Estrogens|estrogens|mesh-ancestor
56016087|NCT05306405|Hormones|hormones|mesh-ancestor
56016088|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016107|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56016108|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016109|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016110|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
56016111|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56016113|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
56016114|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016115|NCT05272397|Methylphenidate|methylphenidate|mesh-list
56016116|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56016117|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016118|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56016119|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56016120|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016121|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016122|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
56016123|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016124|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
56016125|NCT00185900|Nifedipine|nifedipine|mesh-list
56016126|NCT00185900|Analgesics|analgesics|mesh-ancestor
56016127|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
56016128|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016129|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016130|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
56016131|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016132|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56016133|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
56016134|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56016135|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016136|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016137|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56016138|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
56016139|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56016140|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
56016141|NCT00186056|Mifepristone|mifepristone|mesh-list
56188903|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56188904|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016142|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56016144|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56016145|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016169|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56621196|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56621197|NCT00637962|Protective Agents|protective agents|mesh-ancestor
56621198|NCT00913341|Alprazolam|alprazolam|mesh-list
56621199|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56621200|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621201|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621202|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56621203|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56621204|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56621205|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
56621206|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
56621207|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621208|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621209|NCT00620113|Vitamin D|vitamin d|mesh-list
56621210|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
56016170|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016172|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56016173|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
56016174|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56016175|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56016176|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56016177|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016178|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016179|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
56016180|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016181|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016182|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56016183|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56016184|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016185|NCT00189098|Trimethoprim|trimethoprim|mesh-list
56016186|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56016187|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
56016188|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56016189|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016190|NCT00189098|Renal Agents|renal agents|mesh-ancestor
56016191|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
56016219|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56016220|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
56016222|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56016223|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016224|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
56016225|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
56016226|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
56016227|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016228|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
56016229|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56016230|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016231|NCT01447225|Gemcitabine|gemcitabine|mesh-list
56016232|NCT01447225|Carboplatin|carboplatin|mesh-list
56016233|NCT01447225|Pemetrexed|pemetrexed|mesh-list
56016234|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016262|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56016263|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56016264|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016265|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016267|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56016268|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56016269|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56016270|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
56621211|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
56621212|NCT00620113|Calcium|calcium|mesh-list
56621213|NCT00620113|Vitamins|vitamins|mesh-ancestor
56621214|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
56621215|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621216|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56621217|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56621218|NCT00620113|Antacids|antacids|mesh-ancestor
56621219|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621220|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621221|NCT00830115|Pantoprazole|pantoprazole|mesh-list
56621222|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56621223|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621224|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56621272|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621273|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56621274|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621275|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
56621276|NCT00841633|Norepinephrine|norepinephrine|mesh-list
56621277|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56621278|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56621279|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
56621280|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621281|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016271|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016272|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56016273|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016274|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016275|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
56016276|NCT01474213|Remifentanil|remifentanil|mesh-list
56016277|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56016278|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016279|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016310|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016311|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56188905|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
56188906|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188907|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56188908|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56188909|NCT01446926|Vaccines|vaccines|mesh-list
56188910|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56188912|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188914|NCT01446952|Tocopherols|tocopherols|mesh-list
56188915|NCT01446952|Tocotrienols|tocotrienols|mesh-list
56188916|NCT01446952|Vitamins|vitamins|mesh-ancestor
56016312|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016313|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
56016314|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
56016315|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56016316|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
56016317|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016318|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016319|NCT01474915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56016320|NCT01474915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56016321|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016322|NCT01474915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56016323|NCT01474915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56016324|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56016325|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56016349|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
56016350|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56016351|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56016352|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56016353|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55739235|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56016354|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016355|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
56016356|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016357|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016358|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56016359|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016360|NCT02099084|Teduglutide|teduglutide|mesh-list
56016361|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56016362|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56016363|NCT02099084|Protective Agents|protective agents|mesh-ancestor
55803353|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621282|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016364|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016365|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
56016366|NCT00281918|Rituximab|rituximab|mesh-list
56016367|NCT00281918|Fludarabine|fludarabine|mesh-list
56016368|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
56016369|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016370|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
56016371|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016372|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56016373|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56016374|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
56016375|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016376|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016412|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56016413|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56016414|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
56016415|NCT00206336|Topiramate|topiramate|mesh-list
56016416|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
56016417|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56016418|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016448|NCT01108445|Everolimus|everolimus|mesh-list
56016449|NCT01108445|Sunitinib|sunitinib|mesh-list
56188918|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188919|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
56188920|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188921|NCT01446952|Protective Agents|protective agents|mesh-ancestor
56188922|NCT01446978|Vaccines|vaccines|mesh-list
56188923|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
56188924|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188925|NCT01447043|Ranibizumab|ranibizumab|mesh-list
56188926|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56188927|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56188928|NCT01447043|Growth Substances|growth substances|mesh-ancestor
56188929|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016450|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016451|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016452|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
56016453|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016454|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56016455|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56016456|NCT01108445|Growth Substances|growth substances|mesh-ancestor
56016457|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
56016458|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56016459|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016460|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016461|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56016462|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56016463|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016465|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56016466|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
56016480|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
56016481|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
56016482|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
56016483|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016484|NCT01162733|Vancomycin|vancomycin|mesh-list
56016485|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56016486|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016487|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
56016488|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
56016489|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016490|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
56016491|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016492|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016493|NCT05410860|Etripamil|etripamil|mesh-list
56016494|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56016495|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016496|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016497|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56016498|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016499|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
56016500|NCT01131065|Antibodies|antibodies|mesh-list
56016501|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
56016502|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56621283|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
56621284|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
56621285|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621286|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56621287|NCT02823912|Capsaicin|capsaicin|mesh-list
56621288|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
56621289|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
56621290|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621291|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
56621292|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621293|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016503|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56016504|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
56016505|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016506|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56016507|NCT01165541|Mirtazapine|mirtazapine|mesh-list
56016508|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
56016509|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56016510|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56016511|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56188930|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
56188931|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188933|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56188934|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
56188935|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188936|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188937|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56188938|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
56188939|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
56188940|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56188941|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56188942|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56188943|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56188944|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
56188945|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56188946|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188947|NCT01447095|Epoprostenol|epoprostenol|mesh-list
56016512|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016513|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016514|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56016515|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
56016516|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
56016517|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016518|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016519|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56016520|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56016521|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56016522|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56016523|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
56016524|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56016525|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56016527|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56016528|NCT00284180|Trastuzumab|trastuzumab|mesh-list
56016529|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56016539|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016540|NCT04062656|Leucovorin|leucovorin|mesh-list
56016541|NCT04062656|Folic Acid|folic acid|mesh-list
56016542|NCT04062656|Docetaxel|docetaxel|mesh-list
56016543|NCT04062656|Fluorouracil|fluorouracil|mesh-list
56016544|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
56016545|NCT04062656|Nivolumab|nivolumab|mesh-list
56016546|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016547|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
56016548|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
56016549|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
56621294|NCT02823912|Antacids|antacids|mesh-ancestor
56621295|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621296|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621297|NCT00841789|Etanercept|etanercept|mesh-list
56621298|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56016550|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016551|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
56016552|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56016553|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016554|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
56016555|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016556|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56016557|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56016558|NCT04062656|Antidotes|antidotes|mesh-ancestor
56016559|NCT04062656|Protective Agents|protective agents|mesh-ancestor
56188948|NCT01447095|Tezosentan|tezosentan|mesh-list
56188949|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56188950|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56188951|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
56188952|NCT01447160|Cortisone|cortisone|mesh-list
56188953|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56188954|NCT01447173|Vitamin D|vitamin d|mesh-list
56188955|NCT01447173|Vitamins|vitamins|mesh-ancestor
56188956|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
56188957|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188958|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56016560|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
56016561|NCT04062656|Vitamins|vitamins|mesh-ancestor
56016562|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
56016563|NCT04062656|Hematinics|hematinics|mesh-ancestor
56016564|NCT00287222|Bevacizumab|bevacizumab|mesh-list
56016565|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56016566|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56016567|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016568|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56016569|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56016570|NCT00287222|Growth Substances|growth substances|mesh-ancestor
56016571|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016572|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56016573|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56016574|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016575|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016576|NCT00218426|Naltrexone|naltrexone|mesh-list
56016577|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56016578|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56016579|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016580|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
56016581|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016582|NCT01134575|Rituximab|rituximab|mesh-list
56016583|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56016584|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56016585|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016586|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
56016587|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016588|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56016589|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56016590|NCT01790672|Ethanol|ethanol|mesh-list
56016591|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56016592|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016593|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016594|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016595|NCT00223262|Lamotrigine|lamotrigine|mesh-list
56016596|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
56016597|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56016625|NCT00290810|Growth Substances|growth substances|mesh-ancestor
56016626|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016627|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
56016628|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
56016630|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56016632|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56621299|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56621300|NCT00841789|Analgesics|analgesics|mesh-ancestor
56621301|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
56621302|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621303|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621304|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621305|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621306|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621307|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56621308|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
56621309|NCT00841945|Prednisone|prednisone|mesh-list
56621310|NCT00841945|Rituximab|rituximab|mesh-list
56621311|NCT00841945|Doxorubicin|doxorubicin|mesh-list
56621312|NCT00841945|Vincristine|vincristine|mesh-list
56621313|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56621314|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621315|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
56621316|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621317|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621318|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56621319|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56621320|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56621321|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621322|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621323|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621324|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
56016633|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016634|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
56016636|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56016637|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016638|NCT01138475|Vitamins|vitamins|mesh-ancestor
56016639|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
56016665|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56016666|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
56016667|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56016668|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56188959|NCT01447212|Hydromorphone|hydromorphone|mesh-list
56188960|NCT01447212|Heroin|heroin|mesh-list
56188961|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56188962|NCT01447212|Narcotics|narcotics|mesh-ancestor
56188963|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56188964|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188965|NCT01447212|Analgesics|analgesics|mesh-ancestor
56188966|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
56188967|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188968|NCT01447355|Vitamin D|vitamin d|mesh-list
56188969|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
56188970|NCT01447355|Vitamins|vitamins|mesh-ancestor
56188971|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
56188972|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188973|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56621325|NCT00841945|Hormones|hormones|mesh-ancestor
56621326|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56369854|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
56621327|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56621328|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56621329|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
56621330|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
56621331|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
56621332|NCT02822196|Lidocaine|lidocaine|mesh-list
56621333|NCT02822196|Bupivacaine|bupivacaine|mesh-list
56621334|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621335|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
56621336|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621337|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621338|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
56621339|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621340|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56621341|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56621342|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56621343|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56621344|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621345|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
56188974|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56188976|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56188977|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016669|NCT00294632|Rituximab|rituximab|mesh-list
56016670|NCT00294632|Lenalidomide|lenalidomide|mesh-list
56016671|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56016672|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016673|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
56016674|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016675|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56016676|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56016677|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56016678|NCT00294632|Growth Substances|growth substances|mesh-ancestor
56016679|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
56016680|NCT04513145|Ropivacaine|ropivacaine|mesh-list
56016681|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
56016682|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
56016683|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016684|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016685|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
56016686|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016687|NCT01898624|Mirabegron|mirabegron|mesh-list
56016688|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56016725|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016746|NCT01167569|Protective Agents|protective agents|mesh-ancestor
56016747|NCT00296192|Rotigotine|rotigotine|mesh-list
56016748|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
56016749|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
56621346|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56621347|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621348|NCT00829179|Omalizumab|omalizumab|mesh-list
56621349|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56016750|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016751|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016752|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016753|NCT04312139|Lincomycin|lincomycin|mesh-list
56016754|NCT04312139|Calcium|calcium|mesh-list
56016755|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56016756|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016757|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56016758|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016759|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56016760|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016761|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016762|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
56016763|NCT00297596|Trastuzumab|trastuzumab|mesh-list
56016764|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188978|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56188980|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56188981|NCT01447394|Interferons|interferons|mesh-list
56188982|NCT01447394|Ribavirin|ribavirin|mesh-list
56188983|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
56188984|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
56188985|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56188986|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188987|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
56188988|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56188989|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
56188990|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188991|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
56016765|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56016766|NCT00298610|Artesunate|artesunate|mesh-list
56016767|NCT00298610|Atovaquone|atovaquone|mesh-list
56016768|NCT00298610|Proguanil|proguanil|mesh-list
56016769|NCT00298610|Quinidine|quinidine|mesh-list
56016770|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56016771|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
56016772|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56016773|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56016774|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016775|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016776|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
56016777|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
56016778|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56016779|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
56016780|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930012|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56016813|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016815|NCT00215930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016816|NCT00215930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016817|NCT00215930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016818|NCT00215930|Immunologic Factors|immunologic factors|mesh-ancestor
56016819|NCT00215930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016845|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
56016846|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016847|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
56016848|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
56016849|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56016850|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56016851|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016852|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016853|NCT01169519|Urological Agents|urological agents|mesh-ancestor
56016854|NCT04071977|Antioxidants|antioxidants|mesh-list
56016855|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016856|NCT04071977|Protective Agents|protective agents|mesh-ancestor
56016857|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016859|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56016860|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016861|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621350|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56621351|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
56621352|NCT00849355|Rituximab|rituximab|mesh-list
56621353|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56621354|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621355|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
56621356|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621357|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621358|NCT00835393|Pantoprazole|pantoprazole|mesh-list
56621359|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56621360|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621361|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56621362|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621363|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621364|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
56621365|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621366|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56621367|NCT02822742|Latanoprost|latanoprost|mesh-list
56621368|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56621369|NCT00835471|Docetaxel|docetaxel|mesh-list
56016862|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56016863|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56016864|NCT01170533|Omeprazole|omeprazole|mesh-list
56016865|NCT01170533|Pantoprazole|pantoprazole|mesh-list
56016866|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56016867|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56016889|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56016890|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56016891|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
56016892|NCT01149785|Ketoconazole|ketoconazole|mesh-list
56188992|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188994|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56188995|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56188996|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56188997|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188998|NCT01447550|Bosentan|bosentan|mesh-list
56188999|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56189000|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56189001|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189002|NCT01447563|Clopidogrel|clopidogrel|mesh-list
56016893|NCT01149785|Crizotinib|crizotinib|mesh-list
56016894|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
56016895|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016896|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56016897|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56016898|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016899|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016900|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56016901|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
56016902|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016903|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016904|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56016905|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016906|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55803354|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
56621370|NCT00835471|Pemetrexed|pemetrexed|mesh-list
56621371|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56621372|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621373|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
56621374|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
56621375|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
56621376|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621377|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621378|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56621379|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56621380|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56621381|NCT00849511|Melatonin|melatonin|mesh-list
56621382|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
56621383|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621384|NCT00849511|Protective Agents|protective agents|mesh-ancestor
56621385|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016907|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56016908|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016909|NCT03011567|Acetaminophen|acetaminophen|mesh-list
56016910|NCT03011567|Ibuprofen|ibuprofen|mesh-list
56016911|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56016912|NCT03011567|Analgesics|analgesics|mesh-ancestor
56016913|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
56016914|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016915|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016916|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
56016917|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56016918|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56016954|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
56016955|NCT03835949|Atezolizumab|atezolizumab|mesh-list
56016956|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016957|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
56016979|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016980|NCT01152515|Remifentanil|remifentanil|mesh-list
56016981|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56016982|NCT01152515|Narcotics|narcotics|mesh-ancestor
56016983|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016984|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016985|NCT01152515|Analgesics|analgesics|mesh-ancestor
56016986|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
56016987|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016988|NCT03011177|Linagliptin|linagliptin|mesh-list
56016989|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55744192|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56016990|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016991|NCT03011177|Incretins|incretins|mesh-ancestor
56016992|NCT03011177|Hormones|hormones|mesh-ancestor
56016993|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016994|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56016995|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
56016996|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016997|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016998|NCT03465527|Prednisolone|prednisolone|mesh-list
56189003|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56189004|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56189005|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56189006|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56189007|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
56189008|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621386|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621387|NCT02546791|Dasatinib|dasatinib|mesh-list
56621388|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621389|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56621390|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622953|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
56189009|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189010|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189011|NCT01447589|Nelfinavir|nelfinavir|mesh-list
56189012|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56189013|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56189014|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
56189015|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189016|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189017|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56189018|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56189019|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
56189020|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189021|NCT01447654|Losartan|losartan|mesh-list
56189022|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56189023|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56189024|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56189025|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56189026|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016999|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017020|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56017021|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56017022|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56017023|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56017024|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
56017025|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017026|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017027|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017029|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56017030|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
56017031|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017032|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017033|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56017034|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
56189027|NCT01447797|Irbesartan|irbesartan|mesh-list
56189028|NCT01447797|Atorvastatin|atorvastatin|mesh-list
56189029|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56189030|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56189031|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
56189032|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189033|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56189034|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56189035|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189036|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56189037|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56017035|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56017036|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
56017037|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017038|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017039|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56017040|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
56017041|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
56017042|NCT01220687|Protective Agents|protective agents|mesh-ancestor
56017043|NCT03010865|Butyric Acid|butyric acid|mesh-list
56017044|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
56017045|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
56017046|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017047|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017048|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017049|NCT01157429|Cycloserine|cycloserine|mesh-list
56017050|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56621391|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621392|NCT00966875|Ixekizumab|ixekizumab|mesh-list
56621393|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621394|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
56621395|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56621396|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621397|NCT00835627|Sertraline|sertraline|mesh-list
56621398|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
56621399|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56621400|NCT00835627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56369935|NCT00127998|Artesunate|artesunate|mesh-list
56621401|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56621402|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622954|NCT00812955|Simvastatin|simvastatin|mesh-list
56017051|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017052|NCT01157429|Renal Agents|renal agents|mesh-ancestor
56017053|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56017054|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
56017055|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56017056|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
56017057|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017058|NCT00234884|Adalimumab|adalimumab|mesh-list
56017059|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189038|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56189040|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56189041|NCT01447875|Propofol|propofol|mesh-list
56189042|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56116802|NCT04545515|Ivacaftor|ivacaftor|mesh-list
56189043|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189044|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189045|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56189046|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
56189047|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
56189048|NCT01447979|Pancrelipase|pancrelipase|mesh-list
56189049|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56189050|NCT01447992|Pancrelipase|pancrelipase|mesh-list
56189051|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56017060|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017061|NCT04388774|Ketamine|ketamine|mesh-list
56017062|NCT04388774|Analgesics|analgesics|mesh-ancestor
56017063|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
56017064|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017065|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930014|NCT01721733|Ubiquinone|ubiquinone|mesh-list
56017102|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017115|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017116|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56017117|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56017118|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017119|NCT05439876|Melatonin|melatonin|mesh-list
56017120|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
56017121|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017122|NCT05439876|Protective Agents|protective agents|mesh-ancestor
56017123|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017124|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017125|NCT00301028|Paclitaxel|paclitaxel|mesh-list
56017126|NCT00301028|Carboplatin|carboplatin|mesh-list
56017127|NCT00301028|Cetuximab|cetuximab|mesh-list
56017128|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56017129|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017130|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56017131|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56621403|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017132|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56017133|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017134|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56017135|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56017136|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744345|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
56017137|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56017138|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017139|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017140|NCT05414838|Vitamin D|vitamin d|mesh-list
56017141|NCT05414838|Curcumin|curcumin|mesh-list
56017142|NCT05414838|Vitamins|vitamins|mesh-ancestor
56017143|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
56017144|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017145|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56017146|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56017147|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017148|NCT05414838|Analgesics|analgesics|mesh-ancestor
56017149|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
56017150|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017151|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017152|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189054|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56189055|NCT01448018|Growth Substances|growth substances|mesh-ancestor
56189056|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189057|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
56189058|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189059|NCT01448031|Esomeprazole|esomeprazole|mesh-list
56189060|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56189061|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56189062|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56189063|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189064|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189065|NCT01448070|Insulin|insulin|mesh-list
56189066|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56189067|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189068|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017153|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017154|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017157|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017158|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017159|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
56017160|NCT05014230|Narcotics|narcotics|mesh-ancestor
56017161|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017162|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017163|NCT05014230|Analgesics|analgesics|mesh-ancestor
56017164|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
56017196|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
56017197|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017198|NCT00239642|Hematinics|hematinics|mesh-ancestor
56017199|NCT01351896|Lenalidomide|lenalidomide|mesh-list
56017200|NCT01351896|Vaccines|vaccines|mesh-list
56017201|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56017202|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
56017203|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017204|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56017205|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56017206|NCT01351896|Growth Substances|growth substances|mesh-ancestor
56017207|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56017208|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017238|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56017239|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
56017240|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017241|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56017242|NCT00241904|Protective Agents|protective agents|mesh-ancestor
56017243|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
56017244|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56017245|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017246|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017247|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017248|NCT01791296|Analgesics|analgesics|mesh-ancestor
56017249|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
56621404|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621405|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
56621406|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621407|NCT00842491|Cisplatin|cisplatin|mesh-list
56621408|NCT00842491|Capecitabine|capecitabine|mesh-list
56621409|NCT00842491|Endostar protein|endostar protein|mesh-list
56621410|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017250|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189069|NCT01448096|Rituximab|rituximab|mesh-list
56189070|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56189071|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189072|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
56017251|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56017252|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56017253|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56017254|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
56017255|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930015|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
56017293|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
56017343|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017344|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017345|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017346|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56017347|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
56017348|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56017349|NCT05266820|Thalidomide|thalidomide|mesh-list
56017350|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56017351|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
56017352|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017353|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
56017354|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56017355|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017356|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56017357|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56017358|NCT05266820|Growth Substances|growth substances|mesh-ancestor
56017359|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
56017360|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017361|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
56017362|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
56017363|NCT01454791|Diclofenac|diclofenac|mesh-list
56017364|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56017365|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017366|NCT01454791|Analgesics|analgesics|mesh-ancestor
56017367|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
56017368|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017370|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017371|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017372|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56017373|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017374|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017375|NCT02099006|Ketoprofen|ketoprofen|mesh-list
56017376|NCT02099006|Ketamine|ketamine|mesh-list
56017377|NCT02099006|Gabapentin|gabapentin|mesh-list
56017378|NCT02099006|Amitriptyline|amitriptyline|mesh-list
56017379|NCT02099006|Baclofen|baclofen|mesh-list
56017380|NCT02099006|Loperamide|loperamide|mesh-list
56017381|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
56017382|NCT02099006|Analgesics|analgesics|mesh-ancestor
56017383|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
56017384|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017385|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017386|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56017387|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56017388|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
56017389|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
56017390|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017391|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56017405|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56017407|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017408|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621411|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56621412|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
56622955|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56017409|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56017410|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017411|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56017412|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
56017413|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56017414|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56017415|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56017416|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
56017417|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56189073|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189074|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189075|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
56017418|NCT05266274|Azacitidine|azacitidine|mesh-list
56017419|NCT05266274|Antibodies|antibodies|mesh-list
56017420|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56017421|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
56017422|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017423|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56017424|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
56017425|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017426|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017427|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017428|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
56017429|NCT05266196|Topotecan|topotecan|mesh-list
56017430|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56017431|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
56017432|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017433|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017434|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56017435|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
56017436|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017437|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017438|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56017439|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56017440|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56017442|NCT05265962|Decitabine|decitabine|mesh-list
56017443|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56017444|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
56017445|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017446|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017447|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017448|NCT00324896|Eszopiclone|eszopiclone|mesh-list
56017449|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56017450|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017451|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017452|NCT01479517|Tetracaine|tetracaine|mesh-list
56017453|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
56017475|NCT01480297|Analgesics|analgesics|mesh-ancestor
56017476|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
56017478|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017479|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017480|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017481|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56017482|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017483|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017484|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
56017485|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56017486|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017487|NCT01392703|Dasatinib|dasatinib|mesh-list
56017488|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017489|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56017490|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017491|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017492|NCT01392859|Levocetirizine|levocetirizine|mesh-list
56017493|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56017494|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56017495|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
56017496|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
56017497|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621413|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621414|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56621415|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56621416|NCT00842491|Growth Substances|growth substances|mesh-ancestor
56621417|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621418|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
56621419|NCT05659212|Lidocaine|lidocaine|mesh-list
56621420|NCT05659212|Magnesium Sulfate|magnesium sulfate|mesh-list
56621421|NCT05659212|Dexmedetomidine|dexmedetomidine|mesh-list
56621422|NCT05659212|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621423|NCT05659212|Anesthetics|anesthetics|mesh-ancestor
56621424|NCT05659212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621425|NCT05659212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621426|NCT05659212|Sensory System Agents|sensory system agents|mesh-ancestor
56621427|NCT05659212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621428|NCT05659212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56621429|NCT05659212|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56621430|NCT05659212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56621431|NCT05659212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56017498|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017499|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017500|NCT01457521|Ibuprofen|ibuprofen|mesh-list
56017501|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56017502|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017557|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56017558|NCT01482091|Narcotics|narcotics|mesh-ancestor
56017559|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017560|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189076|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56189077|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017600|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
56017601|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017627|NCT05075330|Narcotics|narcotics|mesh-ancestor
56017628|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017629|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017630|NCT05075330|Analgesics|analgesics|mesh-ancestor
56017631|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
56017632|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017633|NCT02108288|Carteolol|carteolol|mesh-list
56017634|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56017635|NCT02108288|Latanoprost|latanoprost|mesh-list
56017636|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56017637|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56017638|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56017639|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
56017640|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017641|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017642|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017643|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56017644|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56017645|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
56017646|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
56017647|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621432|NCT05659212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621433|NCT05659212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56621434|NCT05659212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56621435|NCT05659212|Analgesics|analgesics|mesh-ancestor
56621436|NCT05659212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56004419|NCT05593757|Antimalarials|antimalarials|mesh-ancestor
56017713|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56017714|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
56017715|NCT01183559|Paclitaxel|paclitaxel|mesh-list
56017716|NCT01183559|Carboplatin|carboplatin|mesh-list
56017717|NCT01183559|Fluorouracil|fluorouracil|mesh-list
56017718|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56017719|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017720|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
56017721|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
56017722|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
56017723|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017724|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
56017725|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56017726|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56017727|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
56017728|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017729|NCT01184417|Phenobarbital|phenobarbital|mesh-list
56017765|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56017766|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56017768|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
56017769|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
56017770|NCT01222091|Propranolol|propranolol|mesh-list
56017797|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
56017798|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56017799|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56017800|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017801|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017802|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56017803|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56017804|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
56017805|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017806|NCT01336140|Protective Agents|protective agents|mesh-ancestor
56017807|NCT01184885|Sirolimus|sirolimus|mesh-list
56017808|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
56017809|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56017810|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017811|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017812|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56017813|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017814|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
56017815|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56017816|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
56017844|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56017845|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
56017846|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56017848|NCT01189409|Laxatives|laxatives|mesh-ancestor
56189078|NCT01448174|Atorvastatin|atorvastatin|mesh-list
56189079|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56189080|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56189081|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
56189082|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189083|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56189084|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56189085|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189086|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56189087|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
56189088|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189089|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56189090|NCT01448291|Etonogestrel|etonogestrel|mesh-list
56189091|NCT01448291|NuvaRing|nuvaring|mesh-list
56189092|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
56189093|NCT01448291|Estradiol|estradiol|mesh-list
56189094|NCT01448291|Estrogens|estrogens|mesh-ancestor
56189095|NCT01448291|Hormones|hormones|mesh-ancestor
56621437|NCT05659212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56621438|NCT05659212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56621439|NCT05659212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56621440|NCT05659212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621441|NCT05659212|Anticonvulsants|anticonvulsants|mesh-ancestor
56621442|NCT05659212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56621443|NCT05659212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56621444|NCT05659212|Tocolytic Agents|tocolytic agents|mesh-ancestor
56621445|NCT05659212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56621446|NCT00835939|Lidocaine|lidocaine|mesh-list
56621447|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621448|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
56621449|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621450|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621451|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
56621452|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621453|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56621454|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56621455|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56621456|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56189096|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56189097|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189098|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56189099|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56189100|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56189101|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56189102|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56189103|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56189104|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56017849|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56017850|NCT03010475|Furosemide|furosemide|mesh-list
56017851|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56017852|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56017853|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56017854|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
56017855|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017856|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56017857|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56017858|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017859|NCT03010475|Diuretics|diuretics|mesh-ancestor
56017860|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
56017861|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017862|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56017863|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56017864|NCT02191865|Nintedanib|nintedanib|mesh-list
56017894|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017895|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56017898|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56189106|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189107|NCT01448330|Aspirin|aspirin|mesh-list
56189108|NCT01448330|Clopidogrel|clopidogrel|mesh-list
55803557|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
56621457|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621458|NCT05659368|Tirzepatide|tirzepatide|mesh-list
56621459|NCT05659368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56621460|NCT05659368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621461|NCT05659368|Incretins|incretins|mesh-ancestor
56621462|NCT05659368|Hormones|hormones|mesh-ancestor
56621463|NCT05659368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56621464|NCT00818649|Bortezomib|bortezomib|mesh-list
56621465|NCT00818649|Vorinostat|vorinostat|mesh-list
56621466|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621467|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56621468|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622956|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56189109|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56189110|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56189111|NCT01448330|Analgesics|analgesics|mesh-ancestor
56189112|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
56189113|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189114|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189115|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189116|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189117|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56189118|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56116886|NCT04882241|Leucovorin|leucovorin|mesh-list
56017899|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56017900|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017901|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56017902|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56017903|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
56017904|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017905|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017906|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
56017907|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
56017908|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56017943|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56017944|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017945|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017946|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56017947|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56017949|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56017950|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
56017966|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017967|NCT00349388|Analgesics|analgesics|mesh-ancestor
56017968|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
56017969|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017970|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017971|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017972|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017973|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
56017974|NCT00349778|Melphalan|melphalan|mesh-list
56017975|NCT00349778|Carmustine|carmustine|mesh-list
56017976|NCT00349778|Etoposide|etoposide|mesh-list
56017977|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
56017978|NCT00349778|Lenograstim|lenograstim|mesh-list
56017979|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56017980|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
56017981|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017982|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017983|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56017984|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
56017985|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017986|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017987|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56621469|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621470|NCT05312385|Propofol|propofol|mesh-list
56621471|NCT05312385|Isoflurane|isoflurane|mesh-list
56621472|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56621473|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621474|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621475|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56621476|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
56621478|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56621479|NCT02861105|Enoxaparin|enoxaparin|mesh-list
56017988|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56017989|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56017990|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56017991|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189119|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189120|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56189121|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56189122|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189124|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56189125|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56189126|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56017992|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56017993|NCT00305084|Doxorubicin|doxorubicin|mesh-list
56017994|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56017995|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017996|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56017999|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018000|NCT00305162|Clopidogrel|clopidogrel|mesh-list
56018002|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56018003|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56018004|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56018005|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56018006|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
56018007|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018008|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018009|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018010|NCT00351416|Letrozole|letrozole|mesh-list
56018042|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56018043|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
56018044|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018045|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018046|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56018047|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56018048|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56018049|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
56018050|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56018051|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018071|NCT00310076|Thalidomide|thalidomide|mesh-list
56018072|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018073|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
56018074|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018075|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
56018076|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56018077|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018078|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56018079|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56018080|NCT00310076|Growth Substances|growth substances|mesh-ancestor
56018081|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
56018082|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018084|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56018085|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
56018086|NCT00353834|Exenatide|exenatide|mesh-list
56018087|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56621480|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56621481|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
56621482|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56621483|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56621484|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621485|NCT02820558|Substance P|substance p|mesh-list
56621486|NCT02820558|Neurokinin A|neurokinin a|mesh-list
56018088|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018089|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56018090|NCT00353834|Incretins|incretins|mesh-ancestor
56018091|NCT00353834|Hormones|hormones|mesh-ancestor
56018092|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56018093|NCT05344404|Niacinamide|niacinamide|mesh-list
56018095|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
56018096|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
56018097|NCT05344404|Vitamins|vitamins|mesh-ancestor
56018098|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
56018099|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018100|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56018101|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
56189127|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
56189128|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189129|NCT01448395|Avibactam|avibactam|mesh-list
56189130|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56189131|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189132|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189133|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189134|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189135|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
56189136|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56189137|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56189138|NCT01448499|Clozapine|clozapine|mesh-list
56189139|NCT01448499|Amisulpride|amisulpride|mesh-list
56189140|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56018102|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018103|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56018104|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
56018105|NCT00354224|Capecitabine|capecitabine|mesh-list
56018106|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
56018107|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56018108|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
56018143|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56018144|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
56018145|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56018146|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56018182|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018183|NCT01792700|Amoxicillin|amoxicillin|mesh-list
56018184|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
56018185|NCT01792700|Metronidazole|metronidazole|mesh-list
56018186|NCT01792700|Tetracycline|tetracycline|mesh-list
56018187|NCT01792700|Esomeprazole|esomeprazole|mesh-list
56018206|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018207|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018208|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56018209|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
56018210|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
56018211|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
56018212|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56018213|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56018214|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
56018215|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018216|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018217|NCT00316862|Irinotecan|irinotecan|mesh-list
56018218|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018219|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56018220|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56018221|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018222|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018223|NCT00317720|Trastuzumab|trastuzumab|mesh-list
56018224|NCT00317720|Everolimus|everolimus|mesh-list
56621487|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621488|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621489|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621490|NCT00961571|Capecitabine|capecitabine|mesh-list
56621491|NCT00961571|Sunitinib|sunitinib|mesh-list
56621492|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56621493|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
56621494|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621495|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621496|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56621497|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56621498|NCT00961571|Growth Substances|growth substances|mesh-ancestor
56621499|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621500|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
56621501|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56621502|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621503|NCT02820948|Vitamins|vitamins|mesh-list
56621504|NCT02820948|Vitamin E|vitamin e|mesh-list
56621505|NCT02820948|Tocopherols|tocopherols|mesh-list
56621506|NCT02820948|Tocotrienols|tocotrienols|mesh-list
56018225|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56018226|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018227|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018228|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
56018229|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018230|NCT00357032|Belinostat|belinostat|mesh-list
56018231|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018232|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56018233|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018234|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018235|NCT00357734|Gefitinib|gefitinib|mesh-list
56018236|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189141|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
56189142|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189143|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189144|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189145|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56189146|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56189147|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189148|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56189149|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
56189150|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
56189151|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56189152|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
56189153|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56189154|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
56189155|NCT01448642|Atorvastatin|atorvastatin|mesh-list
56189156|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56189157|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56189158|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
56189159|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189160|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56189161|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56189162|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621507|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
56621508|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
56621509|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621510|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
56621511|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621512|NCT02820948|Protective Agents|protective agents|mesh-ancestor
56621513|NCT02860949|Ketorolac|ketorolac|mesh-list
56621514|NCT02860949|Epinephrine|epinephrine|mesh-list
56621515|NCT02860949|Morphine|morphine|mesh-list
56621516|NCT02860949|Bupivacaine|bupivacaine|mesh-list
56621517|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621518|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
56621519|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621520|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621521|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
56621522|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621523|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56621524|NCT02860949|Narcotics|narcotics|mesh-ancestor
56621525|NCT02860949|Analgesics|analgesics|mesh-ancestor
56018237|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56018238|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018239|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018240|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
56018241|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
56018242|NCT04259060|Hematinics|hematinics|mesh-ancestor
56018243|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
56018273|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
56018274|NCT00980460|Liver Extracts|liver extracts|mesh-list
56018275|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018276|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56018277|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56018278|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56018279|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018280|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018281|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
56018282|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56018283|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018284|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
56018285|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018286|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56018287|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56018288|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
56018289|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
56018290|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
56018291|NCT00980460|Hematinics|hematinics|mesh-ancestor
56018292|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56018293|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018294|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
56018295|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56189164|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56189165|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56189166|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189167|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189168|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56189169|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56189170|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56189171|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
56189172|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621526|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56621527|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56621528|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
56621529|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621530|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621531|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56621532|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56621533|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
56621534|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56621535|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
56621536|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
56621537|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
56621538|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56621539|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56621540|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56621541|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621542|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621543|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56004511|NCT01924052|Calcitonin|calcitonin|mesh-list
56189173|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189174|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56189175|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56189176|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
56189177|NCT01448733|Clindamycin|clindamycin|mesh-list
56189178|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
56189179|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
56189180|NCT01448733|Tretinoin|tretinoin|mesh-list
56189181|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56189182|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189183|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189184|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56189185|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189186|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189187|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
56189188|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189189|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
56189190|NCT01448746|Heparin|heparin|mesh-list
56189191|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56189192|NCT01448746|Tinzaparin|tinzaparin|mesh-list
56189193|NCT01448746|Dalteparin|dalteparin|mesh-list
56189194|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
56189195|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56189196|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56189197|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189198|NCT01448772|Dronabinol|dronabinol|mesh-list
56018296|NCT00980460|Protective Agents|protective agents|mesh-ancestor
56018297|NCT00362882|Docetaxel|docetaxel|mesh-list
56018298|NCT00362882|Bortezomib|bortezomib|mesh-list
56018299|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018336|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
56189199|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
56189200|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189201|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56189202|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56018337|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018369|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
56018370|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56621544|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621545|NCT03248063|Cefazolin|cefazolin|mesh-list
56621546|NCT03248063|Cloxacillin|cloxacillin|mesh-list
56621547|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56621548|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621549|NCT00964223|Clindamycin|clindamycin|mesh-list
56621550|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
56621551|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
56621552|NCT00964223|Adapalene|adapalene|mesh-list
56621553|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56621554|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56621556|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621557|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56621558|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621559|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621560|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621561|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56621562|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56621563|NCT00964223|Analgesics|analgesics|mesh-ancestor
56621564|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
56621565|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621566|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621567|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621568|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621569|NCT05659056|Trastuzumab|trastuzumab|mesh-list
56621570|NCT05659056|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56621571|NCT05659056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56621572|NCT05659056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621573|NCT00620815|Vaccines|vaccines|mesh-list
56621574|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56621575|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
56622957|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
56018371|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
56018372|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018373|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
56018374|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018375|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56018376|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56018377|NCT03561584|Analgesics|analgesics|mesh-ancestor
56018378|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
56018379|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018380|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018381|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56018382|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621576|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621577|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56621578|NCT04238988|Paclitaxel|paclitaxel|mesh-list
56621579|NCT04238988|Carboplatin|carboplatin|mesh-list
56621580|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
56621581|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56621582|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621583|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
56621584|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
56621585|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
56621586|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621587|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56621588|NCT04284215|Paclitaxel|paclitaxel|mesh-list
56621589|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56018406|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018407|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
56018408|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018409|NCT03932136|Sulforaphane|sulforaphane|mesh-list
56018410|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56018411|NCT03932136|Protective Agents|protective agents|mesh-ancestor
56018412|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018413|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018414|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56018415|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56018416|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018417|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56018418|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55745637|NCT02474953|Curcumin|curcumin|mesh-list
56018419|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
56018420|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018421|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018422|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56018423|NCT00390182|Gemcitabine|gemcitabine|mesh-list
56018424|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56018425|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
56018426|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018427|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018428|NCT00390182|Antiviral Agents|antiviral agents|mesh-ancestor
56018429|NCT00390182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018430|NCT00390182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018431|NCT00390182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018432|NCT00390182|Immunologic Factors|immunologic factors|mesh-ancestor
56018433|NCT00390182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018434|NCT05366868|Metformin|metformin|mesh-list
56018449|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018450|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56018451|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
56018452|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56018453|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56018454|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56018455|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
56018456|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018457|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
56018458|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018459|NCT05329428|Vitamin D|vitamin d|mesh-list
56018460|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
56018461|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
56018462|NCT05329428|Vitamins|vitamins|mesh-list
56018463|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
56018464|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739296|NCT04452383|Ketamine|ketamine|mesh-list
56018465|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56621590|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56621591|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621592|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
56621593|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
56621594|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
56621595|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621596|NCT02816970|Vildagliptin|vildagliptin|mesh-list
56621597|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56621598|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621599|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56621600|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
56621601|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621602|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621603|NCT03372941|Dalbavancin|dalbavancin|mesh-list
56621604|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56621605|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621606|NCT04238832|Nicotine|nicotine|mesh-list
56621607|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56621608|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
56621609|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621610|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621611|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56621612|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56621613|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
56621614|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621615|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621616|NCT04622904|Lidocaine|lidocaine|mesh-list
56621617|NCT04622904|Ketamine|ketamine|mesh-list
56621618|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621619|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
56621620|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621621|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621622|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
56621623|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621628|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621629|NCT04622904|Analgesics|analgesics|mesh-ancestor
56621630|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56621631|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56621632|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
56621633|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56621634|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56621635|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621636|NCT00634062|Lamotrigine|lamotrigine|mesh-list
56621637|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
56621638|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56621639|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56018466|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56018467|NCT01794572|Melphalan|melphalan|mesh-list
56018468|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56018469|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
56189203|NCT01448772|Analgesics|analgesics|mesh-ancestor
56189204|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
56189205|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189206|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56018470|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018471|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018472|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56018473|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018474|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
56018475|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018476|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
56018478|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56018479|NCT05385432|Basiliximab|basiliximab|mesh-list
56018480|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56018481|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
56018482|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
56018483|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018484|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56018485|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018486|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018487|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56018488|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018489|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56018490|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
56018491|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56018492|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018493|NCT00392444|Sunitinib|sunitinib|mesh-list
56018525|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018526|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56018528|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56018529|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56018530|NCT00392678|Analgesics|analgesics|mesh-ancestor
56018531|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
56018532|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018533|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018534|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56018535|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56018536|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56018537|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018558|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56018560|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018561|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018562|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56018563|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56621640|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621641|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56621642|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621643|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56018564|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56018565|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56018566|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56018567|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018568|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56018569|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
56018570|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56018571|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56018572|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
56018573|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
56018574|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56018575|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56018576|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56018577|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
56018578|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018579|NCT00392834|Antidotes|antidotes|mesh-ancestor
56018580|NCT00392834|Protective Agents|protective agents|mesh-ancestor
56018581|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
56018582|NCT00392834|Vitamins|vitamins|mesh-ancestor
56018583|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
56018584|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
56018585|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
56018586|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
56018587|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56018588|NCT05363670|Albuterol|albuterol|mesh-list
56189207|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56189208|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189209|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189211|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56189212|NCT01448798|Thrombin|thrombin|mesh-list
56189213|NCT01448798|Hemostatics|hemostatics|mesh-list
56189214|NCT01448798|Coagulants|coagulants|mesh-ancestor
56189215|NCT01448837|Timolol|timolol|mesh-list
56189216|NCT01448837|Bimatoprost|bimatoprost|mesh-list
56189217|NCT01448837|Latanoprost|latanoprost|mesh-list
56189218|NCT01448837|Cloprostenol|cloprostenol|mesh-list
56189219|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56189220|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56189221|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
56189222|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189223|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189224|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189225|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56189226|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56189227|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56189228|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56189229|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
56189230|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56189231|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
56189232|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56189233|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56189234|NCT01448993|Azithromycin|azithromycin|mesh-list
56189235|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189236|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189237|NCT01449045|Lumefantrine|lumefantrine|mesh-list
56189238|NCT01449045|Artemether|artemether|mesh-list
56189239|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56189240|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
56189241|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56189242|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56189243|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189244|NCT01449110|Resveratrol|resveratrol|mesh-list
56189246|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189247|NCT01449110|Protective Agents|protective agents|mesh-ancestor
56189248|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189249|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621644|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56621645|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621646|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56621647|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56621648|NCT00634140|Ezetimibe|ezetimibe|mesh-list
56621649|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56621650|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56621651|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
56621652|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621653|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56621654|NCT02819544|Ropivacaine|ropivacaine|mesh-list
56621655|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621656|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
56621657|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621658|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621659|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
56621660|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621661|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
56189250|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56018589|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56018590|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
56018591|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018592|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018593|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56018594|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
56018595|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
56018616|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018618|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018619|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56018620|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56018621|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56018622|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56018623|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018624|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56018625|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56018626|NCT05361642|Analgesics|analgesics|mesh-ancestor
56018627|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55739337|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018628|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56018629|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56018630|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
56018631|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018632|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
56018633|NCT05358522|Narcotics|narcotics|mesh-ancestor
56018634|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56018635|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018636|NCT05358522|Analgesics|analgesics|mesh-ancestor
56018637|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
56018638|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018639|NCT00395876|Tenecteplase|tenecteplase|mesh-list
56018640|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56018641|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56018642|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018643|NCT05287256|Dronabinol|dronabinol|mesh-list
56018644|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
56018645|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621662|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56621663|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621664|NCT02818140|Ropivacaine|ropivacaine|mesh-list
56621665|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621666|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
56621667|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56004641|NCT01444040|Travoprost|travoprost|mesh-list
56018646|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56018656|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56018657|NCT02662634|Paclitaxel|paclitaxel|mesh-list
56018658|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56018659|NCT02662634|Cisplatin|cisplatin|mesh-list
56018660|NCT02662634|Carboplatin|carboplatin|mesh-list
56018661|NCT02662634|Pemetrexed|pemetrexed|mesh-list
56018662|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56018663|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018664|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
56018665|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
56018666|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
56018667|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018668|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018669|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56018670|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56018671|NCT00396032|Tenecteplase|tenecteplase|mesh-list
56018672|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56018673|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56018674|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018675|NCT02277782|Fentanyl|fentanyl|mesh-list
56018676|NCT02277782|Hydromorphone|hydromorphone|mesh-list
56018677|NCT02277782|Bupivacaine|bupivacaine|mesh-list
56018678|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
56018680|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189252|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56189253|NCT01449123|Diuretics|diuretics|mesh-ancestor
56189254|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
56189255|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189256|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56189257|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189258|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
56189259|NCT01449188|Ondansetron|ondansetron|mesh-list
56189260|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189261|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189262|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56189263|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56189264|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189265|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189266|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018681|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018682|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
56018683|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018684|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56018685|NCT02277782|Narcotics|narcotics|mesh-ancestor
56018686|NCT02277782|Analgesics|analgesics|mesh-ancestor
56018687|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56018688|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56018689|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
56018690|NCT05287100|Midodrine|midodrine|mesh-list
56018691|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
56018692|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
56018693|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018694|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018695|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56018696|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56018697|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56018698|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56018699|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
56018700|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018701|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018702|NCT02271230|Vitamin D|vitamin d|mesh-list
56018703|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
56621668|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621669|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
56621670|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621671|NCT04238208|Lidocaine|lidocaine|mesh-list
56621672|NCT04238208|Capsaicin|capsaicin|mesh-list
56621673|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621674|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
56621675|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621676|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621677|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
56621678|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621679|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56621680|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56621681|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56621682|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56621683|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621684|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
56621685|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621686|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
56621687|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56018704|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
56018705|NCT02271230|Vitamins|vitamins|mesh-list
56018706|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
56018707|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018708|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56018709|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56018710|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
56018711|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56018712|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018733|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56018734|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018735|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
56018736|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018737|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018738|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56018739|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
56018740|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
56018741|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56018742|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56018743|NCT00396266|Plerixafor|plerixafor|mesh-list
56189267|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189268|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
56189269|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
56018744|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56018745|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56018746|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
56018747|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018748|NCT04271384|Nivolumab|nivolumab|mesh-list
56018749|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56018750|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018751|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56018752|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018753|NCT05610384|Ibuprofen|ibuprofen|mesh-list
56018754|NCT05610384|Ketorolac|ketorolac|mesh-list
56621688|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621689|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56621690|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56621691|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621692|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621693|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621694|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56621695|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56621696|NCT02815722|Simvastatin|simvastatin|mesh-list
56621697|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56621698|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56621699|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
56621700|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621701|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56621702|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56621703|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621704|NCT05655468|Dronedarone|dronedarone|mesh-list
56621705|NCT05655468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56621706|NCT02817750|Zolpidem|zolpidem|mesh-list
56621707|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56018763|NCT05610384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56018764|NCT05610384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018765|NCT05610384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018766|NCT03570632|Metformin|metformin|mesh-list
56018767|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56018768|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018769|NCT05352828|Nivolumab|nivolumab|mesh-list
56018770|NCT05352828|Fludarabine|fludarabine|mesh-list
56018807|NCT05314998|Irinotecan|irinotecan|mesh-list
56018808|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
56018809|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56018810|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
56018811|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018845|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
56018846|NCT01795430|Melphalan|melphalan|mesh-list
56018847|NCT01795430|Busulfan|busulfan|mesh-list
56018848|NCT01795430|Topotecan|topotecan|mesh-list
56018849|NCT01795430|Ifosfamide|ifosfamide|mesh-list
56018850|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56018851|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018852|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56018853|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56018854|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739365|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
56018855|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018886|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018887|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56018888|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56018890|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018891|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56018892|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
56018893|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
56018894|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
56018895|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56621708|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56621709|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621710|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621711|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56621712|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
56621713|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
56621714|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621715|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621716|NCT02815410|Levetiracetam|levetiracetam|mesh-list
56621717|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
56621718|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
56621719|NCT02814630|Omalizumab|omalizumab|mesh-list
56621720|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56621721|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56621722|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
56621723|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
56621724|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56621725|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56621726|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621727|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56621728|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621729|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56621730|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
56621731|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56621732|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56621733|NCT04519476|Prednisolone|prednisolone|mesh-list
56621734|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
56621735|NCT04519476|Lenalidomide|lenalidomide|mesh-list
56621736|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56621737|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
56621738|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
56621739|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621740|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56621749|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621750|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
56621751|NCT04519476|Hormones|hormones|mesh-ancestor
56159665|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
56621752|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56621753|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56621754|NCT04519476|Protective Agents|protective agents|mesh-ancestor
56621755|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56621757|NCT00961415|Pemetrexed|pemetrexed|mesh-list
56621758|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56621759|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621760|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56621761|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56621762|NCT00961415|Growth Substances|growth substances|mesh-ancestor
56621763|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621764|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
56621765|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621766|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621767|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56621768|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56621769|NCT00851227|Conivaptan|conivaptan|mesh-list
56621770|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56004726|NCT00002278|Diclazuril|diclazuril|mesh-list
56018896|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56018897|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56018898|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
55930016|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018928|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018930|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56018931|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56018932|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56018933|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56018934|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018935|NCT05305404|Dexamethasone|dexamethasone|mesh-list
56018936|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
56018937|NCT05305404|BB 1101|bb 1101|mesh-list
56018938|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56018939|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
56018940|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
56018941|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189270|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189271|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56189272|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
56189273|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
56189274|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56189275|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
56189276|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189277|NCT01449188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56189278|NCT01449188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56189283|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
56189284|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
56621771|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621772|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
56621773|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370303|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
56621774|NCT03365609|Bismuth|bismuth|mesh-list
56621775|NCT03365609|Antacids|antacids|mesh-ancestor
56621776|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621777|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621778|NCT05636904|Minoxidil|minoxidil|mesh-list
56621779|NCT05636904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56621780|NCT05636904|Dinoprost|dinoprost|mesh-list
56621781|NCT05636904|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
56621782|NCT05636904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56621783|NCT05636904|Vasodilator Agents|vasodilator agents|mesh-ancestor
56621784|NCT05636904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56621785|NCT05636904|Abortifacient Agents|abortifacient agents|mesh-ancestor
56621786|NCT05636904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56621787|NCT05636904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621788|NCT05636904|Oxytocics|oxytocics|mesh-ancestor
56621789|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56621790|NCT00836485|Ketotifen|ketotifen|mesh-list
56621791|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
56621792|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56621793|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56189285|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56189286|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56189287|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189288|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189289|NCT01449253|Urological Agents|urological agents|mesh-ancestor
56189290|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56189291|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56189292|NCT01449344|Cytarabine|cytarabine|mesh-list
56189293|NCT01449344|Dexamethasone|dexamethasone|mesh-list
56018942|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018943|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56018944|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
56018965|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56018966|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56018967|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
56018968|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
56018969|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56018970|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018971|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018972|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56018973|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56018974|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56018975|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56018976|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56018977|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56018978|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56621794|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56621795|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56621796|NCT00836485|Analgesics|analgesics|mesh-ancestor
56018979|NCT05268120|Renal Agents|renal agents|mesh-ancestor
56018980|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56018981|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56018982|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56018983|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56018984|NCT00405704|Trimethoprim|trimethoprim|mesh-list
56018985|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56018986|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
56189294|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
56189295|NCT01449344|Rituximab|rituximab|mesh-list
56189296|NCT01449344|Bortezomib|bortezomib|mesh-list
56189297|NCT01449344|BB 1101|bb 1101|mesh-list
56189298|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56189299|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189300|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
56189301|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189302|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56019005|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019006|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019007|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56019008|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56019009|NCT00375830|Diphosphonates|diphosphonates|mesh-list
56019010|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
56019011|NCT00375830|Listerine|listerine|mesh-list
56019012|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
56019013|NCT00375830|Fluorides|fluorides|mesh-list
56019014|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
56019015|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56019016|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
56019017|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
56019018|NCT00375830|Protective Agents|protective agents|mesh-ancestor
56019019|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019020|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56019021|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019022|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56019023|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019024|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
56019025|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
56019026|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56019032|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019033|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019034|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56019035|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
56019037|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56019038|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56019039|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019040|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
56019041|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
56019042|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019043|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
56019044|NCT05265546|Psilocybin|psilocybin|mesh-list
56019077|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019078|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56019079|NCT05300802|Analgesics|analgesics|mesh-ancestor
56019080|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
56019081|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019082|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56019083|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56019084|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56019085|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
56019086|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930017|NCT01720485|Prednisolone|prednisolone|mesh-list
56019109|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
56019110|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56019111|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56019112|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56019113|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019114|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019115|NCT05299398|Trazodone|trazodone|mesh-list
56621797|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
56621798|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621799|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621800|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621801|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621802|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56621803|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56621804|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56621805|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
56189303|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189304|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
56189305|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
56189306|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189307|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56189308|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
56189309|NCT01449344|Hormones|hormones|mesh-ancestor
56189310|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56189311|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56189312|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
56019116|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56019117|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56019118|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019119|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019120|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019121|NCT05299398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56019122|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56019123|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56019124|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019125|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019126|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
56019127|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56019128|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
56019129|NCT01793480|Methadone|methadone|mesh-list
56019130|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56019131|NCT01793480|Narcotics|narcotics|mesh-ancestor
56019132|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019133|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019168|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019169|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019170|NCT05256264|Ketamine|ketamine|mesh-list
56019171|NCT05256264|Analgesics|analgesics|mesh-ancestor
56019172|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
56019173|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019174|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019232|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019233|NCT00407888|Paclitaxel|paclitaxel|mesh-list
56019234|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56019235|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
56019236|NCT00407888|Doxorubicin|doxorubicin|mesh-list
56019237|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56019238|NCT00407888|Trastuzumab|trastuzumab|mesh-list
56019239|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56019240|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019241|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56019242|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56019243|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56019244|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019245|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019246|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
55746468|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
56019247|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019249|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56019250|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
56019251|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56621806|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
56621807|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621808|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621809|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
56621810|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621811|NCT00963599|Loratadine|loratadine|mesh-list
56621812|NCT00963599|Montelukast|montelukast|mesh-list
56621813|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56621814|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
56621815|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56621816|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
56621817|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56621818|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019252|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56019253|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56019254|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56189313|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189314|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189315|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56189316|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
56189317|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
56189318|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189319|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56189320|NCT01449357|Zalutumumab|zalutumumab|mesh-list
56189321|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56189322|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189323|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
56189324|NCT01449435|Miotics|miotics|mesh-ancestor
56189325|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
56189326|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189327|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189328|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56189329|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56189330|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
56189331|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56189332|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56189333|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
56019255|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019256|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56019257|NCT00407966|Cytarabine|cytarabine|mesh-list
56019258|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
56019259|NCT00407966|Alvocidib|alvocidib|mesh-list
56019260|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56019261|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
56019262|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019263|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019264|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
56019265|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019266|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019267|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
56019268|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019269|NCT00407966|Analgesics|analgesics|mesh-ancestor
56019270|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
56019271|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019272|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56019273|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56019302|NCT05250050|Clarithromycin|clarithromycin|mesh-list
56019303|NCT05250050|Levofloxacin|levofloxacin|mesh-list
56019304|NCT05250050|Tetracycline|tetracycline|mesh-list
56019305|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
56019306|NCT05250050|Esomeprazole|esomeprazole|mesh-list
56019307|NCT05250050|Bismuth|bismuth|mesh-list
56019308|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621819|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56621820|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56621821|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621822|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
56621823|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621824|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56621825|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56621826|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56621827|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
56621828|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
56621829|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621830|NCT05636592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56621831|NCT05636592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621832|NCT05636592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621833|NCT00851461|Goserelin|goserelin|mesh-list
56621834|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56004788|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56019309|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56019310|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019311|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56019312|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56019313|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56019314|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56189335|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189336|NCT01449448|Triamcinolone|triamcinolone|mesh-list
56189337|NCT01449448|Ketorolac|ketorolac|mesh-list
56189338|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189339|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
56189340|NCT01449448|Hormones|hormones|mesh-ancestor
56189341|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56189342|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189343|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189344|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019315|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56019316|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019317|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56019318|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56019319|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56019320|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56019321|NCT05250050|Renal Agents|renal agents|mesh-ancestor
56019340|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56019341|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56019343|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
56019344|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019345|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019346|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019347|NCT05294328|Miotics|miotics|mesh-ancestor
56019348|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
56019349|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019350|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56019351|NCT05254626|Pioglitazone|pioglitazone|mesh-list
56019352|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
56019353|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56019354|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019355|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56621835|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621836|NCT04205136|Spironolactone|spironolactone|mesh-list
56621837|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56004804|NCT00002446|Fluconazole|fluconazole|mesh-list
56019356|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019357|NCT05254236|Vaccines|vaccines|mesh-list
56019358|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
56019359|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019360|NCT05292690|Caffeine|caffeine|mesh-list
56019361|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56019362|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019363|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56019364|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019365|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019366|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56019367|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56019368|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
56019369|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019370|NCT00382148|Omalizumab|omalizumab|mesh-list
56019371|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56019372|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56019373|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
56019374|NCT05292066|Pregabalin|pregabalin|mesh-list
56019375|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56019376|NCT05292066|Analgesics|analgesics|mesh-ancestor
56019377|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
56019378|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019409|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56019410|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019411|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019413|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56189347|NCT01449448|Analgesics|analgesics|mesh-ancestor
56189348|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
56189349|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189350|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189351|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56189352|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
56189353|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56189354|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56019414|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
56019415|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019416|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56019417|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56019418|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56019419|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019431|NCT05198544|Protective Agents|protective agents|mesh-ancestor
56019432|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
56019433|NCT05290662|Fludarabine|fludarabine|mesh-list
56019434|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019435|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
56019436|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019437|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56019438|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56019439|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
56019440|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019441|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019442|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56019443|NCT05143502|Fluticasone|fluticasone|mesh-list
56019444|NCT05143502|Xhance|xhance|mesh-list
56019445|NCT05143502|Prednisolone|prednisolone|mesh-list
56019446|NCT05143502|Montelukast|montelukast|mesh-list
56019447|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56019448|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56019449|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
56019450|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019451|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019452|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56019453|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
56019454|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
56019455|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56621838|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
56621839|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56621840|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621841|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56621842|NCT04205136|Diuretics|diuretics|mesh-ancestor
56621843|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
56621844|NCT02815332|Minocycline|minocycline|mesh-list
56621845|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56621846|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621847|NCT02811354|Osimertinib|osimertinib|mesh-list
56370397|NCT00090896|Ipilimumab|ipilimumab|mesh-list
56621848|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621849|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56621850|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621851|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621852|NCT02810808|Ranibizumab|ranibizumab|mesh-list
56621853|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56019456|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
56019457|NCT05143502|Hormones|hormones|mesh-ancestor
56019458|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56019459|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56019460|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019461|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56019462|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
56019463|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56019464|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56019465|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019466|NCT05290116|Apatinib|apatinib|mesh-list
56019467|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746694|NCT00702949|Analgesics|analgesics|mesh-ancestor
56019468|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56019469|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019470|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019471|NCT00409292|Everolimus|everolimus|mesh-list
56019472|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019473|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019474|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
56019475|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019476|NCT05246046|Bromides|bromides|mesh-list
56189355|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189357|NCT01449552|Coagulants|coagulants|mesh-ancestor
56189358|NCT01449565|Naltrexone|naltrexone|mesh-list
56189359|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56189360|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56189361|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189362|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
56189363|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189364|NCT01449578|Pramipexole|pramipexole|mesh-list
56189365|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
56019479|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
56019480|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019481|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930018|NCT01720485|Betamethasone|betamethasone|mesh-list
56019508|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019511|NCT05288400|Perindopril|perindopril|mesh-list
56019512|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56019513|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56019514|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56621854|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56621855|NCT02810808|Growth Substances|growth substances|mesh-ancestor
56621856|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621857|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
56621858|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621859|NCT00619801|Levocetirizine|levocetirizine|mesh-list
56621860|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56621861|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56621862|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
56621863|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
56621864|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621865|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621866|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621867|NCT02545777|Diclofenac|diclofenac|mesh-list
56621868|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56621869|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56621870|NCT02545777|Analgesics|analgesics|mesh-ancestor
56621871|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
56621872|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621873|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621874|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621875|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621876|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56621877|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621878|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621879|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56621880|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56621881|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621882|NCT00962741|Etanercept|etanercept|mesh-list
56621883|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56621884|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56621885|NCT00962741|Analgesics|analgesics|mesh-ancestor
56621886|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
56621887|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621891|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621892|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56621893|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
56621894|NCT00851929|Ambrisentan|ambrisentan|mesh-list
56621896|NCT02813382|Bupivacaine|bupivacaine|mesh-list
56621897|NCT02813382|Prilocaine|prilocaine|mesh-list
56621898|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
56621899|NCT02813382|Procaine|procaine|mesh-list
56621900|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621901|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
56621902|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621903|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621904|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
56621905|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621906|NCT00619645|Cyclosporine|cyclosporine|mesh-list
56621907|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
56621908|NCT00619645|Fludarabine|fludarabine|mesh-list
56621909|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
56621910|NCT00619645|Busulfan|busulfan|mesh-list
56019515|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019516|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56019517|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019518|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
56019519|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
56019520|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
56019521|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019522|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56019523|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56019524|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56019525|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
56019526|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019527|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56019528|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
56019529|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019551|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019552|NCT00410150|Albuterol|albuterol|mesh-list
56019553|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56019554|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
56019555|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019556|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019557|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56019558|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
56019559|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
56019560|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56019561|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56019562|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56019563|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56019564|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
56019565|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019566|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019567|NCT00385268|Acamprosate|acamprosate|mesh-list
56019568|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56019569|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
56019570|NCT05287464|Nivolumab|nivolumab|mesh-list
56019571|NCT05287464|Ipilimumab|ipilimumab|mesh-list
56019572|NCT05287464|Avelumab|avelumab|mesh-list
56019573|NCT05287464|Atezolizumab|atezolizumab|mesh-list
56019574|NCT05287464|Lenvatinib|lenvatinib|mesh-list
56019575|NCT05287464|Axitinib|axitinib|mesh-list
56019576|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56621911|NCT00619645|Cyclosporins|cyclosporins|mesh-list
56621912|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621913|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56621914|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
56621915|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621916|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56621917|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
56621918|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621919|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56621920|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
56621921|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56621922|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621923|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56621924|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56621925|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56621926|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56621927|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
56621928|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56621929|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
56621930|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56621931|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56621932|NCT05585112|Lidocaine|lidocaine|mesh-list
56621933|NCT05585112|Carticaine|carticaine|mesh-list
56621934|NCT05585112|Anesthetics, Local|anesthetics, local|mesh-ancestor
56621935|NCT05585112|Anesthetics|anesthetics|mesh-ancestor
56004872|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56189367|NCT01449578|Protective Agents|protective agents|mesh-ancestor
56189368|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189369|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56189370|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56189371|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
56189372|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
56189373|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189375|NCT01449617|Clopidogrel|clopidogrel|mesh-list
56189376|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56189377|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56189378|NCT01449617|Analgesics|analgesics|mesh-ancestor
56189379|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
56189380|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189381|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189382|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189383|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189384|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56189385|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55801272|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
56189392|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56019577|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019578|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56019579|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621936|NCT05585112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621937|NCT05585112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621938|NCT05585112|Sensory System Agents|sensory system agents|mesh-ancestor
56621939|NCT05585112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621940|NCT05585112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56621941|NCT05585112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56621942|NCT05585112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56621943|NCT05585112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56621944|NCT05585112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621945|NCT00852163|Busulfan|busulfan|mesh-list
56621946|NCT00852163|Clofarabine|clofarabine|mesh-list
56621947|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
56621948|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621949|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56621950|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
56621951|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621952|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56004898|NCT00002476|Leucovorin|leucovorin|mesh-list
56019580|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56019581|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019582|NCT01657500|Gentamicins|gentamicins|mesh-list
56019583|NCT01657500|Dextrans|dextrans|mesh-list
56019608|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
56019609|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019610|NCT01658904|Melphalan|melphalan|mesh-list
56019611|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
56019612|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019613|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56019614|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
56019615|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019616|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019617|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56019618|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019620|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
56019621|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019622|NCT05238948|Midazolam|midazolam|mesh-list
56189393|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56189394|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
56189395|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189397|NCT01449799|Xhance|xhance|mesh-list
56189398|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189399|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56189400|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
56189401|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019623|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56019624|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56019625|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019626|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019627|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56019628|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56019629|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019630|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56019631|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
56019668|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56621953|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621954|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56621955|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56621956|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
56621957|NCT00855517|Latanoprost|latanoprost|mesh-list
56621958|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56621959|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56621960|NCT02813148|Naloxegol|naloxegol|mesh-list
56621961|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56621962|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621963|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
56621964|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621965|NCT02544919|SMOFlipid|smoflipid|mesh-list
56621966|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56621967|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56159670|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
56621969|NCT00818259|Dexamethasone|dexamethasone|mesh-list
56621970|NCT00818259|Ondansetron|ondansetron|mesh-list
56621971|NCT00818259|Aprepitant|aprepitant|mesh-list
56019670|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56019671|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56019672|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56019673|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56019688|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
56019689|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56019690|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
56019691|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019692|NCT00456014|Citalopram|citalopram|mesh-list
56019693|NCT00456014|Desipramine|desipramine|mesh-list
56019694|NCT00456014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56019695|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56019696|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56019697|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019698|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019699|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
56019700|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019701|NCT00456014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56019702|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
56019703|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55801276|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56019710|NCT00411398|Memantine|memantine|mesh-list
56019711|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56019712|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56019713|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
56019714|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019715|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019716|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019717|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56019718|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56019719|NCT05231694|Mitogens|mitogens|mesh-list
56019720|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
56019721|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019722|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56019723|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56019724|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56019725|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56621972|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
56621973|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621974|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
56621975|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
56621976|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56621977|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56621978|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56621979|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
56621980|NCT00818259|Hormones|hormones|mesh-ancestor
56621981|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56621982|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56621983|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56621984|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
56621985|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
56621986|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56621987|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
56019726|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019727|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189402|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189404|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
56189405|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
56189406|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56189407|NCT01449825|Bevacizumab|bevacizumab|mesh-list
56189408|NCT01449825|Sunitinib|sunitinib|mesh-list
56189409|NCT01449825|Sorafenib|sorafenib|mesh-list
56189410|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56189411|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019728|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019729|NCT00457730|Analgesics|analgesics|mesh-ancestor
56019730|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
56019731|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019759|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56019760|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56019761|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56019762|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
56019763|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019764|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56019765|NCT00462020|Metronidazole|metronidazole|mesh-list
56019766|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
56019767|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
56019768|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
55746991|NCT02465827|Ropivacaine|ropivacaine|mesh-list
56019769|NCT00462020|Ampicillin|ampicillin|mesh-list
56019770|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56019771|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019772|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
56019773|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56019774|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56019775|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019776|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019777|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56019778|NCT05275374|Trametinib|trametinib|mesh-list
56019779|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019795|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019796|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019797|NCT05480046|Risperidone|risperidone|mesh-list
56019798|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56019799|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
56019800|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019801|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621988|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56621989|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56621990|NCT00818259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56621991|NCT00818259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56621992|NCT00818259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56621993|NCT00818259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56621994|NCT00818259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56621995|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56019802|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019803|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56019804|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56019807|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56019808|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
56019810|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56019811|NCT04241640|Analgesics|analgesics|mesh-ancestor
56019812|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
56019813|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019814|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019816|NCT00462332|Fludarabine|fludarabine|mesh-list
56019817|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
56019818|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
56019819|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019820|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56019821|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
56019822|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019823|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019824|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
56019825|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189412|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56189413|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56189414|NCT01449825|Growth Substances|growth substances|mesh-ancestor
56189415|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189416|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
56019826|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
56019827|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019828|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56019830|NCT00462644|Midazolam|midazolam|mesh-list
56019831|NCT00462644|Etomidate|etomidate|mesh-list
56019832|NCT00462644|Succinylcholine|succinylcholine|mesh-list
56019833|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56019834|NCT00462644|Narcotics|narcotics|mesh-ancestor
56019835|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019836|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019837|NCT00462644|Analgesics|analgesics|mesh-ancestor
56019838|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
56019839|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019840|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56019875|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56019876|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
56019877|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019878|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019879|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
56019880|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019881|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019915|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56019916|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
56019917|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019918|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019919|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56019920|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
56019921|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
56019922|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56019923|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56019950|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019951|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56019952|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56621996|NCT05578482|Mometasone Furoate|mometasone furoate|mesh-list
56621997|NCT05578482|Dicloxacillin|dicloxacillin|mesh-list
56621998|NCT05578482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56621999|NCT05578482|Dermatologic Agents|dermatologic agents|mesh-ancestor
56622000|NCT05578482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56622001|NCT05578482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56622002|NCT05578482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622004|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622005|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622006|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
56622007|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622008|NCT00619099|Decitabine|decitabine|mesh-list
56622009|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56622010|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
56622011|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622012|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622013|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622014|NCT04042051|Trastuzumab|trastuzumab|mesh-list
56622015|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56622016|NCT04042051|Maytansine|maytansine|mesh-list
56622017|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56622018|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622019|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56622020|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
56622021|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
56622022|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622023|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622024|NCT02812992|Gemcitabine|gemcitabine|mesh-list
56622025|NCT02812992|Paclitaxel|paclitaxel|mesh-list
56622026|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56622027|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622028|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56622029|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56622030|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622031|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622032|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56019953|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
56019954|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56622033|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
56622034|NCT02812992|Antiviral Agents|antiviral agents|mesh-ancestor
56622035|NCT02812992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622036|NCT02812992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622037|NCT02812992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622038|NCT02812992|Immunologic Factors|immunologic factors|mesh-ancestor
56622039|NCT02812992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622040|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56622041|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56622042|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56622043|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622044|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622045|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
56019955|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019956|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56019957|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56019958|NCT05271084|Protective Agents|protective agents|mesh-ancestor
56019959|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
56019960|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56019963|NCT00531518|Aripiprazole|aripiprazole|mesh-list
56019964|NCT00531518|Bupropion|bupropion|mesh-list
56019965|NCT00531518|Fluoxetine|fluoxetine|mesh-list
56019966|NCT00531518|Sertraline|sertraline|mesh-list
56019967|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56019968|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
56019969|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55801286|NCT04852081|Exemestane|exemestane|mesh-list
56019970|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56019971|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56019998|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019999|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020000|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
56020001|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020002|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020003|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56020005|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020006|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
56020007|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56020008|NCT00533546|Protein C|protein c|mesh-list
56020009|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
56020010|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56020011|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56189417|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56189418|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189419|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189420|NCT01449877|Trimethoprim|trimethoprim|mesh-list
56189421|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56189422|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
56189423|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56189424|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189425|NCT01449877|Renal Agents|renal agents|mesh-ancestor
56189426|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
56020012|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020013|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020014|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56020015|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56020016|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020051|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
56020052|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020053|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56622046|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622047|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622048|NCT02812602|Lidocaine|lidocaine|mesh-list
56622049|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
56622050|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
56622051|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622052|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622053|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
56622054|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622055|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56622056|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56622057|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56622058|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622059|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622060|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
56622061|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56622062|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622063|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622064|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56622065|NCT00837187|Analgesics|analgesics|mesh-ancestor
56622066|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
56622067|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622068|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56005015|NCT00002488|Etoposide|etoposide|mesh-list
56020054|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56020089|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020090|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56020091|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56020092|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
56020093|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
56020094|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
56020095|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56020147|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020148|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56020149|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56020150|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56020151|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
56020152|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020153|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020154|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56020155|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56020156|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020157|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
56020159|NCT05157672|Nicotine|nicotine|mesh-list
56020160|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56020161|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
56020162|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789896|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
56622069|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56622070|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56622071|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
56622072|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622073|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622075|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
56622076|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56622077|NCT00962585|Estrogens|estrogens|mesh-ancestor
56622078|NCT00962585|Hormones|hormones|mesh-ancestor
56622079|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622080|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622081|NCT00621985|Dexamethasone|dexamethasone|mesh-list
56622082|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
56020163|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020164|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56020165|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56020166|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
56020167|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020168|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020169|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020170|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56020171|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56020172|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020173|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56020174|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
56020175|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020176|NCT05157126|Gentamicins|gentamicins|mesh-list
56020177|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56020179|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56020180|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020181|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020182|NCT00469508|Modafinil|modafinil|mesh-list
56189427|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56189428|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56189429|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56189430|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189431|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020183|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56020184|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020185|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56020186|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56020187|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56020188|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020189|NCT05096832|Vaccines|vaccines|mesh-list
56020190|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
56020191|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020192|NCT00470600|Ibuprofen|ibuprofen|mesh-list
56020193|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56020194|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020195|NCT00470600|Analgesics|analgesics|mesh-ancestor
56020229|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56020230|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
56020231|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020232|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56020233|NCT00538850|Fentanyl|fentanyl|mesh-list
56020234|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56020235|NCT00538850|Narcotics|narcotics|mesh-ancestor
56020262|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
56020263|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020264|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56020265|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
56020266|NCT00539942|PENTA|penta|mesh-list
56622083|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622084|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
56622085|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
56622086|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622087|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622088|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56622089|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
56622090|NCT00621985|Hormones|hormones|mesh-ancestor
56622091|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622092|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56622093|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622094|NCT02812368|Clonidine|clonidine|mesh-list
56622095|NCT02812368|Analgesics|analgesics|mesh-ancestor
56622096|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
56622097|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020267|NCT00539942|Fondaparinux|fondaparinux|mesh-list
56020268|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56020269|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
56020270|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56020271|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
56020272|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020273|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020274|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
56020275|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56020276|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56020309|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020310|NCT00542750|Expectorants|expectorants|mesh-ancestor
56020311|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
56020312|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56020313|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
56020314|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020315|NCT00542750|Protective Agents|protective agents|mesh-ancestor
56020316|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020317|NCT00542750|Antidotes|antidotes|mesh-ancestor
56020318|NCT00475904|Gabapentin|gabapentin|mesh-list
56020344|NCT00423878|Olanzapine|olanzapine|mesh-list
56020345|NCT00423878|Risperidone|risperidone|mesh-list
56020346|NCT00423878|Aripiprazole|aripiprazole|mesh-list
56020347|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56020348|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56020349|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
56020350|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020351|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020352|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020353|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56020354|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56020355|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020356|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56020357|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56020358|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
56020359|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
56020360|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
56020361|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020362|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56020363|NCT00423878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56189432|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56189434|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56189435|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189436|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
56189438|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189439|NCT01450163|Analgesics|analgesics|mesh-ancestor
56189440|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
56622098|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622099|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56622100|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
56622101|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
56622102|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56622103|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56622104|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56622105|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
56622106|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622107|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622108|NCT03312257|Atropine|atropine|mesh-list
56622109|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56622110|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56622111|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56622112|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
56622113|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622114|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622115|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56622116|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
56622118|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
56622119|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56622120|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56622121|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
56622122|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622123|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622124|NCT00856687|Montelukast|montelukast|mesh-list
56622125|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56622126|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
56622127|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56622128|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
56622129|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622130|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622131|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56622132|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56622133|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622135|NCT02862665|Hematinics|hematinics|mesh-ancestor
56622136|NCT02807922|Zopiclone|zopiclone|mesh-list
56622137|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56622138|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622139|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622140|NCT00861367|Aspirin|aspirin|mesh-list
56622141|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56622142|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56622143|NCT00861367|Analgesics|analgesics|mesh-ancestor
56622144|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
56622145|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56370684|NCT00126516|Giapreza|giapreza|mesh-list
56622147|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622148|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622149|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56622150|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56622151|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622152|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56622153|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56622154|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622155|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
56622156|NCT04285073|Paclitaxel|paclitaxel|mesh-list
56622157|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56622158|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622159|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
56622160|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
56622161|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622162|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622163|NCT00861445|Lacosamide|lacosamide|mesh-list
56622164|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
56622165|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56622166|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56622167|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622168|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622169|NCT04284059|Vitamin D|vitamin d|mesh-list
56622170|NCT04284059|Vitamins|vitamins|mesh-list
56622173|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56622174|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
56622175|NCT00852709|Clofarabine|clofarabine|mesh-list
56622176|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622177|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
56622178|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622179|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622180|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56622181|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
56622182|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622183|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622184|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56622185|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56622186|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
56622187|NCT00861523|Thiamine|thiamine|mesh-list
56622188|NCT00861523|Promethazine|promethazine|mesh-list
56622189|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
56189441|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189442|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189443|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
56189444|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56189445|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56189446|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189447|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56189448|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56189449|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56189450|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189451|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56189452|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56189453|NCT01450995|Sumatriptan|sumatriptan|mesh-list
56189454|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56189455|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56020364|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56020365|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56020366|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
56020367|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
56020368|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56020398|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
56020399|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56020400|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56020401|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
56020402|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020403|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
56020404|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020405|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56020406|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56020407|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56020409|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
56020410|NCT00425672|Immunotoxins|immunotoxins|mesh-list
56020411|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020441|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56020442|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
55747673|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
56020443|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56020444|NCT00544778|Protective Agents|protective agents|mesh-ancestor
56020445|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56189457|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
56622190|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
56622191|NCT00861523|Vitamins|vitamins|mesh-ancestor
56622192|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
56622193|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622194|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
56622195|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
56622196|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56622197|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
56622198|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
56622199|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622200|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622201|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56622202|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56622203|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56622204|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622205|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
56622206|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
56622207|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
56622208|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189458|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189459|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189460|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189461|NCT01451320|Plasminogen|plasminogen|mesh-list
56189462|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56189463|NCT01451320|Streptokinase|streptokinase|mesh-list
56189464|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56189465|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56189466|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189467|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
56189468|NCT01451489|Tacrolimus|tacrolimus|mesh-list
56020446|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56020447|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
56020448|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020449|NCT00486824|Indomethacin|indomethacin|mesh-list
56020450|NCT00486824|Nifedipine|nifedipine|mesh-list
56020451|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56020452|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56020453|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020454|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56020455|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020456|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
56020471|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
56020472|NCT00489866|Aripiprazole|aripiprazole|mesh-list
56020473|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
56020474|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56020476|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56020477|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020478|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020479|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
56020480|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
56020481|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020482|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020483|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56020484|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56020485|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
56622209|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
56622210|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
56622211|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56622212|NCT02811978|Dexamethasone|dexamethasone|mesh-list
56622213|NCT02811978|Bortezomib|bortezomib|mesh-list
56622214|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622215|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
56622216|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
56622217|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622218|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622219|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56622220|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
56622221|NCT02811978|Hormones|hormones|mesh-ancestor
56622222|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622223|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56622224|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622225|NCT00630149|Pemetrexed|pemetrexed|mesh-list
56020486|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56020487|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56020488|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56020489|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56020490|NCT00546104|Dasatinib|dasatinib|mesh-list
56020491|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020492|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56020493|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020494|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020495|NCT00546728|Metformin|metformin|mesh-list
56020496|NCT00546728|Exenatide|exenatide|mesh-list
56020497|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56020498|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020499|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56020500|NCT00546728|Incretins|incretins|mesh-ancestor
56020501|NCT00546728|Hormones|hormones|mesh-ancestor
56020502|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020503|NCT00547586|Bromides|bromides|mesh-list
56020504|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
56020505|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
56020506|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56020507|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020508|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
56189469|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56189470|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
56189471|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189472|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189473|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56189474|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
56189475|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189476|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189477|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56189478|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56189479|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189480|NCT01451853|Ebselen|ebselen|mesh-list
56189481|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56020509|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020510|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
56020511|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56020512|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020513|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
56020514|NCT00490100|Mecasermin|mecasermin|mesh-list
56020515|NCT00490100|Growth Substances|growth substances|mesh-ancestor
56622226|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622227|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622228|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622229|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56622230|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56622231|NCT04204577|Apatinib|apatinib|mesh-list
56622232|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622233|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56622234|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005183|NCT00437216|Clobetasol|clobetasol|mesh-list
56020516|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020517|NCT00490802|Oxytocin|oxytocin|mesh-list
56020518|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
56020546|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
56020547|NCT00493064|Niacinamide|niacinamide|mesh-list
56020548|NCT00493064|Prednisolone|prednisolone|mesh-list
56020549|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56020550|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
56020551|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56020552|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
56020553|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56020554|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
56020555|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56020556|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
56020558|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020559|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020560|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56020561|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020562|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
56020563|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
56020564|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020565|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56020566|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56020567|NCT00493064|Protective Agents|protective agents|mesh-ancestor
56020568|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56020591|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
56020592|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56020593|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020594|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56020595|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56020596|NCT00432458|Growth Substances|growth substances|mesh-ancestor
56020597|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
56020598|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020599|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56020601|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56020602|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020603|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020604|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020605|NCT00433550|Capecitabine|capecitabine|mesh-list
56020606|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
56020607|NCT00433550|Irinotecan|irinotecan|mesh-list
56020608|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56189482|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56189484|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
56189485|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189486|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189487|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189488|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189489|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56189490|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56189491|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
56189492|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020609|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
56020610|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020611|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622235|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622236|NCT00852787|Digoxin|digoxin|mesh-list
56622237|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56622238|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56622239|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020612|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56020613|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56020614|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020615|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
56020616|NCT02208037|Maraviroc|maraviroc|mesh-list
56020617|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
56020618|NCT02208037|Methotrexate|methotrexate|mesh-list
56020619|NCT02208037|Bortezomib|bortezomib|mesh-list
56020620|NCT02208037|Tacrolimus|tacrolimus|mesh-list
56020621|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56020622|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
56020623|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020624|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020655|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020656|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56020657|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
56020658|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020659|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020660|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56020662|NCT03007927|Bupivacaine|bupivacaine|mesh-list
56020663|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56020664|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
56020665|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
56020666|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020667|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020695|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56020696|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020697|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
56020698|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020699|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020700|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
56020701|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020702|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56020703|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56020704|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56020705|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56020706|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020707|NCT05090358|Canagliflozin|canagliflozin|mesh-list
56020708|NCT05090358|Fulvestrant|fulvestrant|mesh-list
56020709|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56020710|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020711|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56020712|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56020713|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
56020714|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020715|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020738|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020739|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
56020740|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189493|NCT01451853|Protective Agents|protective agents|mesh-ancestor
56189494|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56189495|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117260|NCT00003035|Doxorubicin|doxorubicin|mesh-list
56189496|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56189498|NCT01452243|Calcium|calcium|mesh-list
56189499|NCT01452243|Vitamins|vitamins|mesh-ancestor
56189500|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
56189501|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189502|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56189503|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56189504|NCT01452256|Propofol|propofol|mesh-list
56189505|NCT01452256|Desflurane|desflurane|mesh-list
56020741|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56020742|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55747974|NCT03284593|Azacitidine|azacitidine|mesh-list
56020743|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622240|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622241|NCT00852787|Protective Agents|protective agents|mesh-ancestor
56622242|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622243|NCT02545465|Riociguat|riociguat|mesh-list
56622244|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
56005193|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
56020744|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020745|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56020746|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
56020747|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020748|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020750|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020751|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56020752|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020753|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020754|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56020755|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020756|NCT00555464|Prednisone|prednisone|mesh-list
56020757|NCT00555464|Prednisolone|prednisolone|mesh-list
56020758|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56020759|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
56020760|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56020761|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
56020774|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
56020775|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
56020776|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020777|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
56020778|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
56020779|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020780|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56020781|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56020782|NCT00555464|Protective Agents|protective agents|mesh-ancestor
56020783|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
56020784|NCT01795976|Fludarabine|fludarabine|mesh-list
56020785|NCT01795976|Interleukin-2|interleukin-2|mesh-list
56020786|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56020788|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020789|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020790|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56020791|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
56020792|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020793|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020794|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56020795|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020796|NCT01795976|Analgesics|analgesics|mesh-ancestor
56020797|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
56020798|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020799|NCT01461733|Amiodarone|amiodarone|mesh-list
56020800|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56020801|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
56020802|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56020803|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56189506|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56189507|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189508|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189510|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
56189511|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
56189512|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56189513|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56189514|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56189515|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
56189516|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189517|NCT01452607|Ebselen|ebselen|mesh-list
56189518|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56020804|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020805|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56020806|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56622245|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622246|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
56622247|NCT00961259|Fenofibrate|fenofibrate|mesh-list
56622248|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56622249|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56622250|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
56622251|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622252|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56622253|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
56622254|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56622255|NCT04283747|Antibodies|antibodies|mesh-list
56622256|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
56622257|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622258|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
56020807|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56020808|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020809|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56020810|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56020811|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56020812|NCT01462279|Thiamine|thiamine|mesh-list
56020813|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
56020814|NCT01462279|Vitamins|vitamins|mesh-ancestor
56020815|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
56020816|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020818|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
56020819|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020820|NCT05081466|Vitamin D|vitamin d|mesh-list
56020821|NCT05081466|Calcium|calcium|mesh-list
56020822|NCT05081466|Vitamins|vitamins|mesh-ancestor
56020823|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
56020824|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020825|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56020851|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
56020852|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56020853|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020854|NCT01469767|Fluocinonide|fluocinonide|mesh-list
56020855|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56020856|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
56020857|NCT01469767|Hormones|hormones|mesh-ancestor
56020858|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020859|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020860|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56020861|NCT05029596|Heparin|heparin|mesh-list
56020863|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
56020864|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56020865|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56020866|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020867|NCT03246620|Diazepam|diazepam|mesh-list
56020868|NCT03246620|Haloperidol|haloperidol|mesh-list
56020869|NCT03246620|Olanzapine|olanzapine|mesh-list
56020870|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
56020871|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
56020872|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
56020873|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020874|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020875|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56020876|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56020901|NCT05080218|Etanercept|etanercept|mesh-list
56020902|NCT05080218|Golimumab|golimumab|mesh-list
56020903|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56020904|NCT05080218|Abatacept|abatacept|mesh-list
56020905|NCT05080218|Upadacitinib|upadacitinib|mesh-list
56189519|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56189520|NCT01452607|Analgesics|analgesics|mesh-ancestor
56622259|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56622260|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622261|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622262|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56622263|NCT04111926|Analgesics|analgesics|mesh-ancestor
56622264|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
56622265|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622266|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56622267|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56622268|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56622269|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
56622270|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622271|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622273|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622274|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622275|NCT00961181|Paclitaxel|paclitaxel|mesh-list
56622276|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56622277|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622278|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
56622279|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
56622280|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
56005209|NCT00002524|Vincristine|vincristine|mesh-list
56020906|NCT05080218|Ixekizumab|ixekizumab|mesh-list
56020907|NCT05080218|Tofacitinib|tofacitinib|mesh-list
56020908|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56020909|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020910|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56020911|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020912|NCT05080218|Analgesics|analgesics|mesh-ancestor
56020913|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
56020914|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020915|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020916|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56020917|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56020918|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
56020919|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56020921|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020922|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56020923|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020924|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56020925|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
56020926|NCT01470859|Levodopa|levodopa|mesh-list
56020927|NCT01470859|Carbidopa|carbidopa|mesh-list
56020928|NCT01470859|Pramipexole|pramipexole|mesh-list
55739454|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020942|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
56020943|NCT00436046|Interferons|interferons|mesh-list
56020944|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020945|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
56020946|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020947|NCT01471639|Ketorolac|ketorolac|mesh-list
56020948|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55789897|NCT04885751|Rebamipide|rebamipide|mesh-list
56622281|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622282|NCT02807610|Propofol|propofol|mesh-list
56622283|NCT02807610|Etomidate|etomidate|mesh-list
56622284|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56622285|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020949|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020950|NCT01471639|Analgesics|analgesics|mesh-ancestor
56020951|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
56020952|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020953|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020954|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56020955|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020956|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56020957|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020958|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020959|NCT05622656|Dexmedetomidine|dexmedetomidine|mesh-list
56020960|NCT05622656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56020961|NCT05622656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020962|NCT05622656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020963|NCT05622656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020964|NCT05622656|Analgesics|analgesics|mesh-ancestor
56020965|NCT05622656|Sensory System Agents|sensory system agents|mesh-ancestor
56020966|NCT05622656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020967|NCT05622656|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56020968|NCT05622656|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56020969|NCT05622656|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56020970|NCT05622656|Adrenergic Agents|adrenergic agents|mesh-ancestor
56020971|NCT05622656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020972|NCT05622656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020973|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
56020974|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
56020975|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020976|NCT05079126|Protective Agents|protective agents|mesh-ancestor
56020977|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020978|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56020979|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020981|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
56020982|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56020983|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56020984|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020985|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020986|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
56020987|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
56020988|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56020989|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
56020990|NCT00436904|Rituximab|rituximab|mesh-list
56189521|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
56189522|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189523|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189524|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189525|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189526|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56021023|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021024|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
56021025|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56021026|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56021027|NCT05028348|Growth Substances|growth substances|mesh-ancestor
56021028|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
56021029|NCT01486615|Melatonin|melatonin|mesh-list
56021030|NCT01486615|Alprazolam|alprazolam|mesh-list
56021031|NCT01486615|Azaperone|azaperone|mesh-list
56021032|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
56021033|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021061|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021062|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021063|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021064|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021065|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56021066|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56021067|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622286|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622287|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56622288|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
56622289|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
56622290|NCT04117074|Bupivacaine|bupivacaine|mesh-list
56622291|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
56622292|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
56622293|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622294|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622295|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
56622296|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622297|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
56622298|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
56622299|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56622300|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
56622301|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56021068|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021069|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56021070|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021071|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56021072|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
56021073|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
56021074|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021075|NCT05076006|PF-06700841|pf-06700841|mesh-list
56021076|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56021077|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021078|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021079|NCT00439946|Treprostinil|treprostinil|mesh-list
56021080|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56021081|NCT04227678|Heparin|heparin|mesh-list
56021082|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
56021083|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56021084|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56021101|NCT00440180|Anastrozole|anastrozole|mesh-list
56021102|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56021103|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021104|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56021105|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56021106|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021107|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021108|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56021109|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
56021110|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021111|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021112|NCT05021484|Felzartamab|felzartamab|mesh-list
56021113|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021114|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
56021115|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021116|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56021117|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56021118|NCT05021094|Estradiol|estradiol|mesh-list
55748325|NCT03359057|Folic Acid|folic acid|mesh-list
56021119|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56021120|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
56021121|NCT05021094|Estrogens|estrogens|mesh-ancestor
56021122|NCT05021094|Hormones|hormones|mesh-ancestor
56021123|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021124|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189527|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56189528|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
55789898|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56622302|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56622303|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622304|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56622305|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622306|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622307|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56622308|NCT00857077|Renal Agents|renal agents|mesh-ancestor
56622309|NCT00857155|Clopidogrel|clopidogrel|mesh-list
56622310|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56622311|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56622312|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56622313|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56622314|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
56622315|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622316|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622317|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622318|NCT00817635|Eplerenone|eplerenone|mesh-list
56622319|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56622320|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
56189529|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189530|NCT01452607|Protective Agents|protective agents|mesh-ancestor
56189531|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56189532|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189533|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56189534|NCT01453062|Ofatumumab|ofatumumab|mesh-list
56189535|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189536|NCT01453283|Trabectedin|trabectedin|mesh-list
56189537|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56189538|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
56189539|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189540|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189541|NCT01454700|Insulin|insulin|mesh-list
56189542|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56189543|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189544|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189545|NCT01454869|Heparin|heparin|mesh-list
56189546|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
56189547|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56189548|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56189549|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189550|NCT01455350|Lidocaine|lidocaine|mesh-list
56189551|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
56189552|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
56189553|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189554|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189555|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
56189556|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021125|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56021126|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
56021127|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56021128|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56021129|NCT05021094|Progestins|progestins|mesh-ancestor
56021131|NCT01364298|Gabapentin|gabapentin|mesh-list
56021132|NCT01364298|Analgesics|analgesics|mesh-ancestor
56622321|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622322|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021133|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
56021134|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021135|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021136|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
56021137|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56021138|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56021139|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189557|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56189558|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56189559|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56189560|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56189561|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189563|NCT01455636|Trace Elements|trace elements|mesh-list
56189564|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
56189565|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189566|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56189567|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021162|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021163|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021164|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
56021165|NCT04421742|Hormones|hormones|mesh-ancestor
56021166|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021167|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
56021168|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56021169|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
56021170|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021171|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021172|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56021173|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
56021174|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56021175|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56021176|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56021177|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
56021178|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021179|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021180|NCT01488409|Acipimox|acipimox|mesh-list
56021181|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56021182|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
56021183|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021184|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56021185|NCT01488877|Spironolactone|spironolactone|mesh-list
56021186|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56021187|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
56021188|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021189|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021190|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56021191|NCT01488877|Diuretics|diuretics|mesh-ancestor
56021222|NCT04216524|Doxorubicin|doxorubicin|mesh-list
56021223|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56021224|NCT04216524|Methotrexate|methotrexate|mesh-list
56021225|NCT04216524|Vincristine|vincristine|mesh-list
56021226|NCT04216524|Daunorubicin|daunorubicin|mesh-list
56021228|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
56021229|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56021230|NCT04216524|Antibodies|antibodies|mesh-list
56021231|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
56021232|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56021233|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56021234|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
56021235|NCT04216524|BB 1101|bb 1101|mesh-list
56021236|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56021238|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021239|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021240|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56021241|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
56021242|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021274|NCT04216524|Protective Agents|protective agents|mesh-ancestor
56622323|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56622324|NCT00817635|Diuretics|diuretics|mesh-ancestor
56622325|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
56622326|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56622327|NCT00853177|Lidocaine|lidocaine|mesh-list
56622328|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
56622329|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
56622330|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622331|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622332|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
56622333|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622334|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56622335|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56622336|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56622337|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622338|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622340|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56622341|NCT00924079|Narcotics|narcotics|mesh-ancestor
56622342|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622343|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622344|NCT00924079|Analgesics|analgesics|mesh-ancestor
56622345|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
56622346|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622347|NCT00817479|Dexamethasone|dexamethasone|mesh-list
56622348|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189568|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
56189569|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56189570|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56117347|NCT03713801|Metformin|metformin|mesh-list
56189571|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189573|NCT01456507|Oxycodone|oxycodone|mesh-list
56189574|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56189575|NCT01456507|Narcotics|narcotics|mesh-ancestor
56189576|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021276|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
56021277|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021278|NCT01489969|Protective Agents|protective agents|mesh-ancestor
56021279|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021280|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021281|NCT00509288|Aldesleukin|aldesleukin|mesh-list
56021282|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
56021283|NCT00509288|Fludarabine|fludarabine|mesh-list
56021284|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56021285|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
56021322|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021323|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56021324|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021337|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56021338|NCT00445484|Lenalidomide|lenalidomide|mesh-list
56622349|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
56622350|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
56622351|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622352|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622353|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56622354|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
56622355|NCT00817479|Hormones|hormones|mesh-ancestor
56622356|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622357|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56622358|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021339|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56021340|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
56021341|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021342|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56021343|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55748534|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
56021344|NCT00445484|Growth Substances|growth substances|mesh-ancestor
56021345|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
56021346|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021347|NCT01495585|Lonafarnib|lonafarnib|mesh-list
56021348|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021349|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021350|NCT00446264|Sirolimus|sirolimus|mesh-list
56021351|NCT00446264|Tacrolimus|tacrolimus|mesh-list
56021352|NCT00446264|Daclizumab|daclizumab|mesh-list
56021353|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56021354|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
56021355|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021356|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56021357|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021358|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021359|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56021360|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021361|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56021362|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021363|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
56021364|NCT01495819|Nicotine|nicotine|mesh-list
56021365|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56021366|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
56021367|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021368|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021369|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56021370|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56021371|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
56021372|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021373|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021374|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
56021375|NCT04214886|Fludarabine|fludarabine|mesh-list
56021376|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56021377|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
56021378|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189577|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189579|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
56189580|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189581|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56189582|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56189583|NCT01456585|Gemcitabine|gemcitabine|mesh-list
56189584|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56189585|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
56189586|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189587|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189588|NCT01456585|Antiviral Agents|antiviral agents|mesh-ancestor
56189589|NCT01456585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189590|NCT01456585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189591|NCT01456585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622359|NCT00853411|Prednisone|prednisone|mesh-list
56622360|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622361|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
56622362|NCT00853411|Hormones|hormones|mesh-ancestor
56622363|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005304|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
56189592|NCT01456585|Immunologic Factors|immunologic factors|mesh-ancestor
56189593|NCT01456585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189594|NCT01456650|Glyburide|glyburide|mesh-list
56189595|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189596|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189597|NCT01457040|Etoposide|etoposide|mesh-list
56189598|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
56189599|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56189600|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021379|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021380|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56021381|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
56021382|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021383|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021384|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56021385|NCT05011266|Buprenorphine|buprenorphine|mesh-list
56021386|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56021387|NCT05011266|Naloxone|naloxone|mesh-list
56021388|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56021424|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
56021425|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021426|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021427|NCT05127876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56021428|NCT05127876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56021429|NCT05127876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021464|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
56021465|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021466|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56021467|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021468|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56021469|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
56021470|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021471|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021514|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
56021515|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
56189601|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56189602|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56189603|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189604|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189605|NCT01457508|Edetic Acid|edetic acid|mesh-list
56189606|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
56189607|NCT01457508|Antidotes|antidotes|mesh-ancestor
56189608|NCT01457508|Protective Agents|protective agents|mesh-ancestor
56189609|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189610|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
56189611|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
56189612|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189613|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56189614|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
56189615|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56189616|NCT01458431|Anesthetics|anesthetics|mesh-list
56021516|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56021547|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56021548|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021549|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56021550|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021551|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021552|NCT01395043|Epinephrine|epinephrine|mesh-list
56021553|NCT01395043|Bupivacaine|bupivacaine|mesh-list
56021554|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
56021556|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021557|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021558|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
56622364|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622365|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56622366|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021592|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56021593|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56021594|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
56021595|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56021596|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56021597|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021598|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021599|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021600|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
56021632|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021633|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021634|NCT01542541|Rifaximin|rifaximin|mesh-list
56021635|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56021636|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021637|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021638|NCT00524264|Ketorolac|ketorolac|mesh-list
56021639|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56021640|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56021641|NCT00524264|Analgesics|analgesics|mesh-ancestor
56021642|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
56021643|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021644|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021680|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021681|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021683|NCT00526058|Miconazole|miconazole|mesh-list
56021684|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56021708|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
56021709|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189617|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
56189618|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
56189619|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021710|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021711|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56021712|NCT04521140|Dexamethasone|dexamethasone|mesh-list
56021713|NCT04521140|Prednisolone|prednisolone|mesh-list
56021714|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56021715|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
56021716|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56021717|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
56021718|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56021719|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
56021720|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021721|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
56021722|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
56021723|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021724|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021725|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021726|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
56021727|NCT04521140|Hormones|hormones|mesh-ancestor
56021728|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021729|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56021730|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021731|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56021767|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021768|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
56021769|NCT01504711|Aprepitant|aprepitant|mesh-list
56021770|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
56021771|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
56021814|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021815|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021816|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56021817|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021818|NCT01505179|Ranolazine|ranolazine|mesh-list
56021819|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56021889|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
56021890|NCT02132468|Combretastatin|combretastatin|mesh-list
56021891|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56622367|NCT04030533|Ustekinumab|ustekinumab|mesh-list
56005312|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005313|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
56622368|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56622369|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
56622370|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
56622371|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622372|NCT02807298|Lidocaine|lidocaine|mesh-list
56622373|NCT02807298|Epinephrine|epinephrine|mesh-list
56622374|NCT02807298|Carticaine|carticaine|mesh-list
56622375|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56622376|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56622377|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
56622378|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622379|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622380|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622381|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56622382|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56622383|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
56622384|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622385|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56622386|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
56622387|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
56622388|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
56622389|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56622390|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
56622391|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
56005314|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
56021892|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021896|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021898|NCT01508455|Midazolam|midazolam|mesh-list
56021934|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56021935|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56021936|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
56021937|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021938|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022025|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56022026|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022027|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56022028|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022029|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022030|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
56022031|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56022032|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
56022034|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56022035|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56022036|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56005333|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56622392|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622393|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
56622394|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56622395|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56622396|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56622397|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622398|NCT04041427|Albendazole|albendazole|mesh-list
56622399|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
56622400|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56622401|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622402|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
56622403|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56022037|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
56022038|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022067|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022068|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022069|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56022070|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022071|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56022072|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56022073|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56022074|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56022075|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56022076|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
56022077|NCT00115700|Hormones|hormones|mesh-ancestor
56022078|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56022079|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56022080|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56022081|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56022082|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
56022083|NCT03385304|Iodine|iodine|mesh-list
56022084|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
56022085|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56022114|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022115|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022116|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
56022117|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022118|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56022119|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
56022120|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56022121|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56022122|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56022123|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022124|NCT01556347|Rituximab|rituximab|mesh-list
56022125|NCT01556347|Bortezomib|bortezomib|mesh-list
56022126|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
56022127|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56022128|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56022129|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022130|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022131|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
56022132|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022133|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022134|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022135|NCT00561002|Vaccines|vaccines|mesh-list
56022136|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
56022173|NCT03214562|Idarubicin|idarubicin|mesh-list
56022174|NCT03214562|Lenograstim|lenograstim|mesh-list
56022176|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56022177|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
55803781|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738915|NCT05170061|Valsartan|valsartan|mesh-list
56622404|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56622405|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
56622406|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
56622407|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622408|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622409|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622410|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
56622411|NCT00961961|Fluoxetine|fluoxetine|mesh-list
56622412|NCT00961961|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56622413|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56622414|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622415|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622416|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622417|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
56622418|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622419|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56622420|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
56622421|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56622422|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56622423|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56622424|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622425|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
56622426|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56622427|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56022178|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022208|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022209|NCT00562328|Rituximab|rituximab|mesh-list
56022210|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
56022211|NCT00562328|Sargramostim|sargramostim|mesh-list
56022212|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022213|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022214|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
56022215|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022216|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022217|NCT01514149|Metformin|metformin|mesh-list
56022218|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56022219|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022220|NCT05566093|Ethanol|ethanol|mesh-list
56022221|NCT05566093|Polidocanol|polidocanol|mesh-list
56022222|NCT05566093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56022223|NCT05566093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022224|NCT05566093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56022261|NCT01519063|Memantine|memantine|mesh-list
56022262|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56022290|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022292|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56022293|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55803782|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
56005371|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56622428|NCT02610933|Vitamin K|vitamin k|mesh-list
56622429|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
56622430|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
56622431|NCT02610933|Vitamins|vitamins|mesh-ancestor
56622432|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
56622433|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622434|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56622435|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
56622436|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56622437|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
56622438|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622439|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622440|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
56622441|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56622442|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56622443|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
56622444|NCT02610933|Coagulants|coagulants|mesh-ancestor
56622445|NCT04042441|Insulin|insulin|mesh-list
56622446|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
56622447|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56622448|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622449|NCT00817089|Naltrexone|naltrexone|mesh-list
56622450|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56022294|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022295|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
56022296|NCT00634166|Amphotericin B|amphotericin b|mesh-list
56022297|NCT00634166|Clotrimazole|clotrimazole|mesh-list
56022298|NCT00634166|Miconazole|miconazole|mesh-list
56022299|NCT00634166|Bacitracin|bacitracin|mesh-list
56022300|NCT00634166|Mafenide|mafenide|mesh-list
56022301|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56189621|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
56189622|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022302|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
56022303|NCT00634166|Amebicides|amebicides|mesh-ancestor
56022304|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56022305|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56022306|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56022307|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56022340|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022341|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56022342|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
56022343|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022344|NCT00565916|Estradiol|estradiol|mesh-list
56022345|NCT00565916|Estrogens|estrogens|mesh-list
56022346|NCT00565916|Progesterone|progesterone|mesh-list
56022347|NCT00565916|Hormones|hormones|mesh-ancestor
56022375|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56022376|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56022377|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56022378|NCT03008083|Clopidogrel|clopidogrel|mesh-list
56022379|NCT03008083|Ticagrelor|ticagrelor|mesh-list
56022380|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56022381|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56022382|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56005389|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56622451|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56622452|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622453|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
56622454|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622455|NCT03296033|Enoxaparin|enoxaparin|mesh-list
56622456|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
56622457|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
56622458|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56022383|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56022384|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
56022385|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022386|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022387|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022388|NCT05559398|Glenzocimab|glenzocimab|mesh-list
56022389|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
56022390|NCT00566150|Levetiracetam|levetiracetam|mesh-list
56022391|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
56022392|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
56022393|NCT00566540|Paclitaxel|paclitaxel|mesh-list
56022394|NCT00566540|Cisplatin|cisplatin|mesh-list
56022425|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022426|NCT01522963|Nicotine|nicotine|mesh-list
56022427|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56022428|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
56022429|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022430|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022467|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022468|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022470|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
56022471|NCT02129426|Ketamine|ketamine|mesh-list
56022472|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56022473|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56022474|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022475|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56022477|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
56022478|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022479|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56022480|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56022481|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56022546|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56022547|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56022548|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
56022549|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
56022550|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56022551|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56022552|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56022553|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56022554|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56022555|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56022556|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56022557|NCT01566409|Laxatives|laxatives|mesh-ancestor
56189623|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
56189624|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56189626|NCT01459445|Drospirenone|drospirenone|mesh-list
56189627|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56189628|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189629|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189630|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56189631|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56022558|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56022559|NCT02184416|Everolimus|everolimus|mesh-list
56022560|NCT02184416|Sorafenib|sorafenib|mesh-list
56022561|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022562|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022563|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
56022564|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622459|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56622460|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622461|NCT05758389|Paclitaxel|paclitaxel|mesh-list
56622462|NCT05758389|Cisplatin|cisplatin|mesh-list
56622463|NCT05758389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56622464|NCT05758389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622465|NCT05758389|Tubulin Modulators|tubulin modulators|mesh-ancestor
56622466|NCT05758389|Antimitotic Agents|antimitotic agents|mesh-ancestor
56622467|NCT05758389|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622468|NCT05758389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622469|NCT00857935|Permethrin|permethrin|mesh-list
56622470|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622471|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622472|NCT00853879|Vitamins|vitamins|mesh-list
56622473|NCT00853879|Folic Acid|folic acid|mesh-list
56622474|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
56622475|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
56622476|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
56022565|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56022595|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56022596|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56022597|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022598|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56022599|NCT01528891|Analgesics|analgesics|mesh-ancestor
56022600|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
56022601|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022602|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56022603|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56022604|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56022605|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56022606|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022607|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022608|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
56022609|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56022610|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56022611|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56022644|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022645|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
56022646|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022647|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56022648|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022687|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56022688|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56022689|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56022690|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022691|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
56022692|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022693|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022725|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56022726|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022727|NCT05041946|Methylphenidate|methylphenidate|mesh-list
56022728|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56022729|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022730|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56022731|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56022732|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622477|NCT00853879|Pyridoxal|pyridoxal|mesh-list
56622478|NCT00853879|Pyridoxine|pyridoxine|mesh-list
56622479|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
56622480|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
56622481|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622482|NCT00853879|Hematinics|hematinics|mesh-ancestor
56622483|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
56622484|NCT04171843|Fludarabine|fludarabine|mesh-list
56622485|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622486|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
56022733|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189632|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56189633|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
56189634|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56189635|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56189636|NCT01459445|Estrogens|estrogens|mesh-ancestor
56189637|NCT01459445|Hormones|hormones|mesh-ancestor
56189638|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56189639|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56189640|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
56189641|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56189642|NCT01459445|Diuretics|diuretics|mesh-ancestor
56189643|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
56189644|NCT01460030|Cinacalcet|cinacalcet|mesh-list
56189645|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56022769|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
56022770|NCT00576680|Temozolomide|temozolomide|mesh-list
56022771|NCT00576680|Everolimus|everolimus|mesh-list
56022772|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56022773|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
56022808|NCT01532089|Antibodies|antibodies|mesh-list
56022809|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
56022810|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56022811|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
56022812|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022813|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56022849|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022850|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56022851|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56022852|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56022890|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56022921|NCT00581048|Vitamins|vitamins|mesh-ancestor
56022923|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022924|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
56022925|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022926|NCT00581048|Protective Agents|protective agents|mesh-ancestor
56022927|NCT02134184|Vaccines|vaccines|mesh-list
56022928|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
56022929|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022930|NCT01798472|Cimetidine|cimetidine|mesh-list
56022931|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56022934|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
56022935|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
56022936|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022937|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022967|NCT05121350|Epirubicin|epirubicin|mesh-list
56022968|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56022969|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022970|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56022971|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56022972|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022973|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022974|NCT00583622|Gemcitabine|gemcitabine|mesh-list
56022975|NCT00583622|Bevacizumab|bevacizumab|mesh-list
56022976|NCT00583622|Carboplatin|carboplatin|mesh-list
56022977|NCT00583622|Docetaxel|docetaxel|mesh-list
56022978|NCT00583622|Melphalan|melphalan|mesh-list
56022979|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56622487|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622488|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622489|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56622490|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
56622491|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622492|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622493|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56622494|NCT00815919|Prednisone|prednisone|mesh-list
56622495|NCT00815919|Bortezomib|bortezomib|mesh-list
56622496|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622497|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
56622498|NCT00815919|Hormones|hormones|mesh-ancestor
56622499|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622500|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622501|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56005420|NCT05750056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005421|NCT05750056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56005422|NCT05750056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56005423|NCT05750056|Anesthetics, General|anesthetics, general|mesh-ancestor
56022980|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022981|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56117421|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
56189646|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189647|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56189648|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
56189649|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56022982|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56023020|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56023021|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023022|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930020|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56023055|NCT00605072|Diuretics|diuretics|mesh-ancestor
56023056|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
56023057|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023058|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56023059|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023060|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023061|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56023062|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
56023063|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
56023064|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023099|NCT00585650|Analgesics|analgesics|mesh-ancestor
56023100|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
56023101|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023102|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023139|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
56023140|NCT00605696|Insulin|insulin|mesh-list
56023141|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56023178|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
56023179|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023180|NCT04527770|Dexamethasone|dexamethasone|mesh-list
56023181|NCT04527770|Midazolam|midazolam|mesh-list
56023207|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56023208|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622502|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622503|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56622504|NCT02545153|Aprotinin|aprotinin|mesh-list
56622505|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
56622506|NCT02545153|Coagulants|coagulants|mesh-ancestor
56023209|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56023210|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56023211|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56023213|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
56023214|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023215|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023216|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023217|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023218|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56023219|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56023220|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56023221|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
56023222|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
56023223|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023224|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023226|NCT00668564|Busulfan|busulfan|mesh-list
56023227|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
56023228|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56023229|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
55801302|NCT04851457|Tirofiban|tirofiban|mesh-list
56023262|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023263|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56023264|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56023265|NCT00670202|Fasudil|fasudil|mesh-list
56023266|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56023267|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023268|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023269|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56023270|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023271|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
56023272|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56023273|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023274|NCT00670982|Bevacizumab|bevacizumab|mesh-list
56189650|NCT01460069|Liraglutide|liraglutide|mesh-list
56189651|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189652|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189653|NCT01460069|Incretins|incretins|mesh-ancestor
56189654|NCT01460069|Hormones|hormones|mesh-ancestor
56189655|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56189656|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56189657|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
56189658|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189659|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
56189660|NCT01460212|Citalopram|citalopram|mesh-list
56189661|NCT01460212|Fluoxetine|fluoxetine|mesh-list
56189662|NCT01460212|Paroxetine|paroxetine|mesh-list
56189663|NCT01460212|Sertraline|sertraline|mesh-list
56189664|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
56023275|NCT00670982|Trastuzumab|trastuzumab|mesh-list
56023310|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56023311|NCT04220684|Cytarabine|cytarabine|mesh-list
56023312|NCT04220684|Fludarabine|fludarabine|mesh-list
56023313|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023314|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56023407|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56023408|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
56023409|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023442|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023443|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023444|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56023445|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023446|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023447|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56023448|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56023476|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023477|NCT03007303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56023478|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56622507|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56622508|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56622509|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
56622510|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622511|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023479|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023480|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
56023481|NCT01585441|Finasteride|finasteride|mesh-list
56023482|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56023483|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56023484|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023485|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023486|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
56023487|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023488|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023489|NCT01585441|Urological Agents|urological agents|mesh-ancestor
56023490|NCT00617942|Paclitaxel|paclitaxel|mesh-list
56023491|NCT00617942|Carboplatin|carboplatin|mesh-list
56023492|NCT00617942|Trastuzumab|trastuzumab|mesh-list
56023493|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56023494|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023495|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
56023496|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
56023497|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
56023525|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56023526|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56023527|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
56023528|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56023529|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56189672|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56189673|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56189674|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56189675|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56189676|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189677|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56189678|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56189679|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189680|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56189681|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56189683|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56189684|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56189685|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56189686|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023534|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56023535|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56023536|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
56023537|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023538|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023539|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023540|NCT01589263|Urological Agents|urological agents|mesh-ancestor
56023541|NCT01590979|Ranolazine|ranolazine|mesh-list
56023542|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56023543|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023544|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023545|NCT00619970|Rifaximin|rifaximin|mesh-list
56023582|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
56023583|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023584|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56023585|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56023621|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023622|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56023623|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56023624|NCT00621686|Growth Substances|growth substances|mesh-ancestor
56023657|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
56023658|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
56023659|NCT02446964|Fludarabine|fludarabine|mesh-list
56023660|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
56622512|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56622513|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56622514|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622515|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56622516|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56622517|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622518|NCT00854035|Incretins|incretins|mesh-ancestor
56622519|NCT00854035|Hormones|hormones|mesh-ancestor
56005445|NCT05749900|Trastuzumab|trastuzumab|mesh-list
56023661|NCT02446964|Tacrolimus|tacrolimus|mesh-list
56023662|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56023663|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
56189687|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189688|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
56189689|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189690|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189691|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56189692|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189693|NCT01460420|Lenalidomide|lenalidomide|mesh-list
56189694|NCT01460420|Bortezomib|bortezomib|mesh-list
56189695|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
56189697|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56189698|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56189699|NCT01460420|Growth Substances|growth substances|mesh-ancestor
56189700|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
56189701|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189702|NCT01460498|Azacitidine|azacitidine|mesh-list
56023664|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023665|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023729|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023730|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
56023731|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
56023732|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023733|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023734|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56023735|NCT00624416|Protective Agents|protective agents|mesh-ancestor
56023736|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56023737|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56023738|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
56023739|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023740|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023741|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56023774|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023775|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56023776|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56023777|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56023778|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
56023779|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56023781|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
56023812|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
56023813|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56023814|NCT05566639|Vaccines|vaccines|mesh-list
56023815|NCT05566639|Immunologic Factors|immunologic factors|mesh-ancestor
56023816|NCT05566639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023817|NCT05566405|Anesthetics|anesthetics|mesh-list
56023818|NCT05566405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023819|NCT05566405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023820|NCT03000127|Testosterone|testosterone|mesh-list
56023821|NCT03000127|Androgens|androgens|mesh-ancestor
56023857|NCT03006679|Meropenem|meropenem|mesh-list
56023858|NCT03006679|Tazobactam|tazobactam|mesh-list
56023888|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56023889|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
56023890|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56023891|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
56023892|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622520|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622521|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56622522|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
56371059|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
56622523|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622524|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622525|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
56622526|NCT00957905|Leucovorin|leucovorin|mesh-list
56622527|NCT00957905|Folic Acid|folic acid|mesh-list
56622528|NCT00957905|Fluorouracil|fluorouracil|mesh-list
56622529|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
56622530|NCT00957905|Alvocidib|alvocidib|mesh-list
56622531|NCT00957905|Calcium|calcium|mesh-list
56622532|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
56622533|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56622534|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622535|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56622536|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
56622537|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622538|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56622539|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622540|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622541|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
56622542|NCT00957905|Antidotes|antidotes|mesh-ancestor
56622543|NCT00957905|Protective Agents|protective agents|mesh-ancestor
56622544|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
56622545|NCT00957905|Vitamins|vitamins|mesh-ancestor
56023893|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023894|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56189704|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56189705|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
56189706|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189707|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189708|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189709|NCT01460537|Gemcitabine|gemcitabine|mesh-list
56189710|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189711|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56189712|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
56189713|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189714|NCT01460537|Antiviral Agents|antiviral agents|mesh-ancestor
56189715|NCT01460537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189716|NCT01460537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189717|NCT01460537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56189718|NCT01460537|Immunologic Factors|immunologic factors|mesh-ancestor
56117486|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189719|NCT01460537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189720|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
56023895|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
56622546|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
56622547|NCT00957905|Hematinics|hematinics|mesh-ancestor
56622548|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
56622549|NCT00957905|Growth Substances|growth substances|mesh-ancestor
56622550|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56622551|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622552|NCT02804646|Carboplatin|carboplatin|mesh-list
56622553|NCT02804646|Pemetrexed|pemetrexed|mesh-list
56622554|NCT02804646|Endostatins|endostatins|mesh-list
56622555|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622556|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622557|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622558|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56622559|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56622560|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56622561|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56622562|NCT02804646|Growth Substances|growth substances|mesh-ancestor
56622563|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622564|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
56622565|NCT02858297|Triamcinolone|triamcinolone|mesh-list
56622566|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56622567|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56622568|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56622569|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622570|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
56622571|NCT02858297|Hormones|hormones|mesh-ancestor
56622572|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622573|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622574|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56023896|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
56023897|NCT03006211|Protective Agents|protective agents|mesh-ancestor
56023899|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023901|NCT02247505|Tamsulosin|tamsulosin|mesh-list
56023902|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
56023903|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56023904|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56023941|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023942|NCT05672251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56023943|NCT05672251|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56023944|NCT05672251|Immunologic Factors|immunologic factors|mesh-ancestor
56023945|NCT05672251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023946|NCT05672251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56023947|NCT05672251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023949|NCT05672095|Niraparib|niraparib|mesh-list
56024019|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024021|NCT00251576|Calcium heparin|calcium heparin|mesh-list
56024089|NCT05671081|Adrenergic Agents|adrenergic agents|mesh-ancestor
56622575|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
56622576|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622577|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622578|NCT00858325|Daptomycin|daptomycin|mesh-list
56622579|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56622580|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622581|NCT02804490|Vitamin A|vitamin a|mesh-list
56622582|NCT02804490|Beta Carotene|beta carotene|mesh-list
56622583|NCT02804490|Provitamins|provitamins|mesh-list
56622584|NCT02804490|Carotenoids|carotenoids|mesh-list
56622585|NCT02804490|Vitamins|vitamins|mesh-ancestor
56622586|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
56622587|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622588|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
56005510|NCT05663866|Glucocorticoids|glucocorticoids|mesh-ancestor
56024090|NCT05671081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739514|NCT03398083|Alprazolam|alprazolam|mesh-list
56024091|NCT05671081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024092|NCT05671081|Anesthetics|anesthetics|mesh-ancestor
56024093|NCT05671081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56024094|NCT05671081|Anticonvulsants|anticonvulsants|mesh-ancestor
56024095|NCT05671081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56024096|NCT05671081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56024097|NCT05671081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56024098|NCT05671081|Tocolytic Agents|tocolytic agents|mesh-ancestor
56024132|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
56024133|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024134|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024135|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56024136|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
56024137|NCT00631358|Hormones|hormones|mesh-ancestor
56024169|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56024170|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56024171|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56024172|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56024173|NCT00687674|Dexamethasone|dexamethasone|mesh-list
56024174|NCT00687674|Lenalidomide|lenalidomide|mesh-list
56024175|NCT00687674|Sorafenib|sorafenib|mesh-list
56024176|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024213|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56024214|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
56024250|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56024251|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56024327|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024361|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56024362|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
56024363|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56024364|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56024365|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56024366|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024401|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56024403|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024404|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56024405|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
56024406|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024431|NCT00597428|Lubiprostone|lubiprostone|mesh-list
56024432|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56024433|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56024434|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024435|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56024436|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56622589|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622590|NCT02804490|Protective Agents|protective agents|mesh-ancestor
56622591|NCT00960323|Colchicine|colchicine|mesh-list
56622592|NCT00960323|Atorvastatin|atorvastatin|mesh-list
56622593|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56024437|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56024438|NCT00597818|Analgesics|analgesics|mesh-ancestor
56024439|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
56024440|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024452|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024454|NCT01790282|Progesterone|progesterone|mesh-list
56024455|NCT01790282|Estrogens|estrogens|mesh-ancestor
56024456|NCT01790282|Hormones|hormones|mesh-ancestor
56024476|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024477|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024478|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56024479|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56024480|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56024481|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56024482|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024483|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56024484|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56024485|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56024486|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56024487|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56024488|NCT01798004|Protective Agents|protective agents|mesh-ancestor
56024489|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
56024490|NCT03843541|Ambroxol|ambroxol|mesh-list
56024491|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56024492|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
56189721|NCT01460563|Analgesics|analgesics|mesh-ancestor
56189722|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
56189723|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189724|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189725|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
56189726|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189727|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56189728|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
56189729|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56189730|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56189731|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189732|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56189733|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
56189734|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56189735|NCT01460602|Rituximab|rituximab|mesh-list
56189736|NCT01460602|Bortezomib|bortezomib|mesh-list
56189737|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56189738|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189739|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
56189740|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189741|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189742|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
56189743|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189744|NCT01460667|Acetaminophen|acetaminophen|mesh-list
56189745|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56189746|NCT01460667|Analgesics|analgesics|mesh-ancestor
56189747|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
56189748|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189749|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189750|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
56189751|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
56189752|NCT01460693|Dasatinib|dasatinib|mesh-list
56189753|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189754|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56189757|NCT01460706|Edotreotide|edotreotide|mesh-list
56189761|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189762|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189763|NCT01460836|Tobramycin|tobramycin|mesh-list
56189764|NCT01460836|Aztreonam|aztreonam|mesh-list
56189765|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189766|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189767|NCT01460888|Olaparib|olaparib|mesh-list
56189768|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56005526|NCT05663866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622594|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56622595|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
56622596|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622597|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56622598|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56622599|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622600|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
56622601|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189769|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189770|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189771|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189772|NCT01460979|Sirolimus|sirolimus|mesh-list
56189773|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189774|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189775|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56189776|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189777|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
56189778|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56189779|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
56189780|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189781|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
56189782|NCT01461018|Antibodies|antibodies|mesh-list
56189783|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
56189784|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56189785|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56189786|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
56189787|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189788|NCT01461031|Nefopam|nefopam|mesh-list
56189789|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56189790|NCT01461031|Analgesics|analgesics|mesh-ancestor
56189791|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
56189792|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189793|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189794|NCT01461174|Memantine|memantine|mesh-list
56189795|NCT01461174|Modafinil|modafinil|mesh-list
56189796|NCT01461174|Donepezil|donepezil|mesh-list
56189797|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56189798|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024494|NCT03843541|Expectorants|expectorants|mesh-ancestor
56024495|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
56024496|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56024497|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
56189799|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189800|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
56189801|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189802|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189803|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
56189804|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56189805|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56189806|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
56189807|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56189808|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56189809|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56189810|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56189811|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56189812|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56189813|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
56189814|NCT01461460|Tedizolid|tedizolid|mesh-list
56189815|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
56189816|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
56189817|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189818|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189819|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56024498|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024499|NCT03843541|Protective Agents|protective agents|mesh-ancestor
55803963|NCT05523661|Dasatinib|dasatinib|mesh-list
56622602|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
56622603|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
56622604|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622605|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622607|NCT00617929|Clofarabine|clofarabine|mesh-list
56622608|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
56622609|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56622610|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56622611|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622612|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
56024500|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024501|NCT03843541|Antidotes|antidotes|mesh-ancestor
56024502|NCT00639158|Choline|choline|mesh-list
56024503|NCT00639158|Atorvastatin|atorvastatin|mesh-list
56024504|NCT00639158|Ezetimibe|ezetimibe|mesh-list
56024505|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
56024506|NCT00639158|Fenofibrate|fenofibrate|mesh-list
56024507|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56024508|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56024509|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
56024515|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56024516|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
56024517|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
56024518|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56024553|NCT00601796|Tretinoin|tretinoin|mesh-list
56024554|NCT00601796|Vaccines|vaccines|mesh-list
56024555|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
56024556|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024557|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024558|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024559|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56024560|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
56024588|NCT00645710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024589|NCT00645710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024590|NCT00603044|Fluticasone|fluticasone|mesh-list
56024591|NCT00603044|Xhance|xhance|mesh-list
56024592|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189820|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56189821|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189822|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189823|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024593|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56024594|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
56024595|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024596|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024597|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56024598|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
56024599|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
56024600|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56024601|NCT00646646|Midazolam|midazolam|mesh-list
56024602|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
56024603|NCT00646646|Propofol|propofol|mesh-list
56024604|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56024605|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024606|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024640|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024641|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
56024642|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56024643|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56024644|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024646|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024647|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
56024648|NCT00650078|Hormones|hormones|mesh-ancestor
56024649|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024715|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
56024716|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
56024717|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56024718|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56622613|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622614|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622615|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622616|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56622617|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
56622618|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622619|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
56622620|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622621|NCT02800590|Abp-700|abp-700|mesh-list
56622622|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56622623|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
56622624|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
56622625|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622626|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622627|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622628|NCT00815295|Cetuximab|cetuximab|mesh-list
56622629|NCT00815295|Sorafenib|sorafenib|mesh-list
56622630|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56622631|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622632|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56622633|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622634|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622635|NCT00630383|Histamine|histamine|mesh-list
56622636|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
56622637|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
56622638|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005549|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
56024719|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56024720|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
56024721|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024722|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024723|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56024724|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
56024725|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
56024726|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56024727|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56024728|NCT00701636|Daptomycin|daptomycin|mesh-list
56024729|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56024730|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024731|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
56024732|NCT00701714|Hematinics|hematinics|mesh-ancestor
56024733|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
56024734|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56024766|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
56189829|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56189830|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
56189831|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
56189832|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189833|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189834|NCT01461746|Docetaxel|docetaxel|mesh-list
56622639|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622640|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622641|NCT02806752|Triamcinolone|triamcinolone|mesh-list
56622642|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56622643|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56622644|NCT02806752|Ranibizumab|ranibizumab|mesh-list
56622645|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56622646|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56622647|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56622648|NCT02806752|Growth Substances|growth substances|mesh-ancestor
56622649|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622650|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
56622651|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622652|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622653|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
56622654|NCT02806752|Hormones|hormones|mesh-ancestor
56622655|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622656|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622657|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
56622658|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622659|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622660|NCT00854425|Asparaginase|asparaginase|mesh-list
56622661|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622662|NCT05757999|Magnesium Sulfate|magnesium sulfate|mesh-list
56189835|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189836|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
56189837|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
56189838|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
56189839|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189840|NCT01461759|Cisplatin|cisplatin|mesh-list
56189841|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189842|NCT01461772|Carboplatin|carboplatin|mesh-list
56189843|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189844|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56189845|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
56189846|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189847|NCT01462006|Sirolimus|sirolimus|mesh-list
56024851|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
56024852|NCT01230593|Hormones|hormones|mesh-ancestor
56024853|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024854|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56024855|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024856|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
56024857|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024858|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024859|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56024860|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189850|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56025014|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025015|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56622663|NCT05757999|Analgesics|analgesics|mesh-ancestor
56622664|NCT05757999|Sensory System Agents|sensory system agents|mesh-ancestor
56622665|NCT05757999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622666|NCT05757999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622667|NCT05757999|Anesthetics|anesthetics|mesh-ancestor
56622668|NCT05757999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622669|NCT05757999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56622670|NCT05757999|Anticonvulsants|anticonvulsants|mesh-ancestor
56622671|NCT05757999|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56025016|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56025017|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56025018|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025019|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025020|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
56025022|NCT00703976|Cetuximab|cetuximab|mesh-list
55752232|NCT02451475|Analgesics|analgesics|mesh-ancestor
56025023|NCT00703976|Pemetrexed|pemetrexed|mesh-list
56025024|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56025026|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56025037|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
56025039|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
56025040|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025041|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56025042|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
56025043|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025044|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025045|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56025046|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56025048|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
56025049|NCT00661544|Protective Agents|protective agents|mesh-ancestor
56025050|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56025051|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
56025052|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025053|NCT01511042|Norepinephrine|norepinephrine|mesh-list
56025054|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
56025055|NCT01511042|Giapreza|giapreza|mesh-list
56025056|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
56025057|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56025058|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56025065|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025066|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56025067|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56025068|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
56025069|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025070|NCT02979392|Paclitaxel|paclitaxel|mesh-list
56025071|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56025072|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025073|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
56025074|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
56025075|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
56025076|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025077|NCT02999906|Treprostinil|treprostinil|mesh-list
56025078|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56025079|NCT01238471|Propranolol|propranolol|mesh-list
56025080|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56025081|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56025082|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
56025083|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025084|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025085|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025086|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56025087|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56025088|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
56025089|NCT00664430|Calcitriol|calcitriol|mesh-list
56025090|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56025091|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622672|NCT05757999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622673|NCT05757999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622674|NCT05757999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56622675|NCT05757999|Tocolytic Agents|tocolytic agents|mesh-ancestor
56622676|NCT05757999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56622677|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56622678|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56622679|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56622680|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
56622681|NCT02544529|Laxatives|laxatives|mesh-ancestor
56622682|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56622683|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56622684|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622685|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622686|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
56622687|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622688|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622689|NCT02544529|Miotics|miotics|mesh-ancestor
56622690|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
56622691|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622692|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56622693|NCT02806596|Sevoflurane|sevoflurane|mesh-list
56622694|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56622695|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56622696|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
56622697|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
56622698|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025119|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189851|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025120|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56025121|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56025122|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56025123|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56025124|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56025125|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
56025126|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56025127|NCT02195921|Antiemetics|antiemetics|mesh-list
56025128|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
56025129|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025130|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025131|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56025132|NCT02189213|Sertraline|sertraline|mesh-list
56025158|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56025160|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025161|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622699|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622700|NCT04282031|Letrozole|letrozole|mesh-list
56622701|NCT04282031|Fulvestrant|fulvestrant|mesh-list
56622702|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025162|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56025163|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56025164|NCT00667004|Ecabet|ecabet|mesh-list
56025165|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56025166|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56025167|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025168|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56025169|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56025171|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025172|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025173|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56025174|NCT00667004|Protective Agents|protective agents|mesh-ancestor
56025175|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025176|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025177|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
55810343|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56025208|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025209|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025210|NCT02995304|Analgesics|analgesics|mesh-ancestor
56025211|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
56025212|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025213|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56025214|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56025215|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56025216|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56025217|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025218|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56025219|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
56025220|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
56025221|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
56025222|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
56025223|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025224|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025225|NCT02990858|Leronlimab|leronlimab|mesh-list
56025226|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56025227|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56025260|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56025262|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56025263|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
56025264|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025295|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025296|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025298|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
56025299|NCT01294319|Hormones|hormones|mesh-ancestor
56025300|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56025301|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56025302|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025303|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
56025304|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025305|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930023|NCT01720485|Hormones|hormones|mesh-ancestor
56189852|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
56189853|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56025341|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56025342|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
56025343|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56025344|NCT01295879|Vitamin D|vitamin d|mesh-list
56025381|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025382|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
56025413|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025415|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
56025416|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56025417|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56025418|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
56025419|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56025420|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025421|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56622703|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56622704|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56622705|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005629|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
56025422|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56025423|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56025424|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56025490|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
56025491|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
56025492|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025493|NCT02993588|Melatonin|melatonin|mesh-list
56025494|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
56025495|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025496|NCT02993588|Protective Agents|protective agents|mesh-ancestor
56025497|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025498|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025499|NCT01270178|Entecavir|entecavir|mesh-list
56025500|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
56025501|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025502|NCT01270412|Mitogens|mitogens|mesh-list
56025582|NCT00709826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025583|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025584|NCT00709826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56025585|NCT00709826|Immunologic Factors|immunologic factors|mesh-ancestor
56025586|NCT00709826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025587|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56025588|NCT01271114|Terlipressin|terlipressin|mesh-list
56025589|NCT01271114|Norepinephrine|norepinephrine|mesh-list
56025590|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56025591|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56025592|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
56025625|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025626|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56025627|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56025657|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
56025658|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
56025660|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56025661|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025662|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
56025663|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189854|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
56189855|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189856|NCT01462058|Vitamin D|vitamin d|mesh-list
56189857|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
56189858|NCT01462058|Vitamins|vitamins|mesh-ancestor
56189859|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
56189860|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189861|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56189862|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56189863|NCT01462149|Carboplatin|carboplatin|mesh-list
56189864|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189865|NCT01462214|Everolimus|everolimus|mesh-list
56189866|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189867|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56189868|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
56189869|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025667|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
56025668|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025669|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
56025670|NCT00712244|Protective Agents|protective agents|mesh-ancestor
56025671|NCT02991950|Parnaparin|parnaparin|mesh-list
56025672|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
56025673|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56189888|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189889|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56189890|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56189891|NCT01462617|Nemiralisib|nemiralisib|mesh-list
56189892|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56189893|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189894|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189895|NCT01462669|Ezogabine|ezogabine|mesh-list
56189896|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
56189897|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622706|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622707|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56622708|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
56622709|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622710|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622711|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56622712|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56622713|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56622714|NCT00854503|Simvastatin|simvastatin|mesh-list
56622715|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56622716|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56189898|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189899|NCT01462968|Heparin|heparin|mesh-list
56189900|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
56189901|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56189902|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56189903|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189904|NCT01463046|Cytarabine|cytarabine|mesh-list
56189905|NCT01463046|Daunorubicin|daunorubicin|mesh-list
56189906|NCT01463046|Panobinostat|panobinostat|mesh-list
56025674|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56025675|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025710|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56025711|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025712|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025713|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
56025714|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025715|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56025716|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56025928|NCT01273532|Narcotics|narcotics|mesh-ancestor
56189907|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56189908|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
56189909|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189910|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189911|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
56189912|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189913|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56189914|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
56189915|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189916|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56025929|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025930|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025931|NCT01273532|Analgesics|analgesics|mesh-ancestor
56025932|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
56025933|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025934|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56025935|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56025936|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56025937|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025938|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
56026018|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026019|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56026020|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56026021|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
56026022|NCT01273844|Bortezomib|bortezomib|mesh-list
56026055|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026057|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
56026058|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026059|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56622717|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
56622718|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622719|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56026060|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56026061|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56026062|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56026063|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56026064|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
56026065|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026098|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56026099|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56026100|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56026101|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
56026102|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56026103|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026104|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56026105|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56026106|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
56026107|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56026108|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026109|NCT01275638|Prednisolone|prednisolone|mesh-list
56026145|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56026146|NCT00724568|Growth Substances|growth substances|mesh-ancestor
56189917|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56189918|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56189919|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189920|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56026147|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
56026148|NCT01274000|Ramosetron|ramosetron|mesh-list
56026149|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
56026150|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
56026186|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
56026187|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026188|NCT01277744|Cisplatin|cisplatin|mesh-list
56026189|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026190|NCT01277822|Losartan|losartan|mesh-list
56026191|NCT01277822|Amlodipine|amlodipine|mesh-list
56026217|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
56026218|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56026219|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56026220|NCT01274624|Leucovorin|leucovorin|mesh-list
56026221|NCT01274624|Bevacizumab|bevacizumab|mesh-list
56026222|NCT01274624|Fluorouracil|fluorouracil|mesh-list
56026223|NCT01274624|Irinotecan|irinotecan|mesh-list
56026224|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56026225|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026226|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56026380|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56026382|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56026383|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56026384|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
56026385|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026386|NCT00778310|Methylphenidate|methylphenidate|mesh-list
56026454|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026455|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026456|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56026457|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56026459|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56026460|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56026461|NCT01213199|Analgesics|analgesics|mesh-ancestor
56026462|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
56026496|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56026497|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56026499|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56026500|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026501|NCT01214057|Remifentanil|remifentanil|mesh-list
56026503|NCT01214057|Sevoflurane|sevoflurane|mesh-list
56026504|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56026541|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026542|NCT00780494|Bevacizumab|bevacizumab|mesh-list
56026543|NCT00780494|Carboplatin|carboplatin|mesh-list
56026575|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026576|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55804161|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
56622720|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56622721|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622722|NCT05514912|Gemcitabine|gemcitabine|mesh-list
56622724|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56622725|NCT05514912|Cisplatin|cisplatin|mesh-list
56622726|NCT05514912|Infigratinib|infigratinib|mesh-list
56026577|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56026578|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189921|NCT01463150|Clopidogrel|clopidogrel|mesh-list
56189922|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56189923|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56189924|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56189925|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56026583|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56026585|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56026650|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026651|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026652|NCT03809156|Ambrisentan|ambrisentan|mesh-list
56026653|NCT03809156|Riociguat|riociguat|mesh-list
56026654|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
56026655|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026656|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56026657|NCT03808844|Propofol|propofol|mesh-list
56026658|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56026659|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56026660|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026661|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56026662|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
56026698|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026699|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026700|NCT01303835|Naltrexone|naltrexone|mesh-list
56026701|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56026739|NCT01251575|Sirolimus|sirolimus|mesh-list
56026773|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
56026774|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56026775|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
56026776|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026777|NCT01306175|Empagliflozin|empagliflozin|mesh-list
56026778|NCT01306175|Digoxin|digoxin|mesh-list
56026779|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56026780|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56026808|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56026810|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026811|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026812|NCT04345406|Chloroquine|chloroquine|mesh-list
56026813|NCT04345406|Enalapril|enalapril|mesh-list
55754021|NCT05249621|Diuretics|diuretics|mesh-ancestor
56026814|NCT04345406|Captopril|captopril|mesh-list
56026815|NCT04345406|Amebicides|amebicides|mesh-ancestor
56026816|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56026818|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026819|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
56026820|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026821|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56026822|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
56026823|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026824|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026825|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56026843|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026844|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189933|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56189934|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56189935|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56189936|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56189937|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
56189938|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189939|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026854|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56026856|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
56622727|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56622728|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622729|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
56622730|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
56622731|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
56622732|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622733|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56622734|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
56622735|NCT05514912|Antiviral Agents|antiviral agents|mesh-ancestor
56622736|NCT05514912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622737|NCT05514912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622738|NCT05514912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622739|NCT05514912|Immunologic Factors|immunologic factors|mesh-ancestor
56622740|NCT05514912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622741|NCT00858715|Aspirin|aspirin|mesh-list
56622742|NCT00858715|Clopidogrel|clopidogrel|mesh-list
56026857|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026858|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026859|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56026860|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026861|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56026862|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56026863|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026864|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56026865|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56026866|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026867|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
56026868|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
56026869|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026870|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
56026871|NCT01252745|Testosterone|testosterone|mesh-list
56026872|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
56026873|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
56026874|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56026875|NCT01252745|Androgens|androgens|mesh-ancestor
56026876|NCT01252745|Hormones|hormones|mesh-ancestor
56026877|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026878|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026879|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56026880|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026881|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
56026907|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026908|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026910|NCT05743634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56026911|NCT05743634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56026912|NCT05743634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56026913|NCT05743634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026914|NCT05743634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189948|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56189949|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189950|NCT01463280|Lidocaine|lidocaine|mesh-list
56189951|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
56189952|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
56189953|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189954|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189959|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56189960|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622743|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56622744|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56622745|NCT00858715|Analgesics|analgesics|mesh-ancestor
56622746|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
56622747|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622748|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622749|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622750|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622751|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56622752|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56622753|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622754|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56622755|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56622756|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622757|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
56622758|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56622759|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56622760|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56622761|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
56622762|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005668|NCT05746546|Nicotine|nicotine|mesh-list
56189961|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189962|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
56189963|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56189964|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189965|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189966|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56189967|NCT01463332|Analgesics|analgesics|mesh-ancestor
56189968|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
56189969|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189970|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56189971|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56189972|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56026915|NCT05743634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56026916|NCT05743634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56026917|NCT05743634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026918|NCT05743634|Cholinergic Agents|cholinergic agents|mesh-ancestor
56026919|NCT05743634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026920|NCT05583188|Gemcitabine|gemcitabine|mesh-list
56026921|NCT05583188|Paclitaxel|paclitaxel|mesh-list
56026922|NCT05583188|Vinorelbine|vinorelbine|mesh-list
56026923|NCT05583188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56026924|NCT05583188|Nivolumab|nivolumab|mesh-list
56026925|NCT05583188|Pemetrexed|pemetrexed|mesh-list
56026926|NCT05583188|Carboplatin|carboplatin|mesh-list
56026927|NCT05583188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56026928|NCT05583188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026929|NCT05583188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56026966|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
56026967|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56026999|NCT00794144|Analgesics|analgesics|mesh-ancestor
56027000|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
56622763|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56622764|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
56622765|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622766|NCT00960869|Aspirin|aspirin|mesh-list
56622767|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56622768|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56622769|NCT00960869|Analgesics|analgesics|mesh-ancestor
56622770|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
56622771|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622772|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622774|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622775|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56622776|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56622777|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622778|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56622779|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56622780|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622781|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
56622782|NCT02799888|Cyclosporine|cyclosporine|mesh-list
56622783|NCT02799888|Maraviroc|maraviroc|mesh-list
56622784|NCT02799888|Methotrexate|methotrexate|mesh-list
56622785|NCT02799888|Tacrolimus|tacrolimus|mesh-list
56622786|NCT02799888|Cyclosporins|cyclosporins|mesh-list
56005689|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027001|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027002|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027003|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56189973|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
56189974|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189975|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189976|NCT01463371|Azithromycin|azithromycin|mesh-list
56189977|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189978|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189980|NCT01463592|Interferons|interferons|mesh-list
56189981|NCT01463592|Ribavirin|ribavirin|mesh-list
56189982|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
56189983|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
56189984|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
56189985|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189986|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
56189987|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189988|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
56189989|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189990|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
56189991|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189992|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56189993|NCT01463592|Trace Elements|trace elements|mesh-ancestor
56189994|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
56189995|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
56189996|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56189997|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189998|NCT01463735|Vitamin E|vitamin e|mesh-list
56189999|NCT01463735|Vitamins|vitamins|mesh-ancestor
56622787|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56622788|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
56622789|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56622790|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005711|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
56190000|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
56190001|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190002|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
56190004|NCT01463735|Protective Agents|protective agents|mesh-ancestor
56190021|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027046|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027048|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
56027049|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027050|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56027087|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56027088|NCT00772304|Analgesics|analgesics|mesh-ancestor
56027121|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027122|NCT01339013|Anesthetics|anesthetics|mesh-list
56027123|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56027124|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027125|NCT03834506|Dexamethasone|dexamethasone|mesh-list
56027126|NCT03834506|Prednisone|prednisone|mesh-list
56027127|NCT03834506|Docetaxel|docetaxel|mesh-list
56027128|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
56027129|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027130|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
56027131|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
56027132|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027159|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027160|NCT01339247|Halofantrine|halofantrine|mesh-list
56027162|NCT01339247|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56027163|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56027164|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56027165|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027166|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027167|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
56027168|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027169|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56027170|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
56027171|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56027172|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56027173|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56027174|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027175|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
56027176|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56027177|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56027178|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027208|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027209|NCT05477108|Budesonide|budesonide|mesh-list
56027210|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
56027211|NCT05477108|Charcoal|charcoal|mesh-list
56027212|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027213|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56027214|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
56027215|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027216|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027217|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55810577|NCT05429463|Paclitaxel|paclitaxel|mesh-list
56190037|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190038|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
56190039|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027253|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027255|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027256|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
56027257|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027258|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56027259|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56027260|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
56027261|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56622791|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56622792|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
56622793|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622794|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622795|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
56622796|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622797|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56622798|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622799|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
56622800|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622801|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56622802|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56027262|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
56027263|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56027264|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56027265|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56027266|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56027267|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56027268|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56027327|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
56027328|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56027329|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027330|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027331|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
56027332|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
56027333|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027334|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56027335|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
56027336|NCT02199041|Hormones|hormones|mesh-ancestor
56027337|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56027338|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56027339|NCT02199041|Protective Agents|protective agents|mesh-ancestor
55754543|NCT03305471|Sevelamer|sevelamer|mesh-list
56027340|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56027374|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
56027375|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56027376|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56027377|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56027378|NCT00775658|Analgesics|analgesics|mesh-ancestor
56027379|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
56027380|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027381|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739745|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
56027382|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027383|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027547|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
56027548|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027549|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027550|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56027551|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56027552|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
56027553|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
56027554|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56027555|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56027556|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56027557|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027670|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
56027671|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027672|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027673|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027674|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622803|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
56622804|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622805|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56622806|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56622807|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56622808|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56622809|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
56622810|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56622811|NCT00859105|Imiquimod|imiquimod|mesh-list
56622812|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56622813|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
56622814|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005731|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56027675|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56027677|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190059|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56190060|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027678|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027680|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56027681|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56027682|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
56027683|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027708|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027709|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56027710|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56027713|NCT00802100|Benztropine|benztropine|mesh-list
56027714|NCT00802100|Olanzapine|olanzapine|mesh-list
56027715|NCT00802100|Aripiprazole|aripiprazole|mesh-list
56027716|NCT00802100|Perphenazine|perphenazine|mesh-list
56027717|NCT00802100|Simvastatin|simvastatin|mesh-list
56027718|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56027719|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027720|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56027721|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56027722|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
56027723|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027724|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56027725|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56027726|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027727|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
56027728|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
56027729|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027730|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56027731|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56027732|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56027733|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56027767|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56027768|NCT00802412|Topiramate|topiramate|mesh-list
56027769|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
56027770|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56027771|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027772|NCT01355705|Aspirin|aspirin|mesh-list
56027773|NCT01355705|Dexamethasone|dexamethasone|mesh-list
56027774|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
56027860|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56027861|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56027862|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027863|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56027864|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56190061|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027866|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56027867|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55804603|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56622815|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622816|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
56622817|NCT00859183|Sirolimus|sirolimus|mesh-list
56622818|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56005741|NCT05732272|Bupropion|bupropion|mesh-list
56027902|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56027903|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56027904|NCT04645550|Analgesics|analgesics|mesh-ancestor
56027905|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
56027906|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027907|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027908|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027909|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027910|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56027911|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55801321|NCT02608099|Apixaban|apixaban|mesh-list
56028042|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56028121|NCT00845000|Levodopa|levodopa|mesh-list
56028122|NCT00845000|Carbidopa|carbidopa|mesh-list
56028123|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56028153|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
56028154|NCT01330355|Besifloxacin|besifloxacin|mesh-list
56028155|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56028156|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190062|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56190063|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56190064|NCT01464099|Insulin|insulin|mesh-list
56190065|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56190066|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
56190067|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
56190068|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56190069|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190070|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190071|NCT01464112|Dexamethasone|dexamethasone|mesh-list
56190072|NCT01464112|Bortezomib|bortezomib|mesh-list
56190073|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56190074|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
56190075|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
56190076|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028157|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56028158|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56028159|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56028160|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56028161|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028162|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028163|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755369|NCT02717195|Olanzapine|olanzapine|mesh-list
56028164|NCT02193815|Calcitriol|calcitriol|mesh-list
56028165|NCT02193815|Calcipotriene|calcipotriene|mesh-list
56028166|NCT02193815|Tofacitinib|tofacitinib|mesh-list
56028197|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
56028198|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028199|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028200|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
56028201|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56028202|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56028203|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028204|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56028205|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56028206|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56028207|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028239|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56028241|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55810788|NCT04843917|Antibodies|antibodies|mesh-list
56028246|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56028247|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
56028248|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028249|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028250|NCT01332461|Fluticasone|fluticasone|mesh-list
56028252|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56028318|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028319|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
56028320|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
56005749|NCT05732272|Dopamine Agents|dopamine agents|mesh-ancestor
56622819|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622820|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56622821|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622822|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
56622823|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622824|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
56622825|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622826|NCT02803944|Azithromycin|azithromycin|mesh-list
56622827|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56622828|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56622829|NCT02545231|Pitavastatin|pitavastatin|mesh-list
56622830|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56622831|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56622832|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56622833|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
56028321|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
56028322|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028323|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56028325|NCT03410030|Antiviral Agents|antiviral agents|mesh-ancestor
56028326|NCT03410030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028327|NCT03410030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190077|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190079|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
56190080|NCT01464112|Hormones|hormones|mesh-ancestor
56190081|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190082|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56190083|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190084|NCT01464125|Azithromycin|azithromycin|mesh-list
56190085|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
56190086|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56190087|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190088|NCT01464138|Clindamycin|clindamycin|mesh-list
56190089|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
56190090|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
56190091|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
56190092|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56190093|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190094|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56190095|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190096|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190097|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56028328|NCT03410030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56028329|NCT03410030|Immunologic Factors|immunologic factors|mesh-ancestor
56028330|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028331|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
56028332|NCT03410030|Protective Agents|protective agents|mesh-ancestor
56028333|NCT03410030|Vitamins|vitamins|mesh-ancestor
56028334|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
56028335|NCT01402427|Verapamil|verapamil|mesh-list
56028364|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
56028365|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028366|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56028367|NCT01365611|Fluticasone|fluticasone|mesh-list
56028369|NCT01365611|Ketorolac|ketorolac|mesh-list
56028370|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56028371|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56028372|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56028373|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
56028374|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028375|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622834|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622835|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622836|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56622837|NCT02803788|Dexamethasone|dexamethasone|mesh-list
56622838|NCT02803788|Ondansetron|ondansetron|mesh-list
56622839|NCT02803788|Ramosetron|ramosetron|mesh-list
56622840|NCT02803788|Antiemetics|antiemetics|mesh-list
56622841|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622842|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
56622843|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622844|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028376|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56028377|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
56028378|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
56028379|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56028411|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028412|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028414|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
56028415|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028416|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028417|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56028419|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56028420|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56190100|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190101|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190102|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56190103|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56190104|NCT01464242|Protective Agents|protective agents|mesh-ancestor
56190105|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190106|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
56190107|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56190108|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
56190109|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56190110|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56190111|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190112|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56190113|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
56028455|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028456|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028458|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
56028459|NCT01368809|Fentanyl|fentanyl|mesh-list
56028460|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56028461|NCT01368809|Narcotics|narcotics|mesh-ancestor
56028462|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028499|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56028500|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56028501|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028539|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
56028558|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56028559|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56028560|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
56028561|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028562|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56028563|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56028564|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028565|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028566|NCT01376297|Dexamethasone|dexamethasone|mesh-list
56028567|NCT01376297|Aprepitant|aprepitant|mesh-list
56028568|NCT01376297|Palonosetron|palonosetron|mesh-list
56028569|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56028570|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
56028571|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
56028572|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028573|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622845|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56622846|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
56622847|NCT02803788|Hormones|hormones|mesh-ancestor
56622848|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622849|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56622850|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622851|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
56622852|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
56622853|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56622854|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
56622855|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622856|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622857|NCT02803788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56622858|NCT02803788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56622859|NCT02803788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622860|NCT02803788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56622861|NCT02803788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56622863|NCT02610153|Vitamins|vitamins|mesh-ancestor
56622864|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
56622865|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028574|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56028575|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
56028576|NCT01376297|Hormones|hormones|mesh-ancestor
56028577|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028578|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56028579|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028580|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56028581|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028582|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028583|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56028584|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56028585|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
56028586|NCT00859040|Pasireotide|pasireotide|mesh-list
56028587|NCT00859040|Hormones|hormones|mesh-ancestor
56028588|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190114|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190115|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
56190116|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56190117|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
56190118|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56190119|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
56190120|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190121|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190122|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
56028589|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028590|NCT02669186|Fentanyl|fentanyl|mesh-list
56028591|NCT02669186|Bupivacaine|bupivacaine|mesh-list
56028638|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56028667|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
56028668|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56028669|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56028670|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
56028671|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028672|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
56622866|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56622867|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56622868|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622869|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
56622870|NCT02610153|Coagulants|coagulants|mesh-ancestor
56622871|NCT00862693|Calcitriol|calcitriol|mesh-list
56622872|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56622873|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622874|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56622875|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56622876|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622877|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56622878|NCT00862693|Vitamins|vitamins|mesh-ancestor
56622879|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
56622880|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56028673|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028674|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56028675|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56028676|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56028677|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028678|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56028679|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56028680|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56028681|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
56028682|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56028683|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56028684|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
56028685|NCT01491113|Levetiracetam|levetiracetam|mesh-list
56028719|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56028720|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
56028721|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028722|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028723|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56028724|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56028725|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56028726|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56028727|NCT01492673|Growth Substances|growth substances|mesh-ancestor
56028728|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56028729|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56028730|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56028762|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56028763|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56028764|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56028765|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
56028766|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028767|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190124|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56190125|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56190126|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56190127|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190128|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56190129|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190130|NCT01464489|Atropine|atropine|mesh-list
56028769|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
56028799|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56028801|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622881|NCT05757063|Dexmedetomidine|dexmedetomidine|mesh-list
56622882|NCT05757063|Propofol|propofol|mesh-list
56622883|NCT05757063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56622884|NCT05757063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56622885|NCT05757063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622886|NCT05757063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56622887|NCT05757063|Anesthetics, General|anesthetics, general|mesh-ancestor
56622888|NCT05757063|Anesthetics|anesthetics|mesh-ancestor
56622889|NCT05757063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56622890|NCT05757063|Analgesics|analgesics|mesh-ancestor
56622891|NCT05757063|Sensory System Agents|sensory system agents|mesh-ancestor
56622892|NCT05757063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622893|NCT05757063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56622894|NCT05757063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56622895|NCT05757063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56622896|NCT05757063|Adrenergic Agents|adrenergic agents|mesh-ancestor
56622897|NCT05757063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622898|NCT05757063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622899|NCT02799498|Etanercept|etanercept|mesh-list
56622900|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55810813|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
56028899|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56028934|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
56028935|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028937|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56028938|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56028939|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
56028972|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
56028973|NCT01387139|Analgesics|analgesics|mesh-ancestor
56028974|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
56028975|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028976|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56028977|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56028978|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56028979|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029034|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56029035|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56029053|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56029054|NCT00872534|Aspirin|aspirin|mesh-list
56029055|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56029083|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56029085|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56029086|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
56029087|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810854|NCT05329779|Pregnanolone|pregnanolone|mesh-list
56029092|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56029093|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
56029094|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029095|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
56029096|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029097|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029098|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56029099|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
56029100|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005824|NCT05520892|Antibodies|antibodies|mesh-list
56622901|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56622902|NCT02799498|Analgesics|analgesics|mesh-ancestor
56622903|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
56622904|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622905|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622906|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622907|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56622908|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56622909|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622910|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
56622912|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
56622913|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622914|NCT02806440|Naltrexone|naltrexone|mesh-list
56622915|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56622916|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56622917|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622918|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
56622919|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56622920|NCT00913809|Desipramine|desipramine|mesh-list
56622921|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56622922|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
56622923|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56622924|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622925|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622926|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56622927|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56622928|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56029101|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029126|NCT01507181|Analgesics|analgesics|mesh-ancestor
56029127|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
56029128|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029129|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029130|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56029131|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56029132|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
56029133|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
56029134|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56190148|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56190149|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
56190150|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190151|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56190152|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56190153|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190154|NCT01466712|Beclomethasone|beclomethasone|mesh-list
56622958|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622959|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56622960|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56622961|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56622962|NCT04235478|Triamcinolone|triamcinolone|mesh-list
56622963|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56622964|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56622965|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
56622966|NCT04235478|Hormones|hormones|mesh-ancestor
56622967|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56622968|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622969|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56622970|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
56622971|NCT00619489|Vedolizumab|vedolizumab|mesh-list
56622972|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56622973|NCT02806206|Prucalopride|prucalopride|mesh-list
56622974|NCT02806206|Laxatives|laxatives|mesh-ancestor
56622975|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56622976|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56622977|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56622978|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
56622979|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56622980|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56622981|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56622983|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56622984|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56622985|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
56623004|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56623005|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56623006|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56623007|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56623008|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
56623009|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623010|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623011|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623012|NCT02799264|Cabotegravir|cabotegravir|mesh-list
56623013|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56623014|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56623015|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623016|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623017|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56623019|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
56623063|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623064|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623065|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56623066|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56623067|NCT00855361|Rabeprazole|rabeprazole|mesh-list
56623068|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56623069|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56623070|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56623071|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623072|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623073|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
56623074|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56623075|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623076|NCT05550636|Midazolam|midazolam|mesh-list
56623077|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56623078|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56623079|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623080|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623081|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56623082|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623083|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623084|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56623085|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
56623086|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
56623087|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
56623088|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
56623089|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623090|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623091|NCT02857829|Caffeine|caffeine|mesh-list
56623092|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56623093|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623094|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56623106|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56623107|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623108|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623109|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56623110|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
56623111|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623112|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623113|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56623114|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56623115|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56623116|NCT02798250|Insulin|insulin|mesh-list
56623117|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56623118|NCT02798250|Glucagon|glucagon|mesh-list
56623119|NCT02798250|Hormones|hormones|mesh-list
56623120|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56623121|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623122|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623123|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56623124|NCT00865111|Bupropion|bupropion|mesh-list
56623125|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56623126|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
56623127|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623128|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56623129|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56623130|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623131|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623132|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
56623133|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623137|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623147|NCT02798172|Metformin|metformin|mesh-list
56623148|NCT02798172|Alogliptin|alogliptin|mesh-list
56623149|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56623150|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623151|NCT02798172|Incretins|incretins|mesh-ancestor
56623152|NCT02798172|Hormones|hormones|mesh-ancestor
56623153|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623154|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56623155|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
56623156|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623157|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623158|NCT00865423|Gabapentin|gabapentin|mesh-list
56623159|NCT00865423|Analgesics|analgesics|mesh-ancestor
56623160|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
56623161|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623162|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623163|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
56623164|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56623165|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623166|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623175|NCT00955721|Sorafenib|sorafenib|mesh-list
56623202|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56623203|NCT00865501|Diuretics|diuretics|mesh-ancestor
56623204|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
56623205|NCT02797704|Aflibercept|aflibercept|mesh-list
56623206|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56623207|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56623208|NCT02797704|Growth Substances|growth substances|mesh-ancestor
56623209|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623210|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
56623211|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623212|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
56623213|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56623214|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56623215|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56623216|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623217|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623218|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
56623219|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623220|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623221|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56623222|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623223|NCT00863161|Lesogaberan|lesogaberan|mesh-list
56623224|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56623225|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56623226|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
56623227|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
56623228|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623229|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623230|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623231|NCT00863239|Interferons|interferons|mesh-list
56623232|NCT00863239|Ribavirin|ribavirin|mesh-list
56623233|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
56623234|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
56623235|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56623236|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623237|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
56110448|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110449|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
56110450|NCT02124798|Belimumab|belimumab|mesh-list
56110451|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56623238|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623239|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
56623240|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623241|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
56623242|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623243|NCT02802072|Aspirin|aspirin|mesh-list
56623244|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56623245|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56623246|NCT02802072|Analgesics|analgesics|mesh-ancestor
56623247|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
56623248|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623249|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623250|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56623251|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56623252|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56623253|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56623254|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623255|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56623256|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56623257|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623258|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
56623259|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
56623260|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56623261|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623262|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623263|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56623264|NCT04276883|Analgesics|analgesics|mesh-ancestor
56623265|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
56623266|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110452|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
56110453|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110454|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
56110456|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56110457|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110458|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
56110459|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
56110460|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110461|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56110462|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
56110484|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110486|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56110487|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110488|NCT02145078|Gemcitabine|gemcitabine|mesh-list
56110489|NCT02145078|Docetaxel|docetaxel|mesh-list
56623267|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56623268|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56623269|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56623270|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
56623271|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371829|NCT00430924|Eplerenone|eplerenone|mesh-list
56623272|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623273|NCT00865657|Alprazolam|alprazolam|mesh-list
56623274|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56623275|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623276|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623277|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56623278|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623279|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623280|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
56623281|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
56623282|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623283|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623284|NCT00863395|Lidocaine|lidocaine|mesh-list
56623321|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
56623322|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623323|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56623324|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56623325|NCT03074513|Growth Substances|growth substances|mesh-ancestor
56623326|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623327|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
56623328|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
56623329|NCT02801838|Morphine|morphine|mesh-list
56623330|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56623331|NCT02801838|Narcotics|narcotics|mesh-ancestor
56623332|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623333|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623334|NCT02801838|Analgesics|analgesics|mesh-ancestor
56623335|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
56623336|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623337|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56623338|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56623339|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623340|NCT02797860|Rocuronium|rocuronium|mesh-list
56623341|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56623342|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56623343|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56623344|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623345|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623346|NCT03070223|Pitavastatin|pitavastatin|mesh-list
56110490|NCT02145078|Pemetrexed|pemetrexed|mesh-list
56110491|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56110492|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
56110493|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110494|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110495|NCT02145078|Antiviral Agents|antiviral agents|mesh-ancestor
56196311|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
56196312|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196313|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56196314|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56196315|NCT01503242|Cyclosporine|cyclosporine|mesh-list
56196316|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
56196317|NCT01503242|Fludarabine|fludarabine|mesh-list
56196318|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
56196319|NCT01503242|Antibodies|antibodies|mesh-list
56196320|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56196321|NCT01503242|Cyclosporins|cyclosporins|mesh-list
56196322|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
56196323|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196324|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196325|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56196326|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
56196327|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623347|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56623348|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56623349|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56623350|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
56623351|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623352|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623353|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56623354|NCT00860899|Clonidine|clonidine|mesh-list
56623355|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
56623356|NCT00860899|Analgesics|analgesics|mesh-ancestor
56623357|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
56623358|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623359|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623360|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56623361|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
56057103|NCT00001095|Lamivudine|lamivudine|mesh-list
56623362|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
56623363|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56623364|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56623365|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56623366|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
56623367|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623368|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623369|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
56623370|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
56623371|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623372|NCT02797782|Antibodies|antibodies|mesh-list
56623373|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
56623374|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623375|NCT00863629|Insulin|insulin|mesh-list
56623392|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623393|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
56623394|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56623395|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
56623396|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623397|NCT00863785|Expectorants|expectorants|mesh-ancestor
56623398|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
56623399|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56623400|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
56623401|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623402|NCT00863785|Protective Agents|protective agents|mesh-ancestor
56623403|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623404|NCT00863785|Antidotes|antidotes|mesh-ancestor
56623405|NCT02801526|Amlodipine|amlodipine|mesh-list
56623406|NCT02801526|Candesartan|candesartan|mesh-list
56623407|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56623408|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56623409|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623410|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623411|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56623412|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623413|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
56623414|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56623415|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56623416|NCT02805426|Misoprostol|misoprostol|mesh-list
56623417|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
56623418|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56623419|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56623439|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623440|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56623441|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56623442|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623443|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623444|NCT02544061|Interleukin-12|interleukin-12|mesh-list
56623445|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56623446|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
56623447|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623448|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56623449|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56623450|NCT02544061|Growth Substances|growth substances|mesh-ancestor
56623451|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
56623452|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623453|NCT00863863|Griseofulvin|griseofulvin|mesh-list
56623456|NCT03853044|Prednisone|prednisone|mesh-list
56623498|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56623499|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
56623500|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56623501|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56623502|NCT00866437|Progestins|progestins|mesh-ancestor
56623503|NCT00863941|Bupropion|bupropion|mesh-list
56623504|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56623505|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
56623506|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623507|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56623508|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56159704|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56623509|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623510|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623511|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
56623512|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623513|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623514|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56623515|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56623516|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623517|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
56623518|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56623519|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56623520|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
56623521|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623522|NCT00866515|Ketoconazole|ketoconazole|mesh-list
56623523|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
56623524|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623525|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56623526|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56623527|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623528|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623529|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56623535|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
56623536|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56623537|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56623538|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
56623539|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623540|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623541|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56623542|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56623543|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
56623544|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623545|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56623546|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56623547|NCT00864019|Sertraline|sertraline|mesh-list
56623548|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
56623549|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623550|NCT00864019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56623551|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56623552|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623590|NCT05756595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56623591|NCT00617461|Gabapentin|gabapentin|mesh-list
56623592|NCT00617461|Analgesics|analgesics|mesh-ancestor
56623593|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
56623594|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623595|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623596|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
56623597|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56623598|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623599|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623600|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623601|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56623602|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56623603|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623604|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623605|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
56623606|NCT00812331|Simeprevir|simeprevir|mesh-list
56623607|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
56623608|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623609|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
56623610|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623611|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623612|NCT04233996|Meropenem|meropenem|mesh-list
56623642|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
56623643|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
56623644|NCT02610075|Adavosertib|adavosertib|mesh-list
56623645|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623646|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623647|NCT00866593|Dexetimide|dexetimide|mesh-list
56623648|NCT00866593|Citalopram|citalopram|mesh-list
56623649|NCT00866593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56623650|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56623651|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623652|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623653|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623654|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
56623655|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623656|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56623657|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
56623658|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623659|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56623660|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56623661|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
56623662|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
56623663|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623664|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56623665|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56623666|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
56623667|NCT02796378|Ubiquinone|ubiquinone|mesh-list
56623668|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
56623669|NCT02796378|Simvastatin|simvastatin|mesh-list
56623670|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56623671|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56623672|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
56623673|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623674|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56623675|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56623676|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623677|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
56623680|NCT00864409|Ropivacaine|ropivacaine|mesh-list
56623681|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
56623682|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
56623683|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623684|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623685|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
56623686|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623687|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
56623688|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
56623689|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56623690|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56623691|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623692|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623693|NCT00866983|Urological Agents|urological agents|mesh-ancestor
56623694|NCT05226013|Rasburicase|rasburicase|mesh-list
56623695|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
56623696|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56623697|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
56623698|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56623699|NCT00870883|Deferoxamine|deferoxamine|mesh-list
56623700|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
56623701|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623702|NCT00870883|Expectorants|expectorants|mesh-ancestor
56623703|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
56623704|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56623705|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
56623706|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623707|NCT00870883|Protective Agents|protective agents|mesh-ancestor
56623708|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623709|NCT00870883|Antidotes|antidotes|mesh-ancestor
56623710|NCT00870883|Siderophores|siderophores|mesh-ancestor
56623711|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56623712|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
56623713|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
56623723|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623724|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
56623725|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623726|NCT00864565|Fentanyl|fentanyl|mesh-list
56623727|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56623728|NCT00864565|Narcotics|narcotics|mesh-ancestor
56623729|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623730|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623731|NCT00864565|Analgesics|analgesics|mesh-ancestor
56623732|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
56623733|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623734|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56623735|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56623736|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
56623737|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
56623738|NCT00864643|Atorvastatin|atorvastatin|mesh-list
56623739|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56623740|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56623741|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
56623742|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196328|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110496|NCT02145078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110497|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110498|NCT02145078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110499|NCT02145078|Immunologic Factors|immunologic factors|mesh-ancestor
56110500|NCT02145078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110501|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
56110502|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
56110503|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
56110504|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56110505|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56110506|NCT02100228|Vitamin K|vitamin k|mesh-list
56110507|NCT02100228|Heparin|heparin|mesh-list
56110508|NCT02100228|Apixaban|apixaban|mesh-list
56110509|NCT02100228|Vitamins|vitamins|mesh-ancestor
56110510|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
56110511|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110512|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
56110513|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56110514|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56110564|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
56110565|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110566|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110567|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56110568|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56110569|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56110570|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56110571|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56110572|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110573|NCT02122380|Incretins|incretins|mesh-ancestor
56110574|NCT02122380|Hormones|hormones|mesh-ancestor
56110575|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110576|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56110577|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
56110578|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805467|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
56623743|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56623744|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56623745|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623746|NCT00871039|Midazolam|midazolam|mesh-list
56623747|NCT00871039|Propofol|propofol|mesh-list
56623748|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56623749|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623750|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623751|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56623752|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
56623753|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
56623754|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56623755|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56623756|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623757|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623758|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
56623759|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
56623760|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623761|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623762|NCT00867061|ON 01910|on 01910|mesh-list
56623763|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623764|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56623765|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623766|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623767|NCT00864799|Misoprostol|misoprostol|mesh-list
56623768|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56623769|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
56623775|NCT04234776|Ketamine|ketamine|mesh-list
56623790|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623791|NCT04234776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56623792|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56623793|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623794|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
56623795|NCT04234776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56623796|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
56623797|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623798|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56623799|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623800|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
56623802|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56623803|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56623804|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56623805|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56623806|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56623807|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56623808|NCT05756049|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56623809|NCT05756049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623810|NCT00871273|Capecitabine|capecitabine|mesh-list
56623811|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56623812|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
56623813|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623814|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623816|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56623817|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623818|NCT02794506|Propolis|propolis|mesh-list
56623819|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110579|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110580|NCT02121756|Dipyridamole|dipyridamole|mesh-list
56196329|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196330|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
56124094|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56110583|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110584|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56110585|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
56110586|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56110587|NCT02141490|Hematinics|hematinics|mesh-ancestor
56110588|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56110589|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56110605|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110607|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110609|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56110610|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
56623820|NCT04040491|Gemcitabine|gemcitabine|mesh-list
56623821|NCT04040491|Lenalidomide|lenalidomide|mesh-list
56623822|NCT04040491|Antibodies|antibodies|mesh-list
56623823|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
56623824|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
56623825|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623826|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56623827|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
56623828|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623829|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623830|NCT04040491|Antiviral Agents|antiviral agents|mesh-ancestor
56623831|NCT04040491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623832|NCT04040491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623833|NCT04040491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56623834|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56623881|NCT05755737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623882|NCT05755737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623883|NCT05755737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56623884|NCT05755737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56623885|NCT05755737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623886|NCT05755737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623887|NCT05755737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56623888|NCT04234932|Latanoprost|latanoprost|mesh-list
56623889|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56623890|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56623891|NCT02789592|Clonazepam|clonazepam|mesh-list
56623892|NCT02789592|Melatonin|melatonin|mesh-list
56623893|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
56623894|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623895|NCT02789592|Protective Agents|protective agents|mesh-ancestor
56623896|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623897|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56623898|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
56623899|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
56623900|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
56623901|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623902|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56623903|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56623904|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56623905|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
56623906|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623907|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623908|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623909|NCT00876421|Urological Agents|urological agents|mesh-ancestor
56623910|NCT00872131|Sertraline|sertraline|mesh-list
56623911|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
56623912|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56623924|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623925|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623926|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
56623927|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56623928|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56623929|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56623930|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56623931|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56623932|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623933|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56623934|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56623935|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56623936|NCT00872365|Micronutrients|micronutrients|mesh-list
56623937|NCT00872365|Trace Elements|trace elements|mesh-list
56623938|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623939|NCT03637062|Progesterone|progesterone|mesh-list
56623940|NCT03637062|Progestins|progestins|mesh-ancestor
56623941|NCT03637062|Hormones|hormones|mesh-ancestor
56623942|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56623943|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623944|NCT02793648|Vitamins|vitamins|mesh-list
56623945|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
56372492|NCT01050790|Growth Substances|growth substances|mesh-ancestor
56623946|NCT02793648|Vitamin E|vitamin e|mesh-list
56623947|NCT02793648|Tocopherols|tocopherols|mesh-list
56623948|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
56623949|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
56623950|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623952|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623953|NCT02793648|Protective Agents|protective agents|mesh-ancestor
56623954|NCT02789358|Adenosine|adenosine|mesh-list
56623955|NCT02789358|Analgesics|analgesics|mesh-ancestor
56623956|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
56110611|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110612|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110613|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
56110614|NCT02120664|Corticosterone|corticosterone|mesh-list
56110615|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110616|NCT01627860|Topiramate|topiramate|mesh-list
56110617|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
56110618|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56110619|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110620|NCT01627782|Ketamine|ketamine|mesh-list
56110621|NCT01627782|Analgesics|analgesics|mesh-ancestor
56110622|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
56623957|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56623958|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56623959|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56623960|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
56623961|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56623962|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
56623963|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
56623964|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56623965|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623966|NCT03847506|Amlodipine|amlodipine|mesh-list
56623967|NCT03847506|Candesartan|candesartan|mesh-list
56623968|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
56623969|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56623970|NCT03847506|Ezetimibe|ezetimibe|mesh-list
56623971|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56623972|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56623973|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56623974|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56623975|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56624010|NCT02789202|Protective Agents|protective agents|mesh-ancestor
56624011|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624012|NCT00811395|Interferons|interferons|mesh-list
56624013|NCT00811395|Interferon-beta|interferon-beta|mesh-list
56624014|NCT00811395|Teriflunomide|teriflunomide|mesh-list
56624015|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
56624016|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
56624017|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
56624018|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624019|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
56624020|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624021|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56624022|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
56372568|NCT00434044|Etanercept|etanercept|mesh-list
56624023|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624024|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624025|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624026|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56624027|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56624028|NCT00811395|Analgesics|analgesics|mesh-ancestor
56624029|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
56624030|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624031|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624032|NCT02792946|Ambroxol|ambroxol|mesh-list
56624061|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56624062|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56624063|NCT02787798|Valsartan|valsartan|mesh-list
56624064|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56624065|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56624066|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56624067|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56624068|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624069|NCT02609997|Dexamethasone|dexamethasone|mesh-list
56624070|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
56624071|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624072|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
56624073|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
56624074|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624075|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624076|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624077|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
56624116|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624117|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624118|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624119|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56624120|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624121|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624122|NCT05401110|Osimertinib|osimertinib|mesh-list
56624123|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624124|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56624125|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624126|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624127|NCT02792400|Empagliflozin|empagliflozin|mesh-list
56624128|NCT02792400|Linagliptin|linagliptin|mesh-list
56624129|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56624130|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624131|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56624132|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624133|NCT02792400|Incretins|incretins|mesh-ancestor
56624134|NCT02792400|Hormones|hormones|mesh-ancestor
56624135|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56624136|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56624137|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
56624138|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624139|NCT04040023|Vitamins|vitamins|mesh-list
56624140|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
56624141|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624142|NCT03567720|Paclitaxel|paclitaxel|mesh-list
56624143|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
56624160|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624161|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56624162|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56624163|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624164|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56624165|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56624166|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56624167|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56624169|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56624170|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56624171|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56624172|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56624173|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
56624174|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624175|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624176|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624177|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
56624178|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56624179|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
56624180|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56624181|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624182|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56624183|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56624184|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56624185|NCT00876889|Riluzole|riluzole|mesh-list
56624186|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
56624187|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56624188|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56624189|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624190|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624191|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624192|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56624193|NCT00876889|Protective Agents|protective agents|mesh-ancestor
56110623|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110624|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110625|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56110626|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56624194|NCT00868465|Lumefantrine|lumefantrine|mesh-list
56624195|NCT00868465|Artemether|artemether|mesh-list
56624196|NCT00868465|Piperaquine|piperaquine|mesh-list
56624197|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56624198|NCT00868465|Artenimol|artenimol|mesh-list
56624199|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
56624200|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56624201|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56624202|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624203|NCT02689986|Rituximab|rituximab|mesh-list
56624204|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56624205|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56624206|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624207|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
56624208|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624209|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624210|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56624211|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
56624212|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624213|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
56624224|NCT00877123|Vitamin D|vitamin d|mesh-list
56624249|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
56624250|NCT00615901|Fluorouracil|fluorouracil|mesh-list
56624251|NCT00615901|Methotrexate|methotrexate|mesh-list
56624252|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624253|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
56624254|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624255|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624256|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56624257|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
56624258|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624259|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624260|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56624261|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
56624262|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56624263|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56624264|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
56624265|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56624266|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56624267|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624268|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56624269|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56624270|NCT00616603|Dexamethasone|dexamethasone|mesh-list
56624271|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
56624300|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56624301|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624302|NCT00810693|Riociguat|riociguat|mesh-list
56624303|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
56624304|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624305|NCT02790840|Omeprazole|omeprazole|mesh-list
56624306|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56624307|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624308|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56624309|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624310|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624311|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
56624312|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56624314|NCT02790684|Firuglipel|firuglipel|mesh-list
56624315|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56624316|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372866|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
56624317|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
56624318|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624319|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
56624320|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
56624321|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
56624322|NCT02790450|Benzbromarone|benzbromarone|mesh-list
56624354|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
56624355|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624356|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624357|NCT02785614|Trazodone|trazodone|mesh-list
56624358|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56624359|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56624360|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624361|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624362|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56624363|NCT02785614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56624364|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56624365|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56624366|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624367|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624368|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
56624369|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56624370|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
56624371|NCT02787018|Dexamethasone|dexamethasone|mesh-list
56624372|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
56624373|NCT02787018|Ropivacaine|ropivacaine|mesh-list
56624374|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624375|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
56624376|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
56624377|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624378|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624379|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624380|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
56624381|NCT02787018|Hormones|hormones|mesh-ancestor
56624382|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56624383|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56624384|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624385|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56624386|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624387|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56624389|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
56624392|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56624393|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
56624394|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624395|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624396|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
56624397|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
56624398|NCT00873925|Vitamin D|vitamin d|mesh-list
56624399|NCT00873925|Vitamins|vitamins|mesh-ancestor
56624400|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
56624401|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624402|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56624403|NCT03870529|Vitamins|vitamins|mesh-list
56624404|NCT03870529|Vitamin A|vitamin a|mesh-list
56624405|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
56624406|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
56624407|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
56624408|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624409|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
56624454|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56624455|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56624456|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56624457|NCT00877591|Narcotics|narcotics|mesh-ancestor
56624458|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624459|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624460|NCT00877591|Analgesics|analgesics|mesh-ancestor
56624461|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
56624462|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624463|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56624464|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56624465|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
56624466|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56624467|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
56624479|NCT00874003|Mirtazapine|mirtazapine|mesh-list
56624514|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624515|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56624516|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
56624517|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624518|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56624519|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624520|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624521|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
56624522|NCT02785146|Antidotes|antidotes|mesh-ancestor
56624523|NCT02785146|Protective Agents|protective agents|mesh-ancestor
56624524|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
56624525|NCT02785146|Vitamins|vitamins|mesh-ancestor
56624526|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
56624527|NCT00913965|Atenolol|atenolol|mesh-list
56624528|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56624529|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56624530|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
56624531|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
56624532|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624533|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624534|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56624536|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56624568|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624569|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
56624570|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624571|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56624572|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624573|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
56624574|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624575|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
56624576|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624577|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56624578|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56624579|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
56624580|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56624581|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
56624582|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56624583|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56624584|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
56624585|NCT00874393|Dopamine|dopamine|mesh-list
56624586|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624587|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56624588|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
56624589|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
56624590|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624592|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
56624619|NCT02784054|Carboplatin|carboplatin|mesh-list
56624620|NCT02784054|Etoposide|etoposide|mesh-list
56624622|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624623|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
56624624|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624625|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624626|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56624627|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
56624628|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624629|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624630|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56624631|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56624632|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56624633|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56624634|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624635|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56624636|NCT00874861|Poly ICLC|poly iclc|mesh-list
56624637|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
56624638|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
56624639|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624640|NCT04038853|Vitamin D|vitamin d|mesh-list
56624641|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
56624642|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56624643|NCT04038853|Calcitriol|calcitriol|mesh-list
56624644|NCT04038853|Vitamins|vitamins|mesh-ancestor
56624645|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
56624646|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624647|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56624648|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56624665|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624666|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56624667|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56624668|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
56624669|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
56624670|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
56624671|NCT00573391|Thalidomide|thalidomide|mesh-list
56624672|NCT00573391|Dexamethasone|dexamethasone|mesh-list
56624673|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
56624674|NCT00573391|Melphalan|melphalan|mesh-list
56624675|NCT00573391|Bortezomib|bortezomib|mesh-list
56624676|NCT00573391|BB 1101|bb 1101|mesh-list
56624677|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624678|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
56624679|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
56624730|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624731|NCT05753397|Ropivacaine|ropivacaine|mesh-list
56624732|NCT05753397|Anesthetics, Local|anesthetics, local|mesh-ancestor
56624733|NCT05753397|Anesthetics|anesthetics|mesh-ancestor
56624734|NCT05753397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624735|NCT05753397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624736|NCT05753397|Sensory System Agents|sensory system agents|mesh-ancestor
56624737|NCT05753397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624738|NCT00875173|Selenium|selenium|mesh-list
56624739|NCT00875173|Antioxidants|antioxidants|mesh-list
56624740|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624741|NCT00875173|Protective Agents|protective agents|mesh-ancestor
56624742|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624743|NCT00875173|Trace Elements|trace elements|mesh-ancestor
56624744|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
56624745|NCT05243550|Mitomycins|mitomycins|mesh-list
56624746|NCT05243550|Mitomycin|mitomycin|mesh-list
56624789|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
56624790|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624791|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
56624792|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624793|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624794|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56624795|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
56624796|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624797|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624798|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56624799|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56624800|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
56624801|NCT01716312|Omalizumab|omalizumab|mesh-list
56624802|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56624803|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56624804|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
56624805|NCT00880243|Cytarabine|cytarabine|mesh-list
56624806|NCT00880243|Etoposide|etoposide|mesh-list
56624807|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
56624808|NCT00880243|Daunorubicin|daunorubicin|mesh-list
56624809|NCT00880243|Molgramostim|molgramostim|mesh-list
56624810|NCT00880243|Sargramostim|sargramostim|mesh-list
56624811|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56624812|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624813|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56624814|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56624824|NCT00880243|Analgesics|analgesics|mesh-ancestor
56624839|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624840|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56624841|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56624842|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56624843|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
56624844|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624845|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373394|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624846|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56624847|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56624848|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
56624850|NCT00880321|Midazolam|midazolam|mesh-list
56624851|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56624852|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56624853|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624854|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624855|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56624856|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56624857|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56624858|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56624859|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
56624894|NCT04230330|Antiviral Agents|antiviral agents|mesh-ancestor
56624895|NCT04230330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56624896|NCT04230330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624897|NCT04230330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624898|NCT04230330|Immunologic Factors|immunologic factors|mesh-ancestor
56624899|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56624900|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56624901|NCT02785068|Leucovorin|leucovorin|mesh-list
56624902|NCT02785068|Fluorouracil|fluorouracil|mesh-list
56624903|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
56624904|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624905|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56624906|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624907|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624908|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
56624909|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624910|NCT02785068|Antidotes|antidotes|mesh-ancestor
56624911|NCT02785068|Protective Agents|protective agents|mesh-ancestor
56624912|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
56624913|NCT02785068|Vitamins|vitamins|mesh-ancestor
56624914|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
56624915|NCT05752929|Insulin|insulin|mesh-list
56624951|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56624952|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624953|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56624954|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56624955|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56624956|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56624957|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
56624958|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
56624959|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
56624960|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
56624961|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56624962|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624963|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
56624964|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56624965|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56624966|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56624967|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624968|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56624969|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56624970|NCT02783040|Protective Agents|protective agents|mesh-ancestor
56624971|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
56624972|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
56624974|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56624975|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
56624976|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624977|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56624978|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56110627|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
56110628|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
56110629|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56110630|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56110631|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56110632|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110633|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110634|NCT02119650|Pemetrexed|pemetrexed|mesh-list
56110635|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110636|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144789|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56110637|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110638|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56110639|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56110640|NCT02119416|Caffeine|caffeine|mesh-list
56110641|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56110642|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110643|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56110644|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110672|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56110673|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624979|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
56624980|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624981|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56624982|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56624983|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56624984|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56624985|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56624986|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56624987|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56624988|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56624989|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56624990|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56624991|NCT05275686|Fluticasone|fluticasone|mesh-list
56624992|NCT05275686|Xhance|xhance|mesh-list
56624993|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56624994|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56624995|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
56624996|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56624997|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56624998|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56624999|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
56625000|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
56625001|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56625003|NCT01503606|Cefazolin|cefazolin|mesh-list
56625004|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56625005|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625027|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56625028|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56625029|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625030|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625031|NCT00638118|Fexofenadine|fexofenadine|mesh-list
56625032|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56625033|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56625034|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56625035|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
56625036|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
56625037|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625038|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625039|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625040|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56625041|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56625042|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625043|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
56625044|NCT00590031|Irinotecan|irinotecan|mesh-list
56625081|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625082|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625083|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56625084|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
56625085|NCT05031936|Ropivacaine|ropivacaine|mesh-list
56625086|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
56625087|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
56625088|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625089|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625090|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
56625091|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625092|NCT03577704|Gemcitabine|gemcitabine|mesh-list
56625093|NCT03577704|Paclitaxel|paclitaxel|mesh-list
56625094|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56625095|NCT03577704|Cisplatin|cisplatin|mesh-list
56625096|NCT03577704|Carboplatin|carboplatin|mesh-list
56625097|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
56625098|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56625099|NCT03577704|Antibodies|antibodies|mesh-list
56625100|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
56625101|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56625102|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56625104|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
56625105|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
56110674|NCT02095158|Phenylephrine|phenylephrine|mesh-list
56110675|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
56110676|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56110677|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56110678|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56110679|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110680|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110681|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110682|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
56110683|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
56110684|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110685|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
56110686|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56110687|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
56110688|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56110689|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
56110713|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110714|NCT02138136|Lubiprostone|lubiprostone|mesh-list
56196339|NCT01503359|Glycine|glycine|mesh-list
56196406|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196408|NCT01503437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56196409|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56196410|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196411|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196412|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196413|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
56196414|NCT01503450|Olanzapine|olanzapine|mesh-list
56196415|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
56196416|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
56110715|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56625106|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
56625107|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625108|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
56625109|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625110|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56625111|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
56625112|NCT03577704|Antiviral Agents|antiviral agents|mesh-ancestor
56625113|NCT03577704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625114|NCT03577704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625115|NCT03577704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56625116|NCT05176626|Phentermine|phentermine|mesh-list
56625117|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56625118|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625119|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
56625120|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56625121|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
56625122|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
56625123|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625124|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
56625125|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625126|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625127|NCT05030766|Nicotine|nicotine|mesh-list
56625128|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56625129|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
56625130|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625156|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625157|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56625158|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56625159|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625160|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625161|NCT02782182|Antidotes|antidotes|mesh-ancestor
56625162|NCT02782182|Protective Agents|protective agents|mesh-ancestor
56625163|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625164|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
56625165|NCT02782182|Vitamins|vitamins|mesh-ancestor
56625166|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
56625167|NCT02780778|Docetaxel|docetaxel|mesh-list
56625168|NCT02780778|Apatinib|apatinib|mesh-list
56625169|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625170|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56625171|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56110716|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56110717|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110718|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
56110719|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
56110720|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
56110721|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
56110722|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110723|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56110724|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110725|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
56110726|NCT02092116|Romidepsin|romidepsin|mesh-list
56110727|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56110728|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110729|NCT02091414|Cyclosporine|cyclosporine|mesh-list
56110730|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
56110731|NCT02091414|Cyclosporins|cyclosporins|mesh-list
56110732|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110733|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110734|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110735|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
56110736|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110737|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
56110738|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110764|NCT02116530|Antiemetics|antiemetics|mesh-list
56110765|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110766|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
56110767|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110768|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56110769|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56110770|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
56110771|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110772|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110773|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56110774|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110775|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
56110776|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110777|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56110778|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
56110779|NCT02116530|Hormones|hormones|mesh-ancestor
56110780|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110781|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56110782|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56110783|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56110784|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56625172|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56625173|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625174|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56159771|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56625175|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625176|NCT00881101|Paclitaxel|paclitaxel|mesh-list
56625177|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56625178|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625179|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
56625180|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
56625181|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
56625182|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625183|NCT00883909|Dutasteride|dutasteride|mesh-list
56625184|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56625185|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56625186|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625187|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625188|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
56625189|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56625190|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625191|NCT00634686|Vitamin D|vitamin d|mesh-list
56625223|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625224|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56373781|NCT00103649|Xaliproden|xaliproden|mesh-list
56625225|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56625226|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
56625228|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625229|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625230|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625231|NCT02781246|Analgesics|analgesics|mesh-ancestor
56625232|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
56625233|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625234|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56625235|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56625236|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56625237|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
56625238|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625239|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625240|NCT00613951|Insulin|insulin|mesh-list
56625241|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56625242|NCT00613951|Metformin|metformin|mesh-list
56625243|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
56625244|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
56625245|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56625246|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
56625247|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56625248|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625250|NCT00881413|Pantoprazole|pantoprazole|mesh-list
56625251|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56625252|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56625253|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56625254|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625255|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625256|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56110785|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110786|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
56110787|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
56110788|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56110789|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
56110790|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196417|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196418|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625257|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56625258|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625259|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
56625260|NCT00958841|Pasireotide|pasireotide|mesh-list
56625261|NCT00958841|Hormones|hormones|mesh-ancestor
56625262|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56625263|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625264|NCT02937116|Gemcitabine|gemcitabine|mesh-list
56625265|NCT02937116|Cisplatin|cisplatin|mesh-list
56625266|NCT02937116|Capecitabine|capecitabine|mesh-list
56625267|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
56625268|NCT02937116|Irinotecan|irinotecan|mesh-list
56625269|NCT02937116|Etoposide|etoposide|mesh-list
56625270|NCT02937116|Pemetrexed|pemetrexed|mesh-list
56625271|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625272|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56625273|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
56625274|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625275|NCT02937116|Antiviral Agents|antiviral agents|mesh-ancestor
56625276|NCT02937116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625277|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625278|NCT02937116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56625311|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56625312|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625313|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625314|NCT04649203|Riboflavin|riboflavin|mesh-list
56625315|NCT04649203|Niacinamide|niacinamide|mesh-list
56625316|NCT04649203|Niacin|niacin|mesh-list
56625317|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
56625318|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
56625319|NCT04649203|Vitamins|vitamins|mesh-ancestor
56625320|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
56625321|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059084|NCT02977013|Dalteparin|dalteparin|mesh-list
56625323|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
56625324|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56625325|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
56625326|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625327|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56625328|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
56625329|NCT00881725|Metformin|metformin|mesh-list
56625330|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56625331|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625332|NCT05086224|Lidocaine|lidocaine|mesh-list
56625333|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
56625334|NCT05086224|Anesthetics|anesthetics|mesh-list
56625335|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625336|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625337|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
56625338|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625339|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56196419|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56196420|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56196421|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56196422|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196423|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196424|NCT01503450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56196425|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56196426|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196427|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196430|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
56196431|NCT01503502|HH-GV-678|hh-gv-678|mesh-list
56196432|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110791|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56110792|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56110820|NCT04730856|Dalteparin|dalteparin|mesh-list
56110821|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
56110822|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56110823|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56110824|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110825|NCT02115282|Exemestane|exemestane|mesh-list
56625340|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56625341|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56625342|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56625343|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625344|NCT00954941|Ondansetron|ondansetron|mesh-list
56625345|NCT00954941|Aprepitant|aprepitant|mesh-list
56625346|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
56625347|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
56625348|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625349|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625350|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56625351|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
56625352|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
56625353|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56625354|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
56625355|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625356|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625357|NCT00954941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56625358|NCT00954941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56625359|NCT00954941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625360|NCT00954941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56625361|NCT00954941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56625362|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56625363|NCT05339646|Ritonavir|ritonavir|mesh-list
56625364|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56625365|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56625366|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
56625367|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625368|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625369|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56625370|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56625371|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
56625372|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625373|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56625374|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56110826|NCT02115282|Goserelin|goserelin|mesh-list
56110827|NCT02115282|Entinostat|entinostat|mesh-list
56373915|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625375|NCT00630695|Lanreotide|lanreotide|mesh-list
56625376|NCT00630695|Somatostatin|somatostatin|mesh-list
56625377|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625378|NCT00630695|Hormones|hormones|mesh-ancestor
56625379|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56625380|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625381|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56625382|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56625383|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625384|NCT00954707|Aspirin|aspirin|mesh-list
56625385|NCT00954707|Clopidogrel|clopidogrel|mesh-list
56625386|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56625387|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56625388|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625390|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
56625391|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625392|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625393|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56625394|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625395|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56625396|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56625397|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625398|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56625424|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56625425|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625426|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56625427|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625428|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56625429|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56625430|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56625431|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
56625432|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625433|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56625434|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56625435|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625436|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625437|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56625438|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56625439|NCT03894345|Prazosin|prazosin|mesh-list
56625440|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56625441|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56625442|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56625443|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56625444|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
56625445|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625450|NCT02859077|Pemetrexed|pemetrexed|mesh-list
56625471|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625472|NCT03851835|Ondansetron|ondansetron|mesh-list
56625473|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
56625474|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
56625475|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625476|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625477|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56625478|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
56625479|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
56625480|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56625481|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
56625482|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625534|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
56625535|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625537|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
56625538|NCT02543671|Vitamins|vitamins|mesh-ancestor
56625539|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
56625540|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625541|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56625542|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56625543|NCT02838992|Cyclosporine|cyclosporine|mesh-list
56625544|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
56625545|NCT02838992|Cyclosporins|cyclosporins|mesh-list
56625546|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
56625547|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56625548|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
56625549|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625550|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625551|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56625552|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
56625553|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625554|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625555|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56625556|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625557|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
56625558|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625559|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
56625560|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56625561|NCT00879541|Factor VIII|factor viii|mesh-list
56625562|NCT00879541|Coagulants|coagulants|mesh-ancestor
56625563|NCT00884299|Antioxidants|antioxidants|mesh-list
56625564|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625565|NCT00884299|Protective Agents|protective agents|mesh-ancestor
56625566|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625567|NCT02843126|Trastuzumab|trastuzumab|mesh-list
56625568|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56625569|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625570|NCT04627753|Rituximab|rituximab|mesh-list
56625571|NCT04627753|Lenalidomide|lenalidomide|mesh-list
56625572|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56625573|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625574|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
56625575|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625576|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625577|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56625578|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56625579|NCT04627753|Growth Substances|growth substances|mesh-ancestor
56625580|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
56625581|NCT04201652|Anesthetics|anesthetics|mesh-list
56625582|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
56625583|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625584|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625585|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
56625586|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625587|NCT05338476|Midazolam|midazolam|mesh-list
56625588|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56625589|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56625590|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625591|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625629|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56625630|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
56625631|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625632|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625633|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56625634|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
56625635|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625636|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625637|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56625638|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
56625639|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
56625640|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
56625641|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56625642|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56625643|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56625645|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
56625686|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625687|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
56625688|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56625689|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
56625690|NCT02837198|Dotinurad|dotinurad|mesh-list
56625691|NCT02837198|FYX-051|fyx-051|mesh-list
56625692|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
56625693|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
56625694|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625695|NCT02837198|Renal Agents|renal agents|mesh-ancestor
56625696|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56625697|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625698|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56625699|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56625700|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56625701|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56625702|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625703|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
56625704|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625705|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625706|NCT04038307|Acetaminophen|acetaminophen|mesh-list
56625707|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625708|NCT04038307|Analgesics|analgesics|mesh-ancestor
56625709|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
56625710|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625711|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625712|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
56625713|NCT04985604|Niacinamide|niacinamide|mesh-list
56625714|NCT04985604|Vitamin B Complex|vitamin b complex|mesh-ancestor
56625733|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625734|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625735|NCT02842814|Hormones|hormones|mesh-ancestor
56625736|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56625737|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625738|NCT00882193|Ribavirin|ribavirin|mesh-list
56625739|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56625740|NCT00882193|Betaine|betaine|mesh-list
56625741|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
56625742|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625743|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
56625744|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625745|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56625746|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
56625747|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56625748|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56625749|NCT02778360|Methylphenidate|methylphenidate|mesh-list
56159788|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
56625789|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625790|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56625791|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56625792|NCT04273529|Growth Substances|growth substances|mesh-ancestor
56625793|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
56625794|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625795|NCT02858843|Ivacaftor|ivacaftor|mesh-list
56625796|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56625797|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56625798|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625799|NCT02779530|Diclofenac|diclofenac|mesh-list
56625800|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56625801|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625802|NCT02779530|Analgesics|analgesics|mesh-ancestor
56625803|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
56625804|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625805|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625806|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56625811|NCT00952523|Adapalene|adapalene|mesh-list
56625846|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625847|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
56625848|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56625849|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625850|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56625851|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625852|NCT02232737|Nicotine|nicotine|mesh-list
56625853|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56625854|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
56625855|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625856|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625857|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56625858|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56625859|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
56625860|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110828|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56110829|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110830|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56110831|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56110832|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110833|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110834|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56110835|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
56110836|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110863|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110864|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
56110865|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110866|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56110867|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56110868|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
56110869|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110870|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110871|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56110872|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56110873|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56110874|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
56110875|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110877|NCT02085252|Leuprolide|leuprolide|mesh-list
56110878|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
56110879|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
56110880|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110881|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110882|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110883|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56110884|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
56196433|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56196434|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196435|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196436|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
56196437|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56196438|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56196439|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56196440|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196441|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196442|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196443|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625861|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625862|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56625863|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625864|NCT02777814|Entecavir|entecavir|mesh-list
56625865|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
56625866|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56625867|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
56625868|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56625869|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625870|NCT02778906|Abatacept|abatacept|mesh-list
56625871|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56625872|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625873|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56625874|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56625875|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
56625876|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625877|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625878|NCT00630929|Ibuprofen|ibuprofen|mesh-list
56625879|NCT00630929|Celecoxib|celecoxib|mesh-list
56625880|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56625881|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625882|NCT00630929|Analgesics|analgesics|mesh-ancestor
56625883|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
56625884|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625885|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625910|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56625911|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625912|NCT04227912|Analgesics|analgesics|mesh-ancestor
56625913|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56625914|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56625915|NCT02854787|Phenylephrine|phenylephrine|mesh-list
56625916|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
56625917|NCT02854787|Norepinephrine|norepinephrine|mesh-list
56625918|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56625919|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
56625920|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
56625921|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625922|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625923|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
56625924|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56625925|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
56625934|NCT02778828|Linezolid|linezolid|mesh-list
56625968|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56625969|NCT02836184|Niacin|niacin|mesh-list
56625970|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
56625971|NCT02836184|Niacinamide|niacinamide|mesh-list
56625972|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
56625973|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625974|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56625975|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
56625976|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625977|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56625978|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
56625979|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
56625980|NCT02836184|Vitamins|vitamins|mesh-ancestor
56625981|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
56625982|NCT02836184|Antacids|antacids|mesh-ancestor
56625983|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56625984|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
56625985|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56625986|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56625987|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56625988|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56625989|NCT04824144|Analgesics|analgesics|mesh-ancestor
56625990|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
56625991|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56625992|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56625993|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56625994|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56625995|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
56625996|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56625997|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56625998|NCT02775474|Fentanyl|fentanyl|mesh-list
56625999|NCT02775474|Methadone|methadone|mesh-list
56626000|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56626001|NCT02775474|Narcotics|narcotics|mesh-ancestor
56626002|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196444|NCT01503580|Urological Agents|urological agents|mesh-ancestor
56196445|NCT01503593|Calcium|calcium|mesh-list
56196446|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56110916|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56110917|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110918|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110919|NCT02083380|Piperaquine|piperaquine|mesh-list
56626003|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626004|NCT02775474|Analgesics|analgesics|mesh-ancestor
56626005|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
56626006|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626007|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56626008|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56626009|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
56626010|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
56626011|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
56626012|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
56626013|NCT05158686|Paclitaxel|paclitaxel|mesh-list
56626014|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56626015|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626016|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
56626017|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
56626018|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
56626019|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626020|NCT02835794|Azacitidine|azacitidine|mesh-list
56626021|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
56626022|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56626023|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
56626024|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626025|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626026|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626027|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56626028|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56626029|NCT02836028|Temozolomide|temozolomide|mesh-list
56626049|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626050|NCT04227210|Vaccines|vaccines|mesh-list
56626051|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
56626052|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626053|NCT02833766|Doxorubicin|doxorubicin|mesh-list
56626054|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56626055|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626056|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56626057|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56626058|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626060|NCT04951362|Ivermectin|ivermectin|mesh-list
56626119|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626120|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374671|NCT00437359|Toremifene|toremifene|mesh-list
56626121|NCT02776956|Atorvastatin|atorvastatin|mesh-list
56626122|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56626124|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
56626125|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626126|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56626127|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56626128|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626129|NCT04910178|Empagliflozin|empagliflozin|mesh-list
56626183|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
56626184|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626185|NCT02776878|Dasatinib|dasatinib|mesh-list
56626186|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626187|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626188|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626189|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626190|NCT02772822|Rituximab|rituximab|mesh-list
56626191|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56159794|NCT03057132|Protective Agents|protective agents|mesh-list
56626192|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626193|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
56626194|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374744|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626195|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56626196|NCT00635076|Alprazolam|alprazolam|mesh-list
56626197|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56626198|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626199|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626200|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56626201|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56626202|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56626233|NCT02774460|Protective Agents|protective agents|mesh-ancestor
56626234|NCT02772354|Metoprolol|metoprolol|mesh-list
56626235|NCT02772354|Verapamil|verapamil|mesh-list
56626236|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56626237|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56626238|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
56626239|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
56626240|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626241|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626242|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56626243|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56626244|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56626245|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
56626246|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626247|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626293|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
56626294|NCT02767674|Antiviral Agents|antiviral agents|mesh-ancestor
56626295|NCT02767674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626296|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626297|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626298|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
56626299|NCT02767674|Hormones|hormones|mesh-ancestor
56626300|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56626301|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56626302|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56626303|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56626304|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56626305|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56626306|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
56626307|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
56626308|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
56626309|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
56626310|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56626311|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626312|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626313|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56626314|NCT02833688|Analgesics|analgesics|mesh-ancestor
56626315|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
56626316|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626328|NCT00612313|Fluoxetine|fluoxetine|mesh-list
56626342|NCT00890552|Dexamethasone|dexamethasone|mesh-list
56626343|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
56626344|NCT00890552|Lenalidomide|lenalidomide|mesh-list
56626345|NCT00890552|Melphalan|melphalan|mesh-list
56626346|NCT00890552|BB 1101|bb 1101|mesh-list
56626347|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626348|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
56626349|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
56626350|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626351|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626352|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56626353|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
56626354|NCT00890552|Hormones|hormones|mesh-ancestor
56626355|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56626356|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56626357|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626358|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
56626359|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626360|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626361|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
56626362|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56626363|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56626364|NCT00890552|Growth Substances|growth substances|mesh-ancestor
56110920|NCT02083380|Artefenomel|artefenomel|mesh-list
56110921|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
56110922|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56110923|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56110924|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110925|NCT02109744|Decitabine|decitabine|mesh-list
56110926|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56110954|NCT02082912|Cycloserine|cycloserine|mesh-list
56110955|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56110956|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110957|NCT02082912|Renal Agents|renal agents|mesh-ancestor
56110961|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
56110962|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110963|NCT02082522|Gemcitabine|gemcitabine|mesh-list
56110964|NCT02082522|Cisplatin|cisplatin|mesh-list
56110965|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56110966|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
56110967|NCT02082522|Trioxsalen|trioxsalen|mesh-list
56110968|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110969|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56110970|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
56110971|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110972|NCT02082522|Antiviral Agents|antiviral agents|mesh-ancestor
56110973|NCT02082522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110974|NCT02082522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110975|NCT02082522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110997|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56110998|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
56110999|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56111000|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
55805468|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
56626365|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
56626366|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56626367|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
56626368|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56626369|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56626370|NCT02856503|Vitamin D|vitamin d|mesh-list
56626371|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
56626372|NCT02856503|Vitamins|vitamins|mesh-ancestor
56626373|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
56626374|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626375|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56626376|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56626377|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
56626429|NCT00946985|Risperidone|risperidone|mesh-list
56626430|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56626431|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56626432|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
56626433|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626434|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626435|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626436|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56626437|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56626441|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
56626495|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56626496|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56626497|NCT00633386|Celecoxib|celecoxib|mesh-list
56626498|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56626499|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56626500|NCT00633386|Analgesics|analgesics|mesh-ancestor
56626501|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
56626502|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626503|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626504|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626505|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56626506|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56626507|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56626508|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626509|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626510|NCT02771418|Anesthetics|anesthetics|mesh-list
56626511|NCT02771418|Propofol|propofol|mesh-list
56626512|NCT02771418|Sevoflurane|sevoflurane|mesh-list
56626513|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626514|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626515|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56626516|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56626517|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
56626518|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56626519|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56626520|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56626521|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
56626522|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56626523|NCT00888901|Prednisolone|prednisolone|mesh-list
56626524|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
56626525|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56626526|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
56626528|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
56626537|NCT00888901|Protective Agents|protective agents|mesh-ancestor
56626538|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56626539|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626540|NCT00803049|Teriflunomide|teriflunomide|mesh-list
56626541|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56626542|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56626543|NCT00803049|Analgesics|analgesics|mesh-ancestor
56626544|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
56626545|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626546|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626547|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626548|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56626549|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56626550|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
56626551|NCT00884767|Leucovorin|leucovorin|mesh-list
56626552|NCT00884767|Fluorouracil|fluorouracil|mesh-list
56626553|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
56626554|NCT00884767|Calcium|calcium|mesh-list
56626555|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
56626556|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56111001|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111002|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111003|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56111004|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56111005|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111006|NCT01624662|Fluticasone|fluticasone|mesh-list
56196447|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196448|NCT01503658|Aspirin|aspirin|mesh-list
56196449|NCT01503658|Clopidogrel|clopidogrel|mesh-list
56196450|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56196451|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56196452|NCT01503658|Analgesics|analgesics|mesh-ancestor
56196453|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
56196454|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196455|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196456|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56196457|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196458|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56196459|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56196460|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196461|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56196462|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56196463|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196464|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
56196465|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56196466|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56111008|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111009|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56111010|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
56111011|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111012|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111013|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56111014|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
56111015|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56626557|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626558|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
56626559|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626560|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56626561|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626562|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56626563|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
56626565|NCT00884767|Protective Agents|protective agents|mesh-ancestor
56626566|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
56626567|NCT00884767|Vitamins|vitamins|mesh-ancestor
56111016|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56111017|NCT02106390|Vaccines|vaccines|mesh-list
56111018|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
56111019|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111020|NCT02064894|Ibuprofen|ibuprofen|mesh-list
56111021|NCT02064894|Morphine|morphine|mesh-list
56111022|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56111023|NCT02064894|Narcotics|narcotics|mesh-ancestor
56111024|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56111025|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111026|NCT02064894|Analgesics|analgesics|mesh-ancestor
56111027|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
56111028|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111029|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56111030|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56111064|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56111065|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
56111066|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111067|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
56111069|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56196467|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56111070|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56111071|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
56111072|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111073|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111074|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111075|NCT02045862|Urological Agents|urological agents|mesh-ancestor
56111076|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56111092|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56111093|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111094|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
56111095|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56111096|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111097|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111098|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56111099|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56111100|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
56111101|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56111102|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111104|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
56111105|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56111106|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56111107|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56111108|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
56111109|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111111|NCT02044302|Narcotics|narcotics|mesh-list
56111112|NCT02044302|Analgesics|analgesics|mesh-list
56111113|NCT02044302|Bupivacaine|bupivacaine|mesh-list
56111153|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56111154|NCT02043366|Narcotics|narcotics|mesh-ancestor
56111155|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56111156|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111157|NCT02043366|Analgesics|analgesics|mesh-ancestor
56111158|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
56111159|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626568|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
56626569|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56626570|NCT00890084|Telmisartan|telmisartan|mesh-list
56626571|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
56626572|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56626573|NCT00890084|Diuretics|diuretics|mesh-ancestor
56626574|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
56626575|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626576|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56626577|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56626578|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626579|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56111160|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56111161|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56111162|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
56111163|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
56111164|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56111165|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56111166|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111167|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56111168|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56111169|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111170|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111171|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
56111172|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
56111173|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56111187|NCT01622088|Protective Agents|protective agents|mesh-ancestor
56111188|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111189|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56111190|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56111191|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
56111192|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
56111193|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111194|NCT02021292|Macitentan|macitentan|mesh-list
56111195|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56111196|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56111198|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56111199|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
56111200|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
56111201|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56111202|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111203|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
56111204|NCT02043132|Coagulants|coagulants|mesh-ancestor
56111205|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
56111207|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56111208|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
56111209|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111210|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196468|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
56196469|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111211|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56111212|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
56111213|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
56111214|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56111215|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
56111216|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111217|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111218|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56111219|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56111220|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56626580|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56626581|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56626582|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626583|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626584|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626585|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626586|NCT02773602|Dexamethasone|dexamethasone|mesh-list
56626587|NCT02773602|Clonidine|clonidine|mesh-list
56626588|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626589|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
56626590|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
56626591|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626592|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626593|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56626594|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
56626595|NCT02773602|Hormones|hormones|mesh-ancestor
56626596|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56626597|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56111221|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56111222|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
56111223|NCT02059278|Latanoprost|latanoprost|mesh-list
56111224|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56111225|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56111226|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
56111227|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56111228|NCT04722354|Growth Substances|growth substances|mesh-ancestor
56111229|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111230|NCT02020512|Bimatoprost|bimatoprost|mesh-list
56111231|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56111233|NCT02019420|Tedizolid|tedizolid|mesh-list
56111234|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
56111243|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56111244|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56111245|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111246|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111247|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56111248|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111249|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
56111250|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
56111251|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111252|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
56111253|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111254|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
56111255|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56111256|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56111257|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56111258|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56111260|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111261|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111262|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
56111263|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111264|NCT02040870|Ceritinib|ceritinib|mesh-list
56111265|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111266|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56111267|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111268|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626598|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626599|NCT02773602|Analgesics|analgesics|mesh-ancestor
56626600|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
56626601|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56626602|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
56626603|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56626604|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56626605|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56626606|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
56626607|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626608|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626609|NCT02770950|Indomethacin|indomethacin|mesh-list
56626610|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56626611|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56626612|NCT02770950|Analgesics|analgesics|mesh-ancestor
56626613|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
56626614|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626615|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626616|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626617|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56626618|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
56111269|NCT04720716|Sorafenib|sorafenib|mesh-list
56111270|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111271|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56111272|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111273|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111274|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
56111275|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111276|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111277|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111278|NCT02039778|Temozolomide|temozolomide|mesh-list
56111279|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56111280|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
55742050|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
56111281|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111282|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111283|NCT02015676|Paclitaxel|paclitaxel|mesh-list
56111284|NCT02015676|Trastuzumab|trastuzumab|mesh-list
56111285|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56111286|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111287|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
56196471|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56111292|NCT02058108|Telbivudine|telbivudine|mesh-list
56111293|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
56111294|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111295|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56111296|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111297|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111298|NCT04678362|Avelumab|avelumab|mesh-list
56111299|NCT04678362|Talazoparib|talazoparib|mesh-list
56111300|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111301|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626619|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
56626620|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56626621|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56626622|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626623|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626624|NCT00889057|Sorafenib|sorafenib|mesh-list
56626625|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626626|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626627|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626628|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626629|NCT05684289|Sildenafil Citrate|sildenafil citrate|mesh-list
56626630|NCT05684289|Vasodilator Agents|vasodilator agents|mesh-ancestor
56626631|NCT05684289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56626632|NCT05684289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56626633|NCT05684289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626634|NCT05684289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626635|NCT05684289|Urological Agents|urological agents|mesh-ancestor
56626636|NCT02829008|Bevacizumab|bevacizumab|mesh-list
56626637|NCT02829008|Pemetrexed|pemetrexed|mesh-list
56626638|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56626639|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111302|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56111303|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111304|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111305|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
56111306|NCT04678050|Ketamine|ketamine|mesh-list
56111307|NCT04678050|Propofol|propofol|mesh-list
56111308|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56111309|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56111310|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111311|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56111312|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
56111313|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
55838267|NCT01900730|Valproic Acid|valproic acid|mesh-list
56111314|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56111315|NCT04678050|Analgesics|analgesics|mesh-ancestor
56111316|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
56111317|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111318|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56111319|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56111320|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56111321|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
56111322|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111323|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111324|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56111325|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56111326|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56111327|NCT02038920|Vedolizumab|vedolizumab|mesh-list
56111328|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56111329|NCT01622868|Lapatinib|lapatinib|mesh-list
56111330|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111331|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626640|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56626641|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56626642|NCT02829008|Growth Substances|growth substances|mesh-ancestor
56626643|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626644|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
56626645|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375221|NCT00441181|Travoprost|travoprost|mesh-list
56626646|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626647|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56626648|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56626650|NCT05683821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56626651|NCT05683821|Autonomic Agents|autonomic agents|mesh-ancestor
56626652|NCT05683821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626653|NCT05683821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626654|NCT05683821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56626655|NCT05683821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56626656|NCT05683821|Cholinergic Agents|cholinergic agents|mesh-ancestor
56626657|NCT05683821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626658|NCT05683821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626659|NCT00889135|Droxidopa|droxidopa|mesh-list
56626660|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56626661|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56111332|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111345|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111346|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
56111347|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111348|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111349|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56111350|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
56111351|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111352|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56111353|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
56111354|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111355|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
56111356|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
56111357|NCT02057250|Methotrexate|methotrexate|mesh-list
56111358|NCT02057250|Leflunomide|leflunomide|mesh-list
56111359|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56111360|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
56111361|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56111362|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111363|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56111365|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111366|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111367|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56111368|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111369|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56111370|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111371|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
56111372|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56626662|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56626663|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
56626664|NCT00889213|Coagulants|coagulants|mesh-ancestor
56626665|NCT00382200|Decitabine|decitabine|mesh-list
56626666|NCT00382200|Tretinoin|tretinoin|mesh-list
56626667|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56626668|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
56626669|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626670|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196473|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
56196474|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196475|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56196476|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56196477|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196478|NCT01503736|Citric Acid|citric acid|mesh-list
56196479|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
56196480|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
56196481|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
56196482|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56196483|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
56196484|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
56196485|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196486|NCT01503736|Hematinics|hematinics|mesh-ancestor
56196487|NCT01503788|Midazolam|midazolam|mesh-list
56196488|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56196489|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56196490|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196491|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196492|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56196493|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56196494|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196495|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56196496|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
56196497|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
56196498|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
56111373|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56111374|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
56111375|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56111376|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56111377|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111378|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56111379|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56111380|NCT02057250|Analgesics|analgesics|mesh-ancestor
56111381|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
56111382|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111383|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111384|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56111385|NCT02036502|Dexamethasone|dexamethasone|mesh-list
56111386|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
56111387|NCT02036502|Lenalidomide|lenalidomide|mesh-list
56111397|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56111398|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111399|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111401|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56111402|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56111403|NCT02036502|Growth Substances|growth substances|mesh-ancestor
56111404|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
56111405|NCT02056626|Carvedilol|carvedilol|mesh-list
56196499|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
56196500|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196501|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196502|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
56196503|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
56196504|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56196505|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
56196506|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196507|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196508|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56626671|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626672|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
56626673|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
56626674|NCT02696928|Lumefantrine|lumefantrine|mesh-list
56626675|NCT02696928|Primaquine|primaquine|mesh-list
56626676|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
56626677|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56626678|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56626679|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626680|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
56626681|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
56626682|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56626683|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56626684|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56626685|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56626686|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626687|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626688|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626689|NCT00889369|Analgesics|analgesics|mesh-ancestor
56626690|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
56626691|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626692|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
56626693|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56626694|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
56626695|NCT02766192|Ketamine|ketamine|mesh-list
56626696|NCT02766192|Analgesics|analgesics|mesh-ancestor
56626697|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
56626698|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626699|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626700|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56626716|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56626717|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56626718|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
56375274|NCT00107822|Lidocaine|lidocaine|mesh-list
56626719|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
56626720|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626721|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626722|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626724|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
56196509|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
56196510|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56196511|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
56111406|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56111407|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56111408|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
56111409|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111410|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111411|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111412|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56111413|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
56111414|NCT02056626|Protective Agents|protective agents|mesh-ancestor
56111415|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56111416|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56111417|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56111418|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
56111419|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56111420|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56111421|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
56111422|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56111423|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111424|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56111425|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55742052|NCT04841499|Vitamins|vitamins|mesh-ancestor
56111426|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111427|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111428|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111430|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
56111431|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56111432|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111433|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
56111434|NCT02034552|Hormones|hormones|mesh-ancestor
56111461|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111463|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111464|NCT02034006|Ranibizumab|ranibizumab|mesh-list
56111465|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56111466|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56111467|NCT02034006|Growth Substances|growth substances|mesh-ancestor
56111468|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111469|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
56111470|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111471|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
56111472|NCT02054520|Nivolumab|nivolumab|mesh-list
56111473|NCT02054520|Ipilimumab|ipilimumab|mesh-list
56111474|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111475|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111476|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56196512|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196513|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196515|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
56196516|NCT01503801|Protective Agents|protective agents|mesh-ancestor
56196517|NCT01503905|Tamoxifen|tamoxifen|mesh-list
56196518|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
56196519|NCT01503905|Docetaxel|docetaxel|mesh-list
56196520|NCT01503905|Trastuzumab|trastuzumab|mesh-list
56196521|NCT01503905|Epirubicin|epirubicin|mesh-list
56196522|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111477|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626725|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56626726|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56626727|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
56626728|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56111478|NCT04675788|Ibutilide|ibutilide|mesh-list
56111479|NCT04675788|Testosterone|testosterone|mesh-list
56111480|NCT04675788|Progesterone|progesterone|mesh-list
56111481|NCT04675788|Androgens|androgens|mesh-ancestor
56111482|NCT04675788|Hormones|hormones|mesh-ancestor
56111499|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111500|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
56111501|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111502|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56111503|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111504|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
56111505|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111506|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111507|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56111508|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
56111509|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111511|NCT02052414|Analgesics|analgesics|mesh-ancestor
56111512|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
56111513|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111514|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111515|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
56111516|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56111517|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56111518|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56111519|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56111520|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56111521|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56111522|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111523|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111524|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
56111525|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56111526|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
56111527|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111528|NCT01363440|Aflibercept|aflibercept|mesh-list
56111529|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56111530|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56111531|NCT01363440|Growth Substances|growth substances|mesh-ancestor
56111532|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111533|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
56111534|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111535|NCT02007096|Bupivacaine|bupivacaine|mesh-list
56111536|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
56111537|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
55838491|NCT01408888|Dulaglutide|dulaglutide|mesh-list
56111538|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56111539|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111551|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111553|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
56111554|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111555|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56111556|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56111557|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
56111558|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56111559|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56196523|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
56196524|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196525|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196526|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56196527|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
56196528|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196529|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196530|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56196531|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
56111560|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
56111561|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111562|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
56111563|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626729|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56626730|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
56626731|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
56626732|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626733|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626734|NCT02766270|Temozolomide|temozolomide|mesh-list
56111564|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56111565|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111566|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56111567|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111568|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
56111569|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
56111570|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111571|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56111572|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
56111574|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111575|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56111576|NCT02006706|Protective Agents|protective agents|mesh-ancestor
56111577|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56111578|NCT02049138|Upadacitinib|upadacitinib|mesh-list
56111579|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56111580|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56111581|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111582|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111583|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56111616|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
56111617|NCT02029638|Hormones|hormones|mesh-ancestor
56111618|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111619|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56111620|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56111621|NCT02029638|Analgesics|analgesics|mesh-ancestor
56111622|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
56111623|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111624|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
56111625|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56111626|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56111641|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56111642|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
56111643|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
56111644|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111645|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56111646|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
56111647|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
56111648|NCT02047734|Interferons|interferons|mesh-list
56111649|NCT02047734|Interferon-beta|interferon-beta|mesh-list
56111650|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
56111651|NCT02047734|Ozanimod|ozanimod|mesh-list
56111652|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111653|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
56111654|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111655|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
56111656|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196532|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
56196533|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
56196534|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111657|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56111658|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56111659|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111660|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111661|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56111662|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111663|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111664|NCT01994382|Rituximab|rituximab|mesh-list
56111665|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111666|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111667|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
56111668|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111669|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56111670|NCT02003898|Insulin|insulin|mesh-list
56626735|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56626736|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
56626737|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626738|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626739|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56626740|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
56626741|NCT02766348|Gemcitabine|gemcitabine|mesh-list
56626742|NCT02766348|Cisplatin|cisplatin|mesh-list
56626743|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56626744|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
56626745|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626746|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626747|NCT02766348|Antiviral Agents|antiviral agents|mesh-ancestor
56626748|NCT02766348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626749|NCT02766348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626750|NCT02766348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56626751|NCT02766348|Immunologic Factors|immunologic factors|mesh-ancestor
56626752|NCT02766348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626753|NCT00608569|Ritonavir|ritonavir|mesh-list
56626754|NCT00608569|Lopinavir|lopinavir|mesh-list
56626755|NCT00608569|Tenofovir|tenofovir|mesh-list
56626756|NCT00608569|Zidovudine|zidovudine|mesh-list
56626757|NCT00608569|Emtricitabine|emtricitabine|mesh-list
56626758|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56626759|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56626760|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56626761|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
56626762|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626763|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626764|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56626765|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56626766|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
56626767|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111671|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56111672|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111673|NCT02027376|Docetaxel|docetaxel|mesh-list
56111674|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111675|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
56111722|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111724|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56111725|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
56111726|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56626768|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56626769|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56626770|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56626771|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56626772|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
56626773|NCT04699422|Pirinitramide|pirinitramide|mesh-list
56626774|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56626775|NCT04699422|Narcotics|narcotics|mesh-ancestor
56626776|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626777|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626778|NCT04699422|Analgesics|analgesics|mesh-ancestor
56626779|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
56626780|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626781|NCT02828384|Psyllium|psyllium|mesh-list
56626782|NCT02828384|Cathartics|cathartics|mesh-ancestor
56626783|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56626784|NCT00886717|Paclitaxel|paclitaxel|mesh-list
56626785|NCT00886717|Carboplatin|carboplatin|mesh-list
56626786|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56626787|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626788|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
56626789|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
56111727|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111728|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56111729|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56111730|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56111731|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
56111732|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56111733|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56111734|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
56111735|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111736|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
56111737|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56111738|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56111739|NCT01999218|Metformin|metformin|mesh-list
56111740|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56111741|NCT01999218|Glimepiride|glimepiride|mesh-list
56111742|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
56111743|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56111744|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111745|NCT01999218|Incretins|incretins|mesh-ancestor
56111746|NCT01999218|Hormones|hormones|mesh-ancestor
56111747|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111748|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56111772|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56111773|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56111774|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56111779|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56111781|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
56111782|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111783|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111784|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626790|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
56626791|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626792|NCT00889837|Loxapine|loxapine|mesh-list
56375344|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
56626793|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56626794|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56626795|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626796|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626797|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56626798|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56626799|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
56626800|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626801|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111785|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56111786|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56111787|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111788|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111789|NCT01989546|Talazoparib|talazoparib|mesh-list
56111790|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56111791|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196535|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56196536|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56196537|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56196538|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196539|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56196540|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
56196541|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56196542|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56196543|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56196544|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56196545|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56196546|NCT01503918|Valacyclovir|valacyclovir|mesh-list
56196547|NCT01503918|Valganciclovir|valganciclovir|mesh-list
56196548|NCT01503918|Acyclovir|acyclovir|mesh-list
56196549|NCT01503918|Ganciclovir|ganciclovir|mesh-list
56196550|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56196551|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
56196552|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111792|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111793|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111794|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56111859|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
56111860|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56111861|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56111862|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56111863|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56111864|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111865|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55742059|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
56111866|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56111867|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56111868|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56111869|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
56111870|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111871|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111872|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56111873|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56111874|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
56111875|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56626802|NCT02770404|Nafithromycin|nafithromycin|mesh-list
56626803|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56626804|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626805|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56626806|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626807|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626808|NCT00886873|Mifepristone|mifepristone|mesh-list
56626809|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56626810|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
56626811|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56626812|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626813|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56626814|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56626863|NCT00610675|Mirtazapine|mirtazapine|mesh-list
56626864|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
56626865|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56626866|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56626867|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
56626868|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
56111876|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56111877|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
56111879|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56111880|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111881|NCT01945242|Incretins|incretins|mesh-ancestor
56111882|NCT01945242|Hormones|hormones|mesh-ancestor
56111883|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111884|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56111885|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
56111886|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111887|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111888|NCT01945086|Ustekinumab|ustekinumab|mesh-list
56111889|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
56111890|NCT04658160|Imidacloprid|imidacloprid|mesh-list
56111892|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196553|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56196554|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196555|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196556|NCT01503983|Capecitabine|capecitabine|mesh-list
56196557|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
56196558|NCT01503983|Trastuzumab|trastuzumab|mesh-list
56196559|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56196560|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
56196561|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196562|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196563|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56196564|NCT01504074|Triamcinolone|triamcinolone|mesh-list
56196565|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56196566|NCT01504074|Levobunolol|levobunolol|mesh-list
56111893|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111894|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111895|NCT01963728|Insulin|insulin|mesh-list
56111896|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56111897|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
56111898|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
56111899|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
56111900|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
56111901|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56111902|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111903|NCT01962948|Paclitaxel|paclitaxel|mesh-list
56111904|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56111937|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
56111938|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111939|NCT01942590|Clenbuterol|clenbuterol|mesh-list
56111940|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56111941|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56111942|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
56111943|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111944|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111945|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111946|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56111947|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
56111973|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
56111974|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111975|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111976|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111977|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56111978|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111979|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56111980|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
56111981|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
56111982|NCT01984164|Candesartan|candesartan|mesh-list
56111983|NCT01984164|Lisinopril|lisinopril|mesh-list
56111984|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56626869|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375410|NCT00442585|Ibuprofen|ibuprofen|mesh-list
56626870|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626871|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626872|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56626873|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56111985|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56111986|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56111987|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111988|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56111989|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
56111990|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111991|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56111992|NCT01984164|Protective Agents|protective agents|mesh-ancestor
56111993|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196567|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56196568|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
56196569|NCT01504074|Hormones|hormones|mesh-ancestor
56111994|NCT01983774|Esomeprazole|esomeprazole|mesh-list
56111995|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56111996|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56112016|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112017|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
56112018|NCT01940484|Hematinics|hematinics|mesh-ancestor
56112019|NCT01960296|Clopidogrel|clopidogrel|mesh-list
56112020|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56112021|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56112022|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56112023|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56112025|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112026|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112027|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112028|NCT04653246|Dexamethasone|dexamethasone|mesh-list
56112029|NCT04653246|Lenalidomide|lenalidomide|mesh-list
56112030|NCT04653246|Bortezomib|bortezomib|mesh-list
56112031|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112032|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
56112033|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
56112034|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112035|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112036|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56112037|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
56112038|NCT04653246|Hormones|hormones|mesh-ancestor
56112039|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112040|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56112041|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112042|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
56112043|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56112044|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56112045|NCT04653246|Growth Substances|growth substances|mesh-ancestor
56112046|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
56112047|NCT01939314|Bupivacaine|bupivacaine|mesh-list
56112048|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
56112049|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
56112050|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56112051|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112074|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112075|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112076|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
56112077|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56112078|NCT01938846|Paclitaxel|paclitaxel|mesh-list
56112079|NCT01938846|Exemestane|exemestane|mesh-list
56112080|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56112081|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112082|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
56112083|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56112084|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
56112085|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626874|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626875|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56626876|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56626877|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56626878|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
56626879|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56626880|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56626881|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
56626882|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56626883|NCT02828228|Vitamin D|vitamin d|mesh-list
56626884|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
56626885|NCT02828228|Vitamins|vitamins|mesh-ancestor
56626886|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
56626887|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626888|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56626889|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56626890|NCT02769936|Cycloserine|cycloserine|mesh-list
56626891|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56626892|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626893|NCT02769936|Renal Agents|renal agents|mesh-ancestor
56626894|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56626895|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
56626896|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56626897|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
56626898|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626899|NCT00887029|Timolol|timolol|mesh-list
56626900|NCT00887029|Travoprost|travoprost|mesh-list
56626901|NCT00887029|Latanoprost|latanoprost|mesh-list
56626902|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56626903|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56626904|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56626905|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
56626906|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626907|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626915|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
56626916|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626917|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626918|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
56626919|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56626920|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626921|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56112086|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56112087|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56112088|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112089|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56112090|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
56112091|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112092|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112093|NCT04652700|Tenofovir|tenofovir|mesh-list
56112094|NCT04652700|Emtricitabine|emtricitabine|mesh-list
56112095|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56112096|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56112097|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
56112098|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112099|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56112100|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56112101|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196570|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56196571|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196572|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196573|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56196574|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196575|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56196576|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56196577|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
56196578|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196579|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
56196580|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
56196582|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56112137|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56112139|NCT01959672|Protective Agents|protective agents|mesh-ancestor
56112140|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
56112141|NCT01959672|Vitamins|vitamins|mesh-ancestor
56112142|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
56112144|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56112145|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56112146|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
56112147|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56112148|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56112149|NCT01980888|Rituximab|rituximab|mesh-list
56112150|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56112151|NCT01980888|Idelalisib|idelalisib|mesh-list
56112152|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56112153|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112154|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
56112155|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112156|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112157|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56112158|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
56112159|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112160|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112161|NCT04650282|Lidocaine|lidocaine|mesh-list
56112193|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112194|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56112195|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56112196|NCT01936974|Growth Substances|growth substances|mesh-ancestor
56112197|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112198|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
56112199|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56112200|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
56626922|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
56626923|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56626924|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56626925|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626926|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626927|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56626928|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
56626929|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
56626930|NCT00887107|Sorafenib|sorafenib|mesh-list
56626931|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626932|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626933|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56626934|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626935|NCT00802737|Ofatumumab|ofatumumab|mesh-list
56626936|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56626937|NCT02769390|Clonidine|clonidine|mesh-list
56626938|NCT02769390|Diazepam|diazepam|mesh-list
56112201|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112202|NCT01936974|Antiviral Agents|antiviral agents|mesh-ancestor
56112215|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
56112216|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56112217|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
56112218|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112219|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112220|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56112221|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56112222|NCT01979016|Emollients|emollients|mesh-list
56112223|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
56112224|NCT01935336|Ponatinib|ponatinib|mesh-list
56112225|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196583|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56196584|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
56112226|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56112227|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112228|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112229|NCT01978236|Trametinib|trametinib|mesh-list
56112230|NCT01978236|Dabrafenib|dabrafenib|mesh-list
56112231|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112232|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56112233|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112234|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112235|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56112236|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112237|NCT01934556|Ranibizumab|ranibizumab|mesh-list
56112238|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56112239|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56112240|NCT01934556|Growth Substances|growth substances|mesh-ancestor
56112241|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112242|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
56112243|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112244|NCT04411212|Lenograstim|lenograstim|mesh-list
56112245|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56112246|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
56112247|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112248|NCT01620138|Cabergoline|cabergoline|mesh-list
56112249|NCT01620138|Pasireotide|pasireotide|mesh-list
56112250|NCT01620138|Hormones|hormones|mesh-ancestor
56112251|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55805555|NCT02328105|Carboplatin|carboplatin|mesh-list
56626939|NCT02769390|Analgesics|analgesics|mesh-ancestor
56626940|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
56626941|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626942|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626943|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56375488|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112252|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112253|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56112254|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56112272|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112273|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
56112274|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112275|NCT01977456|Eptifibatide|eptifibatide|mesh-list
56112276|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56112277|NCT01957644|Azacitidine|azacitidine|mesh-list
56112278|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56112279|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
56112280|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112281|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112282|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112284|NCT01931202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55839232|NCT01753401|Hormones|hormones|mesh-ancestor
56112285|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56112286|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56112287|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112288|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112289|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
56112290|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112291|NCT01931202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56112292|NCT01931202|Antidepressive Agents|antidepressive agents|mesh-ancestor
56112293|NCT01931202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56112294|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
56112295|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56112296|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112297|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56112298|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
56112299|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56112300|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112301|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112302|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112303|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56112304|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56112305|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112307|NCT01930188|Hormones|hormones|mesh-ancestor
56112345|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112346|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112347|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56196585|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196586|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196587|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196588|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56196589|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56196590|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
56196591|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56196592|NCT01504139|Estradiol|estradiol|mesh-list
56196593|NCT01504139|Progesterone|progesterone|mesh-list
56196594|NCT01504139|Estrogens|estrogens|mesh-ancestor
56196595|NCT01504139|Hormones|hormones|mesh-ancestor
56196596|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56196597|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196598|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56196599|NCT01504139|Progestins|progestins|mesh-ancestor
56196600|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56112348|NCT01928940|Trametinib|trametinib|mesh-list
56112349|NCT01928940|Dabrafenib|dabrafenib|mesh-list
56112350|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112351|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56626944|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
56626945|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
56626946|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56626947|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56626948|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56626949|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
56112352|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112353|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112354|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
56112355|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112356|NCT01975272|Iron|iron|mesh-list
56112358|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
56112359|NCT01975272|Trace Elements|trace elements|mesh-ancestor
56112360|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
56112361|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112362|NCT01975272|Hematinics|hematinics|mesh-ancestor
56112363|NCT03965039|Fluorides|fluorides|mesh-list
56112364|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
56112365|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
56112366|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
56112367|NCT03965039|Protective Agents|protective agents|mesh-ancestor
56112368|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112369|NCT03961295|Vedolizumab|vedolizumab|mesh-list
56112370|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56112371|NCT03935399|Oxytocin|oxytocin|mesh-list
56112372|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
55715308|NCT02200757|Topotecan|topotecan|mesh-list
56112374|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112375|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56112376|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
56112377|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112378|NCT03993119|Anticoagulants|anticoagulants|mesh-list
56112379|NCT03910439|Avelumab|avelumab|mesh-list
56112380|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56112438|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112439|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56112440|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56112442|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112443|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56112444|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56112445|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
56112446|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112447|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
56112448|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
56112449|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112450|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56112451|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
56196602|NCT01504178|Apomorphine|apomorphine|mesh-list
56112452|NCT02994251|Gemcitabine|gemcitabine|mesh-list
56112453|NCT02994251|Doxorubicin|doxorubicin|mesh-list
56112454|NCT02994251|Mitomycins|mitomycins|mesh-list
56112455|NCT02994251|Mitomycin|mitomycin|mesh-list
56112456|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112457|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56112458|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
56112459|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112460|NCT02994251|Antiviral Agents|antiviral agents|mesh-ancestor
56112461|NCT02994251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112462|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112463|NCT02994251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56112464|NCT02994251|Immunologic Factors|immunologic factors|mesh-ancestor
56112482|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112484|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112485|NCT00378443|Prednisone|prednisone|mesh-list
56112486|NCT00378443|Losartan|losartan|mesh-list
56112487|NCT00378443|Cilazapril|cilazapril|mesh-list
56112488|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112489|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
56112490|NCT00378443|Hormones|hormones|mesh-ancestor
56112491|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112492|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626950|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626951|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626952|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56626953|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
56626954|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
56626955|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56626956|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56626957|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56626958|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56626959|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56626960|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56626961|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56626962|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56626963|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56112493|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56112494|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112495|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56112496|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56112497|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56112498|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56112499|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112500|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56112501|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
56112502|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112503|NCT01340573|Interferons|interferons|mesh-list
56112504|NCT01340573|Ribavirin|ribavirin|mesh-list
56112505|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56112506|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112507|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
56112508|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112509|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
56112510|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112511|NCT01340885|Rivastigmine|rivastigmine|mesh-list
56112512|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56112513|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56112514|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56112515|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56112516|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112517|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
56112518|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112519|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112520|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56112547|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56112548|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56112549|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
56112550|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112551|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
56112552|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56112553|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56112554|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56112555|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112556|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
56112557|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112558|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112559|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56112560|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112561|NCT02708849|Lamotrigine|lamotrigine|mesh-list
56112562|NCT02708849|Ketamine|ketamine|mesh-list
56112563|NCT02708849|Analgesics|analgesics|mesh-ancestor
56626964|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
56626965|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
56626966|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
56626967|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
56626968|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
56626969|NCT00890539|Miotics|miotics|mesh-ancestor
56626970|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
56626971|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626972|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626973|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56626974|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56626975|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
56626976|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56626977|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56626978|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
56626979|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56626980|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56626981|NCT00887263|Budesonide|budesonide|mesh-list
56112564|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
56196603|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56196604|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56196605|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56196606|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196607|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196608|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196609|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196610|NCT01504178|Analgesics|analgesics|mesh-ancestor
56196611|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
56196612|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112565|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112566|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112567|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56112568|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56112569|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
56112570|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
56112571|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56112572|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56112598|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56112599|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112600|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
56112601|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112602|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112603|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56112604|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56112605|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112606|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56112607|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112608|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56112609|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56112610|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56112611|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56112612|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
56112613|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56112614|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56626982|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56626983|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56626984|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
56626985|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56626986|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626988|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
56626989|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
56626990|NCT00887263|Hormones|hormones|mesh-ancestor
56626991|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56626992|NCT00415233|Hormones|hormones|mesh-list
56626993|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112615|NCT01216631|Prednisolone|prednisolone|mesh-list
56112616|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
56112617|NCT01216631|Infliximab|infliximab|mesh-list
56112618|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56112619|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
56112620|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112645|NCT02687165|Milnacipran|milnacipran|mesh-list
56112646|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
56112647|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56112648|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112649|NCT02687165|Renal Agents|renal agents|mesh-ancestor
56112650|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56112651|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
56112652|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56112653|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
56112654|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112655|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56112658|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112659|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112660|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56112661|NCT02687165|Analgesics|analgesics|mesh-ancestor
56112662|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
56196614|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196615|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
56112663|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112664|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
56112665|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56112666|NCT01169753|Modafinil|modafinil|mesh-list
56112667|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55742083|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
56112668|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112669|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56112672|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112674|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56112675|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112676|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56112677|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56112678|NCT02654639|Growth Substances|growth substances|mesh-ancestor
56112679|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112680|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
56112681|NCT02634827|Decitabine|decitabine|mesh-list
56112682|NCT02634827|Midostaurin|midostaurin|mesh-list
56112683|NCT02634827|Staurosporine|staurosporine|mesh-list
56112684|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56112685|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
56112686|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112687|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112688|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112689|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56112690|NCT02506985|Warfarin|warfarin|mesh-list
56112691|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
56112692|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
56626994|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56626995|NCT00914667|Warfarin|warfarin|mesh-list
56626996|NCT00914667|Fesoterodine|fesoterodine|mesh-list
56626997|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
56626998|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56626999|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56627000|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
56627001|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627002|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627003|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627004|NCT00914667|Urological Agents|urological agents|mesh-ancestor
56627005|NCT00887978|Treprostinil|treprostinil|mesh-list
56112693|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56112694|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
56112695|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56112696|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
56112697|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112698|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112699|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
56112700|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112701|NCT01133639|Ketorolac|ketorolac|mesh-list
56112702|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56112703|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56112704|NCT01133639|Analgesics|analgesics|mesh-ancestor
56112705|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
56112706|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112707|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112708|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112709|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112710|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56112711|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112712|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112742|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112743|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
56112744|NCT02499887|Hormones|hormones|mesh-ancestor
56112745|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112746|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112747|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56112748|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112749|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56112750|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
56112751|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112752|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56112753|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
56112754|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
56112755|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56112756|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56112757|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56112758|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56112759|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
56112760|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196616|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56196617|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56196618|NCT01504178|Emetics|emetics|mesh-ancestor
56196619|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
56196620|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56196621|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
56196622|NCT01504256|Leucovorin|leucovorin|mesh-list
56196623|NCT01504256|Docetaxel|docetaxel|mesh-list
56196624|NCT01504256|Fluorouracil|fluorouracil|mesh-list
56196625|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
56196626|NCT01504256|Catumaxomab|catumaxomab|mesh-list
56196627|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56196628|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
56627006|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56627007|NCT00608023|Tesamorelin|tesamorelin|mesh-list
56627008|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56627009|NCT00608023|Growth Substances|growth substances|mesh-ancestor
56627010|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627011|NCT00608023|Hormones|hormones|mesh-ancestor
56627012|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627013|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56627014|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56627015|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
56627016|NCT02765022|Hormones|hormones|mesh-ancestor
56627017|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56196629|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112761|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112762|NCT02504099|Ritonavir|ritonavir|mesh-list
56112763|NCT02504099|Ribavirin|ribavirin|mesh-list
56112764|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56112765|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56112766|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
56112767|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112768|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112769|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56112770|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56112771|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
56112772|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112773|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56112776|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56112777|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112778|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56112779|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112780|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112782|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56112783|NCT01094561|Hormones|hormones|mesh-ancestor
56112784|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112785|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112786|NCT01074437|Prednisolone|prednisolone|mesh-list
56112787|NCT01074437|Propranolol|propranolol|mesh-list
56112788|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112789|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
56112790|NCT01074437|Hormones|hormones|mesh-ancestor
56112791|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112792|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112793|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56112794|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112795|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56112796|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56112797|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
56112798|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112799|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112800|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56112801|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56112802|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
56112803|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56112805|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
56112806|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112807|NCT03807245|Antacids|antacids|mesh-ancestor
56112808|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112809|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56112824|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56112825|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
56112826|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627018|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627019|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627020|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627021|NCT04224636|Bevacizumab|bevacizumab|mesh-list
56627022|NCT04224636|Atezolizumab|atezolizumab|mesh-list
56196630|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56196632|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56196633|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196634|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
56196635|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56196636|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56196637|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
56196638|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196639|NCT01504256|Antidotes|antidotes|mesh-ancestor
56112827|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112828|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
56112829|NCT02351063|Diuretics|diuretics|mesh-list
56112830|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56112831|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56112832|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56112833|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
56112834|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112835|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112836|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
56112837|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112838|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56112839|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
56112840|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112841|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56112842|NCT01016561|Cisplatin|cisplatin|mesh-list
56112843|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112844|NCT01009931|Dexamethasone|dexamethasone|mesh-list
56112845|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
56112846|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
56112847|NCT01009931|Choline|choline|mesh-list
56112848|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56112849|NCT01009931|BB 1101|bb 1101|mesh-list
56112850|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112851|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
56112852|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
56112853|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112854|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112855|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56112856|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
56112857|NCT01009931|Hormones|hormones|mesh-ancestor
56112858|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112859|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56112860|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112966|NCT00378677|Cyclosporine|cyclosporine|mesh-list
56112967|NCT00378677|Cyclosporins|cyclosporins|mesh-list
56112968|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112969|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112970|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56112971|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
56112972|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112973|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
56112974|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112975|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
56112976|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112977|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56112978|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
56112979|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56112980|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56112981|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56112982|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56112983|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112984|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196640|NCT01504256|Protective Agents|protective agents|mesh-ancestor
56627023|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627024|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627025|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56627026|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56627027|NCT04224636|Growth Substances|growth substances|mesh-ancestor
56196641|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
56196643|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
56196644|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56196645|NCT01504282|Mitomycins|mitomycins|mesh-list
56196646|NCT01504282|Mitomycin|mitomycin|mesh-list
56196647|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56196648|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196649|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
56196650|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196651|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56196652|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196653|NCT01504295|Metadoxine|metadoxine|mesh-list
56196654|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56196655|NCT01504321|Moxonidine|moxonidine|mesh-list
56196656|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56196657|NCT01504334|Pirfenidone|pirfenidone|mesh-list
56196658|NCT01504334|Analgesics|analgesics|mesh-ancestor
56112985|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112986|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112987|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56112988|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112989|NCT02017379|Erythromycin|erythromycin|mesh-list
56112990|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
56113052|NCT01893359|Dextrans|dextrans|mesh-list
56113053|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56113054|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56113055|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
56113056|NCT01893359|Vitamins|vitamins|mesh-ancestor
56113057|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
56113058|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113059|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56113060|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
56113061|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
56113062|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
56113063|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
56113064|NCT00795665|Bevacizumab|bevacizumab|mesh-list
56113065|NCT00795665|Carmustine|carmustine|mesh-list
56113066|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56113067|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113086|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113088|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113089|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
56113090|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113091|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56113092|NCT00755261|Bevacizumab|bevacizumab|mesh-list
56113093|NCT00755261|Doxorubicin|doxorubicin|mesh-list
56113094|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56113095|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113096|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56113097|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56113098|NCT00755261|Growth Substances|growth substances|mesh-ancestor
56113099|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113100|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
56113101|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56113102|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56113103|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56113104|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742094|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56196659|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
56113105|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113106|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
56113107|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56113108|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113109|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113110|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113111|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56627028|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627029|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
56627030|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56627031|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56627032|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56627033|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56627034|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627035|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627036|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113112|NCT00746603|Simvastatin|simvastatin|mesh-list
56113113|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56113114|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56113115|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
56113116|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113117|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56113118|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56113119|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113129|NCT00716807|Narcotics|narcotics|mesh-ancestor
56113130|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113131|NCT00716807|Analgesics|analgesics|mesh-ancestor
56113132|NCT03426137|Ketorolac|ketorolac|mesh-list
56113133|NCT03426137|Oxycodone|oxycodone|mesh-list
56113134|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56113135|NCT03426137|Narcotics|narcotics|mesh-ancestor
56113136|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113137|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113138|NCT03426137|Analgesics|analgesics|mesh-ancestor
56113139|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
56113140|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113141|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56113142|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56113143|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56113144|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56113145|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56113146|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113147|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113148|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56113149|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55715736|NCT02363127|Progesterone|progesterone|mesh-list
56113151|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56113152|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56113153|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56113154|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113155|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
56113156|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113157|NCT00669461|Lubiprostone|lubiprostone|mesh-list
56113158|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56113159|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56113160|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113161|NCT00673595|Varenicline|varenicline|mesh-list
56113162|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56113163|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56113164|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
56113165|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113166|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113167|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113182|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113184|NCT01754987|Protective Agents|protective agents|mesh-ancestor
56113185|NCT05600309|Pembrolizumab|pembrolizumab|mesh-list
56113186|NCT05600309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56113187|NCT05600309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627037|NCT00607789|Analgesics|analgesics|mesh-ancestor
56627038|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
56627039|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627040|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
56627041|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56627042|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
56627043|NCT02761512|Lansoprazole|lansoprazole|mesh-list
56627044|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
56627045|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56627046|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56627047|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56627048|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627049|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627050|NCT00893269|Zolpidem|zolpidem|mesh-list
56113188|NCT05600231|Listerine|listerine|mesh-list
56113189|NCT05600231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56113190|NCT05600231|Sodium Fluoride|sodium fluoride|mesh-list
56113191|NCT05600231|Cariostatic Agents|cariostatic agents|mesh-ancestor
56113192|NCT05600231|Protective Agents|protective agents|mesh-ancestor
56113193|NCT05600231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113194|NCT05600231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113195|NCT00652457|Memantine|memantine|mesh-list
56113196|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56196660|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196661|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196662|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56196663|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56196664|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56196665|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196666|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196667|NCT01504347|Vaccines|vaccines|mesh-list
56196668|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
56196669|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196670|NCT01504386|Ropivacaine|ropivacaine|mesh-list
56196671|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
56196672|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
56196673|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196674|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196675|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
56196676|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196677|NCT01504490|Bexarotene|bexarotene|mesh-list
56196678|NCT01504490|Efatutazone|efatutazone|mesh-list
56196679|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196680|NCT01504503|Donepezil|donepezil|mesh-list
56196681|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56113197|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56113198|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
56113199|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113200|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113201|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113202|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56113203|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56113204|NCT00625703|Linezolid|linezolid|mesh-list
56113205|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56113206|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113207|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56113208|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113209|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113210|NCT00616577|Ropivacaine|ropivacaine|mesh-list
56113211|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
56113212|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
56113213|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113214|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627051|NCT00893269|Eszopiclone|eszopiclone|mesh-list
56627052|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56627053|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56627054|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113215|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
56113238|NCT05599919|Protective Agents|protective agents|mesh-ancestor
56113239|NCT05599841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56113241|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56113242|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56113243|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56113244|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113245|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56113246|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113247|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
56113248|NCT00608465|Ramipril|ramipril|mesh-list
56196682|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196683|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196684|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196685|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196686|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196687|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
56196688|NCT01504516|Donepezil|donepezil|mesh-list
56196689|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56196690|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196691|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196692|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196693|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196694|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196695|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
56113250|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56113251|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
56113252|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113253|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113254|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56113255|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56113256|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
56113257|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56113258|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113305|NCT01629329|Acetaminophen|acetaminophen|mesh-list
56113306|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
56113307|NCT01629329|Caffeine|caffeine|mesh-list
56113308|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56113309|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56113310|NCT01629329|Analgesics|analgesics|mesh-ancestor
56113311|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
56113312|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113313|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113314|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56113315|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56113316|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56113317|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56113318|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113319|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56113320|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56113321|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113322|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
56113323|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56113324|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56113325|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56113326|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56113327|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
56113328|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113330|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
56113331|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56113332|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56113333|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56113334|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627055|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159820|NCT03061812|Hormones|hormones|mesh-ancestor
56627057|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
56627058|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
56627059|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113335|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56113336|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56113337|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
56113338|NCT01606709|Leuprolide|leuprolide|mesh-list
56113339|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56113340|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
56113341|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56196697|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
56196698|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196699|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56196702|NCT01504620|Insulin|insulin|mesh-list
56196703|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56196704|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196705|NCT01504646|Lyprinol|lyprinol|mesh-list
56196706|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56196707|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
56196708|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56113342|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113343|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56113344|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113345|NCT00423059|Bevacizumab|bevacizumab|mesh-list
56113370|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
56113371|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
56113372|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56113373|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56113374|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56113375|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
56113376|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113377|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113378|NCT00379691|Protective Agents|protective agents|mesh-ancestor
56113379|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
56113380|NCT01685333|Hematinics|hematinics|mesh-ancestor
56113381|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56113382|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56113383|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
56113384|NCT00546455|Fenretinide|fenretinide|mesh-list
56113385|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113386|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56113387|NCT00546455|Protective Agents|protective agents|mesh-ancestor
56113388|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113389|NCT00000737|Megestrol|megestrol|mesh-list
56113390|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
56113391|NCT00000737|Dronabinol|dronabinol|mesh-list
56113392|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
56113393|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113394|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56113395|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56113396|NCT00000737|Analgesics|analgesics|mesh-ancestor
56113397|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
56113440|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56113441|NCT00506909|Oxytocin|oxytocin|mesh-list
56113442|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
56113443|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56113444|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113446|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
56113447|NCT00500045|Niacinamide|niacinamide|mesh-list
56113448|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56113449|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
56113450|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113451|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56113452|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
56113453|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
56113454|NCT00500045|Vitamins|vitamins|mesh-ancestor
56113455|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
56113456|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113457|NCT00000767|Vaccines|vaccines|mesh-list
56113458|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
56113459|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196709|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627060|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627061|NCT05672667|Oxytocin|oxytocin|mesh-list
56627062|NCT05672667|Oxytocics|oxytocics|mesh-ancestor
56627063|NCT05672667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56627064|NCT05672667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627065|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
56196711|NCT01504659|Analgesics|analgesics|mesh-ancestor
56196712|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
56113460|NCT05383547|Bortezomib|bortezomib|mesh-list
56113461|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113462|NCT00456989|Docetaxel|docetaxel|mesh-list
56113463|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113464|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
56113465|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
56113466|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
56113467|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113468|NCT00000773|Atovaquone|atovaquone|mesh-list
56113469|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113470|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
56113471|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56113472|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56113473|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742101|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56113474|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113475|NCT00428207|Insulin|insulin|mesh-list
56113476|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56113477|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
56113478|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
56113479|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56113480|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
56113532|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56113533|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113534|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113535|NCT01351415|Bevacizumab|bevacizumab|mesh-list
56113536|NCT01351415|Docetaxel|docetaxel|mesh-list
56113537|NCT01351415|Pemetrexed|pemetrexed|mesh-list
56113538|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56113539|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56113540|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113541|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56113542|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56113543|NCT01351415|Growth Substances|growth substances|mesh-ancestor
56113544|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113545|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
56113546|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
56113547|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
56113548|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
56113549|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113550|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113598|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56113599|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
56113600|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
56113601|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113602|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56113603|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
56113604|NCT00281879|Hormones|hormones|mesh-ancestor
56113605|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56113624|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56113625|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
56113626|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113627|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113628|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113630|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56113631|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113632|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113633|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56113634|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56113635|NCT00205049|Protective Agents|protective agents|mesh-ancestor
56113636|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627066|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56627067|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627068|NCT00887822|Bevacizumab|bevacizumab|mesh-list
56627069|NCT00887822|Capecitabine|capecitabine|mesh-list
56627070|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627071|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627072|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56113637|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
56113638|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56113639|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
56113640|NCT00000833|Ribavirin|ribavirin|mesh-list
56113641|NCT00000833|Didanosine|didanosine|mesh-list
56196713|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113642|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
56113643|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113644|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
56113645|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113646|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56113647|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113648|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113649|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56113650|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56113651|NCT00000839|Didanosine|didanosine|mesh-list
56113652|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
56113653|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113654|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56113655|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113683|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113684|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113685|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
56113686|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113687|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55864291|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
56113689|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
56113690|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113691|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56113692|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56113693|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113694|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
56113695|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
56113696|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
56113697|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
56113698|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56113699|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56113700|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
56113701|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
56113702|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113703|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56113704|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
56113705|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
56113706|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56113732|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113734|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
56113735|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56113736|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
56113737|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113738|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
56113739|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
56113740|NCT00000881|Cidofovir|cidofovir|mesh-list
56113741|NCT00000881|Probenecid|probenecid|mesh-list
56113742|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
56113743|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
56113744|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56113745|NCT00000881|Renal Agents|renal agents|mesh-ancestor
56113746|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
56113747|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113748|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113749|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113750|NCT00000887|Lamivudine|lamivudine|mesh-list
56113751|NCT00000887|Zidovudine|zidovudine|mesh-list
56113752|NCT00000887|Nelfinavir|nelfinavir|mesh-list
56627073|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56627074|NCT00887822|Growth Substances|growth substances|mesh-ancestor
56627075|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627076|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
56627077|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56627078|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
56113753|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56113754|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113755|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113756|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113757|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
56113818|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
56113819|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113820|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56113821|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56113822|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56113823|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56113824|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113825|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56113826|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56113827|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113828|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
56196714|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196715|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56196716|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56196717|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
56196718|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
56113829|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
56113830|NCT00000161|Protective Agents|protective agents|mesh-ancestor
56113831|NCT00000161|Provitamins|provitamins|mesh-ancestor
56113832|NCT00000929|Nonoxynol|nonoxynol|mesh-list
56113860|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
55840810|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
56113861|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
56113862|NCT04375631|Cladribine|cladribine|mesh-list
56113863|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56113864|NCT04375631|Cyclosporins|cyclosporins|mesh-list
56113865|NCT04375631|Lenograstim|lenograstim|mesh-list
56113866|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56113867|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
56113868|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113869|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56113870|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56113871|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
56113872|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113874|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56113875|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56113876|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
56113877|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
56113878|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113879|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56113880|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113881|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
56113904|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56113905|NCT00000209|Buprenorphine|buprenorphine|mesh-list
56113906|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56113907|NCT00000209|Narcotics|narcotics|mesh-ancestor
56113908|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113909|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113910|NCT00000209|Analgesics|analgesics|mesh-ancestor
56113911|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
56113912|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113913|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56113914|NCT00000215|Pergolide|pergolide|mesh-list
56113915|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
56113916|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
56113917|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113918|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113919|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113920|NCT00000953|Acyclovir|acyclovir|mesh-list
56627079|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627080|NCT04222920|Adalimumab|adalimumab|mesh-list
56627081|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627082|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56627083|NCT04115163|Gemcitabine|gemcitabine|mesh-list
56627084|NCT04115163|Paclitaxel|paclitaxel|mesh-list
56627085|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56627086|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56627087|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627088|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
56627089|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
56627090|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
56627091|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113921|NCT00000953|Sorivudine|sorivudine|mesh-list
56113922|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
56113923|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113924|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113925|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113926|NCT00000983|Zidovudine|zidovudine|mesh-list
56113927|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
56113928|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113929|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56113930|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113931|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113932|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
56113933|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113934|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56113935|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56113968|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113969|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56113970|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56113971|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56113972|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
56113973|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113974|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113975|NCT00000263|Ethanol|ethanol|mesh-list
56196719|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196720|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56196721|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56196722|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196723|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196724|NCT01504724|Bevacizumab|bevacizumab|mesh-list
56196725|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55715166|NCT03532763|Vitamin E|vitamin e|mesh-list
56113976|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
56113977|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56113978|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113979|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114006|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
56114007|NCT04030559|Niraparib|niraparib|mesh-list
56114008|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56114009|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114010|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114011|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114012|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
56114013|NCT03967223|Fludarabine|fludarabine|mesh-list
56114014|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56114015|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
56114016|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114017|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56627092|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56627093|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
56627094|NCT04115163|Antiviral Agents|antiviral agents|mesh-ancestor
56627095|NCT04115163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627096|NCT04115163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627097|NCT04115163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627098|NCT04115163|Immunologic Factors|immunologic factors|mesh-ancestor
56627099|NCT04115163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627101|NCT02542111|Dexamethasone|dexamethasone|mesh-list
56627102|NCT02542111|Bortezomib|bortezomib|mesh-list
56627103|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627104|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
56627105|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
56627106|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627107|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627108|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56627109|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
56627110|NCT02542111|Hormones|hormones|mesh-ancestor
56627111|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627112|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56627113|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627114|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56627115|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
56627116|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627117|NCT02542111|Antiviral Agents|antiviral agents|mesh-ancestor
56627118|NCT02542111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627119|NCT02542111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627120|NCT02542111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627121|NCT02542111|Immunologic Factors|immunologic factors|mesh-ancestor
56627122|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
56627123|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56627124|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627125|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627127|NCT02768688|Analgesics|analgesics|mesh-ancestor
56627134|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627135|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627136|NCT05662527|Pembrolizumab|pembrolizumab|mesh-list
56627137|NCT05662527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627138|NCT05662527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627139|NCT00891163|Lidocaine|lidocaine|mesh-list
56627140|NCT00891163|Tetracaine|tetracaine|mesh-list
56627141|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
56627142|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
56627143|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627144|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627145|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
56627146|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627147|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56627148|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56159873|NCT03088800|Ibuprofen|ibuprofen|mesh-list
56627150|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56627151|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627152|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
56627153|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56627154|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
56627155|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627156|NCT00893425|Ramipril|ramipril|mesh-list
56627183|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
56627184|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
56627185|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
56627186|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627187|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627188|NCT02769078|Warfarin|warfarin|mesh-list
56627189|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
56627190|NCT02769078|Dabigatran|dabigatran|mesh-list
56627191|NCT02769078|Apixaban|apixaban|mesh-list
56627192|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
56627193|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56627194|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
56627195|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56627196|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
56627197|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627198|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627199|NCT04036201|Bupivacaine|bupivacaine|mesh-list
56627200|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
56627201|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
56627202|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
56627203|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627204|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627205|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
56627206|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627207|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56627208|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
56627209|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
56114018|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56114020|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114021|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114022|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56114023|NCT00000989|Zidovudine|zidovudine|mesh-list
56114024|NCT00000989|Ganciclovir|ganciclovir|mesh-list
56114025|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56114026|NCT00000989|Sargramostim|sargramostim|mesh-list
56114027|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
56114028|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114029|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114030|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114057|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56114058|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56114059|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114060|NCT00001025|Zidovudine|zidovudine|mesh-list
56114061|NCT00001025|Didanosine|didanosine|mesh-list
56114062|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
56114063|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114064|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55805798|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627210|NCT04036201|Protective Agents|protective agents|mesh-ancestor
56627211|NCT00801099|Amoxicillin|amoxicillin|mesh-list
56627212|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56627213|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
56627214|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
56627215|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56627216|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627217|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56627218|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627219|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627220|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
56627221|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56627222|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627223|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627224|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56627225|NCT02768610|Analgesics|analgesics|mesh-ancestor
56627226|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
56627227|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627228|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56627229|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56627230|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56627231|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
56627232|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627233|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627234|NCT02764710|Amoxicillin|amoxicillin|mesh-list
56627235|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
56627236|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
56627237|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56627238|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56627239|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375785|NCT00451672|Bromocriptine|bromocriptine|mesh-list
56114065|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114066|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114067|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
56114068|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114069|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114070|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114071|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
56114072|NCT03121001|Sirolimus|sirolimus|mesh-list
56114073|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
56114074|NCT03121001|Fludarabine|fludarabine|mesh-list
56114075|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
56114076|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627240|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56627241|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627242|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627243|NCT00923169|Mitogens|mitogens|mesh-list
56627244|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
56627245|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627246|NCT02541019|Ondansetron|ondansetron|mesh-list
56627247|NCT02541019|Palonosetron|palonosetron|mesh-list
56627248|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
56627249|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
56627250|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627251|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627252|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56627253|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
56627254|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
56627255|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56627256|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
56627257|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627258|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627259|NCT02541019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56627260|NCT02541019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56627261|NCT02541019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627262|NCT02541019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56627263|NCT02541019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56627264|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56627265|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56627266|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
56627267|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56627268|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56627269|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56114077|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
56114078|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114079|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56114106|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
56114107|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114108|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114109|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114110|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196726|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196727|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56196728|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56196729|NCT01504724|Growth Substances|growth substances|mesh-ancestor
56196730|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627270|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627271|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627272|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
56627273|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627274|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56627275|NCT04114383|Protective Agents|protective agents|mesh-ancestor
56627276|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627277|NCT05658003|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56627278|NCT05658003|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56627279|NCT05658003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627280|NCT01786265|Prednisone|prednisone|mesh-list
56627281|NCT01786265|Cortisone|cortisone|mesh-list
56627282|NCT01786265|Leuprolide|leuprolide|mesh-list
56627283|NCT01786265|Goserelin|goserelin|mesh-list
56627284|NCT01786265|Flutamide|flutamide|mesh-list
56627285|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
56627286|NCT01786265|Bicalutamide|bicalutamide|mesh-list
56627287|NCT01786265|Nilutamide|nilutamide|mesh-list
56627288|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627289|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
56627290|NCT01786265|Hormones|hormones|mesh-ancestor
56627291|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627292|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627293|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56627294|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627295|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56627296|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
56627297|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56627298|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56627316|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
56627317|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627318|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56627319|NCT02768376|Narcotics|narcotics|mesh-ancestor
56627320|NCT02768376|Analgesics|analgesics|mesh-ancestor
56627321|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56627322|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56627323|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
56627324|NCT02696460|Lidocaine|lidocaine|mesh-list
56627325|NCT02696460|Prilocaine|prilocaine|mesh-list
56627326|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56627327|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
56627328|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
56627329|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627330|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627331|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
56627332|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627333|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56627334|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56627335|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56627336|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56627337|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627338|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56627339|NCT00888043|Bevacizumab|bevacizumab|mesh-list
56627340|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627341|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627342|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56627343|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56627344|NCT00888043|Growth Substances|growth substances|mesh-ancestor
56627345|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627346|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
56627347|NCT02768220|Empagliflozin|empagliflozin|mesh-list
56627348|NCT02768220|Linagliptin|linagliptin|mesh-list
56196731|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
56196732|NCT01504776|Bortezomib|bortezomib|mesh-list
56196733|NCT01504776|Panobinostat|panobinostat|mesh-list
56196734|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196735|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56114111|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
56114112|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114113|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56627349|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56627350|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627351|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56627352|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627353|NCT02768220|Incretins|incretins|mesh-ancestor
56627354|NCT02768220|Hormones|hormones|mesh-ancestor
56627355|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627356|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56627357|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
56627358|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627359|NCT02760888|Diclofenac|diclofenac|mesh-list
56627361|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56627362|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56627363|NCT02760888|Analgesics|analgesics|mesh-ancestor
56627364|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
56627365|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627366|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627367|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627368|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56627369|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56627370|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627371|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627372|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56627373|NCT02760888|Narcotics|narcotics|mesh-ancestor
56627374|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627375|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
56627376|NCT00799617|Testosterone|testosterone|mesh-list
56627377|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
56114114|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114115|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
56114116|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56114117|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
56114118|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114119|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56114120|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114121|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
56114122|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114123|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
56114124|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56114125|NCT00001055|Protective Agents|protective agents|mesh-ancestor
56114126|NCT00000275|Flupenthixol|flupenthixol|mesh-list
56114127|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
56114159|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114160|NCT00001067|Lamivudine|lamivudine|mesh-list
56627378|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
56627379|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56627380|NCT00799617|Androgens|androgens|mesh-ancestor
56627381|NCT00799617|Hormones|hormones|mesh-ancestor
56627382|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627383|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627384|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56627385|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627386|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
56627387|NCT00607087|Insulin|insulin|mesh-list
56627388|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56627389|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
56627390|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
56627391|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
56627392|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56627393|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627394|NCT00610363|Rilonacept|rilonacept|mesh-list
56627395|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627396|NCT00887588|Valsartan|valsartan|mesh-list
56627397|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56627398|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56627399|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56627400|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56627401|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627402|NCT00799383|Vitamin D|vitamin d|mesh-list
56627403|NCT00799383|Calcium|calcium|mesh-list
56627404|NCT00799383|Vitamins|vitamins|mesh-ancestor
56627405|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
56114161|NCT00001067|Zidovudine|zidovudine|mesh-list
56114162|NCT00001067|Stavudine|stavudine|mesh-list
56114163|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114164|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114165|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114166|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114168|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114189|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
56114190|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56114191|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56114192|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56114193|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
56114194|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56114195|NCT00000293|Nefazodone|nefazodone|mesh-list
56114196|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56114197|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56114198|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55805799|NCT02566889|Infliximab|infliximab|mesh-list
56627406|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627407|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56627408|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56627409|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
56627410|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627411|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627412|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
56627413|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627414|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627415|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
56627416|NCT04114149|Narcotics|narcotics|mesh-ancestor
56627417|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627418|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627419|NCT04114149|Analgesics|analgesics|mesh-ancestor
56627420|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
56627421|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627422|NCT00891397|Pregabalin|pregabalin|mesh-list
56627423|NCT00891397|Analgesics|analgesics|mesh-ancestor
56627424|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
56627425|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627426|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627427|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
56627428|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56627429|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56627430|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627431|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56627432|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56114199|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114200|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114201|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114202|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56114203|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
56114204|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56114205|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56114206|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56114207|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
56114208|NCT00001091|Ritonavir|ritonavir|mesh-list
56114209|NCT00001091|Nelfinavir|nelfinavir|mesh-list
56114210|NCT00001091|Lamivudine|lamivudine|mesh-list
56114211|NCT00001091|Nevirapine|nevirapine|mesh-list
56114212|NCT00001091|Stavudine|stavudine|mesh-list
56114213|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56114214|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56114215|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
56627433|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56627434|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627435|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56627436|NCT02767596|Lixisenatide|lixisenatide|mesh-list
56627437|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56627438|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627439|NCT02826902|Remifentanil|remifentanil|mesh-list
56627440|NCT02826902|Propofol|propofol|mesh-list
56627441|NCT02826902|Desflurane|desflurane|mesh-list
56627442|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56627443|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627444|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627445|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56627446|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
56627447|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
56627448|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56627449|NCT02826902|Narcotics|narcotics|mesh-ancestor
56627450|NCT02826902|Analgesics|analgesics|mesh-ancestor
56627451|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
56627452|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627453|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56627454|NCT04504734|Bucillamine|bucillamine|mesh-list
56627455|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56114216|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196736|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196737|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196738|NCT01504828|Ramipril|ramipril|mesh-list
56196739|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56196740|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
56196741|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196742|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196743|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56196744|NCT01504906|Cyclosporine|cyclosporine|mesh-list
56196745|NCT01504906|Ticagrelor|ticagrelor|mesh-list
56196746|NCT01504906|Cyclosporins|cyclosporins|mesh-list
56196747|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715283|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715284|NCT02294734|Nemiralisib|nemiralisib|mesh-list
55715285|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55715286|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715287|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715291|NCT03533231|Propolis|propolis|mesh-list
56114217|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114218|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114219|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114220|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
56114221|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114222|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56114223|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56114250|NCT00000311|Narcotics|narcotics|mesh-ancestor
56114251|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114252|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114253|NCT00000311|Analgesics|analgesics|mesh-ancestor
56627456|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56627457|NCT04504734|Analgesics|analgesics|mesh-ancestor
56627458|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
56627459|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627460|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627461|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627462|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56627463|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
56627464|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627465|NCT04504734|Protective Agents|protective agents|mesh-ancestor
56627466|NCT00798759|Travoprost|travoprost|mesh-list
56627467|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56627468|NCT00798759|Latanoprost|latanoprost|mesh-list
56627469|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56627470|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56627471|NCT00891475|Interferons|interferons|mesh-list
56627472|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
56627473|NCT00891475|Sunitinib|sunitinib|mesh-list
56627474|NCT00891475|Maleic acid|maleic acid|mesh-list
56627475|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627476|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
56627477|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627478|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
56627479|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627480|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56627481|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56627482|NCT00891475|Growth Substances|growth substances|mesh-ancestor
56627483|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
56627506|NCT04113915|Cyclosporins|cyclosporins|mesh-list
56627507|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627508|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
56627509|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627510|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56627511|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627512|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
56627513|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
56627514|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627515|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56627516|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
56627517|NCT04113915|Hormones|hormones|mesh-ancestor
56627518|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627519|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56627520|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627521|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627522|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627523|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
56627524|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627525|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
56627526|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56627527|NCT03590821|Aspirin|aspirin|mesh-list
56627528|NCT03590821|Celecoxib|celecoxib|mesh-list
56627529|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56627530|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56627531|NCT03590821|Analgesics|analgesics|mesh-ancestor
56627536|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56627554|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56627555|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56627556|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
56627557|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627558|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627559|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56627560|NCT02758470|Acetazolamide|acetazolamide|mesh-list
56627561|NCT02758470|Methazolamide|methazolamide|mesh-list
56627562|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
56627563|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56627564|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627565|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627566|NCT02758470|Diuretics|diuretics|mesh-ancestor
56627567|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
56627568|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627569|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
56627570|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56627571|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56627572|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627573|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
56627574|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
56627575|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
56627576|NCT02764008|Bupivacaine|bupivacaine|mesh-list
56627577|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
56627578|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
56627579|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627580|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627581|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
56627582|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627583|NCT00798603|Bevacizumab|bevacizumab|mesh-list
56114254|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
56114255|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114256|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56114257|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
56114258|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
56114259|NCT00000317|Risperidone|risperidone|mesh-list
56114260|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56114261|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
56114262|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114263|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114264|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114265|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56114266|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56627584|NCT00798603|Carboplatin|carboplatin|mesh-list
56627585|NCT00798603|Pemetrexed|pemetrexed|mesh-list
56627586|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627587|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627588|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56627589|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56627590|NCT00798603|Growth Substances|growth substances|mesh-ancestor
56627591|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627592|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
56627593|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627594|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627595|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56627596|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56627597|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
56627598|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56627599|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56627600|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56627601|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56627602|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627603|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
56627604|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627605|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627606|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56627607|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627608|NCT00887354|Vitamin D|vitamin d|mesh-list
56627609|NCT00887354|Teriparatide|teriparatide|mesh-list
56627610|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
56627611|NCT00887354|Calcium|calcium|mesh-list
56627612|NCT00887354|Vitamins|vitamins|mesh-ancestor
56627613|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
56627628|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627629|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627630|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
56627631|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
56627632|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627633|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56627634|NCT02760420|Amoxicillin|amoxicillin|mesh-list
56627635|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56627636|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114267|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114268|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56114269|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56114270|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
56114290|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
56114291|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114292|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114293|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114294|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114295|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
56114296|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114297|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56114298|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56196748|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196749|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56196750|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
56196751|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196752|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
56196753|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196754|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56196755|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196756|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56196757|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56196758|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56196759|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56114299|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
56114300|NCT00000329|Narcotics|narcotics|mesh-ancestor
56114301|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114302|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114303|NCT00000329|Analgesics|analgesics|mesh-ancestor
56114304|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
56114305|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114306|NCT00000335|Morphine|morphine|mesh-list
56114307|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56114308|NCT00000335|Narcotics|narcotics|mesh-ancestor
56114309|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114310|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114311|NCT00000335|Analgesics|analgesics|mesh-ancestor
55841269|NCT03828292|Dexamethasone|dexamethasone|mesh-list
56114312|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
56114313|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114314|NCT00000341|Buprenorphine|buprenorphine|mesh-list
56114315|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56114316|NCT00000341|Narcotics|narcotics|mesh-ancestor
56114317|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114318|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114319|NCT00000341|Analgesics|analgesics|mesh-ancestor
56114320|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
56114321|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114322|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56114323|NCT00000347|Risperidone|risperidone|mesh-list
56114324|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56114351|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114352|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114354|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
56114355|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627637|NCT04612530|Nivolumab|nivolumab|mesh-list
56627638|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627639|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627640|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56627641|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627642|NCT00945815|Cytarabine|cytarabine|mesh-list
56627643|NCT00945815|Clofarabine|clofarabine|mesh-list
56627644|NCT00945815|Epratuzumab|epratuzumab|mesh-list
56627645|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56627646|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
56627647|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627648|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627649|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
56627650|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627651|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627652|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
56627653|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627654|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56627655|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56627656|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56627657|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627658|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627659|NCT00798369|Triamcinolone|triamcinolone|mesh-list
56627660|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56627661|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56627662|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56627663|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56627664|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627665|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
56627666|NCT00798369|Hormones|hormones|mesh-ancestor
56627667|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627668|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627677|NCT02760342|Metformin|metformin|mesh-list
56627678|NCT02760342|Peficitinib|peficitinib|mesh-list
56627679|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56627680|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627681|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627682|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627683|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627684|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
56627685|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56627686|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
56627687|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56627688|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56627689|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56627690|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627691|NCT00894283|Enoxaparin|enoxaparin|mesh-list
56627692|NCT00894283|PENTA|penta|mesh-list
56627693|NCT00894283|Fondaparinux|fondaparinux|mesh-list
56627694|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
56627695|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56627696|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56627697|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114356|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56114357|NCT00000377|Nortriptyline|nortriptyline|mesh-list
56114358|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56114359|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
56114360|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56114361|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56114362|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56114363|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56114364|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114365|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
56114366|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114367|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114368|NCT00001865|Daclizumab|daclizumab|mesh-list
56114369|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56114370|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
56114371|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114406|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196760|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56196761|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
56196762|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196763|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
56196764|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715409|NCT04972123|Phenylephrine|phenylephrine|mesh-list
56114408|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56114409|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114410|NCT00001889|Dobutamine|dobutamine|mesh-list
56114411|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56114412|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
56114413|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
56114414|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114415|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114416|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56627698|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56627699|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
56627700|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56627701|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
56627702|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627703|NCT00895609|Neostigmine|neostigmine|mesh-list
56627704|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56627705|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627706|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627707|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
56627708|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627709|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627710|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56627711|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
56627712|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627713|NCT00894439|Piperacillin|piperacillin|mesh-list
56627714|NCT00894439|BLI-489|bli-489|mesh-list
56159908|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56627715|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56627716|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56627717|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56627718|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627719|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627720|NCT04035889|Melatonin|melatonin|mesh-list
56627721|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
56627722|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627723|NCT04035889|Protective Agents|protective agents|mesh-ancestor
56627743|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56627744|NCT02762838|Folic Acid|folic acid|mesh-list
56627745|NCT02762838|Methotrexate|methotrexate|mesh-list
56627746|NCT02762838|Infliximab|infliximab|mesh-list
56627747|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56627748|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
56627749|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56627750|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627751|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56627752|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
56627753|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627754|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627755|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
56627756|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627757|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56627758|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627759|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
56627760|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56627761|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56627762|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56376307|NCT00112983|Eculizumab|eculizumab|mesh-list
56627763|NCT02762838|Hematinics|hematinics|mesh-ancestor
56627764|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
56627765|NCT02762838|Vitamins|vitamins|mesh-ancestor
56627766|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
56627767|NCT02753166|Dexamethasone|dexamethasone|mesh-list
56627768|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627769|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
56627770|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
56627771|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627772|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627773|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56627774|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
56627775|NCT02753166|Hormones|hormones|mesh-ancestor
56627776|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627777|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56627778|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627781|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
56627782|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56627783|NCT02753088|Diuretics|diuretics|mesh-ancestor
56627784|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
56627785|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627786|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56627787|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
56627788|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627789|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56627790|NCT02757534|Domperidone|domperidone|mesh-list
56627791|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
56627792|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
56627793|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627794|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627795|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56627796|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56627797|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
56627798|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627799|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627800|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56627801|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56627802|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
56627803|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114417|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56114418|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56114419|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
56114420|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114421|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114422|NCT00001889|Protective Agents|protective agents|mesh-ancestor
56114423|NCT00001901|Etanercept|etanercept|mesh-list
56114424|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56114425|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56114426|NCT00001901|Analgesics|analgesics|mesh-ancestor
56114427|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
56114428|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114453|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114454|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56114455|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
56114456|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
56114457|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56114458|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
56114459|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114460|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114461|NCT00000443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56114462|NCT00000443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56114463|NCT00000443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114464|NCT00000443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56114465|NCT00000443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56114466|NCT00000449|Naltrexone|naltrexone|mesh-list
56114467|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56114468|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56114469|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114470|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
56627804|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627805|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56627806|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
56627807|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56627808|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56627809|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56627810|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
56627811|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627812|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627813|NCT00797823|Insulin|insulin|mesh-list
56627814|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56627815|NCT00797823|Glucagon|glucagon|mesh-list
56627816|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56627817|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627818|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56627819|NCT00797823|Hormones|hormones|mesh-ancestor
56114471|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114472|NCT00000455|Naltrexone|naltrexone|mesh-list
56114473|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56114474|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56114475|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114476|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
56114477|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114478|NCT00001307|Capsaicin|capsaicin|mesh-list
56114479|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
56114480|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
56114540|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114541|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56114542|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56114543|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56114544|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
56114545|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56114546|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56114547|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56114548|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56114549|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56114550|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114552|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56114553|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114554|NCT00000623|Decitabine|decitabine|mesh-list
56114555|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
56114556|NCT00000623|Deferiprone|deferiprone|mesh-list
56114557|NCT00000623|Deferoxamine|deferoxamine|mesh-list
56114558|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56114559|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
56114560|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114561|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114562|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114563|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
56114564|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56114565|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56114566|NCT00000623|Urological Agents|urological agents|mesh-ancestor
56114567|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56114568|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
56114569|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
56114570|NCT00000623|Siderophores|siderophores|mesh-ancestor
56114572|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114573|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
56114574|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56114575|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56627820|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627821|NCT02760030|Fulvestrant|fulvestrant|mesh-list
56627822|NCT02760030|Palbociclib|palbociclib|mesh-list
56627823|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56627824|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56627825|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627826|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56627827|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56627828|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
56627829|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627830|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627831|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56627832|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627833|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114576|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114603|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114605|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
56114606|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114607|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114608|NCT00002009|Sargramostim|sargramostim|mesh-list
56114609|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
56114610|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114612|NCT00000629|Valproic Acid|valproic acid|mesh-list
56114613|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
56114614|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114615|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114616|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114617|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114618|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
56114619|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114620|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114621|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114622|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
56114623|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
56114624|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114625|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114650|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114651|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114652|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
56114653|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114654|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114655|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114656|NCT00001409|Interleukin-2|interleukin-2|mesh-list
56114657|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114658|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56114659|NCT00001409|Analgesics|analgesics|mesh-ancestor
56114660|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
56114661|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114662|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114664|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
56114665|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114666|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114667|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114668|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114669|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
56114670|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114671|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56627834|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56627835|NCT02757144|Esomeprazole|esomeprazole|mesh-list
56627836|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56627837|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56627838|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56627839|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627840|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627841|NCT04568616|Letrozole|letrozole|mesh-list
56627842|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627843|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56627844|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56627845|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627846|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627847|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56627848|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
56627849|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627850|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627851|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
56627852|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56627853|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
56114672|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114673|NCT00381017|Interferons|interferons|mesh-list
56114674|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
56114675|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
56114676|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56114677|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114678|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
56114706|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114707|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
56114708|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114709|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
56114710|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114711|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56196765|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56196766|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196767|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196768|NCT01505049|Vaccines|vaccines|mesh-list
56114712|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114713|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114714|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114715|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114716|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
56114717|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114718|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56114720|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
56114721|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114722|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114723|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114724|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114725|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
56114726|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114727|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114728|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56627854|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627855|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627856|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56627857|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
56627858|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
56627859|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56627860|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
56627861|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627862|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627864|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
56627865|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
56627866|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627867|NCT00608881|Vitamins|vitamins|mesh-ancestor
56627868|NCT05608395|Carbon-11 methionine|carbon-11 methionine|mesh-list
56627869|NCT05608395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56627870|NCT05608395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627871|NCT04221906|Betamethasone|betamethasone|mesh-list
56627872|NCT04221906|Calcipotriene|calcipotriene|mesh-list
56627873|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56627874|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627875|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
56627876|NCT04221906|Hormones|hormones|mesh-ancestor
56114729|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56114730|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
56114731|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114732|NCT00000725|Interferons|interferons|mesh-list
56114733|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
56114734|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
56114735|NCT00000725|Zidovudine|zidovudine|mesh-list
56114736|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114737|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
56114738|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114739|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
56114740|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114741|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
56114742|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114779|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
56114780|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114854|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114855|NCT00002075|Fluconazole|fluconazole|mesh-list
56114856|NCT00002075|Amphotericin B|amphotericin b|mesh-list
56114857|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56114858|NCT00002075|Flucytosine|flucytosine|mesh-list
56114859|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
56114860|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114861|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56114862|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56114863|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114864|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114865|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56114866|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
56114867|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56114868|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627877|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56627878|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627879|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56627880|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
56627881|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
56627882|NCT00945191|Paclitaxel|paclitaxel|mesh-list
56627883|NCT00945191|Carboplatin|carboplatin|mesh-list
56627884|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56627885|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627886|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
56627887|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
56627888|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
56627889|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627890|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
56627891|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
56627892|NCT01082393|Tacrolimus|tacrolimus|mesh-list
56627893|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56627894|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
56627895|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627896|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56627897|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627898|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114869|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56114870|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56114871|NCT00002075|Amebicides|amebicides|mesh-ancestor
56114872|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56114873|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56114874|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56114875|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
56114876|NCT00001577|Melphalan|melphalan|mesh-list
56114877|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56114878|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
56114879|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114880|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114881|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56114882|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56114883|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
56114884|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114885|NCT00002081|Zidovudine|zidovudine|mesh-list
56114886|NCT00002081|Zalcitabine|zalcitabine|mesh-list
56114887|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
56114948|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56196769|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
56196770|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196771|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
56196772|NCT01505088|Dexamethasone|dexamethasone|mesh-list
56196773|NCT01505088|Prednisolone|prednisolone|mesh-list
56196774|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56196775|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
56196776|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56196777|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
56627899|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56627900|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
56627901|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56627902|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56627903|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56627904|NCT01082393|Analgesics|analgesics|mesh-ancestor
56627905|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
56627906|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627907|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56627908|NCT02757066|Melatonin|melatonin|mesh-list
56627909|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
56627910|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627911|NCT02757066|Protective Agents|protective agents|mesh-ancestor
56627912|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627914|NCT00894673|Heparin|heparin|mesh-list
56627915|NCT00894673|Calcium heparin|calcium heparin|mesh-list
56627916|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
56627917|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56627918|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56627919|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627920|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56627921|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56627922|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56627923|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627924|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627925|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56627926|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56627927|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56627928|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
56196778|NCT01505088|Citric Acid|citric acid|mesh-list
56196779|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
56196780|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56124550|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196781|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56196782|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56196783|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
56196784|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56196785|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56196786|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
56196787|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
56196788|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196789|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196790|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55715645|NCT03522649|Leucovorin|leucovorin|mesh-list
56114949|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56627929|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627930|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627931|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56627932|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56627934|NCT02752308|Atropine|atropine|mesh-list
56627935|NCT02752308|Epinephrine|epinephrine|mesh-list
56627936|NCT02752308|Fentanyl|fentanyl|mesh-list
56627937|NCT02752308|Bupivacaine|bupivacaine|mesh-list
56627938|NCT02752308|Neostigmine|neostigmine|mesh-list
56627939|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
56627940|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
56627941|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627942|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627943|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
56627944|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627945|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56627946|NCT02752308|Narcotics|narcotics|mesh-ancestor
56627947|NCT02752308|Analgesics|analgesics|mesh-ancestor
56627948|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56627949|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56627950|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
56627951|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56627952|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56114951|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114952|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114953|NCT00002339|Fluconazole|fluconazole|mesh-list
56114954|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
56114955|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114956|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56114957|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56114958|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114959|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114960|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56114961|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
56114962|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56114963|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114964|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56114965|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56114966|NCT00002105|Doxorubicin|doxorubicin|mesh-list
56114967|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56114968|NCT00002105|Bleomycin|bleomycin|mesh-list
56114969|NCT00002105|Vincristine|vincristine|mesh-list
56114970|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56114971|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115002|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
56115003|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115004|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56115005|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115006|NCT00002351|Indinavir|indinavir|mesh-list
56115007|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115008|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56196791|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
56196792|NCT01505088|Hormones|hormones|mesh-ancestor
56627953|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
56627954|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627955|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627956|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56627957|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56627958|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
56627959|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56627960|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
56627961|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
56627962|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
56627963|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56627964|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56627965|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
56627966|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56196793|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56196794|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56196795|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196796|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
56196797|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56196798|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
56196799|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
56196800|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196801|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56196802|NCT01505088|Protective Agents|protective agents|mesh-ancestor
56196803|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56196804|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196805|NCT01505127|Amoxicillin|amoxicillin|mesh-list
56196806|NCT01505127|Clarithromycin|clarithromycin|mesh-list
56196807|NCT01505127|Lansoprazole|lansoprazole|mesh-list
56196808|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
56196809|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56196810|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196811|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56196812|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196813|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196814|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56196815|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56196816|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56196817|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56196818|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56196819|NCT01505218|Propofol|propofol|mesh-list
56196820|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56115009|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115010|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115011|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115012|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115014|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
56115015|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115047|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115048|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
56115049|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115050|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
56115051|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115052|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115053|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115054|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
56196821|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196822|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115055|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115056|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56627967|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56627968|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
56627969|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56627970|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56627971|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56627972|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
56627973|NCT00894751|Propofol|propofol|mesh-list
56627974|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56627975|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56627976|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627977|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56627978|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
56627979|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
56627980|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56627981|NCT00894751|Analgesics|analgesics|mesh-ancestor
56627982|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
56627983|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627984|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56627985|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56627986|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56627987|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
56627988|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56627989|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56627990|NCT00896077|Lisofylline|lisofylline|mesh-list
56627991|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56627992|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
56627993|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56627994|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56627995|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56627996|NCT00896077|Analgesics|analgesics|mesh-ancestor
56627997|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
56627998|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56627999|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56628000|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628001|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628002|NCT00792909|Vaccines|vaccines|mesh-list
56628003|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56628004|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
56628005|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628007|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56628008|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
56628009|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56628010|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628011|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56628012|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628013|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56628014|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56628015|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56628016|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
56628017|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
56628018|NCT02751996|Tenofovir|tenofovir|mesh-list
56628019|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
56628020|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628021|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56628022|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56628023|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628024|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628025|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56628026|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56628028|NCT00944645|Niacinamide|niacinamide|mesh-list
56628029|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
56628030|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56628031|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
56628032|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628033|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56628034|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
56628035|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
56628036|NCT00944645|Vitamins|vitamins|mesh-ancestor
56628037|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
56628039|NCT02751918|Doxorubicin|doxorubicin|mesh-list
56628047|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628048|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56628049|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
56628050|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
56628051|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
56628052|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
56628053|NCT00901069|Rituximab|rituximab|mesh-list
56628054|NCT00901069|Vincristine|vincristine|mesh-list
56628055|NCT00901069|Azacitidine|azacitidine|mesh-list
56628056|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628057|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
56628058|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628059|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628060|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56628061|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
56628062|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628063|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628064|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56628065|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56628066|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56628067|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
56628068|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
56628069|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
56628070|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628071|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
56628072|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628073|NCT02853539|Denosumab|denosumab|mesh-list
56115057|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56115059|NCT05752409|Propofol|propofol|mesh-list
56115081|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115082|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
56115083|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115084|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56115085|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56115086|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115087|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115088|NCT00002129|Protective Agents|protective agents|mesh-ancestor
56115089|NCT00002135|Ganciclovir|ganciclovir|mesh-list
56115090|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56115091|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
56115092|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115093|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115094|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115095|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115096|NCT00002141|Abacavir|abacavir|mesh-list
56115097|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115098|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56628074|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56628075|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628076|NCT02751840|Caffeine|caffeine|mesh-list
56628077|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56628078|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628079|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56628080|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628081|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628082|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56628083|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56628084|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
56628085|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628086|NCT00894829|Heparin|heparin|mesh-list
56628087|NCT00894829|Calcium heparin|calcium heparin|mesh-list
56628088|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
56628089|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56628090|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56628091|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628092|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56628093|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
56628094|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628095|NCT00606229|Aripiprazole|aripiprazole|mesh-list
56628096|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
56628097|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56628098|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56628099|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56628100|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56628101|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628102|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
56628103|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
56628104|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628105|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115099|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115100|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115101|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
56115102|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115103|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115104|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115105|NCT00002369|Lamivudine|lamivudine|mesh-list
56628106|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56628107|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56628108|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
56628109|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56628110|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56628111|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56628112|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56628113|NCT02756598|Sufentanil|sufentanil|mesh-list
56628114|NCT02756598|Dsuvia|dsuvia|mesh-list
56628115|NCT02756598|Propofol|propofol|mesh-list
56628116|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56628117|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56628118|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628119|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56628120|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
56628121|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
56628122|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56628123|NCT02756598|Narcotics|narcotics|mesh-ancestor
56628124|NCT02756598|Analgesics|analgesics|mesh-ancestor
56628125|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
56628126|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628127|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56628128|NCT00950651|Tramadol|tramadol|mesh-list
56628129|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56628130|NCT00950651|Narcotics|narcotics|mesh-ancestor
56115107|NCT00002369|Stavudine|stavudine|mesh-list
56115108|NCT00002369|Indinavir|indinavir|mesh-list
56115109|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115110|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115111|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115112|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115113|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
56115161|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56115162|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56115163|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115164|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115165|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115166|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115167|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115168|NCT00002393|Efavirenz|efavirenz|mesh-list
56115169|NCT00002393|Indinavir|indinavir|mesh-list
56115170|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115171|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115172|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115173|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115196|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
56115197|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56115198|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115199|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56115200|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56628131|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56628132|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628133|NCT00950651|Analgesics|analgesics|mesh-ancestor
56628134|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
56628135|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628136|NCT00901147|Bortezomib|bortezomib|mesh-list
56628137|NCT00901147|Panobinostat|panobinostat|mesh-list
56628138|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628139|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56628140|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628141|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628143|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
56628144|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
56628145|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628146|NCT02756130|Carboplatin|carboplatin|mesh-list
56628147|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628148|NCT05598723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56628149|NCT05598723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56628150|NCT05598723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56628151|NCT05598723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56628152|NCT05598723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628153|NCT05598723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628154|NCT05598723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56628155|NCT05598723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56628156|NCT05598723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628157|NCT05598723|Cholinergic Agents|cholinergic agents|mesh-ancestor
56628158|NCT05598723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628159|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
56628160|NCT00605293|Hematinics|hematinics|mesh-ancestor
56628161|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56628162|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56628163|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
56628164|NCT05594589|Lemborexant|lemborexant|mesh-list
56628165|NCT05594589|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56628166|NCT05594589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56115201|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56115202|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56115203|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56115204|NCT00002405|Amprenavir|amprenavir|mesh-list
56628167|NCT05594589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628168|NCT05594589|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56628169|NCT05594589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56628170|NCT05594589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56628171|NCT05594589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628172|NCT00602303|Torsemide|torsemide|mesh-list
56628173|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56628174|NCT00602303|Diuretics|diuretics|mesh-ancestor
56628175|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
56628176|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628177|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56628178|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56628179|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628180|NCT05593575|Valsartan|valsartan|mesh-list
56628181|NCT05593575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56628182|NCT05593575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56628183|NCT05593575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56628184|NCT05593575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628185|NCT00631085|Tocopherols|tocopherols|mesh-list
56628186|NCT00631085|Vitamin E|vitamin e|mesh-list
56628187|NCT00631085|Tocotrienols|tocotrienols|mesh-list
56628188|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
56628189|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
56628190|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
56628191|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628192|NCT00631085|Protective Agents|protective agents|mesh-ancestor
56628193|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628194|NCT00631085|Vitamins|vitamins|mesh-ancestor
56628195|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
56628196|NCT04269863|Aspirin|aspirin|mesh-list
56628197|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56115205|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56115206|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
56115207|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115208|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842168|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
56115209|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115210|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115211|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115212|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115213|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628198|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56628199|NCT04269863|Analgesics|analgesics|mesh-ancestor
56628200|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
56628201|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628202|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628203|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56628204|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628205|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56628206|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56628207|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628208|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56628209|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56628210|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628211|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
56628212|NCT00901381|Lenograstim|lenograstim|mesh-list
56628213|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56628214|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
56628215|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628216|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
56628217|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
56628218|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196823|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56196824|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
56196825|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
56196826|NCT01505231|Vasopressins|vasopressins|mesh-list
56196827|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
56196828|NCT01505231|Norepinephrine|norepinephrine|mesh-list
56196829|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56196830|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56196831|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
56196832|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196833|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196834|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196835|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
56196836|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
56196837|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196838|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56196839|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
56115215|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115216|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
56115217|NCT00002417|Amprenavir|amprenavir|mesh-list
56115218|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56115219|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
56115220|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115221|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115292|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115293|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56115294|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115325|NCT00002471|Leucovorin|leucovorin|mesh-list
56115327|NCT00002471|Dexamethasone|dexamethasone|mesh-list
56115328|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
56115329|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
56115330|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56115331|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56115332|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56628219|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628220|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628221|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
56628222|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56628223|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56628224|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628225|NCT02751528|Vaccines|vaccines|mesh-list
56628226|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
56628227|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628228|NCT00901537|Azacitidine|azacitidine|mesh-list
56628229|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628230|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628231|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
56628232|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628233|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628234|NCT00894985|Heparin|heparin|mesh-list
56628235|NCT00894985|Calcium heparin|calcium heparin|mesh-list
56628236|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
56628237|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56628238|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56628239|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628240|NCT04585152|Rituximab|rituximab|mesh-list
56628241|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56628242|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628243|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
56628244|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628245|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628246|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56628247|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628248|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
56628249|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56628250|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56628251|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628258|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56628259|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628260|NCT00901615|Lenalidomide|lenalidomide|mesh-list
56628261|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
56628262|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628263|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56628264|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56628265|NCT00901615|Growth Substances|growth substances|mesh-ancestor
56628266|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
56628267|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628268|NCT00949325|Sirolimus|sirolimus|mesh-list
56628269|NCT00949325|Doxorubicin|doxorubicin|mesh-list
56628270|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56628271|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56628272|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628273|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56628274|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56628275|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628276|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628277|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56628278|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628279|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
56628280|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628281|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
56628282|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628283|NCT02853071|Estramustine|estramustine|mesh-list
56628284|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56628285|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
56628286|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628303|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628305|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628306|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56628307|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56628308|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628309|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628310|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56628311|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628312|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
56628313|NCT04221672|Terlipressin|terlipressin|mesh-list
56628314|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56628315|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56628316|NCT00895297|Dasatinib|dasatinib|mesh-list
56628317|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628318|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56628319|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628320|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628321|NCT00943319|Fludarabine|fludarabine|mesh-list
56628322|NCT00943319|Busulfan|busulfan|mesh-list
56628323|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
56628324|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628325|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628326|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628327|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
56628328|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628329|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
56628330|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56628331|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56628332|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56628333|NCT02603991|Levetiracetam|levetiracetam|mesh-list
56628334|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
56628335|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
56628336|NCT02540785|Levofloxacin|levofloxacin|mesh-list
56628337|NCT02540785|Ofloxacin|ofloxacin|mesh-list
56628338|NCT02540785|Tobramycin|tobramycin|mesh-list
56628340|NCT02540785|Dexamethasone|dexamethasone|mesh-list
56628344|NCT02540785|Dipivefrin|dipivefrin|mesh-list
56628345|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56628346|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
56628347|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
56628348|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628349|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628350|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56628351|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
56628352|NCT02540785|Hormones|hormones|mesh-ancestor
56628353|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56628354|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56628355|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628356|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
56628357|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628358|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628359|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56628360|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628361|NCT02540785|Renal Agents|renal agents|mesh-ancestor
56628362|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56376967|NCT00348361|Xhance|xhance|mesh-list
56628363|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56628364|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115333|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
56115334|NCT00002471|Thiotepa|thiotepa|mesh-list
56115335|NCT00002471|Methotrexate|methotrexate|mesh-list
56115336|NCT00002471|Etoposide|etoposide|mesh-list
56115403|NCT00002489|Carboplatin|carboplatin|mesh-list
56115404|NCT00002489|Doxorubicin|doxorubicin|mesh-list
56115439|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56115440|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115441|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115442|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56115443|NCT00002495|Doxorubicin|doxorubicin|mesh-list
56115444|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56115445|NCT00002495|Vinblastine|vinblastine|mesh-list
56115446|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115447|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115448|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115449|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115450|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115451|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115452|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115453|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
56115454|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
56115455|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
56115456|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
56115457|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115458|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
56115459|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115460|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56196840|NCT01505231|Coagulants|coagulants|mesh-ancestor
56196841|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56196842|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
56196843|NCT01505283|Lidocaine|lidocaine|mesh-list
56196844|NCT01505283|Sufentanil|sufentanil|mesh-list
56628365|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56628366|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56628367|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56628368|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
56628369|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
56628370|NCT02540785|Protective Agents|protective agents|mesh-ancestor
56628371|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56628372|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
56628373|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628374|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56628375|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56628376|NCT04243278|Aspirin|aspirin|mesh-list
56628377|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56628378|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56628380|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
56628381|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628382|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628383|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56628384|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628385|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56628386|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56628387|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628388|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56628389|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56628390|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628391|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
56628392|NCT00915369|Paclitaxel|paclitaxel|mesh-list
56628393|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56628394|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628395|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
56628396|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
56628397|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
56196845|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
56196846|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
56196847|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864824|NCT01957709|Interferons|interferons|mesh-list
56196848|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115461|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115462|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
56115463|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115464|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628398|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628399|NCT00901849|Sirolimus|sirolimus|mesh-list
56628400|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56628401|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56628402|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628403|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56628404|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628405|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
56628406|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628407|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
56628408|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628409|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56628410|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628411|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628412|NCT04243122|Aspirin|aspirin|mesh-list
56628413|NCT04243122|Apixaban|apixaban|mesh-list
56628414|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56628415|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56628416|NCT04243122|Analgesics|analgesics|mesh-ancestor
56628417|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
56628418|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628419|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628420|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56628421|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628422|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56628423|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56628424|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628425|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56628426|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56628427|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628428|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
56628437|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628438|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56628439|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56628440|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628441|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628442|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56628443|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
56628444|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56628445|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628446|NCT04268927|Hormones|hormones|mesh-ancestor
56628447|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
56628448|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56628449|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56628450|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628451|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
56628452|NCT05429580|Coagulants|coagulants|mesh-ancestor
56628453|NCT00790647|Bortezomib|bortezomib|mesh-list
56628454|NCT00790647|Melphalan|melphalan|mesh-list
56628455|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
56628456|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628457|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628458|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56628459|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
56628460|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628486|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56628487|NCT02754882|Growth Substances|growth substances|mesh-ancestor
56628488|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628489|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
56628490|NCT00790569|Nicotine|nicotine|mesh-list
56628491|NCT00790569|Varenicline|varenicline|mesh-list
56628492|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56628493|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
56628494|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628495|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628496|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56628497|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56628498|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
56628499|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628500|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628501|NCT00939029|Nicotine|nicotine|mesh-list
56628545|NCT02540239|Emollients|emollients|mesh-ancestor
56628546|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
56628547|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
56628548|NCT02540395|Prednisolone|prednisolone|mesh-list
56628549|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56628550|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
56628551|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56628552|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
56628553|NCT02540395|Tacrolimus|tacrolimus|mesh-list
56628554|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56628555|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
56628611|NCT00602693|Allopurinol|allopurinol|mesh-list
56628612|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628613|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
56628614|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628615|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56628616|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56628617|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
56628618|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628619|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628620|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56628621|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628622|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
56628623|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56628630|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
56628672|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628673|NCT00902473|Topiramate|topiramate|mesh-list
56628674|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
56628675|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56628676|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628677|NCT05177484|Ferric maltol|ferric maltol|mesh-list
56628678|NCT05177484|Hematinics|hematinics|mesh-ancestor
56628679|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
56628680|NCT04104789|Tetracaine|tetracaine|mesh-list
56628681|NCT04104789|Carticaine|carticaine|mesh-list
56628682|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
56628683|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
56628684|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56628685|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628686|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
56628687|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56628734|NCT02754726|Paclitaxel|paclitaxel|mesh-list
56628735|NCT02754726|Nivolumab|nivolumab|mesh-list
56628736|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56377282|NCT00350467|Olanzapine|olanzapine|mesh-list
56628737|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56628738|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628739|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
56628740|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
56628741|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
56628742|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628743|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628744|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
56628795|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56628796|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56628797|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
56628798|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
56628799|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
56628867|NCT02754102|Protective Agents|protective agents|mesh-ancestor
56628868|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628869|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
56628870|NCT00134303|Metformin|metformin|mesh-list
56628871|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56628872|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628873|NCT00902941|Rasagiline|rasagiline|mesh-list
56628874|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56628875|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628876|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628877|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56628878|NCT00902941|Protective Agents|protective agents|mesh-ancestor
56628879|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628880|NCT02754258|Methylphenidate|methylphenidate|mesh-list
56628881|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56628882|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628883|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56628884|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56628885|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56628886|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628887|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
56628888|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56628889|NCT04267991|Tacrolimus|tacrolimus|mesh-list
56628890|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628891|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
56628892|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628893|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56628894|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628895|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628896|NCT02852681|Drospirenone|drospirenone|mesh-list
56628897|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56628898|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
56628899|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56628902|NCT02852681|Diuretics|diuretics|mesh-ancestor
56628904|NCT02754180|Gemcitabine|gemcitabine|mesh-list
56628905|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56628906|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
56628907|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56628908|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56628909|NCT02754180|Antiviral Agents|antiviral agents|mesh-ancestor
56628910|NCT02754180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56628911|NCT02754180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56628912|NCT02754180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56628913|NCT02754180|Immunologic Factors|immunologic factors|mesh-ancestor
56628914|NCT02754180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56628915|NCT00602849|Sertraline|sertraline|mesh-list
56628916|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
56628917|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56628918|NCT00602849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56628919|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56628961|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
56628962|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56628963|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377502|NCT00351637|Narcotics|narcotics|mesh-ancestor
56628965|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56628995|NCT04321668|Hylan|hylan|mesh-list
56629030|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
56629031|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56629032|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56629033|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56629039|NCT04220892|Pemetrexed|pemetrexed|mesh-list
56629100|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629101|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56629173|NCT00635856|Gefitinib|gefitinib|mesh-list
56629174|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629175|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56629176|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629177|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629178|NCT00906685|Bevacizumab|bevacizumab|mesh-list
56629179|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56377729|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56629180|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629181|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56629182|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56629232|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629233|NCT02750670|Gemcitabine|gemcitabine|mesh-list
56629234|NCT02750670|Dexamethasone|dexamethasone|mesh-list
56629235|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
56629236|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629237|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
56629238|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
56629239|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629240|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629241|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629242|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
56629243|NCT02750670|Hormones|hormones|mesh-ancestor
56629244|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629245|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56629246|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629247|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56629289|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629290|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
56629291|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629292|NCT04919096|Aflibercept|aflibercept|mesh-list
56629293|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56629294|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56629295|NCT04919096|Growth Substances|growth substances|mesh-ancestor
56629296|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629301|NCT00781599|Varenicline|varenicline|mesh-list
56629355|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56629356|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56629357|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629358|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629359|NCT05379257|Furosemide|furosemide|mesh-list
56629360|NCT05379257|Diuretics|diuretics|mesh-ancestor
56629361|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
56629362|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629363|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56629364|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629419|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
56629420|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
56629421|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629422|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56629423|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56629424|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56629425|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629426|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56629427|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56629484|NCT04218552|Telmisartan|telmisartan|mesh-list
56629485|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56629486|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56629487|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629488|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629489|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56629490|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629491|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
56629492|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56629493|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56629560|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56629561|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629562|NCT02746380|Adalimumab|adalimumab|mesh-list
56629563|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629564|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56629565|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
56629566|NCT02745990|Hematinics|hematinics|mesh-ancestor
56629567|NCT04417062|Olaparib|olaparib|mesh-list
56629568|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56629569|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629570|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629571|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629572|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56629573|NCT00915915|Gestodene|gestodene|mesh-list
56629623|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
56629624|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629625|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
56629626|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
56629627|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629628|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629629|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56629630|NCT00900445|Protective Agents|protective agents|mesh-ancestor
56629691|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
56629692|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629693|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629694|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56629695|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56629696|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56629697|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56629698|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629699|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56629756|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56629757|NCT04242758|Diuretics|diuretics|mesh-ancestor
56629758|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
56629759|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56629760|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56629761|NCT02745912|Metformin|metformin|mesh-list
56629762|NCT02745912|Naltrexone|naltrexone|mesh-list
56629799|NCT04239560|Boron|boron|mesh-list
56629823|NCT02851433|Propofol|propofol|mesh-list
56629824|NCT02851433|Sevoflurane|sevoflurane|mesh-list
56629825|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56629826|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629827|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56629828|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56629829|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
56629830|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56629831|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56629832|NCT05629806|Metformin|metformin|mesh-list
56629833|NCT05629806|Pioglitazone|pioglitazone|mesh-list
56629834|NCT05629806|Acarbose|acarbose|mesh-list
56629835|NCT05629806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56629836|NCT05629806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629837|NCT05629806|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56629886|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56629887|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56629888|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56629889|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
56629890|NCT04217148|Hormones|hormones|mesh-ancestor
56629891|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56629892|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56629893|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56629894|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
56629895|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56629951|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56629952|NCT02749578|Atorvastatin|atorvastatin|mesh-list
56629953|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56630021|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56630022|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
56630023|NCT02821520|Verteporfin|verteporfin|mesh-list
56630026|NCT00604955|Paromomycin|paromomycin|mesh-list
56630093|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56630094|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630095|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
56630096|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
56630097|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
56630109|NCT02538211|Vaccines|vaccines|mesh-list
56630163|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56630164|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56630165|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
56630166|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
56630167|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630168|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56630169|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56630170|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56630171|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630230|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630231|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630232|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56630303|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630304|NCT04015375|Dapsone|dapsone|mesh-list
56378852|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
56630305|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630306|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
56630378|NCT05658692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378928|NCT00458731|Bevacizumab|bevacizumab|mesh-list
56630379|NCT05658692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56630380|NCT05658692|Hormones|hormones|mesh-ancestor
56630381|NCT05658692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56630382|NCT05658692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56630383|NCT05658692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630384|NCT05658692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630388|NCT05658692|Anesthetics, General|anesthetics, general|mesh-ancestor
56630442|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56630443|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630444|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56630449|NCT00927511|Fulvestrant|fulvestrant|mesh-list
56630512|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56630513|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56630514|NCT02748330|Aspirin|aspirin|mesh-list
56630516|NCT02748330|Ticagrelor|ticagrelor|mesh-list
56630585|NCT05657678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56630586|NCT05657678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56630587|NCT02747940|Pregabalin|pregabalin|mesh-list
56630588|NCT02747940|Flunarizine|flunarizine|mesh-list
56630589|NCT02747940|Analgesics|analgesics|mesh-ancestor
56630590|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
56630591|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630592|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630593|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
56630594|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56630595|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56630598|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56630650|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56630651|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630652|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
56630653|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630654|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
56630655|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630656|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56630657|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
56630659|NCT00606983|Tamsulosin|tamsulosin|mesh-list
56630714|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56630715|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630716|NCT00934661|Morphine|morphine|mesh-list
56630717|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56630718|NCT00934661|Narcotics|narcotics|mesh-ancestor
56630719|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630720|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630721|NCT00934661|Analgesics|analgesics|mesh-ancestor
56630722|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
56630723|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630724|NCT02743182|Interferons|interferons|mesh-list
56630733|NCT00775437|Adalimumab|adalimumab|mesh-list
56630781|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56630782|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
56630783|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
56630784|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
56630785|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56630786|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56630787|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
56630788|NCT00775203|Trazodone|trazodone|mesh-list
56630789|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56630808|NCT02747316|Iron|iron|mesh-list
56630849|NCT04239170|Antiviral Agents|antiviral agents|mesh-ancestor
56630850|NCT04239170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56630851|NCT04239170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630852|NCT04239170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56630853|NCT04239170|Immunologic Factors|immunologic factors|mesh-ancestor
56630854|NCT04239170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630855|NCT04480190|Gemcitabine|gemcitabine|mesh-list
56630917|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630918|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630919|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630920|NCT00568321|Tanezumab|tanezumab|mesh-list
56630921|NCT00568321|Analgesics|analgesics|mesh-ancestor
56630922|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
56630923|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630924|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630925|NCT02742480|Dabigatran|dabigatran|mesh-list
56630926|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
56630927|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
56630928|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56630929|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
56630930|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56630931|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56630932|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
56630933|NCT00774345|Lenalidomide|lenalidomide|mesh-list
56630934|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
56630935|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630936|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56630937|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56630938|NCT00774345|Growth Substances|growth substances|mesh-ancestor
56630939|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
56630940|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56630968|NCT00927979|Ropivacaine|ropivacaine|mesh-list
56630969|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
56630970|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
56630971|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56630972|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56630973|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
56630974|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56630975|NCT00931957|Prednisolone|prednisolone|mesh-list
56630976|NCT00931957|Etanercept|etanercept|mesh-list
56630977|NCT00931957|Methotrexate|methotrexate|mesh-list
56630978|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56630979|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
56631031|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56631032|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56631033|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631034|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56631035|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
56631036|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56631037|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
56631038|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56631039|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56631040|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56631041|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56631042|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631043|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
56631044|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631045|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631046|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56631047|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631048|NCT00928213|Heparin|heparin|mesh-list
56631049|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56631050|NCT00928213|Tinzaparin|tinzaparin|mesh-list
56631051|NCT00928213|Dalteparin|dalteparin|mesh-list
56631052|NCT00928213|Progesterone|progesterone|mesh-list
56631053|NCT00928213|Hormones|hormones|mesh-ancestor
56631054|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631055|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631056|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
56631057|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56631077|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631078|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
56631079|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56631080|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
56631081|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56631082|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56631083|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56631084|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
56631085|NCT04287816|Antithrombins|antithrombins|mesh-list
56631086|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56631087|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
56631088|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631089|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631090|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
56631091|NCT04313790|Heparin|heparin|mesh-list
56631092|NCT04313790|Calcium heparin|calcium heparin|mesh-list
56631093|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
56631094|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56631095|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56631096|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631097|NCT02735928|Doxorubicin|doxorubicin|mesh-list
56631098|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631099|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56631100|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56631101|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56631102|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631103|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631104|NCT05464680|Dimercaprol|dimercaprol|mesh-list
56631105|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
56631106|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
56631107|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631108|NCT02731560|Rituximab|rituximab|mesh-list
56115465|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56115466|NCT00002147|Doxorubicin|doxorubicin|mesh-list
56115467|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56115501|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115503|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115504|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115505|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115506|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115566|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115567|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
56631109|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56631110|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631111|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
56631112|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631113|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631114|NCT00773097|Poly ICLC|poly iclc|mesh-list
56631115|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
56631116|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
56631117|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631118|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
56631119|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631120|NCT02814110|Lenograstim|lenograstim|mesh-list
56631121|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56631122|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
56631123|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631124|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
56631125|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631126|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56631127|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631128|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631129|NCT04264481|Lidocaine|lidocaine|mesh-list
56631130|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
56631131|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
56631132|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631133|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631134|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
56631135|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631136|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56160002|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631137|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56631138|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56631139|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56631140|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631148|NCT04306692|Clomiphene|clomiphene|mesh-list
56631149|NCT04306692|Enclomiphene|enclomiphene|mesh-list
56631150|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
56631151|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56631152|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
56631153|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631154|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631155|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56631156|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
56631157|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56631158|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56631159|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56631160|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
56631161|NCT04306692|Vitamins|vitamins|mesh-ancestor
56631162|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
56631163|NCT00772941|Varenicline|varenicline|mesh-list
56631164|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56631165|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56631166|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
56631167|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631168|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631169|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631170|NCT02735694|Cycloserine|cycloserine|mesh-list
56631171|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56631172|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631173|NCT02735694|Renal Agents|renal agents|mesh-ancestor
56631174|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56631175|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
56631176|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56631177|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
56631178|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631179|NCT05345717|Abatacept|abatacept|mesh-list
56631180|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
56115568|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56115569|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
56115570|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115571|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115572|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115573|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115574|NCT00002201|Ritonavir|ritonavir|mesh-list
56115575|NCT00002201|Nelfinavir|nelfinavir|mesh-list
56115576|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55805800|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
56631181|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56631182|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631183|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631184|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56631185|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
56631186|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631187|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631188|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
56631189|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631190|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
56631191|NCT04717375|Cetuximab|cetuximab|mesh-list
56631192|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56631193|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631194|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
56631195|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56631196|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631197|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631198|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56631199|NCT04237532|Analgesics|analgesics|mesh-ancestor
56631200|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
56631201|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631202|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56631203|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56631204|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56631205|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
56379753|NCT00117026|Benphothiamine|benphothiamine|mesh-list
56631206|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176767|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115577|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115578|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115579|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115580|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115581|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115582|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115583|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
56115584|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115585|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56115614|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115616|NCT00002219|Adefovir|adefovir|mesh-list
56115617|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56115618|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115619|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115620|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115621|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742136|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55805964|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
56631207|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631208|NCT02731092|Lactoferrin|lactoferrin|mesh-list
56631209|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065029|NCT01824901|Docetaxel|docetaxel|mesh-list
56631211|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56631212|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56631213|NCT00928837|Analgesics|analgesics|mesh-ancestor
56631214|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
56631215|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631216|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631217|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56631218|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631219|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
56631220|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56631221|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631222|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631223|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
56631224|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56631225|NCT00925093|Vancomycin|vancomycin|mesh-list
56631226|NCT00925093|Linezolid|linezolid|mesh-list
56631227|NCT00925093|Teicoplanin|teicoplanin|mesh-list
56631228|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115622|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115623|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115624|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115625|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
56115626|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115627|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115660|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115661|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115662|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115663|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56115664|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115666|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
56115667|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
56115668|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115688|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115689|NCT00002519|Paclitaxel|paclitaxel|mesh-list
56115690|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56196849|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
56196850|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196851|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56196852|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56196853|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56196854|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196855|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124628|NCT04044222|Carboplatin|carboplatin|mesh-list
56196856|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56196857|NCT01505283|Narcotics|narcotics|mesh-ancestor
56196858|NCT01505283|Analgesics|analgesics|mesh-ancestor
56196859|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56196860|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56631229|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631230|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56631231|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631232|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631233|NCT01562977|Gemcitabine|gemcitabine|mesh-list
56631234|NCT01562977|Rituximab|rituximab|mesh-list
56631235|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
56631236|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56631237|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631238|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
56631239|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631240|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631241|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56631242|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
56631243|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631244|NCT01562977|Antiviral Agents|antiviral agents|mesh-ancestor
56631245|NCT01562977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631246|NCT01562977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631247|NCT01562977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56631248|NCT00607685|Fluorouracil|fluorouracil|mesh-list
56631249|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
56631250|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
56631281|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
56631282|NCT00928915|Coagulants|coagulants|mesh-ancestor
56631283|NCT02814500|Amlodipine|amlodipine|mesh-list
56631284|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56065107|NCT02437253|Adalimumab|adalimumab|mesh-list
56631285|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56631286|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56631287|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56631288|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631289|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56631290|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631291|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
56631292|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56631293|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56631294|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
56631295|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56631297|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631337|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631338|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56631339|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631340|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56631341|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56631342|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631343|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56631344|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56631345|NCT02739906|Insulin|insulin|mesh-list
56631346|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56631347|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
56631348|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56631349|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631350|NCT02739672|Amlodipine|amlodipine|mesh-list
56631351|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56631352|NCT02739672|Telmisartan|telmisartan|mesh-list
56631353|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56379905|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631354|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56631355|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56631356|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56631357|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631358|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56631359|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631360|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
56631361|NCT02739672|Diuretics|diuretics|mesh-ancestor
56631362|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
56631365|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56631381|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631382|NCT05382143|Atosiban|atosiban|mesh-list
56631383|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
56631384|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631385|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631386|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
56631387|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56631388|NCT00933049|Amoxicillin|amoxicillin|mesh-list
56631389|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56631390|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56631391|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631392|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56631393|NCT00933049|Renal Agents|renal agents|mesh-ancestor
56631394|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
56631395|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56631396|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56631397|NCT05788458|Bupivacaine|bupivacaine|mesh-list
56631398|NCT05788458|Anesthetics, Local|anesthetics, local|mesh-ancestor
56631399|NCT05788458|Anesthetics|anesthetics|mesh-ancestor
56631400|NCT05788458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631401|NCT05788458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631402|NCT05788458|Sensory System Agents|sensory system agents|mesh-ancestor
56631404|NCT05788393|Lidocaine|lidocaine|mesh-list
56631432|NCT05788328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56631433|NCT05788328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631434|NCT05788328|Antithrombins|antithrombins|mesh-ancestor
56631435|NCT05788328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56631436|NCT05788328|Protease Inhibitors|protease inhibitors|mesh-ancestor
56631437|NCT05788328|Anticoagulants|anticoagulants|mesh-ancestor
56631438|NCT05788289|Lenalidomide|lenalidomide|mesh-list
56631439|NCT05788289|Immunologic Factors|immunologic factors|mesh-ancestor
56631440|NCT05788289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631441|NCT05788289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56631442|NCT05788289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56631443|NCT05788289|Growth Substances|growth substances|mesh-ancestor
56631444|NCT05788289|Growth Inhibitors|growth inhibitors|mesh-ancestor
56196861|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
56196862|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56196864|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
56196865|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56196866|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56196867|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
56196868|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196869|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196870|NCT01505413|Antiviral Agents|antiviral agents|mesh-ancestor
56115691|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115692|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
56115693|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
56115694|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
55742137|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115695|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115697|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115698|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115699|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56115700|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
56115701|NCT00002273|Ganciclovir|ganciclovir|mesh-list
56115702|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56115703|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
56115704|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115705|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115706|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115707|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115708|NCT00002279|Zalcitabine|zalcitabine|mesh-list
56115709|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
56115710|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115711|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115712|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115713|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115714|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
56115715|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115716|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115717|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115718|NCT00002285|Zidovudine|zidovudine|mesh-list
56196871|NCT01505413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196872|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196873|NCT01505413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56196874|NCT01505413|Immunologic Factors|immunologic factors|mesh-ancestor
56196875|NCT01505413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196876|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56196877|NCT01505426|Metformin|metformin|mesh-list
56196878|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
56196879|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56196880|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196881|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56631445|NCT05788289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631446|NCT05788276|Dapagliflozin|dapagliflozin|mesh-list
56631447|NCT05788276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56631448|NCT05788276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631449|NCT05788276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56631450|NCT05788276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631451|NCT05788159|Lacosamide|lacosamide|mesh-list
56631452|NCT05788159|Anticonvulsants|anticonvulsants|mesh-ancestor
56631453|NCT05788159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56631454|NCT05788159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56631455|NCT05788159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56631456|NCT05788159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631457|NCT05788094|Chloroquine|chloroquine|mesh-list
56631458|NCT05788094|Piperaquine|piperaquine|mesh-list
56631459|NCT05788094|Artenimol|artenimol|mesh-list
56631460|NCT05788094|Tafenoquine|tafenoquine|mesh-list
56631461|NCT05788094|Amebicides|amebicides|mesh-ancestor
56631462|NCT05788094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56631463|NCT05788094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56631464|NCT05788094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631465|NCT05788094|Antimalarials|antimalarials|mesh-ancestor
56631466|NCT05788094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631467|NCT05788081|Rituximab|rituximab|mesh-list
56631468|NCT05788081|Nivolumab|nivolumab|mesh-list
56631469|NCT05788081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56631477|NCT05788016|Narcotics|narcotics|mesh-ancestor
56631496|NCT05787808|Vitamin D|vitamin d|mesh-list
56631497|NCT05787808|Vitamins|vitamins|mesh-ancestor
56631498|NCT05787808|Micronutrients|micronutrients|mesh-ancestor
56631499|NCT05787808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631500|NCT05787808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56631501|NCT05787743|Tocotrienols|tocotrienols|mesh-list
56631502|NCT05787743|Vitamin E|vitamin e|mesh-list
56631503|NCT05787743|Tocopherols|tocopherols|mesh-list
56631504|NCT05787743|Antioxidants|antioxidants|mesh-ancestor
56631505|NCT05787743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631506|NCT05787743|Protective Agents|protective agents|mesh-ancestor
56631507|NCT05787743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631509|NCT05787743|Micronutrients|micronutrients|mesh-ancestor
56631510|NCT05787613|Paclitaxel|paclitaxel|mesh-list
56631511|NCT05787613|Carboplatin|carboplatin|mesh-list
56631512|NCT05787613|Pemetrexed|pemetrexed|mesh-list
56631513|NCT05787613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56631514|NCT05787613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631515|NCT05787613|Tubulin Modulators|tubulin modulators|mesh-ancestor
56631516|NCT05787613|Antimitotic Agents|antimitotic agents|mesh-ancestor
56631517|NCT05787613|Mitosis Modulators|mitosis modulators|mesh-ancestor
56631518|NCT05787613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631519|NCT05787613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631520|NCT05787613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56631521|NCT05787613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56631522|NCT05787600|Chlorhexidine|chlorhexidine|mesh-list
56631523|NCT05787600|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56631524|NCT05787600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56631525|NCT05787600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631526|NCT05787600|Disinfectants|disinfectants|mesh-ancestor
56631527|NCT05787600|Dermatologic Agents|dermatologic agents|mesh-ancestor
56631528|NCT05787574|Dexamethasone|dexamethasone|mesh-list
56631529|NCT05787574|Fludarabine|fludarabine|mesh-list
56631530|NCT05787574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56631531|NCT05787574|Antiemetics|antiemetics|mesh-ancestor
56196882|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196883|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
56115719|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
56115720|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115721|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115722|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115723|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805965|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
56631532|NCT05787574|Autonomic Agents|autonomic agents|mesh-ancestor
56631533|NCT05787574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631534|NCT05787574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631535|NCT05787574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56631536|NCT05787574|Glucocorticoids|glucocorticoids|mesh-ancestor
56631537|NCT05787574|Hormones|hormones|mesh-ancestor
56631538|NCT05787574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631539|NCT05787574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56631540|NCT05787574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631541|NCT05787535|Cyclophosphamide|cyclophosphamide|mesh-list
56631542|NCT05787535|Fludarabine|fludarabine|mesh-list
56631543|NCT05787535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56631544|NCT05787535|Immunologic Factors|immunologic factors|mesh-ancestor
56631545|NCT05787535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631546|NCT05787535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631547|NCT05787535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56631548|NCT05787535|Alkylating Agents|alkylating agents|mesh-ancestor
56631549|NCT05787535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631550|NCT05787535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631551|NCT05787535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56631552|NCT05787509|Progesterone|progesterone|mesh-list
56631553|NCT05787509|Progestins|progestins|mesh-ancestor
56631554|NCT05787509|Hormones|hormones|mesh-ancestor
56631555|NCT05787509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631556|NCT05787509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631557|NCT05787002|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56631558|NCT05787002|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56631559|NCT05787002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56631560|NCT05787002|Antimetabolites|antimetabolites|mesh-ancestor
56115753|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115754|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115755|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56115756|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56115757|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
56115758|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
56115759|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56115760|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56115761|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
56115762|NCT00002531|Hormones|hormones|mesh-ancestor
56115763|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56115764|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56115765|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115766|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115767|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56631561|NCT05787002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631562|NCT05787002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56631563|NCT05787002|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56631564|NCT05787002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631565|NCT05786950|Bromides|bromides|mesh-list
56631566|NCT05786950|Albuterol|albuterol|mesh-list
56631567|NCT05786950|Ipratropium|ipratropium|mesh-list
56631568|NCT05786950|Anticonvulsants|anticonvulsants|mesh-ancestor
56631569|NCT05786950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56631570|NCT05786950|Autonomic Agents|autonomic agents|mesh-ancestor
56631571|NCT05786950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631572|NCT05786950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631573|NCT05786950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56631574|NCT05786950|Respiratory System Agents|respiratory system agents|mesh-ancestor
56631575|NCT05786950|Tocolytic Agents|tocolytic agents|mesh-ancestor
56631576|NCT05786950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56631577|NCT05786950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56631582|NCT05786950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631583|NCT05786950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56631584|NCT05786950|Cholinergic Agents|cholinergic agents|mesh-ancestor
56631585|NCT05786885|Vitamins|vitamins|mesh-list
56631586|NCT05786885|Ascorbic Acid|ascorbic acid|mesh-list
56631587|NCT05786885|Micronutrients|micronutrients|mesh-ancestor
56631589|NCT05786885|Antioxidants|antioxidants|mesh-ancestor
56631617|NCT05785897|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56631618|NCT05785897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631619|NCT05785897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631620|NCT05785897|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56631621|NCT05785897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56631622|NCT05785897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631623|NCT05785897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56631624|NCT05785897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631625|NCT05785897|Antifungal Agents|antifungal agents|mesh-ancestor
56631626|NCT05785897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56631627|NCT05785897|Immunologic Factors|immunologic factors|mesh-ancestor
56631628|NCT05785897|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56631629|NCT05785897|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56631630|NCT05785897|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56631631|NCT05785897|Purinergic Agents|purinergic agents|mesh-ancestor
56631632|NCT05785897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631633|NCT05785819|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56631634|NCT05785819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631635|NCT05784688|Pembrolizumab|pembrolizumab|mesh-list
56631636|NCT05784688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56631637|NCT05784688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631638|NCT05784363|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56631639|NCT05784363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56631640|NCT05784363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631641|NCT05784363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631642|NCT05784363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56115768|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115769|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56115770|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
56115771|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56115772|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56115773|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
56115774|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
56115775|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56115776|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115814|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
56115815|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115816|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115817|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115818|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
56115819|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115820|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115821|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56631643|NCT05784363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56631644|NCT05784363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631645|NCT05784363|Cholinergic Agents|cholinergic agents|mesh-ancestor
56631646|NCT05784363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631647|NCT05782270|Warfarin|warfarin|mesh-list
56631648|NCT05782270|Anticoagulants|anticoagulants|mesh-ancestor
56631656|NCT05776459|Prednisolone|prednisolone|mesh-list
56380209|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56631657|NCT05776459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56631658|NCT05776459|Glucocorticoids|glucocorticoids|mesh-ancestor
56631659|NCT05776459|Hormones|hormones|mesh-ancestor
56631660|NCT05776459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631661|NCT05776459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631662|NCT05776459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56631663|NCT05776459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631664|NCT05770297|Propolis|propolis|mesh-list
56631665|NCT05770297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631666|NCT05765084|Pemetrexed|pemetrexed|mesh-list
56631667|NCT05765084|Atezolizumab|atezolizumab|mesh-list
56631668|NCT05765084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631669|NCT05765084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631670|NCT05765084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631671|NCT05765084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56631672|NCT05765084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56631673|NCT05764044|Gemcitabine|gemcitabine|mesh-list
56631674|NCT05764044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631675|NCT05764044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56631676|NCT05764044|Antimetabolites|antimetabolites|mesh-ancestor
56631677|NCT05764044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631678|NCT05764044|Antiviral Agents|antiviral agents|mesh-ancestor
56631679|NCT05764044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631680|NCT05764044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631681|NCT05764044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115822|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115823|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115824|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115825|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115826|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56115827|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
56115828|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
56115829|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631682|NCT05764044|Immunologic Factors|immunologic factors|mesh-ancestor
56631683|NCT05764044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631684|NCT05763121|Pramipexole|pramipexole|mesh-list
56631685|NCT05763121|Antioxidants|antioxidants|mesh-ancestor
56631686|NCT05763121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631687|NCT05763121|Protective Agents|protective agents|mesh-ancestor
56631688|NCT05763121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631689|NCT05763121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56631690|NCT05763121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56631691|NCT05763121|Dopamine Agonists|dopamine agonists|mesh-ancestor
56631692|NCT05763121|Dopamine Agents|dopamine agents|mesh-ancestor
56631693|NCT05763121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631694|NCT05760378|Carboplatin|carboplatin|mesh-list
56631695|NCT05760378|Capecitabine|capecitabine|mesh-list
56631696|NCT05760378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631697|NCT05760378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56631698|NCT05760378|Antimetabolites|antimetabolites|mesh-ancestor
56631699|NCT05760378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631700|NCT05748600|Pramipexole|pramipexole|mesh-list
56631701|NCT05748600|Antioxidants|antioxidants|mesh-ancestor
56631702|NCT05748600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631703|NCT05748600|Protective Agents|protective agents|mesh-ancestor
56631704|NCT05748600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631705|NCT05748600|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56631706|NCT05748600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56631707|NCT05748600|Dopamine Agonists|dopamine agonists|mesh-ancestor
56631708|NCT05748600|Dopamine Agents|dopamine agents|mesh-ancestor
56631709|NCT05748600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631710|NCT05746520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56631711|NCT05746520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56631712|NCT05746520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631713|NCT05746520|Antitubercular Agents|antitubercular agents|mesh-ancestor
56631714|NCT05739136|Norethindrone|norethindrone|mesh-list
56631715|NCT05739136|Norethindrone Acetate|norethindrone acetate|mesh-list
56115830|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56196884|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56196885|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56196886|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196887|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196888|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196889|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631716|NCT05739136|Estradiol|estradiol|mesh-list
56631717|NCT05739136|Relugolix|relugolix|mesh-list
56631718|NCT05739136|Estrogens|estrogens|mesh-ancestor
56631719|NCT05739136|Hormones|hormones|mesh-ancestor
56631720|NCT05739136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631721|NCT05739136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631722|NCT05739136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56631723|NCT05739136|Contraceptive Agents|contraceptive agents|mesh-ancestor
56631724|NCT05739136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56160014|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
56631725|NCT05739136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56631726|NCT05739136|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56631727|NCT05739136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56631728|NCT05739136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56631729|NCT05739136|Androgen Antagonists|androgen antagonists|mesh-ancestor
56631730|NCT05739136|Hormone Antagonists|hormone antagonists|mesh-ancestor
56631731|NCT05739123|Relugolix|relugolix|mesh-list
56631732|NCT05739123|Androgen Antagonists|androgen antagonists|mesh-ancestor
56631733|NCT05739123|Hormone Antagonists|hormone antagonists|mesh-ancestor
56631734|NCT05739123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631735|NCT05739123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631736|NCT05737030|N-Methylaspartate|n-methylaspartate|mesh-list
56631737|NCT05737030|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56631738|NCT05737030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56631739|NCT05737030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56631740|NCT05737030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631741|NCT05737030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631742|NCT05723601|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56631743|NCT05723601|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56196890|NCT01505439|Urological Agents|urological agents|mesh-ancestor
56196891|NCT01505504|Mirtazapine|mirtazapine|mesh-list
56196892|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
56196893|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196894|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56196895|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
56196896|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
56196897|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196898|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115831|NCT00002549|Analgesics|analgesics|mesh-ancestor
56115832|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
56115833|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56115835|NCT00002555|Trace Elements|trace elements|mesh-ancestor
56115836|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
56115837|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631744|NCT05723601|Estradiol|estradiol|mesh-list
56631745|NCT05723601|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56631746|NCT05723601|Estrogens|estrogens|mesh-ancestor
56631747|NCT05723601|Hormones|hormones|mesh-ancestor
56631748|NCT05723601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631749|NCT05723601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631750|NCT05723601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56631751|NCT05723601|Contraceptive Agents|contraceptive agents|mesh-ancestor
56631752|NCT05723601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56631753|NCT05723601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56631754|NCT05716295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56631755|NCT05716295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631756|NCT05716295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631757|NCT05715216|Nivolumab|nivolumab|mesh-list
56631758|NCT05715216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56631759|NCT05715216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631760|NCT05715216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56631761|NCT05715216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631762|NCT05714059|Insulin|insulin|mesh-list
56631763|NCT05714059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56631764|NCT05714059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631780|NCT05708625|Doxycycline|doxycycline|mesh-list
56631781|NCT05708625|Voriconazole|voriconazole|mesh-list
56631782|NCT05708625|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56631783|NCT05708625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56631784|NCT05708625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631785|NCT05708625|Antimalarials|antimalarials|mesh-ancestor
56631786|NCT05708625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56631787|NCT05708625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56631788|NCT05708625|Antifungal Agents|antifungal agents|mesh-ancestor
56115838|NCT00002561|Doxorubicin|doxorubicin|mesh-list
56115839|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56115840|NCT00002561|Bleomycin|bleomycin|mesh-list
56115841|NCT00002561|Dacarbazine|dacarbazine|mesh-list
56115842|NCT00002561|Vinblastine|vinblastine|mesh-list
56115843|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115907|NCT05704049|BB 1101|bb 1101|mesh-list
56115908|NCT05704049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56115909|NCT05704049|Antiemetics|antiemetics|mesh-ancestor
56115910|NCT05704049|Autonomic Agents|autonomic agents|mesh-ancestor
56115911|NCT05704049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56115912|NCT05704049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115913|NCT05704049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56115914|NCT05704049|Glucocorticoids|glucocorticoids|mesh-ancestor
56115915|NCT05704049|Hormones|hormones|mesh-ancestor
56115916|NCT05704049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631789|NCT05708625|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56631790|NCT05708625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56631791|NCT05708625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631792|NCT05708625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631793|NCT05708625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56631794|NCT05708625|Hormone Antagonists|hormone antagonists|mesh-ancestor
56631795|NCT05708625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631796|NCT05708625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631797|NCT05708625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56631798|NCT05708625|Schistosomicides|schistosomicides|mesh-ancestor
56631799|NCT05708625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56631800|NCT05708625|Anthelmintics|anthelmintics|mesh-ancestor
56631801|NCT05706844|Anesthetics|anesthetics|mesh-list
56631802|NCT05706844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56631803|NCT05706844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631804|NCT05706506|Tirzepatide|tirzepatide|mesh-list
56631805|NCT05706506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56631806|NCT05706506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631807|NCT05706506|Incretins|incretins|mesh-ancestor
56631808|NCT05706506|Hormones|hormones|mesh-ancestor
56631809|NCT05706506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631839|NCT05696847|Hormones|hormones|mesh-ancestor
56631840|NCT05696847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56631863|NCT05690698|Haloperidol|haloperidol|mesh-list
56631864|NCT05690698|Haloperidol decanoate|haloperidol decanoate|mesh-list
56631865|NCT05690698|Antiemetics|antiemetics|mesh-ancestor
56631866|NCT05690698|Autonomic Agents|autonomic agents|mesh-ancestor
56631867|NCT05690698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56631868|NCT05690698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631869|NCT05690698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56631882|NCT05685628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631900|NCT05673889|Dabigatran|dabigatran|mesh-list
56631901|NCT05673889|Antithrombins|antithrombins|mesh-ancestor
56631902|NCT05673889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56631903|NCT05673889|Protease Inhibitors|protease inhibitors|mesh-ancestor
56631904|NCT05673889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631905|NCT05673889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631906|NCT05673889|Anticoagulants|anticoagulants|mesh-ancestor
56631907|NCT05658510|Dexmedetomidine|dexmedetomidine|mesh-list
56631908|NCT05658510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56631912|NCT05658510|Analgesics|analgesics|mesh-ancestor
56631962|NCT05631093|Antiviral Agents|antiviral agents|mesh-ancestor
56631963|NCT05631093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56631964|NCT05631093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631965|NCT05631093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631966|NCT05631093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56631967|NCT05631093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56631968|NCT05631093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56631984|NCT05622318|Mycophenolic Acid|mycophenolic acid|mesh-list
56631985|NCT05622318|Cyclophosphamide|cyclophosphamide|mesh-list
56631986|NCT05622318|Tacrolimus|tacrolimus|mesh-list
56631987|NCT05622318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56631988|NCT05622318|Immunologic Factors|immunologic factors|mesh-ancestor
56631989|NCT05622318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56631990|NCT05622318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56631991|NCT05622318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56631992|NCT05622318|Alkylating Agents|alkylating agents|mesh-ancestor
56631993|NCT05622318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56631994|NCT05622318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56631995|NCT05622318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56631996|NCT05622318|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56631997|NCT05622318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56631998|NCT05622318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56631999|NCT05622318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56632000|NCT05622318|Antitubercular Agents|antitubercular agents|mesh-ancestor
56632001|NCT05622318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56632002|NCT05622318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632003|NCT05618613|Onapristone|onapristone|mesh-list
56632004|NCT05618613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632005|NCT05618613|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56632006|NCT05618613|Fertility Agents|fertility agents|mesh-ancestor
56632007|NCT05618613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56632008|NCT05618613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632009|NCT05618613|Hormone Antagonists|hormone antagonists|mesh-ancestor
56632010|NCT05618613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632011|NCT05617963|Durvalumab|durvalumab|mesh-list
56632012|NCT05617963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632013|NCT05617963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632014|NCT05613088|Paclitaxel|paclitaxel|mesh-list
56632015|NCT05613088|Doxorubicin|doxorubicin|mesh-list
56632016|NCT05613088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56632018|NCT05613088|Farletuzumab|farletuzumab|mesh-list
56632019|NCT05613088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56632020|NCT05613088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632021|NCT05613088|Tubulin Modulators|tubulin modulators|mesh-ancestor
56632022|NCT05613088|Antimitotic Agents|antimitotic agents|mesh-ancestor
56632023|NCT05613088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56632024|NCT05613088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632025|NCT05613088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56632026|NCT05613088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56632027|NCT05613088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56632028|NCT05613088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632029|NCT05613088|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56632041|NCT05594563|Eflornithine|eflornithine|mesh-list
56632042|NCT05594563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632043|NCT05594563|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56632044|NCT05594563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56632045|NCT05594563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56632046|NCT05594563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632047|NCT05594563|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56632048|NCT05594563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632050|NCT05587036|Rifaximin|rifaximin|mesh-list
56115917|NCT05704049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56115918|NCT05704049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115919|NCT05704049|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115920|NCT05704049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115921|NCT05704049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115922|NCT00002609|Cytarabine|cytarabine|mesh-list
56115923|NCT00002609|Idarubicin|idarubicin|mesh-list
56115924|NCT00002609|Lintuzumab|lintuzumab|mesh-list
56115925|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56115926|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
56115927|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115928|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115929|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
56115930|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115931|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115932|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
55864825|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
56115933|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115934|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115935|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115936|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115937|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115938|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56115939|NCT00002615|Fluorouracil|fluorouracil|mesh-list
56115940|NCT00002615|Epirubicin|epirubicin|mesh-list
56196899|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196900|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56196901|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56196902|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56196903|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56196904|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56196905|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56196906|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
56115941|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115942|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
56115943|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115944|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56115963|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115964|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115965|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
56115966|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
55842917|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115967|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
56115968|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115969|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115970|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
56115971|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115972|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115973|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115974|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
56115975|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56115978|NCT00002633|Flutamide|flutamide|mesh-list
56115979|NCT00002633|Bicalutamide|bicalutamide|mesh-list
56115980|NCT00002633|Nilutamide|nilutamide|mesh-list
56115981|NCT00002633|Buserelin|buserelin|mesh-list
56115982|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56115983|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
56115984|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56115985|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115986|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56115987|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115988|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
56115989|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
56115990|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56115991|NCT00002639|Suramin|suramin|mesh-list
56115993|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
56115994|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56115995|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115996|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115997|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56115998|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56115999|NCT00002657|Interferons|interferons|mesh-list
56116000|NCT00002657|Cytarabine|cytarabine|mesh-list
56116001|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
56116002|NCT00002657|Prednisone|prednisone|mesh-list
56116003|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
56116004|NCT00002657|Doxorubicin|doxorubicin|mesh-list
56116005|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56116006|NCT00002657|Methotrexate|methotrexate|mesh-list
56116030|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56116031|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116032|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
56116033|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
56116034|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56116035|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56116036|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56116037|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
56116038|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116039|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
56116040|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
56116041|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
56116042|NCT05673785|Prednisone|prednisone|mesh-list
56196907|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55865091|NCT00856024|Ribavirin|ribavirin|mesh-list
56196913|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56196914|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
56196915|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196916|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196917|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196918|NCT01505790|Clopidogrel|clopidogrel|mesh-list
56196919|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56196920|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56196921|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56196922|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56196923|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56116043|NCT05673785|Cyclophosphamide|cyclophosphamide|mesh-list
56116044|NCT05673785|Doxorubicin|doxorubicin|mesh-list
56116045|NCT05673785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56116046|NCT05673785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116047|NCT05673785|Immunologic Factors|immunologic factors|mesh-ancestor
56116048|NCT05673785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116049|NCT05673785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116050|NCT05673785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56116051|NCT05673785|Alkylating Agents|alkylating agents|mesh-ancestor
56116052|NCT05673785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116053|NCT05673785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116054|NCT05673785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56116055|NCT05673785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56116056|NCT05673785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56116075|NCT00002669|Interferons|interferons|mesh-list
56116076|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
56116077|NCT00002669|Aldesleukin|aldesleukin|mesh-list
56116078|NCT00002669|Dacarbazine|dacarbazine|mesh-list
56116079|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116080|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
56632088|NCT05571514|Calcium Carbonate|calcium carbonate|mesh-list
56632089|NCT05571514|Calcium|calcium|mesh-list
56632090|NCT05571514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56632100|NCT05567731|Hormones|hormones|mesh-list
56632101|NCT05567731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632102|NCT05567731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632103|NCT05566756|Ofatumumab|ofatumumab|mesh-list
56632104|NCT05566756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632105|NCT05564637|Treprostinil|treprostinil|mesh-list
56632106|NCT05564637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56632107|NCT05561543|Peppermint oil|peppermint oil|mesh-list
56632108|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
56632109|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
56632110|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632111|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632112|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56632113|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
56632126|NCT05550532|Aticaprant|aticaprant|mesh-list
56632127|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56632128|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632129|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
56632174|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632175|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56632176|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56632177|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
56632178|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56632179|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56632180|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56632181|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56632182|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
56632183|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632184|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
56632185|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56632186|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
56632187|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56632188|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
56632189|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632190|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632191|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
56632192|NCT05487040|Ritonavir|ritonavir|mesh-list
56632193|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56632194|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56632195|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
56632196|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632197|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632198|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56632199|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56632222|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
56632223|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632224|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56632225|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56632226|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56632227|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56632228|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632229|NCT05455320|Dexamethasone|dexamethasone|mesh-list
56632230|NCT05455320|Daratumumab|daratumumab|mesh-list
56632231|NCT05455320|Pomalidomide|pomalidomide|mesh-list
56632232|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56632233|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
56632234|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
56632235|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632236|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632237|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56632238|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
56632240|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632241|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56632242|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632243|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
56632244|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56632245|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56632246|NCT05455320|Growth Substances|growth substances|mesh-ancestor
56632247|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
56632248|NCT05452512|Vitamin D|vitamin d|mesh-list
56632249|NCT05452512|Vitamins|vitamins|mesh-list
56632250|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
56632251|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632252|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56632253|NCT05432089|Oxytocin|oxytocin|mesh-list
56632254|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
56632255|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56116081|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116082|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
56116083|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116084|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56116085|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56116086|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56116087|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
56632256|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632257|NCT05430399|Docetaxel|docetaxel|mesh-list
56632258|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632259|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
56632260|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
56632261|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
56632262|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632263|NCT05428826|Prednisone|prednisone|mesh-list
56632264|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56632265|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
56632266|NCT05428826|Hormones|hormones|mesh-ancestor
56632267|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632268|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632269|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56632270|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632271|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
56632272|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56632273|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56632274|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632275|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
56632276|NCT05427513|Coagulants|coagulants|mesh-ancestor
56632284|NCT05411718|Aspirin|aspirin|mesh-list
56632285|NCT05411718|Naproxen|naproxen|mesh-list
56632286|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56632287|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56632288|NCT05411718|Analgesics|analgesics|mesh-ancestor
56632289|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
56632290|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632291|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632292|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56632293|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56632294|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56632295|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56632296|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632297|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56632298|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56632300|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
56632301|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
56632302|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56632303|NCT05408845|Trastuzumab|trastuzumab|mesh-list
56632304|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56632305|NCT05408845|Docetaxel|docetaxel|mesh-list
56632306|NCT05408845|Maytansine|maytansine|mesh-list
56632307|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56632308|NCT05408845|Antibodies|antibodies|mesh-list
56632309|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
56632310|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56632311|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
56632312|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
56632313|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632320|NCT05403723|Carboplatin|carboplatin|mesh-list
56632321|NCT05403723|Etoposide|etoposide|mesh-list
56632322|NCT05403723|Durvalumab|durvalumab|mesh-list
56632323|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632324|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56632325|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56632444|NCT05344469|Interferons|interferons|mesh-list
56632445|NCT05344469|Interferon-beta|interferon-beta|mesh-list
56632446|NCT05344469|Ofatumumab|ofatumumab|mesh-list
56632447|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
56632448|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
56632449|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632450|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
56632451|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632452|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56632453|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
56632454|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632455|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56632456|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56632457|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
56632458|NCT05327686|Nivolumab|nivolumab|mesh-list
56632459|NCT05327686|Ipilimumab|ipilimumab|mesh-list
56632460|NCT05327686|Avelumab|avelumab|mesh-list
56632461|NCT05327686|Lenvatinib|lenvatinib|mesh-list
56632462|NCT05327686|Axitinib|axitinib|mesh-list
56632463|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56632469|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632470|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
56632471|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632472|NCT05323812|Edaravone|edaravone|mesh-list
56632473|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56632474|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
56632475|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632476|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56632477|NCT05323812|Protective Agents|protective agents|mesh-ancestor
56632478|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632479|NCT05322954|Psilocybin|psilocybin|mesh-list
56632480|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
56632481|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632482|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56632483|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56632484|NCT05321524|Cathartics|cathartics|mesh-ancestor
56632485|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56632486|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
56632487|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56632488|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
56116088|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632489|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632491|NCT05316233|Protective Agents|protective agents|mesh-ancestor
56632492|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
56632493|NCT05306873|Cyclosporine|cyclosporine|mesh-list
56632494|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56632495|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632496|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56632497|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
56632498|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56632499|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632500|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632501|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632502|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
56632503|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
56632504|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56632505|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
56632506|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632507|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56632508|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56632514|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
56632515|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632516|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632517|NCT05285982|Nintedanib|nintedanib|mesh-list
56632518|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632519|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56632520|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632521|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632522|NCT05283720|Prednisone|prednisone|mesh-list
56116089|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
56116090|NCT00002675|Carboplatin|carboplatin|mesh-list
56116091|NCT00002675|Etoposide|etoposide|mesh-list
56116092|NCT00002675|Vincristine|vincristine|mesh-list
56116093|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116094|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
56116095|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116096|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116097|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56116098|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
56116099|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116100|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56196924|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
56196925|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196926|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196927|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196928|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56632523|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
56632524|NCT05283720|Rituximab|rituximab|mesh-list
56632525|NCT05283720|Doxorubicin|doxorubicin|mesh-list
56632526|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56632527|NCT05283720|Lenalidomide|lenalidomide|mesh-list
56632528|NCT05283720|Venetoclax|venetoclax|mesh-list
56632529|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56632530|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
56632531|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632532|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56632533|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56632534|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
56632535|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632536|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632537|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56632538|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56160032|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632539|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56632540|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56632541|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56632542|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632543|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56632544|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
56632545|NCT05283720|Hormones|hormones|mesh-ancestor
56632547|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56632572|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632573|NCT05275010|Trastuzumab|trastuzumab|mesh-list
56632574|NCT05275010|Pertuzumab|pertuzumab|mesh-list
56632575|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632576|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632577|NCT05267600|Prednisone|prednisone|mesh-list
56632578|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56632579|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
56632580|NCT05267600|Hormones|hormones|mesh-ancestor
56632581|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632582|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632583|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56632584|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632585|NCT05247268|Letrozole|letrozole|mesh-list
56632586|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56632587|NCT05247268|Megestrol|megestrol|mesh-list
56632588|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
56632589|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
56632590|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632591|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56632592|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56632593|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632594|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632623|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
56632624|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632625|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632626|NCT05136560|Dexamethasone|dexamethasone|mesh-list
56632627|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
56632628|NCT05136560|BB 1101|bb 1101|mesh-list
56632629|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56632630|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
56632631|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
56632632|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632633|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632634|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56632635|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
56632636|NCT05136560|Hormones|hormones|mesh-ancestor
56632637|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632638|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56632639|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632640|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
56632641|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632642|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632644|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632645|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632646|NCT05095376|Temozolomide|temozolomide|mesh-list
56632647|NCT05095376|Lomustine|lomustine|mesh-list
56632648|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56632649|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
56196929|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
56196930|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196931|NCT01505894|BI 409306|bi 409306|mesh-list
56196932|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56196933|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196934|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196935|NCT01505920|Lidocaine|lidocaine|mesh-list
56196936|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
56196937|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
56116102|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56116103|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56116104|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56116105|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116106|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
56116107|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
56116108|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
56116109|NCT00002681|Aldesleukin|aldesleukin|mesh-list
56116110|NCT00002681|Daclizumab|daclizumab|mesh-list
56116111|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116112|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56116113|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56116130|NCT00002693|Carboplatin|carboplatin|mesh-list
56116131|NCT00002693|Topotecan|topotecan|mesh-list
56632650|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632651|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632652|NCT05091567|Carboplatin|carboplatin|mesh-list
56632653|NCT05091567|Etoposide|etoposide|mesh-list
56632654|NCT05091567|Atezolizumab|atezolizumab|mesh-list
56632655|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632656|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56632657|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56632658|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56632659|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632660|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632661|NCT05084586|Epirubicin|epirubicin|mesh-list
56632662|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56632663|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56632664|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632665|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56632666|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56632667|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632668|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632669|NCT05077085|Vancomycin|vancomycin|mesh-list
56632670|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56632671|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632672|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
56632673|NCT05059626|Simvastatin|simvastatin|mesh-list
56632674|NCT05059626|Estrogens|estrogens|mesh-list
56632675|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56632676|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56632677|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
56632678|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632679|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56632680|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56632682|NCT05059626|Hormones|hormones|mesh-ancestor
56632691|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
56632692|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632693|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632694|NCT05050162|Cisplatin|cisplatin|mesh-list
56632695|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
56632696|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632697|NCT05050084|Leuprolide|leuprolide|mesh-list
56632698|NCT05050084|Goserelin|goserelin|mesh-list
56632699|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56632700|NCT05050084|Flutamide|flutamide|mesh-list
56632701|NCT05050084|Bicalutamide|bicalutamide|mesh-list
56632702|NCT05050084|Tryptophan|tryptophan|mesh-list
56632703|NCT05050084|Buserelin|buserelin|mesh-list
56632704|NCT05050084|Hormones|hormones|mesh-list
56632705|NCT05050084|Relugolix|relugolix|mesh-list
56632706|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632707|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116132|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116133|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56116134|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56116135|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116136|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116137|NCT05750459|Artesunate|artesunate|mesh-list
56116138|NCT05750459|Antimalarials|antimalarials|mesh-ancestor
56116139|NCT05750459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56116140|NCT05750459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56116141|NCT05750459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116142|NCT05750459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116143|NCT05750459|Antiviral Agents|antiviral agents|mesh-ancestor
56116144|NCT05750459|Schistosomicides|schistosomicides|mesh-ancestor
56116146|NCT05750459|Anthelmintics|anthelmintics|mesh-ancestor
56116147|NCT00002705|Topotecan|topotecan|mesh-list
56116148|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56116149|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56116150|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116151|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116152|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116153|NCT00002711|Paclitaxel|paclitaxel|mesh-list
56116154|NCT00002711|Cisplatin|cisplatin|mesh-list
56116155|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56116156|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116157|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
56116158|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
56116159|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
56116160|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116161|NCT00002717|Paclitaxel|paclitaxel|mesh-list
56116162|NCT00002717|Cisplatin|cisplatin|mesh-list
56196939|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196940|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
56196941|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196942|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56196943|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56196944|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56196945|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196946|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196947|NCT01505946|Thrombin|thrombin|mesh-list
56196948|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
56196949|NCT01505946|Coagulants|coagulants|mesh-ancestor
56196950|NCT01505998|Amlodipine|amlodipine|mesh-list
56196951|NCT01505998|Benazepril|benazepril|mesh-list
56632708|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56632709|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
56632710|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56632711|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56632712|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632713|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
56632714|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
56632715|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
56632716|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56632717|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
56632718|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56632719|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56632720|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
56632721|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56632723|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
56632724|NCT05035407|Fludarabine|fludarabine|mesh-list
56632725|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56632726|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
56632727|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632728|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56632729|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56632730|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
56632731|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632732|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632733|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56632734|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56632735|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56632757|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
56632758|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
56632759|NCT04974528|Insulin Detemir|insulin detemir|mesh-list
56632760|NCT04974528|Insulin glulisine|insulin glulisine|mesh-list
56632761|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
56632762|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56066586|NCT00550459|Tolvaptan|tolvaptan|mesh-list
56632764|NCT04973930|Citalopram|citalopram|mesh-list
56632765|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56632766|NCT04973930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56632767|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56632768|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56632769|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632770|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56632771|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
56632772|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632773|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56632774|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
56632775|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56632776|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56632777|NCT04972942|Daratumumab|daratumumab|mesh-list
56632778|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632779|NCT04950764|Seladelpar|seladelpar|mesh-list
56632780|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56632781|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
56632782|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381330|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
56632783|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56196952|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56196953|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56196954|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196955|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716291|NCT02359617|Insulin|insulin|mesh-list
56116163|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56116164|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116165|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
56116166|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
56116167|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
56116168|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116169|NCT00002723|Suramin|suramin|mesh-list
56116170|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
56116171|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
56632797|NCT04930744|Metformin|metformin|mesh-list
56632798|NCT04930744|Rifampin|rifampin|mesh-list
56632799|NCT04930744|Isoniazid|isoniazid|mesh-list
56632800|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
56632801|NCT04930744|Ethambutol|ethambutol|mesh-list
56632802|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56632803|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632804|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56632805|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
56632806|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56632807|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632808|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
56632809|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56632810|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632811|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632812|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56632813|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56632814|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56632815|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56632816|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56632817|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56632818|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56632819|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56632820|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
56632821|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56632846|NCT04884763|Erenumab|erenumab|mesh-list
56176771|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
56116172|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56116175|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56116201|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116202|NCT00002747|Trace Elements|trace elements|mesh-ancestor
56116203|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
56116205|NCT02973035|Valsartan|valsartan|mesh-list
56116206|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56116207|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56632847|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56632848|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632849|NCT04884763|Analgesics|analgesics|mesh-ancestor
56632850|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
56632851|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632852|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632853|NCT04877093|Clonidine|clonidine|mesh-list
56632854|NCT04877093|Analgesics|analgesics|mesh-ancestor
56632855|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
56632856|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632857|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632858|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56632859|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
56632860|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
56632861|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56632862|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56632863|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56632864|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
56632865|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56632866|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632867|NCT04866017|Durvalumab|durvalumab|mesh-list
56632868|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632869|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632870|NCT04850911|Ketamine|ketamine|mesh-list
56632871|NCT04850911|Analgesics|analgesics|mesh-ancestor
56632872|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
56632895|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632896|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56632897|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
56632898|NCT04847453|Hormones|hormones|mesh-ancestor
56632899|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56632900|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56632901|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632902|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
56632903|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632904|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632905|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
56632906|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
56632907|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56632908|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
56632909|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56632910|NCT04828694|Naltrexone|naltrexone|mesh-list
56632911|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56632912|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56632913|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632914|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
56632915|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632916|NCT04827056|Ethanol|ethanol|mesh-list
56632917|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
56632918|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56632919|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56116208|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56116209|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116210|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56116211|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116212|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
56116213|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56116214|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56116215|NCT00002753|Antibodies|antibodies|mesh-list
56116216|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56116217|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
56116218|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116219|NCT00002759|Cyclosporine|cyclosporine|mesh-list
56116220|NCT00002759|Irinotecan|irinotecan|mesh-list
56116221|NCT00002759|Phenobarbital|phenobarbital|mesh-list
56116222|NCT00002759|Cyclosporins|cyclosporins|mesh-list
56116223|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56116224|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56116268|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56116269|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56116270|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56196956|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56196957|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196958|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
56632920|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632921|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56632922|NCT04827056|Analgesics|analgesics|mesh-ancestor
56632923|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
56632924|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56632925|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56632926|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56632927|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56632928|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
56632929|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56632930|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632931|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56632932|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632933|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
56632934|NCT04807127|Durvalumab|durvalumab|mesh-list
56632935|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56632936|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632937|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632938|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632939|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
56632940|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56196959|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56196960|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
56196961|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196962|NCT01506011|Amlodipine|amlodipine|mesh-list
56196963|NCT01506011|Benazepril|benazepril|mesh-list
56196964|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56196965|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56196966|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56196967|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196968|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56196969|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196970|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
56196971|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56196972|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
56196973|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196974|NCT01506024|Tacrine|tacrine|mesh-list
56196975|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56196976|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196977|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196978|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196979|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196980|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716360|NCT02222987|Clopidogrel|clopidogrel|mesh-list
56116271|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116272|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
56116273|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56116274|NCT00002777|Tamoxifen|tamoxifen|mesh-list
56116275|NCT00002777|Exemestane|exemestane|mesh-list
56116276|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632941|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56632942|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632943|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632944|NCT04804644|Memantine|memantine|mesh-list
56632945|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56632946|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56632947|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
56632948|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56632949|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632950|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56632951|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56632952|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56632953|NCT04776252|Islatravir|islatravir|mesh-list
56632954|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
56632955|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56632956|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632957|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632958|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56632959|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56632960|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56632961|NCT04770896|Sorafenib|sorafenib|mesh-list
56632962|NCT04770896|Atezolizumab|atezolizumab|mesh-list
56632963|NCT04770896|Lenvatinib|lenvatinib|mesh-list
56632964|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632966|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56632996|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56632997|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56632998|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56632999|NCT04642404|Cannabidiol|cannabidiol|mesh-list
56633000|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
56633001|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56633002|NCT04642352|Bupivacaine|bupivacaine|mesh-list
56633003|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
56633004|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
56633005|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56633006|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633007|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
56633008|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633009|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56633010|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
56633011|NCT04642352|Hormones|hormones|mesh-ancestor
56381548|NCT00486421|Prednisone|prednisone|mesh-list
56633012|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56633013|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633014|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
56633015|NCT04640623|Gemcitabine|gemcitabine|mesh-list
56633016|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633017|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
56633018|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116277|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56116278|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
56116279|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116280|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116281|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56116333|NCT00381953|Interferons|interferons|mesh-list
56116334|NCT00381953|Ribavirin|ribavirin|mesh-list
56116335|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
56116336|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
56116337|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56116338|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116339|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
56116340|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116341|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
56116342|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196981|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56196982|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
56196983|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56196984|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
56196985|NCT01506037|Desloratadine|desloratadine|mesh-list
56196986|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56196987|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196988|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196989|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56196990|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196991|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56633019|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633020|NCT04640623|Antiviral Agents|antiviral agents|mesh-ancestor
56633021|NCT04640623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633022|NCT04640623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633023|NCT04640623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633024|NCT04640623|Immunologic Factors|immunologic factors|mesh-ancestor
56633025|NCT04640623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633026|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
56633027|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56633028|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
56633029|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633030|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56633031|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56633032|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56633033|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633034|NCT04609046|Rituximab|rituximab|mesh-list
56633035|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56633036|NCT04609046|Nivolumab|nivolumab|mesh-list
56633037|NCT04609046|Methotrexate|methotrexate|mesh-list
56633038|NCT04609046|Lenalidomide|lenalidomide|mesh-list
56196992|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56196993|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
56196994|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
56196995|NCT01506050|Desloratadine|desloratadine|mesh-list
56196996|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56196997|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
56196998|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196999|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197000|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197001|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56197002|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56197003|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
56197004|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
56197005|NCT01506063|Levocetirizine|levocetirizine|mesh-list
56197006|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56197007|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56197008|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
56197009|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
56197010|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197011|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197013|NCT01506076|Levocetirizine|levocetirizine|mesh-list
56197021|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56197022|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
56197023|NCT01506115|Trioxsalen|trioxsalen|mesh-list
56197024|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197025|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
56197026|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56197027|NCT01506167|Leucovorin|leucovorin|mesh-list
56197028|NCT01506167|Folic Acid|folic acid|mesh-list
56197029|NCT01506167|Bevacizumab|bevacizumab|mesh-list
56197030|NCT01506167|Fluorouracil|fluorouracil|mesh-list
56197031|NCT01506167|Capecitabine|capecitabine|mesh-list
56197032|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
56197033|NCT01506167|Irinotecan|irinotecan|mesh-list
56116343|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
56116344|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116345|NCT00382343|Trimethoprim|trimethoprim|mesh-list
55805966|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633039|NCT04609046|Antibodies|antibodies|mesh-list
56633040|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
56633041|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56633042|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
56633043|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633044|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633045|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56633046|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56633047|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
56633048|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56633049|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633050|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
56633051|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633052|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
56633064|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
56633065|NCT04598477|Hormones|hormones|mesh-ancestor
56633066|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56633070|NCT04594408|Epinephrine|epinephrine|mesh-list
56633108|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
56633109|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56633110|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
56633111|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633112|NCT04557215|Protective Agents|protective agents|mesh-ancestor
56633113|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633114|NCT04557215|Antidotes|antidotes|mesh-ancestor
56633115|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56633116|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56066947|NCT05586971|Antioxidants|antioxidants|mesh-ancestor
56633133|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56633135|NCT04513717|Leuprolide|leuprolide|mesh-list
56633136|NCT04513717|Goserelin|goserelin|mesh-list
56633137|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56633138|NCT04513717|Flutamide|flutamide|mesh-list
56633139|NCT04513717|Bicalutamide|bicalutamide|mesh-list
56633140|NCT04513717|Tryptophan|tryptophan|mesh-list
56633141|NCT04513717|Buserelin|buserelin|mesh-list
56633142|NCT04513717|Hormones|hormones|mesh-list
56633143|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56633144|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633145|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56116346|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56116347|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
56116348|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56116349|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116350|NCT00382343|Renal Agents|renal agents|mesh-ancestor
56116351|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
56116352|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56116353|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56116354|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56116355|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116356|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116357|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56116358|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56116359|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56116360|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56116362|NCT05749445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56116363|NCT05749445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56116364|NCT05749445|Protease Inhibitors|protease inhibitors|mesh-ancestor
56116365|NCT05749445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116366|NCT05749445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116367|NCT05749445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56116368|NCT05749445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56116369|NCT05749445|Antiviral Agents|antiviral agents|mesh-ancestor
56116370|NCT05749445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865092|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56116386|NCT05749211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56116387|NCT05749211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116388|NCT05749211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116389|NCT05749211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116390|NCT02972957|Azithromycin|azithromycin|mesh-list
56116391|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56633146|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
56633147|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56633148|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56633149|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633150|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
56633151|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
56633152|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
56633153|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56633154|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
56633155|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56633156|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56633157|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
56633158|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56633159|NCT04499248|Bimatoprost|bimatoprost|mesh-list
56633160|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56633161|NCT04498117|Paclitaxel|paclitaxel|mesh-list
56633162|NCT04498117|Carboplatin|carboplatin|mesh-list
56116392|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116394|NCT05568095|Fluorouracil|fluorouracil|mesh-list
56116395|NCT05568095|Capecitabine|capecitabine|mesh-list
56116396|NCT05568095|Oxaliplatin|oxaliplatin|mesh-list
56116397|NCT05568095|Nivolumab|nivolumab|mesh-list
56116398|NCT05568095|Antimetabolites|antimetabolites|mesh-ancestor
56116399|NCT05568095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116400|NCT05568095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116401|NCT05568095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116402|NCT05568095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116403|NCT05568095|Immunologic Factors|immunologic factors|mesh-ancestor
56116404|NCT05568095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116405|NCT05568095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116406|NCT05568095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56116407|NCT05568095|Antidotes|antidotes|mesh-ancestor
56116408|NCT05568095|Protective Agents|protective agents|mesh-ancestor
56116409|NCT05568095|Vitamin B Complex|vitamin b complex|mesh-ancestor
56116410|NCT05568095|Vitamins|vitamins|mesh-ancestor
56116411|NCT05568095|Micronutrients|micronutrients|mesh-ancestor
56116412|NCT05561387|Dexamethasone|dexamethasone|mesh-list
56197034|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
56197035|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56197036|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197037|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56197038|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56197039|NCT01506167|Growth Substances|growth substances|mesh-ancestor
56197040|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197041|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
56197042|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
56197043|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197044|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116413|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
56116414|NCT05561387|Lenalidomide|lenalidomide|mesh-list
56116415|NCT05561387|Bortezomib|bortezomib|mesh-list
56116416|NCT05561387|Daratumumab|daratumumab|mesh-list
56116417|NCT05561387|Ichthammol|ichthammol|mesh-list
56116418|NCT05561387|BB 1101|bb 1101|mesh-list
56116419|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56116420|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116421|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
56116422|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
56116423|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116424|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116425|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56633163|NCT04498117|Oregovomab|oregovomab|mesh-list
56633164|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56633165|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633166|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633167|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
56633168|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633169|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633170|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633171|NCT04496960|Tofacitinib|tofacitinib|mesh-list
56633172|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56633173|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633174|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633175|NCT04468230|Nicotine|nicotine|mesh-list
56633176|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56633177|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
56633178|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633179|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633180|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56633181|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56633182|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
56633183|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56633184|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633185|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
56633186|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633187|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633188|NCT04428151|Paclitaxel|paclitaxel|mesh-list
56633189|NCT04428151|Docetaxel|docetaxel|mesh-list
56633190|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
56633191|NCT04428151|Capecitabine|capecitabine|mesh-list
56633192|NCT04428151|Cetuximab|cetuximab|mesh-list
56633193|NCT04428151|Lenvatinib|lenvatinib|mesh-list
56633194|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56633195|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633196|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633203|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56633204|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633205|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56633206|NCT04423627|Clonidine|clonidine|mesh-list
56633207|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56633208|NCT04423627|Diuretics|diuretics|mesh-ancestor
56633209|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
56633210|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633211|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56633212|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56633213|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633214|NCT04423627|Analgesics|analgesics|mesh-ancestor
56633215|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
56633216|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633217|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
56633218|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
56633219|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56633220|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56633221|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56633222|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
56633223|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56633224|NCT04410653|Afatinib|afatinib|mesh-list
56116426|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
56116427|NCT05561387|Hormones|hormones|mesh-ancestor
56116428|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116429|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56116430|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116431|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
56116432|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116466|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
56116467|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
56116468|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116469|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116470|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56116471|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
56116472|NCT05522465|Hormones|hormones|mesh-ancestor
56116473|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116474|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56116475|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116476|NCT05237297|Celecoxib|celecoxib|mesh-list
56116477|NCT05237297|Naproxen|naproxen|mesh-list
56116478|NCT05237297|Aceclofenac|aceclofenac|mesh-list
56116479|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56116480|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56116481|NCT05237297|Analgesics|analgesics|mesh-ancestor
56116482|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
56116483|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116484|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116485|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116511|NCT04824053|Selenium|selenium|mesh-list
56116512|NCT04824053|Caseins|caseins|mesh-list
56116513|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
56116514|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633225|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633226|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56633227|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633228|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633229|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56633230|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56633231|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56633232|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56633233|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633234|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56633235|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633236|NCT04395001|Analgesics|analgesics|mesh-ancestor
56633237|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
56633238|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633239|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
56633240|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56633241|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
56633242|NCT04391764|Naltrexone|naltrexone|mesh-list
56633243|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56633244|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56116515|NCT04824053|Protective Agents|protective agents|mesh-ancestor
56116516|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116517|NCT04824053|Trace Elements|trace elements|mesh-ancestor
56116518|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
56116519|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
56116520|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
56116521|NCT04811339|Bismuth|bismuth|mesh-list
56116522|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56116523|NCT04811339|Antacids|antacids|mesh-ancestor
56116524|NCT04811339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116525|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197045|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197046|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
56197047|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56197048|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56197049|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197050|NCT01506167|Antidotes|antidotes|mesh-ancestor
56197051|NCT01506167|Protective Agents|protective agents|mesh-ancestor
56197052|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
56197053|NCT01506167|Vitamins|vitamins|mesh-ancestor
56197054|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
56197055|NCT01506167|Hematinics|hematinics|mesh-ancestor
56116526|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
56116527|NCT05168423|Cyclophosphamide|cyclophosphamide|mesh-list
56116528|NCT05168423|Fludarabine|fludarabine|mesh-list
56116529|NCT05168423|Isotretinoin|isotretinoin|mesh-list
56116530|NCT05168423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116531|NCT05168423|Immunologic Factors|immunologic factors|mesh-ancestor
56116532|NCT05168423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116533|NCT05168423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116534|NCT05168423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56116535|NCT05168423|Alkylating Agents|alkylating agents|mesh-ancestor
56116563|NCT05116241|Vaccines|vaccines|mesh-list
56116564|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
56116565|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633245|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633246|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
56633247|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633248|NCT04391049|Paclitaxel|paclitaxel|mesh-list
56633249|NCT04391049|Carboplatin|carboplatin|mesh-list
56633250|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56633251|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56633252|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633253|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633254|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
56633255|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633256|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633276|NCT04339062|Sirolimus|sirolimus|mesh-list
56633277|NCT04339062|Prednisone|prednisone|mesh-list
56633278|NCT04339062|Everolimus|everolimus|mesh-list
56633279|NCT04339062|Cemiplimab|cemiplimab|mesh-list
56633280|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56633281|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
56633282|NCT04339062|Hormones|hormones|mesh-ancestor
56116566|NCT04735367|Letrozole|letrozole|mesh-list
56116567|NCT04735367|Palbociclib|palbociclib|mesh-list
56116568|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116569|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56116570|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56116571|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116572|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116573|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56116574|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
56116575|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116576|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843524|NCT04763434|Analgesics|analgesics|mesh-ancestor
56116577|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56116579|NCT00382421|Amlodipine|amlodipine|mesh-list
56116580|NCT00382421|Bisoprolol|bisoprolol|mesh-list
56116581|NCT00382421|Molsidomine|molsidomine|mesh-list
56116582|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56116583|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56116635|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
56116636|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56116637|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116687|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
56116688|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116689|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116690|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56116691|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56116692|NCT00382499|Lidocaine|lidocaine|mesh-list
56116693|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
56116694|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
56116695|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56116696|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116697|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
56116698|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116699|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56116700|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56116701|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56116702|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137544|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56633283|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56633284|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633285|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56633286|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633287|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633288|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
56633289|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56633290|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633291|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56633292|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
56633293|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633294|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
56633295|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
56633296|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56633297|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56116705|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
56116706|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116707|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197056|NCT01506336|Sunitinib|sunitinib|mesh-list
56197057|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197058|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56197059|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56197060|NCT01506336|Growth Substances|growth substances|mesh-ancestor
56197061|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197062|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
56197063|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56197064|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197065|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197066|NCT01506388|Misoprostol|misoprostol|mesh-list
56197067|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56197068|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
56197069|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56197070|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197071|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56197072|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197073|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
56197074|NCT01506414|Rituximab|rituximab|mesh-list
56197075|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56197076|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116709|NCT00382889|Albuterol|albuterol|mesh-list
56116725|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
56116726|NCT00382889|Hormones|hormones|mesh-ancestor
56116727|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116728|NCT04977167|Antibodies|antibodies|mesh-list
56116729|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
56116730|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116734|NCT05269355|Dacarbazine|dacarbazine|mesh-list
56116735|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56116736|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
56116737|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116738|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116739|NCT04482959|Carbetocin|carbetocin|mesh-list
56116740|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
56116741|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56116742|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116743|NCT04581395|Rocuronium|rocuronium|mesh-list
56116744|NCT04581395|Succinylcholine|succinylcholine|mesh-list
56116745|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56633298|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633299|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56633300|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
56633301|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56633302|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
56633303|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
56633304|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56633305|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633306|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56633307|NCT04305158|Analgesics|analgesics|mesh-ancestor
56633308|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
56633309|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633310|NCT04303195|Metopimazine|metopimazine|mesh-list
56633311|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
56633312|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
56633313|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633314|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633315|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56633317|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
56633318|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633319|NCT04292470|Amitriptyline|amitriptyline|mesh-list
56633320|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56633321|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
56633322|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56633323|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56633324|NCT04292470|Analgesics|analgesics|mesh-ancestor
56633325|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
56633326|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633327|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633328|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56633329|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56633330|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56633331|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633332|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
56633333|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56633334|NCT04208334|Curcumin|curcumin|mesh-list
56116746|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56633335|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56633336|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56633337|NCT04208334|Analgesics|analgesics|mesh-ancestor
56633338|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
56633339|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633340|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633341|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56633342|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56160051|NCT02856126|Sorafenib|sorafenib|mesh-list
56633358|NCT04182204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633359|NCT04182204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633360|NCT04182204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633361|NCT04158141|Cisplatin|cisplatin|mesh-list
56633362|NCT04158141|Carboplatin|carboplatin|mesh-list
56633363|NCT04158141|Pemetrexed|pemetrexed|mesh-list
56633364|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633365|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633366|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633367|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56633368|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56633369|NCT04134260|Hormones|hormones|mesh-list
56633370|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56633371|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633372|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
56633373|NCT04123366|Olaparib|olaparib|mesh-list
56633374|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633375|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633376|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56633377|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633378|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633408|NCT04073797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56633409|NCT04073797|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633410|NCT04073797|Antimitotic Agents|antimitotic agents|mesh-ancestor
56633411|NCT04073797|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633412|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633413|NCT04073797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633414|NCT04065399|Cobicistat|cobicistat|mesh-list
56633415|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56633416|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56633417|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
56633420|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56633421|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633422|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633423|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
56633424|NCT04060017|Leucovorin|leucovorin|mesh-list
56633425|NCT04060017|Calcium|calcium|mesh-list
56633426|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
56633427|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56633428|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633429|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56633430|NCT04060017|Antidotes|antidotes|mesh-ancestor
56633431|NCT04060017|Protective Agents|protective agents|mesh-ancestor
56633432|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
56633433|NCT04060017|Vitamins|vitamins|mesh-ancestor
56633434|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
56633438|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
56633439|NCT04052334|Fludarabine|fludarabine|mesh-list
56633440|NCT04052334|Interleukin-2|interleukin-2|mesh-list
55930233|NCT01360866|Citalopram|citalopram|mesh-list
56116747|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56116748|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116749|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116750|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56116751|NCT04571879|Lidocaine|lidocaine|mesh-list
56116752|NCT04571879|Midazolam|midazolam|mesh-list
56116753|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
56116754|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
56116755|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56116756|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116757|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
56197077|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
56197078|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197079|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56197080|NCT01506505|Aspirin|aspirin|mesh-list
56197081|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56197082|NCT01506505|Lisinopril|lisinopril|mesh-list
56197083|NCT01506505|Simvastatin|simvastatin|mesh-list
56197084|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56197085|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56197086|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
56633441|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633442|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
56633443|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633444|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56633445|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56633446|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
56633447|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633448|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633449|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56633450|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56633451|NCT04052334|Analgesics|analgesics|mesh-ancestor
56633452|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
56633453|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633454|NCT04046549|Abatacept|abatacept|mesh-list
56633455|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633456|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633457|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633458|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633459|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
56381993|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56633460|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633461|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56633462|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
56633463|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
56633464|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633465|NCT04042935|Protective Agents|protective agents|mesh-ancestor
56633466|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633467|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
56197087|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197088|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56197089|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56197090|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197091|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56197092|NCT01506505|Diuretics|diuretics|mesh-ancestor
56197093|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
56116758|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116759|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56116760|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56116761|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56116762|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56116763|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116764|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56116765|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56633468|NCT04042935|Vitamins|vitamins|mesh-ancestor
56633469|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
56633470|NCT04027309|Midostaurin|midostaurin|mesh-list
56633471|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633472|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56633473|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633474|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633475|NCT04026412|Nivolumab|nivolumab|mesh-list
56633476|NCT04026412|Ipilimumab|ipilimumab|mesh-list
56633477|NCT04026412|Durvalumab|durvalumab|mesh-list
56633478|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633479|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633480|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633481|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633482|NCT03988933|Rifampin|rifampin|mesh-list
56633483|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56633484|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
56633485|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56633486|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633487|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
56633488|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56633489|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633490|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633491|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56633492|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56633493|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56633494|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56633495|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56633496|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56633497|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
56633498|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
56633510|NCT03934216|BMS-986165|bms-986165|mesh-list
56633511|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
56633512|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56633513|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633514|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633515|NCT03910452|Sirolimus|sirolimus|mesh-list
56633516|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
56633517|NCT03910452|Busulfan|busulfan|mesh-list
56633518|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
56633519|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633520|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
56633521|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633522|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116793|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116794|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56116795|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56116796|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56116797|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56116798|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56116799|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
56116800|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56116801|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56116803|NCT04545515|Elexacaftor|elexacaftor|mesh-list
56116804|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56116805|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56116806|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116808|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56116809|NCT04509791|Antibodies|antibodies|mesh-list
56116810|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
56116811|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
56116812|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116813|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116869|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56116870|NCT04920539|Analgesics|analgesics|mesh-ancestor
56116871|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
56116872|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116873|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56116874|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56116875|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56116876|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116877|NCT04920539|Hormones|hormones|mesh-ancestor
56116878|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116879|NCT04503551|Ranibizumab|ranibizumab|mesh-list
56116880|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56116881|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56197094|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197095|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56197096|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56197097|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56197098|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56197099|NCT01506505|Analgesics|analgesics|mesh-ancestor
56197100|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
56197101|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197102|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56197103|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56197104|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56197105|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56197106|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56197107|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56197108|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
56197109|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56633523|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56633524|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
56633525|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633526|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633527|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56633528|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56633529|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633530|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56633531|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
56633532|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633533|NCT03891953|Spartalizumab|spartalizumab|mesh-list
56633534|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633535|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633536|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633537|NCT03869190|Gemcitabine|gemcitabine|mesh-list
56633538|NCT03869190|Atezolizumab|atezolizumab|mesh-list
56633539|NCT03869190|Niraparib|niraparib|mesh-list
56633540|NCT03869190|Magrolimab|magrolimab|mesh-list
56633541|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633542|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633543|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
56633544|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633545|NCT03869190|Antiviral Agents|antiviral agents|mesh-ancestor
56633546|NCT03869190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633547|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633548|NCT03869190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633549|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
56633550|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633551|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56633580|NCT03785925|Nivolumab|nivolumab|mesh-list
56633581|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633582|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633585|NCT03783403|Rituximab|rituximab|mesh-list
56633591|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56633612|NCT03759288|Adalimumab|adalimumab|mesh-list
56633613|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56633614|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56633615|NCT03752398|Ipilimumab|ipilimumab|mesh-list
56633616|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633617|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633618|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633619|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633620|NCT03742895|Olaparib|olaparib|mesh-list
56633621|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56633622|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633623|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716738|NCT03146793|Antidotes|antidotes|mesh-ancestor
56116882|NCT04503551|Growth Substances|growth substances|mesh-ancestor
56116883|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116884|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
56116885|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116888|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
56116889|NCT04882241|Fluorouracil|fluorouracil|mesh-list
56116890|NCT04882241|Capecitabine|capecitabine|mesh-list
56116891|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
56116892|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116893|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
56116894|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
56116895|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
56116896|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116897|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116899|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116929|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
56116930|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116931|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116932|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56116933|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
56116934|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56116935|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
56116936|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56116938|NCT04431635|Nivolumab|nivolumab|mesh-list
56116939|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116940|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116941|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
56116942|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116943|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116944|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56116945|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116946|NCT03596645|Golimumab|golimumab|mesh-list
56116947|NCT03596645|Infliximab|infliximab|mesh-list
56116994|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
56116996|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56116997|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116998|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116999|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56117000|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56197110|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
56197111|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56197112|NCT01506505|Protective Agents|protective agents|mesh-ancestor
56197113|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
56197114|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197115|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
56197116|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197117|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197118|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56633624|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633625|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56633626|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
56633627|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633628|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633629|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
55930365|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
56197119|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
56197120|NCT01506557|Vitamin D|vitamin d|mesh-list
56197121|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56197122|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197123|NCT01506557|Vitamins|vitamins|mesh-ancestor
56197124|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
56197125|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56117001|NCT00383045|Naltrexone|naltrexone|mesh-list
56117002|NCT00383045|Buprenorphine|buprenorphine|mesh-list
56117003|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56117004|NCT00383045|Narcotics|narcotics|mesh-ancestor
56117005|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56117006|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117007|NCT00383045|Analgesics|analgesics|mesh-ancestor
56117008|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
56117009|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117010|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56117011|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56117012|NCT00383591|Vaccines|vaccines|mesh-list
56117037|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117038|NCT00002939|Paclitaxel|paclitaxel|mesh-list
56117039|NCT00002939|Irinotecan|irinotecan|mesh-list
56117040|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117041|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117042|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117043|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117044|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117045|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117046|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56117047|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117048|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117049|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
56117050|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56117051|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117052|NCT03085823|Sirolimus|sirolimus|mesh-list
56117053|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56117054|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117055|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117056|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117057|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
56117058|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117060|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117061|NCT00002945|Cytarabine|cytarabine|mesh-list
56117062|NCT00002945|Aldesleukin|aldesleukin|mesh-list
56117063|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
56117064|NCT00002945|Melphalan|melphalan|mesh-list
56117065|NCT00002945|Etoposide|etoposide|mesh-list
56117066|NCT00002945|Idarubicin|idarubicin|mesh-list
56117067|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117147|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117148|NCT02919683|Nivolumab|nivolumab|mesh-list
56117149|NCT02919683|Ipilimumab|ipilimumab|mesh-list
56117150|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56197126|NCT01506570|Vaccines|vaccines|mesh-list
56197127|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
56197128|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197129|NCT01506622|Fentanyl|fentanyl|mesh-list
56197130|NCT01506622|Propofol|propofol|mesh-list
56197131|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56197132|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56197133|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197134|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56197135|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
56197136|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
56197137|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56197138|NCT01506622|Narcotics|narcotics|mesh-ancestor
56633630|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633639|NCT03700476|Gemcitabine|gemcitabine|mesh-list
56633640|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633641|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633642|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
56633643|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633644|NCT03700476|Antiviral Agents|antiviral agents|mesh-ancestor
56633645|NCT03700476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633646|NCT03700476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633647|NCT03700476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633648|NCT03700476|Immunologic Factors|immunologic factors|mesh-ancestor
56633649|NCT03700476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633650|NCT03678883|Gemcitabine|gemcitabine|mesh-list
56633651|NCT03678883|Paclitaxel|paclitaxel|mesh-list
56633652|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56633653|NCT03678883|Carboplatin|carboplatin|mesh-list
56633654|NCT03678883|Doxorubicin|doxorubicin|mesh-list
56633655|NCT03678883|Irinotecan|irinotecan|mesh-list
56633656|NCT03678883|Lomustine|lomustine|mesh-list
56633657|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56633658|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633659|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633660|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
56633661|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633662|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633663|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633664|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
56633665|NCT03678883|Antiviral Agents|antiviral agents|mesh-ancestor
56633666|NCT03678883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633667|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633688|NCT03644667|Prednisone|prednisone|mesh-list
56633689|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
56633691|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56633692|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56633693|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
56633694|NCT03644667|Hormones|hormones|mesh-ancestor
56633695|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56633696|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633697|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56633698|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633699|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633700|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
56633701|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633702|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633703|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56633704|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56633705|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
56633706|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56633707|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633708|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
56633709|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
56633710|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633711|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56633712|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56633713|NCT03644667|Protective Agents|protective agents|mesh-ancestor
56633714|NCT03638141|Durvalumab|durvalumab|mesh-list
56633715|NCT03638141|Ipilimumab|ipilimumab|mesh-list
56633716|NCT03638141|Tremelimumab|tremelimumab|mesh-list
56633717|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56633718|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633719|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633720|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
56633721|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633722|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633723|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633732|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56633733|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56633734|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633735|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633736|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
56633737|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633738|NCT03586453|Osimertinib|osimertinib|mesh-list
56633739|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633740|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56633741|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633742|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633743|NCT03554473|Temozolomide|temozolomide|mesh-list
56633744|NCT03554473|Topotecan|topotecan|mesh-list
56633745|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117151|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117152|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56117153|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117154|NCT03933293|Ezetimibe|ezetimibe|mesh-list
56117155|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56117156|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56117157|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
56117158|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117159|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56117160|NCT00002993|Doxorubicin|doxorubicin|mesh-list
56117161|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56117162|NCT00002993|Mitomycins|mitomycins|mesh-list
56117163|NCT00002993|Mitomycin|mitomycin|mesh-list
56117164|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117165|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117166|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117167|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117168|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117169|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117170|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
56117171|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56117172|NCT01928394|Nivolumab|nivolumab|mesh-list
56117173|NCT01928394|Ipilimumab|ipilimumab|mesh-list
56117174|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56117175|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117176|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56117177|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117178|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56117179|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56117180|NCT01928082|Estradiol|estradiol|mesh-list
56117181|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56117182|NCT01928082|Estrogens|estrogens|mesh-ancestor
56117183|NCT01928082|Hormones|hormones|mesh-ancestor
55742168|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117184|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117185|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117208|NCT00003005|Pentostatin|pentostatin|mesh-list
56117209|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117210|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56117211|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117212|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117213|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
56117214|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117215|NCT03905603|Cosyntropin|cosyntropin|mesh-list
56117216|NCT03905603|Hormones|hormones|mesh-ancestor
56117217|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56633746|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
56633747|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633748|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633749|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56633750|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56633751|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633752|NCT03330106|Paclitaxel|paclitaxel|mesh-list
56633753|NCT03330106|Docetaxel|docetaxel|mesh-list
56633754|NCT03330106|Carboplatin|carboplatin|mesh-list
56633755|NCT03330106|Pevonedistat|pevonedistat|mesh-list
56633756|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117218|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117219|NCT00003011|Marimastat|marimastat|mesh-list
56117220|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117221|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197142|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56117222|NCT00003017|Interleukin-12|interleukin-12|mesh-list
56117223|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56117224|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
56117225|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117226|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56117227|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56117228|NCT00003017|Growth Substances|growth substances|mesh-ancestor
56117229|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
56117230|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117231|NCT00003023|Vaccines|vaccines|mesh-list
56117232|NCT00003023|Antibodies|antibodies|mesh-list
56117233|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56117234|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
56117235|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
56117236|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117237|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56117264|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117265|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117266|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117267|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117268|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117269|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117270|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117271|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117272|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117273|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56117274|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
56117275|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117276|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117277|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56117278|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56117279|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56117280|NCT00003041|NSC 366140|nsc 366140|mesh-list
56117281|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117282|NCT00003053|Etoposide|etoposide|mesh-list
56117283|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117284|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117285|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117286|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117287|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117324|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117325|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117351|NCT00003101|Busulfan|busulfan|mesh-list
56117352|NCT00003101|Thiotepa|thiotepa|mesh-list
56117353|NCT00003101|Lomustine|lomustine|mesh-list
56117354|NCT00003101|Procarbazine|procarbazine|mesh-list
56117355|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
56117356|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117357|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56633757|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633758|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633759|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
56633760|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633761|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117358|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117359|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117360|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117361|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117362|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117363|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
56117364|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117365|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117366|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117367|NCT03690869|Cemiplimab|cemiplimab|mesh-list
56117368|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56117369|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117370|NCT01958021|Letrozole|letrozole|mesh-list
56117371|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117372|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56117373|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56117374|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197144|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56197145|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56197146|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
56197147|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197148|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197149|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197150|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56197151|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56197152|NCT01506713|Clopidogrel|clopidogrel|mesh-list
55716988|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117375|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117376|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56117377|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
56117409|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
56117410|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56117411|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117412|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
56117413|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117414|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56117415|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56117416|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56117417|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56117418|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117468|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117469|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56117470|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
56117471|NCT00003401|Hormones|hormones|mesh-ancestor
56117472|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117473|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117474|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117475|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
56117476|NCT00003401|Antiviral Agents|antiviral agents|mesh-ancestor
56117477|NCT00003401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117478|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117479|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117480|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117514|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117515|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117516|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117517|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
56117518|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117519|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117520|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
56117521|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117522|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633762|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117523|NCT00003137|Irinotecan|irinotecan|mesh-list
56117524|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56117525|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117553|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56117554|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56117555|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56117556|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
56117557|NCT00001259|Leuprolide|leuprolide|mesh-list
56117558|NCT00001259|Estradiol|estradiol|mesh-list
56117559|NCT00001259|Progesterone|progesterone|mesh-list
56117560|NCT00001259|Estrogens|estrogens|mesh-ancestor
56117561|NCT00001259|Hormones|hormones|mesh-ancestor
56117562|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117563|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117564|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56117565|NCT00001259|Progestins|progestins|mesh-ancestor
56117566|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56117567|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
56197153|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56197154|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56197155|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56197156|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56197157|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
56197158|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197159|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197160|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197162|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56117568|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117569|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117570|NCT00003143|Amifostine|amifostine|mesh-list
56117571|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56117572|NCT00003143|Protective Agents|protective agents|mesh-ancestor
56117606|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117607|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
56117608|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117609|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117610|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117611|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56117612|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
56117613|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
56117614|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117615|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56117616|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
56117617|NCT00003437|Hormones|hormones|mesh-ancestor
56117618|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117642|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117643|NCT00003449|Gemcitabine|gemcitabine|mesh-list
56117644|NCT00003449|Dexamethasone|dexamethasone|mesh-list
56117645|NCT00003449|Paclitaxel|paclitaxel|mesh-list
56117646|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117647|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117648|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117649|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117650|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117651|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117652|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56117653|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
56117654|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
56117655|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117656|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117657|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56117658|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
56117659|NCT00003449|Hormones|hormones|mesh-ancestor
56117660|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117661|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117662|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117663|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
56117664|NCT00003449|Antiviral Agents|antiviral agents|mesh-ancestor
56633768|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
56633769|NCT03239145|Trebananib|trebananib|mesh-list
56633770|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633771|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633772|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56633773|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56633774|NCT03239145|Growth Substances|growth substances|mesh-ancestor
56633775|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117665|NCT00003449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117666|NCT00003449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117667|NCT00003449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117668|NCT00003449|Immunologic Factors|immunologic factors|mesh-ancestor
56117669|NCT00002801|Leucovorin|leucovorin|mesh-list
56117670|NCT00002801|Tegafur|tegafur|mesh-list
56117710|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117711|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117712|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117713|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844653|NCT03366766|Gemcitabine|gemcitabine|mesh-list
56117714|NCT00002825|Docetaxel|docetaxel|mesh-list
56117715|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117716|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117717|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
56197163|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197164|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197165|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
56197166|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197167|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197168|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
56197169|NCT01506752|Donepezil|donepezil|mesh-list
56197170|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56197171|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717122|NCT02296567|Aflibercept|aflibercept|mesh-list
56117718|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117719|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117720|NCT00002831|Cyclosporine|cyclosporine|mesh-list
56117721|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
56117722|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56117723|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56117724|NCT00002831|Prednisolone|prednisolone|mesh-list
56117725|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
56117726|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
56117727|NCT00002831|Busulfan|busulfan|mesh-list
56117728|NCT00002831|Methotrexate|methotrexate|mesh-list
56117729|NCT00002831|Decitabine|decitabine|mesh-list
56117730|NCT00002831|Tacrolimus|tacrolimus|mesh-list
56117731|NCT00002831|Cyclosporins|cyclosporins|mesh-list
56117732|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56117734|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117760|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
56117761|NCT00002831|Hormones|hormones|mesh-ancestor
56117762|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117763|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56117764|NCT00002831|Protective Agents|protective agents|mesh-ancestor
56117765|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117766|NCT00002837|Paclitaxel|paclitaxel|mesh-list
56117767|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
56117768|NCT00002837|Doxorubicin|doxorubicin|mesh-list
56117769|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56117770|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117771|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117772|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117773|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117774|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117775|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117776|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117777|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
56117778|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117779|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117780|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56633776|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
56633777|NCT03164564|Tenofovir|tenofovir|mesh-list
56633778|NCT03164564|Emtricitabine|emtricitabine|mesh-list
56633779|NCT03164564|Cabotegravir|cabotegravir|mesh-list
56633780|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
56633781|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633782|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55761439|NCT02601027|Acetaminophen|acetaminophen|mesh-list
56117781|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
56117782|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117808|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117810|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
56117811|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117812|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
56117813|NCT00002855|Ketoconazole|ketoconazole|mesh-list
56117814|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
56117815|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56117816|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56117817|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56117818|NCT00002855|Doxorubicin|doxorubicin|mesh-list
56117819|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56117820|NCT00002855|Bicalutamide|bicalutamide|mesh-list
56117821|NCT00002855|Vinblastine|vinblastine|mesh-list
56117822|NCT00002855|Flutamide|flutamide|mesh-list
56117823|NCT00002855|Estramustine|estramustine|mesh-list
56117824|NCT00002855|Nilutamide|nilutamide|mesh-list
56117825|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117826|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117827|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56197172|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197173|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
56197174|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197175|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197176|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
56197177|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
56197178|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56197179|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
56197180|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197181|NCT01506765|Expectorants|expectorants|mesh-ancestor
56197182|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
56197183|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56197184|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
56197185|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197186|NCT01506765|Protective Agents|protective agents|mesh-ancestor
56117828|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117829|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117830|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117831|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56117832|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
56117943|NCT00003953|Tamoxifen|tamoxifen|mesh-list
56117944|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
56117945|NCT00003953|Docetaxel|docetaxel|mesh-list
56117946|NCT00003953|Doxorubicin|doxorubicin|mesh-list
56117947|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56117948|NCT00003953|Fluorouracil|fluorouracil|mesh-list
56117949|NCT00003953|Methotrexate|methotrexate|mesh-list
56117950|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117951|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
56117952|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117953|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117954|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117955|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
56117956|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117957|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117958|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117959|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117960|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117961|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117962|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117994|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117995|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117996|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
56633783|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56633784|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633785|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633786|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56633787|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56633788|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56633789|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56633790|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
56633791|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
56633792|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633793|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
56633794|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633795|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56633796|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56633797|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
56633798|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633799|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633800|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56633801|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633802|NCT03113422|Venetoclax|venetoclax|mesh-list
56633803|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633804|NCT03070886|Docetaxel|docetaxel|mesh-list
56633805|NCT03070886|Leuprolide|leuprolide|mesh-list
56633806|NCT03070886|Goserelin|goserelin|mesh-list
56633807|NCT03070886|Bicalutamide|bicalutamide|mesh-list
56633808|NCT03070886|Flutamide|flutamide|mesh-list
56633809|NCT03070886|Nilutamide|nilutamide|mesh-list
56633810|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633811|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633812|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
56633813|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
55930491|NCT00633061|Enoxaparin|enoxaparin|mesh-list
56117997|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117998|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117999|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56118000|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118001|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118002|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118003|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118004|NCT00003575|Etoposide|etoposide|mesh-list
56118005|NCT00003575|Ifosfamide|ifosfamide|mesh-list
56118006|NCT00003575|Interleukin-12|interleukin-12|mesh-list
56118007|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118008|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118009|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56633814|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633815|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56633816|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
56633817|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56633818|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118010|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118011|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118012|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118013|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56118014|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
56197187|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118015|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118016|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118018|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56118019|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56118020|NCT00003575|Growth Substances|growth substances|mesh-ancestor
56118021|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
56118043|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118044|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56118045|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118046|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
56118047|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56118048|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118049|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118050|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118051|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118052|NCT00003587|Gemcitabine|gemcitabine|mesh-list
56118053|NCT00003587|Paclitaxel|paclitaxel|mesh-list
56118054|NCT00003587|Vinorelbine|vinorelbine|mesh-list
56118055|NCT00003587|Docetaxel|docetaxel|mesh-list
56118056|NCT00003587|Carboplatin|carboplatin|mesh-list
56118057|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118058|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118059|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118060|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118061|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118062|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118063|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118064|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
56118065|NCT00003587|Antiviral Agents|antiviral agents|mesh-ancestor
56118066|NCT00003587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118067|NCT00003587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118068|NCT00003587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118069|NCT00003587|Immunologic Factors|immunologic factors|mesh-ancestor
56118070|NCT00003587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118071|NCT00003215|Leucovorin|leucovorin|mesh-list
56118072|NCT00003215|Cytarabine|cytarabine|mesh-list
56118073|NCT00003215|Prednisone|prednisone|mesh-list
56118074|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
56118075|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
56118076|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56118077|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56118078|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56118079|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
56118080|NCT00003215|Melphalan|melphalan|mesh-list
56118167|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56118168|NCT00003593|Methotrexate|methotrexate|mesh-list
56118169|NCT00003593|Thioguanine|thioguanine|mesh-list
56118170|NCT00003593|Daunorubicin|daunorubicin|mesh-list
56118171|NCT00003593|Asparaginase|asparaginase|mesh-list
56118172|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56118173|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
56118174|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56118175|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118176|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118177|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
56118178|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118179|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118180|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
56118181|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633819|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56633820|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
56633821|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
56633822|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56633823|NCT03066648|Azacitidine|azacitidine|mesh-list
56633824|NCT03066648|Decitabine|decitabine|mesh-list
56633825|NCT03066648|Spartalizumab|spartalizumab|mesh-list
56633826|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633827|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
56633828|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633829|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633830|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118182|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56118183|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118184|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
56118185|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118215|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56118217|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
56118218|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
56118219|NCT00003617|Clarithromycin|clarithromycin|mesh-list
56118220|NCT00003617|Tinidazole|tinidazole|mesh-list
56118221|NCT00003617|Chlorambucil|chlorambucil|mesh-list
56118222|NCT00003617|Omeprazole|omeprazole|mesh-list
56118223|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56118224|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56118225|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56118226|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118227|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197188|NCT01506765|Antidotes|antidotes|mesh-ancestor
56197189|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
56197190|NCT01506791|Ephedrine|ephedrine|mesh-list
56197191|NCT01506791|Desloratadine|desloratadine|mesh-list
56197192|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56118228|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56118229|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118230|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56118231|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56118232|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56118233|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118261|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56118262|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118263|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56118264|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56118265|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118266|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56118267|NCT00004043|Vitamins|vitamins|mesh-ancestor
56118268|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
56118269|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56118270|NCT00004055|Paclitaxel|paclitaxel|mesh-list
56118271|NCT00004055|Topotecan|topotecan|mesh-list
56118272|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118273|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118274|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118275|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118276|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118277|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118278|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56118279|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118280|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118315|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56118316|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118317|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56633831|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633832|NCT02987257|Cyclosporine|cyclosporine|mesh-list
56633833|NCT02987257|Etanercept|etanercept|mesh-list
56633834|NCT02987257|Cyclosporins|cyclosporins|mesh-list
56633835|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633836|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633837|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633838|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
56633839|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633840|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
56633841|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633842|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
56633843|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118318|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118319|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56118321|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
56118322|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
56118323|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56118324|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118325|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118326|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56118327|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56118328|NCT00004085|Antibodies|antibodies|mesh-list
56118329|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56118330|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
56118331|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118332|NCT00004091|Antibodies|antibodies|mesh-list
56118333|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
56118334|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118335|NCT00004097|Gemcitabine|gemcitabine|mesh-list
56118336|NCT00004097|Paclitaxel|paclitaxel|mesh-list
56118337|NCT00004097|Fluorouracil|fluorouracil|mesh-list
56118338|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118339|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118340|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118341|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118342|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118343|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118344|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118345|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
56118372|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
56118373|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
56118374|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118375|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
56118376|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118377|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118378|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
56118379|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118380|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118381|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
56197193|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
56197194|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197195|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197196|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197197|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56197198|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56197199|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
56197200|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
56197201|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56118382|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118383|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118384|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56118385|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633844|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56633845|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56633846|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56633848|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
56633849|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56633850|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56633851|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56633852|NCT02944071|Paclitaxel|paclitaxel|mesh-list
56633853|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56633854|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118386|NCT00004115|Antibodies|antibodies|mesh-list
56118387|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56118388|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
56118389|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118390|NCT00003245|Irinotecan|irinotecan|mesh-list
56118391|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56118392|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118393|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118418|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118419|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118420|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118421|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118422|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56118423|NCT00003251|Protective Agents|protective agents|mesh-ancestor
56118424|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118426|NCT00004139|Docetaxel|docetaxel|mesh-list
56118427|NCT00004139|Irinotecan|irinotecan|mesh-list
56118428|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118429|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
56118430|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118431|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118432|NCT00004139|Antiviral Agents|antiviral agents|mesh-ancestor
56118433|NCT00004139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118434|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118435|NCT00004139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118436|NCT00004139|Immunologic Factors|immunologic factors|mesh-ancestor
56118437|NCT00004139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118438|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118439|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118440|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118441|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56118442|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118443|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
56118444|NCT00004145|Fludarabine|fludarabine|mesh-list
56118445|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
56118446|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56118447|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118476|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
56118477|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118478|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118480|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118481|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118482|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118483|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118484|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56118485|NCT00003269|Protective Agents|protective agents|mesh-ancestor
56118487|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56118488|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118489|NCT00003281|Paclitaxel|paclitaxel|mesh-list
56118490|NCT00003281|Topotecan|topotecan|mesh-list
56118491|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56197202|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
56197203|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197204|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55717462|NCT02299063|Analgesics|analgesics|mesh-ancestor
56633855|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633856|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
56633857|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633858|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633859|NCT02913274|Paclitaxel|paclitaxel|mesh-list
56633860|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56633861|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633862|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
56633863|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118492|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118493|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118520|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118521|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
56118522|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118523|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118524|NCT00384137|Tacrolimus|tacrolimus|mesh-list
56118525|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118526|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
56118527|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118528|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56118529|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118530|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118531|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
56118532|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56118533|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118534|NCT00003293|Procarbazine|procarbazine|mesh-list
56118535|NCT00003293|Leflunomide|leflunomide|mesh-list
56118536|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118537|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118538|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118539|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
56118540|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118541|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118542|NCT00004199|Gemcitabine|gemcitabine|mesh-list
56118543|NCT00004199|Prinomastat|prinomastat|mesh-list
56118544|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118566|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118567|NCT00004205|Tamoxifen|tamoxifen|mesh-list
56118568|NCT00004205|Letrozole|letrozole|mesh-list
56118569|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118570|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118571|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56118572|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56118573|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118574|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56118575|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
56118576|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56118577|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118578|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56118579|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56118580|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56118581|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56118582|NCT00003305|Leucovorin|leucovorin|mesh-list
56118583|NCT00003305|Calcium|calcium|mesh-list
56118584|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
56118585|NCT00003305|Aminopterin|aminopterin|mesh-list
56118586|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56118587|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118588|NCT00003305|Antidotes|antidotes|mesh-ancestor
56118589|NCT00003305|Protective Agents|protective agents|mesh-ancestor
56118590|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
56118591|NCT00003305|Vitamins|vitamins|mesh-ancestor
56118592|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
56118593|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56118594|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805967|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
56633864|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
56633865|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633866|NCT02896335|Palbociclib|palbociclib|mesh-list
56633867|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633868|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56633869|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118595|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118596|NCT00003311|Cytarabine|cytarabine|mesh-list
56118597|NCT00003311|Dexamethasone|dexamethasone|mesh-list
56118631|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56118632|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56118633|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
56118634|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118635|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118636|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118658|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118659|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56197205|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
56197206|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
56197207|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55717534|NCT02294071|Ibuprofen|ibuprofen|mesh-list
56118660|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118661|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118662|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118663|NCT00004223|Gemcitabine|gemcitabine|mesh-list
56118664|NCT00004223|Docetaxel|docetaxel|mesh-list
56118665|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118666|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
56118667|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118668|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118669|NCT00004223|Antiviral Agents|antiviral agents|mesh-ancestor
56118670|NCT00004223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118671|NCT00004223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118672|NCT00004223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118673|NCT00004223|Immunologic Factors|immunologic factors|mesh-ancestor
56118674|NCT00004223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118675|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118676|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118677|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118678|NCT00003323|Flutamide|flutamide|mesh-list
56118679|NCT00003323|Finasteride|finasteride|mesh-list
56118680|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56118681|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56118682|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118683|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118684|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
56118685|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56118686|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118687|NCT00003323|Urological Agents|urological agents|mesh-ancestor
56118688|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
56118689|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56118690|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118691|NCT00004229|Endostatins|endostatins|mesh-list
56118719|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
56118720|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118721|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
56118722|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118723|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56118724|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56118725|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
56118726|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
56118727|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56118728|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56118729|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
56118730|NCT00003335|Hormones|hormones|mesh-ancestor
56118731|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56118732|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56118733|NCT00003335|Protective Agents|protective agents|mesh-ancestor
56118734|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633870|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633871|NCT02821754|Durvalumab|durvalumab|mesh-list
56633872|NCT02821754|Tremelimumab|tremelimumab|mesh-list
56633873|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633874|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633875|NCT02781883|Decitabine|decitabine|mesh-list
56633876|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633877|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
55930564|NCT03097848|Sorafenib|sorafenib|mesh-list
56118735|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118736|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
56118737|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56118738|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
56118739|NCT00003341|Hematinics|hematinics|mesh-ancestor
56118740|NCT00004253|Paclitaxel|paclitaxel|mesh-list
56118741|NCT00004253|Carboplatin|carboplatin|mesh-list
56118742|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118764|NCT00003365|Curcumin|curcumin|mesh-list
56118765|NCT00003365|Sulindac|sulindac|mesh-list
56118766|NCT00003365|Quercetin|quercetin|mesh-list
56118767|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56118768|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56118769|NCT00003365|Analgesics|analgesics|mesh-ancestor
56118770|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
56118771|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137545|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
56118772|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118773|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56118774|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118775|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118776|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197208|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56197209|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
56197210|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
56118777|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118779|NCT00003365|Protective Agents|protective agents|mesh-ancestor
56118780|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56118782|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56118783|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118784|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56118785|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56118786|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
56118787|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118788|NCT00004853|Lenograstim|lenograstim|mesh-list
56118789|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56118790|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
56118791|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118792|NCT00004865|Paclitaxel|paclitaxel|mesh-list
56118793|NCT00004865|Fluorouracil|fluorouracil|mesh-list
56118794|NCT00004865|Cetuximab|cetuximab|mesh-list
56118795|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118796|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118824|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
56118825|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
56118826|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56118827|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118828|NCT00004871|Azacitidine|azacitidine|mesh-list
56118829|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56118830|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118831|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
56118832|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118833|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118834|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118835|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56118836|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118837|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118838|NCT00004883|Trastuzumab|trastuzumab|mesh-list
56118839|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633878|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633879|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633880|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633881|NCT02772003|Interleukin-12|interleukin-12|mesh-list
56633882|NCT02772003|Vaccines|vaccines|mesh-list
56633883|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
56633884|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633885|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56633886|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56118840|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118841|NCT00004403|Albendazole|albendazole|mesh-list
56118842|NCT00004403|Dexamethasone|dexamethasone|mesh-list
56118872|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56118874|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
56118875|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118876|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118877|NCT00385307|Amibegron|amibegron|mesh-list
56118878|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56118879|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56118880|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
56118881|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56118882|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118883|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118884|NCT00004901|Fluorouracil|fluorouracil|mesh-list
56118885|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
56118886|NCT00004901|Eniluracil|eniluracil|mesh-list
56118887|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
56118917|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118918|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
56118919|NCT00004913|Antidotes|antidotes|mesh-ancestor
56118920|NCT00004913|Protective Agents|protective agents|mesh-ancestor
56118921|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
56118922|NCT00004913|Vitamins|vitamins|mesh-ancestor
56118923|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
56118924|NCT00004919|Irinotecan|irinotecan|mesh-list
56118925|NCT00004919|Amifostine|amifostine|mesh-list
56118926|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118927|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56118928|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118929|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118930|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118931|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56118932|NCT00004919|Protective Agents|protective agents|mesh-ancestor
56118933|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118959|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
56118960|NCT00004931|Vitamins|vitamins|mesh-ancestor
56197211|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
56197212|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56197213|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56197214|NCT01506804|Prednisolone|prednisolone|mesh-list
56118961|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
56118962|NCT00004979|Paclitaxel|paclitaxel|mesh-list
56118963|NCT00004979|Topotecan|topotecan|mesh-list
56118964|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118965|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118966|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118967|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118968|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118969|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118970|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56118971|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118972|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118973|NCT00004985|Nelfinavir|nelfinavir|mesh-list
56118974|NCT00004985|Capravirine|capravirine|mesh-list
56118975|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56118976|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56118977|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
56118978|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118979|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633887|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56633888|NCT02772003|Growth Substances|growth substances|mesh-ancestor
56633889|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
56633890|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56160098|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
56118980|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56118981|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56118982|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
56118983|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118984|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56119011|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56119012|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56119013|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119014|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
56119015|NCT00005015|Fluoxetine|fluoxetine|mesh-list
56119016|NCT00005015|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56119017|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56119018|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56119019|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119020|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56119021|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
56119022|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119023|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56119024|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
56119025|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56119026|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56119027|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56119028|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119029|NCT00004637|Vitamin E|vitamin e|mesh-list
56119030|NCT00004637|Vitamins|vitamins|mesh-ancestor
56119031|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
56119032|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119033|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
56119034|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119035|NCT00004637|Protective Agents|protective agents|mesh-ancestor
56119036|NCT00005021|Paclitaxel|paclitaxel|mesh-list
56119060|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119061|NCT00005039|Vaccines|vaccines|mesh-list
56119062|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
56119063|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119064|NCT00004685|Albuterol|albuterol|mesh-list
56119065|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56119066|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
56119067|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119068|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119069|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56119070|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
56119071|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
56119072|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56119073|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56119074|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56119075|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56119076|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
56119077|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197215|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
56197216|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56197217|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
56119078|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119079|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
56119080|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119081|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56119082|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56144790|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119083|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119084|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56119085|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119109|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56119110|NCT00004727|Analgesics|analgesics|mesh-ancestor
56119111|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
56119112|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119113|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119114|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56119115|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56119116|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56119117|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56119118|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119119|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56119120|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56119121|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119122|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
56119123|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56119124|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56119125|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56119126|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
56119127|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56119128|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56119129|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56119131|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56119132|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56119133|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
56119134|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56119135|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119136|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119137|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56119164|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56119165|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56119166|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56119167|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
56119168|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119169|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119170|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56119171|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56119172|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56119173|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56119174|NCT00004787|Lenograstim|lenograstim|mesh-list
56119175|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56119176|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
56119177|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119178|NCT00005081|Carmustine|carmustine|mesh-list
56119179|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56119180|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119181|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
56119182|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119183|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119184|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119185|NCT00005087|Paclitaxel|paclitaxel|mesh-list
56119186|NCT00005087|Cisplatin|cisplatin|mesh-list
56119187|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119218|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119219|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197218|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56197219|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
56197220|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
56197221|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805968|NCT04085237|Ropivacaine|ropivacaine|mesh-list
56633908|NCT02684162|Guadecitabine|guadecitabine|mesh-list
56633909|NCT02684162|Azacitidine|azacitidine|mesh-list
56633910|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633911|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633912|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
56633913|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633914|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633915|NCT02619682|Lenalidomide|lenalidomide|mesh-list
56633916|NCT02619682|Ixazomib|ixazomib|mesh-list
56633917|NCT02619682|Glycine|glycine|mesh-list
56633918|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
56197222|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718632|NCT02337855|Antacids|antacids|mesh-ancestor
56197224|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
56197225|NCT01506804|Hormones|hormones|mesh-ancestor
56197226|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197227|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56197228|NCT01506804|Protective Agents|protective agents|mesh-ancestor
56124993|NCT01383486|Naproxen|naproxen|mesh-list
56197229|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56197230|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197231|NCT01506895|Darapladib|darapladib|mesh-list
56197232|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56197233|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717823|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119220|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56119221|NCT00004817|Phenytoin|phenytoin|mesh-list
56119222|NCT00004817|Valproic Acid|valproic acid|mesh-list
56119223|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
56119224|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119225|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119226|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
56119227|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56119228|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119229|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
56119249|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56119250|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119251|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
56119253|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56119254|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56119255|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
56119256|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56119257|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
56119258|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119259|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119260|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56119261|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56119262|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119263|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56119264|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
56119265|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119266|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
56119267|NCT00385463|Hormones|hormones|mesh-ancestor
56119268|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
56119269|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
56119270|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56119271|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
56119272|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119273|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
56119274|NCT00423371|Protective Agents|protective agents|mesh-ancestor
56119275|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
56119276|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119277|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119278|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119279|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
56197234|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633919|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633920|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56633921|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56633922|NCT02619682|Growth Substances|growth substances|mesh-ancestor
56633923|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
56633924|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197236|NCT01506921|Esketamine|esketamine|mesh-list
56197237|NCT01506921|Analgesics|analgesics|mesh-ancestor
56197238|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
56197239|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197240|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197241|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56197242|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56197243|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
56197244|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
56197245|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56197246|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56197247|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56197248|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197249|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197250|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
56197251|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56197252|NCT01507064|Sorafenib|sorafenib|mesh-list
56119280|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119281|NCT00005585|Leucovorin|leucovorin|mesh-list
56119282|NCT00005585|Cytarabine|cytarabine|mesh-list
56119323|NCT00005585|Protective Agents|protective agents|mesh-ancestor
56119324|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
56119325|NCT00005585|Vitamins|vitamins|mesh-ancestor
56119326|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
56119327|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119328|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119329|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119330|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119331|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56119332|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56119333|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119334|NCT00005591|Gemcitabine|gemcitabine|mesh-list
56119335|NCT00005591|Cetuximab|cetuximab|mesh-list
56119336|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119337|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
56119338|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119339|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119340|NCT00005591|Antiviral Agents|antiviral agents|mesh-ancestor
56119341|NCT00005591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119342|NCT00005591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119343|NCT00005591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119344|NCT00005591|Immunologic Factors|immunologic factors|mesh-ancestor
56119345|NCT00005591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119346|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56119347|NCT01926444|Trimebutine|trimebutine|mesh-list
56119348|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119349|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
56119350|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
56119351|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119352|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119353|NCT00005597|Temozolomide|temozolomide|mesh-list
56119354|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119355|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
56197253|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197254|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56197255|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197256|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197257|NCT01507077|CKD732|ckd732|mesh-list
56197258|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56197259|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56197260|NCT01507077|Growth Substances|growth substances|mesh-ancestor
56197261|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197262|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
56633925|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633926|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
56633927|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633928|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
56633929|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197263|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197264|NCT01507194|Ondansetron|ondansetron|mesh-list
56197265|NCT01507194|Vestipitant|vestipitant|mesh-list
56119356|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119357|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119358|NCT04172844|Azacitidine|azacitidine|mesh-list
56119359|NCT04172844|Venetoclax|venetoclax|mesh-list
56119360|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56119361|NCT04172844|Pevonedistat|pevonedistat|mesh-list
56119362|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119363|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
56119364|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119365|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119366|NCT00005603|Cytarabine|cytarabine|mesh-list
56119422|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119423|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
56119424|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119425|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
56119426|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119427|NCT00005627|Carboplatin|carboplatin|mesh-list
56119429|NCT00005627|Estramustine|estramustine|mesh-list
56119430|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119431|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119432|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119433|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119434|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119435|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119436|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
56119437|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119438|NCT00005639|Azacitidine|azacitidine|mesh-list
56119439|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56119440|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119441|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
56119442|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119443|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119444|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119445|NCT00005663|Valacyclovir|valacyclovir|mesh-list
56119446|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
56119482|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
56119483|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119511|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119513|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119514|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119515|NCT00003653|Leuprolide|leuprolide|mesh-list
56119516|NCT00003653|Goserelin|goserelin|mesh-list
56119517|NCT00003653|Flutamide|flutamide|mesh-list
56119518|NCT00003653|Bicalutamide|bicalutamide|mesh-list
56119519|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
56119520|NCT00003653|Nilutamide|nilutamide|mesh-list
56119521|NCT00003653|Buserelin|buserelin|mesh-list
56119522|NCT00003653|Cyproterone|cyproterone|mesh-list
56119523|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56119524|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
56119525|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56197267|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
56197268|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197269|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119526|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119527|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119528|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119529|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
56119530|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
56119531|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119532|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56119533|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
56119534|NCT00003671|Leucovorin|leucovorin|mesh-list
56119535|NCT00003671|Cytarabine|cytarabine|mesh-list
56633930|NCT02617589|Nivolumab|nivolumab|mesh-list
56633931|NCT02617589|Temozolomide|temozolomide|mesh-list
56633932|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633933|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633934|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633935|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633936|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56633937|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
56633944|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
56633945|NCT02540707|Mirabegron|mirabegron|mesh-list
56633946|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56633947|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56633948|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
56119536|NCT00003671|Dexamethasone|dexamethasone|mesh-list
55846454|NCT01923844|Beractant|beractant|mesh-list
56119537|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
56119538|NCT00003671|Methotrexate|methotrexate|mesh-list
56119539|NCT00003671|Vincristine|vincristine|mesh-list
56119540|NCT00003671|Daunorubicin|daunorubicin|mesh-list
56119541|NCT00003671|Asparaginase|asparaginase|mesh-list
56119542|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
56119543|NCT00003671|Thioguanine|thioguanine|mesh-list
56119544|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
56119545|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119546|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
56119547|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119570|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56119571|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119573|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119574|NCT00003671|Antidotes|antidotes|mesh-ancestor
56119575|NCT00003671|Protective Agents|protective agents|mesh-ancestor
56119576|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
56119577|NCT00003671|Vitamins|vitamins|mesh-ancestor
56119578|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
56119579|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119580|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119581|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119582|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119583|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56119584|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56119585|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119586|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
56119587|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119588|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119589|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119590|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119591|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119592|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
56119593|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56119594|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56119595|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56119624|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56119625|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119626|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137546|NCT02128230|Hormones|hormones|mesh-ancestor
56119628|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
56119629|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56119630|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119631|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119632|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
56633949|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56633950|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633951|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633952|NCT02540707|Urological Agents|urological agents|mesh-ancestor
56633953|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56633954|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56633955|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56633956|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
56633957|NCT02531932|Carboplatin|carboplatin|mesh-list
56633958|NCT02531932|Everolimus|everolimus|mesh-list
56633959|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633960|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633961|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
56633962|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119633|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56119634|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56119635|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119636|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
56119637|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56119638|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119639|NCT00003707|Gemcitabine|gemcitabine|mesh-list
56119640|NCT00003707|Tipifarnib|tipifarnib|mesh-list
56119641|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119642|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
56119698|NCT00003797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718075|NCT04636437|Emtricitabine|emtricitabine|mesh-list
56119699|NCT00003797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119700|NCT00003797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119701|NCT00003797|Immunologic Factors|immunologic factors|mesh-ancestor
56119702|NCT00003797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119703|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56119704|NCT00003803|Gemcitabine|gemcitabine|mesh-list
56119705|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119706|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119707|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
56119708|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119709|NCT00003803|Antiviral Agents|antiviral agents|mesh-ancestor
56119710|NCT00003803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119711|NCT00003803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119712|NCT00003803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119713|NCT00003803|Immunologic Factors|immunologic factors|mesh-ancestor
56119714|NCT00003803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119715|NCT00003809|Cetuximab|cetuximab|mesh-list
56119716|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119717|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56119718|NCT00003815|Cytarabine|cytarabine|mesh-list
56119719|NCT00003815|Prednisolone|prednisolone|mesh-list
56119720|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
56119721|NCT00003815|Melphalan|melphalan|mesh-list
56119722|NCT00003815|Carmustine|carmustine|mesh-list
56119723|NCT00003815|Doxorubicin|doxorubicin|mesh-list
56119724|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56119725|NCT00003815|Etoposide|etoposide|mesh-list
56119726|NCT00003815|Vincristine|vincristine|mesh-list
56119760|NCT00003827|Amifostine|amifostine|mesh-list
56119761|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119762|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
56119763|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119764|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119765|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
56119766|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119803|NCT00003893|Mitomycins|mitomycins|mesh-list
56119804|NCT00003893|Mitomycin|mitomycin|mesh-list
56119805|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633963|NCT02506959|Gemcitabine|gemcitabine|mesh-list
56633964|NCT02506959|Melphalan|melphalan|mesh-list
56633965|NCT02506959|Busulfan|busulfan|mesh-list
56633966|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
56633967|NCT02506959|Panobinostat|panobinostat|mesh-list
56633968|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56633969|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56633970|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
56633971|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633972|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119806|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
56119807|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119808|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56119809|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119810|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
56119811|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119812|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119813|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56119814|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56119815|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56119816|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119817|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119818|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
56119819|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119820|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56119821|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
56119822|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56119823|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
56119824|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55801966|NCT04797793|Adapalene|adapalene|mesh-list
56119829|NCT00003899|Paclitaxel|paclitaxel|mesh-list
56119830|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
56119831|NCT00003899|Melphalan|melphalan|mesh-list
56119832|NCT00003899|Thiotepa|thiotepa|mesh-list
56119833|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119834|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119835|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119837|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119857|NCT00003929|Lomustine|lomustine|mesh-list
56119858|NCT00003929|Procarbazine|procarbazine|mesh-list
56119859|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119860|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
56119861|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119862|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119863|NCT02210663|Veliparib|veliparib|mesh-list
56197270|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197272|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
56197273|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56197274|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
56197275|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197276|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197277|NCT01507194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56197278|NCT01507194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56197279|NCT01507194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56197280|NCT01507194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56197281|NCT01507194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56197282|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56119864|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56119865|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119866|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119867|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119868|NCT04568837|Dexamethasone|dexamethasone|mesh-list
56119869|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
56119870|NCT04568837|Prednisone|prednisone|mesh-list
56119871|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56119872|NCT04568837|BB 1101|bb 1101|mesh-list
56119873|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56633973|NCT02506959|Antiviral Agents|antiviral agents|mesh-ancestor
56633974|NCT02506959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633975|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56633976|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56633977|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
56633978|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56633979|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56633980|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
56633981|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56633982|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56633983|NCT02506153|Interferons|interferons|mesh-list
56633984|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
56633985|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
56633986|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
56633987|NCT02506153|Ipilimumab|ipilimumab|mesh-list
56633988|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56633989|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633990|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
56633991|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56633992|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56633993|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56633994|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
56633995|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119874|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
56119875|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
56119876|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119877|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119878|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119879|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
56119880|NCT04568837|Hormones|hormones|mesh-ancestor
56119881|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119882|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119883|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119884|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
56119885|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119886|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119887|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
56119888|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56119889|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
56119890|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56119891|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
56119892|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119923|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56119924|NCT04563299|Prednisolone|prednisolone|mesh-list
56119925|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56119926|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
56119927|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56119928|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
56119929|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56119930|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
56119931|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56119932|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
56119933|NCT04563299|Hormones|hormones|mesh-ancestor
56633996|NCT02504346|Osimertinib|osimertinib|mesh-list
56633997|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56633998|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56633999|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634000|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634001|NCT02500797|Nivolumab|nivolumab|mesh-list
56634002|NCT02500797|Ipilimumab|ipilimumab|mesh-list
56634003|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634004|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634005|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56634006|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634007|NCT02466971|Cisplatin|cisplatin|mesh-list
56634008|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930671|NCT03598673|Nebivolol|nebivolol|mesh-list
56119963|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
56119964|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119970|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119971|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56119972|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119973|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197284|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197285|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119974|NCT01948908|Midazolam|midazolam|mesh-list
56119975|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56119976|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56119977|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120002|NCT01948830|Growth Substances|growth substances|mesh-ancestor
56120003|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120004|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
56120005|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120006|NCT01972464|Progesterone|progesterone|mesh-list
56120007|NCT01972464|Progestins|progestins|mesh-ancestor
56120008|NCT01972464|Hormones|hormones|mesh-ancestor
56120009|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120010|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120011|NCT01924182|Morphine|morphine|mesh-list
56120012|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56120013|NCT01924182|Narcotics|narcotics|mesh-ancestor
56120014|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120015|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120016|NCT01924182|Analgesics|analgesics|mesh-ancestor
56120017|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
56120018|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120019|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
56120020|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
56120021|NCT01946880|Chloroquine|chloroquine|mesh-list
56120022|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56120023|NCT01946880|Prednisone|prednisone|mesh-list
56120024|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120025|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
56120026|NCT01946880|Hormones|hormones|mesh-ancestor
56120027|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120028|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120058|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56120059|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
56120060|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120061|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120062|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120063|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56120064|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56120065|NCT01618266|Dexamethasone|dexamethasone|mesh-list
56634009|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
56634010|NCT02451982|Nivolumab|nivolumab|mesh-list
56634011|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
56634012|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634013|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634014|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56634015|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56634016|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
56634017|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634018|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634019|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56634020|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634021|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56634022|NCT02395666|Eflornithine|eflornithine|mesh-list
56634023|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634024|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56634025|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56634026|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56634027|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634028|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56634029|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634030|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634031|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
56634032|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634033|NCT02345265|Olaparib|olaparib|mesh-list
56634034|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56634035|NCT02345265|Cediranib|cediranib|mesh-list
56634036|NCT02345265|Maleic acid|maleic acid|mesh-list
56634037|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634038|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120066|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120067|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
56120068|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
56120069|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120070|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120071|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56120072|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
56120100|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
56120101|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120102|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120103|NCT01921140|Olaparib|olaparib|mesh-list
56120104|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56120105|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805969|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
56634039|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634040|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56634041|NCT02340169|Desoximetasone|desoximetasone|mesh-list
56634042|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634043|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
56634044|NCT02340169|Hormones|hormones|mesh-ancestor
56634045|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56634046|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634047|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
56634048|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634049|NCT02317874|Paclitaxel|paclitaxel|mesh-list
56634050|NCT02317874|Carboplatin|carboplatin|mesh-list
56634051|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56634052|NCT02317874|Talazoparib|talazoparib|mesh-list
56634053|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56634054|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634055|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
56634056|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
56634057|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
56634058|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634059|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56634060|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634061|NCT02257528|Nivolumab|nivolumab|mesh-list
56634062|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56120106|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120107|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120108|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
56120109|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56120110|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56120111|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56120112|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56120113|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120114|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
56120115|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120145|NCT01919190|Bupivacaine|bupivacaine|mesh-list
56120146|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
56120147|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
56120148|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56197286|NCT01507272|Incretins|incretins|mesh-ancestor
56197287|NCT01507272|Hormones|hormones|mesh-ancestor
56197289|NCT01507285|Liraglutide|liraglutide|mesh-list
56197360|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56120149|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120150|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
56120151|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120152|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56120153|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56120154|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56120155|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120156|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634063|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634064|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56634065|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634066|NCT02179086|Temozolomide|temozolomide|mesh-list
56634067|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56634068|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
55930724|NCT05024448|Hormones|hormones|mesh-ancestor
56120157|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56120158|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56120159|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56120160|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56120161|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
56120162|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120181|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56120182|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
56120183|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
56120184|NCT01913340|Hematinics|hematinics|mesh-ancestor
56120185|NCT01912872|Omalizumab|omalizumab|mesh-list
56120186|NCT01912872|Budesonide|budesonide|mesh-list
56120187|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
56120188|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120189|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56120190|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
56120191|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120192|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120193|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56120194|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
56120195|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
56120196|NCT01912872|Hormones|hormones|mesh-ancestor
56120197|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742248|NCT00807651|Insulin|insulin|mesh-list
56120198|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56120199|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56120200|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56120201|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
56120202|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120203|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120204|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56120205|NCT01911780|Amlodipine|amlodipine|mesh-list
56120206|NCT01911780|Telmisartan|telmisartan|mesh-list
56120207|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56120208|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56120209|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56120210|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56120211|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120212|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56120213|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120214|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
56120244|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120245|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120246|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56120247|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56120248|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56120249|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56120250|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56120251|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56120252|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56120253|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56120254|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
55742252|NCT00700791|Vitamins|vitamins|mesh-list
56120287|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120288|NCT01885182|Analgesics|analgesics|mesh-ancestor
56120289|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
56120290|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120291|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56120292|NCT01885104|Bisacodyl|bisacodyl|mesh-list
56197361|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634069|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634070|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634071|NCT02160015|Rituximab|rituximab|mesh-list
56634072|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56634073|NCT02160015|Lenalidomide|lenalidomide|mesh-list
56634074|NCT02160015|Antibodies|antibodies|mesh-list
56634075|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
56634076|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56634077|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
56634078|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197362|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56197363|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56197364|NCT01507480|Growth Substances|growth substances|mesh-ancestor
56197365|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197366|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
56197368|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56120293|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56120294|NCT01885104|Laxatives|laxatives|mesh-list
56120295|NCT01885104|Cathartics|cathartics|mesh-ancestor
56120296|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56120297|NCT01906008|Minocycline|minocycline|mesh-list
56120298|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56120299|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120300|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
56120301|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56120302|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120303|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120304|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56120305|NCT01904760|Analgesics|analgesics|mesh-ancestor
56120306|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
56120307|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120308|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56120309|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56120310|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56120311|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
56120343|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56120344|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
56120345|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120346|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56120347|NCT01903356|Linagliptin|linagliptin|mesh-list
56120348|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56120349|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120350|NCT01903356|Incretins|incretins|mesh-ancestor
56120351|NCT01903356|Hormones|hormones|mesh-ancestor
56120352|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120353|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56120354|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
56120382|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
56120383|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
56120384|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120385|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56120386|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
56120387|NCT01862328|Antiviral Agents|antiviral agents|mesh-ancestor
56120388|NCT01862328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120389|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120390|NCT01862328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56120391|NCT01862328|Immunologic Factors|immunologic factors|mesh-ancestor
56120392|NCT01862328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120393|NCT01862250|Clonidine|clonidine|mesh-list
56120394|NCT01862250|Analgesics|analgesics|mesh-ancestor
56120395|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
56120396|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120397|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120398|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56120399|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
56634079|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634080|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56634081|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56634082|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56634083|NCT02160015|Growth Substances|growth substances|mesh-ancestor
56120400|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
56120401|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56120402|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56120403|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55801976|NCT04796857|Lenalidomide|lenalidomide|mesh-list
56120430|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56120431|NCT01898442|Ticagrelor|ticagrelor|mesh-list
56120432|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56197369|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197370|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56197371|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197372|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
56197373|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197374|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
56125147|NCT01394718|Analgesics|analgesics|mesh-ancestor
56197375|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197376|NCT01507558|Dexamethasone|dexamethasone|mesh-list
56197377|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
56197378|NCT01507558|BB 1101|bb 1101|mesh-list
56197379|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56197380|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
56197381|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
56197382|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197383|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197384|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197385|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
56197386|NCT01507558|Hormones|hormones|mesh-ancestor
56197387|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197388|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56197389|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197390|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
56197391|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197392|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197393|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
56197394|NCT01507597|Glucagon|glucagon|mesh-list
55847353|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56120433|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56120434|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56120435|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56120436|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
56120437|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120438|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120439|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120440|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
56120441|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56120442|NCT01898130|Bevacizumab|bevacizumab|mesh-list
56120443|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56120444|NCT01898130|Antibodies|antibodies|mesh-list
56120445|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
56120446|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56120447|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120448|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56120449|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56120450|NCT01898130|Growth Substances|growth substances|mesh-ancestor
56120451|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120452|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
56120453|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
56197395|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56197396|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197397|NCT01507597|Hormones|hormones|mesh-ancestor
56197398|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197399|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197400|NCT01507597|Incretins|incretins|mesh-ancestor
56197401|NCT01507701|Clonidine|clonidine|mesh-list
56197402|NCT01507701|Analgesics|analgesics|mesh-ancestor
56634084|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
56634085|NCT02135042|Gemcitabine|gemcitabine|mesh-list
56634086|NCT02135042|Paclitaxel|paclitaxel|mesh-list
56634087|NCT02135042|Cisplatin|cisplatin|mesh-list
56634088|NCT02135042|Fluorouracil|fluorouracil|mesh-list
56634089|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56634090|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56634091|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634092|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56634093|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
56634094|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56634095|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634096|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56634097|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
56197403|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
56120483|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56120484|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56120486|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56120487|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56120488|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56120489|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56120490|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56120491|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56120492|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56120494|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56120538|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
56120539|NCT01895322|Tolvaptan|tolvaptan|mesh-list
56120540|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56120541|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120542|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
56120543|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120544|NCT01894776|Maraviroc|maraviroc|mesh-list
56120545|NCT01894776|Rifabutin|rifabutin|mesh-list
56120546|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56120547|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56120548|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120549|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56120550|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56120551|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
56120552|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120553|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56120554|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56120555|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56120556|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
56120557|NCT01854918|Evolocumab|evolocumab|mesh-list
56120558|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56120559|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56120560|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
56120561|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120562|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56120563|NCT01894152|Everolimus|everolimus|mesh-list
56120564|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120565|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56120566|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
56120567|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120568|NCT01854528|Interferons|interferons|mesh-list
56120569|NCT01854528|Ribavirin|ribavirin|mesh-list
56120570|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120571|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
56120572|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120573|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
56634098|NCT02135042|Antiviral Agents|antiviral agents|mesh-ancestor
56634099|NCT02135042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634100|NCT02135042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634101|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634102|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
56634103|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634104|NCT01899326|Desipramine|desipramine|mesh-list
56634105|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634106|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56634107|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
56634108|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56634109|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634110|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634111|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56634112|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56634113|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634114|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
56634115|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634117|NCT01856192|Cortisone|cortisone|mesh-list
56634118|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
56634119|NCT01856192|Rituximab|rituximab|mesh-list
56634120|NCT01856192|Doxorubicin|doxorubicin|mesh-list
56634121|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56634122|NCT01856192|Vincristine|vincristine|mesh-list
56634123|NCT01856192|Lenalidomide|lenalidomide|mesh-list
56120574|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120575|NCT01853982|Tazobactam|tazobactam|mesh-list
56120576|NCT01853982|Piperacillin|piperacillin|mesh-list
56120598|NCT01891890|Levetiracetam|levetiracetam|mesh-list
56120599|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
56120600|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
56120601|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56120602|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56120603|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197404|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197405|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197406|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56197407|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
56197408|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
56120604|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56120605|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120606|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56120607|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56120608|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120609|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56120610|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56120611|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56120612|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56120613|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56120615|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56634124|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56634125|NCT01856192|Antibodies|antibodies|mesh-list
56634126|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
56634127|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56634128|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634129|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
56634130|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634131|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56120616|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
56120617|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56120618|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
56120619|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120620|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120621|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55719354|NCT02324491|CKD732|ckd732|mesh-list
56120623|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120624|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
56120653|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120655|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56120656|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
56120657|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
56120658|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
56120659|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56120660|NCT01851330|Ledipasvir|ledipasvir|mesh-list
56120661|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
56120662|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120663|NCT01868022|Paclitaxel|paclitaxel|mesh-list
56120664|NCT01868022|Docetaxel|docetaxel|mesh-list
56120665|NCT01868022|Carboplatin|carboplatin|mesh-list
56120666|NCT01868022|Pemetrexed|pemetrexed|mesh-list
56120667|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56120668|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120669|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
56120670|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
56120671|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
56120672|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120704|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56120705|NCT01832766|Analgesics|analgesics|mesh-ancestor
56120706|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
56120707|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120708|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56120709|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56120710|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120711|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120712|NCT01832766|Hormones|hormones|mesh-ancestor
56120713|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120734|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
56120735|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
56120736|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56120737|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120738|NCT01867086|Carboplatin|carboplatin|mesh-list
56120739|NCT01867086|Vaccines|vaccines|mesh-list
56120740|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
56120741|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120742|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120743|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
56120744|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56120745|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120746|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56120747|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
56197409|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56197410|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56120748|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120750|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
56120751|NCT01830816|Ixazomib|ixazomib|mesh-list
56120752|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120753|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
56120754|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634132|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56634133|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
56634134|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634135|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634136|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56634137|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56634138|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56634139|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56634140|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634141|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634142|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
56634143|NCT01856192|Hormones|hormones|mesh-ancestor
56634144|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120755|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120756|NCT01846416|Atezolizumab|atezolizumab|mesh-list
56120757|NCT01846416|Antibodies|antibodies|mesh-list
56120758|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
56120759|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120760|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120761|NCT04589754|Ifosfamide|ifosfamide|mesh-list
56120762|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120763|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120764|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56120765|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
56120766|NCT01846104|Vaccines|vaccines|mesh-list
56120767|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
56120768|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120769|NCT01803282|Leucovorin|leucovorin|mesh-list
56120770|NCT01803282|Gemcitabine|gemcitabine|mesh-list
56120771|NCT01803282|Paclitaxel|paclitaxel|mesh-list
56120772|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56120819|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120820|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
56120821|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120822|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56120823|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56120825|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120826|NCT01844700|Risperidone|risperidone|mesh-list
56120827|NCT01844700|Aripiprazole|aripiprazole|mesh-list
56120828|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56120829|NCT01844700|Ziprasidone|ziprasidone|mesh-list
56120830|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56120831|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
56120832|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120833|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120834|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120835|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56120836|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56120837|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120838|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56120839|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56120840|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
56120841|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
56120842|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
56120843|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56120844|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56120845|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56120846|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56120847|NCT01827384|Carboplatin|carboplatin|mesh-list
56120849|NCT01827384|Temozolomide|temozolomide|mesh-list
56120850|NCT01827384|Trametinib|trametinib|mesh-list
56634145|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56634146|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56634147|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
56634148|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
56634149|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
56634150|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56634151|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56634152|NCT01856192|Growth Substances|growth substances|mesh-ancestor
56634153|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
56634155|NCT01849146|Adavosertib|adavosertib|mesh-list
56634156|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56634157|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
56634158|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634159|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634160|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634161|NCT01819064|Atropine|atropine|mesh-list
56634162|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56634163|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56634164|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56634165|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
56634166|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634167|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120851|NCT01827384|Veliparib|veliparib|mesh-list
56120852|NCT01827384|Adavosertib|adavosertib|mesh-list
56120853|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120884|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56120885|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120886|NCT01826370|Incretins|incretins|mesh-ancestor
56120887|NCT01826370|Hormones|hormones|mesh-ancestor
56120888|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120889|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56120890|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
56120891|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120892|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120893|NCT01799226|Triclosan|triclosan|mesh-list
56120894|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56120895|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120934|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197411|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56197412|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
56197413|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120935|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120937|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56120938|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
56120939|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
56120940|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120941|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56120942|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56120943|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120944|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634168|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56634169|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
56634170|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
56634171|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
56634172|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56634173|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56634174|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
56634175|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634176|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634177|NCT01572480|Dexamethasone|dexamethasone|mesh-list
56634178|NCT01572480|Lenalidomide|lenalidomide|mesh-list
56634179|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634180|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
56634181|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
56634182|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634183|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634184|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56634185|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
56634186|NCT01572480|Hormones|hormones|mesh-ancestor
56634187|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56634188|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56634189|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634190|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
56120945|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56120946|NCT01840410|Ranibizumab|ranibizumab|mesh-list
56120947|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56120948|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56120949|NCT01840410|Growth Substances|growth substances|mesh-ancestor
56120950|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120951|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
56120952|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120953|NCT01797432|Triamcinolone|triamcinolone|mesh-list
56120954|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56120955|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56120956|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56120957|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120980|NCT01796964|Growth Substances|growth substances|mesh-ancestor
56120981|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120982|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
56120983|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120984|NCT01794780|Fluticasone|fluticasone|mesh-list
56120985|NCT01794780|Budesonide|budesonide|mesh-list
56120986|NCT01794780|Theophylline|theophylline|mesh-list
56120987|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
56120988|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
56120989|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56120990|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120991|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56120992|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
56120993|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120994|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120995|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56120996|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
56120997|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
56634191|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56634192|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56634193|NCT01572480|Growth Substances|growth substances|mesh-ancestor
56634194|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
56634195|NCT01515137|Sulindac|sulindac|mesh-list
56634196|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56634197|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634198|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56634199|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176772|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56120998|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56120999|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
56121000|NCT01794780|Hormones|hormones|mesh-ancestor
56121001|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121002|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56121003|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56121004|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56121005|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
56121006|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121007|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121008|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
56121043|NCT04580472|Cephalexin|cephalexin|mesh-list
56121044|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56121045|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121046|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56121047|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121048|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121086|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
56121087|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121108|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56121109|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121110|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
56121111|NCT01792830|Metformin|metformin|mesh-list
56121112|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
56121113|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121114|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121115|NCT01792518|Linagliptin|linagliptin|mesh-list
56121116|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121117|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121118|NCT01792518|Incretins|incretins|mesh-ancestor
56197414|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197415|NCT01507727|Tolvaptan|tolvaptan|mesh-list
56197416|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56197417|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197418|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
56197419|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197420|NCT01507740|Bevacizumab|bevacizumab|mesh-list
56197421|NCT01507740|Sorafenib|sorafenib|mesh-list
56197422|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56197423|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197424|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56197425|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56197426|NCT01507740|Growth Substances|growth substances|mesh-ancestor
56197427|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121119|NCT01792518|Hormones|hormones|mesh-ancestor
56121120|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121121|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56121122|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
56121123|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121124|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121125|NCT01792284|Insulin|insulin|mesh-list
56121126|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56121127|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
56121128|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56634200|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634201|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56634202|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56634203|NCT01515137|Analgesics|analgesics|mesh-ancestor
55930821|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
56121129|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121130|NCT04414566|Gemcitabine|gemcitabine|mesh-list
56121131|NCT04414566|Cisplatin|cisplatin|mesh-list
56121132|NCT04414566|Docetaxel|docetaxel|mesh-list
56121133|NCT04414566|Fluorouracil|fluorouracil|mesh-list
56121134|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121135|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56121136|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
56121137|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121138|NCT04414566|Antiviral Agents|antiviral agents|mesh-ancestor
56121142|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
56121198|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56121199|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121200|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56121201|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121202|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121203|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56121204|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56121205|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
56121206|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56121207|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56121208|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
56121209|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121210|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121211|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56121212|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
56121213|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56121214|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56121215|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56121216|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56121217|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197428|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
56197429|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56197430|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197431|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197433|NCT01507792|Omeprazole|omeprazole|mesh-list
56197434|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56197435|NCT01507792|Histamine|histamine|mesh-list
56197436|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56197437|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197438|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197439|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197440|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
56197441|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121218|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56121253|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121256|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56121257|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
56121258|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121259|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
56121260|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121261|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121262|NCT01814748|Metformin|metformin|mesh-list
56121263|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121264|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121265|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
56121266|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56121267|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56121268|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56121269|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121270|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121271|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
56634204|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
56634205|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56634206|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634207|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56634208|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121272|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121273|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121274|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56121275|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121276|NCT01814046|Aldesleukin|aldesleukin|mesh-list
56121277|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
56121278|NCT01814046|Fludarabine|fludarabine|mesh-list
56121279|NCT01814046|Interleukin-2|interleukin-2|mesh-list
56121280|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121281|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
56121282|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121283|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121315|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121316|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56121317|NCT01786668|Tofacitinib|tofacitinib|mesh-list
55801985|NCT04796623|Fulvestrant|fulvestrant|mesh-list
56121362|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121363|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56197442|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56121364|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
56121365|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
56121366|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56121367|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56121368|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56121369|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121397|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121398|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56121399|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
56121400|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848343|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56121401|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121402|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121403|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121404|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56121405|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121406|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
56121407|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121408|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56121409|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
56121410|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56121411|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56121412|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121413|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56121434|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121435|NCT01809210|Antiviral Agents|antiviral agents|mesh-ancestor
56121436|NCT01809210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121437|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121438|NCT01809210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121439|NCT01809210|Immunologic Factors|immunologic factors|mesh-ancestor
56121440|NCT01809210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121441|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56121442|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56121444|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
56121445|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56121446|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56121447|NCT01809132|Prednisolone|prednisolone|mesh-list
56121448|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
56121449|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56121450|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
56121451|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
56121452|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56121453|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
56121454|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121455|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
56121456|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
56634209|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56634210|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
56634211|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634212|NCT01375829|Sirolimus|sirolimus|mesh-list
56634213|NCT01375829|Epothilone B|epothilone b|mesh-list
56634214|NCT01375829|Epothilones|epothilones|mesh-list
56634215|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56634216|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634217|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56634218|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634219|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
56634220|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56634221|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
56634222|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634223|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
56634224|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
56121458|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121459|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56121460|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
56121461|NCT01809132|Hormones|hormones|mesh-ancestor
56121462|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121463|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56121464|NCT01809132|Protective Agents|protective agents|mesh-ancestor
56121465|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56121466|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121467|NCT01809132|Trace Elements|trace elements|mesh-ancestor
56121468|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
56121469|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121489|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
56121490|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56121491|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56121492|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56121493|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56121494|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121495|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56121496|NCT01808118|Adalimumab|adalimumab|mesh-list
56121497|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121498|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121499|NCT01782690|Gemcitabine|gemcitabine|mesh-list
56121500|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56197443|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56197444|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55718964|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
56121501|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56121502|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
56121503|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121504|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121505|NCT01782690|Antiviral Agents|antiviral agents|mesh-ancestor
56121506|NCT01782690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121507|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121508|NCT01782690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121509|NCT01782690|Immunologic Factors|immunologic factors|mesh-ancestor
56121510|NCT01782690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121511|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56121512|NCT01766310|Folic Acid|folic acid|mesh-list
56121513|NCT01766310|Hematinics|hematinics|mesh-ancestor
56121514|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
56121515|NCT01766310|Vitamins|vitamins|mesh-ancestor
56634225|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
56634226|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634227|NCT01126190|Docetaxel|docetaxel|mesh-list
56634228|NCT01126190|Doxorubicin|doxorubicin|mesh-list
56634229|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634230|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
56634231|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
56634232|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
56634233|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634234|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56634235|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56634236|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56121516|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
56121517|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121518|NCT01782222|Rotigotine|rotigotine|mesh-list
56121519|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
56121520|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
56121521|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121522|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121523|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121524|NCT01807182|Aldesleukin|aldesleukin|mesh-list
56121525|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
56121526|NCT01807182|Fludarabine|fludarabine|mesh-list
56121542|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
56121543|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121545|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56121546|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
56121547|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121548|NCT01765764|Bimatoprost|bimatoprost|mesh-list
56121549|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56121550|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56121551|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
56121552|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
56121553|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121555|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121556|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
56121557|NCT01780974|Vitamins|vitamins|mesh-ancestor
56121558|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
56121559|NCT01780662|Gemcitabine|gemcitabine|mesh-list
56121560|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56121561|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56121562|NCT01780662|Antibodies|antibodies|mesh-list
56121563|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
56121564|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56121565|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
56121566|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
56121567|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121568|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56121569|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
56121570|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121571|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121572|NCT01780662|Antiviral Agents|antiviral agents|mesh-ancestor
56121573|NCT01780662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121574|NCT01780662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121575|NCT01780662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121576|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56121577|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56121578|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56121579|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
56121580|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121581|NCT01762800|Fluticasone|fluticasone|mesh-list
56121583|NCT01762800|Bromides|bromides|mesh-list
56121584|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
56121585|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56634237|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634238|NCT00866554|Tamoxifen|tamoxifen|mesh-list
56634239|NCT00866554|Bicalutamide|bicalutamide|mesh-list
56634240|NCT00866554|Dutasteride|dutasteride|mesh-list
56634241|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56634242|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
56634243|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56634244|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634245|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56634246|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56634247|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56634248|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56634249|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56121586|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56121587|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121631|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197445|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
56197447|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197448|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197449|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
56197450|NCT01507857|Vaccines|vaccines|mesh-list
56197451|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
56197452|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197453|NCT01507922|Fenoverine|fenoverine|mesh-list
56197454|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
56197455|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
55719053|NCT02305693|Letrozole|letrozole|mesh-list
56121632|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56121633|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56121634|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56121635|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121636|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
56121637|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121638|NCT01777854|Omeprazole|omeprazole|mesh-list
56121639|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56121640|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56121641|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56121642|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121643|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121644|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
56121645|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56121646|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56121647|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56121648|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121649|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121650|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
56121651|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121652|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121653|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56121654|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121655|NCT01777542|Insulin|insulin|mesh-list
56121656|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56121657|NCT01777542|Mitogens|mitogens|mesh-list
56121658|NCT01777542|Mecasermin|mecasermin|mesh-list
56121659|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121660|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121661|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
56121662|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121663|NCT01777542|Growth Substances|growth substances|mesh-ancestor
56121664|NCT01777152|Prednisone|prednisone|mesh-list
56121665|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
56634250|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
56634251|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56634252|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56634253|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56634254|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56634255|NCT00472654|Vitamin D|vitamin d|mesh-list
56634256|NCT00472654|Vitamins|vitamins|mesh-ancestor
56121666|NCT01777152|Doxorubicin|doxorubicin|mesh-list
56121667|NCT01777152|Vincristine|vincristine|mesh-list
56121668|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56121686|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56121687|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56121688|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
56121689|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
56121690|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
56121691|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56121692|NCT01775124|Ranibizumab|ranibizumab|mesh-list
56121693|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56121694|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56121695|NCT01775124|Growth Substances|growth substances|mesh-ancestor
56121696|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121697|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
56121698|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121699|NCT01733316|Cysteamine|cysteamine|mesh-list
56121700|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56121701|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121702|NCT01732926|Rituximab|rituximab|mesh-list
56197456|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197457|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197458|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56197459|NCT01507974|Amoxicillin|amoxicillin|mesh-list
56197460|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
56197461|NCT01507974|Cephalexin|cephalexin|mesh-list
56197462|NCT01507974|Cefuroxime|cefuroxime|mesh-list
56197463|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
56197464|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56197465|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56197466|NCT01507974|Trimethoprim|trimethoprim|mesh-list
56197467|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
56197468|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848651|NCT03820180|Fluticasone|fluticasone|mesh-list
56121703|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56121704|NCT01732926|Idelalisib|idelalisib|mesh-list
56121705|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56121706|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121707|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
56121708|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121709|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121710|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56121711|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
56121712|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121713|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121714|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
56121715|NCT01732770|Denosumab|denosumab|mesh-list
56121716|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56121717|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121718|NCT01774968|Insulin|insulin|mesh-list
56121719|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121720|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121721|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
56121722|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121723|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121738|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121739|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
56121740|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56121741|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56121742|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56121743|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56121744|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
56634257|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
56634258|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634259|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56121745|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121746|NCT01732458|Ondansetron|ondansetron|mesh-list
56121747|NCT01732458|Aprepitant|aprepitant|mesh-list
56121748|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
56121749|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
56121750|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
56121751|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121752|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121753|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56121754|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
56121755|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121756|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56121757|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
56121758|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121759|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121760|NCT01732458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56121761|NCT01732458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56121762|NCT01732458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121763|NCT01732458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56121764|NCT01732458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56121765|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56121766|NCT01708902|Metformin|metformin|mesh-list
56121767|NCT01708902|Linagliptin|linagliptin|mesh-list
56197469|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
56121768|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121769|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121770|NCT01708902|Incretins|incretins|mesh-ancestor
56121771|NCT01708902|Hormones|hormones|mesh-ancestor
56121772|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121773|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56121774|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
56121775|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121776|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121777|NCT01755546|Buprenorphine|buprenorphine|mesh-list
56121778|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56121780|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121781|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121782|NCT01755546|Analgesics|analgesics|mesh-ancestor
56121783|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
56121784|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121785|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56121786|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
56121835|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56121836|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56121837|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
56121838|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121839|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56121840|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121841|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121854|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121856|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56121857|NCT01730040|Ezetimibe|ezetimibe|mesh-list
56121858|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56121859|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56121860|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
56121861|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121862|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56121863|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56121864|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121865|NCT01706328|Fluticasone|fluticasone|mesh-list
56121867|NCT01706328|Albuterol|albuterol|mesh-list
56121868|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56121869|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121870|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56121871|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
56121872|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121873|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121874|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56121875|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
56634260|NCT00323037|Carvedilol|carvedilol|mesh-list
56634261|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56634262|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56634263|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
56634264|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56634265|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121876|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121877|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56121878|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56121879|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56121880|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56121881|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
56121882|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121883|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121884|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
56121885|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56121886|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
56121887|NCT01706250|Salicylates|salicylates|mesh-list
56121888|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121889|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
56121890|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
56121891|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121892|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56121893|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56121894|NCT01706250|Analgesics|analgesics|mesh-ancestor
56121895|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
56121896|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121897|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121898|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121899|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121900|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56121901|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121902|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197470|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56197471|NCT01507974|Renal Agents|renal agents|mesh-ancestor
56197473|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56197474|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56197475|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56197476|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197477|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197478|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56197479|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56197480|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56197481|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56197482|NCT01508000|Bevacizumab|bevacizumab|mesh-list
56197483|NCT01508000|Panitumumab|panitumumab|mesh-list
56197484|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56197485|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197486|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56197487|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56197488|NCT01508000|Growth Substances|growth substances|mesh-ancestor
56197489|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197490|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
56197491|NCT01508104|Everolimus|everolimus|mesh-list
56197492|NCT01508104|Dactolisib|dactolisib|mesh-list
56197493|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197494|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121903|NCT01729728|Tapentadol|tapentadol|mesh-list
56121904|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56121905|NCT01729728|Narcotics|narcotics|mesh-ancestor
56121913|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121914|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121915|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
56121916|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121917|NCT01728324|Ribavirin|ribavirin|mesh-list
56121918|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
56121919|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121920|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
56121921|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56634266|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56634267|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56634268|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
56634269|NCT00323037|Protective Agents|protective agents|mesh-ancestor
56121922|NCT01728246|Acetaminophen|acetaminophen|mesh-list
56121923|NCT01728246|Tramadol|tramadol|mesh-list
56121924|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56121925|NCT01728246|Analgesics|analgesics|mesh-ancestor
56121926|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
56121927|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121928|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121929|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
56121930|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56121931|NCT01728246|Narcotics|narcotics|mesh-ancestor
56121932|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121933|NCT04414020|Progesterone|progesterone|mesh-list
56121934|NCT04414020|Progestins|progestins|mesh-ancestor
56121936|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197495|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
56197496|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197497|NCT01507610|Sumatriptan|sumatriptan|mesh-list
56121937|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121938|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56121939|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56121940|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121941|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121942|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
56121943|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121944|NCT01751802|Ecopipam|ecopipam|mesh-list
56121945|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56121946|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56121947|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121948|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121949|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56121950|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56121951|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
56121952|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121953|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121954|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
56121955|NCT04550832|Bedaquiline|bedaquiline|mesh-list
56121956|NCT04550832|Delpazolid|delpazolid|mesh-list
56121957|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56121958|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121959|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56121960|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56121961|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121962|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121963|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121964|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
56121965|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56121967|NCT01703286|Linagliptin|linagliptin|mesh-list
56121968|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56121969|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121970|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121971|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121972|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
56121973|NCT01703286|Incretins|incretins|mesh-ancestor
56122016|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122017|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56122018|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122019|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56122020|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56122021|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
56122022|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122024|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
56122025|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
56122026|NCT01751646|Vitamins|vitamins|mesh-list
56122027|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
56122028|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122029|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56122030|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56122031|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
56634270|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56634271|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56634272|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56634273|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
56122032|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56122033|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56122034|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
56122035|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122036|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56122037|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56122054|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56122055|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56122056|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56122057|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
56122058|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122059|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122060|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56122061|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56122062|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
56122063|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
56122064|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
56197498|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56197499|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56122065|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122066|NCT01722162|Bevacizumab|bevacizumab|mesh-list
56122067|NCT01722162|Capecitabine|capecitabine|mesh-list
56122068|NCT01722162|Levocetirizine|levocetirizine|mesh-list
56122069|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122070|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122071|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56122072|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56122073|NCT01722162|Growth Substances|growth substances|mesh-ancestor
56122074|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122075|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
56122076|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56122077|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
56122078|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122079|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56122080|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56122081|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
56122082|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
56122083|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122084|NCT01721772|Nivolumab|nivolumab|mesh-list
56122085|NCT01721772|Dacarbazine|dacarbazine|mesh-list
56122086|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122087|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122088|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56122089|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122090|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56122092|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56122093|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
56122094|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122119|NCT01700946|Asparaginase|asparaginase|mesh-list
56122120|NCT01700946|Interleukin-2|interleukin-2|mesh-list
56122121|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
56122122|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
56122123|NCT01700946|Clofarabine|clofarabine|mesh-list
56122124|NCT01700946|Vinblastine|vinblastine|mesh-list
56122125|NCT01700946|Pegaspargase|pegaspargase|mesh-list
56122126|NCT01700946|Teniposide|teniposide|mesh-list
56122127|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122128|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
56122129|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122130|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56122131|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56122132|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
56122133|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122134|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122135|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56122136|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56634274|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56634275|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56634276|NCT00128297|Pamidronate|pamidronate|mesh-list
56634277|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56634278|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383572|NCT00502567|Leucovorin|leucovorin|mesh-list
56384032|NCT00504283|Morphine|morphine|mesh-list
56384708|NCT00403637|Maleic acid|maleic acid|mesh-list
56384928|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56385845|NCT00135824|Povidone|povidone|mesh-list
56386133|NCT00159705|Pregabalin|pregabalin|mesh-list
56386278|NCT00137774|Bevacizumab|bevacizumab|mesh-list
56386355|NCT00160485|Glyburide|glyburide|mesh-list
56386428|NCT00154089|Analgesics|analgesics|mesh-ancestor
56386503|NCT00138710|Letrozole|letrozole|mesh-list
56387313|NCT00162318|Cetuximab|cetuximab|mesh-list
56387538|NCT00162552|Protective Agents|protective agents|mesh-ancestor
56387620|NCT00505531|Tramadol|tramadol|mesh-list
56387693|NCT04514419|Docetaxel|docetaxel|mesh-list
56387841|NCT04511299|SMOFlipid|smoflipid|mesh-list
56388212|NCT00143702|Riboflavin|riboflavin|mesh-list
56388437|NCT00507052|Protective Agents|protective agents|mesh-ancestor
56388517|NCT05141422|Efavirenz|efavirenz|mesh-list
56388741|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
56388890|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
56389118|NCT00406887|Difluprednate|difluprednate|mesh-list
56389423|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56389504|NCT03271255|Bevacizumab|bevacizumab|mesh-list
56390028|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
56390266|NCT00425191|Docetaxel|docetaxel|mesh-list
56390478|NCT00150657|Gemcitabine|gemcitabine|mesh-list
56390705|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
56390778|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
56391002|NCT04620200|Nivolumab|nivolumab|mesh-list
56391304|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
56391527|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
56392126|NCT00512668|Flutamide|flutamide|mesh-list
56392209|NCT03879122|Hormones|hormones|mesh-ancestor
56392949|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
56393101|NCT00528073|Rifaximin|rifaximin|mesh-list
56393176|NCT00528502|Lidocaine|lidocaine|mesh-list
56393249|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56393994|NCT00146627|Eflornithine|eflornithine|mesh-list
56394069|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56122137|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56122138|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
56394290|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
56394663|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
56395190|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
56395409|NCT05785195|Autonomic Agents|autonomic agents|mesh-ancestor
56396544|NCT04941287|Atezolizumab|atezolizumab|mesh-list
56397004|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
56397086|NCT04334759|Cisplatin|cisplatin|mesh-list
56122139|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
56122140|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122141|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56122142|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
56122143|NCT01700946|Hormones|hormones|mesh-ancestor
56122144|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122145|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742309|NCT01674621|Abaloparatide|abaloparatide|mesh-list
56122146|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56122148|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56122177|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122178|NCT01721070|Analgesics|analgesics|mesh-ancestor
56122179|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
56122180|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122181|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56122182|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56122183|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
56122184|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
56122185|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
56122186|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122187|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56197500|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56197501|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
56197502|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197503|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197504|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197505|NCT01508143|Misoprostol|misoprostol|mesh-list
56197506|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56197507|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
56197508|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56197509|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197510|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56197511|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197512|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
56197513|NCT01508182|Metformin|metformin|mesh-list
56197514|NCT01508182|Canagliflozin|canagliflozin|mesh-list
56197515|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197516|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197517|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56197518|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122188|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56122189|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122190|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122191|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56122192|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
56122193|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122194|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56122195|NCT01748292|Ranibizumab|ranibizumab|mesh-list
56122217|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56122218|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56122219|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
56122220|NCT01746732|Evacetrapib|evacetrapib|mesh-list
56122221|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56122222|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56122223|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56122224|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
56122225|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122226|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56122227|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56122228|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122229|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56397165|NCT04255433|Dulaglutide|dulaglutide|mesh-list
56397693|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397839|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
56397915|NCT03149770|Naloxone|naloxone|mesh-list
56398145|NCT02296125|Gefitinib|gefitinib|mesh-list
56398291|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56333987|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56333988|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
56333989|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56333990|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56333991|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56333992|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56333993|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333994|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
56333995|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56280228|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
56280229|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280230|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
56280231|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930925|NCT03591575|Deferiprone|deferiprone|mesh-list
56122230|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56122231|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122232|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122233|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56122234|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
56122235|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56122236|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122237|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56122238|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56122239|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56122240|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
56122241|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
56122242|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56197520|NCT01508195|Canagliflozin|canagliflozin|mesh-list
56197521|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197522|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197523|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56197524|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197525|NCT01508221|Vitamin E|vitamin e|mesh-list
56197526|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
56197527|NCT01508221|Vitamins|vitamins|mesh-ancestor
56197528|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
56197529|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197530|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
56197531|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197532|NCT01508221|Protective Agents|protective agents|mesh-ancestor
56197533|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56197534|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197535|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56197536|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56197537|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
56197538|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56197540|NCT01508260|Diuretics|diuretics|mesh-ancestor
56197541|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
56122243|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56280232|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56280233|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280234|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56280236|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56280237|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
56280238|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
56280239|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56280240|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280241|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280242|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
56280243|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56280244|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56280245|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280246|NCT02648997|Nivolumab|nivolumab|mesh-list
56280247|NCT02648997|Ipilimumab|ipilimumab|mesh-list
56280248|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122244|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122245|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122246|NCT01720524|Urological Agents|urological agents|mesh-ancestor
56122247|NCT01698918|Dexamethasone|dexamethasone|mesh-list
56122248|NCT01698918|Everolimus|everolimus|mesh-list
56122280|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122281|NCT01745094|Urological Agents|urological agents|mesh-ancestor
56122282|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56122283|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56122284|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56122285|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
56122286|NCT01717326|Ribavirin|ribavirin|mesh-list
56122287|NCT01717326|Grazoprevir|grazoprevir|mesh-list
56122288|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
56122289|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122290|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
56122291|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122292|NCT01744782|Cysteamine|cysteamine|mesh-list
56122293|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56122320|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122321|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
56122322|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122323|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
56122324|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56122325|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
56122326|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122327|NCT01739790|Expectorants|expectorants|mesh-ancestor
56122328|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56122329|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56122331|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122332|NCT01739790|Protective Agents|protective agents|mesh-ancestor
56197542|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197543|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56197544|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55719540|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56122333|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122334|NCT01739790|Antidotes|antidotes|mesh-ancestor
56122335|NCT01696032|Gemcitabine|gemcitabine|mesh-list
56122336|NCT01696032|Paclitaxel|paclitaxel|mesh-list
56122337|NCT01696032|Carboplatin|carboplatin|mesh-list
56122338|NCT01696032|Doxorubicin|doxorubicin|mesh-list
56122339|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56122340|NCT01696032|Topotecan|topotecan|mesh-list
56122341|NCT01696032|Guadecitabine|guadecitabine|mesh-list
56280249|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280250|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56280251|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280252|NCT02593110|Telmisartan|telmisartan|mesh-list
56280253|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56280254|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56280255|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56280256|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280257|NCT02373813|Folic Acid|folic acid|mesh-list
56280258|NCT02373813|Etanercept|etanercept|mesh-list
56280259|NCT02373813|Methotrexate|methotrexate|mesh-list
56280260|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56280261|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
56280262|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56122366|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
56122367|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122368|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122369|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56122370|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56122371|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
56122372|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122373|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56122374|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56122375|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56122376|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56122377|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56122378|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56122379|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55849323|NCT02495896|Cisplatin|cisplatin|mesh-list
56122380|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56122381|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56122382|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56122383|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56122384|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56122386|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56122387|NCT01694706|Omeprazole|omeprazole|mesh-list
56122388|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56122389|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56122390|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56122397|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
56122398|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122399|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122400|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122401|NCT01739400|Macitentan|macitentan|mesh-list
56122402|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56122403|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56122404|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122405|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56122406|NCT01712490|Doxorubicin|doxorubicin|mesh-list
56122407|NCT01712490|Bleomycin|bleomycin|mesh-list
56122408|NCT01712490|Dacarbazine|dacarbazine|mesh-list
56122409|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56122410|NCT01712490|Vinblastine|vinblastine|mesh-list
56122411|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56122412|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122413|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56122414|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56122415|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280263|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280264|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280265|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
56280266|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280267|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280268|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
56280269|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280270|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56280271|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280272|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
55930965|NCT04377399|Vitamin D|vitamin d|mesh-list
56122416|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122417|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56122418|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
56122419|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122420|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56122421|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
56122422|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
56197545|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197546|NCT01508286|Ribavirin|ribavirin|mesh-list
56197547|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
55719610|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
56122423|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
56122424|NCT01712178|Adalimumab|adalimumab|mesh-list
56122427|NCT01693068|Dacarbazine|dacarbazine|mesh-list
56122428|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56122429|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
56122430|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122431|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122432|NCT01691898|Rituximab|rituximab|mesh-list
56122433|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
56122434|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122435|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122436|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
56122437|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122438|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56122439|NCT01737840|Pantoprazole|pantoprazole|mesh-list
56122440|NCT01737840|Ranitidine|ranitidine|mesh-list
56122441|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56122442|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56122443|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56122444|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56122445|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122446|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122447|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56122460|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56122461|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
56122463|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122464|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122465|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56122466|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122467|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56122468|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
56122469|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56122470|NCT01709838|Deferasirox|deferasirox|mesh-list
56122471|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56122472|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
56122473|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
56122474|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122475|NCT01688466|Pomalidomide|pomalidomide|mesh-list
56122476|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
56122477|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122478|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56280273|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280274|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56280275|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56280276|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56280277|NCT02373813|Analgesics|analgesics|mesh-ancestor
56280278|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
55930972|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122479|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56122480|NCT01688466|Growth Substances|growth substances|mesh-ancestor
56122481|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
56122482|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122483|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
56122484|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56122485|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56122486|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56122487|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56122488|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122489|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
56122490|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122491|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122492|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56122493|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122494|NCT01681992|Vaccines|vaccines|mesh-list
56122495|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
56122496|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122497|NCT01687998|Evacetrapib|evacetrapib|mesh-list
56122498|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56122499|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56122500|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
56122501|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122502|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56197548|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197549|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
56122503|NCT01681212|Ipilimumab|ipilimumab|mesh-list
56122504|NCT01681212|Dacarbazine|dacarbazine|mesh-list
56122505|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122506|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122507|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55801998|NCT04815265|Analgesics|analgesics|mesh-ancestor
56122562|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122563|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
56122564|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
56122565|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122566|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
56122567|NCT01568034|Levodopa|levodopa|mesh-list
56122568|NCT01568034|Carbidopa|carbidopa|mesh-list
56122569|NCT01568034|Opicapone|opicapone|mesh-list
56122570|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56122571|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56122572|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
56122573|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122603|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56122604|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122605|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122606|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56122607|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
56122608|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122609|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122610|NCT01686828|Androgens|androgens|mesh-ancestor
56122611|NCT01686828|Hormones|hormones|mesh-ancestor
56122612|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56122613|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
56122614|NCT01592370|Dexamethasone|dexamethasone|mesh-list
56122615|NCT01592370|Nivolumab|nivolumab|mesh-list
56122616|NCT01592370|Ipilimumab|ipilimumab|mesh-list
56122617|NCT01592370|Daratumumab|daratumumab|mesh-list
56122618|NCT01592370|Pomalidomide|pomalidomide|mesh-list
56122619|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56122620|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
56122645|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56280279|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280280|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56280281|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56280282|NCT02373813|Hematinics|hematinics|mesh-ancestor
56280283|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
56280284|NCT02373813|Vitamins|vitamins|mesh-ancestor
56280285|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
56122646|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122647|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56122648|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122649|NCT01684878|Gemcitabine|gemcitabine|mesh-list
56122650|NCT01684878|Paclitaxel|paclitaxel|mesh-list
56122651|NCT01684878|Topotecan|topotecan|mesh-list
56122652|NCT01684878|Pertuzumab|pertuzumab|mesh-list
56122653|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56122654|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122655|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
56122656|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
56122657|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
56122658|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742333|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
56122659|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56122660|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
56122661|NCT01684878|Antiviral Agents|antiviral agents|mesh-ancestor
56122662|NCT01684878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122663|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122664|NCT01684878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122665|NCT01684878|Immunologic Factors|immunologic factors|mesh-ancestor
56122666|NCT01684878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122667|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56122694|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122695|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122696|NCT01565850|Darunavir|darunavir|mesh-list
56122697|NCT01565850|Cobicistat|cobicistat|mesh-list
56122698|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122699|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122700|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
56122701|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122702|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56197550|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197551|NCT01508364|Sorafenib|sorafenib|mesh-list
55719757|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
56122703|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56122704|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56122705|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56122706|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
56122707|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56122708|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56122709|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
56122710|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56122711|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56122712|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
56122713|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122714|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122715|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122716|NCT01565694|Urological Agents|urological agents|mesh-ancestor
56122717|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
56122773|NCT01539642|Narcotics|narcotics|mesh-ancestor
56122774|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56122775|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122776|NCT01539642|Analgesics|analgesics|mesh-ancestor
56122777|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
56122778|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122779|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56122780|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56122781|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
56122782|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
56122783|NCT01538472|Cytarabine|cytarabine|mesh-list
56122784|NCT01538472|Rituximab|rituximab|mesh-list
56122785|NCT01538472|Melphalan|melphalan|mesh-list
56122786|NCT01538472|Carmustine|carmustine|mesh-list
56280286|NCT01959204|Oxycodone|oxycodone|mesh-list
56280287|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56280288|NCT01959204|Narcotics|narcotics|mesh-ancestor
56280289|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56280290|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280291|NCT01959204|Analgesics|analgesics|mesh-ancestor
56280292|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
55930984|NCT03406299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122787|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56122788|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122789|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122790|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
56122791|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122792|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56122793|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56122794|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
56122795|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122796|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
56122797|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122798|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122799|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56122800|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
56122857|NCT01585194|Ipilimumab|ipilimumab|mesh-list
56122858|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122859|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122860|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56122861|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122862|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56122863|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56122864|NCT01585038|Efavirenz|efavirenz|mesh-list
56122865|NCT01585038|Rilpivirine|rilpivirine|mesh-list
56122866|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56122867|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56122868|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122869|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122870|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
56122871|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122872|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56122873|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56122874|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56122875|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56122876|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56122877|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56122878|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56122879|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56122880|NCT01559844|Ribavirin|ribavirin|mesh-list
56122881|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
56122882|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
56197552|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197553|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56197554|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197555|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197556|NCT01508429|Misoprostol|misoprostol|mesh-list
56197557|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56197558|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
56197559|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56122883|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122884|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
56122885|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122886|NCT01584648|Trametinib|trametinib|mesh-list
56122887|NCT01584648|Dabrafenib|dabrafenib|mesh-list
56122903|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56122904|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
56122905|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
56122906|NCT01583166|Epinephrine|epinephrine|mesh-list
56122907|NCT01583166|Bupivacaine|bupivacaine|mesh-list
56122908|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
56280293|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280294|NCT01853748|Paclitaxel|paclitaxel|mesh-list
56280295|NCT01853748|Maytansine|maytansine|mesh-list
56280296|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56280297|NCT01853748|Trastuzumab|trastuzumab|mesh-list
56280298|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55930992|NCT03590873|Vasopressins|vasopressins|mesh-list
56122909|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
56122910|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56122911|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122912|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
56122913|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122914|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56122915|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56122916|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
56122917|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122918|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122919|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56122920|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56122921|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
56122922|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56122923|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
56122924|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
56122925|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
56122926|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56122927|NCT01582854|Actovegin|actovegin|mesh-list
56122928|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56122929|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122930|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56122931|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56122932|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
56122933|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122934|NCT01582854|Protective Agents|protective agents|mesh-ancestor
56122935|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56122936|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56122937|NCT01582308|Vildagliptin|vildagliptin|mesh-list
56122938|NCT01582308|Saxagliptin|saxagliptin|mesh-list
56122939|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56122940|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122941|NCT01582308|Incretins|incretins|mesh-ancestor
56122942|NCT01582308|Hormones|hormones|mesh-ancestor
56122943|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122944|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56122945|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
56122946|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122967|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56122968|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56122969|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122971|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122972|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122973|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56197561|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56197562|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197563|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
56197564|NCT01508468|Rituximab|rituximab|mesh-list
56197565|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
56197566|NCT01508468|Giapreza|giapreza|mesh-list
56197567|NCT01508468|Calcium|calcium|mesh-list
56197568|NCT01508468|Diuretics|diuretics|mesh-list
56197569|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56197570|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56197571|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
56197572|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56197573|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56197574|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197575|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
56197576|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197577|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56197578|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56280299|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280300|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
56280301|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
55902285|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
56280302|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
56280303|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197579|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
56197581|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
56197582|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197583|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197584|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55719915|NCT02262533|Atenolol|atenolol|mesh-list
56122974|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56122976|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122977|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
56122978|NCT01557504|Metformin|metformin|mesh-list
56122979|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56122980|NCT01557504|Hormones|hormones|mesh-list
56122981|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56122982|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122983|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122984|NCT01557504|Incretins|incretins|mesh-ancestor
56122985|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56122986|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
56122987|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122988|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122989|NCT01580670|Infliximab|infliximab|mesh-list
56122990|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56122991|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56122992|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56122993|NCT01534260|Bortezomib|bortezomib|mesh-list
56122994|NCT01534260|Sorafenib|sorafenib|mesh-list
56122995|NCT01534260|Vorinostat|vorinostat|mesh-list
56122996|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122997|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56122998|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122999|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123041|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123042|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
56123043|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56197585|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56197586|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
56197587|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
56123044|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
56123045|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123046|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
56123047|NCT03028428|Protective Agents|protective agents|mesh-ancestor
56123048|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56123049|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56123050|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123051|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123052|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
56123053|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123054|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56123055|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56123056|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56123057|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56123058|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123059|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56123060|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56123061|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56123062|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
56123063|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123064|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123065|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56123066|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56123067|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
56123069|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56280304|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280305|NCT01756248|Aflibercept|aflibercept|mesh-list
56280306|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56280307|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56280308|NCT01756248|Growth Substances|growth substances|mesh-ancestor
56280309|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280310|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
56280311|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280312|NCT00006045|Cytarabine|cytarabine|mesh-list
56280313|NCT00006045|Etoposide|etoposide|mesh-list
56280314|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
56280315|NCT00006045|Lintuzumab|lintuzumab|mesh-list
56280316|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280317|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280318|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56280319|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280320|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280321|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280322|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56123093|NCT01531998|Growth Substances|growth substances|mesh-ancestor
56123094|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
56123095|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
56123096|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
56123097|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56123098|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123099|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123100|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
56123101|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56123102|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56123103|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123104|NCT01553136|Varenicline|varenicline|mesh-list
56123105|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56123106|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56123107|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
56123108|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123109|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123110|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123111|NCT01552902|Methylphenidate|methylphenidate|mesh-list
56123112|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56123113|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56123114|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123115|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56123116|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56123117|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123118|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123119|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
56123120|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123152|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
56123153|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56123154|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56123155|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56123156|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123157|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123158|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
56280323|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
56280324|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
56280325|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280326|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280327|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
56280328|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280329|NCT00006045|Analgesics|analgesics|mesh-ancestor
56280330|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
56280331|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280332|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280333|NCT00006048|Gemcitabine|gemcitabine|mesh-list
56280334|NCT00006048|Gefitinib|gefitinib|mesh-list
56280335|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280336|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280337|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
56123159|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123160|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123161|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56123162|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123202|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
56123203|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
56197588|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123204|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56123205|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
56123206|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123207|NCT01572792|Bromides|bromides|mesh-list
56123208|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
56123209|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56123210|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
56123211|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123212|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123213|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56123214|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
56123215|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56123216|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56123217|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56123218|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
56123219|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123220|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123221|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
56123222|NCT01547598|Timolol|timolol|mesh-list
56123223|NCT01547598|Bimatoprost|bimatoprost|mesh-list
56123224|NCT01547598|Travoprost|travoprost|mesh-list
56123225|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56123226|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56123227|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56123228|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56123229|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
56123230|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123231|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123232|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123233|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56123234|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56123235|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
56123236|NCT01547286|Miotics|miotics|mesh-ancestor
56123237|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
56123238|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123262|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
56123264|NCT01524198|Hormones|hormones|mesh-ancestor
56123265|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123266|NCT01523886|Rocuronium|rocuronium|mesh-list
56280338|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280339|NCT00006048|Antiviral Agents|antiviral agents|mesh-ancestor
56280340|NCT00006048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280341|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280342|NCT00006048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280343|NCT00006048|Immunologic Factors|immunologic factors|mesh-ancestor
56280344|NCT00006048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280345|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56280346|NCT00006051|Fluorouracil|fluorouracil|mesh-list
56123267|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56123268|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56123269|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56123271|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123320|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
56123321|NCT01571232|Hormones|hormones|mesh-ancestor
56123322|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123323|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56123324|NCT01522950|Atenolol|atenolol|mesh-list
56123325|NCT01522950|Nebivolol|nebivolol|mesh-list
56123326|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56123327|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56123328|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
56123329|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
56123330|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123331|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123332|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56123333|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56123334|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56123335|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
56123363|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123364|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
56123365|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123366|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123367|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56123368|NCT01518192|Doxycycline|doxycycline|mesh-list
56123369|NCT01518192|Cefuroxime|cefuroxime|mesh-list
56123370|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
56123371|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56123372|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123373|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
56197589|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56197590|NCT01508494|Galantamine|galantamine|mesh-list
56197591|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56197592|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197593|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197594|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
56197595|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197596|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197597|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56197598|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
56197599|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197600|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
56197601|NCT01508572|Bevacizumab|bevacizumab|mesh-list
56197602|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56197603|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197604|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56197605|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56197607|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197608|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
56197609|NCT01508611|Fluorides|fluorides|mesh-list
56197610|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
56197611|NCT01508611|Protective Agents|protective agents|mesh-ancestor
56197612|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197613|NCT01508637|Terazosin|terazosin|mesh-list
56197614|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56280347|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280348|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
56280349|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280350|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280351|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280352|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
56280353|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280354|NCT00006054|Cyclosporine|cyclosporine|mesh-list
56197615|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56197616|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56123374|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56123375|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56123376|NCT01517802|Prednisone|prednisone|mesh-list
56123377|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
56123378|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123397|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
56123398|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56123399|NCT01520922|Ofatumumab|ofatumumab|mesh-list
56123400|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56123401|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
56123402|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123403|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123404|NCT01517412|Metformin|metformin|mesh-list
56123405|NCT01517412|Lixisenatide|lixisenatide|mesh-list
56123406|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56123407|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123408|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56123409|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
56123411|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56123412|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
56123413|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197617|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
56197618|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720140|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56123415|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56123416|NCT01516008|Narcotics|narcotics|mesh-ancestor
56123417|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56123418|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123419|NCT01516008|Analgesics|analgesics|mesh-ancestor
56123420|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
56123421|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123422|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56123423|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56123424|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123425|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123426|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
56123427|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123428|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
56123430|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56123456|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123457|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123458|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123459|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742349|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56123460|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123462|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56123463|NCT01519674|Insulin|insulin|mesh-list
56123464|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56123465|NCT01519674|Metformin|metformin|mesh-list
56123466|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
56123467|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
56123468|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56123469|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56123470|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
56123471|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56123472|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
56280355|NCT00006054|Prednisone|prednisone|mesh-list
56280356|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
56280357|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
56280358|NCT00006054|Busulfan|busulfan|mesh-list
56280359|NCT00006054|Methotrexate|methotrexate|mesh-list
56280360|NCT00006054|Etoposide|etoposide|mesh-list
56123473|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56123474|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123475|NCT01519674|Incretins|incretins|mesh-ancestor
56123476|NCT01519674|Hormones|hormones|mesh-ancestor
56123477|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123478|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56123479|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
56123480|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123481|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123545|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56123546|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56123547|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56123548|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123549|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123550|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
56123551|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123552|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123553|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56123554|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123578|NCT01462266|Metformin|metformin|mesh-list
56123579|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
56123580|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56123581|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56123582|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123583|NCT01462266|Incretins|incretins|mesh-ancestor
56123584|NCT01462266|Hormones|hormones|mesh-ancestor
56123585|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123586|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56123587|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
56123588|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123589|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123590|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
56123591|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
56197620|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197623|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56197624|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197625|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197626|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
56197627|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197628|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
56197629|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197630|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197631|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56123592|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56123593|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
56123594|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123595|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123596|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56123597|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
56123598|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56123599|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56123600|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56123601|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
56123602|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123603|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123604|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56123605|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56123606|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56123607|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
56123645|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56123647|NCT01461096|Vaccines|vaccines|mesh-list
56123648|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
56123649|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280361|NCT00006054|Cyclosporins|cyclosporins|mesh-list
56280362|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56280363|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280364|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
56280365|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280366|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280367|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56280368|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
55931050|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56123650|NCT01480674|Trastuzumab|trastuzumab|mesh-list
56123651|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56123652|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123653|NCT01506882|Levetiracetam|levetiracetam|mesh-list
56123654|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
56123655|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
56123656|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
56123657|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56123658|NCT01506726|Salicylates|salicylates|mesh-list
56123659|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56123660|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56123689|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
56123690|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56123691|NCT01460628|Modafinil|modafinil|mesh-list
56123692|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56123693|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123694|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56123695|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56123696|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56123697|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123698|NCT01480596|Belimumab|belimumab|mesh-list
56123699|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123700|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
56123701|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123702|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56123703|NCT01459614|Gemcitabine|gemcitabine|mesh-list
56123704|NCT01459614|Docetaxel|docetaxel|mesh-list
56197632|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56197633|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
56197634|NCT01508806|Liraglutide|liraglutide|mesh-list
56197635|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197636|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197637|NCT01508806|Incretins|incretins|mesh-ancestor
56197638|NCT01508806|Hormones|hormones|mesh-ancestor
56197639|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197640|NCT01508845|Vitamin D|vitamin d|mesh-list
56197641|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
56197642|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
56197643|NCT01508845|Vitamins|vitamins|mesh-list
56197644|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
56197645|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197646|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56123705|NCT01459614|Capecitabine|capecitabine|mesh-list
56123706|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123747|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56123748|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56123749|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123750|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123751|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56123752|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
56123753|NCT01458210|Dulaglutide|dulaglutide|mesh-list
56123754|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
55742352|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56123755|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56123756|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56123757|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123758|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56123759|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280369|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280370|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280371|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56280372|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56280373|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
56123760|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56123832|NCT01454076|Ketoconazole|ketoconazole|mesh-list
56123834|NCT01454076|Glycine|glycine|mesh-list
56123835|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56123836|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123837|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56123838|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123858|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123859|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
56123860|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
56123861|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123862|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56123863|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
56123864|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123866|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56123868|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123869|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
56123870|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123871|NCT01453140|Sirolimus|sirolimus|mesh-list
56123872|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
56123873|NCT01453140|Interleukin-2|interleukin-2|mesh-list
56123874|NCT01453140|Azacitidine|azacitidine|mesh-list
56123875|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123876|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
56123877|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123878|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123879|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56123880|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
56123881|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197647|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56197648|NCT01508858|Liraglutide|liraglutide|mesh-list
56197649|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
56197650|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56197651|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197652|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197653|NCT01508858|Incretins|incretins|mesh-ancestor
56197654|NCT01508858|Hormones|hormones|mesh-ancestor
56197655|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123882|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123883|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56123884|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56123885|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123887|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
56123888|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56123889|NCT01453140|Analgesics|analgesics|mesh-ancestor
56123913|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56123914|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
56123915|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123916|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56123917|NCT01498068|Interferons|interferons|mesh-list
56123918|NCT01498068|Ribavirin|ribavirin|mesh-list
56123919|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
56123920|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
56123921|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56123922|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123923|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
56123924|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123925|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
56123926|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123927|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
56123928|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123929|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
56123930|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
56123931|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123932|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
56123933|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56280374|NCT00006054|Hormones|hormones|mesh-ancestor
56280375|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280376|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56280378|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
56280379|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56280380|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280381|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
56280382|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
56123934|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56123935|NCT01496976|Prednisolone|prednisolone|mesh-list
56123936|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
56123937|NCT01496976|Lenalidomide|lenalidomide|mesh-list
56123938|NCT01496976|Ofatumumab|ofatumumab|mesh-list
56123939|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56123940|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
56123941|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
56123942|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123943|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56123975|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56123977|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123978|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56123979|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
56123980|NCT04408326|Giapreza|giapreza|mesh-list
56123981|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
56123982|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123983|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56124008|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56124010|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124011|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56124012|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56124013|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
56124014|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124015|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
56124016|NCT01473732|Everolimus|everolimus|mesh-list
55850988|NCT04779892|Infliximab|infliximab|mesh-list
56124018|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56124019|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
56124020|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124021|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56197656|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56197657|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
56197658|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56197659|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56197660|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56197661|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56197662|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56197663|NCT01508858|Estrogens|estrogens|mesh-ancestor
56197664|NCT01508884|Imiquimod|imiquimod|mesh-list
56197665|NCT01508884|Vaccines|vaccines|mesh-list
56197666|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
55720467|NCT01253603|Xhance|xhance|mesh-list
56124022|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124023|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124024|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124025|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56124026|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56124027|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
56124028|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56124029|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124030|NCT01450098|Evacetrapib|evacetrapib|mesh-list
56124031|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
56124032|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56124047|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124048|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124049|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56124050|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56124051|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56280383|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280384|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56280385|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56124052|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124053|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124054|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
56124055|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
56124056|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124057|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
56124058|NCT01473420|Hematinics|hematinics|mesh-ancestor
56124059|NCT04674774|Lansoprazole|lansoprazole|mesh-list
56124060|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
56124062|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56124063|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56124064|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124065|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124067|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56124068|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
56124069|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124070|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56124071|NCT01492686|Protective Agents|protective agents|mesh-ancestor
56124072|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124073|NCT01449006|Maraviroc|maraviroc|mesh-list
56124074|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56124075|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56124076|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124077|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56124078|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56124079|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
56124080|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124081|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56124082|NCT04085172|Guanfacine|guanfacine|mesh-list
56124083|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56124084|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56124085|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56124086|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56197667|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197668|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56197669|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197670|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
56197672|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197673|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197674|NCT01508897|Incretins|incretins|mesh-ancestor
56197675|NCT01508897|Hormones|hormones|mesh-ancestor
56197676|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197677|NCT01508923|Liraglutide|liraglutide|mesh-list
56197678|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197679|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197680|NCT01508923|Incretins|incretins|mesh-ancestor
56197681|NCT01508923|Hormones|hormones|mesh-ancestor
56197682|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197683|NCT01508949|Liraglutide|liraglutide|mesh-list
56197684|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197685|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197686|NCT01508949|Incretins|incretins|mesh-ancestor
56197687|NCT01508949|Hormones|hormones|mesh-ancestor
55720482|NCT02268383|Luspatercept|luspatercept|mesh-list
56124087|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124088|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
56124089|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851057|NCT04769908|Lenvatinib|lenvatinib|mesh-list
56124090|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124091|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56124092|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56124131|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56124132|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56124133|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
56124134|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56124135|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
56124136|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
56124137|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
56280386|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280387|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56280388|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280389|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
56280390|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280391|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56280393|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
56280394|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124138|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56124139|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56124140|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
56124141|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124142|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124143|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56124144|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56124145|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56124146|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56124147|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56124148|NCT01490190|Etonogestrel|etonogestrel|mesh-list
56124149|NCT01490190|NuvaRing|nuvaring|mesh-list
56124150|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56124151|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56124152|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56124153|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
56124154|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56124155|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124156|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56197688|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197689|NCT01509001|Metformin|metformin|mesh-list
56124157|NCT01490190|Estrogens|estrogens|mesh-ancestor
56124158|NCT01490190|Hormones|hormones|mesh-ancestor
56124159|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124160|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
56124161|NCT01446042|Testosterone|testosterone|mesh-list
56124162|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
56124163|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
56124188|NCT04073316|Warfarin|warfarin|mesh-list
56124189|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
56124190|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
56124191|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56124192|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
56124193|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56124194|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
56124195|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124196|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124197|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
56124198|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56124199|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
56124200|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
56124201|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56124202|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124203|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56124204|NCT04089852|Analgesics|analgesics|mesh-ancestor
56124205|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
56124206|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124207|NCT01440816|Interleukin-12|interleukin-12|mesh-list
56124208|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56124209|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
56124210|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124211|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56124212|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56124213|NCT01440816|Growth Substances|growth substances|mesh-ancestor
56124241|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
55851203|NCT01475721|Hormones|hormones|mesh-ancestor
56124242|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56124243|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56124245|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
56124246|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56280395|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56280396|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56280397|NCT00006054|Protective Agents|protective agents|mesh-ancestor
56280398|NCT00006063|Pancrelipase|pancrelipase|mesh-list
56124247|NCT01443078|Gemcitabine|gemcitabine|mesh-list
56124248|NCT01443078|Carboplatin|carboplatin|mesh-list
56124249|NCT01443078|Docetaxel|docetaxel|mesh-list
56124250|NCT01443078|Pemetrexed|pemetrexed|mesh-list
56124251|NCT01443078|Vinorelbine|vinorelbine|mesh-list
56124252|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124253|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56124254|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
56124255|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124256|NCT01443078|Antiviral Agents|antiviral agents|mesh-ancestor
56124257|NCT01443078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124258|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124259|NCT01443078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56124260|NCT01443078|Immunologic Factors|immunologic factors|mesh-ancestor
56124261|NCT01443078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124262|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
56124263|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
56124264|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
56124283|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124284|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124286|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124287|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124288|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124289|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124290|NCT01442688|Amoxicillin|amoxicillin|mesh-list
56124291|NCT01442688|Mesalamine|mesalamine|mesh-list
56124292|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56124293|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124294|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56124295|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56124297|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
56124298|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124299|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197690|NCT01509001|Glimepiride|glimepiride|mesh-list
56197691|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197692|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197693|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56197694|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197695|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
56197696|NCT01509131|Bisacodyl|bisacodyl|mesh-list
56197697|NCT01509131|Cathartics|cathartics|mesh-ancestor
56197698|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197699|NCT01509131|Laxatives|laxatives|mesh-ancestor
56197700|NCT01509144|Vaccines|vaccines|mesh-list
56197701|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
56197702|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197703|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
56197704|NCT01509209|Ephedrine|ephedrine|mesh-list
56197705|NCT01509209|Levocetirizine|levocetirizine|mesh-list
56197706|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56197707|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56124300|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124301|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56124302|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
56124303|NCT01468818|Fludarabine|fludarabine|mesh-list
56124304|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56124305|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
56124306|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124307|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56124308|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56124309|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
56124310|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124311|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124312|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56124313|NCT01442376|Ondansetron|ondansetron|mesh-list
56124314|NCT01442376|Palonosetron|palonosetron|mesh-list
56124315|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
56124316|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
56124317|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124318|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280399|NCT00006063|Pancreatin|pancreatin|mesh-list
56280400|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56280401|NCT00006066|Aldesleukin|aldesleukin|mesh-list
56280402|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280403|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56280404|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56280405|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
56280406|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124319|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56124320|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
56124368|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124370|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56124371|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
56124372|NCT04066764|Nadroparin|nadroparin|mesh-list
56124373|NCT04066764|Warfarin|warfarin|mesh-list
56124374|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
56124375|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
56124376|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56124377|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
56124378|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56124379|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
56124380|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124381|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124382|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56124383|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56124384|NCT01437540|Bromides|bromides|mesh-list
56124385|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
56124386|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56124387|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
56124411|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124412|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
56124413|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197708|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
56197709|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
56197710|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720657|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
56124414|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
56124415|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124416|NCT01466790|Ribavirin|ribavirin|mesh-list
56124417|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
56124418|NCT01466790|Simeprevir|simeprevir|mesh-list
56124419|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
56124420|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124421|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
56124422|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124423|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
56124424|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124425|NCT01418352|Aripiprazole|aripiprazole|mesh-list
56124426|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
56124427|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56124428|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56124429|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56124430|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56124431|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124432|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
56124433|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
56124434|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124435|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124436|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56124437|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56124438|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
56124439|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56124440|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56124441|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56124470|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124471|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124472|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124473|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124474|NCT01393626|Tofacitinib|tofacitinib|mesh-list
56280407|NCT00006072|Rituximab|rituximab|mesh-list
56280408|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280409|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280410|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
56280411|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931088|NCT03593213|Cariprazine|cariprazine|mesh-list
56124475|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124476|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124477|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124479|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56124480|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56124481|NCT01393158|Analgesics|analgesics|mesh-ancestor
56124482|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
56124483|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124484|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124485|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124486|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56124487|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56124488|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56124505|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124507|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
56124508|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124509|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56124510|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56124511|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
56124512|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56124513|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56124514|NCT01392378|Acetaminophen|acetaminophen|mesh-list
56124515|NCT01392378|Ibuprofen|ibuprofen|mesh-list
56124516|NCT01392378|Vaccines|vaccines|mesh-list
56124517|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56124518|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
56124519|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124520|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56124521|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56124522|NCT01392378|Analgesics|analgesics|mesh-ancestor
56124523|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
56124524|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124525|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56197711|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197712|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197713|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56197714|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
56197715|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197716|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56197717|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
56197718|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
56197719|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56197720|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56124526|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56124527|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56124528|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124529|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124530|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
56124531|NCT01412424|Octreotide|octreotide|mesh-list
56124532|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56124533|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56124534|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124535|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56124536|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
56124537|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124538|NCT01432938|Dulaglutide|dulaglutide|mesh-list
56124540|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
56124541|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56124542|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124543|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56124544|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55851498|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
56280412|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280413|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
56280414|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56280415|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56280416|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280417|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
56124545|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124599|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56124600|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56124601|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124602|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124603|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
56124605|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124606|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56124607|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56124608|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
56124609|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
56124610|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
56124611|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
56124612|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
56124613|NCT01408914|Rifampin|rifampin|mesh-list
56124614|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56124615|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
56124616|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56144931|NCT00824460|Iron|iron|mesh-list
56144949|NCT00825786|Ropivacaine|ropivacaine|mesh-list
56124617|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145383|NCT00899574|Imiquimod|imiquimod|mesh-list
56145764|NCT00950352|Choline|choline|mesh-list
56124618|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
56145973|NCT00997620|Fluticasone|fluticasone|mesh-list
55902297|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55902299|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55902300|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
55902301|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
55902302|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
55902303|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55902304|NCT02558374|Timolol|timolol|mesh-list
55902305|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55902306|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55902307|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902308|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56197721|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
56197722|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
56197723|NCT01509261|Lansoprazole|lansoprazole|mesh-list
56197724|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
56197725|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56197726|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197727|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56197728|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197729|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197730|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
56197731|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
56197732|NCT01509300|Rituximab|rituximab|mesh-list
56197733|NCT01509300|Fludarabine|fludarabine|mesh-list
56197734|NCT01509300|Tacrolimus|tacrolimus|mesh-list
56197735|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56197736|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197737|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
56197738|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197739|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56197740|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56197741|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
56197742|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720794|NCT05401214|Hormones|hormones|mesh-ancestor
55902309|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55902310|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
55902311|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902312|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902313|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55902314|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55902316|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56280418|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
56280419|NCT00006078|Lycopene|lycopene|mesh-list
56280420|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56280421|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
56280422|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931100|NCT03595163|Folic Acid|folic acid|mesh-list
55902317|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
55902318|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55902319|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902320|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55902321|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55902322|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902323|NCT03168828|Trospium chloride|trospium chloride|mesh-list
55902324|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
55902325|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
55902326|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902327|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902328|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55902329|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55902330|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
55902331|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902332|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902333|NCT03168828|Urological Agents|urological agents|mesh-ancestor
55902334|NCT02562898|Gemcitabine|gemcitabine|mesh-list
55902335|NCT02562898|Paclitaxel|paclitaxel|mesh-list
55902336|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55902337|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902338|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
55902339|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
55902340|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
56197743|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197744|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55902341|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902342|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55902374|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
55902375|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902376|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902377|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902378|NCT02567968|Caffeine|caffeine|mesh-list
55902379|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
55902380|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902381|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55902382|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902383|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55902405|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55902406|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902407|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55902409|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55902410|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55902411|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55902412|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
55902413|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55902414|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55902415|NCT02574598|Docetaxel|docetaxel|mesh-list
55902416|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
55902417|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902418|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
55902419|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
55902420|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
55902421|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902422|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902423|NCT02574832|Lidocaine|lidocaine|mesh-list
55902424|NCT02574832|Fentanyl|fentanyl|mesh-list
55902425|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
55902426|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
55902427|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902428|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902429|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
56280423|NCT00006078|Protective Agents|protective agents|mesh-ancestor
56280424|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280425|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56280426|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56280427|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280428|NCT00006081|Paclitaxel|paclitaxel|mesh-list
56280429|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
56280430|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55902430|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902431|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55902432|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55902433|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55902434|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55902435|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721523|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
55902455|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55902456|NCT02406690|Progestins|progestins|mesh-ancestor
55902457|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55902458|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
55902459|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55902460|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902461|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
55902462|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
55902463|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
55902464|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902465|NCT02974348|Acetaminophen|acetaminophen|mesh-list
55902466|NCT02974348|Amoxicillin|amoxicillin|mesh-list
55902467|NCT02974348|Artesunate|artesunate|mesh-list
55902468|NCT02974348|Lumefantrine|lumefantrine|mesh-list
55902469|NCT02974348|Piperaquine|piperaquine|mesh-list
55902470|NCT02974348|Artenimol|artenimol|mesh-list
55902471|NCT02974348|Mefloquine|mefloquine|mesh-list
55902472|NCT02974348|Quinine|quinine|mesh-list
55902473|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55902474|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902475|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55902476|NCT02974348|Analgesics|analgesics|mesh-ancestor
55902477|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
55902478|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902479|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902480|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
55902481|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
55902482|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56197745|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56197746|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56197747|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197748|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55902483|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55902484|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902485|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
55902486|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
55902487|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55902488|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
55902489|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55902490|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55902491|NCT03170310|Apatinib|apatinib|mesh-list
55902492|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902493|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55902494|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902495|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902517|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
55902518|NCT03970252|Nivolumab|nivolumab|mesh-list
55902519|NCT03970252|Irinotecan|irinotecan|mesh-list
55902520|NCT03970252|Camptothecin|camptothecin|mesh-list
55902521|NCT03970252|Calcium|calcium|mesh-list
55902522|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
55902523|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55902524|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902525|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55902526|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
56280431|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280432|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
56280433|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
56280434|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
56280435|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280436|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56280437|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
55931111|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55902527|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902528|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55902529|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902530|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55902531|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
55902532|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902533|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55902534|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55902535|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55902536|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902537|NCT03970252|Antidotes|antidotes|mesh-ancestor
55902538|NCT03970252|Protective Agents|protective agents|mesh-ancestor
55902539|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
55902540|NCT03970252|Vitamins|vitamins|mesh-ancestor
55902541|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
55902542|NCT03970252|Hematinics|hematinics|mesh-ancestor
55902543|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55902544|NCT02403804|Betaine|betaine|mesh-list
55902545|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55902546|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
55902547|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55902548|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
55902549|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902575|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55902576|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55902578|NCT03169764|Protective Agents|protective agents|mesh-ancestor
55902579|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
55902581|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
55902582|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55902583|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55902584|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55902585|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
55902586|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902587|NCT03874936|Dexamethasone|dexamethasone|mesh-list
55902589|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55902590|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
55902591|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
55902592|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902593|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902594|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55902595|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
55902596|NCT03874936|Hormones|hormones|mesh-ancestor
55902597|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197749|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56197751|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56197752|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197753|NCT01509365|Clopidogrel|clopidogrel|mesh-list
56197754|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56197755|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56197756|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56125515|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56197757|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56197758|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
56197759|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197760|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197761|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902598|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56280438|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280439|NCT00006084|Lintuzumab|lintuzumab|mesh-list
56280440|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280441|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280442|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
55902599|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902600|NCT02399592|Bevacizumab|bevacizumab|mesh-list
55902627|NCT00365170|Insulin|insulin|mesh-list
55902628|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55902629|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
55902630|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55902631|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902632|NCT02403648|Glucagon|glucagon|mesh-list
55902633|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55902634|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55902635|NCT02403648|Hormones|hormones|mesh-ancestor
55902636|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902637|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902638|NCT02403648|Incretins|incretins|mesh-ancestor
55902639|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55902640|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55902641|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902642|NCT02396862|Factor VIII|factor viii|mesh-list
55902643|NCT02396862|Coagulants|coagulants|mesh-ancestor
55902644|NCT02377492|Vasopressins|vasopressins|mesh-list
55902645|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
55902646|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
55902647|NCT02377492|Coagulants|coagulants|mesh-ancestor
55902648|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55902649|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55902667|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902668|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902670|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
55902671|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
55902672|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55902673|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
55902674|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902675|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902676|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55902677|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
55902678|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
55902679|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55902680|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
55902681|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902682|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902684|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
55902687|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902688|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197762|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56197763|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56197764|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
56197765|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197767|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
56197768|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
55902689|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55902690|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
55902691|NCT02402868|Ketamine|ketamine|mesh-list
55902692|NCT02402868|Analgesics|analgesics|mesh-ancestor
55902693|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
55902694|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902695|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902696|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55902697|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55902698|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
55902699|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
55902700|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902701|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55902702|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55902703|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902704|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902705|NCT02402712|Docetaxel|docetaxel|mesh-list
56280443|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280444|NCT00006096|Cisplatin|cisplatin|mesh-list
56280445|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280446|NCT00006105|Gemcitabine|gemcitabine|mesh-list
56280447|NCT00006105|Amifostine|amifostine|mesh-list
56280448|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280449|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55902706|NCT02402712|Trastuzumab|trastuzumab|mesh-list
55902707|NCT02402712|Pertuzumab|pertuzumab|mesh-list
55902734|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55902735|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
55902736|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902737|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902738|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902739|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
55902740|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
55902741|NCT02610868|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55902742|NCT02610868|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55902743|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55902744|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55902745|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902746|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
55902747|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902748|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902749|NCT02610868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55902750|NCT02610868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902751|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55902752|NCT02395068|Irinotecan|irinotecan|mesh-list
55902753|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
55902754|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55902778|NCT00365638|Simvastatin|simvastatin|mesh-list
55902779|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55902780|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55902781|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
55902782|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902783|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55902784|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55902785|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902787|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902788|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902789|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
55902790|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902791|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55902792|NCT05731258|Doxorubicin|doxorubicin|mesh-list
55902793|NCT05731258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55902794|NCT05731258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55902795|NCT05731258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902796|NCT05731258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55902797|NCT05731258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55902798|NCT05731258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902799|NCT05731258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902800|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
55721767|NCT03199755|Artemether|artemether|mesh-list
56197769|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197770|NCT01509521|Phenylephrine|phenylephrine|mesh-list
56197771|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
55902801|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55902821|NCT05705830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55902822|NCT05745714|Cytarabine|cytarabine|mesh-list
55902823|NCT05745714|Dexamethasone|dexamethasone|mesh-list
55902824|NCT05745714|Cyclophosphamide|cyclophosphamide|mesh-list
55902825|NCT05745714|Venetoclax|venetoclax|mesh-list
55902826|NCT05745714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55902827|NCT05745714|Immunologic Factors|immunologic factors|mesh-ancestor
55902828|NCT05745714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902829|NCT05745714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55902830|NCT05745714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55902831|NCT05745714|Alkylating Agents|alkylating agents|mesh-ancestor
55902832|NCT05745714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280450|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
56280451|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280452|NCT00006105|Antiviral Agents|antiviral agents|mesh-ancestor
55902833|NCT05745714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902834|NCT05745714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55902835|NCT05745714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55902836|NCT05745714|Antiemetics|antiemetics|mesh-ancestor
55902837|NCT05745714|Autonomic Agents|autonomic agents|mesh-ancestor
55902838|NCT05745714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902839|NCT05745714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55902840|NCT05745714|Glucocorticoids|glucocorticoids|mesh-ancestor
55902841|NCT05745714|Hormones|hormones|mesh-ancestor
55902842|NCT05745714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902843|NCT05745714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55902844|NCT05745714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55902845|NCT05745714|Antimetabolites|antimetabolites|mesh-ancestor
55902846|NCT05745714|Antiviral Agents|antiviral agents|mesh-ancestor
55902847|NCT05745714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902848|NCT02974270|Leuprolide|leuprolide|mesh-list
55902849|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55902850|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
55902851|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55902852|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902853|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55902854|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902878|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902879|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902880|NCT02393898|Paclitaxel|paclitaxel|mesh-list
55902881|NCT02393898|Bevacizumab|bevacizumab|mesh-list
55902882|NCT02393898|Carboplatin|carboplatin|mesh-list
55902883|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55902884|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902885|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
55902886|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
55902887|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
55902888|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902889|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902890|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55902891|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55902892|NCT02393898|Growth Substances|growth substances|mesh-ancestor
55902893|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902894|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
55902895|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
55902896|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55902897|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55902898|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902899|NCT04258852|Nicotine|nicotine|mesh-list
55902900|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55902901|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
55902902|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902903|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902904|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55902905|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55902906|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
55902907|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902908|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902958|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
55902959|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902960|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197772|NCT01509521|Ephedrine|ephedrine|mesh-list
56197773|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
56197774|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56197775|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
55902963|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55902964|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55902966|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55902967|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55903044|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55903045|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55903046|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
55903047|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
55903048|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903049|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
56280453|NCT00006105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280455|NCT00006105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280456|NCT00006105|Immunologic Factors|immunologic factors|mesh-ancestor
56280457|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280458|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56280459|NCT00006105|Protective Agents|protective agents|mesh-ancestor
56280460|NCT00006108|Paclitaxel|paclitaxel|mesh-list
56280461|NCT00006108|Capecitabine|capecitabine|mesh-list
55903050|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903051|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
55903052|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55903053|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55903054|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55903055|NCT02397330|Morphine|morphine|mesh-list
55903056|NCT02397330|Bupivacaine|bupivacaine|mesh-list
55903057|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
55903058|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
55903059|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903060|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903061|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
55903062|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903063|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55903064|NCT02397330|Narcotics|narcotics|mesh-ancestor
55903065|NCT02397330|Analgesics|analgesics|mesh-ancestor
55903066|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
55903095|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55903097|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903098|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
55903099|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55903100|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903101|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903102|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903103|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
55903104|NCT02876302|Paclitaxel|paclitaxel|mesh-list
55903105|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
55903106|NCT02876302|Doxorubicin|doxorubicin|mesh-list
55903107|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55903108|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903109|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
55903110|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
55903111|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
56197783|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56197784|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56197785|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56197786|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
56197787|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197788|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197789|NCT01509521|Protective Agents|protective agents|mesh-ancestor
56197790|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56197791|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55903181|NCT01587352|Vorinostat|vorinostat|mesh-list
55903182|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903183|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55903184|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721875|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
55903187|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903252|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55903253|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55903254|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903255|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55903256|NCT01582061|Pasireotide|pasireotide|mesh-list
55903257|NCT01582061|Hormones|hormones|mesh-ancestor
55903258|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903259|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903260|NCT01693523|Minocycline|minocycline|mesh-list
55903261|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55903262|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280462|NCT00006108|Trastuzumab|trastuzumab|mesh-list
56280463|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280464|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280465|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
56280466|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
56280467|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
55903263|NCT03924323|Citalopram|citalopram|mesh-list
55903264|NCT03924323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55903265|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55903266|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903267|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903268|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903269|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
55903270|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903305|NCT02696226|Clopidogrel|clopidogrel|mesh-list
55903306|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55903307|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55903308|NCT02696226|Analgesics|analgesics|mesh-ancestor
55903309|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
55903310|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903311|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903312|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903313|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55903314|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55903315|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55903316|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903317|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55903318|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55903319|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903320|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
55903321|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55903322|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55903323|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55903324|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
55903325|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903326|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
55903327|NCT03167112|Leucovorin|leucovorin|mesh-list
55903328|NCT03167112|Fluorouracil|fluorouracil|mesh-list
55903329|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
55903330|NCT03167112|Irinotecan|irinotecan|mesh-list
55903389|NCT01692197|Hormones|hormones|mesh-ancestor
56197792|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56197793|NCT01509560|Everolimus|everolimus|mesh-list
56197794|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197795|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197796|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
56197797|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197798|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
56197799|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56197800|NCT01509742|Liraglutide|liraglutide|mesh-list
56197801|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197802|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197803|NCT01509742|Incretins|incretins|mesh-ancestor
56197804|NCT01509742|Hormones|hormones|mesh-ancestor
56197805|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197806|NCT01509755|Liraglutide|liraglutide|mesh-list
56197807|NCT01509755|Glimepiride|glimepiride|mesh-list
56197808|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197809|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197810|NCT01509755|Incretins|incretins|mesh-ancestor
55903390|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903391|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55903392|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903393|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55903394|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
55721949|NCT01352741|Pregabalin|pregabalin|mesh-list
55903397|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903398|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903399|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
55903400|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56280468|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280469|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280470|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
56280471|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55903401|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55903402|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55903403|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903404|NCT03166644|Sufentanil|sufentanil|mesh-list
55903405|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55903406|NCT03166644|Narcotics|narcotics|mesh-ancestor
55903407|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903408|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903409|NCT03166644|Analgesics|analgesics|mesh-ancestor
55903410|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
55903411|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903412|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55903413|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55903414|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
55903415|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
55903416|NCT01691885|Fluticasone|fluticasone|mesh-list
55903417|NCT01691885|Xhance|xhance|mesh-list
55903418|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903419|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55903420|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
55903432|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55903433|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903434|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
55903435|NCT02651428|Taurolidine|taurolidine|mesh-list
55903436|NCT02651428|Heparin|heparin|mesh-list
55903437|NCT02651428|Calcium heparin|calcium heparin|mesh-list
55903438|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
55903439|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903440|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56197811|NCT01509755|Hormones|hormones|mesh-ancestor
56197812|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197813|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56197814|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197815|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
56197816|NCT01509911|Gemcitabine|gemcitabine|mesh-list
56197817|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56197818|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
56197819|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197820|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197821|NCT01509911|Antiviral Agents|antiviral agents|mesh-ancestor
56197822|NCT01509911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197823|NCT01509911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197824|NCT01509911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903441|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55903442|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903443|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55903444|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903445|NCT02686164|Lenvatinib|lenvatinib|mesh-list
55903446|NCT02686164|Midazolam|midazolam|mesh-list
55903447|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55903448|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55903449|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903450|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903451|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55903452|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55903453|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55903454|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55903455|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
55903456|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
55903457|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
55903458|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
55903459|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903460|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903461|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903462|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55903463|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903464|NCT02651584|Buprenorphine|buprenorphine|mesh-list
55903465|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56280472|NCT00006111|Fluorouracil|fluorouracil|mesh-list
56280473|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280474|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
56280475|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280476|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280477|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280478|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
56280479|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280480|NCT00006114|Vinorelbine|vinorelbine|mesh-list
55903466|NCT02651584|Narcotics|narcotics|mesh-ancestor
55903468|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903469|NCT02651584|Analgesics|analgesics|mesh-ancestor
55903470|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
55903471|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903472|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55903473|NCT02685072|Progesterone|progesterone|mesh-list
55903474|NCT02685072|Progestins|progestins|mesh-ancestor
55903475|NCT02685072|Hormones|hormones|mesh-ancestor
55903476|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903477|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903478|NCT04782258|Tolvaptan|tolvaptan|mesh-list
55903479|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55903480|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903481|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
55903482|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903483|NCT02653144|Dexamethasone|dexamethasone|mesh-list
55903484|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
55903485|NCT02653144|Ropivacaine|ropivacaine|mesh-list
55903513|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55903514|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55903515|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56197825|NCT01509911|Immunologic Factors|immunologic factors|mesh-ancestor
56197826|NCT01509911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197827|NCT01509976|Triclosan|triclosan|mesh-list
55903516|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903517|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
55903518|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903519|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903520|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55903521|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55903522|NCT00118365|Analgesics|analgesics|mesh-ancestor
55903523|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
55903524|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903525|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903526|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903527|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55903528|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55903529|NCT03165240|Eplerenone|eplerenone|mesh-list
55903530|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55903531|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
55903565|NCT02654860|Analgesics|analgesics|mesh-ancestor
55903566|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
55903567|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
55903568|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55903569|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
55903570|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903571|NCT01587001|Expectorants|expectorants|mesh-ancestor
55903572|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
55903573|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55903574|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
55903575|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903576|NCT01587001|Protective Agents|protective agents|mesh-ancestor
55903577|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903578|NCT01587001|Antidotes|antidotes|mesh-ancestor
55903579|NCT01568047|Levodopa|levodopa|mesh-list
55903580|NCT01568047|Carbidopa|carbidopa|mesh-list
55903581|NCT01568047|Opicapone|opicapone|mesh-list
56280481|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
56280482|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280483|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280484|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
56280485|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
56280486|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
55931156|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
55903582|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55903583|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55903584|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
55903585|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903586|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903587|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903588|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55903589|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903590|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55903591|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55903592|NCT02694978|Hematinics|hematinics|mesh-ancestor
55903593|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55903594|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55903595|NCT04739566|Trametinib|trametinib|mesh-list
55903596|NCT04739566|Dabrafenib|dabrafenib|mesh-list
55903623|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55903625|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
55903626|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903627|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903628|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55903629|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55903630|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
55903631|NCT02662036|Bupivacaine|bupivacaine|mesh-list
55903632|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
55903633|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
55903634|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903635|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903636|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
55903637|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903639|NCT01687673|Sorafenib|sorafenib|mesh-list
55903640|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903641|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55903642|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903680|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903681|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55903682|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56197828|NCT01509976|Triclocarban|triclocarban|mesh-list
56197829|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56197830|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197831|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55903683|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55903684|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903685|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903686|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55903687|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
55903688|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55903689|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55903690|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55903692|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55903693|NCT02664922|Ketamine|ketamine|mesh-list
55903694|NCT02664922|Remifentanil|remifentanil|mesh-list
55903695|NCT02664922|Propofol|propofol|mesh-list
55903696|NCT02664922|Sevoflurane|sevoflurane|mesh-list
55903697|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55903698|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903699|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903700|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55903701|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
55903702|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
55903703|NCT02664922|Analgesics|analgesics|mesh-ancestor
55903704|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
56280487|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280488|NCT00006114|Analgesics|analgesics|mesh-ancestor
56280489|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
56280490|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280491|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280492|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55903732|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903734|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55903735|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55903736|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903737|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55903738|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55903739|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55903740|NCT01687283|Fluticasone|fluticasone|mesh-list
55903741|NCT01687283|Xhance|xhance|mesh-list
55903742|NCT01687283|Budesonide|budesonide|mesh-list
55903743|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903744|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55903745|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
55903746|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903747|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903748|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55903749|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
55903750|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
55903776|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903777|NCT02691936|Estrogens|estrogens|mesh-list
55903778|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55903779|NCT02691936|Hormones|hormones|mesh-ancestor
55903780|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903781|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903782|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
55903783|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55903784|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
55903785|NCT04707742|Povidone|povidone|mesh-list
55903786|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
55903787|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
55903788|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55903789|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903791|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
55903792|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55903793|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903794|NCT00367978|Amlodipine|amlodipine|mesh-list
55903795|NCT00367978|Benazepril|benazepril|mesh-list
55903796|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55903797|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55903798|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903799|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903800|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55903829|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903830|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
55903831|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903832|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56125592|NCT00217464|Fulvestrant|fulvestrant|mesh-list
56197832|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55903833|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55903834|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55903835|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903836|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903837|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903838|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
55903839|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
55903840|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55903841|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
55903843|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903844|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55903845|NCT05339542|Protective Agents|protective agents|mesh-ancestor
56280493|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280494|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280495|NCT00006117|Gemcitabine|gemcitabine|mesh-list
56280496|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
56280497|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280498|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
55903846|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55903847|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903848|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
55903890|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55903892|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
55903893|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903894|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903895|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903896|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55903897|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55903898|NCT01683071|Bupivacaine|bupivacaine|mesh-list
55903899|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
55903900|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
55903901|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903902|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903903|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
55903904|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903933|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903935|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
55903936|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903937|NCT05044936|Cannabidiol|cannabidiol|mesh-list
55903938|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
55903939|NCT05005000|Triamcinolone|triamcinolone|mesh-list
55903940|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55903941|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55903942|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55903943|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903944|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
55903945|NCT05005000|Hormones|hormones|mesh-ancestor
55903946|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903947|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903948|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903949|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
55903950|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903968|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903970|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55903971|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55903972|NCT04973566|Analgesics|analgesics|mesh-ancestor
55903973|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
55903974|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903975|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903976|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55722301|NCT01657760|Citalopram|citalopram|mesh-list
55903977|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55903978|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903979|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
55903980|NCT04635826|Adderall|adderall|mesh-list
55903981|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55903982|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903983|NCT04338802|Nintedanib|nintedanib|mesh-list
55903984|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903985|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55903986|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903987|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903988|NCT04395508|Trastuzumab|trastuzumab|mesh-list
55903989|NCT04395508|Pertuzumab|pertuzumab|mesh-list
55903990|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55903991|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903992|NCT00368914|Sirolimus|sirolimus|mesh-list
56197833|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
56197834|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197835|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56197836|NCT01510015|Risperidone|risperidone|mesh-list
56197837|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56280499|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280500|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280501|NCT00006117|Antiviral Agents|antiviral agents|mesh-ancestor
56280502|NCT00006117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280503|NCT00006117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280504|NCT00006117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280505|NCT00006117|Immunologic Factors|immunologic factors|mesh-ancestor
56280506|NCT00006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280507|NCT00006120|Paclitaxel|paclitaxel|mesh-list
56280508|NCT00006120|Docetaxel|docetaxel|mesh-list
56280509|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56197838|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
56197839|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197840|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197841|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197842|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56197843|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56197844|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903993|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55903994|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903995|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55903996|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903997|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
55903998|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903999|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
55904000|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904001|NCT01567085|Eculizumab|eculizumab|mesh-list
55904002|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55904003|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904004|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
55904005|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904006|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
55904007|NCT04344184|Vitamins|vitamins|mesh-ancestor
55904008|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
55904009|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904027|NCT04134442|Bupivacaine|bupivacaine|mesh-list
55904028|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
55904029|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
55904030|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904031|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904032|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
55904033|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904034|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
55904035|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904036|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55904037|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904038|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904039|NCT04127578|Sirolimus|sirolimus|mesh-list
55904040|NCT04127578|Prednisone|prednisone|mesh-list
55904041|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
55904042|NCT04127578|Rituximab|rituximab|mesh-list
55904043|NCT04127578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55904044|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904045|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
55904046|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904047|NCT04127578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904048|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904049|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
55904050|NCT04127578|Hormones|hormones|mesh-ancestor
55904051|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904052|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55904053|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55904054|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904055|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56280510|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280511|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
56280512|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
56280513|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
56280514|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280515|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
56280516|NCT00006123|Thiotepa|thiotepa|mesh-list
56280517|NCT00006123|Carmustine|carmustine|mesh-list
56280518|NCT00006123|Carboplatin|carboplatin|mesh-list
56280519|NCT00006123|Trastuzumab|trastuzumab|mesh-list
56280520|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280521|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
56280522|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904056|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
55904057|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904059|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
55904060|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197845|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56197846|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55904061|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55904062|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55904063|NCT04127578|Protective Agents|protective agents|mesh-ancestor
55904064|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
55904065|NCT04103476|Estrogens|estrogens|mesh-list
55904066|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55904067|NCT04103476|Hormones|hormones|mesh-ancestor
55904068|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904109|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55904111|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
55904112|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55904113|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55904114|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
55904115|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55904116|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55904117|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55904118|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55904119|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55904120|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55904121|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55904122|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
55904123|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55904124|NCT03417388|Protective Agents|protective agents|mesh-ancestor
55904125|NCT03382834|Tamoxifen|tamoxifen|mesh-list
55904126|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55904127|NCT03382834|Vorinostat|vorinostat|mesh-list
55904128|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55904129|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
55904130|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904131|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904132|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55904133|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904134|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55904171|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55904172|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904196|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55904197|NCT03295240|Rituximab|rituximab|mesh-list
55904198|NCT03295240|Venetoclax|venetoclax|mesh-list
55904199|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55904200|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55904201|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904202|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
55904203|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904204|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805970|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
56280523|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280524|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56280525|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
56280526|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280527|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280528|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55931181|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
55904205|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55904206|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
55904207|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904208|NCT03293368|Triamcinolone|triamcinolone|mesh-list
55904209|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55904210|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55904211|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55904212|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904213|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
55904214|NCT03293368|Hormones|hormones|mesh-ancestor
55904215|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904216|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904217|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904218|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
55904219|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904220|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904221|NCT03273712|Octreotide|octreotide|mesh-list
55904222|NCT03273712|Edotreotide|edotreotide|mesh-list
55904223|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55904224|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55904238|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55904239|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55904240|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
55904241|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865093|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
55904242|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197847|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
56197848|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
56197849|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197850|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197851|NCT01510132|Timolol|timolol|mesh-list
56197852|NCT01510132|Travoprost|travoprost|mesh-list
56197853|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56197854|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56197855|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
56197856|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197857|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197858|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197859|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56197860|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56197861|NCT01510171|Ticagrelor|ticagrelor|mesh-list
56197862|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56197863|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56197864|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56197865|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55904243|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904244|NCT01561079|Buprenorphine|buprenorphine|mesh-list
55904245|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55904246|NCT01561079|Narcotics|narcotics|mesh-ancestor
55904247|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904248|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904249|NCT01561079|Analgesics|analgesics|mesh-ancestor
55904250|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
55904251|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904252|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55904253|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
55904254|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55904255|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55904256|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56280529|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280531|NCT00006126|Busulfan|busulfan|mesh-list
56280532|NCT00006126|Fludarabine|fludarabine|mesh-list
56280533|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
56280534|NCT00006126|Etoposide|etoposide|mesh-list
56280535|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280536|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
56280537|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280538|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931188|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
55904257|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55904258|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55904259|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
55904260|NCT01559675|Prednisolone|prednisolone|mesh-list
55904261|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
55904262|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55904263|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
55904264|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904265|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
55904267|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904268|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904269|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55904270|NCT01559675|Protective Agents|protective agents|mesh-ancestor
55904271|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55904272|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904273|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
55904274|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
55904275|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904276|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55904277|NCT01374906|Pasireotide|pasireotide|mesh-list
55904278|NCT01374906|Hormones|hormones|mesh-ancestor
55904279|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904280|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197866|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56197867|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
56197868|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904281|NCT03228394|Ganaxolone|ganaxolone|mesh-list
55904282|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
55904283|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904284|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904317|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55904319|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
55904320|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
55904321|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55904322|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55904323|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55904324|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55904325|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904327|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55904328|NCT02683746|Incretins|incretins|mesh-ancestor
55904329|NCT02683746|Hormones|hormones|mesh-ancestor
55904330|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904331|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904332|NCT01559129|Pomalidomide|pomalidomide|mesh-list
55904333|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
55904334|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904335|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55904365|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904366|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904367|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55904368|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
55904370|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55904371|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
55904372|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904373|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280539|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56280540|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
56280541|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280542|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280543|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55904374|NCT03114228|Midostaurin|midostaurin|mesh-list
55904375|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904376|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55904377|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904378|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904379|NCT02678286|Meloxicam|meloxicam|mesh-list
55904410|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55904411|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
55904412|NCT04775550|Hormones|hormones|mesh-ancestor
55904413|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904414|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55904415|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904416|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
55904417|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55904418|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55904419|NCT04775550|Growth Substances|growth substances|mesh-ancestor
55904420|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
55904421|NCT02998528|Gemcitabine|gemcitabine|mesh-list
55904422|NCT02998528|Paclitaxel|paclitaxel|mesh-list
55904423|NCT02998528|Vinorelbine|vinorelbine|mesh-list
55904424|NCT02998528|Docetaxel|docetaxel|mesh-list
55904425|NCT02998528|Carboplatin|carboplatin|mesh-list
55904426|NCT02998528|Nivolumab|nivolumab|mesh-list
55904427|NCT02998528|Pemetrexed|pemetrexed|mesh-list
55904452|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904453|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
55904454|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
55904455|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
55904456|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904457|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55904458|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
55904459|NCT02930902|Antiviral Agents|antiviral agents|mesh-ancestor
55904460|NCT02930902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904461|NCT02930902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904462|NCT02930902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904463|NCT02930902|Immunologic Factors|immunologic factors|mesh-ancestor
55904464|NCT02930902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904465|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55904466|NCT02905318|Palbociclib|palbociclib|mesh-list
55904467|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904468|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56197869|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197870|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197871|NCT01510288|Ipilimumab|ipilimumab|mesh-list
56197872|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56197873|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197874|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56197875|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197876|NCT01510366|Vaccines|vaccines|mesh-list
56197877|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
56197878|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197879|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
56197880|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56197881|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
56197882|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197883|NCT01510509|Everolimus|everolimus|mesh-list
56197884|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197885|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197886|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
56197887|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197888|NCT01510522|Metformin|metformin|mesh-list
56197889|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56197890|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197892|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56197893|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56197894|NCT01510561|Gemcitabine|gemcitabine|mesh-list
56280544|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280545|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
56280546|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280547|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56280548|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280549|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280550|NCT00006129|Testosterone|testosterone|mesh-list
56280551|NCT00006129|Androgens|androgens|mesh-ancestor
56280552|NCT00006129|Hormones|hormones|mesh-ancestor
56280553|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280554|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280555|NCT00006132|Acyclovir|acyclovir|mesh-list
56280556|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
56280557|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280558|NCT00006135|Acyclovir|acyclovir|mesh-list
56280559|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
56280560|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280561|NCT00006144|Ritonavir|ritonavir|mesh-list
56280562|NCT00006144|Lopinavir|lopinavir|mesh-list
56280563|NCT00006144|Emtricitabine|emtricitabine|mesh-list
56280564|NCT00006144|Stavudine|stavudine|mesh-list
56280565|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56280566|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56197895|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56197896|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56197897|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56197898|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
55721935|NCT02038257|Petrolatum|petrolatum|mesh-list
55904469|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904470|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904471|NCT02824276|Morphine|morphine|mesh-list
55904472|NCT02824276|Oxycodone|oxycodone|mesh-list
55904473|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55904474|NCT02824276|Narcotics|narcotics|mesh-ancestor
55904475|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904476|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904495|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904497|NCT01541215|Hormones|hormones|mesh-ancestor
55904498|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904499|NCT01585987|Ipilimumab|ipilimumab|mesh-list
55904500|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55904501|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197899|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197901|NCT01510561|Antiviral Agents|antiviral agents|mesh-ancestor
55904502|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55904503|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904504|NCT01585831|Testosterone|testosterone|mesh-list
55904505|NCT01585831|Androgens|androgens|mesh-ancestor
55904506|NCT01585831|Hormones|hormones|mesh-ancestor
55904507|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904508|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904509|NCT01565941|Insulin|insulin|mesh-list
55904510|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55904511|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56280567|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
56280568|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280569|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280570|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55931216|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
55904512|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904513|NCT01558271|Liraglutide|liraglutide|mesh-list
55904514|NCT01558271|Dulaglutide|dulaglutide|mesh-list
55904515|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55904516|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904517|NCT01558271|Incretins|incretins|mesh-ancestor
55904518|NCT01558271|Hormones|hormones|mesh-ancestor
55904519|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904520|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
55904521|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55904522|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55904523|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
55904524|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904525|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904526|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904527|NCT01565707|Urological Agents|urological agents|mesh-ancestor
55904528|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55904529|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55904530|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55904531|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55904532|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904557|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55904558|NCT01556165|Protective Agents|protective agents|mesh-ancestor
55904559|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904560|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
55904561|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
55904562|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
55904563|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904564|NCT01537549|Protective Agents|protective agents|mesh-ancestor
55904565|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904566|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
55904567|NCT01537549|Vitamins|vitamins|mesh-ancestor
55904568|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
55904569|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
55904570|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
55904571|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55904572|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
55904573|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55904575|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55904576|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55904577|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55904578|NCT01583179|Buprenorphine|buprenorphine|mesh-list
55904579|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55742530|NCT05128617|Paclitaxel|paclitaxel|mesh-list
55904580|NCT01583179|Narcotics|narcotics|mesh-ancestor
55904581|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904582|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904583|NCT01583179|Analgesics|analgesics|mesh-ancestor
55904584|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
55904585|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904609|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
55904610|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904611|NCT01555463|Azelaic acid|azelaic acid|mesh-list
55904612|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904613|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
55904614|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
55904615|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56197902|NCT01510561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56197903|NCT01510561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904616|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
55904617|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55904618|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
55904619|NCT01537081|Guaifenesin|guaifenesin|mesh-list
55904620|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
55904621|NCT01537081|Expectorants|expectorants|mesh-ancestor
56280571|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56280572|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
56280573|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280574|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55931221|NCT04196855|Teriparatide|teriparatide|mesh-list
55904622|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
55904623|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55904624|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55904625|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
55904626|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904627|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904628|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904629|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
55904630|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55904631|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
55904632|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
55904633|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904634|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
55904635|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55904636|NCT01555073|Celecoxib|celecoxib|mesh-list
55904637|NCT01555073|Pregabalin|pregabalin|mesh-list
55904638|NCT01555073|Analgesics|analgesics|mesh-ancestor
55904639|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
55904670|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904671|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904672|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55904673|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904674|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55904675|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55904676|NCT01536535|Analgesics|analgesics|mesh-ancestor
55904677|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
55904678|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904679|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904680|NCT01553747|Eluxadoline|eluxadoline|mesh-list
55904681|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55904734|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
55904735|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904736|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55904737|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904738|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904739|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
55904740|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904741|NCT01581307|Antidotes|antidotes|mesh-ancestor
55904742|NCT01581307|Protective Agents|protective agents|mesh-ancestor
55904743|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
55904745|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
55904746|NCT01581307|Hematinics|hematinics|mesh-ancestor
55904747|NCT01580995|Valacyclovir|valacyclovir|mesh-list
55904748|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
55904749|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904750|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55904751|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
55904752|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904753|NCT01562743|Rotigotine|rotigotine|mesh-list
55904754|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
55904755|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
55904756|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904757|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904758|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904759|NCT03028571|Trimethaphan|trimethaphan|mesh-list
55904760|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
55904761|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55904762|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55904763|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
55904764|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
55904765|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904766|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904767|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55904768|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55904769|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
55806134|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
55904770|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904771|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904772|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
55904773|NCT01535443|Bromfenac|bromfenac|mesh-list
55904774|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55904775|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55904776|NCT01535443|Analgesics|analgesics|mesh-ancestor
55904777|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
55904778|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904779|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904780|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904781|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904782|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
55904783|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55904784|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904785|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904810|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55904811|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55904812|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55904813|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904814|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
55904815|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904816|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904817|NCT01546883|Dabigatran|dabigatran|mesh-list
55904818|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
55904819|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55904820|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
55904821|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904822|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904823|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
55904824|NCT01580293|Factor VIII|factor viii|mesh-list
55904825|NCT01580293|Coagulants|coagulants|mesh-ancestor
55904826|NCT01546649|Leuprolide|leuprolide|mesh-list
55904827|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55904828|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
55904829|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55904830|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904831|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55904832|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904833|NCT02985983|Brodalumab|brodalumab|mesh-list
55904834|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
55904835|NCT01544309|Atorvastatin|atorvastatin|mesh-list
55904836|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55904856|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55904857|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55904859|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
55904860|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904861|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904862|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904863|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904864|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55904865|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55904866|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904867|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904868|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
55904869|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
55904870|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55904871|NCT01540565|Veliparib|veliparib|mesh-list
55904872|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55904873|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904874|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904875|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904876|NCT01540487|Metformin|metformin|mesh-list
55904877|NCT01540487|Linagliptin|linagliptin|mesh-list
55904878|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55904879|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904880|NCT01540487|Incretins|incretins|mesh-ancestor
55904881|NCT01540487|Hormones|hormones|mesh-ancestor
55904882|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904883|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55904884|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
55904885|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904886|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904887|NCT01539317|Lidocaine|lidocaine|mesh-list
56280575|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56280576|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56280577|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56280578|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
56280579|NCT00006168|Methotrexate|methotrexate|mesh-list
56280580|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56280581|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
56280582|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55904888|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
55904889|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
56197904|NCT01510561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197905|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
56197906|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197907|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
56197908|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
56197909|NCT01510574|Misoprostol|misoprostol|mesh-list
56197910|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56197911|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
56197912|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56197913|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722194|NCT00890591|Olmesartan|olmesartan|mesh-list
55904890|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904891|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904946|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55904947|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55904948|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55904949|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
55904950|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904951|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904952|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
55904953|NCT02985905|Astringents|astringents|mesh-ancestor
55904954|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904955|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
55904956|NCT01535261|Ranibizumab|ranibizumab|mesh-list
55904957|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55904958|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55904959|NCT01535261|Growth Substances|growth substances|mesh-ancestor
55904960|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904961|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
55904962|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904963|NCT01534637|Gemcitabine|gemcitabine|mesh-list
55904964|NCT01534637|Fluorouracil|fluorouracil|mesh-list
55904965|NCT01534637|Capecitabine|capecitabine|mesh-list
55904966|NCT01534637|Aprepitant|aprepitant|mesh-list
55904967|NCT01534637|Antiemetics|antiemetics|mesh-list
55904968|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55904969|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
55905000|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905002|NCT02570542|Plerixafor|plerixafor|mesh-list
55905003|NCT02570542|Etoposide|etoposide|mesh-list
55905004|NCT02570542|Melphalan|melphalan|mesh-list
55905005|NCT02570542|Carmustine|carmustine|mesh-list
55905006|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55905007|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905008|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55905009|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55905010|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905011|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905012|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905014|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
55905015|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905016|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905017|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
55905018|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905019|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55905020|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
55905021|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56280583|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280584|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280585|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
55905022|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55905023|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55905024|NCT01532687|Gemcitabine|gemcitabine|mesh-list
55905025|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905026|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
55905027|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905028|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905029|NCT01532687|Antiviral Agents|antiviral agents|mesh-ancestor
56197914|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56197915|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197916|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
56197917|NCT01510613|Dexamethasone|dexamethasone|mesh-list
55905030|NCT01532687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905031|NCT01532687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905032|NCT01532687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905033|NCT01532687|Immunologic Factors|immunologic factors|mesh-ancestor
55905034|NCT01532687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905035|NCT02677116|Doxorubicin|doxorubicin|mesh-list
55905036|NCT02677116|Irinotecan|irinotecan|mesh-list
55905037|NCT02677116|Vincristine|vincristine|mesh-list
55905038|NCT02677116|Ifosfamide|ifosfamide|mesh-list
55905039|NCT02677116|Olaratumab|olaratumab|mesh-list
55905040|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55905041|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905061|NCT02681094|Saxagliptin|saxagliptin|mesh-list
55905062|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55905063|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905064|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55905065|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905066|NCT02681094|Incretins|incretins|mesh-ancestor
55905067|NCT02681094|Hormones|hormones|mesh-ancestor
55905068|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905069|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55905070|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
55905071|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905072|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
55905073|NCT03164304|Analgesics|analgesics|mesh-ancestor
55905074|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
55905075|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905076|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905077|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
55905078|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905079|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55905080|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
55905081|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55905082|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55905083|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905084|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55905085|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
55905086|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55905087|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
55905088|NCT02689284|Margetuximab|margetuximab|mesh-list
55905089|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55905090|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55905091|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905092|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
55905093|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905094|NCT03165396|Propofol|propofol|mesh-list
55905095|NCT03165396|Sevoflurane|sevoflurane|mesh-list
55905115|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905116|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
55905117|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905118|NCT03161574|Fluorouracil|fluorouracil|mesh-list
55905119|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
55905120|NCT03161574|Irinotecan|irinotecan|mesh-list
55905121|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
55905122|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905123|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905124|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905125|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280586|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280587|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280588|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
56280589|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280590|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56280591|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280592|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
56280593|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931236|NCT04196231|Insulin|insulin|mesh-list
55905126|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
55905127|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905128|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55905129|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55905130|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905131|NCT05676216|Diphenhydramine|diphenhydramine|mesh-list
55905132|NCT05676216|Promethazine|promethazine|mesh-list
55905133|NCT05676216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55905134|NCT05676216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55905135|NCT05676216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56197918|NCT01510613|Pomalidomide|pomalidomide|mesh-list
56197919|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56197920|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
56197921|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
56197922|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197923|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197924|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197925|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
56197926|NCT01510613|Hormones|hormones|mesh-ancestor
56197927|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197928|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56197929|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197930|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
56197931|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56197932|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56197933|NCT01510613|Growth Substances|growth substances|mesh-ancestor
56197934|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
56197935|NCT01510626|Omalizumab|omalizumab|mesh-list
56197936|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56197937|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55905136|NCT05676216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905137|NCT05676216|Anesthetics, Local|anesthetics, local|mesh-ancestor
55905138|NCT05676216|Anesthetics|anesthetics|mesh-ancestor
55905139|NCT05676216|Sensory System Agents|sensory system agents|mesh-ancestor
55905140|NCT05676216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905141|NCT05676216|Antiemetics|antiemetics|mesh-ancestor
55905142|NCT05676216|Autonomic Agents|autonomic agents|mesh-ancestor
55905143|NCT05676216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55905144|NCT05676216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55905145|NCT05676216|Histamine Antagonists|histamine antagonists|mesh-ancestor
55905146|NCT05676216|Histamine Agents|histamine agents|mesh-ancestor
55905147|NCT05676216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905148|NCT05676216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905149|NCT05676216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55905150|NCT05676216|Antipruritics|antipruritics|mesh-ancestor
55905197|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905198|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905199|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55905200|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
55905201|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905202|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905203|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55905204|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55905206|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55905207|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55905208|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55806135|NCT02336815|Hormones|hormones|mesh-ancestor
56280594|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56280595|NCT00006174|Letrozole|letrozole|mesh-list
56280596|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280597|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56280598|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56280599|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905209|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55905210|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
55905211|NCT04574232|Hormones|hormones|mesh-ancestor
55905212|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905213|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905214|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905215|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
55905216|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197938|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
56197939|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
55905217|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905219|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55905220|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905221|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55905222|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
55905223|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55905224|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
55905225|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905226|NCT04557384|Ramucirumab|ramucirumab|mesh-list
55905227|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905255|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905256|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55905257|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905258|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
55905259|NCT05039736|Nivolumab|nivolumab|mesh-list
55905260|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55905261|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905262|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55905263|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905264|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
55905265|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905266|NCT03163212|Lactoferrin|lactoferrin|mesh-list
55905267|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905268|NCT05007678|Leflunomide|leflunomide|mesh-list
55905269|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905270|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905271|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905272|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
55905273|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905275|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55905276|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
55905297|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55905298|NCT03320070|Hormones|hormones|mesh-ancestor
55905299|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905300|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905301|NCT03306264|Decitabine|decitabine|mesh-list
55905302|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905303|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
55905304|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905305|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905306|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905307|NCT04977336|Acetaminophen|acetaminophen|mesh-list
55905308|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55905309|NCT04977336|Analgesics|analgesics|mesh-ancestor
55905310|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
55905311|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905312|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905313|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
55905314|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
55905315|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55905316|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905317|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55905318|NCT02674854|Latanoprost|latanoprost|mesh-list
56280600|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280601|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56280602|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
55905319|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55905320|NCT04036188|Vitamin D|vitamin d|mesh-list
55905321|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
55905322|NCT04036188|Triamcinolone|triamcinolone|mesh-list
55905323|NCT04036188|Vitamins|vitamins|mesh-ancestor
55905324|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
55905325|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905326|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55905327|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55905328|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55905329|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
55905330|NCT04036188|Hormones|hormones|mesh-ancestor
55905331|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905332|NCT04797780|Azacitidine|azacitidine|mesh-list
55905388|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905389|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905390|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
56197940|NCT01510665|Cathartics|cathartics|mesh-ancestor
56197941|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197942|NCT01510795|Spironolactone|spironolactone|mesh-list
56197943|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56197944|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
56197945|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197946|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197947|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56197948|NCT01510795|Diuretics|diuretics|mesh-ancestor
56197949|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
56197950|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
56197951|NCT01510847|Androgens|androgens|mesh-ancestor
56197952|NCT01510847|Hormones|hormones|mesh-ancestor
56197953|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56197954|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197955|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56197956|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56197957|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197958|NCT01510977|Bisacodyl|bisacodyl|mesh-list
56197959|NCT01510977|Cathartics|cathartics|mesh-ancestor
56197960|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56197961|NCT01510977|Laxatives|laxatives|mesh-ancestor
56197962|NCT01510990|Gefitinib|gefitinib|mesh-list
56197963|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197964|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56197965|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197966|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197967|NCT01511003|Tacrolimus|tacrolimus|mesh-list
56197968|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56197969|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
56197970|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197971|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56197972|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197973|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197974|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
56197981|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197982|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197984|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
56197985|NCT01511029|Protective Agents|protective agents|mesh-ancestor
56197986|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56197987|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56197988|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
56197989|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
56197990|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56197991|NCT01511146|Gemcitabine|gemcitabine|mesh-list
56197992|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
56197993|NCT01511146|Mitomycins|mitomycins|mesh-list
56197994|NCT01511146|Mitomycin|mitomycin|mesh-list
55905391|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
55905392|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905393|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905394|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280603|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280604|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280605|NCT00006180|Alendronate|alendronate|mesh-list
55902588|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56280606|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56280607|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280609|NCT00006195|Risperidone|risperidone|mesh-list
55905395|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
55905396|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
55905397|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
55905398|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55905399|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55905400|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55905401|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55905402|NCT01531673|Ivacaftor|ivacaftor|mesh-list
55905403|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55905404|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55905405|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905406|NCT01531205|Leuprolide|leuprolide|mesh-list
55905407|NCT01531205|Goserelin|goserelin|mesh-list
55905408|NCT01531205|Bicalutamide|bicalutamide|mesh-list
55905409|NCT01531205|Androgens|androgens|mesh-list
55905410|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55905427|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905428|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905430|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55905431|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55905432|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905433|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905434|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55905435|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55905436|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
55905437|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905438|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55905439|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55905440|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55905441|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55905442|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55905443|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55905444|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55905446|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
55905447|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
55905448|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55905449|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55905450|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
55905451|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
55905452|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55905453|NCT01529645|Vaccines|vaccines|mesh-list
55905454|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
55905455|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905457|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55905458|NCT01528709|Atorvastatin|atorvastatin|mesh-list
55905459|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56197995|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56197996|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
56197997|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197998|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56197999|NCT01511146|Antiviral Agents|antiviral agents|mesh-ancestor
56198000|NCT01511146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198001|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198002|NCT01511146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56198003|NCT01511146|Immunologic Factors|immunologic factors|mesh-ancestor
56198004|NCT01511146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722554|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
55905460|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55905461|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
55806301|NCT05490407|Carboplatin|carboplatin|mesh-list
56280610|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56280611|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
56280612|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56280613|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280614|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905462|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905463|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55905464|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55905465|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905466|NCT01527383|Vaccines|vaccines|mesh-list
55905467|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
55905468|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905469|NCT01527149|Cytarabine|cytarabine|mesh-list
55905470|NCT01527149|Dexamethasone|dexamethasone|mesh-list
55905543|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905545|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55905546|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
55905547|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55905548|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905549|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55905550|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55905551|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55905552|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
55905553|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905554|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55905555|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55905556|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905558|NCT00264381|Tinzaparin|tinzaparin|mesh-list
55905559|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55905560|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
55905561|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55905562|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55905563|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905564|NCT00246441|Paroxetine|paroxetine|mesh-list
55905565|NCT00246441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55905566|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55905567|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55905568|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905569|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905570|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
55905571|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905597|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905598|NCT00248547|Dexamethasone|dexamethasone|mesh-list
55905599|NCT00248547|Ondansetron|ondansetron|mesh-list
55905600|NCT00248547|Aprepitant|aprepitant|mesh-list
55905601|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55905602|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
55905603|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
55905604|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905605|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905606|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55905607|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
55905608|NCT00248547|Hormones|hormones|mesh-ancestor
55905609|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905610|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56198005|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56198006|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
56198007|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56198008|NCT01511159|Insulin|insulin|mesh-list
56198009|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56198010|NCT01511159|Liraglutide|liraglutide|mesh-list
56198011|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56198013|NCT01511159|Incretins|incretins|mesh-ancestor
56198014|NCT01511159|Hormones|hormones|mesh-ancestor
56198015|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198016|NCT01511172|Metformin|metformin|mesh-list
56198017|NCT01511172|Liraglutide|liraglutide|mesh-list
56198018|NCT01511172|Glimepiride|glimepiride|mesh-list
56198019|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56280615|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56280616|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56280617|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56280618|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56280619|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56280620|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
56198020|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198021|NCT01511172|Incretins|incretins|mesh-ancestor
56198022|NCT01511172|Hormones|hormones|mesh-ancestor
55905611|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905612|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
55905613|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
55905614|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55905615|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
55905616|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905617|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905618|NCT00248547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55905619|NCT00248547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55905644|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55905645|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55905646|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
55905647|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905648|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55905649|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55905650|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905651|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55905652|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
55905653|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55905654|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
55905655|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905656|NCT00125931|Pentazocine|pentazocine|mesh-list
55905657|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55905658|NCT00125931|Narcotics|narcotics|mesh-ancestor
55905659|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905660|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905661|NCT00125931|Analgesics|analgesics|mesh-ancestor
55905662|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
55905663|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905664|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55905665|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55905666|NCT00267111|Tetracaine|tetracaine|mesh-list
55905667|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
55905668|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
55905669|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905670|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905671|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
55905672|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905673|NCT01521923|Methotrexate|methotrexate|mesh-list
55905674|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
55905675|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56198023|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198024|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55905676|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
55905677|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55905678|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905679|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905680|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
55905681|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905682|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905683|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
55905684|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905685|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55905686|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905687|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
55905688|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55742624|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
55905689|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55905690|NCT05240781|Sirolimus|sirolimus|mesh-list
55905691|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56280621|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
56280622|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
56280623|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280624|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56280625|NCT00006195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56280626|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56280627|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56280628|NCT00006198|Thalidomide|thalidomide|mesh-list
56280629|NCT00006198|Doxorubicin|doxorubicin|mesh-list
56280630|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56280631|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280632|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56280633|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280634|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280635|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280636|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280637|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
56280638|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280639|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
56280640|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56280641|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280642|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56280643|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56280644|NCT00006198|Growth Substances|growth substances|mesh-ancestor
56280645|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
56280646|NCT00006204|Naltrexone|naltrexone|mesh-list
56280647|NCT00006204|Fluoxetine|fluoxetine|mesh-list
56280648|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56280649|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56280650|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280651|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
56280652|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905733|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55905734|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55905735|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905736|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55905737|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55905738|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905740|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
55905741|NCT01535053|Leucovorin|leucovorin|mesh-list
55905742|NCT01535053|Folic Acid|folic acid|mesh-list
55905743|NCT01535053|Dactinomycin|dactinomycin|mesh-list
55905744|NCT01535053|Methotrexate|methotrexate|mesh-list
55905745|NCT01535053|Calcium|calcium|mesh-list
56280653|NCT00006204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56280654|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56280655|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56280656|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280657|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56280658|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
55902683|NCT02395926|Choline|choline|mesh-list
56280718|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
56280719|NCT00006240|Dexamethasone|dexamethasone|mesh-list
56280720|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56280721|NCT00006240|Sargramostim|sargramostim|mesh-list
56280722|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56280723|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
56280724|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
56280725|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280726|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280727|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56280728|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
56280729|NCT00006240|Hormones|hormones|mesh-ancestor
56280731|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56280783|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
56280784|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280785|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280786|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56280787|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56280788|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
56280789|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56280790|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280791|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
56280792|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
56280793|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280794|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56280795|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56280796|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280797|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56280798|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280799|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
56280800|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
56280801|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
56280802|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
56280803|NCT00006261|Docetaxel|docetaxel|mesh-list
56280804|NCT00006261|Doxorubicin|doxorubicin|mesh-list
56280805|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56280806|NCT00006261|Fludarabine|fludarabine|mesh-list
56280807|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
56280825|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
56280833|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56280834|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280835|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
56280836|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56280837|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56280838|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56280839|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280840|NCT00006267|Rubitecan|rubitecan|mesh-list
56280841|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280842|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56280843|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280844|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280845|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280846|NCT00006270|Cosyntropin|cosyntropin|mesh-list
56280847|NCT00006270|Metyrapone|metyrapone|mesh-list
56280848|NCT00006270|Hormones|hormones|mesh-ancestor
56280849|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280850|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280851|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
56280852|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280853|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280854|NCT00006276|Paclitaxel|paclitaxel|mesh-list
56280855|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280856|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280885|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280886|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56280887|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280888|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
56280889|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56280890|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
56280891|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280892|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56280893|NCT00006294|Protective Agents|protective agents|mesh-ancestor
56280894|NCT00006294|Diuretics|diuretics|mesh-ancestor
56280895|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
56160127|NCT03598842|Albendazole|albendazole|mesh-list
56280896|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56280897|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56280898|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56280899|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56280900|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
56280901|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56280902|NCT00005818|Irinotecan|irinotecan|mesh-list
56280903|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56280904|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280905|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280906|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280907|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280909|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
56280932|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
56280933|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280934|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280935|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56280936|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
56280937|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280938|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280939|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56280940|NCT00005827|Genistein|genistein|mesh-list
56280941|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56280942|NCT00005827|Protective Agents|protective agents|mesh-ancestor
56280943|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280944|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280945|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56280946|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280947|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280948|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
56280949|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56280950|NCT00005827|Estrogens|estrogens|mesh-ancestor
56280951|NCT00005827|Hormones|hormones|mesh-ancestor
56280952|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280953|NCT00005830|Doxorubicin|doxorubicin|mesh-list
56280954|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56280955|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280956|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56280957|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56280958|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56280959|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280960|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280961|NCT00005833|Tipifarnib|tipifarnib|mesh-list
56280962|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280963|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
56280964|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280973|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
56280974|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280975|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
56280976|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280977|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280978|NCT00005842|Trastuzumab|trastuzumab|mesh-list
55902965|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
56280979|NCT00005842|Tipifarnib|tipifarnib|mesh-list
56280980|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280981|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280982|NCT00005845|Tipifarnib|tipifarnib|mesh-list
56280983|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280984|NCT00005848|Tipifarnib|tipifarnib|mesh-list
56280985|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280986|NCT00005851|Cyclosporine|cyclosporine|mesh-list
56280987|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
56280988|NCT00005851|Fludarabine|fludarabine|mesh-list
56280989|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
56280990|NCT00005851|Cyclosporins|cyclosporins|mesh-list
56280991|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280992|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280993|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
56280994|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280995|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281008|NCT00005854|Cyclosporine|cyclosporine|mesh-list
55931317|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55931318|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
55931319|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931320|NCT04194515|Metformin|metformin|mesh-list
55931321|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55931322|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931323|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56281024|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281025|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
56281026|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
56281027|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281083|NCT00005866|Cyclosporins|cyclosporins|mesh-list
56281084|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281085|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
56281086|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281087|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281088|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281089|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
56281090|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281091|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281092|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56281093|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56281094|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
56281095|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56281096|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281097|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
56281098|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
56281099|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281140|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56281141|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56281144|NCT00005884|Eflornithine|eflornithine|mesh-list
56281213|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56281214|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281215|NCT00006345|Dexamethasone|dexamethasone|mesh-list
56281216|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
56281217|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56281218|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
56281283|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281284|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281285|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281286|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281287|NCT00005941|Cyclosporine|cyclosporine|mesh-list
56281288|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
56281289|NCT00005941|Fludarabine|fludarabine|mesh-list
56281290|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
56281291|NCT00005941|Cyclosporins|cyclosporins|mesh-list
56281292|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281293|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281294|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
56281347|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
56281348|NCT00005959|Rituximab|rituximab|mesh-list
56281349|NCT00005959|Doxorubicin|doxorubicin|mesh-list
56281350|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56281351|NCT00005959|Vincristine|vincristine|mesh-list
56281352|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281353|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
56281354|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281355|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281356|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281414|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281415|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281416|NCT00387777|Buprenorphine|buprenorphine|mesh-list
56281417|NCT00387777|Analgesics|analgesics|mesh-list
56281418|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56281419|NCT00387777|Narcotics|narcotics|mesh-ancestor
56281420|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56281421|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281422|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
56281423|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281480|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
56281481|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56281482|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281483|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281484|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
56281485|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281486|NCT00005977|Antidotes|antidotes|mesh-ancestor
56281487|NCT00005977|Protective Agents|protective agents|mesh-ancestor
56281488|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
56281489|NCT00005977|Vitamins|vitamins|mesh-ancestor
56281490|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
56281547|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281548|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281549|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
56281550|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
56281551|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281552|NCT00005998|Analgesics|analgesics|mesh-ancestor
56281553|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
56281554|NCT00006351|Gemcitabine|gemcitabine|mesh-list
56281555|NCT00006351|Lonafarnib|lonafarnib|mesh-list
56281556|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281557|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
56281558|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281559|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281560|NCT00006351|Antiviral Agents|antiviral agents|mesh-ancestor
56281609|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281610|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
56281611|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281612|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281613|NCT00006010|Antiviral Agents|antiviral agents|mesh-ancestor
56281614|NCT00006010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281615|NCT00006010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281616|NCT00006010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281617|NCT00006010|Immunologic Factors|immunologic factors|mesh-ancestor
56281618|NCT00006010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281619|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
56281673|NCT00006025|Irinotecan|irinotecan|mesh-list
56281674|NCT00006025|Temozolomide|temozolomide|mesh-list
56281675|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56281676|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281677|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281678|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281679|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281680|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56281681|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
56281682|NCT00386659|Ritonavir|ritonavir|mesh-list
56281683|NCT00386659|Lopinavir|lopinavir|mesh-list
56281684|NCT00386659|Tenofovir|tenofovir|mesh-list
56281685|NCT00386659|Abacavir|abacavir|mesh-list
56281686|NCT00386659|Efavirenz|efavirenz|mesh-list
56281687|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
56281688|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56281689|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56281690|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
56281691|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281730|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281731|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281732|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281733|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281734|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281735|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281737|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
56281738|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281739|NCT00006037|Fluorouracil|fluorouracil|mesh-list
56281740|NCT00006037|Irinotecan|irinotecan|mesh-list
56281741|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
56281742|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281743|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281744|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281745|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281790|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56281791|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56281792|NCT05680870|Omeprazole|omeprazole|mesh-list
56281793|NCT05680870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56281794|NCT05680870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56281795|NCT05680870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56281796|NCT05680870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281797|NCT05680870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281798|NCT00006366|Fluorouracil|fluorouracil|mesh-list
56281799|NCT00006366|Irinotecan|irinotecan|mesh-list
56281800|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
56281801|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281802|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56281803|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281804|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281805|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
56281806|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281807|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56281808|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281809|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281810|NCT05680792|Ritonavir|ritonavir|mesh-list
55903790|NCT02680054|Insulin|insulin|mesh-list
56281811|NCT05680792|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56281812|NCT05680792|Nitazoxanide|nitazoxanide|mesh-list
56281813|NCT05680792|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56281814|NCT05680792|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56281815|NCT05680792|Protease Inhibitors|protease inhibitors|mesh-ancestor
56281816|NCT05680792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281818|NCT05680792|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56281836|NCT00006372|Antiviral Agents|antiviral agents|mesh-ancestor
56281837|NCT00006372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281838|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281839|NCT00006372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56281840|NCT00006372|Immunologic Factors|immunologic factors|mesh-ancestor
56281841|NCT00006372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281842|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56281843|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56281844|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56281845|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281846|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
56281847|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
56281848|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
56281849|NCT00006378|Paclitaxel|paclitaxel|mesh-list
56281850|NCT00006378|Carboplatin|carboplatin|mesh-list
56281851|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56281852|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281853|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
56281854|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
56281855|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
56281856|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281857|NCT00006381|Celecoxib|celecoxib|mesh-list
56281858|NCT00006381|Trastuzumab|trastuzumab|mesh-list
56281859|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56281860|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281861|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56281862|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56281863|NCT00006381|Analgesics|analgesics|mesh-ancestor
56281864|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
56281865|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56281866|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281867|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56281868|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56281877|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281878|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
56281879|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56281880|NCT00386815|Pemetrexed|pemetrexed|mesh-list
56281881|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56281882|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281883|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56281884|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56281885|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56281886|NCT05679388|Ritonavir|ritonavir|mesh-list
56281887|NCT05679388|Itraconazole|itraconazole|mesh-list
56281888|NCT05679388|Relugolix|relugolix|mesh-list
56281889|NCT05679388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56281890|NCT05679388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56281891|NCT05679388|Protease Inhibitors|protease inhibitors|mesh-ancestor
56281892|NCT05679388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56281894|NCT05679388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56281935|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56281936|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56281937|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56281938|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56281939|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56281940|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
56281941|NCT03996148|Remifentanil|remifentanil|mesh-list
56281942|NCT03996148|Propofol|propofol|mesh-list
56281943|NCT03996148|Desflurane|desflurane|mesh-list
56282004|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282005|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56282006|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56282007|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
56282008|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56282010|NCT05546320|Aspirin|aspirin|mesh-list
56282072|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
56282073|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282074|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56282075|NCT05413018|Azacitidine|azacitidine|mesh-list
56282077|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282078|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
56282079|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282080|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282081|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282082|NCT05401786|Ipilimumab|ipilimumab|mesh-list
56282083|NCT05401786|Cemiplimab|cemiplimab|mesh-list
56282084|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282135|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
56282136|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282137|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56282138|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56282139|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
56282140|NCT05147233|Dexamethasone|dexamethasone|mesh-list
56282141|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56282142|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
56282143|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
56282144|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282145|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282200|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
56282201|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282202|NCT00388011|Morphine|morphine|mesh-list
56282203|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56282204|NCT00388011|Narcotics|narcotics|mesh-ancestor
56282205|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56282206|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282207|NCT00388011|Analgesics|analgesics|mesh-ancestor
56282208|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
56282209|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282266|NCT00006468|Calcium|calcium|mesh-list
56282267|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
56282268|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56282269|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282270|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
56282271|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282272|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282273|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282274|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282275|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
56282276|NCT00006468|Antidotes|antidotes|mesh-ancestor
56282277|NCT00006468|Protective Agents|protective agents|mesh-ancestor
56282278|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
56282279|NCT00006468|Vitamins|vitamins|mesh-ancestor
56282280|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
56282281|NCT04513522|Nivolumab|nivolumab|mesh-list
56282282|NCT04513522|Ipilimumab|ipilimumab|mesh-list
56282283|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282284|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282285|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56282299|NCT04355572|Vitamin D|vitamin d|mesh-list
56282321|NCT04192435|Coagulants|coagulants|mesh-ancestor
56282322|NCT04191187|Fludarabine|fludarabine|mesh-list
56282323|NCT04191187|Melphalan|melphalan|mesh-list
56282324|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282325|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282326|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282327|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
56282328|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282329|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56282330|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
56282331|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56282332|NCT04164199|Capecitabine|capecitabine|mesh-list
56282333|NCT04164199|Pemetrexed|pemetrexed|mesh-list
56282334|NCT04164199|Temozolomide|temozolomide|mesh-list
56282335|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282336|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
56282337|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282338|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282378|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282379|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
56282380|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282381|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
56282382|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282383|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56282384|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282385|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282386|NCT03352765|Rituximab|rituximab|mesh-list
56282387|NCT03352765|Melphalan|melphalan|mesh-list
56282388|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56282389|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282390|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282391|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
56282392|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282393|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282394|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56282395|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
56282433|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282434|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282435|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56282436|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282437|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56282503|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56282504|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282505|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282506|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
56282507|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282508|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56282509|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56282510|NCT00006591|Ritonavir|ritonavir|mesh-list
56282511|NCT00006591|Amprenavir|amprenavir|mesh-list
56282512|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56282513|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56282527|NCT00006630|Antibodies|antibodies|mesh-list
56282568|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282569|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282580|NCT00006747|Cytarabine|cytarabine|mesh-list
56282643|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56282644|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282645|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282646|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282647|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56282649|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282650|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56282651|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56282652|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
56282711|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
56282712|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
56282713|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023000|NCT00583700|Vitamin E|vitamin e|mesh-list
56282714|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56282715|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282716|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
56282717|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282718|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56282719|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282720|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282722|NCT00006055|Prednisone|prednisone|mesh-list
56282723|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
56282724|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
56282772|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282773|NCT00006082|Rubitecan|rubitecan|mesh-list
56282774|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282775|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56282776|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56282777|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282778|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282779|NCT00006088|Vinorelbine|vinorelbine|mesh-list
56282843|NCT00006112|Mitomycins|mitomycins|mesh-list
56282844|NCT00006112|Mitomycin|mitomycin|mesh-list
56282845|NCT00006112|Calcium|calcium|mesh-list
56282846|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
56282847|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56282848|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282849|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
56282850|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282851|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56282852|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282853|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56282854|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
56282855|NCT00006112|Antidotes|antidotes|mesh-ancestor
56282856|NCT00006112|Protective Agents|protective agents|mesh-ancestor
56282857|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
56282858|NCT00006112|Vitamins|vitamins|mesh-ancestor
56282859|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
56282860|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56282861|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
56282903|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56282904|NCT00006124|Celecoxib|celecoxib|mesh-list
56282905|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56282906|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56282907|NCT00006124|Analgesics|analgesics|mesh-ancestor
56282908|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
56282909|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56282910|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56282911|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56282912|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56282913|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56282914|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56282915|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282916|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282917|NCT00006127|Amifostine|amifostine|mesh-list
56282918|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56282919|NCT00006127|Protective Agents|protective agents|mesh-ancestor
56282921|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56282960|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
56282961|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56282962|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56282963|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56282964|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56282965|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
56282966|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56282967|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56283026|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
56283027|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
56283028|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283029|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283030|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283031|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
56283032|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
56283033|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56283034|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
56283035|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283036|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283045|NCT00006208|Efavirenz|efavirenz|mesh-list
56283089|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56283090|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
56283091|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283092|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56283093|NCT00006223|Protective Agents|protective agents|mesh-ancestor
56283094|NCT03761953|Oritavancin|oritavancin|mesh-list
56283095|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56283096|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283097|NCT00006226|Thalidomide|thalidomide|mesh-list
56283098|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283099|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
56283100|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283101|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
56283102|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56283152|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56283153|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
56283154|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283156|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56283157|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56283158|NCT00006247|Growth Substances|growth substances|mesh-ancestor
56283159|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283160|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
56283161|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283162|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56283163|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283164|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283165|NCT00006250|Dexamethasone|dexamethasone|mesh-list
56283166|NCT00006250|Fludarabine|fludarabine|mesh-list
56283167|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
56283168|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
56283193|NCT00006265|Cytarabine|cytarabine|mesh-list
56283213|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283214|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56283215|NCT00006280|Tobramycin|tobramycin|mesh-list
56283216|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56283217|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283218|NCT00006286|Fluoxetine|fluoxetine|mesh-list
56283219|NCT00006286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56283220|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56283221|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56283222|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283223|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283273|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56283274|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56283275|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
56283276|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56283279|NCT00007683|Aspirin|aspirin|mesh-list
56283345|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283346|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283347|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283348|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283349|NCT03616717|Modafinil|modafinil|mesh-list
56283350|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56283351|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283352|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56283353|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56283354|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56283355|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283356|NCT00006349|Vitamin E|vitamin e|mesh-list
56283357|NCT00006349|Donepezil|donepezil|mesh-list
56283358|NCT00006349|Vitamins|vitamins|mesh-ancestor
56283359|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
56283360|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283361|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56283362|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283402|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
56283403|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283404|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
56283405|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56283406|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283407|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56283408|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56283409|NCT00006358|Growth Substances|growth substances|mesh-ancestor
56283410|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
56283411|NCT00006361|Semaxinib|semaxinib|mesh-list
56283412|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56283413|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56283414|NCT00006361|Growth Substances|growth substances|mesh-ancestor
56283415|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283416|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
56283417|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283418|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56283419|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283420|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283421|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
56283422|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283423|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283424|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56283425|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283426|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283451|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283452|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
56283453|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283454|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
56283455|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283456|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56283457|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56283458|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283459|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283460|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283461|NCT00006370|Edotreotide|edotreotide|mesh-list
56283462|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56283463|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283464|NCT00007956|Antibodies|antibodies|mesh-list
56283465|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56283466|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
56283467|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283468|NCT00006373|Etoposide|etoposide|mesh-list
56283469|NCT00006373|Topotecan|topotecan|mesh-list
56283470|NCT00006373|Ifosfamide|ifosfamide|mesh-list
56283471|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283472|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283473|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283474|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283475|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905445|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56283476|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283477|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56283478|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283479|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
56283481|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283482|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
55905746|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
55905747|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55905748|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905749|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55905750|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55905752|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55905753|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905754|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
55905755|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905756|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283483|NCT00006379|Fludarabine|fludarabine|mesh-list
56283484|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
56283485|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56283486|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283487|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
56283488|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283489|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56283490|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283491|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
56283492|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283493|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283494|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56283495|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283496|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
56283497|NCT00006385|Interferons|interferons|mesh-list
56283498|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
56283499|NCT00006385|Sargramostim|sargramostim|mesh-list
56283500|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
56283501|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283502|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
56283503|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283504|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
56283505|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283506|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56283507|NCT00007995|Interferons|interferons|mesh-list
56283508|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
56283533|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56283534|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
56283535|NCT00008034|Capecitabine|capecitabine|mesh-list
56283536|NCT00008034|Epirubicin|epirubicin|mesh-list
56283537|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283538|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
56283539|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283540|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56283541|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283542|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
56283543|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283544|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283545|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56283546|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283548|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56283549|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56283550|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56283551|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283552|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
56283553|NCT00006391|Topotecan|topotecan|mesh-list
56283554|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283555|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56283557|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283586|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56283587|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56283588|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
56283589|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56283590|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56283591|NCT00006412|Fenofibrate|fenofibrate|mesh-list
56283592|NCT00006412|Pravastatin|pravastatin|mesh-list
56283593|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56283594|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
56283595|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283596|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56283597|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56283598|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56283599|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283600|NCT00008112|Cisplatin|cisplatin|mesh-list
56283602|NCT00006427|Amitriptyline|amitriptyline|mesh-list
56283645|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56283646|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56283647|NCT00006448|Methadone|methadone|mesh-list
56283648|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56283649|NCT00006448|Narcotics|narcotics|mesh-ancestor
56283650|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56283651|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283652|NCT00006448|Analgesics|analgesics|mesh-ancestor
56283653|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
56283654|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283655|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
56283656|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
56283657|NCT00008190|Aldesleukin|aldesleukin|mesh-list
56283658|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
56283659|NCT00008190|Melphalan|melphalan|mesh-list
56283660|NCT00008190|Busulfan|busulfan|mesh-list
56283661|NCT00008190|Etoposide|etoposide|mesh-list
56283662|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283663|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
56283664|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283665|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56283666|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283667|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
56283675|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56283698|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
56283699|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
56283700|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283701|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56283702|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56283703|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
56283704|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56283705|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56071626|NCT02034578|Apixaban|apixaban|mesh-list
56283706|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56283707|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
56283708|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
56283709|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283710|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283711|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
56283713|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56283714|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56283715|NCT00006451|Protective Agents|protective agents|mesh-ancestor
56283716|NCT00006454|Paclitaxel|paclitaxel|mesh-list
56283717|NCT00006454|Carboplatin|carboplatin|mesh-list
56283718|NCT00006454|Topotecan|topotecan|mesh-list
56283719|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283720|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283721|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
56283722|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
56283723|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
56283725|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56283748|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56283749|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56283750|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283751|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283752|NCT00008268|Melphalan|melphalan|mesh-list
56283753|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
56283754|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283755|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56283756|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
56283757|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283814|NCT00006472|Fluorouracil|fluorouracil|mesh-list
56283815|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283816|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283817|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56283818|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56283819|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56283820|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283821|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
56283822|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56283823|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56283824|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
56283825|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283826|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
56283827|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283828|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56283829|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56283831|NCT00008424|Irinotecan|irinotecan|mesh-list
56283873|NCT00006682|Vinorelbine|vinorelbine|mesh-list
56283874|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283875|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
56283876|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
56283877|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
56283878|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283879|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283880|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
56283881|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283882|NCT00006760|Vinorelbine|vinorelbine|mesh-list
56283883|NCT00006760|Ifosfamide|ifosfamide|mesh-list
56283884|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56283885|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56283886|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
56283887|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
56283888|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
56283891|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
56283930|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
56283931|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56283932|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56283933|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56283934|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56283935|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
56283936|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56283937|NCT00388401|Alvimopan|alvimopan|mesh-list
56283938|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283939|NCT00007189|Celecoxib|celecoxib|mesh-list
56283940|NCT00007189|Naproxen|naproxen|mesh-list
56283941|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56283942|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56283994|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56283995|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56283996|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56283997|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56283998|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56283999|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56284000|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56284001|NCT00007774|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56284002|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56284003|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56284004|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284005|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284006|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
56284007|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56284008|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
56284009|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56284010|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
56284011|NCT00007813|Carboplatin|carboplatin|mesh-list
56284012|NCT00007813|Etoposide|etoposide|mesh-list
56284013|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56284014|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
56284015|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284046|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56284047|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
56284048|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56284049|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56284050|NCT00007891|Antibodies|antibodies|mesh-list
56284051|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
56284052|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56284053|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
56284054|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284056|NCT00007969|Verteporfin|verteporfin|mesh-list
56284057|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
56284058|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56284059|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
56284060|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56284061|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
56284062|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284063|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
56284064|NCT00008008|Thiotepa|thiotepa|mesh-list
56284065|NCT00008008|Sargramostim|sargramostim|mesh-list
56284066|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56284067|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
56284068|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284069|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56284070|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56284071|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
56284072|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284073|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284074|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56284075|NCT00008047|Paclitaxel|paclitaxel|mesh-list
56284076|NCT00008047|Fluorouracil|fluorouracil|mesh-list
56284077|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
56284093|NCT00008086|Carboplatin|carboplatin|mesh-list
56284094|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284095|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56284096|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284097|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56284098|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56284099|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284100|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56284101|NCT00008086|Vitamins|vitamins|mesh-ancestor
56284102|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
56284103|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56284104|NCT00008125|Gemcitabine|gemcitabine|mesh-list
56284105|NCT00008125|Carboplatin|carboplatin|mesh-list
56284106|NCT00008125|Docetaxel|docetaxel|mesh-list
56284107|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284108|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56284109|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
56284110|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284111|NCT00008125|Antiviral Agents|antiviral agents|mesh-ancestor
56284120|NCT00008203|Interferons|interferons|mesh-list
56284151|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
56284152|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284153|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284154|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56284155|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
56284156|NCT00008242|Hormones|hormones|mesh-ancestor
56284157|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906128|NCT01519817|Vaccines|vaccines|mesh-list
56284158|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56284159|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284160|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56284161|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56284162|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56284163|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284164|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284165|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56284166|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
56284167|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
56284168|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56284169|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284170|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56284171|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56284172|NCT00008242|Growth Substances|growth substances|mesh-ancestor
56284173|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56284174|NCT00008281|Leucovorin|leucovorin|mesh-list
56284201|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284202|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284203|NCT00008398|Sargramostim|sargramostim|mesh-list
56284204|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
56284205|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284206|NCT00008476|Capsaicin|capsaicin|mesh-list
56284207|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
56284208|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
56284209|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
56284210|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284211|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284212|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56284213|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56284214|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
56284215|NCT00008515|Hormones|hormones|mesh-ancestor
56284216|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284217|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284218|NCT00008554|Lamivudine|lamivudine|mesh-list
56284257|NCT05637073|Dienogest|dienogest|mesh-list
56284258|NCT05637073|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56284259|NCT05637073|Contraceptive Agents|contraceptive agents|mesh-ancestor
56284260|NCT05637073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56284261|NCT05637073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284262|NCT05637073|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56284263|NCT05637073|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56284264|NCT05637073|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56284265|NCT05637073|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56284266|NCT05637073|Hormone Antagonists|hormone antagonists|mesh-ancestor
56284267|NCT05637073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284268|NCT05637073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56284269|NCT05637073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284270|NCT05637268|Paclitaxel|paclitaxel|mesh-list
56284271|NCT05637268|Cisplatin|cisplatin|mesh-list
56284272|NCT05637268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56284273|NCT05637268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284274|NCT05637268|Tubulin Modulators|tubulin modulators|mesh-ancestor
56284275|NCT05637268|Antimitotic Agents|antimitotic agents|mesh-ancestor
56284276|NCT05637268|Mitosis Modulators|mitosis modulators|mesh-ancestor
56284277|NCT05637268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284278|NCT05637216|Losartan|losartan|mesh-list
56284279|NCT05637216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56284280|NCT05637216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56284281|NCT05637216|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56284282|NCT05637216|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56284284|NCT05638087|Dexamethasone|dexamethasone|mesh-list
56284303|NCT05638633|Corticosterone|corticosterone|mesh-list
56284304|NCT05638633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56284305|NCT05638633|Prednisolone phosphate|prednisolone phosphate|mesh-list
56284306|NCT05638633|Micronutrients|micronutrients|mesh-ancestor
56284307|NCT05638633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284308|NCT05638633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56284309|NCT05638633|Glucocorticoids|glucocorticoids|mesh-ancestor
56284310|NCT05638633|Hormones|hormones|mesh-ancestor
56284311|NCT05638633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284312|NCT05638633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56284313|NCT05638633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284314|NCT05638633|Antiemetics|antiemetics|mesh-ancestor
56284315|NCT05638633|Autonomic Agents|autonomic agents|mesh-ancestor
56284316|NCT05638633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284317|NCT05638633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56284318|NCT05638633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56284362|NCT05639257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56284363|NCT05639257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56284364|NCT05639257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56284365|NCT05639257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56284366|NCT05639257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56284367|NCT05639257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56284368|NCT05639257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56284397|NCT00000145|Zinc|zinc|mesh-list
56284430|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56284431|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284432|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56284433|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56284434|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284435|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
56284436|NCT00000172|Galantamine|galantamine|mesh-list
56284498|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284499|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56284500|NCT00000256|Analgesics|analgesics|mesh-ancestor
56284501|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
56284502|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284503|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
56284566|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56284567|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56284568|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56284569|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56284638|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56284639|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
56284640|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284641|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284642|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284643|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56284644|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56284645|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
56284706|NCT00000520|Antibodies|antibodies|mesh-list
56284707|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
56284708|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56284709|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56284710|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56284711|NCT00000520|Analgesics|analgesics|mesh-ancestor
56284712|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
56284713|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284714|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284715|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56284716|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56284717|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56284718|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56284721|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56284771|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
56284772|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56284773|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56284774|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284775|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284776|NCT00000556|Protective Agents|protective agents|mesh-ancestor
56284777|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284778|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
56284779|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56284780|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56284781|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56284782|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56284783|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56284784|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56284785|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56284786|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56284787|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56284788|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56284789|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56284790|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56284791|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56284792|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
56284793|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
56284794|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56284795|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56284796|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55905757|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
55905758|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905759|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55905760|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905761|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
55905762|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55905763|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55905764|NCT01535053|Antidotes|antidotes|mesh-ancestor
55905765|NCT01535053|Protective Agents|protective agents|mesh-ancestor
55905766|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
55905767|NCT01535053|Vitamins|vitamins|mesh-ancestor
55905768|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
55905796|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
55905797|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55905798|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905799|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905800|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
55905801|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905802|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905803|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
56284797|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
56284798|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56284799|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56284800|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284801|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56284802|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56284803|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
56284804|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56284805|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
56284806|NCT00000559|Hormones|hormones|mesh-list
56284807|NCT00000559|Estradiol|estradiol|mesh-list
56284808|NCT00000559|Estrogens|estrogens|mesh-list
56284809|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56284810|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284811|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56284812|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
56284813|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56284814|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56284816|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56284854|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284855|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56284856|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284857|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284858|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
56284859|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284860|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56284861|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56284862|NCT00000637|Zidovudine|zidovudine|mesh-list
56284863|NCT00000637|Didanosine|didanosine|mesh-list
56284864|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
56284865|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284869|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
56284918|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56284919|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56284920|NCT00000646|Protective Agents|protective agents|mesh-ancestor
56284921|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56284940|NCT00000652|Zidovudine|zidovudine|mesh-list
56284987|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284988|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56284989|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56284990|NCT00000688|Ganciclovir|ganciclovir|mesh-list
56284991|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56284992|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
56284993|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56284994|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56284995|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56284996|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56284997|NCT00000712|Zidovudine|zidovudine|mesh-list
56284998|NCT00000712|Acyclovir|acyclovir|mesh-list
56284999|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
56285000|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285001|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285002|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285003|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285004|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
56285005|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285044|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285045|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285046|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
56285047|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285048|NCT00000742|Zidovudine|zidovudine|mesh-list
56285049|NCT00000742|Didanosine|didanosine|mesh-list
56285050|NCT00000742|Atevirdine|atevirdine|mesh-list
56285051|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
56285052|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285053|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285054|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285110|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285111|NCT00000760|Zidovudine|zidovudine|mesh-list
56285112|NCT00000760|Didanosine|didanosine|mesh-list
56285113|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
56285114|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285115|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285116|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285181|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285182|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56285183|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56285184|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56285185|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285186|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
56285187|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56285188|NCT00000820|Aldesleukin|aldesleukin|mesh-list
56285189|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285190|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285243|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285244|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285245|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285246|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285247|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285248|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285249|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285250|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
56285251|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285252|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285253|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56285254|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
56285255|NCT00000883|Azithromycin|azithromycin|mesh-list
56285256|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285257|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285258|NCT00000892|Ritonavir|ritonavir|mesh-list
56285259|NCT00000892|Nelfinavir|nelfinavir|mesh-list
56285260|NCT00000892|Saquinavir|saquinavir|mesh-list
56285261|NCT00000892|Delavirdine|delavirdine|mesh-list
56285262|NCT00000892|Adefovir|adefovir|mesh-list
56285263|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56285264|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285265|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285266|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285267|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285268|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285269|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285270|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285271|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
56285291|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285292|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285293|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285295|NCT00000898|Nelfinavir|nelfinavir|mesh-list
56285296|NCT00000898|Saquinavir|saquinavir|mesh-list
56285297|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285298|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285299|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285300|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285301|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285302|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285303|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285304|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
56285305|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285356|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56285357|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56285358|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56285359|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56285360|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285361|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
56285362|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56285363|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
56285364|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285365|NCT00000922|Lamivudine|lamivudine|mesh-list
56285366|NCT00000922|Efavirenz|efavirenz|mesh-list
56285367|NCT00000922|Nevirapine|nevirapine|mesh-list
56285368|NCT00000922|Abacavir|abacavir|mesh-list
56285369|NCT00000922|Didanosine|didanosine|mesh-list
56285370|NCT00000922|Stavudine|stavudine|mesh-list
56285371|NCT00000922|Nelfinavir|nelfinavir|mesh-list
56285372|NCT00000922|Indinavir|indinavir|mesh-list
56285373|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285375|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285416|NCT00000952|Ritonavir|ritonavir|mesh-list
56285417|NCT00000952|Lamivudine|lamivudine|mesh-list
56285418|NCT00000952|Zidovudine|zidovudine|mesh-list
56285419|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285420|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285421|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285422|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285423|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285424|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285425|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285426|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
56285427|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285435|NCT00000970|Foscarnet|foscarnet|mesh-list
56285481|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285482|NCT00001003|Zidovudine|zidovudine|mesh-list
56285483|NCT00001003|Pentamidine|pentamidine|mesh-list
56285484|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
56285485|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285486|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285487|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285488|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285489|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
56285490|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285491|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285492|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285493|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
56285494|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56285495|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56285497|NCT00001030|Clarithromycin|clarithromycin|mesh-list
56285541|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56285542|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56285543|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56285544|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56285545|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56285547|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56285613|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56285614|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56285615|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
56285617|NCT00001075|Lamivudine|lamivudine|mesh-list
56285618|NCT00001075|Zidovudine|zidovudine|mesh-list
56285619|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56285620|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56285621|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
56285622|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285623|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160500|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285683|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56285684|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285685|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56285686|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56285687|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
56285688|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56285689|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56285690|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56285691|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56285692|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56285694|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56285695|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
56285696|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285697|NCT00001111|Zidovudine|zidovudine|mesh-list
56285739|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285740|NCT00001180|Hormones|hormones|mesh-list
56285741|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56285742|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
56285743|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56285744|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285745|NCT00389272|Acetaminophen|acetaminophen|mesh-list
56285806|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
56285807|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
56285808|NCT00001303|Protective Agents|protective agents|mesh-ancestor
56285809|NCT00000120|Erythromycin|erythromycin|mesh-list
56285810|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
56285811|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56285812|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
56285813|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
56285814|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56285815|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56285816|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56285817|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56285870|NCT00001474|Analgesics|analgesics|mesh-ancestor
56285871|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
56285872|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56285873|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285874|NCT00001483|Sertraline|sertraline|mesh-list
56285875|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56285876|NCT00001483|Bupropion|bupropion|mesh-list
56285877|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
56285878|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56285879|NCT00001483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56285880|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56285881|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56285882|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285883|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56285884|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
56285885|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285886|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56285887|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56285888|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56285889|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
56285890|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56285891|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56285892|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285893|NCT00001495|Irinotecan|irinotecan|mesh-list
56285894|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56285895|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56285919|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56285920|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
56285921|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56285922|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56285923|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56285924|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56285925|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
56285926|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56285927|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
56285928|NCT00000147|Prednisone|prednisone|mesh-list
56285929|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
56285930|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56285931|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56285932|NCT00000147|Prednisolone|prednisolone|mesh-list
56285933|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
56285934|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56285935|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
56285936|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56285937|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
56285938|NCT00000147|Hormones|hormones|mesh-ancestor
56285943|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
56285974|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56285975|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56285976|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56285977|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56285978|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56073873|NCT05658055|Amoxicillin|amoxicillin|mesh-list
56285979|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56285980|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56285982|NCT00001696|Genistein|genistein|mesh-list
56286038|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286039|NCT00000171|Melatonin|melatonin|mesh-list
56286040|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
56286041|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286042|NCT00000171|Protective Agents|protective agents|mesh-ancestor
56286043|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286044|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286045|NCT05641636|Hormones|hormones|mesh-list
56286046|NCT05641636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286047|NCT05641636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286048|NCT00000177|Estrogens|estrogens|mesh-list
56286100|NCT05640817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286101|NCT05640817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286102|NCT05640817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56286103|NCT05640817|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56286104|NCT05640817|Protective Agents|protective agents|mesh-ancestor
56286105|NCT05640817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286106|NCT05640817|Vasodilator Agents|vasodilator agents|mesh-ancestor
56286107|NCT05640817|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56286108|NCT05640817|Antioxidants|antioxidants|mesh-ancestor
56286109|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
56286110|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56286164|NCT05640427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56286165|NCT05640427|Adrenergic Agents|adrenergic agents|mesh-ancestor
56286166|NCT05640427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286167|NCT05640427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286168|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
56286169|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56286170|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
56286171|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286172|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286173|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286174|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
56286175|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286176|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286177|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286178|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286179|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
56286180|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56286181|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286208|NCT03575208|Antibodies|antibodies|mesh-list
56286222|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286223|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286224|NCT05631925|Propofol|propofol|mesh-list
56286225|NCT05631925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56286226|NCT05631925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286227|NCT05631925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286228|NCT05631925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56286229|NCT05631925|Anesthetics, General|anesthetics, general|mesh-ancestor
56286288|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286289|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
56286290|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
56286291|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286292|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286293|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56286294|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
56286295|NCT00389701|Hormones|hormones|mesh-ancestor
56286296|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286353|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56286354|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286355|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286356|NCT00000468|Plasminogen|plasminogen|mesh-list
56286357|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56286358|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56286359|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56286360|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286361|NCT02972476|Fluticasone|fluticasone|mesh-list
56286363|NCT02972476|Budesonide|budesonide|mesh-list
56286364|NCT02972476|Bromides|bromides|mesh-list
56286365|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
56286366|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56286367|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56286368|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286369|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56286370|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
56286371|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286372|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286373|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56286374|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
56286375|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
56286376|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56286406|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56286407|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56286408|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286409|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286410|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56286411|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56286412|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
56286413|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286414|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56286415|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56286416|NCT05312008|Oxytocin|oxytocin|mesh-list
56286417|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
56286418|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56286419|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286420|NCT03164980|Trabectedin|trabectedin|mesh-list
56286421|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56286423|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286424|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286464|NCT00000504|Imipramine|imipramine|mesh-list
56286465|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56286466|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56286467|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56286468|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286469|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286470|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56286471|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286472|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286473|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56286474|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56286478|NCT00389935|Thalidomide|thalidomide|mesh-list
56286526|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286527|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
56286528|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
56286529|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56286530|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
56286531|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
56286532|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286533|NCT00000522|Acebutolol|acebutolol|mesh-list
56286534|NCT00000522|Amlodipine|amlodipine|mesh-list
56286535|NCT00000522|Enalapril|enalapril|mesh-list
56286536|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
56286537|NCT00000522|Doxazosin|doxazosin|mesh-list
56286538|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56286539|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56286540|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286541|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286542|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56286543|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286544|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
56286545|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56286546|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
56286547|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286548|NCT00000522|Diuretics|diuretics|mesh-ancestor
56286549|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
56286550|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56286551|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56286552|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56286553|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56286574|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56286575|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
56286576|NCT00000525|Triamterene|triamterene|mesh-list
56286577|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56286578|NCT00000525|Diuretics|diuretics|mesh-ancestor
56286589|NCT05019430|Cocaine|cocaine|mesh-list
56286643|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56286644|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56286645|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286646|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
56286647|NCT00000555|Vitamin E|vitamin e|mesh-list
56286648|NCT00000555|Hormones|hormones|mesh-list
56286649|NCT00000555|Progesterone|progesterone|mesh-list
56286650|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56286651|NCT00000555|Estrogens|estrogens|mesh-list
56286652|NCT00000555|Vitamins|vitamins|mesh-ancestor
56286653|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
56286654|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286655|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286656|NCT00000555|Progestins|progestins|mesh-ancestor
56286657|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
56286659|NCT00000555|Protective Agents|protective agents|mesh-ancestor
56286704|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286705|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286706|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56286707|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
56286709|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56286710|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56286711|NCT04862221|Protective Agents|protective agents|mesh-ancestor
56286712|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56286713|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286714|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
56286715|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56286716|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56286717|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56286718|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56286719|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
56286721|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
56286722|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56286723|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
56286724|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
56286725|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286726|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286727|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56286728|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
56286756|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
56286757|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56286758|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
56286759|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
56286760|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56286761|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286762|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56286823|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
56286824|NCT04601077|Protective Agents|protective agents|mesh-ancestor
56286825|NCT00000609|Amiodarone|amiodarone|mesh-list
56286826|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56286827|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
56286828|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56286829|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56286830|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286831|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56286832|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56286833|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56286838|NCT04547530|Vitamin D|vitamin d|mesh-list
56286882|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56286883|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56286884|NCT00000639|Amebicides|amebicides|mesh-ancestor
56286885|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56286886|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56286887|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56286888|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
56286889|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
56286890|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
56286891|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286892|NCT00000645|Hypericin|hypericin|mesh-list
56286893|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
56286894|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56286895|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286896|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
56286897|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286898|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908906|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56286942|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
56286943|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
56286944|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56286945|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286946|NCT00390247|Thalidomide|thalidomide|mesh-list
56286947|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56286948|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
56286949|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286950|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
56286951|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56286952|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286953|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56286954|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56286955|NCT00390247|Growth Substances|growth substances|mesh-ancestor
56286956|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
56286957|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56286958|NCT00000651|Zidovudine|zidovudine|mesh-list
56286959|NCT00000651|Zalcitabine|zalcitabine|mesh-list
56286960|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
56286961|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286962|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56286963|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56286964|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286965|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
56286966|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56286967|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56286968|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56286969|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
56286989|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56286990|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56286991|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56286992|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
56286993|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
56286994|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56286995|NCT00000678|Zidovudine|zidovudine|mesh-list
56286996|NCT00000678|Zalcitabine|zalcitabine|mesh-list
56287057|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
56287058|NCT00000687|Interferons|interferons|mesh-list
56287060|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
56287062|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287063|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
56287064|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287065|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
56287066|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287067|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
56287068|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287069|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287122|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56287123|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56287124|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
56287125|NCT04205812|Paclitaxel|paclitaxel|mesh-list
56287126|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56287127|NCT04205812|Carboplatin|carboplatin|mesh-list
56287128|NCT04205812|Pemetrexed|pemetrexed|mesh-list
56287129|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56287130|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287131|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56287132|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56287190|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287191|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
56287192|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287193|NCT04142983|Vaccines|vaccines|mesh-list
56287194|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
56287195|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287196|NCT00000726|Foscarnet|foscarnet|mesh-list
56287197|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56287198|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
56287199|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287200|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287201|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287202|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287251|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56287252|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56287253|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
56287254|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
56287255|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56287256|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287257|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56287259|NCT04038346|Naproxen|naproxen|mesh-list
56287260|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56287261|NCT04038346|Analgesics|analgesics|mesh-ancestor
56287262|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
56287263|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287264|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287265|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
56287266|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56287311|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287312|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287313|NCT04004416|Lorazepam|lorazepam|mesh-list
56287314|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
56287316|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
56287317|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287318|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909281|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287319|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56287320|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56287344|NCT00000789|Stavudine|stavudine|mesh-list
56287378|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
56287379|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287380|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56287381|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287382|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
56287448|NCT03797560|Pregabalin|pregabalin|mesh-list
56287449|NCT03797560|Analgesics|analgesics|mesh-ancestor
56287450|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
56287451|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287452|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287453|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
56287454|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56287455|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56287456|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287457|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56287463|NCT03729271|Lactulose|lactulose|mesh-list
56287515|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56287516|NCT03574402|Gemcitabine|gemcitabine|mesh-list
56287517|NCT03574402|Carboplatin|carboplatin|mesh-list
56287518|NCT03574402|Pemetrexed|pemetrexed|mesh-list
56287519|NCT03574402|Afatinib|afatinib|mesh-list
56287520|NCT03574402|Crizotinib|crizotinib|mesh-list
56287521|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
56287522|NCT03574402|Ensartinib|ensartinib|mesh-list
56287523|NCT03574402|Maleic acid|maleic acid|mesh-list
56287524|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287525|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56287526|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
56287527|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287528|NCT03574402|Antiviral Agents|antiviral agents|mesh-ancestor
56287529|NCT03574402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287530|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287531|NCT03574402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56287532|NCT03574402|Immunologic Factors|immunologic factors|mesh-ancestor
56287533|NCT03574402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287534|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56287536|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56287572|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287573|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287574|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
56287575|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287576|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287577|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287578|NCT03317392|Olaparib|olaparib|mesh-list
56287579|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56287580|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56287581|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56160552|NCT03572478|Nivolumab|nivolumab|mesh-list
56287582|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287583|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287584|NCT00000867|Memantine|memantine|mesh-list
56287585|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56287586|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56287587|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
56287632|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
56287633|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56287634|NCT00390871|Analgesics|analgesics|mesh-ancestor
56287635|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
56287636|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56287637|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56287638|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56287639|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56287640|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
56287641|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56287642|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287643|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56287644|NCT00390871|Narcotics|narcotics|mesh-ancestor
56287645|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56287646|NCT03211741|Bevacizumab|bevacizumab|mesh-list
56287647|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56287648|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287649|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56287650|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56287651|NCT03211741|Growth Substances|growth substances|mesh-ancestor
56287652|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287653|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
56287654|NCT03206203|Carboplatin|carboplatin|mesh-list
56287655|NCT03206203|Atezolizumab|atezolizumab|mesh-list
56287656|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287657|NCT00000882|Lamivudine|lamivudine|mesh-list
56287658|NCT00000882|Zidovudine|zidovudine|mesh-list
56287660|NCT00000882|Delavirdine|delavirdine|mesh-list
56287661|NCT00000882|Indinavir|indinavir|mesh-list
56287662|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287663|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287680|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287681|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287682|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287683|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287684|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
56287685|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287686|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56287687|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287688|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287689|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287690|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
56287691|NCT00000891|Ritonavir|ritonavir|mesh-list
56287692|NCT00000891|Saquinavir|saquinavir|mesh-list
56287743|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56287744|NCT00000906|Ritonavir|ritonavir|mesh-list
56287745|NCT00000906|Saquinavir|saquinavir|mesh-list
56287746|NCT00000906|Methadone|methadone|mesh-list
56287747|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56287748|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56287749|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
56287750|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287751|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287752|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287753|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287754|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
56287755|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287756|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56287757|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56287758|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56287759|NCT00000906|Narcotics|narcotics|mesh-ancestor
56287760|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56287761|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287762|NCT00000906|Analgesics|analgesics|mesh-ancestor
56287763|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
56287797|NCT02627443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287798|NCT02491099|Afatinib|afatinib|mesh-list
56287799|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287800|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287801|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56287802|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287803|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
56287804|NCT02419495|Leucovorin|leucovorin|mesh-list
56287805|NCT02419495|Folic Acid|folic acid|mesh-list
56287806|NCT02419495|Paclitaxel|paclitaxel|mesh-list
56287807|NCT02419495|Camptothecin|camptothecin|mesh-list
56287808|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
56287810|NCT02419495|Doxorubicin|doxorubicin|mesh-list
56287811|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56287812|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
56287813|NCT02419495|Fluorouracil|fluorouracil|mesh-list
56287814|NCT02419495|Capecitabine|capecitabine|mesh-list
56287815|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
56287817|NCT02419495|Irinotecan|irinotecan|mesh-list
56287818|NCT02419495|Pemetrexed|pemetrexed|mesh-list
56287819|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56287820|NCT02419495|Ipilimumab|ipilimumab|mesh-list
56287821|NCT02419495|Daunorubicin|daunorubicin|mesh-list
56287822|NCT02419495|Topotecan|topotecan|mesh-list
56287823|NCT02419495|Olaparib|olaparib|mesh-list
56287824|NCT02419495|Calcium|calcium|mesh-list
56287825|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
56287826|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56287827|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287828|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
56287829|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
56287830|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
56287831|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287832|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56287833|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
56287834|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287845|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56287846|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
56287847|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56287848|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56287849|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56287850|NCT02419495|Antidotes|antidotes|mesh-ancestor
55909807|NCT03026881|Paclitaxel|paclitaxel|mesh-list
56287851|NCT02419495|Protective Agents|protective agents|mesh-ancestor
56287852|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
56287853|NCT02419495|Vitamins|vitamins|mesh-ancestor
56287854|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
56287857|NCT02419495|Hematinics|hematinics|mesh-ancestor
56287909|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
56287910|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287911|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287912|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287913|NCT00000999|Zidovudine|zidovudine|mesh-list
56287914|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
56287915|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287916|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287917|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56287918|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287919|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
56287920|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56287921|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56287922|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56287923|NCT00001002|Zidovudine|zidovudine|mesh-list
56287925|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56287926|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
56287927|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287928|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56287967|NCT00391144|Bevacizumab|bevacizumab|mesh-list
56287968|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56287969|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287970|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56287971|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56287972|NCT00391144|Growth Substances|growth substances|mesh-ancestor
56287973|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287974|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
56287975|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56287976|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
56287977|NCT00391144|Hormones|hormones|mesh-ancestor
56287978|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56287979|NCT00005822|Tamoxifen|tamoxifen|mesh-list
56287980|NCT00005822|Doxorubicin|doxorubicin|mesh-list
56287981|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56287982|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56287983|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56287984|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56287985|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56287986|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56287987|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56287988|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56287989|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
56287990|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56287991|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287992|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56287993|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56287994|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56287995|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56287996|NCT00391261|Metformin|metformin|mesh-list
56287997|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56287998|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56287999|NCT00001008|Zidovudine|zidovudine|mesh-list
56288006|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
56288007|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288008|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288009|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288010|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56288011|NCT00001008|Narcotics|narcotics|mesh-ancestor
56288012|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56288013|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288014|NCT00001008|Analgesics|analgesics|mesh-ancestor
56288015|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
56288016|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288017|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
56288018|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
56288072|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56288073|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56288074|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56288075|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288076|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288077|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56288078|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56288079|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56288080|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56288081|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
56288082|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56288083|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
56288084|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288085|NCT00005831|Gemcitabine|gemcitabine|mesh-list
56288086|NCT00005831|Paclitaxel|paclitaxel|mesh-list
56288087|NCT00005831|Carboplatin|carboplatin|mesh-list
56288130|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
56288131|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56288132|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288133|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56288134|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56288135|NCT00005834|Growth Substances|growth substances|mesh-ancestor
56288136|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
56288137|NCT00001029|Zidovudine|zidovudine|mesh-list
56288138|NCT00001029|Didanosine|didanosine|mesh-list
56288139|NCT00001029|Zalcitabine|zalcitabine|mesh-list
56288140|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
56288141|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288142|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288196|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56288197|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56288198|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
56288199|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56288200|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56288201|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
56288202|NCT00005852|Cyclosporine|cyclosporine|mesh-list
56288203|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
56288204|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
56288205|NCT00005852|Cyclosporins|cyclosporins|mesh-list
56288206|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56288207|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
56288208|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288209|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
56288210|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288211|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288212|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56288213|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
56288214|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288215|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288216|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56288217|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288218|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
56288219|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288220|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56288223|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
56288247|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288248|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288249|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288250|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
56288251|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288252|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
56288253|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288254|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288255|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288256|NCT00005858|Immunotoxins|immunotoxins|mesh-list
56288257|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
56288258|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288259|NCT00005861|Doxorubicin|doxorubicin|mesh-list
56288260|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56288261|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288262|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288263|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56288264|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288266|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288267|NCT00001083|Ritonavir|ritonavir|mesh-list
56288268|NCT00001083|Indinavir|indinavir|mesh-list
56288269|NCT00001083|Lamivudine|lamivudine|mesh-list
56288270|NCT00001083|Zidovudine|zidovudine|mesh-list
56288271|NCT00001083|Nevirapine|nevirapine|mesh-list
56288272|NCT00001083|Stavudine|stavudine|mesh-list
56288273|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56288274|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56288275|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
56288276|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905804|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905805|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55905806|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905807|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
55905808|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55905809|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55905810|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55905811|NCT01561963|Rifampin|rifampin|mesh-list
55905812|NCT01561963|Apremilast|apremilast|mesh-list
55905813|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55905896|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
56198025|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56198026|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
56198027|NCT01511185|Liraglutide|liraglutide|mesh-list
56198028|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55905897|NCT01560949|Irinotecan|irinotecan|mesh-list
55905898|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905899|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
55905900|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905901|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905902|NCT01560949|Antiviral Agents|antiviral agents|mesh-ancestor
56288277|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288278|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288279|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288280|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
56288281|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288282|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56288284|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288344|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288345|NCT00005867|Prednisolone|prednisolone|mesh-list
56288346|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
56288347|NCT00005867|Doxorubicin|doxorubicin|mesh-list
56288348|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56288349|NCT00005867|Etoposide|etoposide|mesh-list
56288350|NCT00005867|Vincristine|vincristine|mesh-list
56288351|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
56288352|NCT00005867|Bleomycin|bleomycin|mesh-list
56288353|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288354|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
56288355|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288356|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288357|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56288358|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
56288359|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288360|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288361|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56288362|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56288404|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288405|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288406|NCT00008866|Didanosine|didanosine|mesh-list
56288407|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
56288408|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288409|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
56288410|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288411|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288412|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288413|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
56288414|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288415|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
56288416|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288417|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288418|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288419|NCT00001119|Ritonavir|ritonavir|mesh-list
56288465|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288466|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56288467|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56288468|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56288469|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56288470|NCT00005873|Rubitecan|rubitecan|mesh-list
56288471|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288472|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56288473|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288474|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288475|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288476|NCT00009178|Fluoxetine|fluoxetine|mesh-list
56288477|NCT00009178|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56288523|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288524|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
56288525|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
56288526|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56288527|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56288528|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288529|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288530|NCT00009763|Cyclosporine|cyclosporine|mesh-list
56288532|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56288533|NCT00009763|Antibodies|antibodies|mesh-list
56288534|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
56288535|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56288536|NCT00009763|Cyclosporins|cyclosporins|mesh-list
56288537|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288538|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288539|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288540|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288541|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288543|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
56288582|NCT00009880|Fluorouracil|fluorouracil|mesh-list
56288583|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56288584|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288585|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288586|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288587|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288588|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288589|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
56288590|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56288591|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288592|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
56288593|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288594|NCT00009919|Semaxinib|semaxinib|mesh-list
56288595|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56288596|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56288597|NCT00009919|Growth Substances|growth substances|mesh-ancestor
56288598|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288599|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
56288600|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288601|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56288602|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288637|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56288638|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
56288639|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288640|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56288641|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56288643|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56288644|NCT00010036|Carboplatin|carboplatin|mesh-list
56288645|NCT00010036|Irinotecan|irinotecan|mesh-list
56288646|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288647|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56288648|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288649|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288650|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288651|NCT00010075|Leucovorin|leucovorin|mesh-list
56288652|NCT00010075|Fluorouracil|fluorouracil|mesh-list
56288653|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
56288654|NCT00010075|Calcium|calcium|mesh-list
56288697|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
56288698|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288699|NCT00005912|Voriconazole|voriconazole|mesh-list
56288700|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
56288701|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288702|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56288703|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56288704|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288705|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288706|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56288707|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
56288708|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288709|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288710|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56288711|NCT00010231|Calcitriol|calcitriol|mesh-list
56288712|NCT00010231|Dexamethasone|dexamethasone|mesh-list
56288713|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56288714|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
56288715|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
56288716|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288717|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288718|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56288719|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
56288720|NCT00010231|Hormones|hormones|mesh-ancestor
56288721|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288722|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56288723|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288724|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56288725|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56288726|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56288728|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56288738|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288739|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288740|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56288741|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
56288742|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288743|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288744|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56288745|NCT00010426|Cysteamine|cysteamine|mesh-list
56288746|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56288806|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288807|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288808|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56288809|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
56288810|NCT00011362|Hormones|hormones|mesh-ancestor
56288811|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288812|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56288813|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288814|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
56288815|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288816|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288817|NCT00001212|Cyclosporine|cyclosporine|mesh-list
56288818|NCT00001212|Prednisone|prednisone|mesh-list
56288819|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
56288820|NCT00001212|Cyclosporins|cyclosporins|mesh-list
56288821|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288822|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
56288823|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288824|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288825|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56288826|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
56288827|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288828|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288829|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56288855|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288856|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288857|NCT00391417|Estradiol|estradiol|mesh-list
56288858|NCT00391417|Estrogens|estrogens|mesh-ancestor
56288859|NCT00391417|Hormones|hormones|mesh-ancestor
56160568|NCT03574818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288860|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56288861|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288863|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56288864|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288865|NCT00012025|Fulvestrant|fulvestrant|mesh-list
56288866|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56288867|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288917|NCT00005945|Thioguanine|thioguanine|mesh-list
56288918|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288919|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
56288920|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288921|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56288922|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56288923|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
56288924|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288925|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288926|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56288927|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56288928|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
56288929|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
56288930|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56288931|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56288976|NCT00012220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288978|NCT00012220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56288979|NCT00012220|Immunologic Factors|immunologic factors|mesh-ancestor
56288980|NCT00012220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56288981|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
56288982|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
56288983|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
56288984|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56288985|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56288986|NCT00012259|Troxacitabine|troxacitabine|mesh-list
56288987|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288988|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56288989|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56288990|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
56288991|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56288992|NCT00012337|Gefitinib|gefitinib|mesh-list
56288993|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56288994|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56288995|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56288996|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56288997|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
56288998|NCT00012376|Sargramostim|sargramostim|mesh-list
56288999|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
56289000|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289003|NCT00001266|Suramin|suramin|mesh-list
56289031|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56289032|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289033|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
56289034|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
56289035|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56289036|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
56289037|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56289038|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56289039|NCT00005951|Irinotecan|irinotecan|mesh-list
56289040|NCT00005951|Temozolomide|temozolomide|mesh-list
56289041|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56289042|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289043|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289095|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56289096|NCT00013585|Protective Agents|protective agents|mesh-ancestor
56289097|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289098|NCT00013624|Levodopa|levodopa|mesh-list
56289099|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56289100|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56289101|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
56289102|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289103|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289104|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289105|NCT00013663|Aldesleukin|aldesleukin|mesh-list
56289106|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289107|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56289108|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56289109|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
56289110|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289111|NCT00013702|Adefovir|adefovir|mesh-list
56289112|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
56289113|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289114|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56289115|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56289116|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289117|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289118|NCT00005966|Interferons|interferons|mesh-list
56289119|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
56289120|NCT00005966|Thalidomide|thalidomide|mesh-list
56289121|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289122|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
56289123|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289124|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
56289125|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289126|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905903|NCT01560949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905904|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905905|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905906|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
55905907|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905908|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55905909|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55905910|NCT03113448|Capsaicin|capsaicin|mesh-list
55905911|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
55905912|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
55905913|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
55905914|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289127|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
56289128|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56289129|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56289130|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56289131|NCT00005966|Growth Substances|growth substances|mesh-ancestor
56289132|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
56289134|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289135|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
56289136|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
56289137|NCT00014014|Lamivudine|lamivudine|mesh-list
56289138|NCT00014014|Zidovudine|zidovudine|mesh-list
56289139|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56289140|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56289141|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56289142|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289143|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289144|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
56289145|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289146|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56289147|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56289148|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
56289149|NCT00014092|Interferons|interferons|mesh-list
56289150|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
56289151|NCT00014092|Aldesleukin|aldesleukin|mesh-list
56289152|NCT00014092|Temozolomide|temozolomide|mesh-list
56289153|NCT00014092|Sargramostim|sargramostim|mesh-list
56289154|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289155|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
56289156|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289157|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56289158|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
56289159|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289160|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
56289171|NCT00005972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289172|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289173|NCT00005972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289174|NCT00005972|Immunologic Factors|immunologic factors|mesh-ancestor
56289175|NCT00005972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289176|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56289177|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289178|NCT00014170|Gefitinib|gefitinib|mesh-list
56289179|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289180|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56289181|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289182|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289183|NCT00014209|Gemcitabine|gemcitabine|mesh-list
56289184|NCT00014209|Dexamethasone|dexamethasone|mesh-list
56289185|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56289186|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
56289187|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
56289188|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289189|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289190|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56289191|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
56289192|NCT00014209|Hormones|hormones|mesh-ancestor
56289193|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56289195|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289223|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289227|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289295|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56289296|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
56289297|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56289298|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289299|NCT00001341|Raltitrexed|raltitrexed|mesh-list
56289300|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289301|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
56289302|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289303|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289304|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56289305|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289306|NCT00014677|Interleukin-4|interleukin-4|mesh-list
56289307|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56289308|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
56289355|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
56289356|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289357|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289358|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56289359|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56289360|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
56289361|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
56289362|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289363|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56289364|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
56289365|NCT00005987|Hormones|hormones|mesh-ancestor
56289366|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56289367|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56289368|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289369|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56289370|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289371|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289372|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
56289373|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289374|NCT00005987|Analgesics|analgesics|mesh-ancestor
56289375|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
56289408|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
56289409|NCT00014989|Analgesics|analgesics|mesh-ancestor
56289410|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
56289411|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289412|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289413|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
56289414|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56289415|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56289416|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
56289417|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56289418|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56289419|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289420|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56289421|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
56289422|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56289423|NCT00005993|Aldesleukin|aldesleukin|mesh-list
56289424|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289425|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56289465|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289466|NCT00005996|Antiviral Agents|antiviral agents|mesh-ancestor
56289467|NCT00005996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289468|NCT00005996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289469|NCT00005996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289470|NCT00005996|Immunologic Factors|immunologic factors|mesh-ancestor
56289471|NCT00005996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289472|NCT00001359|Penicillins|penicillins|mesh-list
56289473|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56289474|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289475|NCT00015223|Methylphenidate|methylphenidate|mesh-list
56289476|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56289477|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289478|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56289560|NCT00015925|Entinostat|entinostat|mesh-list
56289561|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289562|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56289563|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289564|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289565|NCT00006005|Thalidomide|thalidomide|mesh-list
56289566|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289567|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
56289568|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289569|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
56289570|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56289571|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289572|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56289624|NCT00016198|Fluorouracil|fluorouracil|mesh-list
56289625|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
56289626|NCT00016198|Calcium|calcium|mesh-list
56289627|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
56289628|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56289629|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289630|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
56289631|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289632|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289633|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289634|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911608|NCT00546897|Lenalidomide|lenalidomide|mesh-list
56289635|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
56289636|NCT00016198|Antidotes|antidotes|mesh-ancestor
56289637|NCT00016198|Protective Agents|protective agents|mesh-ancestor
56289638|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
56289640|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
56289641|NCT00016276|Tamoxifen|tamoxifen|mesh-list
56289642|NCT00016276|Paclitaxel|paclitaxel|mesh-list
56289643|NCT00016276|Razoxane|razoxane|mesh-list
56289644|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
56289645|NCT00016276|Doxorubicin|doxorubicin|mesh-list
56289646|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56289647|NCT00016276|Trastuzumab|trastuzumab|mesh-list
56289648|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
56289678|NCT00016315|Carboplatin|carboplatin|mesh-list
56289679|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289680|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289681|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289682|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289683|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289684|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289685|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289686|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
56289687|NCT00016315|Antiviral Agents|antiviral agents|mesh-ancestor
56289688|NCT00016315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289689|NCT00016315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289690|NCT00016315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289691|NCT00016315|Immunologic Factors|immunologic factors|mesh-ancestor
56289692|NCT00016315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289693|NCT00006014|Semaxinib|semaxinib|mesh-list
56289694|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56289695|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56289696|NCT00006014|Growth Substances|growth substances|mesh-ancestor
56289697|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289698|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
56289699|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289729|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289730|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289731|NCT00016588|Tenofovir|tenofovir|mesh-list
56289732|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
56289733|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289734|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56289735|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56289736|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289737|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289738|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56289739|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56289740|NCT00006026|Rubitecan|rubitecan|mesh-list
56289791|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
56289792|NCT00386672|Vitamin D|vitamin d|mesh-list
56289793|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
56289794|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
56289795|NCT00386672|Vitamins|vitamins|mesh-list
56289796|NCT00386672|Calcium|calcium|mesh-list
56289797|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
56289798|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289799|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56289800|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56289801|NCT00016978|Leucovorin|leucovorin|mesh-list
56289802|NCT00016978|Fluorouracil|fluorouracil|mesh-list
56289803|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
56289804|NCT00016978|Calcium|calcium|mesh-list
56289805|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
56289814|NCT00016978|Antidotes|antidotes|mesh-ancestor
56289855|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289856|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911831|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56289857|NCT00006029|Antiviral Agents|antiviral agents|mesh-ancestor
56289858|NCT00006029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56289859|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289860|NCT00006029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289861|NCT00006029|Immunologic Factors|immunologic factors|mesh-ancestor
56289862|NCT00006029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289863|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56289864|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56289865|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56289866|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56289867|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289868|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289869|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289870|NCT00371059|Memantine|memantine|mesh-list
56289871|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56289872|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56289873|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
56289874|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56289875|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289876|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289877|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56289878|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56289879|NCT00001482|Lamotrigine|lamotrigine|mesh-list
56289880|NCT00001482|Gabapentin|gabapentin|mesh-list
56289881|NCT00001482|Analgesics|analgesics|mesh-ancestor
56289882|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
56289883|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56289884|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289885|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
56289886|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56289887|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56289888|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56289893|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289894|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
56289895|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56289896|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56289897|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56289898|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56160613|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56289899|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56289901|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289902|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56289903|NCT00017134|Protective Agents|protective agents|mesh-ancestor
56289904|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289957|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56289958|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289959|NCT00006038|Leucovorin|leucovorin|mesh-list
56289960|NCT00006038|Docetaxel|docetaxel|mesh-list
56289961|NCT00006038|Fluorouracil|fluorouracil|mesh-list
56289962|NCT00006038|Floxuridine|floxuridine|mesh-list
56289963|NCT00006038|Calcium|calcium|mesh-list
56289964|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
56289965|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56289966|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
56289967|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
56289968|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56289969|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56289970|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56289971|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289972|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
56289973|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56289974|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289975|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
56289976|NCT00006038|Antidotes|antidotes|mesh-ancestor
56289977|NCT00006038|Protective Agents|protective agents|mesh-ancestor
56289978|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
56289979|NCT00006038|Vitamins|vitamins|mesh-ancestor
56289980|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
56289981|NCT00017290|Prednisone|prednisone|mesh-list
56289982|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
56289983|NCT00017290|Vincristine|vincristine|mesh-list
56289984|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
56289985|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56289986|NCT00017290|Antibodies|antibodies|mesh-list
56289987|NCT00017290|Sargramostim|sargramostim|mesh-list
56289988|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56289989|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56289990|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56289991|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
56289992|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56289993|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56289995|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
56289998|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56289999|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56290000|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
56290001|NCT00017290|Hormones|hormones|mesh-ancestor
56290002|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290003|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56290004|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56290005|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
56290006|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
56290007|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
56290065|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56290066|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
56290067|NCT00017602|Hormones|hormones|mesh-ancestor
56290068|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290069|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56290070|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290071|NCT00001533|Cyclosporine|cyclosporine|mesh-list
56290072|NCT00001533|Cyclosporins|cyclosporins|mesh-list
56290073|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290074|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290075|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56290076|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
56290077|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290078|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
56290079|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290080|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
56290124|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290125|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56290126|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56290127|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290128|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290129|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56290130|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
56290131|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290132|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290133|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56290134|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56290136|NCT00017758|Nelfinavir|nelfinavir|mesh-list
56290137|NCT00017758|Atorvastatin|atorvastatin|mesh-list
56290138|NCT00017758|Simvastatin|simvastatin|mesh-list
56290139|NCT00017758|Pravastatin|pravastatin|mesh-list
56290140|NCT00017758|Calcium|calcium|mesh-list
56290141|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56290142|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290143|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56290144|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56290145|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
56290146|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290147|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56290148|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56290149|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290150|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56290151|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56290152|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
56290153|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290154|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56290155|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56290156|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56290157|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56290161|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56290162|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
56290163|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56290164|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55912128|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
56290165|NCT00017992|Ritonavir|ritonavir|mesh-list
56290166|NCT00017992|Lopinavir|lopinavir|mesh-list
56290167|NCT00017992|Emtricitabine|emtricitabine|mesh-list
56290168|NCT00017992|Stavudine|stavudine|mesh-list
56290169|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56290170|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56290171|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
56290172|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290173|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290174|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56290175|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56290176|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
56290177|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290178|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56290179|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56290180|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56290181|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56290182|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
56290183|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56290211|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290212|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290213|NCT00018187|Mecamylamine|mecamylamine|mesh-list
56290214|NCT00018187|Bupropion|bupropion|mesh-list
56290215|NCT00018187|Nicotine|nicotine|mesh-list
56290216|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56290217|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
56290218|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290219|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290220|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56290221|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56290222|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
56290223|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290224|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290225|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56290226|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
56290227|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56290228|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56290229|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56290230|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290231|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
56290232|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56290233|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56290234|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290235|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56290236|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56290237|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55912204|NCT01687478|Olanzapine|olanzapine|mesh-list
56290238|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56290239|NCT00018343|Estrogens|estrogens|mesh-list
56290255|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290256|NCT00018460|Vitamins|vitamins|mesh-list
56290257|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
56290259|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290260|NCT00386750|Lumefantrine|lumefantrine|mesh-list
56290261|NCT00386750|Artemether|artemether|mesh-list
56290262|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56290263|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
56290264|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56290265|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56290266|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290267|NCT00001575|Edetic Acid|edetic acid|mesh-list
56290268|NCT00001575|Calcium|calcium|mesh-list
56290269|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
56290318|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56290319|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
56290320|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290321|NCT00392002|Esomeprazole|esomeprazole|mesh-list
56290322|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56290323|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56290324|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56290325|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290326|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290327|NCT00392080|Naproxen|naproxen|mesh-list
56290328|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56290329|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56290330|NCT00392080|Analgesics|analgesics|mesh-ancestor
56290331|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
56290342|NCT05680142|Narcotics|narcotics|mesh-ancestor
56290381|NCT00001656|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56290382|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56290383|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290384|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290385|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290386|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
56290387|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56290388|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
56290389|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
56290390|NCT05573191|Lidocaine|lidocaine|mesh-list
56290391|NCT05573191|Anesthetics, Local|anesthetics, local|mesh-ancestor
56290394|NCT05573191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290445|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290446|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56290447|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
56290448|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290449|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290450|NCT05465317|Empagliflozin|empagliflozin|mesh-list
56290451|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56290452|NCT05465317|Glucagon|glucagon|mesh-list
56290453|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56290454|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290455|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56290456|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290457|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56290458|NCT05465317|Hormones|hormones|mesh-ancestor
56290459|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290460|NCT05465317|Incretins|incretins|mesh-ancestor
56290461|NCT05419921|Lidocaine|lidocaine|mesh-list
56290462|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
56290463|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
56290464|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290465|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290466|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
56290467|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290494|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290495|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56290496|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290497|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56290498|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290499|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290500|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
56290501|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290502|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56290503|NCT05679401|Cyclophosphamide|cyclophosphamide|mesh-list
56290504|NCT05679401|Glucocorticoids|glucocorticoids|mesh-list
56290514|NCT05679401|Hormones|hormones|mesh-ancestor
56290554|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56290555|NCT00392158|Anesthetics|anesthetics|mesh-list
56290556|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290557|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290558|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56290559|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56290560|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56290561|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56290562|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56290563|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56290564|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56290565|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
56290618|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
56290619|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
56290620|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
56290621|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290622|NCT00001758|Efavirenz|efavirenz|mesh-list
56290623|NCT00001758|Abacavir|abacavir|mesh-list
56290624|NCT00001758|Amprenavir|amprenavir|mesh-list
56290625|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56290626|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56290627|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290628|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290683|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290684|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290685|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
56290686|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56290687|NCT05620628|Durvalumab|durvalumab|mesh-list
56290688|NCT05620628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290689|NCT05620628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290690|NCT05591651|Hyaluronic Acid|hyaluronic acid|mesh-list
56290691|NCT05591651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56290692|NCT05591651|Immunologic Factors|immunologic factors|mesh-ancestor
56290693|NCT05591651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290694|NCT05591651|Viscosupplements|viscosupplements|mesh-ancestor
56290695|NCT05591651|Protective Agents|protective agents|mesh-ancestor
56290696|NCT04905121|Psilocybin|psilocybin|mesh-list
56290697|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
56290698|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290699|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56290700|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
56290701|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290702|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
56290703|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290704|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290705|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56290706|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
56290707|NCT04887805|Lenvatinib|lenvatinib|mesh-list
56290708|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290709|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290710|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56290730|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290731|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
56290732|NCT04866706|Protective Agents|protective agents|mesh-ancestor
56290733|NCT05641623|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|mesh-list
56290734|NCT05641623|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56290735|NCT05641623|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56290736|NCT05641623|Dopamine Agents|dopamine agents|mesh-ancestor
56290737|NCT05641623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56290738|NCT05641623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290739|NCT05641623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290740|NCT05573360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56290741|NCT05573360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56290742|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
56290790|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290791|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290792|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
56290793|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56290794|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
56290795|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56290796|NCT05562713|Denatonium|denatonium|mesh-list
56290797|NCT05562713|Aversive Agents|aversive agents|mesh-ancestor
56290798|NCT05562713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290799|NCT05562713|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
56290800|NCT05562713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290801|NCT05562713|Sensory System Agents|sensory system agents|mesh-ancestor
56290837|NCT04526119|Z 338|z 338|mesh-list
56290851|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290852|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56290853|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56290854|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56290855|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290856|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290857|NCT04487236|Capecitabine|capecitabine|mesh-list
56290858|NCT04487236|Trastuzumab|trastuzumab|mesh-list
56290859|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56290860|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
56290861|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290862|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290863|NCT04487236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290864|NCT00392431|Amiodarone|amiodarone|mesh-list
56290865|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56290866|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
56290867|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56290868|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290908|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56290909|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56290910|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290911|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56290912|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56290913|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290914|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56290915|NCT03960151|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56290916|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56290917|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56290918|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290924|NCT04733326|Ketorolac|ketorolac|mesh-list
56290969|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56290970|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56290971|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290972|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290973|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
56290975|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
56290976|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290977|NCT00387179|Melatonin|melatonin|mesh-list
56290978|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
56290979|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290980|NCT00387179|Protective Agents|protective agents|mesh-ancestor
56290981|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56290982|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56290983|NCT03959332|Baloxavir|baloxavir|mesh-list
56290984|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
56290985|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56290986|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56290987|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56290988|NCT03959293|Durvalumab|durvalumab|mesh-list
56290989|NCT03959293|Tremelimumab|tremelimumab|mesh-list
56290990|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56290991|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290992|NCT04733521|Cisplatin|cisplatin|mesh-list
56290993|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56290994|NCT05640726|Leucovorin|leucovorin|mesh-list
56290995|NCT05640726|Bevacizumab|bevacizumab|mesh-list
56290996|NCT05640726|Fluorouracil|fluorouracil|mesh-list
56290997|NCT05640726|Oxaliplatin|oxaliplatin|mesh-list
56290998|NCT05640726|Calcium|calcium|mesh-list
56290999|NCT05640726|Levoleucovorin|levoleucovorin|mesh-list
56291018|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56291019|NCT03959176|Phenylephrine|phenylephrine|mesh-list
56291020|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
56291021|NCT03959176|Tropicamide|tropicamide|mesh-list
56291022|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56291023|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
56291024|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
56291025|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291026|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291027|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
56291028|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56291029|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
56291030|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
56291031|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56291032|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56291033|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56291034|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
56291035|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291036|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291037|NCT03959176|Protective Agents|protective agents|mesh-ancestor
56291038|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56291039|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56291040|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56031248|NCT01726478|Oxytocin|oxytocin|mesh-list
56291041|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56291042|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
56291044|NCT03958981|Cathartics|cathartics|mesh-ancestor
56291045|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291046|NCT03958942|Bupivacaine|bupivacaine|mesh-list
56291047|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
56291048|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
56291049|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291050|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291051|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
55905915|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905916|NCT01533493|Memantine|memantine|mesh-list
55905917|NCT01533493|Methylphenidate|methylphenidate|mesh-list
55905918|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55905919|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905920|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55905921|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55905922|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56291052|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291053|NCT03958708|Rifaximin|rifaximin|mesh-list
56291054|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56291055|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291056|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291057|NCT05640609|Bevacizumab|bevacizumab|mesh-list
56291058|NCT05640609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913023|NCT00501891|Temozolomide|temozolomide|mesh-list
56291059|NCT05640609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291060|NCT05640609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56291061|NCT05640609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56291062|NCT05640609|Growth Substances|growth substances|mesh-ancestor
56291063|NCT05640609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291064|NCT05640609|Growth Inhibitors|growth inhibitors|mesh-ancestor
56291065|NCT05411861|Analgesics|analgesics|mesh-list
56291066|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56291067|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
56291068|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291069|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291070|NCT03958513|Bupivacaine|bupivacaine|mesh-list
56291071|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
56291072|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
56291073|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291074|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291075|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
56291076|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291077|NCT03958396|Remifentanil|remifentanil|mesh-list
56291078|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56291079|NCT03958396|Narcotics|narcotics|mesh-ancestor
56291080|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291081|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291082|NCT03958396|Analgesics|analgesics|mesh-ancestor
56291083|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
56291084|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291085|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
56291090|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56291091|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291092|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291093|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291094|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56291095|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
56291096|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56291097|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291098|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56291099|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56291100|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56291101|NCT03933865|Ketamine|ketamine|mesh-list
56291102|NCT03933865|Hydromorphone|hydromorphone|mesh-list
56291103|NCT03933865|Analgesics|analgesics|mesh-ancestor
56291104|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
56291105|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291106|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291107|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56291108|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56291109|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
56291110|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
56291111|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291112|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56291113|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56291114|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291115|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291117|NCT03933865|Narcotics|narcotics|mesh-ancestor
56291118|NCT05640453|Pregabalin|pregabalin|mesh-list
56291119|NCT05640453|Dexmedetomidine|dexmedetomidine|mesh-list
56291120|NCT05640453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56291121|NCT05640453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291122|NCT05640453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291123|NCT05640453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56291124|NCT05640453|Analgesics|analgesics|mesh-ancestor
56291125|NCT05640453|Sensory System Agents|sensory system agents|mesh-ancestor
55932815|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56291127|NCT05640453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56291128|NCT05640453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56291129|NCT05640453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56291130|NCT05640453|Adrenergic Agents|adrenergic agents|mesh-ancestor
56291131|NCT05640453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291132|NCT05640453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291133|NCT05640453|Anticonvulsants|anticonvulsants|mesh-ancestor
56291134|NCT05640453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56291135|NCT05640453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55913098|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
56291136|NCT05640453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56291137|NCT05640453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56291138|NCT05640453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56291139|NCT05640453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56291140|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
56291141|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56291142|NCT03819322|Velpatasvir|velpatasvir|mesh-list
56291143|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
56291144|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291145|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
56291147|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
56291179|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291180|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291181|NCT05638893|Metformin|metformin|mesh-list
56291182|NCT05638893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56291183|NCT05638893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291184|NCT00392938|Docetaxel|docetaxel|mesh-list
56291185|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
56291186|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291187|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
56291188|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
56291189|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
56291190|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291191|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
56291192|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56291193|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291194|NCT05637567|Aspirin|aspirin|mesh-list
56291195|NCT05637567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56291196|NCT05637567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56291197|NCT05637567|Analgesics|analgesics|mesh-ancestor
56291198|NCT05637567|Sensory System Agents|sensory system agents|mesh-ancestor
56291199|NCT05637567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291200|NCT05637567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291201|NCT05637567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56291202|NCT05637567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56291203|NCT05637567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56291204|NCT05637567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56291205|NCT05637567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291206|NCT05637567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56291207|NCT05637567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56291208|NCT05637567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913179|NCT02130063|Iron|iron|mesh-list
56291210|NCT03514108|Metformin|metformin|mesh-list
56291211|NCT03514108|Hydralazine|hydralazine|mesh-list
56291212|NCT03514108|Isosorbide|isosorbide|mesh-list
56291219|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
56291220|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
56291221|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56291222|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291223|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56291224|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
56291225|NCT03508726|Vitamins|vitamins|mesh-ancestor
56291226|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
56291227|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291228|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
56291229|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291230|NCT03508726|Protective Agents|protective agents|mesh-ancestor
56291231|NCT05636787|Melphalan|melphalan|mesh-list
56291232|NCT05636787|Treosulfan|treosulfan|mesh-list
56291233|NCT05636787|Busulfan|busulfan|mesh-list
56291234|NCT05636787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56291235|NCT05636787|Alkylating Agents|alkylating agents|mesh-ancestor
56291236|NCT05636787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291237|NCT05636787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291238|NCT05636787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56291239|NCT05636787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291240|NCT05636787|Immunologic Factors|immunologic factors|mesh-ancestor
56291241|NCT05636787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291242|NCT03432091|Melatonin|melatonin|mesh-list
56291243|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
56291244|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291245|NCT03432091|Protective Agents|protective agents|mesh-ancestor
56291246|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291247|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291248|NCT05634564|Gemcitabine|gemcitabine|mesh-list
56291249|NCT05634564|Paclitaxel|paclitaxel|mesh-list
56291250|NCT05634564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56291251|NCT05634564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291260|NCT05634564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291261|NCT05634564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291262|NCT05634564|Immunologic Factors|immunologic factors|mesh-ancestor
56291263|NCT05634564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291265|NCT03152149|Xhance|xhance|mesh-list
56291266|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
56291267|NCT03152149|Olodaterol|olodaterol|mesh-list
56291268|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56291269|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56291270|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
56291271|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291272|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291273|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56291274|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
56291275|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
56291276|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56291277|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
56291278|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56291279|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
56291280|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291281|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913249|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56291282|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56291283|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56291284|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56291285|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291286|NCT05633472|Vitamin D|vitamin d|mesh-list
56291287|NCT05633472|Vitamins|vitamins|mesh-ancestor
56291288|NCT05633472|Micronutrients|micronutrients|mesh-ancestor
56291289|NCT05633472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291306|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56291307|NCT03151720|Loratadine|loratadine|mesh-list
56291308|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
56291309|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
56291310|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56291311|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56291312|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56291313|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
56291314|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
56291315|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291316|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291317|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291318|NCT05632809|Durvalumab|durvalumab|mesh-list
56291319|NCT05632809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291320|NCT05632809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291321|NCT03151603|Fosfomycin|fosfomycin|mesh-list
56291322|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56291323|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291324|NCT03151525|Azathioprine|azathioprine|mesh-list
56291325|NCT03151525|Infliximab|infliximab|mesh-list
56291326|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
56291327|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291328|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56291329|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
56291330|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291331|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291332|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291333|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291334|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
56291335|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291336|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
56291337|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
56291338|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56291344|NCT00387374|Paclitaxel|paclitaxel|mesh-list
56291346|NCT00387374|Carboplatin|carboplatin|mesh-list
56291347|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56291348|NCT00387374|Antibodies|antibodies|mesh-list
56291349|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
56291350|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56291351|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56291352|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291353|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
56291354|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
56291355|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
56291356|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291357|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56291358|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56291359|NCT00387374|Growth Substances|growth substances|mesh-ancestor
56291360|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291362|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
56291364|NCT03151369|Analgesics|analgesics|mesh-list
56291365|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56291366|NCT03151369|Narcotics|narcotics|mesh-ancestor
56291367|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291368|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291369|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
56291370|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291371|NCT04712266|Insulin|insulin|mesh-list
56291372|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56291373|NCT04712266|Glucagon|glucagon|mesh-list
56291374|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56291375|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291376|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291377|NCT04712266|Hormones|hormones|mesh-ancestor
56291378|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56291392|NCT03912818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291393|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291394|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291395|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
56291396|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291397|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56291398|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56291399|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56291400|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56291401|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
56291402|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56291403|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
56291404|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56291405|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56291406|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56291407|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291408|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56291409|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
56291410|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
56291411|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
56291412|NCT03151213|Pregabalin|pregabalin|mesh-list
56291413|NCT03151213|Analgesics|analgesics|mesh-ancestor
56291414|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
56291415|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291416|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291442|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56291443|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56291444|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
56291445|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291446|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56291447|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56291448|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291449|NCT00389688|Pemetrexed|pemetrexed|mesh-list
56291450|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291451|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291452|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291453|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56291454|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56291455|NCT05605665|Sirolimus|sirolimus|mesh-list
56291456|NCT05605665|Aldesleukin|aldesleukin|mesh-list
56291457|NCT05605665|Interleukin-2|interleukin-2|mesh-list
56291458|NCT05605665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56291459|NCT05605665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291460|NCT05605665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56291473|NCT03150706|Avelumab|avelumab|mesh-list
56291497|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56291498|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56291499|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291500|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291501|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291502|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
56291503|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56291504|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56291505|NCT03150316|Growth Substances|growth substances|mesh-ancestor
56291506|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
56291507|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56291508|NCT02972125|Lacosamide|lacosamide|mesh-list
56291509|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
56291510|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56291511|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56291512|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56291513|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291515|NCT05597553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291516|NCT05597553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291517|NCT05597553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291518|NCT05597553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56291519|NCT05597553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56291520|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
56291521|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56291522|NCT03086044|Velpatasvir|velpatasvir|mesh-list
56291523|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
56291524|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291525|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
56291526|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56291527|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291528|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56291529|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291530|NCT03083665|Brivaracetam|brivaracetam|mesh-list
56291531|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
56291532|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
56291533|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291534|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291535|NCT02866006|Topotecan|topotecan|mesh-list
56291536|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56291537|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56291538|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291539|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291540|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291541|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56291542|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56291543|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56291544|NCT02633098|Artesunate|artesunate|mesh-list
56291545|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
56291546|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56291547|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56291548|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291549|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291550|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
56291551|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
56291552|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56291553|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
56291554|NCT00393289|Calcium|calcium|mesh-list
56291555|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56291556|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291557|NCT02285179|Tamoxifen|tamoxifen|mesh-list
56291558|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56291559|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
56291560|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56291561|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291562|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56291563|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291569|NCT02250937|Busulfan|busulfan|mesh-list
56291576|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291577|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291578|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
56291579|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291580|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
56291581|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56291582|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56291583|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
56291585|NCT02122081|Tacrolimus|tacrolimus|mesh-list
56291586|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
55913550|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
56291587|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56291588|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
56291589|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291590|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
56291591|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291592|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56291593|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56291594|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
56291595|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291596|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291597|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56291598|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56291599|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
56291600|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56291601|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291602|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
56291603|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
56291604|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291605|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56291606|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56291608|NCT02020720|Fluorides|fluorides|mesh-list
56291618|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56291619|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56291620|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
56291621|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291622|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291623|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56291624|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56291625|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
56291626|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291627|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56291628|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56291629|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
56291630|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56291631|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56291632|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56291633|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56291634|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291635|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
56291636|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
56291637|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291638|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56291639|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56291640|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
56291641|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56291642|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56291643|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56291644|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56291645|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56291646|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291647|NCT01807429|Midazolam|midazolam|mesh-list
56291648|NCT01807429|Ketamine|ketamine|mesh-list
56291649|NCT01807429|Morphine|morphine|mesh-list
56291650|NCT01807429|Analgesics|analgesics|mesh-ancestor
56291660|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56291661|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291662|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291663|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56291664|NCT01807429|Narcotics|narcotics|mesh-ancestor
56291665|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56291666|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56291667|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56291668|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56291669|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56291670|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
56291671|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
56291672|NCT01807078|Ezetimibe|ezetimibe|mesh-list
56291673|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56291674|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56291675|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
56291676|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291677|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56291678|NCT04650581|Fulvestrant|fulvestrant|mesh-list
56291679|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56291680|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291681|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56291682|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56291683|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
56291684|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56291685|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291686|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
56291687|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56291688|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
56291689|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291690|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291691|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56291701|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291702|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56291703|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56291704|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
56291705|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291706|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291707|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291708|NCT01806805|Zonisamide|zonisamide|mesh-list
56291709|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
56291710|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56291711|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56291712|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291713|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56291714|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291715|NCT00387413|Niacinamide|niacinamide|mesh-list
56291716|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56291717|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56291718|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56291719|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56291720|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291721|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291722|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291723|NCT00387413|Analgesics|analgesics|mesh-ancestor
56291724|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
56079578|NCT03492463|Nicotine|nicotine|mesh-list
56291726|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
56291727|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56291728|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
56291729|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
56291730|NCT00387413|Vitamins|vitamins|mesh-ancestor
56291731|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
56291732|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56291741|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291742|NCT01806571|Cytarabine|cytarabine|mesh-list
56291743|NCT01806571|Daunorubicin|daunorubicin|mesh-list
56291744|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56291745|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
56291746|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291747|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291748|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
56291749|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56291750|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291751|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
56291752|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291753|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56291754|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56291755|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56291756|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291757|NCT04590248|Adavosertib|adavosertib|mesh-list
56291758|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291759|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291760|NCT01806454|Calcium|calcium|mesh-list
56291761|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56291762|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291763|NCT01806415|Imidazole|imidazole|mesh-list
56291764|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291765|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291766|NCT01806376|Maleic acid|maleic acid|mesh-list
56291767|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291768|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291786|NCT05482542|Rituximab|rituximab|mesh-list
56291787|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291788|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
56291789|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291790|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56291791|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56291792|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
56291793|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291794|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291795|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56291797|NCT00393445|Glucagon|glucagon|mesh-list
56291849|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56291850|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291851|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
56291852|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291853|NCT01805596|Clopidogrel|clopidogrel|mesh-list
56291854|NCT01805596|Ticagrelor|ticagrelor|mesh-list
56291855|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56291856|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56291857|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56291858|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56291859|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
56291860|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56291861|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291862|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291864|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291865|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291866|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56291867|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291868|NCT04474223|Dexamethasone|dexamethasone|mesh-list
56291869|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56291871|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
56291872|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291873|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291874|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291875|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
56291876|NCT04474223|Hormones|hormones|mesh-ancestor
56291877|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56291878|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56291879|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291893|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56291894|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291895|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56291896|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56291897|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
56291898|NCT01466452|Aspirin|aspirin|mesh-list
56291899|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56291900|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56291901|NCT01466452|Analgesics|analgesics|mesh-ancestor
56291902|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
56291903|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291904|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291905|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56291906|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56291907|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56291908|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56291909|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291910|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56291911|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56291912|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56291913|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
56291914|NCT01466374|Antibodies|antibodies|mesh-list
56291915|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
56291916|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56291917|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
56291918|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291919|NCT01466257|Cetuximab|cetuximab|mesh-list
56291920|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56291921|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56291922|NCT04390763|Gemcitabine|gemcitabine|mesh-list
56291923|NCT04390763|Paclitaxel|paclitaxel|mesh-list
56291924|NCT04390763|Spartalizumab|spartalizumab|mesh-list
56291936|NCT04390763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56291937|NCT04390763|Immunologic Factors|immunologic factors|mesh-ancestor
56291938|NCT04390763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291939|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56291940|NCT01466101|Pregabalin|pregabalin|mesh-list
56291941|NCT01466101|Analgesics|analgesics|mesh-ancestor
56291942|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
56079803|NCT00003597|Etoposide|etoposide|mesh-list
56291943|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56291944|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291945|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
56291946|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56291947|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56291948|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291949|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56291950|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56291994|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56291995|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56291996|NCT01465438|Adalimumab|adalimumab|mesh-list
56291997|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56291998|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56291999|NCT01465399|Mitogens|mitogens|mesh-list
56292000|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292001|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292002|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56292003|NCT05393505|Amoxicillin|amoxicillin|mesh-list
56292004|NCT05393505|Levofloxacin|levofloxacin|mesh-list
56292005|NCT05393505|Ofloxacin|ofloxacin|mesh-list
56292006|NCT05393505|Meropenem|meropenem|mesh-list
56292007|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
56292008|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
56292056|NCT00389766|Topotecan|topotecan|mesh-list
56292057|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56292058|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56292059|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56292060|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292061|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292062|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292063|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56292064|NCT01464697|Progesterone|progesterone|mesh-list
56292065|NCT01464697|Progestins|progestins|mesh-ancestor
56292066|NCT01464697|Hormones|hormones|mesh-ancestor
56292067|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292068|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292069|NCT05361720|Nivolumab|nivolumab|mesh-list
56292070|NCT05361720|Ipilimumab|ipilimumab|mesh-list
56292071|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292072|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292073|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56292074|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292075|NCT04083950|Aspirin|aspirin|mesh-list
56292076|NCT04083950|Vaccines|vaccines|mesh-list
56292077|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
56292078|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292079|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56292080|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56292081|NCT04083950|Analgesics|analgesics|mesh-ancestor
56292082|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
56292083|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292084|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56292085|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292086|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56292087|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56292088|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292089|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56292090|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56292091|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292093|NCT00393679|Artesunate|artesunate|mesh-list
56292094|NCT00393679|Lumefantrine|lumefantrine|mesh-list
56292095|NCT00393679|Artemether|artemether|mesh-list
56292096|NCT00393679|Piperaquine|piperaquine|mesh-list
56292097|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56292098|NCT00393679|Amodiaquine|amodiaquine|mesh-list
56292099|NCT00393679|Artenimol|artenimol|mesh-list
56292100|NCT00393679|Dapsone|dapsone|mesh-list
56292101|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
56292102|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
56292103|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56292104|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56292105|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292106|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292107|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
55914073|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
56292108|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
56292109|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56292110|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
56292111|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56292112|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292113|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292114|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
56292115|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56292116|NCT00393835|Azithromycin|azithromycin|mesh-list
56292117|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56292119|NCT04078568|Aspirin|aspirin|mesh-list
56292145|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
56292146|NCT01057069|Paclitaxel|paclitaxel|mesh-list
56292147|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56292148|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
56292149|NCT01057069|Carboplatin|carboplatin|mesh-list
56292150|NCT01057069|Doxorubicin|doxorubicin|mesh-list
56292151|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56292152|NCT01057069|Thiotepa|thiotepa|mesh-list
56292153|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292154|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292155|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292156|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292157|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292158|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292159|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56292160|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
56292161|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292162|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292163|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56292164|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
56292165|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56292166|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56292168|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56292169|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292170|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56292171|NCT00847834|Irbesartan|irbesartan|mesh-list
56292172|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56292173|NCT00847834|Diuretics|diuretics|mesh-ancestor
56292174|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
56292175|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292176|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56292177|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56292178|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292179|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56292187|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56292188|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292189|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56292190|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
56292191|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
56292192|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292193|NCT00847639|Lenalidomide|lenalidomide|mesh-list
56292194|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
56292195|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292196|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56292197|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56292198|NCT00847639|Growth Substances|growth substances|mesh-ancestor
56292199|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
56292200|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292201|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
56292202|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56292203|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292204|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56292205|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292206|NCT00847483|Bimatoprost|bimatoprost|mesh-list
56292207|NCT00847483|Travoprost|travoprost|mesh-list
56292208|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56292209|NCT00847483|Latanoprost|latanoprost|mesh-list
56292210|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56292211|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56292212|NCT04034927|Olaparib|olaparib|mesh-list
56292213|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56292214|NCT04034927|Tremelimumab|tremelimumab|mesh-list
56292215|NCT04034927|Ipilimumab|ipilimumab|mesh-list
56292216|NCT04034927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56292217|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292219|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292226|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292227|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292228|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56292229|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
56292230|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292231|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292232|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56292233|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56292234|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56292235|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56292236|NCT05321160|Ketamine|ketamine|mesh-list
56292237|NCT05321160|Sevoflurane|sevoflurane|mesh-list
56292238|NCT05321160|Esketamine|esketamine|mesh-list
56292239|NCT05321160|Analgesics|analgesics|mesh-ancestor
56292286|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292287|NCT03940586|Letermovir|letermovir|mesh-list
56292288|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56292289|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292290|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292291|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292292|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
56292293|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292294|NCT00847093|Lidocaine|lidocaine|mesh-list
56292295|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
56292296|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
56292297|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56292298|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292299|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
56292300|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292301|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56292302|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56292303|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56292304|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56292305|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292306|NCT00847054|Antibodies|antibodies|mesh-list
56292307|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56292308|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
56292309|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292310|NCT00846976|Bicalutamide|bicalutamide|mesh-list
56292311|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
56292312|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
56292313|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292314|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292315|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292316|NCT00846859|Varenicline|varenicline|mesh-list
56292317|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55905923|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905924|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
55905925|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905926|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55905927|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55905928|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55905929|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55905930|NCT02388048|Ofatumumab|ofatumumab|mesh-list
55905931|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292318|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56292319|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
56292320|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292321|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292322|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292323|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
56292324|NCT03885830|Dasatinib|dasatinib|mesh-list
56292329|NCT00846703|Dexamethasone|dexamethasone|mesh-list
56292387|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56292388|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56292390|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292391|NCT00846274|Antithrombins|antithrombins|mesh-list
56292392|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
56292393|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56292394|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
56292395|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292396|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292397|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
56292398|NCT00846235|Glycerol|glycerol|mesh-list
56292399|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56292400|NCT00846235|Protective Agents|protective agents|mesh-ancestor
56292401|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292402|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
56292403|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
56292404|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56292405|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56292406|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292407|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56292408|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292409|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56292410|NCT00846118|Pitavastatin|pitavastatin|mesh-list
56292411|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56292412|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56292413|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56292414|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
56292415|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292416|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292417|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56292418|NCT00846079|Regadenoson|regadenoson|mesh-list
56292419|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56292420|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56292427|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
56292428|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
56292429|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
56292434|NCT03620942|Phenylephrine|phenylephrine|mesh-list
56292498|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56292499|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56292500|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56292501|NCT00276835|Aldesleukin|aldesleukin|mesh-list
56292502|NCT00276835|Interleukin-2|interleukin-2|mesh-list
56292503|NCT00276835|Genistein|genistein|mesh-list
56292504|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292505|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56292506|NCT00276835|Analgesics|analgesics|mesh-ancestor
56292507|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
56292508|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292509|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292510|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56292511|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56292512|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
56292513|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292514|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56292515|NCT00276835|Protective Agents|protective agents|mesh-ancestor
56292516|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56292517|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292518|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292519|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
56292520|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56292521|NCT00276835|Estrogens|estrogens|mesh-ancestor
56292522|NCT00276835|Hormones|hormones|mesh-ancestor
56292523|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292524|NCT00276796|Paclitaxel|paclitaxel|mesh-list
56292525|NCT00276796|Topotecan|topotecan|mesh-list
56292526|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292527|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292528|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292529|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292530|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292543|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56292544|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
56292545|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56292546|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56292547|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
56292548|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292549|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292550|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
56292551|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292552|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56292553|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55914530|NCT00629499|Paclitaxel|paclitaxel|mesh-list
56292554|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
56292555|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292556|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56292557|NCT00276757|Antidotes|antidotes|mesh-ancestor
56292558|NCT00276757|Protective Agents|protective agents|mesh-ancestor
56292559|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
56292560|NCT00276757|Vitamins|vitamins|mesh-ancestor
56292561|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
56292562|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56292563|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
56292564|NCT00276757|Hormones|hormones|mesh-ancestor
56292565|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292566|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56292567|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292568|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292569|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292570|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292571|NCT00276718|Carboplatin|carboplatin|mesh-list
56292572|NCT00276718|Etoposide|etoposide|mesh-list
56292573|NCT00276718|Bleomycin|bleomycin|mesh-list
56292585|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292586|NCT00276640|Carboplatin|carboplatin|mesh-list
56292587|NCT00276640|Etoposide|etoposide|mesh-list
56292588|NCT00276640|Vincristine|vincristine|mesh-list
56292589|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292590|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292591|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56292592|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56292593|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292594|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292595|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292596|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292597|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292598|NCT00276601|Cytarabine|cytarabine|mesh-list
56292599|NCT00276601|Methotrexate|methotrexate|mesh-list
56292600|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
56292601|NCT00276601|Daunorubicin|daunorubicin|mesh-list
56292602|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
56292603|NCT00276601|Tretinoin|tretinoin|mesh-list
56292604|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56292605|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
56292606|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56292607|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160688|NCT04420572|Betamethasone|betamethasone|mesh-list
55905932|NCT02387892|Vitamin D|vitamin d|mesh-list
55905933|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
55905934|NCT02387892|Vitamins|vitamins|mesh-ancestor
55905935|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
55905936|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905937|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55905968|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55905969|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
55905970|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55905971|NCT00133575|Vaccines|vaccines|mesh-list
55905972|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
55905973|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905974|NCT00134043|Vorinostat|vorinostat|mesh-list
55905975|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905976|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55905977|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905978|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905979|NCT03715998|Ramipril|ramipril|mesh-list
55905980|NCT03715998|Firibastat|firibastat|mesh-list
55905981|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55905982|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
55906012|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
55906013|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55906014|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55906015|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906016|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906017|NCT04641507|Urological Agents|urological agents|mesh-ancestor
55906018|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55906019|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55906020|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56292608|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56292609|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
56292610|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292611|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292612|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
56292614|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56292615|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56292616|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
56292617|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292618|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56292619|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
56292620|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292621|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56292622|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56292623|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56292624|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
56292625|NCT00276523|Interferons|interferons|mesh-list
56292626|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
56292627|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
56292628|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56292629|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292630|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
56292631|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292632|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
56292633|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292634|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
56292635|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56292636|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
56292637|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292638|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56292639|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56292640|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292641|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292642|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
56292643|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292649|NCT00389922|Lapatinib|lapatinib|mesh-list
56292650|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292651|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292652|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292653|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
56292654|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
56292655|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292656|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56292657|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292658|NCT00276289|Spironolactone|spironolactone|mesh-list
56292659|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56292660|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
56292661|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292662|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292663|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56292664|NCT00276289|Diuretics|diuretics|mesh-ancestor
56292665|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
56292666|NCT00276250|Abatacept|abatacept|mesh-list
56292667|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56292668|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292669|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292670|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56292671|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
56292672|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292673|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56292674|NCT00394186|Solabegron|solabegron|mesh-list
56292675|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56292696|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292697|NCT00276055|Gemcitabine|gemcitabine|mesh-list
56292698|NCT00276055|Bevacizumab|bevacizumab|mesh-list
56292699|NCT00276055|Docetaxel|docetaxel|mesh-list
56292700|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292701|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292702|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56292703|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56292704|NCT00276055|Growth Substances|growth substances|mesh-ancestor
56292705|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292706|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
56292762|NCT05566054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292763|NCT05566054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292764|NCT05566054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292765|NCT05565430|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56292766|NCT05565430|Cholinergic Agents|cholinergic agents|mesh-ancestor
56292767|NCT05565430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56292768|NCT05565430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292769|NCT05565430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292770|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
56292771|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292772|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292773|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56292774|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56292775|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292776|NCT02979977|Cetuximab|cetuximab|mesh-list
56292777|NCT02979977|Afatinib|afatinib|mesh-list
56292778|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292779|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292818|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292819|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56292820|NCT05070585|Protective Agents|protective agents|mesh-ancestor
56292821|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292822|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292823|NCT00387530|Valganciclovir|valganciclovir|mesh-list
56292824|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56292825|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
56292826|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292827|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292828|NCT02687906|Meropenem|meropenem|mesh-list
56292829|NCT02687906|Vaborbactam|vaborbactam|mesh-list
56292830|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
56292831|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56292832|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292833|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292834|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292835|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
56292836|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56292837|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292839|NCT00390000|Vatalanib|vatalanib|mesh-list
56292840|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292841|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292842|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292843|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56292844|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56292845|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56292846|NCT04856176|Paclitaxel|paclitaxel|mesh-list
56292847|NCT04856176|Carboplatin|carboplatin|mesh-list
56292848|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
56292849|NCT04856176|Pemetrexed|pemetrexed|mesh-list
56292850|NCT04856176|Molgramostim|molgramostim|mesh-list
56292851|NCT04856176|Sargramostim|sargramostim|mesh-list
56292852|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56292853|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292854|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
56292859|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292860|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56292861|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56292862|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
56292863|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292864|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56292865|NCT02632760|Hematinics|hematinics|mesh-ancestor
56292866|NCT04732507|Lidocaine|lidocaine|mesh-list
56292867|NCT04732507|Bupivacaine|bupivacaine|mesh-list
56292868|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
56292869|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
56292870|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56292871|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292872|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
56292873|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292874|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56292875|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56292876|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56292877|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56292878|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292879|NCT05047770|Vaccines|vaccines|mesh-list
56292880|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
56292881|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292882|NCT02453984|Atezolizumab|atezolizumab|mesh-list
56292883|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292884|NCT04599478|Naltrexone|naltrexone|mesh-list
56292885|NCT04599478|Bupropion|bupropion|mesh-list
56292886|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56292887|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56292888|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292889|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
56292890|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292901|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56292902|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292904|NCT04556617|Olaparib|olaparib|mesh-list
56292905|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
56292906|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56292907|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
56292908|NCT04556617|Hormones|hormones|mesh-ancestor
56292909|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56292910|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292911|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56292913|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56292914|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56292915|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56292916|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56292917|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
56292918|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56292919|NCT04554862|Ketorolac|ketorolac|mesh-list
56292920|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56292921|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
56292922|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56292923|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56292924|NCT04554862|Analgesics|analgesics|mesh-ancestor
56292925|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
56292926|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56292927|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292951|NCT04230499|Sirolimus|sirolimus|mesh-list
56292952|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56292953|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292954|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56292955|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56292956|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
56292957|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56292958|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
56292959|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56292960|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
56292961|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56292962|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
56292963|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56292964|NCT04712435|Expectorants|expectorants|mesh-ancestor
56292965|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
56293015|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
56293016|NCT02966665|Fexofenadine|fexofenadine|mesh-list
56293017|NCT02966665|Valsartan|valsartan|mesh-list
56293018|NCT02966665|Nitroprusside|nitroprusside|mesh-list
56293019|NCT02966665|Phentolamine|phentolamine|mesh-list
56293020|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56293021|NCT02966665|Norepinephrine|norepinephrine|mesh-list
56293022|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
56293023|NCT02966665|Giapreza|giapreza|mesh-list
56293024|NCT02966665|Acetylcholine|acetylcholine|mesh-list
56293025|NCT02966665|Ranitidine|ranitidine|mesh-list
56293026|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
56293027|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
56293028|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293029|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56293030|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56293081|NCT00006044|Hormones|hormones|mesh-ancestor
56293082|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56293083|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293084|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
56293085|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
56293086|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56293087|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293088|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293089|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
56293090|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56293091|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293092|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293093|NCT02395705|Paclitaxel|paclitaxel|mesh-list
56293094|NCT02395705|Cisplatin|cisplatin|mesh-list
56293095|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293096|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293097|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293098|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293099|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293100|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293101|NCT00006047|Etoposide|etoposide|mesh-list
56293102|NCT00006047|Rubitecan|rubitecan|mesh-list
56293103|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
56293104|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293105|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293106|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56293107|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293108|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293109|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293110|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56293111|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
56293112|NCT00083824|Estrogens|estrogens|mesh-list
56293113|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56293114|NCT00083824|Hormones|hormones|mesh-ancestor
56293115|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906021|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
55906022|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806385|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56293116|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293117|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56293118|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56293119|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56293120|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
56293121|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56293122|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56293123|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56293124|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56293125|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56293126|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293128|NCT00083902|Dexamethasone|dexamethasone|mesh-list
56293129|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56293130|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
56293131|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
56293132|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293133|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293134|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56293135|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
56293136|NCT00083902|Hormones|hormones|mesh-ancestor
56293137|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56293138|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56293139|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293140|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293141|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
56293142|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
56293143|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56293144|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293145|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56293146|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56293160|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293161|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
56293162|NCT00006050|Antidotes|antidotes|mesh-ancestor
56293163|NCT00006050|Protective Agents|protective agents|mesh-ancestor
56293164|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
56293165|NCT00006050|Vitamins|vitamins|mesh-ancestor
56293166|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
56293167|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56293168|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56293169|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56293170|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56293171|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293172|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293173|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293174|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56293175|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
56293176|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56293177|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
56293178|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56293179|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
56293180|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293181|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
56293212|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56293213|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293214|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293215|NCT00084097|Omalizumab|omalizumab|mesh-list
56293216|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56293217|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56293218|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
56293219|NCT00084214|Paclitaxel|paclitaxel|mesh-list
56293220|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293221|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293222|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293223|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293224|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293225|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293226|NCT00006056|Cyclosporine|cyclosporine|mesh-list
56293227|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
56293228|NCT00006056|Busulfan|busulfan|mesh-list
56293229|NCT00006056|Methotrexate|methotrexate|mesh-list
56293230|NCT00006056|Etoposide|etoposide|mesh-list
56293231|NCT00006056|Cyclosporins|cyclosporins|mesh-list
56293232|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56293233|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293234|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
56293235|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293236|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293237|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56293238|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
56293239|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293241|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56293242|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56293259|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56293260|NCT00084370|Analgesics|analgesics|mesh-ancestor
56293261|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
56293262|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56293270|NCT00084448|Celecoxib|celecoxib|mesh-list
56293328|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293329|NCT00084721|Celecoxib|celecoxib|mesh-list
56293330|NCT00084721|Irinotecan|irinotecan|mesh-list
56293331|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56293332|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293333|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293334|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293335|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293397|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56293398|NCT00400114|Growth Substances|growth substances|mesh-ancestor
56160713|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
56293399|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293400|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
56293401|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56293402|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56293403|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
56293404|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56293405|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
56293406|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293407|NCT00085228|Docetaxel|docetaxel|mesh-list
56293408|NCT00085228|Oblimersen|oblimersen|mesh-list
56293409|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293410|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293411|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293412|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293458|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
56293459|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55915437|NCT01414075|Iron|iron|mesh-list
56293460|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293461|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
56293462|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293463|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
56293464|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293466|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293467|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56293468|NCT00006080|Protective Agents|protective agents|mesh-ancestor
56293469|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293470|NCT00085462|Aldesleukin|aldesleukin|mesh-list
56293471|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
56293472|NCT00085462|Fludarabine|fludarabine|mesh-list
56293473|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
56293474|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293475|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
56160733|NCT04179474|Analgesics|analgesics|mesh-ancestor
56293476|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293478|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56293479|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
56293480|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293481|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293482|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56293483|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293484|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
56293485|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56293486|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56293487|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
56293488|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293489|NCT00085501|Paclitaxel|paclitaxel|mesh-list
56293490|NCT00085501|Carboplatin|carboplatin|mesh-list
56293491|NCT00085501|Cetuximab|cetuximab|mesh-list
56293492|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56198029|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198030|NCT01511185|Incretins|incretins|mesh-ancestor
56198031|NCT01511185|Hormones|hormones|mesh-ancestor
56198032|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198033|NCT01511198|Metformin|metformin|mesh-list
56198034|NCT01511198|Liraglutide|liraglutide|mesh-list
56198035|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56198036|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198037|NCT01511198|Incretins|incretins|mesh-ancestor
56293493|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293494|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293495|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293496|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293497|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293498|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56293499|NCT00006083|Dalteparin|dalteparin|mesh-list
56293500|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
56293501|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56293502|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56293503|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293504|NCT00085579|Aldesleukin|aldesleukin|mesh-list
56293505|NCT00085579|Sargramostim|sargramostim|mesh-list
56293506|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
56293507|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293508|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293509|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56293553|NCT00085969|Hormones|hormones|mesh-ancestor
56293554|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56293555|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
56293556|NCT00086086|Hematinics|hematinics|mesh-ancestor
56293557|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
56293558|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293559|NCT00086125|Sirolimus|sirolimus|mesh-list
56293560|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56293561|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293562|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56293563|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293564|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
56293565|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293566|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
56293567|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293568|NCT00086203|Rituximab|rituximab|mesh-list
56293569|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56293570|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293571|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
56293572|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293573|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293574|NCT00006095|Irinotecan|irinotecan|mesh-list
56293575|NCT00006095|Vincristine|vincristine|mesh-list
56293576|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56198038|NCT01511198|Hormones|hormones|mesh-ancestor
56198039|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906023|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906024|NCT04489173|Trifluridine|trifluridine|mesh-list
55906025|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
55906026|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906027|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
55906028|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906029|NCT00512070|Olanzapine|olanzapine|mesh-list
55906030|NCT00512070|Melatonin|melatonin|mesh-list
55906059|NCT05661552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906060|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
55906062|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906063|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906064|NCT03534102|Analgesics|analgesics|mesh-ancestor
55906065|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
55906066|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906067|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
55906068|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55906069|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55906070|NCT04051203|Prednisolone|prednisolone|mesh-list
55906071|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
55906072|NCT04051203|Lidocaine|lidocaine|mesh-list
55906073|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55906074|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
55906075|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
55906091|NCT04051203|Hormones|hormones|mesh-ancestor
55906092|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906093|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55906094|NCT04051203|Protective Agents|protective agents|mesh-ancestor
56293577|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56293578|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293579|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293580|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293581|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293583|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293584|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293585|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56293586|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56293587|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56293588|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293589|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293590|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56293591|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56293592|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56293593|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
56293594|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56293595|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293596|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56293597|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56293598|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
56293599|NCT00086359|Ritonavir|ritonavir|mesh-list
56293600|NCT00086359|Lopinavir|lopinavir|mesh-list
56293601|NCT00086359|Lamivudine|lamivudine|mesh-list
56293602|NCT00086359|Zidovudine|zidovudine|mesh-list
56293603|NCT00086359|Abacavir|abacavir|mesh-list
55800205|NCT05048615|Venetoclax|venetoclax|mesh-list
55906095|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55906096|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906097|NCT00144963|Dexamethasone|dexamethasone|mesh-list
55906098|NCT00144963|Vincristine|vincristine|mesh-list
55906099|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55906100|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
55906101|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
55906102|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906103|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906104|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906105|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
55906106|NCT00144963|Hormones|hormones|mesh-ancestor
55906107|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906108|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55906109|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906110|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55906111|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
55906112|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
55906113|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
55906114|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906115|NCT02662764|Sufentanil|sufentanil|mesh-list
55906116|NCT02662764|Dsuvia|dsuvia|mesh-list
55906117|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56293604|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56293605|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56293606|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56293607|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
56293608|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293609|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293610|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55915561|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56293611|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56293612|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
56293613|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293614|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56293615|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56293616|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56293617|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56293618|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
56293620|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293621|NCT00086593|Lamotrigine|lamotrigine|mesh-list
56293622|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
56293623|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56293624|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56293625|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293626|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56293627|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293628|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56293629|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56293630|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293631|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56293632|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56293633|NCT00387569|Vaccines|vaccines|mesh-list
56293634|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
56293635|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293644|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56293645|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293646|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56293647|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56293648|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
56293649|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293650|NCT00006104|Docetaxel|docetaxel|mesh-list
56293651|NCT00006104|Trastuzumab|trastuzumab|mesh-list
56293652|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293653|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293654|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293655|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293656|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293657|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56293658|NCT00086827|Romidepsin|romidepsin|mesh-list
56293659|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56293660|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293661|NCT00086944|Rituximab|rituximab|mesh-list
56293662|NCT00086944|Carboplatin|carboplatin|mesh-list
56293663|NCT00086944|Etoposide|etoposide|mesh-list
56293664|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
56293665|NCT00086944|Ifosfamide|ifosfamide|mesh-list
56293666|NCT00086944|Oblimersen|oblimersen|mesh-list
56293667|NCT00086944|Lenograstim|lenograstim|mesh-list
56293668|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56293669|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293670|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
56293671|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293672|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56293673|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293674|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56293681|NCT00006107|Docetaxel|docetaxel|mesh-list
56293690|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293691|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293692|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293693|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56293694|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56293695|NCT00006113|Interferons|interferons|mesh-list
56293696|NCT00006113|Aldesleukin|aldesleukin|mesh-list
56293697|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
56293698|NCT00006113|Interleukin-4|interleukin-4|mesh-list
56293699|NCT00006113|Sargramostim|sargramostim|mesh-list
56293701|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
56293757|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293758|NCT04762953|Antidotes|antidotes|mesh-ancestor
56293759|NCT04762953|Protective Agents|protective agents|mesh-ancestor
56293760|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
56293762|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
56293763|NCT00087334|Capecitabine|capecitabine|mesh-list
56293764|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
56293765|NCT00087334|Gefitinib|gefitinib|mesh-list
56293766|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293767|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
56293768|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293769|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293770|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56293771|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293772|NCT00087373|Metronidazole|metronidazole|mesh-list
56293773|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293774|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56293775|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56293776|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56293777|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
56293778|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293779|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
56293780|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293781|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293782|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56293783|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56293784|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933814|NCT04405193|Expectorants|expectorants|mesh-ancestor
55906118|NCT02662764|Narcotics|narcotics|mesh-ancestor
55906119|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906120|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906121|NCT02662764|Analgesics|analgesics|mesh-ancestor
56198040|NCT01511211|Dexamethasone|dexamethasone|mesh-list
56198041|NCT01511211|Ropivacaine|ropivacaine|mesh-list
56198042|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198043|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
56198044|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
56198045|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906122|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
55906123|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906124|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55906125|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55906126|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
55906127|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
55906129|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
55906130|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906132|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
55906133|NCT03478956|Etrolizumab|etrolizumab|mesh-list
55906134|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906135|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
56293785|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56293786|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293787|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293788|NCT00087451|Sirolimus|sirolimus|mesh-list
56293789|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56293790|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293791|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56293792|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293793|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
56293794|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293795|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
56293796|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293797|NCT00006122|Cytarabine|cytarabine|mesh-list
56293798|NCT00006122|Etoposide|etoposide|mesh-list
56293799|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
56293800|NCT00006122|Idarubicin|idarubicin|mesh-list
56293801|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
56293802|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293803|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293804|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56160783|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56293806|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293807|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293808|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293809|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
56293810|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
56293811|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293812|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293813|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
56293814|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293815|NCT00006122|Analgesics|analgesics|mesh-ancestor
56293816|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
56293821|NCT00087802|Paclitaxel|paclitaxel|mesh-list
56293829|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034020|NCT01656629|Vitamin D|vitamin d|mesh-list
56293830|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56293831|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
56293832|NCT00087802|Antiviral Agents|antiviral agents|mesh-ancestor
56293833|NCT00087802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56293834|NCT00087802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293835|NCT00087802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293836|NCT00087802|Immunologic Factors|immunologic factors|mesh-ancestor
56293837|NCT00087802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293838|NCT04760613|Cannabidiol|cannabidiol|mesh-list
56293839|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
56293890|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56293891|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56293892|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56293893|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56293894|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
56293895|NCT00088114|Paclitaxel|paclitaxel|mesh-list
56293896|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56293897|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293898|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
56293899|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
56293900|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
56293901|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293902|NCT00006131|Valacyclovir|valacyclovir|mesh-list
56293903|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
56293905|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
56293906|NCT00088231|Vatalanib|vatalanib|mesh-list
56293907|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293908|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56293909|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293910|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293911|NCT00088270|Leucovorin|leucovorin|mesh-list
56293912|NCT00088270|Fluorouracil|fluorouracil|mesh-list
56293913|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
56293923|NCT00088270|Vitamins|vitamins|mesh-ancestor
56293946|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
56293947|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293948|NCT00006137|Enalapril|enalapril|mesh-list
56293949|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56293950|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
56293951|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56293952|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56293953|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56293954|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
56293955|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56293956|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
56293957|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293958|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56293959|NCT00088582|Octreotide|octreotide|mesh-list
56293960|NCT00088582|Pasireotide|pasireotide|mesh-list
56293961|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56293962|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56293963|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293964|NCT00088582|Hormones|hormones|mesh-ancestor
56293965|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56293966|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56293967|NCT00088816|Tegafur|tegafur|mesh-list
56293968|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56293998|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56293999|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294000|NCT00088894|Growth Substances|growth substances|mesh-ancestor
56294001|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294002|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294003|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
56294068|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56294069|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294070|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294072|NCT00089089|Azacitidine|azacitidine|mesh-list
56294073|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56294074|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
56294075|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294076|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294077|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294078|NCT00089167|Thalidomide|thalidomide|mesh-list
56294079|NCT00089167|Dexamethasone|dexamethasone|mesh-list
56294080|NCT00089167|Melphalan|melphalan|mesh-list
56294081|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56294082|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
56294083|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
56294084|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294085|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294086|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56294087|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
56294127|NCT00423826|Busulfan|busulfan|mesh-list
56294128|NCT00423826|Tacrolimus|tacrolimus|mesh-list
56294208|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294209|NCT00089401|Melphalan|melphalan|mesh-list
56294210|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56294211|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
56294212|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294213|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294214|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56294215|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294216|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
56294217|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294218|NCT00089440|Aripiprazole|aripiprazole|mesh-list
56294219|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
56294220|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56294221|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56294222|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56294223|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56294224|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294225|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
56294226|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
56294227|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56294228|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294229|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56294230|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56294231|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
56294232|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56294233|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56294234|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56294235|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56294236|NCT00089518|Valsartan|valsartan|mesh-list
56294237|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56294241|NCT00089557|Capsaicin|capsaicin|mesh-list
56294250|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56294251|NCT00089830|Protective Agents|protective agents|mesh-ancestor
56294252|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294253|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294254|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56294255|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294256|NCT00089830|Growth Substances|growth substances|mesh-ancestor
56294257|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294319|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294320|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56294390|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294391|NCT00091468|Nicotine|nicotine|mesh-list
56294392|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56294393|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
56294394|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294460|NCT00390195|Everolimus|everolimus|mesh-list
56294461|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294462|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56294463|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
56294464|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294465|NCT00091897|Rituximab|rituximab|mesh-list
56294530|NCT00092326|Acetaminophen|acetaminophen|mesh-list
56294531|NCT00092326|Rofecoxib|rofecoxib|mesh-list
56294532|NCT00092326|Oxycodone|oxycodone|mesh-list
56294533|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56294534|NCT00092326|Analgesics|analgesics|mesh-ancestor
56294535|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
56294536|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56294537|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294538|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
56294539|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56294540|NCT00092326|Narcotics|narcotics|mesh-ancestor
56294541|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56294542|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55916539|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
56294594|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294595|NCT00006224|Antiviral Agents|antiviral agents|mesh-ancestor
56294596|NCT00006224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294597|NCT00006224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294601|NCT00093223|Paclitaxel|paclitaxel|mesh-list
56294662|NCT00093769|Rituximab|rituximab|mesh-list
56294663|NCT00093769|Bortezomib|bortezomib|mesh-list
56294664|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56294665|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294666|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
56294667|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916615|NCT03147378|Docetaxel|docetaxel|mesh-list
56294730|NCT00094081|Tirapazamine|tirapazamine|mesh-list
56294731|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294732|NCT00094120|Squalamine|squalamine|mesh-list
56294733|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294734|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56294735|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56294736|NCT00094120|Protective Agents|protective agents|mesh-ancestor
56294737|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294738|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294739|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56294740|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56294741|NCT00094120|Growth Substances|growth substances|mesh-ancestor
56294742|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294743|NCT00006245|Paclitaxel|paclitaxel|mesh-list
56294744|NCT00006245|Alvocidib|alvocidib|mesh-list
56294745|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56294746|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294747|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
56294748|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
56294749|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
56294750|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294751|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
56294752|NCT00006245|Growth Substances|growth substances|mesh-ancestor
56294753|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294756|NCT00094315|Cocaine|cocaine|mesh-list
56294780|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294781|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56294782|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56294852|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
56294853|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56294926|NCT00006260|Ifosfamide|ifosfamide|mesh-list
56294927|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56294928|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56294929|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56294930|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56294931|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56294932|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56294933|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56294934|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
56294935|NCT00095329|Sirolimus|sirolimus|mesh-list
56294936|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56294988|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56294989|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56294990|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56294991|NCT04476030|Citalopram|citalopram|mesh-list
56295058|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56295059|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295060|NCT04432428|Analgesics|analgesics|mesh-ancestor
56295061|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
56295062|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295063|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56295064|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56295065|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
56295066|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
56295067|NCT00096070|Gemcitabine|gemcitabine|mesh-list
56295068|NCT00096070|Fluorouracil|fluorouracil|mesh-list
56295069|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
56295070|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56295071|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
56295072|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295073|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295074|NCT00096070|Antiviral Agents|antiviral agents|mesh-ancestor
56295075|NCT00096070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295076|NCT00096070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295077|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56295115|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295116|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295117|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295118|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56295119|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56295120|NCT00096304|Docetaxel|docetaxel|mesh-list
56295185|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56295186|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56295187|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
56295188|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295189|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295190|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56295256|NCT00390273|Metformin|metformin|mesh-list
56295257|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56295258|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295259|NCT00097318|Interferons|interferons|mesh-list
56295260|NCT00097318|Interferon-beta|interferon-beta|mesh-list
56295261|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
56295263|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
56295331|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295332|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56295333|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56295400|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56295403|NCT00098683|Amifostine|amifostine|mesh-list
56295474|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56295475|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56295549|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295550|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56295618|NCT00006368|Edotreotide|edotreotide|mesh-list
56295619|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56295620|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295689|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
56295765|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
56295766|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
56295767|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295768|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
56295769|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56295770|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56295771|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295772|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56295773|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56295774|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
56295775|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56295828|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56295831|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56295899|NCT00101569|Aripiprazole|aripiprazole|mesh-list
56295900|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
56295901|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56295907|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
56295971|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56295972|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56295973|NCT00101842|Gemcitabine|gemcitabine|mesh-list
56295974|NCT00101842|Pemetrexed|pemetrexed|mesh-list
56295975|NCT00101842|Cisplatin|cisplatin|mesh-list
56296043|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296044|NCT00006428|Amitriptyline|amitriptyline|mesh-list
56296045|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56296046|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
56296047|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56296048|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56296049|NCT00006428|Analgesics|analgesics|mesh-ancestor
56296050|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
56296051|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56296052|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296053|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56296105|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56296106|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296107|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
56296108|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56296109|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
56296110|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56296111|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56296112|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56296113|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56296114|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56296115|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
56296116|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56296117|NCT00006443|Lamivudine|lamivudine|mesh-list
56296118|NCT00006443|Stavudine|stavudine|mesh-list
56296119|NCT00006443|Nelfinavir|nelfinavir|mesh-list
56296120|NCT00006443|Indinavir|indinavir|mesh-list
56296121|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56296122|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56296123|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296163|NCT00103246|Silicon|silicon|mesh-list
56296239|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56296240|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
56296241|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296312|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56296313|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56296386|NCT03869892|Capecitabine|capecitabine|mesh-list
56296387|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56296395|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
56296460|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296461|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56296462|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
56296464|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56296534|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56296535|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
56296536|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56296539|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
56296608|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
56296609|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56296681|NCT03746106|Vitamins|vitamins|mesh-ancestor
56296682|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
56296683|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296756|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56296831|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
56296903|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56296904|NCT00108238|Progestins|progestins|mesh-ancestor
56296905|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56296906|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
56296907|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56296908|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56296910|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
56296969|NCT03619551|Busulfan|busulfan|mesh-list
56297039|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56297041|NCT00109135|Hormones|hormones|mesh-ancestor
56297044|NCT00006929|Suramin|suramin|mesh-list
56297112|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56297113|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56297114|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56297115|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297116|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297117|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56297118|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56297119|NCT00109798|Temozolomide|temozolomide|mesh-list
56297120|NCT00109798|Topotecan|topotecan|mesh-list
56297121|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56297178|NCT00110071|Trace Elements|trace elements|mesh-ancestor
56297179|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
56297180|NCT00110188|Sirolimus|sirolimus|mesh-list
56297185|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
56297252|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
56297253|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
56297324|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56297400|NCT00111748|Hormones|hormones|mesh-ancestor
56297401|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56297473|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56297474|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56297475|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
56297476|NCT00007358|Hormones|hormones|mesh-ancestor
56297480|NCT00112138|Gabapentin|gabapentin|mesh-list
56297546|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56297547|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56297548|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297549|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56297616|NCT00007670|Gabapentin|gabapentin|mesh-list
56297617|NCT00007670|Analgesics|analgesics|mesh-ancestor
56297618|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
56297619|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56297621|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
56297688|NCT00113113|Rubitecan|rubitecan|mesh-list
56297689|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56297690|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56297764|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56297765|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297766|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56297836|NCT00113854|Diuretics|diuretics|mesh-ancestor
56297911|NCT00114400|Hematinics|hematinics|mesh-ancestor
56297912|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
56297913|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
56297914|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56297915|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56297985|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298062|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298063|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56298064|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56298065|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
56298066|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
56298067|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56298068|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56298069|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56298070|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298071|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298072|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56298073|NCT00115102|Narcotics|narcotics|mesh-ancestor
56298074|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56298075|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
56298077|NCT00115219|Etanercept|etanercept|mesh-list
55937972|NCT01193049|Prednisone|prednisone|mesh-list
56298123|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
56298194|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
56298195|NCT00008294|Floxuridine|floxuridine|mesh-list
56298269|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56298271|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
56298343|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298345|NCT00116545|Troglitazone|troglitazone|mesh-list
56298419|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298494|NCT00117442|Paclitaxel|paclitaxel|mesh-list
56298502|NCT00117520|Caffeine|caffeine|mesh-list
56298568|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56298569|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298570|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298572|NCT00118027|Renal Agents|renal agents|mesh-ancestor
56298642|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56298644|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298645|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298646|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56298647|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
56298648|NCT00118261|Antidotes|antidotes|mesh-ancestor
56298649|NCT00118261|Protective Agents|protective agents|mesh-ancestor
56298650|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
56298651|NCT00118261|Vitamins|vitamins|mesh-ancestor
56298652|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
56298653|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56298654|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56298655|NCT00118300|Capecitabine|capecitabine|mesh-list
56298656|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56298657|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
56298689|NCT00118690|Xhance|xhance|mesh-list
56298704|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56298705|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298779|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56298851|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56298852|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56298927|NCT00391014|Amebicides|amebicides|mesh-ancestor
56298928|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56298929|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56298930|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56298931|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56298932|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
56298933|NCT00120601|Naltrexone|naltrexone|mesh-list
56298934|NCT00120601|Acamprosate|acamprosate|mesh-list
56298935|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56298936|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56298937|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56298938|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
56298958|NCT00120640|Hormones|hormones|mesh-ancestor
56298991|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56298992|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299065|NCT05637398|Gout Suppressants|gout suppressants|mesh-ancestor
56299066|NCT05637398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56299067|NCT05637398|Tubulin Modulators|tubulin modulators|mesh-ancestor
55939049|NCT04278599|Zinc|zinc|mesh-list
56299207|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
56299209|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299281|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299282|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299283|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56299284|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299285|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
56299286|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56299287|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
56299288|NCT00129142|Toremifene|toremifene|mesh-list
56299330|NCT00128752|Vitamins|vitamins|mesh-ancestor
56299347|NCT05638451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56299348|NCT05638451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299349|NCT05638451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56299350|NCT05638451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56299351|NCT05638451|Growth Substances|growth substances|mesh-ancestor
56299352|NCT05638451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299353|NCT05638451|Growth Inhibitors|growth inhibitors|mesh-ancestor
56299354|NCT05638451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56299355|NCT05638451|Alkylating Agents|alkylating agents|mesh-ancestor
56299356|NCT05638451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299357|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56299358|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
56299408|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56299409|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56299478|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56299479|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299550|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
56299551|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
56299552|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56299553|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
56299554|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56299555|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56299556|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56299557|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56299558|NCT00018850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56299559|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56299560|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
56299561|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56299562|NCT00009750|Cyclosporine|cyclosporine|mesh-list
56299563|NCT00009750|Paclitaxel|paclitaxel|mesh-list
56299564|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56299612|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299613|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299614|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299615|NCT00019318|Romidepsin|romidepsin|mesh-list
56299616|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56299617|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299618|NCT00019357|Aldesleukin|aldesleukin|mesh-list
56299619|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299620|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56299621|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56299622|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
56299623|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299624|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56299625|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
56299626|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56299627|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
56299628|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299629|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56299630|NCT00019396|Protective Agents|protective agents|mesh-ancestor
56299631|NCT00009828|Leucovorin|leucovorin|mesh-list
56299632|NCT00009828|Paclitaxel|paclitaxel|mesh-list
56299633|NCT00009828|Tegafur|tegafur|mesh-list
56299634|NCT00009828|Calcium|calcium|mesh-list
56299635|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
56299636|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56299637|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299638|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
56299639|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
56299647|NCT00009828|Vitamins|vitamins|mesh-ancestor
56299662|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299663|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
56299664|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299665|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
56299666|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299667|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
56299668|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299669|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56299670|NCT00019513|Leucovorin|leucovorin|mesh-list
56299671|NCT00019513|Gemcitabine|gemcitabine|mesh-list
56299672|NCT00019513|Fluorouracil|fluorouracil|mesh-list
56299673|NCT00019513|Calcium|calcium|mesh-list
56299674|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
56299675|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299676|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
56299677|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299678|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299679|NCT00019513|Antiviral Agents|antiviral agents|mesh-ancestor
56299680|NCT00019513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299681|NCT00019513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299682|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56299683|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
56299684|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299685|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56299686|NCT00019513|Antidotes|antidotes|mesh-ancestor
56299714|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56299715|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56299716|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
56299717|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299718|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
56299719|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299720|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56299721|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299722|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299723|NCT00019786|Melphalan|melphalan|mesh-list
56299781|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56299782|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56299783|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
56299784|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299785|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299786|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56299787|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56299788|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
56299789|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921743|NCT03153163|Maytansine|maytansine|mesh-list
56299790|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
56299791|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299792|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
56299793|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56299794|NCT00020254|Aldesleukin|aldesleukin|mesh-list
56299795|NCT00020254|Nilutamide|nilutamide|mesh-list
56299796|NCT00020254|Vaccines|vaccines|mesh-list
56299797|NCT00020254|Sargramostim|sargramostim|mesh-list
56299798|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
56299799|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299836|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299837|NCT00020371|Lenograstim|lenograstim|mesh-list
56299838|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56299839|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
56299840|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299841|NCT00020410|Antibodies|antibodies|mesh-list
56299842|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56299843|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
56299844|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56299845|NCT00020449|Paclitaxel|paclitaxel|mesh-list
56299846|NCT00020449|Doxorubicin|doxorubicin|mesh-list
56299847|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56299848|NCT00020449|Interleukin-12|interleukin-12|mesh-list
56299849|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56299850|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299851|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
56299852|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
56299853|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
56299854|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299855|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56299856|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56299857|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56299858|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299859|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56299860|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
56160967|NCT02966184|Albuterol|albuterol|mesh-list
56299888|NCT00020488|Protective Agents|protective agents|mesh-ancestor
56299889|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
56299890|NCT00020488|Vitamins|vitamins|mesh-ancestor
56299891|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
56299892|NCT00020527|Caspofungin|caspofungin|mesh-list
56299893|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
56299894|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56299895|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299896|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299897|NCT00020566|Dactinomycin|dactinomycin|mesh-list
56299898|NCT00020566|Doxorubicin|doxorubicin|mesh-list
56299899|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56299900|NCT00020566|Etoposide|etoposide|mesh-list
56299901|NCT00020566|Vincristine|vincristine|mesh-list
56299902|NCT00020566|Melphalan|melphalan|mesh-list
56299903|NCT00020566|Busulfan|busulfan|mesh-list
56299904|NCT00020566|Ifosfamide|ifosfamide|mesh-list
56299905|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56299906|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299907|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56299908|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56299909|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56299910|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299911|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56299912|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
56299925|NCT00010062|Fluorouracil|fluorouracil|mesh-list
56299940|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
56299941|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56299942|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56299943|NCT00020644|Antiviral Agents|antiviral agents|mesh-ancestor
55921897|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
56299944|NCT00020644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300009|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300010|NCT00020917|Leucovorin|leucovorin|mesh-list
56300011|NCT00020917|Fluorouracil|fluorouracil|mesh-list
56300012|NCT00020917|Irinotecan|irinotecan|mesh-list
56300013|NCT00020917|Cetuximab|cetuximab|mesh-list
56300014|NCT00020917|Calcium|calcium|mesh-list
56300015|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
56300016|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56300017|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300018|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
56300019|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921986|NCT04404751|Iron|iron|mesh-list
56300020|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300021|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300022|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300072|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
56300073|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300074|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300075|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300076|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300077|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
56300078|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300140|NCT00021502|Analgesics|analgesics|mesh-ancestor
56300141|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
56300142|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300143|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300144|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300145|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56300146|NCT00000134|Ganciclovir|ganciclovir|mesh-list
56300147|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56300148|NCT00000134|Foscarnet|foscarnet|mesh-list
56300149|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
56300150|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300151|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300152|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300155|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
56300201|NCT00022009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300202|NCT00022009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300203|NCT00022009|Immunologic Factors|immunologic factors|mesh-ancestor
56300204|NCT00022009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300205|NCT00388661|Melatonin|melatonin|mesh-list
56300206|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
56300207|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300208|NCT00388661|Protective Agents|protective agents|mesh-ancestor
56300209|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300272|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300273|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
56300274|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
56300275|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300276|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56300277|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
56300278|NCT00022126|Hormones|hormones|mesh-ancestor
56300279|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56300280|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56300281|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56300282|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56300284|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300337|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56300338|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
56300339|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
56300340|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56300341|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56300342|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56300343|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56300344|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
56300345|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56300404|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56300405|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56300406|NCT00000146|Prednisolone|prednisolone|mesh-list
56300407|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
56300408|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56300409|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
56300410|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300411|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
56300412|NCT00000146|Hormones|hormones|mesh-ancestor
56300413|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56300414|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300415|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56300416|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300417|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
56300423|NCT00010725|Vitamins|vitamins|mesh-list
56300466|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300467|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
56300468|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
56300469|NCT00000152|Protective Agents|protective agents|mesh-ancestor
56300470|NCT00000152|Provitamins|provitamins|mesh-ancestor
56300471|NCT00000152|Vitamins|vitamins|mesh-ancestor
56300472|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
56300474|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300475|NCT00010881|Protective Agents|protective agents|mesh-ancestor
56300476|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300478|NCT00022906|Antibodies|antibodies|mesh-list
56300534|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300535|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300536|NCT00000170|Atropine|atropine|mesh-list
56300537|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56300538|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56300539|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56300540|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
56300541|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300542|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300543|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56160977|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56300545|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
56300546|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
56300547|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56300548|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56300549|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
56300550|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56300592|NCT00023296|Protective Agents|protective agents|mesh-ancestor
56300593|NCT00023335|Isoniazid|isoniazid|mesh-list
56300594|NCT00023335|Rifapentine|rifapentine|mesh-list
56300595|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
56300596|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56300597|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56300598|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56300599|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56300600|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
56300601|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300602|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56300603|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56300604|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
56300605|NCT00000173|Vitamin E|vitamin e|mesh-list
56300606|NCT00000173|Donepezil|donepezil|mesh-list
56300607|NCT00000173|Vitamins|vitamins|mesh-ancestor
56300609|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300610|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56300650|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56300651|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
56300652|NCT00023530|Thalidomide|thalidomide|mesh-list
56300653|NCT00023530|Fluconazole|fluconazole|mesh-list
56300654|NCT00023530|Voriconazole|voriconazole|mesh-list
56300655|NCT00023530|Dexamethasone|dexamethasone|mesh-list
56300656|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56300720|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300721|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
56300722|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300723|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56300724|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300725|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300726|NCT00391404|Alendronate|alendronate|mesh-list
56300727|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56300729|NCT00000191|Carbamazepine|carbamazepine|mesh-list
56300791|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300862|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
56300863|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56300938|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
56300939|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300940|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300941|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
56300942|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56300943|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300944|NCT00024349|Fluorouracil|fluorouracil|mesh-list
56300945|NCT00024349|Mitomycins|mitomycins|mesh-list
56300946|NCT00024349|Mitomycin|mitomycin|mesh-list
56300947|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
56300948|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56300949|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56300950|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56300951|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56300952|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
56300953|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300954|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56300955|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
56300956|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56300957|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56300958|NCT00000251|Isoflurane|isoflurane|mesh-list
56300960|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
56300994|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
56300995|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56300996|NCT04733131|Abatacept|abatacept|mesh-list
56301004|NCT00024544|Antibodies|antibodies|mesh-list
56301066|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301067|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
56301068|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301069|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301070|NCT00025168|Antiviral Agents|antiviral agents|mesh-ancestor
56301071|NCT00025168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301072|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301073|NCT00025168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301074|NCT00025168|Immunologic Factors|immunologic factors|mesh-ancestor
56301075|NCT00025168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301132|NCT00025363|Sargramostim|sargramostim|mesh-list
56301133|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301134|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
56301135|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301136|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56301137|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301138|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
56301139|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301140|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301141|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56301152|NCT00025402|Cytarabine|cytarabine|mesh-list
56301198|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56301199|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301200|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301273|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56301274|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
56301275|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301276|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56301277|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301278|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
56301279|NCT00025597|Carboplatin|carboplatin|mesh-list
56301341|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
56301342|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
56301343|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301344|NCT00025675|Gefitinib|gefitinib|mesh-list
56301414|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301415|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301416|NCT00026182|Growth Substances|growth substances|mesh-ancestor
56301417|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301418|NCT00026260|Semaxinib|semaxinib|mesh-list
56301419|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56301420|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301421|NCT00026260|Growth Substances|growth substances|mesh-ancestor
56301480|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56301481|NCT00026416|Growth Substances|growth substances|mesh-ancestor
56301482|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
56301483|NCT00026533|Thalidomide|thalidomide|mesh-list
56301484|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301485|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
56301486|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301487|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
56301488|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56301489|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56301548|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
56301549|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56301550|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56301551|NCT00000428|Analgesics|analgesics|mesh-ancestor
56301552|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
56301553|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56301554|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301555|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56301556|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56301559|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
56301614|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301615|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301616|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
56301685|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56301686|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
56301687|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56301688|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56301759|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
56301760|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301761|NCT00027820|Cyclosporine|cyclosporine|mesh-list
56301762|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
56301763|NCT00027820|Fludarabine|fludarabine|mesh-list
56301764|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
56301765|NCT00027820|Cyclosporins|cyclosporins|mesh-list
56301766|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301767|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56301768|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
56301769|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301770|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301771|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
56301772|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301773|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301820|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56301821|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56301822|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56301823|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301825|NCT00027937|Paclitaxel|paclitaxel|mesh-list
56301826|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
56301827|NCT00027937|Melphalan|melphalan|mesh-list
56301828|NCT00027937|Busulfan|busulfan|mesh-list
56301829|NCT00027937|Thiotepa|thiotepa|mesh-list
56301830|NCT00027937|Sargramostim|sargramostim|mesh-list
56301831|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56301832|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56301833|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
56301834|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
56301835|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
56301836|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56301837|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301838|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
56301879|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56301880|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56301884|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
56301952|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56301953|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56301954|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
56302023|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56302024|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
56302025|NCT00028366|Ritonavir|ritonavir|mesh-list
56302026|NCT00028366|Lopinavir|lopinavir|mesh-list
56302027|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
56302028|NCT00028366|Tenofovir|tenofovir|mesh-list
56302029|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56302030|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56302169|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302170|NCT00028756|Gemcitabine|gemcitabine|mesh-list
56302171|NCT00028756|Doxorubicin|doxorubicin|mesh-list
56302172|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56302173|NCT00028756|Methotrexate|methotrexate|mesh-list
56302174|NCT00028756|Vinblastine|vinblastine|mesh-list
56302175|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302176|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302177|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
56302236|NCT00028834|Bevacizumab|bevacizumab|mesh-list
56302237|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56302238|NCT00028834|Antibodies|antibodies|mesh-list
56302239|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
56302240|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56302241|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302242|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56302243|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56302244|NCT00028834|Growth Substances|growth substances|mesh-ancestor
56302245|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302246|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
56302247|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
56302248|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302249|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
56302250|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302251|NCT00028834|Antiviral Agents|antiviral agents|mesh-ancestor
56302252|NCT00028834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302253|NCT00028834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302254|NCT00028834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56302255|NCT00028873|Paclitaxel|paclitaxel|mesh-list
56302256|NCT00028873|Docetaxel|docetaxel|mesh-list
56302257|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56302258|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161013|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
56302288|NCT00028990|Paclitaxel|paclitaxel|mesh-list
56302289|NCT00028990|Bevacizumab|bevacizumab|mesh-list
56302290|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56302291|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302292|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302293|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
56302294|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302295|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302296|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56302297|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56302298|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56302299|NCT00028990|Growth Substances|growth substances|mesh-ancestor
56302300|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302350|NCT00029458|Clozapine|clozapine|mesh-list
56302351|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56302352|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
56302353|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56302354|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302355|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302356|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56302357|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56302358|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56302359|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56302360|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
56302361|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
56302362|NCT00029497|Amitriptyline|amitriptyline|mesh-list
56302363|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56302364|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
56302365|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56302366|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56302367|NCT00029497|Analgesics|analgesics|mesh-ancestor
56302368|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
56302370|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302392|NCT00012519|Ritonavir|ritonavir|mesh-list
56302405|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56302481|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302482|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302483|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56302484|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56302485|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56302486|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302487|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56302488|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56302489|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302490|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
56302491|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
56302492|NCT00000500|Protective Agents|protective agents|mesh-ancestor
56302493|NCT00395902|Cinacalcet|cinacalcet|mesh-list
56302543|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56302544|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56302616|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
56302690|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56302691|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302692|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302693|NCT00030745|Gemcitabine|gemcitabine|mesh-list
56302694|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302695|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302696|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
56302697|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302706|NCT00030784|Ifosfamide|ifosfamide|mesh-list
56302757|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
56302758|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302759|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302760|NCT00031057|Riboflavin|riboflavin|mesh-list
56302761|NCT00031057|Thiamine|thiamine|mesh-list
56302762|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
56302763|NCT00031057|Vitamins|vitamins|mesh-ancestor
56302764|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
56302765|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302766|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56302767|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
56302768|NCT00000554|Dobutamine|dobutamine|mesh-list
56302769|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56302770|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
56302771|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
56302819|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56302820|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56302821|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56302822|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56302823|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302824|NCT00000563|Dexamethasone|dexamethasone|mesh-list
56302825|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56302826|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
56302827|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
56302828|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302830|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56302884|NCT01791816|Phenylephrine|phenylephrine|mesh-list
56302885|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
56302886|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56302887|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56302888|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
56302889|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
56302890|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56302891|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56302892|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
56302893|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56302894|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
56302949|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56302950|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
56302951|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
56302952|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
56302953|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56302954|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56302955|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
56302956|NCT00031954|Antiviral Agents|antiviral agents|mesh-ancestor
56302957|NCT00031954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56302958|NCT00031954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56302959|NCT00031954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303011|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56303012|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56303013|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303014|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303015|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303016|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
56303017|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303018|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
56303019|NCT00032149|Hormones|hormones|mesh-ancestor
56303020|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56303021|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56303022|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303023|NCT00032149|Analgesics|analgesics|mesh-ancestor
56303025|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56303026|NCT00032188|Aldesleukin|aldesleukin|mesh-list
56303027|NCT00032188|Interleukin-2|interleukin-2|mesh-list
56303028|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
56303029|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303030|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56303031|NCT00032188|Analgesics|analgesics|mesh-ancestor
56303032|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
56303033|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303034|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303035|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56303036|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56303037|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
56303038|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303039|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56303040|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
55924967|NCT04403191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56303059|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56303060|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56303061|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303062|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
56303063|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56303064|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56303065|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56303066|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303126|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303127|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303128|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56303129|NCT00032929|Protective Agents|protective agents|mesh-ancestor
56303130|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303131|NCT00000611|Vitamin D|vitamin d|mesh-list
56303132|NCT00000611|Calcium|calcium|mesh-list
56303133|NCT00000611|Hormones|hormones|mesh-list
56303134|NCT00000611|Estrogens|estrogens|mesh-list
56303135|NCT00000611|Progestins|progestins|mesh-list
56303136|NCT00000611|Vitamins|vitamins|mesh-ancestor
56303137|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
56303138|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303188|NCT00033241|Gemcitabine|gemcitabine|mesh-list
56303267|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56303268|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56303269|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
56303270|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56303271|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56303272|NCT00000620|Urological Agents|urological agents|mesh-ancestor
56303273|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56303274|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56303275|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56303276|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56303277|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56303278|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56303279|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56303282|NCT00033280|Temozolomide|temozolomide|mesh-list
56303328|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303329|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56303330|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303331|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303332|NCT00033436|Niacinamide|niacinamide|mesh-list
56303333|NCT00033436|Niacin|niacin|mesh-list
56303334|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
56303335|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
56303397|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56303398|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303399|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56303400|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303401|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303402|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56303403|NCT00013689|Renal Agents|renal agents|mesh-ancestor
56303404|NCT00033709|Thalidomide|thalidomide|mesh-list
56303405|NCT00033709|Temozolomide|temozolomide|mesh-list
56303406|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56303407|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
56303422|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
56303460|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56303461|NCT02971423|Imipenem|imipenem|mesh-list
56303462|NCT02971423|Sulbactam|sulbactam|mesh-list
56303463|NCT02971423|Cilastatin|cilastatin|mesh-list
56303464|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56303465|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303466|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
56303467|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303468|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303469|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56303470|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56303471|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56303472|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
56303474|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303518|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303520|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56303521|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56303522|NCT00389129|Analgesics|analgesics|mesh-ancestor
56303523|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
56303524|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303525|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303526|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303586|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303587|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56303588|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303589|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303590|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
56303591|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303592|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56303593|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56303595|NCT02971540|Tramadol|tramadol|mesh-list
56303596|NCT02971540|Bupivacaine|bupivacaine|mesh-list
56303597|NCT02971540|Ropivacaine|ropivacaine|mesh-list
56303598|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
56303599|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
56303600|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56303651|NCT00000674|Vitamins|vitamins|mesh-ancestor
56303652|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
56303653|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56303654|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303655|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56303656|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303657|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303658|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
56303659|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56303660|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56303661|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56303730|NCT00014118|Paclitaxel|paclitaxel|mesh-list
56303790|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56303791|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303792|NCT00000689|Leucovorin|leucovorin|mesh-list
56303793|NCT00000689|Cytarabine|cytarabine|mesh-list
56303794|NCT00000689|Dexamethasone|dexamethasone|mesh-list
56303795|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
56303797|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56303798|NCT00000689|Methotrexate|methotrexate|mesh-list
56303799|NCT00000689|Vincristine|vincristine|mesh-list
56303800|NCT00000689|Bleomycin|bleomycin|mesh-list
56303801|NCT00000689|Sargramostim|sargramostim|mesh-list
56303802|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
56303803|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56303804|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
56303805|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303806|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303807|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56303808|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
56303809|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303810|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303811|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56303812|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56303813|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
56303814|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
56303815|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56303816|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56303817|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
56303818|NCT00000689|Hormones|hormones|mesh-ancestor
56303824|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303840|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56303841|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
56303842|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
56303843|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
56303844|NCT00034879|Gefitinib|gefitinib|mesh-list
56303845|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303846|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56303847|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56303910|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56303911|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56303912|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
56303913|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56303914|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
56303915|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56303916|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56303917|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56303918|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56303975|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56303976|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56303977|NCT00000722|Pentamidine|pentamidine|mesh-list
56303978|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
56303979|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56303980|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56303981|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56303982|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56303983|NCT00035152|Paclitaxel|paclitaxel|mesh-list
56303984|NCT00035152|Carboplatin|carboplatin|mesh-list
56303985|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56303986|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304039|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304040|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
56304041|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304042|NCT00035308|Abetimus|abetimus|mesh-list
56304043|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304044|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
56304045|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304046|NCT00035347|Azithromycin|azithromycin|mesh-list
56304048|NCT00035347|Ofloxacin|ofloxacin|mesh-list
56304107|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
56304108|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56304109|NCT00035464|Azimilide|azimilide|mesh-list
56304110|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56304111|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56304112|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56304113|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304114|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56304117|NCT00014469|Melphalan|melphalan|mesh-list
56304175|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304176|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
56304177|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
56304178|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304179|NCT00000758|Fluorouracil|fluorouracil|mesh-list
56304180|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
56304181|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304182|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56304183|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304184|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304240|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304241|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56304242|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56304243|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
56161073|NCT02280252|Paclitaxel|paclitaxel|mesh-list
56304244|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304245|NCT00000779|Antacids|antacids|mesh-ancestor
56304246|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304247|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56304248|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56304249|NCT00035893|Poly I-C|poly i-c|mesh-list
56304250|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
56304251|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304252|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
56304253|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
56304271|NCT02971345|Epirubicin|epirubicin|mesh-list
56304298|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56304299|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
56304300|NCT00036127|Aripiprazole|aripiprazole|mesh-list
56304301|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
56304302|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56304303|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56304304|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56304305|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56304306|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304307|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
56304308|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
56304310|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304311|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56304312|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56304360|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304361|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304362|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56304363|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56304364|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
56304365|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56304366|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56304367|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56304368|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
56304369|NCT00036244|Secretin|secretin|mesh-list
56304370|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56304371|NCT00036244|Hormones|hormones|mesh-ancestor
56304372|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56304373|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304374|NCT00036283|Celecoxib|celecoxib|mesh-list
56304377|NCT00036283|Analgesics|analgesics|mesh-ancestor
56304418|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56304419|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
56304420|NCT00036400|Hematinics|hematinics|mesh-ancestor
56304421|NCT00036439|Infliximab|infliximab|mesh-list
56304422|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
56304423|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56304424|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304425|NCT00000821|Aldesleukin|aldesleukin|mesh-list
56304426|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304427|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304428|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304429|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
56304430|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304483|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304484|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
56304485|NCT00036868|Fluorouracil|fluorouracil|mesh-list
56304486|NCT00036868|Methotrexate|methotrexate|mesh-list
56304487|NCT00036868|Trastuzumab|trastuzumab|mesh-list
56304488|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56304489|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
56304490|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304491|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56304492|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56304493|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
56304494|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304495|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304496|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56304545|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304546|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304547|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304548|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
56304549|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304550|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304551|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304552|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56304553|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56304554|NCT00037102|Interferons|interferons|mesh-list
56304555|NCT00037102|Interferon-beta|interferon-beta|mesh-list
56304556|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
56304557|NCT00037102|Methotrexate|methotrexate|mesh-list
56304608|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56304610|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
56304611|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304612|NCT00000893|Efavirenz|efavirenz|mesh-list
56304613|NCT00000893|Nelfinavir|nelfinavir|mesh-list
56304614|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304615|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304616|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304617|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304619|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304620|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56304621|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56304622|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56304623|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56304629|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304668|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304669|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304670|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304671|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
56304672|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304673|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304674|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304675|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56304676|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56304677|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
56304678|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
56304679|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
56304680|NCT00037609|Capecitabine|capecitabine|mesh-list
56304681|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56304682|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
56334004|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56304683|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304684|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304685|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56304686|NCT00037609|Protective Agents|protective agents|mesh-ancestor
56304687|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304688|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56304689|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304690|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56304691|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56304692|NCT00037609|Analgesics|analgesics|mesh-ancestor
56304715|NCT00037999|Androgens|androgens|mesh-ancestor
56304716|NCT00037999|Hormones|hormones|mesh-ancestor
56304717|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56304718|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304719|NCT00038077|Metoprolol|metoprolol|mesh-list
56304720|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56304721|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56304722|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
56304723|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
56304781|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304782|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
56304783|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304784|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304785|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56304786|NCT00000941|Ritonavir|ritonavir|mesh-list
56304787|NCT00000941|Nelfinavir|nelfinavir|mesh-list
56304788|NCT00000941|Saquinavir|saquinavir|mesh-list
56304849|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
56304850|NCT00000959|Vitamins|vitamins|mesh-ancestor
56304851|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
56304852|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304853|NCT00396604|Maleic acid|maleic acid|mesh-list
56304854|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56304855|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304856|NCT00000962|Nevirapine|nevirapine|mesh-list
56304857|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304914|NCT00015132|Sertraline|sertraline|mesh-list
56304915|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
56304916|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56304917|NCT00015132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56304918|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56304919|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56304920|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304921|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56304922|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
56304923|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56304924|NCT00000971|Zidovudine|zidovudine|mesh-list
56304925|NCT00000971|Didanosine|didanosine|mesh-list
56304926|NCT00000971|Clarithromycin|clarithromycin|mesh-list
56304927|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
56304928|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56304929|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56304971|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
56304972|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304973|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56304974|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56304975|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56304976|NCT00015249|Amantadine|amantadine|mesh-list
56304977|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56304978|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56304979|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
56304980|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56304981|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
56305039|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305040|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56305041|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305042|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305043|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
56305044|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305045|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56305046|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56305047|NCT05076877|Metformin|metformin|mesh-list
56305048|NCT05076877|Midazolam|midazolam|mesh-list
56305049|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56305050|NCT05076877|Lazertinib|lazertinib|mesh-list
56305051|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56305056|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56305103|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305104|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305105|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56305106|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56305107|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
56305108|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56305109|NCT01786434|Fentanyl|fentanyl|mesh-list
56305110|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56305111|NCT01786434|Narcotics|narcotics|mesh-ancestor
56305112|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56305114|NCT01786434|Analgesics|analgesics|mesh-ancestor
56305169|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56305170|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305171|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56305172|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56305173|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56305174|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56305175|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305176|NCT00015834|Cytarabine|cytarabine|mesh-list
56305177|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
56305178|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305179|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
56305180|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305181|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305182|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
56305229|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56305230|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
56305231|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
56305232|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
56305233|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56305234|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
56305235|NCT00015873|Hormones|hormones|mesh-ancestor
56305236|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305237|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305238|NCT00015912|Interferons|interferons|mesh-list
56305239|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
56305240|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
56305241|NCT00015912|Thalidomide|thalidomide|mesh-list
56305294|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
56305295|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56305296|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305297|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
56305298|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56305299|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
56305300|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305301|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56305302|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305303|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
56305304|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305305|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
56305306|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56305307|NCT00001076|Protective Agents|protective agents|mesh-ancestor
56305308|NCT00015990|Thalidomide|thalidomide|mesh-list
56305309|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305310|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
56305352|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305353|NCT00016107|Bevacizumab|bevacizumab|mesh-list
56305354|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56305355|NCT00016107|Docetaxel|docetaxel|mesh-list
56305356|NCT00016107|Estramustine|estramustine|mesh-list
56305357|NCT00016107|Antibodies|antibodies|mesh-list
56305358|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
56305359|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56305360|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305361|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56305362|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56305363|NCT00016107|Growth Substances|growth substances|mesh-ancestor
56305365|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
56305366|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
56305367|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
56305368|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56305369|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56305371|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56305410|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56305411|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305412|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56305413|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56305414|NCT00016224|Growth Substances|growth substances|mesh-ancestor
56305415|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
56305416|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305417|NCT00016263|Dacarbazine|dacarbazine|mesh-list
56305418|NCT00016263|Oblimersen|oblimersen|mesh-list
56305419|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56305420|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
56305421|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305422|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305423|NCT00016302|Leucovorin|leucovorin|mesh-list
56305424|NCT00016302|Cytarabine|cytarabine|mesh-list
56305425|NCT00016302|Dexamethasone|dexamethasone|mesh-list
56305426|NCT00016302|Prednisone|prednisone|mesh-list
56305427|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
56305428|NCT00016302|Doxorubicin|doxorubicin|mesh-list
56305429|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56305430|NCT00016302|Methotrexate|methotrexate|mesh-list
56305431|NCT00016302|Vincristine|vincristine|mesh-list
56305467|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305468|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
56305469|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305470|NCT00016302|Antidotes|antidotes|mesh-ancestor
56305471|NCT00016302|Protective Agents|protective agents|mesh-ancestor
56305472|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
56305473|NCT00016302|Vitamins|vitamins|mesh-ancestor
56305474|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
56305475|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56305476|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
56305477|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
56305532|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305533|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
56305534|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
56305535|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56305536|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
56305537|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56305538|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305539|NCT00016380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56305600|NCT01140516|Trimethoprim|trimethoprim|mesh-list
56305601|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56305602|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305603|NCT01140516|Renal Agents|renal agents|mesh-ancestor
56305604|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
56305605|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56305606|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56305607|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56305608|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305609|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305610|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56305611|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56305652|NCT00001262|Copper|copper|mesh-list
56305661|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305662|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305663|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56305664|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
56305665|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305666|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305667|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56305668|NCT00016887|Interferons|interferons|mesh-list
56305669|NCT00016887|Cytarabine|cytarabine|mesh-list
56305670|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
56305671|NCT00016887|Dexamethasone|dexamethasone|mesh-list
56305672|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
56305673|NCT00016887|Melphalan|melphalan|mesh-list
56305674|NCT00016887|Carmustine|carmustine|mesh-list
56305675|NCT00016887|Etoposide|etoposide|mesh-list
56305676|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56305677|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
56305679|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56305720|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
56305721|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56305722|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56305723|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56305724|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305725|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305787|NCT00039013|Exenatide|exenatide|mesh-list
56305788|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56305789|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56305790|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56305791|NCT00039013|Incretins|incretins|mesh-ancestor
56305792|NCT00039013|Hormones|hormones|mesh-ancestor
56305793|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56305859|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56305860|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56305861|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56305862|NCT00039403|Gemcitabine|gemcitabine|mesh-list
56305863|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56305864|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56305865|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
56305867|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56305926|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56305927|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306000|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306001|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306002|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56306004|NCT00040027|Thymalfasin|thymalfasin|mesh-list
56306005|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
56306006|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306007|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
56306008|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306009|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56306010|NCT00001343|Oxandrolone|oxandrolone|mesh-list
56306011|NCT00001343|Androgens|androgens|mesh-ancestor
56306012|NCT00001343|Hormones|hormones|mesh-ancestor
56306065|NCT00040378|Tocotrienols|tocotrienols|mesh-list
56306066|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
56306067|NCT00040378|Selenium|selenium|mesh-list
56306068|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
56306069|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306070|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
56306071|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306072|NCT00040378|Protective Agents|protective agents|mesh-ancestor
56306073|NCT00040378|Trace Elements|trace elements|mesh-ancestor
56306074|NCT00017199|Bortezomib|bortezomib|mesh-list
56306075|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306133|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56306134|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
56306135|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306136|NCT00040690|Antidotes|antidotes|mesh-ancestor
56306137|NCT00040690|Protective Agents|protective agents|mesh-ancestor
56306138|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
56306139|NCT00040690|Vitamins|vitamins|mesh-ancestor
56306140|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
56306141|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56306142|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56306143|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56306144|NCT00040768|Bortezomib|bortezomib|mesh-list
56306198|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
56306199|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306200|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
56306201|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306202|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306203|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56306204|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56306205|NCT00017316|Growth Substances|growth substances|mesh-ancestor
56306206|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
56306265|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
56306266|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
56306267|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
56306268|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306269|NCT00041431|Hormones|hormones|mesh-list
56306270|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56306271|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306272|NCT00001436|Tamoxifen|tamoxifen|mesh-list
56306273|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56306274|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
56306276|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306328|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306329|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
56306330|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56306331|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
56306332|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56306333|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306334|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56306335|NCT00041977|Doxycycline|doxycycline|mesh-list
56306336|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306337|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306341|NCT00042016|Decitabine|decitabine|mesh-list
56306395|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56306396|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
56306397|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306398|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56306399|NCT02970643|Olanzapine|olanzapine|mesh-list
56306400|NCT02970643|Palonosetron|palonosetron|mesh-list
56306401|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
56306402|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
56306403|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306404|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306460|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56306461|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
56306462|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56306463|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56306464|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
56306465|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306466|NCT00042601|Pramlintide|pramlintide|mesh-list
56306467|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56306468|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306469|NCT00042679|Gemcitabine|gemcitabine|mesh-list
56306470|NCT00042679|Carboplatin|carboplatin|mesh-list
56306471|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306472|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306473|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
56306523|NCT00017784|Valganciclovir|valganciclovir|mesh-list
56306524|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
56306525|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306526|NCT00042874|Leucovorin|leucovorin|mesh-list
56306527|NCT00042874|Fluorouracil|fluorouracil|mesh-list
56306528|NCT00042874|Irinotecan|irinotecan|mesh-list
56306529|NCT00042874|Alvocidib|alvocidib|mesh-list
56306530|NCT00042874|Calcium|calcium|mesh-list
56306531|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
56306532|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56306534|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
56306590|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56306591|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306592|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56306593|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306594|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
56306595|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
56306596|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56306597|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56306598|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56306599|NCT00043147|Protective Agents|protective agents|mesh-ancestor
56306600|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56306653|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306654|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306655|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306656|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
56306657|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56306658|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
56306659|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306660|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
56306663|NCT00043537|Fluoxetine|fluoxetine|mesh-list
56306716|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
56306717|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306718|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306719|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
56306720|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306721|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306722|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
56306723|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306724|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
56306725|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56306726|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56306727|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56306776|NCT00043927|Etoposide|etoposide|mesh-list
56306777|NCT00043927|Topotecan|topotecan|mesh-list
56306778|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306779|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56306780|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56306781|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56306782|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306783|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306784|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56306785|NCT00043966|Ritonavir|ritonavir|mesh-list
56306786|NCT00043966|Lopinavir|lopinavir|mesh-list
56306787|NCT00043966|Tenofovir|tenofovir|mesh-list
56306839|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56306840|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56306841|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306842|NCT00044473|Levofloxacin|levofloxacin|mesh-list
56306843|NCT00044473|Ofloxacin|ofloxacin|mesh-list
56306844|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56306845|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56306846|NCT00044473|Renal Agents|renal agents|mesh-ancestor
56306847|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56306848|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56306849|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56306850|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306851|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306852|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306853|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56306854|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56306855|NCT00044551|Taxane|taxane|mesh-list
56306856|NCT00044551|IDN 5109|idn 5109|mesh-list
56306859|NCT00018135|Calcium|calcium|mesh-list
56306895|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306896|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306897|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
56306898|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306899|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
56306900|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56306901|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56306902|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306903|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
56306904|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56306905|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56306915|NCT00018174|Fluoxetine|fluoxetine|mesh-list
56306960|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
56306961|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56306962|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56306963|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56306964|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56306965|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
56306966|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56306967|NCT00044785|Antidotes|antidotes|mesh-ancestor
56306968|NCT00044785|Protective Agents|protective agents|mesh-ancestor
56306969|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
56306970|NCT00044785|Vitamins|vitamins|mesh-ancestor
56306971|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
56307024|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56307025|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56307026|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307027|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56094809|NCT01055756|Loratadine|loratadine|mesh-list
56307028|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56307029|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307030|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307031|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
56307032|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56307033|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
56307034|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56307035|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56307036|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
56307037|NCT00045175|Topotecan|topotecan|mesh-list
56307038|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56307039|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56307082|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
56307083|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307084|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
56307085|NCT00045448|Growth Substances|growth substances|mesh-ancestor
56307086|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307087|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56307088|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307150|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56307151|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56307152|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
56307153|NCT00389402|Ritonavir|ritonavir|mesh-list
56307154|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56307155|NCT00389402|Saquinavir|saquinavir|mesh-list
56307156|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56307157|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56307158|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
56307159|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307160|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307215|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56307216|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56307217|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56307218|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56307219|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56307220|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56307221|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56307222|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
56307223|NCT04380207|QPX7728|qpx7728|mesh-list
56307224|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56307225|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307226|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307227|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56307228|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307229|NCT00045955|Fexofenadine|fexofenadine|mesh-list
56307273|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56307274|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307275|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307276|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307277|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
56307278|NCT00001724|Analgesics|analgesics|mesh-ancestor
56307279|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
56307342|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
56307343|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307344|NCT00397735|Expectorants|expectorants|mesh-ancestor
56307345|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
56307346|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56307347|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
56307348|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307349|NCT00397735|Protective Agents|protective agents|mesh-ancestor
56307350|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307351|NCT00397735|Antidotes|antidotes|mesh-ancestor
56307352|NCT00046384|Aripiprazole|aripiprazole|mesh-list
56307353|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
56307354|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307355|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56307404|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56307405|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56307406|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56307407|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
56307408|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56307409|NCT00046501|Insulin|insulin|mesh-list
56307410|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
56307411|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56307412|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
56307413|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
56307469|NCT00047047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56307470|NCT00047047|Immunologic Factors|immunologic factors|mesh-ancestor
56307541|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56307542|NCT00047281|Analgesics|analgesics|mesh-ancestor
56307543|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
56307544|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56307545|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56307546|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56307547|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56307548|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
56307549|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56307550|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56307551|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56307552|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56307553|NCT00047281|Growth Substances|growth substances|mesh-ancestor
56307554|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
56307555|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56307556|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56307557|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307558|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56307595|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56307596|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
56307597|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56307598|NCT00047710|Bevacizumab|bevacizumab|mesh-list
56307599|NCT00047710|Capecitabine|capecitabine|mesh-list
56307600|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56307601|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307602|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56307603|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56307604|NCT00047710|Growth Substances|growth substances|mesh-ancestor
56307605|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307606|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
56307658|NCT05641337|Insulin|insulin|mesh-list
56307659|NCT05641337|Metformin|metformin|mesh-list
56307660|NCT05641337|Insulin Aspart|insulin aspart|mesh-list
56307661|NCT05641337|Linagliptin|linagliptin|mesh-list
56307662|NCT05641337|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56307663|NCT05641337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56307664|NCT05641337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56307665|NCT05641337|Incretins|incretins|mesh-ancestor
56307666|NCT05641337|Hormones|hormones|mesh-ancestor
56307672|NCT00048412|Fludarabine|fludarabine|mesh-list
56307726|NCT00048802|Olanzapine|olanzapine|mesh-list
56307727|NCT00048802|Risperidone|risperidone|mesh-list
56307728|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56307798|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56307799|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307800|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
56307801|NCT00049192|Oblimersen|oblimersen|mesh-list
56307802|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56307803|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56307804|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56307805|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56307806|NCT05576181|Cyclophosphamide|cyclophosphamide|mesh-list
56307807|NCT05576181|Fludarabine|fludarabine|mesh-list
56307808|NCT05576181|Etoposide|etoposide|mesh-list
56307865|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
56307866|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56307872|NCT02970409|Heparin|heparin|mesh-list
56307940|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308014|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56308015|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308016|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56308017|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56308018|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56308019|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56308021|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308022|NCT00050596|Docetaxel|docetaxel|mesh-list
56308023|NCT00050596|Ipilimumab|ipilimumab|mesh-list
56308080|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56308081|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56308082|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56308083|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56308084|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308085|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
56308086|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56308087|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308088|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56308089|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56308142|NCT00051571|Docetaxel|docetaxel|mesh-list
56308143|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308144|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308145|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308146|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308147|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308148|NCT05573958|Aspirin|aspirin|mesh-list
56308149|NCT05573958|Rivaroxaban|rivaroxaban|mesh-list
56308190|NCT00052000|Antibodies|antibodies|mesh-list
56308209|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56308211|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308212|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
56308213|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56308214|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56308215|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56308216|NCT00052273|Capecitabine|capecitabine|mesh-list
56308217|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308218|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
56308219|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308220|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308221|NCT00052312|Paclitaxel|paclitaxel|mesh-list
56308222|NCT00052312|Doxorubicin|doxorubicin|mesh-list
56308273|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56308274|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308275|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308276|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308277|NCT00052468|Gemcitabine|gemcitabine|mesh-list
56308278|NCT00052468|Paclitaxel|paclitaxel|mesh-list
56308279|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56308280|NCT00052468|Carboplatin|carboplatin|mesh-list
56308288|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
56308342|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56308343|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56308344|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56308345|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56308346|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308347|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56308348|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
56308349|NCT00052936|Hormones|hormones|mesh-ancestor
56308350|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56308351|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56308352|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56308353|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308354|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308402|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56308403|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56308404|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
56308405|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
56308406|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308407|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56308408|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308409|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308410|NCT00053287|Thalidomide|thalidomide|mesh-list
56308411|NCT00053287|Carboplatin|carboplatin|mesh-list
56308412|NCT00053287|Fludarabine|fludarabine|mesh-list
56308413|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
56308415|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308416|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308417|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
56308418|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308462|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56308463|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56308464|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56308465|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56308466|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56308467|NCT00053716|Alprostadil|alprostadil|mesh-list
56308468|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56308469|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
56308470|NCT00053716|Urological Agents|urological agents|mesh-ancestor
56308471|NCT05626478|Moxifloxacin|moxifloxacin|mesh-list
56308472|NCT05626478|Dexamethasone|dexamethasone|mesh-list
56308473|NCT05626478|Prednisolone|prednisolone|mesh-list
56308474|NCT05626478|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56308475|NCT05626478|Methylprednisolone|methylprednisolone|mesh-list
56308476|NCT05626478|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56308477|NCT05626478|Prednisolone acetate|prednisolone acetate|mesh-list
56308478|NCT05626478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56308520|NCT05624918|Gemcitabine|gemcitabine|mesh-list
56308521|NCT05624918|Paclitaxel|paclitaxel|mesh-list
56308522|NCT05624918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56308523|NCT05624918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308524|NCT05624918|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308525|NCT05624918|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308526|NCT05624918|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308527|NCT05624918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308528|NCT05624918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308529|NCT05624918|Antimetabolites|antimetabolites|mesh-ancestor
56308530|NCT05624918|Antiviral Agents|antiviral agents|mesh-ancestor
56308585|NCT00054184|Paclitaxel|paclitaxel|mesh-list
56308586|NCT00054184|Docetaxel|docetaxel|mesh-list
56308587|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56308588|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56308589|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308590|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308591|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308592|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308593|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308594|NCT00054340|Cyclosporine|cyclosporine|mesh-list
56308595|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
56308596|NCT00054340|Busulfan|busulfan|mesh-list
56308597|NCT00054340|Methotrexate|methotrexate|mesh-list
56308598|NCT00054340|Cyclosporins|cyclosporins|mesh-list
56308599|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56308600|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308601|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
56308646|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
56308647|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56308648|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308649|NCT00054457|Docetaxel|docetaxel|mesh-list
56308650|NCT00054457|Capecitabine|capecitabine|mesh-list
56308651|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308652|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
56308653|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
56308654|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
56308655|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308656|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308657|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
56308658|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56308659|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308660|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56308706|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56308707|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56308708|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56308709|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56308710|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
56308711|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
56308712|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56308713|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308772|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930666|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
56308773|NCT05525325|Anesthetics|anesthetics|mesh-list
56308774|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56308775|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308776|NCT00055393|Bupropion|bupropion|mesh-list
56308777|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56308778|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
56308779|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56308780|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56308781|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56308782|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56308783|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308784|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
56308850|NCT00055666|Beclomethasone|beclomethasone|mesh-list
56308851|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56308852|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
56308853|NCT00055666|Hormones|hormones|mesh-ancestor
56308854|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56308855|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308856|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56308857|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
56308858|NCT00055822|Leucovorin|leucovorin|mesh-list
56308859|NCT00055822|Fluorouracil|fluorouracil|mesh-list
56308860|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
56308861|NCT00055822|Oblimersen|oblimersen|mesh-list
56308862|NCT00055822|Calcium|calcium|mesh-list
56308863|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
56308864|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56308865|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308866|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
56308867|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308868|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56308869|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56308870|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56308871|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
56308872|NCT00055822|Antidotes|antidotes|mesh-ancestor
56308873|NCT00055822|Protective Agents|protective agents|mesh-ancestor
56308874|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
56308875|NCT00055822|Vitamins|vitamins|mesh-ancestor
56308876|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
56308901|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56308902|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308903|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56308904|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56308905|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56308906|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308907|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56308968|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56308969|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56308970|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308971|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56308972|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56308973|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
56308974|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56308975|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56308976|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56308977|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56308979|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56308980|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56308981|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309026|NCT00056836|Ranibizumab|ranibizumab|mesh-list
56309027|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56309028|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56309029|NCT00056836|Growth Substances|growth substances|mesh-ancestor
56309030|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309031|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
56309032|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309033|NCT05495321|Aldesleukin|aldesleukin|mesh-list
56309034|NCT05495321|Interleukin-2|interleukin-2|mesh-list
56309035|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309036|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56309037|NCT05495321|Analgesics|analgesics|mesh-ancestor
56309038|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
56309039|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309040|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309087|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309088|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309089|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
56309090|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309091|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56309092|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56309093|NCT00057304|Insulin|insulin|mesh-list
56309094|NCT00057304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56309096|NCT00057343|Rituximab|rituximab|mesh-list
56309155|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
56309156|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309157|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309158|NCT00058006|Celecoxib|celecoxib|mesh-list
56309159|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56309160|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56309161|NCT00058006|Analgesics|analgesics|mesh-ancestor
56309162|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
56309163|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56309164|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309165|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56309166|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56309167|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56309168|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56309169|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309171|NCT00058045|Aldesleukin|aldesleukin|mesh-list
56309216|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309217|NCT00058201|Antiviral Agents|antiviral agents|mesh-ancestor
56309218|NCT00058201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309219|NCT00058201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309220|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309221|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
56309222|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309223|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56309224|NCT00058201|Antidotes|antidotes|mesh-ancestor
55931117|NCT04199819|Entecavir|entecavir|mesh-list
56309225|NCT00058201|Protective Agents|protective agents|mesh-ancestor
56309227|NCT00058201|Vitamins|vitamins|mesh-ancestor
56309228|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
56309229|NCT00058279|Aldesleukin|aldesleukin|mesh-list
56309230|NCT00058279|Ipilimumab|ipilimumab|mesh-list
56309231|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309232|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309233|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56309234|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309235|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56309236|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56309237|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
56309238|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309240|NCT00058318|Capecitabine|capecitabine|mesh-list
56309242|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
56309269|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
56309270|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309271|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56309272|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309273|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56309274|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
56309275|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309276|NCT00392262|Amlodipine|amlodipine|mesh-list
56309334|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309335|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56309336|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309337|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56309338|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309339|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309340|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
56309341|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56309342|NCT00059722|Gefitinib|gefitinib|mesh-list
56309401|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309402|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309403|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56309404|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
56309405|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56309406|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309407|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56309408|NCT00059917|Camptothecin|camptothecin|mesh-list
56309409|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309410|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309411|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56309412|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309413|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309414|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309460|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56309461|NCT00398515|Growth Substances|growth substances|mesh-ancestor
56309462|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
56309463|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309464|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56309465|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309466|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56309467|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
56309528|NCT00060502|Gemcitabine|gemcitabine|mesh-list
56309529|NCT00060502|Infliximab|infliximab|mesh-list
56309530|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56309531|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
56309532|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309533|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309534|NCT00060502|Antiviral Agents|antiviral agents|mesh-ancestor
56309535|NCT00060502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309543|NCT05312372|Paclitaxel|paclitaxel|mesh-list
56309595|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56309596|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56309597|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56309599|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56309600|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56309601|NCT00061087|Methylphenidate|methylphenidate|mesh-list
56309602|NCT00061087|Bupropion|bupropion|mesh-list
56309603|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56309604|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309605|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56309606|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56309607|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56309617|NCT00061243|Vaccines|vaccines|mesh-list
56309655|NCT00061477|Pemetrexed|pemetrexed|mesh-list
56309656|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56309657|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
56309658|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309659|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309660|NCT00061477|Antiviral Agents|antiviral agents|mesh-ancestor
56309661|NCT00061477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309668|NCT02968342|Progesterone|progesterone|mesh-list
56309719|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56309720|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56309721|NCT00061711|Estrogens|estrogens|mesh-ancestor
56309722|NCT00061750|Deferasirox|deferasirox|mesh-list
56309723|NCT00061750|Deferoxamine|deferoxamine|mesh-list
56309724|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56309725|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
56309726|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
56309727|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309728|NCT00061750|Siderophores|siderophores|mesh-ancestor
56309729|NCT00061789|Acetylcholine|acetylcholine|mesh-list
56309730|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
56309731|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56309783|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309784|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309785|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309786|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309787|NCT04917900|Paclitaxel|paclitaxel|mesh-list
56309788|NCT04917900|Trastuzumab|trastuzumab|mesh-list
56309789|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56309790|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309791|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309792|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309793|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309794|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309796|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56309847|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56309848|NCT00392340|Vincristine|vincristine|mesh-list
56309849|NCT00392340|Topotecan|topotecan|mesh-list
56309850|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56309851|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309852|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56309853|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56309854|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56309855|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56309856|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309857|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309858|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
56309859|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
56309860|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56309861|NCT00062101|Celecoxib|celecoxib|mesh-list
56309862|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56309905|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56309907|NCT00062257|Irofulven|irofulven|mesh-list
56309979|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56309980|NCT00063193|Minocycline|minocycline|mesh-list
56309981|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56309982|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56309983|NCT04736823|Paclitaxel|paclitaxel|mesh-list
56309984|NCT04736823|Docetaxel|docetaxel|mesh-list
56309985|NCT04736823|Carboplatin|carboplatin|mesh-list
56309986|NCT04736823|Pemetrexed|pemetrexed|mesh-list
56309987|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56309988|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56309989|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
56309990|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
56310045|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310046|NCT02967172|Analgesics|analgesics|mesh-ancestor
56310047|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
56310048|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310049|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
56310051|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56310052|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56310053|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
56310054|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310055|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310056|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56310057|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56310058|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
56310059|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56310060|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
56310061|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
56310062|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
56310104|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310105|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
56310106|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310107|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310108|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
56310109|NCT00064285|Alvocidib|alvocidib|mesh-list
56310110|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310111|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56310112|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310113|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310114|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
56310169|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310170|NCT00398788|Analgesics|analgesics|mesh-ancestor
56310171|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
56310172|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310173|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
56310174|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56310175|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56310176|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310177|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56310178|NCT00398827|Analgesics|analgesics|mesh-ancestor
56310179|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
56310180|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310181|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56310182|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56310231|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
56310232|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56310233|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56310234|NCT04488081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56310235|NCT04488081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56310236|NCT04488081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56310237|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56310238|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56310239|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
56310240|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
56310241|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310295|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56310296|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
56310297|NCT00066157|Estradiol|estradiol|mesh-list
56310298|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56310299|NCT00066157|Estrogens|estrogens|mesh-list
56310300|NCT00066157|Progesterone|progesterone|mesh-list
56310301|NCT00066157|Hormones|hormones|mesh-ancestor
56310302|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310303|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310316|NCT05080322|Xhance|xhance|mesh-list
56310363|NCT04401150|Vitamins|vitamins|mesh-ancestor
56310364|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
56310365|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310366|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
56310367|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310368|NCT04401150|Protective Agents|protective agents|mesh-ancestor
56310369|NCT00066352|Bortezomib|bortezomib|mesh-list
56310370|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310371|NCT00066391|Irinotecan|irinotecan|mesh-list
56310372|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310373|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56310374|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56310375|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310382|NCT00389987|Tazobactam|tazobactam|mesh-list
56310428|NCT00066859|Sertraline|sertraline|mesh-list
56310429|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
56310430|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56310431|NCT00066859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56310432|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56310433|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56310434|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310438|NCT04235673|Melatonin|melatonin|mesh-list
56310497|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310499|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
56310500|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310501|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56310502|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
56310503|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56310504|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56310514|NCT00399022|Analgesics|analgesics|mesh-ancestor
56161241|NCT01545648|Denosumab|denosumab|mesh-list
56310563|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310564|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56310565|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56310566|NCT04999241|Analgesics|analgesics|mesh-ancestor
56310567|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
56310568|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310569|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310570|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310571|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56310625|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56310626|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310627|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56310628|NCT00068497|Gefitinib|gefitinib|mesh-list
56310629|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310630|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56310631|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310632|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310634|NCT00068653|Gefitinib|gefitinib|mesh-list
56310635|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56310636|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56310637|NCT00068653|Analgesics|analgesics|mesh-ancestor
56310638|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
56310639|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310640|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310641|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310682|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310683|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310684|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310685|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56310686|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56310687|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
56310688|NCT04963712|Thymalfasin|thymalfasin|mesh-list
56310689|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56310690|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
56310691|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310692|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
56310693|NCT00069550|Donepezil|donepezil|mesh-list
56310694|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56310695|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310744|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56310745|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56310746|NCT00070057|Analgesics|analgesics|mesh-ancestor
56310747|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
56310748|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310749|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310750|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310751|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310752|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56310753|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56310754|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310755|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310756|NCT00070174|Cytarabine|cytarabine|mesh-list
56310759|NCT00070174|Busulfan|busulfan|mesh-list
56310806|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310807|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56310808|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56310809|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56310810|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
56310811|NCT00070213|Antidotes|antidotes|mesh-ancestor
56310812|NCT00070213|Protective Agents|protective agents|mesh-ancestor
56310813|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
56310874|NCT00070486|Immunologic Factors|immunologic factors|mesh-ancestor
56310875|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310876|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56310877|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56310878|NCT00070486|Analgesics|analgesics|mesh-ancestor
56310879|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
56310880|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56310881|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56310882|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56310883|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56310884|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56310885|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56310886|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56310887|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
56310888|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56310889|NCT00070525|Tipifarnib|tipifarnib|mesh-list
56310932|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56310933|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
56098691|NCT01788475|BB 1101|bb 1101|mesh-list
56310934|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310935|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56310936|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
56310937|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
56310938|NCT00071266|Vitamins|vitamins|mesh-ancestor
56310939|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
56310940|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310941|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56310942|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56310943|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56310944|NCT04908371|Lidocaine|lidocaine|mesh-list
56310945|NCT04908371|Epinephrine|epinephrine|mesh-list
56310946|NCT04908371|Racepinephrine|racepinephrine|mesh-list
56310947|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
56310948|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
56310949|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
56310950|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
56310951|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56310953|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
56310985|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56310986|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56310987|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56310988|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56310989|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56310990|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56310991|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56310992|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
56310993|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
56310994|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
56310995|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
56310996|NCT00071539|Immunotoxins|immunotoxins|mesh-list
56310997|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
56310998|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56310999|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56311000|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56311001|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56311002|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56311003|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56311004|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311005|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311007|NCT00071695|Analgesics|analgesics|mesh-ancestor
56311037|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
56311038|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
56311039|NCT00390065|Protective Agents|protective agents|mesh-ancestor
56311040|NCT00072007|Prednisone|prednisone|mesh-list
56311041|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
56311042|NCT00072007|Rituximab|rituximab|mesh-list
56311043|NCT00072007|Doxorubicin|doxorubicin|mesh-list
56311044|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56311045|NCT00072007|Vincristine|vincristine|mesh-list
56311046|NCT00072007|Cladribine|cladribine|mesh-list
56311047|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311048|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
56311049|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311050|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311051|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311052|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
56311053|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311062|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
56311095|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56311096|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56311097|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56311098|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
56311099|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311100|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311101|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56311104|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
56311163|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311164|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
56311165|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
56311166|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311167|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311168|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311169|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
56311170|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311171|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311172|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56311173|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
56311174|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56311175|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56311176|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56311177|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56311178|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311179|NCT03959397|Paclitaxel|paclitaxel|mesh-list
56311180|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56311181|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55933082|NCT04994262|Menthol|menthol|mesh-list
56311182|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311183|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
56311184|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
56311185|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311186|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311187|NCT00072436|Gemcitabine|gemcitabine|mesh-list
56311188|NCT00072436|Alvocidib|alvocidib|mesh-list
56311189|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311209|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311210|NCT00072553|Leucovorin|leucovorin|mesh-list
56311211|NCT00072553|Celecoxib|celecoxib|mesh-list
56311212|NCT00072553|Fluorouracil|fluorouracil|mesh-list
56311213|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
56311214|NCT00072553|Calcium|calcium|mesh-list
56311215|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
56311216|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56311217|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311227|NCT00072553|Vitamins|vitamins|mesh-ancestor
56311277|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311278|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311279|NCT00072787|Cisplatin|cisplatin|mesh-list
56311280|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311281|NCT00072826|Acetylcholine|acetylcholine|mesh-list
56311282|NCT00072826|Oxypurinol|oxypurinol|mesh-list
56311283|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
56311284|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56311285|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
56311286|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311288|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311344|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
56311345|NCT04827953|Antiviral Agents|antiviral agents|mesh-ancestor
56311346|NCT04827953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311347|NCT04827953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311348|NCT04827953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311349|NCT04827953|Immunologic Factors|immunologic factors|mesh-ancestor
56311350|NCT04827953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311351|NCT04711291|Tacrolimus|tacrolimus|mesh-list
56311352|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311353|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
56311354|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311355|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56311356|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311357|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311358|NCT00073372|Abciximab|abciximab|mesh-list
56311359|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
56311360|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56311361|NCT04821830|Levodopa|levodopa|mesh-list
56311362|NCT04821830|Carbidopa|carbidopa|mesh-list
56311363|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56311364|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56311365|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56311366|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
56311397|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56311398|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
56311399|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
56311400|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56311401|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
56311402|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56311403|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311404|NCT02966041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56311405|NCT02966041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56311406|NCT02966041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56311407|NCT02966041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56311408|NCT02966041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56311409|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56311410|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311411|NCT00073840|Albuterol|albuterol|mesh-list
56311412|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56311456|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56311457|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
56311458|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
56311459|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56311460|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311461|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56311462|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
56311463|NCT00074191|Hormones|hormones|mesh-ancestor
56051605|NCT04847063|Mitomycins|mitomycins|mesh-list
56311464|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56311465|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56311466|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311467|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56311468|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
56311515|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56311516|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
56311517|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311518|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311519|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
56311520|NCT04767776|Antidotes|antidotes|mesh-ancestor
56311521|NCT04767776|Protective Agents|protective agents|mesh-ancestor
56311522|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311524|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311525|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311526|NCT04730245|Rifaximin|rifaximin|mesh-list
56311527|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56311528|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311529|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56311530|NCT00074620|Hirudins|hirudins|mesh-list
56311531|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
56311532|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56311533|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
56311534|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311535|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311536|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
56311537|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56311538|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56311568|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56311569|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56311570|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56311571|NCT00075010|Decitabine|decitabine|mesh-list
56311572|NCT00075010|Valproic Acid|valproic acid|mesh-list
56311573|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311574|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
56311575|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311576|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311577|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311578|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
56311579|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
56311631|NCT00075595|Irinotecan|irinotecan|mesh-list
56311632|NCT00075595|Calcium|calcium|mesh-list
56311633|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
56311634|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56311635|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311636|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
56311637|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311638|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311639|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311640|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56311641|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
56311642|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56311643|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56311644|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311645|NCT00075595|Antidotes|antidotes|mesh-ancestor
56311646|NCT00075595|Protective Agents|protective agents|mesh-ancestor
56311647|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
56311691|NCT00075712|Paclitaxel|paclitaxel|mesh-list
56311692|NCT00075712|Carboplatin|carboplatin|mesh-list
56311693|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56311694|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311695|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
56311696|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
56311697|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
56311698|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311699|NCT03958500|Methylene Blue|methylene blue|mesh-list
56311700|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311701|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311702|NCT00075751|Gemcitabine|gemcitabine|mesh-list
56311703|NCT00075751|Carboplatin|carboplatin|mesh-list
56311704|NCT00075751|Bortezomib|bortezomib|mesh-list
56311715|NCT00075868|Octreotide|octreotide|mesh-list
56311751|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311752|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311753|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
56311754|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56311755|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
56311756|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56311757|NCT00399256|Expectorants|expectorants|mesh-ancestor
56311758|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
56311759|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56311760|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
56311761|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311762|NCT00399256|Protective Agents|protective agents|mesh-ancestor
56311763|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311764|NCT00399256|Antidotes|antidotes|mesh-ancestor
56311765|NCT00399295|Naltrexone|naltrexone|mesh-list
56311812|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56311813|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56311814|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56311815|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311816|NCT00077077|Capecitabine|capecitabine|mesh-list
56311817|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56311818|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
56311820|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311880|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
56311881|NCT00077233|Vitamins|vitamins|mesh-ancestor
56311882|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
56311883|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56311884|NCT02958631|Losartan|losartan|mesh-list
56311885|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56311886|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56311887|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56311888|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56311889|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56311890|NCT03927222|Temozolomide|temozolomide|mesh-list
56311891|NCT03927222|Molgramostim|molgramostim|mesh-list
56311943|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311944|NCT04551482|Oxytocin|oxytocin|mesh-list
56311945|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
56311946|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56311947|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56311948|NCT00077545|Cisplatin|cisplatin|mesh-list
56311949|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56311950|NCT00077584|Bosentan|bosentan|mesh-list
56311951|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56311952|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56312011|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56312012|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312013|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
56312014|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312015|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312016|NCT00078247|Lamivudine|lamivudine|mesh-list
56312017|NCT00078247|Zidovudine|zidovudine|mesh-list
56312018|NCT00078247|Abacavir|abacavir|mesh-list
56312019|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56312020|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56312021|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312023|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
56312075|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56312076|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
56312077|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56312078|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312079|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56312080|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
56312081|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56312082|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
56312083|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312085|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
56312139|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56312143|NCT00079105|Prednisolone|prednisolone|mesh-list
56312144|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
56312145|NCT00079105|Etoposide|etoposide|mesh-list
56312146|NCT00079105|Vincristine|vincristine|mesh-list
56312147|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
56312148|NCT00079105|Bleomycin|bleomycin|mesh-list
56312149|NCT00079105|Vinblastine|vinblastine|mesh-list
56312150|NCT00079105|Procarbazine|procarbazine|mesh-list
56312151|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
56312152|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312153|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
56312154|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312155|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312156|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312157|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
56312158|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312159|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312160|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312161|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56312162|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312163|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312195|NCT00079144|Fludarabine|fludarabine|mesh-list
56312196|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
56312197|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
56312198|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312199|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
56312200|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312201|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312202|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56312203|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
56312204|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312205|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312206|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56312207|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56312214|NCT00079222|Itraconazole|itraconazole|mesh-list
56312254|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56312255|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56312256|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312257|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312258|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312259|NCT00079300|Imiquimod|imiquimod|mesh-list
56312260|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56312261|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
56312262|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312322|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
56312323|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56312324|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312325|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
56312326|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
56312327|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312328|NCT00079807|Protective Agents|protective agents|mesh-ancestor
56312329|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312330|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
56312331|NCT00079807|Vitamins|vitamins|mesh-ancestor
56312332|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
56312333|NCT00079885|Tigecycline|tigecycline|mesh-list
56312334|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56312335|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312336|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56312337|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312338|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312349|NCT00079963|Vitamins|vitamins|mesh-list
56312380|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56312381|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56312382|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312383|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312384|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312385|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312386|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312387|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
56312388|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312389|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56312390|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
56312392|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312393|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312394|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312440|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56312441|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
56312442|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312443|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56312444|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56312445|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312446|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
56312448|NCT00080275|Vitamins|vitamins|mesh-ancestor
56312507|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312508|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312509|NCT00080665|Docetaxel|docetaxel|mesh-list
56312510|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
56312511|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312512|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312513|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312514|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312515|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312572|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312573|NCT00081055|Cyclosporine|cyclosporine|mesh-list
56312574|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
56312575|NCT00081055|Busulfan|busulfan|mesh-list
56312576|NCT00081055|Methotrexate|methotrexate|mesh-list
56312577|NCT00081055|Cyclosporins|cyclosporins|mesh-list
56312578|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312579|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
56312580|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312608|NCT00081172|Antibodies|antibodies|mesh-list
56312641|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56312642|NCT00081757|Thalidomide|thalidomide|mesh-list
56312643|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312644|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
56312645|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312646|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
56312647|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56312648|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56312649|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56312650|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56312651|NCT00081757|Growth Substances|growth substances|mesh-ancestor
56312652|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
56312653|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312654|NCT00081796|Capecitabine|capecitabine|mesh-list
56312701|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312702|NCT00081874|Everolimus|everolimus|mesh-list
56312703|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312704|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56312705|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
56312706|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312712|NCT00082186|Bosentan|bosentan|mesh-list
56312775|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56312776|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56312777|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312778|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312779|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312780|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312781|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56312782|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56312783|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312784|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56312785|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
56312786|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
56312791|NCT03151863|Analgesics|analgesics|mesh-ancestor
56312836|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312838|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56312839|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56312840|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56312841|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56312842|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56312843|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56312844|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312845|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312846|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
56312847|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
56312848|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56312849|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56312850|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56312851|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56312852|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56312864|NCT00083707|Thalidomide|thalidomide|mesh-list
56312900|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56312901|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56312902|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56312903|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
56312904|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56312905|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56312906|NCT05568082|Itraconazole|itraconazole|mesh-list
56312907|NCT05568082|Antifungal Agents|antifungal agents|mesh-ancestor
56312921|NCT05567653|Sulfalene|sulfalene|mesh-list
56312968|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56312969|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56312970|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
56312971|NCT00135499|Hormones|hormones|mesh-ancestor
56312972|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56312973|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56312974|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56312975|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
56312976|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
56312977|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
56312978|NCT03151434|Hydromorphone|hydromorphone|mesh-list
56312979|NCT03151434|Bupivacaine|bupivacaine|mesh-list
56313032|NCT00135967|Prednisolone|prednisolone|mesh-list
56313033|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
56313034|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56313035|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
56313036|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313037|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
56313038|NCT00135967|Hormones|hormones|mesh-ancestor
56313039|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56313040|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313041|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56313051|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
56313098|NCT00404053|Clopidogrel|clopidogrel|mesh-list
56313099|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56313100|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56313101|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56313102|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56313103|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
56313104|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313105|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313163|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56313164|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56313165|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
56313166|NCT03968822|Lidocaine|lidocaine|mesh-list
56313167|NCT03968822|Bupivacaine|bupivacaine|mesh-list
56313168|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56313169|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
56313170|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
56313171|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313172|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313173|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
56313174|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313216|NCT00137098|Caffeine|caffeine|mesh-list
56313226|NCT00137254|Insulin|insulin|mesh-list
56313227|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56313228|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313229|NCT03151044|Rituximab|rituximab|mesh-list
56313230|NCT03151044|Epirubicin|epirubicin|mesh-list
56313231|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56313232|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313233|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
56313234|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313235|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313236|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56313237|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56313290|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313291|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56313292|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313293|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313294|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
56313295|NCT02858921|Trametinib|trametinib|mesh-list
56313296|NCT02858921|Dabrafenib|dabrafenib|mesh-list
56313297|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56313298|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313299|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56313356|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56313357|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56313358|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
56313359|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313360|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56313361|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56313362|NCT02826161|Paclitaxel|paclitaxel|mesh-list
56313363|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56313364|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313365|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
56313366|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
56313367|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
56313369|NCT03150810|Temozolomide|temozolomide|mesh-list
56313418|NCT03150732|Nalbuphine|nalbuphine|mesh-list
56313419|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56313420|NCT03150732|Narcotics|narcotics|mesh-ancestor
56313421|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56313422|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313424|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
56313425|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313426|NCT03893825|Risperidone|risperidone|mesh-list
56313427|NCT03893825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56313428|NCT03893825|Serotonin Agents|serotonin agents|mesh-ancestor
56313429|NCT03893825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313430|NCT03893825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313431|NCT03893825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313481|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
56313482|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313483|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
56313484|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313485|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56313486|NCT03890666|Albuterol|albuterol|mesh-list
56313487|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56313488|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
56313489|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313491|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56313492|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
56313493|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
56313494|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56313495|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56313496|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56313543|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
56313544|NCT03861767|Metformin|metformin|mesh-list
56313545|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56313546|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313547|NCT00139360|Bevacizumab|bevacizumab|mesh-list
56313548|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56313549|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313550|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56313551|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56313609|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313610|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56313611|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56313612|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313613|NCT03837977|Leucovorin|leucovorin|mesh-list
56313614|NCT03837977|Folic Acid|folic acid|mesh-list
56313615|NCT03837977|Docetaxel|docetaxel|mesh-list
56313616|NCT03837977|Fluorouracil|fluorouracil|mesh-list
56313617|NCT03837977|Irinotecan|irinotecan|mesh-list
56313618|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
56313620|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
56313677|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313678|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313679|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313680|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56313681|NCT00140023|Azithromycin|azithromycin|mesh-list
56313682|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56313683|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56313684|NCT00140062|Latanoprost|latanoprost|mesh-list
56313685|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56313686|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56313687|NCT00140101|Paclitaxel|paclitaxel|mesh-list
56313688|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56313689|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313690|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
56313691|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
56313695|NCT03150420|Antidotes|antidotes|mesh-ancestor
56313738|NCT00140452|Growth Substances|growth substances|mesh-ancestor
56313739|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
56313740|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313742|NCT00140530|Paclitaxel|paclitaxel|mesh-list
55935633|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
56313743|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56313744|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313745|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
56313746|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
56313747|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
56313806|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
56313807|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56313808|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313809|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56313810|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56313811|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56313812|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313813|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313814|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56313815|NCT03136497|Rituximab|rituximab|mesh-list
56313816|NCT03136497|Venetoclax|venetoclax|mesh-list
56313817|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935716|NCT05074056|Ketorolac|ketorolac|mesh-list
56313819|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
56313866|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56313867|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
56313868|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313869|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56313870|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56313871|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56313873|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56313874|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
56313875|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313876|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56313929|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
56313930|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
56313931|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56313932|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56313933|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56313934|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56313935|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56314011|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314012|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56314013|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314014|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
56314015|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
56314016|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56314017|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
56314018|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314019|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314020|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56314021|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
56314022|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56314023|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
56314024|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314025|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314026|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56314071|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314072|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314073|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
56314074|NCT00142402|Modafinil|modafinil|mesh-list
56314075|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56314076|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314077|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56314078|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56314079|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56314080|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314081|NCT00142480|Bevacizumab|bevacizumab|mesh-list
56314082|NCT00142480|Capecitabine|capecitabine|mesh-list
56314130|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314131|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
56314132|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56314133|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56314199|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314200|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56314201|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56314202|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56314203|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56314204|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56314205|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
56314206|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
56314207|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56314208|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56314261|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56314262|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314263|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
56314264|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314265|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
56314266|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314267|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314268|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56314269|NCT00393315|Paclitaxel|paclitaxel|mesh-list
56314270|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56314271|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314272|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
56314273|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
56314274|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
56314275|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314276|NCT00143689|Ritonavir|ritonavir|mesh-list
56314277|NCT00143689|Lopinavir|lopinavir|mesh-list
56314278|NCT00143689|Lamivudine|lamivudine|mesh-list
56314279|NCT00143689|Zidovudine|zidovudine|mesh-list
56314318|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56314319|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
56314320|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56314321|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314322|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56314323|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56314324|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314325|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
56314326|NCT00144118|Sevoflurane|sevoflurane|mesh-list
56314327|NCT00144118|Isoflurane|isoflurane|mesh-list
56314328|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56314329|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56314330|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
56314331|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
56314332|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56314333|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314334|NCT00144157|Zidovudine|zidovudine|mesh-list
56314335|NCT00144157|Nevirapine|nevirapine|mesh-list
56314336|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
56314337|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314338|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56314339|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56314340|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314341|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
56314342|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314368|NCT00144274|Ambroxol|ambroxol|mesh-list
56314369|NCT00144274|Expectorants|expectorants|mesh-ancestor
56314370|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
56314371|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
56314372|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
56314373|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56314374|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
56314375|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56314376|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56314377|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314378|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56314379|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314380|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314381|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56314382|NCT00144352|Renal Agents|renal agents|mesh-ancestor
56314383|NCT00144430|Pentostatin|pentostatin|mesh-list
56314384|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314385|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56314386|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314387|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314388|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56314389|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
56314390|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314391|NCT00404716|Cilostazol|cilostazol|mesh-list
56314392|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56314393|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
56314414|NCT00404794|Tacrolimus|tacrolimus|mesh-list
56314417|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56314418|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
56314419|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314420|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56314421|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314422|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314423|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56314424|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56314425|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56314426|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
56314482|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
56314483|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
56314484|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314485|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314486|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56314487|NCT00404833|Protective Agents|protective agents|mesh-ancestor
56314488|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56314489|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
56314556|NCT05594602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56314557|NCT05594602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56314558|NCT05594602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56314559|NCT05594602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56314560|NCT05594602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56314561|NCT05594602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56314562|NCT05594602|Adrenergic Agents|adrenergic agents|mesh-ancestor
56314563|NCT05594602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314564|NCT05594602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56314633|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56314634|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314635|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
56314636|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314637|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56314638|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56314639|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56314642|NCT05594017|Scopolamine|scopolamine|mesh-list
56314699|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56314700|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314702|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56314703|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56314704|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56314705|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
56314706|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
56314707|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
56314708|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
55936613|NCT04972032|Estrogens|estrogens|mesh-list
56314709|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314710|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314711|NCT03090737|Nivolumab|nivolumab|mesh-list
56314763|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314764|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
56314766|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56314767|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
56314768|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56314769|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
56314770|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314771|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314772|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
56314773|NCT03079427|Gemcitabine|gemcitabine|mesh-list
56314774|NCT03079427|Cisplatin|cisplatin|mesh-list
56314775|NCT03079427|Capecitabine|capecitabine|mesh-list
56314776|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161414|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
56314777|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56314779|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314780|NCT03079427|Antiviral Agents|antiviral agents|mesh-ancestor
56314781|NCT03079427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56314823|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
56314824|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314825|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314826|NCT05374525|Cabotegravir|cabotegravir|mesh-list
56314827|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56314828|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56314829|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56314830|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314831|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56314832|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56314885|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56314886|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314887|NCT01806753|Midazolam|midazolam|mesh-list
56314888|NCT01806753|Propofol|propofol|mesh-list
56314889|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56314890|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56314891|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314892|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56314893|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
56314894|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
56314895|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56314950|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
56314951|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
56314952|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56314953|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56314954|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56314955|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
56314956|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
56314957|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56314958|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
56314959|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56314960|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56314961|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56315011|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56315012|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56315013|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
56315014|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315015|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315016|NCT04861051|Ketamine|ketamine|mesh-list
56315017|NCT04861051|Analgesics|analgesics|mesh-ancestor
56315018|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
56315019|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315074|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315075|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
56315076|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56315077|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
56315078|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
56315079|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315080|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315081|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56315082|NCT04749043|Analgesics|analgesics|mesh-ancestor
56315139|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315140|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56315141|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56315143|NCT02647892|Lidocaine|lidocaine|mesh-list
56315144|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
56315145|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
56315146|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315147|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315148|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
56315149|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315150|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56315206|NCT04341181|Maytansine|maytansine|mesh-list
56315207|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56315208|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315209|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56315210|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315211|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315212|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56315213|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56315214|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
56161421|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
56315215|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
56315216|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
56315269|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315270|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315271|NCT00405418|Insulin|insulin|mesh-list
56315272|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56315273|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
56315274|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
56315275|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56315276|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315277|NCT02157077|Aflibercept|aflibercept|mesh-list
56315278|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56315279|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56315280|NCT02157077|Growth Substances|growth substances|mesh-ancestor
56315281|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315282|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
56315283|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315284|NCT01805700|Caffeine|caffeine|mesh-list
56315328|NCT03781063|Fulvestrant|fulvestrant|mesh-list
56315329|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56315330|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315331|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56315332|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56315333|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
56315334|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56315335|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315336|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
56315337|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56315338|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
56315339|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56315340|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
56315341|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315342|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315343|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
56315344|NCT03770767|Insulin|insulin|mesh-list
56315345|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56315403|NCT01902173|Trametinib|trametinib|mesh-list
56315404|NCT01902173|Dabrafenib|dabrafenib|mesh-list
56315405|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56315406|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315407|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56315408|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315409|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315410|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56315411|NCT01902173|Protective Agents|protective agents|mesh-ancestor
56315412|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315458|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315459|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315460|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56315461|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
56315462|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315463|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315464|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56315465|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56315466|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
56315467|NCT01878617|Antiviral Agents|antiviral agents|mesh-ancestor
56315468|NCT01878617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315469|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315470|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56315471|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
56315472|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
56315473|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
56315474|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56315475|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56315476|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56315477|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
56315478|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315480|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
56315481|NCT00405496|Hormones|hormones|mesh-ancestor
56315509|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56315510|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56315511|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315512|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315513|NCT02825641|Oxytocin|oxytocin|mesh-list
56315514|NCT02825641|Dinoprostone|dinoprostone|mesh-list
56315515|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
56315516|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56315517|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315518|NCT01646034|Gemcitabine|gemcitabine|mesh-list
56315519|NCT01646034|Paclitaxel|paclitaxel|mesh-list
56315520|NCT01646034|Docetaxel|docetaxel|mesh-list
56315521|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
56315522|NCT01646034|Carboplatin|carboplatin|mesh-list
56315523|NCT01646034|Doxorubicin|doxorubicin|mesh-list
56315524|NCT01646034|Thiotepa|thiotepa|mesh-list
56315525|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56315526|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315570|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
56315571|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315572|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315573|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56315574|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56315575|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56315576|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315577|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315578|NCT01466478|Calcitriol|calcitriol|mesh-list
56315579|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56315635|NCT01466244|Cetuximab|cetuximab|mesh-list
56315636|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315637|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56315638|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
56315639|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
56315640|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
56315641|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56315642|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315701|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56315702|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
56315703|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56315704|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315705|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56315706|NCT00009698|Aldesleukin|aldesleukin|mesh-list
56315707|NCT00009698|Interleukin-2|interleukin-2|mesh-list
56315708|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315709|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56315710|NCT00009698|Analgesics|analgesics|mesh-ancestor
56315711|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
56315714|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56315767|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
56315768|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56315769|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315770|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56315771|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315772|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315773|NCT00009854|Ethanol|ethanol|mesh-list
56315774|NCT00009854|Carmustine|carmustine|mesh-list
56315775|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56315776|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315777|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56315778|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315779|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56315780|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
56315781|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315827|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56315828|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
56315829|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56315830|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315831|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56315832|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
56315833|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315834|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56315835|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315837|NCT00010088|Leucovorin|leucovorin|mesh-list
56315895|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56315896|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56315897|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56315898|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56315899|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315900|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315901|NCT01465074|Nicotine|nicotine|mesh-list
56315902|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56315903|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
56315904|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56315957|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315958|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56315959|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56315960|NCT01464840|Azithromycin|azithromycin|mesh-list
56315961|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56315962|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315963|NCT01464801|Resveratrol|resveratrol|mesh-list
56315964|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
56103766|NCT05749393|Heparin|heparin|mesh-list
56315965|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56315966|NCT01464801|Protective Agents|protective agents|mesh-ancestor
56315967|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315968|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56315969|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56315970|NCT01464762|Bedaquiline|bedaquiline|mesh-list
56315971|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
56315972|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56315973|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56315975|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56315976|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56315977|NCT01464723|Growth Substances|growth substances|mesh-ancestor
56315978|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56315979|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
56315980|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316008|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56316009|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
56316010|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316011|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
56316012|NCT01464528|Protective Agents|protective agents|mesh-ancestor
56316013|NCT00393744|Amoxicillin|amoxicillin|mesh-list
56316014|NCT00393744|Pristinamycin|pristinamycin|mesh-list
56316015|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56316016|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316017|NCT01280994|Xenon|xenon|mesh-list
56316018|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56316019|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
56316020|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
56316021|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56316023|NCT00011297|Gabapentin|gabapentin|mesh-list
56316070|NCT00847860|Analgesics|analgesics|mesh-ancestor
56316071|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
56316072|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316073|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937952|NCT03518801|Cannabidiol|cannabidiol|mesh-list
56316074|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56316075|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56316076|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56316077|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56316078|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316079|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56316080|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56316081|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316082|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
56316128|NCT00011804|Topiramate|topiramate|mesh-list
56316129|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
56316130|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56316131|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316132|NCT00011921|Paclitaxel|paclitaxel|mesh-list
56316133|NCT00011921|Etoposide|etoposide|mesh-list
56316134|NCT00011921|Carboplatin|carboplatin|mesh-list
56316135|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
56316136|NCT00011921|Epirubicin|epirubicin|mesh-list
56316197|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56316198|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
56316199|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316200|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56316201|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56316202|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316203|NCT00847080|Incretins|incretins|mesh-ancestor
56316204|NCT00847080|Hormones|hormones|mesh-ancestor
56316205|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56316206|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56316207|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
56316208|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316209|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316210|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56316211|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316212|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56316256|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56316257|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56316258|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
56316259|NCT00012389|Irinotecan|irinotecan|mesh-list
56316260|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316261|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56316263|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316264|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316265|NCT00846885|Sumatriptan|sumatriptan|mesh-list
56316269|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
56316322|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56316396|NCT00012857|Analgesics|analgesics|mesh-ancestor
56316397|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
56316398|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316399|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316400|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
56316401|NCT00394056|Paroxetine|paroxetine|mesh-list
56316402|NCT00394056|Vestipitant|vestipitant|mesh-list
56316403|NCT00394056|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56316404|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56316405|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316406|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316407|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316408|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
56316409|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316410|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56316411|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
56316453|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56316454|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56316455|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
56316456|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56316457|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56316458|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56316459|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56316461|NCT00845910|Docetaxel|docetaxel|mesh-list
56316462|NCT00845910|Capecitabine|capecitabine|mesh-list
56316463|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56316464|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316465|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56316466|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56316467|NCT00845910|Growth Substances|growth substances|mesh-ancestor
56316468|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316514|NCT00277017|Interferons|interferons|mesh-list
56316515|NCT00277017|Thalidomide|thalidomide|mesh-list
56316586|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56316587|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
56316588|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316589|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316590|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56316591|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56316592|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56316653|NCT00276549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316654|NCT00276549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316655|NCT00276549|Immunologic Factors|immunologic factors|mesh-ancestor
56316656|NCT00276549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316657|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
56316658|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
56316659|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56316660|NCT00014183|Gefitinib|gefitinib|mesh-list
56316661|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316662|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56316663|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316664|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316665|NCT00014261|Interferons|interferons|mesh-list
56316666|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
56316667|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
56316668|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56316669|NCT00014261|Temozolomide|temozolomide|mesh-list
56316670|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316710|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316711|NCT00014534|Gemcitabine|gemcitabine|mesh-list
56316712|NCT00014534|Doxorubicin|doxorubicin|mesh-list
56316713|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56316714|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316715|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56316716|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
56316717|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316718|NCT00014534|Antiviral Agents|antiviral agents|mesh-ancestor
56316719|NCT00014534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56316720|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316721|NCT00014534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56316722|NCT00014534|Immunologic Factors|immunologic factors|mesh-ancestor
56316723|NCT00014534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316724|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56316728|NCT00014573|Paclitaxel|paclitaxel|mesh-list
56316770|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316771|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316772|NCT00014690|Topotecan|topotecan|mesh-list
56316773|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56316774|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56316775|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56316776|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316777|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316836|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316837|NCT00015041|Analgesics|analgesics|mesh-ancestor
56316838|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
56316839|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316840|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56316841|NCT00015080|Naltrexone|naltrexone|mesh-list
56316842|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56316843|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56316844|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316845|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
56316846|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316847|NCT00015236|Amantadine|amantadine|mesh-list
56316900|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56316901|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56316902|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
56316903|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316904|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56316905|NCT00015548|Olanzapine|olanzapine|mesh-list
56316906|NCT00015548|Risperidone|risperidone|mesh-list
56316907|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56316908|NCT00015548|Citalopram|citalopram|mesh-list
56316909|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56316910|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
56316911|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56316912|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56316913|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56316914|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56316915|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56316916|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56316917|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56316918|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56316919|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
56316920|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
56316921|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
56104725|NCT00002785|Hormones|hormones|mesh-ancestor
56316922|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56316924|NCT00015548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56316925|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56316926|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56316927|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
56316928|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56316929|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
56316930|NCT00275535|Sirolimus|sirolimus|mesh-list
56316931|NCT00275535|Prednisone|prednisone|mesh-list
56316932|NCT00275535|Tacrolimus|tacrolimus|mesh-list
56316933|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
56316934|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56316935|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56316936|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
56317016|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56317017|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317092|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317093|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317094|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56317095|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
56317096|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56317097|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56317098|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
56317099|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56317100|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56317101|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56317102|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
56317103|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317104|NCT00275106|Antidotes|antidotes|mesh-ancestor
56317105|NCT00275106|Protective Agents|protective agents|mesh-ancestor
56317106|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
56317107|NCT00275106|Vitamins|vitamins|mesh-ancestor
56317108|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
56317152|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
56317153|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56317154|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56317155|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56317156|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56317157|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56317158|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56317159|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317160|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317161|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
56317162|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56317163|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56317164|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
56317165|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
56317166|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
56317167|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
56317168|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56317212|NCT00130455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56317213|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56317214|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56317215|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317216|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317217|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
56317218|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317219|NCT00130455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56317220|NCT00130455|Antidepressive Agents|antidepressive agents|mesh-ancestor
56317221|NCT00130455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56317222|NCT00016055|Temozolomide|temozolomide|mesh-list
56317276|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
56317277|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56317278|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56317279|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317280|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
56317281|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
56317282|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56317283|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317284|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56317285|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317286|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317287|NCT00394368|Fluticasone|fluticasone|mesh-list
56317288|NCT00394368|Xhance|xhance|mesh-list
56317289|NCT00394368|Beclomethasone|beclomethasone|mesh-list
56317339|NCT00130065|Hematinics|hematinics|mesh-ancestor
56317340|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
56317341|NCT00130065|Vitamins|vitamins|mesh-ancestor
56317342|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
56317343|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317344|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
56317345|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56317346|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56317347|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317348|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56317349|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317350|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317351|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56317352|NCT00130065|Renal Agents|renal agents|mesh-ancestor
56317353|NCT00016328|Sirolimus|sirolimus|mesh-list
56317354|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56317355|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317398|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317399|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317400|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317401|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317402|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
56317403|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317404|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317405|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317412|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
56317463|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
56317464|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317465|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56317466|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56317467|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56317468|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56317469|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56317470|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56317471|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56317472|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56317473|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56317474|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56317475|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56317476|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56317477|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
56317478|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56317479|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317480|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56317481|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56317482|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56317483|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56317484|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317485|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
56317486|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56317487|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317488|NCT00129519|Imiquimod|imiquimod|mesh-list
56317489|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56317490|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
56317491|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317492|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317493|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
56317503|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56317504|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317505|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
56317506|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
56317507|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317508|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317509|NCT00016952|Leucovorin|leucovorin|mesh-list
56317510|NCT00016952|Fluorouracil|fluorouracil|mesh-list
56317511|NCT00016952|Irinotecan|irinotecan|mesh-list
56317512|NCT00016952|Calcium|calcium|mesh-list
56317568|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317569|NCT00129285|Modafinil|modafinil|mesh-list
56317570|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56317571|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317572|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56317573|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56317574|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56317575|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317576|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
56317577|NCT00017108|Chlorambucil|chlorambucil|mesh-list
56317578|NCT00017108|Fludarabine|fludarabine|mesh-list
55939452|NCT03010761|Citalopram|citalopram|mesh-list
56317579|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
56317580|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317581|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
56317582|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317583|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317623|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317624|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317625|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
56317626|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56317627|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317628|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
56317629|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317630|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56317631|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56317632|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56317633|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317634|NCT00129090|Rituximab|rituximab|mesh-list
56317635|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56317636|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317637|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
56317638|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317639|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317682|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
56317683|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
56317684|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
56317685|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
56317686|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56317687|NCT00128934|Estradiol|estradiol|mesh-list
56317688|NCT00128934|Estrogens|estrogens|mesh-ancestor
56317689|NCT00128934|Hormones|hormones|mesh-ancestor
56317690|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56317691|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317692|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56317693|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
56317694|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56317695|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56317696|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56317697|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56317698|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56317740|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
56317741|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
56317743|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56317744|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
56317745|NCT00017381|Rituximab|rituximab|mesh-list
56317746|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56317747|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56317748|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
56317749|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317750|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317751|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56317752|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
56317802|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56317803|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
56317804|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56317806|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56317807|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56317808|NCT00017576|Calcitriol|calcitriol|mesh-list
56317809|NCT00017576|Carboplatin|carboplatin|mesh-list
56317810|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317811|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56317812|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317813|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56317814|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56317815|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317816|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56317818|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
56317819|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56317820|NCT00017654|Cyclosporine|cyclosporine|mesh-list
56317860|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317861|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317862|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
56317863|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56317864|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56317865|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56317866|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
56317867|NCT00017693|Interleukin-4|interleukin-4|mesh-list
56317868|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56317869|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
56317870|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317871|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56317872|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56317873|NCT00128466|Gentamicins|gentamicins|mesh-list
56317922|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56317923|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56317924|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56317925|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317926|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
56317927|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
56317928|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56317929|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56317930|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56317931|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
56317932|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56317933|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56317934|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56317935|NCT00018083|Efavirenz|efavirenz|mesh-list
56317936|NCT00018083|Isoniazid|isoniazid|mesh-list
56317937|NCT00018083|Rifabutin|rifabutin|mesh-list
56317982|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56317983|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56317984|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
56317985|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56317986|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56317987|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56317988|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56317989|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56317990|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56317991|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
56317992|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56318046|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56318047|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318048|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56318119|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318139|NCT00018551|Folic Acid|folic acid|mesh-list
56318192|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318266|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56318267|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56318268|NCT00020046|Growth Substances|growth substances|mesh-ancestor
56318269|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
56318270|NCT00020124|Doxorubicin|doxorubicin|mesh-list
56318271|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56318272|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318273|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318274|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56318275|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56318276|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318277|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318331|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56318332|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318333|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56318334|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56318335|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56318336|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56318337|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318338|NCT00020670|Vaccines|vaccines|mesh-list
56318339|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
56318340|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318341|NCT05576324|Ivacaftor|ivacaftor|mesh-list
56318342|NCT05576324|Elexacaftor|elexacaftor|mesh-list
56318396|NCT00020943|Carmustine|carmustine|mesh-list
56318397|NCT00020943|Rituximab|rituximab|mesh-list
56318398|NCT00020943|Doxorubicin|doxorubicin|mesh-list
56318473|NCT05574257|Anesthetics, General|anesthetics, general|mesh-ancestor
56318549|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56318550|NCT00392093|Estrogens|estrogens|mesh-list
56318623|NCT00021645|Protective Agents|protective agents|mesh-ancestor
56318698|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56318699|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
56318700|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56318701|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56318702|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56318703|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56318704|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318705|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56318706|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56318707|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
56318708|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56318710|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318711|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56318712|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56318713|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318714|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318716|NCT00022386|Hematinics|hematinics|mesh-ancestor
56318717|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
56318718|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318719|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56318721|NCT00022464|Sirolimus|sirolimus|mesh-list
56318755|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56318756|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
56318757|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56318832|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56318833|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56318907|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
56318915|NCT00023244|Sirolimus|sirolimus|mesh-list
56318984|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
56318985|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
56318986|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56318987|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56319059|NCT00023868|Leucovorin|leucovorin|mesh-list
56319060|NCT00023868|Doxorubicin|doxorubicin|mesh-list
56319061|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56319062|NCT00023868|Fluorouracil|fluorouracil|mesh-list
56319063|NCT00023868|Irinotecan|irinotecan|mesh-list
56319064|NCT00023868|Mitomycins|mitomycins|mesh-list
56319065|NCT00023868|Mitomycin|mitomycin|mesh-list
56319066|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
56319067|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319079|NCT00023868|Antidotes|antidotes|mesh-ancestor
56319129|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
56319131|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319201|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319202|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319203|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56319204|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56319205|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
56319206|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
56319207|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56319208|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
56319209|NCT05055830|Acetaminophen|acetaminophen|mesh-list
56319210|NCT05055830|Methadone|methadone|mesh-list
56319211|NCT05055830|Caffeine|caffeine|mesh-list
56319212|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56319213|NCT05055830|Analgesics|analgesics|mesh-ancestor
56319214|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
56319217|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
56319262|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319263|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319264|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
56319265|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319335|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319336|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319341|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319407|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56319408|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56319409|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319410|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56319411|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
56319412|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
56319413|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
56319414|NCT04955678|Sorbitol|sorbitol|mesh-list
56319415|NCT04955678|Calcium|calcium|mesh-list
56319416|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56319472|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319473|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319474|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56319475|NCT00026052|Protective Agents|protective agents|mesh-ancestor
56319477|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56319478|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56319479|NCT00026091|Protective Agents|protective agents|mesh-ancestor
56319480|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319481|NCT00026130|Gemcitabine|gemcitabine|mesh-list
56319538|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319616|NCT00027066|Analgesics|analgesics|mesh-ancestor
56319689|NCT00027573|Methotrexate|methotrexate|mesh-list
56319690|NCT00027573|Fludarabine|fludarabine|mesh-list
56319766|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319840|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319841|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56319842|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56319843|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56319844|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56319845|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56319846|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56319910|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
56319911|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56319912|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56319983|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
56319985|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320057|NCT00028860|Antiviral Agents|antiviral agents|mesh-ancestor
56320058|NCT00028860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320059|NCT00028860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320060|NCT00028860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320217|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
56320218|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320219|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320220|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56320221|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
56320222|NCT00030069|Hormones|hormones|mesh-ancestor
56320223|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56320285|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56320286|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320287|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56320288|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320289|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320290|NCT03873857|Venetoclax|venetoclax|mesh-list
56320291|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320292|NCT03866408|Pioglitazone|pioglitazone|mesh-list
56320293|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56320294|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320349|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320353|NCT03852407|Melphalan|melphalan|mesh-list
56320427|NCT03779789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56320428|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56320429|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56320497|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56320498|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56320643|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
56320644|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320645|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320646|NCT00031473|Ribavirin|ribavirin|mesh-list
56320647|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
56320648|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320650|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320651|NCT00031629|Gemcitabine|gemcitabine|mesh-list
56320652|NCT00031629|Docetaxel|docetaxel|mesh-list
56320653|NCT00031629|Lenograstim|lenograstim|mesh-list
56320654|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56320655|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
56320656|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320657|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320658|NCT00031629|Antiviral Agents|antiviral agents|mesh-ancestor
56320659|NCT00031629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320660|NCT00031629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320661|NCT00031629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56320701|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56320702|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320775|NCT00031902|Hormones|hormones|mesh-ancestor
56320850|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
56320851|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56320852|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320853|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56320854|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320855|NCT03151460|Protective Agents|protective agents|mesh-ancestor
56320856|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
56320857|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56320858|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56320859|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
56320860|NCT03151382|Tandospirone|tandospirone|mesh-list
56320861|NCT03151382|Donepezil|donepezil|mesh-list
56320863|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56320911|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56320912|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320913|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56320914|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56320915|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56320916|NCT00032292|Visilizumab|visilizumab|mesh-list
56320917|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
56320918|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56320919|NCT03150914|Sirolimus|sirolimus|mesh-list
56320920|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56320921|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56320922|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56320931|NCT03150836|Durvalumab|durvalumab|mesh-list
56320973|NCT00396396|Antidotes|antidotes|mesh-ancestor
56321049|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56321050|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321123|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
56321199|NCT00034047|Nafarelin|nafarelin|mesh-list
56321200|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56321204|NCT00034086|Ritonavir|ritonavir|mesh-list
56321274|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56321275|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56321286|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
56321344|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56321345|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56321346|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56321347|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56321348|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56321349|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
56321350|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56321351|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56321411|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
56321412|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56321413|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56321414|NCT00034944|Aprepitant|aprepitant|mesh-list
56321415|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
56321416|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
56321417|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56321418|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321419|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56321420|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56321421|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321422|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321423|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
56321424|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
56321425|NCT01806272|Vitamins|vitamins|mesh-ancestor
56321470|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321471|NCT00035139|Methylphenidate|methylphenidate|mesh-list
56321472|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56321473|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321474|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56321475|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56321476|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56321477|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321478|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
56321479|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321480|NCT00035178|Argatroban|argatroban|mesh-list
56321481|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
56321482|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56321483|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
56321501|NCT00035295|Aprepitant|aprepitant|mesh-list
56321528|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56161550|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56321602|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
56321603|NCT00035958|Prednisone|prednisone|mesh-list
56321604|NCT00035958|Etanercept|etanercept|mesh-list
56321605|NCT00035958|Methotrexate|methotrexate|mesh-list
56321673|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56321674|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56321675|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
56321676|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
56321677|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321678|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321737|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56321738|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56321810|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
56321884|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56321959|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56321960|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56321961|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56322034|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
56322035|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322109|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56322110|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322111|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
56322112|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56322113|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322114|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56322115|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56322116|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322117|NCT00846989|Latanoprost|latanoprost|mesh-list
56322118|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56322119|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56322120|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
56322123|NCT00396747|Prednisolone|prednisolone|mesh-list
56322172|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56322174|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
56322245|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322246|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56322284|NCT00846326|Xhance|xhance|mesh-list
56322318|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322330|NCT00845936|Metformin|metformin|mesh-list
56322392|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56322393|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
56322394|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56322467|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56322468|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56322469|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56322540|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56322541|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322542|NCT00276068|Lidocaine|lidocaine|mesh-list
56322543|NCT00276068|Desipramine|desipramine|mesh-list
56322544|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
56322545|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
56322546|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56322547|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322548|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
56322549|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56322550|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56322551|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56322602|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56322673|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322674|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56322746|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56322747|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
56322825|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56322898|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
56322899|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56322900|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56322903|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
56322969|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56322979|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
56323042|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56323043|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
56323044|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
56323045|NCT00470223|Doxorubicin|doxorubicin|mesh-list
56323046|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56323047|NCT00470223|Methotrexate|methotrexate|mesh-list
56323048|NCT00470223|Etoposide|etoposide|mesh-list
56323049|NCT00470223|Ifosfamide|ifosfamide|mesh-list
56323050|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323051|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56323053|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56323109|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323110|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56323191|NCT05770375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56323192|NCT05770375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323193|NCT05770375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56323196|NCT05770375|Adrenergic Agents|adrenergic agents|mesh-ancestor
56323267|NCT05769478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323272|NCT05769309|Fentanyl|fentanyl|mesh-list
56323342|NCT05762146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56323344|NCT05760612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56323345|NCT05760612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323346|NCT05760144|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56323347|NCT05760144|Etonogestrel|etonogestrel|mesh-list
56323348|NCT05760144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56323356|NCT05744674|Ropivacaine|ropivacaine|mesh-list
56323417|NCT05697783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56323418|NCT05697783|Anesthetics, General|anesthetics, general|mesh-ancestor
56323419|NCT05697783|Anesthetics|anesthetics|mesh-ancestor
56323420|NCT05697783|Antitussive Agents|antitussive agents|mesh-ancestor
56323421|NCT05697783|Respiratory System Agents|respiratory system agents|mesh-ancestor
56323422|NCT05686408|Tianeptine|tianeptine|mesh-list
56323423|NCT05686408|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56323424|NCT05686408|Antidepressive Agents|antidepressive agents|mesh-ancestor
56323425|NCT05686408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56323426|NCT05672225|Dexmedetomidine|dexmedetomidine|mesh-list
56323427|NCT05672225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56323428|NCT05672225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323431|NCT05672225|Analgesics|analgesics|mesh-ancestor
56323479|NCT05654623|Fulvestrant|fulvestrant|mesh-list
56323480|NCT05654623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56323481|NCT05654623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56323494|NCT05633615|Antibodies|antibodies|mesh-list
56323559|NCT05595603|Vasodilator Agents|vasodilator agents|mesh-ancestor
56323560|NCT05595603|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56323649|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
56323650|NCT05453955|Propofol|propofol|mesh-list
56323651|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56323652|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56323653|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323654|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56323655|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
56323656|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
56323657|NCT05452772|Niacin|niacin|mesh-list
56323658|NCT05452772|Psilocybin|psilocybin|mesh-list
56323659|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56323660|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
56323661|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323716|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
56323790|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56323791|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56323796|NCT05351801|Dronabinol|dronabinol|mesh-list
56323798|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
56323799|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56323800|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56323801|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56323802|NCT05351801|Analgesics|analgesics|mesh-ancestor
56323803|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
56323804|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56323805|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56323806|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56323853|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56323855|NCT05298696|Cilostazol|cilostazol|mesh-list
56323927|NCT05255003|Tinzaparin|tinzaparin|mesh-list
56323928|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56324000|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324076|NCT05054439|Paclitaxel|paclitaxel|mesh-list
56324104|NCT05048797|Pemetrexed|pemetrexed|mesh-list
56324151|NCT05012189|Baloxavir|baloxavir|mesh-list
56324152|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
56324153|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324154|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324155|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324156|NCT05006573|Benralizumab|benralizumab|mesh-list
56324157|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56324158|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
56324159|NCT04954599|Carboplatin|carboplatin|mesh-list
56324160|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
56324230|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
56324231|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324232|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56324233|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56324234|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324235|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324236|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56324238|NCT04859296|Dronabinol|dronabinol|mesh-list
56324296|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56324373|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56324446|NCT04654689|Protective Agents|protective agents|mesh-ancestor
56324536|NCT04577833|Prednisone|prednisone|mesh-list
56324597|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56324598|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
56324599|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
56324600|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56324601|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
56324602|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56324603|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56324604|NCT04499274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56324605|NCT04499274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56324606|NCT04499274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56324607|NCT04499274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56324608|NCT04499274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56324661|NCT04488159|Vitamins|vitamins|mesh-ancestor
56324662|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
56324663|NCT04449861|Durvalumab|durvalumab|mesh-list
56324664|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324665|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324666|NCT04439539|Tenofovir|tenofovir|mesh-list
56324667|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
56324668|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56324669|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
56324670|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56324729|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56324730|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56324731|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56324732|NCT04319224|Nivolumab|nivolumab|mesh-list
56324733|NCT04319224|Ipilimumab|ipilimumab|mesh-list
56324734|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324735|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324805|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56161607|NCT05164614|Teriparatide|teriparatide|mesh-list
56324879|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
56324880|NCT04181827|Hormones|hormones|mesh-ancestor
56324881|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56324883|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324884|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
56324886|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56324887|NCT04181827|Growth Substances|growth substances|mesh-ancestor
56324888|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
56324889|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
56324890|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56324891|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56324892|NCT04167163|Abaloparatide|abaloparatide|mesh-list
56324893|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56324894|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324940|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56324941|NCT04101357|Carboplatin|carboplatin|mesh-list
56324942|NCT04101357|Etoposide|etoposide|mesh-list
56325016|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
56325017|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56325018|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325019|NCT03901963|Lenalidomide|lenalidomide|mesh-list
56325020|NCT03901963|Daratumumab|daratumumab|mesh-list
56325021|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
56325022|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325023|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56325028|NCT03878082|Acetaminophen|acetaminophen|mesh-list
56325086|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
56325087|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325093|NCT03767244|Androgens|androgens|mesh-list
56325160|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325235|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065347|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325236|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325237|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
56325238|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325239|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56325242|NCT03539900|Naltrexone|naltrexone|mesh-list
56325300|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325301|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325302|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
56325303|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325304|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56325305|NCT03476798|Bevacizumab|bevacizumab|mesh-list
56325306|NCT03476798|Rucaparib|rucaparib|mesh-list
56325307|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325308|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325309|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56325310|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56325311|NCT03476798|Growth Substances|growth substances|mesh-ancestor
56325312|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325313|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325314|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56325315|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325316|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325317|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
56325318|NCT03456843|Docetaxel|docetaxel|mesh-list
56325319|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
56325320|NCT03456843|Hormones|hormones|mesh-list
56325321|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56325322|NCT03456843|Androgens|androgens|mesh-list
56325354|NCT03432741|Rituximab|rituximab|mesh-list
56325355|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56325356|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
56325357|NCT03432741|Nivolumab|nivolumab|mesh-list
56325358|NCT03432741|Trastuzumab|trastuzumab|mesh-list
56325359|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
56325360|NCT03432741|Daratumumab|daratumumab|mesh-list
56325428|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325429|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56325504|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
56325505|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56325506|NCT03255473|Dexamethasone|dexamethasone|mesh-list
56325507|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
56325508|NCT03255473|Prednisone|prednisone|mesh-list
56325509|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56325510|NCT03255473|BB 1101|bb 1101|mesh-list
56325511|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56325512|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
56325574|NCT03110107|Nivolumab|nivolumab|mesh-list
56325575|NCT03110107|Ipilimumab|ipilimumab|mesh-list
56325576|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56325577|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325578|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56325579|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56325580|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
56325581|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56325582|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56325594|NCT03098225|Hormones|hormones|mesh-ancestor
56325718|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56325719|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325720|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56325721|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
56325722|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
56325723|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56325724|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56325725|NCT02663518|Rituximab|rituximab|mesh-list
56325726|NCT02663518|Nivolumab|nivolumab|mesh-list
56325727|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
56325735|NCT02603848|Ibuprofen|ibuprofen|mesh-list
56325783|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
56325784|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
56325859|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
56325860|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56325861|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56325862|NCT02316106|Daratumumab|daratumumab|mesh-list
56325863|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56325864|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325865|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
56325866|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325867|NCT02288247|Prednisolone|prednisolone|mesh-list
56325868|NCT02288247|Docetaxel|docetaxel|mesh-list
56325869|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325870|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
56325871|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
56325921|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
56325922|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
56325923|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56325924|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56325925|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56325926|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
56325927|NCT02252172|Hormones|hormones|mesh-ancestor
56325928|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56325929|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56325930|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56325987|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56325988|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56325990|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
56326062|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
56326138|NCT01615029|Hormones|hormones|mesh-ancestor
56326139|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56326140|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56326141|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326142|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
56326143|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56326144|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56326145|NCT01615029|Growth Substances|growth substances|mesh-ancestor
56326146|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
56326147|NCT01604135|Riboflavin|riboflavin|mesh-list
56326148|NCT01604135|Dextrans|dextrans|mesh-list
56326149|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
56326151|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
56326152|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326153|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56326200|NCT00630032|Epirubicin|epirubicin|mesh-list
56326201|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326202|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
56326203|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326204|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326205|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56326206|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
56326208|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326267|NCT05772832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326283|NCT05772676|Aprepitant|aprepitant|mesh-list
56326340|NCT05772039|Fluorides|fluorides|mesh-list
56326341|NCT05772039|Sodium Fluoride|sodium fluoride|mesh-list
56326342|NCT05772039|Cariostatic Agents|cariostatic agents|mesh-ancestor
56326416|NCT05771012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326417|NCT05771012|Antifungal Agents|antifungal agents|mesh-ancestor
56326418|NCT05771012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56326419|NCT05771012|Dermatologic Agents|dermatologic agents|mesh-ancestor
56326420|NCT05771012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56326421|NCT05771012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56326422|NCT05770960|Codeine|codeine|mesh-list
56326423|NCT05770960|Naloxegol|naloxegol|mesh-list
56326424|NCT05770960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56326425|NCT05770960|Narcotics|narcotics|mesh-ancestor
56326426|NCT05770960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326482|NCT05756166|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56326483|NCT05756166|Celecoxib|celecoxib|mesh-list
56326557|NCT05715073|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56326633|NCT05672173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56326634|NCT05672173|Immunologic Factors|immunologic factors|mesh-ancestor
56326635|NCT05672173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326712|NCT05646693|Antacids|antacids|mesh-ancestor
56326804|NCT05597878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56326805|NCT05597878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56326818|NCT05592223|Isoniazid|isoniazid|mesh-list
56326877|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56326878|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326879|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
56326880|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326881|NCT05506943|Paclitaxel|paclitaxel|mesh-list
56326882|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56326883|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326884|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
56326885|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
56326886|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
56326887|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56326888|NCT05502237|Paclitaxel|paclitaxel|mesh-list
56326889|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56326890|NCT05502237|Carboplatin|carboplatin|mesh-list
56326891|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
56326892|NCT05502237|Pemetrexed|pemetrexed|mesh-list
56326893|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56326894|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56326895|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56326896|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56326897|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56326940|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
56326941|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56326942|NCT05420337|Morphine|morphine|mesh-list
56327018|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56327019|NCT05372354|Dexamethasone|dexamethasone|mesh-list
56327020|NCT05372354|Trametinib|trametinib|mesh-list
56327021|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56327022|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
56327103|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327104|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56327105|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
56327106|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56327107|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
56327108|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327109|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56327110|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
56327111|NCT05150938|Coagulants|coagulants|mesh-ancestor
56327112|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56327113|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56327114|NCT05148962|Vaccines|vaccines|mesh-list
56327115|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
56327116|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327117|NCT05147805|Treprostinil|treprostinil|mesh-list
56327118|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56327137|NCT05112848|Vaccines|vaccines|mesh-list
56327138|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
56327139|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56327140|NCT05053503|Lofexidine|lofexidine|mesh-list
56327141|NCT05053503|Naltrexone|naltrexone|mesh-list
56327178|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327179|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327180|NCT05006794|Antiviral Agents|antiviral agents|mesh-ancestor
56327181|NCT05006794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56327182|NCT05006794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327183|NCT05006794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56327190|NCT04949256|Leucovorin|leucovorin|mesh-list
56327254|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327278|NCT04855695|Venetoclax|venetoclax|mesh-list
56327349|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
56327351|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56327424|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56327425|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56327426|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56327427|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
56327428|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56327429|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56327430|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56327431|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327432|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
56327433|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
56327434|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327435|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56327436|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56327437|NCT04702256|Protective Agents|protective agents|mesh-ancestor
56327486|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327559|NCT04580134|Risperidone|risperidone|mesh-list
56327636|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56327641|NCT04508725|Mitogens|mitogens|mesh-list
56327747|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56327748|NCT04392622|Cisplatin|cisplatin|mesh-list
56327823|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
56327824|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
56327839|NCT04220489|Ketamine|ketamine|mesh-list
56327903|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56327905|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56327906|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
56327907|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56327908|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56327909|NCT04166331|Protective Agents|protective agents|mesh-ancestor
56327910|NCT04147494|Edetic Acid|edetic acid|mesh-list
55949718|NCT04836156|Carboplatin|carboplatin|mesh-list
56327911|NCT04147494|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56327912|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56327913|NCT04147494|FAPI-46|fapi-46|mesh-list
56327978|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56327979|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
56327980|NCT03975231|Trametinib|trametinib|mesh-list
56327981|NCT03975231|Dabrafenib|dabrafenib|mesh-list
56328054|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56328055|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328056|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328057|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328058|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56328059|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55949869|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
56328060|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56328061|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328160|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
56328234|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56328235|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56328236|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328304|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
56328324|NCT03179930|Entinostat|entinostat|mesh-list
56328388|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
56328502|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328503|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328504|NCT02750202|Vaccines|vaccines|mesh-list
56328505|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
56328506|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328507|NCT02645266|Aflibercept|aflibercept|mesh-list
56328508|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56328574|NCT02573831|Oxycodone|oxycodone|mesh-list
56328651|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56328652|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328653|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
56328654|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56328655|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328656|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56328657|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328658|NCT02101905|Lapatinib|lapatinib|mesh-list
56328659|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328660|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56328661|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328724|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328725|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328726|NCT01013649|Antiviral Agents|antiviral agents|mesh-ancestor
56328727|NCT01013649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328728|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328729|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56328730|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
56328731|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328732|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56328747|NCT00038766|Semapimod|semapimod|mesh-list
56328748|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56328749|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56328750|NCT00038766|Analgesics|analgesics|mesh-ancestor
56328751|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
56328754|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398585|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56328797|NCT00042393|Adefovir|adefovir|mesh-list
56328798|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56328799|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
56328800|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328801|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56328802|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56328803|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56328804|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328805|NCT00042471|Pramlintide|pramlintide|mesh-list
56328806|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
56328807|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56328808|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56328816|NCT00042588|Antibodies|antibodies|mesh-list
56328856|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56328857|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328858|NCT00018902|Fluoxetine|fluoxetine|mesh-list
56328859|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56328860|NCT00018902|Citalopram|citalopram|mesh-list
56328861|NCT00018902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56328862|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56328863|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56328864|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56328865|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56328918|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
56328919|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56328920|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
56328994|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56328995|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56328996|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56328997|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
56328998|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56328999|NCT00039273|Panitumumab|panitumumab|mesh-list
56329000|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56329001|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329065|NCT00039351|Vincristine|vincristine|mesh-list
56329066|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329067|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
56329068|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329069|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329070|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56329071|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
56329072|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329073|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329074|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329075|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56329076|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
56329078|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56329079|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56329080|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329125|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329126|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329127|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329128|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
56329129|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329130|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
56329131|NCT00039468|Thalidomide|thalidomide|mesh-list
56329132|NCT00039468|Irinotecan|irinotecan|mesh-list
56329133|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56329134|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329135|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329136|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329189|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56329190|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329262|NCT00020189|Growth Substances|growth substances|mesh-ancestor
56329263|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56329264|NCT00039975|Ritonavir|ritonavir|mesh-list
56329336|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56329337|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56329412|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
56329413|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56329485|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329486|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56329487|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329488|NCT00021047|Carboplatin|carboplatin|mesh-list
56329489|NCT00021047|Capecitabine|capecitabine|mesh-list
56329490|NCT00021047|Epirubicin|epirubicin|mesh-list
56329491|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329492|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329493|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
56329494|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329495|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56329496|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56329497|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56329498|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329499|NCT00021164|Aldesleukin|aldesleukin|mesh-list
56329500|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
56329547|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56329548|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329549|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
56329550|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329551|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56329552|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56329553|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329554|NCT00021281|Leucovorin|leucovorin|mesh-list
56329555|NCT00021281|Fluorouracil|fluorouracil|mesh-list
56329556|NCT00021281|Irinotecan|irinotecan|mesh-list
56329557|NCT00021281|Calcium|calcium|mesh-list
56329558|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
56329559|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56329570|NCT00021281|Antidotes|antidotes|mesh-ancestor
56329612|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56329613|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
56329614|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
56329615|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56329616|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329686|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329759|NCT00049296|Docetaxel|docetaxel|mesh-list
56329760|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329761|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329762|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329763|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329764|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329765|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56329766|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
56329767|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329768|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
56329769|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56329770|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329822|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329823|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56329824|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56329825|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56329826|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56329828|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329829|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329830|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329831|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329832|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56329833|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
56329834|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56329835|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951687|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
56329885|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56329886|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
56329887|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56329888|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56329889|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
56329890|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
56329891|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56161712|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56329892|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56329893|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329894|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
56329895|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56329896|NCT00049569|Antidotes|antidotes|mesh-ancestor
56329897|NCT00049569|Protective Agents|protective agents|mesh-ancestor
56329898|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
56329899|NCT00049569|Vitamins|vitamins|mesh-ancestor
56329900|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
56329940|NCT00049608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56329941|NCT00022217|Paclitaxel|paclitaxel|mesh-list
56329942|NCT00022217|Carboplatin|carboplatin|mesh-list
56329943|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56329944|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56329945|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
56329946|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
56329947|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
56329948|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330006|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330082|NCT00023153|Adefovir|adefovir|mesh-list
56330157|NCT00023348|Rifabutin|rifabutin|mesh-list
56330230|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56330243|NCT00051090|Lamivudine|lamivudine|mesh-list
56330303|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330304|NCT00023699|Gefitinib|gefitinib|mesh-list
56330305|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330306|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56330307|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330308|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330309|NCT00051441|Benzydamine|benzydamine|mesh-list
56330310|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56330311|NCT00023738|Doxorubicin|doxorubicin|mesh-list
56330312|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56330315|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56330316|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56330371|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330372|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56330373|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56330374|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330375|NCT00023933|Antibodies|antibodies|mesh-list
56330376|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56330377|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
56330378|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330379|NCT00051597|Antibodies|antibodies|mesh-list
56330380|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56330381|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
56330382|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56330383|NCT00023972|Gemcitabine|gemcitabine|mesh-list
56330384|NCT00023972|Exatecan|exatecan|mesh-list
56330385|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56330431|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56330507|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
56330584|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56330585|NCT00052338|Antiviral Agents|antiviral agents|mesh-ancestor
56330660|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
56330661|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
56330662|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56330663|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56330664|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56330665|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
56330666|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56330667|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56330668|NCT00052611|Celecoxib|celecoxib|mesh-list
56330669|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56330670|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56330671|NCT00052611|Analgesics|analgesics|mesh-ancestor
56330672|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
56330721|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56330875|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56330877|NCT00025142|Antidotes|antidotes|mesh-ancestor
56330878|NCT00025142|Protective Agents|protective agents|mesh-ancestor
56330879|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
56330880|NCT00025142|Vitamins|vitamins|mesh-ancestor
56330881|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
56330884|NCT00053118|Carboplatin|carboplatin|mesh-list
56330948|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
56331024|NCT00025610|Etoposide|etoposide|mesh-list
56331025|NCT00025610|Vincristine|vincristine|mesh-list
56331044|NCT00025649|Melphalan|melphalan|mesh-list
56331099|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
56331100|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331101|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
56331102|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56331103|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56331104|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56331105|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56331106|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
56331167|NCT00026078|Docetaxel|docetaxel|mesh-list
56331168|NCT00026078|Ifosfamide|ifosfamide|mesh-list
56331243|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56331244|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331245|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
56331246|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331247|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56331248|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331254|NCT00026273|Antidotes|antidotes|mesh-ancestor
56331312|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56331314|NCT00054522|Dexamethasone|dexamethasone|mesh-list
56331315|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56331316|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
56331317|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
56331318|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331319|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331320|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56331321|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
56331379|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56331380|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331453|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
56331531|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331607|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331608|NCT00027716|Bortezomib|bortezomib|mesh-list
56331609|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331610|NCT00055887|Gemcitabine|gemcitabine|mesh-list
56331611|NCT00055887|Paclitaxel|paclitaxel|mesh-list
56331682|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56331683|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56331756|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331757|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56331758|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56331759|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
56331760|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331761|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331762|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331763|NCT00028535|Growth Substances|growth substances|mesh-ancestor
56331764|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331765|NCT00056277|Lamotrigine|lamotrigine|mesh-list
56331766|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
56071811|NCT02361476|Clonidine|clonidine|mesh-list
56331767|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56331815|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331816|NCT00028691|Chlorambucil|chlorambucil|mesh-list
56331817|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56331888|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56331889|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56331890|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56331891|NCT00028886|Growth Substances|growth substances|mesh-ancestor
56331892|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
56331893|NCT00028925|Carboplatin|carboplatin|mesh-list
56331894|NCT00028925|Topotecan|topotecan|mesh-list
56331895|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56331896|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56331955|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56331956|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56331957|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56331958|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56331959|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
56331960|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56331961|NCT00029159|Estrogens|estrogens|mesh-list
56331962|NCT00029159|Androgens|androgens|mesh-list
56331963|NCT00029159|Hormones|hormones|mesh-ancestor
56331964|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56331965|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56331966|NCT00423696|Leucovorin|leucovorin|mesh-list
56331967|NCT00423696|Bevacizumab|bevacizumab|mesh-list
56331968|NCT00423696|Fluorouracil|fluorouracil|mesh-list
56331969|NCT00423696|Capecitabine|capecitabine|mesh-list
56332018|NCT02970084|Vitamin K|vitamin k|mesh-list
56332093|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56332168|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332172|NCT00030407|Analgesics|analgesics|mesh-ancestor
56332239|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332240|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332241|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332242|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332243|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332245|NCT00057798|Vinorelbine|vinorelbine|mesh-list
56332246|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56332247|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
56332249|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332307|NCT00030758|Lenograstim|lenograstim|mesh-list
56332308|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56332309|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
56332310|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332311|NCT04730895|Tretinoin|tretinoin|mesh-list
56332312|NCT04730895|Isotretinoin|isotretinoin|mesh-list
56332313|NCT04730895|Vaccines|vaccines|mesh-list
55954099|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56332314|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
56332315|NCT04730895|Paraproteins|paraproteins|mesh-list
56332316|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
56332317|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332318|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332368|NCT00058227|Fludarabine|fludarabine|mesh-list
56332369|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
56332370|NCT00058227|Alvocidib|alvocidib|mesh-list
56332371|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56332372|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332373|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
56332374|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332375|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332376|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56332377|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
56332378|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332379|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332380|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
56332381|NCT00058227|Growth Substances|growth substances|mesh-ancestor
56332382|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56332428|NCT00058461|Methotrexate|methotrexate|mesh-list
56332429|NCT00058461|Etoposide|etoposide|mesh-list
56332503|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56332504|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56332505|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56332506|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56332507|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56332508|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56332509|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56332510|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332511|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
56332512|NCT00396071|Vildagliptin|vildagliptin|mesh-list
56332513|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56332514|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332516|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
56332565|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332566|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
56332567|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332568|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
56332569|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332570|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
56332571|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332572|NCT00031577|Paclitaxel|paclitaxel|mesh-list
56332573|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56332574|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332575|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332576|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332630|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56332631|NCT02969265|Amlodipine|amlodipine|mesh-list
56332632|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
56332633|NCT02969265|Candesartan|candesartan|mesh-list
56332634|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56332635|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56332636|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56332637|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332638|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56332652|NCT00031850|Goserelin|goserelin|mesh-list
56332692|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332693|NCT00031967|Protective Agents|protective agents|mesh-ancestor
56332694|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332695|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56332696|NCT00059826|Interferons|interferons|mesh-list
56332697|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
56332698|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
56332699|NCT00059826|Fluorouracil|fluorouracil|mesh-list
56332758|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332759|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332760|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56332761|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56332762|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
56332763|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56332764|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56332765|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332766|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56332767|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332768|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332769|NCT00059943|Docetaxel|docetaxel|mesh-list
56332770|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332771|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
56332772|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
56332773|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
56332774|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332775|NCT00032162|Carboplatin|carboplatin|mesh-list
56332776|NCT00032162|Doxorubicin|doxorubicin|mesh-list
56332777|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56332778|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332779|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56332780|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56332781|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332782|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332784|NCT00032279|Visilizumab|visilizumab|mesh-list
56332809|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56332810|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56332811|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
56332812|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56332813|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332814|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56072847|NCT04820036|Insulin|insulin|mesh-list
56332815|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56332817|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56332818|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56332819|NCT00060294|Rituximab|rituximab|mesh-list
56332874|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56332875|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
56332876|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
56332877|NCT00060450|Protective Agents|protective agents|mesh-ancestor
56332878|NCT00032747|Vasopressins|vasopressins|mesh-list
56332879|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
56332880|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
56332881|NCT00032747|Coagulants|coagulants|mesh-ancestor
56332882|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56332883|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56332884|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
56332885|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332886|NCT00032786|Natalizumab|natalizumab|mesh-list
56332887|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
56332888|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332935|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56332936|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
56332937|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56332938|NCT00060684|Dexamethasone|dexamethasone|mesh-list
56332939|NCT00060684|Rituximab|rituximab|mesh-list
56332940|NCT00060684|Fludarabine|fludarabine|mesh-list
56332941|NCT00060684|Pixantrone|pixantrone|mesh-list
56332942|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56332943|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56332948|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
56333001|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
56333002|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56333003|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56333004|NCT00033098|Metyrapone|metyrapone|mesh-list
56333005|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
56333006|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333007|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333069|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
56333070|NCT00033332|Pamidronate|pamidronate|mesh-list
56333071|NCT00033332|Thalidomide|thalidomide|mesh-list
56333072|NCT00033332|Dexamethasone|dexamethasone|mesh-list
56333073|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56333074|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
56333075|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
56333076|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333077|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333078|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333135|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56333136|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333137|NCT00033644|Doxorubicin|doxorubicin|mesh-list
56333138|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56333139|NCT00033644|Mitomycins|mitomycins|mesh-list
56333140|NCT00033644|Mitomycin|mitomycin|mesh-list
56333141|NCT00033644|Dacarbazine|dacarbazine|mesh-list
56333142|NCT00033644|Sargramostim|sargramostim|mesh-list
56333143|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333144|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56333145|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56333146|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333147|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333148|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333149|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
56333150|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333154|NCT00033683|Tamoxifen|tamoxifen|mesh-list
56333194|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
56333195|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333196|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333197|NCT00061308|Antiviral Agents|antiviral agents|mesh-ancestor
56333198|NCT00061308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333199|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333200|NCT00061308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56333201|NCT00061308|Immunologic Factors|immunologic factors|mesh-ancestor
56333202|NCT00061308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56333261|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333263|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56333264|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333266|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333267|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333268|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333269|NCT00034229|Felbamate|felbamate|mesh-list
56333270|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
56333271|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56333272|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56333273|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56333276|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
56333326|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333327|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
56333328|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56333329|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56333330|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333331|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333332|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
56333333|NCT00034502|Irinotecan|irinotecan|mesh-list
56333334|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56333335|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333336|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333337|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333338|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333339|NCT00034541|Paclitaxel|paclitaxel|mesh-list
56333340|NCT00034541|Carboplatin|carboplatin|mesh-list
56333388|NCT00061854|Soblidotin|soblidotin|mesh-list
56333389|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333390|NCT00034658|Posaconazole|posaconazole|mesh-list
56333391|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
56333392|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333458|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56333460|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
56333532|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56333533|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56333534|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333535|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
56333536|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
56333537|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56333538|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56333539|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56333540|NCT00062283|Alanosine|alanosine|mesh-list
56333541|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56333542|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333595|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333596|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56333597|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56333598|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333599|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333600|NCT00035243|Epothilones|epothilones|mesh-list
56333601|NCT00035243|Epothilone B|epothilone b|mesh-list
56333602|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
56333603|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
56333607|NCT00035282|Aprepitant|aprepitant|mesh-list
56333665|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
55973085|NCT00670241|Betamethasone|betamethasone|mesh-list
56333734|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333807|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56333808|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
56333809|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56333810|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333811|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56333812|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56333813|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
56333814|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56333815|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56333819|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
56398602|NCT02915809|Vaccines|vaccines|mesh-list
56398678|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56398679|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
56398680|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398749|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398750|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56398751|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56398752|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56398753|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398754|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56398760|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
56398816|NCT00150293|Pregabalin|pregabalin|mesh-list
56398817|NCT00150293|Analgesics|analgesics|mesh-ancestor
56398818|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
56398819|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398820|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398886|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56398887|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
56398888|NCT02912182|Betamethasone|betamethasone|mesh-list
56398889|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56398890|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
56398891|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398892|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
56398894|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56398895|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398896|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56398950|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398951|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398952|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
56398953|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56398954|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
56398955|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56398956|NCT00171327|Valsartan|valsartan|mesh-list
56398957|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56398958|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56398959|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56398961|NCT02911597|Naltrexone|naltrexone|mesh-list
56399012|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
56399013|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399014|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399082|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56399155|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
56399156|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
56399158|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399226|NCT02716012|Sorafenib|sorafenib|mesh-list
56399232|NCT00151073|Docetaxel|docetaxel|mesh-list
56399300|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
56399374|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56399375|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
56399376|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56399377|NCT00171678|Diclofenac|diclofenac|mesh-list
56399378|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56399379|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56399380|NCT00171678|Analgesics|analgesics|mesh-ancestor
56399381|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
56399382|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56399383|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399384|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56399385|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56399386|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56399387|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399388|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399389|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
56399390|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399391|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
56399392|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56399393|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56399394|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399395|NCT00151463|Urological Agents|urological agents|mesh-ancestor
56399396|NCT05464654|Estrogens|estrogens|mesh-list
56399397|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56399398|NCT05464654|Hormones|hormones|mesh-ancestor
56399401|NCT00171717|Cyclosporine|cyclosporine|mesh-list
56399421|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
56399422|NCT00164463|Isoniazid|isoniazid|mesh-list
56399423|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56399424|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399425|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56399426|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56399427|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399497|NCT00151619|Amlodipine|amlodipine|mesh-list
56399563|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56399635|NCT00164736|Zidovudine|zidovudine|mesh-list
56399707|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56399708|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56399710|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
56399776|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56399778|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
56399849|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399850|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399851|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56399852|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56399853|NCT00164892|Rofecoxib|rofecoxib|mesh-list
56399854|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56399855|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56399856|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56399857|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399858|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56399913|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56399914|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56399915|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
56399916|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56399917|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399918|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56399919|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56399920|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
56399921|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56399922|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56399923|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56399974|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56399975|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
56399976|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56399977|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56399978|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56399979|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56399980|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56399981|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56399982|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56399983|NCT00425490|Incretins|incretins|mesh-ancestor
56399984|NCT00425490|Hormones|hormones|mesh-ancestor
56399990|NCT03457753|Riluzole|riluzole|mesh-list
56400038|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56400039|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400040|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400041|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56400042|NCT00165087|Protective Agents|protective agents|mesh-ancestor
56400043|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400044|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
56400045|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
56400105|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56400106|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56400107|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400108|NCT02935972|Lidocaine|lidocaine|mesh-list
56400109|NCT02935972|Diazepam|diazepam|mesh-list
56400110|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
56400111|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
56400112|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56400113|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400114|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
56400173|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56400174|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56400175|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56400176|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56400177|NCT00152945|Protective Agents|protective agents|mesh-ancestor
56400178|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400179|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56400180|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
56400181|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56400183|NCT02935231|Nicotine|nicotine|mesh-list
56400238|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56400239|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56400240|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400241|NCT00153023|Valsartan|valsartan|mesh-list
56400242|NCT00153023|Telmisartan|telmisartan|mesh-list
56400243|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56400244|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56400247|NCT00165204|Tibolone|tibolone|mesh-list
56400304|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400305|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56400306|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56400307|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
56400308|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400309|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56400310|NCT02934061|Tizanidine|tizanidine|mesh-list
56400311|NCT02934061|Analgesics|analgesics|mesh-ancestor
56400371|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
56400372|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56147990|NCT01292304|Tolvaptan|tolvaptan|mesh-list
56400373|NCT02933788|Protective Agents|protective agents|mesh-ancestor
56400374|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56400375|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56400377|NCT00165399|Goserelin|goserelin|mesh-list
56400378|NCT00165399|Bicalutamide|bicalutamide|mesh-list
56400379|NCT00165399|Estramustine|estramustine|mesh-list
56400380|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400381|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
56400382|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
56400392|NCT02933593|Hydralazine|hydralazine|mesh-list
56400433|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400434|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400435|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
56400436|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400437|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56400438|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56400439|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
56400440|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400441|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56400442|NCT00165477|Lenalidomide|lenalidomide|mesh-list
56400443|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
56400496|NCT00153725|Aspirin|aspirin|mesh-list
56400497|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56400498|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56400499|NCT00153725|Analgesics|analgesics|mesh-ancestor
56400500|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
56400501|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56400502|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400503|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56400504|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400505|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56400506|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56400512|NCT00153764|Vitamins|vitamins|mesh-list
56400562|NCT02931877|Propofol|propofol|mesh-list
56400563|NCT02931877|Sevoflurane|sevoflurane|mesh-list
56400638|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
56400639|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
56400640|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
56400641|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400642|NCT00154076|Topiramate|topiramate|mesh-list
56400643|NCT00154076|Zonisamide|zonisamide|mesh-list
56400644|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
56400645|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56400646|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400647|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56400648|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56400649|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400650|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56400651|NCT00154115|Simendan|simendan|mesh-list
56400652|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56400660|NCT02924506|Meloxicam|meloxicam|mesh-list
56400696|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56400697|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
56400698|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400699|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
56400700|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56400701|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
56400702|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56400703|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56400704|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
56400713|NCT00154271|Valsartan|valsartan|mesh-list
56400761|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56400762|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400763|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400764|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56400765|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56400766|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
56400767|NCT02922946|Entinostat|entinostat|mesh-list
56400768|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400769|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56400772|NCT02922712|Nimesulide|nimesulide|mesh-list
56400824|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
56400825|NCT02921659|Vitamins|vitamins|mesh-ancestor
56400826|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
56400827|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400828|NCT04689100|Leucovorin|leucovorin|mesh-list
56400829|NCT04689100|Fluorouracil|fluorouracil|mesh-list
56400830|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
56400831|NCT04689100|Irinotecan|irinotecan|mesh-list
56400832|NCT04689100|Calcium|calcium|mesh-list
56400833|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
56400834|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56400835|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400836|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
56400837|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56400838|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56400839|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56400840|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56400841|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
56400842|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56400843|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56400844|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400880|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56400881|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56400882|NCT02921269|Growth Substances|growth substances|mesh-ancestor
56400883|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56400884|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
56400885|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
56400886|NCT02921191|Lenograstim|lenograstim|mesh-list
56400887|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56400937|NCT02920489|Dsuvia|dsuvia|mesh-list
56400949|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56161933|NCT00000210|Buprenorphine|buprenorphine|mesh-list
56400950|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
56400951|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
56400952|NCT02920372|Hematinics|hematinics|mesh-ancestor
56400953|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
56400954|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56400955|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56400956|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401016|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56401017|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56401018|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56401019|NCT00154778|Leucovorin|leucovorin|mesh-list
56401020|NCT00154778|Antidotes|antidotes|mesh-ancestor
56401021|NCT00154778|Protective Agents|protective agents|mesh-ancestor
56401022|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401023|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
56401024|NCT00154778|Vitamins|vitamins|mesh-ancestor
56401025|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
56401026|NCT02919202|Listerine|listerine|mesh-list
56401027|NCT02919202|Fluorides|fluorides|mesh-list
56401028|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
56401029|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
56401030|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
56401031|NCT02919202|Protective Agents|protective agents|mesh-ancestor
56401032|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401033|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56401034|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401035|NCT00154895|Minocycline|minocycline|mesh-list
56401036|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56401037|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401073|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
56401074|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56401075|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56401076|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401145|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
56401146|NCT00188604|Trace Elements|trace elements|mesh-ancestor
56401219|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56401293|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56401365|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
56401366|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401367|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56401371|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
56401435|NCT00181935|Risperidone|risperidone|mesh-list
56401436|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56401437|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
56401446|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
56401506|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401507|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56401508|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56401509|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
56401510|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
56401511|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
56401512|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401513|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56401518|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
56401575|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56401576|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56401577|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56401578|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56401579|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56401580|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
56401582|NCT05471479|Antidotes|antidotes|mesh-ancestor
56401583|NCT05471479|Protective Agents|protective agents|mesh-ancestor
56401584|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401585|NCT00188877|Fluorouracil|fluorouracil|mesh-list
56401586|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
56401587|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401588|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56401591|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
56401639|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56401640|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56401704|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56401705|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
56401706|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401707|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401708|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
56401709|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
56401710|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56401711|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56401712|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56401713|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56401714|NCT05469529|Analgesics|analgesics|mesh-ancestor
56401715|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
56401716|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56401717|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56401718|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56401719|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56401720|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
56401721|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56401723|NCT00189033|Psyllium|psyllium|mesh-list
56401759|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56401760|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56401761|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56401762|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56401763|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
56401764|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56401828|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
56401903|NCT00536770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56401979|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
56401980|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402052|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56402053|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402054|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56402055|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56402056|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402057|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
56402058|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56402059|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56402060|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56402063|NCT00406796|Ranibizumab|ranibizumab|mesh-list
56402119|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56402193|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402194|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402264|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56402267|NCT00182871|Testosterone|testosterone|mesh-list
56402341|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56402415|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56402416|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56402417|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
56402418|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402419|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402420|NCT00158171|Hematinics|hematinics|mesh-ancestor
56402421|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
56402422|NCT00158171|Vitamins|vitamins|mesh-ancestor
56402423|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
56402424|NCT03370783|Ethanol|ethanol|mesh-list
56402425|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56402426|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56402427|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56402480|NCT00158405|Zidovudine|zidovudine|mesh-list
56402481|NCT00158405|Efavirenz|efavirenz|mesh-list
56402557|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56402558|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56402559|NCT04724486|Cetrorelix|cetrorelix|mesh-list
56402560|NCT04724486|Menotropins|menotropins|mesh-list
56402627|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56402707|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
56402777|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402778|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
56402779|NCT05381623|Hemostatics|hemostatics|mesh-list
56402780|NCT05381623|Coagulants|coagulants|mesh-ancestor
56402849|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56402850|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
56402851|NCT00539149|Amoxicillin|amoxicillin|mesh-list
56402924|NCT00540202|Analgesics|analgesics|mesh-ancestor
56402925|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
56402926|NCT00183885|Mitomycins|mitomycins|mesh-list
56402927|NCT00183885|Mitomycin|mitomycin|mesh-list
56402928|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402929|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56402930|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
56402931|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402932|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56402933|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402934|NCT00540241|Pemetrexed|pemetrexed|mesh-list
56402935|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56402936|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56402937|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402938|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56402939|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56402940|NCT00159224|Ritonavir|ritonavir|mesh-list
56402941|NCT00159224|Lopinavir|lopinavir|mesh-list
56402942|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56402943|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56402944|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
56402978|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56402979|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56402980|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56402981|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
56402982|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56402983|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
56402984|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56402985|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56402986|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56402987|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
56402988|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
56402989|NCT00159302|Protective Agents|protective agents|mesh-ancestor
56402990|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
56402991|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56402993|NCT00540748|Oxytocin|oxytocin|mesh-list
56403037|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403038|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56403039|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56403040|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56403041|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56403042|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403104|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
56403105|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
56403106|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
56403107|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56403108|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56403109|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
56403110|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403111|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403112|NCT00541216|Ephedrine|ephedrine|mesh-list
56403113|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56403114|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403115|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
56403116|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
56403117|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56163537|NCT00002448|Ritonavir|ritonavir|mesh-list
56403118|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56403120|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403121|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403122|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
56403123|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56403124|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
56403125|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403126|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56403127|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403128|NCT00541372|Insulin|insulin|mesh-list
56403129|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56403130|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403131|NCT00159536|Metformin|metformin|mesh-list
56403132|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56403133|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403134|NCT00541411|Dactinomycin|dactinomycin|mesh-list
56403135|NCT00541411|Vincristine|vincristine|mesh-list
56403136|NCT00541411|Ifosfamide|ifosfamide|mesh-list
56403137|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56403138|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403144|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
56403151|NCT00541489|Naproxen|naproxen|mesh-list
56403217|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56403293|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403299|NCT00542347|Omeprazole|omeprazole|mesh-list
56403367|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403368|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56403369|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
56403370|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56403434|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
56403440|NCT00543244|Ribavirin|ribavirin|mesh-list
56403507|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
56403651|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
56403652|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56403663|NCT00160238|Betahistine|betahistine|mesh-list
56403725|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56403726|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56403727|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
56403728|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403729|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56403730|NCT00160355|Fludarabine|fludarabine|mesh-list
56403731|NCT00160355|Melphalan|melphalan|mesh-list
56403732|NCT00160355|Thiotepa|thiotepa|mesh-list
56403791|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56403792|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403793|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56403794|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56403795|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
56403796|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56403797|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56403798|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56403799|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56403800|NCT00545857|Pioglitazone|pioglitazone|mesh-list
56403801|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56403802|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56403932|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56403933|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
56403934|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56403941|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
56404002|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404003|NCT00547417|Urological Agents|urological agents|mesh-ancestor
56404004|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56404005|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56404006|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56404007|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56404068|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
56404144|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
56404145|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404146|NCT00191490|Antiviral Agents|antiviral agents|mesh-ancestor
56404147|NCT00191490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404148|NCT00191490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404149|NCT00191490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404150|NCT00191490|Immunologic Factors|immunologic factors|mesh-ancestor
56404151|NCT00191490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404152|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
56404153|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
56404154|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
56404155|NCT00548080|Caspofungin|caspofungin|mesh-list
56404156|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
56404157|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56404158|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404159|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404160|NCT00161096|Pantoprazole|pantoprazole|mesh-list
56404161|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56404162|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56404203|NCT00548704|Protective Agents|protective agents|mesh-ancestor
56404204|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404278|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56404279|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404280|NCT00184938|Analgesics|analgesics|mesh-ancestor
56404281|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
56404282|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404284|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404348|NCT00161447|Acyline|acyline|mesh-list
56404349|NCT00161447|Androgens|androgens|mesh-ancestor
56404350|NCT00161447|Hormones|hormones|mesh-ancestor
56404351|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56404352|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404353|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56404354|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404355|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56151973|NCT04360044|Dronabinol|dronabinol|mesh-list
56404356|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56404357|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56404358|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
56404359|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56404360|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56404408|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404409|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
56404410|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404411|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56404412|NCT00185055|Valsartan|valsartan|mesh-list
56404413|NCT00185055|Olmesartan|olmesartan|mesh-list
56404414|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56404415|NCT00185055|Irbesartan|irbesartan|mesh-list
56404416|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56404417|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56404474|NCT02963454|Dobutamine|dobutamine|mesh-list
56404475|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56404476|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
56404477|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56404478|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56404479|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404480|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404481|NCT02963454|Protective Agents|protective agents|mesh-ancestor
56404539|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404613|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56404614|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404615|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
56404616|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404617|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404618|NCT00551317|Darapladib|darapladib|mesh-list
56404619|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56404620|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404621|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404622|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
56404623|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56404624|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404625|NCT02963337|Remifentanil|remifentanil|mesh-list
56404626|NCT02963337|Bupivacaine|bupivacaine|mesh-list
56404628|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
56404673|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404674|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56404675|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56404676|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404677|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56404678|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56404679|NCT00191997|Olanzapine|olanzapine|mesh-list
56404680|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
56404681|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
56404682|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404683|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404684|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56404685|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56404686|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56404687|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56404688|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56404689|NCT00191997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56404690|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56404691|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56404692|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404693|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56404723|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404724|NCT00162110|Cetuximab|cetuximab|mesh-list
56404725|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56404726|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56404789|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56404790|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
56404791|NCT04653337|Norepinephrine|norepinephrine|mesh-list
56404792|NCT04653337|Serotonin|serotonin|mesh-list
56404793|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
56404794|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56404795|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56404796|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
56404797|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56152415|NCT05739630|Fludarabine|fludarabine|mesh-list
56404798|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404799|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404800|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
56404801|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
56404802|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56404803|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56404804|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56404805|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
56404806|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56404807|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56404808|NCT04652089|Simvastatin|simvastatin|mesh-list
56404841|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404842|NCT04382326|Vaccines|vaccines|mesh-list
56404843|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56404844|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
56404845|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404846|NCT00162383|Dapsone|dapsone|mesh-list
56404847|NCT00162383|Debrisoquin|debrisoquin|mesh-list
56404848|NCT00162383|Mephenytoin|mephenytoin|mesh-list
56404849|NCT00162383|Caffeine|caffeine|mesh-list
56404850|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56163653|NCT00002514|Leucovorin|leucovorin|mesh-list
56404851|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404852|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56404853|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56404854|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404855|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56404900|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404901|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56404902|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
56404903|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56404904|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
56404905|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56404906|NCT04233034|Verapamil|verapamil|mesh-list
56404907|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56404908|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56404966|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
56404967|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
56404968|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56404969|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56404970|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56404986|NCT00162695|Etoposide|etoposide|mesh-list
56405035|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56405036|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56405037|NCT00162968|Citalopram|citalopram|mesh-list
56405038|NCT00162968|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56405042|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56405107|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56405109|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56405179|NCT00192660|Amprenavir|amprenavir|mesh-list
56405180|NCT00192660|Tenofovir|tenofovir|mesh-list
56405252|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
56405253|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56405326|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56405478|NCT05208307|BB 1101|bb 1101|mesh-list
56405479|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56405480|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
56405551|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56405553|NCT00193362|Gemcitabine|gemcitabine|mesh-list
56405627|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
56405628|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
56405631|NCT00193557|Bortezomib|bortezomib|mesh-list
56405777|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56405778|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
56405779|NCT00176241|Antiviral Agents|antiviral agents|mesh-ancestor
56163720|NCT00002526|Doxorubicin|doxorubicin|mesh-list
56405922|NCT04378933|Methamphetamine|methamphetamine|mesh-list
56405923|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56405924|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980713|NCT04693715|RNS60|rns60|mesh-list
56406068|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406069|NCT03991936|Triamcinolone|triamcinolone|mesh-list
56406070|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56406075|NCT03991936|Hormones|hormones|mesh-ancestor
56406138|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
56406139|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56406210|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406211|NCT00177060|Analgesics|analgesics|mesh-ancestor
56406282|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
56406354|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56406360|NCT00166400|Metoprolol|metoprolol|mesh-list
56406426|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56406427|NCT00166595|Risperidone|risperidone|mesh-list
56406428|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56406550|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56406551|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56406621|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56406622|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
56406770|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56406846|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
56406920|NCT02905708|Protective Agents|protective agents|mesh-ancestor
56406921|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407055|NCT00407264|Xhance|xhance|mesh-list
56407070|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407071|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
56407145|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56407146|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56407297|NCT02902432|Endostatins|endostatins|mesh-list
56407298|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56407371|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
56407372|NCT02901145|Nivolumab|nivolumab|mesh-list
56407446|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407519|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56407520|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56407595|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56407601|NCT00408252|Sunitinib|sunitinib|mesh-list
56407669|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56407744|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56407745|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
56407817|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407818|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
56407890|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56407891|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
56407894|NCT05424445|Misoprostol|misoprostol|mesh-list
56407962|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56407963|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408055|NCT00170690|Treosulfan|treosulfan|mesh-list
56408105|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56408106|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408173|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408174|NCT05393674|Nivolumab|nivolumab|mesh-list
56408175|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56408176|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56408240|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
56408241|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56408313|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408314|NCT00171470|Tegaserod|tegaserod|mesh-list
56408316|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
56408386|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56408387|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56408457|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56408531|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56408607|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
56408608|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56408610|NCT04958122|Penicillins|penicillins|mesh-list
56408679|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56408681|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56408752|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56408825|NCT00202800|Antiviral Agents|antiviral agents|mesh-ancestor
56408826|NCT00202800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56408898|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56408975|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56408976|NCT00203034|Protective Agents|protective agents|mesh-ancestor
56409049|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409050|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56409123|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409124|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56409129|NCT02962986|Phenylephrine|phenylephrine|mesh-list
56409198|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56409199|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
56409201|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56409271|NCT00410748|Analgesics|analgesics|mesh-ancestor
56409272|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
56409353|NCT00555100|Hormones|hormones|mesh-ancestor
56409421|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
56409496|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409497|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56409570|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
56409571|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56409644|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56409720|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56409722|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
56409795|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56409796|NCT00174629|Gemcitabine|gemcitabine|mesh-list
56409869|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56409944|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56410017|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56410093|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56410094|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
56410166|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56410242|NCT04111315|Dipyrone|dipyrone|mesh-list
56410316|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56158041|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
56410465|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56410478|NCT02830360|Sotalol|sotalol|mesh-list
56410538|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164024|NCT00002634|Doxorubicin|doxorubicin|mesh-list
56410613|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56410615|NCT00410943|Analgesics|analgesics|mesh-ancestor
56410688|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56410689|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
56410762|NCT02320708|Analgesics|analgesics|mesh-ancestor
56410766|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
56410835|NCT00554632|Ortho Evra|ortho evra|mesh-list
56410836|NCT00554632|Estradiol|estradiol|mesh-list
56410838|NCT00554632|Estrogens|estrogens|mesh-ancestor
56410910|NCT04659109|Glenzocimab|glenzocimab|mesh-list
56410986|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411057|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
56411070|NCT04654819|Anesthetics|anesthetics|mesh-list
56411126|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
56411127|NCT04653493|Fludarabine|fludarabine|mesh-list
56411137|NCT00200694|Valsartan|valsartan|mesh-list
56411198|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56411216|NCT04652284|Rifabutin|rifabutin|mesh-list
56411271|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411272|NCT00205764|Melphalan|melphalan|mesh-list
56411345|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
56411347|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
56411348|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56411421|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56411424|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56411659|NCT00201630|Alfuzosin|alfuzosin|mesh-list
56411717|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56411718|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
56411719|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56411720|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56411721|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56411722|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411790|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56411862|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56411863|NCT00561067|Hematinics|hematinics|mesh-ancestor
56411864|NCT00561106|Valacyclovir|valacyclovir|mesh-list
56411865|NCT00561106|Prednisone|prednisone|mesh-list
56411939|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56412015|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412087|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56412088|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56412162|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412237|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56412238|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
56412310|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
56412384|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56412459|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
56412460|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56412537|NCT04576975|Analgesics|analgesics|mesh-ancestor
56412606|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56412607|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56412608|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56412678|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
56412752|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56412824|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56412843|NCT00584779|Gabapentin|gabapentin|mesh-list
56412904|NCT00585520|Progesterone|progesterone|mesh-list
56412973|NCT00408551|Vitamins|vitamins|mesh-ancestor
56412974|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
56413047|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413051|NCT00587119|Budesonide|budesonide|mesh-list
56413121|NCT00182429|Rifampin|rifampin|mesh-list
56413122|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56413123|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56413192|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413265|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56413274|NCT00216762|Rituximab|rituximab|mesh-list
56413339|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56413340|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
56413341|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
56413411|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413484|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
56413485|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
56413558|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56413559|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56413560|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56413561|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56413562|NCT00476593|Dexamethasone|dexamethasone|mesh-list
56413563|NCT00476593|Diclofenac|diclofenac|mesh-list
56413564|NCT00476593|Lactitol|lactitol|mesh-list
56413565|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56413566|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56413567|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
56413568|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
56413569|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413570|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56413571|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56413572|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
56413573|NCT00476593|Hormones|hormones|mesh-ancestor
56413575|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56413614|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56413685|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56413686|NCT00183833|Capecitabine|capecitabine|mesh-list
56413760|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56413761|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56413830|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
56413903|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56413904|NCT00210561|Narcotics|narcotics|mesh-ancestor
56413905|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56413906|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
56413976|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414053|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
56414056|NCT00210912|Topiramate|topiramate|mesh-list
56414126|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414127|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
56414199|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56414273|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56414274|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56414344|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56414419|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414420|NCT00211653|Antidotes|antidotes|mesh-ancestor
56414493|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56414494|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
56414567|NCT00188045|Diuretics|diuretics|mesh-ancestor
56414568|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
56414569|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56414643|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414644|NCT00188630|Expectorants|expectorants|mesh-ancestor
56414653|NCT00188669|Vitamin E|vitamin e|mesh-list
56414717|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56414718|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56414791|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56414866|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
56414867|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56414868|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56414869|NCT02963129|Mupirocin|mupirocin|mesh-list
56414870|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56414871|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56414872|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56414873|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56414933|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56415009|NCT00213252|Montelukast|montelukast|mesh-list
56415158|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56415159|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56415227|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56415228|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56415297|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56415367|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56415439|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56415440|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
56415511|NCT00214266|Rituximab|rituximab|mesh-list
56415584|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
56415585|NCT00221442|Zonisamide|zonisamide|mesh-list
56415658|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56415659|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
56415731|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56415732|NCT00221754|Pravastatin|pravastatin|mesh-list
56415733|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56415802|NCT00192062|Vinorelbine|vinorelbine|mesh-list
56415803|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56415804|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
56415829|NCT00215007|Ofloxacin|ofloxacin|mesh-list
56415875|NCT00474487|Vaccines|vaccines|mesh-list
56416034|NCT00192569|Interferons|interferons|mesh-list
56416174|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
56416175|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56416176|NCT00192803|Candesartan|candesartan|mesh-list
56416247|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416249|NCT00193076|Gemcitabine|gemcitabine|mesh-list
56416321|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56416322|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56416395|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56416471|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56416472|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56416481|NCT00409526|Iloprost|iloprost|mesh-list
56416544|NCT00124475|Alitretinoin|alitretinoin|mesh-list
56416626|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
56416690|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56416694|NCT00193973|Methotrexate|methotrexate|mesh-list
56416761|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56416762|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56416763|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56416832|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56416907|NCT00125567|Entacapone|entacapone|mesh-list
56416908|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56416930|NCT00473083|Hormones|hormones|mesh-ancestor
56416982|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56417053|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417054|NCT00125918|Tadalafil|tadalafil|mesh-list
56417202|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
56417203|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56417204|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417205|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
56417274|NCT00126269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56417275|NCT00126269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56417276|NCT00126269|Immunologic Factors|immunologic factors|mesh-ancestor
56417278|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
56417347|NCT00195455|Estrogens|estrogens|mesh-ancestor
56417348|NCT00195455|Hormones|hormones|mesh-ancestor
56417424|NCT00202280|Hematinics|hematinics|mesh-ancestor
56417425|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
56417501|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
56417574|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
56417575|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56417576|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56417648|NCT00202592|Perindopril|perindopril|mesh-list
56417721|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56417727|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
56417795|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
56417796|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
56417799|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
56417869|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56417871|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
56417873|NCT00226317|Aripiprazole|aripiprazole|mesh-list
56417942|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
56417943|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56418016|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418029|NCT00410657|Prednisone|prednisone|mesh-list
56418090|NCT00203372|Growth Substances|growth substances|mesh-ancestor
56418099|NCT00226551|Isoproterenol|isoproterenol|mesh-list
56418162|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
56165883|NCT00003240|Ifosfamide|ifosfamide|mesh-list
56418163|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56418164|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56418165|NCT00226707|Analgesics|analgesics|mesh-ancestor
56418166|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
56418167|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56418168|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418169|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56418170|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56418171|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
56418172|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56418173|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
56418174|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56418175|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418176|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56418177|NCT00203528|Valproic Acid|valproic acid|mesh-list
56418178|NCT00203528|Risperidone|risperidone|mesh-list
56418179|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56418180|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
56418181|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418183|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418217|NCT00226746|Gemcitabine|gemcitabine|mesh-list
56418292|NCT00226902|Chrysarobin|chrysarobin|mesh-list
56418294|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56418367|NCT00203957|Istradefylline|istradefylline|mesh-list
56418368|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56418440|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56418441|NCT00197639|Ritonavir|ritonavir|mesh-list
56418442|NCT00197639|Indinavir|indinavir|mesh-list
56418515|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56418516|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56418588|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56418737|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56418739|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56418811|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56418812|NCT00198614|Metoprolol|metoprolol|mesh-list
56418885|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56418886|NCT00478426|Growth Substances|growth substances|mesh-ancestor
56418959|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
56418961|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56419034|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56419107|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56419185|NCT00232362|Pioglitazone|pioglitazone|mesh-list
56419256|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56419257|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419258|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56419259|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
56419260|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
56419261|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56419262|NCT00229515|Protective Agents|protective agents|mesh-ancestor
56419263|NCT00206024|Esomeprazole|esomeprazole|mesh-list
56419321|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56419322|NCT00206258|Pramlintide|pramlintide|mesh-list
56419393|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419394|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56419464|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56419538|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
56419539|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
56419612|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56419613|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419614|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
56419683|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
56419684|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56419685|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56419686|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56419687|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
56419688|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56419689|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56419708|NCT00233532|Verapamil|verapamil|mesh-list
56419747|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
56419821|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56419894|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56419895|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56419967|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56420043|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56420046|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
56420115|NCT00237627|Doxorubicin|doxorubicin|mesh-list
56420188|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56420189|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
56420190|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56420191|NCT00209651|Irinotecan|irinotecan|mesh-list
56420260|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
56420266|NCT00209729|Docetaxel|docetaxel|mesh-list
56420332|NCT00209846|Analgesics|analgesics|mesh-ancestor
56420407|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56420408|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56420409|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56420410|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
56420422|NCT00209924|Gaboxadol|gaboxadol|mesh-list
56420478|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
56420479|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420480|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
56420551|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420699|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
56420700|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56420701|NCT04570306|Belimumab|belimumab|mesh-list
56420702|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56420770|NCT00237900|Vitamins|vitamins|mesh-ancestor
56420771|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
56420772|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56420845|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
56420846|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
56420922|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
56420923|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56420924|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56420925|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
56420926|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56420927|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56420928|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
56420929|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56420933|NCT00238251|Gefitinib|gefitinib|mesh-list
56420990|NCT00211367|Anecortave|anecortave|mesh-list
56421069|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56421144|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421213|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56421214|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56421284|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56421360|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
56421361|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56421436|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56421437|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56421445|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
56421509|NCT00212342|Estrogens|estrogens|mesh-ancestor
56421510|NCT00212342|Hormones|hormones|mesh-ancestor
56421513|NCT00414414|Prednisone|prednisone|mesh-list
56421583|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
56421584|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56421588|NCT00239499|Fluticasone|fluticasone|mesh-list
56421656|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56421657|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56421658|NCT00222651|Tenecteplase|tenecteplase|mesh-list
56421728|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56421729|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421730|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56421799|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56421801|NCT00243750|Methotrexate|methotrexate|mesh-list
56421872|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56421873|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56421963|NCT00214682|Vitamins|vitamins|mesh-ancestor
56422022|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56422093|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56422094|NCT00215345|Analgesics|analgesics|mesh-ancestor
56422095|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
56422164|NCT00215579|Risperidone|risperidone|mesh-list
56422165|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56422239|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
56422240|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422255|NCT00244530|Nifedipine|nifedipine|mesh-list
56422312|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56422313|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
56422386|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56422387|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56422458|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422459|NCT00216164|Gemcitabine|gemcitabine|mesh-list
56422528|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56422529|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56422594|NCT00244998|Fulvestrant|fulvestrant|mesh-list
56422667|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56422669|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
56422742|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56422743|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56422815|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56422816|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56422850|NCT00558181|Hormones|hormones|mesh-ancestor
56422889|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
56422890|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56422894|NCT04647838|Tepotinib|tepotinib|mesh-list
56422964|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56422965|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56422966|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56422968|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
56423037|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56423038|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56423039|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
56423040|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56423041|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56423042|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
56423043|NCT04645303|Hormones|hormones|mesh-ancestor
56423044|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56423045|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423104|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56423106|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423107|NCT04643821|Protective Agents|protective agents|mesh-ancestor
56423108|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423109|NCT04643821|Antidotes|antidotes|mesh-ancestor
56423110|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56423111|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56423173|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56423174|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423244|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56423247|NCT00218504|Hormones|hormones|mesh-ancestor
56423394|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423395|NCT00561496|Tenofovir|tenofovir|mesh-list
56423468|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423469|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56423539|NCT00246675|Diuretics|diuretics|mesh-ancestor
56423540|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
56423545|NCT00219479|Phenytoin|phenytoin|mesh-list
56423611|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56423612|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56423684|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56423685|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56423758|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
56423844|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
56423906|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
56423907|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
56423909|NCT00220298|Androgens|androgens|mesh-ancestor
56423979|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56423980|NCT04621513|Montelukast|montelukast|mesh-list
56423984|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
56424049|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
56424050|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
56424126|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56424127|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
56424128|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56424129|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424130|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424131|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424132|NCT04619251|Itraconazole|itraconazole|mesh-list
56424133|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
56424134|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56424135|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56424136|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56424137|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56424138|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424139|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56424140|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
56424141|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424142|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424143|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56424144|NCT00243399|Oxandrolone|oxandrolone|mesh-list
56171898|NCT00555438|PENTA|penta|mesh-list
56424146|NCT00243399|Hormones|hormones|mesh-ancestor
56424147|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56424148|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424149|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
56424174|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
56424245|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
56424250|NCT00247650|Letrozole|letrozole|mesh-list
56424318|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56424396|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
56424397|NCT04615702|Protective Agents|protective agents|mesh-ancestor
56424398|NCT04615351|Metformin|metformin|mesh-list
56424547|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56424548|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424621|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424622|NCT04611724|Folfirinox|folfirinox|mesh-list
56424623|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56424624|NCT00563758|Tegaserod|tegaserod|mesh-list
56424625|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56424626|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
56424627|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424628|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56424629|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424630|NCT00563836|Catumaxomab|catumaxomab|mesh-list
56424631|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56424632|NCT00563875|Aspirin|aspirin|mesh-list
56424648|NCT04611685|Parecoxib|parecoxib|mesh-list
56424684|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56424760|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56424761|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424762|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
56424791|NCT00564187|Irbesartan|irbesartan|mesh-list
56424905|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56424906|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
56424907|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56424975|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56424976|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
56424977|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56424978|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56425050|NCT04719507|Meperidine|meperidine|mesh-list
56425123|NCT00565123|Renal Agents|renal agents|mesh-ancestor
56425199|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56425209|NCT04603456|Antacids|antacids|mesh-ancestor
56425272|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56425273|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425346|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56425347|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
56425348|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
56425350|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
56425416|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56425489|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56425490|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56425563|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56425716|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
56425723|NCT00249405|Citalopram|citalopram|mesh-list
56425828|NCT04593706|BB 1101|bb 1101|mesh-list
56425869|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56425939|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56425940|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
56426009|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
56426010|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56426159|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56426160|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
56426161|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56426165|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56426231|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56426306|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
56426307|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
56426383|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426457|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426530|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56426604|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
56426682|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56426683|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56426684|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56426685|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
56426753|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56426754|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426755|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56426756|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56426826|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56426827|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56426832|NCT00415116|Carboplatin|carboplatin|mesh-list
56426900|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
56426901|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56426975|NCT00569920|Dexamethasone|dexamethasone|mesh-list
56427048|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56427049|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56427122|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56427198|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427199|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56427270|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56427344|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
56427345|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427418|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56427419|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56427420|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56427421|NCT00235014|Verapamil|verapamil|mesh-list
56427422|NCT00235014|Trandolapril|trandolapril|mesh-list
56427434|NCT00225290|Thalidomide|thalidomide|mesh-list
56427487|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56427558|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56427630|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
56427706|NCT00235248|Aspirin|aspirin|mesh-list
56427782|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56427855|NCT00255606|Prednisone|prednisone|mesh-list
56427856|NCT00255606|Docetaxel|docetaxel|mesh-list
56427857|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56427858|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
56427927|NCT03450109|Goserelin|goserelin|mesh-list
56428000|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428073|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56428074|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
56428075|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428076|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428077|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428078|NCT00226694|Citalopram|citalopram|mesh-list
56428089|NCT00255996|Linezolid|linezolid|mesh-list
56428141|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56428214|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428215|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56428286|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428287|NCT00227981|Fluoxetine|fluoxetine|mesh-list
56428288|NCT00227981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56428357|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56428358|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
56428359|NCT00236106|Tacrolimus|tacrolimus|mesh-list
56428431|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56428432|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
56428433|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428434|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428435|NCT00193063|Antiviral Agents|antiviral agents|mesh-ancestor
56428436|NCT00193063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428437|NCT00193063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428438|NCT00193063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56428439|NCT00193063|Immunologic Factors|immunologic factors|mesh-ancestor
56428440|NCT00193063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428441|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56428442|NCT00228488|Gefitinib|gefitinib|mesh-list
56428443|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428444|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56428445|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428507|NCT00228839|Infliximab|infliximab|mesh-list
56428566|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56428645|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56428716|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56428718|NCT00257127|Vaccines|vaccines|mesh-list
56428719|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56428792|NCT00199316|Morphine|morphine|mesh-list
56428793|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56428794|NCT00199316|Narcotics|narcotics|mesh-ancestor
56428795|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428796|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428797|NCT00199316|Analgesics|analgesics|mesh-ancestor
56428798|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
56428799|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428800|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
56428801|NCT00196339|Cyproterone|cyproterone|mesh-list
56428802|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
56428803|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
56428856|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56428857|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
56428858|NCT00199433|Istradefylline|istradefylline|mesh-list
56428859|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
56428860|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56428861|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56428862|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
56428863|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56428864|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428865|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428866|NCT00199472|Diuretics|diuretics|mesh-list
56428867|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
56428868|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428869|NCT00199511|Mannitol|mannitol|mesh-list
56428870|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56428871|NCT00199511|Diuretics|diuretics|mesh-ancestor
56428872|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
56428873|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428874|NCT00236613|Topiramate|topiramate|mesh-list
56428875|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
56428876|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56428877|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428878|NCT00236652|Levofloxacin|levofloxacin|mesh-list
56428879|NCT00236652|Ofloxacin|ofloxacin|mesh-list
56428880|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56428906|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56428907|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56428908|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56428909|NCT00236691|Topiramate|topiramate|mesh-list
56428910|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
56428911|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56428912|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428913|NCT00236730|Topiramate|topiramate|mesh-list
56428914|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
56428915|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56428916|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428917|NCT00199745|Atorvastatin|atorvastatin|mesh-list
56428970|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56428971|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56428972|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56428973|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56428974|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56429040|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429041|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429042|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429043|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
56429044|NCT00179647|Hormones|hormones|mesh-ancestor
56429045|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429046|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56429047|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429053|NCT00257751|Aprotinin|aprotinin|mesh-list
56429107|NCT00177307|Bevacizumab|bevacizumab|mesh-list
56429180|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429181|NCT00176254|Paclitaxel|paclitaxel|mesh-list
56429182|NCT00176254|Carboplatin|carboplatin|mesh-list
56429183|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56429184|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429185|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
56429186|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
56429251|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56429252|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56429253|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56429254|NCT00174265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56429255|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56429256|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56429257|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429258|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429259|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
56429260|NCT00200603|Calcium|calcium|mesh-list
56429261|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56429314|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56429315|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56429316|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429317|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
56429318|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429319|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56429321|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
56429322|NCT00171925|Calcium|calcium|mesh-list
56429323|NCT00171925|Vitamins|vitamins|mesh-ancestor
56429324|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
56429325|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429326|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56429327|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56429328|NCT00258375|Docetaxel|docetaxel|mesh-list
56429329|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429330|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
56429331|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
56429332|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
56429333|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429334|NCT00201305|Leucovorin|leucovorin|mesh-list
56429371|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
56429372|NCT00201344|Vitamins|vitamins|mesh-ancestor
56429373|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
56429374|NCT00201383|Cisplatin|cisplatin|mesh-list
56429375|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429377|NCT00201422|Clarithromycin|clarithromycin|mesh-list
56429378|NCT00201422|Omeprazole|omeprazole|mesh-list
56429379|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56429380|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56429440|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56429441|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56429442|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429443|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56429444|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
56429445|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
56429446|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
56429447|NCT00410345|Mifepristone|mifepristone|mesh-list
56429507|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56429508|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429509|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429510|NCT00201812|Hormones|hormones|mesh-ancestor
56429511|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429512|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56429513|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56429514|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56429515|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56429516|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56429517|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429518|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56429519|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56429520|NCT00201812|Analgesics|analgesics|mesh-ancestor
56429566|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429567|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56429568|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
56429569|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56429570|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429571|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56429572|NCT00202007|Risperidone|risperidone|mesh-list
56429573|NCT00202007|Aripiprazole|aripiprazole|mesh-list
56429574|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56429575|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
56429576|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56429577|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56429578|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429579|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56429580|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56429581|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56429591|NCT00171301|Deferasirox|deferasirox|mesh-list
56429620|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
56429621|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56429622|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56429623|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
56177458|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429689|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56429690|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429691|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56429759|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429760|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
56429761|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
56429764|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56429832|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56429833|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56429835|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429906|NCT00477490|Coagulants|coagulants|mesh-ancestor
56429907|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56429908|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
56429909|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56429910|NCT00231530|Topiramate|topiramate|mesh-list
56429911|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
56429970|NCT04560049|Phenol|phenol|mesh-list
56429978|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
56429979|NCT04559425|BB 1101|bb 1101|mesh-list
56429980|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56429981|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
56429987|NCT04559425|Hormones|hormones|mesh-ancestor
56430051|NCT02211976|Bisacodyl|bisacodyl|mesh-list
56430124|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430125|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
56430126|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430196|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430197|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430198|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56430199|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
56430200|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56430201|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430202|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56430203|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56430214|NCT04557202|Tamsulosin|tamsulosin|mesh-list
56430258|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56430259|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56430260|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56430263|NCT04566211|Antacids|antacids|mesh-ancestor
56430328|NCT00267267|Atorvastatin|atorvastatin|mesh-list
56430329|NCT00267267|Simvastatin|simvastatin|mesh-list
56430330|NCT00267267|Ezetimibe|ezetimibe|mesh-list
56430340|NCT04564690|Vitamin E|vitamin e|mesh-list
56430401|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56430402|NCT00259896|Incretins|incretins|mesh-ancestor
56430403|NCT00259896|Hormones|hormones|mesh-ancestor
56430405|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
56430474|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
56430475|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56430476|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56430549|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56430621|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56430694|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
56430767|NCT00234026|Immunologic Factors|immunologic factors|mesh-ancestor
56430769|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
56430842|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56430843|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56430844|NCT04556071|Growth Substances|growth substances|mesh-ancestor
56430845|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430846|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
56430847|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56430848|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430849|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430850|NCT04563871|Osimertinib|osimertinib|mesh-list
56430851|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430852|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56430853|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56430854|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430902|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56430903|NCT00260793|Ropinirole|ropinirole|mesh-list
56430904|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56430905|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56430906|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
56430907|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
56430908|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56430909|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56430910|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56430929|NCT02211391|Caseins|caseins|mesh-list
56430959|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56430960|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
56430961|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56430962|NCT04561687|Azelastine|azelastine|mesh-list
56430963|NCT04561687|Budesonide|budesonide|mesh-list
56430964|NCT04561687|Montelukast|montelukast|mesh-list
56430965|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56430966|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56430967|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
56430968|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431026|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431027|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55931733|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56431028|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56431029|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
56431030|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56431031|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56431032|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56431033|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56431034|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56431035|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
56431036|NCT02213887|Pantoprazole|pantoprazole|mesh-list
56431037|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56431038|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56431084|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431086|NCT04551781|Prednisone|prednisone|mesh-list
56431158|NCT00235235|Gemcitabine|gemcitabine|mesh-list
56431159|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
56431160|NCT00235235|Doxorubicin|doxorubicin|mesh-list
56431161|NCT00235235|Capecitabine|capecitabine|mesh-list
56431162|NCT00235235|Vinorelbine|vinorelbine|mesh-list
56431163|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56431164|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
56431165|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431166|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56431227|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431228|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431229|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56431301|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431302|NCT02214433|Pantoprazole|pantoprazole|mesh-list
56431303|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56431304|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56431305|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56431306|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56431307|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431308|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431309|NCT02212561|Cytarabine|cytarabine|mesh-list
56431310|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
56431365|NCT00261183|Protective Agents|protective agents|mesh-ancestor
56431366|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431367|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56431368|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
56431369|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56431370|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431371|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431372|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56431373|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431429|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56431430|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56431431|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431432|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431433|NCT02212639|Protective Agents|protective agents|mesh-ancestor
56431434|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431435|NCT02212756|Metformin|metformin|mesh-list
56431436|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56431495|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431496|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431497|NCT00235859|Adalimumab|adalimumab|mesh-list
56431498|NCT00235859|Methotrexate|methotrexate|mesh-list
56431499|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56431500|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
56431501|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56431515|NCT02213029|Oxytocin|oxytocin|mesh-list
56431564|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431565|NCT00235937|Anastrozole|anastrozole|mesh-list
56431566|NCT00235937|Goserelin|goserelin|mesh-list
56431567|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56431568|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431569|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56431570|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56431571|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431572|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431573|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56431574|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
56431575|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56431576|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431577|NCT00261339|Pantoprazole|pantoprazole|mesh-list
56431578|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56431579|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56431580|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56431581|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56431582|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431583|NCT04553380|Insulin|insulin|mesh-list
56431584|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
56431585|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56431586|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431587|NCT00236015|Tiagabine|tiagabine|mesh-list
56431588|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
56431589|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56431590|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56431591|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56431592|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431593|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
56431594|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431595|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431596|NCT00261378|Doxorubicin|doxorubicin|mesh-list
56431597|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56431603|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56431677|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431678|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56431679|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
56431680|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56431681|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
56431682|NCT04548271|Apatinib|apatinib|mesh-list
56431683|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56431687|NCT04541719|Remifentanil|remifentanil|mesh-list
56431744|NCT00269061|Pioglitazone|pioglitazone|mesh-list
56431745|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56431746|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431815|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431816|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56431817|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56431821|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
56431887|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56431888|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
56431898|NCT00236561|Topiramate|topiramate|mesh-list
56431960|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56431961|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
56431962|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56431963|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56431964|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
56432029|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56432031|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56432103|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
56432104|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432173|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56432174|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
56432175|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432176|NCT00237341|Fentanyl|fentanyl|mesh-list
56432177|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56432178|NCT00237341|Narcotics|narcotics|mesh-ancestor
56432179|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56432180|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432181|NCT00237341|Analgesics|analgesics|mesh-ancestor
56432182|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
56432183|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56432184|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56432185|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56432186|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
56432187|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
56432188|NCT04539301|Anticoagulants|anticoagulants|mesh-list
56432189|NCT00237419|Infliximab|infliximab|mesh-list
56432190|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
56432191|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56432192|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56432193|NCT04539106|Ranibizumab|ranibizumab|mesh-list
56432194|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56432195|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56432196|NCT04539106|Growth Substances|growth substances|mesh-ancestor
56432197|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432198|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
56432199|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432200|NCT00237497|Zopiclone|zopiclone|mesh-list
56432201|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56432221|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432222|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56432223|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432293|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432294|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56432366|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432367|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56432368|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56432369|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56432370|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432371|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
56432372|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432373|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56432375|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56432432|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56432433|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
56432434|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432435|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432436|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56432437|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56432438|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
56432439|NCT00414245|Metformin|metformin|mesh-list
56432440|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56432499|NCT02215993|Ticagrelor|ticagrelor|mesh-list
56432500|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56432574|NCT04536961|Famotidine|famotidine|mesh-list
56432575|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56432576|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56432577|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56432578|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
56432579|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
56432580|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432581|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432582|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432583|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
56432584|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56432585|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56432586|NCT00238160|Fluorouracil|fluorouracil|mesh-list
56432587|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432634|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
56432635|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
56432636|NCT00262587|Hormones|hormones|mesh-ancestor
56432637|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56432638|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
56432639|NCT00238199|Calcitriol|calcitriol|mesh-list
56432640|NCT00238199|Docetaxel|docetaxel|mesh-list
56432641|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432642|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
56432643|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
56432644|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
56432645|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432646|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56432647|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432648|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56432649|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56432650|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56432651|NCT00238199|Vitamins|vitamins|mesh-ancestor
56432652|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
56432654|NCT04536493|Lidocaine|lidocaine|mesh-list
56432689|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56432690|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56432691|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
56432692|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
56432694|NCT02216227|Iodine|iodine|mesh-list
56432761|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
56432762|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
56432765|NCT02216383|Oxytocin|oxytocin|mesh-list
56432837|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56432911|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
56432912|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56432913|NCT00263133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56432980|NCT02217007|Calcium|calcium|mesh-list
56432981|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56432982|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56432983|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56432984|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56432985|NCT00239096|Losartan|losartan|mesh-list
56432986|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56432987|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56432988|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56432989|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56432990|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56432991|NCT04532554|Hormones|hormones|mesh-list
56432994|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
56433040|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
56433041|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433113|NCT00263484|Growth Substances|growth substances|mesh-ancestor
56433114|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
56433115|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56433116|NCT02217319|Sevoflurane|sevoflurane|mesh-list
56433117|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56433118|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56433119|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
56433120|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
56433121|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56433122|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433123|NCT02217514|Midazolam|midazolam|mesh-list
56433124|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56433176|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433177|NCT00239330|Atorvastatin|atorvastatin|mesh-list
56433178|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56433179|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56433180|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56433181|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
56433182|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433183|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56433184|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56433186|NCT02218021|Oxycodone|oxycodone|mesh-list
56433241|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56433242|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433243|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56433310|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433311|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433312|NCT00239486|Pramipexole|pramipexole|mesh-list
56433382|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
56433383|NCT01644838|Scopolamine|scopolamine|mesh-list
56433384|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56433455|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56433456|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56433457|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
56433458|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433459|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56433460|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56433461|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433462|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
56433522|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
56433595|NCT00240149|Insulin|insulin|mesh-list
56433596|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56433597|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56433666|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56433667|NCT00264186|Norepinephrine|norepinephrine|mesh-list
56433668|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
56433740|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
56433741|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433742|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433743|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433744|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56433745|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56433746|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56433747|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56433748|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
56433749|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
56433751|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
56433752|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
56433753|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56433754|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
56433799|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56433800|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
56433801|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56433802|NCT01649830|Temozolomide|temozolomide|mesh-list
56433803|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56433804|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
56433805|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56433806|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56433807|NCT00240656|Carvedilol|carvedilol|mesh-list
56433808|NCT00240656|Captopril|captopril|mesh-list
56433809|NCT00240656|Spironolactone|spironolactone|mesh-list
56433811|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
56433862|NCT04720248|Analgesics|analgesics|mesh-ancestor
56433868|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
56433935|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56433936|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56433937|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56433938|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434005|NCT00241007|Valsartan|valsartan|mesh-list
56434006|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56434007|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56434009|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56434077|NCT02277106|Brexanolone|brexanolone|mesh-list
56434078|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
56434079|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434121|NCT00241475|Gefitinib|gefitinib|mesh-list
56434149|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
56434150|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434152|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
56434221|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56434222|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434293|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56434294|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
56434295|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434365|NCT02961842|Bupivacaine|bupivacaine|mesh-list
56434438|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434439|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56434440|NCT00282399|Decitabine|decitabine|mesh-list
56434441|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56434442|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
56434443|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434506|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56434507|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56434508|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56434509|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56434510|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
56434511|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56434512|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56434576|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56434577|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56434580|NCT00273468|Granisetron|granisetron|mesh-list
56434651|NCT00243815|Analgesics|analgesics|mesh-ancestor
56434652|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
56434653|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56434654|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56434719|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
56434720|NCT00244127|Hormones|hormones|mesh-ancestor
56434792|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
56434793|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56434863|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56434898|NCT00244907|Genistein|genistein|mesh-list
56434938|NCT00245024|Analgesics|analgesics|mesh-ancestor
56434939|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
56434948|NCT00274326|Satavaptan|satavaptan|mesh-list
56435012|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56435013|NCT00245375|Analgesics|analgesics|mesh-ancestor
56435014|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
56435015|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56435082|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56435155|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
56435156|NCT00284193|Coagulants|coagulants|mesh-ancestor
56435157|NCT00246194|Risperidone|risperidone|mesh-list
56435158|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56435159|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
56435228|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56435229|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
56435230|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435231|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56435232|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56435233|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56435235|NCT00284271|Hormones|hormones|mesh-ancestor
56435295|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435296|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
56435297|NCT00284427|Vitamins|vitamins|mesh-ancestor
56435298|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
56435299|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435300|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
56435303|NCT00246701|Simvastatin|simvastatin|mesh-list
56435365|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435366|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56435367|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56435368|NCT00277602|Protective Agents|protective agents|mesh-ancestor
56435369|NCT00277641|Lamotrigine|lamotrigine|mesh-list
56435434|NCT00247364|Levetiracetam|levetiracetam|mesh-list
56435435|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
56435436|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
56435437|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
56435438|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
56435439|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435440|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
56435503|NCT00247715|Ranitidine|ranitidine|mesh-list
56435504|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56435505|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
56435506|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56435507|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56435574|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435575|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56435576|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56435646|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56435798|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56435799|NCT00249197|Renal Agents|renal agents|mesh-ancestor
56435808|NCT00278967|Bisacodyl|bisacodyl|mesh-list
56435871|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56435872|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
56436020|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
56436096|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56436097|NCT00250874|Trastuzumab|trastuzumab|mesh-list
56436165|NCT00416832|Hormones|hormones|mesh-ancestor
56436236|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56436242|NCT01640782|Leucovorin|leucovorin|mesh-list
56436313|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56436314|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
56436315|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56436387|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56436388|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
56436461|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56436535|NCT00251966|Esomeprazole|esomeprazole|mesh-list
56436606|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56436607|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56436680|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56436692|NCT02758717|Nivolumab|nivolumab|mesh-list
56436756|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
56436832|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56436907|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56436981|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
56437056|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56437057|NCT01682902|Insulin|insulin|mesh-list
56437131|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437206|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437207|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56437280|NCT00287859|Topotecan|topotecan|mesh-list
56437286|NCT01684969|Haloperidol|haloperidol|mesh-list
56437353|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437354|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437429|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56437436|NCT01686607|Itraconazole|itraconazole|mesh-list
56437502|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56437503|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437505|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
56437506|NCT00253799|Protective Agents|protective agents|mesh-ancestor
56437508|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
56437571|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437572|NCT01687894|Vasopressins|vasopressins|mesh-list
56437651|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
56437724|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56437725|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56437797|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56437798|NCT00288561|Growth Substances|growth substances|mesh-ancestor
56437799|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56437800|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
56437801|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56437864|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
56437865|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56437937|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56437938|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438009|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438085|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
56438087|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438159|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
56438160|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56438161|NCT00289419|Narcotics|narcotics|mesh-ancestor
56438162|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56438163|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56438164|NCT00289419|Analgesics|analgesics|mesh-ancestor
56438165|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
56438226|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56438303|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
56186268|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56438608|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56438681|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56438682|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56438754|NCT00257387|Cyclosporins|cyclosporins|mesh-list
56438755|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56438765|NCT00257426|Octreotide|octreotide|mesh-list
56438828|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56438832|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
56438902|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
56438977|NCT02961101|Decitabine|decitabine|mesh-list
56438978|NCT02961101|Antibodies|antibodies|mesh-list
56438982|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
56439047|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56439048|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
56439122|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56439195|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
56439270|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56439271|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56439354|NCT01340014|Timolol|timolol|mesh-list
56439422|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56439423|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56439496|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56439497|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
56439506|NCT00271791|Prednisone|prednisone|mesh-list
56439570|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56439571|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56439719|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
56439792|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56439794|NCT00272610|Vitamin A|vitamin a|mesh-list
56439865|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56439866|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
56439938|NCT01331005|Nepafenac|nepafenac|mesh-list
56439940|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56440012|NCT01330381|Prucalopride|prucalopride|mesh-list
56440084|NCT00298779|Omeprazole|omeprazole|mesh-list
56440085|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56440091|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56440234|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
56440235|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
56440310|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
56440387|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
56440463|NCT00299559|Camphor|camphor|mesh-list
56440464|NCT00299559|Menthol|menthol|mesh-list
56440465|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
56440538|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56440610|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440755|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56440756|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56440757|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56440826|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56440899|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56440971|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441043|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
56441044|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441045|NCT00295425|Cyclosporine|cyclosporine|mesh-list
56441115|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441116|NCT00295542|Atenolol|atenolol|mesh-list
56441117|NCT00295542|Valsartan|valsartan|mesh-list
56441118|NCT00295542|Telmisartan|telmisartan|mesh-list
56441119|NCT00295542|Carvedilol|carvedilol|mesh-list
56441188|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
56441189|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56441190|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441191|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56441259|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441260|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56441261|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56441262|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
56441263|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
56441264|NCT00266747|Amibegron|amibegron|mesh-list
56441265|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56441266|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56441267|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
56441268|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56441269|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441270|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441271|NCT00266786|Ketorolac|ketorolac|mesh-list
56441272|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56441273|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56441274|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56441275|NCT00266786|Analgesics|analgesics|mesh-ancestor
56441276|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
56441280|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441312|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56441313|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56441314|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56441315|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56441316|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
56441382|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56441383|NCT00267332|Modafinil|modafinil|mesh-list
56441454|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
56441455|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441526|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56441527|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56441528|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56441597|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56441600|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
56441670|NCT00268814|Narcotics|narcotics|mesh-ancestor
56441671|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56441744|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56441817|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56441887|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56441888|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
56441967|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56441968|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56441969|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56441970|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56442040|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
56442041|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442114|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56442115|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
56442116|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56442117|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56442118|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56442184|NCT00271466|Analgesics|analgesics|mesh-ancestor
56442210|NCT00306774|Vitamin D|vitamin d|mesh-list
56442259|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56442260|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56442261|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
56442266|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56442332|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56442407|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56442408|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56442409|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56442477|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56442478|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442549|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56442620|NCT00273338|Vitamins|vitamins|mesh-ancestor
56442621|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
56442623|NCT00273377|Dexamethasone|dexamethasone|mesh-list
56442692|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
56442693|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56442694|NCT00308334|Domperidone|domperidone|mesh-list
56442766|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
56442767|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
56442841|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56442843|NCT00274274|Insulin|insulin|mesh-list
56442844|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56442915|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56442988|NCT00274820|Protective Agents|protective agents|mesh-ancestor
56442989|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56442990|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
56443060|NCT00277472|Diuretics|diuretics|mesh-ancestor
56443065|NCT00277511|Levofloxacin|levofloxacin|mesh-list
56443135|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56443208|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56443266|NCT00315744|Xhance|xhance|mesh-list
56443283|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443284|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
56443286|NCT00309543|Leucovorin|leucovorin|mesh-list
56443357|NCT00279266|Vitamins|vitamins|mesh-ancestor
56443433|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
56443434|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56443508|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56443509|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56443582|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56443591|NCT00316563|Hormones|hormones|mesh-ancestor
56443656|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
56443657|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56443730|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56164926|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
56443731|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56443803|NCT00281255|Allopurinol|allopurinol|mesh-list
56443879|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
56443881|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
56443882|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56443883|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56443884|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
56443893|NCT00417053|Melphalan|melphalan|mesh-list
56443950|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56443951|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
56443952|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56443953|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56164929|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
56444018|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56444019|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56444091|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56444164|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56444238|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56444239|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56444387|NCT00318825|Analgesics|analgesics|mesh-ancestor
56444461|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
56444462|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
56444535|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56192355|NCT01480765|Pregabalin|pregabalin|mesh-list
56444610|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
56444611|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56444612|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444613|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56444614|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56444615|NCT00285662|Renal Agents|renal agents|mesh-ancestor
56444616|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56444677|NCT00286130|Antidotes|antidotes|mesh-ancestor
56444750|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56444822|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
56444823|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56444838|NCT00417404|Vitamins|vitamins|mesh-list
56444897|NCT02960906|Sunitinib|sunitinib|mesh-list
56444898|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56444973|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
56444974|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56445045|NCT00287651|Insulin|insulin|mesh-list
56445046|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56445047|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56164955|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445048|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445049|NCT00322296|Bexarotene|bexarotene|mesh-list
56445050|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445051|NCT00320736|Galantamine|galantamine|mesh-list
56445062|NCT00287768|Docetaxel|docetaxel|mesh-list
56445112|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445188|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56445261|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
56445335|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445407|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56445408|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
56445480|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56445483|NCT00289406|Amlodipine|amlodipine|mesh-list
56445557|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
56445558|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56445559|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445561|NCT00289835|Paclitaxel|paclitaxel|mesh-list
56445628|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56445701|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56445703|NCT00303537|Metformin|metformin|mesh-list
56445773|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56445774|NCT00324363|Incretins|incretins|mesh-ancestor
56445850|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56445851|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
56445852|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
56445853|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
56445854|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56445855|NCT00291707|Pemetrexed|pemetrexed|mesh-list
56445856|NCT00291707|Cetuximab|cetuximab|mesh-list
56445863|NCT00324519|Misoprostol|misoprostol|mesh-list
56445919|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56445920|NCT00304200|Growth Substances|growth substances|mesh-ancestor
56445921|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56445922|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
56446066|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56446067|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56446137|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56446138|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446211|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56446212|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
56446213|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56446280|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56446355|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56446356|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
56446357|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
56446428|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56446502|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56446503|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56446504|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56446569|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56446570|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56446644|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
56446718|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56446792|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
56446864|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
56446865|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56446937|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56446938|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
56447009|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447086|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
56447087|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447088|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56447156|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447157|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
56447158|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56447159|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447160|NCT00299351|Romidepsin|romidepsin|mesh-list
56447161|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56447228|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
56447302|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
56447303|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56447309|NCT01539447|Naproxen|naproxen|mesh-list
56447375|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
56447376|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447449|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
56447525|NCT05238831|Pertuzumab|pertuzumab|mesh-list
56447676|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56447677|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447678|NCT00328380|Rifaximin|rifaximin|mesh-list
56447679|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56447680|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56447681|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56447683|NCT00418496|Sorafenib|sorafenib|mesh-list
56447684|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56447685|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56447686|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56447687|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56447688|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56447689|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56447690|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
56447738|NCT05008224|Etoposide|etoposide|mesh-list
56447739|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
56447740|NCT05008224|Vincristine|vincristine|mesh-list
56447741|NCT05008224|Bleomycin|bleomycin|mesh-list
56447742|NCT05008224|Vinblastine|vinblastine|mesh-list
56447743|NCT05008224|Procarbazine|procarbazine|mesh-list
56447744|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56447745|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
56447746|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56447747|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56447808|NCT04998669|Rituximab|rituximab|mesh-list
56447877|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56447953|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56195848|NCT01501136|Mesna|mesna|mesh-list
56448025|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56448026|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
56448049|NCT00332436|Timolol|timolol|mesh-list
56448096|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56448119|NCT00304772|Micafungin|micafungin|mesh-list
56448167|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448238|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
56448301|NCT00333021|PENTA|penta|mesh-list
56448312|NCT00305552|Thalidomide|thalidomide|mesh-list
56448388|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56448389|NCT00305786|Gemcitabine|gemcitabine|mesh-list
56448390|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
56448392|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
56448461|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56448533|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56448608|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56448685|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56448686|NCT00330798|Analgesics|analgesics|mesh-ancestor
56448758|NCT00333996|Hormones|hormones|mesh-ancestor
56448760|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56448829|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
56448830|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56448845|NCT03275012|Morphine|morphine|mesh-list
56448901|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
56448977|NCT00335166|Pramipexole|pramipexole|mesh-list
56448978|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
56449052|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449124|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56449125|NCT00453908|Urological Agents|urological agents|mesh-ancestor
56449196|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
56449241|NCT00336765|XL647|xl647|mesh-list
56449271|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56449272|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56449345|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56449422|NCT00337740|Propranolol|propranolol|mesh-list
56449498|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56449499|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
56449500|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56449570|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
56449571|NCT00308321|Hormones|hormones|mesh-ancestor
56449576|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
56449645|NCT00338481|Analgesics|analgesics|mesh-ancestor
56449715|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56449716|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56449717|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56449718|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
56449719|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56449720|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
56449721|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
56449781|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
56449857|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56449933|NCT00339066|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56449934|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56449937|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56450008|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56450079|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56450153|NCT00311870|Lisinopril|lisinopril|mesh-list
56450154|NCT00311870|Nisoldipine|nisoldipine|mesh-list
56450168|NCT00311987|Hormones|hormones|mesh-ancestor
56450226|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
56450227|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56450300|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56450301|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56450302|NCT00347685|Tramadol|tramadol|mesh-list
56450303|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56450304|NCT00347685|Narcotics|narcotics|mesh-ancestor
56450305|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56450306|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450445|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
56450446|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56450447|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56450463|NCT00348153|Adalimumab|adalimumab|mesh-list
56450516|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55854057|NCT01519167|Midazolam|midazolam|mesh-list
55854093|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854094|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854095|NCT00318136|Growth Substances|growth substances|mesh-ancestor
56450591|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56450592|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56450593|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56450655|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56450730|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56450732|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
56450804|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56450806|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56450877|NCT00315887|Buprenorphine|buprenorphine|mesh-list
56450889|NCT00315926|Melatonin|melatonin|mesh-list
56450952|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56450953|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56451024|NCT00316472|Niacinamide|niacinamide|mesh-list
56451100|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56451101|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451103|NCT00344955|Atorvastatin|atorvastatin|mesh-list
56451171|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56451177|NCT00317408|Leucovorin|leucovorin|mesh-list
56451251|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56451325|NCT00345657|Lovastatin|lovastatin|mesh-list
56451326|NCT00345657|L 647318|l 647318|mesh-list
56451399|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56451474|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56451548|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56451622|NCT00319358|Antioxidants|antioxidants|mesh-list
56451698|NCT00320099|Insulin|insulin|mesh-list
56451774|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56451775|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56451776|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56451777|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56451843|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451851|NCT00347256|Cisplatin|cisplatin|mesh-list
56451919|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56451920|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56451921|NCT00321581|Cediranib|cediranib|mesh-list
56451993|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56452067|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56452071|NCT00352950|Panitumumab|panitumumab|mesh-list
56452138|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56452139|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56452140|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56452209|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56452210|NCT00353340|Expectorants|expectorants|mesh-ancestor
56452211|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
56452212|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56452213|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
56452214|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452215|NCT00353340|Protective Agents|protective agents|mesh-ancestor
56452279|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56452359|NCT00324467|Analgesics|analgesics|mesh-ancestor
56452430|NCT00419471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56452433|NCT00426348|Valsartan|valsartan|mesh-list
56452579|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56452580|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
56452590|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
56452650|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56452651|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452723|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56452725|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56452793|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
56452867|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56452942|NCT00427089|Protective Agents|protective agents|mesh-ancestor
56452943|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453015|NCT00427362|Adalimumab|adalimumab|mesh-list
56453095|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453255|NCT00432627|Deferasirox|deferasirox|mesh-list
56453323|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
56453404|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453478|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56453479|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56453549|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56453550|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56453551|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56453622|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56453695|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56453696|NCT04704297|Analgesics|analgesics|mesh-ancestor
56453769|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453770|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56453778|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
56453912|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
56453913|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56453985|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56454066|NCT00330044|Carboplatin|carboplatin|mesh-list
56454135|NCT00434382|Narcotics|narcotics|mesh-ancestor
55785685|NCT05737693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454282|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56454283|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56454285|NCT00331058|Prednisolone|prednisolone|mesh-list
56454352|NCT00431106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56454429|NCT00331955|Vorinostat|vorinostat|mesh-list
56454578|NCT00332774|Nepafenac|nepafenac|mesh-list
56454579|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56454580|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56454650|NCT00435747|Analgesics|analgesics|mesh-ancestor
56454651|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
56454652|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56454656|NCT00333047|Letrozole|letrozole|mesh-list
56454719|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454720|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56454721|NCT00333281|Tadalafil|tadalafil|mesh-list
56454791|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
56454865|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56454941|NCT00334412|Caspofungin|caspofungin|mesh-list
56455014|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56455015|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
56455088|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56455090|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
56455180|NCT00335192|Tenofovir|tenofovir|mesh-list
56455316|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
56455317|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455322|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
56455385|NCT03277170|Montelukast|montelukast|mesh-list
56455534|NCT00337259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56455535|NCT00337259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56455536|NCT00337259|Immunologic Factors|immunologic factors|mesh-ancestor
56455538|NCT04699734|Lidocaine|lidocaine|mesh-list
56455605|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56455606|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56455608|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56203566|NCT01540526|Axitinib|axitinib|mesh-list
56455688|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
56455750|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
56455751|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
56455825|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
56455894|NCT03275415|Hormones|hormones|mesh-ancestor
56455896|NCT00425204|Panitumumab|panitumumab|mesh-list
56455967|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56455968|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456041|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56456042|NCT00452556|Hormones|hormones|mesh-ancestor
56456043|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56456115|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56456116|NCT00452907|Renal Agents|renal agents|mesh-ancestor
56456188|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56456190|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
56456260|NCT00343265|Progestins|progestins|mesh-ancestor
56456261|NCT00343265|Hormones|hormones|mesh-ancestor
56456264|NCT00453609|Naltrexone|naltrexone|mesh-list
56456332|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56456334|NCT00343733|Fentanyl|fentanyl|mesh-list
56456407|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56456408|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
56456479|NCT00447915|Calcium|calcium|mesh-list
56456480|NCT00447915|Vitamins|vitamins|mesh-ancestor
56456481|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
56456552|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456554|NCT00344942|Triamcinolone|triamcinolone|mesh-list
56456626|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
56456627|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
56456699|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56456700|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
56456701|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
56456704|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
56456771|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56456772|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56456846|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56456847|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456848|NCT02273817|Ciclesonide|ciclesonide|mesh-list
56456919|NCT00455286|Methotrexate|methotrexate|mesh-list
56456920|NCT00455286|Temozolomide|temozolomide|mesh-list
56456921|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56456922|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
56456923|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56456924|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
56456925|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56456926|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56456927|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56456928|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
56456929|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56456930|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56456931|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
56456979|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56457127|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
56457202|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457274|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56457275|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457346|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
56457347|NCT00456339|Hormones|hormones|mesh-ancestor
56457419|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56457420|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
56457434|NCT00450138|Cisplatin|cisplatin|mesh-list
56457492|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457493|NCT00350441|Urological Agents|urological agents|mesh-ancestor
56457494|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56457495|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
56457564|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
56457641|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56457642|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56457715|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56457789|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56457790|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56457791|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56457858|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56457861|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
56457932|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56457933|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
56457934|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56457935|NCT00353912|Amlodipine|amlodipine|mesh-list
56458003|NCT00354302|Vitamins|vitamins|mesh-ancestor
56458079|NCT03274011|Apatinib|apatinib|mesh-list
56458080|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56458084|NCT00425906|Nicotine|nicotine|mesh-list
56458154|NCT00426140|Epothilone B|epothilone b|mesh-list
56458227|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56458302|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
56458311|NCT00426608|Alprazolam|alprazolam|mesh-list
56458379|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56458455|NCT00427076|Vancomycin|vancomycin|mesh-list
56458456|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56458460|NCT00427076|Renal Agents|renal agents|mesh-ancestor
56458527|NCT00427388|Hormones|hormones|mesh-ancestor
56458528|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458529|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56458597|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56458598|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56458742|NCT00469443|Bevacizumab|bevacizumab|mesh-list
56458743|NCT00469443|Fluorouracil|fluorouracil|mesh-list
56458744|NCT00469443|Capecitabine|capecitabine|mesh-list
56458745|NCT00469443|Irinotecan|irinotecan|mesh-list
56458816|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56458894|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56458895|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
56458896|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56458897|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
56458898|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56458899|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56458964|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56458965|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56459033|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56459037|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
56459103|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
56459177|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56459178|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
56459251|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459252|NCT00462852|Gemcitabine|gemcitabine|mesh-list
56459326|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56459327|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
56459328|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
56459329|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
56459331|NCT00463086|Isoniazid|isoniazid|mesh-list
56459393|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56459467|NCT00463515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459538|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459614|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56459615|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56459617|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56459684|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459830|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56459831|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
56459902|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
56459903|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56459904|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56459905|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
56459972|NCT00465036|Cathartics|cathartics|mesh-ancestor
56459973|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56460045|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460046|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56460047|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
56460048|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
56460116|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56460117|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56460191|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56460192|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
56460193|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56460264|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
56460265|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56460266|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56460269|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
56460335|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56460336|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460337|NCT00482313|Methylphenidate|methylphenidate|mesh-list
56460338|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56460339|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460403|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56460404|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
56460405|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
56460406|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56460474|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56460475|NCT00438113|Diuretics|diuretics|mesh-ancestor
56460476|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
56460477|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460478|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56460479|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56460480|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460542|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56460543|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56460544|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56460545|NCT03279809|Aspirin|aspirin|mesh-list
56460546|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56460548|NCT03279809|Analgesics|analgesics|mesh-ancestor
56460610|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56460611|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
56460612|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460613|NCT00475293|Panitumumab|panitumumab|mesh-list
56460614|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56460615|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56460682|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460753|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56460754|NCT00439361|Carboplatin|carboplatin|mesh-list
56460803|NCT00476073|Xhance|xhance|mesh-list
56460827|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56460828|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460829|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56460830|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
56460831|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56460832|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56460833|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56460890|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56460891|NCT00439751|Goserelin|goserelin|mesh-list
56460963|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56460964|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56461037|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461038|NCT00440648|Sevelamer|sevelamer|mesh-list
56461039|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
56461040|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
56461041|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461042|NCT00440687|Fluticasone|fluticasone|mesh-list
56461043|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56461044|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56461045|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
56461046|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461053|NCT03271047|Ipilimumab|ipilimumab|mesh-list
56461103|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461104|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
56461105|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56461106|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56461107|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56461172|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56461173|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461174|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461175|NCT00441428|Urological Agents|urological agents|mesh-ancestor
56461176|NCT00438984|Aldesleukin|aldesleukin|mesh-list
56461242|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461243|NCT00477048|Saquinavir|saquinavir|mesh-list
56461244|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56461245|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56461246|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
56461247|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461249|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56461311|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461312|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56461313|NCT00439530|Oseltamivir|oseltamivir|mesh-list
56461384|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56461385|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
56461386|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461387|NCT00442676|Celecoxib|celecoxib|mesh-list
56461456|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56461457|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
56461459|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56461529|NCT00440622|Gemcitabine|gemcitabine|mesh-list
56461530|NCT00440622|Capecitabine|capecitabine|mesh-list
56461604|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56461605|NCT00440973|Growth Substances|growth substances|mesh-ancestor
56461606|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461609|NCT00440973|Analgesics|analgesics|mesh-ancestor
56461676|NCT00478959|Lenalidomide|lenalidomide|mesh-list
56461677|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
56461678|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56461679|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56461748|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461750|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
56461823|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461824|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
56461899|NCT00445094|Imipenem|imipenem|mesh-list
56461900|NCT00445094|Amikacin|amikacin|mesh-list
56461901|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56461902|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
56461970|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56461971|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56461972|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56461973|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56461974|NCT03274700|Tamsulosin|tamsulosin|mesh-list
56461975|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56461976|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56461983|NCT00442221|Naproxen|naproxen|mesh-list
56462037|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462038|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462039|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
56462040|NCT00480090|Cytarabine|cytarabine|mesh-list
56462108|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56462110|NCT00455117|Analgesics|analgesics|mesh-ancestor
56462184|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56462259|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
56462260|NCT04700709|Sirolimus|sirolimus|mesh-list
56462261|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56462262|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462331|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
56462332|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56462333|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
56462401|NCT04700046|Mexiletine|mexiletine|mesh-list
56462402|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56462403|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56462404|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56462472|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462473|NCT02956538|Thalidomide|thalidomide|mesh-list
56462474|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56462475|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
56462543|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56462544|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56462546|NCT00481182|Narcotics|narcotics|mesh-ancestor
56462547|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56462548|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462549|NCT00481182|Analgesics|analgesics|mesh-ancestor
56462614|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56462615|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
56462616|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56462617|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462682|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56462683|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462684|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56462685|NCT01242384|Silicon|silicon|mesh-list
56462686|NCT01242384|Trace Elements|trace elements|mesh-ancestor
56462687|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
56462688|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56462689|NCT00488436|Cyclosporine|cyclosporine|mesh-list
56210639|NCT01597206|Cobalt|cobalt|mesh-list
56462690|NCT00488436|Cyclosporins|cyclosporins|mesh-list
56462691|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56462692|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56462695|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
56462744|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462745|NCT00459836|Antiviral Agents|antiviral agents|mesh-ancestor
56462820|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56462894|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56462895|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56462896|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56462897|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56462909|NCT00460928|Antibodies|antibodies|mesh-list
56462965|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
56462966|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56462967|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
56462968|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463039|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463040|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463041|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56463111|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
56463112|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463113|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56463115|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
56463183|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56463184|NCT00497250|Gefitinib|gefitinib|mesh-list
56463185|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463257|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463258|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463260|NCT00105443|Sorafenib|sorafenib|mesh-list
56463330|NCT00466154|Analgesics|analgesics|mesh-ancestor
56463331|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
56463332|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56463401|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463402|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
56463474|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56463549|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463551|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463620|NCT01327612|Vitamins|vitamins|mesh-ancestor
56463621|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
56463622|NCT01243281|Entecavir|entecavir|mesh-list
56463623|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
56463625|NCT00464399|Everolimus|everolimus|mesh-list
56463694|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56463695|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56463697|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56463765|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56463766|NCT00464789|Hormones|hormones|mesh-ancestor
56463767|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56463773|NCT00467012|Paclitaxel|paclitaxel|mesh-list
56463837|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56463838|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56463898|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56463899|NCT00491712|Triamcinolone|triamcinolone|mesh-list
56463974|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56463975|NCT00491985|Vaccines|vaccines|mesh-list
56463976|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
56463977|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464042|NCT00465257|Artesunate|artesunate|mesh-list
56464043|NCT00465257|Amodiaquine|amodiaquine|mesh-list
56464044|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
56464045|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56464046|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56464113|NCT01243632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464189|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56464190|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56464191|NCT00593008|Gemcitabine|gemcitabine|mesh-list
56464192|NCT00593008|Sirolimus|sirolimus|mesh-list
56464193|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56464258|NCT05653453|Immunologic Factors|immunologic factors|mesh-ancestor
56464259|NCT05653453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464260|NCT00468182|Interferons|interferons|mesh-list
56464261|NCT00468182|Interferon-beta|interferon-beta|mesh-list
56464262|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
56464329|NCT01245816|Analgesics|analgesics|mesh-ancestor
56464337|NCT00492687|Carboplatin|carboplatin|mesh-list
56464404|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
56464405|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
56464406|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
56464407|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212401|NCT05703555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212402|NCT05703425|Sulfasalazine|sulfasalazine|mesh-list
56212416|NCT05702190|Opium|opium|mesh-list
56464542|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56464620|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
56212551|NCT05062083|11C-PS13|11c-ps13|mesh-list
56464695|NCT00469352|Ranibizumab|ranibizumab|mesh-list
56464696|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56464766|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464839|NCT01244100|Aspirin|aspirin|mesh-list
56464840|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56464841|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56464912|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
56464913|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56464914|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56464915|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56464916|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
56464981|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56464982|NCT00501267|Urological Agents|urological agents|mesh-ancestor
56464983|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56465052|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56465055|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
56465122|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465123|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56465124|NCT00470015|Analgesics|analgesics|mesh-ancestor
56465195|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465196|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56465197|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465203|NCT00600535|Hormones|hormones|mesh-ancestor
56465266|NCT00600769|Clarithromycin|clarithromycin|mesh-list
56465267|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56465268|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56465274|NCT00470210|Ribavirin|ribavirin|mesh-list
56465337|NCT00501696|Naltrexone|naltrexone|mesh-list
56465338|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56465339|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56465340|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465410|NCT00475514|Frovatriptan|frovatriptan|mesh-list
56465411|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56465412|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
56465413|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56465424|NCT00601588|Sertraline|sertraline|mesh-list
56465480|NCT00601159|Gemcitabine|gemcitabine|mesh-list
56465481|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56465491|NCT00602017|Amlodipine|amlodipine|mesh-list
56465554|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56465569|NCT00470522|Hematinics|hematinics|mesh-ancestor
56465628|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56465629|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56465630|NCT00470873|Urological Agents|urological agents|mesh-ancestor
56465699|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
56465700|NCT00493857|Antibodies|antibodies|mesh-list
56465774|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56465848|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56465849|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56465850|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
56465921|NCT00472004|Tibolone|tibolone|mesh-list
56465922|NCT00472004|Estradiol|estradiol|mesh-list
56465923|NCT00472004|Estrogens|estrogens|mesh-ancestor
56465924|NCT00472004|Hormones|hormones|mesh-ancestor
56465925|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56466003|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
56466069|NCT05645302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466070|NCT05645302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466078|NCT00494988|Insulin|insulin|mesh-list
56466139|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466140|NCT00503568|Vaccines|vaccines|mesh-list
56466141|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
56466142|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466211|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56466212|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466213|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56466229|NCT00477815|Rituximab|rituximab|mesh-list
56466284|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56466285|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466286|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56466287|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56466288|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56466354|NCT05645146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466355|NCT05645146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466356|NCT05645146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56466428|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56466429|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
56466430|NCT01247961|Hormones|hormones|mesh-ancestor
56466431|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56466500|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466503|NCT01248234|Propofol|propofol|mesh-list
56466573|NCT05644717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56466574|NCT05644717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56466580|NCT02891161|Durvalumab|durvalumab|mesh-list
56466581|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56466582|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466583|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
56466584|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56466646|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
56466647|NCT04207411|Lidocaine|lidocaine|mesh-list
56466717|NCT01313728|Dapsone|dapsone|mesh-list
56466718|NCT01313728|Tretinoin|tretinoin|mesh-list
56466794|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56466795|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56466940|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
56466941|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56466942|NCT00480389|Sorafenib|sorafenib|mesh-list
56466943|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56466947|NCT04519710|Rituximab|rituximab|mesh-list
56467013|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56467089|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56467090|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56467091|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56467092|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56467093|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56467094|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56467156|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
56467157|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467228|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56467229|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56467230|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
56467231|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56467248|NCT04517526|Durvalumab|durvalumab|mesh-list
56467296|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56467297|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56467367|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56467368|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467392|NCT01240941|Goserelin|goserelin|mesh-list
56467437|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467438|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467439|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56467507|NCT00483275|Vitamins|vitamins|mesh-ancestor
56467508|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
56467509|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
56467510|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56467511|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
56467512|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56467581|NCT05644210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56467655|NCT00483743|Hormones|hormones|mesh-ancestor
56467656|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56467657|NCT00483782|Paclitaxel|paclitaxel|mesh-list
56467658|NCT00483782|Bevacizumab|bevacizumab|mesh-list
56467659|NCT00483782|Carboplatin|carboplatin|mesh-list
56467660|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56467661|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56467662|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
56467663|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
56467665|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56467666|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56467667|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56467669|NCT00483782|Growth Substances|growth substances|mesh-ancestor
56467729|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56467730|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56467731|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56467800|NCT01303627|Analgesics|analgesics|mesh-ancestor
56467801|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
56467802|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56467870|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
56467871|NCT05643820|Ivermectin|ivermectin|mesh-list
56467872|NCT05643820|Permethrin|permethrin|mesh-list
56467873|NCT05643820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56467943|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56467944|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
56468016|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56468091|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56468092|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56468093|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468162|NCT00485030|Sirolimus|sirolimus|mesh-list
56468163|NCT00485030|Everolimus|everolimus|mesh-list
56468164|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468172|NCT04513821|Ethanol|ethanol|mesh-list
56468310|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56334350|NCT00070122|Leucovorin|leucovorin|mesh-list
56468311|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56468380|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56468453|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
56468454|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56468522|NCT00485888|Citalopram|citalopram|mesh-list
56468523|NCT00485888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56468595|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468667|NCT00486356|Epirubicin|epirubicin|mesh-list
56468668|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56468669|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56468670|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
56468671|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56468672|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56468673|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56468674|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56468735|NCT00491114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56468736|NCT00491114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56468737|NCT00491114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56468738|NCT00491114|Immunologic Factors|immunologic factors|mesh-ancestor
56468739|NCT00491114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468804|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56468876|NCT04510818|Capecitabine|capecitabine|mesh-list
56468877|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56468878|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
56468881|NCT05642845|Atorvastatin|atorvastatin|mesh-list
56468949|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56468950|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56468951|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
56469022|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
56469097|NCT05641909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56469098|NCT05641909|Analgesics|analgesics|mesh-ancestor
56469099|NCT05641909|Sensory System Agents|sensory system agents|mesh-ancestor
56469171|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469172|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56469246|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56469319|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56469320|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56469394|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
56469395|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469396|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
56469397|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469398|NCT00495287|Cytarabine|cytarabine|mesh-list
56469399|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56469400|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
56469401|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56469402|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56469403|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
56469404|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56469405|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56469406|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
56469408|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
56469455|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
56469456|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56469528|NCT00495872|Dasatinib|dasatinib|mesh-list
56469529|NCT00495872|Lapatinib|lapatinib|mesh-list
56469530|NCT00495872|Valproic Acid|valproic acid|mesh-list
56469602|NCT01243970|Protective Agents|protective agents|mesh-ancestor
56469603|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56469674|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56334406|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56469747|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
56469748|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333913|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
56333914|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56333915|NCT00064194|Protective Agents|protective agents|mesh-ancestor
56333916|NCT00064194|Trace Elements|trace elements|mesh-ancestor
56333918|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56333920|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56469848|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
56469849|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56469922|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56469995|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
56470070|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470071|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470142|NCT00495092|Caffeine|caffeine|mesh-list
56470143|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56470144|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470145|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56470146|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56470147|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470148|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56470149|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56470208|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56470283|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
56470284|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470292|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
56470357|NCT00503243|Mesalamine|mesalamine|mesh-list
56470358|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56470359|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56470360|NCT00503243|Analgesics|analgesics|mesh-ancestor
56470361|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
56470362|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470363|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470364|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56470365|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56470366|NCT00498992|Vitamin E|vitamin e|mesh-list
56470367|NCT00498992|Lidocaine|lidocaine|mesh-list
56470368|NCT00498992|Vitamins|vitamins|mesh-ancestor
56470369|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
56470370|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470371|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
56470372|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
56470373|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56470374|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
56470375|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56470376|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56470377|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56470378|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56470379|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56470381|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
56470407|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56470408|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
56470409|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56470478|NCT05148195|Docetaxel|docetaxel|mesh-list
56470479|NCT05148195|Irinotecan|irinotecan|mesh-list
56470480|NCT05148195|Calcium|calcium|mesh-list
56470626|NCT00499850|Antidotes|antidotes|mesh-ancestor
56470627|NCT00499850|Protective Agents|protective agents|mesh-ancestor
56470628|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
56470629|NCT00499850|Vitamins|vitamins|mesh-ancestor
56470630|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
56470699|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470700|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
56470771|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56470772|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56470773|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
56470774|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56470775|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56470840|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56470841|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
56470914|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56470915|NCT01248260|Folic Acid|folic acid|mesh-list
56470987|NCT00509379|Rituximab|rituximab|mesh-list
56470988|NCT00509379|Bortezomib|bortezomib|mesh-list
56470990|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471062|NCT00501410|Protective Agents|protective agents|mesh-ancestor
56471063|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
56471064|NCT00501410|Vitamins|vitamins|mesh-ancestor
56471065|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
56471132|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471133|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56471205|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56471206|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56471207|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
56471208|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56471278|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56471279|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471352|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56471353|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56471426|NCT01249430|Cytarabine|cytarabine|mesh-list
56471427|NCT01249430|Etoposide|etoposide|mesh-list
56471428|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
55972480|NCT03086096|Irinotecan|irinotecan|mesh-list
56471500|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471501|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56471574|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56471575|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56471648|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56471649|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471650|NCT01249664|Aflibercept|aflibercept|mesh-list
56471651|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56471652|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56471653|NCT01249664|Growth Substances|growth substances|mesh-ancestor
56471654|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471655|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
56471656|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471657|NCT00513162|Etoposide|etoposide|mesh-list
56471714|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56471715|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56471716|NCT00504959|Ranibizumab|ranibizumab|mesh-list
56471717|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56471718|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56471719|NCT00504959|Growth Substances|growth substances|mesh-ancestor
56471720|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471721|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
56471722|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56471723|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
56471724|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56471781|NCT00512811|Furosemide|furosemide|mesh-list
56471854|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
56471855|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56471856|NCT00513981|Leucovorin|leucovorin|mesh-list
56471926|NCT01244984|Fluticasone|fluticasone|mesh-list
56471927|NCT01244984|Xhance|xhance|mesh-list
56471928|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56472001|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56472002|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56472003|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
56472004|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
56472005|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472006|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472072|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
56472147|NCT01243346|Crenolanib|crenolanib|mesh-list
56472148|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472149|NCT01249443|Paclitaxel|paclitaxel|mesh-list
56472150|NCT01249443|Carboplatin|carboplatin|mesh-list
56472219|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56472221|NCT04696848|Durvalumab|durvalumab|mesh-list
56472289|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56472290|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472291|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56472292|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
56472357|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56472358|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
56472359|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56472362|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
56472427|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56472428|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
56472501|NCT02275988|Clarithromycin|clarithromycin|mesh-list
56472502|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56472503|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56472504|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56472505|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56472506|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472507|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56472508|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56472509|NCT02950155|Rituximab|rituximab|mesh-list
56472510|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56472511|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56472564|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
56220623|NCT01657448|Methenamine|methenamine|mesh-list
56472638|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472639|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56472710|NCT01240863|Narcotics|narcotics|mesh-ancestor
56220701|NCT01657825|Warfarin|warfarin|mesh-list
56472711|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56472712|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472780|NCT04516304|Equol|equol|mesh-list
56472781|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
56472782|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56472852|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56472853|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56472856|NCT00505505|Insulin|insulin|mesh-list
56472926|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56472927|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56472928|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56472994|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
56473064|NCT02594072|Goserelin|goserelin|mesh-list
56473065|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56473066|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473137|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473138|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56473139|NCT04514081|Decitabine|decitabine|mesh-list
56473207|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473208|NCT02598557|Exemestane|exemestane|mesh-list
56473209|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473218|NCT00520806|Methocarbamol|methocarbamol|mesh-list
56473276|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56473277|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56473281|NCT00521157|Naltrexone|naltrexone|mesh-list
56473349|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473350|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
56473352|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56473422|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56473425|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
56473496|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
56473497|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56473498|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473499|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56473500|NCT00522015|Protective Agents|protective agents|mesh-ancestor
56473501|NCT00523380|Doxorubicin|doxorubicin|mesh-list
56473502|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56473565|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473566|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56473567|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56473568|NCT00522249|Growth Substances|growth substances|mesh-ancestor
56473569|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473570|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
56473571|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
56473572|NCT05148767|Irinotecan|irinotecan|mesh-list
56473573|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56473574|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56473575|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473576|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473577|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473578|NCT00523692|Etanercept|etanercept|mesh-list
56473579|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56473580|NCT00523692|Methotrexate|methotrexate|mesh-list
56473581|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56473621|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
56473622|NCT00522444|Analgesics|analgesics|mesh-ancestor
56473694|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473695|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473696|NCT00523965|Amphotericin B|amphotericin b|mesh-list
56473697|NCT00523965|Paromomycin|paromomycin|mesh-list
56473698|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56473699|NCT00523965|Miltefosine|miltefosine|mesh-list
56473700|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56473701|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
56473702|NCT00523965|Amebicides|amebicides|mesh-ancestor
56473703|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56473704|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56473705|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473706|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56473707|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
56473708|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56473709|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56473710|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56473711|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56473714|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56473751|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473752|NCT00523068|Urological Agents|urological agents|mesh-ancestor
56473754|NCT02276378|Telmisartan|telmisartan|mesh-list
56473827|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56473828|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56473829|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
56473830|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56473831|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56473832|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56473833|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56473834|NCT00525993|Etoricoxib|etoricoxib|mesh-list
56473893|NCT05143073|Ethanol|ethanol|mesh-list
56473894|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56473895|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56473896|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56473898|NCT05144243|Azacitidine|azacitidine|mesh-list
56473964|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56473965|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56473966|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56474038|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474039|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
56474040|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474110|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56474111|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474112|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
56474184|NCT02945982|Protective Agents|protective agents|mesh-ancestor
56474185|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56474259|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56474405|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56474406|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56474407|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56474408|NCT03458715|Incretins|incretins|mesh-ancestor
56474409|NCT03458715|Hormones|hormones|mesh-ancestor
56474411|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
56474475|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56474551|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56474552|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56474623|NCT05648487|Antibodies|antibodies|mesh-list
56165417|NCT00002898|Etoposide|etoposide|mesh-list
56474700|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56474701|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
56474769|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
56474770|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56474772|NCT00510263|Valacyclovir|valacyclovir|mesh-list
56474844|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56474845|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474851|NCT02951897|Pemetrexed|pemetrexed|mesh-list
56474920|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56474921|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56474922|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56474923|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56474924|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56474925|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56474926|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
56474927|NCT00513188|Hormones|hormones|mesh-ancestor
56474928|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56474990|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56474991|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56474992|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
56474996|NCT00515892|Antibodies|antibodies|mesh-list
56475064|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475065|NCT00512291|Olanzapine|olanzapine|mesh-list
56475066|NCT00512291|Fluoxetine|fluoxetine|mesh-list
56475067|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
56475134|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
56475135|NCT00530556|Zolpidem|zolpidem|mesh-list
56475136|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56475207|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
56475208|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475209|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
56475210|NCT00512681|Irinotecan|irinotecan|mesh-list
56475211|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475212|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56475213|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56475276|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
56475277|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56475278|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56475279|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56475343|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56475419|NCT00515138|Rituximab|rituximab|mesh-list
56475420|NCT00515138|Carboplatin|carboplatin|mesh-list
56475421|NCT00515138|Etoposide|etoposide|mesh-list
56475422|NCT00515138|Bortezomib|bortezomib|mesh-list
56475423|NCT00515138|Ifosfamide|ifosfamide|mesh-list
56475424|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56475425|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475426|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
56475427|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56475428|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56475429|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56475430|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56475431|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56475432|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56475481|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56475482|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
56475483|NCT00516152|Methotrexate|methotrexate|mesh-list
56475554|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56475555|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56475556|NCT02941731|Oseltamivir|oseltamivir|mesh-list
56475557|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
56475628|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
56475629|NCT00516425|Doxorubicin|doxorubicin|mesh-list
56475630|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56475702|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56475705|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
56475778|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56475779|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56475780|NCT02942043|Bevacizumab|bevacizumab|mesh-list
56475851|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
56475859|NCT02940756|Artesunate|artesunate|mesh-list
56475926|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56475927|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
56475933|NCT04988685|Sirolimus|sirolimus|mesh-list
56475999|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476000|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
56476001|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
56476002|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
56476073|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56476145|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56476146|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56476147|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476217|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476218|NCT00520325|Coagulants|coagulants|mesh-ancestor
56476219|NCT00520442|Ibuprofen|ibuprofen|mesh-list
56476220|NCT00520442|Codeine|codeine|mesh-list
56476287|NCT02938260|Metoprolol|metoprolol|mesh-list
56476288|NCT02938260|Diltiazem|diltiazem|mesh-list
56476289|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56476291|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
56476358|NCT02931357|Lidocaine|lidocaine|mesh-list
56476452|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56476528|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476530|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56476601|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56476602|NCT00524498|Cisplatin|cisplatin|mesh-list
56476603|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56476604|NCT00523406|Triamcinolone|triamcinolone|mesh-list
56476670|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56476745|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56476746|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56476818|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56476819|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
56476821|NCT00524186|Leucovorin|leucovorin|mesh-list
56476895|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
56476904|NCT00525239|Ritonavir|ritonavir|mesh-list
56476968|NCT00525473|Azathioprine|azathioprine|mesh-list
56477042|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
56477045|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
56477118|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56477119|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477192|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56477264|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
56477265|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477266|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56477335|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
56477336|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477338|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
56477408|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56477482|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56477553|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56477554|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477556|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
56477625|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56477626|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56477649|NCT04033419|Memantine|memantine|mesh-list
56477698|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477764|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56477765|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
56477766|NCT04231968|Ziresovir|ziresovir|mesh-list
56477839|NCT02922660|Desflurane|desflurane|mesh-list
56477846|NCT02922660|Narcotics|narcotics|mesh-ancestor
56477915|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56477916|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
56477917|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
56477918|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56477923|NCT02922348|Norgestimate|norgestimate|mesh-list
56477986|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56478060|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
56478061|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56478062|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56478063|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56478064|NCT00531596|Selegiline|selegiline|mesh-list
56478132|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
56478133|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478134|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56478205|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478206|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56478207|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
56478276|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56478277|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478278|NCT02942693|Apatinib|apatinib|mesh-list
56478283|NCT02920593|Vitamin D|vitamin d|mesh-list
56478346|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56478410|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
56478411|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478412|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478413|NCT02919501|Vortioxetine|vortioxetine|mesh-list
56478414|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
56478415|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56478416|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56478417|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56478418|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56478419|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56478425|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
56478552|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
56478553|NCT02919072|Ropivacaine|ropivacaine|mesh-list
56478554|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
56478555|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
56478626|NCT02915055|Oxycodone|oxycodone|mesh-list
56478627|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56478628|NCT02915055|Analgesics|analgesics|mesh-ancestor
56478629|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
56478698|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
56478699|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478700|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56478701|NCT02914626|Ranibizumab|ranibizumab|mesh-list
56478769|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478770|NCT02910141|Insulin|insulin|mesh-list
56478771|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56478844|NCT02937662|Cytarabine|cytarabine|mesh-list
56478920|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56478921|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56478997|NCT02909712|Renal Agents|renal agents|mesh-ancestor
56478998|NCT02913885|Fluorides|fluorides|mesh-list
56478999|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
56479000|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
56479001|NCT02913885|Protective Agents|protective agents|mesh-ancestor
56479002|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479003|NCT01290601|Chloroquine|chloroquine|mesh-list
56227108|NCT03435185|Lidocaine|lidocaine|mesh-list
56227109|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
56479135|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
56479148|NCT02913690|Vitamin E|vitamin e|mesh-list
56479210|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56479211|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56479213|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
56479283|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56479293|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
56479362|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
56479438|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
56479512|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479513|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56479515|NCT02933099|Hormones|hormones|mesh-ancestor
56479584|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479585|NCT02932436|Empagliflozin|empagliflozin|mesh-list
56479586|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56479587|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479588|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56479655|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479656|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56479724|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479725|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
56479726|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56479727|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56479793|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
56479794|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56479882|NCT02933853|Insulin|insulin|mesh-list
56479945|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56479946|NCT02921984|Docetaxel|docetaxel|mesh-list
56479947|NCT02921984|Pemetrexed|pemetrexed|mesh-list
56480018|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
56480019|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480092|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56480093|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
56480094|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480104|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
56480162|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56480163|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56547772|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56547773|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56547774|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56547775|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56547789|NCT02668861|Vitamin D|vitamin d|mesh-list
56547844|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56547845|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
56547917|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56547918|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
56547991|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
56548069|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
56548144|NCT04920682|Trace Elements|trace elements|mesh-ancestor
56548219|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56548221|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
56548289|NCT00647101|Latanoprost|latanoprost|mesh-list
56548290|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56548291|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56548360|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56548361|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
56548363|NCT01166178|Vitamin D|vitamin d|mesh-list
56548434|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56548435|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56548506|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56296778|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
56548517|NCT05125146|Trazodone|trazodone|mesh-list
56548577|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548651|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56548653|NCT02663713|Clopidogrel|clopidogrel|mesh-list
56548800|NCT03602235|Protective Agents|protective agents|mesh-ancestor
56548875|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
56548880|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
56548948|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56548950|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
56549019|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
56549024|NCT04170751|Vasopressins|vasopressins|mesh-list
56549172|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
56549243|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56549244|NCT00650065|Cetirizine|cetirizine|mesh-list
56549253|NCT04170439|Chromium|chromium|mesh-list
56549316|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56549317|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
56549318|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56549390|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56549392|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56549463|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56549465|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56549535|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549536|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56549605|NCT02653651|Analgesics|analgesics|mesh-ancestor
56549678|NCT00650611|Ziprasidone|ziprasidone|mesh-list
56549679|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56549753|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56549754|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56549755|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56549756|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56549757|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549759|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56549824|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56549825|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56549826|NCT02652325|Iodine|iodine|mesh-list
56549827|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
56549828|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
56549829|NCT02652325|Povidone|povidone|mesh-list
56549894|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
56549895|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56549897|NCT00650923|Temozolomide|temozolomide|mesh-list
56549968|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550003|NCT04811014|Naloxone|naloxone|mesh-list
56550046|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56550115|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56550190|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56550193|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
56550263|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
56550264|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550265|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550335|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550336|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56550410|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
56550484|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
56550485|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56550486|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56550487|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
56550558|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
56550559|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550636|NCT04829344|Carticaine|carticaine|mesh-list
56550706|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56550707|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56550779|NCT03421288|Vitamins|vitamins|mesh-ancestor
56550780|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
56550856|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56550860|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56550928|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56550929|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56550930|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56550931|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
56550932|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
56550933|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56550934|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
56550935|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56550936|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56550937|NCT00654277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56550938|NCT00654277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56550939|NCT00654277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56550940|NCT00654277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56550941|NCT00654277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56550993|NCT04260412|Psyllium|psyllium|mesh-list
56551065|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56551066|NCT02638831|Ketoprofen|ketoprofen|mesh-list
56551139|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56551212|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56551288|NCT01198522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56551291|NCT02638285|Clomiphene|clomiphene|mesh-list
56551362|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56551368|NCT00630357|Levetiracetam|levetiracetam|mesh-list
56551438|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
56551446|NCT05419180|Stiripentol|stiripentol|mesh-list
56551513|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56551514|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
56551515|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56551519|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
56551660|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56551661|NCT00630513|Ampicillin|ampicillin|mesh-list
56551734|NCT04202536|Tenofovir|tenofovir|mesh-list
56551735|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
56551743|NCT02794402|Exenatide|exenatide|mesh-list
56551807|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
56551808|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551809|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56551879|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
56551953|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56551954|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552026|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56552027|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56552098|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
56552099|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56552170|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
56552171|NCT03561376|Emollients|emollients|mesh-ancestor
56552245|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56552246|NCT00630981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56552247|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
56552317|NCT02852577|Clonazepam|clonazepam|mesh-list
56552318|NCT02852577|Paroxetine|paroxetine|mesh-list
56552393|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56552394|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552480|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
56552545|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56552547|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56552550|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56552622|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
56552698|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
56552699|NCT00656929|Vitamins|vitamins|mesh-ancestor
56552704|NCT00884221|Menotropins|menotropins|mesh-list
56552774|NCT00212836|Asenapine|asenapine|mesh-list
56552848|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56552922|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552923|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
56552924|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
56552925|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56552926|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56552927|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
56552928|NCT01328626|Venetoclax|venetoclax|mesh-list
56552929|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56552930|NCT01212770|Thalidomide|thalidomide|mesh-list
56552931|NCT01212770|Apremilast|apremilast|mesh-list
56552991|NCT04318652|Hormones|hormones|mesh-ancestor
56552992|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56553064|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
56553065|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553141|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
56553210|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
56553214|NCT00665743|Naproxen|naproxen|mesh-list
56553284|NCT00666055|Etravirine|etravirine|mesh-list
56553358|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56553359|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56553431|NCT00657943|Insulin|insulin|mesh-list
56553506|NCT01210352|Narcotics|narcotics|mesh-ancestor
56553600|NCT02838940|Cefazolin|cefazolin|mesh-list
56553674|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
56553748|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56553749|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
56553823|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56553824|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553895|NCT00669721|Heparin|heparin|mesh-list
56553970|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56553971|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554045|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56554046|NCT02885441|Ketorolac|ketorolac|mesh-list
56554048|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56554116|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56554117|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56554190|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
56554191|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
56554262|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
56554267|NCT01157117|Omalizumab|omalizumab|mesh-list
56554338|NCT02832700|Caseins|caseins|mesh-list
56554414|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
56554557|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
56554632|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554633|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554704|NCT05660278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56554777|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56554849|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
56554924|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56554925|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56554926|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56555072|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
56555150|NCT01203878|Imiquimod|imiquimod|mesh-list
56555222|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56555223|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555224|NCT00680641|Simvastatin|simvastatin|mesh-list
56555295|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56555296|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
56555297|NCT00912145|Alprazolam|alprazolam|mesh-list
56555298|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56555301|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56555367|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
56555446|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
56555515|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56555521|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56555586|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56555587|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
56555661|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56555662|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56555663|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56555733|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
56555735|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
56555806|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56555881|NCT05658640|Antiemetics|antiemetics|mesh-ancestor
56555954|NCT00678457|Olanzapine|olanzapine|mesh-list
56556028|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56556029|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56556030|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56556031|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
56556032|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556033|NCT00685009|Hormones|hormones|mesh-list
56556034|NCT00685009|Progesterone|progesterone|mesh-list
56556035|NCT00685009|Estrogens|estrogens|mesh-list
56556037|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56556096|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
56556098|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556169|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56556320|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56556393|NCT02810782|Phenobarbital|phenobarbital|mesh-list
56556467|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
56556469|NCT04237090|Cetirizine|cetirizine|mesh-list
56556470|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56556543|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
56556544|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
56556546|NCT00683137|Valdecoxib|valdecoxib|mesh-list
56556616|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56556765|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56556840|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56556912|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56556987|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56557061|NCT05538052|Narcotics|narcotics|mesh-ancestor
56557062|NCT05538052|Analgesics|analgesics|mesh-ancestor
56557134|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56557148|NCT02800486|Cetuximab|cetuximab|mesh-list
56557211|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56557284|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56557285|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56557293|NCT02799316|Antibodies|antibodies|mesh-list
56557356|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56557431|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
56557506|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56509535|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56509610|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509917|NCT01204294|Hormones|hormones|mesh-ancestor
56509918|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509990|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510061|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510139|NCT04546256|Xhance|xhance|mesh-list
56510208|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56510209|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
56510213|NCT01680042|Phenytoin|phenytoin|mesh-list
56510282|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56510355|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56510356|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56510428|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
56510429|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56510430|NCT04528095|Clozapine|clozapine|mesh-list
56510579|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56510652|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56510724|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
56510725|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56510797|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56510870|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56510871|NCT01683552|Fexofenadine|fexofenadine|mesh-list
56510942|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56510948|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
56511015|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56511088|NCT04531475|Lansoprazole|lansoprazole|mesh-list
56511163|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
56511165|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511238|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56511239|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56511240|NCT02887534|Tizanidine|tizanidine|mesh-list
56511311|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
56511313|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56511396|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
56511471|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56511472|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56511473|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511545|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56511620|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56511621|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
56511622|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56511694|NCT02219672|Lamivudine|lamivudine|mesh-list
56511695|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
56511765|NCT04533867|Ondansetron|ondansetron|mesh-list
56511766|NCT04533867|Palonosetron|palonosetron|mesh-list
56511839|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56511840|NCT04532931|Acetaminophen|acetaminophen|mesh-list
56511841|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
56511915|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56511916|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56511917|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56511985|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56512057|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
56512058|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56512206|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56512281|NCT01680107|Cycloserine|cycloserine|mesh-list
56512283|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56512355|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56512364|NCT01680536|Maraviroc|maraviroc|mesh-list
56512428|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
56512446|NCT01602900|Rolipram|rolipram|mesh-list
56512502|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56512503|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56512505|NCT01645748|Cisplatin|cisplatin|mesh-list
56512577|NCT01646567|Calcipotriene|calcipotriene|mesh-list
56512578|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56512579|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56512580|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
56512649|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
56512650|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
56512797|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56512798|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56512890|NCT01609101|Cobalt|cobalt|mesh-list
56512952|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56512953|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56513026|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
56513099|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56513100|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513174|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56513175|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56513176|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56513177|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56513178|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
56513179|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
56513180|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
56513181|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56513185|NCT01684865|Rituximab|rituximab|mesh-list
56513240|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56513383|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56513456|NCT01686659|Analgesics|analgesics|mesh-ancestor
56513457|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
56513531|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
56513606|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
56513607|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
56513679|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513680|NCT01688024|Mitomycins|mitomycins|mesh-list
56513751|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56513757|NCT01316133|Tacrolimus|tacrolimus|mesh-list
56513828|NCT01680965|Ofatumumab|ofatumumab|mesh-list
56513900|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56513901|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56513973|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56514049|NCT04828226|Clonidine|clonidine|mesh-list
56514050|NCT04828226|Analgesics|analgesics|mesh-ancestor
56514063|NCT01331109|Milnacipran|milnacipran|mesh-list
56514121|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514126|NCT01348542|Trazodone|trazodone|mesh-list
56514194|NCT01340625|Norethindrone|norethindrone|mesh-list
56514195|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
56514270|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514271|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56514272|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56514273|NCT01193257|Prednisone|prednisone|mesh-list
56514274|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56514275|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
56514276|NCT01193257|Hormones|hormones|mesh-ancestor
56514277|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56514278|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56514279|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56514280|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56514334|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
56514404|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56514557|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56514631|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
56514632|NCT00591708|Citric Acid|citric acid|mesh-list
56514703|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56514704|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56514778|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
56514779|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56514852|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56514853|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
56514854|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
56514923|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56514925|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56514999|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515000|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
56515001|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56515005|NCT01608698|Drospirenone|drospirenone|mesh-list
56515072|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56515149|NCT00592917|Antacids|antacids|mesh-ancestor
56515150|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515151|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56515221|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56515222|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56515295|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
56515371|NCT02274155|Antibodies|antibodies|mesh-list
56515444|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56515445|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
56515518|NCT00595140|Cabergoline|cabergoline|mesh-list
56515519|NCT00595140|Somatostatin|somatostatin|mesh-list
56515593|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56515665|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56515666|NCT01109173|Analgesics|analgesics|mesh-ancestor
56515738|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56515811|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
56515812|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56515885|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56515961|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
56515962|NCT00107198|Hormones|hormones|mesh-ancestor
56516033|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
56516034|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56516107|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516179|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56516249|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56516250|NCT01357616|Brinzolamide|brinzolamide|mesh-list
56516271|NCT01348763|Maraviroc|maraviroc|mesh-list
56516322|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
56516323|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516396|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56516468|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516469|NCT00623064|Gemcitabine|gemcitabine|mesh-list
56516470|NCT00623064|Lapatinib|lapatinib|mesh-list
56516471|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56516472|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56516473|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
56516474|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516475|NCT00623064|Antiviral Agents|antiviral agents|mesh-ancestor
56516476|NCT00623064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516477|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56516478|NCT00623064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56516479|NCT00623064|Immunologic Factors|immunologic factors|mesh-ancestor
56516480|NCT00623064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56516481|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56516482|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
56516483|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56516484|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
56516485|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
56516523|NCT00601692|Docetaxel|docetaxel|mesh-list
56516524|NCT00601692|Irinotecan|irinotecan|mesh-list
56516597|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56516705|NCT02878837|Midazolam|midazolam|mesh-list
56516747|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516748|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
56516749|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56516750|NCT04407572|Vitamin D|vitamin d|mesh-list
56516751|NCT04407572|Vitamins|vitamins|mesh-list
56516752|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
56516753|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
56516754|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
56516815|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
56516830|NCT00592670|Fluoxetine|fluoxetine|mesh-list
56516885|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
56516960|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56516961|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56517032|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517040|NCT00600626|Insulin|insulin|mesh-list
56517112|NCT01096849|Levofloxacin|levofloxacin|mesh-list
56517181|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56517255|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168060|NCT00357084|Prednisone|prednisone|mesh-list
56517329|NCT00600405|Analgesics|analgesics|mesh-ancestor
56517330|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
56517331|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517401|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
56517405|NCT00601887|Meloxicam|meloxicam|mesh-list
56517473|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517546|NCT05644743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517548|NCT01317615|Carboplatin|carboplatin|mesh-list
56517621|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56517696|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56517697|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517698|NCT01310127|Nepafenac|nepafenac|mesh-list
56517770|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56517771|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56517772|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56517773|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517774|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56517775|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56517776|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517777|NCT01169038|Azithromycin|azithromycin|mesh-list
56517833|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517834|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56517835|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56517836|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
56517837|NCT01114672|Vitamin D|vitamin d|mesh-list
56517838|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56517904|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56517905|NCT01078441|Bortezomib|bortezomib|mesh-list
56517979|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56517980|NCT00626509|Sunitinib|sunitinib|mesh-list
56517981|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56517982|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56517983|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56517984|NCT00626509|Growth Substances|growth substances|mesh-ancestor
56517985|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56517986|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
56517987|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56518044|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518118|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56518135|NCT04746235|Decitabine|decitabine|mesh-list
56518189|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56518264|NCT04972396|Hormones|hormones|mesh-ancestor
56518265|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56518335|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56518408|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
56518409|NCT01308567|Hormones|hormones|mesh-ancestor
56518481|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56518556|NCT00593801|Hematinics|hematinics|mesh-ancestor
56518557|NCT00593879|Mecamylamine|mecamylamine|mesh-list
56518558|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56518627|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518628|NCT00595985|Sorafenib|sorafenib|mesh-list
56518631|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518779|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
56518781|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56518854|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
56518857|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56518929|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
56518930|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
56518931|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
56518932|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
56518933|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56518934|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56518935|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56518936|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56518937|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56518938|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56518939|NCT00600587|Gemcitabine|gemcitabine|mesh-list
56518998|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519072|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56519073|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519074|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519171|NCT01301001|Gabapentin|gabapentin|mesh-list
56519172|NCT01301001|Analgesics|analgesics|mesh-ancestor
56519173|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
56519174|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56519175|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56519176|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
56519177|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56519178|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56519179|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267279|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56519180|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56519181|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56519182|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56519183|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519184|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519185|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
56519186|NCT01035463|Cytarabine|cytarabine|mesh-list
56519187|NCT01035463|Rituximab|rituximab|mesh-list
56519188|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56519189|NCT01035463|Etoposide|etoposide|mesh-list
56519190|NCT01035463|Lenalidomide|lenalidomide|mesh-list
56519191|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
56519192|NCT01035463|Melphalan|melphalan|mesh-list
56519193|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
56519194|NCT01035463|Carmustine|carmustine|mesh-list
56519195|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
56519196|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56519197|NCT01035463|Antibodies|antibodies|mesh-list
56519198|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
56519219|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
56519291|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56519292|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56519367|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56519368|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56519442|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
56519516|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
56519517|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56519590|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56519591|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56519592|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56519593|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
56519594|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56519595|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519596|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
56519597|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56519598|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
56519599|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
56519600|NCT01312961|Hormones|hormones|mesh-ancestor
56519629|NCT01309997|Rituximab|rituximab|mesh-list
56519656|NCT05644301|Minocycline|minocycline|mesh-list
56519723|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56519724|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56519795|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56519796|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56519866|NCT01029535|Protective Agents|protective agents|mesh-ancestor
56519867|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56519869|NCT01028053|Flutemetamol|flutemetamol|mesh-list
56519940|NCT01294449|Methotrexate|methotrexate|mesh-list
56519941|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56520010|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
56520011|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56520017|NCT01290315|Dextrans|dextrans|mesh-list
56520084|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56520087|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
56520163|NCT01020019|Hormones|hormones|mesh-ancestor
56520233|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56520236|NCT01287039|Reslizumab|reslizumab|mesh-list
56520319|NCT01280955|Plerixafor|plerixafor|mesh-list
56520384|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520438|NCT01313676|Xhance|xhance|mesh-list
56520460|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56520462|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
56520533|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56520534|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
56520607|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56520608|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56520610|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56520679|NCT01011907|Varenicline|varenicline|mesh-list
56520680|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56520755|NCT05657925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56520756|NCT05657925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56520775|NCT01005901|Bromides|bromides|mesh-list
56520826|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56520827|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56269019|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56520901|NCT01011283|Decitabine|decitabine|mesh-list
56520974|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
56520975|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56520976|NCT01003639|Narcotics|narcotics|mesh-ancestor
56521046|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521047|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56521122|NCT05340465|Hematinics|hematinics|mesh-ancestor
56269316|NCT01988961|Golimumab|golimumab|mesh-list
56521272|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56521274|NCT04320225|Hormones|hormones|mesh-ancestor
56521345|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56521420|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521425|NCT05640804|Dasatinib|dasatinib|mesh-list
56521493|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56521494|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521567|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56521641|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56521715|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56521790|NCT02876146|Albendazole|albendazole|mesh-list
56521864|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56521865|NCT02889822|Alprostadil|alprostadil|mesh-list
56521867|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
56521933|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
56521934|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56521936|NCT04640896|Lidocaine|lidocaine|mesh-list
56522004|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56522154|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56522155|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522156|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56522227|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522375|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56522450|NCT05642624|Amphotericin B|amphotericin b|mesh-list
56522451|NCT05642624|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56522452|NCT05642624|Deoxycholic Acid|deoxycholic acid|mesh-list
56522453|NCT05642624|Amebicides|amebicides|mesh-ancestor
56522529|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56522530|NCT01299584|Narcotics|narcotics|mesh-ancestor
56522531|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56522532|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522533|NCT01299584|Analgesics|analgesics|mesh-ancestor
56522534|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
56522535|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56522536|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
56522537|NCT01236573|Fludarabine|fludarabine|mesh-list
56522538|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56522539|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
56522551|NCT04322760|Lidocaine|lidocaine|mesh-list
56522591|NCT01299272|Serotonin|serotonin|mesh-list
56522661|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522662|NCT01056718|Nebivolol|nebivolol|mesh-list
56522663|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56522664|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
56522665|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56522666|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56522667|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56522668|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
56522669|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522671|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522728|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56522729|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
56522730|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56522731|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522732|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
56522733|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
56522734|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56522735|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522736|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522737|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
56522738|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56522792|NCT04481256|Paclitaxel|paclitaxel|mesh-list
56522793|NCT04481256|Carboplatin|carboplatin|mesh-list
56522794|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56522795|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522796|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56522797|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56522798|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56522799|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522800|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
56522801|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
56522802|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56522803|NCT03434418|Osimertinib|osimertinib|mesh-list
56522804|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56522805|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56522806|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56522807|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56522808|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
56522809|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56522810|NCT03377478|Velpatasvir|velpatasvir|mesh-list
56522811|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
56522812|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522848|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56522996|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523069|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56523070|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56523071|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
56523072|NCT01052272|Protective Agents|protective agents|mesh-ancestor
56523073|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523074|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56523075|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
56523076|NCT01257204|Interferons|interferons|mesh-list
56523078|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
56523079|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
56523080|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56523081|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523082|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
56523083|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56523084|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
56523085|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523086|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
56523087|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523088|NCT01231581|Gemcitabine|gemcitabine|mesh-list
56523089|NCT01231581|Trametinib|trametinib|mesh-list
56523091|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
56523125|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56523126|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
56523127|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56523128|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
56523129|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56523130|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523131|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56523132|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56523133|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523199|NCT01001377|Cetuximab|cetuximab|mesh-list
56523264|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
56523265|NCT01002547|Pioglitazone|pioglitazone|mesh-list
56523266|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
56523267|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523268|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56523269|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
56168454|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523270|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523271|NCT01002547|Protective Agents|protective agents|mesh-ancestor
56523329|NCT01294670|Etoposide|etoposide|mesh-list
56523330|NCT01294670|Vorinostat|vorinostat|mesh-list
56523331|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56523332|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523333|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56523334|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56523335|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523336|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523337|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56523338|NCT01006603|Glimepiride|glimepiride|mesh-list
56523393|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56523394|NCT02869321|Narcotics|narcotics|mesh-ancestor
56523395|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56523396|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523397|NCT02869321|Analgesics|analgesics|mesh-ancestor
56523398|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
56523399|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523400|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56168476|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56523401|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56523457|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523458|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523459|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56523460|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523461|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56523462|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56523463|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56523464|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56523465|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523466|NCT01224171|Vedolizumab|vedolizumab|mesh-list
56523467|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56523520|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523521|NCT01019980|Acetaminophen|acetaminophen|mesh-list
56523522|NCT01019980|Diclofenac|diclofenac|mesh-list
56523523|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56271657|NCT02004509|Anticoagulants|anticoagulants|mesh-list
56523524|NCT01019980|Analgesics|analgesics|mesh-ancestor
56523525|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
56523526|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523527|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523528|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
56523529|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56523530|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56523531|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56523532|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56523533|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56523534|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523535|NCT00993499|Sirolimus|sirolimus|mesh-list
56523536|NCT00993499|Afatinib|afatinib|mesh-list
56523653|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56523654|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56523728|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523729|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523730|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56523731|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
56523732|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
56523733|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56523734|NCT04566328|Dexamethasone|dexamethasone|mesh-list
56523735|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
56523736|NCT04566328|Lenalidomide|lenalidomide|mesh-list
56523737|NCT04566328|Bortezomib|bortezomib|mesh-list
56523738|NCT04566328|Daratumumab|daratumumab|mesh-list
56523739|NCT04566328|Ichthammol|ichthammol|mesh-list
56523740|NCT04566328|BB 1101|bb 1101|mesh-list
56523791|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
56523792|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
56523793|NCT00989833|Hormones|hormones|mesh-ancestor
56523794|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56523795|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56523796|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56523797|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56523861|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56523862|NCT00985621|Narcotics|narcotics|mesh-ancestor
56523936|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
56523937|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56523938|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
56523939|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56523940|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523941|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56523942|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
56523943|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
56523944|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56523945|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
56523946|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56523947|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523948|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56523949|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56523950|NCT00982657|Sunitinib|sunitinib|mesh-list
56523951|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56523952|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56523953|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56523954|NCT00982657|Growth Substances|growth substances|mesh-ancestor
56523955|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56523991|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
56523992|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56523993|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56523994|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56523995|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523996|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
56523998|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56523999|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56524000|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
56524001|NCT04290793|Trastuzumab|trastuzumab|mesh-list
56524002|NCT04290793|Epirubicin|epirubicin|mesh-list
56524004|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56524005|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
56524006|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524007|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524008|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56524009|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
56524010|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524011|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524012|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56524013|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524014|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56524015|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56524016|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56524042|NCT00981409|Fondaparinux|fondaparinux|mesh-list
56524043|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
56524044|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56524045|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56524046|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524047|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56524048|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
56524049|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56524050|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
56524051|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524052|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
56524053|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56524054|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
56524055|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56524056|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
56524057|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524058|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524059|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
56524060|NCT01008748|Nicotine|nicotine|mesh-list
56524099|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56524173|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56524174|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
56524175|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524176|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56524177|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56524178|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56524179|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56524180|NCT01002820|Ganaxolone|ganaxolone|mesh-list
56524181|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
56524182|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524183|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524184|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524185|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
56524186|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
56524187|NCT01012258|Cetuximab|cetuximab|mesh-list
56524188|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524189|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524190|NCT00628810|Leucovorin|leucovorin|mesh-list
56524191|NCT00628810|Bevacizumab|bevacizumab|mesh-list
56524192|NCT00628810|Fluorouracil|fluorouracil|mesh-list
56524193|NCT00628810|Irinotecan|irinotecan|mesh-list
56524194|NCT00628810|Calcium|calcium|mesh-list
56524195|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
56524196|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524197|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524226|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524227|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524228|NCT01011868|Empagliflozin|empagliflozin|mesh-list
56524229|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56524230|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524231|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56524232|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524233|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
56524234|NCT04290013|Norethindrone|norethindrone|mesh-list
56524235|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
56524236|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56524237|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56524238|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524239|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
56524286|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524287|NCT04288765|Dexamethasone|dexamethasone|mesh-list
56524288|NCT04288765|Lenalidomide|lenalidomide|mesh-list
56524289|NCT04288765|Daratumumab|daratumumab|mesh-list
56524290|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56524291|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
56524292|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
56524293|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524294|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524295|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56524296|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
56524297|NCT04288765|Hormones|hormones|mesh-ancestor
56524298|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56524299|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56524347|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
56524348|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
56524349|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56272485|NCT05777369|Hormones|hormones|mesh-ancestor
56524350|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56524351|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
56524352|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524353|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524354|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524355|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524356|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56524357|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524358|NCT00977665|Rasagiline|rasagiline|mesh-list
56524359|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56524360|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524361|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524362|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56524363|NCT00977665|Protective Agents|protective agents|mesh-ancestor
56524364|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524365|NCT04298008|Durvalumab|durvalumab|mesh-list
56524366|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524367|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524368|NCT00628342|Esomeprazole|esomeprazole|mesh-list
56524369|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56524370|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56524371|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56524372|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524373|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524374|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
56524392|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
56524393|NCT00624429|Hormones|hormones|mesh-ancestor
56524394|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56524395|NCT01001572|Amlodipine|amlodipine|mesh-list
56524396|NCT01001572|Valsartan|valsartan|mesh-list
56524397|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56524398|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56524399|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524400|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524401|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56524402|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524403|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
56524404|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56524406|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
56524453|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524454|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56524524|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56524525|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524526|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56524527|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524528|NCT01001104|Dulaglutide|dulaglutide|mesh-list
56524529|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56524530|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524531|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
56524532|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
56524533|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56524534|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56524535|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56524536|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56524537|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524538|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524539|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524540|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56524543|NCT01204671|Vaccines|vaccines|mesh-list
56524580|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
56524581|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524582|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524583|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56524584|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524585|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56524586|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56524587|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524588|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56524589|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56524590|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524591|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
56524592|NCT01200069|Ibuprofen|ibuprofen|mesh-list
56524593|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56524594|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56524595|NCT01200069|Analgesics|analgesics|mesh-ancestor
56524596|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
56524597|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524598|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524599|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56524600|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524601|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56524602|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524604|NCT01199289|Brodalumab|brodalumab|mesh-list
56524632|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56524633|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56524634|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56524635|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524636|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56524637|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56524639|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
56524697|NCT03933163|Protective Agents|protective agents|mesh-ancestor
56524698|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524699|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56524700|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56524702|NCT00977197|Analgesics|analgesics|mesh-ancestor
56524703|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
56524704|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524705|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524706|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
56524707|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56524708|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56524711|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56524760|NCT01196091|Antimalarials|antimalarials|mesh-list
56524761|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56524762|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56524763|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56524764|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56524765|NCT01196091|Analgesics|analgesics|mesh-ancestor
56524766|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
56524767|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56524829|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56524830|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
56524831|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524832|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524833|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524834|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56524835|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56524836|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56524837|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56524838|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56524839|NCT01193283|Cyclosporine|cyclosporine|mesh-list
56524892|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56524893|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56524894|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
56524895|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524896|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56524897|NCT01307111|Misoprostol|misoprostol|mesh-list
56524898|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56524899|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
56524900|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56524901|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524902|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56524903|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56524904|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
56524955|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56524956|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
56524957|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
56524958|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
56524959|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
56524960|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56524961|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524962|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
56524963|NCT02887443|Protective Agents|protective agents|mesh-ancestor
56524964|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
56524965|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56524966|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56524967|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56524968|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56524969|NCT05655273|Tacrolimus|tacrolimus|mesh-list
56524977|NCT01305941|Everolimus|everolimus|mesh-list
56525016|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56525017|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56525018|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525019|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525020|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56525021|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
56525022|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525081|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
56525082|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56525083|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
56525084|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525085|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525086|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
56525087|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273228|NCT04565483|Benralizumab|benralizumab|mesh-list
56525088|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56525089|NCT01302899|Ramipril|ramipril|mesh-list
56525090|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525091|NCT01302899|Diuretics|diuretics|mesh-ancestor
56525092|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
56525093|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525094|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56525095|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56525096|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525097|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56525098|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
56525099|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525100|NCT01187901|Sulindac|sulindac|mesh-list
56525115|NCT01302119|Tavaborole|tavaborole|mesh-list
56525133|NCT05643677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525134|NCT05643677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525135|NCT02890589|Chromium|chromium|mesh-list
56525136|NCT02890589|Everolimus|everolimus|mesh-list
56525137|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525138|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56525139|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
56525140|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525141|NCT02890589|Trace Elements|trace elements|mesh-ancestor
56525142|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
56525198|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525199|NCT01289990|Incretins|incretins|mesh-ancestor
56525200|NCT01289990|Hormones|hormones|mesh-ancestor
56525201|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525202|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56525203|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
56525204|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525205|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525206|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56525207|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56525208|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56525209|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56525222|NCT01300247|Fludarabine|fludarabine|mesh-list
56525257|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525258|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56525259|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525260|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56525261|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56525262|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56525263|NCT01183221|Oxytocin|oxytocin|mesh-list
56525264|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
56525265|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56525266|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525267|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56525268|NCT01183143|Hormones|hormones|mesh-ancestor
56525269|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56525320|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525321|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56525322|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
56525323|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56525324|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56525325|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56525326|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56525327|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56525328|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
56525329|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56525330|NCT01182207|Diuretics|diuretics|mesh-ancestor
56525384|NCT01180647|Naltrexone|naltrexone|mesh-list
56525385|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56525386|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56525387|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525388|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
56525389|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525390|NCT03692065|Apixaban|apixaban|mesh-list
56525391|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56525392|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
56525393|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56525394|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
56168555|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
56525395|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56525396|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525397|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
56525398|NCT01178853|Warfarin|warfarin|mesh-list
56525399|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56525400|NCT01178853|Pitavastatin|pitavastatin|mesh-list
56525401|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56525402|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56525439|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525514|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525515|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56525516|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56525517|NCT03661723|Growth Substances|growth substances|mesh-ancestor
56525518|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525519|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
56525520|NCT00629863|Fluorouracil|fluorouracil|mesh-list
56525521|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525522|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
56525523|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525565|NCT00998296|Nintedanib|nintedanib|mesh-list
56525577|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525578|NCT01178073|Urological Agents|urological agents|mesh-ancestor
56525579|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525580|NCT00997984|Guanfacine|guanfacine|mesh-list
56525581|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56525582|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56525583|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56525584|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56525585|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
56525795|NCT01298531|Analgesics|analgesics|mesh-ancestor
56525873|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
56525943|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56525944|NCT01296035|Panitumumab|panitumumab|mesh-list
56525945|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56525946|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56525947|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
56525948|NCT01294787|Bromides|bromides|mesh-list
56525949|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
56525950|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56525951|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
56525952|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56525953|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56525954|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56526007|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526008|NCT01292837|Levetiracetam|levetiracetam|mesh-list
56526009|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
56526010|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
56526011|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56526012|NCT00965731|Crizotinib|crizotinib|mesh-list
56526013|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526014|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56526015|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526016|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526017|NCT03248479|Azacitidine|azacitidine|mesh-list
56526018|NCT03248479|Magrolimab|magrolimab|mesh-list
56526020|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
56526070|NCT04315155|Belinostat|belinostat|mesh-list
56526071|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526142|NCT05569382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56526143|NCT05569382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56526144|NCT05569382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56526145|NCT05569382|Adrenergic Agents|adrenergic agents|mesh-ancestor
56526146|NCT05569382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526147|NCT00963547|Trastuzumab|trastuzumab|mesh-list
56526149|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526150|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526151|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56526152|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526153|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526154|NCT01285310|Thalidomide|thalidomide|mesh-list
56526155|NCT01285310|Apremilast|apremilast|mesh-list
56526156|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56526157|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56526204|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56526205|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56526206|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56526207|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526208|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526209|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
56526210|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56526211|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
56526227|NCT01292603|Rituximab|rituximab|mesh-list
56526270|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526271|NCT01290341|Naftifine|naftifine|mesh-list
56526272|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
56526273|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526274|NCT01290263|Bevacizumab|bevacizumab|mesh-list
56526275|NCT01290263|Trebananib|trebananib|mesh-list
56526276|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526277|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526278|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56526279|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56526280|NCT01290263|Growth Substances|growth substances|mesh-ancestor
56168636|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56526281|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526282|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
56526283|NCT01290029|Cinacalcet|cinacalcet|mesh-list
56526284|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526285|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526286|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56526326|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56526327|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56526328|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
56526329|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526330|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56526331|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56526332|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526333|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
56526334|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526335|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56526342|NCT01288079|Analgesics|analgesics|mesh-ancestor
56526388|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526389|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526390|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526391|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526392|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
56526393|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56526394|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56526395|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
56526396|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56526397|NCT01166763|Vitamin D|vitamin d|mesh-list
56526398|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
56526399|NCT01166763|Vitamins|vitamins|mesh-ancestor
56526400|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
56526401|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526402|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56526403|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526404|NCT02885961|Dabigatran|dabigatran|mesh-list
56526405|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
56526406|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56526442|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
56526443|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526444|NCT02860819|Antiviral Agents|antiviral agents|mesh-ancestor
56526445|NCT02860819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56526446|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526447|NCT02860819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526448|NCT02860819|Immunologic Factors|immunologic factors|mesh-ancestor
56526449|NCT02860819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526450|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56526451|NCT04284007|Dexamethasone|dexamethasone|mesh-list
56526452|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
56526454|NCT04284007|BB 1101|bb 1101|mesh-list
56526508|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526580|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526582|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
56526652|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526653|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526654|NCT03202849|Vitamin D|vitamin d|mesh-list
56526655|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
56526656|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
56526657|NCT03202849|Vitamins|vitamins|mesh-list
56526658|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
56526659|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526660|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56526661|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526662|NCT04277533|Calcium|calcium|mesh-list
56526663|NCT04277533|Bilirubin|bilirubin|mesh-list
56526664|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56526665|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526666|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
56526667|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526668|NCT04277533|Protective Agents|protective agents|mesh-ancestor
56526669|NCT02445391|Cisplatin|cisplatin|mesh-list
56526710|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56526711|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526712|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56526713|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526714|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526715|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56526716|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56526717|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
56526718|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56526719|NCT02140255|Ritonavir|ritonavir|mesh-list
56526720|NCT02140255|Lopinavir|lopinavir|mesh-list
56526721|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
56526722|NCT02140255|Nevirapine|nevirapine|mesh-list
56526723|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56526724|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56526725|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56526726|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
56526727|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526767|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56526768|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56526769|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56526770|NCT00953017|Bisacodyl|bisacodyl|mesh-list
56526771|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56526772|NCT00953017|Lubiprostone|lubiprostone|mesh-list
56526773|NCT00953017|Cathartics|cathartics|mesh-ancestor
56526774|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56526775|NCT00953017|Laxatives|laxatives|mesh-ancestor
56526776|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56526777|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526778|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526779|NCT00955357|Lacosamide|lacosamide|mesh-list
56526780|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
56526781|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56526782|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56526783|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56526815|NCT02857465|Dsuvia|dsuvia|mesh-list
56526826|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56526827|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56526828|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526829|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
56526830|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526831|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526832|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
56526833|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
56526891|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526892|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56526893|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56526894|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526895|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526896|NCT01962415|Fludarabine|fludarabine|mesh-list
56526897|NCT01962415|Melphalan|melphalan|mesh-list
56526898|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
56526899|NCT01962415|Thiotepa|thiotepa|mesh-list
56526900|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
56526901|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56526902|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56526903|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56526904|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
56526905|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56526906|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56526907|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
56526908|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56526909|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56526910|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
56526911|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56526912|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56526913|NCT02860663|Vitamin D|vitamin d|mesh-list
56527022|NCT01232790|Antidotes|antidotes|mesh-ancestor
56527251|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56527474|NCT04268563|Metformin|metformin|mesh-list
56527544|NCT01147497|Misoprostol|misoprostol|mesh-list
56527941|NCT04312347|Tamoxifen|tamoxifen|mesh-list
56527988|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
56528166|NCT00934843|Hormones|hormones|mesh-ancestor
56528298|NCT04322240|Vitamins|vitamins|mesh-ancestor
56528740|NCT01217814|Protective Agents|protective agents|mesh-ancestor
56528888|NCT01133379|Fluorides|fluorides|mesh-list
56528963|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56277221|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
56529184|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529258|NCT01127763|Carboplatin|carboplatin|mesh-list
56529715|NCT01269125|Leuprolide|leuprolide|mesh-list
56529792|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56529867|NCT05534087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529868|NCT01261793|Epratuzumab|epratuzumab|mesh-list
56529869|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56529870|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56529871|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
56529873|NCT04321655|Ibuprofen|ibuprofen|mesh-list
56530164|NCT01256879|Cimetidine|cimetidine|mesh-list
56530240|NCT01256411|Diuretics|diuretics|mesh-ancestor
56530314|NCT01123395|Colchicine|colchicine|mesh-list
56530460|NCT02868814|Analgesics|analgesics|mesh-ancestor
56530922|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56530923|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
56530924|NCT01259492|Methylphenidate|methylphenidate|mesh-list
56530926|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56531074|NCT03918278|Paclitaxel|paclitaxel|mesh-list
56531226|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56531300|NCT01259102|Analgesics|analgesics|mesh-ancestor
56531388|NCT01204398|Amlodipine|amlodipine|mesh-list
56531596|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56531597|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56531598|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56531599|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
56531600|NCT01254656|Efavirenz|efavirenz|mesh-list
56531601|NCT01254656|Etravirine|etravirine|mesh-list
56531602|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56531603|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56531745|NCT01108731|Milnacipran|milnacipran|mesh-list
56531916|NCT01106625|Metformin|metformin|mesh-list
56334961|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
56335113|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
56335196|NCT00071838|Daclizumab|daclizumab|mesh-list
56335415|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56335490|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335565|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56335637|NCT00072540|Celecoxib|celecoxib|mesh-list
56335638|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56335639|NCT00072540|Mitogens|mitogens|mesh-list
56335710|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56335786|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56335787|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
56335788|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56335789|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56335857|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56335858|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56335933|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336010|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56336011|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
56336086|NCT00040586|Antibodies|antibodies|mesh-list
56336087|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56336088|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
56336089|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56336157|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336158|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56336162|NCT00208312|Adenosine|adenosine|mesh-list
56336227|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56336301|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
56336302|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56336375|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56336376|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56336377|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336448|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336525|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
56336600|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56336605|NCT00073164|Olanzapine|olanzapine|mesh-list
56336674|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56336752|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56336753|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56336825|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56336899|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
56336900|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
56336972|NCT00213109|Miglitol|miglitol|mesh-list
56337045|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337046|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
56337047|NCT00214240|Antibodies|antibodies|mesh-list
56337117|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56337190|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55958982|NCT00232505|Cetuximab|cetuximab|mesh-list
56337261|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
56337262|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337263|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337333|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337408|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
56337409|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
56337410|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56337411|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
56337412|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337413|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337414|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56337415|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
56337416|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56337417|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
56337418|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337419|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56337420|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56337421|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
56337422|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
56337423|NCT00041561|Protective Agents|protective agents|mesh-ancestor
56337470|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
56337471|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56337472|NCT00217048|Yohimbine|yohimbine|mesh-list
56337542|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337543|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
56337614|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337686|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56337687|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337760|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56337834|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337907|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56337908|NCT00042575|Analgesics|analgesics|mesh-ancestor
56337909|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
56337910|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56337911|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
56337912|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56337913|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
56337914|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56337973|NCT00220480|Antidepressive Agents|antidepressive agents|mesh-ancestor
56337974|NCT00220480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56338048|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56338120|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338191|NCT00042965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338192|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56338193|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
56338264|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56338265|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56338267|NCT00123370|Modafinil|modafinil|mesh-list
56338334|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
56338337|NCT00124111|Fluorouracil|fluorouracil|mesh-list
56338407|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56338408|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56338479|NCT00124384|Modafinil|modafinil|mesh-list
56338486|NCT00077883|Cisplatin|cisplatin|mesh-list
56338553|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56338554|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56338625|NCT00043394|Trastuzumab|trastuzumab|mesh-list
56338626|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56338627|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338698|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56338699|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338772|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338773|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56338774|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56338775|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
56338776|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338777|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56338778|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56338779|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
56338780|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56338781|NCT00126100|Lenograstim|lenograstim|mesh-list
56338785|NCT00126139|Abciximab|abciximab|mesh-list
56338837|NCT00126373|Bupropion|bupropion|mesh-list
56338838|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55960627|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56338856|NCT00043706|Antibodies|antibodies|mesh-list
56338907|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
56338908|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56338909|NCT00126646|Antibodies|antibodies|mesh-list
56338910|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
56338911|NCT00126646|Immunotoxins|immunotoxins|mesh-list
56338914|NCT00126763|Fentanyl|fentanyl|mesh-list
56338980|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56338981|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56338986|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
56339050|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56339051|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339052|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56339053|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56339054|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56339055|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56339056|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56339057|NCT00127777|Amantadine|amantadine|mesh-list
56339058|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56339115|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56339116|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
56339117|NCT00402766|Hormones|hormones|mesh-ancestor
56339187|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56339261|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56339262|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56339266|NCT00044525|Taxane|taxane|mesh-list
56339335|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339336|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
56339409|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
56339410|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339411|NCT00078858|Cyclosporine|cyclosporine|mesh-list
56339412|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
56339413|NCT00078858|Fludarabine|fludarabine|mesh-list
56339482|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
56339483|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339484|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339550|NCT04321408|Protective Agents|protective agents|mesh-ancestor
56339551|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56339622|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
56339623|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
56339624|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56339697|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56339702|NCT03948568|Tamoxifen|tamoxifen|mesh-list
56339771|NCT00075231|Efavirenz|efavirenz|mesh-list
56339772|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56339773|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56339774|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
56339775|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56339776|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339777|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56339778|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56339779|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
56339780|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56339791|NCT00403312|Nicotine|nicotine|mesh-list
56339834|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56339846|NCT00045539|Vitamins|vitamins|mesh-ancestor
56339911|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
56340066|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56340217|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
56340287|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56340288|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56340291|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
56340362|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56340363|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56340364|NCT00403819|Laxatives|laxatives|mesh-ancestor
56340447|NCT00132613|Bleomycin|bleomycin|mesh-list
56340512|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56340513|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56340584|NCT00133354|Hormones|hormones|mesh-list
56340586|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340656|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56340657|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56340658|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56340730|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56340748|NCT00134095|Irinotecan|irinotecan|mesh-list
56340815|NCT00134173|Atorvastatin|atorvastatin|mesh-list
56340881|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56341030|NCT00134875|Narcotics|narcotics|mesh-ancestor
56341031|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56341105|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56341106|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
56341180|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56341254|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341255|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341329|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56341330|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341403|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341404|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56170286|NCT03017820|Interferons|interferons|mesh-list
56341475|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56341551|NCT00147355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56341626|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
56341627|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
56341653|NCT00147784|Ribavirin|ribavirin|mesh-list
56341701|NCT00148018|Bortezomib|bortezomib|mesh-list
56341702|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56341703|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
56341704|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
56341708|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
56341773|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341786|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
56341844|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56341846|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56341847|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56341915|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963703|NCT00425477|Bexarotene|bexarotene|mesh-list
56341988|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56341989|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
56341990|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56341991|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56341993|NCT00149578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56341994|NCT00149578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56341995|NCT00149578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56341996|NCT00149578|Immunologic Factors|immunologic factors|mesh-ancestor
56341997|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56341998|NCT00149578|Antidotes|antidotes|mesh-ancestor
56341999|NCT00149578|Protective Agents|protective agents|mesh-ancestor
56342000|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
56342001|NCT00149578|Vitamins|vitamins|mesh-ancestor
56342052|NCT00049088|Antibodies|antibodies|mesh-list
56342053|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
56342128|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342138|NCT00082251|Simvastatin|simvastatin|mesh-list
56342202|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342203|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56342214|NCT00150436|Pregabalin|pregabalin|mesh-list
56342273|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
56342274|NCT00150748|Levetiracetam|levetiracetam|mesh-list
56342275|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
56342276|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
56342349|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56342423|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
56342424|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56342425|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56342492|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56342568|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56342569|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342598|NCT04725253|Niacin|niacin|mesh-list
56342642|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342643|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
56342717|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56342718|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56342765|NCT00152581|Ribavirin|ribavirin|mesh-list
56342792|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56342797|NCT00050141|Tipifarnib|tipifarnib|mesh-list
56342865|NCT00152893|Niacin|niacin|mesh-list
56342875|NCT00152893|Vitamins|vitamins|mesh-ancestor
56342939|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343011|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56343086|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343160|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56343161|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343230|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343231|NCT00154414|Incretins|incretins|mesh-ancestor
56343232|NCT00154414|Hormones|hormones|mesh-ancestor
56343234|NCT04705987|Colchicine|colchicine|mesh-list
56343300|NCT00154687|Paclitaxel|paclitaxel|mesh-list
56343301|NCT00154687|Fluorouracil|fluorouracil|mesh-list
56343302|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56343308|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
56343374|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56343375|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56343376|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56343377|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56343378|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
56343379|NCT00154882|Paclitaxel|paclitaxel|mesh-list
56343380|NCT00154882|Cisplatin|cisplatin|mesh-list
56343381|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56343382|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56343383|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
56343384|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
56343385|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
56343438|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343439|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56343440|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56343661|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56343662|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
56343743|NCT00158158|Nicotine|nicotine|mesh-list
56343824|NCT00158782|Lapatinib|lapatinib|mesh-list
56343889|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
56343966|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56343967|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
56343968|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56343969|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56343970|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343971|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56343972|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56343973|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56343974|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56343975|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56343976|NCT00159718|Amlodipine|amlodipine|mesh-list
56343977|NCT00159718|Atorvastatin|atorvastatin|mesh-list
56343978|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56343979|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56343980|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
56343981|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56343982|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56343984|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56344022|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56344173|NCT00160966|Tacrolimus|tacrolimus|mesh-list
56344174|NCT00160966|Cyclosporins|cyclosporins|mesh-list
56344175|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56344190|NCT00052559|Bevacizumab|bevacizumab|mesh-list
56344247|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344248|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56344249|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344317|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344318|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56344392|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
56344393|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56344408|NCT00053105|Hormones|hormones|mesh-ancestor
56344467|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344468|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56344469|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344539|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56344540|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56344608|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56344610|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56344681|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56344754|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56344755|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
56344756|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56344831|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56344832|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56344905|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55991276|NCT04771156|Analgesics|analgesics|mesh-ancestor
56344984|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56345058|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56345133|NCT00054197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56345209|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56345210|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345211|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345212|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345213|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345280|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345281|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
56345298|NCT00054587|Docetaxel|docetaxel|mesh-list
56345355|NCT00054626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56345430|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
56345431|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
56345502|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
56345503|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
56345579|NCT00169000|Capecitabine|capecitabine|mesh-list
56345580|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56345599|NCT00169039|Clozapine|clozapine|mesh-list
56345654|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56345728|NCT00407641|Tinzaparin|tinzaparin|mesh-list
56345729|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56345730|NCT00407641|Dalteparin|dalteparin|mesh-list
56345806|NCT00170404|Protective Agents|protective agents|mesh-ancestor
56345876|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56345950|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56345951|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
56345952|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346022|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56346096|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346097|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56346170|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
56346171|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346172|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56346173|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56346174|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
56346176|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346242|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346247|NCT00056030|Antidotes|antidotes|mesh-ancestor
56346310|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
56346311|NCT00174304|Amlodipine|amlodipine|mesh-list
56346312|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56346313|NCT00174304|Atorvastatin|atorvastatin|mesh-list
56346379|NCT00056225|Vitamins|vitamins|mesh-list
56346457|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56346458|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56346459|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56346534|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346535|NCT00175513|Valacyclovir|valacyclovir|mesh-list
56346536|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
56346607|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56346608|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56346609|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56346679|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56346680|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56346681|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346682|NCT00056693|Sunitinib|sunitinib|mesh-list
56346750|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
56346824|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56346825|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346826|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346894|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56346897|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
56346964|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
56346965|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56346966|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56346967|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
56346968|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
56346969|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56346970|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56346971|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56346972|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56346973|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56346974|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56346975|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56346976|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
56346977|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
56347024|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
56347025|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56347026|NCT00408382|Atorvastatin|atorvastatin|mesh-list
56347027|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56347028|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56347029|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
56347031|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56347093|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347094|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56347095|NCT00179881|Thalidomide|thalidomide|mesh-list
56347241|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56347245|NCT00181558|Atrasentan|atrasentan|mesh-list
56347313|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56347317|NCT00182104|Warfarin|warfarin|mesh-list
56347389|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56347390|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56347391|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
56347392|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347393|NCT00182650|Aldesleukin|aldesleukin|mesh-list
56347394|NCT00182650|Rituximab|rituximab|mesh-list
56347395|NCT00182650|Fludarabine|fludarabine|mesh-list
56347396|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
56347397|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56347456|NCT00183235|Aripiprazole|aripiprazole|mesh-list
56347457|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
56347532|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
56347533|NCT00183820|Antiviral Agents|antiviral agents|mesh-ancestor
56347534|NCT00183820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56347539|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
56347603|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56347604|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56347675|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
56347752|NCT00185107|Ezetimibe|ezetimibe|mesh-list
56347753|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56347754|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56347755|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56347824|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56347825|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347896|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
56347897|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
56347898|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56347899|NCT00185887|Terbutaline|terbutaline|mesh-list
56347969|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56347970|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56347971|NCT00186823|Antibodies|antibodies|mesh-list
56348046|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348048|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
56348121|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348122|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
56348128|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
56348197|NCT00187915|Cyclosporine|cyclosporine|mesh-list
56348198|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
56348199|NCT00187915|Tacrolimus|tacrolimus|mesh-list
56348200|NCT00187915|Cyclosporins|cyclosporins|mesh-list
56348270|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
56348271|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348272|NCT00188383|Amantadine|amantadine|mesh-list
56348285|NCT02969447|Oxytocin|oxytocin|mesh-list
56348341|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
56348342|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56348417|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56348418|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56348419|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
56348489|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348565|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348638|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348639|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56348640|NCT00047307|Antiviral Agents|antiviral agents|mesh-ancestor
56348641|NCT00047307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56348707|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348708|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348716|NCT00190840|Pemetrexed|pemetrexed|mesh-list
56348774|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991293|NCT03086356|Dabigatran|dabigatran|mesh-list
56348846|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56348847|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56348848|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
56348849|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56348854|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56348912|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56348986|NCT00059852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56348987|NCT00059852|Immunologic Factors|immunologic factors|mesh-ancestor
56348988|NCT00059852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56348989|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56348990|NCT00047580|Tizanidine|tizanidine|mesh-list
56348991|NCT00047580|Analgesics|analgesics|mesh-ancestor
56348992|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
56348993|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56349054|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
56349131|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56349132|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349133|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
56349134|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
56349135|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349136|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349137|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56349138|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56349139|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349198|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56349199|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349200|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56349201|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
56349266|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
56349267|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56349268|NCT00194272|Methotrexate|methotrexate|mesh-list
56349269|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56349270|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
56349271|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56349272|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349409|NCT00195481|Sirolimus|sirolimus|mesh-list
56349482|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349558|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56349559|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349708|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56349709|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56349710|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
56349711|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56349777|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56349778|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56349779|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56349780|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56349783|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56349846|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56349917|NCT00084708|Gefitinib|gefitinib|mesh-list
56349918|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56349991|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56349992|NCT00198523|Protective Agents|protective agents|mesh-ancestor
56349993|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56349994|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56349995|NCT00198562|Losartan|losartan|mesh-list
56349996|NCT00198562|Amlodipine|amlodipine|mesh-list
56349997|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
56350061|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56350062|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
56350063|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350064|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56350131|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350206|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56350207|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56350280|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56350281|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56350282|NCT00200512|Apomorphine|apomorphine|mesh-list
56350283|NCT00200512|Emetics|emetics|mesh-ancestor
56350356|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56350357|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56350359|NCT00200941|Topiramate|topiramate|mesh-list
56350429|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56350503|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
56350504|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
56350577|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56350578|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56350652|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
56350726|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56350798|NCT00223717|Losartan|losartan|mesh-list
56350799|NCT00223717|Metoprolol|metoprolol|mesh-list
56350800|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56350801|NCT00223717|Clonidine|clonidine|mesh-list
56350802|NCT00223717|Eplerenone|eplerenone|mesh-list
56350803|NCT00223717|Nebivolol|nebivolol|mesh-list
56350804|NCT00223717|Bosentan|bosentan|mesh-list
56350805|NCT00223717|Diltiazem|diltiazem|mesh-list
56350806|NCT00223717|Guanfacine|guanfacine|mesh-list
56350807|NCT00223717|Prazosin|prazosin|mesh-list
56350808|NCT00223717|Hydralazine|hydralazine|mesh-list
56350866|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
56350867|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56350941|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56351016|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
56351017|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
56351018|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
56351019|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
56351085|NCT00062270|Gemcitabine|gemcitabine|mesh-list
56351086|NCT00062270|Docetaxel|docetaxel|mesh-list
56351087|NCT00062270|Gefitinib|gefitinib|mesh-list
56351160|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56351161|NCT00225043|Protective Agents|protective agents|mesh-ancestor
56351162|NCT00095355|Valproic Acid|valproic acid|mesh-list
56351235|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56351307|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56351308|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56351385|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351386|NCT00226096|Analgesics|analgesics|mesh-ancestor
56351457|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56351458|NCT00062660|Tipranavir|tipranavir|mesh-list
56351459|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56351460|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56351461|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
56351462|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56351463|NCT00413296|Levetiracetam|levetiracetam|mesh-list
56351464|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
56351465|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
56351466|NCT00413452|Etanercept|etanercept|mesh-list
56351467|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56351468|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56351469|NCT00413452|Analgesics|analgesics|mesh-ancestor
56351478|NCT00095823|Aripiprazole|aripiprazole|mesh-list
56351520|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56351521|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351522|NCT00399243|Sumatriptan|sumatriptan|mesh-list
56351523|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56351592|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56351593|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56351594|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
56351666|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56351670|NCT00227812|Bupropion|bupropion|mesh-list
56351738|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56351739|NCT00228046|Valproic Acid|valproic acid|mesh-list
56351740|NCT00228046|Methylphenidate|methylphenidate|mesh-list
56351741|NCT00228046|Amphetamine|amphetamine|mesh-list
56351813|NCT00096525|Growth Substances|growth substances|mesh-ancestor
56351814|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
56351815|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56351816|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
56351886|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
56351887|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56351889|NCT00228904|Insulin|insulin|mesh-list
56351957|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56351958|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56351971|NCT00075699|Mitomycins|mitomycins|mesh-list
56352028|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56352029|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352030|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352031|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
56352032|NCT00096720|Protective Agents|protective agents|mesh-ancestor
56352097|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352171|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352172|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56352246|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56352247|NCT02967614|Dorzolamide|dorzolamide|mesh-list
56352248|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56352321|NCT00231595|Topiramate|topiramate|mesh-list
56352325|NCT00231634|Topiramate|topiramate|mesh-list
56352395|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56352396|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
56352397|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352405|NCT00063791|Bortezomib|bortezomib|mesh-list
56352469|NCT00097266|Aripiprazole|aripiprazole|mesh-list
56352470|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
56352471|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
56352472|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56352473|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56352539|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56352540|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
56352618|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352691|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56352692|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56352766|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56352767|NCT00233662|Alefacept|alefacept|mesh-list
56352768|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56352841|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56352842|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56352843|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
56352844|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56352845|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56352846|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56352847|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56352905|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
56352982|NCT00400491|Vitamins|vitamins|mesh-list
56352983|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
56352984|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56352987|NCT00235105|Adalimumab|adalimumab|mesh-list
56353054|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56353055|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56353056|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56353127|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56353128|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353201|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353205|NCT00236626|Topiramate|topiramate|mesh-list
56353279|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56353353|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56353354|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56353355|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56353356|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
56353427|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353428|NCT00398684|Nevirapine|nevirapine|mesh-list
56353429|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56353498|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
56353499|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353504|NCT00238147|Docetaxel|docetaxel|mesh-list
56353574|NCT00238459|Vaccines|vaccines|mesh-list
56353648|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
56353649|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353722|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56353723|NCT00239278|Prednisolone|prednisolone|mesh-list
56353724|NCT00239278|Budesonide|budesonide|mesh-list
56353744|NCT00239395|Meloxicam|meloxicam|mesh-list
56353795|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
56170969|NCT01724424|Melatonin|melatonin|mesh-list
56353796|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353797|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56353798|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56353799|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56353800|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56353801|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56353802|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56353803|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
56353804|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
56353805|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56353806|NCT00076674|Levodopa|levodopa|mesh-list
56353807|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56353808|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56353809|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
56353851|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
56353926|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
56353927|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56353928|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56353998|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
56353999|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354000|NCT04720807|Letrozole|letrozole|mesh-list
56354072|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354144|NCT00066443|Docetaxel|docetaxel|mesh-list
56354145|NCT00066443|Epirubicin|epirubicin|mesh-list
56354146|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354147|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
56354148|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
56354219|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56354220|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
56354221|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354222|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354223|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56354225|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
56354226|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
56354227|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56354228|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354286|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56354287|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354362|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56354363|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
56354364|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354365|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354366|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
56354367|NCT00242944|Atorvastatin|atorvastatin|mesh-list
56354368|NCT00242944|Pitavastatin|pitavastatin|mesh-list
56354369|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56354370|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56354371|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
56354372|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354373|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56354374|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56354375|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56354422|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354423|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354494|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56354495|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
56354568|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56354569|NCT00099489|Interferons|interferons|mesh-list
56354643|NCT00245206|Risperidone|risperidone|mesh-list
56354644|NCT00245206|Aripiprazole|aripiprazole|mesh-list
56354645|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56354719|NCT00245596|Urological Agents|urological agents|mesh-ancestor
56354792|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354866|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56354867|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
56354868|NCT00102882|Hormones|hormones|mesh-ancestor
56354869|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56354870|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
56354871|NCT00246220|Methylphenidate|methylphenidate|mesh-list
56354872|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56354873|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354874|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56354875|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56354880|NCT00424801|Nicorandil|nicorandil|mesh-list
56354929|NCT00246532|Narcotics|narcotics|mesh-ancestor
56354930|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56354931|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56354932|NCT00246532|Analgesics|analgesics|mesh-ancestor
56355003|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
56355004|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56355005|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56355006|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
56355072|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355073|NCT00248131|Octreotide|octreotide|mesh-list
56355077|NCT00248209|Bupropion|bupropion|mesh-list
56355145|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355146|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355147|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56355148|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56355149|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56355150|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56355151|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56355152|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
56355153|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56355154|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56355155|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355156|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56355157|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
56355158|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355204|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355205|NCT00249574|Analgesics|analgesics|mesh-ancestor
56355279|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355280|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
56355281|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355282|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56355350|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355423|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56355424|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355498|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
56355499|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
56355500|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355501|NCT00100074|Lobeline|lobeline|mesh-list
56355567|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355568|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56355569|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56355570|NCT02966522|Growth Substances|growth substances|mesh-ancestor
56355571|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
56355572|NCT00251485|Cetuximab|cetuximab|mesh-list
56355573|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355574|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355575|NCT00251524|Bevacizumab|bevacizumab|mesh-list
56355576|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
56355577|NCT00251524|Pemetrexed|pemetrexed|mesh-list
56355578|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56355579|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355580|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56355581|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56355582|NCT00251524|Growth Substances|growth substances|mesh-ancestor
56355627|NCT02961166|Antibodies|antibodies|mesh-list
56355630|NCT00103818|Gaboxadol|gaboxadol|mesh-list
56355703|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355704|NCT00103935|Exenatide|exenatide|mesh-list
56355708|NCT00103935|Incretins|incretins|mesh-ancestor
56355775|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56355776|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355777|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
56355778|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56355779|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355780|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56355781|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56355782|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355783|NCT00252889|Doxorubicin|doxorubicin|mesh-list
56355784|NCT00252889|Topotecan|topotecan|mesh-list
56355785|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
56355786|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56355787|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56355788|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56355834|NCT00253318|Everolimus|everolimus|mesh-list
56355835|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56355836|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
56355837|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
55991351|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56355838|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56355839|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56355904|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56355905|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56355906|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56355907|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56355908|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56355909|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
56355910|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355911|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56355912|NCT00253591|Vinorelbine|vinorelbine|mesh-list
56355915|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
56355969|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56355970|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56355971|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56355972|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
56355973|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56355974|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56355975|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56355976|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56355977|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56355978|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
56356034|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356035|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56356036|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
56356037|NCT00104403|Hormones|hormones|mesh-ancestor
56356038|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356039|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356041|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
56356103|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
56356104|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356105|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356106|NCT00104442|Rivastigmine|rivastigmine|mesh-list
56356107|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56356108|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356109|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356110|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
56356111|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56356112|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356113|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56356114|NCT00104442|Protective Agents|protective agents|mesh-ancestor
56356115|NCT00255385|Micronutrients|micronutrients|mesh-list
56356116|NCT00255385|Trace Elements|trace elements|mesh-list
56356117|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356118|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56356119|NCT00255424|Hematinics|hematinics|mesh-ancestor
56356161|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56356162|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356163|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56356164|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
56356165|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356166|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
56356167|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356168|NCT00070148|Megestrol|megestrol|mesh-list
56356231|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356232|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56356233|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56356234|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356235|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356237|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356238|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56356239|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
56356240|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356241|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
56356242|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356243|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56356244|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
56356293|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56356294|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
56356295|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56356296|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56356297|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56356298|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56356299|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356300|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
56356358|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356360|NCT00104715|Goserelin|goserelin|mesh-list
56356361|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
56356362|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356363|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
56356364|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
56356365|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
56356366|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356367|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56356424|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56356425|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
56356426|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
56356427|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356428|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356429|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56356430|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
56356431|NCT04709185|Hormones|hormones|mesh-ancestor
56356432|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356487|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356488|NCT00257140|Renal Agents|renal agents|mesh-ancestor
56356489|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56356490|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56356491|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56356492|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356493|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356494|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356495|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56356551|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
56356552|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56356553|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
56356554|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356555|NCT00257530|Imiquimod|imiquimod|mesh-list
56356556|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56356557|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
56356558|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56356559|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356560|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
56356561|NCT00257569|Cetirizine|cetirizine|mesh-list
56356562|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56356563|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56356613|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56356614|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
56356615|NCT00070733|Testosterone|testosterone|mesh-list
56356616|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
56356617|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
56356618|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56356619|NCT00070733|Androgens|androgens|mesh-ancestor
56356620|NCT00070733|Hormones|hormones|mesh-ancestor
56356621|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356680|NCT00258388|Prednisone|prednisone|mesh-list
56356681|NCT00258388|Docetaxel|docetaxel|mesh-list
56356682|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56356683|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
56356684|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
56356685|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
56356686|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356687|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56356688|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
56356689|NCT00258388|Hormones|hormones|mesh-ancestor
56356690|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56356693|NCT00101088|Sirolimus|sirolimus|mesh-list
56356745|NCT00258739|Antiviral Agents|antiviral agents|mesh-ancestor
56356746|NCT00258739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56356747|NCT00258739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56356748|NCT00258739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56356817|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
56356818|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56356821|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
56356888|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
56356889|NCT00259792|Hormones|hormones|mesh-ancestor
56356963|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56356964|NCT00260611|Docetaxel|docetaxel|mesh-list
56357038|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357039|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357114|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
56357124|NCT00261820|Hormones|hormones|mesh-ancestor
56357191|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
56357192|NCT00262210|Etoposide|etoposide|mesh-list
56357193|NCT00262210|Epirubicin|epirubicin|mesh-list
56357194|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56357195|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
56357196|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357197|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56357198|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56357199|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
56357200|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357201|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357202|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56357203|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56357204|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56357206|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357249|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
56357250|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357251|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357320|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56357321|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357322|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56357323|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56357389|NCT00072527|Etoposide|etoposide|mesh-list
56357466|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357467|NCT00101829|Rituximab|rituximab|mesh-list
56357468|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56357536|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56357537|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357541|NCT00265408|Aspirin|aspirin|mesh-list
56357609|NCT00415831|Levodopa|levodopa|mesh-list
56357610|NCT00415831|Carbidopa|carbidopa|mesh-list
56357685|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56357686|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56357687|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56357688|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56357689|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56357690|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357691|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56357692|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56357750|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56357751|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56357752|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
56357824|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
56357825|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56357828|NCT00268216|Xhance|xhance|mesh-list
56357897|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357971|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56357972|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56358041|NCT00106821|Bromides|bromides|mesh-list
56358042|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
56358115|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358117|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56358188|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56358189|NCT00074204|Gemcitabine|gemcitabine|mesh-list
56358190|NCT00074204|Carboplatin|carboplatin|mesh-list
56358191|NCT00074204|Docetaxel|docetaxel|mesh-list
56358192|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358193|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56358194|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
56358195|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358196|NCT00074204|Antiviral Agents|antiviral agents|mesh-ancestor
56358251|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358253|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56358254|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56358255|NCT00269854|Infliximab|infliximab|mesh-list
56358256|NCT00269854|Antibodies|antibodies|mesh-list
56358257|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
56358258|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56358259|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
56358260|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358319|NCT00107016|Everolimus|everolimus|mesh-list
56358320|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358321|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56358322|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56358323|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56358324|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358325|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56358326|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
56358327|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56358386|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358387|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56358459|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358460|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358461|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
56358529|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56358530|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
56358607|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358676|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358749|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358757|NCT00273871|Tacrolimus|tacrolimus|mesh-list
56358822|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56358823|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
56358824|NCT00274105|Telmisartan|telmisartan|mesh-list
56358825|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56358826|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56358827|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56358828|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56358829|NCT00274144|Telmisartan|telmisartan|mesh-list
56358834|NCT00108186|Celecoxib|celecoxib|mesh-list
56358882|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56358883|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56358884|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56358885|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
55996498|NCT03746002|Metolazone|metolazone|mesh-list
56358953|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56358985|NCT00277342|Insulin|insulin|mesh-list
56359026|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
56359027|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56359028|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
55996883|NCT00980174|Denosumab|denosumab|mesh-list
56359031|NCT00075452|Antiviral Agents|antiviral agents|mesh-ancestor
56359096|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56359097|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359098|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
56359168|NCT00108771|Narcotics|narcotics|mesh-ancestor
56359169|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359170|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359171|NCT00108771|Analgesics|analgesics|mesh-ancestor
56359172|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
56359241|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
56359242|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359243|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359311|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
56359312|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
56359313|NCT00075998|Interferons|interferons|mesh-list
56359314|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
56359316|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
56359384|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
56359386|NCT00280033|Antacids|antacids|mesh-ancestor
56359457|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56359458|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359459|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981338|NCT02646839|Biotin|biotin|mesh-list
56359529|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56359530|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56359597|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56359670|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56359671|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359744|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
56359745|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56359746|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56359817|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56359818|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56359819|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359820|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
56359821|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
56359822|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56359823|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56359880|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56359881|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56359882|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
56359883|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56359887|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
56359946|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56359947|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56359948|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
56359949|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56359950|NCT00283309|Protective Agents|protective agents|mesh-ancestor
56359951|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56359952|NCT00417157|Ganirelix|ganirelix|mesh-list
56359953|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
56360017|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56360018|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56360019|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360020|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56360021|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56360023|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
56360086|NCT00284791|Lamotrigine|lamotrigine|mesh-list
56360087|NCT00284791|Sertraline|sertraline|mesh-list
56360088|NCT00284791|Fluoxetine|fluoxetine|mesh-list
56360089|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
56360090|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56360091|NCT00284791|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56360092|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56360093|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56360094|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360151|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56360152|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360153|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
56360154|NCT00425035|Panitumumab|panitumumab|mesh-list
56360155|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56360156|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360157|NCT00110760|Lidocaine|lidocaine|mesh-list
56360217|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56360218|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360219|NCT00285727|Ropinirole|ropinirole|mesh-list
56360290|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360291|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360312|NCT00286273|Heparin|heparin|mesh-list
56360361|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56360362|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
56360363|NCT00111072|Hormones|hormones|mesh-ancestor
56360433|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56360434|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
56360435|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56360438|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
56360505|NCT00287209|Amiodarone|amiodarone|mesh-list
56360578|NCT00077987|Growth Substances|growth substances|mesh-ancestor
56360579|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360652|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56360653|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56360654|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56360655|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360656|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
56360724|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360725|NCT00288535|Sirolimus|sirolimus|mesh-list
56360726|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56360727|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360729|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56360796|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56360798|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56360799|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360800|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56360864|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56360865|NCT00078260|Pemetrexed|pemetrexed|mesh-list
56360874|NCT00290602|Prednisolone|prednisolone|mesh-list
56360939|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56360940|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56360941|NCT00290719|Irinotecan|irinotecan|mesh-list
56360942|NCT00290719|Gefitinib|gefitinib|mesh-list
56360949|NCT00290836|Thrombin|thrombin|mesh-list
56361010|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361011|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
56361085|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56361086|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
56361161|NCT00275197|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56361162|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56361163|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56361165|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361231|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56361232|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
56361233|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
56361234|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56361301|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
56361302|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361303|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56361304|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361305|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
56361376|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
56361377|NCT00119340|Cyclosporins|cyclosporins|mesh-list
56361378|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56361379|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56361380|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
56361382|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56361446|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56361447|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56361448|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56361449|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361450|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
56361451|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56361452|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
56361453|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56361512|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56361586|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56361587|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56361588|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56361589|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56361659|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
56361660|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56361733|NCT00299650|Atracurium|atracurium|mesh-list
56361807|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56361808|NCT00418171|Olanzapine|olanzapine|mesh-list
56361809|NCT00418171|Ziprasidone|ziprasidone|mesh-list
56361810|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
56361880|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56361881|NCT00300196|Ancrod|ancrod|mesh-list
56361953|NCT00300664|Hormones|hormones|mesh-list
56361954|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56361956|NCT04718038|Cetuximab|cetuximab|mesh-list
56362022|NCT00301210|Tramadol|tramadol|mesh-list
56362023|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56362024|NCT00301210|Narcotics|narcotics|mesh-ancestor
56362025|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56362026|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362027|NCT00301210|Analgesics|analgesics|mesh-ancestor
56362030|NCT00080327|Aripiprazole|aripiprazole|mesh-list
56362092|NCT00080444|Ondansetron|ondansetron|mesh-list
56362093|NCT00080444|Aprepitant|aprepitant|mesh-list
56362094|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
56362166|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56362167|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
56362241|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56362242|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362243|NCT00080678|Docetaxel|docetaxel|mesh-list
56362244|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
56362245|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362246|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
56362247|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
56362248|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
56362249|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362250|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56362251|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362306|NCT00202189|Budesonide|budesonide|mesh-list
56362307|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56362308|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56362309|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
56362310|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362311|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362312|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56362313|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
56362375|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362376|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
56362381|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
56362451|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56362452|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56362453|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56362454|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
56362455|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56362456|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56362457|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
56362458|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56362459|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56362460|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56362461|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
56362462|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56362514|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56362526|NCT00087165|Prednisone|prednisone|mesh-list
56362585|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56362660|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56362661|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56362734|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56362735|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56362736|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56362805|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56362807|NCT00081848|Celecoxib|celecoxib|mesh-list
56362882|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56362883|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
56362884|NCT00304018|Hormones|hormones|mesh-ancestor
56362885|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56362907|NCT00304135|Gemcitabine|gemcitabine|mesh-list
56362952|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
56362953|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56362954|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363021|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56363095|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56363096|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
56363097|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363099|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56363166|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363239|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56363240|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
56363242|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56363312|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56363313|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363326|NCT00307411|Hormones|hormones|mesh-list
56363385|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
56363386|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363457|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56363458|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56363459|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56363460|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363461|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56363462|NCT00120822|Folic Acid|folic acid|mesh-list
56363530|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
56363607|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
56363608|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
56363753|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56363827|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
56363828|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56363829|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56363831|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56363899|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
56363900|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
56363974|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364046|NCT00311389|Travoprost|travoprost|mesh-list
56364047|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56364048|NCT00311389|Latanoprost|latanoprost|mesh-list
56364119|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56364124|NCT00311857|Cetuximab|cetuximab|mesh-list
56364193|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364194|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56364195|NCT00089115|Rituximab|rituximab|mesh-list
56171485|NCT02242656|Analgesics|analgesics|mesh-ancestor
56364269|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56364345|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56364419|NCT00423969|Antidepressive Agents|antidepressive agents|mesh-ancestor
56364420|NCT00423969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56364493|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56364494|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56364566|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
56364656|NCT00295165|Sargramostim|sargramostim|mesh-list
56364657|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
56364658|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56364659|NCT00295243|Topotecan|topotecan|mesh-list
56364729|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56364807|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
56364881|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56364882|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56364953|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
56364954|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56364955|NCT00297349|Topiramate|topiramate|mesh-list
56364956|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
56365027|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
56365028|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56365101|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
56365102|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56365173|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
56365175|NCT00314080|Antitoxins|antitoxins|mesh-list
56365251|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
56365252|NCT00323011|Hematinics|hematinics|mesh-ancestor
56365253|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
56365254|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56365325|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56365399|NCT00313105|Lobeline|lobeline|mesh-list
56365400|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56365475|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56365476|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56365477|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56365478|NCT00314314|Insulin|insulin|mesh-list
56365479|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56365545|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56365546|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56365619|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
56365620|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
56365621|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
56365622|NCT00314743|Dexamethasone|dexamethasone|mesh-list
56365623|NCT00314743|Ondansetron|ondansetron|mesh-list
56365690|NCT00091104|Fludarabine|fludarabine|mesh-list
56365691|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
56365717|NCT00313534|Masoprocol|masoprocol|mesh-list
56365762|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
56365763|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56365834|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56365858|NCT04542278|Prednisone|prednisone|mesh-list
56365919|NCT03878524|Sunitinib|sunitinib|mesh-list
56365920|NCT03878524|Daunorubicin|daunorubicin|mesh-list
56365921|NCT03878524|Venetoclax|venetoclax|mesh-list
56365922|NCT03878524|Dasatinib|dasatinib|mesh-list
56365923|NCT03878524|Olaparib|olaparib|mesh-list
56365996|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
56365997|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
56366000|NCT00122889|Allicin|allicin|mesh-list
56366068|NCT00314977|Doxorubicin|doxorubicin|mesh-list
56366069|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56366070|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56366071|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
56366072|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56366140|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
56366212|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
56366286|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56366296|NCT04716868|Levan|levan|mesh-list
56366361|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
56366362|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56366435|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56366512|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56366513|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56366586|NCT03272477|Tamoxifen|tamoxifen|mesh-list
56366662|NCT00123669|Progesterone|progesterone|mesh-list
56366736|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56366737|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
56366809|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56366810|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56366813|NCT00329095|Travoprost|travoprost|mesh-list
56366884|NCT00329446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56366885|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
56366886|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56366955|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56367030|NCT00330577|Latanoprost|latanoprost|mesh-list
56367031|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
56367102|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56367178|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
56367179|NCT00317746|Citalopram|citalopram|mesh-list
56367180|NCT00317746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56367184|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56367250|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
56367251|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367260|NCT00093366|Etanercept|etanercept|mesh-list
56367323|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367397|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56367467|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367468|NCT02959879|Folfirinox|folfirinox|mesh-list
56367469|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367470|NCT04717609|Ropivacaine|ropivacaine|mesh-list
56367537|NCT00325858|Tramadol|tramadol|mesh-list
56367538|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56367539|NCT00325858|Narcotics|narcotics|mesh-ancestor
56367611|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56367682|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367683|NCT00326131|Taxane|taxane|mesh-list
56367684|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367755|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56367756|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56367757|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56367826|NCT00085553|Tipifarnib|tipifarnib|mesh-list
56367827|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56367901|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56367902|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56367903|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56367904|NCT00320125|Calcium|calcium|mesh-list
56367973|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56367974|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56367975|NCT00327184|PENTA|penta|mesh-list
56367980|NCT00419302|Insulin|insulin|mesh-list
56368044|NCT00320827|Antibodies|antibodies|mesh-list
56368045|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
56368046|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368047|NCT00320983|Topotecan|topotecan|mesh-list
56368048|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56368049|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56368050|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56368051|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368110|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56368111|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56368112|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56368113|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
56368114|NCT05458492|Sirolimus|sirolimus|mesh-list
56368115|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368116|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368123|NCT00086333|Docetaxel|docetaxel|mesh-list
56368179|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56368180|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56368181|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
56368184|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56368251|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56368252|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56368256|NCT00086606|Omalizumab|omalizumab|mesh-list
56368322|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56368323|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
56368396|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56368397|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56368398|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
56368399|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56368400|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56368401|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368402|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56368403|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56368464|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
56368465|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368466|NCT00322114|Protective Agents|protective agents|mesh-ancestor
56368535|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56368536|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
56368607|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
56368608|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368682|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56368685|NCT00331045|Alvimopan|alvimopan|mesh-list
56368756|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368757|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56368829|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368904|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56368905|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
56368906|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56368907|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56368972|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56368973|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56368974|NCT00332059|Timolol|timolol|mesh-list
56368975|NCT00332059|Bimatoprost|bimatoprost|mesh-list
56368976|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56368977|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56368978|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
56368979|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368980|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368981|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368982|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56368983|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56368984|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56368985|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56368986|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56368987|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
56368988|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56368989|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56368990|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368991|NCT00332137|Urological Agents|urological agents|mesh-ancestor
56368992|NCT00126789|Fentanyl|fentanyl|mesh-list
56368993|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56368994|NCT00126789|Narcotics|narcotics|mesh-ancestor
56368995|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56368996|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56368997|NCT00126789|Analgesics|analgesics|mesh-ancestor
56369020|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369021|NCT00087854|Amonafide|amonafide|mesh-list
56369022|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369023|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
56369092|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56369093|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56369094|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56369105|NCT00332995|Dapivirine|dapivirine|mesh-list
56369163|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
56369164|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56369165|NCT00088556|Paclitaxel|paclitaxel|mesh-list
56369166|NCT00088556|Carboplatin|carboplatin|mesh-list
56369173|NCT00127140|Vorinostat|vorinostat|mesh-list
56369237|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56369238|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56369246|NCT00421018|Montelukast|montelukast|mesh-list
56369307|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
56369310|NCT00334321|Paclitaxel|paclitaxel|mesh-list
56369382|NCT00127569|Rituximab|rituximab|mesh-list
56369383|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56369384|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369388|NCT00334594|Pemetrexed|pemetrexed|mesh-list
56369455|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369456|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56369457|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369458|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
56369459|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
56369526|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
56369528|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56369529|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
56369530|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
56369598|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56369599|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56369600|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56369672|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
56369673|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56369675|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
56369747|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369748|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56369749|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56369750|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56369818|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56369819|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
56369893|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
56369894|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
56369895|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56369965|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370039|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56370111|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56370112|NCT00128232|Octreotide|octreotide|mesh-list
56370113|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56370114|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56370115|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370116|NCT04708249|Inositol|inositol|mesh-list
56370117|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
56370118|NCT04708249|Vitamins|vitamins|mesh-ancestor
56370119|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
56370180|NCT00090428|Caseins|caseins|mesh-list
56370181|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
56370182|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
56370183|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370251|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56370252|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56370309|NCT00346879|PENTA|penta|mesh-list
56370327|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
56370328|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370329|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370401|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370402|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56370403|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370404|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56370473|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56370474|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56370475|NCT00126048|Atorvastatin|atorvastatin|mesh-list
56370476|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56370477|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56370478|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
56370479|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370480|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56370481|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56370482|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370483|NCT00126087|Dopamine|dopamine|mesh-list
56370484|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56370534|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370535|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370536|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370537|NCT00126204|Doxycycline|doxycycline|mesh-list
56370538|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56370539|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370540|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
56370541|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56370542|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56370543|NCT04705402|Mannitol|mannitol|mesh-list
56370601|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
56370674|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56370675|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
56370683|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
56370748|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56370749|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56370750|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56370751|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370752|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370753|NCT00427102|Cisplatin|cisplatin|mesh-list
56370754|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370755|NCT00427414|Daunorubicin|daunorubicin|mesh-list
56370814|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56370815|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56370816|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
56370817|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56370818|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370819|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370820|NCT00427882|Urological Agents|urological agents|mesh-ancestor
56370821|NCT04704622|Midazolam|midazolam|mesh-list
56370822|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
56370823|NCT04704622|Ketamine|ketamine|mesh-list
56370824|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56370878|NCT00428272|Lexatumumab|lexatumumab|mesh-list
56370879|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56370880|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56370881|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
56370882|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56370883|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
56171836|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
56370884|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56370946|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56370947|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56370948|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56370949|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56370950|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56370951|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56370952|NCT00092339|Analgesics|analgesics|mesh-ancestor
56370953|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
56371011|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371012|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371081|NCT00093509|Mesna|mesna|mesh-list
56371087|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371088|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56371089|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
56371090|NCT00093509|Protective Agents|protective agents|mesh-ancestor
56371091|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371092|NCT00093548|Vaccines|vaccines|mesh-list
56371093|NCT00093548|Sargramostim|sargramostim|mesh-list
56371096|NCT05549895|Dexamethasone|dexamethasone|mesh-list
56371155|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56371156|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56371157|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56371158|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56371159|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56371160|NCT00093665|Fluorouracil|fluorouracil|mesh-list
56371161|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371162|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
56371163|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371170|NCT00093704|Bortezomib|bortezomib|mesh-list
56371221|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56371223|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371224|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371225|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
56371226|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371227|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371228|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
56371229|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371230|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
56371231|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56371232|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56371233|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56371234|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56371283|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371284|NCT00094484|Cinacalcet|cinacalcet|mesh-list
56371285|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56371286|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371287|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56371288|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
56371289|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371290|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
56371348|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56371349|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371350|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56371351|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371352|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56371353|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56371354|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
56371355|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371356|NCT00403338|Sirolimus|sirolimus|mesh-list
56371414|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56371415|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56371416|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56371417|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56371418|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371420|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371421|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371422|NCT00095459|Bevacizumab|bevacizumab|mesh-list
56371423|NCT00095459|Sorafenib|sorafenib|mesh-list
56371424|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56371478|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56371479|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371480|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
56371482|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
56371550|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56371551|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371552|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56371553|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
56371554|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56371555|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
56371556|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371557|NCT00095927|Paclitaxel|paclitaxel|mesh-list
56371558|NCT00095927|Carboplatin|carboplatin|mesh-list
56371616|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56371617|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
56371618|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
56371619|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
56371620|NCT00429871|Docetaxel|docetaxel|mesh-list
56371688|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
56371689|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56371690|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371691|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371692|NCT00096083|Melphalan|melphalan|mesh-list
56371693|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56371694|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
56371695|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371696|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371697|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56371698|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371699|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
56371700|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371748|NCT00096395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56371749|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371750|NCT00096395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56371821|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56371822|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56371823|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
56371824|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56371825|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
56371826|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56371827|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
56371828|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371830|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56371831|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
56371832|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56371833|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56371834|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56371835|NCT00430924|Diuretics|diuretics|mesh-ancestor
56371837|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56371838|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
56371839|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
56371879|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56371880|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
56371881|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56371882|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56371951|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56371952|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56371953|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56371954|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56371955|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
56371956|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56171959|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372017|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
56372018|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
56372019|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56372020|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56372021|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56372022|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
56372023|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56372024|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372025|NCT00431392|Protective Agents|protective agents|mesh-ancestor
56372026|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56372027|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56372028|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56372078|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56372152|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372153|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
56372154|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372155|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372156|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
56372157|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56372158|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56372159|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56171985|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
56372219|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372220|NCT00097799|Ritonavir|ritonavir|mesh-list
56372221|NCT00097799|Tipranavir|tipranavir|mesh-list
56372222|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56372223|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56372290|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56372291|NCT01580371|CKD-581|ckd-581|mesh-list
56372362|NCT00433225|Ketorolac|ketorolac|mesh-list
56372363|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56372364|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
56372365|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372366|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
56372367|NCT00433225|Hormones|hormones|mesh-ancestor
56372368|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56372369|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372428|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56372429|NCT00433498|Carboplatin|carboplatin|mesh-list
56372430|NCT00433498|Etoposide|etoposide|mesh-list
56372432|NCT00433498|Pravastatin|pravastatin|mesh-list
56372433|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372434|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56372435|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56372436|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56372437|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372439|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56372496|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
56372497|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372498|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372499|NCT00433927|Leucovorin|leucovorin|mesh-list
56372500|NCT00433927|Folic Acid|folic acid|mesh-list
56372501|NCT00433927|Bevacizumab|bevacizumab|mesh-list
56372502|NCT00433927|Cetuximab|cetuximab|mesh-list
56372503|NCT00433927|Irinotecan|irinotecan|mesh-list
56372504|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
56372505|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56372506|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372561|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
56372562|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56372563|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
56372564|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372565|NCT00434005|Protective Agents|protective agents|mesh-ancestor
56372566|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372567|NCT00434005|Antidotes|antidotes|mesh-ancestor
56372570|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56372628|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372629|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56372630|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56372632|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372699|NCT00131703|Amebicides|amebicides|mesh-ancestor
56372700|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56372701|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56372702|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372773|NCT00403728|Cyclosporins|cyclosporins|mesh-list
56372774|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372775|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372776|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372777|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
56372778|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372779|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
56372780|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372781|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
56372782|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372837|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372838|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56372839|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56372840|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56372841|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56372842|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56372843|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56372845|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56372901|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56372902|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
56372903|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56372904|NCT00100100|Modafinil|modafinil|mesh-list
56372905|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56372906|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56372907|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56372908|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56372970|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56372971|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56372972|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56372973|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56372974|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56372975|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56372976|NCT00132561|Artesunate|artesunate|mesh-list
56372977|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
56373036|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
56373037|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
56373038|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373039|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56373040|NCT04728386|Eusol|eusol|mesh-list
56373041|NCT04728386|Curcumin|curcumin|mesh-list
56373042|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56373043|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56373044|NCT04728386|Analgesics|analgesics|mesh-ancestor
56373045|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
56373103|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
56373104|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56373105|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
56373106|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373107|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373108|NCT00132912|Vorapaxar|vorapaxar|mesh-list
56373109|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56373110|NCT00403182|Letrozole|letrozole|mesh-list
56373111|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373112|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56373113|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56373120|NCT00101114|Interferons|interferons|mesh-list
56373168|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373169|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56373170|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56373171|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
56373172|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373173|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373174|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56373175|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
56373176|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
56373178|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56373179|NCT00101231|Alvocidib|alvocidib|mesh-list
56373180|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373181|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
56373228|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56373229|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
56373230|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373298|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56373375|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56373449|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
56373450|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56373451|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56373452|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56373453|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373454|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373455|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56373456|NCT00102635|Fenretinide|fenretinide|mesh-list
56373457|NCT00102635|Lonafarnib|lonafarnib|mesh-list
56373515|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56373516|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
56373518|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373590|NCT00102986|Ritonavir|ritonavir|mesh-list
56373591|NCT00102986|Lopinavir|lopinavir|mesh-list
56373592|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56373593|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56373594|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
56373595|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56373596|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373597|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56373598|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56373599|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
56373604|NCT00136383|Paroxetine|paroxetine|mesh-list
56373657|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56373658|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56373659|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
56373660|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373661|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56373662|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56373663|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
56373664|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56373665|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
56373726|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887724|NCT02989012|Oseltamivir|oseltamivir|mesh-list
56373798|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373799|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373800|NCT00103727|Risperidone|risperidone|mesh-list
56373801|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56373802|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
56373803|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56373804|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373805|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373806|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56373807|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56373808|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56373809|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56373810|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56373861|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
56373862|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56373863|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373873|NCT00136773|Amlodipine|amlodipine|mesh-list
56373929|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56373930|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56373931|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
56373932|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56373933|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56373934|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56373935|NCT00104468|Troxacitabine|troxacitabine|mesh-list
56373936|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56373997|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56373998|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
56373999|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56374001|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
56374069|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
56374070|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
56374071|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
56374072|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56374073|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
56374074|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
56374075|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56374076|NCT00104975|Fludarabine|fludarabine|mesh-list
56374077|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
56374079|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
56374080|NCT00104975|Thiotepa|thiotepa|mesh-list
56374081|NCT00104975|Tacrolimus|tacrolimus|mesh-list
56374082|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374083|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374084|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
56374085|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374086|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374087|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
56374088|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374128|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374129|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374202|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374203|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
56374204|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56374205|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
56374206|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374207|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374208|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56374209|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
56374210|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56374211|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56374212|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56374264|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
56374265|NCT03277495|Nicotine|nicotine|mesh-list
56374267|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
56374339|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374340|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374341|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
56374342|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56374352|NCT00434941|Capecitabine|capecitabine|mesh-list
56374411|NCT00435292|Analgesics|analgesics|mesh-ancestor
56374412|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
56374413|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374414|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374415|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56374416|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56374417|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
56374421|NCT00435331|Verapamil|verapamil|mesh-list
56374479|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374480|NCT00142467|Antiviral Agents|antiviral agents|mesh-ancestor
56374481|NCT00142467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374482|NCT00142467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56374483|NCT00142467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374484|NCT00142467|Immunologic Factors|immunologic factors|mesh-ancestor
56374485|NCT00435955|Rituximab|rituximab|mesh-list
56374491|NCT00436033|Milnacipran|milnacipran|mesh-list
56374550|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
56374622|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56374623|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56374624|NCT00436423|Gemcitabine|gemcitabine|mesh-list
56374625|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56374626|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
56374627|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374628|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56374629|NCT00436423|Antiviral Agents|antiviral agents|mesh-ancestor
56374630|NCT00436423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374688|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56374689|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
56374690|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374691|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
56374759|NCT00438217|Leuprolide|leuprolide|mesh-list
56374760|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56374761|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56374762|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56374763|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
56374827|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56374828|NCT00106886|Folic Acid|folic acid|mesh-list
56374901|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56374902|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374903|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56374904|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56374905|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56374906|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374907|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
56374908|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374909|NCT00439504|Lobeline|lobeline|mesh-list
56374910|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56374911|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
56374912|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56374913|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374914|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56374915|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56374916|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
56374917|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56374918|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56374956|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
56374957|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56374958|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56374959|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
56374960|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56374961|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56374962|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56374963|NCT00107354|Analgesics|analgesics|mesh-ancestor
56374964|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
56374965|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375023|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
56375024|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375025|NCT00105586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56375026|NCT00105586|Antidepressive Agents|antidepressive agents|mesh-ancestor
56375027|NCT00105586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375029|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375030|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56375031|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375032|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375033|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
56375034|NCT00439972|Ortho Evra|ortho evra|mesh-list
56375086|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375087|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375088|NCT00404157|Rituximab|rituximab|mesh-list
56375090|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375155|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375156|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56375230|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56375231|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56375232|NCT00441415|Adapalene|adapalene|mesh-list
56375233|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56375234|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56375235|NCT00441415|Analgesics|analgesics|mesh-ancestor
56375236|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
56375237|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375238|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375239|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375240|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375241|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
56375242|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
56375290|NCT00142974|Tegaserod|tegaserod|mesh-list
56375291|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56375292|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
56375293|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375294|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375295|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375296|NCT00441844|Simvastatin|simvastatin|mesh-list
56375297|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56375299|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
56375300|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375301|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56375355|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56375356|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56375357|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375358|NCT00108095|Ondansetron|ondansetron|mesh-list
56375359|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
56375360|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
56375361|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375362|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375363|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56375364|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
56375365|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
56375366|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56375367|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
56375368|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375369|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375371|NCT00108095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56375372|NCT00108095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56375373|NCT00108095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375411|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56375412|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56375413|NCT00442585|Analgesics|analgesics|mesh-ancestor
56375414|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
56375415|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375416|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375417|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56375418|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56375420|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375476|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56375477|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56375478|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375479|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56375548|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56375549|NCT00108446|Narcotics|narcotics|mesh-ancestor
56375550|NCT00108446|Analgesics|analgesics|mesh-ancestor
56375551|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56375552|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56375553|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
56375554|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56375555|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
56375556|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
56375557|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56375558|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56375559|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375560|NCT00138606|Vildagliptin|vildagliptin|mesh-list
56375561|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56375562|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375563|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56375564|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
56375565|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375566|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375567|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
56375568|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56375569|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
56375602|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
56375603|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56375604|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375605|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
56375606|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56375607|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56375608|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
56375609|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
56375610|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
56375611|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375612|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56375613|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
56375620|NCT04726332|Prednisone|prednisone|mesh-list
56375662|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375663|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56375664|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56375665|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56375666|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
56375667|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56375669|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
56375729|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56375731|NCT03275701|Triumeq|triumeq|mesh-list
56375805|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56375806|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56375807|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
56375808|NCT00139074|Valproic Acid|valproic acid|mesh-list
56375809|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56375810|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
56375811|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56375819|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
56375874|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
56375875|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56375882|NCT00143130|Pregabalin|pregabalin|mesh-list
56375945|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
56375946|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
56375947|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56375948|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56375949|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56375950|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56375951|NCT00109148|Hormones|hormones|mesh-ancestor
56375952|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56375953|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56375954|NCT00452296|Insulin|insulin|mesh-list
56375955|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56375957|NCT00452569|Thalidomide|thalidomide|mesh-list
56376003|NCT00109226|Growth Substances|growth substances|mesh-ancestor
56376004|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376005|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
56376006|NCT00143325|Varenicline|varenicline|mesh-list
56376007|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56376008|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56376009|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
56376070|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56376071|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56376072|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376073|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
56376074|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56376075|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55997942|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56376076|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56376077|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
56376078|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56376079|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56376134|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56376135|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
56376136|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376137|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376138|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56376139|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
56376140|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
56376141|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56376142|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
56376143|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56376147|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
56376202|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376203|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56376204|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
56376205|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376206|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56376207|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
56376208|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376209|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
56376210|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376211|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376266|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
56376267|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376268|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376269|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376270|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
56376271|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
56376272|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56376273|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56376274|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376275|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376277|NCT00143715|Vitamin K|vitamin k|mesh-list
56376332|NCT02273791|Estradiol|estradiol|mesh-list
56376333|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56376334|NCT02273791|Estrogens|estrogens|mesh-ancestor
56376335|NCT02273791|Hormones|hormones|mesh-ancestor
56376336|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56376337|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376338|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56376339|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
56376340|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56376342|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56376398|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56376399|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
56376400|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
56376401|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
56376402|NCT00455806|Amoxicillin|amoxicillin|mesh-list
56376403|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
56376404|NCT00455806|Esomeprazole|esomeprazole|mesh-list
56376405|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56376406|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376415|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
56376465|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376466|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56376467|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376468|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56376469|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
56376470|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56376471|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56376530|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56376531|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376532|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376533|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
56376534|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56376535|NCT00110708|Antibodies|antibodies|mesh-list
56376536|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
56376537|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376538|NCT00456820|Bupropion|bupropion|mesh-list
56172890|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
56376552|NCT00456898|Codeine|codeine|mesh-list
56376591|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56376592|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376593|NCT00456937|Citalopram|citalopram|mesh-list
56376594|NCT00456937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56376595|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56376596|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56376597|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376599|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
56376600|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376601|NCT00456937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56376602|NCT00456937|Antidepressive Agents|antidepressive agents|mesh-ancestor
56376603|NCT00456937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56376604|NCT00456976|Selegiline|selegiline|mesh-list
56376649|NCT00110864|Insulin|insulin|mesh-list
56376650|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56376651|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376652|NCT00457678|Dexamethasone|dexamethasone|mesh-list
56376653|NCT00457678|Ranibizumab|ranibizumab|mesh-list
56376654|NCT00457678|Verteporfin|verteporfin|mesh-list
56376655|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56376656|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
56376657|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
56376658|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376659|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376661|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
56376714|NCT00465673|Doxorubicin|doxorubicin|mesh-list
56376715|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56376716|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56376717|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56376718|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56376719|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56376720|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56376721|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376781|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376782|NCT00144222|Telmisartan|telmisartan|mesh-list
56376783|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56376784|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56376785|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56376786|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376787|NCT00466180|Nevirapine|nevirapine|mesh-list
56376788|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56376846|NCT00347815|Narcotics|narcotics|mesh-ancestor
56376847|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56376848|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376849|NCT00347815|Analgesics|analgesics|mesh-ancestor
56172972|NCT05275439|Venetoclax|venetoclax|mesh-list
56376850|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
56376851|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56376852|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56376853|NCT00113802|Epratuzumab|epratuzumab|mesh-list
56376913|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56376914|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
56376915|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56376916|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56172974|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
56376917|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56376918|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
56376919|NCT00111215|Coagulants|coagulants|mesh-ancestor
56376920|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56376921|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
56376922|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56376923|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
56376924|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
56376975|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
56376976|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56376977|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56376979|NCT00348400|Latanoprost|latanoprost|mesh-list
56376980|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56377051|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56377052|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
56377053|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377054|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377055|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377056|NCT00349180|Enoxaparin|enoxaparin|mesh-list
56377057|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
56377058|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
56377059|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56377060|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56377061|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377062|NCT00421369|Sertraline|sertraline|mesh-list
56377063|NCT00421369|Reboxetine|reboxetine|mesh-list
56377065|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377112|NCT00111449|Analgesics|analgesics|mesh-ancestor
56377113|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
56377114|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377115|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377116|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56377117|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377118|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56377119|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377120|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
56377121|NCT00349258|Leuprolide|leuprolide|mesh-list
56377122|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56377123|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
56377124|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56377125|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377126|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56377127|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377171|NCT00349726|Inositol|inositol|mesh-list
56377173|NCT00349726|Vitamins|vitamins|mesh-ancestor
56377247|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
56377248|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56377249|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
56377250|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
56377251|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56377252|NCT00404781|Protective Agents|protective agents|mesh-ancestor
56377253|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56377254|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56377255|NCT00350311|Nicotine|nicotine|mesh-list
56377256|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56377257|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
55891323|NCT05719714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55891324|NCT05719714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891342|NCT05586789|Tryptophan|tryptophan|mesh-list
55891343|NCT05586789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56377312|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377313|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
56377376|NCT00401609|Etoposide|etoposide|mesh-list
56377377|NCT00401609|Vinorelbine|vinorelbine|mesh-list
56377378|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56377379|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377380|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
56377381|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377382|NCT00401609|Antiviral Agents|antiviral agents|mesh-ancestor
56377383|NCT00401609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56377384|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377437|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
56377438|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56377439|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56377440|NCT00112034|Prednisolone|prednisolone|mesh-list
56377441|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
56377442|NCT00112034|Methotrexate|methotrexate|mesh-list
56377443|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56377444|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
56377445|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56377461|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
55999373|NCT05489796|Narcotics|narcotics|mesh-ancestor
56377503|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377504|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377505|NCT00351637|Analgesics|analgesics|mesh-ancestor
56377506|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
56377507|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377508|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
56377509|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
56377510|NCT00351715|Methadone|methadone|mesh-list
56377511|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56377512|NCT00351715|Narcotics|narcotics|mesh-ancestor
56377513|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377514|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377515|NCT00351715|Analgesics|analgesics|mesh-ancestor
56377516|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
56377517|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377518|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
56377520|NCT00351832|Vildagliptin|vildagliptin|mesh-list
56377558|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56377559|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56377560|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377569|NCT00112346|Cetuximab|cetuximab|mesh-list
56377631|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377632|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
56377633|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377634|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56377635|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56377636|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56377637|NCT00112658|Antidotes|antidotes|mesh-ancestor
56377638|NCT00112658|Protective Agents|protective agents|mesh-ancestor
56377639|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
56377640|NCT00112658|Vitamins|vitamins|mesh-ancestor
56377697|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
56377698|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377769|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56377770|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56377771|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377772|NCT00353002|Lidocaine|lidocaine|mesh-list
56377773|NCT00353002|Tetracaine|tetracaine|mesh-list
56377774|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
56377775|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
56377776|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56377777|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377778|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
56377779|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377831|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56377832|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
56377833|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56377834|NCT00353665|Protective Agents|protective agents|mesh-ancestor
56377835|NCT05594784|Prednisone|prednisone|mesh-list
56377836|NCT05594784|Vincristine|vincristine|mesh-list
56377837|NCT05594784|Venetoclax|venetoclax|mesh-list
56377838|NCT05594784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56377839|NCT05594784|Glucocorticoids|glucocorticoids|mesh-ancestor
56377840|NCT05594784|Hormones|hormones|mesh-ancestor
56377841|NCT05594784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56377842|NCT05594784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377843|NCT05594784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56173124|NCT05062044|Vitamins|vitamins|mesh-ancestor
56377891|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377892|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56377893|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
56377894|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
56377895|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56377896|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
56377897|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377898|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56377899|NCT00354406|Abciximab|abciximab|mesh-list
56377900|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
56377901|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56377902|NCT00354523|Capecitabine|capecitabine|mesh-list
56377952|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56377953|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56377954|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56377956|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377957|NCT00115011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56377958|NCT00115011|Antidepressive Agents|antidepressive agents|mesh-ancestor
56377959|NCT00115011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56377960|NCT00113594|Olanzapine|olanzapine|mesh-list
56377961|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
56377962|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
56377963|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56377964|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56377976|NCT00426049|Everolimus|everolimus|mesh-list
56378015|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378016|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56378017|NCT00444340|Etanercept|etanercept|mesh-list
56378019|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56378077|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56378078|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378079|NCT04699903|Antibodies|antibodies|mesh-list
56378080|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
56378081|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
56378082|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378083|NCT00444808|Calcitonin|calcitonin|mesh-list
56378084|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
56378085|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56378086|NCT00444808|Katacalcin|katacalcin|mesh-list
56378087|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56378091|NCT00113828|Cyclosporine|cyclosporine|mesh-list
56378139|NCT00445081|Prednisolone|prednisolone|mesh-list
56378140|NCT00445081|Cyclosporins|cyclosporins|mesh-list
56378141|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378142|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
56378143|NCT00445081|Hormones|hormones|mesh-ancestor
56378144|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56378145|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378146|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56378147|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378203|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
56378204|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
56378205|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
56378206|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378207|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56378209|NCT00445900|Prednisone|prednisone|mesh-list
56378210|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
56378211|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378212|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
56378213|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378215|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56378216|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
56378217|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378218|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378219|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56378220|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378263|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56378264|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56378265|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378266|NCT00446017|Protective Agents|protective agents|mesh-ancestor
56378267|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
56378268|NCT00446173|Busulfan|busulfan|mesh-list
56378269|NCT00446173|Sargramostim|sargramostim|mesh-list
56378270|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378271|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
56378272|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378273|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56378274|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56378275|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
56378276|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378277|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378322|NCT05589753|Acetazolamide|acetazolamide|mesh-list
56378323|NCT05589753|Anticonvulsants|anticonvulsants|mesh-ancestor
56378324|NCT05589753|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56378325|NCT05589753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378326|NCT05589753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378327|NCT05589753|Diuretics|diuretics|mesh-ancestor
56378328|NCT05589753|Natriuretic Agents|natriuretic agents|mesh-ancestor
56378329|NCT05589753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378330|NCT00114179|Gemcitabine|gemcitabine|mesh-list
56378331|NCT00114179|Bevacizumab|bevacizumab|mesh-list
56378332|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56378333|NCT00114179|Capecitabine|capecitabine|mesh-list
56378334|NCT00114179|Antibodies|antibodies|mesh-list
56378335|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
56378336|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56378384|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56378385|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56378386|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378387|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378388|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
56378389|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378390|NCT00114374|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56378391|NCT00114374|Antidepressive Agents|antidepressive agents|mesh-ancestor
56378448|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378449|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56378450|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56378451|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378452|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378453|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378454|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56378455|NCT00447577|Tobramycin|tobramycin|mesh-list
56378456|NCT00447577|Dexamethasone|dexamethasone|mesh-list
56378457|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378458|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
56378459|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
56378460|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378461|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378510|NCT05564598|Antiviral Agents|antiviral agents|mesh-list
56378511|NCT05564598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378512|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
56378513|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
56378514|NCT00447967|Leucovorin|leucovorin|mesh-list
56378515|NCT00447967|Fluorouracil|fluorouracil|mesh-list
56378516|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
56378517|NCT00447967|Irinotecan|irinotecan|mesh-list
56378518|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
56378581|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378582|NCT00448552|Capecitabine|capecitabine|mesh-list
56378583|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
56378584|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56378585|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
56378586|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378587|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378588|NCT03276520|Ethanol|ethanol|mesh-list
56378589|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56378590|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378591|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378592|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378593|NCT00114764|Lenograstim|lenograstim|mesh-list
56378599|NCT00448786|Imetelstat|imetelstat|mesh-list
56378644|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378645|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56378646|NCT03276325|Narcotics|narcotics|mesh-ancestor
56378647|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378648|NCT03276325|Analgesics|analgesics|mesh-ancestor
56378649|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
56378650|NCT00449020|Carboplatin|carboplatin|mesh-list
56378651|NCT00449020|Docetaxel|docetaxel|mesh-list
56378652|NCT00449020|Irinotecan|irinotecan|mesh-list
56378653|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56378654|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
56378655|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
56378656|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
56378657|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378658|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56378659|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56378660|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378661|NCT00115752|Valdecoxib|valdecoxib|mesh-list
56378662|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
56378703|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56378705|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
56378706|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378707|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56378708|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56378709|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378710|NCT00449449|Lidocaine|lidocaine|mesh-list
56378769|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56378770|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56378771|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
56378772|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378773|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378774|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378775|NCT00449683|Urological Agents|urological agents|mesh-ancestor
56378776|NCT00449722|Mesalamine|mesalamine|mesh-list
56378777|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56378778|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56378779|NCT00449722|Analgesics|analgesics|mesh-ancestor
56378780|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
56378781|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378782|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378784|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56378785|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
56378786|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56378787|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56378827|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378828|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378829|NCT05536362|Clonidine|clonidine|mesh-list
56378830|NCT05536362|Ketamine|ketamine|mesh-list
56378831|NCT05536362|Propofol|propofol|mesh-list
56378832|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56378833|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56378834|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378835|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56378836|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
56378837|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
56378838|NCT05536362|Analgesics|analgesics|mesh-ancestor
56378839|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
56378840|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378890|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
56378891|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56378892|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56378893|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56378894|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56378895|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56378896|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56378958|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56378959|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56378960|NCT00459004|Rimonabant|rimonabant|mesh-list
56378961|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56378962|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56378963|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56378964|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56378966|NCT00459004|Hormones|hormones|mesh-ancestor
56379024|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379100|NCT00460681|Thymopentin|thymopentin|mesh-list
56379101|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56379102|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
56379174|NCT03273634|Lansoprazole|lansoprazole|mesh-list
56379250|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56379252|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
56379323|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56379324|NCT00116181|Etanercept|etanercept|mesh-list
56379325|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56379395|NCT00462787|Thiotepa|thiotepa|mesh-list
56379396|NCT00462787|Clofarabine|clofarabine|mesh-list
56379397|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56379398|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
56379404|NCT00462787|Hormones|hormones|mesh-ancestor
56379464|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
56379538|NCT00464347|Bevacizumab|bevacizumab|mesh-list
56379539|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56379613|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379614|NCT00116870|Lovastatin|lovastatin|mesh-list
56379615|NCT00116870|L 647318|l 647318|mesh-list
56379616|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
56379686|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379687|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379759|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379760|NCT00473980|Celecoxib|celecoxib|mesh-list
56379761|NCT00473980|Indomethacin|indomethacin|mesh-list
56379762|NCT00473980|Esomeprazole|esomeprazole|mesh-list
56379763|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56379764|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56379765|NCT00473980|Analgesics|analgesics|mesh-ancestor
56379766|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
56379767|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56379768|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56379826|NCT00117182|Hormones|hormones|mesh-ancestor
56379827|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56379828|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
56379830|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56379831|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56379832|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56379833|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56379834|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
56379835|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56379836|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56379891|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56379892|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56379893|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56379894|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56379963|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56379964|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
56379965|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56380035|NCT00117078|Hematinics|hematinics|mesh-ancestor
56380036|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
56173697|NCT04111978|Letrozole|letrozole|mesh-list
56380037|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56380114|NCT00117533|Ribavirin|ribavirin|mesh-list
56380186|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
56380187|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380188|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56380189|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380191|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56380256|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56380257|NCT00118235|Irinotecan|irinotecan|mesh-list
56380258|NCT00118235|Antibodies|antibodies|mesh-list
56380259|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
56380328|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56380329|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380330|NCT00477373|Valproic Acid|valproic acid|mesh-list
56380331|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
56380332|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380333|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380334|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
56380335|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56380336|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380337|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
56380338|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56380339|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56380340|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56380341|NCT00477763|Cyclosporine|cyclosporine|mesh-list
56380342|NCT00477763|Cyclosporins|cyclosporins|mesh-list
56380386|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380388|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
56380457|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56380458|NCT00118976|Protective Agents|protective agents|mesh-ancestor
56380460|NCT05288361|Acetylcholine|acetylcholine|mesh-list
56380531|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56380532|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56380535|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56380604|NCT00480103|Emollients|emollients|mesh-ancestor
56380606|NCT00480142|Oxycodone|oxycodone|mesh-list
56380679|NCT00480454|Vaccines|vaccines|mesh-list
56380680|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
56380682|NCT00480571|Perphenazine|perphenazine|mesh-list
56380753|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56380754|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380756|NCT05236998|Hormones|hormones|mesh-ancestor
56380826|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380903|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56380904|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56380905|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56380906|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56380907|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56380908|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
56380909|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56380968|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56380969|NCT01240642|Vadimezan|vadimezan|mesh-list
56173802|NCT03936998|Vancomycin|vancomycin|mesh-list
56381115|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381116|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56381195|NCT01241110|Ofloxacin|ofloxacin|mesh-list
56381262|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
56381337|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
56381338|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
56381339|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
56381406|NCT02274181|Enclomiphene|enclomiphene|mesh-list
56381407|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56381478|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56381479|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56381547|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56381549|NCT00486421|Rituximab|rituximab|mesh-list
56381551|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381621|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56381622|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56381623|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381637|NCT01242202|Acarbose|acarbose|mesh-list
56381690|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56381691|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381692|NCT00487786|Docetaxel|docetaxel|mesh-list
56381693|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56381694|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
56381695|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
56381696|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
56381697|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56381698|NCT00488137|Prucalopride|prucalopride|mesh-list
56381761|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56381830|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56381831|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
56381832|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56381833|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
56381901|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56381902|NCT00489385|Ribavirin|ribavirin|mesh-list
56381903|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
56381907|NCT01242631|Everolimus|everolimus|mesh-list
56381975|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56381976|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56381977|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56381979|NCT00489892|Modafinil|modafinil|mesh-list
56382046|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
56382120|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
56382128|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
56382197|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
56382273|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56382274|NCT00492661|Tacrolimus|tacrolimus|mesh-list
56382275|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56382276|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
56382281|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
56382347|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
56382348|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
56382420|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56382494|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382496|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382565|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56382574|NCT00494611|Cetuximab|cetuximab|mesh-list
56382637|NCT00495118|Risperidone|risperidone|mesh-list
56382638|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56382711|NCT00127478|Atrasentan|atrasentan|mesh-list
56382712|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382713|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56382714|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56382715|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382716|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56382717|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56382718|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56382719|NCT00496405|Bevacizumab|bevacizumab|mesh-list
56382720|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56382721|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382722|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56382723|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56382724|NCT00496405|Growth Substances|growth substances|mesh-ancestor
56382725|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56382754|NCT00496600|Everolimus|everolimus|mesh-list
56382769|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56382770|NCT00127595|Antiviral Agents|antiviral agents|mesh-ancestor
56382771|NCT00127595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56382772|NCT00127595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56382779|NCT04665765|Etoposide|etoposide|mesh-list
56382844|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
56382845|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56382846|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56382847|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382848|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56382849|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56382850|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56382852|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56382911|NCT00127868|Protective Agents|protective agents|mesh-ancestor
56382912|NCT00127868|Trace Elements|trace elements|mesh-ancestor
56382913|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
56382914|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
56382984|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
56382985|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56382986|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
56382987|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56382988|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56382990|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
56382991|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56382992|NCT00402623|Protective Agents|protective agents|mesh-ancestor
56382993|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383051|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
56383052|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383122|NCT00498979|Vinblastine|vinblastine|mesh-list
56383123|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383124|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
56383140|NCT01245205|Lapatinib|lapatinib|mesh-list
56383196|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56383197|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56383203|NCT00127985|Prednisolone|prednisolone|mesh-list
56383268|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56383269|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383270|NCT00499291|Paclitaxel|paclitaxel|mesh-list
56383271|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56383272|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56383273|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383274|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
56383275|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
56383276|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
56383335|NCT00499993|Lanreotide|lanreotide|mesh-list
56383336|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383337|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
56383338|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56383339|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56383340|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383341|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383343|NCT04710914|Isoflurane|isoflurane|mesh-list
56383403|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
56383404|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56383474|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383475|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383476|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56383477|NCT00501514|Hormones|hormones|mesh-list
56383478|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56383479|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383480|NCT00147186|Hylan|hylan|mesh-list
56383481|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
56383482|NCT00147186|Protective Agents|protective agents|mesh-ancestor
56383547|NCT00502294|Visilizumab|visilizumab|mesh-list
56383624|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56383625|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56383696|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
56383698|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383766|NCT05560919|Vitamins|vitamins|mesh-ancestor
56383767|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
56383768|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56383769|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
56383770|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56383771|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56383772|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56383773|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56383774|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56383775|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
56383832|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
56383833|NCT00503932|Capecitabine|capecitabine|mesh-list
56383835|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
56383906|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56383907|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56383908|NCT01248442|Vitamins|vitamins|mesh-ancestor
56383978|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56383980|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
56384052|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
56384053|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56384054|NCT00504439|Simvastatin|simvastatin|mesh-list
56384055|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56384056|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56384057|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
56384058|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384059|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56384060|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56384061|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384062|NCT04054830|Diclofenac|diclofenac|mesh-list
56384063|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56384064|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56384113|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56384114|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56384115|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
56384116|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
56384117|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56384118|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56384181|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56384182|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
56384183|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
56384184|NCT02952092|Hematinics|hematinics|mesh-ancestor
56384185|NCT00139152|Omalizumab|omalizumab|mesh-list
56384186|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56384187|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56384188|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
56384189|NCT02824523|Aspirin|aspirin|mesh-list
56384190|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56384192|NCT02824523|Analgesics|analgesics|mesh-ancestor
56384248|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
56384249|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56384266|NCT02086175|Rituximab|rituximab|mesh-list
56384321|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56384322|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
56384323|NCT00139386|Candesartan|candesartan|mesh-list
56384324|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56384325|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56384326|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56384327|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384394|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56384395|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384396|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384397|NCT03500913|Hormones|hormones|mesh-list
56384398|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56384399|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384400|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56384414|NCT00139698|Olmesartan|olmesartan|mesh-list
56384458|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56384459|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56384460|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56384461|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56384531|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56384533|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
56384605|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56384679|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384680|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56384681|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
56384689|NCT00131768|Hylan|hylan|mesh-list
56384754|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56384755|NCT00140361|Renal Agents|renal agents|mesh-ancestor
56384756|NCT00131846|Diuretics|diuretics|mesh-list
56384827|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56384829|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56384830|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56384831|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56384832|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56384833|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
56384834|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56384895|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
56384896|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56384897|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
56384968|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
56384969|NCT02261415|Coagulants|coagulants|mesh-ancestor
56384970|NCT00132743|Cilostazol|cilostazol|mesh-list
56385041|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385042|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
56385043|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
56385044|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56385114|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385189|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385190|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385261|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385262|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56385333|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385334|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
56385408|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385409|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56385482|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56385483|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385554|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56385555|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
56385629|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56385630|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56385702|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56385703|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
56385704|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56385705|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56385707|NCT00135473|Insulin|insulin|mesh-list
56385772|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
56385775|NCT00152802|Vaccines|vaccines|mesh-list
56385844|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56385846|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56385921|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56385922|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
56385923|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
56385924|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
56385925|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56385926|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56385927|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
56385944|NCT00136292|Daptomycin|daptomycin|mesh-list
56385991|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56385992|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56385993|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56385994|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
56385995|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56385996|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
56385997|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386057|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56386058|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386059|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386061|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386062|NCT00136526|Docetaxel|docetaxel|mesh-list
56386125|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386126|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
56386127|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56386128|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386129|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
56386130|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56386131|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56386132|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56386134|NCT00159705|Analgesics|analgesics|mesh-ancestor
56386135|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
56386136|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386137|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386138|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
56386139|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56386140|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56386143|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56386182|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56386254|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56386255|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56386256|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56386257|NCT00153699|Topiramate|topiramate|mesh-list
56386258|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
56386259|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56386261|NCT00160290|Lactulose|lactulose|mesh-list
56386323|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
56386324|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386330|NCT00160407|Orlistat|orlistat|mesh-list
56386398|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56386399|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
56386400|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386401|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56386403|NCT00138242|Docetaxel|docetaxel|mesh-list
56386468|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386469|NCT00138554|Pioglitazone|pioglitazone|mesh-list
56386470|NCT00138554|Vildagliptin|vildagliptin|mesh-list
56386471|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56386472|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386473|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56386474|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
56386475|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56386477|NCT00138593|Vildagliptin|vildagliptin|mesh-list
56386531|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56386532|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56386536|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56386601|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56386602|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56386604|NCT00154440|Amoxicillin|amoxicillin|mesh-list
56386673|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
56386674|NCT00139256|Hormones|hormones|mesh-ancestor
56386676|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386746|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386749|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
56386816|NCT00406497|Difluprednate|difluprednate|mesh-list
56386817|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
56386818|NCT00406497|Hormones|hormones|mesh-ancestor
56386819|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56386820|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386821|NCT00161655|Etanercept|etanercept|mesh-list
56386822|NCT00161655|Methotrexate|methotrexate|mesh-list
56386823|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56386884|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56386885|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56386886|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56386957|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56386958|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56386959|NCT01240759|Metformin|metformin|mesh-list
56386960|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56387030|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387031|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
56387032|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387033|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56387034|NCT00154869|Ribavirin|ribavirin|mesh-list
56387035|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56387036|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
56387037|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387095|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56387096|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56387167|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387168|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56387169|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
56387170|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56387172|NCT00504946|Vitamins|vitamins|mesh-ancestor
56387236|NCT00141362|Analgesics|analgesics|mesh-ancestor
56387237|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
56009234|NCT00003634|Oregovomab|oregovomab|mesh-list
56387305|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56387306|NCT04511728|Propofol|propofol|mesh-list
56387307|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56387308|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56387309|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387312|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
56387375|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
56387376|NCT04518982|Lenalidomide|lenalidomide|mesh-list
56387377|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
56387447|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56387448|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56387449|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56387452|NCT04517890|Lidocaine|lidocaine|mesh-list
56387592|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
56387593|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56387594|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56387595|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56387665|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56387666|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387667|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56387668|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56387670|NCT00141986|Vitamin D|vitamin d|mesh-list
56387735|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56387736|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
56387737|NCT00505804|Haloperidol|haloperidol|mesh-list
56387807|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387808|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56387809|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
56387810|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
56387811|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56387880|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56387952|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56387953|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
56387962|NCT04512430|Bevacizumab|bevacizumab|mesh-list
56388023|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388095|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56388096|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388167|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56388168|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388169|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56388170|NCT00155883|Leucovorin|leucovorin|mesh-list
56388171|NCT00155883|Fluorouracil|fluorouracil|mesh-list
56388182|NCT00155883|Vitamins|vitamins|mesh-ancestor
56388238|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56388239|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56388240|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56388241|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56388242|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56388243|NCT00506623|Capecitabine|capecitabine|mesh-list
56388244|NCT00506623|Irinotecan|irinotecan|mesh-list
56388245|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56388304|NCT00506701|Urological Agents|urological agents|mesh-ancestor
56388305|NCT05147857|Misoprostol|misoprostol|mesh-list
56388306|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56388307|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
56388308|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56388309|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388310|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56174872|NCT01386567|Clomiphene|clomiphene|mesh-list
56388312|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
56388372|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388373|NCT00144287|Ritonavir|ritonavir|mesh-list
56388374|NCT00144287|Tipranavir|tipranavir|mesh-list
56388375|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56388376|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56388377|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
56388378|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388400|NCT02954692|Metformin|metformin|mesh-list
56174951|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
56388444|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388519|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56388520|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56388521|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388522|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
56388523|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56388524|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56388525|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56388526|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56388592|NCT05594849|Hormones|hormones|mesh-ancestor
56388594|NCT00507247|Daptomycin|daptomycin|mesh-list
56388597|NCT00507286|Alprostadil|alprostadil|mesh-list
56388669|NCT05594615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56388670|NCT05594615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56388671|NCT05594615|Anesthetics, General|anesthetics, general|mesh-ancestor
56388672|NCT05594615|Anesthetics|anesthetics|mesh-ancestor
56388673|NCT05594615|GABA Modulators|gaba modulators|mesh-ancestor
56388674|NCT05594615|GABA Agents|gaba agents|mesh-ancestor
56388675|NCT05594615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56388676|NCT05594615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56388677|NCT05594615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56388678|NCT05594615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56388679|NCT05594615|Antimetabolites|antimetabolites|mesh-ancestor
56175005|NCT01387048|Adapalene|adapalene|mesh-list
56388680|NCT05594615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56388731|NCT05594459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56388732|NCT05594459|Sensory System Agents|sensory system agents|mesh-ancestor
56388733|NCT05594459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388734|NCT00507403|Infliximab|infliximab|mesh-list
56388735|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
56388736|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56388737|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56388738|NCT00156975|Capecitabine|capecitabine|mesh-list
56388739|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
56388799|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56388800|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388801|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
56388870|NCT00148590|Memantine|memantine|mesh-list
56388948|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56388949|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56388950|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56389018|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389019|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
56389020|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56389021|NCT00148863|Interferons|interferons|mesh-list
56389022|NCT00148863|Ribavirin|ribavirin|mesh-list
56389091|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389092|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56389093|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56389095|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56389165|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56389166|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
56389169|NCT00468364|Insulin|insulin|mesh-list
56389242|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389243|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56389244|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56389245|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56389246|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
56389247|NCT00469495|Anthelmintics|anthelmintics|mesh-list
56389248|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56389249|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56389250|NCT00469651|Vaccines|vaccines|mesh-list
56389251|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
56389252|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389253|NCT00149253|Etoricoxib|etoricoxib|mesh-list
56389254|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56389304|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
56389305|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56389306|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56389307|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389308|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
56389309|NCT00157677|Coagulants|coagulants|mesh-ancestor
56389310|NCT05425979|Bupivacaine|bupivacaine|mesh-list
56389311|NCT05425979|Mepivacaine|mepivacaine|mesh-list
56389312|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
56389313|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
56389318|NCT00470041|Lamivudine|lamivudine|mesh-list
56389372|NCT00149292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56389373|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56389374|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56389375|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389376|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56389377|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
56389378|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
56389379|NCT00470353|Vitamin D|vitamin d|mesh-list
56389380|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
56389381|NCT00470353|Calcium|calcium|mesh-list
56389437|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
56389438|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56389439|NCT00470821|Protective Agents|protective agents|mesh-ancestor
56389442|NCT00335920|Dexamethasone|dexamethasone|mesh-list
56389510|NCT03271255|Growth Substances|growth substances|mesh-ancestor
56389587|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
56389588|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
56389589|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56389660|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56389661|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56389733|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
56389734|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56389735|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
56389804|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56389820|NCT02964104|Insulin|insulin|mesh-list
56389878|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
56389957|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56389958|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
56389959|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390034|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56390035|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56390036|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390104|NCT00509938|Lactoferrin|lactoferrin|mesh-list
56390105|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390106|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
56390107|NCT00337948|Hematinics|hematinics|mesh-ancestor
56390108|NCT02958215|Phenylephrine|phenylephrine|mesh-list
56390109|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
56390110|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56390178|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56390179|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56390185|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
56390249|NCT00150384|Amlodipine|amlodipine|mesh-list
56390250|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
56390324|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390325|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56390395|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56390469|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56390470|NCT00511732|Insulin|insulin|mesh-list
56390542|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
56390543|NCT00165633|Coagulants|coagulants|mesh-ancestor
56390544|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56390545|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56390617|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
56390618|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
56390619|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56390620|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56390626|NCT00511576|Docetaxel|docetaxel|mesh-list
56390691|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390692|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
56390693|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56390694|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56390696|NCT00512980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56390762|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56390763|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56390834|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56390835|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
56390836|NCT00513955|Prednisolone|prednisolone|mesh-list
56390837|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
56390838|NCT00513955|Doxorubicin|doxorubicin|mesh-list
56390839|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56390840|NCT00513955|Vincristine|vincristine|mesh-list
56390841|NCT00513955|Bortezomib|bortezomib|mesh-list
56390842|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56390902|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56390903|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56390905|NCT00151125|Oprelvekin|oprelvekin|mesh-list
56390974|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56390975|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56390976|NCT00151203|Clarithromycin|clarithromycin|mesh-list
56390977|NCT00151203|Dexamethasone|dexamethasone|mesh-list
56390978|NCT00151203|Lenalidomide|lenalidomide|mesh-list
56391045|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56391055|NCT00515905|Propofol|propofol|mesh-list
56391120|NCT02950441|Vitamins|vitamins|mesh-ancestor
56391121|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
56391122|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391123|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56391124|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
56391126|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56391192|NCT00516841|Growth Substances|growth substances|mesh-ancestor
56391193|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391194|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
56391195|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56391264|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391265|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
56391266|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56391335|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56391336|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56391337|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391338|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391404|NCT02949466|Hormones|hormones|mesh-ancestor
56391405|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56391406|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391407|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
56391408|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56391409|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
56391474|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56391475|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391476|NCT02949193|Incretins|incretins|mesh-ancestor
56391477|NCT02949193|Hormones|hormones|mesh-ancestor
56391480|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
56391546|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56391620|NCT00520507|Olanzapine|olanzapine|mesh-list
56391621|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
56391622|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
56391623|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56391625|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56391688|NCT00521092|Growth Substances|growth substances|mesh-ancestor
56391689|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56391690|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
56391691|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56391759|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
56391760|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
56391761|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391831|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56391832|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
56391840|NCT04168112|Hormones|hormones|mesh-ancestor
56391903|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56391904|NCT00523159|Sargramostim|sargramostim|mesh-list
56391976|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56391977|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56391979|NCT02951728|Prednisone|prednisone|mesh-list
56392050|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392051|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
56392128|NCT00512668|Nilutamide|nilutamide|mesh-list
56392129|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56392130|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
56392202|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392203|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
56392273|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
56392347|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56392348|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392421|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
56392422|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
56392495|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
56392496|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56392497|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392566|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
56392567|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56392568|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56392569|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56392570|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56392636|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392637|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56392710|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56392711|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56392712|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392713|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56392780|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56392781|NCT02460887|Antiviral Agents|antiviral agents|mesh-ancestor
56392782|NCT02460887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56392783|NCT02460887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56392784|NCT02460887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56392785|NCT02460887|Immunologic Factors|immunologic factors|mesh-ancestor
56392786|NCT02460887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56392788|NCT02945527|Acetazolamide|acetazolamide|mesh-list
56392847|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
56392849|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56392920|NCT04692376|Cyclosporine|cyclosporine|mesh-list
56392998|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56392999|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393000|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393001|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56393069|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56393070|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56393071|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
56393072|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393073|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56393074|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56393075|NCT02944942|Anesthetics|anesthetics|mesh-list
56393076|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56393077|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393078|NCT00144872|Lamotrigine|lamotrigine|mesh-list
56393134|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393135|NCT00168597|Vitamin A|vitamin a|mesh-list
56393136|NCT00168597|Vitamins|vitamins|mesh-ancestor
56393137|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
56393138|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393139|NCT00528385|Spironolactone|spironolactone|mesh-list
56393141|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
56393204|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
56393205|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393206|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
56393207|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56393208|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
56393209|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393275|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56393279|NCT00145184|Vitamins|vitamins|mesh-list
56393349|NCT00168870|Treosulfan|treosulfan|mesh-list
56393350|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56393351|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
56393421|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56393422|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56393426|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
56393491|NCT05319301|Melatonin|melatonin|mesh-list
56393492|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
56393493|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393563|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393564|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393565|NCT00145847|Naltrexone|naltrexone|mesh-list
56393566|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56393567|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56393635|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393636|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56393708|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56393709|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
56393710|NCT00169299|Estrogens|estrogens|mesh-list
56393780|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393781|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393782|NCT02276989|Riboflavin|riboflavin|mesh-list
56393853|NCT00146276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56393854|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56393862|NCT02940808|Caffeine|caffeine|mesh-list
56393924|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
56393925|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56393926|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56393927|NCT00146549|Paclitaxel|paclitaxel|mesh-list
56393928|NCT00146549|Vinorelbine|vinorelbine|mesh-list
56393929|NCT00146549|Docetaxel|docetaxel|mesh-list
56393930|NCT00146549|Trastuzumab|trastuzumab|mesh-list
56175560|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
56393932|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56393933|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
56393934|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
56393935|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56393936|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56393937|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56393986|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56393987|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56393988|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
56393989|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56393990|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
56393991|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56393992|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56393993|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56393995|NCT00146627|Nifurtimox|nifurtimox|mesh-list
56393996|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394052|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
56394053|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
56394054|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56394055|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394056|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56394057|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
56394058|NCT02944045|Hormones|hormones|mesh-ancestor
56394059|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394060|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56394119|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56394120|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394121|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56394122|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56394123|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56394124|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56394125|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56394126|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56394127|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56394128|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394129|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56016112|NCT02246855|Antibodies|antibodies|mesh-list
56394178|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56394179|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56394182|NCT02939482|Hormones|hormones|mesh-ancestor
56394251|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394252|NCT00175383|Hormones|hormones|mesh-list
56394253|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56394321|NCT02941822|Ambroxol|ambroxol|mesh-list
56394322|NCT02941822|Expectorants|expectorants|mesh-ancestor
56394323|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
56394394|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394395|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56394469|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56394470|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
56394542|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56394543|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
56394544|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56394617|NCT00175734|Chrysarobin|chrysarobin|mesh-list
56394692|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
56394693|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56394694|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394695|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
56394696|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56394765|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56394766|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56394767|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56394841|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56394842|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394843|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394844|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
56394845|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394846|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56394847|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56394848|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
56394849|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394850|NCT02927587|Propofol|propofol|mesh-list
56394851|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56394852|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56394853|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394854|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56394904|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
56394905|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394906|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56394907|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56394908|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56394909|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394910|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56394911|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
56394912|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56394913|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394914|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56394915|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56394916|NCT00149084|Amoxicillin|amoxicillin|mesh-list
56394917|NCT00149084|Clarithromycin|clarithromycin|mesh-list
56394918|NCT00149084|Lansoprazole|lansoprazole|mesh-list
56394919|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
56394920|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56394921|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56394922|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56394923|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723226|NCT02273050|Metformin|metformin|mesh-list
56394955|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
56394956|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394957|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56394958|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56394959|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56394960|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
56394961|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56394962|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
56394963|NCT02925559|Gliclazide|gliclazide|mesh-list
56394964|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56394965|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56394966|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56016925|NCT01173029|Diuretics|diuretics|mesh-list
56394967|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395014|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56395016|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
56395086|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395087|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
56395088|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
56395091|NCT00170937|Valsartan|valsartan|mesh-list
56395157|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56395158|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395159|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
56395160|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56395161|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56395162|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
56395163|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56395164|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395196|NCT00171015|Valsartan|valsartan|mesh-list
56395231|NCT05786547|Varenicline|varenicline|mesh-list
56395232|NCT05786547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56395233|NCT05786547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56395234|NCT05786547|Cholinergic Agents|cholinergic agents|mesh-ancestor
56395235|NCT05786547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56395236|NCT05786547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395237|NCT05786547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395238|NCT05786495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56395239|NCT05786495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56395336|NCT05785689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56395413|NCT05785195|Respiratory System Agents|respiratory system agents|mesh-ancestor
56395414|NCT05785195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56395415|NCT05785195|Antioxidants|antioxidants|mesh-ancestor
56395489|NCT05784467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56395490|NCT05784467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56395491|NCT05784467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56395492|NCT05784246|Mirikizumab|mirikizumab|mesh-list
56395493|NCT05784246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56395494|NCT05784246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56395495|NCT05784246|Analgesics|analgesics|mesh-ancestor
56395496|NCT05784246|Sensory System Agents|sensory system agents|mesh-ancestor
56395497|NCT05784246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395498|NCT05784246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395499|NCT05784246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56395500|NCT05784246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56395562|NCT05779007|Pirfenidone|pirfenidone|mesh-list
56395563|NCT05779007|Nintedanib|nintedanib|mesh-list
56395564|NCT05779007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395568|NCT05779007|Analgesics|analgesics|mesh-ancestor
56395640|NCT05757869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56395641|NCT05757869|Anticoagulants|anticoagulants|mesh-ancestor
56395642|NCT05750017|Vaccines|vaccines|mesh-list
56395643|NCT05750017|Immunologic Factors|immunologic factors|mesh-ancestor
56395644|NCT05750017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395771|NCT05634577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56395772|NCT05634577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56395965|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56395966|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56395967|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56395968|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
56395969|NCT05519085|Hormones|hormones|mesh-ancestor
56396035|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396044|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56396047|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
56396203|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
56396204|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
56396205|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
56396206|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
56396207|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56396281|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396282|NCT05288166|Prednisone|prednisone|mesh-list
56396283|NCT05288166|Prednisolone|prednisolone|mesh-list
56396284|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56396285|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
56396360|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396361|NCT05152628|Tacrolimus|tacrolimus|mesh-list
56396362|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396363|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
56396431|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
56396507|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396508|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
56396509|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396510|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56396595|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
56396596|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56396597|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56396598|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396599|NCT04901377|Dienogest|dienogest|mesh-list
56396600|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56396601|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56396602|NCT04901377|Estradiol|estradiol|mesh-list
56396603|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56396604|NCT04901377|Estrogens|estrogens|mesh-ancestor
56396605|NCT04901377|Hormones|hormones|mesh-ancestor
56396606|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56396607|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396608|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56396609|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
56396610|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56396681|NCT04813926|Riociguat|riociguat|mesh-list
56396682|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
56396683|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396684|NCT04803877|Nivolumab|nivolumab|mesh-list
56396689|NCT04792502|Lenalidomide|lenalidomide|mesh-list
56396755|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56396756|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
56396757|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56396827|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56396828|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56396829|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
56396830|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396907|NCT04561375|Fentanyl|fentanyl|mesh-list
56396908|NCT04561375|Sufentanil|sufentanil|mesh-list
56396909|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56396910|NCT04561375|Narcotics|narcotics|mesh-ancestor
56396982|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
56396983|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56396984|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56396985|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
56396986|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56397080|NCT04335669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397081|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56397082|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56397083|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56397088|NCT04334759|Nivolumab|nivolumab|mesh-list
56397178|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
56397179|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397180|NCT04236609|Sirolimus|sirolimus|mesh-list
56397181|NCT04236609|Everolimus|everolimus|mesh-list
56397182|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397183|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397184|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
56397185|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397186|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56397187|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56397188|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56397189|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
56397190|NCT04232657|Denosumab|denosumab|mesh-list
56397191|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56397192|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397193|NCT04232553|Mirikizumab|mirikizumab|mesh-list
56397270|NCT04172987|Hormones|hormones|mesh-ancestor
56397271|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56397272|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
56397273|NCT04145349|Vinorelbine|vinorelbine|mesh-list
56397274|NCT04145349|Ramucirumab|ramucirumab|mesh-list
56397275|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397276|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
56397277|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397278|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397279|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56397281|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397282|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397283|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56397284|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56397285|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
56397286|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
56397287|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
56397288|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
56397289|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397359|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56397365|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
56397443|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
56397444|NCT03914625|Prednisone|prednisone|mesh-list
56397445|NCT03914625|Prednisolone|prednisolone|mesh-list
56397447|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
56397520|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
56397521|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56397522|NCT03914625|Hematinics|hematinics|mesh-ancestor
56397593|NCT03739814|Antibodies|antibodies|mesh-list
56397594|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
56397595|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56397596|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
56397597|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56397598|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
56397599|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397600|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397601|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56397602|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397685|NCT03519945|Mirikizumab|mirikizumab|mesh-list
56397686|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56397687|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56397688|NCT03519945|Analgesics|analgesics|mesh-ancestor
56397689|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
56397690|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019619|NCT05284812|Vaccines|vaccines|mesh-list
56397691|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397751|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397752|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
56397753|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56397754|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397755|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56397756|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
56397757|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56397758|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56397762|NCT03448042|Trastuzumab|trastuzumab|mesh-list
56175715|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56397822|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56397823|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
56397897|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56397898|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
56397899|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56397900|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56397901|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56397902|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
56397903|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56397904|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56397905|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56397906|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56397907|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
56397908|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
56397909|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56397910|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56397911|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
56397969|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56397970|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56397972|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
56397973|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56175722|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
56398040|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
56398041|NCT02700048|Naloxone|naloxone|mesh-list
56398042|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56398043|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398044|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
56398045|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398046|NCT02639273|Nalmefene|nalmefene|mesh-list
56398047|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56398109|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398110|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398111|NCT02406209|Prednisolone|prednisolone|mesh-list
56398112|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56398113|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
56398114|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56398115|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
56398116|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56398117|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
56398118|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56398138|NCT02356159|Rituximab|rituximab|mesh-list
56398182|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
56398183|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398184|NCT02233829|Dopamine|dopamine|mesh-list
56398185|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56398186|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
56398187|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
56398188|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56398189|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398190|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
56398245|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56398246|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56175729|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56398247|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398249|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56398250|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56398251|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56398252|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398253|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56398254|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56398255|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
56398256|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398257|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398263|NCT01964989|Vaccines|vaccines|mesh-list
56398264|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
56398265|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398275|NCT01799538|Albuterol|albuterol|mesh-list
56398286|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56398287|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
56398288|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56398290|NCT01776840|Rituximab|rituximab|mesh-list
56398362|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56398363|NCT01445509|Growth Substances|growth substances|mesh-ancestor
56398364|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398365|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
56398366|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56398367|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56398368|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398369|NCT01419561|Zidovudine|zidovudine|mesh-list
56398370|NCT01419561|Rituximab|rituximab|mesh-list
56398371|NCT01419561|Doxorubicin|doxorubicin|mesh-list
56398372|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56398373|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56398374|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398440|NCT01306019|Busulfan|busulfan|mesh-list
56398441|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
56398442|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398443|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56398444|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
56398445|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56398446|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56398507|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
56398508|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56398509|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398510|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
56398511|NCT00558961|Chlorambucil|chlorambucil|mesh-list
56398512|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56398513|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56398514|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020545|NCT00493064|Niacin|niacin|mesh-list
56020600|NCT01482715|Rucaparib|rucaparib|mesh-list
56020679|NCT05041842|Pertuzumab|pertuzumab|mesh-list
56020749|NCT00555152|Lapatinib|lapatinib|mesh-list
56020817|NCT00435812|Vaccines|vaccines|mesh-list
56020980|NCT05140278|Artesunate|artesunate|mesh-list
56021055|NCT05077332|Celecoxib|celecoxib|mesh-list
56044164|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073147|NCT05107856|Venetoclax|venetoclax|mesh-list
56146339|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56146412|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56146413|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56146415|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
56146484|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146485|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146488|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56146557|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146559|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56002265|NCT02743598|Liraglutide|liraglutide|mesh-list
56146629|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
56146630|NCT01061034|Aspirin|aspirin|mesh-list
56146631|NCT01061034|Omeprazole|omeprazole|mesh-list
56146633|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56146702|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56146703|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56146773|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146774|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146775|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
56146776|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56146844|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56146845|NCT01105650|Cyclosporine|cyclosporine|mesh-list
56146846|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
56146917|NCT01112670|Hormones|hormones|mesh-ancestor
56146918|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146919|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56146920|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
56146921|NCT01115556|Ranibizumab|ranibizumab|mesh-list
56146924|NCT01115556|Growth Substances|growth substances|mesh-ancestor
56146988|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56146989|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56146990|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
56146991|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147060|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147061|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
56147062|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
56147063|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147064|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56147131|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56147132|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147133|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56147204|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56147275|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56147276|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147347|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56147348|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56147419|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56147493|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
56147494|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56147569|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
56147570|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56147642|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
56147645|NCT01225068|Milnacipran|milnacipran|mesh-list
56147715|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56147716|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56147717|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56147718|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147719|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
56147720|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56147784|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56147785|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56147786|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56147787|NCT01251978|Ranibizumab|ranibizumab|mesh-list
56147788|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56147789|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56147790|NCT01251978|Growth Substances|growth substances|mesh-ancestor
56147791|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56147792|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
56147793|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147794|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
56147847|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56147848|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56147851|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
56147919|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56147924|NCT01276314|Analgesics|analgesics|mesh-ancestor
56147993|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
56147995|NCT01293396|Insulin|insulin|mesh-list
56148068|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
56148142|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56148143|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
56148144|NCT01312818|Hormones|hormones|mesh-ancestor
56148146|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56148216|NCT01318356|Doxycycline|doxycycline|mesh-list
56148217|NCT01318356|Tetracycline|tetracycline|mesh-list
56148218|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56148231|NCT01324128|Iron|iron|mesh-list
56148288|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
56148361|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
56148362|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56148363|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56076020|NCT05430048|Bisoprolol|bisoprolol|mesh-list
56148432|NCT01347060|Fluticasone|fluticasone|mesh-list
56148506|NCT01363128|Ofatumumab|ofatumumab|mesh-list
56148507|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56148508|NCT01363128|BB 1101|bb 1101|mesh-list
56148510|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
56148579|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56076236|NCT00362102|Cetuximab|cetuximab|mesh-list
56148652|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
56148653|NCT01391286|Bimatoprost|bimatoprost|mesh-list
56148654|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56148655|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56148656|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56148726|NCT01404936|Bleomycin|bleomycin|mesh-list
56148727|NCT01404936|Dacarbazine|dacarbazine|mesh-list
56148728|NCT01404936|Vinblastine|vinblastine|mesh-list
56148729|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56148799|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56148873|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56148945|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56148946|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56148947|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56148948|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149016|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56149017|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149089|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149090|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56149095|NCT01511640|Pregabalin|pregabalin|mesh-list
56149159|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149160|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56149161|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56149162|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56149163|NCT01520688|Fluticasone|fluticasone|mesh-list
56149164|NCT01520688|Xhance|xhance|mesh-list
56149165|NCT01520688|Budesonide|budesonide|mesh-list
56149166|NCT01520688|Beclomethasone|beclomethasone|mesh-list
56149167|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56149168|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56149169|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
56149170|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56149171|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149172|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56149173|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
56149174|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
56149175|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56149176|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
56149177|NCT01520688|Hormones|hormones|mesh-ancestor
56149178|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56149179|NCT01521546|Eplerenone|eplerenone|mesh-list
56149180|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56149181|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
56149182|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56149183|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149184|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56149185|NCT01521546|Diuretics|diuretics|mesh-ancestor
56149186|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
56149187|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56149188|NCT01523496|Vitamin D|vitamin d|mesh-list
56149189|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
56149203|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56149204|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
56149206|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
56149277|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149278|NCT01541358|Listerine|listerine|mesh-list
56149279|NCT01541358|Fluorides|fluorides|mesh-list
56149280|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
56149281|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
56149282|NCT01541358|Protective Agents|protective agents|mesh-ancestor
56149283|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56149284|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56149285|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56149286|NCT01542372|Prazosin|prazosin|mesh-list
56149340|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56149341|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56149344|NCT01556724|Ropivacaine|ropivacaine|mesh-list
56149411|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56149412|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56149481|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56149482|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56149574|NCT05672784|Meloxicam|meloxicam|mesh-list
56149628|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
56149629|NCT05379972|Olaparib|olaparib|mesh-list
56149630|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56149702|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
56149704|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149775|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
56149776|NCT04868760|Ipilimumab|ipilimumab|mesh-list
56149777|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56149778|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56149844|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56149845|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56149990|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56149992|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56150063|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56124661|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
56150064|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56150065|NCT01641120|Interferons|interferons|mesh-list
56150066|NCT01641120|Interferon-beta|interferon-beta|mesh-list
56150067|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
56150134|NCT01652040|Androgens|androgens|mesh-ancestor
56150135|NCT01652040|Hormones|hormones|mesh-ancestor
56150141|NCT01652976|Leucovorin|leucovorin|mesh-list
56150213|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56150214|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
56150215|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56150285|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
56150286|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
56150289|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
56150360|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150361|NCT05711082|Dopamine|dopamine|mesh-list
56150519|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
56150523|NCT04068948|Midazolam|midazolam|mesh-list
56175938|NCT01392807|Naloxegol|naloxegol|mesh-list
56150593|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56150594|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56150665|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
56150666|NCT01728636|Coagulants|coagulants|mesh-ancestor
56150741|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
56150742|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56150743|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56150745|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
56150813|NCT02996760|Mitogens|mitogens|mesh-list
56150814|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
56150815|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150816|NCT02987946|Nadroparin|nadroparin|mesh-list
56150817|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
56150883|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56150884|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56150885|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56150886|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
56150887|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56150888|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56150889|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
56150890|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56150948|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56150952|NCT01753362|Liraglutide|liraglutide|mesh-list
56151022|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56151023|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151024|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56151025|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56151095|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
56151096|NCT01785186|Rifampin|rifampin|mesh-list
56151170|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
56151243|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56151319|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
56151320|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151393|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56151394|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56151395|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151465|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
56151466|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56151467|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151468|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
56151472|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
56151535|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151536|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
56151538|NCT01856712|Naltrexone|naltrexone|mesh-list
56151609|NCT01878006|Narcotics|narcotics|mesh-ancestor
56151610|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151611|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151612|NCT01878006|Analgesics|analgesics|mesh-ancestor
56151613|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
56151614|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151678|NCT03921060|Denosumab|denosumab|mesh-list
56151679|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56151680|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151681|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
56151747|NCT05650554|Vaccines|vaccines|mesh-list
56151748|NCT05650554|Immunologic Factors|immunologic factors|mesh-ancestor
56151749|NCT05650554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151750|NCT05606718|Dapagliflozin|dapagliflozin|mesh-list
56151751|NCT05606718|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56151752|NCT05606718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151753|NCT05606718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56151754|NCT05606718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151814|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151815|NCT05163522|Midazolam|midazolam|mesh-list
56151816|NCT05163522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56151817|NCT05163522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56151818|NCT05163522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151819|NCT05163522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151820|NCT05163522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56151821|NCT05163522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56151822|NCT05163522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56151823|NCT05163522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56151881|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
56151882|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
56151883|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56151884|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151885|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
56151886|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56151887|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56151888|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56151889|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56151890|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56151891|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151892|NCT04873362|Trastuzumab|trastuzumab|mesh-list
56151893|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56151894|NCT04873362|Atezolizumab|atezolizumab|mesh-list
56151895|NCT04873362|Maytansine|maytansine|mesh-list
56151896|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56151897|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151898|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56151899|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
56151900|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
56151901|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
56151902|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56151903|NCT04740918|Trastuzumab|trastuzumab|mesh-list
56151904|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56151905|NCT04740918|Atezolizumab|atezolizumab|mesh-list
56151906|NCT04740918|Maytansine|maytansine|mesh-list
56151907|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56151908|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56151909|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56151910|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
56151952|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56151987|NCT04360044|Hormones|hormones|mesh-ancestor
56152026|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
56152027|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152028|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56152096|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56152097|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
56152098|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56152100|NCT01881828|Metformin|metformin|mesh-list
56152168|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152169|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152170|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56152171|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
56152172|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
56152173|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56152174|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56152175|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56152183|NCT01907334|Hormones|hormones|mesh-ancestor
56152233|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152234|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56152235|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56152236|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
56152304|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56152305|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56152379|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152380|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56152384|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
56152530|NCT05725200|Abortifacient Agents|abortifacient agents|mesh-ancestor
56152531|NCT05725200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56152532|NCT05725200|Dermatologic Agents|dermatologic agents|mesh-ancestor
56152602|NCT05567952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56152603|NCT05567952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56152677|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
56152751|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
56152752|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
56152753|NCT04696146|Complement C1s|complement c1s|mesh-list
56152754|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56152760|NCT04676646|Spironolactone|spironolactone|mesh-list
56152824|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56152827|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56152898|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
56152993|NCT02723994|Hormones|hormones|mesh-ancestor
56153051|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
56153204|NCT01980654|Rituximab|rituximab|mesh-list
56153205|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56153206|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153207|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
56153208|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153209|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56153210|NCT01984398|Citric Acid|citric acid|mesh-list
56153211|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
56153212|NCT01984398|Enclomiphene|enclomiphene|mesh-list
56153213|NCT01984398|Clomiphene|clomiphene|mesh-list
56153214|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
56153215|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
56153216|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56153217|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
56153218|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
56153219|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153220|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56153263|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153264|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153265|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153266|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
56153267|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
56153268|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153269|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
56153270|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56153271|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
56153272|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
56153273|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56153274|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56153275|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153276|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
56153277|NCT01998438|Coagulants|coagulants|mesh-ancestor
56153278|NCT01999530|Prazosin|prazosin|mesh-list
56153279|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56153280|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56153281|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56153282|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56153283|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
56153284|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153285|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153286|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153287|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56153299|NCT02002650|Indomethacin|indomethacin|mesh-list
56153384|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56153385|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
56153386|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
56153387|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56153388|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56153453|NCT02036424|Growth Substances|growth substances|mesh-ancestor
56153528|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153529|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56153530|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153531|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
56153532|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56153533|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153534|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56153595|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
56153670|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56153671|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56153672|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56153673|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56153741|NCT02160990|Hormones|hormones|mesh-ancestor
56153742|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56153743|NCT02164422|Guanfacine|guanfacine|mesh-list
56153744|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56153812|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56153888|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
56153889|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56153891|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
56153961|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
56153962|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56153963|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56153964|NCT02239770|Nicotine|nicotine|mesh-list
56154031|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154032|NCT02258412|Ethanol|ethanol|mesh-list
56154102|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
56154103|NCT02282514|Rituximab|rituximab|mesh-list
56154104|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
56154105|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56154106|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
56154173|NCT02284854|Analgesics|analgesics|mesh-ancestor
56154174|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
56154182|NCT02285634|Lidocaine|lidocaine|mesh-list
56154245|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
56154246|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154247|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56154316|NCT02303184|Growth Substances|growth substances|mesh-ancestor
56154317|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154318|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
56154319|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154320|NCT02304432|Cycloserine|cycloserine|mesh-list
56154321|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56154322|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56154323|NCT02304432|Renal Agents|renal agents|mesh-ancestor
56154324|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56154380|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56154381|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
56154382|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154383|NCT02331108|Propofol|propofol|mesh-list
56154384|NCT02331108|Anesthetics|anesthetics|mesh-list
56154385|NCT02331108|Sevoflurane|sevoflurane|mesh-list
56154386|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56154387|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154388|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154389|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56154390|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
56154393|NCT02332902|Everolimus|everolimus|mesh-list
56154442|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56154443|NCT02357706|Analgesics|analgesics|mesh-ancestor
56154444|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
56154445|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154446|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154447|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
56154448|NCT02359110|Gabapentin|gabapentin|mesh-list
56154449|NCT02359110|Analgesics|analgesics|mesh-ancestor
56154450|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
56154451|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154452|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154453|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
56154454|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56154455|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56154456|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56154457|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56154458|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56154459|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56154460|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154461|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154463|NCT02360124|Fluorides|fluorides|mesh-list
56154464|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
56154465|NCT02360124|Protective Agents|protective agents|mesh-ancestor
56154467|NCT02369172|Bupropion|bupropion|mesh-list
56154493|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154494|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56154495|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56154565|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154566|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56154567|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56154568|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56154569|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154570|NCT02401542|Docetaxel|docetaxel|mesh-list
56154571|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154572|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
56154573|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
56154574|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
56154575|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154576|NCT02411916|Misoprostol|misoprostol|mesh-list
56154584|NCT02413320|Paclitaxel|paclitaxel|mesh-list
56154627|NCT05718024|Remifentanil|remifentanil|mesh-list
56154702|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154703|NCT05273346|Analgesics|analgesics|mesh-list
56154704|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
56154705|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154706|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154707|NCT05159934|Nicotine|nicotine|mesh-list
56154708|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56154709|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
56154710|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56154711|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154712|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56154713|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56154714|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
56154715|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56154716|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56154717|NCT05105256|Prednisolone|prednisolone|mesh-list
56154718|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56154761|NCT04711824|Paclitaxel|paclitaxel|mesh-list
56154762|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56154763|NCT04711824|Cisplatin|cisplatin|mesh-list
56154834|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56154841|NCT04031508|SMOFlipid|smoflipid|mesh-list
56154845|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
56154920|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56154921|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56154928|NCT02828358|Hormones|hormones|mesh-ancestor
56154994|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
56155069|NCT05722548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56155070|NCT05722548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56155071|NCT05722548|Gout Suppressants|gout suppressants|mesh-ancestor
56155072|NCT05722548|Tocolytic Agents|tocolytic agents|mesh-ancestor
56155294|NCT05570292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155295|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
56155296|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56155297|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56155298|NCT05557812|Eugenol|eugenol|mesh-list
56155299|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
56155300|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
56155310|NCT05549466|Docetaxel|docetaxel|mesh-list
56155364|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
56155439|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
56155440|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
56155441|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
56155442|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155443|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56155444|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
56155445|NCT05251038|Antiviral Agents|antiviral agents|mesh-ancestor
56155509|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56155510|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56155582|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155659|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
56155660|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56155661|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56155662|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56155663|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56155664|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
56155665|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56155726|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56155727|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
56155728|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56155729|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
56155730|NCT04320342|Hormones|hormones|mesh-ancestor
56155731|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56155792|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56155795|NCT03937986|Cocaine|cocaine|mesh-list
56155796|NCT03937986|Suvorexant|suvorexant|mesh-list
56155797|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
56155798|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
56155799|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155808|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
56155864|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56155941|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56155942|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56155943|NCT03367572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56083628|NCT03678428|Leucovorin|leucovorin|mesh-list
56156009|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
56156010|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56156011|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56156012|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56156013|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156014|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156015|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56156074|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56156075|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56156164|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156165|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56156166|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156167|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56156168|NCT02025036|Capecitabine|capecitabine|mesh-list
56156169|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
56156170|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56156171|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
56156173|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156244|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56156318|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
56084005|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
56156319|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
56156393|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084078|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
56156467|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56156468|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56156476|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
56156542|NCT02491944|Osimertinib|osimertinib|mesh-list
56156614|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56156615|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56084307|NCT05673811|Gemcitabine|gemcitabine|mesh-list
56156685|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156686|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56156761|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56156762|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56156836|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156837|NCT02562924|Prednisone|prednisone|mesh-list
56156838|NCT02562924|Budesonide|budesonide|mesh-list
56156839|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56156840|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
56156841|NCT02562924|Hormones|hormones|mesh-ancestor
56156842|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56156843|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156844|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56156845|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56156901|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156902|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
56156903|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
56156904|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56156973|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56156974|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56156975|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157050|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157051|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157052|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56157053|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
56157054|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157055|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56157056|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
56157123|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
56157126|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56157196|NCT05730816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56157197|NCT05730816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56157198|NCT05730816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157199|NCT05730816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56157200|NCT05730816|Tocolytic Agents|tocolytic agents|mesh-ancestor
56157201|NCT05730816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56157202|NCT05730738|4-Aminopyridine|4-aminopyridine|mesh-list
56157203|NCT05730738|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56157204|NCT05730738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56157262|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56157264|NCT04905654|Cromakalim|cromakalim|mesh-list
56157340|NCT02960646|Rituximab|rituximab|mesh-list
56157341|NCT02960646|Fludarabine|fludarabine|mesh-list
56157342|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
56157414|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157487|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
56157488|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157490|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
56157557|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157558|NCT03529890|Nivolumab|nivolumab|mesh-list
56157559|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56157560|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157561|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56157562|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56157563|NCT03471624|Tenofovir|tenofovir|mesh-list
56157626|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
56157627|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56157628|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56157629|NCT02652390|Prednisolone|prednisolone|mesh-list
56157630|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
56157631|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56157632|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
56157633|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56157634|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
56157694|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56157698|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56157764|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
56157765|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56157766|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
56157767|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
56157768|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
56157769|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56157770|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
56157771|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
56157772|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56157832|NCT02698566|Growth Substances|growth substances|mesh-ancestor
56157833|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157834|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
56157835|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56157836|NCT02701062|Warfarin|warfarin|mesh-list
56157903|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56157904|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002379|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
56157974|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56157975|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56158045|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158046|NCT05063604|Citalopram|citalopram|mesh-list
56158052|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
56158110|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158177|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56158178|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158261|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158263|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
56158322|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56158381|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
56158382|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56158449|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158451|NCT04129554|Entecavir|entecavir|mesh-list
56158452|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
56158453|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
56158454|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158455|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56016143|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
56158456|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56158457|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158458|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158459|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56158510|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56158511|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158512|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
56158513|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158515|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56158516|NCT03443856|Nivolumab|nivolumab|mesh-list
56158518|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56158519|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158522|NCT03269136|Thalidomide|thalidomide|mesh-list
56158578|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56158579|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158580|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56158581|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
56158582|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
56158583|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56158584|NCT02952924|Midazolam|midazolam|mesh-list
56158642|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
56158643|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56158644|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56158645|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56158646|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158647|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56158648|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56158649|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56158650|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
56158651|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56158652|NCT05444478|Lenvatinib|lenvatinib|mesh-list
56020022|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56158653|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56158654|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56158655|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56158698|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56158699|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
56158700|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
56158702|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56158703|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56158704|NCT04978584|Growth Substances|growth substances|mesh-ancestor
56158705|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
56158706|NCT04674462|Vaccines|vaccines|mesh-list
56158707|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
56021141|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56158708|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158710|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165363|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56158712|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
56158758|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56158759|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022469|NCT02129426|Midazolam|midazolam|mesh-list
56158760|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56158761|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
56158820|NCT02747628|Melatonin|melatonin|mesh-list
56158821|NCT02747628|Nicotine|nicotine|mesh-list
56158822|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56158823|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
56158896|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56158897|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56158974|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
56159047|NCT03845010|Verapamil|verapamil|mesh-list
56159110|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159112|NCT00039780|Protective Agents|protective agents|mesh-ancestor
56159179|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159180|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159181|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159182|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56159183|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56159184|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
56159185|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56159186|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159187|NCT03743766|Nivolumab|nivolumab|mesh-list
56159188|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56159189|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159190|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56159191|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159194|NCT03556800|Estradiol|estradiol|mesh-list
56159239|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
56159240|NCT02791308|Tacrolimus|tacrolimus|mesh-list
56159241|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56159242|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56159243|NCT02791308|Analgesics|analgesics|mesh-ancestor
56159244|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
56159245|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56159246|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159247|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56159248|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56159249|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
56159250|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56159251|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
56159252|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56159253|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159254|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159255|NCT02796144|Metformin|metformin|mesh-list
56159256|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56035300|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
56159257|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159258|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
56159259|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56159260|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56159261|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56035541|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
56035666|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56159262|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56159263|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159264|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035890|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
56159265|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159266|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56035966|NCT05070650|Expectorants|expectorants|mesh-ancestor
56159267|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56159268|NCT02813070|Flutemetamol|flutemetamol|mesh-list
56036414|NCT01113632|Ofatumumab|ofatumumab|mesh-list
56159272|NCT02815644|Linagliptin|linagliptin|mesh-list
56036487|NCT01099202|Hematinics|hematinics|mesh-ancestor
56159273|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56159274|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036564|NCT02437383|Propranolol|propranolol|mesh-list
56159275|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56036639|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
56159276|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159277|NCT02815644|Incretins|incretins|mesh-ancestor
56159278|NCT02815644|Hormones|hormones|mesh-ancestor
56165365|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56159279|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037478|NCT02579343|Dexetimide|dexetimide|mesh-list
56159324|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
56159325|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
56038376|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56159326|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56159327|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
56159380|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042383|NCT04226495|Dsuvia|dsuvia|mesh-list
56159446|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56159447|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047006|NCT05166083|Testosterone|testosterone|mesh-list
56159577|NCT02956044|Glimepiride|glimepiride|mesh-list
56159578|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
56159579|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56159639|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56159710|NCT03020004|Ritonavir|ritonavir|mesh-list
56159851|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56159852|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56159920|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56159921|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56165383|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56159992|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
56160062|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
56160136|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
56160137|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
56160140|NCT03409614|Cemiplimab|cemiplimab|mesh-list
56160207|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56160208|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56160209|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56160276|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56160352|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56160353|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56160354|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
56160363|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
56160423|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56160424|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56160426|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
56073431|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
56076522|NCT03674294|Aprepitant|aprepitant|mesh-list
56160564|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
56160628|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078102|NCT05064085|Cemiplimab|cemiplimab|mesh-list
56160696|NCT04511520|Trimetazidine|trimetazidine|mesh-list
56160773|NCT03976752|Cobicistat|cobicistat|mesh-list
56160774|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56081541|NCT02483000|Biotin|biotin|mesh-list
56160838|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56160839|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56160845|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
56160905|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56160906|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
56160907|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56160910|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56160969|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
56161039|NCT02345460|Calcium|calcium|mesh-list
56161040|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
56161041|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56161109|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56161176|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161177|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56161178|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
56161179|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095756|NCT00001016|Leucovorin|leucovorin|mesh-list
56161181|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56161182|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
56161183|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56161184|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56161185|NCT01756560|Bupivacaine|bupivacaine|mesh-list
56161186|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
56161187|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
56161188|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56165388|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
56161242|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56161243|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161310|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
56161383|NCT01031550|Propofol|propofol|mesh-list
56161384|NCT01031550|Isoflurane|isoflurane|mesh-list
56161444|NCT00749658|Bupropion|bupropion|mesh-list
56104473|NCT00002755|Cobalt|cobalt|mesh-list
56161446|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56161511|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56107721|NCT00003541|Prednisone|prednisone|mesh-list
56161512|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
56161514|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
56161578|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56161645|NCT04575090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56161646|NCT04575090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56114514|NCT00001955|Analgesics|analgesics|mesh-ancestor
56161647|NCT04575090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56161648|NCT04575090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161649|NCT04100772|Vaccines|vaccines|mesh-list
56161708|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161782|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56161783|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121582|NCT01762800|Xhance|xhance|mesh-list
56121796|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56161858|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56161859|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56161860|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56161861|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56161875|NCT00000138|Acyclovir|acyclovir|mesh-list
56161922|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56161923|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
56161997|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
56161999|NCT00000270|Cocaine|cocaine|mesh-list
56162145|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56162147|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56162219|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162220|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162221|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56162222|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56162290|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56162292|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162365|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162366|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162367|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
56162368|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162369|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56162437|NCT00000918|Saquinavir|saquinavir|mesh-list
56162438|NCT00000918|Amprenavir|amprenavir|mesh-list
56162439|NCT00000918|Lamivudine|lamivudine|mesh-list
56162440|NCT00000918|Zidovudine|zidovudine|mesh-list
56162441|NCT00000918|Didanosine|didanosine|mesh-list
56162510|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56162584|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56162585|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56162587|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
56162658|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56162731|NCT00001698|Ketorolac|ketorolac|mesh-list
56162733|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56162734|NCT00001698|Analgesics|analgesics|mesh-ancestor
56162806|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
56162879|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56162880|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56163028|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163029|NCT00002148|OPC 14117|opc 14117|mesh-list
56163030|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56163031|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
56163032|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163033|NCT00002148|Protective Agents|protective agents|mesh-ancestor
56163099|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163100|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56163101|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56163102|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
56163173|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163176|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
56163245|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
56163246|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56163249|NCT00002286|Zidovudine|zidovudine|mesh-list
56163319|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56163320|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163321|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163391|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56163392|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
56163393|NCT00002382|Saquinavir|saquinavir|mesh-list
56163465|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56163466|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56163540|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55903727|NCT02668432|Amiodarone|amiodarone|mesh-list
55903802|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
56163608|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
56163609|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56163618|NCT00002496|Cobalt|cobalt|mesh-list
56163683|NCT00002514|Hormones|hormones|mesh-ancestor
56163684|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56163687|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
56163757|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56163758|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
56163832|NCT00002562|Paclitaxel|paclitaxel|mesh-list
56163906|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
56163907|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
56163908|NCT00002592|Busulfan|busulfan|mesh-list
56163909|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56163910|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
56163975|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56163989|NCT00002616|Aldesleukin|aldesleukin|mesh-list
56164047|NCT00002634|Trace Elements|trace elements|mesh-ancestor
56164048|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
56164049|NCT00002646|Tamoxifen|tamoxifen|mesh-list
56164122|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164123|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56164189|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164190|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
56164197|NCT00002688|Analgesics|analgesics|mesh-ancestor
56164261|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
56164262|NCT00002718|Cytarabine|cytarabine|mesh-list
56164263|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
56164264|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
56164325|NCT00002748|Analgesics|analgesics|mesh-ancestor
56164326|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
56164330|NCT00002754|Antibodies|antibodies|mesh-list
56164391|NCT00002784|Fluorouracil|fluorouracil|mesh-list
56164451|NCT05752110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55929630|NCT03836703|Iron|iron|mesh-list
56164514|NCT05748834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164515|NCT05748834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56164516|NCT05746806|Androgens|androgens|mesh-list
56164517|NCT05746806|Hormones|hormones|mesh-ancestor
56164518|NCT05746806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56164589|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56164590|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
56164674|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56164675|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164676|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164677|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56164678|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56164679|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164680|NCT05360628|Allopurinol|allopurinol|mesh-list
56164681|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
56164682|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937379|NCT01114971|Labetalol|labetalol|mesh-list
56164735|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56164736|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56164820|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55940034|NCT01176461|Nivolumab|nivolumab|mesh-list
56164821|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164887|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942151|NCT04120363|Hormones|hormones|mesh-ancestor
56164888|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56164889|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56164890|NCT04538664|Carboplatin|carboplatin|mesh-list
56164891|NCT04538664|Pemetrexed|pemetrexed|mesh-list
55942296|NCT03822559|Timolol|timolol|mesh-list
56164893|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56164894|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56164895|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945273|NCT04881474|Ibuprofen|ibuprofen|mesh-list
55945400|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56164949|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
56164950|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56164951|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55945547|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56164952|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56164953|NCT04331652|Anesthetics|anesthetics|mesh-list
56165023|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
56165024|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165025|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165086|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165088|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55951326|NCT05606315|Propofol|propofol|mesh-list
56165102|NCT03652428|Gemcitabine|gemcitabine|mesh-list
56165156|NCT02829918|Nivolumab|nivolumab|mesh-list
56165157|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56165158|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952522|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165212|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165213|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165287|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56334059|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
56334060|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334061|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56334062|NCT00065130|Insulin|insulin|mesh-list
56334063|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56334064|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
56334122|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334123|NCT00038168|Paclitaxel|paclitaxel|mesh-list
56334187|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56334188|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334189|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334190|NCT00065559|Celecoxib|celecoxib|mesh-list
56334249|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56334250|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965995|NCT04165135|Factor VIII|factor viii|mesh-list
56334311|NCT00396734|Modafinil|modafinil|mesh-list
56334312|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
56334313|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56334314|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56334315|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56334316|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56334385|NCT00070200|Melphalan|melphalan|mesh-list
56334453|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56334526|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
56334527|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56334600|NCT00066768|Docetaxel|docetaxel|mesh-list
56165418|NCT00002898|Vincristine|vincristine|mesh-list
56334601|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56334669|NCT04732364|Bupivacaine|bupivacaine|mesh-list
55982611|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
56334741|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56334742|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
56334805|NCT00071136|Immunologic Factors|immunologic factors|mesh-ancestor
56334806|NCT00071136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985612|NCT00915967|Vancomycin|vancomycin|mesh-list
56334807|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56334870|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334872|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56334873|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55956657|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56334874|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56334875|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
56334877|NCT03338621|Isoniazid|isoniazid|mesh-list
56334879|NCT03338621|Ethambutol|ethambutol|mesh-list
56334880|NCT03338621|Bedaquiline|bedaquiline|mesh-list
55988407|NCT02802514|Incretins|incretins|mesh-ancestor
55988480|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56334881|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56334882|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56334883|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56334919|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
55990918|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
56334920|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167886|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167887|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56167888|NCT00005796|Vincristine|vincristine|mesh-list
56167949|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168020|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56168097|NCT00357240|Omeprazole|omeprazole|mesh-list
56168098|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56168099|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56168167|NCT00357942|Morphine|morphine|mesh-list
56168168|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56168169|NCT00357942|Narcotics|narcotics|mesh-ancestor
56168170|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56168232|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56168233|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56168295|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56168296|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56168297|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168308|NCT00360984|Insulin|insulin|mesh-list
56168371|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
56168372|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56168373|NCT00362778|Insulin|insulin|mesh-list
56168442|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56168443|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
56168444|NCT00364806|Metoclopramide|metoclopramide|mesh-list
56168516|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56168517|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56168585|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56168586|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56168593|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
56168657|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56168658|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
56168659|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168725|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56168726|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168727|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
56168798|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
56168799|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56168800|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56168801|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56168802|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
56168867|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
56168868|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56168869|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56168870|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168941|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56168942|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56168943|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56168945|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56168946|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
56169014|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784012|NCT05002517|Protective Agents|protective agents|mesh-ancestor
56169017|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
56169018|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56169021|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169081|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56169082|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
56169084|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55784133|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169155|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169226|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56169228|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56169229|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
56169230|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169231|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169232|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55784230|NCT02578069|Sirolimus|sirolimus|mesh-list
56169233|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56169234|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
56169235|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56169236|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169239|NCT00385398|Temozolomide|temozolomide|mesh-list
56169292|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56169293|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
56169294|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56169295|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
56169296|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56169297|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56169360|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
56097055|NCT04714177|Edaravone|edaravone|mesh-list
56169434|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56169435|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56169436|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56169438|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
56169502|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
56169503|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56169513|NCT02993640|Coagulants|coagulants|mesh-ancestor
56169578|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
56169579|NCT02999958|Antioxidants|antioxidants|mesh-list
56169651|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56169652|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169653|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
56169654|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784653|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169655|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169656|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
56097284|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
56169657|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56169658|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56169659|NCT01270932|Growth Substances|growth substances|mesh-ancestor
56169660|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
56169662|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56169663|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
55784663|NCT04988789|Paclitaxel|paclitaxel|mesh-list
56169711|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56169712|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56169713|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169714|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56169715|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56169716|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
56169717|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56169718|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
56169719|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56169776|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
56169777|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56169778|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56169779|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56169780|NCT01277640|Dapivirine|dapivirine|mesh-list
56169847|NCT01276236|Maraviroc|maraviroc|mesh-list
56169848|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56169849|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56169850|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56169918|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
56169919|NCT01271790|Ribavirin|ribavirin|mesh-list
56169920|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
56169924|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
56169989|NCT00249288|Vitamins|vitamins|mesh-ancestor
56169990|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
56169992|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
56170061|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170062|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56170131|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
56170133|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56170134|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
56170210|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56170211|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56170212|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170213|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56170214|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56170215|NCT04096638|Atezolizumab|atezolizumab|mesh-list
56170216|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785231|NCT01794793|Cabergoline|cabergoline|mesh-list
56170226|NCT03467256|Cytarabine|cytarabine|mesh-list
56170291|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56170384|NCT05311722|Narcotics|narcotics|mesh-ancestor
56170385|NCT05311254|Fosfomycin|fosfomycin|mesh-list
56170386|NCT05311254|Calcium|calcium|mesh-list
56170388|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170455|NCT03216876|Analgesics|analgesics|mesh-ancestor
56170463|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
56170524|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
56170525|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55852954|NCT00242632|Memantine|memantine|mesh-list
56170592|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
56170593|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56170594|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170662|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56170663|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
56170678|NCT01835340|Propofol|propofol|mesh-list
56170738|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
56170739|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56170740|NCT01838928|Bupivacaine|bupivacaine|mesh-list
56170741|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
56170814|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56170815|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56170817|NCT01836432|Gemcitabine|gemcitabine|mesh-list
56170818|NCT01836432|Paclitaxel|paclitaxel|mesh-list
56170819|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56170887|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56170888|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56170889|NCT01721694|Azithromycin|azithromycin|mesh-list
56170957|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56170958|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
56170961|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
56178163|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
56171032|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56171105|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
55786046|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56171107|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56171192|NCT01046682|Analgesics|analgesics|mesh-ancestor
56171253|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56171254|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171255|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171256|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
56171257|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56171258|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171317|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171318|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56171319|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56171388|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56171389|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171390|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171393|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55786364|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56171460|NCT02241876|Antidotes|antidotes|mesh-ancestor
56171461|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56171462|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56171527|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56171528|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56171529|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56171530|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56171531|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
56171532|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
56171533|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56171534|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56171535|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
56171536|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171537|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56171538|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
56171581|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171582|NCT02244294|Urological Agents|urological agents|mesh-ancestor
56171583|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
56171584|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
56171585|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56171586|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56171649|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
56171650|NCT02247648|Tramadol|tramadol|mesh-list
56171651|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56171652|NCT02247648|Narcotics|narcotics|mesh-ancestor
56171715|NCT02249130|Lamivudine|lamivudine|mesh-list
56171716|NCT02249130|Zidovudine|zidovudine|mesh-list
56171717|NCT02249130|Stavudine|stavudine|mesh-list
56171718|NCT02249130|Tipranavir|tipranavir|mesh-list
56171719|NCT02249130|Delavirdine|delavirdine|mesh-list
56171725|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56171786|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56171787|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56171788|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56171789|NCT02245308|Bupropion|bupropion|mesh-list
56171790|NCT02245308|Nicotine|nicotine|mesh-list
56171791|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56171792|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
56171793|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56171795|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56171848|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56171849|NCT00558636|Paclitaxel|paclitaxel|mesh-list
56171850|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56171851|NCT00558636|Carboplatin|carboplatin|mesh-list
56171919|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56171920|NCT00552240|Tenofovir|tenofovir|mesh-list
56171921|NCT00552240|Emtricitabine|emtricitabine|mesh-list
56171922|NCT00552240|Nevirapine|nevirapine|mesh-list
56171923|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56171938|NCT00550836|Gemcitabine|gemcitabine|mesh-list
56171989|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
55786820|NCT01402271|Paclitaxel|paclitaxel|mesh-list
56171990|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56171992|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
56172062|NCT03839160|Narcotics|narcotics|mesh-ancestor
56172063|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56172064|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172065|NCT03839160|Analgesics|analgesics|mesh-ancestor
56172066|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
56172133|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
56172134|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
56172203|NCT05768542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172204|NCT05768464|Axitinib|axitinib|mesh-list
56172205|NCT05768464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172206|NCT05768464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56172207|NCT05768464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172208|NCT05768464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56172209|NCT05768373|Fluorides|fluorides|mesh-list
56172210|NCT05768373|Cariostatic Agents|cariostatic agents|mesh-ancestor
56172211|NCT05768373|Protective Agents|protective agents|mesh-ancestor
56172212|NCT05768373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172213|NCT05768360|Metformin|metformin|mesh-list
56172214|NCT05768360|Digoxin|digoxin|mesh-list
56172215|NCT05768360|Furosemide|furosemide|mesh-list
56172216|NCT05768360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56172217|NCT05768360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56172218|NCT05768360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172262|NCT05768204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56172263|NCT05768204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172264|NCT05768204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56172265|NCT05768204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56172266|NCT05768204|Antiemetics|antiemetics|mesh-ancestor
56172335|NCT05767827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56172336|NCT05767827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55787176|NCT04977557|Thiamine|thiamine|mesh-list
56172408|NCT05767684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56172409|NCT05767684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56172410|NCT05767671|Dimercaprol|dimercaprol|mesh-list
56172411|NCT05767671|Chelating Agents|chelating agents|mesh-ancestor
56172412|NCT05767671|Sequestering Agents|sequestering agents|mesh-ancestor
56172414|NCT05767632|Solifenacin Succinate|solifenacin succinate|mesh-list
56172481|NCT05767229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56172482|NCT05767229|Antioxidants|antioxidants|mesh-ancestor
56172483|NCT05767229|Protective Agents|protective agents|mesh-ancestor
56172484|NCT05767229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56172485|NCT05767229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56172571|NCT05754073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172572|NCT05753267|Mesalamine|mesalamine|mesh-list
56172642|NCT05642416|Anesthetics, Local|anesthetics, local|mesh-ancestor
56172643|NCT05642416|Anesthetics|anesthetics|mesh-ancestor
56172665|NCT05621616|Mirabegron|mirabegron|mesh-list
56172715|NCT05604599|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56172716|NCT05604599|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56172717|NCT05604599|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56172791|NCT05581823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172792|NCT05581823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56172793|NCT05581823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56172794|NCT05581823|Analgesics|analgesics|mesh-ancestor
56172795|NCT05581823|Sensory System Agents|sensory system agents|mesh-ancestor
56172796|NCT05581823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56172797|NCT05581823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56172798|NCT05581823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56172863|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56172864|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56172935|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56172936|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
56172940|NCT05284019|Erenumab|erenumab|mesh-list
56173007|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56173013|NCT05249634|Hormones|hormones|mesh-ancestor
56173088|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
55787921|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56173171|NCT05019638|Epinephrine|epinephrine|mesh-list
56173172|NCT05019638|Racepinephrine|racepinephrine|mesh-list
56173173|NCT05019638|Morphine|morphine|mesh-list
56173174|NCT05019638|Bupivacaine|bupivacaine|mesh-list
56173175|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
56173176|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
56173177|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
56173178|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56173179|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173180|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
56173269|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56173270|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173271|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
56173340|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56173342|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173343|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
56173404|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56173500|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56173501|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
56173503|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56173575|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56173576|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56173577|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56173578|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56173579|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788212|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56173580|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56173581|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56173582|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
56173587|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173637|NCT04189783|Bupivacaine|bupivacaine|mesh-list
56173638|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
56173639|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
56173642|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
56173715|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
56173716|NCT04090567|Olaparib|olaparib|mesh-list
56173717|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56173810|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56173811|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56173812|NCT03911505|Miglustat|miglustat|mesh-list
56173889|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56173893|NCT03654833|Bevacizumab|bevacizumab|mesh-list
56173961|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
56174038|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56174039|NCT02995252|Tenofovir|tenofovir|mesh-list
56174040|NCT02995252|Liver Extracts|liver extracts|mesh-list
56174116|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56174117|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56174129|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
56174189|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56174190|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56174262|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56174263|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56174264|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56174333|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56174404|NCT01850303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174411|NCT01763671|Paclitaxel|paclitaxel|mesh-list
56174476|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174477|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174547|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56130234|NCT00631488|Incretins|incretins|mesh-ancestor
56174548|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
56174617|NCT01384682|Maraviroc|maraviroc|mesh-list
56174621|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56174694|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174695|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56174759|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56174760|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56174761|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56174831|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56174832|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56174833|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56174834|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56174835|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56174836|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56174837|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56174838|NCT01386333|Oxytocin|oxytocin|mesh-list
56174839|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
56174840|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56174841|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174842|NCT01386346|Capecitabine|capecitabine|mesh-list
56174896|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56174967|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
56174968|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56174969|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56174970|NCT01386853|Atorvastatin|atorvastatin|mesh-list
56175103|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175173|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56175174|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56175175|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175248|NCT01388660|Clopidogrel|clopidogrel|mesh-list
56175252|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56175322|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56175323|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
56175324|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56134532|NCT00224952|Carbamazepine|carbamazepine|mesh-list
56175390|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56175463|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56175464|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
56175465|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56175470|NCT01389778|Metformin|metformin|mesh-list
56175531|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56175532|NCT01390311|Azacitidine|azacitidine|mesh-list
56175533|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56175606|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56139185|NCT05239741|Vitamins|vitamins|mesh-ancestor
56175607|NCT01390766|Azathioprine|azathioprine|mesh-list
56175675|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56142387|NCT03008148|Temozolomide|temozolomide|mesh-list
56143783|NCT00706446|Xhance|xhance|mesh-list
56175817|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56175897|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56175898|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56175899|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
56175900|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56175901|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56175902|NCT01392755|Ritonavir|ritonavir|mesh-list
56175903|NCT01392755|Omeprazole|omeprazole|mesh-list
56175904|NCT01392755|Ranitidine|ranitidine|mesh-list
56175970|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56176137|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56176138|NCT01393925|Analgesics|analgesics|mesh-ancestor
56176139|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
56176213|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56176214|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56176215|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56176216|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176217|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
56176218|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56178934|NCT02195986|Estradiol|estradiol|mesh-list
56176219|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
56176283|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
56176284|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
56176285|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56176286|NCT01394731|Acetaminophen|acetaminophen|mesh-list
56176287|NCT01394731|Meperidine|meperidine|mesh-list
56176288|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56176289|NCT01394731|Analgesics|analgesics|mesh-ancestor
56176290|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
56176291|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56176347|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56176348|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56176349|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176350|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56176351|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
56176352|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176353|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56176354|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56176359|NCT01394887|Metformin|metformin|mesh-list
56176407|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56176408|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176482|NCT01395654|Isoniazid|isoniazid|mesh-list
56176483|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
56176484|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56176485|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
56176486|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56176552|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
56176553|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
56176554|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56176555|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56176622|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
56176623|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56176624|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56176696|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
56176697|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56176698|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56176699|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56176700|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56176701|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56176778|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56176779|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56176855|NCT04975269|Acetazolamide|acetazolamide|mesh-list
56176929|NCT03524170|Atezolizumab|atezolizumab|mesh-list
56176930|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56176931|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
56176932|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56176995|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56104720|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
56176996|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177018|NCT02420912|Nivolumab|nivolumab|mesh-list
56177067|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56177143|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
56177219|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56177220|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56177221|NCT05271253|Analgesics|analgesics|mesh-ancestor
56177222|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56177223|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56177224|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56177290|NCT05270421|Diuretics|diuretics|mesh-ancestor
56177367|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
56177368|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56177369|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
56177370|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
56177372|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56177373|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
56177374|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56177436|NCT05162118|Nivolumab|nivolumab|mesh-list
56177526|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56177527|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
56177600|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56177609|NCT05045313|Digoxin|digoxin|mesh-list
56177676|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56177777|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56177877|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56177956|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56178108|NCT03758170|Hormones|hormones|mesh-ancestor
56178110|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56178186|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178265|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56178266|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
56178267|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56178268|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178269|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56178270|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56178271|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56178272|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56178273|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56178274|NCT03315039|Annamycin|annamycin|mesh-list
56178275|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56178277|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
56178320|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56178398|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56178545|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178551|NCT02879942|Growth Substances|growth substances|mesh-ancestor
56178639|NCT02711826|Acetaminophen|acetaminophen|mesh-list
56178640|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
56178641|NCT02711826|Promethazine|promethazine|mesh-list
56178642|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
56178643|NCT02711826|Everolimus|everolimus|mesh-list
56178644|NCT02711826|Tacrolimus|tacrolimus|mesh-list
56178645|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56178646|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
56178647|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178712|NCT02636322|Prednisone|prednisone|mesh-list
56178713|NCT02636322|Cortisone|cortisone|mesh-list
56178714|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
56178715|NCT02636322|Rituximab|rituximab|mesh-list
56178716|NCT02636322|Doxorubicin|doxorubicin|mesh-list
56178718|NCT02636322|Etoposide|etoposide|mesh-list
56178787|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56178788|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56178864|NCT02369653|Anticoagulants|anticoagulants|mesh-list
56178944|NCT01982630|Liraglutide|liraglutide|mesh-list
56178945|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56178947|NCT01982630|Incretins|incretins|mesh-ancestor
56179016|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56179090|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179164|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179166|NCT00600015|Sorafenib|sorafenib|mesh-list
56179167|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56179235|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
56179312|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56179313|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179326|NCT01398189|Clozapine|clozapine|mesh-list
56179383|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56179447|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56181809|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182026|NCT01415765|Hormones|hormones|mesh-ancestor
56179518|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56179519|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179520|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
56185087|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
56179585|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187029|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56187030|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56187838|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
56187839|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56187840|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56187841|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187842|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187844|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56187845|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56187846|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188648|NCT01445392|Pemetrexed|pemetrexed|mesh-list
56179591|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56179592|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56179593|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56188797|NCT01446211|Protective Agents|protective agents|mesh-ancestor
56188798|NCT01446276|Resveratrol|resveratrol|mesh-list
56188799|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
56189245|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
56189756|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189758|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56189760|NCT01460797|Metformin|metformin|mesh-list
56190287|NCT01467362|V0034CR|v0034cr|mesh-list
56193240|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56179681|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56194702|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
56179744|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
56179758|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56179760|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56197309|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
56198899|NCT01515553|Liraglutide|liraglutide|mesh-list
56198928|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
56201481|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
56202603|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202725|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
56202727|NCT01536028|Insulin|insulin|mesh-list
56202728|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56202797|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56179927|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202895|NCT01536743|Palbociclib|palbociclib|mesh-list
56202967|NCT01537354|Poractant alfa|poractant alfa|mesh-list
56203092|NCT01538316|Hormones|hormones|mesh-ancestor
56203093|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56203159|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
56203292|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56203504|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56203653|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56203654|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56203655|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56203656|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
56203703|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56203704|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56203705|NCT01541124|Morphine|morphine|mesh-list
56203706|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56203707|NCT01541124|Narcotics|narcotics|mesh-ancestor
56203708|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180049|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
56204042|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204043|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
56204044|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56204045|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56204046|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56204047|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204095|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204096|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56204160|NCT01543945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56204235|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56204526|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56204527|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56204674|NCT01547416|Fentanyl|fentanyl|mesh-list
56204815|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56204816|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56204817|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56204818|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56204819|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56204820|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
56204821|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56204823|NCT01548326|Atorvastatin|atorvastatin|mesh-list
56204877|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56204878|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56204879|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56204886|NCT01548859|Midazolam|midazolam|mesh-list
56204945|NCT01549158|Torsemide|torsemide|mesh-list
56205008|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205009|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
56205010|NCT01549548|Ponatinib|ponatinib|mesh-list
56205011|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56180137|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56205151|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
56205152|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56205263|NCT01551368|Nimodipine|nimodipine|mesh-list
56205401|NCT01552044|Spironolactone|spironolactone|mesh-list
56146043|NCT01001442|Maytansine|maytansine|mesh-list
56205876|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
56206078|NCT01557335|Clopidogrel|clopidogrel|mesh-list
56180370|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56206278|NCT01558713|Fentanyl|fentanyl|mesh-list
56180398|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206460|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56206461|NCT01559974|Vitamins|vitamins|mesh-ancestor
56206462|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
56206463|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56206464|NCT01560117|Rituximab|rituximab|mesh-list
56206465|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56206603|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206664|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56206665|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56206666|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56206667|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206668|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206669|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
56206670|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
56206733|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56206734|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56206735|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
56206736|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56206737|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56206738|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206739|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56206871|NCT04298853|Morphine|morphine|mesh-list
56206872|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56206946|NCT03972280|Antibodies|antibodies|mesh-list
56207143|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56207273|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56207274|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
56207275|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207276|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56207279|NCT01561586|Cisplatin|cisplatin|mesh-list
56207614|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
56180601|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56180602|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56180603|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56180604|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56180605|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56207784|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56207785|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56207786|NCT01572012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56207787|NCT01572012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56207788|NCT01572012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56207789|NCT01572012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56207790|NCT01572012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56207791|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56207797|NCT01572116|Lidocaine|lidocaine|mesh-list
56207888|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56207889|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56207890|NCT01572350|Bevacizumab|bevacizumab|mesh-list
56207891|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56207892|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56207953|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55877589|NCT03529422|Durvalumab|durvalumab|mesh-list
56208063|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56208064|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
56208129|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56208130|NCT01573806|Exenatide|exenatide|mesh-list
56208131|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56208132|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208133|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56208134|NCT01573806|Incretins|incretins|mesh-ancestor
56208135|NCT01573806|Hormones|hormones|mesh-ancestor
56208136|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208137|NCT01573975|Clarithromycin|clarithromycin|mesh-list
56208273|NCT01575613|Lumefantrine|lumefantrine|mesh-list
56208341|NCT01576094|Simendan|simendan|mesh-list
56208410|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56208411|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56208412|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56208480|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56208653|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56208654|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56208655|NCT01578174|Analgesics|analgesics|mesh-ancestor
56208656|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
56208657|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56208658|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56208659|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56180865|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
56208824|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56180935|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
56180940|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56180941|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56180942|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56180943|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56181020|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181021|NCT01408524|Diltiazem|diltiazem|mesh-list
56181022|NCT01408524|Labetalol|labetalol|mesh-list
56181023|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56181024|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56181025|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56209135|NCT01583062|Amoxicillin|amoxicillin|mesh-list
56209210|NCT01587482|Paclitaxel|paclitaxel|mesh-list
56209266|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56209267|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56209268|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56209269|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56209270|NCT01589614|Erythromycin|erythromycin|mesh-list
56181112|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181113|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
56181114|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56181123|NCT01409005|Gemcitabine|gemcitabine|mesh-list
56181215|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
56209859|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56209862|NCT01593410|Hormones|hormones|mesh-ancestor
56209980|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
56209981|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56210104|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56210105|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210160|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
56210227|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210228|NCT01595724|Dienogest|dienogest|mesh-list
56109208|NCT00004207|Daunorubicin|daunorubicin|mesh-list
56210284|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
56210285|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210286|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56181471|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181472|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56181473|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56181482|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
56181483|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
56210342|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56210343|NCT01596075|Cannabidiol|cannabidiol|mesh-list
56210344|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
56210345|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
56210346|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
56210410|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
56210411|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210412|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56181484|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56181485|NCT01411423|Sorafenib|sorafenib|mesh-list
56210527|NCT01596777|Naltrexone|naltrexone|mesh-list
56210529|NCT01596777|Loperamide|loperamide|mesh-list
56210603|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56210604|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
56210614|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
56210658|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
56210659|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
56210660|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210661|NCT01597310|Protective Agents|protective agents|mesh-ancestor
56210662|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56210663|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56210664|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56210665|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
56210858|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
56210859|NCT01598259|Melatonin|melatonin|mesh-list
56210860|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
56210862|NCT01598259|Protective Agents|protective agents|mesh-ancestor
56210926|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56210984|NCT01598883|Calcium heparin|calcium heparin|mesh-list
56210985|NCT01598883|Antithrombins|antithrombins|mesh-list
56210986|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
56181632|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
56181633|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211053|NCT01599338|Hormones|hormones|mesh-ancestor
56211054|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56211055|NCT01599364|Ritonavir|ritonavir|mesh-list
56211147|NCT05690646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56211148|NCT05690646|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56211149|NCT05690646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56211151|NCT05690321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56181655|NCT01412840|Diclofenac|diclofenac|mesh-list
56181666|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211209|NCT05689996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56211210|NCT05689983|Budesonide|budesonide|mesh-list
56211211|NCT05689983|Formoterol Fumarate|formoterol fumarate|mesh-list
56211212|NCT05689983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56211220|NCT05689983|Hormones|hormones|mesh-ancestor
56211500|NCT05251376|Morphine|morphine|mesh-list
56211580|NCT05106192|Hormones|hormones|mesh-ancestor
56211664|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211666|NCT04873557|Copper|copper|mesh-list
56211732|NCT04742634|Decitabine|decitabine|mesh-list
56211733|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211734|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
56211735|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211736|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211737|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211738|NCT04734990|Azacitidine|azacitidine|mesh-list
56211739|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56211740|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
56211741|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56211742|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211743|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56211744|NCT04733118|Trastuzumab|trastuzumab|mesh-list
56211745|NCT04733118|Pertuzumab|pertuzumab|mesh-list
56181919|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211753|NCT04714619|Letrozole|letrozole|mesh-list
56211902|NCT04265755|Erenumab|erenumab|mesh-list
56182165|NCT01416701|Vitamin D|vitamin d|mesh-list
56182195|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182196|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56212093|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212094|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56212095|NCT03470675|Narcotics|narcotics|mesh-ancestor
56212096|NCT03462251|Paclitaxel|paclitaxel|mesh-list
56212097|NCT03462251|Bevacizumab|bevacizumab|mesh-list
56212098|NCT03462251|Capecitabine|capecitabine|mesh-list
56212099|NCT03462251|Fulvestrant|fulvestrant|mesh-list
56212100|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56212101|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212102|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212104|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212105|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212108|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56212153|NCT03418038|Hormones|hormones|mesh-ancestor
56212155|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56212212|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56212216|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182285|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182286|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182287|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56110031|NCT00005113|Tacrolimus|tacrolimus|mesh-list
56182288|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56182289|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
56182290|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182375|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56182376|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56182377|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
56182378|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182379|NCT01418118|Dobutamine|dobutamine|mesh-list
56182380|NCT01418118|Epinephrine|epinephrine|mesh-list
56182381|NCT01418118|Norepinephrine|norepinephrine|mesh-list
56182382|NCT01418118|Dopexamine|dopexamine|mesh-list
56182383|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56182384|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56182385|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
56182386|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182387|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182388|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182404|NCT01418131|Tacrolimus|tacrolimus|mesh-list
56182512|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56212532|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56212533|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212534|NCT05274243|Phenol|phenol|mesh-list
56212535|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56212536|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212537|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
56212538|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56212539|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56212540|NCT05270733|Ustekinumab|ustekinumab|mesh-list
56212541|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
56212542|NCT05253417|Cannabidiol|cannabidiol|mesh-list
56212543|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
56212544|NCT05184803|Docetaxel|docetaxel|mesh-list
56212546|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212581|NCT04935359|Antiviral Agents|antiviral agents|mesh-ancestor
56212582|NCT04935359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212583|NCT04935359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212584|NCT04935359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212585|NCT04935359|Immunologic Factors|immunologic factors|mesh-ancestor
56212586|NCT04935359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212587|NCT04929028|Fluorouracil|fluorouracil|mesh-list
56212588|NCT04929028|Capecitabine|capecitabine|mesh-list
56212589|NCT04929028|Nivolumab|nivolumab|mesh-list
56212590|NCT04929028|Mitomycins|mitomycins|mesh-list
56212591|NCT04929028|Mitomycin|mitomycin|mesh-list
56212592|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
56212593|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212594|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56212595|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212596|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212597|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
56212699|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212700|NCT04452877|Trametinib|trametinib|mesh-list
56212701|NCT04452877|Dabrafenib|dabrafenib|mesh-list
56212702|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56212703|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56212704|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212705|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212706|NCT04427709|Oxytocin|oxytocin|mesh-list
56212707|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
55752268|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212764|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56212765|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56212766|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212767|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56212768|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
56212769|NCT04231877|Hormones|hormones|mesh-ancestor
56212770|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56212771|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56212772|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56212773|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56212819|NCT04037527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56212820|NCT04037527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212821|NCT04037527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56212822|NCT04037527|Immunologic Factors|immunologic factors|mesh-ancestor
56212823|NCT04037527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212824|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
56212825|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212826|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212827|NCT04009044|Tamoxifen|tamoxifen|mesh-list
56212828|NCT04009044|Afimoxifene|afimoxifene|mesh-list
56212847|NCT03980769|Fludarabine|fludarabine|mesh-list
56212877|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212878|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212879|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56212891|NCT03921008|Paclitaxel|paclitaxel|mesh-list
56212944|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56212945|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56212990|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212992|NCT03710564|Aflibercept|aflibercept|mesh-list
56213069|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
56213104|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56213158|NCT02938442|Paclitaxel|paclitaxel|mesh-list
56165470|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
56165471|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753401|NCT03198403|Epinephrine|epinephrine|mesh-list
56165472|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56165473|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56165474|NCT00002952|Growth Substances|growth substances|mesh-ancestor
56182780|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
56182781|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182782|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182783|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56182784|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56182785|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56182786|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56182827|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56182828|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182829|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56182830|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
56182831|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56182832|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
56182833|NCT01420913|Pregabalin|pregabalin|mesh-list
56182834|NCT01420913|Analgesics|analgesics|mesh-ancestor
56182835|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
56165484|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56165485|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56165486|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56165529|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165530|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165531|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
56165532|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165533|NCT00002988|Irinotecan|irinotecan|mesh-list
56165534|NCT00002988|Carmustine|carmustine|mesh-list
56165535|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56165595|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165596|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
56165664|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56165665|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165666|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
56165667|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
56165668|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
56165669|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165670|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56165671|NCT00003072|Protective Agents|protective agents|mesh-ancestor
56165672|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165673|NCT00003078|Fluorouracil|fluorouracil|mesh-list
56165674|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165675|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
56165677|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56165703|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
56165704|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56165705|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56165706|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56165707|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56165709|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56165750|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
56165818|NCT00003198|Topotecan|topotecan|mesh-list
56182916|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182917|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56182918|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56182919|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56182920|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56182921|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56182922|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56182923|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56182924|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56182925|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56182954|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56182955|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56182956|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56182957|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56165961|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55755519|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
56165962|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
56165963|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56165964|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56165965|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56165966|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56165967|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
56165968|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
56165969|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56165970|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56165971|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
56165972|NCT00003336|Hormones|hormones|mesh-ancestor
56165975|NCT00003336|Protective Agents|protective agents|mesh-ancestor
56166010|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56166011|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166012|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166013|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166014|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166015|NCT00003378|Gemcitabine|gemcitabine|mesh-list
56166016|NCT00003378|Paclitaxel|paclitaxel|mesh-list
56166017|NCT00003378|Carboplatin|carboplatin|mesh-list
56166018|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166019|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755677|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56166020|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166021|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166068|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56166069|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
56166070|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
56166071|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56166072|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56166073|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
56166074|NCT00003402|Hormones|hormones|mesh-ancestor
56166075|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56166111|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
56166112|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56166113|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56166114|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56166268|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56166269|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166270|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
56166271|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756707|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56166273|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56166274|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56166275|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56166276|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56166326|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166327|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56166328|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55757014|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
56166329|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56166330|NCT00003684|Theophylline|theophylline|mesh-list
56166331|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56166332|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
56166333|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56166334|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166335|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56166336|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
56183110|NCT01422616|Labetalol|labetalol|mesh-list
56183111|NCT01422616|Hydralazine|hydralazine|mesh-list
56183112|NCT01422616|Nicardipine|nicardipine|mesh-list
56166362|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
56166363|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
56166364|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
56166365|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166366|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166367|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
56166411|NCT00003744|Antiviral Agents|antiviral agents|mesh-ancestor
56166412|NCT00003744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56166413|NCT00003744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166414|NCT00003744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56166415|NCT00003744|Immunologic Factors|immunologic factors|mesh-ancestor
56166416|NCT00003744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166417|NCT00003762|Gemcitabine|gemcitabine|mesh-list
56166418|NCT00003762|Docetaxel|docetaxel|mesh-list
56166419|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56166420|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
56183131|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56183157|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
56183158|NCT01422733|Cosyntropin|cosyntropin|mesh-list
56183159|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56183160|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
56183161|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
56183162|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56183163|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183164|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56183165|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
56166447|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56166448|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
56166451|NCT00003792|Lenograstim|lenograstim|mesh-list
56183170|NCT01422785|Clindamycin|clindamycin|mesh-list
56183171|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
56183172|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
56183173|NCT01422785|Tretinoin|tretinoin|mesh-list
56183174|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56183175|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56166564|NCT00003864|Carboplatin|carboplatin|mesh-list
56166636|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56166637|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166638|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56166639|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166640|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56166641|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56166642|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56166644|NCT00003912|Doxorubicin|doxorubicin|mesh-list
56166645|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56183187|NCT01422954|Amebicides|amebicides|mesh-ancestor
56166827|NCT00004062|Azacitidine|azacitidine|mesh-list
56166936|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56166937|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166938|NCT00004158|Melphalan|melphalan|mesh-list
56166976|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56166977|NCT00004176|Protective Agents|protective agents|mesh-ancestor
56166978|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56166979|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
56166980|NCT00004188|Melphalan|melphalan|mesh-list
56166981|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
56166982|NCT00004188|Cisplatin|cisplatin|mesh-list
56166983|NCT00004188|Carboplatin|carboplatin|mesh-list
56166984|NCT00004188|Doxorubicin|doxorubicin|mesh-list
56166985|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56166986|NCT00004188|Etoposide|etoposide|mesh-list
56166987|NCT00004188|Vincristine|vincristine|mesh-list
56167038|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167039|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167041|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
56167323|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56167324|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56167325|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56167326|NCT00004482|Protective Agents|protective agents|mesh-ancestor
56167327|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
56167328|NCT00004488|Vitamin D|vitamin d|mesh-list
56167329|NCT00004488|Alendronate|alendronate|mesh-list
56167330|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
56167331|NCT00004488|Calcium|calcium|mesh-list
55760608|NCT04859283|Analgesics|analgesics|mesh-ancestor
56167332|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56167334|NCT00004488|Vitamins|vitamins|mesh-ancestor
56167335|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
56167336|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56167337|NCT00004488|Antacids|antacids|mesh-ancestor
56167340|NCT00004554|Naltrexone|naltrexone|mesh-list
56167368|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56167419|NCT00004728|Aspirin|aspirin|mesh-list
56183381|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
56183382|NCT01423955|Hematinics|hematinics|mesh-ancestor
56183383|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
56183384|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56167529|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56167530|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
56167531|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56167584|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56167585|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56167586|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56167587|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56167588|NCT00004884|Gemcitabine|gemcitabine|mesh-list
56167589|NCT00004884|Docetaxel|docetaxel|mesh-list
55762219|NCT03526185|Nivolumab|nivolumab|mesh-list
56167590|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56167591|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167592|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
56167593|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167595|NCT00004884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167596|NCT00004884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167628|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167629|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167630|NCT00004938|Fluconazole|fluconazole|mesh-list
56167631|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
56167632|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56167671|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167672|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56213169|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167673|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56167674|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167675|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56167676|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56167677|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56167678|NCT00005022|Etoposide|etoposide|mesh-list
56183440|NCT01424332|Darexaban|darexaban|mesh-list
56183443|NCT01424332|Analgesics|analgesics|mesh-ancestor
56183461|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
56183480|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
56183481|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56183482|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56217257|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217258|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217259|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56217260|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56217261|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
56217262|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219480|NCT01651923|Heparin|heparin|mesh-list
56224823|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224824|NCT01693328|Fentanyl|fentanyl|mesh-list
56224825|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56224826|NCT01693328|Narcotics|narcotics|mesh-ancestor
56224827|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224838|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224839|NCT01693393|Cyclosporine|cyclosporine|mesh-list
56224840|NCT01693393|Cyclosporins|cyclosporins|mesh-list
56224841|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224842|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224843|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800739|NCT01594333|Methotrexate|methotrexate|mesh-list
56225538|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
56225539|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
56227805|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56227806|NCT02886286|Narcotics|narcotics|mesh-ancestor
56228039|NCT02363998|Analgesics|analgesics|mesh-ancestor
56228253|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228254|NCT01916317|Lidocaine|lidocaine|mesh-list
56228255|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
56228256|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
56228257|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228478|NCT01160107|Melphalan|melphalan|mesh-list
56228479|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228480|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
56228481|NCT01160107|Hormones|hormones|mesh-ancestor
56228482|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56183687|NCT01425476|Analgesics|analgesics|mesh-ancestor
56229691|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56231091|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56183703|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56183704|NCT01425580|Incretins|incretins|mesh-ancestor
56183705|NCT01425580|Hormones|hormones|mesh-ancestor
56183722|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56183723|NCT01425658|Clonidine|clonidine|mesh-list
56183785|NCT05386290|Analgesics|analgesics|mesh-ancestor
56183979|NCT04765371|Dexamethasone|dexamethasone|mesh-list
56184054|NCT04673162|Hormones|hormones|mesh-ancestor
56184171|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
56184183|NCT03945084|Niraparib|niraparib|mesh-list
56238795|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56238796|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56238962|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56239072|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239073|NCT01765010|Vitamins|vitamins|mesh-ancestor
56239074|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
56239075|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56239076|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56239362|NCT01766609|Hormones|hormones|mesh-ancestor
56184258|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
56239500|NCT01767610|Infliximab|infliximab|mesh-list
56239646|NCT01768351|Vitamins|vitamins|mesh-ancestor
56239647|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
56239648|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56239649|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56239863|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239864|NCT01769625|Vitamin D|vitamin d|mesh-list
56239865|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
56184342|NCT02547662|Ixazomib|ixazomib|mesh-list
56184343|NCT02547662|Ichthammol|ichthammol|mesh-list
56184344|NCT02547662|BB 1101|bb 1101|mesh-list
56184345|NCT02547662|Glycine|glycine|mesh-list
56184346|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56184347|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
56184348|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
56184351|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240312|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56240661|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240662|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
56240663|NCT01774812|Vitamin D|vitamin d|mesh-list
56240906|NCT01777477|Immunologic Factors|immunologic factors|mesh-ancestor
56240907|NCT01777477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184591|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56184592|NCT01426490|Protective Agents|protective agents|mesh-ancestor
56184593|NCT01426490|Hematinics|hematinics|mesh-ancestor
56242672|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56242673|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56243269|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56243270|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56243276|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
56243340|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243341|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
56243449|NCT01803503|Sunitinib|sunitinib|mesh-list
56243450|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243712|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
56243713|NCT01808131|Renal Agents|renal agents|mesh-ancestor
56243714|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
56243715|NCT01808300|Pregabalin|pregabalin|mesh-list
56243716|NCT01808300|Analgesics|analgesics|mesh-ancestor
56243755|NCT01808521|Protective Agents|protective agents|mesh-ancestor
56244022|NCT01810458|Hematinics|hematinics|mesh-ancestor
56244023|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
56244024|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
56244025|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244026|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
56244154|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244158|NCT01811381|Curcumin|curcumin|mesh-list
56244239|NCT01812122|Vildagliptin|vildagliptin|mesh-list
56244240|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56244310|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56244311|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56244312|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
56244421|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56244432|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
56184669|NCT01426971|Ibuprofen|ibuprofen|mesh-list
56244759|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244904|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56184818|NCT01427699|Antibodies|antibodies|mesh-list
56184902|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56184903|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56184904|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
56184905|NCT01428388|Bevacizumab|bevacizumab|mesh-list
56184906|NCT01428388|Ranibizumab|ranibizumab|mesh-list
56245066|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245067|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245068|NCT01816659|Metformin|metformin|mesh-list
56245069|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56245204|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56184953|NCT01428492|Hormones|hormones|mesh-ancestor
56184969|NCT01428531|PENTA|penta|mesh-list
56245790|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
56245892|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245895|NCT01822405|Protective Agents|protective agents|mesh-ancestor
56246081|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246082|NCT01823770|Rotigotine|rotigotine|mesh-list
56246083|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
56246084|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
56246085|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246086|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246184|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
56246185|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246292|NCT01825083|Ketamine|ketamine|mesh-list
56246595|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56246976|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246977|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247210|NCT01840696|Regadenoson|regadenoson|mesh-list
56247393|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
56247795|NCT01844141|Ethanol|ethanol|mesh-list
56247940|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56248174|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
56248175|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248282|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
56248340|NCT01847677|Paclitaxel|paclitaxel|mesh-list
56249045|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55824304|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249069|NCT01852630|Imipenem|imipenem|mesh-list
56185388|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
56250972|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56251827|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
56252142|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252143|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252144|NCT01871935|Sufentanil|sufentanil|mesh-list
56252145|NCT01871935|Remifentanil|remifentanil|mesh-list
56252146|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56252147|NCT01871935|Narcotics|narcotics|mesh-ancestor
56252148|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252149|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252150|NCT01871935|Analgesics|analgesics|mesh-ancestor
56252212|NCT01872351|Vitamins|vitamins|mesh-ancestor
56252404|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252405|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252406|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56252407|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252408|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252542|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252543|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252544|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56252545|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56252546|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56252547|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56252548|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256335|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256336|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256342|NCT01907984|Diclofenac|diclofenac|mesh-list
56256792|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
56256793|NCT01910766|Vitamins|vitamins|mesh-ancestor
56256794|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
56256946|NCT01911624|Enoxaparin|enoxaparin|mesh-list
56256947|NCT01911624|Dabigatran|dabigatran|mesh-list
56256948|NCT01911624|Argatroban|argatroban|mesh-list
56256949|NCT01911624|Thrombin|thrombin|mesh-list
56256950|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
56257258|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257259|NCT01913847|Urological Agents|urological agents|mesh-ancestor
56257260|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56257261|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257262|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
56257263|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
56257264|NCT01913964|Vitamins|vitamins|mesh-ancestor
56257265|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
56257267|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
56257318|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259069|NCT01933503|Cathartics|cathartics|mesh-ancestor
56259204|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
56259366|NCT01935505|Bupropion|bupropion|mesh-list
56259481|NCT01935817|Protective Agents|protective agents|mesh-ancestor
56259841|NCT01937767|Fentanyl|fentanyl|mesh-list
56260203|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260204|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
56260205|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260398|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
56260574|NCT01941979|Capecitabine|capecitabine|mesh-list
56261011|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56261012|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56261645|NCT02138617|Fluorouracil|fluorouracil|mesh-list
56261646|NCT02138617|Irinotecan|irinotecan|mesh-list
56261647|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
56262417|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
56262857|NCT03626922|Vitamins|vitamins|mesh-ancestor
56263343|NCT01947205|Analgesics|analgesics|mesh-ancestor
56263344|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
56263345|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263346|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263627|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
56263628|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
56263629|NCT01949129|Busulfan|busulfan|mesh-list
56263919|NCT01951027|Lenograstim|lenograstim|mesh-list
56185898|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55887105|NCT01807949|Ivacaftor|ivacaftor|mesh-list
56265196|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56265736|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
56186146|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56186147|NCT01435291|Tacrolimus|tacrolimus|mesh-list
56186148|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265950|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56265951|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265952|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
56265953|NCT01964781|Coagulants|coagulants|mesh-ancestor
56265954|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56265955|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56265956|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265957|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265958|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56265959|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56266010|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266011|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266056|NCT01965405|Bupropion|bupropion|mesh-list
56186213|NCT01435707|Hormones|hormones|mesh-ancestor
56186220|NCT01435837|Caffeine|caffeine|mesh-list
56266254|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56266367|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
56266975|NCT01971489|Gemcitabine|gemcitabine|mesh-list
56267192|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56267193|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56267194|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267367|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56267368|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
56267369|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267370|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
56267371|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
56267372|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267373|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267374|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56267550|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
56267660|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267663|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267776|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56267777|NCT01977300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56267916|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
56267917|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267918|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268045|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268524|NCT01983527|Prednisolone|prednisolone|mesh-list
56186395|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000893|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56269773|NCT01992146|Naloxone|naloxone|mesh-list
56269958|NCT01993472|Andrographolide|andrographolide|mesh-list
56269959|NCT01993472|Capecitabine|capecitabine|mesh-list
56269960|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56269961|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
56269967|NCT01993472|Analgesics|analgesics|mesh-ancestor
56270099|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
56270100|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
55893422|NCT04349410|Losartan|losartan|mesh-list
56186580|NCT01438086|Mecasermin|mecasermin|mesh-list
56272098|NCT02007837|Analgesics|analgesics|mesh-ancestor
56272275|NCT02008786|Ramipril|ramipril|mesh-list
55847469|NCT02735902|Analgesics|analgesics|mesh-ancestor
56272603|NCT05632133|Anticonvulsants|anticonvulsants|mesh-ancestor
56272608|NCT05624151|Magnesium Sulfate|magnesium sulfate|mesh-list
56272946|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
56272971|NCT05103332|Indapamide|indapamide|mesh-list
56186669|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56273548|NCT03994731|Acetaminophen|acetaminophen|mesh-list
56186792|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56186794|NCT05129748|Mannitol|mannitol|mesh-list
56186795|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56186796|NCT05129748|Diuretics|diuretics|mesh-ancestor
56274087|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56274753|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
56274956|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
56186868|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56275297|NCT02015988|Simvastatin|simvastatin|mesh-list
56275687|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275688|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275783|NCT02019056|Pyridoxine|pyridoxine|mesh-list
56186927|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
56276053|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
56276122|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
56276187|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276479|NCT02023450|Ritonavir|ritonavir|mesh-list
56276508|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
56276509|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276650|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276651|NCT02024334|Leflunomide|leflunomide|mesh-list
56276802|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276803|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56276804|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
56276955|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56276956|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
56276957|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276996|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56276997|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56276998|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56276999|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
56277000|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277001|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277002|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277004|NCT02026310|Glimepiride|glimepiride|mesh-list
56277005|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277010|NCT02026479|Dexamethasone|dexamethasone|mesh-list
56277147|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
56187099|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
56187100|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56187119|NCT04083170|Vidarabine|vidarabine|mesh-list
56187120|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
56277340|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56277345|NCT02028494|Capecitabine|capecitabine|mesh-list
56277485|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56277486|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56277487|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56277488|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56277489|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
56277490|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
56277491|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56277493|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56277552|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56277553|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
56277554|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56187189|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
56187191|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56187192|NCT03671746|Ketorolac|ketorolac|mesh-list
56187193|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56277827|NCT02040220|Aflibercept|aflibercept|mesh-list
56277828|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55852919|NCT00237718|Vitamin E|vitamin e|mesh-list
56278000|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56278001|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56278144|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
56278145|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56278170|NCT02042664|Metformin|metformin|mesh-list
56278300|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278301|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278696|NCT02046460|Aspirin|aspirin|mesh-list
56278870|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
56279081|NCT00005853|Analgesics|analgesics|mesh-ancestor
56280071|NCT03945357|Gemcitabine|gemcitabine|mesh-list
56280222|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280223|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
56280224|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280225|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56280226|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280227|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991237|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
55991353|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
55991612|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991785|NCT00993187|Metformin|metformin|mesh-list
55992168|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992170|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
56187396|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56187519|NCT01438580|Warfarin|warfarin|mesh-list
56187520|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56187521|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56187522|NCT01438580|Analgesics|analgesics|mesh-ancestor
55993172|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
55993173|NCT01924286|Hormones|hormones|mesh-ancestor
55993211|NCT01920386|Tramadol|tramadol|mesh-list
55993276|NCT03115424|Hormones|hormones|mesh-ancestor
55993471|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
55993873|NCT01074463|Protective Agents|protective agents|mesh-ancestor
56187599|NCT01439100|Analgesics|analgesics|mesh-ancestor
55994649|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55994650|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
55994651|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995131|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56187635|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
56187651|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995741|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995742|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995743|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995744|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995745|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55995746|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55995747|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995748|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995990|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55995991|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55995992|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995993|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996142|NCT03670030|Sirolimus|sirolimus|mesh-list
55996143|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55996144|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996145|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55996146|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996147|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
55996148|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996149|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
55996150|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996151|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
55996179|NCT05314270|Copper|copper|mesh-list
55996180|NCT05314270|Trace Elements|trace elements|mesh-ancestor
55996181|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
55996182|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996184|NCT01167829|Acyline|acyline|mesh-list
55996185|NCT01167829|Androgens|androgens|mesh-ancestor
55996186|NCT01167829|Hormones|hormones|mesh-ancestor
55996190|NCT02066623|Everolimus|everolimus|mesh-list
55996398|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
55996605|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996606|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55996607|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55996880|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996881|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996941|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
55996942|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996943|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996944|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996945|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55996946|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55996947|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996949|NCT00981656|Fluorouracil|fluorouracil|mesh-list
55997204|NCT01016483|Antiviral Agents|antiviral agents|mesh-ancestor
55997205|NCT01016483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997206|NCT01016483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997415|NCT05600660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55997416|NCT05600660|Antimetabolites|antimetabolites|mesh-ancestor
55997423|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
55997560|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55997561|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997562|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997667|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997668|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55997693|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
55997694|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55997695|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
55997696|NCT00982007|Hematinics|hematinics|mesh-ancestor
55997697|NCT04814940|Menotropins|menotropins|mesh-list
55997698|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55997699|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
55997700|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55997701|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997702|NCT05042934|Irinotecan|irinotecan|mesh-list
55997703|NCT05042934|Camptothecin|camptothecin|mesh-list
55997704|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55997705|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55997706|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997707|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997708|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997808|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
55997809|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997810|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997927|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55997928|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55998060|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
55998061|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
55998062|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998063|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
55998064|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998065|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55998066|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55998067|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55998068|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55998130|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
55998131|NCT04694586|Ethambutol|ethambutol|mesh-list
55998132|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55998133|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
55998134|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55998135|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998136|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
55998137|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55998193|NCT02854670|Capsaicin|capsaicin|mesh-list
55998316|NCT05564286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998317|NCT05564286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998318|NCT05564286|Glucocorticoids|glucocorticoids|mesh-ancestor
55862655|NCT01276756|Ribavirin|ribavirin|mesh-list
55998838|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999058|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999059|NCT04222062|Carmustine|carmustine|mesh-list
55999060|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55999117|NCT00377806|Analgesics|analgesics|mesh-ancestor
56187942|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56187943|NCT01441388|Growth Substances|growth substances|mesh-ancestor
56187944|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56187945|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
55999246|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999248|NCT05494710|Bleomycin|bleomycin|mesh-list
55999536|NCT04139304|Hormones|hormones|mesh-ancestor
55999537|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56188001|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56188009|NCT01441869|Metformin|metformin|mesh-list
56188033|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56188034|NCT01441934|Urological Agents|urological agents|mesh-ancestor
56188035|NCT01441986|Amantadine|amantadine|mesh-list
56188036|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
56006197|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56006199|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006421|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006907|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006908|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188081|NCT01442428|Dexamethasone|dexamethasone|mesh-list
56007335|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
56007336|NCT04156828|Hormones|hormones|mesh-ancestor
56007448|NCT03998488|Psyllium|psyllium|mesh-list
56007656|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007921|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008146|NCT00003394|Leuprolide|leuprolide|mesh-list
56008147|NCT00003394|Goserelin|goserelin|mesh-list
56008375|NCT02494258|Azacitidine|azacitidine|mesh-list
56188154|NCT01442610|Protective Agents|protective agents|mesh-ancestor
56188165|NCT01442662|Immunologic Factors|immunologic factors|mesh-ancestor
56188166|NCT01442662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009013|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009014|NCT00003598|Tretinoin|tretinoin|mesh-list
56009015|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009016|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
56009017|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
56009018|NCT00003604|Aldesleukin|aldesleukin|mesh-list
56009042|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009158|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
56009404|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56188236|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
56188280|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009703|NCT00003946|Danazol|danazol|mesh-list
56188309|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
56009856|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56188385|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56010030|NCT00004006|Etoposide|etoposide|mesh-list
56188414|NCT01443897|Vitamin D|vitamin d|mesh-list
56188454|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
56010959|NCT05776407|Fludarabine|fludarabine|mesh-list
56010960|NCT05776407|Etoposide|etoposide|mesh-list
56010961|NCT05776407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010962|NCT05776407|Immunologic Factors|immunologic factors|mesh-ancestor
56188508|NCT01444612|PENTA|penta|mesh-list
56011950|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011976|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011977|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012266|NCT04385277|Dinutuximab|dinutuximab|mesh-list
56012267|NCT04385277|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56012268|NCT04385277|Isotretinoin|isotretinoin|mesh-list
56012269|NCT04385277|Sargramostim|sargramostim|mesh-list
56188525|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
56188526|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56013082|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56013085|NCT00004192|Cytarabine|cytarabine|mesh-list
56013296|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013297|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
56013298|NCT00005578|Hormones|hormones|mesh-ancestor
56188595|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
56013578|NCT00005092|Thiotepa|thiotepa|mesh-list
56013579|NCT00005092|Methoxsalen|methoxsalen|mesh-list
56013580|NCT00005092|Furocoumarins|furocoumarins|mesh-list
56013617|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013618|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56013650|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56013651|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56013652|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013692|NCT00385450|Nelfinavir|nelfinavir|mesh-list
56013789|NCT02197273|Analgesics|analgesics|mesh-ancestor
56013790|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56188596|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56188598|NCT01445223|Lopinavir|lopinavir|mesh-list
56013791|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56013933|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013934|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013935|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56013936|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56013937|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
56013938|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56013939|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
56188600|NCT01445223|Efavirenz|efavirenz|mesh-list
56014250|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56188698|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014352|NCT01409239|Insulin|insulin|mesh-list
56014572|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
56014573|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56014778|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
56014952|NCT03008551|Metformin|metformin|mesh-list
56015344|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56015345|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
56188839|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015566|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015567|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
56015821|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015893|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
56015897|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56016040|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016041|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016042|NCT05307341|Analgesics|analgesics|mesh-ancestor
56016043|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
56016072|NCT01100723|Vitamins|vitamins|mesh-ancestor
56016073|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
56188900|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56188902|NCT01446900|Cladribine|cladribine|mesh-list
56016171|NCT00136760|Bupropion|bupropion|mesh-list
56188911|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
56188913|NCT01446952|Vitamin E|vitamin e|mesh-list
56016464|NCT01108757|Renal Agents|renal agents|mesh-ancestor
56016526|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
56016635|NCT01138475|Vitamin D|vitamin d|mesh-list
56188979|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
56017000|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
56017001|NCT03465527|Hormones|hormones|mesh-ancestor
56017002|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56017003|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739252|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56017004|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56017005|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017006|NCT03418805|Ibuprofen|ibuprofen|mesh-list
56017155|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017156|NCT05414214|Anesthetics|anesthetics|mesh-list
56017369|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017477|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017767|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
56017896|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
56189105|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
56017997|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56017998|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018094|NCT05344404|Niacin|niacin|mesh-list
56018405|NCT00369590|Growth Substances|growth substances|mesh-ancestor
56018679|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
56189251|NCT01449123|Mannitol|mannitol|mesh-list
56018755|NCT05610384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56018756|NCT05610384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56018757|NCT05610384|Analgesics|analgesics|mesh-ancestor
56018758|NCT05610384|Sensory System Agents|sensory system agents|mesh-ancestor
56018759|NCT05610384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018760|NCT05610384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018761|NCT05610384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56018762|NCT05610384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56189279|NCT01449188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56189280|NCT01449188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56189281|NCT01449188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56189282|NCT01449253|Bosentan|bosentan|mesh-list
56019027|NCT05286008|Dexamethasone|dexamethasone|mesh-list
56019028|NCT05286008|Ropivacaine|ropivacaine|mesh-list
56019029|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56019030|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
56019031|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
56019175|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56019226|NCT00407654|Growth Substances|growth substances|mesh-ancestor
56019227|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019228|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
56019229|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019231|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56019301|NCT05250050|Metronidazole|metronidazole|mesh-list
56189345|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56189346|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56189366|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019477|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
56019478|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56189386|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189387|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56189388|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56189389|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189390|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
56189391|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56019704|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56019705|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019706|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56019707|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
56019708|NCT05235516|Cisplatin|cisplatin|mesh-list
56019709|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019805|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019806|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019815|NCT00462332|Vidarabine|vidarabine|mesh-list
56020004|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
56020178|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189433|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56020475|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56189509|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56020920|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021034|NCT01486615|Protective Agents|protective agents|mesh-ancestor
56021130|NCT01364298|Pregabalin|pregabalin|mesh-list
56021237|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
56021275|NCT01489969|Melatonin|melatonin|mesh-list
56189578|NCT01456507|Analgesics|analgesics|mesh-ancestor
56021555|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
56021601|NCT01796366|Insulin|insulin|mesh-list
56021893|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
56021894|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
56021895|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
56021897|NCT01508455|Fentanyl|fentanyl|mesh-list
56022205|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022206|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022207|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56022431|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56022432|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56022433|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
56022464|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56022465|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56022466|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
56022649|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
56022650|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022651|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56022682|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022683|NCT00572234|Bupropion|bupropion|mesh-list
56022684|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56022685|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
56022686|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56022932|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56022933|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56023230|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023261|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023530|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56023531|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56023533|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56189665|NCT01460212|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56189666|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56189667|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56189668|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189669|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189670|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
56189671|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189682|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
56189696|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189703|NCT01460498|Decitabine|decitabine|mesh-list
56023905|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023906|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023907|NCT02247505|Urological Agents|urological agents|mesh-ancestor
56023938|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56023939|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
56023940|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
56024441|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024442|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024443|NCT00597896|Pramipexole|pramipexole|mesh-list
56024444|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
56024445|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024446|NCT00597896|Protective Agents|protective agents|mesh-ancestor
56024447|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024448|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56024449|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56024450|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
56024451|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
56024453|NCT01790282|Estradiol|estradiol|mesh-list
56189755|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024510|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024511|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56024512|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56024513|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024514|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
56024767|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024768|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56024769|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
56024770|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
56024771|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024772|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56024773|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
56024774|NCT02997332|Docetaxel|docetaxel|mesh-list
56024775|NCT02997332|Fluorouracil|fluorouracil|mesh-list
56024776|NCT02997332|Durvalumab|durvalumab|mesh-list
56024777|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024778|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
56024779|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
56024780|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
56024781|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024816|NCT01284335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024817|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024818|NCT01284335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024819|NCT01284335|Immunologic Factors|immunologic factors|mesh-ancestor
56024820|NCT01284335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189824|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56189826|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189827|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189828|NCT01461616|Insulin|insulin|mesh-list
56024861|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56024862|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56024863|NCT01195025|Chrysarobin|chrysarobin|mesh-list
56024864|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56024900|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024901|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024902|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
56024903|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024904|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024906|NCT00658736|Hormones|hormones|mesh-ancestor
55930021|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024941|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
56024942|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024943|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
56024944|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56024982|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025012|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56025013|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56189848|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56189849|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025059|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
56025060|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025061|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025062|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025063|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
56025064|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
56025178|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55930022|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
56025206|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56025207|NCT02995304|Narcotics|narcotics|mesh-ancestor
56025503|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
56025539|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
55752749|NCT02451787|Vitamins|vitamins|mesh-ancestor
56025540|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025541|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
56025542|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025543|NCT01278056|Deferasirox|deferasirox|mesh-list
56025570|NCT01270724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025571|NCT01270724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025572|NCT01270724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56025573|NCT01270724|Immunologic Factors|immunologic factors|mesh-ancestor
56025574|NCT01270724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025575|NCT00709826|Gemcitabine|gemcitabine|mesh-list
55739574|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
56025576|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56025577|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56025578|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
56025579|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025580|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025581|NCT00709826|Antiviral Agents|antiviral agents|mesh-ancestor
56025659|NCT01278602|Rituximab|rituximab|mesh-list
56189870|NCT01462422|Misoprostol|misoprostol|mesh-list
56189871|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56189872|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
56189873|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56189874|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189875|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56189876|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56189877|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
56189878|NCT01462474|Cisplatin|cisplatin|mesh-list
56189879|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56189880|NCT01462487|Zanamivir|zanamivir|mesh-list
56189881|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
56189882|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56189883|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56189884|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189885|NCT01462500|Miltefosine|miltefosine|mesh-list
56189886|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
56189887|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025664|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56025665|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
56025666|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56025775|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56025807|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56025808|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025809|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
56025810|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56025811|NCT04385654|Axitinib|axitinib|mesh-list
56025812|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025813|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56025814|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025815|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025816|NCT01273064|Interferons|interferons|mesh-list
56025817|NCT01273064|Ribavirin|ribavirin|mesh-list
56025818|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025819|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
56025820|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025821|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
56025856|NCT00741104|Infliximab|infliximab|mesh-list
56025857|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
56025858|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56025859|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56025894|NCT01273454|Narcotics|narcotics|mesh-ancestor
56025895|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025896|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025897|NCT01273454|Analgesics|analgesics|mesh-ancestor
56025925|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
56025926|NCT01273532|Tapentadol|tapentadol|mesh-list
56025927|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56025939|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025941|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
56025942|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56025978|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56025979|NCT00744848|Epinephrine|epinephrine|mesh-list
56025980|NCT00744848|Bupivacaine|bupivacaine|mesh-list
56025981|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
56025982|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
55744404|NCT03330613|Anesthetics|anesthetics|mesh-list
56026014|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026016|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56026017|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
56026227|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56026228|NCT01274624|Growth Substances|growth substances|mesh-ancestor
56026229|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026230|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
56026231|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
56026232|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026233|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56026234|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56026235|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
56026236|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56026237|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56026275|NCT01275248|Ondansetron|ondansetron|mesh-list
56026276|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
56026277|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
56026339|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
56026340|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56026341|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56026343|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026344|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
56026502|NCT01214057|Propofol|propofol|mesh-list
56189926|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56189927|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
56189928|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56189929|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56189930|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189931|NCT01463163|Ticagrelor|ticagrelor|mesh-list
56189932|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56026579|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026581|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56026582|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56189940|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56189942|NCT01463215|Expectorants|expectorants|mesh-ancestor
56189943|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
56189944|NCT01463228|Metformin|metformin|mesh-list
56189945|NCT01463228|Canagliflozin|canagliflozin|mesh-list
56189946|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56189947|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026845|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026846|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56026847|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56026848|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56026849|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56026850|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56026851|NCT00783614|Aspirin|aspirin|mesh-list
56026852|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56026853|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56026855|NCT00783614|Analgesics|analgesics|mesh-ancestor
56189955|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
56189956|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56189957|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56189958|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56189979|NCT01463592|Iodine|iodine|mesh-list
56190022|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
56190023|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
56190024|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
56190025|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190026|NCT01463865|Ropivacaine|ropivacaine|mesh-list
56027004|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027005|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56027006|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56027007|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56027008|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
56027009|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
56027010|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027047|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027218|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
56027219|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
56027220|NCT05477108|Hormones|hormones|mesh-ancestor
56027221|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56027222|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56190027|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
56190028|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
56190029|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56190030|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190031|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
56190032|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190033|NCT01463956|Interferons|interferons|mesh-list
56190034|NCT01463956|Ribavirin|ribavirin|mesh-list
56190035|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190036|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
56027477|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
56027478|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027479|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027480|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56027481|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56027538|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
56190040|NCT01464008|Interferons|interferons|mesh-list
56190041|NCT01464008|Ribavirin|ribavirin|mesh-list
56190042|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
56190043|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
56190044|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56190045|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190046|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
56190047|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190048|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
56190049|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190050|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
56190051|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190052|NCT01464060|Amoxicillin|amoxicillin|mesh-list
56190053|NCT01464060|Metronidazole|metronidazole|mesh-list
56190054|NCT01464060|Clarithromycin|clarithromycin|mesh-list
56190055|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56190056|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190057|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56190058|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56027539|NCT01268111|Vitamin D|vitamin d|mesh-list
56027540|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56027541|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027542|NCT01268111|Vitamins|vitamins|mesh-ancestor
56027543|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
56027544|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56027545|NCT01349231|Ketamine|ketamine|mesh-list
56027546|NCT01349231|Analgesics|analgesics|mesh-ancestor
56027558|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027559|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
56027560|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
56027561|NCT01350245|Tacrolimus|tacrolimus|mesh-list
56027562|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56027563|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
56027597|NCT01269047|Hormones|hormones|mesh-ancestor
56027598|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56027599|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
56027600|NCT03800264|Bisoprolol|bisoprolol|mesh-list
56027601|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027602|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56027603|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
56027604|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
56027605|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027712|NCT00802100|Metformin|metformin|mesh-list
56027803|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56027804|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56027805|NCT01355705|Growth Substances|growth substances|mesh-ancestor
56027806|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
56027807|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
56027808|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027809|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
56027810|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
56027811|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
56027812|NCT00802880|Dacarbazine|dacarbazine|mesh-list
56027813|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56027814|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
56027815|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027816|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027817|NCT05118854|Cisplatin|cisplatin|mesh-list
56027818|NCT05118854|Carboplatin|carboplatin|mesh-list
56027819|NCT05118854|Pemetrexed|pemetrexed|mesh-list
56027820|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027821|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027822|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027823|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56027855|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027856|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
56027857|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027858|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56027859|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56027865|NCT05089526|Analgesics|analgesics|mesh-ancestor
56027943|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027944|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56027945|NCT01274897|Lactitol|lactitol|mesh-list
56027946|NCT01274897|Cathartics|cathartics|mesh-ancestor
56027947|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56027948|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
56027949|NCT02323217|Idazoxan|idazoxan|mesh-list
56027950|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56027951|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56027952|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56027953|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
56027954|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027955|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027956|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027984|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027985|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56027986|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56027987|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027988|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027989|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56027990|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
56027991|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56027992|NCT04155164|Metformin|metformin|mesh-list
56027993|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56027994|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027995|NCT00806078|Quinine|quinine|mesh-list
56027996|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
56027997|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56027998|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56027999|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028000|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56028001|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028002|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56028003|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028004|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56028041|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55809597|NCT01653847|Everolimus|everolimus|mesh-list
56028043|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56028073|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56028075|NCT00811850|Maleic acid|maleic acid|mesh-list
56028076|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028077|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028078|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56028079|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56028080|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
56028081|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028082|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028083|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56028084|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56028119|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56028242|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
56028243|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028244|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028245|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56028251|NCT01332461|Xhance|xhance|mesh-list
56028421|NCT00815360|Ranibizumab|ranibizumab|mesh-list
56028422|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56190098|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
56190099|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56028592|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
56028593|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
56028594|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028595|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028596|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
56028631|NCT02348762|Antidotes|antidotes|mesh-ancestor
56028632|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
56028634|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
56028635|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56028636|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028637|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028802|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028803|NCT01380197|Analgesics|analgesics|mesh-ancestor
56028804|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
56028805|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028806|NCT00862784|Leucovorin|leucovorin|mesh-list
56028807|NCT00862784|Folic Acid|folic acid|mesh-list
56028808|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
56028809|NCT00862784|Fluorouracil|fluorouracil|mesh-list
56028810|NCT00862784|Ramucirumab|ramucirumab|mesh-list
56028811|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56028812|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
56028813|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028814|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
56028847|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028849|NCT01419977|Tinzaparin|tinzaparin|mesh-list
56028850|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56028851|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
56028852|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56028853|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56028854|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028855|NCT01499147|Vidarabine|vidarabine|mesh-list
56028856|NCT01499147|Fludarabine|fludarabine|mesh-list
56028857|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
56028858|NCT01499147|Melphalan|melphalan|mesh-list
56028859|NCT01499147|Busulfan|busulfan|mesh-list
56028860|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
56028894|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
56028895|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56028896|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028897|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028898|NCT05236634|Urological Agents|urological agents|mesh-ancestor
56029036|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56029037|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
56029038|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029039|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029040|NCT02513394|Palbociclib|palbociclib|mesh-list
56029041|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029042|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56029043|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190131|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56190132|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56190133|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56190134|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
56190135|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190136|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190137|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56190138|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
56190140|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
56190141|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56190142|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56190143|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
56190144|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56190145|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190146|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56190147|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56029044|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029045|NCT00825734|Sorafenib|sorafenib|mesh-list
56029046|NCT00825734|Epothilones|epothilones|mesh-list
56029047|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029048|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56029049|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029050|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029051|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56029052|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56029088|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029089|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56029090|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
56029091|NCT02513160|Hormones|hormones|mesh-ancestor
56029303|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56029304|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
56029305|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
56029306|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
56029307|NCT01363986|Trastuzumab|trastuzumab|mesh-list
56029308|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56029309|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029310|NCT01510457|Milnacipran|milnacipran|mesh-list
56190167|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029440|NCT01395329|Nebivolol|nebivolol|mesh-list
56029441|NCT01395329|Nitroprusside|nitroprusside|mesh-list
56029442|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56029443|NCT01395329|BQ 788|bq 788|mesh-list
56029444|NCT01395329|Acetylcholine|acetylcholine|mesh-list
56190178|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190179|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190180|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56190181|NCT01466855|Topotecan|topotecan|mesh-list
56190182|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56190183|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56190184|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190185|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190186|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029445|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56029446|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56029447|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
56029448|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
56029449|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029450|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029579|NCT05000450|Fludarabine|fludarabine|mesh-list
56029580|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029581|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
56029582|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029583|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029584|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56029585|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
56029586|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029614|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029615|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
56029616|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
56029617|NCT03247088|Busulfan|busulfan|mesh-list
56029618|NCT03247088|Fludarabine|fludarabine|mesh-list
56029619|NCT03247088|Sorafenib|sorafenib|mesh-list
56029620|NCT03247088|Tacrolimus|tacrolimus|mesh-list
56190187|NCT01466959|Acetic Acid|acetic acid|mesh-list
56190188|NCT01466959|Retinol acetate|retinol acetate|mesh-list
56190189|NCT01466959|Citric Acid|citric acid|mesh-list
56190190|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
56190191|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
56029715|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56029716|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56029717|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
56029718|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029719|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56029747|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029748|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56029749|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
56190214|NCT01467115|Leucovorin|leucovorin|mesh-list
56029793|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56029794|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56029795|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
56029796|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029797|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56029798|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
56190224|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190225|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
56190226|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56190227|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029799|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
56029800|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
56029801|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56029802|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56029803|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
56029804|NCT01433081|Analgesics|analgesics|mesh-ancestor
56029805|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
56029806|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029807|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029808|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
56029809|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029810|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56029835|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
56029836|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029837|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56029838|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
56029839|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56029840|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56029843|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
56029857|NCT01436279|Mifepristone|mifepristone|mesh-list
56029889|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029890|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56029891|NCT00836888|Nivolumab|nivolumab|mesh-list
56029892|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56029893|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029894|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55757092|NCT05074589|Leucovorin|leucovorin|mesh-list
56029895|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029896|NCT02262026|Saracatinib|saracatinib|mesh-list
56029929|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029930|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029931|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56029932|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030023|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56030024|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030025|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
56030060|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030061|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56030063|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
56030064|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56030065|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030066|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56030129|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030130|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
56030131|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56030132|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030133|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
56030134|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56030135|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030136|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
56030137|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56030138|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56030175|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56030176|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56030177|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56030243|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56030244|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030245|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030246|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
56030247|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030249|NCT04380818|Lopinavir|lopinavir|mesh-list
56030250|NCT04380818|Azithromycin|azithromycin|mesh-list
56030251|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
56030252|NCT04380818|Heparin|heparin|mesh-list
56030253|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56030294|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56030295|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030296|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030329|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
56030330|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030331|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56030332|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56190328|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190329|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56190330|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56190331|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
56190332|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190333|NCT01467596|Lidocaine|lidocaine|mesh-list
56190334|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
56190335|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
56190336|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
56190337|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56190338|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190339|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
56190340|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56190341|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56030545|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56030546|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
56030579|NCT00905060|Temozolomide|temozolomide|mesh-list
56030580|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56030581|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
56030582|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030583|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030584|NCT01535573|Dexetimide|dexetimide|mesh-list
56030619|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030620|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56030621|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
56030649|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
56030650|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030652|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56030653|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030654|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
56030655|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
56030656|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
56030668|NCT03212456|Narcotics|narcotics|mesh-ancestor
56030669|NCT03212456|Analgesics|analgesics|mesh-ancestor
56030707|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
56030741|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56030742|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
56030743|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030744|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030745|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030747|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
56030748|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030749|NCT01836536|Bevacizumab|bevacizumab|mesh-list
56030780|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56030782|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
56030783|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
56030784|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030785|NCT01457885|Busulfan|busulfan|mesh-list
56030786|NCT01457885|Clofarabine|clofarabine|mesh-list
56030787|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
56030788|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030789|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030915|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
56030916|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
56030917|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56030918|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
56030919|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56030920|NCT01839812|Cosyntropin|cosyntropin|mesh-list
56030921|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56030922|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56030923|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
56030924|NCT01839812|Hormones|hormones|mesh-ancestor
56030925|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56030926|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030927|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030928|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030998|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56030999|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56031000|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031001|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
56031002|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56031003|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
56031004|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031005|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
56031006|NCT01838252|Protective Agents|protective agents|mesh-ancestor
56031007|NCT01838330|Psyllium|psyllium|mesh-list
56031045|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56190365|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
56190366|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190367|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
56190368|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190369|NCT01467986|Sirolimus|sirolimus|mesh-list
56190370|NCT01467986|Irinotecan|irinotecan|mesh-list
56190371|NCT01467986|Temozolomide|temozolomide|mesh-list
56190372|NCT01467986|Dasatinib|dasatinib|mesh-list
56031078|NCT01720238|Entecavir|entecavir|mesh-list
56031292|NCT02497404|Fludarabine|fludarabine|mesh-list
56031293|NCT02497404|Azacitidine|azacitidine|mesh-list
56031294|NCT02497404|Melphalan|melphalan|mesh-list
56031295|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
56031296|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031297|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56031298|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
56031299|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031300|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56031301|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
56031302|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031335|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
56031336|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56031337|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56031338|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031339|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031340|NCT01573949|Metformin|metformin|mesh-list
56031576|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56031577|NCT01722656|Growth Substances|growth substances|mesh-ancestor
56031578|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031579|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
56031580|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031581|NCT04963764|Amoxicillin|amoxicillin|mesh-list
56031582|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56031583|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031584|NCT03405584|Amoxicillin|amoxicillin|mesh-list
56031624|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56031625|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56031626|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
56031650|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56031652|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031653|NCT01580423|Aprepitant|aprepitant|mesh-list
56031654|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
56031655|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
56031656|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031657|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031658|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56031659|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56031660|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031661|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031662|NCT01049984|Rasagiline|rasagiline|mesh-list
56031663|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56031664|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031673|NCT03001349|Edotreotide|edotreotide|mesh-list
56031713|NCT01724372|Aripiprazole|aripiprazole|mesh-list
56031714|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
56031715|NCT01724372|Fluoxetine|fluoxetine|mesh-list
56031716|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
56031717|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56031718|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56031755|NCT03405194|Efavirenz|efavirenz|mesh-list
56032073|NCT05566301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032074|NCT05566301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032075|NCT03404024|Mitogens|mitogens|mesh-list
56032354|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56032355|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
56032356|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56032387|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56032388|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032389|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032391|NCT04374188|Levofloxacin|levofloxacin|mesh-list
56032392|NCT04374188|Ofloxacin|ofloxacin|mesh-list
56032393|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56032394|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032532|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032533|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032534|NCT04376528|Cyclosporine|cyclosporine|mesh-list
56032535|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
56032565|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56032566|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56032567|NCT04373018|Eusol|eusol|mesh-list
56032568|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56032569|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032570|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
56032571|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
56032572|NCT04934748|Phenylephrine|phenylephrine|mesh-list
56032573|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
56032574|NCT04934748|Norepinephrine|norepinephrine|mesh-list
56032575|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56032576|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
56032577|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
56032578|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032579|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032580|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
56032767|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
56032768|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56032769|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56032770|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032771|NCT04371224|Leucovorin|leucovorin|mesh-list
56032772|NCT04371224|Fluorouracil|fluorouracil|mesh-list
56190405|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190406|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56190407|NCT01468038|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56190420|NCT01468051|Antacids|antacids|mesh-ancestor
56033141|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56033142|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56033143|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
56033144|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033397|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033398|NCT00928694|Fenofibrate|fenofibrate|mesh-list
56033399|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56033400|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
56033402|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56033572|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033573|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
56033574|NCT02486952|Hormones|hormones|mesh-ancestor
56033575|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033576|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56033605|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033606|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190473|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
56190474|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56190475|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190476|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56190477|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56190478|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190479|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56190480|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
56190481|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
56190482|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190483|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
56033796|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033797|NCT02229461|Aspirin|aspirin|mesh-list
56033798|NCT02229461|Naproxen|naproxen|mesh-list
56033799|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56033800|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56033801|NCT02229461|Analgesics|analgesics|mesh-ancestor
56033802|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
56033803|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033804|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033805|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033806|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033807|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56033808|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56033809|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033810|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56033811|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56033812|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190484|NCT01468480|Calcium|calcium|mesh-list
56190485|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56190486|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190487|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56190488|NCT01468519|Insulin|insulin|mesh-list
56190489|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56190490|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190491|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190492|NCT01468545|Iloprost|iloprost|mesh-list
56033854|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033855|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
56033856|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56033857|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033858|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
56033859|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033860|NCT02245490|Tamsulosin|tamsulosin|mesh-list
56033861|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56033862|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56033885|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033894|NCT01651793|Caffeine|caffeine|mesh-list
56033951|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033952|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
56033953|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56033954|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56033955|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56033956|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56033957|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
56034024|NCT01656629|Vitamins|vitamins|mesh-ancestor
56034025|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
56034026|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034163|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56034164|NCT01661621|Doxazosin|doxazosin|mesh-list
56190534|NCT01468740|Vincristine|vincristine|mesh-list
56190535|NCT01468740|Bleomycin|bleomycin|mesh-list
56190536|NCT01468740|Vinblastine|vinblastine|mesh-list
56190537|NCT01468740|Procarbazine|procarbazine|mesh-list
56190538|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56190539|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
56190540|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190541|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56190542|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56190543|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
56190544|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034165|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56034358|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190548|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56190549|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56034359|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56034360|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56034361|NCT03034850|Doxorubicin|doxorubicin|mesh-list
56034363|NCT03034850|Ifosfamide|ifosfamide|mesh-list
56034609|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
56034610|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56034611|NCT01006538|Ranibizumab|ranibizumab|mesh-list
56034902|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
56034903|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
56034904|NCT01685411|Busulfan|busulfan|mesh-list
56190554|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56034905|NCT01685411|Allopurinol|allopurinol|mesh-list
56034906|NCT01685411|Levetiracetam|levetiracetam|mesh-list
56034907|NCT01685411|Tacrolimus|tacrolimus|mesh-list
56034908|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56035087|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56035088|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56035089|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56035276|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56035277|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035278|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56190559|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
56190560|NCT01469143|Insulin|insulin|mesh-list
56190561|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56190562|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
56190563|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
56035285|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
56035566|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56035567|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56035600|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035601|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56035602|NCT02417064|Citalopram|citalopram|mesh-list
56190565|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190566|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190567|NCT01469169|Iloprost|iloprost|mesh-list
56190568|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56190569|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
56190570|NCT01469338|Prednisone|prednisone|mesh-list
56190571|NCT01469338|Octreotide|octreotide|mesh-list
56190572|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56190573|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
56190574|NCT01469338|Hormones|hormones|mesh-ancestor
56190575|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56190576|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190577|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56035603|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56035604|NCT02417064|Sertraline|sertraline|mesh-list
56035605|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
56035606|NCT02417064|Esketamine|esketamine|mesh-list
56035607|NCT02417064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56035608|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56035609|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56035644|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035645|NCT05592860|Insulin|insulin|mesh-list
56035682|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
56035803|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035804|NCT03014882|Antidotes|antidotes|mesh-ancestor
56035805|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56035806|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
56035807|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56035808|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56035874|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56035876|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
56035877|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
56035878|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56035910|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035911|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55811541|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56199034|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56199036|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199037|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199038|NCT01516255|Liraglutide|liraglutide|mesh-list
56199039|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
56199040|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56199041|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199042|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56199043|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56199044|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199045|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199046|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199047|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199048|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199049|NCT01516255|Incretins|incretins|mesh-ancestor
56199050|NCT01516255|Hormones|hormones|mesh-ancestor
56199051|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199052|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
56213212|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
56199059|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199060|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199061|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56199062|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
56199063|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56199064|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199065|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56199066|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56199067|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56199068|NCT01516450|Belimumab|belimumab|mesh-list
56199069|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56199070|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
56199071|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199072|NCT01516463|Bacitracin|bacitracin|mesh-list
56199073|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56199074|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199075|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56199076|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
55915293|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55915294|NCT04049851|Ivermectin|ivermectin|mesh-list
55915295|NCT04049851|Moxidectin|moxidectin|mesh-list
55915296|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55915297|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915298|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
55915299|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
55915300|NCT01414855|Prednisone|prednisone|mesh-list
55915301|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
55915302|NCT01414855|Doxorubicin|doxorubicin|mesh-list
55915303|NCT01414855|Vincristine|vincristine|mesh-list
55915304|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
55915305|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035912|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56035913|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56035914|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035915|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
56035916|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035917|NCT05150756|Lidocaine|lidocaine|mesh-list
56035918|NCT05150756|Morphine|morphine|mesh-list
56035919|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
56190578|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56190579|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56190580|NCT01469351|Liraglutide|liraglutide|mesh-list
56190581|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190582|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190612|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190613|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
56190614|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56190615|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
56190616|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036009|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56036010|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56036035|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
56036036|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
56036037|NCT01077596|Serotonin|serotonin|mesh-list
56036038|NCT01077596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56036040|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56036178|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56036179|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036180|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
56036181|NCT01085006|Coagulants|coagulants|mesh-ancestor
56036182|NCT01085786|Amoxicillin|amoxicillin|mesh-list
56036183|NCT01085786|Metronidazole|metronidazole|mesh-list
56036184|NCT01085786|Clarithromycin|clarithromycin|mesh-list
56036185|NCT01085786|Esomeprazole|esomeprazole|mesh-list
56036186|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036187|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036188|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56036223|NCT02386098|Dolutegravir|dolutegravir|mesh-list
56036401|NCT03013556|Tenofovir|tenofovir|mesh-list
56190624|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190625|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190626|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
56190627|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56190628|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56190629|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56190630|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
56190631|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56190632|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56190633|NCT01469559|Insulin|insulin|mesh-list
56190634|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190635|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190636|NCT01469572|Everolimus|everolimus|mesh-list
56190637|NCT01469572|Pasireotide|pasireotide|mesh-list
56190638|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036544|NCT02435901|Cyclosporins|cyclosporins|mesh-list
56036545|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036546|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036547|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56036548|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
56036549|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036577|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036578|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
56036579|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
56036580|NCT01099358|Fluorouracil|fluorouracil|mesh-list
56036581|NCT01099358|Cetuximab|cetuximab|mesh-list
56036582|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036583|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
56036584|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036585|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56036586|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56036587|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
56036588|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036589|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036590|NCT01118624|Vitamins|vitamins|mesh-list
56036591|NCT01118624|Folic Acid|folic acid|mesh-list
55915306|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
55915307|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915308|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915309|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55915310|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
56036592|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
56036593|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
56036594|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
56036595|NCT01118624|Aminopterin|aminopterin|mesh-list
56036596|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
56036597|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036598|NCT01118624|Hematinics|hematinics|mesh-ancestor
56036632|NCT02819024|Alovudine|alovudine|mesh-list
56036633|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
56036634|NCT02819024|Dexamethasone|dexamethasone|mesh-list
56036635|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
56036636|NCT02819024|Ichthammol|ichthammol|mesh-list
56036637|NCT02819024|BB 1101|bb 1101|mesh-list
56036638|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56036640|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
56036643|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036770|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
56036771|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036772|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56036775|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
56037060|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037061|NCT05305508|Mannitol|mannitol|mesh-list
56037062|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
56037184|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037185|NCT05269628|Hormones|hormones|mesh-ancestor
56037210|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56037211|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56037212|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037213|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56037214|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037215|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037216|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
56037217|NCT02561481|Sulforaphane|sulforaphane|mesh-list
56037218|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56037219|NCT02561481|Protective Agents|protective agents|mesh-ancestor
56190663|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56190664|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56190665|NCT01469624|Protective Agents|protective agents|mesh-ancestor
56037220|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037221|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037222|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
56037285|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037286|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037305|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037306|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037307|NCT02491437|Progesterone|progesterone|mesh-list
56037308|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
56037309|NCT02491437|Progestins|progestins|mesh-ancestor
56037310|NCT02491437|Hormones|hormones|mesh-ancestor
56037311|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037312|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037313|NCT02383758|Bisacodyl|bisacodyl|mesh-list
56037314|NCT02383758|Glycerol|glycerol|mesh-list
56037315|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56037316|NCT02383758|Protective Agents|protective agents|mesh-ancestor
56037318|NCT02383758|Cathartics|cathartics|mesh-ancestor
56037423|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037424|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037425|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56037426|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56037467|NCT01650558|Chloroquine|chloroquine|mesh-list
56037697|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
56037698|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
56037699|NCT01189292|Dexamethasone|dexamethasone|mesh-list
56037700|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56037701|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
56037929|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56037930|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56037931|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
56037932|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037934|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56038144|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56038177|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038178|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56038179|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
56038180|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
56038182|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038183|NCT05220813|Lidocaine|lidocaine|mesh-list
56038475|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55801452|NCT04792645|Memantine|memantine|mesh-list
55915311|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915312|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915313|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55915314|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55915315|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55915335|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55915336|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
55915337|NCT01527110|Zanamivir|zanamivir|mesh-list
55915338|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
55915339|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915340|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915341|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915342|NCT01441063|Zidovudine|zidovudine|mesh-list
55915343|NCT01441063|Valganciclovir|valganciclovir|mesh-list
55915344|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
55915345|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915346|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55915347|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55915348|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915349|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
55915350|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199077|NCT01516554|Testosterone|testosterone|mesh-list
56199078|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
56199079|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
56199080|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56199081|NCT01516554|Androgens|androgens|mesh-ancestor
56199082|NCT01516554|Hormones|hormones|mesh-ancestor
56199083|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199084|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199085|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56199086|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728333|NCT04596826|Analgesics|analgesics|mesh-ancestor
55915351|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55915352|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55915353|NCT01436071|Fluticasone|fluticasone|mesh-list
55915355|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55915356|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55915357|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
55915358|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915359|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915360|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55915361|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
55915362|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
55915363|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55915364|NCT01514864|Dasatinib|dasatinib|mesh-list
55915365|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915366|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55915367|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915368|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915369|NCT01514240|Mesalamine|mesalamine|mesh-list
55915370|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55915383|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55915384|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55915385|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55915386|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915387|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
55915388|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915389|NCT04061239|Cytarabine|cytarabine|mesh-list
55915390|NCT04061239|Azacitidine|azacitidine|mesh-list
55915391|NCT04061239|Daunorubicin|daunorubicin|mesh-list
55915392|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55915393|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
55915394|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915395|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915396|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
55915397|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915398|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55915399|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
55915400|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915401|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915402|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56038476|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038477|NCT02377479|Letrozole|letrozole|mesh-list
56038478|NCT02377479|Clomiphene|clomiphene|mesh-list
56038479|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038480|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56038481|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56038482|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038483|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038484|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56038818|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56038819|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56038820|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
56038821|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56038822|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56038823|NCT01215344|Growth Substances|growth substances|mesh-ancestor
56038947|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56038948|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
56039300|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56039301|NCT01246076|Growth Substances|growth substances|mesh-ancestor
56039302|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
56039303|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039304|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
56039305|NCT00364455|Hematinics|hematinics|mesh-ancestor
56039307|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
56039308|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039310|NCT01307462|Xhance|xhance|mesh-list
56039765|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56039766|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56039767|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
56039768|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039770|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190771|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190772|NCT01470209|Everolimus|everolimus|mesh-list
56190773|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040006|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
56040007|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56040118|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56040119|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
56040120|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040213|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56040214|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
56040215|NCT03924791|Hormones|hormones|mesh-ancestor
56040217|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56040597|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040598|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040599|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56040600|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
56040601|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
56040852|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
56040853|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040883|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040884|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
56040885|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56040886|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040887|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56041227|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56041228|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
56041229|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56041230|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041231|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041232|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041233|NCT01378988|Analgesics|analgesics|mesh-ancestor
56041261|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041263|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56041478|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56041479|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56041480|NCT01749969|Growth Substances|growth substances|mesh-ancestor
56041481|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
56041901|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041902|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041903|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56042142|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56042143|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042144|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56042145|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042146|NCT01843751|Buprenorphine|buprenorphine|mesh-list
56042147|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56042148|NCT01843751|Naloxone|naloxone|mesh-list
56042149|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56042150|NCT01843751|Narcotics|narcotics|mesh-ancestor
56042151|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042152|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042153|NCT01843751|Analgesics|analgesics|mesh-ancestor
56042154|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
56042302|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56042303|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56042304|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042305|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042306|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56042307|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56042343|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56042344|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
56042345|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042346|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042542|NCT01400906|Xhance|xhance|mesh-list
56042706|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042707|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56042708|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56042709|NCT05442411|Analgesics|analgesics|mesh-ancestor
56042710|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042711|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56042712|NCT05654363|Morphine|morphine|mesh-list
56042713|NCT05654363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56042714|NCT05654363|Narcotics|narcotics|mesh-ancestor
56042715|NCT05654363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042716|NCT05654363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043094|NCT02396316|Growth Substances|growth substances|mesh-ancestor
56043095|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043096|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
56043137|NCT02683707|Lidocaine|lidocaine|mesh-list
56043138|NCT02683707|Fentanyl|fentanyl|mesh-list
56043139|NCT02683707|Midazolam|midazolam|mesh-list
56043140|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
56043141|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
56043142|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043143|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043144|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
56043145|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043146|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56043147|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56043148|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56043149|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56043150|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043151|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56043180|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56043181|NCT02867865|Gemcitabine|gemcitabine|mesh-list
56043182|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043183|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56043184|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
56043185|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043186|NCT02867865|Antiviral Agents|antiviral agents|mesh-ancestor
56043192|NCT02833233|Nivolumab|nivolumab|mesh-list
56190845|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56190846|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190847|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
56190848|NCT01471067|Rituximab|rituximab|mesh-list
56043388|NCT02980016|Isoniazid|isoniazid|mesh-list
56190873|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56190874|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
56190875|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56190876|NCT01471132|Paclitaxel|paclitaxel|mesh-list
56190877|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
56190878|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56190879|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043440|NCT04375605|Leucovorin|leucovorin|mesh-list
56043441|NCT04375605|Docetaxel|docetaxel|mesh-list
56043442|NCT04375605|Fluorouracil|fluorouracil|mesh-list
56043443|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
56043444|NCT04375605|Calcium|calcium|mesh-list
56043445|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
56043446|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043447|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
56043480|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56043481|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56043482|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043483|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56043484|NCT05448183|Gemcitabine|gemcitabine|mesh-list
56043485|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
56043486|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56043487|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
56043488|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190881|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
56190882|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
56190883|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190884|NCT01471145|Naltrexone|naltrexone|mesh-list
56190885|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56190886|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56190887|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043521|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043522|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043524|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56043525|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56043526|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56043527|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043528|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043529|NCT02371746|Travoprost|travoprost|mesh-list
56043530|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56043567|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043599|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043600|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56043601|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56043603|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043604|NCT03160911|Hemostatics|hemostatics|mesh-list
56043653|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043654|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56043655|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043656|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
56043657|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
56043658|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56043695|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56043900|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56043901|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
56043902|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
56043903|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043904|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043905|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043906|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
56043907|NCT01555281|Hormones|hormones|mesh-ancestor
56043935|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56043936|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043937|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56043938|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
56043939|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56043940|NCT00370539|Triamcinolone|triamcinolone|mesh-list
56043941|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56043942|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56043943|NCT00370539|Bevacizumab|bevacizumab|mesh-list
56190937|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
56190938|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56190939|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
56190940|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
56190941|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55915403|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55915404|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55915405|NCT04060849|Ethanol|ethanol|mesh-list
55915406|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55915407|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55915408|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915409|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915410|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915411|NCT01393405|Methotrexate|methotrexate|mesh-list
55915412|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55915413|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
55915414|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56199087|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
56199088|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
56199089|NCT01516567|Rituximab|rituximab|mesh-list
56199090|NCT01516567|Doxorubicin|doxorubicin|mesh-list
56199091|NCT01516567|Etoposide|etoposide|mesh-list
56199092|NCT01516567|Vincristine|vincristine|mesh-list
56199093|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56199094|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
56199095|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199096|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56199097|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56199098|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
56199099|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199100|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199101|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56199102|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56199103|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56199104|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56199106|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199107|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56190942|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56190943|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56190944|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
56190945|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56190946|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044122|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56044123|NCT04459611|Paclitaxel|paclitaxel|mesh-list
56044124|NCT04459611|Carboplatin|carboplatin|mesh-list
56044125|NCT04459611|Pemetrexed|pemetrexed|mesh-list
56044334|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
56044625|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044660|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044792|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
56044793|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
56045124|NCT05062317|Vitamins|vitamins|mesh-ancestor
56045397|NCT01578278|Xhance|xhance|mesh-list
56045406|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
56045519|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
56045524|NCT02818569|Analgesics|analgesics|mesh-ancestor
56191082|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56191083|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56191084|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56045855|NCT02988089|Metronidazole|metronidazole|mesh-list
56045856|NCT02988089|Clarithromycin|clarithromycin|mesh-list
56045857|NCT02988089|Levofloxacin|levofloxacin|mesh-list
56045858|NCT02988089|Ofloxacin|ofloxacin|mesh-list
56045859|NCT02988089|Tetracycline|tetracycline|mesh-list
56045860|NCT02988089|Tinidazole|tinidazole|mesh-list
56045861|NCT02988089|Furazolidone|furazolidone|mesh-list
56045862|NCT02988089|Bismuth|bismuth|mesh-list
56191123|NCT01472640|Liraglutide|liraglutide|mesh-list
56191124|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56046511|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
56046512|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046514|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56047045|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56047365|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191257|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
56191258|NCT01473316|Ketoconazole|ketoconazole|mesh-list
56047709|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
56047877|NCT01944293|Midazolam|midazolam|mesh-list
56047878|NCT01944293|Ketamine|ketamine|mesh-list
56048045|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
56048103|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048104|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56048105|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56048106|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048107|NCT04903002|Oxytocin|oxytocin|mesh-list
56048348|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56048382|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
56048383|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048384|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048817|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048819|NCT04901975|Diuretics|diuretics|mesh-ancestor
56049234|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049235|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049236|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56051557|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051558|NCT05132075|Docetaxel|docetaxel|mesh-list
56051564|NCT04873349|Oleuropein|oleuropein|mesh-list
56051867|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051962|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56053120|NCT00557492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054508|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055968|NCT02953665|Liraglutide|liraglutide|mesh-list
56055969|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56055970|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055971|NCT02953665|Incretins|incretins|mesh-ancestor
56056452|NCT00001689|Vincristine|vincristine|mesh-list
56056680|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056681|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056682|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056819|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056820|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56056821|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56056822|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056823|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
56056824|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056825|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056826|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056827|NCT05322707|Budesonide|budesonide|mesh-list
56056828|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
56056905|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
56057073|NCT05501483|Empagliflozin|empagliflozin|mesh-list
56057074|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56057075|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057211|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057212|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057213|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057214|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
56057215|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057216|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
56057217|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057218|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
56057239|NCT05270057|Rituximab|rituximab|mesh-list
56057312|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56057313|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
56057500|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
56057501|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56057659|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
56057768|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057769|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
56057935|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057938|NCT00002181|Cidofovir|cidofovir|mesh-list
56058162|NCT00002217|Amprenavir|amprenavir|mesh-list
56058305|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058448|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56191552|NCT01476189|Acetaminophen|acetaminophen|mesh-list
56191554|NCT01476189|Analgesics|analgesics|mesh-ancestor
56058838|NCT00002565|Analgesics|analgesics|mesh-ancestor
56058839|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
56059029|NCT05752305|Glucocorticoids|glucocorticoids|mesh-ancestor
56059266|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
56059482|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56191616|NCT01476488|Tacrolimus|tacrolimus|mesh-list
56059711|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059712|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56059714|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
56059999|NCT05493501|Paclitaxel|paclitaxel|mesh-list
56060130|NCT02219581|Dexamethasone|dexamethasone|mesh-list
56060316|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
56060317|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56191699|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060870|NCT00000477|L 647318|l 647318|mesh-list
56191736|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061217|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061218|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
56061220|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56191771|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191772|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061467|NCT04683939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061468|NCT04683939|Immunologic Factors|immunologic factors|mesh-ancestor
56061469|NCT04683939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061651|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
56061652|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
56061653|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56061654|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061825|NCT05578820|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56061826|NCT05578820|Antiviral Agents|antiviral agents|mesh-ancestor
56061921|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56191812|NCT01477606|Cytarabine|cytarabine|mesh-list
56191813|NCT01477606|Daunorubicin|daunorubicin|mesh-list
56191814|NCT01477606|Midostaurin|midostaurin|mesh-list
56062216|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56062217|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56062218|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
56062246|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
56062508|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56062799|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062988|NCT00002955|Antidotes|antidotes|mesh-ancestor
56063131|NCT00002985|Daunorubicin|daunorubicin|mesh-list
56191887|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063409|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
56063533|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063534|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063536|NCT00003135|Doxorubicin|doxorubicin|mesh-list
56063743|NCT05585125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56063744|NCT05585125|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064039|NCT01777945|Docetaxel|docetaxel|mesh-list
56191997|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56064426|NCT01800877|Protective Agents|protective agents|mesh-ancestor
56192044|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064840|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56064841|NCT00363935|Analgesics|analgesics|mesh-ancestor
56192105|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56192108|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065159|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56065193|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56065194|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
56192129|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56192130|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192131|NCT01479192|Fenretinide|fenretinide|mesh-list
56192132|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192133|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56192134|NCT01479192|Protective Agents|protective agents|mesh-ancestor
56065371|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065372|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065373|NCT04477733|Analgesics|analgesics|mesh-ancestor
56065374|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
56065375|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065376|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
56065377|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
56065378|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56065379|NCT05688943|Anesthetics|anesthetics|mesh-list
56065385|NCT04218773|Synephrine|synephrine|mesh-list
56065516|NCT01837069|Metoprolol|metoprolol|mesh-list
56065879|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066053|NCT05649618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066204|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56066205|NCT04740931|Growth Substances|growth substances|mesh-ancestor
56066238|NCT00364871|Bupropion|bupropion|mesh-list
56066265|NCT00550771|Paclitaxel|paclitaxel|mesh-list
56066324|NCT05259839|Growth Substances|growth substances|mesh-ancestor
56066515|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066516|NCT02629991|Oxytocin|oxytocin|mesh-list
56192199|NCT01479751|Ketamine|ketamine|mesh-list
56192214|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56067183|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56067184|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56067476|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56067477|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
56067478|NCT01643772|Oxycodone|oxycodone|mesh-list
56067653|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56067795|NCT05444543|Xhance|xhance|mesh-list
56192304|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56192305|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
56068031|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068032|NCT02661971|Antidotes|antidotes|mesh-ancestor
56192352|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068451|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
56068746|NCT01909141|Hormones|hormones|mesh-list
56068747|NCT01909141|Estradiol|estradiol|mesh-list
56068927|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068931|NCT03273023|Chromium|chromium|mesh-list
56069238|NCT05668585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56069460|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56069461|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56069462|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56069463|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069464|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069465|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56192398|NCT01480817|Sorafenib|sorafenib|mesh-list
56069635|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56069636|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
56069637|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56192402|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192404|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
56192410|NCT01480869|Vitamins|vitamins|mesh-ancestor
56192411|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
56192412|NCT01480986|Irinotecan|irinotecan|mesh-list
56192413|NCT01480986|Octreotide|octreotide|mesh-list
56192414|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56192438|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56192439|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56192440|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
56192441|NCT01481194|Hormones|hormones|mesh-ancestor
56070066|NCT02788097|Progesterone|progesterone|mesh-list
56070165|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56070217|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
56070390|NCT03488420|Edoxaban|edoxaban|mesh-list
56070435|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56070437|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56070560|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070675|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070676|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56070954|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
56071177|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071283|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
56071393|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56071394|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56071610|NCT02062177|Midazolam|midazolam|mesh-list
56071754|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071755|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071800|NCT02040116|Rituximab|rituximab|mesh-list
56071934|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072146|NCT02039947|Trametinib|trametinib|mesh-list
56072319|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56072321|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
56192660|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56072714|NCT02069041|Vitamins|vitamins|mesh-ancestor
56072933|NCT05638880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073070|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56073290|NCT03319277|Narcotics|narcotics|mesh-ancestor
56073291|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073483|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56073560|NCT00358202|Cefepime|cefepime|mesh-list
56074069|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
56074287|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56074611|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192781|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192782|NCT01483508|Protective Agents|protective agents|mesh-ancestor
56075001|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56075151|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56075378|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075423|NCT03478163|Clindamycin|clindamycin|mesh-list
56075637|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
56075894|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075895|NCT05625594|Cyclophosphamide|cyclophosphamide|mesh-list
56075896|NCT05625594|Fludarabine|fludarabine|mesh-list
56075897|NCT05625594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075898|NCT05625594|Immunologic Factors|immunologic factors|mesh-ancestor
56075899|NCT05625594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075900|NCT05625594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075901|NCT05625594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56075902|NCT05625594|Alkylating Agents|alkylating agents|mesh-ancestor
56075903|NCT05625594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075904|NCT05625594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075943|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075980|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56144723|NCT00808470|Protective Agents|protective agents|mesh-ancestor
56076191|NCT04160546|Aspirin|aspirin|mesh-list
56076192|NCT04160546|Ponatinib|ponatinib|mesh-list
56076222|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56076223|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56076224|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56076225|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56192845|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56192846|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56192876|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56120651|NCT01851720|Analgesics|analgesics|mesh-ancestor
56192877|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56076502|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
56076844|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
56192907|NCT01484990|Levodopa|levodopa|mesh-list
56077157|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077158|NCT02464969|Apixaban|apixaban|mesh-list
56192913|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077304|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
56077305|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56077306|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56077569|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56077570|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56077571|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56077602|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
56077603|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077605|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
56077606|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56077607|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56077608|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56077609|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077611|NCT02453360|Bupivacaine|bupivacaine|mesh-list
56077856|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56077857|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56077858|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077860|NCT00359359|Sagopilone|sagopilone|mesh-list
56078068|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078069|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
56078588|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078589|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078590|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56078591|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
56078592|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078844|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
56078845|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078846|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
56078847|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
56078848|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
56078849|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56078850|NCT00003273|Leucovorin|leucovorin|mesh-list
56078851|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
56078852|NCT00003273|Temozolomide|temozolomide|mesh-list
56078853|NCT00003273|Thiotepa|thiotepa|mesh-list
56078854|NCT00003273|Carboplatin|carboplatin|mesh-list
56078855|NCT00003273|Methotrexate|methotrexate|mesh-list
56078856|NCT00003273|Etoposide|etoposide|mesh-list
56078889|NCT04329585|Antidotes|antidotes|mesh-ancestor
56078890|NCT04329585|Protective Agents|protective agents|mesh-ancestor
56078891|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078892|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
56078893|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
56078894|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078895|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078896|NCT00003279|Antibodies|antibodies|mesh-list
56078897|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56078898|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
56079102|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079138|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079180|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079181|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079217|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56079468|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079469|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
56079470|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56079471|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56079472|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079473|NCT00003375|Vincristine|vincristine|mesh-list
56079474|NCT00003375|Lomustine|lomustine|mesh-list
56079475|NCT00003375|Procarbazine|procarbazine|mesh-list
56079476|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079519|NCT00003543|Carmustine|carmustine|mesh-list
56192958|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56192959|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56079902|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080198|NCT00004107|Antibodies|antibodies|mesh-list
56080209|NCT00004125|Tamoxifen|tamoxifen|mesh-list
56080430|NCT00005049|Carboplatin|carboplatin|mesh-list
56080431|NCT00005049|Floxuridine|floxuridine|mesh-list
56193042|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
56193043|NCT01485692|Midazolam|midazolam|mesh-list
56080908|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56081054|NCT00362960|Olmesartan|olmesartan|mesh-list
56081089|NCT00363116|Daclizumab|daclizumab|mesh-list
56081313|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081314|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56081315|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
56081316|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081317|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081318|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56081319|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56081354|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081355|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081357|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081358|NCT00005649|Paclitaxel|paclitaxel|mesh-list
56081395|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56081396|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56081431|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56081432|NCT00005799|Cyclosporine|cyclosporine|mesh-list
56081482|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
56193140|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56193141|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081838|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081839|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
56082237|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56082238|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
56082326|NCT02464657|Cytarabine|cytarabine|mesh-list
56193211|NCT01486433|Aspirin|aspirin|mesh-list
56193212|NCT01486433|Simvastatin|simvastatin|mesh-list
56082703|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
56193350|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082936|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
56082937|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082938|NCT02607254|Pregabalin|pregabalin|mesh-list
56082939|NCT02607254|Analgesics|analgesics|mesh-ancestor
56082940|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
56082941|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082974|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56082975|NCT05525858|Growth Substances|growth substances|mesh-ancestor
56082976|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56193370|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56193371|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083470|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083681|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083818|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56083820|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
56083821|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083822|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56083823|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56084180|NCT02508259|Suramin|suramin|mesh-list
56084181|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
56084216|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084468|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
56084469|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56193530|NCT01488266|Mirtazapine|mirtazapine|mesh-list
56193531|NCT01488266|Citalopram|citalopram|mesh-list
56193532|NCT01488266|Bupropion|bupropion|mesh-list
56193533|NCT01488266|Fluoxetine|fluoxetine|mesh-list
56084880|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084881|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56084882|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56084883|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56084915|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56084916|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56084917|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
56085049|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085196|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085375|NCT05587933|Autonomic Agents|autonomic agents|mesh-ancestor
56193595|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085586|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085752|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56085753|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56085754|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
56085755|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085756|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
56085757|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085905|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56086061|NCT05261672|Midazolam|midazolam|mesh-list
56086254|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56086750|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086751|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086903|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56087044|NCT04806919|Progestins|progestins|mesh-ancestor
56087045|NCT04806919|Hormones|hormones|mesh-ancestor
56087075|NCT05448937|Protective Agents|protective agents|mesh-ancestor
56087378|NCT02197416|Dabigatran|dabigatran|mesh-list
56087431|NCT04027322|Dexamethasone|dexamethasone|mesh-list
56087432|NCT04027322|Budesonide|budesonide|mesh-list
56193727|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
56193728|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56087568|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087569|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087930|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
56088153|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56088372|NCT00372008|Hormones|hormones|mesh-ancestor
56088373|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088374|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088375|NCT02973763|Aflutinib|aflutinib|mesh-list
56088376|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56088377|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088623|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
56088624|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088625|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
56088626|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56088661|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088662|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088663|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56088664|NCT04061330|Narcotics|narcotics|mesh-ancestor
56088699|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088700|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56193738|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56193739|NCT01489371|Doxorubicin|doxorubicin|mesh-list
56193740|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56193741|NCT01489371|Interleukin-12|interleukin-12|mesh-list
56193742|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56088970|NCT02885012|Ambrisentan|ambrisentan|mesh-list
56089177|NCT02888665|Doxorubicin|doxorubicin|mesh-list
56089178|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56089179|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
56089180|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56089181|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089182|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56089183|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56089184|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089185|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089186|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56089258|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
56089289|NCT03001843|Ketamine|ketamine|mesh-list
56089555|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089557|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56089750|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
56089751|NCT03035929|Hormones|hormones|mesh-ancestor
56089758|NCT02951702|Vancomycin|vancomycin|mesh-list
56089925|NCT02964416|Narcotics|narcotics|mesh-ancestor
56089926|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089975|NCT02846792|Nivolumab|nivolumab|mesh-list
56090208|NCT02846233|Empagliflozin|empagliflozin|mesh-list
56090209|NCT02846233|Dulaglutide|dulaglutide|mesh-list
56090210|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56090211|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
56090238|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56090378|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
56090379|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090380|NCT03068312|Ivacaftor|ivacaftor|mesh-list
56090381|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56090382|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56090383|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090384|NCT03119168|Simethicone|simethicone|mesh-list
56090385|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
56090386|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090387|NCT03119168|Emollients|emollients|mesh-ancestor
56090388|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
56090389|NCT03070730|Atenolol|atenolol|mesh-list
56090390|NCT03070730|Droxidopa|droxidopa|mesh-list
56090391|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56090392|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56090475|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
56090476|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
56090477|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
56090489|NCT05404334|Androgens|androgens|mesh-list
56090637|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090975|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
56090976|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090977|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56090978|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
56090979|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090980|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56090981|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56091084|NCT03132571|Naltrexone|naltrexone|mesh-list
56091085|NCT03132571|Bupropion|bupropion|mesh-list
56193882|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
56091358|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091359|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
56091360|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091361|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
56091362|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091363|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
56091364|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091365|NCT04736186|Loperamide|loperamide|mesh-list
56091366|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
56091367|NCT04736186|Bentonite|bentonite|mesh-list
56091393|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091394|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56091395|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091396|NCT03347929|Naproxen|naproxen|mesh-list
56091398|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56091446|NCT03324373|Lenvatinib|lenvatinib|mesh-list
56091447|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091448|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56091449|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
56091450|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091591|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091592|NCT04088786|Irinotecan|irinotecan|mesh-list
56091593|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56091594|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56091595|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091596|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091597|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091598|NCT00392821|Everolimus|everolimus|mesh-list
56091599|NCT00392821|Sorafenib|sorafenib|mesh-list
56091600|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091601|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56091602|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
56091603|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091605|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091727|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56091728|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56091868|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
56091894|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56091895|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091896|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56091897|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091931|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091932|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091933|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
56091934|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56091935|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56091954|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56091955|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
56091956|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091965|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
56092280|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092281|NCT00376064|Octreotide|octreotide|mesh-list
56092282|NCT00376064|Cabergoline|cabergoline|mesh-list
56092283|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56092284|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56092285|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092286|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56092287|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56092356|NCT02176356|Bimatoprost|bimatoprost|mesh-list
56092357|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56092358|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
56092359|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56092401|NCT01599234|Nabiximols|nabiximols|mesh-list
56092570|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56194065|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
56092948|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56092949|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
56093086|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093087|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
56093088|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093089|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
56093090|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093092|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093203|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093204|NCT05314400|Liver Extracts|liver extracts|mesh-list
56093205|NCT05314400|Hematinics|hematinics|mesh-ancestor
56093206|NCT04039412|Levofloxacin|levofloxacin|mesh-list
56093233|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093238|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56093396|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093584|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093586|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
56093931|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093933|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56094038|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
56094213|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56094293|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094437|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094438|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
56094439|NCT03636061|Varenicline|varenicline|mesh-list
56094440|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56094480|NCT01718444|Hormones|hormones|mesh-ancestor
56094653|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56094654|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56094778|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
55822062|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56194207|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56194232|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56194233|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56122005|NCT01725126|Metformin|metformin|mesh-list
56095116|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095117|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095118|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095173|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56095174|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56095180|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56095247|NCT00075608|Melphalan|melphalan|mesh-list
56095625|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
56095626|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55822735|NCT01646177|Analgesics|analgesics|mesh-ancestor
56095627|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
56095628|NCT00000950|Vitamins|vitamins|mesh-ancestor
56095650|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095651|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095652|NCT00000224|Analgesics|analgesics|mesh-ancestor
56095653|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
56095654|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095655|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56095656|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
56095657|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
56095658|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56095659|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56095660|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095661|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095662|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095663|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56095675|NCT00000236|Naloxone|naloxone|mesh-list
56095719|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56095720|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
56194338|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56095927|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56096101|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
56096102|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
56096103|NCT04085341|Sunitinib|sunitinib|mesh-list
56096268|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096269|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
56096270|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56096377|NCT00002102|Vitamins|vitamins|mesh-ancestor
56096379|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
56097114|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097161|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
56097163|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097327|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097328|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097329|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097330|NCT00002366|Ritonavir|ritonavir|mesh-list
56097331|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56097333|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
56097438|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
56097526|NCT05709626|Aspirin|aspirin|mesh-list
56097542|NCT03538015|Carvedilol|carvedilol|mesh-list
56097602|NCT05701436|Antimetabolites|antimetabolites|mesh-ancestor
56097713|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097789|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097877|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56194568|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
56098049|NCT00002552|Vitamins|vitamins|mesh-ancestor
56098073|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098207|NCT02234011|Ketamine|ketamine|mesh-list
56098533|NCT00002714|Prednisone|prednisone|mesh-list
56098706|NCT00381914|Vitamin D|vitamin d|mesh-list
56098780|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098851|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56098930|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098937|NCT01122511|Dexamethasone|dexamethasone|mesh-list
56194799|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
56099186|NCT05546047|Tacrolimus|tacrolimus|mesh-list
56194831|NCT01495195|Protective Agents|protective agents|mesh-ancestor
56194833|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56195010|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56099550|NCT04630028|Ustekinumab|ustekinumab|mesh-list
56099795|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
56099796|NCT04330586|Hormones|hormones|mesh-ancestor
56099990|NCT04330664|Adagrasib|adagrasib|mesh-list
56195242|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56195247|NCT01497561|Insulin|insulin|mesh-list
56100406|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56195300|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56195303|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
56100495|NCT00002912|Etoposide|etoposide|mesh-list
56100629|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
56100757|NCT00000649|Nevirapine|nevirapine|mesh-list
56101009|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56101010|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56101011|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
56101012|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
56101076|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101077|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101078|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101079|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101080|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
56101081|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101082|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101083|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101084|NCT00001027|Pentamidine|pentamidine|mesh-list
56101085|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
56101086|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101087|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56101088|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56101089|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56101090|NCT00000727|Zidovudine|zidovudine|mesh-list
56101091|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
56101092|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
56101093|NCT00000727|Trimethoprim|trimethoprim|mesh-list
56101094|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
56101095|NCT00000727|Pentamidine|pentamidine|mesh-list
56101096|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56101229|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101230|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101374|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
56101375|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56101376|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
56101377|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101380|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
56195500|NCT01499433|Caspofungin|caspofungin|mesh-list
56101728|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56101771|NCT00002125|Foscarnet|foscarnet|mesh-list
56195536|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56195537|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
56101937|NCT02176148|Hormones|hormones|mesh-ancestor
56102070|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
56102071|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102193|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56102288|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
56195582|NCT01499953|PENTA|penta|mesh-list
56195602|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
56195603|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102562|NCT00002804|Lenograstim|lenograstim|mesh-list
56102563|NCT00002804|Mesna|mesna|mesh-list
56102564|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56102565|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102567|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102671|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56195648|NCT01500408|Interferons|interferons|mesh-list
56103087|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103162|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103306|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103307|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103308|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103346|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103432|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103433|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
56103434|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103612|NCT00003518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103613|NCT00002647|Verteporfin|verteporfin|mesh-list
56103614|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56103615|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
56103616|NCT00002653|Prednisone|prednisone|mesh-list
56103617|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
56103787|NCT00004010|Vinblastine|vinblastine|mesh-list
56195722|NCT01500837|Ofloxacin|ofloxacin|mesh-list
56104084|NCT00004082|Gemcitabine|gemcitabine|mesh-list
56104085|NCT00004082|Carboplatin|carboplatin|mesh-list
56104086|NCT00004082|Docetaxel|docetaxel|mesh-list
56104087|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104088|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104089|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
56104090|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104204|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56104205|NCT00003332|Gemcitabine|gemcitabine|mesh-list
56104382|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104413|NCT00002749|Carboplatin|carboplatin|mesh-list
56104456|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104663|NCT00003680|Methotrexate|methotrexate|mesh-list
56104963|NCT05487235|Omeprazole|omeprazole|mesh-list
56105278|NCT00003758|Cytarabine|cytarabine|mesh-list
56105279|NCT00003758|Idarubicin|idarubicin|mesh-list
56105458|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105635|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
56105853|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
56123719|NCT01458522|Lacosamide|lacosamide|mesh-list
56195982|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56195983|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56195984|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
56195986|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56106374|NCT00005642|Growth Substances|growth substances|mesh-ancestor
56106402|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106403|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106404|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56106405|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106406|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
56106407|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
56106408|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106409|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56106410|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
56106411|NCT04512235|Hormones|hormones|mesh-ancestor
56106412|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106414|NCT00005654|Metformin|metformin|mesh-list
56106501|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106503|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56196042|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56196043|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56196044|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
56196045|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56106859|NCT04561856|Hormones|hormones|mesh-ancestor
56107060|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107288|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55834289|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
56107495|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107739|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107895|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108012|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108013|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108206|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56196125|NCT01501799|Analgesics|analgesics|mesh-ancestor
56108637|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108638|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108639|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108640|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108641|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
56108642|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
56108643|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108644|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108646|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108769|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
56108931|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109522|NCT00004879|Panitumumab|panitumumab|mesh-list
56109805|NCT00005017|Abacavir|abacavir|mesh-list
56109806|NCT00005017|Stavudine|stavudine|mesh-list
56196291|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56196292|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110296|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110455|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
56110581|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56110582|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110608|NCT02120898|Imiquimod|imiquimod|mesh-list
56196407|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56196428|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56196429|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
56110958|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56110959|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
56110960|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56111060|NCT02079636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111061|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111062|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56111063|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56111103|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
56111197|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111206|NCT02059434|LAS190792|las190792|mesh-list
56111364|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
56111573|NCT02006706|Hormones|hormones|mesh-ancestor
56111627|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
56111638|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56111639|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
56111640|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
56111775|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111776|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111778|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56111780|NCT01967550|Analgesics|analgesics|mesh-ancestor
56111891|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
56112024|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
56112143|NCT01959672|Hematinics|hematinics|mesh-ancestor
56112283|NCT01931202|Citalopram|citalopram|mesh-list
56112373|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56112545|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112656|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56112657|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56112991|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56113150|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113240|NCT01645709|Verapamil|verapamil|mesh-list
56196700|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
56196701|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840435|NCT04605393|Dronabinol|dronabinol|mesh-list
56113688|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56113873|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114019|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
56114167|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
56114169|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115013|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55715867|NCT02361879|Leuprolide|leuprolide|mesh-list
56196863|NCT01505413|Gemcitabine|gemcitabine|mesh-list
56196908|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56196909|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
56196910|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56196911|NCT01505777|Mosapride|mosapride|mesh-list
56196912|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56196938|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716233|NCT02222519|Bromides|bromides|mesh-list
56116101|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56116173|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116174|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116393|NCT05568095|Leucovorin|leucovorin|mesh-list
56116703|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116704|NCT04330547|Analgesics|analgesics|mesh-list
56116708|NCT00382889|Beclomethasone|beclomethasone|mesh-list
56116898|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
56117059|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
56197139|NCT01506622|Analgesics|analgesics|mesh-ancestor
56197140|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
56197141|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197143|NCT01506635|Timolol|timolol|mesh-list
56117733|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
56118479|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56118778|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
56119130|NCT00004733|Levodopa|levodopa|mesh-list
56197223|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119322|NCT00005585|Antidotes|antidotes|mesh-ancestor
56119627|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56119825|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119826|NCT00003893|Analgesics|analgesics|mesh-ancestor
56119827|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
56119828|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119966|NCT02211521|Protective Agents|protective agents|mesh-ancestor
56119967|NCT01597908|Trametinib|trametinib|mesh-list
56119968|NCT01597908|Vemurafenib|vemurafenib|mesh-list
56119969|NCT01597908|Dabrafenib|dabrafenib|mesh-list
56120116|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120117|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56120144|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56120255|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56120257|NCT01907100|Pemetrexed|pemetrexed|mesh-list
56120258|NCT01907100|Nintedanib|nintedanib|mesh-list
56120259|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120286|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120426|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120427|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120428|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56120429|NCT04414800|Narcotics|narcotics|mesh-ancestor
56120493|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
56120622|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56120824|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
56121139|NCT04414566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121140|NCT04414566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121141|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121318|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56121319|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121320|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121321|NCT04414254|Cefprozil|cefprozil|mesh-list
56121322|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56121323|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121324|NCT01770912|Triamcinolone|triamcinolone|mesh-list
56121325|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56121356|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56121358|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121359|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
56121360|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121361|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56121457|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197472|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
56121966|NCT01703286|Glimepiride|glimepiride|mesh-list
56122091|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
56122330|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
56122425|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56122426|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56122508|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122559|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122560|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56122561|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56197560|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197580|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56123270|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123410|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56197619|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56197621|NCT01508637|Urological Agents|urological agents|mesh-ancestor
56123833|NCT01454076|Ixazomib|ixazomib|mesh-list
56124061|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56124066|NCT01492686|Edaravone|edaravone|mesh-list
56124296|NCT01442688|Analgesics|analgesics|mesh-ancestor
56124539|NCT01432938|Warfarin|warfarin|mesh-list
55902315|NCT01582451|Insulin|insulin|mesh-list
55902580|NCT03169764|Vitamins|vitamins|mesh-ancestor
55902685|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55902686|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
56197776|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
56197777|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56197778|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56197779|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
56197780|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56197781|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
56197782|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
55902961|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
55902962|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903185|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903395|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903396|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
55903467|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903638|NCT01687673|Sirolimus|sirolimus|mesh-list
55904058|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
56197891|NCT01510548|Adalimumab|adalimumab|mesh-list
55904574|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905274|NCT03161106|Lactulose|lactulose|mesh-list
55905456|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56198012|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906353|NCT04123561|Dexamethasone|dexamethasone|mesh-list
55906475|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
56198085|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56198086|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56198087|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
56198088|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198089|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55906678|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55906679|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906827|NCT02379546|Desflurane|desflurane|mesh-list
55906828|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55907122|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907123|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55907125|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907252|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907256|NCT02037126|Promethazine|promethazine|mesh-list
55907589|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55907868|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908177|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56198173|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
55908734|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55909014|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55909160|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55909348|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
55909622|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
55909623|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909624|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909804|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909805|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909978|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909979|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909980|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
55909981|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198306|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910220|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55910572|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910832|NCT01478113|Amphetamine|amphetamine|mesh-list
55726111|NCT02479880|Tenofovir|tenofovir|mesh-list
55911714|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55911839|NCT01472185|Ranolazine|ranolazine|mesh-list
56198504|NCT01513083|Trastuzumab|trastuzumab|mesh-list
55912071|NCT01453049|Glimepiride|glimepiride|mesh-list
55912072|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
55912073|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55912074|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55912075|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912076|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55912313|NCT03887936|Androgens|androgens|mesh-ancestor
55912314|NCT03887936|Hormones|hormones|mesh-ancestor
55912317|NCT01684202|Tolvaptan|tolvaptan|mesh-list
56198511|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
55912626|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912627|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55912763|NCT01553084|Nicotine|nicotine|mesh-list
56198535|NCT01513525|Hormones|hormones|mesh-ancestor
55913900|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914181|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914330|NCT01516970|Zidovudine|zidovudine|mesh-list
55914331|NCT01516970|Efavirenz|efavirenz|mesh-list
55914332|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55914333|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55914468|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
55914469|NCT02394795|Antidotes|antidotes|mesh-ancestor
55914470|NCT02394795|Protective Agents|protective agents|mesh-ancestor
55914471|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
55914472|NCT02394795|Vitamins|vitamins|mesh-ancestor
56198656|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198657|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55914752|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55914753|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55914754|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56198746|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198747|NCT01514721|Timolol|timolol|mesh-list
56198768|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
56198807|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198812|NCT01514942|Inositol|inositol|mesh-list
56198832|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55915354|NCT01436071|Xhance|xhance|mesh-list
56199108|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
56199109|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
56199110|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
56199111|NCT01516580|Cytarabine|cytarabine|mesh-list
56199429|NCT01518166|Hormones|hormones|mesh-ancestor
56199112|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
56199113|NCT01516580|Rituximab|rituximab|mesh-list
56199114|NCT01516580|Doxorubicin|doxorubicin|mesh-list
56199115|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56199116|NCT01516580|Methotrexate|methotrexate|mesh-list
56199117|NCT01516580|Vincristine|vincristine|mesh-list
56199118|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56199119|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
55915415|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915416|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55915417|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
56199519|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55915418|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915419|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915420|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
55916540|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
55916650|NCT02914470|Atezolizumab|atezolizumab|mesh-list
55915421|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917172|NCT04505670|Donepezil|donepezil|mesh-list
55917274|NCT05738148|Mydriatics|mydriatics|mesh-ancestor
55917275|NCT05738148|Sympathomimetics|sympathomimetics|mesh-ancestor
55917427|NCT02999919|Bupivacaine|bupivacaine|mesh-list
55915422|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55915423|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55915424|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
55915425|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915426|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56199873|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
55917779|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
56199943|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
55918158|NCT01431287|Olodaterol|olodaterol|mesh-list
55915427|NCT01419197|Trastuzumab|trastuzumab|mesh-list
55918403|NCT04044131|Cathartics|cathartics|mesh-ancestor
55918567|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918818|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918819|NCT03590431|Trace Elements|trace elements|mesh-ancestor
56200136|NCT01522612|Vitamins|vitamins|mesh-ancestor
55918878|NCT05102058|Analgesics|analgesics|mesh-ancestor
55918887|NCT03956797|Anesthetics|anesthetics|mesh-list
56200163|NCT01522820|Sirolimus|sirolimus|mesh-list
55919085|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55915428|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55915429|NCT01419197|Maytansine|maytansine|mesh-list
56199120|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199121|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55919172|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
55919340|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55919673|NCT04146259|Antacids|antacids|mesh-ancestor
55919687|NCT05100186|Hormones|hormones|mesh-ancestor
55919803|NCT04530630|Emtricitabine|emtricitabine|mesh-list
56199122|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56199123|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
56199124|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199125|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199126|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56199127|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56199128|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56199129|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56199130|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56199131|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199132|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56199133|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
56199134|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56199135|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56199136|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
56199137|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
56199138|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56199139|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56199140|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
56199141|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199142|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55920431|NCT04701060|Apatinib|apatinib|mesh-list
56200462|NCT01524081|Amoxicillin|amoxicillin|mesh-list
56199143|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
56199144|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
56199145|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
56199146|NCT01516710|Liver Extracts|liver extracts|mesh-list
56199147|NCT01516710|Hematinics|hematinics|mesh-ancestor
56199148|NCT01516723|Sirolimus|sirolimus|mesh-list
56199149|NCT01516723|Everolimus|everolimus|mesh-list
55915430|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915431|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915496|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915517|NCT01416389|Lenograstim|lenograstim|mesh-list
55915518|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55915519|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
55743034|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
55915520|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921057|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55921207|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
55921343|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
55915522|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55915523|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55915524|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
55915525|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200610|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
55915526|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915527|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199150|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199151|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56199152|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
56199153|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199154|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56199155|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199156|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56199157|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
56199158|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56199159|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199160|NCT01516814|Heparin|heparin|mesh-list
56199161|NCT01516814|Calcium heparin|calcium heparin|mesh-list
56199162|NCT01516814|Warfarin|warfarin|mesh-list
56199163|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
56199164|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
56199165|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56199166|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56199167|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199168|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56199169|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
56199170|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56199171|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
56199172|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199173|NCT01516840|Heparin|heparin|mesh-list
56199174|NCT01516840|Calcium heparin|calcium heparin|mesh-list
56199175|NCT01516840|Warfarin|warfarin|mesh-list
56199176|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
56199177|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
56200652|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
56199178|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56199187|NCT01516866|Fluorides|fluorides|mesh-list
56199202|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
56199203|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199204|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
56199205|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
56199206|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
56199207|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199208|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56199209|NCT01517009|Docetaxel|docetaxel|mesh-list
56199210|NCT01517009|Capecitabine|capecitabine|mesh-list
56199211|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199212|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
56199213|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
56199214|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922136|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922213|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55922469|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
56199215|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199216|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56199217|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
56199218|NCT01517022|Nicotine|nicotine|mesh-list
55870474|NCT00949234|Emtricitabine|emtricitabine|mesh-list
55922690|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
55922838|NCT05123976|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56199219|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56199220|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
55923481|NCT03806595|Lidocaine|lidocaine|mesh-list
55923562|NCT04325880|Tamsulosin|tamsulosin|mesh-list
56200866|NCT01526174|Golimumab|golimumab|mesh-list
55923809|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55923811|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
56199221|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199222|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199223|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56199224|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56199225|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
56200894|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199226|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199227|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925247|NCT01498952|Sorafenib|sorafenib|mesh-list
56199228|NCT01517165|Pioglitazone|pioglitazone|mesh-list
56199229|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199230|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199231|NCT01517308|Interferons|interferons|mesh-list
56199232|NCT01517308|Ribavirin|ribavirin|mesh-list
55925443|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55925711|NCT04760821|Trimetazidine|trimetazidine|mesh-list
55925712|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
56199233|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
55926062|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199234|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
56199235|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56199236|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201238|NCT01527864|Paclitaxel|paclitaxel|mesh-list
55915528|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
55915529|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
55915530|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201324|NCT01528176|Vitamin D|vitamin d|mesh-list
55928788|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55915531|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55915532|NCT01544348|Omalizumab|omalizumab|mesh-list
55915533|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55915534|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55915535|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
56199237|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
56199238|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199239|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
56199240|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002529|NCT02152982|Veliparib|veliparib|mesh-list
56003822|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
56199241|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
56199242|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199243|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56199244|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199245|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199246|NCT01517321|Incretins|incretins|mesh-ancestor
56199247|NCT01517321|Hormones|hormones|mesh-ancestor
56199248|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199249|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56004262|NCT05751850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004263|NCT05751850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56004264|NCT05751850|Antidotes|antidotes|mesh-ancestor
55744389|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
56201831|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201832|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201833|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56201834|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56201835|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
56201836|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201837|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199250|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
56199251|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199252|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915536|NCT01416155|Natalizumab|natalizumab|mesh-list
55915537|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
55915538|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915539|NCT01415921|Bromides|bromides|mesh-list
55915540|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55915541|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
56201839|NCT01530698|Vaccines|vaccines|mesh-list
56201840|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
56201841|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201842|NCT01530711|Terlipressin|terlipressin|mesh-list
56201843|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56201844|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56201845|NCT01530737|Antithrombins|antithrombins|mesh-list
56201846|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
56201847|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56201848|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
56201849|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201850|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201851|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
56201852|NCT01530763|Amoxicillin|amoxicillin|mesh-list
56201853|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
56201854|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
56201855|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
56201856|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56201857|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56201858|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201859|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915542|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55915543|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915544|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915545|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
55915546|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915547|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915548|NCT01415531|Nebivolol|nebivolol|mesh-list
56201860|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56201861|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201862|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201863|NCT01530815|Bupivacaine|bupivacaine|mesh-list
56201864|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
56201865|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
56201866|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737358|NCT03433807|Idebenone|idebenone|mesh-list
55762976|NCT01318317|Lenograstim|lenograstim|mesh-list
55802186|NCT04802083|Eculizumab|eculizumab|mesh-list
56201867|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201868|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
56201869|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201870|NCT01530984|Ipilimumab|ipilimumab|mesh-list
56201871|NCT01530984|Sargramostim|sargramostim|mesh-list
56201872|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56201873|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201874|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56201888|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201890|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56201891|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56201892|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56201893|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56201894|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56201895|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
55763129|NCT02109562|Risperidone|risperidone|mesh-list
55744390|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201896|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201897|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201898|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201899|NCT01531140|Bisacodyl|bisacodyl|mesh-list
56201900|NCT01531140|Senna Extract|senna extract|mesh-list
56201901|NCT01531140|Sennosides|sennosides|mesh-list
56201902|NCT01531140|Cathartics|cathartics|mesh-ancestor
56201903|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56201906|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
56201907|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
56201908|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56201909|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201910|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
56201911|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201912|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
56201913|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201914|NCT01531192|Nystatin|nystatin|mesh-list
56201915|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201916|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201917|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
55763155|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
56201919|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201920|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201921|NCT01531218|Azithromycin|azithromycin|mesh-list
56201922|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201923|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201924|NCT01531244|Dactinomycin|dactinomycin|mesh-list
56201925|NCT01531244|Cactinomycin|cactinomycin|mesh-list
56201926|NCT01531244|Melphalan|melphalan|mesh-list
56201927|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56201928|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
56201929|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201930|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201931|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56201932|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201933|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
56201934|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201935|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201936|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201937|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56201938|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56201939|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201940|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55915549|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55915550|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
55915567|NCT01544114|Analgesics|analgesics|mesh-ancestor
55915568|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
55915569|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915570|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915571|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55915572|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915573|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
55915574|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55915575|NCT01410799|Hormones|hormones|mesh-list
55915576|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
55915577|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55915578|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915579|NCT01432171|Lacosamide|lacosamide|mesh-list
55915580|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
55915581|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55915582|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56201946|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56201947|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
56201948|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201949|NCT01531361|Sorafenib|sorafenib|mesh-list
56201950|NCT01531361|Vemurafenib|vemurafenib|mesh-list
56201951|NCT01531361|Crizotinib|crizotinib|mesh-list
56201952|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201953|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56201954|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129680|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201955|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201956|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
56201957|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201958|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
56201959|NCT01531517|Propolis|propolis|mesh-list
56201960|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
56201961|NCT01531517|Vitamins|vitamins|mesh-ancestor
56201962|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
56201963|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201964|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201965|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
56201966|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
56201967|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56201968|NCT01531569|Estrogens|estrogens|mesh-ancestor
56201969|NCT01531569|Hormones|hormones|mesh-ancestor
56201970|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201971|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915583|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55728900|NCT02294279|Beclomethasone|beclomethasone|mesh-list
55915584|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915585|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
55915586|NCT04046263|Hematinics|hematinics|mesh-ancestor
55915587|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
55915588|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915589|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915590|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
55915591|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915592|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199253|NCT01517334|Minocycline|minocycline|mesh-list
56199254|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56127028|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
56201972|NCT01531582|Minocycline|minocycline|mesh-list
56201973|NCT01531582|Tetracycline|tetracycline|mesh-list
56201974|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201975|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201976|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56201977|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201978|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201979|NCT01531595|Bevacizumab|bevacizumab|mesh-list
56201980|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
56201981|NCT01531595|Irinotecan|irinotecan|mesh-list
56201982|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56201983|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201984|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56201985|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56201986|NCT01531595|Growth Substances|growth substances|mesh-ancestor
56201987|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201988|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
56201989|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56201990|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56201991|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737992|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56201992|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201994|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
56201995|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56201996|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56201997|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
56201998|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201999|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202000|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56202001|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56202002|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
56202003|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738056|NCT02735707|Cysteamine|cysteamine|mesh-list
55809598|NCT01653847|Tacrolimus|tacrolimus|mesh-list
55809599|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809600|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
55809601|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809602|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55809604|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809605|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809606|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55809613|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809614|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809615|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56202004|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56202005|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56202006|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56202007|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56202008|NCT01531712|Gemcitabine|gemcitabine|mesh-list
56202009|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
56202010|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56202011|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56202012|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
56202016|NCT01531712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202017|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202018|NCT01531712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202019|NCT01531712|Immunologic Factors|immunologic factors|mesh-ancestor
56202020|NCT01531712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202021|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56202022|NCT01531764|Vinorelbine|vinorelbine|mesh-list
56202023|NCT01531764|Afatinib|afatinib|mesh-list
56202024|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56202025|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202026|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
55763279|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
56202027|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
56202028|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
56202029|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202030|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56202031|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202032|NCT01531777|Apatinib|apatinib|mesh-list
56202033|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202034|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56202035|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202036|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202037|NCT01531790|Carboplatin|carboplatin|mesh-list
56199255|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199256|NCT01517347|Interleukin-2|interleukin-2|mesh-list
56199257|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199258|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56199259|NCT01517347|Analgesics|analgesics|mesh-ancestor
56199260|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
56199261|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199262|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199263|NCT01517360|Oxytocin|oxytocin|mesh-list
56199264|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
56199265|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56199266|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199267|NCT01517399|Vitamin K|vitamin k|mesh-list
56199268|NCT01517399|Digoxin|digoxin|mesh-list
56199269|NCT01517399|Midazolam|midazolam|mesh-list
56199270|NCT01517399|Caffeine|caffeine|mesh-list
56199271|NCT01517399|Omeprazole|omeprazole|mesh-list
56199272|NCT01517399|Warfarin|warfarin|mesh-list
56199273|NCT01517399|Vitamins|vitamins|mesh-ancestor
56199274|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
56199275|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199276|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56199277|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56199278|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56202046|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56202047|NCT01531790|Growth Substances|growth substances|mesh-ancestor
56202048|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202049|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
56202050|NCT01531829|Heparin|heparin|mesh-list
56202051|NCT01531829|Plasminogen|plasminogen|mesh-list
56202052|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56202053|NCT01531829|Tinzaparin|tinzaparin|mesh-list
56202054|NCT01531829|Dalteparin|dalteparin|mesh-list
56202055|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56199279|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56199280|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56199281|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56199282|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56199283|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
56199284|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
56199285|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
56199286|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
56199287|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199288|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199289|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
55763397|NCT02104804|Incretins|incretins|mesh-ancestor
56202057|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
56202058|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56202059|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56202060|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202061|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56202062|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202063|NCT01531855|Insulin|insulin|mesh-list
56202064|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
56202065|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
56202066|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56202067|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202068|NCT01531920|Ethanol|ethanol|mesh-list
55738523|NCT01111565|Aripiprazole|aripiprazole|mesh-list
55809616|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809617|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809619|NCT02493517|Somatostatin|somatostatin|mesh-list
55809620|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809621|NCT02493517|Hormones|hormones|mesh-ancestor
55809622|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809623|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809624|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
55809625|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809626|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809627|NCT04959799|Dalbavancin|dalbavancin|mesh-list
55809628|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55809629|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809630|NCT04959331|Fosfomycin|fosfomycin|mesh-list
55809631|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
55809632|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
55809633|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55809634|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809635|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55809636|NCT04959331|Renal Agents|renal agents|mesh-ancestor
55809637|NCT02478463|Cabotegravir|cabotegravir|mesh-list
55809638|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55809639|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55809640|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809641|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809642|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55809643|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55809644|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
55809645|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809646|NCT02491411|Dexamethasone|dexamethasone|mesh-list
55809647|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
55809650|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809651|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
55809652|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
55809653|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809654|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809655|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55809656|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
56202069|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56202070|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202071|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56202072|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202073|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56202074|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202075|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56202076|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202078|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56202079|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
56202080|NCT01532076|Coagulants|coagulants|mesh-ancestor
56202081|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
55763438|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
56202082|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202083|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
56202084|NCT01532115|Opicapone|opicapone|mesh-list
56202085|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55738727|NCT03412721|Analgesics|analgesics|mesh-list
56202086|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202087|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56202088|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56202089|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202090|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202091|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202092|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56202093|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56202094|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56202095|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
56202096|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56202097|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56202098|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202099|NCT01532232|Varenicline|varenicline|mesh-list
56202100|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55744391|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55809657|NCT02491411|Hormones|hormones|mesh-ancestor
55809658|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809659|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55809660|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809661|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
55809662|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202101|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56202102|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
56202103|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202104|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202105|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129839|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
56202106|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
56202108|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56202110|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56202111|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56202112|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56199290|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55915593|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915594|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56199291|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56199292|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199293|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56199294|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56202114|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202115|NCT01532518|MEN 11420|men 11420|mesh-list
56202117|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
56202118|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202119|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202120|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56202121|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
56202122|NCT01532544|Heparin|heparin|mesh-list
56202123|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56202124|NCT01532544|Tinzaparin|tinzaparin|mesh-list
56199295|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
56199296|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55915595|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55915596|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
55915597|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915598|NCT05021562|Niraparib|niraparib|mesh-list
55915599|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55915600|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915601|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915602|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915603|NCT01412957|Panitumumab|panitumumab|mesh-list
55915604|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56202125|NCT01532544|Dalteparin|dalteparin|mesh-list
56202126|NCT01532544|Eptifibatide|eptifibatide|mesh-list
56202127|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
56202128|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56202129|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55810804|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
55810805|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810851|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55810888|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810889|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810890|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810891|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
55810892|NCT04411329|Hormones|hormones|mesh-ancestor
55810893|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810894|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55810895|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810896|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
55810897|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
55810898|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810899|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
55810900|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55810901|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55810902|NCT04411329|Analgesics|analgesics|mesh-ancestor
55810903|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55810904|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55810905|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55810906|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
55810907|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810908|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810909|NCT05171673|Diclofenac|diclofenac|mesh-list
55810910|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
55810911|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55810912|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55810913|NCT05171673|Analgesics|analgesics|mesh-ancestor
55810914|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
55810915|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810917|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810918|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810919|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55810920|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810921|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810923|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55810924|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55810925|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
55810926|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
55810927|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810928|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810929|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55810930|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55810931|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55810932|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
55810933|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810934|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810936|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
55810937|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
56202130|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202131|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56202132|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
56202133|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56202134|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56202135|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
56202136|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56202144|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202145|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56202146|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56202147|NCT01532804|Growth Substances|growth substances|mesh-ancestor
56202148|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202149|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
56202150|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55811881|NCT02226003|Hormones|hormones|mesh-ancestor
55811882|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811883|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55811884|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
55811885|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145008|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
56202151|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
56202152|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202153|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56202154|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202155|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56202156|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
56202157|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202158|NCT01532856|Thalidomide|thalidomide|mesh-list
56202159|NCT01532856|Dexamethasone|dexamethasone|mesh-list
56202160|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
56202161|NCT01532856|Prednisone|prednisone|mesh-list
56202162|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
56202163|NCT01532856|Melphalan|melphalan|mesh-list
56202164|NCT01532856|BB 1101|bb 1101|mesh-list
56202165|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202166|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
56202167|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202168|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56202169|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56202170|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
55738371|NCT01328093|Aripiprazole|aripiprazole|mesh-list
56202171|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202172|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202173|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56202174|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56202175|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
56202176|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
56202177|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202178|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56202179|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
56202180|NCT01532856|Hormones|hormones|mesh-ancestor
56202181|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56202185|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
56202186|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56202187|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202188|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56202189|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56202190|NCT01532856|Growth Substances|growth substances|mesh-ancestor
56202191|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
56202192|NCT01532895|Hydromorphone|hydromorphone|mesh-list
55915605|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915606|NCT04973826|Aztreonam|aztreonam|mesh-list
55915625|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915626|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
55915627|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55915628|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
55915629|NCT05062278|Vinblastine|vinblastine|mesh-list
55915630|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915631|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
55915632|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728984|NCT03521063|Hormones|hormones|mesh-ancestor
55915633|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915634|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56202216|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56202217|NCT01533155|Narcotics|narcotics|mesh-ancestor
56202218|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56202219|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202220|NCT01533155|Analgesics|analgesics|mesh-ancestor
56202221|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
56202242|NCT01533220|Pheniramine|pheniramine|mesh-list
56202285|NCT01533324|Vitamins|vitamins|mesh-ancestor
56202286|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
56202287|NCT01533376|Timolol|timolol|mesh-list
56202288|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
55739754|NCT04447105|Anesthetics|anesthetics|mesh-list
56202289|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56202290|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56202291|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
56202292|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202293|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763831|NCT05390307|Liraglutide|liraglutide|mesh-list
56202294|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202295|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56202296|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56202297|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56202298|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56202300|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56202301|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56202302|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56202303|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
56202304|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213217|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56202305|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202306|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202307|NCT01533389|Urological Agents|urological agents|mesh-ancestor
56202308|NCT01533441|Vitamin K|vitamin k|mesh-list
55915635|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55915636|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
55915637|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
55915638|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
55915639|NCT02823990|Nivolumab|nivolumab|mesh-list
55915640|NCT02823990|Interleukin-2|interleukin-2|mesh-list
55915641|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915642|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915643|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915644|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56202310|NCT01533441|Vitamin K 1|vitamin k 1|mesh-list
56202311|NCT01533441|Vitamins|vitamins|mesh-ancestor
56202312|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
56202313|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202314|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56202315|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56202316|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202317|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
56202318|NCT01533441|Coagulants|coagulants|mesh-ancestor
56202319|NCT01533506|Stiripentol|stiripentol|mesh-list
56202320|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
56202321|NCT01533545|Epinephrine|epinephrine|mesh-list
56202322|NCT01533545|Mepivacaine|mepivacaine|mesh-list
56202323|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56202324|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56202325|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
56202326|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202327|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202328|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202329|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56202330|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56202331|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
56202332|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202333|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56202334|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
56202335|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
56202336|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
56202337|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56202338|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
56202339|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
56202340|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56202341|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
56202342|NCT01533558|Caspofungin|caspofungin|mesh-list
56202344|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202345|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202346|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202347|NCT01533662|Phenylephrine|phenylephrine|mesh-list
56202348|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
56202349|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56202350|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
55740084|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
56202351|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
56202352|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202353|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202354|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
56202355|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56202356|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
56202357|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
56202358|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56202359|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56202360|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56202361|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
56202366|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56202367|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202368|NCT01533740|Leucovorin|leucovorin|mesh-list
56202369|NCT01533740|Folic Acid|folic acid|mesh-list
56202370|NCT01533740|Bevacizumab|bevacizumab|mesh-list
56202371|NCT01533740|Fluorouracil|fluorouracil|mesh-list
56202372|NCT01533740|Irinotecan|irinotecan|mesh-list
56202373|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
56202374|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56202375|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202389|NCT01533740|Antidotes|antidotes|mesh-ancestor
56202409|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56202410|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56202411|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56202412|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56202413|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56202414|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56202415|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202416|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
56202417|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202418|NCT01534026|Aspirin|aspirin|mesh-list
56202419|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56202420|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56202421|NCT01534026|Analgesics|analgesics|mesh-ancestor
56202422|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
56202445|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202446|NCT01534247|Metronidazole|metronidazole|mesh-list
56202447|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202448|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56202449|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56202450|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56202451|NCT01534312|Mesalamine|mesalamine|mesh-list
56202452|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56202453|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56202454|NCT01534312|Analgesics|analgesics|mesh-ancestor
56202455|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
56202456|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202457|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202458|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56202459|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56202460|NCT01534442|Atropine|atropine|mesh-list
56202461|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56202497|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
56202498|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202499|NCT01534702|Cytarabine|cytarabine|mesh-list
56202500|NCT01534702|Clofarabine|clofarabine|mesh-list
56202501|NCT01534702|Idarubicin|idarubicin|mesh-list
56202502|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56202503|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
56202504|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202505|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202506|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
56202507|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202508|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202546|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
56202547|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202548|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56202549|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
56202550|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202551|NCT01534884|Rituximab|rituximab|mesh-list
56202552|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56202553|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202554|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
56202556|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915645|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915646|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55915647|NCT02823990|Analgesics|analgesics|mesh-ancestor
56480367|NCT02932254|Analgesics|analgesics|mesh-ancestor
55915648|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
55915649|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480660|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55915650|NCT02427126|Aspirin|aspirin|mesh-list
55915651|NCT02427126|Apixaban|apixaban|mesh-list
55915652|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55915653|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55915654|NCT02427126|Analgesics|analgesics|mesh-ancestor
55915655|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
56480877|NCT04322565|Colchicine|colchicine|mesh-list
56480959|NCT04269408|Nicardipine|nicardipine|mesh-list
55915656|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481042|NCT00532857|Paclitaxel|paclitaxel|mesh-list
55915657|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915658|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55915659|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915680|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
55915681|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915682|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
55915683|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55915684|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55915685|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
55915686|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915687|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56481348|NCT02021474|Phenol|phenol|mesh-list
55915689|NCT04797312|Remifentanil|remifentanil|mesh-list
55915690|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
55915691|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
55915692|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915693|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915694|NCT04797312|Narcotics|narcotics|mesh-ancestor
55915695|NCT04797312|Analgesics|analgesics|mesh-ancestor
55915696|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
56199297|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56481417|NCT05471063|Fluconazole|fluconazole|mesh-list
56481558|NCT00536237|Niacinamide|niacinamide|mesh-list
56481637|NCT02496585|Hormones|hormones|mesh-ancestor
56481788|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56199298|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56199299|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56199300|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56199301|NCT01517399|Protective Agents|protective agents|mesh-ancestor
56199302|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56199303|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56482144|NCT05466305|Cobalt|cobalt|mesh-list
56199304|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
56199305|NCT01517399|Coagulants|coagulants|mesh-ancestor
56199306|NCT01517490|Insulin|insulin|mesh-list
56199307|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56199308|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199309|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199310|NCT01517555|Acetaminophen|acetaminophen|mesh-list
56199311|NCT01517555|Liraglutide|liraglutide|mesh-list
56199312|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56199313|NCT01517555|Analgesics|analgesics|mesh-ancestor
55915697|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915698|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55915699|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55915700|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
55915701|NCT05080140|Ezetimibe|ezetimibe|mesh-list
55915702|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55915703|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55915704|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
55915705|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915706|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55915707|NCT01390441|Acetaminophen|acetaminophen|mesh-list
55915708|NCT01390441|Loratadine|loratadine|mesh-list
55915709|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
55915710|NCT01390441|Rituximab|rituximab|mesh-list
55915711|NCT01390441|Methotrexate|methotrexate|mesh-list
55915712|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915713|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915714|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
55915715|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915736|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482517|NCT00537524|Vaccines|vaccines|mesh-list
55915737|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
55915738|NCT01390441|Hormones|hormones|mesh-ancestor
56482582|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55915739|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55915740|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55915741|NCT01390441|Protective Agents|protective agents|mesh-ancestor
56482707|NCT04741997|Nivolumab|nivolumab|mesh-list
55915742|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
56482877|NCT05136898|Mitomycins|mitomycins|mesh-list
56482952|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
55915743|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56483027|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56483112|NCT04003805|Nicotine|nicotine|mesh-list
56483178|NCT03795701|Liraglutide|liraglutide|mesh-list
56483250|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56483323|NCT02722616|Pancrelipase|pancrelipase|mesh-list
55915744|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56483559|NCT04246684|Vitamins|vitamins|mesh-ancestor
56483707|NCT01246960|Leucovorin|leucovorin|mesh-list
55915745|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56483926|NCT03610412|Antacids|antacids|mesh-ancestor
55915746|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
55915747|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
56484391|NCT00659711|Hormones|hormones|mesh-ancestor
56484449|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
55915748|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915750|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55915751|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55915752|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915753|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915754|NCT03025867|Niraparib|niraparib|mesh-list
55915755|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55915756|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915757|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484588|NCT00547599|Tadalafil|tadalafil|mesh-list
56484667|NCT00534807|Rifampin|rifampin|mesh-list
56485039|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915758|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915759|NCT01412879|Leucovorin|leucovorin|mesh-list
55915760|NCT01412879|Cytarabine|cytarabine|mesh-list
55915761|NCT01412879|Dexamethasone|dexamethasone|mesh-list
55915762|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
56199314|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
56199315|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199316|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199318|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199319|NCT01517555|Incretins|incretins|mesh-ancestor
56199320|NCT01517555|Hormones|hormones|mesh-ancestor
56199321|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199322|NCT01517568|Liraglutide|liraglutide|mesh-list
56199323|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199324|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199325|NCT01517568|Incretins|incretins|mesh-ancestor
56199326|NCT01517568|Hormones|hormones|mesh-ancestor
56199327|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199328|NCT01517607|Mesalamine|mesalamine|mesh-list
56199329|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56199330|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55915763|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56207988|NCT01572688|Melphalan|melphalan|mesh-list
56485388|NCT00553748|Alovudine|alovudine|mesh-list
56485469|NCT03391882|Emetics|emetics|mesh-ancestor
56485630|NCT00551109|SA 4503|sa 4503|mesh-list
55915764|NCT01412879|Rituximab|rituximab|mesh-list
55915765|NCT01412879|Doxorubicin|doxorubicin|mesh-list
55915766|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55915767|NCT01412879|Methotrexate|methotrexate|mesh-list
55915768|NCT01412879|Vincristine|vincristine|mesh-list
55915769|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
55915770|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55915771|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
55915772|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915799|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55915800|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55915801|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
55915802|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915803|NCT01412879|Antidotes|antidotes|mesh-ancestor
55915804|NCT01412879|Protective Agents|protective agents|mesh-ancestor
55915805|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
55915806|NCT01412879|Vitamins|vitamins|mesh-ancestor
55915807|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
55915808|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55915809|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
55915810|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
55915811|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
56485985|NCT04090775|Nivolumab|nivolumab|mesh-list
55915812|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
56486056|NCT03911336|Ketoprofen|ketoprofen|mesh-list
56486116|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486193|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486344|NCT03421353|Gemcitabine|gemcitabine|mesh-list
55915813|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56486425|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
55915814|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915815|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915816|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55915817|NCT03143010|Analgesics|analgesics|mesh-ancestor
55915835|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
55915836|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915837|NCT03140826|Meropenem|meropenem|mesh-list
55915838|NCT03140826|Tazobactam|tazobactam|mesh-list
55915839|NCT03140826|Piperacillin|piperacillin|mesh-list
55915840|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56486636|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56486712|NCT01962636|Cyclosporine|cyclosporine|mesh-list
56486786|NCT01209832|Midazolam|midazolam|mesh-list
56486933|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915841|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55915842|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915843|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55915844|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915845|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915846|NCT01389973|Ustekinumab|ustekinumab|mesh-list
55915847|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
55915848|NCT04529460|Antibodies|antibodies|mesh-list
56487541|NCT00541008|Sunitinib|sunitinib|mesh-list
56487834|NCT00542139|Betamethasone|betamethasone|mesh-list
55915849|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
56127102|NCT01673724|Pramipexole|pramipexole|mesh-list
56199331|NCT01517607|Analgesics|analgesics|mesh-ancestor
56487977|NCT00543075|Oblimersen|oblimersen|mesh-list
56199332|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
56199333|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199334|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199335|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56199336|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56199337|NCT01517724|Bortezomib|bortezomib|mesh-list
56199338|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199339|NCT01517815|Tazobactam|tazobactam|mesh-list
56199340|NCT01517815|Piperacillin|piperacillin|mesh-list
56199341|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56488345|NCT02909049|Midazolam|midazolam|mesh-list
56488579|NCT01237327|Exemestane|exemestane|mesh-list
56199342|NCT01517815|Doripenem|doripenem|mesh-list
56199343|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56199344|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488870|NCT04643132|Ketamine|ketamine|mesh-list
56237034|NCT01754701|Iron|iron|mesh-list
56489028|NCT00559481|Ketoconazole|ketoconazole|mesh-list
56199345|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56199346|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489247|NCT02897037|Heparin|heparin|mesh-list
56489322|NCT01234675|Analgesics|analgesics|mesh-ancestor
56211089|NCT05691010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489695|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489696|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
56489697|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489698|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
56489700|NCT02903004|Gemcitabine|gemcitabine|mesh-list
56199347|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199348|NCT01517828|Midazolam|midazolam|mesh-list
56199349|NCT01517828|Ketamine|ketamine|mesh-list
56199350|NCT01517828|Analgesics|analgesics|mesh-ancestor
56199351|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
56199352|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199353|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199354|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56199355|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56199356|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
56199357|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
56490078|NCT03455322|Octreotide|octreotide|mesh-list
56490200|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
56199358|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56199359|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56199360|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56199361|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490346|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56199362|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199363|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56199364|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56199365|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56199366|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56199369|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
56199370|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
56199371|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
56199372|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56199373|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56199374|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199375|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199376|NCT01517854|Urological Agents|urological agents|mesh-ancestor
56199377|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
56199378|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56199379|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56199380|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199381|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56199382|NCT01517932|Analgesics|analgesics|mesh-ancestor
56199383|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
56199384|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56211460|NCT05344911|Alfentanil|alfentanil|mesh-list
55915850|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915851|NCT04032067|Finasteride|finasteride|mesh-list
56490618|NCT00450203|Capecitabine|capecitabine|mesh-list
55915852|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55915853|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55915854|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915855|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915856|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
55915857|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55915858|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915859|NCT04032067|Urological Agents|urological agents|mesh-ancestor
55915860|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
55915861|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55915862|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915863|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
55915864|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
55915865|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56490909|NCT03993132|Empagliflozin|empagliflozin|mesh-list
56490986|NCT04679142|Baclofen|baclofen|mesh-list
55915866|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55915867|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491345|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
55915868|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915869|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56491574|NCT01661634|Ularitide|ularitide|mesh-list
55915870|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55915871|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915872|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915906|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55915907|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915908|NCT04149990|Valsartan|valsartan|mesh-list
55915909|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55915910|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55915911|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55915912|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55915913|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915914|NCT00591825|Cycloserine|cycloserine|mesh-list
55915936|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915937|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915938|NCT00595101|Latanoprost|latanoprost|mesh-list
55915939|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55915940|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55915941|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55915942|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199385|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56199386|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56199387|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56199388|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
56199389|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199390|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199391|NCT01517997|Paclitaxel|paclitaxel|mesh-list
56491646|NCT02081118|Hormones|hormones|mesh-ancestor
56199392|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56491840|NCT00555399|Temozolomide|temozolomide|mesh-list
56199393|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199394|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
56199395|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
56199396|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
56199397|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199398|NCT01518062|Estrogens|estrogens|mesh-list
56199399|NCT01518062|Hormones|hormones|mesh-ancestor
56199400|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213213|NCT02606045|Coagulants|coagulants|mesh-ancestor
55915943|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915944|NCT00660075|Incretins|incretins|mesh-ancestor
55915945|NCT00660075|Hormones|hormones|mesh-ancestor
55915946|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55915947|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55915948|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
55915949|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915950|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915951|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
55915952|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55915953|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915954|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56492052|NCT01185964|Doxorubicin|doxorubicin|mesh-list
55915955|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915956|NCT01429051|Fentanyl|fentanyl|mesh-list
55915957|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55915958|NCT01429051|Narcotics|narcotics|mesh-ancestor
55915959|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915960|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915961|NCT01429051|Analgesics|analgesics|mesh-ancestor
55915962|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
56492420|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
55915963|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915964|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55915965|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55915966|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
55915967|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
55915968|NCT03968562|Doxycycline|doxycycline|mesh-list
55915969|NCT03968562|Petrolatum|petrolatum|mesh-list
55915991|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55915993|NCT00596271|Vaccines|vaccines|mesh-list
55915994|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
55915995|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915996|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
55915997|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
55915998|NCT03139422|Calcium|calcium|mesh-list
56492792|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55915999|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55916000|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916001|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55916002|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56493007|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55916003|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916004|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
56493087|NCT00533585|Growth Substances|growth substances|mesh-ancestor
56493388|NCT04664595|Propofol|propofol|mesh-list
56199401|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199402|NCT01518101|Metformin|metformin|mesh-list
56199403|NCT01518101|Liraglutide|liraglutide|mesh-list
56199404|NCT01518101|Vildagliptin|vildagliptin|mesh-list
56199405|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199406|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199407|NCT01518101|Incretins|incretins|mesh-ancestor
56199408|NCT01518101|Hormones|hormones|mesh-ancestor
56199409|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493678|NCT03245021|Nivolumab|nivolumab|mesh-list
56199410|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55916005|NCT03139422|Coagulants|coagulants|mesh-ancestor
55916006|NCT01428583|Naltrexone|naltrexone|mesh-list
55916007|NCT01428583|Oxycodone|oxycodone|mesh-list
55916008|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55916009|NCT01428583|Narcotics|narcotics|mesh-ancestor
55916010|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916011|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916012|NCT01428583|Analgesics|analgesics|mesh-ancestor
55916013|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
55916014|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494356|NCT00541463|Nelfinavir|nelfinavir|mesh-list
55916015|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55916016|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55916017|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55916018|NCT00660543|Hematinics|hematinics|mesh-ancestor
55916019|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56212512|NCT05476939|Everolimus|everolimus|mesh-list
55916020|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55916021|NCT01428193|Flutamide|flutamide|mesh-list
55916022|NCT01428193|Estradiol|estradiol|mesh-list
55916023|NCT01428193|Progesterone|progesterone|mesh-list
55916024|NCT01428193|Estrogens|estrogens|mesh-ancestor
55916025|NCT01428193|Hormones|hormones|mesh-ancestor
56495092|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56495233|NCT00549146|Xhance|xhance|mesh-list
55916026|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495394|NCT04898231|Prednisolone|prednisolone|mesh-list
55916051|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495463|NCT04633746|Growth Substances|growth substances|mesh-ancestor
56495615|NCT00553124|Protective Agents|protective agents|mesh-ancestor
55916052|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495769|NCT04628559|Analgesics|analgesics|mesh-ancestor
55916054|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55916055|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916056|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916057|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916058|NCT01427803|Naproxen|naproxen|mesh-list
55916059|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55916060|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55916061|NCT01427803|Analgesics|analgesics|mesh-ancestor
55916062|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
55916063|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916064|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916065|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55916066|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55916067|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
55916068|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55916069|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916070|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244540|NCT01813656|Aripiprazole|aripiprazole|mesh-list
55916071|NCT03139500|Midazolam|midazolam|mesh-list
55916072|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55916073|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55916074|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916075|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916076|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56496646|NCT04621929|Topiramate|topiramate|mesh-list
55916077|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56244828|NCT01814891|Vitamin A|vitamin a|mesh-list
56496944|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56497117|NCT01165216|Ipilimumab|ipilimumab|mesh-list
56497171|NCT05419583|Aspirin|aspirin|mesh-list
55916097|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55916098|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55916099|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
55916100|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916101|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916102|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916103|NCT04476966|Urological Agents|urological agents|mesh-ancestor
55916104|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
55916105|NCT03821610|Melphalan|melphalan|mesh-list
56199411|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
56199412|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199413|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199414|NCT01518166|Liraglutide|liraglutide|mesh-list
56497456|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199415|NCT01518166|Griseofulvin|griseofulvin|mesh-list
56199416|NCT01518166|Digoxin|digoxin|mesh-list
56199417|NCT01518166|Lisinopril|lisinopril|mesh-list
56199418|NCT01518166|Atorvastatin|atorvastatin|mesh-list
56199419|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55916106|NCT03821610|Fludarabine|fludarabine|mesh-list
55916107|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
55916108|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55916109|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
55916111|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55916112|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55916113|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
55916114|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916115|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916116|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55916117|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55916118|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
55916119|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
55916120|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55916121|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497898|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498042|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56498190|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55916122|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55916123|NCT03768414|Gemcitabine|gemcitabine|mesh-list
55916124|NCT03768414|Paclitaxel|paclitaxel|mesh-list
55916125|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55916126|NCT03768414|Cisplatin|cisplatin|mesh-list
55916127|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55916128|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916129|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
55916130|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
55916131|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
55916132|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916133|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56498266|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498475|NCT01780844|Hormones|hormones|mesh-ancestor
55916165|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916167|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55916168|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916169|NCT01405027|Interferons|interferons|mesh-list
56498737|NCT01632137|Rebamipide|rebamipide|mesh-list
55916170|NCT01405027|Ribavirin|ribavirin|mesh-list
56499169|NCT00560924|Hormones|hormones|mesh-ancestor
55916171|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
55916172|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
55916173|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55916174|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55916175|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916176|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
56499475|NCT01156051|Guanfacine|guanfacine|mesh-list
55916177|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499551|NCT01155583|Hormones|hormones|mesh-ancestor
55916178|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
55916179|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916180|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
56500065|NCT04622033|Brodalumab|brodalumab|mesh-list
56500358|NCT00568503|Bromides|bromides|mesh-list
55916212|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916213|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55916214|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55916215|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916216|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916217|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55916218|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56500512|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
55916219|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500732|NCT00563069|Midazolam|midazolam|mesh-list
56500798|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56500800|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500947|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
55916220|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55916221|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
55916222|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
55916223|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
55916224|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
55916225|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916226|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916227|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56199420|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56199421|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
56199422|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199423|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56199424|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56199425|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199426|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199427|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199428|NCT01518166|Incretins|incretins|mesh-ancestor
56501456|NCT00573963|Ropivacaine|ropivacaine|mesh-list
56501541|NCT04595942|Midodrine|midodrine|mesh-list
56199430|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501609|NCT01147744|Fluticasone|fluticasone|mesh-list
56199431|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55916228|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55916260|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916261|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56501682|NCT00578370|Cyclosporine|cyclosporine|mesh-list
56501745|NCT00578721|Analgesics|analgesics|mesh-ancestor
56501973|NCT00581139|Midazolam|midazolam|mesh-list
55916262|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
56502198|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502273|NCT00566904|Analgesics|analgesics|mesh-ancestor
55916263|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55916264|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55916266|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
55916267|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916268|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55916269|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55916270|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55916271|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55916272|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
55916273|NCT02320695|Bacitracin|bacitracin|mesh-list
55916274|NCT02320695|Neomycin|neomycin|mesh-list
55916275|NCT02320695|Polymyxin B|polymyxin b|mesh-list
56502639|NCT00583986|Albuterol|albuterol|mesh-list
56502716|NCT00570440|Estradiol|estradiol|mesh-list
55916292|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916293|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55916294|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
55916295|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
55916296|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55916297|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
55916298|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250965|NCT01864057|Thiamine|thiamine|mesh-list
56503000|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56503072|NCT01140061|MK 0873|mk 0873|mesh-list
56503223|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
56503453|NCT05181436|Analgesics|analgesics|mesh-ancestor
55916299|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916300|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
55916301|NCT01543958|Sevelamer|sevelamer|mesh-list
56503638|NCT02883439|Xhance|xhance|mesh-list
56503679|NCT00195351|Metronidazole|metronidazole|mesh-list
56503829|NCT00192075|Leucovorin|leucovorin|mesh-list
56504056|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
55916302|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
55916303|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
55916304|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916305|NCT04055909|Nangibotide|nangibotide|mesh-list
55916306|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55916307|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56504866|NCT00475020|Fludarabine|fludarabine|mesh-list
56504941|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916308|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55916309|NCT01411085|Risperidone|risperidone|mesh-list
55916310|NCT01411085|Desipramine|desipramine|mesh-list
55916311|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55916312|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
55916313|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916314|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505090|NCT04568772|Proguanil|proguanil|mesh-list
55916315|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505241|NCT01084005|Hormones|hormones|mesh-ancestor
55916317|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56505380|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505454|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
55916318|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916319|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55916320|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55916321|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
55916322|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55916323|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
55916324|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916325|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56199432|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56199433|NCT01518166|Protective Agents|protective agents|mesh-ancestor
56199434|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56199435|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
56505668|NCT02211066|Ticagrelor|ticagrelor|mesh-list
56199436|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56199437|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
56199438|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199439|NCT01518231|Aspirin|aspirin|mesh-list
56199440|NCT01518231|Edaravone|edaravone|mesh-list
56199441|NCT01518231|Warfarin|warfarin|mesh-list
56199442|NCT01518231|Atorvastatin|atorvastatin|mesh-list
56199443|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56199444|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56199445|NCT01518231|Analgesics|analgesics|mesh-ancestor
56199446|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
56199447|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199448|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199449|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56199450|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56199451|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56199452|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56506120|NCT00198107|Renal Agents|renal agents|mesh-ancestor
56199453|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199454|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56199455|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56199456|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199457|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
56199458|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56199459|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56199460|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
56199461|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56199462|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56507217|NCT00171951|Hormones|hormones|mesh-ancestor
56199463|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
56507298|NCT00171210|Deferasirox|deferasirox|mesh-list
56507826|NCT01129882|Aripiprazole|aripiprazole|mesh-list
56507968|NCT01128595|Xhance|xhance|mesh-list
56199464|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56199465|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
55916326|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55916327|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507978|NCT01128244|Pyridoxine|pyridoxine|mesh-list
56508126|NCT04558268|Hormones|hormones|mesh-ancestor
56508283|NCT02212340|Desflurane|desflurane|mesh-list
55916328|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
55916329|NCT03473574|Gemcitabine|gemcitabine|mesh-list
55916330|NCT03473574|Durvalumab|durvalumab|mesh-list
55916331|NCT03473574|Tremelimumab|tremelimumab|mesh-list
55916332|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916333|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55916334|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
56199466|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56199467|NCT01518231|Protective Agents|protective agents|mesh-ancestor
56199468|NCT01518413|Irinotecan|irinotecan|mesh-list
56199469|NCT01518413|Sorafenib|sorafenib|mesh-list
56509389|NCT04577378|Isotretinoin|isotretinoin|mesh-list
56199470|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56199471|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56199472|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199473|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199474|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509462|NCT02219646|Urological Agents|urological agents|mesh-ancestor
55934761|NCT01672788|Metformin|metformin|mesh-list
55934842|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934843|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934844|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55934845|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55934846|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55934847|NCT03824483|Venetoclax|venetoclax|mesh-list
55934848|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
55934849|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
55934850|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934851|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55934857|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55934858|NCT03814109|Diuretics|diuretics|mesh-ancestor
55934859|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
55934860|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935022|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935185|NCT05319756|Analgesics|analgesics|mesh-ancestor
56199475|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56199476|NCT01518465|Dexamethasone|dexamethasone|mesh-list
56199477|NCT01518465|Lenalidomide|lenalidomide|mesh-list
56199478|NCT01518465|Dalteparin|dalteparin|mesh-list
56199479|NCT01518465|Tinzaparin|tinzaparin|mesh-list
56199480|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56199481|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56199482|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
56199483|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
56199484|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935570|NCT03685331|Olaparib|olaparib|mesh-list
55935634|NCT03675737|Fluorouracil|fluorouracil|mesh-list
55935635|NCT03675737|Capecitabine|capecitabine|mesh-list
55935764|NCT05056974|UB-421|ub-421|mesh-list
55935957|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935958|NCT03598595|Antiviral Agents|antiviral agents|mesh-ancestor
55936049|NCT02627274|Cetuximab|cetuximab|mesh-list
56199485|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199486|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56199487|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
56199488|NCT01518465|Hormones|hormones|mesh-ancestor
56199489|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199490|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56199491|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199492|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
56199493|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56199494|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56199495|NCT01518465|Growth Substances|growth substances|mesh-ancestor
55936196|NCT02163837|Rifaximin|rifaximin|mesh-list
56199496|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
56199497|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
56199498|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56199499|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56199500|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199501|NCT01518569|Urinastatin|urinastatin|mesh-list
56199507|NCT01518595|Bosentan|bosentan|mesh-list
55936295|NCT03283878|Cefazolin|cefazolin|mesh-list
56199508|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56199509|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56199510|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199511|NCT01518608|Alfentanil|alfentanil|mesh-list
56199512|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56199513|NCT01518608|Narcotics|narcotics|mesh-ancestor
55936326|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
56199514|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999649|NCT01350232|Rituximab|rituximab|mesh-list
55999657|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
55936759|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199515|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199516|NCT01518608|Analgesics|analgesics|mesh-ancestor
56199517|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
56199518|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199520|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
56199521|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
56199522|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56199523|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199524|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56199525|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199526|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199527|NCT01518634|Imipramine|imipramine|mesh-list
56199528|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56199529|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
56199530|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56199531|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55937042|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55937115|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55937195|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
56199532|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56199533|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56199534|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199535|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56199536|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199537|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199550|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56199551|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56199552|NCT01518790|Laxatives|laxatives|mesh-ancestor
56199553|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56199554|NCT01518855|Amlodipine|amlodipine|mesh-list
56199555|NCT01518855|Nifedipine|nifedipine|mesh-list
56199556|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56199557|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55937709|NCT01135329|Fludarabine|fludarabine|mesh-list
55937710|NCT01135329|Tacrolimus|tacrolimus|mesh-list
55937786|NCT01624259|Liraglutide|liraglutide|mesh-list
55937791|NCT01624259|Hormones|hormones|mesh-ancestor
55937858|NCT02078219|Verinurad|verinurad|mesh-list
55938041|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55938057|NCT03492437|Tepotinib|tepotinib|mesh-list
55938140|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56199558|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56199559|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199560|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56199561|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199562|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
55938287|NCT01201863|Androgens|androgens|mesh-ancestor
56199563|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
56199564|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56199565|NCT01518933|Silybin|silybin|mesh-list
56199566|NCT01518933|Silymarin|silymarin|mesh-list
56199567|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
55938427|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
56199568|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916346|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
55916347|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
55916348|NCT01431521|Pioglitazone|pioglitazone|mesh-list
55916349|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55916350|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938501|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916352|NCT00601965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55916353|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55916354|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55916355|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916356|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938669|NCT03080675|Vitamins|vitamins|mesh-list
55999746|NCT05599126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55916357|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
55916358|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916359|NCT00601965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55999751|NCT05599126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55938881|NCT01216761|Iodine|iodine|mesh-list
55938953|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938954|NCT01220973|Celecoxib|celecoxib|mesh-list
55938955|NCT01220973|Atorvastatin|atorvastatin|mesh-list
55938956|NCT01220973|Calcium|calcium|mesh-list
55938957|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55938958|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938959|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55938960|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55938961|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
55938962|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938963|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55916360|NCT00601965|Antidepressive Agents|antidepressive agents|mesh-ancestor
55916361|NCT00601965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55916362|NCT04751994|Sorbitol|sorbitol|mesh-list
55939035|NCT01153581|Estradiol|estradiol|mesh-list
55939099|NCT05162027|Analgesics|analgesics|mesh-ancestor
55916363|NCT04751994|Cathartics|cathartics|mesh-ancestor
55916364|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55916365|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
55939562|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916366|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55916367|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916368|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55916369|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55916370|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916371|NCT04738422|Glycine|glycine|mesh-list
55916372|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
55916373|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916374|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916375|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916376|NCT02998437|Amoxicillin|amoxicillin|mesh-list
55916377|NCT02998437|Clarithromycin|clarithromycin|mesh-list
55916378|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55916379|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916380|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55916381|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199569|NCT01518933|Protective Agents|protective agents|mesh-ancestor
56199570|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199571|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56199572|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939844|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
55939845|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939846|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939847|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55939848|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55939849|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
55939850|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939932|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56199573|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
56199574|NCT01518959|Vitamin D|vitamin d|mesh-list
56199575|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55940186|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940280|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940365|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55940476|NCT00638963|Temozolomide|temozolomide|mesh-list
55940558|NCT04127851|Cyclosporine|cyclosporine|mesh-list
55940637|NCT04394377|Heparin|heparin|mesh-list
55940715|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56199576|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199577|NCT01518959|Vitamins|vitamins|mesh-ancestor
56199578|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
56199579|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56199580|NCT01518998|Amlodipine|amlodipine|mesh-list
56199581|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56199582|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56199583|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55940881|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
55940959|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
55941043|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55941121|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
55941122|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55941123|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55941124|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55941125|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55941126|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
55941127|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941208|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55999824|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55863907|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
55941209|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941210|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55941211|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55941212|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941214|NCT01293825|Ziprasidone|ziprasidone|mesh-list
55941365|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55941366|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
56199584|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199585|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56199586|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199587|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
56199588|NCT01519011|Azacitidine|azacitidine|mesh-list
55941445|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56199589|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56199590|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
56199591|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199592|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199593|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999838|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
55916382|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916383|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55916384|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55916385|NCT02618148|Estrogens|estrogens|mesh-list
55941765|NCT01923623|Ropivacaine|ropivacaine|mesh-list
55941920|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
55941921|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55916386|NCT02618148|Hormones|hormones|mesh-ancestor
55941989|NCT05601479|Micronutrients|micronutrients|mesh-ancestor
56485993|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916387|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55916388|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916389|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55916390|NCT01404325|Everolimus|everolimus|mesh-list
55942350|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55916391|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916392|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942425|NCT04975932|Estrogens|estrogens|mesh-ancestor
55916393|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
55916394|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916395|NCT00602355|Sertraline|sertraline|mesh-list
55916396|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
55916397|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55916500|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
55916514|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916515|NCT05392374|TIC10 compound|tic10 compound|mesh-list
55916516|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916517|NCT04028388|Docetaxel|docetaxel|mesh-list
55942507|NCT02905591|Paclitaxel|paclitaxel|mesh-list
55916518|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916519|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
56199594|NCT01519037|Cinacalcet|cinacalcet|mesh-list
55916520|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
55916521|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
55916522|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916523|NCT01402063|Temozolomide|temozolomide|mesh-list
55916524|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
55916525|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55916526|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
55916527|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916528|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942571|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55942572|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942573|NCT01451905|Incretins|incretins|mesh-ancestor
55942574|NCT01451905|Hormones|hormones|mesh-ancestor
55942575|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942576|NCT01455649|Cyclosporine|cyclosporine|mesh-list
55942577|NCT01455649|Everolimus|everolimus|mesh-list
55942578|NCT01455649|Tacrolimus|tacrolimus|mesh-list
55942579|NCT01455649|Cyclosporins|cyclosporins|mesh-list
55942580|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55942647|NCT01456117|Pioglitazone|pioglitazone|mesh-list
55942648|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55942649|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942819|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942820|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55942928|NCT01352637|Renal Agents|renal agents|mesh-ancestor
55916529|NCT01796301|Teriparatide|teriparatide|mesh-list
55916530|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55916531|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916532|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55916533|NCT00868179|Dabigatran|dabigatran|mesh-list
55916534|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
55916535|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55916536|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
55916537|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144584|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
55916538|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916541|NCT01204905|Maraviroc|maraviroc|mesh-list
55916542|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55916543|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55916544|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
55916545|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916546|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55916547|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55943222|NCT04957212|Docetaxel|docetaxel|mesh-list
55916548|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916549|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916550|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55916551|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55916552|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55916553|NCT00691665|Fluticasone|fluticasone|mesh-list
55916554|NCT00691665|Xhance|xhance|mesh-list
55916555|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55916556|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55916557|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55916558|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
55943647|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
55916559|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943814|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
55943901|NCT05022901|Melphalan|melphalan|mesh-list
55916560|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916561|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55916586|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
55944077|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944160|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944257|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55944343|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
55916587|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999944|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55944600|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55944781|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
55944848|NCT03051906|Cetuximab|cetuximab|mesh-list
55916588|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55916589|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55945027|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
55945133|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55999997|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000001|NCT05491902|Flutemetamol|flutemetamol|mesh-list
56000002|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55945392|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55789242|NCT04907123|Diuretics|diuretics|mesh-list
55945638|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55945713|NCT04393025|Clopidogrel|clopidogrel|mesh-list
55945791|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
55946056|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
55946217|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
55916590|NCT03359460|Growth Substances|growth substances|mesh-ancestor
55916591|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
55916592|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916593|NCT03025477|Paclitaxel|paclitaxel|mesh-list
55916594|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55916595|NCT03025477|Cisplatin|cisplatin|mesh-list
55916596|NCT03025477|Carboplatin|carboplatin|mesh-list
55916597|NCT03025477|Epirubicin|epirubicin|mesh-list
55916598|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55916599|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916600|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
55916601|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
55916602|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
55946726|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55946731|NCT02614560|Fludarabine|fludarabine|mesh-list
55946828|NCT01450865|Flupirtine|flupirtine|mesh-list
55946897|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916603|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916604|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55916605|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55916606|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55947327|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
55947412|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55947413|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55947414|NCT01459211|Growth Substances|growth substances|mesh-ancestor
56000132|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56000134|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56000135|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56000136|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
56000137|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000138|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
56000139|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789363|NCT04916093|Metformin|metformin|mesh-list
55947560|NCT04776655|Leucovorin|leucovorin|mesh-list
55916607|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916608|NCT00856947|Vitamin D|vitamin d|mesh-list
55947767|NCT03043482|Vitamins|vitamins|mesh-ancestor
55916609|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
55916610|NCT00856947|Vitamins|vitamins|mesh-ancestor
55916611|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
55916612|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916641|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
55916642|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55916643|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55916644|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916645|NCT00713817|Nabiximols|nabiximols|mesh-list
56199595|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56199596|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199597|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56199598|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
56199599|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199600|NCT01519076|Coal Tar|coal tar|mesh-list
56199601|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
56199602|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
56199603|NCT01519102|Hormones|hormones|mesh-list
56199604|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199605|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199606|NCT01519128|Rilpivirine|rilpivirine|mesh-list
56199607|NCT01519128|Digoxin|digoxin|mesh-list
56199608|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55948005|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199609|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56199610|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485994|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199611|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199612|NCT01519128|Protective Agents|protective agents|mesh-ancestor
55916646|NCT00713817|Analgesics|analgesics|mesh-ancestor
55916647|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
55916648|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916649|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916651|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916652|NCT05088330|Daratumumab|daratumumab|mesh-list
55916653|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916654|NCT00695097|Rituximab|rituximab|mesh-list
55789439|NCT04901663|Clarithromycin|clarithromycin|mesh-list
55916655|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55916656|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916657|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
55916658|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916659|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55916660|NCT01795911|Interferons|interferons|mesh-list
55916661|NCT01795911|Ribavirin|ribavirin|mesh-list
55916662|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949142|NCT01894061|Bevacizumab|bevacizumab|mesh-list
55949143|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55916683|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55916684|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
55916685|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
55949293|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
55916686|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916687|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949385|NCT04832880|Dexamethasone|dexamethasone|mesh-list
55949475|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
55949511|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55949611|NCT05618496|Hyaluronic Acid|hyaluronic acid|mesh-list
55949612|NCT05618496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55949893|NCT01455519|Narcotics|narcotics|mesh-ancestor
55916688|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55916689|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55950238|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
55916690|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55916691|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
55950596|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950599|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
55916692|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916693|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916694|NCT05088174|Cyclosporine|cyclosporine|mesh-list
55950809|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
55950990|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950992|NCT04354428|Folic Acid|folic acid|mesh-list
55951060|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951179|NCT02218203|Lidocaine|lidocaine|mesh-list
55951542|NCT01972919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951543|NCT01972919|Immunologic Factors|immunologic factors|mesh-ancestor
56000507|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000508|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916695|NCT05088174|Cyclosporins|cyclosporins|mesh-list
55916696|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916697|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916698|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55916699|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
55916700|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951931|NCT04281108|Xhance|xhance|mesh-list
55916701|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
55916702|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916703|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
55951972|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
56199613|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199614|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56199615|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56199616|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
56199617|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199618|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56199619|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56199620|NCT01519154|Ketamine|ketamine|mesh-list
56199621|NCT01519154|Propofol|propofol|mesh-list
56199622|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56199623|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952301|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55952478|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
55952657|NCT00083551|Cytarabine|cytarabine|mesh-list
55953008|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
56199624|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199625|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56199626|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
56199627|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
55953170|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953173|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55953268|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953446|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55953717|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
55953812|NCT01490060|Aprepitant|aprepitant|mesh-list
55954065|NCT01946373|Interleukin-2|interleukin-2|mesh-list
55954199|NCT01894685|Mesalamine|mesalamine|mesh-list
55954279|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
55954371|NCT01671423|Prednisone|prednisone|mesh-list
55954455|NCT01701375|Palbociclib|palbociclib|mesh-list
55954727|NCT05555316|Lenvatinib|lenvatinib|mesh-list
56199628|NCT01519154|Analgesics|analgesics|mesh-ancestor
56199629|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
56199630|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199631|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56199632|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56199633|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56199634|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199635|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199636|NCT01519297|Irbesartan|irbesartan|mesh-list
56199637|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56199638|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56199639|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56199640|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916704|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955078|NCT05547516|Gemcitabine|gemcitabine|mesh-list
55916705|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55916706|NCT03041688|Decitabine|decitabine|mesh-list
55955148|NCT00073073|Vitamin D|vitamin d|mesh-list
55955262|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955352|NCT05698524|Temozolomide|temozolomide|mesh-list
55955445|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55955614|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55916707|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55916708|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
55955710|NCT00243061|Cediranib|cediranib|mesh-list
55916709|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916710|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916711|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916712|NCT00695409|Cytarabine|cytarabine|mesh-list
55916713|NCT00695409|Rituximab|rituximab|mesh-list
55916714|NCT00695409|Etoposide|etoposide|mesh-list
55916715|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
55916735|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
55916736|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55916737|NCT03469050|Rifaximin|rifaximin|mesh-list
55916738|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55916739|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916740|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55916741|NCT05087706|Bicalutamide|bicalutamide|mesh-list
56199641|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56199642|NCT01519310|Metronidazole|metronidazole|mesh-list
56199643|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
56199644|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199645|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56199646|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56199647|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56199648|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56199649|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199650|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199651|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956037|NCT00149227|Valsartan|valsartan|mesh-list
55916742|NCT05087706|Leuprolide|leuprolide|mesh-list
55916743|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
55916744|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
55916745|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55916746|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916747|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916748|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55916749|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
55916750|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55956290|NCT04639843|Cc-486|cc-486|mesh-list
55916751|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55916752|NCT02990403|Aspirin|aspirin|mesh-list
55916753|NCT02990403|Prednisone|prednisone|mesh-list
55916754|NCT02990403|Heparin|heparin|mesh-list
55916755|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
55916756|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
55916757|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55916758|NCT02990403|Antibodies|antibodies|mesh-list
55916759|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55916760|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
55916761|NCT02990403|Hormones|hormones|mesh-ancestor
55956542|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
55916762|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55916763|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956672|NCT02584452|Hormones|hormones|mesh-ancestor
55916764|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55916765|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916766|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55916767|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55916768|NCT02990403|Analgesics|analgesics|mesh-ancestor
55916769|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
55916770|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485995|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55916795|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916797|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916798|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55916799|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
55916800|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916801|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55916802|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55916803|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916804|NCT05086848|Antidotes|antidotes|mesh-ancestor
55916805|NCT05086848|Protective Agents|protective agents|mesh-ancestor
55916806|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
55916807|NCT05086848|Vitamins|vitamins|mesh-ancestor
55916808|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
55916809|NCT00830895|Everolimus|everolimus|mesh-list
55916810|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916811|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55916812|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
55916813|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916814|NCT01158417|Resveratrol|resveratrol|mesh-list
55916815|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
55916816|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916817|NCT01158417|Protective Agents|protective agents|mesh-ancestor
55916818|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916819|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916820|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56199652|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56199653|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56199655|NCT01519336|Darunavir|darunavir|mesh-list
56199656|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56199657|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56199658|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
56199659|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199660|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199661|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56199662|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55957226|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
55957243|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
56199663|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
56199664|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199665|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56199666|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56199667|NCT01519401|Drospirenone|drospirenone|mesh-list
56199668|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56199669|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56199670|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56199671|NCT01519401|Estradiol|estradiol|mesh-list
56199672|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56199673|NCT01519401|Estrogens|estrogens|mesh-ancestor
56199674|NCT01519401|Hormones|hormones|mesh-ancestor
56199675|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55916821|NCT05086614|Thymalfasin|thymalfasin|mesh-list
55916822|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55916872|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916874|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55916875|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916876|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916877|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916878|NCT02339415|Edoxaban|edoxaban|mesh-list
55916879|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55916880|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
55916881|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55916882|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
55916883|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916884|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916885|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
55916886|NCT02998047|Lintuzumab|lintuzumab|mesh-list
55916887|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55916888|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916889|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55916890|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55916891|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55916892|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55916893|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916894|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916895|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916896|NCT03110172|Analgesics|analgesics|mesh-ancestor
55916897|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
56199676|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199677|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55957744|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56199678|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
56199679|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56199680|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56199681|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56199682|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56199683|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56199684|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
56199685|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56199686|NCT01519401|Diuretics|diuretics|mesh-ancestor
56199687|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
56199688|NCT01519544|Acetazolamide|acetazolamide|mesh-list
56199689|NCT01519544|Temazepam|temazepam|mesh-list
56199690|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
56199691|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56199692|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199693|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199694|NCT01519544|Diuretics|diuretics|mesh-ancestor
56199695|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
56199696|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199697|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55916898|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916899|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
55916900|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55916901|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
55916902|NCT01400503|Siltuximab|siltuximab|mesh-list
55916903|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916904|NCT00706719|Enclomiphene|enclomiphene|mesh-list
55916905|NCT00706719|Clomiphene|clomiphene|mesh-list
55916906|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
55916907|NCT00706719|Testosterone|testosterone|mesh-list
55916908|NCT00706719|Androgens|androgens|mesh-ancestor
55916909|NCT00706719|Hormones|hormones|mesh-ancestor
55916910|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55916911|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916912|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55916913|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
55958013|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958016|NCT04677114|Narcotics|narcotics|mesh-ancestor
55916914|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55916915|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
55916916|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55916917|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55916918|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55916920|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55916921|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916922|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916954|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55916955|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55916956|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55916957|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55916958|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958081|NCT01465802|Hormones|hormones|mesh-ancestor
55916959|NCT02864004|Apomorphine|apomorphine|mesh-list
55916960|NCT02864004|Emetics|emetics|mesh-ancestor
56199698|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56199699|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56199700|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56199701|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56199702|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
56199703|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
56199704|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199705|NCT01519687|Tofisopam|tofisopam|mesh-list
56199706|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
56199707|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56199708|NCT01519726|Midazolam|midazolam|mesh-list
56199709|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56199710|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56199711|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56199712|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199713|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56199714|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56199715|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55916961|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916962|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
55916963|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916964|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55916965|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
55916966|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
55916967|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916983|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
55916984|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916985|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916986|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
55916987|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916988|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55916989|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55916990|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55916991|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55916992|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916993|NCT05068206|Bevacizumab|bevacizumab|mesh-list
55916994|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55916995|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958432|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55916996|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55916997|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55916998|NCT05068206|Growth Substances|growth substances|mesh-ancestor
55916999|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917000|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
55917002|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55917003|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
55917004|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55917005|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55917006|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917007|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917008|NCT05063370|Protective Agents|protective agents|mesh-ancestor
55917009|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917010|NCT05090124|Adalimumab|adalimumab|mesh-list
55917011|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55917012|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917013|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
55917014|NCT01421017|Imiquimod|imiquimod|mesh-list
55917015|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56199716|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56199718|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
56199719|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
56199720|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
56199721|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485996|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56199722|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917016|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
55917017|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917018|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917019|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55917020|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
55917021|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917022|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917023|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55917024|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55958622|NCT03323658|Bexarotene|bexarotene|mesh-list
55917042|NCT01517100|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55917043|NCT01517100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917044|NCT01517100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917046|NCT01517100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958750|NCT00218387|Modafinil|modafinil|mesh-list
55917047|NCT05020392|Vidarabine|vidarabine|mesh-list
55917048|NCT05020392|Cyclophosphamide|cyclophosphamide|mesh-list
55917049|NCT05020392|Fludarabine|fludarabine|mesh-list
55917050|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
55917051|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917052|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
55917053|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917054|NCT05020392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917055|NCT05020392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55917056|NCT05020392|Alkylating Agents|alkylating agents|mesh-ancestor
55917057|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917058|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917059|NCT05020392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55917060|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55917061|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
55917062|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
55917063|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917064|NCT04951050|Sirolimus|sirolimus|mesh-list
55917065|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917066|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917067|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55917068|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917069|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
55917070|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917071|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
55917072|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917073|NCT05089344|Clomiphene|clomiphene|mesh-list
55917074|NCT05089344|Enclomiphene|enclomiphene|mesh-list
55917075|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
55917076|NCT05089344|Hormones|hormones|mesh-list
55917077|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55917078|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917080|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
55917081|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55917082|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
55917083|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55917084|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55958910|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55917106|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917107|NCT04726098|Dexamethasone|dexamethasone|mesh-list
55917108|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
55917110|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55917111|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
55917112|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
55917113|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917114|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917115|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55917116|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
56199723|NCT01519752|Oxiconazole|oxiconazole|mesh-list
56199724|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
56199725|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199726|NCT01519856|Piribedil|piribedil|mesh-list
56199727|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56199728|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56199729|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
56199730|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
56199731|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199732|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199733|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199734|NCT01519986|Vitamin D|vitamin d|mesh-list
56199735|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
56199736|NCT01519986|Vitamins|vitamins|mesh-ancestor
56199737|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
56199738|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199739|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56199740|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56199741|NCT01520012|Esomeprazole|esomeprazole|mesh-list
56199742|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56199743|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56199744|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56199745|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199746|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199747|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56199748|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56199749|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199750|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
55959230|NCT00287989|Paclitaxel|paclitaxel|mesh-list
56199751|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56199752|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56199753|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
56199754|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199755|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56199756|NCT01520103|Everolimus|everolimus|mesh-list
56199757|NCT01520103|Vinorelbine|vinorelbine|mesh-list
56199758|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917117|NCT04726098|Hormones|hormones|mesh-ancestor
55917118|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55917119|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56199759|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56199760|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
56199761|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199762|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56199763|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
56199764|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
56199765|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
56199766|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199767|NCT01520116|Timolol|timolol|mesh-list
56199768|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56199769|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55959470|NCT01619111|Lapatinib|lapatinib|mesh-list
56199770|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
56199771|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199772|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213237|NCT02420821|Sunitinib|sunitinib|mesh-list
56199773|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199774|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56199775|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56199776|NCT01520181|Lactams|lactams|mesh-list
56199777|NCT01520181|beta-Lactams|beta-lactams|mesh-list
56199778|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917120|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917121|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
55917122|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917123|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917124|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
55917125|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
55917126|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917127|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917128|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917129|NCT05088720|Misoprostol|misoprostol|mesh-list
55917130|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55917131|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
55917132|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55917133|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917134|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55917135|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55917136|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
55917137|NCT01383499|Bromides|bromides|mesh-list
55917138|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
55917139|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55917140|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
55917168|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917169|NCT01397461|Retapamulin|retapamulin|mesh-list
55917170|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917171|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917173|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
55959733|NCT05748093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55917174|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55917175|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917176|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917177|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
55917178|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917179|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917180|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
55917181|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56199780|NCT01520285|Felodipine|felodipine|mesh-list
56199781|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56199782|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56199783|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56199784|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56199785|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959794|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56199786|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55917182|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
55917183|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55917184|NCT04505670|Protective Agents|protective agents|mesh-ancestor
55917185|NCT04335084|Vitamin D|vitamin d|mesh-list
55917186|NCT04335084|Vitamins|vitamins|mesh-list
55917187|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
55917206|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917208|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55917209|NCT02996019|Etrolizumab|etrolizumab|mesh-list
55917210|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55917211|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
55917212|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917213|NCT02997501|Osimertinib|osimertinib|mesh-list
55917214|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917215|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55917216|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917217|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917218|NCT02998827|Thalidomide|thalidomide|mesh-list
55917219|NCT02998827|Azathioprine|azathioprine|mesh-list
55917220|NCT02998827|Infliximab|infliximab|mesh-list
55917221|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
55917222|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55917223|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917224|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917225|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
55917226|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917227|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
55917228|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917229|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917230|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55917231|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55917232|NCT02998827|Growth Substances|growth substances|mesh-ancestor
55917233|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
55917234|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917235|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
56485997|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55917236|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917237|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55917238|NCT02995707|Thalidomide|thalidomide|mesh-list
55917239|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917240|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
55917241|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917242|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
55917243|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917266|NCT05738148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917267|NCT05738148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917268|NCT05738148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55917269|NCT05738148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55917270|NCT05738148|Autonomic Agents|autonomic agents|mesh-ancestor
55917271|NCT05738148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917272|NCT05738148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55917273|NCT05738148|Respiratory System Agents|respiratory system agents|mesh-ancestor
55917276|NCT05738148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55917277|NCT05738148|Hemostatics|hemostatics|mesh-ancestor
55917278|NCT05738148|Coagulants|coagulants|mesh-ancestor
55917279|NCT05738148|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55917280|NCT05738148|Natriuretic Agents|natriuretic agents|mesh-ancestor
55917281|NCT00704379|Sertraline|sertraline|mesh-list
55917282|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
56199787|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199788|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
56199789|NCT01520298|Acetaminophen|acetaminophen|mesh-list
56199790|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55917283|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55917284|NCT00704379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55917285|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55917286|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55917287|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917288|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917289|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
55917290|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917291|NCT02991495|Vaccines|vaccines|mesh-list
55960168|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55960229|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917292|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
55917293|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917294|NCT04449042|Anesthetics|anesthetics|mesh-list
55960446|NCT05737329|Estradiol|estradiol|mesh-list
55917295|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917296|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917298|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917336|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55917337|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55917338|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55917339|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917358|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55917359|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55917360|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
55917361|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
55917362|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917363|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917364|NCT03925350|Niraparib|niraparib|mesh-list
55917365|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55917366|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917367|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917368|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917369|NCT00707967|Vaccines|vaccines|mesh-list
55917370|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
55917371|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917372|NCT02994381|Ozanimod|ozanimod|mesh-list
55917373|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55917374|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917375|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917377|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917378|NCT00716079|Metoprolol|metoprolol|mesh-list
55917379|NCT00716079|Clonidine|clonidine|mesh-list
55917380|NCT00716079|Labetalol|labetalol|mesh-list
55917381|NCT00716079|Hydralazine|hydralazine|mesh-list
55917382|NCT00716079|Nicardipine|nicardipine|mesh-list
55917383|NCT00716079|Phentolamine|phentolamine|mesh-list
55917384|NCT00716079|Urapidil|urapidil|mesh-list
55917385|NCT00716079|Enalaprilat|enalaprilat|mesh-list
55917386|NCT00716079|Esmolol|esmolol|mesh-list
55917387|NCT00716079|Glycerol|glycerol|mesh-list
55917388|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55917389|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55917390|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
55917391|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
55917392|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917393|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917394|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55917395|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55917418|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960765|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
55917420|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
55917421|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55917422|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917423|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55917424|NCT01270191|Incretins|incretins|mesh-ancestor
55917425|NCT01270191|Hormones|hormones|mesh-ancestor
55917426|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55917428|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
56199792|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
56199793|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199794|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199795|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
56199796|NCT01520350|Aripiprazole|aripiprazole|mesh-list
56199797|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
56199798|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56199799|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56199800|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56199801|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56199802|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199803|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
56199804|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
56199805|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199806|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199807|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56199808|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56199809|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
56199810|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56199811|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56199812|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56199813|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56199814|NCT01520389|Irinotecan|irinotecan|mesh-list
56199815|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56199816|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56199817|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56199818|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485998|NCT01232296|Sorafenib|sorafenib|mesh-list
56199819|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730120|NCT02305901|Bupropion|bupropion|mesh-list
55917429|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
55917430|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917431|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917432|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
55917433|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917434|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
55917435|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55917436|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917437|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917438|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55917439|NCT04526652|Analgesics|analgesics|mesh-ancestor
55917440|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
55917441|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917442|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56199820|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199821|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
56199822|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199823|NCT01520415|Lidocaine|lidocaine|mesh-list
56199824|NCT01520415|Bupivacaine|bupivacaine|mesh-list
56199825|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
56199826|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
56199827|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56199828|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199829|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
56199830|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199831|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56199832|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56199833|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56199834|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56199835|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199836|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56199837|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56199838|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199839|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199840|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56199841|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55917443|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55917444|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55917461|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55917462|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55917463|NCT00159432|Growth Substances|growth substances|mesh-ancestor
55917464|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917465|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
55917466|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55917467|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
55917468|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917469|NCT02969850|Vitamin D|vitamin d|mesh-list
55917470|NCT02969850|Calcium|calcium|mesh-list
55917471|NCT02969850|Vitamins|vitamins|mesh-ancestor
55917472|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
55917473|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917474|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55917475|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55917476|NCT02339766|Morphine|morphine|mesh-list
55917477|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55917478|NCT02339766|Narcotics|narcotics|mesh-ancestor
55917479|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917480|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917481|NCT02339766|Analgesics|analgesics|mesh-ancestor
55917482|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
55917483|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917484|NCT04287660|Clarithromycin|clarithromycin|mesh-list
55917485|NCT04287660|Dexamethasone|dexamethasone|mesh-list
55917486|NCT04287660|Lenalidomide|lenalidomide|mesh-list
55917487|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56199842|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199843|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
55730217|NCT04539327|Rucaparib|rucaparib|mesh-list
55917488|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
55917489|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
55917490|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917491|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917492|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55917493|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
55917494|NCT04287660|Hormones|hormones|mesh-ancestor
55917495|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55917496|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55917497|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917498|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
55917499|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55917500|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55917501|NCT04287660|Growth Substances|growth substances|mesh-ancestor
55917502|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
55961210|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55917503|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917504|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917520|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55917523|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55961253|NCT00360685|Methotrexate|methotrexate|mesh-list
55917524|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55917525|NCT01396057|Growth Substances|growth substances|mesh-ancestor
55917526|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
55917527|NCT02419560|Venetoclax|venetoclax|mesh-list
55917528|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917529|NCT04011163|Morphine|morphine|mesh-list
55917530|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55917531|NCT04011163|Narcotics|narcotics|mesh-ancestor
55917532|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917533|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917534|NCT04011163|Analgesics|analgesics|mesh-ancestor
55917535|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
55917536|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917537|NCT00704847|Calcitonin|calcitonin|mesh-list
55917538|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
55917539|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55917540|NCT00704847|Katacalcin|katacalcin|mesh-list
55917541|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55917542|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917543|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55917544|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
55917545|NCT03393468|Dapivirine|dapivirine|mesh-list
55917546|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55917547|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55917548|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
55917549|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917550|NCT05091606|Anesthetics|anesthetics|mesh-list
55917551|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917552|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917553|NCT01395901|Ondansetron|ondansetron|mesh-list
55917554|NCT01395901|Palonosetron|palonosetron|mesh-list
55917555|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
55917556|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
55917557|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917558|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917559|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55917560|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
55917561|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
55917562|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55917582|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917583|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55917584|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961678|NCT02104739|Exenatide|exenatide|mesh-list
55917585|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917586|NCT00158184|Oxycodone|oxycodone|mesh-list
55917587|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55917588|NCT00158184|Narcotics|narcotics|mesh-ancestor
55917589|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917590|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917591|NCT00158184|Analgesics|analgesics|mesh-ancestor
55917592|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
55961735|NCT00315341|Methadone|methadone|mesh-list
55917593|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199844|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199845|NCT01520467|Anastrozole|anastrozole|mesh-list
56199846|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56199847|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199848|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55917594|NCT02405520|Vaccines|vaccines|mesh-list
55917595|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
55917596|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917598|NCT02993835|Trace Elements|trace elements|mesh-ancestor
55917599|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
55917600|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917601|NCT05091138|Buprenorphine|buprenorphine|mesh-list
55917602|NCT05091138|Bupivacaine|bupivacaine|mesh-list
55917603|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
55917604|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
55961874|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
55917605|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917606|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917607|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
55917608|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917609|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55917610|NCT05091138|Narcotics|narcotics|mesh-ancestor
55917611|NCT05091138|Analgesics|analgesics|mesh-ancestor
55917612|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55917613|NCT02999295|Nivolumab|nivolumab|mesh-list
55917614|NCT02999295|Ramucirumab|ramucirumab|mesh-list
55917615|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55917616|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917617|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55917618|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917619|NCT02998905|Aspirin|aspirin|mesh-list
55917632|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55917633|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917634|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
55917635|NCT05735184|Cytarabine|cytarabine|mesh-list
55917636|NCT05735184|Azacitidine|azacitidine|mesh-list
55917637|NCT05735184|Daunorubicin|daunorubicin|mesh-list
55917638|NCT05735184|Venetoclax|venetoclax|mesh-list
55917639|NCT05735184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55917640|NCT05735184|Antimetabolites|antimetabolites|mesh-ancestor
55917641|NCT05735184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917642|NCT05735184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917643|NCT05735184|Antiviral Agents|antiviral agents|mesh-ancestor
55917644|NCT05735184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917645|NCT05735184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917646|NCT05735184|Immunologic Factors|immunologic factors|mesh-ancestor
55917647|NCT05735184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917648|NCT05735184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917649|NCT05735184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55917650|NCT05735184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55917651|NCT05735184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55917652|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
55917653|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55917654|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55917655|NCT02993367|Protective Agents|protective agents|mesh-ancestor
55917656|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917657|NCT05094492|Fluorides|fluorides|mesh-list
55917658|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
55917659|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
55962050|NCT00363779|Cyclosporine|cyclosporine|mesh-list
55917660|NCT05094492|Protective Agents|protective agents|mesh-ancestor
55917661|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917662|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
55917663|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55917664|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917665|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
55917666|NCT05094414|Valacyclovir|valacyclovir|mesh-list
55917667|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
55917668|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917669|NCT02835222|Cytarabine|cytarabine|mesh-list
55917670|NCT02835222|Daunorubicin|daunorubicin|mesh-list
55917671|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55917672|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
55917673|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199849|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56199850|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199851|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199852|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56199853|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
56199854|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199855|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199856|NCT01520584|Vitamins|vitamins|mesh-list
56199857|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
56199858|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199859|NCT01520753|Insulin|insulin|mesh-list
56199860|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56199861|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
56199862|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
56199863|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56199864|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
56199865|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199866|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199867|NCT01520766|Methamphetamine|methamphetamine|mesh-list
56199868|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56199869|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917675|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
55917676|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917677|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917678|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
55917679|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917680|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55917681|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55917682|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55917700|NCT00725361|Ambrisentan|ambrisentan|mesh-list
55917701|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55917703|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
55917704|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917705|NCT02816424|Protective Agents|protective agents|mesh-ancestor
55917706|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917707|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
55917708|NCT01275885|Vitamin D|vitamin d|mesh-list
55917709|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55917710|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917711|NCT01275885|Vitamins|vitamins|mesh-ancestor
55917712|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
55917713|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55917714|NCT02794896|Fentanyl|fentanyl|mesh-list
55917715|NCT02794896|Propofol|propofol|mesh-list
55917716|NCT02794896|Sevoflurane|sevoflurane|mesh-list
55917717|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55917718|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917719|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917720|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55917721|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
55917722|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
55917723|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55917724|NCT02794896|Narcotics|narcotics|mesh-ancestor
55917725|NCT02794896|Analgesics|analgesics|mesh-ancestor
56199870|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
56199871|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
55962216|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
56199872|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199874|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199875|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199876|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
56199877|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56199878|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56199879|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56199880|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56199881|NCT01520792|Acetaminophen|acetaminophen|mesh-list
56199882|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56199883|NCT01520792|Analgesics|analgesics|mesh-ancestor
56199884|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
56199885|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199886|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199887|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
56199888|NCT01520818|Insulin|insulin|mesh-list
56199889|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56199890|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
56199891|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
55917726|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
55917727|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917728|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55917729|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55917730|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55917731|NCT01271283|Lenalidomide|lenalidomide|mesh-list
55917732|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
55917733|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917734|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55917735|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55917736|NCT01271283|Growth Substances|growth substances|mesh-ancestor
55917737|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
55917738|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917739|NCT01271439|Cetuximab|cetuximab|mesh-list
55962419|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917740|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55917741|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917742|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
55917743|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
55917763|NCT02992665|Ionophores|ionophores|mesh-list
55917764|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55917765|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917766|NCT05093478|Lidocaine|lidocaine|mesh-list
55917767|NCT05093478|Capsaicin|capsaicin|mesh-list
55917768|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
55917769|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
55917770|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917771|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917772|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
55917773|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917774|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55917775|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55917776|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56199892|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56199893|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
56199894|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199895|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199897|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56199898|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
56199899|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
56199900|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56199901|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
56199902|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56199903|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199904|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199905|NCT01520896|Ketoconazole|ketoconazole|mesh-list
56199906|NCT01520896|Naloxegol|naloxegol|mesh-list
56199907|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
56199908|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962534|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199909|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56199910|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56199911|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199912|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917777|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55917778|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917780|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
55917781|NCT00725751|Interferons|interferons|mesh-list
55917782|NCT00725751|Ribavirin|ribavirin|mesh-list
55917783|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
55917784|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
55917785|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55917786|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917787|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
55917788|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917789|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
55917790|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917791|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
55917792|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917808|NCT05364385|Budesonide|budesonide|mesh-list
55917809|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55917810|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55917811|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55917812|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
55917813|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917837|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55917838|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55917839|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55917840|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
55917841|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917842|NCT01394185|Dronabinol|dronabinol|mesh-list
55917843|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
55917844|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917845|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56199913|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56199914|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
56199915|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56199916|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199917|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56199918|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56199919|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
56199920|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199922|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
56199923|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
56199924|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
56199925|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199926|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
56199927|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199928|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199929|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56199930|NCT01521312|Saxagliptin|saxagliptin|mesh-list
56199931|NCT01521312|Incretins|incretins|mesh-ancestor
56199932|NCT01521312|Hormones|hormones|mesh-ancestor
56199933|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127709|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
56199934|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199935|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56199936|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
56199937|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730516|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
55917846|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55917847|NCT01394185|Analgesics|analgesics|mesh-ancestor
55917848|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
55917849|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917850|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55917851|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55917852|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917853|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917854|NCT01394185|Hormones|hormones|mesh-ancestor
55917855|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55917856|NCT05375916|Hydromorphone|hydromorphone|mesh-list
55917857|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55917858|NCT05375916|Narcotics|narcotics|mesh-ancestor
55917859|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917860|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917861|NCT05375916|Analgesics|analgesics|mesh-ancestor
55917862|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
55917863|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917864|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
55962835|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
56199938|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199939|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199940|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56199941|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
56199942|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199944|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56199945|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56199946|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199947|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56199948|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56199949|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199950|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199951|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917883|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55917884|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
55917885|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
55917886|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917887|NCT05001360|Nivolumab|nivolumab|mesh-list
55917888|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55917889|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55917890|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917891|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917892|NCT05022810|Acetaminophen|acetaminophen|mesh-list
55917893|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55917894|NCT05022810|Analgesics|analgesics|mesh-ancestor
55917895|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
55917896|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917897|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917898|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
55917899|NCT01525550|Sunitinib|sunitinib|mesh-list
55963187|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917900|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917901|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55917902|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55917903|NCT01525550|Growth Substances|growth substances|mesh-ancestor
55917904|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917905|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
55917906|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55917907|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917908|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917909|NCT04730232|Paclitaxel|paclitaxel|mesh-list
55917910|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55917911|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917912|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
55917913|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
55917914|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
55917915|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917916|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
55917917|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55917918|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917919|NCT04540848|Bupivacaine|bupivacaine|mesh-list
55917920|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
55917921|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
55917943|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
55917944|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917945|NCT05365555|Anesthetics|anesthetics|mesh-list
55917946|NCT05365555|Ropivacaine|ropivacaine|mesh-list
55917947|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
56199952|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56199953|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
56199954|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56199955|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199956|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56199957|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56199958|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56199959|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56199960|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55963462|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
56199961|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
56199962|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199963|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199964|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56199965|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
56199966|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
56199967|NCT01521455|Hormones|hormones|mesh-ancestor
56199968|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213424|NCT01545843|Fluoxetine|fluoxetine|mesh-list
56199969|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
56199970|NCT01521481|Anesthetics|anesthetics|mesh-list
56199971|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56199972|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199973|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56199974|NCT01521520|Hematinics|hematinics|mesh-ancestor
56199975|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56199976|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56199977|NCT01521572|Albuterol|albuterol|mesh-list
56199978|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56199979|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
56199980|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56199981|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199982|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56199983|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
56199984|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
56199985|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56199991|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199993|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56199994|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199995|NCT01521689|Rituximab|rituximab|mesh-list
56199996|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56199997|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199998|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
56199999|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200000|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200001|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55917948|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917949|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917950|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
55963705|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
55917951|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917952|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
55917953|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55917954|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917955|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55917956|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917957|NCT05374356|Morphine|morphine|mesh-list
55917958|NCT05374356|Bupivacaine|bupivacaine|mesh-list
55917959|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
55917960|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
55917961|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917962|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917963|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
55917964|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917965|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55917966|NCT05374356|Narcotics|narcotics|mesh-ancestor
55963771|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55917967|NCT05374356|Analgesics|analgesics|mesh-ancestor
55917968|NCT00717405|Bevacizumab|bevacizumab|mesh-list
55917969|NCT00717405|Trastuzumab|trastuzumab|mesh-list
55743077|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
55917970|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55917971|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917993|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917994|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917995|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55917996|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
55917997|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963837|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963838|NCT04338698|Azithromycin|azithromycin|mesh-list
55917998|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917999|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55918000|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55918001|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918002|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55918003|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55918004|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55918005|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
55918006|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55918007|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918009|NCT01276977|Eletriptan|eletriptan|mesh-list
55918010|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55918011|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55918012|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
55918013|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918014|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963974|NCT00537511|Etoposide|etoposide|mesh-list
55918015|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918016|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
55918017|NCT03832699|Progesterone|progesterone|mesh-list
55918018|NCT03832699|Progestins|progestins|mesh-ancestor
55918019|NCT03832699|Hormones|hormones|mesh-ancestor
55918020|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200002|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56200003|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56200004|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
56200005|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127806|NCT03824106|Vitamin D|vitamin d|mesh-list
56200006|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200007|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200008|NCT01521767|Urological Agents|urological agents|mesh-ancestor
56200009|NCT01521793|Retinol acetate|retinol acetate|mesh-list
56200010|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56200011|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
55964113|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
55964116|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
56200012|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918021|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918022|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
55918023|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918024|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55918025|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918026|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918027|NCT01277289|Dexamethasone|dexamethasone|mesh-list
55918056|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55918057|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
55918058|NCT03599791|Fluticasone|fluticasone|mesh-list
55918060|NCT03599791|Azelastine|azelastine|mesh-list
55918061|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918062|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55918063|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
55918064|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964177|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
55918065|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918066|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55918067|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
55918068|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
55918069|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55918070|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
55918071|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918072|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918106|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
55918107|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55918108|NCT02991339|BB 1101|bb 1101|mesh-list
55918109|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918110|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
55918111|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
55918112|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918113|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918114|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918134|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55918135|NCT03597997|Propofol|propofol|mesh-list
55918136|NCT03597997|Sevoflurane|sevoflurane|mesh-list
55918137|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55918138|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55918139|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918140|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55918141|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
55918142|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
55918143|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55918144|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55918145|NCT01277835|Lidocaine|lidocaine|mesh-list
55918146|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
55918147|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
55918148|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213477|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55918149|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918150|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
55918151|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918152|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56200013|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56200014|NCT01521793|Protective Agents|protective agents|mesh-ancestor
56200015|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200016|NCT01521819|Ranibizumab|ranibizumab|mesh-list
56200017|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56200018|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56200019|NCT01521819|Growth Substances|growth substances|mesh-ancestor
56200020|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200021|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
56200022|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918153|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55918154|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55918155|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918156|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964431|NCT00501943|Riluzole|riluzole|mesh-list
55918157|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
55918159|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55918160|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
55918161|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918162|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918163|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55918164|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
55918165|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
55918166|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55918167|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
55918168|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918169|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918170|NCT05632159|Anesthetics|anesthetics|mesh-list
55918193|NCT05631847|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55964480|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918195|NCT05631847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55918196|NCT05631847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918197|NCT00729807|Pentamidine|pentamidine|mesh-list
55918198|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
55918199|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918200|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55918201|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55918202|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55918203|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55964556|NCT05630846|Vaccines|vaccines|mesh-list
55918204|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55918205|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918206|NCT03992131|Rucaparib|rucaparib|mesh-list
55918207|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55918208|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918209|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918210|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918211|NCT03592693|Vitamins|vitamins|mesh-list
55918212|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
55918213|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
55918214|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918215|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918216|NCT00730353|Paclitaxel|paclitaxel|mesh-list
55918217|NCT00730353|Sunitinib|sunitinib|mesh-list
55918218|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55918219|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918220|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
55918221|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
55918222|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
55918245|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55918246|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55918247|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
55918248|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918249|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918250|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918251|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55730879|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
55918252|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55918253|NCT03595189|Cilastatin|cilastatin|mesh-list
55918254|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
55918255|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918256|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918257|NCT01410227|Factor VIII|factor viii|mesh-list
55918258|NCT01410227|Coagulants|coagulants|mesh-ancestor
55964749|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
55918259|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
55918260|NCT04007029|Fludarabine|fludarabine|mesh-list
55918261|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
55918262|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
55918263|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
55918264|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55918265|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
55918266|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918267|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55918268|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55918269|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
55918270|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918271|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918272|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55918273|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55918274|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
55918275|NCT01274559|Niacin|niacin|mesh-list
55918304|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918305|NCT01409837|Lisinopril|lisinopril|mesh-list
55918306|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55918307|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
55918308|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918309|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918310|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55918311|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55918312|NCT01409837|Protective Agents|protective agents|mesh-ancestor
55918313|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918314|NCT01278459|Atorvastatin|atorvastatin|mesh-list
55918315|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55918316|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55918317|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
55918318|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918319|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55918320|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55918321|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918322|NCT00731055|Varenicline|varenicline|mesh-list
55918345|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918347|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
55918348|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918349|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918350|NCT04005859|Lidocaine|lidocaine|mesh-list
55918351|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
55918352|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
55918353|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55918354|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918355|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
55918356|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918357|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55918358|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55918359|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55918360|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918361|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918362|NCT04004611|Mirikizumab|mirikizumab|mesh-list
55918363|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55918364|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55918365|NCT04004611|Analgesics|analgesics|mesh-ancestor
55918366|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
55918367|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965030|NCT03948464|Narcotics|narcotics|mesh-ancestor
55918368|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918369|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918370|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55918371|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55918372|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918373|NCT05633719|Carboplatin|carboplatin|mesh-list
56200024|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
55965172|NCT04023110|Carvedilol|carvedilol|mesh-list
56200025|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
56200026|NCT01521936|Vitamins|vitamins|mesh-list
56200027|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
56200028|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200029|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56200030|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56200031|NCT01521962|Alogliptin|alogliptin|mesh-list
56200032|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56200033|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200034|NCT01521962|Incretins|incretins|mesh-ancestor
56200035|NCT01521962|Hormones|hormones|mesh-ancestor
56200036|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918395|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55918396|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918397|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55918398|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55918399|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
55918400|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55918401|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918404|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918405|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
55918406|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
55918407|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
55918408|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55918409|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55918410|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55918411|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918412|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
55918413|NCT01428713|Coagulants|coagulants|mesh-ancestor
55918414|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55918415|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965249|NCT04194086|Posaconazole|posaconazole|mesh-list
55918416|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55918417|NCT03976375|Docetaxel|docetaxel|mesh-list
55918418|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
55918419|NCT03976375|Lenvatinib|lenvatinib|mesh-list
55918420|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918421|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
55918422|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
55918423|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
55918424|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918425|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55918426|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55918427|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918429|NCT01408043|Etoposide|etoposide|mesh-list
55918430|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
55918492|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918493|NCT01406795|Heparin|heparin|mesh-list
55918494|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
55918495|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55918496|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55918497|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918498|NCT01406015|Spironolactone|spironolactone|mesh-list
55918499|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55918500|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
55918501|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918502|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918503|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55918504|NCT01406015|Diuretics|diuretics|mesh-ancestor
55918505|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
55918506|NCT00215137|Citalopram|citalopram|mesh-list
55918507|NCT00215137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55965514|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55965516|NCT01797991|Hormones|hormones|mesh-ancestor
56200037|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56200038|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
56200039|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200040|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200042|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56200043|NCT01521975|Telbivudine|telbivudine|mesh-list
55965664|NCT05415397|Celecoxib|celecoxib|mesh-list
55965733|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
56200044|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
56200045|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200046|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56200047|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56200048|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200049|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200050|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
56200051|NCT01522040|Analgesics|analgesics|mesh-ancestor
56200052|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
55918508|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55918509|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918510|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918511|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918512|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
55918557|NCT03597919|Vaccines|vaccines|mesh-list
55918558|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
55918559|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918560|NCT04001413|Durvalumab|durvalumab|mesh-list
55965909|NCT03934814|Rituximab|rituximab|mesh-list
55918561|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55918562|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965968|NCT04961359|Vaccines|vaccines|mesh-list
55918563|NCT01677858|Dexamethasone|dexamethasone|mesh-list
55918564|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918565|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
55918566|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
55918568|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918569|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918570|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
55918571|NCT01677858|Hormones|hormones|mesh-ancestor
56144586|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55918572|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55966125|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918573|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55918574|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918576|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918577|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55966201|NCT04146116|Povidone|povidone|mesh-list
55918578|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
55918579|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918580|NCT03027284|Antiviral Agents|antiviral agents|mesh-ancestor
55918581|NCT03027284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918582|NCT03027284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918583|NCT03027284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55918584|NCT03027284|Immunologic Factors|immunologic factors|mesh-ancestor
55918585|NCT03027284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918586|NCT03592069|Amoxicillin|amoxicillin|mesh-list
55918587|NCT03592069|Metronidazole|metronidazole|mesh-list
55918588|NCT03592069|Clarithromycin|clarithromycin|mesh-list
55918589|NCT03592069|Esomeprazole|esomeprazole|mesh-list
55918590|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55918591|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918592|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55918593|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55918594|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56200053|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200054|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200056|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200057|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56200058|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
56200059|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56200060|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200061|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966414|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200062|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56200063|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
56200064|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56200065|NCT01522092|Citalopram|citalopram|mesh-list
56200066|NCT01522092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56200067|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56200068|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200069|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200070|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200071|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
56200072|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200073|NCT01522092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56200074|NCT01522092|Antidepressive Agents|antidepressive agents|mesh-ancestor
56200075|NCT01522092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55918595|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918596|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55918597|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918598|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918599|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55966636|NCT02979704|Atorvastatin|atorvastatin|mesh-list
55918600|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55918601|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55918602|NCT03591991|Empagliflozin|empagliflozin|mesh-list
55918603|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55918656|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
55918657|NCT04438434|Protective Agents|protective agents|mesh-ancestor
55918658|NCT03591679|Oxytocin|oxytocin|mesh-list
55918659|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
55918660|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55918661|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918662|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
55918663|NCT04064814|Flunarizine|flunarizine|mesh-list
55918664|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
55918665|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918666|NCT04064814|Protective Agents|protective agents|mesh-ancestor
55966779|NCT01590277|Ethanol|ethanol|mesh-list
55918667|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918668|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
55918669|NCT04064814|Vitamins|vitamins|mesh-ancestor
55918670|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
55918671|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
55918672|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56200076|NCT01522105|Daptomycin|daptomycin|mesh-list
56200077|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56200078|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200079|NCT01522326|Ibuprofen|ibuprofen|mesh-list
56200080|NCT01522326|Metoclopramide|metoclopramide|mesh-list
56200081|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56213215|NCT02567409|Cisplatin|cisplatin|mesh-list
55918673|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918674|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55918675|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55918676|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
55918677|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
55918678|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918679|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
55918680|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55918681|NCT04197817|Antibodies|antibodies|mesh-list
55918682|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
55918683|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55918684|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
55918685|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918686|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918687|NCT04585854|Caffeine|caffeine|mesh-list
55918688|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55918689|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918690|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55918691|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918692|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967112|NCT03585374|Analgesics|analgesics|mesh-ancestor
55918693|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55918694|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55918695|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
55918696|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918697|NCT03481842|Axitinib|axitinib|mesh-list
55918698|NCT03481842|Afatinib|afatinib|mesh-list
55918699|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918700|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55918701|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918702|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967182|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55918703|NCT04197739|Amikacin|amikacin|mesh-list
55918714|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918715|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918716|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918717|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
55918718|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55918719|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
55918720|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918721|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55918723|NCT03422094|Ipilimumab|ipilimumab|mesh-list
55918724|NCT03422094|Poly ICLC|poly iclc|mesh-list
55918725|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55918726|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918727|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55918728|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918729|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
55918730|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
55918731|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918732|NCT03973489|Methamphetamine|methamphetamine|mesh-list
55918733|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55918734|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918735|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
55918736|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
55918737|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918738|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
55918739|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918740|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918741|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
55918742|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55918743|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55967245|NCT00502853|Methotrexate|methotrexate|mesh-list
55918744|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200082|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56200083|NCT01522326|Analgesics|analgesics|mesh-ancestor
55967289|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
56200084|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
56200085|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200086|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200087|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200088|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200089|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56200090|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200091|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200092|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
56200093|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
56200094|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56200095|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56200096|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56200097|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
56200098|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200099|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56200100|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200101|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967443|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55967445|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
56200102|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200103|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56200104|NCT01522534|Morphine|morphine|mesh-list
56200105|NCT01522534|Mepivacaine|mepivacaine|mesh-list
56200106|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56200107|NCT01522534|Narcotics|narcotics|mesh-ancestor
56200108|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200109|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918745|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55918746|NCT04356534|Antibodies|antibodies|mesh-list
55918747|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
55918748|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918749|NCT03591289|Bromides|bromides|mesh-list
55918750|NCT03591289|Rocuronium|rocuronium|mesh-list
55918751|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
55918752|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55967714|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55918753|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55918754|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55918755|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918756|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918757|NCT05338866|Capecitabine|capecitabine|mesh-list
55918758|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55918759|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
55918760|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918761|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918762|NCT02471118|Adalimumab|adalimumab|mesh-list
55918763|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918764|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200110|NCT01522534|Analgesics|analgesics|mesh-ancestor
56200111|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
56200112|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200113|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
56200114|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
56200115|NCT01522547|Pomalidomide|pomalidomide|mesh-list
56200116|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
56200117|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200118|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56200119|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56200120|NCT01522547|Growth Substances|growth substances|mesh-ancestor
56200121|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
56200122|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200123|NCT01522612|Leucovorin|leucovorin|mesh-list
56200124|NCT01522612|Fluorouracil|fluorouracil|mesh-list
56200125|NCT01522612|Cetuximab|cetuximab|mesh-list
56200126|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
56200127|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200128|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55918765|NCT04197115|Vitamins|vitamins|mesh-list
55918766|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
55918807|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918808|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918809|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
55968070|NCT00630955|Memantine|memantine|mesh-list
55918810|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918811|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
55918812|NCT03590587|Hormones|hormones|mesh-ancestor
55918813|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918814|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918815|NCT03590431|Iodine|iodine|mesh-list
55918816|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
55918817|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55918820|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
55918821|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918822|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
55918823|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918824|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55918825|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55918826|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918827|NCT05102448|Methotrexate|methotrexate|mesh-list
55918828|NCT05102448|Tofacitinib|tofacitinib|mesh-list
55918829|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55918830|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
55968222|NCT04405154|Cisplatin|cisplatin|mesh-list
55918831|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55918832|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918833|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55918834|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
55918835|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968293|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
55968353|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55918836|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918837|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
55968536|NCT00641641|Tenofovir|tenofovir|mesh-list
55918838|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918839|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55918840|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55918841|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
55918842|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55918843|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56200129|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200130|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200131|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
55968682|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968685|NCT00654511|Analgesics|analgesics|mesh-ancestor
56200132|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200133|NCT01522612|Antidotes|antidotes|mesh-ancestor
56200134|NCT01522612|Protective Agents|protective agents|mesh-ancestor
56200135|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
56200137|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
56200138|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56200139|NCT01522625|Tenofovir|tenofovir|mesh-list
56200140|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
56200141|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200142|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56200143|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56200144|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200145|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200146|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56200147|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56200148|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56200149|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56200150|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
56200151|NCT01522729|Fentanyl|fentanyl|mesh-list
56200152|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56200153|NCT01522729|Narcotics|narcotics|mesh-ancestor
55731270|NCT05390749|Rituximab|rituximab|mesh-list
55918844|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55918845|NCT03599323|Clotrimazole|clotrimazole|mesh-list
55918846|NCT03599323|Miconazole|miconazole|mesh-list
55918847|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55918848|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918849|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
55918850|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55918851|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55918852|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918853|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918867|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55918868|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55918869|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55918870|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
55918871|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918872|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918873|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
55918874|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55918875|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55918876|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968814|NCT04404686|Indomethacin|indomethacin|mesh-list
55918877|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55918879|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
56200154|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200155|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200157|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
55918880|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918881|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55918882|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55918883|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55918884|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
55918885|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918886|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968847|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55918888|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213651|NCT02578680|Carboplatin|carboplatin|mesh-list
55918889|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918890|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
55918891|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55918892|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55918893|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55918894|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918895|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918896|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
55918897|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918898|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918899|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55918900|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918901|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
55918902|NCT04195243|Empagliflozin|empagliflozin|mesh-list
55918903|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56213667|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969087|NCT00557193|Hormones|hormones|mesh-ancestor
55918904|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918905|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55918906|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918907|NCT04195321|Phenylephrine|phenylephrine|mesh-list
55918908|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
55918909|NCT04195321|Norepinephrine|norepinephrine|mesh-list
55918922|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
55918923|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918924|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918925|NCT04195321|Protective Agents|protective agents|mesh-ancestor
55918927|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918928|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55918929|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918930|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918931|NCT04766359|Paclitaxel|paclitaxel|mesh-list
55918932|NCT04766359|Cisplatin|cisplatin|mesh-list
55918933|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55969233|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
55969234|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
55918934|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55918935|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918936|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
55918937|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
55918938|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
55918939|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918940|NCT04020601|Ropivacaine|ropivacaine|mesh-list
55918941|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
55918942|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
55969398|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918943|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55918944|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918945|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
55918946|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918947|NCT03964051|Omalizumab|omalizumab|mesh-list
55969478|NCT03714620|Ketamine|ketamine|mesh-list
55969613|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969705|NCT00663169|Hormones|hormones|mesh-ancestor
55918948|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55918949|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55918950|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
55918951|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
55918952|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55918953|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970173|NCT00591019|Modafinil|modafinil|mesh-list
55918954|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918955|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918956|NCT04193137|Captopril|captopril|mesh-list
55970216|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
56200158|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200159|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56200160|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56200161|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
56200164|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55970285|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56200165|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200166|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56200167|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200168|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
56200169|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200170|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
56200171|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200172|NCT01522846|Heparin|heparin|mesh-list
56200173|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
56200174|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56200175|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56200176|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200177|NCT01522872|Dexamethasone|dexamethasone|mesh-list
56200178|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
56200179|NCT01522872|Bortezomib|bortezomib|mesh-list
56200180|NCT01522872|Pomalidomide|pomalidomide|mesh-list
56200181|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
55970415|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970479|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55970480|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
56200182|NCT01522872|BB 1101|bb 1101|mesh-list
56200183|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200184|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
56200185|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
55731395|NCT04345887|Diuretics|diuretics|mesh-ancestor
55918957|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55918958|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
55918959|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918960|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918961|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55918962|NCT05060484|Vaccines|vaccines|mesh-list
55918963|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
55970637|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970639|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55918964|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213794|NCT01599871|Theophylline|theophylline|mesh-list
56213795|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56213796|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
55790371|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55970999|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55971000|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
55971001|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971002|NCT05362799|Cathartics|cathartics|mesh-ancestor
55971003|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55971004|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
55971005|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55971006|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55971008|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
55971042|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55971043|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971044|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55971045|NCT04388189|Analgesics|analgesics|mesh-ancestor
55971046|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
55971047|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971048|NCT00599053|Azithromycin|azithromycin|mesh-list
55971049|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55971050|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971051|NCT01941927|Trametinib|trametinib|mesh-list
55971052|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971056|NCT05220917|Insulin|insulin|mesh-list
55971059|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
55971060|NCT05220917|Pioglitazone|pioglitazone|mesh-list
55971061|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55971062|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
55971063|NCT05220917|Liraglutide|liraglutide|mesh-list
55971064|NCT05220917|Empagliflozin|empagliflozin|mesh-list
55971065|NCT05220917|Exenatide|exenatide|mesh-list
55971066|NCT05220917|Glimepiride|glimepiride|mesh-list
55971067|NCT05220917|Linagliptin|linagliptin|mesh-list
55971068|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
55918965|NCT04193059|Paclitaxel|paclitaxel|mesh-list
55918966|NCT04193059|Docetaxel|docetaxel|mesh-list
55918967|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
55918968|NCT04193059|Carboplatin|carboplatin|mesh-list
55918969|NCT04193059|Trastuzumab|trastuzumab|mesh-list
55918970|NCT04193059|Epirubicin|epirubicin|mesh-list
55971188|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971268|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971357|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
55971358|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971430|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55971504|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
55971674|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971763|NCT01958073|Estradiol|estradiol|mesh-list
55918971|NCT04193059|Pertuzumab|pertuzumab|mesh-list
55919034|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
55919035|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
55919036|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919037|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919038|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55919039|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55919040|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55919041|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56200186|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200187|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919042|NCT05096676|Oxytocin|oxytocin|mesh-list
55971839|NCT05735145|Paclitaxel|paclitaxel|mesh-list
55972012|NCT00578279|Ethanol|ethanol|mesh-list
55972082|NCT00580073|Leucovorin|leucovorin|mesh-list
55972186|NCT05731323|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55972349|NCT00611351|Busulfan|busulfan|mesh-list
55972438|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919043|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
55919044|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55919045|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919046|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
55919047|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55919048|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919049|NCT05096520|Lidocaine|lidocaine|mesh-list
55919050|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
55972793|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
55972859|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972863|NCT00733993|Caffeine|caffeine|mesh-list
55972955|NCT02285283|Itraconazole|itraconazole|mesh-list
55973026|NCT05688020|Respiratory System Agents|respiratory system agents|mesh-ancestor
55973107|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55973283|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55973284|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
55973285|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973286|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973287|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973288|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55973289|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973290|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55973291|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55973292|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
55973357|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973432|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973433|NCT05589597|Nivolumab|nivolumab|mesh-list
55973508|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
55973516|NCT00674609|Nabiximols|nabiximols|mesh-list
55973683|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55973754|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973755|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55973990|NCT04998032|Metformin|metformin|mesh-list
55973991|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55973992|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919051|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
55919052|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55919053|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919054|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
55919055|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974233|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55974236|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974237|NCT04683315|Gemcitabine|gemcitabine|mesh-list
55974238|NCT04683315|Paclitaxel|paclitaxel|mesh-list
55974311|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974379|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974454|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974455|NCT03686306|Urological Agents|urological agents|mesh-ancestor
55974538|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974623|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974624|NCT03231722|Antidotes|antidotes|mesh-ancestor
55974625|NCT03231722|Protective Agents|protective agents|mesh-ancestor
55974705|NCT00654329|Analgesics|analgesics|mesh-ancestor
55974706|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
55974794|NCT00696449|Adapalene|adapalene|mesh-list
55974876|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55919071|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919072|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919073|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55919074|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55919076|NCT04190173|Laxatives|laxatives|mesh-ancestor
55919077|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975130|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55975214|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55975215|NCT00541697|Atorvastatin|atorvastatin|mesh-list
55975216|NCT00541697|Simvastatin|simvastatin|mesh-list
55919078|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55919079|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55919080|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
55919081|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919082|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919083|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919084|NCT01272219|Liraglutide|liraglutide|mesh-list
55731605|NCT02317679|Bosentan|bosentan|mesh-list
55919086|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975476|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975477|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
55975478|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975479|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975480|NCT02996825|Gemcitabine|gemcitabine|mesh-list
55975481|NCT02996825|Maytansine|maytansine|mesh-list
55975482|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55975483|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
55975484|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975485|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975486|NCT02996825|Antiviral Agents|antiviral agents|mesh-ancestor
55975487|NCT02996825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975753|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
55919087|NCT01272219|Incretins|incretins|mesh-ancestor
55975834|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
55975906|NCT00739999|Atorvastatin|atorvastatin|mesh-list
56485999|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976047|NCT00719966|Anastrozole|anastrozole|mesh-list
55976121|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976122|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55976123|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
55976128|NCT00721513|Docetaxel|docetaxel|mesh-list
55919089|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919090|NCT04198363|Amoxicillin|amoxicillin|mesh-list
55919091|NCT04198363|Clarithromycin|clarithromycin|mesh-list
55919092|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
55919093|NCT04198363|Esomeprazole|esomeprazole|mesh-list
55919094|NCT04198363|Bismuth|bismuth|mesh-list
55919095|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919096|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919097|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919098|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55919099|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55919100|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55976306|NCT01276691|Aspirin|aspirin|mesh-list
55919101|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919102|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55976444|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976446|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919103|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55976591|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976650|NCT01278745|Tacrolimus|tacrolimus|mesh-list
55919104|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55919105|NCT04198363|Antacids|antacids|mesh-ancestor
55976878|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919106|NCT04198363|Diuretics|diuretics|mesh-ancestor
55919107|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
55976958|NCT00639002|Dexamethasone|dexamethasone|mesh-list
55977022|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977097|NCT00736229|Exenatide|exenatide|mesh-list
55919108|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919109|NCT04198363|Expectorants|expectorants|mesh-ancestor
55919110|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919111|NCT04020133|Epinephrine|epinephrine|mesh-list
55919112|NCT04020133|Bupivacaine|bupivacaine|mesh-list
55919113|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
55919114|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
55919128|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919129|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
55919130|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
55919131|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55977169|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977170|NCT02994485|Simvastatin|simvastatin|mesh-list
55919132|NCT04565574|Rifampin|rifampin|mesh-list
55919133|NCT04565574|Rabeprazole|rabeprazole|mesh-list
55919134|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55919135|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55919136|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55919137|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486000|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56486001|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486002|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486003|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55977454|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977455|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
55977534|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919138|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919139|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55919140|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
55919141|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919142|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200188|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56200189|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
56200190|NCT01522872|Hormones|hormones|mesh-ancestor
55977901|NCT00786643|Interferons|interferons|mesh-list
55977996|NCT05742607|Paclitaxel|paclitaxel|mesh-list
55978067|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978144|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
55978213|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55978363|NCT01994109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978364|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56200191|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919143|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
55919144|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55919145|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55919146|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55919147|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55919148|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55919149|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55919150|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55919152|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
55919153|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
55919154|NCT04195633|Treosulfan|treosulfan|mesh-list
55919155|NCT04195633|Busulfan|busulfan|mesh-list
55978535|NCT03533283|Atezolizumab|atezolizumab|mesh-list
55978600|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
55978603|NCT04894123|Trifluridine|trifluridine|mesh-list
55919156|NCT04195633|Fludarabine|fludarabine|mesh-list
55919157|NCT04195633|Cyclosporins|cyclosporins|mesh-list
55919158|NCT04195633|Lenograstim|lenograstim|mesh-list
55919159|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55919160|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
55919161|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919162|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55919163|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55978840|NCT03367689|Olaparib|olaparib|mesh-list
55919164|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
55919165|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979073|NCT00817999|Clopidogrel|clopidogrel|mesh-list
55979236|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
55919166|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919167|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55919168|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55919169|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919170|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
55919171|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919173|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55919174|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55979617|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55979687|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979765|NCT05718609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55979773|NCT05718609|Antacids|antacids|mesh-ancestor
55979841|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
55919175|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55979990|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55979991|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
55980140|NCT02051595|Vancomycin|vancomycin|mesh-list
55980218|NCT05741021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55980219|NCT05741021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980220|NCT05741021|Tubulin Modulators|tubulin modulators|mesh-ancestor
55980437|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
55980450|NCT03831113|Buprenorphine|buprenorphine|mesh-list
55919176|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
55919230|NCT04026685|Protective Agents|protective agents|mesh-ancestor
55919232|NCT00751179|Rocuronium|rocuronium|mesh-list
55919233|NCT00751179|Succinylcholine|succinylcholine|mesh-list
55919234|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
55919235|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55919236|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55919237|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55919238|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919239|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919240|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
55919241|NCT01273233|Vaccines|vaccines|mesh-list
55919242|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
55919243|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919244|NCT01277211|NuvaRing|nuvaring|mesh-list
55980510|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
55919245|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55919246|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
55919247|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55919248|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919249|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
55919250|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55980581|NCT04637529|Ibuprofen|ibuprofen|mesh-list
55980641|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980642|NCT03806751|Diuretics|diuretics|mesh-ancestor
55980710|NCT04724447|Valganciclovir|valganciclovir|mesh-list
55980793|NCT03496623|Treprostinil|treprostinil|mesh-list
55980864|NCT04923893|Hormones|hormones|mesh-ancestor
55919251|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
55919252|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919253|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919254|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55919255|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919256|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55919257|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
55919258|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919259|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919260|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55919261|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
55919262|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
55919263|NCT04022161|Protective Agents|protective agents|mesh-ancestor
55919264|NCT01676220|Insulin|insulin|mesh-list
56200192|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56200193|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200194|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
56200195|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981202|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55981275|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55981350|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55981499|NCT00860015|Antiviral Agents|antiviral agents|mesh-ancestor
55981571|NCT05236907|Melatonin|melatonin|mesh-list
55981643|NCT00860171|Antibodies|antibodies|mesh-list
56200196|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200197|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
56200198|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56200199|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56200200|NCT01522872|Growth Substances|growth substances|mesh-ancestor
56200201|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
56200202|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56200203|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
56200204|NCT01522989|Fluorouracil|fluorouracil|mesh-list
56200205|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
56200206|NCT01522989|Palbociclib|palbociclib|mesh-list
56200207|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
55919265|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55919323|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
55981790|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55981917|NCT00859495|Pemetrexed|pemetrexed|mesh-list
55919324|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55919325|NCT01275105|Protective Agents|protective agents|mesh-ancestor
55919328|NCT01270347|Tobramycin|tobramycin|mesh-list
55919329|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55919330|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55919331|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919332|NCT01270347|Renal Agents|renal agents|mesh-ancestor
55919333|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919334|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55982103|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982107|NCT04339816|Azithromycin|azithromycin|mesh-list
55919335|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55919336|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919337|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919338|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919339|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55919341|NCT03608436|Bromides|bromides|mesh-list
55919342|NCT03608436|Rocuronium|rocuronium|mesh-list
55919343|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
55919344|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55919357|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
55919358|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982172|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
55982236|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982245|NCT00867217|Vitamins|vitamins|mesh-list
55982310|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982377|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
55982452|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
55982542|NCT05315479|Meloxicam|meloxicam|mesh-list
55982606|NCT00896779|Ranibizumab|ranibizumab|mesh-list
55982683|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
55982758|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55982833|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55982840|NCT05446480|Desloratadine|desloratadine|mesh-list
55982911|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
55982931|NCT01830517|Losartan|losartan|mesh-list
55982983|NCT01830829|Urological Agents|urological agents|mesh-ancestor
55983067|NCT00369148|Nateglinide|nateglinide|mesh-list
55983129|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
56214334|NCT01612468|Hormones|hormones|mesh-ancestor
56214336|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55983313|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919359|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55919360|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
55919361|NCT03412188|Hormones|hormones|mesh-ancestor
55919362|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919364|NCT03412188|Protective Agents|protective agents|mesh-ancestor
55919365|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55919366|NCT05019846|Bicalutamide|bicalutamide|mesh-list
55919367|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55919368|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
55919369|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
55983590|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55983663|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
55983734|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983808|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55983810|NCT02504554|Vancomycin|vancomycin|mesh-list
55919370|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919371|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919372|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919373|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
55919374|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55919375|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
55919376|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55919377|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55919378|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55919379|NCT01278849|Vadimezan|vadimezan|mesh-list
56200208|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200209|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56200210|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984168|NCT00827255|Cyclosporine|cyclosporine|mesh-list
55984169|NCT00827255|Cyclosporins|cyclosporins|mesh-list
55984170|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984172|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55984244|NCT00828191|Progestins|progestins|mesh-ancestor
55984245|NCT00828191|Hormones|hormones|mesh-ancestor
55984313|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55984314|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200211|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200212|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
56200213|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200214|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56200215|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200216|NCT01523002|Artesunate|artesunate|mesh-list
56200217|NCT01523002|Pyronaridine|pyronaridine|mesh-list
56200218|NCT01523002|Metoprolol|metoprolol|mesh-list
55984522|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
55984523|NCT00872027|Citalopram|citalopram|mesh-list
55984524|NCT00872027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56214411|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56214412|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214413|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214414|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984525|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55984526|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55984527|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984529|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
55984530|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984531|NCT00872027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56214416|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
56214417|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214418|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984564|NCT01743742|Protective Agents|protective agents|mesh-ancestor
55984565|NCT01723735|Ezetimibe|ezetimibe|mesh-list
55984566|NCT01723735|Fenofibrate|fenofibrate|mesh-list
55984568|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55984569|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
55984572|NCT00872729|Cysteamine|cysteamine|mesh-list
55984626|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
55984627|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
56200219|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56200220|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55984766|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984767|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
55984837|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984913|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
56200221|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
56200222|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
55985054|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985122|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985200|NCT05515770|Cabotegravir|cabotegravir|mesh-list
55985279|NCT00884897|Oxytocin|oxytocin|mesh-list
56200223|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985346|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
56200224|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200225|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55985425|NCT01724983|Narcotics|narcotics|mesh-ancestor
56200226|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56200227|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56200228|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
56214470|NCT01613209|Candesartan|candesartan|mesh-list
55985553|NCT05720559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985613|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55985618|NCT01044745|Rituximab|rituximab|mesh-list
55985685|NCT02767492|Hormones|hormones|mesh-ancestor
55985781|NCT01041859|Tapentadol|tapentadol|mesh-list
55985832|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55985857|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
55986001|NCT05456542|Hormones|hormones|mesh-ancestor
56200229|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731651|NCT05256745|Paclitaxel|paclitaxel|mesh-list
55919380|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919381|NCT04949412|Vitamin D|vitamin d|mesh-list
55919382|NCT04949412|Vitamins|vitamins|mesh-ancestor
55919383|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
55919384|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986136|NCT00373282|Triamcinolone|triamcinolone|mesh-list
55986200|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986276|NCT02778880|Narcotics|narcotics|mesh-ancestor
55986347|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55986353|NCT03214055|Mannitol|mannitol|mesh-list
55986413|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55919385|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55919386|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56214564|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
55986631|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
55986704|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919387|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
55919388|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55919389|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
55919390|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919391|NCT01485614|Metformin|metformin|mesh-list
55919392|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55919393|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55919394|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919395|NCT01485614|Incretins|incretins|mesh-ancestor
55919396|NCT01485614|Hormones|hormones|mesh-ancestor
55919397|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919398|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55919399|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
55919400|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919401|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919402|NCT00722553|Vitamins|vitamins|mesh-list
55919403|NCT00722553|Folic Acid|folic acid|mesh-list
55919404|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
55986852|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55986853|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
56214577|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56214578|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
55986979|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
55986980|NCT01839383|Calcium|calcium|mesh-list
55919405|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
55919406|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
55919407|NCT00722553|Aminopterin|aminopterin|mesh-list
55919429|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919430|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
56200230|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128019|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56200231|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
56200232|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56200233|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56200234|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200235|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200236|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
56200237|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
56200238|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56200239|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
56200241|NCT01523015|Fluorouracil|fluorouracil|mesh-list
56200242|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
55987407|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987477|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987621|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
56200243|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200244|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
56200245|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
56200246|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
56200247|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200248|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
55731692|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55988213|NCT02796352|Analgesics|analgesics|mesh-ancestor
55919431|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55988529|NCT03798691|Vaccines|vaccines|mesh-list
56214671|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55791030|NCT01729455|Belimumab|belimumab|mesh-list
55988726|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988798|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919432|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55919433|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55988943|NCT00955747|Tagatose|tagatose|mesh-list
55919434|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55919435|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919436|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919437|NCT03928015|Hormones|hormones|mesh-ancestor
55989083|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989085|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
55989165|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55989166|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55989167|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55989168|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989169|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989216|NCT02951182|Ivacaftor|ivacaftor|mesh-list
55989355|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
55989356|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989357|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55919438|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919440|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
55716760|NCT03159741|Hormones|hormones|mesh-ancestor
55989502|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
55989648|NCT02241083|Norepinephrine|norepinephrine|mesh-list
55989662|NCT04372589|Heparin|heparin|mesh-list
55919441|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919442|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
55919443|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919444|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
55919445|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919446|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
55919447|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55919448|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55919449|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919450|NCT03229512|Urological Agents|urological agents|mesh-ancestor
55919451|NCT01279083|Timolol|timolol|mesh-list
55919452|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55919453|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919454|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55919455|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55919456|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
55919457|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919458|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990198|NCT05445609|Nivolumab|nivolumab|mesh-list
55990263|NCT05582499|Tubulin Modulators|tubulin modulators|mesh-ancestor
55919459|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55919460|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55919461|NCT03022201|Domperidone|domperidone|mesh-list
55919473|NCT04716114|Azacitidine|azacitidine|mesh-list
55919474|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
55919475|NCT04716114|Aclarubicin|aclarubicin|mesh-list
55990494|NCT03023527|Nivolumab|nivolumab|mesh-list
55919476|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919477|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55919478|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
56200249|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56200250|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200251|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
56200252|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200253|NCT01523041|Insulin|insulin|mesh-list
56200254|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56200255|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
56200256|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
56200257|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56200258|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
56200259|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55990624|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56200260|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919479|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919480|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55919481|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
55990692|NCT00976183|Vorinostat|vorinostat|mesh-list
55919482|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919483|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
55919484|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990758|NCT00936377|Analgesics|analgesics|mesh-ancestor
55919485|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919486|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55919487|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55919488|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55919489|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55919490|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55919491|NCT00752973|Malathion|malathion|mesh-list
55990882|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
55919492|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55919493|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919494|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919495|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
55919496|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919497|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919498|NCT04025593|Prednisone|prednisone|mesh-list
55919499|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
55919500|NCT04025593|Rituximab|rituximab|mesh-list
55919501|NCT04025593|Doxorubicin|doxorubicin|mesh-list
55919502|NCT04025593|Vincristine|vincristine|mesh-list
55919503|NCT04025593|Lenalidomide|lenalidomide|mesh-list
55919504|NCT04025593|Decitabine|decitabine|mesh-list
55919505|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991032|NCT05017545|Abatacept|abatacept|mesh-list
55919506|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
55919507|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919508|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55919509|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55919510|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
55919511|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919512|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919513|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55919514|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55919515|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55765900|NCT05516589|Paclitaxel|paclitaxel|mesh-list
55919516|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55919517|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55919518|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766026|NCT01623310|Xhance|xhance|mesh-list
55919519|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55919520|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
55919521|NCT04025593|Hormones|hormones|mesh-ancestor
55919522|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919523|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55919524|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55919525|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
55919526|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
55919556|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
55919557|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919559|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56200261|NCT01523054|Metoprolol|metoprolol|mesh-list
55766164|NCT02416739|Niacin|niacin|mesh-list
55766231|NCT04482881|Misoprostol|misoprostol|mesh-list
55766292|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766434|NCT04887831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766435|NCT04887831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200262|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56200263|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56200264|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
56200265|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
55766515|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
56200266|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200267|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200268|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56200269|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56200270|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56200271|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
55731812|NCT02223364|Bupivacaine|bupivacaine|mesh-list
55919560|NCT03023124|Dacarbazine|dacarbazine|mesh-list
55919561|NCT03023124|Trabectedin|trabectedin|mesh-list
55919562|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55919563|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919564|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55919565|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55919566|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919567|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919568|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55919569|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
55919570|NCT03022123|Prednisone|prednisone|mesh-list
55919571|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
55919572|NCT03022123|Doxorubicin|doxorubicin|mesh-list
55919573|NCT03022123|Vincristine|vincristine|mesh-list
55919574|NCT03022123|Epirubicin|epirubicin|mesh-list
55871307|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
55766888|NCT02408705|Analgesics|analgesics|mesh-ancestor
55919601|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
55919602|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767020|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767094|NCT03116087|Hormones|hormones|mesh-ancestor
55767167|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767226|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55919603|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919605|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55767496|NCT04596579|Antibodies|antibodies|mesh-list
55767551|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55919606|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55919607|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767688|NCT02056288|Fentanyl|fentanyl|mesh-list
55767761|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55767762|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919608|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55919609|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919610|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919611|NCT00722865|Bevacizumab|bevacizumab|mesh-list
55919612|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55919613|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919614|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55919615|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55919616|NCT00722865|Growth Substances|growth substances|mesh-ancestor
55919617|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919618|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
55919619|NCT02700529|Ubenimex|ubenimex|mesh-list
55919620|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55919643|NCT00723099|Cyclosporins|cyclosporins|mesh-list
55919644|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55919645|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
55919646|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919647|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55919648|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55919649|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
55919650|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919651|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919652|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55919653|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55919654|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
55919655|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919656|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
55919657|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919658|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
55919659|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56200272|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200273|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200274|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
56215020|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
56200275|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
56200276|NCT01523080|Acetaminophen|acetaminophen|mesh-list
56200277|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56200278|NCT01523080|Analgesics|analgesics|mesh-ancestor
56200279|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
56200280|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200340|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56200341|NCT01523327|Uric Acid|uric acid|mesh-list
56200342|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
56486004|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56200343|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200344|NCT01523327|Protective Agents|protective agents|mesh-ancestor
56200345|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200346|NCT01523379|Parecoxib|parecoxib|mesh-list
56200347|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56200348|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56200349|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200350|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200351|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56200352|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55768232|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
56200353|NCT01523379|Analgesics|analgesics|mesh-ancestor
56200354|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
56200355|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919660|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55919661|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55919662|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
55919663|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919664|NCT01508936|Reslizumab|reslizumab|mesh-list
55919665|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55919666|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919667|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
55919668|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55919669|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
55919670|NCT04146259|Calcium|calcium|mesh-list
55919671|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56486005|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55919672|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919674|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919688|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919689|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55919690|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919691|NCT04323462|Insulin|insulin|mesh-list
55919692|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55919693|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
55768422|NCT05493969|Dolutegravir|dolutegravir|mesh-list
55768433|NCT05493657|Aspirin|aspirin|mesh-list
55919694|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55919695|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919696|NCT00723177|Ibudilast|ibudilast|mesh-list
55919697|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55919698|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
55919699|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919700|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919701|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55919702|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919703|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55768492|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
55768554|NCT04276155|Anticoagulants|anticoagulants|mesh-list
55768558|NCT05488899|Iodine|iodine|mesh-list
55768559|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
55768560|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55768562|NCT05488899|Trace Elements|trace elements|mesh-ancestor
55919704|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919705|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919706|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55919707|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
55919709|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
55919710|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
55919711|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919712|NCT04698434|Esketamine|esketamine|mesh-list
55919713|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
56200357|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200358|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55731996|NCT03494387|Vitamins|vitamins|mesh-ancestor
55919714|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55919715|NCT04142749|Oltipraz|oltipraz|mesh-list
55919716|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
55919717|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919718|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
55919719|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55919720|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
55919721|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55768834|NCT02394119|Rituximab|rituximab|mesh-list
55919722|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55919723|NCT04142749|Protective Agents|protective agents|mesh-ancestor
55919724|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919725|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919726|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55919727|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55919728|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919729|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919730|NCT01508702|Lesinurad|lesinurad|mesh-list
55919731|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
55768972|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55769048|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
55769049|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769191|NCT02534883|Misoprostol|misoprostol|mesh-list
55769272|NCT03206073|Durvalumab|durvalumab|mesh-list
55919732|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55919733|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
55919734|NCT01508702|Renal Agents|renal agents|mesh-ancestor
55919736|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55919737|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
56486006|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
55769400|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769481|NCT02683187|Incretins|incretins|mesh-ancestor
55769553|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55769554|NCT02680847|Narcotics|narcotics|mesh-ancestor
55769631|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
55769709|NCT02034916|Talazoparib|talazoparib|mesh-list
55769786|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55769862|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55769931|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
55919738|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919739|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55919740|NCT01276041|Paclitaxel|paclitaxel|mesh-list
55919753|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55919771|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
55919772|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
55919773|NCT04026438|Protective Agents|protective agents|mesh-ancestor
55919774|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919775|NCT01275339|Tadalafil|tadalafil|mesh-list
55770016|NCT04205903|Paclitaxel|paclitaxel|mesh-list
55919776|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
55919777|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55919778|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55919780|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919781|NCT01275339|Urological Agents|urological agents|mesh-ancestor
55919782|NCT01520402|Warfarin|warfarin|mesh-list
55919783|NCT01520402|Anticoagulants|anticoagulants|mesh-list
55919784|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
55919785|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55919786|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919787|NCT05108220|Cannabidiol|cannabidiol|mesh-list
55919788|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
55919789|NCT03027674|Nifedipine|nifedipine|mesh-list
55919790|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
55919791|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
55919792|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55919793|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55919794|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770076|NCT05674877|Dexmedetomidine|dexmedetomidine|mesh-list
55919795|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919796|NCT03027674|Urological Agents|urological agents|mesh-ancestor
55919797|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55919798|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55770134|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55770266|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55919799|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55770408|NCT02382263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770409|NCT02382029|Clonazepam|clonazepam|mesh-list
55770485|NCT02384837|Sirolimus|sirolimus|mesh-list
55919800|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919801|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
55919802|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55919804|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
55919805|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919806|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55919807|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55919808|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770557|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55919809|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919810|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55919811|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55919812|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
55919813|NCT04144153|Anesthetics|anesthetics|mesh-list
56200359|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
55770646|NCT02053246|Nebivolol|nebivolol|mesh-list
55770695|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55770767|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200360|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56200361|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
56200362|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56200363|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
56200364|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200365|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200366|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
56200367|NCT01523431|Leucovorin|leucovorin|mesh-list
56200368|NCT01523431|Fluorouracil|fluorouracil|mesh-list
56200369|NCT01523431|Irinotecan|irinotecan|mesh-list
56200370|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
56200371|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200372|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56200373|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200374|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200375|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
55919814|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55919815|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919816|NCT04144153|Narcotics|narcotics|mesh-ancestor
55919817|NCT04144153|Analgesics|analgesics|mesh-ancestor
55771263|NCT02958917|Pirfenidone|pirfenidone|mesh-list
55919818|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
55919819|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919820|NCT04094948|Clenbuterol|clenbuterol|mesh-list
55919821|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55919822|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55919834|NCT04023565|Moxonidine|moxonidine|mesh-list
55771333|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55771413|NCT03112577|Xhance|xhance|mesh-list
55919835|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55919836|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
55919837|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919838|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771706|NCT02356679|Ethanol|ethanol|mesh-list
55919839|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55919840|NCT01506908|Nicotine|nicotine|mesh-list
55919841|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55919842|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
55919843|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919844|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919845|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55919846|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55919847|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
55919848|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919849|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919850|NCT01519778|Tedizolid|tedizolid|mesh-list
55919851|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919852|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919854|NCT04144933|Dexamethasone|dexamethasone|mesh-list
55919855|NCT04144933|Lidocaine|lidocaine|mesh-list
55919856|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
55919857|NCT04144933|Sufentanil|sufentanil|mesh-list
55919858|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
55771879|NCT02350439|Adenosine|adenosine|mesh-list
55919859|NCT04144933|Ketamine|ketamine|mesh-list
55919860|NCT04144933|Gabapentin|gabapentin|mesh-list
55919861|NCT04144933|Dsuvia|dsuvia|mesh-list
55772010|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
56215249|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215252|NCT01617733|Hormones|hormones|mesh-ancestor
55919862|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
55772185|NCT02345993|Beclomethasone|beclomethasone|mesh-list
55919863|NCT04144933|Ondansetron|ondansetron|mesh-list
55919864|NCT04144933|Sevoflurane|sevoflurane|mesh-list
55919865|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55919866|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55919867|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
55919868|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
55772254|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919869|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772340|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
55772414|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215305|NCT01618006|Analgesics|analgesics|mesh-ancestor
55772554|NCT02442427|Palivizumab|palivizumab|mesh-list
55919870|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772685|NCT02331251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772686|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772687|NCT02331251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55772688|NCT02331251|Immunologic Factors|immunologic factors|mesh-ancestor
55772689|NCT02331251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772690|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55772691|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55772692|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55772693|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55772694|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55772695|NCT02435797|Nicorandil|nicorandil|mesh-list
56200376|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200377|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56200378|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56200379|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200380|NCT01523431|Antidotes|antidotes|mesh-ancestor
56200381|NCT01523431|Protective Agents|protective agents|mesh-ancestor
56200382|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
56200383|NCT01523431|Vitamins|vitamins|mesh-ancestor
56200384|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
56128171|NCT00089778|Mitogens|mitogens|mesh-list
56200385|NCT01523483|Progesterone|progesterone|mesh-list
56200386|NCT01523483|Progestins|progestins|mesh-ancestor
56200387|NCT01523483|Hormones|hormones|mesh-ancestor
56200388|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200389|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200390|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
56200391|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
56200392|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200393|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
56200394|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200395|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200396|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
55772968|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55919871|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55919872|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
55919873|NCT04144933|Hormones|hormones|mesh-ancestor
55919874|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919875|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55919876|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919877|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
55919878|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
55919879|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55919880|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
55919881|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55919882|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55783117|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55773079|NCT03144947|Trastuzumab|trastuzumab|mesh-list
55919883|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55919884|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743113|NCT02517619|Dexamethasone|dexamethasone|mesh-list
55919885|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919887|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55919901|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55919902|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
55919903|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55919904|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55919905|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55919906|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
55919907|NCT04144933|Narcotics|narcotics|mesh-ancestor
55919908|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
55773290|NCT04996199|Zileuton|zileuton|mesh-list
55773386|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773411|NCT02432365|Paclitaxel|paclitaxel|mesh-list
55773479|NCT02428777|Diclofenac|diclofenac|mesh-list
55773520|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773603|NCT03185845|Warfarin|warfarin|mesh-list
55919909|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
55773736|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55773737|NCT03182413|Modafinil|modafinil|mesh-list
55773813|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
55919910|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55919911|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
55919912|NCT04144933|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55919913|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55773952|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
55919914|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55919915|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
56200397|NCT01523574|Vitamin E|vitamin e|mesh-list
56200398|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
56200399|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
56200400|NCT01523574|Calcium|calcium|mesh-list
56200401|NCT01523574|Vitamins|vitamins|mesh-ancestor
56200402|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
56200403|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200404|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56200405|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56200406|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200407|NCT01523574|Analgesics|analgesics|mesh-ancestor
55774264|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
56215466|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56200408|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
56200409|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200410|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
55919916|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55919917|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55919918|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55919919|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
55919920|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55919921|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919922|NCT04149067|Incretins|incretins|mesh-ancestor
55919923|NCT04149067|Hormones|hormones|mesh-ancestor
55919924|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919925|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55919926|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
55919927|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919928|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215522|NCT01619163|Hormones|hormones|mesh-ancestor
56215606|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56215610|NCT01619683|Clomiphene|clomiphene|mesh-list
55919929|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55919930|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
55919931|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
55919932|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919933|NCT05087862|Anesthetics|anesthetics|mesh-list
55919934|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
55919935|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55919936|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774696|NCT04850651|Fluconazole|fluconazole|mesh-list
55919937|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
55919938|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919939|NCT01519700|Lenograstim|lenograstim|mesh-list
55774746|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
55774835|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
56215829|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
55775055|NCT02423239|Protective Agents|protective agents|mesh-ancestor
55919940|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55919941|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
55919942|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919943|NCT04977024|Vaccines|vaccines|mesh-list
55919944|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
55775185|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55919945|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775328|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56215999|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55775569|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
55919946|NCT04143685|Misoprostol|misoprostol|mesh-list
55919947|NCT04143685|Oxytocin|oxytocin|mesh-list
55919948|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
55919949|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55919975|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919976|NCT05110482|Oxytocin|oxytocin|mesh-list
55919977|NCT05110482|Carbetocin|carbetocin|mesh-list
55919978|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
55919979|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55919980|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775712|NCT05095571|Niacin|niacin|mesh-list
55919981|NCT04930458|Listerine|listerine|mesh-list
55919982|NCT04930458|Calcium|calcium|mesh-list
55919983|NCT04930458|Fluorides|fluorides|mesh-list
55775837|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
55775982|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
55776120|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216179|NCT01623102|Gemcitabine|gemcitabine|mesh-list
55776236|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55776244|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
55919984|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
55919985|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
55919986|NCT04930458|Caseins|caseins|mesh-list
55919987|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55919988|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919989|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
55919990|NCT04930458|Protective Agents|protective agents|mesh-ancestor
55919991|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56200411|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200412|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56200413|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
56200414|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56200415|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200416|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200417|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
56200418|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56200419|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
56200420|NCT01523574|Protective Agents|protective agents|mesh-ancestor
56200421|NCT01523639|Metformin|metformin|mesh-list
55919992|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919993|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
55919994|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
55919995|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919996|NCT04917588|Lidocaine|lidocaine|mesh-list
55919997|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
55920012|NCT03769285|Vitamins|vitamins|mesh-ancestor
55920013|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
55920014|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920015|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55776697|NCT03172741|Dronabinol|dronabinol|mesh-list
55920016|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
55920017|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920018|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55920019|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
55776854|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
55920020|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
55920021|NCT05101356|Vaccines|vaccines|mesh-list
55920022|NCT05101356|Sargramostim|sargramostim|mesh-list
55920023|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
55920024|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920025|NCT04022317|Insulin|insulin|mesh-list
55920026|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55920027|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920028|NCT04022005|Gemcitabine|gemcitabine|mesh-list
55920029|NCT04022005|Rituximab|rituximab|mesh-list
55920030|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
55920031|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55920032|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920033|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
55777054|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
55920034|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920035|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777116|NCT05115149|Protective Agents|protective agents|mesh-ancestor
55777219|NCT02700841|Melphalan|melphalan|mesh-list
55777341|NCT01962298|Rocuronium|rocuronium|mesh-list
55777420|NCT01982812|Levetiracetam|levetiracetam|mesh-list
55920036|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55920037|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
55920038|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920039|NCT04022005|Antiviral Agents|antiviral agents|mesh-ancestor
55920040|NCT04022005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920041|NCT04022005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920042|NCT04022005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920043|NCT03943537|Insulin|insulin|mesh-list
55920044|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55920045|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920046|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
55920047|NCT05099250|Bupivacaine|bupivacaine|mesh-list
55920048|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
55920049|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
55920050|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920051|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777893|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
55920052|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
55920053|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920054|NCT05099250|Analgesics|analgesics|mesh-ancestor
55920055|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55920056|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
55920057|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55920071|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55920072|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
56200423|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200424|NCT01523678|Paclitaxel|paclitaxel|mesh-list
55777989|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55920073|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920074|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920075|NCT05105412|Antiviral Agents|antiviral agents|mesh-ancestor
55920076|NCT05105412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920077|NCT05105412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778192|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778193|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
55778414|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55778419|NCT05697055|Ritonavir|ritonavir|mesh-list
55920078|NCT05105412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920079|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
55920080|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920081|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55920083|NCT05105412|Growth Substances|growth substances|mesh-ancestor
55920084|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
55920085|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
55920086|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55920087|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778696|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
55920088|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920089|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55920091|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
55920092|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920093|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55920094|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55920095|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55920096|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
55778886|NCT04310995|Diuretics|diuretics|mesh-ancestor
55778891|NCT04310995|Vitamins|vitamins|mesh-ancestor
55783493|NCT03895099|Progestins|progestins|mesh-ancestor
55920097|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920098|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920099|NCT05105022|Propofol|propofol|mesh-list
55920100|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55920101|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920102|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779235|NCT04955249|Analgesics|analgesics|mesh-ancestor
55920103|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55920104|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
55920105|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
55920106|NCT02080819|Levodopa|levodopa|mesh-list
55920107|NCT02080819|Carbidopa|carbidopa|mesh-list
55920108|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55920109|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55920110|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
55920111|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920112|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920113|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920114|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55920115|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920116|NCT05104788|Carboplatin|carboplatin|mesh-list
55920117|NCT05104788|Pemetrexed|pemetrexed|mesh-list
55920118|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920119|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920155|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55920157|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920158|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55920191|NCT03896737|Hormones|hormones|mesh-ancestor
55920192|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920193|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55920194|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
55779363|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55920195|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920196|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
55779686|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
55779773|NCT03938831|Narcotics|narcotics|mesh-ancestor
55779845|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920197|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55920198|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920199|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55920200|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55920201|NCT03896737|Growth Substances|growth substances|mesh-ancestor
55920202|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
55920203|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
55779937|NCT04701593|Hormones|hormones|mesh-ancestor
55920204|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55920205|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55920206|NCT04685772|Prednisolone|prednisolone|mesh-list
55780197|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780198|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
55920207|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
55920226|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55920228|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55920229|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200425|NCT01523678|Carboplatin|carboplatin|mesh-list
56200426|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56200427|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200428|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
56216636|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200429|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
55780492|NCT02376595|Rocuronium|rocuronium|mesh-list
55783531|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783533|NCT02332135|Vitamins|vitamins|mesh-ancestor
56200430|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
55780700|NCT02369965|Ritonavir|ritonavir|mesh-list
55783567|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
55780992|NCT02368561|Hylan|hylan|mesh-list
55781032|NCT02374567|Levetiracetam|levetiracetam|mesh-list
55781033|NCT02374567|Valproic Acid|valproic acid|mesh-list
55781137|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
56200431|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200432|NCT01523847|Doxorubicin|doxorubicin|mesh-list
55732325|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920230|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920232|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
55920233|NCT03476317|Neomycin|neomycin|mesh-list
55920234|NCT03476317|Fluconazole|fluconazole|mesh-list
55920235|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55920236|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55920237|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920238|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55920239|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55920240|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920241|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920242|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920243|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55920244|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55920245|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
55920246|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55781236|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55920247|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55920248|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
55920249|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920250|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920251|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55920252|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55781292|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920253|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55920254|NCT03476317|Laxatives|laxatives|mesh-ancestor
55920261|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920262|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55920263|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
55920264|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
55783592|NCT02637323|FX006|fx006|mesh-list
55920265|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
55920266|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920267|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55920290|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55920291|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920293|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
55920294|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920295|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
55920296|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55920297|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55920298|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55920299|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55920300|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920301|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
55920302|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920303|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920304|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55920305|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920311|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
55920312|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55920313|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
55920314|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55920315|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
55920316|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781671|NCT05053841|Metformin|metformin|mesh-list
55920317|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200433|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56200434|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200435|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56200436|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55920319|NCT04642950|Sargramostim|sargramostim|mesh-list
55920320|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
55920321|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920322|NCT05110170|Goserelin|goserelin|mesh-list
55920323|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55920324|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920325|NCT04374240|Tretazicar|tretazicar|mesh-list
55920382|NCT04748250|Hormones|hormones|mesh-ancestor
55920383|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920384|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920386|NCT04726878|Oxycodone|oxycodone|mesh-list
55920387|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920388|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920389|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55920390|NCT04726878|Analgesics|analgesics|mesh-ancestor
55920391|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
55920392|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920393|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
55920394|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55920395|NCT04726878|Narcotics|narcotics|mesh-ancestor
55920396|NCT04525638|Nivolumab|nivolumab|mesh-list
55920397|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55920398|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55920399|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920400|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55920401|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920402|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55920403|NCT03512262|Abaloparatide|abaloparatide|mesh-list
55920404|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
55920428|NCT01482962|Immunologic Factors|immunologic factors|mesh-ancestor
55920429|NCT01482962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920430|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55920432|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920433|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55920434|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920435|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920436|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
55920437|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
55920438|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782055|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
55920439|NCT05116098|Protective Agents|protective agents|mesh-ancestor
55920440|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920441|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55920442|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55920443|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782256|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920444|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55920445|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55783725|NCT02331511|Clopidogrel|clopidogrel|mesh-list
55782550|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55782551|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
55782617|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
55782618|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
55920446|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55920447|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
55920448|NCT04464408|Favipiravir|favipiravir|mesh-list
55920449|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
55920450|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920451|NCT04339218|Carboplatin|carboplatin|mesh-list
55920452|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
55920453|NCT04339218|Pemetrexed|pemetrexed|mesh-list
55920454|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920455|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55920456|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920472|NCT03021421|Bupivacaine|bupivacaine|mesh-list
55920473|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
55920474|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
55920475|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782868|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791928|NCT05068453|Antibodies|antibodies|mesh-list
55800758|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
56216796|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55920476|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920477|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
56200437|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200438|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200439|NCT01523860|Rituximab|rituximab|mesh-list
56200440|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56200441|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
56200442|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56200443|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200444|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
56200445|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200446|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200447|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56200448|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
55732465|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
55920478|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920479|NCT04521582|Amlodipine|amlodipine|mesh-list
55920480|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55803498|NCT05579509|Anesthetics|anesthetics|mesh-ancestor
55920482|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55920483|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920484|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55920485|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920486|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
55920487|NCT03588091|Docetaxel|docetaxel|mesh-list
55920488|NCT03588091|Trastuzumab|trastuzumab|mesh-list
55920489|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920490|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
55806443|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784013|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55784014|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216811|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56216812|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56216813|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55806520|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55920491|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
55920492|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
55920493|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920494|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55920495|NCT05065554|Rituximab|rituximab|mesh-list
55920496|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
55810745|NCT04853355|Diuretics|diuretics|mesh-ancestor
55920497|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55920498|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920499|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
55920500|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920501|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920502|NCT04436172|Anesthetics|anesthetics|mesh-list
55920503|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920504|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920505|NCT04720326|Tacrolimus|tacrolimus|mesh-list
55920506|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920507|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
55813826|NCT02161575|Ranibizumab|ranibizumab|mesh-list
55920508|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920509|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55920510|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920511|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920512|NCT03587779|Sevoflurane|sevoflurane|mesh-list
55920513|NCT03587779|Desflurane|desflurane|mesh-list
55920514|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55920515|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55920534|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920536|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55920537|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
55920538|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
55920539|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920540|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55920541|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
55920542|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920543|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920544|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56200452|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200453|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56200454|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56200455|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200456|NCT01524068|Rituximab|rituximab|mesh-list
55814473|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56200457|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56200458|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200459|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
55920545|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55920546|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55920547|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
55920548|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55920549|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55920553|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
55920554|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
55920555|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
55920556|NCT03581149|Laxatives|laxatives|mesh-list
55814951|NCT04995497|Lidocaine|lidocaine|mesh-list
55920557|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920558|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
55920559|NCT03581149|Protective Agents|protective agents|mesh-ancestor
55920560|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920561|NCT03581149|Vitamins|vitamins|mesh-ancestor
55920562|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
55920563|NCT03581149|Cathartics|cathartics|mesh-ancestor
55920564|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920565|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55920566|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920567|NCT04765267|Vitamin D|vitamin d|mesh-list
55920568|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
55920569|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
55920570|NCT04765267|Vitamins|vitamins|mesh-ancestor
55920571|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
55920572|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920573|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55920639|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920640|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
55920643|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55815103|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
55920644|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920645|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55920646|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920647|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920648|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
55920649|NCT03217201|Methamphetamine|methamphetamine|mesh-list
55920650|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55920651|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920652|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
55920653|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
55920654|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920655|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
55920656|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920657|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920658|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
55920659|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55920660|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55920661|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55920726|NCT05702359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55920727|NCT05702359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56200460|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200461|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200463|NCT01524081|Metronidazole|metronidazole|mesh-list
56200464|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
56200465|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
56200466|NCT01524081|Cefuroxime|cefuroxime|mesh-list
56200467|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
56200468|NCT01524081|Fluconazole|fluconazole|mesh-list
56200469|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56200470|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56200471|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200472|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56200473|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56200474|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
56200475|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56200476|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56200477|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200478|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200479|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56200480|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
56200481|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200482|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200483|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56200484|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55920728|NCT02936388|Cisplatin|cisplatin|mesh-list
55920729|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920730|NCT03586141|Chrysarobin|chrysarobin|mesh-list
55920731|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55920745|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920746|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
55920747|NCT04591626|Dulaglutide|dulaglutide|mesh-list
55920748|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55920749|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920750|NCT04518306|Amlodipine|amlodipine|mesh-list
55920751|NCT04518306|Telmisartan|telmisartan|mesh-list
55920752|NCT04518306|Indapamide|indapamide|mesh-list
55920753|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55920754|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55920755|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55920756|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920757|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55920758|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920759|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
55920760|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55920761|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55920762|NCT04518306|Diuretics|diuretics|mesh-ancestor
55920763|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
56200485|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56200487|NCT01524094|Fluorouracil|fluorouracil|mesh-list
56200488|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
56200489|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
56200490|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
56200491|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200492|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56200493|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200494|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200495|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
56200496|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200497|NCT01524094|Antidotes|antidotes|mesh-ancestor
55920764|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55920765|NCT03580135|Propolis|propolis|mesh-list
55920766|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920767|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55920768|NCT03901573|Atezolizumab|atezolizumab|mesh-list
55920769|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920770|NCT03585829|Prednisolone|prednisolone|mesh-list
55920771|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
55920772|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920773|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
55920774|NCT03585829|Hormones|hormones|mesh-ancestor
55920775|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871308|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
55920776|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920777|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55920778|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920779|NCT05701969|Melatonin|melatonin|mesh-list
55920780|NCT05701969|Antioxidants|antioxidants|mesh-ancestor
55920781|NCT05701969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920782|NCT05701969|Protective Agents|protective agents|mesh-ancestor
55920783|NCT05701969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920784|NCT05701969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920785|NCT03583255|Dexamethasone|dexamethasone|mesh-list
55920786|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
55920787|NCT03583255|Ichthammol|ichthammol|mesh-list
55920788|NCT03583255|BB 1101|bb 1101|mesh-list
55920789|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920790|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
55920791|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
55920792|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920793|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920851|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
55920853|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920854|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
55920855|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
55920856|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
55920857|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920858|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55920859|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55920860|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56216869|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55920861|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55920862|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920863|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
55920864|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
55920865|NCT05701813|Inositol|inositol|mesh-list
55920866|NCT05701813|Vitamin B Complex|vitamin b complex|mesh-ancestor
55920867|NCT05701813|Vitamins|vitamins|mesh-ancestor
55920868|NCT05701813|Micronutrients|micronutrients|mesh-ancestor
55920869|NCT05701813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920870|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
55920871|NCT03586219|Narcotics|narcotics|mesh-ancestor
55920872|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920873|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200498|NCT01524094|Protective Agents|protective agents|mesh-ancestor
56200499|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
55920874|NCT03586219|Analgesics|analgesics|mesh-ancestor
55920875|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
55920876|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920877|NCT05118984|Azithromycin|azithromycin|mesh-list
55784134|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55920878|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55920879|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920880|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55920881|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55920882|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920883|NCT02802852|Lenograstim|lenograstim|mesh-list
55920913|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55920914|NCT05118048|Analgesics|analgesics|mesh-ancestor
55920915|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
55920916|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920917|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920918|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920919|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920920|NCT04405375|Gemcitabine|gemcitabine|mesh-list
55920921|NCT04405375|Dexamethasone|dexamethasone|mesh-list
55920922|NCT04405375|Etoposide|etoposide|mesh-list
55920923|NCT04405375|Pegaspargase|pegaspargase|mesh-list
55920924|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920925|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
55920926|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
55920927|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920953|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920954|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920955|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
55920956|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55920957|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
55920958|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
55920959|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
55920960|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55816027|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920961|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
55920962|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
55920963|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55920964|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55920965|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55920966|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
55920967|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920968|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920969|NCT05118672|Protective Agents|protective agents|mesh-ancestor
55920970|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55920971|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55920972|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55920973|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
55920974|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
55920975|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
55920976|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
55920977|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921000|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921002|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921003|NCT03589495|Antidotes|antidotes|mesh-ancestor
55921004|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55921005|NCT03159559|Alprostadil|alprostadil|mesh-list
55921006|NCT03159559|Clopidogrel|clopidogrel|mesh-list
55921007|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921008|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921009|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55921010|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55921011|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55921012|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55921013|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
55921014|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921015|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
55921016|NCT03159559|Urological Agents|urological agents|mesh-ancestor
55921017|NCT03159403|Oritavancin|oritavancin|mesh-list
55921018|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55921019|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921020|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
55921021|NCT03583567|Ranitidine|ranitidine|mesh-list
55921022|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
55921023|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56200500|NCT01524094|Vitamins|vitamins|mesh-ancestor
56200501|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
56200502|NCT01524237|Ketamine|ketamine|mesh-list
55921024|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55921025|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55921026|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
55921027|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
55921028|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921029|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921030|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921031|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
55921032|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
55921033|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55921043|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55921044|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
55921045|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921046|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921047|NCT03583489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55921048|NCT03583489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55921049|NCT03583489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921050|NCT03583489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55921051|NCT03583489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55921052|NCT03158935|Aldesleukin|aldesleukin|mesh-list
55921053|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
55921054|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
55921055|NCT03158935|Fludarabine|fludarabine|mesh-list
55921056|NCT03158935|Interleukin-2|interleukin-2|mesh-list
55921058|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
55921059|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921060|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55921061|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55921062|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
55921063|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921064|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921065|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55921066|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55921067|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55921068|NCT03158935|Analgesics|analgesics|mesh-ancestor
55921069|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
55743133|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921070|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921071|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55921072|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55921073|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
55921074|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921075|NCT04818372|Dexamethasone|dexamethasone|mesh-list
55921076|NCT04818372|Lenalidomide|lenalidomide|mesh-list
55921077|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55921078|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
55921079|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
55921080|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921081|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921082|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55921083|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
55921085|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921086|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55921087|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921088|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
55921089|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55921090|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55921091|NCT04818372|Growth Substances|growth substances|mesh-ancestor
55921092|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
55921093|NCT05701189|Immunoglobulins|immunoglobulins|mesh-list
55921094|NCT05701189|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55921095|NCT05701189|Antibodies|antibodies|mesh-list
55921096|NCT05701189|gamma-Globulins|gamma-globulins|mesh-list
55921097|NCT05701189|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55921098|NCT05701189|Immunologic Factors|immunologic factors|mesh-ancestor
55817070|NCT02517515|Ritonavir|ritonavir|mesh-list
55921099|NCT05701189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921100|NCT01462578|Azacitidine|azacitidine|mesh-list
55921101|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55921120|NCT03059173|Vitamins|vitamins|mesh-ancestor
55921121|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
55921122|NCT05122338|Lidocaine|lidocaine|mesh-list
56200503|NCT01524237|Analgesics|analgesics|mesh-ancestor
56200504|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
56200505|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200506|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200507|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56200508|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56200509|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
56200510|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
56200511|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921123|NCT05122338|Ropivacaine|ropivacaine|mesh-list
55921124|NCT05122338|Esketamine|esketamine|mesh-list
55921125|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
55921126|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
55921127|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921128|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921129|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
55921130|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921131|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55921132|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55921133|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55921134|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55921135|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817382|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55921136|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
55921137|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55921138|NCT03157843|Heparin|heparin|mesh-list
55921139|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55921140|NCT03157843|Tinzaparin|tinzaparin|mesh-list
55921141|NCT03157843|Dalteparin|dalteparin|mesh-list
55921142|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
55921144|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55921145|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921146|NCT03589027|Ritonavir|ritonavir|mesh-list
55921147|NCT03589027|Darunavir|darunavir|mesh-list
55921148|NCT03589027|Rilpivirine|rilpivirine|mesh-list
55921149|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
55921150|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55921151|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55921152|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
55921153|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921154|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921155|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55921156|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55921157|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
55921158|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921159|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55921160|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55921175|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55817561|NCT02358668|PAZ320|paz320|mesh-list
55921176|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921177|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921178|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
55921179|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
55921180|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921181|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921182|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55921183|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55921184|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
55921185|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55921186|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55921187|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55921188|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55921190|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55921191|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921192|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921193|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
56200512|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56200513|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56200514|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200515|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200517|NCT01524315|Thiamine|thiamine|mesh-list
56200518|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
56200519|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
56200520|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200521|NCT01524354|Anesthetics|anesthetics|mesh-list
56200522|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200523|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200524|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
56200525|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56200526|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200527|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200528|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56200529|NCT01524367|Analgesics|analgesics|mesh-ancestor
56200530|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
56200531|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200532|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56200533|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56200534|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56200535|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
56128318|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921194|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921195|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921196|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55921197|NCT03156439|Protective Agents|protective agents|mesh-ancestor
55921198|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
55921199|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55921200|NCT03156361|Insulin|insulin|mesh-list
55921201|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55921202|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
55921203|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55921204|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921205|NCT05002530|Vitamin D|vitamin d|mesh-list
55921206|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
55921208|NCT05002530|Vitamins|vitamins|mesh-list
55921209|NCT05002530|Tretinoin|tretinoin|mesh-list
55921210|NCT05002530|Isotretinoin|isotretinoin|mesh-list
55921211|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
55921212|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921213|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55921214|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55921215|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921216|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
55921217|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
55921219|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55921220|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200536|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200537|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200538|NCT01524432|Clotrimazole|clotrimazole|mesh-list
56200539|NCT01524432|Miconazole|miconazole|mesh-list
56200540|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
56200541|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56200542|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200543|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56200544|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56200545|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200546|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200547|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56200548|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
56200549|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200550|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200551|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55921221|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921250|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55921252|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55921253|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921254|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
55921255|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
55921256|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
55921257|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921258|NCT03582319|Formaldehyde|formaldehyde|mesh-list
55921259|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
55921260|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921261|NCT00307242|Adefovir|adefovir|mesh-list
55921262|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
55921263|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
55921264|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817869|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
55921265|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55921288|NCT03582007|Murepavadin|murepavadin|mesh-list
55921289|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921290|NCT05120622|Tremelimumab|tremelimumab|mesh-list
55921291|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921292|NCT02895373|Alprostadil|alprostadil|mesh-list
55921294|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
55921295|NCT02895373|Urological Agents|urological agents|mesh-ancestor
55921296|NCT05698771|Niacinamide|niacinamide|mesh-list
55921297|NCT05698771|Niacin|niacin|mesh-list
55921298|NCT05698771|Nicotinic Acids|nicotinic acids|mesh-list
55921299|NCT05698771|Vitamin B Complex|vitamin b complex|mesh-ancestor
55921300|NCT05698771|Vitamins|vitamins|mesh-ancestor
55921301|NCT05698771|Micronutrients|micronutrients|mesh-ancestor
55921302|NCT05698771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921303|NCT05698771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55921304|NCT05698771|Antimetabolites|antimetabolites|mesh-ancestor
55921305|NCT05698771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921306|NCT05698771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55921307|NCT05698771|Vasodilator Agents|vasodilator agents|mesh-ancestor
55921308|NCT05698147|Rituximab|rituximab|mesh-list
55921309|NCT05698147|Methotrexate|methotrexate|mesh-list
55921310|NCT05698147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55921311|NCT05698147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818842|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55921312|NCT05698147|Immunologic Factors|immunologic factors|mesh-ancestor
55921313|NCT05698147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200552|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56200553|NCT01524445|Bortezomib|bortezomib|mesh-list
56200554|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200555|NCT01524497|Trazodone|trazodone|mesh-list
55733025|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
55921314|NCT05698147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55921315|NCT05698147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55921316|NCT05698147|Abortifacient Agents|abortifacient agents|mesh-ancestor
55921317|NCT05698147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55921341|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55921342|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
55921344|NCT04319328|Cefazolin|cefazolin|mesh-list
55921345|NCT04319328|Ceftazidime|ceftazidime|mesh-list
55921346|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55921347|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921348|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55921349|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55921350|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921351|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921352|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921353|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55921354|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55921355|NCT05229510|Ribavirin|ribavirin|mesh-list
55921356|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
55921357|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921358|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
55921359|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921360|NCT05229276|Bone wax|bone wax|mesh-list
55921361|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
55921362|NCT05229276|Coagulants|coagulants|mesh-ancestor
55921363|NCT03581773|Folic Acid|folic acid|mesh-list
55921364|NCT03581773|Hematinics|hematinics|mesh-ancestor
55921365|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
55921366|NCT03581773|Vitamins|vitamins|mesh-ancestor
55921367|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
55921368|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921369|NCT04425174|Anesthetics|anesthetics|mesh-list
55921392|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921393|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55921394|NCT02788591|Esomeprazole|esomeprazole|mesh-list
55921395|NCT02788591|Omeprazole|omeprazole|mesh-list
55921396|NCT02788591|Pantoprazole|pantoprazole|mesh-list
55921397|NCT02788591|Lansoprazole|lansoprazole|mesh-list
55921398|NCT02788591|Sucralfate|sucralfate|mesh-list
55921399|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55921400|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55921401|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55921402|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921403|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921404|NCT05229042|Ricolinostat|ricolinostat|mesh-list
55921405|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921406|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55921407|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921408|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921409|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
55921410|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
55921411|NCT03267498|Nivolumab|nivolumab|mesh-list
55921412|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921413|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55921414|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55921415|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921416|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55921417|NCT03076164|Trametinib|trametinib|mesh-list
55921418|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921419|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55921420|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921421|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921422|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55921423|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55921443|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200556|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56200557|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56200558|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200559|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200560|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56200561|NCT01524497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56200562|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56200563|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200564|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921445|NCT02939742|Hormones|hormones|mesh-ancestor
55921446|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921447|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921448|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55921449|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
55921450|NCT01670929|Progesterone|progesterone|mesh-list
55921451|NCT01670929|Progestins|progestins|mesh-ancestor
55921452|NCT01670929|Hormones|hormones|mesh-ancestor
55921453|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921454|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921455|NCT02673996|Phenylephrine|phenylephrine|mesh-list
55921456|NCT02673996|Isoproterenol|isoproterenol|mesh-list
55921457|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
55921458|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55921459|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
55921460|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
55921461|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921462|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921463|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
55921464|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55921465|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
55921466|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
55921467|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55921468|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55921469|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55921470|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
55921471|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921472|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921473|NCT02673996|Protective Agents|protective agents|mesh-ancestor
55921474|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55921475|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55921476|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55921477|NCT05633563|Trimetazidine|trimetazidine|mesh-list
55921478|NCT05633563|Vasodilator Agents|vasodilator agents|mesh-ancestor
55921479|NCT05632627|Cannabidiol|cannabidiol|mesh-list
55921504|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921505|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819502|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55921506|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
55921507|NCT05220319|Hormones|hormones|mesh-ancestor
55921508|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921509|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55921510|NCT05220319|Protective Agents|protective agents|mesh-ancestor
55921511|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55921512|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921513|NCT04543591|Ravulizumab|ravulizumab|mesh-list
55921514|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55921515|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55921516|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
55921517|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921518|NCT03155035|Vitamin D|vitamin d|mesh-list
55921519|NCT03155035|Albendazole|albendazole|mesh-list
55921520|NCT03155035|Calcium|calcium|mesh-list
55921521|NCT03155035|Vitamins|vitamins|mesh-ancestor
55921522|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
55921523|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819593|NCT02421419|Hormones|hormones|mesh-ancestor
56200565|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200566|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
56200567|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56200568|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
56200569|NCT01524575|Gemcitabine|gemcitabine|mesh-list
56200570|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
56200571|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56200572|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
56200573|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200574|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200575|NCT01524575|Antiviral Agents|antiviral agents|mesh-ancestor
55921524|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55921525|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55921526|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
55819650|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55921527|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55921528|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921529|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
55921530|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55921567|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55921568|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
55921569|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921627|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
55921628|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55921629|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55921630|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
55921631|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55921632|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55921633|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921634|NCT05222256|Protective Agents|protective agents|mesh-ancestor
55921635|NCT01671787|Tenofovir|tenofovir|mesh-list
55921656|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55921657|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921658|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55921659|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55921660|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
55921661|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55921662|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
55921663|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55921664|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55921665|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55921666|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55921667|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
55921668|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55921669|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55921670|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
55921671|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921672|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
55921673|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55921674|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55784307|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921675|NCT02570503|Ketorolac|ketorolac|mesh-list
55921676|NCT02570503|Clonidine|clonidine|mesh-list
55921677|NCT02570503|Epinephrine|epinephrine|mesh-list
55921678|NCT02570503|Ropivacaine|ropivacaine|mesh-list
55921679|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
55921680|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
55921681|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921682|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921683|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
55921684|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921685|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55921686|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55921687|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
55921688|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200576|NCT01524575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200577|NCT01524575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200578|NCT01524575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200579|NCT01524575|Immunologic Factors|immunologic factors|mesh-ancestor
56200580|NCT01524575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200581|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56200582|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56200583|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56200584|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
56200585|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200586|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56200587|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56200588|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200589|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56200590|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56200591|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56200592|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
56200593|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200594|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56200595|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56200596|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200597|NCT01524705|Insulin|insulin|mesh-list
56200598|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56200599|NCT01524705|Metformin|metformin|mesh-list
56200600|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
56200601|NCT01524705|Exenatide|exenatide|mesh-list
56200602|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56200603|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56200604|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200605|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56200606|NCT01524705|Incretins|incretins|mesh-ancestor
56200607|NCT01524705|Hormones|hormones|mesh-ancestor
56200608|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200609|NCT01524731|Dexamethasone|dexamethasone|mesh-list
56200611|NCT01524731|BB 1101|bb 1101|mesh-list
55921715|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921716|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55921717|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56200612|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200613|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
56200614|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
55733256|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55921718|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55921719|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
55921720|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921721|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921722|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
55921723|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55921724|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
55921725|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921726|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
55921727|NCT05561179|Protective Agents|protective agents|mesh-ancestor
55921728|NCT02467153|Vitamin D|vitamin d|mesh-list
55921729|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
55921730|NCT02467153|Vitamins|vitamins|mesh-ancestor
55921731|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
55820222|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55820225|NCT02367131|Empagliflozin|empagliflozin|mesh-list
55921732|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921733|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55921734|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55921735|NCT04933903|Nivolumab|nivolumab|mesh-list
55921736|NCT04933903|Ipilimumab|ipilimumab|mesh-list
55921760|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55921761|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921762|NCT05391061|Abrocitinib|abrocitinib|mesh-list
55921763|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55921764|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921765|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921766|NCT03463525|Osimertinib|osimertinib|mesh-list
55921767|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921768|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55921769|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921770|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921771|NCT01675128|Irinotecan|irinotecan|mesh-list
55921772|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55921773|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55921774|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921775|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921776|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921777|NCT02626507|Fulvestrant|fulvestrant|mesh-list
55921778|NCT02626507|Goserelin|goserelin|mesh-list
55921779|NCT02626507|Palbociclib|palbociclib|mesh-list
55921780|NCT02626507|Gedatolisib|gedatolisib|mesh-list
55921781|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55921782|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921783|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55820502|NCT02359877|Interferons|interferons|mesh-list
55921784|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55921785|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
55921786|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921787|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921812|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921814|NCT04764955|Vitamin D|vitamin d|mesh-list
55921815|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
55921816|NCT04764955|Vitamins|vitamins|mesh-ancestor
55921817|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
55921818|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921819|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55921820|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55921821|NCT03126331|Nivolumab|nivolumab|mesh-list
55921822|NCT03126331|Ipilimumab|ipilimumab|mesh-list
55921823|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55921824|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921825|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55921826|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921827|NCT01674127|Methyldopa|methyldopa|mesh-list
55802107|NCT04803175|Valsartan|valsartan|mesh-list
55921828|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55921829|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
55921830|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
55921831|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200615|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200616|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200617|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56200618|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
56200619|NCT01524731|Hormones|hormones|mesh-ancestor
56200620|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200621|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56200622|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200623|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
56200624|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921832|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921833|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55921834|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55921835|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55921890|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921891|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921893|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55921894|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921895|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55921896|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55921898|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55921899|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55921900|NCT01427309|Vaccines|vaccines|mesh-list
55921901|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
55921902|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921903|NCT01675219|Mitomycins|mitomycins|mesh-list
55921904|NCT01675219|Mitomycin|mitomycin|mesh-list
55921905|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55921906|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921907|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
55921908|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921909|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55921910|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921932|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
55921933|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55921934|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55921935|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
55921936|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921937|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
55921938|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921939|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55921940|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55921941|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
55921942|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55921943|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55921944|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
55921945|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55921946|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55921947|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921948|NCT03852901|Empagliflozin|empagliflozin|mesh-list
55921949|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55921950|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921951|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55921952|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921953|NCT01675999|Leucovorin|leucovorin|mesh-list
55921954|NCT01675999|Cetuximab|cetuximab|mesh-list
55921955|NCT01675999|Fluorouracil|fluorouracil|mesh-list
55921956|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
55921957|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55921958|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921959|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
55921960|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200625|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200627|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56200628|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56200629|NCT01524744|Analgesics|analgesics|mesh-ancestor
55784468|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821467|NCT04907851|Pembrolizumab|pembrolizumab|mesh-list
56200630|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
56200631|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200632|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200633|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200634|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200635|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56200636|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200637|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
56200638|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56200639|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200640|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921988|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
55921989|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921990|NCT04404751|Trace Elements|trace elements|mesh-ancestor
55921991|NCT04404751|Hematinics|hematinics|mesh-ancestor
55921992|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
55921993|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
55921994|NCT01403051|Vitamin D|vitamin d|mesh-list
55921995|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
55921996|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
55921997|NCT01403051|Vitamins|vitamins|mesh-list
55921998|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
55921999|NCT01403051|Calcium|calcium|mesh-list
55922000|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
55922001|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922002|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55922003|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55922004|NCT01403051|Antacids|antacids|mesh-ancestor
55922005|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922006|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55922007|NCT03873337|Nicotine|nicotine|mesh-list
55922008|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55922009|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
55922010|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922011|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922012|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55922013|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55922014|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
55922027|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922028|NCT03838159|Paclitaxel|paclitaxel|mesh-list
55922029|NCT03838159|Carboplatin|carboplatin|mesh-list
55922030|NCT03838159|Nivolumab|nivolumab|mesh-list
55922031|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55922032|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922033|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
55922034|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
55922035|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922036|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922037|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55922038|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55922039|NCT04747015|Oxytocin|oxytocin|mesh-list
55922040|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
55922041|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55922042|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200641|NCT01524757|Pantoprazole|pantoprazole|mesh-list
56200642|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56200643|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56200644|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56200645|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200646|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200647|NCT01524809|Insulin|insulin|mesh-list
55821546|NCT01731886|Dexamethasone|dexamethasone|mesh-list
56200648|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56200649|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
56200650|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
56200651|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56200653|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56200654|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56200655|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200656|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
56200657|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
56200658|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
56200659|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200660|NCT01524861|Protective Agents|protective agents|mesh-ancestor
56200661|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200662|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
56200663|NCT01524861|Vitamins|vitamins|mesh-ancestor
56200664|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
56200665|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
55922043|NCT03754933|Fludarabine|fludarabine|mesh-list
55922044|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
55922045|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922046|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55922047|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
55922048|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922049|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922050|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
55922051|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922052|NCT03870919|Palbociclib|palbociclib|mesh-list
55821559|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55821561|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
55922053|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922054|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55922055|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922056|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922057|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
55922058|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55922059|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922060|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922061|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55922062|NCT04747171|Analgesics|analgesics|mesh-ancestor
55922063|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
55922064|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922065|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55922066|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55922067|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56200666|NCT01524874|Vitamin D|vitamin d|mesh-list
56200667|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
56200668|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
56200669|NCT01524874|Calcitriol|calcitriol|mesh-list
56200670|NCT01524874|Vitamins|vitamins|mesh-list
56200671|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
55733500|NCT04418128|Analgesics|analgesics|mesh-ancestor
55922068|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
55922069|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821697|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55922070|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922071|NCT02082769|Allopurinol|allopurinol|mesh-list
55922072|NCT02082769|Febuxostat|febuxostat|mesh-list
55922073|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
55922074|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922075|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922076|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
55922129|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
55922130|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821862|NCT05652751|Mitosis Modulators|mitosis modulators|mesh-ancestor
55821868|NCT02909335|Prednisone|prednisone|mesh-list
55922131|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922132|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922133|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922134|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55922135|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55922137|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55922138|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55922139|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922141|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55922142|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55922143|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55922144|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
55922145|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922146|NCT03742297|Dexamethasone|dexamethasone|mesh-list
55922147|NCT03742297|Prednisone|prednisone|mesh-list
55922148|NCT03742297|Lenalidomide|lenalidomide|mesh-list
55922149|NCT03742297|Bortezomib|bortezomib|mesh-list
55922150|NCT03742297|Melphalan|melphalan|mesh-list
55922151|NCT03742297|Daratumumab|daratumumab|mesh-list
55922152|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922153|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
55922154|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
55922155|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922156|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922157|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55922158|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
55922159|NCT03742297|Hormones|hormones|mesh-ancestor
55922160|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55922161|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55922162|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922163|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
55922164|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55922186|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922187|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
55922188|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55922189|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
55922190|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
55922191|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922192|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922193|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55922194|NCT03826693|Analgesics|analgesics|mesh-ancestor
55922195|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
55922196|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922197|NCT03423264|Gabapentin|gabapentin|mesh-list
55922198|NCT03423264|Analgesics|analgesics|mesh-ancestor
55922199|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
55922200|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922201|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922202|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
55922203|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55922204|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55922205|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200672|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200673|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56200674|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56200675|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55733574|NCT02824679|Scopolamine|scopolamine|mesh-list
55922206|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55922207|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55922208|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55922209|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922210|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922211|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
55922212|NCT03660553|Insulin|insulin|mesh-list
55922214|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
55822035|NCT04661397|Tenofovir|tenofovir|mesh-list
55922215|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
55922216|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
55922217|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55922218|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922219|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55922234|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
55922235|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
55922236|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55922237|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55922238|NCT03825757|Analgesics|analgesics|mesh-ancestor
55922239|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
55922240|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922241|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922242|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922243|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922244|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55922245|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922246|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922247|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55922248|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55922249|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55922250|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
55922251|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55922252|NCT03657433|Hematinics|hematinics|mesh-ancestor
55922253|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55922254|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55922255|NCT04827030|Ropivacaine|ropivacaine|mesh-list
55922256|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
55922257|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
55922258|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922259|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922260|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
55922261|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922262|NCT03820141|Trastuzumab|trastuzumab|mesh-list
55922263|NCT03820141|Durvalumab|durvalumab|mesh-list
55922264|NCT03820141|Pertuzumab|pertuzumab|mesh-list
55922265|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55922266|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922268|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55922269|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922270|NCT03818191|Acamprosate|acamprosate|mesh-list
55922271|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55922272|NCT02398656|Tenecteplase|tenecteplase|mesh-list
55922273|NCT02398656|Clopidogrel|clopidogrel|mesh-list
55922274|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55922275|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55922276|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55922277|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55922278|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
55922279|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922280|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922281|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922310|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
55922311|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922312|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200676|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200677|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200679|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
56200680|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56200681|NCT01524939|Antibodies|antibodies|mesh-list
56200682|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
56200683|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
56200684|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200685|NCT01525004|Vaccines|vaccines|mesh-list
56200686|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
56200687|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200688|NCT01525043|Naproxen|naproxen|mesh-list
56200689|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56200690|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56200691|NCT01525043|Analgesics|analgesics|mesh-ancestor
55733640|NCT04503707|Hormones|hormones|mesh-ancestor
55922313|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55922314|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55922316|NCT03805399|Paclitaxel|paclitaxel|mesh-list
55922317|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55922318|NCT03805399|Capecitabine|capecitabine|mesh-list
55922319|NCT03805399|Everolimus|everolimus|mesh-list
55922320|NCT03805399|Apatinib|apatinib|mesh-list
55922321|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55922322|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55922323|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922324|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
55922325|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
55922326|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922327|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922328|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55922329|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
55922330|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822635|NCT01545271|Xenon|xenon|mesh-list
55822636|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55922359|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922360|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922361|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
55922362|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922363|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922364|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55922365|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
55922366|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55922367|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55922368|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55922369|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55922370|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922371|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55922372|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55922373|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
55922374|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922375|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55922376|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55922388|NCT03637075|Insulin|insulin|mesh-list
55922389|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55922414|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922415|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922416|NCT01279551|Lidocaine|lidocaine|mesh-list
55922417|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
55922418|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
56200692|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
55822940|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56200693|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200694|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200695|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200696|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200697|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
55922419|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
55922420|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922421|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922422|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
55922423|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922424|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55922425|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55922426|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55922427|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55922428|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922429|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
55922430|NCT03738696|Bupivacaine|bupivacaine|mesh-list
55922431|NCT03738696|Ropivacaine|ropivacaine|mesh-list
55922432|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
55922433|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
55922434|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922435|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922436|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
55922437|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922438|NCT00780403|Cetirizine|cetirizine|mesh-list
55922439|NCT00780403|Desloratadine|desloratadine|mesh-list
55922461|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922462|NCT01979796|Nicotine|nicotine|mesh-list
55922463|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55922464|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
55922465|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922466|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922467|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55922468|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55922470|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922471|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922472|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
55922473|NCT03630211|Thiotepa|thiotepa|mesh-list
55922474|NCT03630211|Rituximab|rituximab|mesh-list
55922475|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
55922476|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
55922477|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55922478|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
55922479|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55922480|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
55922481|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55922482|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922483|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
55922484|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922485|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922486|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55922487|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
55922488|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922489|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922490|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55922491|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55922492|NCT03628339|Tepotinib|tepotinib|mesh-list
55922493|NCT03628339|Midazolam|midazolam|mesh-list
55922494|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55922521|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55823258|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922522|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
55922524|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55922525|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55922526|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922527|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
55922528|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922529|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200698|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56200699|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200700|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200701|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56200702|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56200703|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56200704|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200706|NCT01525394|Lenvatinib|lenvatinib|mesh-list
56200707|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56200708|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200709|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56200710|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56200711|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200712|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200713|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200714|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56200715|NCT01525537|Sufentanil|sufentanil|mesh-list
55922530|NCT03627715|Proxigermanium|proxigermanium|mesh-list
55922531|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922532|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
55922533|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
55922534|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922535|NCT00246753|Lapatinib|lapatinib|mesh-list
55922536|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922537|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55922538|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922539|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922540|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
55922541|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55922542|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55922543|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
55922544|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922565|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
55922566|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922567|NCT03783715|Ketoprofen|ketoprofen|mesh-list
55922568|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55922569|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55922570|NCT03783715|Analgesics|analgesics|mesh-ancestor
55922571|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
55922572|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922573|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922574|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922575|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922576|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55922577|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922578|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922579|NCT01279629|Tazarotene|tazarotene|mesh-list
55922580|NCT01279629|Calcipotriene|calcipotriene|mesh-list
55922581|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
55922582|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
55922583|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55922584|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55922585|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
56200717|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56200718|NCT01525537|Narcotics|narcotics|mesh-ancestor
56200719|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200720|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200721|NCT01525537|Analgesics|analgesics|mesh-ancestor
56200722|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
56200723|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200724|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55922586|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922587|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922588|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55922589|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
55922590|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
55922591|NCT01274325|Hormones|hormones|mesh-ancestor
55922592|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55922593|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
55784603|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55922594|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
55922595|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922596|NCT01274403|Thalidomide|thalidomide|mesh-list
55922597|NCT01274403|Prednisone|prednisone|mesh-list
55922598|NCT01274403|Melphalan|melphalan|mesh-list
55922599|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922623|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922624|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922625|NCT01274481|Iloprost|iloprost|mesh-list
55922626|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55922627|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
55922628|NCT00245583|Topiramate|topiramate|mesh-list
55922629|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
55922630|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55922631|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922632|NCT01379989|Carboplatin|carboplatin|mesh-list
55922633|NCT01379989|Doxorubicin|doxorubicin|mesh-list
55922634|NCT01379989|Trabectedin|trabectedin|mesh-list
55922635|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922636|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55922637|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55922638|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55922639|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784649|NCT05084365|Sulforaphane|sulforaphane|mesh-list
55922640|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922641|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55922642|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
55922643|NCT00754845|Letrozole|letrozole|mesh-list
55922644|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922645|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55922646|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55922647|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922648|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922649|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55922650|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
55922682|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922683|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922684|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55922685|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55922686|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922687|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922688|NCT03699319|Antidotes|antidotes|mesh-ancestor
55922689|NCT03699319|Protective Agents|protective agents|mesh-ancestor
55922691|NCT03699319|Vitamins|vitamins|mesh-ancestor
55922692|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
55922693|NCT03699319|Hematinics|hematinics|mesh-ancestor
55922694|NCT00754923|Sorafenib|sorafenib|mesh-list
55922695|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922696|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55922724|NCT01274793|Mosapride|mosapride|mesh-list
55922725|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200725|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56200726|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
56200727|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
56200728|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
56200729|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922726|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55922727|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55922728|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
55922729|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922730|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922731|NCT00746889|Triamcinolone|triamcinolone|mesh-list
55922732|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55922733|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55922734|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55922735|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922736|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
55922737|NCT00746889|Hormones|hormones|mesh-ancestor
55922738|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55922739|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922740|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922741|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
55922742|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922769|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55922770|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922771|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922772|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
55922774|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922775|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
55922776|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922777|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922778|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55784704|NCT04985201|Irinotecan|irinotecan|mesh-list
55922779|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
55922780|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922781|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922782|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55922783|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55922784|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55922785|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922786|NCT00244881|Cediranib|cediranib|mesh-list
55922787|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922788|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922789|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823981|NCT01642589|Vaccines|vaccines|mesh-list
55922790|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55922791|NCT00530517|Sumatriptan|sumatriptan|mesh-list
55922816|NCT03765541|Hormones|hormones|mesh-ancestor
55922817|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55922818|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55922819|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922820|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55922821|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
55922822|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922823|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
55922824|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922825|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922826|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
55922827|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922828|NCT05123976|Olanzapine|olanzapine|mesh-list
55922829|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
55922830|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
55922831|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922832|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922833|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55922834|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55922835|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55922836|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922837|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55922839|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55922840|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200731|NCT01525706|Paclitaxel|paclitaxel|mesh-list
56200732|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56200733|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56200734|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200735|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
56200736|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
56200737|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922841|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922842|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922843|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
55922883|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
55922906|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55922907|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55922908|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922909|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
55922910|NCT05126004|Azacitidine|azacitidine|mesh-list
55922911|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55922912|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55922913|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
55922914|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922915|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922916|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824183|NCT02194465|Spironolactone|spironolactone|mesh-list
55922917|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
55922918|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922919|NCT05126004|Expectorants|expectorants|mesh-ancestor
55922920|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
55922921|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55922922|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
55922923|NCT05126004|Protective Agents|protective agents|mesh-ancestor
55922924|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922925|NCT05126004|Antidotes|antidotes|mesh-ancestor
55922926|NCT03672643|Crizotinib|crizotinib|mesh-list
55922927|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922928|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55922929|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922930|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922931|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
55922932|NCT00350701|Testosterone|testosterone|mesh-list
55922933|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
55922934|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
55922935|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55922936|NCT00350701|Androgens|androgens|mesh-ancestor
55922937|NCT00350701|Hormones|hormones|mesh-ancestor
55922938|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55922939|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922940|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55922968|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
55922969|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55922970|NCT03666559|Azacitidine|azacitidine|mesh-list
55922971|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55922972|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
55922973|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922974|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922975|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922976|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
55922977|NCT04187898|Docetaxel|docetaxel|mesh-list
55922978|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922979|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
55922980|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922981|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922982|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55922983|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
55922984|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922985|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923006|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55923008|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
55923009|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
56200738|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200739|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56200740|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200741|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200742|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200743|NCT01525719|Everolimus|everolimus|mesh-list
56200744|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200745|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200746|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
56200747|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200748|NCT01525771|Cisplatin|cisplatin|mesh-list
56200749|NCT01525771|Docetaxel|docetaxel|mesh-list
56200750|NCT01525771|Capecitabine|capecitabine|mesh-list
55923010|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
55923011|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923012|NCT01679899|Vildagliptin|vildagliptin|mesh-list
55923013|NCT01679899|Gliclazide|gliclazide|mesh-list
55923014|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55923015|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923016|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55923017|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
55923018|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923019|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923020|NCT01276821|Epinephrine|epinephrine|mesh-list
55923021|NCT01276821|Racepinephrine|racepinephrine|mesh-list
55923022|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
55923023|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55923024|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55923025|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
55923026|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923027|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923028|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923029|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55923030|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55923031|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
55923032|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923033|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55923034|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
55923035|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
55923036|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
55923037|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55923038|NCT00245037|Cyclosporine|cyclosporine|mesh-list
55923039|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
55923040|NCT00245037|Methotrexate|methotrexate|mesh-list
55923041|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
55923063|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923064|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55923065|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55824391|NCT02260154|Alverine|alverine|mesh-list
55923066|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55923067|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
55923068|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55923069|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
55923070|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55923071|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55923072|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55923073|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
55923074|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55923075|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55923076|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923077|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55923078|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55923079|NCT03532399|Bivalirudin|bivalirudin|mesh-list
56200751|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200752|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
56200753|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
56200754|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
56200755|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200756|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56200757|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
56200758|NCT01525823|Metformin|metformin|mesh-list
56200759|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56200760|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200761|NCT01525836|Rituximab|rituximab|mesh-list
56200762|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56200763|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200765|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200766|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200767|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56200768|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56200769|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56200770|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200771|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
55923080|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
55923081|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55923082|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
55923083|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923084|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923085|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
55923086|NCT00241839|Allopurinol|allopurinol|mesh-list
55923087|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
55923088|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
55923089|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923090|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824524|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824530|NCT01641692|Albuterol|albuterol|mesh-list
55923091|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
55923092|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55923093|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55923094|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
55923095|NCT00241839|Protective Agents|protective agents|mesh-ancestor
55923117|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55923118|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
55923119|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55923120|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923121|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55824545|NCT01682512|Rituximab|rituximab|mesh-list
55923122|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
55923123|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55923124|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55923125|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55923126|NCT01276353|Donepezil|donepezil|mesh-list
55923127|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55923128|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923129|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923130|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
55923131|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923132|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923133|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
56200772|NCT01525914|Dutasteride|dutasteride|mesh-list
56200773|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56200774|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56200775|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200776|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200777|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
56200778|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200779|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200780|NCT01526005|Nicotine|nicotine|mesh-list
56200781|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56200782|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
56200783|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200784|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200785|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56200786|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56200787|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
56200788|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200789|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200790|NCT01526070|Aflibercept|aflibercept|mesh-list
56200791|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56200792|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56200793|NCT01526070|Growth Substances|growth substances|mesh-ancestor
56200794|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200795|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
55923134|NCT03809013|Trastuzumab|trastuzumab|mesh-list
55923135|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55923136|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923137|NCT03807921|Aspirin|aspirin|mesh-list
55923138|NCT03807921|Warfarin|warfarin|mesh-list
55923139|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55923140|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55923141|NCT03807921|Analgesics|analgesics|mesh-ancestor
55923142|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
55923143|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923144|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824776|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
55923145|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55923146|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55923147|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55923148|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55923176|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55923177|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55923178|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
55923179|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923180|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55923181|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
55923183|NCT03458455|Ipilimumab|ipilimumab|mesh-list
55923184|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55923185|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923186|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56200796|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200797|NCT01526083|Lacosamide|lacosamide|mesh-list
56200798|NCT01526083|Warfarin|warfarin|mesh-list
56200799|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
56200800|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
56200801|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56200802|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56200803|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200804|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200805|NCT01526096|Plerixafor|plerixafor|mesh-list
55923187|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784805|NCT05635955|Esketamine|esketamine|mesh-list
55923188|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55923189|NCT02536794|Durvalumab|durvalumab|mesh-list
55923190|NCT02536794|Ipilimumab|ipilimumab|mesh-list
55923191|NCT02536794|Tremelimumab|tremelimumab|mesh-list
55923192|NCT02536794|Antibodies|antibodies|mesh-list
55923193|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
55923194|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55923195|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
55923196|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923221|NCT05125380|Lugol's solution|lugol's solution|mesh-list
55923222|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55923223|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923224|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55923225|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
55923226|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923227|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55923228|NCT05125380|Protective Agents|protective agents|mesh-ancestor
55923229|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923230|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
55923231|NCT05125380|Coagulants|coagulants|mesh-ancestor
55923232|NCT00762645|Travoprost|travoprost|mesh-list
55923233|NCT00762645|Pilocarpine|pilocarpine|mesh-list
55923234|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55923235|NCT00762645|Miotics|miotics|mesh-ancestor
55923236|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
55923237|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923238|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923239|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55923240|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55923241|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
55923242|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825099|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55825100|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923243|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923244|NCT02403193|Spartalizumab|spartalizumab|mesh-list
55923245|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55923269|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55923271|NCT03573349|Analgesics|analgesics|mesh-ancestor
55923272|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
55923273|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923274|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923275|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55923276|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55923277|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
55923278|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
55923279|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923280|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55923281|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55923282|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923283|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923284|NCT05387148|Cannabidiol|cannabidiol|mesh-list
55923285|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
55923287|NCT03458221|Everolimus|everolimus|mesh-list
55923288|NCT03458221|Letrozole|letrozole|mesh-list
55923289|NCT03458221|Bicalutamide|bicalutamide|mesh-list
55923290|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923291|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55923292|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
56200807|NCT01526096|Basiliximab|basiliximab|mesh-list
56200808|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56200809|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
56200810|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200811|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200812|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56200813|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200814|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
56200815|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200816|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56200817|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56200818|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
56200819|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56200820|NCT01526122|Aspirin|aspirin|mesh-list
56200821|NCT01526122|Clopidogrel|clopidogrel|mesh-list
56200822|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56200823|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56200824|NCT01526122|Analgesics|analgesics|mesh-ancestor
55923293|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923294|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55923295|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55923296|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923319|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923320|NCT03513445|Analgesics|analgesics|mesh-ancestor
55923321|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
55923322|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923323|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55923325|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
55923326|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923327|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923328|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55923329|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55923330|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
55923331|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55923332|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
55923333|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
55923334|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
55923335|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55923336|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
55923337|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
55923338|NCT03802071|Doxorubicin|doxorubicin|mesh-list
55923339|NCT03802071|Durvalumab|durvalumab|mesh-list
55923340|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55923341|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923342|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55923343|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55923344|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923345|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923346|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55923347|NCT03809793|Acipimox|acipimox|mesh-list
55923348|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55923378|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55923379|NCT03508921|Renal Agents|renal agents|mesh-ancestor
55923380|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
55923381|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55923382|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56200825|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
56200826|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200827|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200828|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200829|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200830|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56200831|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56200832|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128555|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55734335|NCT03448705|Vaccines|vaccines|mesh-list
55923383|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55923384|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923385|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55923386|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55923387|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55923388|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55825568|NCT02159365|Hormones|hormones|mesh-ancestor
55923389|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55923390|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923391|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
55923392|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
55923393|NCT04412850|Analgesics|analgesics|mesh-ancestor
55923428|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
55923429|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55923431|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
55923482|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55923483|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
55923484|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
55923485|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923486|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923487|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
55923488|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923489|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55923490|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55923491|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55923492|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923493|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923494|NCT03807999|Gemcitabine|gemcitabine|mesh-list
55923495|NCT03807999|Paclitaxel|paclitaxel|mesh-list
55923496|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55923497|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923498|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
55923499|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
55923500|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
55923501|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923502|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55923503|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
55923504|NCT03807999|Antiviral Agents|antiviral agents|mesh-ancestor
55923505|NCT03807999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923506|NCT03807999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923507|NCT03807999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55923508|NCT03807999|Immunologic Factors|immunologic factors|mesh-ancestor
55923509|NCT03807999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923510|NCT04901988|Nivolumab|nivolumab|mesh-list
55923511|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55923512|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923513|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55923514|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923515|NCT04762147|Acetaminophen|acetaminophen|mesh-list
55923546|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923547|NCT04183062|Gemcitabine|gemcitabine|mesh-list
55923549|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55923550|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
56200833|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56200834|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56200835|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200836|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
56200837|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56200838|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56200839|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56200840|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
56200841|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200842|NCT01526161|Fluticasone|fluticasone|mesh-list
56200843|NCT01526161|Xhance|xhance|mesh-list
56200844|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56200845|NCT01526161|Montelukast|montelukast|mesh-list
55825626|NCT04803734|Albuterol|albuterol|mesh-list
56200846|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200847|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56200848|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
56200849|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200850|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200851|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56200852|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
56200853|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
55923551|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923552|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923553|NCT04183062|Antiviral Agents|antiviral agents|mesh-ancestor
55923554|NCT04183062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923555|NCT04183062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923556|NCT04183062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55923557|NCT04183062|Immunologic Factors|immunologic factors|mesh-ancestor
55923558|NCT04183062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923559|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
55923560|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
55923561|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
55923563|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
55923594|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55923595|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
55923596|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923597|NCT02512692|Antiviral Agents|antiviral agents|mesh-ancestor
55923598|NCT02512692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923599|NCT02512692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923600|NCT02512692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55923601|NCT02512692|Immunologic Factors|immunologic factors|mesh-ancestor
55923602|NCT02512692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923603|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55923604|NCT01594398|Exemestane|exemestane|mesh-list
55923605|NCT01594398|Entinostat|entinostat|mesh-list
55923606|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923631|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
55923632|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
55923633|NCT00782379|Busulfan|busulfan|mesh-list
55923634|NCT00782379|Fludarabine|fludarabine|mesh-list
55923635|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
55923636|NCT00782379|Tacrolimus|tacrolimus|mesh-list
55923637|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55923638|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
55784849|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
55923639|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923640|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200854|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56200855|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56200856|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56200857|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56200858|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
56200859|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200860|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200861|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56200862|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
56200863|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734452|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
55784869|NCT03013933|Verapamil|verapamil|mesh-list
55923641|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55923642|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
55923643|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923644|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923645|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55923646|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55923647|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
55923648|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55923649|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923650|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55923651|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55923652|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
55923653|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55923671|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55923672|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923673|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923674|NCT05134194|Gemcitabine|gemcitabine|mesh-list
55923675|NCT05134194|Capecitabine|capecitabine|mesh-list
55923676|NCT05134194|Vinorelbine|vinorelbine|mesh-list
55923677|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55923678|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
55826210|NCT04619979|Anesthetics|anesthetics|mesh-list
55923679|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826335|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55923680|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923681|NCT05134194|Antiviral Agents|antiviral agents|mesh-ancestor
55923682|NCT05134194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923683|NCT05134194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923684|NCT05134194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55923685|NCT05134194|Immunologic Factors|immunologic factors|mesh-ancestor
55923686|NCT05134194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923687|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55923688|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
55923689|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
55923690|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
55923691|NCT04435704|Oxytocin|oxytocin|mesh-list
55923692|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
55923693|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55923694|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923695|NCT00761085|Morphine|morphine|mesh-list
55923696|NCT00761085|Methadone|methadone|mesh-list
55923697|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55923698|NCT00761085|Narcotics|narcotics|mesh-ancestor
55923699|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923700|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923701|NCT00761085|Analgesics|analgesics|mesh-ancestor
55923702|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
55923703|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923704|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
55923705|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
55923706|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
55923707|NCT02145039|Fludarabine|fludarabine|mesh-list
55923708|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200864|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56200865|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56200867|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56200868|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734525|NCT04602533|Durvalumab|durvalumab|mesh-list
55923709|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
55826628|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
55923710|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923711|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55923731|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923732|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
55923733|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55923734|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923735|NCT00089479|Capecitabine|capecitabine|mesh-list
55923736|NCT00089479|Docetaxel|docetaxel|mesh-list
55923737|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55923738|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
55923739|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923740|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923741|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
55923742|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
55923743|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
55923744|NCT01463306|Pregabalin|pregabalin|mesh-list
55923745|NCT01463306|Analgesics|analgesics|mesh-ancestor
55923746|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
55923747|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923748|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923749|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
55923750|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55923751|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923752|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923753|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55923754|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55923755|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55923756|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923757|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55923758|NCT05055726|Benzydamine|benzydamine|mesh-list
55923759|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55923760|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
55923761|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55923762|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55923763|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55923764|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923789|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55923790|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923791|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55923793|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
55923794|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55923795|NCT05744115|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55923796|NCT05744115|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55743193|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923797|NCT05744115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923798|NCT01677559|Paclitaxel|paclitaxel|mesh-list
55923799|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55826992|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55923800|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923801|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
55923802|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
55923803|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
55923804|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923805|NCT05132712|Losartan|losartan|mesh-list
55923806|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55923807|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55923808|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55923810|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923812|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55923813|NCT02149173|Fluorides|fluorides|mesh-list
55923837|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200869|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200870|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
56200871|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200872|NCT01526278|Alendronate|alendronate|mesh-list
56200873|NCT01526278|Calcitriol|calcitriol|mesh-list
56200874|NCT01526278|Maxmarvil|maxmarvil|mesh-list
55923839|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55923840|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923841|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923842|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55923843|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55923844|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55923845|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923846|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55827135|NCT05619653|Hormones|hormones|mesh-ancestor
55923847|NCT04702464|Fluconazole|fluconazole|mesh-list
55923848|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
55923849|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923850|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55923851|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55923852|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923853|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923854|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55923855|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
55923856|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55923857|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923858|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55923859|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55923860|NCT00088465|Olanzapine|olanzapine|mesh-list
55923861|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
55923914|NCT05743725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55923915|NCT05743725|Analgesics|analgesics|mesh-ancestor
55923916|NCT05743725|Sensory System Agents|sensory system agents|mesh-ancestor
55923918|NCT05743725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55923919|NCT05743725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55923920|NCT05743725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55923921|NCT05743725|Adrenergic Agents|adrenergic agents|mesh-ancestor
55923922|NCT05743725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923923|NCT05743725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923924|NCT05743725|Anesthetics|anesthetics|mesh-ancestor
55923925|NCT05743725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55923926|NCT05743725|Anticonvulsants|anticonvulsants|mesh-ancestor
55923927|NCT05743725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55923928|NCT05743725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923929|NCT05743725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55923930|NCT05743725|Tocolytic Agents|tocolytic agents|mesh-ancestor
55923931|NCT05743725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55923932|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
55923933|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55923934|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923935|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
55923936|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55923937|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923938|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923939|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55923940|NCT04912518|Analgesics|analgesics|mesh-ancestor
55923941|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
55923942|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923943|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55923944|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55923945|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55923946|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
55923947|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923948|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923949|NCT00087685|Everolimus|everolimus|mesh-list
55923950|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923951|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200875|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56200876|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200877|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56200878|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56200879|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56200880|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200881|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56200882|NCT01526278|Vitamins|vitamins|mesh-ancestor
55923952|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
55924004|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924006|NCT05535231|Protective Agents|protective agents|mesh-ancestor
55924007|NCT01502072|Ribavirin|ribavirin|mesh-list
55924008|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
55924009|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924010|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
55924011|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924012|NCT01462370|Acetaminophen|acetaminophen|mesh-list
55924013|NCT01462370|Ibuprofen|ibuprofen|mesh-list
55924014|NCT01462370|Etoricoxib|etoricoxib|mesh-list
55924015|NCT01462370|Caffeine|caffeine|mesh-list
55924016|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924017|NCT01462370|Analgesics|analgesics|mesh-ancestor
55924018|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
55924019|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924020|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924021|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
55924022|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55924023|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924024|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924025|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55924026|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924027|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924028|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55924029|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55924030|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55924031|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55924032|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
55924033|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924034|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55924042|NCT05743179|Zoledronic Acid|zoledronic acid|mesh-list
55924043|NCT05743179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55924069|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55924070|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55924071|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55924072|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924073|NCT01479374|Analgesics|analgesics|mesh-ancestor
55924074|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
55924075|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924076|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924077|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924078|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924079|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55924080|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55924081|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55924082|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
55924083|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
55924084|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924085|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924086|NCT00087529|Rituximab|rituximab|mesh-list
55924087|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924088|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924089|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
55924090|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200883|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
56200884|NCT01526317|Metformin|metformin|mesh-list
56200885|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56200886|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56200887|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200888|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56200889|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56200890|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
56200891|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200892|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56200893|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56200895|NCT01526369|Paclitaxel|paclitaxel|mesh-list
56200896|NCT01526369|Trastuzumab|trastuzumab|mesh-list
56200897|NCT01526369|Lapatinib|lapatinib|mesh-list
56200898|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56200899|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200900|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
56200901|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
56217248|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200902|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
56200903|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200904|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924091|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924092|NCT00794313|Topiramate|topiramate|mesh-list
55924093|NCT00794313|Amantadine|amantadine|mesh-list
55924094|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
55924095|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55827962|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55924096|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924210|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924212|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
55924213|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55924214|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
55924215|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55924216|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
55924217|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55924218|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55924219|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
55924220|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
55924221|NCT03837015|Estradiol|estradiol|mesh-list
55924222|NCT03837015|Estrogens|estrogens|mesh-ancestor
55924223|NCT03837015|Hormones|hormones|mesh-ancestor
55924224|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924225|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924226|NCT05742789|Propofol|propofol|mesh-list
55784979|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55924227|NCT05742789|Sevoflurane|sevoflurane|mesh-list
55924255|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924256|NCT00086281|Zolpidem|zolpidem|mesh-list
55924257|NCT00086281|Modafinil|modafinil|mesh-list
55924258|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55924259|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924260|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55924261|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55924262|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55924263|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200905|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56200906|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128648|NCT05679492|Meplazumab|meplazumab|mesh-list
56200907|NCT01526395|Propofol|propofol|mesh-list
56200908|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56200909|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200910|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200911|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56200912|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
56200913|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
56200914|NCT01526460|Atorvastatin|atorvastatin|mesh-list
56200915|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56200916|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56200917|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56200918|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
56200919|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200920|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56200921|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56200922|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56200923|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
56200924|NCT01526499|Docetaxel|docetaxel|mesh-list
56200925|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200926|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
56200927|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200928|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200929|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56200930|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
56200931|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200932|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200933|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56200934|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
56200935|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
56200936|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
56200937|NCT01526525|Acetaminophen|acetaminophen|mesh-list
56200947|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56200948|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
56200949|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
56200950|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56200951|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55924264|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55924265|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55924266|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924267|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55924268|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
55924269|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
55924270|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924271|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
55924272|NCT00787761|Busulfan|busulfan|mesh-list
55924273|NCT00787761|Methotrexate|methotrexate|mesh-list
55924274|NCT00787761|Fludarabine|fludarabine|mesh-list
55924275|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
55924276|NCT00787761|Tacrolimus|tacrolimus|mesh-list
55924277|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
55924357|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924358|NCT03447379|Analgesics|analgesics|mesh-ancestor
55924359|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
55924360|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924361|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924362|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924363|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924364|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55924365|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56144587|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55924366|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924367|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55924368|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55924369|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924370|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
55924371|NCT03803553|Fluorouracil|fluorouracil|mesh-list
55924372|NCT03803553|Nivolumab|nivolumab|mesh-list
55924373|NCT03803553|Irinotecan|irinotecan|mesh-list
55924374|NCT03803553|Cetuximab|cetuximab|mesh-list
55924375|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
55924376|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924377|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55924378|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830868|NCT02202551|Amantadine|amantadine|mesh-list
55924379|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924380|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
55924381|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924411|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924412|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55924413|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
55924414|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924415|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924416|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55924417|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55924418|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55924419|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55924420|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924421|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55924422|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
55924423|NCT03483883|Gemcitabine|gemcitabine|mesh-list
55924424|NCT03483883|Avelumab|avelumab|mesh-list
55924425|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55924426|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
55924427|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924491|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924493|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924494|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924495|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
55924496|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924497|NCT04384653|Furosemide|furosemide|mesh-list
55924498|NCT04384653|Diuretics|diuretics|mesh-ancestor
55924529|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217317|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
55924530|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200952|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56200953|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56200954|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200955|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56200956|NCT01526525|Narcotics|narcotics|mesh-ancestor
56200957|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56200958|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
56200959|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56200960|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56200961|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924532|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55924533|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
55924534|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924535|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
55924536|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924537|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
55924538|NCT04215120|Hematinics|hematinics|mesh-ancestor
55924539|NCT00081289|Leucovorin|leucovorin|mesh-list
55924540|NCT00081289|Folic Acid|folic acid|mesh-list
55924541|NCT00081289|Fluorouracil|fluorouracil|mesh-list
55924573|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924574|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924575|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55924576|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
55924577|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
55924578|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55924579|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55924580|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55924581|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55924582|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
55924583|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924584|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924585|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
55924586|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55924587|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924621|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55831573|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924622|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
55924623|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924624|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924625|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55924626|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
55924627|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55924628|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55924629|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55924661|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55924662|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55924663|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
55924664|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
55924666|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
55924667|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924669|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55924670|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924671|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924672|NCT03159000|Lidocaine|lidocaine|mesh-list
55924710|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924740|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55924741|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924743|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55924744|NCT02951364|Ledipasvir|ledipasvir|mesh-list
55924745|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
55924746|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924747|NCT01678417|Rituximab|rituximab|mesh-list
55924748|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924749|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200962|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56200963|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200964|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56200965|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
56200966|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
56200968|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
56200969|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200970|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
56200971|NCT01526616|Metformin|metformin|mesh-list
56200972|NCT01526616|Spironolactone|spironolactone|mesh-list
56200973|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55924750|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
55924751|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924752|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924753|NCT00083941|Interleukin-2|interleukin-2|mesh-list
55924754|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924790|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924791|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924930|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
55924931|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924932|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55924933|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
55924935|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55924936|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55924937|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
55924938|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924939|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924968|NCT04403191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55924969|NCT04383093|Tadalafil|tadalafil|mesh-list
55924970|NCT04383093|Tamsulosin|tamsulosin|mesh-list
55924971|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
55924972|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55924973|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55924974|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924975|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924976|NCT04383093|Urological Agents|urological agents|mesh-ancestor
55924977|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55924978|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55924979|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55924980|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
55924981|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924982|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924983|NCT05301660|Nicotine|nicotine|mesh-list
55831650|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
55924984|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55924985|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
55924986|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924987|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925023|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55925024|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
55925025|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925026|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925027|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200974|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200975|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56200976|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
56200977|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200978|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56200979|NCT01526616|Diuretics|diuretics|mesh-ancestor
56200980|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
56200981|NCT01526694|Thalidomide|thalidomide|mesh-list
56200982|NCT01526694|Dexamethasone|dexamethasone|mesh-list
56200983|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55925118|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925119|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925120|NCT04585776|Insulin|insulin|mesh-list
55925121|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55925122|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925123|NCT01401647|Lidocaine|lidocaine|mesh-list
55925124|NCT01401647|Amiodarone|amiodarone|mesh-list
55925125|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
55925126|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
55925127|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925128|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925129|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
55925130|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925131|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55925132|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55925133|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55925134|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925135|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925136|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
55925137|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55925138|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55925139|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55925140|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925141|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55925233|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925234|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55925235|NCT00773955|Protective Agents|protective agents|mesh-ancestor
55925236|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925237|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55925238|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
55925239|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55925240|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55925241|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55925242|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
55925243|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
55925244|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
56217407|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55925245|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55925246|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925248|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925249|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55925250|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925251|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925252|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
55925253|NCT04499196|Hormones|hormones|mesh-ancestor
55925289|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
55925343|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925344|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
55925345|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55925346|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55925347|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925348|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200984|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56200985|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
56200986|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
56200987|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56200988|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56200989|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56200990|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
56200991|NCT01526694|Hormones|hormones|mesh-ancestor
56200992|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56200993|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56200994|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56200995|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56200996|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
56200997|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56200998|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56200999|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
56201000|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
56201001|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201002|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201003|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56201004|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56201005|NCT01526694|Growth Substances|growth substances|mesh-ancestor
56201006|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
56201007|NCT01526837|Bevacizumab|bevacizumab|mesh-list
56201008|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56201009|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201010|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55925349|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55925350|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55925351|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
55925352|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925353|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
55925355|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
55925356|NCT01400243|Nicotine|nicotine|mesh-list
55925357|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55925358|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
55925359|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925360|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925361|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55925362|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55925363|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
55925364|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925365|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925366|NCT05685277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55925367|NCT05685277|Ramipril|ramipril|mesh-list
55925368|NCT05685277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55925369|NCT05685277|Diuretics|diuretics|mesh-ancestor
55925370|NCT05685277|Natriuretic Agents|natriuretic agents|mesh-ancestor
56201011|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56201012|NCT01526837|Growth Substances|growth substances|mesh-ancestor
56201013|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201014|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
56201015|NCT01526850|Cyclosporine|cyclosporine|mesh-list
56201016|NCT01526850|Cyclosporins|cyclosporins|mesh-list
56201017|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
56201018|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201019|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201020|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201021|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
56201022|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201023|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
56201024|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785089|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56201025|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
56201026|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56201027|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56201028|NCT01526850|Hormones|hormones|mesh-ancestor
56201029|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201030|NCT01526876|Clevidipine|clevidipine|mesh-list
56201031|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56201032|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201033|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201034|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56201035|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201036|NCT01526941|Insulin|insulin|mesh-list
56201037|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56201038|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
56201039|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
55735134|NCT00003857|Tamoxifen|tamoxifen|mesh-list
55925400|NCT05689021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925401|NCT05689021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925402|NCT05689021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55925403|NCT05689021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925404|NCT05689021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55925406|NCT05689021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925407|NCT05689021|Hormone Antagonists|hormone antagonists|mesh-ancestor
55925408|NCT05689021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55925409|NCT05689021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55925410|NCT03082885|Thymalfasin|thymalfasin|mesh-list
55925411|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55925412|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
55925413|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201040|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56201041|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
55833807|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
56217461|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217462|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56201042|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56201043|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201044|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201046|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56201047|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
56201048|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
56201049|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56201050|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
56201051|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56201052|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201053|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201054|NCT01527019|Cephalosporins|cephalosporins|mesh-list
56201055|NCT01527019|Norfloxacin|norfloxacin|mesh-list
56201056|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201057|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925442|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925445|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55925446|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925447|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55925448|NCT03082339|Cortisone|cortisone|mesh-list
55925449|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925450|NCT03801759|Adefovir|adefovir|mesh-list
55925451|NCT03801759|Digoxin|digoxin|mesh-list
55925452|NCT03801759|Furosemide|furosemide|mesh-list
55925453|NCT03801759|Diuretics|diuretics|mesh-ancestor
55925454|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
55925455|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833996|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925456|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55925457|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925519|NCT00804609|Lidocaine|lidocaine|mesh-list
55834129|NCT01822899|Xhance|xhance|mesh-list
55925520|NCT00804609|Morphine|morphine|mesh-list
55925521|NCT00804609|Anesthetics|anesthetics|mesh-list
55925522|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
55925523|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925585|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55925587|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
55925588|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925589|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56217492|NCT01631838|Vitamin E|vitamin e|mesh-list
55925590|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55925591|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55925592|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55925593|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55925594|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55925595|NCT04401085|Antibodies|antibodies|mesh-list
55925622|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55925623|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
55925624|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
55925625|NCT05044962|Etonogestrel|etonogestrel|mesh-list
55925626|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55925627|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
56201058|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56201059|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56201060|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201061|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201062|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201063|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56201064|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56201065|NCT01527032|Thalidomide|thalidomide|mesh-list
55834588|NCT01814397|Letrozole|letrozole|mesh-list
56201066|NCT01527032|Dexamethasone|dexamethasone|mesh-list
56201067|NCT01527032|Melphalan|melphalan|mesh-list
56201068|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56201069|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
56201070|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
55834698|NCT02016625|Cyclosporine|cyclosporine|mesh-list
56201071|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201072|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735232|NCT05096715|Atezolizumab|atezolizumab|mesh-list
55925628|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55925629|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925630|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55925631|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55925632|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55925633|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55925634|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55925635|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55925636|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925637|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55925638|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55925639|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925640|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925641|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
55925642|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925643|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55925644|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55925705|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55925706|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
55925707|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55925708|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925709|NCT04721691|Cannabidiol|cannabidiol|mesh-list
55925710|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
55925713|NCT04382079|Propolis|propolis|mesh-list
55925714|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925715|NCT05019222|Anesthetics|anesthetics|mesh-list
55925716|NCT05019222|Sevoflurane|sevoflurane|mesh-list
55925717|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925718|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925719|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55925720|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55925721|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
55925722|NCT05688007|Hormones|hormones|mesh-list
55925723|NCT05688007|Parathyroid Hormone|parathyroid hormone|mesh-list
55925724|NCT05688007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925725|NCT05688007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925726|NCT05688007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55925727|NCT01459718|Deferasirox|deferasirox|mesh-list
55925728|NCT01459718|Deferoxamine|deferoxamine|mesh-list
55925729|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56201073|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56201074|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
56201075|NCT01527032|Hormones|hormones|mesh-ancestor
56201076|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201077|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56201078|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201079|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56201080|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
56201081|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201082|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55925785|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55925786|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
55925787|NCT04663347|Hormones|hormones|mesh-ancestor
55925788|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925789|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55925790|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55925791|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
55925792|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
55925793|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925794|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925795|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55925796|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55925797|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55925798|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55925799|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
55925800|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
55925801|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
55925802|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55925803|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55925804|NCT04663347|Growth Substances|growth substances|mesh-ancestor
55925805|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
55925806|NCT04384731|Poractant alfa|poractant alfa|mesh-list
55925807|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
55925808|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
55925812|NCT05042466|Psilocybin|psilocybin|mesh-list
55925813|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
55925814|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925815|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55925816|NCT05615467|Metformin|metformin|mesh-list
55925882|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925883|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925884|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55925885|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55925886|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
56217584|NCT01632722|Bevacizumab|bevacizumab|mesh-list
55925887|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925888|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925920|NCT04951986|Ofloxacin|ofloxacin|mesh-list
55925921|NCT04951986|Rifampin|rifampin|mesh-list
55925922|NCT04951986|Isoniazid|isoniazid|mesh-list
55925923|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
55925924|NCT04951986|Ethambutol|ethambutol|mesh-list
55925925|NCT04951986|Prednisone|prednisone|mesh-list
55925926|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925927|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
55925928|NCT04951986|Hormones|hormones|mesh-ancestor
55925929|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925930|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925949|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55925950|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55925951|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55925952|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55925953|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56201083|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201084|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
56201085|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
56201086|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201087|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835782|NCT01987453|Ledipasvir|ledipasvir|mesh-list
56201088|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56201089|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56201090|NCT01527032|Growth Substances|growth substances|mesh-ancestor
56201091|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
56201093|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56201094|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56201095|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
56201096|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201097|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56201098|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56201099|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201100|NCT01527279|Antazoline|antazoline|mesh-list
56201101|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56201102|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
56201103|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
55925954|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55925955|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
55925956|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55925958|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55925959|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
55925960|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925961|NCT04484337|Cabotegravir|cabotegravir|mesh-list
55925962|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55925963|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55925964|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55925965|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55925966|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925967|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925968|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55925969|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55925970|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
55925971|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925972|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55925973|NCT04484337|Analgesics|analgesics|mesh-ancestor
55925974|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
55837551|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55925975|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925976|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925977|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55925978|NCT01474538|Insulin|insulin|mesh-list
55925979|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55925980|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
55925981|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
55925982|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55925983|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925984|NCT04278703|Oxycodone|oxycodone|mesh-list
55925985|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55925986|NCT04278703|Narcotics|narcotics|mesh-ancestor
55926020|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
55926021|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
56201104|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201105|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201106|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201107|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56201108|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55926022|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926023|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926024|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
55926025|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926026|NCT03318133|Anesthetics|anesthetics|mesh-list
55926057|NCT05431764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926058|NCT05431764|Immunologic Factors|immunologic factors|mesh-ancestor
55926059|NCT05431764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926060|NCT04311411|Liraglutide|liraglutide|mesh-list
55926061|NCT04311411|Tirzepatide|tirzepatide|mesh-list
55926063|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926064|NCT04311411|Incretins|incretins|mesh-ancestor
55926065|NCT04311411|Hormones|hormones|mesh-ancestor
55793808|NCT04994743|Cortisone|cortisone|mesh-list
55926066|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926067|NCT03382561|Cisplatin|cisplatin|mesh-list
55926068|NCT03382561|Carboplatin|carboplatin|mesh-list
55926069|NCT03382561|Nivolumab|nivolumab|mesh-list
55926070|NCT03382561|Etoposide|etoposide|mesh-list
55926106|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55926107|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55926234|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55926235|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926236|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55926237|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926238|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926239|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55926240|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55926269|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
55926270|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55926271|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55926272|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
55926273|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
55926274|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
55926275|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
55926276|NCT01420679|Aminopterin|aminopterin|mesh-list
55926277|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55926278|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926279|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926280|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926281|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55926282|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55926283|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926284|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
55926285|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926312|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55926313|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55926315|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926316|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
55926317|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926318|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56217628|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217629|NCT01633177|Vitamin D|vitamin d|mesh-list
55926319|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55926320|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55926321|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55926322|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55926323|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55926324|NCT00818337|Aspirin|aspirin|mesh-list
55926325|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55926326|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55926327|NCT00818337|Analgesics|analgesics|mesh-ancestor
55926328|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
56201109|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56201110|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56201111|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201112|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201113|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201114|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56201115|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56201116|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
56201117|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201118|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201119|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56201120|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56201121|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
56201122|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
56201123|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56201124|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56201125|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
56213216|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926363|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926364|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55926365|NCT00853671|Adenosine|adenosine|mesh-list
55926366|NCT00853671|Analgesics|analgesics|mesh-ancestor
55926367|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
55926368|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926390|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
55926391|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
55926392|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926393|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217662|NCT01633450|Zinc|zinc|mesh-list
55926394|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55926395|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55926396|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55926397|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55926398|NCT00854061|Prednisone|prednisone|mesh-list
55926399|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
55926400|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55926401|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
55926402|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55926403|NCT00854061|Prednisolone|prednisolone|mesh-list
55926404|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55926405|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
55926406|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926407|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
55926408|NCT00854061|Hormones|hormones|mesh-ancestor
55839252|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839253|NCT01752855|Adalimumab|adalimumab|mesh-list
55926409|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926410|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926411|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55926412|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926413|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
55926414|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
55926415|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926416|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55926417|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55926418|NCT00854061|Protective Agents|protective agents|mesh-ancestor
55926446|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55926448|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926449|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201126|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201127|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56201128|NCT01527422|Prednisone|prednisone|mesh-list
56201129|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
56201130|NCT01527422|Doxorubicin|doxorubicin|mesh-list
56201131|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56201133|NCT01527422|Sargramostim|sargramostim|mesh-list
56201134|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201135|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
56201136|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201137|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56201138|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56201139|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
56201140|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201141|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201142|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56201143|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56201144|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56201145|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56201146|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201147|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56201148|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
56201149|NCT01527422|Hormones|hormones|mesh-ancestor
56201150|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201151|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56201152|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56201153|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
56201154|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
55839886|NCT01743027|Analgesics|analgesics|mesh-ancestor
56201155|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
56201156|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56201157|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
56201158|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201159|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56201160|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56201167|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201168|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201170|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201171|NCT01527474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56201172|NCT01527474|Antidepressive Agents|antidepressive agents|mesh-ancestor
56201173|NCT01527474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201174|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
56201175|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
56201176|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56201177|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201178|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201179|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
56201180|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
56201181|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201182|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735575|NCT04019873|Lamivudine|lamivudine|mesh-list
55926450|NCT01496612|Buspirone|buspirone|mesh-list
55926451|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55926452|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55926453|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926454|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926455|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55926456|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55926457|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
55926458|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926459|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926460|NCT00790218|Adenosine|adenosine|mesh-list
55926461|NCT00790218|Analgesics|analgesics|mesh-ancestor
55926462|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
55926490|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55926491|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
55926492|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840243|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
55926493|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926494|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55926495|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55926496|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55926497|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
55926498|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55926499|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55926500|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
55926501|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
55926502|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926503|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55926504|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55926505|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55926506|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
55926507|NCT05431218|Vitamin D|vitamin d|mesh-list
55926541|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926542|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55926543|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55926544|NCT03298945|Laxatives|laxatives|mesh-ancestor
55926545|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55926547|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55926548|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926549|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
55926613|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
56201184|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
56201185|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201186|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201187|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
56201188|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
56201189|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201190|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201191|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
56201192|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
56201193|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201194|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201195|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
56201196|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
56201197|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201198|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201199|NCT01527669|Lovastatin|lovastatin|mesh-list
56201200|NCT01527669|L 647318|l 647318|mesh-list
56201201|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
56201202|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56201203|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56201204|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
55840785|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
56201205|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128932|NCT04401852|Analgesics|analgesics|mesh-ancestor
55840873|NCT01824290|Tadalafil|tadalafil|mesh-list
56201206|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56201207|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56201208|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201209|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
56201210|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
56201211|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
56201212|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201213|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201214|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
56201215|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926614|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
55926615|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926616|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926617|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55926618|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55926619|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55926620|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
55926621|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926622|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926623|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
56201216|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56201217|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201218|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201220|NCT01527747|Incretins|incretins|mesh-ancestor
56201222|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201223|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201224|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55841375|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201225|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
56201226|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201227|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201228|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201229|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56201230|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56201231|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56201232|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201233|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201234|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201235|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201236|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
56201237|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201239|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56201240|NCT01527864|Carboplatin|carboplatin|mesh-list
56201241|NCT01527864|Endostatins|endostatins|mesh-list
56201242|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56201243|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201244|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
56201245|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
56201246|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
56201247|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201248|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56201249|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56201250|NCT01527864|Growth Substances|growth substances|mesh-ancestor
56201254|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56201255|NCT01527890|Narcotics|narcotics|mesh-ancestor
56201256|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201257|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201258|NCT01527890|Analgesics|analgesics|mesh-ancestor
56201259|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
56201260|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201261|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56201262|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56201263|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
56201264|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
56201265|NCT01527903|Midazolam|midazolam|mesh-list
56201266|NCT01527903|Propofol|propofol|mesh-list
56201267|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56201268|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201269|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201270|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56217922|NCT01634932|Iron|iron|mesh-list
56201271|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
56201272|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
56201273|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56201274|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56201275|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56201276|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201277|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
56201278|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
56129003|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56201279|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201280|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201281|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
56201282|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
56201283|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56201284|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56201285|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201286|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
56201287|NCT01527968|Coagulants|coagulants|mesh-ancestor
56201288|NCT01527994|Aprepitant|aprepitant|mesh-list
56201289|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
56201293|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56201294|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56201295|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201296|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201297|NCT01528007|Naltrexone|naltrexone|mesh-list
56201298|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56201299|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56201300|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201301|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
56201302|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201303|NCT01528137|Lactoferrin|lactoferrin|mesh-list
56201304|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
56201305|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201306|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201307|NCT01528163|Methotrexate|methotrexate|mesh-list
56201308|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56201309|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
56201310|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56201311|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735740|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
55926624|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55926625|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
55926626|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55926627|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
55926628|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926629|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926693|NCT00860379|Trace Elements|trace elements|mesh-ancestor
55926694|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
55926695|NCT00860457|Rituximab|rituximab|mesh-list
55926696|NCT00860457|Fludarabine|fludarabine|mesh-list
55926697|NCT00860457|Lenalidomide|lenalidomide|mesh-list
55926698|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55926699|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926700|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
55926701|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926735|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
55926736|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926737|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926739|NCT02155101|Lopinavir|lopinavir|mesh-list
55926740|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55926741|NCT02155101|Darunavir|darunavir|mesh-list
55926742|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55926772|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
55926773|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55926774|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55926775|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55926776|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55926777|NCT03243019|Sirolimus|sirolimus|mesh-list
55926778|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55926779|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926780|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55926781|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926782|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
55926783|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926784|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
56201312|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56201313|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
56201314|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201315|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201316|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
56201317|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201318|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56201319|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201320|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
56201321|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56201322|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56201323|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
56201325|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56201326|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926785|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926786|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
55926787|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
55926923|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926924|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
55926925|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
55927153|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55785282|NCT05392075|Vaccines|vaccines|mesh-list
55927154|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927155|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55927156|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927157|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
55927158|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927159|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
55927160|NCT00870363|Efavirenz|efavirenz|mesh-list
55927161|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
55927162|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
55927163|NCT00870363|Maraviroc|maraviroc|mesh-list
55927164|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55927265|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
55927266|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55927267|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927268|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55927331|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55927332|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201327|NCT01528176|Vitamins|vitamins|mesh-ancestor
56201328|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
56201329|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56201330|NCT01528371|Midazolam|midazolam|mesh-list
56201331|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56201332|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56201333|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201334|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201335|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56201336|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56201337|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201338|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56201339|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
56201340|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
56201341|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
56201342|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
56201343|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201344|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201345|NCT01528501|Panobinostat|panobinostat|mesh-list
56201346|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201347|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56201348|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201349|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201350|NCT01528540|Pregabalin|pregabalin|mesh-list
56201351|NCT01528540|Antioxidants|antioxidants|mesh-list
56201352|NCT01528540|Analgesics|analgesics|mesh-ancestor
55841797|NCT05583058|Hormones|hormones|mesh-list
56201353|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
56201354|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735859|NCT03443141|Vitamin E|vitamin e|mesh-list
55927333|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
55927334|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927335|NCT03995004|Protective Agents|protective agents|mesh-ancestor
55927336|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55927337|NCT03995004|Cathartics|cathartics|mesh-ancestor
55927338|NCT03216525|Alvimopan|alvimopan|mesh-list
55927339|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55927340|NCT03249181|Dolutegravir|dolutegravir|mesh-list
55927341|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55927342|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55927343|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927344|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927345|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55927346|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55927347|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
55927348|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927349|NCT03216447|Tacrolimus|tacrolimus|mesh-list
55927350|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927351|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
55927352|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201357|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56201358|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201359|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201360|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56201361|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56201362|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56201363|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201364|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201365|NCT01528540|Protective Agents|protective agents|mesh-ancestor
56201366|NCT01528618|Gemcitabine|gemcitabine|mesh-list
56201367|NCT01528618|Cisplatin|cisplatin|mesh-list
56201368|NCT01528618|Fluorouracil|fluorouracil|mesh-list
56201369|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201370|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56201371|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
56201372|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201373|NCT01528618|Antiviral Agents|antiviral agents|mesh-ancestor
56201374|NCT01528618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201375|NCT01528618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201376|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201377|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
56201378|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201379|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
56201380|NCT01528644|Iron|iron|mesh-list
56201381|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
56201382|NCT01528644|Calcium|calcium|mesh-list
56201383|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56201384|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201385|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56201386|NCT01528644|Trace Elements|trace elements|mesh-ancestor
56201387|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
56201388|NCT01528644|Hematinics|hematinics|mesh-ancestor
56201389|NCT01528722|Bupivacaine|bupivacaine|mesh-list
55927353|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55927354|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927716|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927717|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927718|NCT03176173|Immunologic Factors|immunologic factors|mesh-list
55927719|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927720|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
56201391|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
56201392|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201393|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201394|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
56201395|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201396|NCT01528800|Vitamin K|vitamin k|mesh-list
56201397|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
56201398|NCT01528800|Vitamins|vitamins|mesh-ancestor
56201399|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
56201400|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201401|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56201402|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56201403|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201404|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
56201405|NCT01528800|Coagulants|coagulants|mesh-ancestor
56201406|NCT01528813|Amorolfine|amorolfine|mesh-list
56201407|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
56201408|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201409|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
56201410|NCT01528826|Vinorelbine|vinorelbine|mesh-list
56201411|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201412|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56201413|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
56201414|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
56201415|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
56201416|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201417|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
56201418|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56201419|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56201420|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201421|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
56201422|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56201423|NCT01528865|Tenofovir|tenofovir|mesh-list
56201424|NCT01528865|Lamivudine|lamivudine|mesh-list
56201434|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201435|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201436|NCT01528943|Epoprostenol|epoprostenol|mesh-list
56201437|NCT01528943|Tezosentan|tezosentan|mesh-list
56201438|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56201439|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56201440|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
56201441|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
56201442|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56201443|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201444|NCT01529125|Lamivudine|lamivudine|mesh-list
56201445|NCT01529125|Zidovudine|zidovudine|mesh-list
55842163|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201446|NCT01529125|Nevirapine|nevirapine|mesh-list
56201447|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56201448|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56201449|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201450|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201451|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
56201452|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201453|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56201454|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56201455|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
56201456|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56201457|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56201458|NCT01529138|Sirolimus|sirolimus|mesh-list
56201459|NCT01529138|Axitinib|axitinib|mesh-list
56201460|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55842238|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56201461|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201462|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56201471|NCT01529164|Leucovorin|leucovorin|mesh-list
56201483|NCT01529164|Antidotes|antidotes|mesh-ancestor
56201484|NCT01529164|Protective Agents|protective agents|mesh-ancestor
56201485|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
56201486|NCT01529164|Vitamins|vitamins|mesh-ancestor
56201487|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
56201488|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56201489|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56201490|NCT01529164|Growth Substances|growth substances|mesh-ancestor
56201491|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
56201492|NCT01529177|Metformin|metformin|mesh-list
56201493|NCT01529177|Citric Acid|citric acid|mesh-list
56201494|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
56201495|NCT01529177|Clomiphene|clomiphene|mesh-list
56201496|NCT01529177|Enclomiphene|enclomiphene|mesh-list
56201497|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
56201498|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201499|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201500|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
56201501|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56201502|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
56201503|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
55736007|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55736008|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
55736009|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736010|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927721|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
55927722|NCT02220985|Thiotepa|thiotepa|mesh-list
55927723|NCT02220985|Methotrexate|methotrexate|mesh-list
55927724|NCT02220985|Fludarabine|fludarabine|mesh-list
55927725|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
55927726|NCT02220985|Tacrolimus|tacrolimus|mesh-list
55927727|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927728|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
55927729|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927730|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55927838|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
55927839|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927840|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55927841|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55928015|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55928081|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55928117|NCT05314569|Analgesics|analgesics|mesh-ancestor
55928118|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
55928119|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928120|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55928121|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55928153|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
55928154|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
55928155|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928156|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928157|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
55928158|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928159|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55928160|NCT03167905|Narcotics|narcotics|mesh-ancestor
56201504|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201505|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56201506|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
56201507|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201508|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56201509|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
56201510|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56201511|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56201512|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56201513|NCT01529190|Pregabalin|pregabalin|mesh-list
56201514|NCT01529190|Analgesics|analgesics|mesh-ancestor
55928161|NCT03167905|Analgesics|analgesics|mesh-ancestor
55928162|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55928163|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55928164|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
55928165|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55928166|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55928167|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55928168|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55928169|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
55928196|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928197|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928198|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55928199|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55928200|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55928201|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
55928202|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928203|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928204|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55928205|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55928206|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
55928207|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928209|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55928210|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928211|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
55928212|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928213|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
55928214|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
55928215|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55928216|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55928285|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928287|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
55928288|NCT04337827|Rituximab|rituximab|mesh-list
55928289|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
55928290|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928291|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928292|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
55928293|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928294|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928295|NCT01494506|Leucovorin|leucovorin|mesh-list
56217993|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928340|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928341|NCT00894465|Midazolam|midazolam|mesh-list
55928342|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55928343|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55928344|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928461|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55928462|NCT03218631|Oxandrolone|oxandrolone|mesh-list
55928463|NCT03218631|Androgens|androgens|mesh-ancestor
55928464|NCT03218631|Hormones|hormones|mesh-ancestor
55928465|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55928466|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928467|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
55928468|NCT03451045|Dronabinol|dronabinol|mesh-list
56201515|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
56201516|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201517|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201518|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
56201519|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56201520|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201521|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201522|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56201523|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56201524|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56201525|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201526|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201527|NCT01529229|Prednisolone|prednisolone|mesh-list
56201528|NCT01529229|Betamethasone|betamethasone|mesh-list
56201529|NCT01529229|Desloratadine|desloratadine|mesh-list
56201530|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56201531|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56201532|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
56201533|NCT01529229|Hormones|hormones|mesh-ancestor
56201534|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201535|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201536|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55842563|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56201537|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201538|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56201539|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
56201540|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56201541|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
56201542|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201543|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201544|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56201545|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56201546|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
56201547|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
56201548|NCT01529242|Prednisolone|prednisolone|mesh-list
55928469|NCT03451045|Lenabasum|lenabasum|mesh-list
55928536|NCT03415854|Paclitaxel|paclitaxel|mesh-list
55928595|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55928596|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55928597|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56201549|NCT01529242|Betamethasone|betamethasone|mesh-list
56201550|NCT01529242|Desloratadine|desloratadine|mesh-list
56201551|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
56201552|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56201553|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
56201554|NCT01529242|Hormones|hormones|mesh-ancestor
56201555|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201556|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201557|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56201558|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201559|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56201560|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
55928598|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55928599|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928601|NCT00114517|Estradiol|estradiol|mesh-list
55928602|NCT00114517|Estrogens|estrogens|mesh-list
55928603|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55928604|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928605|NCT01831479|Olmesartan|olmesartan|mesh-list
55928606|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55928607|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55928669|NCT01383707|Protective Agents|protective agents|mesh-ancestor
55928670|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
55928671|NCT01383707|Vitamins|vitamins|mesh-ancestor
55928672|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
55928704|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56218008|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56218009|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55928705|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55928707|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928708|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
55928709|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928710|NCT01383161|Curcumin|curcumin|mesh-list
55928711|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55928712|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55928713|NCT01383161|Analgesics|analgesics|mesh-ancestor
55842709|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
55928750|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928751|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
55928752|NCT01382225|Protective Agents|protective agents|mesh-ancestor
55928753|NCT01381679|Ezetimibe|ezetimibe|mesh-list
55928789|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
55928790|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928927|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928928|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55928929|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55928930|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55928931|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
55928932|NCT01494350|Gentamicins|gentamicins|mesh-list
55928933|NCT01494350|Paromomycin|paromomycin|mesh-list
55928934|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55928935|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928994|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928995|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928997|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55928998|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55928999|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55929000|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55929052|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
55929053|NCT03101124|Coagulants|coagulants|mesh-ancestor
55929054|NCT02985203|Vinorelbine|vinorelbine|mesh-list
55929055|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55929056|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929057|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
55929058|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
56201561|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56201563|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201564|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201565|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56201566|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56201567|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
56201568|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
56201569|NCT01529255|Telbivudine|telbivudine|mesh-list
56201570|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
56201571|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201572|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56201573|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201574|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201575|NCT01529294|Iloperidone|iloperidone|mesh-list
56201576|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56201577|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56201578|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201579|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201580|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201581|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
55929059|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
55929090|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55929091|NCT00805584|Desloratadine|desloratadine|mesh-list
55929092|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55929093|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
55929094|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929095|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929096|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929097|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55929098|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55929099|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
55929101|NCT01833351|Vitamins|vitamins|mesh-list
55929150|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929151|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55929152|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929153|NCT05243251|Olanzapine|olanzapine|mesh-list
55929154|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
55929155|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
55929254|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55929255|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
55929256|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
55929257|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929258|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929296|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55929364|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929365|NCT00370890|Antiviral Agents|antiviral agents|mesh-ancestor
55929366|NCT00370890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929367|NCT00370890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929368|NCT00370890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929369|NCT00370890|Immunologic Factors|immunologic factors|mesh-ancestor
55929370|NCT00370890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201582|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56201583|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56201584|NCT01529320|Prednisolone|prednisolone|mesh-list
56201585|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
56201586|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
56201587|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56201588|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
56201589|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56201590|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
56201591|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
56201592|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843079|NCT03861988|Analgesics|analgesics|mesh-ancestor
56201593|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201594|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56201595|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
56201596|NCT01529320|Hormones|hormones|mesh-ancestor
56201597|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201598|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56201599|NCT01529320|Protective Agents|protective agents|mesh-ancestor
56201600|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56201601|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201602|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
56201603|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201604|NCT01529476|Levofloxacin|levofloxacin|mesh-list
56201605|NCT01529476|Ofloxacin|ofloxacin|mesh-list
56201606|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56201607|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201608|NCT01529476|Renal Agents|renal agents|mesh-ancestor
56201609|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201610|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56201611|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56201612|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201613|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201614|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201615|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56201616|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56201617|NCT01529528|Anagliptin|anagliptin|mesh-list
55929502|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
55929503|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
56201618|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56201619|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
56201620|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201621|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201622|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201623|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201624|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56201626|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201627|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201628|NCT01529541|Incretins|incretins|mesh-ancestor
56201629|NCT01529541|Hormones|hormones|mesh-ancestor
56201630|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56201631|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56201632|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
56201633|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201634|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201635|NCT01529554|Everolimus|everolimus|mesh-list
56201636|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201637|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201638|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
56201639|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201640|NCT01529619|Rivastigmine|rivastigmine|mesh-list
56201641|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56201642|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201643|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201644|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
56201645|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201646|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201647|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56201648|NCT01529619|Protective Agents|protective agents|mesh-ancestor
56201649|NCT01529710|Praziquantel|praziquantel|mesh-list
56201650|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
56201651|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56201652|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201654|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56201656|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201657|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201658|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56201659|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201660|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201661|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
56201662|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218116|NCT01636037|Carbidopa|carbidopa|mesh-list
56201663|NCT01529892|Methamphetamine|methamphetamine|mesh-list
56201664|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56201665|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201666|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
56201667|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
56201668|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201669|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
56201670|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201671|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201672|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
56201673|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56201674|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56201675|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201676|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56201677|NCT01530022|Lacosamide|lacosamide|mesh-list
56201678|NCT01530022|Carbamazepine|carbamazepine|mesh-list
56201679|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
56201680|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56201681|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56201682|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201683|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201684|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
56201685|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56201688|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201696|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56201697|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201698|NCT01530126|Becaplermin|becaplermin|mesh-list
56201699|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
56201700|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56201701|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56201702|NCT01530126|Growth Substances|growth substances|mesh-ancestor
56201703|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201704|NCT01530152|Lidocaine|lidocaine|mesh-list
56201705|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
56201706|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
56201707|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201708|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201709|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
56201710|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843456|NCT00004054|Bicalutamide|bicalutamide|mesh-list
55843457|NCT00004054|Flutamide|flutamide|mesh-list
55843458|NCT00004054|Estramustine|estramustine|mesh-list
56201711|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56201712|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56201713|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56201714|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56201715|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201716|NCT01530217|Ibuprofen|ibuprofen|mesh-list
56201717|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56201718|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56201719|NCT01530217|Analgesics|analgesics|mesh-ancestor
56201720|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
56201721|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201722|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201723|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56201724|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56201725|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56201726|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201727|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929504|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929505|NCT03099408|Metronidazole|metronidazole|mesh-list
55929506|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929507|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929508|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55929509|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55929510|NCT05246293|Tofacitinib|tofacitinib|mesh-list
56201729|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
56129461|NCT04398108|Margetuximab|margetuximab|mesh-list
56201730|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56201731|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201733|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201734|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
56201735|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
56201736|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
56201737|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201738|NCT01530308|Dopamine|dopamine|mesh-list
56201739|NCT01530308|Haloperidol|haloperidol|mesh-list
56201740|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
56201741|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
56201742|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
56201743|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
56201744|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
55843535|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
55843536|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843581|NCT04112043|Niacinamide|niacinamide|mesh-list
56201745|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201746|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201747|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56201748|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56201749|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201750|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56201751|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
56201752|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201753|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201754|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56218157|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218158|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218159|NCT01636245|Vaccines|vaccines|mesh-list
56218160|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
56218161|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218162|NCT01636271|Darapladib|darapladib|mesh-list
56218163|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56218164|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218165|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218166|NCT01636310|Nicotine|nicotine|mesh-list
56218167|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55843655|NCT03682978|Baclofen|baclofen|mesh-list
56201755|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56201756|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
56201757|NCT01530308|Protective Agents|protective agents|mesh-ancestor
56201758|NCT01530386|Lacosamide|lacosamide|mesh-list
56201759|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
56201760|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56201761|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56201771|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
56201772|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201773|NCT01530490|Cabergoline|cabergoline|mesh-list
56201774|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56201775|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
55929511|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55929512|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929660|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55929661|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929663|NCT01922713|Beta Carotene|beta carotene|mesh-list
55929664|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
55929665|NCT01922713|Vitamins|vitamins|mesh-ancestor
55929666|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
55929667|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929668|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
55929669|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929670|NCT01922713|Protective Agents|protective agents|mesh-ancestor
55929671|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55929672|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929728|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929729|NCT01835067|Ranibizumab|ranibizumab|mesh-list
55929730|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55929731|NCT01835067|Plasminogen|plasminogen|mesh-list
55929732|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55929733|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55929734|NCT01835067|Growth Substances|growth substances|mesh-ancestor
55929974|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55929975|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55929976|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55929977|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
55843886|NCT03662074|Gemcitabine|gemcitabine|mesh-list
55929979|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55929980|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55929981|NCT05045274|Analgesics|analgesics|mesh-ancestor
56002413|NCT01227655|Benserazide|benserazide|mesh-list
56002414|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56002415|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56002416|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
56002417|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769632|NCT05421819|Vitamin D|vitamin d|mesh-list
56002418|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002419|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002420|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56002421|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002422|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56002423|NCT00000316|Cocaine|cocaine|mesh-list
56002424|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
56002425|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
56002426|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002427|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002428|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
56002429|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002430|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56002431|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56002432|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56002433|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002434|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002435|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
56002436|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002437|NCT00001990|Atovaquone|atovaquone|mesh-list
56002438|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002439|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
56002440|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56002441|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56002442|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002443|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002444|NCT01026623|Sirolimus|sirolimus|mesh-list
56002445|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56002446|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56201777|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56201778|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56201779|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
56201780|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
56201781|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201782|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201783|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201784|NCT01530503|Capecitabine|capecitabine|mesh-list
56201785|NCT01530503|Mitomycins|mitomycins|mesh-list
56002447|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002448|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56002449|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002450|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
56002451|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56002452|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
56002453|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002454|NCT00001996|Atovaquone|atovaquone|mesh-list
56002455|NCT00001996|Pentamidine|pentamidine|mesh-list
56002456|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002457|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
56002458|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56002459|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56002460|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002495|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56002496|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56002497|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
56002499|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56002500|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002501|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56002502|NCT02157974|Incretins|incretins|mesh-ancestor
56002503|NCT02157974|Hormones|hormones|mesh-ancestor
56002504|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002505|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
56002506|NCT00000328|Narcotics|narcotics|mesh-ancestor
56002507|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002508|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002509|NCT00000328|Analgesics|analgesics|mesh-ancestor
56002510|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
56002511|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002512|NCT00380224|Olanzapine|olanzapine|mesh-list
56002513|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
56002514|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
56002515|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002516|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002517|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56002518|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56002519|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56002520|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002521|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56002522|NCT00380224|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56002523|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56002524|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002525|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002526|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002527|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
56002528|NCT02152982|Temozolomide|temozolomide|mesh-list
56002530|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56002531|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
56002532|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002533|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002534|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56002535|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002536|NCT00002002|Leucovorin|leucovorin|mesh-list
56003276|NCT00002110|Cysteamine|cysteamine|mesh-list
56201787|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56201788|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
56201789|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201790|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201791|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56201792|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
56201793|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003277|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
56003278|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003279|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003280|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003281|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003282|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
56003283|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003284|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003285|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003286|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56003287|NCT00001450|Paclitaxel|paclitaxel|mesh-list
56003288|NCT00001450|Cisplatin|cisplatin|mesh-list
56218218|NCT01636557|Warfarin|warfarin|mesh-list
56218219|NCT01636557|Vitamins|vitamins|mesh-ancestor
56003289|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56003290|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844304|NCT00082888|Tipifarnib|tipifarnib|mesh-list
56003291|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
56003292|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
56003293|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
56003294|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003295|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
56003296|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56003297|NCT00000580|Antibodies|antibodies|mesh-list
56003298|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
56003299|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56003300|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
56003301|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003302|NCT00002116|Cidofovir|cidofovir|mesh-list
56003303|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
56003304|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003305|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003306|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003308|NCT00001498|Paclitaxel|paclitaxel|mesh-list
56003309|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
56003310|NCT00001498|Doxorubicin|doxorubicin|mesh-list
56003311|NCT00001498|Fluorouracil|fluorouracil|mesh-list
56003312|NCT00001498|Methotrexate|methotrexate|mesh-list
56003313|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56003314|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003315|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
56003316|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
56003317|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
55844422|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785317|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55844430|NCT01679080|Teriparatide|teriparatide|mesh-list
56003318|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003319|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003320|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
56003321|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003812|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003813|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
56003814|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003815|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003816|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003817|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56003818|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56003819|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
56003821|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003823|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003824|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
56004020|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56004021|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
56004022|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56201794|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56201796|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56201797|NCT01530542|Narcotics|narcotics|mesh-ancestor
56201798|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736671|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56004023|NCT04756622|Expectorants|expectorants|mesh-ancestor
56004024|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
56004025|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56004123|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
56004124|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004125|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004126|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004127|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56004128|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56004129|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
56004130|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56004131|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
56004132|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
56004133|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004134|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004135|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004136|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56004137|NCT01199965|Analgesics|analgesics|mesh-ancestor
56004138|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
56004139|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004140|NCT00995501|Insulin|insulin|mesh-list
56004141|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56004142|NCT00995501|Dexamethasone|dexamethasone|mesh-list
56004143|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
56004227|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56004228|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
56004229|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56004230|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004231|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56004232|NCT02168855|Nicotine|nicotine|mesh-list
56004233|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56004234|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
56004235|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004236|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004237|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56004238|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56004239|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
56004240|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004241|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004242|NCT05751850|Leucovorin|leucovorin|mesh-list
56004243|NCT05751850|Gemcitabine|gemcitabine|mesh-list
56004244|NCT05751850|Paclitaxel|paclitaxel|mesh-list
56004245|NCT05751850|Fluorouracil|fluorouracil|mesh-list
56218279|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004246|NCT05751850|Oxaliplatin|oxaliplatin|mesh-list
56004247|NCT05751850|Calcium|calcium|mesh-list
56004248|NCT05751850|Levoleucovorin|levoleucovorin|mesh-list
56004249|NCT05751850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56004250|NCT05751850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004251|NCT05751850|Tubulin Modulators|tubulin modulators|mesh-ancestor
56004252|NCT05751850|Antimitotic Agents|antimitotic agents|mesh-ancestor
56004253|NCT05751850|Mitosis Modulators|mitosis modulators|mesh-ancestor
56004254|NCT05751850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004255|NCT05751850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56004256|NCT05751850|Antimetabolites|antimetabolites|mesh-ancestor
56004257|NCT05751850|Antiviral Agents|antiviral agents|mesh-ancestor
56004258|NCT05751850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004259|NCT05751850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004260|NCT05751850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56004261|NCT05751850|Immunologic Factors|immunologic factors|mesh-ancestor
56004265|NCT05751850|Protective Agents|protective agents|mesh-ancestor
56004266|NCT05751850|Vitamin B Complex|vitamin b complex|mesh-ancestor
56004267|NCT05751850|Vitamins|vitamins|mesh-ancestor
56004268|NCT05751850|Micronutrients|micronutrients|mesh-ancestor
55736741|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004269|NCT01938248|Aspirin|aspirin|mesh-list
56004270|NCT01938248|Apixaban|apixaban|mesh-list
56004271|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56004272|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56004273|NCT01938248|Analgesics|analgesics|mesh-ancestor
56004274|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
56004607|NCT01001975|Protective Agents|protective agents|mesh-ancestor
56004608|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004609|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
56004610|NCT01459484|Cisplatin|cisplatin|mesh-list
56004611|NCT01459484|Doxorubicin|doxorubicin|mesh-list
56004718|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
56004719|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004720|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56004721|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
56004722|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004723|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004724|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56004725|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004855|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56004856|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56004857|NCT01003769|Protective Agents|protective agents|mesh-ancestor
56201799|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201800|NCT01530542|Analgesics|analgesics|mesh-ancestor
56201801|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
56201802|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129533|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
56201803|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
56201804|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
56201805|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201806|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201807|NCT01530594|Lenalidomide|lenalidomide|mesh-list
56201808|NCT01530594|Bortezomib|bortezomib|mesh-list
56201809|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
56201810|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201811|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56201812|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56201813|NCT01530594|Growth Substances|growth substances|mesh-ancestor
56201814|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56201815|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201816|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
56201817|NCT01530607|Goserelin|goserelin|mesh-list
55736884|NCT03426761|Vancomycin|vancomycin|mesh-list
56201818|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56201819|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
56201820|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201821|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56201822|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56201823|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
56201824|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201825|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201826|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56201827|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56201828|NCT01530620|Propiverine|propiverine|mesh-list
56201829|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
56201830|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
55737090|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
56201838|NCT01530620|Urological Agents|urological agents|mesh-ancestor
56201875|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56201876|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
56201877|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201878|NCT01531049|Nicotine|nicotine|mesh-list
56201879|NCT01531049|Varenicline|varenicline|mesh-list
56129605|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56201880|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55845077|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56201882|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56201883|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201884|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55737422|NCT03569839|Propofol|propofol|mesh-list
56201885|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56201886|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
56201887|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56201904|NCT01531140|Laxatives|laxatives|mesh-ancestor
56201905|NCT01531166|Interferons|interferons|mesh-list
56201941|NCT01531309|S 20098|s 20098|mesh-list
56201942|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56201943|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56201944|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56201945|NCT01531322|Vaccines|vaccines|mesh-list
55737812|NCT03420469|Bupropion|bupropion|mesh-list
56202013|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202014|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202038|NCT01531790|Pemetrexed|pemetrexed|mesh-list
56202039|NCT01531790|Endostar protein|endostar protein|mesh-list
56202040|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202041|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202042|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202043|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56202044|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56202045|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56202077|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845224|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202113|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202137|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56202138|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56202139|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202140|NCT01532804|Bevacizumab|bevacizumab|mesh-list
56202141|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
56202142|NCT01532804|Raltitrexed|raltitrexed|mesh-list
56202143|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56202182|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56202183|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
56202184|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202193|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56202194|NCT01532895|Narcotics|narcotics|mesh-ancestor
56202195|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56202196|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202197|NCT01532895|Analgesics|analgesics|mesh-ancestor
56202198|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
56202199|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202200|NCT01532960|Poly ICLC|poly iclc|mesh-list
56202201|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
56202203|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202204|NCT01533090|Bisacodyl|bisacodyl|mesh-list
55845513|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55845514|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845515|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845516|NCT03588754|Propranolol|propranolol|mesh-list
55845517|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56202205|NCT01533090|Cathartics|cathartics|mesh-ancestor
56202206|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56202207|NCT01533090|Laxatives|laxatives|mesh-ancestor
56202208|NCT01533129|Testosterone|testosterone|mesh-list
56202209|NCT01533129|Androgens|androgens|mesh-ancestor
56202210|NCT01533129|Hormones|hormones|mesh-ancestor
56202211|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56202212|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202213|NCT01533155|Quinidine|quinidine|mesh-list
56218332|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56218333|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
56218334|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
56218335|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218336|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218337|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56202214|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
56202215|NCT01533155|Morphine|morphine|mesh-list
55763789|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
56202343|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
56202362|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202363|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202364|NCT01533662|Protective Agents|protective agents|mesh-ancestor
56202365|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56202376|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56202377|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56202378|NCT01533740|Growth Substances|growth substances|mesh-ancestor
56202379|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202380|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
56202381|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
56202382|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202383|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56202384|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56202385|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
56202386|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56202387|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56202388|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202390|NCT01533740|Protective Agents|protective agents|mesh-ancestor
55845850|NCT04631263|Protective Agents|protective agents|mesh-ancestor
55845851|NCT01929343|Lidocaine|lidocaine|mesh-list
55845852|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
55845884|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
55845885|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55845886|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845887|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55845888|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
55845889|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55845890|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
55845891|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845893|NCT03091192|Sunitinib|sunitinib|mesh-list
56202391|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
56202392|NCT01533740|Vitamins|vitamins|mesh-ancestor
56202393|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
56202394|NCT01533740|Hematinics|hematinics|mesh-ancestor
56202395|NCT01533818|Amoxicillin|amoxicillin|mesh-list
56202396|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56202397|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56202398|NCT01533870|Rifampin|rifampin|mesh-list
56202399|NCT01533870|Naloxegol|naloxegol|mesh-list
56202400|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56202401|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
56202402|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56202423|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202424|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202425|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56202427|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56202428|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56202429|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202430|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56202431|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56202432|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202433|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
56202434|NCT01534169|Dexamethasone|dexamethasone|mesh-list
56202435|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56202436|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
56202437|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
56202438|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202439|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202440|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56202441|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
56218433|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
56202442|NCT01534169|Hormones|hormones|mesh-ancestor
56202443|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56202444|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56202462|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56202463|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56202464|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
56202465|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202466|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202467|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56202468|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
56202469|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
56202470|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
56202471|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56202472|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56202473|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
56202474|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56202475|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202476|NCT01534455|Lapatinib|lapatinib|mesh-list
56202477|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202478|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56202479|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202480|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202481|NCT01534494|Psilocybin|psilocybin|mesh-list
56202482|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
56202483|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202484|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56202485|NCT01534546|Capecitabine|capecitabine|mesh-list
56202486|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
56202487|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56130214|NCT01923948|Pregabalin|pregabalin|mesh-list
56202488|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
56202489|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202490|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202492|NCT01534585|Mitogens|mitogens|mesh-list
56202493|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56202494|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202495|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
56202496|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
56202509|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
56202510|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202511|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56202512|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56202513|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56202514|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56202515|NCT01534754|Mesalamine|mesalamine|mesh-list
55740429|NCT03383315|Tramadol|tramadol|mesh-list
56202516|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56202517|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56202518|NCT01534754|Analgesics|analgesics|mesh-ancestor
55846339|NCT01546623|Leuprolide|leuprolide|mesh-list
56202519|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
56202520|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202521|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202522|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56202523|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56202525|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56202526|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56202527|NCT01534806|Analgesics|analgesics|mesh-ancestor
56202528|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
56202529|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56202530|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202531|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56202532|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56202533|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56202534|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846384|NCT05245786|Trace Elements|trace elements|mesh-ancestor
55846385|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
55846386|NCT00634504|Leucovorin|leucovorin|mesh-list
55846387|NCT00634504|Methotrexate|methotrexate|mesh-list
55846388|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
55846389|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55785352|NCT04648189|Cetuximab|cetuximab|mesh-list
56202535|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202536|NCT01534845|Temozolomide|temozolomide|mesh-list
56202537|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56202538|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
56202539|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56202540|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202541|NCT01534858|Polihexanide|polihexanide|mesh-list
56202542|NCT01534858|Betaine|betaine|mesh-list
56202543|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56202544|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
56202545|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55740486|NCT03387241|Hormones|hormones|mesh-ancestor
56202555|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202557|NCT01534949|Rituximab|rituximab|mesh-list
56202558|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56202559|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56202560|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
56202561|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202562|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56202564|NCT01535027|Teriparatide|teriparatide|mesh-list
56202565|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56202566|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56202567|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202568|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56202569|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56202570|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
56202571|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213218|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
56480263|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480264|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56480265|NCT01280968|Antacids|antacids|mesh-ancestor
56480266|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56480267|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56480268|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
56480269|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56480270|NCT02932020|Prednisolone|prednisolone|mesh-list
56480271|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
56480272|NCT02932020|Bupivacaine|bupivacaine|mesh-list
56480273|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56480274|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
56480275|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
56480276|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
56480277|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480278|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480279|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
56480280|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480281|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480283|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
56480284|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55846446|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
56480285|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
56480286|NCT02932020|Hormones|hormones|mesh-ancestor
56480287|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480288|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56480289|NCT02932020|Protective Agents|protective agents|mesh-ancestor
56480290|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56480291|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480292|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56480293|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56480294|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480295|NCT05466279|Midazolam|midazolam|mesh-list
56480296|NCT05466279|Propofol|propofol|mesh-list
56480297|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56480298|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480299|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480300|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56480301|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
56480302|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
56480303|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56480304|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56480305|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56480306|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56480307|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
56480308|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
56480309|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480310|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480311|NCT01280656|Interferons|interferons|mesh-list
56480312|NCT01280656|Ribavirin|ribavirin|mesh-list
56480313|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56480314|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56480315|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480316|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
56480317|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480318|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
56480319|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846699|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56480320|NCT03741530|Glyburide|glyburide|mesh-list
56480321|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56480322|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480323|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
56480324|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56480325|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
56480326|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480327|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56480328|NCT02932137|Interleukin-2|interleukin-2|mesh-list
56480329|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480330|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56480331|NCT02932137|Analgesics|analgesics|mesh-ancestor
56480332|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
56480333|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480334|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480335|NCT01280266|Amlodipine|amlodipine|mesh-list
56480336|NCT01280266|Udenafil|udenafil|mesh-list
56480337|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56480338|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56480339|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480340|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480341|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56480342|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480343|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
56480344|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56480345|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56480346|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480347|NCT02919917|Midodrine|midodrine|mesh-list
56480348|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
56480349|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
56480350|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480351|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480352|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56480353|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56480354|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56480355|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56480356|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
56480357|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480358|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480359|NCT01279447|Bupivacaine|bupivacaine|mesh-list
56480360|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
56480361|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
56480362|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480363|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480364|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
56480365|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480366|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
56480368|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
56480369|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480370|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480371|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
56480372|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480373|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56480374|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
56480375|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56480376|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480377|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480378|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56480379|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
56480380|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56480381|NCT02920190|Liraglutide|liraglutide|mesh-list
56480382|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56480383|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480384|NCT02920190|Incretins|incretins|mesh-ancestor
56480386|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480387|NCT02919878|Gemcitabine|gemcitabine|mesh-list
56480388|NCT02919878|Capecitabine|capecitabine|mesh-list
56480389|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56480390|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
56480391|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480392|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480393|NCT02919878|Antiviral Agents|antiviral agents|mesh-ancestor
56480394|NCT02919878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480395|NCT02919878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480396|NCT02919878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56480397|NCT02919878|Immunologic Factors|immunologic factors|mesh-ancestor
56480398|NCT02919878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480399|NCT02931786|Ketamine|ketamine|mesh-list
56480400|NCT02931786|Propofol|propofol|mesh-list
56480401|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56480402|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480403|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480404|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56480405|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
56480406|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
56480407|NCT02931786|Analgesics|analgesics|mesh-ancestor
56480408|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
56480409|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480410|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56480411|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56480412|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56480413|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480414|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480415|NCT02919605|Pentamidine|pentamidine|mesh-list
56480416|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
56480417|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480418|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56480419|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56480420|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56480421|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56480422|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56480423|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
56480424|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480425|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480426|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56480427|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56480428|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56480429|NCT05465733|Pemetrexed|pemetrexed|mesh-list
56228438|NCT01254422|Vaccines|vaccines|mesh-list
56480430|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480431|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480432|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480433|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56480434|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56480435|NCT03673787|Atezolizumab|atezolizumab|mesh-list
56480436|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480437|NCT03571802|Simvastatin|simvastatin|mesh-list
56480438|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56480439|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56202726|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
56480441|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480442|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56480443|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56480444|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480445|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
56480446|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56480447|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56480448|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480449|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
56480450|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
56480451|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480452|NCT05465304|Azithromycin|azithromycin|mesh-list
56480453|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56480454|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480455|NCT02919293|Vaccines|vaccines|mesh-list
56480456|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
56480457|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480458|NCT02919371|Bevacizumab|bevacizumab|mesh-list
56480459|NCT02919371|Sunitinib|sunitinib|mesh-list
56480460|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56480461|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480462|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56480463|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56480464|NCT02919371|Growth Substances|growth substances|mesh-ancestor
56480465|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480466|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
56480467|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56480468|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480469|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480470|NCT02919449|Atezolizumab|atezolizumab|mesh-list
56202769|NCT01536223|Cisplatin|cisplatin|mesh-list
56480471|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480473|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
56480474|NCT04736901|Apixaban|apixaban|mesh-list
56480475|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
55846949|NCT01903993|Docetaxel|docetaxel|mesh-list
56480476|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56480477|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
56480478|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56480479|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
56480480|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480481|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480482|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
56480483|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56480484|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56480485|NCT02919176|Pioglitazone|pioglitazone|mesh-list
56480486|NCT02919176|Mirabegron|mirabegron|mesh-list
56480487|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56480488|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480489|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56480490|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56480491|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56480492|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
56480493|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480494|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480495|NCT02919176|Urological Agents|urological agents|mesh-ancestor
56480496|NCT04734678|Infliximab|infliximab|mesh-list
56480497|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
56480498|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56480499|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56480500|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
56480501|NCT02919059|Glimepiride|glimepiride|mesh-list
56480502|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56480503|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480504|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56480505|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56202810|NCT01536314|Memantine|memantine|mesh-list
56480506|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56480507|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56480508|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
56480509|NCT04727775|Remdesivir|remdesivir|mesh-list
56480510|NCT04727775|Favipiravir|favipiravir|mesh-list
56480511|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
56480512|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480513|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
56480514|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480515|NCT02918825|Olanzapine|olanzapine|mesh-list
56480516|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56480517|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
56480518|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
56480519|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480520|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480521|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56480522|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56480523|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56480524|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480525|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56480526|NCT02918825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56480527|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56480528|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480529|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480530|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480531|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
56480532|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56480533|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56480534|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56480535|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56480536|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
56480537|NCT02918747|Gemcitabine|gemcitabine|mesh-list
56480538|NCT02918747|Dexamethasone|dexamethasone|mesh-list
56480539|NCT02918747|Prednisone|prednisone|mesh-list
56480540|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
56480541|NCT02918747|Doxorubicin|doxorubicin|mesh-list
56480542|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
56480543|NCT02918747|Vincristine|vincristine|mesh-list
56130593|NCT04552782|Ethanol|ethanol|mesh-list
56480544|NCT02918747|Pegaspargase|pegaspargase|mesh-list
56480545|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56480546|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
56480547|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480548|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56218569|NCT01637948|Listerine|listerine|mesh-list
56480549|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56480550|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
56480551|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480552|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480553|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56480554|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480555|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
56480556|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
56480557|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480558|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56480559|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
56480560|NCT02918747|Hormones|hormones|mesh-ancestor
56480561|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480562|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56480563|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56480564|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
56480565|NCT02918747|Antiviral Agents|antiviral agents|mesh-ancestor
56480566|NCT02918747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480567|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480568|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56480569|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56480570|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56480571|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56480572|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
56480573|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
56480575|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56480576|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
56480577|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480578|NCT02918591|Empagliflozin|empagliflozin|mesh-list
56480579|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56480580|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480581|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56480582|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480583|NCT04691817|Atezolizumab|atezolizumab|mesh-list
56480584|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480585|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
56480586|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
56480587|NCT02918045|Coagulants|coagulants|mesh-ancestor
56480588|NCT00532545|Teriparatide|teriparatide|mesh-list
56480589|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56480590|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480591|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56480592|NCT03778424|Rufinamide|rufinamide|mesh-list
56480593|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
56480594|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56480595|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56480596|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480597|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480598|NCT04687098|Idarubicin|idarubicin|mesh-list
56480599|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56480600|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480601|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56480602|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56480603|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480604|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480605|NCT00533520|Ranibizumab|ranibizumab|mesh-list
56480606|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56480607|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56480608|NCT00533520|Growth Substances|growth substances|mesh-ancestor
56480609|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480610|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
56480611|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480612|NCT03694262|Bevacizumab|bevacizumab|mesh-list
56480613|NCT03694262|Atezolizumab|atezolizumab|mesh-list
56480614|NCT03694262|Rucaparib|rucaparib|mesh-list
56480615|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56480616|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480617|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56480618|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56480619|NCT03694262|Growth Substances|growth substances|mesh-ancestor
56480620|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480621|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
56480622|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56480623|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480624|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480625|NCT05356104|Exenatide|exenatide|mesh-list
56480626|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56480627|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480628|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56480629|NCT05356104|Incretins|incretins|mesh-ancestor
56480630|NCT05356104|Hormones|hormones|mesh-ancestor
56480631|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480632|NCT03686150|Vitamin D|vitamin d|mesh-list
56480633|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
56480634|NCT03686150|Vitamins|vitamins|mesh-ancestor
56480635|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
56480636|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480637|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56480638|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56480639|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56480640|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480641|NCT03685253|Niacinamide|niacinamide|mesh-list
56480642|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
56480643|NCT03685253|Vitamins|vitamins|mesh-ancestor
56480644|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
56480645|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480646|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
56480647|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56480648|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480649|NCT00532584|Beclomethasone|beclomethasone|mesh-list
56480650|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480651|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
56480653|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480654|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480655|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56480656|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
56228671|NCT00379340|Etoposide|etoposide|mesh-list
56480657|NCT04687332|Tryptophan|tryptophan|mesh-list
55739694|NCT03398837|Dronabinol|dronabinol|mesh-list
56480658|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56480659|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
56480661|NCT05467709|Midazolam|midazolam|mesh-list
56480662|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55785393|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785394|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218604|NCT01638234|Melatonin|melatonin|mesh-list
56218605|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
56218606|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218607|NCT01638234|Protective Agents|protective agents|mesh-ancestor
56218608|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218609|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218610|NCT01638247|Tamoxifen|tamoxifen|mesh-list
56218611|NCT01638247|Goserelin|goserelin|mesh-list
56218612|NCT01638247|Exemestane|exemestane|mesh-list
56218613|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55794668|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480663|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56480664|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480665|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480666|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56480667|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56480668|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56480669|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56480670|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
56480671|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
56480672|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
56480673|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
56480674|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480675|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480676|NCT00532623|Gemcitabine|gemcitabine|mesh-list
56480677|NCT00532623|Vinorelbine|vinorelbine|mesh-list
56480678|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56480679|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
56480680|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480681|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480682|NCT00532623|Antiviral Agents|antiviral agents|mesh-ancestor
56480683|NCT00532623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480684|NCT00532623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480685|NCT00532623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56480686|NCT00532623|Immunologic Factors|immunologic factors|mesh-ancestor
56480687|NCT00532623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480688|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56480689|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
56480690|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
56480691|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
56480692|NCT05467670|Doxorubicin|doxorubicin|mesh-list
56480693|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56480695|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56480696|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480697|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56480698|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56480699|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480700|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480701|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56480702|NCT00532662|Ketamine|ketamine|mesh-list
56480703|NCT00532662|Analgesics|analgesics|mesh-ancestor
56480704|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
56480705|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480706|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480707|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56480708|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56480709|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
56480710|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
56480711|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480712|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56480713|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56480714|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480715|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480716|NCT05341167|Phenylephrine|phenylephrine|mesh-list
56480717|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
56480718|NCT05341167|Norepinephrine|norepinephrine|mesh-list
56480719|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56480720|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
56480721|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
56480722|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480723|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480724|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
56480725|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56480726|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
56480727|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
56480728|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56480729|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56480730|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56480731|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
56228742|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
56480732|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480733|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480734|NCT05341167|Protective Agents|protective agents|mesh-ancestor
56480735|NCT05467436|Analgesics|analgesics|mesh-list
56480737|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
56480738|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480739|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480740|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
56480741|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480742|NCT00533637|Cetirizine|cetirizine|mesh-list
56480743|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56480744|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56480745|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56480746|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
56480747|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
56480748|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480749|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480750|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480751|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
56480752|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56480753|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56480754|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
56480755|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480756|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480757|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480758|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
56480759|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
56480760|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480761|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
56480762|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56480763|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
56480764|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56480765|NCT05467319|Hematinics|hematinics|mesh-ancestor
56480766|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
56480767|NCT05466695|Tadalafil|tadalafil|mesh-list
56480768|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
56480769|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56480770|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56480771|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480772|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480773|NCT05466695|Urological Agents|urological agents|mesh-ancestor
56480774|NCT05466578|Abrocitinib|abrocitinib|mesh-list
56480775|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56480776|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480777|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480778|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
56480779|NCT04484610|Narcotics|narcotics|mesh-ancestor
56480780|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480781|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480782|NCT04484610|Analgesics|analgesics|mesh-ancestor
56480783|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
56480784|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480785|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56480786|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56480787|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480788|NCT05466149|Aflutinib|aflutinib|mesh-list
56480789|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56480790|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480791|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480792|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56480793|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
56480794|NCT00532701|Ribavirin|ribavirin|mesh-list
56480795|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
56480796|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480797|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
56480798|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480799|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
56480800|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480801|NCT01276639|Tofacitinib|tofacitinib|mesh-list
56480802|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56480803|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480804|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480805|NCT04449198|Resveratrol|resveratrol|mesh-list
56480806|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
55739794|NCT03393767|Growth Substances|growth substances|mesh-ancestor
56480807|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480808|NCT04449198|Protective Agents|protective agents|mesh-ancestor
56480809|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480810|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480811|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56480812|NCT00532415|Triamcinolone|triamcinolone|mesh-list
56480813|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56480814|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56480815|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56480816|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480817|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
56480818|NCT00532415|Hormones|hormones|mesh-ancestor
56203091|NCT01538316|Estrogens|estrogens|mesh-ancestor
56480819|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480820|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480821|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56480822|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
56480823|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480824|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480825|NCT00532454|Tamoxifen|tamoxifen|mesh-list
56480826|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56480827|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
56480828|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56480829|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480830|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56480831|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480832|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56480833|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56480834|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56480835|NCT01275625|Maraviroc|maraviroc|mesh-list
56480836|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56480837|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56480838|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480839|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56480840|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56480841|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
56480842|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56480843|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56480844|NCT05459792|Lidocaine|lidocaine|mesh-list
56480845|NCT05459792|Bupivacaine|bupivacaine|mesh-list
56480846|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
56480847|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
56480848|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480849|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480850|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
56480851|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480852|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56480853|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56480854|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56480855|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480856|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480857|NCT04686825|DA-8010|da-8010|mesh-list
56480858|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56480859|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56480860|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
56480861|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480862|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480863|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480864|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
56480865|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56480866|NCT05281185|Factor VIII|factor viii|mesh-list
56480867|NCT05281185|Coagulants|coagulants|mesh-ancestor
56480868|NCT00532532|Tolperisone|tolperisone|mesh-list
56480869|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56480870|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480871|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56480872|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480873|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
56480874|NCT00532571|Vitamins|vitamins|mesh-ancestor
56480875|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
56480876|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480878|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
56480879|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56480880|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
56480882|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
56480883|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480884|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480885|NCT04312503|Olanzapine|olanzapine|mesh-list
56480886|NCT04312503|Risperidone|risperidone|mesh-list
56480887|NCT04312503|Aripiprazole|aripiprazole|mesh-list
56480888|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56480889|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56480890|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56480891|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
56480892|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480893|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480894|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480895|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56480896|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56480897|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480898|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56480899|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56480900|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
56480901|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
56480902|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
56480903|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480904|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56480905|NCT04312503|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56480906|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56480907|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480908|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
56480909|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
56480910|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56480911|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56480912|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56480913|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56480914|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56480915|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56480916|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56480917|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
56480918|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
56480919|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55847999|NCT02384668|Vitamin D|vitamin d|mesh-list
56480920|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
56203241|NCT01538797|Ranitidine|ranitidine|mesh-list
56480924|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56480925|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
56480926|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480927|NCT00532688|Protective Agents|protective agents|mesh-ancestor
56480928|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480929|NCT00532688|Antidotes|antidotes|mesh-ancestor
56480933|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56480934|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
56480935|NCT00534144|Hematinics|hematinics|mesh-ancestor
56480936|NCT00534183|Haloperidol|haloperidol|mesh-list
56480937|NCT00534183|Olanzapine|olanzapine|mesh-list
56480938|NCT00534183|Risperidone|risperidone|mesh-list
56480939|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
56480940|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56480941|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
56480942|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56480943|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480944|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480945|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56480946|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56480947|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56480948|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56480949|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56480950|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
56480951|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
56480952|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
56480953|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480954|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56480955|NCT00534183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56480956|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56480957|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480958|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56480960|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56203257|NCT01538875|Labetalol|labetalol|mesh-list
56480961|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56480962|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56480963|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480964|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56480965|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480967|NCT00532727|Carboplatin|carboplatin|mesh-list
56480968|NCT00532727|Docetaxel|docetaxel|mesh-list
56480969|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480970|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
56480971|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
56480972|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
56480973|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480974|NCT04261218|Paclitaxel|paclitaxel|mesh-list
56480975|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56480976|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480977|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
56480978|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
56480979|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
56480980|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480981|NCT04687449|Curcumin|curcumin|mesh-list
56480982|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56480983|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56480984|NCT04687449|Analgesics|analgesics|mesh-ancestor
56480985|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
56480986|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56480987|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56480988|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56480989|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56480990|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480991|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56480992|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56480993|NCT05258279|Carboplatin|carboplatin|mesh-list
56480994|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
56480995|NCT05258279|Pemetrexed|pemetrexed|mesh-list
56480996|NCT05258279|Lenvatinib|lenvatinib|mesh-list
56480997|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56480998|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56480999|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481000|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481001|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56481002|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56481003|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56481004|NCT00532818|Hydralazine|hydralazine|mesh-list
56481005|NCT00532818|Valproic Acid|valproic acid|mesh-list
56481006|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
56481007|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481008|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481009|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
56481010|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481011|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481012|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
56481013|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56481014|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481015|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56481016|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56481017|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
56481018|NCT05209035|Trazodone|trazodone|mesh-list
56481019|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56481020|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56481021|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481022|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481023|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56481024|NCT05209035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56203343|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481025|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56481026|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56481027|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481028|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481029|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
56481030|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56481031|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
56481033|NCT00534261|Interferon-beta|interferon-beta|mesh-list
56481034|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
56481035|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481036|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
56481037|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481038|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
56481039|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481040|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56481041|NCT00532857|Gemcitabine|gemcitabine|mesh-list
56481043|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56481044|NCT00532857|Trastuzumab|trastuzumab|mesh-list
56481045|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56481046|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481047|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
56481048|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
56481049|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
56481050|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481051|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56481052|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
56481053|NCT00532857|Antiviral Agents|antiviral agents|mesh-ancestor
56481054|NCT00532857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481055|NCT00532857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481056|NCT00532857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56481057|NCT00532857|Immunologic Factors|immunologic factors|mesh-ancestor
56481058|NCT00532857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481066|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
56481075|NCT05152004|Amoxicillin|amoxicillin|mesh-list
56481076|NCT05152004|Metronidazole|metronidazole|mesh-list
56481077|NCT05152004|Clarithromycin|clarithromycin|mesh-list
56481078|NCT05152004|Rabeprazole|rabeprazole|mesh-list
56481079|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56481080|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481081|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56481082|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56481083|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56481084|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481085|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481086|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56481087|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56481088|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56481089|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56481090|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56481092|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56481093|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56481094|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
56481095|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56481096|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56481097|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481098|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481099|NCT05132153|Protective Agents|protective agents|mesh-ancestor
56481100|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481102|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56481103|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56481104|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481105|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481106|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56481107|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56481108|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56481109|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56481110|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
56481112|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
56481113|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
56481114|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481115|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481116|NCT05131997|Atorvastatin|atorvastatin|mesh-list
56481117|NCT05131997|Ezetimibe|ezetimibe|mesh-list
56481118|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56481119|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56481120|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
56481121|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481122|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56481123|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56481124|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481125|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
56481126|NCT00534456|Hematinics|hematinics|mesh-ancestor
56481127|NCT05104229|Aspirin|aspirin|mesh-list
56481128|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56481129|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56481130|NCT05104229|Analgesics|analgesics|mesh-ancestor
56481131|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
56481132|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481133|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481134|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56481135|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56481136|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56481137|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56481138|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481139|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56481140|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56203454|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
56481141|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481142|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
56481143|NCT04153032|Diltiazem|diltiazem|mesh-list
56481144|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56481145|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56481146|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56481147|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481148|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56481149|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481150|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
56481151|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56481152|NCT00532961|Tobramycin|tobramycin|mesh-list
56481153|NCT00532961|Dexamethasone|dexamethasone|mesh-list
56481154|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56481155|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
56481156|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
56481157|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481158|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218663|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56481159|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56481160|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
56481161|NCT00532961|Hormones|hormones|mesh-ancestor
55848171|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56486007|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481162|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56481163|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56481164|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481165|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56218688|NCT01638650|Ritonavir|ritonavir|mesh-list
56481166|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481167|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56481168|NCT00534573|Amisulpride|amisulpride|mesh-list
56481169|NCT00534573|Moclobemide|moclobemide|mesh-list
56481170|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56481171|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56481172|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481173|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481174|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56481175|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56218701|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56218703|NCT01638663|Tolvaptan|tolvaptan|mesh-list
56481176|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
56481177|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481178|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481179|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56229195|NCT01697436|Ribavirin|ribavirin|mesh-list
56481180|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
56203495|NCT01540032|Salicylates|salicylates|mesh-list
56481181|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56481182|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848732|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848735|NCT01451086|Vaccines|vaccines|mesh-list
56481183|NCT04686890|Acetaminophen|acetaminophen|mesh-list
56481184|NCT04686890|Tramadol|tramadol|mesh-list
56481185|NCT04686890|Analgesics|analgesics|mesh-list
56481186|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56208693|NCT01578265|Ondansetron|ondansetron|mesh-list
56481187|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
56481188|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481189|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481190|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
56481191|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56481192|NCT04686890|Narcotics|narcotics|mesh-ancestor
55849119|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849220|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849222|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
56481193|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481194|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
56481195|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56481196|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481197|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481198|NCT05103306|Empagliflozin|empagliflozin|mesh-list
55849339|NCT02493322|Olmesartan|olmesartan|mesh-list
56481199|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56481200|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481201|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56481202|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481203|NCT05047952|Vortioxetine|vortioxetine|mesh-list
56481204|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
56481205|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56481206|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55849525|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
56481207|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56481208|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481209|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481210|NCT05047952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56481211|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56481212|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56481213|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481214|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481215|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
55850245|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
56481216|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56481217|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56481218|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56481219|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56481220|NCT00534651|Acetaminophen|acetaminophen|mesh-list
56481221|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56481222|NCT00534651|Analgesics|analgesics|mesh-ancestor
56481223|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
56481224|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481225|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481226|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
56481227|NCT05080959|Ropivacaine|ropivacaine|mesh-list
56481228|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
56481229|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
56481230|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850606|NCT02319304|Leucovorin|leucovorin|mesh-list
56481231|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481233|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481234|NCT01274338|Interferons|interferons|mesh-list
56481235|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
56481236|NCT01274338|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56481237|NCT01274338|Ipilimumab|ipilimumab|mesh-list
56481238|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481239|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
56481240|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481241|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56481242|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56481243|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481244|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
56481245|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481246|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
56481247|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
56481248|NCT04942730|Busulfan|busulfan|mesh-list
56481249|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55850738|NCT00820846|Vaccines|vaccines|mesh-list
56481250|NCT04942730|Fludarabine|fludarabine|mesh-list
56481251|NCT04942730|Tacrolimus|tacrolimus|mesh-list
56481252|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56481253|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
56229283|NCT01698164|Estradiol|estradiol|mesh-list
56481254|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481255|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56481256|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56481257|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
56481258|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481259|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481260|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56481261|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56481262|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481263|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56481264|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56481265|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
56481266|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56481267|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481268|NCT01272193|Insulin|insulin|mesh-list
56481269|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56481270|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
56481271|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
56481272|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56481273|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481274|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
56481275|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56481276|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
56481277|NCT04687163|Fluorouracil|fluorouracil|mesh-list
56481278|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481279|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
56481280|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481281|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851595|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
55851600|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
56481282|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56481283|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
56481284|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481285|NCT01270828|Pregabalin|pregabalin|mesh-list
56481286|NCT01270828|Analgesics|analgesics|mesh-ancestor
56481287|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
56481288|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481289|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481290|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
56481291|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56481292|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56481293|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481294|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56481295|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56481296|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56481297|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481298|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56481299|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
56481300|NCT00533195|Methoxsalen|methoxsalen|mesh-list
56481301|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56481302|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
56481303|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56481304|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56481305|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56481306|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481307|NCT01269385|Rituximab|rituximab|mesh-list
55852289|NCT00118144|Bortezomib|bortezomib|mesh-list
56481308|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56481309|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
56481310|NCT01269385|Antibodies|antibodies|mesh-list
56481311|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
56481312|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56481313|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
55852457|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56481314|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481315|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481316|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56481317|NCT03878589|Oxytocin|oxytocin|mesh-list
56481318|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
56481319|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55852687|NCT01763996|Febuxostat|febuxostat|mesh-list
56481320|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481321|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
56481322|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56481323|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481324|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
56481325|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481326|NCT02071862|Paclitaxel|paclitaxel|mesh-list
56481327|NCT02071862|Docetaxel|docetaxel|mesh-list
56481328|NCT02071862|Everolimus|everolimus|mesh-list
56481329|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56481330|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853050|NCT00271570|Antibodies|antibodies|mesh-list
56481331|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
56481332|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
56481333|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
56486008|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56481334|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481335|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56481336|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
56481337|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481338|NCT00535691|Tacrolimus|tacrolimus|mesh-list
56481339|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56481340|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
56481341|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481342|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56481343|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853708|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481344|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481345|NCT01268683|Glyburide|glyburide|mesh-list
56481346|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56481347|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481349|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56481350|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481351|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
55854297|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56481352|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56481353|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56481354|NCT01268293|Lenvatinib|lenvatinib|mesh-list
56481355|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481356|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56481357|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854662|NCT00410488|BB 1101|bb 1101|mesh-list
56481358|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481359|NCT01803152|Gemcitabine|gemcitabine|mesh-list
56481360|NCT01803152|Imiquimod|imiquimod|mesh-list
56481361|NCT01803152|Vaccines|vaccines|mesh-list
56481362|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
56481363|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854826|NCT00424840|Carboplatin|carboplatin|mesh-list
56481364|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56481365|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
56481366|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481367|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481368|NCT01803152|Antiviral Agents|antiviral agents|mesh-ancestor
56481369|NCT01803152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481370|NCT01803152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481371|NCT01803152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56481372|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56481373|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
56481374|NCT04959825|Melatonin|melatonin|mesh-list
56481375|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
56481376|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481377|NCT04959825|Protective Agents|protective agents|mesh-ancestor
56481378|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481379|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481380|NCT05471453|Tocotrienols|tocotrienols|mesh-list
56481381|NCT05471453|Vitamin E|vitamin e|mesh-list
56481382|NCT05471453|Tocopherols|tocopherols|mesh-list
56481383|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56481384|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56481385|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
56481386|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481387|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
56481388|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481389|NCT05471453|Protective Agents|protective agents|mesh-ancestor
56481390|NCT05471453|Vitamins|vitamins|mesh-ancestor
56481391|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
56481392|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56481393|NCT03457233|Cetrorelix|cetrorelix|mesh-list
56481394|NCT03457233|Menotropins|menotropins|mesh-list
56481395|NCT03457233|Progesterone|progesterone|mesh-list
56481396|NCT03457233|Progestins|progestins|mesh-ancestor
56481397|NCT03457233|Hormones|hormones|mesh-ancestor
56481398|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855683|NCT01452789|Morphine|morphine|mesh-list
56481399|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481400|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56481401|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56481402|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
56481403|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
56481404|NCT00535808|Nitroprusside|nitroprusside|mesh-list
56481405|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
56481406|NCT00535808|Sevoflurane|sevoflurane|mesh-list
56481407|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56481408|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56481409|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
56481410|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
56481411|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856309|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56481412|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481413|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
56481414|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56481415|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55856615|NCT01425801|Albuterol|albuterol|mesh-list
56481416|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481418|NCT05471063|Amphotericin B|amphotericin b|mesh-list
55856765|NCT01391793|Hormones|hormones|mesh-ancestor
56481419|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56481420|NCT05471063|Flucytosine|flucytosine|mesh-list
56481421|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
56481422|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
56481423|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857042|NCT01750268|Topiramate|topiramate|mesh-list
56481424|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56481425|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56481426|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481427|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481428|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56481429|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
56481430|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56481431|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481432|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56481433|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56481434|NCT05471063|Amebicides|amebicides|mesh-ancestor
56481435|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56481436|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56481437|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56481438|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
56481439|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56481440|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
56481441|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56481442|NCT05471063|Protective Agents|protective agents|mesh-ancestor
56481443|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481444|NCT04910100|Timolol|timolol|mesh-list
56481445|NCT04910100|Nebivolol|nebivolol|mesh-list
56481446|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56481447|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56481448|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56481449|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56481450|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
56481451|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481452|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56203733|NCT01541267|Telmisartan|telmisartan|mesh-list
56481453|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481454|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56481455|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56481456|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
56481457|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56481458|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56481459|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56481460|NCT01268059|Paclitaxel|paclitaxel|mesh-list
56481461|NCT01268059|Carboplatin|carboplatin|mesh-list
56481462|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56481463|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481464|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
56481465|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
56481466|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
56481467|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481468|NCT01267825|Bupivacaine|bupivacaine|mesh-list
56481469|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
56481470|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
56481471|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481472|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481473|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
56481474|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481475|NCT00536003|Progesterone|progesterone|mesh-list
56481476|NCT00536003|Progestins|progestins|mesh-ancestor
56481477|NCT00536003|Hormones|hormones|mesh-ancestor
56219415|NCT01651416|Lumefantrine|lumefantrine|mesh-list
56481478|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802219|NCT04789915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55858244|NCT04198623|Montelukast|montelukast|mesh-list
56481479|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481480|NCT00533091|Sifalimumab|sifalimumab|mesh-list
56481481|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
56481482|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481483|NCT00536042|Minocycline|minocycline|mesh-list
56219498|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
56481484|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56481485|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481486|NCT01606384|Vasopressins|vasopressins|mesh-list
56481487|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
56481488|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
56481489|NCT01606384|Coagulants|coagulants|mesh-ancestor
56481490|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56481491|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56481492|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
56481493|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481494|NCT01606462|Oxytocin|oxytocin|mesh-list
56481495|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
56481496|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56481497|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481498|NCT05470595|Atezolizumab|atezolizumab|mesh-list
56481499|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481500|NCT01606540|Ibuprofen|ibuprofen|mesh-list
56481501|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55859075|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
56481502|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56481503|NCT01606540|Analgesics|analgesics|mesh-ancestor
56481504|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
56481505|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481506|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481507|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56481508|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56481509|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56481510|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481511|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481512|NCT00533169|Tretinoin|tretinoin|mesh-list
56481513|NCT00533169|Isotretinoin|isotretinoin|mesh-list
56481514|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481515|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
56481516|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
56481517|NCT00593710|Losartan|losartan|mesh-list
56481518|NCT00593710|Atenolol|atenolol|mesh-list
55859285|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56481519|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56481520|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56481521|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56481522|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56481523|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481524|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
56481525|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
56481526|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481527|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859683|NCT00619060|Vitamins|vitamins|mesh-ancestor
56481528|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56481529|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56481530|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56481531|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
56481532|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481533|NCT04885686|Formaldehyde|formaldehyde|mesh-list
55859898|NCT00629122|Miconazole|miconazole|mesh-list
56481535|NCT04885686|Dexamethasone|dexamethasone|mesh-list
56481536|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
56481537|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56481538|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
56481539|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
56481540|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481541|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481542|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56481543|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
56481545|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56481546|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56481547|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481548|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
55860335|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
56481549|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481550|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56481551|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
56481552|NCT00594217|Progesterone|progesterone|mesh-list
56481553|NCT00594217|Progestins|progestins|mesh-ancestor
56481554|NCT00594217|Hormones|hormones|mesh-ancestor
56219687|NCT01652560|Bevacizumab|bevacizumab|mesh-list
56481555|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56481556|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481557|NCT00536237|Niacin|niacin|mesh-list
56481559|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
55861036|NCT05582265|Paclitaxel|paclitaxel|mesh-list
56481560|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481561|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481562|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56481563|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
56481564|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56481565|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
56481566|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
56481567|NCT00536237|Vitamins|vitamins|mesh-ancestor
56481568|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
56481569|NCT00533247|Celecoxib|celecoxib|mesh-list
56481570|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56481571|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56481572|NCT00533247|Analgesics|analgesics|mesh-ancestor
56481573|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
56481574|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481575|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481576|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56481577|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56481578|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56481579|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56481580|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481581|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481582|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56481583|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481584|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56481585|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481586|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481588|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
56481589|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
56481590|NCT00536276|Vitamins|vitamins|mesh-list
56481591|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
55861157|NCT01273090|Imetelstat|imetelstat|mesh-list
56481592|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481593|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56481594|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56481595|NCT02690064|Vitamins|vitamins|mesh-list
56481596|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
56481597|NCT02690064|Vitamin E|vitamin e|mesh-list
56481598|NCT02690064|Tocopherols|tocopherols|mesh-list
56481599|NCT02690064|Tocotrienols|tocotrienols|mesh-list
56481600|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
56481601|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
56481602|NCT02690064|Ubiquinone|ubiquinone|mesh-list
56481603|NCT02690064|Resveratrol|resveratrol|mesh-list
56481604|NCT02690064|Antioxidants|antioxidants|mesh-list
56481605|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
55861381|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
55861575|NCT04406025|Anesthetics|anesthetics|mesh-list
56481606|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861644|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
56481607|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481608|NCT02690064|Protective Agents|protective agents|mesh-ancestor
56481609|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481610|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55861922|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
56481611|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
56481612|NCT00594373|Tenofovir|tenofovir|mesh-list
56481613|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
56481614|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481615|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56481616|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56481617|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481618|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481619|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56481620|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56481621|NCT05470166|Lidocaine|lidocaine|mesh-list
56481622|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
56481623|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
56481624|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481625|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481626|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
56481627|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481628|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55862501|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481629|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56481630|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56481631|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56481632|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481633|NCT02496585|Prednisone|prednisone|mesh-list
56481634|NCT02496585|Nintedanib|nintedanib|mesh-list
56481635|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56481636|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
56481638|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56481639|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862986|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
56481640|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56481641|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481642|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56481643|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481644|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481645|NCT01260142|Propofol|propofol|mesh-list
56481646|NCT01260142|Fospropofol|fospropofol|mesh-list
56481647|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56481648|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481649|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481650|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56481651|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
56481652|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
56481653|NCT02116335|Bosentan|bosentan|mesh-list
56481654|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56219928|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56481655|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56481656|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481657|NCT05469659|Metformin|metformin|mesh-list
56481658|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
56481659|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56481660|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481661|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56481662|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481663|NCT01808820|Imiquimod|imiquimod|mesh-list
56481664|NCT01808820|Vaccines|vaccines|mesh-list
56481665|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
56481666|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481667|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56481668|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481669|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
56481670|NCT05469386|Methylphenidate|methylphenidate|mesh-list
56481671|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56481672|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863591|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
55863592|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55863628|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863630|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55863686|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55863687|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55863688|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
55863689|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
55863722|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55863724|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
55863725|NCT05640778|Cyclophosphamide|cyclophosphamide|mesh-list
55863726|NCT05640778|Taxane|taxane|mesh-list
55863727|NCT05640778|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55863728|NCT05640778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55863729|NCT05640778|Immunologic Factors|immunologic factors|mesh-ancestor
55863730|NCT05640778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863731|NCT05640778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55785677|NCT05737693|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55785678|NCT05737693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55785686|NCT05737693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55785687|NCT05737693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56220018|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
56220019|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220020|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56220021|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56220022|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220023|NCT01654575|Methotrexate|methotrexate|mesh-list
56481673|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56481674|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56481675|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56481676|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481677|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
56481678|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481679|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56481680|NCT01468896|Cetuximab|cetuximab|mesh-list
55785689|NCT05737693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55785690|NCT05737693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56220024|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56220025|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
56481681|NCT01468896|Interleukin-12|interleukin-12|mesh-list
56481682|NCT01468896|Antibodies|antibodies|mesh-list
56481683|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
56481684|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56481685|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
56481686|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481687|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481688|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56481689|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55785692|NCT05737693|GABA Agents|gaba agents|mesh-ancestor
55785693|NCT05728619|Temozolomide|temozolomide|mesh-list
55785694|NCT05728619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55785695|NCT05728619|Alkylating Agents|alkylating agents|mesh-ancestor
56220026|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56220027|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220028|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56220029|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
56220030|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220031|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220032|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
56220033|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220034|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56220035|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56220036|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
56220037|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56220038|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56220039|NCT01654640|Metformin|metformin|mesh-list
56220040|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56220041|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220042|NCT01654692|Ipilimumab|ipilimumab|mesh-list
56220043|NCT01654692|Fotemustine|fotemustine|mesh-list
56220044|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56220045|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220046|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56220047|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220048|NCT01654705|Pantoprazole|pantoprazole|mesh-list
56220049|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56220050|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220051|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56220052|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481690|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56481691|NCT01468896|Growth Substances|growth substances|mesh-ancestor
56481692|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56481693|NCT01462890|Paclitaxel|paclitaxel|mesh-list
56481694|NCT01462890|Bevacizumab|bevacizumab|mesh-list
56481695|NCT01462890|Carboplatin|carboplatin|mesh-list
56481696|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56481697|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481698|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56481699|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56481700|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56220055|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56220056|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220057|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56220058|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220059|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220060|NCT01654809|Vaccines|vaccines|mesh-list
56220061|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
56220062|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220063|NCT01654913|Chrysarobin|chrysarobin|mesh-list
56220064|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56220065|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56220066|NCT01654913|Analgesics|analgesics|mesh-ancestor
56220067|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
56220068|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220069|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220070|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56220071|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56220072|NCT01654939|Rifaximin|rifaximin|mesh-list
56220073|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56220074|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220075|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220076|NCT01654965|Topotecan|topotecan|mesh-list
56220077|NCT01654965|Lenograstim|lenograstim|mesh-list
56220078|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56220079|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
56220080|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220081|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56220082|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56220083|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812205|NCT02395081|Vitamin D|vitamin d|mesh-list
55811983|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
55811984|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811985|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55811986|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55811987|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481701|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481702|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56481703|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56481704|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56481705|NCT01462890|Growth Substances|growth substances|mesh-ancestor
56481706|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481707|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
55785696|NCT05728619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785697|NCT05728619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220084|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220085|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220086|NCT01655004|Exemestane|exemestane|mesh-list
56220087|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481708|NCT05469113|Repaglinide|repaglinide|mesh-list
56481709|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56481710|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481711|NCT01259713|Amphotericin B|amphotericin b|mesh-list
56203964|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
56481712|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56481715|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56481716|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481717|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56481718|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
56481719|NCT05469035|Heparin|heparin|mesh-list
55785699|NCT05737303|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55785700|NCT05737303|Carboplatin|carboplatin|mesh-list
55785701|NCT05737303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55785702|NCT05737303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220088|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56220089|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56220090|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220091|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220092|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56220093|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
56220094|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220095|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220096|NCT01655056|Darexaban|darexaban|mesh-list
56220097|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56220098|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
56220099|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56220100|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
56220101|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220102|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220103|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
56220104|NCT01655082|Nicotine|nicotine|mesh-list
56220105|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56481720|NCT05469035|Calcium heparin|calcium heparin|mesh-list
56481721|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
56481722|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56481723|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56481724|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481725|NCT05582590|Cyclophosphamide|cyclophosphamide|mesh-list
56481726|NCT05582590|Fludarabine|fludarabine|mesh-list
56481727|NCT05582590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56220106|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
56220107|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220108|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220109|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56220110|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55796110|NCT05552807|Paclitaxel|paclitaxel|mesh-list
56220111|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
56220112|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220113|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220115|NCT01655095|Bisacodyl|bisacodyl|mesh-list
56220116|NCT01655095|Laxatives|laxatives|mesh-ancestor
56220117|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220118|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56220119|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56220120|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
56220121|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220122|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220123|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220124|NCT01655095|Cathartics|cathartics|mesh-ancestor
56220125|NCT01655108|Minoxidil|minoxidil|mesh-list
56220126|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56220127|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
56220128|NCT01655147|Rifampin|rifampin|mesh-list
56220129|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
56220130|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220131|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56220132|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220133|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220134|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
55785703|NCT05737303|Tubulin Modulators|tubulin modulators|mesh-ancestor
55785704|NCT05737303|Antimitotic Agents|antimitotic agents|mesh-ancestor
55785705|NCT05737303|Mitosis Modulators|mitosis modulators|mesh-ancestor
55785706|NCT05737303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481728|NCT05582590|Immunologic Factors|immunologic factors|mesh-ancestor
56481729|NCT05582590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481730|NCT05582590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56481731|NCT05582590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56481732|NCT05582590|Alkylating Agents|alkylating agents|mesh-ancestor
56481733|NCT05582590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481734|NCT05582590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481735|NCT05582590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56481736|NCT05468879|Glimepiride|glimepiride|mesh-list
56481737|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56481738|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56481739|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481740|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56481741|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
56220135|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220136|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220137|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56220138|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56220139|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
56220140|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56220141|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796156|NCT05552651|Paclitaxel|paclitaxel|mesh-list
55785708|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55785709|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55785710|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785711|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56481742|NCT05471427|Docetaxel|docetaxel|mesh-list
56481743|NCT05471427|Taxane|taxane|mesh-list
56481744|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481745|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
56481746|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
56481747|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
56481748|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481749|NCT05558449|Midazolam|midazolam|mesh-list
56481750|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56481751|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56481752|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481753|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481754|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56481755|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56481756|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56481757|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56481758|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
56481759|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
56220142|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
56220143|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56220144|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56220145|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55796165|NCT04981327|Apixaban|apixaban|mesh-list
56481760|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
56481761|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
56481762|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481763|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481764|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
56481765|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56481766|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
56481767|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481768|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
56481769|NCT04326985|Protective Agents|protective agents|mesh-ancestor
56481770|NCT00536393|Doxorubicin|doxorubicin|mesh-list
56481771|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56481772|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56481773|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481774|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55785712|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55785713|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
55785714|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220146|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56220147|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56220148|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56220149|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56220150|NCT01655199|Albuterol|albuterol|mesh-list
56220151|NCT01655199|Ipratropium|ipratropium|mesh-list
56220152|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56220153|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
56220154|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220155|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220156|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56220157|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
56220158|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
56220159|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56220160|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56220161|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56220162|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56220168|NCT01655212|Valganciclovir|valganciclovir|mesh-list
56481775|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56481776|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481777|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481778|NCT00595543|Ketorolac|ketorolac|mesh-list
56481779|NCT00595543|Diclofenac|diclofenac|mesh-list
56481780|NCT00595543|Bromfenac|bromfenac|mesh-list
56481781|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56481782|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56481783|NCT00595543|Analgesics|analgesics|mesh-ancestor
56481784|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
56481785|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481786|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220182|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56220183|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
56220184|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
56220185|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
56220186|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220187|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56220188|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56220189|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56220190|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56220192|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56220193|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56220194|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56220195|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220196|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56220197|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220198|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
56220199|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
56220200|NCT01655524|Aminophylline|aminophylline|mesh-list
56220201|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56220202|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
56220203|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481787|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56204003|NCT01542827|Analgesics|analgesics|mesh-list
56481789|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56481790|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481791|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481793|NCT04326868|Mebendazole|mebendazole|mesh-list
56481794|NCT04326868|Benzimidazole|benzimidazole|mesh-list
56481795|NCT04326868|Pyrantel|pyrantel|mesh-list
56481796|NCT04326868|Anthelmintics|anthelmintics|mesh-list
56220204|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220205|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55785715|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55785716|NCT05188313|Paclitaxel|paclitaxel|mesh-list
55785717|NCT05188313|Carboplatin|carboplatin|mesh-list
55785718|NCT05188313|Trastuzumab|trastuzumab|mesh-list
56481797|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56481798|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481799|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
56481800|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56481801|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56481802|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
56481803|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
56481804|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
56481805|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481806|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481807|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
56481808|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56220207|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56220208|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55785720|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55785721|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785722|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
55812251|NCT02424097|Listerine|listerine|mesh-list
56220209|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220210|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220211|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56220212|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56220213|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
56220214|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220215|NCT01655524|Protective Agents|protective agents|mesh-ancestor
56220216|NCT01655628|Gemcitabine|gemcitabine|mesh-list
56220217|NCT01655628|Cisplatin|cisplatin|mesh-list
56481809|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56481810|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56481811|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220219|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56481812|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481813|NCT05458024|Vitamin D|vitamin d|mesh-list
56481814|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
56481815|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
56481816|NCT05458024|Vitamins|vitamins|mesh-list
56481817|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
56220220|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
56220221|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220222|NCT01655628|Antiviral Agents|antiviral agents|mesh-ancestor
56220223|NCT01655628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220224|NCT01655628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220225|NCT01655628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56220226|NCT01655628|Immunologic Factors|immunologic factors|mesh-ancestor
56220227|NCT01655628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796246|NCT02518113|Hormones|hormones|mesh-ancestor
55785728|NCT05737069|Ibuprofen arginine|ibuprofen arginine|mesh-list
55785729|NCT05737069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55785730|NCT05737069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55785731|NCT05737069|Analgesics|analgesics|mesh-ancestor
56481818|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481819|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56481820|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56481821|NCT00595972|Endostar protein|endostar protein|mesh-list
56481822|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56481823|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56481824|NCT00595972|Growth Substances|growth substances|mesh-ancestor
56481825|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481826|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
56481827|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481828|NCT00596050|Lidocaine|lidocaine|mesh-list
56481829|NCT00596050|Fentanyl|fentanyl|mesh-list
56481830|NCT00596050|Midazolam|midazolam|mesh-list
56481831|NCT00596050|Ketamine|ketamine|mesh-list
56220228|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
56220229|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56220230|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56220231|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220232|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
56220233|NCT01655641|Coagulants|coagulants|mesh-ancestor
56220234|NCT01655706|Aripiprazole|aripiprazole|mesh-list
56220235|NCT01655706|Citalopram|citalopram|mesh-list
56220236|NCT01655706|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56220237|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56220238|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56220239|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220240|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220241|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
55796252|NCT05541107|Amebicides|amebicides|mesh-ancestor
56220242|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220243|NCT01655706|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56220244|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
55785732|NCT05737069|Sensory System Agents|sensory system agents|mesh-ancestor
55785733|NCT05737069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785734|NCT05737069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785735|NCT05737069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785736|NCT05737069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55785737|NCT05737069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55785738|NCT05737069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785739|NCT05737069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481832|NCT00596050|Etomidate|etomidate|mesh-list
56481833|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
56481834|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
56481835|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481836|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481837|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
56481838|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481839|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56481840|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56481841|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56481842|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56481843|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481844|NCT00596050|Analgesics|analgesics|mesh-ancestor
56481845|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56481846|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56481847|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
56481848|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56481849|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56481850|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481851|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56481852|NCT00596050|Narcotics|narcotics|mesh-ancestor
56481853|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56481854|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56481855|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56481856|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56481857|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56481858|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
56481859|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
56220254|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56220255|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56220256|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55785740|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55785741|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785742|NCT03066011|Voriconazole|voriconazole|mesh-list
55785743|NCT03066011|Posaconazole|posaconazole|mesh-list
56481860|NCT02888899|Loperamide|loperamide|mesh-list
56481861|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
56481862|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
56481863|NCT02888899|Psyllium|psyllium|mesh-list
56481864|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56481865|NCT02888899|Cathartics|cathartics|mesh-ancestor
56481866|NCT05468645|Hemay005|hemay005|mesh-list
56481867|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
56481868|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56481869|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56481870|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481871|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481872|NCT00596128|Insulin|insulin|mesh-list
56481873|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55785744|NCT03066011|Isavuconazole|isavuconazole|mesh-list
55785745|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
55785746|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785747|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55785748|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55785749|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785750|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785751|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55785752|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
55785753|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785754|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785755|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55785756|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55812075|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55812077|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812078|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55812079|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55812080|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812082|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55812083|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55812084|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55812085|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
55812086|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812088|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
55812089|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812090|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
55812093|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
55812094|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
55812095|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
55812096|NCT02399449|Hematinics|hematinics|mesh-ancestor
55812098|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812099|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812100|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
55812101|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55812102|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812103|NCT02428855|Dasatinib|dasatinib|mesh-list
55812104|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812105|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55812106|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812107|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812108|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
55812109|NCT02428699|Liver Extracts|liver extracts|mesh-list
55812110|NCT02428699|Hematinics|hematinics|mesh-ancestor
55812112|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
55812113|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481874|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481875|NCT00596206|Leflunomide|leflunomide|mesh-list
56481876|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481877|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481878|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56481879|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
56481880|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481881|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56481882|NCT00624130|Dacuronium|dacuronium|mesh-list
56481883|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55785757|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55812114|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55812115|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
55812116|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55812117|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
55812118|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812119|NCT02427841|Gemcitabine|gemcitabine|mesh-list
55812120|NCT02427841|Paclitaxel|paclitaxel|mesh-list
55812121|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55812122|NCT02427841|Fluorouracil|fluorouracil|mesh-list
55812123|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55812124|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812125|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
55812126|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
55812127|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
55812128|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812129|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55812130|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
55812131|NCT02427841|Antiviral Agents|antiviral agents|mesh-ancestor
55812132|NCT02427841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812133|NCT02427841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812134|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55812135|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
55812136|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812137|NCT02397889|Midazolam|midazolam|mesh-list
55812138|NCT02397889|Ketamine|ketamine|mesh-list
55812139|NCT02397889|Analgesics|analgesics|mesh-ancestor
55812140|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
55812141|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843831|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
55812147|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55812148|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55812149|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55812150|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812151|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812152|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55812153|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55812154|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55812155|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55812156|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55812158|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
55812159|NCT02396953|Lanreotide|lanreotide|mesh-list
55812160|NCT02396953|Somatostatin|somatostatin|mesh-list
55812161|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812163|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812164|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812165|NCT02387983|Posaconazole|posaconazole|mesh-list
55812166|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
55812167|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812168|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55812169|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55812170|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55812171|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55812172|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55812174|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812175|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55812176|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
55812177|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812178|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812179|NCT05370313|Nicotine|nicotine|mesh-list
55812180|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56481884|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481885|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56481886|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56481887|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56481888|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481889|NCT05468450|Polidocanol|polidocanol|mesh-list
56481890|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
56481891|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56220259|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220260|NCT01655758|Timolol|timolol|mesh-list
56220261|NCT01655758|Bimatoprost|bimatoprost|mesh-list
56220262|NCT01655758|Travoprost|travoprost|mesh-list
55785758|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55785759|NCT03135769|Avelumab|avelumab|mesh-list
56481892|NCT05399329|Palbociclib|palbociclib|mesh-list
56481893|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481894|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56481895|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481896|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481897|NCT00535860|Teriparatide|teriparatide|mesh-list
56481898|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56481899|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220264|NCT01655758|Latanoprost|latanoprost|mesh-list
56220265|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56220266|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56220267|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
55796288|NCT04981093|Hormones|hormones|mesh-ancestor
55785760|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55785761|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837226|NCT02015195|Ethanol|ethanol|mesh-list
55812181|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
55812182|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812183|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812184|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55812185|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55812186|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
55812188|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812189|NCT02395627|Tamoxifen|tamoxifen|mesh-list
55812190|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
55812191|NCT02395627|Vorinostat|vorinostat|mesh-list
55812192|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55812193|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812194|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55812195|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
55812196|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812197|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812198|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55812199|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55812200|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55812202|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55812203|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812204|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812206|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
55812207|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
55812216|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
55812217|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
55812218|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812220|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55812221|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55812222|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55812224|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812225|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812226|NCT02426125|Docetaxel|docetaxel|mesh-list
55812227|NCT02426125|Ramucirumab|ramucirumab|mesh-list
55812228|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812229|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
55812230|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
55812231|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
55812232|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812233|NCT02425111|Vedolizumab|vedolizumab|mesh-list
55812234|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55812235|NCT02393755|Capecitabine|capecitabine|mesh-list
55812236|NCT02393755|Nintedanib|nintedanib|mesh-list
55812237|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55812238|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
55812239|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812240|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812241|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56481900|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56481901|NCT00596479|Lenograstim|lenograstim|mesh-list
56481902|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56481903|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
56481904|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481905|NCT05468372|Amphotericin B|amphotericin b|mesh-list
56481906|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56481907|NCT05468372|Posaconazole|posaconazole|mesh-list
56481908|NCT05468372|Amebicides|amebicides|mesh-ancestor
56481909|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56481910|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56481911|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481912|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56481913|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
56481914|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56481915|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56481916|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56220268|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220269|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220270|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796292|NCT05551247|Endostatins|endostatins|mesh-list
55785762|NCT03123211|Veliparib|veliparib|mesh-list
55785763|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56481917|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481918|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481919|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56481920|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
56481921|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56481922|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481923|NCT04207957|Olorofim|olorofim|mesh-list
56481924|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
56481925|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56481926|NCT00596557|Everolimus|everolimus|mesh-list
56481927|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481928|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56481929|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
56481930|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481931|NCT00596596|Prucalopride|prucalopride|mesh-list
56481932|NCT00596596|Laxatives|laxatives|mesh-ancestor
56481933|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56481934|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56481935|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56481936|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
56481937|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481938|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481939|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229945|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56481941|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56220271|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56220272|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56220273|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56220274|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56220275|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55785764|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785765|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785766|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785767|NCT05520749|Luspatercept|luspatercept|mesh-list
55785768|NCT05520749|Hematinics|hematinics|mesh-ancestor
56220276|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220277|NCT01655810|Vitamin D|vitamin d|mesh-list
56220278|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
56220279|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
56220280|NCT01655810|Vitamins|vitamins|mesh-list
56220281|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
56220282|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
56220283|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220284|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56220285|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56220286|NCT01655810|Antacids|antacids|mesh-ancestor
56220287|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220288|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220316|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56220317|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56220318|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220319|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
56220320|NCT01655927|Coagulants|coagulants|mesh-ancestor
56220321|NCT01655966|Vitamin D|vitamin d|mesh-list
56220322|NCT01655966|Interferons|interferons|mesh-list
56220323|NCT01655966|Ribavirin|ribavirin|mesh-list
55785775|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785776|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55812242|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812244|NCT02393209|Serabelisib|serabelisib|mesh-list
56220325|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
56220326|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220327|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55785777|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55785779|NCT02382445|Propofol|propofol|mesh-list
55785780|NCT02382445|Sevoflurane|sevoflurane|mesh-list
56481942|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481943|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56481944|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481945|NCT05312866|Acetaminophen|acetaminophen|mesh-list
56481946|NCT05312866|Dexamethasone|dexamethasone|mesh-list
56481947|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
56481948|NCT05312866|Fentanyl|fentanyl|mesh-list
56481949|NCT05312866|Bupivacaine|bupivacaine|mesh-list
56220328|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220329|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
56220330|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220331|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
56220332|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220333|NCT01655992|Capecitabine|capecitabine|mesh-list
55785781|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785782|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785783|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55785784|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55785785|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
55785786|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55785787|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55785788|NCT05736757|Plasminogen|plasminogen|mesh-list
55785789|NCT05736757|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55785790|NCT05736757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55785791|NCT05736757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55785792|NCT05736757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481950|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56481951|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
56481952|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
56481953|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481954|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481955|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56481956|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
56481958|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56481959|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55785793|NCT04483739|Dexamethasone|dexamethasone|mesh-list
55785794|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
55785795|NCT04483739|Lenalidomide|lenalidomide|mesh-list
55785796|NCT04483739|BB 1101|bb 1101|mesh-list
55785797|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785798|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
55785799|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
55785800|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785801|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785802|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55785803|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
55785804|NCT04483739|Hormones|hormones|mesh-ancestor
56220334|NCT01655992|Tegafur|tegafur|mesh-list
56220335|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56220336|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
55785805|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785806|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55785807|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785808|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
55785809|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785810|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785811|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
55785812|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55785813|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55785814|NCT04483739|Growth Substances|growth substances|mesh-ancestor
55785815|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
55785816|NCT05473715|Aflibercept|aflibercept|mesh-list
55785817|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55785818|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55785819|NCT05473715|Growth Substances|growth substances|mesh-ancestor
56481960|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481961|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
56481962|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
56481963|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56481964|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
56481965|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56481966|NCT05312866|Narcotics|narcotics|mesh-ancestor
56481967|NCT05312866|Analgesics|analgesics|mesh-ancestor
56481968|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56481969|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56481970|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
56481971|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56481972|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
56481973|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56481974|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
56481975|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56220337|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220338|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220339|NCT01656005|Beclomethasone|beclomethasone|mesh-list
56220340|NCT01656005|Carvedilol|carvedilol|mesh-list
56220341|NCT01656005|Bisoprolol|bisoprolol|mesh-list
56220342|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
56220343|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
56220344|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56220345|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
56220346|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220347|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220348|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56220349|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
56220350|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56220351|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56220352|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55785820|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785821|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
55785822|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220353|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
56220354|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220355|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220356|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
56220357|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56220358|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
56481976|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56481977|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481978|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56481979|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
56481980|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56481981|NCT04326790|Colchicine|colchicine|mesh-list
56481982|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
56481983|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56481984|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
56481985|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
56481986|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
56481987|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220359|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56220360|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56220361|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55785823|NCT05727475|Fluorides|fluorides|mesh-list
55785824|NCT05727475|Cariostatic Agents|cariostatic agents|mesh-ancestor
55785825|NCT05727475|Protective Agents|protective agents|mesh-ancestor
56220363|NCT01656005|Protective Agents|protective agents|mesh-ancestor
56220364|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56220365|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56220366|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56220367|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
56481988|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56481989|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56481990|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56481991|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56481992|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56481993|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56481994|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56481995|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56481996|NCT00596986|Analgesics|analgesics|mesh-ancestor
56481997|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
56220368|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56220369|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56220370|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
56220371|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56220372|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56220373|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
56220374|NCT01656005|Hormones|hormones|mesh-ancestor
56220375|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220376|NCT01656018|Rilpivirine|rilpivirine|mesh-list
56220377|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56220378|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56220379|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220380|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220381|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
56220416|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56220417|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56220418|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
55796437|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
56481998|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56481999|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
56482000|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56482001|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
56482002|NCT00597064|Prednisone|prednisone|mesh-list
56482003|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482004|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
56482005|NCT00597064|Hormones|hormones|mesh-ancestor
56482006|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220419|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220420|NCT01656122|Abacavir|abacavir|mesh-list
56220421|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56220422|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56220423|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220424|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220425|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
56220426|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220427|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56220428|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56220429|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
56220430|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56220431|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56220432|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220433|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
56220434|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56220435|NCT01656226|Protective Agents|protective agents|mesh-ancestor
56220436|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220437|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
56220438|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
56220439|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56220440|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
55796440|NCT05535413|Capecitabine|capecitabine|mesh-list
55785826|NCT05727475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785828|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55785829|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55785830|NCT05091775|Analgesics|analgesics|mesh-ancestor
55785831|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
55785832|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482007|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482008|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56482009|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220445|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
56482010|NCT00597181|Mitomycins|mitomycins|mesh-list
56482011|NCT00597181|Mitomycin|mitomycin|mesh-list
56482012|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56482013|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482014|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
56482015|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482016|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56482017|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482018|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56482019|NCT00597259|Entecavir|entecavir|mesh-list
56482020|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
56482021|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482022|NCT05470764|Amlodipine|amlodipine|mesh-list
56482023|NCT05470764|Perindopril|perindopril|mesh-list
56482024|NCT05470764|Indapamide|indapamide|mesh-list
56482025|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56220446|NCT01656512|Vitamin D|vitamin d|mesh-list
56220447|NCT01656512|Diphosphonates|diphosphonates|mesh-list
56220448|NCT01656512|Calcium|calcium|mesh-list
56220449|NCT01656512|Vitamins|vitamins|mesh-ancestor
56220450|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
56220451|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220452|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56220453|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56220454|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56220455|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
56220456|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220457|NCT01656538|Paclitaxel|paclitaxel|mesh-list
56220458|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56220459|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220460|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
56220461|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
55785835|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482026|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56204218|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
56482027|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56482028|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482029|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56482030|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482031|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
55785855|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
55785856|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55785857|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56220466|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220468|NCT01656642|Vemurafenib|vemurafenib|mesh-list
55785858|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
55785859|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55785860|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55812246|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
55812247|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
55812248|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
56482032|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56482033|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
56482034|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482035|NCT05470764|Diuretics|diuretics|mesh-ancestor
56482036|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
56482037|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56482038|NCT00597415|Celecoxib|celecoxib|mesh-list
56482039|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56482040|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56482041|NCT00597415|Analgesics|analgesics|mesh-ancestor
56482042|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
56220469|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220470|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55785861|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55785862|NCT02631551|Analgesics|analgesics|mesh-ancestor
55785863|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
55785864|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785865|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785866|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55785867|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55785868|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55785869|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
55785870|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
55792930|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
56482043|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482044|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482045|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482046|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482047|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56482048|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56482049|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482050|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482051|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
56482052|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56482053|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482054|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
56482055|NCT05470530|Dexamethasone|dexamethasone|mesh-list
56482056|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482057|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
56482058|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
56204276|NCT01544634|Hormones|hormones|mesh-ancestor
55785871|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785872|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785873|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
55785874|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56220471|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796489|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482059|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482060|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482061|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482062|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
56482063|NCT05470530|Hormones|hormones|mesh-ancestor
56482064|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482065|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56482066|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482067|NCT02891980|Vaccines|vaccines|mesh-list
55785875|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56220472|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220473|NCT01656668|Theobromine|theobromine|mesh-list
56220474|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56220475|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
56220476|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220477|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220478|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56220479|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
55812378|NCT02345161|Budesonide|budesonide|mesh-list
56482068|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
56482069|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482070|NCT05467826|Ribavirin|ribavirin|mesh-list
56482071|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
56482072|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56482073|NCT05467826|Velpatasvir|velpatasvir|mesh-list
56482074|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
56482075|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220480|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
56220482|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
56220483|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
56220484|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220485|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220486|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56220487|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56220488|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56220489|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56220490|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
56220491|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796496|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55785876|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482076|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
56482077|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482078|NCT00598156|Bevacizumab|bevacizumab|mesh-list
56482079|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56482080|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482081|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482082|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56482083|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56482084|NCT00598156|Growth Substances|growth substances|mesh-ancestor
56482085|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482086|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
56482087|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56482088|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220492|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220493|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
56220494|NCT01656798|Citric Acid|citric acid|mesh-list
56220495|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
56220496|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
56220497|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56220498|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
56220499|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
56220500|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785877|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55785879|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
56482089|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482090|NCT00598195|Ketamine|ketamine|mesh-list
56482092|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
56482093|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482094|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482095|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56482096|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56482097|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
56482098|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
56482099|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482100|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56220502|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56220503|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56220504|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220505|NCT01656798|Urological Agents|urological agents|mesh-ancestor
56220506|NCT01656811|Albuterol|albuterol|mesh-list
56220507|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56220508|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
56220509|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796516|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785880|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785881|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55785882|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55785883|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55812430|NCT02379091|Methotrexate|methotrexate|mesh-list
55812431|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
55812432|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55812433|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
55812434|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55812437|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
55812438|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812439|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812440|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
55812441|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812442|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55812443|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55812444|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
55812445|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55812446|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55812447|NCT02379091|Antidotes|antidotes|mesh-ancestor
55812448|NCT02379091|Protective Agents|protective agents|mesh-ancestor
55812451|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
55812452|NCT02379091|Hematinics|hematinics|mesh-ancestor
55812454|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55812455|NCT02378935|Velpatasvir|velpatasvir|mesh-list
55812456|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
55812457|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812459|NCT02250651|Bimatoprost|bimatoprost|mesh-list
55812460|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55812461|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55812462|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
55812463|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812464|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812465|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812468|NCT02214225|Vaccines|vaccines|mesh-list
55812469|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
55812470|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812471|NCT02249949|Efatutazone|efatutazone|mesh-list
55812472|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482101|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56482102|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482103|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482104|NCT00598234|Celecoxib|celecoxib|mesh-list
56482105|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56482106|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56482107|NCT00598234|Analgesics|analgesics|mesh-ancestor
56482108|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
56220510|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220511|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56220512|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
56220513|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
56220514|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56220515|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56220516|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56220517|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56220518|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
56220519|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220520|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220522|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56220523|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
56220524|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220525|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220526|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
56220527|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
56220528|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
56220529|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220530|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220531|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220532|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56220533|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
56220534|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
56220535|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220536|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220537|NCT01657071|Aspirin|aspirin|mesh-list
56220538|NCT01657071|Clopidogrel|clopidogrel|mesh-list
56220539|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56220541|NCT01657071|Analgesics|analgesics|mesh-ancestor
56482109|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482110|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482111|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482112|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482113|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56482114|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56482115|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482116|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482117|NCT00598429|Alprostadil|alprostadil|mesh-list
56482118|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56482119|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
56482120|NCT00598429|Urological Agents|urological agents|mesh-ancestor
56482121|NCT00598624|Treosulfan|treosulfan|mesh-list
56482122|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55785884|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
55785885|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785886|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220546|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56220547|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56482123|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
56482124|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482125|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482126|NCT02891785|Antipain|antipain|mesh-list
56482127|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
56482128|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482129|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482130|NCT00598858|Prednisone|prednisone|mesh-list
56482131|NCT00598858|Cortisone|cortisone|mesh-list
56482132|NCT00598858|Docetaxel|docetaxel|mesh-list
56482133|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482134|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
55785888|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55785889|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56220548|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56220549|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220550|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56482135|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
56482136|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
56482137|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482138|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482139|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
56482140|NCT00598858|Hormones|hormones|mesh-ancestor
56482141|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785890|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55785891|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220551|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56220552|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220553|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
56482142|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482143|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56482145|NCT05466305|Trace Elements|trace elements|mesh-ancestor
56482146|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
56482147|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482148|NCT04207684|Testosterone|testosterone|mesh-list
56482149|NCT04207684|Androgens|androgens|mesh-ancestor
56482150|NCT04207684|Hormones|hormones|mesh-ancestor
56482151|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482152|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482153|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
56482154|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
55802228|NCT04811911|Methotrexate|methotrexate|mesh-list
56482155|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482156|NCT02909400|Protective Agents|protective agents|mesh-ancestor
56482157|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482158|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
56482159|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482160|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482161|NCT02909478|Dexamethasone|dexamethasone|mesh-list
56482162|NCT02909478|Aprepitant|aprepitant|mesh-list
56482163|NCT02909478|Tropisetron|tropisetron|mesh-list
56482164|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482166|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
55785893|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785894|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785895|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55785896|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785899|NCT05092945|Niacinamide|niacinamide|mesh-list
55785900|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55785901|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
55785902|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785903|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55785904|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
55785905|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
55785906|NCT05092945|Vitamins|vitamins|mesh-ancestor
55785907|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
55785908|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785909|NCT05634707|Temozolomide|temozolomide|mesh-list
56220554|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56220555|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55785910|NCT05634707|Fluoxetine|fluoxetine|mesh-list
55785911|NCT05634707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55785912|NCT05634707|Alkylating Agents|alkylating agents|mesh-ancestor
56220556|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56220557|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
56220558|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220559|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
56220560|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56220561|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220562|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56220563|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56220564|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
56220565|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482167|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482168|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482169|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482170|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
56482171|NCT02909478|Hormones|hormones|mesh-ancestor
56482172|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482173|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56482174|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482175|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56482176|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482177|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785913|NCT05634707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220574|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220576|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
56220577|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220578|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796588|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56220579|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56220580|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56220581|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56220582|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56220583|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56220584|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56220585|NCT01657240|Analgesics|analgesics|mesh-ancestor
56220586|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
55785914|NCT05634707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785915|NCT05634707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55785916|NCT05634707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55785917|NCT05634707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56482178|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56482179|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56482180|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
56482181|NCT00536211|Metformin|metformin|mesh-list
56482182|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56482183|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482184|NCT00536705|Montelukast|montelukast|mesh-list
56482185|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56482186|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
56482187|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56482188|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
56482189|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482190|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482191|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56482192|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56482193|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482194|NCT00624208|Droperidol|droperidol|mesh-list
56482195|NCT00624208|Ondansetron|ondansetron|mesh-list
56482196|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
56482197|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
56482198|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482199|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482200|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482201|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
56220587|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796600|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482202|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
56482203|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56482204|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
56482205|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482206|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482207|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56482208|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56204355|NCT01544959|Fentanyl|fentanyl|mesh-list
56482209|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482211|NCT00624208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56482212|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56482213|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56482214|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56220588|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220589|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56220590|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56220591|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56220592|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56220593|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56220594|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
56220595|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
56220596|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220597|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220598|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56220599|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220600|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56220601|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56220602|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56220603|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
56220604|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220605|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482215|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
56482216|NCT05262400|Letrozole|letrozole|mesh-list
56482217|NCT05262400|Fulvestrant|fulvestrant|mesh-list
56482218|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482219|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56482220|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56482221|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482222|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482223|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56482224|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
56482225|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482226|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785918|NCT05634707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785919|NCT05634707|Serotonin Agents|serotonin agents|mesh-ancestor
56220606|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56220607|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
56220608|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56220609|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220610|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
56220611|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
56220612|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56220613|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56220614|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56220615|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56220616|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56220617|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220618|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
56220619|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220620|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220621|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56220622|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220624|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
56220625|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
56220626|NCT01657448|Methylene Blue|methylene blue|mesh-list
56220627|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56220628|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220629|NCT01657448|Renal Agents|renal agents|mesh-ancestor
56220630|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55812450|NCT02379091|Vitamins|vitamins|mesh-ancestor
55812473|NCT02249091|Cytarabine|cytarabine|mesh-list
55812474|NCT02249091|Idarubicin|idarubicin|mesh-list
55812475|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55812476|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
55812477|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812478|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812479|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
55812480|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482227|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56482228|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56482229|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56482230|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
56482231|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56482232|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56482233|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56482234|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482235|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220632|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220633|NCT01657487|Fluticasone|fluticasone|mesh-list
56220634|NCT01657487|Xhance|xhance|mesh-list
56220635|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56220636|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56220637|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56220638|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56220639|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
56220640|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220641|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785920|NCT05634707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785921|NCT05634707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56220642|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56220643|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
56220644|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
56220645|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56220646|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56220647|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56220648|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56220649|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
56482236|NCT02465164|Oxytocin|oxytocin|mesh-list
56482237|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
56482238|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56482239|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482241|NCT04685642|Atorvastatin|atorvastatin|mesh-list
56482242|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56482243|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56482244|NCT04685642|Analgesics|analgesics|mesh-ancestor
56482245|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
55785922|NCT05634707|Antidepressive Agents|antidepressive agents|mesh-ancestor
55785923|NCT05634707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55785924|NCT05634707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56220650|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220651|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220652|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
56220653|NCT01657487|Hormones|hormones|mesh-ancestor
56220654|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220655|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
56220656|NCT01657578|Omeprazole|omeprazole|mesh-list
56220657|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56220658|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220659|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56220660|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220661|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220662|NCT01657656|Vitamin D|vitamin d|mesh-list
56220663|NCT01657656|Vitamins|vitamins|mesh-ancestor
56220664|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
56220665|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796665|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
56220666|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56220667|NCT01657669|Aflibercept|aflibercept|mesh-list
56220668|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56220669|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56220670|NCT01657669|Growth Substances|growth substances|mesh-ancestor
56220671|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785925|NCT05634707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55785926|NCT05634707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785927|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
55785928|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55785929|NCT04447235|Ivermectin|ivermectin|mesh-list
55785930|NCT04447235|Losartan|losartan|mesh-list
56482246|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482247|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482248|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482249|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482250|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56482251|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56482252|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220673|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220674|NCT01657682|Crenolanib|crenolanib|mesh-list
56220675|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220676|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56220677|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
56220678|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
56482253|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56482254|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56482255|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482256|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
56482257|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56482258|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56482259|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
56482260|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56482261|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56482262|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
56482263|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
56220679|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220680|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785931|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55785932|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55785933|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55785934|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56482264|NCT05312346|Hematinics|hematinics|mesh-ancestor
56482265|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
56482266|NCT05312346|Vitamins|vitamins|mesh-ancestor
56482267|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
56482268|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482269|NCT05568563|Ethyl Chloride|ethyl chloride|mesh-list
56482270|NCT05568563|Anesthetics, Local|anesthetics, local|mesh-ancestor
56482271|NCT05568563|Anesthetics|anesthetics|mesh-ancestor
56482272|NCT05568563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482273|NCT05568563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482274|NCT05568563|Sensory System Agents|sensory system agents|mesh-ancestor
56482275|NCT05568563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482276|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56220681|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56220682|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56220683|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
56220684|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796692|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785935|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785936|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55785937|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785938|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
56482277|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482278|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56482279|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482280|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482281|NCT05469984|Gentamicins|gentamicins|mesh-list
56482282|NCT05469984|Ampicillin|ampicillin|mesh-list
56482283|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56482284|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482285|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56482286|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482287|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482288|NCT05312190|Progesterone|progesterone|mesh-list
56482289|NCT05312190|Progestins|progestins|mesh-ancestor
56482290|NCT05312190|Hormones|hormones|mesh-ancestor
56482291|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482292|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482293|NCT00537173|Paclitaxel|paclitaxel|mesh-list
56482294|NCT00537173|Bevacizumab|bevacizumab|mesh-list
56220685|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220686|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
56220687|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55812467|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56482295|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56482296|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482297|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
56482298|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
56482299|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
56482300|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482301|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482302|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56482303|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56482304|NCT00537173|Growth Substances|growth substances|mesh-ancestor
56482305|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785939|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55785940|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220688|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482306|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
56482308|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56482309|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56482310|NCT02503839|Analgesics|analgesics|mesh-ancestor
56482311|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
56230338|NCT01704716|Melphalan|melphalan|mesh-list
56482312|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482313|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482314|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482315|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482316|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56482317|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55785942|NCT01700569|Folic Acid|folic acid|mesh-list
55785943|NCT01700569|Temozolomide|temozolomide|mesh-list
55785944|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
55785945|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785946|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55785947|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
56220689|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220690|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56220692|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
56220693|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220694|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56220695|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56220696|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56220697|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
56220698|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220699|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220700|NCT01657825|Isavuconazole|isavuconazole|mesh-list
56220702|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
56220703|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
56220704|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220705|NCT01657838|Ketoconazole|ketoconazole|mesh-list
56220706|NCT01657838|Isavuconazole|isavuconazole|mesh-list
56220707|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
56220708|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796701|NCT02452047|Imipenem|imipenem|mesh-list
55812497|NCT02309515|Vaccines|vaccines|mesh-list
56482318|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482319|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482320|NCT05469750|Capecitabine|capecitabine|mesh-list
56482321|NCT05469750|Letrozole|letrozole|mesh-list
56482322|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56482323|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
56482324|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482325|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482326|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56482327|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56482328|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785948|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785949|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220709|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56220710|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56220711|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220712|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220713|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56220714|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
56220715|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220716|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796725|NCT02474355|Osimertinib|osimertinib|mesh-list
55785950|NCT01700569|Antidotes|antidotes|mesh-ancestor
55785951|NCT01700569|Protective Agents|protective agents|mesh-ancestor
55785952|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
55785953|NCT01700569|Vitamins|vitamins|mesh-ancestor
55785954|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
56220717|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56220718|NCT01657851|Tamsulosin|tamsulosin|mesh-list
56220719|NCT01657851|Dutasteride|dutasteride|mesh-list
56220720|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56220721|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56220722|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56220723|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
56220724|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220725|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785955|NCT01700569|Hematinics|hematinics|mesh-ancestor
55785956|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
55785957|NCT05090761|Buprenorphine|buprenorphine|mesh-list
56482329|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56482330|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
56482331|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482332|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482333|NCT05525078|Nicotine|nicotine|mesh-list
56482334|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56482335|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
56482336|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220726|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220727|NCT01657851|Urological Agents|urological agents|mesh-ancestor
56220728|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56220729|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56220730|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220731|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
56220732|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220733|NCT01657864|Lamotrigine|lamotrigine|mesh-list
56220734|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
56220735|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56220736|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56220737|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220738|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55796739|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55785959|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56220739|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220740|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56482337|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482338|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56482339|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56482340|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
56482341|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482342|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482343|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
56482344|NCT02143830|Busulfan|busulfan|mesh-list
56482345|NCT02143830|Fludarabine|fludarabine|mesh-list
56482346|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
56482347|NCT02143830|Lenograstim|lenograstim|mesh-list
56482348|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785960|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
55785961|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
55785962|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785963|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220741|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56220742|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56220743|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56220744|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56220745|NCT01657890|Isavuconazole|isavuconazole|mesh-list
56220746|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
56220747|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220748|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56220749|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56220750|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
56220751|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220752|NCT01657929|Antacids|antacids|mesh-ancestor
56220753|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220754|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482349|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
56482350|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482351|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482352|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56482353|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
56482354|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482355|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482356|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56482357|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56482358|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
56482359|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56220759|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220760|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220761|NCT01657513|Adalimumab|adalimumab|mesh-list
56220762|NCT01657513|Etanercept|etanercept|mesh-list
56220763|NCT01657513|Infliximab|infliximab|mesh-list
56220764|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56220765|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56220766|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
55785971|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
55812505|NCT02309359|Methotrexate|methotrexate|mesh-list
55812581|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
55812582|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55812583|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812584|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
55812585|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
55812586|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812587|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55812588|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55812589|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55812590|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55812591|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55812592|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55812593|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
55812594|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
55812595|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812596|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812597|NCT01935700|Colchicine|colchicine|mesh-list
55812598|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
55812599|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55812600|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
55812601|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
55812602|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
55812603|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812611|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812612|NCT04771767|Ketamine|ketamine|mesh-list
55812621|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55812622|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55812623|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55812624|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812625|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812627|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55812628|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812629|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
55812630|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
55812631|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812632|NCT02340949|Leucovorin|leucovorin|mesh-list
55812633|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
55812634|NCT02340949|Aflibercept|aflibercept|mesh-list
55812635|NCT02340949|Fluorouracil|fluorouracil|mesh-list
55812636|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812638|NCT02340949|Protective Agents|protective agents|mesh-ancestor
55812639|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812640|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
56220767|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220768|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56220769|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56220771|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
56220772|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220773|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220774|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56220775|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
56220776|NCT01657981|Darexaban|darexaban|mesh-list
56220777|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56482360|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482361|NCT03457194|Vaccines|vaccines|mesh-list
56482362|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
56482363|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482364|NCT05478707|Dulaglutide|dulaglutide|mesh-list
56482365|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56482366|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482367|NCT05469204|Acetaminophen|acetaminophen|mesh-list
56482368|NCT05469204|Digoxin|digoxin|mesh-list
56482369|NCT05469204|Midazolam|midazolam|mesh-list
56482370|NCT05469204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56482371|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56482372|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56482373|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482374|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482375|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56482376|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55785972|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55785973|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55785974|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220788|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482378|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56482379|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
56482380|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
56482381|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
56482382|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
56482383|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482384|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482385|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56482386|NCT05469204|Analgesics|analgesics|mesh-ancestor
56220789|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
56220790|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56220791|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
56220792|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220793|NCT01658033|Leucovorin|leucovorin|mesh-list
56220794|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
56220795|NCT01658033|Bevacizumab|bevacizumab|mesh-list
56220796|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220797|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56220798|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56220799|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56220800|NCT01658033|Growth Substances|growth substances|mesh-ancestor
55796804|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
56482387|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
56482388|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482389|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
56482390|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56482391|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56482392|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482393|NCT05469204|Protective Agents|protective agents|mesh-ancestor
56482394|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
56482395|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
56482396|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
56482397|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482398|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56482399|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
56482400|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
56220801|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220802|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
56220803|NCT01658033|Antidotes|antidotes|mesh-ancestor
56220804|NCT01658033|Protective Agents|protective agents|mesh-ancestor
56220805|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
56220806|NCT01658033|Vitamins|vitamins|mesh-ancestor
56220807|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
56220808|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
56220809|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56220810|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56220811|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220812|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
56220813|NCT01658124|Coagulants|coagulants|mesh-ancestor
56220814|NCT01658176|Exemestane|exemestane|mesh-list
56220815|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220816|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56220817|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56220818|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796819|NCT03117751|Thioguanine|thioguanine|mesh-list
55785975|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55785976|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
55812521|NCT02375971|Ranibizumab|ranibizumab|mesh-list
56482401|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482402|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482403|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482404|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56482405|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
56482406|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56482407|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56482408|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56482409|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482410|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
56220819|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220820|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56220821|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
56220822|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220823|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220825|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56220826|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
55785977|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55785978|NCT03065309|Remifentanil|remifentanil|mesh-list
55812642|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
55812643|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55812644|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55812645|NCT02340949|Growth Substances|growth substances|mesh-ancestor
55812646|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
55812647|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
55812648|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812649|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55812650|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55812651|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
55812652|NCT02374957|Cilostazol|cilostazol|mesh-list
55812653|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55812654|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
55812655|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812656|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812657|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55812658|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
55812659|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55812660|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55812661|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812662|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55812663|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
55812664|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55812665|NCT02374957|Protective Agents|protective agents|mesh-ancestor
55812666|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55812667|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55812668|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812669|NCT02308033|Metronidazole|metronidazole|mesh-list
55812670|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812671|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55812672|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55812673|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55812674|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
55812675|NCT02339155|Promethazine|promethazine|mesh-list
55797212|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812676|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55812677|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55812678|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55812679|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812680|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
55812681|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
55812682|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
55812683|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785979|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55785980|NCT03065309|Narcotics|narcotics|mesh-ancestor
55785981|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785982|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785983|NCT03065309|Analgesics|analgesics|mesh-ancestor
55785984|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
55785985|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785986|NCT02819479|Bevacizumab|bevacizumab|mesh-list
55785987|NCT02819479|Mannitol|mannitol|mesh-list
55812685|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
56482411|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56482412|NCT02438722|Cetuximab|cetuximab|mesh-list
56482413|NCT02438722|Afatinib|afatinib|mesh-list
56482414|NCT02438722|Antibodies|antibodies|mesh-list
56482415|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
56482416|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56482417|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
56482418|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482419|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482420|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56482421|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220827|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220828|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220829|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56220830|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56220831|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
56220832|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220833|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785990|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55785991|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56220835|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56220836|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
56220837|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785992|NCT02819479|Growth Substances|growth substances|mesh-ancestor
56220838|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482422|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482423|NCT04319926|Lidocaine|lidocaine|mesh-list
56482424|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
56482425|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
56482426|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482427|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482428|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
56482429|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220839|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56220840|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56220841|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
56220842|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220843|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220844|NCT01658319|Fludarabine|fludarabine|mesh-list
56220845|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
56220846|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220847|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55812527|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482430|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56482431|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55802250|NCT04811209|Analgesics|analgesics|mesh-list
56482432|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56482433|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56482434|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482435|NCT05226871|Cetuximab|cetuximab|mesh-list
56482436|NCT05226871|Letrozole|letrozole|mesh-list
56220848|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
56220849|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220850|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56220851|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
56220852|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220853|NCT01658358|Doxorubicin|doxorubicin|mesh-list
56220854|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56220855|NCT01658358|Lapatinib|lapatinib|mesh-list
56220856|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56220857|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220858|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56220859|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56220860|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220861|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220862|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56220863|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56220864|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56220865|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55812529|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
56482437|NCT05226871|Fulvestrant|fulvestrant|mesh-list
56482438|NCT05226871|Palbociclib|palbociclib|mesh-list
56482439|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56204554|NCT01546896|Alprazolam|alprazolam|mesh-list
56482440|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482441|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56482442|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56482443|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482444|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482445|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56482446|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
56482447|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220866|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220867|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
56220868|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56220869|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
56220870|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220871|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
56220872|NCT01658449|Protective Agents|protective agents|mesh-ancestor
56220873|NCT01658462|Docetaxel|docetaxel|mesh-list
56220874|NCT01658462|Nintedanib|nintedanib|mesh-list
56220875|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220876|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
56220877|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
56220878|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
56220879|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220880|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56220881|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220882|NCT01658527|Bicalutamide|bicalutamide|mesh-list
56220883|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
56220884|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
56220885|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220886|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220887|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220888|NCT01658553|Trametinib|trametinib|mesh-list
56220889|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220890|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56220891|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482448|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482449|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56482450|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56482451|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56482452|NCT01366612|Vidarabine|vidarabine|mesh-list
56482453|NCT01366612|Fludarabine|fludarabine|mesh-list
56482454|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
56482455|NCT01366612|Busulfan|busulfan|mesh-list
56482456|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482457|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56482458|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
56482459|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220892|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220893|NCT01658774|Albendazole|albendazole|mesh-list
56220894|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220895|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
56220896|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56220897|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220898|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
56220899|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56220900|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56220901|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
56220902|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
56220903|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
56220904|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220905|NCT01658852|Metronidazole|metronidazole|mesh-list
56220906|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220907|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56220908|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56220909|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56220910|NCT01658878|Nivolumab|nivolumab|mesh-list
56220911|NCT01658878|Ipilimumab|ipilimumab|mesh-list
56220912|NCT01658878|Sorafenib|sorafenib|mesh-list
56220913|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56220914|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482460|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482461|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
56482462|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482464|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482465|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
56482466|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56482467|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56482468|NCT01313923|Sirolimus|sirolimus|mesh-list
56482469|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56482470|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482471|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56482472|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482473|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
56482474|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482475|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
56204597|NCT01547143|Etoposide|etoposide|mesh-list
56482477|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
56482478|NCT01313884|Temozolomide|temozolomide|mesh-list
56482479|NCT01313884|Doxorubicin|doxorubicin|mesh-list
56482480|NCT01313884|Irinotecan|irinotecan|mesh-list
56482481|NCT01313884|Vincristine|vincristine|mesh-list
56482482|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482483|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
56482484|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482485|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482486|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56482487|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
56482488|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812540|NCT02212197|Leuprolide|leuprolide|mesh-list
56482489|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482490|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56482491|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56482492|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56482493|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56482494|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482495|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56482496|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56482497|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
56482498|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
56482499|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
56482500|NCT05180773|Bromocriptine|bromocriptine|mesh-list
56482501|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
55786003|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55786004|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55786005|NCT04074785|Growth Substances|growth substances|mesh-ancestor
56220927|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56220928|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56220929|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56220930|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56220931|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220932|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220933|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56220934|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
56220935|NCT01658891|Hormones|hormones|mesh-ancestor
56220936|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220937|NCT01659008|Estradiol|estradiol|mesh-list
56220938|NCT01659008|Estrogens|estrogens|mesh-ancestor
56482502|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56482503|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
56482504|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56482505|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
56482506|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482507|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482508|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
56482509|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56482510|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56482511|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
56482512|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482513|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482514|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
56220939|NCT01659008|Hormones|hormones|mesh-ancestor
56220940|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220941|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786007|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
56220943|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220944|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220945|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220946|NCT01659086|Vaccines|vaccines|mesh-list
56220947|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
56220948|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220949|NCT01659099|Prednisone|prednisone|mesh-list
56220950|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
56220951|NCT01659099|Rituximab|rituximab|mesh-list
56220952|NCT01659099|Doxorubicin|doxorubicin|mesh-list
56220953|NCT01659099|Vincristine|vincristine|mesh-list
56220954|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
56220955|NCT01659099|Bleomycin|bleomycin|mesh-list
56220956|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56220957|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
56220958|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220959|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56220960|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56482515|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
56482516|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482518|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
56482519|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482520|NCT00537563|Telithromycin|telithromycin|mesh-list
56482521|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56482522|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482523|NCT00537602|Miglustat|miglustat|mesh-list
56482524|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482525|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482526|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56482527|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56482528|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
56482529|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482530|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56482531|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56220978|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
56220979|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
56220980|NCT01659190|Antacids|antacids|mesh-ancestor
56220981|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220982|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220983|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
56220984|NCT01659242|Methotrexate|methotrexate|mesh-list
56220985|NCT01659242|Leflunomide|leflunomide|mesh-list
56220986|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56220987|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
55786016|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
55786017|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55786018|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55786019|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
55786020|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786021|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786022|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56482532|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482533|NCT01259284|Atorvastatin|atorvastatin|mesh-list
56482534|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56482535|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56230553|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
56482536|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
56482537|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220988|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56220989|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220990|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56220991|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
56220992|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220993|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786023|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55786024|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
55786025|NCT04536805|Metformin|metformin|mesh-list
55786026|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55786027|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786028|NCT05376865|Vitamin D|vitamin d|mesh-list
55786029|NCT05376865|Vitamins|vitamins|mesh-ancestor
55786030|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
55812768|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812769|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55812770|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55812771|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55812772|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
55812773|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812774|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812775|NCT02134977|Leuprolide|leuprolide|mesh-list
55812776|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55812777|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
55812778|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55812779|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812780|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55812781|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812782|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
55812783|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
55812784|NCT02374021|Adalimumab|adalimumab|mesh-list
55812785|NCT02374021|Etanercept|etanercept|mesh-list
55812786|NCT02374021|Methotrexate|methotrexate|mesh-list
55812787|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55812788|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
55812789|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55812790|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812791|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55812792|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
55812793|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812794|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812795|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
55812796|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812797|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55812798|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55812806|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812807|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55812808|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55812809|NCT02374021|Analgesics|analgesics|mesh-ancestor
55812810|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
55812811|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812812|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220994|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
56220995|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220996|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56220997|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56220998|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
56220999|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56221000|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56221001|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786031|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786032|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55786033|NCT04064411|Abaloparatide|abaloparatide|mesh-list
55786034|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
55786035|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55786036|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786037|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55786038|NCT04012931|Rilpivirine|rilpivirine|mesh-list
55786039|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55786040|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55786043|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
55786044|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786045|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56221053|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221054|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221055|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221056|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56221057|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
56221058|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56221059|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221061|NCT01659437|Clarithromycin|clarithromycin|mesh-list
56221082|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221083|NCT01659515|Arbekacin|arbekacin|mesh-list
56221084|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221085|NCT01659619|Erythromycin|erythromycin|mesh-list
56221086|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
56221087|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56221088|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
56221089|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56221090|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221091|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482539|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56482540|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482541|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
56482542|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482543|NCT05123040|Prednisone|prednisone|mesh-list
56482544|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
56482545|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482546|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
56482547|NCT05123040|Hormones|hormones|mesh-ancestor
56221104|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
56221105|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482548|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482549|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482550|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56482551|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482553|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
56482554|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482555|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482556|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56482557|NCT05123040|Protective Agents|protective agents|mesh-ancestor
56482558|NCT00537836|Estradiol|estradiol|mesh-list
56482559|NCT00537836|Estrogens|estrogens|mesh-ancestor
56482560|NCT00537836|Hormones|hormones|mesh-ancestor
56482561|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482562|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786049|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56221106|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221107|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221108|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
56221109|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
56221110|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56221111|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
56221112|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221113|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221114|NCT01659775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56221115|NCT01659775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55797122|NCT05586737|Immunologic Factors|immunologic factors|mesh-ancestor
56482563|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
56482564|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482565|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482566|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
56482567|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56482568|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
56482569|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482570|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482571|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56482572|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
56482573|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56482574|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
56482575|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482576|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482577|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56482578|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
56482579|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
56482580|NCT02277171|Protective Agents|protective agents|mesh-ancestor
55786051|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221116|NCT01659775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221117|NCT01659775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56221118|NCT01659775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56221119|NCT01659788|Ubiquinone|ubiquinone|mesh-list
56221120|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
56221121|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
56221122|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221123|NCT01659788|Vitamins|vitamins|mesh-ancestor
56221124|NCT01659827|Bupivacaine|bupivacaine|mesh-list
56482581|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
56482583|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482584|NCT05105061|Ketamine|ketamine|mesh-list
56482585|NCT05105061|Analgesics|analgesics|mesh-ancestor
56482586|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
56482587|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482588|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482589|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56482590|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56482591|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
56482592|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
56221125|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
56221126|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
56221127|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797133|NCT05678933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56221128|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221129|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
56221130|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221132|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56221133|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
56221134|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56221135|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
56221136|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221137|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221138|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56221139|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56221140|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221141|NCT01659905|Montelukast|montelukast|mesh-list
55786052|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786053|NCT03063359|Analgesics|analgesics|mesh-ancestor
56221143|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
56482593|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482594|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56482595|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56482596|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482597|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482598|NCT05056584|Glucagon|glucagon|mesh-list
56482599|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482600|NCT05056584|Hormones|hormones|mesh-ancestor
56482601|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482602|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482603|NCT01840566|Cytarabine|cytarabine|mesh-list
56482604|NCT01840566|Etoposide|etoposide|mesh-list
55786055|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221144|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56221145|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
56482605|NCT01840566|Melphalan|melphalan|mesh-list
56482606|NCT01840566|Carmustine|carmustine|mesh-list
56482607|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56482608|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482609|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56482610|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56482611|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230624|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
56482612|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482613|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56482614|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
56482615|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
56482616|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482617|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482618|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
56482619|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786056|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55786057|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55786058|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
55786059|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
56221146|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221147|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221148|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56221149|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56221150|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221151|NCT01659918|Montelukast|montelukast|mesh-list
56221152|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56221153|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
55812626|NCT02341417|Cinacalcet|cinacalcet|mesh-list
56482620|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56482621|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
56482622|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56482623|NCT00551954|Acarbose|acarbose|mesh-list
56482624|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56482625|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56204748|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56482626|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786060|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
55786061|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56221154|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56221156|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221157|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221158|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55786062|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56482627|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56482628|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482629|NCT00552149|Cetuximab|cetuximab|mesh-list
56482630|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482631|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482632|NCT05467878|Anesthetics|anesthetics|mesh-list
56482633|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482634|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786063|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
55786064|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55786065|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56221159|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55786066|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786067|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
55786068|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221161|NCT01659931|Montelukast|montelukast|mesh-list
56482635|NCT00536640|Gemcitabine|gemcitabine|mesh-list
56482636|NCT00536640|Bevacizumab|bevacizumab|mesh-list
56482637|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56482638|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482639|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482640|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56482641|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56482642|NCT00536640|Growth Substances|growth substances|mesh-ancestor
56482643|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482644|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
56482645|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56482646|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
56221162|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56221163|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
56221164|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56221165|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
56221166|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221167|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221168|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56221169|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56221170|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221171|NCT01659944|Metoprolol|metoprolol|mesh-list
56221172|NCT01659944|Eliglustat|eliglustat|mesh-list
56221173|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56221174|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56221175|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
56221176|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
56221177|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797178|NCT05678621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55786069|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786070|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55812813|NCT02372383|Azithromycin|azithromycin|mesh-list
55812814|NCT02372383|Rifampin|rifampin|mesh-list
55812815|NCT02372383|Ethambutol|ethambutol|mesh-list
55812816|NCT02372383|Pancrelipase|pancrelipase|mesh-list
55812817|NCT02372383|Pancreatin|pancreatin|mesh-list
55812818|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55812819|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812820|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55812821|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
55812822|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
55812823|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55812824|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812825|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812826|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55812827|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55812828|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55812829|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55812837|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812838|NCT01648699|Analgesics|analgesics|mesh-ancestor
55812839|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
56482647|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482648|NCT00536640|Antiviral Agents|antiviral agents|mesh-ancestor
56482649|NCT00536640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482650|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482651|NCT00536640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482652|NCT00536640|Immunologic Factors|immunologic factors|mesh-ancestor
56482653|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56482654|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
56482655|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482656|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482657|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56482658|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482659|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56482660|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482661|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786071|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786072|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
55786073|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
55786074|NCT02728531|Cytarabine|cytarabine|mesh-list
56221178|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221179|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56221180|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56221181|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56221183|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221184|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221185|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221186|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56221187|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
56221188|NCT01660295|Certoparin|certoparin|mesh-list
56221189|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
55786075|NCT02728531|Rituximab|rituximab|mesh-list
55786076|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55786077|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786078|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786079|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
55786080|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786081|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786082|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55786083|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
55786084|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786085|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
55786086|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482662|NCT04768010|Misoprostol|misoprostol|mesh-list
56482663|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56482664|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
56482665|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56482666|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482667|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56482668|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482669|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
56482670|NCT00552266|Methylphenidate|methylphenidate|mesh-list
56482671|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56482672|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482673|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56482674|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56482675|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55786090|NCT04901299|Fulvestrant|fulvestrant|mesh-list
55786091|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55786092|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812637|NCT02340949|Antidotes|antidotes|mesh-ancestor
56221192|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221193|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56221194|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
56221195|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
56221196|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221197|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221198|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56221199|NCT01660295|Analgesics|analgesics|mesh-ancestor
56221200|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
56482676|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482677|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
56482678|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482679|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
56482680|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56482681|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482682|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
56482683|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482684|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482685|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56221205|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56221206|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56482686|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
56482687|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482688|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482689|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56482691|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482692|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482693|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
56221207|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56221208|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
56221209|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797228|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482694|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482695|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482696|NCT00552500|Valproic Acid|valproic acid|mesh-list
56482697|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
56482698|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482699|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482700|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
56482701|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482702|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482703|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
56482704|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56482705|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482706|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56482708|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482709|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482710|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56482711|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482712|NCT01258738|Etanercept|etanercept|mesh-list
56482713|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55786095|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
56221210|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221211|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221212|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56221213|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56221214|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56221215|NCT01660386|Glimepiride|glimepiride|mesh-list
56221216|NCT01660386|Saxagliptin|saxagliptin|mesh-list
56221217|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55797235|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
56482714|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56482715|NCT01258738|Analgesics|analgesics|mesh-ancestor
56482716|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
56482717|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482718|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482719|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482720|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482721|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482722|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482723|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
56482725|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56482726|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221218|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221219|NCT01660386|Incretins|incretins|mesh-ancestor
56221220|NCT01660386|Hormones|hormones|mesh-ancestor
56221221|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221222|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56221223|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
56221224|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221225|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221226|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56221227|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56221228|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
55797237|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56221229|NCT01660399|Docetaxel|docetaxel|mesh-list
56221230|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221231|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
56221232|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
56221233|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
56221234|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221235|NCT01660477|Ritonavir|ritonavir|mesh-list
56221236|NCT01660477|Lopinavir|lopinavir|mesh-list
56221237|NCT01660477|Isavuconazole|isavuconazole|mesh-list
56482727|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56482728|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482729|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
56482730|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482731|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
56482732|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482733|NCT01824537|Vaccines|vaccines|mesh-list
56482734|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
56482735|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482736|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
56482737|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55786096|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786097|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221239|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56221240|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
56221241|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221242|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797260|NCT05041907|Ritonavir|ritonavir|mesh-list
56221243|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56221244|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56221245|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
56221246|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482738|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56482739|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482740|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
56482741|NCT04863339|Coagulants|coagulants|mesh-ancestor
56482742|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
56482743|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56482744|NCT00552734|Insulin|insulin|mesh-list
56482745|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56482746|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56482747|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482748|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56482749|NCT04608539|Hematinics|hematinics|mesh-ancestor
56221247|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56221248|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56482750|NCT04543682|Iloprost|iloprost|mesh-list
56482751|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56482752|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
56482753|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
56482754|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56482755|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
56482756|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482757|NCT01258660|Folic Acid|folic acid|mesh-list
56482758|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
56482759|NCT01258660|Drospirenone|drospirenone|mesh-list
56482760|NCT01258660|Hematinics|hematinics|mesh-ancestor
56482761|NCT01258660|Vitamins|vitamins|mesh-ancestor
56482762|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
56482763|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482764|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56221249|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
56221250|NCT01660542|Docetaxel|docetaxel|mesh-list
56221251|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786098|NCT05067985|Anesthetics|anesthetics|mesh-list
55786099|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786100|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482765|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
56482766|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482767|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56482768|NCT01258660|Diuretics|diuretics|mesh-ancestor
56482769|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
56482770|NCT04772274|Ustekinumab|ustekinumab|mesh-list
56482771|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
56482772|NCT04388852|Ipilimumab|ipilimumab|mesh-list
56482773|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482774|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482775|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56482776|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482777|NCT04362527|Milrinone|milrinone|mesh-list
56482778|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56482779|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56482780|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56482781|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
56482782|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56482783|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56482784|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482785|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482786|NCT04362527|Protective Agents|protective agents|mesh-ancestor
56482787|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482788|NCT04758975|Rituximab|rituximab|mesh-list
56482789|NCT04758975|Venetoclax|venetoclax|mesh-list
56221255|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221256|NCT01660594|Calcium|calcium|mesh-list
56221257|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56221258|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482790|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56482791|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482792|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
56482793|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482794|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482795|NCT01614171|Hormones|hormones|mesh-list
56482796|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482797|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482798|NCT05567367|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56482799|NCT05567367|Vasodilator Agents|vasodilator agents|mesh-ancestor
56482800|NCT05567367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56482801|NCT05567367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56482802|NCT05567367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482803|NCT05567367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482804|NCT05567367|Urological Agents|urological agents|mesh-ancestor
56482805|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
56482806|NCT04291001|Etonogestrel|etonogestrel|mesh-list
56482807|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56221259|NCT01660620|Betaxolol|betaxolol|mesh-list
56221260|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56221261|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
56221262|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
56221263|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221264|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221265|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56221266|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56221267|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56221268|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
56221269|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221270|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221271|NCT01660750|Dexamethasone|dexamethasone|mesh-list
56221272|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
56221273|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56221274|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
56221275|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221276|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56221277|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55797278|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55812684|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
56482808|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
56204881|NCT01548807|Everolimus|everolimus|mesh-list
56482809|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56482810|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482811|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56482813|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482814|NCT04255160|Estradiol|estradiol|mesh-list
56482815|NCT04255160|Estrogens|estrogens|mesh-ancestor
56482816|NCT04255160|Hormones|hormones|mesh-ancestor
56221279|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482817|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482818|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482819|NCT04173533|Azacitidine|azacitidine|mesh-list
56482820|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56482821|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
56482822|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482823|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482824|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482825|NCT04158440|Paclitaxel|paclitaxel|mesh-list
56221280|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221281|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56221282|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221283|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
56221284|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
56221285|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221286|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221287|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
56221289|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221290|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56221291|NCT01660854|Proguanil|proguanil|mesh-list
56221292|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56221293|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
56221294|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56221295|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56221296|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221297|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
55797312|NCT02500641|Naproxen|naproxen|mesh-list
56482826|NCT04158440|Docetaxel|docetaxel|mesh-list
56482827|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56482828|NCT04158440|Cisplatin|cisplatin|mesh-list
56482829|NCT04158440|Carboplatin|carboplatin|mesh-list
56482830|NCT04158440|Pemetrexed|pemetrexed|mesh-list
56482831|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56482832|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482833|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
56482834|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
56482835|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
56482836|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482838|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56221303|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221304|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221305|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221306|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
55797314|NCT02500641|Allopurinol|allopurinol|mesh-list
55812920|NCT02132949|Doxorubicin|doxorubicin|mesh-list
55812921|NCT02132949|Fluorouracil|fluorouracil|mesh-list
55812922|NCT02132949|Trastuzumab|trastuzumab|mesh-list
55812923|NCT02132949|Epirubicin|epirubicin|mesh-list
55812924|NCT02132949|Pertuzumab|pertuzumab|mesh-list
55812925|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55812926|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812927|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
55812928|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
55812929|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
55812930|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812931|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55812932|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
55812933|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812934|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55812935|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55812936|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
55812937|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55812938|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55812939|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55812940|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55812941|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812942|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
55812943|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55812945|NCT02165397|Rituximab|rituximab|mesh-list
55812946|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55812947|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812948|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
55812949|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812950|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55812951|NCT02132637|Insulin|insulin|mesh-list
55812952|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55812953|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
55812954|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55812955|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812956|NCT02164929|Acetaminophen|acetaminophen|mesh-list
55812957|NCT02164929|Dexamethasone|dexamethasone|mesh-list
55812958|NCT02164929|Lidocaine|lidocaine|mesh-list
55812959|NCT02164929|Epinephrine|epinephrine|mesh-list
55812960|NCT02164929|Midazolam|midazolam|mesh-list
55812964|NCT02164929|Sevoflurane|sevoflurane|mesh-list
55812965|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55812966|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
55812967|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
55812968|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812969|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812970|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55812971|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
55812972|NCT02164929|Hormones|hormones|mesh-ancestor
55812973|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812975|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812976|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
55812977|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
55812978|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482839|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56482840|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
56482841|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56482842|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482843|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56482844|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56482845|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56221308|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221309|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56221310|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221311|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56221312|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56221313|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56221314|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
56221315|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221316|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56221317|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56221318|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221319|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56221320|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56221321|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56221322|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
56221323|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221324|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56221325|NCT01660997|Dexamethasone|dexamethasone|mesh-list
56221326|NCT01660997|Ixazomib|ixazomib|mesh-list
56221327|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221328|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
56221329|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
56221332|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221333|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
56221334|NCT01660997|Hormones|hormones|mesh-ancestor
56221335|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221336|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56221337|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221338|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
56221339|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221340|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221341|NCT01661101|Omeprazole|omeprazole|mesh-list
56221342|NCT01661101|Dabigatran|dabigatran|mesh-list
56221343|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56221344|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221345|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56221346|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797348|NCT04962451|Ticagrelor|ticagrelor|mesh-list
55786113|NCT04262869|Paclitaxel|paclitaxel|mesh-list
56221347|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221349|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56482846|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482847|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482848|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482849|NCT04137107|Analgesics|analgesics|mesh-ancestor
56482850|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
56482851|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482852|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
56482853|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56482854|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
56482855|NCT05527470|Gemcitabine|gemcitabine|mesh-list
56482856|NCT05527470|Cisplatin|cisplatin|mesh-list
56482857|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482858|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56482859|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
56482860|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482861|NCT05527470|Antiviral Agents|antiviral agents|mesh-ancestor
56482862|NCT05527470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482863|NCT05527470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482864|NCT05527470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482865|NCT05527470|Immunologic Factors|immunologic factors|mesh-ancestor
56482866|NCT05527470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482867|NCT01258348|Sunitinib|sunitinib|mesh-list
56482868|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482869|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56482870|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56482871|NCT01258348|Growth Substances|growth substances|mesh-ancestor
56482872|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482873|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
56482874|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56482875|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482876|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482878|NCT05136898|Mitomycin|mitomycin|mesh-list
56482879|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56221358|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221359|NCT01661257|Infliximab|infliximab|mesh-list
56221360|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
56221361|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221362|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56221363|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56221364|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56221365|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56221366|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221367|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
56221368|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55813062|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
55813063|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
55813065|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55813066|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
55813067|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
55813068|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813069|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55813070|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
55813071|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
55813072|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
55813073|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55813074|NCT02188719|Protective Agents|protective agents|mesh-ancestor
55813075|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55813076|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55813077|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813078|NCT01933672|Incretins|incretins|mesh-ancestor
55813079|NCT01933672|Hormones|hormones|mesh-ancestor
55813080|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813081|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55813082|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
56482880|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482881|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
56204936|NCT01549093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56482882|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482883|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56482884|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482885|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56482886|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56482887|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56482888|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
56482889|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482890|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56482891|NCT04687878|Insulin|insulin|mesh-list
56482892|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56482893|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56482894|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482895|NCT05116774|Eculizumab|eculizumab|mesh-list
56482896|NCT05116774|Ravulizumab|ravulizumab|mesh-list
56482897|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56482898|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482899|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
56482900|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482901|NCT05014087|Digoxin|digoxin|mesh-list
56482902|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56482903|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56482904|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482905|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482906|NCT05014087|Protective Agents|protective agents|mesh-ancestor
56482907|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482908|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56482909|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56482910|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
56482911|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482912|NCT04687566|Memantine|memantine|mesh-list
56482913|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
56482914|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56482915|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56482916|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
56482917|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56482918|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482919|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482920|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56482921|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56482922|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
56482923|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
56482924|NCT01256593|Pregabalin|pregabalin|mesh-list
56482925|NCT01256593|Analgesics|analgesics|mesh-ancestor
56482926|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
56482927|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221369|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
56221370|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
56221371|NCT01661309|Vitamins|vitamins|mesh-ancestor
56221372|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
55786115|NCT04262869|Pemetrexed|pemetrexed|mesh-list
55786116|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55786117|NCT04262869|Durvalumab|durvalumab|mesh-list
55786118|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
55786119|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56482928|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482929|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
56482930|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56482931|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56482932|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482933|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56482934|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56482935|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56482936|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56482937|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56482938|NCT01256476|Pravastatin|pravastatin|mesh-list
56482939|NCT01256476|Pitavastatin|pitavastatin|mesh-list
56482940|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56482941|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56482942|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
56221373|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786122|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786123|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
55786124|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
55786125|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
55786126|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812833|NCT01648699|Hydromorphone|hydromorphone|mesh-list
56482943|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482944|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56482945|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56482946|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56482947|NCT05507892|Canagliflozin|canagliflozin|mesh-list
56482948|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56482949|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482950|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55786127|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786128|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55786129|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55786130|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786131|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
55786132|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786133|NCT05092165|Methylene Blue|methylene blue|mesh-list
55786134|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786135|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786136|NCT03062813|Entecavir|entecavir|mesh-list
55786137|NCT03062813|Tacrolimus|tacrolimus|mesh-list
55786138|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55786139|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
55786140|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786141|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55786142|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786143|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786144|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
55786145|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786146|NCT04893161|Belimumab|belimumab|mesh-list
55786147|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56221374|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
56221376|NCT01661322|Clopidogrel|clopidogrel|mesh-list
56221377|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56221378|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56221379|NCT01661322|Analgesics|analgesics|mesh-ancestor
55786148|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
55786149|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786150|NCT04884035|Prednisone|prednisone|mesh-list
55786151|NCT04884035|Prednisolone|prednisolone|mesh-list
56221380|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
56221381|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221382|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221383|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221384|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56221385|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56221386|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56482951|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482953|NCT01256398|Leucovorin|leucovorin|mesh-list
56482954|NCT01256398|Folic Acid|folic acid|mesh-list
56482955|NCT01256398|Cytarabine|cytarabine|mesh-list
56482956|NCT01256398|Dexamethasone|dexamethasone|mesh-list
56482957|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
56482958|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
56482959|NCT01256398|Melphalan|melphalan|mesh-list
56482960|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
56482961|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56482962|NCT01256398|Methotrexate|methotrexate|mesh-list
56482963|NCT01256398|Fludarabine|fludarabine|mesh-list
56482964|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
56482965|NCT01256398|Etoposide|etoposide|mesh-list
56482966|NCT01256398|Vincristine|vincristine|mesh-list
56482967|NCT01256398|Daunorubicin|daunorubicin|mesh-list
56482968|NCT01256398|Dasatinib|dasatinib|mesh-list
56482969|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
56482970|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
56482971|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
56482972|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56482973|NCT01256398|Tacrolimus|tacrolimus|mesh-list
56482974|NCT01256398|Antibodies|antibodies|mesh-list
56482975|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
56482976|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56482977|NCT01256398|Lenograstim|lenograstim|mesh-list
56482978|NCT01256398|BB 1101|bb 1101|mesh-list
56221389|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56221390|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221391|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
56221392|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56221393|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56221394|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56221395|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
55797405|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
55786160|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55786161|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
55786162|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786163|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786164|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55786165|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786166|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55786167|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56482979|NCT01256398|Calcium|calcium|mesh-list
56482980|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
56482981|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56482982|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
56482983|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56482984|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56482985|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56482986|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
56482987|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56482988|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56482989|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56482990|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56482991|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
56482992|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
56221397|NCT01661335|Dexamethasone|dexamethasone|mesh-list
56221398|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
56221399|NCT01661335|Ondansetron|ondansetron|mesh-list
56221400|NCT01661335|Aprepitant|aprepitant|mesh-list
55786168|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56482993|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56482994|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56482995|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
56482997|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56482998|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56482999|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
56483000|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483001|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56221401|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
56221402|NCT01661335|BB 1101|bb 1101|mesh-list
56221403|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221404|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
56221405|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
56221406|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221407|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221408|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221409|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
56221410|NCT01661335|Hormones|hormones|mesh-ancestor
56221411|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221412|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56221413|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221414|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
56221415|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797418|NCT04971577|Simvastatin|simvastatin|mesh-list
56205062|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
56483002|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56483003|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56483004|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
56483005|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56483006|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56483007|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
55786169|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786170|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55786171|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
55786172|NCT04884035|Hormones|hormones|mesh-ancestor
55786173|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786174|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56221416|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221417|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
56221418|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
56221419|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56221420|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
56221421|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221422|NCT01661335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56221423|NCT01661335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56221424|NCT01661335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221425|NCT01661335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56221426|NCT01661335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56221427|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56221428|NCT01661439|Heparin|heparin|mesh-list
56221429|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56221430|NCT01661439|Tinzaparin|tinzaparin|mesh-list
56221431|NCT01661439|Dalteparin|dalteparin|mesh-list
56221432|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
56221433|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56221434|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56221435|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221436|NCT01661530|Vitamin E|vitamin e|mesh-list
56483008|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
56483009|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56483010|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56483011|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56483012|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56483013|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56483014|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
56483015|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483016|NCT01256398|Antidotes|antidotes|mesh-ancestor
56483017|NCT01256398|Protective Agents|protective agents|mesh-ancestor
56483018|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
56483019|NCT01256398|Vitamins|vitamins|mesh-ancestor
56483020|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
56483021|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56483022|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56483023|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
56483024|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
56483025|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
56483026|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55786175|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55786176|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
55786177|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
55786178|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
56221437|NCT01661530|Vitamins|vitamins|mesh-ancestor
56221438|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
56221439|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786179|NCT04582981|Raltitrexed|raltitrexed|mesh-list
55786180|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55786181|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
55812901|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
56483028|NCT01256398|Hematinics|hematinics|mesh-ancestor
56483029|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
56483030|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56483031|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483032|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
56483033|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56483034|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483035|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483036|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56483037|NCT04106999|Analgesics|analgesics|mesh-ancestor
56483038|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
56483039|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483040|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56483041|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56483042|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56483043|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
56483044|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483045|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483046|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
56483047|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56483048|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483049|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56483050|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
56483051|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483052|NCT05003089|Prednisolone|prednisolone|mesh-list
56483053|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56483054|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
55786182|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786183|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786184|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55786185|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221440|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
55797454|NCT04970251|Aflibercept|aflibercept|mesh-list
56483055|NCT05003089|Hormones|hormones|mesh-ancestor
56483056|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483057|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483058|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56483059|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483060|NCT04207021|Curcumin|curcumin|mesh-list
56483061|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56483062|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56483063|NCT04207021|Analgesics|analgesics|mesh-ancestor
56483065|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483066|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483067|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56483068|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56483069|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786186|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
55786187|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55786188|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
55786189|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786190|NCT04531579|Valproic Acid|valproic acid|mesh-list
56483070|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483071|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483072|NCT01255423|Diclofenac|diclofenac|mesh-list
56483073|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56483074|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56483075|NCT01255423|Analgesics|analgesics|mesh-ancestor
56483076|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
56483077|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221441|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812963|NCT02164929|Propofol|propofol|mesh-list
56483078|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483079|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56483080|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56483081|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56483082|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483083|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483084|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56483085|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56483086|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56483087|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56221442|NCT01661530|Protective Agents|protective agents|mesh-ancestor
56221443|NCT01661556|Miconazole|miconazole|mesh-list
56221444|NCT01661556|Hydroquinone|hydroquinone|mesh-list
55812974|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56483088|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56483089|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
56483090|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483091|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483092|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483093|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56483094|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
56483095|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56483096|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56483097|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56221445|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
56221446|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221447|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56221448|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56221449|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221450|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221451|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56221452|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
56221453|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221454|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221455|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56221456|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56221457|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
56221458|NCT01661556|Protective Agents|protective agents|mesh-ancestor
56221459|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56221460|NCT01661751|Vaccines|vaccines|mesh-list
56221461|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
56221462|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221463|NCT01661777|Diuretics|diuretics|mesh-list
56221464|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
55797459|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
55797461|NCT04201197|Dronabinol|dronabinol|mesh-list
56221465|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56221466|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
56483098|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483099|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483100|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
56483101|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56483102|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
56483103|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483104|NCT04005053|Expectorants|expectorants|mesh-ancestor
56483105|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
56483106|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56483107|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
56483108|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483109|NCT04005053|Protective Agents|protective agents|mesh-ancestor
56483110|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483111|NCT04005053|Antidotes|antidotes|mesh-ancestor
56483113|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55786193|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221467|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221468|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
56221469|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797482|NCT04970329|Dextrans|dextrans|mesh-list
56483114|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
56483115|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483116|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483117|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56483118|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56483119|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
56483120|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483121|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483122|NCT04001777|Osimertinib|osimertinib|mesh-list
56483123|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483124|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56483125|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221470|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221471|NCT01661855|Riluzole|riluzole|mesh-list
56221472|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
56221473|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56221474|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56221475|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221476|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221477|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221478|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56221479|NCT01661855|Protective Agents|protective agents|mesh-ancestor
56221480|NCT01661868|Olaparib|olaparib|mesh-list
56221481|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56221482|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221483|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221484|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221485|NCT01661985|Azithromycin|azithromycin|mesh-list
55797483|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
55786194|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786195|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
55786196|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221487|NCT01661985|Lymecycline|lymecycline|mesh-list
56221488|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56221489|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813007|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
56483126|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483127|NCT04842604|Azacitidine|azacitidine|mesh-list
56483128|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56483129|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
56483130|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483131|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483132|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483133|NCT04820179|Atezolizumab|atezolizumab|mesh-list
56483134|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483135|NCT01254604|Timolol|timolol|mesh-list
56483136|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483137|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56483138|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56483139|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
56483140|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483141|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483142|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56483143|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56483145|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221490|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
56221491|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56221492|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56221493|NCT01662037|Bosentan|bosentan|mesh-list
55797501|NCT02463357|Metformin|metformin|mesh-list
55786197|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786198|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
55786199|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55789075|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56483146|NCT03911414|Inositol|inositol|mesh-list
56483147|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
56483148|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56483150|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483151|NCT03911414|Expectorants|expectorants|mesh-ancestor
56483152|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
56483153|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56483154|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
56483155|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483156|NCT03911414|Protective Agents|protective agents|mesh-ancestor
56483157|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483158|NCT03911414|Antidotes|antidotes|mesh-ancestor
56221494|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56221495|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56221496|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221497|NCT01662089|Zinc|zinc|mesh-list
56221498|NCT01662089|Trace Elements|trace elements|mesh-ancestor
56221499|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
56221500|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221501|NCT01662128|Capecitabine|capecitabine|mesh-list
56221502|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56221503|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
56221504|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221505|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786200|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786201|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55786202|NCT03839459|Denosumab|denosumab|mesh-list
56483159|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
56483160|NCT03911414|Vitamins|vitamins|mesh-ancestor
56483161|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
56483162|NCT03872180|Venetoclax|venetoclax|mesh-list
56483163|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56483164|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
56483165|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483166|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56483167|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
56483168|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483169|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56221506|NCT01662180|Hormones|hormones|mesh-list
56221507|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56221508|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221509|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221510|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
56221511|NCT01662193|Vitamin D|vitamin d|mesh-list
56221512|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
56221513|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
56221514|NCT01662193|Vitamins|vitamins|mesh-list
56221515|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
56221516|NCT01662193|Calcium|calcium|mesh-list
56221517|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
56221518|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797518|NCT02463357|Diuretics|diuretics|mesh-ancestor
55797530|NCT05595083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56483170|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
56483171|NCT04390698|Anesthetics|anesthetics|mesh-list
56483172|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483173|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483174|NCT04390698|Narcotics|narcotics|mesh-ancestor
56483175|NCT04390698|Analgesics|analgesics|mesh-ancestor
56483176|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
56483177|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483179|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56483180|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483181|NCT03795701|Incretins|incretins|mesh-ancestor
56483182|NCT03795701|Hormones|hormones|mesh-ancestor
56483183|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483184|NCT04673578|Celecoxib|celecoxib|mesh-list
56483185|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56483186|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56483187|NCT04673578|Analgesics|analgesics|mesh-ancestor
56483188|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
56483189|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483190|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483191|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56483192|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56483193|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56483194|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56483195|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483196|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483197|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
56483198|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56483199|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
56483200|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483201|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483202|NCT05414058|Methylphenidate|methylphenidate|mesh-list
56483203|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56483204|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483205|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56483206|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56483207|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56483208|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483209|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
56231220|NCT01710488|Levofloxacin|levofloxacin|mesh-list
56483210|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483212|NCT03757403|Piperazine|piperazine|mesh-list
56483213|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
56483214|NCT03757403|DMP 777|dmp 777|mesh-list
56483215|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
56483216|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
56483217|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56483218|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483219|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
56483220|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
56483221|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
56483222|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483223|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483224|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483225|NCT03724019|Ketamine|ketamine|mesh-list
56483226|NCT03724019|Analgesics|analgesics|mesh-ancestor
55786203|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55786204|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786205|NCT05097781|Antibodies|antibodies|mesh-list
56221519|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56221520|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56221521|NCT01662193|Antacids|antacids|mesh-ancestor
56221522|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221523|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221524|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
56221525|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56221526|NCT01662401|Bupivacaine|bupivacaine|mesh-list
56221527|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
56221528|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
56221529|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221530|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221531|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
56221532|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221533|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
56221534|NCT01662466|Testosterone|testosterone|mesh-list
56221535|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
56221536|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
56221537|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56221538|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56221539|NCT01662466|Androgens|androgens|mesh-ancestor
55797534|NCT04959721|Triamcinolone|triamcinolone|mesh-list
55786206|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
55786207|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
55786209|NCT01117441|Cytarabine|cytarabine|mesh-list
56483227|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
56483228|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483229|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221540|NCT01662466|Hormones|hormones|mesh-ancestor
56483230|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56483231|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56483232|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
56483233|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
56483234|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483235|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56483236|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56483237|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483238|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483239|NCT03712943|Nivolumab|nivolumab|mesh-list
56483240|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56221541|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221542|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221543|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56483241|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483242|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56483243|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483244|NCT00537420|Sibutramine|sibutramine|mesh-list
56483245|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
56483246|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56483247|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
56483248|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56483249|NCT04268706|Fludarabine|fludarabine|mesh-list
56483251|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56205321|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
56221544|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221545|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
56221546|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56221547|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
56221548|NCT01662518|Dexamethasone|dexamethasone|mesh-list
55786210|NCT01117441|Dexamethasone|dexamethasone|mesh-list
55786212|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
55813083|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813084|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813085|NCT02132247|Diclofenac|diclofenac|mesh-list
55813086|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
55813087|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55813088|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55813089|NCT02132247|Analgesics|analgesics|mesh-ancestor
55813092|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813093|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813094|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813095|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55813096|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813097|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813098|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
55813099|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55813100|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
55813101|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55813102|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
55813103|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813104|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813105|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
55813106|NCT05269017|Vitamin D|vitamin d|mesh-list
55813107|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
55813108|NCT05269017|Budesonide|budesonide|mesh-list
55813109|NCT05269017|Vitamins|vitamins|mesh-ancestor
55813110|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
55813111|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813112|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55813113|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55813114|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813115|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55813116|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
55813117|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813118|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55813119|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
55813120|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
55813121|NCT05269017|Hormones|hormones|mesh-ancestor
55813122|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813123|NCT01628913|Everolimus|everolimus|mesh-list
55813124|NCT01628913|Dactolisib|dactolisib|mesh-list
55813125|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813126|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813127|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
55813128|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813129|NCT02164383|Nicotine|nicotine|mesh-list
55813130|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55813133|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813134|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55813135|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55813136|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
55813137|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483252|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483253|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56483254|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
56483256|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56483257|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56483258|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483259|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483260|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56483261|NCT03534284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56483262|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56221549|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221551|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
56221552|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221553|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221554|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221555|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
56221556|NCT01662518|Hormones|hormones|mesh-ancestor
55797559|NCT04676555|Ofatumumab|ofatumumab|mesh-list
55797560|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
56483263|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56483264|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483265|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483266|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
56483267|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56483268|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
56483269|NCT03511196|Prednisone|prednisone|mesh-list
55786214|NCT01117441|Doxorubicin|doxorubicin|mesh-list
55786215|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55786216|NCT01117441|Methotrexate|methotrexate|mesh-list
55786217|NCT01117441|Fludarabine|fludarabine|mesh-list
56221557|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221558|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56221559|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221560|NCT01662622|Sevoflurane|sevoflurane|mesh-list
56221561|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56221562|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56483270|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
56483271|NCT03511196|Androgens|androgens|mesh-list
56483272|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56483273|NCT03511196|Hormones|hormones|mesh-ancestor
56483274|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483275|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483276|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56483277|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483278|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
56483279|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56483280|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
55786219|NCT01117441|Vincristine|vincristine|mesh-list
55786220|NCT01117441|Daunorubicin|daunorubicin|mesh-list
55786221|NCT01117441|Asparaginase|asparaginase|mesh-list
55786222|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
56221563|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
56221564|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
56221565|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221566|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221567|NCT01662674|Metformin|metformin|mesh-list
56221568|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56221569|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221570|NCT01662687|Granisetron|granisetron|mesh-list
56221571|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
56221572|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
56221573|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221574|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221575|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221576|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56221577|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
56221578|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221579|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221580|NCT01662700|Artesunate|artesunate|mesh-list
56221581|NCT01662700|Chloroquine|chloroquine|mesh-list
56483281|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56483282|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483283|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56483284|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56483285|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56483286|NCT03466151|Sirolimus|sirolimus|mesh-list
56483287|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56483288|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483289|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56483290|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483291|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
56483292|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56221582|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
56221583|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56221584|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55786223|NCT01117441|Thioguanine|thioguanine|mesh-list
55786224|NCT01117441|Pegaspargase|pegaspargase|mesh-list
55813132|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483293|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
56483294|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483295|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
56483296|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56483297|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483298|NCT04683458|Paclitaxel|paclitaxel|mesh-list
56483299|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56483300|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56483301|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483302|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
56483303|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
56483304|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
56483305|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483306|NCT01253317|Mecasermin|mecasermin|mesh-list
56483307|NCT01253317|Growth Substances|growth substances|mesh-ancestor
56221585|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221586|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221587|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
56221588|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
56221589|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56221590|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
56221591|NCT01662700|Amebicides|amebicides|mesh-ancestor
56221592|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56483308|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483309|NCT00537537|Telbivudine|telbivudine|mesh-list
56483310|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
56483311|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483312|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56483313|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483314|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483315|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
56483316|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56483317|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
56221593|NCT01662804|Interleukin-2|interleukin-2|mesh-list
56221594|NCT01662804|Antibodies|antibodies|mesh-list
56221595|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56221596|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
56221597|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221598|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221599|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56221600|NCT01662804|Analgesics|analgesics|mesh-ancestor
56221601|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
56221602|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221603|NCT01662869|Leucovorin|leucovorin|mesh-list
56221604|NCT01662869|Folic Acid|folic acid|mesh-list
56221605|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
56221606|NCT01662869|Fluorouracil|fluorouracil|mesh-list
56221607|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
56221608|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221609|NCT01662869|Antidotes|antidotes|mesh-ancestor
56221610|NCT01662869|Protective Agents|protective agents|mesh-ancestor
56221611|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221612|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
56221613|NCT01662869|Vitamins|vitamins|mesh-ancestor
56221614|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
56221615|NCT01662869|Hematinics|hematinics|mesh-ancestor
56483318|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483319|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
56483320|NCT04319770|Protective Agents|protective agents|mesh-ancestor
56483321|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56483322|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
56483324|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56483325|NCT01253200|Acifluorfen|acifluorfen|mesh-list
56483326|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483327|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483328|NCT04515901|Lidocaine|lidocaine|mesh-list
56483329|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
56483330|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
56483331|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483332|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483333|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
56483334|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483335|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56483336|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56483337|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56483338|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56483339|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483340|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
56483341|NCT02605421|Melphalan|melphalan|mesh-list
56221616|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
56221617|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221618|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56221619|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56221620|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
56221621|NCT01662921|Insulin|insulin|mesh-list
56221622|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56221623|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
56221624|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
56221625|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
56221626|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56221627|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797623|NCT03058939|Trastuzumab|trastuzumab|mesh-list
55786226|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813169|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483342|NCT02605421|Thiotepa|thiotepa|mesh-list
56483343|NCT02605421|Carboplatin|carboplatin|mesh-list
56483344|NCT02605421|Etoposide|etoposide|mesh-list
56483345|NCT02605421|Lenograstim|lenograstim|mesh-list
56483346|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56483347|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
56483348|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483349|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56483350|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56483351|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
56483352|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483353|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483354|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56483355|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56221628|NCT01663038|Aspirin|aspirin|mesh-list
56221629|NCT01663038|Clopidogrel|clopidogrel|mesh-list
56221630|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56221631|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56221632|NCT01663038|Analgesics|analgesics|mesh-ancestor
56221633|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
56221634|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221635|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221636|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221637|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56221638|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56221639|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56221640|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221641|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55797644|NCT03058471|Methotrexate|methotrexate|mesh-list
55813189|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
56483356|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56483357|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56483358|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483359|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56483360|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
56483361|NCT04320589|Anesthetics|anesthetics|mesh-list
56483362|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
56483363|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56221642|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56221643|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221644|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
56221645|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56221646|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56221647|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56221648|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
56221649|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221651|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56221652|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
55813204|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56483364|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483365|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483366|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56483367|NCT04320589|Analgesics|analgesics|mesh-ancestor
56483368|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
56483369|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483370|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56483371|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56483372|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56483373|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
56483374|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483375|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483376|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
56483377|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56483378|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
55786228|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786229|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56221653|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221654|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221655|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221657|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56221658|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221659|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56221660|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
56221661|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
56221662|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56221663|NCT01663090|Hematinics|hematinics|mesh-ancestor
56221664|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56221665|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56221666|NCT01663168|Rifabutin|rifabutin|mesh-list
56221667|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56221668|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221669|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56221670|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
56221671|NCT01663441|Oprelvekin|oprelvekin|mesh-list
56221672|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221673|NCT01663558|Imiquimod|imiquimod|mesh-list
56221674|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56221675|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
56221676|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221677|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221678|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
56221679|NCT01663662|Tolvaptan|tolvaptan|mesh-list
56221682|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
56483379|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483380|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483381|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56483382|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
56483383|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56483384|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
56483385|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483386|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483387|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56483388|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
56483389|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
56483390|NCT04397692|Protective Agents|protective agents|mesh-ancestor
56483391|NCT02203643|Dexamethasone|dexamethasone|mesh-list
56483392|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
56483393|NCT02203643|Lenalidomide|lenalidomide|mesh-list
56483394|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56483395|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
56483396|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483397|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56483398|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56483399|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
56483400|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483401|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483402|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56483403|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56483404|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
56483405|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
56483406|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483407|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56483408|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
56483409|NCT02203643|Hormones|hormones|mesh-ancestor
56483410|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483411|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56483412|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56483413|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56483414|NCT02203643|Growth Substances|growth substances|mesh-ancestor
56483415|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
56483416|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
56483417|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
56483418|NCT01252186|Desogestrel|desogestrel|mesh-list
56483419|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
56483420|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56483421|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483422|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56483423|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56483424|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56483425|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56483426|NCT01252186|Progestins|progestins|mesh-ancestor
56483427|NCT01252186|Hormones|hormones|mesh-ancestor
56483428|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483429|NCT02188745|Letrozole|letrozole|mesh-list
56221683|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221684|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56221685|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56221686|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221687|NCT01663805|Everolimus|everolimus|mesh-list
56221688|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221689|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56221690|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
55797687|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56483430|NCT02188745|Anastrozole|anastrozole|mesh-list
56483431|NCT02188745|Exemestane|exemestane|mesh-list
56483432|NCT02188745|Estradiol|estradiol|mesh-list
56483433|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56231458|NCT01711528|Hormones|hormones|mesh-ancestor
56483434|NCT02188745|Estrogens|estrogens|mesh-ancestor
56483435|NCT02188745|Hormones|hormones|mesh-ancestor
56483436|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483437|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483438|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483439|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55786230|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55786231|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
55786232|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221691|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221693|NCT01663961|Mirabegron|mirabegron|mesh-list
56221694|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56221695|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56221696|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221697|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221698|NCT01663961|Protective Agents|protective agents|mesh-ancestor
56221699|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221700|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56221701|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56221702|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56221703|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
56483440|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483441|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483442|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56483443|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
56483444|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56483445|NCT01731782|Bupivacaine|bupivacaine|mesh-list
56483446|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
56483447|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
56483448|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483449|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483450|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
56221704|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221705|NCT01663961|Urological Agents|urological agents|mesh-ancestor
56221706|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
56221707|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56221708|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56221709|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56483451|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483452|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
56483453|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483454|NCT04356430|Prednisone|prednisone|mesh-list
56483455|NCT04356430|Goserelin|goserelin|mesh-list
56483456|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
56483457|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56483458|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
56483459|NCT04356430|Hormones|hormones|mesh-ancestor
56483460|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483461|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483462|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56483463|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483464|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56483465|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483466|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483467|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
56483468|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56483469|NCT03974139|Metformin|metformin|mesh-list
56483470|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56483471|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483472|NCT04320238|Interferons|interferons|mesh-list
56483473|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
56483474|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56483475|NCT04320238|Thymalfasin|thymalfasin|mesh-list
56483476|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483477|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
56483478|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483479|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
56221710|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56221711|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483480|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56205607|NCT01553942|Pemetrexed|pemetrexed|mesh-list
56483481|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56483482|NCT01229072|Heparin|heparin|mesh-list
56483483|NCT01229072|Calcium heparin|calcium heparin|mesh-list
56483484|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
56483485|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56483486|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56483487|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483488|NCT01199978|Losartan|losartan|mesh-list
56483489|NCT01199978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56483490|NCT01199978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56483491|NCT01199978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56483492|NCT01199978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56483493|NCT01199978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483494|NCT00532116|Selegiline|selegiline|mesh-list
56483495|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
56483496|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56483497|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56483498|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56483499|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56483500|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483501|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786233|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786234|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55786235|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813661|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
55813670|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
55813671|NCT01658813|Interferons|interferons|mesh-list
55813672|NCT01658813|Fluorouracil|fluorouracil|mesh-list
55813673|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
55813674|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813675|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55813676|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813677|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813678|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
55813679|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813680|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
55813681|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813682|NCT02187471|Pregabalin|pregabalin|mesh-list
55813683|NCT02187471|Analgesics|analgesics|mesh-ancestor
55813684|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
55813685|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813686|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813687|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
55813688|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55813689|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55813690|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813691|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55813692|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55813693|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55813694|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813695|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55813697|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55813699|NCT02525471|Analgesics|analgesics|mesh-ancestor
55813700|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
55813701|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813702|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813703|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813704|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813705|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55813707|NCT05323487|Diuretics|diuretics|mesh-ancestor
55813708|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
55813709|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813710|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55813711|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55813712|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813713|NCT05284409|Acetaminophen|acetaminophen|mesh-list
55813716|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56483502|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56483503|NCT00532116|Protective Agents|protective agents|mesh-ancestor
56483504|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483505|NCT04283513|Ribavirin|ribavirin|mesh-list
56483506|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
56483507|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483508|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
56483509|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483510|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
56483511|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56483512|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56483513|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56483514|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56483515|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483516|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
56483517|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483518|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483519|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56483520|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483522|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56483523|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56483524|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56483525|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483526|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483527|NCT04685148|Estradiol|estradiol|mesh-list
56483528|NCT04685148|Estrogens|estrogens|mesh-ancestor
56483529|NCT04685148|Hormones|hormones|mesh-ancestor
56483530|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483531|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483532|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
56483533|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56483534|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56483535|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56483536|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56483537|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483538|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
56483539|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56205699|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
56483540|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483541|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56483542|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483544|NCT04246684|Folic Acid|folic acid|mesh-list
56483545|NCT04246684|Capecitabine|capecitabine|mesh-list
56483546|NCT04246684|Fluorouracil|fluorouracil|mesh-list
56483547|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
56483548|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
56483549|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56483550|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
56483551|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483552|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221712|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
56221713|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483553|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56483554|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
56483555|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483556|NCT04246684|Antidotes|antidotes|mesh-ancestor
56483557|NCT04246684|Protective Agents|protective agents|mesh-ancestor
56483558|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
56483560|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
56483561|NCT04246684|Hematinics|hematinics|mesh-ancestor
56483562|NCT03883893|Acetaminophen|acetaminophen|mesh-list
56483563|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56483564|NCT03883893|Analgesics|analgesics|mesh-ancestor
56483565|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
56483566|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483567|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483568|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
56483569|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
56483570|NCT04227275|Fludarabine|fludarabine|mesh-list
56483571|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56483572|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56483573|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
55786236|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
55786237|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
55786238|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813717|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
55813718|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
55813719|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813720|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813721|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55813722|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
55813723|NCT05284409|Hormones|hormones|mesh-ancestor
55813724|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813725|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55813728|NCT05284409|Analgesics|analgesics|mesh-ancestor
55813729|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
55813730|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
55813731|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55813732|NCT05284409|Narcotics|narcotics|mesh-ancestor
55813733|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813734|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55813735|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55813736|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55813737|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813738|NCT02523599|Bupivacaine|bupivacaine|mesh-list
55813739|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
55813740|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
55813741|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813742|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813743|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
55813744|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813746|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55813747|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813748|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813749|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55813751|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
55813752|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813753|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55813754|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55813755|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55813756|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
55813757|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813758|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813759|NCT05354999|Caffeine|caffeine|mesh-list
55813760|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55813761|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813762|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55813763|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813764|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813765|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55813766|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55813767|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
56483574|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483575|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56483576|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56483577|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
56483578|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483579|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483580|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56483581|NCT00537732|Omeprazole|omeprazole|mesh-list
56483582|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56483583|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56483584|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56483585|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483586|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483587|NCT05339256|Buprenorphine|buprenorphine|mesh-list
56483588|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56483589|NCT05339256|Narcotics|narcotics|mesh-ancestor
56483590|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483591|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483592|NCT05339256|Analgesics|analgesics|mesh-ancestor
56483593|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
56483594|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483595|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56483596|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
56483597|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56483598|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
56221714|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221715|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56221716|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221717|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56221718|NCT01664065|Cephalosporins|cephalosporins|mesh-list
55786239|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55786240|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
56483599|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56483600|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
56483601|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483602|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483603|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
56483604|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56483605|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483606|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56483607|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221719|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56221720|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221721|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
56221722|NCT01664195|Hematinics|hematinics|mesh-ancestor
56221723|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
56221724|NCT01664221|Hematinics|hematinics|mesh-ancestor
56221725|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
56221726|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56221727|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
56221728|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221729|NCT01664260|Expectorants|expectorants|mesh-ancestor
56221730|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
56221731|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56221732|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
56221733|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221734|NCT01664260|Protective Agents|protective agents|mesh-ancestor
56221735|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221736|NCT01664260|Antidotes|antidotes|mesh-ancestor
56221737|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
56221738|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56221739|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221740|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221741|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56221742|NCT01664520|Analgesics|analgesics|mesh-ancestor
56221743|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
56221744|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221745|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55786241|NCT01117441|Hormones|hormones|mesh-ancestor
55789077|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56221762|NCT01664650|Hormones|hormones|mesh-ancestor
56221763|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221764|NCT01664676|Liraglutide|liraglutide|mesh-list
56221765|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56221766|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221767|NCT01664676|Incretins|incretins|mesh-ancestor
56221768|NCT01664676|Hormones|hormones|mesh-ancestor
56221769|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221770|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
56483608|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483609|NCT04320277|Ritonavir|ritonavir|mesh-list
56483610|NCT04320277|Lopinavir|lopinavir|mesh-list
56483611|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56483612|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56483613|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
56483614|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483615|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483616|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56483617|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56483618|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
56483619|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483620|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56483621|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56483623|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
56483624|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
56483625|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483626|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483627|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
56483628|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483629|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56483630|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56483631|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56483632|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56221771|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
56221772|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786242|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786243|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55813481|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
56483633|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483634|NCT04157153|Sirolimus|sirolimus|mesh-list
56483635|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56483636|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483637|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56483638|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483639|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
56483640|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56483641|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
56483642|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483643|NCT05329116|Lidocaine|lidocaine|mesh-list
56221773|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56221774|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221775|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221776|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
56221777|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221778|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221779|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55786244|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56483644|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
56483645|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
56483646|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
56483647|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483648|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483649|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
56483650|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483651|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56221781|NCT01664754|Carboplatin|carboplatin|mesh-list
56221782|NCT01664754|Pemetrexed|pemetrexed|mesh-list
56221783|NCT01664754|Exemestane|exemestane|mesh-list
56221784|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221785|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221786|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221787|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56221788|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56221789|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56221790|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56221791|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56221792|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
56221793|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221794|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221795|NCT01664819|Antioxidants|antioxidants|mesh-list
56221796|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221797|NCT01664819|Protective Agents|protective agents|mesh-ancestor
56221798|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221799|NCT01664845|Metformin|metformin|mesh-list
56221800|NCT01664845|Ribavirin|ribavirin|mesh-list
56221801|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56221802|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221803|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
56221805|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
56483652|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56483653|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56483654|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56483655|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483656|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56483657|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483658|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55786245|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55786246|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56221823|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221825|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56221826|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221827|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221828|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56221829|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
56221830|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
56221831|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
56221832|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56221833|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56221834|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221835|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
56221836|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
56221837|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221838|NCT01665209|Morphine|morphine|mesh-list
56221839|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56221840|NCT01665209|Narcotics|narcotics|mesh-ancestor
55797826|NCT04966429|Maraviroc|maraviroc|mesh-list
55797835|NCT04949347|Glycerol|glycerol|mesh-list
56231711|NCT01712893|Goserelin|goserelin|mesh-list
56483659|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56483660|NCT05329116|Protective Agents|protective agents|mesh-ancestor
56483661|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
56483662|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56483663|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
56483664|NCT00537888|Fluconazole|fluconazole|mesh-list
56483665|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
56483666|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483667|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56483668|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56483669|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483670|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483671|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56483672|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
56483673|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483674|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483675|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56483676|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56483677|NCT05264142|Voriconazole|voriconazole|mesh-list
56483678|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
56483679|NCT05264142|Omeprazole|omeprazole|mesh-list
56483680|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56483681|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56483682|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56483683|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483684|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483685|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
56483686|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483687|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56483688|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56483689|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56483690|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
56483691|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483692|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483693|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56483694|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56483695|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56483696|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483697|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56483698|NCT05264142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56483699|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56483700|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56221841|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483701|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483702|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
56483703|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56483704|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
56483705|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56483706|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56205941|NCT01556529|Unithiol|unithiol|mesh-list
56483708|NCT01246960|Fluorouracil|fluorouracil|mesh-list
56483709|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
56483710|NCT01246960|Ramucirumab|ramucirumab|mesh-list
56483711|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
56483712|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483713|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56483714|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483715|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56483716|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
56483717|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483718|NCT01246960|Antidotes|antidotes|mesh-ancestor
55786247|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786248|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56483719|NCT01246960|Protective Agents|protective agents|mesh-ancestor
56483720|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
56483721|NCT01246960|Vitamins|vitamins|mesh-ancestor
56483722|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
56483723|NCT00544986|Anastrozole|anastrozole|mesh-list
56483724|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56483725|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483726|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56483727|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56483728|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483729|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483730|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56231771|NCT01713179|Ambroxol|ambroxol|mesh-list
56483731|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
56483732|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483733|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483734|NCT03851588|Dolutegravir|dolutegravir|mesh-list
56483735|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56221842|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221843|NCT01665209|Analgesics|analgesics|mesh-ancestor
56221844|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
55786250|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55789078|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813600|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
56483736|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56483737|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483738|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483739|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56483740|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56483741|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
56483742|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483744|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56483745|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56483746|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
56483747|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483748|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483749|NCT05239182|Antiviral Agents|antiviral agents|mesh-ancestor
56483750|NCT05239182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483751|NCT05239182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483752|NCT05239182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56483753|NCT05239182|Immunologic Factors|immunologic factors|mesh-ancestor
56483754|NCT05239182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483755|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
56483756|NCT01244620|Tadalafil|tadalafil|mesh-list
56483757|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
56483758|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
56483759|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56483760|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56483761|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483762|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483763|NCT01244620|Urological Agents|urological agents|mesh-ancestor
56483764|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56483765|NCT04319692|Acetic Acid|acetic acid|mesh-list
55742314|NCT04644705|Niclosamide|niclosamide|mesh-list
56483766|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56483767|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221845|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221847|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56221848|NCT01665222|Narcotics|narcotics|mesh-ancestor
56221849|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221850|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221851|NCT01665222|Analgesics|analgesics|mesh-ancestor
56221852|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
56221853|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221854|NCT01665235|Aspirin|aspirin|mesh-list
56221855|NCT01665235|Amlodipine|amlodipine|mesh-list
56221856|NCT01665235|Clopidogrel|clopidogrel|mesh-list
56483768|NCT00545142|Valproic Acid|valproic acid|mesh-list
56483769|NCT00545142|Aripiprazole|aripiprazole|mesh-list
56483770|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
56483771|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56483772|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56483773|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56483774|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483775|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483777|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
56483778|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483779|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483780|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56483781|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56483782|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
56483783|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56483784|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56483785|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56483786|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56483787|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
56483788|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483789|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
56483790|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
56483791|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
56483792|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56483793|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56483794|NCT01267201|Prednisolone|prednisolone|mesh-list
55813696|NCT02525471|RNS60|rns60|mesh-list
56483795|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
56483796|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56483797|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
56483798|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56483799|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
56483800|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
56483801|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483802|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483803|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56483804|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
56231828|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
56221858|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56221859|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56221860|NCT01665235|Analgesics|analgesics|mesh-ancestor
56221861|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
56221862|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221863|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221864|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221865|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56221866|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56221867|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56221868|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221869|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56221870|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56221871|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221872|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
56221873|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56221874|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56221875|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
56483805|NCT01267201|Hormones|hormones|mesh-ancestor
56206030|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
56483806|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483807|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56483808|NCT01267201|Protective Agents|protective agents|mesh-ancestor
56483809|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56483810|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483812|NCT03778931|Anastrozole|anastrozole|mesh-list
56483813|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56221876|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56221877|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56221878|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56221879|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56221880|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56221881|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
56221882|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221883|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56221884|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56221885|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56221886|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56221887|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
55786251|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55786252|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
55786253|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
56483814|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483815|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56483816|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56483817|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
56483818|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56483819|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483820|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56483821|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56483822|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483823|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483824|NCT03736616|Cytarabine|cytarabine|mesh-list
56483825|NCT03736616|Rituximab|rituximab|mesh-list
56483826|NCT03736616|Carboplatin|carboplatin|mesh-list
56483827|NCT03736616|Etoposide|etoposide|mesh-list
56483828|NCT03736616|Melphalan|melphalan|mesh-list
56483829|NCT03736616|Ifosfamide|ifosfamide|mesh-list
56483830|NCT03736616|Carmustine|carmustine|mesh-list
56221888|NCT01665248|Listerine|listerine|mesh-list
56221889|NCT01665248|Fluorides|fluorides|mesh-list
56221890|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
56221891|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
56483831|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
56483832|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56483833|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483834|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
56483835|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483836|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56483837|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56483838|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56483839|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56221892|NCT01665248|Protective Agents|protective agents|mesh-ancestor
56221894|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56221895|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221896|NCT01665378|Folic Acid|folic acid|mesh-list
56221897|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
56221898|NCT01665378|Micronutrients|micronutrients|mesh-list
56221899|NCT01665378|Trace Elements|trace elements|mesh-list
56221900|NCT01665378|Hematinics|hematinics|mesh-ancestor
56221902|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221903|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
56221904|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56221905|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56483840|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742383|NCT04435587|Ritonavir|ritonavir|mesh-list
56483841|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483842|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56483843|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
56483844|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
56483845|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483846|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56483847|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56483848|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
56483849|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56483850|NCT03718403|Theophylline|theophylline|mesh-list
56483851|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56483852|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
56221906|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221907|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221908|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56221909|NCT01665404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56221910|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56221911|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56221912|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221913|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221914|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
56221915|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56221916|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
56221917|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55786254|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56221918|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56221919|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221920|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56221922|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221923|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
56221924|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
56221925|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
56221926|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221927|NCT01665469|Lycopene|lycopene|mesh-list
56221928|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221929|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
56221930|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813750|NCT05283083|Analgesics|analgesics|mesh-ancestor
56483853|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483854|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483855|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56483856|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
56483857|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56483858|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483859|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483860|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
56483861|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56483862|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56221931|NCT01665469|Protective Agents|protective agents|mesh-ancestor
56221932|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221933|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56221934|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56221935|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797918|NCT03058237|Baclofen|baclofen|mesh-list
56221936|NCT01664507|Epinephrine|epinephrine|mesh-list
56221937|NCT01664507|Racepinephrine|racepinephrine|mesh-list
56221938|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
56221939|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55786255|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56483863|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
56483864|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483865|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
56483866|NCT03684590|Narcotics|narcotics|mesh-ancestor
56483867|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56483868|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483869|NCT03684590|Analgesics|analgesics|mesh-ancestor
56483870|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
56483871|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483873|NCT00537966|Darunavir|darunavir|mesh-list
56483874|NCT00537966|Tenofovir|tenofovir|mesh-list
56483875|NCT00537966|Lamivudine|lamivudine|mesh-list
56221940|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56221941|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
56221942|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221943|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221944|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221945|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56221946|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56221947|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
56221948|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221949|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56221950|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
56221951|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
56221952|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
56221953|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56221954|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
56483876|NCT00537966|Emtricitabine|emtricitabine|mesh-list
56483877|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
56483878|NCT00537966|Dolutegravir|dolutegravir|mesh-list
56483880|NCT00537966|Cobicistat|cobicistat|mesh-list
56483881|NCT00537966|Rilpivirine|rilpivirine|mesh-list
56483882|NCT00537966|Elvitegravir|elvitegravir|mesh-list
56483883|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56483884|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56483885|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
56483886|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483887|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483888|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56483889|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56483890|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
56483891|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56483892|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56483893|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56221955|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56221956|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221957|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221958|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56221959|NCT01665586|Analgesics|analgesics|mesh-ancestor
56221960|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
56221961|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221962|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56221963|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55786256|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55786258|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221964|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56221965|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
56221966|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221967|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221968|NCT01665638|Canagliflozin|canagliflozin|mesh-list
56221969|NCT01665638|Somatostatin|somatostatin|mesh-list
56221970|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56221971|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221972|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56221973|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221974|NCT01665638|Hormones|hormones|mesh-ancestor
56221975|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56221976|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56221979|NCT01665742|Tocopherols|tocopherols|mesh-list
56483894|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56483895|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56483896|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56483897|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56483898|NCT01266967|Dabrafenib|dabrafenib|mesh-list
56483899|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483900|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56483901|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483902|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483903|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
56483904|NCT03615326|Capecitabine|capecitabine|mesh-list
56483905|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
56483906|NCT03615326|Trastuzumab|trastuzumab|mesh-list
56221984|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
56221985|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221986|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
56221987|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786259|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
55786260|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
55786261|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
55786262|NCT01101451|Cisplatin|cisplatin|mesh-list
55786263|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483907|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483908|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56483909|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56483910|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
56483911|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483912|NCT00538005|Bevacizumab|bevacizumab|mesh-list
56483913|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
56483914|NCT00538005|Sorafenib|sorafenib|mesh-list
56483915|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56483916|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483917|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56483918|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56483919|NCT00538005|Growth Substances|growth substances|mesh-ancestor
56483920|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483921|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
56221988|NCT01665742|Protective Agents|protective agents|mesh-ancestor
56221989|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221990|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56221991|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56221992|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221993|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
56221994|NCT01665781|Hematinics|hematinics|mesh-ancestor
56221995|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56221996|NCT01665846|Hematinics|hematinics|mesh-ancestor
56221997|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56221998|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56221999|NCT01666041|Fenofibrate|fenofibrate|mesh-list
56222000|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56222001|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
56222002|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222003|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56222004|NCT01666067|Simvastatin|simvastatin|mesh-list
56222005|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56222006|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56222007|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56222008|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
55797986|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483922|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56483923|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483924|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483925|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
56483927|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483928|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56483929|NCT00538044|Simvastatin|simvastatin|mesh-list
56483930|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56483931|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56483932|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
55786264|NCT03656627|Nivolumab|nivolumab|mesh-list
55786265|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786266|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222009|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222010|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56222011|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56222012|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222013|NCT01666171|Metformin|metformin|mesh-list
56222014|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56222015|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222016|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56222017|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
55813901|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55813902|NCT02158533|Narcotics|narcotics|mesh-ancestor
55813903|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813904|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813905|NCT02158533|Analgesics|analgesics|mesh-ancestor
55813906|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
55813907|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813908|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55813909|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55813910|NCT02120469|Everolimus|everolimus|mesh-list
55813911|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813912|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813913|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
55813914|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813915|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
55813916|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55813917|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813918|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
55813919|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
55813921|NCT02120157|Tacrolimus|tacrolimus|mesh-list
55813922|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813923|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
55813924|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813925|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813926|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55813927|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
55813928|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813929|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813930|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55813931|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55813932|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813947|NCT05279807|Amlodipine|amlodipine|mesh-list
55813948|NCT05279807|Zofenopril|zofenopril|mesh-list
55813949|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55813950|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55813951|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55813952|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813953|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56483933|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483934|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56483935|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56483936|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483937|NCT03504956|Metoprolol|metoprolol|mesh-list
56483938|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56483939|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56483940|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56483941|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
56483942|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
56483943|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56483944|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483945|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56483946|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56483947|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
56483948|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56483949|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483951|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
56483952|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56483953|NCT00545493|Antibodies|antibodies|mesh-list
56483954|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56483955|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
56483956|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483957|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56483958|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56483959|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483961|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
56483962|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483963|NCT05119257|Antibodies|antibodies|mesh-list
56222018|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56222019|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56222020|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
56222021|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222022|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56222023|NCT01666223|Cathartics|cathartics|mesh-ancestor
56222024|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222025|NCT01666236|Triamcinolone|triamcinolone|mesh-list
56222026|NCT01666236|Ranibizumab|ranibizumab|mesh-list
56222027|NCT01666236|Verteporfin|verteporfin|mesh-list
56222028|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56222029|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56222030|NCT01666236|Growth Substances|growth substances|mesh-ancestor
55813886|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56483964|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56483965|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
56483966|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56483967|NCT01266265|Treprostinil|treprostinil|mesh-list
56483968|NCT01266265|Bosentan|bosentan|mesh-list
56483969|NCT01266265|Ambrisentan|ambrisentan|mesh-list
56483970|NCT01266265|Epoprostenol|epoprostenol|mesh-list
56483971|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
56483972|NCT01266265|Tadalafil|tadalafil|mesh-list
56483973|NCT01266265|Iloprost|iloprost|mesh-list
56483974|NCT01266265|Tezosentan|tezosentan|mesh-list
56483975|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56483976|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
56483977|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56483978|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222031|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222032|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
55786267|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55786268|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786269|NCT04759703|Pramipexole|pramipexole|mesh-list
56222033|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222034|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222035|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
56222037|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222038|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56222039|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222040|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
56222041|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56222042|NCT01666249|Antibodies|antibodies|mesh-list
56222043|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
56222044|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051976|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56051977|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051978|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051979|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56051980|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56051981|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56051982|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55888870|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888871|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55888872|NCT04346667|Amebicides|amebicides|mesh-ancestor
55888873|NCT03471364|Ketoconazole|ketoconazole|mesh-list
55888874|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
55888875|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888876|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55888877|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55888878|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888879|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888880|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55888881|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
55888882|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888883|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888884|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55888885|NCT03024489|Cetuximab|cetuximab|mesh-list
55888886|NCT03024489|Palbociclib|palbociclib|mesh-list
55888887|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888888|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483979|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483980|NCT01266265|Urological Agents|urological agents|mesh-ancestor
56483981|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56483982|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56483983|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56483984|NCT03338387|Acipimox|acipimox|mesh-list
56483985|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56483986|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
56483987|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483988|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56483989|NCT05112549|Nivolumab|nivolumab|mesh-list
56483990|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56483991|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483992|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56483993|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56483994|NCT03268382|Doxorubicin|doxorubicin|mesh-list
56483995|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56483996|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56483997|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56483998|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56483999|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56484000|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56206283|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
56484001|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484003|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
56484004|NCT01266148|Everolimus|everolimus|mesh-list
56484005|NCT01266148|Cyclosporins|cyclosporins|mesh-list
56484006|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56484007|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484008|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484009|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484010|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
56484011|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484012|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
56484013|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484014|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
56484015|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484016|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56484017|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484018|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56484019|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56484020|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
56484021|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56484022|NCT00538239|Sirolimus|sirolimus|mesh-list
56484023|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56484024|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484025|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56222045|NCT01666262|Vaccines|vaccines|mesh-list
56222046|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
56222047|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222048|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
56222049|NCT01666301|Hematinics|hematinics|mesh-ancestor
56222050|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56222051|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56222052|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222053|NCT01666379|Fentanyl|fentanyl|mesh-list
56222054|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56222055|NCT01666379|Narcotics|narcotics|mesh-ancestor
56222056|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798042|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
55786271|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484026|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484027|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
56484028|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484029|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
56484030|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484031|NCT00538317|Tirofiban|tirofiban|mesh-list
56484032|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56484033|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56484034|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222057|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222058|NCT01666379|Analgesics|analgesics|mesh-ancestor
55814040|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55814041|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55814042|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814043|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814044|NCT05346731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55814045|NCT05346731|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55814046|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55814047|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814048|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55814050|NCT02118597|Ribavirin|ribavirin|mesh-list
55814051|NCT02118597|Simeprevir|simeprevir|mesh-list
55814052|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814053|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
55814054|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814055|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
55814056|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814057|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
55814058|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814059|NCT05218889|Gemcitabine|gemcitabine|mesh-list
55814061|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55814062|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55814063|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814064|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814065|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814080|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814081|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55814082|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55814083|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
55814084|NCT02117349|Coagulants|coagulants|mesh-ancestor
55814085|NCT05214287|Nitrox|nitrox|mesh-list
55814086|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55814087|NCT05214287|Protective Agents|protective agents|mesh-ancestor
55814088|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814089|NCT05211791|Anesthetics|anesthetics|mesh-list
55814090|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814091|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814092|NCT02177175|Carvedilol|carvedilol|mesh-list
55814093|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55814094|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55814095|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
55814096|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814097|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814098|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814101|NCT02177175|Protective Agents|protective agents|mesh-ancestor
55814102|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55814103|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814104|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55814105|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
55814106|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55814107|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55814109|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55814110|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814112|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55814113|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814114|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55814115|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814116|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
55814117|NCT05254925|Petrolatum|petrolatum|mesh-list
56484035|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56484036|NCT01265953|Sulforaphane|sulforaphane|mesh-list
56484037|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56484038|NCT01265953|Protective Agents|protective agents|mesh-ancestor
56484039|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484040|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484041|NCT01265875|Secretin|secretin|mesh-list
56484042|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484043|NCT01265875|Hormones|hormones|mesh-ancestor
56222059|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
56222060|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222061|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55888889|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55888890|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888891|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888892|NCT01775189|Naltrexone|naltrexone|mesh-list
55888893|NCT01775189|Oxycodone|oxycodone|mesh-list
55888894|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55888895|NCT01775189|Narcotics|narcotics|mesh-ancestor
55888896|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55888897|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888899|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
55888900|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888920|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888921|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55888922|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55888923|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55888924|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55888925|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888926|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55888927|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
55888928|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888929|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55888930|NCT01881412|Fluticasone|fluticasone|mesh-list
55888931|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55888932|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55888933|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
55888934|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051983|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56051984|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
56051985|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
56051986|NCT01812044|Lidocaine|lidocaine|mesh-list
56051987|NCT01812044|Bupivacaine|bupivacaine|mesh-list
56051988|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
56051989|NCT01812044|Anesthetics|anesthetics|mesh-list
56051990|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051991|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051992|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
56051993|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051994|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56051995|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55888935|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888936|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55888937|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
55888938|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
55888939|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55888940|NCT03043053|Oxytocin|oxytocin|mesh-list
55888941|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
55888942|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55888943|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888945|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
55888946|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888947|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55888948|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55888949|NCT03832816|Analgesics|analgesics|mesh-ancestor
55888950|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
55888951|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888952|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55888953|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55888954|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484044|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484045|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484046|NCT03202628|Dexamethasone|dexamethasone|mesh-list
56484047|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
56484048|NCT03202628|Pomalidomide|pomalidomide|mesh-list
56484049|NCT03202628|Ixazomib|ixazomib|mesh-list
56484050|NCT03202628|Ichthammol|ichthammol|mesh-list
56484051|NCT03202628|BB 1101|bb 1101|mesh-list
56484052|NCT03202628|Glycine|glycine|mesh-list
56484053|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56484054|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
56484055|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
56484056|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786272|NCT04759703|Protective Agents|protective agents|mesh-ancestor
55786273|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222062|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55814011|NCT05268497|Esketamine|esketamine|mesh-list
56484057|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484058|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484059|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
56484060|NCT03202628|Hormones|hormones|mesh-ancestor
56484061|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484062|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56484063|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484064|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484065|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
56484066|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484067|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
56484068|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56484069|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56484070|NCT03202628|Growth Substances|growth substances|mesh-ancestor
56484071|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
56484072|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
56484073|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
56484074|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484075|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
56484076|NCT00538395|Doxorubicin|doxorubicin|mesh-list
56484077|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56484078|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484079|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
56484080|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484081|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484082|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56484083|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
56484084|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484085|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222063|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
56222064|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
56222065|NCT01666418|Paclitaxel|paclitaxel|mesh-list
56222066|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56484086|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56484087|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56484088|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56484089|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56484090|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484091|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
56484092|NCT01265563|Silybin|silybin|mesh-list
56484093|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56484094|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
56484095|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484096|NCT01265563|Expectorants|expectorants|mesh-ancestor
56484097|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
56484098|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56484099|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
56484100|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786274|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56222067|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222068|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
56222069|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
56222070|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
56222071|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222073|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222074|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56222075|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222076|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222077|NCT01666522|Vitamin D|vitamin d|mesh-list
56222078|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
56222079|NCT01666522|Vitamins|vitamins|mesh-ancestor
56222080|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
55814060|NCT05218889|Paclitaxel|paclitaxel|mesh-list
56484101|NCT01265563|Protective Agents|protective agents|mesh-ancestor
56484102|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484103|NCT01265563|Antidotes|antidotes|mesh-ancestor
56484104|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56484105|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484106|NCT05548660|Analgesics|analgesics|mesh-list
56232122|NCT01714856|Ropinirole|ropinirole|mesh-list
56484107|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
56484108|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484109|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484111|NCT01265056|Analgesics|analgesics|mesh-ancestor
56484112|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
56222081|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222082|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56222083|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56222084|NCT01666587|Ibuprofen|ibuprofen|mesh-list
56222085|NCT01666587|Antioxidants|antioxidants|mesh-list
56222086|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
55798061|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56222087|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56222088|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222089|NCT01666587|Analgesics|analgesics|mesh-ancestor
56222090|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
56222091|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222092|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222093|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222094|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222095|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56222096|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815028|NCT04991597|Epinephrine|epinephrine|mesh-list
55815029|NCT04991597|Racepinephrine|racepinephrine|mesh-list
55815030|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
55815031|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
55815032|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
55815033|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815034|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815035|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
55815036|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815037|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55815038|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55815039|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55815040|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55815041|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815042|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55815043|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55815044|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
55815045|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815046|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55815047|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55815048|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
55815049|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55815050|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
55815051|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
55815064|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815066|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55815067|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
56484113|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484114|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484115|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
56484116|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56484117|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56484118|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56484119|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56484120|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56484121|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56484122|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484123|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484124|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
56484125|NCT02942498|Vitamins|vitamins|mesh-list
56484126|NCT02942498|Vitamin E|vitamin e|mesh-list
56484127|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
56484128|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484129|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
56484130|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484131|NCT02942498|Protective Agents|protective agents|mesh-ancestor
56484132|NCT00545961|Amoxicillin|amoxicillin|mesh-list
56484133|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
56484134|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
56484135|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56484136|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56484137|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484138|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56484139|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484140|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484141|NCT01264939|Omalizumab|omalizumab|mesh-list
56484142|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
56484143|NCT01264939|Promethazine|promethazine|mesh-list
56206449|NCT01559753|Cefotaxime|cefotaxime|mesh-list
56484144|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
56484145|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56484146|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
56484147|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56484148|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56484149|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
56484150|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56484151|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56484152|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56484153|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484154|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
56484155|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
56484156|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
56484157|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484158|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
56484159|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
56484160|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484161|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
56484162|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484163|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786275|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55786276|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
55786277|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
56484164|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
56484165|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
56484166|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
56484167|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484168|NCT02889367|Odalasvir|odalasvir|mesh-list
56484169|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
56484170|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484171|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56484172|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484173|NCT00546039|Genistein|genistein|mesh-list
56484174|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56484175|NCT00546039|Protective Agents|protective agents|mesh-ancestor
56484176|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484177|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484178|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56222097|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222099|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
56222100|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222101|NCT01666600|Nintedanib|nintedanib|mesh-list
56222102|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222103|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56222104|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222105|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222106|NCT01666665|Metformin|metformin|mesh-list
56222107|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56222108|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222109|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
56222110|NCT01666678|Promethazine|promethazine|mesh-list
56222111|NCT01666678|Naproxen|naproxen|mesh-list
56222112|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56222113|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222114|NCT01666678|Analgesics|analgesics|mesh-ancestor
56222115|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
56222116|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484179|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484180|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484181|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
56484182|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56484183|NCT00546039|Estrogens|estrogens|mesh-ancestor
56484184|NCT00546039|Hormones|hormones|mesh-ancestor
56484185|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484187|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484188|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56222117|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222118|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222119|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222120|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
56222121|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56222122|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222123|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222124|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56222125|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56222126|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222127|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
55798111|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55786278|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222128|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
56222129|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
56222130|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
56484189|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484190|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484191|NCT02711969|Apatinib|apatinib|mesh-list
56484192|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484193|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56484194|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484195|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484196|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
56484197|NCT01263925|Alprostadil|alprostadil|mesh-list
56484198|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56484199|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484200|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484201|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56484202|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56222131|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222132|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56222133|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
56222134|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
56222135|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222136|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56222137|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
56222138|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222140|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56222141|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56222142|NCT01666691|Growth Substances|growth substances|mesh-ancestor
56222143|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222144|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
56222145|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222146|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56222147|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56222148|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222149|NCT01666756|Sorafenib|sorafenib|mesh-list
56222150|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484203|NCT01263925|Protective Agents|protective agents|mesh-ancestor
56484204|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484205|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
56484206|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56484207|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
56484208|NCT01263925|Urological Agents|urological agents|mesh-ancestor
56484209|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
56484210|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
56484211|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56484212|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56484213|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484214|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484215|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484216|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484217|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
56484218|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56484219|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
56484220|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484221|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484222|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56484223|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
56484224|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
56484225|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56484226|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
56484227|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484228|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484229|NCT01263769|Axitinib|axitinib|mesh-list
56484230|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484231|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56484232|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484233|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484234|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
56484235|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484236|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
56484237|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484238|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484239|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56484240|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
56222174|NCT01667211|Nedaplatin|nedaplatin|mesh-list
56222175|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55815446|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
55815447|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815448|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815449|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
55815450|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815451|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
55815452|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55815453|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55815454|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
55815455|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815456|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815458|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
55815459|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55815460|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55815461|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
55815462|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815463|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55815464|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55815465|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55815466|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55815468|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
55815469|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815470|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815471|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815472|NCT01883362|Midostaurin|midostaurin|mesh-list
55815473|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815474|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55815475|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815476|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815477|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
56484241|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484242|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484243|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56484244|NCT00539331|Paclitaxel|paclitaxel|mesh-list
56484245|NCT00539331|Carboplatin|carboplatin|mesh-list
56484246|NCT00539331|Cediranib|cediranib|mesh-list
56484247|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56484248|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484249|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
56484250|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
55786279|NCT03597581|Bevacizumab|bevacizumab|mesh-list
56222176|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222177|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
56222178|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
56222179|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
56222180|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222182|NCT01667263|Danazol|danazol|mesh-list
56222183|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222184|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
56222185|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222186|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56222187|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
56222188|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222189|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222190|NCT01667315|Bupivacaine|bupivacaine|mesh-list
55814144|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56484251|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
56484252|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484253|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56484254|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484255|NCT02236013|Cytarabine|cytarabine|mesh-list
56484256|NCT02236013|Daunorubicin|daunorubicin|mesh-list
56484257|NCT02236013|Idarubicin|idarubicin|mesh-list
56484258|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56484259|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
56232272|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484260|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484261|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484262|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
56222191|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
56222192|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
56222193|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56484263|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484264|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484265|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
56484266|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484267|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56484268|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56206620|NCT05491304|Hormones|hormones|mesh-ancestor
56484269|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56484270|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484271|NCT00539409|Insulin|insulin|mesh-list
56484272|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
56484273|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56484274|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56484275|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484276|NCT01263691|Vaccines|vaccines|mesh-list
56222194|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222195|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
55786280|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786281|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484277|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
56484278|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484279|NCT02178410|Vitamin D|vitamin d|mesh-list
56484280|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
56484281|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
56484282|NCT02178410|Vitamins|vitamins|mesh-list
56484283|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
56484284|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484285|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56484286|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56484287|NCT00539448|Insulin|insulin|mesh-list
56484288|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55786282|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56222197|NCT01667445|Morphine|morphine|mesh-list
56222198|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55786283|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55786284|NCT03597581|Growth Substances|growth substances|mesh-ancestor
56484289|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
56484290|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
56484291|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56484292|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484293|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
56484294|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56484295|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484296|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55786285|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786286|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
55786287|NCT05026801|Azithromycin|azithromycin|mesh-list
56222199|NCT01667445|Narcotics|narcotics|mesh-ancestor
56222200|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222201|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222202|NCT01667445|Analgesics|analgesics|mesh-ancestor
56222203|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
56222204|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815478|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
55815479|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
55815480|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815481|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815482|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55815483|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55815484|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
55815485|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
55815486|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793769|NCT04992481|Fluorides|fluorides|mesh-list
55815496|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55815497|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55815498|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815499|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815500|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55815501|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
55815502|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815503|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815504|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55815505|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55815506|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55815507|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55815508|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55815509|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815510|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815511|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55815512|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55815513|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55815514|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55815515|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
55815516|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815517|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815518|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55815519|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55815520|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
55815521|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55815522|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55815523|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
55815524|NCT01928758|Nicotine|nicotine|mesh-list
55815526|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
55815527|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815528|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815529|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55815530|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55815531|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
56484297|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484298|NCT01808456|Vaccines|vaccines|mesh-list
56484299|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
56206686|NCT05229965|Caffeine|caffeine|mesh-list
56484300|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484301|NCT01715714|Atorvastatin|atorvastatin|mesh-list
56484302|NCT01715714|Simvastatin|simvastatin|mesh-list
56484303|NCT01715714|Pravastatin|pravastatin|mesh-list
56484304|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56484305|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56484306|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
56484307|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484308|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56484309|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56484310|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484311|NCT01540253|Docetaxel|docetaxel|mesh-list
56484312|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484313|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
56484314|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
55786288|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
55786289|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55786290|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222205|NCT01667484|Adderall|adderall|mesh-list
56222206|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56222207|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222208|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
56484315|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
56484316|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484317|NCT01497392|Gemcitabine|gemcitabine|mesh-list
56484318|NCT01497392|Capecitabine|capecitabine|mesh-list
56484319|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56484320|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
56484321|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484322|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484323|NCT01497392|Antiviral Agents|antiviral agents|mesh-ancestor
56484324|NCT01497392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56206707|NCT05219604|Promethazine|promethazine|mesh-list
56484325|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786291|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
55786292|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55786293|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55786294|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222209|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56222210|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56484326|NCT01497392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484327|NCT01497392|Immunologic Factors|immunologic factors|mesh-ancestor
56484328|NCT01497392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484330|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
56484331|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56484332|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
56484333|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484334|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484335|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56484336|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
56484337|NCT00539565|Prednisolone|prednisolone|mesh-list
56484338|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56484339|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
56484340|NCT00539565|Hormones|hormones|mesh-ancestor
56484341|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484342|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484343|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56484344|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484345|NCT00539799|Prednisolone|prednisolone|mesh-list
56484346|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55786295|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484347|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
56484348|NCT00539799|Hormones|hormones|mesh-ancestor
56484349|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484350|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484351|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56484352|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484353|NCT00945152|Vancomycin|vancomycin|mesh-list
56484354|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56484355|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484356|NCT00546507|Celecoxib|celecoxib|mesh-list
55786296|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786297|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
56222211|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222212|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
56484357|NCT00546507|Diclofenac|diclofenac|mesh-list
56484358|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56484359|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56484360|NCT00546507|Analgesics|analgesics|mesh-ancestor
56484361|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
56484362|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484363|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484364|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56484365|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484366|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56484367|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56484368|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786298|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55786299|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
55786300|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222214|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
56222215|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222216|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
56222217|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222218|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222219|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56484369|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484370|NCT00546546|Methotrexate|methotrexate|mesh-list
56484371|NCT00546546|Azathioprine|azathioprine|mesh-list
56484372|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56484373|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56484374|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
56484375|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56484376|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484377|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56484378|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
56484379|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484380|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222220|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222221|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56222222|NCT01667523|Protective Agents|protective agents|mesh-ancestor
56222223|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56222224|NCT01667575|Amoxicillin|amoxicillin|mesh-list
56222225|NCT01667575|Clarithromycin|clarithromycin|mesh-list
56222226|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56222227|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
56222228|NCT01667575|Esomeprazole|esomeprazole|mesh-list
56222229|NCT01667575|Bismuth|bismuth|mesh-list
56222230|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56222231|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484381|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
56484382|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484383|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56484384|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
56484385|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484386|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56484387|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56484388|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56484389|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484390|NCT00659711|Incretins|incretins|mesh-ancestor
56222232|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222233|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
56222234|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55786301|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
55786302|NCT05073575|Protective Agents|protective agents|mesh-ancestor
55786303|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
55786304|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55814260|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
56484392|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484393|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56484394|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
56484395|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484396|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484397|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
56484398|NCT02581007|Melphalan|melphalan|mesh-list
56484399|NCT02581007|Fludarabine|fludarabine|mesh-list
56484400|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484401|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
56206796|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56484402|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484403|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222235|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222237|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56222238|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56222239|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56222240|NCT01667575|Antacids|antacids|mesh-ancestor
56222241|NCT01667575|Diuretics|diuretics|mesh-ancestor
55786305|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55786306|NCT03511625|Prednisolone|prednisolone|mesh-list
55814268|NCT05248139|Triamcinolone|triamcinolone|mesh-list
56484404|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56484405|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
56484406|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484407|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484408|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56484410|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
56484411|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56484412|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484413|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56484414|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484416|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56484417|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484418|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56484419|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56484420|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
56222242|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
56222243|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222244|NCT01667575|Expectorants|expectorants|mesh-ancestor
56222245|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
56222246|NCT01667614|Losartan|losartan|mesh-list
56222247|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56222248|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56222249|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56222250|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56222251|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222252|NCT01667692|Azithromycin|azithromycin|mesh-list
56222253|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56222254|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786307|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
55815995|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
55815996|NCT02098395|Liraglutide|liraglutide|mesh-list
55815997|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815998|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815999|NCT02098395|Incretins|incretins|mesh-ancestor
55816000|NCT02098395|Hormones|hormones|mesh-ancestor
55816001|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816002|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55816003|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55816004|NCT02096835|Dexamethasone|dexamethasone|mesh-list
55816005|NCT02096835|Tropisetron|tropisetron|mesh-list
55816006|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816007|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
55816008|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
55816009|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816010|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816011|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816012|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
55816016|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816028|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816029|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55816030|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
55816031|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816032|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816033|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55816035|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55816036|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55816037|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56484421|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484422|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484423|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
56484424|NCT02467361|Nivolumab|nivolumab|mesh-list
56484425|NCT02467361|Ipilimumab|ipilimumab|mesh-list
56484426|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56484427|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484428|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56484429|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484430|NCT00546936|Ranibizumab|ranibizumab|mesh-list
56484431|NCT00546936|Verteporfin|verteporfin|mesh-list
56222255|NCT01667718|Amoxicillin|amoxicillin|mesh-list
56222256|NCT01667718|Levofloxacin|levofloxacin|mesh-list
56222257|NCT01667718|Ofloxacin|ofloxacin|mesh-list
56222258|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
56222259|NCT01667718|Lansoprazole|lansoprazole|mesh-list
56222260|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
56222261|NCT01667718|Bismuth|bismuth|mesh-list
56222262|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56222263|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798237|NCT04939675|Levetiracetam|levetiracetam|mesh-list
55814320|NCT05196815|Protective Agents|protective agents|mesh-ancestor
56484432|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56484433|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56484434|NCT00546936|Growth Substances|growth substances|mesh-ancestor
56484435|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484436|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
56484437|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484438|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56484439|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
56484441|NCT02231723|Gemcitabine|gemcitabine|mesh-list
56484442|NCT02231723|Paclitaxel|paclitaxel|mesh-list
56484443|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56484444|NCT02231723|Fluorouracil|fluorouracil|mesh-list
56484445|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
56484446|NCT02231723|Irinotecan|irinotecan|mesh-list
56484447|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55786308|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56222264|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56222265|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222266|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56222267|NCT01667718|Renal Agents|renal agents|mesh-ancestor
56222268|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55814321|NCT05245877|Enoxaparin|enoxaparin|mesh-list
56484448|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484450|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
56484451|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
56484452|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484453|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56484454|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
56484455|NCT02231723|Antiviral Agents|antiviral agents|mesh-ancestor
56484456|NCT02231723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484457|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222269|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56222270|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222271|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222272|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56484458|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484459|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
56484460|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484461|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56484462|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56484463|NCT02231723|Antidotes|antidotes|mesh-ancestor
56484464|NCT02231723|Protective Agents|protective agents|mesh-ancestor
56484465|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
56484466|NCT02231723|Vitamins|vitamins|mesh-ancestor
56484467|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
56484468|NCT01263496|Alogliptin|alogliptin|mesh-list
56484469|NCT01263496|Voglibose|voglibose|mesh-list
56484470|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56206868|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
56484471|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484472|NCT01263496|Incretins|incretins|mesh-ancestor
56484473|NCT01263496|Hormones|hormones|mesh-ancestor
56484474|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484475|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56484476|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
56484477|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484478|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484479|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56484480|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
56484481|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56484482|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56484483|NCT04681937|Prednisolone|prednisolone|mesh-list
56484484|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
56484485|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56484486|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
56484487|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
56484488|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56484489|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
56484490|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
56484491|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222273|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56222274|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56222275|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222276|NCT01667718|Antacids|antacids|mesh-ancestor
55814347|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
56484492|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484493|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484494|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
56484495|NCT04681937|Hormones|hormones|mesh-ancestor
56484496|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484497|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56484499|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56484500|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484501|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56484502|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
56484503|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
56484504|NCT00547053|Amiloride|amiloride|mesh-list
56484505|NCT00547053|Diuretics|diuretics|mesh-ancestor
56484506|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
56484507|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484508|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56484509|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56484510|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56484511|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484512|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56484513|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56484514|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
56484515|NCT00547092|Tadalafil|tadalafil|mesh-list
56484516|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
56484517|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56484518|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56484519|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484520|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484521|NCT00547092|Urological Agents|urological agents|mesh-ancestor
56484522|NCT00547131|Temozolomide|temozolomide|mesh-list
56145422|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816039|NCT02365285|Galantamine|galantamine|mesh-list
55794608|NCT05201313|Lidocaine|lidocaine|mesh-list
55816046|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55816047|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55816048|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55816049|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816050|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
55816051|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816052|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816053|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55816054|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
55816055|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816056|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
55816057|NCT02041299|Deferiprone|deferiprone|mesh-list
55816058|NCT02041299|Deferoxamine|deferoxamine|mesh-list
55816059|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55816060|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
55816061|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
55816062|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816063|NCT02041299|Siderophores|siderophores|mesh-ancestor
55816081|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55816082|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816083|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
55816084|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55816085|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816087|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
55816088|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816089|NCT01901224|Metformin|metformin|mesh-list
55816090|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55816091|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816092|NCT01901146|Paclitaxel|paclitaxel|mesh-list
55816093|NCT01901146|Trastuzumab|trastuzumab|mesh-list
55816094|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55816095|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816096|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
55816097|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
55816098|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
55816099|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816100|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55816101|NCT01644643|Metronidazole|metronidazole|mesh-list
55816102|NCT01644643|Ceftazidime|ceftazidime|mesh-list
55816103|NCT01644643|Avibactam|avibactam|mesh-list
55816104|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484523|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56484524|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
56484525|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484526|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56206958|NCT03813121|Midazolam|midazolam|mesh-list
56484527|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56484528|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56484529|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484530|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
56222277|NCT01667718|Diuretics|diuretics|mesh-ancestor
56222278|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
56222279|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222280|NCT01667718|Expectorants|expectorants|mesh-ancestor
56222281|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
56222282|NCT01667874|Gentamicins|gentamicins|mesh-list
55798259|NCT04938583|Paclitaxel|paclitaxel|mesh-list
56484532|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56484533|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484534|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
56484535|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56484536|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56484537|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
56484538|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56484539|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
56484540|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
56484541|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222284|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222285|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56222286|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222287|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222288|NCT01668043|UB-421|ub-421|mesh-list
56222289|NCT01668043|Antibodies|antibodies|mesh-list
56222290|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
55814412|NCT05237687|Sirolimus|sirolimus|mesh-list
56484542|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484543|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56484544|NCT00547209|Analgesics|analgesics|mesh-ancestor
56484545|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
56484546|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484547|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
56484548|NCT00547287|Tadalafil|tadalafil|mesh-list
56484549|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
56484550|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56484551|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56222291|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222292|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56222293|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
56222294|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222295|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56222296|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56222297|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222298|NCT01668069|Ondansetron|ondansetron|mesh-list
56222299|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
56222300|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
56222301|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222302|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798275|NCT03055663|Midazolam|midazolam|mesh-list
55786310|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55786311|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55786312|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
55814434|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
56484552|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484553|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484554|NCT00547287|Urological Agents|urological agents|mesh-ancestor
56484555|NCT01263106|Theophylline|theophylline|mesh-list
56484556|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56484557|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
56484558|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786313|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
55786314|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786315|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786316|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55786317|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
55786318|NCT03511625|Hormones|hormones|mesh-ancestor
55786319|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786320|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55786321|NCT03511625|Protective Agents|protective agents|mesh-ancestor
55786322|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55786323|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786324|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
55786325|NCT03493061|Irinotecan|irinotecan|mesh-list
55786326|NCT03493061|Floxuridine|floxuridine|mesh-list
55786327|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786328|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55786329|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55786330|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786331|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786332|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55786334|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
55786335|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55786336|NCT03809533|Velpatasvir|velpatasvir|mesh-list
55786337|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
55786338|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222303|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484559|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484560|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56484561|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
56484562|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56484563|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484564|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56206999|NCT03676725|Lidocaine|lidocaine|mesh-list
56484565|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
56484566|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56484567|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56484568|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
56484569|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484570|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
56484571|NCT01263028|Vitamin D|vitamin d|mesh-list
56484572|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56484573|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484574|NCT01263028|Vitamins|vitamins|mesh-ancestor
56222304|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
56222305|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222306|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55786339|NCT04523935|Topiramate|topiramate|mesh-list
55786340|NCT04523935|Lamotrigine|lamotrigine|mesh-list
55786341|NCT04523935|Diazepam|diazepam|mesh-list
55786342|NCT04523935|Gabapentin|gabapentin|mesh-list
55786343|NCT04523935|Amitriptyline|amitriptyline|mesh-list
55786344|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
55786345|NCT04523935|Clonazepam|clonazepam|mesh-list
55786346|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
55786347|NCT04523935|Baclofen|baclofen|mesh-list
55786348|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
55786349|NCT04523935|Analgesics|analgesics|mesh-ancestor
55786350|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
55786351|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786354|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55786355|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786356|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55786357|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55786358|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56484575|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
56484576|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56484577|NCT00547443|Paclitaxel|paclitaxel|mesh-list
56484578|NCT00547443|Carboplatin|carboplatin|mesh-list
56484579|NCT00547443|Sorafenib|sorafenib|mesh-list
56484580|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56484581|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484582|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
56484583|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
56484584|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
56484585|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484586|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56484587|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786359|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222307|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
56222308|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798285|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
55814492|NCT05228951|Letrozole|letrozole|mesh-list
56484589|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
56484590|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56484591|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56484592|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484593|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484594|NCT00547599|Urological Agents|urological agents|mesh-ancestor
56484595|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55786360|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786361|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
55786362|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56222309|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222310|NCT01668069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56222311|NCT01668069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56484596|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56484597|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
56484598|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484599|NCT02908412|Bupivacaine|bupivacaine|mesh-list
56484600|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
56484601|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
56484602|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222312|NCT01668069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56484603|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484604|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
56484605|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484606|NCT02908295|Misoprostol|misoprostol|mesh-list
56484607|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56484608|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
56484609|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56222313|NCT01668069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56222314|NCT01668069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55786365|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55786366|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55786367|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56484610|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484611|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56484612|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484613|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
56484614|NCT03809442|Dexamethasone|dexamethasone|mesh-list
56484615|NCT03809442|Midazolam|midazolam|mesh-list
56484616|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
56484617|NCT03809442|Ketamine|ketamine|mesh-list
56484618|NCT03809442|Tramadol|tramadol|mesh-list
56484619|NCT03809442|Ropivacaine|ropivacaine|mesh-list
55786368|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55786369|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55786370|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56222315|NCT01668121|Budesonide|budesonide|mesh-list
56222316|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
56222317|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56222318|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222319|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55786371|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
56484620|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56484621|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
56484622|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
56484623|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484624|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484625|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484627|NCT03809442|Hormones|hormones|mesh-ancestor
56484628|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484629|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56484630|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484631|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55786372|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
55786373|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55786374|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
55786375|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55786376|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55786377|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56222320|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
56222321|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222322|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222323|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56222324|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
56222325|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
56222326|NCT01668121|Hormones|hormones|mesh-ancestor
56222327|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222328|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56222329|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56222330|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56222331|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
55816272|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
55816273|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816274|NCT02359435|Amoxicillin|amoxicillin|mesh-list
55816275|NCT02359435|Metronidazole|metronidazole|mesh-list
55816276|NCT02359435|Clarithromycin|clarithromycin|mesh-list
55816277|NCT02359435|Pantoprazole|pantoprazole|mesh-list
55816278|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55816279|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816280|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55816281|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55816282|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55816283|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816284|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816285|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55816286|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55816287|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55816288|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816289|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55816291|NCT04599868|Analgesics|analgesics|mesh-ancestor
55816292|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
55816293|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816294|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816295|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
55816296|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816297|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56484632|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56484633|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56484634|NCT03809442|Analgesics|analgesics|mesh-ancestor
56484635|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
56484636|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56484637|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56484638|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56484639|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56484640|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484641|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484642|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56484643|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56484644|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
56484645|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
56484646|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56484647|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55786379|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55786380|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
55786381|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
55786382|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55786383|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55786384|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55786385|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
55786386|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
55786387|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
55786388|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56222332|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222333|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222334|NCT01668433|Primaquine|primaquine|mesh-list
56222335|NCT01668433|Methylene Blue|methylene blue|mesh-list
56222336|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
56222337|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56222338|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56222339|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222340|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222341|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222342|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
56222343|NCT01668446|Estradiol|estradiol|mesh-list
56222344|NCT01668446|Estrogens|estrogens|mesh-ancestor
56222345|NCT01668446|Hormones|hormones|mesh-ancestor
56222346|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222347|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798315|NCT04938037|Hormones|hormones|mesh-ancestor
56222348|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
56222349|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55786391|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55786392|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
55786393|NCT02630693|Tamoxifen|tamoxifen|mesh-list
55786394|NCT02630693|Fulvestrant|fulvestrant|mesh-list
55786395|NCT02630693|Palbociclib|palbociclib|mesh-list
55786396|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55786397|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55786398|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
55786400|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786407|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55786408|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786409|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786410|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56222350|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56222351|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786412|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55786413|NCT01938430|Ledipasvir|ledipasvir|mesh-list
55786415|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786416|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
55786417|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
56222352|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222353|NCT01668446|Urological Agents|urological agents|mesh-ancestor
55798330|NCT04937101|Analgesics|analgesics|mesh-ancestor
55786430|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55786431|NCT01916824|Sertraline|sertraline|mesh-list
55786432|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
55786433|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56222354|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56484648|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
56484649|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56484650|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56484651|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56484652|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56484653|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
56484654|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
56484655|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56484656|NCT03809442|Narcotics|narcotics|mesh-ancestor
56484657|NCT00534729|Carboplatin|carboplatin|mesh-list
56222356|NCT01668498|Doxycycline|doxycycline|mesh-list
56222357|NCT01668498|Erythromycin|erythromycin|mesh-list
56222358|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
56222359|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56222360|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
56222361|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56222362|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222363|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
56222364|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56222365|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56222366|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222367|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56222368|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222369|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222370|NCT01668550|AZD-0424|azd-0424|mesh-list
56222371|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56222372|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222373|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222374|NCT01668615|Tretinoin|tretinoin|mesh-list
56484658|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484659|NCT00547989|Bupivacaine|bupivacaine|mesh-list
56484660|NCT00547989|Ropivacaine|ropivacaine|mesh-list
56484661|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
56484662|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
56484663|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56484664|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484665|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
56484666|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484668|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56484669|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
56484670|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56484671|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222375|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222376|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
56222377|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222378|NCT01668680|Celecoxib|celecoxib|mesh-list
56222379|NCT01668680|Capecitabine|capecitabine|mesh-list
56222380|NCT01668680|Methotrexate|methotrexate|mesh-list
56222381|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56222382|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
56222383|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222384|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56207126|NCT02918006|Vaccines|vaccines|mesh-list
56484672|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
56484673|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56484674|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484675|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484676|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56484677|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56222385|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56222386|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
55798353|NCT04431349|Clopidogrel|clopidogrel|mesh-list
55786435|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55786436|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55786437|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786438|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786439|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
55786440|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786441|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55786442|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55786443|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786444|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55786445|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
56484678|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56484679|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56484680|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56484681|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56484683|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56484684|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484685|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56484686|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56222388|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222389|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222390|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222391|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56222392|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56222393|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
56222394|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222395|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56222396|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56222397|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222398|NCT01668680|Analgesics|analgesics|mesh-ancestor
56222399|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
56222400|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814546|NCT02152137|Paclitaxel|paclitaxel|mesh-list
56484687|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
56484688|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484689|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484690|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56484691|NCT00548067|Amlodipine|amlodipine|mesh-list
56484692|NCT00548067|Valsartan|valsartan|mesh-list
56484693|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56484694|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55786446|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55786447|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55786448|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786449|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55786451|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
55786452|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55786453|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
55786454|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
55786455|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55786456|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55786457|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786458|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55786459|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56222401|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222402|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56222403|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56222405|NCT01668901|Warfarin|warfarin|mesh-list
56222406|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56222407|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222408|NCT01668901|Analgesics|analgesics|mesh-ancestor
56222409|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
56222410|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222411|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222412|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222413|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222414|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56222415|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56222416|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222420|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
56484695|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56484696|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56484697|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484698|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56484699|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484700|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
56484701|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56484702|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56484703|NCT00548067|Diuretics|diuretics|mesh-ancestor
56484704|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
56484705|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56484706|NCT02907749|Carvedilol|carvedilol|mesh-list
56484707|NCT02907749|Spironolactone|spironolactone|mesh-list
56484708|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56222424|NCT01668927|Tetracycline|tetracycline|mesh-list
56222425|NCT01668927|Furazolidone|furazolidone|mesh-list
56222426|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
56222427|NCT01668927|Lansoprazole|lansoprazole|mesh-list
56222428|NCT01668927|Bismuth|bismuth|mesh-list
56222429|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56222430|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222431|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56222432|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222433|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56222434|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56222435|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56222436|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222437|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222438|NCT01668927|Antacids|antacids|mesh-ancestor
56222439|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56222440|NCT01668927|Diuretics|diuretics|mesh-ancestor
56222441|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
56222442|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222443|NCT01668927|Expectorants|expectorants|mesh-ancestor
56222444|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
56222445|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56222446|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56222447|NCT01668927|Renal Agents|renal agents|mesh-ancestor
56222448|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56222449|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55786461|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
55786462|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56484709|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
56484710|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484711|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484712|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56484713|NCT02907749|Diuretics|diuretics|mesh-ancestor
56484714|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
56484715|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56484716|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56484717|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
56484718|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484719|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484720|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56484721|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
56484722|NCT02907749|Protective Agents|protective agents|mesh-ancestor
56484723|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56484724|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56484725|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56484726|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
56484727|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56484728|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56484729|NCT02907593|Budesonide|budesonide|mesh-list
56484730|NCT02907593|Calfactant|calfactant|mesh-list
56484731|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56484732|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56484733|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
56484734|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484735|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484736|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56484737|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
56222450|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
56222451|NCT01669044|Propofol|propofol|mesh-list
56222452|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56222453|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222454|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222455|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56222456|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
56222457|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
56222458|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222459|NCT01669044|Analgesics|analgesics|mesh-ancestor
56222460|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
56222461|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222462|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56222463|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56484738|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
56484739|NCT02907593|Hormones|hormones|mesh-ancestor
56484740|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484741|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56484742|NCT00548301|Cyclosporine|cyclosporine|mesh-list
56484743|NCT00548301|Cyclosporins|cyclosporins|mesh-list
56484744|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484745|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484746|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484747|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
56484748|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484749|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
56484750|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484751|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
56484752|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484753|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56484754|NCT02907710|Endostar protein|endostar protein|mesh-list
56484755|NCT02907710|Endostatins|endostatins|mesh-list
56222464|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56222465|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
56222466|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484756|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56484757|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56484758|NCT02907710|Growth Substances|growth substances|mesh-ancestor
56484759|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484760|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
56484761|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484762|NCT03781362|Capecitabine|capecitabine|mesh-list
56484763|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56484764|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
56484765|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484766|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484767|NCT04682249|Apatinib|apatinib|mesh-list
56484768|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484769|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55786469|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786470|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56222467|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222468|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
56222469|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55798442|NCT04916821|Propolis|propolis|mesh-list
56484770|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484771|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484772|NCT00548379|Vitamin D|vitamin d|mesh-list
56484773|NCT00548379|Vitamins|vitamins|mesh-ancestor
56484774|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
56484775|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484776|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56484777|NCT04972617|Furosemide|furosemide|mesh-list
56484778|NCT04972617|Diuretics|diuretics|mesh-ancestor
56484779|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
56484780|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484781|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56484782|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56484783|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484784|NCT04682210|Bevacizumab|bevacizumab|mesh-list
56484785|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56484786|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232797|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56484787|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56484788|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56484789|NCT04682210|Growth Substances|growth substances|mesh-ancestor
56484790|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484791|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
56484793|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
56484794|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484795|NCT02907554|Cyclosporine|cyclosporine|mesh-list
56484796|NCT02907554|Cyclosporins|cyclosporins|mesh-list
56484797|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484798|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786471|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786472|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786474|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55786475|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56222470|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222471|NCT01669135|Anesthetics|anesthetics|mesh-list
56222472|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222473|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222474|NCT01669213|Ondansetron|ondansetron|mesh-list
56222475|NCT01669213|Ramosetron|ramosetron|mesh-list
56222476|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
56222477|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
56222478|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222479|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222480|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222481|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
56222482|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222483|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56222484|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
55814640|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
56484799|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484800|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
56484801|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484802|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
56484803|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484804|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
56484805|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484806|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56484807|NCT02907632|Metoclopramide|metoclopramide|mesh-list
56484808|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
56484809|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
56484810|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484811|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484812|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484813|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56484814|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56484815|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
56484816|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56484817|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484818|NCT02907437|Minocycline|minocycline|mesh-list
56484819|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56484820|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484821|NCT01262872|Vaccines|vaccines|mesh-list
56484822|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56484823|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
56222485|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222486|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222487|NCT01669213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56222488|NCT01669213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56222489|NCT01669213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222490|NCT01669213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56484824|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484825|NCT04323280|Dexamethasone|dexamethasone|mesh-list
56484826|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56484827|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
56484828|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
56484829|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484830|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484831|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56484832|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
56484833|NCT04323280|Hormones|hormones|mesh-ancestor
56207310|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56484834|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484835|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56222491|NCT01669213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56484836|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484837|NCT00548574|Mesalamine|mesalamine|mesh-list
56484838|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56484839|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56484840|NCT00548574|Analgesics|analgesics|mesh-ancestor
56484841|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
56484842|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484843|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484844|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222493|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222494|NCT01669239|Doxorubicin|doxorubicin|mesh-list
56222495|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56222496|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56222497|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222498|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56222499|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55786477|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786478|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786479|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786482|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
56484845|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484846|NCT01262677|Pregabalin|pregabalin|mesh-list
56484847|NCT01262677|Analgesics|analgesics|mesh-ancestor
56484848|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
56484849|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484850|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484851|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
56484852|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56484853|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56484854|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222500|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222501|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484855|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56484856|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56484857|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56484858|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56484859|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56484860|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
56484861|NCT02899364|Antidotes|antidotes|mesh-ancestor
56484862|NCT02899364|Protective Agents|protective agents|mesh-ancestor
56484863|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484864|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
56484865|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484866|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
56222502|NCT01669291|Leuprolide|leuprolide|mesh-list
56222503|NCT01669291|Cetrorelix|cetrorelix|mesh-list
56222504|NCT01669291|Menotropins|menotropins|mesh-list
55786483|NCT01618708|Protective Agents|protective agents|mesh-ancestor
55786484|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786486|NCT02229149|Vinorelbine|vinorelbine|mesh-list
56484867|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56484868|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484869|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
56484870|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
56484871|NCT04206865|Valsartan|valsartan|mesh-list
56484872|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
56484873|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56484874|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56484875|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56484876|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56484877|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484878|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56222505|NCT01669291|Ganirelix|ganirelix|mesh-list
56222506|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56222507|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
56222508|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56222509|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222510|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56222511|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222512|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
56222513|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222514|NCT01669304|Verapamil|verapamil|mesh-list
56222515|NCT01669304|Sertraline|sertraline|mesh-list
56222516|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
56222517|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56222518|NCT01669304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56222519|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56222520|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798482|NCT03056599|Docetaxel|docetaxel|mesh-list
55786487|NCT02229149|Docetaxel|docetaxel|mesh-list
55786488|NCT02229149|Capecitabine|capecitabine|mesh-list
55786489|NCT02229149|Trastuzumab|trastuzumab|mesh-list
55786490|NCT02229149|Pertuzumab|pertuzumab|mesh-list
55786491|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55786492|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222521|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222522|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222523|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
56222524|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222525|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56222526|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56222527|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55786494|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
55786495|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
56222528|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
56222530|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
56222531|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56222532|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222533|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484879|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56484880|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56484881|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
56484882|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56484883|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56484884|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
56484885|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484886|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55786496|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786497|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55786499|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786500|NCT04642469|Durvalumab|durvalumab|mesh-list
56484887|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484888|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56484889|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484890|NCT00535119|Paclitaxel|paclitaxel|mesh-list
56484891|NCT00535119|Carboplatin|carboplatin|mesh-list
56484892|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56484893|NCT00535119|Veliparib|veliparib|mesh-list
56484894|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56484895|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484896|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
56484897|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
56484898|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
56484899|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222535|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56222536|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222537|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222538|NCT01669447|Ranibizumab|ranibizumab|mesh-list
56222539|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56222540|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56222541|NCT01669447|Growth Substances|growth substances|mesh-ancestor
56222542|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222543|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
55798512|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56484900|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56484901|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484902|NCT00535158|Vitamin D|vitamin d|mesh-list
56484903|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
56484904|NCT00535158|Vitamins|vitamins|mesh-ancestor
56484905|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
56207414|NCT01568684|Citalopram|citalopram|mesh-list
56484906|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484907|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56484908|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56484909|NCT03436992|Resveratrol|resveratrol|mesh-list
56484910|NCT03436992|Antioxidants|antioxidants|mesh-list
56484911|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484912|NCT03436992|Protective Agents|protective agents|mesh-ancestor
56484913|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484914|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484915|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56222544|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222545|NCT01669499|Dexamethasone|dexamethasone|mesh-list
56484916|NCT04083118|Listerine|listerine|mesh-list
56484917|NCT04083118|Fluorides|fluorides|mesh-list
56484918|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
56484919|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
56484920|NCT04083118|Protective Agents|protective agents|mesh-ancestor
56484921|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484922|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56484923|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484924|NCT04207450|Glutaral|glutaral|mesh-list
56484925|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
56484926|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484927|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
56484928|NCT04070443|Ponatinib|ponatinib|mesh-list
56484929|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484930|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56484931|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786501|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786503|NCT04440371|Betamethasone|betamethasone|mesh-list
56222546|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
56484932|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484933|NCT04043494|Cytarabine|cytarabine|mesh-list
56484934|NCT04043494|Dexamethasone|dexamethasone|mesh-list
56484935|NCT04043494|Prednisone|prednisone|mesh-list
56232949|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56484936|NCT04043494|Prednisolone|prednisolone|mesh-list
56484937|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
56484939|NCT04043494|Doxorubicin|doxorubicin|mesh-list
56484940|NCT04043494|Methotrexate|methotrexate|mesh-list
56484941|NCT04043494|Vincristine|vincristine|mesh-list
56484942|NCT04043494|Daunorubicin|daunorubicin|mesh-list
56484943|NCT04043494|Asparaginase|asparaginase|mesh-list
56484944|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
56484945|NCT04043494|Thioguanine|thioguanine|mesh-list
56484946|NCT04043494|Pegaspargase|pegaspargase|mesh-list
56484947|NCT04043494|Vindesine|vindesine|mesh-list
56484948|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484949|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
56222547|NCT01669499|BB 1101|bb 1101|mesh-list
56222548|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55786504|NCT04440371|Calcipotriene|calcipotriene|mesh-list
55786505|NCT04440371|Tacrolimus|tacrolimus|mesh-list
55786506|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56484950|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56484951|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56484952|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56484953|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
56484954|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484955|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484956|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56484957|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56484958|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
56484959|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
56484960|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484961|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222550|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
56222551|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484962|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
55818653|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
56484964|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484965|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56484966|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56484967|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56484968|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56484969|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56484970|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56484971|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
56484972|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56484973|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56484974|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
56484975|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
56484976|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56484977|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55786507|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
55786508|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786509|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56222552|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786510|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786511|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786512|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814788|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814789|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55814790|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55786513|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
55786514|NCT04440371|Hormones|hormones|mesh-ancestor
56222553|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222554|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
55786515|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55837227|NCT02015195|Acetic Acid|acetic acid|mesh-list
55837228|NCT02015195|Retinol acetate|retinol acetate|mesh-list
55837230|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
55837231|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
55837232|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837233|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837234|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
55837235|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56484978|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
56484979|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56484980|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56484981|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
56484982|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
56484983|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
56484984|NCT02899286|BCT-100|bct-100|mesh-list
56484985|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56484986|NCT04322422|Montelukast|montelukast|mesh-list
56484987|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56484988|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56484989|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56484990|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
56484991|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56484992|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222556|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222557|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55798526|NCT04915807|Irinotecan|irinotecan|mesh-list
55814831|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55814832|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
55814833|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56484993|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56484994|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56484995|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56484996|NCT02899169|Tretinoin|tretinoin|mesh-list
56484997|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
56484998|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
56484999|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485000|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
56485001|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
56485002|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
56485003|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485004|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485005|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56485006|NCT00548964|Ketamine|ketamine|mesh-list
56485007|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
56485008|NCT00548964|Analgesics|analgesics|mesh-ancestor
55743504|NCT04499989|Isoniazid|isoniazid|mesh-list
56485010|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485011|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485012|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55786516|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55786517|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
55786518|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
55786519|NCT01750073|Paclitaxel|paclitaxel|mesh-list
56222558|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222559|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
56222560|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222561|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222562|NCT01669707|Endostar protein|endostar protein|mesh-list
56222563|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56222564|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56222565|NCT01669707|Growth Substances|growth substances|mesh-ancestor
55814847|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
56485014|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
56485015|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
56485016|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485017|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56485018|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56485019|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485020|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222566|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222567|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
56222568|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222569|NCT01669824|Aspirin|aspirin|mesh-list
56222570|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56222571|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222572|NCT01669824|Analgesics|analgesics|mesh-ancestor
56222573|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
56222574|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222575|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222576|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222578|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56222579|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56222580|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222581|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56222582|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56222583|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222584|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
56222585|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56222586|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
55798538|NCT01360021|Budesonide|budesonide|mesh-list
56222587|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56222588|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56222589|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222590|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
56222592|NCT01669967|Lidocaine|lidocaine|mesh-list
56222593|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
56485021|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
56485022|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56485023|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485024|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
56485025|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56485026|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
56485027|NCT03382938|Ropivacaine|ropivacaine|mesh-list
56485028|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56485029|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786520|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
55786521|NCT01750073|Doxorubicin|doxorubicin|mesh-list
55786522|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55786523|NCT01750073|Trastuzumab|trastuzumab|mesh-list
56222605|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56222606|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
56222607|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
56222608|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222609|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56222610|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
56222611|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
56222612|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222613|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56222614|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
56222615|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222616|NCT01670149|Rifaximin|rifaximin|mesh-list
55814889|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
55816298|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
55816299|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55816300|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55816301|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816302|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55816303|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
55816305|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
55816321|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
55816322|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816323|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816324|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55816325|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
55816326|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
55816327|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55816328|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
55816329|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816330|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816331|NCT01615822|Artefenomel|artefenomel|mesh-list
55816332|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
55816333|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55816334|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55816336|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
55816338|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
55816339|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55816340|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
55816341|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816342|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816343|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55816344|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
55816345|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
55816346|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55816347|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
55816348|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816349|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485030|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485031|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56485032|NCT03382938|Analgesics|analgesics|mesh-ancestor
56485033|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
56485034|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485035|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56485036|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55786524|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55786525|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55786526|NCT01750073|Antibodies|antibodies|mesh-list
56222617|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56222618|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222619|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222620|NCT01670370|Gemcitabine|gemcitabine|mesh-list
56222621|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
56222622|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222623|NCT01670370|Immunologic Factors|immunologic factors|mesh-ancestor
56222624|NCT01670370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222625|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56222626|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
56222627|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485037|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56485038|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
56485040|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485041|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
56485042|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
56485044|NCT00535353|Olaparib|olaparib|mesh-list
56485045|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56485046|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56222628|NCT01670370|Antiviral Agents|antiviral agents|mesh-ancestor
55786527|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
55786528|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55786529|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56485047|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485048|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485049|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485050|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56485051|NCT02898779|Primaquine|primaquine|mesh-list
56485052|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
56485053|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56485054|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56485055|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485056|NCT00549120|Propranolol|propranolol|mesh-list
56485057|NCT00549120|Albuterol|albuterol|mesh-list
56485058|NCT00549120|Ipratropium|ipratropium|mesh-list
56485059|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56485060|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56485061|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
55816350|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
55816351|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55816352|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55816354|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55816355|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
55816356|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55816357|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55816358|NCT01898806|Triamcinolone|triamcinolone|mesh-list
55816359|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55816360|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55816361|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55816362|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816363|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
55816364|NCT01898806|Hormones|hormones|mesh-ancestor
55816365|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816366|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816367|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55816368|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
55816369|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816370|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816371|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55816372|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
55816373|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816374|NCT02290873|Midazolam|midazolam|mesh-list
55816375|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55816376|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55816377|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816378|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816379|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55816380|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55816381|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55816382|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55816383|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
55816396|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816397|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
55816398|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816399|NCT02289079|Bupivacaine|bupivacaine|mesh-list
55816400|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
55816401|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
55816402|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816403|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816404|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
55816405|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816406|NCT02318095|Gemcitabine|gemcitabine|mesh-list
55816407|NCT02318095|Paclitaxel|paclitaxel|mesh-list
55816408|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55816409|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816410|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
55816411|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
55816412|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
55816413|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816414|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55816415|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
55816416|NCT02318095|Antiviral Agents|antiviral agents|mesh-ancestor
55816417|NCT02318095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816418|NCT02318095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816419|NCT02318095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55816420|NCT02318095|Immunologic Factors|immunologic factors|mesh-ancestor
56145009|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
56485062|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485063|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485064|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485065|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56485066|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56485067|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
56485068|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56485069|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
56485070|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485071|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56485072|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
56485073|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
56485074|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56485075|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56485076|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56485077|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56485078|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56485079|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
56485080|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
56485081|NCT04680884|Clotrimazole|clotrimazole|mesh-list
56485082|NCT04680884|Miconazole|miconazole|mesh-list
56222629|NCT01670370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222630|NCT01670370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222631|NCT01670370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56222632|NCT01670552|Naproxen|naproxen|mesh-list
56222633|NCT01670552|Nimesulide|nimesulide|mesh-list
56222634|NCT01670552|Esomeprazole|esomeprazole|mesh-list
56222635|NCT01670552|Pantoprazole|pantoprazole|mesh-list
56222636|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56222637|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222638|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56222639|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222640|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798603|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786530|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786531|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814940|NCT02075073|Trastuzumab|trastuzumab|mesh-list
56485083|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485084|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56485085|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56485086|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56485087|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485088|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485089|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56485090|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
56222641|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56222642|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222643|NCT01670552|Analgesics|analgesics|mesh-ancestor
56222644|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
56222645|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222646|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786532|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
55786533|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
55816505|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
55816506|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816508|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55816509|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55816510|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816537|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816538|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55816539|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
55816540|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
55816541|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816542|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55816543|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55816544|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
55816545|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55816546|NCT02059161|Insulin|insulin|mesh-list
55816547|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55816548|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
55816549|NCT02059161|MK-1293|mk-1293|mesh-list
55816550|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55816551|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816552|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55816553|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
55816554|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816555|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55816556|NCT01897714|Dexamethasone|dexamethasone|mesh-list
55816557|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816558|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
55816559|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
55816560|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816561|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816562|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816563|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
55816564|NCT01897714|Hormones|hormones|mesh-ancestor
55816565|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816566|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55816567|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816568|NCT04732065|Dopamine|dopamine|mesh-list
55816569|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55816570|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
55816571|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
55816578|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
55816579|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55816580|NCT01860976|Abatacept|abatacept|mesh-list
55816581|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55816582|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816583|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816584|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55816585|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
56485091|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485092|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485093|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56485094|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56485095|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
56485096|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
56485097|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485098|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56485099|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485101|NCT00535509|Docetaxel|docetaxel|mesh-list
56485102|NCT00535509|Trastuzumab|trastuzumab|mesh-list
56485103|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485104|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
56485105|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
56485106|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
56222647|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814996|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
56485107|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485108|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485109|NCT01262365|Epratuzumab|epratuzumab|mesh-list
56485110|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485111|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485112|NCT03244176|Avelumab|avelumab|mesh-list
56485113|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485114|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786534|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786535|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55786536|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
55786537|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222648|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222649|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
56222650|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56222651|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
56222652|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56222653|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
56222654|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222655|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
56222656|NCT01670578|Protective Agents|protective agents|mesh-ancestor
56222657|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
56222659|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798618|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56485115|NCT00535665|Vaccines|vaccines|mesh-list
56485116|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
56485117|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485118|NCT03971110|Goserelin|goserelin|mesh-list
56485119|NCT03971110|Bicalutamide|bicalutamide|mesh-list
56485120|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56485121|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485122|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
55786538|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786539|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55786540|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
55786541|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55786542|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55786543|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55786544|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55786545|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786546|NCT03118037|Zaleplon|zaleplon|mesh-list
55786547|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
55786548|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55786549|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786550|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786551|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
55786552|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
56222660|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222661|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
56222662|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222663|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222664|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222665|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
56222666|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
56222667|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222668|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222669|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
56222670|NCT01670812|Hormones|hormones|mesh-ancestor
56222671|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222672|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56222673|NCT01670812|Protective Agents|protective agents|mesh-ancestor
56222674|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
56222675|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222676|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
56485123|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
56485124|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485125|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485126|NCT01262287|Dutasteride|dutasteride|mesh-list
56485127|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56485128|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56485129|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485130|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485131|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
56222680|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222681|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
56222682|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222683|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222685|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
56222686|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56222687|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
56222688|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786553|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786554|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889034|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55889035|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55889036|NCT03945448|Amebicides|amebicides|mesh-ancestor
55889037|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55889038|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55889039|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55889040|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
55889041|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889042|NCT03926338|Celecoxib|celecoxib|mesh-list
55889043|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
55889044|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55790663|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
55889045|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56052012|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
56052013|NCT01812668|Protective Agents|protective agents|mesh-ancestor
56052014|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052015|NCT02570477|Vancomycin|vancomycin|mesh-list
56052016|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56052017|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052018|NCT04344821|Calcium|calcium|mesh-list
56052019|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55889047|NCT03926338|Analgesics|analgesics|mesh-ancestor
55889048|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
55889049|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889050|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889051|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889052|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889053|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55889054|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889055|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889056|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889057|NCT04126941|Calcium|calcium|mesh-list
55889058|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55889059|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889060|NCT02506192|Prednisone|prednisone|mesh-list
55889061|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889062|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
55889063|NCT02506192|Hormones|hormones|mesh-ancestor
55889064|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889065|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889066|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56485132|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485133|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485134|NCT01262092|Buprenorphine|buprenorphine|mesh-list
56485135|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56485136|NCT01262092|Narcotics|narcotics|mesh-ancestor
56485137|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485138|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485139|NCT01262092|Analgesics|analgesics|mesh-ancestor
56222689|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222690|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56222691|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
56222692|NCT01673308|Lenalidomide|lenalidomide|mesh-list
56222693|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
55786556|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55786557|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
55786558|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786559|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786560|NCT00694655|Vaccines|vaccines|mesh-list
55816932|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816934|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
55816935|NCT01855750|Hormones|hormones|mesh-ancestor
55816936|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816937|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55816938|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55816939|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
55816940|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
55816941|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
55816942|NCT04963439|Macitentan|macitentan|mesh-list
55816943|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55816944|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55816945|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816946|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55816947|NCT04937699|Aspirin|aspirin|mesh-list
55816948|NCT04937699|Clopidogrel|clopidogrel|mesh-list
55816949|NCT04937699|Ticagrelor|ticagrelor|mesh-list
55816950|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55816951|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55816952|NCT04937699|Analgesics|analgesics|mesh-ancestor
55816953|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
55816954|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816955|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816956|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816957|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816958|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55816959|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55816961|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55816962|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55816963|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816964|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
55816965|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55816967|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55816968|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
55816969|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816970|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
55816971|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
55816972|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55816973|NCT01622673|Antacids|antacids|mesh-list
55816974|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
55816975|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
55816976|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
55816977|NCT01622673|TEMPO|tempo|mesh-list
55816978|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816979|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56145148|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
56485140|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
56485141|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485142|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56485143|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
56485144|NCT03898180|Lenvatinib|lenvatinib|mesh-list
56485145|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485146|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485147|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56485148|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485149|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222694|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222695|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56222696|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56222697|NCT01673308|Growth Substances|growth substances|mesh-ancestor
56222698|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
56222699|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222700|NCT01673737|Vemurafenib|vemurafenib|mesh-list
56222701|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222702|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55798671|NCT03054259|Prednisolone|prednisolone|mesh-list
55786561|NCT00694655|Immunologic Factors|immunologic factors|mesh-ancestor
55786562|NCT00694655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485150|NCT04680962|Rituximab|rituximab|mesh-list
56485151|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485152|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485153|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
56485154|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485155|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56485156|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
56485158|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56222703|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798673|NCT03054259|Rituximab|rituximab|mesh-list
56485159|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485160|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
56485161|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56485162|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56485163|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56485164|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56485165|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485166|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
56485167|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786564|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222704|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222705|NCT01674556|Gemcitabine|gemcitabine|mesh-list
56222706|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56222707|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
56222708|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222709|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222710|NCT01674556|Antiviral Agents|antiviral agents|mesh-ancestor
56222711|NCT01674556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222712|NCT01674556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222713|NCT01674556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56222714|NCT01674556|Immunologic Factors|immunologic factors|mesh-ancestor
56222715|NCT01674556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222716|NCT01675115|Aspirin|aspirin|mesh-list
56222717|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56485168|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485169|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56485170|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485171|NCT03088410|Zidovudine|zidovudine|mesh-list
56485172|NCT03088410|Nevirapine|nevirapine|mesh-list
56485173|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
56485174|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485175|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56485176|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56485177|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485178|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
56485179|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485180|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56485181|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56222718|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222720|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
55786567|NCT04982549|Pemetrexed|pemetrexed|mesh-list
56485182|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56485183|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56485185|NCT02897765|Poly ICLC|poly iclc|mesh-list
56485186|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
56146035|NCT01001052|Colchicine|colchicine|mesh-list
56485187|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485188|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485189|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485190|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56222721|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222722|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485191|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485192|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
56485193|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
56485194|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56485195|NCT00549588|Protective Agents|protective agents|mesh-ancestor
56485196|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485197|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
55786568|NCT04982549|Durvalumab|durvalumab|mesh-list
56485198|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
56485199|NCT04321642|Entonox|entonox|mesh-list
56485200|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56485201|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
56485202|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485203|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485204|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56485205|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
56485206|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56485207|NCT04321642|Analgesics|analgesics|mesh-ancestor
56485208|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
56485209|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485210|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
56485211|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56222723|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56485212|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485213|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56485214|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485215|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
56485216|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
56485217|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485218|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56485219|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485220|NCT04321837|Vitamin D|vitamin d|mesh-list
56485221|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
56485222|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
56485223|NCT04321837|Vitamins|vitamins|mesh-ancestor
56485224|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
56222725|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56222726|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55786571|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
56222727|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222728|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56222729|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56222730|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222731|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
56222732|NCT01675310|Metformin|metformin|mesh-list
56222733|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56222734|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222735|NCT01676649|Paclitaxel|paclitaxel|mesh-list
56222736|NCT01676649|Carboplatin|carboplatin|mesh-list
56222737|NCT01676649|Ipilimumab|ipilimumab|mesh-list
56222738|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56222739|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222757|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222758|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56222759|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56222760|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56222761|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
56222762|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798721|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
55786577|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56222763|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485225|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485226|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56485227|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56485228|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
56485229|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485230|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56485231|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233257|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
55786587|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222767|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222768|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222769|NCT01677065|Oxycodone|oxycodone|mesh-list
55815124|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485232|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485233|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
56485234|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56485235|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56485237|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56485238|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485239|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485240|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56485241|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56485242|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56485243|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56485244|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
56485245|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485246|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485247|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55786588|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55786589|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
55786590|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786591|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222771|NCT01677065|Narcotics|narcotics|mesh-ancestor
56222772|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222773|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222774|NCT01677065|Analgesics|analgesics|mesh-ancestor
56222775|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
56222776|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222777|NCT01677247|Glimepiride|glimepiride|mesh-list
56222778|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56222779|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56222780|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222781|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56222782|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
56485248|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56485249|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
56485250|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56485251|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56485252|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
56485253|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56485254|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
56485255|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56485256|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56485257|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56485258|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56485259|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56485260|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485261|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56485262|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56485263|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485264|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222783|NCT01677260|Metformin|metformin|mesh-list
55798738|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
56222784|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56222785|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222786|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
56222787|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
56222788|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222789|NCT01677650|Methadone|methadone|mesh-list
56222790|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56222791|NCT01677650|Narcotics|narcotics|mesh-ancestor
56222792|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222793|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222794|NCT01677650|Analgesics|analgesics|mesh-ancestor
56222795|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
56222796|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222797|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
56222798|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
56222799|NCT01678053|Omeprazole|omeprazole|mesh-list
56222800|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
56485265|NCT04680923|Bupivacaine|bupivacaine|mesh-list
56485266|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
56485267|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
56485268|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485269|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485270|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
56485271|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485272|NCT04933383|Budesonide|budesonide|mesh-list
56485273|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56485274|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55786592|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55786593|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55786594|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
55786595|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55786596|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
55786597|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55786598|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55786599|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55786600|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55786601|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56485275|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
56485276|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485277|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485278|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56485279|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
56485280|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
56485281|NCT04933383|Hormones|hormones|mesh-ancestor
56207854|NCT01572285|Dexamethasone|dexamethasone|mesh-list
56485282|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485283|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
56485284|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56485285|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485286|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
56485287|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56222801|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56222802|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56222803|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56222804|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56485288|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485289|NCT04891419|Lidocaine|lidocaine|mesh-list
56485290|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
56485291|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
56485292|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485293|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485294|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
56485295|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485296|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55786602|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55786603|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56222805|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56222806|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222807|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
56222808|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222809|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222810|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56222811|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222812|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222813|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56222814|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222815|NCT01678937|Cyclosporine|cyclosporine|mesh-list
56222816|NCT01678937|Sirolimus|sirolimus|mesh-list
56222817|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
56222818|NCT01678937|Tacrolimus|tacrolimus|mesh-list
56222819|NCT01678937|Cyclosporins|cyclosporins|mesh-list
56222820|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56485297|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56485298|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56207887|NCT01572350|Triamcinolone|triamcinolone|mesh-list
56485299|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56485300|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485301|NCT00551577|Carboplatin|carboplatin|mesh-list
56485302|NCT00551577|Docetaxel|docetaxel|mesh-list
56485303|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485304|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
56485305|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
56485306|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
56485307|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485308|NCT04207723|Paroxetine|paroxetine|mesh-list
56485309|NCT04207723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56485310|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56485311|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56485312|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802288|NCT04810819|Prednisolone|prednisolone|mesh-list
56485313|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485314|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
55786604|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786605|NCT02862275|Atezolizumab|atezolizumab|mesh-list
56222821|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
56222822|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222823|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56222824|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818172|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55818173|NCT02033889|Metformin|metformin|mesh-list
55818174|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
55818175|NCT02033889|Glimepiride|glimepiride|mesh-list
55818176|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
55818177|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
55818178|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55818179|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818180|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55818181|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818182|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
55818183|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55818184|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818185|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
55818186|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818187|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818189|NCT04594018|Finasteride|finasteride|mesh-list
55818190|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55818191|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
55818192|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55818197|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818198|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818199|NCT04594018|Urological Agents|urological agents|mesh-ancestor
55818200|NCT02054481|Ustekinumab|ustekinumab|mesh-list
55818201|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55818202|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
55818203|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
55818204|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818205|NCT02054325|Polidocanol|polidocanol|mesh-list
55818206|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55818207|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55818208|NCT02091375|Cannabidiol|cannabidiol|mesh-list
55818209|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
55818210|NCT02032875|Ribavirin|ribavirin|mesh-list
55818211|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
55818212|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
55818213|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818214|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
55818215|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818216|NCT02032407|Dapsone|dapsone|mesh-list
55818217|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818218|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
55818219|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56485315|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485316|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56485317|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
56485318|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56485319|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56485320|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56485321|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786606|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56222825|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222826|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
56222827|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485322|NCT04321096|Camostat|camostat|mesh-list
56485323|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
56485324|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485325|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485326|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56485327|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56485328|NCT03556696|Remifentanil|remifentanil|mesh-list
56485329|NCT03556696|Propofol|propofol|mesh-list
56485330|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56485331|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485332|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485333|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56485334|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
55786607|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786608|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
55786609|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222828|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222829|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222830|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56222831|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222832|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56222833|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
56222834|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56222835|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
56222836|NCT01679041|Fludarabine|fludarabine|mesh-list
56222837|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
56222838|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56222839|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
56222840|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222841|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222842|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56222843|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
56222844|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222845|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222846|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56222847|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56222848|NCT01679093|Dexamethasone|dexamethasone|mesh-list
56222849|NCT01679093|Droperidol|droperidol|mesh-list
56222850|NCT01679093|Ondansetron|ondansetron|mesh-list
56222851|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222852|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
56222853|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
55786610|NCT02621021|Aldesleukin|aldesleukin|mesh-list
56485335|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
56485336|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56485337|NCT03556696|Narcotics|narcotics|mesh-ancestor
56485338|NCT03556696|Analgesics|analgesics|mesh-ancestor
56485339|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
56485340|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485341|NCT04320706|Oxytocin|oxytocin|mesh-list
56485342|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
56485343|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56485344|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485345|NCT03482479|Naltrexone|naltrexone|mesh-list
56485346|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56485347|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56485348|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485349|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
56485350|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485351|NCT00553709|Nicotine|nicotine|mesh-list
56485352|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56485353|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
56485354|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485355|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485356|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56485357|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56485358|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
56485359|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485360|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485361|NCT00551733|Paclitaxel|paclitaxel|mesh-list
56485362|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56485363|NCT00551733|Carboplatin|carboplatin|mesh-list
56485364|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56485365|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56485366|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485367|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
56222854|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222855|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222856|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222857|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
56222858|NCT01679093|Hormones|hormones|mesh-ancestor
56222859|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56222860|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56222861|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222862|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
56222863|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
56222864|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56222865|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
56222866|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222867|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222868|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56222869|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56222870|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798825|NCT03050905|Ritonavir|ritonavir|mesh-list
55786611|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
55786612|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
55786613|NCT02621021|Fludarabine|fludarabine|mesh-list
56485368|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
56485369|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
56485370|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485371|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
56485372|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56485373|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485374|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56485375|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
56485376|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56485377|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485378|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222872|NCT01679093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56222873|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55815201|NCT04725201|Heparin|heparin|mesh-list
56222874|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56222875|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56222876|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
55786614|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55786615|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
56222877|NCT01679743|Trastuzumab|trastuzumab|mesh-list
56222878|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56222879|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222880|NCT01680094|Panobinostat|panobinostat|mesh-list
56222881|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786616|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786617|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55818220|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56222882|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56222883|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222884|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222885|NCT01680120|Anesthetics|anesthetics|mesh-list
56222886|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222887|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222889|NCT01680198|Vitamins|vitamins|mesh-ancestor
55786618|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55786619|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
55786620|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786621|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786622|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55786623|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56222900|NCT05596981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889067|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786624|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55786625|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55786626|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
56485379|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485380|NCT04922424|Atorvastatin|atorvastatin|mesh-list
56233407|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485381|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56485382|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56485384|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485385|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56222903|NCT05596968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56222904|NCT05596968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786627|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786628|NCT02592317|Pioglitazone|pioglitazone|mesh-list
55786629|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55786631|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55786632|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
55786633|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222905|NCT05596968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222906|NCT05596890|Paclitaxel|paclitaxel|mesh-list
56222907|NCT05596890|Carboplatin|carboplatin|mesh-list
55889068|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
55889069|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
55889070|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55889071|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55889072|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889140|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786634|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55786635|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55786636|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222908|NCT05596890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56222909|NCT05596890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222910|NCT05596890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56222911|NCT05596890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56485386|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56485387|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485389|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
56485390|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485391|NCT00551850|MP 412|mp 412|mesh-list
56208039|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485392|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485393|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56485394|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485395|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485396|NCT00550095|Valsartan|valsartan|mesh-list
55786637|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55786638|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786639|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
56222912|NCT05596890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56222913|NCT05596890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485397|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56485398|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56485399|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56485400|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485401|NCT00551889|Celecoxib|celecoxib|mesh-list
56485402|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
56485403|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56485404|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
56485405|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485406|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222914|NCT05596786|Rituximab|rituximab|mesh-list
56222915|NCT05596786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798875|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
55815223|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56485407|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56485408|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
56485409|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485410|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485411|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56485412|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56485413|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56485414|NCT00551889|Analgesics|analgesics|mesh-ancestor
56485415|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
56485416|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485417|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56485418|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56485419|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56485420|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485421|NCT03455764|Trametinib|trametinib|mesh-list
56485423|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485424|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55786641|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786642|NCT00790933|Vedolizumab|vedolizumab|mesh-list
55786643|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56222916|NCT05596786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222917|NCT05596786|Immunologic Factors|immunologic factors|mesh-ancestor
56222918|NCT05596786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222919|NCT05596786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56222920|NCT05596669|Ketamine|ketamine|mesh-list
56222921|NCT05596669|Morphine|morphine|mesh-list
56222922|NCT05596669|Analgesics|analgesics|mesh-ancestor
56222923|NCT05596669|Sensory System Agents|sensory system agents|mesh-ancestor
56485425|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485426|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485427|NCT04902495|Pemetrexed|pemetrexed|mesh-list
56485428|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485429|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485430|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485431|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56485432|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56222924|NCT05596669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222925|NCT05596669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222926|NCT05596669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56222927|NCT05596669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56222928|NCT05596669|Anesthetics, General|anesthetics, general|mesh-ancestor
56222929|NCT05596669|Anesthetics|anesthetics|mesh-ancestor
56222930|NCT05596669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222931|NCT05596669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56222932|NCT05596669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56222933|NCT05596669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222934|NCT05596669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222935|NCT05596669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56222936|NCT05596669|Narcotics|narcotics|mesh-ancestor
56222937|NCT05596617|Melatonin|melatonin|mesh-list
56222938|NCT05596617|Antioxidants|antioxidants|mesh-ancestor
56222939|NCT05596617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786644|NCT04981457|Misoprostol|misoprostol|mesh-list
55786645|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55786646|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
55786647|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55786648|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786649|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55786650|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55786651|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
55786652|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56222940|NCT05596617|Protective Agents|protective agents|mesh-ancestor
56222941|NCT05596617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222942|NCT05596617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222943|NCT05596552|Fentanyl|fentanyl|mesh-list
56222944|NCT05596552|Dexmedetomidine|dexmedetomidine|mesh-list
56222945|NCT05596552|Bupivacaine|bupivacaine|mesh-list
56222946|NCT05596552|Anesthetics, Local|anesthetics, local|mesh-ancestor
56485433|NCT03433183|Sirolimus|sirolimus|mesh-list
56485434|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56485435|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485436|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56485437|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485438|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
56485439|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56485440|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
56485441|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786653|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
55786654|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786655|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
55786656|NCT04981379|Favipiravir|favipiravir|mesh-list
55786657|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
56222964|NCT05596552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56222965|NCT05596552|Anesthetics, General|anesthetics, general|mesh-ancestor
56222966|NCT05596383|Vitamin D|vitamin d|mesh-list
56222967|NCT05596383|Vitamins|vitamins|mesh-ancestor
56485442|NCT02895659|Norepinephrine|norepinephrine|mesh-list
56485443|NCT02895659|Epinephrine|epinephrine|mesh-list
56485444|NCT02895659|Racepinephrine|racepinephrine|mesh-list
56485445|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
56485446|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56485447|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56485448|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
56485449|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485450|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786658|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55786659|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55786660|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786661|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786662|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786663|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786664|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
55786665|NCT04389775|Glucagon|glucagon|mesh-list
55786666|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56222968|NCT05596383|Micronutrients|micronutrients|mesh-ancestor
56222969|NCT05596383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222970|NCT05596383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56222971|NCT05596227|Fentanyl|fentanyl|mesh-list
56222972|NCT05596227|Narcotics|narcotics|mesh-list
56222973|NCT05596227|Propofol|propofol|mesh-list
56222974|NCT05596227|Anesthetics|anesthetics|mesh-list
56222975|NCT05596227|Sevoflurane|sevoflurane|mesh-list
56222976|NCT05596227|Rocuronium|rocuronium|mesh-list
56222977|NCT05596227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56222978|NCT05596227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222979|NCT05596227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222980|NCT05596227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56222981|NCT05596227|Anesthetics, General|anesthetics, general|mesh-ancestor
56222982|NCT05596227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56222983|NCT05596227|Analgesics|analgesics|mesh-ancestor
56222984|NCT05596227|Sensory System Agents|sensory system agents|mesh-ancestor
56222985|NCT05596227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222986|NCT05596227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56222987|NCT05596227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56222988|NCT05596227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55815250|NCT01655069|Urological Agents|urological agents|mesh-ancestor
55806386|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55806387|NCT05494775|Mitogens|mitogens|mesh-list
55806388|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
55806389|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
55806390|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806391|NCT05494775|Growth Substances|growth substances|mesh-ancestor
56485451|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485452|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
56485453|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
56485454|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485455|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56485456|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56485457|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56222989|NCT05596227|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56222990|NCT05596227|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56222991|NCT05596227|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56222993|NCT05596214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56222994|NCT05596214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222995|NCT05596214|Analgesics|analgesics|mesh-ancestor
56222996|NCT05596214|Sensory System Agents|sensory system agents|mesh-ancestor
56222997|NCT05596214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222998|NCT05596214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222999|NCT05596214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223000|NCT05596214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223001|NCT05596214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223002|NCT05596214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223003|NCT05596214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223004|NCT05596149|Listerine|listerine|mesh-list
56223005|NCT05596149|Fluorides|fluorides|mesh-list
56223006|NCT05596149|Sodium Fluoride|sodium fluoride|mesh-list
56223007|NCT05596149|Fluorophosphate|fluorophosphate|mesh-list
56223008|NCT05596149|Cariostatic Agents|cariostatic agents|mesh-ancestor
56223009|NCT05596149|Protective Agents|protective agents|mesh-ancestor
56223010|NCT05596149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223011|NCT05596149|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56223012|NCT05596149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223013|NCT05596097|Zanubrutinib|zanubrutinib|mesh-list
56223014|NCT05596097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223015|NCT05596097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56223016|NCT05596097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223017|NCT05596097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223018|NCT05596071|Sufentanil|sufentanil|mesh-list
56223019|NCT05596071|Dsuvia|dsuvia|mesh-list
56485458|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56485459|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
56485460|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
56485461|NCT00552201|Tacrolimus|tacrolimus|mesh-list
56485462|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56485463|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
56485464|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485465|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56223027|NCT05596071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56223028|NCT05596071|Narcotics|narcotics|mesh-ancestor
56223029|NCT05596071|Analgesics|analgesics|mesh-ancestor
56223030|NCT05596071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56485466|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485467|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485468|NCT03391882|Apomorphine|apomorphine|mesh-list
56485470|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485471|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
56485472|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485473|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56485474|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
56485475|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
56485476|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485477|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485478|NCT00550329|Glipizide|glipizide|mesh-list
56485479|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56485480|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485481|NCT00550485|Citalopram|citalopram|mesh-list
56485482|NCT00550485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56485483|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56485484|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56485485|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223044|NCT05595447|Nivolumab|nivolumab|mesh-list
56223045|NCT05595447|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56223046|NCT05595447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223047|NCT05595447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799001|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815305|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
56485486|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485487|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
56485488|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485489|NCT00550485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56485490|NCT00550485|Antidepressive Agents|antidepressive agents|mesh-ancestor
56485491|NCT00550485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56485492|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
56485493|NCT00550563|Vitamin D|vitamin d|mesh-list
56485494|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56485495|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786669|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786670|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786671|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55786672|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
55786673|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223048|NCT05595447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56223049|NCT05595447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223050|NCT05567822|Esmolol|esmolol|mesh-list
56223051|NCT05567822|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56223052|NCT05567822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56223053|NCT05567822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56223054|NCT05567822|Adrenergic Agents|adrenergic agents|mesh-ancestor
55799007|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
56485496|NCT00550563|Vitamins|vitamins|mesh-ancestor
56485497|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
56485498|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56485499|NCT02895191|Urinastatin|urinastatin|mesh-list
56485500|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
56485501|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56485502|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
56485503|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485504|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485505|NCT04680650|Anesthetics|anesthetics|mesh-list
56485506|NCT04680650|Propofol|propofol|mesh-list
56485507|NCT04680650|Sevoflurane|sevoflurane|mesh-list
56485508|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485509|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485510|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56485511|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56485512|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
55786674|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
55786675|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786676|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223055|NCT05567822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223056|NCT05567822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223057|NCT05567822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223059|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223060|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223061|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
56223062|NCT05539924|Pregabalin|pregabalin|mesh-list
56485513|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56485514|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56485515|NCT02895113|Aspirin|aspirin|mesh-list
56485516|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56485517|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56485518|NCT02895113|Analgesics|analgesics|mesh-ancestor
56485519|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
56485520|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485521|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786677|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55786679|NCT02102789|Dexamethasone|dexamethasone|mesh-list
55786680|NCT02102789|Fluorouracil|fluorouracil|mesh-list
55786681|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
55786682|NCT02102789|Floxuridine|floxuridine|mesh-list
56223065|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
56223066|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223067|NCT05539924|Analgesics|analgesics|mesh-ancestor
56223068|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
56223069|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223070|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
56223071|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56223072|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56223073|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223074|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56223075|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56223076|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56223077|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223078|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56223079|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56223080|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56485522|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56485523|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56485524|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56485525|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56208195|NCT01574508|Insulin|insulin|mesh-list
56485526|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485527|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56485528|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56223081|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223082|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
56223083|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
56223084|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
56223085|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56223086|NCT05514782|Protective Agents|protective agents|mesh-ancestor
56223087|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223088|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
56223089|NCT05488847|Acetaminophen|acetaminophen|mesh-list
56223090|NCT05488847|Dexamethasone|dexamethasone|mesh-list
56223091|NCT05488847|Ibuprofen|ibuprofen|mesh-list
56223092|NCT05488847|Celecoxib|celecoxib|mesh-list
56223093|NCT05488847|Ketorolac|ketorolac|mesh-list
56223094|NCT05488847|Pregabalin|pregabalin|mesh-list
56223095|NCT05488847|Epinephrine|epinephrine|mesh-list
56223096|NCT05488847|Oxycodone|oxycodone|mesh-list
56223097|NCT05488847|Tramadol|tramadol|mesh-list
56223098|NCT05488847|Tizanidine|tizanidine|mesh-list
56223099|NCT05488847|Magnesium Oxide|magnesium oxide|mesh-list
56223100|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223101|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
56223102|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
56223103|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223104|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223105|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56223106|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
56223107|NCT05488847|Hormones|hormones|mesh-ancestor
56223108|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223109|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56223110|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223111|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56223112|NCT05488847|Analgesics|analgesics|mesh-ancestor
56223113|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
56223114|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
56223126|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233555|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485529|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485530|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
56485531|NCT00552630|Penicillamine|penicillamine|mesh-list
56485532|NCT00552630|Antidotes|antidotes|mesh-ancestor
56485533|NCT00552630|Protective Agents|protective agents|mesh-ancestor
56485534|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485535|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
56485536|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
56223130|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56223131|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56223132|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
56223133|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223134|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56223135|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56223136|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56223137|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
56223138|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
56223139|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
56223140|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55799086|NCT04888663|Paclitaxel|paclitaxel|mesh-list
55786683|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55786684|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
55786685|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
55786686|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786687|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786688|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56223141|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56223142|NCT05488847|Antacids|antacids|mesh-ancestor
56485537|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485538|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56485539|NCT02894957|Varenicline|varenicline|mesh-list
56485540|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56485541|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56485542|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
56485543|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485544|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485545|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485546|NCT00550992|Leucovorin|leucovorin|mesh-list
56485547|NCT00550992|Cytarabine|cytarabine|mesh-list
56485548|NCT00550992|Cyclosporine|cyclosporine|mesh-list
56485549|NCT00550992|Prednisone|prednisone|mesh-list
56485550|NCT00550992|Prednisolone|prednisolone|mesh-list
56485551|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
56485552|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56485553|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56485554|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56485555|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
56485556|NCT00550992|Melphalan|melphalan|mesh-list
56223143|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56223144|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56485557|NCT00550992|Busulfan|busulfan|mesh-list
56485558|NCT00550992|Methotrexate|methotrexate|mesh-list
56485559|NCT00550992|Etoposide|etoposide|mesh-list
56485560|NCT00550992|Vincristine|vincristine|mesh-list
56485561|NCT00550992|Daunorubicin|daunorubicin|mesh-list
56485562|NCT00550992|Asparaginase|asparaginase|mesh-list
56485563|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
56485564|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
56485565|NCT00550992|Pegaspargase|pegaspargase|mesh-list
56485566|NCT00550992|Thioguanine|thioguanine|mesh-list
56485567|NCT00550992|Cyclosporins|cyclosporins|mesh-list
56485568|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56485569|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
56485570|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223145|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
56223146|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56223147|NCT05479370|Vaccines|vaccines|mesh-list
56223148|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
56223149|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223150|NCT05468242|Bevacizumab|bevacizumab|mesh-list
56223151|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223152|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799102|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
56223153|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56223154|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56223155|NCT05468242|Growth Substances|growth substances|mesh-ancestor
56223156|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223157|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56223158|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
56223159|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
56223160|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
56223161|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223162|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223163|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56223164|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56223165|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55799116|NCT03051841|Hormones|hormones|mesh-ancestor
56223166|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223167|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56485571|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
56485572|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485573|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56485574|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56485575|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
56485576|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485577|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223168|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56223169|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
56223170|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223171|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223172|NCT05423951|Sufentanil|sufentanil|mesh-list
56223173|NCT05423951|Propofol|propofol|mesh-list
56223174|NCT05423951|Rocuronium|rocuronium|mesh-list
56223175|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56223176|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815381|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56485578|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56485579|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56485580|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
56485581|NCT00550992|Hormones|hormones|mesh-ancestor
56485582|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485583|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56485584|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56485585|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
56485586|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56485587|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56485588|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
55786689|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
55786690|NCT02102789|Hormones|hormones|mesh-ancestor
55789080|NCT03055793|Budesonide|budesonide|mesh-list
56223177|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223178|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56223179|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
56223180|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
56223181|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56223182|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56223183|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56223184|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223185|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56223186|NCT05423951|Narcotics|narcotics|mesh-ancestor
56223187|NCT05423951|Analgesics|analgesics|mesh-ancestor
56223188|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
56223189|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56223190|NCT05416957|Vortioxetine|vortioxetine|mesh-list
56223191|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
56223192|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56223193|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56223194|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56223195|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223196|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223197|NCT05416957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55815385|NCT02503085|Ibuprofen|ibuprofen|mesh-list
56485589|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
56485590|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485591|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56485592|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56485593|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56485594|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56485595|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56485596|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
56485597|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485598|NCT00550992|Antidotes|antidotes|mesh-ancestor
56223198|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56223199|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56223200|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223201|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223202|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
55789081|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
56223203|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56223204|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56223205|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56485599|NCT00550992|Protective Agents|protective agents|mesh-ancestor
56485600|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
56485601|NCT00550992|Vitamins|vitamins|mesh-ancestor
56485602|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
56485603|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56485604|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56485605|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56485606|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
56485607|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56485608|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485609|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56485610|NCT00550992|Analgesics|analgesics|mesh-ancestor
55789082|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223207|NCT05416762|Vortioxetine|vortioxetine|mesh-list
56223208|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
56223209|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56223210|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56223211|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56223212|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223213|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223214|NCT05416762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56223215|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56223216|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56223217|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223218|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223219|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
56223220|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56223221|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56223222|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56223223|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56223224|NCT05405621|Exatecan|exatecan|mesh-list
56223225|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56223226|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56223227|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223228|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223229|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223230|NCT05389722|Itraconazole|itraconazole|mesh-list
56223231|NCT05389722|Rifampin|rifampin|mesh-list
56223232|NCT05389722|Digoxin|digoxin|mesh-list
56223233|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56223234|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56223235|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56223236|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
56223237|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223238|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56223239|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56223240|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223241|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
56223242|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223243|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55799192|NCT04898725|Vitamin D|vitamin d|mesh-list
56485611|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
56485612|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
56485613|NCT02895074|Tropicamide|tropicamide|mesh-list
56485614|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
56485615|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
56485616|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485617|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485618|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56485619|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56485620|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
56485621|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485622|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485623|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
56485624|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
56223249|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56223250|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56223251|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
56223252|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56223253|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
56223254|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56223255|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56223256|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56223257|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56223258|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56223259|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55786693|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789083|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56223260|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56223261|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56223262|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56223263|NCT05389722|Protective Agents|protective agents|mesh-ancestor
56223265|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56223266|NCT05383196|Onvansertib|onvansertib|mesh-list
56223267|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56223268|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223269|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
56223270|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
56485625|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485626|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
56485627|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56485628|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
56485629|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485631|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
56485632|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
56485633|NCT00551265|Oregovomab|oregovomab|mesh-list
56485634|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56485635|NCT00551265|Antibodies|antibodies|mesh-list
56485636|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
56485637|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56485638|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56485639|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
56485640|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223271|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
56223272|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223273|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56223274|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223275|NCT05351541|Zolpidem|zolpidem|mesh-list
56223276|NCT05351541|Modafinil|modafinil|mesh-list
56485641|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56485642|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56485643|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
56485644|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485645|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485646|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56485647|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
56485648|NCT02894606|Basiliximab|basiliximab|mesh-list
56485649|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
56485650|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485651|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56485652|NCT00551343|Exenatide|exenatide|mesh-list
55786694|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786695|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
56223277|NCT05351541|Psilocybin|psilocybin|mesh-list
56223278|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56223279|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56485653|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56485654|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485655|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56485657|NCT00551343|Hormones|hormones|mesh-ancestor
56485658|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485659|NCT00551382|Montelukast|montelukast|mesh-list
56485660|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56485661|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
56223280|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223281|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56223282|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56223283|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56223284|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223285|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55786696|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55786697|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223286|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56223287|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223288|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56223290|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
56223291|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223292|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
56223293|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56223294|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56223295|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
56223296|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56223297|NCT05350696|Morphine|morphine|mesh-list
56485662|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56485663|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
56485664|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485665|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485666|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56485667|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56485668|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485669|NCT02894684|Aztreonam|aztreonam|mesh-list
56485670|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56485671|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485672|NCT02894645|Cytarabine|cytarabine|mesh-list
56485673|NCT02894645|Dexamethasone|dexamethasone|mesh-list
56485674|NCT02894645|Prednisolone|prednisolone|mesh-list
56485675|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
56485676|NCT02894645|Doxorubicin|doxorubicin|mesh-list
56485677|NCT02894645|Methotrexate|methotrexate|mesh-list
56485678|NCT02894645|Fludarabine|fludarabine|mesh-list
56485679|NCT02894645|Vincristine|vincristine|mesh-list
56485680|NCT02894645|Daunorubicin|daunorubicin|mesh-list
56485681|NCT02894645|Asparaginase|asparaginase|mesh-list
56485682|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
56223298|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56223300|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223301|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223302|NCT05350696|Analgesics|analgesics|mesh-ancestor
56223303|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
56223304|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815442|NCT02101359|Tetracaine|tetracaine|mesh-list
56223305|NCT05301361|Methylphenidate|methylphenidate|mesh-list
56223306|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56223307|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223308|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56223309|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56223310|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56223311|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223314|NCT05291156|Cetuximab|cetuximab|mesh-list
55786701|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
55786702|NCT02102789|Vitamins|vitamins|mesh-ancestor
55786703|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
56223327|NCT05098327|Pioglitazone|pioglitazone|mesh-list
56223328|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56223329|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223330|NCT05086250|Ketamine|ketamine|mesh-list
56223331|NCT05086250|Analgesics|analgesics|mesh-ancestor
56223333|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223334|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223335|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55786704|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
55786705|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56485683|NCT02894645|Thioguanine|thioguanine|mesh-list
56485684|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56485685|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
56485686|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485687|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56485688|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56485689|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
56485690|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485691|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742626|NCT05303961|Rebamipide|rebamipide|mesh-list
56485692|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56485693|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56485694|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
56485695|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
55789084|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
56223336|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56223337|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
56223338|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
56223339|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223340|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56223341|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56223342|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223343|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223344|NCT05084222|Budesonide|budesonide|mesh-list
56223345|NCT05084222|Albuterol|albuterol|mesh-list
56223346|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
56223347|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223348|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56223349|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
56223350|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223351|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223352|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56223353|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
56223354|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
56223355|NCT05084222|Hormones|hormones|mesh-ancestor
55799302|NCT04914195|Leuprolide|leuprolide|mesh-list
56223356|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485696|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485697|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56485698|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
56485699|NCT02894645|Hormones|hormones|mesh-ancestor
56485700|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485701|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56485702|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56485703|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56223357|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56223358|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56223359|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56223360|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
56223361|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223362|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786706|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55786707|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786708|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
55786709|NCT02926651|Coagulants|coagulants|mesh-ancestor
56223363|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
56223364|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56223365|NCT05076838|Diazepam|diazepam|mesh-list
56485704|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56485705|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485706|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56485707|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
56485708|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56485709|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56485710|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
56485711|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
56485712|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56485713|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56485714|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
56223366|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56223367|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
56223368|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
55786711|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
56485715|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485716|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56485717|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
56485718|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
56485719|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
56485720|NCT00552747|Fenofibrate|fenofibrate|mesh-list
56485721|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56485722|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
56485723|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485724|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56485725|NCT05427617|Fulvestrant|fulvestrant|mesh-list
56485726|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56223369|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
56223370|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223371|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223372|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56223373|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56223374|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223375|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56223376|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55786712|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56485727|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56485728|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485729|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56485730|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56485731|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
56485732|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485733|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485734|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485735|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485736|NCT05427500|Bupivacaine|bupivacaine|mesh-list
56485737|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
56223377|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56223378|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56223379|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56223380|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56223381|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
56223382|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
56223383|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
56223384|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
56223385|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223386|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223387|NCT05057949|Itraconazole|itraconazole|mesh-list
56223388|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
56223389|NCT05057949|Rifampin|rifampin|mesh-list
56223390|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
56223391|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223392|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56223393|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56223394|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223395|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223396|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56223397|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
56223398|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223399|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223400|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55799332|NCT02486757|Estradiol|estradiol|mesh-list
56223401|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56223402|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
56485738|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
56485739|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485740|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485741|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
56485742|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485744|NCT05427383|Docetaxel|docetaxel|mesh-list
56485745|NCT05427383|Irinotecan|irinotecan|mesh-list
56485746|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56485747|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485748|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
56223410|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56223411|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55786713|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55786714|NCT04305145|Prednisolone|prednisolone|mesh-list
55786715|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
56223414|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223416|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223417|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223418|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
56223419|NCT04901312|Narcotics|narcotics|mesh-ancestor
55799370|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485749|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
56485750|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
56485751|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485752|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56485753|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56485754|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485755|NCT04680221|Bupivacaine|bupivacaine|mesh-list
56485756|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
55786718|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
55786719|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55786720|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
55786721|NCT04305145|Hormones|hormones|mesh-ancestor
55786722|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786723|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786724|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55786725|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786726|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
55786727|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
55786728|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223420|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223421|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786729|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56485757|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
56485758|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485759|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485760|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
56233780|NCT01733459|Metformin|metformin|mesh-list
56485762|NCT05427305|Bevacizumab|bevacizumab|mesh-list
56485763|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485764|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485765|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56485766|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56485767|NCT05427305|Growth Substances|growth substances|mesh-ancestor
56208406|NCT01576640|Bupropion|bupropion|mesh-list
56485768|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786731|NCT04305145|Protective Agents|protective agents|mesh-ancestor
55786732|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
55786733|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786734|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
55786735|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
55786736|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786737|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786738|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786739|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
55786740|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
55786741|NCT04188145|Bevacizumab|bevacizumab|mesh-list
56223422|NCT04901312|Analgesics|analgesics|mesh-ancestor
56223423|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
56223424|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223425|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56223426|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223427|NCT04886297|Resveratrol|resveratrol|mesh-list
56223428|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
56223429|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223430|NCT04886297|Protective Agents|protective agents|mesh-ancestor
56485769|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
56485771|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
56485772|NCT01099449|Calcium|calcium|mesh-list
56485773|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56485774|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485775|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485776|NCT01099449|Analgesics|analgesics|mesh-ancestor
56485777|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
56223431|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786742|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786743|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223432|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223433|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56223434|NCT04830410|Levan|levan|mesh-list
56223435|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223436|NCT04818216|Niacinamide|niacinamide|mesh-list
55815534|NCT01614886|Rivastigmine|rivastigmine|mesh-list
55786744|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55786745|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55786746|NCT04188145|Growth Substances|growth substances|mesh-ancestor
55786747|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786748|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
56223438|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
56223439|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
56223440|NCT04818216|Vitamins|vitamins|mesh-ancestor
55786749|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
55786750|NCT03063983|Methotrexate|methotrexate|mesh-list
55786751|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223441|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
56223442|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223443|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56223444|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
56223445|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223446|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56223447|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
56223449|NCT04810793|Levofloxacin|levofloxacin|mesh-list
56223450|NCT04810793|Ofloxacin|ofloxacin|mesh-list
56223451|NCT04810793|Tetracycline|tetracycline|mesh-list
56223452|NCT04810793|Furazolidone|furazolidone|mesh-list
56223453|NCT04810793|Esomeprazole|esomeprazole|mesh-list
56223454|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56223455|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223456|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55786752|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
55786753|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786754|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223457|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56223458|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56223459|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223460|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223461|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56485778|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485779|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
56485780|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485781|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56485782|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
56485783|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56485784|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56485785|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485786|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
56485787|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56485788|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
56223483|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223484|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56223485|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56223486|NCT04684511|Analgesics|analgesics|mesh-ancestor
56223487|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
56223488|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223489|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223490|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223491|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786755|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55786756|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
55786757|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786758|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786759|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56485789|NCT04680143|Hematinics|hematinics|mesh-ancestor
56485790|NCT05426798|Azacitidine|azacitidine|mesh-list
56485791|NCT05426798|Decitabine|decitabine|mesh-list
56485792|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56208454|NCT01576770|Lidocaine|lidocaine|mesh-list
56485793|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
56485794|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485795|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485796|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485797|NCT00436254|Molgramostim|molgramostim|mesh-list
56485798|NCT00436254|Sargramostim|sargramostim|mesh-list
56485799|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
56485800|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485801|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485802|NCT01234402|Capecitabine|capecitabine|mesh-list
56485803|NCT01234402|Ramucirumab|ramucirumab|mesh-list
56485804|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56485805|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
55786760|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55786761|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
55786762|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55786763|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56223492|NCT04650841|Naloxone|naloxone|mesh-list
56223493|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56223494|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223495|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
56223496|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223497|NCT04624854|Aspirin|aspirin|mesh-list
56223498|NCT04624854|Clopidogrel|clopidogrel|mesh-list
56223499|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56485806|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485807|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485808|NCT01260922|Donepezil|donepezil|mesh-list
56485809|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56485810|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485811|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485812|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
56485813|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485814|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485815|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
55786764|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
55786765|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
55786766|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786767|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55786768|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55786770|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55786771|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786772|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786773|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786774|NCT01876355|Clonidine|clonidine|mesh-list
55786775|NCT01876355|Analgesics|analgesics|mesh-ancestor
55786776|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
56223539|NCT04463368|Ipilimumab|ipilimumab|mesh-list
56223540|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223541|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223542|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56223543|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786777|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786778|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786779|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55786780|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
55786781|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
55815597|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
56485816|NCT05426486|Carboplatin|carboplatin|mesh-list
56485817|NCT05426486|Docetaxel|docetaxel|mesh-list
56485818|NCT05426486|Trastuzumab|trastuzumab|mesh-list
56485819|NCT05426486|Pertuzumab|pertuzumab|mesh-list
56485820|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485821|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
56485822|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
56485823|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
56485824|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485825|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485826|NCT01212094|Rituximab|rituximab|mesh-list
56485827|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485828|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786783|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55786784|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55786785|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
55786786|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786787|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786788|NCT02747407|Vaccines|vaccines|mesh-list
55786789|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
55786790|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223544|NCT04452344|Analgesics|analgesics|mesh-list
56223545|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223546|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
56223547|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485829|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
56485830|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485831|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56485832|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
56485833|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56485834|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
56485835|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485836|NCT05409885|Anesthetics|anesthetics|mesh-list
56485837|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485838|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485839|NCT00552864|Ropivacaine|ropivacaine|mesh-list
56485840|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
55786792|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55786793|NCT01870193|Glycine|glycine|mesh-list
55786794|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
55786795|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786796|NCT01870193|Expectorants|expectorants|mesh-ancestor
55786797|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
55786798|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55786799|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
55786800|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485841|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
56485842|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
56485843|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485844|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485845|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
56485846|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485847|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
56485848|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56485849|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56223549|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56223550|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223551|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
55786801|NCT01870193|Protective Agents|protective agents|mesh-ancestor
55786802|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786803|NCT01870193|Antidotes|antidotes|mesh-ancestor
56485850|NCT01211665|Prednisolone|prednisolone|mesh-list
56485851|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
56485852|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56485853|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
56485854|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56485855|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
56485856|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
56485857|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485858|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223552|NCT04432506|Fludarabine|fludarabine|mesh-list
56223553|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56223554|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223555|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
56223556|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223557|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223558|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56223559|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
56223560|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786804|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
55786805|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786806|NCT03063905|Buprenorphine|buprenorphine|mesh-list
55786807|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55786808|NCT03063905|Narcotics|narcotics|mesh-ancestor
55786809|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786810|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786811|NCT03063905|Analgesics|analgesics|mesh-ancestor
55786812|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
55786813|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786814|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55786815|NCT04432415|Fluorides|fluorides|mesh-list
55815639|NCT01907854|Incretins|incretins|mesh-ancestor
56485859|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56485860|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
56485862|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485863|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56485864|NCT01211665|Protective Agents|protective agents|mesh-ancestor
56485865|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56485866|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485867|NCT04401176|Lidocaine|lidocaine|mesh-list
56485868|NCT04401176|Heparin|heparin|mesh-list
56223561|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223562|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56223563|NCT04408508|Amoxicillin|amoxicillin|mesh-list
56223564|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56223565|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223566|NCT04281017|Anesthetics|anesthetics|mesh-list
55799518|NCT04895059|Ezetimibe|ezetimibe|mesh-list
55786816|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
55815646|NCT02480153|Adalimumab|adalimumab|mesh-list
56485869|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
56485870|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
56485871|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56485872|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485873|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
56485874|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485875|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56223567|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223569|NCT04256941|Letrozole|letrozole|mesh-list
56223570|NCT04256941|Fulvestrant|fulvestrant|mesh-list
56223571|NCT04256941|Palbociclib|palbociclib|mesh-list
56223572|NCT04256941|Anastrozole|anastrozole|mesh-list
56223573|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223574|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55786819|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806660|NCT02554721|Protective Agents|protective agents|mesh-ancestor
55806661|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55806662|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55806663|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
55806664|NCT03810911|Hematinics|hematinics|mesh-ancestor
55806665|NCT02552225|Amitriptyline|amitriptyline|mesh-list
55806666|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55806667|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
55806668|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55806669|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806670|NCT02552225|Analgesics|analgesics|mesh-ancestor
55806671|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
55806672|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806673|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806674|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55806675|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55806676|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55806677|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806678|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
55806679|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792655|NCT05028907|Vitamin E|vitamin e|mesh-list
55792656|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
55806680|NCT02552147|Nicotine|nicotine|mesh-list
55806681|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55806682|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
55806683|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806684|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806685|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55806686|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55806687|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
55806688|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806689|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806690|NCT05479487|Apatinib|apatinib|mesh-list
55806691|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806692|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55806693|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806694|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806695|NCT03418961|Carvedilol|carvedilol|mesh-list
55806696|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55806697|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55806698|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
55806699|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806700|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806701|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806704|NCT03418961|Protective Agents|protective agents|mesh-ancestor
55806705|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55806706|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55806707|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55806708|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
55806709|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56485876|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56485877|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56485878|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56485879|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485880|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
56485881|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56485882|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56485883|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
56485884|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56485885|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485886|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
56485887|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56485888|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223576|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223577|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223578|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56223579|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
56223580|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223581|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223582|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56223583|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55786822|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55786823|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786824|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
55815689|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
56485889|NCT04288089|Palbociclib|palbociclib|mesh-list
56485890|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485891|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56485892|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485893|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485894|NCT05371899|Chiauranib|chiauranib|mesh-list
56485895|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485896|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56485897|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223584|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56223585|NCT04231838|Nicotine|nicotine|mesh-list
56223586|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56223587|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
56223588|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223589|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223590|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56223591|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56223592|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
56223593|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223594|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223595|NCT04218266|Apixaban|apixaban|mesh-list
56223596|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56223597|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
56223598|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56223599|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
56223600|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223601|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223602|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
56223603|NCT04172363|Octenidine|octenidine|mesh-list
56223604|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223605|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56223606|NCT04074603|Insulin|insulin|mesh-list
56223607|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56223608|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786826|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
55786827|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786828|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
55786829|NCT03063671|Ketamine|ketamine|mesh-list
55786830|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55786833|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806800|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806801|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806802|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55818491|NCT02415959|Pancreatin|pancreatin|mesh-list
56485898|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485899|NCT05353140|Aspirin|aspirin|mesh-list
56485900|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
56485901|NCT05353140|Clopidogrel|clopidogrel|mesh-list
56485902|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56485903|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56485904|NCT05353140|Analgesics|analgesics|mesh-ancestor
56485905|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
56485906|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485907|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485908|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56485909|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56485910|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56223610|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56223611|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223612|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
56223613|NCT04063033|Hematinics|hematinics|mesh-ancestor
56223614|NCT04038255|Nicotine|nicotine|mesh-list
56223615|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56223616|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
55799559|NCT03048877|Apatinib|apatinib|mesh-list
55786834|NCT03063671|Analgesics|analgesics|mesh-ancestor
55786835|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
55786836|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786837|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55786838|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55807113|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
55807114|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
55807115|NCT05476679|Celecoxib|celecoxib|mesh-list
55807116|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55807118|NCT05476679|Analgesics|analgesics|mesh-ancestor
55807119|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
55807120|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807121|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807122|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807123|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807124|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55807125|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55807126|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807127|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807128|NCT02546765|Acetaminophen|acetaminophen|mesh-list
55807129|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
55807130|NCT02546765|Propofol|propofol|mesh-list
55807131|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55807132|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807133|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807134|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55807135|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
55807136|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
55807137|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55807138|NCT02546765|Analgesics|analgesics|mesh-ancestor
55807139|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
55807140|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807141|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55807142|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55807143|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55807144|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
55807145|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807146|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807147|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
55807149|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55800476|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485911|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56485912|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485913|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56485914|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56485915|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485916|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
56485917|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55786839|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55786840|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
55786841|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786842|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786843|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55786844|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55786845|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
55786847|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55786848|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55786849|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55786850|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55786851|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56223617|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786852|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786853|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786854|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55786855|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55786857|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
55786914|NCT04979663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786915|NCT04979663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55786916|NCT04979663|Immunologic Factors|immunologic factors|mesh-ancestor
55786917|NCT04979663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807406|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
55807407|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55807409|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807410|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807411|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
55807412|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807413|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807414|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807415|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55807416|NCT05417971|Fludarabine|fludarabine|mesh-list
55807417|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807418|NCT01728259|Dexamethasone|dexamethasone|mesh-list
55807419|NCT01728259|Bortezomib|bortezomib|mesh-list
55807420|NCT01728259|Pomalidomide|pomalidomide|mesh-list
55807421|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807422|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
55807423|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
55807424|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807425|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807426|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56485918|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56485919|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56485920|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
56485921|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485922|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56485923|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
56485924|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56485925|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
56485926|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
56485927|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
56485928|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56485929|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485930|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223618|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223619|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56223620|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56223621|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
56223622|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223623|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786929|NCT04979585|Paclitaxel|paclitaxel|mesh-list
55786930|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55786931|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786932|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
55786933|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
55786934|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
56485931|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56485932|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56485933|NCT04152980|Protective Agents|protective agents|mesh-ancestor
56485934|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485935|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
56485936|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56485937|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
56485938|NCT01232452|Pemetrexed|pemetrexed|mesh-list
56485939|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56485940|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485941|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485942|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55786935|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786936|NCT05103397|Prednisolone|prednisolone|mesh-list
55786937|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55786938|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
55786939|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55786940|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
55786941|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55786942|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
55786943|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223624|NCT04037605|Ketoconazole|ketoconazole|mesh-list
56223625|NCT04037605|Dexamethasone|dexamethasone|mesh-list
56223626|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
56223627|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
56223628|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56223629|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56223630|NCT04037605|Hormones|hormones|mesh-list
56223631|NCT04037605|Cosyntropin|cosyntropin|mesh-list
56223632|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56223633|NCT04037605|BB 1101|bb 1101|mesh-list
56223634|NCT04037605|Ganirelix|ganirelix|mesh-list
56223635|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223636|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
56223637|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
56223638|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56485943|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56485944|NCT05345613|Epinephrine|epinephrine|mesh-list
56485945|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
56485946|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56485947|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56485948|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485949|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
56485950|NCT05345613|Coagulants|coagulants|mesh-ancestor
56485951|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56223639|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223640|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56223641|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
55799588|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55786944|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
55786945|NCT05103397|Hormones|hormones|mesh-ancestor
55786946|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786947|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815740|NCT02325739|Spartalizumab|spartalizumab|mesh-list
56223642|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223643|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56223644|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223645|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
56223646|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223647|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223648|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
56223649|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56208607|NCT01577940|Ropivacaine|ropivacaine|mesh-list
56485952|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56485953|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
56485954|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56485955|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485956|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56485957|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56485958|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
56485959|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786949|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786950|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
55786951|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
55786952|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786953|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55786954|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55786955|NCT05103397|Protective Agents|protective agents|mesh-ancestor
55786956|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
55786957|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55786958|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786959|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55786960|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
55786961|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56223664|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786962|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786963|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786964|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786966|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
55786967|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
55786968|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786969|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786970|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
55786971|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786972|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
55786973|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
55906136|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906180|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55906181|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
55906182|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55906183|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906184|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55906185|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55906186|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55906187|NCT02391480|Venetoclax|venetoclax|mesh-list
55906188|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906189|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
55786974|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55786975|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55786976|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786977|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786978|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786979|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786980|NCT04979273|Epinephrine|epinephrine|mesh-list
55786981|NCT04979273|Racepinephrine|racepinephrine|mesh-list
55786982|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
55786983|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56223666|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56223667|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56223668|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223669|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56223670|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55786984|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55786985|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
55786986|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786987|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786988|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786989|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55786990|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55786991|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
55786992|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786993|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55786997|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55786998|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
55786999|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55787000|NCT05103007|Estrogens|estrogens|mesh-ancestor
55787001|NCT05103007|Hormones|hormones|mesh-ancestor
55815749|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787002|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787003|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787004|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55787005|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787006|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
55787007|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55787008|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55787134|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55787138|NCT04437017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55787139|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55787140|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55787141|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787142|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787143|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
55787144|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55787145|NCT05107375|Vaccines|vaccines|mesh-list
55787146|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
56223701|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
56223702|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
56223703|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223704|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223705|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
56223706|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223707|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56223708|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
56223709|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223710|NCT03681652|Azathioprine|azathioprine|mesh-list
56223711|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223712|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
56223713|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787155|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
55787156|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787157|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787158|NCT05107063|Pravastatin|pravastatin|mesh-list
55787159|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55787160|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55787161|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
56223733|NCT03578198|Rituximab|rituximab|mesh-list
55906190|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906191|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
55906192|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906193|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906194|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55906195|NCT01531153|Galantamine|galantamine|mesh-list
55906196|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55906197|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223755|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56223756|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223757|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56223758|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
56223759|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
56223760|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
56223761|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223762|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
56223764|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223765|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56223766|NCT03554200|Empagliflozin|empagliflozin|mesh-list
56223767|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56223768|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223769|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55787164|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55787165|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787166|NCT04977401|Glycerol|glycerol|mesh-list
56223770|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223771|NCT03518086|Mirikizumab|mirikizumab|mesh-list
56223772|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56223773|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56223774|NCT03518086|Analgesics|analgesics|mesh-ancestor
56223775|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
56223776|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223777|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906198|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906199|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
55906200|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906201|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906202|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55906203|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
55906204|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906205|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
55906206|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
55906207|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
55906208|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55906209|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55906210|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906212|NCT03027973|Coagulants|coagulants|mesh-ancestor
55906241|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
55906242|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906243|NCT01528969|Sorbitol|sorbitol|mesh-list
55906244|NCT01528969|Cathartics|cathartics|mesh-ancestor
55787167|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55787168|NCT04977401|Protective Agents|protective agents|mesh-ancestor
55787169|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807427|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
55807428|NCT01728259|Hormones|hormones|mesh-ancestor
55807429|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807430|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55807431|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807432|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
55807433|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55807434|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55807435|NCT01728259|Growth Substances|growth substances|mesh-ancestor
55807436|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
55807437|NCT05398705|Cepharanthine|cepharanthine|mesh-list
55807438|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55807439|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55807440|NCT05398705|Analgesics|analgesics|mesh-ancestor
55807449|NCT05398705|Protective Agents|protective agents|mesh-ancestor
55807450|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
55807451|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807452|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807453|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55807454|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55807455|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55807456|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807459|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55807460|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807461|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
55807462|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807463|NCT05416021|Dapivirine|dapivirine|mesh-list
55807464|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55807465|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55807466|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
55807467|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807468|NCT05443555|Gabapentin|gabapentin|mesh-list
55807469|NCT05443555|Analgesics|analgesics|mesh-ancestor
55807470|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
55807471|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807472|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807473|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
55807475|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55807476|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807477|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55807478|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55807479|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55807480|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807481|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807482|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
55807483|NCT05415865|Lidocaine|lidocaine|mesh-list
55807484|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
55807485|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
55807486|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798008|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
55906245|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906246|NCT01514201|Temozolomide|temozolomide|mesh-list
55906247|NCT01514201|Veliparib|veliparib|mesh-list
55906248|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55906249|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
55906250|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906251|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906252|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55906253|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906254|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
55906255|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55906256|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
55906287|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906288|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55906289|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56198046|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198047|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787170|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
56223778|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223779|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223780|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56223781|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56223783|NCT03517176|Paclitaxel|paclitaxel|mesh-list
56223784|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56223785|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223786|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
56223787|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
56223788|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
56223789|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223790|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56198048|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
56198049|NCT01511211|Hormones|hormones|mesh-ancestor
56198050|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198051|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56198052|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198053|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
56198054|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
56198055|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198056|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
56198057|NCT01511237|Lamivudine|lamivudine|mesh-list
56198058|NCT01511237|Zidovudine|zidovudine|mesh-list
56198059|NCT01511237|Nevirapine|nevirapine|mesh-list
56198060|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56198061|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56198062|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906290|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906291|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906292|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787179|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
55787180|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787181|NCT04316143|Zamicastat|zamicastat|mesh-list
55787182|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787183|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787184|NCT04530877|Infliximab|infliximab|mesh-list
55787185|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
55787186|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787187|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787188|NCT04971239|Methotrexate|methotrexate|mesh-list
55787189|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55787190|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
55787191|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55787192|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906293|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906294|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55906295|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55906296|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906297|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55906298|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55906299|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
55906300|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906301|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55906302|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
55906303|NCT02386566|Natalizumab|natalizumab|mesh-list
55906304|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
55787193|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55787194|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
56223830|NCT03404193|Venetoclax|venetoclax|mesh-list
56223831|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56223832|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
56223833|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223834|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223835|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223836|NCT03366974|Clarithromycin|clarithromycin|mesh-list
56223837|NCT03366974|Midazolam|midazolam|mesh-list
56223838|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56223839|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56223840|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223841|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223842|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56223843|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56223844|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56223845|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56223846|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
56223847|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
56223848|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
56223849|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
56223850|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815830|NCT01920568|Vitamin D|vitamin d|mesh-list
55906305|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906306|NCT01528345|Fulvestrant|fulvestrant|mesh-list
55906307|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55906308|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906309|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55906310|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55906311|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
55906312|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223851|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223852|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56223853|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223854|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56223855|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223856|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56223857|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56223859|NCT03362515|Diuretics|diuretics|mesh-ancestor
56223860|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
56223861|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223862|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56223863|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56223864|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223865|NCT03340129|Nivolumab|nivolumab|mesh-list
56223866|NCT03340129|Ipilimumab|ipilimumab|mesh-list
56223867|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223868|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223869|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56223870|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223871|NCT03307746|Rituximab|rituximab|mesh-list
56223872|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223873|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223874|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
56223875|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223876|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223877|NCT03294083|Cemiplimab|cemiplimab|mesh-list
56223878|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223879|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223880|NCT03222076|Nivolumab|nivolumab|mesh-list
56223881|NCT03222076|Ipilimumab|ipilimumab|mesh-list
55906313|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906314|NCT01511939|Diclofenac|diclofenac|mesh-list
55906315|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55906344|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906345|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906347|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55906348|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906349|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
55906350|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
55906351|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
55906352|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906354|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
55906355|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55906357|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223884|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56223885|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223886|NCT03128398|Domperidone|domperidone|mesh-list
56223887|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
56223888|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
56223889|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223890|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223891|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56223892|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56223893|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
56223894|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223895|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223896|NCT03119038|Ketorolac|ketorolac|mesh-list
56223897|NCT03119038|Clonidine|clonidine|mesh-list
56223898|NCT03119038|Epinephrine|epinephrine|mesh-list
56223899|NCT03119038|Bupivacaine|bupivacaine|mesh-list
56223900|NCT03119038|Ropivacaine|ropivacaine|mesh-list
56223901|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
56223902|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
56223903|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223904|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223905|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
55906358|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
55906359|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
56198063|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198065|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198066|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55906360|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906361|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906362|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906363|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
55906364|NCT04123561|Hormones|hormones|mesh-ancestor
55906383|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
56223916|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
56223917|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
56223918|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
56223919|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56223920|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56223921|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56223922|NCT03119038|Analgesics|analgesics|mesh-ancestor
56223923|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223924|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223925|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56223926|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223927|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56223928|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
56223929|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56223930|NCT03099265|Leucovorin|leucovorin|mesh-list
56223931|NCT03099265|Fluorouracil|fluorouracil|mesh-list
56223932|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
56223933|NCT03099265|Irinotecan|irinotecan|mesh-list
56223934|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
55799858|NCT05526911|Digoxin|digoxin|mesh-list
56223935|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223936|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56223937|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223938|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223939|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
56223940|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223941|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56223942|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56223943|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223944|NCT03099265|Antidotes|antidotes|mesh-ancestor
56223945|NCT03099265|Protective Agents|protective agents|mesh-ancestor
56223946|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
56223947|NCT03099265|Vitamins|vitamins|mesh-ancestor
55906384|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
55906385|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55906386|NCT02382354|Narcotics|narcotics|mesh-ancestor
55906387|NCT02382354|Analgesics|analgesics|mesh-ancestor
55906388|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
55906389|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906391|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55906392|NCT03027167|Aspirin|aspirin|mesh-list
56485960|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55787264|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55787265|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
55787266|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
55787267|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787268|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55787269|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55787270|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223949|NCT03065387|Everolimus|everolimus|mesh-list
56223950|NCT03065387|Palbociclib|palbociclib|mesh-list
56223951|NCT03065387|Trametinib|trametinib|mesh-list
56223952|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223953|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223954|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
56223955|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223956|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56223957|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223958|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223959|NCT03063749|Sirolimus|sirolimus|mesh-list
56223960|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56223961|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223962|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56223963|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223964|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
56223965|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223966|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
56223967|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223968|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
56223969|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56223970|NCT03007589|Protective Agents|protective agents|mesh-ancestor
55906393|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55906394|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55906395|NCT03027167|Analgesics|analgesics|mesh-ancestor
55906396|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
55906397|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906398|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906399|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55906400|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906401|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55906402|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55906403|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906404|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55906405|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55906406|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906407|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
56223971|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223972|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
56223973|NCT02975037|Clarithromycin|clarithromycin|mesh-list
56223974|NCT02975037|Itraconazole|itraconazole|mesh-list
56223975|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
56223976|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
56223977|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56223978|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56223979|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799926|NCT05216575|Almitrine|almitrine|mesh-list
55787271|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787272|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
55787273|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55787274|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
55787275|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55787276|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
55787277|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787278|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
55787279|NCT04975373|Protective Agents|protective agents|mesh-ancestor
55906408|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
55906409|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55906410|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55906411|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55906412|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
55906413|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906414|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906415|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906416|NCT02382432|Meperidine|meperidine|mesh-list
55906417|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
56223980|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223981|NCT02975037|Urological Agents|urological agents|mesh-ancestor
56223982|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56223983|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223984|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55799930|NCT05146739|Fludarabine|fludarabine|mesh-list
55787287|NCT04974827|Carboplatin|carboplatin|mesh-list
55787288|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787289|NCT04963595|Vinorelbine|vinorelbine|mesh-list
55906418|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55906419|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906420|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906421|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55906454|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
55906456|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906457|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787290|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55787291|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787292|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
55787293|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
55787294|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
55787295|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787296|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55787297|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55787298|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55787299|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
55787300|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787301|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787302|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55787303|NCT04962425|Trastuzumab|trastuzumab|mesh-list
56223985|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56223986|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56223987|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
56223988|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56223989|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56223990|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
56223991|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223992|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223994|NCT02931890|Docetaxel|docetaxel|mesh-list
56223995|NCT02931890|Carboplatin|carboplatin|mesh-list
56223996|NCT02931890|Capecitabine|capecitabine|mesh-list
56223997|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
56223998|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56223999|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224000|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56224001|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56224002|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
55787304|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56224003|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224004|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56224006|NCT02914405|Nivolumab|nivolumab|mesh-list
56224007|NCT02914405|Dinutuximab|dinutuximab|mesh-list
56224008|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
56224009|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
56224010|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56224011|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224012|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56224016|NCT02812862|Tiotropium Bromide|tiotropium bromide|mesh-list
55906458|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55906459|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55906460|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
55906461|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55906462|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55906463|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55906464|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55906465|NCT01560403|Teduglutide|teduglutide|mesh-list
55906466|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56224020|NCT02812862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224021|NCT02812862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224022|NCT02812862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56224023|NCT02812862|Respiratory System Agents|respiratory system agents|mesh-ancestor
56224024|NCT02812862|Parasympatholytics|parasympatholytics|mesh-ancestor
56224025|NCT02812862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56224026|NCT02812862|Cholinergic Agents|cholinergic agents|mesh-ancestor
56224027|NCT02812862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224028|NCT02812862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224029|NCT02587312|Nicotine|nicotine|mesh-list
55787306|NCT03060707|Bromides|bromides|mesh-list
55787307|NCT03060707|Rocuronium|rocuronium|mesh-list
55787308|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
56224030|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56224031|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
56224032|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224033|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224034|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56224035|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55799983|NCT03044665|Ezetimibe|ezetimibe|mesh-list
55807736|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
55807737|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807738|NCT02360397|Ranolazine|ranolazine|mesh-list
55807739|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55807740|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55807741|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807742|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55807743|NCT02317809|Hormones|hormones|mesh-ancestor
55807744|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807745|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807749|NCT01607905|Acetaminophen|acetaminophen|mesh-list
55807750|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55807751|NCT01607905|Analgesics|analgesics|mesh-ancestor
55807752|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
55807753|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807754|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807755|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
55807756|NCT02389543|Dexamethasone|dexamethasone|mesh-list
55807757|NCT02389543|Lenalidomide|lenalidomide|mesh-list
55807758|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807759|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
55807760|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
55807761|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807762|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807763|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787309|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55906467|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55906468|NCT01560403|Protective Agents|protective agents|mesh-ancestor
55906469|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906470|NCT02100579|Bupivacaine|bupivacaine|mesh-list
55906471|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
55906472|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
55906473|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906474|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787310|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55787311|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56224037|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224038|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224039|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
56224040|NCT02549677|Docetaxel|docetaxel|mesh-list
56224041|NCT02549677|Epirubicin|epirubicin|mesh-list
56224042|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224043|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
56224044|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224045|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906476|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906477|NCT04251351|Acetaminophen|acetaminophen|mesh-list
55906478|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198067|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56198068|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
56198069|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56198070|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56198071|NCT01511263|Amiodarone|amiodarone|mesh-list
56198072|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56198073|NCT01511263|Diuretics|diuretics|mesh-list
56224046|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56224047|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
56224048|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224049|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224050|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56224051|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
56224052|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
56224053|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
56224054|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56224055|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56224056|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56224057|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224058|NCT02536300|Idelalisib|idelalisib|mesh-list
56224059|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224060|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224061|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224062|NCT02450253|Tadalafil|tadalafil|mesh-list
56224063|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
56224064|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56224065|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56224066|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224067|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224068|NCT02450253|Urological Agents|urological agents|mesh-ancestor
56224069|NCT02257970|Ketoprofen|ketoprofen|mesh-list
56224070|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56224071|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56224072|NCT02257970|Analgesics|analgesics|mesh-ancestor
56224073|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
55787312|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787313|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198074|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
56198075|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198076|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
56198077|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56198078|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56198079|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906479|NCT04251351|Analgesics|analgesics|mesh-ancestor
55906480|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
55906481|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906482|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906515|NCT00149643|Fluoxetine|fluoxetine|mesh-list
55906516|NCT00149643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55906517|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55906518|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55906519|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906520|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906521|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
55906522|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906523|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56224074|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224075|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224076|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224077|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56224078|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56224080|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224081|NCT02177578|Temozolomide|temozolomide|mesh-list
56224082|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56224083|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
56224084|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224085|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787315|NCT04967417|Carboplatin|carboplatin|mesh-list
55787316|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
55787317|NCT04967417|Pemetrexed|pemetrexed|mesh-list
55787318|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55787319|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224105|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56224106|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56224107|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224108|NCT02066636|Nivolumab|nivolumab|mesh-list
56224109|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56224110|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224111|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56224113|NCT02036086|Vemurafenib|vemurafenib|mesh-list
56224120|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787329|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
55787330|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
55787331|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
55787332|NCT04210141|Antivenins|antivenins|mesh-list
55787333|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
55787334|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906524|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
55906525|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55906526|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55906527|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55906528|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906529|NCT02381730|Aflibercept|aflibercept|mesh-list
55906530|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55906531|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55906532|NCT02381730|Growth Substances|growth substances|mesh-ancestor
55906533|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906534|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
55906535|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906536|NCT00149799|Citalopram|citalopram|mesh-list
55906537|NCT00149799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55787335|NCT04418531|Antibodies|antibodies|mesh-list
55787336|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
55787337|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55787338|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
55787339|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787340|NCT02615119|Isoproterenol|isoproterenol|mesh-list
55787341|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55787342|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55787343|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
55787344|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787345|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787346|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787347|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55787348|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
55787349|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787350|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55787351|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
55787352|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55906538|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55906539|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55906540|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906541|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906542|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
55906543|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906544|NCT00149799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55906545|NCT00149799|Antidepressive Agents|antidepressive agents|mesh-ancestor
55906546|NCT00149799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55787371|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55787372|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787373|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55787374|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
55787375|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
55787376|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787377|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787378|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55787379|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
55787380|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
55787381|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
56224127|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224128|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
56224129|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224130|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224131|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56224132|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224134|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
56224135|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224136|NCT01681446|Interferons|interferons|mesh-list
56224137|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
56224138|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224139|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
56224140|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224141|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
56224142|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224143|NCT01681875|Nicotine|nicotine|mesh-list
56224144|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56224145|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
56224146|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224147|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787382|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787383|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55787384|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224148|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56224149|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56224150|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
56224151|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224159|NCT01683760|Fluconazole|fluconazole|mesh-list
56224164|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224165|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224166|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56224167|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
56224168|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224169|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224170|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56224171|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56224172|NCT01684813|Clopidogrel|clopidogrel|mesh-list
55800116|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
56224173|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56224174|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56224175|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56224176|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56224177|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56224178|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
56224179|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224180|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224181|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224183|NCT01684982|Everolimus|everolimus|mesh-list
56224186|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
56224243|NCT01687517|Vaccines|vaccines|mesh-list
56224244|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
56224245|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224246|NCT01687751|Midazolam|midazolam|mesh-list
56224247|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
56224248|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56224249|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224250|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224251|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56224252|NCT01687751|Analgesics|analgesics|mesh-ancestor
55906547|NCT02390544|Melphalan|melphalan|mesh-list
55906548|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55906549|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
55906614|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
55906615|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906616|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906617|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
55787389|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
55787390|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
55787391|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
55787392|NCT03198559|Vorinostat|vorinostat|mesh-list
55787393|NCT03198559|Disulfiram|disulfiram|mesh-list
55787394|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224287|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56224288|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56224289|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56224290|NCT01689753|Citric Acid|citric acid|mesh-list
56224291|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
56224292|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
56224293|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56224294|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
56224295|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
56224296|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224297|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
56224298|NCT01690039|Furosemide|furosemide|mesh-list
56224299|NCT01690039|Diuretics|diuretics|mesh-ancestor
56224300|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
56224301|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224302|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56224303|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56224304|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224305|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224307|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56224308|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224309|NCT01690104|Rifampin|rifampin|mesh-list
56224310|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56224311|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
56224312|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56224313|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224314|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
55906618|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906619|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55906620|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56198080|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56198081|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56198082|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56198083|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198084|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55723695|NCT00730639|Nivolumab|nivolumab|mesh-list
56198090|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198091|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198092|NCT01511302|Budesonide|budesonide|mesh-list
56198093|NCT01511302|RNS60|rns60|mesh-list
56224317|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224318|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56224319|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56224320|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56224321|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56224322|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56224323|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56224324|NCT01690221|Diltiazem|diltiazem|mesh-list
56224325|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56224326|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56224327|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56224328|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224329|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56224330|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224331|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
56224332|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56224333|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
56224334|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224335|NCT01690286|Ketoconazole|ketoconazole|mesh-list
56224336|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
55800270|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815923|NCT02497781|Ceftazidime|ceftazidime|mesh-list
56198094|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198095|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56198096|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
56198097|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198098|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198099|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56198100|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
56198101|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
56224337|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224338|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56224339|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56224340|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224341|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815924|NCT02497781|Cefepime|cefepime|mesh-list
55906621|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55906622|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55906623|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906624|NCT02381184|Clomiphene|clomiphene|mesh-list
55906625|NCT02381184|Enclomiphene|enclomiphene|mesh-list
55906626|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
55906627|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55906628|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
55906645|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
55906646|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906647|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906648|NCT02385396|Folic Acid|folic acid|mesh-list
55906649|NCT02385396|Inositol|inositol|mesh-list
55906650|NCT02385396|Hematinics|hematinics|mesh-ancestor
55906651|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
55906652|NCT02385396|Vitamins|vitamins|mesh-ancestor
55906653|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
55906654|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906655|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55906656|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906657|NCT02979405|Phenylephrine|phenylephrine|mesh-list
55906658|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
55906659|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55906660|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
55906661|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
55906662|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224342|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55906663|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906664|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
55906665|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55906666|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
56224387|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224388|NCT01690364|Anesthetics|anesthetics|mesh-list
56224389|NCT01690364|Cisatracurium|cisatracurium|mesh-list
56224390|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
56224391|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224392|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224393|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55787395|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55787396|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787397|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787398|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55787399|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
55906667|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
56198103|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198104|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56198105|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198106|NCT01511302|Analgesics|analgesics|mesh-ancestor
56198107|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
56198108|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198109|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56198110|NCT01511367|Fluticasone|fluticasone|mesh-list
55787410|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55787411|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787412|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787413|NCT02749513|Itraconazole|itraconazole|mesh-list
56224398|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56224399|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
56224400|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224401|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787414|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
55787415|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787416|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55787417|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55787418|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787419|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787420|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56224402|NCT01690403|Rifapentine|rifapentine|mesh-list
56224403|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56224404|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
56224405|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56224406|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224407|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
56224408|NCT01690468|Carboplatin|carboplatin|mesh-list
56224409|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224410|NCT01690507|Cytarabine|cytarabine|mesh-list
56224411|NCT01690507|Decitabine|decitabine|mesh-list
56224412|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
56224413|NCT01690507|Lenograstim|lenograstim|mesh-list
56224414|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56224415|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
56224417|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198111|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56198112|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56198113|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
55723200|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906668|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55906669|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55906670|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55906671|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
55906672|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906673|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906674|NCT02979405|Protective Agents|protective agents|mesh-ancestor
55906675|NCT01791231|Canagliflozin|canagliflozin|mesh-list
55906676|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55906677|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906680|NCT01791309|Panitumumab|panitumumab|mesh-list
55906681|NCT01791309|Vemurafenib|vemurafenib|mesh-list
55906682|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787421|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
55787422|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787423|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787424|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55787425|NCT02684227|Paclitaxel|paclitaxel|mesh-list
55787426|NCT02684227|Carboplatin|carboplatin|mesh-list
55787427|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55787428|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56224419|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224420|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224421|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
56224422|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224423|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224424|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56224425|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56224427|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56224428|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56224429|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224430|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56224431|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56224432|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906683|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906684|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55906685|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906707|NCT04932096|Melatonin|melatonin|mesh-list
55906708|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
55906709|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906710|NCT04932096|Protective Agents|protective agents|mesh-ancestor
55906711|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906712|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906713|NCT00289653|Nicotine|nicotine|mesh-list
55906714|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55906715|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
55906716|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906717|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906718|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55906719|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55906720|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
56224444|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224445|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56224446|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56224447|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224448|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224449|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224450|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56224451|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56224453|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
56224454|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56224455|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224456|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
56224457|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
56224458|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
56224465|NCT01690598|Topotecan|topotecan|mesh-list
55906721|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906722|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906723|NCT00291135|Letrozole|letrozole|mesh-list
55906724|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906725|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55906726|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55906727|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224482|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56224483|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224484|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
56224485|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
56224486|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
56224487|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224488|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224489|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
56224490|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224491|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56224492|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56224493|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
56224494|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56224495|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56224496|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56224497|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56224498|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224499|NCT01690767|Lidocaine|lidocaine|mesh-list
56224500|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
56224501|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
56224502|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224503|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224504|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
56224505|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224506|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56224507|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56224508|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56224509|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56224510|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224511|NCT01690780|Ibuprofen|ibuprofen|mesh-list
55807764|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
55807765|NCT02389543|Hormones|hormones|mesh-ancestor
55807766|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807767|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55906728|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906729|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55906730|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
55906731|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906732|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906733|NCT02103855|Abatacept|abatacept|mesh-list
55906734|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55906735|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198114|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224512|NCT01690780|Morphine|morphine|mesh-list
56224513|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56224514|NCT01690780|Narcotics|narcotics|mesh-ancestor
56224515|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224516|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224517|NCT01690780|Analgesics|analgesics|mesh-ancestor
56224518|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
56224519|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224520|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56224521|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56224522|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224523|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56224535|NCT01690871|Dactolisib|dactolisib|mesh-list
56224555|NCT01690962|Hematinics|hematinics|mesh-ancestor
56224556|NCT01690975|Benzonatate|benzonatate|mesh-list
56224557|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
56224558|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
56224559|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
56224560|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56224561|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224562|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800510|NCT05506787|Esketamine|esketamine|mesh-list
56224575|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
56224576|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224577|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224578|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56224579|NCT01691053|Diuretics|diuretics|mesh-ancestor
56224580|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
56224581|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
56198115|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198116|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56198117|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
55906762|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906763|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906764|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55906765|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55906766|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55906767|NCT03026933|Calcium|calcium|mesh-list
55906768|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55906769|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906770|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55906771|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55906772|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
55906773|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906774|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55906775|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55906776|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906777|NCT01502423|Adalimumab|adalimumab|mesh-list
55906778|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55906779|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906780|NCT04861584|Gemcitabine|gemcitabine|mesh-list
55906781|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906782|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55906819|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
55906820|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906821|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55906822|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56224610|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
56224611|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224612|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224613|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56224614|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56224615|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224616|NCT01691495|PENTA|penta|mesh-list
56224617|NCT01691495|Fondaparinux|fondaparinux|mesh-list
56224618|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56224619|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
56224620|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56224621|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
56224622|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224623|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224624|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
56224625|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56224626|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55906823|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55906824|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906825|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
55906826|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906829|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
55906830|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
55906831|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224627|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
56224628|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56224629|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56224630|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56224631|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56224632|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224633|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
56224634|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906832|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906833|NCT00332163|Irinotecan|irinotecan|mesh-list
55906834|NCT00332163|Panitumumab|panitumumab|mesh-list
55906835|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55906836|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55906837|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906838|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906839|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224685|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224686|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
56224687|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56224688|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224689|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224690|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56224692|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
56224693|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224694|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56224695|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56224696|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56224697|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
56224698|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224699|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224700|NCT01692457|Golimumab|golimumab|mesh-list
55906840|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55906841|NCT02379000|Triamcinolone|triamcinolone|mesh-list
55906842|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55906843|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55906844|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55906845|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55906864|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55906865|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
55906866|NCT02379156|Midodrine|midodrine|mesh-list
55906867|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
55906868|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
56224742|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
56224744|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
56224745|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224746|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56224747|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56224748|NCT01692834|Cyclosporine|cyclosporine|mesh-list
56224749|NCT01692834|Cyclosporins|cyclosporins|mesh-list
56224750|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224751|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224752|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224753|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
56224754|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224755|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
56224756|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224757|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
56224758|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800696|NCT05510141|Analgesics|analgesics|mesh-ancestor
55906869|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906870|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906871|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55906872|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55906873|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55906874|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55906875|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
55906876|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906877|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906878|NCT00335283|Lansoprazole|lansoprazole|mesh-list
55906879|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
55906880|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56198118|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
55787469|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787470|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787471|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787472|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787473|NCT03060785|Tenofovir|tenofovir|mesh-list
55787474|NCT03060785|Emtricitabine|emtricitabine|mesh-list
55787475|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
56224759|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56224760|NCT01692886|Vaccines|vaccines|mesh-list
56224761|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56224762|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
56224763|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224764|NCT01692925|Factor VIII|factor viii|mesh-list
56224765|NCT01692925|Coagulants|coagulants|mesh-ancestor
56224766|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
56224767|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56224768|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
56224769|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224770|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224771|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56224772|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
56224773|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
56224774|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55906881|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906882|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55906883|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906884|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906885|NCT03656718|Nivolumab|nivolumab|mesh-list
55906886|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55906887|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906888|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56485961|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
56224775|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
56224776|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224777|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224779|NCT01693081|Emetics|emetics|mesh-ancestor
56224780|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224781|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
56224782|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224783|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56224784|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
56224785|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
56224786|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224787|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224788|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
56224789|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
56224790|NCT01693159|Coagulants|coagulants|mesh-ancestor
55787476|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787477|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55787478|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55787479|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787480|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787481|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55816038|NCT02365285|Heparin|heparin|mesh-list
55787482|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55787483|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
55787484|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
55787485|NCT04952207|Grazoprevir|grazoprevir|mesh-list
55787486|NCT04952207|Ledipasvir|ledipasvir|mesh-list
55787487|NCT04952207|Velpatasvir|velpatasvir|mesh-list
55787488|NCT04952207|Asunaprevir|asunaprevir|mesh-list
55787489|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787490|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
55787491|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787492|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787493|NCT04632589|Losartan|losartan|mesh-list
56224875|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224876|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224877|NCT01693601|Panobinostat|panobinostat|mesh-list
56224878|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224879|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56224880|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224881|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800802|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224884|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224885|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224886|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224887|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
56224888|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224889|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56224890|NCT01693679|Lamivudine|lamivudine|mesh-list
56224891|NCT01693679|Adefovir|adefovir|mesh-list
56224892|NCT01693679|Telbivudine|telbivudine|mesh-list
56224893|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56224894|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55800810|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55787502|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55787503|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55787504|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224896|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224912|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56224913|NCT01693809|Caffeine|caffeine|mesh-list
55787506|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
55787507|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
55787508|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55787509|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55787510|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787511|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
55787512|NCT05102695|Coagulants|coagulants|mesh-ancestor
55787513|NCT04952129|Selenium|selenium|mesh-list
56224914|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56224915|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224916|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56224917|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224918|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224919|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56224920|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56224921|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
56224922|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224924|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224925|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56224926|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224927|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224928|NCT01694017|Tenofovir|tenofovir|mesh-list
56224929|NCT01694017|Zidovudine|zidovudine|mesh-list
56224930|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
56224931|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224932|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56224933|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56224934|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224935|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224936|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56485962|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
56485963|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
56485964|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56485965|NCT01211197|Metformin|metformin|mesh-list
56485966|NCT01211197|Empagliflozin|empagliflozin|mesh-list
56485967|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56485968|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485969|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56485970|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485971|NCT00553137|Fluconazole|fluconazole|mesh-list
56485972|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
56485973|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56485974|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56485975|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55802314|NCT04810507|Anagliptin|anagliptin|mesh-list
56485976|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56485977|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56485978|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56485979|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
56485980|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56485981|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56485982|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56485983|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56234010|NCT01735071|Growth Substances|growth substances|mesh-ancestor
56485986|NCT04090775|Ipilimumab|ipilimumab|mesh-list
56485987|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56485988|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
56485989|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224938|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
56224939|NCT05288829|Ravulizumab|ravulizumab|mesh-list
56224940|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56224941|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224942|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
56224943|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224944|NCT05288816|Ravulizumab|ravulizumab|mesh-list
56224945|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56224946|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224947|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
56224948|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906889|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906890|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55906891|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55906892|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
55906893|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906894|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906895|NCT02779257|Diazoxide|diazoxide|mesh-list
55906896|NCT02779257|Pasireotide|pasireotide|mesh-list
55906897|NCT02779257|Hormones|hormones|mesh-ancestor
55906898|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787521|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55787522|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787523|NCT05007769|Atezolizumab|atezolizumab|mesh-list
55787527|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
55787528|NCT04952051|Amlodipine|amlodipine|mesh-list
55787529|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55787530|NCT04952051|Enalapril|enalapril|mesh-list
55787531|NCT04952051|Enalaprilat|enalaprilat|mesh-list
55787591|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787592|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55787593|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787594|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787595|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
55787596|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787597|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
56224971|NCT05288673|Ravulizumab|ravulizumab|mesh-list
56224972|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56224973|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224974|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
56224975|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224976|NCT05288660|Ravulizumab|ravulizumab|mesh-list
56224977|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56224978|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224979|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
55800907|NCT04429711|Ivermectin|ivermectin|mesh-list
55906899|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906926|NCT00298155|Goserelin|goserelin|mesh-list
55906927|NCT00298155|Bicalutamide|bicalutamide|mesh-list
55906928|NCT00298155|Dutasteride|dutasteride|mesh-list
55906929|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55906930|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906931|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
55906932|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906933|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55906934|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55906935|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787598|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
55787600|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787601|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
55787602|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
55787603|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
55787604|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787605|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55787606|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55787607|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
56224980|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224981|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
56224982|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56224983|NCT05288465|Protective Agents|protective agents|mesh-ancestor
56224984|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906936|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906937|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55906938|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
55906939|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906940|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906941|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55906942|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
55906943|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55906944|NCT01499849|Dexamethasone|dexamethasone|mesh-list
55906945|NCT01499849|Granisetron|granisetron|mesh-list
55906946|NCT01499849|Rolapitant|rolapitant|mesh-list
55906947|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55906981|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
55906982|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906983|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906984|NCT02378532|Amebicides|amebicides|mesh-ancestor
55906985|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55906986|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55906987|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906988|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
55907017|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907018|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907019|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907020|NCT01559389|Urological Agents|urological agents|mesh-ancestor
55907022|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
55907023|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787608|NCT04950569|Simendan|simendan|mesh-list
55787609|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55787610|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
55816086|NCT01919164|Mitogens|mitogens|mesh-list
55907024|NCT04540692|Paclitaxel|paclitaxel|mesh-list
55907025|NCT04540692|Docetaxel|docetaxel|mesh-list
55907026|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
55907027|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55907028|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907029|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
55907030|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
55907031|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
55907032|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907033|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55907034|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
55907035|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907036|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907037|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55907038|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
56198120|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907064|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907065|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55907066|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55907067|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
55907068|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55907069|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55907070|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
55907071|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
55907072|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907073|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55907074|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55907075|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
55907076|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907077|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55907078|NCT00343863|Dexamethasone|dexamethasone|mesh-list
55907079|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
55907080|NCT00343863|Doxorubicin|doxorubicin|mesh-list
55907081|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55907082|NCT00343863|Ondansetron|ondansetron|mesh-list
55907083|NCT00343863|Palonosetron|palonosetron|mesh-list
55907084|NCT00343863|Antiemetics|antiemetics|mesh-list
55907085|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55907086|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
55907087|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907088|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907089|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55907090|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
55907108|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55907109|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
55907110|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907111|NCT00343863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55907112|NCT00343863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55907113|NCT00343863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907114|NCT00343863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55907115|NCT00343863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55907116|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55907117|NCT00344175|Simvastatin|simvastatin|mesh-list
55907118|NCT00344175|Pitavastatin|pitavastatin|mesh-list
55907119|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55907120|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55907121|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
55907124|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55907126|NCT00345033|Aripiprazole|aripiprazole|mesh-list
55907127|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
55907128|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55907129|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55907130|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56224985|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
55907131|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907132|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907133|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
55907134|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
55907135|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907136|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907137|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55907138|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55907139|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
55907140|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55907141|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55907142|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55907143|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55907144|NCT00345969|Testosterone|testosterone|mesh-list
55907145|NCT00345969|Androgens|androgens|mesh-ancestor
55907165|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
55907166|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55907167|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
55907168|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907169|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907170|NCT00309465|Insulin|insulin|mesh-list
55907171|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56198121|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
56198122|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198123|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
55907172|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
55907173|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55907174|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907175|NCT01791699|Moxonidine|moxonidine|mesh-list
55907176|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55907177|NCT00302133|Naltrexone|naltrexone|mesh-list
56224987|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56224988|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56224990|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
56224991|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224992|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224993|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224994|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800915|NCT03042091|Metronidazole|metronidazole|mesh-list
55787611|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55787612|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55787613|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816185|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907178|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55907179|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55907180|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907181|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
55907182|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907183|NCT01525225|Metformin|metformin|mesh-list
55907184|NCT01525225|Saxagliptin|saxagliptin|mesh-list
55907185|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55907186|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907187|NCT01525225|Incretins|incretins|mesh-ancestor
55907188|NCT01525225|Hormones|hormones|mesh-ancestor
55907189|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907190|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55907191|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
55907192|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907193|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907194|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55907195|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55907196|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55907197|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55907198|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907199|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
55907200|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907245|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
55907246|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
55907247|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55907248|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55907249|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55907250|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
55907251|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867731|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
55907253|NCT02376192|Protective Agents|protective agents|mesh-ancestor
55907254|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55907255|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
55907257|NCT02037126|Psilocybin|psilocybin|mesh-list
55907258|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55907259|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55907260|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907261|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907262|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
55907263|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
56485990|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787614|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787615|NCT04950569|Protective Agents|protective agents|mesh-ancestor
56224995|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56224996|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56224997|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224998|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224999|NCT05288192|Triamcinolone|triamcinolone|mesh-list
56225000|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56225001|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56225002|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56225003|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56225004|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
56225005|NCT05288192|Hormones|hormones|mesh-ancestor
56225006|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816216|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
55907264|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
55907265|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907266|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
55907267|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
55907268|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907309|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907310|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
55907311|NCT04645602|Lenvatinib|lenvatinib|mesh-list
55907312|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55907313|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907314|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55907315|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907316|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907317|NCT02368860|Capecitabine|capecitabine|mesh-list
55907318|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
55907319|NCT02368860|Irinotecan|irinotecan|mesh-list
55907320|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55907321|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
55907322|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907323|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800923|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787622|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
55787623|NCT04944173|Durvalumab|durvalumab|mesh-list
55787624|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787625|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787626|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
55787627|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787628|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
55787629|NCT01675765|Cisplatin|cisplatin|mesh-list
56225007|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225008|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56225009|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
56225010|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225011|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225012|NCT05288179|Pirfenidone|pirfenidone|mesh-list
56225013|NCT05288179|Analgesics|analgesics|mesh-ancestor
56225014|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
56225015|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225016|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225017|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56225018|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56225019|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55907324|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56198124|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56198125|NCT01511471|Ticagrelor|ticagrelor|mesh-list
56198126|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55723555|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907325|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55907326|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907327|NCT02375646|Heparin|heparin|mesh-list
55907328|NCT02375646|Enoxaparin|enoxaparin|mesh-list
55907329|NCT02375646|Warfarin|warfarin|mesh-list
55907330|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
55907331|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55907332|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55907378|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787638|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787639|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55787640|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787641|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55787642|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55787643|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
55787644|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55787645|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787646|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55787647|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55787648|NCT04943237|Analgesics|analgesics|mesh-ancestor
55787649|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
55787650|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787651|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787652|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787653|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787655|NCT04285255|Fentanyl|fentanyl|mesh-list
55787656|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
55787657|NCT04285255|Ketamine|ketamine|mesh-list
55787658|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
56225023|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56225024|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225025|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225026|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225027|NCT05291455|Lacosamide|lacosamide|mesh-list
56225028|NCT05291455|Phenobarbital|phenobarbital|mesh-list
55907379|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55907380|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907381|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907383|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
55907384|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55907385|NCT01524133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55907386|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55907387|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55907388|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907389|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907390|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
55907391|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907392|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
55907413|NCT04110301|Antibodies|antibodies|mesh-list
55907414|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55907415|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
55907416|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907417|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55907418|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55907419|NCT04110301|Growth Substances|growth substances|mesh-ancestor
55907420|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
55907421|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907422|NCT02375178|Biguanides|biguanides|mesh-list
55907423|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
55907424|NCT02375178|Polihexanide|polihexanide|mesh-list
55907425|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55907426|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907427|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
55907428|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55907429|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907430|NCT02375100|Acetaminophen|acetaminophen|mesh-list
55907431|NCT02375100|Tramadol|tramadol|mesh-list
55907432|NCT02375100|Analgesics|analgesics|mesh-list
55907433|NCT02375100|Bupivacaine|bupivacaine|mesh-list
55907434|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
55907435|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
55907436|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907437|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907438|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
55907439|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907440|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55907441|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
56225038|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56225039|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225040|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
56225042|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56225043|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56225044|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55907442|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55907443|NCT02375100|Narcotics|narcotics|mesh-ancestor
55907444|NCT02364258|Atorvastatin|atorvastatin|mesh-list
55907445|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55907446|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55907447|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55907448|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
55907449|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907493|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55907494|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907496|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55907497|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55907498|NCT01557283|Analgesics|analgesics|mesh-ancestor
55907499|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
55907500|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907501|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907502|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55907503|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198127|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56198128|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55723626|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
55907504|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907505|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55907506|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
55907507|NCT02374632|Octreotide|octreotide|mesh-list
55907508|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907509|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55907510|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907511|NCT02363400|Cisplatin|cisplatin|mesh-list
55907512|NCT02363400|Epirubicin|epirubicin|mesh-list
55907513|NCT02363400|Mitomycins|mitomycins|mesh-list
55907514|NCT02363400|Mitomycin|mitomycin|mesh-list
55907515|NCT02363400|Tegafur|tegafur|mesh-list
55907516|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907517|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55907518|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55907543|NCT02374320|Bupivacaine|bupivacaine|mesh-list
55907544|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
55907545|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
55907546|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907547|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907548|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
55907549|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907550|NCT01496183|Olanzapine|olanzapine|mesh-list
55907551|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
55907552|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
56225045|NCT05291338|Doxorubicin|doxorubicin|mesh-list
56225046|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
56225047|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56225048|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225049|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56225050|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56225051|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225052|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225053|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
55787660|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787661|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787662|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
55907553|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907554|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907555|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907556|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55907557|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55907558|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907559|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55907560|NCT01496183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55907561|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55907562|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55907563|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907564|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907565|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
55907566|NCT03278106|Trifluridine|trifluridine|mesh-list
55907567|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
55907586|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
55907587|NCT02374008|Hormones|hormones|mesh-ancestor
55907588|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907590|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907591|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907592|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907593|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
55907594|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
55907595|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907596|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
55907597|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55907598|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55907599|NCT02374008|Analgesics|analgesics|mesh-ancestor
55907600|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907601|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55907602|NCT04505280|Lidocaine|lidocaine|mesh-list
55907603|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
55907604|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
55907605|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907606|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907607|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
55907608|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907609|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56225054|NCT05291195|Eusol|eusol|mesh-list
56225055|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
56225056|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225057|NCT05291130|Vitamin E|vitamin e|mesh-list
56225058|NCT05291130|Vitamins|vitamins|mesh-ancestor
56225059|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
56225060|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225061|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
56225062|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225063|NCT05291130|Protective Agents|protective agents|mesh-ancestor
56225064|NCT05291104|Folic Acid|folic acid|mesh-list
56225065|NCT05291104|Choline|choline|mesh-list
56225066|NCT05291104|Hematinics|hematinics|mesh-ancestor
56225067|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
56225068|NCT05291104|Vitamins|vitamins|mesh-ancestor
55907610|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55907611|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55907612|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55907613|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198129|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56198130|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
56198131|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198132|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198133|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198134|NCT01511562|Cytarabine|cytarabine|mesh-list
56198135|NCT01511562|Etoposide|etoposide|mesh-list
56198136|NCT01511562|Thiotepa|thiotepa|mesh-list
56198137|NCT01511562|Carmustine|carmustine|mesh-list
56198138|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56198139|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225069|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
56225070|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225071|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
56225072|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55787667|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55787668|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787669|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55787670|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55787671|NCT04285255|Analgesics|analgesics|mesh-ancestor
55787672|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55787673|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55787674|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55787675|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
55787676|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787677|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56225073|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
56225074|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225075|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56225076|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56225077|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
56225078|NCT05291052|Capecitabine|capecitabine|mesh-list
56225079|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
56225080|NCT05291052|Lenvatinib|lenvatinib|mesh-list
56225081|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56225082|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
56225083|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225084|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225085|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56198140|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56198141|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56198142|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198143|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907614|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
55907615|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55907616|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
55907617|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907618|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
55907619|NCT02366676|Protective Agents|protective agents|mesh-ancestor
55907620|NCT02373384|Allopurinol|allopurinol|mesh-list
55907621|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
55907622|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907623|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
55907646|NCT02881086|Doxorubicin|doxorubicin|mesh-list
55907647|NCT02881086|Daunorubicin|daunorubicin|mesh-list
55907648|NCT02881086|Asparaginase|asparaginase|mesh-list
55907649|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
55907650|NCT02881086|Idarubicin|idarubicin|mesh-list
55907651|NCT02881086|Pegaspargase|pegaspargase|mesh-list
55907652|NCT02881086|Vindesine|vindesine|mesh-list
55907653|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55907654|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
55907655|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907656|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907657|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55907658|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
55907659|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907660|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907661|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55907662|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56225089|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56225090|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225091|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
56225092|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56225093|NCT05290948|Bevacizumab|bevacizumab|mesh-list
56225094|NCT05290948|Acetazolamide|acetazolamide|mesh-list
55800998|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787678|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55787679|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
55787680|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55787681|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56225095|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56225096|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225097|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56225098|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56225099|NCT05290948|Growth Substances|growth substances|mesh-ancestor
55801021|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
55907663|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55907664|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
55907665|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
55907666|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907667|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907668|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
55907669|NCT02881086|Hormones|hormones|mesh-ancestor
55724233|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
55907670|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907671|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55907672|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55907673|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
55907674|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55907675|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55907676|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
55907677|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
55907678|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907679|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55907680|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55907681|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
55787682|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55787683|NCT04285255|Narcotics|narcotics|mesh-ancestor
55787684|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55787685|NCT04121299|Amlodipine|amlodipine|mesh-list
55787686|NCT04121299|Carvedilol|carvedilol|mesh-list
55907682|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907683|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55907684|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
55907777|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742713|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55907778|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55907779|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55907780|NCT02362152|Analgesics|analgesics|mesh-ancestor
55907781|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
55907782|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907783|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55907784|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907785|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55907786|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907787|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55907788|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
55907789|NCT01493531|Allopurinol|allopurinol|mesh-list
55907791|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
55907810|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
55907811|NCT02105415|Analgesics|analgesics|mesh-ancestor
55907812|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
55907813|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907814|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55907815|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55907816|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55907817|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907818|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907819|NCT01523275|Mitomycins|mitomycins|mesh-list
55907820|NCT01523275|Mitomycin|mitomycin|mesh-list
55907821|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55907822|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907823|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
55907824|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787687|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55816507|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
55907825|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55907826|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907827|NCT00304707|Bupropion|bupropion|mesh-list
55907828|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55907829|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
55907830|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55907831|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55907832|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55907833|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55907834|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907835|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
55907836|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907837|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907838|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55907839|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55907840|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907841|NCT04409483|Ritonavir|ritonavir|mesh-list
55907842|NCT04409483|Lopinavir|lopinavir|mesh-list
55907843|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55907844|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55907845|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
55907846|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907847|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907848|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55907864|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55907865|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55907866|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
55907867|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907869|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55907870|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55907871|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
55907872|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907873|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55907874|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55907875|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55907876|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55907877|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55907878|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55907879|NCT05267847|Anesthetics|anesthetics|mesh-list
55907880|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907881|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907882|NCT05267457|Vanadium|vanadium|mesh-list
55907883|NCT05267457|Trace Elements|trace elements|mesh-ancestor
55907884|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
55907885|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907886|NCT00351039|Bevacizumab|bevacizumab|mesh-list
55907887|NCT00351039|Pemetrexed|pemetrexed|mesh-list
55907888|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55907889|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55907890|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907891|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55907892|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55907893|NCT00351039|Growth Substances|growth substances|mesh-ancestor
55907894|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907895|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
55907896|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907897|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907898|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55907899|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55907900|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55907901|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
56225100|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225101|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
56225102|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
56225103|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56225104|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225105|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225106|NCT05290948|Diuretics|diuretics|mesh-ancestor
56225107|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
56225108|NCT05290935|Paclitaxel|paclitaxel|mesh-list
56225109|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56225110|NCT05290935|Antibodies|antibodies|mesh-list
56225111|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56225112|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225113|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
56225114|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
56225115|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
56225126|NCT05290506|Hormones|hormones|mesh-ancestor
55907902|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
55907903|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
55907904|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907905|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907906|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907907|NCT02372916|Ranibizumab|ranibizumab|mesh-list
55907908|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55907909|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55907938|NCT02372526|Orlistat|orlistat|mesh-list
55907939|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907940|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907941|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55907942|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55907943|NCT02985697|Midazolam|midazolam|mesh-list
55907944|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
55907945|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
55907946|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55907947|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907948|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907949|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55907950|NCT02985697|Analgesics|analgesics|mesh-ancestor
55907951|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
55907952|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907953|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55907954|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55907955|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55907956|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
55908025|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55908026|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
55908027|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225144|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55787689|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55787690|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787691|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55787692|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787693|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
55787694|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55787695|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55787696|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
55787697|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787698|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
55787700|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55787701|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55787702|NCT04942769|Selenium|selenium|mesh-list
55908028|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55908047|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55908048|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908049|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908050|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55908051|NCT02372292|Furosemide|furosemide|mesh-list
55908052|NCT02372292|Diuretics|diuretics|mesh-ancestor
55908053|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
55908054|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908055|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55908056|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908057|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908058|NCT01554241|Vitamin D|vitamin d|mesh-list
55908059|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
55908060|NCT01554241|Vitamins|vitamins|mesh-ancestor
55908061|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
55908062|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908063|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55908064|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55723884|NCT04472585|Ivermectin|ivermectin|mesh-list
55908067|NCT02353026|Artesunate|artesunate|mesh-list
55908068|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
55908069|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55908070|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55908071|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908072|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908074|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
55908075|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55908076|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
55908077|NCT01521559|Aflibercept|aflibercept|mesh-list
55908078|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55908079|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55908080|NCT01521559|Growth Substances|growth substances|mesh-ancestor
55908081|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908082|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
55908083|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908084|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
55908085|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55908086|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55908109|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908110|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55908111|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55908113|NCT01554163|Etoricoxib|etoricoxib|mesh-list
55908114|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55908115|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55908116|NCT01554163|Analgesics|analgesics|mesh-ancestor
55908117|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
55908118|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908119|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908120|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908121|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908122|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55908123|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55908124|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225145|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
56225147|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
56225148|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
56225149|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801072|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
55787703|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
55787704|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787705|NCT04942769|Protective Agents|protective agents|mesh-ancestor
55787706|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787707|NCT04942769|Trace Elements|trace elements|mesh-ancestor
55787708|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
55787709|NCT04942301|Endostar protein|endostar protein|mesh-list
55787710|NCT04942301|Endostatins|endostatins|mesh-list
55787711|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55787713|NCT04942301|Growth Substances|growth substances|mesh-ancestor
55908125|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908126|NCT02360826|Simvastatin|simvastatin|mesh-list
55908127|NCT02360826|Pravastatin|pravastatin|mesh-list
55908128|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55908129|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55908130|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
55908131|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908132|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55908133|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55908134|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908135|NCT03818607|Eculizumab|eculizumab|mesh-list
55908136|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55908137|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55908138|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
55908159|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55908161|NCT02360982|Propofol|propofol|mesh-list
55908162|NCT02360982|Bupivacaine|bupivacaine|mesh-list
55908163|NCT02360982|Rocuronium|rocuronium|mesh-list
55908164|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55908165|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908166|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908167|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55908168|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
55908169|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
55908170|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55908171|NCT02360982|Narcotics|narcotics|mesh-ancestor
55908172|NCT02360982|Analgesics|analgesics|mesh-ancestor
55908173|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
55908174|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908175|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55908176|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
55908178|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55908179|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56225169|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56225170|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
56225171|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225172|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225173|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56225174|NCT05292677|Anesthetics|anesthetics|mesh-list
56225175|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225176|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225177|NCT05292573|Metformin|metformin|mesh-list
56225178|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56225180|NCT05291910|Paclitaxel|paclitaxel|mesh-list
55908180|NCT01790139|Simethicone|simethicone|mesh-list
55908181|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
55908182|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198147|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198148|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56198149|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
56198150|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198151|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56198152|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
56198153|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56198154|NCT01511627|Anesthetics|anesthetics|mesh-list
56198155|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198156|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908183|NCT01790139|Emollients|emollients|mesh-ancestor
55908184|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
55908185|NCT03786237|ON 01910|on 01910|mesh-list
55908186|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908187|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55908188|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908189|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908190|NCT01553851|Trametinib|trametinib|mesh-list
55908191|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908192|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55908193|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908212|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908213|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
55908214|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908215|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55908216|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55908217|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55908218|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908219|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908220|NCT03911557|Durvalumab|durvalumab|mesh-list
55908221|NCT03911557|Tremelimumab|tremelimumab|mesh-list
55908222|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55908223|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908224|NCT00356031|Bevacizumab|bevacizumab|mesh-list
55908225|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55908226|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908227|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55908228|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55908229|NCT00356031|Growth Substances|growth substances|mesh-ancestor
55908230|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908231|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
55908232|NCT02038842|Vaccines|vaccines|mesh-list
55908233|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
55908234|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908235|NCT02360592|Interferons|interferons|mesh-list
55908236|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
55908237|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
55908238|NCT02360592|Entecavir|entecavir|mesh-list
55908239|NCT02360592|Interleukin-2|interleukin-2|mesh-list
55908240|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908241|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
55908242|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908243|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
55908244|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908245|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55908246|NCT02360592|Analgesics|analgesics|mesh-ancestor
55908247|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
55908263|NCT00322101|Cyclosporins|cyclosporins|mesh-list
55908264|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55908265|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
55908266|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908267|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908268|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55908269|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
56198157|NCT01511692|Liraglutide|liraglutide|mesh-list
56198158|NCT01511692|Glimepiride|glimepiride|mesh-list
56198159|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56225221|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225222|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225223|NCT05294887|Bisoprolol|bisoprolol|mesh-list
56225224|NCT05294887|Diltiazem|diltiazem|mesh-list
56225225|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56225226|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56225227|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
56225228|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225229|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225230|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225231|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56225232|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
56225233|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
56225234|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225235|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56225236|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56225237|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56225238|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56225239|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
56225240|NCT05294822|Insulin|insulin|mesh-list
55787720|NCT04941911|Octreotide|octreotide|mesh-list
55787721|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56225241|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56225242|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225244|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56225245|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
56225246|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724033|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
55908270|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742745|NCT04475991|Maraviroc|maraviroc|mesh-list
55908271|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908272|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55908273|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55908274|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
55908275|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55908276|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55908277|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
55908278|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
55908279|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908280|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55908281|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55908282|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55908283|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
55908284|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908285|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55908286|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55908287|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
55908288|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55908289|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
55908290|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908291|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
55908292|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
55908293|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908294|NCT02352402|Ticagrelor|ticagrelor|mesh-list
55908295|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55908296|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55787722|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55908297|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55908298|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55908299|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
55908300|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908301|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908302|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908303|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55908304|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55908305|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
55908306|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908308|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
55908321|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
55908322|NCT04751175|Dexamethasone|dexamethasone|mesh-list
55908323|NCT04751175|Ketamine|ketamine|mesh-list
55908324|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908325|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
55908326|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
55908327|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908328|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908329|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908330|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
55908331|NCT04751175|Hormones|hormones|mesh-ancestor
55908332|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908333|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55908334|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908335|NCT04751175|Analgesics|analgesics|mesh-ancestor
55908336|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
55908337|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55908338|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55908339|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
55908341|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908342|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55908343|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55908344|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908345|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908346|NCT01792557|Phenol|phenol|mesh-list
55908347|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55908348|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908349|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
55908350|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56198160|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198161|NCT01511692|Incretins|incretins|mesh-ancestor
55908351|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55908352|NCT01792713|Sertaconazole|sertaconazole|mesh-list
55908353|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
55908354|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908355|NCT02352168|Budesonide|budesonide|mesh-list
55908356|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908357|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55908358|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
55908359|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908360|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908361|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55908362|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
55908363|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
55908364|NCT02352168|Hormones|hormones|mesh-ancestor
56225256|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56225257|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225258|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908365|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908366|NCT02357004|Carvedilol|carvedilol|mesh-list
55908367|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
55908368|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55908369|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55908370|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
55908371|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908372|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908399|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55908400|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908401|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
55908402|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908403|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908404|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
55908405|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55908406|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55908407|NCT01570387|Growth Substances|growth substances|mesh-ancestor
55908408|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
55908409|NCT02348424|Solithromycin|solithromycin|mesh-list
55908410|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55908411|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908412|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
56225259|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56225260|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
56225261|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
55908413|NCT01570309|Vitamin D|vitamin d|mesh-list
55908414|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55908415|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908416|NCT01570309|Vitamins|vitamins|mesh-ancestor
55908417|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
55908418|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55908419|NCT02356146|Tacrolimus|tacrolimus|mesh-list
55908420|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55908437|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
55908438|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
55908440|NCT03147066|Analgesics|analgesics|mesh-ancestor
55908441|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
55908442|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908443|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908444|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55908445|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55908446|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908447|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908448|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55908449|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225262|NCT05294666|Cyclosporine|cyclosporine|mesh-list
56225263|NCT05294666|Tacrolimus|tacrolimus|mesh-list
56225264|NCT05294666|Cyclosporins|cyclosporins|mesh-list
56225265|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56225266|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
56225267|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225268|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56225269|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225270|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225271|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
56225272|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225273|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
56225274|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225276|NCT05294640|Epinephrine|epinephrine|mesh-list
56225277|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
56225278|NCT05294640|Anesthetics|anesthetics|mesh-list
56225317|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56225318|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56225319|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225320|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
56225321|NCT05294393|Ropivacaine|ropivacaine|mesh-list
56225322|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
55808182|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
55808183|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808184|NCT05266807|Vancomycin|vancomycin|mesh-list
55808185|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
55808186|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55808187|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808188|NCT05314621|Fluticasone|fluticasone|mesh-list
55808189|NCT05314621|Xhance|xhance|mesh-list
55808190|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55808191|NCT05314621|Dextrans|dextrans|mesh-list
55808192|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55808193|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55808194|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55808195|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55808196|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
55908450|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908451|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55908452|NCT03147066|Narcotics|narcotics|mesh-ancestor
55908453|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908454|NCT02351622|Dexamethasone|dexamethasone|mesh-list
55908455|NCT02351622|Caffeic acid|caffeic acid|mesh-list
55908456|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908457|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
55908458|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
55908459|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908460|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908462|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
55908463|NCT02351622|Hormones|hormones|mesh-ancestor
55908464|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908465|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55908466|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198163|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198164|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56198165|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56198166|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
56198167|NCT01511705|Ondansetron|ondansetron|mesh-list
56198168|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
56198169|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
56198170|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198171|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198172|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56198174|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
56198175|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56198176|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
56198177|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198178|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724165|NCT02773355|Hormones|hormones|mesh-ancestor
55908467|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
55908468|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908469|NCT02351622|Protective Agents|protective agents|mesh-ancestor
55908470|NCT01552603|Pancrelipase|pancrelipase|mesh-list
55908471|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908472|NCT02348190|Heparin|heparin|mesh-list
55908473|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
55908474|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55908475|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55908476|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908477|NCT01552369|Valganciclovir|valganciclovir|mesh-list
55908478|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
55787723|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787724|NCT04434001|Thrombin|thrombin|mesh-list
55787725|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
55787726|NCT04434001|Coagulants|coagulants|mesh-ancestor
55787727|NCT03540901|Acetazolamide|acetazolamide|mesh-list
55787728|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
55787729|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55787730|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787731|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225323|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
56225324|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816992|NCT02469077|Morphine|morphine|mesh-list
55908479|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908480|NCT02351232|Liraglutide|liraglutide|mesh-list
55908492|NCT02355678|Propacetamol|propacetamol|mesh-list
55908493|NCT02355678|Tramadol|tramadol|mesh-list
55908494|NCT02355678|Anesthetics|anesthetics|mesh-list
55908495|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
55908496|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908497|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
55908498|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
55908499|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908500|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908501|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908502|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
55908503|NCT02355678|Hormones|hormones|mesh-ancestor
55908504|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908505|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55908506|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908507|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908508|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55908509|NCT02355678|Analgesics|analgesics|mesh-ancestor
55908510|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
55908511|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
55908512|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55908513|NCT02355678|Narcotics|narcotics|mesh-ancestor
55908514|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55908515|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908516|NCT02351310|Betamethasone|betamethasone|mesh-list
55908517|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908518|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
55908519|NCT02351310|Hormones|hormones|mesh-ancestor
56198179|NCT01511705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56198180|NCT01511705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56198181|NCT01511705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198182|NCT01511705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56198183|NCT01511705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56198184|NCT01511718|Ondansetron|ondansetron|mesh-list
56198185|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
56198186|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
56198187|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198188|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198189|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908520|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908521|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908522|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55908523|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
55908524|NCT02347878|Aprepitant|aprepitant|mesh-list
55908525|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
55908526|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
55908527|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908528|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742782|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
55908529|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908530|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55908531|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908532|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908533|NCT02355522|Lidocaine|lidocaine|mesh-list
55908534|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
55908535|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
55908536|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908537|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908538|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
55908539|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908540|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55908541|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55908542|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55908543|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908566|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
55908567|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
55908568|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908569|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55908570|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55908571|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
55908572|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55908573|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908574|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55908575|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55908576|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55908577|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908578|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908579|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787758|NCT03400501|Insulin|insulin|mesh-list
55787759|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55787760|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
55787761|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55787762|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787764|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
55787765|NCT04426591|Vitamins|vitamins|mesh-ancestor
55787766|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
55787767|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787768|NCT04940273|Remifentanil|remifentanil|mesh-list
55787769|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55787770|NCT04940273|Narcotics|narcotics|mesh-ancestor
55787771|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225330|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
56225331|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56225332|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56225333|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225334|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55908580|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908581|NCT01552057|Analgesics|analgesics|mesh-ancestor
55908582|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
55908583|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908584|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
55908585|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55908586|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
55908587|NCT02350686|Capecitabine|capecitabine|mesh-list
55908588|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
55908589|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55908590|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
55908591|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198190|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
56198191|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
56198192|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56198193|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
56198194|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198195|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198196|NCT01511718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56198197|NCT01511718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56198198|NCT01511718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198199|NCT01511718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55724287|NCT05648032|Triamcinolone|triamcinolone|mesh-list
55908592|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908593|NCT03159078|Imipenem|imipenem|mesh-list
55908594|NCT03159078|Polymyxins|polymyxins|mesh-list
55908615|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55908616|NCT02350530|Growth Substances|growth substances|mesh-ancestor
55908617|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908618|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
55908619|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
55908620|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908621|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55908622|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55908623|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
55908624|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55908625|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55908626|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908627|NCT01569841|Insulin|insulin|mesh-list
55908628|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55908629|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
55908630|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56225335|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
56225336|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56225337|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56225338|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225339|NCT05293808|Aspirin|aspirin|mesh-list
56225340|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56225341|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56225342|NCT05293808|Analgesics|analgesics|mesh-ancestor
56225343|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
56225344|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225345|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908631|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908632|NCT01550965|Adalimumab|adalimumab|mesh-list
55908633|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908634|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908635|NCT05265819|Hormones|hormones|mesh-list
55908636|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908637|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908638|NCT02353494|Piperaquine|piperaquine|mesh-list
55908639|NCT02353494|Artenimol|artenimol|mesh-list
55908640|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
55908641|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55908642|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55908643|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908644|NCT02353260|Docetaxel|docetaxel|mesh-list
55908645|NCT02353260|Fluorouracil|fluorouracil|mesh-list
55908646|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908647|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
55908648|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
55908649|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
55908650|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908651|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
55908704|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
55908705|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908706|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908707|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55908708|NCT02353182|Narcotics|narcotics|mesh-ancestor
55908709|NCT02349516|Squalamine|squalamine|mesh-list
55908710|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55908711|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55908712|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55908713|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908714|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55908715|NCT02349516|Protective Agents|protective agents|mesh-ancestor
55908716|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908717|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908718|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56198200|NCT01511718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56198201|NCT01511731|Famotidine|famotidine|mesh-list
56198202|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56198203|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56198204|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56198205|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
56198206|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
56198207|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198208|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198209|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198210|NCT01511757|Fluconazole|fluconazole|mesh-list
56198211|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
56198212|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198213|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56198214|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56198215|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198216|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198217|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56198218|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
56198219|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198220|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198221|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56198222|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56198223|NCT01511770|Fluconazole|fluconazole|mesh-list
56198224|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
56198225|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198226|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56198227|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55908719|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56225358|NCT05293704|Analgesics|analgesics|mesh-ancestor
56225359|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
56225360|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225361|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908720|NCT02349516|Growth Substances|growth substances|mesh-ancestor
55908721|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
55908722|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55908723|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55908724|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55908725|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55908726|NCT02346084|Maraviroc|maraviroc|mesh-list
55908727|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55908728|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55908729|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908730|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55908731|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55908732|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
55908733|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198228|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198229|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198230|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56198231|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
56225362|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56225363|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225364|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56225365|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225366|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56225367|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225368|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
56225369|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56225370|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56225371|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225372|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225373|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55801281|NCT04852081|Tamoxifen|tamoxifen|mesh-list
55787772|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225374|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
56225375|NCT05293574|Norethindrone|norethindrone|mesh-list
56225376|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
55867732|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
56198232|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908735|NCT03149250|Hemostatics|hemostatics|mesh-list
55908736|NCT03149250|Coagulants|coagulants|mesh-ancestor
55908738|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55908739|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55908740|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225377|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56225378|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56225379|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56225380|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
56225381|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56225382|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225383|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56225384|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56225385|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
56225386|NCT05293132|Ubiquinone|ubiquinone|mesh-list
56225387|NCT05293132|Montelukast|montelukast|mesh-list
56225388|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56225389|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
55801289|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56225390|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56225391|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
56225392|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787774|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
55787775|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787776|NCT04948385|Propofol|propofol|mesh-list
55787777|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55908741|NCT02343432|Triamcinolone|triamcinolone|mesh-list
55908742|NCT02343432|Bupivacaine|bupivacaine|mesh-list
55908743|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
55908744|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
55908745|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908746|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908747|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
55908748|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908749|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908750|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
55908751|NCT02343432|Hormones|hormones|mesh-ancestor
55908772|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
55908773|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908774|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908775|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55908776|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
55908777|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55908778|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
55908779|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908780|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908781|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55908782|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
55908783|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
55908784|NCT02345616|Protective Agents|protective agents|mesh-ancestor
55908785|NCT00391989|Dasatinib|dasatinib|mesh-list
55908786|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908787|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55908788|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908789|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908790|NCT03148704|Palonosetron|palonosetron|mesh-list
55908791|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
55908792|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
55908793|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908794|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908795|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908796|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55908797|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55908798|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
55908799|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908800|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908801|NCT01795287|Anesthetics|anesthetics|mesh-list
55908802|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908803|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908804|NCT04976283|Pioglitazone|pioglitazone|mesh-list
55908805|NCT04976283|Empagliflozin|empagliflozin|mesh-list
55908835|NCT02345304|Protective Agents|protective agents|mesh-ancestor
55908836|NCT01569295|Rituximab|rituximab|mesh-list
55908837|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55908838|NCT01569295|Idelalisib|idelalisib|mesh-list
55908839|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787778|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787779|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787780|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55787781|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
55787782|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
55787783|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55787784|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55787785|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787786|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
55787787|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
55787788|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55817295|NCT01850602|Sevelamer|sevelamer|mesh-list
55908840|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908841|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
55908842|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908843|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908844|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55908845|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
56198233|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198234|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56198235|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56198237|NCT01511822|Drospirenone|drospirenone|mesh-list
56198238|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56198239|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56198240|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56198241|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56198242|NCT01511822|Estradiol|estradiol|mesh-list
56198243|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56198244|NCT01511822|Estrogens|estrogens|mesh-ancestor
56198245|NCT01511822|Hormones|hormones|mesh-ancestor
56198246|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787789|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55787790|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787791|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787792|NCT04948151|Urological Agents|urological agents|mesh-ancestor
56225393|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225394|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56225395|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56225396|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225397|NCT05293132|Vitamins|vitamins|mesh-ancestor
56225398|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
55787793|NCT02633293|Treprostinil|treprostinil|mesh-list
55787794|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55787795|NCT04938713|Ketamine|ketamine|mesh-list
56225399|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
56225400|NCT05293119|Tofacitinib|tofacitinib|mesh-list
56225401|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56225402|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
56225403|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56225404|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56225405|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225406|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787796|NCT04938713|Esketamine|esketamine|mesh-list
55787810|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
55787811|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55787813|NCT04938011|Progestins|progestins|mesh-ancestor
55787814|NCT04938011|Hormones|hormones|mesh-ancestor
55787815|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787816|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225408|NCT05296863|Minoxidil|minoxidil|mesh-list
56225409|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56225410|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
56225411|NCT05296564|Aldesleukin|aldesleukin|mesh-list
56225412|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
56225413|NCT05296564|Interleukin-2|interleukin-2|mesh-list
55908846|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908847|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908848|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
55908849|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908850|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
55908892|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908893|NCT03148314|Misoprostol|misoprostol|mesh-list
55908894|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55908895|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
55908896|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55787817|NCT03057509|Octreotide|octreotide|mesh-list
56225459|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225460|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
56225461|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
56225462|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
55801354|NCT04842487|Hormones|hormones|mesh-ancestor
55908897|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908898|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55908899|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908900|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
55908901|NCT01517893|Simvastatin|simvastatin|mesh-list
55908902|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55908903|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55908904|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
55908905|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908907|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55908908|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908909|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
55908910|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55908911|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908912|NCT01489891|Lidocaine|lidocaine|mesh-list
55908913|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
55908914|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
55908915|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908916|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225463|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225464|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
56225465|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56225466|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56225467|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
56225468|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225470|NCT05296005|Protective Agents|protective agents|mesh-ancestor
56225471|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
56225472|NCT05296005|Vitamins|vitamins|mesh-ancestor
56225473|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
56225474|NCT05295836|Glycerol|glycerol|mesh-list
56225475|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56225476|NCT05295836|Protective Agents|protective agents|mesh-ancestor
56225477|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225478|NCT05294900|Paclitaxel|paclitaxel|mesh-list
56225479|NCT05294900|Carboplatin|carboplatin|mesh-list
55817424|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56225480|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56225481|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225482|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
55787818|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787819|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55787820|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787822|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55787823|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
55787824|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787825|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787826|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55787827|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55787828|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
55787829|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908917|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
55908918|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908919|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55908920|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55908921|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55908922|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908923|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908924|NCT02342574|Olorofim|olorofim|mesh-list
55908925|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
55908926|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908927|NCT03148002|Lactulose|lactulose|mesh-list
55908928|NCT03148002|Sennosides|sennosides|mesh-list
55908929|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908930|NCT03148002|Laxatives|laxatives|mesh-ancestor
55908931|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55908932|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
56225494|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56225495|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56225496|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225497|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
56225498|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225500|NCT05273242|Infliximab|infliximab|mesh-list
56225501|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225502|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
56225503|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908933|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908965|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
56198247|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908966|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
55908967|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55908968|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55908969|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55908970|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
55908971|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908972|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55908973|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55908974|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908976|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
55909000|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909001|NCT02341638|Aspirin|aspirin|mesh-list
55787842|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55787843|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56225504|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225505|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
56225506|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56225507|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56225508|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225509|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
56225510|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
56225511|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56225512|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
56225513|NCT05269095|Anesthetics|anesthetics|mesh-list
56225514|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225515|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225516|NCT05267938|Lidocaine|lidocaine|mesh-list
56225517|NCT05267938|Epinephrine|epinephrine|mesh-list
56225518|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
56225519|NCT05267938|Anesthetics|anesthetics|mesh-list
56225520|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225521|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225522|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
56225523|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225524|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56225525|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56225526|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56225527|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56225528|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225529|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55817450|NCT02284009|Hormones|hormones|mesh-ancestor
55909002|NCT02341638|Itraconazole|itraconazole|mesh-list
55909003|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55909004|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55909005|NCT02341638|Analgesics|analgesics|mesh-ancestor
55909006|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
55909007|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909008|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909009|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909010|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909011|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55909012|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56225531|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
56225532|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225533|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56225534|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56225535|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
56225545|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56225546|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225547|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56225548|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
56225549|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787844|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789086|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808365|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
55808367|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808368|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
55808370|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
55808371|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55808372|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
55808373|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808374|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808375|NCT05214001|Almotriptan|almotriptan|mesh-list
55808376|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55808377|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
55808378|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808379|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808380|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808381|NCT05249959|Rituximab|rituximab|mesh-list
55808382|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
55808383|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55808384|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55808385|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808386|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
55808387|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808388|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55808389|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55808390|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
55808391|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808393|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55808394|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808395|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808396|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808397|NCT05280223|Analgesics|analgesics|mesh-ancestor
55808398|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
55808399|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808400|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55808401|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55792752|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55742824|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55868466|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
55909013|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909015|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55909016|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909017|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
55909018|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
55909019|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909020|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55909021|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55909022|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55909023|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
55909024|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909025|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56225550|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909048|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
55909049|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909050|NCT02343666|Plerixafor|plerixafor|mesh-list
55909051|NCT02343666|Carmustine|carmustine|mesh-list
55909052|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
55909053|NCT02343666|Lenograstim|lenograstim|mesh-list
55909054|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55909055|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
55909056|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909057|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55909058|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
55909059|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909060|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909061|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55909062|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55909063|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
55909064|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909065|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909067|NCT02332356|Azathioprine|azathioprine|mesh-list
55909068|NCT02332356|Infliximab|infliximab|mesh-list
55909069|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909070|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909071|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
55909072|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787845|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787846|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55787847|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
56225551|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
56225552|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817479|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
55909073|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
55909074|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909075|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55909076|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909077|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55909078|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
55909079|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909080|NCT02340936|Lenalidomide|lenalidomide|mesh-list
55909117|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909118|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55909138|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56198248|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56198249|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
55724604|NCT04158635|Gemcitabine|gemcitabine|mesh-list
56225554|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56225555|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
56225556|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225557|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56225558|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
56225559|NCT05267431|Protective Agents|protective agents|mesh-ancestor
56225560|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56225561|NCT05266248|Caffeine|caffeine|mesh-list
56225562|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56225563|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225564|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56225565|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225566|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225567|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56225568|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56225569|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
55801431|NCT04837261|Amiodarone|amiodarone|mesh-list
55909139|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55909140|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909141|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909142|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909143|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55909144|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55909145|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909147|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
55909148|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55742839|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
55909149|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55909150|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55909151|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909152|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909153|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
55909154|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
55909155|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909156|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909157|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55909158|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55909159|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
56225570|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225571|NCT05264896|Leucovorin|leucovorin|mesh-list
56225572|NCT05264896|Docetaxel|docetaxel|mesh-list
56225573|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
56225574|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225575|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
56225576|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
56225577|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
56225578|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225580|NCT05264896|Protective Agents|protective agents|mesh-ancestor
56225581|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225582|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
56225583|NCT05264896|Vitamins|vitamins|mesh-ancestor
56225584|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
56225585|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
56225586|NCT05264584|Febuxostat|febuxostat|mesh-list
56225587|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55766590|NCT05090085|Z 350|z 350|mesh-list
55909161|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55909162|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55909163|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55909164|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
55909165|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55909166|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909168|NCT02331576|Ropivacaine|ropivacaine|mesh-list
55909169|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
55909170|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
55909171|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225588|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
56225589|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225590|NCT05264584|Expectorants|expectorants|mesh-ancestor
56225591|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
56225592|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56225593|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
56225594|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225595|NCT05264584|Protective Agents|protective agents|mesh-ancestor
55787848|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787849|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787850|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55787851|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55787853|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55792753|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808402|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55808403|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808404|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808405|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808406|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55808407|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55808408|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808409|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808410|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55808411|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55808412|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808413|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
55808414|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808415|NCT05248945|Carbamazepine|carbamazepine|mesh-list
55808416|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
55808417|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
55808418|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55808419|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808420|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808421|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55808422|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808423|NCT05248945|Analgesics|analgesics|mesh-ancestor
55808424|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
55808425|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808426|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55808427|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55808428|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808429|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55808430|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55808431|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
55808432|NCT04240171|Glimepiride|glimepiride|mesh-list
55808433|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56225624|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56225625|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55787854|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787855|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787856|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55787857|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
55787858|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787859|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787860|NCT03219775|Nivolumab|nivolumab|mesh-list
55787861|NCT03219775|Ipilimumab|ipilimumab|mesh-list
55787863|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909189|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909190|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
55909191|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55909192|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
55909193|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909194|NCT00400803|Antiviral Agents|antiviral agents|mesh-ancestor
55909195|NCT00400803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909196|NCT00400803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909197|NCT00400803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55909198|NCT00400803|Immunologic Factors|immunologic factors|mesh-ancestor
55909200|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55909201|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909202|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
55909203|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55909204|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55909205|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
55909206|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55909207|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55909208|NCT02339142|Prednisolone|prednisolone|mesh-list
55909209|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
55909210|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55787874|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
55787875|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
55787876|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55787877|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
56225626|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225628|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56225629|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225630|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56225631|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225632|NCT05225402|Norepinephrine|norepinephrine|mesh-list
56225633|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56225634|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56225635|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
56225636|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225637|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225638|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225639|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
56225640|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
56225641|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225642|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56225643|NCT05220826|Ethanol|ethanol|mesh-list
56225644|NCT05220826|Ethylene|ethylene|mesh-list
56225645|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55909211|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
55909212|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909213|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
55909214|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
55909215|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909216|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909217|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909218|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
55909219|NCT02339142|Hormones|hormones|mesh-ancestor
55909220|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909221|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55909222|NCT02339142|Protective Agents|protective agents|mesh-ancestor
55909223|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55909224|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198250|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56198251|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56198252|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55909225|NCT00362817|Carboplatin|carboplatin|mesh-list
55909226|NCT00362817|Temozolomide|temozolomide|mesh-list
55909227|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909228|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55909263|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55909264|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909265|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909266|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55909298|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909299|NCT03105180|Mannitol|mannitol|mesh-list
55909300|NCT03105180|Sorbitol|sorbitol|mesh-list
55909301|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55909302|NCT03105180|Diuretics|diuretics|mesh-ancestor
55909303|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
55909304|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909305|NCT03105180|Cathartics|cathartics|mesh-ancestor
55909306|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909307|NCT02331030|Ropivacaine|ropivacaine|mesh-list
55909308|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
55909309|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
56225646|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225647|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225648|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225649|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56225650|NCT05220826|Growth Substances|growth substances|mesh-ancestor
56225652|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225653|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56225654|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225655|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225656|NCT05210413|Spartalizumab|spartalizumab|mesh-list
55909310|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909311|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909312|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
55909345|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55909347|NCT02330796|Analgesics|analgesics|mesh-ancestor
55909349|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909350|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909351|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909352|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
55909353|NCT02330796|Protective Agents|protective agents|mesh-ancestor
55909354|NCT02330640|Clopidogrel|clopidogrel|mesh-list
55909356|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55909357|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56225674|NCT05192629|Analgesics|analgesics|mesh-ancestor
56225689|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
56225692|NCT05189444|Amoxicillin|amoxicillin|mesh-list
56225693|NCT05189444|Clarithromycin|clarithromycin|mesh-list
56225694|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
56225695|NCT05189444|Esomeprazole|esomeprazole|mesh-list
56225696|NCT05189444|Bismuth|bismuth|mesh-list
56225697|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225698|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56225699|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225700|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56225701|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56225702|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56225703|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225704|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56225705|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56225706|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56225707|NCT05189444|Antacids|antacids|mesh-ancestor
56225708|NCT05189444|Diuretics|diuretics|mesh-ancestor
55787879|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
55787880|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787881|NCT04946123|Protective Agents|protective agents|mesh-ancestor
55787882|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787883|NCT04946123|Trace Elements|trace elements|mesh-ancestor
55787884|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
55787886|NCT04945577|Vitamins|vitamins|mesh-ancestor
55787887|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
56225710|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225711|NCT05189444|Expectorants|expectorants|mesh-ancestor
56225712|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
56225713|NCT05175274|Colchicine|colchicine|mesh-list
56225714|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
55787888|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787889|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56225716|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
56225717|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
56225718|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
55909358|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55909359|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55909360|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
55909361|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909362|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909363|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909364|NCT02335398|Methadone|methadone|mesh-list
55909365|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55787891|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787892|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787893|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
55787894|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55787895|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55787896|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55787897|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787898|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
55787899|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787900|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787901|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55787902|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787904|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56225719|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225720|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225721|NCT05169268|Aripiprazole|aripiprazole|mesh-list
56225722|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
56225723|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
56225724|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56225725|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55909366|NCT02335398|Narcotics|narcotics|mesh-ancestor
55909367|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909368|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909369|NCT02335398|Analgesics|analgesics|mesh-ancestor
55909370|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
55909371|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909372|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
55909373|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
55909374|NCT02338206|Hormones|hormones|mesh-list
55909375|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909376|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787905|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
55787906|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
55787907|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787910|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55787911|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787912|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55787913|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56225726|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56225733|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56225734|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56225735|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
55909377|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
55909378|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909379|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55909380|NCT02330406|Anagliptin|anagliptin|mesh-list
55909381|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55909382|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909383|NCT02330406|Incretins|incretins|mesh-ancestor
55909384|NCT02330406|Hormones|hormones|mesh-ancestor
55909385|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909386|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55909387|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
55909388|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909389|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198253|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55724730|NCT05647408|Dexamethasone|dexamethasone|mesh-list
55909390|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
55909391|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
55909392|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909393|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
55909394|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909395|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909396|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
55909397|NCT02337972|Povidone|povidone|mesh-list
55909398|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
55909399|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
55909417|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55909419|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
55909420|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55909421|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55909422|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55909423|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55909424|NCT02337426|Temozolomide|temozolomide|mesh-list
55909425|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55909426|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55909427|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
55909428|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225736|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56225737|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56225738|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56225739|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56225747|NCT05129137|Acetaminophen|acetaminophen|mesh-list
56225749|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56225750|NCT05129137|Analgesics|analgesics|mesh-ancestor
56225751|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
56225752|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801591|NCT02603419|Avelumab|avelumab|mesh-list
55787915|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787916|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787917|NCT05114239|Timolol|timolol|mesh-list
55787918|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55787919|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55787920|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55817613|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55909429|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909430|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
55909431|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55909432|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
55909433|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909434|NCT03664830|Plerixafor|plerixafor|mesh-list
55909435|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55909436|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55909437|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
56225753|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225754|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
56225755|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
55787922|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
55787923|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787924|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787925|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787926|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55787927|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55787929|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55787930|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55787931|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55787932|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
55787933|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787934|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55787935|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55787936|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787937|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
55787938|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725236|NCT00569387|Vaccines|vaccines|mesh-list
55909438|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909439|NCT00407355|Ranibizumab|ranibizumab|mesh-list
55909440|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55909441|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55909442|NCT00407355|Growth Substances|growth substances|mesh-ancestor
55909443|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909444|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
55909445|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909446|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55909447|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55909448|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
55909449|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909450|NCT02334462|Antacids|antacids|mesh-ancestor
55909451|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909452|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909453|NCT03144882|Curcumin|curcumin|mesh-list
55909454|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55909468|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55909469|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909470|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55909471|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
55909472|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909473|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909474|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
55909475|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909476|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56225756|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56225757|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225758|NCT05110898|Olmesartan|olmesartan|mesh-list
56225759|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55787939|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
55787940|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
55787941|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
55787942|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787943|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55787944|NCT04418999|Dexamethasone|dexamethasone|mesh-list
55787945|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55787946|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
55787947|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
55787948|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787949|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787950|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787951|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
55787952|NCT04418999|Hormones|hormones|mesh-ancestor
55787953|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56225760|NCT05110898|Indapamide|indapamide|mesh-list
56225761|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55909477|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55909478|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
55909479|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909480|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55909481|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55909482|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55909483|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909484|NCT03111810|Prednisolone|prednisolone|mesh-list
55909485|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55909486|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
55909487|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55909488|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
55909489|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55909490|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
55787954|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55787955|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787956|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55787957|NCT04526197|Celecoxib|celecoxib|mesh-list
55787958|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
55787959|NCT04526197|Choline|choline|mesh-list
55787960|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55787961|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55787962|NCT04526197|Analgesics|analgesics|mesh-ancestor
55787963|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
55787965|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787966|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55787967|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787968|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55787969|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55787971|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787972|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
55787973|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55787974|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
55787975|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787976|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55787977|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
55787978|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
55787979|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
56225762|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56225763|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56225764|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198254|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
56198256|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
56198257|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56198258|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
56198259|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56198260|NCT01511822|Diuretics|diuretics|mesh-ancestor
56198261|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
56198262|NCT01511835|Folic Acid|folic acid|mesh-list
56198263|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
56225771|NCT05103696|Etomidate|etomidate|mesh-list
56225772|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56225773|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225774|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225775|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56225776|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
56225777|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
56225778|NCT05098041|Rifampin|rifampin|mesh-list
56225779|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55801607|NCT05618353|Tubulin Modulators|tubulin modulators|mesh-ancestor
56225780|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
56225781|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56198264|NCT01511835|Inositol|inositol|mesh-list
56198265|NCT01511835|Hematinics|hematinics|mesh-ancestor
56198266|NCT01511835|Vitamins|vitamins|mesh-ancestor
56198267|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
56198268|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198269|NCT01511848|Deferasirox|deferasirox|mesh-list
56198270|NCT01511848|Deferiprone|deferiprone|mesh-list
56198271|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56198272|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
56198273|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
55724803|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
55909491|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909492|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
55909493|NCT03111810|Hormones|hormones|mesh-ancestor
56485991|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56225782|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225783|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
56225784|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56225785|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225786|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225787|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56225788|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56225789|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56225790|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56225791|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56225792|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56225793|NCT05096325|Insulin|insulin|mesh-list
56225794|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56225795|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909494|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909495|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909496|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55909497|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909499|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
55909500|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909501|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909502|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55909503|NCT03111810|Protective Agents|protective agents|mesh-ancestor
55909504|NCT02334150|Sufentanil|sufentanil|mesh-list
55909505|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55909506|NCT02334150|Narcotics|narcotics|mesh-ancestor
55909507|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909508|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909509|NCT02334150|Analgesics|analgesics|mesh-ancestor
55909510|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
55909511|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909512|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55909513|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55909514|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
55909515|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
55909536|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56225796|NCT05096065|Leuprolide|leuprolide|mesh-list
55787980|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55787981|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55787982|NCT04526197|Growth Substances|growth substances|mesh-ancestor
55787983|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
55787984|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787985|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55787986|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787987|NCT05060965|Nicotine|nicotine|mesh-list
55787988|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55787989|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
55787990|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787991|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787992|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56225797|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56225798|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
56225799|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56225800|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909537|NCT02326584|Cytarabine|cytarabine|mesh-list
55909538|NCT02326584|Daunorubicin|daunorubicin|mesh-list
55909539|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55909540|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
55909541|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909542|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909543|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
55909544|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909545|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55909546|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
55909547|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909548|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55909549|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55724860|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
55909550|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55909551|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909552|NCT03111342|Lidocaine|lidocaine|mesh-list
55909553|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
55909554|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
55909555|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909556|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909557|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
55909558|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909559|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55787993|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55787994|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
55787995|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909560|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55909561|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55909562|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55909563|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909564|NCT03111420|Clopidogrel|clopidogrel|mesh-list
55909565|NCT03111420|Ticagrelor|ticagrelor|mesh-list
55909566|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55909567|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55909568|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55909569|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55909570|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55909589|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
55909590|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909591|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909592|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909593|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909594|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55909595|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55909596|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909597|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56225801|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56225802|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225803|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56225804|NCT05083572|Rifaximin|rifaximin|mesh-list
56225805|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225806|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909598|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55909599|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909600|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
55909602|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
55909603|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909604|NCT02326038|Methylphenidate|methylphenidate|mesh-list
55909605|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55909606|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909607|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55909608|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55909609|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56485992|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
55787996|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787997|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55787998|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55787999|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55788001|NCT04935515|Coagulants|coagulants|mesh-list
55788002|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
55788003|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55788004|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788005|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
55788006|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
55788007|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788008|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225808|NCT05057273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56225809|NCT05057273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225810|NCT05033743|Secnidazole|secnidazole|mesh-list
56225811|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56225812|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56225813|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225814|NCT05030025|Lamivudine|lamivudine|mesh-list
56225815|NCT05030025|Abacavir|abacavir|mesh-list
56225816|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
56225817|NCT05030025|Dolutegravir|dolutegravir|mesh-list
56225818|NCT05030025|Triumeq|triumeq|mesh-list
56225819|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55801659|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
55788009|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788010|NCT04376281|Norepinephrine|norepinephrine|mesh-list
55788011|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55788012|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55788013|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
55788014|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909610|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909611|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
55909612|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909613|NCT00970866|Folic Acid|folic acid|mesh-list
55909614|NCT00970866|Micronutrients|micronutrients|mesh-list
55909615|NCT00970866|Trace Elements|trace elements|mesh-list
55909616|NCT00970866|Hematinics|hematinics|mesh-ancestor
55909617|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
55909618|NCT00970866|Vitamins|vitamins|mesh-ancestor
55909619|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909620|NCT03145584|Bupivacaine|bupivacaine|mesh-list
55909621|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
55788015|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225820|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56225821|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225822|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225823|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
56225824|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225825|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56225826|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56225827|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56225828|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56225829|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
56225830|NCT05013567|Ibuprofen|ibuprofen|mesh-list
56225831|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56225832|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56225833|NCT05013567|Analgesics|analgesics|mesh-ancestor
56225834|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
56225835|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225836|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225837|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56225838|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225839|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56225840|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225841|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225842|NCT05008926|Naloxegol|naloxegol|mesh-list
55801670|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
56225844|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225845|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
55909625|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
55909626|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909627|NCT03145194|Ticagrelor|ticagrelor|mesh-list
55909663|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55909664|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55909665|NCT02333058|Treosulfan|treosulfan|mesh-list
55909666|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55909667|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
55909668|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909669|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909670|NCT03111186|Acetaminophen|acetaminophen|mesh-list
55909671|NCT03111186|Ibuprofen|ibuprofen|mesh-list
55909672|NCT03111186|Oxycodone|oxycodone|mesh-list
55909673|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55909674|NCT03111186|Analgesics|analgesics|mesh-ancestor
55909675|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
55909676|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724934|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909677|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909678|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
55909679|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55909680|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909681|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909682|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55909683|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909684|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909685|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55909735|NCT03143244|Analgesics|analgesics|mesh-ancestor
55909736|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
55909737|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909738|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55909739|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55909740|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55909741|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
55909742|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788016|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788018|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
55788019|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909743|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909744|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55909745|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55909746|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55909747|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55909748|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55909749|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
55909750|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
55909751|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
55909752|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
55909753|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55909754|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909755|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909756|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55909757|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909758|NCT03838692|Ponatinib|ponatinib|mesh-list
55909759|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909760|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55909761|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909762|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909763|NCT03774186|Pancrelipase|pancrelipase|mesh-list
55909764|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909765|NCT03505944|Venetoclax|venetoclax|mesh-list
55909766|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909767|NCT01489189|Ranibizumab|ranibizumab|mesh-list
55863975|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863977|NCT04267978|Temozolomide|temozolomide|mesh-list
55863978|NCT04267978|Endostatins|endostatins|mesh-list
55863979|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55863980|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55863981|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863982|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863983|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863984|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55863985|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
55863986|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55863987|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55863988|NCT04267978|Growth Substances|growth substances|mesh-ancestor
55863989|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863990|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
55863991|NCT03839446|Etoposide|etoposide|mesh-list
55863992|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
55863993|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
55863994|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55863995|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863996|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55863997|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55863998|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864025|NCT03839134|Racepinephrine|racepinephrine|mesh-list
55864026|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
55909794|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
55909795|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909797|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909798|NCT03027115|Tamsulosin|tamsulosin|mesh-list
55909799|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55909800|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55909801|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55909802|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
55909803|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909806|NCT03027115|Urological Agents|urological agents|mesh-ancestor
55909808|NCT03026881|Apatinib|apatinib|mesh-list
55909809|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55909810|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909811|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
55909812|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
55909813|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
55909814|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909815|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55909816|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909817|NCT01516879|Atorvastatin|atorvastatin|mesh-list
55864028|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
55909838|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909839|NCT01547299|Leuprolide|leuprolide|mesh-list
55909840|NCT01547299|Dutasteride|dutasteride|mesh-list
55909841|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55909842|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
55909843|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55909844|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909845|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56198274|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198276|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56198277|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
56198278|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56198279|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198280|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56198281|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198282|NCT01511887|Ibuprofen|ibuprofen|mesh-list
56198283|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56198284|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198285|NCT01511887|Analgesics|analgesics|mesh-ancestor
56198286|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
55725010|NCT02830477|Factor VIII|factor viii|mesh-list
55909846|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909847|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55909848|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55909849|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909850|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909851|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
55909852|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909853|NCT04072107|Capecitabine|capecitabine|mesh-list
55909854|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55909855|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
55909856|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909857|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909858|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55909859|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55909860|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909861|NCT00411411|Incretins|incretins|mesh-ancestor
55909862|NCT00411411|Hormones|hormones|mesh-ancestor
55909863|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864395|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
55909864|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55909865|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
55909866|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909867|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909868|NCT01794273|Phenylephrine|phenylephrine|mesh-list
55909869|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
55909870|NCT01794273|Ephedrine|ephedrine|mesh-list
55909871|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55909966|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909967|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909968|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55909969|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909970|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909971|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
55909972|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909973|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
55909975|NCT05287191|Amiodarone|amiodarone|mesh-list
55909976|NCT05287191|Analgesics|analgesics|mesh-ancestor
55909977|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
55909982|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55910009|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55910011|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
55910012|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910013|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
55865324|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198287|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198288|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198289|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198290|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198291|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56198292|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198293|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198294|NCT01511991|Sevoflurane|sevoflurane|mesh-list
56198295|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56198296|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56198297|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
56198298|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
55865456|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
55865615|NCT04553263|Bupropion|bupropion|mesh-list
56198299|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198300|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910014|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
55910015|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910016|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865819|NCT00875212|Calcium|calcium|mesh-list
55910017|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55910018|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
55910019|NCT05287035|Hormones|hormones|mesh-ancestor
55910020|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910021|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55910022|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910023|NCT00416793|Carboplatin|carboplatin|mesh-list
55910024|NCT00416793|Bortezomib|bortezomib|mesh-list
55910025|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910026|NCT00417417|Rilonacept|rilonacept|mesh-list
55910027|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910061|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55910062|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910063|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55910064|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55910065|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910066|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910081|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865905|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55865906|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55910082|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55910083|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910084|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
55910085|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55788315|NCT04784299|Lidocaine|lidocaine|mesh-list
55910086|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
55910087|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910088|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55866241|NCT04382014|Curcumin|curcumin|mesh-list
55910089|NCT01996449|Diuretics|diuretics|mesh-ancestor
55910090|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
55866500|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
55866501|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
55910091|NCT00426855|Bortezomib|bortezomib|mesh-list
55910092|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55910093|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910094|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55910095|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
55910096|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910097|NCT01491737|Trastuzumab|trastuzumab|mesh-list
55910098|NCT01491737|Pertuzumab|pertuzumab|mesh-list
55910099|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55910100|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55910101|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198301|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56198302|NCT01512004|Propiverine|propiverine|mesh-list
56198303|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56198304|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56198305|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
56198307|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198308|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198309|NCT01512004|Urological Agents|urological agents|mesh-ancestor
56198310|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
56198311|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
56198312|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910102|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55910103|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910104|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910105|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55910106|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
55910107|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910108|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910109|NCT00427557|Rituximab|rituximab|mesh-list
55910110|NCT00427557|Fludarabine|fludarabine|mesh-list
55910111|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
55910112|NCT00427557|Melphalan|melphalan|mesh-list
55910113|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55910114|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910115|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
55910116|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910117|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910118|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55910119|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
55910120|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910121|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910122|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55910123|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
55910124|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55910125|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
55910163|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
55910164|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55910166|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
55910167|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910168|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910169|NCT01794897|Valacyclovir|valacyclovir|mesh-list
55910170|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
55910171|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910172|NCT01794975|Ketamine|ketamine|mesh-list
55910173|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55910174|NCT01794975|Analgesics|analgesics|mesh-ancestor
55910175|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
55910190|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
55910191|NCT05285787|Vitamin MK 7|vitamin mk 7|mesh-list
55910192|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
55910193|NCT05285787|Coagulants|coagulants|mesh-ancestor
55910194|NCT01491035|Vortioxetine|vortioxetine|mesh-list
55910195|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
55910196|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910197|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55910198|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55910199|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55910200|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910201|NCT01491035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55910202|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55910203|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910204|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910205|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910206|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
55910207|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55910208|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55910209|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55910210|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55910211|NCT00375999|Docetaxel|docetaxel|mesh-list
55910212|NCT00375999|Epirubicin|epirubicin|mesh-list
55910213|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910214|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
55910215|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
55910216|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
55910217|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910218|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56125071|NCT01381926|Exenatide|exenatide|mesh-list
55910219|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55910221|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910222|NCT04409327|Dactolisib|dactolisib|mesh-list
55910223|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910224|NCT01488071|Vortioxetine|vortioxetine|mesh-list
55910225|NCT01488071|S 20098|s 20098|mesh-list
55910226|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
55910227|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910228|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55910229|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55852180|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
56125279|NCT03997266|Ampicillin|ampicillin|mesh-list
55910230|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55910231|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910232|NCT01488071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55910260|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910261|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910262|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910263|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55910264|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55910265|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56125403|NCT03992196|Rotigotine|rotigotine|mesh-list
55910266|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910268|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910269|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910270|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55910272|NCT01484873|Hormones|hormones|mesh-ancestor
55910273|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910274|NCT01486927|Factor VIII|factor viii|mesh-list
55910275|NCT01486927|Coagulants|coagulants|mesh-ancestor
55910312|NCT00379821|Atovaquone|atovaquone|mesh-list
55910313|NCT00379821|Proguanil|proguanil|mesh-list
55910314|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
55910341|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910342|NCT00435591|Conivaptan|conivaptan|mesh-list
55910343|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55910344|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910345|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
55742909|NCT04501783|Favipiravir|favipiravir|mesh-list
55910346|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910348|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
55910349|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910350|NCT01545817|Everolimus|everolimus|mesh-list
55910351|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910352|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910353|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
55910354|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910355|NCT01512979|Metformin|metformin|mesh-list
55910356|NCT01512979|Linagliptin|linagliptin|mesh-list
55910357|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910358|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910359|NCT01512979|Incretins|incretins|mesh-ancestor
55910360|NCT01512979|Hormones|hormones|mesh-ancestor
55910361|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910362|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55910363|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
55910364|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226258|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125666|NCT04197570|Narcotics|narcotics|mesh-ancestor
55910365|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910417|NCT01477853|Metformin|metformin|mesh-list
55910418|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55910419|NCT01477853|Glimepiride|glimepiride|mesh-list
55910420|NCT01477853|Atorvastatin|atorvastatin|mesh-list
55910421|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910422|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198314|NCT01512017|Emollients|emollients|mesh-ancestor
56198315|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
56198316|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
56198317|NCT01512147|Propofol|propofol|mesh-list
56198318|NCT01512147|Isoflurane|isoflurane|mesh-list
55725300|NCT03480607|Hormones|hormones|mesh-ancestor
55910423|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55910424|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55910425|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
55910426|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910427|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55910428|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55910429|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910430|NCT01477853|Incretins|incretins|mesh-ancestor
55910431|NCT01477853|Hormones|hormones|mesh-ancestor
55910432|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910433|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55910434|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
55910435|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55910436|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910437|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
55910438|NCT00440505|Nicotine|nicotine|mesh-list
55910439|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55910440|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
55910441|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910442|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910443|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55910444|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55910445|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
56126038|NCT03949764|Velpatasvir|velpatasvir|mesh-list
55910446|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910447|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910448|NCT00441285|Albendazole|albendazole|mesh-list
55910449|NCT00441285|Praziquantel|praziquantel|mesh-list
55910450|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
55910451|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55910452|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910453|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
55910454|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55910455|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55910482|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
55910483|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910484|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910485|NCT01511107|Amoxicillin|amoxicillin|mesh-list
55910486|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
55910487|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
55910488|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55910489|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55910490|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910491|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55910492|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910493|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910494|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55910495|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
55910496|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910497|NCT00442689|Flutamide|flutamide|mesh-list
55910498|NCT00442689|Drospirenone|drospirenone|mesh-list
55910499|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55910500|NCT00442689|Estradiol|estradiol|mesh-list
55910501|NCT00442689|Estrogens|estrogens|mesh-ancestor
55910502|NCT00442689|Hormones|hormones|mesh-ancestor
55910533|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
55910534|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910536|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55910537|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55910538|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910539|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55910540|NCT00389493|Risperidone|risperidone|mesh-list
55910541|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55910542|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
55910543|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126223|NCT04145232|Ipilimumab|ipilimumab|mesh-list
56198319|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56198320|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198321|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198322|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56198323|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
56198324|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
56198325|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198326|NCT01512147|Analgesics|analgesics|mesh-ancestor
56198327|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
56198328|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910560|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910562|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55910563|NCT00456807|Vaccines|vaccines|mesh-list
55910564|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
55910565|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910566|NCT00456885|Exenatide|exenatide|mesh-list
55910567|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910568|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910569|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55910570|NCT00456885|Incretins|incretins|mesh-ancestor
55910571|NCT00456885|Hormones|hormones|mesh-ancestor
55910573|NCT01475825|Mipomersen|mipomersen|mesh-list
55910574|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55910575|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55910576|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
55910577|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910578|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55910579|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55910580|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
55910581|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910582|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55910583|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55910584|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55910585|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910586|NCT04085315|Osimertinib|osimertinib|mesh-list
55910587|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910588|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55910589|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910590|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910591|NCT01484431|Tadalafil|tadalafil|mesh-list
55910592|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
55910593|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55910594|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55910595|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910596|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910597|NCT01484431|Urological Agents|urological agents|mesh-ancestor
55910598|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
55910599|NCT00445887|Norgestrel|norgestrel|mesh-list
55910600|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55910601|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
55910614|NCT00457977|Vaccines|vaccines|mesh-list
55910615|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55910616|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
56126531|NCT03941730|Estradiol|estradiol|mesh-list
55910617|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910618|NCT01473563|Pemetrexed|pemetrexed|mesh-list
56126583|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
55910619|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910620|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910621|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910622|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56144581|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910623|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55910624|NCT01795209|Ranibizumab|ranibizumab|mesh-list
56198329|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56198330|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56198331|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56198332|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
56198333|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198334|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198335|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56226526|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
56198336|NCT01512173|Propranolol|propranolol|mesh-list
56198337|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56198338|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56198339|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
56198340|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198341|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198342|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198343|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56198344|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56198345|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
56198346|NCT01512199|Paclitaxel|paclitaxel|mesh-list
56198347|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56198348|NCT01512199|Trastuzumab|trastuzumab|mesh-list
56198349|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56198350|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56198351|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198352|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
55910625|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55910626|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55910627|NCT01795209|Growth Substances|growth substances|mesh-ancestor
55910628|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910629|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
55910630|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910631|NCT01484275|Siltuximab|siltuximab|mesh-list
55910632|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910633|NCT01484197|Maleic acid|maleic acid|mesh-list
55910634|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910635|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910636|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
55910637|NCT01473407|Hematinics|hematinics|mesh-ancestor
55910638|NCT04082897|Atezolizumab|atezolizumab|mesh-list
55910639|NCT04082897|Venetoclax|venetoclax|mesh-list
55910640|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
55742912|NCT04440735|Atezolizumab|atezolizumab|mesh-list
55854083|NCT00318136|Paclitaxel|paclitaxel|mesh-list
55910641|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910642|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55910643|NCT01544179|Pemetrexed|pemetrexed|mesh-list
55910644|NCT01544179|Gefitinib|gefitinib|mesh-list
55910645|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910646|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910647|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910648|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55910649|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56127131|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
55910650|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55910651|NCT01483651|Insulin|insulin|mesh-list
56198353|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
56198354|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
56198355|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725470|NCT04454905|Apatinib|apatinib|mesh-list
55910652|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55910653|NCT01483651|Glucagon|glucagon|mesh-list
55910654|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910655|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910656|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55910657|NCT01483651|Hormones|hormones|mesh-ancestor
55910658|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910659|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55910660|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55910661|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910662|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910678|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
55910679|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910680|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55910681|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
55910682|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
55910683|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910684|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910685|NCT01509547|Varenicline|varenicline|mesh-list
55910686|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55910687|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55910688|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
55910689|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910690|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910691|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910692|NCT01509079|Vitamin D|vitamin d|mesh-list
55910693|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
55910694|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
55910695|NCT01509079|Vitamins|vitamins|mesh-list
55910696|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
55910697|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910698|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55910699|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55910700|NCT04650217|Levodopa|levodopa|mesh-list
55910701|NCT04650217|Carbidopa|carbidopa|mesh-list
55910702|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55910703|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55910704|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55910705|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
55910706|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910707|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910708|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910709|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55910710|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910711|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55910712|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
55910713|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
55910714|NCT01462435|Celecoxib|celecoxib|mesh-list
55910715|NCT01462435|Diclofenac|diclofenac|mesh-list
55910716|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55910717|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55910718|NCT01462435|Analgesics|analgesics|mesh-ancestor
56127395|NCT03866772|Misoprostol|misoprostol|mesh-list
55910719|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
55910720|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910733|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55910734|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910735|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55910736|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55910737|NCT01472081|Growth Substances|growth substances|mesh-ancestor
55910738|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910739|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
55910740|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55910741|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910742|NCT01471691|Ranibizumab|ranibizumab|mesh-list
55910743|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55910744|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55910745|NCT01471691|Growth Substances|growth substances|mesh-ancestor
56198356|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56198357|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
55910746|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127655|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
56127779|NCT03825198|Hormones|hormones|mesh-ancestor
56226700|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56226704|NCT03796416|Misoprostol|misoprostol|mesh-list
55910747|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
55910748|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910749|NCT01471379|Milnacipran|milnacipran|mesh-list
55910750|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
55910751|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55910752|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55910753|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910754|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910755|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910756|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910757|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55910758|NCT01471379|Analgesics|analgesics|mesh-ancestor
55910759|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
55910760|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910761|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
55910762|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910763|NCT01470989|Triamcinolone|triamcinolone|mesh-list
55910764|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55910765|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55910766|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55910767|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910768|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
55910770|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910771|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910772|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910773|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
55910774|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910775|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910777|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55910778|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910779|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910780|NCT01469819|Lubiprostone|lubiprostone|mesh-list
55910781|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55910782|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910807|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
55910808|NCT01478971|Hematinics|hematinics|mesh-ancestor
55910809|NCT01507051|Vitamin K|vitamin k|mesh-list
55910810|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
55910811|NCT01507051|Warfarin|warfarin|mesh-list
55910812|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
55910813|NCT01507051|Vitamins|vitamins|mesh-ancestor
55910814|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
55910815|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910816|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
55910817|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55910818|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
55910819|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55910820|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
55910821|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127992|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56128043|NCT03524820|Cetuximab|cetuximab|mesh-list
56128116|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
55910822|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910823|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55910824|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55910825|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
55910826|NCT01507051|Coagulants|coagulants|mesh-ancestor
55910827|NCT04079257|Eculizumab|eculizumab|mesh-list
55910828|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55910829|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910830|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
55910831|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910833|NCT01478113|Adderall|adderall|mesh-list
55910834|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
55910835|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55910836|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910860|NCT01505881|Warfarin|warfarin|mesh-list
55910861|NCT01505881|Dabigatran|dabigatran|mesh-list
55910862|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
55910863|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
55910864|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55910865|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
55910866|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126126|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55910867|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910868|NCT01505647|Vaccines|vaccines|mesh-list
55910869|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
55910870|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910871|NCT01477333|Treprostinil|treprostinil|mesh-list
55910872|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55910873|NCT01505491|Adalimumab|adalimumab|mesh-list
55910874|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910875|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910876|NCT01504867|Aspirin|aspirin|mesh-list
55910877|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55910878|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55910879|NCT01504867|Analgesics|analgesics|mesh-ancestor
55910880|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
55910881|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910882|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910883|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910884|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910885|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55910886|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55910918|NCT00449007|Bupropion|bupropion|mesh-list
55910919|NCT00449007|Fluoxetine|fluoxetine|mesh-list
55910920|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55910921|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
55910922|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910923|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55742929|NCT03347461|Hormones|hormones|mesh-ancestor
55910924|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56128293|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
55910925|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910926|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910927|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
55910928|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910929|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910997|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55910998|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
55910999|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128342|NCT00083226|Bortezomib|bortezomib|mesh-list
55911000|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911001|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
55911002|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55911003|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55911004|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55911005|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
55911006|NCT01590758|Pexiganan|pexiganan|mesh-list
55911007|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55911008|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911009|NCT00534417|Capecitabine|capecitabine|mesh-list
55911010|NCT00534417|Fulvestrant|fulvestrant|mesh-list
55911011|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55911012|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
55911013|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128405|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788877|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56226820|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56226821|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808520|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
55808521|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808522|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808523|NCT05205811|Zonisamide|zonisamide|mesh-list
55808524|NCT05205811|Bupropion|bupropion|mesh-list
55808527|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55808528|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55808529|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55808530|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55808531|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808532|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
55808533|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808534|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808535|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55808536|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55808537|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808538|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
55808539|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55808540|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55808541|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55808542|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
55808543|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808544|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55808546|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55808547|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55808548|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808549|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808550|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808551|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808552|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55808553|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55808554|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
55808555|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808556|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55808557|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
55808558|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
55808559|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
55808560|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55808561|NCT05237947|Vaccines|vaccines|mesh-list
55808562|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
55808563|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808564|NCT01656733|Nicotine|nicotine|mesh-list
55808565|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55808566|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
55808567|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808568|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808569|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55808570|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55808571|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
55808572|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911031|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911032|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
55911033|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55911034|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911035|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911036|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55911037|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55911038|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226822|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56226823|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911039|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911040|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
55911041|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911042|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911043|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55911044|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55911045|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128590|NCT05684718|Rifabutin|rifabutin|mesh-list
55911047|NCT01475461|Hormones|hormones|mesh-ancestor
55911048|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55911049|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55911050|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
56198359|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
56198360|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55911051|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911052|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911053|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55911054|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
55911055|NCT01589822|Coagulants|coagulants|mesh-ancestor
55911056|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55911057|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55911058|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55911059|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
55911060|NCT01474993|Sulforaphane|sulforaphane|mesh-list
55911061|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55911062|NCT01474993|Protective Agents|protective agents|mesh-ancestor
55911063|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911064|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911065|NCT01691768|Tenofovir|tenofovir|mesh-list
55911066|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
55911067|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911068|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55911122|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911124|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55911125|NCT01564862|Vortioxetine|vortioxetine|mesh-list
55911126|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55911127|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55911128|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55911129|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911130|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911131|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911132|NCT01564862|Analgesics|analgesics|mesh-ancestor
55911133|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
55911134|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911135|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
55911136|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55911137|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
55911138|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55911139|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55742936|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911140|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911141|NCT01564862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55911142|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
55911143|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55911144|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55911145|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55911146|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55911147|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
55911148|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911149|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911150|NCT01467479|Interferons|interferons|mesh-list
55911151|NCT01467479|Ribavirin|ribavirin|mesh-list
55911152|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
55911180|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
55911181|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911182|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911183|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
55911184|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911185|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
55911186|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911187|NCT01564784|Analgesics|analgesics|mesh-ancestor
55911188|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
55911189|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911190|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55911191|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55911192|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911193|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911194|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55911195|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
55911196|NCT00536601|Melphalan|melphalan|mesh-list
55911197|NCT00536601|Busulfan|busulfan|mesh-list
55911198|NCT00536601|Thiotepa|thiotepa|mesh-list
55911199|NCT00536601|Carmustine|carmustine|mesh-list
55911200|NCT00536601|Carboplatin|carboplatin|mesh-list
55911201|NCT00536601|Etoposide|etoposide|mesh-list
55911202|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
56198361|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198362|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198363|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56226906|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56198364|NCT01512355|Analgesics|analgesics|mesh-ancestor
56198365|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
56198366|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198367|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56198368|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56198369|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56129008|NCT03308916|Liver Extracts|liver extracts|mesh-list
56198370|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
56198371|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198372|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198373|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56198374|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56198375|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56198376|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56226925|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198377|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198378|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198379|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198380|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56198381|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
55911203|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911218|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55911220|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55911221|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
55911222|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911223|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911224|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55911225|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
55911226|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
55911227|NCT00536913|Hormones|hormones|mesh-ancestor
55911228|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129121|NCT04857840|Firibastat|firibastat|mesh-list
55911229|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55911230|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55911231|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55911232|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
55911233|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911234|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911235|NCT00462423|Bevacizumab|bevacizumab|mesh-list
55911236|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55911237|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911238|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911239|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55911240|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55911241|NCT00462423|Growth Substances|growth substances|mesh-ancestor
55911242|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911243|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
55911244|NCT00462735|Fluorouracil|fluorouracil|mesh-list
56198383|NCT01512485|Clopidogrel|clopidogrel|mesh-list
56198384|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56198385|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56198386|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56198387|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56198388|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
56198389|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198390|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198391|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198392|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
56198393|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56198394|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
56198395|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
55911245|NCT00462735|Cetuximab|cetuximab|mesh-list
55911246|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
55911247|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
55911248|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911249|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55911250|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911251|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911252|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
55911253|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911254|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911255|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
55911256|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911257|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55911258|NCT01690988|Ketamine|ketamine|mesh-list
55911259|NCT01690988|Analgesics|analgesics|mesh-ancestor
55911260|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
55911286|NCT00464685|Dexamethasone|dexamethasone|mesh-list
55911287|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55911288|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
55911289|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
55911290|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911291|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911292|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55911293|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
55911295|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55911296|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56129376|NCT03204786|Vasopressins|vasopressins|mesh-list
55911297|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911298|NCT01465997|Lacosamide|lacosamide|mesh-list
55911299|NCT01465997|Carbamazepine|carbamazepine|mesh-list
55911300|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
55911301|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55911302|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55911303|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55911304|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911305|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
55911306|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56129483|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911307|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911308|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911309|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55911310|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55911311|NCT01465997|Analgesics|analgesics|mesh-ancestor
55911312|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
55911313|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911314|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55911315|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56198396|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198397|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198398|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55911316|NCT00538863|Fentanyl|fentanyl|mesh-list
55911317|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55911318|NCT00538863|Narcotics|narcotics|mesh-ancestor
55911319|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911320|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911321|NCT00538863|Analgesics|analgesics|mesh-ancestor
55911322|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
55911323|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911324|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55911338|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911339|NCT00540579|Gemcitabine|gemcitabine|mesh-list
55911340|NCT00540579|Pomalidomide|pomalidomide|mesh-list
55911341|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55911342|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
55911343|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911344|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911345|NCT00540579|Antiviral Agents|antiviral agents|mesh-ancestor
55911346|NCT00540579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911347|NCT00540579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911348|NCT00540579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911349|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
55911350|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911351|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55911352|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55911353|NCT00540579|Growth Substances|growth substances|mesh-ancestor
55911354|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
55911355|NCT01690520|Cyclosporine|cyclosporine|mesh-list
56129661|NCT05249478|Bupivacaine|bupivacaine|mesh-list
56129662|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
55911356|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
55911357|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
55911359|NCT01690520|Fludarabine|fludarabine|mesh-list
55911360|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
55911361|NCT01690520|Cyclosporins|cyclosporins|mesh-list
55911362|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911363|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
55911364|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911365|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56227166|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
55911366|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55911367|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
55911368|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911369|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911370|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55911371|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55911372|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
55911373|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911374|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
55911375|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911376|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
55911377|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56129769|NCT02395614|Cefazolin|cefazolin|mesh-list
55911378|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55911379|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55911380|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
55911381|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55911382|NCT04081337|Tirzepatide|tirzepatide|mesh-list
55911383|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55911384|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911385|NCT04081337|Incretins|incretins|mesh-ancestor
55911386|NCT04081337|Hormones|hormones|mesh-ancestor
55911387|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55911388|NCT00541671|Promethazine|promethazine|mesh-list
55911412|NCT01690052|Pilocarpine|pilocarpine|mesh-list
55911413|NCT01690052|Cevimeline|cevimeline|mesh-list
55911414|NCT01690052|Miotics|miotics|mesh-ancestor
55911415|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
55911416|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911417|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911418|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55911419|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55911420|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
56198400|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
56198401|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198403|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
56198404|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
56198405|NCT01512537|Vitamins|vitamins|mesh-list
56198406|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
56198407|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198408|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56198409|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56198410|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56198411|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
56198412|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
56198413|NCT01512680|Insulin|insulin|mesh-list
56198414|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56198415|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198416|NCT01512784|Vaccines|vaccines|mesh-list
56198417|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
56198418|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198419|NCT01512862|Calcitriol|calcitriol|mesh-list
56198420|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56198421|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129935|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56129946|NCT01922466|Loxoprofen|loxoprofen|mesh-list
56198422|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55725924|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
55911421|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911422|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911423|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55911424|NCT01689974|Ipilimumab|ipilimumab|mesh-list
55911425|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911426|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911427|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55911428|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911429|NCT04750083|Carboplatin|carboplatin|mesh-list
55911430|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
55911431|NCT04750083|Pemetrexed|pemetrexed|mesh-list
55911432|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911433|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911434|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911435|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911436|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55911437|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55911438|NCT04409912|Sirolimus|sirolimus|mesh-list
55911439|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55911470|NCT00470301|Doxorubicin|doxorubicin|mesh-list
55911471|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55911472|NCT00470301|Tipifarnib|tipifarnib|mesh-list
55911473|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56130045|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55911474|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911475|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
55911476|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
55911477|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
55911478|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198423|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56198424|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198425|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56198427|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
56198428|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56130100|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55911479|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911480|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
55911481|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911482|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55911483|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55911484|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
55911485|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55911511|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911512|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
55911513|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911514|NCT00471705|Miltefosine|miltefosine|mesh-list
55911515|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
55911516|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
55911517|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911518|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911519|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55911520|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55744502|NCT02488603|Tamoxifen|tamoxifen|mesh-list
55911521|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
55911522|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55911523|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
55911524|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911525|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911526|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
55911527|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911528|NCT01458535|Ritonavir|ritonavir|mesh-list
55911529|NCT01458535|Ribavirin|ribavirin|mesh-list
55911530|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55911531|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55911532|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
55911533|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911534|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130230|NCT00631488|Metformin|metformin|mesh-list
55911535|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55911536|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55911537|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
55911538|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911555|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
55911556|NCT01463111|Lamotrigine|lamotrigine|mesh-list
55911557|NCT01463111|Valproic Acid|valproic acid|mesh-list
55911558|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55911559|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911560|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911561|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
55911562|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55911563|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911564|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911565|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
55911566|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55911567|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55911568|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55911569|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55911570|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55911571|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
55911572|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911573|NCT01463033|Levetiracetam|levetiracetam|mesh-list
55911574|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
55911575|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
55911576|NCT01461551|Propofol|propofol|mesh-list
55911577|NCT01461551|Sevoflurane|sevoflurane|mesh-list
56130269|NCT00630786|Conatumumab|conatumumab|mesh-list
56130275|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
55911578|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55911579|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911580|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911581|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55911583|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
55911584|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56198429|NCT01512901|Betamethasone|betamethasone|mesh-list
56198430|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
56198431|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56198432|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
56198433|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56198434|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198435|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
56198436|NCT01512901|Hormones|hormones|mesh-ancestor
56198437|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198438|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198439|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56198440|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
56198441|NCT01512914|Ropivacaine|ropivacaine|mesh-list
56198442|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
55911585|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55911586|NCT01460381|Quinidine|quinidine|mesh-list
55911587|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
55911588|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55911589|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55911590|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
56227277|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
55911591|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911592|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911593|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911594|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55911595|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
55911596|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55911597|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55911598|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130377|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911609|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
55911610|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911611|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55911612|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55911613|NCT00546897|Growth Substances|growth substances|mesh-ancestor
55911614|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
55911615|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911616|NCT03754725|Deferiprone|deferiprone|mesh-list
55911617|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55911618|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
55911619|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
55911620|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911621|NCT00474123|Simvastatin|simvastatin|mesh-list
55911622|NCT00474123|Ezetimibe|ezetimibe|mesh-list
55911623|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55911624|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55911625|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
55911626|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911627|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56227353|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55911628|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55911629|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911630|NCT00474201|Ritonavir|ritonavir|mesh-list
55911631|NCT00474201|Lopinavir|lopinavir|mesh-list
55911632|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
55911633|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55911634|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56130439|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
55911635|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
55911636|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911637|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911638|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55911639|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55911640|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
55911641|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911642|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56198443|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
56198444|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198445|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198446|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
56198447|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198448|NCT01512953|Lansoprazole|lansoprazole|mesh-list
56198449|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
56198450|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56198451|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56198452|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56198453|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911643|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55911644|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55911645|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
55911646|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55911647|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55911648|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
55911649|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55911650|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55911651|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911652|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
55911653|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
55911654|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
55911655|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55911657|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55911658|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56227470|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55911659|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911660|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
55911661|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911662|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911663|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55911678|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911679|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911680|NCT00477087|Analgesics|analgesics|mesh-ancestor
55911681|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
55911682|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911683|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56130600|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
55911684|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55911685|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911686|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911688|NCT01473589|Teriparatide|teriparatide|mesh-list
55911689|NCT01473589|Calcium|calcium|mesh-list
55911690|NCT01473589|Vitamins|vitamins|mesh-ancestor
55911691|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
55911692|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911693|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55911694|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55911695|NCT00478335|Calcitonin|calcitonin|mesh-list
56227513|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56227514|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56227515|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56227516|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56227517|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56227518|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
56227519|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56227521|NCT02175030|Copper|copper|mesh-list
55911696|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
55911697|NCT00478335|Indomethacin|indomethacin|mesh-list
55911698|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55911699|NCT00478335|Amiloride|amiloride|mesh-list
55911700|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
55911701|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55911702|NCT00478335|Katacalcin|katacalcin|mesh-list
55911703|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
55911704|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55911705|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55911706|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911707|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911708|NCT00478335|Urological Agents|urological agents|mesh-ancestor
55911709|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55911710|NCT00478335|Diuretics|diuretics|mesh-ancestor
55911711|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
56198454|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198455|NCT01512966|Aflibercept|aflibercept|mesh-list
56198456|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56198457|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56198458|NCT01512966|Growth Substances|growth substances|mesh-ancestor
56198459|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198460|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
56198461|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198462|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
56198463|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56198464|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198465|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56198466|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
56198467|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56198468|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198469|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198470|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911712|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911713|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55726610|NCT04859062|Lidocaine|lidocaine|mesh-list
55911715|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55911716|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55911717|NCT00478335|Analgesics|analgesics|mesh-ancestor
55911718|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
55911719|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911720|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55911721|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55911722|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
55911723|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
55911724|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55911725|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55911726|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55911727|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55911728|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55911777|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55911778|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911779|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911780|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911782|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
55911783|NCT00480987|Fludarabine|fludarabine|mesh-list
55911784|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
55911785|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911786|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55911787|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
55911788|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911789|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911790|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
55911791|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911792|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
55911793|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911794|NCT01457053|Torsemide|torsemide|mesh-list
55911795|NCT01457053|Furosemide|furosemide|mesh-list
55911796|NCT01457053|Bumetanide|bumetanide|mesh-list
55911797|NCT01457053|Diuretics|diuretics|mesh-list
55911798|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
55911799|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
56198471|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
56198472|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56198473|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198474|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56198475|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
56198476|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56198477|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198478|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198479|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198481|NCT01513070|Isosorbide|isosorbide|mesh-list
56198482|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56198483|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56198484|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56198485|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198486|NCT01513070|Analgesics|analgesics|mesh-ancestor
56198487|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
56198488|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227771|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
56198489|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198490|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198491|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55911800|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911801|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55911802|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911803|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55911805|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
55911806|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55911821|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55911822|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55911823|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55911824|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
56130727|NCT05601336|Metformin|metformin|mesh-list
55911825|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
55911826|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
55911827|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
55911828|NCT00481845|Anastrozole|anastrozole|mesh-list
55911829|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55911830|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911832|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55911833|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911834|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911835|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55911836|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
55911837|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55911838|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911840|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56130749|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
55911841|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55911842|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911843|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55911844|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911845|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56198493|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56198494|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198495|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56198496|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56198497|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198498|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
56198499|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56198500|NCT01513070|Diuretics|diuretics|mesh-ancestor
56198501|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
56198502|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
56198503|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55911846|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911847|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130787|NCT04126278|Dexamethasone|dexamethasone|mesh-list
55911848|NCT00553839|Ketamine|ketamine|mesh-list
55911849|NCT00553839|Analgesics|analgesics|mesh-ancestor
55911850|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
55911851|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911852|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911853|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55911854|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55911855|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
55911856|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
55911857|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228009|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55911858|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55911859|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55911860|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911861|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911862|NCT00554463|Etoposide|etoposide|mesh-list
55911863|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911864|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55911917|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911919|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911920|NCT01456039|Romidepsin|romidepsin|mesh-list
55911921|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55911922|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911923|NCT01455415|Pregabalin|pregabalin|mesh-list
55911924|NCT01455415|Analgesics|analgesics|mesh-ancestor
55911947|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911948|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911950|NCT01471015|Hematinics|hematinics|mesh-ancestor
55911951|NCT01470469|Guanfacine|guanfacine|mesh-list
55911952|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55911953|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55911954|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55911955|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55911956|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
55911957|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911958|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911959|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911960|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
55911961|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55911962|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55911963|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
55911964|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911965|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911966|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911967|NCT01470001|Urological Agents|urological agents|mesh-ancestor
55911968|NCT01469377|Cariprazine|cariprazine|mesh-list
56130833|NCT04073784|Gemcitabine|gemcitabine|mesh-list
55911969|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55911970|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55911971|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198505|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56126292|NCT05587608|Anesthetics|anesthetics|mesh-list
55911972|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911973|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55911974|NCT01469221|Apaziquone|apaziquone|mesh-list
55911975|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911992|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911993|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228203|NCT02040857|Tamoxifen|tamoxifen|mesh-list
55911994|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911995|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55911996|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
55911997|NCT01586156|Protective Agents|protective agents|mesh-ancestor
55911998|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55911999|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912000|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55912001|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
55912002|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55912003|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55912004|NCT01459913|Interferons|interferons|mesh-list
55912006|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
55912007|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
55912008|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55912009|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912010|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
56228272|NCT01913730|Dexamethasone|dexamethasone|mesh-list
56228273|NCT01913730|Bortezomib|bortezomib|mesh-list
56228274|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228275|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
56228276|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
56228277|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228278|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912011|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912012|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
55912013|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912014|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
55912015|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912016|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55912017|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55912018|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
55912019|NCT01458275|Ciclesonide|ciclesonide|mesh-list
55912020|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
55912021|NCT01458275|Hormones|hormones|mesh-ancestor
55912022|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912023|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912024|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55912025|NCT02334527|Palbociclib|palbociclib|mesh-list
55912026|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912027|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55912028|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912029|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912030|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55912031|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55912032|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55912033|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55912034|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912049|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912050|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55912051|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912052|NCT01453595|Dactolisib|dactolisib|mesh-list
55912053|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912054|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55912055|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55912056|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912057|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56130911|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
55912058|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
55912059|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912060|NCT04124198|Nimorazole|nimorazole|mesh-list
55912061|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55912062|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55912063|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55912064|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912065|NCT01453205|Rituximab|rituximab|mesh-list
55912066|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55912067|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912068|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
55912069|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912070|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198506|NCT01513083|Maytansine|maytansine|mesh-list
55726422|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
55912077|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
55912078|NCT01452347|Warfarin|warfarin|mesh-list
56130970|NCT03012360|Linezolid|linezolid|mesh-list
55912079|NCT01452347|Dabigatran|dabigatran|mesh-list
55912080|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
55912081|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
55912082|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55912083|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
55912084|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912085|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912086|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
55912087|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
55912088|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912089|NCT01451723|Protective Agents|protective agents|mesh-ancestor
55912090|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912091|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55912092|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55912142|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55912143|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55912144|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912145|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55912146|NCT01468987|Insulin|insulin|mesh-list
55912147|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55912148|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
56131091|NCT04393584|Leucovorin|leucovorin|mesh-list
55912218|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912219|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912220|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
55912253|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912254|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912256|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55912257|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55912258|NCT03026725|Calcium|calcium|mesh-list
55912259|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55912282|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55912283|NCT01452529|Narcotics|narcotics|mesh-ancestor
55912284|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912285|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912286|NCT01452529|Analgesics|analgesics|mesh-ancestor
55912287|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
55912288|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912289|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
55912290|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
55912291|NCT01560416|Fulvestrant|fulvestrant|mesh-list
55912292|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56131170|NCT03884556|Gemcitabine|gemcitabine|mesh-list
55912293|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912294|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55912295|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55912296|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
55912297|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912298|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912299|NCT01685372|Vaccines|vaccines|mesh-list
55912300|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
55742968|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
55912301|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912302|NCT01685138|Ceritinib|ceritinib|mesh-list
55912303|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912304|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55912305|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912306|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912307|NCT01685060|Ceritinib|ceritinib|mesh-list
55912308|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912309|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55912310|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912311|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912312|NCT03887936|Testosterone|testosterone|mesh-list
56198507|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56198508|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726499|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
55912315|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912316|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912318|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55912319|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131229|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912320|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
55912321|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912322|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55912323|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
55912324|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912325|NCT01683266|Insulin|insulin|mesh-list
55912326|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55912327|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
55912328|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55912403|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55912404|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55912405|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55912406|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
56131261|NCT04392648|Dexamethasone|dexamethasone|mesh-list
55912407|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912408|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912409|NCT01493557|Pantoprazole|pantoprazole|mesh-list
55912410|NCT01493557|Dabigatran|dabigatran|mesh-list
55912411|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
55912412|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55912413|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
55912414|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912415|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912416|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
55912417|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55912418|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55912419|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55912420|NCT01451749|Donepezil|donepezil|mesh-list
55912421|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55912422|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912423|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912424|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
55912425|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131356|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55912426|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912427|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
55912428|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55912429|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
55912430|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912431|NCT01467505|Interferons|interferons|mesh-list
55912432|NCT01467505|Ribavirin|ribavirin|mesh-list
55912433|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
56131419|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
55912434|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
55912435|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55912436|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56131429|NCT01450410|Niacin|niacin|mesh-list
55912437|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912438|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
55912439|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912440|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
55912441|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912442|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
55912443|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912444|NCT01449929|Ritonavir|ritonavir|mesh-list
55912445|NCT01449929|Darunavir|darunavir|mesh-list
55912446|NCT01449929|Dolutegravir|dolutegravir|mesh-list
55912480|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55912481|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55912482|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
56131472|NCT02947386|Nivolumab|nivolumab|mesh-list
55912483|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912484|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912485|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55912486|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55912487|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
55912488|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
55912489|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198510|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
55912490|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55912491|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
55912492|NCT01451515|Hormones|hormones|mesh-ancestor
55912493|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912494|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55912495|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55912496|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55912497|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55912498|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912499|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55912500|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
55912501|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55912502|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55912503|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
55912504|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55912505|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55912506|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55912507|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
55912508|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912509|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
55912510|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
55912511|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
55912512|NCT01576406|Crizotinib|crizotinib|mesh-list
55912513|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131653|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
55912514|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55912515|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912516|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912517|NCT01576172|Prednisone|prednisone|mesh-list
55912518|NCT01576172|Cortisone|cortisone|mesh-list
55912519|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
55912520|NCT01576172|Veliparib|veliparib|mesh-list
55912521|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55912522|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
55912523|NCT01576172|Hormones|hormones|mesh-ancestor
55912524|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912525|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912588|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55912589|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
55912590|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55912591|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55912593|NCT01556438|Bortezomib|bortezomib|mesh-list
55912594|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55912595|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
55912596|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
55912597|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912598|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912599|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55912600|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
55912601|NCT01556438|Hormones|hormones|mesh-ancestor
55912602|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912603|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55912604|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912605|NCT02073487|Paclitaxel|paclitaxel|mesh-list
56131705|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
55912606|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55912607|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55912608|NCT02073487|Trastuzumab|trastuzumab|mesh-list
55912609|NCT02073487|Lapatinib|lapatinib|mesh-list
55912610|NCT02073487|Pertuzumab|pertuzumab|mesh-list
55912611|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55912612|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912613|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
55912614|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
55912615|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
55912616|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912617|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55912618|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55912619|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912620|NCT01466491|Lidocaine|lidocaine|mesh-list
56228812|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912621|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
55912622|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
56198512|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
55912623|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912624|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912625|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
55912652|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55912653|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912654|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912655|NCT01449955|Sirolimus|sirolimus|mesh-list
55912656|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55912657|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912658|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55912659|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912660|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
55912661|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55912662|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
55912663|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912664|NCT01574612|Acyclovir|acyclovir|mesh-list
55912665|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
55912666|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55912667|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
55742976|NCT04502641|Docetaxel|docetaxel|mesh-list
55912668|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912669|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
55912670|NCT01573910|Ofloxacin|ofloxacin|mesh-list
55912671|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55912672|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55912673|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55912674|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912675|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55912676|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55912677|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912678|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912679|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912680|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55912681|NCT01573910|Renal Agents|renal agents|mesh-ancestor
55912682|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55912683|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56228831|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55912684|NCT01491919|Lisinopril|lisinopril|mesh-list
55804511|NCT01648101|Ezogabine|ezogabine|mesh-list
55912685|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55912686|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
55912687|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912688|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912689|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55912690|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55912691|NCT01491919|Protective Agents|protective agents|mesh-ancestor
55912692|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912693|NCT01573442|Testosterone|testosterone|mesh-list
55912694|NCT01573442|Androgens|androgens|mesh-ancestor
55912695|NCT01573442|Hormones|hormones|mesh-ancestor
55912696|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912697|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912698|NCT02319369|Azacitidine|azacitidine|mesh-list
55912699|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55912700|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
55912701|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912702|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912703|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912704|NCT01491841|Rituximab|rituximab|mesh-list
55912748|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55912749|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912750|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912751|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55912752|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
55912753|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
55912754|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912755|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912756|NCT05622123|Exenatide|exenatide|mesh-list
55912757|NCT05622123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56132005|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
55912758|NCT05622123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912759|NCT05622123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55912760|NCT05622123|Incretins|incretins|mesh-ancestor
55912761|NCT05622123|Hormones|hormones|mesh-ancestor
56198513|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198514|NCT01513174|Olaparib|olaparib|mesh-list
55912762|NCT05622123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912764|NCT01553084|Varenicline|varenicline|mesh-list
55912835|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912836|NCT01552694|Incretins|incretins|mesh-ancestor
55912837|NCT01552694|Hormones|hormones|mesh-ancestor
56132060|NCT02716974|Docetaxel|docetaxel|mesh-list
55912838|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912839|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55912840|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
55912841|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912842|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912843|NCT01464931|Denosumab|denosumab|mesh-list
55912844|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55912845|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912846|NCT01536392|Ondansetron|ondansetron|mesh-list
56132112|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
55912847|NCT01536392|Granisetron|granisetron|mesh-list
55912848|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
55912849|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
55912850|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912851|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912852|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55912853|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
55912854|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
55912855|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55912856|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
56132171|NCT02666742|Aspirin|aspirin|mesh-list
55912857|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912858|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912859|NCT01536392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55912860|NCT01536392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55912861|NCT01536392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912862|NCT01536392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55912863|NCT01536392|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55912864|NCT04767295|Paclitaxel|paclitaxel|mesh-list
55912865|NCT04767295|Carboplatin|carboplatin|mesh-list
55912866|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55912867|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912868|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
55912869|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
55912870|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
55912871|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912872|NCT02118831|Bevacizumab|bevacizumab|mesh-list
55912873|NCT02118831|Ranibizumab|ranibizumab|mesh-list
55912874|NCT02118831|Aflibercept|aflibercept|mesh-list
55912875|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55912876|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912877|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55912878|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55912879|NCT02118831|Growth Substances|growth substances|mesh-ancestor
56132284|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55912898|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912900|NCT05621655|Immunologic Factors|immunologic factors|mesh-ancestor
55912901|NCT05621655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912902|NCT05621499|Lenvatinib|lenvatinib|mesh-list
55912903|NCT05621499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912904|NCT05621499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55912905|NCT05621499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912906|NCT05621499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912907|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
55912908|NCT01490125|Albuterol|albuterol|mesh-list
55912909|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
55912910|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55912911|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
55912912|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912913|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912914|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55912915|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
55912916|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
55912917|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55912918|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
55912919|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912920|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198516|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56198517|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912921|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
55912922|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55912923|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55912924|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55912925|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55912926|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
55912927|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55912928|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55912929|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
55912930|NCT00491751|Atorvastatin|atorvastatin|mesh-list
55912931|NCT00491751|Vitamins|vitamins|mesh-ancestor
55912958|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
55912959|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912960|NCT05560035|Lidocaine|lidocaine|mesh-list
55912961|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
55912962|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
55912963|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912964|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912965|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
55912966|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912967|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55912968|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56132452|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55912969|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55912970|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912971|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912973|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
55912974|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55912975|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55912976|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55912977|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912978|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912979|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
55912980|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
55912981|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912982|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912983|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55913024|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913026|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913027|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913028|NCT00501891|Growth Substances|growth substances|mesh-ancestor
55913029|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913030|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913031|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913032|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
55742983|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
55913069|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55913070|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
55913071|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55913072|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913073|NCT05418777|Renal Agents|renal agents|mesh-ancestor
55913074|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
55913075|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55913076|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55913077|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55913078|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132541|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913079|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913080|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55913081|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55913082|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55913083|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55913084|NCT00505635|Interferons|interferons|mesh-list
55913085|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
55913086|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
55913087|NCT00505635|Thalidomide|thalidomide|mesh-list
55913088|NCT00505635|Cisplatin|cisplatin|mesh-list
55913089|NCT00505635|Temozolomide|temozolomide|mesh-list
55913090|NCT00505635|Interleukin-2|interleukin-2|mesh-list
55913091|NCT00505635|Vinblastine|vinblastine|mesh-list
55913092|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198518|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132607|NCT01943994|Psilocybin|psilocybin|mesh-list
56198519|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913094|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913095|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913096|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
55913097|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913099|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913100|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55913101|NCT00505635|Analgesics|analgesics|mesh-ancestor
55913102|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
55913103|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913104|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913105|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
55913106|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55913107|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913108|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56132663|NCT05578950|Itraconazole|itraconazole|mesh-list
55913109|NCT00505635|Growth Substances|growth substances|mesh-ancestor
55913110|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913111|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55913112|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
55913113|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
55913114|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
55913115|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55913116|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55913160|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913161|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913162|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913163|NCT00514137|Growth Substances|growth substances|mesh-ancestor
55913164|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913165|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913166|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55913167|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913168|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913170|NCT00514215|Sargramostim|sargramostim|mesh-list
55913171|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
55913172|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913173|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913174|NCT03912909|Empagliflozin|empagliflozin|mesh-list
55913175|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55913176|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913177|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55913178|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913180|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55913181|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55913183|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
55913184|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913185|NCT02130063|Hematinics|hematinics|mesh-ancestor
55913186|NCT00515697|Ramucirumab|ramucirumab|mesh-list
55913187|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913188|NCT00516165|Everolimus|everolimus|mesh-list
55913189|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913190|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913191|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
55913192|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913193|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55913194|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913195|NCT04926285|Venetoclax|venetoclax|mesh-list
55913196|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
56132867|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55913197|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913198|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55913199|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55913200|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913201|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913202|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
55913203|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913204|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913205|NCT02132169|Cetirizine|cetirizine|mesh-list
55913206|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55913207|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56132912|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
55913208|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56198521|NCT01513200|Heparin|heparin|mesh-list
56198522|NCT01513200|Calcium heparin|calcium heparin|mesh-list
56198523|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
56198524|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56198525|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56198526|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198527|NCT01513499|Oxytocin|oxytocin|mesh-list
56198528|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
56198529|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56198530|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198531|NCT01513525|Liraglutide|liraglutide|mesh-list
56198532|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56198533|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198534|NCT01513525|Incretins|incretins|mesh-ancestor
56198536|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198537|NCT01513564|Morphine|morphine|mesh-list
56198538|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198539|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198540|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56132963|NCT01331148|Vitamin D|vitamin d|mesh-list
56198541|NCT01513564|Narcotics|narcotics|mesh-ancestor
56198542|NCT01513564|Analgesics|analgesics|mesh-ancestor
56198543|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
56198544|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198545|NCT01513603|Cytarabine|cytarabine|mesh-list
56198546|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
56198547|NCT01513603|Cladribine|cladribine|mesh-list
55913209|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
55913210|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
55913211|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913212|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913213|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913214|NCT03174405|Avelumab|avelumab|mesh-list
55913215|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913216|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913217|NCT00522795|Paclitaxel|paclitaxel|mesh-list
55913262|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913264|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913265|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913266|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
55913267|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55913268|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55913269|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55913270|NCT00525525|Bevacizumab|bevacizumab|mesh-list
55913271|NCT00525525|Temozolomide|temozolomide|mesh-list
55913272|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55913273|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913274|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913275|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56198548|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56198549|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
56198550|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198551|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198552|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
56198553|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198554|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56198555|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
56198556|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198557|NCT01513603|Analgesics|analgesics|mesh-ancestor
56198558|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
56198559|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133192|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56198560|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56198561|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56198562|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913276|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913277|NCT00525525|Growth Substances|growth substances|mesh-ancestor
55913278|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913279|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913384|NCT01448213|Protective Agents|protective agents|mesh-ancestor
55913385|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55913386|NCT01448057|Acetaminophen|acetaminophen|mesh-list
55913387|NCT01448057|Dimethindene|dimethindene|mesh-list
55913388|NCT01448057|Phenylephrine|phenylephrine|mesh-list
55913389|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
55913390|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55913391|NCT01448057|Analgesics|analgesics|mesh-ancestor
55913392|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
55913393|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913394|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913395|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
55913396|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913397|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55913398|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
55913399|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
55913400|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
55913401|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55913402|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
55913403|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
55913404|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55727392|NCT04927949|Cangrelor|cangrelor|mesh-list
55913405|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55913406|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55913407|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
55913408|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913409|NCT01448057|Protective Agents|protective agents|mesh-ancestor
55913410|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
55913411|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
55913412|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55913413|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
55913414|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
55913415|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55913416|NCT05246631|Dexamethasone|dexamethasone|mesh-list
55860299|NCT00691600|Trimethoprim|trimethoprim|mesh-list
55913417|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
55913418|NCT05246631|Haloperidol|haloperidol|mesh-list
55913419|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
55913420|NCT05246631|BB 1101|bb 1101|mesh-list
55913421|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55913422|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
55913423|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
55913424|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133423|NCT05605314|Antifungal Agents|antifungal agents|mesh-ancestor
55913425|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198563|NCT01513668|Acetaminophen|acetaminophen|mesh-list
56198564|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198565|NCT01513668|Analgesics|analgesics|mesh-ancestor
56198566|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
56198567|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198568|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198569|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
56198570|NCT01513681|Lamotrigine|lamotrigine|mesh-list
56198571|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
56198572|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56198573|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56198574|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133482|NCT00054756|Hormones|hormones|mesh-list
56198575|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56198576|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198577|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55913426|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55913427|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
55913429|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55913430|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55913448|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913450|NCT01798875|Metformin|metformin|mesh-list
55913451|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
55913452|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
55913453|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55913454|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913455|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55913456|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55913457|NCT05362851|Celecoxib|celecoxib|mesh-list
55913458|NCT05362851|Tramadol|tramadol|mesh-list
55913459|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55913460|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55913461|NCT05362851|Analgesics|analgesics|mesh-ancestor
55913462|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
55913463|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913464|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913465|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55913466|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913467|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55913468|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55913469|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133576|NCT04880850|Insulin|insulin|mesh-list
55913470|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913471|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55913472|NCT05362851|Narcotics|narcotics|mesh-ancestor
55913473|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55913474|NCT04408235|Enoxaparin|enoxaparin|mesh-list
55913475|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
55913476|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55913477|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55913478|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913479|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
55913480|NCT03517137|Dacarbazine|dacarbazine|mesh-list
55913481|NCT03517137|Etoposide|etoposide|mesh-list
55913482|NCT03517137|Doxorubicin|doxorubicin|mesh-list
55913483|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55913484|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55913485|NCT03517137|Vinblastine|vinblastine|mesh-list
55913486|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913487|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
55913488|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198578|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55727100|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55913589|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
55913590|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55913591|NCT05219877|Levofloxacin|levofloxacin|mesh-list
55913592|NCT05219877|Ofloxacin|ofloxacin|mesh-list
55913593|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55913594|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913595|NCT05219877|Renal Agents|renal agents|mesh-ancestor
55913596|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133727|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55913607|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913608|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913609|NCT05214339|Growth Substances|growth substances|mesh-ancestor
55913610|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913611|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913612|NCT02738229|Valacyclovir|valacyclovir|mesh-list
55913613|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
55913614|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913615|NCT01444781|Vaccines|vaccines|mesh-list
55913616|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55913617|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
55913618|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913619|NCT02471391|Venetoclax|venetoclax|mesh-list
55913620|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913621|NCT02431845|Fluoxetine|fluoxetine|mesh-list
55913622|NCT02431845|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55913623|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55913624|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55913625|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913626|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913627|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
55913628|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133776|NCT01897116|Vemurafenib|vemurafenib|mesh-list
55913629|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55913630|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
55913631|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55913632|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55913633|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55913634|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913635|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55913637|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55913638|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55913639|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55913640|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913641|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913642|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913643|NCT05065671|Analgesics|analgesics|mesh-ancestor
55913644|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
55913645|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133880|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913646|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
55913647|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55913648|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
55913649|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55913650|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55913651|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55913652|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133941|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55913653|NCT01443923|Interferons|interferons|mesh-list
55913654|NCT01443923|Ribavirin|ribavirin|mesh-list
55913655|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
55913656|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
55913657|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55913658|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913659|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
55913677|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
55913678|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913679|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55913680|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913681|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913682|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913683|NCT00573261|Pregabalin|pregabalin|mesh-list
56229415|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913684|NCT00573261|Analgesics|analgesics|mesh-ancestor
55913685|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
55913686|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913687|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198579|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198580|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56126358|NCT05581992|Omeprazole|omeprazole|mesh-list
56198581|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56198583|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
56198584|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56198585|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56198586|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198587|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56198588|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198589|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56198590|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56198591|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198592|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55727182|NCT03531437|Progestins|progestins|mesh-ancestor
55913688|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
55913689|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55913690|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55913691|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913692|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55913693|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55913694|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55913695|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55913696|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55913697|NCT04315233|Belinostat|belinostat|mesh-list
55913698|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913699|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55913700|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913701|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134046|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913702|NCT04268199|Bortezomib|bortezomib|mesh-list
55913703|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913705|NCT04514211|Sevoflurane|sevoflurane|mesh-list
55913706|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55913707|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55913708|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913709|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55913710|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
55913711|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
55913712|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55913713|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55913714|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
55913715|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55913716|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229489|NCT01699594|Mannitol|mannitol|mesh-list
55913717|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55913738|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913739|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913740|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
55913741|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913742|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913743|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913744|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
55913745|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55913746|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55913747|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55913748|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55913749|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913750|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56198593|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56198594|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
56198595|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56198596|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198597|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134166|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
56198598|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198600|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
56198601|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198602|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56198603|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56198604|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56198605|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
56198606|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198607|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198608|NCT01513785|Amoxicillin|amoxicillin|mesh-list
56198609|NCT01513785|Rabeprazole|rabeprazole|mesh-list
56198610|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56198611|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198612|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56198613|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56198614|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56198615|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198616|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198617|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56198618|NCT01513863|Metronidazole|metronidazole|mesh-list
56229597|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
56198619|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198620|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56198621|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56198622|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56198623|NCT01513941|Interferons|interferons|mesh-list
55913751|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55913752|NCT00603993|Adalimumab|adalimumab|mesh-list
55913753|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55913754|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913755|NCT00575367|Azithromycin|azithromycin|mesh-list
55913756|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
55913757|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55913758|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55913759|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55913760|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55913761|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913762|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55913763|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55913764|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913765|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913766|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913767|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55913768|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
55913769|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55913770|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913771|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55913808|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55913809|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134263|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134264|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
56134267|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55913810|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913865|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913866|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
55913867|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
55913868|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
55913869|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913870|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913871|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
55913872|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55913873|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55913874|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
55913875|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55913876|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913877|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55913878|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55913879|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55913880|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55913881|NCT01570244|Estrogens|estrogens|mesh-ancestor
56229715|NCT01701076|Dexamethasone|dexamethasone|mesh-list
55913882|NCT01570244|Hormones|hormones|mesh-ancestor
55913883|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55913884|NCT00579813|Pioglitazone|pioglitazone|mesh-list
55913885|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55913886|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913887|NCT01549886|Rituximab|rituximab|mesh-list
55913888|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913889|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913890|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
55913891|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913892|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913893|NCT00610311|Aldesleukin|aldesleukin|mesh-list
55913894|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
55913895|NCT00610311|Fludarabine|fludarabine|mesh-list
55913896|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
55913897|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913898|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
55913899|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913901|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913955|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56134369|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55913956|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913957|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
55913958|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913959|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55913960|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55913961|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55913962|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55913963|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913964|NCT00611325|Bevacizumab|bevacizumab|mesh-list
55913966|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913967|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913968|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913969|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913970|NCT00611325|Growth Substances|growth substances|mesh-ancestor
55913971|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913972|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913973|NCT00611403|Cyclosporine|cyclosporine|mesh-list
55913974|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
55913975|NCT00611403|Cyclosporins|cyclosporins|mesh-list
55913976|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913977|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913978|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56198625|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
56198626|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
56198627|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56229779|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
56198628|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198629|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
55913979|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
55914004|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
55914005|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914006|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914007|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55914008|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
55914009|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914010|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
55914011|NCT00612339|Bevacizumab|bevacizumab|mesh-list
55914012|NCT00612339|Temozolomide|temozolomide|mesh-list
55914013|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55914014|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914015|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55914016|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55914017|NCT00612339|Growth Substances|growth substances|mesh-ancestor
55914018|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914019|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
55914020|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55914021|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
55914022|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914024|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55914025|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
55914026|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55914027|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914028|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55914050|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229880|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
55914051|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914052|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55914053|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55914054|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914055|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55914056|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55914057|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914059|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
55914060|NCT01517984|Prednisone|prednisone|mesh-list
55914061|NCT01517984|Tacrolimus|tacrolimus|mesh-list
55914062|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
55914063|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55914064|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55914065|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55914066|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914067|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
55914068|NCT01517984|Hormones|hormones|mesh-ancestor
55914069|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55914070|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914071|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55914072|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229908|NCT01702038|Rituximab|rituximab|mesh-list
55914074|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914075|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914076|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55914077|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55914078|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
55914079|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55914080|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914081|NCT00612573|Doxycycline|doxycycline|mesh-list
55914082|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55914083|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914084|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
55914085|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55914086|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55914087|NCT00614445|Pyridoxine|pyridoxine|mesh-list
55914088|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
55914089|NCT00614445|Doxylamine|doxylamine|mesh-list
55914090|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
55914091|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
56198630|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198631|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
56198632|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198633|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
56198634|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198635|NCT01514019|Acebutolol|acebutolol|mesh-list
55914092|NCT00614445|Vitamins|vitamins|mesh-ancestor
55914093|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
55914094|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914095|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
55914120|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55914121|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914122|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
55914123|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
55914124|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914125|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
55914126|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
55914127|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914128|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55914129|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914130|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914131|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
55914132|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55914133|NCT01532648|Budesonide|budesonide|mesh-list
55914134|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914135|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55914136|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
55914137|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914138|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914139|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55914140|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
56134697|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914141|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
55914142|NCT01532648|Hormones|hormones|mesh-ancestor
55914143|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55914144|NCT00617097|Ketorolac|ketorolac|mesh-list
55914161|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914162|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55914163|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914165|NCT01532414|Clomiphene|clomiphene|mesh-list
55914166|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
55914167|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55914168|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
55914169|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55914170|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914171|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55914172|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
55914173|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55914174|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55914175|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56134750|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
55914176|NCT01441973|Elotuzumab|elotuzumab|mesh-list
55914177|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914178|NCT02074709|Bupivacaine|bupivacaine|mesh-list
55914179|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
55914180|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
55868484|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
55914182|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914183|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
55914184|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914185|NCT03571191|Denosumab|denosumab|mesh-list
55914186|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55914187|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914188|NCT01575899|Amoxicillin|amoxicillin|mesh-list
55914189|NCT01575899|Clarithromycin|clarithromycin|mesh-list
55914190|NCT01575899|Levofloxacin|levofloxacin|mesh-list
55914191|NCT01575899|Ofloxacin|ofloxacin|mesh-list
55914192|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
55914193|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55914194|NCT01575899|Rabeprazole|rabeprazole|mesh-list
56134803|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914195|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55914196|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914197|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56198636|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56198637|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56198638|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
56198639|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
56198640|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198641|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198642|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55727520|NCT04842682|Diazepam|diazepam|mesh-list
55914198|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914199|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914200|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55914234|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55914235|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55914236|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55914237|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55914238|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914239|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
55914240|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914241|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914242|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55914243|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55914244|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914268|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55914270|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914271|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914272|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914273|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
56230120|NCT01703390|Cetuximab|cetuximab|mesh-list
55914274|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55914275|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
55914276|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55914277|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55914278|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55914279|NCT03179163|Enalapril|enalapril|mesh-list
55914280|NCT03179163|Captopril|captopril|mesh-list
55914281|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55914282|NCT03179163|Diuretics|diuretics|mesh-ancestor
55914283|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
55914284|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914285|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55914286|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55914287|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914288|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55914289|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
55914290|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914291|NCT01440803|Teriparatide|teriparatide|mesh-list
55914292|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55914293|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914294|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55914295|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
55914323|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134877|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
56134878|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134887|NCT02102100|Menthol|menthol|mesh-list
55914324|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914325|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
55914326|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914327|NCT01516970|Ritonavir|ritonavir|mesh-list
55914328|NCT01516970|Lopinavir|lopinavir|mesh-list
55914329|NCT01516970|Darunavir|darunavir|mesh-list
55914334|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
55914335|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134914|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134918|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
55914336|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914337|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55914338|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56198644|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56198645|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
56198646|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198647|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198648|NCT01514110|Paclitaxel|paclitaxel|mesh-list
56198649|NCT01514110|Carboplatin|carboplatin|mesh-list
56198650|NCT01514110|Everolimus|everolimus|mesh-list
56198651|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56198652|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198653|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
56198654|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
55727586|NCT05206084|Sirolimus|sirolimus|mesh-list
55914339|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
55914340|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134954|NCT00127218|Vitamins|vitamins|mesh-ancestor
55914341|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55914365|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914366|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55914367|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914368|NCT00668811|Sunitinib|sunitinib|mesh-list
55914369|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914370|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55914371|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55914372|NCT00668811|Growth Substances|growth substances|mesh-ancestor
55914373|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914374|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
55914375|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55914376|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914377|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914378|NCT02776605|Prednisone|prednisone|mesh-list
55914379|NCT02776605|Methotrexate|methotrexate|mesh-list
55914380|NCT02776605|Vincristine|vincristine|mesh-list
55914381|NCT02776605|Daunorubicin|daunorubicin|mesh-list
55914382|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
55914383|NCT02776605|Ponatinib|ponatinib|mesh-list
55914384|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914385|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
55914386|NCT02776605|Hormones|hormones|mesh-ancestor
55914387|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55914388|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914416|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
55914417|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914418|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914419|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55914420|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55914421|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55914422|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914423|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914424|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914425|NCT00669279|Atenolol|atenolol|mesh-list
55914426|NCT00669279|Carvedilol|carvedilol|mesh-list
55914427|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55914428|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55914429|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914430|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914431|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914432|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914433|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56135189|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56135194|NCT00324870|Vorinostat|vorinostat|mesh-list
55914463|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55914464|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
55914465|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727641|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
55914466|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55914467|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55914473|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
55914474|NCT01546688|Zonisamide|zonisamide|mesh-list
55914475|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
55914476|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55914477|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55914493|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55914494|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914495|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55914496|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
55914497|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55914498|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
55914499|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914500|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
55914501|NCT04105946|Remifentanil|remifentanil|mesh-list
55914502|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55914503|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914504|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914505|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914506|NCT04105946|Analgesics|analgesics|mesh-ancestor
55914507|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
55914508|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914509|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55914510|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55914511|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55914512|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914513|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914514|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135281|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
55914515|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55914516|NCT04105946|Narcotics|narcotics|mesh-ancestor
55914517|NCT01440569|Darunavir|darunavir|mesh-list
55914518|NCT01440569|Cobicistat|cobicistat|mesh-list
55914519|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56230302|NCT01704638|Protective Agents|protective agents|mesh-ancestor
55914520|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55914521|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
55914522|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914523|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914524|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55914525|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55914526|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
55914527|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914528|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55914529|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55914531|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
55914532|NCT00629499|Trastuzumab|trastuzumab|mesh-list
55914533|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55914534|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914569|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914570|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914572|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
55914573|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55914598|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914600|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
55914601|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914602|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914603|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914604|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55914605|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914606|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914607|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55914608|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
55914609|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55914610|NCT00635817|Leuprolide|leuprolide|mesh-list
55914611|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55914612|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
55914613|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56198655|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
55802043|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198658|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
56198659|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198660|NCT01514123|Bevacizumab|bevacizumab|mesh-list
56198661|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56198662|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198663|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56198664|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56198665|NCT01514123|Growth Substances|growth substances|mesh-ancestor
56198666|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198667|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
56198668|NCT01514175|Ibuprofen|ibuprofen|mesh-list
56198669|NCT01514175|Ketorolac|ketorolac|mesh-list
56198670|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56198671|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198672|NCT01514175|Analgesics|analgesics|mesh-ancestor
56198673|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
56198674|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198675|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198676|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198677|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198678|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55914614|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914615|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55914616|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914617|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
55914618|NCT01439945|Antacids|antacids|mesh-ancestor
56135472|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914619|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914620|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55914707|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914709|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914710|NCT00675987|Losartan|losartan|mesh-list
55914711|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55914712|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55914713|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55914714|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55914715|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914716|NCT00639717|Etanercept|etanercept|mesh-list
55914717|NCT00639717|Methoxsalen|methoxsalen|mesh-list
55914718|NCT00639717|Tacrolimus|tacrolimus|mesh-list
55914719|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55914720|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
55914721|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914722|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55914745|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55914746|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55914747|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55914748|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198679|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198680|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198681|NCT01514188|Doxorubicin|doxorubicin|mesh-list
56198682|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56198683|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198684|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56198685|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56198686|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198687|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198688|NCT01514227|Aspirin|aspirin|mesh-list
56198689|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56198690|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198691|NCT01514227|Analgesics|analgesics|mesh-ancestor
56198692|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
56135651|NCT00360828|Irinotecan|irinotecan|mesh-list
56198693|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198694|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198695|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198696|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198697|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55914749|NCT01571453|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55914750|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
55914751|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55914756|NCT04120961|Bivalirudin|bivalirudin|mesh-list
55914757|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
55914758|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55914759|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
55914760|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914761|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914762|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
55914763|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55914764|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55914765|NCT04410263|Dimercaprol|dimercaprol|mesh-list
55914766|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
55914767|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
55914768|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914769|NCT01444651|Tadalafil|tadalafil|mesh-list
55914797|NCT01438151|Infliximab|infliximab|mesh-list
55914798|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
55914799|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55914800|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914801|NCT02141451|Rituximab|rituximab|mesh-list
55914802|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55914803|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914804|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
55914805|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135781|NCT00314106|Aldesleukin|aldesleukin|mesh-list
55914806|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914807|NCT01418365|Metronidazole|metronidazole|mesh-list
55914808|NCT01418365|Mesalamine|mesalamine|mesh-list
55914809|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914810|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55914811|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55914812|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56198698|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56198699|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198700|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56198701|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56135838|NCT02405676|Cytarabine|cytarabine|mesh-list
56198702|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198703|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
56198704|NCT01514266|Curcumin|curcumin|mesh-list
56198705|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56198706|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198707|NCT01514266|Analgesics|analgesics|mesh-ancestor
56198708|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
56198709|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198710|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198711|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198712|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198713|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198714|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198715|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198716|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
56198717|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56198718|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
56198719|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56198720|NCT01514487|Liraglutide|liraglutide|mesh-list
56198721|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56198722|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198723|NCT01514487|Incretins|incretins|mesh-ancestor
56198724|NCT01514487|Hormones|hormones|mesh-ancestor
56198725|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198726|NCT01514695|Fentanyl|fentanyl|mesh-list
56198727|NCT01514695|Midazolam|midazolam|mesh-list
56198728|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56198729|NCT01514695|Narcotics|narcotics|mesh-ancestor
56198730|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56198731|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198739|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56198740|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56198741|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56136003|NCT00373386|Hormones|hormones|mesh-list
56198742|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56198743|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
56198744|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
56198745|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198748|NCT01514721|Travoprost|travoprost|mesh-list
56198749|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198750|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55914813|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55914814|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914847|NCT01437995|Xhance|xhance|mesh-list
55914848|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55914849|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55914850|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914851|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55914852|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
55914853|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136041|NCT00402714|Pentostatin|pentostatin|mesh-list
56136042|NCT00402714|Methoxsalen|methoxsalen|mesh-list
55914854|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914855|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55914856|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
55914877|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55914878|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914879|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55914880|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55914881|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
55914882|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55914883|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55914884|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55914885|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914886|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55914887|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55914888|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
55914889|NCT01799109|Albuterol|albuterol|mesh-list
55914890|NCT01799109|Analgesics|analgesics|mesh-ancestor
55914891|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
55914892|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914893|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914894|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
55914895|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914896|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55914897|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
56230596|NCT01706510|Clopidogrel|clopidogrel|mesh-list
55914898|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55914899|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55914900|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914901|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55914902|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
55914903|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55914904|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55914905|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
55914906|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55914907|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
55914908|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55914942|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
55914943|NCT01439347|Vincristine|vincristine|mesh-list
55914944|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55914945|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914946|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
56136167|NCT00382824|Ubiquinone|ubiquinone|mesh-list
55914947|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
56198751|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56198752|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
56198753|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56198754|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198755|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56198756|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56198757|NCT01514812|Digoxin|digoxin|mesh-list
56198758|NCT01514812|Darexaban|darexaban|mesh-list
56198759|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56198760|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56198761|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198762|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198763|NCT01514812|Protective Agents|protective agents|mesh-ancestor
56198764|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198765|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56198766|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
56198767|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56198769|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
56198770|NCT01514825|Darexaban|darexaban|mesh-list
56198771|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55914948|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
55914949|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914950|NCT00680823|Ropivacaine|ropivacaine|mesh-list
55914951|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
55914952|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
55915011|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55915012|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55915035|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915036|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55915037|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55915038|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
55915039|NCT00654069|Niacin|niacin|mesh-list
55915040|NCT00654069|Niacinamide|niacinamide|mesh-list
55915041|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
55915042|NCT00654069|Oxycodone|oxycodone|mesh-list
55915043|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55915044|NCT00654069|Narcotics|narcotics|mesh-ancestor
55915045|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915046|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915047|NCT00654069|Analgesics|analgesics|mesh-ancestor
55915048|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
56136282|NCT00410904|Pemetrexed|pemetrexed|mesh-list
55915049|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915050|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55915051|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
55915052|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915053|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55915054|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
55915055|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
55915056|NCT00654069|Vitamins|vitamins|mesh-ancestor
55915057|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
55915058|NCT00654147|Ritonavir|ritonavir|mesh-list
55915059|NCT00654147|Lopinavir|lopinavir|mesh-list
55915060|NCT00654147|Tenofovir|tenofovir|mesh-list
55915061|NCT00654147|Emtricitabine|emtricitabine|mesh-list
55915062|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
56136333|NCT00412464|PENTA|penta|mesh-list
55915063|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55915064|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56198772|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
56198773|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56198774|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
56198775|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198776|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198777|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
56198778|NCT01514838|Acarbose|acarbose|mesh-list
56198779|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
56198780|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56198781|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198782|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198783|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56198784|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198785|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56198786|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
56198787|NCT01514851|Calcium|calcium|mesh-list
56198788|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56198789|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198790|NCT01514851|Antacids|antacids|mesh-ancestor
56198791|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198792|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56198793|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
56198794|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
56198795|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56198796|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56230693|NCT01707251|Ibuprofen|ibuprofen|mesh-list
56230695|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56198797|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198798|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198799|NCT01514903|Urological Agents|urological agents|mesh-ancestor
56198800|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
56198801|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56198802|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198803|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56198804|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56198805|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198806|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198809|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
56198810|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
56198813|NCT01514942|Manganese|manganese|mesh-list
56198814|NCT01514942|Hematinics|hematinics|mesh-ancestor
56198815|NCT01514942|Vitamins|vitamins|mesh-ancestor
56198816|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
56198817|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198818|NCT01514942|Trace Elements|trace elements|mesh-ancestor
56198819|NCT01514968|Cyclosporine|cyclosporine|mesh-list
56198820|NCT01514968|Ritonavir|ritonavir|mesh-list
56198821|NCT01514968|Cyclosporins|cyclosporins|mesh-list
55728007|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
55915065|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
55915066|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915125|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136470|NCT03531918|Lenograstim|lenograstim|mesh-list
55915127|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55915128|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
55915129|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55915130|NCT00656487|Rimonabant|rimonabant|mesh-list
55915131|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55915132|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
55915133|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55915134|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915135|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915136|NCT00656487|Hormones|hormones|mesh-ancestor
55915137|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55915138|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915139|NCT01438411|Cholic Acids|cholic acids|mesh-list
55915140|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55915141|NCT01438177|Chloroquine|chloroquine|mesh-list
55915142|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
55915143|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55915144|NCT01438177|Bortezomib|bortezomib|mesh-list
55915168|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55915169|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55915170|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915171|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915172|NCT01436201|Protective Agents|protective agents|mesh-ancestor
55915173|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915174|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55915175|NCT01437397|Bromides|bromides|mesh-list
55915176|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
55915177|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55915178|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
55915179|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915180|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915181|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55915182|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
55915183|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55915184|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55915185|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55915186|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
55915187|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915188|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915189|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
55915190|NCT04070833|Vitamin D|vitamin d|mesh-list
55915191|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
55915192|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
55915193|NCT04070833|Vitamins|vitamins|mesh-list
55915194|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
55915195|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915196|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55915197|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56198822|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198823|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198824|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56198825|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
56198826|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198827|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
56198828|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198829|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
56198830|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56198831|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55728407|NCT00646204|Memantine|memantine|mesh-list
56198833|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56198834|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
56198835|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56198836|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56198837|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
56198838|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56198839|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56198840|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
56198841|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198842|NCT01515020|Vancomycin|vancomycin|mesh-list
56198843|NCT01515020|Daptomycin|daptomycin|mesh-list
56198844|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56198845|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198861|NCT01515228|Paclitaxel|paclitaxel|mesh-list
56198862|NCT01515228|Everolimus|everolimus|mesh-list
56198863|NCT01515228|Cilostazol|cilostazol|mesh-list
56198864|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55915198|NCT01442155|Capecitabine|capecitabine|mesh-list
55915214|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915215|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915216|NCT01419665|Rituximab|rituximab|mesh-list
55915217|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915218|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198896|NCT01515397|Polygeline|polygeline|mesh-list
56198937|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198938|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56198939|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56198940|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136730|NCT00429702|Ondansetron|ondansetron|mesh-list
56198941|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198942|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56198943|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56198944|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56198945|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56198946|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56198947|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56198948|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56198949|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56198950|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56198951|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56198952|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
56198953|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56198954|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56198955|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
56198956|NCT01515826|Dexamethasone|dexamethasone|mesh-list
56198957|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
56198958|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56198959|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56198960|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56198961|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56198962|NCT01515826|BB 1101|bb 1101|mesh-list
56198963|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56198964|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
56198965|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
56198966|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56198967|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198968|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56198969|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
56198970|NCT01515826|Hormones|hormones|mesh-ancestor
56213211|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915219|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
55915220|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198971|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56198972|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56198973|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56198974|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
56198975|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56198976|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198977|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56198978|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198979|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56198980|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56198981|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56198982|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
56198983|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56198984|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56198985|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56198986|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56198987|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
56198988|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
56198989|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
56198990|NCT01515839|Vinpocetine|vinpocetine|mesh-list
56198991|NCT01515839|Huperzine A|huperzine a|mesh-list
56198992|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
56198993|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56198994|NCT01515839|Protective Agents|protective agents|mesh-ancestor
56198995|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56198996|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
56198997|NCT01515839|Vitamins|vitamins|mesh-ancestor
56198998|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
55915221|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915222|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
55915223|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
55915224|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
55915225|NCT01436305|Abatacept|abatacept|mesh-list
55915226|NCT01436305|Tacrolimus|tacrolimus|mesh-list
55915227|NCT01436305|Basiliximab|basiliximab|mesh-list
55915228|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55915229|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
55915230|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915231|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55915232|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915233|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915234|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55915235|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743020|NCT04282629|Milrinone|milrinone|mesh-list
55915236|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56137050|NCT00544908|Dasatinib|dasatinib|mesh-list
55915237|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
55915238|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55915239|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56198999|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
56199000|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56199001|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199002|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
56199003|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56199004|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56199005|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
56137143|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
56199006|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199007|NCT01515839|Expectorants|expectorants|mesh-ancestor
56199008|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
56199009|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56199010|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56231337|NCT01711060|Oxytocin|oxytocin|mesh-list
56199011|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
56199012|NCT01515852|Anesthetics|anesthetics|mesh-list
56199013|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56199014|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56199015|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56199016|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
56199017|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56199018|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56199019|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55915240|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55915242|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
55915243|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915244|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55915245|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
55915247|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55915248|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55915249|NCT01436305|Protective Agents|protective agents|mesh-ancestor
55915250|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915251|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55915252|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915253|NCT04069273|Paclitaxel|paclitaxel|mesh-list
55915254|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
55915255|NCT04069273|Ramucirumab|ramucirumab|mesh-list
56137322|NCT00525798|Calcitonin|calcitonin|mesh-list
55915256|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55915257|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915258|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
55915259|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
55915260|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
55915279|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
55915280|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915281|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915282|NCT01415401|Timolol|timolol|mesh-list
55915283|NCT01415401|Brinzolamide|brinzolamide|mesh-list
55915284|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915285|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915286|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55915287|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55915288|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
55915289|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915290|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915291|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55915292|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56199020|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199021|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199023|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56199024|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56199025|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56199026|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56199027|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
56199028|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56199029|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56199030|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56137491|NCT00558012|Vitamin D|vitamin d|mesh-list
56199031|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56199032|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56199033|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55807220|NCT02088541|Cytarabine|cytarabine|mesh-list
56486009|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56486010|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486011|NCT01231555|Efavirenz|efavirenz|mesh-list
56486012|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56486013|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56486014|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486015|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486016|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
56486017|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137548|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56486018|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56486019|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56486020|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56486021|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56486022|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56486023|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56486024|NCT04116528|Ketamine|ketamine|mesh-list
56486025|NCT04116528|Buprenorphine|buprenorphine|mesh-list
56486026|NCT04116528|Analgesics|analgesics|mesh-ancestor
56486027|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
56486028|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486029|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486030|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56486031|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56486032|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
56486033|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
56486034|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486035|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56486036|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56231689|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
56486037|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56486038|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486039|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56486040|NCT04116528|Narcotics|narcotics|mesh-ancestor
56486041|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56486042|NCT05288907|Lidocaine|lidocaine|mesh-list
55802317|NCT04810507|Incretins|incretins|mesh-ancestor
56486043|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
56486044|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
56486045|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486046|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486047|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
56486048|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486049|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56486050|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56486051|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56486052|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56486053|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486054|NCT03911336|Acetaminophen|acetaminophen|mesh-list
56234083|NCT01735383|Analgesics|analgesics|mesh-ancestor
56486055|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56486057|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56137643|NCT05363202|Xhance|xhance|mesh-list
56486058|NCT03911336|Analgesics|analgesics|mesh-ancestor
56486059|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
56486060|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486061|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486062|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
56486063|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486064|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486065|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56486066|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486067|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486068|NCT03850535|Cytarabine|cytarabine|mesh-list
56486069|NCT03850535|Daunorubicin|daunorubicin|mesh-list
56486070|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56486071|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
56137709|NCT05362188|Niacin|niacin|mesh-list
56486072|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486073|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486074|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
56486075|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486076|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486077|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
56486078|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486079|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56208763|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
56486080|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56486081|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56486082|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486083|NCT03850301|Etifoxine|etifoxine|mesh-list
56486084|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56486085|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56486086|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56137710|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
56137712|NCT05362188|Vitamins|vitamins|mesh-ancestor
56486087|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486088|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56486089|NCT05255367|Phenol|phenol|mesh-list
56486090|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56486091|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486092|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
56486093|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56486094|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56486095|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56486096|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486097|NCT04005690|Olaparib|olaparib|mesh-list
56486098|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56486099|NCT04005690|Onvansertib|onvansertib|mesh-list
56486100|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486101|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486102|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486103|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56486104|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56486105|NCT03678350|Trioxsalen|trioxsalen|mesh-list
56486106|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486107|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
56486108|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56486109|NCT03654053|Simvastatin|simvastatin|mesh-list
56486110|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56486111|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56486112|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
56486113|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486114|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56486115|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56486117|NCT05189223|Buprenorphine|buprenorphine|mesh-list
56486118|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56486119|NCT05189223|Narcotics|narcotics|mesh-ancestor
56486120|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486121|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486122|NCT05189223|Analgesics|analgesics|mesh-ancestor
56486123|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
56486124|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486125|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56486126|NCT03653000|Anesthetics|anesthetics|mesh-list
56486127|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
56486128|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486129|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486130|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
56231772|NCT01713179|Expectorants|expectorants|mesh-ancestor
56486131|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486133|NCT03639389|Analgesics|analgesics|mesh-list
56486134|NCT03639389|Bupivacaine|bupivacaine|mesh-list
56486135|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
56486136|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
56486137|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486138|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486139|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
56486140|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486141|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56486142|NCT03639389|Narcotics|narcotics|mesh-ancestor
56486143|NCT03950739|Treprostinil|treprostinil|mesh-list
56486144|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56486145|NCT05172531|Cisatracurium|cisatracurium|mesh-list
56486146|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56486147|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56486148|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486149|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486150|NCT03570983|Cytarabine|cytarabine|mesh-list
56486151|NCT03570983|Etoposide|etoposide|mesh-list
56486152|NCT03570983|Melphalan|melphalan|mesh-list
56486153|NCT03570983|Carmustine|carmustine|mesh-list
56486154|NCT03570983|Allopurinol|allopurinol|mesh-list
56486155|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486156|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486157|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56486158|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56486159|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486160|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486161|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56486162|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
56486163|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
56486164|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486165|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486166|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
56137894|NCT03548454|Analgesics|analgesics|mesh-ancestor
56486167|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486168|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56486169|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
56486170|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56486171|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
56486172|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486173|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56486174|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
56208831|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
56486175|NCT03570983|Protective Agents|protective agents|mesh-ancestor
56486176|NCT03540758|Niacin|niacin|mesh-list
56486177|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
56486178|NCT03540758|Niacinamide|niacinamide|mesh-list
56486179|NCT03540758|Diazoxide|diazoxide|mesh-list
56486180|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56486181|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
56486182|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486183|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56486184|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
56486185|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
56486186|NCT03540758|Vitamins|vitamins|mesh-ancestor
56486187|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
56486188|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486189|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56486190|NCT03187379|Bupivacaine|bupivacaine|mesh-list
56486191|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
56486192|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
56486194|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486195|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
56486196|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486197|NCT03182231|Exenatide|exenatide|mesh-list
56486198|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56486199|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486200|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56486201|NCT03182231|Incretins|incretins|mesh-ancestor
56486202|NCT03182231|Hormones|hormones|mesh-ancestor
56486203|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486204|NCT03182192|Exenatide|exenatide|mesh-list
56486206|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486207|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56486208|NCT03182192|Incretins|incretins|mesh-ancestor
56486209|NCT03182192|Hormones|hormones|mesh-ancestor
56486210|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486212|NCT02964884|L 647318|l 647318|mesh-list
56486213|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
56486214|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56486215|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56486216|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
56486217|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486218|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56486219|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56486220|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486221|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
56486222|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56486223|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486224|NCT05098470|Metformin|metformin|mesh-list
56486225|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
56486226|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56486227|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486228|NCT02710643|Ofatumumab|ofatumumab|mesh-list
56486229|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486230|NCT05093205|Midazolam|midazolam|mesh-list
56486231|NCT05093205|Atorvastatin|atorvastatin|mesh-list
56486232|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
56486233|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56486234|NCT05093205|Estradiol|estradiol|mesh-list
56486235|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56486236|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56231962|NCT01714128|Estradiol|estradiol|mesh-list
55807586|NCT02543801|Ropivacaine|ropivacaine|mesh-list
56486237|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486238|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486239|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56486240|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56486241|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56486242|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56486243|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
56486244|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
56486245|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
56486246|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
56486247|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56486248|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486249|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56486250|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56486251|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
56486252|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56486253|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56486254|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486255|NCT05093205|Estrogens|estrogens|mesh-ancestor
56486256|NCT05093205|Hormones|hormones|mesh-ancestor
56486257|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486258|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56486259|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
56486260|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56486261|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56486262|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56486263|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56231969|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
56486264|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56486265|NCT02623751|Exemestane|exemestane|mesh-list
56486266|NCT02623751|Entinostat|entinostat|mesh-list
56486267|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486268|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56486269|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56486270|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486271|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486272|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56486273|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
56486274|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486275|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486276|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56486277|NCT02469155|Risperidone|risperidone|mesh-list
56486278|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56486279|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
56486280|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56486281|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486282|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486283|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56486284|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56208963|NCT01579461|Mirabegron|mirabegron|mesh-list
56486285|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486286|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56486287|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56486288|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
56486289|NCT02465606|Triamcinolone|triamcinolone|mesh-list
56486290|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56486291|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56486292|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
56486293|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56486294|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486295|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
56486297|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486298|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486299|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486300|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
56232018|NCT01714401|Albuterol|albuterol|mesh-list
56486301|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486302|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486303|NCT05080530|Vitamin D|vitamin d|mesh-list
56486304|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
56486305|NCT05080530|Vitamins|vitamins|mesh-ancestor
56486306|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
56486307|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486308|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56486309|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56486310|NCT00554177|Mifepristone|mifepristone|mesh-list
56486311|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56486312|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
56486313|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56486314|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486315|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56486316|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56486317|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56208986|NCT01579539|Prednisolone|prednisolone|mesh-list
56486318|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
56486319|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56486320|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56486321|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
56486322|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486323|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
56486324|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56486325|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56486326|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
56486327|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56486328|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486329|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
56486330|NCT05073627|Dabigatran|dabigatran|mesh-list
56486331|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
56486332|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56486333|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
56486334|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138194|NCT04159974|Durvalumab|durvalumab|mesh-list
56486335|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486336|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
56486337|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56486338|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486339|NCT04678739|Remdesivir|remdesivir|mesh-list
56486340|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
56486341|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486342|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
56486343|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486345|NCT03421353|Paclitaxel|paclitaxel|mesh-list
56486346|NCT03421353|Carboplatin|carboplatin|mesh-list
56486347|NCT03421353|Durvalumab|durvalumab|mesh-list
56138248|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56486348|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486349|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486350|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
56486351|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
56486352|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
56486353|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486354|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56486355|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
56486356|NCT03421353|Antiviral Agents|antiviral agents|mesh-ancestor
56486357|NCT03421353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486358|NCT03421353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486359|NCT03421353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486360|NCT03421353|Immunologic Factors|immunologic factors|mesh-ancestor
56486361|NCT03421353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486362|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56486364|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
56486365|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
56486366|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486367|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486368|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
56486369|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486370|NCT03177291|Pirfenidone|pirfenidone|mesh-list
56232165|NCT01715142|Antiviral Agents|antiviral agents|mesh-ancestor
56486372|NCT03177291|Carboplatin|carboplatin|mesh-list
56486373|NCT03177291|Pemetrexed|pemetrexed|mesh-list
56486374|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486375|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486376|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
56486377|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
56486378|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
56486379|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486380|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486381|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56486382|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56486383|NCT03177291|Analgesics|analgesics|mesh-ancestor
56486384|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
56486385|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486386|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486387|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56486388|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56486389|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486390|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486391|NCT02389985|Paclitaxel|paclitaxel|mesh-list
56486392|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56138312|NCT01168219|Azacitidine|azacitidine|mesh-list
56486393|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486394|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
56486395|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
56486396|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
56486397|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486398|NCT03147612|Cytarabine|cytarabine|mesh-list
56486399|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
56486400|NCT03147612|Rituximab|rituximab|mesh-list
56486401|NCT03147612|Methotrexate|methotrexate|mesh-list
56486402|NCT03147612|Vincristine|vincristine|mesh-list
56138389|NCT05766631|Methadone|methadone|mesh-list
56486403|NCT03147612|Blinatumomab|blinatumomab|mesh-list
56486404|NCT03147612|Ponatinib|ponatinib|mesh-list
56486406|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
56486407|NCT03147612|Antibodies|antibodies|mesh-list
56486408|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
56486409|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56486410|NCT03147612|Lenograstim|lenograstim|mesh-list
56486411|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56486412|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486413|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
56486414|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486415|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486416|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56486417|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
56486418|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486419|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486420|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56486421|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56486422|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
55743240|NCT03218137|Adenosine|adenosine|mesh-list
56486423|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56486424|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138431|NCT05766540|Metformin|metformin|mesh-list
56486426|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
56486427|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486428|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56486429|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56486430|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
56486431|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486432|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56486433|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486434|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
56486435|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56486436|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56138481|NCT05766436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138491|NCT05766384|Xenon|xenon|mesh-list
56486437|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56486438|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56486440|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56486441|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56486442|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486443|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486444|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486445|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
56486446|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56486447|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
56486448|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56486449|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486450|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56486451|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56486452|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56486453|NCT05007132|Trifluridine|trifluridine|mesh-list
56486454|NCT05007132|Bevacizumab|bevacizumab|mesh-list
56486455|NCT05007132|Panitumumab|panitumumab|mesh-list
56486456|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56486457|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486458|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56486459|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56486460|NCT05007132|Growth Substances|growth substances|mesh-ancestor
56486461|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486462|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
56486463|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
56486464|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486465|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
56486466|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486467|NCT04684017|Carboplatin|carboplatin|mesh-list
56486468|NCT04684017|Etoposide|etoposide|mesh-list
56486469|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486470|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486471|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56486472|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56486473|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486474|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486475|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
56138569|NCT05765812|Alkylating Agents|alkylating agents|mesh-ancestor
56486476|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56486477|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486478|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56486479|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486480|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
56486481|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56486482|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486483|NCT00554528|Meloxicam|meloxicam|mesh-list
56486484|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56486485|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56486486|NCT00554528|Analgesics|analgesics|mesh-ancestor
56486487|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
56486488|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486489|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486490|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486491|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486492|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56486493|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56486494|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486495|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486496|NCT04683198|Carboplatin|carboplatin|mesh-list
56486497|NCT04683198|Etoposide|etoposide|mesh-list
56486498|NCT04683198|Apatinib|apatinib|mesh-list
56486499|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486500|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486501|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56486502|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56486503|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486504|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486505|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56486506|NCT03075423|Nivolumab|nivolumab|mesh-list
56486507|NCT03075423|Ipilimumab|ipilimumab|mesh-list
56486508|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56486509|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234527|NCT01738607|Psyllium|psyllium|mesh-list
56486510|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56486511|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486512|NCT02342249|Oseltamivir|oseltamivir|mesh-list
56486513|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
56486514|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486515|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814949|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486516|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486517|NCT02339129|Ibuprofen|ibuprofen|mesh-list
56486518|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56486519|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56486520|NCT02339129|Analgesics|analgesics|mesh-ancestor
56486521|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
56486522|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486523|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486524|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486525|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486526|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56486527|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486528|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486529|NCT02884206|Valsartan|valsartan|mesh-list
56486530|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56486531|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56486532|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56486533|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56486534|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486535|NCT02331134|Lenograstim|lenograstim|mesh-list
56486536|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56486537|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
56486538|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486539|NCT04961541|Vaccines|vaccines|mesh-list
56486540|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
56486541|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486542|NCT02326454|Talaporfin|talaporfin|mesh-list
56486543|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486544|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56486545|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
56486546|NCT02871219|Lenalidomide|lenalidomide|mesh-list
56486547|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
56486548|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
56486549|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486550|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56486551|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56486552|NCT02871219|Growth Substances|growth substances|mesh-ancestor
56486553|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
56486554|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56209298|NCT01590199|Everolimus|everolimus|mesh-list
56486555|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56486556|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
56486557|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56486558|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486559|NCT02306291|Cytarabine|cytarabine|mesh-list
56486560|NCT02306291|Etoposide|etoposide|mesh-list
56486561|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
56486562|NCT02306291|Idarubicin|idarubicin|mesh-list
56486563|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486564|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486565|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56486566|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56486567|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486568|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486569|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56486570|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
56486571|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
56486572|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486573|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486574|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
56486575|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486576|NCT02306291|Analgesics|analgesics|mesh-ancestor
56486577|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
56486578|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486579|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56486580|NCT02302079|Ranibizumab|ranibizumab|mesh-list
56486581|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56486582|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56486583|NCT02302079|Growth Substances|growth substances|mesh-ancestor
56486584|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486585|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
56486586|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486587|NCT01210495|Axitinib|axitinib|mesh-list
56486588|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486589|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56486590|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486591|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486592|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56486593|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
56486594|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486595|NCT04678076|Ketoprofen|ketoprofen|mesh-list
56486596|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
56486597|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56486598|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56486599|NCT04678076|Analgesics|analgesics|mesh-ancestor
56139134|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56486600|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
56486601|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486602|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486603|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486604|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486605|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56486606|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486607|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486608|NCT02257619|Docetaxel|docetaxel|mesh-list
56486609|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486610|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
56486611|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
56486612|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
56486613|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486614|NCT04891302|Clevudine|clevudine|mesh-list
56486615|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
56486616|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486617|NCT02224235|Aspirin|aspirin|mesh-list
56486618|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56486619|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56486620|NCT02224235|Analgesics|analgesics|mesh-ancestor
56486621|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
56486622|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486623|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486624|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486625|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486626|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56486627|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56486628|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486629|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56486630|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56486631|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486632|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
56486633|NCT02529852|Prednisone|prednisone|mesh-list
56486634|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
56486635|NCT02529852|Doxorubicin|doxorubicin|mesh-list
56486637|NCT02529852|Vincristine|vincristine|mesh-list
56486638|NCT02529852|Lenalidomide|lenalidomide|mesh-list
56486639|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
56486640|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486641|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
56486642|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486643|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486644|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56486645|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
56486646|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866138|NCT01709305|Metformin|metformin|mesh-list
56486647|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486648|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56486649|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56486650|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56486651|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56486652|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486653|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56209403|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
56486655|NCT02529852|Hormones|hormones|mesh-ancestor
56486656|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486657|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56486658|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56234677|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
56486659|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
56486660|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139313|NCT05091346|Lenvatinib|lenvatinib|mesh-list
56486661|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
56486662|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56486663|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56486664|NCT02529852|Growth Substances|growth substances|mesh-ancestor
56486665|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
56486666|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56486667|NCT02525757|Paclitaxel|paclitaxel|mesh-list
56486668|NCT02525757|Carboplatin|carboplatin|mesh-list
56486669|NCT02525757|Atezolizumab|atezolizumab|mesh-list
56486670|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486671|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486672|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
56486673|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
56486674|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
56486675|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486676|NCT02221232|Ethanol|ethanol|mesh-list
56486677|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
56486678|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56486679|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56486680|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486681|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486682|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486683|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
56486684|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
56486685|NCT02465268|Molgramostim|molgramostim|mesh-list
56486686|NCT02465268|Sargramostim|sargramostim|mesh-list
56486687|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
56486688|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486689|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486690|NCT02206100|Enoxaparin|enoxaparin|mesh-list
56486691|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
56486692|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56486693|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56486694|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486695|NCT04669145|Ropivacaine|ropivacaine|mesh-list
56486696|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
56486697|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
56486698|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486699|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486700|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
56486701|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486702|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
56486703|NCT01231516|Dolutegravir|dolutegravir|mesh-list
56486704|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56486705|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56486706|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
56139383|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139384|NCT05037552|Hemostatics|hemostatics|mesh-list
56139385|NCT05037552|Coagulants|coagulants|mesh-ancestor
56486707|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486708|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56486709|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56486710|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486711|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486713|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
56486714|NCT01962636|Fludarabine|fludarabine|mesh-list
56486715|NCT01962636|Cyclosporins|cyclosporins|mesh-list
56486716|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486717|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
56486718|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486719|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56209442|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486720|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56486721|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
56486722|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486723|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486724|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56486725|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486726|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
56486727|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486728|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56486729|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56486730|NCT01231321|Adalimumab|adalimumab|mesh-list
56486731|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486732|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486733|NCT01722240|Liraglutide|liraglutide|mesh-list
56139473|NCT04937166|Azacitidine|azacitidine|mesh-list
56234757|NCT01739985|Hormones|hormones|mesh-ancestor
56486734|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56486735|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486736|NCT01722240|Incretins|incretins|mesh-ancestor
56486737|NCT01722240|Hormones|hormones|mesh-ancestor
56486738|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486739|NCT01666080|Fludarabine|fludarabine|mesh-list
56486740|NCT01666080|Busulfan|busulfan|mesh-list
56486741|NCT01666080|Levetiracetam|levetiracetam|mesh-list
56486742|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486743|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486744|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486745|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
56486746|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486747|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
56486748|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56486749|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56486750|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
56486751|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
56486752|NCT01210222|Trebananib|trebananib|mesh-list
56486753|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56486754|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56486755|NCT01210222|Growth Substances|growth substances|mesh-ancestor
56486756|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486757|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
56486758|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486759|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56486760|NCT01210144|Hormones|hormones|mesh-list
56486761|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56486762|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486763|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486764|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56486765|NCT01209949|Adapalene|adapalene|mesh-list
56486766|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56486767|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
56486768|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56486769|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56139580|NCT04761627|Ustekinumab|ustekinumab|mesh-list
56139582|NCT04760691|Tenofovir|tenofovir|mesh-list
56486770|NCT01209949|Analgesics|analgesics|mesh-ancestor
56486771|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
56486772|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486773|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486774|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486775|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56486776|NCT04831593|Anesthetics|anesthetics|mesh-list
56486777|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814952|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
56139617|NCT04736199|Androgens|androgens|mesh-list
56486778|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486779|NCT04667897|Ranibizumab|ranibizumab|mesh-list
56486780|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56486781|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56486782|NCT04667897|Growth Substances|growth substances|mesh-ancestor
56486783|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486784|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
56486785|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486787|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56139658|NCT04712643|Atezolizumab|atezolizumab|mesh-list
56486788|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56486789|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486790|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486791|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56486792|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56486793|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56486794|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56486795|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
56486796|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
56486797|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
56486798|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
56486799|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56486800|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486801|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
56486802|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56486803|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
56486804|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486805|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
56486806|NCT04667819|Protective Agents|protective agents|mesh-ancestor
56486807|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56486808|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56486809|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56486810|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56486811|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56486812|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
56486813|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56486814|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486815|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486816|NCT01230892|Atenolol|atenolol|mesh-list
56486817|NCT01230892|Nebivolol|nebivolol|mesh-list
56486818|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56486819|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56486820|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
56486821|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
56486822|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486823|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486824|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56486825|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56486826|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56486827|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
56209488|NCT01591226|Diuretics|diuretics|mesh-ancestor
56486828|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56486829|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139747|NCT04521335|Copper|copper|mesh-list
56139748|NCT04521335|Disulfiram|disulfiram|mesh-list
56486830|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
56486831|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56486832|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56486833|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56486834|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56486835|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56486836|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56486837|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56486838|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486839|NCT04667351|Fluorouracil|fluorouracil|mesh-list
56486840|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
56486841|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486842|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56486843|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486844|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56486845|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
56486846|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486847|NCT01230814|Metronidazole|metronidazole|mesh-list
56486849|NCT01230814|Clotrimazole|clotrimazole|mesh-list
56486850|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486851|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56486852|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56486853|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56486854|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
56486855|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56486856|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56486857|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486858|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486859|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56486860|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
55814953|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
56486861|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486862|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486863|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56486864|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56486865|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56486866|NCT01230307|Vitamin D|vitamin d|mesh-list
56486867|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
56486868|NCT01230307|Vitamins|vitamins|mesh-ancestor
56486869|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
56486870|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139909|NCT04280692|Renal Agents|renal agents|mesh-ancestor
56139910|NCT04250155|Atezolizumab|atezolizumab|mesh-list
56139911|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139912|NCT04248569|Nivolumab|nivolumab|mesh-list
56486871|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56486872|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56486873|NCT01209598|Palbociclib|palbociclib|mesh-list
56486874|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486875|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56486876|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56209490|NCT01591291|Ondansetron|ondansetron|mesh-list
56486877|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486879|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56486880|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56486881|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486882|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486883|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
56486884|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486885|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56486886|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56486887|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56486888|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56486889|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56486890|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56486891|NCT01209520|Paclitaxel|paclitaxel|mesh-list
56486892|NCT01209520|Vinorelbine|vinorelbine|mesh-list
56486893|NCT01209520|Docetaxel|docetaxel|mesh-list
56486894|NCT01209520|Cisplatin|cisplatin|mesh-list
56486895|NCT01209520|Carboplatin|carboplatin|mesh-list
56486896|NCT01209520|Pemetrexed|pemetrexed|mesh-list
56486897|NCT01209520|Azacitidine|azacitidine|mesh-list
56486898|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486899|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486900|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139969|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56139970|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139971|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139972|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139973|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139974|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139975|NCT04179162|Gemcitabine|gemcitabine|mesh-list
56139976|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
56139977|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139978|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
56139979|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139981|NCT04179162|Antiviral Agents|antiviral agents|mesh-ancestor
56486901|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
56486902|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
56486903|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486904|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486905|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56486906|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56486907|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56486908|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
56486909|NCT04805541|Tropicamide|tropicamide|mesh-list
56486910|NCT04805541|Mydriatics|mydriatics|mesh-list
56486911|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
56486912|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486913|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486914|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56486915|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56486916|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
56486917|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56486918|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486919|NCT04784754|Melatonin|melatonin|mesh-list
56486920|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
56486921|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486922|NCT04784754|Protective Agents|protective agents|mesh-ancestor
56486923|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140003|NCT04163432|Durvalumab|durvalumab|mesh-list
56486924|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56486925|NCT04666805|Tamoxifen|tamoxifen|mesh-list
56486926|NCT04666805|Toremifene|toremifene|mesh-list
56486927|NCT04666805|Letrozole|letrozole|mesh-list
56486928|NCT04666805|Anastrozole|anastrozole|mesh-list
56486929|NCT04666805|Exemestane|exemestane|mesh-list
56486930|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486931|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55818804|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
56486932|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55814954|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232776|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
56486934|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486935|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56486936|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
56486937|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209516|NCT01591668|Vesatolimod|vesatolimod|mesh-list
56486938|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486939|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56486940|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56486941|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56486942|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56486943|NCT04766853|Dexamethasone|dexamethasone|mesh-list
56486944|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
56486945|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56486946|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
56486947|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
56486948|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56486949|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486950|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56486951|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
56486952|NCT04766853|Hormones|hormones|mesh-ancestor
56486953|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56486954|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56486955|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486956|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56486957|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
56234982|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
56486958|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
56486959|NCT04766853|Protective Agents|protective agents|mesh-ancestor
56486960|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
56486961|NCT04721457|Listerine|listerine|mesh-list
56486962|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56486963|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
56486964|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56486965|NCT04721457|Eusol|eusol|mesh-list
56486966|NCT04721457|Povidone|povidone|mesh-list
56486967|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56486968|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
56486969|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
56486970|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
56486971|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56486972|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56486973|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
56486974|NCT04721457|Protective Agents|protective agents|mesh-ancestor
56486975|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56486976|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
56486977|NCT04665986|Docetaxel|docetaxel|mesh-list
56486978|NCT04665986|Vinorelbine|vinorelbine|mesh-list
56486979|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486980|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
56486981|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
56486982|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
56486983|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486984|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56486985|NCT04638309|Azacitidine|azacitidine|mesh-list
56486986|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56486987|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
56232791|NCT01718873|Fluorouracil|fluorouracil|mesh-list
56486988|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486989|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56486990|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56486991|NCT04632927|Ustekinumab|ustekinumab|mesh-list
56486992|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
56486993|NCT04665830|Evolocumab|evolocumab|mesh-list
56486994|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56486995|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56486996|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
56140192|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
56486997|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56486998|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56486999|NCT04683237|Liraglutide|liraglutide|mesh-list
56487000|NCT04683237|Megestrol|megestrol|mesh-list
56487001|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
56487002|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56487003|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487004|NCT04683237|Incretins|incretins|mesh-ancestor
56140258|NCT03783026|Analgesics|analgesics|mesh-ancestor
56487005|NCT04683237|Hormones|hormones|mesh-ancestor
55802330|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487006|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487007|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56487008|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56487009|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56487010|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
56487011|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56487012|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56487013|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56487014|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487015|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487016|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
56487017|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56487018|NCT04665362|Apatinib|apatinib|mesh-list
56140331|NCT03591731|Ipilimumab|ipilimumab|mesh-list
56140332|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140333|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140334|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56232818|NCT01718899|Growth Substances|growth substances|mesh-ancestor
56232819|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
56232820|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232821|NCT01718912|Metronidazole|metronidazole|mesh-list
56232822|NCT01718912|Nystatin|nystatin|mesh-list
56232823|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232824|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56232825|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56487019|NCT04665362|Antibodies|antibodies|mesh-list
56487020|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
56487021|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487022|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487023|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56487024|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487025|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487026|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56487027|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
56140368|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140369|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
56487028|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487029|NCT04665284|Empagliflozin|empagliflozin|mesh-list
56487030|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56487031|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487032|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56487033|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487034|NCT04432974|Anesthetics|anesthetics|mesh-list
56487035|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487036|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487038|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
56487039|NCT04664894|Velpatasvir|velpatasvir|mesh-list
56487040|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
56487041|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487042|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
56487043|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487044|NCT00557102|Leucovorin|leucovorin|mesh-list
56487045|NCT00557102|Fluorouracil|fluorouracil|mesh-list
56487046|NCT00557102|Irinotecan|irinotecan|mesh-list
56487047|NCT00557102|Cetuximab|cetuximab|mesh-list
56487048|NCT00557102|Calcium|calcium|mesh-list
56487049|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
56487050|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56487051|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487052|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
56487053|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487054|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56487055|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487056|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56487057|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
56487058|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56487059|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56487060|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487061|NCT00557102|Antidotes|antidotes|mesh-ancestor
56487062|NCT00557102|Protective Agents|protective agents|mesh-ancestor
56487063|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
56487064|NCT00557102|Vitamins|vitamins|mesh-ancestor
56487065|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
56487066|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56487067|NCT04682691|Erythromycin|erythromycin|mesh-list
56487068|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
56487069|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56487070|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
56487071|NCT04682691|Metoclopramide|metoclopramide|mesh-list
56487072|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
56487073|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
56487074|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487075|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487076|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56487077|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56487078|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56487079|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
56487080|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487081|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487082|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56487083|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487084|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56487085|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487086|NCT01209286|Blinatumomab|blinatumomab|mesh-list
56487087|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487088|NCT04663763|Capecitabine|capecitabine|mesh-list
56487089|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
56487090|NCT04663763|Antibodies|antibodies|mesh-list
56487091|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
56487092|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487093|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56487094|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
56487095|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487096|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487097|NCT04351737|Dexamethasone|dexamethasone|mesh-list
56487098|NCT04351737|Prednisolone|prednisolone|mesh-list
56487099|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56487100|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
56487101|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56487102|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
56487103|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56487104|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
56487105|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487106|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
56487107|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
56487108|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487109|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487110|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56487111|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
56487112|NCT04351737|Hormones|hormones|mesh-ancestor
56487113|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487114|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487115|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487116|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56487117|NCT04351737|Protective Agents|protective agents|mesh-ancestor
56487118|NCT04347915|Clevudine|clevudine|mesh-list
56487119|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
56140649|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487120|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487121|NCT04185051|Aticaprant|aticaprant|mesh-list
56487122|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56487123|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487124|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
56487125|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487126|NCT04171050|Anesthetics|anesthetics|mesh-list
56487127|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
56487128|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487129|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487130|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
56487131|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487132|NCT04662788|Antibodies|antibodies|mesh-list
56487133|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56487134|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
56487135|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487136|NCT04662866|Metformin|metformin|mesh-list
56487137|NCT04662866|Pioglitazone|pioglitazone|mesh-list
56487138|NCT04662866|Empagliflozin|empagliflozin|mesh-list
56487139|NCT04662866|Linagliptin|linagliptin|mesh-list
56487140|NCT04662866|Biguanides|biguanides|mesh-list
56487141|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
56487142|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56487143|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487144|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56487145|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487146|NCT04662866|Incretins|incretins|mesh-ancestor
56487147|NCT04662866|Hormones|hormones|mesh-ancestor
56487148|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487149|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56487150|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487151|NCT04662476|Vitamin D|vitamin d|mesh-list
56487152|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
56140732|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487153|NCT04662476|Vitamins|vitamins|mesh-ancestor
56487154|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
56487155|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487156|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56487157|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56487158|NCT03986424|Memantine|memantine|mesh-list
56487159|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56487160|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56487161|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
56487162|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487163|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487164|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487165|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56487166|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56487167|NCT03918252|Nivolumab|nivolumab|mesh-list
56487168|NCT03918252|Ipilimumab|ipilimumab|mesh-list
56487169|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56487170|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487171|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56487172|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487173|NCT04662125|Acetaminophen|acetaminophen|mesh-list
56487174|NCT04662125|Prednisolone|prednisolone|mesh-list
56487175|NCT04662125|Pregabalin|pregabalin|mesh-list
56487176|NCT04662125|Caffeine|caffeine|mesh-list
56487177|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487178|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
56487179|NCT04662125|Hormones|hormones|mesh-ancestor
56487180|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209579|NCT01592019|Diclofenac|diclofenac|mesh-list
56487181|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487182|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487183|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487184|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487186|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
56487187|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
56487188|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56487189|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56487190|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140774|NCT02003222|Hormones|hormones|mesh-ancestor
56487191|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56487192|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56487193|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56487194|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487195|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56487196|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56487197|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
56487198|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56487199|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56487200|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487201|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56487202|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56487203|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
56487204|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487205|NCT00557180|Beclomethasone|beclomethasone|mesh-list
56487206|NCT00557180|Bromides|bromides|mesh-list
56487207|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
56487208|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56487209|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56487210|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
56487211|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487212|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487213|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56487214|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
56487215|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
56487216|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56487217|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
56487218|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487219|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487220|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56487221|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56487222|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56487223|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
56487224|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
56487225|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487226|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
56487227|NCT00557180|Hormones|hormones|mesh-ancestor
56487228|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487229|NCT00557219|Fenoldopam|fenoldopam|mesh-list
56487230|NCT00557219|Ketanserin|ketanserin|mesh-list
56487231|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56487232|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
56487233|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
56487234|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
56487235|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56140896|NCT01105975|Simvastatin|simvastatin|mesh-list
56487236|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487237|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487238|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56487239|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56487240|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
56487241|NCT03818685|Capecitabine|capecitabine|mesh-list
56487242|NCT03818685|Nivolumab|nivolumab|mesh-list
56487243|NCT03818685|Ipilimumab|ipilimumab|mesh-list
56487244|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56487245|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
56487246|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487247|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140957|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
56487248|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56487249|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56487250|NCT00539877|Irinotecan|irinotecan|mesh-list
56487251|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56487252|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56487253|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487254|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487255|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487256|NCT03798405|Analgesics|analgesics|mesh-list
56487257|NCT03798405|Narcotics|narcotics|mesh-list
56487258|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
56487259|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487260|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487261|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487262|NCT04661696|Paclitaxel|paclitaxel|mesh-list
56487263|NCT04661696|Carboplatin|carboplatin|mesh-list
56233229|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56487264|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56487265|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487266|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
56487267|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
56487268|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
56487269|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487270|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
56487271|NCT03776136|Lenvatinib|lenvatinib|mesh-list
56487272|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56487273|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487274|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56487275|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487276|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233259|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56487277|NCT04661345|Coagulase|coagulase|mesh-list
56487278|NCT04661345|Coagulants|coagulants|mesh-ancestor
56487279|NCT00540072|Daptomycin|daptomycin|mesh-list
56487280|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56487281|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487282|NCT03689946|Listerine|listerine|mesh-list
56487283|NCT03689946|Evolocumab|evolocumab|mesh-list
56487284|NCT03689946|Fluorides|fluorides|mesh-list
56487285|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
56487286|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
56487287|NCT03689946|Protective Agents|protective agents|mesh-ancestor
56487288|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487289|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56233347|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56487290|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487291|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56487292|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56487293|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
56487294|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487295|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56487296|NCT04660916|Isotretinoin|isotretinoin|mesh-list
56487297|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814955|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487298|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
56487299|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56487300|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56487301|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487302|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487303|NCT04660565|Prednisone|prednisone|mesh-list
56487304|NCT04660565|Belimumab|belimumab|mesh-list
56487305|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487306|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
56487307|NCT04660565|Hormones|hormones|mesh-ancestor
56487308|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487309|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487310|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487311|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487312|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56487313|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
56487314|NCT03642132|Bevacizumab|bevacizumab|mesh-list
56487315|NCT03642132|Avelumab|avelumab|mesh-list
56487316|NCT03642132|Talazoparib|talazoparib|mesh-list
56487317|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56487318|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487319|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56487320|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56487321|NCT03642132|Growth Substances|growth substances|mesh-ancestor
56487322|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487323|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
56487324|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56487325|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487326|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487327|NCT04319341|Autoantibodies|autoantibodies|mesh-list
56487328|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
56487329|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487330|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
56487331|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
56487332|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
56487333|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487334|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
56487335|NCT01208038|Testosterone|testosterone|mesh-list
56487336|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
56487337|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
56235368|NCT01743755|Hormones|hormones|mesh-ancestor
56487338|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56487339|NCT01208038|Androgens|androgens|mesh-ancestor
56487340|NCT01208038|Hormones|hormones|mesh-ancestor
56487341|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487342|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487343|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487344|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487345|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
56487346|NCT04659785|Apatinib|apatinib|mesh-list
56487347|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487348|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56487349|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487350|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487351|NCT01207687|Bevacizumab|bevacizumab|mesh-list
56487352|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56487353|NCT01207687|Antibodies|antibodies|mesh-list
56487354|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
56487355|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56487356|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487357|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56487358|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56487359|NCT01207687|Growth Substances|growth substances|mesh-ancestor
56487360|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487361|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
56487362|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
56487363|NCT01207453|Milnacipran|milnacipran|mesh-list
56487364|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
56487365|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56487366|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56487367|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56487368|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487369|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487370|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487371|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56487372|NCT01207453|Analgesics|analgesics|mesh-ancestor
56487373|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
56487374|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487375|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
56487376|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56487377|NCT00540345|Interferons|interferons|mesh-list
56487378|NCT00540345|Ribavirin|ribavirin|mesh-list
56487379|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
56487380|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
56487381|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56487382|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487383|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
56487384|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487385|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
56487386|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487387|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
56487388|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487389|NCT01207414|Iloperidone|iloperidone|mesh-list
56487390|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56487391|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56487392|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809127|NCT02357979|Fluorides|fluorides|mesh-list
56487393|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487394|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56487395|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
56487396|NCT00540384|Hematinics|hematinics|mesh-ancestor
56487397|NCT03579966|Amifampridine|amifampridine|mesh-list
56487398|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56487399|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487400|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487401|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56487402|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56487403|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487404|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
56487405|NCT04659551|Nivolumab|nivolumab|mesh-list
56487406|NCT04659551|Epirubicin|epirubicin|mesh-list
56487407|NCT04659551|Exemestane|exemestane|mesh-list
56487408|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56487409|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56487410|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
56487411|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487412|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56487413|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56487414|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
56487415|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487416|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487417|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56487418|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56233597|NCT01731925|Sunitinib|sunitinib|mesh-list
56487419|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56487420|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56487421|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56487422|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56487423|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487424|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56487425|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56487426|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56487427|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
56487428|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487429|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
56487430|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56487431|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
56487432|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56487433|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56487434|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487435|NCT01207102|Paclitaxel|paclitaxel|mesh-list
56487436|NCT01207102|Carboplatin|carboplatin|mesh-list
56487437|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56487438|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56487439|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487440|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
56487441|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
56487442|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
56487443|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487444|NCT01206517|Asenapine|asenapine|mesh-list
56487445|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56487446|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56209681|NCT01592305|Ritonavir|ritonavir|mesh-list
56487447|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487448|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487449|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56487451|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56487452|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
56487453|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56487454|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56487455|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56487456|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
56487457|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487458|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487459|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487460|NCT01206322|Insulin|insulin|mesh-list
56487461|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56487462|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487463|NCT00540501|Oseltamivir|oseltamivir|mesh-list
56487464|NCT00540501|Zanamivir|zanamivir|mesh-list
56487465|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
56487466|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487467|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487468|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487469|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56487470|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56487471|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487472|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
56487473|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
56487474|NCT04658732|Gabapentin|gabapentin|mesh-list
56487475|NCT04658732|Alprazolam|alprazolam|mesh-list
56233775|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56487476|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56487477|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487478|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487479|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56487480|NCT04658732|Analgesics|analgesics|mesh-ancestor
56487481|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
56209697|NCT01592318|Ritonavir|ritonavir|mesh-list
56487482|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487483|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56487484|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56487485|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56141561|NCT04350528|Pentobarbital|pentobarbital|mesh-list
56487486|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
56487487|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487488|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487489|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
56487490|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56487491|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56487492|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56487493|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56487494|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56141580|NCT04350684|Interferons|interferons|mesh-list
56487495|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
56487496|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
56487497|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
56487498|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
56487499|NCT00540696|Hematinics|hematinics|mesh-ancestor
56487500|NCT04658420|Ketamine|ketamine|mesh-list
56487501|NCT04658420|Analgesics|analgesics|mesh-ancestor
56487502|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
56487503|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487504|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487505|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56487506|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56487507|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
56487508|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
56487509|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487510|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56209742|NCT01593033|Micronutrients|micronutrients|mesh-list
56233892|NCT01734096|Candesartan|candesartan|mesh-list
56487511|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56487512|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487513|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487514|NCT00540891|Alfuzosin|alfuzosin|mesh-list
56487515|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56487516|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56487517|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56487518|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56487519|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233916|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56487520|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487521|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487522|NCT00540891|Urological Agents|urological agents|mesh-ancestor
56487523|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
56487524|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56487525|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487526|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
56487527|NCT05086692|Interleukin-2|interleukin-2|mesh-list
56487528|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487529|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56487530|NCT05086692|Analgesics|analgesics|mesh-ancestor
56487531|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
56487532|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233966|NCT01734954|Midazolam|midazolam|mesh-list
56487533|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487534|NCT00540930|Ranibizumab|ranibizumab|mesh-list
56487535|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56487536|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56487537|NCT00540930|Growth Substances|growth substances|mesh-ancestor
56487538|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487539|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
56487540|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234000|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234019|NCT01735097|Vitamin E|vitamin e|mesh-list
56487542|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487543|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56487544|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56487545|NCT00541008|Growth Substances|growth substances|mesh-ancestor
56487546|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487547|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
56487548|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56487549|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487550|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487552|NCT00541047|Goserelin|goserelin|mesh-list
56487553|NCT00541047|Bicalutamide|bicalutamide|mesh-list
56487554|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56487555|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
56487556|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56487557|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487558|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487559|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487560|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
56487561|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
56487562|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487563|NCT00541086|Tamoxifen|tamoxifen|mesh-list
56487564|NCT00541086|Letrozole|letrozole|mesh-list
56487565|NCT00541086|Anastrozole|anastrozole|mesh-list
56487566|NCT00541086|Exemestane|exemestane|mesh-list
56487567|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487568|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487569|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56141847|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
56487570|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56487571|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487572|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56487573|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
56487574|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487575|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487576|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487577|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56487578|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56487579|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56487580|NCT04657484|Prednisolone|prednisolone|mesh-list
56487581|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56487582|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
56487583|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56487584|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
56487585|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56487586|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
56487587|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487588|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
56487589|NCT04657484|Hormones|hormones|mesh-ancestor
56487590|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56209822|NCT01593319|Ropivacaine|ropivacaine|mesh-list
56487591|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487592|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487593|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487594|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
56487595|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
56487596|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487597|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56487598|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56487599|NCT04657484|Protective Agents|protective agents|mesh-ancestor
56487601|NCT00541125|Bevacizumab|bevacizumab|mesh-list
56487602|NCT00541125|Fluorouracil|fluorouracil|mesh-list
56487603|NCT00541125|Irinotecan|irinotecan|mesh-list
56487604|NCT00541125|Calcium|calcium|mesh-list
56487605|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
56487606|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56487607|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487608|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56487609|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56487610|NCT00541125|Growth Substances|growth substances|mesh-ancestor
56487611|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487612|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
56487613|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56487614|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
56487615|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487616|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56487617|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56487618|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
56487619|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56487620|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56487621|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487622|NCT00541125|Antidotes|antidotes|mesh-ancestor
56487623|NCT00541125|Protective Agents|protective agents|mesh-ancestor
56487624|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
56487625|NCT00541125|Vitamins|vitamins|mesh-ancestor
56487626|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
56487627|NCT00541164|Ubiquinone|ubiquinone|mesh-list
56487628|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
56487629|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
56487630|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487631|NCT00541164|Vitamins|vitamins|mesh-ancestor
56487632|NCT00541281|Prednisone|prednisone|mesh-list
56487633|NCT00541281|Docetaxel|docetaxel|mesh-list
56487634|NCT00541281|Estramustine|estramustine|mesh-list
56487635|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487636|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
56487637|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
56487638|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
56487639|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487640|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487641|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
56487643|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487644|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487645|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56487646|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56487647|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
56487648|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
56487649|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56487650|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
56487651|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56487652|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
56234144|NCT01736020|Ketamine|ketamine|mesh-list
56487653|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487654|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487655|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
56487656|NCT04657172|Pilocarpine|pilocarpine|mesh-list
56487657|NCT04657172|Miotics|miotics|mesh-ancestor
56487658|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
56487659|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487660|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487661|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56487662|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56487663|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
56487664|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487665|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487666|NCT03199794|Factor VIII|factor viii|mesh-list
56487667|NCT03199794|Coagulants|coagulants|mesh-ancestor
56487668|NCT00541359|Bortezomib|bortezomib|mesh-list
56487669|NCT00541359|Topotecan|topotecan|mesh-list
56487670|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487671|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56487672|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56487673|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487674|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487675|NCT03096249|Oxytocin|oxytocin|mesh-list
56487676|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
56487677|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56487678|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487679|NCT04656665|Aspirin|aspirin|mesh-list
56487680|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56487681|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56487682|NCT04656665|Analgesics|analgesics|mesh-ancestor
56487683|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
56487684|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487685|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487686|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487687|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56487688|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56487689|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56487690|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487691|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56487692|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56487693|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487694|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
56487695|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
56487696|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56487697|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56487698|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56487699|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56487700|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487701|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
56487702|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487703|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487704|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56487705|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487706|NCT03013218|Paclitaxel|paclitaxel|mesh-list
56487707|NCT03013218|Rituximab|rituximab|mesh-list
56487708|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
56487709|NCT03013218|Trastuzumab|trastuzumab|mesh-list
56487710|NCT03013218|Ramucirumab|ramucirumab|mesh-list
56487711|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56487712|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487713|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
56487714|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
56487715|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
56487716|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487717|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56487718|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
56487719|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487720|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56487721|NCT04655807|Adalimumab|adalimumab|mesh-list
56487722|NCT04655807|Ustekinumab|ustekinumab|mesh-list
56487723|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56234255|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487724|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56487725|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
56487726|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
56487727|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56487728|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56487729|NCT00541515|Insulin|insulin|mesh-list
56487730|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56487731|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487732|NCT04655729|Infliximab|infliximab|mesh-list
56487733|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
56487734|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56487735|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56487736|NCT00541554|Aripiprazole|aripiprazole|mesh-list
56487737|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
56487738|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56487739|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56487740|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56487741|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487742|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487743|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
56487744|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
56487745|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487746|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487747|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56487748|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56487749|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
56487750|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56487751|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56487752|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56487753|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56487754|NCT02881242|Trametinib|trametinib|mesh-list
56487755|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487756|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56487757|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487758|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487759|NCT04655183|Niraparib|niraparib|mesh-list
56487760|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56487761|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487762|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487763|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487764|NCT00541710|Genistein|genistein|mesh-list
56487765|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56487766|NCT00541710|Protective Agents|protective agents|mesh-ancestor
56487767|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487768|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487769|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56487770|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487771|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234414|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
56487772|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
56487773|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56487774|NCT00541710|Estrogens|estrogens|mesh-ancestor
56487775|NCT00541710|Hormones|hormones|mesh-ancestor
56487776|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487777|NCT02781519|Dronabinol|dronabinol|mesh-list
56487778|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
56487779|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487780|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56142413|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
56487781|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56487782|NCT02781519|Analgesics|analgesics|mesh-ancestor
56487783|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
56487784|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487785|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56487786|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56487787|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487788|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235810|NCT01746680|Tacrolimus|tacrolimus|mesh-list
56487789|NCT02781519|Hormones|hormones|mesh-ancestor
56210015|NCT01594229|Rituximab|rituximab|mesh-list
56487790|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487791|NCT04654676|Vildagliptin|vildagliptin|mesh-list
56487792|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56487793|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487794|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56487795|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
56487796|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487797|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487798|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56487799|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56487800|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487801|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487802|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56487803|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56487804|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487805|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
56487806|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487807|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
56487808|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56487809|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56487810|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
56487811|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142508|NCT03004014|Propofol|propofol|mesh-list
56487812|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487813|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487814|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
56487815|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
56487816|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487817|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
56487818|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56487819|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
56487820|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
56487821|NCT02546583|Furosemide|furosemide|mesh-list
56487822|NCT02546583|Bumetanide|bumetanide|mesh-list
56487823|NCT02546583|Diuretics|diuretics|mesh-list
55814956|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
56487824|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56210017|NCT01594229|Venetoclax|venetoclax|mesh-list
56487825|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
56487826|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487827|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56487828|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487829|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56487830|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56487832|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
56487833|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487835|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487836|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
56487837|NCT00542139|Hormones|hormones|mesh-ancestor
56487838|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487839|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487840|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56487841|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
56487842|NCT02499354|Iron|iron|mesh-list
56487843|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56487844|NCT02499354|Trace Elements|trace elements|mesh-ancestor
56487845|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
56487846|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487847|NCT02499354|Hematinics|hematinics|mesh-ancestor
56487848|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56487849|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56487850|NCT00542295|Mebeverine|mebeverine|mesh-list
56487851|NCT00542295|Alverine|alverine|mesh-list
56487852|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
56487853|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
56487854|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487855|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487856|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
56487857|NCT03454841|Ticagrelor|ticagrelor|mesh-list
56210075|NCT01594619|Diltiazem|diltiazem|mesh-list
56487858|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56487859|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56487860|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56487861|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56487862|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56487863|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
56487864|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487865|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487866|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487867|NCT02335944|Nazartinib|nazartinib|mesh-list
56487868|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487869|NCT02293980|Nivolumab|nivolumab|mesh-list
56487870|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56487871|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487872|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56487873|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487874|NCT04653506|Acetaminophen|acetaminophen|mesh-list
56487875|NCT04653506|Ibuprofen|ibuprofen|mesh-list
56487876|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56487877|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56487878|NCT04653506|Analgesics|analgesics|mesh-ancestor
56487879|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
56487880|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487881|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487882|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487883|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56487884|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56487885|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487886|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487887|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
56487888|NCT00542412|Riluzole|riluzole|mesh-list
56487889|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
56487890|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56487891|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56487892|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487893|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487894|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487895|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56487896|NCT00542412|Protective Agents|protective agents|mesh-ancestor
56487897|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
56487898|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56487899|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56487900|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487901|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
56487902|NCT04653623|Coagulants|coagulants|mesh-ancestor
56487903|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
56487904|NCT00542568|Hematinics|hematinics|mesh-ancestor
56487905|NCT04653779|Metformin|metformin|mesh-list
56487906|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56487907|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487908|NCT00542607|Levocetirizine|levocetirizine|mesh-list
56487909|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56487911|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
56487912|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
56487913|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56487914|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487915|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487916|NCT04685031|Clobetasol|clobetasol|mesh-list
56487917|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
56487918|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
56487919|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487920|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
56487921|NCT04685031|Hormones|hormones|mesh-ancestor
56487922|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487923|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487924|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
56487925|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56487926|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487927|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56487928|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
56487929|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56487930|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487931|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487932|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487933|NCT01854684|Temoporfin|temoporfin|mesh-list
56487934|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487935|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56487936|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
56487937|NCT00542802|Carbamazepine|carbamazepine|mesh-list
56487938|NCT00542802|Levetiracetam|levetiracetam|mesh-list
56487939|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
56487940|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
56487941|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
56487942|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56487943|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56487944|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487945|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56487946|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56487947|NCT00542802|Analgesics|analgesics|mesh-ancestor
56487948|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
56487949|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56487950|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56487951|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56487952|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487953|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56487954|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56487955|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
56487956|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
56487957|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56487958|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56487959|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487960|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487961|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487962|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56487963|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
56487964|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56487965|NCT04652765|Bicalutamide|bicalutamide|mesh-list
56487966|NCT04652765|Camostat|camostat|mesh-list
56487967|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
56487968|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
56487969|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56487970|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487971|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487972|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
56487973|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56487974|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56487975|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55819008|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56487976|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56487978|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487979|NCT00543114|Rituximab|rituximab|mesh-list
56487980|NCT00543114|Fludarabine|fludarabine|mesh-list
56487981|NCT00543114|Lenalidomide|lenalidomide|mesh-list
56487982|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56487983|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487985|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143033|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
56487986|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56487987|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56487988|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56487989|NCT00543114|Growth Substances|growth substances|mesh-ancestor
56487990|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
56487991|NCT03454724|Sirolimus|sirolimus|mesh-list
56487992|NCT03454724|Everolimus|everolimus|mesh-list
56487993|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56487994|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56487995|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
56487996|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56487997|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56487998|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56487999|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56488000|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
56488001|NCT01014546|Vitamins|vitamins|mesh-list
56488002|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
56488003|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
56488004|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
56488005|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488006|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
56488007|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488008|NCT01014546|Protective Agents|protective agents|mesh-ancestor
56488009|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488010|NCT00543231|Oblimersen|oblimersen|mesh-list
56488011|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488012|NCT00557843|Bupivacaine|bupivacaine|mesh-list
56488013|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
56488014|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
56488015|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488016|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488017|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
56488018|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488019|NCT04651556|Acetaminophen|acetaminophen|mesh-list
56488020|NCT04651556|Ketorolac|ketorolac|mesh-list
56488021|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
56488022|NCT04651556|Bupivacaine|bupivacaine|mesh-list
56488023|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
56488024|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
56488025|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488026|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488027|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
56488028|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488029|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56488030|NCT04651556|Analgesics|analgesics|mesh-ancestor
56488031|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
56488032|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56488033|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488034|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56488035|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56488036|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488037|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488038|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56488039|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
56488040|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56488041|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56143133|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56488042|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56488044|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56488045|NCT04651049|Propranolol|propranolol|mesh-list
56488046|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56488047|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56488048|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
56488049|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488050|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488051|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488052|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56488053|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56488054|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
56488055|NCT04651205|Thiamine|thiamine|mesh-list
56488056|NCT04651205|Vitamins|vitamins|mesh-ancestor
56488057|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
56488058|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488059|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
56488060|NCT03456648|Apixaban|apixaban|mesh-list
56488061|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56488062|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
56488063|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56488064|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
56488065|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488066|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488067|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
56488068|NCT00557921|Aspirin|aspirin|mesh-list
56488069|NCT00557921|Omeprazole|omeprazole|mesh-list
56488070|NCT00557921|Clopidogrel|clopidogrel|mesh-list
56488071|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56488072|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56488073|NCT00557921|Analgesics|analgesics|mesh-ancestor
56488074|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
56488075|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488076|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488077|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488078|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56488079|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56488080|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56488081|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488082|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56210217|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488083|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56488084|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488085|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
56488086|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56488087|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56488088|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56488089|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
56488090|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488091|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56488092|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56488093|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56488095|NCT02352558|Bortezomib|bortezomib|mesh-list
56488096|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
56488097|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488098|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
56488099|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
56488100|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234798|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
56488101|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488102|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56488103|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
56488104|NCT02352558|Hormones|hormones|mesh-ancestor
56488105|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488106|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56488107|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488108|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56488110|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488111|NCT02324283|Propofol|propofol|mesh-list
56488112|NCT02324283|Desflurane|desflurane|mesh-list
56488113|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56488114|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488115|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488116|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56488117|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
56488118|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
56488119|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56488120|NCT00557960|Amphetamine|amphetamine|mesh-list
56488121|NCT00557960|Adderall|adderall|mesh-list
56488122|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56488123|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56488124|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56488125|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56488126|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488127|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
56488128|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488129|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488130|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56488131|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
56488132|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
56488133|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488134|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
56488135|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56488136|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56488137|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56488138|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488139|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56488140|NCT00558077|Metformin|metformin|mesh-list
56234829|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234830|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
56234831|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56234832|NCT01740921|Incretins|incretins|mesh-ancestor
56488141|NCT00558077|Clomiphene|clomiphene|mesh-list
56488142|NCT00558077|Enclomiphene|enclomiphene|mesh-list
56488143|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
56488144|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56488145|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488146|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56488147|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
56488148|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143388|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56488149|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56488150|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
56488151|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56488152|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56488153|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56488154|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
56488155|NCT05077254|Vaccines|vaccines|mesh-list
56488156|NCT05077254|Tacrolimus|tacrolimus|mesh-list
56488157|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
56488158|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488159|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488160|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56488161|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488162|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488163|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56488164|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488165|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56488166|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
56488167|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56488168|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488169|NCT00543504|Bevacizumab|bevacizumab|mesh-list
56488170|NCT00543504|Trastuzumab|trastuzumab|mesh-list
56488171|NCT00543504|Cetuximab|cetuximab|mesh-list
56234899|NCT01741285|Hormones|hormones|mesh-ancestor
56488172|NCT00543504|Sunitinib|sunitinib|mesh-list
56488173|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56488174|NCT00543504|Sorafenib|sorafenib|mesh-list
56488175|NCT00543504|Lapatinib|lapatinib|mesh-list
56488176|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56488177|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488178|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56488179|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56488180|NCT00543504|Growth Substances|growth substances|mesh-ancestor
56488181|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488182|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
56488183|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56488184|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488185|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488186|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
56488187|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56488188|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
56488189|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488190|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488191|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56210329|NCT01596010|Norethindrone|norethindrone|mesh-list
56488192|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
56488193|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56488194|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
56488195|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488196|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488197|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56488198|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
56488199|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
56488200|NCT00543933|Protective Agents|protective agents|mesh-ancestor
56488201|NCT00544011|Bevacizumab|bevacizumab|mesh-list
56488202|NCT00544011|Fluorouracil|fluorouracil|mesh-list
56488203|NCT00544011|Capecitabine|capecitabine|mesh-list
56488204|NCT00544011|Irinotecan|irinotecan|mesh-list
56488205|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56488206|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488207|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56488208|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56488209|NCT00544011|Growth Substances|growth substances|mesh-ancestor
56488210|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488211|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
56488212|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
56488213|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488214|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56488215|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488216|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
56488217|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56488218|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56488219|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488220|NCT00544050|Levetiracetam|levetiracetam|mesh-list
56488221|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
56488222|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
56488224|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56488225|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
56488226|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56488227|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488228|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
56488229|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56488230|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488231|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488232|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56143572|NCT00672204|Sirolimus|sirolimus|mesh-list
56143573|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
56488233|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56488234|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56488235|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56488236|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56488237|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56488238|NCT02909088|Ecopipam|ecopipam|mesh-list
56488239|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56236263|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
56488240|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56488241|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488242|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143600|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56143601|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56143602|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488243|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56488244|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56488245|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
56488246|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488247|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488248|NCT04649645|Nicotine|nicotine|mesh-list
56488249|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56488250|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
56488251|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488252|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488253|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56488254|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56488255|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
56488256|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488257|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488258|NCT00544128|Ritonavir|ritonavir|mesh-list
56488259|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56488260|NCT00544128|Tenofovir|tenofovir|mesh-list
56488261|NCT00544128|Lamivudine|lamivudine|mesh-list
56488262|NCT00544128|Emtricitabine|emtricitabine|mesh-list
56488263|NCT00544128|Abacavir|abacavir|mesh-list
56488264|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56488265|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56488266|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
56488267|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488268|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488269|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56488270|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56488271|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
56488272|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488273|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56488274|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56488275|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56488276|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56488277|NCT05476432|Leucovorin|leucovorin|mesh-list
56488278|NCT05476432|Fluorouracil|fluorouracil|mesh-list
56488279|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
56488280|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
56488281|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488282|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56488283|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488284|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488285|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
56488286|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488287|NCT05476432|Antidotes|antidotes|mesh-ancestor
56488288|NCT05476432|Protective Agents|protective agents|mesh-ancestor
56488289|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
56488290|NCT05476432|Vitamins|vitamins|mesh-ancestor
56488291|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
56488292|NCT01239745|Exemestane|exemestane|mesh-list
56488293|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488294|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56488295|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56488296|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143760|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488297|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488298|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56488299|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
56488300|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488301|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488302|NCT01239472|Everolimus|everolimus|mesh-list
56488303|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488304|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488305|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
56488306|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488307|NCT00544284|Temozolomide|temozolomide|mesh-list
56488308|NCT00544284|Bortezomib|bortezomib|mesh-list
56488309|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56488310|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
56488311|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488312|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235057|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56488313|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
56488314|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56488315|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488316|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488317|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56488318|NCT02888275|Analgesics|analgesics|mesh-ancestor
56488319|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
56488320|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488321|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56488322|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56488323|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56488324|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
56488325|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56210428|NCT01596517|Ribavirin|ribavirin|mesh-list
56488326|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488328|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488329|NCT03456531|Aspirin|aspirin|mesh-list
56488330|NCT03456531|Analgesics|analgesics|mesh-list
56488331|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56488332|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56488333|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
56488334|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488335|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488336|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488337|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56488338|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56488339|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56488340|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488341|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56488342|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56488343|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488344|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
56488346|NCT02909049|Ketamine|ketamine|mesh-list
56488347|NCT02909049|Mepivacaine|mepivacaine|mesh-list
56488348|NCT02909049|Analgesics|analgesics|mesh-ancestor
56488349|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
56488350|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488351|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488352|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56488353|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56488354|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
56488355|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
56488356|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488357|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56235131|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56235132|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235134|NCT01742676|Tacrolimus|tacrolimus|mesh-list
56488358|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56488359|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488360|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488361|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56488362|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56488363|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56488364|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56488365|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56488366|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
56488367|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
56488368|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
56488369|NCT01229449|Acetaminophen|acetaminophen|mesh-list
56488370|NCT01229449|Ibuprofen|ibuprofen|mesh-list
56488371|NCT01229449|Codeine|codeine|mesh-list
56488372|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56488373|NCT01229449|Analgesics|analgesics|mesh-ancestor
56488374|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
56488375|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488376|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488377|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
56488378|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56488379|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488380|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56488381|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56488382|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488383|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488384|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56488385|NCT01229449|Narcotics|narcotics|mesh-ancestor
56488386|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488387|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
56488388|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
56488389|NCT01238575|Guanfacine|guanfacine|mesh-list
56488390|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56143791|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
56488391|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56488392|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56488393|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56488394|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
56488395|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488396|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488397|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488398|NCT01237951|Gemcitabine|gemcitabine|mesh-list
56488399|NCT01237951|Dexamethasone|dexamethasone|mesh-list
56488400|NCT01237951|Melphalan|melphalan|mesh-list
56488401|NCT01237951|Busulfan|busulfan|mesh-list
56488402|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488403|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
56488404|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
56235155|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488405|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488406|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488407|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56488408|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
56488409|NCT01237951|Hormones|hormones|mesh-ancestor
56488410|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488411|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56488412|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488413|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56488414|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
56488415|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488416|NCT01237951|Antiviral Agents|antiviral agents|mesh-ancestor
56488417|NCT01237951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488418|NCT01237951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488419|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488420|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
56488421|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56488422|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
56488423|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56488424|NCT02908581|Folic Acid|folic acid|mesh-list
56488425|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
56488426|NCT02908581|Hematinics|hematinics|mesh-ancestor
56488427|NCT02908581|Vitamins|vitamins|mesh-ancestor
56488428|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
56488429|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488430|NCT00544362|Fluorouracil|fluorouracil|mesh-list
56488431|NCT00544362|Cetuximab|cetuximab|mesh-list
56488432|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488433|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
56488434|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488435|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56488436|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488437|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
56488438|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143940|NCT00724464|Ribavirin|ribavirin|mesh-list
56488439|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56488440|NCT00553293|Hormones|hormones|mesh-list
56488441|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56488442|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488443|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488444|NCT04648358|Dexamethasone|dexamethasone|mesh-list
56488445|NCT04648358|Bupivacaine|bupivacaine|mesh-list
56488446|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488447|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
56488448|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
56488449|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488450|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488451|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56488452|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
56488453|NCT04648358|Hormones|hormones|mesh-ancestor
56488454|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488455|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56488456|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488457|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
56488458|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
56488459|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488460|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
56488461|NCT00544518|Metformin|metformin|mesh-list
56488462|NCT00544518|Benfluorex|benfluorex|mesh-list
56488463|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56488464|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488465|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56488466|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
56488467|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488468|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56488469|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
56144063|NCT00736632|Vitamin D|vitamin d|mesh-list
56488470|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56488472|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488473|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
56488474|NCT02908698|Hormones|hormones|mesh-ancestor
56488475|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56210517|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
56488476|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488477|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56488478|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488479|NCT00544596|Acetic Acid|acetic acid|mesh-list
56488480|NCT00544596|Etoposide|etoposide|mesh-list
56488481|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
56488482|NCT00544596|Retinol acetate|retinol acetate|mesh-list
56488483|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
56488484|NCT00544596|Gossypol|gossypol|mesh-list
56488485|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488486|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56488487|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56488488|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56488489|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488490|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488491|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56488492|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488493|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56488494|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
56488495|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488496|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56488497|NCT00544596|Protective Agents|protective agents|mesh-ancestor
56488498|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56488499|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
56488500|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56488501|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56488502|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56144158|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144159|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488503|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56488504|NCT04648280|Fostemsavir|fostemsavir|mesh-list
56488505|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56488506|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56488507|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
56488508|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488509|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56488510|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56488511|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488512|NCT02908191|Tenofovir|tenofovir|mesh-list
56488513|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56488514|NCT02908191|Entecavir|entecavir|mesh-list
56488515|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
56488516|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488517|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56488518|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56488519|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488520|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488521|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56488522|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56488523|NCT00544791|Melatonin|melatonin|mesh-list
56488524|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
56488525|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488526|NCT00544791|Protective Agents|protective agents|mesh-ancestor
56488527|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488528|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488529|NCT04647773|Pregabalin|pregabalin|mesh-list
56488530|NCT04647773|Analgesics|analgesics|mesh-ancestor
56488531|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
56488532|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488533|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488534|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
56488535|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56488536|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56488537|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488538|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56488539|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56488540|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56488541|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488542|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56488543|NCT01237678|Carboplatin|carboplatin|mesh-list
56488544|NCT01237678|Etoposide|etoposide|mesh-list
56488545|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
56488546|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488547|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56488548|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56488549|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56488550|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488551|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488552|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56488553|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56488554|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56488555|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56488556|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56488557|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56488558|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56488559|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56488560|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
56488561|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488562|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488563|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488564|NCT01229371|Vaccines|vaccines|mesh-list
56235329|NCT01743378|Ropivacaine|ropivacaine|mesh-list
56488565|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
56488566|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488567|NCT02908152|Curcumin|curcumin|mesh-list
56488568|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56488569|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56488570|NCT02908152|Analgesics|analgesics|mesh-ancestor
56488571|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
56488572|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235353|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488573|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488574|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488575|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56488576|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488577|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488578|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488580|NCT01237327|Megestrol|megestrol|mesh-list
56488581|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
56488582|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488583|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56488584|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56488585|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235413|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488586|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488587|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56488588|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
56488589|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488590|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488591|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56488592|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56488593|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56488594|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
56488595|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56488596|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56488597|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56488598|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56488599|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
56488600|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56488601|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56488602|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56488603|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
56488604|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814957|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235507|NCT01744366|Goserelin|goserelin|mesh-list
56488605|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488606|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488607|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56488608|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56488609|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488610|NCT04647695|Interferons|interferons|mesh-list
56488611|NCT04647695|Interferon-beta|interferon-beta|mesh-list
56488612|NCT04647695|Remdesivir|remdesivir|mesh-list
56488613|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
56488614|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488615|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
56488616|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488617|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
56488618|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488619|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
56488620|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488621|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56488622|NCT04647344|Paclitaxel|paclitaxel|mesh-list
56488623|NCT04647344|Carboplatin|carboplatin|mesh-list
56488624|NCT04647344|Pemetrexed|pemetrexed|mesh-list
56488625|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56488626|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488627|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
56488628|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
56488629|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
56488630|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488631|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488632|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56488633|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56488634|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
56488635|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56488636|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488637|NCT02907957|Anesthetics|anesthetics|mesh-list
56488638|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488639|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488640|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
56488641|NCT04646876|Analgesics|analgesics|mesh-ancestor
56488642|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
56488643|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488644|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488645|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
56488646|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488647|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56488648|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
56488649|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56488650|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56488651|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488652|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56488653|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
56488654|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56488655|NCT02908035|Sirolimus|sirolimus|mesh-list
56488656|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56488657|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488658|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56488659|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488660|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
56488661|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488662|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
56488663|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488664|NCT04646759|Capecitabine|capecitabine|mesh-list
56488665|NCT04646759|Fulvestrant|fulvestrant|mesh-list
56488666|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56488667|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
56488668|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488669|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488670|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56488671|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56488672|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56488673|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
56488674|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488675|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488676|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56488677|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
56488678|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
56488679|NCT04646135|Lorazepam|lorazepam|mesh-list
56488680|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
56488681|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
56488682|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
56488683|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488684|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488685|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56488686|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56488687|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488688|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56488689|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56488690|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56488691|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
56488692|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
56488693|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488694|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488695|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
56488696|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
56488697|NCT04682184|Propranolol|propranolol|mesh-list
56488698|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
56488699|NCT04682184|Ephedrine|ephedrine|mesh-list
56488700|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56488701|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56488702|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
56488703|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488704|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488705|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488706|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56488707|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56488708|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
56488709|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56488710|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
56488711|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488712|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56235583|NCT01744964|Apomorphine|apomorphine|mesh-list
56488713|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
56488714|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
56488715|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56488716|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56488717|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
56488718|NCT04645940|Rabeprazole|rabeprazole|mesh-list
56488719|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56488720|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56488721|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56488722|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488723|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488724|NCT00558506|Abatacept|abatacept|mesh-list
56488725|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56235612|NCT01745302|Gefitinib|gefitinib|mesh-list
56488726|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488727|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488728|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488729|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
56488730|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488731|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56488732|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
56488733|NCT00558623|Calcium|calcium|mesh-list
56488734|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56488735|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488736|NCT00558623|Antacids|antacids|mesh-ancestor
56488737|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488738|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56488739|NCT00558662|Monensin|monensin|mesh-list
56144462|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488740|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
56488741|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488742|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56488743|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56488744|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
56488745|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
56488746|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
56488747|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488748|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488749|NCT00558662|Ionophores|ionophores|mesh-ancestor
56488750|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56488751|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
56488752|NCT02905890|Norethindrone|norethindrone|mesh-list
56488753|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
56488754|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
56488755|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56488756|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56144511|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56144512|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56144515|NCT00793650|Bortezomib|bortezomib|mesh-list
56488757|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56488758|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
56488759|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56488760|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488761|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56488762|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56488763|NCT02906163|Gefitinib|gefitinib|mesh-list
56488764|NCT02906163|Afatinib|afatinib|mesh-list
56488765|NCT02906163|Thymalfasin|thymalfasin|mesh-list
56235700|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235701|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
56235702|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56235703|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56235704|NCT01745640|Growth Substances|growth substances|mesh-ancestor
56235705|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
56488766|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488767|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56488768|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56210667|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488769|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488770|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56488771|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
56488772|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488774|NCT04645745|Inositol|inositol|mesh-list
56488775|NCT04645745|Hematinics|hematinics|mesh-ancestor
56488776|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
56488777|NCT04645745|Vitamins|vitamins|mesh-ancestor
56488778|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
56235777|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56235778|NCT01746485|Treprostinil|treprostinil|mesh-list
56488779|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488780|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
56488781|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
56488782|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
56488783|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488784|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488785|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
56488786|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488787|NCT00558818|Clevudine|clevudine|mesh-list
56488788|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
56488789|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488790|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
56488791|NCT04681911|Gemcitabine|gemcitabine|mesh-list
56488792|NCT04681911|Paclitaxel|paclitaxel|mesh-list
56488793|NCT04681911|Vinorelbine|vinorelbine|mesh-list
56488794|NCT04681911|Carboplatin|carboplatin|mesh-list
56488795|NCT04681911|Capecitabine|capecitabine|mesh-list
55819009|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56488796|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56488797|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488798|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
56488799|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
56488800|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
56235837|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56235838|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235839|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488801|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488802|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56488803|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
56488804|NCT04681911|Antiviral Agents|antiviral agents|mesh-ancestor
56488805|NCT04681911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488806|NCT04681911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488807|NCT04681911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488808|NCT04681911|Immunologic Factors|immunologic factors|mesh-ancestor
56488809|NCT04681911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488810|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56488811|NCT02905539|Hematinics|hematinics|mesh-ancestor
56488812|NCT02905734|Nicotine|nicotine|mesh-list
56488813|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56488814|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
56488815|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488816|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488817|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56488818|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56488819|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
56488820|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235947|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
56235959|NCT01747252|Resveratrol|resveratrol|mesh-list
56488821|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488822|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
56488823|NCT04644185|Paraproteins|paraproteins|mesh-list
56488824|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
56488825|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488826|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
56488827|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56488828|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488829|NCT02905305|Dexamethasone|dexamethasone|mesh-list
56488830|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488831|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
56236013|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56236014|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56488832|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
56488833|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56210696|NCT01597531|Liraglutide|liraglutide|mesh-list
56488835|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56488836|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
56488837|NCT02905305|Hormones|hormones|mesh-ancestor
56488838|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488839|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56488840|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488841|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
56236867|NCT01752881|Vaccines|vaccines|mesh-list
56488842|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56236077|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56236078|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56236079|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
56236080|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488843|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
56488844|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
56488845|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488846|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488847|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56488849|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
56488850|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488851|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
56488852|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56488853|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56488854|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
56488855|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488856|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488857|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488858|NCT04643483|Adalimumab|adalimumab|mesh-list
56488859|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
56488860|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488861|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56488862|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488863|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
56488864|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488865|NCT00559052|Pancrelipase|pancrelipase|mesh-list
56488866|NCT00559052|Pancreatin|pancreatin|mesh-list
56488867|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56488868|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56488869|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236197|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56488871|NCT04643132|Esketamine|esketamine|mesh-list
56488872|NCT04643132|Analgesics|analgesics|mesh-ancestor
56488873|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
56488874|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488875|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488876|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56488877|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56488878|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
56488879|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
56488880|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488881|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56488882|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56236244|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56210703|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488883|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488884|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488885|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
56488886|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56488887|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56488888|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488889|NCT02899026|Prednisone|prednisone|mesh-list
56488890|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56488891|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56488892|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
56488893|NCT02899026|Hormones|hormones|mesh-ancestor
56488894|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488895|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488896|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56488897|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488898|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
56488899|NCT00559169|Verapamil|verapamil|mesh-list
56488900|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56488901|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56488902|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56488903|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488904|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56488905|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236305|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
56236307|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488906|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
56488907|NCT04642664|Apatinib|apatinib|mesh-list
56488908|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488909|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56488910|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488911|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488912|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56488913|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
56488914|NCT02904759|Coagulants|coagulants|mesh-ancestor
56236350|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56236351|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
56236352|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236353|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236354|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56236355|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56236356|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
55811858|NCT02202837|Etanercept|etanercept|mesh-list
56236357|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236358|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56236359|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56236360|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
56236361|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
56236362|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236363|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56236364|NCT01749228|Etodolac|etodolac|mesh-list
56236365|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56236366|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55743757|NCT02514421|Paclitaxel|paclitaxel|mesh-list
56488915|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56488916|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
56488917|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488918|NCT04642547|Lenvatinib|lenvatinib|mesh-list
56488919|NCT04642547|Gefitinib|gefitinib|mesh-list
56488921|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56488922|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488923|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488924|NCT02898792|Remifentanil|remifentanil|mesh-list
56488925|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56488926|NCT02898792|Narcotics|narcotics|mesh-ancestor
56488927|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488928|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488929|NCT02898792|Analgesics|analgesics|mesh-ancestor
56488930|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
56488931|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488932|NCT04642391|Cosyntropin|cosyntropin|mesh-list
56488933|NCT04642391|Hormones|hormones|mesh-ancestor
56488934|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56488935|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488936|NCT02904564|Fluorouracil|fluorouracil|mesh-list
56236367|NCT01749228|Analgesics|analgesics|mesh-ancestor
56236368|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
56236369|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743765|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
55744225|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
55744226|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744227|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744228|NCT03335059|Mitomycins|mitomycins|mesh-list
55744229|NCT03335059|Mitomycin|mitomycin|mesh-list
55744230|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55744231|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744232|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
55744233|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744234|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55744235|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744246|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
55744247|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
55744249|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55744250|NCT02492503|Carboplatin|carboplatin|mesh-list
55744251|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55744252|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744253|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
55744254|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
55744267|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55776144|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776145|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55744268|NCT03334513|Growth Substances|growth substances|mesh-ancestor
55744269|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744270|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
55744272|NCT02130466|Trametinib|trametinib|mesh-list
55744273|NCT02130466|Dabrafenib|dabrafenib|mesh-list
55744274|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55744275|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744276|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744277|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744278|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744279|NCT03339427|Vitamin D|vitamin d|mesh-list
55744280|NCT03339427|Vitamins|vitamins|mesh-ancestor
55744281|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
55744282|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744283|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55744284|NCT03339349|Enoxaparin|enoxaparin|mesh-list
55744285|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
55744286|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55744287|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55744288|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744290|NCT02496715|Xhance|xhance|mesh-list
55744292|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744293|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55744294|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
56488938|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488939|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56488940|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488941|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56488942|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
56488943|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488944|NCT04642001|Listerine|listerine|mesh-list
56488945|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
56488946|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
56488947|NCT04642001|Protective Agents|protective agents|mesh-ancestor
56488948|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488949|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56488950|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488951|NCT00559286|Telmisartan|telmisartan|mesh-list
56236370|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488952|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56488953|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56488954|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56488955|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488956|NCT04640870|Afatinib|afatinib|mesh-list
56488957|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488958|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56488959|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488960|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488961|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56488962|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
56488963|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488964|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56488965|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56488966|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
56488967|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56488968|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488969|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56488970|NCT02897934|Bupivacaine|bupivacaine|mesh-list
56488971|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
56488972|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
56236371|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56236372|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56236373|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56236374|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56488973|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56488974|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488975|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
56488976|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56488977|NCT04640129|Interferons|interferons|mesh-list
56488978|NCT04640129|Tenofovir|tenofovir|mesh-list
56488979|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
56488980|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488981|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
56488982|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56488983|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56488984|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56488985|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56488986|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56488987|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56488988|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56488989|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
56488990|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144560|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56236375|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236376|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236377|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56488991|NCT02898012|Bevacizumab|bevacizumab|mesh-list
56488992|NCT02898012|Temozolomide|temozolomide|mesh-list
56488993|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56488994|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56488995|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56488996|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56488997|NCT02898012|Growth Substances|growth substances|mesh-ancestor
56488998|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56488999|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
56489000|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56489001|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
56489002|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489004|NCT04640324|Vitamins|vitamins|mesh-list
56489005|NCT04640324|Vitamin E|vitamin e|mesh-list
56489006|NCT04640324|Silybin|silybin|mesh-list
56489007|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
56236378|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56236380|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56489008|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489009|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56489010|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
56489011|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489012|NCT04640324|Protective Agents|protective agents|mesh-ancestor
56489013|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56489014|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489015|NCT04640285|Menthol|menthol|mesh-list
56489016|NCT04640285|Nicotine|nicotine|mesh-list
56489017|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56489018|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
56236381|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236382|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56236383|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236384|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55787062|NCT04973033|Tofacitinib|tofacitinib|mesh-list
55787063|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55787064|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787065|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787066|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
55787067|NCT03061565|Hematinics|hematinics|mesh-ancestor
55787068|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
55787069|NCT02660281|Melphalan|melphalan|mesh-list
55787070|NCT02660281|Busulfan|busulfan|mesh-list
55787071|NCT02660281|Thiotepa|thiotepa|mesh-list
55787072|NCT02660281|Fludarabine|fludarabine|mesh-list
55787073|NCT02660281|Mesna|mesna|mesh-list
55787074|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55787075|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
55787076|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787077|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787078|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55787079|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
55787080|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787081|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787082|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55787083|NCT02660281|Protective Agents|protective agents|mesh-ancestor
55787084|NCT02438995|Cetuximab|cetuximab|mesh-list
55787085|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787086|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787088|NCT05108389|Coagulants|coagulants|mesh-ancestor
55787089|NCT05107921|Bromfenac|bromfenac|mesh-list
55787090|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55787091|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55787092|NCT05107921|Analgesics|analgesics|mesh-ancestor
55787093|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
55787094|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787095|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787096|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55787097|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787098|NCT01669811|Esomeprazole|esomeprazole|mesh-list
55787099|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55787100|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787101|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55787102|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787103|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787104|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55787105|NCT05164081|Clindamycin|clindamycin|mesh-list
55787106|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
55787201|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
55787202|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787203|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55787204|NCT04903093|Famotidine|famotidine|mesh-list
55787205|NCT04903093|Abrocitinib|abrocitinib|mesh-list
55787206|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55787207|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787208|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55787209|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
55787210|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
55787211|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787212|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489019|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489020|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489021|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56489022|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56489023|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
56489024|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489025|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489027|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
56489029|NCT00559481|Dexamethasone|dexamethasone|mesh-list
56489030|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
56489031|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56489032|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56489033|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56489034|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489035|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
56489036|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
56489037|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144561|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236385|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
56236386|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
56236387|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811889|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
55787566|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
55787568|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
55787569|NCT03059615|Doxorubicin|doxorubicin|mesh-list
55787570|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55787571|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787572|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55787573|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55787574|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787575|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787577|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55787578|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787579|NCT04951349|Petrolatum|petrolatum|mesh-list
55787580|NCT04951349|Emollients|emollients|mesh-ancestor
55787581|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
55787582|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
55788055|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55788056|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55788057|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55788058|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788059|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55788060|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55788061|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788062|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
55788063|NCT04431245|Entecavir|entecavir|mesh-list
55788064|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
55788065|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788066|NCT05015335|Adalimumab|adalimumab|mesh-list
55788067|NCT05015335|Methotrexate|methotrexate|mesh-list
55788068|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55788069|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
55788070|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55788071|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788072|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55788074|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788075|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788076|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
55788077|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788078|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55788079|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55788080|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
55788081|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55788082|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55788083|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788084|NCT03056261|Anesthetics|anesthetics|mesh-list
55788085|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788086|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788087|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56489038|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489039|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56489040|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
56489041|NCT00559481|Hormones|hormones|mesh-ancestor
56489042|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56489043|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56489044|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489045|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
56489046|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489047|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56489048|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56489049|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489050|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489051|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56489052|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
56489053|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56489054|NCT02897856|Midazolam|midazolam|mesh-list
56489055|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56489056|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56489057|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489058|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489059|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56489060|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56489061|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236388|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236390|NCT01749371|Vitamin E|vitamin e|mesh-list
56489062|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56489063|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
56489064|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
56489065|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
56489066|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
56489067|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489068|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489069|NCT01236118|Ixekizumab|ixekizumab|mesh-list
56489070|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
56489071|NCT04206631|Doxycycline|doxycycline|mesh-list
56489072|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56489073|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236391|NCT01749371|Tocopherols|tocopherols|mesh-list
56236392|NCT01749371|Tocotrienols|tocotrienols|mesh-list
56236393|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
56236394|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
56236395|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236396|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
56236397|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236398|NCT01749371|Protective Agents|protective agents|mesh-ancestor
55811895|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
56489074|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
56489075|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56489076|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56489077|NCT04639817|Levofloxacin|levofloxacin|mesh-list
56489078|NCT04639817|Ofloxacin|ofloxacin|mesh-list
56489079|NCT04639817|Trimethoprim|trimethoprim|mesh-list
56489080|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56489081|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
56489082|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56489083|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236399|NCT01749384|Bevacizumab|bevacizumab|mesh-list
56236400|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56236401|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
56236402|NCT01749384|Antibodies|antibodies|mesh-list
56236403|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
56489084|NCT04639817|Renal Agents|renal agents|mesh-ancestor
56489085|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56489086|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56489087|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56489088|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489089|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489090|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489091|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56489092|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56489093|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
56489094|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56489095|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56489096|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56489097|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56489098|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56489099|NCT01236001|Lacosamide|lacosamide|mesh-list
56236404|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56236405|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
56236406|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236407|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56236408|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56236409|NCT01749384|Growth Substances|growth substances|mesh-ancestor
56236410|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236411|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
55811906|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
55811907|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55811908|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
56489100|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
56489101|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56489102|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56489103|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56489104|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489105|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
56489106|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56489107|NCT01229254|Amiodarone|amiodarone|mesh-list
56489108|NCT01229254|Betrixaban|betrixaban|mesh-list
56489109|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56489110|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
56236412|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
56236413|NCT01749397|Fluorouracil|fluorouracil|mesh-list
56236414|NCT01749397|Floxuridine|floxuridine|mesh-list
56236415|NCT01749397|Veliparib|veliparib|mesh-list
56236416|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
56236417|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
56236418|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236419|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55811910|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489111|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56489112|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56489113|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489114|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56489115|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56489116|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56489117|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236420|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236421|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56236422|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
56236423|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236424|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56236425|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236426|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
56489118|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56489119|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56489120|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56489121|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56489122|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
56489123|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56489124|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
56489125|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
56489126|NCT04639232|Probenecid|probenecid|mesh-list
56489127|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
56489128|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
56489129|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56489130|NCT04639232|Renal Agents|renal agents|mesh-ancestor
56489131|NCT01235728|Calcitriol|calcitriol|mesh-list
56236427|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56236428|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56236429|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56236430|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55811922|NCT02101281|Mitogens|mitogens|mesh-list
55746153|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56144562|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56489132|NCT01235728|MK 0873|mk 0873|mesh-list
56489133|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56489134|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489135|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56489136|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56489137|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489138|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56489139|NCT01235728|Vitamins|vitamins|mesh-ancestor
56489140|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
56236431|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236432|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
56236433|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811923|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
55788088|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55788089|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788090|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
55788091|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788092|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55788093|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788094|NCT04574479|Morphine|morphine|mesh-list
55788095|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55788097|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788098|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788099|NCT04574479|Analgesics|analgesics|mesh-ancestor
55788100|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
55788101|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788102|NCT04931225|Landiolol|landiolol|mesh-list
55788103|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55788104|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55788105|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
55788107|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788108|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788109|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55788110|NCT04516057|Nabilone|nabilone|mesh-list
55788117|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55788118|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788119|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55788120|NCT02195947|Hormones|hormones|mesh-list
55788121|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788122|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788124|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788125|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55788126|NCT04954339|Bevacizumab|bevacizumab|mesh-list
55788127|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55788128|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788129|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55788130|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55788131|NCT04954339|Growth Substances|growth substances|mesh-ancestor
55788132|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788133|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
55788134|NCT04939753|Sevoflurane|sevoflurane|mesh-list
55788135|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55788136|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55788137|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
55788138|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
55788139|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788140|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788141|NCT04405037|Alvimopan|alvimopan|mesh-list
55788142|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788143|NCT01966263|Epinephrine|epinephrine|mesh-list
55788144|NCT01966263|Racepinephrine|racepinephrine|mesh-list
55788145|NCT01966263|Ropivacaine|ropivacaine|mesh-list
55788146|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
55788147|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
55788148|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
55788149|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788150|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788151|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
55788152|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489141|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56237164|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
56489142|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56489143|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56489144|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489145|NCT00559676|Leucovorin|leucovorin|mesh-list
56489146|NCT00559676|Fluorouracil|fluorouracil|mesh-list
56489147|NCT00559676|Capecitabine|capecitabine|mesh-list
56489148|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
56489149|NCT00559676|Irinotecan|irinotecan|mesh-list
56489150|NCT00559676|Calcium|calcium|mesh-list
56236434|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236435|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56236436|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144563|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56144564|NCT00798018|Lidocaine|lidocaine|mesh-list
56489152|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56489153|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489154|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
56489155|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489156|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56489157|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489158|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56489159|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
56489160|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56236438|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56236439|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56236440|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236441|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236442|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56236443|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56236444|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236445|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56236446|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
56236447|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
56236448|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
56236449|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
56236450|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236451|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811932|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
55811934|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489161|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56489162|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489163|NCT00559676|Antidotes|antidotes|mesh-ancestor
56489164|NCT00559676|Protective Agents|protective agents|mesh-ancestor
56489165|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
56489166|NCT00559676|Vitamins|vitamins|mesh-ancestor
56489167|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
56489168|NCT04639271|Trastuzumab|trastuzumab|mesh-list
56489169|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56489170|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56489171|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489172|NCT04681053|Ivermectin|ivermectin|mesh-list
56236452|NCT01749514|Luspatercept|luspatercept|mesh-list
56236453|NCT01749514|Hematinics|hematinics|mesh-ancestor
56236454|NCT01749540|Luspatercept|luspatercept|mesh-list
56236455|NCT01749540|Hematinics|hematinics|mesh-ancestor
56236456|NCT01749566|Maraviroc|maraviroc|mesh-list
55811947|NCT02201901|Velpatasvir|velpatasvir|mesh-list
56489173|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56489174|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489175|NCT04639193|Acetazolamide|acetazolamide|mesh-list
56489176|NCT04639193|Eszopiclone|eszopiclone|mesh-list
56489177|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56489178|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56489179|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56489180|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56489181|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489182|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489183|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489184|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56489185|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
56489186|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56489187|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
56489188|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56489189|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489190|NCT04639193|Diuretics|diuretics|mesh-ancestor
56236457|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56236458|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56236459|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743982|NCT04495933|Vaccines|vaccines|mesh-list
56489191|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
56489192|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56489193|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489194|NCT01235689|Prednisone|prednisone|mesh-list
56489195|NCT01235689|Adalimumab|adalimumab|mesh-list
56489196|NCT01235689|Azathioprine|azathioprine|mesh-list
56489197|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489198|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
56489199|NCT01235689|Hormones|hormones|mesh-ancestor
56489200|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56489201|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489202|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56489203|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489204|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56489205|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
56489206|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489207|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56489208|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56489209|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
56489210|NCT04638686|Lamivudine|lamivudine|mesh-list
56489211|NCT04638686|Dolutegravir|dolutegravir|mesh-list
56489212|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56489213|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56489214|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489215|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489216|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
56489217|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489219|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56489220|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56489221|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56489222|NCT04680819|Propolis|propolis|mesh-list
56489223|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489224|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
56489225|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489226|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56489227|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489228|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489229|NCT00559715|Bevacizumab|bevacizumab|mesh-list
56489230|NCT00559715|Ranibizumab|ranibizumab|mesh-list
56489231|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56489232|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489233|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56489234|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56489235|NCT00559715|Growth Substances|growth substances|mesh-ancestor
56489236|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489237|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
56489238|NCT02896803|Fluorouracil|fluorouracil|mesh-list
56489239|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
56489240|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
56489241|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236460|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56236461|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56236462|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
56236463|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788782|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
55788783|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788784|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788785|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55788786|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55788787|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788788|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788790|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788791|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55788792|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788793|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788794|NCT03057041|Fentanyl|fentanyl|mesh-list
55788795|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55788796|NCT03057041|Narcotics|narcotics|mesh-ancestor
55788797|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788798|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788799|NCT03057041|Analgesics|analgesics|mesh-ancestor
55788800|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
55788801|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788802|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55788803|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55788818|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788820|NCT04911413|Coagulants|coagulants|mesh-ancestor
55788821|NCT05123053|Amifampridine|amifampridine|mesh-list
55788822|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55788823|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788824|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788825|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55788826|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55788827|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788828|NCT03889795|Metformin|metformin|mesh-list
55788829|NCT03889795|Digoxin|digoxin|mesh-list
55788830|NCT03889795|Simvastatin|simvastatin|mesh-list
55788832|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788833|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55788834|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55788835|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
55788836|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788837|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55788838|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55788839|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788840|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55788842|NCT03889795|Protective Agents|protective agents|mesh-ancestor
55788844|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55788845|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788846|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55788847|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788848|NCT03872791|Paclitaxel|paclitaxel|mesh-list
55788849|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55788850|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489242|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56489243|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489244|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56489245|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
56489246|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489248|NCT02897037|Bivalirudin|bivalirudin|mesh-list
56489249|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
56489250|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56489251|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56489252|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489253|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
56489254|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56489255|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
56489256|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489257|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
56489258|NCT00553683|Poly ICLC|poly iclc|mesh-list
56489259|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56489260|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
56489261|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489262|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56489263|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56489264|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
56489265|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489266|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489267|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56489268|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
56489269|NCT01229176|Vaccines|vaccines|mesh-list
56489270|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56236464|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56236466|NCT01749579|Midazolam|midazolam|mesh-list
56236467|NCT01749579|Propofol|propofol|mesh-list
56236468|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55811959|NCT04762875|Plerixafor|plerixafor|mesh-list
56489271|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
56489272|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489273|NCT01228747|Levetiracetam|levetiracetam|mesh-list
56489274|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
56489275|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
56489276|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
56489277|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56489278|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489279|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489280|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489281|NCT02896413|Analgesics|analgesics|mesh-ancestor
56236469|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236470|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236471|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56236472|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
56236473|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
56489282|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
56489283|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489284|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56489285|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56489286|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56489287|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
56489288|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489289|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489290|NCT00553722|Eplerenone|eplerenone|mesh-list
56489291|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56489292|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
56489293|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56489294|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489295|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56489296|NCT00553722|Diuretics|diuretics|mesh-ancestor
56489297|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
56489298|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56489299|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56489300|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56489301|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56236474|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56236475|NCT01749579|Narcotics|narcotics|mesh-ancestor
56236476|NCT01749579|Analgesics|analgesics|mesh-ancestor
56236477|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
56236478|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236479|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56489302|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56489303|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56489304|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489305|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489306|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489307|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56489308|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
56489309|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56489310|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56236480|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56236481|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56236482|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236483|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
56489311|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56489312|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
56489313|NCT01234675|Milnacipran|milnacipran|mesh-list
56489314|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
56489315|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56489316|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56489317|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56489318|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236484|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
56236485|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236486|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236487|NCT01750060|Fentanyl|fentanyl|mesh-list
56236488|NCT01750060|Naltrexone|naltrexone|mesh-list
56236489|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56489319|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489320|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489321|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489323|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
56489324|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489325|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
56489326|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56489327|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
56489328|NCT02896101|Tacrolimus|tacrolimus|mesh-list
56489329|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56489330|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489331|NCT02896101|Analgesics|analgesics|mesh-ancestor
56489332|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
56489333|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489334|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746166|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
56144566|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
56236491|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236492|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236493|NCT01750060|Analgesics|analgesics|mesh-ancestor
56236494|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
56236495|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489335|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489336|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56489337|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
56489338|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56489339|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
56489340|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56489341|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489342|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489343|NCT02896023|Menotropins|menotropins|mesh-list
56489344|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56489345|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
56489346|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56236496|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56236497|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56236498|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
56236499|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
56236500|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56236501|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56236502|NCT01750099|Lidocaine|lidocaine|mesh-list
56236503|NCT01750099|Epinephrine|epinephrine|mesh-list
56236504|NCT01750099|Fentanyl|fentanyl|mesh-list
56236505|NCT01750099|Bupivacaine|bupivacaine|mesh-list
56236506|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
56236507|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
56236508|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811991|NCT02457325|Carticaine|carticaine|mesh-list
56236509|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236510|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
56236511|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236512|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56236513|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56236514|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56236515|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236516|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236517|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56236518|NCT01750099|Narcotics|narcotics|mesh-ancestor
56236519|NCT01750099|Analgesics|analgesics|mesh-ancestor
55744121|NCT02493283|Dapsone|dapsone|mesh-list
56489347|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489348|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
56489349|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56489350|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56489351|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
56489352|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56489353|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489354|NCT02895672|Exenatide|exenatide|mesh-list
56489355|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56236520|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56236521|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56236522|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
56236523|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56236524|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56236525|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
56236526|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236527|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56236528|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56236529|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
56236530|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56236531|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
56236532|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
56236533|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
56236534|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56236535|NCT01750359|Curcumin|curcumin|mesh-list
56489356|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489357|NCT02895672|Incretins|incretins|mesh-ancestor
56489358|NCT02895672|Hormones|hormones|mesh-ancestor
56489359|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56489360|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56489361|NCT02895750|Metformin|metformin|mesh-list
56489362|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56489363|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489364|NCT01227967|Ribavirin|ribavirin|mesh-list
56489365|NCT01227967|Oseltamivir|oseltamivir|mesh-list
56489366|NCT01227967|Amantadine|amantadine|mesh-list
56489367|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
56489368|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489369|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
56489370|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489371|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489372|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55746170|NCT03900949|Daunorubicin|daunorubicin|mesh-list
56236536|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56236537|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56236538|NCT01750359|Analgesics|analgesics|mesh-ancestor
56236539|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
56236540|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812021|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
56489373|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56489374|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
56489375|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489376|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489377|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489378|NCT01227967|Analgesics|analgesics|mesh-ancestor
56210966|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
56489379|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
56489380|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489381|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56489382|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
56489383|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489384|NCT04637204|Axitinib|axitinib|mesh-list
56489385|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489386|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56489387|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489388|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489389|NCT04637360|Calcitriol|calcitriol|mesh-list
56489390|NCT04637360|Cinacalcet|cinacalcet|mesh-list
56489391|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56489392|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489393|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56489394|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56489395|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489396|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56489397|NCT04637360|Vitamins|vitamins|mesh-ancestor
56489398|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
56489399|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56489400|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56489401|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
56489402|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56489403|NCT04317703|Metformin|metformin|mesh-list
56489404|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56236541|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236542|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56236544|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236545|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489405|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489406|NCT05656534|Suvorexant|suvorexant|mesh-list
56489407|NCT05656534|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56489408|NCT05656534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56489409|NCT05656534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489410|NCT05656534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489411|NCT05656534|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56489412|NCT05656534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489413|NCT05656534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489414|NCT00560222|Lactoferrin|lactoferrin|mesh-list
56489415|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489416|NCT04317508|Benzocaine|benzocaine|mesh-list
56489417|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
56489418|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
56489419|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489420|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489421|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
56236546|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236547|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56236548|NCT01750385|Cephalosporins|cephalosporins|mesh-list
56236549|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144567|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
56489422|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489423|NCT00560300|Vitamin D|vitamin d|mesh-list
56489424|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
56489425|NCT00560300|Calcitriol|calcitriol|mesh-list
56489426|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56489427|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56489428|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
56489429|NCT00560300|Calcium|calcium|mesh-list
56489430|NCT00560300|Sevelamer|sevelamer|mesh-list
56489431|NCT00560300|Vitamins|vitamins|mesh-ancestor
56489432|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
56489433|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489434|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56489435|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56489436|NCT00560300|Antacids|antacids|mesh-ancestor
56489437|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489438|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56489439|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56489440|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56489441|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56489443|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
56489445|NCT02904369|Emtricitabine|emtricitabine|mesh-list
56489446|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
56489447|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489448|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56489449|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56489450|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489451|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489452|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56489453|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56489454|NCT00560378|Tacrolimus|tacrolimus|mesh-list
56489455|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56236551|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56236552|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56236553|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56236554|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812034|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744199|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
56489456|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
56489457|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489458|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56489459|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489460|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489461|NCT02895321|Listerine|listerine|mesh-list
56489462|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
56489463|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
56489464|NCT02895321|Protective Agents|protective agents|mesh-ancestor
56489465|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489466|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56489467|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489468|NCT04635176|Dexamethasone|dexamethasone|mesh-list
56489469|NCT04635176|Epinephrine|epinephrine|mesh-list
56489470|NCT04635176|Bupivacaine|bupivacaine|mesh-list
56489471|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489472|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
56489473|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
56489474|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489475|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489476|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56489477|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
56489478|NCT04635176|Hormones|hormones|mesh-ancestor
56489479|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56489480|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56489481|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489482|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
56489483|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
56489484|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489485|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
56489486|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56236555|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236556|NCT01750463|Chrysarobin|chrysarobin|mesh-list
56236557|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56236558|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489487|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56489488|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
56489489|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489490|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489491|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56489492|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56489493|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56489494|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
56489495|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
56489496|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
56489497|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56489498|NCT02894892|Esomeprazole|esomeprazole|mesh-list
56489499|NCT02894892|Bismuth|bismuth|mesh-list
56489500|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56489501|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56489502|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56489503|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236559|NCT01750463|Analgesics|analgesics|mesh-ancestor
56236560|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
56236561|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236562|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236563|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56236564|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56236565|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55788851|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
55788852|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
55788853|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
55788854|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788855|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
55788858|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788860|NCT04430777|Coagulants|coagulants|mesh-ancestor
55788861|NCT04910477|Atropine|atropine|mesh-list
55788862|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
55788863|NCT04910477|Neostigmine|neostigmine|mesh-list
55788864|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55788865|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788866|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788867|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55788868|NCT04910477|Analgesics|analgesics|mesh-ancestor
55788869|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
55788870|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788871|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55788872|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55788873|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55788874|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
55788875|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788876|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788878|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55788879|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55788880|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
55788881|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55788882|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
55788883|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
55788884|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
55788885|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55788886|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55788887|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
55788888|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55788889|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788890|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55788891|NCT03843151|Itraconazole|itraconazole|mesh-list
55788892|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
55788893|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788894|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55788895|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55788896|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744659|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56489504|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489505|NCT02894892|Antacids|antacids|mesh-ancestor
56489506|NCT04635566|Mebeverine|mebeverine|mesh-list
56489507|NCT04635566|Alverine|alverine|mesh-list
56489508|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
56489509|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
56489510|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
56489511|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489512|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489513|NCT04635293|Simendan|simendan|mesh-list
56489514|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56489515|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
56236566|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
56236567|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56236568|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
56236569|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56236570|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236571|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56236572|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56236573|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56236574|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56236575|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55812041|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56236576|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236577|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56236578|NCT01750541|Valproic Acid|valproic acid|mesh-list
56236579|NCT01750541|Haloperidol|haloperidol|mesh-list
56236580|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
56236581|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
56236582|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
56236583|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236584|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236585|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56236586|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56236587|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55812059|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56489516|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56489517|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56489518|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489519|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489521|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489522|NCT01227889|Dacarbazine|dacarbazine|mesh-list
56489523|NCT01227889|Dabrafenib|dabrafenib|mesh-list
56489524|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56489525|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
56489526|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489527|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489528|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56489529|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489530|NCT02888392|Psyllium|psyllium|mesh-list
56489531|NCT02888392|Cathartics|cathartics|mesh-ancestor
56489532|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56489533|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
56489534|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
56489535|NCT00624676|Salicylates|salicylates|mesh-list
56489536|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56489537|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
56236588|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236589|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236590|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56236591|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
56236592|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236593|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236594|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56236595|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
56489538|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489539|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
56489540|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
56489541|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56489542|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489543|NCT00624676|Analgesics|analgesics|mesh-ancestor
56489544|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
56489545|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489546|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489547|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489548|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56489549|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56489550|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489551|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489552|NCT05655754|Methohexital|methohexital|mesh-list
56489553|NCT05655754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56489554|NCT05655754|Anesthetics, General|anesthetics, general|mesh-ancestor
56489555|NCT05655754|Anesthetics|anesthetics|mesh-ancestor
56489556|NCT05655754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489557|NCT05655754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489558|NCT05655715|Nivolumab|nivolumab|mesh-list
56489559|NCT05655715|Ipilimumab|ipilimumab|mesh-list
56489560|NCT05655715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56489561|NCT05655715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489562|NCT05655715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56489563|NCT05655715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489564|NCT04317235|Ropivacaine|ropivacaine|mesh-list
56489565|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
56489566|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
56489567|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489568|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489569|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
56489570|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489571|NCT00560690|Metformin|metformin|mesh-list
56489572|NCT00560690|Interferons|interferons|mesh-list
56489573|NCT00560690|Ribavirin|ribavirin|mesh-list
56489574|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56489575|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489576|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489577|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
56489578|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489579|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
56236597|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
56236598|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
56236599|NCT01750580|Ipilimumab|ipilimumab|mesh-list
56236600|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56236601|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236602|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55812081|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
56489580|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489581|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
56489582|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56489583|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489584|NCT02903901|Melatonin|melatonin|mesh-list
56489585|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
56489586|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489587|NCT02903901|Protective Agents|protective agents|mesh-ancestor
56489588|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489589|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489590|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56489591|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
56237611|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
56489592|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489593|NCT04634981|Anesthetics|anesthetics|mesh-list
56489594|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489595|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489596|NCT00553449|Rabeprazole|rabeprazole|mesh-list
56489597|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56489598|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56489599|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56489600|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489601|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489602|NCT05655130|Dexamethasone|dexamethasone|mesh-list
56236603|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236604|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
56236605|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55744330|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56489603|NCT05655130|Methylprednisolone|methylprednisolone|mesh-list
56489604|NCT05655130|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56489605|NCT05655130|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56489606|NCT05655130|Prednisolone|prednisolone|mesh-list
56489607|NCT05655130|Prednisolone acetate|prednisolone acetate|mesh-list
56489608|NCT05655130|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56489609|NCT05655130|Prednisolone phosphate|prednisolone phosphate|mesh-list
56489610|NCT05655130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489611|NCT05655130|Antiemetics|antiemetics|mesh-ancestor
56489612|NCT05655130|Autonomic Agents|autonomic agents|mesh-ancestor
56489613|NCT05655130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144569|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746193|NCT02864251|Ipilimumab|ipilimumab|mesh-list
56236606|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236607|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236608|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
56236609|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489614|NCT05655130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489615|NCT05655130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56489616|NCT05655130|Glucocorticoids|glucocorticoids|mesh-ancestor
56489617|NCT05655130|Hormones|hormones|mesh-ancestor
56489618|NCT05655130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56489619|NCT05655130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56489620|NCT05655130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489621|NCT05655130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56236610|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236611|NCT01750723|Acetazolamide|acetazolamide|mesh-list
56236612|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
55812091|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55744368|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
56489622|NCT05655130|Protective Agents|protective agents|mesh-ancestor
56489623|NCT05658484|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56489624|NCT05658484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56489625|NCT05658484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56489626|NCT05658484|Immunologic Factors|immunologic factors|mesh-ancestor
56489627|NCT05658484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489628|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
56489629|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56489630|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489631|NCT04633850|Dexamethasone|dexamethasone|mesh-list
56489632|NCT04633850|Bupivacaine|bupivacaine|mesh-list
56489633|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489634|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
56489635|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
56489636|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489637|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489638|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56489639|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
56489640|NCT04633850|Hormones|hormones|mesh-ancestor
56489641|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56489642|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56489643|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489644|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
56489645|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
56236613|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56236614|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236615|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744579|NCT03323593|Analgesics|analgesics|mesh-ancestor
55744580|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
55744581|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744582|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55744583|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55744584|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55744585|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
55744602|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
55744604|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55744605|NCT04492813|Narcotics|narcotics|mesh-ancestor
55744606|NCT04492813|Analgesics|analgesics|mesh-ancestor
55744607|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
55744608|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744609|NCT03102801|Insulin|insulin|mesh-list
55744610|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55744611|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55744612|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744613|NCT02488057|Liraglutide|liraglutide|mesh-list
55744614|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55744615|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744616|NCT02488057|Incretins|incretins|mesh-ancestor
55744617|NCT02488057|Hormones|hormones|mesh-ancestor
55744618|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744619|NCT04039347|Cyclosporine|cyclosporine|mesh-list
55744620|NCT04039347|Cyclosporins|cyclosporins|mesh-list
55744621|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744622|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744623|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55744624|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
55744625|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744626|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
55744627|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744628|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
55744629|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744630|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55744632|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55777465|NCT02184767|Loxapine|loxapine|mesh-list
55744634|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744635|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744636|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55744637|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55744638|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
55744640|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744641|NCT02488291|Sufentanil|sufentanil|mesh-list
56489646|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489647|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
56489648|NCT04633733|Tacrolimus|tacrolimus|mesh-list
56489649|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56489650|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
56489651|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489652|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56489653|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489654|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489655|NCT05427942|Adalimumab|adalimumab|mesh-list
56489656|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489657|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56489658|NCT05427903|Epinephrine|epinephrine|mesh-list
56489659|NCT05427903|Anesthetics|anesthetics|mesh-list
56489660|NCT05427903|Carticaine|carticaine|mesh-list
56489661|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
56211046|NCT01599312|Trace Elements|trace elements|mesh-ancestor
56489662|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489663|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489664|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56489665|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56489666|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
56237686|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
56489667|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489668|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489669|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56489670|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56489671|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
56489672|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489673|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56236616|NCT01750723|Diuretics|diuretics|mesh-ancestor
56236617|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
56236618|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236619|NCT01750762|Lenalidomide|lenalidomide|mesh-list
56489674|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
56489675|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
56489676|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
56489677|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56489678|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
56489680|NCT05427747|Cefotaxime|cefotaxime|mesh-list
56489681|NCT05427747|Cefoxitin|cefoxitin|mesh-list
56489682|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56489683|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489684|NCT00445406|Bevacizumab|bevacizumab|mesh-list
56489685|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56489686|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489687|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56489688|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56489689|NCT00445406|Growth Substances|growth substances|mesh-ancestor
56489690|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489691|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
56489692|NCT00445523|Interferons|interferons|mesh-list
56489693|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
56489694|NCT00445523|Vaccines|vaccines|mesh-list
56211084|NCT05691010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56211085|NCT05691010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56211086|NCT05691010|Tubulin Modulators|tubulin modulators|mesh-ancestor
56211087|NCT05691010|Antimitotic Agents|antimitotic agents|mesh-ancestor
56211088|NCT05691010|Mitosis Modulators|mitosis modulators|mesh-ancestor
55819010|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
56236620|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
56236621|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236622|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56236623|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56236624|NCT01750762|Growth Substances|growth substances|mesh-ancestor
56236625|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
56236626|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236627|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
56236628|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56236629|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
56236630|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56236631|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
56236632|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236633|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236634|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
56236635|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
56236636|NCT01750801|Propolis|propolis|mesh-list
56236637|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56236638|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236639|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
56236640|NCT01750866|Prednisone|prednisone|mesh-list
56236641|NCT01750866|Lenograstim|lenograstim|mesh-list
55744642|NCT02488291|Dsuvia|dsuvia|mesh-list
55744643|NCT02488291|Ropivacaine|ropivacaine|mesh-list
55744644|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
55744645|NCT02488291|Anesthetics|anesthetics|mesh-list
55744646|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744647|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744648|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
55744657|NCT03323047|Dexamethasone|dexamethasone|mesh-list
55744658|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
56489699|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489701|NCT02903004|Paclitaxel|paclitaxel|mesh-list
56489702|NCT02903004|Carboplatin|carboplatin|mesh-list
56489703|NCT02903004|Doxorubicin|doxorubicin|mesh-list
56489704|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56489705|NCT02903004|Topotecan|topotecan|mesh-list
56489706|NCT02903004|Trabectedin|trabectedin|mesh-list
56489707|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56489708|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489709|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56489710|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56489711|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56489712|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489713|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56489714|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
56489715|NCT02903004|Antiviral Agents|antiviral agents|mesh-ancestor
56489716|NCT02903004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489717|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489718|NCT02903004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56489719|NCT02903004|Immunologic Factors|immunologic factors|mesh-ancestor
56489720|NCT02903004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489721|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56489722|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56489723|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56489724|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56489725|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56489726|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
56236642|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56236643|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
56236644|NCT01750866|Hormones|hormones|mesh-ancestor
56236645|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56236646|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236647|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56236648|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236649|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56236650|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
56236651|NCT01750983|Lenalidomide|lenalidomide|mesh-list
56489727|NCT05427084|Canagliflozin|canagliflozin|mesh-list
56489728|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56489729|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489730|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56489731|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489732|NCT00445796|Artesunate|artesunate|mesh-list
56489733|NCT00445796|Amodiaquine|amodiaquine|mesh-list
56489734|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
56489735|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56489736|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56489737|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489738|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489739|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
56489740|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
56489741|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56489742|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
56489743|NCT01225822|Enoxaparin|enoxaparin|mesh-list
56489744|NCT01225822|Dabigatran|dabigatran|mesh-list
56489745|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
56236653|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
56236654|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236655|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56236656|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56236657|NCT01750983|Growth Substances|growth substances|mesh-ancestor
56236658|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
56236659|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236660|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56236661|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56236662|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236663|NCT01751009|Vitamins|vitamins|mesh-list
56236664|NCT01751009|Vitamin A|vitamin a|mesh-list
56489746|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56489747|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56489748|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489750|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56489751|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
56489752|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489753|NCT00445874|Ketotifen|ketotifen|mesh-list
56489754|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
56489755|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
56489756|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56489757|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
56236665|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
56236666|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
56236667|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236668|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
56489758|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
56489759|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211135|NCT05690646|Ritonavir|ritonavir|mesh-list
56211136|NCT05690646|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56211137|NCT05690646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56211138|NCT05690646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56489760|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489761|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489762|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56489763|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56489764|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56489765|NCT01225549|Budesonide|budesonide|mesh-list
56489766|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489767|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56489768|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
56489769|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489770|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489771|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56489772|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
55746228|NCT03310333|Dinoprostone|dinoprostone|mesh-list
56236669|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236670|NCT01751009|Protective Agents|protective agents|mesh-ancestor
56236671|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56236672|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489773|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
56489774|NCT01225549|Hormones|hormones|mesh-ancestor
56489775|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56489776|NCT05469685|Amoxicillin|amoxicillin|mesh-list
56489777|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56489778|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489779|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
56489780|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489781|NCT00446069|Morphine|morphine|mesh-list
56489782|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56489783|NCT00446069|Narcotics|narcotics|mesh-ancestor
56489784|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489785|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489786|NCT00446069|Analgesics|analgesics|mesh-ancestor
56489787|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
56489788|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489789|NCT02902653|Misoprostol|misoprostol|mesh-list
56489790|NCT02902653|Dinoprostone|dinoprostone|mesh-list
56489791|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56489792|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
56489793|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56489794|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489795|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56236673|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56236674|NCT01751074|Darapladib|darapladib|mesh-list
56236675|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56236676|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56236677|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
56236678|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236679|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56489796|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56489797|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
56489798|NCT00446303|Azacitidine|azacitidine|mesh-list
56489799|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56489800|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
56489801|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489802|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489803|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489804|NCT01223404|Mecamylamine|mecamylamine|mesh-list
56489805|NCT01223404|Nicotine|nicotine|mesh-list
56489806|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56489807|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
56489808|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489809|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489810|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56211150|NCT05690321|Opium|opium|mesh-list
56489811|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56489812|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
56489813|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489814|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489815|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56489816|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56489817|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56489818|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56489819|NCT00446420|Fentanyl|fentanyl|mesh-list
56489820|NCT00446420|Midazolam|midazolam|mesh-list
56489821|NCT00446420|Propofol|propofol|mesh-list
56489822|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56489823|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489824|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489825|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56489826|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
56489827|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
56489828|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56489829|NCT00446420|Narcotics|narcotics|mesh-ancestor
56489830|NCT00446420|Analgesics|analgesics|mesh-ancestor
56489831|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
56489832|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489833|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56489834|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56489835|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56489836|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56489837|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
56489838|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
56236680|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56236681|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236682|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56236683|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
56236684|NCT01751204|Calcium|calcium|mesh-list
56236685|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56489839|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489840|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489841|NCT00446537|Methylphenidate|methylphenidate|mesh-list
56489842|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56489843|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489844|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56489845|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56489846|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56489847|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489848|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
56489849|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489850|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
56489851|NCT00446576|Hematinics|hematinics|mesh-ancestor
56489852|NCT02902302|Ibuprofen|ibuprofen|mesh-list
56489853|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56489854|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489855|NCT02902302|Analgesics|analgesics|mesh-ancestor
56489856|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
56489857|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489858|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211164|NCT05690282|Gabapentin|gabapentin|mesh-list
56489859|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489860|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56236686|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236687|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55812162|NCT02396953|Hormones|hormones|mesh-ancestor
56489861|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56489862|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489863|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489864|NCT01223365|Hydrocodone|hydrocodone|mesh-list
56489865|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56489866|NCT01223365|Narcotics|narcotics|mesh-ancestor
56489867|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489868|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489869|NCT01223365|Analgesics|analgesics|mesh-ancestor
56489870|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
56489871|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489872|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
56489873|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
56489874|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
56489875|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56489876|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489877|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56489878|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489879|NCT04319419|Micronutrients|micronutrients|mesh-list
56489880|NCT04319419|Trace Elements|trace elements|mesh-list
56489881|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489882|NCT05657704|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55746252|NCT02299999|Taxane|taxane|mesh-list
56489883|NCT05657704|Tramadol|tramadol|mesh-list
56236688|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
56236689|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236690|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236691|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56236692|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144570|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
56489884|NCT05657704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56489885|NCT05657704|Narcotics|narcotics|mesh-ancestor
56489886|NCT05657704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489887|NCT05657704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489888|NCT05657704|Analgesics|analgesics|mesh-ancestor
56489889|NCT05657704|Sensory System Agents|sensory system agents|mesh-ancestor
56489890|NCT05657704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489891|NCT05657704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56236693|NCT01751295|Atorvastatin|atorvastatin|mesh-list
56236694|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56236695|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56236696|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
56236697|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236698|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56236699|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56489892|NCT05657704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489893|NCT05657704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56489894|NCT05657704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56489895|NCT00446771|Mannitol|mannitol|mesh-list
56489896|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56489897|NCT00446771|Diuretics|diuretics|mesh-ancestor
56489898|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
56237909|NCT01759524|Lidocaine|lidocaine|mesh-list
56489899|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489900|NCT04317157|Caffeine|caffeine|mesh-list
56489901|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56489902|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489903|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56489904|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489905|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489906|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56489907|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56489908|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
56489909|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236700|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236701|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56236702|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56236703|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236704|NCT01751321|Incretins|incretins|mesh-ancestor
56236705|NCT01751321|Hormones|hormones|mesh-ancestor
56236706|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56236707|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56236708|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
56236709|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236710|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236711|NCT01751347|Lidocaine|lidocaine|mesh-list
56236712|NCT01751347|Bupivacaine|bupivacaine|mesh-list
56236713|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
56236714|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
56236715|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489910|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
56489911|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489912|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
56489913|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489914|NCT04317079|Protective Agents|protective agents|mesh-ancestor
56489915|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211252|NCT05689632|Vitamins|vitamins|mesh-list
56489916|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56489917|NCT03277430|Tacrolimus|tacrolimus|mesh-list
56489918|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56489919|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
56489920|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489921|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56489922|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489923|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812173|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746297|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56236716|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236717|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
56236718|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236719|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56236720|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56236721|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56236722|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236723|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812187|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489924|NCT04699214|Endostar protein|endostar protein|mesh-list
56489925|NCT04699214|Endostatins|endostatins|mesh-list
56489926|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56489927|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56489928|NCT04699214|Growth Substances|growth substances|mesh-ancestor
56489929|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489930|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
56489931|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489932|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
56489933|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56236724|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
56236725|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56236726|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56489934|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56489935|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489936|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56489937|NCT02902380|Analgesics|analgesics|mesh-ancestor
56489938|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
56489939|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56489940|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56489941|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56489942|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56489943|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
56489944|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489945|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489946|NCT01221727|Denosumab|denosumab|mesh-list
56489947|NCT01221727|Midazolam|midazolam|mesh-list
56489948|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56489949|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56489950|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236727|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236728|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236729|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
56236730|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489951|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489952|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56489953|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56489954|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56489955|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56489956|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
56489957|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
56489958|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
56489959|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
56489960|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56489961|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489962|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56489963|NCT01221181|Eculizumab|eculizumab|mesh-list
56489964|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56489965|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746326|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56489966|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
56489967|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489968|NCT03277079|Ezetimibe|ezetimibe|mesh-list
56489969|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56489970|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56489971|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56237995|NCT01759719|Chromium|chromium|mesh-list
56489972|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
56489973|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489974|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56489975|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489976|NCT01220557|Insulin|insulin|mesh-list
56489977|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56489978|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489979|NCT04317001|Modafinil|modafinil|mesh-list
56489980|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56489981|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56489982|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56489983|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56489984|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56489985|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489986|NCT05426499|Fluconazole|fluconazole|mesh-list
56489987|NCT05426499|Isavuconazole|isavuconazole|mesh-list
56236732|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56236733|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236734|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
56236735|NCT01751425|Dasatinib|dasatinib|mesh-list
56236736|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56489988|NCT05426499|Anidulafungin|anidulafungin|mesh-list
56236737|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56489989|NCT05426499|Meropenem|meropenem|mesh-list
56489990|NCT05426499|Cefotaxime|cefotaxime|mesh-list
56489991|NCT05426499|Cefoxitin|cefoxitin|mesh-list
56489992|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
56489993|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56489994|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56489995|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56489996|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56489997|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56489998|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56489999|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
56490000|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490001|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236738|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56236739|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236740|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144571|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490002|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56490003|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56490004|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56490005|NCT00446810|Benphothiamine|benphothiamine|mesh-list
56490006|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56490007|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
56490008|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490009|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
56490010|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
56490011|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490012|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56236742|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490013|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
56490014|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490015|NCT01220167|Ondansetron|ondansetron|mesh-list
56490016|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
56490017|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
56490018|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490019|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490020|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490021|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
56490022|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
56490023|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56490024|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
56490025|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490026|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490027|NCT01220167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56490028|NCT01220167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56236743|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56236744|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236745|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236746|NCT01751828|Sertraline|sertraline|mesh-list
56236747|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
56236748|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236749|NCT01751828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56236750|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56236751|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55812212|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56236752|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236753|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236755|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236756|NCT01751854|Citalopram|citalopram|mesh-list
55812223|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
55746405|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
56236757|NCT01751854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55837729|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
56236758|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56236759|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236760|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236761|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236762|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
56236763|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236764|NCT01751854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56236765|NCT01751854|Antidepressive Agents|antidepressive agents|mesh-ancestor
56236766|NCT01751854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236767|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
56236768|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236769|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56236770|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236771|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236772|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
56236773|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236774|NCT01752075|Lenalidomide|lenalidomide|mesh-list
55812243|NCT02393209|Docetaxel|docetaxel|mesh-list
55744660|NCT03323047|BB 1101|bb 1101|mesh-list
55744661|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744662|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
55744663|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
55744664|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744665|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744666|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55744667|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
55744668|NCT03323047|Hormones|hormones|mesh-ancestor
56236775|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
56236776|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236777|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55812245|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490029|NCT01220167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56490030|NCT01220167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56490031|NCT01220167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56490032|NCT00447239|Insulin|insulin|mesh-list
56490033|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56490034|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490035|NCT05425914|Vitamin D|vitamin d|mesh-list
56490036|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
56490037|NCT05425914|Vitamins|vitamins|mesh-ancestor
56490038|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
56490039|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490040|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56236778|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56236779|NCT01752075|Growth Substances|growth substances|mesh-ancestor
56236780|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
56490041|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56490042|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56490043|NCT00447356|Interferons|interferons|mesh-list
56490044|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
56490045|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490046|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
56490047|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490048|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
55819312|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
56490049|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490050|NCT05425875|Dimercaprol|dimercaprol|mesh-list
56490051|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
56490052|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
55814958|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56236781|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236782|NCT01752153|Silymarin|silymarin|mesh-list
56490053|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490054|NCT00447473|Ketoconazole|ketoconazole|mesh-list
55746446|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56490055|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
56490056|NCT00447473|Analgesics|analgesics|mesh-ancestor
56490057|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
56490058|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490059|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490060|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490061|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56236784|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
56236785|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744851|NCT04493515|Oxytocin|oxytocin|mesh-list
55744852|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
55744853|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55744854|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744855|NCT03318445|Irinotecan|irinotecan|mesh-list
55744856|NCT03318445|Rucaparib|rucaparib|mesh-list
55744857|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55744859|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744860|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744861|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744862|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55744864|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744865|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744866|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744867|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744869|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55744870|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
55744871|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
55744872|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744873|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744875|NCT03316339|Remifentanil|remifentanil|mesh-list
55744876|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55744877|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744878|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744879|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744880|NCT03316339|Analgesics|analgesics|mesh-ancestor
55744881|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
55744882|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744883|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55744884|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55744885|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55744886|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
55744887|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744888|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744889|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55744890|NCT03316339|Narcotics|narcotics|mesh-ancestor
55744892|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55744893|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777669|NCT04752527|Sorafenib|sorafenib|mesh-list
55744894|NCT02490865|Analgesics|analgesics|mesh-ancestor
55744895|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
55744896|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744897|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744898|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744900|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55744901|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
55744902|NCT03318211|Analgesics|analgesics|mesh-ancestor
55744903|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
55744904|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744905|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744906|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
55744907|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744908|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55744909|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
55744910|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55744911|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55752147|NCT03319121|Lansoprazole|lansoprazole|mesh-list
56490062|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56490063|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490064|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490065|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
56490066|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490067|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56490068|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56490069|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56490070|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
56490071|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490072|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56490074|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56490075|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
56490076|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56490077|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490079|NCT03455322|Norepinephrine|norepinephrine|mesh-list
56490080|NCT03455322|Midodrine|midodrine|mesh-list
56236786|NCT01752153|Protective Agents|protective agents|mesh-ancestor
56236787|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236788|NCT01752153|Siderophores|siderophores|mesh-ancestor
56236789|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56236790|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
56490081|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490082|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56490083|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490084|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56490085|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56490086|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
56490087|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490088|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490089|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490090|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
56490091|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
55746518|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
56236791|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
56236792|NCT01752205|Paclitaxel|paclitaxel|mesh-list
56236793|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56236794|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56236795|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236796|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
56236797|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
56236798|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
56236799|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236800|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56236801|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236802|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
56236803|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56236804|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56236805|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236806|NCT01752244|Vitamins|vitamins|mesh-ancestor
56236807|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
56236808|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
56236809|NCT01752270|Cyproterone|cyproterone|mesh-list
56236810|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
56236811|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
56236812|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
56490092|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490093|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56490094|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56490095|NCT05425368|Fluorides|fluorides|mesh-list
56490096|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
56490097|NCT05425368|Protective Agents|protective agents|mesh-ancestor
56490098|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490099|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
56490100|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56490101|NCT00447863|Estradiol|estradiol|mesh-list
56490102|NCT00447863|Estrogens|estrogens|mesh-ancestor
56490103|NCT00447863|Hormones|hormones|mesh-ancestor
56490104|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490105|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490106|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56236813|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56236814|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236815|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236816|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56236817|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
56236818|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56236819|NCT01752322|Lidocaine|lidocaine|mesh-list
56236820|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
56236821|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
56236822|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236823|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236824|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
56236825|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236826|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56236827|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56236828|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56490107|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
56490108|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56490109|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56490110|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56490111|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56490112|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56490113|NCT00448097|Docetaxel|docetaxel|mesh-list
56490114|NCT00448097|Cetuximab|cetuximab|mesh-list
56236829|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236830|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236831|NCT01752517|Vinorelbine|vinorelbine|mesh-list
56236832|NCT01752517|Ifosfamide|ifosfamide|mesh-list
55812299|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
56490115|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490116|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
56490117|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
56490118|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
56490119|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490120|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56490121|NCT00448214|Warfarin|warfarin|mesh-list
56490123|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
56490124|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
56236833|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56236834|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236835|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
56236836|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
56236837|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
56490125|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490126|NCT00448292|Naluzotan|naluzotan|mesh-list
56490127|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56490128|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56490129|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
56490130|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490131|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490132|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490133|NCT02901561|Misoprostol|misoprostol|mesh-list
56490134|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56490135|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
56490136|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56490137|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490138|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56490139|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490140|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
56490141|NCT00448409|Sargramostim|sargramostim|mesh-list
56490142|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
56490143|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490144|NCT02901366|Dotinurad|dotinurad|mesh-list
56490145|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
56490146|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
56490147|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490148|NCT02901366|Renal Agents|renal agents|mesh-ancestor
56490149|NCT03276689|Pregabalin|pregabalin|mesh-list
56490150|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56490151|NCT03276689|Analgesics|analgesics|mesh-ancestor
56490152|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
56490153|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236838|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236839|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56236840|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
56490154|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490155|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
56490156|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56490157|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56490158|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490159|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56490160|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56236841|NCT01752543|Conivaptan|conivaptan|mesh-list
56236842|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56236843|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812309|NCT02384395|Abacavir|abacavir|mesh-list
56490161|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56236844|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
56490162|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56490163|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56490164|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56490165|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56490166|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490167|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
56490168|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
56490169|NCT01220128|Paclitaxel|paclitaxel|mesh-list
56490170|NCT01220128|Docetaxel|docetaxel|mesh-list
56490171|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
56490172|NCT01220128|Carboplatin|carboplatin|mesh-list
56490173|NCT01220128|Doxorubicin|doxorubicin|mesh-list
56490174|NCT01220128|Fluorouracil|fluorouracil|mesh-list
56490175|NCT01220128|Trastuzumab|trastuzumab|mesh-list
56490176|NCT01220128|Epirubicin|epirubicin|mesh-list
56490177|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56236845|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490178|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56211316|NCT05646563|Eculizumab|eculizumab|mesh-list
56490179|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490180|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
56490181|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
56490182|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
56490183|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490184|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490185|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
56490186|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144572|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56236846|NCT01752686|Carboplatin|carboplatin|mesh-list
56236847|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236848|NCT01752699|Methadone|methadone|mesh-list
56236849|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56236850|NCT01752699|Narcotics|narcotics|mesh-ancestor
56236851|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746560|NCT03312283|Growth Substances|growth substances|mesh-ancestor
56490187|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490188|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56490189|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
56490190|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56490191|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56490192|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56490193|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56490194|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490195|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
56490196|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56490197|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56490198|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56490199|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56490201|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490202|NCT04698941|Paclitaxel|paclitaxel|mesh-list
56490203|NCT04698941|Simvastatin|simvastatin|mesh-list
56490204|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56490205|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490206|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
56490207|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
56490208|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
56490209|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490210|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56490211|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56490212|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
56490213|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56490214|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56490215|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490216|NCT02901288|Levofloxacin|levofloxacin|mesh-list
56490217|NCT02901288|Ofloxacin|ofloxacin|mesh-list
56490218|NCT02901288|Rifampin|rifampin|mesh-list
56490219|NCT02901288|Isoniazid|isoniazid|mesh-list
56490220|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
56236852|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490221|NCT02901288|Ethambutol|ethambutol|mesh-list
56490222|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56490223|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490224|NCT02901288|Renal Agents|renal agents|mesh-ancestor
56211319|NCT05646563|Immunologic Factors|immunologic factors|mesh-ancestor
56211320|NCT05646563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211327|NCT05633992|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56211328|NCT05633992|Immunologic Factors|immunologic factors|mesh-ancestor
56211329|NCT05633992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56211330|NCT05618366|Venetoclax|venetoclax|mesh-list
56490225|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56490226|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56490227|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56490228|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490229|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490230|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490231|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56490232|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56490233|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56490234|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
56490235|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
56490236|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56490237|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56490238|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56490239|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56490240|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56490241|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56490242|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56490243|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56490244|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56236855|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236856|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
56236857|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
56236858|NCT01752790|Azathioprine|azathioprine|mesh-list
56490245|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
56490246|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56490247|NCT00448643|Cisplatin|cisplatin|mesh-list
56490248|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490250|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56490251|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56490252|NCT05424393|Analgesics|analgesics|mesh-ancestor
56490253|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
56490254|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490255|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490256|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490257|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490258|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490259|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56236861|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236862|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56236863|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236864|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56236865|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
56236866|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236868|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
56236869|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236870|NCT01752959|Remifentanil|remifentanil|mesh-list
56236871|NCT01752959|Esmolol|esmolol|mesh-list
56236872|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56236873|NCT01752959|Narcotics|narcotics|mesh-ancestor
56236874|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236875|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236876|NCT01752959|Analgesics|analgesics|mesh-ancestor
56236877|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
56236878|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236879|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56236880|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55786885|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
56490260|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
56490261|NCT00448838|Gemcitabine|gemcitabine|mesh-list
56490262|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
56490263|NCT00448838|Cetuximab|cetuximab|mesh-list
56490264|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56490265|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
56490266|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490267|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490268|NCT00448838|Antiviral Agents|antiviral agents|mesh-ancestor
56144573|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56236882|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
56236883|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812346|NCT02347657|Ivacaftor|ivacaftor|mesh-list
56490269|NCT00448838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490270|NCT00448838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238296|NCT01760824|Bismuth|bismuth|mesh-list
56490271|NCT00448838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490272|NCT00448838|Immunologic Factors|immunologic factors|mesh-ancestor
56490273|NCT00448838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490274|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56490275|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
56490276|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56490277|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56490278|NCT01219933|Prednisolone|prednisolone|mesh-list
56490279|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
56490280|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56490281|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
56236884|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236885|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
56236886|NCT01752998|Narcotics|narcotics|mesh-ancestor
55786890|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490282|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490283|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
56490284|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
56490285|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490286|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490287|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490288|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
56490289|NCT01219933|Hormones|hormones|mesh-ancestor
56490290|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490291|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56490292|NCT01219933|Protective Agents|protective agents|mesh-ancestor
56490293|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56236887|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236888|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236889|NCT01752998|Analgesics|analgesics|mesh-ancestor
56236890|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
56236891|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236892|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56236893|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56236894|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
56236895|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236896|NCT01753102|Estradiol|estradiol|mesh-list
56236897|NCT01753102|Estrogens|estrogens|mesh-ancestor
56236898|NCT01753102|Hormones|hormones|mesh-ancestor
55812349|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812350|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
55812351|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55812352|NCT02346721|Velpatasvir|velpatasvir|mesh-list
55812353|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
55812354|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812355|NCT04902625|Naltrexone|naltrexone|mesh-list
55812356|NCT04902625|Bupropion|bupropion|mesh-list
55812357|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55812358|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55812359|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812360|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
55812361|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490294|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490295|NCT05373901|Tretinoin|tretinoin|mesh-list
56490296|NCT05373901|Dinutuximab|dinutuximab|mesh-list
56490297|NCT05373901|Isotretinoin|isotretinoin|mesh-list
56490298|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490299|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
56490300|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56490301|NCT05368441|Midazolam|midazolam|mesh-list
56490302|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56490303|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56236899|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56236900|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236901|NCT01753128|Imipramine|imipramine|mesh-list
55812363|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
56490304|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56490305|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490306|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56490307|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56490308|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56490309|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56490310|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
56490311|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
56490312|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
56490313|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
56490314|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490315|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490316|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
56490317|NCT05468359|Bevacizumab|bevacizumab|mesh-list
56490319|NCT05468359|Atezolizumab|atezolizumab|mesh-list
56490320|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490321|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
56490322|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490323|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490324|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55746602|NCT03301207|Estrogens|estrogens|mesh-ancestor
56236902|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56236903|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
56236904|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236905|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56236906|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56236907|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236908|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236909|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
56236910|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490325|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
56490326|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490327|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490328|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56490329|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56490330|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56490331|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56490332|NCT05468359|Growth Substances|growth substances|mesh-ancestor
56490333|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
56490334|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56490335|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490336|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56490337|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56490338|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490340|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
56490341|NCT05456932|Ferric maltol|ferric maltol|mesh-list
56490342|NCT05456932|Trace Elements|trace elements|mesh-ancestor
56490343|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
56490344|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490345|NCT05456932|Hematinics|hematinics|mesh-ancestor
56490347|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56490348|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56490350|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490351|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56490352|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56236911|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236912|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56236913|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
56236914|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56490353|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490354|NCT05657041|Clopidogrel|clopidogrel|mesh-list
56490355|NCT05657041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56490356|NCT05657041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56490357|NCT05657041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56490358|NCT05657041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56490359|NCT05657041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56490360|NCT05657041|Purinergic Agents|purinergic agents|mesh-ancestor
56490361|NCT05657041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490362|NCT05657041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490363|NCT05657041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139195|NCT05187377|Hormones|hormones|mesh-list
56490364|NCT02887222|Bupivacaine|bupivacaine|mesh-list
56490365|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
56490366|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
56490367|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56490368|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490369|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
56490370|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490371|NCT01218646|Vaccines|vaccines|mesh-list
56490372|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
56236915|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56236916|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56236917|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56490373|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490374|NCT00449423|Acipimox|acipimox|mesh-list
56490375|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56490376|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
56490377|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490378|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56490379|NCT00449501|Budesonide|budesonide|mesh-list
56490380|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
56490381|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490382|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56490383|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
56490384|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490385|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490386|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56490387|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
56490388|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
56490389|NCT00449501|Hormones|hormones|mesh-ancestor
56490390|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56236918|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236919|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
55745490|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55745491|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
55745492|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55745493|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
55745494|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745495|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745497|NCT02479165|Oxycodone|oxycodone|mesh-list
55745498|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55745499|NCT02479165|Narcotics|narcotics|mesh-ancestor
55745500|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745501|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745502|NCT02479165|Analgesics|analgesics|mesh-ancestor
55778069|NCT01959334|Incretins|incretins|mesh-ancestor
55745503|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
55745504|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745505|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
55745506|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55745508|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
55745509|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745511|NCT05714839|Lenalidomide|lenalidomide|mesh-list
55745512|NCT05714839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745513|NCT05714839|Antiemetics|antiemetics|mesh-ancestor
55745514|NCT05714839|Autonomic Agents|autonomic agents|mesh-ancestor
55745515|NCT05714839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745516|NCT05714839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745517|NCT05714839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55745518|NCT05714839|Glucocorticoids|glucocorticoids|mesh-ancestor
55745519|NCT05714839|Hormones|hormones|mesh-ancestor
55745520|NCT05714839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745521|NCT05714839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55745522|NCT05714839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745524|NCT05714839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55745525|NCT05714839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55745526|NCT05714839|Growth Substances|growth substances|mesh-ancestor
55745527|NCT05714839|Growth Inhibitors|growth inhibitors|mesh-ancestor
55745528|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
55745529|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55745530|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745531|NCT05377255|Naloxone|naloxone|mesh-list
55745532|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55745533|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745534|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
55745535|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745536|NCT02475499|Metformin|metformin|mesh-list
55745537|NCT02475499|Pioglitazone|pioglitazone|mesh-list
55745538|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55745539|NCT02475499|Liraglutide|liraglutide|mesh-list
55745540|NCT02475499|Exenatide|exenatide|mesh-list
55745541|NCT02475499|Glimepiride|glimepiride|mesh-list
55745542|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
55745543|NCT02475499|Vildagliptin|vildagliptin|mesh-list
55745544|NCT02475499|Saxagliptin|saxagliptin|mesh-list
55745545|NCT02475499|Acarbose|acarbose|mesh-list
56490391|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56490392|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56490393|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56490394|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
56490395|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490396|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490397|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56236920|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236921|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236922|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56236923|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236924|NCT01753375|Vitamin D|vitamin d|mesh-list
56236926|NCT01753375|Vitamins|vitamins|mesh-ancestor
56236927|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
56236928|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236929|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56236930|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56236931|NCT01753453|Plerixafor|plerixafor|mesh-list
55787030|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
55745546|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55745547|NCT02475499|Repaglinide|repaglinide|mesh-list
55745548|NCT02475499|Gliclazide|gliclazide|mesh-list
55745549|NCT02475499|Glipizide|glipizide|mesh-list
56490398|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56490399|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490400|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
56490401|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
56490402|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
56490403|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490404|NCT01188655|Etanercept|etanercept|mesh-list
56490405|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56490406|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56490407|NCT01188655|Analgesics|analgesics|mesh-ancestor
56236932|NCT01753453|Lenograstim|lenograstim|mesh-list
56236933|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56236934|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
56236935|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236936|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56236937|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56236938|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
56236939|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236940|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55787032|NCT05099575|Oxytocin|oxytocin|mesh-list
56490408|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
56490409|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490410|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490411|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490412|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490413|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490414|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55802362|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
56490415|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
56490416|NCT00449618|Aspirin|aspirin|mesh-list
56490417|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56490418|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56490419|NCT00449618|Analgesics|analgesics|mesh-ancestor
56490420|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
56238458|NCT01761669|Vitamin D|vitamin d|mesh-list
56490421|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490422|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490423|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490424|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490425|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56490426|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56490427|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490428|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56490429|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56490430|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490431|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
56490432|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
56236941|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56236942|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
56236943|NCT01753752|Chitosan|chitosan|mesh-list
56236944|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56236945|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56236946|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56236947|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
56236948|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236949|NCT01753752|Expectorants|expectorants|mesh-ancestor
56490433|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56490434|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56490435|NCT01188538|Analgesics|analgesics|mesh-ancestor
56490436|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
56490437|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490438|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490439|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490440|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56236950|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
56236951|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56236952|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
56236953|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144574|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56490441|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
56490442|NCT00449657|Gemcitabine|gemcitabine|mesh-list
56490443|NCT00449657|Paclitaxel|paclitaxel|mesh-list
56490444|NCT00449657|Carboplatin|carboplatin|mesh-list
56490445|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56490446|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490447|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
56490448|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
56490449|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
56490450|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236954|NCT01753752|Protective Agents|protective agents|mesh-ancestor
56236955|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236956|NCT01753752|Antidotes|antidotes|mesh-ancestor
56236957|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56236958|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55787046|NCT04834063|Selenium|selenium|mesh-list
56490451|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56490452|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
56490453|NCT00449657|Antiviral Agents|antiviral agents|mesh-ancestor
56490454|NCT00449657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490455|NCT00449657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490456|NCT00449657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490457|NCT00449657|Immunologic Factors|immunologic factors|mesh-ancestor
56490458|NCT00449657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490459|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
56490460|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
56490461|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56490462|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56490463|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490464|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490465|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490466|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490467|NCT03276143|Enoxaparin|enoxaparin|mesh-list
56490468|NCT03276143|Apixaban|apixaban|mesh-list
56236959|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
56236960|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56236961|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
56236962|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
56236963|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
56236964|NCT01753752|Coagulants|coagulants|mesh-ancestor
56236965|NCT01753882|Citalopram|citalopram|mesh-list
56236966|NCT01753882|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56236967|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56236968|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236969|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236970|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236971|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
56236972|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236973|NCT01753882|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56236974|NCT01753882|Antidepressive Agents|antidepressive agents|mesh-ancestor
56236975|NCT01753882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236976|NCT01754116|Cabotegravir|cabotegravir|mesh-list
56236977|NCT01754116|Midazolam|midazolam|mesh-list
56236978|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56236979|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56236980|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236981|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236982|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56490469|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
56490470|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56490471|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56490472|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490473|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56490474|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
56490475|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56490476|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
56490477|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236983|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56236984|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236985|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56236986|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
56236987|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
56236988|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
56236989|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
56236990|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236991|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236992|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56236993|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56236994|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236995|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56236996|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56236997|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
55812435|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812436|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56236998|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237000|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56490478|NCT00449774|Lamotrigine|lamotrigine|mesh-list
56490479|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
56490480|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56490481|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56490482|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490483|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56490484|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490485|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56490487|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56490488|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56490489|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56490490|NCT02900742|Gemcitabine|gemcitabine|mesh-list
56490491|NCT02900742|Docetaxel|docetaxel|mesh-list
56490492|NCT02900742|Pemetrexed|pemetrexed|mesh-list
56490493|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56490494|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
56490495|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490496|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490497|NCT02900742|Antiviral Agents|antiviral agents|mesh-ancestor
56490498|NCT02900742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812449|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
56237001|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237002|NCT01754220|Montelukast|montelukast|mesh-list
56237003|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55812453|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
56490499|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490500|NCT02900742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490501|NCT02900742|Immunologic Factors|immunologic factors|mesh-ancestor
56490502|NCT02900742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490503|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
56490504|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
56490505|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
56490506|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56490507|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56490508|NCT00449813|Pantoprazole|pantoprazole|mesh-list
56490509|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56490510|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490511|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56490512|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490513|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490514|NCT01218100|Lisinopril|lisinopril|mesh-list
56490515|NCT01218100|Nebivolol|nebivolol|mesh-list
56490516|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56490517|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
56490518|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490519|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490520|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56490521|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56490522|NCT01218100|Protective Agents|protective agents|mesh-ancestor
56490523|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746628|NCT03311581|Propofol|propofol|mesh-list
56237004|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
56490524|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
56490525|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56490526|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56490527|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56490528|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
56490529|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490530|NCT00450008|Thalidomide|thalidomide|mesh-list
56490531|NCT00450008|Docetaxel|docetaxel|mesh-list
56490532|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490533|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56490534|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56490535|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56490536|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490537|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490538|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
56490539|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490540|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
56490541|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56490542|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237005|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56237006|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
56237007|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812458|NCT02250651|Timolol|timolol|mesh-list
56490543|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56490544|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56490545|NCT00450008|Growth Substances|growth substances|mesh-ancestor
56490546|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
56490547|NCT02900469|Denosumab|denosumab|mesh-list
56490548|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56490549|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490550|NCT00450086|Budesonide|budesonide|mesh-list
56490551|NCT00450086|Mesalamine|mesalamine|mesh-list
56490552|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490553|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56490554|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
56490555|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490556|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490557|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56490558|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
56490559|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
56490560|NCT00450086|Hormones|hormones|mesh-ancestor
56237008|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237009|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56237010|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56490561|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490562|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56490563|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56490564|NCT00450086|Analgesics|analgesics|mesh-ancestor
56490565|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
56490566|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490567|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
56490568|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490569|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56490570|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490571|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490572|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
56490573|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746630|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56237011|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237012|NCT01754285|Octreotide|octreotide|mesh-list
56237013|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56237014|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237015|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237016|NCT01754324|Methadone|methadone|mesh-list
56237017|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56237018|NCT01754324|Narcotics|narcotics|mesh-ancestor
56490574|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490575|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56490577|NCT00450164|Prazosin|prazosin|mesh-list
56490578|NCT00450164|Isosorbide|isosorbide|mesh-list
56490579|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56490580|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56490581|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56490582|NCT00450164|Diuretics|diuretics|mesh-ancestor
56490583|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
56490584|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490585|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
56490586|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56490587|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490588|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56490589|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56490590|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56490591|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56490592|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
56490593|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490594|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56490595|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56490596|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
56490597|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
56490598|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490599|NCT02900157|Durvalumab|durvalumab|mesh-list
56490600|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56490601|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490602|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
56490603|NCT02900430|Clotrimazole|clotrimazole|mesh-list
56490604|NCT02900430|Miconazole|miconazole|mesh-list
56490605|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490606|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56490607|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56490608|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56490609|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490610|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490611|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56490612|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
56490613|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490614|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490615|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56490616|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56211479|NCT05338021|Vancomycin|vancomycin|mesh-list
56490619|NCT00450203|Epirubicin|epirubicin|mesh-list
56490620|NCT00450203|Lapatinib|lapatinib|mesh-list
56490621|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56490622|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490623|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56490624|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56490625|NCT00450203|Growth Substances|growth substances|mesh-ancestor
56490626|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490627|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
56490628|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56490629|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
56237046|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
56237047|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55745551|NCT02475499|Voglibose|voglibose|mesh-list
55745552|NCT02475499|Tolbutamide|tolbutamide|mesh-list
55745553|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
55745554|NCT02475499|Nateglinide|nateglinide|mesh-list
55745555|NCT02475499|Miglitol|miglitol|mesh-list
55745556|NCT02475499|Troglitazone|troglitazone|mesh-list
55745557|NCT02475499|Meglitinide|meglitinide|mesh-list
55745558|NCT02475499|Acetohexamide|acetohexamide|mesh-list
55745559|NCT02475499|Buformin|buformin|mesh-list
55745560|NCT02475499|Phenformin|phenformin|mesh-list
55745561|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
55745562|NCT02475499|Glibornuride|glibornuride|mesh-list
55745563|NCT02475499|Tolazamide|tolazamide|mesh-list
55745564|NCT02475499|Carbutamide|carbutamide|mesh-list
55745565|NCT02475499|Gliquidone|gliquidone|mesh-list
55745566|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55745567|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
55745568|NCT02475499|Incretins|incretins|mesh-list
55745570|NCT02475499|Hormones|hormones|mesh-ancestor
55789024|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745571|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745572|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
55745573|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745574|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745575|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55745576|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55745577|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745578|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
55745579|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
55745581|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745582|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745583|NCT03375645|Analgesics|analgesics|mesh-ancestor
55745584|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
55745585|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745587|NCT03136809|Trace Elements|trace elements|mesh-ancestor
55745588|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
55745589|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745590|NCT02475421|Glucagon|glucagon|mesh-list
55745591|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55745593|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745594|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745595|NCT03646617|Nivolumab|nivolumab|mesh-list
55745596|NCT03646617|Ipilimumab|ipilimumab|mesh-list
55745597|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55745598|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745599|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55745600|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745601|NCT02475343|Riboflavin|riboflavin|mesh-list
55745602|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
55745603|NCT02475343|Vitamins|vitamins|mesh-ancestor
55745604|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
55745605|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745606|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55745607|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
55745608|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55745609|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55745611|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
55745612|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745613|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
55745614|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745616|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
55745617|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55745619|NCT03101085|Hormones|hormones|mesh-ancestor
55745620|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752225|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56490630|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490631|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56490632|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56490633|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56490634|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490635|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56490636|NCT00450281|Antibodies|antibodies|mesh-list
56490637|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
56490638|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490639|NCT04699097|Azithromycin|azithromycin|mesh-list
56490640|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56490641|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490642|NCT04698746|Anesthetics|anesthetics|mesh-list
56490643|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
56238671|NCT01762787|Cantharidin|cantharidin|mesh-list
56490644|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56490645|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490646|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
56490647|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237048|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237049|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56237050|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
56490648|NCT00450320|Sirolimus|sirolimus|mesh-list
56490649|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56490650|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490651|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56490652|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490653|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
56490654|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490655|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
56490656|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237051|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237052|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237053|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
56490657|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
56490658|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56490659|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
56490660|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490661|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56490662|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490663|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
56490664|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237054|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237055|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56237056|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237057|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
56237058|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490665|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
56490666|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56490667|NCT00450398|Protective Agents|protective agents|mesh-ancestor
56490668|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
56490669|NCT05420805|Butyric Acid|butyric acid|mesh-list
56490670|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
56490671|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
56490672|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56490673|NCT05420805|Protective Agents|protective agents|mesh-ancestor
56211482|NCT05338008|Vancomycin|vancomycin|mesh-list
56490674|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237059|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56237061|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
56237062|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
56237063|NCT01754831|Protective Agents|protective agents|mesh-ancestor
56237064|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237065|NCT01754844|AZD7624|azd7624|mesh-list
56237066|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56490675|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
56490676|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
56490677|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490678|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490679|NCT00450515|Capecitabine|capecitabine|mesh-list
56490680|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56490681|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
56490682|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490683|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490684|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
56490685|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
56490686|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
56490687|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56490688|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56490689|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237067|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237068|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237070|NCT01754870|Lenalidomide|lenalidomide|mesh-list
55889141|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889142|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55889143|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
55889144|NCT01919086|Hormones|hormones|mesh-ancestor
55889145|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889146|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55889148|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
55889149|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55889150|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55889151|NCT01919086|Growth Substances|growth substances|mesh-ancestor
55889152|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
55889153|NCT04121091|Pramipexole|pramipexole|mesh-list
55889154|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
56052035|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
56052036|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052037|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889157|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889158|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55889159|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55889160|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
55889161|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
55889162|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889163|NCT03283605|Durvalumab|durvalumab|mesh-list
55889170|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889171|NCT01896544|Vitamins|vitamins|mesh-ancestor
55889172|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
55889173|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55889174|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
55889175|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
55889176|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55889177|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889178|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55889179|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889180|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55889181|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55889182|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889183|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889184|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55889185|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889186|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889187|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
55889188|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889196|NCT01932112|Analgesics|analgesics|mesh-ancestor
55889197|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
55889198|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889199|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889200|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55889201|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
55889202|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55889203|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
56237071|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56237072|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56237073|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237074|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
56237075|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746751|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
55838057|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55889204|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
55889205|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889206|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889207|NCT04120311|Dexamethasone|dexamethasone|mesh-list
56490690|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490691|NCT04447989|Urological Agents|urological agents|mesh-ancestor
56490692|NCT00450827|Bevacizumab|bevacizumab|mesh-list
56490693|NCT00450827|Antibodies|antibodies|mesh-list
56490694|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56490695|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56490696|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490697|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56490698|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56490699|NCT00450827|Growth Substances|growth substances|mesh-ancestor
56490700|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490701|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
56490702|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
56490703|NCT00450944|Immunotoxins|immunotoxins|mesh-list
56490704|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
56490705|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490706|NCT00451061|Tamsulosin|tamsulosin|mesh-list
56490707|NCT00451061|Alfuzosin|alfuzosin|mesh-list
56490708|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56490709|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56490710|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56490711|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
56490712|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490713|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490714|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490715|NCT00451061|Urological Agents|urological agents|mesh-ancestor
56490716|NCT02931383|Liraglutide|liraglutide|mesh-list
56490717|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237076|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237077|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56238747|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56490718|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490719|NCT02931383|Incretins|incretins|mesh-ancestor
56490720|NCT02931383|Hormones|hormones|mesh-ancestor
56490721|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490722|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
56490723|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
56490724|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56490725|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56237078|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56237079|NCT01754870|Growth Substances|growth substances|mesh-ancestor
56237080|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
55871453|NCT01017250|Bevacizumab|bevacizumab|mesh-list
55746756|NCT03299257|Donepezil|donepezil|mesh-list
55787216|NCT04529785|Ethanol|ethanol|mesh-list
56490726|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490727|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490728|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490729|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490730|NCT01187953|Tacrolimus|tacrolimus|mesh-list
56490731|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490732|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
56490733|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490734|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56490735|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490736|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490737|NCT00624325|Interferons|interferons|mesh-list
56237081|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56237083|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237084|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
56237085|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
56237086|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56490738|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
56490739|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
56490740|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490742|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490743|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
56490744|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490745|NCT04262817|Nicotine|nicotine|mesh-list
56490746|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56490747|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
56490748|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490749|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490750|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56490751|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56490752|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
56490753|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490754|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490755|NCT02931188|Anacetrapib|anacetrapib|mesh-list
56490756|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56490757|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56490758|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
56490759|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490760|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56490761|NCT01217944|Ranibizumab|ranibizumab|mesh-list
56490762|NCT01217944|Verteporfin|verteporfin|mesh-list
56490763|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56490764|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56490765|NCT01217944|Growth Substances|growth substances|mesh-ancestor
56490766|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490767|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
56490768|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490769|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56490770|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
56490771|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
56490772|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490773|NCT01187446|Vorinostat|vorinostat|mesh-list
56490774|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490775|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56490776|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490777|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490778|NCT02931071|Plerixafor|plerixafor|mesh-list
56490779|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56490780|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56490781|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
56237087|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237088|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237089|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
56490782|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490783|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
56490784|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56490785|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
56490786|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
56490787|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490788|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490789|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490790|NCT01187407|Serotonin|serotonin|mesh-list
56490791|NCT01187407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56490792|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56490793|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
56490794|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490795|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490796|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490797|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56490798|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56490799|NCT01186939|Azacitidine|azacitidine|mesh-list
56490800|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56490801|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
56237091|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237092|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237093|NCT01754961|Vitamin D|vitamin d|mesh-list
56237094|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
56237095|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
56237096|NCT01754961|Vitamins|vitamins|mesh-list
56237097|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
56237098|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237099|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56237100|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56237101|NCT01754974|Ribavirin|ribavirin|mesh-list
56237102|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56237103|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
56237104|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237105|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
56237107|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
56490802|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490803|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490804|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490805|NCT04480502|Ipilimumab|ipilimumab|mesh-list
56490806|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56490807|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490808|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56490809|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490810|NCT04447040|Acetaminophen|acetaminophen|mesh-list
56490811|NCT04447040|Naproxen|naproxen|mesh-list
56490812|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56490813|NCT04447040|Analgesics|analgesics|mesh-ancestor
56490814|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
56490815|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490816|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490817|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
56490818|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56490819|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490820|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490821|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
56237129|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237130|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490822|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56490823|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490824|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490825|NCT05321043|Riboflavin|riboflavin|mesh-list
56490826|NCT05321043|Vitamins|vitamins|mesh-ancestor
56490827|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
56490828|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490829|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
56490830|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56490831|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
56237132|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56237133|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237134|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56237135|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56237136|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490832|NCT02930954|Gemcitabine|gemcitabine|mesh-list
56490833|NCT02930954|Bevacizumab|bevacizumab|mesh-list
56490834|NCT02930954|Carboplatin|carboplatin|mesh-list
56490835|NCT02930954|Pemetrexed|pemetrexed|mesh-list
56490836|NCT02930954|Gefitinib|gefitinib|mesh-list
56490837|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56490838|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490839|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56490840|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56490841|NCT02930954|Growth Substances|growth substances|mesh-ancestor
56490842|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490843|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
56490844|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56490845|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
56490846|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490847|NCT02930954|Antiviral Agents|antiviral agents|mesh-ancestor
56490848|NCT02930954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490849|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746765|NCT02466373|Analgesics|analgesics|mesh-ancestor
56237137|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237138|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237139|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56490850|NCT02930954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490851|NCT02930954|Immunologic Factors|immunologic factors|mesh-ancestor
56490852|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56490853|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56490854|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56490855|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56490856|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56490857|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490858|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490859|NCT05289492|Dexamethasone|dexamethasone|mesh-list
56490860|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490861|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
56490862|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
56490863|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490864|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490865|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490866|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
56490867|NCT05289492|Hormones|hormones|mesh-ancestor
56490868|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490869|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237140|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55871454|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55889208|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
55889209|NCT04120311|BB 1101|bb 1101|mesh-list
55889210|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889211|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
55889212|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
55889213|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889214|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889215|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55889216|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
55889217|NCT04120311|Hormones|hormones|mesh-ancestor
55889218|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889219|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55889220|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889221|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
55889222|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889223|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889224|NCT01897402|Vaccines|vaccines|mesh-list
55889225|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
56052038|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
56490870|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490872|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56490873|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
56490874|NCT02930057|Hormones|hormones|mesh-ancestor
56490875|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490876|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490877|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56490878|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
56490879|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
56490880|NCT04024761|Fludarabine|fludarabine|mesh-list
56490881|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490882|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
56490883|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490884|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237141|NCT01755299|Caffeine|caffeine|mesh-list
56237142|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56237143|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237144|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56237145|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237146|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237147|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56237148|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56237149|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
56237150|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237151|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
56237152|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56237153|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56237154|NCT01755338|Prednisolone|prednisolone|mesh-list
56237155|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
56237156|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56237157|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
56237158|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237159|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
56237160|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
56237161|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237162|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237163|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56237165|NCT01755338|Hormones|hormones|mesh-ancestor
56237166|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237167|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56237168|NCT01755338|Protective Agents|protective agents|mesh-ancestor
56490885|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56490886|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
56490887|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490888|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490889|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56490890|NCT02929901|Caffeine|caffeine|mesh-list
56490891|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56490892|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237169|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237170|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237171|NCT01755377|Benzonidazole|benzonidazole|mesh-list
56237172|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237173|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
55812614|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
55812615|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812616|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812617|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55812618|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55812619|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
55812620|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
56237174|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237175|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56237176|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56237177|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56237178|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237179|NCT01755403|Benzonidazole|benzonidazole|mesh-list
56237180|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237181|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
56237182|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237183|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56237184|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56237185|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56237186|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237187|NCT01755468|Insulin|insulin|mesh-list
56237188|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56237189|NCT01755468|Metformin|metformin|mesh-list
56237190|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
56237191|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
56237192|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237193|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237194|NCT01755494|Metformin|metformin|mesh-list
56237195|NCT01755494|Saxagliptin|saxagliptin|mesh-list
56490893|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56490894|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490895|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490896|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56490897|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56490898|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
56490899|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490900|NCT02929706|Azathioprine|azathioprine|mesh-list
56490901|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
56211543|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56211544|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237197|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237198|NCT01755494|Incretins|incretins|mesh-ancestor
56237199|NCT01755494|Hormones|hormones|mesh-ancestor
56237200|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237201|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56490902|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490903|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56490904|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490905|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56490906|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
56490907|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490908|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56490910|NCT03993132|Glucagon|glucagon|mesh-list
56490911|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56237202|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
56237203|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237204|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237205|NCT01755520|Aspirin|aspirin|mesh-list
56490912|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56490913|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490914|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56490915|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490916|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490917|NCT03993132|Hormones|hormones|mesh-ancestor
56490918|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490919|NCT03993132|Incretins|incretins|mesh-ancestor
56490920|NCT00553878|Dutasteride|dutasteride|mesh-list
56490921|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56490922|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56490923|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490924|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237206|NCT01755520|Ticagrelor|ticagrelor|mesh-list
56237207|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56237208|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56237209|NCT01755520|Analgesics|analgesics|mesh-ancestor
56490925|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
56490926|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490927|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490928|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56490929|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56490930|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490931|NCT05219409|Incretins|incretins|mesh-ancestor
56490932|NCT05219409|Hormones|hormones|mesh-ancestor
56490933|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56490934|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56490935|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
56490936|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56490937|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238976|NCT01764581|Tacrolimus|tacrolimus|mesh-list
56490938|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56490939|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
56490940|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
55746814|NCT02466919|Renal Agents|renal agents|mesh-ancestor
56237210|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
56237211|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237212|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237213|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237214|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56052039|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052040|NCT01798394|Progesterone|progesterone|mesh-list
56052041|NCT01798394|Progestins|progestins|mesh-ancestor
56052042|NCT01798394|Hormones|hormones|mesh-ancestor
55889226|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889227|NCT01897792|Vitamins|vitamins|mesh-list
55889242|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889243|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
55889244|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889245|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889246|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55889247|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
55889248|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
55889249|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55889250|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55889251|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55889252|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55889253|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
55753179|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
55889255|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889256|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
55889257|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
55889258|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55889259|NCT04126083|Lofexidine|lofexidine|mesh-list
55889260|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55889261|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55889262|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889263|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
55889264|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889265|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55889266|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55889267|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55889268|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
55889269|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889270|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889271|NCT01935622|Doxycycline|doxycycline|mesh-list
55889272|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55889273|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889274|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
55889275|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55889276|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55889277|NCT03010917|Ethanol|ethanol|mesh-list
55889278|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56490941|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490942|NCT05184192|Gabapentin|gabapentin|mesh-list
56490943|NCT05184192|Analgesics|analgesics|mesh-ancestor
56490944|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
56490945|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490946|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490947|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
56490948|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56490949|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56490950|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56490951|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56490952|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56490953|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56490954|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490955|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237215|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56237216|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56237217|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237218|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56237219|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56237220|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812641|NCT02340949|Vitamins|vitamins|mesh-ancestor
55787539|NCT04952051|Diuretics|diuretics|mesh-ancestor
56490956|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
56490957|NCT02929121|Doxycycline|doxycycline|mesh-list
56490958|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56490959|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211576|NCT05106192|Bexarotene|bexarotene|mesh-list
56490960|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
56490961|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56490962|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56490963|NCT02929394|Trabectedin|trabectedin|mesh-list
56490964|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56490965|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
56490966|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237221|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
56237222|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56237223|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56237224|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55787551|NCT04431713|Exenatide|exenatide|mesh-list
56490967|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56490968|NCT02929316|Vedolizumab|vedolizumab|mesh-list
56490969|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56490970|NCT05134974|Phentolamine|phentolamine|mesh-list
56490971|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56490972|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56490973|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56490974|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56490975|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
56490976|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490977|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490978|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237225|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
56237226|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237228|NCT01755559|Lumefantrine|lumefantrine|mesh-list
56237229|NCT01755559|Artemether|artemether|mesh-list
56237230|NCT01755559|Piperaquine|piperaquine|mesh-list
56490979|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56490980|NCT02928965|Minocycline|minocycline|mesh-list
56490981|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56490982|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490983|NCT02928692|Minocycline|minocycline|mesh-list
56490984|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56490985|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56490987|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56490988|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237231|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56237232|NCT01755559|Amodiaquine|amodiaquine|mesh-list
56237233|NCT01755559|Artenimol|artenimol|mesh-list
56237234|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
56237235|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56490989|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56490990|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56490991|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56490992|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
56490993|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
56490994|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56490995|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56490996|NCT02928419|Lenalidomide|lenalidomide|mesh-list
56490997|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
56490998|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56490999|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56491000|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56491001|NCT02928419|Growth Substances|growth substances|mesh-ancestor
56491002|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
55746950|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56237236|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56237237|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237238|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237239|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
56237240|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
55787567|NCT04436419|Vitamins|vitamins|mesh-ancestor
56491003|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491004|NCT03690921|Cisplatin|cisplatin|mesh-list
56491005|NCT03690921|Fluorouracil|fluorouracil|mesh-list
56491006|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491007|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
56491008|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491009|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56491010|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491011|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
56491012|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491013|NCT02928614|Liraglutide|liraglutide|mesh-list
56491014|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56491015|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491016|NCT02928614|Incretins|incretins|mesh-ancestor
56491017|NCT02928614|Hormones|hormones|mesh-ancestor
56491018|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491019|NCT03685500|Emtricitabine|emtricitabine|mesh-list
56491020|NCT03685500|Darunavir|darunavir|mesh-list
56491021|NCT03685500|Cobicistat|cobicistat|mesh-list
56491022|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
56237241|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56237242|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
56237243|NCT01755572|Liraglutide|liraglutide|mesh-list
56491023|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56211585|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491024|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56491025|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56491026|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491027|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491028|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56491029|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56491030|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56491031|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56491032|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
56491033|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56491034|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56491035|NCT02928575|Temozolomide|temozolomide|mesh-list
56491036|NCT02928575|Sunitinib|sunitinib|mesh-list
56491037|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56491038|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
55747028|NCT02465749|Vitamins|vitamins|mesh-list
56237244|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237245|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237246|NCT01755572|Incretins|incretins|mesh-ancestor
55787576|NCT04951505|Cefepime|cefepime|mesh-list
56491039|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491040|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491041|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56491042|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56491043|NCT02928575|Growth Substances|growth substances|mesh-ancestor
56491044|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491045|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
56491046|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56491047|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491048|NCT02927951|Pregabalin|pregabalin|mesh-list
56237247|NCT01755572|Hormones|hormones|mesh-ancestor
56237248|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237249|NCT01755611|Minocycline|minocycline|mesh-list
56237250|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56237251|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237252|NCT01755663|Metoprolol|metoprolol|mesh-list
56237253|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56237254|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56491049|NCT02927951|Analgesics|analgesics|mesh-ancestor
56491050|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
56491051|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491052|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491053|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
56491054|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56491055|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56491056|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491057|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56491058|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56491059|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56491060|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56491061|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56491062|NCT03478488|Gemcitabine|gemcitabine|mesh-list
56237255|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
56237256|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
56237257|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237258|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237259|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56237260|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56237261|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56237262|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
56237263|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237264|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237265|NCT01755676|Orlistat|orlistat|mesh-list
56237266|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237267|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237268|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56237269|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56237270|NCT01755728|Acetaminophen|acetaminophen|mesh-list
56237271|NCT01755728|Ibuprofen|ibuprofen|mesh-list
56237272|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56237273|NCT01755728|Analgesics|analgesics|mesh-ancestor
56237274|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
56237275|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491063|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
56491064|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56491065|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
56491066|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491067|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491068|NCT03478488|Antiviral Agents|antiviral agents|mesh-ancestor
56491069|NCT03478488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491070|NCT03478488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237293|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56237294|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237295|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237296|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
56237297|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237298|NCT01755897|Paclitaxel|paclitaxel|mesh-list
56237299|NCT01755897|Cisplatin|cisplatin|mesh-list
56237300|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55871455|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491071|NCT03478488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491072|NCT03478488|Immunologic Factors|immunologic factors|mesh-ancestor
56491073|NCT03478488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491074|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
56491075|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56491076|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491077|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56491078|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56491079|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491080|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491081|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491082|NCT02927405|Gabapentin|gabapentin|mesh-list
56237301|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237302|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
56237303|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
56237304|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
56237305|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237307|NCT01755923|Gefitinib|gefitinib|mesh-list
56237308|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237309|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
56237310|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
56237311|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
56237312|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237313|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56237314|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237315|NCT01756040|Lactulose|lactulose|mesh-list
56237316|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56237317|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56237318|NCT01756105|Insulin|insulin|mesh-list
56237319|NCT01756105|Metformin|metformin|mesh-list
56237320|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
56237321|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
56237322|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
56237323|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55812714|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237325|NCT01756131|Cabotegravir|cabotegravir|mesh-list
56237326|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56237327|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56491083|NCT02927405|Analgesics|analgesics|mesh-ancestor
56491084|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
56491085|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491086|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491087|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
56491088|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56491089|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56491090|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56491091|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56491092|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56491093|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56491094|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491095|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491097|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
56491098|NCT05005299|Fludarabine|fludarabine|mesh-list
56491099|NCT05005299|Venetoclax|venetoclax|mesh-list
56237328|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237329|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237330|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55747127|NCT01612351|Paclitaxel|paclitaxel|mesh-list
55788073|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
56491100|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491101|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
56491102|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491103|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491104|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56491105|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
56491106|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491107|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491108|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56491109|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55871457|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55871458|NCT01017250|Growth Substances|growth substances|mesh-ancestor
56237331|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56237332|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
56237333|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237334|NCT01756170|Paclitaxel|paclitaxel|mesh-list
56237335|NCT01756170|Cisplatin|cisplatin|mesh-list
56237336|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56237337|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237338|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
56237339|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
56237340|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
56237341|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237342|NCT01756183|Paclitaxel|paclitaxel|mesh-list
56237343|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56237344|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237345|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
56491110|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
56491111|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491112|NCT02927522|Donepezil|donepezil|mesh-list
56491113|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56491114|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491115|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491116|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
56491117|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491118|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491119|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
56491120|NCT02926976|Valproic Acid|valproic acid|mesh-list
56491121|NCT02926976|Risperidone|risperidone|mesh-list
56491122|NCT02926976|Aripiprazole|aripiprazole|mesh-list
56491123|NCT02926976|Clozapine|clozapine|mesh-list
56237365|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56237366|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237367|NCT01756430|Carvedilol|carvedilol|mesh-list
56237368|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56237369|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56237370|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
56237371|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491124|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56491125|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
56491126|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491127|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491128|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491129|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56491130|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56491131|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237424|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56237425|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56237426|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56237427|NCT01756508|Eculizumab|eculizumab|mesh-list
56237428|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56237429|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237430|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
56237431|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237432|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
56237433|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56237434|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812836|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788106|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491132|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56491133|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56491134|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
56491135|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
56491136|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
56491137|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56491138|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56491139|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56491140|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56237435|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56237436|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56237437|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237438|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237439|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237440|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
56237441|NCT01756547|Diuretics|diuretics|mesh-ancestor
55788115|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56491141|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
56491142|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491143|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
56491144|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
56491145|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
56491146|NCT02927015|Iproplatin|iproplatin|mesh-list
56491147|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491148|NCT04871607|Cytarabine|cytarabine|mesh-list
56491149|NCT04871607|Etoposide|etoposide|mesh-list
56491150|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
56237442|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
56237443|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237444|NCT01756547|Expectorants|expectorants|mesh-ancestor
56237445|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
56237446|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
56237447|NCT01756612|Hematinics|hematinics|mesh-ancestor
56237448|NCT01756638|Prednisolone|prednisolone|mesh-list
56237449|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237450|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
56237451|NCT01756638|Hormones|hormones|mesh-ancestor
56237452|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237453|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237454|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237455|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237456|NCT01756651|Fentanyl|fentanyl|mesh-list
56237457|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56237458|NCT01756651|Narcotics|narcotics|mesh-ancestor
56237459|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237460|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237461|NCT01756651|Analgesics|analgesics|mesh-ancestor
56237462|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
56237463|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237464|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56237465|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56237466|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
56237467|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
56237468|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
56237469|NCT01756664|Petrolatum|petrolatum|mesh-list
56237470|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56237471|NCT01756664|Protective Agents|protective agents|mesh-ancestor
56237472|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237473|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
56237474|NCT01756664|Emollients|emollients|mesh-ancestor
56491151|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
56491152|NCT04871607|Carmustine|carmustine|mesh-list
56491153|NCT04871607|Basiliximab|basiliximab|mesh-list
56491154|NCT04871607|Lenograstim|lenograstim|mesh-list
56491155|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56491156|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491157|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56491158|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56491159|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491160|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491161|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56237475|NCT01756768|Palbociclib|palbociclib|mesh-list
56237476|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237477|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56237478|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812876|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812887|NCT01615198|Olmesartan|olmesartan|mesh-list
55747237|NCT02460913|Morphine|morphine|mesh-list
56237479|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237480|NCT01756781|Palbociclib|palbociclib|mesh-list
56237481|NCT01756781|Midazolam|midazolam|mesh-list
56237482|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56237483|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56237484|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237485|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237486|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55812889|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56491162|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
56491163|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
56491164|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491165|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491166|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
56491167|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491168|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56491169|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56237487|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56237488|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56237489|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56237490|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
56237491|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
56237492|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
56237493|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
56237494|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237495|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237496|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237497|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56237498|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237499|NCT01756989|Thalidomide|thalidomide|mesh-list
56237500|NCT01756989|Celecoxib|celecoxib|mesh-list
56237501|NCT01756989|Etoposide|etoposide|mesh-list
56237502|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
56237503|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56237504|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237505|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56237506|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56237507|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491170|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
56491171|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
56491172|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
56491173|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
56491174|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
56491175|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
56491176|NCT04680195|Thalidomide|thalidomide|mesh-list
56491177|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491178|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
56491179|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491180|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
56491181|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56237508|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812903|NCT01913470|Losartan|losartan|mesh-list
55871471|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56237509|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56237510|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56237511|NCT01756989|Analgesics|analgesics|mesh-ancestor
56237512|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
56237513|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237514|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237515|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237516|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237517|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56237518|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56237519|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237520|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
56237521|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
56237522|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56237523|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237524|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56237525|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56237526|NCT01756989|Growth Substances|growth substances|mesh-ancestor
56237527|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
56237528|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
56237529|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56237530|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56237531|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56237532|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
56237533|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237534|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491182|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491183|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56491184|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56491185|NCT04680195|Growth Substances|growth substances|mesh-ancestor
56491186|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
56491187|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491188|NCT04864431|Vitamin D|vitamin d|mesh-list
56491189|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
56491190|NCT04864431|Vitamins|vitamins|mesh-ancestor
56491191|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
56211639|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
56237535|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237537|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56237538|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56237539|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
56237540|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
56237541|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237542|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237543|NCT01757236|Vancomycin|vancomycin|mesh-list
56237544|NCT01757236|Rifampin|rifampin|mesh-list
56237545|NCT01757236|Clindamycin|clindamycin|mesh-list
56237546|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
56237547|NCT01757236|Linezolid|linezolid|mesh-list
56237548|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56237549|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
56237550|NCT01757236|Trimethoprim|trimethoprim|mesh-list
55812944|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56237551|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
56491192|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491193|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55819507|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56491194|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56491195|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56491196|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56491197|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56491199|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
56491200|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491201|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491202|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237552|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56237553|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237554|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56237555|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
56237556|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
56237557|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56237558|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237559|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237560|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55812961|NCT02164929|Hydromorphone|hydromorphone|mesh-list
55812962|NCT02164929|Ropivacaine|ropivacaine|mesh-list
56237561|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55788164|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
56491203|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491204|NCT04798287|Adalimumab|adalimumab|mesh-list
56491205|NCT04798287|Etanercept|etanercept|mesh-list
56491206|NCT04798287|Golimumab|golimumab|mesh-list
56491207|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56491208|NCT04798287|Infliximab|infliximab|mesh-list
56491209|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
56491210|NCT04798287|Tofacitinib|tofacitinib|mesh-list
56491211|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56491212|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491213|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
56237562|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56237563|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56237564|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56237565|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56237566|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56237567|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56237569|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
56237570|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56237571|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56237572|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56237573|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55747364|NCT03289429|Atorvastatin|atorvastatin|mesh-list
56237574|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56237575|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56237576|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
56237577|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56237578|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56237579|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
56237580|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56237581|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56237582|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237583|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56237584|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56237585|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56491214|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56491215|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56491216|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56491217|NCT04798287|Analgesics|analgesics|mesh-ancestor
56491218|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
56491219|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491220|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491221|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491222|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
56491223|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56237586|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56237587|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56237588|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56237589|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56237590|NCT01757262|Clopidogrel|clopidogrel|mesh-list
56237591|NCT01757262|Ticagrelor|ticagrelor|mesh-list
56237592|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56237593|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56237594|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56237595|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56237596|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
56491224|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491225|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491226|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
56491227|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56491228|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56491229|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491230|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56491231|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491232|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56491233|NCT04689191|Vaccines|vaccines|mesh-list
56491234|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
56491235|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491236|NCT02925299|Insulin|insulin|mesh-list
56491237|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56491238|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237597|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237598|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237599|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237600|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
56237601|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56237602|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237603|NCT01757431|Eculizumab|eculizumab|mesh-list
56237604|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56237605|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237606|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
56237607|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237608|NCT01757457|Abciximab|abciximab|mesh-list
56237609|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
56237610|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56237612|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56237613|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237614|NCT01757587|Insulin|insulin|mesh-list
56237615|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56491239|NCT02925416|Oritavancin|oritavancin|mesh-list
56491240|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56491241|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491242|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
56491243|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56491244|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491245|NCT02917889|Caffeine|caffeine|mesh-list
56491246|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56491247|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491248|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56237624|NCT01757639|Ipilimumab|ipilimumab|mesh-list
56237625|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56237626|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237627|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56237628|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237629|NCT01757756|Midazolam|midazolam|mesh-list
56237630|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56237631|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56237632|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237633|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237634|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56237635|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56237636|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56237637|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56237638|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
56237639|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
56237640|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
56237641|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
56237642|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237643|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237644|NCT01757769|Silodosin|silodosin|mesh-list
56237645|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56491249|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491250|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491251|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56491252|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56491253|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
56491254|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491255|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
56491256|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56491257|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56491258|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491259|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
56491260|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491261|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491262|NCT04485273|Anesthetics|anesthetics|mesh-list
56491263|NCT04485273|Sevoflurane|sevoflurane|mesh-list
56237646|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56237647|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56237648|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
55813064|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56237649|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237650|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237651|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237652|NCT01757769|Urological Agents|urological agents|mesh-ancestor
56237653|NCT01757795|Otaplimastat|otaplimastat|mesh-list
56237654|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56237655|NCT01757795|Protective Agents|protective agents|mesh-ancestor
56237656|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237658|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56237659|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56237660|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237661|NCT01757860|Vitamin D|vitamin d|mesh-list
56237662|NCT01757860|Vitamins|vitamins|mesh-ancestor
56237663|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
56237664|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237665|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56237666|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
56237667|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56237668|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56237669|NCT01757899|Prednisolone|prednisolone|mesh-list
56237670|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
56237671|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56237672|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
56237673|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56491264|NCT04485273|Bupivacaine|bupivacaine|mesh-list
56491265|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
56491266|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56491267|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56491268|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491269|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56491270|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56491271|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
56491272|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
56491273|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491274|NCT02205528|Metformin|metformin|mesh-list
56491275|NCT02205528|Liraglutide|liraglutide|mesh-list
56491276|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56491277|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491278|NCT02205528|Incretins|incretins|mesh-ancestor
56237676|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237677|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237678|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56237679|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
56237680|NCT01757899|Hormones|hormones|mesh-ancestor
56237681|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237682|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56237683|NCT01757899|Protective Agents|protective agents|mesh-ancestor
55813090|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
55813091|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747483|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
56491279|NCT02205528|Hormones|hormones|mesh-ancestor
56491280|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491281|NCT03532022|Dexamethasone|dexamethasone|mesh-list
56491282|NCT03532022|Prednisone|prednisone|mesh-list
56491283|NCT03532022|Prednisolone|prednisolone|mesh-list
56491284|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
56491285|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56491286|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56491287|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56491288|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56491289|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
56491290|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
56237684|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237685|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237687|NCT01758029|Testosterone|testosterone|mesh-list
56237688|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
56237689|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
56237690|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56237691|NCT01758029|Androgens|androgens|mesh-ancestor
56237693|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237694|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237695|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237697|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
56237698|NCT01758094|Testosterone|testosterone|mesh-list
56237699|NCT01758094|Androgens|androgens|mesh-ancestor
55745942|NCT04755634|Protective Agents|protective agents|mesh-ancestor
55745944|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55745945|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
55745946|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745947|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745948|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745949|NCT02127970|Dalbavancin|dalbavancin|mesh-list
55745951|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55745952|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745954|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789028|NCT03520231|Denosumab|denosumab|mesh-list
55745955|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55745956|NCT02471677|Hormones|hormones|mesh-ancestor
55745957|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789029|NCT03520231|Gemcitabine|gemcitabine|mesh-list
55745958|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745959|NCT05395507|Interferons|interferons|mesh-list
55745960|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
55745962|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55745963|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745964|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
55745965|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745966|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
55745967|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745968|NCT04470843|Acetazolamide|acetazolamide|mesh-list
55745969|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
55745970|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55745971|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745972|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745973|NCT04470843|Diuretics|diuretics|mesh-ancestor
55745974|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
55745975|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745976|NCT05161741|Insulin|insulin|mesh-list
55745977|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55745978|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745979|NCT02473627|Pioglitazone|pioglitazone|mesh-list
55745980|NCT02473627|Tolbutamide|tolbutamide|mesh-list
56491291|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491292|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491293|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56491294|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
56491295|NCT03532022|Hormones|hormones|mesh-ancestor
56491296|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491297|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237700|NCT01758094|Hormones|hormones|mesh-ancestor
56237701|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237702|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237703|NCT01758107|Cyclosporine|cyclosporine|mesh-list
56237704|NCT01758107|Cyclosporins|cyclosporins|mesh-list
56237705|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237706|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237707|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237708|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
56237709|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237710|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
56237711|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237712|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
56237713|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237714|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56237715|NCT01758120|Prednisone|prednisone|mesh-list
56237716|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
56491298|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491299|NCT02200380|Plerixafor|plerixafor|mesh-list
56491300|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56491301|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56491302|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
56491303|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491304|NCT02160678|Tazarotene|tazarotene|mesh-list
56491305|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
56491306|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
56491307|NCT02153502|Quinidine|quinidine|mesh-list
56491308|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
56491309|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
56491310|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
56491311|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
56491312|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56491313|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56491314|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237717|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237718|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
56237719|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237720|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237721|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56237722|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
56237723|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237724|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237725|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56237726|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237727|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
56237728|NCT01758120|Hormones|hormones|mesh-ancestor
55813131|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
56491315|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491316|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491317|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56491318|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56491319|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
56491320|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56491321|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
56491322|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56491323|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56491324|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491325|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491326|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56237729|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237730|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237732|NCT01758146|Letrozole|letrozole|mesh-list
56237733|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237734|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56237735|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56237736|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237737|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237738|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56237739|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
56237740|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237741|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237742|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56491327|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56491328|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
56491329|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56491330|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56491331|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56491332|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56491333|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56491334|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56491335|NCT02130687|Aprepitant|aprepitant|mesh-list
56237743|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56237744|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56237745|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56237746|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56237747|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
56237748|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
56237750|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
56237751|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237752|NCT01758198|Methotrexate|methotrexate|mesh-list
55838335|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
56491336|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56491337|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491338|NCT02130687|Incretins|incretins|mesh-ancestor
56491339|NCT02130687|Hormones|hormones|mesh-ancestor
56491340|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491341|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56491342|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
56491343|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491344|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237753|NCT01758198|Abatacept|abatacept|mesh-list
56237754|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56237755|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
56237756|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56237757|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237758|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56237759|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
56237760|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237761|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237762|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
56237763|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237764|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56237765|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56237766|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
56237767|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237768|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56237769|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56237770|NCT01758263|Metoprolol|metoprolol|mesh-list
56237771|NCT01758263|Nebivolol|nebivolol|mesh-list
56237772|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56237773|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56237774|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
56237775|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
56491346|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
56491347|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491348|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56491349|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56491350|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491351|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
56491352|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
56491353|NCT01228656|Salicylates|salicylates|mesh-list
56491354|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56491355|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
56491356|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56491357|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491358|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
56491359|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
56491360|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56491361|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56491362|NCT01228656|Analgesics|analgesics|mesh-ancestor
56491363|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
56491364|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491365|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491367|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56491368|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491369|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491370|NCT02125266|Methotrexate|methotrexate|mesh-list
56491371|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56491372|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
56491373|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56491374|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491375|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56491376|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
56491377|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491378|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237776|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237777|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237778|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56237779|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56237780|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56237781|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
56237782|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237783|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237788|NCT01758367|Decitabine|decitabine|mesh-list
56491379|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
56491380|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491381|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56491382|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491383|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
56491384|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491385|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56491386|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56237806|NCT01758393|Hormones|hormones|mesh-ancestor
56237807|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237808|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237809|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237810|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237811|NCT01758471|Acarbose|acarbose|mesh-list
56237812|NCT01758471|Glipizide|glipizide|mesh-list
56237813|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56237814|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237815|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237816|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237817|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237818|NCT01758627|Icodextrin|icodextrin|mesh-list
56237819|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
56237820|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56237821|NCT01758640|Warfarin|warfarin|mesh-list
56237822|NCT01758640|Phenindione|phenindione|mesh-list
56237823|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
56237824|NCT01758666|Leucovorin|leucovorin|mesh-list
56237825|NCT01758666|Methotrexate|methotrexate|mesh-list
56237826|NCT01758666|Calcium|calcium|mesh-list
56237827|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
56237828|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56237829|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237830|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56237831|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
56237832|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56237833|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56237834|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
56237836|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237850|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56237851|NCT01758809|Bupivacaine|bupivacaine|mesh-list
56491387|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56491388|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
56491389|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491391|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491392|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56491393|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
56491394|NCT02110368|Testosterone|testosterone|mesh-list
56491395|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
56491396|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
56491397|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56491398|NCT02110368|Androgens|androgens|mesh-ancestor
56237852|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
56237853|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
56237854|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237855|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237856|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
56237857|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237858|NCT01758835|Calpastatin|calpastatin|mesh-list
56237859|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56237860|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
56237861|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237862|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237863|NCT01758913|Ibuprofen|ibuprofen|mesh-list
56237864|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56237865|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56237866|NCT01758913|Analgesics|analgesics|mesh-ancestor
56237867|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
56237868|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237869|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237870|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237871|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237872|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56237875|NCT01758978|Hydrocodone|hydrocodone|mesh-list
56491399|NCT02110368|Hormones|hormones|mesh-ancestor
56491400|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491401|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491402|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56491403|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491404|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
56491405|NCT02916485|Sirolimus|sirolimus|mesh-list
56491406|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56491407|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237892|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56237893|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56237894|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
56237895|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237896|NCT01759108|Protective Agents|protective agents|mesh-ancestor
56237897|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237898|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237899|NCT01759394|Maleic acid|maleic acid|mesh-list
56237900|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237901|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237902|NCT01759485|Vitamin D|vitamin d|mesh-list
56237903|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
56237904|NCT01759485|Vitamins|vitamins|mesh-ancestor
56237905|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
56237906|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237907|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56237908|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56237910|NCT01759524|Clonidine|clonidine|mesh-list
56237911|NCT01759524|Bupivacaine|bupivacaine|mesh-list
56237912|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
56237913|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
56237914|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237915|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237916|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
56237917|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237918|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56237919|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56237920|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56237921|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55813309|NCT02163447|Renal Agents|renal agents|mesh-ancestor
55788416|NCT04513639|BB 1101|bb 1101|mesh-list
56491408|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56491409|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491410|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
56491411|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491412|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
56491413|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491414|NCT01709214|Oxycodone|oxycodone|mesh-list
56491415|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56491416|NCT01709214|Narcotics|narcotics|mesh-ancestor
56491417|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56491418|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491419|NCT01709214|Analgesics|analgesics|mesh-ancestor
56491420|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
56491421|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491422|NCT02916602|Losartan|losartan|mesh-list
56491423|NCT02916602|Amlodipine|amlodipine|mesh-list
56491424|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
56237922|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237924|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56237925|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
56237926|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
56237927|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56237928|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56237929|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56237930|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
56237931|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237932|NCT01759576|Canagliflozin|canagliflozin|mesh-list
56237933|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56237934|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237935|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237936|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237937|NCT01759589|Remifentanil|remifentanil|mesh-list
56237938|NCT01759589|Propofol|propofol|mesh-list
56237939|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56237940|NCT01759589|Anesthetics|anesthetics|mesh-list
56237941|NCT01759589|Sevoflurane|sevoflurane|mesh-list
56237942|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56237943|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237945|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
56491425|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56491426|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56491427|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56491428|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491429|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56491430|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491431|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
56491432|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56491433|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56491434|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56491435|NCT02916602|Diuretics|diuretics|mesh-ancestor
56491436|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
56491437|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56491438|NCT02916251|Glucagon|glucagon|mesh-list
56237960|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
56491439|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56491440|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56491441|NCT02916251|Hormones|hormones|mesh-ancestor
56491442|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491443|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491444|NCT02916251|Incretins|incretins|mesh-ancestor
56491445|NCT02106546|Paclitaxel|paclitaxel|mesh-list
56491446|NCT02106546|Carboplatin|carboplatin|mesh-list
56491447|NCT02106546|Veliparib|veliparib|mesh-list
56238032|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
56238033|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238034|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56238035|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56238036|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56238037|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56238038|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56238039|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
56238040|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56238041|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
56238042|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56238043|NCT01759940|Ropivacaine|ropivacaine|mesh-list
56238044|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
56238045|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
56238046|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56238047|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813430|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
55813435|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
56238048|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
56238049|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238050|NCT01760018|Desflurane|desflurane|mesh-list
56238051|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56238052|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
56238053|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
56238054|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56238055|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238056|NCT01760096|Cyclosporine|cyclosporine|mesh-list
56238057|NCT01760096|Levamisole|levamisole|mesh-list
56238058|NCT01760096|Cyclosporins|cyclosporins|mesh-list
56238059|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
56238060|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491448|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56491449|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491450|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
56491451|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
56491452|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
56491453|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491454|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56491455|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491456|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56491457|NCT02916173|Hormones|hormones|mesh-list
56491458|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238061|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238062|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238063|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
56238064|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238065|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
56238066|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238067|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
56238068|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238069|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56238070|NCT01760096|Hormones|hormones|mesh-ancestor
55813470|NCT05367401|Azacitidine|azacitidine|mesh-list
56144575|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55788434|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
56491459|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491460|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56491461|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56491462|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491463|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
56491464|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56491465|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238071|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238072|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56238073|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
56238075|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56238076|NCT01760109|Piperacillin|piperacillin|mesh-list
56238077|NCT01760109|Sulbactam|sulbactam|mesh-list
56238078|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238079|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238080|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56238081|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238082|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238083|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56238084|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
56238085|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238086|NCT01760148|Interferons|interferons|mesh-list
56238087|NCT01760148|Ribavirin|ribavirin|mesh-list
56238088|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
56238089|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
56238090|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238091|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
56238092|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238093|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
56238094|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238095|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
56238096|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238097|NCT01760161|Ropivacaine|ropivacaine|mesh-list
56238098|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
56238099|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
56238100|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56238101|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238102|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
56238103|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238104|NCT01760174|Bupivacaine|bupivacaine|mesh-list
56491466|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56491467|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56491468|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491469|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491470|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491471|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56491472|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56491473|NCT01699737|Glimepiride|glimepiride|mesh-list
56491474|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56491475|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56491476|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491477|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491478|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
56491480|NCT04688723|Clopidogrel|clopidogrel|mesh-list
56491481|NCT04688723|Ticagrelor|ticagrelor|mesh-list
56238108|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56238109|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238110|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
56238111|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238112|NCT01760226|Prednisone|prednisone|mesh-list
56238113|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
56238114|NCT01760226|Rituximab|rituximab|mesh-list
56238115|NCT01760226|Doxorubicin|doxorubicin|mesh-list
56238116|NCT01760226|Methotrexate|methotrexate|mesh-list
56238117|NCT01760226|Etoposide|etoposide|mesh-list
56238118|NCT01760226|Vincristine|vincristine|mesh-list
56238119|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238120|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
56238121|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238122|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491482|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56491483|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56491484|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56491485|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56491486|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
56491487|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491488|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491489|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491490|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
56491491|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56491492|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
56491493|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491494|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
56491495|NCT01699464|Timolol|timolol|mesh-list
56491496|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56491497|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56491498|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491499|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56491500|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56491501|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
56491502|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238123|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56238124|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
56238125|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238126|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238127|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56238128|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56238129|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56238130|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56238135|NCT01760226|Hormones|hormones|mesh-ancestor
56491503|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491504|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56491505|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56491506|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56491507|NCT02104050|Dapansutrile|dapansutrile|mesh-list
56491508|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56491509|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56491510|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
56491511|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238171|NCT01760330|Acetaminophen|acetaminophen|mesh-list
56238172|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238173|NCT01760330|Analgesics|analgesics|mesh-ancestor
56238174|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
56238175|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238176|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238177|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
56238178|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
56238179|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
56238180|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56238181|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56238182|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238183|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238184|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238185|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238186|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
56238187|NCT01760460|Anacetrapib|anacetrapib|mesh-list
56238188|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56238189|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56238190|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
56238191|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238192|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56238193|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491512|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56491513|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
56491514|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491515|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491516|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56491517|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56491518|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56491519|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
56491520|NCT01694277|Sunitinib|sunitinib|mesh-list
56491521|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491522|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56491523|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56491524|NCT01694277|Growth Substances|growth substances|mesh-ancestor
56491525|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491526|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
56491527|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56491528|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238298|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238299|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56238300|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56238301|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56238302|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56238303|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56238304|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238305|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238306|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56238307|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56238308|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56238310|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55813706|NCT05323487|Bumetanide|bumetanide|mesh-list
56238312|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
56238313|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56238314|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56238315|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238316|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238317|NCT01760967|Analgesics|analgesics|mesh-ancestor
56238318|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
56238319|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813714|NCT05284409|Dexamethasone|dexamethasone|mesh-list
55813715|NCT05284409|Meperidine|meperidine|mesh-list
56238320|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56238321|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56238322|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56238323|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
56238324|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238325|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238326|NCT01760980|Exemestane|exemestane|mesh-list
56238327|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238328|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56491529|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491530|NCT01669980|Vancomycin|vancomycin|mesh-list
56491531|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
56491532|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56491533|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56491534|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491535|NCT02915666|Trametinib|trametinib|mesh-list
56491536|NCT02915666|Dabrafenib|dabrafenib|mesh-list
56491537|NCT02915666|Digoxin|digoxin|mesh-list
56239573|NCT01768260|Aspirin|aspirin|mesh-list
56491538|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491539|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56491541|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491542|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56491543|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56491544|NCT02915666|Protective Agents|protective agents|mesh-ancestor
56491545|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491546|NCT02092935|Vancomycin|vancomycin|mesh-list
56491547|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238331|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238332|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56238333|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
56238334|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238335|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238336|NCT01761071|Ketorolac|ketorolac|mesh-list
56238337|NCT01761071|Diclofenac|diclofenac|mesh-list
55813726|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238338|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56238339|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238341|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
56238342|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238343|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238344|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238345|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238346|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56238347|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238348|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238349|NCT01761110|Buprenorphine|buprenorphine|mesh-list
56238350|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56238351|NCT01761110|Narcotics|narcotics|mesh-ancestor
56238352|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56491548|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491549|NCT01666977|Carboplatin|carboplatin|mesh-list
56491550|NCT01666977|Pemetrexed|pemetrexed|mesh-list
56491551|NCT01666977|Trebananib|trebananib|mesh-list
56491552|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491553|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491554|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491555|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56491556|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56491557|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56491558|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56491559|NCT01666977|Growth Substances|growth substances|mesh-ancestor
56491560|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491561|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
56238353|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238354|NCT01761110|Analgesics|analgesics|mesh-ancestor
56238355|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
56238356|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813745|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
56238357|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56238359|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56238360|NCT01761149|Narcotics|narcotics|mesh-ancestor
56238361|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56238362|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238363|NCT01761149|Analgesics|analgesics|mesh-ancestor
56238364|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
56238365|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238366|NCT01761201|Levofloxacin|levofloxacin|mesh-list
56238367|NCT01761201|Ofloxacin|ofloxacin|mesh-list
56238368|NCT01761201|Isoniazid|isoniazid|mesh-list
56238369|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56238370|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491562|NCT02915354|Etanercept|etanercept|mesh-list
56491563|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56491564|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56491565|NCT02915354|Analgesics|analgesics|mesh-ancestor
56491566|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
56491567|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491568|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491569|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56491570|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491571|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56491572|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491573|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
56491575|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56238371|NCT01761201|Renal Agents|renal agents|mesh-ancestor
56238372|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238373|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56238374|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56238375|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238376|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238377|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238378|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56238379|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56238380|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
56238381|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56238382|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56238383|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
55813774|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
56491576|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
56491577|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491578|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491579|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56491580|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
56491581|NCT01661634|Diuretics|diuretics|mesh-ancestor
56491582|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
56491583|NCT01661166|Fesoterodine|fesoterodine|mesh-list
56491584|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56491585|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56491586|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
56491587|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491588|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491589|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491590|NCT01661166|Urological Agents|urological agents|mesh-ancestor
56491591|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
56491592|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56491593|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56238384|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56238385|NCT01761214|Amoxicillin|amoxicillin|mesh-list
56238386|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
56238387|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
56238388|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
56238389|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56238390|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
56238391|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238392|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238393|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56238394|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56238395|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238396|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238397|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238398|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56238399|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56238400|NCT01761318|Liraglutide|liraglutide|mesh-list
56238401|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56238402|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491594|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491595|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56491596|NCT02915042|Analgesics|analgesics|mesh-ancestor
56491597|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
56491598|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491599|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56491600|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56491601|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56491602|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
56491603|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491604|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491605|NCT01658826|Valacyclovir|valacyclovir|mesh-list
56491606|NCT01658826|Pritelivir|pritelivir|mesh-list
56491607|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
56491608|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491609|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491610|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491611|NCT02092077|Hormones|hormones|mesh-list
56491612|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491613|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491614|NCT02914886|Insulin|insulin|mesh-list
56238403|NCT01761318|Incretins|incretins|mesh-ancestor
56238404|NCT01761318|Hormones|hormones|mesh-ancestor
56238405|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238406|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
56238407|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238408|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
56238409|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238410|NCT01761487|Gentamicins|gentamicins|mesh-list
56238411|NCT01761487|Polymyxins|polymyxins|mesh-list
56238412|NCT01761487|Colistin|colistin|mesh-list
56238413|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238414|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238415|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56238416|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238417|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238465|NCT01761916|Analgesics|analgesics|mesh-ancestor
56238466|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
56238467|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238468|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238469|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56238470|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
56238471|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
56238472|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56491615|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56491616|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56491617|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491618|NCT01643226|Riboflavin|riboflavin|mesh-list
56491619|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56491620|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
56491621|NCT01643226|Vitamins|vitamins|mesh-ancestor
56491622|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
56491623|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491624|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56491625|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
56491626|NCT02914652|Albuterol|albuterol|mesh-list
56491627|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56491628|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
56491629|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238473|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56238474|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56238475|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
56238476|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238477|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238478|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56238479|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
56238480|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238481|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56238482|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55813880|NCT02301403|Nicotine|nicotine|mesh-list
56211794|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
56491630|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491631|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56491632|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
56491633|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
56491634|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56491635|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56491636|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56491637|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56491638|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
56491639|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238483|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238484|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238485|NCT01761994|Nafamostat|nafamostat|mesh-list
56238486|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56238487|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238488|NCT01761994|Analgesics|analgesics|mesh-ancestor
56238489|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
56238490|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238491|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238492|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238493|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238494|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
56238495|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
56238496|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238497|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238498|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56238499|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56238500|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56238501|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745981|NCT02473627|DS-1971a|ds-1971a|mesh-list
55745982|NCT02473627|Midazolam|midazolam|mesh-list
55745983|NCT02473627|Omeprazole|omeprazole|mesh-list
55745984|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55745985|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55745986|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745987|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745988|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55745989|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55745990|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55745991|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55745992|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
55745993|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
55745994|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
55745995|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
55745996|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745997|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745998|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55745999|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55746000|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746001|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55746003|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55746004|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55752621|NCT03204877|Protective Agents|protective agents|mesh-ancestor
56491640|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491641|NCT02081118|Exenatide|exenatide|mesh-list
56491642|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56491643|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491644|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56491645|NCT02081118|Incretins|incretins|mesh-ancestor
56491647|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491648|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56491649|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56491650|NCT02077881|Gemcitabine|gemcitabine|mesh-list
56238502|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
56238503|NCT01762046|Metformin|metformin|mesh-list
56238504|NCT01762046|Glipizide|glipizide|mesh-list
56238505|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56238506|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238507|NCT01762150|Gemcitabine|gemcitabine|mesh-list
56238508|NCT01762150|Sorafenib|sorafenib|mesh-list
56238509|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238510|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56238511|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
56238512|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238513|NCT01762150|Antiviral Agents|antiviral agents|mesh-ancestor
56238514|NCT01762150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238515|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238516|NCT01762150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238517|NCT01762150|Immunologic Factors|immunologic factors|mesh-ancestor
56238518|NCT01762150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238519|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56238520|NCT01762163|Aspirin|aspirin|mesh-list
56238521|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56238522|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238523|NCT01762163|Analgesics|analgesics|mesh-ancestor
56238524|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
56238525|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238526|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238527|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813920|NCT02120157|Busulfan|busulfan|mesh-list
55788542|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
56491651|NCT02077881|Paclitaxel|paclitaxel|mesh-list
56491652|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56491653|NCT02077881|Tryptophan|tryptophan|mesh-list
56491654|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56491655|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491656|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
56491657|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
56491658|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
56491659|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491660|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56491661|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
56491662|NCT02077881|Antiviral Agents|antiviral agents|mesh-ancestor
56491663|NCT02077881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491664|NCT02077881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491665|NCT02077881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491666|NCT02077881|Immunologic Factors|immunologic factors|mesh-ancestor
56491667|NCT02077881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491668|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56491669|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
56491670|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56491671|NCT01632228|Bevacizumab|bevacizumab|mesh-list
56238528|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238529|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56238530|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56238531|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238532|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56238533|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56238534|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238535|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
56238536|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
56238537|NCT01762202|Fludarabine|fludarabine|mesh-list
56238538|NCT01762202|Ofatumumab|ofatumumab|mesh-list
56238539|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238540|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
56238541|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238542|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238543|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56238544|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
56238545|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238546|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491672|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56491673|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491674|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56491675|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56491676|NCT01632228|Growth Substances|growth substances|mesh-ancestor
56491677|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491678|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
56238570|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
56238571|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238572|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56238573|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
56238574|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56238575|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56238576|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56238577|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
56238578|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
56238579|NCT01762332|Remifentanil|remifentanil|mesh-list
56238580|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56238581|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56238582|NCT01762332|Narcotics|narcotics|mesh-ancestor
56238583|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813974|NCT05561309|Ropivacaine|ropivacaine|mesh-list
56238584|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238585|NCT01762332|Analgesics|analgesics|mesh-ancestor
56238586|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
56238587|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238588|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56238589|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
56238590|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238591|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491679|NCT01628094|Ritonavir|ritonavir|mesh-list
56491680|NCT01628094|Ribavirin|ribavirin|mesh-list
56491681|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56491682|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56491683|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
56239713|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
56491684|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491685|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491686|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56491687|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55746583|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
56491688|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
56238592|NCT01762436|Atenolol|atenolol|mesh-list
56238593|NCT01762436|Bisoprolol|bisoprolol|mesh-list
56238594|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56238595|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56238596|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
56238597|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
55813995|NCT05350085|Midazolam|midazolam|mesh-list
56238598|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238599|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238600|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56238601|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56238602|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56238603|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
56238604|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238605|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788583|NCT03963895|Thrombin|thrombin|mesh-list
56491689|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491690|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56491691|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56491692|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
56491693|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
56491694|NCT02073123|Nivolumab|nivolumab|mesh-list
56491695|NCT02073123|Ipilimumab|ipilimumab|mesh-list
56491696|NCT02073123|Tryptophan|tryptophan|mesh-list
56238607|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
56238608|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56238609|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56238610|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238611|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238612|NCT01762475|Urological Agents|urological agents|mesh-ancestor
56238613|NCT01762514|Amifostine|amifostine|mesh-list
56238614|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56238615|NCT01762514|Protective Agents|protective agents|mesh-ancestor
56238616|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238617|NCT01762540|Prednisolone|prednisolone|mesh-list
56238618|NCT01762540|Calcium|calcium|mesh-list
56238619|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
56238620|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55788592|NCT03490903|Midazolam|midazolam|mesh-list
55746251|NCT02299999|Bicalutamide|bicalutamide|mesh-list
55746253|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55746254|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746255|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
55746256|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
55746257|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
55746258|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746259|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746260|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
55746261|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746262|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55746263|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55746264|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
55746265|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55746266|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746267|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55746268|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55746269|NCT02299999|Growth Substances|growth substances|mesh-ancestor
55746270|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
55746271|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55746272|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
55746273|NCT02299999|Antiviral Agents|antiviral agents|mesh-ancestor
55746274|NCT02299999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746275|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746276|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55746277|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55746278|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55746279|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55746280|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
55746281|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55746282|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
55746283|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55746284|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55746285|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55746286|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
55746287|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
56491697|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56491698|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491699|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56491700|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491701|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56491702|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
56491703|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56491704|NCT02914145|Piperaquine|piperaquine|mesh-list
56491705|NCT02914145|Artenimol|artenimol|mesh-list
56491706|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
56238621|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238622|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238623|NCT01762540|Hormones|hormones|mesh-ancestor
56238624|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238625|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56238626|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238627|NCT01762644|Cyclosporine|cyclosporine|mesh-list
56238628|NCT01762644|Omeprazole|omeprazole|mesh-list
56238629|NCT01762644|Cyclosporins|cyclosporins|mesh-list
56238630|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238631|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238632|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238633|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
56238634|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238635|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
56238636|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238637|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
56238638|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238639|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56238640|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56238641|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56238642|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56238644|NCT01762657|Lansoprazole|lansoprazole|mesh-list
56238645|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
56238646|NCT01762657|Cyclosporins|cyclosporins|mesh-list
56238647|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491707|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56491708|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56491709|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491710|NCT02914028|Acetaminophen|acetaminophen|mesh-list
56491711|NCT02914028|Tramadol|tramadol|mesh-list
56491712|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56491713|NCT02914028|Analgesics|analgesics|mesh-ancestor
56491714|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
56491715|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491716|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491717|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
56491718|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56491719|NCT02914028|Narcotics|narcotics|mesh-ancestor
56491720|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56491721|NCT01566240|Paclitaxel|paclitaxel|mesh-list
56491722|NCT01566240|Carboplatin|carboplatin|mesh-list
56491723|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56491724|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491725|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
56491726|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
56491727|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
56238662|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238663|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56238664|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56238665|NCT01762787|Aspirin|aspirin|mesh-list
56238666|NCT01762787|Prednisolone|prednisolone|mesh-list
56238667|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56238668|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
56238669|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56238670|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
56238672|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56238673|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
56238674|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56238675|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238676|NCT01762787|Analgesics|analgesics|mesh-ancestor
56238677|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
56238678|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238679|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238690|NCT01762787|Hormones|hormones|mesh-ancestor
56491728|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491729|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
56491730|NCT02064426|Hematinics|hematinics|mesh-ancestor
56491731|NCT00896493|Cyclosporine|cyclosporine|mesh-list
56491732|NCT00896493|Cyclosporins|cyclosporins|mesh-list
56491733|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56491734|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491735|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491736|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491737|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
56491738|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491739|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
56491740|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491741|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
56491742|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491743|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56491744|NCT02063997|Colchicine|colchicine|mesh-list
56491745|NCT02063997|Allopurinol|allopurinol|mesh-list
56491746|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
56491747|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491748|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
56491749|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
56491750|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
56238705|NCT01762839|Oritavancin|oritavancin|mesh-list
56491751|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491752|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491753|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
56491754|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491755|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56491756|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
56491757|NCT02063997|Protective Agents|protective agents|mesh-ancestor
56491758|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238759|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238760|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
56238761|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56238762|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238763|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238764|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56238765|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56238771|NCT01763281|Hormones|hormones|mesh-ancestor
56491759|NCT00585507|Fulvestrant|fulvestrant|mesh-list
56491760|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56491761|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491762|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56491763|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56491764|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
56491765|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491766|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491767|NCT02063685|Prednisone|prednisone|mesh-list
56491768|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
56491769|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56491770|NCT02063685|Rituximab|rituximab|mesh-list
56491771|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56491772|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56491773|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
56491774|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491775|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491776|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56491777|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
56491778|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491779|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491780|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56491781|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56491782|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56491783|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
56491784|NCT02063685|Hormones|hormones|mesh-ancestor
56491785|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491786|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56491787|NCT02063295|CKD732|ckd732|mesh-list
56491788|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56239087|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239088|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56239089|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56239090|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239091|NCT01765088|Temozolomide|temozolomide|mesh-list
56239092|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56239093|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
56239094|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239095|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239096|NCT01765231|Entecavir|entecavir|mesh-list
56239097|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
56239098|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239099|NCT01765257|Rasagiline|rasagiline|mesh-list
56239100|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56239101|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239102|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239103|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55814487|NCT04228289|Oxytocin|oxytocin|mesh-list
56239104|NCT01765257|Protective Agents|protective agents|mesh-ancestor
56239105|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239106|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
56239107|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56239108|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56491789|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56491790|NCT02063295|Growth Substances|growth substances|mesh-ancestor
56491791|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491792|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
56491793|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491794|NCT02057172|Liraglutide|liraglutide|mesh-list
56491795|NCT02057172|Exenatide|exenatide|mesh-list
56491796|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56239118|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56239119|NCT01765452|Clopidogrel|clopidogrel|mesh-list
56239120|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56239121|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56239122|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55814509|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55747750|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56239123|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56239124|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
56239125|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239126|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239127|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239128|NCT01765556|Ketoconazole|ketoconazole|mesh-list
56239129|NCT01765556|Vemurafenib|vemurafenib|mesh-list
56239130|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
56239131|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239132|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56239133|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56239134|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239135|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239136|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56239137|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
56239138|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239139|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239140|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56239141|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239142|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56239143|NCT01765608|Zonisamide|zonisamide|mesh-list
56239144|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
56491797|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491798|NCT02057172|Incretins|incretins|mesh-ancestor
56491799|NCT02057172|Hormones|hormones|mesh-ancestor
56491800|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491801|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56491802|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
56491803|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56491804|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
56211868|NCT04456296|Testosterone|testosterone|mesh-list
56491805|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56491806|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
56491807|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491808|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491809|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
56491811|NCT02052648|Temozolomide|temozolomide|mesh-list
56491812|NCT02052648|Tryptophan|tryptophan|mesh-list
56491813|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56491814|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491815|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56491816|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56491817|NCT02052648|Growth Substances|growth substances|mesh-ancestor
56491818|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491819|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
56491820|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56491821|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
56491822|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491823|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56491824|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
56491825|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56491826|NCT01186744|Tofacitinib|tofacitinib|mesh-list
56491827|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56491828|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491829|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239149|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239150|NCT01765738|Minocycline|minocycline|mesh-list
56239151|NCT01765738|Rifampin|rifampin|mesh-list
56239152|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239153|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788678|NCT04875871|Copper|copper|mesh-list
56491830|NCT02044341|Benzocaine|benzocaine|mesh-list
56491831|NCT02044341|Glycerol|glycerol|mesh-list
56491832|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56491833|NCT02044341|Protective Agents|protective agents|mesh-ancestor
56491834|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491835|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
56491836|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
56491837|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56491838|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
56491839|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239862|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491841|NCT00555399|Vorinostat|vorinostat|mesh-list
56491843|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56491844|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
56491845|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491846|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491847|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56491848|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491849|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
56491850|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
56491851|NCT02912663|Verapamil|verapamil|mesh-list
56491852|NCT02912663|Analgesics|analgesics|mesh-ancestor
56491853|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
56491854|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491855|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491856|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
56491857|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56491858|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56491859|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
56491860|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56491861|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56491862|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491863|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56491864|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
56491865|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56491866|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
56491867|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56491868|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
56491869|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56491870|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56491871|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56491872|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
56491873|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56491874|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491875|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56491876|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56491877|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56491878|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56491879|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491881|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
56239247|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56239248|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
56239250|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56239251|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239252|NCT01766063|Interferons|interferons|mesh-list
56239253|NCT01766063|Interferon-beta|interferon-beta|mesh-list
56239254|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
56239255|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239256|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
56239257|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239258|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
56491882|NCT02912702|Doxorubicin|doxorubicin|mesh-list
56491883|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56491884|NCT02912702|Etoposide|etoposide|mesh-list
56491885|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
56491886|NCT02912702|Pegaspargase|pegaspargase|mesh-list
56491887|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56491888|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
56491889|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
56491890|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491891|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491892|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56491893|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
56491894|NCT02912702|Hormones|hormones|mesh-ancestor
56491895|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491896|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56491897|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491898|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56491899|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56491900|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56491901|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491902|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491903|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56491904|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56491905|NCT02912702|Protective Agents|protective agents|mesh-ancestor
56239289|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56239291|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56239292|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56239293|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
56239294|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239295|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239296|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239297|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56239298|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239299|NCT01766323|Modafinil|modafinil|mesh-list
56239300|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56239301|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239302|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56239303|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56239304|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56239305|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239306|NCT01766375|Cyclosporine|cyclosporine|mesh-list
56239307|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
56491906|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
56491907|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
56491908|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
56491909|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56491910|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491911|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
56491912|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491913|NCT02008344|Favipiravir|favipiravir|mesh-list
56491914|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
56239937|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56491915|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491916|NCT02912156|Voriconazole|voriconazole|mesh-list
56491917|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
56491918|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491919|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56491920|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56491921|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491922|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491923|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56491924|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
56491925|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56491926|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491927|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56491928|NCT03455049|Andrographolide|andrographolide|mesh-list
56491929|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56491930|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56491931|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56491932|NCT03455049|Analgesics|analgesics|mesh-ancestor
56491933|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
56491934|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491935|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491936|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56491937|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56491938|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56491939|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56491940|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
56491941|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56491942|NCT02912234|Clarithromycin|clarithromycin|mesh-list
56491943|NCT02912234|Apixaban|apixaban|mesh-list
56491944|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56491945|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239658|NCT01768377|Fentanyl|fentanyl|mesh-list
56239659|NCT01768377|Midazolam|midazolam|mesh-list
56239660|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
56239661|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
56239662|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239663|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239664|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
56239665|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239666|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56239667|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56239668|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56239669|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239670|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239671|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56239672|NCT01768377|Narcotics|narcotics|mesh-ancestor
56239673|NCT01768377|Analgesics|analgesics|mesh-ancestor
56239674|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56239675|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56239676|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
56239677|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56491946|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56491947|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491948|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491949|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56491950|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56491951|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56491952|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
56491953|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56491954|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
56491955|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
56491956|NCT04676139|Fluoxetine|fluoxetine|mesh-list
56491957|NCT04676139|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56491958|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56491959|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56491960|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56491961|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56491962|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
56491963|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491964|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56239711|NCT01768663|Rifampin|rifampin|mesh-list
56239712|NCT01768663|Ivacaftor|ivacaftor|mesh-list
56239714|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239715|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56239716|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56239717|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239718|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239719|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56239720|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
56239721|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239722|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239723|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56239724|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239725|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56239731|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
56491965|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
56491966|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56491967|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56491968|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56491969|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491970|NCT01999764|Retinol acetate|retinol acetate|mesh-list
56491971|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56491972|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
56491973|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491974|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56491975|NCT01999764|Protective Agents|protective agents|mesh-ancestor
56491976|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56491977|NCT02911961|Acetaminophen|acetaminophen|mesh-list
56491978|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56491979|NCT02911961|Analgesics|analgesics|mesh-ancestor
56491980|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
56491981|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56491982|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491983|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
56491984|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
56491985|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56491986|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56491987|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239763|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
56239764|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56239765|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
56239766|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239767|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239768|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56239769|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
56239770|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
56239771|NCT01768884|Protective Agents|protective agents|mesh-ancestor
56239772|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
56239773|NCT01768897|Cytarabine|cytarabine|mesh-list
56239774|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
56239775|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56239776|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
56239777|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239778|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239779|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
56239780|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239781|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56239782|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
56239783|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239784|NCT01768897|Analgesics|analgesics|mesh-ancestor
56239785|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
56491988|NCT04676061|Norethindrone|norethindrone|mesh-list
56491989|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
56491990|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56491991|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56491992|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56491993|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
56491994|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56491995|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56491996|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56491997|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56491998|NCT04675944|Treprostinil|treprostinil|mesh-list
56491999|NCT04675944|Zamicastat|zamicastat|mesh-list
56492000|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56492001|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492002|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492003|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
56492004|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56239786|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239787|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56239788|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56239789|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239790|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
56239791|NCT01768897|Protective Agents|protective agents|mesh-ancestor
56239792|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
56239793|NCT01768897|Vitamins|vitamins|mesh-ancestor
56239794|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
56239795|NCT01768988|Pregabalin|pregabalin|mesh-list
56239796|NCT01768988|Analgesics|analgesics|mesh-ancestor
55815194|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56239797|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
56239798|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239799|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239800|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
56239801|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56239802|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239803|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239804|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56492005|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56492006|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492007|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
56492008|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
56492009|NCT01993641|Azacitidine|azacitidine|mesh-list
56492010|NCT01993641|Decitabine|decitabine|mesh-list
56492011|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56492012|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
56492013|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492014|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239805|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56239806|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56239807|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239808|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56239809|NCT01769040|Rifaximin|rifaximin|mesh-list
56239810|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239811|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239812|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56239813|NCT01769066|Pemetrexed|pemetrexed|mesh-list
56239814|NCT01769066|Gefitinib|gefitinib|mesh-list
56239815|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239816|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492015|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492016|NCT01989429|Vitamin D|vitamin d|mesh-list
56492017|NCT01989429|Vitamins|vitamins|mesh-ancestor
56492018|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
56492019|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492020|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56492021|NCT02911298|Metronidazole|metronidazole|mesh-list
56492022|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492023|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56492024|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56492025|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56492026|NCT01983306|Dolcanatide|dolcanatide|mesh-list
56239889|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
56239890|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239891|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
56492027|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56492028|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
56492029|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492030|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56492031|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
56492032|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56492033|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492034|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
56492035|NCT01975818|Hematinics|hematinics|mesh-ancestor
56492036|NCT00555594|Bevacizumab|bevacizumab|mesh-list
56492037|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56492038|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492039|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56492040|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56492041|NCT00555594|Growth Substances|growth substances|mesh-ancestor
56492042|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492043|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56492044|NCT01973049|Ribavirin|ribavirin|mesh-list
56492045|NCT01973049|Asunaprevir|asunaprevir|mesh-list
56492046|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
56492047|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492048|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
56492049|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492050|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
56239949|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239951|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56239952|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
56239953|NCT01769820|Hormones|hormones|mesh-ancestor
56239954|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239955|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56239956|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239957|NCT01769833|Interferons|interferons|mesh-list
56239958|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
56239959|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
56239960|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56239961|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239962|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
56239963|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239964|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
56239965|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239966|NCT01769898|Budesonide|budesonide|mesh-list
56239967|NCT01769898|Theophylline|theophylline|mesh-list
56239968|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
56239969|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56239970|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56239971|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
56239972|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239973|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239974|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55788841|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56492051|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492053|NCT01185964|Olaratumab|olaratumab|mesh-list
56492054|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56492055|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492056|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56492057|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56492058|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492059|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492060|NCT01972854|Riboflavin|riboflavin|mesh-list
56492061|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56492062|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
56492063|NCT01972854|Vitamins|vitamins|mesh-ancestor
56492064|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
56492065|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492066|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56492067|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
56492068|NCT02550470|Sevoflurane|sevoflurane|mesh-list
56492069|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56492070|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56492071|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
56492072|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
56239975|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
56239977|NCT01769898|Hormones|hormones|mesh-ancestor
56239978|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239979|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56239980|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56239981|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56239982|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
56239983|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239984|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239985|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56239986|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239987|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
56239988|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56239989|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56239990|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
56239991|NCT01769911|Cytarabine|cytarabine|mesh-list
56239992|NCT01769911|Etoposide|etoposide|mesh-list
56239993|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
56239994|NCT01769911|Melphalan|melphalan|mesh-list
56239995|NCT01769911|Carmustine|carmustine|mesh-list
56239996|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56239997|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55815380|NCT02481947|Lubiprostone|lubiprostone|mesh-list
56239998|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239999|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56492073|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492074|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492075|NCT02910518|Insulin|insulin|mesh-list
56492076|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56492077|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
56492078|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
56492079|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
56492080|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
56492081|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
56492082|NCT02910518|Heparin|heparin|mesh-list
56492083|NCT02910518|Calcium heparin|calcium heparin|mesh-list
56492084|NCT02910518|Glucagon|glucagon|mesh-list
56492085|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56492086|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492087|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
56492088|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56240000|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56240001|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240002|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240003|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56240004|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
56240005|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
56240013|NCT01769950|Choline|choline|mesh-list
56492089|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56492090|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492091|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56492092|NCT02910518|Hormones|hormones|mesh-ancestor
56492093|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492094|NCT01217437|Bevacizumab|bevacizumab|mesh-list
56492095|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56492096|NCT01217437|Irinotecan|irinotecan|mesh-list
56492097|NCT01217437|Temozolomide|temozolomide|mesh-list
56492098|NCT01217437|Camptothecin|camptothecin|mesh-list
56492099|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
56492100|NCT01217437|Antibodies|antibodies|mesh-list
56492101|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
56492102|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56492103|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
56492104|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492105|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56211998|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
56492106|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56492107|NCT01217437|Growth Substances|growth substances|mesh-ancestor
56492108|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492109|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
56240056|NCT01770171|Paclitaxel|paclitaxel|mesh-list
56240057|NCT01770171|Bevacizumab|bevacizumab|mesh-list
56240058|NCT01770171|Carboplatin|carboplatin|mesh-list
56240059|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56240060|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240061|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
56240062|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
56240063|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
56240064|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240065|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56240066|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56240067|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56240068|NCT01770171|Growth Substances|growth substances|mesh-ancestor
56240069|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240070|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
56240071|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56240072|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56240073|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56240074|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240075|NCT01770210|Atorvastatin|atorvastatin|mesh-list
56240076|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56240077|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56240078|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
56492110|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
56492111|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56492112|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56492113|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492114|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492115|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56492116|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
56492117|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56492118|NCT00624364|Metformin|metformin|mesh-list
56492119|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
56492120|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
56492121|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56240079|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240080|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56240081|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56240082|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240083|NCT01770223|Ribavirin|ribavirin|mesh-list
56240084|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56240085|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
56240086|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240087|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
56240088|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240089|NCT01770236|Acetaminophen|acetaminophen|mesh-list
56240090|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56240091|NCT01770236|Analgesics|analgesics|mesh-ancestor
56240092|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
56240093|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240094|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240095|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
56240096|NCT01770301|Paclitaxel|paclitaxel|mesh-list
56240097|NCT01770301|Bevacizumab|bevacizumab|mesh-list
56240098|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56240099|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240100|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
56240101|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
56240110|NCT01770444|Cytarabine|cytarabine|mesh-list
56492122|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492123|NCT02910596|Bethanechol|bethanechol|mesh-list
56492124|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56492125|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
56492126|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492127|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492128|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56492129|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56492130|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
56240117|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240118|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240119|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
56240120|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240122|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56240123|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56240124|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
56240125|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240126|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56240127|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
56240128|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
56240129|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
56240130|NCT01770470|Coagulants|coagulants|mesh-ancestor
56240131|NCT01770600|Risperidone|risperidone|mesh-list
56240132|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56240133|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
56240134|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240135|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240136|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240137|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56240138|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56240139|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56240140|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56240141|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56240142|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
56240144|NCT01770769|Cephalothin|cephalothin|mesh-list
56240145|NCT01770769|Dalteparin|dalteparin|mesh-list
56492131|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492132|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492133|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
56492134|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
56492135|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56492136|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56492137|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492138|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240165|NCT01770899|Montelukast|montelukast|mesh-list
56240159|NCT01770795|Antiviral Agents|antiviral agents|mesh-ancestor
56240160|NCT01770795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492139|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492140|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56492142|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56492143|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56492144|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56492145|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56492146|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240286|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240287|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240288|NCT01771874|Bupropion|bupropion|mesh-list
56240289|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56240290|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56240291|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
56240292|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56240293|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56240294|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56240295|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56240296|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240297|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
56240298|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240299|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240300|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56240301|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56240302|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240303|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
56240304|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
56492147|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
56492148|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492149|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492150|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56492151|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492152|NCT04676997|Paclitaxel|paclitaxel|mesh-list
56492153|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
56492154|NCT04676997|Epirubicin|epirubicin|mesh-list
56492155|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56492156|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492157|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
56492158|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
56492159|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
56212041|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
56240347|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56240348|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56240349|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240350|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240351|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56240352|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
56240353|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240354|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240355|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56240356|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56240357|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55815750|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788950|NCT04928495|Expectorants|expectorants|mesh-ancestor
56492160|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492161|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492162|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
56492163|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492164|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56492165|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56492166|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
56492167|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56492168|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56492169|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56492170|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56492171|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492172|NCT02910206|Sufentanil|sufentanil|mesh-list
56240358|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56240363|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
56492173|NCT02910206|Propofol|propofol|mesh-list
56492174|NCT02910206|Etomidate|etomidate|mesh-list
56492175|NCT02910206|Cisatracurium|cisatracurium|mesh-list
56492176|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492177|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492178|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492179|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56492180|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
56492181|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
56492182|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56492183|NCT02910206|Narcotics|narcotics|mesh-ancestor
56492184|NCT02910206|Analgesics|analgesics|mesh-ancestor
56492185|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
56492186|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492187|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56492188|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56492189|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56492190|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
56492191|NCT04675086|Remdesivir|remdesivir|mesh-list
56492192|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
56492193|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56240439|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240440|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56240441|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56240442|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56240443|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56240447|NCT01772953|Treosulfan|treosulfan|mesh-list
56492194|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492195|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
56492196|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492197|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492198|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56492199|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56492200|NCT02909972|Cytarabine|cytarabine|mesh-list
56492201|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56492202|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
56492203|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492204|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492205|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
56492206|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492207|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492208|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
56492209|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492210|NCT02910050|Letrozole|letrozole|mesh-list
56492211|NCT02910050|Anastrozole|anastrozole|mesh-list
56492212|NCT02910050|Exemestane|exemestane|mesh-list
56492213|NCT02910050|Bicalutamide|bicalutamide|mesh-list
56492214|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56492215|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240488|NCT01773096|Cathartics|cathartics|mesh-ancestor
56240489|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240490|NCT01773096|Laxatives|laxatives|mesh-ancestor
56240491|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56240492|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240493|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
56240494|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240495|NCT01773096|Antacids|antacids|mesh-ancestor
56240496|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492216|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56492217|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492218|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492219|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56492220|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
56492221|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492222|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240497|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
56240498|NCT01773174|Dabigatran|dabigatran|mesh-list
56240499|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
55815892|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240500|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56240502|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240503|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240504|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
56240505|NCT01773408|Cytarabine|cytarabine|mesh-list
56240506|NCT01773408|Daunorubicin|daunorubicin|mesh-list
56240507|NCT01773408|Idarubicin|idarubicin|mesh-list
56240508|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56240509|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
56240510|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240511|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240512|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
56240513|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240514|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240515|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
56240516|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788998|NCT04928651|Clonidine|clonidine|mesh-list
56492223|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56492224|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
56492225|NCT02909933|Metformin|metformin|mesh-list
56492226|NCT02909933|Liraglutide|liraglutide|mesh-list
56492227|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56212063|NCT03547999|Nivolumab|nivolumab|mesh-list
56492228|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492229|NCT02909933|Incretins|incretins|mesh-ancestor
56492230|NCT02909933|Hormones|hormones|mesh-ancestor
56492231|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492232|NCT02910245|Prednisone|prednisone|mesh-list
56492233|NCT02910245|Mesalamine|mesalamine|mesh-list
56492234|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
56492235|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56492236|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
56492237|NCT02910245|Hormones|hormones|mesh-ancestor
56240517|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56240518|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56240519|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56240520|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240521|NCT01773460|Everolimus|everolimus|mesh-list
56240522|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240523|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240524|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
56240525|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240526|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56240527|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56240528|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56240530|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240531|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56240532|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56240533|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240534|NCT01773538|Rifaximin|rifaximin|mesh-list
56240535|NCT01773538|Lactulose|lactulose|mesh-list
56240536|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56240537|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240538|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240539|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
56240540|NCT01773616|Prednisolone|prednisolone|mesh-list
56240541|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56240542|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
56240543|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56240544|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
56240545|NCT01773616|Rituximab|rituximab|mesh-list
56492238|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492239|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492240|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56492241|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492242|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
56492243|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492244|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56492245|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492246|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
56492247|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56492248|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240550|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
56240551|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240552|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240553|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56240554|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56240555|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
56240556|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56240557|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240558|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240559|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240560|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240561|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
56240562|NCT01773616|Hormones|hormones|mesh-ancestor
56240563|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240564|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56240565|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
56240566|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
56240567|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240568|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240569|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56240570|NCT01773616|Protective Agents|protective agents|mesh-ancestor
56240571|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
56240572|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240573|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
56240574|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240575|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240576|NCT01773772|Progesterone|progesterone|mesh-list
56240577|NCT01773772|Progestins|progestins|mesh-ancestor
56240578|NCT01773772|Hormones|hormones|mesh-ancestor
56492249|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56492250|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56492251|NCT02910245|Analgesics|analgesics|mesh-ancestor
56492252|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
56492253|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492254|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56492255|NCT01185340|Serotonin|serotonin|mesh-list
56492256|NCT01185340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56240581|NCT01773798|Insulin|insulin|mesh-list
56240582|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56240583|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
56240584|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
56240585|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56240586|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56240587|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240588|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56240589|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240590|NCT01773837|Methylphenidate|methylphenidate|mesh-list
56240591|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56240592|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240593|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56240594|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56240595|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56240596|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240597|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
56240598|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240599|NCT01773876|Micafungin|micafungin|mesh-list
56240600|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
56240601|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240602|NCT01774370|Dabigatran|dabigatran|mesh-list
56240603|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
56240604|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56492257|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56492258|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
56492259|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492260|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492261|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492262|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56492263|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56492264|NCT01959282|Niacinamide|niacinamide|mesh-list
56492265|NCT01959282|Peficitinib|peficitinib|mesh-list
56492266|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492267|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492268|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492269|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
56492270|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492271|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
56492272|NCT01959282|Vitamins|vitamins|mesh-ancestor
56492273|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
56492274|NCT01185301|Adalimumab|adalimumab|mesh-list
56492275|NCT01185301|Methotrexate|methotrexate|mesh-list
56492276|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56492277|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
56492278|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56492279|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492280|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56492281|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
56492282|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492283|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492284|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
56492285|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492286|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56492287|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492288|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
56492289|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56492290|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56240307|NCT01771978|Diltiazem|diltiazem|mesh-list
56492291|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56492292|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56492293|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
56492294|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56492295|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240707|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56240708|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240709|NCT01775540|Dexamethasone|dexamethasone|mesh-list
56240710|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
56240711|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240712|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
56240713|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
56240714|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240715|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240716|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240717|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
56240718|NCT01775540|Hormones|hormones|mesh-ancestor
56240722|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56492296|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492297|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
56492298|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492299|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56492300|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
56492301|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56492302|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56492303|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56492304|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56492305|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492306|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
56492307|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492308|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492309|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56492310|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492311|NCT02909465|Midazolam|midazolam|mesh-list
56492312|NCT02909465|Ketamine|ketamine|mesh-list
56492313|NCT02909465|Haloperidol|haloperidol|mesh-list
56492314|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
56492315|NCT02909465|Analgesics|analgesics|mesh-ancestor
56492316|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
56492317|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240768|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
56492318|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492319|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56492320|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56492321|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
56492322|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
56492323|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492324|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56492325|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56492326|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492327|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492328|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56492329|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492330|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56492331|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56492332|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56492333|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
56240810|NCT01776320|Urological Agents|urological agents|mesh-ancestor
56240811|NCT01776437|Talazoparib|talazoparib|mesh-list
56240812|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56240813|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240814|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240815|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240816|NCT01776515|Acetaminophen|acetaminophen|mesh-list
56240818|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56240819|NCT01776515|Analgesics|analgesics|mesh-ancestor
56240820|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
56240821|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240822|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240823|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
56240824|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56492334|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
56492335|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
56492336|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
56492337|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56492338|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56492339|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56492340|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
56492341|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56492342|NCT04312555|Alprostadil|alprostadil|mesh-list
56492343|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56492344|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
56492345|NCT04312555|Urological Agents|urological agents|mesh-ancestor
56492346|NCT01184989|Dabigatran|dabigatran|mesh-list
56492347|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
56492348|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56492349|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
56492350|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492351|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492352|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
56492353|NCT04674423|Tenofovir|tenofovir|mesh-list
56492354|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
56492355|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492356|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56240856|NCT01776788|Exenatide|exenatide|mesh-list
56240857|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
56240858|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56240859|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240860|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56240861|NCT01776788|Incretins|incretins|mesh-ancestor
56240862|NCT01776788|Hormones|hormones|mesh-ancestor
56240863|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240864|NCT01776853|Levan|levan|mesh-list
56240865|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240866|NCT01776970|Nabiximols|nabiximols|mesh-list
56240867|NCT01776970|Analgesics|analgesics|mesh-ancestor
56240868|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
56240869|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240870|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240871|NCT01777087|Capsaicin|capsaicin|mesh-list
56240872|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
56240873|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
55816261|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492357|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56492358|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492359|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492360|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56492361|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56492362|NCT00555867|Anastrozole|anastrozole|mesh-list
56492363|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56492364|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492365|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56492366|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56492368|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492369|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56492370|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
56492371|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492372|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492373|NCT00555984|Remifentanil|remifentanil|mesh-list
56492374|NCT00555984|Propofol|propofol|mesh-list
56492375|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56240874|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
56240875|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240876|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240878|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56240879|NCT01777100|Narcotics|narcotics|mesh-ancestor
56240880|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56240881|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240882|NCT01777100|Analgesics|analgesics|mesh-ancestor
56240883|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
56240884|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240885|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56240886|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56240887|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
56240888|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
56240889|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56240890|NCT01777464|Histamine|histamine|mesh-list
56240891|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
56240892|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
56240893|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240894|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240895|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240896|NCT01777477|Gemcitabine|gemcitabine|mesh-list
56492376|NCT00555984|Anesthetics|anesthetics|mesh-list
56492377|NCT00555984|Sevoflurane|sevoflurane|mesh-list
56492378|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492379|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492380|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492381|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
56492382|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56492383|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56492384|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56492385|NCT00555984|Narcotics|narcotics|mesh-ancestor
56492386|NCT00555984|Analgesics|analgesics|mesh-ancestor
56492387|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
56492388|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492389|NCT03457337|Gefitinib|gefitinib|mesh-list
56492390|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492391|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56492392|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492393|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492394|NCT02274779|Leuprolide|leuprolide|mesh-list
56240925|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56240926|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56240927|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240928|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56240929|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56240930|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
56240931|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240932|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240933|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56240938|NCT01777737|Renal Agents|renal agents|mesh-ancestor
56492395|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56492396|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
56492397|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56492398|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492399|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56492400|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492401|NCT01908738|Lidocaine|lidocaine|mesh-list
56492402|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
56492403|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
56492404|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492405|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212103|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
56240971|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56240972|NCT01778075|Analgesics|analgesics|mesh-ancestor
56240973|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
56240974|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240975|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240976|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
56240977|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56240978|NCT01778075|Narcotics|narcotics|mesh-ancestor
56240979|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56240980|NCT01778101|Lansoprazole|lansoprazole|mesh-list
56240981|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
56240994|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56240995|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
56240996|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
56240997|NCT01778192|Citric Acid|citric acid|mesh-list
56240998|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
56240999|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
56241000|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56241001|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
56492411|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56492412|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492413|NCT04673955|Cetuximab|cetuximab|mesh-list
56492414|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56492415|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492416|NCT01904409|Rifaximin|rifaximin|mesh-list
56492417|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56492418|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492419|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56492421|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
56492422|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492423|NCT01902381|Protective Agents|protective agents|mesh-ancestor
56492424|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492425|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
56241030|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241031|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241032|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241033|NCT01778413|Tenofovir|tenofovir|mesh-list
56241034|NCT01778413|Emtricitabine|emtricitabine|mesh-list
55816424|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241036|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56241037|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
56241038|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241039|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56241040|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56241041|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241042|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241043|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56241044|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55744513|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492426|NCT01902381|Vitamins|vitamins|mesh-ancestor
56492427|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
56492428|NCT05287568|Venetoclax|venetoclax|mesh-list
56492430|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492431|NCT04673799|Denosumab|denosumab|mesh-list
56492432|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56492433|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492434|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
56492435|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
56492436|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
56492437|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492443|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
56492444|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56492445|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492446|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
56492447|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56492448|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492449|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56492450|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492451|NCT01871415|Metformin|metformin|mesh-list
56492452|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241045|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56241046|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56241047|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56241048|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56241049|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56241050|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56241051|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
56241052|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241053|NCT01778686|Pindolol|pindolol|mesh-list
56241054|NCT01778686|Citalopram|citalopram|mesh-list
56241055|NCT01778686|Tryptophan|tryptophan|mesh-list
56241056|NCT01778686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56241057|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56241058|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56241059|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241060|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241061|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
56492453|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492454|NCT05189717|Everolimus|everolimus|mesh-list
56492455|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492456|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492457|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
56492458|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492459|NCT01866930|Interferons|interferons|mesh-list
56492460|NCT01866930|Ribavirin|ribavirin|mesh-list
56492461|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492462|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
56492463|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492464|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
56492465|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492466|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56492467|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
56492468|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492469|NCT02277197|Cetuximab|cetuximab|mesh-list
56492470|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56492471|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241083|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56241084|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56241085|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
56241086|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241087|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241088|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241089|NCT01779089|Minocycline|minocycline|mesh-list
56241090|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56241091|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241093|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56241094|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
56241095|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241097|NCT01779245|Calcium|calcium|mesh-list
56492472|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
56492473|NCT00555087|Testosterone|testosterone|mesh-list
56492474|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
56492475|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
56492476|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56492477|NCT00555087|Androgens|androgens|mesh-ancestor
56492478|NCT00555087|Hormones|hormones|mesh-ancestor
56492479|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492480|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241151|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56241152|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492481|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56492482|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492483|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
56492484|NCT04673214|Acetaminophen|acetaminophen|mesh-list
56492485|NCT04673214|Azithromycin|azithromycin|mesh-list
56492486|NCT04673214|Ivermectin|ivermectin|mesh-list
56492487|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56492488|NCT04673214|Analgesics|analgesics|mesh-ancestor
56492489|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
56492490|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241222|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56241223|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241224|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241225|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56241226|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
56241227|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
56241228|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241229|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241230|NCT01779843|Cytarabine|cytarabine|mesh-list
56241231|NCT01779843|Idarubicin|idarubicin|mesh-list
56241232|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56241233|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
56241234|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241235|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241236|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
56241237|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241238|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241239|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
55789022|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
55746447|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
55746448|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746449|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55746450|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55746451|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
55746453|NCT03302845|Famotidine|famotidine|mesh-list
55746454|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55746455|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746456|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55746457|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746458|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746459|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55746460|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
55746464|NCT03302689|Ropivacaine|ropivacaine|mesh-list
55746465|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
55746466|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55746467|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
55746469|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746470|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746471|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
55746472|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746473|NCT03307603|Nivolumab|nivolumab|mesh-list
55746474|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746475|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746476|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55746477|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492491|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492492|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
56492493|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56492494|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492495|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56492496|NCT00556023|Gemcitabine|gemcitabine|mesh-list
56492497|NCT00556023|Tremelimumab|tremelimumab|mesh-list
56492498|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56492499|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
56492500|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492501|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492502|NCT00556023|Antiviral Agents|antiviral agents|mesh-ancestor
56492503|NCT00556023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492504|NCT00556023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492505|NCT00556023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241240|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241241|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56241242|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56241243|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56241244|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241245|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
56241246|NCT01779882|Busulfan|busulfan|mesh-list
56241247|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241248|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
56241256|NCT01779908|Vitamin D|vitamin d|mesh-list
56241271|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56241273|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241274|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241275|NCT01780181|Antiviral Agents|antiviral agents|mesh-ancestor
56241276|NCT01780181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241277|NCT01780181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241278|NCT01780181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241279|NCT01780181|Immunologic Factors|immunologic factors|mesh-ancestor
56241280|NCT01780181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241281|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
56241282|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
56241283|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
55816676|NCT02460224|Spartalizumab|spartalizumab|mesh-list
56492506|NCT00556023|Immunologic Factors|immunologic factors|mesh-ancestor
56492507|NCT00556023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492508|NCT05011214|Ketamine|ketamine|mesh-list
56492509|NCT05011214|Sevoflurane|sevoflurane|mesh-list
56492510|NCT05011214|Esketamine|esketamine|mesh-list
56492511|NCT05011214|Analgesics|analgesics|mesh-ancestor
56492512|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
56492513|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492514|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492515|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56240529|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
56492516|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56492517|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
56492518|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
56492519|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492520|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56492521|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56241284|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56241286|NCT01780233|Naltrexone|naltrexone|mesh-list
56241287|NCT01780233|Citric Acid|citric acid|mesh-list
56241288|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
56241289|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56241290|NCT01780233|Narcotics|narcotics|mesh-ancestor
56241291|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241292|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492523|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492524|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56492525|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56492526|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
56492527|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56492528|NCT00556062|Vaccines|vaccines|mesh-list
56492529|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
56492530|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492531|NCT04965155|Dexamethasone|dexamethasone|mesh-list
56492532|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56492533|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
56492534|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
56492535|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492536|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492537|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56492538|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
56492539|NCT04965155|Hormones|hormones|mesh-ancestor
56492540|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241350|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241351|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816731|NCT01857622|Edoxaban|edoxaban|mesh-list
56241352|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56241353|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56241354|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241356|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56241357|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56241358|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
56241359|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
56241360|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241361|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241362|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56241363|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56241364|NCT01780558|Hormones|hormones|mesh-list
56241365|NCT01780558|Estradiol|estradiol|mesh-list
56241366|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56241367|NCT01780558|Progesterone|progesterone|mesh-list
56241368|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241369|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241370|NCT01780558|Estrogens|estrogens|mesh-ancestor
56241371|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56241372|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
56241373|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55816754|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492541|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56492542|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492543|NCT04676763|Histamine|histamine|mesh-list
56492544|NCT04676763|Substance P|substance p|mesh-list
56492545|NCT04676763|Neurokinin A|neurokinin a|mesh-list
56492546|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
56492547|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
56492548|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492549|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492550|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492551|NCT04672707|Bromhexine|bromhexine|mesh-list
56492552|NCT04672707|Expectorants|expectorants|mesh-ancestor
56492553|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
56492554|NCT04932083|Fentanyl|fentanyl|mesh-list
56492555|NCT04932083|Midazolam|midazolam|mesh-list
56492556|NCT04932083|Nalbuphine|nalbuphine|mesh-list
56492557|NCT04932083|Bupivacaine|bupivacaine|mesh-list
56492558|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
56492559|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
56241374|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56241375|NCT01780558|Progestins|progestins|mesh-ancestor
56241376|NCT01780610|Letrozole|letrozole|mesh-list
56241377|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56241378|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56241379|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56241380|NCT01780610|Hormones|hormones|mesh-list
56241381|NCT01780610|Estradiol|estradiol|mesh-list
56241382|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56241383|NCT01780610|Progesterone|progesterone|mesh-list
56241384|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241385|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241386|NCT01780610|Estrogens|estrogens|mesh-ancestor
56241387|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56241388|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
56241389|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56241390|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56241391|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241392|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56241393|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56241394|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241396|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56492560|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492561|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492562|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
56492563|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492564|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56492565|NCT04932083|Narcotics|narcotics|mesh-ancestor
56492566|NCT04932083|Analgesics|analgesics|mesh-ancestor
56492567|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56241414|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241415|NCT01780883|Protective Agents|protective agents|mesh-ancestor
56241416|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241417|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241418|NCT01780909|Paromomycin|paromomycin|mesh-list
56241419|NCT01780909|Domperidone|domperidone|mesh-list
56241421|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
56241422|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56241423|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
56241424|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
56241425|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241426|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241427|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56241428|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
56241429|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241430|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241431|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56241432|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241433|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56241434|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56241435|NCT01780948|Everolimus|everolimus|mesh-list
56492568|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56492569|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
56492570|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492571|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56492572|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56492573|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56492574|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
56492575|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
56492576|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492577|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492578|NCT01825980|Ritonavir|ritonavir|mesh-list
56492579|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56492580|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56492581|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
56492582|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492583|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492584|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56492585|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56241461|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56241462|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
56241463|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
56241464|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
56241465|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
56241466|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241467|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56241468|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56241469|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56241470|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
56241471|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241472|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241473|NCT01781442|Sirolimus|sirolimus|mesh-list
56241474|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56241475|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241476|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56241477|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241478|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
56241479|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241480|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
56241481|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241482|NCT01781507|Cetirizine|cetirizine|mesh-list
56241483|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56492586|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
56492587|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492588|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56492589|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56492590|NCT04858490|Diazepam|diazepam|mesh-list
56492591|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56492592|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
56492593|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
56240608|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
56492594|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
56492595|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492596|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492597|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56492598|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492599|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492600|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56492601|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56492602|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56492603|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56492604|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56492605|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56492606|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
56492607|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
56492608|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
56492609|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
56492610|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241495|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56241496|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56241515|NCT01781897|Mosapride|mosapride|mesh-list
56492611|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492613|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492614|NCT01655225|Pemetrexed|pemetrexed|mesh-list
56492615|NCT01655225|Letrozole|letrozole|mesh-list
56492616|NCT01655225|Fulvestrant|fulvestrant|mesh-list
56492617|NCT01655225|Midazolam|midazolam|mesh-list
56492618|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492619|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56492620|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492621|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492622|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492623|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56492624|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56241541|NCT01782001|Vitamin A|vitamin a|mesh-list
56241542|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
56241543|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
56241544|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241545|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
56241546|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241547|NCT01782001|Protective Agents|protective agents|mesh-ancestor
56241548|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56241549|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241550|NCT01782261|Liraglutide|liraglutide|mesh-list
56241551|NCT01782261|Saxagliptin|saxagliptin|mesh-list
56241552|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241553|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241554|NCT01782261|Incretins|incretins|mesh-ancestor
56241555|NCT01782261|Hormones|hormones|mesh-ancestor
56241556|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816933|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56241557|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56241558|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
56241559|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241560|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241561|NCT01782274|Vaccines|vaccines|mesh-list
56241562|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
56241563|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241564|NCT01782287|Vaccines|vaccines|mesh-list
56241565|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
56241566|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241567|NCT01782300|Vaccines|vaccines|mesh-list
56241568|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
55816960|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492625|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56492626|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56492628|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
56492629|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
56492630|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
56492631|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492632|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492633|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492634|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56492635|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56492636|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56492637|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56492638|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56492639|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
56492640|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492641|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56492642|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56492643|NCT01818921|CKD732|ckd732|mesh-list
56492644|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56492645|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56492646|NCT01818921|Growth Substances|growth substances|mesh-ancestor
56492647|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492648|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
56492649|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492650|NCT01810575|Alprostadil|alprostadil|mesh-list
56492651|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56492652|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
56492653|NCT01810575|Urological Agents|urological agents|mesh-ancestor
56492654|NCT01785771|Exenatide|exenatide|mesh-list
56492655|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241569|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241570|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
56241571|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56241572|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241573|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
56241574|NCT01782508|Interferons|interferons|mesh-list
56241575|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
56241576|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241577|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
56241578|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241579|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56241580|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241581|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492656|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492657|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56492658|NCT01785771|Incretins|incretins|mesh-ancestor
56492659|NCT01785771|Hormones|hormones|mesh-ancestor
56492660|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492661|NCT04660760|Trifluridine|trifluridine|mesh-list
56492662|NCT04660760|Paclitaxel|paclitaxel|mesh-list
56492663|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56492664|NCT04660760|Ramucirumab|ramucirumab|mesh-list
56492665|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56492666|NCT04660760|Antibodies|antibodies|mesh-list
56492667|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
56241582|NCT01782560|Omeprazole|omeprazole|mesh-list
56241583|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56241584|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56241585|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56241586|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241587|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241589|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56241590|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56241591|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241592|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
56241593|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
56241594|NCT01782599|Nicotine|nicotine|mesh-list
56241595|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56241596|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
56241597|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241598|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241599|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56241600|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56241601|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
56241602|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241603|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241604|NCT01782612|Analgesics|analgesics|mesh-list
56241605|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
56241606|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241607|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241608|NCT01782651|Capecitabine|capecitabine|mesh-list
56241609|NCT01782651|Lapatinib|lapatinib|mesh-list
56492668|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56492669|NCT04660760|Lexatumumab|lexatumumab|mesh-list
56240680|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492670|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56492672|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
56492673|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
56492674|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
56492675|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492676|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
56492677|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492678|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
56492679|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
56492680|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492681|NCT01784874|Vaccines|vaccines|mesh-list
56492682|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
56492683|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492684|NCT04607252|Metformin|metformin|mesh-list
56492685|NCT04607252|Megestrol|megestrol|mesh-list
56241620|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241621|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241622|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
56241631|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
56492686|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
56492687|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56492688|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492689|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56492690|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56492691|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56492692|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
56492693|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56492694|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56241690|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241691|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
56241692|NCT01783106|Doxycycline|doxycycline|mesh-list
56241693|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
56241694|NCT01783106|Budesonide|budesonide|mesh-list
56241695|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56241696|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56241697|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
56241698|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241699|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241702|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
56241712|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56492695|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56492696|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56492697|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492698|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
56492699|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56492700|NCT01782729|Tacrolimus|tacrolimus|mesh-list
56492701|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492702|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
56492703|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492704|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56492705|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492706|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492707|NCT01780428|Acetaminophen|acetaminophen|mesh-list
56492708|NCT01780428|Promethazine|promethazine|mesh-list
56241759|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56241760|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
56241761|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241762|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241763|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241764|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
56241765|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241766|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56241767|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492709|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
56492710|NCT01780428|Hydrocodone|hydrocodone|mesh-list
56492711|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56492712|NCT01780428|Analgesics|analgesics|mesh-ancestor
56492713|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
56492714|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492715|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492716|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
56492717|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56492718|NCT01780428|Narcotics|narcotics|mesh-ancestor
56492719|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492720|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
56492721|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
56492722|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
56492723|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
56241819|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241820|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241821|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241822|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56241823|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56241824|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
56241825|NCT01784250|Analgesics|analgesics|mesh-ancestor
56241826|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
56492724|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56492725|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
56492726|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
56492727|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492728|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492729|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56492730|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56492731|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492732|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
56492733|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
56492734|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
56492735|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
56492736|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56492737|NCT04671420|Rituximab|rituximab|mesh-list
56492738|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56492739|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492740|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
56492741|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492742|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56492743|NCT04573556|Lemborexant|lemborexant|mesh-list
56492744|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56492745|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241875|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
56241876|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56241877|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56241878|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56241879|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
56241880|NCT01784445|Ceftazidime|ceftazidime|mesh-list
56241881|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56241882|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241883|NCT01784536|Oritavancin|oritavancin|mesh-list
56241884|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56241885|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241886|NCT01784549|Gemcitabine|gemcitabine|mesh-list
56241887|NCT01784549|Docetaxel|docetaxel|mesh-list
56241888|NCT01784549|Pemetrexed|pemetrexed|mesh-list
56241889|NCT01784549|Vinorelbine|vinorelbine|mesh-list
56241890|NCT01784549|Gefitinib|gefitinib|mesh-list
56241891|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817274|NCT01835158|Sunitinib|sunitinib|mesh-list
55817278|NCT01835158|Growth Substances|growth substances|mesh-ancestor
56492746|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492747|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56212230|NCT03274414|Cisplatin|cisplatin|mesh-list
56492748|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492749|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492750|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492751|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
56492752|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56492753|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
56492754|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492755|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
55747953|NCT04523675|Antidotes|antidotes|mesh-ancestor
56241892|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56241893|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
56241894|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241895|NCT01784549|Antiviral Agents|antiviral agents|mesh-ancestor
56241896|NCT01784549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241897|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241898|NCT01784549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241899|NCT01784549|Immunologic Factors|immunologic factors|mesh-ancestor
56241900|NCT01784549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241901|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
56241902|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
56241903|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56241904|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56241905|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56241906|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56241907|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56241909|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
56241910|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241911|NCT01784640|Pemetrexed|pemetrexed|mesh-list
56241912|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241913|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241914|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241915|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56241916|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56241917|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56241918|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241919|NCT01784900|Catumaxomab|catumaxomab|mesh-list
56241920|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55744785|NCT02487355|Bupivacaine|bupivacaine|mesh-list
56492756|NCT04671108|Protective Agents|protective agents|mesh-ancestor
56492757|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56492758|NCT01779453|Atorvastatin|atorvastatin|mesh-list
56492759|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56492760|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56492761|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
56492762|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492763|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56492764|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56492765|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492766|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241921|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56241922|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
56241923|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241924|NCT01784913|Sargramostim|sargramostim|mesh-list
56241933|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56241934|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56241935|NCT01784978|Growth Substances|growth substances|mesh-ancestor
56241936|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
56241937|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56241938|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241939|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241940|NCT01785004|Vitamin D|vitamin d|mesh-list
56241941|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
56241942|NCT01785004|Vitamins|vitamins|mesh-ancestor
56241943|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
56241944|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241945|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56241946|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56241947|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
56241948|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56241949|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
56241950|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
56241951|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241952|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241953|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242030|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56242031|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56242032|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55744794|NCT02487355|Analgesics|analgesics|mesh-ancestor
56492767|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492768|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
56492769|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56492770|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56492771|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56492772|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56492773|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492774|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
56492775|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492776|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492777|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56492778|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492779|NCT04567160|Propofol|propofol|mesh-list
56492780|NCT04567160|Sevoflurane|sevoflurane|mesh-list
56492781|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492782|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492783|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492784|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56242033|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56242034|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56242035|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
56242036|NCT01785589|Adenosine|adenosine|mesh-list
56242037|NCT01785589|Analgesics|analgesics|mesh-ancestor
56242038|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
56242039|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242040|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242041|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56242042|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
56242043|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56242044|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
56242045|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
56242046|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242047|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242048|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56242049|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
56242050|NCT01785641|Gentamicins|gentamicins|mesh-list
56242052|NCT01785641|Ceftazidime|ceftazidime|mesh-list
56242053|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56242054|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242055|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
56492785|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
56492786|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
56492787|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56492788|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56492789|NCT04545866|Budesonide|budesonide|mesh-list
56492790|NCT04545866|Poractant alfa|poractant alfa|mesh-list
56492791|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56492793|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56492794|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
56242056|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56242057|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56242058|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492795|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492796|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492797|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56492798|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
56492799|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
56492800|NCT04545866|Hormones|hormones|mesh-ancestor
56492801|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492802|NCT01774578|Gemcitabine|gemcitabine|mesh-list
56492803|NCT01774578|Docetaxel|docetaxel|mesh-list
56492804|NCT01774578|Pemetrexed|pemetrexed|mesh-list
56492805|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56212238|NCT03272685|Nicotine|nicotine|mesh-list
56492806|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
56492807|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492808|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492809|NCT01774578|Antiviral Agents|antiviral agents|mesh-ancestor
56492810|NCT01774578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492811|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492812|NCT01774578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492813|NCT01774578|Immunologic Factors|immunologic factors|mesh-ancestor
56492814|NCT01774578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492815|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
56492816|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
56492817|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56492818|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56492819|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56492820|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
56240832|NCT01776671|Gabapentin|gabapentin|mesh-list
56242119|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56242124|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56242125|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242126|NCT01785979|Analgesics|analgesics|mesh-ancestor
56242127|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
56242128|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242129|NCT01785979|Filaricides|filaricides|mesh-ancestor
56242130|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
56242131|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
56242132|NCT01786018|Cyclosporine|cyclosporine|mesh-list
56242133|NCT01786018|Methotrexate|methotrexate|mesh-list
56242134|NCT01786018|Busulfan|busulfan|mesh-list
56242135|NCT01786018|Thiotepa|thiotepa|mesh-list
56242136|NCT01786018|Cyclosporins|cyclosporins|mesh-list
56242137|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56242138|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
56242139|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242140|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242141|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56242142|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
56492821|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56492822|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
56492823|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492824|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
56492825|NCT04670601|Analgesics|analgesics|mesh-ancestor
56492826|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
56492827|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492828|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492829|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56492830|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56492831|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56492832|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242143|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242144|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242145|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
56242146|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242147|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56242148|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56242149|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
56242150|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242151|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56242152|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
56242153|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242154|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56242155|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
56242156|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56242158|NCT01786070|Budesonide|budesonide|mesh-list
56242159|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242160|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56242161|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
56242162|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242163|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242164|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56242221|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242222|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
56242223|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56492833|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56492834|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492835|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492836|NCT04670913|Apatinib|apatinib|mesh-list
56492837|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492838|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56492839|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492840|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492841|NCT04671069|Clopidogrel|clopidogrel|mesh-list
56492842|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56492843|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56242239|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
56242240|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56242241|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
56242242|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242243|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242244|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56242245|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
56242246|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56242247|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56242248|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56242249|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
56242250|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242251|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242252|NCT01786655|Epinephrine|epinephrine|mesh-list
56242253|NCT01786655|Bupivacaine|bupivacaine|mesh-list
56242254|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
56242255|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
56242256|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
56242261|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56492844|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56492845|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56492846|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
56492847|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492848|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492849|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492850|NCT04322123|Azithromycin|azithromycin|mesh-list
56492851|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
56492852|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56492853|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492854|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
56492855|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56242286|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
56242287|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
56242288|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56242289|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56242290|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242291|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242292|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242293|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
56242294|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56242295|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56242296|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56242297|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56242298|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492856|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56492857|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492858|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492859|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56492860|NCT04259138|Vedolizumab|vedolizumab|mesh-list
56492861|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56492862|NCT01741155|Docetaxel|docetaxel|mesh-list
56492863|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492864|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
56492865|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
56212251|NCT03258281|Evolocumab|evolocumab|mesh-list
56492866|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
56492867|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492868|NCT04244630|Antioxidants|antioxidants|mesh-list
56492869|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242348|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242349|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
56242350|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
56242351|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242352|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56242357|NCT01788007|Imiquimod|imiquimod|mesh-list
56492870|NCT04244630|Protective Agents|protective agents|mesh-ancestor
56492871|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492872|NCT04239053|Bupivacaine|bupivacaine|mesh-list
56492873|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
56492874|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
56492875|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492876|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492877|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
56492878|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242412|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
56242413|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56242414|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56242415|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56242416|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56242417|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
56242418|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56242419|NCT01788280|Bevacizumab|bevacizumab|mesh-list
56242420|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56242421|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242424|NCT01788280|Growth Substances|growth substances|mesh-ancestor
56242432|NCT01788371|Lamivudine|lamivudine|mesh-list
56242433|NCT01788371|Telbivudine|telbivudine|mesh-list
56242434|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56242435|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56242436|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242437|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242438|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
56242439|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242440|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56242441|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56242442|NCT01788384|Clindamycin|clindamycin|mesh-list
55748004|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56492879|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
56492880|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56492881|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
56492882|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492883|NCT04119284|Protective Agents|protective agents|mesh-ancestor
56492884|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492885|NCT01718145|Ribavirin|ribavirin|mesh-list
56492886|NCT01718145|Asunaprevir|asunaprevir|mesh-list
56492887|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
56242443|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
56242444|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
56242445|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56242446|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56242447|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242448|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56242449|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242450|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242451|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
56242452|NCT01788462|Tesamorelin|tesamorelin|mesh-list
56242453|NCT01788462|Growth Substances|growth substances|mesh-ancestor
56242454|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242455|NCT01788501|Cyclosporine|cyclosporine|mesh-list
56242456|NCT01788501|Methotrexate|methotrexate|mesh-list
56242457|NCT01788501|Tacrolimus|tacrolimus|mesh-list
56242458|NCT01788501|Cyclosporins|cyclosporins|mesh-list
56242459|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56242460|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
56242461|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242462|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242463|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56242464|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
56242465|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242466|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242467|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
56242468|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242492|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56242493|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492888|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492889|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
56492890|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492891|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
56492892|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492893|NCT00556257|Cyclosporine|cyclosporine|mesh-list
56492894|NCT00556257|Cyclosporins|cyclosporins|mesh-list
56492895|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492896|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492897|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56492898|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
56492899|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242502|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56242503|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56242504|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56242505|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
56242506|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242507|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56242508|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242509|NCT01788774|Risperidone|risperidone|mesh-list
56242510|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56242511|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
56242512|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242513|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242514|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242515|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56242516|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56242517|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242518|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56242519|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56242520|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
56242521|NCT01788969|Citalopram|citalopram|mesh-list
55817894|NCT01844518|Abatacept|abatacept|mesh-list
56492900|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
56492901|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492902|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
56492903|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56492904|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56492905|NCT01712451|Fluticasone|fluticasone|mesh-list
56492906|NCT01712451|Xhance|xhance|mesh-list
56492907|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56492908|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242523|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56242524|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56242525|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242526|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242527|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
56242528|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242529|NCT01788969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56242530|NCT01788969|Antidepressive Agents|antidepressive agents|mesh-ancestor
55817914|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55748035|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56492909|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56492910|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
56492911|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492912|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492913|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56492914|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
56492915|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
56492916|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56492917|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56492918|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56492919|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56492920|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
56492921|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492922|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492923|NCT01712217|Crizotinib|crizotinib|mesh-list
56492924|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492925|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56242531|NCT01788969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56242533|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242534|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56242535|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242537|NCT01789086|Liraglutide|liraglutide|mesh-list
56492926|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212263|NCT05705492|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56492927|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492928|NCT04669158|Idebenone|idebenone|mesh-list
56492929|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
56492930|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492931|NCT04669158|Protective Agents|protective agents|mesh-ancestor
56492932|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492933|NCT04669821|Propofol|propofol|mesh-list
56492934|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56492935|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492936|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492937|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56492938|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
56492939|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
56492940|NCT00532025|Sorafenib|sorafenib|mesh-list
56242586|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
56242587|NCT01789242|Hormones|hormones|mesh-ancestor
56242588|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242589|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56242590|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242591|NCT01789294|Mesalamine|mesalamine|mesh-list
56242592|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55817964|NCT02350478|Hormones|hormones|mesh-ancestor
56242593|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242594|NCT01789294|Analgesics|analgesics|mesh-ancestor
56242595|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
56242596|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242597|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242598|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242599|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242600|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
56242601|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56242602|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242603|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242604|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242605|NCT01789385|Analgesics|analgesics|mesh-ancestor
56242606|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
56492941|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56492942|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56492943|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492944|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492945|NCT04669392|Ethanol|ethanol|mesh-list
56492946|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56492947|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492948|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492949|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818011|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242620|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56242621|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
56242622|NCT01789437|Hormones|hormones|mesh-ancestor
56242623|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242624|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56242625|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242626|NCT01789619|Tacrolimus|tacrolimus|mesh-list
56242627|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56242628|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
56242629|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242630|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56242631|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242632|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242633|NCT01789710|Bupropion|bupropion|mesh-list
55818012|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
56492950|NCT00532142|Triamcinolone|triamcinolone|mesh-list
56492951|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56492952|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
56492953|NCT00532142|Hormones|hormones|mesh-ancestor
56492954|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56492955|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492956|NCT04749641|Vaccines|vaccines|mesh-list
56492957|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
56492958|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492959|NCT00533312|Niacin|niacin|mesh-list
56492960|NCT00533312|Niacinamide|niacinamide|mesh-list
56492961|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
56492962|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56492963|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
56242635|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56242636|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
56242637|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242638|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242639|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56242640|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56242641|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
56242642|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242643|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242644|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56242645|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
56242646|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56242647|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56242648|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56242649|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56492964|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492965|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56492966|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
56492967|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
56492968|NCT00533312|Vitamins|vitamins|mesh-ancestor
56492969|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
56492970|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492971|NCT00533390|Efavirenz|efavirenz|mesh-list
56492972|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56492973|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56492974|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56492975|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492976|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
56492977|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56492978|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56242689|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56242690|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56242691|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56242692|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56242693|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
56242694|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56242695|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56242696|NCT01789892|Prednisolone|prednisolone|mesh-list
56242697|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
56242698|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56242699|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
56242700|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56242701|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242702|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
56242703|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
56242704|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242705|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242706|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56242707|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
56242709|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242710|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56242711|NCT01789892|Protective Agents|protective agents|mesh-ancestor
56242712|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56242713|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242714|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55744932|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
56492979|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56492980|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56492981|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56492982|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56492983|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56492984|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56492985|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56242715|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242716|NCT01789957|Exenatide|exenatide|mesh-list
56492986|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492987|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56492988|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56492989|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56492990|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56492991|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
56492992|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56492993|NCT04668456|Lidocaine|lidocaine|mesh-list
56492994|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
56492995|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
56492996|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
56242791|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242792|NCT01794247|Lidocaine|lidocaine|mesh-list
56242793|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
56242794|NCT01794247|Fentanyl|fentanyl|mesh-list
56242795|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
56242796|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
56242797|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242798|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242799|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
56242800|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56492997|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56492998|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56492999|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
56493000|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493001|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56493002|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56493003|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56493004|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56493005|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493006|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55802449|NCT05613361|Analgesics|analgesics|mesh-ancestor
56493008|NCT04668456|Analgesics|analgesics|mesh-ancestor
56493009|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56242849|NCT01796132|Analgesics|analgesics|mesh-ancestor
56242850|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
56242851|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
56242852|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56242853|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56242855|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56242856|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56242857|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242858|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56242859|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56242860|NCT01796418|Beraprost|beraprost|mesh-list
56242861|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56242862|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
56242863|NCT01796522|Nifedipine|nifedipine|mesh-list
56242864|NCT01796522|Progesterone|progesterone|mesh-list
56242865|NCT01796522|Progestins|progestins|mesh-ancestor
56242866|NCT01796522|Hormones|hormones|mesh-ancestor
56242867|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242868|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242869|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56242870|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56242871|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242872|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56242873|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
56242874|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
56242875|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242876|NCT01796730|Bambuterol|bambuterol|mesh-list
55744965|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
56493010|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56493011|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56493012|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
56493013|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493014|NCT04693169|Choline|choline|mesh-list
56493015|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
56493016|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56493017|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
56493018|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493019|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56493020|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56493021|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
56493022|NCT04668417|Vaccines|vaccines|mesh-list
56493023|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
56242877|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56242878|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
56242879|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242880|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818244|NCT02461589|Liraglutide|liraglutide|mesh-list
56242881|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56242882|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
56242883|NCT01796808|Lidocaine|lidocaine|mesh-list
56242884|NCT01796808|Epinephrine|epinephrine|mesh-list
56242885|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
56242886|NCT01796808|Anesthetics|anesthetics|mesh-list
56493024|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493025|NCT00556413|Leucovorin|leucovorin|mesh-list
56493026|NCT00556413|Fluorouracil|fluorouracil|mesh-list
56493027|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
56493028|NCT00556413|Irinotecan|irinotecan|mesh-list
56493029|NCT00556413|Cetuximab|cetuximab|mesh-list
56493030|NCT00556413|Calcium|calcium|mesh-list
56493031|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
56493032|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56493033|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493034|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
56242928|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
56242929|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
56242930|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
56242931|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242932|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242933|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56242934|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242935|NCT01798446|Axitinib|axitinib|mesh-list
56242936|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242937|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56242938|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242939|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242940|NCT01798680|Vitamin D|vitamin d|mesh-list
56242941|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
56242942|NCT01798680|Vitamins|vitamins|mesh-ancestor
56242943|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
56242947|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56242962|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56242963|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56242964|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
56242965|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242966|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242967|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242969|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56242970|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56242971|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
56242972|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56493035|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493036|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56493037|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493038|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493039|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
56493040|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56212299|NCT05705037|Serotonin Agents|serotonin agents|mesh-ancestor
56493041|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56493042|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242983|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56242984|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56242985|NCT01799863|Laxatives|laxatives|mesh-ancestor
56242986|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56242987|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
56242988|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56242989|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
56242990|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56242991|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
55818378|NCT02029989|Analgesics|analgesics|mesh-ancestor
56493043|NCT00556413|Antidotes|antidotes|mesh-ancestor
56493044|NCT00556413|Protective Agents|protective agents|mesh-ancestor
56493045|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
56493046|NCT00556413|Vitamins|vitamins|mesh-ancestor
56493047|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
56493048|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493049|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
56493050|NCT04668690|Analgesics|analgesics|mesh-ancestor
56493051|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
56242992|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242993|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242994|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
56242995|NCT01800019|Nicotine|nicotine|mesh-list
56242996|NCT01800019|Varenicline|varenicline|mesh-list
56242997|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56242998|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
56242999|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243000|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243001|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56243002|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56243003|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
56243004|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243005|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243006|NCT01800097|Modafinil|modafinil|mesh-list
56243007|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56243013|NCT01800227|Metformin|metformin|mesh-list
56493052|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493053|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493054|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493055|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56493056|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56493057|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493058|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493059|NCT04622813|Acetaminophen|acetaminophen|mesh-list
56493060|NCT04622813|Ketoprofen|ketoprofen|mesh-list
56493061|NCT04622813|Nefopam|nefopam|mesh-list
56493062|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56493063|NCT04622813|Analgesics|analgesics|mesh-ancestor
56493064|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
56493065|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748145|NCT03107923|Dobutamine|dobutamine|mesh-list
56493066|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493067|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
56493068|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56493069|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56493070|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56493071|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56493072|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493073|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493074|NCT00533585|Paclitaxel|paclitaxel|mesh-list
56493075|NCT00533585|Bevacizumab|bevacizumab|mesh-list
56493076|NCT00533585|Carboplatin|carboplatin|mesh-list
56493077|NCT00533585|Sorafenib|sorafenib|mesh-list
56493078|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56493079|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493080|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
56493081|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
56243117|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243118|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
56243119|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243120|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243124|NCT01800799|Celecoxib|celecoxib|mesh-list
56243135|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243136|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243137|NCT01800825|Clindamycin|clindamycin|mesh-list
56243138|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
56243139|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
56243140|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243141|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243142|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56243143|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243144|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243145|NCT01800942|Azithromycin|azithromycin|mesh-list
56243146|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243147|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243148|NCT01801046|Cytarabine|cytarabine|mesh-list
56243149|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
56243150|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56243151|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
56243152|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243153|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243154|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
56243155|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493082|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
56493083|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493084|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493085|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56493086|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56493088|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493089|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
56493090|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56493091|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493092|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
56243162|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56243163|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56243164|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243165|NCT01801137|Everolimus|everolimus|mesh-list
56243166|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243167|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243168|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
55818550|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55871472|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243169|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243170|NCT01801163|Sorafenib|sorafenib|mesh-list
56243171|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243172|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56243173|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243174|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243175|NCT01801228|Eplerenone|eplerenone|mesh-list
56243176|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56243177|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
56243178|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493093|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56493094|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493095|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56493096|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
56493097|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56493098|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493099|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493100|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493101|NCT04562441|Avelumab|avelumab|mesh-list
56243179|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243180|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56243181|NCT01801228|Diuretics|diuretics|mesh-ancestor
56243182|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
56243183|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56243184|NCT01801410|Misoprostol|misoprostol|mesh-list
56243185|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56243186|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
56243187|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55818564|NCT02458469|Buspirone|buspirone|mesh-list
56243188|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243189|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56243190|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56243191|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
56243192|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
56243193|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243194|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
56243195|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243196|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243197|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56243198|NCT01801644|Gemcitabine|gemcitabine|mesh-list
56243199|NCT01801644|Cisplatin|cisplatin|mesh-list
56243200|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243201|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56243202|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
56243203|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243204|NCT01801644|Antiviral Agents|antiviral agents|mesh-ancestor
56243205|NCT01801644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243206|NCT01801644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243207|NCT01801644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243208|NCT01801644|Immunologic Factors|immunologic factors|mesh-ancestor
56493102|NCT04562441|Axitinib|axitinib|mesh-list
56493103|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493104|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493105|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56493106|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493107|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493108|NCT04659057|Lidocaine|lidocaine|mesh-list
56493109|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
56493110|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
56493111|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
56493112|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493113|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493114|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
56493115|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493116|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56243209|NCT01801644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243210|NCT01801774|Triamcinolone|triamcinolone|mesh-list
56243211|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56243212|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56243213|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56243214|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56243215|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
56243216|NCT01801774|Hormones|hormones|mesh-ancestor
56243217|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56243218|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243219|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243220|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
56243221|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243222|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243223|NCT01802255|Midazolam|midazolam|mesh-list
56243224|NCT01802255|Sevoflurane|sevoflurane|mesh-list
56243225|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56243226|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56243227|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243228|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243229|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56243230|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56243231|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56243232|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56493117|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56493118|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56493119|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56493120|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493121|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56493122|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56493123|NCT04659057|Analgesics|analgesics|mesh-ancestor
56493124|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56493125|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56493126|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56493127|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
56493128|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493129|NCT04547153|Docetaxel|docetaxel|mesh-list
56493130|NCT04547153|Fluorouracil|fluorouracil|mesh-list
56493131|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493132|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
56493133|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
56493134|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
56493135|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493136|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
56493137|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56493138|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493139|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
56493140|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243365|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56243366|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56243367|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
56243368|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243369|NCT01802918|Ritonavir|ritonavir|mesh-list
56243370|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
56243371|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56243372|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56243373|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
56243374|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243375|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243376|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56243377|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56243378|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
55818754|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
55748220|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
56493141|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56493142|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56493143|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
56493144|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493145|NCT00533741|Antacids|antacids|mesh-ancestor
56493146|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493147|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56493148|NCT00533858|Losartan|losartan|mesh-list
56493149|NCT00533858|Lacidipine|lacidipine|mesh-list
56493150|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56493151|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56493152|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56243379|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243380|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56243381|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56243382|NCT01802931|Ketoconazole|ketoconazole|mesh-list
56243383|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
56243384|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243385|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56243386|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56243387|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243388|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243389|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56243390|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
56243391|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56243392|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243393|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56243395|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56243396|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212336|NCT05704374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56493153|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56493154|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493155|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56493156|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56493157|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56493158|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493159|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
56493160|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56493161|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
56493162|NCT04658355|Povidone|povidone|mesh-list
56493163|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56493164|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493165|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
56243398|NCT01802970|Vinorelbine|vinorelbine|mesh-list
56243399|NCT01802970|Capecitabine|capecitabine|mesh-list
56243400|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56243401|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56243402|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243403|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
56243404|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
56243405|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
56243406|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243407|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56243408|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
56243409|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56243410|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
56243411|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56243412|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
56243413|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243414|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243415|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56243416|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
56243417|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56243418|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56243419|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56243420|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
56243421|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243422|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243423|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
56243424|NCT01803191|Fosfomycin|fosfomycin|mesh-list
56493166|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
56493167|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
56493168|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
56493169|NCT00533936|Paclitaxel|paclitaxel|mesh-list
56493170|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
56493171|NCT00533936|Doxorubicin|doxorubicin|mesh-list
56493172|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56493173|NCT00533936|Fluorouracil|fluorouracil|mesh-list
56493174|NCT00533936|Trastuzumab|trastuzumab|mesh-list
56493175|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56493176|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493177|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
56493178|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
56493179|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
56243429|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243430|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243431|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243432|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56243433|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56243434|NCT01803321|Rilonacept|rilonacept|mesh-list
56243435|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56243436|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56243437|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
56243438|NCT01803347|Coagulants|coagulants|mesh-ancestor
56243439|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
56243440|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243441|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243442|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56243443|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56243444|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243447|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56493180|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493181|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493182|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
56493183|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493184|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56493185|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56493186|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
56493187|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56243500|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56243501|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243502|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56243503|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
56243504|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56243505|NCT01804218|Nadolol|nadolol|mesh-list
56243506|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56243507|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56243508|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
56243509|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243510|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243511|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493188|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56493189|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56493190|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56493191|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493192|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
56493193|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56493194|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493195|NCT00557544|Ketoprofen|ketoprofen|mesh-list
56493196|NCT00557544|Metoclopramide|metoclopramide|mesh-list
56493197|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
56493198|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
56493199|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493200|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493201|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56493202|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56493203|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56493204|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
56493205|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243566|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56243567|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243568|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56243569|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56243570|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243571|NCT01804413|Insulin|insulin|mesh-list
56243572|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56243573|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56243574|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243575|NCT01804543|Ranolazine|ranolazine|mesh-list
56243576|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56243577|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56243578|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243579|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
56243580|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56243581|NCT01804595|Protective Agents|protective agents|mesh-ancestor
56243582|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243583|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
56243584|NCT01804712|Rituximab|rituximab|mesh-list
56243585|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56243586|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243591|NCT01804777|Amiloride|amiloride|mesh-list
56493206|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493207|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56493208|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56493209|NCT00557544|Analgesics|analgesics|mesh-ancestor
56493210|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
56493211|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56493212|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56493213|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56493214|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493216|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56493217|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56493218|NCT04667910|Growth Substances|growth substances|mesh-ancestor
56493219|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493220|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
56493221|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493222|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56493223|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
56493225|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56493226|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
56493227|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493228|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
56493229|NCT00556608|Protective Agents|protective agents|mesh-ancestor
56493230|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
56493231|NCT00534287|Meropenem|meropenem|mesh-list
56493232|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56243685|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56243686|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
56243687|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243688|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56243689|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56243690|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
56243691|NCT01807962|Lidocaine|lidocaine|mesh-list
56243692|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
56243693|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
56243694|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243695|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243703|NCT01808014|Nefopam|nefopam|mesh-list
56243719|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871473|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56243720|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
56243721|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56243722|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56243723|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243724|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56243725|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56243726|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56243727|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243728|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56243729|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
56493233|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56493234|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493235|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56493236|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56493237|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493238|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493239|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493240|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56493241|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
56493242|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56493243|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493244|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56493245|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56493246|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56493247|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
56493248|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493249|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493250|NCT04166396|Resveratrol|resveratrol|mesh-list
56493251|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
56493252|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493253|NCT04166396|Protective Agents|protective agents|mesh-ancestor
56493254|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493255|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493256|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56493257|NCT01215916|Pemetrexed|pemetrexed|mesh-list
56493258|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493259|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493260|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493261|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56493262|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56493263|NCT01184872|Vancomycin|vancomycin|mesh-list
56493264|NCT01184872|Daptomycin|daptomycin|mesh-list
56493265|NCT01184872|Penicillins|penicillins|mesh-list
56493266|NCT01184872|Floxacillin|floxacillin|mesh-list
56493267|NCT01184872|Cloxacillin|cloxacillin|mesh-list
56493268|NCT01184872|Oxacillin|oxacillin|mesh-list
56493269|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56493270|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493271|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
56493272|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56493273|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56493274|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
56493275|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493276|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493277|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493278|NCT01215721|Urological Agents|urological agents|mesh-ancestor
56493279|NCT04083365|Capecitabine|capecitabine|mesh-list
56493280|NCT04083365|Durvalumab|durvalumab|mesh-list
56493281|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56493282|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
56493283|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493284|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493285|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493286|NCT04666623|Esketamine|esketamine|mesh-list
56243863|NCT01809340|Minocycline|minocycline|mesh-list
56243864|NCT01809340|Ketamine|ketamine|mesh-list
56243865|NCT01809340|Analgesics|analgesics|mesh-ancestor
56243866|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
56493287|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
56493288|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56493289|NCT00534677|Octreotide|octreotide|mesh-list
56493290|NCT00534677|Terlipressin|terlipressin|mesh-list
56493291|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56493292|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56493293|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493294|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56493295|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56493296|NCT00556959|Clonidine|clonidine|mesh-list
56493297|NCT00556959|Analgesics|analgesics|mesh-ancestor
56493298|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
56243900|NCT01809626|Zolpidem|zolpidem|mesh-list
56243915|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243916|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56243917|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
56243918|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56243919|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
56243920|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
56243921|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493299|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493300|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493301|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56493302|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
56493303|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
56493304|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56493305|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56493306|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56493307|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
56493308|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243984|NCT01810393|Trastuzumab|trastuzumab|mesh-list
56243985|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56243986|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243987|NCT01810458|Acetaminophen|acetaminophen|mesh-list
56243988|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56243990|NCT01810458|Fentanyl|fentanyl|mesh-list
56243991|NCT01810458|Midazolam|midazolam|mesh-list
56243992|NCT01810458|Oxycodone|oxycodone|mesh-list
56243993|NCT01810458|Lorazepam|lorazepam|mesh-list
56243994|NCT01810458|Ondansetron|ondansetron|mesh-list
56243995|NCT01810458|Liver Extracts|liver extracts|mesh-list
56243996|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
56243997|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
56243998|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243999|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244000|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
56244001|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244002|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56244003|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56493309|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493310|NCT01184326|Everolimus|everolimus|mesh-list
56493311|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493312|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244318|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
56493313|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
56493314|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493315|NCT01215253|Ranolazine|ranolazine|mesh-list
56493316|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56493317|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56493318|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493319|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
56493320|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493321|NCT03813875|Fentanyl|fentanyl|mesh-list
56493322|NCT03813875|Midazolam|midazolam|mesh-list
56493323|NCT03813875|Alfentanil|alfentanil|mesh-list
56493324|NCT03813875|Propofol|propofol|mesh-list
56493325|NCT03813875|Sevoflurane|sevoflurane|mesh-list
56493326|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56493327|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493328|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493329|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56493330|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
56493331|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
56493332|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56493333|NCT03813875|Narcotics|narcotics|mesh-ancestor
56493334|NCT03813875|Analgesics|analgesics|mesh-ancestor
56244651|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493335|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
56493336|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493337|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56244727|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
56493338|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56493339|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56493340|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56493341|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
56493342|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
56493343|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493344|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493345|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56493346|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56493347|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56493348|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493349|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56493350|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245049|NCT01816620|Hormones|hormones|mesh-ancestor
56493351|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493352|NCT05449522|Vitamin D|vitamin d|mesh-list
56493353|NCT05449522|Vitamins|vitamins|mesh-ancestor
56493354|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
56493355|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493356|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56493357|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56493358|NCT03737981|Venetoclax|venetoclax|mesh-list
56493359|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
56493360|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493361|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493362|NCT04665141|Omalizumab|omalizumab|mesh-list
56493363|NCT04665141|Benralizumab|benralizumab|mesh-list
56493364|NCT04665141|Reslizumab|reslizumab|mesh-list
56493365|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56245276|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493366|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56493367|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
56493368|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
56493369|NCT04665063|Fludarabine|fludarabine|mesh-list
56493370|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493371|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
56493372|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493373|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56493374|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56493375|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
56493376|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493377|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493378|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56493379|NCT03646058|Buprenorphine|buprenorphine|mesh-list
56493380|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56493381|NCT03646058|Narcotics|narcotics|mesh-ancestor
56493382|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493383|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493384|NCT03646058|Analgesics|analgesics|mesh-ancestor
56493385|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
56493386|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493387|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56493389|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56493390|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245628|NCT01820793|Cefoxitin|cefoxitin|mesh-list
56493391|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493392|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56493393|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
56493394|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
56493395|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56493396|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
56493397|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493398|NCT03580148|Cortisone|cortisone|mesh-list
56493399|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56493400|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56493401|NCT04664517|Anesthetics|anesthetics|mesh-list
56245723|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
56493402|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493403|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493404|NCT05335915|Nicotine|nicotine|mesh-list
56493405|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56493406|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
56493407|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493408|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493409|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56493410|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56493411|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
56493412|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493413|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493414|NCT01215097|Linagliptin|linagliptin|mesh-list
56493415|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56493416|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493417|NCT01215097|Incretins|incretins|mesh-ancestor
56493418|NCT01215097|Hormones|hormones|mesh-ancestor
56493419|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493420|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56493421|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
56493422|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493423|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493424|NCT03554174|Psilocybin|psilocybin|mesh-list
56493425|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
56493426|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493427|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56493428|NCT03527576|Dexamethasone|dexamethasone|mesh-list
56493429|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56493430|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
56493431|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
56493432|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493433|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493434|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56493435|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
56493436|NCT03527576|Hormones|hormones|mesh-ancestor
56493437|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493438|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56493439|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493440|NCT04664010|Vitamins|vitamins|mesh-list
56493441|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
56493442|NCT04664010|Interferons|interferons|mesh-list
56493443|NCT04664010|Ribavirin|ribavirin|mesh-list
56493444|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
56493445|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56493446|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
56493447|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493448|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493449|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
56493450|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493451|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
56493452|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493453|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
56493454|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
56493455|NCT04664010|Protective Agents|protective agents|mesh-ancestor
56493456|NCT04664127|Valacyclovir|valacyclovir|mesh-list
56493457|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
56493458|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493459|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56493460|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56493461|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56493462|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56493463|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245933|NCT01822613|Docetaxel|docetaxel|mesh-list
56245934|NCT01822613|Irinotecan|irinotecan|mesh-list
56245944|NCT01822639|Amlodipine|amlodipine|mesh-list
56493464|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493465|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493466|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56493467|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
56493468|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56493469|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
56493470|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493471|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493472|NCT04663386|Budesonide|budesonide|mesh-list
56493473|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
56493474|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56493475|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56493476|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
56493477|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493478|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493479|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56493480|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
56493481|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
56493482|NCT04663386|Hormones|hormones|mesh-ancestor
56493483|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493484|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56493485|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56493486|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56493487|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
56493488|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493489|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493490|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56493491|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493492|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493493|NCT04663269|Dexamethasone|dexamethasone|mesh-list
56493494|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56493495|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
56493496|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
56493497|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493498|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493499|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56493501|NCT04663269|Hormones|hormones|mesh-ancestor
56493502|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493503|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56493504|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493505|NCT03312738|Everolimus|everolimus|mesh-list
56493506|NCT03312738|Exemestane|exemestane|mesh-list
56493507|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493508|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493509|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
56493510|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493511|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56493512|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56493513|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493514|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493515|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56493516|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
56493517|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493518|NCT03303339|Cytarabine|cytarabine|mesh-list
56493519|NCT03303339|Decitabine|decitabine|mesh-list
56493520|NCT03303339|Onvansertib|onvansertib|mesh-list
56493521|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56493522|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
56493523|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493524|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493525|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
56493526|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493527|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493528|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
56493529|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493530|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493531|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56493532|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56493533|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493534|NCT03299946|Nivolumab|nivolumab|mesh-list
56493535|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493536|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493537|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56493538|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493539|NCT00535340|Amibegron|amibegron|mesh-list
56493540|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56493541|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56493542|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
56493543|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493544|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493545|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493546|NCT00535379|Sunitinib|sunitinib|mesh-list
56493547|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493548|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56493549|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56493550|NCT00535379|Growth Substances|growth substances|mesh-ancestor
56493551|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493552|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
56493553|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56493554|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493555|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493556|NCT00535418|Letrozole|letrozole|mesh-list
56493557|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493558|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56493559|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56245972|NCT01822808|Hydralazine|hydralazine|mesh-list
56493560|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493561|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493562|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56493563|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
56493564|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493565|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493566|NCT03377543|Aspirin|aspirin|mesh-list
56493567|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56493568|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56493569|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56493570|NCT03377543|Analgesics|analgesics|mesh-ancestor
56493571|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
56241588|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
56493572|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493573|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493574|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56493575|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56493576|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56493577|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493578|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56493579|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56493580|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493581|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
56493582|NCT04679064|Gemcitabine|gemcitabine|mesh-list
56493583|NCT04679064|Paclitaxel|paclitaxel|mesh-list
56493584|NCT04679064|Bevacizumab|bevacizumab|mesh-list
56493585|NCT04679064|Doxorubicin|doxorubicin|mesh-list
56493586|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56493587|NCT04679064|Topotecan|topotecan|mesh-list
56493588|NCT04679064|Niraparib|niraparib|mesh-list
56493589|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56493590|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493591|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
56493592|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
56493593|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
56493594|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493595|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493596|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56493597|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56493598|NCT04679064|Growth Substances|growth substances|mesh-ancestor
56493599|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493600|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
56493601|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56493602|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
56493603|NCT04679064|Antiviral Agents|antiviral agents|mesh-ancestor
56493604|NCT04679064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493605|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493606|NCT04679064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493607|NCT04679064|Immunologic Factors|immunologic factors|mesh-ancestor
56493608|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56493609|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56493610|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56493611|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56493612|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56493613|NCT01183780|Leucovorin|leucovorin|mesh-list
56493614|NCT01183780|Folic Acid|folic acid|mesh-list
56493615|NCT01183780|Fluorouracil|fluorouracil|mesh-list
56493616|NCT01183780|Irinotecan|irinotecan|mesh-list
56493617|NCT01183780|Ramucirumab|ramucirumab|mesh-list
56493618|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
56493619|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
56493620|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493621|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56493622|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493623|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493624|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
56493625|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493626|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56493627|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56493628|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493629|NCT01183780|Antidotes|antidotes|mesh-ancestor
56493630|NCT01183780|Protective Agents|protective agents|mesh-ancestor
56493631|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
56493632|NCT01183780|Vitamins|vitamins|mesh-ancestor
56493633|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
56493634|NCT01183780|Hematinics|hematinics|mesh-ancestor
56493635|NCT03253289|Meclizine|meclizine|mesh-list
56493636|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
56493637|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
56493638|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493639|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493640|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56493641|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56493642|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
56493643|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
56493644|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493645|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493646|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56493647|NCT04679103|Eculizumab|eculizumab|mesh-list
56493648|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56493649|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493650|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
56493651|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493652|NCT03250832|Bevacizumab|bevacizumab|mesh-list
56493653|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493654|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493655|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56493656|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56493657|NCT03250832|Growth Substances|growth substances|mesh-ancestor
56493658|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493659|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
56493660|NCT00535574|Bexarotene|bexarotene|mesh-list
56493661|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493662|NCT04678830|Leronlimab|leronlimab|mesh-list
56493663|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56493664|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56493665|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493666|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56493667|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56493668|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
56493669|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493670|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56493671|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
56493672|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56493673|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56493674|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
56493675|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493676|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493677|NCT03245021|Rituximab|rituximab|mesh-list
56493679|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493680|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493681|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
56493682|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493683|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56493684|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56493685|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493686|NCT04678791|Cisplatin|cisplatin|mesh-list
56493687|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
56493688|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493689|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493690|NCT01183390|Anastrozole|anastrozole|mesh-list
56493691|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56493692|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493694|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56493695|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493696|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493697|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56493698|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
56493699|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493700|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493701|NCT02887807|Cyclosporine|cyclosporine|mesh-list
56493702|NCT02887807|Cyclosporins|cyclosporins|mesh-list
56493703|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493704|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493705|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493706|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
56493707|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493708|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
56493709|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493710|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
56493711|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56493712|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56493713|NCT04662840|Anesthetics|anesthetics|mesh-list
56493714|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
56493715|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493716|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493717|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
56493718|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493719|NCT03098589|Lenalidomide|lenalidomide|mesh-list
56493720|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
56493721|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493722|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56493723|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56241740|NCT01783587|Docetaxel|docetaxel|mesh-list
56493724|NCT03098589|Growth Substances|growth substances|mesh-ancestor
56493725|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
56493726|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493727|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
56493728|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56493729|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493730|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493731|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56493732|NCT04662177|Analgesics|analgesics|mesh-ancestor
56493733|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
56493734|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493735|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56493736|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56493737|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56493738|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
56493739|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493740|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493741|NCT03026517|Phenformin|phenformin|mesh-list
56493742|NCT03026517|Trametinib|trametinib|mesh-list
56493743|NCT03026517|Dabrafenib|dabrafenib|mesh-list
56493744|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493745|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56493746|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493747|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493748|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56493749|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493750|NCT00537953|Miltefosine|miltefosine|mesh-list
56493751|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56493752|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
56493753|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493754|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493755|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56493756|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56493757|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
56493758|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493759|NCT05226299|Capsaicin|capsaicin|mesh-list
56493760|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
56493761|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
56493762|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
56493763|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493764|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493765|NCT00557232|Bevacizumab|bevacizumab|mesh-list
56493766|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56493767|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493768|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56493769|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56493770|NCT00557232|Growth Substances|growth substances|mesh-ancestor
56493771|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493772|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
56493773|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
56493774|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56493775|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56493776|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493777|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
56493778|NCT02797119|Coagulants|coagulants|mesh-ancestor
56493779|NCT05161208|Varenicline|varenicline|mesh-list
56493780|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56493781|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56493782|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
56493783|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493784|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493785|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493786|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
56493787|NCT02650986|Decitabine|decitabine|mesh-list
56493788|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493789|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
56493790|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493791|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56493792|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56493793|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
56493794|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493795|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493796|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56493797|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56493798|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
56493799|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493801|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
56493802|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493803|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493804|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493805|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
56493806|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493807|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56493808|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493809|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493810|NCT00538148|Telithromycin|telithromycin|mesh-list
56493811|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56493812|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493813|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
56493814|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493815|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
56493816|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
56493817|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56493818|NCT05119439|Misoprostol|misoprostol|mesh-list
56493819|NCT05119439|Mifepristone|mifepristone|mesh-list
56246172|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
56493820|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56493821|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
56493822|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56493823|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493824|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56493825|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56493826|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
56493827|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56493828|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56493829|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56493830|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56493831|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
56493832|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56493833|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56493834|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
56493835|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56493836|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
56493837|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56493838|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56493839|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56493840|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56493841|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493843|NCT00538187|Obatoclax|obatoclax|mesh-list
56493844|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493845|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493846|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493847|NCT04661709|Aspirin|aspirin|mesh-list
56493848|NCT04661709|Metoprolol|metoprolol|mesh-list
56493849|NCT04661709|Isosorbide|isosorbide|mesh-list
56493850|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56493851|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56493852|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
56493853|NCT04661709|Trimetazidine|trimetazidine|mesh-list
56493854|NCT04661709|Clopidogrel|clopidogrel|mesh-list
56493855|NCT04661709|Atorvastatin|atorvastatin|mesh-list
56493856|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493857|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56493858|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56493859|NCT04661709|Analgesics|analgesics|mesh-ancestor
56493860|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
56493861|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493862|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56493863|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56493864|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56493865|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56493866|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493867|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56493868|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56493869|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56493870|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
56493871|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56493872|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56493873|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
56493874|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56241908|NCT01784562|Riociguat|riociguat|mesh-list
56493875|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56493876|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56493877|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56493878|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56493879|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
56493880|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493881|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56493882|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56493883|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
56493884|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
56493885|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56493886|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56493887|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56493888|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
56493889|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56493890|NCT04661709|Diuretics|diuretics|mesh-ancestor
56493891|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
56493892|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
56493893|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56493894|NCT02466867|Naftifine|naftifine|mesh-list
56493895|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
56493896|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493897|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
56493898|NCT00538265|Tacrolimus|tacrolimus|mesh-list
56493899|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
56493900|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493901|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
56493902|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493903|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56493904|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819810|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56493905|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493906|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56493907|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493908|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56493909|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
56493910|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56493911|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493912|NCT02462811|Acetaminophen|acetaminophen|mesh-list
56493913|NCT02462811|Promethazine|promethazine|mesh-list
56493914|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
56493915|NCT02462811|Hydrocodone|hydrocodone|mesh-list
56493916|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56493917|NCT02462811|Analgesics|analgesics|mesh-ancestor
56493918|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
56493919|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493920|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493921|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
56493922|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56493923|NCT02462811|Narcotics|narcotics|mesh-ancestor
56493924|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493925|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
56493926|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
56493927|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
56493928|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
56246280|NCT01825044|Cyclosporine|cyclosporine|mesh-list
56493929|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56493930|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
56493931|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
56493932|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493933|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493934|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56493935|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56493936|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56493937|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
56493938|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
56493939|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
56493940|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
56493941|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56493942|NCT00538382|Artesunate|artesunate|mesh-list
56493943|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
56493944|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56493945|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56493946|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56493947|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493948|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
56493949|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
56493950|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56242008|NCT01785446|Dsuvia|dsuvia|mesh-list
56493951|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
56493952|NCT00538421|Propofol|propofol|mesh-list
56493954|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56493955|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56212458|NCT05645380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56493956|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493957|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56493958|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
56493960|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56493961|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56493962|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
56493963|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56493964|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493965|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493966|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56493967|NCT04661475|Analgesics|analgesics|mesh-ancestor
56493968|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
56493969|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493970|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56493971|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56493972|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56493973|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
56493974|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56493975|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56493976|NCT00538499|Fentanyl|fentanyl|mesh-list
56493977|NCT00538499|Bupivacaine|bupivacaine|mesh-list
56493978|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
56493979|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
56493980|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56493981|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493982|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
56493983|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56493984|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56493985|NCT00538499|Narcotics|narcotics|mesh-ancestor
56493986|NCT00538499|Analgesics|analgesics|mesh-ancestor
56493987|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56493988|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56493989|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
56493990|NCT00538538|Ranibizumab|ranibizumab|mesh-list
56493991|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56493992|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56493993|NCT00538538|Growth Substances|growth substances|mesh-ancestor
56493994|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56493995|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
56493996|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56493997|NCT00554346|Etoricoxib|etoricoxib|mesh-list
56493998|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56493999|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56494000|NCT00554346|Analgesics|analgesics|mesh-ancestor
56494001|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
56494002|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494003|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494004|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494005|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494006|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56494007|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56494008|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494009|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494010|NCT00538655|Modafinil|modafinil|mesh-list
56494011|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56494012|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494013|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56494014|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56494015|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56494016|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494017|NCT00538694|Daptomycin|daptomycin|mesh-list
56494018|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56494019|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494020|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
56494021|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56494022|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
56494023|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56494024|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56494025|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242051|NCT01785641|Cefazolin|cefazolin|mesh-list
56494026|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56494027|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494028|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56494029|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494030|NCT00538811|Interferons|interferons|mesh-list
56494031|NCT00538811|Ribavirin|ribavirin|mesh-list
56494032|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
56494033|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
56494034|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
56494035|NCT00538811|Amantadine|amantadine|mesh-list
56494036|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494037|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
56494038|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494039|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
56494040|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494041|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
56494042|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494043|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56494044|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56494045|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
56494046|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494047|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56494048|NCT00538811|Analgesics|analgesics|mesh-ancestor
56494049|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
56494050|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494051|NCT04660773|Pregabalin|pregabalin|mesh-list
56494052|NCT04660773|Analgesics|analgesics|mesh-ancestor
56494053|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
56494054|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494055|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494056|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
56494057|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56494058|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494059|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246364|NCT01825603|Antiviral Agents|antiviral agents|mesh-ancestor
56494060|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56494061|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56494062|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56494063|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494064|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56494065|NCT00538889|Citalopram|citalopram|mesh-list
56494066|NCT00538889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56494067|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56494068|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494069|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494070|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494071|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
56494072|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494073|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56494074|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
56494075|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56494076|NCT02413827|Ipilimumab|ipilimumab|mesh-list
56494077|NCT02413827|Poly ICLC|poly iclc|mesh-list
56494078|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56494079|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56494080|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494081|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56494082|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494083|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
56494084|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
56494085|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494086|NCT00538967|Doxycycline|doxycycline|mesh-list
56494087|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56494088|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494089|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
56494090|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56494091|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56494092|NCT00539123|Buprenorphine|buprenorphine|mesh-list
56494093|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56494094|NCT00539123|Narcotics|narcotics|mesh-ancestor
56212471|NCT05645380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56494095|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494096|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494098|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
56494099|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494100|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56494101|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
56494102|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56494103|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
56494104|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494105|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494106|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56494107|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
56494108|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
56494109|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56494110|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
56494111|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494112|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494114|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56246404|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56494115|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494116|NCT00539435|Insulin|insulin|mesh-list
56494117|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
56494118|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56494119|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494120|NCT00539630|Docetaxel|docetaxel|mesh-list
56494121|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494122|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
56494123|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
56494124|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
56494125|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494126|NCT04660461|Lansoprazole|lansoprazole|mesh-list
56494127|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
56494128|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56494129|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56494130|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56494131|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494132|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494133|NCT00539669|Docetaxel|docetaxel|mesh-list
56494134|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494135|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
56494136|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
56494137|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
56494138|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494139|NCT00554424|Lidocaine|lidocaine|mesh-list
56494140|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
56494141|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
56494142|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494143|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494144|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
56494145|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494146|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56494147|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56494148|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56494149|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494150|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494151|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
56494152|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56494153|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494154|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56494155|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56494156|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
56494157|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494158|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
56494159|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494160|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494161|NCT00539786|Rabeprazole|rabeprazole|mesh-list
56494162|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56494163|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56494164|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56494165|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494166|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494167|NCT02341989|Carboplatin|carboplatin|mesh-list
56494168|NCT02341989|Etoposide|etoposide|mesh-list
56494169|NCT02341989|Bleomycin|bleomycin|mesh-list
56494170|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494171|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56494172|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56494173|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56494174|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494175|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494176|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56494178|NCT00540098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56494179|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56494180|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494181|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494182|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494183|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
56494184|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494185|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56494186|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
56494187|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56494188|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56494189|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56494190|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494191|NCT00540137|Ritonavir|ritonavir|mesh-list
56494192|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56494193|NCT00540137|Nevirapine|nevirapine|mesh-list
56494194|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56494195|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56246469|NCT01826747|Progesterone|progesterone|mesh-list
56494196|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
56494197|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494198|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494199|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56494200|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56494201|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
56494202|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494203|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56494204|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56494205|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56494206|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56494207|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56494208|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56494209|NCT04660110|Piperaquine|piperaquine|mesh-list
56494210|NCT04660110|Artenimol|artenimol|mesh-list
56494211|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
56494212|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56494213|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56494214|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494215|NCT02339064|Apomorphine|apomorphine|mesh-list
56494216|NCT02339064|Emetics|emetics|mesh-ancestor
56494217|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494218|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
56494219|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494220|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56494221|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
56494222|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
56494223|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494224|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494225|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56494226|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494227|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
56494228|NCT00540410|Artesunate|artesunate|mesh-list
56494229|NCT00540410|Lumefantrine|lumefantrine|mesh-list
56494230|NCT00540410|Amodiaquine|amodiaquine|mesh-list
56494231|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56494232|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
56494233|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56494234|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56494235|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494236|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494237|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
56494238|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
56494239|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56494240|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
56494241|NCT00540527|Plasminogen|plasminogen|mesh-list
56494242|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56494243|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56494244|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56494245|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494247|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
56494248|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494249|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56494250|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56494251|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494252|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494253|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56494254|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56494255|NCT04659915|Metformin|metformin|mesh-list
56494256|NCT04659915|Prednisone|prednisone|mesh-list
56494257|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56494258|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494259|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494260|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
56494261|NCT04659915|Hormones|hormones|mesh-ancestor
56494262|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56494263|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56494264|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494265|NCT00557427|Fluoxetine|fluoxetine|mesh-list
56494266|NCT00557427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56494267|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56494268|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494269|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494270|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494271|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
56494272|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494273|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56494274|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
56494275|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56494276|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56494277|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56494278|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494279|NCT00540800|Docetaxel|docetaxel|mesh-list
56494280|NCT00540800|Capecitabine|capecitabine|mesh-list
56494281|NCT00540800|Epirubicin|epirubicin|mesh-list
56494282|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494283|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
56494284|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
56494285|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
56494286|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494287|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56494288|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
56494289|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56494290|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56494291|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56494292|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494293|NCT00540956|Cytarabine|cytarabine|mesh-list
56494294|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56494295|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
56494296|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246676|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56246679|NCT01828125|Glucagon|glucagon|mesh-list
56494297|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494298|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
56494299|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494300|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56494301|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
56494302|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494303|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
56494304|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
56494305|NCT00541073|Pemetrexed|pemetrexed|mesh-list
56494306|NCT00541073|Vitamins|vitamins|mesh-ancestor
56494307|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
56494308|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494309|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494310|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494311|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494312|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56494313|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56494314|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
56494315|NCT00541073|Hematinics|hematinics|mesh-ancestor
56494316|NCT00541112|Leucovorin|leucovorin|mesh-list
56494317|NCT00541112|Fluorouracil|fluorouracil|mesh-list
56494318|NCT00541112|Capecitabine|capecitabine|mesh-list
56494319|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
56494320|NCT00541112|Cetuximab|cetuximab|mesh-list
56494321|NCT00541112|Calcium|calcium|mesh-list
56494322|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
56494323|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56494324|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494325|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
56494326|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494327|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56494328|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494329|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56494330|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
56494331|NCT00541112|Antidotes|antidotes|mesh-ancestor
56494332|NCT00541112|Protective Agents|protective agents|mesh-ancestor
56246734|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
56494333|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
56494334|NCT00541112|Vitamins|vitamins|mesh-ancestor
56494335|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
56494336|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56494337|NCT04659525|Ezetimibe|ezetimibe|mesh-list
56494338|NCT04659525|Evolocumab|evolocumab|mesh-list
56494339|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56494340|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56494341|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
56494342|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494343|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56494344|NCT02333643|Digoxin|digoxin|mesh-list
56494345|NCT02333643|Furosemide|furosemide|mesh-list
56494346|NCT02333643|Diuretics|diuretics|mesh-ancestor
56494347|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
56494348|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494349|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56494350|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494351|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494352|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56494353|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56494354|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494355|NCT02333643|Protective Agents|protective agents|mesh-ancestor
56494357|NCT00541463|Indinavir|indinavir|mesh-list
56494358|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494359|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56494360|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56494361|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
56494362|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494363|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56494364|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56494365|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
56494366|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494367|NCT02324985|Ibuprofen|ibuprofen|mesh-list
56494368|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56494369|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56494370|NCT02324985|Analgesics|analgesics|mesh-ancestor
56494371|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
56494372|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494373|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494374|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494375|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494376|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56494377|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494378|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494380|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
56494381|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56494382|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494383|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494384|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56494385|NCT04659642|Analgesics|analgesics|mesh-ancestor
56494386|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
56494387|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494388|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56494389|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56494390|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56494391|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
56494392|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494393|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494394|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56494395|NCT04659642|Narcotics|narcotics|mesh-ancestor
56494396|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56494397|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56494398|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
56494399|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
56494400|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
56494401|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
56242427|NCT01788332|Olaparib|olaparib|mesh-list
56494402|NCT00541814|Cyclosporine|cyclosporine|mesh-list
56494404|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494405|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494406|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56494407|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
56494408|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494409|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
56494410|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494411|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
56494412|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494413|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56494414|NCT00541853|Candesartan|candesartan|mesh-list
56494415|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
56494416|NCT00541853|Cilnidipine|cilnidipine|mesh-list
56494417|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56494418|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56494419|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56494420|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494421|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56494422|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494423|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56494424|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494425|NCT02301234|Celecoxib|celecoxib|mesh-list
56494426|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56494427|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56494428|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56494429|NCT02301234|Analgesics|analgesics|mesh-ancestor
56494430|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
56494431|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494432|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494433|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494434|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494435|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56494436|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56494438|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494439|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
56494440|NCT02300142|Vaccines|vaccines|mesh-list
56494441|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
56494442|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494443|NCT01214668|Doxorubicin|doxorubicin|mesh-list
56494444|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56494445|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56494446|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494447|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56494448|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56494449|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494450|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246805|NCT01828892|Vancomycin|vancomycin|mesh-list
56494451|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56494452|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
56494453|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56494454|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
56494455|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56494456|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494457|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56494458|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56494459|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494460|NCT00542165|Alfuzosin|alfuzosin|mesh-list
56494461|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56494462|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56494463|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56494464|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
56494465|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494466|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494467|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494468|NCT00542165|Urological Agents|urological agents|mesh-ancestor
56494469|NCT00542243|Finasteride|finasteride|mesh-list
56494470|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56494471|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56494472|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494473|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494474|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
56494475|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56494476|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494477|NCT00542243|Urological Agents|urological agents|mesh-ancestor
56494478|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
56494479|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56494480|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494481|NCT00542555|Naproxen|naproxen|mesh-list
56494482|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56494483|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56494484|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56494485|NCT00542555|Analgesics|analgesics|mesh-ancestor
56494486|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
56494487|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494488|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494489|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494490|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494491|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
56494492|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56494493|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494494|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494495|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56494496|NCT00542711|Curcumin|curcumin|mesh-list
56494497|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56494498|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56494499|NCT00542711|Analgesics|analgesics|mesh-ancestor
56494500|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
56494501|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494502|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494503|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494504|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494505|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494506|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494507|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494508|NCT00542984|Teriparatide|teriparatide|mesh-list
56494509|NCT00542984|Calcitonin|calcitonin|mesh-list
56494510|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
56494511|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56494512|NCT00542984|Katacalcin|katacalcin|mesh-list
56494513|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56494514|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494515|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56494516|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
56494517|NCT02257983|Ubiquinone|ubiquinone|mesh-list
56494518|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
56494519|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494520|NCT00543023|Teriparatide|teriparatide|mesh-list
56494521|NCT00543023|Calcitonin|calcitonin|mesh-list
56494522|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
56494523|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56494524|NCT00543023|Katacalcin|katacalcin|mesh-list
56494525|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56494526|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494527|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56494528|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
56494529|NCT04648917|Caffeic acid|caffeic acid|mesh-list
56494530|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
56494531|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494532|NCT04648917|Protective Agents|protective agents|mesh-ancestor
56494533|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494534|NCT00543179|Lanreotide|lanreotide|mesh-list
56494535|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494536|NCT00543218|Teriparatide|teriparatide|mesh-list
56494537|NCT00543218|Calcitonin|calcitonin|mesh-list
56494538|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
56494539|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56494540|NCT00543218|Katacalcin|katacalcin|mesh-list
56494541|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56494542|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494543|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56494544|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
56494545|NCT02252835|Colchicine|colchicine|mesh-list
56494546|NCT02252835|Febuxostat|febuxostat|mesh-list
56494547|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
56494548|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494549|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
56494550|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
56494552|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494553|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494554|NCT03456752|Dexamethasone|dexamethasone|mesh-list
56494555|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494556|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
56494557|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
56494558|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494559|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494560|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56494561|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
56494562|NCT03456752|Hormones|hormones|mesh-ancestor
56494563|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56494564|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56494565|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494566|NCT03456713|Mirikizumab|mirikizumab|mesh-list
56494567|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56494568|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56494569|NCT03456713|Analgesics|analgesics|mesh-ancestor
56494570|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
55802468|NCT03267121|Apatinib|apatinib|mesh-list
56494571|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494572|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494573|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494574|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494575|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56494576|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56494577|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56494578|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
56494579|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494580|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56494581|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
56494582|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494583|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494584|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56494585|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56494586|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494587|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
56494588|NCT04648332|Bupivacaine|bupivacaine|mesh-list
56494589|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
56494590|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
56494591|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494592|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494593|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
56494594|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494595|NCT00543335|Sorafenib|sorafenib|mesh-list
56494596|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494597|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56494598|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246876|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56494599|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494600|NCT00543413|Enalapril|enalapril|mesh-list
56494601|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56494602|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
56494603|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494604|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494605|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56494606|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56494607|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
56494608|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56494609|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56494610|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56494611|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494612|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494613|NCT00543608|Vancomycin|vancomycin|mesh-list
56494614|NCT00543608|Iclaprim|iclaprim|mesh-list
56494615|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56494616|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494617|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56494618|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494619|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56212545|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
56494620|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56494621|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494622|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56494623|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494624|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494625|NCT00543647|Fenofibrate|fenofibrate|mesh-list
56494626|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56494627|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
56494628|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494629|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56494630|NCT04647669|Interferons|interferons|mesh-list
56494631|NCT04647669|Interferon-beta|interferon-beta|mesh-list
56494632|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
56494633|NCT04647669|Remdesivir|remdesivir|mesh-list
56494634|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
56494635|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494636|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
56246925|NCT01830270|Paclitaxel|paclitaxel|mesh-list
56494637|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494638|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
56494639|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494640|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56494641|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
56494642|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494643|NCT00543686|Fluticasone|fluticasone|mesh-list
56494644|NCT00543686|Montelukast|montelukast|mesh-list
56494645|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494646|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56494647|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
56494648|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494649|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494650|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56494651|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
56494652|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
56494653|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56494654|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56494655|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
56494656|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56494657|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56494658|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56494659|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494660|NCT00543842|Bevacizumab|bevacizumab|mesh-list
56494661|NCT00543842|Capecitabine|capecitabine|mesh-list
56494662|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56494663|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56494664|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494665|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56494666|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56494667|NCT00543842|Growth Substances|growth substances|mesh-ancestor
56494668|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494669|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
56494670|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56494671|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
56494672|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494673|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56494674|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494675|NCT04638816|Lidocaine|lidocaine|mesh-list
56494676|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
56494677|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
56494678|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
56494679|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494680|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494681|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
56246996|NCT01833221|Lidocaine|lidocaine|mesh-list
56494682|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494683|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56494684|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56494685|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56494686|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494687|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494688|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56494689|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
56494690|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
56494691|NCT04638816|Protective Agents|protective agents|mesh-ancestor
56494692|NCT00543959|Pioglitazone|pioglitazone|mesh-list
56494693|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56494694|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494695|NCT00544037|Interferons|interferons|mesh-list
56494696|NCT00544037|Interferon-beta|interferon-beta|mesh-list
56494697|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
56242717|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56494698|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494699|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
56494700|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494701|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
56494702|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494703|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56494704|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
56494705|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56494706|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
56494707|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494708|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494709|NCT04638582|Paclitaxel|paclitaxel|mesh-list
56494710|NCT04638582|Carboplatin|carboplatin|mesh-list
56494711|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
56494712|NCT04638582|Pemetrexed|pemetrexed|mesh-list
56494713|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56494714|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247008|NCT01834820|Dexamethasone|dexamethasone|mesh-list
56247009|NCT01834820|Epinephrine|epinephrine|mesh-list
56247010|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56247011|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
56247012|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
56494715|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56494716|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56494717|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56494718|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494719|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56494720|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494721|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56494722|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56494723|NCT00544193|Gemcitabine|gemcitabine|mesh-list
56494724|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56494725|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
56494726|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494727|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494728|NCT00544193|Antiviral Agents|antiviral agents|mesh-ancestor
56494729|NCT00544193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494730|NCT00544193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494731|NCT00544193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56494732|NCT00544193|Immunologic Factors|immunologic factors|mesh-ancestor
56494733|NCT00544193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494734|NCT00544232|Paclitaxel|paclitaxel|mesh-list
56494735|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56494736|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
56494737|NCT00544232|Methotrexate|methotrexate|mesh-list
56494738|NCT00544232|Epirubicin|epirubicin|mesh-list
56494739|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
56494740|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56494741|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494742|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
56494743|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
56494744|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
56494745|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494746|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56494747|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
56494748|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494749|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494750|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56494751|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
56494752|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56494753|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56494754|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
56494755|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56494756|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56494757|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
56494758|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
56494759|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494760|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56247058|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247059|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247067|NCT01837251|Bevacizumab|bevacizumab|mesh-list
56494761|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56494762|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56494763|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56494764|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56494765|NCT00544232|Hematinics|hematinics|mesh-ancestor
56494766|NCT01191268|Insulin|insulin|mesh-list
56494767|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56494768|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
56494769|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
56494770|NCT01191268|Dulaglutide|dulaglutide|mesh-list
56494771|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56494772|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494773|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
56494774|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56494776|NCT00544349|Fluorouracil|fluorouracil|mesh-list
56494777|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
56494778|NCT00544349|Cetuximab|cetuximab|mesh-list
56494779|NCT00544349|Calcium|calcium|mesh-list
56494780|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
56494781|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56494782|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494783|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
56494784|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494785|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56494786|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494787|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56494788|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
56494789|NCT00544349|Antidotes|antidotes|mesh-ancestor
56494790|NCT00544349|Protective Agents|protective agents|mesh-ancestor
56494791|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
56494792|NCT00544349|Vitamins|vitamins|mesh-ancestor
56494793|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
56494794|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56494795|NCT01191190|Ofatumumab|ofatumumab|mesh-list
56494796|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494797|NCT00544388|Levocetirizine|levocetirizine|mesh-list
56494798|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56494799|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56494800|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
56494801|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
56494802|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494803|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494804|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494805|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
56247087|NCT01837290|Analgesics|analgesics|mesh-ancestor
56494806|NCT00544505|Fluorouracil|fluorouracil|mesh-list
56494807|NCT00544505|Epirubicin|epirubicin|mesh-list
56494808|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56494809|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
56494810|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494811|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494812|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56494813|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
56494814|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494815|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494816|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56494817|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
56494818|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56494819|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56494820|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56494821|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56494822|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494823|NCT00544700|Bevacizumab|bevacizumab|mesh-list
56494824|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56494825|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494826|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56494827|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56494828|NCT00544700|Growth Substances|growth substances|mesh-ancestor
56494829|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494830|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
56494831|NCT00545012|Levetiracetam|levetiracetam|mesh-list
56494832|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
56494833|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
56494834|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
56494835|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56494836|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494837|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
56247118|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247147|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56247148|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56247149|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247150|NCT01839344|Acarbose|acarbose|mesh-list
56247151|NCT01839344|Quercetin|quercetin|mesh-list
56247152|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56247153|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247154|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247155|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56247156|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247157|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
56247158|NCT01839344|Protective Agents|protective agents|mesh-ancestor
56247159|NCT01839578|Heparin|heparin|mesh-list
56247160|NCT01839578|Calcium heparin|calcium heparin|mesh-list
56247161|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
56247162|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247163|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56494838|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56494839|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494840|NCT00545246|Docetaxel|docetaxel|mesh-list
56494841|NCT00545246|Aflibercept|aflibercept|mesh-list
56494842|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494843|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
56494844|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
56494845|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
56494846|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494847|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56494848|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56494849|NCT00545246|Growth Substances|growth substances|mesh-ancestor
56494850|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494851|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
56494852|NCT03456401|Sorafenib|sorafenib|mesh-list
56494853|NCT03456401|Sunitinib|sunitinib|mesh-list
56494854|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494855|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56494856|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494857|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494858|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56494859|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56494860|NCT03456401|Growth Substances|growth substances|mesh-ancestor
56494861|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494862|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
56494863|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
56494864|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56494865|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494866|NCT04646694|Ketamine|ketamine|mesh-list
56494867|NCT04646694|Analgesics|analgesics|mesh-ancestor
56494868|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
56494869|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494870|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494871|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56494872|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56494873|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
56494874|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
56494875|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494876|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56494877|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56494878|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494879|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494880|NCT04638036|Cetuximab|cetuximab|mesh-list
56494881|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56494882|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494883|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
56494884|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
56494885|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494886|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56494887|NCT00545558|Tenofovir|tenofovir|mesh-list
56494888|NCT00545558|Emtricitabine|emtricitabine|mesh-list
56494889|NCT00545558|Efavirenz|efavirenz|mesh-list
56247169|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
56247170|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56247171|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56247172|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56247173|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56247174|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
56247175|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56247176|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247177|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494890|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56494891|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
56494892|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494893|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56494894|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56494895|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494896|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494897|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56494898|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56494899|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56494900|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56494901|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56494902|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56494903|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56494904|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56494905|NCT04684667|Propranolol|propranolol|mesh-list
56494906|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56494907|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56494908|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
56494909|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494910|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494911|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494912|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56494913|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56494914|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
56494915|NCT00545675|Valproic Acid|valproic acid|mesh-list
56494916|NCT00545675|Aripiprazole|aripiprazole|mesh-list
56494917|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
56494918|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56494919|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56494920|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56494921|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56494922|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494923|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
56494924|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
56494925|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494926|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494927|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56494928|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56494930|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56494931|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56494932|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56494933|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56494934|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
56494935|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494936|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
56494937|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
56494938|NCT00545831|Taurolidine|taurolidine|mesh-list
56494939|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56494940|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56494941|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494942|NCT00545870|Bevacizumab|bevacizumab|mesh-list
56494943|NCT00545870|Ranibizumab|ranibizumab|mesh-list
56494944|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56494945|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494946|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56494947|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56494948|NCT00545870|Growth Substances|growth substances|mesh-ancestor
56494949|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494950|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
56494951|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
56494952|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56494953|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494955|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56494956|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
56494957|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56494958|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494959|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56494960|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56494961|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
56494962|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494963|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494964|NCT00546065|Esomeprazole|esomeprazole|mesh-list
56494965|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56494966|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56494967|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56494968|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494969|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494970|NCT00546143|Omalizumab|omalizumab|mesh-list
56494971|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56494972|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56494973|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56494974|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
56494975|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
56494976|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494977|NCT00560079|Allopurinol|allopurinol|mesh-list
56494978|NCT00560079|Dipyridamole|dipyridamole|mesh-list
56494979|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
56494980|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494981|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56494982|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
56247275|NCT01841125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56494983|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56494984|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56494985|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
56494986|NCT00560079|Protective Agents|protective agents|mesh-ancestor
56494987|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56494988|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56494989|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56494990|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
56494991|NCT00560118|Fotemustine|fotemustine|mesh-list
56494992|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56494993|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56494994|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56494995|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56494996|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56494997|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56494998|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56494999|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495000|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56495001|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
56495002|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56495003|NCT00546533|Etanercept|etanercept|mesh-list
56495004|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56495005|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56495006|NCT00546533|Analgesics|analgesics|mesh-ancestor
56495007|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
56495008|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495009|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495010|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495011|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56495012|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56495013|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56495014|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
56495015|NCT00558480|Vitamins|vitamins|mesh-list
56495016|NCT00558480|Vitamin A|vitamin a|mesh-list
56495017|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
56495018|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
56495019|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495020|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
56495021|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495022|NCT00558480|Protective Agents|protective agents|mesh-ancestor
56495023|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56495024|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495025|NCT00546650|Sumatriptan|sumatriptan|mesh-list
56495026|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56495027|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56495028|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56495029|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
56495030|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495031|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495032|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495033|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56495034|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56495035|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56495036|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56495037|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495038|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495039|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495040|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56495041|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
56495042|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56495043|NCT00547001|Estradiol|estradiol|mesh-list
56495044|NCT00547001|Estrogens|estrogens|mesh-ancestor
56495045|NCT00547001|Hormones|hormones|mesh-ancestor
56495046|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495047|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495048|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
56495049|NCT00547352|Tadalafil|tadalafil|mesh-list
56495050|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
56495051|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56495052|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56495053|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495054|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495055|NCT00547352|Urological Agents|urological agents|mesh-ancestor
56495056|NCT00547508|Tadalafil|tadalafil|mesh-list
56495057|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
56495058|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56495059|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56495060|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56212610|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
56495061|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495062|NCT00547508|Urological Agents|urological agents|mesh-ancestor
56495063|NCT00560274|Ribavirin|ribavirin|mesh-list
56495064|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56495065|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
56495066|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495067|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
56495068|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495069|NCT00547547|Selenium|selenium|mesh-list
56495070|NCT00547547|Capecitabine|capecitabine|mesh-list
56495071|NCT00547547|Irinotecan|irinotecan|mesh-list
56495072|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56495073|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
56495074|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495075|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495076|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56495077|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56247325|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
56495078|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495079|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
56495080|NCT00547547|Protective Agents|protective agents|mesh-ancestor
56495081|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495082|NCT00547547|Trace Elements|trace elements|mesh-ancestor
56495083|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
56495084|NCT00547625|Tadalafil|tadalafil|mesh-list
56495085|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
56495086|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56495087|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56495088|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495089|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495090|NCT00547625|Urological Agents|urological agents|mesh-ancestor
56495091|NCT00547664|Morphine|morphine|mesh-list
56495093|NCT00547664|Narcotics|narcotics|mesh-ancestor
56495094|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495095|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495096|NCT00547664|Analgesics|analgesics|mesh-ancestor
56495097|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
56495098|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495099|NCT00560430|Telmisartan|telmisartan|mesh-list
56495100|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56495101|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56495102|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56495103|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495104|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
56495105|NCT00560547|Hematinics|hematinics|mesh-ancestor
56495106|NCT04636125|Doxycycline|doxycycline|mesh-list
56495107|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56495108|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495109|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
56495110|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56495111|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56495112|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56495113|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56495114|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495115|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56495116|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56495117|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
56495118|NCT00548288|Pamidronate|pamidronate|mesh-list
56495119|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56495120|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495121|NCT04644354|Nifedipine|nifedipine|mesh-list
56495122|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56495123|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56495124|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495125|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56495126|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495127|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
56495128|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
56495129|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56495130|NCT00548483|Dexamethasone|dexamethasone|mesh-list
56495131|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495132|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
56495133|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
56495134|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495135|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495136|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56495137|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
56495138|NCT00548483|Hormones|hormones|mesh-ancestor
56495139|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495140|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56495141|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495142|NCT04635852|Fentanyl|fentanyl|mesh-list
56495143|NCT04635852|Morphine|morphine|mesh-list
56495144|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56495145|NCT04635852|Narcotics|narcotics|mesh-ancestor
56495146|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495147|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495148|NCT04635852|Analgesics|analgesics|mesh-ancestor
56495149|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
56495150|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495151|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56495152|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56495153|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
56495155|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
56495156|NCT00548561|Razoxane|razoxane|mesh-list
56495157|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495158|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56495159|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56495160|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56495161|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495162|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495163|NCT00548561|Protective Agents|protective agents|mesh-ancestor
56495164|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495165|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
56495166|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
56495167|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
56495168|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
56495169|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
56495170|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495171|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495172|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
56495173|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495174|NCT00548678|Aspirin|aspirin|mesh-list
56495175|NCT00548678|Ketorolac|ketorolac|mesh-list
56495176|NCT00548678|Diclofenac|diclofenac|mesh-list
56495177|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56495178|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56495179|NCT00548678|Analgesics|analgesics|mesh-ancestor
56495180|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
56247524|NCT01842893|Fentanyl|fentanyl|mesh-list
56495181|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495182|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495183|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495184|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56495185|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56495186|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56495187|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495188|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56495189|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56495190|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495191|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
56495192|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
56495193|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56495194|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
56495195|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495196|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56495197|NCT04684199|Melatonin|melatonin|mesh-list
56495198|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
56495199|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495200|NCT04684199|Protective Agents|protective agents|mesh-ancestor
56495201|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495202|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495203|NCT00560586|Budesonide|budesonide|mesh-list
56495204|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495205|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56495206|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
56495207|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495208|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495209|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56495210|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
56495211|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
56495212|NCT00560586|Hormones|hormones|mesh-ancestor
56495213|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495214|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
56495215|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56495216|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56495217|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247560|NCT01843075|Liraglutide|liraglutide|mesh-list
56495218|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56495219|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495220|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56495221|NCT00549107|Simendan|simendan|mesh-list
56495222|NCT00549107|Milrinone|milrinone|mesh-list
56495223|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56495225|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56495226|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56495227|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495228|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495229|NCT00549107|Protective Agents|protective agents|mesh-ancestor
56495230|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495231|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56495232|NCT00549146|Fluticasone|fluticasone|mesh-list
56212697|NCT04484532|Vaccines|vaccines|mesh-list
56495234|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56495235|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56495236|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495237|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56495239|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495240|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495241|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56495242|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
56495243|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
56495244|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56495245|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56495246|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56495247|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56495248|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
56495249|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495250|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495251|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
56495252|NCT00549146|Hormones|hormones|mesh-ancestor
56247640|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
56495253|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495254|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
56495255|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
56495256|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56495257|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56495258|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495259|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
56495260|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495261|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495262|NCT00549419|Dobutamine|dobutamine|mesh-list
56495263|NCT00549419|Norepinephrine|norepinephrine|mesh-list
56495264|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56495265|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56495266|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
56495267|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495268|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495269|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495270|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
56495271|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
56495272|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495273|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56495274|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56495275|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56495276|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56495277|NCT00549419|Protective Agents|protective agents|mesh-ancestor
56495278|NCT04643691|Losartan|losartan|mesh-list
56495279|NCT04643691|Spironolactone|spironolactone|mesh-list
56495280|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56495281|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56495282|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56495283|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56495284|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495285|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56247687|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
56495286|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
56495287|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495288|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495289|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56495290|NCT04643691|Diuretics|diuretics|mesh-ancestor
56495291|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
56495292|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
56495293|NCT00549536|Calcium|calcium|mesh-list
56495294|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56495295|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495296|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56495297|NCT00549614|Acipimox|acipimox|mesh-list
56495298|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56495299|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
56495300|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495301|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56495302|NCT04923542|Hormones|hormones|mesh-list
56495303|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495304|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495305|NCT00559026|Dacarbazine|dacarbazine|mesh-list
56495306|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56495307|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
56495308|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495309|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495310|NCT00549887|Insulin|insulin|mesh-list
56495311|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56495312|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749757|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
56495313|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495314|NCT00549926|Atorvastatin|atorvastatin|mesh-list
56495315|NCT00549926|Pravastatin|pravastatin|mesh-list
56495316|NCT00549926|Pitavastatin|pitavastatin|mesh-list
56495317|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56495318|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56495319|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
56495320|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495321|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56495322|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56495323|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495324|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
56495325|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56495326|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56495327|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495328|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56495329|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495330|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56495331|NCT00550004|Gemcitabine|gemcitabine|mesh-list
56495332|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56495333|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
56495334|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495335|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495336|NCT00550004|Antiviral Agents|antiviral agents|mesh-ancestor
56495337|NCT00550004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495338|NCT00550004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495339|NCT00550004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56495340|NCT00550004|Immunologic Factors|immunologic factors|mesh-ancestor
56495341|NCT00550004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495342|NCT04634721|Bupivacaine|bupivacaine|mesh-list
56495343|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
56495344|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
56495345|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495346|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495347|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
56495348|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495349|NCT00550160|Artesunate|artesunate|mesh-list
56495350|NCT00550160|Amodiaquine|amodiaquine|mesh-list
56495351|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
56495352|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56495353|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56495354|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495355|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495356|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
56495357|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
56495358|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56495359|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
56495360|NCT00550199|Gemcitabine|gemcitabine|mesh-list
56495361|NCT00550199|Panobinostat|panobinostat|mesh-list
56495362|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56495363|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
56495364|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495365|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495366|NCT00550199|Antiviral Agents|antiviral agents|mesh-ancestor
56495367|NCT00550199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495368|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495369|NCT00550199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243394|NCT01802944|Insulin|insulin|mesh-list
56495371|NCT00550199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495372|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56495373|NCT04643301|Liraglutide|liraglutide|mesh-list
56495374|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56495375|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495376|NCT04643301|Incretins|incretins|mesh-ancestor
56495377|NCT04643301|Hormones|hormones|mesh-ancestor
56495378|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495379|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
56495380|NCT00550433|Estrogens|estrogens|mesh-list
56495381|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56495382|NCT00550433|Hormones|hormones|mesh-ancestor
56495383|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495384|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495385|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56495386|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56495387|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
56495388|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56495389|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56495390|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495391|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
56495392|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56495393|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56495395|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
56495396|NCT04898231|Infliximab|infliximab|mesh-list
56495397|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56495398|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56495399|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
56495400|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495401|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
56495402|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
56495403|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495404|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495405|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56495406|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
56495407|NCT04898231|Hormones|hormones|mesh-ancestor
56495408|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495409|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56495410|NCT04898231|Protective Agents|protective agents|mesh-ancestor
56495411|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56495412|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495413|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
56495414|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56495415|NCT04634058|Antibodies|antibodies|mesh-list
56495416|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
56247875|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56247876|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56495417|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
56495418|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495419|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56495420|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56495421|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495422|NCT00560820|Deferasirox|deferasirox|mesh-list
56495423|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56495424|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
56495425|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
56495426|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495427|NCT00550784|Paclitaxel|paclitaxel|mesh-list
56495428|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
56495429|NCT00550784|Melphalan|melphalan|mesh-list
56495430|NCT00550784|Topotecan|topotecan|mesh-list
56495431|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56495432|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495433|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
56495434|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
56495435|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
56495436|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495437|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56495438|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
56495439|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495440|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56495441|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56495442|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
56495443|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56495444|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56495445|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56495446|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495447|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
56495448|NCT00550901|Razoxane|razoxane|mesh-list
56495449|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247899|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
56495450|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56495451|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56495452|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56495453|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495454|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495455|NCT00550901|Protective Agents|protective agents|mesh-ancestor
56495456|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495457|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
56495458|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
56495459|NCT04633746|Endostatins|endostatins|mesh-list
56495460|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495461|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56495462|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55749888|NCT02515565|Erythromycin|erythromycin|mesh-list
56495464|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495465|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
56495466|NCT00551018|Tenofovir|tenofovir|mesh-list
56495467|NCT00551018|Emtricitabine|emtricitabine|mesh-list
56495468|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
56495469|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495470|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56495471|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56495472|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495473|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495474|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56495475|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56495476|NCT04643106|Hemostatics|hemostatics|mesh-list
56495477|NCT04643106|Coagulants|coagulants|mesh-ancestor
56495478|NCT00551096|Gemcitabine|gemcitabine|mesh-list
56495479|NCT00551096|Capecitabine|capecitabine|mesh-list
56495480|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56495481|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
56495482|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495483|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495484|NCT00551096|Antiviral Agents|antiviral agents|mesh-ancestor
56495485|NCT00551096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495486|NCT00551096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495487|NCT00551096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56495488|NCT00551096|Immunologic Factors|immunologic factors|mesh-ancestor
56495489|NCT00551096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495490|NCT00551252|Gemcitabine|gemcitabine|mesh-list
56495491|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
56247964|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495492|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56495493|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
56495494|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495495|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495496|NCT00551252|Antiviral Agents|antiviral agents|mesh-ancestor
56495497|NCT00551252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495498|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495499|NCT00551252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56495500|NCT00551252|Immunologic Factors|immunologic factors|mesh-ancestor
56495501|NCT00551252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495502|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56495503|NCT01125761|Clemastine|clemastine|mesh-list
56495504|NCT01125761|Dexamethasone|dexamethasone|mesh-list
56495505|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
56495506|NCT01125761|BB 1101|bb 1101|mesh-list
56495507|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495508|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
56495509|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
56495510|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495511|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495512|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56495513|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
56495514|NCT01125761|Hormones|hormones|mesh-ancestor
56495515|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495516|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56243541|NCT01804374|Sorafenib|sorafenib|mesh-list
56495517|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495518|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
56495519|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495520|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495521|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
56495522|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
56495523|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56495524|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
56495525|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
56495526|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495527|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56495528|NCT00871013|Thalidomide|thalidomide|mesh-list
56495529|NCT00871013|Dexamethasone|dexamethasone|mesh-list
56495530|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
56495531|NCT00871013|Melphalan|melphalan|mesh-list
56495532|NCT00871013|Doxorubicin|doxorubicin|mesh-list
56495533|NCT00871013|Etoposide|etoposide|mesh-list
56495534|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56495535|NCT00871013|Bortezomib|bortezomib|mesh-list
56495536|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56495537|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
56495538|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495539|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56495540|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56495541|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
56495542|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495543|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495544|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56495545|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495546|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
56495547|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
56495548|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495549|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56495550|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
56495551|NCT00871013|Hormones|hormones|mesh-ancestor
56248088|NCT01845688|Losartan|losartan|mesh-list
56495552|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495553|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56495554|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56495555|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56495556|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56495557|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495558|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56495559|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
56495560|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56495561|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495562|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56495563|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56495564|NCT00871013|Growth Substances|growth substances|mesh-ancestor
56495565|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
56495566|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
56495567|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
56495568|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495569|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495570|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495571|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
56495572|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
56495573|NCT05431595|Valproic Acid|valproic acid|mesh-list
56495574|NCT05431595|Haloperidol|haloperidol|mesh-list
56495575|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
56495576|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
56495577|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
56495578|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
56495579|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495580|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495581|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56495582|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56495583|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56495584|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495585|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56495586|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56495587|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
56495588|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495589|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495590|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56495591|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
56495592|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495593|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
56495594|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
56495595|NCT05408312|Vaccines|vaccines|mesh-list
56495596|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
56495597|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495598|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56495599|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
56495600|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495601|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
56495602|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56495603|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495604|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
56495605|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495606|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
56495607|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495608|NCT00553124|Vitamin E|vitamin e|mesh-list
56495609|NCT00553124|Selenium|selenium|mesh-list
56495610|NCT00553124|Vitamins|vitamins|mesh-ancestor
56495611|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
56495612|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495613|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
56495614|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495616|NCT00553124|Trace Elements|trace elements|mesh-ancestor
56495617|NCT04640181|Enoxaparin|enoxaparin|mesh-list
56495618|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
56495619|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56495620|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
56495621|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56495622|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
56495623|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495624|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495625|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
56495626|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56495627|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56495628|NCT05317364|Estradiol|estradiol|mesh-list
56495629|NCT05317364|Estrogens|estrogens|mesh-ancestor
56495630|NCT05317364|Hormones|hormones|mesh-ancestor
56495631|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495632|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495633|NCT00559455|Leucovorin|leucovorin|mesh-list
56495634|NCT00559455|Fluorouracil|fluorouracil|mesh-list
56495635|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
56495636|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
56495637|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495638|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56495639|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495640|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56495641|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
56495642|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495643|NCT00559455|Antidotes|antidotes|mesh-ancestor
56495644|NCT00559455|Protective Agents|protective agents|mesh-ancestor
56495645|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
56495646|NCT00559455|Vitamins|vitamins|mesh-ancestor
56495647|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
56495648|NCT00559494|Minocycline|minocycline|mesh-list
56495649|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56495650|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495651|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56495652|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
56495653|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56495654|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56495655|NCT05292755|Laxatives|laxatives|mesh-ancestor
56495656|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56495657|NCT05209412|Aspirin|aspirin|mesh-list
56495658|NCT05209412|Paclitaxel|paclitaxel|mesh-list
56495659|NCT05209412|Clopidogrel|clopidogrel|mesh-list
56495660|NCT05209412|Ticagrelor|ticagrelor|mesh-list
56495661|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56495662|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495663|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
56495664|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
56495665|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
56495666|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495667|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56495668|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56495669|NCT05209412|Analgesics|analgesics|mesh-ancestor
56495670|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
56495671|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495672|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495673|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495674|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56495675|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56495676|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56495677|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56495678|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56495679|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495680|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
56495681|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56495682|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56495683|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56495684|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
56495685|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495686|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
56495687|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56495688|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495689|NCT05186675|Epinephrine|epinephrine|mesh-list
56495690|NCT05186675|Racepinephrine|racepinephrine|mesh-list
56495691|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
55750086|NCT03242239|Trastuzumab|trastuzumab|mesh-list
56495692|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56495693|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56495694|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
56495695|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495696|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495697|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495698|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56495699|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56495700|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
56495701|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495702|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56495703|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
56495704|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
56495705|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
56495706|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56495707|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56495708|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495709|NCT04639362|Venetoclax|venetoclax|mesh-list
56495710|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
56495711|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495712|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56495713|NCT05120141|Listerine|listerine|mesh-list
56495714|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56248397|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
56495715|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495716|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56495717|NCT04639284|Antibodies|antibodies|mesh-list
56495718|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
56495719|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495720|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56495721|NCT04639284|Growth Substances|growth substances|mesh-ancestor
56495722|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
56495723|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495724|NCT00559689|Budesonide|budesonide|mesh-list
56495725|NCT00559689|Beclomethasone|beclomethasone|mesh-list
56495726|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495727|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56495728|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
56495729|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495730|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495731|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56495732|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
56495733|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
56495734|NCT00559689|Hormones|hormones|mesh-ancestor
56495735|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495736|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56495737|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495738|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495739|NCT00561288|Acetaminophen|acetaminophen|mesh-list
56495740|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56495741|NCT00561288|Analgesics|analgesics|mesh-ancestor
56495742|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
56495743|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495744|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495746|NCT00561327|Losartan|losartan|mesh-list
56495747|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56495748|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56212795|NCT04162015|Pemetrexed|pemetrexed|mesh-list
56495749|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56495750|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56495751|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495752|NCT00561522|Capecitabine|capecitabine|mesh-list
56495753|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56495754|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
56495755|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495756|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495757|NCT03454620|Irinotecan|irinotecan|mesh-list
56495758|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56495759|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56495760|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495761|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495762|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495763|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
56495764|NCT04628559|Ketamine|ketamine|mesh-list
56495765|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56495766|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495767|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495768|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56495770|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
56495771|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495772|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56495773|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56495774|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56495775|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
56495776|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495777|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495778|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56495779|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56495780|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
56495781|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
56495782|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56495783|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56495784|NCT04683341|Tenofovir|tenofovir|mesh-list
56495785|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
56495786|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495787|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56248522|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56495788|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56495789|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495790|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495791|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56495792|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56495793|NCT04628676|Epinephrine|epinephrine|mesh-list
56495794|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
56495795|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
56495796|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56495797|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56495798|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495799|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
56495800|NCT04628676|Coagulants|coagulants|mesh-ancestor
56495801|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56495802|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56495803|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
56495804|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495805|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212864|NCT03980184|Guanfacine|guanfacine|mesh-list
56495806|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56495807|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56495809|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495810|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56495811|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
56495812|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
56495813|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
56495814|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56495815|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
56495816|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56495817|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56495818|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495819|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56495820|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56495821|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495822|NCT04628325|Furosemide|furosemide|mesh-list
56495823|NCT04628325|Diuretics|diuretics|mesh-ancestor
56495824|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
56495825|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495826|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56243842|NCT01809171|Vitamins|vitamins|mesh-ancestor
56495827|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56495828|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495829|NCT04657497|Camostat|camostat|mesh-list
56495830|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
56495831|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495832|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495833|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56495834|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56495835|NCT01214434|Emollients|emollients|mesh-list
56495836|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
56495837|NCT04971356|Aspirin|aspirin|mesh-list
56495838|NCT04971356|Ticagrelor|ticagrelor|mesh-list
56495839|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56495840|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56495841|NCT04971356|Analgesics|analgesics|mesh-ancestor
56495842|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
56495843|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495844|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495845|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495846|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56495847|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56495848|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56495849|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495850|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56248690|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56248692|NCT01850251|Vitamin D|vitamin d|mesh-list
56248693|NCT01850251|Vitamins|vitamins|mesh-ancestor
56248694|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
56248695|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495851|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56495852|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495853|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
56495854|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56495855|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56495856|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56495857|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
56495858|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495859|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
56495860|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56495861|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495862|NCT01214239|Linagliptin|linagliptin|mesh-list
56495863|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56495864|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495865|NCT01214239|Incretins|incretins|mesh-ancestor
56495866|NCT01214239|Hormones|hormones|mesh-ancestor
56495867|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56495868|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56495869|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
56495870|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495871|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495872|NCT01214044|Dexetimide|dexetimide|mesh-list
56495873|NCT01214044|Citalopram|citalopram|mesh-list
56212882|NCT03953898|Olaparib|olaparib|mesh-list
56495874|NCT01214044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56495875|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56495876|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56495877|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495879|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
56495880|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495881|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56495882|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
56495883|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56495884|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56495885|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56495886|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
56495887|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
56495888|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495889|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56495890|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56495891|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
56495892|NCT01213966|Artefenomel|artefenomel|mesh-list
56495893|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
56495894|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56495895|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56495896|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495897|NCT01213264|Anesthetics|anesthetics|mesh-list
56495898|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495899|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495900|NCT04657107|Ketamine|ketamine|mesh-list
56495901|NCT04657107|Esketamine|esketamine|mesh-list
56495902|NCT04657107|Analgesics|analgesics|mesh-ancestor
56495903|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
56495904|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495905|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495906|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56495907|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56495908|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
56495909|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
56495910|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56495911|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56495912|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56495913|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495914|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495915|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
56495916|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56495917|NCT00561717|Cetirizine|cetirizine|mesh-list
56495918|NCT00561717|Loratadine|loratadine|mesh-list
56495919|NCT00561717|Azelastine|azelastine|mesh-list
56495920|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56495921|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56495922|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56495923|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
56495925|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495926|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495927|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495928|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
56495929|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
56495930|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56495931|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
56495932|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495933|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56495934|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
56495935|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56495936|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495937|NCT00561756|Vaccines|vaccines|mesh-list
56495938|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
56495939|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495940|NCT04863950|Lomustine|lomustine|mesh-list
56495941|NCT04863950|Imipramine|imipramine|mesh-list
56495942|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56495943|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
56495944|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495945|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56495946|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56495947|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
56495948|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56495949|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56495950|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56495951|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56495952|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
56495953|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495954|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495955|NCT04824911|Aspirin|aspirin|mesh-list
56495956|NCT04824911|Clopidogrel|clopidogrel|mesh-list
56495957|NCT04824911|Atorvastatin|atorvastatin|mesh-list
56495958|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56495959|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56495960|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56495961|NCT04824911|Analgesics|analgesics|mesh-ancestor
56495962|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
56495963|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56495964|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495965|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56495966|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56495967|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56495968|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56495969|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495970|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56495971|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56495972|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56495973|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
56495974|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56495975|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56244039|NCT01810601|Hormones|hormones|mesh-ancestor
56495976|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
56495977|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56495978|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56495979|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56495980|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56495981|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56495982|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
56495983|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495984|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
56495985|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56495986|NCT04683146|Propranolol|propranolol|mesh-list
56495987|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56495988|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56495989|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
56495990|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
56495991|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56495992|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56495993|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
56495994|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56495995|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56495996|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56495997|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56495998|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56495999|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
56496000|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
56496001|NCT04816877|Narcotics|narcotics|mesh-ancestor
56496002|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496003|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496004|NCT04816877|Analgesics|analgesics|mesh-ancestor
56496005|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
56496006|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496007|NCT04800302|Morphine|morphine|mesh-list
56496008|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56496009|NCT04800302|Narcotics|narcotics|mesh-ancestor
56496010|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496011|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496012|NCT04800302|Analgesics|analgesics|mesh-ancestor
56496013|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
56496014|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496015|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
56496016|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56496017|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
56496018|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248894|NCT01851551|Rituximab|rituximab|mesh-list
56496019|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
56496020|NCT04711304|Protective Agents|protective agents|mesh-ancestor
56496021|NCT04710719|Triamcinolone|triamcinolone|mesh-list
56496022|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56496023|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56496024|NCT04710719|Fluorouracil|fluorouracil|mesh-list
56496025|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56496026|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
56496027|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496028|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56496029|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496030|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496031|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
56496032|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496033|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496034|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
56496035|NCT04710719|Hormones|hormones|mesh-ancestor
56496036|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56496037|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496038|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
56496039|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
56496040|NCT04627779|Analgesics|analgesics|mesh-ancestor
56496041|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
56496042|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496043|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496044|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56496045|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496046|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496047|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496048|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56496049|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496050|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496051|NCT04561739|Aspirin|aspirin|mesh-list
56496052|NCT04561739|Sirolimus|sirolimus|mesh-list
56496053|NCT04561739|Paclitaxel|paclitaxel|mesh-list
56496054|NCT04561739|Clopidogrel|clopidogrel|mesh-list
56496055|NCT04561739|Ticagrelor|ticagrelor|mesh-list
56496056|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56496057|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496058|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
56496059|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
56496060|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
56496061|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496062|NCT04561739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56496063|NCT04561739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496064|NCT04561739|Analgesics|analgesics|mesh-ancestor
56496065|NCT04561739|Sensory System Agents|sensory system agents|mesh-ancestor
56496066|NCT04561739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496067|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496068|NCT04561739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496069|NCT04561739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496070|NCT04561739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56496071|NCT04561739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56496072|NCT04561739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56496073|NCT04561739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56496074|NCT04561739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496075|NCT04561739|Antipyretics|antipyretics|mesh-ancestor
56496076|NCT04561739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56496077|NCT04561739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56496078|NCT04561739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56496079|NCT04561739|Purinergic Agents|purinergic agents|mesh-ancestor
56496080|NCT04561739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496081|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56496082|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496083|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56496084|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
56496085|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496086|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
56496087|NCT04537598|Morphine|morphine|mesh-list
56496088|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56496089|NCT04537598|Narcotics|narcotics|mesh-ancestor
56496090|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496091|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496092|NCT04537598|Analgesics|analgesics|mesh-ancestor
56496093|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
56496094|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496095|NCT04627467|Chloroquine|chloroquine|mesh-list
56496096|NCT04627467|Amebicides|amebicides|mesh-ancestor
56496097|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56496098|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56496099|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496100|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
56496101|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496102|NCT04627623|Antibodies|antibodies|mesh-list
56496103|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
56212934|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
56496104|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
56496105|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496107|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496108|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56496109|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496110|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496111|NCT04481555|Azithromycin|azithromycin|mesh-list
56496112|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56496113|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496114|NCT04682795|Insulin|insulin|mesh-list
56496115|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56496116|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496117|NCT04396496|Daratumumab|daratumumab|mesh-list
56496118|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496119|NCT04655664|Vitamin D|vitamin d|mesh-list
56496120|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
56496121|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
56496122|NCT04655664|Vitamins|vitamins|mesh-list
56496123|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
56496124|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496125|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56496126|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56496127|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56496128|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56496129|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
56496130|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496131|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496132|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56496133|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
56496134|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
56496135|NCT04655508|Hormones|hormones|mesh-ancestor
56496136|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56496137|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
56496138|NCT04655040|Caffeine|caffeine|mesh-list
56496139|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56496140|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496141|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56496142|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496143|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249128|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56496144|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56496145|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56496146|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
56496147|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496148|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
56496149|NCT04626765|Fludarabine|fludarabine|mesh-list
56496150|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496151|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
56496152|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496153|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496154|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56496155|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
56496156|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496157|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496158|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56496159|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
56496160|NCT04626726|Fludarabine|fludarabine|mesh-list
56496161|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496162|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
56496163|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496164|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496165|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56496166|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
56496167|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496168|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496169|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56496170|NCT04654962|Anesthetics|anesthetics|mesh-list
56496171|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496172|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496173|NCT04626414|Ferric maltol|ferric maltol|mesh-list
56496174|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
56496175|NCT04626414|Hematinics|hematinics|mesh-ancestor
56496176|NCT04654416|Colchicine|colchicine|mesh-list
56496177|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
56496178|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496179|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
56496180|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
56496181|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
56496182|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496183|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496184|NCT02906150|Cisplatin|cisplatin|mesh-list
56496185|NCT02906150|Carboplatin|carboplatin|mesh-list
56496186|NCT02906150|Pemetrexed|pemetrexed|mesh-list
56496187|NCT02906150|Thymalfasin|thymalfasin|mesh-list
56496188|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496189|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496190|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496191|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56496192|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56496193|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56496194|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
56496195|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496196|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
56496197|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56496198|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496199|NCT02905994|Cytarabine|cytarabine|mesh-list
56496200|NCT02905994|Idarubicin|idarubicin|mesh-list
56496201|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56496202|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
56496203|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496204|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496206|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496207|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496208|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
56496209|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496210|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56496211|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56496212|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56496213|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496214|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56496215|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
56496216|NCT02905682|Coagulants|coagulants|mesh-ancestor
56496217|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56496218|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
56496219|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496220|NCT04626258|Fluconazole|fluconazole|mesh-list
56496221|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
56496222|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496223|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56496224|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56496225|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496226|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496227|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56496228|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
56496229|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56496230|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496231|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56496232|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56496233|NCT04681820|HH-GV-678|hh-gv-678|mesh-list
56496234|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56496235|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496236|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496237|NCT04626063|Acetaminophen|acetaminophen|mesh-list
56496238|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56496239|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56496240|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496241|NCT04626063|Analgesics|analgesics|mesh-ancestor
56496242|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
56496243|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496244|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496245|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
56496246|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496247|NCT04625985|Metformin|metformin|mesh-list
56496248|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56496249|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496250|NCT02905760|Furosemide|furosemide|mesh-list
56496251|NCT02905760|Diuretics|diuretics|mesh-list
56496252|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
56496253|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496254|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56496255|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56496256|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496257|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
56496258|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56496259|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496260|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
56496261|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56496262|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56496263|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496264|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
56496265|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
56496266|NCT04654026|Aspirin|aspirin|mesh-list
56496267|NCT04654026|Clopidogrel|clopidogrel|mesh-list
56496268|NCT04654026|Ticagrelor|ticagrelor|mesh-list
56496269|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56496270|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496271|NCT04654026|Analgesics|analgesics|mesh-ancestor
56496272|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
56496273|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496274|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496275|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496276|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496277|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56496278|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56496279|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802478|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
56496280|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56496281|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56496282|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496283|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
56496284|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56496285|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56496286|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56496287|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
56496288|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496289|NCT04625595|Methyldopa|methyldopa|mesh-list
56496290|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56496291|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
56496292|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
56496293|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496294|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56212978|NCT03780829|Cycloserine|cycloserine|mesh-list
56496295|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56496296|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56496297|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56496298|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496299|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496300|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496301|NCT02905058|Ketoprofen|ketoprofen|mesh-list
56496302|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56496303|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496304|NCT02905058|Analgesics|analgesics|mesh-ancestor
56496305|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
56496306|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496307|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496308|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496309|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496310|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56496311|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496312|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496313|NCT04653792|Pregabalin|pregabalin|mesh-list
56496314|NCT04653792|Analgesics|analgesics|mesh-ancestor
56496315|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
56496316|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496317|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496318|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
56496319|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56496320|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56496321|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496322|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56496323|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56496324|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56496325|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496326|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496327|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56496328|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
56496329|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
56496330|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496331|NCT00557700|Bromides|bromides|mesh-list
56496332|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
56496333|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56496334|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
56496335|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496336|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496337|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56496338|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
56496339|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
56496340|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56496341|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
56496342|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496343|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496344|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
56496345|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
56496346|NCT00557739|Nortriptyline|nortriptyline|mesh-list
56496347|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496348|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
56496349|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56496350|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56496351|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
56496352|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496353|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56496354|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56496355|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56496356|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496357|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496358|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496359|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496361|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56496362|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
56496363|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56496364|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496365|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56496366|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56496367|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56496368|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
56496369|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
56496370|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56496371|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56496372|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496373|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496374|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496375|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496376|NCT04652739|Prednisolone|prednisolone|mesh-list
56496377|NCT04652739|Lycopene|lycopene|mesh-list
56496378|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496379|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
56496380|NCT04652739|Hormones|hormones|mesh-ancestor
56496381|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56496382|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496383|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56496384|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496385|NCT04652739|Protective Agents|protective agents|mesh-ancestor
56496386|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
56496387|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496388|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56496389|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56496390|NCT04652661|Midazolam|midazolam|mesh-list
56496391|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
56496392|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56496393|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496394|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496395|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496396|NCT04652661|Analgesics|analgesics|mesh-ancestor
56496397|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
56496398|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496399|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56496400|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56496401|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56496402|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496403|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496404|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496405|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56496406|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56496407|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56496408|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496409|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56496410|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
56496411|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
56496412|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
56496413|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
56496414|NCT02903498|Tegafur|tegafur|mesh-list
56496415|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56496416|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
56496417|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496418|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496419|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
56496420|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56496421|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496422|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819975|NCT01620489|Liraglutide|liraglutide|mesh-list
56496423|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56212999|NCT03703492|Estradiol|estradiol|mesh-list
56496425|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
56496426|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496427|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56496428|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56496429|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56496430|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496431|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496432|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496433|NCT04623879|Ivacaftor|ivacaftor|mesh-list
56496434|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56496435|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56496436|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496437|NCT02903537|Vitamin D|vitamin d|mesh-list
56496438|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
56496439|NCT02903537|Interferons|interferons|mesh-list
56496440|NCT02903537|Interferon-beta|interferon-beta|mesh-list
56496441|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496442|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
56496443|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496444|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
56496445|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496446|NCT02903537|Vitamins|vitamins|mesh-ancestor
56496447|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
56496448|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56496449|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56496450|NCT00562068|Prednisolone|prednisolone|mesh-list
56496451|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
56496452|NCT00562068|Doxorubicin|doxorubicin|mesh-list
56496453|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56496454|NCT00562068|Vincristine|vincristine|mesh-list
56496455|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
56496456|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496457|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
56496458|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496459|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496460|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56249567|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
56249568|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496461|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
56496462|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496463|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496464|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56496465|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56496466|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56496467|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56496468|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496469|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56496470|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
56496471|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
56496472|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
56496473|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496474|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
56496475|NCT00562068|Hormones|hormones|mesh-ancestor
56496476|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56496477|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56496478|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56496479|NCT00562185|Carboplatin|carboplatin|mesh-list
56496480|NCT00562185|Doxorubicin|doxorubicin|mesh-list
56496481|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56496482|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496483|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56496484|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56496485|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56496486|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496487|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496489|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56496490|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496491|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496492|NCT02903069|Temozolomide|temozolomide|mesh-list
56496493|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56496494|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
56496495|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496496|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496497|NCT04623840|Tadalafil|tadalafil|mesh-list
56496498|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
56496499|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56496500|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56249576|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56249577|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56249579|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
56249580|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56249581|NCT01856166|Narcotics|narcotics|mesh-ancestor
56496501|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496502|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496503|NCT04623840|Urological Agents|urological agents|mesh-ancestor
56496504|NCT02902640|Trimethoprim|trimethoprim|mesh-list
56496505|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
56496506|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
56496507|NCT02902640|Guaifenesin|guaifenesin|mesh-list
56496508|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56496509|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56496510|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496511|NCT02902640|Renal Agents|renal agents|mesh-ancestor
56496512|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
56496513|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56496514|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56496515|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56496516|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496517|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496518|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56496519|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56496520|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56496521|NCT02902640|Expectorants|expectorants|mesh-ancestor
56496522|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
56496523|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56496524|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56496525|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496526|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496527|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496528|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
56496529|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56496530|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
56496531|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
56496532|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496533|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
56496534|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56496535|NCT02902523|Tenofovir|tenofovir|mesh-list
56496536|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
56496537|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496538|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56496539|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56496540|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496541|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496542|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56496543|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56496544|NCT02902289|Ibuprofen|ibuprofen|mesh-list
56496545|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56496546|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496547|NCT02902289|Analgesics|analgesics|mesh-ancestor
56496548|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
56496549|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496550|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496551|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496552|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496553|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56496554|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496555|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496556|NCT02902133|Acetazolamide|acetazolamide|mesh-list
56496557|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
56496558|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56496559|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496560|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496561|NCT02902133|Diuretics|diuretics|mesh-ancestor
56496562|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
56496563|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496564|NCT04623021|Nafamostat|nafamostat|mesh-list
56249608|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56249609|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55746478|NCT02468323|Ondansetron|ondansetron|mesh-list
55746479|NCT02468323|Palonosetron|palonosetron|mesh-list
55746480|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
55746481|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
55746482|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746483|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746484|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56496565|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56496566|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496567|NCT04623021|Analgesics|analgesics|mesh-ancestor
56496568|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
56496569|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496570|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496571|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496572|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496573|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
56244605|NCT01814085|Citalopram|citalopram|mesh-list
56496574|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
56496575|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496576|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496577|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56496578|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56496579|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56496580|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496581|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
56496582|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
56496583|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56496584|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496585|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496586|NCT02901977|Ramipril|ramipril|mesh-list
56496587|NCT02901977|Doxazosin|doxazosin|mesh-list
56496588|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56496589|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
56496590|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496591|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496592|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56496593|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56496594|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56496595|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56496596|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496597|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496598|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496599|NCT00553553|Morphine|morphine|mesh-list
56496600|NCT00553553|Remifentanil|remifentanil|mesh-list
56496601|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56496602|NCT00553553|Narcotics|narcotics|mesh-ancestor
56496603|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496604|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496605|NCT00553553|Analgesics|analgesics|mesh-ancestor
56496606|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
56496607|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496608|NCT04622982|Vitamin D|vitamin d|mesh-list
56496609|NCT04622982|Vitamins|vitamins|mesh-ancestor
56496610|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
56496611|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496612|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56496613|NCT04622202|Pregabalin|pregabalin|mesh-list
56496614|NCT04622202|Analgesics|analgesics|mesh-ancestor
56496615|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
56496616|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496617|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496618|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
56496619|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56496620|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56496621|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496622|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56496623|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56496624|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56496625|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496626|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496627|NCT04622358|Rabeprazole|rabeprazole|mesh-list
56496628|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56496629|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56496630|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56496631|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496632|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496633|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56496634|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
56496635|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496636|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56496637|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56496638|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496639|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496640|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
56496641|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56496642|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56496643|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496644|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
56496645|NCT04622397|Coagulants|coagulants|mesh-ancestor
56496647|NCT04621929|Phentermine|phentermine|mesh-list
56244676|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
56496648|NCT04621929|Allopurinol|allopurinol|mesh-list
56496649|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496650|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
56496651|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56496652|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496653|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
56496654|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496655|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
56496656|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496657|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56496658|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
56496659|NCT04621929|Protective Agents|protective agents|mesh-ancestor
56496660|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56496661|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
56496662|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56496663|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
56496664|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
56496665|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496666|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496667|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496668|NCT02901353|Sirolimus|sirolimus|mesh-list
56496669|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56496670|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496671|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56496672|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496673|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
56496674|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496675|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
56496676|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496677|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
56496678|NCT04621461|Astringents|astringents|mesh-ancestor
56496679|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496680|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
56496681|NCT02901236|Bevacizumab|bevacizumab|mesh-list
56496682|NCT02901236|Mitomycins|mitomycins|mesh-list
56496683|NCT02901236|Mitomycin|mitomycin|mesh-list
56496684|NCT02901236|Antimetabolites|antimetabolites|mesh-list
56496685|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56496686|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496687|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56496688|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56496689|NCT02901236|Growth Substances|growth substances|mesh-ancestor
56496690|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496691|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
56496692|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56496693|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
56496694|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496695|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56496696|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496697|NCT04621617|Midodrine|midodrine|mesh-list
56496698|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
56496699|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
56496700|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496701|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496702|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56496703|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56496704|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56496705|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56496706|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496707|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496708|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496709|NCT01212757|Thalidomide|thalidomide|mesh-list
56496710|NCT01212757|Apremilast|apremilast|mesh-list
56496711|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56496712|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496713|NCT01212757|Analgesics|analgesics|mesh-ancestor
56496714|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
55802486|NCT01667107|Posaconazole|posaconazole|mesh-list
56496715|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496716|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496717|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56496718|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496719|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56496720|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56496721|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496722|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496723|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496724|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
56496725|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
56496726|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56496727|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496728|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56496729|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56496730|NCT01212757|Growth Substances|growth substances|mesh-ancestor
56496731|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
56496732|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496734|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56496735|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56496736|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496737|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496738|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496739|NCT00562458|Anastrozole|anastrozole|mesh-list
56496740|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56496741|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496742|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56249759|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
56496743|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56496744|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496745|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496746|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56496747|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
56496748|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56496749|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496750|NCT02900729|Losartan|losartan|mesh-list
56496751|NCT02900729|Amlodipine|amlodipine|mesh-list
56496752|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56496753|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56496754|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56496755|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56496756|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496757|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56496758|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496759|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
56496760|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56496761|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56496762|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56496763|NCT02900729|Diuretics|diuretics|mesh-ancestor
56496764|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
56496765|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56496766|NCT05440201|Enoxaparin|enoxaparin|mesh-list
56496767|NCT05440201|Anticoagulants|anticoagulants|mesh-list
56496768|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56496769|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56249789|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
56496770|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496771|NCT04621227|Midazolam|midazolam|mesh-list
56496772|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56496773|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56496774|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56496775|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496776|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496777|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56496778|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56496779|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496780|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56496781|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
56496782|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
56496783|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
56496784|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
56496785|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496786|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496787|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56496788|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56496789|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
56496790|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56496791|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56496792|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496793|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
56496794|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496795|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
56496796|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496797|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496798|NCT01190254|Asenapine|asenapine|mesh-list
56496799|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56496800|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56496801|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496802|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496803|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496804|NCT04620954|Nivolumab|nivolumab|mesh-list
56496805|NCT04620954|Oregovomab|oregovomab|mesh-list
56496806|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56496807|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496808|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56496809|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496810|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56496811|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
56496812|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496813|NCT04621110|Fentanyl|fentanyl|mesh-list
56496814|NCT04621110|Midazolam|midazolam|mesh-list
56496815|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
56496816|NCT04621110|Ketamine|ketamine|mesh-list
56496817|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56496818|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496819|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496820|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496821|NCT04621110|Analgesics|analgesics|mesh-ancestor
56496822|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
56496823|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496824|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56496825|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56496826|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56496827|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496828|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496829|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496830|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56496831|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56496832|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
56496833|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
56496834|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56496835|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56496836|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56496837|NCT04621110|Narcotics|narcotics|mesh-ancestor
56496838|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56496839|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56496840|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56496841|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496842|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
56496843|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
56496845|NCT04620720|Analgesics|analgesics|mesh-ancestor
56496846|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
56496847|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496848|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496849|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
56496850|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56496851|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56496852|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496853|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496854|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56496855|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56496856|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496857|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496858|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
56496859|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56496860|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56496861|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496862|NCT02900417|Incretins|incretins|mesh-ancestor
56496863|NCT02900417|Hormones|hormones|mesh-ancestor
56496864|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56496865|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56496866|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
56496867|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496868|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496869|NCT04620018|Amoxicillin|amoxicillin|mesh-list
56496870|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56496871|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496872|NCT02900105|Letrozole|letrozole|mesh-list
56496873|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496874|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56496875|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56496877|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249908|NCT01857843|Everolimus|everolimus|mesh-list
56496878|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56496879|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
56496880|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56496881|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496882|NCT04620213|Phentolamine|phentolamine|mesh-list
56496883|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56496884|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56496885|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56496886|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56496887|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496888|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496889|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496890|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496891|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56496892|NCT04619862|Gabapentin|gabapentin|mesh-list
56496893|NCT04619862|Analgesics|analgesics|mesh-ancestor
56496894|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
56496895|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496896|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496897|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
56496898|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56496899|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56496900|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496901|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56496902|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56496903|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56496904|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496905|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496906|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
56496907|NCT01190839|Infliximab|infliximab|mesh-list
56496908|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
56496909|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56496910|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56496911|NCT00562770|Valacyclovir|valacyclovir|mesh-list
56496912|NCT00562770|Valganciclovir|valganciclovir|mesh-list
56496913|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
56496914|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496915|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56496916|NCT05424692|Fluorouracil|fluorouracil|mesh-list
56496917|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
56496918|NCT05424692|Irinotecan|irinotecan|mesh-list
56496919|NCT05424692|Cetuximab|cetuximab|mesh-list
56496920|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
56496921|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496922|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56496923|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496924|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56496925|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
56496926|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496927|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56496928|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56496929|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496930|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56496931|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
56496932|NCT05424692|Vitamins|vitamins|mesh-ancestor
56496933|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
56496934|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
56496935|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56496936|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56496937|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496938|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56496940|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
56496941|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496942|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56496943|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56496945|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
56496946|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496947|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496949|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496950|NCT00562809|Irbesartan|irbesartan|mesh-list
56496951|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56496952|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56496953|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56496954|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496955|NCT01190098|Lacosamide|lacosamide|mesh-list
56496956|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
56496957|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56496958|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56496959|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56496960|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496961|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
56250010|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496962|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56496963|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56496964|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
56496965|NCT04314739|Resveratrol|resveratrol|mesh-list
56496966|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
56496967|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496968|NCT04314739|Protective Agents|protective agents|mesh-ancestor
56496969|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496970|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496971|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56496972|NCT02885740|Adenosine|adenosine|mesh-list
56496973|NCT02885740|Analgesics|analgesics|mesh-ancestor
56496974|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
56496975|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56496976|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496977|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56496978|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
56496979|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56496980|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
56165446|NCT00002922|Paclitaxel|paclitaxel|mesh-list
56496981|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
56496982|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56496983|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496984|NCT05309785|Canagliflozin|canagliflozin|mesh-list
56496985|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56496986|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496987|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56496988|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56496989|NCT01190020|Lubiprostone|lubiprostone|mesh-list
56496990|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56496991|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56496992|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496993|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56496994|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56496995|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56496996|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56496997|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56496998|NCT01165996|Decitabine|decitabine|mesh-list
56496999|NCT01165996|Azacitidine|azacitidine|mesh-list
56497000|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56497001|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
56497002|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497003|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497004|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497005|NCT04619433|Carboplatin|carboplatin|mesh-list
56497006|NCT04619433|Pemetrexed|pemetrexed|mesh-list
56497007|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497008|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497009|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497010|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56497011|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56497012|NCT04619160|Propofol|propofol|mesh-list
56497013|NCT04619160|Sevoflurane|sevoflurane|mesh-list
56497014|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56497015|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497016|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497017|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56497018|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
56497019|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
56245048|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
56497020|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56497021|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56497022|NCT01165684|Insulin|insulin|mesh-list
56497023|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56497024|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
56497025|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
56497026|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56497027|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
56497028|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56497029|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497030|NCT01189201|Linagliptin|linagliptin|mesh-list
56497031|NCT01189201|Empagliflozin|empagliflozin|mesh-list
56497032|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56497033|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497034|NCT01189201|Incretins|incretins|mesh-ancestor
56497036|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56497037|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56497038|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
56497039|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497040|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497041|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56497042|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
56497043|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
56497044|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497045|NCT01188811|Protective Agents|protective agents|mesh-ancestor
56497046|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497047|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
56497048|NCT01188811|Vitamins|vitamins|mesh-ancestor
56497049|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
56497050|NCT01183234|Methylphenidate|methylphenidate|mesh-list
56497051|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56250068|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250069|NCT01858311|Protective Agents|protective agents|mesh-ancestor
56250070|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250071|NCT01858311|Vitamins|vitamins|mesh-ancestor
56250072|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
56250073|NCT01858402|Acetaminophen|acetaminophen|mesh-list
56250074|NCT01858402|Dipyrone|dipyrone|mesh-list
56250075|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56497052|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497053|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56497054|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56497055|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56497056|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497057|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
56497058|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497059|NCT04618497|Ketorolac|ketorolac|mesh-list
56497060|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
56497061|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56497062|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56497063|NCT04618497|Analgesics|analgesics|mesh-ancestor
56497064|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
56497065|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497066|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497067|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56497068|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56497069|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56497070|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497071|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497072|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56497073|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
56497074|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
56497075|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497076|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56497077|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56497078|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56497079|NCT04679948|Midazolam|midazolam|mesh-list
56497080|NCT04679948|Caffeine|caffeine|mesh-list
56497081|NCT04679948|Omeprazole|omeprazole|mesh-list
56250076|NCT01858402|Analgesics|analgesics|mesh-ancestor
56250077|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
56250078|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250079|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250080|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
56250081|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56250082|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250083|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250084|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
56250085|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250086|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56250087|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250088|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250089|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
56250090|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56250091|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250092|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56250093|NCT01858571|Thalidomide|thalidomide|mesh-list
56250094|NCT01858571|Celecoxib|celecoxib|mesh-list
56250095|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
56250096|NCT01858571|Etoposide|etoposide|mesh-list
55825392|NCT05651750|Fluticasone|fluticasone|mesh-list
56497082|NCT04679948|Warfarin|warfarin|mesh-list
56497083|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56497084|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56497085|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497086|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497087|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56497088|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56497089|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56497090|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56497091|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
56497092|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
56497093|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
56497094|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
56497095|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497096|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497097|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
56497098|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56497099|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56497100|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497101|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56497102|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56497103|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
56497104|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56497105|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56497106|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56497107|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
56497108|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56497109|NCT04618536|Protective Agents|protective agents|mesh-ancestor
56497110|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497111|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56497112|NCT04651959|Favipiravir|favipiravir|mesh-list
56497113|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
56497114|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497116|NCT01165216|Carboplatin|carboplatin|mesh-list
56497118|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56497119|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497120|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
56497121|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
56497122|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
56497123|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497124|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497125|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56497126|NCT04652115|Defibrotide|defibrotide|mesh-list
56497127|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56497128|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56497129|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497130|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56497131|NCT04618107|Anesthetics|anesthetics|mesh-list
56497132|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497133|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497134|NCT05423015|Levan|levan|mesh-list
56497135|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497136|NCT04618146|Morphine|morphine|mesh-list
56250097|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56250098|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
56497137|NCT04618146|Bupivacaine|bupivacaine|mesh-list
56497138|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
56497139|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
56497140|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497141|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497142|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
56497143|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497144|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56497145|NCT04618146|Narcotics|narcotics|mesh-ancestor
56497146|NCT04618146|Analgesics|analgesics|mesh-ancestor
56497147|NCT04651842|Insulin|insulin|mesh-list
56497148|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56497149|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497150|NCT05421962|Fentanyl|fentanyl|mesh-list
56497151|NCT05421962|Ketamine|ketamine|mesh-list
56497152|NCT05421962|Analgesics|analgesics|mesh-ancestor
56497153|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
56497154|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497155|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497156|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56497157|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56497158|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
56497159|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
56497160|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497161|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56497162|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56497163|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497164|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497165|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56497166|NCT05421962|Narcotics|narcotics|mesh-ancestor
56497167|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56497169|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56497170|NCT00557817|Hematinics|hematinics|mesh-ancestor
56497172|NCT05419583|Warfarin|warfarin|mesh-list
56497173|NCT05419583|Apixaban|apixaban|mesh-list
56497174|NCT05419583|Anticoagulants|anticoagulants|mesh-list
56497175|NCT05419583|Edoxaban|edoxaban|mesh-list
56497176|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56497177|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56497178|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56497179|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56497180|NCT05419583|Analgesics|analgesics|mesh-ancestor
56497181|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
56497182|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497183|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497184|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56497185|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56497186|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56497187|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56497188|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497189|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56497190|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497191|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
56497192|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56497193|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
56497194|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56497195|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
56497196|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56497197|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56497198|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
56497199|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56497200|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
56497201|NCT05387408|Narcotics|narcotics|mesh-ancestor
56497202|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497203|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497204|NCT05387408|Analgesics|analgesics|mesh-ancestor
56497205|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
56497206|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497207|NCT04617795|Insulin|insulin|mesh-list
56497208|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56497209|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497210|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
56497211|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56497212|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497213|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497214|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56497215|NCT05376761|Analgesics|analgesics|mesh-ancestor
56497216|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
56497217|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497218|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56497219|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56497220|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56497221|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
56497222|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497223|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497224|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
56497225|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56250126|NCT01858610|Irbesartan|irbesartan|mesh-list
56497226|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56497227|NCT04617561|Prednisolone|prednisolone|mesh-list
56497228|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
56497229|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56497230|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56497231|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
56497232|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
56497233|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56497234|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
56497235|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
56497236|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497237|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497238|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56497240|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56497241|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56497242|NCT04617561|Protective Agents|protective agents|mesh-ancestor
56497243|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56497244|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497245|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56245277|NCT01818648|Exenatide|exenatide|mesh-list
56497246|NCT04617483|Vaccines|vaccines|mesh-list
56497247|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
56497248|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497249|NCT04617249|Anesthetics|anesthetics|mesh-list
56497250|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497251|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497252|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
56497253|NCT05349383|Antibodies|antibodies|mesh-list
56497254|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
56497255|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
56497256|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
56497257|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497258|NCT04617171|Benralizumab|benralizumab|mesh-list
56497259|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56497260|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
56497261|NCT00557934|Dobutamine|dobutamine|mesh-list
56497262|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56497263|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
56497264|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
56497265|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497266|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497267|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56497268|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56497269|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56497270|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
56497271|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497272|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497273|NCT00557934|Protective Agents|protective agents|mesh-ancestor
56497274|NCT00558051|Vaccines|vaccines|mesh-list
56497275|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
56497276|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497277|NCT00558090|Morphine|morphine|mesh-list
56497278|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56497279|NCT00558090|Narcotics|narcotics|mesh-ancestor
56497280|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497281|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497282|NCT00558090|Analgesics|analgesics|mesh-ancestor
56497283|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
56497284|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497285|NCT04617015|Bromides|bromides|mesh-list
56497286|NCT04617015|Ipratropium|ipratropium|mesh-list
56497287|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
56497288|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56497289|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
56497290|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497291|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497292|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56497293|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
56497294|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56497295|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
56497296|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497297|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497298|NCT04650828|Tenofovir|tenofovir|mesh-list
56497299|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
56497300|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497301|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56497302|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56497303|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497304|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497305|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56497306|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56497307|NCT04650555|Genistein|genistein|mesh-list
56497308|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56497309|NCT04650555|Protective Agents|protective agents|mesh-ancestor
56497310|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497311|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497312|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56497313|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497314|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497315|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
56497316|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56497317|NCT04650555|Estrogens|estrogens|mesh-ancestor
56497318|NCT04650555|Hormones|hormones|mesh-ancestor
56497319|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56497320|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
56497321|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
56497322|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497323|NCT05153525|Cisatracurium|cisatracurium|mesh-list
56497324|NCT05153525|Atracurium|atracurium|mesh-list
56497325|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56497326|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56497327|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497328|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497329|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56497330|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56497331|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56497332|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
56497333|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497334|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497335|NCT04649892|Naltrexone|naltrexone|mesh-list
56497336|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56497337|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56497338|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497339|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
56497340|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497341|NCT05125796|Acetaminophen|acetaminophen|mesh-list
56497342|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56497343|NCT05125796|Ketoprofen|ketoprofen|mesh-list
56497344|NCT05125796|Lidocaine|lidocaine|mesh-list
56497345|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
56497346|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
56497347|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497348|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497349|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
56497350|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497351|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56497352|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56497353|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56497354|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56497355|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497356|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56497357|NCT05125796|Analgesics|analgesics|mesh-ancestor
56497358|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
56497359|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56497360|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56497361|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56497362|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56497363|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497364|NCT05096117|ASP8062|asp8062|mesh-list
56497365|NCT05096117|Analgesics|analgesics|mesh-ancestor
56497366|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
56497367|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497368|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497369|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
56497370|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
56497371|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497372|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497373|NCT04616859|Ethanol|ethanol|mesh-list
56497374|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56497375|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497376|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497377|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497378|NCT04616586|Siltuximab|siltuximab|mesh-list
56497379|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802500|NCT04589611|Amobarbital|amobarbital|mesh-list
56497380|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56497381|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497382|NCT04616352|Cefuroxime|cefuroxime|mesh-list
56497383|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
56497384|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56497385|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497386|NCT00553943|Cytarabine|cytarabine|mesh-list
56497387|NCT00553943|Rituximab|rituximab|mesh-list
56497388|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497389|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497390|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
56497391|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497392|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56497393|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56497394|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
56497395|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497396|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
56497397|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245419|NCT01819285|Hormones|hormones|mesh-ancestor
56497398|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56497400|NCT00563160|Carboplatin|carboplatin|mesh-list
56497401|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497402|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56497403|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
56497404|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497405|NCT00563160|Antiviral Agents|antiviral agents|mesh-ancestor
56497406|NCT00563160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497407|NCT00563160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497408|NCT00563160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56497409|NCT00563160|Immunologic Factors|immunologic factors|mesh-ancestor
56497410|NCT00563160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497411|NCT00563238|Metoprolol|metoprolol|mesh-list
56497412|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56497413|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56497414|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
56497415|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
56497416|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497417|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497418|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56497419|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56497420|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56497421|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
56497422|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165524|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
56497423|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497425|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56497426|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
56497427|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
56497428|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497429|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497430|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
56497431|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56497432|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497433|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
56497434|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56497435|NCT04934228|Clonidine|clonidine|mesh-list
56497436|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56497437|NCT04934228|Diuretics|diuretics|mesh-ancestor
56497438|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
56497439|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497440|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56497441|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56497442|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497443|NCT04934228|Analgesics|analgesics|mesh-ancestor
56497444|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
56497445|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497446|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
56497447|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
56497448|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56497449|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56497450|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56497451|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
56497452|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497453|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
56497454|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497455|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56497457|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497458|NCT04616391|Insulin|insulin|mesh-list
56497459|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56497460|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497461|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
56497462|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
56497463|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56497464|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56497465|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56497466|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56497467|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
56497468|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56497469|NCT04881929|Docetaxel|docetaxel|mesh-list
56497470|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497471|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
56497472|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
56497473|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
56245499|NCT01819870|Carvedilol|carvedilol|mesh-list
56497474|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497475|NCT04615767|Inositol|inositol|mesh-list
56497476|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
56497477|NCT04615767|Vitamins|vitamins|mesh-ancestor
56497478|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
56497479|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497480|NCT04863638|Vaccines|vaccines|mesh-list
56497481|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
56497482|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497483|NCT04615611|Albuterol|albuterol|mesh-list
56497484|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56497485|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
56497486|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497487|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497488|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56497489|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
56497490|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
56497491|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56497492|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56497493|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56497494|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56497495|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
56497496|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497497|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497498|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56497499|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497500|NCT04833959|Panitumumab|panitumumab|mesh-list
56497501|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497502|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497503|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
56497504|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
56497505|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497506|NCT04725812|Eculizumab|eculizumab|mesh-list
56497507|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56497508|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56497509|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
56497510|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497511|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
56497512|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
56497513|NCT04713371|Ipilimumab|ipilimumab|mesh-list
56497514|NCT04713371|Sargramostim|sargramostim|mesh-list
56497515|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56497516|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
56497517|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497518|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250529|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
56497519|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56497520|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
56497521|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497522|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497523|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56497524|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497525|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56497526|NCT04683614|Norepinephrine|norepinephrine|mesh-list
56497527|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56497528|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56497529|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
56497530|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497531|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497532|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497533|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
56497534|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
56497535|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497536|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56497537|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
56497538|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
56497539|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
56497540|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
56497541|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497542|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497543|NCT04613700|Secretin|secretin|mesh-list
56497544|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56497545|NCT04613700|Hormones|hormones|mesh-ancestor
56497546|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56497547|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497548|NCT04675151|Phentolamine|phentolamine|mesh-list
56497549|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56497550|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56497551|NCT04675151|Pilocarpine|pilocarpine|mesh-list
56497552|NCT04675151|Miotics|miotics|mesh-ancestor
56497553|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
56497554|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497555|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497556|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56497557|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56497558|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
56497559|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497560|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497561|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56497562|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56497563|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
56497564|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56497565|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
56497566|NCT00563355|Hematinics|hematinics|mesh-ancestor
56497567|NCT00563394|Ofloxacin|ofloxacin|mesh-list
56497568|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56497569|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497570|NCT00563394|Renal Agents|renal agents|mesh-ancestor
56497571|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56497572|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56497573|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56497574|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497575|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497576|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497577|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56497578|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56497579|NCT00563433|Ofloxacin|ofloxacin|mesh-list
56497580|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56497581|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497582|NCT00563433|Renal Agents|renal agents|mesh-ancestor
56497583|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56497584|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56497585|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56497586|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497587|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497588|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497589|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56497590|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56497591|NCT00563472|Desogestrel|desogestrel|mesh-list
56497592|NCT00563472|Progesterone|progesterone|mesh-list
56497593|NCT00563472|Progestins|progestins|mesh-ancestor
56497594|NCT00563472|Hormones|hormones|mesh-ancestor
56497595|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56497596|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497597|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56250608|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
56497598|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56497599|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56497600|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
56497601|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56497602|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56497603|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56497604|NCT04679597|Capecitabine|capecitabine|mesh-list
56497605|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
56497606|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56497607|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
56497608|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497609|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497610|NCT04615910|Exenatide|exenatide|mesh-list
56497611|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56497612|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497613|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56497614|NCT04615910|Incretins|incretins|mesh-ancestor
56497615|NCT04615910|Hormones|hormones|mesh-ancestor
56497616|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56497617|NCT04609397|Hemay005|hemay005|mesh-list
56497618|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
56497619|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56497620|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56245643|NCT01820858|Carboplatin|carboplatin|mesh-list
56497621|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497622|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497623|NCT04587947|Valsartan|valsartan|mesh-list
56497624|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56497625|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56497626|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56497627|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56497628|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497630|NCT04612998|Ephedrine|ephedrine|mesh-list
56497631|NCT04612998|Metoclopramide|metoclopramide|mesh-list
56497632|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56497633|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56497634|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56497635|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
56497636|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497637|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497638|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56497639|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
56497640|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
56497641|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
56497642|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56497643|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56497644|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
56497645|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497646|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497648|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56497649|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56497650|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56497651|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
56250658|NCT01862302|Haloperidol|haloperidol|mesh-list
56497652|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56497653|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
56497654|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56497655|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
56497656|NCT00563589|Cyclosporine|cyclosporine|mesh-list
56497657|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
56497658|NCT00563589|Methotrexate|methotrexate|mesh-list
56497659|NCT00563589|Cyclosporins|cyclosporins|mesh-list
56497660|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56497661|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
56497662|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56497663|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497664|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56497665|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
56497666|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497667|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497668|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
56497669|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497670|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56497671|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56497672|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
56497673|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56497674|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56497675|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
56497676|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497677|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56497678|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56497679|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56497680|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
56497681|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56497682|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
56497683|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497684|NCT04465643|Nivolumab|nivolumab|mesh-list
56497685|NCT04465643|Ipilimumab|ipilimumab|mesh-list
56497686|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497687|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497688|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56497689|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497690|NCT04465487|Cemiplimab|cemiplimab|mesh-list
56497691|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497692|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497693|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
56497694|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56497695|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
56497696|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497697|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497698|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497699|NCT02204345|Paclitaxel|paclitaxel|mesh-list
56497700|NCT02204345|Carboplatin|carboplatin|mesh-list
56497701|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56497702|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497703|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
56497704|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
56497705|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
56497706|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497707|NCT02187302|Bevacizumab|bevacizumab|mesh-list
56497708|NCT02187302|Sunitinib|sunitinib|mesh-list
56497709|NCT02187302|Everolimus|everolimus|mesh-list
56497710|NCT02187302|Sorafenib|sorafenib|mesh-list
56497711|NCT02187302|Axitinib|axitinib|mesh-list
56497712|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497713|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497714|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56497715|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56497716|NCT02187302|Growth Substances|growth substances|mesh-ancestor
56497717|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497718|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
56497719|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56497720|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
56497721|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56497722|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497723|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497724|NCT02179151|CKD732|ckd732|mesh-list
56497725|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56497726|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56497727|NCT02179151|Growth Substances|growth substances|mesh-ancestor
56497728|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497729|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
56497730|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497731|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56497732|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56497733|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
56497734|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497735|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56497736|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497737|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56497738|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497739|NCT04612257|Insulin|insulin|mesh-list
56497740|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56497741|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497742|NCT02160665|Tazarotene|tazarotene|mesh-list
56497743|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
56497744|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
56497745|NCT02138630|Capsaicin|capsaicin|mesh-list
56497746|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
56497747|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
56497748|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
56497749|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497750|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497751|NCT02137343|Capecitabine|capecitabine|mesh-list
56497752|NCT02137343|Rilotumumab|rilotumumab|mesh-list
56497753|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497754|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56497755|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
56497756|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497757|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497758|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
56497759|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56497760|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
56497761|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56497762|NCT02114060|Vaccines|vaccines|mesh-list
56497763|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
56497764|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497765|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56497766|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56497767|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56497768|NCT04633044|Betaine|betaine|mesh-list
56497769|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56497770|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
56497771|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56497772|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
56497773|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497774|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56250779|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56497775|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
56497776|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56497777|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497778|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497780|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
56497781|NCT00563823|Vatalanib|vatalanib|mesh-list
56497782|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56497783|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497784|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497785|NCT00563862|Fluorouracil|fluorouracil|mesh-list
56497786|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497787|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
56497788|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497789|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56497790|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56497791|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
56497792|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497793|NCT04611711|Decitabine|decitabine|mesh-list
56497794|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56497795|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
56497796|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497797|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497798|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497799|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
56497800|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56497801|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
56497802|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497803|NCT02092922|Filanesib|filanesib|mesh-list
56497804|NCT02092922|Lenograstim|lenograstim|mesh-list
56497805|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56497806|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
56497807|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497808|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
56497809|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
56497810|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497811|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497812|NCT02092454|Benzocaine|benzocaine|mesh-list
56497813|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
56497814|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
56497815|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497816|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250855|NCT01863511|Tolvaptan|tolvaptan|mesh-list
56497817|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
56497818|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497819|NCT02083289|Latanoprost|latanoprost|mesh-list
56497820|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56497821|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56497822|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
56497823|NCT02081300|Testosterone|testosterone|mesh-list
56497824|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
56497825|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
56497826|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56497827|NCT02081300|Androgens|androgens|mesh-ancestor
56497828|NCT02081300|Hormones|hormones|mesh-ancestor
56497829|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56497830|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497831|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56497832|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497833|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
56497834|NCT02074007|Benzocaine|benzocaine|mesh-list
56497835|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497836|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
56497837|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
56497838|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497839|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
56497840|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497841|NCT02072954|Asenapine|asenapine|mesh-list
56497842|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56497843|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56497844|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56497845|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497846|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56497847|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
56497848|NCT00554918|Prednisolone|prednisolone|mesh-list
56497849|NCT00554918|Docetaxel|docetaxel|mesh-list
56497850|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497851|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
56497852|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
56497853|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
56497854|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497855|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56497856|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
56497857|NCT00554918|Hormones|hormones|mesh-ancestor
56497858|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56497859|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497860|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56497861|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56497862|NCT04631874|Varenicline|varenicline|mesh-list
56497863|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56497864|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56497865|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
56497866|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497867|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497868|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497869|NCT02057315|Ketoprofen|ketoprofen|mesh-list
56497870|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56497871|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56497872|NCT02057315|Analgesics|analgesics|mesh-ancestor
56497873|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
56497874|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56497875|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497876|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56497877|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56497878|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56497879|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497880|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497881|NCT02047214|Bevacizumab|bevacizumab|mesh-list
56497882|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497883|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497884|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56497885|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56497886|NCT02047214|Growth Substances|growth substances|mesh-ancestor
56497887|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497888|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
56497889|NCT02046395|Amlodipine|amlodipine|mesh-list
56497890|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56497891|NCT02046395|Hydralazine|hydralazine|mesh-list
56497892|NCT02046395|Terazosin|terazosin|mesh-list
56497893|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56497894|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56497895|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56497896|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497897|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56497899|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
56497901|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
56497902|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56497903|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56497904|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56497905|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56497906|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
56497907|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56497908|NCT02046395|Urological Agents|urological agents|mesh-ancestor
56497909|NCT02042378|Rucaparib|rucaparib|mesh-list
56497910|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56497911|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497912|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497913|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497914|NCT02032277|Paclitaxel|paclitaxel|mesh-list
56497915|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
56497916|NCT02032277|Carboplatin|carboplatin|mesh-list
56497917|NCT02032277|Doxorubicin|doxorubicin|mesh-list
56497918|NCT02032277|Veliparib|veliparib|mesh-list
56497919|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56497920|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497921|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
56497922|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
56497923|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
56497924|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497925|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56497926|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
56250996|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56497927|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497928|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56497929|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56497930|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
56497931|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56497932|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56497933|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56497934|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56497935|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497936|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56497937|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56497938|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
56497939|NCT00560976|Hematinics|hematinics|mesh-ancestor
56497940|NCT02026349|Favipiravir|favipiravir|mesh-list
56497941|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
56497942|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497943|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
56497944|NCT04611126|Nivolumab|nivolumab|mesh-list
56497945|NCT04611126|Fludarabine|fludarabine|mesh-list
56497946|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
56497947|NCT04611126|Ipilimumab|ipilimumab|mesh-list
56497948|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56497949|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
56497950|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497951|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56497952|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56497953|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
56497954|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497955|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497956|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56497957|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497958|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56497959|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56497960|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
56497961|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
56497962|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
56497963|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56497964|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56497965|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497966|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497967|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497968|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56497969|NCT04611165|Nivolumab|nivolumab|mesh-list
56497970|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56497971|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497972|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56497973|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497974|NCT02014649|Laninamivir|laninamivir|mesh-list
56497975|NCT02014649|Zanamivir|zanamivir|mesh-list
56497976|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
56497977|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56497978|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56497979|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497980|NCT02014142|Latanoprost|latanoprost|mesh-list
56497981|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56497982|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56497983|NCT04610580|Choline|choline|mesh-list
56497984|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
56497985|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56497986|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
56497987|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497988|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56497989|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56497990|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
56497991|NCT02009579|Nintedanib|nintedanib|mesh-list
56497992|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56497993|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56497994|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251049|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826341|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56497995|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56497996|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56497997|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56497998|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
56497999|NCT01998035|Azacitidine|azacitidine|mesh-list
56498000|NCT01998035|Romidepsin|romidepsin|mesh-list
56498001|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56498002|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
56498003|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498004|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498005|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498006|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56498007|NCT04611243|Vaccines|vaccines|mesh-list
56498008|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
56498009|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498010|NCT00564057|Candesartan|candesartan|mesh-list
56498011|NCT00564057|Lercanidipine|lercanidipine|mesh-list
56498012|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56498013|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56498014|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56498015|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498016|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56498017|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56498018|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56498019|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498020|NCT04610541|Remdesivir|remdesivir|mesh-list
56498021|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
56498022|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498024|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498025|NCT04677335|Lovastatin|lovastatin|mesh-list
56498026|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56498027|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56498028|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
56498029|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498030|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56498031|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56498032|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498033|NCT04630548|Copper|copper|mesh-list
56498034|NCT04630548|Trace Elements|trace elements|mesh-ancestor
56498035|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
56498036|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498037|NCT01975610|Spebrutinib|spebrutinib|mesh-list
56498038|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56498039|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498040|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498041|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
56498043|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498044|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498045|NCT01967810|Bevacizumab|bevacizumab|mesh-list
56498046|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56498047|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498048|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56498049|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56498050|NCT01967810|Growth Substances|growth substances|mesh-ancestor
56498051|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498052|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
56498053|NCT01165138|Fluticasone|fluticasone|mesh-list
56498054|NCT01165138|Xhance|xhance|mesh-list
56498055|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498056|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56498057|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
56498058|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498059|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498060|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56498061|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
56498062|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
56498063|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56498064|NCT00561054|Cetuximab|cetuximab|mesh-list
56498065|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56498066|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498067|NCT04206358|Molgramostim|molgramostim|mesh-list
56498068|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498069|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56498070|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
56498071|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56498072|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498073|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498074|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56498075|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56498076|NCT00561093|Protective Agents|protective agents|mesh-ancestor
56498077|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498078|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
56498079|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56498081|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56498082|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56498083|NCT01165021|Folic Acid|folic acid|mesh-list
56498085|NCT01165021|Dexamethasone|dexamethasone|mesh-list
56498086|NCT01165021|Pemetrexed|pemetrexed|mesh-list
56498087|NCT01165021|Vitamins|vitamins|mesh-ancestor
56498088|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
56498089|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498090|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498091|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
56498092|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
56498093|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498094|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56498095|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
56498096|NCT01165021|Hormones|hormones|mesh-ancestor
56498097|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498098|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56498099|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498100|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498101|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498102|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56498103|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56498104|NCT01165021|Hematinics|hematinics|mesh-ancestor
56498105|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
56498106|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
56498107|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
56498108|NCT00561132|Antacids|antacids|mesh-ancestor
56498109|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498110|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56498111|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56498112|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498113|NCT01956812|Gemcitabine|gemcitabine|mesh-list
56498114|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56498115|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
56498116|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498117|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498118|NCT01956812|Antiviral Agents|antiviral agents|mesh-ancestor
56498119|NCT01956812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498120|NCT01956812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498121|NCT01956812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56498122|NCT01956812|Immunologic Factors|immunologic factors|mesh-ancestor
56498123|NCT01956812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498124|NCT01952990|Phenylephrine|phenylephrine|mesh-list
56498125|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
56498126|NCT01952990|Tetracaine|tetracaine|mesh-list
56498127|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
56498128|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
56498129|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498130|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498131|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
56498132|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498133|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56498134|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56498135|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
56498136|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498137|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498138|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
56498139|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
56498140|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
56498141|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56498142|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
55750051|NCT02453503|Hormones|hormones|mesh-ancestor
56498143|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56498144|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
56498145|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56498146|NCT01952990|Protective Agents|protective agents|mesh-ancestor
56498147|NCT04314310|Tenoxicam|tenoxicam|mesh-list
56498148|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56498149|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498150|NCT04314310|Analgesics|analgesics|mesh-ancestor
56498151|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
56498152|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498153|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498154|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498155|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165708|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
56498156|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56498157|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498158|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498159|NCT04610307|Anesthetics|anesthetics|mesh-list
56498160|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498161|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498162|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
56498163|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56498164|NCT04610502|Antibodies|antibodies|mesh-list
56498165|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
56498166|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498167|NCT01164475|Plerixafor|plerixafor|mesh-list
56498168|NCT01164475|Lenograstim|lenograstim|mesh-list
56498169|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56498170|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
56498171|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498172|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56498173|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56498174|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
56498175|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498176|NCT01164007|Bevacizumab|bevacizumab|mesh-list
56498177|NCT01164007|Dacarbazine|dacarbazine|mesh-list
56498178|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56498179|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498180|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56498181|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56498182|NCT01164007|Growth Substances|growth substances|mesh-ancestor
56498183|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498184|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
56498185|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56498186|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
56498187|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498188|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56498189|NCT01941836|Ezetimibe|ezetimibe|mesh-list
56498191|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56498192|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
56498193|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498194|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56498195|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498196|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56498197|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498198|NCT04629885|Oxytocin|oxytocin|mesh-list
56498199|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
56498200|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56498201|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498202|NCT01163851|Bococizumab|bococizumab|mesh-list
56498203|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56498204|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56498205|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
56498206|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498207|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56498208|NCT01917383|Timolol|timolol|mesh-list
56498209|NCT01917383|Latanoprost|latanoprost|mesh-list
56498210|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56498211|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56498212|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
56498213|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498214|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498215|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498216|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56498217|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56498218|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56498219|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56498221|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498222|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56498223|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56498224|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
56498225|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56498226|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
56498227|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498228|NCT04629846|Docetaxel|docetaxel|mesh-list
56498229|NCT04629846|Trastuzumab|trastuzumab|mesh-list
56498230|NCT04629846|Pertuzumab|pertuzumab|mesh-list
56498231|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498232|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
56498233|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56498234|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
56498235|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498236|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56498237|NCT01909427|Methotrexate|methotrexate|mesh-list
56498238|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56498239|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
56498240|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56498241|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498242|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56498243|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
56498244|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498245|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498246|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
56498247|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498248|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56498249|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56498250|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
56498251|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56498252|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56498253|NCT04629573|Anesthetics|anesthetics|mesh-list
56498254|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498255|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498256|NCT00564174|Aspirin|aspirin|mesh-list
56498257|NCT00564174|Heparin|heparin|mesh-list
56498258|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56498259|NCT00564174|Tinzaparin|tinzaparin|mesh-list
56498260|NCT00564174|Dalteparin|dalteparin|mesh-list
56498261|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56498262|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498263|NCT00564174|Analgesics|analgesics|mesh-ancestor
56498264|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
56498265|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498267|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498268|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56498269|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56498270|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56498271|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498272|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56498273|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56498274|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498275|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
56498276|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
56498277|NCT01163266|Vortioxetine|vortioxetine|mesh-list
56498278|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
56498279|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56498280|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56498281|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56498282|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498283|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498284|NCT01163266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56498285|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56498286|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56498287|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498288|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498290|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56498291|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56498292|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56498293|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56498294|NCT01873703|Azacitidine|azacitidine|mesh-list
56498295|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56498296|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
56498297|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246310|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56498298|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498299|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498300|NCT01870505|Letrozole|letrozole|mesh-list
56498301|NCT01870505|Exemestane|exemestane|mesh-list
56498302|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498303|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56498304|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56498305|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498306|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498307|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56498308|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
56498309|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498310|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498311|NCT04629612|Anesthetics|anesthetics|mesh-list
56498312|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498313|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498314|NCT00564213|Mitomycins|mitomycins|mesh-list
56498315|NCT00564213|Mitomycin|mitomycin|mesh-list
56498316|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56498317|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498318|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
56498319|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498320|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56498321|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498322|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56498323|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56498324|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
56498325|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498326|NCT00564252|Finasteride|finasteride|mesh-list
56498327|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56498328|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56498329|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498330|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498331|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
56498332|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498333|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498334|NCT00564252|Urological Agents|urological agents|mesh-ancestor
56498335|NCT04629144|Belimumab|belimumab|mesh-list
56498336|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56498337|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
56498338|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498339|NCT01858883|Gemcitabine|gemcitabine|mesh-list
56498340|NCT01858883|Paclitaxel|paclitaxel|mesh-list
56498341|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56498342|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498343|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
56498344|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
56498345|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
56498346|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498347|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56498348|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
56251054|NCT01864798|Denosumab|denosumab|mesh-list
56498349|NCT01858883|Antiviral Agents|antiviral agents|mesh-ancestor
56498350|NCT01858883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498351|NCT01858883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498352|NCT01858883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56498353|NCT01858883|Immunologic Factors|immunologic factors|mesh-ancestor
56498354|NCT01858883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498355|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56498356|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
56498358|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498359|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
56498360|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56498361|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56498362|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498363|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56498364|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498365|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498366|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56498367|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56498368|NCT01847573|Growth Substances|growth substances|mesh-ancestor
56498369|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498370|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
56246386|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56498371|NCT04609254|Acetaminophen|acetaminophen|mesh-list
56498372|NCT04609254|Ibuprofen|ibuprofen|mesh-list
56498373|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56498374|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56498375|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498376|NCT04609254|Analgesics|analgesics|mesh-ancestor
56498377|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
56498378|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498379|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498380|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498381|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56498382|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56498383|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498384|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498385|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
56498386|NCT01846481|Cocaine|cocaine|mesh-list
56498387|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
56498388|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
56498389|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498390|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498391|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
56498392|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498393|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56498394|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56498395|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56498396|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56498397|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498398|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
56498399|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498400|NCT04609293|Apatinib|apatinib|mesh-list
56498401|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498402|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56498403|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498404|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498405|NCT04609176|Apatinib|apatinib|mesh-list
56498406|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498407|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56498408|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498409|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498410|NCT04676789|Pegaspargase|pegaspargase|mesh-list
56498411|NCT04676789|Antibodies|antibodies|mesh-list
56498412|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56498413|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
56498414|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498415|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498416|NCT01811576|Hormones|hormones|mesh-list
56498417|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498418|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498419|NCT01811498|Bevacizumab|bevacizumab|mesh-list
56498420|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56498421|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498422|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56498423|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56498424|NCT01811498|Growth Substances|growth substances|mesh-ancestor
56498425|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498426|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
56498427|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
56498428|NCT01804829|Antibodies|antibodies|mesh-list
56498429|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
56498430|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56498431|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56498432|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
56498433|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
56498434|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498435|NCT00565422|Citalopram|citalopram|mesh-list
56498436|NCT00565422|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56498437|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56498438|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56498439|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498440|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498441|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
56498442|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498443|NCT00565422|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56246459|NCT01826396|Irinotecan|irinotecan|mesh-list
56498444|NCT00565422|Antidepressive Agents|antidepressive agents|mesh-ancestor
56498445|NCT00565422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56498446|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56498447|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56498448|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
56498449|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498450|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498451|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56498452|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
56498453|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56498454|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56498455|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56498456|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
56498457|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498458|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498459|NCT01789736|Travoprost|travoprost|mesh-list
56498460|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56498461|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56498462|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56498463|NCT00564330|Esomeprazole|esomeprazole|mesh-list
56498464|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56498465|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56498466|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56498467|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498468|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498469|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
56498470|NCT01780844|Prednisone|prednisone|mesh-list
56498471|NCT01780844|Tacrolimus|tacrolimus|mesh-list
56498472|NCT01780844|Basiliximab|basiliximab|mesh-list
56498473|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498474|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
56498476|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498477|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498478|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56498479|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498480|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56498481|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
56498482|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56498483|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498484|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498485|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56498486|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56498487|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
56498488|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56498489|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498490|NCT01779947|Estradiol|estradiol|mesh-list
56498491|NCT01779947|Estrogens|estrogens|mesh-ancestor
56498492|NCT01779947|Hormones|hormones|mesh-ancestor
56498493|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498494|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498495|NCT00564408|Carbachol|carbachol|mesh-list
56498496|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56498497|NCT00564408|Miotics|miotics|mesh-ancestor
56498498|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
56498499|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498500|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498501|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56498502|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
56498503|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498504|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498505|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498506|NCT00564408|Analgesics|analgesics|mesh-ancestor
56498507|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
56498508|NCT00564408|Protective Agents|protective agents|mesh-ancestor
56498509|NCT01773785|Docetaxel|docetaxel|mesh-list
56498510|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498511|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
56498512|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
56498513|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
56498514|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498515|NCT01758458|Interferons|interferons|mesh-list
56498516|NCT01758458|Aldesleukin|aldesleukin|mesh-list
56498517|NCT01758458|Interferon-beta|interferon-beta|mesh-list
56498518|NCT01758458|Interleukin-2|interleukin-2|mesh-list
56498519|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498520|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
56498521|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498522|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498523|NCT01758458|Analgesics|analgesics|mesh-ancestor
56498524|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
56498525|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498526|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498527|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56498528|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56498529|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
56498530|NCT04608981|Prednisolone|prednisolone|mesh-list
56498531|NCT04608981|Diclofenac|diclofenac|mesh-list
56498532|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498533|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
56498534|NCT04608981|Hormones|hormones|mesh-ancestor
56498535|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498536|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498537|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56498549|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498550|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56498551|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498552|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498553|NCT01737905|Epinephrine|epinephrine|mesh-list
56498554|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56498555|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56498556|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
56498557|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498558|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498559|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498560|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56498561|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56498562|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
56498563|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498564|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56498565|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
56498566|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
56498567|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
56498568|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56498581|NCT01730027|Montelukast|montelukast|mesh-list
56498582|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56498583|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
56498584|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56498585|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
56498586|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498587|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498588|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56498589|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56498590|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498591|NCT04608669|Acetaminophen|acetaminophen|mesh-list
56498592|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498593|NCT04608669|Analgesics|analgesics|mesh-ancestor
56498594|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
56498595|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498596|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498597|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
56498598|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56498599|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56498601|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
56498602|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498603|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56498604|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56498605|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498606|NCT04600089|Ketamine|ketamine|mesh-list
56498607|NCT04600089|Analgesics|analgesics|mesh-ancestor
56498608|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
56498609|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498610|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498611|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56498612|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56498613|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
56498614|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
56498615|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498616|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56498617|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56498618|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498619|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498620|NCT01704365|Vaccines|vaccines|mesh-list
56498621|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
56498622|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498623|NCT01698281|Dexamethasone|dexamethasone|mesh-list
56498624|NCT01698281|Doxorubicin|doxorubicin|mesh-list
56498625|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498626|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
56498627|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
56498628|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498629|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498630|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56498631|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
56498632|NCT01698281|Hormones|hormones|mesh-ancestor
56498633|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498634|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56498635|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498636|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56498637|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56498638|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56498639|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498640|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498641|NCT00565461|Vaccines|vaccines|mesh-list
56498642|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
56498643|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498644|NCT01697072|Cisplatin|cisplatin|mesh-list
56498645|NCT01697072|Capecitabine|capecitabine|mesh-list
56498646|NCT01697072|Epirubicin|epirubicin|mesh-list
56498647|NCT01697072|Rilotumumab|rilotumumab|mesh-list
56498648|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498649|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56498650|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
56498651|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498652|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56498653|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56498654|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56498655|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498656|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56498657|NCT00565500|Ibuprofen|ibuprofen|mesh-list
56498658|NCT00565500|Celecoxib|celecoxib|mesh-list
56498659|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56498660|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498661|NCT00565500|Analgesics|analgesics|mesh-ancestor
56498662|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
56498663|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498664|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498665|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498666|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55750560|NCT01597245|Etanercept|etanercept|mesh-list
56498667|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56498668|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246689|NCT01828294|Antibodies|antibodies|mesh-list
56498669|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498670|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56498671|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56498672|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56498674|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56498675|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498676|NCT01658501|Metformin|metformin|mesh-list
56498677|NCT01658501|Liraglutide|liraglutide|mesh-list
56498678|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56498679|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498680|NCT01658501|Incretins|incretins|mesh-ancestor
56498681|NCT01658501|Hormones|hormones|mesh-ancestor
56498682|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498683|NCT01651871|Cetirizine|cetirizine|mesh-list
56498684|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56498685|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56498686|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56498687|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
56498688|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
56498689|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498690|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498691|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498692|NCT04608006|Fentanyl|fentanyl|mesh-list
56498693|NCT04608006|Bupivacaine|bupivacaine|mesh-list
56498694|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
56498695|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
56498696|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498697|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498698|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
56498699|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498700|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56498701|NCT04608006|Narcotics|narcotics|mesh-ancestor
56498702|NCT04608006|Analgesics|analgesics|mesh-ancestor
56498703|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56498704|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56498705|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
56498706|NCT04599621|Uric Acid|uric acid|mesh-list
56498707|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
56498708|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498709|NCT04599621|Protective Agents|protective agents|mesh-ancestor
56498710|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498711|NCT00564525|Amitriptyline|amitriptyline|mesh-list
56498712|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56498713|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
56498714|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56498715|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498716|NCT00564525|Analgesics|analgesics|mesh-ancestor
56498717|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
56498718|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802544|NCT02590003|Carboplatin|carboplatin|mesh-list
56498719|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498720|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56498721|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56498722|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56498723|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498724|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
56498725|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498726|NCT04607733|Mirikizumab|mirikizumab|mesh-list
56498727|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56498728|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498729|NCT04607733|Analgesics|analgesics|mesh-ancestor
56498730|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
56498731|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498732|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498733|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498734|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56498735|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56498736|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56498738|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56498739|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56498740|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
56498741|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498742|NCT01632137|Protective Agents|protective agents|mesh-ancestor
56246762|NCT01828606|Monensin|monensin|mesh-list
56498743|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498744|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498745|NCT00565539|Interferons|interferons|mesh-list
56498746|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498747|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
56498748|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498749|NCT04599699|Androgens|androgens|mesh-list
56498750|NCT04599699|Hormones|hormones|mesh-ancestor
56498751|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498752|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498753|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
56498754|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
56498755|NCT01563731|Atorvastatin|atorvastatin|mesh-list
56498756|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56498757|NCT01563731|Simvastatin|simvastatin|mesh-list
56498758|NCT01563731|Pravastatin|pravastatin|mesh-list
56498759|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56498760|NCT01563731|Diuretics|diuretics|mesh-list
56498761|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56498762|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56498763|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56498764|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56498765|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56498766|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498767|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56498768|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56498769|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
56498770|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498771|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56498772|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56498773|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
56498774|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
56498775|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56498776|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
56498777|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498778|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56498779|NCT01516346|Hydralazine|hydralazine|mesh-list
56498780|NCT01516346|Isosorbide|isosorbide|mesh-list
56498781|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56498782|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56498783|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56498784|NCT01516346|Diuretics|diuretics|mesh-ancestor
56498785|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
56498786|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498787|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
56498788|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56498789|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498790|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56498791|NCT01303796|Decitabine|decitabine|mesh-list
56498792|NCT01303796|Sapacitabine|sapacitabine|mesh-list
56498793|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56498794|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
56498795|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498796|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498797|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498798|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
56498799|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
56498800|NCT04598880|Cathartics|cathartics|mesh-ancestor
56498801|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56498802|NCT00194714|Vaccines|vaccines|mesh-list
56498803|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
56498804|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498805|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56498806|NCT00564564|Clomipramine|clomipramine|mesh-list
56498807|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
56498808|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251188|NCT01865916|Laxatives|laxatives|mesh-ancestor
56498809|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56498810|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56498811|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498812|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498813|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56498814|NCT00564564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56498815|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56498816|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246845|NCT01829529|Amoxicillin|amoxicillin|mesh-list
56498817|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498818|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498819|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
56498820|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56498821|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56498822|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56498823|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498824|NCT00565656|Bevacizumab|bevacizumab|mesh-list
56498825|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56498826|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498827|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56498828|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56498829|NCT00565656|Growth Substances|growth substances|mesh-ancestor
56498830|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498831|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
56498832|NCT00564603|Dexamethasone|dexamethasone|mesh-list
56498833|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
56498834|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56498835|NCT00564603|BB 1101|bb 1101|mesh-list
56498836|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498837|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
56498838|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
56498839|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498840|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498841|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56498842|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
56498843|NCT00564603|Hormones|hormones|mesh-ancestor
56498844|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56498845|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56498846|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498847|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
56498848|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498849|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498850|NCT00555347|Modafinil|modafinil|mesh-list
56498851|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56498852|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498853|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56498854|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56498855|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56498856|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498857|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
56498858|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56498859|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
56498860|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498861|NCT00564642|Expectorants|expectorants|mesh-ancestor
56498862|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
56498863|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56498864|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
55819976|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56498865|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498866|NCT00564642|Protective Agents|protective agents|mesh-ancestor
56498867|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498868|NCT00564642|Antidotes|antidotes|mesh-ancestor
56498869|NCT00555386|Selenium|selenium|mesh-list
56498870|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
56498871|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498872|NCT00555386|Protective Agents|protective agents|mesh-ancestor
56498873|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498874|NCT00555386|Trace Elements|trace elements|mesh-ancestor
56498875|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
56498876|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
56498877|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251191|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498878|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498879|NCT04675697|Etoposide|etoposide|mesh-list
56498880|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56498881|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498882|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56498883|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56498884|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498885|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498886|NCT04606836|Bupivacaine|bupivacaine|mesh-list
56498887|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
56498888|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
56498889|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498890|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498891|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
56498892|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498893|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
56498894|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
56498895|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498896|NCT04676126|Dorzolamide|dorzolamide|mesh-list
56498897|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56498898|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56498899|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498900|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498901|NCT04675619|Pirfenidone|pirfenidone|mesh-list
56498902|NCT04675619|Analgesics|analgesics|mesh-ancestor
56498903|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
56498904|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498905|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498906|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56498907|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56498908|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56498909|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56165845|NCT00003204|Hormones|hormones|mesh-ancestor
56498910|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498911|NCT05305300|Vaccines|vaccines|mesh-list
56498912|NCT05305300|Somatomedin B|somatomedin b|mesh-list
56498913|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
56498914|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498915|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56498916|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56498917|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
56498918|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498919|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498920|NCT04187755|Ceftazidime|ceftazidime|mesh-list
56498921|NCT04187755|Cefepime|cefepime|mesh-list
56498922|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56498923|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498924|NCT00555542|Rituximab|rituximab|mesh-list
56498925|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56498926|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498927|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
56498928|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498929|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56498930|NCT04606563|Losartan|losartan|mesh-list
56498931|NCT04606563|Valsartan|valsartan|mesh-list
56498932|NCT04606563|Telmisartan|telmisartan|mesh-list
56498933|NCT04606563|Candesartan|candesartan|mesh-list
56498934|NCT04606563|Olmesartan|olmesartan|mesh-list
56498935|NCT04606563|Irbesartan|irbesartan|mesh-list
56498936|NCT04606563|Eprosartan|eprosartan|mesh-list
56498937|NCT04606563|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56498938|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56498939|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56498940|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56498941|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498942|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56498943|NCT04606563|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
56498944|NCT00565968|Sorafenib|sorafenib|mesh-list
56498945|NCT00565968|Melphalan|melphalan|mesh-list
56498946|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56498947|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56498948|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498949|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498950|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56498951|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
56498952|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56498953|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56498954|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
56498955|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498956|NCT01162486|Rifampin|rifampin|mesh-list
56498957|NCT01162486|Rifapentine|rifapentine|mesh-list
56498958|NCT01162486|Midazolam|midazolam|mesh-list
56498959|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56498960|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56498961|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56498962|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498963|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56498964|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56498965|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56498966|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56498967|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
56498968|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
56498969|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
56498970|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
56498971|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56498972|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498973|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56498974|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
56498975|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56498976|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56498977|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
56498979|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498980|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56498981|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56498982|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56498983|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56498984|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56498985|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56498986|NCT01162135|Digoxin|digoxin|mesh-list
56498987|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56498988|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56498989|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56498990|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56498991|NCT01162135|Protective Agents|protective agents|mesh-ancestor
56498992|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498993|NCT00555776|Gabapentin|gabapentin|mesh-list
56498994|NCT00555776|Analgesics|analgesics|mesh-ancestor
56498995|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
56498996|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56498997|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56498998|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
56498999|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56499000|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56499001|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499002|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56499003|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56499004|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56499005|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499006|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499007|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
56499008|NCT01161628|Rituximab|rituximab|mesh-list
56499009|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56499010|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499011|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
56499012|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499013|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499014|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
56499015|NCT04314505|Narcotics|narcotics|mesh-ancestor
56499016|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499017|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499018|NCT04314505|Analgesics|analgesics|mesh-ancestor
56499019|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
56499020|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499021|NCT02885545|Anticoagulants|anticoagulants|mesh-list
56499022|NCT01161472|Alprazolam|alprazolam|mesh-list
56499023|NCT01161472|Fesoterodine|fesoterodine|mesh-list
56499024|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56499025|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499026|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499027|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56499028|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56499029|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56499030|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
56499031|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
56499032|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499033|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499034|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56499035|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56499036|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
56499037|NCT01161472|Urological Agents|urological agents|mesh-ancestor
56499039|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56499040|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
56499041|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247076|NCT01837290|Midazolam|midazolam|mesh-list
56499042|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
56499043|NCT04675385|Protective Agents|protective agents|mesh-ancestor
56499044|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
56499045|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56499046|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499047|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499048|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56499050|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
56499051|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499052|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56499053|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56499054|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56499055|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
56499056|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499057|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499058|NCT04674956|Gemcitabine|gemcitabine|mesh-list
56499059|NCT04674956|Paclitaxel|paclitaxel|mesh-list
56499060|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56499061|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499062|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
56499063|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
56499064|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
56499065|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499066|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56499067|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
56499068|NCT04674956|Antiviral Agents|antiviral agents|mesh-ancestor
56499069|NCT04674956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499070|NCT04674956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499071|NCT04674956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499072|NCT04674956|Immunologic Factors|immunologic factors|mesh-ancestor
56499073|NCT04674956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499074|NCT00564720|Gemcitabine|gemcitabine|mesh-list
56251228|NCT01866267|Maraviroc|maraviroc|mesh-list
56499075|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
56499076|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56499077|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56499078|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
56499079|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499080|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499081|NCT00564720|Antiviral Agents|antiviral agents|mesh-ancestor
56499082|NCT00564720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499083|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499084|NCT00564720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499085|NCT00564720|Immunologic Factors|immunologic factors|mesh-ancestor
56499086|NCT00564720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499087|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56499088|NCT01160770|Clobazam|clobazam|mesh-list
56499089|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
56499090|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56499091|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56499092|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499093|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499094|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56499095|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56499096|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
56499097|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
56499098|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165876|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56499099|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499100|NCT04632758|Crizotinib|crizotinib|mesh-list
56499101|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499102|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56499103|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499104|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499105|NCT00566046|Levetiracetam|levetiracetam|mesh-list
56499106|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
56499107|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
56499108|NCT01160614|Oxycodone|oxycodone|mesh-list
56499109|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56499110|NCT01160614|Narcotics|narcotics|mesh-ancestor
56499111|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499112|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499113|NCT01160614|Analgesics|analgesics|mesh-ancestor
56499114|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
56499115|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499116|NCT00566124|Insulin|insulin|mesh-list
56247132|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
56499117|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56499118|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
56499119|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
56499120|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
56499121|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
56499122|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
56499123|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56499124|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499125|NCT01159912|Fluticasone|fluticasone|mesh-list
56499126|NCT01159912|Xhance|xhance|mesh-list
56499127|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499128|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56499129|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
56499130|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499131|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499132|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56499133|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
56499134|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
56499135|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56499136|NCT04606212|Losartan|losartan|mesh-list
56499137|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56499138|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56499139|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56499140|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56499141|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499142|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
56499143|NCT04606017|Antacids|antacids|mesh-ancestor
56499144|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499145|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56499146|NCT04631822|Dexamethasone|dexamethasone|mesh-list
56499147|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499148|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
56499149|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
56499150|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499151|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499152|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56499153|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
56499154|NCT04631822|Hormones|hormones|mesh-ancestor
56499155|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499156|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56499157|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499158|NCT04605705|Chrysarobin|chrysarobin|mesh-list
56499159|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56499161|NCT04605705|Analgesics|analgesics|mesh-ancestor
56499162|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
56499163|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499164|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499165|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499166|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499167|NCT00560924|Estradiol|estradiol|mesh-list
56499168|NCT00560924|Estrogens|estrogens|mesh-ancestor
56499170|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499171|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499172|NCT00560963|Everolimus|everolimus|mesh-list
56499173|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499174|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499175|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
56499176|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499177|NCT01159600|Empagliflozin|empagliflozin|mesh-list
56499178|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56499179|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499180|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56499181|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499182|NCT04631627|Aspirin|aspirin|mesh-list
56499183|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56499184|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56499185|NCT04631627|Analgesics|analgesics|mesh-ancestor
56499186|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
56499187|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499188|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247218|NCT01840774|Ketamine|ketamine|mesh-list
56499189|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499190|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499191|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56499192|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56499193|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499194|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56499195|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56499196|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499198|NCT04314193|Prednisolone|prednisolone|mesh-list
56499199|NCT04314193|Methotrexate|methotrexate|mesh-list
56499200|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56499201|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
56499202|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56499203|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499204|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56499205|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
56499206|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499207|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499208|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
56499209|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499210|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56499211|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499212|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
56499213|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499214|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56499215|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499216|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
56499217|NCT04314193|Hormones|hormones|mesh-ancestor
56499218|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499219|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56499220|NCT01159171|Bevacizumab|bevacizumab|mesh-list
56499221|NCT01159171|Capecitabine|capecitabine|mesh-list
56499222|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
56499223|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56499224|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499225|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56499226|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56499227|NCT01159171|Growth Substances|growth substances|mesh-ancestor
56499228|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499229|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
56499230|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56499231|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
56499232|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499233|NCT04631315|Prednisolone|prednisolone|mesh-list
56499234|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56499235|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
56499236|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56499237|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
56499238|NCT04631315|Phenylephrine|phenylephrine|mesh-list
56499239|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
56499240|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56499241|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55753075|NCT05002725|Lidocaine|lidocaine|mesh-list
56499242|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
56499243|NCT04631315|Difluprednate|difluprednate|mesh-list
56499244|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56499245|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499246|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
56499247|NCT04631315|Hormones|hormones|mesh-ancestor
56499248|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499249|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499250|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56499251|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499252|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
56499253|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
56499254|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499255|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56499256|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56499257|NCT04631315|Protective Agents|protective agents|mesh-ancestor
56499258|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56499259|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
56499260|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
56499261|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56499262|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
56499263|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
56499264|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56499265|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56247288|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
56499266|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56499267|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
56499268|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56165919|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499269|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499270|NCT04597203|Hydroquinone|hydroquinone|mesh-list
56499271|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
56499272|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499273|NCT04597203|Protective Agents|protective agents|mesh-ancestor
56499274|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499275|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56499276|NCT01158118|Plerixafor|plerixafor|mesh-list
56499277|NCT01158118|Sargramostim|sargramostim|mesh-list
56499278|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
56499279|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499280|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56499281|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56499282|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
56499283|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499284|NCT02885311|Naltrexone|naltrexone|mesh-list
56499285|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56499286|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56499287|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499288|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
56499289|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499290|NCT00566241|Mecasermin|mecasermin|mesh-list
56499291|NCT00566241|Growth Substances|growth substances|mesh-ancestor
56499292|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499293|NCT00561119|Gemcitabine|gemcitabine|mesh-list
56499294|NCT00561119|Paclitaxel|paclitaxel|mesh-list
56499295|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56499296|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499297|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
56499298|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
56499299|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
56499300|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499301|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56499302|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
56499303|NCT00561119|Antiviral Agents|antiviral agents|mesh-ancestor
56499304|NCT00561119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499305|NCT00561119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499306|NCT00561119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499307|NCT00561119|Immunologic Factors|immunologic factors|mesh-ancestor
56499308|NCT00561119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499309|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
56499310|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56499311|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499312|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56499313|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
56499314|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56499315|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499316|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56499317|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56499318|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56499319|NCT00564993|Dobutamine|dobutamine|mesh-list
56499320|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56499321|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
56093629|NCT02892500|Hormones|hormones|mesh-ancestor
56499323|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499324|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499325|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56499326|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56499327|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56499328|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
56499329|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499330|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499331|NCT00564993|Protective Agents|protective agents|mesh-ancestor
56499332|NCT04629209|TIC10 compound|tic10 compound|mesh-list
56499333|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499334|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
56499335|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56499336|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
56251262|NCT01866553|Interferons|interferons|mesh-list
56499337|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499338|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56499339|NCT04604886|Dobutamine|dobutamine|mesh-list
56499340|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56499341|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
56499343|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499344|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499345|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56499346|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56499347|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56499348|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56499349|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499350|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499351|NCT04604886|Protective Agents|protective agents|mesh-ancestor
56499352|NCT04595877|Dipyrone|dipyrone|mesh-list
56499353|NCT04595877|Endorphins|endorphins|mesh-list
56499354|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
56499355|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56499356|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56499357|NCT04595877|Analgesics|analgesics|mesh-ancestor
56499358|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
56499359|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499360|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499361|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499362|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499363|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
56499364|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499365|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499366|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
56499367|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56499368|NCT03454646|Rivastigmine|rivastigmine|mesh-list
56499369|NCT03454646|Donepezil|donepezil|mesh-list
56499370|NCT03454646|Galantamine|galantamine|mesh-list
56499371|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
56499372|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499373|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499374|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
56499375|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499376|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499377|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
56499378|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56499379|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
56499381|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56499382|NCT03454646|Protective Agents|protective agents|mesh-ancestor
56499383|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
56499384|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56499385|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499386|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
56499387|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499388|NCT00566553|Protective Agents|protective agents|mesh-ancestor
56499389|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499390|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56499391|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56499392|NCT01157182|Norethindrone|norethindrone|mesh-list
56499393|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
56499394|NCT01157182|Estradiol|estradiol|mesh-list
56499395|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56499396|NCT01157182|Estrogens|estrogens|mesh-ancestor
56499397|NCT01157182|Hormones|hormones|mesh-ancestor
56499398|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499399|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499400|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56499401|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
56499402|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56499403|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56499404|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56499405|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56499406|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56499407|NCT01157065|Ranibizumab|ranibizumab|mesh-list
56499408|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56499409|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56499410|NCT01157065|Growth Substances|growth substances|mesh-ancestor
56499411|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499412|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
56499413|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499414|NCT00566592|Ethanol|ethanol|mesh-list
56499415|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56499416|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499417|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499418|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499420|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56499421|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
56499422|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56499423|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
56499424|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499425|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499426|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56499427|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56499428|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499430|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56499431|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499432|NCT04628624|Antioxidants|antioxidants|mesh-list
56499433|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499434|NCT04628624|Protective Agents|protective agents|mesh-ancestor
56499435|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499436|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
56499437|NCT04604028|Lenalidomide|lenalidomide|mesh-list
56499438|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499439|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
56499440|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499441|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499442|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56499443|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
56499444|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499445|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499446|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56499447|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56499448|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56499449|NCT04604028|Growth Substances|growth substances|mesh-ancestor
56499450|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
56499451|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
56499452|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499453|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56499454|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
56499455|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56499456|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56499457|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56499458|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499459|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499460|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
56499461|NCT01156363|Hematinics|hematinics|mesh-ancestor
56499462|NCT02884921|Acetaminophen|acetaminophen|mesh-list
56499463|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56499464|NCT02884921|Analgesics|analgesics|mesh-ancestor
56499465|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
56499466|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499467|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499468|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
56499469|NCT00561704|Losartan|losartan|mesh-list
56499470|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56499471|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56499472|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56499473|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56499474|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499476|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56499477|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56499478|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56499479|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56499480|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
56499481|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499482|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499483|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499484|NCT04595409|Ustekinumab|ustekinumab|mesh-list
56499485|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
56499486|NCT04628000|Vitamin D|vitamin d|mesh-list
56499487|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
56499489|NCT04628000|Vitamins|vitamins|mesh-list
56499490|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
56499491|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499492|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56499493|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56499495|NCT01155661|Serotonin|serotonin|mesh-list
56499496|NCT01155661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56499497|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56499498|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
56499499|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499500|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499501|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499502|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56499503|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56499504|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56499505|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499506|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
56499507|NCT00565188|Adenosine|adenosine|mesh-list
56499508|NCT00565188|Analgesics|analgesics|mesh-ancestor
56499509|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
56499510|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499511|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499512|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56499513|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
56499514|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56499515|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
56499516|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
56499517|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499518|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499519|NCT04603833|Docetaxel|docetaxel|mesh-list
56499520|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499521|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
56499522|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
56499523|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
56499524|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499525|NCT04603872|Dasatinib|dasatinib|mesh-list
56499526|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499527|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56499528|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499529|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499530|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
56499531|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56499532|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
56499533|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56499534|NCT04603794|Povidone|povidone|mesh-list
56499535|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56499536|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499537|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
56499538|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
56499539|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
56499540|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
56499541|NCT01155583|Dexamethasone|dexamethasone|mesh-list
56499542|NCT01155583|Lenalidomide|lenalidomide|mesh-list
56499543|NCT01155583|Azacitidine|azacitidine|mesh-list
56499544|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499545|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
56499546|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
56499547|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499548|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499549|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56499550|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
56499552|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499553|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56499554|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499555|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
56499556|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56499557|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56499558|NCT01155583|Growth Substances|growth substances|mesh-ancestor
56499559|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
56499560|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56499561|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
56499562|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499563|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499564|NCT04603131|Vaccines|vaccines|mesh-list
56499565|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
56499566|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499567|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
56499568|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
56499569|NCT04627181|Hematinics|hematinics|mesh-ancestor
56499570|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
56499571|NCT04627181|Vitamins|vitamins|mesh-ancestor
56499572|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
56499573|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499574|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
56499575|NCT04626752|Fludarabine|fludarabine|mesh-list
56499576|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499577|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
56499578|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499579|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499580|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56499581|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
56499582|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499583|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499584|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56499585|NCT01155466|Rasagiline|rasagiline|mesh-list
56499586|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56499587|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499588|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499589|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56499590|NCT01155466|Protective Agents|protective agents|mesh-ancestor
56499591|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499592|NCT00561899|Piperaquine|piperaquine|mesh-list
56499593|NCT00561899|Amodiaquine|amodiaquine|mesh-list
56499594|NCT00561899|Artenimol|artenimol|mesh-list
56499595|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
56499596|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56499597|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56499598|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499599|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
56499600|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56499601|NCT01155388|Hematinics|hematinics|mesh-ancestor
56499602|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56499603|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56499604|NCT01155388|Trace Elements|trace elements|mesh-ancestor
56499605|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
56499606|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499607|NCT00565227|Docetaxel|docetaxel|mesh-list
56499608|NCT00565227|Vorinostat|vorinostat|mesh-list
56499609|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499610|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
56499611|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
56499612|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
56499613|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499614|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56499615|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499616|NCT04602273|Azacitidine|azacitidine|mesh-list
55802552|NCT04134325|Nivolumab|nivolumab|mesh-list
56499617|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56499618|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
56499619|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499620|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499621|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499622|NCT04313764|Bupivacaine|bupivacaine|mesh-list
56499623|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
56499624|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
56499625|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499626|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499627|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
56499628|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499629|NCT04626089|Metformin|metformin|mesh-list
56499630|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56499631|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499632|NCT04601961|Propofol|propofol|mesh-list
56499633|NCT04601961|Sevoflurane|sevoflurane|mesh-list
56499634|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56499635|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499636|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499637|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56499638|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
56499639|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
56499640|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56499641|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56499642|NCT04601688|Dexamethasone|dexamethasone|mesh-list
56499643|NCT04601688|Bevacizumab|bevacizumab|mesh-list
56499644|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56499645|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499646|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56499647|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56499648|NCT04601688|Growth Substances|growth substances|mesh-ancestor
56499649|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499650|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
56499651|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499652|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
56499653|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
56499654|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499655|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56499656|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
56499657|NCT04601688|Hormones|hormones|mesh-ancestor
56499658|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499659|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56499660|NCT01154452|R04929097|r04929097|mesh-list
56499661|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499662|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499663|NCT04313452|Insulin|insulin|mesh-list
56499664|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56499665|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499666|NCT01154218|Crizotinib|crizotinib|mesh-list
56499667|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499668|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56499669|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499670|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499671|NCT04625699|Durvalumab|durvalumab|mesh-list
56499672|NCT04625699|Tremelimumab|tremelimumab|mesh-list
56499673|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56499674|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499675|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
56499676|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56499677|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56499678|NCT04601142|Prednisolone|prednisolone|mesh-list
56499679|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
56499680|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56499681|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
56499683|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
56499684|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
56499685|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499686|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499687|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56499688|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
56499689|NCT04601142|Hormones|hormones|mesh-ancestor
56499690|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499691|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56499692|NCT04601142|Protective Agents|protective agents|mesh-ancestor
56499693|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56499694|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499695|NCT04625543|Paclitaxel|paclitaxel|mesh-list
56499696|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56499697|NCT04625543|Cisplatin|cisplatin|mesh-list
56499698|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56499699|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499700|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
56499701|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
56499702|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
56499703|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499704|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
56499705|NCT04601259|Salicylates|salicylates|mesh-list
56499706|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499707|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
56499708|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
56499709|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
56499710|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56499711|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56499712|NCT04601259|Analgesics|analgesics|mesh-ancestor
56499713|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
56499714|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499715|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499716|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499717|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499718|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56499719|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499720|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499721|NCT00565383|Fentanyl|fentanyl|mesh-list
56499722|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56499723|NCT00565383|Narcotics|narcotics|mesh-ancestor
56499724|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499725|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499726|NCT00565383|Analgesics|analgesics|mesh-ancestor
56499727|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
56499728|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499729|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56499730|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56499731|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
56499732|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
56499733|NCT04625426|Protective Agents|protective agents|mesh-list
56499734|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499735|NCT04625114|Gabexate|gabexate|mesh-list
56499736|NCT04625114|Camostat|camostat|mesh-list
56499737|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
56499738|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499739|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499740|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56499741|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56499742|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
56499743|NCT00567099|Aripiprazole|aripiprazole|mesh-list
56499744|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
56499745|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56499746|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56499747|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56499748|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499749|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499750|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
56499751|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
56499752|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499753|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499754|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56499755|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56499756|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
56499757|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56499758|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56499759|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56499760|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56499761|NCT00567177|Cyclosporine|cyclosporine|mesh-list
56499762|NCT00567177|Cyclosporins|cyclosporins|mesh-list
56499763|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499764|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499765|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499766|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
56499767|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499768|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
56499769|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499770|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
56499771|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499772|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56499773|NCT00567216|Nadolol|nadolol|mesh-list
56499774|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56499775|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56499776|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
56499777|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499778|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499779|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499780|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56499781|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56499782|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
56499783|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
56499784|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499785|NCT00562055|Reboxetine|reboxetine|mesh-list
56499786|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56499787|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56499788|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56499789|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56499790|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499791|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
56499792|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499793|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247809|NCT01844401|Albuterol|albuterol|mesh-list
56499794|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
56499795|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56499796|NCT04624217|Gemcitabine|gemcitabine|mesh-list
56499797|NCT04624217|Paclitaxel|paclitaxel|mesh-list
56499798|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56499799|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499800|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
56499801|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
56499802|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
56499803|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499804|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56499805|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
56499806|NCT04624217|Antiviral Agents|antiviral agents|mesh-ancestor
56499807|NCT04624217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56499808|NCT04624217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499809|NCT04624217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499810|NCT04624217|Immunologic Factors|immunologic factors|mesh-ancestor
56499811|NCT04624217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499812|NCT04623866|Valsartan|valsartan|mesh-list
56499813|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56499814|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56499815|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56499816|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499817|NCT00567372|Bevacizumab|bevacizumab|mesh-list
56499818|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56499819|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499820|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56499821|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56499822|NCT00567372|Growth Substances|growth substances|mesh-ancestor
56499823|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499824|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
56499825|NCT00562133|Insulin|insulin|mesh-list
56499826|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56499827|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
56499828|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56499829|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499830|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56499831|NCT00567411|Apraclonidine|apraclonidine|mesh-list
56499832|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56499833|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56499834|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56499835|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56499836|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
56499837|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499838|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499839|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499840|NCT00562172|Metformin|metformin|mesh-list
56499841|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
56499842|NCT00562172|Glimepiride|glimepiride|mesh-list
56499843|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56499844|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499845|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56499846|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499847|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
56499848|NCT00567450|Ropivacaine|ropivacaine|mesh-list
56499849|NCT00567450|Mepivacaine|mepivacaine|mesh-list
56499850|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
56499851|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
56499852|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56499853|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499854|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
56499855|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499856|NCT00567528|Ibuprofen|ibuprofen|mesh-list
56499857|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56499858|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56499859|NCT00567528|Analgesics|analgesics|mesh-ancestor
56499860|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
56499861|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499862|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499863|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499864|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499865|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56499866|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499867|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247885|NCT01844791|Antiviral Agents|antiviral agents|mesh-ancestor
56499868|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
56499869|NCT00567606|Calcium|calcium|mesh-list
56499870|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56499871|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499872|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56499873|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56499874|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499875|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56499876|NCT04590612|Levodopa|levodopa|mesh-list
56499877|NCT04590612|Carbidopa|carbidopa|mesh-list
56499878|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56499879|NCT04590612|Citalopram|citalopram|mesh-list
56499880|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56499881|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56499882|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56499883|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
56499884|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499885|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499886|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499887|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56499888|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499889|NCT04590612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56499890|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56499891|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56499892|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
56499893|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56499894|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
56499895|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56499896|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56499897|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
56499898|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
56499899|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
56499900|NCT00562250|Glimepiride|glimepiride|mesh-list
56499901|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56499902|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499903|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56499904|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499905|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56499906|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499907|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
56499908|NCT00562289|Aspirin|aspirin|mesh-list
56499909|NCT00562289|Dipyridamole|dipyridamole|mesh-list
56499910|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
56499911|NCT00562289|Apixaban|apixaban|mesh-list
56499912|NCT00562289|Dabigatran|dabigatran|mesh-list
56499913|NCT00562289|Antivitamins K|antivitamins k|mesh-list
56499914|NCT00562289|Clopidogrel|clopidogrel|mesh-list
56499915|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56499916|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56499917|NCT00562289|Analgesics|analgesics|mesh-ancestor
56499918|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
56499919|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499920|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499921|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499922|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499923|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56499924|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56499925|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499926|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56499927|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56499928|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499929|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
56499930|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56499931|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56499932|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56499933|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
56499934|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56499935|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56499936|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
56499937|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56499938|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
56499939|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
56499940|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56499941|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
56499942|NCT04313218|Misoprostol|misoprostol|mesh-list
56499943|NCT04313218|Carbetocin|carbetocin|mesh-list
56499944|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56499945|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
56499946|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56499947|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499948|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56499949|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56499950|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
56499951|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
56499952|NCT00624871|Ibuprofen|ibuprofen|mesh-list
56499953|NCT00624871|Vitamins|vitamins|mesh-ancestor
56499954|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
56499955|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499956|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56499957|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56499958|NCT00624871|Analgesics|analgesics|mesh-ancestor
56499959|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
56499960|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56499961|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499962|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56499963|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56499964|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499965|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499966|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
56499967|NCT00624871|Protective Agents|protective agents|mesh-ancestor
56499968|NCT04623086|Insulin|insulin|mesh-list
56499969|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56499970|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
56499971|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56499972|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499973|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56499974|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499975|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56499976|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499977|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499978|NCT04590183|Prednisolone|prednisolone|mesh-list
56499979|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56499980|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
56499981|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56499982|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
56499983|NCT04590183|Tacrolimus|tacrolimus|mesh-list
56499984|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56499985|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
56499986|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56499987|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
56499988|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56499989|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56499990|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56499991|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56499992|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56499993|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
56499994|NCT04590183|Hormones|hormones|mesh-ancestor
56499995|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56499996|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56499997|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56499998|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
56499999|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
56500000|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500001|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56500002|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56500003|NCT04590183|Protective Agents|protective agents|mesh-ancestor
56500004|NCT04622618|Gabapentin|gabapentin|mesh-list
56500005|NCT04622618|Analgesics|analgesics|mesh-ancestor
56500006|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
56500007|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500008|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500009|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
56500010|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56500011|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56500012|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500013|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500014|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56500015|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56500016|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500017|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500018|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
56500019|NCT04622891|Azithromycin|azithromycin|mesh-list
56500020|NCT04622891|Clarithromycin|clarithromycin|mesh-list
56500021|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56500022|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500023|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56500024|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500025|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500026|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56500027|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56500028|NCT04622579|Rituximab|rituximab|mesh-list
56500029|NCT04622579|Lenalidomide|lenalidomide|mesh-list
56500030|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56500031|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500032|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
56500033|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500034|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56500035|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56500036|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56500037|NCT04622579|Growth Substances|growth substances|mesh-ancestor
56500038|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
56500039|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56500040|NCT01153009|Vortioxetine|vortioxetine|mesh-list
56500041|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56500042|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56500043|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56500044|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56166133|NCT00003462|Busulfan|busulfan|mesh-list
56500045|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500046|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500047|NCT01153009|Analgesics|analgesics|mesh-ancestor
56500048|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
56500049|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500050|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
56500051|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500052|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
56500053|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56500054|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56500055|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500056|NCT01153009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56500057|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
56500058|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56500059|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56500060|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56500061|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56500062|NCT04622111|Metformin|metformin|mesh-list
56500063|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56500064|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500066|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
56500067|NCT01152580|Melatonin|melatonin|mesh-list
56500068|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
56500069|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500070|NCT01152580|Protective Agents|protective agents|mesh-ancestor
56500071|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500072|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500073|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56500074|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
56500075|NCT04621799|Coagulants|coagulants|mesh-ancestor
56500076|NCT04621370|Capecitabine|capecitabine|mesh-list
56500077|NCT04621370|Durvalumab|durvalumab|mesh-list
56500078|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56500079|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
56500080|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500081|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500082|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56251495|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500083|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
56500084|NCT04589130|Naltrexone|naltrexone|mesh-list
56500085|NCT04589130|Bupropion|bupropion|mesh-list
56500086|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56500087|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56500088|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500089|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
56500090|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500091|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56500092|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
56500093|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500094|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56500095|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56500096|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56500097|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500098|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
56500099|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500100|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56166142|NCT00003528|Raltitrexed|raltitrexed|mesh-list
56500101|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56500102|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500103|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56500104|NCT04621487|Amoxicillin|amoxicillin|mesh-list
56500105|NCT04621487|Metronidazole|metronidazole|mesh-list
56500106|NCT04621487|Clarithromycin|clarithromycin|mesh-list
56500107|NCT04621487|Pantoprazole|pantoprazole|mesh-list
56500108|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56500109|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500110|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56500111|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56500112|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56500113|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500114|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500115|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56500116|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56500117|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56500118|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56500119|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56500120|NCT01152190|Tadalafil|tadalafil|mesh-list
56500121|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
56500122|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56500123|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56500124|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500125|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500126|NCT01152190|Urological Agents|urological agents|mesh-ancestor
56500127|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
56500128|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56500129|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56500130|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56500131|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500132|NCT01151410|Enalapril|enalapril|mesh-list
56500133|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56500134|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
56500135|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500136|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753656|NCT03197077|Hormones|hormones|mesh-ancestor
56500137|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56500138|NCT00562406|Ranibizumab|ranibizumab|mesh-list
56500139|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56500140|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56500141|NCT00562406|Growth Substances|growth substances|mesh-ancestor
56500142|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500143|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
56500144|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251511|NCT01868750|Calcitriol|calcitriol|mesh-list
56500145|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
56500146|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56500147|NCT04588935|Bisoprolol|bisoprolol|mesh-list
56500148|NCT04588935|Perindopril|perindopril|mesh-list
56500149|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56500150|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
56500151|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
56500152|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500153|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500154|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56500155|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56500156|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56500157|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
56500158|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500159|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500160|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56500161|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
56500162|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500163|NCT00562523|Sorafenib|sorafenib|mesh-list
56500164|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56166156|NCT00003540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500165|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56500166|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500167|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500168|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
56500169|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56500170|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
56500171|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500172|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56500173|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56500174|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
56500175|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500176|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500177|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56500178|NCT04649697|Clobetasol|clobetasol|mesh-list
56500179|NCT04649697|Rebamipide|rebamipide|mesh-list
56500180|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500181|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
56500182|NCT04649697|Hormones|hormones|mesh-ancestor
56500183|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500184|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500185|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56500186|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56500187|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
56500188|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500189|NCT04649697|Protective Agents|protective agents|mesh-ancestor
56500190|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500191|NCT04649502|Metformin|metformin|mesh-list
56500192|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56500193|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500194|NCT04621253|Dipyrone|dipyrone|mesh-list
56500195|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56500196|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56500197|NCT04621253|Analgesics|analgesics|mesh-ancestor
56500198|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
56500199|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500200|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500201|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500202|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56500203|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
56500204|NCT00567762|Tacrolimus|tacrolimus|mesh-list
56500205|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56500206|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
56500207|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500208|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56500209|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500210|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500211|NCT04620785|Methylene Blue|methylene blue|mesh-list
56500212|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500213|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500214|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
56500215|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56500216|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500217|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56500218|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500219|NCT04691063|Carboplatin|carboplatin|mesh-list
56500220|NCT04691063|Etoposide|etoposide|mesh-list
56500221|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
56500222|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500223|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56500224|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56500225|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56500226|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500227|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500228|NCT05096702|Primaquine|primaquine|mesh-list
56500229|NCT05096702|Tafenoquine|tafenoquine|mesh-list
56500230|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
56500231|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56500232|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56500233|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500234|NCT01151215|Anastrozole|anastrozole|mesh-list
56500235|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56500236|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251557|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251558|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56251559|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56500237|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56500238|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56500239|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500240|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500241|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56500242|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
56500243|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500244|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500245|NCT04588389|Lidocaine|lidocaine|mesh-list
56500246|NCT04588389|Ropivacaine|ropivacaine|mesh-list
56500247|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
56500248|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
56500249|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500250|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500251|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
56500252|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500253|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56500254|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56500255|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56500256|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56500257|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500258|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
56500259|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
56500260|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56500261|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56500262|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56500263|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500264|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56500265|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56500266|NCT04588194|Dexamethasone|dexamethasone|mesh-list
56500267|NCT04588194|Rituximab|rituximab|mesh-list
56500268|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56500269|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500270|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
56500271|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500272|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56500273|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500274|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
56500275|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
56500276|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500277|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56500278|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
56500279|NCT04588194|Hormones|hormones|mesh-ancestor
56500280|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500281|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56500282|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
56500283|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56500284|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56500285|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
56500286|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500287|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500288|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500289|NCT02940314|Urological Agents|urological agents|mesh-ancestor
56500290|NCT04581213|Anesthetics|anesthetics|mesh-list
56500291|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500292|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500293|NCT01151137|Dronedarone|dronedarone|mesh-list
56500294|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56500295|NCT01151098|Buprenorphine|buprenorphine|mesh-list
56500296|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56500297|NCT01151098|Narcotics|narcotics|mesh-ancestor
56500298|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500299|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500300|NCT01151098|Analgesics|analgesics|mesh-ancestor
56500301|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
56500302|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500303|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56500304|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
56500305|NCT04587843|Naltrexone|naltrexone|mesh-list
56500306|NCT04587843|Bupropion|bupropion|mesh-list
56500307|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56500308|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56500309|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500310|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
56500311|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500312|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56500313|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
56500314|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500315|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56500316|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56500317|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56500318|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500319|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
56500320|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500321|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56500322|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56500323|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500324|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56500325|NCT04619303|Dexamethasone|dexamethasone|mesh-list
56500326|NCT04619303|Bevacizumab|bevacizumab|mesh-list
56500327|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56500328|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500329|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56500330|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56500331|NCT04619303|Growth Substances|growth substances|mesh-ancestor
56500332|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500333|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
56500334|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500335|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
56500336|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
56500337|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500338|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56500339|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
56500340|NCT04619303|Hormones|hormones|mesh-ancestor
56500341|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500342|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56500343|NCT04619537|Docetaxel|docetaxel|mesh-list
56500344|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500345|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
56500346|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
56500347|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
56500348|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500349|NCT04619381|Clopidogrel|clopidogrel|mesh-list
56500350|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56500351|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56500352|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56500353|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56500354|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
56500355|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500356|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500357|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500359|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
56500360|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56500361|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
56500362|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500363|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500364|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56500365|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
56500366|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
56500367|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56500368|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
56500369|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500370|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500371|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
56500372|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
56500373|NCT00568542|Hematinics|hematinics|mesh-ancestor
56500374|NCT00562835|Thiamine|thiamine|mesh-list
56500375|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
56500376|NCT00562835|Vitamins|vitamins|mesh-ancestor
56500377|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
56500378|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500379|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500380|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
56500381|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
56500382|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500383|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56500384|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
56500385|NCT00562835|Hormones|hormones|mesh-ancestor
56500386|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500387|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56500388|NCT00562835|Protective Agents|protective agents|mesh-ancestor
56500389|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
56500390|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56500391|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500393|NCT04587141|Hematinics|hematinics|mesh-ancestor
56500394|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56500395|NCT04586790|Epinephrine|epinephrine|mesh-list
56500396|NCT04586790|Racepinephrine|racepinephrine|mesh-list
56500397|NCT04586790|Midodrine|midodrine|mesh-list
56500398|NCT04586790|Norepinephrine|norepinephrine|mesh-list
56500399|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
56500400|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56500401|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56500402|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
56500403|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500404|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500405|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500406|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56500407|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56500408|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
56500409|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500410|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56500411|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56500412|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
56500413|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
56500414|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56500415|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56500416|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
56500417|NCT04586790|Coagulants|coagulants|mesh-ancestor
56500418|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56500419|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
56500420|NCT00568815|Rituximab|rituximab|mesh-list
56500421|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56251627|NCT01869556|Oxytocin|oxytocin|mesh-list
56500422|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500423|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
56500424|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500425|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56500426|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56500427|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500428|NCT00568971|Docetaxel|docetaxel|mesh-list
56500429|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500430|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
56500431|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
56500432|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
56500433|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500434|NCT00562913|Sorafenib|sorafenib|mesh-list
56500435|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500436|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56500437|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500438|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500439|NCT00569088|Mannitol|mannitol|mesh-list
56500440|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56500441|NCT00569088|Diuretics|diuretics|mesh-ancestor
56500442|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
56500443|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500444|NCT04586088|Apatinib|apatinib|mesh-list
56500445|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500446|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56500447|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500448|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500449|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56500450|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56166238|NCT00003594|Leucovorin|leucovorin|mesh-list
56500451|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500452|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
56500453|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56500454|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
56500455|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500456|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
56500457|NCT04586361|Protective Agents|protective agents|mesh-ancestor
56500458|NCT04618952|Calcium|calcium|mesh-list
56500459|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56500460|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500461|NCT04619069|Hormones|hormones|mesh-list
56500462|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500463|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500464|NCT04585932|Leuprolide|leuprolide|mesh-list
56248506|NCT01848743|Tenofovir|tenofovir|mesh-list
56500465|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56500466|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
56500467|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56500468|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500469|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56500470|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500472|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56500473|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56500474|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500475|NCT04618367|Lenvatinib|lenvatinib|mesh-list
56500476|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500477|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56500478|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500479|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500480|NCT00562952|Telmisartan|telmisartan|mesh-list
56500481|NCT00562952|Bisoprolol|bisoprolol|mesh-list
56500482|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56500483|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56500484|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56500485|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500486|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
56500487|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
56500488|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500489|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500490|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56500491|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56500492|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56500493|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
56500494|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500495|NCT05035316|Aspirin|aspirin|mesh-list
56500496|NCT05035316|Calcium|calcium|mesh-list
56500497|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56500498|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500499|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56500500|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56500501|NCT05035316|Analgesics|analgesics|mesh-ancestor
56500502|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
55802557|NCT05474053|Ticagrelor|ticagrelor|mesh-list
56500503|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500504|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500505|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56500506|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56166254|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500508|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500509|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56500510|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56500511|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500513|NCT04618601|Spironolactone|spironolactone|mesh-list
56500514|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56251678|NCT01869907|Minocycline|minocycline|mesh-list
56500515|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
56500516|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500517|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500518|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56500519|NCT04618601|Diuretics|diuretics|mesh-ancestor
56500520|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
56500521|NCT00567918|Tacrolimus|tacrolimus|mesh-list
56500522|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56500523|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
56500524|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500525|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56500526|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500527|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500528|NCT00569712|Budesonide|budesonide|mesh-list
56500529|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
56500530|NCT00569712|Dimercaprol|dimercaprol|mesh-list
56500531|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500532|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56500533|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
56500534|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500535|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500536|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56500537|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
56500538|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
56500539|NCT00569712|Hormones|hormones|mesh-ancestor
56248572|NCT01849094|Milrinone|milrinone|mesh-list
56500540|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500541|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56500542|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56500543|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56500544|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
56500545|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500546|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500547|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
56500548|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
56500549|NCT00569751|Paclitaxel|paclitaxel|mesh-list
56500550|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56500551|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500552|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
56500553|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
56500554|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
56500555|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500556|NCT00569790|Bevacizumab|bevacizumab|mesh-list
56500557|NCT00569790|Irinotecan|irinotecan|mesh-list
56500558|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56500559|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500560|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56500561|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56500562|NCT00569790|Growth Substances|growth substances|mesh-ancestor
56500563|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500564|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
56500565|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56500566|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56500567|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166272|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500568|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500569|NCT00567957|Remifentanil|remifentanil|mesh-list
56500570|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56500571|NCT00567957|Narcotics|narcotics|mesh-ancestor
56500572|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500573|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500574|NCT00567957|Analgesics|analgesics|mesh-ancestor
56500575|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
56500576|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500577|NCT02940002|Betamethasone|betamethasone|mesh-list
56500578|NCT02940002|Clobetasol|clobetasol|mesh-list
56500579|NCT02940002|Calcipotriene|calcipotriene|mesh-list
56500580|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500581|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
56500582|NCT02940002|Hormones|hormones|mesh-ancestor
56500583|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500584|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500585|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56500586|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
56500587|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
56500588|NCT04618328|Tretinoin|tretinoin|mesh-list
56500589|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500590|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
56500591|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
56500592|NCT04617782|Donepezil|donepezil|mesh-list
56500593|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56500594|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500595|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500596|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
56500597|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500598|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500599|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
56500600|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
56500601|NCT00569985|Carmustine|carmustine|mesh-list
56500602|NCT00569985|Etoposide|etoposide|mesh-list
56500603|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
56500604|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56500605|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
56500606|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500607|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56500608|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56500609|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
56500610|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500611|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500612|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56500613|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56500614|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56500615|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56500616|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500617|NCT04617626|Azithromycin|azithromycin|mesh-list
56500618|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56500619|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500620|NCT04585230|Mineral Oil|mineral oil|mesh-list
56500621|NCT04585230|Emollients|emollients|mesh-ancestor
56500622|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
56500623|NCT00570180|Bortezomib|bortezomib|mesh-list
56500624|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500625|NCT02939846|Trametinib|trametinib|mesh-list
56500626|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500627|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56500628|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500629|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500630|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
56500631|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
56500632|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56500633|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56500634|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500635|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500636|NCT02939495|Urological Agents|urological agents|mesh-ancestor
56500637|NCT00570219|Valproic Acid|valproic acid|mesh-list
56500638|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
56500639|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500640|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500641|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
56500642|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500643|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500644|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
56500645|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56500646|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500647|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500648|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56500649|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500650|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56500651|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500652|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500653|NCT00568074|Repaglinide|repaglinide|mesh-list
56500654|NCT00568074|Acarbose|acarbose|mesh-list
56500655|NCT00568074|Gliquidone|gliquidone|mesh-list
56500656|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56500657|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500658|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56500659|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500660|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500661|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
56500662|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56500663|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
56500664|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500665|NCT00568113|Expectorants|expectorants|mesh-ancestor
56500666|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
56500667|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56500668|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
56500669|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500670|NCT00568113|Protective Agents|protective agents|mesh-ancestor
56500671|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500672|NCT00568113|Antidotes|antidotes|mesh-ancestor
56500673|NCT00568152|Aspirin|aspirin|mesh-list
56500674|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56500675|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56500676|NCT00568152|Analgesics|analgesics|mesh-ancestor
56500677|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
56500678|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500679|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500680|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500681|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56500682|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56500683|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56500684|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500685|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56500686|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56500687|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500688|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
56500689|NCT04610879|Carbamazepine|carbamazepine|mesh-list
56500690|NCT04610879|Levetiracetam|levetiracetam|mesh-list
56500691|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
56500692|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
56500693|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
56500694|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56500695|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500696|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500697|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500698|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56500699|NCT04610879|Analgesics|analgesics|mesh-ancestor
56500700|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
56500701|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500702|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56500703|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56500704|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500705|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56500706|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56500707|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56500708|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
56500709|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56500710|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
56500711|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56500712|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500713|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56500714|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56500715|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500716|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
56500717|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56500718|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
56500719|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500720|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
56500721|NCT00570648|Protective Agents|protective agents|mesh-ancestor
56500722|NCT00570726|Ranibizumab|ranibizumab|mesh-list
56500723|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56500724|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56500725|NCT00570726|Growth Substances|growth substances|mesh-ancestor
56251814|NCT01870284|Adalimumab|adalimumab|mesh-list
56500726|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500727|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
56500728|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500729|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
56500730|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56500731|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56500733|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56500734|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56500735|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500736|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500737|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56500738|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56500739|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500740|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56500741|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
56500742|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
56500743|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
56500744|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
56500745|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500746|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500747|NCT04580355|Amoxicillin|amoxicillin|mesh-list
56500748|NCT04580355|Metronidazole|metronidazole|mesh-list
56500749|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56500750|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500751|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56500752|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56500753|NCT00563108|Basiliximab|basiliximab|mesh-list
56500754|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56500755|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
56166315|NCT00003666|Irofulven|irofulven|mesh-list
56500756|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500758|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500759|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56500760|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56500761|NCT00570882|Growth Substances|growth substances|mesh-ancestor
56500762|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500763|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
56248790|NCT01851005|Analgesics|analgesics|mesh-ancestor
56500764|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56500765|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500766|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500767|NCT00563147|Sirolimus|sirolimus|mesh-list
56500768|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56500769|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500770|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56500771|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500772|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
56500773|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56500774|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
56500775|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500776|NCT00570999|Mitogens|mitogens|mesh-list
56500777|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
56500778|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500779|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
56500780|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56500781|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
56500782|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500783|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500784|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56500785|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
56500786|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56500787|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56500788|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56500789|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
56500790|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500791|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500792|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
56500793|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56500794|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500795|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
56500796|NCT00571116|Disulfiram|disulfiram|mesh-list
56500797|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754119|NCT02473601|Mivacurium|mivacurium|mesh-list
56500799|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56500801|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500802|NCT00571155|Levetiracetam|levetiracetam|mesh-list
56500803|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
56500804|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
56500805|NCT04615481|Metronidazole|metronidazole|mesh-list
56500806|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500807|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56500808|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56500809|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56500810|NCT04615403|Travoprost|travoprost|mesh-list
56500811|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56500812|NCT04614584|Mirtazapine|mirtazapine|mesh-list
56500813|NCT04614584|Methamphetamine|methamphetamine|mesh-list
56500814|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
56500815|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500816|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56500817|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
56500818|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
56500819|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500820|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500821|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500822|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56500823|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56251897|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
56500824|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500825|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56500826|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56500827|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56500828|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
56500829|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56500830|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56500831|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
56500832|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56500833|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56500834|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
56500835|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
56500836|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500837|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
56500838|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56500839|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56500840|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56500841|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56500843|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500844|NCT00571506|Pioglitazone|pioglitazone|mesh-list
56500845|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
56500846|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56500847|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500848|NCT04614194|Letrozole|letrozole|mesh-list
56500849|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500850|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56500851|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56500852|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56500853|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500854|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56500855|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
56500856|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500857|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500858|NCT04613609|Nicotine|nicotine|mesh-list
56500859|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56500860|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
56500861|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500862|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500863|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56500864|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56500865|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
56500866|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500867|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500868|NCT00571740|Leucovorin|leucovorin|mesh-list
56500869|NCT00571740|Bevacizumab|bevacizumab|mesh-list
56500870|NCT00571740|Cetuximab|cetuximab|mesh-list
56166346|NCT00003690|Alvocidib|alvocidib|mesh-list
56500871|NCT00571740|Fluorouracil|fluorouracil|mesh-list
56500872|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
56500873|NCT00571740|Calcium|calcium|mesh-list
56500874|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
56500875|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56500876|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500877|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56500878|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56500879|NCT00571740|Growth Substances|growth substances|mesh-ancestor
56500880|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500881|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
56500882|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56500883|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
56500884|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500885|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56500886|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56500887|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
56500888|NCT00571740|Antidotes|antidotes|mesh-ancestor
56500889|NCT00571740|Protective Agents|protective agents|mesh-ancestor
56500890|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
56500891|NCT00571740|Vitamins|vitamins|mesh-ancestor
56500892|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
56500893|NCT00563342|Ethanol|ethanol|mesh-list
56500894|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56500895|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500896|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500897|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500898|NCT04583046|Iloprost|iloprost|mesh-list
56500899|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56500900|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
56500901|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56500902|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56500903|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500904|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251963|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56251964|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
56500905|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56500906|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56500907|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500908|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
56500909|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500910|NCT04613726|Ondansetron|ondansetron|mesh-list
56500911|NCT04613726|Granisetron|granisetron|mesh-list
56500912|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
56500913|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
56500914|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500915|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248946|NCT01851941|Vitamins|vitamins|mesh-ancestor
56500916|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56500917|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
56500918|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
56500919|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56500920|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
56500921|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500922|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500923|NCT04613726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56500924|NCT04613726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56500925|NCT04613726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500926|NCT04613726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56500927|NCT04613726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56500928|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56500929|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500930|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500931|NCT04613102|Cannabidiol|cannabidiol|mesh-list
56500932|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
56500933|NCT04613219|Tofacitinib|tofacitinib|mesh-list
56500934|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56500936|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500937|NCT00563615|Tegaserod|tegaserod|mesh-list
56500938|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56500939|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
56500940|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500941|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500942|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500943|NCT00563654|Alfuzosin|alfuzosin|mesh-list
56500944|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56500945|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56500946|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56500948|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56500949|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500950|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500951|NCT00563654|Urological Agents|urological agents|mesh-ancestor
56500952|NCT04613180|Montelukast|montelukast|mesh-list
56500953|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56500954|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
56500955|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56500956|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
56500957|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56500958|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500959|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56500960|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56500961|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56500962|NCT00571935|Insulin|insulin|mesh-list
56500963|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56500964|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
56500965|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56500966|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500967|NCT00572013|Rituximab|rituximab|mesh-list
56500968|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56500969|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56500970|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
56500971|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500972|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56500973|NCT04612634|Vaccines|vaccines|mesh-list
56500974|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
56500975|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500976|NCT04612556|Vaccines|vaccines|mesh-list
56500977|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
56500978|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500979|NCT04580199|Ethanol|ethanol|mesh-list
56500980|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56500981|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56500982|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56500983|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500984|NCT00568347|Fluticasone|fluticasone|mesh-list
56500985|NCT00568347|Xhance|xhance|mesh-list
56500986|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56500987|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56500988|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56500989|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56500990|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
56500991|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56500992|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56500993|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56500994|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
56500995|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
56500996|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56500997|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56500998|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56500999|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56501000|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
56501001|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501002|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501003|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
56501004|NCT00568347|Hormones|hormones|mesh-ancestor
55874112|NCT01163656|Cobalt|cobalt|mesh-list
56501005|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501006|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
56501007|NCT04611971|Belimumab|belimumab|mesh-list
56501008|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501009|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
56501010|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501011|NCT00572208|Gabapentin|gabapentin|mesh-list
56501012|NCT00572208|Analgesics|analgesics|mesh-ancestor
56501013|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
56501014|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501015|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501016|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
56501017|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56501018|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56501019|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56501020|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56501021|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56501022|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56501023|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501024|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501025|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
56501026|NCT00572364|Olaparib|olaparib|mesh-list
56501027|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56501028|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501029|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501030|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501031|NCT00563771|Rasburicase|rasburicase|mesh-list
56501032|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
56501033|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501034|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56501035|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56501036|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56501037|NCT04582032|Analgesics|analgesics|mesh-ancestor
56501038|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
56501039|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501040|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501041|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501042|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501043|NCT00563849|Leflunomide|leflunomide|mesh-list
56501044|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501045|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501046|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501047|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
56501048|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501049|NCT04581876|Paclitaxel|paclitaxel|mesh-list
56501050|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56501051|NCT04581876|Raltitrexed|raltitrexed|mesh-list
56501052|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56501053|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501054|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
56501055|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
56501056|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
56501057|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501058|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56501059|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
56501060|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56501061|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501062|NCT00563927|Fluorouracil|fluorouracil|mesh-list
56501063|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249095|NCT01852994|Hormones|hormones|mesh-ancestor
56501065|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501066|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56501067|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501068|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
56501069|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501070|NCT01150123|Vaccines|vaccines|mesh-list
56501071|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
56501072|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501073|NCT00572559|Vancomycin|vancomycin|mesh-list
56501074|NCT00572559|Linezolid|linezolid|mesh-list
56501075|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56501076|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252107|NCT01871844|Hormones|hormones|mesh-ancestor
56501077|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56501078|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501079|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501080|NCT04611464|Misoprostol|misoprostol|mesh-list
56501081|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56501082|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
56501083|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56501084|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501085|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56501086|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501087|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
56501088|NCT04611776|Gemcitabine|gemcitabine|mesh-list
56501089|NCT04611776|Paclitaxel|paclitaxel|mesh-list
56501090|NCT04611776|Carboplatin|carboplatin|mesh-list
56501091|NCT04611776|Pemetrexed|pemetrexed|mesh-list
56501092|NCT04611776|Atezolizumab|atezolizumab|mesh-list
56501093|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56501094|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501095|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
56501096|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
56501097|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
56501098|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501099|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56501100|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
56501101|NCT04611776|Antiviral Agents|antiviral agents|mesh-ancestor
56501102|NCT04611776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501103|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501104|NCT04611776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501105|NCT04611776|Immunologic Factors|immunologic factors|mesh-ancestor
56501106|NCT04611776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501107|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56252192|NCT01872026|ASP7991|asp7991|mesh-list
56501108|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56501109|NCT00572637|Delanzomib|delanzomib|mesh-list
56501110|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
56501111|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
56501112|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501113|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501114|NCT01149655|Aripiprazole|aripiprazole|mesh-list
56501115|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
56501116|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56501117|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56166394|NCT00003732|Paclitaxel|paclitaxel|mesh-list
56501118|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56501119|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56501120|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501121|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
56501122|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
56501123|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501124|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501125|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56501126|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56501127|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
56501128|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56501129|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56501130|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56501131|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56501132|NCT00575406|Prednisolone|prednisolone|mesh-list
56501133|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
56501134|NCT00575406|Rituximab|rituximab|mesh-list
56501135|NCT00575406|Doxorubicin|doxorubicin|mesh-list
56501136|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56501137|NCT00575406|Vincristine|vincristine|mesh-list
56501138|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501139|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
56501140|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501141|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501142|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56501143|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
56501144|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501145|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501146|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56501147|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56501148|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56501149|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56501150|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56501151|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501152|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501153|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
56501154|NCT00575406|Hormones|hormones|mesh-ancestor
56501155|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501156|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56501157|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56501158|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
56252369|NCT01872897|Antacids|antacids|mesh-ancestor
56501159|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
56501160|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
56501161|NCT01149538|Choline|choline|mesh-list
56501162|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
56501163|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56501164|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
56501165|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501166|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501167|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56501168|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
56501169|NCT01149460|Valacyclovir|valacyclovir|mesh-list
56501170|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
56501171|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501172|NCT00575523|Atropine|atropine|mesh-list
56501173|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56501174|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56501175|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56166406|NCT00003744|Gemcitabine|gemcitabine|mesh-list
56501176|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
56501177|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501178|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501179|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56501180|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
56501181|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
56501182|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
56501183|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56501184|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56501185|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
56501186|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501187|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501188|NCT01149421|Dulaglutide|dulaglutide|mesh-list
56501189|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56501190|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501191|NCT00575601|Simvastatin|simvastatin|mesh-list
56501192|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56501193|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56501194|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
56501195|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501196|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56501197|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56501198|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501199|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56501200|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56501201|NCT04600271|Norepinephrine|norepinephrine|mesh-list
56501203|NCT04600271|Diuretics|diuretics|mesh-list
56501204|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
56501205|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501206|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501207|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
56501208|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56501209|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56501210|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
56501211|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501212|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501213|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
56249244|NCT01854424|Dimercaprol|dimercaprol|mesh-list
56501214|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
56501215|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56501216|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56501217|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501218|NCT00575640|Hydralazine|hydralazine|mesh-list
56501219|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56501220|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
56501221|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
56501222|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501223|NCT04579731|Lactitol|lactitol|mesh-list
56501224|NCT04579731|Cathartics|cathartics|mesh-ancestor
56501225|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501226|NCT00565487|Capecitabine|capecitabine|mesh-list
56501227|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56501228|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56501229|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
56501230|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501231|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501232|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56501233|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501234|NCT04600115|Adenosine|adenosine|mesh-list
56501235|NCT04600115|Regadenoson|regadenoson|mesh-list
56501236|NCT04600115|Analgesics|analgesics|mesh-ancestor
56501237|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
56501238|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501239|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501240|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56501241|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
56501242|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56501243|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
56501244|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
56501245|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501246|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501247|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56501248|NCT04600037|Pregabalin|pregabalin|mesh-list
56501249|NCT04600037|Analgesics|analgesics|mesh-ancestor
56501250|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
56501251|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501252|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501253|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
56501254|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56501255|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56501256|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501257|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56501258|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56501259|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56501260|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56501261|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56501262|NCT00575796|Vinblastine|vinblastine|mesh-list
56501263|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56501264|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501265|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
56501266|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
56501267|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
56501268|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501269|NCT00575835|Vitamin D|vitamin d|mesh-list
56501270|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
56501271|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
56501272|NCT00575835|Vitamins|vitamins|mesh-list
56501273|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
56501274|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501275|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56501276|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56501277|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56501278|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56501279|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
56501280|NCT00575874|Pioglitazone|pioglitazone|mesh-list
56501281|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56501282|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501283|NCT03454217|Oxycodone|oxycodone|mesh-list
56501284|NCT03454217|Tramadol|tramadol|mesh-list
56501285|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56501286|NCT03454217|Narcotics|narcotics|mesh-ancestor
56501287|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56501288|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501289|NCT03454217|Analgesics|analgesics|mesh-ancestor
56501290|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
56501291|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501292|NCT00575913|Alfuzosin|alfuzosin|mesh-list
56501293|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56501294|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56501295|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56501296|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
56501297|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501298|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501299|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501300|NCT00575913|Urological Agents|urological agents|mesh-ancestor
56501301|NCT04579302|Bupivacaine|bupivacaine|mesh-list
56501302|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
56501303|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
56501304|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56501305|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501306|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
56501307|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501309|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56501310|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56501311|NCT00565682|Analgesics|analgesics|mesh-ancestor
56501312|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
56501313|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501314|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501315|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501316|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501317|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56501318|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56501319|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501320|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501321|NCT00575952|Paclitaxel|paclitaxel|mesh-list
56501322|NCT00575952|Doxorubicin|doxorubicin|mesh-list
56501323|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56501324|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56501325|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501326|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
56501327|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
56501328|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
56501329|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501330|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56501331|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56501332|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56501333|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501334|NCT00573417|Modafinil|modafinil|mesh-list
56501335|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56501336|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501337|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56501338|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56501339|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56501340|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501341|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
56501342|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56501343|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
56501344|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501345|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501346|NCT00565955|Montelukast|montelukast|mesh-list
56501347|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56501348|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
56501349|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56501350|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
56501351|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501352|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501353|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56501354|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56501355|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501356|NCT04598594|Nicotine|nicotine|mesh-list
56501357|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56501358|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
56501359|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501360|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501361|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56501362|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56501363|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
56501364|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501365|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501366|NCT00576069|Fluticasone|fluticasone|mesh-list
56501367|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
56501368|NCT00576069|Prednisone|prednisone|mesh-list
56501369|NCT00576069|Budesonide|budesonide|mesh-list
56501370|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
56501371|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56501372|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56501373|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56501374|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501375|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
56501376|NCT00576069|Hormones|hormones|mesh-ancestor
55802574|NCT04330729|Aspirin|aspirin|mesh-list
55754688|NCT05727371|Hylan|hylan|mesh-list
56501377|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501378|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501379|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56501380|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501381|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56501382|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
56501383|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501384|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56501385|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
56501386|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
56501387|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56501388|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56501389|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56501390|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56501391|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
56501392|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501393|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501394|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
56501395|NCT00573690|Carboplatin|carboplatin|mesh-list
56501396|NCT00573690|Etoposide|etoposide|mesh-list
56501397|NCT00573690|Pemetrexed|pemetrexed|mesh-list
56501398|NCT00573690|Sorafenib|sorafenib|mesh-list
56501399|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501400|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56501401|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56501402|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56501403|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501404|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501405|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56501406|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56501407|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56501408|NCT00576225|Paclitaxel|paclitaxel|mesh-list
56501409|NCT00576225|Carboplatin|carboplatin|mesh-list
56501410|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56501411|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56501412|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501413|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
56501414|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
56501415|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
56501416|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501417|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
56501418|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56501419|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501420|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56501421|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501422|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
56501423|NCT00576459|Hormones|hormones|mesh-ancestor
56501424|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501425|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501426|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
56501427|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
56501428|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56501429|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56501430|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501431|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56166450|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501432|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501433|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501434|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56501435|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
56249473|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
56501436|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501437|NCT00573885|Protective Agents|protective agents|mesh-ancestor
56501438|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501439|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56501440|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56501441|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501442|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56501444|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56501445|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501446|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
56501447|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56501448|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56501449|NCT00573924|Lansoprazole|lansoprazole|mesh-list
56501450|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
56501451|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56501452|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56501453|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501454|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501455|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501457|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
56501458|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
56501459|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56501460|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501461|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
56501462|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501463|NCT00576615|Propofol|propofol|mesh-list
56501464|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56501465|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56501466|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501467|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56501468|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
56252635|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56252643|NCT01874574|Hylan|hylan|mesh-list
56501469|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
56501470|NCT00574041|Interferons|interferons|mesh-list
56501471|NCT00574041|Interferon-beta|interferon-beta|mesh-list
56501472|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
56501473|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501474|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
56501475|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501476|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
56501477|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501478|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56501479|NCT00566267|Simvastatin|simvastatin|mesh-list
56501480|NCT00566267|Ezetimibe|ezetimibe|mesh-list
56501481|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56501482|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56501483|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
56501484|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501485|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56501486|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56501487|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501488|NCT00574353|Misonidazole|misonidazole|mesh-list
56501489|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501490|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56501491|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56501492|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501493|NCT04596839|Remdesivir|remdesivir|mesh-list
56501494|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
56252693|NCT01874964|Narcotics|narcotics|mesh-ancestor
56252694|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252695|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252696|NCT01874964|Analgesics|analgesics|mesh-ancestor
56252697|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
56252698|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252699|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
56252700|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
56252701|NCT01875107|Insulin|insulin|mesh-list
56252702|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56252703|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501495|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501496|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
56501497|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501499|NCT00574470|Daclizumab|daclizumab|mesh-list
56501500|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
56501501|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501502|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501503|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501504|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
56501505|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501506|NCT00577161|Vidarabine|vidarabine|mesh-list
56501507|NCT00577161|Rituximab|rituximab|mesh-list
56501508|NCT00577161|Fludarabine|fludarabine|mesh-list
56501509|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
56501510|NCT00577161|Pixantrone|pixantrone|mesh-list
56501511|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56501512|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501513|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
56501514|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501515|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501516|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56501517|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
56501518|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501519|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501520|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
56501521|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501522|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56501523|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56501524|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501525|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
56501526|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501528|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56501529|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56501530|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501531|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501532|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
56501533|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501534|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56501535|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56501536|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56501537|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56501538|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56501539|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56501540|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
56501542|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
56501543|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
56501544|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501545|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501546|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56501547|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56252734|NCT01875224|Abatacept|abatacept|mesh-list
56252735|NCT01875224|Tacrolimus|tacrolimus|mesh-list
56252736|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252737|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
56252738|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252739|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56252740|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252741|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252742|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56252743|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252744|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753536|NCT02481323|Protective Agents|protective agents|mesh-ancestor
56501548|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56501549|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56501550|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
56501551|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501552|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501553|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501554|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56501555|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56501556|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
56501557|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501558|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
56501559|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56501560|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501561|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56501562|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
56501563|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56501564|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501565|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501566|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501567|NCT04595825|Antibodies|antibodies|mesh-list
56501568|NCT04595825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56501569|NCT04595825|Immunologic Factors|immunologic factors|mesh-ancestor
56501570|NCT04595825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501571|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56501572|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56501573|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501574|NCT04595318|Varenicline|varenicline|mesh-list
56501575|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56501576|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56501577|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
56501578|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501579|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501580|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501581|NCT00577668|Thalidomide|thalidomide|mesh-list
56501582|NCT00577668|Dexamethasone|dexamethasone|mesh-list
56501583|NCT00577668|Melphalan|melphalan|mesh-list
56501584|NCT00577668|Bortezomib|bortezomib|mesh-list
56501585|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501586|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
56501587|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
56501588|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501589|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501590|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501591|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
56501592|NCT00577668|Hormones|hormones|mesh-ancestor
56501593|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501594|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56501595|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501596|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56501597|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
56501598|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501599|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56501600|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501601|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
56501602|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
56501603|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56501604|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501605|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56501606|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56501607|NCT00577668|Growth Substances|growth substances|mesh-ancestor
56501608|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
56501610|NCT01147744|Xhance|xhance|mesh-list
56501611|NCT01147744|Montelukast|montelukast|mesh-list
56501612|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501613|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56501614|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
56501615|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501616|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501617|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56501618|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
56501619|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56501620|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56501621|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56501622|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
56501623|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501624|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56501625|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56501626|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501627|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56501628|NCT04313374|Morphine|morphine|mesh-list
56501629|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56501630|NCT04313374|Narcotics|narcotics|mesh-ancestor
56501631|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56501632|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501633|NCT04313374|Analgesics|analgesics|mesh-ancestor
56501634|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
56501635|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501636|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56501637|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56501638|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501639|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501640|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56501641|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56501642|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56252745|NCT01875263|Levofloxacin|levofloxacin|mesh-list
56252746|NCT01875263|Ofloxacin|ofloxacin|mesh-list
56252747|NCT01875263|Cloxacillin|cloxacillin|mesh-list
56252748|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56252749|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252750|NCT01875263|Renal Agents|renal agents|mesh-ancestor
56252751|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252752|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56252753|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56252754|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252755|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252756|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501643|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56501644|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501645|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501646|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501647|NCT04313335|Analgesics|analgesics|mesh-ancestor
56501648|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
56501649|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501650|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
56501651|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56501652|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
56501653|NCT00577980|Testosterone|testosterone|mesh-list
56501654|NCT00577980|Androgens|androgens|mesh-ancestor
56501655|NCT00577980|Hormones|hormones|mesh-ancestor
56501656|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501657|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501658|NCT04594343|Disulfiram|disulfiram|mesh-list
56501659|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56501660|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56501661|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501662|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501664|NCT01147393|Veltuzumab|veltuzumab|mesh-list
56501665|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56501666|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56501667|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501668|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
56252767|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56252768|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252769|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56252770|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252771|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252772|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
56252773|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252774|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56252775|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252789|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252790|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252791|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252792|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252793|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252794|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252795|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252796|NCT01875926|Gontivimab|gontivimab|mesh-list
56252799|NCT01875952|Isoniazid|isoniazid|mesh-list
56501669|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
56501670|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501671|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
56501672|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56501673|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56501674|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56501675|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56501676|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501677|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
56501678|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501679|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501680|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56501681|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501683|NCT00578370|Betamethasone|betamethasone|mesh-list
56501684|NCT00578370|Calcipotriene|calcipotriene|mesh-list
56501685|NCT00578370|Cyclosporins|cyclosporins|mesh-list
56501686|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501687|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501688|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501689|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
56501690|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501691|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
56501692|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56501693|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
56501694|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501695|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56501696|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501697|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
56501698|NCT00578370|Hormones|hormones|mesh-ancestor
56501699|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501700|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56501701|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
56501702|NCT04593836|Peppermint oil|peppermint oil|mesh-list
56501703|NCT04593836|Menthol|menthol|mesh-list
56501704|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
56501705|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
56501706|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
56501707|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
56501708|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501709|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501710|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501711|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
56501712|NCT04593524|Vitamin D|vitamin d|mesh-list
56501713|NCT04593524|Vitamins|vitamins|mesh-ancestor
56501714|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
56501715|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501716|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56501717|NCT00578526|Sunitinib|sunitinib|mesh-list
56501718|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501719|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56501720|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56501721|NCT00578526|Growth Substances|growth substances|mesh-ancestor
56501722|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501723|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
56501724|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56501725|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501726|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501727|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
56501728|NCT04593446|Cathartics|cathartics|mesh-ancestor
56501729|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501730|NCT00566891|Tirofiban|tirofiban|mesh-list
56501731|NCT00566891|Clopidogrel|clopidogrel|mesh-list
56501732|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56501733|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56501734|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56249771|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501735|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56501736|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
56501737|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501738|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501739|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501740|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56501741|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56501742|NCT00578721|Aspirin|aspirin|mesh-list
56501743|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56501744|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56501746|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
56501747|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501748|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501749|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501750|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501751|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56501752|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56501753|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501754|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56501755|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56501756|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501757|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
56501758|NCT00578760|Aspirin|aspirin|mesh-list
56501759|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56501760|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56501761|NCT00578760|Analgesics|analgesics|mesh-ancestor
56501762|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
56501763|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501764|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501765|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501766|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501767|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56501768|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56501769|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501770|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56501771|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56501772|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501773|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
56501774|NCT04592822|Dabigatran|dabigatran|mesh-list
56501775|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
56501776|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56501777|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
56501778|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501779|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501780|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
56501781|NCT00567047|Vildagliptin|vildagliptin|mesh-list
56501782|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56501783|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501784|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56501785|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
56501786|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501787|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501788|NCT04592666|Carboplatin|carboplatin|mesh-list
56501789|NCT04592666|Pemetrexed|pemetrexed|mesh-list
56501790|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501791|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501792|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501793|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56501794|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56501795|NCT04593056|Warfarin|warfarin|mesh-list
56501796|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
56501797|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
56501798|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56501799|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
56501800|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56501801|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
56501802|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501803|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501804|NCT04592198|Palonosetron|palonosetron|mesh-list
56501805|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
56501806|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
56501807|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501808|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249846|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
56501809|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501810|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56501811|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56501812|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
56501813|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501814|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501815|NCT04592081|Dexamethasone|dexamethasone|mesh-list
56501816|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
56501817|NCT04592081|BB 1101|bb 1101|mesh-list
56501818|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56501819|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
56501820|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
56501821|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501822|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501823|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56501824|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
56501825|NCT04592081|Hormones|hormones|mesh-ancestor
56501826|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501827|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56501828|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501829|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
56501830|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501831|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501832|NCT00579969|Timolol|timolol|mesh-list
56501833|NCT00579969|Latanoprost|latanoprost|mesh-list
56501834|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56501835|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56501836|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
56501837|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501838|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501839|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501840|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56501841|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56501842|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56501843|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56501844|NCT04591847|Vitamin D|vitamin d|mesh-list
56501845|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
56501846|NCT04591847|Vitamins|vitamins|mesh-ancestor
56501847|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
56501848|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501849|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56501850|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56501851|NCT04591535|Levodopa|levodopa|mesh-list
56501852|NCT04591535|Carbidopa|carbidopa|mesh-list
56501853|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56166554|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
56501854|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56501855|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56501856|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
56501857|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501858|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501859|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501860|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56501861|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501862|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56501863|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
56501864|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
56501865|NCT00580242|Lenalidomide|lenalidomide|mesh-list
56501866|NCT00580242|Bortezomib|bortezomib|mesh-list
56501867|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
56501868|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501869|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56501870|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56501871|NCT00580242|Growth Substances|growth substances|mesh-ancestor
56501872|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56501873|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252809|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56252810|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
56252811|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56252812|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252813|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56252814|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
56252816|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501874|NCT04591457|Insulin|insulin|mesh-list
56501875|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56501876|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
56501877|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56501878|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501879|NCT00580320|Bortezomib|bortezomib|mesh-list
56501880|NCT00580320|Dacarbazine|dacarbazine|mesh-list
56501881|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501882|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56501883|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
56501884|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501885|NCT00580359|Capecitabine|capecitabine|mesh-list
56501886|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56501887|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
56501888|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501889|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501890|NCT00580437|Dobutamine|dobutamine|mesh-list
56501891|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56501892|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
56501893|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
56501894|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501895|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501896|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56501897|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56501898|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56501899|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
56501900|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501901|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501902|NCT00580437|Protective Agents|protective agents|mesh-ancestor
56501903|NCT00580827|Disulfiram|disulfiram|mesh-list
56501904|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56501905|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56501906|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501907|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501908|NCT00580905|Adenosine|adenosine|mesh-list
56501909|NCT00580905|Nitroprusside|nitroprusside|mesh-list
56501910|NCT00580905|Analgesics|analgesics|mesh-ancestor
56501911|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
56501912|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501913|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501914|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56501915|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
56501916|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56501917|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
56501918|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
56501919|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501920|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501921|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56501922|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56501924|NCT04590638|Racepinephrine|racepinephrine|mesh-list
56501925|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
56501926|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56501927|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56501928|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
56501929|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501930|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252817|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
56252818|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252819|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56252820|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252821|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
56252822|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252823|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56501931|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501932|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56501933|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56501934|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
56501935|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56501936|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56501937|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
56501938|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
56501939|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
56501940|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56501941|NCT00567554|Paclitaxel|paclitaxel|mesh-list
56501942|NCT00567554|Docetaxel|docetaxel|mesh-list
56501943|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56501944|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
56501945|NCT00567554|Bevacizumab|bevacizumab|mesh-list
56501946|NCT00567554|Trastuzumab|trastuzumab|mesh-list
56501947|NCT00567554|Everolimus|everolimus|mesh-list
56501948|NCT00567554|Epirubicin|epirubicin|mesh-list
56501949|NCT00567554|Lapatinib|lapatinib|mesh-list
56501950|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56501951|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501952|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
56501953|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
56501954|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
56501955|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501956|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56501957|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
56501958|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501959|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56501960|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56501961|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
56501962|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56501963|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56501964|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56501965|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56501967|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
56501968|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56501969|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56501970|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56501971|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501972|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56501974|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
56501975|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56501976|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501977|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56501978|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56501979|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56501980|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56501981|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56501982|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56501983|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
56501984|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
56501985|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
56501986|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56501987|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501988|NCT04590482|Letrozole|letrozole|mesh-list
56501989|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56501990|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56501991|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56501992|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56501993|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56501994|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56501995|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
56501996|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56501997|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56501998|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56501999|NCT00581217|Laxatives|laxatives|mesh-ancestor
56502000|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502001|NCT00567710|Risperidone|risperidone|mesh-list
56502002|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56502003|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
56502004|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502005|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502006|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502007|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56502008|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56502009|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502010|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502011|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56502012|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
56502013|NCT04589429|Morphine|morphine|mesh-list
56502014|NCT04589429|Nalbuphine|nalbuphine|mesh-list
56502015|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56502016|NCT04589429|Narcotics|narcotics|mesh-ancestor
56502017|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502018|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502019|NCT04589429|Analgesics|analgesics|mesh-ancestor
56502020|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
56502021|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502022|NCT04589390|Selexipag|selexipag|mesh-list
56502023|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56502024|NCT04577040|Tadalafil|tadalafil|mesh-list
56502025|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
56502026|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56502027|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56502028|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502029|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502030|NCT04577040|Urological Agents|urological agents|mesh-ancestor
56502031|NCT04589234|Gemcitabine|gemcitabine|mesh-list
56502032|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56502033|NCT04589234|Folfirinox|folfirinox|mesh-list
56502034|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56502035|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
56502036|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502037|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502038|NCT04589234|Antiviral Agents|antiviral agents|mesh-ancestor
56502039|NCT04589234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502040|NCT04589234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502041|NCT04589234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56502042|NCT04589234|Immunologic Factors|immunologic factors|mesh-ancestor
56502043|NCT04589234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502044|NCT03453177|Fosfomycin|fosfomycin|mesh-list
56502045|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56502046|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502047|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
56502048|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
56502049|NCT04588532|Doxepin|doxepin|mesh-list
56502050|NCT04588532|Histamine|histamine|mesh-list
56502051|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
56502052|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
56502053|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502054|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502055|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502056|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56502057|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56502058|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502059|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56502060|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
56502061|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502062|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
56502063|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
56502064|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56502065|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502066|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502067|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56502068|NCT04577430|Analgesics|analgesics|mesh-ancestor
56502069|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
56502070|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502071|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56502072|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56502073|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56502074|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
56502075|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502076|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502077|NCT00567788|Bimatoprost|bimatoprost|mesh-list
56502078|NCT00567788|Latanoprost|latanoprost|mesh-list
56502079|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56502080|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56502081|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56502082|NCT00581607|Bosentan|bosentan|mesh-list
56502083|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56502084|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56502085|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502086|NCT00581685|Celecoxib|celecoxib|mesh-list
56502087|NCT00581685|Pregabalin|pregabalin|mesh-list
56502088|NCT00581685|Analgesics|analgesics|mesh-ancestor
56502089|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
56502090|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502091|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502092|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
56502093|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56502094|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56502095|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502096|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56502097|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56502098|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56502099|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502100|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502101|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56502102|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56502103|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56502104|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502105|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56502106|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56502107|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502108|NCT04588220|Plasminogen|plasminogen|mesh-list
56502109|NCT04588220|Melatonin|melatonin|mesh-list
56502110|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
56252830|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252831|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56252834|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502111|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502112|NCT04588220|Protective Agents|protective agents|mesh-ancestor
56502113|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502114|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502115|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56502116|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56502118|NCT04586543|Selegiline|selegiline|mesh-list
56502119|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502120|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
56502121|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
56502122|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
56502123|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502124|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
56502125|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502126|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56502127|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56502128|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56502129|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502130|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56502131|NCT04586543|Protective Agents|protective agents|mesh-ancestor
56502132|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502133|NCT04593654|Dalteparin|dalteparin|mesh-list
56502134|NCT04593654|Tinzaparin|tinzaparin|mesh-list
56502135|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56502136|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
56502137|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56502138|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56502139|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502140|NCT04586465|Gemcitabine|gemcitabine|mesh-list
56502141|NCT04586465|Carboplatin|carboplatin|mesh-list
56502142|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
56502143|NCT04586465|Pemetrexed|pemetrexed|mesh-list
56502144|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502145|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56502146|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
56502147|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502148|NCT04586465|Antiviral Agents|antiviral agents|mesh-ancestor
56502149|NCT04586465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502150|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502151|NCT04586465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56502152|NCT04586465|Immunologic Factors|immunologic factors|mesh-ancestor
56502153|NCT04586465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502154|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56502155|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56502156|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56502157|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
56502158|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56502159|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
56502160|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502161|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56502162|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56502163|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56502164|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502165|NCT04586348|Iodine|iodine|mesh-list
56502166|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
56502167|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56502168|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502169|NCT04586348|Trace Elements|trace elements|mesh-ancestor
56502170|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
56502171|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502172|NCT04585997|Omalizumab|omalizumab|mesh-list
56502173|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56502174|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56502175|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
56502176|NCT04593108|Letrozole|letrozole|mesh-list
56502177|NCT04593108|Misoprostol|misoprostol|mesh-list
56502178|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502179|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56502180|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56502181|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502182|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502183|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56250222|NCT01859377|Ibuprofen|ibuprofen|mesh-list
56502184|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
56502185|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502186|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502187|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56502189|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56502190|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56502191|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502192|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
56502193|NCT04585334|Diclofenac|diclofenac|mesh-list
56502194|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56502195|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56502196|NCT04585334|Analgesics|analgesics|mesh-ancestor
56502197|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
56502199|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502200|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56502201|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502202|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56502203|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502204|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502205|NCT04585412|Palonosetron|palonosetron|mesh-list
56502206|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
56502207|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
56502208|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502209|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502210|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502211|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56502212|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56502213|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
56502214|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502215|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502216|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56502217|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
56502218|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502219|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56502220|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56502221|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502222|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502223|NCT04593030|Warfarin|warfarin|mesh-list
56502224|NCT04593030|Apixaban|apixaban|mesh-list
56502225|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
56502226|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56502227|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
56502228|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56502229|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
56502230|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502231|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502232|NCT00567983|Cyclosporine|cyclosporine|mesh-list
56502233|NCT00567983|Cyclosporins|cyclosporins|mesh-list
56502234|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502235|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502236|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56502237|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
56502238|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502239|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
56502240|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502241|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
56502242|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502243|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56502244|NCT00582582|Vitamin D|vitamin d|mesh-list
56502245|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56502246|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56502247|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56502248|NCT00582582|Docetaxel|docetaxel|mesh-list
56502249|NCT00582582|Vitamins|vitamins|mesh-ancestor
56502250|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
56502251|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502252|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502253|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56502254|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56502255|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56502256|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502257|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56502258|NCT00566904|Aspirin|aspirin|mesh-list
56502259|NCT00566904|Lidocaine|lidocaine|mesh-list
56502260|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
56502261|NCT00566904|Anesthetics|anesthetics|mesh-list
56502262|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502264|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
56502265|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502266|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56502267|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56502268|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56502269|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56502270|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502271|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56502272|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56502274|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56502275|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502276|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56502277|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56502278|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56502279|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56502280|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502281|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
56502282|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56502283|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56502284|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56502285|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56502286|NCT04584515|Itraconazole|itraconazole|mesh-list
56502288|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
56502289|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502290|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56502291|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56502292|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502293|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502294|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56502295|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
56502296|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502297|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502298|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56502299|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56502300|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
56502301|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56502302|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
56502303|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56502304|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56502305|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56502306|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56502307|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56502308|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56502309|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56502310|NCT04584710|Dactolisib|dactolisib|mesh-list
56502311|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502312|NCT04584671|Xenon|xenon|mesh-list
56502313|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56502314|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
56502315|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
56502316|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502317|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502318|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56502319|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502320|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502321|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502322|NCT04592211|Paclitaxel|paclitaxel|mesh-list
56502323|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
56502324|NCT04592211|Olaparib|olaparib|mesh-list
56502325|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56502326|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502327|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
56502328|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
56502329|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
56502330|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502331|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56502332|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56250370|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502333|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502334|NCT04583813|Empagliflozin|empagliflozin|mesh-list
56502335|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56502336|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502337|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56502338|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502339|NCT04576143|Paclitaxel|paclitaxel|mesh-list
56502340|NCT04576143|Docetaxel|docetaxel|mesh-list
56502341|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
56502342|NCT04576143|Epirubicin|epirubicin|mesh-list
56502343|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56502344|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502345|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
56502346|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
56502347|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
56502348|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502349|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56502350|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
56502351|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502352|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502353|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56502354|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
56502355|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56502356|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56502357|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56502358|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56502359|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502360|NCT04583267|Tenofovir|tenofovir|mesh-list
56502361|NCT04583267|Emtricitabine|emtricitabine|mesh-list
56502362|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
56502363|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502364|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56502365|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56502366|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502367|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502368|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56502369|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56502370|NCT04583111|Domperidone|domperidone|mesh-list
56502371|NCT04583111|Sulpiride|sulpiride|mesh-list
56502372|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
56502373|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
56502374|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502375|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502376|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502377|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56502378|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
56502379|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502380|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502381|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56502382|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55754363|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
56166702|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
56502383|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502385|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56502386|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
56502387|NCT01146613|Varenicline|varenicline|mesh-list
56502388|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56502389|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56502390|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
56502391|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502392|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502393|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502394|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56502395|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56502396|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56502397|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56502398|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502399|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502400|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502401|NCT01145755|Analgesics|analgesics|mesh-ancestor
56502402|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
56502403|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502404|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
56502405|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502406|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
56502408|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56502409|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
56502410|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502411|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502412|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56502413|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56502414|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
56502415|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502416|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502417|NCT02884180|Dexamethasone|dexamethasone|mesh-list
56502418|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56502419|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
56502420|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
56502421|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502422|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502423|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502424|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
56502425|NCT02884180|Hormones|hormones|mesh-ancestor
56502426|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502427|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56502428|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502429|NCT00567060|Piracetam|piracetam|mesh-list
56502430|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56502431|NCT00567060|Protective Agents|protective agents|mesh-ancestor
56502432|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502433|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
56502434|NCT00568217|Acetaminophen|acetaminophen|mesh-list
56502435|NCT00568217|Ibuprofen|ibuprofen|mesh-list
56502436|NCT00568217|Diclofenac|diclofenac|mesh-list
56502437|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56502438|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56502439|NCT00568217|Analgesics|analgesics|mesh-ancestor
56502440|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
56502441|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502442|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502443|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56502444|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502445|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56502446|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502447|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502448|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
56502449|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
56502450|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502451|NCT04582604|Decitabine|decitabine|mesh-list
56502452|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56502453|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
56502454|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502455|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502456|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502457|NCT00590928|Esomeprazole|esomeprazole|mesh-list
56502458|NCT00590928|Ranitidine|ranitidine|mesh-list
56502459|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56502460|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56502461|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502462|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56502463|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502464|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502465|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56502466|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
56502467|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
56502468|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502469|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502470|NCT01145482|Insulin|insulin|mesh-list
56502471|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
56502472|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56502473|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502474|NCT00568295|Acetaminophen|acetaminophen|mesh-list
56502475|NCT00568295|Rofecoxib|rofecoxib|mesh-list
56502476|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56502477|NCT00568295|Analgesics|analgesics|mesh-ancestor
56502478|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
56502479|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502480|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502481|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
56502482|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56502483|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56502484|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502485|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502486|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56502487|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56502488|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502489|NCT00591162|Tetracycline|tetracycline|mesh-list
56502490|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56502491|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502492|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56502493|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502494|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502495|NCT00583518|Hormones|hormones|mesh-list
56502496|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
56502497|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502498|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502499|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56502501|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56502502|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502503|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56502504|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502505|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
56502506|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56502507|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
56502508|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502509|NCT00591201|Infliximab|infliximab|mesh-list
56502510|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
56502511|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502512|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502513|NCT04582097|Ramipril|ramipril|mesh-list
56502514|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56502515|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
56502516|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502517|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502518|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56502519|NCT00591357|Loperamide|loperamide|mesh-list
56502520|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
56502521|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502522|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
56502523|NCT04575675|Valsartan|valsartan|mesh-list
56252854|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502524|NCT04575675|Carvedilol|carvedilol|mesh-list
56502525|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56502526|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56502527|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
56502528|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56502529|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56502530|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56502531|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56502532|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502533|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56502534|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56502535|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502536|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56502537|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
56502538|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502539|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
56502540|NCT04575675|Protective Agents|protective agents|mesh-ancestor
56502541|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56502542|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56502543|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56502544|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
56502545|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56502546|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56502547|NCT04575675|Hormones|hormones|mesh-ancestor
56502548|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502549|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
56502550|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56502551|NCT04575675|Diuretics|diuretics|mesh-ancestor
56502552|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
56502553|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
56502554|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56502555|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56502556|NCT00568412|Analgesics|analgesics|mesh-ancestor
56502557|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
56502558|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502559|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502560|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56502561|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502562|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
56502563|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56502564|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
56502565|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56502566|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502567|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502568|NCT00568529|Capecitabine|capecitabine|mesh-list
56502569|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
56502570|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56502571|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
56502572|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502573|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502575|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502576|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871474|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56502577|NCT04575558|Azithromycin|azithromycin|mesh-list
56502578|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
56502579|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56502580|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502581|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
56502582|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56502583|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56502584|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502585|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502586|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502587|NCT00568763|Sargramostim|sargramostim|mesh-list
56502588|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
56502589|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502590|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56502591|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502592|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56502593|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502594|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502595|NCT00583869|Pregabalin|pregabalin|mesh-list
56502596|NCT00583869|Analgesics|analgesics|mesh-ancestor
56502597|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
56502598|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502599|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502600|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
56502601|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56502602|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56502603|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502604|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56502605|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56502606|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56502607|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502608|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502609|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
56502610|NCT00568880|Bortezomib|bortezomib|mesh-list
56502611|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502612|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
56502613|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56502614|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56502615|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502616|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502617|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502618|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502619|NCT03451695|Morphine|morphine|mesh-list
56502620|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56502621|NCT03451695|Narcotics|narcotics|mesh-ancestor
56502622|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502623|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502624|NCT03451695|Analgesics|analgesics|mesh-ancestor
56502625|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
56502626|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502627|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
56502628|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56502629|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
56502630|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502631|NCT00569465|Expectorants|expectorants|mesh-ancestor
56502632|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
56502633|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56502634|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
56502635|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502636|NCT00569465|Protective Agents|protective agents|mesh-ancestor
56502637|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502638|NCT00569465|Antidotes|antidotes|mesh-ancestor
56502640|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56502641|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
56502642|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502643|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502644|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56502645|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
56502646|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
56502647|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56502648|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56502649|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56502650|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56502651|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
56502652|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502653|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502654|NCT00569621|Moxaverine|moxaverine|mesh-list
56502655|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
56502656|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
56502657|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502658|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502659|NCT00569699|Bevacizumab|bevacizumab|mesh-list
56502660|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56502661|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502662|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56502663|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56502664|NCT00569699|Growth Substances|growth substances|mesh-ancestor
56502665|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502666|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
56502667|NCT00569816|Sevoflurane|sevoflurane|mesh-list
56502668|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56502669|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56502670|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
56502671|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
56502672|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502673|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502674|NCT00570050|Insulin|insulin|mesh-list
56502675|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56502676|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56502677|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502678|NCT03451500|Levodopa|levodopa|mesh-list
56502679|NCT03451500|Carbidopa|carbidopa|mesh-list
56502680|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56502681|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56502682|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56502683|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
56502684|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502685|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502686|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502687|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56502688|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502689|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56502690|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
56502691|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
56502692|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
56502693|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56502694|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
56502695|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502696|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502697|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56502698|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
56502699|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56502700|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
56502701|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502702|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502703|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56250753|NCT01863147|Acarbose|acarbose|mesh-list
56502704|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
56502705|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
56502706|NCT00570245|Protective Agents|protective agents|mesh-ancestor
56502707|NCT00570284|Panobinostat|panobinostat|mesh-list
56502708|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502709|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56502710|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502711|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502712|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
56502713|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56502714|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
56502715|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
56502717|NCT00570440|Estrogens|estrogens|mesh-ancestor
56502718|NCT00570440|Hormones|hormones|mesh-ancestor
56502719|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502720|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502721|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56502722|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56502723|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56502724|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56502725|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56502726|NCT00570479|Anecortave|anecortave|mesh-list
56502727|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56502728|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56502729|NCT00570479|Growth Substances|growth substances|mesh-ancestor
56502730|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502731|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
56502732|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502733|NCT00584298|Octreotide|octreotide|mesh-list
56502734|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502735|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56502736|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502737|NCT00584376|Pregabalin|pregabalin|mesh-list
56502738|NCT00584376|Analgesics|analgesics|mesh-ancestor
56502739|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
56502740|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502741|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502742|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
56502743|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56502744|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56502745|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502746|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56502747|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56502748|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56502749|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502750|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502751|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56502752|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252855|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252856|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252857|NCT01876186|Urological Agents|urological agents|mesh-ancestor
56252858|NCT01876290|Dexamethasone|dexamethasone|mesh-list
56252859|NCT01876290|Ondansetron|ondansetron|mesh-list
56252860|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252861|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
56252862|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
56252863|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502753|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
56502754|NCT00570830|Hormones|hormones|mesh-ancestor
56502755|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502756|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502757|NCT00584493|Tremelimumab|tremelimumab|mesh-list
56502758|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502759|NCT04580342|Propranolol|propranolol|mesh-list
56502760|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56502761|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56502762|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
56502763|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502764|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502765|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502766|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56502767|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56502768|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
56502769|NCT00571142|Bevacizumab|bevacizumab|mesh-list
56502770|NCT00571142|Temazepam|temazepam|mesh-list
56502771|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56502772|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502773|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56502774|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56502775|NCT00571142|Growth Substances|growth substances|mesh-ancestor
56250817|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
56502776|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502777|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
56502778|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56502779|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755944|NCT04981899|Etoposide|etoposide|mesh-list
56502780|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56502781|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56502782|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502783|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
56502784|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
56502785|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502786|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502787|NCT00584532|Genistein|genistein|mesh-list
56502788|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56252864|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252865|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56252866|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
56252867|NCT01876290|Hormones|hormones|mesh-ancestor
56252868|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56252869|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56252870|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252871|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
56252872|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
56252873|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56252874|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
56252875|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252876|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252877|NCT01876290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56252878|NCT01876290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56252879|NCT01876290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252880|NCT01876290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56252881|NCT01876290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56502789|NCT00584532|Protective Agents|protective agents|mesh-ancestor
56502790|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502791|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502792|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56502793|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502794|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502795|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
56502796|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56502797|NCT00584532|Estrogens|estrogens|mesh-ancestor
56502798|NCT00584532|Hormones|hormones|mesh-ancestor
56502799|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502800|NCT00584571|Dexetimide|dexetimide|mesh-list
56502801|NCT00584571|Citalopram|citalopram|mesh-list
56502802|NCT00584571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56502803|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56502804|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56502805|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502806|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502807|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
56502808|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502809|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56502810|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
56502811|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502812|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56502813|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56502814|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
56502815|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
56502816|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502817|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56502818|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56502819|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
56502820|NCT00584610|Copper|copper|mesh-list
56502821|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
56502822|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56502823|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
56502824|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56502825|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502826|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56502827|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56502828|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56502829|NCT00584610|Trace Elements|trace elements|mesh-ancestor
56502830|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
56502831|NCT00571298|Gemcitabine|gemcitabine|mesh-list
56502832|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
56502833|NCT00571298|Amifostine|amifostine|mesh-list
56502834|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502835|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56502836|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
56502837|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502838|NCT00571298|Antiviral Agents|antiviral agents|mesh-ancestor
56502839|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502840|NCT00571298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502841|NCT00571298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56502842|NCT00571298|Immunologic Factors|immunologic factors|mesh-ancestor
56502843|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502844|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56502845|NCT00571298|Protective Agents|protective agents|mesh-ancestor
56502846|NCT00571298|Antidotes|antidotes|mesh-ancestor
56502847|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
56502848|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
56502849|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56502850|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
56502851|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
56502852|NCT00571337|Infliximab|infliximab|mesh-list
56250891|NCT01863641|Vitamins|vitamins|mesh-ancestor
56502853|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
56502854|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502855|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502856|NCT04575519|Aspirin|aspirin|mesh-list
56502857|NCT04575519|Ibuprofen|ibuprofen|mesh-list
56502858|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56502859|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56502860|NCT04575519|Analgesics|analgesics|mesh-ancestor
56502861|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
56502862|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502863|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502864|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56502865|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502866|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56502867|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502868|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502869|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56502870|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56502871|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56502872|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
56502873|NCT04573803|Phenytoin|phenytoin|mesh-list
56502874|NCT04573803|Levetiracetam|levetiracetam|mesh-list
56502875|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
56502876|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
56502877|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56502878|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56502879|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56502880|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502881|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56502882|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56502883|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56502884|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
56502885|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502886|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56502887|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56502888|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502889|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502890|NCT00571727|Mecasermin|mecasermin|mesh-list
56502891|NCT00571727|Growth Substances|growth substances|mesh-ancestor
56502892|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502893|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
56502894|NCT04573686|Hematinics|hematinics|mesh-ancestor
56502895|NCT01143337|Methotrexate|methotrexate|mesh-list
56502896|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56502897|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
56502898|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56502899|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502900|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56502901|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
56502902|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502903|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502904|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
56502905|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502906|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56502907|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56502908|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
56502909|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502910|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56502911|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
56502912|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
56502913|NCT02883595|Thymalfasin|thymalfasin|mesh-list
56502914|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56502915|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
56502916|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502917|NCT01143259|Alvimopan|alvimopan|mesh-list
56502918|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502919|NCT00571805|Varenicline|varenicline|mesh-list
56502920|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56502921|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56502922|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
56502923|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56502924|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502925|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502926|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
56502927|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56502928|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502929|NCT00585000|Tremelimumab|tremelimumab|mesh-list
56502930|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502931|NCT00572078|Sorafenib|sorafenib|mesh-list
56502932|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56502933|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56502934|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502935|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502936|NCT00572312|Atorvastatin|atorvastatin|mesh-list
56502937|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56502938|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56502939|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
56502940|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502941|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56252927|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56252928|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
56252929|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252930|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252931|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252932|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56252933|NCT01876797|Ticagrelor|ticagrelor|mesh-list
56252934|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56252935|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56252936|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56252937|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56252938|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56502942|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56502943|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502944|NCT00585156|Celecoxib|celecoxib|mesh-list
56502945|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56502946|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56502947|NCT00585156|Analgesics|analgesics|mesh-ancestor
56502948|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
56502949|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56502950|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502951|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56502952|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502953|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56502954|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56502955|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502956|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502957|NCT01142596|Asenapine|asenapine|mesh-list
56502958|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56502959|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56502960|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56502961|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502962|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56502963|NCT00572390|Estrogens|estrogens|mesh-list
56502964|NCT00572390|Hormones|hormones|mesh-ancestor
56502965|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56502966|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502967|NCT01142128|Esomeprazole|esomeprazole|mesh-list
56502968|NCT01142128|Pancrelipase|pancrelipase|mesh-list
56502969|NCT01142128|Pancreatin|pancreatin|mesh-list
56502970|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56502971|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56502972|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56502973|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56502974|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502975|NCT04572867|Diuretics|diuretics|mesh-list
56502976|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
56502977|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56502978|NCT01142089|Rifamycins|rifamycins|mesh-list
56502979|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
56502980|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56502981|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502982|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56502983|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
56502984|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56502985|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
56502986|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56502987|NCT00572663|Expectorants|expectorants|mesh-ancestor
56502988|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
56502989|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56502990|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
56502991|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56502992|NCT00572663|Protective Agents|protective agents|mesh-ancestor
56502993|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252943|NCT01876849|Exenatide|exenatide|mesh-list
56252944|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56252945|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252946|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55754967|NCT03299387|Renal Agents|renal agents|mesh-ancestor
56502994|NCT00572663|Antidotes|antidotes|mesh-ancestor
56502995|NCT01140880|Tenofovir|tenofovir|mesh-list
56502997|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56502998|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
56502999|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503001|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56503002|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503003|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251046|NCT01864681|Metformin|metformin|mesh-list
56503004|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56503005|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56503006|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
56503007|NCT00572741|Vitamins|vitamins|mesh-ancestor
56503008|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
56503009|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503010|NCT00572819|Misoprostol|misoprostol|mesh-list
56503011|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56503012|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
56503013|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56503014|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503015|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56503016|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503017|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
56503018|NCT04580498|Paclitaxel|paclitaxel|mesh-list
56503019|NCT04580498|Carboplatin|carboplatin|mesh-list
56503020|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56503021|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503022|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
56503023|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
56503024|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503025|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503026|NCT03451110|Fluconazole|fluconazole|mesh-list
56503027|NCT03451110|Lemborexant|lemborexant|mesh-list
56503028|NCT03451110|Famotidine|famotidine|mesh-list
56503029|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
56503030|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
56503031|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503032|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56503033|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56503034|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503035|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503036|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56503037|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
56503038|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56503039|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503040|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56503041|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56503042|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56503043|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503044|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56503045|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
56503046|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
56503047|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56503048|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56503049|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56503050|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56503051|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503052|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56503053|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56503054|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56503055|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
56503056|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55755016|NCT04782687|Dexamethasone|dexamethasone|mesh-list
55746485|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
55746486|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
55746487|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55746488|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
55746489|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746490|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746491|NCT02468323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55746492|NCT02468323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55746493|NCT02468323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503057|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56503058|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56503059|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
56503060|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56503062|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
56503063|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503064|NCT03450798|Anesthetics|anesthetics|mesh-list
56503065|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503066|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503067|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
56503068|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503069|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56503070|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756212|NCT03290963|Ketamine|ketamine|mesh-list
56503071|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503073|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56503074|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56503075|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503076|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503078|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
56503079|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
56503080|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503081|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503082|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
56503083|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503084|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56503085|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56503086|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56503087|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56503088|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503089|NCT00573404|Sunitinib|sunitinib|mesh-list
56503090|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
56503091|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503092|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56503093|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56503094|NCT00573404|Growth Substances|growth substances|mesh-ancestor
56503095|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503096|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
56503097|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56503098|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503099|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503100|NCT01139125|Cysteamine|cysteamine|mesh-list
56503101|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56503102|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503103|NCT01139047|Metronidazole|metronidazole|mesh-list
56503104|NCT01139047|Azelaic acid|azelaic acid|mesh-list
56503105|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503106|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56503107|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56503108|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56503109|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503110|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
56503111|NCT01139008|Metronidazole|metronidazole|mesh-list
56503113|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503114|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56503115|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56503116|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56503117|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503118|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
56503119|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
56503120|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
56503121|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56503122|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56503123|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503124|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503125|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
56503126|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
56503127|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
56503128|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503129|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
56503130|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
56503131|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503132|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56503133|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
56503134|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
56503135|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56503136|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503137|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56503138|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56503139|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56503140|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56503141|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56503142|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
56503143|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56503144|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56503145|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56503146|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503147|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503148|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56503149|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56503150|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503151|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
56503152|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56503153|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56503154|NCT00573638|Latanoprost|latanoprost|mesh-list
56503155|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56503157|NCT01138657|Adalimumab|adalimumab|mesh-list
56503158|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503159|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
56503160|NCT01138657|Hormones|hormones|mesh-ancestor
56503161|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56503162|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503163|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56503164|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503165|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503166|NCT01138501|Factor VIII|factor viii|mesh-list
56503167|NCT01138501|Coagulants|coagulants|mesh-ancestor
56503168|NCT01138150|Naproxen|naproxen|mesh-list
56503169|NCT01138150|Sumatriptan|sumatriptan|mesh-list
56503170|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56503171|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56503172|NCT01138150|Analgesics|analgesics|mesh-ancestor
56503173|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
56503174|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503175|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503176|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503177|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503178|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
56503179|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56503180|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503181|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503182|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56503183|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56503184|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56503185|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
56503186|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56503187|NCT00586092|Bevacizumab|bevacizumab|mesh-list
56503188|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503189|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503190|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56503191|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56503192|NCT00586092|Growth Substances|growth substances|mesh-ancestor
56503193|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503194|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
56503195|NCT01137955|Rifaximin|rifaximin|mesh-list
56503196|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56503197|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503198|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503199|NCT00573950|Cilostazol|cilostazol|mesh-list
56503200|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56503201|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
56503202|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503203|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503204|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56503205|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
56503206|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56503207|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56503208|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503209|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56503210|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
56503211|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56503212|NCT00573950|Protective Agents|protective agents|mesh-ancestor
56503213|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56503214|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56503215|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503216|NCT00586131|Citric Acid|citric acid|mesh-list
56503217|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
56503218|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
56503219|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56503220|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
56503221|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
56503222|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503224|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
56503225|NCT00586365|Naproxen|naproxen|mesh-list
56251266|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503226|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56503227|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56503228|NCT00586365|Analgesics|analgesics|mesh-ancestor
56503229|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
56503230|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503231|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503232|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503233|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503234|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
56503235|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56503236|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503237|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503238|NCT00574652|Aldesleukin|aldesleukin|mesh-list
56503239|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503240|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56503241|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56503242|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
56503243|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503244|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56503245|NCT00574730|Rituximab|rituximab|mesh-list
56503246|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503247|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503248|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
56503249|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503250|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503251|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
56503252|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503253|NCT00574769|Bevacizumab|bevacizumab|mesh-list
56503254|NCT00574769|Docetaxel|docetaxel|mesh-list
56503255|NCT00574769|Everolimus|everolimus|mesh-list
56503256|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503257|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503258|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56503259|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56503260|NCT00574769|Growth Substances|growth substances|mesh-ancestor
56503261|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503262|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
56503263|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
56503264|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
56503265|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503266|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503267|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503268|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
56503269|NCT00586443|Bevacizumab|bevacizumab|mesh-list
56503270|NCT00586443|Panitumumab|panitumumab|mesh-list
56503271|NCT00586443|Everolimus|everolimus|mesh-list
56503272|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503273|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503274|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56503275|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56503276|NCT00586443|Growth Substances|growth substances|mesh-ancestor
56503277|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503278|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
56503279|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503280|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
56503281|NCT00574925|Esomeprazole|esomeprazole|mesh-list
56503282|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56503283|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503284|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56503285|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503286|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503287|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
56503288|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503289|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
56503290|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503291|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503292|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56252947|NCT01876849|Incretins|incretins|mesh-ancestor
56252948|NCT01876849|Hormones|hormones|mesh-ancestor
56252949|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56252950|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56252951|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
56252952|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252953|NCT01876966|Ritonavir|ritonavir|mesh-list
56252954|NCT01876966|Darunavir|darunavir|mesh-list
56503293|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
56503294|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503295|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503296|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56503298|NCT00574964|Carmustine|carmustine|mesh-list
56503299|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56503300|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
56503301|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503302|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503304|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503305|NCT01137682|Octreotide|octreotide|mesh-list
56503306|NCT01137682|Lanreotide|lanreotide|mesh-list
56503307|NCT01137682|Pasireotide|pasireotide|mesh-list
56503308|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503309|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56503310|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503311|NCT01137682|Hormones|hormones|mesh-ancestor
56503312|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56503313|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503314|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
56503315|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
56503316|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56503317|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56503318|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503319|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503320|NCT00586794|Urological Agents|urological agents|mesh-ancestor
56503321|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
56503322|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503323|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503324|NCT00575354|Sevoflurane|sevoflurane|mesh-list
56503325|NCT00575354|Isoflurane|isoflurane|mesh-list
56503326|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56503327|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56503328|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
56503329|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
56503330|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503331|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503332|NCT00586911|Betaine|betaine|mesh-list
56503333|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503334|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
56503335|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56503336|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
56503337|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503338|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56503339|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
56503340|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503341|NCT00575549|Dobutamine|dobutamine|mesh-list
56503342|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56503343|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
56503344|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
56503345|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503346|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503347|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56503348|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56503349|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56503350|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
56503351|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56503352|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503353|NCT00575549|Protective Agents|protective agents|mesh-ancestor
56503354|NCT03453684|Vancomycin|vancomycin|mesh-list
56503355|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56503356|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503357|NCT00575627|Interferons|interferons|mesh-list
56503358|NCT00575627|Ribavirin|ribavirin|mesh-list
56503359|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
56503360|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
56503361|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56252965|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56503362|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503363|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
56503364|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503365|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
56503366|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503367|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
56503368|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503369|NCT00555854|Benzocaine|benzocaine|mesh-list
56503370|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
56503371|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
56503372|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503373|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503374|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
55820138|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
56503375|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503376|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
56503377|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251438|NCT01868113|Xhance|xhance|mesh-list
56503378|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503379|NCT00587145|Docetaxel|docetaxel|mesh-list
56503380|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503381|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
56503382|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
56503383|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503384|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503385|NCT04674176|Rifaximin|rifaximin|mesh-list
56503386|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56503387|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503388|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503389|NCT04674527|Temozolomide|temozolomide|mesh-list
56503390|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56503391|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
56503392|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503393|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503394|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56503395|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56503396|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
56503397|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503398|NCT00199797|Leucovorin|leucovorin|mesh-list
56503399|NCT00199797|Fluorouracil|fluorouracil|mesh-list
56503400|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
56503401|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
56503402|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503403|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503404|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503405|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503406|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
56503407|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503408|NCT00199797|Antidotes|antidotes|mesh-ancestor
56503409|NCT00199797|Protective Agents|protective agents|mesh-ancestor
56503410|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
56503411|NCT00199797|Vitamins|vitamins|mesh-ancestor
56503412|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
56503413|NCT01137604|Bevacizumab|bevacizumab|mesh-list
56503414|NCT01137604|Lenvatinib|lenvatinib|mesh-list
56503415|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503416|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503417|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56503418|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56503419|NCT01137604|Growth Substances|growth substances|mesh-ancestor
56503420|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503421|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
56503422|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56503423|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503424|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503425|NCT03454919|Palbociclib|palbociclib|mesh-list
56503426|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503427|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56503428|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503429|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503430|NCT00198822|Vitamin A|vitamin a|mesh-list
56503431|NCT00198822|Beta Carotene|beta carotene|mesh-list
56503432|NCT00198822|Carotenoids|carotenoids|mesh-list
56503433|NCT00198822|Vitamins|vitamins|mesh-ancestor
56503434|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
56503435|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503436|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
56503437|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503438|NCT00198822|Protective Agents|protective agents|mesh-ancestor
56503439|NCT00198822|Provitamins|provitamins|mesh-ancestor
56503440|NCT05214976|Paclitaxel|paclitaxel|mesh-list
56503441|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56503442|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503443|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
56503444|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
56503445|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503446|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503447|NCT05204134|Insulin|insulin|mesh-list
56503448|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56503449|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503450|NCT05181436|Chrysarobin|chrysarobin|mesh-list
56251498|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
56503451|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56503452|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56503454|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
56503455|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503456|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503457|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503458|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503459|NCT01137292|Voriconazole|voriconazole|mesh-list
56503460|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
56503461|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503462|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56503463|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56503464|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503465|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503466|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56503467|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
56503468|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56252971|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56503469|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503470|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56503471|NCT02883478|Riboflavin|riboflavin|mesh-list
56503472|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
56503473|NCT02883478|Vitamins|vitamins|mesh-ancestor
56503474|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
56503475|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503476|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56503477|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56503478|NCT00197145|Aplaviroc|aplaviroc|mesh-list
56503479|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56503480|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56503481|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503482|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56503483|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56503484|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
56503485|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503486|NCT04674137|Histamine|histamine|mesh-list
56503487|NCT04674137|Glutarimide|glutarimide|mesh-list
56503488|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
56503489|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
56503490|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56503491|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503492|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503493|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56503494|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503495|NCT04312438|Caseins|caseins|mesh-list
56503496|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
56503497|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
56503498|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503499|NCT04312360|Metronidazole|metronidazole|mesh-list
56503500|NCT04312360|Fosfomycin|fosfomycin|mesh-list
56503501|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503502|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56503503|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56503504|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56503505|NCT00197106|Fluticasone|fluticasone|mesh-list
56503507|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56503508|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503509|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56503510|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
56503511|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503512|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503513|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56503514|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
56503515|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56503516|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56503517|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56503518|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56503519|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56503520|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
56503521|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56503522|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503523|NCT01136746|Insulin|insulin|mesh-list
56503524|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56503525|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
56503526|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
56503527|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56503528|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503529|NCT01136356|Morphine|morphine|mesh-list
56503530|NCT01136356|Buprenorphine|buprenorphine|mesh-list
56503531|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56503532|NCT01136356|Narcotics|narcotics|mesh-ancestor
56503533|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503534|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503535|NCT01136356|Analgesics|analgesics|mesh-ancestor
56503536|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
56503537|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503538|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56503539|NCT00587379|Atorvastatin|atorvastatin|mesh-list
56503540|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56503541|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56503542|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
56503543|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252988|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56503544|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56503545|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56503546|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503547|NCT04673396|Norcantharidin|norcantharidin|mesh-list
56503548|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503549|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503550|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503551|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
56503552|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503553|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503554|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
56503555|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56503556|NCT00196326|Estradiol|estradiol|mesh-list
56503557|NCT00196326|Estrogens|estrogens|mesh-ancestor
56503558|NCT00196326|Hormones|hormones|mesh-ancestor
56503559|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56503560|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503561|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56503562|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
56503563|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56503564|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56503565|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56503566|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56503567|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56503568|NCT00587496|Aspirin|aspirin|mesh-list
56503569|NCT00587496|Valacyclovir|valacyclovir|mesh-list
56503570|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56503571|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56503572|NCT00587496|Analgesics|analgesics|mesh-ancestor
56503573|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
56503574|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503575|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503576|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503577|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503578|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56503579|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56503580|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503581|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56503582|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56503583|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503584|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
56503585|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
56503586|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503587|NCT00195663|Adalimumab|adalimumab|mesh-list
56503588|NCT00195663|Methotrexate|methotrexate|mesh-list
56503589|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56503590|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
56503591|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56503592|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503593|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503594|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
56503595|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503596|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503597|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
56503598|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503599|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56503600|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503601|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
56503602|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503603|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56503604|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503605|NCT01135498|Bevacizumab|bevacizumab|mesh-list
56503606|NCT01135498|Capecitabine|capecitabine|mesh-list
56503607|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56503608|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
56503609|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503610|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503611|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56167053|NCT00004218|Prednisolone|prednisolone|mesh-list
56503612|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56503613|NCT01135498|Growth Substances|growth substances|mesh-ancestor
56503614|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503615|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
56503616|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503617|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
56503618|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503619|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56503620|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503621|NCT04610567|Methotrexate|methotrexate|mesh-list
56503622|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56503623|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
56503624|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56503625|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503626|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503627|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
56503628|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503629|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503630|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
56503631|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503632|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56503633|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503634|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
56503635|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503636|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56503637|NCT02883439|Fluticasone|fluticasone|mesh-list
56503639|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503640|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56503641|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
56503642|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503643|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503644|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56503645|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
56503646|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
56503647|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56503648|NCT00195507|Etanercept|etanercept|mesh-list
56503649|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56503650|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56503651|NCT00195507|Analgesics|analgesics|mesh-ancestor
56503652|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
56503653|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503654|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503655|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503656|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503657|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503658|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503659|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
56503660|NCT00195429|Sirolimus|sirolimus|mesh-list
56503661|NCT00195429|Prednisone|prednisone|mesh-list
56503662|NCT00195429|Tacrolimus|tacrolimus|mesh-list
56503663|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503664|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
56503665|NCT00195429|Hormones|hormones|mesh-ancestor
56503666|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56503667|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503668|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56503669|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503670|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503671|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
56503672|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56503673|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503674|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503675|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56503676|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253004|NCT01877512|Hormones|hormones|mesh-list
56503677|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56503678|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
56503680|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
56503681|NCT00195351|Tigecycline|tigecycline|mesh-list
56503682|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503683|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56503684|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56503685|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56503686|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56503687|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503688|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503689|NCT04609748|Nimesulide|nimesulide|mesh-list
56503690|NCT04609748|Cannabidiol|cannabidiol|mesh-list
56503691|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
56503692|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56503693|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56503694|NCT04609748|Analgesics|analgesics|mesh-ancestor
56503695|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
56503696|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503697|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503698|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503699|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503700|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56503701|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503702|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503703|NCT00195273|Cyclosporine|cyclosporine|mesh-list
56503704|NCT00195273|Sirolimus|sirolimus|mesh-list
56503705|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
56503706|NCT00195273|Cyclosporins|cyclosporins|mesh-list
56503707|NCT00195273|Daclizumab|daclizumab|mesh-list
56503708|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503709|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503710|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503711|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
56503712|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503713|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
56503714|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503715|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
56503716|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503717|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56503718|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56503719|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503720|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56503721|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
56503722|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56503723|NCT00564200|Dexamethasone|dexamethasone|mesh-list
56503724|NCT00564200|Fludarabine|fludarabine|mesh-list
56503725|NCT00564200|Bortezomib|bortezomib|mesh-list
56503726|NCT00564200|Melphalan|melphalan|mesh-list
56503727|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503728|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
56503729|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
56503730|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503731|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503732|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503733|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
56503734|NCT00564200|Hormones|hormones|mesh-ancestor
56503735|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56503736|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56503737|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503738|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503739|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503740|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
56503741|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56503742|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
56503743|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56503744|NCT00193479|Prednisone|prednisone|mesh-list
56503745|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
56503746|NCT00193479|Rituximab|rituximab|mesh-list
56503747|NCT00193479|Vincristine|vincristine|mesh-list
56503748|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
56503749|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503750|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
56503751|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503752|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503753|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56503754|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
56503755|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503756|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503757|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56503758|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503759|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503761|NCT00193479|Hormones|hormones|mesh-ancestor
56503762|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56503763|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56503764|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56503765|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
56503766|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
56503767|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503768|NCT00193479|Analgesics|analgesics|mesh-ancestor
56503769|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
56503770|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503771|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56503772|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56503773|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503774|NCT00193206|Gemcitabine|gemcitabine|mesh-list
56503775|NCT00193206|Paclitaxel|paclitaxel|mesh-list
56503776|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56503777|NCT00193206|Epirubicin|epirubicin|mesh-list
56503778|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56503779|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503780|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56503781|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56167112|NCT00004242|Gemcitabine|gemcitabine|mesh-list
56503782|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503783|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503784|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503785|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
56503786|NCT00193206|Antiviral Agents|antiviral agents|mesh-ancestor
56503787|NCT00193206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503788|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503789|NCT00193206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503790|NCT00193206|Immunologic Factors|immunologic factors|mesh-ancestor
56503791|NCT00193206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503792|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56503793|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56503794|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56503796|NCT00193050|Docetaxel|docetaxel|mesh-list
56503797|NCT00193050|Epirubicin|epirubicin|mesh-list
56253022|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
56253023|NCT01877746|Prednisone|prednisone|mesh-list
56253024|NCT01877746|Azathioprine|azathioprine|mesh-list
55755803|NCT04706715|Cemiplimab|cemiplimab|mesh-list
56503798|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503799|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
56503800|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503801|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503802|NCT00193050|Antiviral Agents|antiviral agents|mesh-ancestor
56503803|NCT00193050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503804|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503805|NCT00193050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503806|NCT00193050|Immunologic Factors|immunologic factors|mesh-ancestor
56503807|NCT00193050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503808|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
56503809|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
56503810|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503811|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56503812|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56503813|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56503814|NCT04608734|Midazolam|midazolam|mesh-list
56503815|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56503816|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56503817|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503818|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503819|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56503820|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56503821|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56503822|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56503823|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
56503824|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
56503825|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
56503826|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
56503827|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56503828|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503830|NCT00192075|Folic Acid|folic acid|mesh-list
56503831|NCT00192075|Gemcitabine|gemcitabine|mesh-list
56251872|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
56503832|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
56503833|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
56503834|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503835|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
56503836|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503837|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503838|NCT00192075|Antiviral Agents|antiviral agents|mesh-ancestor
56503839|NCT00192075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503840|NCT00192075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503841|NCT00192075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503842|NCT00192075|Immunologic Factors|immunologic factors|mesh-ancestor
56503843|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503844|NCT00192075|Antidotes|antidotes|mesh-ancestor
56503845|NCT00192075|Protective Agents|protective agents|mesh-ancestor
56503846|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
56503847|NCT00192075|Vitamins|vitamins|mesh-ancestor
56503848|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
56503849|NCT00192075|Hematinics|hematinics|mesh-ancestor
56503850|NCT00192036|Gemcitabine|gemcitabine|mesh-list
56503851|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503852|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503853|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
56167125|NCT00004248|Aldesleukin|aldesleukin|mesh-list
56503854|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503855|NCT00192036|Antiviral Agents|antiviral agents|mesh-ancestor
56503856|NCT00192036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503857|NCT00192036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503858|NCT00192036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503859|NCT00192036|Immunologic Factors|immunologic factors|mesh-ancestor
56503860|NCT00192036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503861|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
56503862|NCT00191724|Enoxaparin|enoxaparin|mesh-list
56503863|NCT00191724|Protein C|protein c|mesh-list
56503864|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
56503865|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56503866|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55755831|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
56503867|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503868|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503869|NCT00191646|Gemcitabine|gemcitabine|mesh-list
56503870|NCT00191646|Paclitaxel|paclitaxel|mesh-list
56503871|NCT00191646|Carboplatin|carboplatin|mesh-list
56503872|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56503873|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503874|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
56503875|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
56503876|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503877|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503878|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503879|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
56503880|NCT00191646|Antiviral Agents|antiviral agents|mesh-ancestor
56503881|NCT00191646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503882|NCT00191646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503883|NCT00191646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503884|NCT00191646|Immunologic Factors|immunologic factors|mesh-ancestor
56503885|NCT00191646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503886|NCT00191451|Gemcitabine|gemcitabine|mesh-list
56503887|NCT00191451|Carboplatin|carboplatin|mesh-list
56503888|NCT00191451|Trastuzumab|trastuzumab|mesh-list
56503889|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503890|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503891|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
56503892|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503893|NCT00191451|Antiviral Agents|antiviral agents|mesh-ancestor
56503894|NCT00191451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503895|NCT00191451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503896|NCT00191451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503897|NCT00191451|Immunologic Factors|immunologic factors|mesh-ancestor
56503898|NCT00191451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503899|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503900|NCT00191334|Gemcitabine|gemcitabine|mesh-list
56503901|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503902|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503903|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
56503904|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503905|NCT00191334|Antiviral Agents|antiviral agents|mesh-ancestor
56503906|NCT00191334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503907|NCT00191334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503908|NCT00191334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503909|NCT00191334|Immunologic Factors|immunologic factors|mesh-ancestor
56503910|NCT00191334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503912|NCT00191139|Cisplatin|cisplatin|mesh-list
56503913|NCT00191139|Docetaxel|docetaxel|mesh-list
56503914|NCT00191139|Etoposide|etoposide|mesh-list
56503915|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
56503916|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503917|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56503918|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
56503919|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503920|NCT00191139|Antiviral Agents|antiviral agents|mesh-ancestor
56503921|NCT00191139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56503922|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503923|NCT00191139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503924|NCT00191139|Immunologic Factors|immunologic factors|mesh-ancestor
56503925|NCT00191139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503926|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
56503927|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
56503928|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
56503929|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56503930|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56503931|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56503932|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
56503933|NCT00564512|Rituximab|rituximab|mesh-list
56503934|NCT00564512|Fludarabine|fludarabine|mesh-list
56503935|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
56503936|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56503937|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
56503938|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503939|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56503940|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56503941|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
56503942|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503943|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503944|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56503945|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56503946|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
56503947|NCT00564551|Calcium|calcium|mesh-list
56503948|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56503949|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503950|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56503951|NCT00190983|Pemetrexed|pemetrexed|mesh-list
56503952|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503953|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503954|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503955|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56503956|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56503957|NCT00190749|Olanzapine|olanzapine|mesh-list
56503958|NCT00190749|Risperidone|risperidone|mesh-list
56503959|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56503960|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
56503961|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56503962|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503963|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56503964|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56503966|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56503967|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56503968|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56503969|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
56503970|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
56503971|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
56503972|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503973|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503974|NCT00190749|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56503975|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56503976|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56503977|NCT04607447|Dexamethasone|dexamethasone|mesh-list
56503978|NCT04607447|Atorvastatin|atorvastatin|mesh-list
56503979|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56503980|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
56503981|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
56503982|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56503983|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253025|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253026|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
56253027|NCT01877746|Hormones|hormones|mesh-ancestor
56253028|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253029|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253030|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56253031|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503984|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56503985|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
56503986|NCT04607447|Hormones|hormones|mesh-ancestor
56503987|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56503988|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56503989|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56503990|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56503991|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56503992|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
56503993|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56503994|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56503995|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56503996|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56503997|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
56503998|NCT00190671|Pemetrexed|pemetrexed|mesh-list
56503999|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56504000|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
56504001|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504002|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56167172|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
56504003|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56504004|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
56504005|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504006|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504007|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56504008|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504009|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56504010|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56504011|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
56504012|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56504013|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504014|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504015|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56504016|NCT04607525|Analgesics|analgesics|mesh-ancestor
56504017|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
56504018|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504019|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56504020|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56504021|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56504022|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
56504023|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504024|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504025|NCT00198276|Bleomycin|bleomycin|mesh-list
56504026|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56504027|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504028|NCT04607642|Manganese|manganese|mesh-list
56504029|NCT04607642|Trace Elements|trace elements|mesh-ancestor
56504030|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
56504031|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504032|NCT00588003|Anastrozole|anastrozole|mesh-list
56504033|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56504034|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504035|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56504036|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56504037|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504038|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504039|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56504040|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
56504041|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504042|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504043|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
56504044|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56504045|NCT00564590|Melatonin|melatonin|mesh-list
56504046|NCT00564590|Omeprazole|omeprazole|mesh-list
56504047|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
56504048|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504049|NCT00564590|Protective Agents|protective agents|mesh-ancestor
56504050|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504051|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504052|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56504053|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56504054|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56504055|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504057|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
56504058|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56504059|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504060|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
56504061|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56504062|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56504063|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56504064|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504065|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504066|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
56504067|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504068|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504069|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56504070|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504071|NCT04574778|Acetaminophen|acetaminophen|mesh-list
56504072|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56504073|NCT04574778|Analgesics|analgesics|mesh-ancestor
56504074|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
56504075|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504076|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504077|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
56504078|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56504079|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56504080|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504081|NCT04605770|Pemetrexed|pemetrexed|mesh-list
56504082|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504083|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504084|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504085|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56504086|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56504087|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56504088|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56504089|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
56504090|NCT04605419|Calcium|calcium|mesh-list
56504091|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56504092|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504093|NCT04605575|Vinorelbine|vinorelbine|mesh-list
56504094|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56504095|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504096|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
56504097|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
56504098|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
56504099|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504100|NCT00589134|Ganirelix|ganirelix|mesh-list
56504101|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
56504102|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504103|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504104|NCT00589251|Penicillins|penicillins|mesh-list
56504105|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56504106|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56504107|NCT00564824|Caffeine|caffeine|mesh-list
56167225|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504108|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56504109|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504110|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56504111|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504112|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504113|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56504114|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56504115|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
56504116|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504117|NCT00589485|Cobalt|cobalt|mesh-list
56504118|NCT00589485|Trace Elements|trace elements|mesh-ancestor
56504119|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
56504120|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504121|NCT00564941|Deferasirox|deferasirox|mesh-list
56504122|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56504123|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
56504124|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
56504125|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504126|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56504127|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56504128|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504129|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
56504130|NCT00589953|Hematinics|hematinics|mesh-ancestor
56504131|NCT00589992|Ibutilide|ibutilide|mesh-list
56504132|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56504133|NCT00590070|Adenosine|adenosine|mesh-list
56252187|NCT01872013|ASP7991|asp7991|mesh-list
56504135|NCT00590070|Analgesics|analgesics|mesh-ancestor
56504136|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
56504137|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504138|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504139|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56504140|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
56504141|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56504142|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
56504143|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
56504144|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504145|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253125|NCT01878422|Vitamins|vitamins|mesh-ancestor
56504146|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56504147|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56504148|NCT00565019|Triamcinolone|triamcinolone|mesh-list
56504149|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56504150|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56504151|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56504152|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504153|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
56504154|NCT00565019|Hormones|hormones|mesh-ancestor
56504155|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504156|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504157|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56504158|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
56504159|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504160|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504161|NCT00565097|Lanreotide|lanreotide|mesh-list
56504162|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504163|NCT04604756|Losartan|losartan|mesh-list
56504164|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56504165|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56504166|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56504167|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56504168|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504169|NCT00590343|Vatalanib|vatalanib|mesh-list
56504170|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56504171|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504172|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504173|NCT04604678|Metformin|metformin|mesh-list
56504174|NCT04604678|Naltrexone|naltrexone|mesh-list
56504175|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56504176|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504177|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56504178|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56504179|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
56253143|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56253144|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56253145|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56253146|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253147|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56253148|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56253149|NCT01878643|Vancomycin|vancomycin|mesh-list
56253150|NCT01878643|Gentamicins|gentamicins|mesh-list
56253151|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56253152|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253153|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56253154|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253155|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253156|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
56504180|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504181|NCT04604795|Itraconazole|itraconazole|mesh-list
56504182|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
56504183|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56504184|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56504185|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56504186|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504187|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504188|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56504189|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
56504190|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504191|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504192|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56504193|NCT04604327|Bemiparin|bemiparin|mesh-list
56504194|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
56504195|NCT00590694|Ranibizumab|ranibizumab|mesh-list
56504196|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56504197|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56504198|NCT00590694|Growth Substances|growth substances|mesh-ancestor
56504199|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504200|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
56504201|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504202|NCT00565175|Famotidine|famotidine|mesh-list
56504203|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56504204|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56504205|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56504206|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
56504207|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
56504208|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504209|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504210|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504212|NCT00477165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56504213|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56504214|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504215|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504216|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504217|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
56504218|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504219|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56504220|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
56504221|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56504222|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56504223|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56504224|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504225|NCT00476229|Rituximab|rituximab|mesh-list
56504226|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
56504227|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56504228|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56504229|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504230|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
56167255|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56504231|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504232|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56504233|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56504234|NCT04603976|Erenumab|erenumab|mesh-list
56504235|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56504236|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504237|NCT04603976|Analgesics|analgesics|mesh-ancestor
56504238|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
56504239|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504240|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504241|NCT00476151|Ketamine|ketamine|mesh-list
55756226|NCT03294707|Coal Tar|coal tar|mesh-list
56504242|NCT00476151|Amitriptyline|amitriptyline|mesh-list
56504243|NCT00476151|Analgesics|analgesics|mesh-ancestor
56504244|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
56504245|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504246|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504247|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56504248|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56504249|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
56504250|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
56504251|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504252|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56504253|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56504254|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504255|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504256|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56504257|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
56504258|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56504259|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56504260|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56504261|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56504262|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504263|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
56504264|NCT04603664|Cystatins|cystatins|mesh-list
56504265|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56504266|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
56504267|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504268|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504269|NCT00474903|Aspirin|aspirin|mesh-list
56504270|NCT00474903|Esomeprazole|esomeprazole|mesh-list
56504271|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56504272|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56504273|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56504274|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504275|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504276|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56504277|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56504278|NCT00474903|Analgesics|analgesics|mesh-ancestor
56504279|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
56504280|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504281|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504283|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56504284|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56504285|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56504286|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56504287|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56504288|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
56504289|NCT01134055|Ranibizumab|ranibizumab|mesh-list
56504290|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56504291|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56504292|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56504293|NCT01134055|Growth Substances|growth substances|mesh-ancestor
56504294|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504295|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
56504296|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504297|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56504298|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56504299|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56504300|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56504301|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504302|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504303|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504304|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504305|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56504306|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
56504307|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56504308|NCT00474240|Atorvastatin|atorvastatin|mesh-list
56504309|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56504310|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56504311|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
56504312|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504313|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56504314|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56504315|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504316|NCT04602767|Phenylephrine|phenylephrine|mesh-list
56504317|NCT04602767|Vasopressins|vasopressins|mesh-list
56504318|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
56504319|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
56504320|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56504321|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
56504322|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
56504323|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504324|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504325|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
56504326|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56504327|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
56504328|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
56167307|NCT00004482|Hormones|hormones|mesh-ancestor
56504329|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56504330|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56504332|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
56504333|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504334|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504335|NCT04602767|Protective Agents|protective agents|mesh-ancestor
56504336|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
56504337|NCT04602767|Coagulants|coagulants|mesh-ancestor
56504338|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56504339|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
56504340|NCT00473889|Paclitaxel|paclitaxel|mesh-list
56504341|NCT00473889|Carboplatin|carboplatin|mesh-list
56504342|NCT00473889|Vorinostat|vorinostat|mesh-list
56504343|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56504344|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504345|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
56504346|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
56504347|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
56504348|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504349|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56504350|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504351|NCT00565214|Vitamins|vitamins|mesh-list
56504352|NCT00565214|Vitamin E|vitamin e|mesh-list
56504353|NCT00565214|Selenium|selenium|mesh-list
56253157|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56253158|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
56253159|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56504354|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
56504355|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504356|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
56504357|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504358|NCT00565214|Protective Agents|protective agents|mesh-ancestor
56504359|NCT00565214|Trace Elements|trace elements|mesh-ancestor
56504360|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
56504361|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56504362|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
56504363|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504364|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504365|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56504366|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
56504367|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56504368|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
56504369|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504370|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504371|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56504372|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
56504373|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
56504374|NCT00565253|Protective Agents|protective agents|mesh-ancestor
56504375|NCT02277600|Darunavir|darunavir|mesh-list
56504376|NCT02277600|Cobicistat|cobicistat|mesh-list
56504377|NCT02277600|Fostemsavir|fostemsavir|mesh-list
56504378|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56504379|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56504380|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
56504381|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504382|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504383|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56504384|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56504385|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
56504386|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56504387|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56504388|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56504389|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56504390|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56504391|NCT04602143|Testosterone|testosterone|mesh-list
56504392|NCT04602143|Androgens|androgens|mesh-ancestor
56504393|NCT04602143|Hormones|hormones|mesh-ancestor
56094975|NCT03909763|Danazol|danazol|mesh-list
56167321|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
56504394|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504395|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504396|NCT02277678|Morphine|morphine|mesh-list
56504397|NCT02277678|Oxycodone|oxycodone|mesh-list
56504398|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
56504399|NCT02277678|Narcotics|narcotics|mesh-ancestor
56504400|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253160|NCT01878695|Expectorants|expectorants|mesh-ancestor
56253161|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
56253162|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56504401|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504402|NCT02277678|Analgesics|analgesics|mesh-ancestor
56504403|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
56504404|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504405|NCT02277717|Trastuzumab|trastuzumab|mesh-list
56504406|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56504407|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504408|NCT04601675|Dexamethasone|dexamethasone|mesh-list
56504409|NCT04601675|Ranibizumab|ranibizumab|mesh-list
56504410|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504411|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
56504412|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
56504413|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504414|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504415|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56504416|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
56504417|NCT04601675|Hormones|hormones|mesh-ancestor
56504418|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504419|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56504420|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504421|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56504422|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56504423|NCT04601675|Growth Substances|growth substances|mesh-ancestor
56504424|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
56504425|NCT00565292|Anacetrapib|anacetrapib|mesh-list
56504426|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56504427|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56504428|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
56504429|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504430|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56504431|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
56504432|NCT01580865|Tacrolimus|tacrolimus|mesh-list
56504433|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56504434|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
56504435|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504436|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56504437|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504438|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504439|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56504440|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504441|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56504442|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
56504443|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56504444|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56504445|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
56504446|NCT00473694|Rocuronium|rocuronium|mesh-list
56504447|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
56504448|NCT00473694|Neostigmine|neostigmine|mesh-list
56504449|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56504450|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56504451|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56504452|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504453|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504454|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56504455|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56167333|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504456|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504457|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
56504458|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504459|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56504460|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
56504461|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56504462|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56504463|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56504464|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56504465|NCT04601324|Fluticasone|fluticasone|mesh-list
56504466|NCT04601324|Xhance|xhance|mesh-list
56504467|NCT04601324|Azelastine|azelastine|mesh-list
56504468|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504469|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56504470|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
56504471|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504472|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504473|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56504474|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
56504475|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
56504476|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56504477|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56504478|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504479|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504480|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56504481|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56504482|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
56504483|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
56504484|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504485|NCT02215980|Dexamethasone|dexamethasone|mesh-list
56504486|NCT02215980|Lenalidomide|lenalidomide|mesh-list
56504487|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504488|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
56504489|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
56504490|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504491|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504492|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56504493|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
56504494|NCT02215980|Hormones|hormones|mesh-ancestor
55757494|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
56504495|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504496|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56504497|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504498|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
56504499|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56504500|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56504501|NCT02215980|Growth Substances|growth substances|mesh-ancestor
56504502|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
56504503|NCT00565331|Rituximab|rituximab|mesh-list
56167354|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
56504504|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56504505|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504506|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
56504507|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504508|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56504509|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56504510|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56504511|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56504513|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504514|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56504515|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56504516|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504517|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
56504518|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56504519|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504521|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56504522|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56504523|NCT00473382|Growth Substances|growth substances|mesh-ancestor
56504524|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504525|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
56504526|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504527|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
56504528|NCT04576364|Analgesics|analgesics|mesh-ancestor
56504529|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
56253185|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756524|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504530|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504531|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504532|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
56504533|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504534|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56504535|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
56504536|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56504537|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504538|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504539|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56504540|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
56504541|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56504542|NCT02210325|Azithromycin|azithromycin|mesh-list
56504543|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
56504544|NCT02210325|Solithromycin|solithromycin|mesh-list
56504545|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56504546|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56504547|NCT00473265|Teriparatide|teriparatide|mesh-list
56504548|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56504549|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504550|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56504551|NCT00472641|Ziprasidone|ziprasidone|mesh-list
56504552|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56504553|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
56504554|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504555|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504556|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504557|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56504558|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56504559|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504560|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56504561|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56504562|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
56504563|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
56504564|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56504565|NCT04571151|Halobetasol|halobetasol|mesh-list
56504566|NCT04571151|Calcipotriene|calcipotriene|mesh-list
56504567|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
56504568|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56504569|NCT01133977|Lenvatinib|lenvatinib|mesh-list
56504570|NCT01133977|Dacarbazine|dacarbazine|mesh-list
56504571|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504572|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56504573|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504574|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504575|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56504576|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
56504577|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56504578|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56504579|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56252628|NCT01874470|Diuretics|diuretics|mesh-list
56504580|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504581|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504582|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504583|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504584|NCT00583193|Analgesics|analgesics|mesh-ancestor
56504585|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
56504586|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504587|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
56504588|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56504589|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
56504590|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56504591|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
56504592|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56504593|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56504594|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56504595|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504596|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504597|NCT00583271|Ethanol|ethanol|mesh-list
56504598|NCT00583271|Triamcinolone|triamcinolone|mesh-list
56504599|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504600|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
56504601|NCT00583271|Hormones|hormones|mesh-ancestor
56504602|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504603|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504604|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56504605|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56504606|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504607|NCT04571229|Mifamurtide|mifamurtide|mesh-list
56504608|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56504609|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
56504610|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504611|NCT00583349|Paclitaxel|paclitaxel|mesh-list
56504612|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56504613|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504614|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
56504615|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
56504616|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
56504617|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504618|NCT01133665|Lenalidomide|lenalidomide|mesh-list
56504619|NCT01133665|Cetuximab|cetuximab|mesh-list
56504620|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
56504621|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504622|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56504623|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56504624|NCT01133665|Growth Substances|growth substances|mesh-ancestor
56504625|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
56504626|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504627|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56504628|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
56504629|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
56504630|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56504631|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
56504632|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504633|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56504634|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56504635|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56504636|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56504637|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504638|NCT01133626|Prednisone|prednisone|mesh-list
56504639|NCT01133626|Beclomethasone|beclomethasone|mesh-list
56504640|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504641|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
56504642|NCT01133626|Hormones|hormones|mesh-ancestor
56504643|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504644|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504645|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56504646|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504647|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56504648|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
56504649|NCT01133392|Insulin|insulin|mesh-list
56504650|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56504651|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
56504652|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56504653|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504654|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56504655|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56504656|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56504657|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504658|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504659|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
56504660|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504661|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504662|NCT01133275|Prednisone|prednisone|mesh-list
56504663|NCT01133275|Lenalidomide|lenalidomide|mesh-list
56504664|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504665|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
56504666|NCT01133275|Hormones|hormones|mesh-ancestor
56504667|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504668|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504669|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56504670|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504671|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
56504672|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56504673|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56504674|NCT01133275|Growth Substances|growth substances|mesh-ancestor
56504675|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
56504676|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56504677|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56504678|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56504679|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504680|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504681|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56504682|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504683|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504684|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
56504685|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504686|NCT02210364|Capecitabine|capecitabine|mesh-list
56504687|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56504688|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
56504689|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504690|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504691|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56504692|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56504693|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56504694|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504695|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504696|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504697|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504698|NCT00471315|Analgesics|analgesics|mesh-ancestor
56504699|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
56504700|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504701|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
56504702|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56504703|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
56504704|NCT00471237|Alendronate|alendronate|mesh-list
56504705|NCT00471237|Teriparatide|teriparatide|mesh-list
56504706|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56504707|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504708|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56504709|NCT04570683|Nivolumab|nivolumab|mesh-list
56504710|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56504711|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504712|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56504713|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504714|NCT04570449|Fluoxetine|fluoxetine|mesh-list
56504715|NCT04570449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56504716|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56504717|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504718|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504719|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504720|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
56504721|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504722|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56504723|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
56504724|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56252777|NCT01875757|Vitamin D|vitamin d|mesh-list
56504725|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56504726|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56504727|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504728|NCT00470847|Trastuzumab|trastuzumab|mesh-list
56504729|NCT00470847|Lapatinib|lapatinib|mesh-list
56504730|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56504731|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504732|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56504733|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504734|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504735|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
56504736|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56504737|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56504738|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
56504739|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504740|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504741|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504742|NCT00584090|Urological Agents|urological agents|mesh-ancestor
56504743|NCT00584168|Dexamethasone|dexamethasone|mesh-list
56504744|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504745|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
56504746|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
56504747|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504748|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504749|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56504750|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
56504751|NCT00584168|Hormones|hormones|mesh-ancestor
56504752|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504753|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56504754|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504755|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56504756|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504757|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56504758|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504759|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504760|NCT00470184|Capecitabine|capecitabine|mesh-list
56504761|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
56504762|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56504763|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
56504764|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504765|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504766|NCT04570254|Vitamins|vitamins|mesh-list
56504767|NCT04570254|Vitamin E|vitamin e|mesh-list
56504768|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
56504769|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
56504770|NCT04570254|Melatonin|melatonin|mesh-list
56504771|NCT04570254|Antioxidants|antioxidants|mesh-list
56504772|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56504773|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
56504774|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504775|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504776|NCT04570254|Protective Agents|protective agents|mesh-ancestor
56504777|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504778|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56504779|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504780|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56504781|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56504782|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
56504783|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56504784|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
56504785|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56504786|NCT04570254|Expectorants|expectorants|mesh-ancestor
56504787|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
56504788|NCT04570254|Antidotes|antidotes|mesh-ancestor
56504789|NCT00470067|Carboplatin|carboplatin|mesh-list
56504790|NCT00470067|Doxorubicin|doxorubicin|mesh-list
56504791|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56504792|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504793|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56504794|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56504795|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56504796|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504797|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504798|NCT00584636|Budesonide|budesonide|mesh-list
56504799|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504800|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56504801|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
56504802|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504803|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504804|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56504805|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
56504806|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
56504807|NCT00584636|Hormones|hormones|mesh-ancestor
56504808|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504809|NCT00479817|Paclitaxel|paclitaxel|mesh-list
56504810|NCT00479817|Trebananib|trebananib|mesh-list
56504811|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56504812|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504813|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
56504814|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
56504815|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
56504816|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504817|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56504818|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56504819|NCT00479817|Growth Substances|growth substances|mesh-ancestor
56504820|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504821|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
56504822|NCT04575194|Liraglutide|liraglutide|mesh-list
56504823|NCT04575194|Naltrexone|naltrexone|mesh-list
56504824|NCT04575194|Bupropion|bupropion|mesh-list
56504825|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56504826|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56504827|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504828|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
56504829|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504830|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56504831|NCT04575194|Incretins|incretins|mesh-ancestor
56504832|NCT04575194|Hormones|hormones|mesh-ancestor
56504833|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504834|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56504835|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
56504836|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56504837|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56504838|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56253226|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56253227|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56253228|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56253229|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756863|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756864|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756865|NCT04970043|Pemetrexed|pemetrexed|mesh-list
55756866|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756867|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504839|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504840|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504841|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
56504842|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504843|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56504844|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56504845|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504847|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
56504848|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
56504849|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504850|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504851|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
56504852|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56504853|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56504854|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56504855|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56504856|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
56504857|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504858|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56504859|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56504860|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504861|NCT00585260|Mannitol|mannitol|mesh-list
56504862|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56504863|NCT00585260|Diuretics|diuretics|mesh-ancestor
56504864|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
56504865|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504867|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
56504868|NCT00475020|Busulfan|busulfan|mesh-list
56504869|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
56504870|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56504871|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504872|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56504873|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
56504874|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504875|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56504876|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
56504877|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504878|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
56504879|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56504880|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56504881|NCT00585455|Sertraline|sertraline|mesh-list
56504882|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
56504883|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56504884|NCT00585455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56504885|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56504886|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56504887|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504888|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504889|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
56504890|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504891|NCT01083966|Bevacizumab|bevacizumab|mesh-list
56504892|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56504893|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504894|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56504895|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56504896|NCT01083966|Growth Substances|growth substances|mesh-ancestor
56504897|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504898|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
56504899|NCT01132807|Prednisone|prednisone|mesh-list
56504900|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
56504901|NCT01132807|Dacarbazine|dacarbazine|mesh-list
56504902|NCT01132807|Doxorubicin|doxorubicin|mesh-list
56504903|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56504904|NCT01132807|Etoposide|etoposide|mesh-list
56504905|NCT01132807|Bleomycin|bleomycin|mesh-list
56504906|NCT01132807|Vinblastine|vinblastine|mesh-list
56504907|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
56504909|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56504910|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56504911|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
56504912|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504913|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56504914|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56504915|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
56504916|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504917|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504918|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56504919|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56504920|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56504921|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56504922|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504923|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504924|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
56504925|NCT01132807|Hormones|hormones|mesh-ancestor
56504926|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504927|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56504928|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56504929|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56504930|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
56504931|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
56504932|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
56504933|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
56504934|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56504935|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504936|NCT01089543|Rabeprazole|rabeprazole|mesh-list
56504937|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56504938|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56504939|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56504940|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504942|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56504943|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504944|NCT01089504|Phenobarbital|phenobarbital|mesh-list
56504945|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
56504946|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56504947|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504948|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504949|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56504950|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56504951|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56504952|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504953|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
56504954|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
56504955|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56504956|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56504957|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56504958|NCT03452696|Calcium|calcium|mesh-list
56504959|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56504960|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504961|NCT01088997|Milrinone|milrinone|mesh-list
56504962|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56504963|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56504964|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
56504965|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56504966|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56504967|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504968|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504969|NCT01088997|Protective Agents|protective agents|mesh-ancestor
56504970|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504971|NCT00586118|Propofol|propofol|mesh-list
56504972|NCT00586118|Sevoflurane|sevoflurane|mesh-list
55756993|NCT03278483|Isoniazid|isoniazid|mesh-list
56504973|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56504974|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56504975|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504976|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56504977|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
56504978|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
56504979|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56504980|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56504981|NCT01088529|Prednisone|prednisone|mesh-list
56504982|NCT01088529|Leuprolide|leuprolide|mesh-list
56504983|NCT01088529|Goserelin|goserelin|mesh-list
56504984|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
56504985|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56504986|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
56504987|NCT01088529|Hormones|hormones|mesh-ancestor
56504988|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56504989|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56504990|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56504991|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56504992|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56504993|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
56504994|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56504995|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56504996|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56504997|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56504998|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
56504999|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56505000|NCT00586274|Fludarabine|fludarabine|mesh-list
56505001|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
56505002|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505003|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56505004|NCT00586430|Lorazepam|lorazepam|mesh-list
56505005|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
56505006|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
56505007|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
56505008|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505009|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505010|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56505011|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56505012|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505013|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56505014|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56505015|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56505016|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
56505017|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
56505018|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505019|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505020|NCT04569279|Warfarin|warfarin|mesh-list
56505021|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
56505022|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
56505023|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56505024|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
56505025|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56505026|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
56505027|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505028|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505030|NCT04312204|Carboplatin|carboplatin|mesh-list
56505031|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505032|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56505033|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
56505034|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505035|NCT04312204|Antiviral Agents|antiviral agents|mesh-ancestor
56505036|NCT04312204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505037|NCT04312204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505038|NCT04312204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505039|NCT04312204|Immunologic Factors|immunologic factors|mesh-ancestor
56505040|NCT04312204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505041|NCT04312282|Itraconazole|itraconazole|mesh-list
56505042|NCT04312282|Rifampin|rifampin|mesh-list
55871475|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505043|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
56505044|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505045|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56505046|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56505047|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505048|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505049|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56505050|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
56505051|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505052|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505053|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56505054|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56505055|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
56505056|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56505057|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
56505058|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56505059|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56505060|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56505061|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56505062|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56505063|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56505064|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56505066|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56505067|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
56505068|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505069|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505070|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56505071|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56505072|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
56505073|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505074|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505075|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
56505076|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505077|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
56505078|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505079|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505080|NCT00586976|Ropivacaine|ropivacaine|mesh-list
56505081|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
56505082|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
56505083|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505084|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505085|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
56505086|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505087|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
56505088|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505089|NCT04568772|Atovaquone|atovaquone|mesh-list
56505091|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56505092|NCT04568772|Esomeprazole|esomeprazole|mesh-list
56505093|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56505094|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56505095|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56505096|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505097|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505098|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505099|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
56505100|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56505101|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56505102|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
56505103|NCT04575389|Uric Acid|uric acid|mesh-list
56505104|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
56505105|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505106|NCT04575389|Protective Agents|protective agents|mesh-ancestor
56505107|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505108|NCT01086150|Lidocaine|lidocaine|mesh-list
56505109|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
56505110|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
56505111|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505112|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505113|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
56505114|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505115|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56505116|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56505117|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56505118|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56167496|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56505119|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505120|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56505121|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56505122|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
56505123|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505124|NCT00587249|Antacids|antacids|mesh-ancestor
56505125|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505126|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56505127|NCT00587327|Atosiban|atosiban|mesh-list
56505128|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
56505129|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505130|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505131|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
56505132|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56505133|NCT00587444|Heparin|heparin|mesh-list
56505134|NCT00587444|Calcium heparin|calcium heparin|mesh-list
56505135|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
56505136|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56505137|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56505138|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505139|NCT02278302|Ethanol|ethanol|mesh-list
56505140|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
56505141|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56505142|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505143|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505144|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505145|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56505146|NCT00587717|Simvastatin|simvastatin|mesh-list
56505147|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56505148|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56505149|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
56505150|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505151|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56505152|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56505153|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505154|NCT01085136|Afatinib|afatinib|mesh-list
56505155|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505156|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56505157|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505158|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505159|NCT00587873|Leucovorin|leucovorin|mesh-list
56505160|NCT00587873|Methotrexate|methotrexate|mesh-list
56505161|NCT00587873|Thioguanine|thioguanine|mesh-list
56505162|NCT00587873|Calcium|calcium|mesh-list
56505163|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
56505164|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56505165|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505166|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56505167|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
56505168|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56505169|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56167503|NCT00004800|Vaccines|vaccines|mesh-list
56505170|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
56505171|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505172|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505173|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
56505174|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505175|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56505176|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505177|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
56505178|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505179|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56505180|NCT00587873|Antidotes|antidotes|mesh-ancestor
56505181|NCT00587873|Protective Agents|protective agents|mesh-ancestor
56505182|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
56505183|NCT00587873|Vitamins|vitamins|mesh-ancestor
56505184|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
56505185|NCT01084707|Nicotine|nicotine|mesh-list
56505186|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56505187|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
56505188|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505189|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505190|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56505191|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56505192|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
56505193|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505194|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505195|NCT02210598|Oxytocin|oxytocin|mesh-list
56505196|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
56505197|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56505198|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505199|NCT04574960|Gemcitabine|gemcitabine|mesh-list
56505200|NCT04574960|Carboplatin|carboplatin|mesh-list
56505201|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505202|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56505203|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
56505204|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505205|NCT04574960|Antiviral Agents|antiviral agents|mesh-ancestor
56505206|NCT04574960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505207|NCT04574960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505208|NCT04574960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505209|NCT04574960|Immunologic Factors|immunologic factors|mesh-ancestor
56505210|NCT04574960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505211|NCT03452657|Ranibizumab|ranibizumab|mesh-list
56505212|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56505213|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56505214|NCT03452657|Growth Substances|growth substances|mesh-ancestor
56505215|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505216|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
56505217|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505218|NCT03452501|Infliximab|infliximab|mesh-list
56505219|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
56505220|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56505221|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505222|NCT01084083|Paclitaxel|paclitaxel|mesh-list
56505223|NCT01084083|Cetuximab|cetuximab|mesh-list
56505224|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56505225|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505226|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
56505227|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
56505228|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
56505229|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505230|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56505231|NCT00588302|Moexipril|moexipril|mesh-list
56505232|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56505233|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
56505234|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505235|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253230|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
56253231|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505236|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56505237|NCT01084005|Linagliptin|linagliptin|mesh-list
56505238|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56505239|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505240|NCT01084005|Incretins|incretins|mesh-ancestor
56505242|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505243|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56505244|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
56505245|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505246|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505247|NCT01083810|Ritonavir|ritonavir|mesh-list
56505248|NCT01083810|Lopinavir|lopinavir|mesh-list
56505249|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56505250|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56505251|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
56505252|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505253|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505254|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56505255|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56505256|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
56505257|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505258|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56505259|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56505260|NCT00588926|Remifentanil|remifentanil|mesh-list
56505261|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56505262|NCT00588926|Narcotics|narcotics|mesh-ancestor
56505263|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505264|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505265|NCT00588926|Analgesics|analgesics|mesh-ancestor
56505266|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
56505267|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505268|NCT00589082|Daunorubicin|daunorubicin|mesh-list
56505269|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56505270|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505271|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56505272|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56505273|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505274|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505275|NCT00589238|Paclitaxel|paclitaxel|mesh-list
56505276|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
56505277|NCT00589238|Carboplatin|carboplatin|mesh-list
56505278|NCT00589238|Doxorubicin|doxorubicin|mesh-list
56505279|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56505280|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56505281|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505282|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
56505283|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
56505284|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
56505285|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505286|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505287|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
56505288|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505289|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505290|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56505291|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
56505292|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56505293|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56505294|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56505295|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56505296|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505297|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56505298|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
56505299|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505300|NCT01083576|Gentamicins|gentamicins|mesh-list
56505301|NCT01083576|Paromomycin|paromomycin|mesh-list
56505302|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56505303|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505304|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56505305|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505306|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505307|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56505308|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56505310|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
56505311|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505312|NCT04568304|Gemcitabine|gemcitabine|mesh-list
56505313|NCT04568304|Carboplatin|carboplatin|mesh-list
56505314|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505315|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56505316|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
56505317|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505318|NCT04568304|Antiviral Agents|antiviral agents|mesh-ancestor
56505319|NCT04568304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505320|NCT04568304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505321|NCT04568304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505322|NCT04568304|Immunologic Factors|immunologic factors|mesh-ancestor
56505323|NCT04568304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505324|NCT01082640|Febuxostat|febuxostat|mesh-list
56505325|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
56505326|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505327|NCT00589862|Clopidogrel|clopidogrel|mesh-list
56505328|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56505329|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56505330|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56505331|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56505332|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
56505333|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505334|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505335|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505336|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
56505337|NCT00589901|Capecitabine|capecitabine|mesh-list
56505338|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505339|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
56505340|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505341|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505342|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56505343|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
56505344|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505345|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505346|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56505347|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56505348|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
56505349|NCT00590174|Aspirin|aspirin|mesh-list
56505350|NCT00590174|Clopidogrel|clopidogrel|mesh-list
56505351|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56505352|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56505353|NCT00590174|Analgesics|analgesics|mesh-ancestor
56505354|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
56505355|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505356|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505357|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56505358|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505359|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56505360|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56505361|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505362|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56505363|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56505364|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505365|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
56505366|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56505367|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56505368|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56505369|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
56505370|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505371|NCT00590213|Bicalutamide|bicalutamide|mesh-list
56505372|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
56505373|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
56505374|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505375|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505376|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505378|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
56505379|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
56505381|NCT00590408|Vitamins|vitamins|mesh-ancestor
56505382|NCT00590447|Rituximab|rituximab|mesh-list
56505383|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56505384|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505385|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
56505386|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505387|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505388|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56505389|NCT01081626|Hormones|hormones|mesh-ancestor
56505390|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505391|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505392|NCT01080768|Amlodipine|amlodipine|mesh-list
56505393|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56505394|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56505395|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56505396|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505397|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56505398|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253464|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
56505399|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
56505400|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56505401|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56505402|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505403|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505404|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56505405|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56505406|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505407|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
56505408|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505410|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56505411|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505412|NCT01080300|Gabapentin|gabapentin|mesh-list
56505413|NCT01080300|Analgesics|analgesics|mesh-ancestor
56505414|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
56505415|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505416|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505417|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
56505418|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56505419|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56505420|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505421|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56505422|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56505423|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56505424|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505425|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505426|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
56505427|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
56505428|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56505429|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56505430|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
56505431|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505432|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56505433|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56505434|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505435|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505436|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
56505437|NCT00590603|Bortezomib|bortezomib|mesh-list
56505438|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
56505439|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505440|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
56505441|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505442|NCT00590603|Protective Agents|protective agents|mesh-ancestor
56505443|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505444|NCT00590603|Vitamins|vitamins|mesh-ancestor
56505445|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
56505446|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
56505447|NCT01085097|Prednisone|prednisone|mesh-list
56505448|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
56505449|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56505450|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56505451|NCT01085097|Prednisolone|prednisolone|mesh-list
56505452|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
56505453|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56505455|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56505456|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
56505457|NCT01085097|Hormones|hormones|mesh-ancestor
56505458|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505459|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505460|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56505461|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505462|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56505463|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56505464|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
56505465|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56505466|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505467|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505468|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505469|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
56505470|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
56505471|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505472|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56505473|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56505474|NCT01085097|Protective Agents|protective agents|mesh-ancestor
56505475|NCT00590837|Lomustine|lomustine|mesh-list
56505476|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56505477|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
56505478|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505479|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505480|NCT01086267|Cetuximab|cetuximab|mesh-list
56505481|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56505482|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505483|NCT00590915|Asparaginase|asparaginase|mesh-list
56505484|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505485|NCT04567290|Ticagrelor|ticagrelor|mesh-list
56505486|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56505487|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56505488|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56505489|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56505490|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
56505491|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505492|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253256|NCT01879488|Edetic Acid|edetic acid|mesh-list
56253257|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
56253258|NCT01879488|Antidotes|antidotes|mesh-ancestor
56253259|NCT01879488|Protective Agents|protective agents|mesh-ancestor
56253260|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253261|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
56253263|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253264|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56253265|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
56253266|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56253267|NCT01879514|Prednisone|prednisone|mesh-list
56505493|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505494|NCT01084161|Morphine|morphine|mesh-list
56505495|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56505496|NCT01084161|Narcotics|narcotics|mesh-ancestor
56505497|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505498|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505499|NCT01084161|Analgesics|analgesics|mesh-ancestor
56505500|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
56505501|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505502|NCT01083615|Prednisone|prednisone|mesh-list
56505503|NCT01083615|Docetaxel|docetaxel|mesh-list
56505504|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505505|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
56505506|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
56505507|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
56505508|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505509|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56505510|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
56505511|NCT01083615|Hormones|hormones|mesh-ancestor
56505512|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505513|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505514|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56167548|NCT00004866|Exatecan|exatecan|mesh-list
56505515|NCT00591188|Interferons|interferons|mesh-list
56505516|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
56505517|NCT00591188|Capecitabine|capecitabine|mesh-list
56505518|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56505519|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
56505520|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505521|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505522|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
56505523|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505524|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
56505525|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505526|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56505527|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505528|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56505529|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505530|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505531|NCT01081782|Ceralifimod|ceralifimod|mesh-list
56505532|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56505533|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505534|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505535|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
56505536|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505537|NCT01080222|Ribavirin|ribavirin|mesh-list
56505538|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56505539|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
56505540|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505541|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
56505542|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505543|NCT03452267|Metformin|metformin|mesh-list
56505544|NCT03452267|Pioglitazone|pioglitazone|mesh-list
56505545|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56505546|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505547|NCT01088802|Carboplatin|carboplatin|mesh-list
56253611|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56505548|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505549|NCT03451682|Procyanidin|procyanidin|mesh-list
56505550|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
56505551|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505552|NCT03451682|Protective Agents|protective agents|mesh-ancestor
56253275|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56253276|NCT01879527|Amiloride|amiloride|mesh-list
56253277|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
56253279|NCT01879527|Diuretics|diuretics|mesh-ancestor
56505553|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505554|NCT04992624|Dronabinol|dronabinol|mesh-list
56505555|NCT04992624|Cannabidiol|cannabidiol|mesh-list
56505556|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
56505557|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
56505558|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505559|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56505560|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56505561|NCT04992624|Analgesics|analgesics|mesh-ancestor
56505562|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
56505563|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505564|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56505565|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56505566|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505567|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505568|NCT04992624|Hormones|hormones|mesh-ancestor
56505569|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505570|NCT03451487|Acetaminophen|acetaminophen|mesh-list
56505571|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56505572|NCT03451487|Analgesics|analgesics|mesh-ancestor
56505573|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
56505574|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505575|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505576|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
56505577|NCT02210754|Menthol|menthol|mesh-list
56505578|NCT02210754|Nicotine|nicotine|mesh-list
56505579|NCT02210754|Glycerol|glycerol|mesh-list
56505580|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56505581|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
56505582|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505583|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505584|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56505585|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56505586|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
56505587|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505588|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505589|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
56505590|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
56505591|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56505592|NCT02210754|Protective Agents|protective agents|mesh-ancestor
56505593|NCT04998279|Lenograstim|lenograstim|mesh-list
56505594|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56505595|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
56505596|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505597|NCT04574141|Melatonin|melatonin|mesh-list
56505598|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
56505599|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505600|NCT04574141|Protective Agents|protective agents|mesh-ancestor
56505601|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505602|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505603|NCT04998981|Fenofibrate|fenofibrate|mesh-list
56505604|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56505605|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
56505606|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505607|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56505608|NCT04573049|Simendan|simendan|mesh-list
56505609|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56505610|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
56505611|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56505612|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56505613|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505614|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505615|NCT04573049|Protective Agents|protective agents|mesh-ancestor
56505616|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505617|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
56505618|NCT04572698|Growth Substances|growth substances|mesh-ancestor
56505619|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505620|NCT04572620|Rituximab|rituximab|mesh-list
56505621|NCT04572620|Abatacept|abatacept|mesh-list
56505622|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56505623|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505624|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
56505625|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505626|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505627|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56505628|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505629|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505630|NCT04572542|Paclitaxel|paclitaxel|mesh-list
56505631|NCT04572542|Apatinib|apatinib|mesh-list
56505632|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56505633|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505634|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
56505635|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
56505636|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
56505637|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505638|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56505639|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505640|NCT04991103|Dexamethasone|dexamethasone|mesh-list
56505641|NCT04991103|Lenalidomide|lenalidomide|mesh-list
56505642|NCT04991103|Bortezomib|bortezomib|mesh-list
56505643|NCT04991103|Daratumumab|daratumumab|mesh-list
56505644|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56505645|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
56505646|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
56505647|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505648|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505649|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56505650|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
56505651|NCT04991103|Hormones|hormones|mesh-ancestor
56505652|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505653|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56505654|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505655|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
56505656|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56505657|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56505658|NCT04991103|Growth Substances|growth substances|mesh-ancestor
56505659|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
56505660|NCT03451019|Sevelamer|sevelamer|mesh-list
56505661|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
56505662|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
56505663|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505664|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
56505665|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56505666|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505667|NCT02211066|Clopidogrel|clopidogrel|mesh-list
56505669|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56505670|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56505671|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56505672|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56505673|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
56505674|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505675|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505676|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505677|NCT04995978|Pioglitazone|pioglitazone|mesh-list
56505678|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56505679|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505680|NCT03450317|Aspirin|aspirin|mesh-list
56505681|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56505682|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56505683|NCT03450317|Analgesics|analgesics|mesh-ancestor
55757702|NCT04965051|Insulin|insulin|mesh-list
56505684|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
56505685|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505686|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505687|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56505688|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505689|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56505690|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56505691|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505692|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56505693|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56505694|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505695|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
56505696|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
56505697|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56505698|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505700|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56505701|NCT03450161|Narcotics|narcotics|mesh-ancestor
56505702|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505703|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505704|NCT03450161|Analgesics|analgesics|mesh-ancestor
56505705|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
56505706|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505707|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56505708|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56505709|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
56505710|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
56505711|NCT04565184|Artesunate|artesunate|mesh-list
56505712|NCT04565184|Lumefantrine|lumefantrine|mesh-list
56505713|NCT04565184|Artemether|artemether|mesh-list
56505714|NCT04565184|Amodiaquine|amodiaquine|mesh-list
56505715|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56505716|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
56505717|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
56505718|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56505719|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56505720|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505721|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505722|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
56505724|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56505725|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
56505726|NCT03452579|Bevacizumab|bevacizumab|mesh-list
56505727|NCT03452579|Nivolumab|nivolumab|mesh-list
56505728|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56505729|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505730|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56505731|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56505732|NCT03452579|Growth Substances|growth substances|mesh-ancestor
56505733|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505734|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
56505735|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56505736|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505737|NCT04997850|Lenvatinib|lenvatinib|mesh-list
56505738|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505739|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56505740|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505741|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781872|NCT02362165|Bortezomib|bortezomib|mesh-list
56505742|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56505743|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56505744|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56505745|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56505746|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56505747|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56505748|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56505749|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
56505750|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253284|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253285|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56253286|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56505751|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505752|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505753|NCT03456947|Pregabalin|pregabalin|mesh-list
56505754|NCT03456947|Analgesics|analgesics|mesh-ancestor
56505755|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
56505756|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505757|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505758|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
56505759|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56505760|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56505761|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505762|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56505763|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56505764|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56505765|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505766|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56505767|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
56505768|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505769|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505770|NCT04564638|Cyclosporine|cyclosporine|mesh-list
56505771|NCT04564638|Cyclosporins|cyclosporins|mesh-list
56505772|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253839|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505773|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505774|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505775|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
56505776|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505777|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
56505778|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505779|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
56505780|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505781|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56505783|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56505784|NCT04564326|Narcotics|narcotics|mesh-ancestor
56505785|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505786|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505787|NCT04564326|Analgesics|analgesics|mesh-ancestor
56505788|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
56505789|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505790|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56505791|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56505792|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
56505793|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
56505795|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56505796|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505797|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56505798|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505799|NCT03450434|Histamine|histamine|mesh-list
56505800|NCT03450434|Glutarimide|glutarimide|mesh-list
56505801|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
56505802|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
56253289|NCT01879605|Bisacodyl|bisacodyl|mesh-list
56253290|NCT01879605|Sorbitol|sorbitol|mesh-list
56253291|NCT01879605|Cathartics|cathartics|mesh-ancestor
56253292|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746494|NCT02468323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55746495|NCT02468323|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55746496|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55746497|NCT02469259|Oxytocin|oxytocin|mesh-list
55746498|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
55746499|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55746500|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746501|NCT03307213|Sirolimus|sirolimus|mesh-list
55746502|NCT03307213|Umirolimus|umirolimus|mesh-list
55746503|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55746504|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55778512|NCT02651987|Lanreotide|lanreotide|mesh-list
55746506|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746507|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55746508|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746509|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55746510|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505803|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505804|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505805|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505806|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56505807|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505808|NCT00198029|Hylan|hylan|mesh-list
56505809|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
56505810|NCT00198029|Protective Agents|protective agents|mesh-ancestor
56505811|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505812|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56505813|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56505814|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
56505815|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505816|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505817|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56505818|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
56505819|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
56505820|NCT02215122|Hormones|hormones|mesh-ancestor
56505821|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505822|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
56505823|NCT00196976|Edetic Acid|edetic acid|mesh-list
56505824|NCT00196976|Vaccines|vaccines|mesh-list
56505825|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
56505826|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
56505827|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505828|NCT00196976|Antidotes|antidotes|mesh-ancestor
56505829|NCT00196976|Protective Agents|protective agents|mesh-ancestor
56505830|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
56505831|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
56505832|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505833|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56505834|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
56505835|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56505836|NCT04563936|Goserelin|goserelin|mesh-list
56505837|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56505838|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505839|NCT04563975|Paclitaxel|paclitaxel|mesh-list
56505840|NCT04563975|Docetaxel|docetaxel|mesh-list
56505841|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56505842|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505843|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
56505844|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
56505845|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
56505846|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505847|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
56253915|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56505848|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56505849|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
56505850|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56505851|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505852|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56505853|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56505854|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56505855|NCT00195650|Adalimumab|adalimumab|mesh-list
56505856|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56505857|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505858|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
56505859|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56505860|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505861|NCT04560894|Sorafenib|sorafenib|mesh-list
56505862|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505863|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56505864|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505865|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505866|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
56505867|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56505868|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56505869|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505870|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
56505871|NCT04560465|Coagulants|coagulants|mesh-ancestor
56505872|NCT00195494|Etanercept|etanercept|mesh-list
56505873|NCT00195494|Methotrexate|methotrexate|mesh-list
56505874|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56505875|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
56505876|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56505877|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505878|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56505879|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
56505880|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505881|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505882|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
56505883|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505884|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56505885|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505886|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
56505887|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505888|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56505889|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56505890|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56505891|NCT00195494|Analgesics|analgesics|mesh-ancestor
56505892|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
56505893|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505894|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56505895|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56505896|NCT00194987|Prednisone|prednisone|mesh-list
56505897|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
56505898|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56505899|NCT00194987|Antibodies|antibodies|mesh-list
56505900|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
56505901|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56505902|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56505903|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
56505904|NCT00194987|Hormones|hormones|mesh-ancestor
56505905|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505906|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505907|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56505908|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505909|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
56505910|NCT00194792|Paclitaxel|paclitaxel|mesh-list
56505911|NCT00194792|Vinorelbine|vinorelbine|mesh-list
56505912|NCT00194792|Capecitabine|capecitabine|mesh-list
56505913|NCT00194792|Methotrexate|methotrexate|mesh-list
56505914|NCT00194792|Exemestane|exemestane|mesh-list
56253293|NCT01879605|Laxatives|laxatives|mesh-ancestor
56253294|NCT01879748|Rasagiline|rasagiline|mesh-list
56253295|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55757959|NCT04423731|Leucovorin|leucovorin|mesh-list
56505915|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56505916|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56505917|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505918|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
56505919|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
56505920|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
56505921|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505922|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56505923|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
56505924|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56505925|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
56505926|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56505927|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505928|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
56167582|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
56505929|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505930|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56505931|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56505932|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
56505933|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56505934|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56505935|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56505936|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56505937|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56505938|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
56505939|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505940|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
56505941|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56505942|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
56505943|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56505944|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56505947|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56505948|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56505949|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56505950|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56505951|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
56505952|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505953|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505954|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505955|NCT00194675|Testosterone|testosterone|mesh-list
56505956|NCT00194675|Dutasteride|dutasteride|mesh-list
56505957|NCT00194675|Androgens|androgens|mesh-ancestor
56505958|NCT00194675|Hormones|hormones|mesh-ancestor
56505959|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505960|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505961|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56505962|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56505963|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56505964|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253296|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253297|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253298|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56253299|NCT01879748|Protective Agents|protective agents|mesh-ancestor
56253300|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253301|NCT01879917|Liraglutide|liraglutide|mesh-list
56253302|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56253303|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253304|NCT01879917|Incretins|incretins|mesh-ancestor
56253305|NCT01879917|Hormones|hormones|mesh-ancestor
56253306|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56505965|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
56505966|NCT00194012|Aripiprazole|aripiprazole|mesh-list
55820359|NCT01733758|Incretins|incretins|mesh-ancestor
56505967|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
56505968|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56505969|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56505970|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56505971|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505972|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505973|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
56505974|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
56505975|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56505976|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505977|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56505978|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56505979|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
56505980|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56505981|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56505982|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56505983|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56505984|NCT04563351|Anesthetics|anesthetics|mesh-list
56505985|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
56505986|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56505987|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56505988|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
56505989|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56505990|NCT00192647|Ribavirin|ribavirin|mesh-list
56505991|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56505992|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
56505993|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
56505994|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56505995|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
56254081|NCT01886196|Ibuprofen|ibuprofen|mesh-list
56505996|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56505997|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56505998|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
56505999|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
56506001|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56506002|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506003|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56506004|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56506005|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506006|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506007|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506008|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506009|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
56506010|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56506011|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
56506012|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56506013|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56506014|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
56506015|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
56506016|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
56506017|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56506018|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56506019|NCT04560816|Growth Substances|growth substances|mesh-ancestor
56506020|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
56506021|NCT04563429|Vitamin A|vitamin a|mesh-list
56506022|NCT04563429|Vitamins|vitamins|mesh-ancestor
56506023|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
56506024|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506025|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56506026|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56506027|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56506028|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55746511|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
55746512|NCT03302299|Pyridoxine|pyridoxine|mesh-list
55746513|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
55746514|NCT03302299|Isoniazid|isoniazid|mesh-list
55746515|NCT03302299|Vitamins|vitamins|mesh-ancestor
55746516|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
55746517|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746519|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
55746520|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55746521|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746522|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55746523|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56506029|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506030|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
56506031|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506032|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506033|NCT00191984|Irinotecan|irinotecan|mesh-list
56506034|NCT00191984|Pemetrexed|pemetrexed|mesh-list
56506035|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56506036|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56506037|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506038|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506039|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506040|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56506041|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56506042|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
56506043|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56506044|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506045|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56506046|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56506047|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56506048|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56506049|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506050|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
56506051|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506052|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506053|NCT00191789|Gemcitabine|gemcitabine|mesh-list
56506054|NCT00191789|Doxorubicin|doxorubicin|mesh-list
56506055|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506056|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56506057|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
56506058|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506059|NCT00191789|Antiviral Agents|antiviral agents|mesh-ancestor
56506060|NCT00191789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506061|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506062|NCT00191789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506063|NCT00191789|Immunologic Factors|immunologic factors|mesh-ancestor
56506064|NCT00191789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506065|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56506066|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56506067|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56506068|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
56506069|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56506070|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56506071|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506072|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
56506073|NCT04559880|Coagulants|coagulants|mesh-ancestor
56506074|NCT00191282|Insulin|insulin|mesh-list
56506075|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56506076|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
56506077|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
56506078|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
56506079|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
56506080|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
56506081|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56506082|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506083|NCT04560231|Remdesivir|remdesivir|mesh-list
56506084|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
56506085|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506086|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
56506087|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506088|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56506089|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56506090|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56506091|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56506092|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506093|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
56506094|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506095|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506096|NCT00198263|Bleomycin|bleomycin|mesh-list
56506097|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56506098|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506099|NCT00198107|Cycloserine|cycloserine|mesh-list
56506100|NCT00198107|Aripiprazole|aripiprazole|mesh-list
56506101|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
56506102|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56506103|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56506104|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56506105|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56506106|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506107|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
56506108|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
56506109|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506110|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506111|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56506112|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56506113|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
56506114|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56506115|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56506116|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56506117|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56506118|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56506119|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506121|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56506122|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
56506123|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56506124|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
56506125|NCT00179660|Lenalidomide|lenalidomide|mesh-list
56506126|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
56506127|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506128|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56506129|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56506130|NCT00179660|Growth Substances|growth substances|mesh-ancestor
56506131|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
56506132|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506133|NCT00178256|Paclitaxel|paclitaxel|mesh-list
56253307|NCT01879930|Doxycycline|doxycycline|mesh-list
56506134|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56506135|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506136|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
56506137|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
56506138|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
56167594|NCT00004884|Antiviral Agents|antiviral agents|mesh-ancestor
56506139|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506141|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506142|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56506143|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254217|NCT01887119|Eplerenone|eplerenone|mesh-list
56506144|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506146|NCT00177164|Risperidone|risperidone|mesh-list
56506147|NCT00177164|Aripiprazole|aripiprazole|mesh-list
56506148|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56506149|NCT00177164|Ziprasidone|ziprasidone|mesh-list
56506150|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
56506151|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56506152|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
56506153|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506154|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506155|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506156|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56506157|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56506158|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56506159|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56506160|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
56506161|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
56506162|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
56506163|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506164|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56506165|NCT00177164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56506166|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56506167|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56506168|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
56506169|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
56506170|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56506171|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56506172|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56506173|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56506174|NCT04559841|Simvastatin|simvastatin|mesh-list
56506175|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56506176|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56506177|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
56506178|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506179|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56506180|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56506181|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506182|NCT02489942|Empagliflozin|empagliflozin|mesh-list
56506183|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56506184|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506185|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56506186|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506187|NCT04559568|Midazolam|midazolam|mesh-list
56506188|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56506189|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56506190|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56506191|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506192|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56506193|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56506194|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56506195|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56506196|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
56506197|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
56506198|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
56506199|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
56506200|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506201|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506202|NCT00176462|Leucovorin|leucovorin|mesh-list
56506203|NCT00176462|Cytarabine|cytarabine|mesh-list
56506204|NCT00176462|Dexamethasone|dexamethasone|mesh-list
56506205|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
56506206|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
56506207|NCT00176462|Methotrexate|methotrexate|mesh-list
56506208|NCT00176462|Vincristine|vincristine|mesh-list
56506209|NCT00176462|Asparaginase|asparaginase|mesh-list
56506210|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
56506211|NCT00176462|Thioguanine|thioguanine|mesh-list
56506212|NCT00176462|Daunorubicin|daunorubicin|mesh-list
56506213|NCT00176462|Aminopterin|aminopterin|mesh-list
56506214|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506215|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
56506216|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506217|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506218|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56506219|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
56506220|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506221|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506222|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56506223|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506224|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
56506225|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
56506226|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506227|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56506228|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
56506229|NCT00176462|Hormones|hormones|mesh-ancestor
56506230|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506231|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56506232|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56506233|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
56506234|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56506235|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56506236|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
56506237|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
56506238|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506239|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56506240|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56506241|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
56506242|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506243|NCT00176462|Antidotes|antidotes|mesh-ancestor
56506244|NCT00176462|Protective Agents|protective agents|mesh-ancestor
56506245|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
56506246|NCT00176462|Vitamins|vitamins|mesh-ancestor
56506247|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
56506248|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56506249|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
56506250|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
56506251|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
56506252|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56506253|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56506254|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56506255|NCT00175019|Allopurinol|allopurinol|mesh-list
56506256|NCT00175019|Febuxostat|febuxostat|mesh-list
56506257|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
56506258|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506259|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506260|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
56506261|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506262|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56506263|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
56506264|NCT00175019|Protective Agents|protective agents|mesh-ancestor
56167616|NCT00004926|Vitamin D|vitamin d|mesh-list
56506265|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506266|NCT00174941|Febuxostat|febuxostat|mesh-list
56506267|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
55758276|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56506268|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506269|NCT00171704|Tamoxifen|tamoxifen|mesh-list
56506270|NCT00171704|Letrozole|letrozole|mesh-list
56506271|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506272|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56506273|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56506274|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506275|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506276|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56506277|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
56506278|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506279|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506280|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56506281|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56506282|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56506283|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56506284|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
56506285|NCT00171314|Letrozole|letrozole|mesh-list
56506286|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506287|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56506288|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56506289|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506290|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506291|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56506292|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
56506293|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506294|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506295|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56506296|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
56506297|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506298|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56506299|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506300|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506301|NCT00170846|Everolimus|everolimus|mesh-list
56506302|NCT00170846|Azathioprine|azathioprine|mesh-list
56506303|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56506304|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506305|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506306|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
56506307|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506308|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506309|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506310|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
56506311|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56506312|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506313|NCT00476606|Ritonavir|ritonavir|mesh-list
56506314|NCT00476606|Nelfinavir|nelfinavir|mesh-list
56506315|NCT00476606|Indinavir|indinavir|mesh-list
56506316|NCT00476606|Saquinavir|saquinavir|mesh-list
56506317|NCT00476606|Lamivudine|lamivudine|mesh-list
56506318|NCT00476606|Zidovudine|zidovudine|mesh-list
56506319|NCT00476606|Nevirapine|nevirapine|mesh-list
56506320|NCT00476606|Didanosine|didanosine|mesh-list
56506321|NCT00476606|Stavudine|stavudine|mesh-list
56506322|NCT00476606|Efavirenz|efavirenz|mesh-list
56506323|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56506324|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56506325|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
56506326|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506327|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506328|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56506329|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56506330|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
56506331|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506332|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56506333|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56506334|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56506335|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56506336|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
55746524|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
55746525|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746526|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55746527|NCT03302221|Ropivacaine|ropivacaine|mesh-list
55746528|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
55746529|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56506337|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56506338|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56506339|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56506340|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56506341|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56506342|NCT04562103|Epinephrine|epinephrine|mesh-list
56506343|NCT04562103|Ropivacaine|ropivacaine|mesh-list
56506344|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
56506345|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
56506346|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56506347|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506348|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
56506349|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506350|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56506351|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56506352|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
56506353|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506354|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506355|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56506356|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56506357|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
56506358|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56506359|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
56506360|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
56506361|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
56506362|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56506363|NCT04561635|Micronutrients|micronutrients|mesh-list
56506364|NCT04561635|Trace Elements|trace elements|mesh-list
56506365|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506366|NCT00479882|Simvastatin|simvastatin|mesh-list
56506367|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56506368|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56506369|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
56506370|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506371|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56506372|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56506373|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506374|NCT00479765|Paclitaxel|paclitaxel|mesh-list
56506375|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56506376|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506377|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
56506378|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
56506379|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
56506380|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506381|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
56506382|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56506383|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
56506384|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506385|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
56506386|NCT00479687|Protective Agents|protective agents|mesh-ancestor
56506387|NCT00479336|Tolvaptan|tolvaptan|mesh-list
56506388|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56506389|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506390|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
56506391|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506392|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
56506393|NCT00478244|Busulfan|busulfan|mesh-list
56506394|NCT00478244|Fludarabine|fludarabine|mesh-list
56506395|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
56506396|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506397|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
56506398|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506399|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506400|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56506401|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
56506402|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506403|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506404|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56506405|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56506406|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
56506408|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56506409|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506410|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506411|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
56506412|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506413|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506414|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
56506415|NCT00477971|Dexamethasone|dexamethasone|mesh-list
56506416|NCT00477971|Melphalan|melphalan|mesh-list
56506417|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506418|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
56506419|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
56506420|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506421|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506422|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56506423|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
56506424|NCT00477971|Hormones|hormones|mesh-ancestor
56506425|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506426|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56506427|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506428|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
56506429|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56506430|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
56506431|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506432|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56506433|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506434|NCT00477464|Capecitabine|capecitabine|mesh-list
56506435|NCT00477464|Lapatinib|lapatinib|mesh-list
56506436|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56506437|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
56506438|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506439|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506440|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56506441|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506442|NCT00477386|Decitabine|decitabine|mesh-list
56506443|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56506444|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
56506445|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506446|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506447|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506448|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
56506449|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506450|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56506451|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506452|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506454|NCT00476996|Leflunomide|leflunomide|mesh-list
56506455|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
56506456|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56506457|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
56506458|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56506459|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506460|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56506461|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
56506462|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506463|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506464|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
56506465|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506466|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56506467|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506468|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
56506469|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506470|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56506471|NCT00476957|Sirolimus|sirolimus|mesh-list
56506472|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56506473|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506474|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56506475|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506476|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
55758490|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
56506477|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506478|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
56506479|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506480|NCT00475865|Teriflunomide|teriflunomide|mesh-list
56506481|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
56506482|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
56506483|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56506484|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
56506485|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506486|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506487|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506488|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56506489|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56506490|NCT00475865|Analgesics|analgesics|mesh-ancestor
56506491|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
56506492|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506493|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506494|NCT00475670|Paclitaxel|paclitaxel|mesh-list
56506495|NCT00475670|Docetaxel|docetaxel|mesh-list
56506496|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56506497|NCT00475670|Trastuzumab|trastuzumab|mesh-list
56506499|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56506500|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506501|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
56506502|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
56506503|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
56506504|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506505|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56506506|NCT04556760|Prednisolone|prednisolone|mesh-list
56506507|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506508|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
56506509|NCT04556760|Hormones|hormones|mesh-ancestor
56506510|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506511|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506512|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56506513|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506514|NCT00474929|Everolimus|everolimus|mesh-list
56506515|NCT00474929|Sorafenib|sorafenib|mesh-list
56506516|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506517|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506518|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
56506519|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506520|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56506521|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506522|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506523|NCT00474812|Dasatinib|dasatinib|mesh-list
56506524|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506525|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56506526|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506527|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506528|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
56506529|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
56506530|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506531|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56506532|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506533|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506534|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
56506535|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506536|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506537|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56506538|NCT00474383|Hormones|hormones|mesh-ancestor
56506539|NCT00472199|Pramipexole|pramipexole|mesh-list
56506540|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
56506541|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167646|NCT00004992|Metformin|metformin|mesh-list
56506542|NCT00472199|Protective Agents|protective agents|mesh-ancestor
56506543|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506544|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56506545|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56506546|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
56506547|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
56506548|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506549|NCT04556136|Vitamin D|vitamin d|mesh-list
56506550|NCT04556136|Vitamins|vitamins|mesh-ancestor
56506551|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
56506552|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506553|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56506554|NCT00471887|Tremelimumab|tremelimumab|mesh-list
56506555|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506556|NCT04556058|Perindopril|perindopril|mesh-list
56506557|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56506558|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
56506559|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506560|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506561|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56506562|NCT00470834|Bicalutamide|bicalutamide|mesh-list
56506563|NCT00470834|Dutasteride|dutasteride|mesh-list
56506564|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
56506565|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
56506566|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506567|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506568|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506569|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56506570|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56506571|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506572|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506573|NCT00470366|Paclitaxel|paclitaxel|mesh-list
56506574|NCT00470366|Ifosfamide|ifosfamide|mesh-list
56506575|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56506576|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506577|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
56506578|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
56506579|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
56506580|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506581|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56506582|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
56506583|NCT02212431|Cysteamine|cysteamine|mesh-list
56506584|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56506585|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506586|NCT00470093|Interferons|interferons|mesh-list
56506587|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506588|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
56506589|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506590|NCT00470054|Dasatinib|dasatinib|mesh-list
56506591|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506592|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56506593|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506594|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254663|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
56506595|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56506596|NCT00478595|Rimonabant|rimonabant|mesh-list
56506597|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56506598|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56506599|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56506600|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506601|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506602|NCT00478595|Hormones|hormones|mesh-ancestor
56506603|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506604|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506605|NCT04555707|Betamethasone|betamethasone|mesh-list
56253337|NCT01880307|Prednisolone|prednisolone|mesh-list
56506606|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
56506607|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56506608|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
56506609|NCT04555707|Apremilast|apremilast|mesh-list
56506610|NCT04555707|Calcipotriene|calcipotriene|mesh-list
56506611|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56506612|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56167649|NCT00004998|Lamivudine|lamivudine|mesh-list
56506613|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
56506614|NCT04555707|Hormones|hormones|mesh-ancestor
56506615|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506616|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506617|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56506618|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
56506619|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56506620|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56506621|NCT04555707|Analgesics|analgesics|mesh-ancestor
56506622|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
56506623|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506624|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506625|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56506626|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56506627|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506628|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506629|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
56506630|NCT00474188|Dexamethasone|dexamethasone|mesh-list
56506631|NCT00474188|Lenalidomide|lenalidomide|mesh-list
56506632|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506633|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
56506634|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
56506635|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506636|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506637|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56506638|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
56506639|NCT00474188|Hormones|hormones|mesh-ancestor
56506640|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506641|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56506642|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506643|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
56506644|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56506645|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56506646|NCT00474188|Growth Substances|growth substances|mesh-ancestor
56506647|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
56506648|NCT01089647|Budesonide|budesonide|mesh-list
56506649|NCT01089647|Montelukast|montelukast|mesh-list
56506650|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506651|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56506652|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
56506653|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506654|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506655|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56506656|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
56506657|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
56506658|NCT01089647|Hormones|hormones|mesh-ancestor
56506659|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506660|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56253348|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
56253349|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55758696|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
56506661|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
56506662|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56506663|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56506664|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506665|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
56506666|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56506667|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56254739|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
56506668|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56506669|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56506670|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506672|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506673|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506674|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56506675|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506676|NCT01089608|Azithromycin|azithromycin|mesh-list
56506677|NCT01089608|Povidone|povidone|mesh-list
56506678|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56506679|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506680|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
56506681|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
56506682|NCT04554654|Progesterone|progesterone|mesh-list
56506683|NCT04554654|Progestins|progestins|mesh-ancestor
56506684|NCT04554654|Hormones|hormones|mesh-ancestor
56506685|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506686|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506688|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56506689|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506690|NCT01089413|Bevacizumab|bevacizumab|mesh-list
56506691|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56506692|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506693|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56506694|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56506695|NCT01089413|Growth Substances|growth substances|mesh-ancestor
56506696|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506697|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
56506698|NCT02212782|Linagliptin|linagliptin|mesh-list
56506699|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55820360|NCT01733758|Hormones|hormones|mesh-ancestor
56506700|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506701|NCT02212782|Incretins|incretins|mesh-ancestor
56506702|NCT02212782|Hormones|hormones|mesh-ancestor
56506703|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506704|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56506705|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
56506706|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506707|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506708|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56506709|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56506710|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
56506711|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506712|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506713|NCT02212821|Erythromycin|erythromycin|mesh-list
56506714|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
56506715|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56506716|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
56506717|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56506718|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506719|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56506720|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56506721|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506722|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506723|NCT01088243|Mesalamine|mesalamine|mesh-list
56506724|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56506725|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56506726|NCT01088243|Analgesics|analgesics|mesh-ancestor
56506727|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
56506728|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506729|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506730|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506731|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506732|NCT04672499|Cortisone|cortisone|mesh-list
56506733|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506734|NCT04554303|Amlodipine|amlodipine|mesh-list
56506735|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56506736|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56506737|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56506738|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506739|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56254820|NCT01889914|Insulin|insulin|mesh-list
56506740|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506741|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
56506742|NCT01088048|Rituximab|rituximab|mesh-list
56506743|NCT01088048|Fludarabine|fludarabine|mesh-list
56506744|NCT01088048|Lenalidomide|lenalidomide|mesh-list
56506745|NCT01088048|Everolimus|everolimus|mesh-list
56506746|NCT01088048|Bortezomib|bortezomib|mesh-list
56506747|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56506748|NCT01088048|Ofatumumab|ofatumumab|mesh-list
56506749|NCT01088048|Idelalisib|idelalisib|mesh-list
56506750|NCT01088048|Chlorambucil|chlorambucil|mesh-list
56506751|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56506752|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506753|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
56506754|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506755|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506756|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506757|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506758|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56506759|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56506760|NCT01088048|Growth Substances|growth substances|mesh-ancestor
56506761|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
56506762|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56506763|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
56506764|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506765|NCT01087970|Carboplatin|carboplatin|mesh-list
56253351|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253352|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253353|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253354|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
56253355|NCT01880346|Vitamin D|vitamin d|mesh-list
56253356|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
56253357|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
56253358|NCT01880346|Vitamins|vitamins|mesh-list
56253359|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
56253360|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253361|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56506766|NCT01087970|Pemetrexed|pemetrexed|mesh-list
56506767|NCT01087970|Cetuximab|cetuximab|mesh-list
56506768|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506769|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506770|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506771|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56506772|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56506773|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56506774|NCT01087814|Efavirenz|efavirenz|mesh-list
56506775|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56506776|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56506777|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506778|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506779|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
56506780|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506781|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56506782|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56506783|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56506784|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56506785|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56506786|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56506787|NCT01087502|Glimepiride|glimepiride|mesh-list
56506788|NCT01087502|Linagliptin|linagliptin|mesh-list
56506789|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56506790|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56506791|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506792|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56506793|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
56506794|NCT01087502|Incretins|incretins|mesh-ancestor
56506795|NCT01087502|Hormones|hormones|mesh-ancestor
56506796|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506797|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56506798|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
56506799|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506800|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506801|NCT02213211|Lumefantrine|lumefantrine|mesh-list
56506802|NCT02213211|Artemether|artemether|mesh-list
56506803|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56506804|NCT02213211|Artemisinins|artemisinins|mesh-list
56506805|NCT02213211|Artemisinin|artemisinin|mesh-list
56506806|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
56506807|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56506808|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56506809|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506810|NCT01086410|Fluticasone|fluticasone|mesh-list
56506811|NCT01086410|Xhance|xhance|mesh-list
56506812|NCT01086410|Prednisolone|prednisolone|mesh-list
56506813|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506814|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56506815|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
56506816|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758864|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
56506817|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506818|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56506819|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
56506820|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
56506821|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56506822|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
56506823|NCT01086410|Hormones|hormones|mesh-ancestor
56506824|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506825|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56506826|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506827|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56506828|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56506829|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506830|NCT04553328|Bupivacaine|bupivacaine|mesh-list
56506831|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
56506832|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
56506833|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56506834|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506835|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
56506836|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506837|NCT01085591|Vancomycin|vancomycin|mesh-list
56506838|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56506839|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506840|NCT04552977|Temozolomide|temozolomide|mesh-list
56506841|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56506842|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
56506843|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506844|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506845|NCT01085201|Regadenoson|regadenoson|mesh-list
56506846|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56506847|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56506848|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
56506849|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
56506850|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506851|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506852|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506853|NCT02213718|Sufentanil|sufentanil|mesh-list
56506854|NCT02213718|Propofol|propofol|mesh-list
56506855|NCT02213718|Desflurane|desflurane|mesh-list
56506856|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56506857|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56506858|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506859|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56506860|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
56506861|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
56506862|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56506863|NCT02213718|Narcotics|narcotics|mesh-ancestor
56506864|NCT02213718|Analgesics|analgesics|mesh-ancestor
56506865|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
56506866|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506867|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56506868|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56506869|NCT01085045|Bromides|bromides|mesh-list
56506870|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
56506871|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
56506872|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56506873|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
56506874|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506875|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506876|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56506877|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
56506878|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56506879|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56506880|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56506881|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
56506882|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506883|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506884|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
56506885|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56506886|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
56506887|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
56506888|NCT02213796|Meropenem|meropenem|mesh-list
56506889|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56506890|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506891|NCT00179673|Lenalidomide|lenalidomide|mesh-list
56506892|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
56506893|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506894|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56506895|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56506896|NCT00179673|Growth Substances|growth substances|mesh-ancestor
56506897|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56506898|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506899|NCT01084655|Prednisone|prednisone|mesh-list
56506900|NCT01084655|Docetaxel|docetaxel|mesh-list
56506901|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506902|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
56506903|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
56506904|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
56506905|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506906|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506907|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
56506908|NCT01084655|Hormones|hormones|mesh-ancestor
56506909|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506910|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506911|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56506912|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
56506913|NCT04552431|Tamsulosin|tamsulosin|mesh-list
56506914|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56506915|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56506916|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56506917|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56506918|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506919|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506920|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506921|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56506922|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56506923|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56506924|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56506925|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56506926|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
56506927|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56506928|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506929|NCT04552431|Urological Agents|urological agents|mesh-ancestor
56506930|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
56506931|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56506932|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506933|NCT01084538|Vitamins|vitamins|mesh-ancestor
56506934|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
56506935|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56506936|NCT00179517|Anastrozole|anastrozole|mesh-list
56506937|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56506938|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506939|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56506940|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56506941|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506942|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506943|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56506944|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
56506945|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506946|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506947|NCT01083641|Estradiol|estradiol|mesh-list
56506948|NCT01083641|Estrogens|estrogens|mesh-ancestor
56506949|NCT01083641|Hormones|hormones|mesh-ancestor
56506950|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506951|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506952|NCT00179010|Adenosine|adenosine|mesh-list
56506953|NCT00179010|Analgesics|analgesics|mesh-ancestor
55758993|NCT04898907|Mitogens|mitogens|mesh-list
56506954|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
56506955|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506956|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506957|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56506958|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
56506959|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56506960|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
56506961|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
56167670|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
56506963|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506964|NCT01083602|Dexamethasone|dexamethasone|mesh-list
56506965|NCT01083602|Bortezomib|bortezomib|mesh-list
56506966|NCT01083602|Panobinostat|panobinostat|mesh-list
56506967|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506969|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
56506970|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506971|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506972|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56506973|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
56506974|NCT01083602|Hormones|hormones|mesh-ancestor
56506975|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56506976|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56506977|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56506978|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56506979|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506980|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506981|NCT00178464|Aspirin|aspirin|mesh-list
56506982|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56506983|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56506984|NCT00178464|Analgesics|analgesics|mesh-ancestor
56506985|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
56506986|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56506987|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56506988|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56506989|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56506990|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56506991|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56506992|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56506993|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56506994|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56506995|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56506996|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
56506997|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
56506998|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56506999|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
56507000|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507001|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
56507002|NCT04671914|Protective Agents|protective agents|mesh-ancestor
56507003|NCT01083485|Oxycodone|oxycodone|mesh-list
56507004|NCT01083485|Naloxone|naloxone|mesh-list
56507005|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56507006|NCT01083485|Narcotics|narcotics|mesh-ancestor
56507007|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507008|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507009|NCT01083485|Analgesics|analgesics|mesh-ancestor
56507010|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
56507011|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507012|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56507013|NCT04551924|Ropivacaine|ropivacaine|mesh-list
56507014|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
56507015|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
56507016|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507017|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507018|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
56507019|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507020|NCT04671836|Lorazepam|lorazepam|mesh-list
56507021|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
56507022|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
56507023|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
56507024|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253364|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
56507025|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507026|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507027|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56507028|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507029|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56507030|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56507031|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56507032|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
56507033|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
56507034|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507035|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507037|NCT00556088|Bevacizumab|bevacizumab|mesh-list
56507038|NCT00556088|Carboplatin|carboplatin|mesh-list
56507039|NCT00556088|Panobinostat|panobinostat|mesh-list
56507040|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56507041|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507042|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
56507043|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
56507044|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56507045|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507046|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56507047|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56507048|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56507049|NCT00556088|Growth Substances|growth substances|mesh-ancestor
56507050|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507051|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
56507052|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56507053|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507055|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
56507056|NCT02213913|Rituximab|rituximab|mesh-list
56507057|NCT02213913|Doxorubicin|doxorubicin|mesh-list
56507058|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56507059|NCT02213913|Etoposide|etoposide|mesh-list
56507060|NCT02213913|Vincristine|vincristine|mesh-list
56507061|NCT02213913|Lenalidomide|lenalidomide|mesh-list
56507062|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
56507063|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507064|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
56507065|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507066|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56507067|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56507068|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
56507069|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507070|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507071|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56507072|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56507073|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56507074|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56507075|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56507076|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507077|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507078|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
56507079|NCT02213913|Hormones|hormones|mesh-ancestor
56253367|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253368|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
56253369|NCT01880372|Vitamins|vitamins|mesh-ancestor
56253370|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
56253371|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
56253372|NCT01880385|Bevacizumab|bevacizumab|mesh-list
56253373|NCT01880385|Docetaxel|docetaxel|mesh-list
56253374|NCT01880385|Fluorouracil|fluorouracil|mesh-list
56253375|NCT01880385|Trastuzumab|trastuzumab|mesh-list
56253376|NCT01880385|Epirubicin|epirubicin|mesh-list
56507080|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507081|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56507082|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56507083|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
56507084|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
56507085|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
56507086|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56507087|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56507088|NCT02213913|Growth Substances|growth substances|mesh-ancestor
56507089|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
56507090|NCT00177294|Citalopram|citalopram|mesh-list
56507091|NCT00177294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56507092|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56507093|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507094|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507095|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507096|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
56507097|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507098|NCT00177294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56507099|NCT00177294|Antidepressive Agents|antidepressive agents|mesh-ancestor
56507100|NCT00177294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56507101|NCT01082081|Acetaminophen|acetaminophen|mesh-list
56507102|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56507103|NCT01082081|Analgesics|analgesics|mesh-ancestor
56507104|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
56507105|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507106|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507107|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
56507108|NCT00177216|Zolpidem|zolpidem|mesh-list
56507109|NCT00177216|Citalopram|citalopram|mesh-list
56507110|NCT00177216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56507111|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56507112|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507113|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507114|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507115|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
56507116|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507117|NCT00177216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56507118|NCT00177216|Antidepressive Agents|antidepressive agents|mesh-ancestor
56507119|NCT00177216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56507120|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56507121|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56507122|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507123|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56507124|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
56507125|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
56507126|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56507127|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
56507128|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56507129|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507130|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507131|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56507132|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56507133|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56507134|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
56507135|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507136|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507137|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56507138|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55759181|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56507139|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
56507140|NCT04551768|Ribavirin|ribavirin|mesh-list
56507141|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
56507142|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507143|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
56507144|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507145|NCT04671563|Tenofovir|tenofovir|mesh-list
56507146|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
56507147|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507148|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56507149|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56507150|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507151|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507152|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56507153|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56507154|NCT04551573|Rifapentine|rifapentine|mesh-list
56507155|NCT04551573|Rifampin|rifampin|mesh-list
56507156|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56507157|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
56507158|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56507159|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507160|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
56507161|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56507162|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507163|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56167682|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56507164|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56507165|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56507166|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56507167|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56507168|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56507169|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56507170|NCT01081145|Guanfacine|guanfacine|mesh-list
56507171|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56507172|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56507173|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56507174|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56507175|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
56507176|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507177|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507178|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507179|NCT00174915|Allopurinol|allopurinol|mesh-list
56507180|NCT00174915|Febuxostat|febuxostat|mesh-list
56507181|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
56507182|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507183|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507184|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
56507185|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56507186|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56507187|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
56507188|NCT00174915|Protective Agents|protective agents|mesh-ancestor
56507189|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507190|NCT01080716|Vaccines|vaccines|mesh-list
56507191|NCT01080716|Complement Factor H|complement factor h|mesh-list
56507192|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
56507193|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507194|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56507195|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507196|NCT04671446|Autoantibodies|autoantibodies|mesh-list
56507197|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
56507198|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507199|NCT04571489|Gemcitabine|gemcitabine|mesh-list
56507200|NCT04571489|Tegafur|tegafur|mesh-list
56507201|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56507202|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
56507203|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507204|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507205|NCT04571489|Antiviral Agents|antiviral agents|mesh-ancestor
56507206|NCT04571489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507207|NCT04571489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507208|NCT04571489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507209|NCT04571489|Immunologic Factors|immunologic factors|mesh-ancestor
56507210|NCT04571489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507211|NCT00172185|Teduglutide|teduglutide|mesh-list
56507212|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507213|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56507214|NCT00172185|Protective Agents|protective agents|mesh-ancestor
56507215|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507216|NCT00171951|Pasireotide|pasireotide|mesh-list
56507218|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507219|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507220|NCT01080131|Triamcinolone|triamcinolone|mesh-list
56507221|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56507222|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56507223|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56507224|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56507225|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507226|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
56507227|NCT01080131|Hormones|hormones|mesh-ancestor
56507228|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507229|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507230|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507231|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
56507232|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507233|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507234|NCT00171873|Octreotide|octreotide|mesh-list
56507235|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507236|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56507237|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507239|NCT01087151|Navitoclax|navitoclax|mesh-list
56507240|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56507241|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507242|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
56507243|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507244|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56507245|NCT00171834|Epothilones|epothilones|mesh-list
56507246|NCT00171834|Epothilone B|epothilone b|mesh-list
56507247|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
56507248|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
56507249|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
56507250|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507251|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507252|NCT04670978|Bevacizumab|bevacizumab|mesh-list
56507253|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56507254|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507255|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56507256|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56507257|NCT04670978|Growth Substances|growth substances|mesh-ancestor
56507258|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507259|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
56507260|NCT04571996|Acetaminophen|acetaminophen|mesh-list
56507261|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56507262|NCT04571996|Analgesics|analgesics|mesh-ancestor
56507263|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
56507264|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507265|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507266|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
56507268|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507269|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56507270|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507271|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507272|NCT04671056|Pioglitazone|pioglitazone|mesh-list
56507273|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56253383|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507274|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507275|NCT01082549|Gemcitabine|gemcitabine|mesh-list
56507276|NCT01082549|Carboplatin|carboplatin|mesh-list
56507277|NCT01082549|Iniparib|iniparib|mesh-list
56507278|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507279|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56507280|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
56507281|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507282|NCT01082549|Antiviral Agents|antiviral agents|mesh-ancestor
56507283|NCT01082549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507284|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507285|NCT01082549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507286|NCT01082549|Immunologic Factors|immunologic factors|mesh-ancestor
56507287|NCT01082549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507288|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56507289|NCT04550949|Denosumab|denosumab|mesh-list
56507290|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56507291|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507292|NCT01085630|Pemetrexed|pemetrexed|mesh-list
56507293|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507294|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507295|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507296|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56507297|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56507299|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56507300|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
56507301|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
56507302|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507303|NCT00171054|Amlodipine|amlodipine|mesh-list
56507304|NCT00171054|Valsartan|valsartan|mesh-list
56507305|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56507306|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56507307|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56167698|NCT00005046|Paclitaxel|paclitaxel|mesh-list
56507308|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507309|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507310|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56507311|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507312|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
56507313|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56507314|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56507315|NCT00171054|Diuretics|diuretics|mesh-ancestor
56507316|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
56507317|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56507318|NCT00174837|Tirapazamine|tirapazamine|mesh-list
56507319|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507320|NCT00179400|Pioglitazone|pioglitazone|mesh-list
56507321|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56507322|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507323|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
56507324|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56507325|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507326|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507327|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
56507328|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507329|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507331|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507332|NCT00479856|Paclitaxel|paclitaxel|mesh-list
56507333|NCT00479856|Docetaxel|docetaxel|mesh-list
56507334|NCT00479856|Capecitabine|capecitabine|mesh-list
56507335|NCT00479856|Lapatinib|lapatinib|mesh-list
56507336|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56507337|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507338|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
56507339|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
56507340|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
56255414|NCT01902017|Ketotifen|ketotifen|mesh-list
56507341|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507342|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56507343|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
56507344|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56507345|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507346|NCT04997759|Neostigmine|neostigmine|mesh-list
56507347|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56507348|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507349|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507350|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
56507351|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507352|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507353|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56507354|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
56507355|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507356|NCT00479466|Metformin|metformin|mesh-list
56507357|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56507358|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507359|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
56507360|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56507361|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507362|NCT04990778|Venetoclax|venetoclax|mesh-list
56507363|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507364|NCT00479388|Niacin|niacin|mesh-list
56507365|NCT00479388|Atorvastatin|atorvastatin|mesh-list
56507366|NCT00479388|Simvastatin|simvastatin|mesh-list
56507367|NCT00479388|Calcium|calcium|mesh-list
56507368|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56507369|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507370|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56507371|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56507372|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
56167703|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
56507373|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507374|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56507375|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56507377|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
56253406|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56253407|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55748361|NCT03357653|Losartan|losartan|mesh-list
56507378|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
56507379|NCT00479388|Vitamins|vitamins|mesh-ancestor
56507380|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
56507381|NCT00479232|Decitabine|decitabine|mesh-list
56507382|NCT00479232|Vorinostat|vorinostat|mesh-list
56507383|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56507384|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
56507385|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507386|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507387|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507388|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56507389|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56507390|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
56507391|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56507392|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56507393|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507394|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507395|NCT00478881|Urological Agents|urological agents|mesh-ancestor
56507396|NCT00556127|Cytarabine|cytarabine|mesh-list
56507397|NCT00556127|Dexamethasone|dexamethasone|mesh-list
56507398|NCT00556127|Prednisone|prednisone|mesh-list
56507399|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
56507400|NCT00556127|Melphalan|melphalan|mesh-list
56507401|NCT00556127|Carmustine|carmustine|mesh-list
56507402|NCT00556127|Rituximab|rituximab|mesh-list
56507403|NCT00556127|Etoposide|etoposide|mesh-list
56507404|NCT00556127|Vincristine|vincristine|mesh-list
56507405|NCT00556127|Epirubicin|epirubicin|mesh-list
56507406|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
56507407|NCT00556127|Lenograstim|lenograstim|mesh-list
56507408|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507409|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
56507410|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507411|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56507412|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56507413|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
56507414|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507415|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507416|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56507417|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56507418|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507420|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
56507421|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507422|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507423|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
56507424|NCT00556127|Hormones|hormones|mesh-ancestor
56507425|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507426|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56507427|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56507428|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56507429|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56507430|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507431|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56507432|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
56507433|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
56507434|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507435|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
56507436|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
56507437|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
56507438|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56507439|NCT00556127|Analgesics|analgesics|mesh-ancestor
56507440|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
56507441|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56507442|NCT00556205|Bevacizumab|bevacizumab|mesh-list
56507443|NCT00556205|Sunitinib|sunitinib|mesh-list
56507444|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56507445|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253409|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
56253410|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56507446|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56507447|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56507448|NCT00556205|Growth Substances|growth substances|mesh-ancestor
56507449|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507450|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
56507451|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56507452|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507453|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507454|NCT00478608|Sirolimus|sirolimus|mesh-list
56507455|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56507456|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507457|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56507458|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507459|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
56507460|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507461|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
56507462|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507463|NCT00478140|Trastuzumab|trastuzumab|mesh-list
56507464|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56507465|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507466|NCT00478023|Morphine|morphine|mesh-list
56507467|NCT00478023|Tapentadol|tapentadol|mesh-list
56507468|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56507469|NCT00478023|Narcotics|narcotics|mesh-ancestor
56507470|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507471|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507472|NCT00478023|Analgesics|analgesics|mesh-ancestor
56507473|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
56507474|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507475|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56507476|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56507477|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507478|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507479|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
56507480|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507481|NCT00477750|Prednisone|prednisone|mesh-list
56507482|NCT00477750|Lenalidomide|lenalidomide|mesh-list
56507483|NCT00477750|Melphalan|melphalan|mesh-list
56507484|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507485|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
56507486|NCT00477750|Hormones|hormones|mesh-ancestor
56507487|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507488|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507489|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56507490|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507491|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
56507492|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56507493|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56507494|NCT00477750|Growth Substances|growth substances|mesh-ancestor
56507495|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
56507496|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56507497|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
56507498|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507499|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56507500|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507502|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56507503|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56507504|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56507505|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56253416|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253417|NCT01880619|Urological Agents|urological agents|mesh-ancestor
56253418|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56253419|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55828704|NCT03507491|Gemcitabine|gemcitabine|mesh-list
55759554|NCT04876521|Olanzapine|olanzapine|mesh-list
56507506|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507507|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507508|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56507509|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56507510|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56507511|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
56507512|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507513|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507514|NCT04549935|Prednisolone|prednisolone|mesh-list
56507515|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507516|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
56507517|NCT04549935|Hormones|hormones|mesh-ancestor
56507518|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56167715|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56507519|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507520|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56507521|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507522|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56507523|NCT00477633|Norethindrone|norethindrone|mesh-list
56507524|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
56507525|NCT00477633|Estradiol|estradiol|mesh-list
56507526|NCT00477633|Estrogens|estrogens|mesh-ancestor
56507527|NCT00477633|Hormones|hormones|mesh-ancestor
56507528|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507529|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507530|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56507531|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
56507532|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56507533|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56507534|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56507535|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56507536|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56507537|NCT04541823|Propofol|propofol|mesh-list
56507538|NCT04541823|Desflurane|desflurane|mesh-list
56507539|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56507540|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507541|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507542|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56507543|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
56507544|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
56507545|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56507546|NCT00556361|Ketamine|ketamine|mesh-list
56507547|NCT00556361|Analgesics|analgesics|mesh-ancestor
56507548|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
56507549|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507550|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507551|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56507552|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56507553|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
56507554|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
56507555|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507556|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56507557|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56507558|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871477|NCT05687253|Bromides|bromides|mesh-list
55871478|NCT05687253|Rocuronium|rocuronium|mesh-list
56507559|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507560|NCT04571606|Bupivacaine|bupivacaine|mesh-list
56507561|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
56507562|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
56507563|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507564|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507565|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
56507566|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507567|NCT02210117|Bevacizumab|bevacizumab|mesh-list
56507568|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56507569|NCT02210117|Nivolumab|nivolumab|mesh-list
56507570|NCT02210117|Ipilimumab|ipilimumab|mesh-list
56507571|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
56507572|NCT02210117|Antibodies|antibodies|mesh-list
56507573|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
56507574|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56507575|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
56507576|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507577|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56507578|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56507579|NCT02210117|Growth Substances|growth substances|mesh-ancestor
56507580|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507581|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
56507582|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
56507583|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56507584|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507585|NCT04541277|Cytarabine|cytarabine|mesh-list
56507586|NCT04541277|Azacitidine|azacitidine|mesh-list
56507587|NCT04541277|Decitabine|decitabine|mesh-list
56507588|NCT04541277|Idarubicin|idarubicin|mesh-list
56507589|NCT04541277|Lenograstim|lenograstim|mesh-list
56507590|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56507591|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
56507592|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507593|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507594|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
56507595|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507596|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507597|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
56507598|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507599|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507600|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56507601|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56507602|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56507603|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56507605|NCT04996823|Axitinib|axitinib|mesh-list
56507606|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56507607|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507608|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56507609|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507610|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56507611|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507612|NCT04995653|Vancomycin|vancomycin|mesh-list
56507613|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56507614|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507615|NCT04540926|Cyclosporine|cyclosporine|mesh-list
56507616|NCT04540926|Cyclosporins|cyclosporins|mesh-list
56507617|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507618|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507619|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507620|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
56507621|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507622|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
56507623|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507624|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
56507625|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56507626|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55759679|NCT02613507|Docetaxel|docetaxel|mesh-list
56507627|NCT04540965|Famotidine|famotidine|mesh-list
56507628|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56507629|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507630|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56507631|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
56507632|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
56507633|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507634|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507635|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507636|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
56507637|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56507638|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507639|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56507640|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255716|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
56507641|NCT04570592|Dexamethasone|dexamethasone|mesh-list
56507642|NCT04570592|Granisetron|granisetron|mesh-list
56507643|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56507644|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507645|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
56507646|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
56507647|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507648|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507649|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507650|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
56507651|NCT04570592|Hormones|hormones|mesh-ancestor
56507652|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507653|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56507654|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507655|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56507656|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
56507657|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507658|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507660|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
56507661|NCT02215395|Estradiol|estradiol|mesh-list
56507662|NCT02215395|Estrogens|estrogens|mesh-ancestor
56507663|NCT02215395|Hormones|hormones|mesh-ancestor
56507664|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507665|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507666|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56507667|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56507668|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56507669|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56507670|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56507671|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
56507672|NCT02215434|Testosterone|testosterone|mesh-list
56507673|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
56507674|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
56507675|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56507676|NCT02215434|Androgens|androgens|mesh-ancestor
56507677|NCT02215434|Hormones|hormones|mesh-ancestor
56507678|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507679|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507680|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56507681|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507682|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
56507683|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
56507684|NCT04561076|Paraproteins|paraproteins|mesh-list
56507685|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
56507686|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507687|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
56507688|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56507689|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56507690|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507691|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
56507692|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
56507693|NCT04548219|Mirikizumab|mirikizumab|mesh-list
56507694|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56507695|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56507696|NCT04548219|Analgesics|analgesics|mesh-ancestor
56507697|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
56507698|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507699|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507700|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507701|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56507702|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56507703|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507704|NCT04547829|Lenograstim|lenograstim|mesh-list
56507705|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56507706|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
56507707|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507708|NCT02211911|Bisacodyl|bisacodyl|mesh-list
56507709|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
56507710|NCT02211911|Cathartics|cathartics|mesh-ancestor
56507711|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507712|NCT02211911|Laxatives|laxatives|mesh-ancestor
56507713|NCT01131676|Empagliflozin|empagliflozin|mesh-list
56507714|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56507715|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507716|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56507717|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507718|NCT04560569|Antibodies|antibodies|mesh-list
56507719|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
56507720|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507721|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
56507722|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56507723|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56507724|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56507725|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507726|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507727|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
56507728|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507729|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507730|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56507731|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507732|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56507734|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56507735|NCT02214498|Diuretics|diuretics|mesh-ancestor
56507736|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
56507737|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507738|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56507739|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507740|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507741|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56507742|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
56507743|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507744|NCT04560218|Misoprostol|misoprostol|mesh-list
56507745|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56507746|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
56507747|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56507748|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507749|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56507750|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507751|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
56507752|NCT05135104|Palbociclib|palbociclib|mesh-list
56507753|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507754|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56507755|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507756|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507757|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
56507758|NCT04540185|Vaccines|vaccines|mesh-list
56507759|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
56507760|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507761|NCT04540185|Protective Agents|protective agents|mesh-ancestor
56507762|NCT01130272|Eluxadoline|eluxadoline|mesh-list
56507763|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507764|NCT04546815|Daptomycin|daptomycin|mesh-list
56507765|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56507766|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507767|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56507768|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
56253420|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
56507769|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56507770|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56507771|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507772|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507773|NCT04559165|Chitosan|chitosan|mesh-list
56507774|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56507775|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56507776|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
56507777|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507778|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56507779|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
56507780|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
56507781|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
56507782|NCT04559165|Coagulants|coagulants|mesh-ancestor
56507783|NCT04312048|Isosorbide|isosorbide|mesh-list
56507784|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56507785|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56507786|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56507787|NCT04312048|Diuretics|diuretics|mesh-ancestor
56507788|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
56507789|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507790|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
56507791|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56507792|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507793|NCT04311697|Phentolamine|phentolamine|mesh-list
56507794|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
56507795|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56507796|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56507797|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
56507798|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507799|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507800|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507801|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56507802|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507803|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
56507804|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56507805|NCT04311697|Protective Agents|protective agents|mesh-ancestor
56507806|NCT00575861|Zileuton|zileuton|mesh-list
56507807|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56507808|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56507809|NCT00575861|Analgesics|analgesics|mesh-ancestor
56507810|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
56507811|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507812|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507813|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507814|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56507815|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56507816|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507817|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507818|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56507819|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
56507820|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507821|NCT04547088|Apatinib|apatinib|mesh-list
56507822|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507823|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56507824|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507825|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507827|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
56507828|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56507829|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56507830|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56507831|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507832|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507833|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
56507834|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
56507835|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253421|NCT01880658|Capecitabine|capecitabine|mesh-list
56253422|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253423|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
56507836|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507837|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56507838|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56507839|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
56507840|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56507841|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56507842|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56507843|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56507844|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
56507845|NCT02278419|Simeprevir|simeprevir|mesh-list
56507846|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
56507847|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507848|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
56507849|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507850|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507851|NCT04311580|Mitomycins|mitomycins|mesh-list
56507852|NCT04311580|Mitomycin|mitomycin|mesh-list
56507853|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56507854|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507855|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
56507856|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507857|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56507858|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507859|NCT02882737|Glucagon|glucagon|mesh-list
56507860|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56507861|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507862|NCT02882737|Hormones|hormones|mesh-ancestor
56507863|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507864|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507865|NCT02882737|Incretins|incretins|mesh-ancestor
56507866|NCT02211950|Acarbose|acarbose|mesh-list
56507867|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56507868|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507869|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507870|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56507871|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507872|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
56507873|NCT04539249|Pentazocine|pentazocine|mesh-list
56507874|NCT04539249|Analgesics|analgesics|mesh-ancestor
56507875|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
56507876|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507877|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507878|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
56507879|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507880|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56507881|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
56507882|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56507883|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507884|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507885|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56507886|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
56507887|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56507888|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56507889|NCT04539249|Narcotics|narcotics|mesh-ancestor
56507890|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56507891|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56507892|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
56507893|NCT01129336|Diphosphonates|diphosphonates|mesh-list
56507894|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56507895|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507897|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507898|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
56507899|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507900|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56507901|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507902|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507903|NCT04538820|Dexamethasone|dexamethasone|mesh-list
56507904|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
56507905|NCT04538820|BB 1101|bb 1101|mesh-list
55746639|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
55746640|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55746641|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55746642|NCT03311425|Prednisolone|prednisolone|mesh-list
55746643|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
55746644|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56507906|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507907|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
56507908|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
56507909|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507910|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507911|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56507912|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
56507913|NCT04538820|Hormones|hormones|mesh-ancestor
56507914|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56507915|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56507916|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507917|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
56507918|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507919|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507920|NCT00575978|Hydralazine|hydralazine|mesh-list
56507921|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56507922|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
56507923|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56507924|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56507925|NCT04539054|Caffeine|caffeine|mesh-list
56507926|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56507927|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507928|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56507929|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507930|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507931|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56507932|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56507933|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
56507934|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56507935|NCT00576017|Fentanyl|fentanyl|mesh-list
56507936|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56507937|NCT00576017|Narcotics|narcotics|mesh-ancestor
56507938|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56507939|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507940|NCT00576017|Analgesics|analgesics|mesh-ancestor
56507941|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
56507942|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507943|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56507944|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56507945|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
56507946|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
56507947|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
56507948|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56507949|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507950|NCT04558580|Rufinamide|rufinamide|mesh-list
56507951|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
56507952|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56507953|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56507954|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56507955|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507956|NCT02278458|Gemcitabine|gemcitabine|mesh-list
56507957|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56507958|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
56507959|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56507960|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56507961|NCT02278458|Antiviral Agents|antiviral agents|mesh-ancestor
56507962|NCT02278458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56507963|NCT02278458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56507964|NCT02278458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56507965|NCT02278458|Immunologic Factors|immunologic factors|mesh-ancestor
56507966|NCT02278458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507967|NCT01128595|Fluticasone|fluticasone|mesh-list
56507969|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56507970|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56507971|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
56507972|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507973|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507974|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55746645|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
55746646|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55746647|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
55746648|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
55746649|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746650|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752787|NCT02488889|Ethanol|ethanol|mesh-list
56507975|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
56507976|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
56507977|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56507979|NCT01128244|Pyridoxal|pyridoxal|mesh-list
56507980|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
56507981|NCT01128244|Vitamins|vitamins|mesh-ancestor
56507982|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
56507983|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507984|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
56507985|NCT01127893|Tanezumab|tanezumab|mesh-list
56507986|NCT01127893|Analgesics|analgesics|mesh-ancestor
56507987|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
56507988|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507989|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507990|NCT00576173|Acetaminophen|acetaminophen|mesh-list
56507991|NCT00576173|Tramadol|tramadol|mesh-list
56507992|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56507993|NCT00576173|Analgesics|analgesics|mesh-ancestor
56507994|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
56507995|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56507996|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56507997|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
56507998|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56507999|NCT00576173|Narcotics|narcotics|mesh-ancestor
56508000|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508001|NCT00625339|Lamivudine|lamivudine|mesh-list
56508002|NCT00625339|Entecavir|entecavir|mesh-list
56508003|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56508004|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56508005|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508006|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508007|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
56508008|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508009|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56508010|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56508011|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56508012|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
56508013|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508014|NCT04558463|Oseltamivir|oseltamivir|mesh-list
56508015|NCT04558463|Favipiravir|favipiravir|mesh-list
56508016|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
56508017|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508018|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508019|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508020|NCT01126879|Genistein|genistein|mesh-list
56256095|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
56508021|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56508022|NCT01126879|Protective Agents|protective agents|mesh-ancestor
56508023|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508024|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508025|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56508026|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508027|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508029|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56508030|NCT01126879|Estrogens|estrogens|mesh-ancestor
56508031|NCT01126879|Hormones|hormones|mesh-ancestor
56508032|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508033|NCT04311658|Isosorbide|isosorbide|mesh-list
56508034|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56508035|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56508036|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56508037|NCT04311658|Diuretics|diuretics|mesh-ancestor
56508038|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
56508039|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508040|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
56508041|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56508042|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508043|NCT02882308|Durvalumab|durvalumab|mesh-list
56508044|NCT02882308|Olaparib|olaparib|mesh-list
56508045|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508046|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56508047|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56508048|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508049|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508050|NCT00625456|Molgramostim|molgramostim|mesh-list
56508051|NCT00625456|Sargramostim|sargramostim|mesh-list
56508052|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
56508053|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508054|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508055|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56508056|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508057|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508058|NCT00576329|Ketorolac|ketorolac|mesh-list
56508059|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56508060|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56508061|NCT00576329|Analgesics|analgesics|mesh-ancestor
56508062|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
56508063|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508064|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508065|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508066|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56508067|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56508068|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508069|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508070|NCT02882581|Metformin|metformin|mesh-list
56508071|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56508072|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508073|NCT02882347|Somatostatin|somatostatin|mesh-list
56508074|NCT02882347|Hormones|hormones|mesh-ancestor
56508075|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508076|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508077|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
56508078|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56508079|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508080|NCT00637468|Aspirin|aspirin|mesh-list
56508081|NCT00637468|Heparin|heparin|mesh-list
56508082|NCT00637468|Acetazolamide|acetazolamide|mesh-list
56508083|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56508084|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
56508085|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56508086|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56508087|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508088|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56508089|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56508090|NCT00637468|Analgesics|analgesics|mesh-ancestor
56508091|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
56508092|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508093|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256171|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
56508094|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508095|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871479|NCT05687253|Anticonvulsants|anticonvulsants|mesh-ancestor
56508096|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56508097|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56508098|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508099|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
56508100|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
56508101|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56508102|NCT00637468|Diuretics|diuretics|mesh-ancestor
56508103|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
56508104|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56508105|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
56508106|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508107|NCT02278575|Antithrombins|antithrombins|mesh-list
56508108|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
56508109|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56508110|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
56508111|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508112|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508113|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
56508114|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56508115|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
56508116|NCT01126060|Coagulants|coagulants|mesh-ancestor
56508117|NCT01125748|Omalizumab|omalizumab|mesh-list
56508118|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56508119|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56508120|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
56508121|NCT04558268|Folic Acid|folic acid|mesh-list
56508122|NCT04558268|Prednisone|prednisone|mesh-list
56508123|NCT04558268|Progesterone|progesterone|mesh-list
56508124|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508125|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
56508127|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508128|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508129|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56508130|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508131|NCT04558268|Progestins|progestins|mesh-ancestor
56508132|NCT04558268|Hematinics|hematinics|mesh-ancestor
56508133|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
56508134|NCT04558268|Vitamins|vitamins|mesh-ancestor
56508135|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
56508136|NCT01125514|Furosemide|furosemide|mesh-list
56508137|NCT01125514|Diuretics|diuretics|mesh-ancestor
56508138|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
56508139|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508140|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56508141|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56508142|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508143|NCT04545879|Allicin|allicin|mesh-list
56508144|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508145|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56508146|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
56508147|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508148|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56508149|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
56508150|NCT04545879|Protective Agents|protective agents|mesh-ancestor
56508151|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508152|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56508153|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56508154|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56508155|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56508156|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56508157|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508158|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508159|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56508160|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56508161|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508162|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
56508163|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508164|NCT04538391|Bupivacaine|bupivacaine|mesh-list
56508165|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
56508166|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
56508167|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508168|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508169|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
56508170|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508172|NCT04545801|Analgesics|analgesics|mesh-ancestor
56508173|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
56508174|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508175|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508176|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56508177|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56508178|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
56508179|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
56508180|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508181|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56508182|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56508183|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508184|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508185|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
56508186|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
56508187|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508188|NCT04558424|Protective Agents|protective agents|mesh-ancestor
56508189|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508190|NCT04558424|Vitamins|vitamins|mesh-ancestor
56508191|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
56508192|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
56508193|NCT00576602|Hematinics|hematinics|mesh-ancestor
56508194|NCT02212223|Vitamin D|vitamin d|mesh-list
56508195|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
56508196|NCT02212223|Vitamins|vitamins|mesh-ancestor
56508197|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
56508198|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508199|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56508200|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56508201|NCT00637585|Fexofenadine|fexofenadine|mesh-list
56508202|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56508203|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56508204|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56508205|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
56508206|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
56508207|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508208|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508209|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508210|NCT02214810|Bupivacaine|bupivacaine|mesh-list
56508211|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
56508212|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
56508213|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508214|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508215|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
56508216|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508217|NCT01125046|Bevacizumab|bevacizumab|mesh-list
56508218|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56508219|NCT01125046|Antibodies|antibodies|mesh-list
56508220|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
56508221|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56508222|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508223|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56508224|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56508225|NCT01125046|Growth Substances|growth substances|mesh-ancestor
56508226|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508227|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
56508228|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
56253425|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253426|NCT01880749|Everolimus|everolimus|mesh-list
56253427|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508229|NCT04557878|Mitogens|mitogens|mesh-list
56508230|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
56508231|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508232|NCT01124734|Temozolomide|temozolomide|mesh-list
56508233|NCT01124734|Interleukin-2|interleukin-2|mesh-list
56508234|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56508235|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
56508236|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508237|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508238|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56508239|NCT01124734|Analgesics|analgesics|mesh-ancestor
56508240|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
56508241|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508242|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508243|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
56508244|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
56508245|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56508247|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508248|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508249|NCT04538976|Urological Agents|urological agents|mesh-ancestor
56508250|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
56508251|NCT04545450|Testosterone|testosterone|mesh-list
56508252|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
56508253|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
56508254|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56508255|NCT04545450|Dutasteride|dutasteride|mesh-list
56508256|NCT04545450|Androgens|androgens|mesh-ancestor
56508257|NCT04545450|Hormones|hormones|mesh-ancestor
56508258|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508259|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508260|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56508261|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508262|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
56508263|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56508264|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56508265|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508266|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508267|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
56508268|NCT04579133|Durvalumab|durvalumab|mesh-list
56508269|NCT04579133|Olaparib|olaparib|mesh-list
56508270|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56508271|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508272|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56508273|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508274|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508275|NCT00576914|Endostatins|endostatins|mesh-list
56508276|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56508277|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56508278|NCT00576914|Growth Substances|growth substances|mesh-ancestor
56508279|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508280|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
56508281|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508282|NCT02212340|Remifentanil|remifentanil|mesh-list
56508284|NCT02212340|Propofol|propofol|mesh-list
56508285|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56508286|NCT02212340|Narcotics|narcotics|mesh-ancestor
56508287|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508288|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508289|NCT02212340|Analgesics|analgesics|mesh-ancestor
56508290|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
56508291|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508292|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56508293|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
56508294|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
56508295|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56508296|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56508297|NCT01124617|Tapentadol|tapentadol|mesh-list
56508298|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56508299|NCT01124617|Narcotics|narcotics|mesh-ancestor
56508300|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508301|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508302|NCT01124617|Analgesics|analgesics|mesh-ancestor
56508303|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
56508304|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508305|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56508306|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56508307|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56508308|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508309|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
56508310|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508311|NCT04205890|Ketamine|ketamine|mesh-list
56508312|NCT04205890|Analgesics|analgesics|mesh-ancestor
56508313|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
56508314|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508315|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508316|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56508317|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56508318|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
56508319|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
56256407|NCT01908257|Renal Agents|renal agents|mesh-ancestor
56508320|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508321|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56508322|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56508323|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508324|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508326|NCT00577109|Bevacizumab|bevacizumab|mesh-list
56508327|NCT00577109|Cetuximab|cetuximab|mesh-list
56508328|NCT00577109|Irinotecan|irinotecan|mesh-list
56508329|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56508330|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508331|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56508332|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56508333|NCT00577109|Growth Substances|growth substances|mesh-ancestor
56508334|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508335|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
56508336|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56508337|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56508338|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508339|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508340|NCT00577109|Antidotes|antidotes|mesh-ancestor
56508341|NCT00577109|Protective Agents|protective agents|mesh-ancestor
56508342|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
56508343|NCT00577109|Vitamins|vitamins|mesh-ancestor
56508344|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
56508345|NCT01124422|Fluticasone|fluticasone|mesh-list
56508347|NCT01124422|Bromides|bromides|mesh-list
56508348|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
56508349|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56508350|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508351|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56508352|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
56508353|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508354|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508355|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56508356|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56508357|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
56508358|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56508359|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
56508360|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56508361|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
56508362|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508363|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508364|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56508365|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56508366|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56508367|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
56508368|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
56508369|NCT00625495|Esomeprazole|esomeprazole|mesh-list
56508370|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56508371|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56508372|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56508373|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508374|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508375|NCT02882425|Selexipag|selexipag|mesh-list
56508376|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56508377|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
56508378|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
56508379|NCT01124149|Mesalamine|mesalamine|mesh-list
56508380|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56508381|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56508382|NCT01124149|Analgesics|analgesics|mesh-ancestor
56508383|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
56508384|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508385|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508386|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508387|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56508388|NCT04545099|Neostigmine|neostigmine|mesh-list
56508389|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56508390|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508391|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508392|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
56508393|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508394|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256474|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56508395|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56508396|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
56508397|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508398|NCT02882269|Capecitabine|capecitabine|mesh-list
56508399|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56508400|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
56508401|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508402|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508403|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
56508404|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56508405|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508406|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
56508407|NCT04537767|Esmolol|esmolol|mesh-list
56508408|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56508409|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56508410|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56508411|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
56508412|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508413|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508414|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508415|NCT01121926|Trazodone|trazodone|mesh-list
56508416|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56508417|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56508418|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508419|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508420|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56508421|NCT01121926|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56508422|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56508423|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56508424|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508425|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508426|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
56508427|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56508428|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
56508429|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
56508430|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56253445|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253446|NCT01880931|Remifentanil|remifentanil|mesh-list
56508431|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56508432|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508433|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56508434|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508435|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56508436|NCT00577694|Clofarabine|clofarabine|mesh-list
56508437|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
56508438|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56508439|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
56508440|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508441|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508442|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56508443|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
56508444|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56508445|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56508446|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508447|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
56508448|NCT04537533|Coagulants|coagulants|mesh-ancestor
56508449|NCT02216058|Sirolimus|sirolimus|mesh-list
56508450|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56508451|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508452|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56508453|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508454|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
56508455|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56508456|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
56508457|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508458|NCT00577850|Alendronate|alendronate|mesh-list
56508459|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
56508460|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56508461|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508462|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56508463|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56508464|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508465|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56508466|NCT00577967|Gabapentin|gabapentin|mesh-list
56508467|NCT00577967|Analgesics|analgesics|mesh-ancestor
56508468|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
56508469|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508470|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508471|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
56508472|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56508473|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56508474|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508475|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56508476|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56508477|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56508478|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508479|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508480|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
56508481|NCT00578201|Cetuximab|cetuximab|mesh-list
56508482|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56508483|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508484|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
56508485|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56508486|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508487|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56508488|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508489|NCT04578470|Vitamin D|vitamin d|mesh-list
56508490|NCT04578470|Vitamins|vitamins|mesh-ancestor
56508491|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
56508492|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508493|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56508494|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
56508495|NCT00578435|Busulfan|busulfan|mesh-list
56508496|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56508497|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
56508498|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508499|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56508500|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56508501|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
56508502|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508503|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508504|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56508505|NCT04537065|Mydriatics|mydriatics|mesh-list
56508506|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
56508507|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508508|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508509|NCT04544163|Lidocaine|lidocaine|mesh-list
56508510|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
56508511|NCT04544163|Fentanyl|fentanyl|mesh-list
56508512|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
56508513|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
56508514|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508515|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508516|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
56508517|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508518|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56508519|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56508520|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56508521|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56508522|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508523|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56508524|NCT04544163|Narcotics|narcotics|mesh-ancestor
56508525|NCT04544163|Analgesics|analgesics|mesh-ancestor
56508526|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56508527|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56508528|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
56508529|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
56508530|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56508531|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56508532|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
56508533|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56508534|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
56508535|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56508536|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508537|NCT00578591|Rituximab|rituximab|mesh-list
56508538|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56508539|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508540|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
56508541|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508542|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56508543|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
56508544|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56508545|NCT04543890|Etoposide|etoposide|mesh-list
56253451|NCT01880931|Analgesics|analgesics|mesh-ancestor
56253452|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
56253453|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253454|NCT01881074|Listerine|listerine|mesh-list
56253455|NCT01881074|Triclosan|triclosan|mesh-list
56253456|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
56508546|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508547|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56508548|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56508549|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56508550|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508551|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508552|NCT04536831|Vitamin D|vitamin d|mesh-list
56508553|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
56508554|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
56508555|NCT04536831|Vitamins|vitamins|mesh-list
56508556|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
56508557|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508558|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56508559|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56508560|NCT02214966|Telmisartan|telmisartan|mesh-list
56508561|NCT02214966|Ramipril|ramipril|mesh-list
56508562|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56508563|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56508564|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56508565|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508566|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56508567|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
56508568|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508569|NCT04536558|Olanzapine|olanzapine|mesh-list
56508570|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
56508571|NCT04536558|Aprepitant|aprepitant|mesh-list
56508572|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
56508573|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
56508574|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508575|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508576|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56508577|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56508578|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56508579|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508580|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56508581|NCT04536558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56508582|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56508583|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56508584|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508585|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508586|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
56508587|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56508588|NCT04557137|Somatostatin|somatostatin|mesh-list
56508589|NCT04557137|Hormones|hormones|mesh-ancestor
56508590|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508591|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508592|NCT04536675|Bromides|bromides|mesh-list
56508593|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
56508594|NCT04536363|Alprostadil|alprostadil|mesh-list
56508595|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56508596|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
56508597|NCT04536363|Urological Agents|urological agents|mesh-ancestor
56508598|NCT00578825|Ritonavir|ritonavir|mesh-list
56508599|NCT00578825|Lopinavir|lopinavir|mesh-list
56508600|NCT00578825|Ribavirin|ribavirin|mesh-list
56508601|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56508602|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56508603|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
56508604|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508605|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508606|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56508607|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56508608|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
56508609|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508610|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55746727|NCT04791475|Analgesics|analgesics|mesh-ancestor
55746728|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55862780|NCT00243412|Rituximab|rituximab|mesh-list
55746729|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55746730|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55746731|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
55746732|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746733|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746735|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746736|NCT03299725|Antacids|antacids|mesh-ancestor
56508611|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56508612|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
56508613|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
56508614|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508615|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
56508616|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56508617|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508618|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
56508619|NCT04535973|Hormones|hormones|mesh-list
56508620|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508621|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508622|NCT04536051|Acetaminophen|acetaminophen|mesh-list
56508623|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56508624|NCT04536051|Analgesics|analgesics|mesh-ancestor
56508625|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
56508626|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508627|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508628|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
56508629|NCT02215005|Telmisartan|telmisartan|mesh-list
56508630|NCT02215005|Ramipril|ramipril|mesh-list
56508631|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56508632|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56508633|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56508634|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508635|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56508636|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
56508637|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508638|NCT02215044|Gemcitabine|gemcitabine|mesh-list
56508639|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56508640|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
56508641|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508642|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508643|NCT02215044|Antiviral Agents|antiviral agents|mesh-ancestor
56508644|NCT02215044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508645|NCT02215044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508646|NCT02215044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56508647|NCT02215044|Immunologic Factors|immunologic factors|mesh-ancestor
56508648|NCT02215044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508649|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56508650|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
56508651|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508652|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508653|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56508654|NCT04556279|Diuretics|diuretics|mesh-ancestor
56508655|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
56508656|NCT02216331|Rifampin|rifampin|mesh-list
56508657|NCT02216331|Rifapentine|rifapentine|mesh-list
56508658|NCT02216331|Bedaquiline|bedaquiline|mesh-list
56508659|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56508660|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
56508661|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56508662|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508663|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
56508664|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56508665|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508666|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508667|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56508668|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56508669|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56508670|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56508671|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56508672|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55760747|NCT03038607|Aspirin|aspirin|mesh-list
56508673|NCT04535817|Omalizumab|omalizumab|mesh-list
56508674|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56508675|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56508676|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
56508677|NCT04578236|Tretinoin|tretinoin|mesh-list
56508678|NCT04578236|Captopril|captopril|mesh-list
56508679|NCT04578236|Isotretinoin|isotretinoin|mesh-list
56508680|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508681|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
56508682|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
56508683|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56508684|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
56508685|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508686|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508687|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56508688|NCT04542759|Besifloxacin|besifloxacin|mesh-list
56508689|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56508690|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56508691|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56508692|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256778|NCT01910766|Ubiquinone|ubiquinone|mesh-list
56508693|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56508694|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56508695|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508696|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508697|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508698|NCT04542213|Insulin|insulin|mesh-list
56508699|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56508700|NCT04542213|Linagliptin|linagliptin|mesh-list
56508701|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56508702|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508703|NCT04542213|Incretins|incretins|mesh-ancestor
56508704|NCT04542213|Hormones|hormones|mesh-ancestor
56508705|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508706|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56508707|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
56508708|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508709|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508710|NCT04542369|Etoposide|etoposide|mesh-list
56508711|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508712|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56508713|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56508714|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56508715|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508716|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508717|NCT04542252|Cyclosporine|cyclosporine|mesh-list
56508718|NCT04542252|Cyclosporins|cyclosporins|mesh-list
56508719|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508720|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508721|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56508722|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
55761303|NCT03976245|Analgesics|analgesics|mesh-ancestor
55760845|NCT04838145|Ribavirin|ribavirin|mesh-list
56508723|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508724|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
56508725|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508726|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
56508727|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56508728|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56508729|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56508730|NCT04555694|Cyclosporine|cyclosporine|mesh-list
56508731|NCT04555694|Dexamethasone|dexamethasone|mesh-list
56508732|NCT04555694|Cyclosporins|cyclosporins|mesh-list
56508733|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508734|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
56508735|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
56508736|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508737|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508738|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56508739|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
56508740|NCT04555694|Hormones|hormones|mesh-ancestor
56508741|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508742|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56508743|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508744|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508745|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508746|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56508747|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
56508748|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
56508749|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508750|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
56508751|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56508752|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56508753|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56508754|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
56508755|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56508756|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56508757|NCT04532775|Prednisolone|prednisolone|mesh-list
56508758|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
56508759|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
56508760|NCT04532775|Bupivacaine|bupivacaine|mesh-list
56508761|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56508762|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
56508763|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
56508764|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
56508765|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508766|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508767|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
56256855|NCT01911247|Metformin|metformin|mesh-list
56508768|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508769|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508770|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
56508771|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
56508772|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56508773|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
56508774|NCT04532775|Hormones|hormones|mesh-ancestor
56508775|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508776|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56508777|NCT04532775|Protective Agents|protective agents|mesh-ancestor
56508778|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56508779|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508780|NCT04532775|Analgesics|analgesics|mesh-ancestor
56508781|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56508782|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
56508783|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56508784|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56508785|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508786|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56508787|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
56508788|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56508789|NCT00579644|Minocycline|minocycline|mesh-list
56508790|NCT00579644|Methotrexate|methotrexate|mesh-list
56508791|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56508792|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
56508793|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56508794|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508795|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56508796|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
55761382|NCT04814589|Ezetimibe|ezetimibe|mesh-list
56508797|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508798|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508799|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
56508800|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508801|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56508802|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56508803|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
56508804|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56508805|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56508806|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56508807|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508808|NCT04578158|Quercetin|quercetin|mesh-list
56508809|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
56508810|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508811|NCT04578158|Protective Agents|protective agents|mesh-ancestor
56508812|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508813|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
56508814|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
56508815|NCT04532736|Methotrexate|methotrexate|mesh-list
56508816|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56508817|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
56508818|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56508819|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508820|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56508821|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
56508822|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508823|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508824|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
56508825|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508826|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56508827|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56508828|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
56508829|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56508830|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56508831|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508832|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
56508833|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
56508834|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508835|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56508836|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
56508837|NCT04532736|Hormones|hormones|mesh-ancestor
56508838|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508839|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56508840|NCT04532736|Protective Agents|protective agents|mesh-ancestor
56508841|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56508842|NCT04555733|Lemborexant|lemborexant|mesh-list
56508843|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56508844|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508845|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508846|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56508847|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56508848|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508849|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508850|NCT02216994|Mineral Oil|mineral oil|mesh-list
56508851|NCT02216994|Lactulose|lactulose|mesh-list
56508852|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56508853|NCT02216994|Emollients|emollients|mesh-ancestor
56508854|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
56508855|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
56253457|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
56508856|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
56508857|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508858|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508859|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508860|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
56508861|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
56508862|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
56508863|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56508864|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508865|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
56508866|NCT02217189|Astringents|astringents|mesh-ancestor
56508867|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508868|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
56508869|NCT00579956|Meropenem|meropenem|mesh-list
56508870|NCT00579956|Ceftazidime|ceftazidime|mesh-list
56508871|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56508872|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508873|NCT04555304|Paclitaxel|paclitaxel|mesh-list
56508874|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56508875|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56508876|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508877|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
56508878|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
56508879|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
56508880|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508881|NCT04531800|Mitogens|mitogens|mesh-list
56508882|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
56508883|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508884|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
56508885|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56508886|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
56508887|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508888|NCT00579995|Expectorants|expectorants|mesh-ancestor
56508889|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
56508890|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56508891|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
56508892|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508893|NCT00579995|Protective Agents|protective agents|mesh-ancestor
56508894|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508895|NCT00579995|Antidotes|antidotes|mesh-ancestor
56508896|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
56508897|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56508898|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508899|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508900|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56508901|NCT04531371|Analgesics|analgesics|mesh-ancestor
56508902|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
56508903|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508904|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56508905|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56508906|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56508907|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56508908|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508909|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508910|NCT00580112|Dexamethasone|dexamethasone|mesh-list
56508911|NCT00580112|Trabectedin|trabectedin|mesh-list
56508912|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508913|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
56508914|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
56508915|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508916|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508917|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56257003|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
56508918|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
56508919|NCT00580112|Hormones|hormones|mesh-ancestor
56508920|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508921|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56508922|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508923|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56508924|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
56508925|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508926|NCT04531332|Linezolid|linezolid|mesh-list
56508927|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56508928|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508929|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56508930|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508931|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508932|NCT04530864|Dexamethasone|dexamethasone|mesh-list
56508933|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
56508934|NCT04530864|BB 1101|bb 1101|mesh-list
56508935|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56508936|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
56508937|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
56508938|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508939|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508940|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56508941|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
56508942|NCT04530864|Hormones|hormones|mesh-ancestor
56508943|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56508944|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56508945|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508946|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
56508947|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508948|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508949|NCT00580190|Alprazolam|alprazolam|mesh-list
56508950|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56508951|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508952|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508953|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56508954|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56508955|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56508956|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
56508957|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
56508958|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508959|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508960|NCT04530903|Clonidine|clonidine|mesh-list
56508961|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
56508962|NCT04530903|Analgesics|analgesics|mesh-ancestor
56508963|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
56508964|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56508965|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508966|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56508967|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
56508968|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
56508969|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56508970|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56508971|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56508972|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
56508973|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56508974|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508975|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
56508976|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
56508977|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56508978|NCT04530474|Ivermectin|ivermectin|mesh-list
56508979|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56508980|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56508981|NCT04554680|Trametinib|trametinib|mesh-list
56508982|NCT04554680|Dabrafenib|dabrafenib|mesh-list
56508983|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508984|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56508985|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56508986|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56508987|NCT00580424|Norethindrone|norethindrone|mesh-list
56508988|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
56508989|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56508990|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56508991|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56508992|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
56508993|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56508994|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56508995|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56508996|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56508998|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56508999|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56509000|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509001|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509002|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56509003|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509004|NCT04205851|Gimsilumab|gimsilumab|mesh-list
56509005|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509006|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
56509007|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509008|NCT02882113|Tacrolimus|tacrolimus|mesh-list
56509009|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56509010|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
56509011|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509012|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56509013|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509014|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509015|NCT04530045|Piperacillin|piperacillin|mesh-list
56509016|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509017|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509018|NCT01121536|Modafinil|modafinil|mesh-list
56509019|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56509020|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509021|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56509022|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56509023|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56509024|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509025|NCT00580619|Methyldopa|methyldopa|mesh-list
56509026|NCT00580619|Trimethaphan|trimethaphan|mesh-list
56509027|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
56509028|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509029|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56509030|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
56509031|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
56509032|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509033|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509034|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56509035|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56509036|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56509037|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
56509038|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509039|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56509040|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56509041|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56509042|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56509043|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
56509044|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
56509045|NCT04554524|Paclitaxel|paclitaxel|mesh-list
56509046|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
56509047|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56509048|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509049|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
56509050|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
56509051|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
56509052|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509053|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56509054|NCT02212652|Vitamin D|vitamin d|mesh-list
56509055|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
56509056|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
56509057|NCT02212652|Vitamins|vitamins|mesh-list
56509058|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
56509059|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509060|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56509061|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56509062|NCT02212769|Losartan|losartan|mesh-list
56509063|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56509064|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56509065|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56509066|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56509067|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509069|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56509070|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56509071|NCT02217852|Captopril|captopril|mesh-list
56509072|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
56509073|NCT02217852|Nitrendipine|nitrendipine|mesh-list
56509074|NCT02217852|Diuretics|diuretics|mesh-ancestor
56509075|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
56509076|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509077|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56509078|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56509079|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509080|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56509081|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
56509082|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509083|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56509084|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56509085|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
56509086|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
56509087|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509088|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509089|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56509090|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56509091|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509092|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509093|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509094|NCT04577846|Cephalexin|cephalexin|mesh-list
56509095|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509096|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509097|NCT04529811|Rifaximin|rifaximin|mesh-list
56509098|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509099|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509100|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509101|NCT02218047|Interferons|interferons|mesh-list
56509102|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
56509103|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
56509104|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509105|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
56509106|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509107|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
56509108|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509109|NCT00580814|Methylphenidate|methylphenidate|mesh-list
56509110|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56509111|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509112|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56509113|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56509114|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56509115|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509116|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
56509117|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509118|NCT01120600|Vitamin D|vitamin d|mesh-list
56509119|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
56509120|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
56509121|NCT01120600|Calcium|calcium|mesh-list
56509122|NCT01120600|Vitamins|vitamins|mesh-ancestor
56509123|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
56509124|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509125|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56509126|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56509127|NCT01120600|Antacids|antacids|mesh-ancestor
56509128|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509129|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509130|NCT04577885|Rifampin|rifampin|mesh-list
56509131|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56509132|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
56509133|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509134|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509135|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
56509136|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56509137|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509138|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253469|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
56509139|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56257223|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
56509140|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56509141|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56509142|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56509143|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56509144|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56509145|NCT00580931|Niacinamide|niacinamide|mesh-list
56509146|NCT00580931|Niacin|niacin|mesh-list
56509147|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
56509148|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
56509149|NCT00580931|Vitamins|vitamins|mesh-ancestor
56509150|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
56509151|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509152|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56509153|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
56509154|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509155|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56509156|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
56509157|NCT01120093|Bromides|bromides|mesh-list
56509158|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
56509159|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56509160|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
56509161|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509162|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509163|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56509164|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
55820485|NCT02390531|Growth Substances|growth substances|mesh-ancestor
56509165|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56509166|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56509167|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56509168|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
56509169|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56167787|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56509170|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509171|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
56509172|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
56509173|NCT00581009|Sertraline|sertraline|mesh-list
56509174|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
56509175|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56509176|NCT00581009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56509177|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56509178|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56509179|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509180|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761265|NCT04829097|Temozolomide|temozolomide|mesh-list
56509181|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
56509182|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509183|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509184|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
56509185|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56509186|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509187|NCT02218359|Amikacin|amikacin|mesh-list
56509188|NCT02218359|Fosfomycin|fosfomycin|mesh-list
56509189|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56509190|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56509191|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509192|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
56509193|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56509194|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
56509195|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56509196|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509197|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56509198|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56509199|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56509200|NCT02218398|Albuterol|albuterol|mesh-list
56509201|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56509202|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
56509203|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509204|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509205|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56509206|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
56509207|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
56509208|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56509209|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56509210|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56509211|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56509212|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
56509213|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509214|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509216|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56509217|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509218|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509219|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
56509220|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
56509221|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56509222|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
56509223|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509224|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509225|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56509226|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
56509227|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
56509228|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56509229|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
56509230|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509231|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509232|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56509233|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56509234|NCT01119898|Diclofenac|diclofenac|mesh-list
56509235|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56253477|NCT01881347|Resveratrol|resveratrol|mesh-list
56253478|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
56253479|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253480|NCT01881347|Protective Agents|protective agents|mesh-ancestor
56253481|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253482|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253483|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56509236|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56509237|NCT01119898|Analgesics|analgesics|mesh-ancestor
56509238|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
56509239|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509240|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509241|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509242|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509243|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56509244|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509245|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509246|NCT01119859|Adalimumab|adalimumab|mesh-list
56509247|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509248|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509249|NCT02278926|Insulin|insulin|mesh-list
56509250|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56509251|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509252|NCT01119703|Vaccines|vaccines|mesh-list
56509253|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
56509254|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509255|NCT02882230|Dolutegravir|dolutegravir|mesh-list
56509256|NCT02882230|Rilpivirine|rilpivirine|mesh-list
56509257|NCT02882230|Elvitegravir|elvitegravir|mesh-list
56509258|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56509259|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56509260|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509261|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509262|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56509263|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56509264|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
56509265|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509266|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56509267|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56509268|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56509269|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
56509270|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509271|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56509272|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56509273|NCT02881762|Maraviroc|maraviroc|mesh-list
56509274|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56509275|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56509276|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253491|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
56253492|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
56253493|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55871480|NCT05687253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56509277|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56509278|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56509279|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
56509280|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509281|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56509282|NCT04561947|Mitogens|mitogens|mesh-list
56509283|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
56509284|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509285|NCT01118962|Lacosamide|lacosamide|mesh-list
56509286|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
56509287|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56509288|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56509289|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56509290|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509292|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56509293|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56509294|NCT00581165|Analgesics|analgesics|mesh-ancestor
56509295|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
56509296|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509297|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509298|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509299|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509300|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509301|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56509302|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
56509303|NCT05092984|Spironolactone|spironolactone|mesh-list
56509304|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56509305|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
56509306|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509307|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509308|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56509309|NCT05092984|Diuretics|diuretics|mesh-ancestor
56509310|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
56509311|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
56509312|NCT02213159|Morphine|morphine|mesh-list
56509313|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56509314|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56509315|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509316|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56509317|NCT02213159|Analgesics|analgesics|mesh-ancestor
56509318|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
56509319|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509320|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56509321|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56509322|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56509323|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
56509324|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509325|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509326|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56509327|NCT02213159|Narcotics|narcotics|mesh-ancestor
56509328|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
56509329|NCT02219100|Mifepristone|mifepristone|mesh-list
56509330|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56509331|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
56509332|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56509333|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509334|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56509335|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56509336|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56509337|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
56509338|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56509339|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56509340|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
55761407|NCT04813653|Dexamethasone|dexamethasone|mesh-list
56509341|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509342|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
56509343|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56509344|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56509345|NCT01118377|Capecitabine|capecitabine|mesh-list
56509346|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56509347|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
56509348|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509349|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509350|NCT02219178|Dexamethasone|dexamethasone|mesh-list
56509351|NCT02219178|Lenalidomide|lenalidomide|mesh-list
56509352|NCT02219178|Bortezomib|bortezomib|mesh-list
56509353|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509354|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
56509355|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
56509356|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509357|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509358|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56509359|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
56509360|NCT02219178|Hormones|hormones|mesh-ancestor
56509361|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509362|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56509363|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509364|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
56509365|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56509366|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56509367|NCT02219178|Growth Substances|growth substances|mesh-ancestor
56509368|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
56509369|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
56509370|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56509371|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509372|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
56509373|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509374|NCT02219217|Dolutegravir|dolutegravir|mesh-list
56509375|NCT02219217|Cobicistat|cobicistat|mesh-list
56509376|NCT02219217|Elvitegravir|elvitegravir|mesh-list
56509377|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56509378|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56509379|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509380|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509381|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56509382|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56509383|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
56509384|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509385|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56509386|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56509387|NCT04577378|Itraconazole|itraconazole|mesh-list
56509388|NCT04577378|Tretinoin|tretinoin|mesh-list
56509390|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
56509391|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509392|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56509393|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56509394|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509395|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509396|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56509397|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
56509398|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56509399|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509400|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56509401|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509402|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
56509403|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
56509404|NCT02219412|Aspirin|aspirin|mesh-list
56509405|NCT02219412|Ticagrelor|ticagrelor|mesh-list
56509406|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56509407|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56509408|NCT02219412|Analgesics|analgesics|mesh-ancestor
56509409|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
56509410|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828780|NCT01574716|Immunologic Factors|immunologic factors|mesh-ancestor
56253494|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56509411|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509412|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509413|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509414|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56509415|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56509416|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509417|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56509418|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56509419|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509420|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
56509421|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56509422|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56509423|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56509424|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
56509425|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509426|NCT04577027|Travoprost|travoprost|mesh-list
56509427|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56509428|NCT02211690|Tenofovir|tenofovir|mesh-list
56509429|NCT02211690|Emtricitabine|emtricitabine|mesh-list
56509430|NCT02211690|Dolutegravir|dolutegravir|mesh-list
56509431|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
56509432|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56509433|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56509434|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56509435|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509436|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257524|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56509437|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56509438|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56509439|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56509440|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56509441|NCT04553393|Decitabine|decitabine|mesh-list
56509442|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56509443|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
56509444|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509445|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509446|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509447|NCT02211846|Mirabegron|mirabegron|mesh-list
56509448|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56509449|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56509450|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56509451|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
56509452|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509453|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509454|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509455|NCT02211846|Urological Agents|urological agents|mesh-ancestor
56509456|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56509457|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
56509458|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56509459|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56509460|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509461|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509463|NCT04553510|Bevacizumab|bevacizumab|mesh-list
56509464|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56509465|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253497|NCT01881568|Coagulants|coagulants|mesh-ancestor
56253498|NCT01881919|Quercetin|quercetin|mesh-list
56253499|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
56253503|NCT01881971|Calcium|calcium|mesh-list
56509466|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56509467|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56509468|NCT04553510|Growth Substances|growth substances|mesh-ancestor
56509469|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509470|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
56509471|NCT03453281|Aflibercept|aflibercept|mesh-list
56509472|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56509473|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56509474|NCT03453281|Growth Substances|growth substances|mesh-ancestor
56509475|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509476|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
56509477|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509478|NCT01642134|Aspirin|aspirin|mesh-list
56509479|NCT01642134|Clopidogrel|clopidogrel|mesh-list
56509480|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56509481|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56509482|NCT01642134|Analgesics|analgesics|mesh-ancestor
56509483|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
56509484|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56509485|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56509486|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56509487|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56509488|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56509489|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56509490|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509491|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56509492|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56509493|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509494|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
56509495|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56509496|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56509497|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56509498|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
56509499|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56509500|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56509501|NCT00581789|Sunitinib|sunitinib|mesh-list
56509502|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56509503|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56509504|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56509505|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56509506|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56509507|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56509508|NCT00581789|Growth Substances|growth substances|mesh-ancestor
56509509|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999581|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55999582|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
55999583|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
55934743|NCT05573568|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
55934744|NCT05573568|Hallucinogens|hallucinogens|mesh-ancestor
55934745|NCT05573568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934746|NCT05573568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55934747|NCT05573568|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55934748|NCT05573568|Serotonin Agents|serotonin agents|mesh-ancestor
55934749|NCT05573568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934750|NCT05573568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934751|NCT05573568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55934752|NCT03858491|Cobicistat|cobicistat|mesh-list
55934753|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55934754|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55934755|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
55934756|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934757|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55934758|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55934760|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934762|NCT01672788|Empagliflozin|empagliflozin|mesh-list
55934763|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55934764|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934765|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55934766|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934767|NCT02705963|Trametinib|trametinib|mesh-list
55934768|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55934769|NCT02705963|Norethindrone|norethindrone|mesh-list
55934770|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
55934771|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
55934772|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
55934773|NCT02705963|Estradiol|estradiol|mesh-list
55934774|NCT02705963|Estrogens|estrogens|mesh-ancestor
55934775|NCT02705963|Hormones|hormones|mesh-ancestor
55934776|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55934777|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934778|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55934779|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55934780|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55934781|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934782|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55934783|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934784|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934785|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55934786|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55934787|NCT03914742|Temozolomide|temozolomide|mesh-list
55934788|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55934789|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55934800|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55934801|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55934802|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
55934803|NCT03844061|Rituximab|rituximab|mesh-list
55934804|NCT03844061|Belimumab|belimumab|mesh-list
55934805|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55934806|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934807|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
55934808|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934809|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934810|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55934811|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55934812|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
55934813|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934814|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934815|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934816|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934817|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55934818|NCT03840239|Capecitabine|capecitabine|mesh-list
55934819|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
55934820|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55934821|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
55999584|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999585|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934822|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934823|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761665|NCT02597049|Metformin|metformin|mesh-list
55934824|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55934825|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55934826|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
55934827|NCT03831425|Ubiquinone|ubiquinone|mesh-list
55934828|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
55934829|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
55934830|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934831|NCT03831425|Vitamins|vitamins|mesh-ancestor
55934832|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55934833|NCT03830723|Hormones|hormones|mesh-ancestor
55934834|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55934835|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934836|NCT03829319|Carboplatin|carboplatin|mesh-list
55934837|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
55934838|NCT03829319|Pemetrexed|pemetrexed|mesh-list
55934839|NCT03829319|Lenvatinib|lenvatinib|mesh-list
55934840|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934841|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55934861|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55934862|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55934863|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934864|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55934865|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
55934866|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55934867|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
55934868|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
55934869|NCT03814109|Vitamins|vitamins|mesh-ancestor
55934870|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
55934871|NCT01016769|Sirolimus|sirolimus|mesh-list
55934872|NCT01016769|Paclitaxel|paclitaxel|mesh-list
55934873|NCT01016769|Carboplatin|carboplatin|mesh-list
55934874|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55934876|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934877|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
55934878|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934879|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934880|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934881|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934882|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55934883|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
55934884|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55934885|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
55934886|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934887|NCT03807479|Ponatinib|ponatinib|mesh-list
55934888|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934889|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55934890|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934891|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999586|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55999587|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
55999588|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
55999589|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55934906|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55934907|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55934908|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
55934909|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934911|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
55934912|NCT03802799|Cannabidiol|cannabidiol|mesh-list
55934913|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
55934914|NCT00964431|Celecoxib|celecoxib|mesh-list
55934915|NCT00964431|Indomethacin|indomethacin|mesh-list
55934916|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55934917|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55934918|NCT00964431|Analgesics|analgesics|mesh-ancestor
55934919|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
55934920|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934921|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934922|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55934923|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934924|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55934925|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56253514|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56253515|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55934946|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934947|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55934948|NCT01017237|Analgesics|analgesics|mesh-ancestor
55934949|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
55934950|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934951|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55934953|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55934954|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
55934955|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934956|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934957|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55934958|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55934959|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
55934960|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
55934961|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55934962|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55934963|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55934964|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55934965|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55934966|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55934967|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
55934968|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
55934969|NCT04442412|Vitamin D|vitamin d|mesh-list
55934970|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
55934971|NCT04442412|Vitamins|vitamins|mesh-ancestor
55934972|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
55934973|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934974|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55934975|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55934976|NCT01018095|Metronidazole|metronidazole|mesh-list
55934977|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934978|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934979|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55934980|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55934981|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
55934982|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
55934983|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934992|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934993|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55934994|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55934995|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55999590|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55999591|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
56253519|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
56253520|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253521|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
55999592|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55934996|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
55934997|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934998|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934999|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
55935000|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935001|NCT00970203|Vaccines|vaccines|mesh-list
55935002|NCT00970203|Androgens|androgens|mesh-list
55935003|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
55935004|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935005|NCT00970203|Hormones|hormones|mesh-ancestor
55935006|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935007|NCT00971295|Metformin|metformin|mesh-list
55935008|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55935009|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55935010|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935011|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
55935012|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55935013|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55935014|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55935015|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935016|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55935017|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
55935018|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55935019|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55935020|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55935021|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55935023|NCT05395533|Antibodies|antibodies|mesh-list
55935024|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55935025|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
55935026|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935027|NCT00971841|Paclitaxel|paclitaxel|mesh-list
55935028|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55935029|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935030|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
55935031|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
55935032|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
55935033|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935034|NCT04913220|Cemiplimab|cemiplimab|mesh-list
55935035|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935036|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935037|NCT05395299|Ethylene|ethylene|mesh-list
55935038|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
55935039|NCT05395299|Growth Substances|growth substances|mesh-ancestor
55935040|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935041|NCT02246049|Leucovorin|leucovorin|mesh-list
55935042|NCT02246049|Bevacizumab|bevacizumab|mesh-list
55935043|NCT02246049|Fluorouracil|fluorouracil|mesh-list
55935044|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
55935045|NCT02246049|Irinotecan|irinotecan|mesh-list
55935046|NCT02246049|Calcium|calcium|mesh-list
55935047|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
55935048|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935049|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935050|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55935051|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55935052|NCT02246049|Growth Substances|growth substances|mesh-ancestor
55935053|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935054|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
55935060|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
55935061|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55935062|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55935063|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935065|NCT02246049|Protective Agents|protective agents|mesh-ancestor
55935066|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
55935067|NCT02246049|Vitamins|vitamins|mesh-ancestor
56253549|NCT01882296|Pantoprazole|pantoprazole|mesh-list
56253550|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56253551|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56253553|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935068|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
55935069|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
55935070|NCT05395143|Astringents|astringents|mesh-ancestor
55935071|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935072|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
55999593|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55999594|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55999595|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55935073|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
55935074|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935075|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
55935076|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
55935077|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935078|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935079|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55935080|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
55935081|NCT05394909|Hormones|hormones|mesh-ancestor
55935082|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935083|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55935084|NCT05394909|Protective Agents|protective agents|mesh-ancestor
55935085|NCT05694858|Lidocaine|lidocaine|mesh-list
55935086|NCT05694858|Anesthetics, Local|anesthetics, local|mesh-ancestor
55935087|NCT05694858|Anesthetics|anesthetics|mesh-ancestor
55935088|NCT05694858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55935089|NCT05694858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935090|NCT05694858|Sensory System Agents|sensory system agents|mesh-ancestor
55935091|NCT05694858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935092|NCT05694858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55935093|NCT05694858|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55935094|NCT05694858|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55935095|NCT05694858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55935096|NCT05694858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935097|NCT02159859|Ertapenem|ertapenem|mesh-list
55935098|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55935099|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935100|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55935101|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55935102|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935103|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
55935104|NCT02083679|Gemcitabine|gemcitabine|mesh-list
55935105|NCT02083679|Paclitaxel|paclitaxel|mesh-list
55935106|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55935107|NCT02083679|Cisplatin|cisplatin|mesh-list
55935108|NCT02083679|Carboplatin|carboplatin|mesh-list
55935109|NCT02083679|Pemetrexed|pemetrexed|mesh-list
55935110|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55935111|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55935112|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935113|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
55935115|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
55935116|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935117|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935118|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
55935119|NCT02083679|Antiviral Agents|antiviral agents|mesh-ancestor
55935120|NCT02083679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935121|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935122|NCT02083679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935123|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
55935124|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935125|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55935131|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935132|NCT03769025|Analgesics|analgesics|mesh-ancestor
55935133|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
55935134|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935135|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55935136|NCT01672710|Niacin|niacin|mesh-list
55935137|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55935138|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
56253556|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253557|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
56253558|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253559|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55935139|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935140|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55935141|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
55935142|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
55935143|NCT01672710|Vitamins|vitamins|mesh-ancestor
55935144|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
55935145|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935146|NCT03766763|Venetoclax|venetoclax|mesh-list
55935147|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935148|NCT04790448|Irinotecan|irinotecan|mesh-list
55935149|NCT04790448|Camptothecin|camptothecin|mesh-list
55935150|NCT04790448|Cetuximab|cetuximab|mesh-list
55999596|NCT04138212|Paclitaxel|paclitaxel|mesh-list
55999597|NCT04138212|Cisplatin|cisplatin|mesh-list
55863744|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935151|NCT04790448|Vemurafenib|vemurafenib|mesh-list
55935152|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55935153|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55935154|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935155|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935156|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935157|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935158|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55935159|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55935160|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
55935161|NCT04784052|Rituximab|rituximab|mesh-list
55935162|NCT04784052|Fludarabine|fludarabine|mesh-list
55935163|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
55935164|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55935165|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253561|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935166|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
55935167|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935168|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935169|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55935170|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
55935171|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935172|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935173|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55935174|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935175|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
55935176|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55935177|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935178|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935179|NCT05319756|Oxycodone|oxycodone|mesh-list
55935181|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55935182|NCT05319756|Narcotics|narcotics|mesh-ancestor
55935183|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55935184|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935186|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
55935187|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935188|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
55935189|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55935190|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55935191|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55935192|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55935193|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55935194|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935195|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935196|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
55935201|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
55935202|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55935203|NCT04410588|Narcotics|narcotics|mesh-ancestor
55935204|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55935205|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935206|NCT04410588|Analgesics|analgesics|mesh-ancestor
55935207|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
55935208|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935209|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55935210|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55935211|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
55935212|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
55935213|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
55935214|NCT05303220|Branebrutinib|branebrutinib|mesh-list
55935215|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55935216|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935217|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935218|NCT04444830|Ketorolac|ketorolac|mesh-list
55935219|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55935220|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55935221|NCT04444830|Analgesics|analgesics|mesh-ancestor
55935222|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
55935223|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935224|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999598|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55999599|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935225|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935226|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935227|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55935228|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935229|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935230|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55935231|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56253562|NCT01882361|Naltrexone|naltrexone|mesh-list
55935232|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
55935233|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935234|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
55935235|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55935236|NCT04717362|Testosterone|testosterone|mesh-list
55935237|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
55935238|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
55935239|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55935240|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935241|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
55935242|NCT04717362|Hormones|hormones|mesh-ancestor
55935243|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935244|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935245|NCT04717362|Androgens|androgens|mesh-ancestor
55935246|NCT03739619|Gemcitabine|gemcitabine|mesh-list
55935247|NCT03739619|Nivolumab|nivolumab|mesh-list
55935248|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55935249|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935250|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
55935251|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935252|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935253|NCT03739619|Antiviral Agents|antiviral agents|mesh-ancestor
55935254|NCT03739619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935255|NCT03739619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935256|NCT03739619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935257|NCT03739619|Immunologic Factors|immunologic factors|mesh-ancestor
55935258|NCT03739619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935259|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935260|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55935261|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55743412|NCT02516527|Ipilimumab|ipilimumab|mesh-list
55935262|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
55935264|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
55935265|NCT03738917|Ipratropium|ipratropium|mesh-list
55935266|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
55935267|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
55935268|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
55935270|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55935271|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55935272|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935273|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935274|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935275|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55935277|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935278|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55935279|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
55935280|NCT00976599|Methotrexate|methotrexate|mesh-list
55935281|NCT00976599|Tofacitinib|tofacitinib|mesh-list
55935282|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55935283|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
55935284|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55935285|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935286|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935287|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
55935288|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935289|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935290|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
55935291|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935292|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55935293|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935294|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
55935295|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999600|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
55999601|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
55935296|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56253573|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
56253574|NCT01882400|Alendronate|alendronate|mesh-list
56253575|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
56253576|NCT01882400|Diphosphonates|diphosphonates|mesh-list
56253577|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55935297|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55935298|NCT02630472|Quinine|quinine|mesh-list
55935299|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
55935300|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55935301|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55935302|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935303|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55935304|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935305|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55935306|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935307|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55935308|NCT02630472|Analgesics|analgesics|mesh-ancestor
55935309|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
55935310|NCT03729011|Propofol|propofol|mesh-list
55935311|NCT03729011|Sevoflurane|sevoflurane|mesh-list
55935312|NCT03729011|Desflurane|desflurane|mesh-list
55935313|NCT03729011|Isoflurane|isoflurane|mesh-list
55935314|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55935315|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55935316|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935317|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55935318|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
55935319|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
55935320|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55935321|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55935322|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55935323|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
55935324|NCT05264922|Coagulants|coagulants|mesh-ancestor
55935325|NCT03728933|Rotigotine|rotigotine|mesh-list
55935326|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
55935327|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
55935328|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935329|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935330|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935331|NCT03727061|Carboplatin|carboplatin|mesh-list
55935332|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
55935333|NCT03727061|Fluorouracil|fluorouracil|mesh-list
55935334|NCT03727061|Nivolumab|nivolumab|mesh-list
55935335|NCT03727061|Cetuximab|cetuximab|mesh-list
55935336|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
55935337|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
55935338|NCT03727061|Trioxsalen|trioxsalen|mesh-list
55935339|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935340|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935341|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
55935342|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935343|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935346|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935347|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55935348|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
55935349|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55935351|NCT00977769|Carbetocin|carbetocin|mesh-list
55935352|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
55935353|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55935354|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935355|NCT03725501|Ranibizumab|ranibizumab|mesh-list
55935356|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55935357|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55935358|NCT03725501|Growth Substances|growth substances|mesh-ancestor
55935359|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935360|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
55935361|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935362|NCT00979017|Bevacizumab|bevacizumab|mesh-list
55935363|NCT00979017|Irinotecan|irinotecan|mesh-list
55935364|NCT00979017|Temozolomide|temozolomide|mesh-list
55935365|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935366|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935367|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55935368|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55935369|NCT00979017|Growth Substances|growth substances|mesh-ancestor
55935370|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935371|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
55935372|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55999602|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
55999603|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935373|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55935374|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935375|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935376|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55935377|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
55935378|NCT01670526|Rivastigmine|rivastigmine|mesh-list
55935379|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
55935380|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935381|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935382|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
55935383|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935384|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935385|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55935386|NCT01670526|Protective Agents|protective agents|mesh-ancestor
55935387|NCT00945035|Etoricoxib|etoricoxib|mesh-list
55935388|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55935389|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55935390|NCT00945035|Analgesics|analgesics|mesh-ancestor
55935391|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
55935392|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935393|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935394|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935395|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935396|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55935397|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55935398|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935399|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935400|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
55935401|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935402|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935403|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55935404|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55935405|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
55935406|NCT05176548|Paraproteins|paraproteins|mesh-list
55935407|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
55935408|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935409|NCT03719105|Dexamethasone|dexamethasone|mesh-list
55935410|NCT03719105|Prednisone|prednisone|mesh-list
55935411|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
55935412|NCT03719105|Ifosfamide|ifosfamide|mesh-list
55935413|NCT03719105|Doxorubicin|doxorubicin|mesh-list
55935414|NCT03719105|Methotrexate|methotrexate|mesh-list
55935415|NCT03719105|Etoposide|etoposide|mesh-list
55935416|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55935417|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935418|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
55935419|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762179|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746895|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55746896|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55746897|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55746898|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55746899|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55746900|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
55746901|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746902|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55746903|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746904|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935421|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55935423|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935424|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935425|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55935426|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935427|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
55935428|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
55935429|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935430|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55935431|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
55935432|NCT03719105|Hormones|hormones|mesh-ancestor
55935433|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935434|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55935435|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55935436|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55935437|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55935438|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935439|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55935440|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
55935441|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55935442|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935443|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
55935444|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
55999605|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55999606|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
55999607|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935445|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55935446|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55935447|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55935448|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935449|NCT00979875|Insulin|insulin|mesh-list
55935450|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55935451|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
55935452|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
55935453|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
55935454|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55935455|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935456|NCT03710603|Dexamethasone|dexamethasone|mesh-list
55935457|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
55935458|NCT03710603|Lenalidomide|lenalidomide|mesh-list
55935459|NCT03710603|Bortezomib|bortezomib|mesh-list
55935460|NCT03710603|Daratumumab|daratumumab|mesh-list
55935461|NCT03710603|BB 1101|bb 1101|mesh-list
55935462|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935463|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
55935464|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
55935465|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935466|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935467|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55935468|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
55935469|NCT03710603|Hormones|hormones|mesh-ancestor
55935470|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935471|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55935472|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935473|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
55935474|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935475|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935476|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
55935477|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55935478|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55935479|NCT03710603|Growth Substances|growth substances|mesh-ancestor
56253578|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253579|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56253580|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55935480|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
55935481|NCT02630706|Metformin|metformin|mesh-list
55935482|NCT02630706|Glimepiride|glimepiride|mesh-list
55935483|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
55935484|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55935485|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935486|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55935487|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935488|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
55935489|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55743414|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935490|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935491|NCT03709043|Ethanol|ethanol|mesh-list
55935492|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55935496|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
55935497|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55935498|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
55935499|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935500|NCT03707951|Expectorants|expectorants|mesh-ancestor
55935501|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
55935502|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55935503|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
55935504|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935505|NCT03707951|Protective Agents|protective agents|mesh-ancestor
55935506|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935507|NCT03707951|Antidotes|antidotes|mesh-ancestor
55935508|NCT04763057|Calcium|calcium|mesh-list
55935509|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55935510|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935511|NCT03702179|Durvalumab|durvalumab|mesh-list
55935512|NCT03702179|Tremelimumab|tremelimumab|mesh-list
55935513|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935514|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999608|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999609|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935518|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
55935519|NCT03698669|Narcotics|narcotics|mesh-ancestor
55935520|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55935521|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935522|NCT03698669|Analgesics|analgesics|mesh-ancestor
55935523|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
55935524|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935525|NCT03695237|Leuprolide|leuprolide|mesh-list
55935526|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55935527|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
55935528|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55935529|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935530|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55935531|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935532|NCT01677143|Bupivacaine|bupivacaine|mesh-list
55935533|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
55935534|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
55935535|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55935536|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935537|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
55935538|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935539|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
55935540|NCT03692663|Fludarabine|fludarabine|mesh-list
55935541|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935542|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
55935543|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935544|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935545|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55935546|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
55935547|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935548|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935549|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55935550|NCT02084069|Atorvastatin|atorvastatin|mesh-list
55935551|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55935552|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55828859|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
55828860|NCT02161406|Abatacept|abatacept|mesh-list
55828861|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55935553|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
55935554|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935555|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55935556|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55935557|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935558|NCT04439292|Trametinib|trametinib|mesh-list
55935559|NCT04439292|Dabrafenib|dabrafenib|mesh-list
55935560|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
55935561|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935562|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55935563|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935564|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935566|NCT04439292|Protective Agents|protective agents|mesh-ancestor
55935567|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935568|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55935569|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
55935571|NCT03685331|Fulvestrant|fulvestrant|mesh-list
55935572|NCT03685331|Palbociclib|palbociclib|mesh-list
55935573|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55935574|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935575|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935576|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935577|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55935578|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55935579|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55935580|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
55935581|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935582|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935583|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55935584|NCT04628988|Prednisone|prednisone|mesh-list
55935585|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
55935586|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999610|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55935587|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
55935588|NCT04628988|Hormones|hormones|mesh-ancestor
55935589|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935590|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935591|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55935592|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935593|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935594|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935595|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
55935596|NCT04626024|Dasatinib|dasatinib|mesh-list
55935597|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935598|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55935599|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935600|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935601|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55935602|NCT00981045|Hematinics|hematinics|mesh-ancestor
55935603|NCT00981435|Prednisolone|prednisolone|mesh-list
55935604|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
55935605|NCT00981435|Ketorolac|ketorolac|mesh-list
55935606|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
55935607|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935608|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
55935609|NCT00981435|Hormones|hormones|mesh-ancestor
55935610|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935611|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935612|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55935613|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935614|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935615|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55935616|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55935617|NCT00981435|Analgesics|analgesics|mesh-ancestor
55935618|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
55935619|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935620|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55935621|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935622|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935623|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55935624|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55935625|NCT04571580|Reteplase|reteplase|mesh-list
55935626|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55935627|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55935628|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55935629|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935630|NCT00981669|Vaccines|vaccines|mesh-list
55935631|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
55935632|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935636|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
55935637|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935638|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935651|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935652|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55935653|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935654|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55935655|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55935656|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
55935657|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935658|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55935659|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55935660|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935661|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55935662|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935663|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935664|NCT04762745|Thalidomide|thalidomide|mesh-list
55935665|NCT04762745|Dexamethasone|dexamethasone|mesh-list
55935666|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
55935667|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55935668|NCT04762745|Pomalidomide|pomalidomide|mesh-list
55935669|NCT04762745|BB 1101|bb 1101|mesh-list
55935670|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935671|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
55999611|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55935672|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
55935673|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935674|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935675|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55935676|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
55935677|NCT04762745|Hormones|hormones|mesh-ancestor
55935678|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935679|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55935680|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935681|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
55935682|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935683|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935684|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55935685|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
55935686|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
55935687|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55935688|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55935689|NCT04762745|Growth Substances|growth substances|mesh-ancestor
55935690|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
55935691|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935692|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
55935693|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55935694|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935695|NCT00983541|Gemcitabine|gemcitabine|mesh-list
55935696|NCT00983541|Fluorouracil|fluorouracil|mesh-list
55935697|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935698|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
55935699|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935700|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935701|NCT00983541|Antiviral Agents|antiviral agents|mesh-ancestor
55935702|NCT00983541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935705|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
55935706|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935707|NCT03667703|Famotidine|famotidine|mesh-list
55935708|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55935709|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55935710|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55935711|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
55935712|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
55935713|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935714|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935715|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935717|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55935718|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55935719|NCT05074056|Analgesics|analgesics|mesh-ancestor
55935720|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
55762884|NCT05700669|Olaparib|olaparib|mesh-list
55935721|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935722|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935723|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935724|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935725|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55935726|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935727|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935728|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
55935729|NCT05061420|Cetuximab|cetuximab|mesh-list
55935730|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935731|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935732|NCT03965130|Glucagon|glucagon|mesh-list
55935733|NCT03965130|Hormones|hormones|mesh-ancestor
55935734|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935735|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935736|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55935737|NCT03656549|Pemetrexed|pemetrexed|mesh-list
55935738|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935739|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935740|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935741|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55935742|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55935743|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
55935744|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
55999612|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999614|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55935745|NCT03062904|Miotics|miotics|mesh-ancestor
55935746|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
55935747|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935748|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935749|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55935750|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
55935751|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
55935752|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55935753|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55935754|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
55935755|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935756|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935757|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55935758|NCT00986583|Succinylcholine|succinylcholine|mesh-list
55935759|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
55935760|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55935761|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55935762|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935763|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935765|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55935766|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
55935767|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935768|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
55935769|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55935770|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762526|NCT02116972|FX006|fx006|mesh-list
55935771|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935772|NCT04762511|Vaccines|vaccines|mesh-list
55935773|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
55935774|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935775|NCT04762901|Paclitaxel|paclitaxel|mesh-list
55935776|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
55935781|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935782|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
55935783|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
55935784|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
55935785|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935786|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935787|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
55935788|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935789|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935790|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55935791|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
55935792|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55935793|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55935794|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55935795|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55935796|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935797|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55935798|NCT00988143|Vaccines|vaccines|mesh-list
55935799|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
55935800|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935801|NCT04491942|Gemcitabine|gemcitabine|mesh-list
55935802|NCT04491942|Cisplatin|cisplatin|mesh-list
55935803|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935804|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935805|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
55935806|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935807|NCT04491942|Antiviral Agents|antiviral agents|mesh-ancestor
55935808|NCT04491942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935809|NCT04491942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935810|NCT04491942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935811|NCT04491942|Immunologic Factors|immunologic factors|mesh-ancestor
55935812|NCT04491942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935813|NCT03018171|Clonidine|clonidine|mesh-list
55935814|NCT03018171|Sufentanil|sufentanil|mesh-list
55935815|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55935816|NCT03018171|Narcotics|narcotics|mesh-ancestor
55935817|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999615|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
55999616|NCT05022758|Warfarin|warfarin|mesh-list
55935818|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935819|NCT03018171|Analgesics|analgesics|mesh-ancestor
55935820|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
55935821|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935822|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55935823|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55935824|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
55935825|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
55935826|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55935827|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
55935828|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
55935829|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55935830|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55935831|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55935832|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
55935833|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935834|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935835|NCT03638375|Interferons|interferons|mesh-list
55935836|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
55935837|NCT03638375|Nivolumab|nivolumab|mesh-list
55935838|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935839|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935840|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55935841|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935842|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
55935843|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935844|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
55935845|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935846|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55935847|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55935848|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55935853|NCT00989157|Analgesics|analgesics|mesh-ancestor
55935854|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
55935855|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935856|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
55935857|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55935858|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
55935859|NCT00990561|Clobetasol|clobetasol|mesh-list
55935860|NCT00990561|Halobetasol|halobetasol|mesh-list
55935861|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55935862|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935863|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
55935864|NCT00990561|Hormones|hormones|mesh-ancestor
55935865|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55935866|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935867|NCT03018015|Ibuprofen|ibuprofen|mesh-list
55935868|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55935869|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55935870|NCT03018015|Analgesics|analgesics|mesh-ancestor
55935871|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
55935872|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935873|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935874|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55935875|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935876|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55935877|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935878|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935879|NCT03614741|Tinzaparin|tinzaparin|mesh-list
55935880|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55935881|NCT03614741|Dalteparin|dalteparin|mesh-list
55935882|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
55935883|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55935884|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55935885|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935886|NCT04438824|Palbociclib|palbociclib|mesh-list
55935887|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935888|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55935889|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935890|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935891|NCT03609593|Rituximab|rituximab|mesh-list
55935892|NCT03609593|Venetoclax|venetoclax|mesh-list
55935893|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55999617|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
55999618|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
55999619|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55999620|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
55999621|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55999622|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
55935894|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935895|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935896|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
55935897|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935898|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935899|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55762668|NCT02151682|Tapentadol|tapentadol|mesh-list
55935900|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
55935901|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935902|NCT00004547|Paclitaxel|paclitaxel|mesh-list
55935903|NCT00004547|Cisplatin|cisplatin|mesh-list
55935904|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55935905|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935906|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
55935907|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
55935908|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
55935909|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935910|NCT00005669|Metformin|metformin|mesh-list
55935911|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55935912|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935913|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
55935914|NCT02394834|Leucovorin|leucovorin|mesh-list
55935915|NCT02394834|Bevacizumab|bevacizumab|mesh-list
55935916|NCT02394834|Panitumumab|panitumumab|mesh-list
55935917|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
55935918|NCT02394834|Fluorouracil|fluorouracil|mesh-list
55935919|NCT02394834|Calcium|calcium|mesh-list
55935920|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
55935931|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935932|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935933|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935934|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
55935935|NCT02394834|Antidotes|antidotes|mesh-ancestor
55935936|NCT02394834|Protective Agents|protective agents|mesh-ancestor
55935937|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
55935939|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
55935940|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
55935941|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55935942|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55935943|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935944|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55935945|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935946|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55935947|NCT01363661|Molsidomine|molsidomine|mesh-list
55935948|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
55935949|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55935950|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935951|NCT03598595|Gemcitabine|gemcitabine|mesh-list
55935952|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
55935953|NCT03598595|Docetaxel|docetaxel|mesh-list
55935954|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935955|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
55935956|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935959|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935960|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935961|NCT03598595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935962|NCT03598595|Immunologic Factors|immunologic factors|mesh-ancestor
55935963|NCT03598595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935964|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
55935965|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
55935966|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
55935967|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
55935968|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56253590|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253591|NCT01882530|Analgesics|analgesics|mesh-ancestor
56253592|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
56253593|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935969|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55935970|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999623|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999624|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999625|NCT05021978|Pramoxine|pramoxine|mesh-list
55999626|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
55999627|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
55935971|NCT02628600|Amikacin|amikacin|mesh-list
55935972|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55935973|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935974|NCT00006101|Eflornithine|eflornithine|mesh-list
55935975|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935976|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55935977|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55935978|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55935979|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935980|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
55935981|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935982|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936004|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936005|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55936006|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55936007|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936008|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936010|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55936011|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936012|NCT00991029|Clopidogrel|clopidogrel|mesh-list
55936013|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55936014|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55936015|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55936016|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55936017|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
55936018|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936019|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936020|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936021|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
55936022|NCT00991809|Promethazine|promethazine|mesh-list
55936023|NCT00991809|Alfentanil|alfentanil|mesh-list
55936024|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55936025|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55936026|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936027|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936028|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
55936029|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
55936030|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
55936031|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936032|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
55936033|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
55936034|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55936035|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55936036|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
55936037|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
55936038|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936039|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936041|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
55936042|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
55936043|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55936044|NCT00991809|Narcotics|narcotics|mesh-ancestor
55936045|NCT00991809|Analgesics|analgesics|mesh-ancestor
55936046|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55936047|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
55936048|NCT02627274|Trastuzumab|trastuzumab|mesh-list
55936050|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55936051|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936052|NCT04982016|Methamphetamine|methamphetamine|mesh-list
55936053|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56253605|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55936054|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936055|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
55936056|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
55999628|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999629|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999630|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
55999631|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999632|NCT04280406|Azithromycin|azithromycin|mesh-list
55999633|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55999634|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999635|NCT05599828|Omeprazole|omeprazole|mesh-list
55999636|NCT05599828|Famotidine|famotidine|mesh-list
55999637|NCT05599828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55863768|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936057|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936058|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
55936059|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936060|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936061|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
55936062|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55936063|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55936064|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55936065|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55936066|NCT04436250|Ketamine|ketamine|mesh-list
55936067|NCT04436250|Esketamine|esketamine|mesh-list
55936068|NCT04436250|Analgesics|analgesics|mesh-ancestor
55936069|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
55936070|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936071|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936072|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55936073|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55936074|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
55936075|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
55936076|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936077|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55936078|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55936079|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936080|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936081|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
55936082|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55936083|NCT00994929|Oprelvekin|oprelvekin|mesh-list
55936084|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936086|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55936087|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55936088|NCT00929253|Narcotics|narcotics|mesh-ancestor
55936089|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936090|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936091|NCT00929253|Analgesics|analgesics|mesh-ancestor
55936092|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
55936093|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936094|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55936095|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
55936096|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
55936097|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55936098|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55936099|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936100|NCT04374903|Sirolimus|sirolimus|mesh-list
55936101|NCT04374903|Azithromycin|azithromycin|mesh-list
55936102|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
55936103|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55936104|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936105|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55936106|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936107|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
55936108|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55936109|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
55936110|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999638|NCT05599828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55762865|NCT02149108|Nintedanib|nintedanib|mesh-list
55999639|NCT05599828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55936111|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
55936112|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55936113|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55936114|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936117|NCT03063060|Vitamin D|vitamin d|mesh-list
55936118|NCT03063060|Calcium|calcium|mesh-list
55936119|NCT03063060|Vitamins|vitamins|mesh-ancestor
55936120|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
55936121|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936122|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55936123|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55936124|NCT00995475|Fluticasone|fluticasone|mesh-list
55936126|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936127|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55936128|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
55936129|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936130|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936131|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55936132|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
55936133|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
55936134|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55936135|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
55936136|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
55936137|NCT03062436|Protective Agents|protective agents|mesh-ancestor
55936138|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936139|NCT03500874|Leucovorin|leucovorin|mesh-list
55936140|NCT03500874|Fluorouracil|fluorouracil|mesh-list
55936141|NCT03500874|Floxuridine|floxuridine|mesh-list
55936142|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
55936143|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
55936144|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936145|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55936146|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936147|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55936148|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
55936149|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936150|NCT03500874|Antidotes|antidotes|mesh-ancestor
55936151|NCT03500874|Protective Agents|protective agents|mesh-ancestor
55936152|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
55936153|NCT03500874|Vitamins|vitamins|mesh-ancestor
55936154|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
55936155|NCT00997113|Alfentanil|alfentanil|mesh-list
55936156|NCT00997113|Propofol|propofol|mesh-list
55936157|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55936158|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936159|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936160|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55936161|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
55936162|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
55936163|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55936164|NCT00997113|Narcotics|narcotics|mesh-ancestor
55936165|NCT00997113|Analgesics|analgesics|mesh-ancestor
55936166|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
55936167|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936168|NCT04981704|Itraconazole|itraconazole|mesh-list
55936170|NCT04981704|Paroxetine|paroxetine|mesh-list
55936171|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
55936172|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936173|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55936174|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55936175|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936176|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936177|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55936178|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
55936179|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936180|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936181|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55936182|NCT04981704|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55936183|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55936184|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55936185|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999640|NCT05599828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802669|NCT01650519|Ibuprofen|ibuprofen|mesh-list
55999641|NCT05599828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999642|NCT05599828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55999643|NCT05599828|Histamine Antagonists|histamine antagonists|mesh-ancestor
55936186|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
55936187|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55936188|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
55936190|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55936192|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55936193|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55936194|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55936195|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55936197|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55936198|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936199|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55936200|NCT04974060|Remifentanil|remifentanil|mesh-list
55936201|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55936202|NCT04974060|Narcotics|narcotics|mesh-ancestor
55936203|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936204|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936205|NCT04974060|Analgesics|analgesics|mesh-ancestor
55936206|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
55936207|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936208|NCT01021761|Ketorolac|ketorolac|mesh-list
55936209|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55936210|NCT01021761|Nepafenac|nepafenac|mesh-list
55936211|NCT01021761|Bromfenac|bromfenac|mesh-list
55936212|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55936213|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936214|NCT01021761|Analgesics|analgesics|mesh-ancestor
55936215|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
55936216|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936217|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936218|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936219|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936220|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55936221|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936222|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936223|NCT04973904|Paclitaxel|paclitaxel|mesh-list
55936224|NCT04973904|Bevacizumab|bevacizumab|mesh-list
55936225|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55936226|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936227|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
55936228|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
55936229|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
55936230|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936231|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55936232|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55936233|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55936234|NCT04973904|Growth Substances|growth substances|mesh-ancestor
55936235|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936236|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
55936237|NCT00998049|Plerixafor|plerixafor|mesh-list
55936238|NCT00998049|Lenograstim|lenograstim|mesh-list
55936239|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55936240|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
55936241|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936242|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55936243|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55936244|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
55936245|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936246|NCT00998205|Atropine|atropine|mesh-list
55936247|NCT00998205|Dobutamine|dobutamine|mesh-list
55936248|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55936249|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55936250|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55936251|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
55936252|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802674|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
55936253|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936254|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55936255|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
55936256|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
55936257|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
55936258|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55936259|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55936260|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
55936261|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936264|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
55936265|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55936266|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55936267|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55936268|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
55936269|NCT00998205|Protective Agents|protective agents|mesh-ancestor
55936270|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
55936271|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
55936272|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55936273|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55936274|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936275|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936276|NCT02626182|Urological Agents|urological agents|mesh-ancestor
55936277|NCT01023477|Chloroquine|chloroquine|mesh-list
55936278|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
55936279|NCT01023477|Amebicides|amebicides|mesh-ancestor
55936280|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55936281|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55936282|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936283|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
55936284|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936285|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55936286|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936287|NCT01023477|Analgesics|analgesics|mesh-ancestor
55936288|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
55936289|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936290|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936291|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936292|NCT01023477|Filaricides|filaricides|mesh-ancestor
55936293|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
55936294|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
55936296|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55936297|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936298|NCT01023711|Vaccines|vaccines|mesh-list
55936299|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
55936300|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936301|NCT01001403|Nafamostat|nafamostat|mesh-list
55936302|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55936303|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936304|NCT01001403|Analgesics|analgesics|mesh-ancestor
55936305|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
55936306|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936307|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936308|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936309|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936310|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
55936311|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
55936312|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936313|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936314|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55936315|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55936316|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55936317|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55936318|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
55936319|NCT01024335|Naltrexone|naltrexone|mesh-list
56253613|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56253614|NCT01883011|Piracetam|piracetam|mesh-list
56253615|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55936320|NCT01024335|Dronabinol|dronabinol|mesh-list
55936321|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55936322|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55936323|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936324|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
55936325|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936327|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55999645|NCT05599828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999646|NCT05599828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999647|NCT01350232|Cytarabine|cytarabine|mesh-list
55936328|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936329|NCT01024335|Analgesics|analgesics|mesh-ancestor
55936330|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55936331|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55936332|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936333|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936334|NCT01024335|Hormones|hormones|mesh-ancestor
55936338|NCT01001559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55936339|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
55936340|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55936342|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
55936343|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936344|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936345|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936346|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
55936347|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
55936348|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936349|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55936350|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55936351|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
55936352|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55936353|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55936354|NCT01025427|Tenofovir|tenofovir|mesh-list
55936355|NCT01025427|Emtricitabine|emtricitabine|mesh-list
55936356|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
55936357|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
55936358|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936359|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55936360|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55936361|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936362|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936363|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55936364|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55936365|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55936366|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55936367|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
55936368|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55936369|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936370|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253616|NCT01883011|Protective Agents|protective agents|mesh-ancestor
56253617|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253618|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
56253619|NCT01883024|Insulin|insulin|mesh-list
56253620|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56253621|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253622|NCT01883102|Capsaicin|capsaicin|mesh-list
56253623|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
56253624|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
56253625|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
56253626|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253627|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763130|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55936371|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936372|NCT02162433|Analgesics|analgesics|mesh-ancestor
55936373|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
55936374|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936375|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55936376|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55936377|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55936378|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
55936379|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936380|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936381|NCT03404661|Secretin|secretin|mesh-list
55936382|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55936383|NCT03404661|Hormones|hormones|mesh-ancestor
56144598|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55936384|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936385|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936386|NCT01004991|Prednisone|prednisone|mesh-list
55936387|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
55936388|NCT01004991|Rituximab|rituximab|mesh-list
55936389|NCT01004991|Doxorubicin|doxorubicin|mesh-list
55936390|NCT01004991|Vincristine|vincristine|mesh-list
55936391|NCT01004991|Azacitidine|azacitidine|mesh-list
55936392|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55936393|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
55936394|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936395|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936396|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55936397|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
55936398|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999648|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
55999650|NCT01350232|Fludarabine|fludarabine|mesh-list
55936399|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936400|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55936401|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55936402|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55936403|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55936407|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
55936409|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936410|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55936411|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55936412|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
55936413|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
55936414|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
55936415|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55936416|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
55936417|NCT03115047|Meperidine|meperidine|mesh-list
55936418|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
55936419|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55936420|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936421|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936422|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936423|NCT03115047|Analgesics|analgesics|mesh-ancestor
55936424|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
55936425|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936426|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55936427|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55936428|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55936429|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
55763182|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
55936430|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936431|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936432|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55936433|NCT03115047|Narcotics|narcotics|mesh-ancestor
55936434|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55936435|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55936436|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936437|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
55936438|NCT03015519|Incretins|incretins|mesh-ancestor
55936439|NCT03015519|Hormones|hormones|mesh-ancestor
55936440|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936441|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936442|NCT02754141|Nivolumab|nivolumab|mesh-list
55936443|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55936444|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936445|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55936446|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936447|NCT01030653|Voriconazole|voriconazole|mesh-list
55936448|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
55936449|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936450|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55936451|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55936452|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936453|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936454|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55936455|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
55936456|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936457|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936458|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55936459|NCT01031043|Bethanechol|bethanechol|mesh-list
55936460|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55936461|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
55936462|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936463|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936464|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55936465|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55936466|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
55936467|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936468|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936469|NCT01050153|Aspirin|aspirin|mesh-list
55936470|NCT01050153|Dalteparin|dalteparin|mesh-list
55999651|NCT01350232|Bortezomib|bortezomib|mesh-list
55999652|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55999653|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
55936471|NCT01050153|Tinzaparin|tinzaparin|mesh-list
55936472|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55936473|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55936476|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
55936477|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936478|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936479|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936480|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936481|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55936482|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55936483|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936484|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55936485|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55936486|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936487|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
55936488|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
55936489|NCT04358133|Morphine|morphine|mesh-list
55936490|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55936491|NCT04358133|Narcotics|narcotics|mesh-ancestor
55936492|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763243|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
55936493|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936494|NCT04358133|Analgesics|analgesics|mesh-ancestor
55936495|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
55936496|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936497|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
55936498|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55936499|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
55936500|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936501|NCT04291209|Expectorants|expectorants|mesh-ancestor
55936502|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
55936503|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55936504|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
55936505|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936506|NCT04291209|Protective Agents|protective agents|mesh-ancestor
55936507|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936508|NCT04291209|Antidotes|antidotes|mesh-ancestor
55936509|NCT01032759|Memantine|memantine|mesh-list
55936510|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55936511|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55936512|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
55936513|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936514|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936515|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936516|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55936517|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55936518|NCT01032993|Ubiquinone|ubiquinone|mesh-list
55936519|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
55936520|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
55936521|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936522|NCT01032993|Vitamins|vitamins|mesh-ancestor
55936523|NCT01033773|Metformin|metformin|mesh-list
55936524|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55936525|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936526|NCT01053507|Naproxen|naproxen|mesh-list
55936527|NCT01053507|Sumatriptan|sumatriptan|mesh-list
55936528|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55936529|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56253628|NCT01883167|Febuxostat|febuxostat|mesh-list
56253629|NCT01883167|Verinurad|verinurad|mesh-list
56253630|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
56253631|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253632|NCT01883193|Micronutrients|micronutrients|mesh-list
56253633|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253634|NCT01883232|Lidocaine|lidocaine|mesh-list
56253635|NCT01883232|Epinephrine|epinephrine|mesh-list
56253636|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
56253637|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
56253638|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253639|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253640|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
56253641|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828911|NCT01533688|Laxatives|laxatives|mesh-ancestor
55936530|NCT01053507|Analgesics|analgesics|mesh-ancestor
55936531|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
55936532|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936533|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936534|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936535|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936536|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
55936537|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55936538|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936539|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936540|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55936541|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55936542|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55936543|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
55999654|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999655|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999656|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55936544|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936545|NCT01053819|Etanercept|etanercept|mesh-list
55936546|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55936547|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936548|NCT01053819|Analgesics|analgesics|mesh-ancestor
55936550|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936551|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936553|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936554|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55936555|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55936556|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
55936557|NCT01054911|Sunitinib|sunitinib|mesh-list
55936558|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936559|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55936560|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55936561|NCT01054911|Growth Substances|growth substances|mesh-ancestor
55936562|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936563|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
55936564|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55936565|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936566|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936567|NCT01055223|Troglitazone|troglitazone|mesh-list
55936568|NCT01055223|Amiloride|amiloride|mesh-list
55936569|NCT01055223|Spironolactone|spironolactone|mesh-list
55936570|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55936571|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
55936572|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936573|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936574|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55936575|NCT01055223|Diuretics|diuretics|mesh-ancestor
55936576|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
55936577|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55936578|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55936579|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55936580|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936581|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55936582|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55936583|NCT02168361|Interferons|interferons|mesh-list
55936584|NCT02168361|Ribavirin|ribavirin|mesh-list
55936585|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
55936586|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
55936587|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
55936588|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55936589|NCT02168361|Simeprevir|simeprevir|mesh-list
55936590|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936591|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
55936592|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936593|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
55936594|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936595|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
55936596|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936597|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
55936598|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936599|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55936600|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936601|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55936602|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936603|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936604|NCT01055769|Linezolid|linezolid|mesh-list
55936605|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55936606|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936607|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55936608|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936609|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936610|NCT01057017|Panitumumab|panitumumab|mesh-list
55936611|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55936612|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936614|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
55936615|NCT04972032|Hormones|hormones|mesh-ancestor
55936616|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936617|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936618|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55936619|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
55936620|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
55936621|NCT04972032|Protective Agents|protective agents|mesh-ancestor
55936622|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
55936624|NCT02918370|Aripiprazole|aripiprazole|mesh-list
55936625|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
55936626|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55936627|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55936628|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55936629|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936630|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936631|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
55936632|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
55936633|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936634|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936635|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55936636|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55936637|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
55936638|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55936639|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55936640|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55936641|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55936642|NCT02494986|Rilpivirine|rilpivirine|mesh-list
55936643|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55936644|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55936645|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936646|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936647|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
55936648|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936649|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55936650|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55936651|NCT04152564|Bupivacaine|bupivacaine|mesh-list
55936652|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
55936653|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
55936654|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
55936655|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936656|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936657|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
55936658|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936660|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
55936661|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55936662|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
55936663|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936664|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936665|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55936666|NCT04977960|Diuretics|diuretics|mesh-ancestor
55936667|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
55936668|NCT05593809|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
55936669|NCT05593809|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55936670|NCT05593809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936671|NCT05593731|Melatonin|melatonin|mesh-list
55936672|NCT05593731|Antioxidants|antioxidants|mesh-ancestor
55936673|NCT05593731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936674|NCT05593731|Protective Agents|protective agents|mesh-ancestor
55936675|NCT05593731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936676|NCT05593731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936677|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
55936678|NCT01062009|Astringents|astringents|mesh-ancestor
55936679|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936680|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
55936681|NCT01062165|Caspofungin|caspofungin|mesh-list
55936682|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
55936683|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936684|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936685|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936686|NCT05592951|Methamphetamine|methamphetamine|mesh-list
55936687|NCT05592951|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55999658|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999659|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999660|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55936688|NCT05592951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936689|NCT05592951|Sympathomimetics|sympathomimetics|mesh-ancestor
55936690|NCT05592951|Autonomic Agents|autonomic agents|mesh-ancestor
55936691|NCT05592951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936692|NCT05592951|Dopamine Agents|dopamine agents|mesh-ancestor
55936693|NCT05592951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936694|NCT05592951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936695|NCT05592951|Adrenergic Agents|adrenergic agents|mesh-ancestor
55936697|NCT05592951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55936698|NCT05592951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55936699|NCT05592951|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55936700|NCT04041843|Apixaban|apixaban|mesh-list
55936701|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55936702|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
55936703|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55936704|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
55936705|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936706|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936707|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
55936708|NCT01068873|Ritonavir|ritonavir|mesh-list
55936709|NCT01068873|Lopinavir|lopinavir|mesh-list
55936710|NCT01068873|Maraviroc|maraviroc|mesh-list
55936711|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55936712|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55936713|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
55936714|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936715|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936716|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55936717|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55936718|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
55936719|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936720|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55828932|NCT02217566|Prednisone|prednisone|mesh-list
56253642|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55763513|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
55936721|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55936722|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55936723|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55936724|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55936725|NCT01072773|Dexamethasone|dexamethasone|mesh-list
55936726|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
55936727|NCT01072773|Bortezomib|bortezomib|mesh-list
55936728|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55936729|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
55936730|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936731|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936732|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55936733|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
55936734|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936735|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936736|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55936737|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936738|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
55936739|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
55936740|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743434|NCT02516059|Oxycodone|oxycodone|mesh-list
55936741|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55936743|NCT01072773|Hormones|hormones|mesh-ancestor
55936744|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936745|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55936746|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55936747|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55936748|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55936749|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
55936750|NCT01074177|Afatinib|afatinib|mesh-list
55936751|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936752|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55936753|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936754|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936755|NCT01075971|Buprenorphine|buprenorphine|mesh-list
55999661|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55999662|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55999663|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
55936756|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55936757|NCT01075971|Narcotics|narcotics|mesh-ancestor
55936758|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936761|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
55936762|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936763|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55936764|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
55936765|NCT01076283|Baclofen|baclofen|mesh-list
55936766|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55936767|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936768|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55936769|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936770|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55936771|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
55936778|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55936779|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
55936781|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55936782|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
55936783|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55936784|NCT03805581|Defibrotide|defibrotide|mesh-list
55936785|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55936786|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55936787|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936788|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55936789|NCT01076985|Ritonavir|ritonavir|mesh-list
55936790|NCT01076985|Lopinavir|lopinavir|mesh-list
55936791|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55936792|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55936793|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
55936794|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936795|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936796|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55936797|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55936798|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
55936799|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936800|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55936801|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55936802|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
55936803|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55936804|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936805|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55936806|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55936807|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936808|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936809|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936810|NCT05539911|Fentanyl|fentanyl|mesh-list
55936811|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55936812|NCT05539911|Narcotics|narcotics|mesh-ancestor
55936813|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743437|NCT02516059|Narcotics|narcotics|mesh-ancestor
55936814|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936815|NCT05539911|Analgesics|analgesics|mesh-ancestor
55936816|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
55936817|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936818|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55936819|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55936820|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
55936821|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
55936822|NCT03589833|Methotrexate|methotrexate|mesh-list
55936823|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55936824|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
55936825|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55936826|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936827|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55936828|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
55936829|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936830|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999664|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
55999665|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999666|NCT02822378|Vitamin D|vitamin d|mesh-list
55999667|NCT02822378|Calcium|calcium|mesh-list
55999668|NCT02822378|Vitamins|vitamins|mesh-ancestor
55999669|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
55936831|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
55936832|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936833|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55936834|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55936835|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
55936836|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936837|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55936838|NCT01077921|Propranolol|propranolol|mesh-list
55936840|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55936841|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
55936842|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936843|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936844|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936845|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55936846|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55936847|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
55936848|NCT03484299|Gemcitabine|gemcitabine|mesh-list
55936850|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55936851|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
55936852|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936853|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936854|NCT03484299|Antiviral Agents|antiviral agents|mesh-ancestor
55936855|NCT03484299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936856|NCT03484299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936857|NCT03484299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55936858|NCT03484299|Immunologic Factors|immunologic factors|mesh-ancestor
55936859|NCT03484299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936860|NCT05498181|Valsartan|valsartan|mesh-list
55936861|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55936862|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55936863|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55936864|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55936865|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936866|NCT04970238|Simendan|simendan|mesh-list
55936867|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55936868|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
55936869|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55936870|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55936871|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936872|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936873|NCT04970238|Protective Agents|protective agents|mesh-ancestor
55936874|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936875|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55936876|NCT02169453|Opicapone|opicapone|mesh-list
55936877|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55936878|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
55936879|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936880|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55936881|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55936882|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
55936883|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
55936884|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936885|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936886|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55936887|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936889|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55936890|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55936891|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936892|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
55936893|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
55936894|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
55936895|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936896|NCT01765296|Celecoxib|celecoxib|mesh-list
55999670|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999671|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55999672|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55999673|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
55936897|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55936898|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936899|NCT01765296|Analgesics|analgesics|mesh-ancestor
55936900|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
55936901|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936902|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936903|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936904|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936905|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55936906|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55936907|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936908|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936909|NCT01081041|Carboplatin|carboplatin|mesh-list
55936910|NCT01081041|Fluorouracil|fluorouracil|mesh-list
56253655|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
56253656|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
56253657|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
56253658|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55936911|NCT01081041|Cetuximab|cetuximab|mesh-list
55936914|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936915|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55936916|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55936917|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
55936918|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936919|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55936920|NCT03022617|Apremilast|apremilast|mesh-list
55936921|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55936922|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936923|NCT03022617|Analgesics|analgesics|mesh-ancestor
55936924|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
55936925|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936926|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936927|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936928|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936929|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55936930|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55936931|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936932|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936933|NCT05427981|Buprenorphine|buprenorphine|mesh-list
55936934|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55936935|NCT05427981|Narcotics|narcotics|mesh-ancestor
55936936|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936937|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936938|NCT05427981|Analgesics|analgesics|mesh-ancestor
55936939|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
55936940|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936941|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55936942|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55936943|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55936944|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936945|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
55936946|NCT02089685|Ipilimumab|ipilimumab|mesh-list
55936947|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55936948|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936949|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55936950|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936951|NCT01088295|Telmisartan|telmisartan|mesh-list
55936952|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55936953|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55936954|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55936955|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936956|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
55936957|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55936958|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55936959|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
55936960|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
55936961|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55999674|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55999675|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726923|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
55999676|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999677|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936962|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936963|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936964|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936965|NCT04730609|Analgesics|analgesics|mesh-ancestor
55936966|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
55936967|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936968|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55936969|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55936970|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55936971|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
55936972|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936973|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936974|NCT03013335|Nivolumab|nivolumab|mesh-list
55746905|NCT00702325|Budesonide|budesonide|mesh-list
55746906|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
55746907|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55746908|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55746909|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55746910|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
55936975|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55936976|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936977|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55936978|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936979|NCT04730531|Epinephrine|epinephrine|mesh-list
55936980|NCT04730531|Bupivacaine|bupivacaine|mesh-list
55936981|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
55936992|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55936993|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55936994|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
55936995|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55936996|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
55936997|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
55936998|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
55936999|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55937000|NCT05569733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55937001|NCT05569733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55937002|NCT05569733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937003|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55937004|NCT05307003|Trazodone|trazodone|mesh-list
55937005|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
55937006|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55937007|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55937008|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55937009|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937010|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937011|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55937012|NCT05307003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55937013|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55937014|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55937015|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937016|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937017|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
55937018|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55937019|NCT03586661|Niraparib|niraparib|mesh-list
55937020|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55937021|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937022|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937023|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937024|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
55937025|NCT03153917|Melatonin|melatonin|mesh-list
55937026|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
55937027|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937028|NCT03153917|Protective Agents|protective agents|mesh-ancestor
55937029|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937030|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937031|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937032|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55937033|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55999678|NCT05493228|Analgesics|analgesics|mesh-ancestor
55999679|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
55999680|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937034|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253659|NCT01883323|Aldesleukin|aldesleukin|mesh-list
56253660|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
56253661|NCT01883323|Fludarabine|fludarabine|mesh-list
56253662|NCT01883323|Interleukin-2|interleukin-2|mesh-list
55937035|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937036|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55937037|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55937038|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937039|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
55937040|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937041|NCT01096875|Atorvastatin|atorvastatin|mesh-list
55937043|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55937046|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55937047|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55937048|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937049|NCT01097343|Clopidogrel|clopidogrel|mesh-list
55937050|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55937051|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55937052|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55937053|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55937054|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
55937055|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937056|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937057|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937058|NCT03580187|Morphine|morphine|mesh-list
55937059|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55937060|NCT03580187|Narcotics|narcotics|mesh-ancestor
55937061|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937062|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937063|NCT03580187|Analgesics|analgesics|mesh-ancestor
55937064|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
55937065|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937066|NCT01098747|Ibuprofen|ibuprofen|mesh-list
55937067|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55937068|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55937069|NCT01098747|Analgesics|analgesics|mesh-ancestor
55937070|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
55937071|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937072|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937073|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937074|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937075|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55937076|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937077|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937078|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
55937079|NCT02085161|Olodaterol|olodaterol|mesh-list
55937080|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55937081|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
55937082|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937083|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937084|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55937085|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
55937086|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
55937087|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55937088|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
55937089|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937090|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937091|NCT01034553|Bortezomib|bortezomib|mesh-list
55937092|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937093|NCT01035333|Orlistat|orlistat|mesh-list
55937094|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937095|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937096|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55937097|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55937098|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
55937099|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55937100|NCT02648477|Doxorubicin|doxorubicin|mesh-list
55937101|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55937102|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
55999681|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55999682|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55863809|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
55937103|NCT02648477|Letrozole|letrozole|mesh-list
55937104|NCT02648477|Anastrozole|anastrozole|mesh-list
55937105|NCT02648477|Exemestane|exemestane|mesh-list
55937106|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55937107|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937108|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55937109|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55937110|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937111|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937112|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937113|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55937116|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
55937117|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937118|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937119|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55937121|NCT03152981|Propofol|propofol|mesh-list
55937122|NCT03152981|Desflurane|desflurane|mesh-list
55937123|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55937124|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937125|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937126|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55937127|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
55937128|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
55937129|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55937130|NCT03152981|Narcotics|narcotics|mesh-ancestor
55937131|NCT03152981|Analgesics|analgesics|mesh-ancestor
55937132|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
55937133|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937134|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55937135|NCT03576755|Spironolactone|spironolactone|mesh-list
55937136|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55937137|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
55937138|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937139|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937140|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55937141|NCT03576755|Diuretics|diuretics|mesh-ancestor
55937142|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
55937143|NCT05384015|Carboplatin|carboplatin|mesh-list
55937144|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
55937145|NCT05384015|Etoposide|etoposide|mesh-list
55937146|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
55937147|NCT05384015|Lenvatinib|lenvatinib|mesh-list
55937148|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937149|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937150|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55937151|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55937152|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55937153|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253670|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253671|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56253672|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56253673|NCT01883323|Analgesics|analgesics|mesh-ancestor
56253674|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
56253675|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253676|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55828939|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746987|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
55746988|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
55746989|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
55746990|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746992|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
55746993|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
55746994|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746995|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746996|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
55937154|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937155|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55937156|NCT03572387|Azacitidine|azacitidine|mesh-list
55937157|NCT03572387|Tretinoin|tretinoin|mesh-list
55937158|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55937159|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
55937160|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937161|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937162|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937163|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
55937164|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
55937165|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
55937166|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55937167|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
55937168|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937169|NCT04728971|Caspofungin|caspofungin|mesh-list
55937170|NCT04728971|Micafungin|micafungin|mesh-list
55937171|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
55937172|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937173|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937174|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937176|NCT03568643|Azithromycin|azithromycin|mesh-list
55937177|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55937178|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937179|NCT01100931|Paclitaxel|paclitaxel|mesh-list
55937180|NCT01100931|Carboplatin|carboplatin|mesh-list
55937181|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55937182|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937183|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
55937184|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
55937185|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
55937186|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937187|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
55937188|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
55937189|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55937191|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937192|NCT04999449|Scopolamine|scopolamine|mesh-list
55937193|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55937194|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55937196|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
55937197|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937198|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937199|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55937200|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
55937201|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55937202|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
55937203|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937204|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937205|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55937206|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
55937207|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
55937208|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55937209|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55937210|NCT03013959|Analgesics|analgesics|mesh-ancestor
55748447|NCT02458339|Methotrexate|methotrexate|mesh-list
56253677|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55747074|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
55747075|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747076|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55747077|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55747078|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747079|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747080|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55747081|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55747082|NCT02462941|Adenosine|adenosine|mesh-list
55747083|NCT02462941|Analgesics|analgesics|mesh-ancestor
55747084|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
55747085|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747086|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747087|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55747088|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
55747089|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55747090|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
55937211|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
55937212|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937213|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937214|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937215|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937216|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
55937217|NCT02246595|Vilobelimab|vilobelimab|mesh-list
55937218|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55937219|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55937220|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
55937221|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937223|NCT01106859|Zopiclone|zopiclone|mesh-list
55937224|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55937225|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55937226|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937227|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937228|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55937229|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
55937230|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
55937231|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937232|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937233|NCT01042509|Rituximab|rituximab|mesh-list
55937234|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
55937235|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937236|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937237|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
55937238|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937239|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937240|NCT04814355|Celecoxib|celecoxib|mesh-list
55937241|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55937242|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55937243|NCT04814355|Analgesics|analgesics|mesh-ancestor
55937244|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
55937245|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937246|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937247|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999684|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
55999685|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937249|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55937250|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55937251|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937252|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937253|NCT02179671|Docetaxel|docetaxel|mesh-list
55937254|NCT02179671|Gefitinib|gefitinib|mesh-list
55937255|NCT02179671|Tremelimumab|tremelimumab|mesh-list
55937256|NCT02179671|Osimertinib|osimertinib|mesh-list
55937257|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937258|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
55937259|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
55937260|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
55937261|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937262|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55937263|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937264|NCT01110135|Dexamethasone|dexamethasone|mesh-list
55937265|NCT01110135|Etoposide|etoposide|mesh-list
55937268|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937269|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
55937270|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
55937271|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937272|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937273|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55937274|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
55937275|NCT01110135|Hormones|hormones|mesh-ancestor
55937276|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937277|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55937278|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937279|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55937280|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56253678|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
56253679|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253680|NCT01883505|Levodopa|levodopa|mesh-list
55937281|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55937282|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937283|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937284|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55937285|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
55937286|NCT01112241|Albuterol|albuterol|mesh-list
55937287|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
55937288|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55937289|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
55937290|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937291|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937292|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55937293|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
55937294|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
55937295|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55937296|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
55937297|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937298|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937299|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
55937300|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55937301|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55937302|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55937303|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55937304|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
55937305|NCT03013881|Trastuzumab|trastuzumab|mesh-list
55937306|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937307|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937308|NCT02174913|Fentanyl|fentanyl|mesh-list
55937309|NCT02174913|Propofol|propofol|mesh-list
55937310|NCT02174913|Atracurium|atracurium|mesh-list
55937311|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55937312|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937313|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937314|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55937315|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
55937316|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
55937317|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55937318|NCT02174913|Narcotics|narcotics|mesh-ancestor
55937319|NCT02174913|Analgesics|analgesics|mesh-ancestor
55937320|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
55937321|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937322|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55999686|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999687|NCT02758132|Denosumab|denosumab|mesh-list
55937323|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55937324|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55937325|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55937326|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55937327|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55937328|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
55937329|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937330|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937331|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
55937332|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55937333|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55937334|NCT01114503|Prednisolone|prednisolone|mesh-list
55937335|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
55937336|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55937337|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
55871481|NCT05687253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55937338|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937343|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55937344|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
55937345|NCT01114503|Hormones|hormones|mesh-ancestor
55937346|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937347|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55937348|NCT01114503|Protective Agents|protective agents|mesh-ancestor
55937349|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55937350|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937351|NCT03015831|Colchicine|colchicine|mesh-list
55937352|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
55937353|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937354|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
55937355|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
55937356|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
55937357|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937358|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937359|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
55937360|NCT01114581|Guaifenesin|guaifenesin|mesh-list
55937361|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
55937362|NCT01114581|Expectorants|expectorants|mesh-ancestor
55937363|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
55937364|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55937365|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55937366|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
55937367|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937368|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937369|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937370|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
55937371|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55937372|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
55937373|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
55937374|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937375|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
55937376|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55937377|NCT01114893|Travoprost|travoprost|mesh-list
55743451|NCT02506231|Vitamins|vitamins|mesh-ancestor
55937378|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55937380|NCT01114971|Fentanyl|fentanyl|mesh-list
55937381|NCT01114971|Esmolol|esmolol|mesh-list
55937382|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55937383|NCT01114971|Narcotics|narcotics|mesh-ancestor
55937384|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937385|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937386|NCT01114971|Analgesics|analgesics|mesh-ancestor
55937387|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
55937388|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937389|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55937390|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55937391|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
55937392|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
55937393|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55937394|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55937395|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55937396|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
55937397|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999688|NCT02758132|Prednisone|prednisone|mesh-list
55999689|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999690|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
55999691|NCT02758132|Hormones|hormones|mesh-ancestor
55863814|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55937398|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937399|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55937400|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
55937401|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
55937402|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55937403|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55937404|NCT01044693|Metoprolol|metoprolol|mesh-list
55937405|NCT01044693|Nebivolol|nebivolol|mesh-list
55937406|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
55937407|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
55937408|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55937409|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55764203|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55937410|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937416|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
55937417|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937418|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937419|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55937420|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55937421|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55937422|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
55937423|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937424|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55937425|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55937426|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55937427|NCT01115517|Bevacizumab|bevacizumab|mesh-list
55937428|NCT01115517|Mitomycins|mitomycins|mesh-list
55937429|NCT01115517|Mitomycin|mitomycin|mesh-list
55937430|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937431|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937432|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55937433|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55937434|NCT01115517|Growth Substances|growth substances|mesh-ancestor
55937435|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937436|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
55937437|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55937438|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
55937439|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937440|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55937441|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937442|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
55937443|NCT03015675|Vitamins|vitamins|mesh-ancestor
55937444|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
55937445|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937446|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
55937447|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937448|NCT03015675|Protective Agents|protective agents|mesh-ancestor
55937449|NCT01044771|Tenofovir|tenofovir|mesh-list
55937450|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
55937451|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
55743467|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
55937452|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937453|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55937454|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55937455|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937456|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937457|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55937458|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55937459|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55937460|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55937461|NCT01115673|Acetaminophen|acetaminophen|mesh-list
55937462|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55937463|NCT01115673|Analgesics|analgesics|mesh-ancestor
55937464|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
55937465|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937466|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999692|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999693|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999694|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55937467|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
55937468|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55937469|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
55937470|NCT04582383|Doxycycline|doxycycline|mesh-list
55937471|NCT04582383|Spironolactone|spironolactone|mesh-list
55937472|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55937473|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937474|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
55937475|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55937476|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55937477|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55937478|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
55937483|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
55937484|NCT01118091|Aldesleukin|aldesleukin|mesh-list
55764475|NCT05627271|Ofatumumab|ofatumumab|mesh-list
55937485|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937486|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55937487|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55937488|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
55937489|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937491|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55937492|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55937493|NCT01045551|Analgesics|analgesics|mesh-ancestor
55937494|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
55937495|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937496|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937497|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937498|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937499|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55937500|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55937501|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937502|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937503|NCT01047189|Clindamycin|clindamycin|mesh-list
55937504|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
55937505|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
55937506|NCT01047189|Tretinoin|tretinoin|mesh-list
55937507|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55937508|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937509|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55937510|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937511|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937512|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937513|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
55937514|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
55937515|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
55937516|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55937517|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55937518|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937519|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
55937520|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937521|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937522|NCT03012945|Anesthetics|anesthetics|mesh-list
55937523|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937524|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937525|NCT01121211|Testosterone|testosterone|mesh-list
55937526|NCT01121211|Androgens|androgens|mesh-ancestor
55937527|NCT01121211|Hormones|hormones|mesh-ancestor
55937528|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937529|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937530|NCT01162551|Sirolimus|sirolimus|mesh-list
55937531|NCT01162551|Methotrexate|methotrexate|mesh-list
55937532|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55937533|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
55937534|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55937535|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747091|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
55747092|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747093|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747094|NCT04042831|Olaparib|olaparib|mesh-list
55747095|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55747096|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747097|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747098|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747099|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
55747100|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55747101|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55747102|NCT04824391|Vaccines|vaccines|mesh-list
55747103|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
55747104|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747105|NCT03297073|Acetaminophen|acetaminophen|mesh-list
55747106|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55747107|NCT03297073|Analgesics|analgesics|mesh-ancestor
55747108|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
55747109|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747110|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747111|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
55747112|NCT02462317|Baclofen|baclofen|mesh-list
55747113|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55937536|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55937537|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
55999696|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55999697|NCT01891916|Caseins|caseins|mesh-list
55999698|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
55999699|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
55999700|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937538|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937539|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937540|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
55937541|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937542|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55937543|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55937544|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
55937545|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937546|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55937547|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55937548|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937552|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
55937553|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55937554|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55937555|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937556|NCT03013101|Antibodies|antibodies|mesh-list
55937557|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55937558|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
55937559|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937560|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55937561|NCT03088137|Hormones|hormones|mesh-ancestor
55937562|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937563|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937564|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
55937565|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55937566|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
55937567|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937568|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937569|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55937570|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
55937571|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55937572|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
55937573|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937574|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937575|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55937576|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
55937577|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
55937578|NCT01165047|Protective Agents|protective agents|mesh-ancestor
55937579|NCT01166997|Heparin|heparin|mesh-list
55937580|NCT01166997|Calcium heparin|calcium heparin|mesh-list
55937581|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
55937582|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55937583|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55937584|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937585|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
55937586|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55937587|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937588|NCT02647437|Levetiracetam|levetiracetam|mesh-list
55937589|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
55937590|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
55937591|NCT01170117|Olanzapine|olanzapine|mesh-list
55937592|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
55937593|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
55937594|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937595|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937596|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55937597|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55937598|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55937599|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937600|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55937601|NCT01170117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55937602|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55937603|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55937604|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937605|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937606|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
55937607|NCT01172145|Modafinil|modafinil|mesh-list
55937608|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55937609|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937610|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55937611|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55937612|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55937613|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937614|NCT01175343|R04929097|r04929097|mesh-list
55937615|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937616|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937617|NCT01176435|Levodopa|levodopa|mesh-list
55937618|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55937619|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55937620|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
55937624|NCT01176591|Aprepitant|aprepitant|mesh-list
55937625|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
55937626|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
55937627|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
55937628|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937629|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937630|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55937631|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55937632|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937633|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937634|NCT01176981|Methotrexate|methotrexate|mesh-list
55937635|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55937636|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
55937637|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55937638|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937639|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55937640|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
55937641|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937642|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937643|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
55937644|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937645|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55937646|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55937647|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
55937648|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937649|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55937650|NCT01126593|Bupivacaine|bupivacaine|mesh-list
55937651|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
55937652|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
55937653|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937654|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937655|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
55937656|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937657|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
55937658|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55937659|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937660|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937661|NCT01126671|Vitamin D|vitamin d|mesh-list
55937662|NCT01126671|Vitamins|vitamins|mesh-ancestor
55937663|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
55937664|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937665|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55937666|NCT01182675|Plerixafor|plerixafor|mesh-list
55937667|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
56253682|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56253683|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55937668|NCT01182675|Lenograstim|lenograstim|mesh-list
55937669|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55937670|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
55937671|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937672|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937674|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55937675|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55937676|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
55937677|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937678|NCT01129245|Celecoxib|celecoxib|mesh-list
55937679|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55937680|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55937681|NCT01129245|Analgesics|analgesics|mesh-ancestor
55937682|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
55999702|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55999703|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
55863824|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55937683|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937684|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937685|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937686|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937687|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55937688|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55937689|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937690|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937691|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55937692|NCT01183533|Plasminogen|plasminogen|mesh-list
55937694|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55937695|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937696|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55937697|NCT01188369|Simendan|simendan|mesh-list
55937698|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55937699|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
55937700|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55937701|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55937702|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937703|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937704|NCT01188369|Protective Agents|protective agents|mesh-ancestor
55937705|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937706|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
55937707|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
55937708|NCT01135329|Busulfan|busulfan|mesh-list
55937711|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55937712|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
55937713|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937714|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937715|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55937716|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
55937717|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937718|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937719|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55937720|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55937721|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937722|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55937723|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55937724|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
55937725|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55937726|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937727|NCT03012009|Lidocaine|lidocaine|mesh-list
55937728|NCT03012009|Epinephrine|epinephrine|mesh-list
55937729|NCT03012009|Racepinephrine|racepinephrine|mesh-list
55937730|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
55937731|NCT03012009|Anesthetics|anesthetics|mesh-list
55937732|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55937733|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
55937734|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55937735|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937736|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
55937737|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937738|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55937739|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55937740|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55937741|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55937742|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937743|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55937745|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
55937746|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937747|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55937748|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55937749|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
55937750|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55937751|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
55937752|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
55999704|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999705|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999706|NCT01313416|Antiviral Agents|antiviral agents|mesh-ancestor
55937753|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
55937754|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55937755|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55937756|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
55937757|NCT04403555|Ivermectin|ivermectin|mesh-list
55937758|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55937759|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937760|NCT03565835|Prednisone|prednisone|mesh-list
55937761|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
55937762|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937763|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
55937764|NCT03565835|Hormones|hormones|mesh-ancestor
55937765|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937766|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937767|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55937772|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
55937773|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55937774|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
55937775|NCT03563729|Nivolumab|nivolumab|mesh-list
55937776|NCT03563729|Ipilimumab|ipilimumab|mesh-list
55937777|NCT03563729|Trametinib|trametinib|mesh-list
55937778|NCT03563729|Dabrafenib|dabrafenib|mesh-list
55937779|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937780|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764604|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55937781|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55937782|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937783|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55937784|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937785|NCT01624259|Metformin|metformin|mesh-list
55937787|NCT01624259|Dulaglutide|dulaglutide|mesh-list
55937788|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55937789|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937790|NCT01624259|Incretins|incretins|mesh-ancestor
55937792|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937793|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
55937794|NCT02081183|Prednisone|prednisone|mesh-list
55937795|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
55937796|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55937797|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
55937798|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937799|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937800|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55937801|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
55937802|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937803|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937804|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55937805|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937806|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
55937807|NCT02081183|Hormones|hormones|mesh-ancestor
55937808|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937809|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55937810|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55937811|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55937812|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
55937813|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55937814|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937815|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937816|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
55937817|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55937818|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55937819|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937820|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
55937821|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
55937822|NCT02079077|Aspirin|aspirin|mesh-list
55937823|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
55937824|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
55937825|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55937826|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55999707|NCT01313416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999708|NCT01313416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999709|NCT01313416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55999710|NCT01313416|Immunologic Factors|immunologic factors|mesh-ancestor
55937827|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937828|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937829|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937830|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937831|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55937832|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55937833|NCT02079077|Analgesics|analgesics|mesh-ancestor
55937834|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
55937835|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937836|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937837|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937839|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55937840|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55937841|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55937842|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
55937843|NCT03547271|Vaccines|vaccines|mesh-list
55937844|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55937845|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
55937846|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937847|NCT03547115|Venetoclax|venetoclax|mesh-list
55937848|NCT03547115|Voruciclib|voruciclib|mesh-list
55937849|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937850|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55937851|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937852|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937853|NCT01191255|Sevelamer|sevelamer|mesh-list
55937854|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
55937855|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
55937856|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937857|NCT02078219|Allopurinol|allopurinol|mesh-list
55937859|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
55937860|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937861|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937862|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
55937863|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937864|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55937865|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
55937866|NCT02078219|Protective Agents|protective agents|mesh-ancestor
55937867|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937868|NCT03536039|Prednisone|prednisone|mesh-list
55937869|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
55937870|NCT03536039|Rituximab|rituximab|mesh-list
55937871|NCT03536039|Doxorubicin|doxorubicin|mesh-list
55937872|NCT03536039|Vincristine|vincristine|mesh-list
55937873|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55937874|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
55937875|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937876|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937877|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55937878|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
55937879|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937880|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937881|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55937882|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937883|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55937884|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55937885|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55937886|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937887|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937888|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
55937889|NCT03536039|Hormones|hormones|mesh-ancestor
55937890|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937891|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55937892|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55937893|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
55937894|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
55937904|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937906|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
55937907|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55937908|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55937909|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
55937910|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937911|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937912|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937928|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55937929|NCT03527147|Rituximab|rituximab|mesh-list
55937930|NCT03527147|Magrolimab|magrolimab|mesh-list
55937931|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
55937932|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937933|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937934|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
55743497|NCT03345667|Ranibizumab|ranibizumab|mesh-list
55937935|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937936|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937937|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55937938|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55937939|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55937940|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
55937941|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937942|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55937943|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55937944|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937945|NCT01677611|Resveratrol|resveratrol|mesh-list
55937946|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
56144600|NCT00801138|Hormones|hormones|mesh-ancestor
55937947|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937948|NCT01677611|Protective Agents|protective agents|mesh-ancestor
55937949|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937950|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937951|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55937953|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
55937954|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
55937955|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55937956|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55937957|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55937958|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55937959|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937960|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937961|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937973|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55937974|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
55937975|NCT01193049|Hormones|hormones|mesh-ancestor
55937976|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937977|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937978|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55937979|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937980|NCT01679951|Methotrexate|methotrexate|mesh-list
55937981|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55937982|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
55937983|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55937984|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999711|NCT01313416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999712|NCT05599360|Gemtuzumab|gemtuzumab|mesh-list
55999713|NCT05599360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55937985|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55937986|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
55937987|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937988|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937989|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
55937990|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937991|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55937992|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55937993|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
55937994|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55937995|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55937996|NCT03514589|Cosyntropin|cosyntropin|mesh-list
55937997|NCT03514589|Hormones|hormones|mesh-ancestor
55937998|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937999|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938000|NCT01194297|Vaccines|vaccines|mesh-list
55938001|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
55938002|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938003|NCT01194453|Folic Acid|folic acid|mesh-list
55938004|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
55938005|NCT01194453|Gemcitabine|gemcitabine|mesh-list
55938006|NCT01194453|Dexamethasone|dexamethasone|mesh-list
55938007|NCT01194453|Cisplatin|cisplatin|mesh-list
55938008|NCT01194453|Vitamins|vitamins|mesh-ancestor
55938009|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
55938010|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938011|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938012|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
55938013|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
55938014|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938015|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55938016|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
55938017|NCT01194453|Hormones|hormones|mesh-ancestor
55938018|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938019|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55938020|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938021|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55938022|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
55938023|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938024|NCT01194453|Antiviral Agents|antiviral agents|mesh-ancestor
55938025|NCT01194453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764804|NCT03187457|Metronidazole|metronidazole|mesh-list
55938026|NCT01194453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938027|NCT01194453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938028|NCT01194453|Immunologic Factors|immunologic factors|mesh-ancestor
55938029|NCT01194453|Hematinics|hematinics|mesh-ancestor
55938030|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
55938031|NCT03507413|Metformin|metformin|mesh-list
55938032|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55938033|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938034|NCT01195467|Tenofovir|tenofovir|mesh-list
55938035|NCT01195467|Emtricitabine|emtricitabine|mesh-list
55938036|NCT01195467|Efavirenz|efavirenz|mesh-list
55938037|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
55938038|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55938039|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
55938040|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938042|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55938043|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938045|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55938046|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55938047|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55938048|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55938049|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55938050|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55938051|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55938052|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55938053|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55938054|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55999714|NCT05599360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999715|NCT05499234|Acetaminophen|acetaminophen|mesh-list
55938055|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55938056|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
55938058|NCT03492437|Dabigatran|dabigatran|mesh-list
55938059|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
55938060|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55938061|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
55938062|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938063|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938064|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
55938065|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938092|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
55938093|NCT02405585|Irinotecan|irinotecan|mesh-list
55938094|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55938095|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
55938096|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938097|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938098|NCT02405585|Antiviral Agents|antiviral agents|mesh-ancestor
55938099|NCT02405585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938100|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938101|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938102|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
55938103|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938104|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55938105|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55938106|NCT02405585|Antidotes|antidotes|mesh-ancestor
55938107|NCT02405585|Protective Agents|protective agents|mesh-ancestor
55938108|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
55938109|NCT02405585|Vitamins|vitamins|mesh-ancestor
55938110|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
55938111|NCT03491345|Avelumab|avelumab|mesh-list
55938112|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55938113|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938114|NCT00089999|Lapatinib|lapatinib|mesh-list
55938115|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938116|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55938117|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938118|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938119|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
55938120|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55938121|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938122|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
55938123|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
55764875|NCT05307627|Naltrexone|naltrexone|mesh-list
55938124|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
55938125|NCT00089843|Testosterone|testosterone|mesh-list
55938126|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
55938127|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
55938128|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55938129|NCT00089843|Androgens|androgens|mesh-ancestor
55938130|NCT00089843|Hormones|hormones|mesh-ancestor
55938131|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938132|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938133|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55938134|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938135|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
55938136|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55938137|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55938138|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938139|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55938141|NCT03485417|Aripiprazole|aripiprazole|mesh-list
55938142|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55938145|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55938146|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55938147|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938148|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938149|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
55938150|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
55938151|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938152|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938153|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55999717|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55999718|NCT05499234|Analgesics|analgesics|mesh-ancestor
55999719|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
55938154|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55938155|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
55938156|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55938157|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55938158|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55938159|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55938160|NCT01677923|Metformin|metformin|mesh-list
55938161|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55938162|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938163|NCT00089297|Paclitaxel|paclitaxel|mesh-list
55938164|NCT00089297|Carboplatin|carboplatin|mesh-list
55938165|NCT00089297|Cetuximab|cetuximab|mesh-list
55938166|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55938167|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938168|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
55938169|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
55938170|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
55938171|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938172|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55938173|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55938174|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55938175|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938176|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253684|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
56253685|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253686|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253687|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253688|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56253689|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253690|NCT01883518|Vaccines|vaccines|mesh-list
56253691|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
56253692|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747114|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55747115|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55938177|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55938178|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55938179|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938180|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
55938181|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938182|NCT03482297|Midodrine|midodrine|mesh-list
55938183|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
55938184|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
55938185|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938186|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938187|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55938188|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55938189|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55938190|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55938191|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
55938192|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938193|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938194|NCT00088907|Docetaxel|docetaxel|mesh-list
55938195|NCT00088907|Gefitinib|gefitinib|mesh-list
55938196|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938197|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
55938198|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
55938199|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
55938200|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938201|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55938202|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938203|NCT00088829|Paclitaxel|paclitaxel|mesh-list
55938204|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55938205|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55938206|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938207|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
55938208|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
55938209|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
55938210|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938211|NCT00088595|Pasireotide|pasireotide|mesh-list
55938212|NCT00088595|Hormones|hormones|mesh-ancestor
55938213|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938216|NCT03450707|Vitamins|vitamins|mesh-ancestor
55938217|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
55938218|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938219|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
55938220|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
55938221|NCT01678079|Calcium|calcium|mesh-list
55938222|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55999720|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999721|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999722|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
55938223|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938224|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55938225|NCT01678235|Insulin|insulin|mesh-list
55938226|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55938227|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
55938228|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
55938229|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55938230|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938231|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
55938233|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
55938234|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938235|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
55938236|NCT01197495|Protective Agents|protective agents|mesh-ancestor
55938237|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55938238|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55938239|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55938240|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938241|NCT03011931|Simvastatin|simvastatin|mesh-list
55938242|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55938243|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55938244|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
56253693|NCT01883531|Mannitol|mannitol|mesh-list
56253694|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56253695|NCT01883531|Diuretics|diuretics|mesh-ancestor
55938245|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938246|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55938247|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55938248|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938249|NCT02185131|Mirtazapine|mirtazapine|mesh-list
55938250|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
55938251|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55938252|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55938253|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
55938254|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
55938255|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938256|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938257|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938258|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55938259|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55938260|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938261|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55938262|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55938263|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55938264|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
55938265|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55938266|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55938267|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
55938268|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55938269|NCT00085709|Cytarabine|cytarabine|mesh-list
55938270|NCT00085709|Daunorubicin|daunorubicin|mesh-list
55938271|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
55938272|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55938273|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
55938274|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938275|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938276|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
55938277|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938278|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938279|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
55938280|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938281|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55938282|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55938283|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55938284|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938285|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55938286|NCT01201863|Testosterone|testosterone|mesh-list
55938288|NCT01201863|Hormones|hormones|mesh-ancestor
55938290|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938291|NCT01202253|Anidulafungin|anidulafungin|mesh-list
55938292|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
55938293|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999723|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55999725|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938294|NCT01678703|Misoprostol|misoprostol|mesh-list
55938295|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55938296|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
55938297|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55938298|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938299|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55938300|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55938301|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
55938302|NCT00085631|Cisplatin|cisplatin|mesh-list
55938303|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938304|NCT01141491|Vaccines|vaccines|mesh-list
55938305|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
55938306|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
55938307|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938308|NCT01141569|R04929097|r04929097|mesh-list
55938309|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938310|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938311|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55938312|NCT01141725|Idarubicin|idarubicin|mesh-list
55938313|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55938314|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
55889279|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889280|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55889281|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889282|NCT02979561|Warfarin|warfarin|mesh-list
55889283|NCT02979561|Dabigatran|dabigatran|mesh-list
55938315|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938316|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938317|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55938318|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55938319|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55938320|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938321|NCT01202721|Atenolol|atenolol|mesh-list
55938322|NCT01202721|Telmisartan|telmisartan|mesh-list
55938323|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55938324|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55938325|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55938326|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938327|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55938328|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
55938329|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
55938330|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938331|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938332|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55938333|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55938334|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55938335|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
55938336|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938337|NCT00084617|Capecitabine|capecitabine|mesh-list
55938338|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
55938339|NCT00084617|Irinotecan|irinotecan|mesh-list
55938340|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55938341|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
55938342|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938343|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938344|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55938345|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55938346|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938347|NCT04270175|Dexamethasone|dexamethasone|mesh-list
55938348|NCT04270175|Daratumumab|daratumumab|mesh-list
55938349|NCT04270175|Pomalidomide|pomalidomide|mesh-list
55938350|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938351|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
55938352|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
55938353|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938354|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938355|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55938356|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
55938357|NCT04270175|Hormones|hormones|mesh-ancestor
55938358|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938359|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55938360|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938361|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
55938363|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55999726|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55999727|NCT01269034|Insulin|insulin|mesh-list
55999728|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55938364|NCT04270175|Growth Substances|growth substances|mesh-ancestor
55938365|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
55938366|NCT01203189|Ketoconazole|ketoconazole|mesh-list
55938367|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
55765143|NCT02432027|Hormones|hormones|mesh-ancestor
55938368|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938369|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55938370|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55938371|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938372|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938373|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55938374|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
55938375|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938376|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938377|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55938378|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
55938379|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55938380|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938381|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
55938382|NCT01679327|Leucovorin|leucovorin|mesh-list
55938383|NCT01679327|Bevacizumab|bevacizumab|mesh-list
55938384|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
55938385|NCT01679327|Calcium|calcium|mesh-list
55938386|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
55938387|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55938388|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938389|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55938390|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55938391|NCT01679327|Growth Substances|growth substances|mesh-ancestor
55938392|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938393|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
55938394|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55938395|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55938396|NCT01679327|Antidotes|antidotes|mesh-ancestor
55938397|NCT01679327|Protective Agents|protective agents|mesh-ancestor
55938399|NCT01679327|Vitamins|vitamins|mesh-ancestor
55938400|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
55938401|NCT01206387|Desoximetasone|desoximetasone|mesh-list
55938402|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938403|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
55938404|NCT01206387|Hormones|hormones|mesh-ancestor
55938405|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938406|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938407|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55938408|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55938409|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55938410|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55938411|NCT01679639|Rifampin|rifampin|mesh-list
55938412|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55938413|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
55938414|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55938415|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938416|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
55938417|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55938418|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938419|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938420|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55938421|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55938422|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55938423|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55938424|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55938425|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55938426|NCT01679795|Tibolone|tibolone|mesh-list
55938428|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
55938429|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938430|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938431|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55999730|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
55999731|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
55938432|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55938433|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938434|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55938439|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938440|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55938441|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938442|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938443|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
55938444|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938446|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
55938447|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
55938448|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938449|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938450|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
55743512|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55938451|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938453|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55938454|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55938455|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55938456|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938457|NCT04761731|Tacrolimus|tacrolimus|mesh-list
55938458|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938459|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
55938460|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938461|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55938462|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938463|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938464|NCT03087539|Abciximab|abciximab|mesh-list
55938465|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
55938466|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55938467|NCT03087149|Vitamin D|vitamin d|mesh-list
55938468|NCT03087149|Vitamins|vitamins|mesh-ancestor
55938469|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
55938470|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938471|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55938472|NCT03086681|Cisplatin|cisplatin|mesh-list
55938473|NCT03086681|Endostar protein|endostar protein|mesh-list
55938474|NCT03086681|Endostatins|endostatins|mesh-list
55938475|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938476|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55938477|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55938478|NCT03086681|Growth Substances|growth substances|mesh-ancestor
55938479|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938480|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
55938481|NCT03086759|Triamcinolone|triamcinolone|mesh-list
55938482|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55938483|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55938484|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55938485|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938486|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
55938487|NCT03086759|Hormones|hormones|mesh-ancestor
55938488|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938489|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938490|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938491|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
55938492|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938493|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938494|NCT03086291|Simvastatin|simvastatin|mesh-list
55938495|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55938496|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56253697|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253698|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
55938497|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
55938498|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938499|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55802716|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938500|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55938502|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
55938503|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55938504|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999732|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
55863845|NCT04520776|Analgesics|analgesics|mesh-ancestor
55938505|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938522|NCT03084809|Vitamins|vitamins|mesh-ancestor
55938523|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
55938524|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
55938525|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938526|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55938527|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938528|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
55938529|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
55938530|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55938531|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55938532|NCT01144143|Prednisolone|prednisolone|mesh-list
55938533|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
55938534|NCT01144143|Infliximab|infliximab|mesh-list
55938535|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55938536|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
55938537|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938538|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
55938539|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
55938540|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938541|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938542|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55938543|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
55938544|NCT01144143|Hormones|hormones|mesh-ancestor
55938545|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938546|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55938547|NCT01144143|Protective Agents|protective agents|mesh-ancestor
55938548|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55938549|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938550|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
55938551|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55938552|NCT03084575|Glycerol|glycerol|mesh-list
55938553|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55938554|NCT03084575|Protective Agents|protective agents|mesh-ancestor
55938555|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938556|NCT01212471|Bromfenac|bromfenac|mesh-list
55938557|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55938558|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55938559|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55938560|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55938561|NCT01212471|Analgesics|analgesics|mesh-ancestor
55938562|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
55938563|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938564|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938565|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938566|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55938567|NCT03084419|Abatacept|abatacept|mesh-list
55938570|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938571|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938572|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
55938573|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938574|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55938575|NCT03084029|Oxytocin|oxytocin|mesh-list
55938576|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
55938577|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55938578|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938579|NCT04278053|Inositol|inositol|mesh-list
55938580|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
55938581|NCT04278053|Vitamins|vitamins|mesh-ancestor
55938582|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
55938583|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938584|NCT05346107|Paclitaxel|paclitaxel|mesh-list
55938585|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
55938586|NCT05346107|Doxorubicin|doxorubicin|mesh-list
55938587|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55938588|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55938589|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938590|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
55938591|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
55938592|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
55938593|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938594|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938595|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
55938596|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999733|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55999734|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999735|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55999736|NCT01269034|Incretins|incretins|mesh-ancestor
55999737|NCT01269034|Hormones|hormones|mesh-ancestor
55999738|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999739|NCT05599126|Lorazepam|lorazepam|mesh-list
55999740|NCT05599126|Mianserin|mianserin|mesh-list
55999741|NCT05599126|Anticonvulsants|anticonvulsants|mesh-ancestor
55999742|NCT05599126|Antiemetics|antiemetics|mesh-ancestor
55999743|NCT05599126|Autonomic Agents|autonomic agents|mesh-ancestor
55999744|NCT05599126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938597|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55938598|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55938599|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
55938600|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55938601|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55938602|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55938603|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55938604|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938605|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55938607|NCT00083915|Dexamethasone|dexamethasone|mesh-list
55938608|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
55938609|NCT00083915|Melphalan|melphalan|mesh-list
55938610|NCT00083915|Cisplatin|cisplatin|mesh-list
55938611|NCT00083915|Doxorubicin|doxorubicin|mesh-list
55938612|NCT00083915|Etoposide|etoposide|mesh-list
55938613|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55938614|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938615|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
55938616|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938617|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55938618|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55938619|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
55938620|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938621|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938622|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55938623|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938624|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
55938625|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
55938626|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938627|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55938628|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
55938629|NCT00083915|Hormones|hormones|mesh-ancestor
55938630|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938631|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55938632|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55938633|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55938634|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55938635|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938636|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55938637|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
55938638|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55938639|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938640|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55938641|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55938644|NCT04401839|Oxytocin|oxytocin|mesh-list
55938645|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
55938646|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55938647|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938648|NCT04761185|Raltitrexed|raltitrexed|mesh-list
55938649|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55938650|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
55938651|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999745|NCT05599126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938652|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938653|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55938654|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938656|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
55938657|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55938658|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
55938659|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938660|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938661|NCT01144455|Antiviral Agents|antiviral agents|mesh-ancestor
55938662|NCT01144455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938663|NCT01144455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938664|NCT01144455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938665|NCT01144455|Immunologic Factors|immunologic factors|mesh-ancestor
55938666|NCT01144455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743518|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938667|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55938670|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
55938671|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938672|NCT03080363|Lidocaine|lidocaine|mesh-list
55938673|NCT03080363|Bupivacaine|bupivacaine|mesh-list
55938674|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
55938675|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
55938676|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938677|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938678|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
55938679|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938680|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55938681|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55938682|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55938683|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55938684|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938685|NCT01145001|Nicotine|nicotine|mesh-list
55938686|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55938687|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
55938688|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938689|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938690|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55938691|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55938692|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
55938693|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938694|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938695|NCT03011463|Clarithromycin|clarithromycin|mesh-list
55938696|NCT03011463|Ranitidine|ranitidine|mesh-list
55938697|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
55938698|NCT03011463|Trospium chloride|trospium chloride|mesh-list
55938699|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55938700|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938701|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55938702|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938703|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938704|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55938705|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55938706|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55938707|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55938708|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55938709|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
55938710|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
55938711|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938712|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938713|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
55938715|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938716|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55938717|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55938719|NCT03011463|Urological Agents|urological agents|mesh-ancestor
55938721|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
55938722|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938723|NCT01214109|Protective Agents|protective agents|mesh-ancestor
55938724|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999747|NCT05599126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55938725|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55938726|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55938727|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
55938728|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
55938729|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938730|NCT05339087|Riociguat|riociguat|mesh-list
55938731|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
55938732|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938733|NCT05688761|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55938734|NCT05688761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938735|NCT05688761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938736|NCT01215123|Bevacizumab|bevacizumab|mesh-list
55938737|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55938738|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938739|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55938740|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55938741|NCT01215123|Growth Substances|growth substances|mesh-ancestor
55938742|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938743|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
55938744|NCT05312645|Diclofenac|diclofenac|mesh-list
55938745|NCT05312645|Petrolatum|petrolatum|mesh-list
55938746|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55938747|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55938748|NCT05312645|Analgesics|analgesics|mesh-ancestor
55938749|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
55938750|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938751|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938752|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938753|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55938754|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55938755|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938756|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938757|NCT05312645|Emollients|emollients|mesh-ancestor
55938758|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
55938759|NCT05688449|Fentanyl|fentanyl|mesh-list
55938760|NCT05688449|Bupivacaine|bupivacaine|mesh-list
55938761|NCT05688449|Anesthetics, Local|anesthetics, local|mesh-ancestor
55938762|NCT05688449|Anesthetics|anesthetics|mesh-ancestor
55938763|NCT05688449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938764|NCT05688449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938765|NCT05688449|Sensory System Agents|sensory system agents|mesh-ancestor
55938766|NCT05688449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938767|NCT05688449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55938768|NCT05688449|Narcotics|narcotics|mesh-ancestor
55938769|NCT05688449|Analgesics|analgesics|mesh-ancestor
55938770|NCT05688449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55938771|NCT05688449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55938772|NCT05688449|Anesthetics, General|anesthetics, general|mesh-ancestor
55938773|NCT04401137|Topiramate|topiramate|mesh-list
55938774|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
55938775|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55938776|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938777|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55938778|NCT02189889|Hematinics|hematinics|mesh-ancestor
55938779|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55938780|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55938781|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55938782|NCT01148745|Hematinics|hematinics|mesh-ancestor
55938783|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55938784|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55938785|NCT05685407|Caffeine|caffeine|mesh-list
55938786|NCT05685407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55938787|NCT05685407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938788|NCT05685407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55938800|NCT04761029|Analgesics|analgesics|mesh-ancestor
55938801|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
55938802|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938803|NCT05687981|Dexamethasone|dexamethasone|mesh-list
55938804|NCT05687981|Bupivacaine|bupivacaine|mesh-list
55938805|NCT05687981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938806|NCT05687981|Antiemetics|antiemetics|mesh-ancestor
55938807|NCT05687981|Autonomic Agents|autonomic agents|mesh-ancestor
55999748|NCT05599126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999749|NCT05599126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55938808|NCT05687981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938809|NCT05687981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938810|NCT05687981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55938811|NCT05687981|Glucocorticoids|glucocorticoids|mesh-ancestor
55938812|NCT05687981|Hormones|hormones|mesh-ancestor
55938813|NCT05687981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938814|NCT05687981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55938815|NCT05687981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938816|NCT05687981|Anesthetics, Local|anesthetics, local|mesh-ancestor
55938817|NCT05687981|Anesthetics|anesthetics|mesh-ancestor
55938818|NCT05687981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938819|NCT05687981|Sensory System Agents|sensory system agents|mesh-ancestor
55938820|NCT05687747|FAPI-46|fapi-46|mesh-list
55938821|NCT05687747|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55938822|NCT05687747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938823|NCT05687669|Phentolamine|phentolamine|mesh-list
55938824|NCT05687669|Nitroglycerin|nitroglycerin|mesh-list
55938825|NCT05687669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55938826|NCT05687669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55938827|NCT05687669|Adrenergic Agents|adrenergic agents|mesh-ancestor
55938828|NCT05687669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938829|NCT05687669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938830|NCT05687669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938831|NCT05687669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55938832|NCT05687669|Vasodilator Agents|vasodilator agents|mesh-ancestor
55938833|NCT05687357|Paclitaxel|paclitaxel|mesh-list
55938834|NCT05687357|Oxaliplatin|oxaliplatin|mesh-list
55938835|NCT05687357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55938836|NCT05687357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938837|NCT05687357|Tubulin Modulators|tubulin modulators|mesh-ancestor
55938838|NCT05687357|Antimitotic Agents|antimitotic agents|mesh-ancestor
55938839|NCT05687357|Mitosis Modulators|mitosis modulators|mesh-ancestor
55938840|NCT05687357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938841|NCT05687123|Sunitinib|sunitinib|mesh-list
55938842|NCT05687123|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55938843|NCT05687123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938844|NCT05687123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55938845|NCT05687123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55938846|NCT05687123|Growth Substances|growth substances|mesh-ancestor
55938847|NCT05687123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938848|NCT05687123|Growth Inhibitors|growth inhibitors|mesh-ancestor
55938849|NCT05687123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55938850|NCT05687123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938851|NCT05687123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938855|NCT04400747|Vitamins|vitamins|mesh-ancestor
55938856|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
55938857|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938858|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55938859|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55938860|NCT02190903|Anesthetics|anesthetics|mesh-list
55938861|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938862|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938863|NCT03369041|Irinotecan|irinotecan|mesh-list
55938864|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55938865|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56253719|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56253720|NCT01883921|Antibodies|antibodies|mesh-list
55938866|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938867|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938868|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938869|NCT01149759|Cyclosporine|cyclosporine|mesh-list
55938870|NCT01149759|Cyclosporins|cyclosporins|mesh-list
55938871|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938872|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938873|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55938874|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
55938875|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938876|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
55938877|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938878|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
55938879|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55938880|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55999750|NCT05599126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55938882|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
55938883|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55938884|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
55938885|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
55938886|NCT01216761|Povidone|povidone|mesh-list
55938887|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55938888|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938889|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
55938890|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
55938891|NCT01216761|Trace Elements|trace elements|mesh-ancestor
55938892|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
55938893|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938894|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
55938895|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
55938896|NCT04279379|Decitabine|decitabine|mesh-list
55938897|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55938898|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
55938899|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938900|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938901|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938902|NCT05685719|Itraconazole|itraconazole|mesh-list
55938903|NCT05685719|Rifampin|rifampin|mesh-list
55938904|NCT05685719|Antifungal Agents|antifungal agents|mesh-ancestor
55938905|NCT05685719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55938906|NCT05685719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55938907|NCT05685719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55938908|NCT05685719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938909|NCT05685719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938910|NCT05685719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55938911|NCT05685719|Hormone Antagonists|hormone antagonists|mesh-ancestor
55938912|NCT05685719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938913|NCT05685719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938914|NCT05685719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55938915|NCT05685719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55938916|NCT05685719|Antitubercular Agents|antitubercular agents|mesh-ancestor
55938917|NCT05685719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55938918|NCT05685719|Leprostatic Agents|leprostatic agents|mesh-ancestor
55938919|NCT05685719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55938920|NCT05685719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55938921|NCT05685719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55938922|NCT05685719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55938923|NCT05685719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55938927|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
55938928|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55938929|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55938930|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55938931|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55938932|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938933|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55938934|NCT01218399|Budesonide|budesonide|mesh-list
55938935|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55938936|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938937|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55938938|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
55938939|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938940|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938941|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55938942|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
55938943|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
55938944|NCT01218399|Hormones|hormones|mesh-ancestor
55938945|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938946|NCT01219881|Sevoflurane|sevoflurane|mesh-list
55938947|NCT01219881|Desflurane|desflurane|mesh-list
55938948|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55938949|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55938950|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
55938951|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
55938952|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999753|NCT05599126|GABA Agents|gaba agents|mesh-ancestor
55999754|NCT05599126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863858|NCT01709084|Rilpivirine|rilpivirine|mesh-list
55938964|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55938965|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938966|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55938967|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55938968|NCT01220973|Analgesics|analgesics|mesh-ancestor
55938969|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
55938970|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55938971|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55938972|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55938973|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55938974|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55938975|NCT05375747|Propofol|propofol|mesh-list
55938976|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55938977|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938978|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938979|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55938980|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
55938981|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
55938982|NCT01221207|Calpastatin|calpastatin|mesh-list
55938983|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55938984|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
55938985|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938986|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938997|NCT03296813|Torsemide|torsemide|mesh-list
55938998|NCT03296813|Furosemide|furosemide|mesh-list
55938999|NCT03296813|Diuretics|diuretics|mesh-ancestor
55939000|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
55939001|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939002|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55939003|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55939004|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253721|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
56253722|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253724|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56253725|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56253726|NCT01884116|Capsaicin|capsaicin|mesh-list
56253727|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
56253728|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
56253729|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
56253730|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253731|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939005|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55939006|NCT05338619|Lazertinib|lazertinib|mesh-list
55939007|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55939008|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939009|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939010|NCT03289949|Ketanserin|ketanserin|mesh-list
55939011|NCT03289949|Psilocybin|psilocybin|mesh-list
55939012|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
56253732|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56253734|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253735|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253736|NCT01884272|Naproxen|naproxen|mesh-list
56253737|NCT01884272|Indomethacin|indomethacin|mesh-list
56253738|NCT01884272|Lesinurad|lesinurad|mesh-list
56253739|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56253740|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56253741|NCT01884272|Analgesics|analgesics|mesh-ancestor
56253742|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
55829010|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829011|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889284|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
55889285|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
55889286|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55889287|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
55889288|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889289|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889290|NCT01937026|Probenecid|probenecid|mesh-list
55889291|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
55889292|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
55889304|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
55889305|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753188|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
55889306|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889307|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55889308|NCT01937260|Brodalumab|brodalumab|mesh-list
55889309|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
55889310|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
55889311|NCT04569461|Androgens|androgens|mesh-list
55889312|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55889313|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889314|NCT04569461|Hormones|hormones|mesh-ancestor
55889315|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052043|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052044|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052045|NCT01798550|Enoxaparin|enoxaparin|mesh-list
55870999|NCT04402359|Meropenem|meropenem|mesh-list
56052048|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56052049|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052051|NCT00357305|Etoposide|etoposide|mesh-list
56052052|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
56052053|NCT00357305|Vorinostat|vorinostat|mesh-list
56052054|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56052055|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052056|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56052057|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56052058|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052059|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052060|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56052061|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
56052062|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
56052063|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052064|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939013|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939014|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55939015|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55939016|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55939017|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55939018|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
55939019|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939020|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939021|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
55939022|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55939023|NCT04400045|Treosulfan|treosulfan|mesh-list
55939024|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55939025|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
55939026|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939027|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939028|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55939029|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939030|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55939031|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939032|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939033|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55939034|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55939036|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55939037|NCT01153581|Progesterone|progesterone|mesh-list
55939038|NCT01153581|Ganirelix|ganirelix|mesh-list
55939039|NCT01153581|Estrogens|estrogens|mesh-ancestor
55939040|NCT01153581|Hormones|hormones|mesh-ancestor
55939041|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939042|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939043|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55939044|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
55939045|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55829022|NCT02180438|Tenofovir|tenofovir|mesh-list
56253743|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253744|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253745|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253746|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253747|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
56253748|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56253749|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253750|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939046|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55939047|NCT01153581|Progestins|progestins|mesh-ancestor
55939048|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
55939050|NCT04278599|Trace Elements|trace elements|mesh-ancestor
55939051|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
55939052|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939053|NCT05277623|Mannitol|mannitol|mesh-list
55939054|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55871482|NCT05687253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56253751|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
56253752|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56253753|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
56253754|NCT01884272|Renal Agents|renal agents|mesh-ancestor
56253755|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
56253756|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253757|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56253758|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253759|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253760|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
56253761|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253762|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253763|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56253764|NCT01884298|Lidocaine|lidocaine|mesh-list
56253765|NCT01884298|Remifentanil|remifentanil|mesh-list
55829026|NCT02180438|Elvitegravir|elvitegravir|mesh-list
55939055|NCT05277623|Diuretics|diuretics|mesh-ancestor
55939056|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
55939057|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939058|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55939059|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55939060|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55939061|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939062|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253766|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
56253767|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
56253768|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253769|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253770|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
56253771|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253772|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56253773|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56253774|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56253775|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56253776|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829040|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
55829044|NCT01920555|Midazolam|midazolam|mesh-list
55871483|NCT05687253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939063|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55939064|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55939065|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939066|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
55939067|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939068|NCT04760327|Cisplatin|cisplatin|mesh-list
55939069|NCT04760327|Bleomycin|bleomycin|mesh-list
55939071|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55939073|NCT01225263|Simvastatin|simvastatin|mesh-list
55939074|NCT01225263|Vitamins|vitamins|mesh-ancestor
55939075|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
55939076|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939077|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55939078|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56253777|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56253778|NCT01884298|Narcotics|narcotics|mesh-ancestor
56253779|NCT01884298|Analgesics|analgesics|mesh-ancestor
56253781|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56253782|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
56253783|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253784|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
56253785|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253786|NCT01884415|Vaccines|vaccines|mesh-list
56253787|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
56253788|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253789|NCT01884428|Gemcitabine|gemcitabine|mesh-list
56253790|NCT01884428|Prednisolone|prednisolone|mesh-list
56253791|NCT01884428|Vinorelbine|vinorelbine|mesh-list
56253792|NCT01884428|Ifosfamide|ifosfamide|mesh-list
56253793|NCT01884428|Panobinostat|panobinostat|mesh-list
56253794|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253795|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
56253796|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253797|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253798|NCT01884428|Antiviral Agents|antiviral agents|mesh-ancestor
55863743|NCT01743560|Exemestane|exemestane|mesh-list
55939079|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55939080|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
55939081|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939082|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55939083|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55939084|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939085|NCT04278287|Paclitaxel|paclitaxel|mesh-list
56253800|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253801|NCT01884428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253802|NCT01884428|Immunologic Factors|immunologic factors|mesh-ancestor
56052065|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
56052066|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052067|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56052068|NCT02340000|Amoxicillin|amoxicillin|mesh-list
56052069|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
56052070|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
56052071|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55889316|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889317|NCT03829371|Dexamethasone|dexamethasone|mesh-list
55889318|NCT03829371|Prednisone|prednisone|mesh-list
55889319|NCT03829371|Lenalidomide|lenalidomide|mesh-list
55889320|NCT03829371|Melphalan|melphalan|mesh-list
55889321|NCT03829371|Bortezomib|bortezomib|mesh-list
55889322|NCT03829371|Daratumumab|daratumumab|mesh-list
55889323|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889324|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
55889325|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
55889326|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889327|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889328|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55889329|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
55889330|NCT03829371|Hormones|hormones|mesh-ancestor
55889331|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889332|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56052072|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56052073|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052074|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56052075|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889333|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889334|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
55889335|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55889336|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55889337|NCT03829371|Growth Substances|growth substances|mesh-ancestor
55889338|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
55889339|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55889340|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
55889341|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889342|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55889343|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55889344|NCT03827889|Fluorides|fluorides|mesh-list
55889345|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
55889346|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
55889347|NCT03827889|Protective Agents|protective agents|mesh-ancestor
55889348|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889349|NCT01902004|Memantine|memantine|mesh-list
55889350|NCT01902004|Citalopram|citalopram|mesh-list
55889351|NCT01902004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55889352|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55889353|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889354|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889373|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889374|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889375|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55889376|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889377|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889378|NCT03829839|Lorazepam|lorazepam|mesh-list
55889379|NCT03829839|Oxytocin|oxytocin|mesh-list
55889380|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
55889381|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55889382|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889383|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
56253803|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253804|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253805|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
56253806|NCT01884428|Hormones|hormones|mesh-ancestor
56253807|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253808|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56253809|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56253810|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
56253811|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
56253812|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
56253813|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56253814|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
56253815|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56253816|NCT01884441|Gemcitabine|gemcitabine|mesh-list
56253817|NCT01884441|Vinorelbine|vinorelbine|mesh-list
56253818|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56253819|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253820|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
55939086|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55939087|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55939088|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939089|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
55939090|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
55939091|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
55939092|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939093|NCT05169905|Vaccines|vaccines|mesh-list
55939094|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
56253821|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253822|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253823|NCT01884441|Antiviral Agents|antiviral agents|mesh-ancestor
56253824|NCT01884441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999755|NCT05599126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999757|NCT05599126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55999758|NCT05599126|Adrenergic Agents|adrenergic agents|mesh-ancestor
55939095|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939096|NCT05162027|Erenumab|erenumab|mesh-list
55802731|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55939097|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55939098|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939100|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
55939101|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939102|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939103|NCT03278717|Olaparib|olaparib|mesh-list
55939104|NCT03278717|Cediranib|cediranib|mesh-list
55939105|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55939106|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871484|NCT05687253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253825|NCT01884441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253826|NCT01884441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253827|NCT01884441|Immunologic Factors|immunologic factors|mesh-ancestor
56253828|NCT01884441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253829|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56253830|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
56253831|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
56253832|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
56253833|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56253834|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
56253835|NCT01884467|Gentamicins|gentamicins|mesh-list
56253836|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55829098|NCT01920477|Ofatumumab|ofatumumab|mesh-list
55889384|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
55889385|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
55889386|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889387|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55889388|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55889389|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55889390|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55889391|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55889392|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55889393|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
55889394|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
55889395|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889396|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889397|NCT01938664|Candesartan|candesartan|mesh-list
55889398|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55889399|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55889400|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55889401|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889402|NCT03829917|Paromomycin|paromomycin|mesh-list
55889403|NCT03829917|Miltefosine|miltefosine|mesh-list
55889404|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55889405|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889406|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55889407|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55889408|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
55889409|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889410|NCT02284126|Vancomycin|vancomycin|mesh-list
55889411|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55889421|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939107|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939108|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939109|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55939115|NCT01227993|Finasteride|finasteride|mesh-list
55939116|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55939117|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55939118|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939119|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939120|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
56253837|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253838|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56253840|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253841|NCT01884506|Iron|iron|mesh-list
56253842|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
56253843|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56253844|NCT01884506|Trace Elements|trace elements|mesh-ancestor
56253845|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
56253846|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253847|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
55829111|NCT02213042|Lapatinib|lapatinib|mesh-list
55939121|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939122|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939123|NCT01227993|Urological Agents|urological agents|mesh-ancestor
55939124|NCT01155999|Tobramycin|tobramycin|mesh-list
55939125|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55939126|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939127|NCT03275597|Durvalumab|durvalumab|mesh-list
55939128|NCT03275597|Tremelimumab|tremelimumab|mesh-list
55939129|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939130|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939131|NCT01228149|Acetazolamide|acetazolamide|mesh-list
55939132|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
55939133|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55939134|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939135|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939136|NCT01228149|Diuretics|diuretics|mesh-ancestor
55939137|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
55939138|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253848|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253849|NCT01884506|Protective Agents|protective agents|mesh-ancestor
56253851|NCT01884558|Metformin|metformin|mesh-list
55939139|NCT04989413|Dronabinol|dronabinol|mesh-list
55939140|NCT04989413|Cannabidiol|cannabidiol|mesh-list
55939141|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
55939142|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
55939151|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939152|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939154|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939155|NCT04986839|Acetaminophen|acetaminophen|mesh-list
55939156|NCT04986839|Ibuprofen|ibuprofen|mesh-list
55939157|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55939158|NCT04986839|Analgesics|analgesics|mesh-ancestor
55939159|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
55939160|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939161|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939162|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
56253902|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56253903|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56253904|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
56253905|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253906|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253907|NCT01884896|Metoprolol|metoprolol|mesh-list
56253925|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253926|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253927|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56253928|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56253929|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56253930|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
56253931|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253932|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253933|NCT01884935|Natalizumab|natalizumab|mesh-list
56253934|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
56253935|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253936|NCT01885013|Metformin|metformin|mesh-list
56253937|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
56253938|NCT01885013|Doxorubicin|doxorubicin|mesh-list
56253939|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871485|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
56253940|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
56253941|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253942|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253943|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56253944|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
56253945|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747197|NCT04488367|Coagulants|coagulants|mesh-ancestor
55747198|NCT03734653|Testosterone|testosterone|mesh-list
56253946|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253947|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56253948|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56253949|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56253950|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56253951|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56253952|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253953|NCT01885091|Kinetin|kinetin|mesh-list
56253954|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56253955|NCT01885091|Growth Substances|growth substances|mesh-ancestor
56253956|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253957|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
56253958|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56253959|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
56253960|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253961|NCT01885338|Expectorants|expectorants|mesh-ancestor
56253962|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
56253963|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56253964|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
56253965|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253966|NCT01885338|Protective Agents|protective agents|mesh-ancestor
56253967|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253968|NCT01885338|Antidotes|antidotes|mesh-ancestor
56253969|NCT01885364|Remifentanil|remifentanil|mesh-list
56253970|NCT01885364|Propofol|propofol|mesh-list
56253971|NCT01885364|Esmolol|esmolol|mesh-list
56253972|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55829236|NCT02985658|Cisplatin|cisplatin|mesh-list
56253973|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253974|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253975|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55829247|NCT02177786|Selonsertib|selonsertib|mesh-list
55939163|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55939164|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55939165|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55939166|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55939167|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999759|NCT05599126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55999760|NCT05599126|Histamine Antagonists|histamine antagonists|mesh-ancestor
55999761|NCT05599126|Histamine Agents|histamine agents|mesh-ancestor
55939168|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939169|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
55939170|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55939171|NCT02192541|Aflibercept|aflibercept|mesh-list
56253976|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
56253977|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
56253978|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56253979|NCT01885364|Narcotics|narcotics|mesh-ancestor
56253980|NCT01885364|Analgesics|analgesics|mesh-ancestor
56253981|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
56253982|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253983|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56253984|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56253985|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56253986|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
56253987|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253988|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253989|NCT01885481|Dexamethasone|dexamethasone|mesh-list
56253990|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
56253991|NCT01885481|Betamethasone|betamethasone|mesh-list
56253992|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
55939172|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55939173|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55939174|NCT02192541|Growth Substances|growth substances|mesh-ancestor
55939175|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939176|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
55939177|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939178|NCT01156701|Zanamivir|zanamivir|mesh-list
55939179|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
55939180|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939181|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939182|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939183|NCT03266081|Bupivacaine|bupivacaine|mesh-list
55939184|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
55939185|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
55939186|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939187|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939188|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
55939189|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939190|NCT03010995|Prazosin|prazosin|mesh-list
55939191|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55939192|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55939193|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56253993|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56253994|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
56253995|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56253996|NCT01885481|BB 1101|bb 1101|mesh-list
56253997|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253998|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
56253999|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
56254000|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254001|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254002|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56254003|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
56254004|NCT01885481|Hormones|hormones|mesh-ancestor
56254005|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254006|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56254007|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254008|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254009|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254010|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254011|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56254012|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
56254013|NCT01885585|Apixaban|apixaban|mesh-list
55829270|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56254014|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56254015|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
56254016|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55939194|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55939195|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
55939196|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939197|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939198|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939199|NCT01230177|Etanercept|etanercept|mesh-list
55939200|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55939201|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55939202|NCT01230177|Analgesics|analgesics|mesh-ancestor
56254018|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254019|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254020|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
56254021|NCT01885598|Apixaban|apixaban|mesh-list
56254022|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56254023|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
56254024|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56254025|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254026|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254027|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254028|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
56254029|NCT01885715|Neostigmine|neostigmine|mesh-list
56254030|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56254031|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254032|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254033|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
56254034|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254035|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254036|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56254037|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
56254038|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939203|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
55939204|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939205|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939206|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55939207|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55939220|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939221|NCT03683069|Amlodipine|amlodipine|mesh-list
55939222|NCT03683069|Eplerenone|eplerenone|mesh-list
55939223|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55939224|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55939225|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56254039|NCT01885988|Nebivolol|nebivolol|mesh-list
56254040|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56254041|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
56254042|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56254043|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56254044|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56254045|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
56254046|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254049|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
55939226|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939227|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55939228|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939230|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55939231|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
55939232|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939233|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56254096|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56254097|NCT01886209|Prednisolone|prednisolone|mesh-list
56254098|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
56254099|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56254100|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
56254101|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56254102|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
56254103|NCT01886209|Hormones|hormones|mesh-ancestor
56254104|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254105|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254106|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56254108|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
56254109|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
56254110|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254111|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55939234|NCT03683069|Diuretics|diuretics|mesh-ancestor
55939235|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
55939236|NCT04826393|Cemiplimab|cemiplimab|mesh-list
55939237|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939238|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939239|NCT03262103|Poly I-C|poly i-c|mesh-list
55939240|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55939241|NCT03262103|Poly ICLC|poly iclc|mesh-list
55939242|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
56254112|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56254113|NCT01886209|Protective Agents|protective agents|mesh-ancestor
56254114|NCT01886248|Antithrombins|antithrombins|mesh-list
56254115|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
56254116|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56254117|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254118|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254119|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254120|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
56254121|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
56254122|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
56254123|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
56254124|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254125|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254126|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
56254127|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254128|NCT01886365|Insulin|insulin|mesh-list
56254129|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56254130|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254131|NCT01886404|Efavirenz|efavirenz|mesh-list
56254132|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56254133|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56254134|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254135|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254136|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
56254137|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254138|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56254139|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56254140|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56254141|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55939243|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
55939244|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939245|NCT03262103|Laxatives|laxatives|mesh-ancestor
55939246|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55939247|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
55939248|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939249|NCT04777643|Cannabidiol|cannabidiol|mesh-list
55999762|NCT05599126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55999763|NCT05599126|Serotonin Agents|serotonin agents|mesh-ancestor
56254157|NCT01886443|Protective Agents|protective agents|mesh-ancestor
56254158|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254159|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254160|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
56254161|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56254162|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56254163|NCT01886443|Hematinics|hematinics|mesh-ancestor
56254164|NCT01886443|Vitamins|vitamins|mesh-ancestor
56254165|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
56254166|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56254167|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254168|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254169|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
56254170|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56254171|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56254172|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
56254173|NCT01886443|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56254174|NCT01886443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829426|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56254175|NCT01886443|Immunologic Factors|immunologic factors|mesh-ancestor
56254176|NCT01886534|Diuretics|diuretics|mesh-list
56254177|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
56254178|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254179|NCT01886560|Doxycycline|doxycycline|mesh-list
56254180|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56254181|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254182|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
56254183|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56254184|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56254185|NCT01886573|Azacitidine|azacitidine|mesh-list
56254186|NCT01886573|Entinostat|entinostat|mesh-list
56254187|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56254204|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56254205|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56254206|NCT01886664|Sevoflurane|sevoflurane|mesh-list
56254207|NCT01886664|Desflurane|desflurane|mesh-list
56254208|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56254209|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56254210|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
56254211|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
56254212|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254213|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254214|NCT01886768|Anesthetics|anesthetics|mesh-list
56254215|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254216|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254218|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55889423|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55999764|NCT05599126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55999765|NCT05599126|Antidepressive Agents|antidepressive agents|mesh-ancestor
55939250|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
55939251|NCT04775225|Lidocaine|lidocaine|mesh-list
55939252|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
55939253|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
55939254|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939255|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939256|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
55939257|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939258|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55939259|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55939260|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55939261|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55871486|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56254219|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
56254220|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254221|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254222|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56254223|NCT01887119|Diuretics|diuretics|mesh-ancestor
56254224|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
56254225|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56254226|NCT01887158|Bisacodyl|bisacodyl|mesh-list
56254227|NCT01887158|Cathartics|cathartics|mesh-ancestor
56254228|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56254229|NCT01887158|Laxatives|laxatives|mesh-ancestor
56254230|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
56254231|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55939262|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939263|NCT04731467|Gemcitabine|gemcitabine|mesh-list
55939264|NCT04731467|Paclitaxel|paclitaxel|mesh-list
55939265|NCT04731467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55939266|NCT04731467|Nivolumab|nivolumab|mesh-list
55939267|NCT04731467|Fluorouracil|fluorouracil|mesh-list
55939268|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55939269|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939270|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
55939273|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254232|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254233|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254234|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56254236|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
56254237|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254238|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56254239|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56254240|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56254241|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
56254242|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829502|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254243|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254245|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56254246|NCT01887197|Diuretics|diuretics|mesh-ancestor
56254247|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
56254248|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254249|NCT01887223|Timolol|timolol|mesh-list
56254250|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56254251|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56254252|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56254254|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55939274|NCT04731467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55939276|NCT04731467|Antiviral Agents|antiviral agents|mesh-ancestor
55939277|NCT04731467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939278|NCT04731467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939279|NCT04731467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939280|NCT04731467|Immunologic Factors|immunologic factors|mesh-ancestor
55939281|NCT04731467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939282|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939283|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55939284|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
55939285|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939286|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
55939287|NCT04399187|Eusol|eusol|mesh-list
55939288|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
56254276|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56254277|NCT01887275|Interferons|interferons|mesh-list
56254278|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254279|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
56254280|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254281|NCT01887340|Carboplatin|carboplatin|mesh-list
56254282|NCT01887340|Etoposide|etoposide|mesh-list
56254283|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254284|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56254285|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56254286|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56254287|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254288|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254289|NCT01887379|Furosemide|furosemide|mesh-list
56254290|NCT01887379|Diuretics|diuretics|mesh-ancestor
56254291|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
56254292|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254293|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56254294|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55829551|NCT01511536|Prednisone|prednisone|mesh-list
56254295|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254296|NCT01887405|Epinephrine|epinephrine|mesh-list
56254297|NCT01887405|Racepinephrine|racepinephrine|mesh-list
56254298|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
56254299|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56254300|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56254301|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
56254302|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254303|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254304|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254305|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56254306|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56254307|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
56254308|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939289|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939290|NCT03240809|Brodalumab|brodalumab|mesh-list
55939291|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55939292|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
55939293|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
55939294|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939295|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
55939296|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55939297|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939298|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
55939300|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
55939301|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55939302|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55939303|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939304|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254341|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56254342|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56254343|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254344|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254345|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
56254346|NCT01887626|Ticagrelor|ticagrelor|mesh-list
56254347|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56254348|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56254349|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56254350|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56254351|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
56254352|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254353|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254354|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254355|NCT01887691|Eszopiclone|eszopiclone|mesh-list
56254356|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56254357|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254358|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939305|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939306|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55939307|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
55939308|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55939309|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939310|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939311|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55939312|NCT04399343|Analgesics|analgesics|mesh-ancestor
55939313|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
55939314|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939315|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55939316|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55939317|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55939318|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
55939319|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939320|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999766|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
56254381|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56254382|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254383|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
56254384|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56254385|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
56254386|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56254387|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56254388|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56254389|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
56254390|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254391|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56254392|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254393|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56254394|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
56254395|NCT01887743|Pantoprazole|pantoprazole|mesh-list
56254396|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56254397|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56254398|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55999767|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55999768|NCT01892150|Protective Agents|protective agents|mesh-ancestor
55999769|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999770|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
55939321|NCT03676049|Cannabidiol|cannabidiol|mesh-list
55939322|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
55939323|NCT03233633|Cannabidiol|cannabidiol|mesh-list
55939324|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
55939325|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
56254399|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254400|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254401|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56254402|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254403|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56254404|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254405|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254406|NCT01887821|Chloroquine|chloroquine|mesh-list
56254407|NCT01887821|Piperaquine|piperaquine|mesh-list
56254408|NCT01887821|Artenimol|artenimol|mesh-list
56254409|NCT01887821|Amebicides|amebicides|mesh-ancestor
56254410|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56254411|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56254412|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254413|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
56254414|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871487|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254415|NCT01887847|Nicotine|nicotine|mesh-list
56254416|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56254417|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
56254418|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254419|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254420|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56254421|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56254422|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
56254423|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254424|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254425|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
56254426|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56254427|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
56254428|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254429|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
55939326|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939327|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
55939328|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939329|NCT02984345|Caseins|caseins|mesh-list
55939330|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
55939331|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
55939332|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939333|NCT01232205|Micronutrients|micronutrients|mesh-list
55939334|NCT01232205|Trace Elements|trace elements|mesh-list
55939335|NCT01232205|Antioxidants|antioxidants|mesh-list
55939336|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939337|NCT01232205|Protective Agents|protective agents|mesh-ancestor
55939338|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939339|NCT04584125|Riboflavin|riboflavin|mesh-list
55939340|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
55939341|NCT04584125|Dextrans|dextrans|mesh-list
55939342|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56254430|NCT01887873|Protective Agents|protective agents|mesh-ancestor
56254431|NCT01887951|Tramadol|tramadol|mesh-list
55829684|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
55829699|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56254432|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56254433|NCT01887951|Narcotics|narcotics|mesh-ancestor
56254434|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254435|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254436|NCT01887951|Analgesics|analgesics|mesh-ancestor
56254437|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
56254438|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254439|NCT01888042|Everolimus|everolimus|mesh-list
56254440|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939343|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55939344|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
55939345|NCT04584125|Vitamins|vitamins|mesh-ancestor
55939346|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
55939348|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55939349|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
55939350|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
55939351|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
55939352|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
55939354|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55939355|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871488|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56254441|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56254442|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
56254443|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863798|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55939356|NCT01158885|Cytarabine|cytarabine|mesh-list
55939357|NCT01158885|Methotrexate|methotrexate|mesh-list
55939358|NCT01158885|Clofarabine|clofarabine|mesh-list
55939359|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55939360|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
55939361|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55939362|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939363|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55939364|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
55871489|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748699|NCT04507217|Carboplatin|carboplatin|mesh-list
56254444|NCT01888107|Risperidone|risperidone|mesh-list
56254445|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56254446|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
56254447|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829711|NCT04080076|Tacrolimus|tacrolimus|mesh-list
55889424|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55889425|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052076|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052078|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052079|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56052080|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052081|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052082|NCT01815008|Aspirin|aspirin|mesh-list
56052083|NCT01815008|Clopidogrel|clopidogrel|mesh-list
56052084|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56052085|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56052086|NCT01815008|Analgesics|analgesics|mesh-ancestor
56052087|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
56052088|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052089|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052090|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56052091|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56052092|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56052093|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56052094|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052095|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56052096|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56052097|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052098|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
56052099|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56052100|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56052101|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56052102|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
56052103|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052120|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56052122|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56052123|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052124|NCT03331965|Metoclopramide|metoclopramide|mesh-list
56052125|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
56052126|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
56052127|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052128|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052129|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56052130|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56052131|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56052132|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
56052133|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052134|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052135|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56052136|NCT03279237|Leucovorin|leucovorin|mesh-list
56052137|NCT03279237|Paclitaxel|paclitaxel|mesh-list
56052138|NCT03279237|Carboplatin|carboplatin|mesh-list
56052139|NCT03279237|Fluorouracil|fluorouracil|mesh-list
56052140|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
56052141|NCT03279237|Irinotecan|irinotecan|mesh-list
56052142|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56052143|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939365|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939366|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939367|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
55939368|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939369|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55939370|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939371|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
55939372|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56254453|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254454|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56254455|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
56254456|NCT01888120|Ziconotide|ziconotide|mesh-list
56254457|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56254458|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56254459|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829713|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
55939373|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55939374|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
55939375|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939376|NCT01232829|R04929097|r04929097|mesh-list
55939377|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939378|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939379|NCT01233921|Mitogens|mitogens|mesh-list
55939380|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
55939381|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939382|NCT03367013|Lactoferrin|lactoferrin|mesh-list
56254460|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56254461|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254462|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56254463|NCT01888120|Protective Agents|protective agents|mesh-ancestor
56254464|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56254465|NCT01888120|Analgesics|analgesics|mesh-ancestor
56254466|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
56254467|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254468|NCT01888224|Isotretinoin|isotretinoin|mesh-list
56254469|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
56254470|NCT01888250|Lamotrigine|lamotrigine|mesh-list
56254471|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
56254472|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56254473|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56254474|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254475|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56254476|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254477|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56254478|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254479|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254480|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254481|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56254482|NCT01888263|Lamotrigine|lamotrigine|mesh-list
55939383|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939384|NCT03226301|Venetoclax|venetoclax|mesh-list
55939385|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939386|NCT01236105|Charcoal|charcoal|mesh-list
55939387|NCT01236105|Antidotes|antidotes|mesh-ancestor
55939388|NCT01236105|Protective Agents|protective agents|mesh-ancestor
55939389|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939390|NCT04533347|Tafenoquine|tafenoquine|mesh-list
55939391|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
55999771|NCT02663752|Deferasirox|deferasirox|mesh-list
55939392|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55939393|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55939394|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939395|NCT01160445|Aldesleukin|aldesleukin|mesh-list
55939396|NCT01160445|Zanolimumab|zanolimumab|mesh-list
55939397|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939398|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55939399|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55939400|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
55939401|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939402|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939403|NCT01237041|Niacin|niacin|mesh-list
55939404|NCT01237041|Niacinamide|niacinamide|mesh-list
55939405|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
55939406|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55939407|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
55939408|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939409|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55939410|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
55939411|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
55939412|NCT01237041|Vitamins|vitamins|mesh-ancestor
55939413|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
55939414|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254483|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
56254484|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56254485|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56254486|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254487|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56254488|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254489|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56254490|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254491|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254492|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254493|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56254495|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
56254496|NCT01888302|Gemcitabine|gemcitabine|mesh-list
56254497|NCT01888302|Sirolimus|sirolimus|mesh-list
56254498|NCT01888302|Cisplatin|cisplatin|mesh-list
56254499|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254500|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56254501|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
55939415|NCT01237197|Exenatide|exenatide|mesh-list
55939416|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55939417|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939418|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55939419|NCT01237197|Incretins|incretins|mesh-ancestor
55939420|NCT01237197|Hormones|hormones|mesh-ancestor
55939421|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939422|NCT01237353|Rabeprazole|rabeprazole|mesh-list
55939423|NCT01237353|Betaine|betaine|mesh-list
55939424|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55939439|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55939440|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55939441|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939443|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
55939444|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939445|NCT04410341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55939446|NCT04410341|Antidepressive Agents|antidepressive agents|mesh-ancestor
55939447|NCT04410341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55939448|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55939449|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56254509|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56254510|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56254511|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
56254512|NCT01888328|Isotretinoin|isotretinoin|mesh-list
56254513|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
56254514|NCT01888341|Isotretinoin|isotretinoin|mesh-list
56254515|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
56254516|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56254517|NCT01888354|Hormones|hormones|mesh-ancestor
56254518|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254519|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254520|NCT01888393|Ivacaftor|ivacaftor|mesh-list
56254521|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56254522|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55829775|NCT01888497|Gabapentin|gabapentin|mesh-list
55939450|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
55939451|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939453|NCT03010761|Moclobemide|moclobemide|mesh-list
55939454|NCT03010761|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55939455|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55939456|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55939457|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254523|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254524|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
56254525|NCT01888445|Hematinics|hematinics|mesh-ancestor
56254526|NCT01888458|Micafungin|micafungin|mesh-list
56254527|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
56254528|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254529|NCT01888536|Pregabalin|pregabalin|mesh-list
56254530|NCT01888536|Alprostadil|alprostadil|mesh-list
56254531|NCT01888536|Analgesics|analgesics|mesh-ancestor
56254532|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
56254533|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254534|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254535|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
56254536|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56254537|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56254538|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254539|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56254540|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56254541|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254542|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254543|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254544|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55838337|NCT01410448|Cyclosporins|cyclosporins|mesh-list
55748728|NCT03352895|Protective Agents|protective agents|mesh-ancestor
56254545|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
56254546|NCT01888536|Urological Agents|urological agents|mesh-ancestor
56254547|NCT01888562|Ponatinib|ponatinib|mesh-list
56254548|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254549|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56254550|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254551|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254552|NCT01888575|Aspirin|aspirin|mesh-list
56254553|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56254554|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55939458|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939459|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
55939460|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939461|NCT03010761|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55939462|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
55939463|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55939464|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55939465|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939466|NCT01243593|Anesthetics|anesthetics|mesh-list
55939467|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254577|NCT01888731|Lamotrigine|lamotrigine|mesh-list
56254578|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
56254579|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56052144|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56052145|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56052146|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56052147|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052148|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
56052149|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55753228|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
55889426|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55889427|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
55889428|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55889429|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
55889430|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
55889431|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
55889432|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
55889433|NCT01736579|Antibodies|antibodies|mesh-list
55889434|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
55889435|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55889436|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55889437|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
55889438|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889439|NCT03004287|Thalidomide|thalidomide|mesh-list
55889440|NCT03004287|Dexamethasone|dexamethasone|mesh-list
55889441|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
55889442|NCT03004287|Melphalan|melphalan|mesh-list
56052150|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56052151|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
56052152|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052153|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56052154|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56052155|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889443|NCT03004287|Doxorubicin|doxorubicin|mesh-list
55889444|NCT03004287|Etoposide|etoposide|mesh-list
55889445|NCT03004287|Lenalidomide|lenalidomide|mesh-list
55889446|NCT03004287|Bortezomib|bortezomib|mesh-list
55889447|NCT03004287|Daratumumab|daratumumab|mesh-list
55889448|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55889449|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
55889450|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889451|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889452|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55889453|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
55889454|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889455|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889456|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55889457|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889458|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
55889460|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889461|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55889462|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
55889463|NCT03004287|Hormones|hormones|mesh-ancestor
55889464|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889465|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55889466|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55889467|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55889468|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55889469|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889470|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55889471|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55939468|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939469|NCT04362761|Ivacaftor|ivacaftor|mesh-list
55939470|NCT04362761|Elexacaftor|elexacaftor|mesh-list
55939471|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55939472|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55939473|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939474|NCT01162005|Tacrolimus|tacrolimus|mesh-list
56254580|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56254581|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254582|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55748751|NCT03350399|Mitogens|mitogens|mesh-list
55863817|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
55747199|NCT03734653|Androgens|androgens|mesh-ancestor
55747200|NCT03734653|Hormones|hormones|mesh-ancestor
55747201|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55747202|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747203|NCT04489459|Meropenem|meropenem|mesh-list
55747204|NCT04489459|Colistin|colistin|mesh-list
55747205|NCT04489459|Tigecycline|tigecycline|mesh-list
55747206|NCT04489459|Polymyxins|polymyxins|mesh-list
55747207|NCT04489459|Polymyxin B|polymyxin b|mesh-list
55747208|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55747209|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747210|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55747211|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789036|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55863012|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747212|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747214|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
55747215|NCT03296137|Nivolumab|nivolumab|mesh-list
55747216|NCT03296137|Ipilimumab|ipilimumab|mesh-list
55747217|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
55747218|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747219|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
55747220|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747221|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747222|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55747223|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
55747224|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747225|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747226|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55747227|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55747228|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55747229|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55747230|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
55747231|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55747232|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55747233|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
55747234|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747235|NCT03295903|Cannabidiol|cannabidiol|mesh-list
55747236|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
55747238|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55747239|NCT02460913|Narcotics|narcotics|mesh-ancestor
55747240|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747241|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747242|NCT02460913|Analgesics|analgesics|mesh-ancestor
55747243|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
55747244|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747245|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
55747247|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55747248|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747250|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747251|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747254|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55747255|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55747256|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747257|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
55939475|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939476|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
55939477|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939478|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55939479|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939480|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863871|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55939482|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
55939483|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55939511|NCT01281501|Antacids|antacids|mesh-list
55939512|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56254583|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254585|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254586|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876619|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254587|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254588|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56254589|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56254590|NCT01888744|Cetrorelix|cetrorelix|mesh-list
56254591|NCT01888744|Progesterone|progesterone|mesh-list
56254592|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56254593|NCT01888744|Ganirelix|ganirelix|mesh-list
56254594|NCT01888744|Progestins|progestins|mesh-ancestor
56254595|NCT01888744|Hormones|hormones|mesh-ancestor
55939513|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55939514|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55939515|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939516|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939517|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55939519|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
55939520|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939521|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939522|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
55939523|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55939524|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
56254596|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254597|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254598|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56254599|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56254600|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
56254601|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
56254602|NCT01888757|Lamotrigine|lamotrigine|mesh-list
56254603|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
56254604|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56254605|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56254606|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254607|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56254608|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254609|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56254610|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254611|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254612|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254613|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56254614|NCT01888796|Linagliptin|linagliptin|mesh-list
56254615|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56254616|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254617|NCT01888796|Incretins|incretins|mesh-ancestor
56254619|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254620|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55939525|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939526|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55939527|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
55939528|NCT03353831|Bevacizumab|bevacizumab|mesh-list
55939529|NCT03353831|Atezolizumab|atezolizumab|mesh-list
55939530|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939531|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939532|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55939557|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56254632|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254633|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254634|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254635|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56254636|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56254637|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56254638|NCT01888835|Mirtazapine|mirtazapine|mesh-list
56254639|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
56254640|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254641|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56254642|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
56254643|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
56254644|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254645|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254646|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254647|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56254648|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254649|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254650|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56254651|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56254652|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56254653|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
55829894|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
55748786|NCT03352115|Hormones|hormones|mesh-ancestor
56254654|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56254655|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56254656|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
56254657|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56254658|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
56254659|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
55939558|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55939559|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55939561|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
55939563|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939564|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
55939565|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
55939566|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939567|NCT05617313|Pembrolizumab|pembrolizumab|mesh-list
55939568|NCT05617313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939569|NCT05617313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939570|NCT04303325|Esketamine|esketamine|mesh-list
55939571|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
55939572|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254660|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254661|NCT01888861|Protective Agents|protective agents|mesh-ancestor
56254662|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254664|NCT01888861|Vitamins|vitamins|mesh-ancestor
56254665|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
56254666|NCT01888978|Leucovorin|leucovorin|mesh-list
56254667|NCT01888978|Gemcitabine|gemcitabine|mesh-list
56254668|NCT01888978|Fluorouracil|fluorouracil|mesh-list
56254669|NCT01888978|Docetaxel|docetaxel|mesh-list
56254670|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
56254671|NCT01888978|Irinotecan|irinotecan|mesh-list
56254672|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
56254673|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56254674|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
56254675|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939573|NCT04248335|Midazolam|midazolam|mesh-list
55939574|NCT04248335|Pantoprazole|pantoprazole|mesh-list
55939575|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55939576|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55939577|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939578|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939579|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55939580|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55939581|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55939582|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55939583|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
55939584|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
55939595|NCT04176419|Acetaminophen|acetaminophen|mesh-list
55939597|NCT04176419|Lidocaine|lidocaine|mesh-list
55939598|NCT04176419|Ketamine|ketamine|mesh-list
55939599|NCT04176419|Gabapentin|gabapentin|mesh-list
55939600|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
55939601|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
55939602|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254676|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254677|NCT01888978|Antiviral Agents|antiviral agents|mesh-ancestor
56254678|NCT01888978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254679|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254680|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56254681|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
56254682|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254683|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
56254684|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
56254685|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
56254686|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56254687|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56254688|NCT01888978|Antidotes|antidotes|mesh-ancestor
56254689|NCT01888978|Protective Agents|protective agents|mesh-ancestor
56254690|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
56254691|NCT01888978|Vitamins|vitamins|mesh-ancestor
56254692|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
56254693|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
56254694|NCT01889004|Propofol|propofol|mesh-list
56254695|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56254696|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254700|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
56254713|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56254714|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56254715|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254716|NCT01889134|Alendronate|alendronate|mesh-list
56254717|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56254718|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254719|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
56254720|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56254721|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
55829972|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871490|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254722|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254723|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56254724|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254725|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56254726|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254727|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254728|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254729|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56254730|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939603|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939604|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
55939605|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939606|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55939607|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55939608|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55939609|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55939610|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939611|NCT04176419|Analgesics|analgesics|mesh-ancestor
55939612|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55939613|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56254736|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254737|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
56254738|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254740|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56254741|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254742|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
55829988|NCT01462318|Vitamin K|vitamin k|mesh-list
56254743|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939614|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
55939615|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55939616|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55939617|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999772|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55999773|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
55863873|NCT01776307|Capecitabine|capecitabine|mesh-list
55939618|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55939619|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
56254744|NCT01889368|Protective Agents|protective agents|mesh-ancestor
56254745|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871491|NCT00417664|Midazolam|midazolam|mesh-list
55939620|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55939621|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55939622|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55939623|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55939624|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55939625|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939626|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
55939627|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55939628|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55939629|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55939630|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
55939631|NCT04168931|Trastuzumab|trastuzumab|mesh-list
55939632|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56254747|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56254748|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254749|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55939633|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939634|NCT04165967|Nivolumab|nivolumab|mesh-list
55939635|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939636|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939637|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55939638|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939639|NCT03211949|Mepivacaine|mepivacaine|mesh-list
55939640|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
56254750|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56254751|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254752|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254753|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56254754|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
55939641|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
55939642|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939643|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939644|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
55939645|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939646|NCT01285635|Docetaxel|docetaxel|mesh-list
55939647|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939648|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
55939649|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
55939670|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939671|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939672|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
56254755|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254757|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55830016|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56254758|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254760|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
56254761|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56254762|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254763|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254764|NCT01889498|Diuretics|diuretics|mesh-ancestor
56254765|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
56254766|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254767|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
55939673|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939674|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55939675|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55939676|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55939677|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
55939678|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939679|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55939680|NCT00632749|Cytarabine|cytarabine|mesh-list
55939681|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55939682|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
55939683|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939684|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939685|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
55939686|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939687|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939688|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
55939689|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939690|NCT01289067|Satraplatin|satraplatin|mesh-list
55939691|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939692|NCT01248585|Dexamethasone|dexamethasone|mesh-list
55939693|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55939694|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
55939695|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
55939696|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939697|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939698|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55939699|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
55939700|NCT01248585|Hormones|hormones|mesh-ancestor
55939701|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939702|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55939703|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939728|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55939729|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
55939730|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939731|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254769|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939732|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55939733|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
55939734|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
55939735|NCT03924635|Hormones|hormones|mesh-ancestor
55939736|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939737|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55939738|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55939739|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55939740|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
55939741|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939742|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939743|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
55939744|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56254770|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56254771|NCT01889680|Leucovorin|leucovorin|mesh-list
55939746|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55939747|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55939748|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
55939749|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939750|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939751|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939752|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55939777|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939778|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
55939779|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939780|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
55939781|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939782|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56254772|NCT01889680|Fluorouracil|fluorouracil|mesh-list
56254773|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
55939783|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55939784|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55939785|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939786|NCT03830333|Metronidazole|metronidazole|mesh-list
55939787|NCT03830333|Meropenem|meropenem|mesh-list
55939788|NCT03830333|Tazobactam|tazobactam|mesh-list
55939789|NCT03830333|Ceftolozane|ceftolozane|mesh-list
55939790|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55939791|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939792|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55939793|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55939794|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55939795|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55939796|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939797|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939798|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56254774|NCT01889680|Aflibercept|aflibercept|mesh-list
56254775|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
56254776|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
56254777|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254778|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55939799|NCT03830333|Renal Agents|renal agents|mesh-ancestor
55939800|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
55939801|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55939802|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
55939803|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939804|NCT01251315|Expectorants|expectorants|mesh-ancestor
55939811|NCT01251315|Antidotes|antidotes|mesh-ancestor
55939812|NCT03810287|Domperidone|domperidone|mesh-list
55939813|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
55939815|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939816|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939817|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55939818|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55939819|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
55939820|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939821|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939822|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
55939823|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56254779|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748939|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55939824|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
55939825|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55939826|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
55939827|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939828|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939829|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
55939830|NCT01290237|Vancomycin|vancomycin|mesh-list
55939831|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55939832|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939833|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
55939834|NCT03613727|Vitamins|vitamins|mesh-ancestor
55939835|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
55939836|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939837|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
55999774|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
55748952|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
56254780|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56254781|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
56254782|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254783|NCT01889680|Antidotes|antidotes|mesh-ancestor
56254784|NCT01889680|Protective Agents|protective agents|mesh-ancestor
55863855|NCT01709084|Tenofovir|tenofovir|mesh-list
55999775|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999776|NCT01253668|Antibodies|antibodies|mesh-list
55999777|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55999778|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
55999779|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999780|NCT01890200|Ribavirin|ribavirin|mesh-list
55939838|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939839|NCT03613727|Protective Agents|protective agents|mesh-ancestor
55939840|NCT01251393|Biperiden|biperiden|mesh-list
55939841|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55939842|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55939843|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
55939851|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939852|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
55939853|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
55939854|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55939855|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55939856|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939857|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254786|NCT01889680|Vitamins|vitamins|mesh-ancestor
56254787|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
56254788|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56254789|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56254790|NCT01889680|Growth Substances|growth substances|mesh-ancestor
56254791|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
56254792|NCT01889758|Tacrolimus|tacrolimus|mesh-list
55939858|NCT00631969|Urological Agents|urological agents|mesh-ancestor
55939867|NCT01255137|Axitinib|axitinib|mesh-list
55939868|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939869|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55939870|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939871|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939872|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
55939873|NCT03253133|Oxycodone|oxycodone|mesh-list
55939874|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939875|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55939890|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56254793|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56254794|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
56254795|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254796|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56254797|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254798|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254799|NCT01889771|Nicotine|nicotine|mesh-list
56254800|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56254801|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
56254802|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254803|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254804|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56254805|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56254806|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
56254807|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254808|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254809|NCT01889810|Vitamin D|vitamin d|mesh-list
56254810|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
56254811|NCT01889810|Vitamins|vitamins|mesh-ancestor
56254812|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
56254816|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56254849|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254855|NCT01891292|Enalapril|enalapril|mesh-list
55939891|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55939892|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55939894|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
55939895|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939896|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939897|NCT00631657|Mirtazapine|mirtazapine|mesh-list
55939898|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
55939899|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55939900|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55939901|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
55939902|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
56254954|NCT01895049|Tacrolimus|tacrolimus|mesh-list
55830197|NCT02105636|Docetaxel|docetaxel|mesh-list
56254955|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
56254956|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56254957|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56254958|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
56254959|NCT01895049|Hormones|hormones|mesh-ancestor
56254960|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254961|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254962|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56254963|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254964|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56254965|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
56254966|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56254967|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254968|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254969|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56254970|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56254971|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
56254972|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56254973|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254974|NCT01896622|Ritonavir|ritonavir|mesh-list
56254975|NCT01896622|Cobicistat|cobicistat|mesh-list
56254976|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56254977|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56254978|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254979|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254980|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254981|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56254982|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56254983|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
55939903|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939904|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939905|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939906|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55939907|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55939908|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939909|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55939910|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55939911|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55939912|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
56254984|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254985|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56254986|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56254987|NCT01897051|Rifaximin|rifaximin|mesh-list
56254988|NCT01897051|Propranolol|propranolol|mesh-list
56254989|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56254990|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56254991|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
56254992|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254993|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254994|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254995|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56254996|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56254997|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
56254998|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56254999|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255000|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56255001|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
56255002|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
56255003|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56255004|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56255005|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255006|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999781|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55999782|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
55999783|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939913|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55939914|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55939915|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
55939916|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55939917|NCT01257087|Insulin|insulin|mesh-list
55939918|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55939919|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
55939920|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55939921|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939922|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
55939923|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939924|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939925|NCT00631189|Atorvastatin|atorvastatin|mesh-list
55939926|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55939927|NCT00631189|Pravastatin|pravastatin|mesh-list
56255023|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56255024|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255025|NCT01899105|Ivacaftor|ivacaftor|mesh-list
56255026|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56255027|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56255028|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255029|NCT01900015|Efavirenz|efavirenz|mesh-list
56255030|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
56255031|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56255033|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939928|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55939929|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55939930|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
55939931|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939933|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55939934|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939935|NCT00630877|Aspirin|aspirin|mesh-list
55939936|NCT00630877|Niacin|niacin|mesh-list
55939937|NCT00630877|Niacinamide|niacinamide|mesh-list
55939945|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55939946|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55939947|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56255067|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56255068|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255069|NCT01900106|Ritonavir|ritonavir|mesh-list
56255070|NCT01900106|Darunavir|darunavir|mesh-list
56255071|NCT01900106|Lamivudine|lamivudine|mesh-list
56255072|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
56255073|NCT01900106|Abacavir|abacavir|mesh-list
56255074|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
56255075|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56255076|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56255077|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
56255078|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255079|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255080|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56255081|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56255082|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
56255083|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255084|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56255085|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56255086|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56255087|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55830319|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749041|NCT03261115|Anesthetics|anesthetics|mesh-list
56255088|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56255089|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56255090|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
56255091|NCT01900158|Gemcitabine|gemcitabine|mesh-list
56255092|NCT01900158|Cisplatin|cisplatin|mesh-list
56255093|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255094|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55939948|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55939949|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939950|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55939951|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55939952|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939953|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
55939954|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55939955|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
56255095|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
56255096|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255097|NCT01900158|Antiviral Agents|antiviral agents|mesh-ancestor
56255098|NCT01900158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255099|NCT01900158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255100|NCT01900158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255101|NCT01900158|Immunologic Factors|immunologic factors|mesh-ancestor
56255102|NCT01900158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255103|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56255104|NCT01900197|Hematinics|hematinics|mesh-ancestor
56255105|NCT01900301|Scopolamine|scopolamine|mesh-list
56255106|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56255107|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56255108|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
56255109|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
56255110|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255111|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255112|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56255113|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
56255114|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56255115|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
56255116|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255117|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255137|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
56255138|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255139|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56255140|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56255141|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56255142|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255143|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255144|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255145|NCT01900496|Rituximab|rituximab|mesh-list
56255146|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56255147|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56255148|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255149|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
56255151|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56255196|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255197|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255198|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56255199|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56255200|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56255201|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56255202|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255203|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55939956|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55939957|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
55939958|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
55939959|NCT00630877|Vitamins|vitamins|mesh-ancestor
55939960|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
55939961|NCT04557163|Itraconazole|itraconazole|mesh-list
55939962|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
55939963|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255213|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56255214|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56255215|NCT01900717|Growth Substances|growth substances|mesh-ancestor
56255216|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255217|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
56255218|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
56255219|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255220|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56255221|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255222|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
56255223|NCT01900717|Antidotes|antidotes|mesh-ancestor
56255224|NCT01900717|Protective Agents|protective agents|mesh-ancestor
56255225|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
56255226|NCT01900717|Vitamins|vitamins|mesh-ancestor
56255227|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
56255228|NCT01900795|Ibuprofen|ibuprofen|mesh-list
56255229|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56255230|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56255231|NCT01900795|Analgesics|analgesics|mesh-ancestor
56255240|NCT01900847|Ketamine|ketamine|mesh-list
56255269|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
56255270|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255271|NCT01900938|Midazolam|midazolam|mesh-list
56255272|NCT01900938|Propofol|propofol|mesh-list
56255273|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56255274|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749084|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
56255275|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255276|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56255278|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
56255279|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56255280|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56255281|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56255282|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56255283|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
56255284|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
56255285|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255286|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255287|NCT01900951|Temozolomide|temozolomide|mesh-list
56255288|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56255289|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
56255290|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255291|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255292|NCT01901003|Lorazepam|lorazepam|mesh-list
56255293|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
56255294|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
56255295|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
56255296|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255297|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255327|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56255328|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
56255329|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56255330|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255332|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
56255333|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
55939964|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55939965|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55939966|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939967|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939968|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55939969|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
55939970|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939971|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939972|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55939974|NCT02915783|Lenvatinib|lenvatinib|mesh-list
55939975|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255352|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255353|NCT01901471|Cyclosporine|cyclosporine|mesh-list
56255354|NCT01901471|Cyclosporins|cyclosporins|mesh-list
56255355|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255356|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255357|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255358|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
56255359|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255360|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
56255361|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255362|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
56255363|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56255364|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56255365|NCT01901484|Praziquantel|praziquantel|mesh-list
56255366|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
56255367|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56255368|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255369|NCT01901549|Metoprolol|metoprolol|mesh-list
56255370|NCT01901549|Lisinopril|lisinopril|mesh-list
56255371|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56255372|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56255373|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
56255374|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
55939976|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939977|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
55939978|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939979|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55939980|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939981|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939983|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55939984|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
55939985|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939986|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56255375|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939987|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255437|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55939988|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55939989|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999784|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
55999785|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999786|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55999787|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55939990|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
55939991|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939992|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939993|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56255438|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56255439|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255440|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255441|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255442|NCT01902121|Insulin|insulin|mesh-list
56255443|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56255444|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56255445|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255446|NCT01902160|Sirolimus|sirolimus|mesh-list
56255447|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56255448|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56255449|NCT01902160|Antibodies|antibodies|mesh-list
56255450|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
56255451|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56255452|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
56255453|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
56255454|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255455|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255456|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56255457|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255458|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56255459|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
56255460|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255461|NCT01902186|Ritonavir|ritonavir|mesh-list
56255462|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56255463|NCT01902186|Tenofovir|tenofovir|mesh-list
55939994|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55939995|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
55939996|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55939997|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939998|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939999|NCT02307149|Ipilimumab|ipilimumab|mesh-list
55940000|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55940001|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940002|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55940003|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940004|NCT02134301|Oritavancin|oritavancin|mesh-list
55940019|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
55940020|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255475|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56255476|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56255479|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55940021|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940022|NCT03174197|Temozolomide|temozolomide|mesh-list
55940023|NCT03174197|Atezolizumab|atezolizumab|mesh-list
55940024|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55940025|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55940026|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
55940027|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940028|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255532|NCT01902511|Hematinics|hematinics|mesh-ancestor
56255533|NCT01902524|Fentanyl|fentanyl|mesh-list
56255534|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56255535|NCT01902524|Narcotics|narcotics|mesh-ancestor
56255536|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255537|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255538|NCT01902524|Analgesics|analgesics|mesh-ancestor
56255539|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
56255540|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255541|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56255542|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56255543|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
56255544|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
56255545|NCT01902537|Prucalopride|prucalopride|mesh-list
56255546|NCT01902537|Laxatives|laxatives|mesh-ancestor
56255547|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940029|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
55940030|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940031|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
55940032|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55940033|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940035|NCT01176461|Vaccines|vaccines|mesh-list
55940036|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55940037|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
55940038|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940039|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55940040|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940041|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56255585|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56255586|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255587|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255588|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255589|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255590|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56255591|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56255592|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
56255593|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
56255594|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
56255595|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255596|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56255597|NCT01902862|Rituximab|rituximab|mesh-list
56255598|NCT01902862|Bortezomib|bortezomib|mesh-list
56255599|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56255600|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255601|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
56255602|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255645|NCT01903083|Antiviral Agents|antiviral agents|mesh-ancestor
56255646|NCT01903083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255647|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255648|NCT01903083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830878|NCT02202551|Analgesics|analgesics|mesh-ancestor
56255650|NCT01903083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255651|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
56255652|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56255653|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56255654|NCT01903083|Urological Agents|urological agents|mesh-ancestor
56255655|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
56255656|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56255657|NCT01903109|Cevimeline|cevimeline|mesh-list
56255658|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56255659|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
56255660|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255661|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255662|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56255663|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56255664|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
55940042|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940043|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55940044|NCT00630331|Vaccines|vaccines|mesh-list
55940045|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
55940046|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940047|NCT04555291|Ropivacaine|ropivacaine|mesh-list
55940048|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
55940049|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
55940050|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940051|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940052|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
55940053|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940054|NCT04275115|Midazolam|midazolam|mesh-list
55940055|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56255666|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255667|NCT01903122|Cevimeline|cevimeline|mesh-list
56255668|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56255669|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
56255670|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255671|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255672|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56255673|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56255674|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
56255675|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255676|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255677|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56255678|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
55940056|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55940057|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940058|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940059|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55940060|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55940061|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55940062|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55940063|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
55940064|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
55940065|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
56255712|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255713|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255714|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56255715|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
55830943|NCT03039413|Copper|copper|mesh-list
56255717|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56255718|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56255719|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56255720|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56255721|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255722|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255723|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255725|NCT01903824|Donepezil|donepezil|mesh-list
56255726|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56255727|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255728|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255729|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
56255730|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255731|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255732|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
56255733|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56255734|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56255735|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55940066|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
55940067|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940076|NCT04559347|Bupivacaine|bupivacaine|mesh-list
55940077|NCT04559347|Ropivacaine|ropivacaine|mesh-list
55940078|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
55940079|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
55940080|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999788|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55999789|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999790|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940081|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940082|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
56255752|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255753|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56255754|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56255755|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56255756|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255757|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56255758|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
56255759|NCT01904110|Vitamin D|vitamin d|mesh-list
56255760|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
56255761|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
56255762|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56255763|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255764|NCT01904110|Vitamins|vitamins|mesh-ancestor
56255765|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
56255766|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56255767|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56255768|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56255769|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255770|NCT01904162|Finafloxacin|finafloxacin|mesh-list
55830998|NCT01483690|Dexamethasone|dexamethasone|mesh-list
55830999|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
55749149|NCT05585177|Hormones|hormones|mesh-list
56255771|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56255772|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255773|NCT01904162|Renal Agents|renal agents|mesh-ancestor
56255774|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56255775|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56255776|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56255777|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255780|NCT01904214|Siponimod|siponimod|mesh-list
56255781|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56255782|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255783|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255784|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
56255785|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255786|NCT01904253|Topotecan|topotecan|mesh-list
56255787|NCT01904253|Amrubicin|amrubicin|mesh-list
56255788|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56255789|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56255790|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255791|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255792|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940083|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940084|NCT00631111|Aspirin|aspirin|mesh-list
55940085|NCT00631111|Ibuprofen|ibuprofen|mesh-list
55940086|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940087|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55940088|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55940089|NCT00631111|Analgesics|analgesics|mesh-ancestor
55940090|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
55940091|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940092|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55940093|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940094|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55940095|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55940096|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940097|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55940098|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55940099|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940100|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
55940101|NCT03535363|Osimertinib|osimertinib|mesh-list
55940102|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940103|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55940104|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940105|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940106|NCT00630799|Leuprolide|leuprolide|mesh-list
55940107|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55940108|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
55940109|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55940110|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940111|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55940112|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940113|NCT01925287|Curcumin|curcumin|mesh-list
55940114|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55940115|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55940116|NCT01925287|Analgesics|analgesics|mesh-ancestor
55940117|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
55940118|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940119|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940120|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55940121|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940122|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940123|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940124|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940125|NCT00676715|Interferons|interferons|mesh-list
55940126|NCT00676715|Interferon-beta|interferon-beta|mesh-list
55940127|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
55940128|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940129|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
55940130|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940131|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
55940132|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940146|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940147|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940149|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55940150|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56255956|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
56255957|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
56255958|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56255959|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56255960|NCT01905150|Antidotes|antidotes|mesh-ancestor
56255961|NCT01905150|Protective Agents|protective agents|mesh-ancestor
56255962|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
56255963|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
56255964|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56255965|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
56255966|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56255967|NCT01905215|Vaccines|vaccines|mesh-list
56255968|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
56255969|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255970|NCT01905371|Amphetamine|amphetamine|mesh-list
56255971|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
56255972|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56255973|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255974|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
56256013|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
55940151|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940152|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55940153|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55940154|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55940155|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940156|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
55940157|NCT00667121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55940158|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55940159|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55999791|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55999792|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55940160|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
56256040|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256041|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56256042|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56256043|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
56256044|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
56256045|NCT01906125|Palbociclib|palbociclib|mesh-list
56256046|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256047|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56256048|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256049|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256050|NCT01906216|Sorafenib|sorafenib|mesh-list
56256051|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256052|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56256053|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256054|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256055|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
56256056|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56256057|NCT01906242|Eusol|eusol|mesh-list
56256058|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55831294|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
56256059|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256060|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
56256061|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56256062|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256063|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
56256064|NCT01906307|Giapreza|giapreza|mesh-list
56256065|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56256066|NCT01906411|Dopamine|dopamine|mesh-list
56256067|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56256068|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
56256069|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
56256070|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256071|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256072|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
56256073|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256074|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256075|NCT01906411|Protective Agents|protective agents|mesh-ancestor
56256076|NCT01906450|Azithromycin|azithromycin|mesh-list
56256077|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56256079|NCT01906528|Mivacurium|mivacurium|mesh-list
56256112|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256113|NCT01906762|Analgesics|analgesics|mesh-ancestor
56256114|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
56256115|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256116|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56256117|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
56256118|NCT01906788|Lumefantrine|lumefantrine|mesh-list
56256119|NCT01906788|Artemether|artemether|mesh-list
55940161|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55940162|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
55940163|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55940164|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55940165|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
55940166|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
55940167|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55940168|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55940169|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
55940170|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55940171|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
55940172|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940173|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55940174|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940175|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55940176|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55940177|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55940178|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56256172|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56256173|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
56256174|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56256175|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
56256176|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256177|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256178|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
56256179|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
56256180|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56256181|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
56256182|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256183|NCT01907061|Expectorants|expectorants|mesh-ancestor
56256184|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
56256185|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55940179|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
55940180|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55940181|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
55940182|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940183|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
55940184|NCT04276649|Antacids|antacids|mesh-ancestor
55940185|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940187|NCT04553419|Cephalexin|cephalexin|mesh-list
55940188|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56256187|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256188|NCT01907061|Protective Agents|protective agents|mesh-ancestor
56256189|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256190|NCT01907061|Antidotes|antidotes|mesh-ancestor
56256191|NCT01907074|Cholic Acids|cholic acids|mesh-list
56256192|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256193|NCT01907165|Copper|copper|mesh-list
56256194|NCT01907165|Temozolomide|temozolomide|mesh-list
56256195|NCT01907165|Disulfiram|disulfiram|mesh-list
56256196|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56256197|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
56256198|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256199|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256200|NCT01907165|Trace Elements|trace elements|mesh-ancestor
56256201|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
56256202|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256203|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56256204|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
55871494|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56256205|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256206|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
55940189|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940190|NCT03097783|Lidocaine|lidocaine|mesh-list
55940191|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
55940192|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
55940193|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940194|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940195|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
55940204|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940205|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56256207|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56256208|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56256209|NCT01907204|Prednisolone|prednisolone|mesh-list
56256210|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
56256211|NCT01907204|Budesonide|budesonide|mesh-list
56256212|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56256213|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
56256214|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256215|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
56256216|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
56256217|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256218|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256219|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256220|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
56256221|NCT01907204|Hormones|hormones|mesh-ancestor
56256222|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256223|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56256224|NCT01907204|Protective Agents|protective agents|mesh-ancestor
56256225|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56256226|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256227|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56256228|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56256229|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
56256230|NCT01907230|Entecavir|entecavir|mesh-list
56256231|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
56256232|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256233|NCT01907308|Docetaxel|docetaxel|mesh-list
56256234|NCT01907308|Trebananib|trebananib|mesh-list
56256235|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256236|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
56256237|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
56256238|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
55940206|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55940207|NCT04346407|Analgesics|analgesics|mesh-ancestor
55940208|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
55940209|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940210|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55940211|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55940212|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940213|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940214|NCT04346407|Hormones|hormones|mesh-ancestor
55940215|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256242|NCT01907308|Growth Substances|growth substances|mesh-ancestor
56256243|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256244|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
56256245|NCT01907373|Probenecid|probenecid|mesh-list
56256246|NCT01907373|Olmesartan|olmesartan|mesh-list
55878299|NCT01870583|Iodine|iodine|mesh-list
56256247|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56256248|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56256249|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56256250|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56256251|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256252|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
56256253|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
56256254|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256256|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
56256257|NCT01907529|Docetaxel|docetaxel|mesh-list
56256258|NCT01907529|Epirubicin|epirubicin|mesh-list
56256259|NCT01907529|Endostar protein|endostar protein|mesh-list
56256260|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256261|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
56256262|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256263|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256264|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56256265|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
56256266|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256267|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256268|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56256269|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
56256270|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
56256271|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
56256272|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55940216|NCT04397549|Morphine|morphine|mesh-list
55940217|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55940218|NCT04397549|Narcotics|narcotics|mesh-ancestor
55940219|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940220|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940221|NCT04397549|Analgesics|analgesics|mesh-ancestor
55940222|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
55940223|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940224|NCT03080441|Midodrine|midodrine|mesh-list
55940225|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
56256275|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256276|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56256277|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56256278|NCT01907529|Growth Substances|growth substances|mesh-ancestor
56256279|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
56256280|NCT01907594|Cycloserine|cycloserine|mesh-list
56256281|NCT01907594|Nicotine|nicotine|mesh-list
56256282|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56256283|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
56256284|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256285|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256286|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56256287|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56256288|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
56256289|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256290|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256291|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56256292|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256293|NCT01907594|Renal Agents|renal agents|mesh-ancestor
56256294|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56256295|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
56256296|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56256297|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
56256298|NCT01907633|Domperidone|domperidone|mesh-list
56256299|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
56256300|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
55940226|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
55940227|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940228|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940229|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55940230|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55940231|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55940232|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55940233|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
55940234|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940235|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871495|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256316|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256317|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
55749294|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
55748101|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
55748102|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55748103|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55748104|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748105|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55748106|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
55748107|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55748108|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
55748109|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748110|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
55748111|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748112|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
55748113|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
55748114|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
55748115|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55748116|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55748117|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748118|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
55748119|NCT02458729|Coagulants|coagulants|mesh-ancestor
55748120|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55748121|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
55748122|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55748123|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
55748124|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748125|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
55748126|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
55748127|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55748128|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55748129|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55748130|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55748131|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748132|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748133|NCT03920527|Itraconazole|itraconazole|mesh-list
55748134|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
55748135|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748136|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55748137|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55748138|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748139|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779182|NCT04941937|Growth Substances|growth substances|mesh-ancestor
55748140|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55748142|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55748143|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748144|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55748146|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55748147|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
55748148|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
55748149|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748150|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748151|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55748152|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55748153|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55748154|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
55752788|NCT02488889|Varenicline|varenicline|mesh-list
55940236|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
55999793|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55999794|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
55999795|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940237|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
55940238|NCT05243147|Coagulants|coagulants|mesh-ancestor
55940239|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
55940240|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55940241|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
55940242|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55940243|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
56256318|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256319|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256320|NCT01907776|Arbekacin|arbekacin|mesh-list
56256321|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56256322|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256323|NCT01907802|Dabrafenib|dabrafenib|mesh-list
56256324|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256325|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56256326|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256327|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256328|NCT01907867|Finafloxacin|finafloxacin|mesh-list
56256329|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56256330|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256331|NCT01907867|Renal Agents|renal agents|mesh-ancestor
56256332|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56256333|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56256376|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56256377|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56256378|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256379|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56256380|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56256381|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
56256382|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256383|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256384|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56256386|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
55940244|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940245|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940246|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
55940247|NCT01920919|Dexamethasone|dexamethasone|mesh-list
55940248|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55940249|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
55940250|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
55940251|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256397|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256398|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56256399|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
56256400|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
56256401|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256402|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256403|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256404|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
56256408|NCT01908283|Vaccines|vaccines|mesh-list
55940252|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940253|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940254|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
55940256|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940257|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55940258|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940259|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
55940260|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55940261|NCT03057847|Velpatasvir|velpatasvir|mesh-list
55940276|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
55940277|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256465|NCT01908478|Immunologic Factors|immunologic factors|mesh-ancestor
56256466|NCT01908478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256467|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56256468|NCT01908556|Letrozole|letrozole|mesh-list
56256469|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256470|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56256471|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56256472|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256473|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256475|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
56256476|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256477|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256478|NCT01908621|Cytarabine|cytarabine|mesh-list
56256479|NCT01908621|Lenograstim|lenograstim|mesh-list
56256480|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56256481|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
56256482|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256483|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56256484|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
56256485|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256486|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256487|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
56256488|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256489|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256490|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56256491|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
56256492|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256493|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
56256494|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55940278|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940279|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55940281|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55940282|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940283|NCT01921231|Bupivacaine|bupivacaine|mesh-list
55940284|NCT01921231|Prilocaine|prilocaine|mesh-list
55940285|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
55940286|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
55940287|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940288|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940289|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
55940290|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940291|NCT03056833|Paclitaxel|paclitaxel|mesh-list
55940292|NCT03056833|Carboplatin|carboplatin|mesh-list
55940293|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55940294|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940295|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
55940296|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
55940297|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
55940298|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940299|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55940300|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
55940301|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55940302|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55940303|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55940304|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940305|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940306|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
55940307|NCT03148457|Apixaban|apixaban|mesh-list
55940308|NCT03148457|Edoxaban|edoxaban|mesh-list
55940309|NCT03148457|Dabigatran|dabigatran|mesh-list
55940310|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55940311|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
55940312|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55940313|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
55940314|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940315|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940316|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
55940317|NCT05601817|Tocopherols|tocopherols|mesh-list
55940318|NCT05601817|Vitamin E|vitamin e|mesh-list
55940319|NCT05601817|alpha-Tocopherol|alpha-tocopherol|mesh-list
55940320|NCT05601817|Antioxidants|antioxidants|mesh-ancestor
55999796|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940330|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55940331|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55940333|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940334|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55940336|NCT05249309|Analgesics|analgesics|mesh-ancestor
55940337|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
55940338|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940339|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940340|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55940341|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55940342|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
55940343|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
56256498|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56256499|NCT01909037|Analgesics|analgesics|mesh-ancestor
56256500|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
56256501|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940344|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940345|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55940346|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55940347|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940348|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940349|NCT04373785|Temozolomide|temozolomide|mesh-list
55940350|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55940351|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
55940352|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940353|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940355|NCT02393183|Antioxidants|antioxidants|mesh-list
55940356|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940357|NCT02393183|Protective Agents|protective agents|mesh-ancestor
55940358|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940359|NCT02393183|Trace Elements|trace elements|mesh-ancestor
55940360|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
55940361|NCT05599295|Oritavancin|oritavancin|mesh-list
55940362|NCT05599295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55940363|NCT05599295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940364|NCT03554291|Famotidine|famotidine|mesh-list
55940366|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940367|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55940368|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
55940369|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
55940370|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940371|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940372|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940373|NCT03351647|Ustekinumab|ustekinumab|mesh-list
55940374|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
55940375|NCT05601271|Allopurinol|allopurinol|mesh-list
55940376|NCT05601271|Antimetabolites|antimetabolites|mesh-ancestor
55940377|NCT05601271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940378|NCT05601271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940379|NCT05601271|Gout Suppressants|gout suppressants|mesh-ancestor
55940380|NCT05601271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940381|NCT05601271|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55940382|NCT05601271|Antioxidants|antioxidants|mesh-ancestor
55940383|NCT05601271|Protective Agents|protective agents|mesh-ancestor
55940384|NCT05601271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940385|NCT02392637|Gemcitabine|gemcitabine|mesh-list
55940386|NCT02392637|Paclitaxel|paclitaxel|mesh-list
55940387|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55940388|NCT02392637|Cisplatin|cisplatin|mesh-list
55940406|NCT05600881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55940407|NCT05600881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55940408|NCT05600881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55940409|NCT05600881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940411|NCT05600881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940412|NCT01926769|Metformin|metformin|mesh-list
55940413|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55940414|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940415|NCT04394143|Mannitol|mannitol|mesh-list
55940416|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55940417|NCT04394143|Diuretics|diuretics|mesh-ancestor
55940418|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
55940419|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940420|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55940421|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
55999797|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55999798|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55999799|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
55999800|NCT05586620|Mitomycins|mitomycins|mesh-list
55940422|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940423|NCT01926847|Riociguat|riociguat|mesh-list
55940424|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
55940425|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940426|NCT05586815|Minocycline|minocycline|mesh-list
55940427|NCT05586815|Colistin|colistin|mesh-list
55940428|NCT05586815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55940429|NCT05586815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940430|NCT05607901|Hydrocortisone|hydrocortisone|mesh-list
55940431|NCT05607901|Tacrolimus|tacrolimus|mesh-list
55940432|NCT05607901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55940433|NCT05607901|Immunologic Factors|immunologic factors|mesh-ancestor
55940434|NCT05607901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940435|NCT05607901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55940436|NCT05607901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940437|NCT05607901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940438|NCT05607901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55940439|NCT05604859|Methylprednisolone|methylprednisolone|mesh-list
55940440|NCT05604859|Heparin|heparin|mesh-list
55940441|NCT05604859|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55940442|NCT05604859|Tinzaparin|tinzaparin|mesh-list
55940443|NCT05604859|Dalteparin|dalteparin|mesh-list
55940444|NCT05604859|Immunoglobulins|immunoglobulins|mesh-list
55940445|NCT05604859|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55940463|NCT05604859|Immunologic Factors|immunologic factors|mesh-ancestor
55940464|NCT03133325|Lidocaine|lidocaine|mesh-list
55940465|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
55940466|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
55940467|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940468|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940469|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
55940470|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940471|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55940472|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55940473|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55940474|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55940475|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940477|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55940478|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
55940479|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940480|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940481|NCT04278677|Melatonin|melatonin|mesh-list
55940482|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
55940483|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940484|NCT04278677|Protective Agents|protective agents|mesh-ancestor
55940485|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940486|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940487|NCT00638027|Memantine|memantine|mesh-list
55940488|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55940489|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55940490|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
55940491|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256521|NCT01909115|Vitamin D|vitamin d|mesh-list
56256522|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
55940492|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940493|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940494|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55940495|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55940496|NCT04218565|Golimumab|golimumab|mesh-list
55940497|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55940498|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55940499|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55940500|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
55940501|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940509|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
55940510|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940511|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55999802|NCT05586620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55999803|NCT05586620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940512|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55940513|NCT05607199|Calcium|calcium|mesh-list
55940514|NCT05607199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55940515|NCT05607199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940516|NCT01927315|Fenofibrate|fenofibrate|mesh-list
55940517|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55940518|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
55940519|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940520|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55940521|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
55940522|NCT00636155|Rituximab|rituximab|mesh-list
55940523|NCT00636155|Fludarabine|fludarabine|mesh-list
55940524|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55940525|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
55940526|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940527|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940528|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55940529|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
55940530|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940531|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940532|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55940533|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55940534|NCT00634907|Warfarin|warfarin|mesh-list
55940535|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
55940536|NCT03430219|Calcium|calcium|mesh-list
55940537|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55940538|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940539|NCT04124497|Dexamethasone|dexamethasone|mesh-list
55940540|NCT04124497|Daratumumab|daratumumab|mesh-list
55940541|NCT04124497|Pomalidomide|pomalidomide|mesh-list
55940542|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55940543|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
55940544|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
55940545|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940546|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940547|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940548|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
55940549|NCT04124497|Hormones|hormones|mesh-ancestor
55940550|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940551|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55940552|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940553|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
55940554|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55940555|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55940556|NCT04124497|Growth Substances|growth substances|mesh-ancestor
55940557|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
56256523|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
56256524|NCT01909115|Vitamins|vitamins|mesh-list
56256525|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
56256526|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256527|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55940559|NCT04127851|Cyclosporins|cyclosporins|mesh-list
55940560|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940561|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940562|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55940563|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
55940564|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940565|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
55940566|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940567|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
55940568|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940569|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55940570|NCT04394533|Bupivacaine|bupivacaine|mesh-list
55940571|NCT04394533|Prilocaine|prilocaine|mesh-list
55940581|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55940582|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940583|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
55940584|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940585|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55940586|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
55940587|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55940588|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55999804|NCT05586620|Alkylating Agents|alkylating agents|mesh-ancestor
55940589|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55940590|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55940591|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940593|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940594|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55940595|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55940596|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940597|NCT05602129|Heparin|heparin|mesh-list
55940598|NCT05602129|Calcium heparin|calcium heparin|mesh-list
55940599|NCT05602129|Anticoagulants|anticoagulants|mesh-ancestor
55940600|NCT05602129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55940601|NCT05602129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55940602|NCT05602129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940603|NCT05609929|Omeprazole|omeprazole|mesh-list
55940604|NCT05609929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55940605|NCT05609929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940606|NCT05609929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55940607|NCT05609929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940608|NCT05609929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940609|NCT01928563|Udenafil|udenafil|mesh-list
55940610|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55940611|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55940612|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940613|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940614|NCT04129255|Octreotide|octreotide|mesh-list
55940615|NCT04129255|Somatostatin|somatostatin|mesh-list
55940616|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940617|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55940618|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940619|NCT04129255|Hormones|hormones|mesh-ancestor
55940620|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940621|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940622|NCT03044977|Octreotide|octreotide|mesh-list
55940623|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940624|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55940625|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940626|NCT03422731|Alovudine|alovudine|mesh-list
56256528|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56256529|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
55940628|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940629|NCT04129489|Cannabidiol|cannabidiol|mesh-list
55940630|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
55940631|NCT04128787|Omeprazole|omeprazole|mesh-list
55940632|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55940633|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940634|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55940635|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940636|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940638|NCT04394377|Enoxaparin|enoxaparin|mesh-list
55940640|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
55940641|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
55940642|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
55940643|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55940644|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55940645|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940646|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55940647|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
55940648|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55940649|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
55940650|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940651|NCT02984293|Atorvastatin|atorvastatin|mesh-list
55940652|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55940653|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55940654|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
55940655|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940657|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55940658|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940659|NCT01929187|Amorolfine|amorolfine|mesh-list
55940660|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
55940661|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940662|NCT00634751|Capecitabine|capecitabine|mesh-list
55940663|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
55940664|NCT00634751|Sorafenib|sorafenib|mesh-list
55940665|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55940666|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
55940667|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940668|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940669|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55940670|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940671|NCT04396223|Methotrexate|methotrexate|mesh-list
55940672|NCT04396223|Avelumab|avelumab|mesh-list
55940673|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55940674|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
55940675|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55940676|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940677|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55940678|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
55940679|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940680|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940681|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
55940682|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940683|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55940684|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55940685|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
55940686|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940687|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55940688|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55940689|NCT04396067|Tretinoin|tretinoin|mesh-list
55940690|NCT04396067|Isotretinoin|isotretinoin|mesh-list
55940691|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940692|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
55940693|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
55940694|NCT05608213|Lenvatinib|lenvatinib|mesh-list
55940695|NCT05608213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940696|NCT05608213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55940697|NCT05608213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940698|NCT05608213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940699|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55940700|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55940701|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940702|NCT03015259|Budesonide|budesonide|mesh-list
55940703|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
55940704|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55940705|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55940706|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55940707|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
55940708|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940709|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940710|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55940711|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
55940712|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
55940716|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55940717|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55940718|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
55940719|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940720|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940722|NCT03236545|Estrogens|estrogens|mesh-list
55940723|NCT03236545|Hormones|hormones|mesh-ancestor
55940724|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940725|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940726|NCT04126993|Apatinib|apatinib|mesh-list
55940727|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940728|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55940729|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940730|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940731|NCT04127227|Gemcitabine|gemcitabine|mesh-list
55940732|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
55940733|NCT04127227|Pegaspargase|pegaspargase|mesh-list
55940734|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55940735|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
55940736|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940737|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940738|NCT04127227|Antiviral Agents|antiviral agents|mesh-ancestor
55999805|NCT05586620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999806|NCT05586620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55999807|NCT05586620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999808|NCT01893788|Eplerenone|eplerenone|mesh-list
55940739|NCT04127227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256543|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
56256544|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256545|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56256546|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56256547|NCT01909661|Caseins|caseins|mesh-list
55940740|NCT04127227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940741|NCT04127227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55940742|NCT04127227|Immunologic Factors|immunologic factors|mesh-ancestor
55940743|NCT04127227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940744|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55940745|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55940746|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55940747|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55940748|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
55940749|NCT03292861|Sirolimus|sirolimus|mesh-list
55940750|NCT03292861|Tacrolimus|tacrolimus|mesh-list
55940751|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
55940752|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55940753|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
55940754|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940755|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55940756|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940757|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940758|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55940759|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940760|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55940761|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
55940762|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55940763|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940764|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
55940765|NCT03828175|Anesthetics|anesthetics|mesh-list
55940766|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940767|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940768|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
55940769|NCT04392973|Favipiravir|favipiravir|mesh-list
55940770|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
55940771|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55940772|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55940773|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940774|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940775|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940776|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940777|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
55940778|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
55940779|NCT03267277|Antidotes|antidotes|mesh-ancestor
55940780|NCT03267277|Protective Agents|protective agents|mesh-ancestor
55940781|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940782|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
55940783|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940784|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
55940785|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55940809|NCT03336203|Febuxostat|febuxostat|mesh-list
55940810|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
55940811|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940812|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940813|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
55940814|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940815|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55940816|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
55940817|NCT03336203|Protective Agents|protective agents|mesh-ancestor
55940818|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940819|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
55940820|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940821|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940822|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940823|NCT04274257|Rituximab|rituximab|mesh-list
55940824|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55940825|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940826|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
55940827|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999809|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55999810|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
55940828|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940829|NCT03128879|Venetoclax|venetoclax|mesh-list
55940830|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
55940831|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940832|NCT03831815|Rocuronium|rocuronium|mesh-list
55940833|NCT03831815|Cisatracurium|cisatracurium|mesh-list
55940834|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55940835|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55940836|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55940837|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940838|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940839|NCT00632099|Progesterone|progesterone|mesh-list
55940840|NCT00632099|Progestins|progestins|mesh-ancestor
55940841|NCT00632099|Hormones|hormones|mesh-ancestor
55940844|NCT03827629|Naloxone|naloxone|mesh-list
55940845|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55940846|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940847|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
55940848|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940849|NCT00631475|Bosentan|bosentan|mesh-list
55940850|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55940851|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55940852|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940853|NCT03826615|Gabapentin|gabapentin|mesh-list
55940854|NCT03826615|Analgesics|analgesics|mesh-ancestor
55940855|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
55940856|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940857|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940858|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
55940859|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55940860|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55940861|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940862|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55940863|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55940864|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55940865|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940866|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940867|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
55940868|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
55940869|NCT04124887|Listerine|listerine|mesh-list
55940870|NCT04124887|Calcium|calcium|mesh-list
55940871|NCT04124887|Fluorides|fluorides|mesh-list
55940872|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
55940873|NCT04124887|Caseins|caseins|mesh-list
55940874|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55940875|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256590|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256591|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
56256592|NCT01909856|Hormones|hormones|mesh-ancestor
56256593|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831819|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55748233|NCT02730377|Incretins|incretins|mesh-ancestor
55748235|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940876|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55940877|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
55940878|NCT04124887|Protective Agents|protective agents|mesh-ancestor
55940879|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55940880|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940882|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
55940883|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940884|NCT04121767|Warfarin|warfarin|mesh-list
55940885|NCT04121767|Edoxaban|edoxaban|mesh-list
55940886|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
55940887|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55940888|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
55940889|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55940890|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
55940891|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940892|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940893|NCT04121689|Caseins|caseins|mesh-list
55940894|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
55940895|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
55940896|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940897|NCT03830827|Vortioxetine|vortioxetine|mesh-list
55940898|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
55940899|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55940900|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55940901|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55999811|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999812|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940902|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940903|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940904|NCT03830827|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55940905|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55940906|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55940907|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743594|NCT02510287|Lidocaine|lidocaine|mesh-list
55940908|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940909|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
55940910|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55940911|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55940912|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55940924|NCT03098485|Renal Agents|renal agents|mesh-ancestor
55940925|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55940926|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55940927|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940928|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940929|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940930|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55940931|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55940932|NCT04121533|Vitamin D|vitamin d|mesh-list
55940933|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
55940934|NCT04121533|Vitamins|vitamins|mesh-ancestor
55940935|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
55940936|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940937|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55940938|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55940939|NCT03822091|Terlipressin|terlipressin|mesh-list
55940940|NCT03822091|Norepinephrine|norepinephrine|mesh-list
55940941|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55940942|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55940943|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55940944|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55940945|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
55940946|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940947|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748396|NCT04521491|Fluorouracil|fluorouracil|mesh-list
55748397|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
55748398|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
55748399|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748400|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55748401|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748402|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55748403|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
55748404|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748405|NCT04521491|Antidotes|antidotes|mesh-ancestor
55940948|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940949|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
55940950|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
55940951|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940952|NCT03822169|Choline|choline|mesh-list
55940953|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
55940954|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55940955|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
55940956|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940957|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940958|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55940960|NCT03825601|Flumazenil|flumazenil|mesh-list
55940961|NCT03825601|Antidotes|antidotes|mesh-ancestor
55940962|NCT03825601|Protective Agents|protective agents|mesh-ancestor
55940963|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940964|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
55940965|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
55940966|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55940967|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940968|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55940969|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55940970|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940971|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55940972|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55940973|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940974|NCT03064867|Rituximab|rituximab|mesh-list
55940975|NCT03064867|Carboplatin|carboplatin|mesh-list
55940976|NCT03064867|Etoposide|etoposide|mesh-list
55940987|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999813|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55999814|NCT01893788|Diuretics|diuretics|mesh-ancestor
55999815|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
55999816|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55940988|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940989|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55940990|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
55940991|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55940993|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55940994|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
55940995|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55940996|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55940997|NCT03824665|Fentanyl|fentanyl|mesh-list
55940998|NCT03824665|Nalbuphine|nalbuphine|mesh-list
55940999|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55941000|NCT03824665|Narcotics|narcotics|mesh-ancestor
55941001|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941002|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941003|NCT03824665|Analgesics|analgesics|mesh-ancestor
55941004|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
55941005|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941006|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55941007|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55941008|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
55941009|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
55941010|NCT04120831|Abatacept|abatacept|mesh-list
55941011|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941012|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
55941013|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941014|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55941015|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55941016|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941017|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941018|NCT00631163|Deferasirox|deferasirox|mesh-list
55941019|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55941020|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
55941021|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
55941022|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941023|NCT02677051|Sulforaphane|sulforaphane|mesh-list
55941024|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55941025|NCT02677051|Protective Agents|protective agents|mesh-ancestor
55941026|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941027|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941028|NCT03056755|Letrozole|letrozole|mesh-list
55941029|NCT03056755|Fulvestrant|fulvestrant|mesh-list
55941030|NCT03056755|Leuprolide|leuprolide|mesh-list
55941031|NCT03056755|Goserelin|goserelin|mesh-list
55941032|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941033|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55941034|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55941035|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941036|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941037|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55941038|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
55941039|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941040|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941044|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
55941045|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55941046|NCT04120519|Thalidomide|thalidomide|mesh-list
55941047|NCT04120519|Dexamethasone|dexamethasone|mesh-list
55941048|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
55941049|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941050|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
55941051|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941052|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55941053|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55941054|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
55941055|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941056|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941057|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55999817|NCT01231750|Capsaicin|capsaicin|mesh-list
55999818|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
55999819|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
55999820|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
55999821|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941058|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55941059|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
55941060|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
55941061|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941062|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55941063|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
55941065|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941066|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55941067|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
55941068|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55941069|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941070|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55941071|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55941072|NCT04120519|Growth Substances|growth substances|mesh-ancestor
55941073|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
55941074|NCT00631007|Pioglitazone|pioglitazone|mesh-list
55941075|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55941076|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941077|NCT03014167|Albendazole|albendazole|mesh-list
55941078|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
55941079|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55941080|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941081|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
55941082|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55941083|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55941084|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
55941085|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
55941086|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
55941087|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941088|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941089|NCT00630539|Tamoxifen|tamoxifen|mesh-list
55941090|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55941091|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
55941092|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941093|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941094|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55941095|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941096|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55941097|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55941098|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55941099|NCT00634829|Albuterol|albuterol|mesh-list
55941100|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55941101|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
55941102|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941103|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941104|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55941105|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
55941106|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
55941107|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55941108|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55941109|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55941111|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
55941112|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941120|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
55941128|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941129|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55941130|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
55999822|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999823|NCT05488860|Triamcinolone|triamcinolone|mesh-list
55941131|NCT01920113|Remifentanil|remifentanil|mesh-list
55941132|NCT01920113|Propofol|propofol|mesh-list
55941133|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55941134|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941135|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941136|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55941137|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
55941138|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
55941139|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55941140|NCT01920113|Analgesics|analgesics|mesh-ancestor
55941141|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
55941142|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941143|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55941144|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55941145|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55941146|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
55941147|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941148|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941149|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55941150|NCT01920113|Narcotics|narcotics|mesh-ancestor
55941151|NCT01920191|Poly ICLC|poly iclc|mesh-list
55941152|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
55941153|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
55867609|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
55941154|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941155|NCT01920269|Mitomycins|mitomycins|mesh-list
55941156|NCT01920269|Mitomycin|mitomycin|mesh-list
55941157|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55941158|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941159|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
55941160|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941161|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55941162|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941163|NCT02921893|Dexamethasone|dexamethasone|mesh-list
55941164|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
55941165|NCT02921893|Lenalidomide|lenalidomide|mesh-list
55941166|NCT02921893|Ixazomib|ixazomib|mesh-list
55941167|NCT02921893|Ichthammol|ichthammol|mesh-list
55941168|NCT02921893|BB 1101|bb 1101|mesh-list
55941169|NCT02921893|Glycine|glycine|mesh-list
55941170|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55941171|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
55941172|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
55941173|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941174|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941175|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55941176|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
55941177|NCT02921893|Hormones|hormones|mesh-ancestor
55941178|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941179|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55941180|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941184|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
55941185|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55941186|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55941187|NCT02921893|Growth Substances|growth substances|mesh-ancestor
55941188|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
55941189|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
55941190|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
55941191|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941213|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941215|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55941216|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
55941217|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941218|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941219|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941220|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55941221|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55941222|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941223|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55941224|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55941225|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
55941226|NCT03009513|Glimepiride|glimepiride|mesh-list
55941227|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55941228|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55941229|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941230|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941231|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
55941232|NCT02983591|Misoprostol|misoprostol|mesh-list
55941233|NCT02983591|Oxytocin|oxytocin|mesh-list
55941234|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
55941235|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55941236|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941237|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55941238|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
55941239|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55941240|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55941241|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
55941242|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55941243|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941244|NCT03115151|Fentanyl|fentanyl|mesh-list
56256594|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56256595|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256596|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55941245|NCT03115151|Hydromorphone|hydromorphone|mesh-list
55941246|NCT03115151|Bupivacaine|bupivacaine|mesh-list
55941247|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
55941248|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
55941249|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941250|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941251|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
55941252|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941253|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55941254|NCT03115151|Narcotics|narcotics|mesh-ancestor
55941255|NCT03115151|Analgesics|analgesics|mesh-ancestor
55941264|NCT01263717|Growth Substances|growth substances|mesh-ancestor
55941265|NCT04120753|Amlodipine|amlodipine|mesh-list
55941266|NCT04120753|Olmesartan|olmesartan|mesh-list
55941267|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55941268|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55941269|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55941270|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941271|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55941272|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941273|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
55941274|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55941275|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55941276|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
55941277|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
55941278|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55743617|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941279|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941280|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941281|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55941282|NCT01921361|Analgesics|analgesics|mesh-ancestor
55941283|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
55941284|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941285|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55941286|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55941287|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55999826|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55999827|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
55941288|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
55941289|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941290|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941291|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
55941292|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
55941293|NCT04121455|Bevacizumab|bevacizumab|mesh-list
55941294|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
55941295|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55941296|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941297|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55941298|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55941299|NCT04121455|Growth Substances|growth substances|mesh-ancestor
55941300|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941301|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
55941302|NCT01921673|Docetaxel|docetaxel|mesh-list
55941303|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941304|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
55941305|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
55941306|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
55941307|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941308|NCT01921985|Terlipressin|terlipressin|mesh-list
55941309|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56256601|NCT01910077|Tacrolimus|tacrolimus|mesh-list
56256602|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256603|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
56256604|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831826|NCT02169791|Ixazomib|ixazomib|mesh-list
55867820|NCT01045798|Caspofungin|caspofungin|mesh-list
55941310|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55941311|NCT02943733|Temozolomide|temozolomide|mesh-list
55941312|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55941313|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
55941314|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941315|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941316|NCT01922141|Amlodipine|amlodipine|mesh-list
55941317|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55941318|NCT01922141|Ramipril|ramipril|mesh-list
55941319|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55941320|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55941329|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55941331|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941332|NCT03828019|Cyclosporine|cyclosporine|mesh-list
55941333|NCT03828019|Adalimumab|adalimumab|mesh-list
55941334|NCT03828019|Methotrexate|methotrexate|mesh-list
55941335|NCT03828019|Azathioprine|azathioprine|mesh-list
55941337|NCT03828019|Cyclosporins|cyclosporins|mesh-list
55941338|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55941339|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
55941340|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55941341|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941342|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55941343|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
55941344|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941345|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941346|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
55941347|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941348|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55941349|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941350|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
55941351|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55941352|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55941353|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55941354|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
55941355|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941356|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55941357|NCT03111485|Levodopa|levodopa|mesh-list
55941358|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55941359|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55941360|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55941361|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
55941362|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941363|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941364|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941367|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
55999829|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999830|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
55999831|NCT05488860|Hormones|hormones|mesh-ancestor
55863909|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941368|NCT02856295|Enoxaparin|enoxaparin|mesh-list
55941369|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
55941370|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55941371|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55941372|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941373|NCT01266447|Topotecan|topotecan|mesh-list
55941374|NCT01266447|Veliparib|veliparib|mesh-list
55941375|NCT01266447|Lenograstim|lenograstim|mesh-list
55867888|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
55941376|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55941377|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
55941378|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941379|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55941380|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55941381|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941382|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941383|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941384|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55941385|NCT01922375|Naftopidil|naftopidil|mesh-list
55941395|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55941396|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55941397|NCT03823339|Liraglutide|liraglutide|mesh-list
55941398|NCT03823339|Xultophy|xultophy|mesh-list
55941399|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55941400|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941401|NCT03823339|Incretins|incretins|mesh-ancestor
55941402|NCT03823339|Hormones|hormones|mesh-ancestor
55941403|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941404|NCT04395989|Paclitaxel|paclitaxel|mesh-list
55941405|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55941406|NCT04395989|Capecitabine|capecitabine|mesh-list
55941407|NCT04395989|Everolimus|everolimus|mesh-list
55941408|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55941409|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941410|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
55941411|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
55941412|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
55941413|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941414|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55941415|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
55941416|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941417|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
55941418|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941419|NCT03108131|Atezolizumab|atezolizumab|mesh-list
55941420|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55941421|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941422|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
55941423|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941424|NCT01922687|Amlodipine|amlodipine|mesh-list
55941425|NCT01922687|Atorvastatin|atorvastatin|mesh-list
55941426|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55941427|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55941428|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
55941429|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941430|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55941431|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55941432|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941433|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55941434|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55941435|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55941436|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55941437|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941438|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
55941439|NCT01922765|Amoxicillin|amoxicillin|mesh-list
55941440|NCT01922765|Metronidazole|metronidazole|mesh-list
55941441|NCT01922765|Clarithromycin|clarithromycin|mesh-list
55866659|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866676|NCT01830946|Caseins|caseins|mesh-list
55941442|NCT01922765|Rabeprazole|rabeprazole|mesh-list
55941443|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55941444|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941446|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55941447|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55941448|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941449|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941452|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55941453|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55941454|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55941455|NCT01268553|Treprostinil|treprostinil|mesh-list
55941456|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55941457|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
55941458|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55941459|NCT01922921|Trastuzumab|trastuzumab|mesh-list
55941460|NCT01922921|Pertuzumab|pertuzumab|mesh-list
55941461|NCT01922921|Antibodies|antibodies|mesh-list
55941462|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
55941463|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55941464|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
55941465|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941466|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941467|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55941468|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55941469|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
55941470|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941471|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
55941472|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55941473|NCT01922921|Protective Agents|protective agents|mesh-ancestor
55941474|NCT01922999|Melatonin|melatonin|mesh-list
55941475|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
55941476|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941477|NCT01922999|Protective Agents|protective agents|mesh-ancestor
55941478|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941479|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941480|NCT01268943|Capecitabine|capecitabine|mesh-list
55941481|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55941482|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
55941483|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941484|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941485|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55941487|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55941488|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55941489|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
55941490|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941491|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55941492|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55941493|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941494|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
55941495|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55941496|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55941497|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55941498|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743621|NCT02515201|Calcium heparin|calcium heparin|mesh-list
55941499|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941500|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
55941501|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941502|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256605|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56256606|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256607|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256608|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
56256609|NCT01910090|Famotidine|famotidine|mesh-list
56256610|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56256611|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55941503|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55941504|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941505|NCT01297335|Clonidine|clonidine|mesh-list
55941506|NCT01297335|Analgesics|analgesics|mesh-ancestor
55941507|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
55941508|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941509|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941510|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55941511|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
55941512|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
55941513|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55941514|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55999832|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999833|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999834|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866742|NCT00909064|PENTA|penta|mesh-list
55941515|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55941516|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
55941517|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941518|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941519|NCT05498129|Micronutrients|micronutrients|mesh-list
55941520|NCT05498129|Trace Elements|trace elements|mesh-list
55941521|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941522|NCT01270659|Acetaminophen|acetaminophen|mesh-list
55941527|NCT01270659|Narcotics|narcotics|mesh-ancestor
55941528|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941529|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941530|NCT01270659|Analgesics|analgesics|mesh-ancestor
55941531|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
55941532|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941533|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55941534|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55941535|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
55941536|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
55941537|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55941538|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
55941539|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55941540|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55941541|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55941542|NCT01271907|Aldesleukin|aldesleukin|mesh-list
55941543|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
55941544|NCT01271907|Fludarabine|fludarabine|mesh-list
55941545|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941546|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
55941547|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941548|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55941549|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55941550|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
55941551|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941552|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941553|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55941554|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55941555|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55941556|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
55941557|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941558|NCT01929941|Gemcitabine|gemcitabine|mesh-list
55941559|NCT01929941|Paclitaxel|paclitaxel|mesh-list
55941560|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55941561|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941562|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
55941563|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
56256616|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256617|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256618|NCT01910090|Analgesics|analgesics|mesh-ancestor
55941564|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
55941565|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941566|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55941567|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
55941568|NCT01929941|Antiviral Agents|antiviral agents|mesh-ancestor
55941569|NCT01929941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941570|NCT01929941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941571|NCT01929941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941572|NCT01929941|Immunologic Factors|immunologic factors|mesh-ancestor
55941573|NCT01929941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941575|NCT01920737|Cytarabine|cytarabine|mesh-list
55941576|NCT01920737|Dexamethasone|dexamethasone|mesh-list
55941577|NCT01920737|Prednisone|prednisone|mesh-list
55941578|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
55941579|NCT01920737|Methotrexate|methotrexate|mesh-list
55941580|NCT01920737|Vincristine|vincristine|mesh-list
55941581|NCT01920737|Daunorubicin|daunorubicin|mesh-list
55941582|NCT01920737|Asparaginase|asparaginase|mesh-list
55941583|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
55941584|NCT01920737|Pegaspargase|pegaspargase|mesh-list
55941585|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941586|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
55941587|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941588|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999835|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
55999836|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999837|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941589|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55941590|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
55941591|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941592|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941593|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55941594|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55941595|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
55941596|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
55941597|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941612|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
55941613|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941614|NCT01920737|Antidotes|antidotes|mesh-ancestor
55941615|NCT01920737|Protective Agents|protective agents|mesh-ancestor
55941616|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
55941617|NCT01920737|Vitamins|vitamins|mesh-ancestor
55941618|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
55941619|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55941620|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
55941621|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
55941622|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
55941623|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55941624|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55941625|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55941626|NCT01922843|Calcitriol|calcitriol|mesh-list
55941627|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55941628|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941629|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55941630|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55941631|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941632|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55941633|NCT01922843|Vitamins|vitamins|mesh-ancestor
55941634|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
55941635|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55941637|NCT01302483|Phenylephrine|phenylephrine|mesh-list
55941638|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
55868183|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55941639|NCT01302483|Tetracaine|tetracaine|mesh-list
55941640|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
55941641|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
55941642|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941643|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941644|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
55941645|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941646|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55941647|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55941648|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55941649|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55941650|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941651|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55941652|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55941653|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
55941654|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941655|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
55941656|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
55941657|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
55941676|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55941677|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941678|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941679|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941680|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55941681|NCT01304589|Analgesics|analgesics|mesh-ancestor
55941682|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
55941683|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941684|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
55941685|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55941686|NCT01280409|Metformin|metformin|mesh-list
55941687|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55999839|NCT02549716|Acetaminophen|acetaminophen|mesh-list
55999840|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55999841|NCT02549716|Analgesics|analgesics|mesh-ancestor
55789098|NCT04926155|Metformin|metformin|mesh-list
55941688|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941689|NCT01926197|Leucovorin|leucovorin|mesh-list
55941690|NCT01926197|Fluorouracil|fluorouracil|mesh-list
55941691|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
55941692|NCT01926197|Irinotecan|irinotecan|mesh-list
55941693|NCT01926197|Camptothecin|camptothecin|mesh-list
55941694|NCT01926197|Antimetabolites|antimetabolites|mesh-ancestor
55941695|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941696|NCT01926197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55941697|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941698|NCT01926197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941699|NCT01926197|Immunologic Factors|immunologic factors|mesh-ancestor
55941700|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941701|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55743639|NCT02504359|Cytarabine|cytarabine|mesh-list
55941702|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55941703|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941705|NCT01926197|Protective Agents|protective agents|mesh-ancestor
55941706|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
55941707|NCT01926197|Vitamins|vitamins|mesh-ancestor
55941708|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
55941709|NCT01926197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55941710|NCT01923545|Lenograstim|lenograstim|mesh-list
55941711|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55941712|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
55941713|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941714|NCT01925027|Sirolimus|sirolimus|mesh-list
55941715|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55941716|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941719|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
55941720|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941721|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
55749357|NCT03249025|Lidocaine|lidocaine|mesh-list
55941722|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941724|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55941725|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
55941726|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
55941727|NCT01305213|Antibodies|antibodies|mesh-list
55941728|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
55941729|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55941730|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
55941731|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941732|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55941733|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55941734|NCT01305213|Growth Substances|growth substances|mesh-ancestor
55941735|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941736|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
55941737|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
55941738|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55941739|NCT00989963|Beraprost|beraprost|mesh-list
55941740|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55941741|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
55941742|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55941743|NCT01339299|Hormones|hormones|mesh-list
55941744|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941745|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941746|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55941747|NCT01307007|Dextrans|dextrans|mesh-list
55941748|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
55941749|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
55941750|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
55941751|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
55941752|NCT01307007|Hematinics|hematinics|mesh-ancestor
55941753|NCT02197455|Tofacitinib|tofacitinib|mesh-list
55941754|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55941755|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941756|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941757|NCT03101501|Mitomycins|mitomycins|mesh-list
55941758|NCT03101501|Mitomycin|mitomycin|mesh-list
55941759|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55941760|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941761|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
55999842|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
55999843|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999844|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941762|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941763|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55941764|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941766|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
55941767|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
55941768|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55941769|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941770|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
55941771|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941772|NCT01923857|Enclomiphene|enclomiphene|mesh-list
55941773|NCT01923857|Clomiphene|clomiphene|mesh-list
55941774|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
55941775|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55941776|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
55941777|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941778|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941779|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55941780|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
55941781|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55941782|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56256619|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
56256620|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748406|NCT04521491|Protective Agents|protective agents|mesh-ancestor
55748407|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
55748409|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
55748410|NCT04509635|Cetuximab|cetuximab|mesh-list
55748411|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55748412|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748413|NCT04444817|Tacrolimus|tacrolimus|mesh-list
55844254|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
55844255|NCT00084838|Vitamins|vitamins|mesh-ancestor
55844256|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
55941783|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55941784|NCT03100253|Adalimumab|adalimumab|mesh-list
55941785|NCT03100253|Etanercept|etanercept|mesh-list
55941786|NCT03100253|Golimumab|golimumab|mesh-list
55941787|NCT03100253|Infliximab|infliximab|mesh-list
55941788|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
55941789|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55941790|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55941791|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
55941794|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55941795|NCT03100253|Analgesics|analgesics|mesh-ancestor
55941796|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
55941797|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941798|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941799|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941800|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
55941801|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55941803|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55941804|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55941805|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
55941806|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941807|NCT03485729|TIC10 compound|tic10 compound|mesh-list
55941808|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941809|NCT01924325|Aspirin|aspirin|mesh-list
55941810|NCT01924325|Apixaban|apixaban|mesh-list
55941811|NCT01924325|Clopidogrel|clopidogrel|mesh-list
55941812|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55941813|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55941814|NCT01924325|Analgesics|analgesics|mesh-ancestor
55941815|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
55941816|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941817|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941818|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55941819|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55941820|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55941821|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55941822|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941823|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55941824|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55941825|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941826|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
55941827|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55941828|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55941829|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55941830|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
55941831|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941832|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55941833|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
55941834|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55999845|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
55999846|NCT01207726|Azacitidine|azacitidine|mesh-list
55941835|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
55941836|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
55941837|NCT01924481|Theobromine|theobromine|mesh-list
55941838|NCT01924481|Caffeine|caffeine|mesh-list
55941839|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55941840|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941841|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55941842|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941843|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941844|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55941845|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56256621|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56256622|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56256623|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256624|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256626|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941846|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
55941847|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941848|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55941849|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
55941850|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941851|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55941852|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
55941853|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
55941854|NCT01924637|Insulin|insulin|mesh-list
55941855|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55941856|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
55941857|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
55941858|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55941859|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55941860|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941861|NCT01925729|Phenylephrine|phenylephrine|mesh-list
55941862|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
55941863|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
55941864|NCT01925729|Ephedrine|ephedrine|mesh-list
55941865|NCT01925729|Histamine|histamine|mesh-list
55941873|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55941874|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55941875|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
55941876|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
55941877|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941878|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941879|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55941880|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55941881|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55941882|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
55941883|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55941884|NCT01925729|Protective Agents|protective agents|mesh-ancestor
55941885|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
55941886|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
55941887|NCT01926587|Azacitidine|azacitidine|mesh-list
55941888|NCT01926587|ON 01910|on 01910|mesh-list
55941889|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55941890|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
55941891|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941892|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941893|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941894|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55941895|NCT01926665|Dexamethasone|dexamethasone|mesh-list
55941896|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55941897|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
55941898|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
55941899|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941900|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941901|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55941902|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
55941903|NCT01926665|Hormones|hormones|mesh-ancestor
55941904|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941905|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55941906|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941907|NCT01926821|Sizofiran|sizofiran|mesh-list
55941908|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55941909|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
55941910|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941911|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55941912|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941913|NCT01926899|Bortezomib|bortezomib|mesh-list
55941914|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999847|NCT01207726|Entinostat|entinostat|mesh-list
55789102|NCT05301517|Hematinics|hematinics|mesh-ancestor
55941915|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55941916|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55941917|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941918|NCT04395365|Renal Agents|renal agents|mesh-ancestor
55941919|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55941922|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55941923|NCT03430661|Clopidogrel|clopidogrel|mesh-list
55941924|NCT03430661|Ticagrelor|ticagrelor|mesh-list
55941925|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55941926|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55941927|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55941928|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55941929|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55941930|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
55941931|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941932|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941933|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941935|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
55941936|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941937|NCT01927913|Deferasirox|deferasirox|mesh-list
55941938|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55941939|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
55941940|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
55941941|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941942|NCT01928069|Montelukast|montelukast|mesh-list
55941943|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55941944|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
55941945|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55941946|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
55941947|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941948|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941949|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55941950|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55941951|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941952|NCT01928459|Infigratinib|infigratinib|mesh-list
55941953|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941954|NCT01928537|ON 01910|on 01910|mesh-list
55941955|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941956|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55941957|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941958|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941959|NCT01307397|Vemurafenib|vemurafenib|mesh-list
55941960|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941961|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55941962|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941963|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941964|NCT01929161|Oxytocin|oxytocin|mesh-list
55941965|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
55941966|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55941967|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941968|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
55941969|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941970|NCT04552535|Afatinib|afatinib|mesh-list
55941971|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941972|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55941973|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941974|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941975|NCT02197767|Rituximab|rituximab|mesh-list
55868632|NCT03401476|Analgesics|analgesics|mesh-ancestor
55868633|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
55868634|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941976|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55941977|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941978|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
55941979|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941980|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55941981|NCT01342029|Ranolazine|ranolazine|mesh-list
55941982|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55941983|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55999848|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55999849|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55999850|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
55941984|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941985|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55941986|NCT05601479|Acetylcarnitine|acetylcarnitine|mesh-list
55941987|NCT05601479|Vitamin B Complex|vitamin b complex|mesh-ancestor
55941988|NCT05601479|Vitamins|vitamins|mesh-ancestor
55941990|NCT05601479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941991|NCT05601479|Nootropic Agents|nootropic agents|mesh-ancestor
55941992|NCT04275245|Meplazumab|meplazumab|mesh-list
55941993|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
55941994|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941995|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
55941996|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
55941997|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941998|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55941999|NCT04394897|Remifentanil|remifentanil|mesh-list
55942000|NCT04394897|Propofol|propofol|mesh-list
55942002|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942003|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942004|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55942005|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
55942006|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
55942007|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55942016|NCT05607641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55942018|NCT05607641|Sensory System Agents|sensory system agents|mesh-ancestor
55942019|NCT05607641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942020|NCT05607641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942021|NCT05607641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942022|NCT05607641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942023|NCT05607641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55942024|NCT05607641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942025|NCT05607641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942026|NCT05607017|Losartan|losartan|mesh-list
55942027|NCT05607017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55942028|NCT05607017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55942029|NCT05607017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55942030|NCT05607017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55942031|NCT05607017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942032|NCT05603039|Bevacizumab|bevacizumab|mesh-list
55942033|NCT05603039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942034|NCT05603039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942035|NCT05603039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55942036|NCT05603039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55942037|NCT05603039|Growth Substances|growth substances|mesh-ancestor
55942038|NCT05603039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942039|NCT05603039|Growth Inhibitors|growth inhibitors|mesh-ancestor
55942040|NCT05609903|Paclitaxel|paclitaxel|mesh-list
55942041|NCT05609903|Atezolizumab|atezolizumab|mesh-list
55942042|NCT05609903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55942043|NCT05609903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942044|NCT05609903|Tubulin Modulators|tubulin modulators|mesh-ancestor
55942045|NCT05609903|Antimitotic Agents|antimitotic agents|mesh-ancestor
55942046|NCT05609903|Mitosis Modulators|mitosis modulators|mesh-ancestor
55942047|NCT05609903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942048|NCT03045029|Treprostinil|treprostinil|mesh-list
55942049|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55942050|NCT04161599|Metronidazole|metronidazole|mesh-list
55942051|NCT04161599|Cefuroxime|cefuroxime|mesh-list
55942052|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
55942053|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
55942054|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
55942055|NCT04161599|Citric Acid|citric acid|mesh-list
55942056|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
55942057|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942058|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55942059|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55942060|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55942061|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
55942062|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55942063|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
55999851|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999852|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942064|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
55942065|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942067|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55942068|NCT04161599|Antacids|antacids|mesh-ancestor
55942069|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55942070|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55942071|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942072|NCT05608499|Clobetasol|clobetasol|mesh-list
55942073|NCT05608499|Halobetasol|halobetasol|mesh-list
55942074|NCT05608499|Tazarotene|tazarotene|mesh-list
55942075|NCT05608499|Dermatologic Agents|dermatologic agents|mesh-ancestor
55942076|NCT05608499|Keratolytic Agents|keratolytic agents|mesh-ancestor
55942099|NCT05605613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942101|NCT05602259|Dimercaprol|dimercaprol|mesh-list
55942102|NCT05602259|Chelating Agents|chelating agents|mesh-ancestor
55942103|NCT05602259|Sequestering Agents|sequestering agents|mesh-ancestor
55942104|NCT05602259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942105|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
55942106|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942107|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942108|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
55942109|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
55942110|NCT03032783|Tacrolimus|tacrolimus|mesh-list
55942111|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942112|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
55942113|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942114|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942115|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55942116|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
55942117|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942118|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942119|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55942120|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55942121|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942122|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55942123|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55942124|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
55942125|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55942126|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942140|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
55942141|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55942142|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55942143|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
55942144|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256630|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
56256631|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256632|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56256633|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56256634|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55942145|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
55942146|NCT04120363|Testosterone|testosterone|mesh-list
55942147|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
55942148|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
55942149|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55942150|NCT04120363|Androgens|androgens|mesh-ancestor
55942152|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942153|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942154|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55942155|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942156|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
55942157|NCT02981173|Psilocybin|psilocybin|mesh-list
55942158|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
55942159|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942160|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55942161|NCT04125745|CXA-10|cxa-10|mesh-list
55942162|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942163|NCT04393805|Heparin|heparin|mesh-list
55942164|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55942165|NCT04393805|Tinzaparin|tinzaparin|mesh-list
55942166|NCT04393805|Dalteparin|dalteparin|mesh-list
55942167|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
55942168|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55942169|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55942170|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942171|NCT04122755|Buprenorphine|buprenorphine|mesh-list
55942172|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55999853|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999854|NCT02534038|Quinidine|quinidine|mesh-list
55999855|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
55999856|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
55999857|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
55999858|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55999859|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55999860|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789108|NCT04909775|Antiviral Agents|antiviral agents|mesh-ancestor
55942173|NCT04122755|Narcotics|narcotics|mesh-ancestor
55942174|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942175|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942176|NCT04122755|Analgesics|analgesics|mesh-ancestor
55942177|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
55942178|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942179|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55942180|NCT04129697|Dexamethasone|dexamethasone|mesh-list
55942181|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
55942182|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55942183|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55942184|NCT04129697|Prednisolone|prednisolone|mesh-list
55942185|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
55942186|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55942187|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
55942188|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942189|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
55942190|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
55942210|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942211|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
55942212|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942214|NCT02760667|Carboplatin|carboplatin|mesh-list
55942215|NCT02760667|Docetaxel|docetaxel|mesh-list
55942216|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942217|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
55942218|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
56256635|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256636|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
56256637|NCT01910142|Coagulants|coagulants|mesh-ancestor
55942219|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
55942220|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942221|NCT04127357|Fluorides|fluorides|mesh-list
55942222|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
55942223|NCT04127357|Protective Agents|protective agents|mesh-ancestor
55942224|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942225|NCT02713945|Simvastatin|simvastatin|mesh-list
55942226|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55942227|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55942228|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
55942229|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942230|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55942231|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55942232|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942233|NCT01450111|Lacosamide|lacosamide|mesh-list
55942234|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
55942235|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55942236|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55942237|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55942238|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942239|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55942240|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55942241|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942242|NCT02697253|Incretins|incretins|mesh-ancestor
55942243|NCT02697253|Hormones|hormones|mesh-ancestor
55942244|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942246|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
55942247|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942248|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942249|NCT02660905|Tenofovir|tenofovir|mesh-list
55999861|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867620|NCT03408574|Mecamylamine|mecamylamine|mesh-list
55942250|NCT02660905|Emtricitabine|emtricitabine|mesh-list
55942252|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55942253|NCT02660905|Rilpivirine|rilpivirine|mesh-list
55942254|NCT02660905|Ledipasvir|ledipasvir|mesh-list
55942255|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
55942256|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942257|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55942258|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55942259|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942260|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942261|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55942262|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55942263|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55942264|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55942265|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942266|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942267|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55942268|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
55942269|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871496|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869015|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
55942270|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942271|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
55942272|NCT03825289|Trametinib|trametinib|mesh-list
55942273|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
55942274|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55942275|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55942276|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942277|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942278|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942279|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942280|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942281|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55942282|NCT01450345|Pregabalin|pregabalin|mesh-list
55942283|NCT01450345|Analgesics|analgesics|mesh-ancestor
55942284|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
55942285|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942286|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942287|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
55942288|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55942289|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55942290|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942291|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55942292|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55942293|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55942294|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942295|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55942297|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55942298|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55942299|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55942300|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55942301|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
55942302|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55942303|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942304|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942305|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55942306|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55942307|NCT01647828|Gemcitabine|gemcitabine|mesh-list
55942308|NCT01647828|Paclitaxel|paclitaxel|mesh-list
55942309|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55942310|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942311|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
55942312|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
55942313|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
55942314|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942315|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55942316|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
55942330|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
55942331|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942332|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
55942333|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55999862|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999863|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55999864|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55999865|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
55999866|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55999867|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
55942334|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56256649|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56256650|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256651|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56256652|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256653|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56256654|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55942335|NCT04273321|Prednisolone|prednisolone|mesh-list
55942336|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
55942337|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55942338|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
55942339|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942340|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
55942341|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
55942342|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942343|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942344|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55942345|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
55942346|NCT04273321|Hormones|hormones|mesh-ancestor
55942347|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942348|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55942349|NCT04273321|Protective Agents|protective agents|mesh-ancestor
55820848|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55942351|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942352|NCT02654119|Paclitaxel|paclitaxel|mesh-list
55942353|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
55942354|NCT02654119|Trastuzumab|trastuzumab|mesh-list
55942355|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55942356|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55942357|NCT02654119|Antibodies|antibodies|mesh-list
55942358|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
55942359|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55942360|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55942361|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942362|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
55942363|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
55942364|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
55942365|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942366|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942367|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
55942368|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942369|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942370|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55942371|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
55942372|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55942373|NCT01243476|Lenalidomide|lenalidomide|mesh-list
55942374|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
55942375|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942376|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55942377|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55942378|NCT01243476|Growth Substances|growth substances|mesh-ancestor
55942381|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
55942382|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55942383|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55942384|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
55942385|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942386|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55942387|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55942388|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942389|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942390|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
56256655|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256656|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256657|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56256658|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56256660|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56256661|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256662|NCT01910246|Metformin|metformin|mesh-list
56256663|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55869143|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942391|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942392|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942393|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
55942394|NCT01454011|Testosterone|testosterone|mesh-list
55942395|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
55942396|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
55942397|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55999868|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55999869|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55999870|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999871|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999872|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55942398|NCT01454011|Androgens|androgens|mesh-ancestor
55942399|NCT01454011|Hormones|hormones|mesh-ancestor
55942400|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942401|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942402|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55942403|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942404|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
55942405|NCT03060018|Oxitropium|oxitropium|mesh-list
55942406|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
55942407|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
55942408|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942409|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942410|NCT04976088|Diclofenac|diclofenac|mesh-list
55942411|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
55942412|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55942413|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55942414|NCT04976088|Analgesics|analgesics|mesh-ancestor
55942415|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
55942416|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942417|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942418|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942419|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942420|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55942421|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942422|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942423|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
55942424|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55942426|NCT04975932|Hormones|hormones|mesh-ancestor
55942427|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942428|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942429|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55942430|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942431|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
55942432|NCT04968132|Narcotics|narcotics|mesh-ancestor
55942433|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942434|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942435|NCT04968132|Analgesics|analgesics|mesh-ancestor
55942436|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
55942437|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942438|NCT03829111|Nivolumab|nivolumab|mesh-list
55942439|NCT03829111|Ipilimumab|ipilimumab|mesh-list
55942440|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942441|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942442|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55942443|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942444|NCT01454479|Lapatinib|lapatinib|mesh-list
55942445|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942446|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55942447|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942448|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942449|NCT03061032|Ribavirin|ribavirin|mesh-list
55942450|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
55942451|NCT03061032|Ledipasvir|ledipasvir|mesh-list
55942453|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942454|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
55942455|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942456|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
55942457|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55942458|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55942459|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942460|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
55942461|NCT02911831|Coagulants|coagulants|mesh-ancestor
55942462|NCT03061734|Acetaminophen|acetaminophen|mesh-list
55942463|NCT03061734|Naltrexone|naltrexone|mesh-list
55942464|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55999873|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55942465|NCT03061734|Analgesics|analgesics|mesh-ancestor
55942466|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
55942467|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942468|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942469|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
55942470|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55942471|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55942472|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
55942473|NCT03061656|Melphalan|melphalan|mesh-list
55942474|NCT03061656|Thiotepa|thiotepa|mesh-list
55942475|NCT03061656|Carboplatin|carboplatin|mesh-list
55942476|NCT03061656|Etoposide|etoposide|mesh-list
55942477|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942478|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
55942479|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942480|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942481|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55942482|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
55942483|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942484|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942485|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55942486|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55942487|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55942488|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55942489|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942490|NCT02906761|Aspirin|aspirin|mesh-list
55942491|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55942492|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55942493|NCT02906761|Analgesics|analgesics|mesh-ancestor
55942494|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
55942495|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942496|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942497|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942498|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942499|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55942500|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55942501|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256664|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256666|NCT01910259|Riluzole|riluzole|mesh-list
56256667|NCT01910259|Fluoxetine|fluoxetine|mesh-list
56256668|NCT01910259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56256669|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56256670|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55942502|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55942503|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55942504|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942505|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
55942506|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
55942508|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55942509|NCT02905591|Carboplatin|carboplatin|mesh-list
55942510|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55942511|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942512|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
55942513|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
55942514|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
55942515|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942516|NCT02905591|Vitamins|vitamins|mesh-ancestor
55942517|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
55942518|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942519|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
55942520|NCT02905591|Protective Agents|protective agents|mesh-ancestor
55942521|NCT01455025|Plerixafor|plerixafor|mesh-list
55942522|NCT01455025|Lenograstim|lenograstim|mesh-list
55942523|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55942524|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
55942525|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942526|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55942527|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55942537|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55942538|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55942539|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55942540|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
55942541|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
55942542|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942544|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
55942545|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55942546|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55942547|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55999874|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
55999875|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55942548|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942549|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55942550|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55942551|NCT01455103|BMS-936559|bms-936559|mesh-list
55942552|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55942553|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942554|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942555|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
55942556|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942557|NCT04975074|Iron|iron|mesh-list
55942558|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
55942559|NCT04975074|Trace Elements|trace elements|mesh-ancestor
55942560|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
55942561|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942562|NCT04975074|Hematinics|hematinics|mesh-ancestor
55942563|NCT04963998|Copper|copper|mesh-list
55942564|NCT04963998|Trace Elements|trace elements|mesh-ancestor
55942565|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
55942566|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942567|NCT03148327|Durvalumab|durvalumab|mesh-list
55942568|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942569|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942570|NCT01451905|Liraglutide|liraglutide|mesh-list
55942581|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942582|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
55942583|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942584|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942585|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942586|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
55942587|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942588|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
55942589|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942590|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942591|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55942592|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
55942593|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942594|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55942595|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55942610|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
55942611|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55942612|NCT01455883|Incretins|incretins|mesh-ancestor
55942613|NCT01455883|Hormones|hormones|mesh-ancestor
55942614|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942615|NCT01452217|Secretin|secretin|mesh-list
55942616|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55942617|NCT01452217|Hormones|hormones|mesh-ancestor
55942618|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942619|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942620|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
55942621|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55942622|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942623|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942624|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55942625|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
55942626|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942628|NCT04954560|Eprosartan|eprosartan|mesh-list
55942629|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55942630|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55942631|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55942632|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55999876|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55999877|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55999878|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55942633|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942634|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
55942650|NCT04962672|Anesthetics|anesthetics|mesh-list
55942651|NCT04962672|Propofol|propofol|mesh-list
55942652|NCT04962672|Sevoflurane|sevoflurane|mesh-list
55942653|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942654|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942655|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55942656|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55942667|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55942668|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942669|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942670|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
55942671|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942672|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942673|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942674|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55942675|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
55942676|NCT02541955|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55942678|NCT02541955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942679|NCT02541955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942680|NCT01452685|Leuprolide|leuprolide|mesh-list
55942681|NCT01452685|Relugolix|relugolix|mesh-list
55942682|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55942683|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
55942684|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55942685|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942686|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55942687|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942688|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
55942689|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
55942690|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942691|NCT01452763|Lansoprazole|lansoprazole|mesh-list
55942692|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
55942693|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55942694|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55942695|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55942696|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942697|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942699|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942700|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942701|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55942702|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55942703|NCT04954014|Growth Substances|growth substances|mesh-ancestor
55942704|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942705|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
55942706|NCT00988559|Imiquimod|imiquimod|mesh-list
55942707|NCT00988559|Vaccines|vaccines|mesh-list
55942708|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
55942709|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942710|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55999879|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55999880|NCT01202110|Propranolol|propranolol|mesh-list
55942711|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942712|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
55942713|NCT03059862|Tryptophan|tryptophan|mesh-list
55942714|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55942715|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
55942716|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55942717|NCT02967289|Irinotecan|irinotecan|mesh-list
55942718|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55942719|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55942720|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942730|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55942731|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942732|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
55942733|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
55942734|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
55942735|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942736|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942737|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55942739|NCT04961970|Gemcitabine|gemcitabine|mesh-list
55942740|NCT04961970|Fluorouracil|fluorouracil|mesh-list
55942741|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
55942742|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942743|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55942744|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
55942745|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942746|NCT04961970|Antiviral Agents|antiviral agents|mesh-ancestor
55942747|NCT04961970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942748|NCT04961970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942749|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942750|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
56256689|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55831891|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256690|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55942751|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942752|NCT04961970|Antidotes|antidotes|mesh-ancestor
55942753|NCT04961970|Protective Agents|protective agents|mesh-ancestor
55942754|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
55942755|NCT04961970|Vitamins|vitamins|mesh-ancestor
55942756|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
55942757|NCT01311687|Dexamethasone|dexamethasone|mesh-list
55942758|NCT01311687|Pomalidomide|pomalidomide|mesh-list
55942759|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942760|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
55942761|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
55942762|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942763|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942764|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55942765|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
55942766|NCT01311687|Hormones|hormones|mesh-ancestor
55942767|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942768|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55942769|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942770|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
55942771|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55942772|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55942773|NCT01311687|Growth Substances|growth substances|mesh-ancestor
55942774|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
55942775|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
55942776|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55942777|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
55942778|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942779|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
55942780|NCT00988091|Protective Agents|protective agents|mesh-ancestor
55942781|NCT04965324|Anesthetics|anesthetics|mesh-list
55942782|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942783|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942784|NCT02965027|Prazosin|prazosin|mesh-list
55942785|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55942786|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55942799|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942800|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942801|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
55942802|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55942803|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942804|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999881|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55999882|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55999883|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
55999884|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999885|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999886|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999887|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55999888|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55942805|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55942806|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942807|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942808|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55942809|NCT04961268|Narcotics|narcotics|mesh-ancestor
55942810|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942811|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55942812|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
55942813|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942814|NCT01346397|Cyclosporine|cyclosporine|mesh-list
55942816|NCT01346397|Cyclosporins|cyclosporins|mesh-list
55942817|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942818|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
55942821|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942822|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942823|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
56256692|NCT01910285|Sufentanil|sufentanil|mesh-list
55942824|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942825|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
55942826|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942827|NCT01347255|Betamethasone|betamethasone|mesh-list
55942828|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
55942829|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55942830|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
55942831|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55942832|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942833|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
55942834|NCT01347255|Hormones|hormones|mesh-ancestor
55942835|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942836|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942837|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55942838|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
55942839|NCT02908477|Docetaxel|docetaxel|mesh-list
55942840|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942841|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
55942842|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
55942843|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
55942844|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942845|NCT04392427|Ribavirin|ribavirin|mesh-list
55942846|NCT04392427|Ivermectin|ivermectin|mesh-list
55942847|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
55942848|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
55942849|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942850|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
55942879|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55942881|NCT01455337|Protective Agents|protective agents|mesh-ancestor
55942882|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55942883|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942884|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942885|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55942886|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55942887|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
55942888|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55942889|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
55942890|NCT03059316|Labetalol|labetalol|mesh-list
55942891|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
55942892|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
55999889|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
55999891|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55942893|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55942894|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55942895|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
55942896|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55942904|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55942905|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
55942906|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55942907|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
55942908|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942909|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55942910|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
55942911|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942912|NCT04943952|Asparaginase|asparaginase|mesh-list
55942913|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942914|NCT04410978|Teriflunomide|teriflunomide|mesh-list
55749397|NCT03245671|BB 1101|bb 1101|mesh-list
55869816|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748449|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
55748450|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55748451|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748452|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55748454|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748455|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748456|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
55748457|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748458|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55748459|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55748460|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
55748461|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748462|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55748463|NCT03268525|Bupivacaine|bupivacaine|mesh-list
55748464|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
55942915|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55942916|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55942917|NCT04410978|Analgesics|analgesics|mesh-ancestor
55942918|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
55942919|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942920|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942921|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942922|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942923|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942924|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
55942925|NCT01352637|Cycloserine|cycloserine|mesh-list
55942926|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55942927|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942929|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55942930|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
55942931|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55942932|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
55942933|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942934|NCT03058536|Progesterone|progesterone|mesh-list
55942935|NCT03058536|Progestins|progestins|mesh-ancestor
55942936|NCT03058536|Hormones|hormones|mesh-ancestor
55942937|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942938|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144601|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144602|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56144603|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144604|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
56144605|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
56144606|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144607|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
56144608|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56144609|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
56144610|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56144611|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
56144612|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144613|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144614|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56144615|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
56144616|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56144617|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56144618|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56144619|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
56144620|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144621|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144622|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
56144635|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144636|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56144638|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144639|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144640|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
56144641|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999892|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
55999893|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55999894|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
55999895|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
56144642|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56144643|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144644|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
56144645|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56144646|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56144647|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56144648|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56144649|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144650|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56144651|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
56144652|NCT00803400|Alprazolam|alprazolam|mesh-list
56144653|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56144654|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144655|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144656|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55942939|NCT01314417|Methotrexate|methotrexate|mesh-list
55942940|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55942941|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
55942942|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55942943|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942944|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55942945|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
55942946|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942947|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942948|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
55942949|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942950|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55942951|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942952|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
55942953|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942954|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55942955|NCT01457911|Metformin|metformin|mesh-list
55942956|NCT01457911|Glimepiride|glimepiride|mesh-list
55942957|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55942958|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942959|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55942960|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942961|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
55942962|NCT02893423|Ropivacaine|ropivacaine|mesh-list
55942963|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
55942964|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
55942965|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942966|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942967|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
55942968|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942970|NCT05586919|Polidocanol|polidocanol|mesh-list
55942971|NCT05586919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55942972|NCT05586919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942973|NCT05586919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942974|NCT05586919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942975|NCT05586919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55942976|NCT05586919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55942977|NCT01890889|Ezetimibe|ezetimibe|mesh-list
55942978|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55942979|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55942980|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
55942981|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942982|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55942983|NCT04951752|Ropivacaine|ropivacaine|mesh-list
55942984|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
55942985|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
55942986|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942987|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942988|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
55942989|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942990|NCT01315665|Sulforaphane|sulforaphane|mesh-list
55999896|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55999897|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942991|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55942992|NCT01315665|Protective Agents|protective agents|mesh-ancestor
55942993|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942994|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942995|NCT01454089|Gemcitabine|gemcitabine|mesh-list
55942996|NCT01454089|Carboplatin|carboplatin|mesh-list
55942997|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942998|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55942999|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
55943000|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943001|NCT01454089|Antiviral Agents|antiviral agents|mesh-ancestor
55943002|NCT01454089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943003|NCT01454089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943004|NCT01454089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943005|NCT01454089|Immunologic Factors|immunologic factors|mesh-ancestor
55943006|NCT01454089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943007|NCT01457989|Ezogabine|ezogabine|mesh-list
55943008|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
55943009|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943010|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943011|NCT01458067|GSK2636771|gsk2636771|mesh-list
55943012|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943013|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55943014|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943015|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943016|NCT04942860|Methotrexate|methotrexate|mesh-list
55943017|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55943018|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
55943019|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55943020|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943021|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55943022|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
55802811|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
55943023|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943024|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943025|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
55943026|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943027|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55943028|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943029|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
55943030|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55943031|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55943032|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55943033|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55943034|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943035|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
55943036|NCT04959786|Ribavirin|ribavirin|mesh-list
55943037|NCT04959786|Ivermectin|ivermectin|mesh-list
55943038|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
55943039|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
55943040|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943041|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
55943058|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943059|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
55943060|NCT04951128|Coagulants|coagulants|mesh-ancestor
55943061|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
55943062|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943063|NCT01458301|Leuprolide|leuprolide|mesh-list
55943064|NCT01458301|Relugolix|relugolix|mesh-list
55943065|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55943066|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
55943067|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55943068|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943069|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55943070|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943071|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
55943072|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
55943073|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55943074|NCT03059238|Celecoxib|celecoxib|mesh-list
55943075|NCT03059238|Parecoxib|parecoxib|mesh-list
55871497|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55870033|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943076|NCT03059238|Oxycodone|oxycodone|mesh-list
55943077|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55868730|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868739|NCT03840915|Paclitaxel|paclitaxel|mesh-list
55943078|NCT03059238|Narcotics|narcotics|mesh-ancestor
55943079|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943080|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943081|NCT03059238|Analgesics|analgesics|mesh-ancestor
55943082|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
55943083|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943084|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55943085|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943086|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943087|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55943088|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55943089|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55943090|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943091|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943092|NCT01891201|Oxytocin|oxytocin|mesh-list
55943093|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
55943094|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55943095|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943096|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
55943097|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55943098|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55943099|NCT04942002|Prednisolone|prednisolone|mesh-list
55943100|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
55943101|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55943102|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
55943111|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55943112|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55943113|NCT04942002|Protective Agents|protective agents|mesh-ancestor
55943114|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55943115|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943116|NCT01891435|Acetaminophen|acetaminophen|mesh-list
55943117|NCT01891435|Diclofenac|diclofenac|mesh-list
55943118|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943119|NCT01891435|Analgesics|analgesics|mesh-ancestor
55943120|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
55943121|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943122|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943123|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
55943124|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55943125|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943126|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55943127|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55943128|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943129|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943130|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55943131|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55943132|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55943133|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
55943134|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256700|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
56256701|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256702|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56256703|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56256704|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
56256705|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
56256706|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
56256707|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56256708|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55943135|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943136|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55943137|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55943138|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
55943139|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943140|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55943141|NCT04941846|Nimodipine|nimodipine|mesh-list
55943142|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55943143|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55943144|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943145|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943146|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55943147|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943148|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
55943149|NCT01891513|Losartan|losartan|mesh-list
55943150|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55943151|NCT01891513|Perindopril|perindopril|mesh-list
55943152|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55943153|NCT01891513|Diuretics|diuretics|mesh-list
55943154|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
55999898|NCT02556918|Incretins|incretins|mesh-ancestor
55999899|NCT02556918|Hormones|hormones|mesh-ancestor
55999900|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999901|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55943155|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55943156|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55943157|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55943158|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55943159|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943160|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
55943161|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943162|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943163|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
55943164|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943166|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55943167|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55943168|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943169|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943181|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
55943182|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943184|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55943185|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55943186|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943187|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943188|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55943189|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55943190|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
55943191|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943192|NCT04948788|Gemcitabine|gemcitabine|mesh-list
55943193|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
55943194|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55943195|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
55802815|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943196|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943197|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943198|NCT04948788|Antiviral Agents|antiviral agents|mesh-ancestor
55943199|NCT04948788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943200|NCT04948788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943201|NCT04948788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943202|NCT04948788|Immunologic Factors|immunologic factors|mesh-ancestor
55870179|NCT03032536|Entecavir|entecavir|mesh-list
55748465|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
55748466|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748467|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748468|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
55748469|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748470|NCT02456935|Esomeprazole|esomeprazole|mesh-list
55748471|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55748472|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55748473|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55748474|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748475|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943203|NCT04948788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943204|NCT02865811|Doxorubicin|doxorubicin|mesh-list
55943205|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55943206|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
55943207|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55943208|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943209|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55943210|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55943211|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943212|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943213|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55943214|NCT03058224|Acetaminophen|acetaminophen|mesh-list
55943215|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943216|NCT03058224|Analgesics|analgesics|mesh-ancestor
55943217|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
55943218|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943219|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943220|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
55943221|NCT04957212|Carboplatin|carboplatin|mesh-list
55943223|NCT04957212|Trastuzumab|trastuzumab|mesh-list
55943224|NCT04957212|Pertuzumab|pertuzumab|mesh-list
55943225|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943226|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
55943227|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
55943228|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
55943229|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943230|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55943231|NCT02879617|Durvalumab|durvalumab|mesh-list
55943232|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55999902|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
55999903|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868950|NCT03721653|Antidotes|antidotes|mesh-ancestor
55943233|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943247|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
55943248|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55943249|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943250|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943251|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55943252|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55943253|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55943254|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
55943255|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943257|NCT02808871|Analgesics|analgesics|mesh-ancestor
55943258|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
55943259|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943260|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943261|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55943262|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943263|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943264|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55943265|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943266|NCT01892683|Propofol|propofol|mesh-list
55943267|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
55943268|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943269|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943270|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55943271|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55943272|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
55943273|NCT01459627|Ticagrelor|ticagrelor|mesh-list
55802819|NCT05700721|Niraparib|niraparib|mesh-list
55943274|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55943275|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55943276|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55943277|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55943278|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55943279|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
55943280|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943281|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943282|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943283|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
55943284|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
55943285|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55943286|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943287|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943288|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943289|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55943290|NCT04411836|Primaquine|primaquine|mesh-list
55943291|NCT04411836|Tafenoquine|tafenoquine|mesh-list
55943292|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
55943293|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55943294|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55943305|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943306|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943307|NCT04937946|Analgesics|analgesics|mesh-ancestor
55943308|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
55943309|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943310|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55943311|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55943312|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
55943313|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
55943314|NCT05160987|Midazolam|midazolam|mesh-list
55943315|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55943316|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55943317|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943318|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943319|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55943320|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55943321|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55943322|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55943323|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
55943324|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
55943325|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
55943326|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
55943327|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943328|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943329|NCT01892995|Ketamine|ketamine|mesh-list
55943330|NCT01892995|Analgesics|analgesics|mesh-ancestor
55943331|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
55943332|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943333|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943334|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55943335|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55943336|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
55943337|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
55943338|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943339|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55749427|NCT03245515|Branebrutinib|branebrutinib|mesh-list
55943340|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55943341|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943342|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943343|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
55943344|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55943345|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55943346|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55943347|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943348|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943349|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
55943350|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943351|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943352|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55943353|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943354|NCT02181075|Doxorubicin|doxorubicin|mesh-list
55943355|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55943356|NCT02181075|Liver Extracts|liver extracts|mesh-list
55943357|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55943358|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943359|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55943376|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55943377|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55943378|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943379|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943380|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55943381|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55943382|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55943383|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55943384|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
55943385|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
55943386|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
55943387|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
55943388|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943389|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943390|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55943391|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55943392|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943393|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55943394|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55943395|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
55943396|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55943397|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55943398|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55943399|NCT01361217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55943400|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55943401|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943402|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
55943403|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55943404|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
55943405|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55943406|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55943407|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
55943408|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
56256711|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256712|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
56256713|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256719|NCT01910415|Ivacaftor|ivacaftor|mesh-list
55943409|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55943410|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55943411|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55869137|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55869138|NCT03716739|Androgens|androgens|mesh-ancestor
55943412|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55943413|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
55943414|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55943415|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55943416|NCT04271839|Fluticasone|fluticasone|mesh-list
55943417|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
55743673|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
55943418|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943419|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55943431|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943432|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943433|NCT02869789|Nivolumab|nivolumab|mesh-list
55943434|NCT02869789|Ipilimumab|ipilimumab|mesh-list
55943435|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55943436|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943437|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55943438|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943439|NCT04945434|Methamphetamine|methamphetamine|mesh-list
55943440|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55943441|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943442|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
55943443|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
55943444|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943445|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
55943446|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943447|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943448|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
55943449|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55943450|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55943451|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943452|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55943453|NCT04411758|Propolis|propolis|mesh-list
55943454|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943455|NCT04408560|Acetaminophen|acetaminophen|mesh-list
55943456|NCT04408560|Analgesics|analgesics|mesh-list
55943457|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943458|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
55943459|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256726|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256727|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56256728|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
56256729|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56256730|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871498|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
55870437|NCT04402203|Favipiravir|favipiravir|mesh-list
55943460|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943461|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
55943462|NCT04844905|Ivermectin|ivermectin|mesh-list
55943463|NCT04844905|Piperaquine|piperaquine|mesh-list
55943464|NCT04844905|Artenimol|artenimol|mesh-list
55943465|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55943466|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943467|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
55943468|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55943469|NCT04418856|Methamphetamine|methamphetamine|mesh-list
55943470|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55943471|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943472|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
55943473|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
55943474|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943475|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
55943476|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943477|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943478|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
55943479|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55943480|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55943481|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943482|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55943484|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
55943485|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55943486|NCT01454635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55943487|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55943488|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743674|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55943489|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943491|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
55943498|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55943500|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55943501|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55943502|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943503|NCT04955262|Nivolumab|nivolumab|mesh-list
55943504|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55943505|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943506|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55943507|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943508|NCT01363479|Dexamethasone|dexamethasone|mesh-list
55943509|NCT01363479|Palonosetron|palonosetron|mesh-list
55943510|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943511|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
55943512|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
55943513|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943514|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943515|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55943516|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
55943517|NCT01363479|Hormones|hormones|mesh-ancestor
55943518|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55943519|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55943520|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943521|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55943522|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55943523|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
55943524|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943525|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943526|NCT02792257|Dronabinol|dronabinol|mesh-list
55943527|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
56256731|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56256732|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56256733|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56256734|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56256735|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56256736|NCT01910428|Asparaginase|asparaginase|mesh-list
55943528|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943529|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55943530|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943531|NCT02792257|Analgesics|analgesics|mesh-ancestor
55943532|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
55943533|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943534|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55943535|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55943536|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144657|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55943537|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943539|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55943540|NCT01893385|Vitamin D|vitamin d|mesh-list
55943541|NCT01893385|Vitamins|vitamins|mesh-ancestor
55943542|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
55943543|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943544|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55943552|NCT04935450|Dimercaprol|dimercaprol|mesh-list
55943553|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
55943554|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
55943555|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943556|NCT02181231|Buprenorphine|buprenorphine|mesh-list
55943584|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943585|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943586|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
55943587|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943588|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
55943589|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55943590|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55943591|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999904|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999905|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
55943592|NCT01365585|Urological Agents|urological agents|mesh-ancestor
55943593|NCT02664181|Nivolumab|nivolumab|mesh-list
55943594|NCT02664181|Decitabine|decitabine|mesh-list
55943595|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
55943596|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55943597|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943598|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55943599|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256739|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
56256740|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256741|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55943600|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55943601|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
55943602|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943603|NCT04407390|Niacinamide|niacinamide|mesh-list
55943612|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943613|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55943614|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
55943616|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943617|NCT02181387|Analgesics|analgesics|mesh-ancestor
55943618|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
55943619|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943620|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943621|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
55943622|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
55943623|NCT04921878|Analgesics|analgesics|mesh-ancestor
55943624|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
55943625|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943626|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943627|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943628|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55943629|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55943630|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943631|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943632|NCT04351347|Ivermectin|ivermectin|mesh-list
55943633|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55943634|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943635|NCT04932564|Leflunomide|leflunomide|mesh-list
55943636|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943637|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943638|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943639|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
55943640|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943641|NCT02782663|Upadacitinib|upadacitinib|mesh-list
55943642|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
55943643|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55943644|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943645|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943646|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55943648|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55943649|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943650|NCT04921566|Torsemide|torsemide|mesh-list
55943651|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55943652|NCT04921566|Diuretics|diuretics|mesh-ancestor
55943653|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
55943654|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943655|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55943656|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943657|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943658|NCT02655601|Manganese|manganese|mesh-list
55943659|NCT02655601|Temozolomide|temozolomide|mesh-list
55943660|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55943661|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
55943662|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943663|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943664|NCT02655601|Trace Elements|trace elements|mesh-ancestor
55943665|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
55943666|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943667|NCT02652247|Dimercaprol|dimercaprol|mesh-list
55943668|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
55878799|NCT01412710|Vitamin D|vitamin d|mesh-list
55943669|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
55789151|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943670|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943671|NCT04934514|Gemcitabine|gemcitabine|mesh-list
55943681|NCT04934514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943682|NCT01365819|Varenicline|varenicline|mesh-list
55943683|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55943684|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55943685|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
55943686|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943687|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943688|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943689|NCT02635555|Phenylephrine|phenylephrine|mesh-list
55943690|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
55943691|NCT02635555|Ephedrine|ephedrine|mesh-list
55943692|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55943693|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
55943694|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
55943695|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943696|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943697|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
55943698|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55943699|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
55943700|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
55943701|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55943702|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55943703|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55943704|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
55943705|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743678|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
55943706|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943708|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55943709|NCT01893541|Propranolol|propranolol|mesh-list
55943710|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55943711|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55943712|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
55943713|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943714|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943715|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943716|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55943717|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55943718|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
55943719|NCT02849899|Vildagliptin|vildagliptin|mesh-list
55943720|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55943721|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943722|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55943723|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
55943724|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943725|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943726|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
55943727|NCT02771197|Fludarabine|fludarabine|mesh-list
55943728|NCT02771197|Melphalan|melphalan|mesh-list
55943729|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55943730|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943731|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943732|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943733|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
55943734|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943735|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55943748|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943749|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55943750|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55943751|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55943752|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
55943753|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943754|NCT02620189|Adalimumab|adalimumab|mesh-list
55943755|NCT02620189|Etanercept|etanercept|mesh-list
55943756|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
55943757|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943758|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55943759|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55943760|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943761|NCT02620189|Analgesics|analgesics|mesh-ancestor
55943762|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
55999907|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55999908|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55999909|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943763|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943764|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943765|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55943766|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943767|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
55943768|NCT02763319|Rituximab|rituximab|mesh-list
55943769|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55943770|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55943771|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943772|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
55943773|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943774|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55943775|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55943776|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
55943777|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943778|NCT02755597|Dexamethasone|dexamethasone|mesh-list
55943779|NCT02755597|Bortezomib|bortezomib|mesh-list
55943780|NCT02755597|Venetoclax|venetoclax|mesh-list
55943781|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943782|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
55943783|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
55943784|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943785|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943786|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55943787|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
55943788|NCT02755597|Hormones|hormones|mesh-ancestor
55943789|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55943790|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55943791|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943792|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
55943793|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55943794|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55943795|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
55943796|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943797|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55943798|NCT04920708|Fulvestrant|fulvestrant|mesh-list
55943799|NCT04920708|Palbociclib|palbociclib|mesh-list
55943806|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943808|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943809|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943810|NCT02594371|Paclitaxel|paclitaxel|mesh-list
55943811|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55943812|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55943813|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943815|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
55943816|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
55943817|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943818|NCT02197065|Atorvastatin|atorvastatin|mesh-list
55943819|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55943820|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55943821|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
55943822|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943823|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55943824|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55943825|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943826|NCT04405596|Ambroxol|ambroxol|mesh-list
55943827|NCT04405596|Expectorants|expectorants|mesh-ancestor
55943828|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
55943829|NCT01375491|Doxycycline|doxycycline|mesh-list
55943830|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55943831|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943832|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
55943833|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55943834|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55943835|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
55943836|NCT02591251|Povidone|povidone|mesh-list
55943837|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55943838|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
55869695|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943839|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
55943840|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55943841|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943842|NCT01325181|Ranibizumab|ranibizumab|mesh-list
55943843|NCT01325181|Verteporfin|verteporfin|mesh-list
55943844|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55943845|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55943846|NCT01325181|Growth Substances|growth substances|mesh-ancestor
55943847|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943848|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
55943849|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943850|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55943851|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
55943852|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55943854|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943855|NCT04238637|Durvalumab|durvalumab|mesh-list
55943856|NCT04238637|Tremelimumab|tremelimumab|mesh-list
55943857|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55943858|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943859|NCT02588443|Gemcitabine|gemcitabine|mesh-list
55943860|NCT02588443|Paclitaxel|paclitaxel|mesh-list
55943861|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55943862|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943863|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
55943864|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
55943865|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
55943866|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943876|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55943877|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55943878|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943879|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55943880|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55943881|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
55943882|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943883|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55943884|NCT02582359|Cytarabine|cytarabine|mesh-list
55943885|NCT02582359|Daunorubicin|daunorubicin|mesh-list
55943886|NCT02582359|Ixazomib|ixazomib|mesh-list
55943887|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55943888|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
55943889|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943890|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943891|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
55943892|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943893|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943894|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
55943895|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943896|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55943897|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55943898|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55943899|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943900|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
55943902|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55943903|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
55943904|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943905|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943906|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55943907|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943908|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
55943909|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943910|NCT00227253|Hormones|hormones|mesh-list
55943911|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55943912|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943913|NCT05021809|Calcium|calcium|mesh-list
55943914|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55943915|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943916|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
55943917|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55943918|NCT02730715|Basiliximab|basiliximab|mesh-list
55943919|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
55999910|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999911|NCT00379756|Urological Agents|urological agents|mesh-ancestor
55943920|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943921|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943922|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
55943923|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
55943924|NCT04919460|Coagulants|coagulants|mesh-ancestor
55943925|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
55943926|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943928|NCT04037241|Gemcitabine|gemcitabine|mesh-list
55943930|NCT04037241|Capecitabine|capecitabine|mesh-list
55943931|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55943932|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943933|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
55943934|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
55943945|NCT04037241|Antidotes|antidotes|mesh-ancestor
55943946|NCT04037241|Protective Agents|protective agents|mesh-ancestor
55943947|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
55943948|NCT04037241|Vitamins|vitamins|mesh-ancestor
55943949|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
55943950|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
55943951|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55943952|NCT04912128|Growth Substances|growth substances|mesh-ancestor
55943953|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943954|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
55943955|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943956|NCT01327677|Fentanyl|fentanyl|mesh-list
55943957|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55943958|NCT01327677|Narcotics|narcotics|mesh-ancestor
55943959|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943960|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943961|NCT01327677|Analgesics|analgesics|mesh-ancestor
55943962|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
55943963|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943964|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55943965|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55943966|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
55943967|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
55943968|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
55943969|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55943970|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55943971|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55943972|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943973|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943974|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
55943975|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943976|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943977|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55943978|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943979|NCT04918914|Dapsone|dapsone|mesh-list
55943980|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943981|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
55943982|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55943983|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55943984|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55943985|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943986|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943987|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
55943988|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55943989|NCT04918524|Aspirin|aspirin|mesh-list
55943990|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
55943991|NCT04918524|Prednisone|prednisone|mesh-list
55943992|NCT04918524|Heparin|heparin|mesh-list
55943993|NCT04918524|Enoxaparin|enoxaparin|mesh-list
55943994|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55943995|NCT04918524|Tinzaparin|tinzaparin|mesh-list
55943996|NCT04918524|Dalteparin|dalteparin|mesh-list
55943997|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943998|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
55943999|NCT04918524|Hormones|hormones|mesh-ancestor
55944000|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944001|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944016|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
55944017|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
55944018|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
55999912|NCT02518750|Cytarabine|cytarabine|mesh-list
55999913|NCT02518750|Dexamethasone|dexamethasone|mesh-list
55999914|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
55999915|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
55999916|NCT02518750|Methotrexate|methotrexate|mesh-list
55999917|NCT02518750|Etoposide|etoposide|mesh-list
55999918|NCT02518750|Vincristine|vincristine|mesh-list
55999919|NCT02518750|Bortezomib|bortezomib|mesh-list
55999920|NCT02518750|Asparaginase|asparaginase|mesh-list
55999921|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
55999922|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
55999923|NCT02518750|Clofarabine|clofarabine|mesh-list
55999924|NCT02518750|Panobinostat|panobinostat|mesh-list
55999925|NCT02518750|Pegaspargase|pegaspargase|mesh-list
55999926|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55999927|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
55999928|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999929|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944019|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55944020|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55944021|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944022|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
55944023|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55944024|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55944025|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944026|NCT05586763|Promethazine|promethazine|mesh-list
55944027|NCT05586763|Diphenhydramine|diphenhydramine|mesh-list
55944028|NCT05586763|Metoclopramide|metoclopramide|mesh-list
55944029|NCT05586763|Antiemetics|antiemetics|mesh-ancestor
55944030|NCT05586763|Autonomic Agents|autonomic agents|mesh-ancestor
55944031|NCT05586763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944032|NCT05586763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944033|NCT05586763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944034|NCT05586763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55944035|NCT05586763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55944036|NCT05586763|Dopamine Agents|dopamine agents|mesh-ancestor
55944037|NCT05586763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55944038|NCT05586763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944039|NCT05586763|Antipruritics|antipruritics|mesh-ancestor
55944040|NCT05586763|Dermatologic Agents|dermatologic agents|mesh-ancestor
55944041|NCT05586763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55944042|NCT05586763|Histamine Antagonists|histamine antagonists|mesh-ancestor
55944043|NCT05586763|Histamine Agents|histamine agents|mesh-ancestor
55944044|NCT05586763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55944045|NCT05586763|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55944046|NCT05586763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55944047|NCT05586763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55944048|NCT05586763|Anesthetics, Local|anesthetics, local|mesh-ancestor
55944049|NCT05586763|Anesthetics|anesthetics|mesh-ancestor
55944050|NCT05586763|Sensory System Agents|sensory system agents|mesh-ancestor
55944051|NCT01328769|Febuxostat|febuxostat|mesh-list
55944052|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
55944053|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944054|NCT02552641|Amoxicillin|amoxicillin|mesh-list
55944055|NCT02552641|Clarithromycin|clarithromycin|mesh-list
55944056|NCT02552641|Esomeprazole|esomeprazole|mesh-list
55944057|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55944058|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944059|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55944060|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944061|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55944076|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944078|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
55944079|NCT01378299|Testosterone|testosterone|mesh-list
55999930|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55999931|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
55944080|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
55944081|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
55944082|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55944083|NCT01378299|Androgens|androgens|mesh-ancestor
55944084|NCT01378299|Hormones|hormones|mesh-ancestor
55944085|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944086|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944087|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55944088|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944089|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
55944090|NCT04929522|Anesthetics|anesthetics|mesh-list
55944091|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55944092|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944093|NCT02549833|Poly I-C|poly i-c|mesh-list
55944094|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55944095|NCT02549833|Poly ICLC|poly iclc|mesh-list
55944096|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
55944097|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
55944098|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944099|NCT02549833|Laxatives|laxatives|mesh-ancestor
55944100|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944101|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
55944102|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944103|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55944104|NCT02542969|Simvastatin|simvastatin|mesh-list
55944105|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55944106|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55944107|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
55944108|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944109|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55944110|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55944111|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944112|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
55944113|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
55944114|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944115|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
55944116|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944117|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944118|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55944119|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
55944120|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944121|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944137|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944139|NCT03054168|Androgens|androgens|mesh-ancestor
55944140|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55944141|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944142|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
55944143|NCT02518945|Liraglutide|liraglutide|mesh-list
55944144|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55944145|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257059|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56257060|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56257061|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56257062|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257063|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944146|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55944147|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944148|NCT02518945|Incretins|incretins|mesh-ancestor
55944149|NCT02518945|Hormones|hormones|mesh-ancestor
55743686|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55944150|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944151|NCT05023369|Dexamethasone|dexamethasone|mesh-list
55944152|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944153|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
55944154|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
55944155|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944156|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944157|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944158|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
55944159|NCT05023369|Hormones|hormones|mesh-ancestor
55944161|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55944162|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944163|NCT02390869|Rituximab|rituximab|mesh-list
55999932|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870083|NCT04761705|Latanoprost|latanoprost|mesh-list
55944164|NCT02390869|Lenalidomide|lenalidomide|mesh-list
55944165|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944166|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944167|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
55944168|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944169|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944170|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55944171|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55944172|NCT02390869|Growth Substances|growth substances|mesh-ancestor
55944173|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
55944174|NCT04757779|Docetaxel|docetaxel|mesh-list
55944175|NCT04757779|Irinotecan|irinotecan|mesh-list
55944176|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944177|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
55944178|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944179|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
55944191|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944192|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944194|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
55944195|NCT02389309|Dasatinib|dasatinib|mesh-list
55944196|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944197|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
55944198|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944199|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944200|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55944201|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
55944202|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944203|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944204|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55944205|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55944206|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944207|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55944208|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
55944209|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55944210|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944211|NCT02489695|Axitinib|axitinib|mesh-list
55944212|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944213|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55944214|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944215|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944216|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
55944217|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55944218|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
55944219|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944220|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944221|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55944222|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
55944223|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55944224|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
55944225|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944226|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55944227|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55944228|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
55944229|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
55944230|NCT03053388|Protective Agents|protective agents|mesh-ancestor
55944231|NCT03053544|Metformin|metformin|mesh-list
55944232|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55944233|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944234|NCT02384083|Dexamethasone|dexamethasone|mesh-list
55944235|NCT02384083|Pomalidomide|pomalidomide|mesh-list
55944236|NCT02384083|Filanesib|filanesib|mesh-list
55944237|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944238|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
55944239|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
55944240|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257095|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257096|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
56257097|NCT01912638|Protective Agents|protective agents|mesh-ancestor
56257098|NCT01912677|Labetalol|labetalol|mesh-list
55944241|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944255|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944258|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999933|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999934|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55999935|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944260|NCT02484391|Cytarabine|cytarabine|mesh-list
55944261|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
55944262|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55944263|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
56257145|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
56257244|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
56257245|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257246|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
56257247|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257248|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257249|NCT01913834|Teriparatide|teriparatide|mesh-list
56257250|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55944264|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944265|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944266|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
55944267|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944268|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944269|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
55944270|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944271|NCT02484391|Analgesics|analgesics|mesh-ancestor
55944272|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
55944273|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944274|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55944275|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55944276|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944277|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
55944278|NCT02484391|Protective Agents|protective agents|mesh-ancestor
55944279|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
55944280|NCT02484391|Vitamins|vitamins|mesh-ancestor
55944281|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
56257392|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257393|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257394|NCT01914718|Rituximab|rituximab|mesh-list
56257395|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56257396|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257397|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
56257398|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257399|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56257400|NCT01914744|Lamivudine|lamivudine|mesh-list
56257401|NCT01914744|Entecavir|entecavir|mesh-list
56257402|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56257403|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56257406|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
56257434|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257435|NCT01914939|Oxytocin|oxytocin|mesh-list
56257436|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
56257437|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56257438|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257439|NCT01914965|Bupropion|bupropion|mesh-list
56257440|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56257441|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
56257442|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55944282|NCT03053622|Mirikizumab|mirikizumab|mesh-list
55944283|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55944284|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55944285|NCT03053622|Analgesics|analgesics|mesh-ancestor
55944286|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
55944287|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944288|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944289|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944290|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871499|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
55871500|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55871501|NCT00417664|Analgesics|analgesics|mesh-ancestor
55871502|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
55871503|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871504|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55871505|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55871506|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55871507|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
55871508|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871509|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871510|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55871511|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55871512|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55871513|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55871514|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
55871515|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
55871516|NCT05657613|Fluconazole|fluconazole|mesh-list
55871517|NCT05657613|Bosentan|bosentan|mesh-list
55944291|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55944292|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944293|NCT02380573|Methylene Blue|methylene blue|mesh-list
55944294|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944295|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944296|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
55944297|NCT02461537|Analgesics|analgesics|mesh-ancestor
55944298|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
55944299|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944300|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944302|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55944303|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55944316|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944318|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55944319|NCT02460445|Cyproterone|cyproterone|mesh-list
55944320|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55944321|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55944322|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55944323|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
55944324|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55944325|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944326|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55944327|NCT02460445|Estrogens|estrogens|mesh-ancestor
55944328|NCT02460445|Hormones|hormones|mesh-ancestor
55944329|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944330|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
55944331|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
55944332|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944333|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55944334|NCT02455687|Budesonide|budesonide|mesh-list
55944335|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
55944336|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944337|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55944338|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
55944339|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944340|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944341|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55944342|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
55871662|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
55871671|NCT01024738|Triclosan|triclosan|mesh-list
55999936|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
55944345|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944346|NCT02455687|Analgesics|analgesics|mesh-ancestor
55944347|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
55944348|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
55871692|NCT01024972|Mannitol|mannitol|mesh-list
55944349|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55944350|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55944351|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
55944352|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55944353|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55944354|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944355|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55871723|NCT03081039|Gemcitabine|gemcitabine|mesh-list
55944356|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
55944357|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55944358|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
55944359|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944360|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944361|NCT02358967|Vitamin E|vitamin e|mesh-list
55944362|NCT02358967|Tocopherols|tocopherols|mesh-list
55944363|NCT02358967|Tocotrienols|tocotrienols|mesh-list
55944364|NCT02358967|Vitamins|vitamins|mesh-ancestor
55944365|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
55944383|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55944384|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944385|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944386|NCT02352337|Gemcitabine|gemcitabine|mesh-list
55944387|NCT02352337|Folfirinox|folfirinox|mesh-list
55944388|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55944389|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
55944390|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944391|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944392|NCT02352337|Antiviral Agents|antiviral agents|mesh-ancestor
55944393|NCT02352337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944394|NCT02352337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944395|NCT02352337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944396|NCT02352337|Immunologic Factors|immunologic factors|mesh-ancestor
56257735|NCT01916863|Canagliflozin|canagliflozin|mesh-list
55944397|NCT02352337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944398|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
55944399|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944400|NCT02827201|Gemcitabine|gemcitabine|mesh-list
55944401|NCT02827201|Paclitaxel|paclitaxel|mesh-list
55944402|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55944403|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944404|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
55872022|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55944405|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944406|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
55944407|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258091|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56258143|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258490|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944408|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55872265|NCT04101838|Vaccines|vaccines|mesh-list
55944409|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
55944410|NCT02827201|Antiviral Agents|antiviral agents|mesh-ancestor
55944411|NCT02827201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944412|NCT02827201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944413|NCT02827201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872623|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
55944414|NCT02827201|Immunologic Factors|immunologic factors|mesh-ancestor
56259909|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56259910|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944415|NCT02827201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944416|NCT02346253|Leuprolide|leuprolide|mesh-list
55944417|NCT02346253|Goserelin|goserelin|mesh-list
56260173|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872893|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835452|NCT01837719|Cobicistat|cobicistat|mesh-list
55944418|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55944419|NCT02346253|Bicalutamide|bicalutamide|mesh-list
55944420|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55944421|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
55944422|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55944423|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944424|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55944425|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260406|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55873140|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55944426|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
55873222|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
56260562|NCT01941966|Capecitabine|capecitabine|mesh-list
56260617|NCT01942187|Aripiprazole|aripiprazole|mesh-list
55944455|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260723|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55873540|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55944456|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55944457|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944458|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873769|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55873935|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260886|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55944459|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55944460|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
55999937|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
55999938|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789177|NCT03933007|Fexofenadine|fexofenadine|mesh-list
56261054|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55944461|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55944462|NCT03009045|Tedizolid|tedizolid|mesh-list
55944463|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
55944464|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
55836292|NCT04670666|Metformin|metformin|mesh-list
55944465|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55944466|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944467|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55944468|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874337|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
56261253|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
55874540|NCT05439798|Dexamethasone|dexamethasone|mesh-list
55749769|NCT02454205|Ofloxacin|ofloxacin|mesh-list
55874664|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55944469|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944470|NCT04915482|Rituximab|rituximab|mesh-list
55944471|NCT04915482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944472|NCT04915482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875100|NCT01105312|Panobinostat|panobinostat|mesh-list
55875101|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944473|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
55944474|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944484|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55944485|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944486|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55944487|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944488|NCT03056118|Aspirin|aspirin|mesh-list
55944489|NCT03056118|Clopidogrel|clopidogrel|mesh-list
55944490|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55944491|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55944492|NCT03056118|Analgesics|analgesics|mesh-ancestor
55944493|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
55944494|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944495|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944496|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944497|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55875339|NCT04614714|Niacin|niacin|mesh-list
55944498|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55944499|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55875820|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944500|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944501|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56262609|NCT05251493|Iron|iron|mesh-list
55876123|NCT05054868|Ketorolac|ketorolac|mesh-list
55944502|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55944503|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944504|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
55944505|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55944506|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55944507|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55944508|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
55944509|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55944510|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55944511|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55944512|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
55944513|NCT00987935|Sorafenib|sorafenib|mesh-list
55944514|NCT00987935|Nintedanib|nintedanib|mesh-list
55944515|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944516|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55944517|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944518|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944519|NCT00987467|Cyclosporine|cyclosporine|mesh-list
55944520|NCT00987467|Cyclosporins|cyclosporins|mesh-list
55944521|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876550|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944522|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944523|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944524|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
55944525|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944526|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
55944527|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944528|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
55944529|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944530|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55944531|NCT01332357|Fluticasone|fluticasone|mesh-list
55944532|NCT01332357|Xhance|xhance|mesh-list
55944533|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55944534|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55944535|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944536|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55944537|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
55944538|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999939|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55999940|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
55999941|NCT02518750|Hormones|hormones|mesh-ancestor
55999942|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999943|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55999945|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
55999946|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55999947|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55999948|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
55999949|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
55999950|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999951|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55999952|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55999953|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55999954|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55999955|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55999956|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
55789184|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56264054|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
55944539|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944540|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55944549|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944550|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
55944551|NCT01332357|Hormones|hormones|mesh-ancestor
55944552|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944553|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
55944554|NCT04914936|Rifampin|rifampin|mesh-list
55944555|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
55944556|NCT04914936|Omeprazole|omeprazole|mesh-list
55944557|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
55944558|NCT04914936|Calcium|calcium|mesh-list
55944559|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55944560|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944561|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55944562|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944563|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55944564|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264816|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55944565|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944566|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55944567|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
55944568|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55944569|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944570|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
55944571|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55944572|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55944573|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55944574|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55944575|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55944576|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55944577|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55944578|NCT04914936|Antacids|antacids|mesh-ancestor
55944579|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944580|NCT04914390|Paclitaxel|paclitaxel|mesh-list
55999957|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999958|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
55999959|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
55999960|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
55999961|NCT02518750|Analgesics|analgesics|mesh-ancestor
55944581|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55944582|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944583|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
55944584|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944585|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
56265365|NCT01960647|Paclitaxel|paclitaxel|mesh-list
55944586|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944587|NCT03054948|SMOFlipid|smoflipid|mesh-list
55944588|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56144658|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55944589|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55944590|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55944591|NCT00986921|Mifepristone|mifepristone|mesh-list
55944592|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55944593|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
55944594|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55944595|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944596|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55944597|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55944598|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55944599|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
55944601|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55944602|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
55944603|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944614|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944615|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888143|NCT02246920|Xhance|xhance|mesh-list
55944616|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944617|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
55944618|NCT01383759|Hormones|hormones|mesh-ancestor
56266730|NCT01969682|Rifampin|rifampin|mesh-list
55944619|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944620|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55944621|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267007|NCT01971632|Oxycodone|oxycodone|mesh-list
55944622|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
56267412|NCT01974375|Fluconazole|fluconazole|mesh-list
55944623|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944624|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944625|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
55944626|NCT01384539|Vitamin D|vitamin d|mesh-list
55944627|NCT01384539|Calcitriol|calcitriol|mesh-list
55944628|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55944629|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944630|NCT01384539|Vitamins|vitamins|mesh-ancestor
55944631|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
55944632|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55944633|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55944634|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55944635|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944636|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55944637|NCT03399981|Natalizumab|natalizumab|mesh-list
55944638|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
55944639|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944640|NCT04902222|Morphine|morphine|mesh-list
55944641|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55944642|NCT04902222|Narcotics|narcotics|mesh-ancestor
55944643|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55944644|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944645|NCT04902222|Analgesics|analgesics|mesh-ancestor
55944646|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
55944647|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944648|NCT04904406|Lamivudine|lamivudine|mesh-list
55944649|NCT04904406|Abacavir|abacavir|mesh-list
55944650|NCT04904406|Dolutegravir|dolutegravir|mesh-list
55944651|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55944652|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55999962|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
55999963|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55999964|NCT01194856|Ritonavir|ritonavir|mesh-list
55944653|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944654|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843363|NCT03813160|Analgesics|analgesics|mesh-ancestor
55944655|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
56268461|NCT01983137|Analgesics|analgesics|mesh-ancestor
55944656|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944657|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55944658|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56268798|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
55944659|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55944660|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55944661|NCT00985751|Vaccines|vaccines|mesh-list
56268896|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
55944662|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55944663|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
55944664|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944665|NCT02337985|Prednisone|prednisone|mesh-list
55944666|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
55944667|NCT02337985|Rituximab|rituximab|mesh-list
55944668|NCT02337985|Doxorubicin|doxorubicin|mesh-list
55944669|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55944670|NCT02337985|Etoposide|etoposide|mesh-list
55944671|NCT02337985|Vincristine|vincristine|mesh-list
55944672|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944688|NCT02337985|Hormones|hormones|mesh-ancestor
55944689|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944690|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56270475|NCT01996618|Ranolazine|ranolazine|mesh-list
55944691|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56270606|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270608|NCT01997658|Hormones|hormones|mesh-ancestor
56270698|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
55944692|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
55944693|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944694|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
55944695|NCT02429557|Midodrine|midodrine|mesh-list
55944696|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
56270980|NCT02000388|Analgesics|analgesics|mesh-ancestor
56271104|NCT02001272|Paclitaxel|paclitaxel|mesh-list
55944697|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
55893198|NCT02069704|Leucovorin|leucovorin|mesh-list
55944698|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944699|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944700|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55944701|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55944702|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55944703|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55944704|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
55944705|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55944706|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944707|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55944708|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55944709|NCT04884516|Vitamin A|vitamin a|mesh-list
55944710|NCT04884516|Vitamins|vitamins|mesh-ancestor
55944711|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
56272159|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
55944712|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944713|NCT04884282|Docetaxel|docetaxel|mesh-list
55944714|NCT04884282|Nivolumab|nivolumab|mesh-list
56272291|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
55944715|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944716|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
55944717|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944718|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
56272674|NCT05590468|Vasodilator Agents|vasodilator agents|mesh-ancestor
56272783|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272784|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56272785|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56272786|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
56272787|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847906|NCT02720068|Vitamins|vitamins|mesh-ancestor
55876620|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
56272788|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272789|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56272790|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56272791|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
56272792|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
56272793|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272794|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56272795|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
56272796|NCT05459571|Hormones|hormones|mesh-ancestor
56272799|NCT05455424|Niraparib|niraparib|mesh-list
55944719|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944720|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944721|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55944722|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
55944723|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
55944724|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55944725|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55944726|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944727|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944728|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944729|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944730|NCT02422381|Gemcitabine|gemcitabine|mesh-list
55944731|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
56273625|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273626|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
56273627|NCT03829683|Vitamins|vitamins|mesh-ancestor
56273628|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
56273629|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273630|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
56273631|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273632|NCT03829683|Protective Agents|protective agents|mesh-ancestor
56273645|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56273646|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944741|NCT02422381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944742|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944744|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944745|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
55944746|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
55944747|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
55944748|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55999965|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55999966|NCT01194856|Efavirenz|efavirenz|mesh-list
55999967|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55999968|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55944749|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944750|NCT01387815|Adalimumab|adalimumab|mesh-list
55944751|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944752|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944753|NCT04883034|Analgesics|analgesics|mesh-list
55944754|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
55944755|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944756|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944757|NCT01596504|Metformin|metformin|mesh-list
55944758|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
55944759|NCT01596504|Liraglutide|liraglutide|mesh-list
55944760|NCT01596504|Lixisenatide|lixisenatide|mesh-list
55944761|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55944762|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944763|NCT01596504|Incretins|incretins|mesh-ancestor
55944764|NCT01596504|Hormones|hormones|mesh-ancestor
55944765|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944766|NCT02394769|Aspirin|aspirin|mesh-list
56273866|NCT02858310|Aldesleukin|aldesleukin|mesh-list
55944767|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55944768|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55944769|NCT02394769|Analgesics|analgesics|mesh-ancestor
55944770|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
55944771|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944772|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944773|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944774|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944775|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55944776|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55944777|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944778|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55820849|NCT02310581|Narcotics|narcotics|mesh-ancestor
55944779|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55944780|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944782|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55944783|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55944784|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944785|NCT01334229|Incretins|incretins|mesh-ancestor
55944786|NCT01334229|Hormones|hormones|mesh-ancestor
56274424|NCT02009943|Hematinics|hematinics|mesh-ancestor
55944787|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944788|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55944789|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
55944790|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944791|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944792|NCT01390077|Nitisinone|nitisinone|mesh-list
55944793|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944794|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944795|NCT02292979|Doxorubicin|doxorubicin|mesh-list
55944796|NCT02292979|Bleomycin|bleomycin|mesh-list
55944797|NCT02292979|Dacarbazine|dacarbazine|mesh-list
55944810|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
55944811|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944812|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
55944813|NCT02394535|Paclitaxel|paclitaxel|mesh-list
55944814|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55944815|NCT02394535|Capecitabine|capecitabine|mesh-list
55944816|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55944817|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944818|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
55944819|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944820|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
55944821|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944822|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55944823|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
56275139|NCT02014753|Cobalt|cobalt|mesh-list
55944824|NCT02285959|Bevacizumab|bevacizumab|mesh-list
55944825|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944826|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944827|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56275315|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275428|NCT02016547|Abciximab|abciximab|mesh-list
56275595|NCT02018094|Iodine|iodine|mesh-list
56276197|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944828|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55999969|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
55999970|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999971|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999972|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55999973|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56277325|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56277326|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55999974|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
55999975|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999976|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56277839|NCT02040285|Bisacodyl|bisacodyl|mesh-list
55999977|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55999978|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55999979|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56278511|NCT02045069|Ivermectin|ivermectin|mesh-list
55999980|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55999981|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55999982|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55999983|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55999984|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55999985|NCT01182610|Paclitaxel|paclitaxel|mesh-list
55999986|NCT01182610|Carboplatin|carboplatin|mesh-list
55789209|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789210|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789211|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55789216|NCT04907747|Antacids|antacids|mesh-ancestor
55944829|NCT02285959|Growth Substances|growth substances|mesh-ancestor
55944830|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944831|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
55944832|NCT01404429|Methotrexate|methotrexate|mesh-list
56279334|NCT00005949|Interleukin-2|interleukin-2|mesh-list
55944833|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55944834|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
56279789|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944835|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55944836|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944837|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55944838|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
55944839|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944840|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944841|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
55944842|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944843|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56279877|NCT05605509|Antiviral Agents|antiviral agents|mesh-ancestor
56279995|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280164|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56280165|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
56280166|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280167|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280168|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56280169|NCT03530124|Vaccines|vaccines|mesh-list
56280170|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55944844|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944845|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
55944846|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944847|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55944849|NCT03051906|Durvalumab|durvalumab|mesh-list
55944850|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944851|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944852|NCT01390233|Dinoprostone|dinoprostone|mesh-list
55991247|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55991248|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55991249|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55991250|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55991251|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55991252|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
55991253|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
55991254|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
55991255|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
55991256|NCT00987415|Allopurinol|allopurinol|mesh-list
55991257|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
55991258|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991259|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991260|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
55991261|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55991262|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55991263|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
55991264|NCT00987415|Protective Agents|protective agents|mesh-ancestor
55991273|NCT04771156|Ketorolac|ketorolac|mesh-list
55991274|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55991275|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55991277|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
55991278|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991279|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991280|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55991281|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944853|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
55944854|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55944855|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944856|NCT05026567|Midazolam|midazolam|mesh-list
55944857|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55999987|NCT01182610|Fluorouracil|fluorouracil|mesh-list
55999988|NCT01182610|Panitumumab|panitumumab|mesh-list
55870926|NCT00946348|Hormones|hormones|mesh-ancestor
55944858|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55991301|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55991302|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991303|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991305|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55991306|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55991307|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991308|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
55991309|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
55991310|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
55991311|NCT03140722|Hematinics|hematinics|mesh-ancestor
55991312|NCT04915755|Niraparib|niraparib|mesh-list
55991313|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55991329|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
55991330|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
55991331|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991332|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991333|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
55991380|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
55991395|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
55944870|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944872|NCT01391013|Darunavir|darunavir|mesh-list
55991505|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55944873|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
55944874|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55944875|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55944876|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
55944877|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944878|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944879|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55944880|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55944881|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
55944882|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944883|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55991896|NCT04342065|Analgesics|analgesics|mesh-ancestor
55991995|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55944884|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55944885|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55944886|NCT01891747|Bevacizumab|bevacizumab|mesh-list
55944887|NCT01891747|Temozolomide|temozolomide|mesh-list
55944888|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944889|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944890|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55944891|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55992383|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
55944892|NCT01891747|Growth Substances|growth substances|mesh-ancestor
55944893|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944894|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
55944895|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55944896|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
55944897|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944898|NCT04899570|Prednisone|prednisone|mesh-list
55944899|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
55944900|NCT04899570|Rituximab|rituximab|mesh-list
55944901|NCT04899570|Epirubicin|epirubicin|mesh-list
55944902|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
55944903|NCT04899570|Vindesine|vindesine|mesh-list
55944904|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944905|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
55944906|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992665|NCT03296800|Rifampin|rifampin|mesh-list
55944907|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944908|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55944909|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
55992729|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
55944910|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944911|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944912|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55944913|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55992928|NCT01923584|Ubiquinone|ubiquinone|mesh-list
55932870|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
55993083|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993084|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
55944914|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55932948|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932949|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932969|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55993575|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993576|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
55944915|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
55944916|NCT04899570|Hormones|hormones|mesh-ancestor
55993706|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944917|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944918|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55944919|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55944920|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55944921|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55994140|NCT03378076|FX006|fx006|mesh-list
55944937|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944938|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944940|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55944941|NCT03049878|Narcotics|narcotics|mesh-ancestor
55944942|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55944943|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
55944944|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
55944945|NCT01391325|Allopurinol|allopurinol|mesh-list
55994928|NCT03030911|Fentanyl|fentanyl|mesh-list
55944946|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
55944947|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944948|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944949|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
55944950|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944951|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55944952|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
55944953|NCT01391325|Protective Agents|protective agents|mesh-ancestor
55944954|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944955|NCT01980823|Metformin|metformin|mesh-list
55999989|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55999990|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999991|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
55999992|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
55999993|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
55944956|NCT01980823|Atorvastatin|atorvastatin|mesh-list
55944957|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55944958|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944959|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55944960|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55944961|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
55743695|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
55944962|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944963|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55944964|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55944965|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944966|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55944967|NCT01976065|Metronidazole|metronidazole|mesh-list
55944968|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
55944969|NCT01976065|Minocycline|minocycline|mesh-list
55944970|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944971|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55944972|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55944973|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55944974|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55944975|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944976|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944977|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944978|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55944979|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55944980|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
55944993|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55944995|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
55944996|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55944997|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944998|NCT04899414|Dexamethasone|dexamethasone|mesh-list
55944999|NCT04899414|Azacitidine|azacitidine|mesh-list
55945000|NCT04899414|Pegaspargase|pegaspargase|mesh-list
55945001|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945002|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
55945003|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
55945004|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945005|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945006|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945007|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
55945008|NCT04899414|Hormones|hormones|mesh-ancestor
55945009|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945010|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55945011|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945012|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55945013|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
55945014|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945015|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945016|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
55945017|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55945018|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55945019|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945020|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
55945021|NCT03008655|Coagulants|coagulants|mesh-ancestor
55945022|NCT01894633|Chloroquine|chloroquine|mesh-list
55945023|NCT01894633|Amebicides|amebicides|mesh-ancestor
55945024|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55945025|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55945026|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945028|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55945029|NCT05585671|Belimumab|belimumab|mesh-list
55945030|NCT05585671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945031|NCT05585671|Immunologic Factors|immunologic factors|mesh-ancestor
55945032|NCT05585671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789231|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55871175|NCT05689047|Pyronaridine|pyronaridine|mesh-list
55945033|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55945034|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
55945035|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55945036|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
55945037|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945038|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945039|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55945040|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
55945041|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55945042|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55945043|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55945062|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945063|NCT01894711|Trastuzumab|trastuzumab|mesh-list
55945064|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945065|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945066|NCT00985439|Celecoxib|celecoxib|mesh-list
55945067|NCT00985439|Diclofenac|diclofenac|mesh-list
55945068|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55945069|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55945070|NCT00985439|Analgesics|analgesics|mesh-ancestor
55945071|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
55945072|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945073|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945074|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945075|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55945076|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55945077|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55945078|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945079|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945080|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
55945081|NCT02984111|Hematinics|hematinics|mesh-ancestor
55945082|NCT04412148|Triamcinolone|triamcinolone|mesh-list
55945083|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55945084|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55945085|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55945086|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945087|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
55945088|NCT04412148|Hormones|hormones|mesh-ancestor
55995188|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55945089|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945090|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945091|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945092|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
55945093|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945094|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945095|NCT04890522|Gemcitabine|gemcitabine|mesh-list
55945096|NCT04890522|Fluorouracil|fluorouracil|mesh-list
55945097|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945098|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55945099|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
55945100|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945101|NCT04890522|Antiviral Agents|antiviral agents|mesh-ancestor
55945102|NCT04890522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945103|NCT04890522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945122|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55945123|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
55945124|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945125|NCT01525069|Antiviral Agents|antiviral agents|mesh-ancestor
55945126|NCT01525069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945127|NCT01525069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945128|NCT01525069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945129|NCT01525069|Immunologic Factors|immunologic factors|mesh-ancestor
55945130|NCT04898946|Vaccines|vaccines|mesh-list
55945131|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
55945132|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945134|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55945135|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55945136|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55945137|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55945138|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
55945139|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999994|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999995|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
55999996|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55789233|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
55945140|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945141|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945142|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
55945143|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55945144|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55945145|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
55945146|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55945147|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945148|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55945149|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55945150|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55945151|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55945152|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945153|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55945154|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55945155|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945156|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945157|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945158|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
55945180|NCT03074045|Drospirenone|drospirenone|mesh-list
55945181|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
55945182|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55945184|NCT03074045|Estrogens|estrogens|mesh-ancestor
55945185|NCT03074045|Hormones|hormones|mesh-ancestor
55945186|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945187|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945188|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55945189|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
55945190|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55945191|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55945192|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55945193|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55945194|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55945195|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55945196|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
55945197|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55945198|NCT03074045|Diuretics|diuretics|mesh-ancestor
55945199|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
55945200|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
55945201|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
55945202|NCT02248597|Busulfan|busulfan|mesh-list
55945203|NCT02248597|Fludarabine|fludarabine|mesh-list
55945204|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
55945205|NCT02248597|Tacrolimus|tacrolimus|mesh-list
55945206|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945207|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
55945208|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945209|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55945210|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55945211|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
55945212|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945213|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945214|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55945215|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55945216|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
55945228|NCT04126811|Apatinib|apatinib|mesh-list
55945229|NCT04126811|Ifosfamide|ifosfamide|mesh-list
55945230|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
55945231|NCT04126811|Pirarubicin|pirarubicin|mesh-list
55945232|NCT04126811|Doxorubicin|doxorubicin|mesh-list
55945233|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945234|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55945235|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945236|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999998|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
55945237|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55945238|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
55945239|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55945240|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55945241|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55945242|NCT01406223|Bupropion|bupropion|mesh-list
55945243|NCT01406223|Nicotine|nicotine|mesh-list
55945244|NCT01406223|Varenicline|varenicline|mesh-list
55945245|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55945246|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
55945247|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945248|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945249|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55945250|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55945251|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
55945252|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945253|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945254|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55743703|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
55945255|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
55945256|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55945257|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55945258|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55945259|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55945260|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
55945261|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55945262|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55945263|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945264|NCT02230969|Interferons|interferons|mesh-list
55945265|NCT02230969|Interferon-beta|interferon-beta|mesh-list
55945266|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
55945267|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945268|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
55945269|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945270|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
55945271|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945272|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55945274|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55945275|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55945276|NCT04881474|Analgesics|analgesics|mesh-ancestor
55945277|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
55945278|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945279|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945280|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945281|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995275|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
55945288|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55945289|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945291|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945292|NCT00981149|Analgesics|analgesics|mesh-ancestor
55945293|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
55945294|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945295|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
55945296|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55945297|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
55945298|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
55945299|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55945300|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945301|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55945302|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945303|NCT01595646|Insulin|insulin|mesh-list
55945304|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55945305|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
55945306|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55945307|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945308|NCT01907191|Bupivacaine|bupivacaine|mesh-list
55945309|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
55945310|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
55945311|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999999|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000000|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000003|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945312|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945313|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
55945314|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945315|NCT01395537|Paclitaxel|paclitaxel|mesh-list
55945316|NCT01395537|Carboplatin|carboplatin|mesh-list
55945317|NCT01395537|Lapatinib|lapatinib|mesh-list
55945318|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55945319|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945320|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
55945321|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
55945322|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
55945323|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945324|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55945325|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945326|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
55743705|NCT02509429|Insulin|insulin|mesh-list
55945327|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55945328|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55945329|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945330|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
55945331|NCT04898712|Coagulants|coagulants|mesh-ancestor
55945332|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55945333|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55945334|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
55945335|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945336|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
55945337|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55945338|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55945339|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945340|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
55945341|NCT02317549|Coagulants|coagulants|mesh-ancestor
55945342|NCT05583643|Calcium, Dietary|calcium, dietary|mesh-list
55995304|NCT00952133|BB 1101|bb 1101|mesh-list
55945343|NCT05583643|Atorvastatin|atorvastatin|mesh-list
55945344|NCT05583643|Calcium|calcium|mesh-list
55945345|NCT05583643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55945358|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945359|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55945360|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55945361|NCT02225275|Growth Substances|growth substances|mesh-ancestor
55945362|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
55945363|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945364|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945365|NCT01897441|Paclitaxel|paclitaxel|mesh-list
55945366|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
55945367|NCT01897441|Doxorubicin|doxorubicin|mesh-list
55945368|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55945369|NCT01897441|Trastuzumab|trastuzumab|mesh-list
55945370|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55945371|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55945372|NCT01897441|Antibodies|antibodies|mesh-list
55945373|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
55945374|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55945375|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55945376|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945377|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
55945378|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
55945379|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
55945380|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945381|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945382|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
55945383|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945384|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55945385|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55945386|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
56000004|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
56000005|NCT05485896|Lenvatinib|lenvatinib|mesh-list
56000006|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945387|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55945388|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55945389|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55945390|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55945391|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945393|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55945394|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
55945395|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945396|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55995316|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
55945397|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55945398|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
55995323|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
55945399|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
55945401|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945402|NCT04430556|Sertraline|sertraline|mesh-list
55945403|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
55945404|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55945405|NCT04430556|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55945406|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55945407|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55945424|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
55945426|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55945427|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945428|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55945429|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55945430|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55945431|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945432|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
55945433|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945434|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55945435|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
55945436|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
55945437|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
55945438|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945439|NCT04897386|Pemetrexed|pemetrexed|mesh-list
55945440|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945441|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945442|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945443|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55945444|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55945445|NCT02213107|Dutasteride|dutasteride|mesh-list
55945446|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55945447|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55945448|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945449|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945450|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
55945451|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945452|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995343|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
55945453|NCT04879446|Mitogens|mitogens|mesh-list
55945454|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
55945455|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945456|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
55945457|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55945458|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55945459|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945460|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
55945461|NCT02618382|Coagulants|coagulants|mesh-ancestor
55945462|NCT02196961|Nivolumab|nivolumab|mesh-list
55945463|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945471|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55945472|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
55945473|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55945474|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945475|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55945476|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
55789240|NCT03052673|Narcotics|narcotics|mesh-ancestor
56000007|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000008|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56000009|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000010|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000011|NCT05526430|Harmine|harmine|mesh-list
56000012|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
56000013|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000014|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56000015|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55789241|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55945477|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945478|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945479|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
55945480|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945481|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55945482|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945483|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
55945484|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55945485|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55945486|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945487|NCT02166463|Prednisone|prednisone|mesh-list
55945488|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
55945489|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55945490|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55945491|NCT02166463|Prednisolone|prednisolone|mesh-list
55945492|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
55945493|NCT02166463|Cortisone|cortisone|mesh-list
55945494|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
55945495|NCT02166463|Doxorubicin|doxorubicin|mesh-list
55945496|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55945497|NCT02166463|Etoposide|etoposide|mesh-list
55945498|NCT02166463|Vincristine|vincristine|mesh-list
55945499|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
55945500|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55945501|NCT02166463|Bleomycin|bleomycin|mesh-list
55945502|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
55945503|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55945504|NCT02166463|Antibodies|antibodies|mesh-list
55945505|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
55945506|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55945507|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
55945508|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55945509|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
55945510|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945511|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
55945512|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945513|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55945514|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55945515|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
55995389|NCT03023111|Miltefosine|miltefosine|mesh-list
55945516|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945517|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945518|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55945519|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55945520|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55945521|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55945522|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945523|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945524|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
55945525|NCT02166463|Hormones|hormones|mesh-ancestor
55945526|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945527|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55945528|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56000016|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945529|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
55945530|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
55945531|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
55945533|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
55945541|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
55945542|NCT04889196|Protective Agents|protective agents|mesh-ancestor
55945543|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945544|NCT03049176|Tenofovir|tenofovir|mesh-list
55945545|NCT03049176|Emtricitabine|emtricitabine|mesh-list
55743710|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
55945546|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55945548|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
55945549|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945550|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55945551|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55945552|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945553|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945554|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55945555|NCT01895023|Midazolam|midazolam|mesh-list
55945556|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
55945557|NCT01895023|GABA Modulators|gaba modulators|mesh-list
55945558|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55945559|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55945560|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945561|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55945562|NCT01895023|Analgesics|analgesics|mesh-ancestor
55945563|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
55945564|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945565|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55945566|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55995391|NCT03023111|Molgramostim|molgramostim|mesh-list
55945567|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55945568|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
55945569|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945570|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945571|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55945572|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55945573|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55945574|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55945575|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55945576|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
55945577|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
55945578|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
55945579|NCT04888728|Nebivolol|nebivolol|mesh-list
55945580|NCT04888728|Paroxetine|paroxetine|mesh-list
55945581|NCT04888728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55945582|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55945583|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55945584|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945585|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945586|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
55945587|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945588|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55945589|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
55945590|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55945591|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55945592|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55995443|NCT03017495|Midazolam|midazolam|mesh-list
55945593|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945594|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55945595|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
55945596|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55945597|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55945598|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55945599|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
55945600|NCT04125719|Nivolumab|nivolumab|mesh-list
55945601|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945610|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
55945611|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55945612|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945613|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945614|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000017|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000018|NCT05507398|Metformin|metformin|mesh-list
56000019|NCT05507398|Atorvastatin|atorvastatin|mesh-list
56000020|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55945615|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
55743713|NCT02509273|Clonidine|clonidine|mesh-list
55945616|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945617|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
55945618|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945619|NCT01421797|Dexamethasone|dexamethasone|mesh-list
55945620|NCT01421797|Cosyntropin|cosyntropin|mesh-list
55945621|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945622|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
55945623|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
55945624|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945625|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945626|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945627|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
55945628|NCT01421797|Hormones|hormones|mesh-ancestor
55945629|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945630|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55945631|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945632|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55945633|NCT01475643|Prednisolone|prednisolone|mesh-list
55945634|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55945635|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
55945636|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55945637|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
55945639|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
55945640|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945641|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
55945643|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945644|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945645|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55945646|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945647|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
55945648|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
55945649|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945650|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945651|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55945652|NCT01475643|Protective Agents|protective agents|mesh-ancestor
55945653|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55945654|NCT01846663|Rifaximin|rifaximin|mesh-list
55945655|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55945656|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945657|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945658|NCT03004001|Atorvastatin|atorvastatin|mesh-list
55945659|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55945660|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55945661|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55945662|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
55945663|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945664|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55945665|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55945666|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945667|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
55945670|NCT04395222|Melphalan|melphalan|mesh-list
55945671|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
55945672|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55945673|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945674|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945675|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945676|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
55945677|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945678|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55945679|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
55945680|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55945681|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55945682|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55945683|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56000021|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000022|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56000024|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
56000025|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000026|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56000027|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55789251|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55945684|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
55945685|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945686|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55945687|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55945688|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945689|NCT03237377|Durvalumab|durvalumab|mesh-list
55945690|NCT03237377|Tremelimumab|tremelimumab|mesh-list
55945691|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945692|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945693|NCT04124081|Entecavir|entecavir|mesh-list
55945694|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
55945695|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945696|NCT04123925|Nivolumab|nivolumab|mesh-list
55945697|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945698|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945699|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55945700|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945701|NCT04759079|Antiemetics|antiemetics|mesh-list
55945702|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
55945703|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945704|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995579|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
55945705|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945706|NCT03048942|Paclitaxel|paclitaxel|mesh-list
55945707|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55995601|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945708|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945709|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
55945710|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
55945711|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
55995602|NCT01008059|Alfentanil|alfentanil|mesh-list
55995603|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55945712|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945714|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945715|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945716|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55945717|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55945718|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55945719|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55945720|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
55945721|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945722|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55945723|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55945724|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945725|NCT05580445|Gemcitabine|gemcitabine|mesh-list
55945726|NCT05580445|Conteltinib|conteltinib|mesh-list
55945727|NCT05580445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55945728|NCT05580445|Antimetabolites|antimetabolites|mesh-ancestor
55945729|NCT05580445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945730|NCT05580445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945731|NCT05580445|Antiviral Agents|antiviral agents|mesh-ancestor
55945732|NCT05580445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945733|NCT05580445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945734|NCT05580445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945735|NCT05580445|Immunologic Factors|immunologic factors|mesh-ancestor
55945736|NCT05580445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945737|NCT05580445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55945739|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
55945740|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56000028|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000029|NCT05487300|Levodopa|levodopa|mesh-list
56000030|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55945753|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945754|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945755|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945756|NCT02143219|Antidotes|antidotes|mesh-ancestor
55945757|NCT02143219|Protective Agents|protective agents|mesh-ancestor
55945758|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945759|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
55945760|NCT02143219|Vitamins|vitamins|mesh-ancestor
55945761|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
55945762|NCT02143219|Hematinics|hematinics|mesh-ancestor
55945763|NCT04122911|Temozolomide|temozolomide|mesh-list
55945764|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55945765|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
55945766|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945767|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945768|NCT04122599|Melatonin|melatonin|mesh-list
55945769|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
55945770|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945771|NCT04122599|Protective Agents|protective agents|mesh-ancestor
55945772|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945773|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55945774|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55945775|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55945776|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
55945777|NCT03048474|Nivolumab|nivolumab|mesh-list
55945778|NCT03048474|Ipilimumab|ipilimumab|mesh-list
55945779|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945780|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945781|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55945782|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945783|NCT04121975|Endostar protein|endostar protein|mesh-list
55945784|NCT04121975|Endostatins|endostatins|mesh-list
55945785|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945786|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55945787|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55945788|NCT04121975|Growth Substances|growth substances|mesh-ancestor
55945789|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945790|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
55945792|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55945793|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55945794|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945795|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
55945796|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945797|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945798|NCT03830957|Metoprolol|metoprolol|mesh-list
55945799|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55945800|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55945801|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
55945802|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
55945803|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945804|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945805|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55945815|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945816|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
55945817|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945818|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945819|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
55945820|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945821|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
55945822|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55945823|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55945824|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
55945825|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945826|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55945828|NCT05189730|Carboplatin|carboplatin|mesh-list
55945829|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55945830|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945831|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
55945832|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
56000031|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56000032|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
56000033|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789263|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945833|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
55945834|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995759|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55945835|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
55945836|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55945837|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945838|NCT04121039|Apatinib|apatinib|mesh-list
55945839|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945840|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55945841|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945842|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945843|NCT01401543|Tadalafil|tadalafil|mesh-list
55945844|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
55945845|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55945846|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55945847|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945848|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945849|NCT01401543|Urological Agents|urological agents|mesh-ancestor
55945850|NCT02985749|Oxytocin|oxytocin|mesh-list
55945851|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
55945852|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55945853|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945854|NCT04120259|Metformin|metformin|mesh-list
55945855|NCT04120259|Acetic Acid|acetic acid|mesh-list
55945856|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55945857|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945858|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55945859|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945860|NCT04392102|Niraparib|niraparib|mesh-list
55945861|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55945862|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945863|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945864|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945866|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
55945867|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55945868|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945869|NCT02124421|Paclitaxel|paclitaxel|mesh-list
55945870|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55945880|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55945882|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55945883|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945884|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945885|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945886|NCT05256342|Analgesics|analgesics|mesh-ancestor
55945887|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
55945888|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945889|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
55945890|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55945891|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
55945892|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55945893|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55945894|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945895|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55945896|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55945897|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55945898|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945899|NCT02117167|Pemetrexed|pemetrexed|mesh-list
55945900|NCT02117167|Durvalumab|durvalumab|mesh-list
55945901|NCT02117167|Olaparib|olaparib|mesh-list
55945902|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995779|NCT03644212|Vitamin D|vitamin d|mesh-list
55945903|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945904|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945905|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55945906|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55945907|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945908|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56000034|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000035|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000037|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
56000038|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000039|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
56000040|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000041|NCT05485272|Fluorides|fluorides|mesh-list
55789265|NCT04916951|Cephalexin|cephalexin|mesh-list
55945909|NCT04123379|Nivolumab|nivolumab|mesh-list
55945910|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945911|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945912|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55945913|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945915|NCT01895881|Estrogens|estrogens|mesh-ancestor
55945916|NCT01895881|Hormones|hormones|mesh-ancestor
55945917|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945918|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945919|NCT04537962|Listerine|listerine|mesh-list
55945920|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
55945921|NCT04537962|Fluorides|fluorides|mesh-list
55945922|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
55945923|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
55945924|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
55945925|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
55945926|NCT04537962|Protective Agents|protective agents|mesh-ancestor
55945927|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945928|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55945929|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945930|NCT05205252|Dexamethasone|dexamethasone|mesh-list
55945931|NCT05205252|Lenalidomide|lenalidomide|mesh-list
55945932|NCT05205252|Daratumumab|daratumumab|mesh-list
55945933|NCT05205252|Pomalidomide|pomalidomide|mesh-list
55945934|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
55945944|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995816|NCT01104025|Dexamethasone|dexamethasone|mesh-list
55945945|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55945947|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
55945948|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55945949|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55945950|NCT05205252|Growth Substances|growth substances|mesh-ancestor
55945951|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
55945952|NCT04126733|Nivolumab|nivolumab|mesh-list
55945953|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945954|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945955|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55945956|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945957|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
55945958|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
55945959|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945960|NCT04885764|Vaccines|vaccines|mesh-list
55945961|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
55945962|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945963|NCT04311606|Aflibercept|aflibercept|mesh-list
55945964|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55945965|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55945966|NCT04311606|Growth Substances|growth substances|mesh-ancestor
55945967|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945968|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
55945969|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945970|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
55945971|NCT02981069|Exenatide|exenatide|mesh-list
55945972|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55945973|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945974|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55945975|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945976|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55945977|NCT02981069|Incretins|incretins|mesh-ancestor
55945978|NCT02981069|Hormones|hormones|mesh-ancestor
56000043|NCT05485272|Protective Agents|protective agents|mesh-ancestor
56000044|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945979|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945980|NCT02980835|Dexamethasone|dexamethasone|mesh-list
55945981|NCT02980835|Epinephrine|epinephrine|mesh-list
55945982|NCT02980835|Ropivacaine|ropivacaine|mesh-list
55945983|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945984|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
55945985|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
55743719|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55945986|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945987|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945988|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945989|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
55945990|NCT02980835|Hormones|hormones|mesh-ancestor
55945991|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945992|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55945993|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945994|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
55945995|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
55945996|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55945997|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
55945998|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55945999|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55946011|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55946012|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946013|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946014|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
55946015|NCT03824327|Urological Agents|urological agents|mesh-ancestor
55946016|NCT04871724|Fluconazole|fluconazole|mesh-list
55946017|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
55946018|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946019|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55946020|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55946021|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946022|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946023|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55946024|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
55946025|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946026|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946027|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55946028|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55946030|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55946031|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55946032|NCT04871802|Analgesics|analgesics|mesh-ancestor
55946033|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
55946034|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946035|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946036|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946037|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946038|NCT04871646|Nafamostat|nafamostat|mesh-list
55946039|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55946040|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55946041|NCT04871646|Analgesics|analgesics|mesh-ancestor
55946042|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
55946043|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995870|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55946044|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946045|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946046|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946047|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
55946048|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
55946049|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946050|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946051|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55946052|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55946053|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55946054|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55946055|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
56000045|NCT01108666|Nelfinavir|nelfinavir|mesh-list
56000046|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56000047|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56000048|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
56000049|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000050|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000051|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56000052|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55789278|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946057|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946059|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55946060|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55946061|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
55946062|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946073|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946074|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
55946076|NCT04884906|Cisplatin|cisplatin|mesh-list
55946077|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55946078|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946079|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
55946080|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
55946081|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
55946082|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946083|NCT03826589|Avelumab|avelumab|mesh-list
55946084|NCT03826589|Axitinib|axitinib|mesh-list
55946085|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55946086|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946087|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55946088|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144659|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
55946089|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946090|NCT03046758|Metronidazole|metronidazole|mesh-list
55946092|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946093|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55946094|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55946095|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55946096|NCT04382664|Nivolumab|nivolumab|mesh-list
55946097|NCT04382664|Ipilimumab|ipilimumab|mesh-list
55946098|NCT04382664|Sargramostim|sargramostim|mesh-list
55946099|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55946100|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946101|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55946102|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946103|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
55946104|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946105|NCT04392479|Aflibercept|aflibercept|mesh-list
55995892|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55946106|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55946107|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55946108|NCT04392479|Growth Substances|growth substances|mesh-ancestor
55946109|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946110|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
55946111|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946112|NCT03825887|Morphine|morphine|mesh-list
55946113|NCT03825887|Nalbuphine|nalbuphine|mesh-list
55946114|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55946115|NCT03825887|Narcotics|narcotics|mesh-ancestor
55946116|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946117|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946118|NCT03825887|Analgesics|analgesics|mesh-ancestor
55946119|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
55946120|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946121|NCT03825809|Acetaminophen|acetaminophen|mesh-list
55946122|NCT03825809|Celecoxib|celecoxib|mesh-list
55946123|NCT03825809|Ketorolac|ketorolac|mesh-list
55946124|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55946125|NCT03825809|Diazepam|diazepam|mesh-list
55946126|NCT03825809|Gabapentin|gabapentin|mesh-list
55946127|NCT03825809|Hydrocodone|hydrocodone|mesh-list
56000053|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
56000054|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000055|NCT02317276|Triamcinolone|triamcinolone|mesh-list
56000056|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56000057|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56000058|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55946128|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55946139|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946140|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946141|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
55946142|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55946143|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55946144|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946145|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55946146|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55946147|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55946148|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946149|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
55946150|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55946151|NCT03825809|Narcotics|narcotics|mesh-ancestor
55946152|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
55946153|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
55946154|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55946155|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
55946156|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
55946157|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55946158|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55946159|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55946160|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55946161|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55946162|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
55946163|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
55946164|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
55946165|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
55946166|NCT03824717|Ropivacaine|ropivacaine|mesh-list
55946167|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
55946168|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
55946169|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946170|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946171|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
55946172|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946174|NCT04392557|Pioglitazone|pioglitazone|mesh-list
55946176|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55946177|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946178|NCT04392557|Incretins|incretins|mesh-ancestor
55946179|NCT04392557|Hormones|hormones|mesh-ancestor
55946180|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946181|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55946182|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
55946183|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946184|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946185|NCT02115373|Tepotinib|tepotinib|mesh-list
55946186|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946187|NCT02948543|Mitomycins|mitomycins|mesh-list
55946188|NCT02948543|Mitomycin|mitomycin|mesh-list
55946189|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55946190|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946191|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
55946192|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946193|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55946207|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55946208|NCT02079181|Fluorides|fluorides|mesh-list
55946209|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
55946210|NCT02079181|Protective Agents|protective agents|mesh-ancestor
55946211|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946212|NCT02946125|Phenylephrine|phenylephrine|mesh-list
55946213|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
55946214|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55946215|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56000059|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56000060|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
56000061|NCT02317276|Hormones|hormones|mesh-ancestor
55946216|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
55946218|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946219|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946220|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
55946221|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55946222|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
55946223|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
55946224|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55946225|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55946226|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55946227|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
55946228|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946229|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946230|NCT02946125|Protective Agents|protective agents|mesh-ancestor
55946231|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55946233|NCT01895257|Fluorouracil|fluorouracil|mesh-list
55946234|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
55946235|NCT01895257|Antidotes|antidotes|mesh-ancestor
55946236|NCT01895257|Protective Agents|protective agents|mesh-ancestor
55946237|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946238|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
55946239|NCT01895257|Vitamins|vitamins|mesh-ancestor
55946240|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
55946241|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
55946242|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144660|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
55946243|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55946244|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946245|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55946246|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
55946248|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55946249|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55946250|NCT02064673|Analgesics|analgesics|mesh-ancestor
55946251|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
55946252|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946253|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946254|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946255|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946265|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946266|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55946267|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946269|NCT02053909|Ticagrelor|ticagrelor|mesh-list
55946270|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55946271|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55946272|NCT02053909|Analgesics|analgesics|mesh-ancestor
55946273|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
55946274|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946275|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946276|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946277|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946278|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55946279|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55946280|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946281|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55946282|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55946283|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946284|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
55946285|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55996028|NCT03866434|Omeprazole|omeprazole|mesh-list
55946286|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55946287|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55946288|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
55946289|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946290|NCT02863991|TIC10 compound|tic10 compound|mesh-list
55946291|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946292|NCT02860091|Ropivacaine|ropivacaine|mesh-list
55946293|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
55946294|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
56000062|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000063|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946295|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946296|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946297|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
55946298|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946299|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
55946300|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55946301|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55946302|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55946303|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55946304|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946305|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
55946306|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946307|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946308|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55946309|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946310|NCT03823781|Milrinone|milrinone|mesh-list
55946311|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55946312|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55946313|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
55946314|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55946315|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55946316|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946317|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946318|NCT03823781|Protective Agents|protective agents|mesh-ancestor
55946319|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946332|NCT02614794|Trastuzumab|trastuzumab|mesh-list
55946333|NCT02614794|Tucatinib|tucatinib|mesh-list
55946334|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55946335|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
55946336|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946337|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946338|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55946339|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55946340|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946341|NCT03823079|Irinotecan|irinotecan|mesh-list
55946342|NCT03823079|Raltitrexed|raltitrexed|mesh-list
55946343|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55946344|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55946345|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946346|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946347|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946348|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55946349|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
55946350|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55946351|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
55946352|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55946353|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
55996074|NCT03012763|Acetaminophen|acetaminophen|mesh-list
55946354|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946355|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55946356|NCT02839265|Protective Agents|protective agents|mesh-ancestor
55946357|NCT00988247|Beclomethasone|beclomethasone|mesh-list
55946358|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946359|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
55946360|NCT00988247|Hormones|hormones|mesh-ancestor
55946361|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946362|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946363|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55946364|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
55946365|NCT02832401|Caffeine|caffeine|mesh-list
55946366|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55946367|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946368|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55946369|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946370|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946371|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55946372|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55946373|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
56000064|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000065|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
56000066|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789294|NCT02609815|Metformin|metformin|mesh-list
55946374|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946375|NCT03044808|Lidocaine|lidocaine|mesh-list
55946376|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
55946377|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
55946378|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946379|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946380|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
55946381|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946382|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55946391|NCT04877106|Metformin|metformin|mesh-list
55946392|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55946393|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55946394|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946395|NCT04877106|Incretins|incretins|mesh-ancestor
55946396|NCT04877106|Hormones|hormones|mesh-ancestor
55946397|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946398|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55946399|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
55946400|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946401|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946402|NCT00981617|ALKS-33|alks-33|mesh-list
55946403|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55946404|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946405|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
55946406|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946407|NCT04876716|Voriconazole|voriconazole|mesh-list
55946408|NCT04876716|Posaconazole|posaconazole|mesh-list
55946409|NCT04876716|Isavuconazole|isavuconazole|mesh-list
55946410|NCT04876716|Anidulafungin|anidulafungin|mesh-list
55946411|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
55946412|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946413|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55946414|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55946415|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996100|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55946416|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946417|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55946418|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
55946419|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946420|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946421|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55946422|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55946423|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55946424|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55946425|NCT04865250|Paclitaxel|paclitaxel|mesh-list
55946426|NCT04865250|Carboplatin|carboplatin|mesh-list
55946427|NCT04865250|Atezolizumab|atezolizumab|mesh-list
55946428|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55946429|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946430|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
55946431|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
55946432|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
55946433|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946434|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
55946435|NCT04865562|Testosterone|testosterone|mesh-list
55946436|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
55946437|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
55946438|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55946439|NCT04865562|Androgens|androgens|mesh-ancestor
55946440|NCT04865562|Hormones|hormones|mesh-ancestor
55946441|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946442|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946443|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55946444|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946445|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
55946446|NCT04864782|Paclitaxel|paclitaxel|mesh-list
55946447|NCT04864782|Carboplatin|carboplatin|mesh-list
55946448|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55946462|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
56000067|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000068|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
55946463|NCT04875702|Protective Agents|protective agents|mesh-ancestor
55946464|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946465|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55946466|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
55946467|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946469|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
55946470|NCT04385940|Vitamins|vitamins|mesh-ancestor
55946471|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
55946472|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946473|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55946474|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55946475|NCT00984659|Fluticasone|fluticasone|mesh-list
55946477|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55946478|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946479|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55946480|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
55946481|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946482|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946483|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55946484|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
55946485|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
55946486|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55946487|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55946488|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55946489|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55946490|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
55946491|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946492|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946493|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
55946494|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55946495|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
55946496|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946497|NCT04864314|Protective Agents|protective agents|mesh-ancestor
55946498|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946499|NCT04874844|Antibodies|antibodies|mesh-list
55946500|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55946501|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
55946502|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946503|NCT02740985|Docetaxel|docetaxel|mesh-list
55946504|NCT02740985|Durvalumab|durvalumab|mesh-list
55946505|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
55946506|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946507|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
55946508|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
55946509|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
55946510|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946522|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946523|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946524|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
55946525|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946526|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55946527|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55946528|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55946529|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55946530|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946531|NCT04349124|Nifedipine|nifedipine|mesh-list
55946532|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55946533|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55946534|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946535|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55946536|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946537|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
55946538|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
55946539|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55946540|NCT04874688|Provitamins|provitamins|mesh-list
56000069|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56000070|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56000071|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56000072|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56000073|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000074|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
56000075|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000076|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000077|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56000078|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000079|NCT00378976|Valacyclovir|valacyclovir|mesh-list
55789298|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55946541|NCT04874688|Beta Carotene|beta carotene|mesh-list
55946542|NCT04874688|Vitamins|vitamins|mesh-ancestor
55946543|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
55946544|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946545|NCT02932475|Metformin|metformin|mesh-list
55946546|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55946547|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946548|NCT02612064|Fluorides|fluorides|mesh-list
55946549|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
55946550|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
55946551|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
55946552|NCT02612064|Protective Agents|protective agents|mesh-ancestor
55946553|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946554|NCT04553003|Prednisone|prednisone|mesh-list
55946555|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
55946556|NCT04553003|Choline|choline|mesh-list
55946557|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
55946558|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
55946559|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946560|NCT04553003|Hormones|hormones|mesh-ancestor
55946561|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946562|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946563|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55946564|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946565|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
55946566|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
55996115|NCT04290676|Dexamethasone|dexamethasone|mesh-list
55946567|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946568|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55946569|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55946570|NCT04553003|Protective Agents|protective agents|mesh-ancestor
55946571|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
55946572|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55946573|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
55946591|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946593|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55946594|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55946595|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
55946596|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946597|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55946598|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55946599|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946600|NCT03047538|Amlodipine|amlodipine|mesh-list
55946601|NCT03047538|Perindopril|perindopril|mesh-list
55946602|NCT03047538|Atorvastatin|atorvastatin|mesh-list
55946603|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55946604|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55946605|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
55946606|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946607|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55946608|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55946609|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000080|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
56000081|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000082|NCT05342974|Misoprostol|misoprostol|mesh-list
56000083|NCT05342974|Atorvastatin|atorvastatin|mesh-list
55946610|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55946611|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55946612|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55946613|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55946614|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946615|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
55946616|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55946617|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
55946619|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
55946620|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946621|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55946622|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946623|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946625|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946626|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946627|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55946639|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
55802842|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55946640|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55946641|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
55946642|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946643|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946644|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55946645|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
55946646|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946647|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946648|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55946649|NCT04273763|Interferons|interferons|mesh-list
55946650|NCT04273763|Bromhexine|bromhexine|mesh-list
55946651|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946652|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
55946653|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946654|NCT04273763|Expectorants|expectorants|mesh-ancestor
55946655|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
55946656|NCT01718743|Lenalidomide|lenalidomide|mesh-list
55946657|NCT01718743|Ixazomib|ixazomib|mesh-list
55946658|NCT01718743|Glycine|glycine|mesh-list
55946659|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
55946660|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946661|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55946662|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55946663|NCT01718743|Growth Substances|growth substances|mesh-ancestor
55946664|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
55946665|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946666|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946667|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
55946668|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946669|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
55946670|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946671|NCT01712815|Clevudine|clevudine|mesh-list
55946672|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
55946673|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946674|NCT03820193|Acetaminophen|acetaminophen|mesh-list
55946675|NCT03820193|Celecoxib|celecoxib|mesh-list
55946676|NCT03820193|Ketorolac|ketorolac|mesh-list
55946677|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55946678|NCT03820193|Diazepam|diazepam|mesh-list
55946679|NCT03820193|Gabapentin|gabapentin|mesh-list
55946680|NCT03820193|Hydrocodone|hydrocodone|mesh-list
55946681|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55946682|NCT03820193|Analgesics|analgesics|mesh-ancestor
55946683|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
55946684|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946685|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946686|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
55946687|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55946688|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946689|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946690|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56000084|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56000085|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55789312|NCT04012957|Hematinics|hematinics|mesh-ancestor
55946691|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55946703|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55946704|NCT03820193|Narcotics|narcotics|mesh-ancestor
55946705|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
55946706|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
55946707|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55946708|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
55946709|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
55946710|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55946711|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55946712|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55946713|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55946714|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55946715|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
55946716|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
55946717|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
55946718|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
55946719|NCT03820037|Opicapone|opicapone|mesh-list
55946720|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55946721|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946722|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946723|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55946724|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55946725|NCT03829007|Durvalumab|durvalumab|mesh-list
55996175|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55996176|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946727|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55946728|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946729|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
55946730|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946732|NCT02614560|Melphalan|melphalan|mesh-list
55946733|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946734|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946735|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55946736|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
55946737|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946738|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55946739|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
55946740|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55946741|NCT03828929|Thiamine|thiamine|mesh-list
55946742|NCT03828929|Vitamins|vitamins|mesh-ancestor
55946743|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
55946744|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946745|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
55946746|NCT04873440|Manganese|manganese|mesh-list
55946747|NCT04873440|Trace Elements|trace elements|mesh-ancestor
55946748|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
55946749|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946750|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
55946751|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
55946752|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55946753|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946754|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55946755|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55946756|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946773|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
55946774|NCT04391621|Hormones|hormones|mesh-ancestor
55946775|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946776|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946777|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55946778|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
55946779|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946780|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946781|NCT01669122|Nicotine|nicotine|mesh-list
55946782|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55946783|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
55946784|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946785|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946786|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55946787|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55946788|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
56000086|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
56000087|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000088|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55946789|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946790|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946791|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
55946792|NCT03629483|Ropivacaine|ropivacaine|mesh-list
55946793|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55946794|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946795|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946796|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55946797|NCT03629483|Analgesics|analgesics|mesh-ancestor
55946798|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
55946799|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996210|NCT04974151|Hematinics|hematinics|mesh-ancestor
55946800|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55946801|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55946802|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55946803|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
55946804|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946805|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946806|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
55946807|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
55946808|NCT04873284|Dexamethasone|dexamethasone|mesh-list
55946809|NCT04873284|Aprepitant|aprepitant|mesh-list
55946810|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
55946811|NCT04873284|Granisetron|granisetron|mesh-list
55946812|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946813|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
55946814|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
55946815|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946823|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55946824|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946825|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946826|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55946827|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
55946829|NCT01450865|Analgesics|analgesics|mesh-ancestor
55946830|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
55946831|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946832|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946833|NCT01308619|Doxycycline|doxycycline|mesh-list
55946834|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55946835|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946836|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
55946837|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55946838|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55946839|NCT02611752|Buprenorphine|buprenorphine|mesh-list
55946840|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55946841|NCT02611752|Narcotics|narcotics|mesh-ancestor
55946842|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946843|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946844|NCT02611752|Analgesics|analgesics|mesh-ancestor
55946845|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
55946846|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946847|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55946848|NCT01307605|Rituximab|rituximab|mesh-list
55946849|NCT01307605|Lenalidomide|lenalidomide|mesh-list
55946850|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55946851|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946852|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
55946853|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946854|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946855|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55946856|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55946857|NCT01307605|Growth Substances|growth substances|mesh-ancestor
55946858|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
55946859|NCT04758689|Methotrexate|methotrexate|mesh-list
55946860|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55946861|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
55946862|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55946863|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000089|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56000090|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000091|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56000092|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
56000093|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56000094|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000095|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55789316|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996269|NCT01169467|Analgesics|analgesics|mesh-ancestor
55946864|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55946865|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
55946866|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946867|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946868|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
55946869|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946870|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55946871|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55946872|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
55946873|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946874|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55946875|NCT01451333|Efavirenz|efavirenz|mesh-list
55946876|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55946877|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55946878|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946879|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946880|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
55946881|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946892|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946893|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55946894|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55946895|NCT01702831|Growth Substances|growth substances|mesh-ancestor
55946896|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
55946898|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55946899|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
55946900|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946901|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55946902|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55946904|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55946905|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
55946906|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946907|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946908|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946909|NCT01451879|Miglustat|miglustat|mesh-list
55946910|NCT01451879|Rituximab|rituximab|mesh-list
55946911|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55946912|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946913|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
55946914|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946915|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946916|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946917|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946918|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55946919|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55946920|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
55946921|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946922|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55946923|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55946924|NCT03045198|Azithromycin|azithromycin|mesh-list
55946925|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55946926|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946927|NCT01305499|Azacitidine|azacitidine|mesh-list
55946928|NCT01305499|Entinostat|entinostat|mesh-list
55996273|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55996274|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55946929|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55946930|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
56000096|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56000097|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
56000098|NCT02297230|Paclitaxel|paclitaxel|mesh-list
56000099|NCT02297230|Capecitabine|capecitabine|mesh-list
56000100|NCT02297230|Trastuzumab|trastuzumab|mesh-list
56000101|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56000102|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000103|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
56000104|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
56000105|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
56000106|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000107|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55946931|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946932|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946933|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946934|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55946935|NCT05417113|Bupivacaine|bupivacaine|mesh-list
55946936|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
55946937|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
55946938|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946939|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946940|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
55946941|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946942|NCT01452113|Vildagliptin|vildagliptin|mesh-list
55946943|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55743732|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55946961|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
55946962|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946963|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55946964|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55946965|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55946966|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946967|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55946968|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55946969|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946970|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55946971|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55946972|NCT02635841|Deferiprone|deferiprone|mesh-list
55946973|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55946974|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
55946975|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
55946976|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946977|NCT00608725|Propranolol|propranolol|mesh-list
55946978|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55946979|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55946980|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
55946981|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946982|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946983|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946984|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55946985|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55946986|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
55946987|NCT01452659|Relugolix|relugolix|mesh-list
55946988|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
55946989|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
55946990|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946991|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946992|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55946993|NCT01896349|Amitriptyline|amitriptyline|mesh-list
55946994|NCT01896349|Risperidone|risperidone|mesh-list
55946995|NCT01896349|Sulpiride|sulpiride|mesh-list
55946996|NCT01896349|Mirtazapine|mirtazapine|mesh-list
56000108|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
56000109|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55946997|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
55946998|NCT01896349|Trazodone|trazodone|mesh-list
55946999|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
55947000|NCT01896349|Citalopram|citalopram|mesh-list
55947001|NCT01896349|Bupropion|bupropion|mesh-list
55947002|NCT01896349|Sertraline|sertraline|mesh-list
55947003|NCT01896349|Fluoxetine|fluoxetine|mesh-list
55947004|NCT01896349|Paroxetine|paroxetine|mesh-list
55947012|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947013|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947014|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947015|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55947016|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55947017|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947018|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55947020|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
55947021|NCT01896349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55947022|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55947023|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55947024|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55947025|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947026|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55947027|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55947028|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55947029|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947030|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55947031|NCT01896349|Analgesics|analgesics|mesh-ancestor
55947032|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
55947033|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55947034|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
55947035|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
55947036|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55947037|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55947038|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55947039|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55947040|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
55947041|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55947042|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55947043|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55947044|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55947045|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55947046|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55947047|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55947048|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55947050|NCT01452737|Cathartics|cathartics|mesh-ancestor
55947051|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55947052|NCT01452737|Laxatives|laxatives|mesh-ancestor
55947053|NCT00595933|Muramidase|muramidase|mesh-list
55947054|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947055|NCT00580489|Fentanyl|fentanyl|mesh-list
55947056|NCT00580489|Morphine|morphine|mesh-list
55947057|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55947058|NCT00580489|Narcotics|narcotics|mesh-ancestor
55947059|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947060|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947061|NCT00580489|Analgesics|analgesics|mesh-ancestor
55947062|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
55996363|NCT03805672|Enoxaparin|enoxaparin|mesh-list
55947063|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947064|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55947065|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55947066|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
55947067|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
55947068|NCT01659307|Aspirin|aspirin|mesh-list
55947069|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55947070|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55947072|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
55947073|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947074|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947088|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947089|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55947090|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56000110|NCT02282332|Ticagrelor|ticagrelor|mesh-list
56000111|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56000112|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56000113|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56000114|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55947091|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55947092|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
55947093|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55947094|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947095|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947096|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55947097|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55947098|NCT04391231|Protective Agents|protective agents|mesh-ancestor
55947099|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947100|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
55947101|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55947102|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
55947103|NCT04872270|Caffeine|caffeine|mesh-list
55947104|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55947105|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947106|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55947107|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947108|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947109|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55947110|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55947111|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
55947112|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947113|NCT04872192|Anesthetics|anesthetics|mesh-list
55947114|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947115|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947116|NCT01624285|Sorafenib|sorafenib|mesh-list
55947117|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947118|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55947119|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947120|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947121|NCT01454609|Clonidine|clonidine|mesh-list
55947122|NCT01454609|Bupivacaine|bupivacaine|mesh-list
55947123|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
55947124|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
55947125|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947126|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947127|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
55947128|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947129|NCT01454609|Analgesics|analgesics|mesh-ancestor
55947130|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55947131|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
55947132|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
55947133|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55947134|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55947135|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55947146|NCT02905799|Protective Agents|protective agents|mesh-ancestor
55947147|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947148|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947149|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55947150|NCT00505063|Vaccines|vaccines|mesh-list
55947151|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55947152|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
55947153|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947154|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
55947155|NCT00469183|Tretinoin|tretinoin|mesh-list
55947156|NCT00469183|Hydroquinone|hydroquinone|mesh-list
55947157|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947158|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
55947159|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
55947160|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55947161|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
55947162|NCT00469183|Hormones|hormones|mesh-ancestor
55947163|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947164|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000115|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
56000116|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000117|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000118|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947165|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
55947166|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947167|NCT00469183|Protective Agents|protective agents|mesh-ancestor
55947168|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55947169|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55947170|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55947171|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55947172|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947173|NCT00468715|Bicalutamide|bicalutamide|mesh-list
55947174|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
55947175|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
55947176|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947177|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947178|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947179|NCT01456247|Lansoprazole|lansoprazole|mesh-list
55947180|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
55947181|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55947182|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55947183|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55947184|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947185|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947186|NCT00452023|Interferons|interferons|mesh-list
55947187|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
55947188|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
55947189|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55947190|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947191|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
55947192|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947193|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
55947194|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947195|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55947196|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947197|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55947198|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947199|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947201|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55947202|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55947203|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947205|NCT05053867|Coagulants|coagulants|mesh-ancestor
55947207|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
55947208|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947209|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947210|NCT04866654|Nivolumab|nivolumab|mesh-list
55947211|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55947212|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947213|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55947214|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947215|NCT01546987|Leuprolide|leuprolide|mesh-list
55947216|NCT01546987|Goserelin|goserelin|mesh-list
55947217|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55947218|NCT01546987|Flutamide|flutamide|mesh-list
55947219|NCT01546987|Bicalutamide|bicalutamide|mesh-list
55947221|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55947222|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
55947223|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55820989|NCT04672005|Paclitaxel|paclitaxel|mesh-list
55947224|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947225|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55947226|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947227|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-ancestor
55947228|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
55947229|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947230|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
55947231|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55947232|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
55947233|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56000119|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56000120|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56000121|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000122|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
56000123|NCT02253394|Ambrisentan|ambrisentan|mesh-list
56000124|NCT02253394|Spironolactone|spironolactone|mesh-list
55947234|NCT01456715|Vaccines|vaccines|mesh-list
55947235|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
55947236|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947237|NCT01895569|Metformin|metformin|mesh-list
55947238|NCT01895569|Pioglitazone|pioglitazone|mesh-list
55947239|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55947240|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55947241|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947242|NCT01895569|Incretins|incretins|mesh-ancestor
55947244|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947245|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55947246|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
55947247|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947248|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947249|NCT01457261|Albuterol|albuterol|mesh-list
55996419|NCT03797872|Analgesics|analgesics|mesh-ancestor
55947250|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55947251|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
55947252|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947253|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947254|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55947255|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
55947256|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
55947257|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55947258|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55947259|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55947260|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55947261|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
55947262|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947263|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947264|NCT01457495|Edetic Acid|edetic acid|mesh-list
55947265|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
55947266|NCT01457495|Antidotes|antidotes|mesh-ancestor
55947267|NCT01457495|Protective Agents|protective agents|mesh-ancestor
55947268|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947269|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
55947270|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
55947271|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947272|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55947273|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
55947274|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55947275|NCT04778137|Omalizumab|omalizumab|mesh-list
55947276|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55947296|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947297|NCT00394147|Antiviral Agents|antiviral agents|mesh-ancestor
55947298|NCT00394147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947299|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947300|NCT00394147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55947301|NCT00394147|Immunologic Factors|immunologic factors|mesh-ancestor
55947302|NCT00394147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947303|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55947304|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55947305|NCT01458041|Iloprost|iloprost|mesh-list
55947306|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55947307|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
55947308|NCT02610816|Fluticasone|fluticasone|mesh-list
55947309|NCT02610816|Xhance|xhance|mesh-list
55947310|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55947311|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55947312|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
55947313|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947314|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947315|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55947316|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
55947317|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
56000125|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56000126|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
55789352|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55947318|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55947328|NCT00332605|Naltrexone|naltrexone|mesh-list
55947329|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55947330|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55947331|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55947332|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947333|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
55947334|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947335|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
55947336|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947337|NCT00332605|Expectorants|expectorants|mesh-ancestor
55947338|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
55947339|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55947340|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
55947353|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947355|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
55947356|NCT01415583|Hormones|hormones|mesh-ancestor
55947357|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947358|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55947359|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947360|NCT01458977|Tenofovir|tenofovir|mesh-list
55947361|NCT01458977|Emtricitabine|emtricitabine|mesh-list
55947362|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55947363|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
55947364|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947365|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55947366|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55947367|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947368|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947369|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55947370|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55947371|NCT02508311|Albuterol|albuterol|mesh-list
55947372|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55947373|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
55947374|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947375|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947376|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55947377|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
55947378|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
55947379|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55947380|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55947381|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55947382|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55947383|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
55947384|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947385|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947386|NCT00256399|Alfuzosin|alfuzosin|mesh-list
55947387|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55947388|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55947389|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55947390|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
55947391|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947392|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947393|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947394|NCT00256399|Urological Agents|urological agents|mesh-ancestor
55947396|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55947397|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947398|NCT01459211|Dexamethasone|dexamethasone|mesh-list
55947399|NCT01459211|Lenalidomide|lenalidomide|mesh-list
55947400|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55947401|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
55947402|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
55947403|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000127|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000128|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000129|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56000130|NCT02253394|Diuretics|diuretics|mesh-ancestor
55947415|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
55947416|NCT00198991|Cytarabine|cytarabine|mesh-list
55947417|NCT00198991|Dexamethasone|dexamethasone|mesh-list
55947418|NCT00198991|Prednisolone|prednisolone|mesh-list
55947419|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
55947420|NCT00198991|Methotrexate|methotrexate|mesh-list
55947421|NCT00198991|Fludarabine|fludarabine|mesh-list
55947422|NCT00198991|Etoposide|etoposide|mesh-list
55947423|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
55947424|NCT00198991|Vincristine|vincristine|mesh-list
55947425|NCT00198991|Doxorubicin|doxorubicin|mesh-list
55947426|NCT00198991|Daunorubicin|daunorubicin|mesh-list
55947427|NCT00198991|Asparaginase|asparaginase|mesh-list
55947428|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
55947429|NCT00198991|Idarubicin|idarubicin|mesh-list
55947430|NCT00198991|Thioguanine|thioguanine|mesh-list
55947431|NCT00198991|Cladribine|cladribine|mesh-list
55947432|NCT00198991|Vindesine|vindesine|mesh-list
55947433|NCT00198991|Teniposide|teniposide|mesh-list
55947434|NCT00198991|Pegaspargase|pegaspargase|mesh-list
55947435|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55947436|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
55947437|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947438|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55947439|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55947440|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
55947441|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947442|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947443|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55947444|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55947445|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
55947446|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
55947447|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947448|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55947449|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
55947450|NCT00198991|Hormones|hormones|mesh-ancestor
55947451|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947452|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55947453|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55947454|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
55947455|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55947456|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55947457|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
55947458|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
55947459|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947460|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55947461|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55947462|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55947463|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55947464|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55947465|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
55996484|NCT04141930|Baloxavir|baloxavir|mesh-list
55996485|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
55947466|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947467|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
55947468|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
55947469|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
55947470|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55947471|NCT01459367|Lansoprazole|lansoprazole|mesh-list
55947472|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
55947473|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55947477|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947478|NCT04777591|Bupivacaine|bupivacaine|mesh-list
55947479|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
55947480|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
55947481|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947482|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947483|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
55947484|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000131|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
56000140|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000141|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000142|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55947493|NCT01459601|Cabergoline|cabergoline|mesh-list
55947494|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55947495|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55947496|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
55947497|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
55947498|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947499|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947500|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947501|NCT01418001|Gemcitabine|gemcitabine|mesh-list
55947502|NCT01418001|Docetaxel|docetaxel|mesh-list
55947503|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55947504|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
55947505|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947506|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947507|NCT01418001|Antiviral Agents|antiviral agents|mesh-ancestor
55947508|NCT01418001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947509|NCT01418001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947510|NCT01418001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55947511|NCT01418001|Immunologic Factors|immunologic factors|mesh-ancestor
55947512|NCT01418001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947513|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
55947514|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
55947515|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
55947516|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55947517|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55947518|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55947519|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
55947520|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947521|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56144661|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947522|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55947523|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947524|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
55947526|NCT01542255|Vinblastine|vinblastine|mesh-list
55947527|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55947528|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
55947529|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947530|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55947531|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55947532|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
55933905|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
55933910|NCT03067740|Bupivacaine|bupivacaine|mesh-list
55947533|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947534|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000143|NCT05479032|Analgesics|analgesics|mesh-ancestor
56000144|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
56000145|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000146|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
55789368|NCT04916093|Incretins|incretins|mesh-ancestor
55947535|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55947536|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55947537|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
55947538|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
55947539|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
55947540|NCT01456481|Midodrine|midodrine|mesh-list
55947541|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
55947542|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
55947543|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947554|NCT02872259|Dabrafenib|dabrafenib|mesh-list
55822080|NCT01973283|Analgesics|analgesics|mesh-ancestor
55947555|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55947556|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947557|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55947558|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947559|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947561|NCT04776655|Bevacizumab|bevacizumab|mesh-list
55947562|NCT04776655|Cetuximab|cetuximab|mesh-list
55947563|NCT04776655|Fluorouracil|fluorouracil|mesh-list
55947564|NCT04776655|Irinotecan|irinotecan|mesh-list
55947565|NCT04776655|Calcium|calcium|mesh-list
55947566|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
55947567|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55947568|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947569|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55947570|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55947571|NCT04776655|Growth Substances|growth substances|mesh-ancestor
55947572|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947573|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
55947574|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55947575|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
55947576|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947577|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55947578|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55947579|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
55947580|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55947581|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55947582|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947583|NCT04776655|Antidotes|antidotes|mesh-ancestor
55947584|NCT04776655|Protective Agents|protective agents|mesh-ancestor
55947585|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
55947586|NCT04776655|Vitamins|vitamins|mesh-ancestor
55947587|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
55947588|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
55947589|NCT01455233|Besifloxacin|besifloxacin|mesh-list
55947590|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55947591|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55947592|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55947593|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55947594|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947595|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55947596|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55947597|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947598|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947599|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947600|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55947601|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
55947602|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55947603|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933922|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55947604|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55947605|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55947606|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55947608|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55947612|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
55947613|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947614|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56000147|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56000148|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56000149|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000150|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
55947615|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
55947616|NCT00048295|Alicaforsen|alicaforsen|mesh-list
55947617|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55947618|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55947619|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
55947620|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947622|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55947623|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947624|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55947625|NCT01455857|Incretins|incretins|mesh-ancestor
55947626|NCT01455857|Hormones|hormones|mesh-ancestor
55947627|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947628|NCT01067287|Pidilizumab|pidilizumab|mesh-list
55947629|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55947630|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947631|NCT03043248|Digoxin|digoxin|mesh-list
55947632|NCT03043248|Midazolam|midazolam|mesh-list
55947633|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55947634|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55947635|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947636|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947637|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55947638|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55947639|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55947640|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55947641|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
55947642|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
55947643|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
55947644|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
55947645|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947646|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947647|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55947648|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55947649|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947650|NCT03043248|Protective Agents|protective agents|mesh-ancestor
55947651|NCT04843631|Ustekinumab|ustekinumab|mesh-list
55947652|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
55947653|NCT03043326|Tenofovir|tenofovir|mesh-list
55947654|NCT03043326|Emtricitabine|emtricitabine|mesh-list
55947655|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
55947656|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947657|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55947658|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55947659|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947660|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947661|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55947662|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55947663|NCT04845737|Vitamin D|vitamin d|mesh-list
55947664|NCT04845737|Vitamins|vitamins|mesh-ancestor
55947665|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
55947666|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947667|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55947668|NCT04849715|Rituximab|rituximab|mesh-list
55947669|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55947670|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55947671|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947672|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
55947673|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947674|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55947675|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55947676|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
55947677|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947678|NCT03044964|Ranolazine|ranolazine|mesh-list
55947679|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55947680|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55947681|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947682|NCT01419639|Everolimus|everolimus|mesh-list
55947683|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000151|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
56000152|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000153|NCT05484648|Dexamethasone|dexamethasone|mesh-list
55789375|NCT05130619|Ethanol|ethanol|mesh-list
55947684|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55947686|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947688|NCT02856893|Osimertinib|osimertinib|mesh-list
55947689|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947690|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55947691|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947692|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947693|NCT01419795|Rituximab|rituximab|mesh-list
55947694|NCT01419795|Lenalidomide|lenalidomide|mesh-list
55947695|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55947696|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947697|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
55947698|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947699|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55947700|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55947701|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55947702|NCT01419795|Growth Substances|growth substances|mesh-ancestor
55947703|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
55947704|NCT04783753|Itraconazole|itraconazole|mesh-list
55947705|NCT04783753|Quinidine|quinidine|mesh-list
55947706|NCT04783753|Carbamazepine|carbamazepine|mesh-list
55947707|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
55947708|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947709|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55947710|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55947711|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947712|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947713|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55947714|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
55947715|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996520|NCT03783130|Antacids|antacids|mesh-ancestor
55947716|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947717|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55947718|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
55947719|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
55947720|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55947721|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947722|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55947723|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55947724|NCT04783753|Analgesics|analgesics|mesh-ancestor
55947725|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
55947726|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947727|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55947728|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55947729|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55947730|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55947731|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55947732|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55947733|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
55947734|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947735|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55947736|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
55947737|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55947738|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55947739|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55947740|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55947741|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
55947742|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55947743|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55947744|NCT02856581|Varenicline|varenicline|mesh-list
55947745|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55947746|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55947747|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
55947748|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947749|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947750|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947751|NCT03042000|Capecitabine|capecitabine|mesh-list
55947752|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
55947753|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55947754|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
55947755|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947756|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947757|NCT01039285|Poractant alfa|poractant alfa|mesh-list
55947765|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947768|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
55947769|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55947770|NCT04775563|Vaccines|vaccines|mesh-list
55947771|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
55947772|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947773|NCT01480089|Ropivacaine|ropivacaine|mesh-list
55947774|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
55947775|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
55947776|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947777|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947778|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
55947779|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947780|NCT03523975|Rituximab|rituximab|mesh-list
55947781|NCT03523975|Lenalidomide|lenalidomide|mesh-list
55947782|NCT03523975|Venetoclax|venetoclax|mesh-list
55947783|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55947784|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947785|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
55947786|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947787|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55947788|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55947789|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55947790|NCT03523975|Growth Substances|growth substances|mesh-ancestor
55947791|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
55947792|NCT01542645|Fentanyl|fentanyl|mesh-list
55947793|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
55947794|NCT01542645|Methadone|methadone|mesh-list
55947795|NCT01542645|Narcotics|narcotics|mesh-ancestor
55947796|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947797|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947798|NCT01542645|Analgesics|analgesics|mesh-ancestor
55947799|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
55947800|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947801|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55947802|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55947803|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
55947804|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
55947805|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
55947806|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
55947807|NCT04857450|Ketamine|ketamine|mesh-list
55947808|NCT04857450|Etomidate|etomidate|mesh-list
55947809|NCT04857450|Analgesics|analgesics|mesh-ancestor
55947810|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
55947811|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947812|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947813|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55947814|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55947815|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
55947816|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
55947817|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947818|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55947819|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55947820|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947821|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947822|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55947823|NCT01420653|Acetaminophen|acetaminophen|mesh-list
55947836|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947837|NCT03042936|Insulin|insulin|mesh-list
55947838|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55947839|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947840|NCT04849026|Clozapine|clozapine|mesh-list
55947841|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55947842|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
55947843|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947844|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000154|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
56000155|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56000156|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
56000157|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
56000158|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000159|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947845|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947846|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55947847|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55947848|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947849|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55947850|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
55947851|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
55947852|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55947853|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55947854|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55947855|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
55947856|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947857|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947858|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55947859|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55947860|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
55947861|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947862|NCT04844957|Vitamin D|vitamin d|mesh-list
55947863|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
55947864|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
55947865|NCT04844957|Vitamins|vitamins|mesh-list
55947866|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
55947867|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947868|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55947869|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55947870|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
55947871|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55947872|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55947873|NCT04782115|Growth Substances|growth substances|mesh-ancestor
55947874|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947875|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
55947876|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947877|NCT01421589|Hormones|hormones|mesh-list
55947878|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947879|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947880|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
55947881|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55947882|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947883|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
55947884|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
55947885|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55947886|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55947887|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947888|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947897|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947898|NCT04848246|Bupropion|bupropion|mesh-list
55947899|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55947900|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
55947901|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55947902|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55947903|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55947904|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55947905|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947906|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
55947907|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947908|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947909|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55947910|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55947911|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947912|NCT04842071|Listerine|listerine|mesh-list
55947913|NCT04842071|Fluorides|fluorides|mesh-list
55947914|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
55947915|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
56000160|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56000161|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
56000162|NCT05484648|Hormones|hormones|mesh-ancestor
56000163|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000164|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56000165|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000166|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56000167|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000168|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56000169|NCT05484648|Analgesics|analgesics|mesh-ancestor
55947916|NCT04842071|Protective Agents|protective agents|mesh-ancestor
55947917|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947918|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55947919|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947920|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
55947921|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55947922|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55947923|NCT04038619|Loperamide|loperamide|mesh-list
55947924|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
55947925|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55947926|NCT04774627|Olaparib|olaparib|mesh-list
55947927|NCT04774627|Niraparib|niraparib|mesh-list
55947928|NCT04774627|Talazoparib|talazoparib|mesh-list
55947929|NCT04774627|Veliparib|veliparib|mesh-list
55947930|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55947931|NCT04774627|Rucaparib|rucaparib|mesh-list
55947932|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947933|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947934|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947935|NCT04142658|Warfarin|warfarin|mesh-list
55947936|NCT04142658|Apixaban|apixaban|mesh-list
55947937|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
55947938|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55947939|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
55947940|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55947941|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
55947942|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947943|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947944|NCT01545141|Interferons|interferons|mesh-list
55947945|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
55947946|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
55947947|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
55947948|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
55947949|NCT01545141|Poly I-C|poly i-c|mesh-list
55947950|NCT01545141|Celecoxib|celecoxib|mesh-list
55947951|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947952|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
55947953|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947954|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
55947955|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947956|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55947957|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55947970|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55947972|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
55947973|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947974|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947975|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55947976|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
55947977|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55947978|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
55947979|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947980|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947982|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
55947983|NCT04855968|Analgesics|analgesics|mesh-list
55947984|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
55947985|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947986|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000170|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
56000171|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56000172|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56000173|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56000174|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
56000175|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789389|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
55947987|NCT01545765|Lidocaine|lidocaine|mesh-list
55947988|NCT01545765|Tetracaine|tetracaine|mesh-list
55947989|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
55947990|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
55947991|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55947992|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947993|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
55947994|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947995|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55947996|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55947997|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55947998|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55947999|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948000|NCT04856124|Ketamine|ketamine|mesh-list
55948001|NCT04856124|Esketamine|esketamine|mesh-list
55948002|NCT04856124|Analgesics|analgesics|mesh-ancestor
55948003|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
55948004|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948006|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55948007|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55948008|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
55948009|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
55948010|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948011|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55948012|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55948013|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948014|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948015|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
55948016|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55948017|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55948018|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55948019|NCT04847622|Remdesivir|remdesivir|mesh-list
55948020|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
55948029|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
55948030|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948031|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
55948032|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948033|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
55948034|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55948035|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55948036|NCT01422369|Ritonavir|ritonavir|mesh-list
55948037|NCT01422369|Darunavir|darunavir|mesh-list
55948038|NCT01422369|Pitavastatin|pitavastatin|mesh-list
55948039|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55948040|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55948041|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
55948042|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948043|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948044|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55948045|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55948046|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
55948047|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948048|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55948049|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55948050|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55948051|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55948052|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55948053|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
55948054|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55948055|NCT05023343|Ropivacaine|ropivacaine|mesh-list
56000176|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000177|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
56000178|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
56000179|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56000180|NCT05478954|Amodiaquine|amodiaquine|mesh-list
56000181|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
56000182|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56000183|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56000184|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000185|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56000186|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000187|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000188|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56000189|NCT05478954|Renal Agents|renal agents|mesh-ancestor
56000190|NCT02137096|Carboplatin|carboplatin|mesh-list
56000191|NCT02137096|Etoposide|etoposide|mesh-list
56000192|NCT02137096|Ifosfamide|ifosfamide|mesh-list
56000193|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
56000194|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000195|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56000196|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55789394|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
55948056|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
55948057|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
55948058|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934017|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55948059|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948060|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
55948061|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948062|NCT05024513|Fluorouracil|fluorouracil|mesh-list
55948063|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
55948064|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
55948065|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948066|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55948067|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948068|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948069|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
55948070|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948071|NCT04859556|Dipivefrin|dipivefrin|mesh-list
55948072|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55948073|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
55948074|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948075|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948076|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948077|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55948078|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55948079|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948080|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55948081|NCT04773301|Ropivacaine|ropivacaine|mesh-list
55948082|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
55948083|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
55948084|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
55948085|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000197|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56000198|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000199|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000200|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55948086|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948087|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
55948102|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948103|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948105|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948106|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
55948107|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55948108|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
55948109|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948110|NCT01427517|Expectorants|expectorants|mesh-ancestor
55948111|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
55948112|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55948113|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
55948114|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948115|NCT01427517|Protective Agents|protective agents|mesh-ancestor
55948116|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948117|NCT01427517|Antidotes|antidotes|mesh-ancestor
55934033|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55948118|NCT02835131|Pasireotide|pasireotide|mesh-list
55948119|NCT02835131|Hormones|hormones|mesh-ancestor
55948120|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948121|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948122|NCT00840853|Acetaminophen|acetaminophen|mesh-list
55948123|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
55948124|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55948125|NCT00840853|Analgesics|analgesics|mesh-ancestor
55948126|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
55948127|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948128|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948129|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
55948130|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55948131|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55948132|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948133|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
55948134|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
55948135|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
55948136|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
55948137|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948138|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55948139|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
55948140|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
55948141|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948142|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948143|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55948144|NCT04846452|Paclitaxel|paclitaxel|mesh-list
55948145|NCT04846452|Carboplatin|carboplatin|mesh-list
55948146|NCT04846452|Pemetrexed|pemetrexed|mesh-list
55948147|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55948148|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948149|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
55948166|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
55948168|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
55948169|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
55948170|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
55948171|NCT01549587|Protective Agents|protective agents|mesh-ancestor
55948172|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948173|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55948174|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948175|NCT04779853|Antibodies|antibodies|mesh-list
55948176|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
55948177|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948178|NCT04855110|Warfarin|warfarin|mesh-list
55948179|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
55948180|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
55948181|NCT01485393|Zolpidem|zolpidem|mesh-list
55948182|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55948183|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948184|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000201|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
56000202|NCT02130622|Promethazine|promethazine|mesh-list
56000203|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
56000204|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
55948185|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55948186|NCT01485393|Analgesics|analgesics|mesh-ancestor
55948187|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
55948188|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948189|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55948190|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55948191|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55948192|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
55948193|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948194|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948195|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55948196|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55948197|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
55948198|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
55948199|NCT04772521|Nicotine|nicotine|mesh-list
55948200|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55948201|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
55996664|NCT03069326|Thalidomide|thalidomide|mesh-list
55948202|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948203|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948204|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55948205|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55948206|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
55948207|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948208|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948209|NCT04772287|Gemcitabine|gemcitabine|mesh-list
55948210|NCT04772287|Paclitaxel|paclitaxel|mesh-list
55948211|NCT04772287|Vinorelbine|vinorelbine|mesh-list
55948230|NCT04772287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948231|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55948232|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55948233|NCT01890005|Aspirin|aspirin|mesh-list
55948234|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55948235|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55948236|NCT01890005|Analgesics|analgesics|mesh-ancestor
55948237|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
55948238|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948239|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948240|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948241|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55948242|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55948243|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55948244|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948245|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55948246|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55948247|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948248|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
55948249|NCT02822573|Donepezil|donepezil|mesh-list
55948250|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55948251|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948252|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948253|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
55948254|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948255|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948256|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
55948257|NCT04854252|Fentanyl|fentanyl|mesh-list
55948258|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55948259|NCT04854252|Narcotics|narcotics|mesh-ancestor
55948260|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948261|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948262|NCT04854252|Analgesics|analgesics|mesh-ancestor
55948263|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
55948264|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948265|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55948266|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55948267|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
55948268|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
55948269|NCT03040830|Progesterone|progesterone|mesh-list
55948270|NCT03040830|Progestins|progestins|mesh-ancestor
55948281|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000205|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56000206|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56000207|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
56000208|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
56000209|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000210|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000211|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000212|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55934039|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
56000213|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56000214|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56000215|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000216|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
55789423|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948282|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
55948283|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55948284|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55948285|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948286|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
55948287|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
55948288|NCT01890629|Metformin|metformin|mesh-list
55948289|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55948290|NCT01890629|Glimepiride|glimepiride|mesh-list
55948291|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55948292|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948293|NCT01890629|Incretins|incretins|mesh-ancestor
55948294|NCT01890629|Hormones|hormones|mesh-ancestor
55948295|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948296|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55948297|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
55948298|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948299|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948300|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55948301|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948302|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
55948303|NCT01890863|Fluticasone|fluticasone|mesh-list
55948304|NCT01890863|Xhance|xhance|mesh-list
55948305|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55948306|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55948307|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948308|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55948309|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
55948310|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948311|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948312|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55948313|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
55948314|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
55948315|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55948316|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55948317|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55948318|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55948319|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
55948320|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948321|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948322|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
55948323|NCT01890863|Hormones|hormones|mesh-ancestor
55996674|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
55948324|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948325|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
55948326|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
55948327|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
55948328|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
55948329|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
56000218|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
56000219|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000221|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
56000222|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948330|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55948331|NCT02950051|Rituximab|rituximab|mesh-list
55948332|NCT02950051|Fludarabine|fludarabine|mesh-list
55948333|NCT02950051|Venetoclax|venetoclax|mesh-list
55948334|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
55948335|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948351|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
55948352|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55948353|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948354|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55948355|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55948356|NCT01891019|Growth Substances|growth substances|mesh-ancestor
55948357|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
55948358|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948360|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948361|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55948362|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
55948363|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948364|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948365|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55948366|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
55948367|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
55948368|NCT04374474|Hormones|hormones|mesh-ancestor
55948369|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948370|NCT02983097|Cytarabine|cytarabine|mesh-list
55948371|NCT02983097|Dexamethasone|dexamethasone|mesh-list
55948372|NCT02983097|Rituximab|rituximab|mesh-list
55948373|NCT02983097|Carboplatin|carboplatin|mesh-list
55948374|NCT02983097|Lenalidomide|lenalidomide|mesh-list
55948375|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948376|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948377|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
55948378|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948379|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55948380|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948381|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
55948382|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
55948383|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948384|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948385|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
55948386|NCT02983097|Hormones|hormones|mesh-ancestor
55948387|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948388|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55948389|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55948390|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
55948391|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948392|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
55948393|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934052|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55948394|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948395|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55948411|NCT01550367|Aldesleukin|aldesleukin|mesh-list
55948412|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
55948413|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55948414|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55948415|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948416|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948417|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948418|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55948419|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948420|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55948421|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55948422|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
55948423|NCT01427595|Metformin|metformin|mesh-list
55948424|NCT01427595|Progesterone|progesterone|mesh-list
55948425|NCT01427595|Estradiol|estradiol|mesh-list
55948426|NCT01427595|Estrogens|estrogens|mesh-list
55948427|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55948428|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948429|NCT01427595|Progestins|progestins|mesh-ancestor
56000224|NCT02134912|Crizotinib|crizotinib|mesh-list
56000225|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000226|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000227|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000228|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55948430|NCT01427595|Hormones|hormones|mesh-ancestor
55948431|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948432|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
55948433|NCT04390061|Tofacitinib|tofacitinib|mesh-list
55948434|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
55948435|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55948436|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55948437|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948438|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948439|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948440|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55948441|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55948443|NCT01892813|Nicotine|nicotine|mesh-list
55948444|NCT01892813|Varenicline|varenicline|mesh-list
55948445|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55948446|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
55948447|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948448|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948449|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55948450|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55948451|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
55948452|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948453|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948454|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55948455|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
55948456|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55948465|NCT00716443|Tetracaine|tetracaine|mesh-list
55948466|NCT00716443|Benzocaine|benzocaine|mesh-list
55948467|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
55948468|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
55948469|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948470|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948471|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
55948472|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948473|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55948474|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55948475|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55948476|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55948477|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948478|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55948479|NCT00650143|Lenograstim|lenograstim|mesh-list
55948480|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55948481|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948482|NCT00650143|Incretins|incretins|mesh-ancestor
55948483|NCT00650143|Hormones|hormones|mesh-ancestor
55948484|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948485|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55948486|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
55948487|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948488|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948489|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55948490|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
55948491|NCT04770961|Ropivacaine|ropivacaine|mesh-list
55948492|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
55948493|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
55948494|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948495|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948496|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
55948497|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948498|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
56000229|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56000230|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55948499|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55948500|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
55802880|NCT04326283|Trametinib|trametinib|mesh-list
55948501|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55948502|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
55948503|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948504|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948505|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
55948506|NCT04769557|Acetaminophen|acetaminophen|mesh-list
55948507|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55948508|NCT04769557|Analgesics|analgesics|mesh-ancestor
55948509|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
55948510|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948511|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948512|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
55948513|NCT05606497|Dexamethasone|dexamethasone|mesh-list
55948514|NCT05606497|Betamethasone|betamethasone|mesh-list
55948515|NCT05606497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948516|NCT05606497|Antiemetics|antiemetics|mesh-ancestor
55948517|NCT05606497|Autonomic Agents|autonomic agents|mesh-ancestor
55948518|NCT05606497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948519|NCT05606497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948520|NCT05606497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948521|NCT05606497|Glucocorticoids|glucocorticoids|mesh-ancestor
55948522|NCT05606497|Hormones|hormones|mesh-ancestor
55948538|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55948539|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948540|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
55948541|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55948542|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55948543|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948544|NCT05606263|Nimotuzumab|nimotuzumab|mesh-list
55948545|NCT05606263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948546|NCT05606263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948547|NCT02213289|Nivolumab|nivolumab|mesh-list
55948548|NCT02213289|Trastuzumab|trastuzumab|mesh-list
55948549|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
55948550|NCT02213289|Ramucirumab|ramucirumab|mesh-list
55948551|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948552|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948553|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55948554|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948555|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
55948556|NCT02779751|Anastrozole|anastrozole|mesh-list
55948557|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948558|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948559|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55948560|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55948561|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55948562|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948563|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948564|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55948565|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
55948566|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948567|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948568|NCT05606107|Tofacitinib|tofacitinib|mesh-list
55948569|NCT05606107|Glucocorticoids|glucocorticoids|mesh-list
55948570|NCT05606107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55948571|NCT05606107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948572|NCT05606107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948573|NCT05606107|Hormones|hormones|mesh-ancestor
55948574|NCT05606107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948575|NCT05606107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948576|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
55948577|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
55948578|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
55948579|NCT00053989|Fludarabine|fludarabine|mesh-list
55948580|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
55948581|NCT00053989|Tacrolimus|tacrolimus|mesh-list
55948582|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55948590|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948591|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948592|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55948593|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55948595|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55948596|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948597|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55948598|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55948599|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
55948600|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55948601|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948602|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948603|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
55948604|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
55948605|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948606|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948607|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
55948608|NCT00053989|Hormones|hormones|mesh-ancestor
55948609|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948610|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55948611|NCT00053989|Protective Agents|protective agents|mesh-ancestor
55948612|NCT02775695|Doxycycline|doxycycline|mesh-list
55948613|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55948614|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948615|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
55948616|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55948617|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55948618|NCT02752685|Paclitaxel|paclitaxel|mesh-list
55948619|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
55948620|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55948621|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948622|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
55948623|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
55948624|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
55948625|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948626|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948627|NCT02740595|Nicotine|nicotine|mesh-list
55948628|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55948629|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
55996717|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
55948630|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948631|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948632|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55948633|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55948634|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
55948635|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948636|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948637|NCT02737787|Nivolumab|nivolumab|mesh-list
55948638|NCT02737787|Vaccines|vaccines|mesh-list
55948639|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
55948640|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948641|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948642|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948643|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55948644|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000231|NCT02094352|Ketamine|ketamine|mesh-list
56000232|NCT02094352|Analgesics|analgesics|mesh-ancestor
55948674|NCT02713997|Etanercept|etanercept|mesh-list
55948675|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55948676|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
55948677|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55948678|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55948679|NCT02713997|Analgesics|analgesics|mesh-ancestor
55948680|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
55948681|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948682|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948683|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948684|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55948685|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948686|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948687|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
55948688|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55948689|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55948690|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
55948691|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948692|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948693|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
55948694|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948695|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948696|NCT02697227|Nicotine|nicotine|mesh-list
55948697|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55948698|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
55948699|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948700|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948701|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55948702|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55948703|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
55948704|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948705|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948706|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55948707|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55948708|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
55948709|NCT02689427|Paclitaxel|paclitaxel|mesh-list
55948710|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55948711|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55948712|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948713|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
55948714|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
55948715|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934126|NCT01673087|Cosyntropin|cosyntropin|mesh-list
55948716|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948717|NCT02670707|Cytarabine|cytarabine|mesh-list
55948718|NCT02670707|Prednisone|prednisone|mesh-list
55948719|NCT02670707|Vinblastine|vinblastine|mesh-list
55948720|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948731|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948732|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948733|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
55948734|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55948735|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
55948736|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
55948737|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
55948738|NCT02214615|Carbamazepine|carbamazepine|mesh-list
55948739|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
55948740|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
55948741|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55948742|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948743|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948744|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55948745|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55948746|NCT02214615|Analgesics|analgesics|mesh-ancestor
55948747|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
55948748|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948749|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55948750|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55948751|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948752|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55948753|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55948754|NCT02661503|Dexamethasone|dexamethasone|mesh-list
55948755|NCT02661503|Prednisone|prednisone|mesh-list
56000234|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000235|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000236|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56000237|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56000238|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
56000239|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
56000240|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000241|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56000242|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56000243|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000244|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000245|NCT01188421|Clonidine|clonidine|mesh-list
56000246|NCT01188421|Buprenorphine|buprenorphine|mesh-list
56000247|NCT01188421|Tramadol|tramadol|mesh-list
56000248|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56000249|NCT01188421|Naloxone|naloxone|mesh-list
55948756|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
55948757|NCT02661503|Dacarbazine|dacarbazine|mesh-list
55948758|NCT02661503|Doxorubicin|doxorubicin|mesh-list
55948759|NCT02661503|Etoposide|etoposide|mesh-list
55948760|NCT02661503|Vincristine|vincristine|mesh-list
55948761|NCT02661503|Bleomycin|bleomycin|mesh-list
55948762|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55948763|NCT02661503|Procarbazine|procarbazine|mesh-list
55948764|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948765|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
55948766|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948767|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55948768|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55948769|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
55948770|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948771|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948772|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55948773|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948774|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
55948775|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
55948790|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948791|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55743766|NCT02514421|Antiviral Agents|antiviral agents|mesh-ancestor
55948792|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55948793|NCT02647385|Lidocaine|lidocaine|mesh-list
55948794|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
55948795|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
55948796|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948797|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948798|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
55948799|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948800|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55948801|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55948802|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55948803|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55948804|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948805|NCT03040752|Nifedipine|nifedipine|mesh-list
55948806|NCT03040752|Ritodrine|ritodrine|mesh-list
55948807|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55948808|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56000250|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56000251|NCT01188421|Narcotics|narcotics|mesh-ancestor
56000252|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000253|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000254|NCT01188421|Analgesics|analgesics|mesh-ancestor
56000255|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
56000256|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000257|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56000258|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56000259|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
56000260|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
55789448|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55948809|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948810|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55948811|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948812|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
55948813|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
55948814|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55948815|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
55948816|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
55948817|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948818|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55948819|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55948820|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55948821|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
55948822|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948823|NCT01668654|Ezogabine|ezogabine|mesh-list
55948824|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
55948825|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55948826|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948827|NCT01431105|Atorvastatin|atorvastatin|mesh-list
55948828|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55948829|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55948830|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
55948831|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948832|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55948841|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
55948842|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948844|NCT04840290|Carboplatin|carboplatin|mesh-list
55948845|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55948846|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948847|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
55948848|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
55948849|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
55948850|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948851|NCT02630069|Choline|choline|mesh-list
55948852|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55948853|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
55948854|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55948855|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
55822208|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56000261|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56000262|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56000263|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56000264|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
56000265|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000266|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000267|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
56000268|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55948856|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948857|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948858|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55948859|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
55948860|NCT01431339|Vancomycin|vancomycin|mesh-list
55948861|NCT01431339|Linezolid|linezolid|mesh-list
55948862|NCT01431339|Dalbavancin|dalbavancin|mesh-list
55948863|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55948864|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948865|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55948866|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948867|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948869|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55948870|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
55948871|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948872|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948873|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55948874|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55948875|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
55948876|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55948877|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948878|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
55934162|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55948879|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
55948880|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55948881|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948882|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948883|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
55948884|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55948885|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948886|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948887|NCT04843644|Propolis|propolis|mesh-list
55948888|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948890|NCT02588105|Folic Acid|folic acid|mesh-list
55948891|NCT02588105|Fluorouracil|fluorouracil|mesh-list
55948892|NCT02588105|Irinotecan|irinotecan|mesh-list
55948893|NCT02588105|Olaparib|olaparib|mesh-list
55948894|NCT02588105|AZD0156|azd0156|mesh-list
55948895|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
55948896|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
55948897|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948898|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55948899|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948900|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948901|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
55948902|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948920|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
55948921|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948922|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948923|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948924|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
55948925|NCT01488279|Hormones|hormones|mesh-ancestor
55948926|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948927|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55948928|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948929|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
55948930|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948931|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948932|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56000269|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56000270|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000271|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
56000272|NCT03780894|Coagulants|coagulants|mesh-ancestor
56000273|NCT01006018|Pioglitazone|pioglitazone|mesh-list
56000274|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56000275|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56000276|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000277|NCT01006018|Incretins|incretins|mesh-ancestor
56000278|NCT01006018|Hormones|hormones|mesh-ancestor
56000279|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000280|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55727542|NCT04969276|Vaccines|vaccines|mesh-list
56000281|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
56000282|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000283|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000284|NCT00996502|Prednisone|prednisone|mesh-list
56000285|NCT00996502|Bevacizumab|bevacizumab|mesh-list
56000286|NCT00996502|Docetaxel|docetaxel|mesh-list
56000287|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56000288|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000289|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000290|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56000291|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55789453|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55789454|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
55948933|NCT01488279|Incretins|incretins|mesh-ancestor
55948934|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55948935|NCT02586623|Droxidopa|droxidopa|mesh-list
55948936|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55948937|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55948938|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
55948940|NCT04839666|Propofol|propofol|mesh-list
55948941|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55948942|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000292|NCT00996502|Growth Substances|growth substances|mesh-ancestor
56000293|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000294|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
56000295|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
56000296|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
56000297|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
56000298|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000299|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55789455|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948943|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948944|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55948945|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
55948947|NCT03008109|Endostatins|endostatins|mesh-list
55948948|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948949|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55948950|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55948951|NCT03008109|Growth Substances|growth substances|mesh-ancestor
55948952|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948953|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
55948954|NCT02562443|ON 01910|on 01910|mesh-list
55948955|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948956|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55948957|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948958|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948959|NCT04843098|Paclitaxel|paclitaxel|mesh-list
55948960|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55948961|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948962|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
55948963|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
55948964|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
55948987|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948988|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948989|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55948990|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55948991|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55948992|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55948993|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948995|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948996|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55948997|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948998|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948999|NCT01433913|Metformin|metformin|mesh-list
55949000|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55949001|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949002|NCT02535533|Selenium|selenium|mesh-list
55949003|NCT02535533|Axitinib|axitinib|mesh-list
55949004|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949005|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55949006|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949007|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949008|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
55949009|NCT02535533|Protective Agents|protective agents|mesh-ancestor
55949010|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949011|NCT02535533|Trace Elements|trace elements|mesh-ancestor
56000300|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
56000301|NCT00996502|Hormones|hormones|mesh-ancestor
56000302|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949012|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
55949013|NCT04839198|Nicotine|nicotine|mesh-list
55949014|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55949015|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
55949023|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
55949024|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55949025|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55949026|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55949027|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949028|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
55949029|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949030|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949031|NCT05586347|Nicardipine|nicardipine|mesh-list
55949032|NCT05586347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55949033|NCT05586347|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55949034|NCT05586347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55949035|NCT05586347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949036|NCT05586347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55949037|NCT05586347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949038|NCT05586347|Vasodilator Agents|vasodilator agents|mesh-ancestor
55949040|NCT01436799|Propofol|propofol|mesh-list
55949041|NCT01436799|Desflurane|desflurane|mesh-list
55949042|NCT01436799|Rocuronium|rocuronium|mesh-list
55949043|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55949044|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949045|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949046|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55949047|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
55949048|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
55949049|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55949050|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55949051|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55949052|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949053|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55949054|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55949055|NCT01436799|Narcotics|narcotics|mesh-ancestor
55949056|NCT01436799|Analgesics|analgesics|mesh-ancestor
55949057|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
55949058|NCT02507687|Bimatoprost|bimatoprost|mesh-list
55949059|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55949060|NCT04851132|Durvalumab|durvalumab|mesh-list
55949061|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949062|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949063|NCT02504489|Docetaxel|docetaxel|mesh-list
55949064|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949065|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
55949066|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
55949067|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
55949068|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949069|NCT02479451|Theophylline|theophylline|mesh-list
55949070|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55949071|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
55949072|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996772|NCT01178281|Pomalidomide|pomalidomide|mesh-list
55949073|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949074|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55949075|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
55949076|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55949077|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949078|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949079|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
55949080|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55949081|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55949092|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
55949093|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
55949094|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949095|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949096|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55949097|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
56000303|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56000304|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56000305|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000306|NCT00984490|Metformin|metformin|mesh-list
56000307|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56000308|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000309|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56000310|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000311|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000312|NCT02027272|Dexamethasone|dexamethasone|mesh-list
56000313|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
56000314|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56000315|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
56000316|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
56000317|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789457|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789458|NCT04394663|Omeprazole|omeprazole|mesh-list
55789459|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55789460|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789461|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55789462|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789463|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789464|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55789465|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55949098|NCT02444429|Hormones|hormones|mesh-ancestor
55949099|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949100|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55949101|NCT02444429|Protective Agents|protective agents|mesh-ancestor
55949102|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55949103|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949104|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55949105|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949106|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55949107|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949108|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949109|NCT02415413|Dexamethasone|dexamethasone|mesh-list
55949110|NCT02415413|Lenalidomide|lenalidomide|mesh-list
55949111|NCT02415413|Melphalan|melphalan|mesh-list
55949112|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949113|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
55949114|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
55949115|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949116|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949117|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55949118|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
55949119|NCT02415413|Hormones|hormones|mesh-ancestor
55949120|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949121|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55949122|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949123|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
56000318|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000319|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56000320|NCT02027272|Hormones|hormones|mesh-ancestor
55949124|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55949125|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55949126|NCT02415413|Growth Substances|growth substances|mesh-ancestor
55949127|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
55949128|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55949129|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
55949130|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949131|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55949132|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55949135|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55949136|NCT02379377|Fluorides|fluorides|mesh-list
55949137|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55949138|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949139|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
55949140|NCT02379377|Protective Agents|protective agents|mesh-ancestor
55949141|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949144|NCT01894061|Antibodies|antibodies|mesh-list
55949145|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
55949146|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55949162|NCT01561833|Sorafenib|sorafenib|mesh-list
55949163|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949164|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55949165|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949166|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949167|NCT02607306|Insulin|insulin|mesh-list
55949168|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55949169|NCT02607306|Liraglutide|liraglutide|mesh-list
55949170|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
55949171|NCT02607306|Xultophy|xultophy|mesh-list
55949172|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55949173|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949174|NCT02607306|Incretins|incretins|mesh-ancestor
55949175|NCT02607306|Hormones|hormones|mesh-ancestor
55949176|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949177|NCT03040128|Minocycline|minocycline|mesh-list
55949178|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55949179|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949180|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
55949181|NCT04850040|Apatinib|apatinib|mesh-list
55949182|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949183|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55949184|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949185|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949186|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
55949187|NCT03038334|Analgesics|analgesics|mesh-ancestor
55949188|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
55949189|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949190|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949191|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
55949192|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949193|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55949194|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
55949195|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55949196|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55949197|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949198|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55949199|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
55949200|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55949201|NCT01441245|Furosemide|furosemide|mesh-list
55949202|NCT01441245|Diuretics|diuretics|mesh-ancestor
55949203|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
55949212|NCT02298257|Vinblastine|vinblastine|mesh-list
55949213|NCT02298257|Antibodies|antibodies|mesh-list
55949214|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
55949215|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55949216|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
55949217|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
56000321|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000322|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56000323|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000324|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
56000325|NCT05475444|Chitosan|chitosan|mesh-list
56000326|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56000327|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000328|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56000329|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56000330|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000331|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000332|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000333|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56000334|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56000335|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56000336|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56000337|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
56000338|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56000339|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
56000340|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
55949218|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949219|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55949220|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949221|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55949222|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55949223|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949224|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949225|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949226|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55949227|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
55949228|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55949229|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
55949230|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
55949231|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
55949232|NCT02288195|Capecitabine|capecitabine|mesh-list
55949233|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
55949234|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55949235|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
55949236|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949237|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996998|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996999|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
55997000|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997006|NCT01927874|Bupivacaine|bupivacaine|mesh-list
55949238|NCT01563081|Cetirizine|cetirizine|mesh-list
55949239|NCT01563081|Levocetirizine|levocetirizine|mesh-list
55949240|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55949241|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55949242|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
55949243|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
55949244|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949245|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949246|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949247|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55949248|NCT02278601|Fentanyl|fentanyl|mesh-list
55949249|NCT02278601|Ropivacaine|ropivacaine|mesh-list
56000342|NCT05475444|Coagulants|coagulants|mesh-ancestor
56000343|NCT03472092|Amitriptyline|amitriptyline|mesh-list
56000344|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56000345|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
56000346|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56000347|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56000348|NCT03472092|Analgesics|analgesics|mesh-ancestor
56000349|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
56000350|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949250|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
55949251|NCT02278601|Anesthetics|anesthetics|mesh-list
55949252|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949253|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949254|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
55949255|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949256|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55949257|NCT02278601|Narcotics|narcotics|mesh-ancestor
55949258|NCT02278601|Analgesics|analgesics|mesh-ancestor
55949259|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55949260|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55949261|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
55949262|NCT04833738|Triamcinolone|triamcinolone|mesh-list
55949263|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55949264|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55949265|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
55949266|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55949267|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949268|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
55949269|NCT04833738|Hormones|hormones|mesh-ancestor
55949270|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949279|NCT01441401|Gabapentin|gabapentin|mesh-list
55949280|NCT01441401|Analgesics|analgesics|mesh-ancestor
55949281|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
55949282|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949283|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949284|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
55949285|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55949286|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55949287|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949288|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55949289|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55949290|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55949291|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949292|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949294|NCT02268695|Docetaxel|docetaxel|mesh-list
55949295|NCT02268695|Cetuximab|cetuximab|mesh-list
55949296|NCT02268695|Lenograstim|lenograstim|mesh-list
55949297|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949298|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
55949299|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
55949300|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
55949301|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949302|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949303|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55949304|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
55949305|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949307|NCT01495923|Analgesics|analgesics|mesh-ancestor
55949308|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
55949309|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949310|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949311|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
55949312|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55949313|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55949314|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949315|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55949316|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55949317|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55949318|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949319|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949320|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
55949321|NCT03037944|Drospirenone|drospirenone|mesh-list
55949322|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
55949323|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55949324|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
55949325|NCT03037944|Estradiol|estradiol|mesh-list
55949326|NCT03037944|Estrogens|estrogens|mesh-ancestor
55949327|NCT03037944|Hormones|hormones|mesh-ancestor
55949328|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949329|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949330|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55949331|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
55949332|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55949333|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55949334|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55949335|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55949336|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55949351|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55949352|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55949353|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949354|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949355|NCT03039426|Diclofenac|diclofenac|mesh-list
55949356|NCT03039426|Bupivacaine|bupivacaine|mesh-list
55949357|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
55949358|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
55949359|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949360|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949361|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
55949362|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949363|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55949364|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55949365|NCT03039426|Analgesics|analgesics|mesh-ancestor
55949366|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949367|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55949368|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55949369|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949370|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949371|NCT02205515|Everolimus|everolimus|mesh-list
55949372|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949373|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55949374|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
55949375|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949376|NCT04833036|Irinotecan|irinotecan|mesh-list
55949377|NCT04833036|Cetuximab|cetuximab|mesh-list
55949378|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55949379|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55949380|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869871|NCT00928954|Gabapentin|gabapentin|mesh-list
55949381|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949382|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949383|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949386|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949387|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
55949388|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
55949389|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949390|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949391|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55949392|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
55949393|NCT04832880|Hormones|hormones|mesh-ancestor
55949394|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949395|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55949396|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949397|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
55949406|NCT01894295|Vitamins|vitamins|mesh-ancestor
55949407|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
55949408|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949409|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55949410|NCT02169089|Spironolactone|spironolactone|mesh-list
55949411|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55949412|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
55949413|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949414|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949415|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55949416|NCT02169089|Diuretics|diuretics|mesh-ancestor
55949417|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
55949418|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55949419|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55949420|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
55949421|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949422|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949423|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949425|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
55949426|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55949427|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949428|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55949429|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55949430|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949431|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949432|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949433|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
55949434|NCT04557449|Letrozole|letrozole|mesh-list
55949435|NCT04557449|Fulvestrant|fulvestrant|mesh-list
55949436|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949437|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55949438|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55949439|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949440|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949441|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55949442|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
55949443|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949444|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949445|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55949446|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55949447|NCT04824924|Venetoclax|venetoclax|mesh-list
55949448|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949449|NCT04553705|Quinine|quinine|mesh-list
55949450|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
55949451|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55949452|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55949453|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949454|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55949455|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949456|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55949457|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949458|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55949459|NCT04553705|Analgesics|analgesics|mesh-ancestor
55949460|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
55949461|NCT02140151|Ranibizumab|ranibizumab|mesh-list
55949462|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56000351|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000352|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56000353|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56000354|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55727605|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56000355|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000357|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000358|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
56000359|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000360|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
56000361|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56000362|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56000363|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000364|NCT01996852|Urological Agents|urological agents|mesh-ancestor
56000366|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
56000367|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
56000368|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000369|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000370|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56000371|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000372|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55949476|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55949477|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949478|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
55949479|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949480|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949481|NCT04837170|Ketamine|ketamine|mesh-list
55949482|NCT04837170|Esketamine|esketamine|mesh-list
55949483|NCT04837170|Analgesics|analgesics|mesh-ancestor
55949484|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
55949485|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949486|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949487|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55949488|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55949489|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
55949490|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
55949491|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949492|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55949493|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55949494|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949495|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949496|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
55949497|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55949498|NCT04824612|Triamcinolone|triamcinolone|mesh-list
55949499|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55949500|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55949501|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56000373|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56000374|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000375|NCT04331626|Gemcitabine|gemcitabine|mesh-list
56000376|NCT04331626|Nivolumab|nivolumab|mesh-list
56000377|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56000378|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
56000379|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000380|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000381|NCT04331626|Antiviral Agents|antiviral agents|mesh-ancestor
56000382|NCT04331626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000383|NCT04331626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000384|NCT04331626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000385|NCT04331626|Immunologic Factors|immunologic factors|mesh-ancestor
56000386|NCT04331626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000387|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949502|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949503|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
55949504|NCT04824612|Hormones|hormones|mesh-ancestor
55949505|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949506|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949507|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55949508|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
55949509|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949510|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949512|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
55949513|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55949514|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
55949515|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55949516|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949517|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55949518|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55949519|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949520|NCT02101775|Gemcitabine|gemcitabine|mesh-list
55949521|NCT02101775|Adavosertib|adavosertib|mesh-list
55949522|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55949523|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
55743796|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
55949524|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949538|NCT01568073|Carbidopa|carbidopa|mesh-list
55949539|NCT01568073|Opicapone|opicapone|mesh-list
55949540|NCT01568073|Entacapone|entacapone|mesh-list
55949541|NCT01568073|Benserazide|benserazide|mesh-list
55949542|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55949543|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55949544|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
55949545|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949546|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949547|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949548|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55949549|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949550|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55949551|NCT04274933|Capecitabine|capecitabine|mesh-list
55949552|NCT04274933|Venetoclax|venetoclax|mesh-list
55949553|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55949554|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
55949555|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949556|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789504|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
55949558|NCT04394975|Axitinib|axitinib|mesh-list
55949559|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949560|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55949561|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55949562|NCT04394975|Growth Substances|growth substances|mesh-ancestor
55949563|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949564|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
55949565|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55949566|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949567|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949568|NCT02603952|Oseltamivir|oseltamivir|mesh-list
55949569|NCT02603952|MEDI8852|medi8852|mesh-list
55949570|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
55949571|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949572|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949573|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949574|NCT02062463|Budesonide|budesonide|mesh-list
55949575|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
55949576|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55949577|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949578|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55949579|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
55949580|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949581|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949582|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55949583|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
55949584|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
55949585|NCT02062463|Hormones|hormones|mesh-ancestor
55949586|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949587|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55949604|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
55949605|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949606|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949607|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
55997120|NCT04550546|Ionophores|ionophores|mesh-ancestor
55949608|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55949609|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55949610|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55949613|NCT05618496|Immunologic Factors|immunologic factors|mesh-ancestor
55949614|NCT05618496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949615|NCT05618496|Viscosupplements|viscosupplements|mesh-ancestor
55949616|NCT05618496|Protective Agents|protective agents|mesh-ancestor
55949618|NCT02049593|Temozolomide|temozolomide|mesh-list
55949619|NCT02049593|Talazoparib|talazoparib|mesh-list
55949620|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55949621|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55949622|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55949623|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949624|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949625|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949626|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55949627|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
55949628|NCT02049047|Everolimus|everolimus|mesh-list
55949629|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949630|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55949631|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
55949632|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949633|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55949634|NCT04778358|Hormones|hormones|mesh-ancestor
55949635|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949636|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949637|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55949638|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55949639|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949640|NCT01449747|Incretins|incretins|mesh-ancestor
55949641|NCT01449747|Hormones|hormones|mesh-ancestor
55949642|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949643|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56000388|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56000389|NCT03699540|Ethanol|ethanol|mesh-list
55949644|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
55949645|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949647|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
55949648|NCT03035838|Aprepitant|aprepitant|mesh-list
55949649|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
55949650|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
55949651|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949652|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949653|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55949654|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55949655|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949656|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949657|NCT01569087|Lenograstim|lenograstim|mesh-list
55949658|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55949659|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
55949660|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949661|NCT02024087|Sorafenib|sorafenib|mesh-list
55949662|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949663|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55949664|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949665|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949666|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
55949667|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
55949668|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949669|NCT01895621|Protective Agents|protective agents|mesh-ancestor
55949670|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949671|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
55949673|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
55949674|NCT01517711|Tramadol|tramadol|mesh-list
55949675|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55949676|NCT01517711|Narcotics|narcotics|mesh-ancestor
55949677|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949678|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949679|NCT01517711|Analgesics|analgesics|mesh-ancestor
55949680|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
55949681|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949682|NCT04836078|Chitosan|chitosan|mesh-list
55949683|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55949684|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55949685|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
55949686|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949687|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55949688|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
55949689|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
55949690|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
55949691|NCT04836078|Coagulants|coagulants|mesh-ancestor
55949692|NCT01517243|Sirolimus|sirolimus|mesh-list
55949693|NCT01517243|Sunitinib|sunitinib|mesh-list
55949694|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949695|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55997163|NCT05609942|Azacitidine|azacitidine|mesh-list
55949696|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55949697|NCT01517243|Growth Substances|growth substances|mesh-ancestor
55949698|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949699|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
55949700|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55949701|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949702|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949703|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55949704|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949705|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55949706|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
55949707|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55949708|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
55949709|NCT00055237|Bevacizumab|bevacizumab|mesh-list
55949710|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949711|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949712|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55949713|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55949714|NCT00055237|Growth Substances|growth substances|mesh-ancestor
55949715|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000390|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56000391|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000392|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949716|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
55949717|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
55949720|NCT04836156|Epirubicin|epirubicin|mesh-list
55949721|NCT04836156|Phenobarbital|phenobarbital|mesh-list
55949722|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55949733|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
55949734|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55949735|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55949736|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55949737|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949738|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
55949739|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55949740|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949741|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55949742|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55997185|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
55949743|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949744|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
55949745|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
55949746|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55949747|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55949748|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55949749|NCT01502787|Metoprolol|metoprolol|mesh-list
55949750|NCT01502787|Nebivolol|nebivolol|mesh-list
55949751|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
55949752|NCT01502787|Giapreza|giapreza|mesh-list
55949753|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
55949754|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55949755|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55949756|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
55949757|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
55949758|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949759|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949760|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55949761|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55949762|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55949763|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
55949764|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949765|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949766|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
55949767|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55949768|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55949769|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55949770|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55949771|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55949772|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
55949773|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949774|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
55949775|NCT04363164|Testosterone|testosterone|mesh-list
55949776|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
55949777|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
55949778|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55949779|NCT04363164|Androgens|androgens|mesh-ancestor
55949780|NCT04363164|Hormones|hormones|mesh-ancestor
55949781|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55949782|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949783|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55949784|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949785|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
55949786|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55949803|NCT01431755|Protective Agents|protective agents|mesh-ancestor
55949804|NCT04835922|Anesthetics|anesthetics|mesh-list
55949805|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949806|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949807|NCT00153985|Fludarabine|fludarabine|mesh-list
55949808|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
55949809|NCT00153985|Busulfan|busulfan|mesh-list
55949810|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949811|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949812|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000393|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997279|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
56000394|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55949813|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
55949814|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949815|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949816|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
55949817|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55949818|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55949819|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
55949820|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55949821|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949822|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
55949823|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55949824|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55949825|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55949826|NCT02318303|Analgesics|analgesics|mesh-ancestor
55949827|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
55949828|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949829|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949830|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55949831|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55949832|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55949833|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
55949834|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
55949835|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949836|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949837|NCT01451775|Empagliflozin|empagliflozin|mesh-list
55949838|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55949839|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949840|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55949841|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949875|NCT00156247|Acitretin|acitretin|mesh-list
55949876|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
55949877|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
55949878|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55949879|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
55949880|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55949881|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55949882|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55949883|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949884|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949885|NCT01573533|Rituximab|rituximab|mesh-list
55949886|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949887|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949888|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
55949889|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949890|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55949891|NCT01455519|Hydromorphone|hydromorphone|mesh-list
55949892|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55949894|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949895|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949896|NCT01455519|Analgesics|analgesics|mesh-ancestor
55949897|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
55949898|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949899|NCT00157573|Sargramostim|sargramostim|mesh-list
55949900|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
55949901|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949902|NCT04822038|Vitamin D|vitamin d|mesh-list
55949903|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
55949904|NCT04822038|Vitamins|vitamins|mesh-ancestor
55949905|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
55949906|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949907|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55949908|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55949909|NCT01576809|Acetaminophen|acetaminophen|mesh-list
55949910|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
55949911|NCT01576809|Phenylephrine|phenylephrine|mesh-list
55949912|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
55949913|NCT01576809|Guaifenesin|guaifenesin|mesh-list
55949914|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
55949915|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56000395|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56000396|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56000397|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
56000398|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949931|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
55949932|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949933|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949934|NCT01576809|Protective Agents|protective agents|mesh-ancestor
55949935|NCT01576809|Expectorants|expectorants|mesh-ancestor
55949936|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
55949937|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55949938|NCT01456143|Proflavine|proflavine|mesh-list
55949939|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55949940|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949941|NCT01456299|Remifentanil|remifentanil|mesh-list
55949942|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55949943|NCT01456299|Narcotics|narcotics|mesh-ancestor
55949944|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949945|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949946|NCT01456299|Analgesics|analgesics|mesh-ancestor
55949947|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
55949948|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949949|NCT00158743|Digoxin|digoxin|mesh-list
55949950|NCT00158743|Antibodies|antibodies|mesh-list
55949951|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
55949952|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
55949953|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949954|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55949955|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55949956|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949957|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949958|NCT00158743|Protective Agents|protective agents|mesh-ancestor
55949959|NCT00161473|Prazosin|prazosin|mesh-list
55949960|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55949961|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55949962|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55949963|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55949964|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
55949965|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949966|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949967|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949968|NCT01319981|Cytarabine|cytarabine|mesh-list
55949969|NCT01319981|Dexamethasone|dexamethasone|mesh-list
55949970|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
55949971|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55949972|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55949973|NCT01319981|Prednisolone|prednisolone|mesh-list
55949974|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
55949975|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
55949976|NCT01319981|Rituximab|rituximab|mesh-list
55949977|NCT01319981|Doxorubicin|doxorubicin|mesh-list
55949978|NCT01319981|Methotrexate|methotrexate|mesh-list
55949990|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949991|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55949992|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55949993|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949994|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
55949995|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
55949996|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949997|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55949998|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
55949999|NCT01319981|Hormones|hormones|mesh-ancestor
55950000|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950001|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55950002|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55950003|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55950004|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55950005|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950006|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55950007|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
55950008|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55950009|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56000399|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56000400|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56000401|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000403|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56000404|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000405|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000406|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
56000407|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000408|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56000409|NCT03661320|Gemcitabine|gemcitabine|mesh-list
56000410|NCT03661320|Nivolumab|nivolumab|mesh-list
56000411|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000412|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950010|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
55950011|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
55950012|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55950013|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55950014|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
55950015|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950016|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55950017|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950018|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950019|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950020|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55950021|NCT01319981|Protective Agents|protective agents|mesh-ancestor
55950022|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55950023|NCT01458561|Thrombin|thrombin|mesh-list
55950024|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55950025|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
55950026|NCT01458561|Coagulants|coagulants|mesh-ancestor
55950027|NCT01896011|Teriparatide|teriparatide|mesh-list
55950028|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55950029|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950030|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55950031|NCT00065611|Dexamethasone|dexamethasone|mesh-list
55950032|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55950033|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
55997317|NCT00971789|Sirolimus|sirolimus|mesh-list
55950034|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
55950035|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950036|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950037|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55950038|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
55950039|NCT00065611|Hormones|hormones|mesh-ancestor
55950040|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950041|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55950050|NCT00066781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950051|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950052|NCT00066781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950053|NCT00066781|Immunologic Factors|immunologic factors|mesh-ancestor
55950054|NCT00066781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950055|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55950056|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55950059|NCT01189643|Temozolomide|temozolomide|mesh-list
55950060|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55950061|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950062|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55950063|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55950064|NCT01189643|Growth Substances|growth substances|mesh-ancestor
55950065|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950066|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
55950067|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55950068|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55950069|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950070|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950071|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55950072|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
55950073|NCT00066937|Benztropine|benztropine|mesh-list
55950074|NCT00066937|Nortriptyline|nortriptyline|mesh-list
55950075|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55950076|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
55950077|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55950078|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55950079|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55950080|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55950081|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950082|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
55950083|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950084|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950085|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55950086|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55950087|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
55950088|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
55950089|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950090|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55950091|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55950092|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
55950093|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55950094|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
55950095|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
55950096|NCT01064375|Molgramostim|molgramostim|mesh-list
55950097|NCT01064375|Sargramostim|sargramostim|mesh-list
55950098|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950099|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
55950100|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950101|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55950102|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55950103|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
55950104|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950105|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950106|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55950108|NCT01061411|Dalteparin|dalteparin|mesh-list
55950109|NCT01061411|Tinzaparin|tinzaparin|mesh-list
55950122|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55950123|NCT01505673|Liraglutide|liraglutide|mesh-list
55950124|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55950125|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950126|NCT01505673|Incretins|incretins|mesh-ancestor
55950127|NCT01505673|Hormones|hormones|mesh-ancestor
55950128|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950129|NCT01046825|Leucovorin|leucovorin|mesh-list
55950130|NCT01046825|Folic Acid|folic acid|mesh-list
55950131|NCT01046825|Cytarabine|cytarabine|mesh-list
55950132|NCT01046825|Prednisone|prednisone|mesh-list
55950133|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
55950134|NCT01046825|Doxorubicin|doxorubicin|mesh-list
55950135|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55950136|NCT01046825|Rituximab|rituximab|mesh-list
55950137|NCT01046825|Rasburicase|rasburicase|mesh-list
55950138|NCT01046825|Lenograstim|lenograstim|mesh-list
55950139|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
55950140|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55950141|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
55950142|NCT01046825|Hormones|hormones|mesh-ancestor
55950143|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950144|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950145|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55950146|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950147|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55950148|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
55950149|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950150|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55950151|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55950152|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
55950153|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950154|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55950155|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55950156|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55950157|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55950158|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950159|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55950160|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950161|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
55950162|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
55950163|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950164|NCT01046825|Antidotes|antidotes|mesh-ancestor
55950165|NCT01046825|Protective Agents|protective agents|mesh-ancestor
55997376|NCT02569242|Paclitaxel|paclitaxel|mesh-list
55950166|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
55950167|NCT01046825|Vitamins|vitamins|mesh-ancestor
55950168|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
55950169|NCT01046825|Hematinics|hematinics|mesh-ancestor
55950170|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
55950171|NCT04834986|Lenvatinib|lenvatinib|mesh-list
55950172|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950173|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55950174|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950183|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950184|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55950186|NCT04827966|Protective Agents|protective agents|mesh-ancestor
55950187|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55950188|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950189|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
55950190|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
55950191|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950192|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
55950193|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55950194|NCT02247141|Antibodies|antibodies|mesh-list
55950195|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
55950196|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950197|NCT01896245|Sevoflurane|sevoflurane|mesh-list
55950198|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55950199|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55950200|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
55950201|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
55950202|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950203|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950204|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
55950205|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55950206|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
55950207|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950208|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
55950209|NCT04821804|Protective Agents|protective agents|mesh-ancestor
55950210|NCT04835064|Gemcitabine|gemcitabine|mesh-list
55950211|NCT04835064|Paclitaxel|paclitaxel|mesh-list
55950212|NCT04835064|Folfirinox|folfirinox|mesh-list
55950213|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55950214|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950215|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950216|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950217|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950218|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950219|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950220|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
55950221|NCT04835064|Antiviral Agents|antiviral agents|mesh-ancestor
55950222|NCT04835064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950223|NCT04835064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950224|NCT04835064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950225|NCT04835064|Immunologic Factors|immunologic factors|mesh-ancestor
55950226|NCT04835064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950227|NCT00819221|Doxorubicin|doxorubicin|mesh-list
55950228|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55950229|NCT00819221|Olaparib|olaparib|mesh-list
55950230|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55950231|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950232|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55950233|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55950234|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950235|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950236|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55950237|NCT01507779|Vaccines|vaccines|mesh-list
55950239|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000413|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
56000414|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000415|NCT03661320|Antiviral Agents|antiviral agents|mesh-ancestor
55950240|NCT01896323|Ketoconazole|ketoconazole|mesh-list
55950241|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
55950242|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950249|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950251|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55950252|NCT00068341|Carboplatin|carboplatin|mesh-list
55950253|NCT00068341|Docetaxel|docetaxel|mesh-list
55950254|NCT00068341|Trastuzumab|trastuzumab|mesh-list
55950255|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950256|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950257|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950258|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950259|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950260|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55950261|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
55950262|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55950263|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
55950264|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950265|NCT02605824|Expectorants|expectorants|mesh-ancestor
55950266|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
55950267|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55950268|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
55950269|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950270|NCT02605824|Protective Agents|protective agents|mesh-ancestor
55950271|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950272|NCT02605824|Antidotes|antidotes|mesh-ancestor
55950273|NCT01896661|Amlodipine|amlodipine|mesh-list
55950274|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
55950275|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
55950276|NCT01896661|Amiloride|amiloride|mesh-list
55950277|NCT01896661|Calcium|calcium|mesh-list
55950278|NCT01896661|Diuretics|diuretics|mesh-list
55950279|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55950280|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950281|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55950282|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55950283|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950284|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
55950285|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
55950286|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55950287|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55950288|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55950289|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55950290|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55950291|NCT01462773|Interferons|interferons|mesh-list
55950292|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
55950293|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
55950294|NCT01462773|Bortezomib|bortezomib|mesh-list
55997452|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950295|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950296|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
55950297|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950298|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
55950299|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950300|NCT02096029|Nicotine|nicotine|mesh-list
55950301|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55950302|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
55950303|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950304|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950305|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55950306|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55950307|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
55950308|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950319|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950320|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
55950321|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950322|NCT04834440|Ropivacaine|ropivacaine|mesh-list
55950323|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
55950324|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
56000416|NCT03661320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000417|NCT03661320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789526|NCT04400695|Capecitabine|capecitabine|mesh-list
55950325|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950326|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950327|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
55950328|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950329|NCT00068575|Interferons|interferons|mesh-list
55950330|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
55950331|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
55950333|NCT00068575|Fluorouracil|fluorouracil|mesh-list
55950334|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950335|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
55950336|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950337|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950338|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950339|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
55950340|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950341|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
55950342|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950343|NCT00784823|Bortezomib|bortezomib|mesh-list
55950344|NCT00784823|Melphalan|melphalan|mesh-list
55950345|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950346|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55950347|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
55950348|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950349|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55950350|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950351|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
55950352|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950353|NCT04428684|Goserelin|goserelin|mesh-list
55950354|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55950355|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950356|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55950357|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
55950358|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950359|NCT00773357|Guanfacine|guanfacine|mesh-list
55950360|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55950361|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55950362|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55950363|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55950364|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
55950365|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950366|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950367|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950368|NCT05617950|Salicylic Acid|salicylic acid|mesh-list
55950369|NCT05617950|Salicylates|salicylates|mesh-list
55950370|NCT05617950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950371|NCT05617950|Antifungal Agents|antifungal agents|mesh-ancestor
55950372|NCT05617950|Keratolytic Agents|keratolytic agents|mesh-ancestor
55950373|NCT05617950|Dermatologic Agents|dermatologic agents|mesh-ancestor
55950391|NCT04834752|Famotidine|famotidine|mesh-list
55950392|NCT04834752|Ranitidine|ranitidine|mesh-list
55950393|NCT04834752|Cimetidine|cimetidine|mesh-list
55950394|NCT04834752|Nizatidine|nizatidine|mesh-list
55950395|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55950396|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55950397|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55950398|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950399|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950400|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55950401|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
55950402|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
55950403|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950404|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950405|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55950406|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55950407|NCT04834674|Apatinib|apatinib|mesh-list
55950408|NCT04834674|Antibodies|antibodies|mesh-list
55950409|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
55950410|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950411|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950412|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56000418|NCT03661320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000419|NCT03661320|Immunologic Factors|immunologic factors|mesh-ancestor
56000420|NCT03661320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000421|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000422|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55950413|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950414|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950415|NCT04826562|Lamivudine|lamivudine|mesh-list
55950416|NCT04826562|Dolutegravir|dolutegravir|mesh-list
55950417|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55950418|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55950419|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950420|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950421|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
55934275|NCT00956085|Memantine|memantine|mesh-list
55950422|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950423|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55950424|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55950425|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55950426|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55950428|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950429|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55950430|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950431|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950432|NCT05617872|Acetic Acid|acetic acid|mesh-list
55950447|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55950448|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
55950450|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950451|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950452|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55950453|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
55950454|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
55950455|NCT02324673|Cannabidiol|cannabidiol|mesh-list
55950456|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
55950457|NCT00373217|Paclitaxel|paclitaxel|mesh-list
55950458|NCT00373217|Carboplatin|carboplatin|mesh-list
55950459|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55950460|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950461|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950462|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950463|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950464|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950465|NCT02605122|Amoxicillin|amoxicillin|mesh-list
55950466|NCT02605122|Azithromycin|azithromycin|mesh-list
55950467|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
55950468|NCT02605122|Erythromycin|erythromycin|mesh-list
55950469|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
55950470|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55950471|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
55950472|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
55950473|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
55950474|NCT02605122|Ampicillin|ampicillin|mesh-list
55950475|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55950476|NCT02605122|Solithromycin|solithromycin|mesh-list
55950477|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
55950478|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55950479|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950480|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55950481|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55950482|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950483|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950484|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55950485|NCT01579305|Lidocaine|lidocaine|mesh-list
55950486|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
55950487|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
55950488|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950489|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950490|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
55950491|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950492|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56000424|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56000425|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
55950493|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55950494|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55950509|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950510|NCT01454102|Gemcitabine|gemcitabine|mesh-list
55950511|NCT01454102|Paclitaxel|paclitaxel|mesh-list
55950512|NCT01454102|Bevacizumab|bevacizumab|mesh-list
55950513|NCT01454102|Carboplatin|carboplatin|mesh-list
55950514|NCT01454102|Nivolumab|nivolumab|mesh-list
55950515|NCT01454102|Pemetrexed|pemetrexed|mesh-list
55950516|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55950517|NCT01454102|Ipilimumab|ipilimumab|mesh-list
55950518|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55950519|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950520|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950521|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950522|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950523|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950524|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55950525|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55950526|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55950527|NCT01454102|Growth Substances|growth substances|mesh-ancestor
55950528|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950529|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
55950530|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950531|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
55950532|NCT01454102|Antiviral Agents|antiviral agents|mesh-ancestor
55950533|NCT01454102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950534|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950535|NCT01454102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950536|NCT01454102|Immunologic Factors|immunologic factors|mesh-ancestor
55950537|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55950538|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55950539|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55950540|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55950541|NCT04819776|Iloperidone|iloperidone|mesh-list
55950542|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55950543|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55950544|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950545|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950546|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55950547|NCT04192253|Paclitaxel|paclitaxel|mesh-list
55950548|NCT04192253|Carboplatin|carboplatin|mesh-list
55950549|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55950550|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950551|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950552|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950553|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950554|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950555|NCT04825938|Paclitaxel|paclitaxel|mesh-list
55950556|NCT04825938|Carboplatin|carboplatin|mesh-list
55950565|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950566|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950567|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950568|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950569|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950570|NCT01509807|Morphine|morphine|mesh-list
55950571|NCT01509807|Bupivacaine|bupivacaine|mesh-list
55950572|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
55950573|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
55950574|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950575|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950576|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
55950577|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950578|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55950579|NCT01509807|Narcotics|narcotics|mesh-ancestor
55950580|NCT01509807|Analgesics|analgesics|mesh-ancestor
55950581|NCT00070135|Methotrexate|methotrexate|mesh-list
55950582|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
55950583|NCT00070135|Fludarabine|fludarabine|mesh-list
55950584|NCT00070135|Busulfan|busulfan|mesh-list
55950585|NCT00070135|Tacrolimus|tacrolimus|mesh-list
55950586|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55950587|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56000426|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
56000427|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000428|NCT04915612|Cytarabine|cytarabine|mesh-list
56000429|NCT04915612|Daunorubicin|daunorubicin|mesh-list
56000430|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
56000431|NCT04915612|Calicheamicins|calicheamicins|mesh-list
55950588|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
55950589|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55950590|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950591|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950592|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
55950593|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950594|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950595|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
55950597|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55950598|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950600|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55950601|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55950602|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55950603|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
55950604|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55950605|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55950606|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
55950607|NCT01583985|Narcotics|narcotics|mesh-ancestor
55950608|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950609|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950610|NCT01583985|Analgesics|analgesics|mesh-ancestor
55950611|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
55950612|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950613|NCT04816344|Anesthetics|anesthetics|mesh-list
55950614|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950615|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950616|NCT01467999|Guanfacine|guanfacine|mesh-list
55950617|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55950618|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55950619|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55950620|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55950621|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
55950622|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950623|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934313|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55950641|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55950642|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950643|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55950644|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55950645|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55950646|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950647|NCT01512225|Domperidone|domperidone|mesh-list
55950648|NCT01512225|Maleic acid|maleic acid|mesh-list
55950649|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950650|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950651|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
55950652|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
55950653|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950654|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950655|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55950656|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55950657|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
55950658|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950659|NCT01472445|Vitamin D|vitamin d|mesh-list
55950660|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
55950661|NCT01472445|Vitamins|vitamins|mesh-ancestor
55950662|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
55950663|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950664|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55950665|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55950666|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55950667|NCT04782089|Antibodies|antibodies|mesh-list
56000432|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56000433|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
56000434|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000435|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950668|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
55950669|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950670|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950671|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950672|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950673|NCT02604342|Docetaxel|docetaxel|mesh-list
55950674|NCT02604342|Pemetrexed|pemetrexed|mesh-list
55950675|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950676|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950677|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950678|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950679|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871429|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
55950700|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950702|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55950703|NCT05565573|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55950704|NCT05565573|Levonorgestrel|levonorgestrel|mesh-list
55950705|NCT05565573|Medroxyprogesterone|medroxyprogesterone|mesh-list
55950706|NCT05565573|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55950707|NCT05565573|Contraceptive Agents|contraceptive agents|mesh-ancestor
55950708|NCT05565573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55950709|NCT05565573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950710|NCT05565573|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55950711|NCT05565573|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55950712|NCT05565573|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55950713|NCT05565573|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55950714|NCT05565573|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55743815|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
55950715|NCT05565573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55950716|NCT05565573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950717|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
55950718|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
55950719|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55950720|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55950721|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950722|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950723|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950724|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55950725|NCT01587027|Aminophylline|aminophylline|mesh-list
55950726|NCT01587027|Methazolamide|methazolamide|mesh-list
55950727|NCT01587027|Theophylline|theophylline|mesh-list
55950728|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55950729|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
55950730|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950731|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950732|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55950755|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
55950756|NCT01471340|Prednisone|prednisone|mesh-list
55950757|NCT01471340|Prednisolone|prednisolone|mesh-list
55950758|NCT01471340|Albuterol|albuterol|mesh-list
55950759|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
55950760|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
55950761|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55950762|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
55950763|NCT01471340|Hormones|hormones|mesh-ancestor
55950764|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950765|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950766|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55950767|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950768|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
55950769|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950770|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55950771|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55950772|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
55950773|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56000436|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
56000437|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000438|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000439|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
56000440|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950774|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55950775|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55950776|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
55950777|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950778|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950779|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
55950780|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55950782|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55950783|NCT04754789|Aspirin|aspirin|mesh-list
55997586|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55950784|NCT04754789|Ticagrelor|ticagrelor|mesh-list
55950785|NCT04754789|Atorvastatin|atorvastatin|mesh-list
55950802|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55950803|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
55950804|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55950805|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55950806|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55950807|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55950808|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55950810|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950811|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55950812|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55950813|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55950814|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
55950815|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950816|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55950817|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55950818|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950819|NCT04815408|Paclitaxel|paclitaxel|mesh-list
55950820|NCT04815408|Carboplatin|carboplatin|mesh-list
55950821|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55950822|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55950823|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950824|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950825|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950826|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950827|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950828|NCT04806906|Azacitidine|azacitidine|mesh-list
55950829|NCT04806906|Cc-486|cc-486|mesh-list
55950830|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950831|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
55950832|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950833|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950834|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950835|NCT04778813|Artesunate|artesunate|mesh-list
55950836|NCT04778813|Lumefantrine|lumefantrine|mesh-list
55950837|NCT04778813|Artemether|artemether|mesh-list
55950838|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55950839|NCT04778813|Artenimol|artenimol|mesh-list
55950840|NCT04778813|Pyronaridine|pyronaridine|mesh-list
55950841|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
55950842|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55950852|NCT04817982|Lidocaine|lidocaine|mesh-list
55950853|NCT04817982|BB 1101|bb 1101|mesh-list
55950854|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55950855|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
55950856|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
55950857|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950858|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950859|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55950860|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
55950861|NCT04817982|Hormones|hormones|mesh-ancestor
55950862|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950863|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55950864|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000441|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56000442|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56000443|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56000444|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950865|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
55950866|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950867|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950868|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
55950870|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950871|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
55950872|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55950873|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55950874|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55997622|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
55997623|NCT04128254|Apixaban|apixaban|mesh-list
55950875|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55950876|NCT04779047|Ritonavir|ritonavir|mesh-list
55950877|NCT04779047|Lopinavir|lopinavir|mesh-list
55950878|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
55950879|NCT04779047|Ivermectin|ivermectin|mesh-list
55950880|NCT04779047|Remdesivir|remdesivir|mesh-list
55950881|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55950882|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55950883|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
55950884|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950885|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950886|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55822572|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
55950887|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55950888|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
55950889|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950890|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55950891|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55950892|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
55950893|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55950894|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55950895|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55950896|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
55950897|NCT04427826|Morphine|morphine|mesh-list
55950898|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55950899|NCT04427826|Narcotics|narcotics|mesh-ancestor
55950900|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950901|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950902|NCT04427826|Analgesics|analgesics|mesh-ancestor
55950903|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
55950904|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950905|NCT03699995|Lidocaine|lidocaine|mesh-list
55950906|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
55950907|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
55950908|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950909|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950910|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
55950911|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950938|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950939|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55950941|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55950942|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55950943|NCT01492400|Growth Substances|growth substances|mesh-ancestor
55950944|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
55950945|NCT00168337|Dexamethasone|dexamethasone|mesh-list
55950946|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55997734|NCT02979548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55950947|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
55950948|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
55950949|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950950|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950951|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55950952|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
55950953|NCT00168337|Hormones|hormones|mesh-ancestor
55950954|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55950955|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55950956|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950957|NCT01515657|Aspirin|aspirin|mesh-list
55950966|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55950967|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56000445|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000446|NCT00979810|Alovudine|alovudine|mesh-list
56000447|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
56000448|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000449|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56000450|NCT04549116|Progesterone|progesterone|mesh-list
56000451|NCT04549116|Progestins|progestins|mesh-ancestor
55950968|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950969|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55950970|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55950971|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950972|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
55950973|NCT01515891|Opicapone|opicapone|mesh-list
55950974|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55950975|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950976|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950977|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55950978|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55950979|NCT00073957|Cytarabine|cytarabine|mesh-list
55950980|NCT00073957|Rituximab|rituximab|mesh-list
55950981|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55950982|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950983|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
55950984|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950985|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55950986|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950987|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
55950988|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950989|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
55822865|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55950991|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55950993|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
55950994|NCT04354428|Ritonavir|ritonavir|mesh-list
55950995|NCT04354428|Lopinavir|lopinavir|mesh-list
55950996|NCT04354428|Azithromycin|azithromycin|mesh-list
55950997|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
55950998|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55950999|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55951000|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
55951001|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951002|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951003|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55951004|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55951005|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
55951006|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951007|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55951008|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55951009|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55951012|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55951013|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951014|NCT04354428|Hematinics|hematinics|mesh-ancestor
55951015|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
55951016|NCT04354428|Vitamins|vitamins|mesh-ancestor
55951017|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
55951018|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951019|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
55951020|NCT04354428|Protective Agents|protective agents|mesh-ancestor
55951021|NCT02090075|Warfarin|warfarin|mesh-list
55951022|NCT02090075|Apixaban|apixaban|mesh-list
55951023|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
55951024|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55951025|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
55951026|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55951036|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951038|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55951039|NCT04775303|Cyclosporins|cyclosporins|mesh-list
55951040|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951041|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951042|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000452|NCT04549116|Hormones|hormones|mesh-ancestor
56000453|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997819|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56000454|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000455|NCT00947284|Nalbuphine|nalbuphine|mesh-list
56000456|NCT00947284|Naloxone|naloxone|mesh-list
55997820|NCT03822962|Analgesics|analgesics|mesh-ancestor
56000457|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56000458|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000459|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
56000460|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000461|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56000462|NCT00947284|Narcotics|narcotics|mesh-ancestor
56000463|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000464|NCT00947284|Analgesics|analgesics|mesh-ancestor
56000465|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56000466|NCT00932152|Bevacizumab|bevacizumab|mesh-list
56000467|NCT00932152|Fulvestrant|fulvestrant|mesh-list
56000468|NCT00932152|Anastrozole|anastrozole|mesh-list
56000469|NCT00932152|Analgesics|analgesics|mesh-list
56000470|NCT00932152|Antiemetics|antiemetics|mesh-list
56000471|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000472|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951043|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
55951044|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951045|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
55951046|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951047|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
55951048|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951049|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55951050|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55951051|NCT04816968|Vancomycin|vancomycin|mesh-list
55951052|NCT04816968|Meropenem|meropenem|mesh-list
55951053|NCT04816968|Tazobactam|tazobactam|mesh-list
55951054|NCT04816968|Piperacillin|piperacillin|mesh-list
55951055|NCT04816968|Cefepime|cefepime|mesh-list
55951056|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55951057|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55951058|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951059|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55951061|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951062|NCT02210247|Bupivacaine|bupivacaine|mesh-list
55951063|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
55951064|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
55951065|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951066|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951067|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
55951068|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951069|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55951070|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
55951071|NCT04806438|Lidocaine|lidocaine|mesh-list
55951072|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
55951073|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
55951074|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951075|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951076|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
55951077|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951078|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56000473|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55951079|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55951080|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55951081|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55951082|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951083|NCT00074035|Pentostatin|pentostatin|mesh-list
55951084|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997843|NCT03825380|Bimatoprost|bimatoprost|mesh-list
55743824|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55951085|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
55951086|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951087|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951088|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55951089|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55951113|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951114|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55951115|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55951116|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
55951117|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55951118|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
55951120|NCT00074815|Fluoxetine|fluoxetine|mesh-list
55951121|NCT00074815|Paroxetine|paroxetine|mesh-list
55951122|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55951123|NCT00074815|Sertraline|sertraline|mesh-list
55951124|NCT00074815|Clomipramine|clomipramine|mesh-list
55951125|NCT00074815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55951126|NCT00074815|Serotonin|serotonin|mesh-list
55951127|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55951128|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55951129|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951130|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951131|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
55951132|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951133|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55951134|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
55951135|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55951136|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55951137|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55951138|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951139|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55951140|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55951141|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55951142|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55951143|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951160|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
55951161|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
55951162|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951163|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951164|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55951165|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
55951167|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55951168|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55951169|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822866|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55951170|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951171|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
55951172|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
55951173|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55951174|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951175|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55951176|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55951177|NCT00075829|Growth Substances|growth substances|mesh-ancestor
55951178|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
55951180|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
55997860|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55951181|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
55951182|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
55951183|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951184|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951185|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
55951186|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951187|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56000474|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56000475|NCT00932152|Growth Substances|growth substances|mesh-ancestor
56000476|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000477|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
56000478|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951188|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55951189|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55951190|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55951191|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951192|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
55951193|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
55951194|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55951195|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55951196|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951197|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
55951198|NCT04771715|Nivolumab|nivolumab|mesh-list
55951199|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55951200|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951201|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55951202|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951217|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55951219|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951220|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55951221|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
55951222|NCT00585559|Acetaminophen|acetaminophen|mesh-list
55951223|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
55951224|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55951225|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55951226|NCT00585559|Analgesics|analgesics|mesh-ancestor
55951227|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
55951228|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951229|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951230|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
55951231|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
55951232|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951233|NCT00585559|Expectorants|expectorants|mesh-ancestor
55951234|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
55951235|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55951236|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
55951237|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951238|NCT00585559|Protective Agents|protective agents|mesh-ancestor
55951239|NCT00585559|Antidotes|antidotes|mesh-ancestor
55951240|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55951242|NCT02763137|Levodopa|levodopa|mesh-list
55951243|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55951244|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
55951245|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951246|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55951247|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55951248|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
55951249|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
55951250|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951251|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951252|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55951253|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951254|NCT01896739|Vaccines|vaccines|mesh-list
55951255|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
55951256|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951257|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
55951258|NCT00176839|Melphalan|melphalan|mesh-list
55951259|NCT00176839|Busulfan|busulfan|mesh-list
55951260|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55951261|NCT00176839|Lenograstim|lenograstim|mesh-list
55951262|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951263|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
55951264|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951265|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951266|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55951291|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
55951292|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56000479|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56000480|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56000481|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55951293|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55951294|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951295|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55951296|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
55951297|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55951298|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
55951299|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951300|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55951301|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
55951302|NCT02664155|Coagulants|coagulants|mesh-ancestor
55951303|NCT04770389|Ezetimibe|ezetimibe|mesh-list
55951304|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
55951305|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55951306|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
55951307|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951308|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55951309|NCT04753619|Niclosamide|niclosamide|mesh-list
55951310|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
55951311|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55951312|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
55951313|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55951314|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951315|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
55951316|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55951317|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55951318|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951319|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
55951320|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55951334|NCT05606315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55951335|NCT05606315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55997882|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55951336|NCT05606315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55951337|NCT05606315|GABA Modulators|gaba modulators|mesh-ancestor
55951338|NCT05606315|GABA Agents|gaba agents|mesh-ancestor
55951339|NCT05606315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951340|NCT05606315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951341|NCT05605925|Ivermectin|ivermectin|mesh-list
55951342|NCT05605925|Lumefantrine|lumefantrine|mesh-list
55951343|NCT05605925|Artemether|artemether|mesh-list
55951344|NCT05605925|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55951345|NCT05605925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55951346|NCT05605925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951347|NCT05605925|Antimalarials|antimalarials|mesh-ancestor
55951348|NCT05605925|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55951349|NCT01520727|Opicapone|opicapone|mesh-list
55951350|NCT01520727|Entacapone|entacapone|mesh-list
55951351|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55951352|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951353|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951354|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55951355|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55951356|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
55951357|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55951358|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951359|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951360|NCT01855607|Menthol|menthol|mesh-list
55951361|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
55951362|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
55951363|NCT01596699|Fludarabine|fludarabine|mesh-list
55951364|NCT01596699|Busulfan|busulfan|mesh-list
55951365|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
55951366|NCT01596699|Clofarabine|clofarabine|mesh-list
55823578|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
55951367|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951368|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55951369|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
55951370|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951371|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951372|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
55951373|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951374|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
55951375|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55951376|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56000482|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
56000483|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000484|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55951377|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55951378|NCT01148849|Margetuximab|margetuximab|mesh-list
55951379|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951380|NCT05605301|Deoxyglucose|deoxyglucose|mesh-list
55951381|NCT05605301|Antimetabolites|antimetabolites|mesh-ancestor
55951382|NCT05605301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951383|NCT05605301|Antiviral Agents|antiviral agents|mesh-ancestor
55951384|NCT05605301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951385|NCT05566743|Capecitabine|capecitabine|mesh-list
55951402|NCT05566665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55951403|NCT05566665|Renal Agents|renal agents|mesh-ancestor
55951404|NCT05596721|Azithromycin|azithromycin|mesh-list
55951405|NCT05596721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55951406|NCT05596721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951407|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
55951408|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55951409|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55951410|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55951411|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55951412|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951413|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
55951414|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951415|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951416|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55951417|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951418|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55951419|NCT01525173|Bimatoprost|bimatoprost|mesh-list
55951420|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55951421|NCT01525173|Latanoprost|latanoprost|mesh-list
55951422|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55951423|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
55951424|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55951425|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55951426|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55951427|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55951428|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
55951429|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951430|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951431|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951432|NCT03007563|Bilirubin|bilirubin|mesh-list
55951433|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
55951434|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951435|NCT03007563|Protective Agents|protective agents|mesh-ancestor
55951436|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951437|NCT05417087|Vortioxetine|vortioxetine|mesh-list
55951438|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
55951439|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55951440|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55951441|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55951442|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997994|NCT03008408|Everolimus|everolimus|mesh-list
55997995|NCT03008408|Letrozole|letrozole|mesh-list
55951443|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951457|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951458|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951459|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55951460|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55951461|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
55951462|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
55951463|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951464|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55951465|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55823580|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55951466|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951467|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951468|NCT01526577|Ticagrelor|ticagrelor|mesh-list
55951469|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55951470|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55951471|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55951472|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56000485|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56000486|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000487|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000488|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
56000489|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000490|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
56000491|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56000492|NCT01916590|Bupivacaine|bupivacaine|mesh-list
56000493|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
56000494|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
56000495|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000496|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000497|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
55951473|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
55951474|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951475|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951476|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951477|NCT02938793|Durvalumab|durvalumab|mesh-list
55951478|NCT02938793|Tremelimumab|tremelimumab|mesh-list
55998097|NCT02925650|Phenserine|phenserine|mesh-list
55951479|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55951480|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951481|NCT01894451|Bevacizumab|bevacizumab|mesh-list
55951482|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
55951483|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55951484|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951485|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55951486|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55951487|NCT01894451|Growth Substances|growth substances|mesh-ancestor
55951488|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951489|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
55951490|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55951491|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951492|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
55951493|NCT01527045|Cyclosporine|cyclosporine|mesh-list
55951494|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
55951495|NCT01527045|Fludarabine|fludarabine|mesh-list
55951496|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
55951497|NCT01527045|Atorvastatin|atorvastatin|mesh-list
55951498|NCT01527045|Calcium|calcium|mesh-list
55951499|NCT01527045|Cyclosporins|cyclosporins|mesh-list
55951500|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55951501|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951502|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55951517|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55998164|NCT05509374|Hormones|hormones|mesh-ancestor
55998165|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55951518|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55951519|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55951520|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55951521|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
55951522|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55951523|NCT00078403|Ribavirin|ribavirin|mesh-list
55951524|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55951525|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
55951526|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951527|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
55951528|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951529|NCT01976585|Poly ICLC|poly iclc|mesh-list
55951530|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
55951531|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
55951532|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951533|NCT01972919|Gemcitabine|gemcitabine|mesh-list
55951534|NCT01972919|Capecitabine|capecitabine|mesh-list
55951535|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55951537|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951538|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951539|NCT01972919|Antiviral Agents|antiviral agents|mesh-ancestor
55998228|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55951540|NCT01972919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951541|NCT01972919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825357|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
55951544|NCT01972919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951545|NCT03440567|Rituximab|rituximab|mesh-list
55951546|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55951547|NCT03440567|Avelumab|avelumab|mesh-list
55951548|NCT03440567|Carboplatin|carboplatin|mesh-list
55951549|NCT03440567|Etoposide|etoposide|mesh-list
55951550|NCT03440567|Ifosfamide|ifosfamide|mesh-list
55951551|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
55951552|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
55951553|NCT03440567|Antibodies|antibodies|mesh-list
55951554|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
55951555|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55951556|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
55951557|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
55951558|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951559|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951560|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998401|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
55951561|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55951562|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55951563|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55951564|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951572|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55951573|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951574|NCT03001635|Oxytocin|oxytocin|mesh-list
55951575|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
55951576|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55951577|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951578|NCT02592798|Abatacept|abatacept|mesh-list
55951579|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55998477|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998479|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
55951580|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951581|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951582|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951583|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
55998542|NCT03780010|Carboplatin|carboplatin|mesh-list
55951584|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951585|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951586|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55951587|NCT01530243|Terazosin|terazosin|mesh-list
55951588|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55951589|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55951590|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
55951591|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951592|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951593|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951594|NCT01530243|Urological Agents|urological agents|mesh-ancestor
55951595|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55951596|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55951597|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55951598|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
55951599|NCT04797546|Morphine|morphine|mesh-list
55951600|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55951601|NCT04797546|Narcotics|narcotics|mesh-ancestor
55951602|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951603|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951604|NCT04797546|Analgesics|analgesics|mesh-ancestor
55951605|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
55951606|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951607|NCT02980809|Apatinib|apatinib|mesh-list
55951608|NCT02980809|Topotecan|topotecan|mesh-list
55951609|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951610|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55951611|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951612|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951613|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55951614|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56000498|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000500|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56000501|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000502|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
56000503|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000504|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
55998619|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000505|NCT05474898|Analgesics|analgesics|mesh-ancestor
56000506|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
56000509|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
55789592|NCT02650921|Lidocaine|lidocaine|mesh-list
55951615|NCT00078559|Acetaminophen|acetaminophen|mesh-list
55951616|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
55951617|NCT00078559|Promethazine|promethazine|mesh-list
55951618|NCT00078559|Sirolimus|sirolimus|mesh-list
55951619|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55951620|NCT00078559|Nystatin|nystatin|mesh-list
55951621|NCT00078559|Clotrimazole|clotrimazole|mesh-list
55951622|NCT00078559|Miconazole|miconazole|mesh-list
55951623|NCT00078559|Pentamidine|pentamidine|mesh-list
55951624|NCT00078559|Trimethoprim|trimethoprim|mesh-list
55951625|NCT00078559|Valganciclovir|valganciclovir|mesh-list
55951626|NCT00078559|Acyclovir|acyclovir|mesh-list
55951627|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
55951628|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
55951629|NCT00078559|Tacrolimus|tacrolimus|mesh-list
55951630|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951631|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
55951644|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951645|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
55951646|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55951647|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
55951648|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
55951649|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55951650|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
55951651|NCT00078559|Hormones|hormones|mesh-ancestor
55951652|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55951653|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55951654|NCT00078559|Protective Agents|protective agents|mesh-ancestor
55951655|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55951656|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55951657|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55951658|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951659|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
55951660|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
55951661|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55951662|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
55951663|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
55951664|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951665|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55951666|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
55951667|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
55951668|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55951669|NCT00078559|Renal Agents|renal agents|mesh-ancestor
55951670|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
55951671|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55951672|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55951673|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55951674|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55934519|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55951675|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55951676|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55951677|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
55951678|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55951679|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56000510|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000511|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56000512|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
55951680|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55951681|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
55951682|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55951683|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55951684|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55951685|NCT00078559|Ionophores|ionophores|mesh-ancestor
55951686|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55951688|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55951689|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951690|NCT00078715|Yohimbine|yohimbine|mesh-list
55951691|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
55951692|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
55951693|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951702|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
55951703|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951704|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
55951705|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55951706|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55951707|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951708|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
55951709|NCT01530399|Coagulants|coagulants|mesh-ancestor
55951710|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55951711|NCT02596620|Amoxicillin|amoxicillin|mesh-list
55951712|NCT02596620|Metronidazole|metronidazole|mesh-list
55951713|NCT02596620|Levofloxacin|levofloxacin|mesh-list
55951714|NCT02596620|Esomeprazole|esomeprazole|mesh-list
55951715|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55951716|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951717|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55951718|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55951719|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55951720|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55951721|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55951722|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951723|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951724|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55951725|NCT02596620|Renal Agents|renal agents|mesh-ancestor
55951726|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55951727|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55951728|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951729|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55951730|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55951731|NCT01531959|Midodrine|midodrine|mesh-list
55951732|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
55951733|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
55743851|NCT03121573|Analgesics|analgesics|mesh-ancestor
55951734|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951735|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951736|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55951737|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55951738|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55951739|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55951740|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
55951741|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951742|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951744|NCT01532349|Vitamin D|vitamin d|mesh-list
55951745|NCT01532349|Vitamins|vitamins|mesh-ancestor
55951746|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
55951747|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951748|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55951749|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55951750|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
55951751|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55951752|NCT01533207|Gemcitabine|gemcitabine|mesh-list
55951753|NCT01533207|Docetaxel|docetaxel|mesh-list
55951754|NCT01533207|Doxorubicin|doxorubicin|mesh-list
55951755|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55951756|NCT01533207|Lenograstim|lenograstim|mesh-list
56000513|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56000514|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55789604|NCT04913987|Cimetidine|cimetidine|mesh-list
55951757|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55951758|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
55951759|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951760|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951773|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55951774|NCT00182767|Doxorubicin|doxorubicin|mesh-list
55951775|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55951776|NCT00182767|Epothilone B|epothilone b|mesh-list
55951777|NCT00182767|Epothilones|epothilones|mesh-list
55951778|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55951779|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951780|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55951781|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55951782|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951783|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951784|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
55951785|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
55951786|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
55951787|NCT01533597|Tamsulosin|tamsulosin|mesh-list
55951788|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
55951789|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55951790|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55951791|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55951792|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
55951793|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951794|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951795|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951796|NCT01533597|Urological Agents|urological agents|mesh-ancestor
55951797|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55951798|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55951799|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
55951800|NCT03006627|Morphine|morphine|mesh-list
55951801|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55951802|NCT03006627|Narcotics|narcotics|mesh-ancestor
55951803|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951804|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951805|NCT03006627|Analgesics|analgesics|mesh-ancestor
55998914|NCT01451294|Phenylephrine|phenylephrine|mesh-list
55951806|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
55951807|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951808|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
55951809|NCT04796688|Fludarabine|fludarabine|mesh-list
55951810|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951811|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
55951812|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951813|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951814|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55951815|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
55951816|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951817|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951818|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55951819|NCT01535001|Acetaminophen|acetaminophen|mesh-list
55951820|NCT01535001|Pantoprazole|pantoprazole|mesh-list
55951821|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55951822|NCT01535001|Analgesics|analgesics|mesh-ancestor
55951823|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
55951824|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951835|NCT03000777|Protective Agents|protective agents|mesh-ancestor
55951836|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951837|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951839|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55951840|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55951841|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951842|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55951843|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
55951844|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55951845|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55951846|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55951847|NCT04426734|Dexamethasone|dexamethasone|mesh-list
55951848|NCT04426734|Prednisolone|prednisolone|mesh-list
56000515|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000516|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56000517|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
56000518|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56000519|NCT03428958|Leucovorin|leucovorin|mesh-list
56000520|NCT03428958|Bevacizumab|bevacizumab|mesh-list
56000521|NCT03428958|Cetuximab|cetuximab|mesh-list
56000522|NCT03428958|Panitumumab|panitumumab|mesh-list
56000523|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
56000524|NCT03428958|Irinotecan|irinotecan|mesh-list
56000525|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
55789605|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55951849|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55998982|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55951850|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
55951851|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55951852|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
55951853|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55951854|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
55951855|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55951856|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
55951857|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
55951858|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951859|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951860|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55951861|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
55951862|NCT04426734|Hormones|hormones|mesh-ancestor
55951863|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55951864|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55951865|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951866|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55951867|NCT04426734|Protective Agents|protective agents|mesh-ancestor
55951868|NCT03006081|Aflibercept|aflibercept|mesh-list
55951869|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55951870|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55951871|NCT03006081|Growth Substances|growth substances|mesh-ancestor
55951872|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951873|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
55951874|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951875|NCT01535937|Midazolam|midazolam|mesh-list
55951876|NCT01535937|Ketamine|ketamine|mesh-list
55951877|NCT01535937|Analgesics|analgesics|mesh-ancestor
55951878|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
55951879|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951880|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951881|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55951882|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55951883|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
55951884|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
55951885|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951886|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55951887|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55951888|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951910|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
55951911|NCT01537029|Doxorubicin|doxorubicin|mesh-list
55999012|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55951912|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951913|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
55951914|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951915|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951916|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55951917|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
55951918|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951919|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951920|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55951921|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56000526|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55951922|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55951923|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55951924|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951925|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55951926|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951927|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55951928|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951929|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951930|NCT04281108|Fluticasone|fluticasone|mesh-list
55951932|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55951933|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55951934|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
55951935|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951936|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951937|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55951938|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
55951939|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
55951940|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55951941|NCT04803318|Everolimus|everolimus|mesh-list
55951942|NCT04803318|Lenvatinib|lenvatinib|mesh-list
55951943|NCT04803318|Trametinib|trametinib|mesh-list
55951957|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55951958|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55951960|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951961|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55951962|NCT02999217|Hematinics|hematinics|mesh-ancestor
55999063|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951963|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55951964|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55951965|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
55951966|NCT02980965|Docetaxel|docetaxel|mesh-list
55951967|NCT02980965|Fluorouracil|fluorouracil|mesh-list
55951968|NCT02980965|Letrozole|letrozole|mesh-list
55951969|NCT02980965|Epirubicin|epirubicin|mesh-list
55951970|NCT02980965|Leuprolide|leuprolide|mesh-list
55951971|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951973|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951974|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951975|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55951976|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
55951977|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951978|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951979|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55951980|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
55951981|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
55951982|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
55951983|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
55951984|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55951985|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55951986|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55951987|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951988|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55951989|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
55951990|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55951991|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55951992|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55951993|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55951994|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55951995|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
55934572|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55999156|NCT04713904|Estradiol|estradiol|mesh-list
55951996|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55951997|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55951998|NCT01538745|Ketamine|ketamine|mesh-list
55951999|NCT01538745|Morphine|morphine|mesh-list
55952000|NCT01538745|Analgesics|analgesics|mesh-ancestor
55952001|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
55952002|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952003|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952004|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55952005|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55952014|NCT01538745|Narcotics|narcotics|mesh-ancestor
55952015|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
55952016|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55952017|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
55952018|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000527|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000528|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56000529|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56000530|NCT03428958|Growth Substances|growth substances|mesh-ancestor
55952019|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
55952020|NCT04803240|Protective Agents|protective agents|mesh-ancestor
55952021|NCT04803474|Hormones|hormones|mesh-list
55952022|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952023|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952024|NCT01539135|Methylene Blue|methylene blue|mesh-list
55952025|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952026|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952027|NCT04426578|Perhexiline|perhexiline|mesh-list
55952028|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55952029|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952030|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952031|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55952032|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952033|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
55952035|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
55952036|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55952037|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952038|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55952039|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55952040|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
55952041|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952042|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55952043|NCT05365425|Choline|choline|mesh-list
55952044|NCT05365425|Policosanol|policosanol|mesh-list
55952045|NCT05365425|Fenofibrate|fenofibrate|mesh-list
55952046|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55952047|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
55934706|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952048|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952049|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55952050|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
55952051|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55952052|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
55952053|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55952054|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55952055|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55952056|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952057|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55952058|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006022|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55952059|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952060|NCT05350371|Pirfenidone|pirfenidone|mesh-list
55952061|NCT05350371|Analgesics|analgesics|mesh-ancestor
55952062|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
55952063|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952064|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952065|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55952066|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55952067|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006675|NCT05465226|Analgesics|analgesics|mesh-ancestor
55952068|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55952069|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952070|NCT04794738|Morphine|morphine|mesh-list
55952071|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55952088|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952089|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
55952090|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952092|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952093|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55952094|NCT02591238|Melatonin|melatonin|mesh-list
55952095|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
55952096|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006875|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56006876|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56006877|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55734055|NCT03464305|Aspirin|aspirin|mesh-list
56006879|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55952097|NCT02591238|Protective Agents|protective agents|mesh-ancestor
55952098|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952099|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952100|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
55952101|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55952102|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
56006941|NCT02544750|Cannabidiol|cannabidiol|mesh-list
56000531|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000532|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
56000533|NCT03428958|Antidotes|antidotes|mesh-ancestor
55952103|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952104|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952105|NCT04793256|Listerine|listerine|mesh-list
55952106|NCT04793256|Fluorides|fluorides|mesh-list
55952107|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
55952108|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
55952109|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
55952110|NCT04793256|Protective Agents|protective agents|mesh-ancestor
56007173|NCT04242238|Avelumab|avelumab|mesh-list
55952111|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952112|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55952113|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007253|NCT01059929|Analgesics|analgesics|mesh-ancestor
55952114|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55952115|NCT04997811|Valproic Acid|valproic acid|mesh-list
55952116|NCT04997811|Bezafibrate|bezafibrate|mesh-list
55952117|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
55952118|NCT04997811|Danazol|danazol|mesh-list
55952119|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
55952120|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007425|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55952121|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952122|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
55952123|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952124|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952125|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
55952126|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55952127|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952128|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55952129|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55952130|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55952143|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
55952144|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55952145|NCT05672355|Vaccines|vaccines|mesh-list
55952146|NCT05672355|Immunologic Factors|immunologic factors|mesh-ancestor
55802894|NCT05700565|Immunologic Factors|immunologic factors|mesh-ancestor
55952147|NCT05672355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952148|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55952149|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
55952150|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55952151|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55952152|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56007834|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952153|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952154|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952155|NCT04792710|Metronidazole|metronidazole|mesh-list
55952156|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952157|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55952158|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55952159|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55952160|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55952161|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55952162|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952163|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952164|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55952165|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952166|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952167|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
55952168|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952169|NCT04814433|Lidocaine|lidocaine|mesh-list
55952170|NCT04814433|Epinephrine|epinephrine|mesh-list
55952171|NCT04814433|Racepinephrine|racepinephrine|mesh-list
55952172|NCT04814433|Bupivacaine|bupivacaine|mesh-list
55952173|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
55952174|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
55952175|NCT04814433|Thrombin|thrombin|mesh-list
55952176|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
55952177|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
55952178|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
55952179|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952180|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952181|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
55952182|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952183|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55952184|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55952185|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56000534|NCT03428958|Protective Agents|protective agents|mesh-ancestor
56000535|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
55952186|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952187|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952188|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55952189|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55952190|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
56008082|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
55952199|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55952200|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
55952202|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
55952203|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55952204|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
55952205|NCT03004209|Hematinics|hematinics|mesh-ancestor
55952206|NCT04800978|Durvalumab|durvalumab|mesh-list
55952207|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55952208|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952209|NCT04731363|Erythritol|erythritol|mesh-list
55952210|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
55952211|NCT04791774|Caseins|caseins|mesh-list
55952212|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
55952213|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
55952214|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952215|NCT00183469|Lamotrigine|lamotrigine|mesh-list
55952216|NCT00183469|Valproic Acid|valproic acid|mesh-list
55952217|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
56008406|NCT04776512|Bupivacaine|bupivacaine|mesh-list
55952218|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55952219|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952220|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952221|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55952222|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952223|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55952224|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55952225|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802899|NCT04325503|Levodopa|levodopa|mesh-list
55952226|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55952227|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55952228|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952229|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
56008517|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
56008518|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008519|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008520|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56008521|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56008523|NCT00003490|Hormones|hormones|mesh-ancestor
56008524|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56008525|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56008526|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008527|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008528|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008529|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008530|NCT00003034|Doxorubicin|doxorubicin|mesh-list
56008531|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56008532|NCT00003034|Ranpirnase|ranpirnase|mesh-list
56008533|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56008540|NCT03584516|Prednisone|prednisone|mesh-list
55952230|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952231|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
55952232|NCT02248155|Pramipexole|pramipexole|mesh-list
55952233|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
55743866|NCT02502565|Uric Acid|uric acid|mesh-list
55952234|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952235|NCT02248155|Protective Agents|protective agents|mesh-ancestor
55952236|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952237|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55952238|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55952239|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
55952240|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
55952241|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952242|NCT02597946|Paclitaxel|paclitaxel|mesh-list
56008581|NCT00003046|Growth Substances|growth substances|mesh-ancestor
56008582|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
56008583|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008584|NCT00003052|Doxorubicin|doxorubicin|mesh-list
56008585|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56008586|NCT00003052|Etoposide|etoposide|mesh-list
56008587|NCT00003052|Ifosfamide|ifosfamide|mesh-list
56008588|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56008589|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008590|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56008591|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008592|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008597|NCT00003058|Troglitazone|troglitazone|mesh-list
55952243|NCT02597946|Afatinib|afatinib|mesh-list
55952244|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55952245|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952246|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
55952247|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
55952248|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
55952249|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952250|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55952251|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952252|NCT02248233|Nimodipine|nimodipine|mesh-list
55952253|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55952254|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
55952255|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55952256|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55952257|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952258|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952268|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
55952269|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952270|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952271|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55952272|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
55952273|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
55952274|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56000536|NCT03428958|Vitamins|vitamins|mesh-ancestor
56000537|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
56000538|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56008912|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
56008913|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008914|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008915|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56008916|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56008917|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
56008918|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008919|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008920|NCT02668562|Ticagrelor|ticagrelor|mesh-list
56008921|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56008922|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56008923|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56008924|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56008925|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
56008926|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008927|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760384|NCT03209219|Cyclosporine|cyclosporine|mesh-list
56008928|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008929|NCT00067028|Cytarabine|cytarabine|mesh-list
56008930|NCT00067028|Clofarabine|clofarabine|mesh-list
56008931|NCT00067028|Idarubicin|idarubicin|mesh-list
56008932|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008933|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
56008934|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008935|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008936|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
56008937|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008938|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000539|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55952275|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55952276|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55952277|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55952278|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
55952279|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952280|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952281|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
55952282|NCT04790838|Hormones|hormones|mesh-ancestor
55952283|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952284|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
55952285|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55952286|NCT03003273|Amoxicillin|amoxicillin|mesh-list
55952287|NCT03003273|Levofloxacin|levofloxacin|mesh-list
55952288|NCT03003273|Ofloxacin|ofloxacin|mesh-list
55952289|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
55952290|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
55952291|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952292|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55952293|NCT03003273|Renal Agents|renal agents|mesh-ancestor
55952294|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55952295|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55952296|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952297|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952298|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952299|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55952300|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55952302|NCT05571345|Oxycodone|oxycodone|mesh-list
55952303|NCT05571345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55952304|NCT05571345|Narcotics|narcotics|mesh-ancestor
55952305|NCT05571345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952306|NCT05571345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952307|NCT05571345|Analgesics|analgesics|mesh-ancestor
56009168|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55952308|NCT05571345|Sensory System Agents|sensory system agents|mesh-ancestor
55952309|NCT05571345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952310|NCT02981121|Metformin|metformin|mesh-list
55952311|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55952312|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952313|NCT02597478|Fentanyl|fentanyl|mesh-list
55952314|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55952315|NCT02597478|Narcotics|narcotics|mesh-ancestor
55952316|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952317|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952318|NCT02597478|Analgesics|analgesics|mesh-ancestor
55952319|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
55952320|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952321|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55952322|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55952323|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
56009227|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55952324|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
55952325|NCT02219997|Methamphetamine|methamphetamine|mesh-list
55952334|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
55952335|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952336|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952337|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
55952338|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55952339|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55952340|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952341|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55952342|NCT02219997|Hormones|hormones|mesh-ancestor
55952343|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952344|NCT04811274|Dimercaprol|dimercaprol|mesh-list
55952345|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
55952346|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
56009301|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009302|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009303|NCT01260649|Ketamine|ketamine|mesh-list
56009304|NCT01260649|Anesthetics|anesthetics|mesh-list
56009305|NCT01260649|Analgesics|analgesics|mesh-ancestor
56009306|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
56009307|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009308|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009309|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56009310|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56009311|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
56009312|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56009313|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56009314|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55952347|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952348|NCT04799184|Epinephrine|epinephrine|mesh-list
55952349|NCT04799184|Racepinephrine|racepinephrine|mesh-list
55952350|NCT04799184|Bupivacaine|bupivacaine|mesh-list
56000540|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000541|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000542|NCT01844206|Morphine|morphine|mesh-list
55952351|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
55952352|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
55952353|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
55952354|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
55952355|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952356|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952357|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
55952358|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952359|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55952360|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55952361|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
55952362|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952363|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952364|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55952365|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55952366|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
55952367|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55952368|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
55952369|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
55952370|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
55952371|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55952372|NCT05562297|Gemcitabine|gemcitabine|mesh-list
55952373|NCT05562297|Paclitaxel|paclitaxel|mesh-list
55952374|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55952375|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952376|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
55952377|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
55952378|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
55952379|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826139|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952380|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55952381|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
55952382|NCT05562297|Antiviral Agents|antiviral agents|mesh-ancestor
55952383|NCT05562297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952384|NCT05562297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952385|NCT05562297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55952386|NCT05562297|Immunologic Factors|immunologic factors|mesh-ancestor
56009457|NCT00002854|Paclitaxel|paclitaxel|mesh-list
55952387|NCT05562297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952388|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55952389|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55952390|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
55952391|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952407|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55952408|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952409|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55952410|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
55952411|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55952412|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
55952413|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55952414|NCT03003039|Rituximab|rituximab|mesh-list
55952415|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55952416|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952417|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
56009519|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55952418|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952419|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55952420|NCT03002961|Buprenorphine|buprenorphine|mesh-list
55952421|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55952422|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55952423|NCT03002961|Narcotics|narcotics|mesh-ancestor
55952424|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952425|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952426|NCT03002961|Analgesics|analgesics|mesh-ancestor
55952427|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
55952428|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952429|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55952430|NCT03002805|Doxorubicin|doxorubicin|mesh-list
55952431|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55952432|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000543|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56000544|NCT01844206|Narcotics|narcotics|mesh-ancestor
55952433|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55952434|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55952435|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952436|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952437|NCT05401227|Ketamine|ketamine|mesh-list
55952438|NCT05401227|Analgesics|analgesics|mesh-ancestor
55952439|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
55952440|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952441|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952442|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55952443|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55952444|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
55952445|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
55952446|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56009677|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
55952447|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55952448|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55952449|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952450|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952451|NCT04214691|Acetaminophen|acetaminophen|mesh-list
55952452|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56009791|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952453|NCT04214691|Analgesics|analgesics|mesh-ancestor
55952460|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952462|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952463|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55952464|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
55952465|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
55952466|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952467|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952468|NCT05367687|Apatinib|apatinib|mesh-list
55952469|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952470|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55952471|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952472|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952473|NCT03002493|Rifampin|rifampin|mesh-list
55952474|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55952475|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
55952476|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55952477|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952479|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55952480|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952481|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952482|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55952483|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55952484|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55952485|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55952486|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55952487|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55952488|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55952489|NCT04197687|Trastuzumab|trastuzumab|mesh-list
55952490|NCT04197687|Pertuzumab|pertuzumab|mesh-list
55952491|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55952492|NCT04197687|Maytansine|maytansine|mesh-list
55952493|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
55952494|NCT04197687|Vaccines|vaccines|mesh-list
55952495|NCT04197687|Antibodies|antibodies|mesh-list
55952496|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
55952497|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55952498|NCT04197687|Sargramostim|sargramostim|mesh-list
55952499|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
55952500|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
55952501|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952502|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952503|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55952504|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
55952505|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
55952506|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
55952507|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952508|NCT04786470|Ropivacaine|ropivacaine|mesh-list
55952509|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
55952510|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
56000545|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56009864|NCT02106572|Mitomycins|mitomycins|mesh-list
56000546|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000547|NCT01844206|Analgesics|analgesics|mesh-ancestor
56000548|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
55952511|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952512|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952513|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
55952514|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952515|NCT04786002|Busulfan|busulfan|mesh-list
55952516|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
55952517|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952518|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55952519|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
55952520|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009948|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764069|NCT05674305|Cisplatin|cisplatin|mesh-list
55952536|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55952537|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952538|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55952539|NCT04788654|Analgesics|analgesics|mesh-ancestor
55952540|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
55952541|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
55952542|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56010051|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952543|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55952544|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55952545|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55952546|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952547|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952548|NCT04785768|Morphine|morphine|mesh-list
55952549|NCT04785768|Hydromorphone|hydromorphone|mesh-list
55952550|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55952551|NCT04785768|Narcotics|narcotics|mesh-ancestor
55952552|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56010140|NCT00004024|Sargramostim|sargramostim|mesh-list
56010141|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
56010142|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
56010143|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010144|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010145|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56010146|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56010147|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
56010148|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010149|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010150|NCT00003334|Paclitaxel|paclitaxel|mesh-list
56010151|NCT00003334|Doxorubicin|doxorubicin|mesh-list
56010152|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010153|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010154|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010155|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010156|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010157|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010158|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010159|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010160|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010161|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010162|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010163|NCT00093782|Sirolimus|sirolimus|mesh-list
56010164|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55952553|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952554|NCT04785768|Analgesics|analgesics|mesh-ancestor
55952555|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
55952556|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952557|NCT02223351|Ritonavir|ritonavir|mesh-list
55952558|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55826232|NCT01691092|Ketamine|ketamine|mesh-list
55952559|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55952560|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
55952561|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952562|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952563|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55952564|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55952565|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
55952566|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952567|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55952568|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55952569|NCT04768296|Topotecan|topotecan|mesh-list
55952570|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55952571|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55952572|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952573|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952574|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952575|NCT02223429|Vasopressins|vasopressins|mesh-list
55952576|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
55952577|NCT02223429|Oxytocin|oxytocin|mesh-list
55952578|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952579|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
55952580|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55952581|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
55952582|NCT02223429|Coagulants|coagulants|mesh-ancestor
55952583|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55952584|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55952585|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
55952602|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55952603|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55952604|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
55952605|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952606|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000549|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000550|NCT03626454|Norepinephrine|norepinephrine|mesh-list
56000551|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56000552|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55952607|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
55952608|NCT04808856|Hormones|hormones|mesh-list
55952609|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55952610|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55952611|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
55952612|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952613|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952614|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952615|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
55952616|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
55952617|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952618|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55952619|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
55952620|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55952621|NCT04808856|Protective Agents|protective agents|mesh-ancestor
55952622|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952623|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952624|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
55952625|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
55952626|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952627|NCT04808622|Protective Agents|protective agents|mesh-ancestor
55952628|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952629|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55952630|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952631|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
55952632|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
55952633|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
55952634|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55952635|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55952636|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
55952637|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952638|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55952639|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55952640|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952641|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952651|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952654|NCT01625013|Protective Agents|protective agents|mesh-ancestor
55952655|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952656|NCT00083551|Interferons|interferons|mesh-list
55952658|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
55952659|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
55952660|NCT00083551|Thalidomide|thalidomide|mesh-list
55952661|NCT00083551|Dexamethasone|dexamethasone|mesh-list
55952662|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
55952663|NCT00083551|Melphalan|melphalan|mesh-list
55952664|NCT00083551|Carmustine|carmustine|mesh-list
55952665|NCT00083551|Cisplatin|cisplatin|mesh-list
55952666|NCT00083551|Doxorubicin|doxorubicin|mesh-list
55952667|NCT00083551|Etoposide|etoposide|mesh-list
55952668|NCT00083551|Vincristine|vincristine|mesh-list
55952669|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55952670|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
55952671|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952672|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010303|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010304|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010305|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56010306|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
55952673|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55952674|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
55952675|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952676|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952677|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55952678|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952679|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
55952680|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
56010331|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010332|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010333|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010334|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55952681|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952682|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55952683|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
55952684|NCT00083551|Hormones|hormones|mesh-ancestor
55952685|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000553|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56000554|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56000555|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000556|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000557|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952686|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55952687|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55952688|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010409|NCT00004066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010410|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010411|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010412|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010414|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010415|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
56010416|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010417|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010418|NCT00003376|Paclitaxel|paclitaxel|mesh-list
56010419|NCT00003376|Vinblastine|vinblastine|mesh-list
56010420|NCT00003376|Carboplatin|carboplatin|mesh-list
56010421|NCT00003376|Doxorubicin|doxorubicin|mesh-list
56010422|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010423|NCT00003376|Methotrexate|methotrexate|mesh-list
56010424|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010425|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010426|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010427|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010428|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010429|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010430|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010431|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010432|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010433|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010434|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56010435|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
55952689|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55952690|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952691|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55952692|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
55952693|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952694|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55952695|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
55952696|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
55952697|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
55952698|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
55952699|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
55952700|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55952701|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55952702|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55952703|NCT00083551|Growth Substances|growth substances|mesh-ancestor
55952704|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
55952705|NCT01625169|Etravirine|etravirine|mesh-list
55952706|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55952707|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55952708|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952709|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952710|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
55952723|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55952724|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
55952725|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952726|NCT04091022|Eflornithine|eflornithine|mesh-list
55952727|NCT04091022|Diclofenac|diclofenac|mesh-list
55952728|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55952729|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55952730|NCT04091022|Analgesics|analgesics|mesh-ancestor
55952731|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
55952732|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952733|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952734|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952735|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55952736|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55952737|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952738|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952739|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952740|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55952741|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55952742|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55952743|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010519|NCT00003802|NSC 366140|nsc 366140|mesh-list
56010520|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952744|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
55952746|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55952747|NCT01490918|Acarbose|acarbose|mesh-list
55952748|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55952749|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952750|NCT01490918|Incretins|incretins|mesh-ancestor
55952751|NCT01490918|Hormones|hormones|mesh-ancestor
55952752|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952753|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55952754|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
55952755|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952756|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952757|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55952758|NCT02230995|Metformin|metformin|mesh-list
55952759|NCT02230995|Empagliflozin|empagliflozin|mesh-list
55952760|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56000558|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
56000559|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
56000560|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000561|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55952761|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952762|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55952763|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952764|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
55952765|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55952766|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55952767|NCT02995083|Prednisolone|prednisolone|mesh-list
55952768|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
55952769|NCT02995083|Lidocaine|lidocaine|mesh-list
55952770|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55952771|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
55952772|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
55952773|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
55952774|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952785|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
55952786|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55952787|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
55952788|NCT02995083|Hormones|hormones|mesh-ancestor
55952789|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952790|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55952791|NCT02995083|Protective Agents|protective agents|mesh-ancestor
55952792|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55952793|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952794|NCT03794388|Pregabalin|pregabalin|mesh-list
55952795|NCT03794388|Capsaicin|capsaicin|mesh-list
55952796|NCT03794388|Analgesics|analgesics|mesh-ancestor
55952797|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
55952798|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952799|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952800|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
55952801|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55952802|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952803|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952804|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55952805|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55952806|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55952807|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952808|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56010849|NCT05776979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952809|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
55952810|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
55952811|NCT04426422|Metformin|metformin|mesh-list
55952812|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55952813|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952814|NCT05471700|Azacitidine|azacitidine|mesh-list
55952815|NCT05471700|Venetoclax|venetoclax|mesh-list
55952816|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55952823|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55952824|NCT04976868|Analgesics|analgesics|mesh-ancestor
55952825|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
55952826|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952827|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952828|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952829|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55952830|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
55952831|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55952832|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
55952833|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55952834|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952835|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952836|NCT01632423|Bimatoprost|bimatoprost|mesh-list
55952837|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55952838|NCT05466318|Gemcitabine|gemcitabine|mesh-list
55952839|NCT05466318|Cytarabine|cytarabine|mesh-list
55952840|NCT05466318|Etoposide|etoposide|mesh-list
55952841|NCT05466318|Melphalan|melphalan|mesh-list
55952842|NCT05466318|Busulfan|busulfan|mesh-list
55952843|NCT05466318|Carmustine|carmustine|mesh-list
55952844|NCT05466318|Cladribine|cladribine|mesh-list
55952845|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55952854|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952855|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55952856|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55952857|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55952858|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55952859|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
55952860|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55952861|NCT04928664|Bupivacaine|bupivacaine|mesh-list
55952862|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
55952863|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
55952864|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952865|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952866|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
55952867|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952868|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56011179|NCT05774964|Vitamins|vitamins|mesh-ancestor
56011180|NCT05774964|Micronutrients|micronutrients|mesh-ancestor
55952869|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952870|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952871|NCT01469546|Axitinib|axitinib|mesh-list
55952872|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952873|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55952874|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952875|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952876|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
55952877|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55952878|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952879|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55952880|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55952881|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
56011255|NCT05773950|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56011256|NCT05773950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011257|NCT05773950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011258|NCT05773222|Apixaban|apixaban|mesh-list
56011259|NCT05773222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56011260|NCT05773222|Antithrombins|antithrombins|mesh-ancestor
56011261|NCT05773222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56011262|NCT05773222|Protease Inhibitors|protease inhibitors|mesh-ancestor
56011263|NCT05773222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011264|NCT05773222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011265|NCT05773222|Anticoagulants|anticoagulants|mesh-ancestor
55739107|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
56011291|NCT05738694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011292|NCT05738694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56011294|NCT05738694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011304|NCT05682443|Chelating Agents|chelating agents|mesh-ancestor
55952882|NCT05613894|177Lu-PSMA-617|177lu-psma-617|mesh-list
55952883|NCT05613894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55952884|NCT05613894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952899|NCT00081263|Analgesics|analgesics|mesh-ancestor
55952900|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
55952901|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952902|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952903|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952904|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55952905|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55952906|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55952907|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952908|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952909|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55952910|NCT03138603|Metoprolol|metoprolol|mesh-list
55952911|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55952912|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55952913|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
55952914|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
55952915|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952916|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011334|NCT05638594|Hormone Antagonists|hormone antagonists|mesh-ancestor
56011335|NCT05635227|Dexamethasone|dexamethasone|mesh-list
56011336|NCT05635227|Olanzapine|olanzapine|mesh-list
56011337|NCT05635227|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55952917|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55952918|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55952919|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55952920|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
55952921|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952922|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952923|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
55952924|NCT05087381|Niclosamide|niclosamide|mesh-list
55952936|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952937|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952938|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
56011388|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56011389|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
56011390|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011391|NCT05493475|Fentanyl|fentanyl|mesh-list
56011392|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56011393|NCT05493475|Narcotics|narcotics|mesh-ancestor
56011394|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56011395|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011396|NCT05493475|Analgesics|analgesics|mesh-ancestor
56011397|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
56011398|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011399|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56011400|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56011401|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
56011402|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
56011404|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56011405|NCT05463341|Narcotics|narcotics|mesh-ancestor
56011406|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56011407|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011408|NCT05463341|Analgesics|analgesics|mesh-ancestor
56011409|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
56011410|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011417|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011424|NCT05429970|Etodolac|etodolac|mesh-list
56011425|NCT05429970|Propofol|propofol|mesh-list
56011426|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56011431|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
55952939|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55952940|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
55952941|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55952942|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55952943|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55952944|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
55952945|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55952946|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
55952947|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55952948|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011439|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56011440|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56011441|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011442|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011443|NCT05408429|Vaccines|vaccines|mesh-list
56011444|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56011445|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
56011446|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011457|NCT05383495|Midazolam|midazolam|mesh-list
56011458|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
56011459|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
56011460|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55738636|NCT04814745|Morphine|morphine|mesh-list
55952949|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
55952950|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
56000562|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
56000563|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000564|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
56000565|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56000566|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56000567|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011501|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011502|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56011503|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011504|NCT05337137|Bevacizumab|bevacizumab|mesh-list
56011505|NCT05337137|Nivolumab|nivolumab|mesh-list
56011506|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011507|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011508|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56011509|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56011510|NCT05337137|Growth Substances|growth substances|mesh-ancestor
56011511|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011512|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
56011513|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56011514|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011515|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
56011516|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56011535|NCT05317416|Lenalidomide|lenalidomide|mesh-list
56011536|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
56011537|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011538|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56011539|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56011540|NCT05317416|Growth Substances|growth substances|mesh-ancestor
56011541|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
56011542|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011543|NCT05304767|Xanomeline|xanomeline|mesh-list
56011544|NCT05304767|Trospium chloride|trospium chloride|mesh-list
56011545|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
55738712|NCT04448015|Narcotics|narcotics|mesh-ancestor
56000568|NCT01830790|Urological Agents|urological agents|mesh-ancestor
56000569|NCT01662102|Rituximab|rituximab|mesh-list
56000570|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000571|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000572|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
56000573|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000574|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56000575|NCT03950076|Edoxaban|edoxaban|mesh-list
56000576|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56000577|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
55952951|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
55952952|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55952953|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55952954|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
55952955|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
55952956|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55952957|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55952959|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
55952960|NCT05611710|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55952961|NCT05611710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55952962|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
56011556|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56011557|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56011559|NCT05304585|Dactinomycin|dactinomycin|mesh-list
55952963|NCT00080483|Testosterone|testosterone|mesh-list
55952964|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
55952965|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
55952966|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55952967|NCT00080483|Androgens|androgens|mesh-ancestor
55952968|NCT00080483|Hormones|hormones|mesh-ancestor
55952969|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952970|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952971|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55952972|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952973|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
55952974|NCT05248620|Amoxicillin|amoxicillin|mesh-list
55952975|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55952976|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952977|NCT01639599|Dexamethasone|dexamethasone|mesh-list
55952978|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
55952979|NCT01639599|Haloperidol|haloperidol|mesh-list
55952980|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
55952981|NCT01639599|BB 1101|bb 1101|mesh-list
55952982|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952983|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
55952984|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
55952985|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952986|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952987|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55952988|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
55953000|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55953001|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
55953002|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953003|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55953004|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
55953005|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55953006|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953007|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56000578|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56000579|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
55953009|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56011736|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56011737|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011738|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011739|NCT05090566|Dexamethasone|dexamethasone|mesh-list
56011740|NCT05090566|Lenalidomide|lenalidomide|mesh-list
56011741|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011742|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
56011743|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
56011744|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011746|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55953010|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953011|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953012|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953013|NCT02227329|Ethanol|ethanol|mesh-list
55953014|NCT02227329|Heparin|heparin|mesh-list
55953015|NCT02227329|Calcium heparin|calcium heparin|mesh-list
55953016|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
55953017|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55953018|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55953019|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953020|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55953021|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953022|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953023|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953024|NCT05611242|Cangrelor|cangrelor|mesh-list
55953025|NCT05611242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55953026|NCT05611242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55953027|NCT05611242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55953028|NCT05611242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55953029|NCT05611242|Purinergic Agents|purinergic agents|mesh-ancestor
55953030|NCT05611242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953031|NCT05611242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953032|NCT05611242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953033|NCT05615142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55953034|NCT05615142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953035|NCT05615142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953036|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
55953037|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55953038|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953039|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
55953040|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
55953041|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55953042|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953043|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953044|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55953046|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
55953047|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953048|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55953059|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953061|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
55953062|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011774|NCT05042817|Morphine|morphine|mesh-list
56011775|NCT05042817|Prilocaine|prilocaine|mesh-list
55953063|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55953064|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
55953065|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953066|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
55953067|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
55953068|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
55953069|NCT05346419|Vitamin D|vitamin d|mesh-list
55953070|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
55953071|NCT05346419|Vitamins|vitamins|mesh-ancestor
55953072|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
55953073|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953074|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55953075|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55953076|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55953077|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953078|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55953079|NCT00084409|Iloprost|iloprost|mesh-list
55953080|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55953081|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
55953082|NCT03831165|Acyclovir|acyclovir|mesh-list
55953083|NCT03831165|Melatonin|melatonin|mesh-list
55953084|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
55953085|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953086|NCT03831165|Protective Agents|protective agents|mesh-ancestor
55953087|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000580|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000581|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953088|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953089|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
55953090|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953091|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55953092|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55953093|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55953094|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953095|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953096|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55953097|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55953098|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55953099|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55953100|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
55953101|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953102|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953103|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55953104|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55953105|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
56012156|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56012158|NCT04569747|Trastuzumab|trastuzumab|mesh-list
56012159|NCT04569747|Pertuzumab|pertuzumab|mesh-list
56012160|NCT04569747|Letrozole|letrozole|mesh-list
56012161|NCT04569747|Anastrozole|anastrozole|mesh-list
56012162|NCT04569747|Leuprolide|leuprolide|mesh-list
56012163|NCT04569747|Exemestane|exemestane|mesh-list
56012164|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012165|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953106|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55953107|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55953108|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
55953109|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
55953110|NCT03849651|Melphalan|melphalan|mesh-list
55953111|NCT03849651|Thiotepa|thiotepa|mesh-list
55953112|NCT03849651|Fludarabine|fludarabine|mesh-list
55953113|NCT03849651|Blinatumomab|blinatumomab|mesh-list
55953114|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
55953126|NCT05574985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953127|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
55953128|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55953129|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953130|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55953131|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953132|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012225|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55953133|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55953134|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953135|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953136|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953137|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55953138|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
55953139|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55953140|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55953141|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55953142|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55953143|NCT04773366|Cytarabine|cytarabine|mesh-list
55953144|NCT04773366|Prednisone|prednisone|mesh-list
55953145|NCT04773366|Vincristine|vincristine|mesh-list
55953146|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
55953147|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55953148|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
55953149|NCT04773366|Hormones|hormones|mesh-ancestor
55953150|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012523|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55953151|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012524|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
56012525|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56012526|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012527|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56012528|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012529|NCT03297359|Dalteparin|dalteparin|mesh-list
56012530|NCT03297359|Tinzaparin|tinzaparin|mesh-list
56012531|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56012532|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
56012533|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56012534|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56012535|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739685|NCT03391609|Analgesics|analgesics|mesh-ancestor
56012536|NCT03213652|Ensartinib|ensartinib|mesh-list
56012537|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012538|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012539|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012540|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012541|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
56012542|NCT03197506|Temozolomide|temozolomide|mesh-list
56012544|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953152|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55953153|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953154|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953155|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
55953156|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953157|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
55953158|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953159|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953160|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
55953161|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55953162|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953163|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
55953164|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953165|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55953166|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953167|NCT04714541|Ketamine|ketamine|mesh-list
55953168|NCT04714541|Analgesics|analgesics|mesh-ancestor
56000582|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
56000583|NCT05292976|Albuterol|albuterol|mesh-list
56000584|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
55953169|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
55953171|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012664|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56012665|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
56012666|NCT02112864|Hormones|hormones|mesh-ancestor
56012667|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012668|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56012669|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012670|NCT02106988|Dexamethasone|dexamethasone|mesh-list
56012671|NCT02106988|Carboplatin|carboplatin|mesh-list
56012672|NCT02106988|Etoposide|etoposide|mesh-list
56012673|NCT02106988|Ifosfamide|ifosfamide|mesh-list
56012674|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
56012675|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56012676|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
56012677|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
56012678|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012679|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012680|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56012681|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
56012682|NCT02106988|Hormones|hormones|mesh-ancestor
55953172|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55953174|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
55953175|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
55953188|NCT02414724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953189|NCT02414724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953190|NCT02414724|Immunologic Factors|immunologic factors|mesh-ancestor
55953191|NCT02414724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953192|NCT00187681|Metformin|metformin|mesh-list
55953193|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56012711|NCT00723697|Buprenorphine|buprenorphine|mesh-list
56012712|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56012713|NCT00723697|Narcotics|narcotics|mesh-ancestor
56012714|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56012715|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012716|NCT00723697|Analgesics|analgesics|mesh-ancestor
56012717|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
56012718|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012719|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56012720|NCT00694850|Riociguat|riociguat|mesh-list
56012721|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
56012722|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953194|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953195|NCT00083759|Natalizumab|natalizumab|mesh-list
55953196|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
55953197|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953198|NCT02412228|Dexamethasone|dexamethasone|mesh-list
55953199|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
55953200|NCT02412228|Ixazomib|ixazomib|mesh-list
55953201|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953202|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
55953203|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953204|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55953205|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55953206|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
55953207|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953208|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953209|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55953210|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55953211|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
55953212|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
55953213|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953214|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55953215|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
55953216|NCT02412228|Hormones|hormones|mesh-ancestor
55953217|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55953218|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55953219|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
55953220|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953221|NCT03693807|Gemcitabine|gemcitabine|mesh-list
55953222|NCT03693807|Fluorouracil|fluorouracil|mesh-list
55953223|NCT03693807|Floxuridine|floxuridine|mesh-list
55953224|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
55953225|NCT03693807|Irinotecan|irinotecan|mesh-list
55953226|NCT03693807|Cetuximab|cetuximab|mesh-list
55953227|NCT03693807|Panitumumab|panitumumab|mesh-list
55953228|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953229|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
55953230|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953231|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953232|NCT03693807|Antiviral Agents|antiviral agents|mesh-ancestor
55953233|NCT03693807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953234|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953235|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953236|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
55953251|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953252|NCT01828710|Folic Acid|folic acid|mesh-list
55953253|NCT01828710|Inositol|inositol|mesh-list
55953254|NCT01828710|Hematinics|hematinics|mesh-ancestor
55743909|NCT02502175|Methadone|methadone|mesh-list
55953255|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
55953256|NCT01828710|Vitamins|vitamins|mesh-ancestor
55953257|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
55953258|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953259|NCT00088699|Ketamine|ketamine|mesh-list
55953260|NCT00088699|Analgesics|analgesics|mesh-ancestor
55953261|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
55740057|NCT03126071|Bevacizumab|bevacizumab|mesh-list
56012915|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56012916|NCT01215643|Ribavirin|ribavirin|mesh-list
56012917|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56012918|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
56012919|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012920|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
56012921|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012923|NCT00004924|Irinotecan|irinotecan|mesh-list
56012924|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012925|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012926|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012927|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012928|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012929|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012930|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56012931|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012932|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012933|NCT00004144|Gemcitabine|gemcitabine|mesh-list
55953262|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953263|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953264|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56000585|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56000586|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
56000587|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000588|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953265|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55953266|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
55953267|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
55953269|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55953270|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55953271|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953272|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953273|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
55953274|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55953275|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55953276|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953277|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
55953278|NCT02233101|Coagulants|coagulants|mesh-ancestor
55953279|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
55953280|NCT00089011|Fludarabine|fludarabine|mesh-list
55953281|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
55953282|NCT00089011|Tacrolimus|tacrolimus|mesh-list
55953283|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953284|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953285|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
55953286|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953287|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953288|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
55953289|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953290|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55953291|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013136|NCT00004198|Vaccines|vaccines|mesh-list
56013137|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
56013138|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013139|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56013140|NCT01264705|Sorafenib|sorafenib|mesh-list
56013141|NCT01264705|Bavituximab|bavituximab|mesh-list
56013142|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56013152|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
56013153|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013154|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013155|NCT01217515|Diltiazem|diltiazem|mesh-list
56013156|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56013157|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56013158|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56013159|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013160|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56013161|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013162|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
55953292|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55953293|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55953294|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
55953295|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55953305|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953306|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953307|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55953308|NCT00347412|Paclitaxel|paclitaxel|mesh-list
55953309|NCT00347412|Carboplatin|carboplatin|mesh-list
55953310|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55953311|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953312|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953313|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
55953314|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953315|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953316|NCT00189475|Montelukast|montelukast|mesh-list
55953317|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55953318|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
55953319|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55953320|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
55953321|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013188|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013189|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013190|NCT00016718|Emtricitabine|emtricitabine|mesh-list
56013191|NCT00016718|Efavirenz|efavirenz|mesh-list
56013192|NCT00016718|Didanosine|didanosine|mesh-list
56013193|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
56013194|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013195|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56013196|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56013197|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013198|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013199|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56013200|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56013201|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56013202|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56013203|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56013204|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55953322|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953323|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55953324|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55953325|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953326|NCT00091273|Sargramostim|sargramostim|mesh-list
55953327|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
55953328|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
55953329|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953330|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55953331|NCT00193375|Bevacizumab|bevacizumab|mesh-list
55953332|NCT00193375|Carboplatin|carboplatin|mesh-list
55953333|NCT00193375|Irinotecan|irinotecan|mesh-list
55953334|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953335|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953336|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55953337|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55953338|NCT00193375|Growth Substances|growth substances|mesh-ancestor
56000589|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56000590|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
55953339|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953340|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
55953341|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55953342|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55953343|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013222|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56013223|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56013224|NCT00004216|Renal Agents|renal agents|mesh-ancestor
56013225|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
56013226|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56013227|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56013231|NCT00005032|Paclitaxel|paclitaxel|mesh-list
56013244|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56013246|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013247|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
56013248|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
56013249|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013250|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013251|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013252|NCT00019682|Aldesleukin|aldesleukin|mesh-list
56013253|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56013254|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013255|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56013256|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56013257|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
56013258|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013259|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56013260|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
56013261|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953344|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953345|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55953346|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
55953347|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55953348|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953349|NCT04589208|Ketamine|ketamine|mesh-list
55953350|NCT04589208|Analgesics|analgesics|mesh-ancestor
56013266|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013267|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013268|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013269|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013270|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
56013271|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013272|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013274|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
56013277|NCT00005578|Etoposide|etoposide|mesh-list
55953351|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
55953352|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953353|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953354|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55953355|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55953356|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
55953357|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
55953358|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953359|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56013341|NCT00097448|Hormones|hormones|mesh-ancestor
56013342|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013343|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013344|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56013349|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56013350|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56013351|NCT00097448|Protective Agents|protective agents|mesh-ancestor
56013352|NCT00004246|Fludarabine|fludarabine|mesh-list
56013353|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
56013361|NCT00028262|Cysteamine|cysteamine|mesh-list
55953369|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953370|NCT00193453|Antiviral Agents|antiviral agents|mesh-ancestor
55953371|NCT00193453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953372|NCT00193453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953373|NCT00193453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953374|NCT00193453|Immunologic Factors|immunologic factors|mesh-ancestor
55953375|NCT00193453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953376|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953377|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013402|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
56013403|NCT00005596|Methotrexate|methotrexate|mesh-list
56013404|NCT00005596|Vincristine|vincristine|mesh-list
56013405|NCT00005596|Daunorubicin|daunorubicin|mesh-list
56013406|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
56013407|NCT00005596|Pegaspargase|pegaspargase|mesh-list
56013408|NCT00005596|Thioguanine|thioguanine|mesh-list
56013409|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
56013410|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013411|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
56013412|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013413|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56013414|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56013415|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
56013416|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013417|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013418|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56013419|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013420|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
56013421|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
56013422|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013423|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56013424|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
56013425|NCT00005596|Hormones|hormones|mesh-ancestor
56013451|NCT00005068|Leucovorin|leucovorin|mesh-list
55953378|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953379|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953380|NCT05614518|Methylene diphosphonate|methylene diphosphonate|mesh-list
55953381|NCT05614518|Listerine|listerine|mesh-list
55953382|NCT05614518|Fluorides|fluorides|mesh-list
55953383|NCT05614518|Sodium Fluoride|sodium fluoride|mesh-list
55953384|NCT05614518|Cariostatic Agents|cariostatic agents|mesh-ancestor
55953385|NCT05614518|Protective Agents|protective agents|mesh-ancestor
55953386|NCT05614518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953387|NCT05614518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55953388|NCT05614518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953389|NCT05614518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55953390|NCT00091507|Insulin|insulin|mesh-list
55953391|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55953392|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953393|NCT05611086|Acetylcysteine|acetylcysteine|mesh-list
55953394|NCT05611086|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55953395|NCT05611086|Antiviral Agents|antiviral agents|mesh-ancestor
55953396|NCT05611086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953397|NCT05611086|Expectorants|expectorants|mesh-ancestor
55953398|NCT05611086|Respiratory System Agents|respiratory system agents|mesh-ancestor
55953399|NCT05611086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55953400|NCT05611086|Antioxidants|antioxidants|mesh-ancestor
55953401|NCT05611086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953402|NCT05611086|Protective Agents|protective agents|mesh-ancestor
55953403|NCT05611086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953404|NCT05611086|Antidotes|antidotes|mesh-ancestor
55953405|NCT00093379|Capecitabine|capecitabine|mesh-list
55953406|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
55953407|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953408|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
55953409|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953410|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953411|NCT05614440|Tramadol|tramadol|mesh-list
55953412|NCT05614440|Anesthetics|anesthetics|mesh-list
55953413|NCT05614440|Anesthetics, Local|anesthetics, local|mesh-list
55953414|NCT05614440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953415|NCT05614440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953416|NCT05614440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55953417|NCT05614440|Narcotics|narcotics|mesh-ancestor
56000591|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
56000592|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56000593|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55953418|NCT05614440|Analgesics|analgesics|mesh-ancestor
55953419|NCT05614440|Sensory System Agents|sensory system agents|mesh-ancestor
55953420|NCT05614440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953421|NCT05613192|Vitamin D|vitamin d|mesh-list
55953422|NCT05613192|Cholecalciferol|cholecalciferol|mesh-list
55953423|NCT05613192|Vitamins|vitamins|mesh-ancestor
55953424|NCT05613192|Micronutrients|micronutrients|mesh-ancestor
55953425|NCT05613192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953426|NCT05613192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55953427|NCT05613192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55953443|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953445|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953447|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55953448|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
55953449|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55953450|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55953451|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55953452|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55953453|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953454|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953455|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
55953456|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55953457|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
55953458|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55953459|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
55953460|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55953461|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55953462|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56013826|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953463|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55953464|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55953465|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55953466|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
55953467|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55953468|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55953469|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55953470|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55953471|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55953481|NCT05474664|Camostat|camostat|mesh-list
55953482|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
55953483|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953484|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953485|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55953486|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55953487|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
55953499|NCT04338984|Anesthetics|anesthetics|mesh-list
55953500|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
55953501|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
55953502|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953503|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953504|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
55953505|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953506|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55953507|NCT04338984|Narcotics|narcotics|mesh-ancestor
55953508|NCT04338984|Analgesics|analgesics|mesh-ancestor
55953509|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55953510|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55953511|NCT00095563|Lapatinib|lapatinib|mesh-list
55953512|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000594|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56000595|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56000596|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
56000597|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014001|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55789667|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55953513|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55953514|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953515|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953516|NCT05473806|Pioglitazone|pioglitazone|mesh-list
55953517|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55953518|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953519|NCT00089609|Thalidomide|thalidomide|mesh-list
55953520|NCT00089609|Prednisone|prednisone|mesh-list
55953521|NCT00089609|Bevacizumab|bevacizumab|mesh-list
55953522|NCT00089609|Docetaxel|docetaxel|mesh-list
55953523|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953524|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953525|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55953526|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55953527|NCT00089609|Growth Substances|growth substances|mesh-ancestor
55953528|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953529|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
55953530|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953531|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
55953532|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953533|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953534|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55953535|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
55953536|NCT00089609|Hormones|hormones|mesh-ancestor
55953537|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55953538|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55953539|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953540|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
55953541|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
55953542|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55953543|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953544|NCT04661514|Psilocybin|psilocybin|mesh-list
55953545|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
55953546|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953547|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55953548|NCT00195403|Etanercept|etanercept|mesh-list
55953549|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55953550|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55953551|NCT00195403|Analgesics|analgesics|mesh-ancestor
55953552|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
55953553|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014122|NCT00004816|Antibodies|antibodies|mesh-list
56014123|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56014124|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
56014125|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014126|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
56014127|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
56014129|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014130|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
56014131|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014132|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014133|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56014134|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
56014135|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014136|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014137|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56014138|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55953554|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953555|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55953571|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
55953572|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953573|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953574|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
55953575|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953577|NCT03086993|Melphalan|melphalan|mesh-list
55953578|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014140|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56014141|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56014142|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
56014143|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56014144|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014145|NCT01273207|Cyclosporine|cyclosporine|mesh-list
56014146|NCT01273207|Cyclosporins|cyclosporins|mesh-list
56014147|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953579|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953580|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
56014310|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
55953581|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953582|NCT03086993|Antiviral Agents|antiviral agents|mesh-ancestor
55953583|NCT03086993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953584|NCT03086993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953585|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953586|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
55953587|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953588|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55953589|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
55953590|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55953591|NCT03704363|Infliximab|infliximab|mesh-list
55953592|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
55953593|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55953594|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56000598|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000599|NCT05292976|Miotics|miotics|mesh-ancestor
56000600|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56000601|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
55953595|NCT04089072|Phenylephrine|phenylephrine|mesh-list
55953596|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
55953597|NCT04089072|Methylene Blue|methylene blue|mesh-list
55953598|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55953599|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
56014513|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
55953600|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
55953601|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953602|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953603|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
55953604|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55953605|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
55953606|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
55953607|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56014607|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014608|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56014609|NCT03015857|Narcotics|narcotics|mesh-ancestor
56014610|NCT03015857|Analgesics|analgesics|mesh-ancestor
56014611|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56014612|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56014613|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
56014614|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56014615|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
56014616|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
56014617|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
56014618|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56014619|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
56014620|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
56014621|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56014622|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56014623|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56014624|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
56014625|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953608|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55953609|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55953610|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
55953611|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953612|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953613|NCT04089072|Protective Agents|protective agents|mesh-ancestor
55953614|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953615|NCT00006227|Paclitaxel|paclitaxel|mesh-list
55953616|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55953617|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953618|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953619|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
55953631|NCT05612880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953633|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55953634|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
55953635|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
55953636|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953637|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953638|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55953639|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
55953640|NCT03995628|Hormones|hormones|mesh-ancestor
55953641|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55953642|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55953643|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953644|NCT00010439|Alendronate|alendronate|mesh-list
55953645|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55953646|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953647|NCT03908736|Picolinic acid|picolinic acid|mesh-list
55953648|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55953649|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
55953650|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
55953651|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953652|NCT05468892|Trifluridine|trifluridine|mesh-list
55953653|NCT05468892|Panitumumab|panitumumab|mesh-list
55953654|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953655|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953656|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
55953657|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953658|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
55953659|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953660|NCT00200161|Temozolomide|temozolomide|mesh-list
55953661|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55953662|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
55953663|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953664|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953665|NCT00016913|Paclitaxel|paclitaxel|mesh-list
55953666|NCT00016913|Carboplatin|carboplatin|mesh-list
55953667|NCT00016913|Leuprolide|leuprolide|mesh-list
55953668|NCT00016913|Goserelin|goserelin|mesh-list
55953669|NCT00016913|Estramustine|estramustine|mesh-list
55953670|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55953671|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953672|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953673|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
56000602|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56000603|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55953674|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953675|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953676|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55953677|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
56015407|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
55953678|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55953679|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953680|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55953681|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55953682|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
55953683|NCT00023309|Lamivudine|lamivudine|mesh-list
55953684|NCT00023309|Adefovir|adefovir|mesh-list
55953693|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55953694|NCT00098059|Famciclovir|famciclovir|mesh-list
55953695|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
55953696|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953697|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55953698|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953699|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953701|NCT02440581|Teriparatide|teriparatide|mesh-list
55953702|NCT02440581|Cinacalcet|cinacalcet|mesh-list
55953703|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55953704|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953705|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55953706|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
55953707|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
55953708|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55953709|NCT01359150|Tofacitinib|tofacitinib|mesh-list
55953710|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55953711|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953712|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953713|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
55953714|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55953715|NCT00098371|Alvocidib|alvocidib|mesh-list
55953716|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953718|NCT00098371|Growth Substances|growth substances|mesh-ancestor
55953719|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953720|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55953721|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953722|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953724|NCT04745988|Docetaxel|docetaxel|mesh-list
55953725|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
55953726|NCT04745988|Fluorouracil|fluorouracil|mesh-list
56015919|NCT00132002|Vorinostat|vorinostat|mesh-list
55953727|NCT04745988|Oxaliplatin|oxaliplatin|mesh-list
55953728|NCT04745988|Lenvatinib|lenvatinib|mesh-list
55953729|NCT04745988|Levoleucovorin|levoleucovorin|mesh-list
55953730|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953731|NCT04745988|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953732|NCT04745988|Antimitotic Agents|antimitotic agents|mesh-ancestor
55953733|NCT04745988|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953734|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953735|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953736|NCT04745988|Antimetabolites|antimetabolites|mesh-ancestor
55953737|NCT04745988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953738|NCT04745988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953739|NCT04745988|Immunologic Factors|immunologic factors|mesh-ancestor
55953740|NCT04745988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953741|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55953742|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953743|NCT04745988|Antidotes|antidotes|mesh-ancestor
55953744|NCT04745988|Protective Agents|protective agents|mesh-ancestor
55953745|NCT04745988|Vitamin B Complex|vitamin b complex|mesh-ancestor
55953746|NCT04745988|Vitamins|vitamins|mesh-ancestor
55953747|NCT04745988|Micronutrients|micronutrients|mesh-ancestor
55953748|NCT01647945|Tacrolimus|tacrolimus|mesh-list
55953749|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953750|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
55953751|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953752|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55953753|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953770|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55953771|NCT04351191|Amebicides|amebicides|mesh-ancestor
55953772|NCT01469000|Pemetrexed|pemetrexed|mesh-list
55953773|NCT01469000|Gefitinib|gefitinib|mesh-list
55953774|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953775|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953776|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953777|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56016393|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
55953778|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55953779|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55953780|NCT05557578|Gemcitabine|gemcitabine|mesh-list
55953781|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
55953782|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953783|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
55953784|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953785|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953786|NCT05557578|Antiviral Agents|antiviral agents|mesh-ancestor
55953787|NCT05557578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953788|NCT05557578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016535|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55953789|NCT05557578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953790|NCT05557578|Immunologic Factors|immunologic factors|mesh-ancestor
55953791|NCT05557578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953792|NCT00201877|Rituximab|rituximab|mesh-list
55953793|NCT00201877|Bortezomib|bortezomib|mesh-list
55953794|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953795|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953796|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
55953797|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953798|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55953799|NCT05358691|Durvalumab|durvalumab|mesh-list
55953800|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953801|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953802|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55953803|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
55953804|NCT01490060|Dexamethasone|dexamethasone|mesh-list
55953805|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
55953806|NCT01490060|Doxorubicin|doxorubicin|mesh-list
55953807|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55953808|NCT01490060|Vincristine|vincristine|mesh-list
55953809|NCT01490060|Ifosfamide|ifosfamide|mesh-list
55953810|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
55953811|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
55953825|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
55953826|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016693|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016694|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016695|NCT01898624|Urological Agents|urological agents|mesh-ancestor
56016696|NCT01140191|Gentamicins|gentamicins|mesh-list
56016697|NCT01140191|Paromomycin|paromomycin|mesh-list
56016698|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56016699|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016700|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55953827|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953828|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55953829|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55953830|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55953831|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55953832|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953833|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
55953834|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953835|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56016782|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
55953836|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
55953837|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55953838|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953840|NCT04090736|Pevonedistat|pevonedistat|mesh-list
55953841|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953842|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
55953843|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953844|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953845|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953846|NCT05557344|Acetaminophen|acetaminophen|mesh-list
55953847|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55953848|NCT05557344|Analgesics|analgesics|mesh-ancestor
55953849|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
55953850|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953851|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953852|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
55953853|NCT00101413|Sorafenib|sorafenib|mesh-list
55953854|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953855|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55953856|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953857|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953858|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
55953859|NCT01246869|Imidazole|imidazole|mesh-list
55953860|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953861|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000604|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
56000605|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
56000606|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56000607|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56000608|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56000609|NCT00850720|Vasopressins|vasopressins|mesh-list
56000610|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017105|NCT05415462|Vaccines|vaccines|mesh-list
56000611|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
56000612|NCT00850720|Coagulants|coagulants|mesh-ancestor
56000613|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56000614|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56000615|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
56000616|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55953862|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
55953863|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
55953864|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953865|NCT01452152|Clopidogrel|clopidogrel|mesh-list
55953866|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55953867|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55953868|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55953869|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55953870|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56017460|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
56017461|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017462|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56017463|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56017464|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017465|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017466|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56017467|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
56017468|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56017469|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017470|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56017471|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56017472|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
56017473|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56017474|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017503|NCT01457521|Analgesics|analgesics|mesh-ancestor
56017504|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
56017505|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017506|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017507|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017508|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017509|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56017510|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017511|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017512|NCT00325442|Treprostinil|treprostinil|mesh-list
56017513|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56017514|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56017515|NCT01393717|Antibodies|antibodies|mesh-list
55953871|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
55953872|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953873|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953879|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55953880|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55953881|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953882|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017520|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017521|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56017522|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017523|NCT01460875|Interferons|interferons|mesh-list
56017524|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
56017525|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
55953883|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
55953884|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
55953885|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
55953886|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953887|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
55953888|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
55953889|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55953890|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55826233|NCT01691092|Analgesics|analgesics|mesh-ancestor
55953891|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
55953892|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
55953893|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953894|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953895|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55953896|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
55744868|NCT04941573|Xenon|xenon|mesh-list
55953897|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
55953898|NCT01654107|Nicotine|nicotine|mesh-list
55953899|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55953900|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
55953901|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953902|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953903|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55953904|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55953905|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
55953906|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953907|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953908|NCT03085680|Curcumin|curcumin|mesh-list
55953909|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55953910|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55953911|NCT03085680|Analgesics|analgesics|mesh-ancestor
55953912|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
55953913|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953914|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953915|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56000617|NCT00843310|Dexamethasone|dexamethasone|mesh-list
56000618|NCT00843310|Lenalidomide|lenalidomide|mesh-list
56000620|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55953916|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55953917|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953918|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953919|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953920|NCT01468844|Minocycline|minocycline|mesh-list
55953921|NCT01468844|Bevacizumab|bevacizumab|mesh-list
55953922|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953923|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953924|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55953925|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55953926|NCT01468844|Growth Substances|growth substances|mesh-ancestor
55953927|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953928|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
55953929|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55953930|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953931|NCT03029598|Carboplatin|carboplatin|mesh-list
55953932|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
55953933|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953934|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953935|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55953936|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55953937|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55953938|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55953939|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953940|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953941|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953942|NCT01451606|Analgesics|analgesics|mesh-ancestor
55953943|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
55953957|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953958|NCT01655043|Regadenoson|regadenoson|mesh-list
55953959|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55953960|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55953961|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
55953962|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
55953963|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953964|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953965|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953966|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55953967|NCT00473343|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55953968|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55953969|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
55953970|NCT00003927|Paclitaxel|paclitaxel|mesh-list
55953971|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
55953972|NCT00003927|Doxorubicin|doxorubicin|mesh-list
55953973|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55953974|NCT00003927|Amifostine|amifostine|mesh-list
55826589|NCT02178709|Folfirinox|folfirinox|mesh-list
55953975|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55953976|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953977|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953978|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
55953979|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953980|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953981|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953982|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
55953983|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953984|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55953985|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55953986|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
55953987|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55953988|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55953989|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55953990|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55953991|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953992|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55953993|NCT00003927|Protective Agents|protective agents|mesh-ancestor
55953994|NCT00032591|Thrombin|thrombin|mesh-list
55953995|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
55953996|NCT00032591|Coagulants|coagulants|mesh-ancestor
55953997|NCT01660191|Atorvastatin|atorvastatin|mesh-list
56000621|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
56000622|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
56000623|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000624|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000625|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56000626|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
55953998|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55953999|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56018332|NCT00366626|Naltrexone|naltrexone|mesh-list
55954000|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55954001|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
55954002|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954003|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55954004|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55954005|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954006|NCT00033917|Indomethacin|indomethacin|mesh-list
55954007|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55954008|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55954027|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954029|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
55954030|NCT01660893|Tetracaine|tetracaine|mesh-list
55954031|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
55954032|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
55954033|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55954034|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954035|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
55954036|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954037|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55954038|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55954039|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
55954040|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954041|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954042|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
55954043|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
55954044|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
55954045|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55954046|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
55954047|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55954048|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
55954049|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55954050|NCT01660893|Protective Agents|protective agents|mesh-ancestor
55954051|NCT01661283|Bevacizumab|bevacizumab|mesh-list
55954052|NCT01661283|Everolimus|everolimus|mesh-list
55954053|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55954054|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954055|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55954056|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55954057|NCT01661283|Growth Substances|growth substances|mesh-ancestor
55954058|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954059|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
55954060|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954061|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
55954063|NCT01946373|Fludarabine|fludarabine|mesh-list
55954064|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
55954066|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954067|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
55954092|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55954093|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954094|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954095|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
55954096|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56018866|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
56018867|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018868|NCT04750382|Antiviral Agents|antiviral agents|mesh-ancestor
56018869|NCT04750382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018870|NCT04750382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954097|NCT01600287|Propofol|propofol|mesh-list
55954098|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55954100|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954101|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55954102|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
55954103|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
55954104|NCT00040937|Thalidomide|thalidomide|mesh-list
55954105|NCT00040937|Dexamethasone|dexamethasone|mesh-list
55954106|NCT00040937|Prednisone|prednisone|mesh-list
55954107|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
56000627|NCT00843310|Hormones|hormones|mesh-ancestor
56000628|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000629|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55954108|NCT00040937|Melphalan|melphalan|mesh-list
55954109|NCT00040937|Sargramostim|sargramostim|mesh-list
55954110|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954111|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
55954112|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954113|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954114|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55954115|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
55954116|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019089|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56019096|NCT00405938|Bevacizumab|bevacizumab|mesh-list
56019189|NCT00379574|Lenograstim|lenograstim|mesh-list
56019190|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019209|NCT00379574|Hormones|hormones|mesh-ancestor
55954117|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954145|NCT02234427|Aspirin|aspirin|mesh-list
55954146|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55954147|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55954148|NCT02234427|Analgesics|analgesics|mesh-ancestor
55954149|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
55954150|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954151|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954152|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954153|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954154|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55954155|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55954156|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954157|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55954158|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55954159|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954160|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
55954161|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
55954162|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55954163|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55954164|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954165|NCT01663935|Levodopa|levodopa|mesh-list
55954166|NCT01663935|Carbidopa|carbidopa|mesh-list
55954167|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55954177|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56019649|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55954179|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
55954180|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954181|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954182|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954183|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954184|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55954185|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954186|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954187|NCT00046475|Midodrine|midodrine|mesh-list
55954188|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
55954189|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
55954190|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954191|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954192|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56020109|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020110|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020111|NCT00535652|Ertapenem|ertapenem|mesh-list
56020114|NCT00418028|Capecitabine|capecitabine|mesh-list
55954193|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55954194|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55954195|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55954196|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
55954197|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954198|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954200|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55954201|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55954202|NCT01894685|Analgesics|analgesics|mesh-ancestor
55954203|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
55954204|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954205|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954206|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954207|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954208|NCT01695291|Minocycline|minocycline|mesh-list
55954209|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55954210|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000630|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000631|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
56000632|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56020333|NCT00420992|Naltrexone|naltrexone|mesh-list
55954211|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
55954213|NCT00048737|Fludarabine|fludarabine|mesh-list
55954214|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
55954215|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954216|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
55954217|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954218|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954219|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55954220|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
55954221|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020431|NCT00544778|Ifosfamide|ifosfamide|mesh-list
55954222|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020670|NCT03007927|Hormones|hormones|mesh-ancestor
55954223|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55954224|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55954225|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954226|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
55954227|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
55954228|NCT01604109|Caseins|caseins|mesh-list
55954229|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55954238|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55954239|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
55954240|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954241|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954242|NCT01666197|Diclofenac|diclofenac|mesh-list
55954243|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55954244|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55954245|NCT01666197|Analgesics|analgesics|mesh-ancestor
55954246|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
55954247|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954248|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954249|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954250|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954251|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55954252|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954253|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954254|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55954255|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
55954256|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55954257|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55954258|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55954259|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55954260|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954261|NCT00048815|Citalopram|citalopram|mesh-list
55954262|NCT00048815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55954263|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55954264|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55954265|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954266|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954267|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
55954268|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954269|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55954270|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
55954271|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55954272|NCT01605903|Acetaminophen|acetaminophen|mesh-list
55954273|NCT01605903|Ibuprofen|ibuprofen|mesh-list
55954274|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55954275|NCT01605903|Analgesics|analgesics|mesh-ancestor
55954276|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
55954277|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954278|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954280|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55954281|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954282|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954283|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55954284|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954285|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000633|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55954287|NCT00048893|Paclitaxel|paclitaxel|mesh-list
55954288|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
55954289|NCT00048893|Doxorubicin|doxorubicin|mesh-list
55954290|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55954291|NCT00048893|Fludarabine|fludarabine|mesh-list
55954292|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
55954293|NCT00048893|Vaccines|vaccines|mesh-list
55954294|NCT00048893|Sargramostim|sargramostim|mesh-list
56021211|NCT04216524|Dexamethasone|dexamethasone|mesh-list
55954295|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
55954296|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954305|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55954307|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55954308|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55954309|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55954310|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55954311|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954312|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954313|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
55954314|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021300|NCT00510224|Octreotide|octreotide|mesh-list
55954315|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55954316|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55954317|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55954318|NCT01607853|Calcitriol|calcitriol|mesh-list
55954319|NCT01607853|Betamethasone|betamethasone|mesh-list
55954320|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954321|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
55954322|NCT01607853|Hormones|hormones|mesh-ancestor
55954323|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021413|NCT05127876|Ephedrine|ephedrine|mesh-list
55954324|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954325|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56021489|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
55954326|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
55954327|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55954328|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56021587|NCT03813108|Lumefantrine|lumefantrine|mesh-list
55954329|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55954330|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954331|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55954332|NCT01607853|Vitamins|vitamins|mesh-ancestor
55954333|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
55954334|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55954335|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55954336|NCT01700517|Anesthetics|anesthetics|mesh-list
55954337|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021884|NCT02514174|Afatinib|afatinib|mesh-list
56021968|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56021969|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56021970|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
55954338|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954339|NCT00101647|Dasatinib|dasatinib|mesh-list
55954340|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954341|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55954342|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022204|NCT03143270|Nivolumab|nivolumab|mesh-list
56022319|NCT00565370|Sorafenib|sorafenib|mesh-list
55954343|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022511|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022512|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56022513|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022514|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954344|NCT01669785|Listerine|listerine|mesh-list
55954345|NCT01669785|Fluorides|fluorides|mesh-list
55954346|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
55954347|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
55954348|NCT01669785|Protective Agents|protective agents|mesh-ancestor
55954349|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954350|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55954351|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954352|NCT03089645|Docetaxel|docetaxel|mesh-list
55954353|NCT03089645|Durvalumab|durvalumab|mesh-list
55954354|NCT03089645|Tremelimumab|tremelimumab|mesh-list
55954355|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55954356|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022804|NCT01532089|Bevacizumab|bevacizumab|mesh-list
55954357|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
55954358|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
55954359|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
55954360|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826717|NCT02124811|Minocycline|minocycline|mesh-list
55954361|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55954372|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954373|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
55954374|NCT01671423|Hormones|hormones|mesh-ancestor
55954375|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000634|NCT00843310|Growth Substances|growth substances|mesh-ancestor
56000635|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
56000636|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56000637|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
55954376|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954377|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55954378|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954380|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55954381|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55954382|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55954383|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
55954384|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954385|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954386|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023354|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56023355|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56023356|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023357|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
56023358|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023359|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
56023360|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56023361|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56023362|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56023363|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56023364|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
56023365|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56023366|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56023367|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
56023368|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023369|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56023370|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56023371|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023372|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023373|NCT02513550|Ixekizumab|ixekizumab|mesh-list
56023374|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56023375|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
56023376|NCT00673712|Narcotics|narcotics|mesh-ancestor
56023377|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023378|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954387|NCT02092181|Urological Agents|urological agents|mesh-ancestor
55954388|NCT01672827|Flutemetamol|flutemetamol|mesh-list
56023397|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
55954389|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55954390|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954391|NCT01906853|Vaccines|vaccines|mesh-list
55954392|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
55954393|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
55954394|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954395|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55954396|NCT01700907|Sevoflurane|sevoflurane|mesh-list
55954397|NCT01700907|Desflurane|desflurane|mesh-list
55954398|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55954399|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55954400|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
55954401|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
55954402|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55954403|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954404|NCT03089567|Listerine|listerine|mesh-list
56023679|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023680|NCT01799954|Vaccines|vaccines|mesh-list
56023681|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
56023682|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023683|NCT00623714|Fluticasone|fluticasone|mesh-list
56023684|NCT00623714|Xhance|xhance|mesh-list
56023685|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023686|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55954405|NCT03089567|Fluorides|fluorides|mesh-list
55954406|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
55954407|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
55954408|NCT03089567|Protective Agents|protective agents|mesh-ancestor
55954409|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023839|NCT02999815|Antibodies|antibodies|mesh-list
55954410|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55954411|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954412|NCT03431987|Ethanol|ethanol|mesh-list
55954413|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55954414|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954415|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55954416|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954417|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
55954418|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55954419|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
55954420|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954421|NCT01612221|Expectorants|expectorants|mesh-ancestor
55954422|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
55954423|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55954424|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
55954425|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954426|NCT01612221|Protective Agents|protective agents|mesh-ancestor
56024088|NCT05671081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55954427|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954428|NCT01612221|Antidotes|antidotes|mesh-ancestor
55954441|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55954442|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954443|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55954444|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55954445|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
55954446|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55954447|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954448|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
55954450|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
55954451|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954452|NCT02642640|Protective Agents|protective agents|mesh-ancestor
56024329|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55954453|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954454|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024414|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56000638|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000639|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56000640|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000641|NCT00809458|Vitamin E|vitamin e|mesh-list
56000642|NCT00809458|Tocopherols|tocopherols|mesh-list
56000643|NCT00809458|Tocotrienols|tocotrienols|mesh-list
56000644|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
56000645|NCT00809458|Vitamins|vitamins|mesh-ancestor
56000646|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
56000647|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000648|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
55954456|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954457|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55954458|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954459|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954460|NCT05556408|Propofol|propofol|mesh-list
55954461|NCT05556408|Succinylcholine|succinylcholine|mesh-list
55954462|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55954463|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55954464|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954465|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55954466|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
55954467|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
55954468|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
55954469|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55954470|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55954471|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954472|NCT00054353|Cyclosporine|cyclosporine|mesh-list
55954473|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
55954474|NCT00054353|Fludarabine|fludarabine|mesh-list
56025378|NCT01210079|Analgesics|analgesics|mesh-ancestor
56025391|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
55954475|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
55954476|NCT00054353|Melphalan|melphalan|mesh-list
55954477|NCT00054353|Cyclosporins|cyclosporins|mesh-list
55954478|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954479|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954480|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
55954481|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954482|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954483|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
55954484|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954485|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954486|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
55954487|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954488|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
55954489|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954490|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55954491|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55954511|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55954512|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55954513|NCT00208975|Analgesics|analgesics|mesh-ancestor
55954514|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
55954515|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954516|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55954517|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55954518|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954519|NCT01702233|Dexamethasone|dexamethasone|mesh-list
56025900|NCT01270256|Budesonide|budesonide|mesh-list
55954520|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
55954521|NCT01702233|BB 1101|bb 1101|mesh-list
55954522|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954523|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
55954524|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
55954525|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954526|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954527|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55954528|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
55954529|NCT01702233|Hormones|hormones|mesh-ancestor
56000649|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000650|NCT00809458|Protective Agents|protective agents|mesh-ancestor
55954530|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55954531|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55954532|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954533|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
55954534|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954535|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954536|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
55954537|NCT01852890|Gemcitabine|gemcitabine|mesh-list
55954538|NCT01852890|Vitamins|vitamins|mesh-ancestor
55954539|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
55954540|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954541|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954542|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
55954543|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954544|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954545|NCT01852890|Antiviral Agents|antiviral agents|mesh-ancestor
55954546|NCT01852890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954547|NCT01852890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026251|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56026252|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954548|NCT01852890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954549|NCT01852890|Immunologic Factors|immunologic factors|mesh-ancestor
55954550|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
55954562|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
55954563|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954565|NCT00217399|Anastrozole|anastrozole|mesh-list
55954566|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954567|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55954568|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954569|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954570|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55954571|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55954572|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55954573|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55954574|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
56026379|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026381|NCT00241358|Plerixafor|plerixafor|mesh-list
55954575|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55954576|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954577|NCT04739670|Gemcitabine|gemcitabine|mesh-list
55954578|NCT04739670|Bevacizumab|bevacizumab|mesh-list
55954579|NCT04739670|Carboplatin|carboplatin|mesh-list
55954580|NCT04739670|Atezolizumab|atezolizumab|mesh-list
55954581|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55954583|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55954584|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55954585|NCT04739670|Growth Substances|growth substances|mesh-ancestor
55954586|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954587|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
55954588|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954589|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
56026538|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55954590|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954591|NCT04739670|Antiviral Agents|antiviral agents|mesh-ancestor
55954592|NCT04739670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954593|NCT04739670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954594|NCT04739670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954595|NCT04739670|Immunologic Factors|immunologic factors|mesh-ancestor
55954596|NCT05549778|Polaprezinc|polaprezinc|mesh-list
55954597|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55954598|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55954599|NCT05286619|Gemcitabine|gemcitabine|mesh-list
55954600|NCT05286619|Carboplatin|carboplatin|mesh-list
55954601|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
55954602|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954603|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954604|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
55954605|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954606|NCT05286619|Antiviral Agents|antiviral agents|mesh-ancestor
55954607|NCT05286619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026706|NCT01250717|Dexamethasone|dexamethasone|mesh-list
55954608|NCT05286619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954609|NCT05286619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954610|NCT05286619|Immunologic Factors|immunologic factors|mesh-ancestor
55954611|NCT05286619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000652|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
56000653|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954612|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55954613|NCT04329624|Simendan|simendan|mesh-list
55954614|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55954615|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
55954616|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55954617|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55954627|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954629|NCT00218023|Levodopa|levodopa|mesh-list
55954630|NCT00218023|Carbidopa|carbidopa|mesh-list
55954631|NCT00218023|Modafinil|modafinil|mesh-list
55954632|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55954633|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55827236|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954634|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954635|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
55954636|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954637|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55954638|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55954639|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
56027082|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55954640|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954641|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954642|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55954643|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954644|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55954645|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55954646|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55954647|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56027183|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
55954648|NCT00054665|Prednisone|prednisone|mesh-list
55954649|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
55954650|NCT00054665|Doxorubicin|doxorubicin|mesh-list
55954651|NCT00054665|Etoposide|etoposide|mesh-list
55954652|NCT00054665|Vincristine|vincristine|mesh-list
55954653|NCT00054665|Bortezomib|bortezomib|mesh-list
55954654|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954655|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
55954656|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954657|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954658|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55954659|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
56027280|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
56027281|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954660|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954661|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954662|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55954663|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55954664|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55954665|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55954666|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954667|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954668|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
55954669|NCT00054665|Hormones|hormones|mesh-ancestor
56027323|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55954670|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55954671|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55954672|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55954673|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
55954674|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
55954675|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
55954676|NCT00476190|Cytarabine|cytarabine|mesh-list
55954677|NCT00476190|Dexamethasone|dexamethasone|mesh-list
55954678|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
55954679|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55954680|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55954681|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55954695|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954696|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954697|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55954698|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954700|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
55954701|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954702|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55954703|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
55954704|NCT00476190|Hormones|hormones|mesh-ancestor
55954705|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55954706|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55954707|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55954708|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55954709|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55954710|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954711|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55954712|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
55954713|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55954714|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954715|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
55954716|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
55954717|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55954718|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56027620|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
56027624|NCT05287724|Antidotes|antidotes|mesh-ancestor
55954719|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55954720|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
55828337|NCT04755764|Nifedipine|nifedipine|mesh-list
55954721|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954722|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
55954723|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
55954724|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
55954725|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
55954726|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55954728|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954729|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55954730|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954731|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954732|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
55954733|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55954734|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
55954735|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954736|NCT00218491|Expectorants|expectorants|mesh-ancestor
55954737|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
55954738|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55954739|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
55954740|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954741|NCT00218491|Protective Agents|protective agents|mesh-ancestor
55954742|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954743|NCT00218491|Antidotes|antidotes|mesh-ancestor
55954744|NCT05700864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55954745|NCT05700864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55954754|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55954755|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55954756|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
55954757|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
55954758|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55954759|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55954760|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028012|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56028013|NCT00806234|Ziprasidone|ziprasidone|mesh-list
55954761|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55954762|NCT05554848|Analgesics|analgesics|mesh-ancestor
55954763|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
55954764|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954765|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55954766|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55954767|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55954768|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
55954769|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954770|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954771|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
55954772|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55954773|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
55954774|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55954775|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55954776|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55954777|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
55954778|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55954779|NCT00057785|Fluorouracil|fluorouracil|mesh-list
55954780|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954781|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
55954782|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954783|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954784|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954785|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
55954786|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000655|NCT00786682|Docetaxel|docetaxel|mesh-list
56000656|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000657|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
56000658|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
56000659|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
55954787|NCT05554224|Liver Extracts|liver extracts|mesh-list
55954788|NCT05554224|Hematinics|hematinics|mesh-ancestor
55954789|NCT05548998|Anesthetics|anesthetics|mesh-list
55954790|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55954791|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954792|NCT01666782|Vaccines|vaccines|mesh-list
55954793|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
55954794|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954795|NCT00058019|Epothilones|epothilones|mesh-list
55954796|NCT00058019|Epothilone B|epothilone b|mesh-list
55954797|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
55954798|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
55954799|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
56028341|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954800|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954801|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954802|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55954803|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
55954804|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954805|NCT00110461|Aripiprazole|aripiprazole|mesh-list
55954806|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
55954807|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55954808|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56028437|NCT01474109|Macitentan|macitentan|mesh-list
55954817|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55954818|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
55954819|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55954820|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55954821|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55954822|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55954823|NCT00061373|Aspirin|aspirin|mesh-list
55954824|NCT00061373|Tinzaparin|tinzaparin|mesh-list
55954825|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55954826|NCT00061373|Dalteparin|dalteparin|mesh-list
55954827|NCT00061373|Eptifibatide|eptifibatide|mesh-list
55954828|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55954829|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56028621|NCT02348762|Glycine|glycine|mesh-list
55954830|NCT00061373|Analgesics|analgesics|mesh-ancestor
55954831|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
55954832|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954833|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954834|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954835|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954836|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55954837|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55954838|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028716|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
56028717|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028732|NCT00818324|Rebamipide|rebamipide|mesh-list
55954839|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55954840|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55954841|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954842|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
55954843|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
55954844|NCT01897337|Aprepitant|aprepitant|mesh-list
55954845|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
55954846|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
55954847|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954848|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954850|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55954851|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954852|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954853|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
55954854|NCT03089333|Glyburide|glyburide|mesh-list
56028905|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55954855|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55954856|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954857|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55954858|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954859|NCT00112723|Alvocidib|alvocidib|mesh-list
55954860|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000660|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954861|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
55954862|NCT00112723|Growth Substances|growth substances|mesh-ancestor
55954863|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954864|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55954865|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954866|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954867|NCT04327206|Vaccines|vaccines|mesh-list
55954868|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
55954869|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
55954870|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954871|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55954884|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
55954885|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55954886|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
55954887|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802909|NCT05540977|Donepezil|donepezil|mesh-list
55954888|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954889|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55954890|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55954891|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954892|NCT00116857|Sertraline|sertraline|mesh-list
56028985|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954893|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
55954894|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55954895|NCT00116857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55954896|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55954897|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55954898|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954899|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954900|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
55954901|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954902|NCT01672983|Ritonavir|ritonavir|mesh-list
55954903|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55954904|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55954905|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
55954906|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954907|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954908|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55954909|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55954910|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
55954911|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954912|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55954913|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55954914|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
55954915|NCT00117715|Caffeine|caffeine|mesh-list
55954916|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55954917|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954918|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55954919|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954920|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954921|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55954922|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55954923|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
55954924|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954925|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
55954926|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
56029300|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
55954927|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55954928|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55954929|NCT00227617|Leucovorin|leucovorin|mesh-list
55954930|NCT00227617|Bevacizumab|bevacizumab|mesh-list
55954931|NCT00227617|Fluorouracil|fluorouracil|mesh-list
55954932|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
55954933|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55954934|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954949|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
55954950|NCT00228943|Tryptophan|tryptophan|mesh-list
55954951|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55954952|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
55954953|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56000661|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
56000662|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56000663|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55954954|NCT01439282|Capecitabine|capecitabine|mesh-list
55954955|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954956|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
55954957|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954958|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954959|NCT01879085|Gemcitabine|gemcitabine|mesh-list
55954960|NCT01879085|Docetaxel|docetaxel|mesh-list
55954961|NCT01879085|Vorinostat|vorinostat|mesh-list
55954962|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56029609|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
55954963|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
55954964|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954965|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954966|NCT01879085|Antiviral Agents|antiviral agents|mesh-ancestor
55954967|NCT01879085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954968|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954969|NCT01879085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954970|NCT01879085|Immunologic Factors|immunologic factors|mesh-ancestor
55954971|NCT01879085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954972|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
55954973|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
55954974|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
55954975|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55954976|NCT01439204|Abatacept|abatacept|mesh-list
56029703|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56029704|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
56029705|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029706|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029707|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56029720|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
56029721|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56029722|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56029723|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
56029724|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
56029725|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56029726|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55954977|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55954978|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954979|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954980|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954981|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
55954982|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954983|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954984|NCT00063635|Vitamin E|vitamin e|mesh-list
55954985|NCT00063635|Metformin|metformin|mesh-list
55954986|NCT00063635|Vitamins|vitamins|mesh-ancestor
55954987|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
55954988|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954989|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55954990|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
55954991|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954992|NCT00063635|Protective Agents|protective agents|mesh-ancestor
55954993|NCT01439126|Clonidine|clonidine|mesh-list
55954994|NCT01439126|Analgesics|analgesics|mesh-ancestor
55954995|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
55954996|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954997|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955014|NCT01615731|Misoprostol|misoprostol|mesh-list
55955015|NCT01615731|Mifepristone|mifepristone|mesh-list
55955016|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55955017|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
55955018|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56030108|NCT03215498|Insulin|insulin|mesh-list
55955019|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955020|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55955021|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55955022|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
55955023|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55955024|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55955025|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955026|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955027|NCT01615731|Protective Agents|protective agents|mesh-ancestor
55955028|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55955029|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55955030|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55955031|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55955032|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
55955033|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55955034|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55955035|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
55955036|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955037|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
55955038|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56030248|NCT04380818|Ritonavir|ritonavir|mesh-list
56000664|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000665|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955039|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55955040|NCT02334800|Palbociclib|palbociclib|mesh-list
55955041|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955042|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55955043|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955044|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955045|NCT01665144|Siponimod|siponimod|mesh-list
55955046|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55955047|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030351|NCT01448525|Bimatoprost|bimatoprost|mesh-list
55955048|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955049|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
55955050|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955051|NCT01675635|Morphine|morphine|mesh-list
55955052|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55955053|NCT01675635|Narcotics|narcotics|mesh-ancestor
55955054|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55955074|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55955075|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030428|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
55955076|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
55955077|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55955079|NCT05547516|Epirubicin|epirubicin|mesh-list
55955080|NCT05547516|Mitomycins|mitomycins|mesh-list
55955081|NCT05547516|Mitomycin|mitomycin|mesh-list
55955082|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55955083|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
55955084|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955085|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955086|NCT05547516|Antiviral Agents|antiviral agents|mesh-ancestor
55955087|NCT05547516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955088|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955089|NCT05547516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955090|NCT05547516|Immunologic Factors|immunologic factors|mesh-ancestor
55955091|NCT05547516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955092|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55955093|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55955094|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55955095|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
55955096|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55955097|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55955099|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
55955100|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55955101|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
55955102|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955103|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955104|NCT01707225|Octreotide|octreotide|mesh-list
55955105|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55955106|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55955107|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955108|NCT01707381|Timolol|timolol|mesh-list
56030849|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955109|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955110|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55955111|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55955112|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
55955113|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955114|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955124|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955126|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55955127|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955128|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
55955129|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955130|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955131|NCT04756661|Misoprostol|misoprostol|mesh-list
55955132|NCT04756661|Oxytocin|oxytocin|mesh-list
55955133|NCT04756661|Carbetocin|carbetocin|mesh-list
55955134|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
55955135|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55955136|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955137|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55955138|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
55955139|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56000666|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56000667|NCT01675960|Gabapentin|gabapentin|mesh-list
56000668|NCT01675960|Analgesics|analgesics|mesh-ancestor
56000669|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
56000670|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000671|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000672|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
56000673|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56000674|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56000675|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000676|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55955140|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55955141|NCT01708629|Ustekinumab|ustekinumab|mesh-list
55955142|NCT01708629|Brodalumab|brodalumab|mesh-list
55955143|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55955144|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
55955145|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
55955146|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955147|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55955149|NCT00073073|Exemestane|exemestane|mesh-list
55955150|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
55955151|NCT00073073|Calcium|calcium|mesh-list
55955152|NCT00073073|Vitamins|vitamins|mesh-ancestor
55955153|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
55955154|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955155|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55955156|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55955157|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955158|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55955159|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55955160|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955161|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955162|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55955163|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
55955164|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955165|NCT00073073|Antacids|antacids|mesh-ancestor
55955166|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55955167|NCT00074165|Cytarabine|cytarabine|mesh-list
55955168|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
55955169|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
55955170|NCT00074165|Rituximab|rituximab|mesh-list
55955171|NCT00074165|Carboplatin|carboplatin|mesh-list
55955172|NCT00074165|Etoposide|etoposide|mesh-list
56031544|NCT02517528|Ribavirin|ribavirin|mesh-list
55955173|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
55955174|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955175|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
56031645|NCT03006809|Vancomycin|vancomycin|mesh-list
55955176|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955177|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955178|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55955179|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
55955180|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955181|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955206|NCT05710887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55955207|NCT05710887|Anesthetics, General|anesthetics, general|mesh-ancestor
55955208|NCT05710887|Anesthetics|anesthetics|mesh-ancestor
55955209|NCT05710887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55955210|NCT05710887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955211|NCT05710887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55955212|NCT05710887|Analgesics|analgesics|mesh-ancestor
55955213|NCT05710887|Sensory System Agents|sensory system agents|mesh-ancestor
55955214|NCT05710887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955215|NCT00075335|Plerixafor|plerixafor|mesh-list
55955216|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55955217|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56031828|NCT01045694|Hormones|hormones|mesh-ancestor
55955218|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
55955219|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000677|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55955220|NCT01680549|Gabapentin|gabapentin|mesh-list
55955221|NCT01680549|Analgesics|analgesics|mesh-ancestor
55955222|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
55955223|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955224|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955225|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
55955226|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55955227|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56031976|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55955228|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55955229|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55955230|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55955232|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955233|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955234|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
55955235|NCT01466348|Acetaminophen|acetaminophen|mesh-list
55955252|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55955253|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032135|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
55955254|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955255|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
55955256|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955257|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955258|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
55955260|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55955261|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56032215|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032217|NCT03401294|Antidotes|antidotes|mesh-ancestor
55955263|NCT01466192|Ribavirin|ribavirin|mesh-list
55955264|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55955265|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
55955266|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955267|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
55955268|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955269|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
55955270|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55955271|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55955272|NCT00120523|Analgesics|analgesics|mesh-ancestor
55955273|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
55955274|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032403|NCT04374188|Renal Agents|renal agents|mesh-ancestor
55955275|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955276|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55955277|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955278|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
55955279|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955280|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
55955281|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55955282|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955283|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955284|NCT01438814|Metformin|metformin|mesh-list
55955285|NCT01438814|Linagliptin|linagliptin|mesh-list
55955286|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55955287|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955288|NCT01438814|Incretins|incretins|mesh-ancestor
55955289|NCT01438814|Hormones|hormones|mesh-ancestor
55955290|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955291|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55955292|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
55955293|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955304|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56032596|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55955305|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955306|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955307|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
55955308|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55955309|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955310|NCT05545800|Insulin|insulin|mesh-list
56032685|NCT04365686|Propofol|propofol|mesh-list
55955311|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55955312|NCT05545800|Metformin|metformin|mesh-list
55955313|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
55955314|NCT05545800|Empagliflozin|empagliflozin|mesh-list
55955315|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55955316|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955317|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55955318|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955325|NCT00230737|Melatonin|melatonin|mesh-list
55955326|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
56032759|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000678|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56000679|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955327|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955328|NCT00230737|Protective Agents|protective agents|mesh-ancestor
55955329|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955330|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55955331|NCT04425564|Capecitabine|capecitabine|mesh-list
55955332|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
55955333|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55955334|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
56033045|NCT03283007|Nintedanib|nintedanib|mesh-list
55955335|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955336|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955338|NCT01686165|Belinostat|belinostat|mesh-list
55955339|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55955340|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55955341|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955342|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
55955343|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955344|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033109|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55955345|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55955346|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955347|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955348|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
55955349|NCT00123643|Glyburide|glyburide|mesh-list
55955350|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55955351|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955353|NCT05698524|Abexinostat|abexinostat|mesh-list
55955354|NCT05698524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55955355|NCT05698524|Alkylating Agents|alkylating agents|mesh-ancestor
55955356|NCT05698524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955357|NCT05698524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955358|NCT05698524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55955359|NCT05698524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955360|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
55955361|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
55955362|NCT00235573|Vitamins|vitamins|mesh-ancestor
55955363|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
55955364|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955374|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955375|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
55955376|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955377|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
55955378|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56033485|NCT01640171|Analgesics|analgesics|mesh-ancestor
55955379|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55955380|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955381|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955382|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955383|NCT00124579|Thalidomide|thalidomide|mesh-list
55955384|NCT00124579|Dexamethasone|dexamethasone|mesh-list
55955385|NCT00124579|Bortezomib|bortezomib|mesh-list
55955386|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033664|NCT01607645|Cytarabine|cytarabine|mesh-list
55955387|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
55955388|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
55955389|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955390|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955391|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761089|NCT04833777|Lidocaine|lidocaine|mesh-list
55955392|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
55955393|NCT00124579|Hormones|hormones|mesh-ancestor
55955394|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955395|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55955396|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955397|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955398|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
55955399|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
55955400|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55955401|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955402|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55955403|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55955404|NCT00124579|Growth Substances|growth substances|mesh-ancestor
56034202|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56000680|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000681|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
55955405|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
55955406|NCT05550246|Oxybutynin|oxybutynin|mesh-list
55955407|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55955408|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55955409|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55955410|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55955411|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955412|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
55955413|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955414|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955415|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
55955416|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
55955417|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955418|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55955419|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55955420|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
55955421|NCT05550246|Urological Agents|urological agents|mesh-ancestor
55955422|NCT00124735|Rocuronium|rocuronium|mesh-list
55955423|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55955424|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55955425|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56034498|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
56034500|NCT03030716|Procyanidin|procyanidin|mesh-list
55955426|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955427|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955428|NCT05340309|Atezolizumab|atezolizumab|mesh-list
55955429|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55955430|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034603|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
55955431|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
55955443|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955444|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034695|NCT05218733|Fentanyl|fentanyl|mesh-list
55955446|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55955448|NCT00125593|Ezetimibe|ezetimibe|mesh-list
56034785|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
55955449|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55955450|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55955451|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
56034880|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955452|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955453|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55955454|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55955456|NCT01689441|Calcitriol|calcitriol|mesh-list
55955457|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55955458|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955459|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55955460|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55955461|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955462|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56035124|NCT00974246|Hormones|hormones|mesh-ancestor
55955463|NCT01689441|Vitamins|vitamins|mesh-ancestor
55955464|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
55955465|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55955466|NCT00236977|Iron|iron|mesh-list
55955467|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55955468|NCT00236977|Trace Elements|trace elements|mesh-ancestor
55955469|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
55955470|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955471|NCT00236977|Hematinics|hematinics|mesh-ancestor
55955472|NCT04753177|Paclitaxel|paclitaxel|mesh-list
55955473|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
55955474|NCT04753177|Doxorubicin|doxorubicin|mesh-list
55955475|NCT04753177|Fulvestrant|fulvestrant|mesh-list
56035240|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955476|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55955477|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55955478|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955479|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
55955480|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
55955481|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
56035433|NCT02455050|Laxatives|laxatives|mesh-ancestor
55955482|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955483|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955484|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
55955485|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955486|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955487|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56000682|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56035678|NCT03015350|Sevoflurane|sevoflurane|mesh-list
56000683|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56000684|NCT01607320|Clomiphene|clomiphene|mesh-list
56000685|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
56000686|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56000687|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
56000688|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955488|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
55955489|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56035765|NCT05509634|Hormones|hormones|mesh-ancestor
55955490|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55955491|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55955492|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55955493|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955494|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56036029|NCT02176382|Denosumab|denosumab|mesh-list
55955495|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55955511|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955512|NCT00079001|Vitamin D|vitamin d|mesh-list
55955513|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
55955514|NCT00079001|Calcium|calcium|mesh-list
55955515|NCT00079001|Androgens|androgens|mesh-list
55955516|NCT00079001|Vitamins|vitamins|mesh-ancestor
55955517|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
55955518|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955519|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55955520|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55955521|NCT00079001|Hormones|hormones|mesh-ancestor
55955522|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955523|NCT05234307|Nivolumab|nivolumab|mesh-list
55955524|NCT05234307|Adenosine|adenosine|mesh-list
55955525|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
55955526|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55955527|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955528|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55955529|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955530|NCT05234307|Analgesics|analgesics|mesh-ancestor
56036741|NCT03013322|Miotics|miotics|mesh-ancestor
55955531|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
55955532|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955533|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955534|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55955535|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
55955536|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55955537|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
55955538|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
55955539|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955540|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55955541|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55955542|NCT04937881|Tenofovir|tenofovir|mesh-list
55955543|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
55955544|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955545|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56037294|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
55955546|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55955547|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955548|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955549|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55955550|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55955551|NCT00238615|Carboplatin|carboplatin|mesh-list
55955552|NCT00238615|Docetaxel|docetaxel|mesh-list
55955553|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955564|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955565|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55955566|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
55955567|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955568|NCT03088631|Metformin|metformin|mesh-list
55955569|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55955570|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955571|NCT00131677|Tenofovir|tenofovir|mesh-list
55955572|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
56000689|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000691|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
55955573|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955574|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55955575|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55955576|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955577|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955578|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55955579|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55955580|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
55955581|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55955582|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
55955583|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955584|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955585|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55955586|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
55955587|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55955588|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
55955589|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955590|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955591|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55955592|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
55955593|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
55955594|NCT00240487|Protective Agents|protective agents|mesh-ancestor
55955595|NCT02126917|Ethanol|ethanol|mesh-list
55955596|NCT02126917|Hydrocodone|hydrocodone|mesh-list
55955597|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55955598|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955599|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55955600|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955601|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55955602|NCT02126917|Narcotics|narcotics|mesh-ancestor
55955603|NCT02126917|Analgesics|analgesics|mesh-ancestor
55955604|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
55955605|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955606|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
55877019|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55955607|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
55955609|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55955610|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55955611|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
55955612|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955613|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955615|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
55955616|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
55955617|NCT01895075|Hormones|hormones|mesh-ancestor
55955618|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955631|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955632|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
55955633|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955634|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955635|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56038045|NCT00363909|Dexetimide|dexetimide|mesh-list
55955636|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
55955637|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955638|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955639|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55955640|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55955641|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955642|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55955643|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55955644|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
55955645|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55955646|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955647|NCT03139305|Glucagon|glucagon|mesh-list
55955648|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55955649|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55955650|NCT03139305|Hormones|hormones|mesh-ancestor
55955651|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955652|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955653|NCT03139305|Incretins|incretins|mesh-ancestor
56000692|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56000693|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56000694|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56000695|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56000696|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
56000697|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56000698|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56000699|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56000700|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000701|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56000702|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56000703|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56000704|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56000705|NCT01606150|Lidocaine|lidocaine|mesh-list
56000706|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
55789760|NCT04898387|Timolol|timolol|mesh-list
55955654|NCT00084149|Ritonavir|ritonavir|mesh-list
55955655|NCT00084149|Lopinavir|lopinavir|mesh-list
55955656|NCT00084149|Lamivudine|lamivudine|mesh-list
55955657|NCT00084149|Zidovudine|zidovudine|mesh-list
55955658|NCT00084149|Abacavir|abacavir|mesh-list
55955659|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55955660|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55955661|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
55955662|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955663|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955664|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55955665|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55955666|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
55955667|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955668|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55955669|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55955670|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55955671|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55955672|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
55955673|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
55955674|NCT02959905|Fludarabine|fludarabine|mesh-list
55955675|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
55955676|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955677|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
55955678|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955679|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955680|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55955681|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
56038173|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038175|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
55955682|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955707|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955708|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55955709|NCT04783051|Renal Agents|renal agents|mesh-ancestor
55955711|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955712|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955713|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955714|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56038244|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955715|NCT00245557|Sertraline|sertraline|mesh-list
55955716|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
55955717|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55955718|NCT00245557|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56000707|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
56000708|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55955719|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55955720|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55955721|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955722|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955723|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
55955724|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955725|NCT00245635|Fluoxetine|fluoxetine|mesh-list
55955726|NCT00245635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55955727|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55955728|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55877061|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
55955729|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955730|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955731|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
55955745|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55955747|NCT00141739|Analgesics|analgesics|mesh-ancestor
55955748|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
55955749|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955750|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955751|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877102|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955752|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955753|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55955754|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955755|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
55955756|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55955757|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
55955758|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955759|NCT00086957|Docetaxel|docetaxel|mesh-list
55955760|NCT00086957|Trastuzumab|trastuzumab|mesh-list
55955761|NCT00086957|Gefitinib|gefitinib|mesh-list
55955762|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955763|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
55955764|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
55955765|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
55955766|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877116|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
55877117|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955767|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55955768|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55955769|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955770|NCT00144391|Testosterone|testosterone|mesh-list
55955771|NCT00144391|Androgens|androgens|mesh-ancestor
55955772|NCT00144391|Hormones|hormones|mesh-ancestor
55955773|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955774|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955775|NCT00145249|Fluconazole|fluconazole|mesh-list
55955776|NCT00145249|Amphotericin B|amphotericin b|mesh-list
55955777|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55955778|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
55955779|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955780|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55955781|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55955782|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955783|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955784|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55955785|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
55955786|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955787|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955788|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55955789|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55955790|NCT00145249|Amebicides|amebicides|mesh-ancestor
55955805|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55955806|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955807|NCT00088985|Trastuzumab|trastuzumab|mesh-list
55955808|NCT00088985|Vinorelbine|vinorelbine|mesh-list
55955809|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55955810|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955811|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55955812|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
56000709|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000710|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
55955813|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
55955814|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
55955815|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038435|NCT04250805|Lidocaine|lidocaine|mesh-list
55955816|NCT00156923|Naltrexone|naltrexone|mesh-list
55955817|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55955818|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55955819|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955820|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
55955821|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955822|NCT00093041|Zalutumumab|zalutumumab|mesh-list
55955823|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55955824|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955825|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55955826|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
55955827|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55955828|NCT01895231|Hematinics|hematinics|mesh-ancestor
55955829|NCT04745663|Iodine|iodine|mesh-list
55955830|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
55955831|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
55955832|NCT04745663|Povidone|povidone|mesh-list
55955833|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55955834|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038530|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
55955835|NCT04745663|Trace Elements|trace elements|mesh-ancestor
55955836|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
56038604|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955837|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955838|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
55955839|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
55955840|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
55955841|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55955842|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55955843|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
55955844|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955845|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955846|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955847|NCT01747577|Urological Agents|urological agents|mesh-ancestor
55955848|NCT00159263|Budesonide|budesonide|mesh-list
55955849|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
55955850|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55955851|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55955859|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955860|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55955861|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55955862|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55955863|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
55955864|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955865|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955866|NCT00159419|Alendronate|alendronate|mesh-list
55955867|NCT00159419|Pamidronate|pamidronate|mesh-list
55955868|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55955869|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955871|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
55955872|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55955873|NCT00159965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55955874|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55955875|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55955876|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955877|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955878|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
55955879|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955880|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
55955881|NCT02926833|Fludarabine|fludarabine|mesh-list
55955882|NCT02926833|Atezolizumab|atezolizumab|mesh-list
55955883|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955884|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
55955885|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038731|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56038741|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
55955886|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955887|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55955888|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
55955889|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955890|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000711|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000712|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56000713|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56000714|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56000715|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56000716|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955891|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55955893|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
55955894|NCT00096161|Vidarabine|vidarabine|mesh-list
55955895|NCT00096161|Pentostatin|pentostatin|mesh-list
55955896|NCT00096161|Cyclosporins|cyclosporins|mesh-list
55955897|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955898|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955899|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955900|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
55955901|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955902|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
55955903|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955904|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
55955905|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877320|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
55955906|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55955907|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55955908|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955909|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55955910|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
55955911|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56038944|NCT01337336|Ipratropium|ipratropium|mesh-list
55955912|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
55955913|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
55955914|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
55955915|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
55955916|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955917|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
55955918|NCT01898039|Vaccines|vaccines|mesh-list
55955935|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55955936|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955937|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55955938|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55955939|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955940|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955941|NCT02851797|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
55955942|NCT02851797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55955943|NCT02851797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955944|NCT02851797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955945|NCT00253435|Carboplatin|carboplatin|mesh-list
55955946|NCT00253435|Etoposide|etoposide|mesh-list
55955947|NCT00253435|Melphalan|melphalan|mesh-list
55955948|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955949|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55955950|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55955951|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55955952|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955953|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955954|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
55955955|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955956|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55955957|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
55955958|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55955959|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955960|NCT00253513|Fludarabine|fludarabine|mesh-list
55955961|NCT00253513|Treosulfan|treosulfan|mesh-list
55955962|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743987|NCT02500069|Caseins|caseins|mesh-list
55955963|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955964|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55955965|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
55955966|NCT05033847|Vaccines|vaccines|mesh-list
56000717|NCT01602016|Leucovorin|leucovorin|mesh-list
56000718|NCT01602016|Folic Acid|folic acid|mesh-list
56000719|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
55955967|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
55955968|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955969|NCT04963725|Ustekinumab|ustekinumab|mesh-list
55955970|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
55955971|NCT02098993|Heparin|heparin|mesh-list
55955972|NCT02098993|Calcium heparin|calcium heparin|mesh-list
55955973|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
55955974|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55955983|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955984|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55955985|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
55955986|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955987|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955988|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55955989|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55955991|NCT00100841|Bevacizumab|bevacizumab|mesh-list
55955992|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55955993|NCT00100841|Cetuximab|cetuximab|mesh-list
55955994|NCT00100841|Fluorouracil|fluorouracil|mesh-list
55955995|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
55955996|NCT00100841|Antibodies|antibodies|mesh-list
55955997|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
55955998|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55955999|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
55956000|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956001|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55956002|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56039386|NCT04425239|Vitamins|vitamins|mesh-ancestor
56039387|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
56039388|NCT04425239|Hematinics|hematinics|mesh-ancestor
56039389|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56039390|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
56039391|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56039392|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55956003|NCT00100841|Growth Substances|growth substances|mesh-ancestor
56039393|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55956004|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956005|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
55877687|NCT00985959|Prednisolone|prednisolone|mesh-list
55956006|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
55956007|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
55956008|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956009|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55956010|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55956011|NCT00100841|Antidotes|antidotes|mesh-ancestor
55956012|NCT00100841|Protective Agents|protective agents|mesh-ancestor
55956013|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
55956014|NCT00100841|Vitamins|vitamins|mesh-ancestor
55956015|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
55956016|NCT04908579|Ketamine|ketamine|mesh-list
55956017|NCT04908579|Bupivacaine|bupivacaine|mesh-list
55956018|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
55956019|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
55956020|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55956021|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956022|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
55956023|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956024|NCT04908579|Analgesics|analgesics|mesh-ancestor
55877781|NCT05606913|Dulaglutide|dulaglutide|mesh-list
55956025|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55956026|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55956027|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
55956028|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55956029|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55956030|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956031|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956032|NCT00147199|Treprostinil|treprostinil|mesh-list
55956033|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55956034|NCT05709171|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55956035|NCT05709171|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55956036|NCT05709171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956038|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
55956039|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55956040|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55956041|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956043|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56039475|NCT05363007|Leucovorin|leucovorin|mesh-list
55956044|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
55956045|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956046|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
56000721|NCT01602016|Protective Agents|protective agents|mesh-ancestor
55956047|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55956048|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55956049|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56039595|NCT05556681|Sirolimus|sirolimus|mesh-list
55956050|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55956051|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55877965|NCT01297348|Estrogens|estrogens|mesh-ancestor
55956052|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956053|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
55956054|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956055|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956056|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55956057|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956059|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55956060|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55956061|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
55956062|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956063|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956064|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956065|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55956066|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55956067|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
55956068|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956069|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55956070|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039831|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039832|NCT01354652|Lamivudine|lamivudine|mesh-list
55956071|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956072|NCT02243709|Mifepristone|mifepristone|mesh-list
55956073|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55956074|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
55956075|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55956076|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956077|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55956078|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55956079|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55956080|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
55956081|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55956082|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55956083|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
55956084|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956085|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
55956086|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55956087|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55956088|NCT00258349|Trastuzumab|trastuzumab|mesh-list
55956089|NCT00258349|Vorinostat|vorinostat|mesh-list
55956090|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55878193|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956091|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956092|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55956093|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956094|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956095|NCT01713621|Artefenomel|artefenomel|mesh-list
55956096|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
55956097|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55956098|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55956099|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956100|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
55956101|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55956102|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
55956103|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956104|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956105|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55956106|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
55956107|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
55956108|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55956109|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
55956110|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956111|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956112|NCT00258817|Vaccines|vaccines|mesh-list
55956131|NCT00259285|Pemetrexed|pemetrexed|mesh-list
55956132|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956133|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956134|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000722|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000723|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
56000724|NCT01602016|Vitamins|vitamins|mesh-ancestor
55956135|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55956136|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55956137|NCT05682339|Quinine|quinine|mesh-list
55956138|NCT05682339|Antimalarials|antimalarials|mesh-ancestor
55956139|NCT05682339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55956140|NCT05682339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55956141|NCT05682339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956142|NCT05682339|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55956143|NCT05682339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956144|NCT05682339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55956145|NCT05682339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956146|NCT05682339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56040230|NCT01318694|Ribavirin|ribavirin|mesh-list
55956147|NCT05682339|Analgesics|analgesics|mesh-ancestor
55956148|NCT05682339|Sensory System Agents|sensory system agents|mesh-ancestor
55956149|NCT01716039|Adalimumab|adalimumab|mesh-list
55956150|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956151|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956152|NCT01716195|Paclitaxel|paclitaxel|mesh-list
55956153|NCT01716195|Carboplatin|carboplatin|mesh-list
55956154|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55956155|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956156|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
55956157|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
55956158|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
55956159|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956160|NCT02249481|Bupivacaine|bupivacaine|mesh-list
55956161|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
55956162|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
55956163|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040253|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55743997|NCT02499757|Nicotine|nicotine|mesh-list
55956164|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956165|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
55956166|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956167|NCT01717053|Prednisone|prednisone|mesh-list
55956168|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
55956169|NCT01717053|Androgens|androgens|mesh-list
55956170|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956171|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
55956172|NCT01717053|Hormones|hormones|mesh-ancestor
55956187|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956188|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55956189|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956190|NCT01717209|Epoprostenol|epoprostenol|mesh-list
55956191|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
55956192|NCT01717209|Tezosentan|tezosentan|mesh-list
56040329|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55956193|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55956194|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
55956195|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956196|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956197|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55878513|NCT03009292|Lenvatinib|lenvatinib|mesh-list
55956198|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
55956199|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55956200|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
55956201|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956202|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956203|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55956204|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
55956205|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
55956206|NCT01717209|Protective Agents|protective agents|mesh-ancestor
55956207|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55956208|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56040384|NCT01323140|Testosterone|testosterone|mesh-list
55956209|NCT05535738|Fluticasone|fluticasone|mesh-list
55956211|NCT05535738|Adalimumab|adalimumab|mesh-list
55956212|NCT05535738|Triamcinolone|triamcinolone|mesh-list
55956213|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55956214|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55956215|NCT05535738|Betamethasone|betamethasone|mesh-list
55956216|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
55956217|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55956218|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
55956219|NCT05535738|Ustekinumab|ustekinumab|mesh-list
55956220|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55956221|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
56000725|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
56000726|NCT01602016|Hematinics|hematinics|mesh-ancestor
56000727|NCT00731770|Fluticasone|fluticasone|mesh-list
56000728|NCT00731770|Xhance|xhance|mesh-list
55956222|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55956223|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956224|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55956225|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
55956226|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956227|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956228|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55956229|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
55956230|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
55956231|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55956232|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956235|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956236|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55956237|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
55956238|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956239|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956240|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55956241|NCT00260689|Cyclosporine|cyclosporine|mesh-list
56040615|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56040619|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
55956242|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
55956243|NCT00260689|Cyclosporins|cyclosporins|mesh-list
55956244|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55956245|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
55956246|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956247|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956248|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55956249|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
55878725|NCT03420378|Vitamin D|vitamin d|mesh-list
55956250|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956251|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
55956252|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956253|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
55956254|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956255|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55956256|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956257|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956258|NCT00262639|Gabapentin|gabapentin|mesh-list
55956259|NCT00262639|Flumazenil|flumazenil|mesh-list
55956260|NCT00262639|Analgesics|analgesics|mesh-ancestor
55956261|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
55956262|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878765|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956263|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956264|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
55956265|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56040700|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
55956266|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55956267|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55956268|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55956269|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55956270|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55956271|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040712|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55956272|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956274|NCT00262639|Antidotes|antidotes|mesh-ancestor
56040797|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
55956275|NCT00262639|Protective Agents|protective agents|mesh-ancestor
55956276|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
55956277|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
55956278|NCT01062451|Candesartan|candesartan|mesh-list
55956279|NCT01062451|Perindopril|perindopril|mesh-list
55956280|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55956281|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55956282|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55956283|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956284|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55956285|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
55956286|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040798|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
56040799|NCT01786967|Fesoterodine|fesoterodine|mesh-list
56040800|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56040801|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55956287|NCT04639843|Doxorubicin|doxorubicin|mesh-list
55956288|NCT04639843|Romidepsin|romidepsin|mesh-list
55956289|NCT04639843|Azacitidine|azacitidine|mesh-list
55956291|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55956292|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789787|NCT03050411|Apatinib|apatinib|mesh-list
55956293|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55956294|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55956295|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956296|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956297|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55956298|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
55956299|NCT01718691|Rituximab|rituximab|mesh-list
55956300|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956301|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956302|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
56040912|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
55956303|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956304|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956305|NCT05699148|Ivacaftor|ivacaftor|mesh-list
55956306|NCT05699148|Elexacaftor|elexacaftor|mesh-list
55956307|NCT05699148|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55956315|NCT04467723|Pirfenidone|pirfenidone|mesh-list
55956316|NCT04467723|Atezolizumab|atezolizumab|mesh-list
55956317|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956318|NCT04467723|Analgesics|analgesics|mesh-ancestor
55956319|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
55956320|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956321|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956322|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55956323|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55956324|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956325|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956327|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55956328|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
55956329|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
55956330|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55956331|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55956332|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956333|NCT04425642|Methamphetamine|methamphetamine|mesh-list
55956334|NCT04425642|SMOFlipid|smoflipid|mesh-list
56040997|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
56040998|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55956335|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55956336|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956337|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
55956338|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
55956339|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956340|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
55956341|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956342|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956343|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
55956344|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55956345|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55956346|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55956347|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55956348|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55956349|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55956350|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55956351|NCT00266851|Azithromycin|azithromycin|mesh-list
55956352|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55956353|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956354|NCT00015847|Interferons|interferons|mesh-list
55956355|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
55956356|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
56041093|NCT01332500|Naproxen|naproxen|mesh-list
55956357|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956358|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
55956359|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956360|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
55956361|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956362|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55956363|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956364|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956366|NCT01665768|Everolimus|everolimus|mesh-list
55956367|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956368|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956369|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
55956370|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956371|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956372|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000730|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56000731|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956373|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
55956374|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
55956375|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956395|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55956396|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55956397|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
55956398|NCT00017563|Docetaxel|docetaxel|mesh-list
55956399|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
55956400|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956401|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
55956402|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
55956403|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
55956404|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956405|NCT00017563|Analgesics|analgesics|mesh-ancestor
55956406|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
55956407|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956408|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956409|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55956410|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55956411|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956412|NCT00018031|Ribavirin|ribavirin|mesh-list
55956413|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55956414|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
55956415|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
56041308|NCT01404260|Carboplatin|carboplatin|mesh-list
55956416|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956417|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
55956418|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956419|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
55956420|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956421|NCT04734210|Betamethasone|betamethasone|mesh-list
55956422|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
55956423|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55956424|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
56041439|NCT02023593|Vitamins|vitamins|mesh-ancestor
55956425|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56041440|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
55956426|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956427|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
55956428|NCT04734210|Hormones|hormones|mesh-ancestor
55956429|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956430|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956431|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55956432|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
55956433|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
55956434|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956435|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55956452|NCT05609565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55956453|NCT05609565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956455|NCT05609565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956456|NCT00026221|Interferons|interferons|mesh-list
55956457|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
55956458|NCT00026221|Bevacizumab|bevacizumab|mesh-list
55956459|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956460|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956461|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55879178|NCT03411330|Bupivacaine|bupivacaine|mesh-list
55956462|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55956463|NCT00026221|Growth Substances|growth substances|mesh-ancestor
55956464|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956465|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
55956466|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
55879223|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
55956467|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956468|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
55956469|NCT00028093|Ribavirin|ribavirin|mesh-list
55956470|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55956471|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
55956472|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
55956473|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879245|NCT03404544|Carbetocin|carbetocin|mesh-list
55956474|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
55956475|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956476|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
55956477|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956478|NCT05697510|Siltuximab|siltuximab|mesh-list
55956479|NCT05697510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956480|NCT01721967|Ranolazine|ranolazine|mesh-list
56000732|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56000733|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
55956481|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55956482|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56041871|NCT02698215|Naltrexone|naltrexone|mesh-list
55956483|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956484|NCT04026451|Propofol|propofol|mesh-list
55956485|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56041925|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
55956486|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55956487|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956488|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55956489|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
55956490|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
55956491|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
55956492|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55956493|NCT01722435|Narcotics|narcotics|mesh-ancestor
55956494|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041975|NCT01836185|Evacetrapib|evacetrapib|mesh-list
55956495|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956504|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956505|NCT04389229|Aldesleukin|aldesleukin|mesh-list
55956506|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
55956507|NCT04389229|Fludarabine|fludarabine|mesh-list
55956508|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55956509|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
55956510|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956511|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956512|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55956513|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
55956514|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956515|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956516|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55956517|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55956518|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55956519|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
55956520|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956521|NCT03861702|Irinotecan|irinotecan|mesh-list
55956522|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55956523|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55956524|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956525|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956526|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956527|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
55956528|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55956529|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956530|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55956531|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956532|NCT05538702|Menthol|menthol|mesh-list
55956534|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
55956535|NCT00271219|Buprenorphine|buprenorphine|mesh-list
55956536|NCT00271219|Methadone|methadone|mesh-list
55956537|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55956538|NCT00271219|Narcotics|narcotics|mesh-ancestor
55956539|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55956540|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956541|NCT00271219|Analgesics|analgesics|mesh-ancestor
55956543|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956544|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55956545|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
55956546|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
55956547|NCT03340506|Trametinib|trametinib|mesh-list
55956548|NCT03340506|Dabrafenib|dabrafenib|mesh-list
55956549|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956550|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55956551|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956552|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956553|NCT02240667|Vitamin K|vitamin k|mesh-list
56042240|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
55956554|NCT02240667|Dabigatran|dabigatran|mesh-list
55956555|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
55956556|NCT02240667|Vitamins|vitamins|mesh-ancestor
55956557|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
55956558|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956559|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
55956560|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55956561|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
56000734|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000735|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000736|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55956562|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956563|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956576|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55956578|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
55956579|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956580|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956581|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956582|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956583|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55956584|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55956585|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956586|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55956587|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55956588|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956590|NCT00038857|Fludarabine|fludarabine|mesh-list
55956591|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
55956592|NCT00038857|Melphalan|melphalan|mesh-list
55956593|NCT00038857|Thiotepa|thiotepa|mesh-list
55956594|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
55956595|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55956596|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956597|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55956598|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
55956599|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956600|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55956601|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
56042264|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55956602|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956603|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55956604|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
55956605|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55956606|NCT03097068|Ranibizumab|ranibizumab|mesh-list
55956607|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55956608|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55956609|NCT03097068|Growth Substances|growth substances|mesh-ancestor
55956610|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956611|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
55956612|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956613|NCT01729845|Cytarabine|cytarabine|mesh-list
55956614|NCT01729845|Etoposide|etoposide|mesh-list
55956615|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
55956616|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
55956617|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
55956618|NCT01729845|Decitabine|decitabine|mesh-list
55956619|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55956620|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956621|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55956622|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55956623|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956624|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879391|NCT01611857|Vitamins|vitamins|mesh-ancestor
55956625|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55956626|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
55956627|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
55956628|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956667|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
55956668|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956669|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956670|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55956671|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
55956673|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956674|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55956675|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956676|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
55956677|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
56042604|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55956678|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879453|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
55956679|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
55956680|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55956681|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55956682|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
56042689|NCT02271425|Evacetrapib|evacetrapib|mesh-list
55956683|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55956684|NCT02584452|Narcotics|narcotics|mesh-ancestor
55956685|NCT02584452|Analgesics|analgesics|mesh-ancestor
55956686|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55956687|NCT02502006|Celecoxib|celecoxib|mesh-list
55956688|NCT02502006|Naproxen|naproxen|mesh-list
56042774|NCT03021083|Analgesics|analgesics|mesh-ancestor
55956689|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55956690|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55956691|NCT02502006|Analgesics|analgesics|mesh-ancestor
55956692|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
55956693|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956694|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956695|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956696|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956697|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56042839|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
56042840|NCT04048161|Tacrolimus|tacrolimus|mesh-list
56042841|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56042842|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
55956698|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55956699|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956700|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956701|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
55956702|NCT05679102|Amlodipine|amlodipine|mesh-list
55956703|NCT05679102|Atorvastatin|atorvastatin|mesh-list
55956704|NCT05679102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55956705|NCT05679102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55956706|NCT05679102|Antimetabolites|antimetabolites|mesh-ancestor
55956707|NCT05679102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956708|NCT05679102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55956709|NCT05679102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55956710|NCT05679102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956711|NCT05679102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55956712|NCT05679102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55956713|NCT05679102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55956714|NCT05679102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55956715|NCT05679102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956716|NCT05679102|Vasodilator Agents|vasodilator agents|mesh-ancestor
55956717|NCT03520491|Nivolumab|nivolumab|mesh-list
55956718|NCT03520491|Ipilimumab|ipilimumab|mesh-list
55956719|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956720|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956721|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55956722|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956723|NCT05591118|Anticoagulants|anticoagulants|mesh-list
55956724|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
55956725|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
55956726|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956727|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956728|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
55956729|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956730|NCT05588934|Caffeine|caffeine|mesh-list
55956731|NCT05588934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55956732|NCT05588934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879677|NCT04697693|Analgesics|analgesics|mesh-ancestor
55956733|NCT05588934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55956734|NCT05588934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789534|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
55956735|NCT05588934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956736|NCT05588934|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55956737|NCT05588934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55956738|NCT05588934|Purinergic Agents|purinergic agents|mesh-ancestor
55956739|NCT05588934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956740|NCT02243007|Gemcitabine|gemcitabine|mesh-list
55956742|NCT02243007|Capecitabine|capecitabine|mesh-list
55956743|NCT02243007|Folfirinox|folfirinox|mesh-list
55956744|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55956745|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956748|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
55956749|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956750|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55956751|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
55956752|NCT02243007|Antiviral Agents|antiviral agents|mesh-ancestor
55956753|NCT02243007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956754|NCT02243007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956755|NCT02243007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043239|NCT04766463|Morphine|morphine|mesh-list
55956756|NCT02243007|Immunologic Factors|immunologic factors|mesh-ancestor
56000738|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
56000739|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56000740|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56000741|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56000742|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56043425|NCT01431014|BB 1101|bb 1101|mesh-list
56000743|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
56000744|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956757|NCT02243007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956758|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
55956759|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
55956760|NCT05536596|Melatonin|melatonin|mesh-list
55956761|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
56043516|NCT04306965|Apremilast|apremilast|mesh-list
55956762|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956763|NCT05536596|Protective Agents|protective agents|mesh-ancestor
55956764|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956765|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55956766|NCT05536596|Hematinics|hematinics|mesh-ancestor
55956767|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
55956768|NCT05536596|Vitamins|vitamins|mesh-ancestor
55956769|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
55956770|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
55956771|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956772|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55956773|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956774|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956775|NCT03430791|Nivolumab|nivolumab|mesh-list
55956776|NCT03430791|Ipilimumab|ipilimumab|mesh-list
55956777|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956778|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956779|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55956780|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956781|NCT05536284|Bisoprolol|bisoprolol|mesh-list
55956782|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55956783|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
55956784|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
55956785|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043881|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956786|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956787|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55956788|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55956789|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55956790|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
55956791|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956792|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956793|NCT05536128|Olaparib|olaparib|mesh-list
55956794|NCT05536128|Fulvestrant|fulvestrant|mesh-list
55956795|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55956796|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802944|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
56044177|NCT04293393|Taxane|taxane|mesh-list
55956797|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956798|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956799|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55956800|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55956801|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55956802|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
55956803|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956804|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956809|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55956810|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956811|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
56044284|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956812|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956813|NCT05316675|Isotretinoin|isotretinoin|mesh-list
55956814|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
55956815|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
56000745|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000747|NCT00731770|Hormones|hormones|mesh-ancestor
56000748|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000749|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
56000750|NCT00719914|Eptifibatide|eptifibatide|mesh-list
56000751|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56000752|NCT01566370|Zonisamide|zonisamide|mesh-list
56000753|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
56000754|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56000755|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55956816|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56044403|NCT02209610|Analgesics|analgesics|mesh-ancestor
55956833|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55956834|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956835|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956836|NCT05328414|Prednisolone|prednisolone|mesh-list
55956837|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956838|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
55956839|NCT05328414|Hormones|hormones|mesh-ancestor
55956840|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956841|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956842|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55956843|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956844|NCT01739361|Acetaminophen|acetaminophen|mesh-list
55956845|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55956846|NCT01739361|Analgesics|analgesics|mesh-ancestor
55956847|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
55956848|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956849|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771971|NCT03112187|Iron|iron|mesh-list
55956850|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
55956851|NCT01743729|Lifitegrast|lifitegrast|mesh-list
55956852|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55956853|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55956854|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
55956855|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55956856|NCT01744353|Paclitaxel|paclitaxel|mesh-list
55956857|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044805|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044811|NCT04080843|Capecitabine|capecitabine|mesh-list
55956858|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956859|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55956860|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
55956861|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
55956862|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
55956863|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
55956864|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
55956865|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55956866|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55956867|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956868|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956869|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956870|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956871|NCT01744821|Vitamin D|vitamin d|mesh-list
55956872|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
55956873|NCT01744821|Vitamins|vitamins|mesh-ancestor
55956874|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
55956875|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956876|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55956893|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55956894|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55956895|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
55956896|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045143|NCT05045937|Ibuprofen|ibuprofen|mesh-list
55956897|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56045277|NCT01524302|Ofloxacin|ofloxacin|mesh-list
55956898|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55956899|NCT01745133|Calcitriol|calcitriol|mesh-list
55956900|NCT01745133|Clobetasol|clobetasol|mesh-list
56045426|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
56000756|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000757|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56000758|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000759|NCT03414684|Carboplatin|carboplatin|mesh-list
56000761|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000762|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000763|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56000764|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000765|NCT01558492|Paclitaxel|paclitaxel|mesh-list
56000766|NCT01558492|Carboplatin|carboplatin|mesh-list
56000767|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56000768|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000769|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
56000770|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
56000771|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
55879734|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
56000772|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789814|NCT03051503|Morphine|morphine|mesh-list
55956901|NCT01745133|Calcipotriene|calcipotriene|mesh-list
55879747|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55956902|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956903|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
55956904|NCT01745133|Hormones|hormones|mesh-ancestor
56045925|NCT01592006|Ribavirin|ribavirin|mesh-list
55956905|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956906|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956907|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
55956908|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55956909|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55956910|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55956911|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956912|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55956913|NCT01745133|Vitamins|vitamins|mesh-ancestor
55956914|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
55956915|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55956916|NCT05302011|Carboplatin|carboplatin|mesh-list
55956917|NCT05302011|Docetaxel|docetaxel|mesh-list
55956918|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
55956919|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956920|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
55956921|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
55956922|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
55956923|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956924|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956925|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
55956926|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55956927|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956928|NCT04246359|Interferons|interferons|mesh-list
55956929|NCT04246359|Rituximab|rituximab|mesh-list
55956930|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956931|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956932|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
55956933|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956934|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956935|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
55956948|NCT05192265|Lumefantrine|lumefantrine|mesh-list
55956949|NCT05192265|Artemether|artemether|mesh-list
56000773|NCT03579472|Halichondrin B|halichondrin b|mesh-list
56000774|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000775|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
55956950|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55956951|NCT05192265|Pyronaridine|pyronaridine|mesh-list
55956952|NCT05192265|Antimalarials|antimalarials|mesh-list
55956953|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55956954|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55956955|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956956|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956957|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
55956958|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
55956959|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55956960|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
55956961|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
55956963|NCT01748643|Neostigmine|neostigmine|mesh-list
56046168|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55956964|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55956965|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56046282|NCT02998970|Empagliflozin|empagliflozin|mesh-list
55956966|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55956967|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956968|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956969|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55956970|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046381|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
55956971|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956972|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
55956973|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956974|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55956975|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
55956976|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55956977|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55956978|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55956979|NCT00106535|Methotrexate|methotrexate|mesh-list
55956980|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55956981|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
55956982|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55956983|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956984|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879793|NCT01435174|Ranolazine|ranolazine|mesh-list
55956985|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
55956986|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956987|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956988|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
55956989|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956990|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55956991|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55956992|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
55956993|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956994|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55956995|NCT01748799|Ethanol|ethanol|mesh-list
55956996|NCT01748799|Nabiximols|nabiximols|mesh-list
55956997|NCT01748799|Dronabinol|dronabinol|mesh-list
55956998|NCT01748799|Cannabidiol|cannabidiol|mesh-list
55956999|NCT01748799|Peppermint oil|peppermint oil|mesh-list
55957000|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55957014|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957015|NCT01748799|Hormones|hormones|mesh-ancestor
56046970|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
55957016|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957017|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
55957018|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
55957019|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957020|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
55957021|NCT04107051|Nalmefene|nalmefene|mesh-list
55957022|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55957023|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957024|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
55957025|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957026|NCT05696886|Meperidine|meperidine|mesh-list
55957027|NCT05696886|Tramadol|tramadol|mesh-list
55957028|NCT05696886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55957029|NCT05696886|Narcotics|narcotics|mesh-ancestor
55957030|NCT05696886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957031|NCT05696886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957033|NCT05696886|Sensory System Agents|sensory system agents|mesh-ancestor
56000776|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
55957034|NCT05696886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047187|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957035|NCT05696886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55957036|NCT01748955|Bupropion|bupropion|mesh-list
55957037|NCT01748955|Paroxetine|paroxetine|mesh-list
55957038|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55957039|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
55957040|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957041|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55957042|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55957043|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55957044|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957045|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
55957046|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957047|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957048|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55957049|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56047263|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
55957050|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957051|NCT01748955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55957052|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
55957053|NCT05687448|Warfarin|warfarin|mesh-list
55957054|NCT05687448|Apixaban|apixaban|mesh-list
55957055|NCT05687448|Anticoagulants|anticoagulants|mesh-ancestor
55957056|NCT05687448|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55957057|NCT05687448|Antithrombins|antithrombins|mesh-ancestor
55957058|NCT05687448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55957059|NCT05687448|Protease Inhibitors|protease inhibitors|mesh-ancestor
55957060|NCT05687448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957061|NCT05687448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957062|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
55957079|NCT02255175|Progesterone|progesterone|mesh-list
55957080|NCT02255175|Estrogens|estrogens|mesh-ancestor
55957081|NCT02255175|Hormones|hormones|mesh-ancestor
55957082|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957083|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957084|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55957085|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
55957086|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55957087|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55957088|NCT02255175|Progestins|progestins|mesh-ancestor
55957089|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55957090|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957091|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
55957092|NCT03899103|Rituximab|rituximab|mesh-list
55957093|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55957094|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957095|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
55957096|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957097|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957098|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55957099|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55957100|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
55957101|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55957102|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957103|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957104|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957105|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
55957106|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957107|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55957108|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957109|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957110|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
55957111|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957112|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957113|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55957114|NCT01438424|Lamivudine|lamivudine|mesh-list
55957115|NCT01438424|Entecavir|entecavir|mesh-list
55957116|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55957117|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55957127|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
55957128|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55957129|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56000777|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
55789549|NCT05205499|Sirolimus|sirolimus|mesh-list
56000778|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957130|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
55957131|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55957132|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
55957133|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
55957134|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957135|NCT05299866|Ketamine|ketamine|mesh-list
55957136|NCT05299866|Esketamine|esketamine|mesh-list
55957137|NCT05299866|Analgesics|analgesics|mesh-ancestor
55957138|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
55957139|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957140|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957141|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55957142|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55957143|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
55957144|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
55957145|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957146|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55957147|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55957148|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957149|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957150|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
55957151|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957152|NCT04133376|Nicotine|nicotine|mesh-list
55957153|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55957154|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
55957155|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957156|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957157|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55957158|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55957159|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
55957160|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957161|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957162|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
55957163|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55957164|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
55957165|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957166|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957167|NCT05267886|Dobutamine|dobutamine|mesh-list
55957168|NCT05267886|Milrinone|milrinone|mesh-list
55957169|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55957170|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
55957171|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
55957172|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957173|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957174|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55957175|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55957176|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55957177|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
55957178|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957179|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957180|NCT05267886|Protective Agents|protective agents|mesh-ancestor
55957181|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55957182|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
55957183|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55957184|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55957219|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957220|NCT02252445|Propofol|propofol|mesh-list
55957221|NCT02252445|Sevoflurane|sevoflurane|mesh-list
55957222|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56047963|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55957223|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957224|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957225|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55957236|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957238|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
55957239|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957240|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957241|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55957242|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56000779|NCT05286190|Bupivacaine|bupivacaine|mesh-list
56000780|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
56000781|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
55789836|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55957244|NCT00176423|Galantamine|galantamine|mesh-list
55957245|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55957246|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957247|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957248|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
55957249|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957250|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957251|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55957252|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
55957253|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957254|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
55957255|NCT02094443|Ribavirin|ribavirin|mesh-list
55957256|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
55957257|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957258|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
55957259|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957260|NCT00110513|Antithrombins|antithrombins|mesh-list
55957261|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
55957262|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55957263|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
55957264|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957265|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957266|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
55957267|NCT05663658|Morphine|morphine|mesh-list
55957268|NCT05663658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55957269|NCT05663658|Narcotics|narcotics|mesh-ancestor
55957270|NCT05663658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957271|NCT05663658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957272|NCT05663658|Analgesics|analgesics|mesh-ancestor
55957273|NCT05663658|Sensory System Agents|sensory system agents|mesh-ancestor
55957274|NCT05663658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957275|NCT05691426|Nitric Oxide|nitric oxide|mesh-list
55957276|NCT05691426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55957277|NCT05691426|Autonomic Agents|autonomic agents|mesh-ancestor
55957278|NCT05691426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957279|NCT05691426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957280|NCT05691426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55957281|NCT05691426|Respiratory System Agents|respiratory system agents|mesh-ancestor
55957282|NCT05691426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55957283|NCT05691426|Antioxidants|antioxidants|mesh-ancestor
55957284|NCT05691426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957285|NCT05691426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957286|NCT05691426|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55957287|NCT05691426|Vasodilator Agents|vasodilator agents|mesh-ancestor
55957288|NCT05691426|Gasotransmitters|gasotransmitters|mesh-ancestor
55957289|NCT05691426|Protective Agents|protective agents|mesh-ancestor
55957290|NCT05696574|Misoprostol|misoprostol|mesh-list
55957308|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957309|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
55957310|NCT05162742|Colchicine|colchicine|mesh-list
55957311|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
55957312|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957313|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
55957314|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
55957315|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
55957316|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957317|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957318|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
55957319|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55957320|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957321|NCT00113321|Decitabine|decitabine|mesh-list
55957322|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55957323|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
55957324|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957325|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957326|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957327|NCT05669742|Empagliflozin|empagliflozin|mesh-list
56000782|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000783|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048255|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
56000784|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
55957328|NCT05669742|Olanzapine|olanzapine|mesh-list
55957329|NCT05669742|Antiemetics|antiemetics|mesh-ancestor
55957330|NCT05669742|Autonomic Agents|autonomic agents|mesh-ancestor
55957331|NCT05669742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957332|NCT05669742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957333|NCT05669742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957334|NCT05669742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55957335|NCT05669742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55957336|NCT05669742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957337|NCT05669742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957338|NCT05669742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55957339|NCT05669742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55957340|NCT05669742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55957341|NCT05669742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957342|NCT05669742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957343|NCT05669742|Serotonin Agents|serotonin agents|mesh-ancestor
55957344|NCT05669742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55957345|NCT05669742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55957346|NCT03718065|Lofexidine|lofexidine|mesh-list
55957347|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55957366|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
55957367|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957368|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048390|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55957369|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55957370|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55957371|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55957372|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
55957373|NCT00178841|Bexarotene|bexarotene|mesh-list
55957374|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55957375|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957376|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957377|NCT01756209|Acetaminophen|acetaminophen|mesh-list
55957378|NCT01756209|Ibuprofen|ibuprofen|mesh-list
55957379|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55957380|NCT01756209|Analgesics|analgesics|mesh-ancestor
55957381|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
55957382|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957383|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048449|NCT02288273|Incretins|incretins|mesh-ancestor
56048450|NCT02288273|Hormones|hormones|mesh-ancestor
56048453|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
55957384|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
55957385|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55957386|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55957387|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957388|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55957389|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957390|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957391|NCT00116207|Niacinamide|niacinamide|mesh-list
55957392|NCT00116207|Allopurinol|allopurinol|mesh-list
55957393|NCT00116207|Antioxidants|antioxidants|mesh-list
55957394|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
55880024|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55880025|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
55957395|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957396|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957397|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
55957398|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957399|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55957400|NCT00116207|Protective Agents|protective agents|mesh-ancestor
55957401|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957402|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
55957403|NCT00116207|Vitamins|vitamins|mesh-ancestor
56048501|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
55957404|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
55957405|NCT04129398|Letermovir|letermovir|mesh-list
55957422|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55957423|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
55957424|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789572|NCT03909217|Dexetimide|dexetimide|mesh-list
55957425|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
55957427|NCT05609682|Analgesics|analgesics|mesh-ancestor
55957428|NCT05609682|Sensory System Agents|sensory system agents|mesh-ancestor
55957429|NCT05609682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957430|NCT05609682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957431|NCT05609682|Anticonvulsants|anticonvulsants|mesh-ancestor
56000785|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000786|NCT03399552|Avelumab|avelumab|mesh-list
56000787|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000788|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000789|NCT00691444|Melatonin|melatonin|mesh-list
56000790|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
56000791|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000792|NCT00691444|Protective Agents|protective agents|mesh-ancestor
56000793|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000794|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000795|NCT05477004|Ketamine|ketamine|mesh-list
56000796|NCT05477004|Analgesics|analgesics|mesh-ancestor
56000797|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
56000798|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000799|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000800|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56000801|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56000802|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
56000803|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
56000804|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000805|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55957432|NCT05609682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55957433|NCT05609682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55957434|NCT05609682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048522|NCT05316935|Letrozole|letrozole|mesh-list
55957435|NCT05609682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957436|NCT05609682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55957437|NCT05609682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55957438|NCT05609682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957439|NCT05609682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957440|NCT05609682|Antimanic Agents|antimanic agents|mesh-ancestor
55957441|NCT03453489|Tryptophan|tryptophan|mesh-list
55957442|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55957443|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
55957444|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957445|NCT04284839|Warfarin|warfarin|mesh-list
55957446|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
55957447|NCT04284839|Dabigatran|dabigatran|mesh-list
55957448|NCT04284839|Apixaban|apixaban|mesh-list
55957449|NCT04284839|Edoxaban|edoxaban|mesh-list
55957450|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
55880134|NCT00782184|Atorvastatin|atorvastatin|mesh-list
55957451|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55957452|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
55957453|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55957454|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
55957455|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957456|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957457|NCT05656248|Cytarabine|cytarabine|mesh-list
55957458|NCT05656248|Hydrocortisone|hydrocortisone|mesh-list
55957459|NCT05656248|Methotrexate|methotrexate|mesh-list
55957460|NCT05656248|Daunorubicin|daunorubicin|mesh-list
55957461|NCT05656248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55957462|NCT05656248|Abortifacient Agents|abortifacient agents|mesh-ancestor
55957463|NCT05656248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56000806|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56000807|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000808|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000811|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
56000812|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000813|NCT01530880|Acetaminophen|acetaminophen|mesh-list
56000814|NCT01530880|Ibuprofen|ibuprofen|mesh-list
56000815|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56000816|NCT01530880|Analgesics|analgesics|mesh-ancestor
56048659|NCT05736419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048662|NCT05736419|Antitubercular Agents|antitubercular agents|mesh-ancestor
56000817|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
56000818|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000819|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789867|NCT04882163|Rituximab|rituximab|mesh-list
55957464|NCT05656248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957476|NCT05656248|Antiviral Agents|antiviral agents|mesh-ancestor
55828841|NCT01534078|Dacarbazine|dacarbazine|mesh-list
55957477|NCT05656248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957478|NCT05656248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55957479|NCT05656248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55957480|NCT05656248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55957481|NCT05656248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55957482|NCT05577000|Cyclophosphamide|cyclophosphamide|mesh-list
55957484|NCT05577000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55957485|NCT05577000|Immunologic Factors|immunologic factors|mesh-ancestor
55957486|NCT05577000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957487|NCT05577000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957488|NCT05577000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55957489|NCT05577000|Alkylating Agents|alkylating agents|mesh-ancestor
55957490|NCT05577000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957491|NCT05577000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957492|NCT05577000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55957493|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55957494|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957495|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048746|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
55957497|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
55957498|NCT00122447|Olmesartan|olmesartan|mesh-list
55957499|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55957500|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55957501|NCT00122447|Analgesics|analgesics|mesh-ancestor
55957502|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
55957503|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957504|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957505|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55957506|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880204|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55957507|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55957508|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55957509|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957510|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55957511|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55957512|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957513|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
55957514|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55880213|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957515|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55957516|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55957517|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
55957518|NCT00122447|Protective Agents|protective agents|mesh-ancestor
55957519|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
55957520|NCT00122447|Vitamins|vitamins|mesh-ancestor
55957521|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
56000820|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
56000821|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56000822|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56000823|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957522|NCT00125957|Bupropion|bupropion|mesh-list
55957523|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55957524|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
55957525|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957526|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55957527|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55957545|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957547|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
55957548|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
55957549|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957550|NCT02579928|Midazolam|midazolam|mesh-list
55957551|NCT02579928|Ketamine|ketamine|mesh-list
55957552|NCT02579928|Analgesics|analgesics|mesh-ancestor
55957553|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
55957554|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957555|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957556|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55957557|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55957558|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
55957559|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
55957560|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957561|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55957562|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55957563|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957564|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957565|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55957566|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55957567|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55957568|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55957569|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957570|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
55957571|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
55957573|NCT00183677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55957574|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55957575|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55957576|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957578|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
55957579|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957580|NCT00183677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55957581|NCT00183677|Antidepressive Agents|antidepressive agents|mesh-ancestor
55957582|NCT00183677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957583|NCT00186017|Olanzapine|olanzapine|mesh-list
55957584|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
55957598|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
55957599|NCT00041119|Paclitaxel|paclitaxel|mesh-list
55957600|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
55957601|NCT00041119|Doxorubicin|doxorubicin|mesh-list
55957602|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55957603|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55957604|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957605|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
55957606|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
55957607|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
55880291|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
55957608|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957609|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55957610|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
55957611|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957612|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957613|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55957614|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
55957615|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55957616|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55957617|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55957618|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55957619|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957620|NCT00186875|Cytarabine|cytarabine|mesh-list
55957621|NCT00186875|Dexamethasone|dexamethasone|mesh-list
56000824|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55957622|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
55957623|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
55957624|NCT00186875|Methotrexate|methotrexate|mesh-list
55957625|NCT00186875|Etoposide|etoposide|mesh-list
55957626|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
55957627|NCT00186875|Vincristine|vincristine|mesh-list
55957628|NCT00186875|Asparaginase|asparaginase|mesh-list
55957629|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
55957630|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
55957631|NCT00186875|Vinblastine|vinblastine|mesh-list
55957632|NCT00186875|Pegaspargase|pegaspargase|mesh-list
55957633|NCT00186875|Teniposide|teniposide|mesh-list
55957634|NCT00186875|BB 1101|bb 1101|mesh-list
55957635|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55957636|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
55957637|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957638|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957639|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55957640|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
55957641|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957642|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957643|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55880358|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
55957644|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55957645|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
55957646|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
55957647|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957663|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55957664|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55957665|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55957666|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
55957667|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957668|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
55957669|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
55957670|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
55957671|NCT00186875|Analgesics|analgesics|mesh-ancestor
55957672|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
55957673|NCT00551460|Methotrexate|methotrexate|mesh-list
55957674|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
55957675|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
55957676|NCT00551460|Tretinoin|tretinoin|mesh-list
55957677|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
55957678|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55957679|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
55957680|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55957681|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957682|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55957683|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
55957684|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957685|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957686|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
55957687|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957688|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55957689|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55957690|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
55957691|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957692|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55957693|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
55957694|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55957695|NCT04751227|Modafinil|modafinil|mesh-list
55957696|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55957697|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957698|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55957699|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55957700|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55957701|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957702|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
55957703|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55957704|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
55957705|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957706|NCT02579772|Expectorants|expectorants|mesh-ancestor
55957707|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
55957708|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55957720|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957721|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
55957723|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000825|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000826|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957724|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55957725|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957727|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55957728|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957729|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55957730|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957731|NCT04887285|Anesthetics|anesthetics|mesh-list
55957732|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
55957733|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957734|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957735|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
55957736|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957737|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55957738|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55957739|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55957740|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957741|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957742|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957743|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55957745|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55957746|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
55957747|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957748|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957749|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55957750|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55957751|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
55957752|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55957753|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55957754|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
55957755|NCT02989701|Plerixafor|plerixafor|mesh-list
55957756|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55957757|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55957758|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
56049321|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55880566|NCT03389958|Copper|copper|mesh-list
55957759|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957760|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
55957761|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55957762|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
55957763|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957764|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049388|NCT03186261|Fluorides|fluorides|mesh-list
55957765|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55957766|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
55957767|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957768|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957771|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
55957772|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55957773|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957774|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957775|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55957777|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
55957778|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957779|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55957780|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55957781|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56049495|NCT01682642|Goserelin|goserelin|mesh-list
55957782|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
55957783|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957784|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957785|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
55957786|NCT01761747|Ponatinib|ponatinib|mesh-list
55957787|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957788|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55957789|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957790|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957791|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55957792|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957793|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56000827|NCT05482074|Olaparib|olaparib|mesh-list
56000828|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55957794|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957795|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957796|NCT04097730|Riboflavin|riboflavin|mesh-list
55880706|NCT01568008|Bimatoprost|bimatoprost|mesh-list
55957797|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
55957798|NCT04097730|Difluprednate|difluprednate|mesh-list
55957799|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55957800|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957801|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55957802|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55957803|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957804|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049626|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55957805|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957806|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957807|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
55957808|NCT04097730|Vitamins|vitamins|mesh-ancestor
55957809|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
55957810|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55957811|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
55957812|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
55957813|NCT04097730|Hormones|hormones|mesh-ancestor
55957814|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957815|NCT00278863|Capecitabine|capecitabine|mesh-list
55957816|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55957817|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
55957818|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957819|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957820|NCT01762059|Pancrelipase|pancrelipase|mesh-list
56049654|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55957821|NCT01762059|Pancreatin|pancreatin|mesh-list
55957822|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957823|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
55957824|NCT04938024|Vitamins|vitamins|mesh-ancestor
55957825|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
55957826|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957827|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
55957828|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957829|NCT04938024|Protective Agents|protective agents|mesh-ancestor
55957830|NCT01808547|Bromfenac|bromfenac|mesh-list
55957831|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55957832|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55880820|NCT04632264|Oxytocin|oxytocin|mesh-list
55957833|NCT01808547|Analgesics|analgesics|mesh-ancestor
55957834|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
55957835|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957836|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957837|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55957838|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957839|NCT00187655|Cefotaxime|cefotaxime|mesh-list
55957840|NCT00187655|Cefoxitin|cefoxitin|mesh-list
55957841|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55957843|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55957844|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957845|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55957846|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957847|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957848|NCT02579616|Lenvatinib|lenvatinib|mesh-list
55957849|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957850|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55957851|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881002|NCT03383328|Hormones|hormones|mesh-ancestor
55957852|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957853|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
55957854|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55957855|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
55957856|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55957857|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957858|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55957859|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55957860|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55957861|NCT05534802|Urinastatin|urinastatin|mesh-list
55957862|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55802960|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957863|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55957864|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
55957865|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000829|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000830|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957866|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957867|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55957868|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55957869|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957870|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55957871|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957873|NCT04666740|Olaparib|olaparib|mesh-list
55957874|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55957875|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957876|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55957877|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957878|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957879|NCT01790893|Aflibercept|aflibercept|mesh-list
55957880|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55957881|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55957882|NCT01790893|Growth Substances|growth substances|mesh-ancestor
55957883|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957884|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
55957885|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957886|NCT04123873|Acetaminophen|acetaminophen|mesh-list
55957887|NCT04123873|Dexamethasone|dexamethasone|mesh-list
55957888|NCT04123873|Ibuprofen|ibuprofen|mesh-list
55957889|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55957890|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
55957891|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
55957892|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957893|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957894|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957895|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
55957896|NCT04123873|Hormones|hormones|mesh-ancestor
55957897|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957898|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55957899|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957900|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55957901|NCT04123873|Analgesics|analgesics|mesh-ancestor
55957902|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
55957903|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
55957904|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55957905|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957906|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55957907|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957908|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957909|NCT02256111|Androgens|androgens|mesh-list
55957910|NCT02256111|Hormones|hormones|mesh-ancestor
55957911|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881366|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55881375|NCT03374280|Cisplatin|cisplatin|mesh-list
55957912|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957913|NCT01790971|Morphine|morphine|mesh-list
55957915|NCT01790971|Narcotics|narcotics|mesh-ancestor
55957916|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881409|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
55957917|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957918|NCT01790971|Analgesics|analgesics|mesh-ancestor
55957919|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
55957920|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957921|NCT00189137|Gemcitabine|gemcitabine|mesh-list
55957922|NCT00189137|Docetaxel|docetaxel|mesh-list
55957923|NCT00189137|Doxorubicin|doxorubicin|mesh-list
55957924|NCT00189137|Ifosfamide|ifosfamide|mesh-list
55957925|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55957926|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
55957927|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957928|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957929|NCT00189137|Antiviral Agents|antiviral agents|mesh-ancestor
55957930|NCT00189137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957931|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957932|NCT00189137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55957933|NCT00189137|Immunologic Factors|immunologic factors|mesh-ancestor
55881687|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55881688|NCT05609253|Itraconazole|itraconazole|mesh-list
55957934|NCT00189137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957935|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
55957936|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
56000831|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957937|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
55957938|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55957939|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55957940|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55957941|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55881748|NCT01593592|Amoxicillin|amoxicillin|mesh-list
55957942|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
55957943|NCT02099461|Denosumab|denosumab|mesh-list
55957944|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55957945|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957946|NCT04860960|Betadex|betadex|mesh-list
55957947|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
55957948|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957949|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55957950|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55957951|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957952|NCT02256189|Incretins|incretins|mesh-ancestor
55957953|NCT02256189|Hormones|hormones|mesh-ancestor
55881795|NCT01593748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957954|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957955|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55957956|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
55957957|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957958|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957959|NCT00193037|Docetaxel|docetaxel|mesh-list
55957960|NCT00193037|Doxorubicin|doxorubicin|mesh-list
55957961|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55957962|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957963|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
55957964|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
55957965|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
55957966|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957967|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55957968|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55881833|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55957969|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55957970|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957971|NCT02100007|Topotecan|topotecan|mesh-list
55957972|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55957973|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55957974|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957975|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957976|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957977|NCT05392764|Empagliflozin|empagliflozin|mesh-list
55957978|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55957979|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957980|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55957981|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957982|NCT02866383|Nivolumab|nivolumab|mesh-list
55957983|NCT02866383|Ipilimumab|ipilimumab|mesh-list
55957984|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55957985|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957986|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55957987|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958001|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55958002|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881961|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958003|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958004|NCT01763931|Protective Agents|protective agents|mesh-ancestor
55958005|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958006|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55958007|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958008|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958009|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55958010|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55958011|NCT04677114|Buprenorphine|buprenorphine|mesh-list
55958012|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55958014|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
55958015|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55958017|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000833|NCT00678574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55789885|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
55882011|NCT05035888|Protective Agents|protective agents|mesh-ancestor
55958018|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958019|NCT04677114|Analgesics|analgesics|mesh-ancestor
55958020|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
55958021|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958022|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55958023|NCT02783859|Amoxicillin|amoxicillin|mesh-list
55958024|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
55958025|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
55958026|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55958027|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55958028|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958029|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958030|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882079|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958031|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55958032|NCT01765803|Thioridazine|thioridazine|mesh-list
55958033|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55958034|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55958035|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958036|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958037|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958038|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55958039|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
55958040|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958041|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958042|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
55882131|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958043|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55958044|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
55958045|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958046|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958047|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55958048|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
55958060|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958061|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
55958062|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55958063|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55958064|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55958065|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958066|NCT01767285|Etonogestrel|etonogestrel|mesh-list
55958067|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55958068|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
55958069|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55958070|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958071|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55958072|NCT01465802|Doxycycline|doxycycline|mesh-list
55882179|NCT05672680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958073|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
55958074|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55958075|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958076|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
55958077|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55958078|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55958079|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958080|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
55958082|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958083|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958084|NCT01813149|Clonidine|clonidine|mesh-list
55958085|NCT01813149|Phenylephrine|phenylephrine|mesh-list
55958086|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
55958087|NCT01813149|Anesthetics|anesthetics|mesh-list
55958088|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
55958089|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958090|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882294|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958091|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
55958092|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958093|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55958094|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
55958095|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
55958096|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
55958097|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55958098|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
55958099|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
56000834|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56000835|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55958100|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55958101|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55958102|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55958103|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
55958104|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958105|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958106|NCT01813149|Protective Agents|protective agents|mesh-ancestor
55958108|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55958109|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
55958110|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55958111|NCT03787680|Olaparib|olaparib|mesh-list
55958112|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55958114|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958116|NCT00137969|Acetaminophen|acetaminophen|mesh-list
55958117|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
55958118|NCT00137969|Promethazine|promethazine|mesh-list
55882410|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958119|NCT00137969|Prednisone|prednisone|mesh-list
55958120|NCT00137969|Rituximab|rituximab|mesh-list
55958121|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958122|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958123|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
55958124|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958125|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958126|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958127|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
55958128|NCT00137969|Hormones|hormones|mesh-ancestor
55882472|NCT04525326|Growth Substances|growth substances|mesh-ancestor
55882476|NCT03357822|Tenofovir|tenofovir|mesh-list
55958129|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958130|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55958131|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55958132|NCT00137969|Analgesics|analgesics|mesh-ancestor
55958133|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
55958134|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958135|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
55958136|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55958137|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55958138|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958139|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
55958140|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
55958141|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
55958142|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
55882523|NCT03123276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050291|NCT03309657|Tazobactam|tazobactam|mesh-list
55958143|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55958144|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55958145|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
55958146|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
55958147|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958148|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958149|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55958150|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
55958151|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
55958152|NCT01437878|Iloprost|iloprost|mesh-list
55958153|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55882572|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55958154|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
55958155|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
55958156|NCT04767308|Fludarabine|fludarabine|mesh-list
55958157|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55958158|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
55958159|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958160|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958161|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55958162|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
55958163|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958164|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958165|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55958166|NCT00138125|Trastuzumab|trastuzumab|mesh-list
55958167|NCT00138125|Fulvestrant|fulvestrant|mesh-list
55958168|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958169|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958170|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55958171|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55882631|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958172|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56000836|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000837|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000838|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
56000839|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958173|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
55958174|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958175|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958176|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55958177|NCT01815333|Hematinics|hematinics|mesh-ancestor
55958178|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55958179|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55958180|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
55958182|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55958183|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882679|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958185|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
55958186|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55958187|NCT00138203|Vorinostat|vorinostat|mesh-list
55958189|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55958190|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958191|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958192|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55958193|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55958194|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55958195|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958196|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958197|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55882729|NCT04509258|Mineral Oil|mineral oil|mesh-list
55958198|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55958199|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958200|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
55958201|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958202|NCT00194129|Valproic Acid|valproic acid|mesh-list
55958203|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
55958204|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
55958205|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958206|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958207|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958208|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
55958209|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55958210|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882787|NCT04444284|Vaccines|vaccines|mesh-list
55958211|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958212|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
55958213|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
55958214|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958215|NCT01817907|Trazodone|trazodone|mesh-list
55958216|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55958217|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55958218|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958219|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958220|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958221|NCT01817907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55958222|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55958223|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55958224|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958225|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958226|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
55882843|NCT03355716|Analgesics|analgesics|mesh-ancestor
55958227|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55958228|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
55958229|NCT01445678|Metronidazole|metronidazole|mesh-list
55958230|NCT01445678|Meropenem|meropenem|mesh-list
55958231|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958232|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55958233|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55958234|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55958236|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55958237|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55958238|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
55958239|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958240|NCT01818063|Paclitaxel|paclitaxel|mesh-list
55958241|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
55789893|NCT04882163|Growth Substances|growth substances|mesh-ancestor
55958242|NCT01818063|Carboplatin|carboplatin|mesh-list
55958243|NCT01818063|Doxorubicin|doxorubicin|mesh-list
55958244|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55958245|NCT01818063|Veliparib|veliparib|mesh-list
55958246|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55958247|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958248|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
55958249|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
55958250|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
55958251|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958252|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55958253|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
55958254|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958255|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958256|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55958257|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
55958258|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55958259|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55958260|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55958261|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55958262|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958265|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958266|NCT01465022|Estrogens|estrogens|mesh-list
55958267|NCT01465022|Progestins|progestins|mesh-list
55958268|NCT01465022|Hormones|hormones|mesh-ancestor
55958269|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958270|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958271|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55958272|NCT02258217|Hormones|hormones|mesh-ancestor
55958273|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958274|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958275|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
55958276|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958277|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958278|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55958279|NCT01464788|Argatroban|argatroban|mesh-list
55958280|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55958281|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55958282|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958283|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
55802995|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55958284|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55958285|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
55958286|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958287|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
55958288|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55958289|NCT01444898|Exenatide|exenatide|mesh-list
55958290|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55958291|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958292|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55958293|NCT01444898|Incretins|incretins|mesh-ancestor
55958294|NCT01444898|Hormones|hormones|mesh-ancestor
55958295|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050380|NCT01602380|Fulvestrant|fulvestrant|mesh-list
55958296|NCT00201773|Celecoxib|celecoxib|mesh-list
55958297|NCT00201773|Exemestane|exemestane|mesh-list
55958298|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55958299|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55958300|NCT00201773|Analgesics|analgesics|mesh-ancestor
55958301|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
55958302|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958303|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958304|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958305|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958306|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55958307|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55958308|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958309|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958310|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958311|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55958312|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55958313|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55958314|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
55958315|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958316|NCT00256217|Anastrozole|anastrozole|mesh-list
55958317|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55958318|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958319|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55958320|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55958321|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958322|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958323|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55958324|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
55958325|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958326|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958327|NCT05643066|Ketamine|ketamine|mesh-list
55958328|NCT05643066|Propofol|propofol|mesh-list
55958329|NCT05643066|Esketamine|esketamine|mesh-list
55958330|NCT05643066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55958331|NCT05643066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958332|NCT05643066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958333|NCT05643066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55883193|NCT00709098|Iloprost|iloprost|mesh-list
55958334|NCT05643066|Anesthetics, General|anesthetics, general|mesh-ancestor
55958336|NCT05643066|Analgesics|analgesics|mesh-ancestor
55958337|NCT05643066|Sensory System Agents|sensory system agents|mesh-ancestor
55958338|NCT05643066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958339|NCT05643066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55958340|NCT05643066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55958341|NCT05643066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55958342|NCT05643066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958343|NCT05643066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883246|NCT05585346|Hormones|hormones|mesh-ancestor
55958344|NCT05643066|Antidepressive Agents|antidepressive agents|mesh-ancestor
55958345|NCT05643066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958346|NCT01733745|Vitamins|vitamins|mesh-list
55958347|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55958348|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
55958349|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958350|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55958351|NCT00256451|Ethanol|ethanol|mesh-list
55958352|NCT00256451|Naltrexone|naltrexone|mesh-list
55958353|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55958354|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958355|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958356|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958357|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55883298|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55958358|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55958359|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
55958360|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958361|NCT03582618|Sorafenib|sorafenib|mesh-list
55958362|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958363|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55958364|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958365|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958366|NCT00257309|Tenecteplase|tenecteplase|mesh-list
55958367|NCT00257309|Clopidogrel|clopidogrel|mesh-list
55958368|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55883340|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55883341|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
55958369|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55958370|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55958371|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55958372|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
55958373|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958374|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958375|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958376|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55958377|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55958378|NCT01444742|Cytarabine|cytarabine|mesh-list
55958379|NCT01444742|Clofarabine|clofarabine|mesh-list
55883389|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
55958380|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55958381|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
55958382|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958383|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958384|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
55958385|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958386|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55958387|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
55958388|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958389|NCT01770483|Interferons|interferons|mesh-list
55958390|NCT01770483|Ribavirin|ribavirin|mesh-list
55958391|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
55958392|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
56000840|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55958393|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958394|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
55958395|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958396|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
55958397|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958398|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
55958399|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958400|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55958401|NCT00257933|Prednisolone|prednisolone|mesh-list
55958402|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55958403|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
55958404|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55958405|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
55958406|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55958407|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
55958408|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958409|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
55958430|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958433|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958434|NCT03478878|Vitamin A|vitamin a|mesh-list
55958435|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
55958436|NCT03478878|Vitamins|vitamins|mesh-ancestor
55958437|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
55958438|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958439|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
55958440|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958441|NCT03478878|Protective Agents|protective agents|mesh-ancestor
55958442|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55958443|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958444|NCT00264641|Insulin|insulin|mesh-list
55958445|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55958446|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55958447|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958448|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
55958449|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958450|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
55958451|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55958452|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55883491|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
55958453|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958454|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
55958455|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958456|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958457|NCT00266279|Capecitabine|capecitabine|mesh-list
55958458|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
55958459|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55958460|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
55958461|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958462|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958463|NCT01736085|Nicotine|nicotine|mesh-list
55958467|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958468|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55958469|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55958470|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
55958471|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958472|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958473|NCT00210353|Rituximab|rituximab|mesh-list
55958474|NCT00210353|Chlorambucil|chlorambucil|mesh-list
56050438|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958475|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958476|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958477|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
55958478|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958479|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958480|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55958481|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
55958482|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958483|NCT00267059|Lenalidomide|lenalidomide|mesh-list
55958484|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
55958485|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958486|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55958487|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55958488|NCT00267059|Growth Substances|growth substances|mesh-ancestor
55958489|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
55958490|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958491|NCT00213239|Remifentanil|remifentanil|mesh-list
55958492|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55958493|NCT00213239|Narcotics|narcotics|mesh-ancestor
55958494|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958495|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958496|NCT00213239|Analgesics|analgesics|mesh-ancestor
55958497|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
56050466|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55958498|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958499|NCT01444430|Budesonide|budesonide|mesh-list
55958500|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55958501|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958502|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55958503|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
55958504|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958505|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958506|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55958507|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
55958508|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
55958509|NCT01444430|Hormones|hormones|mesh-ancestor
55958510|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958511|NCT01774149|Diazepam|diazepam|mesh-list
55958512|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55958513|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
55958514|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
55958515|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
55958516|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958517|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958518|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55958519|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55958520|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958521|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55958522|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55958523|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55958524|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55958525|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958526|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55958527|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
55958528|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
55958529|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
55958530|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
55958531|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958532|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050511|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56050512|NCT02061683|Bimatoprost|bimatoprost|mesh-list
55958534|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55958535|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
55958536|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958539|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55958540|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
55958541|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958542|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958543|NCT00267293|Acetaminophen|acetaminophen|mesh-list
55958544|NCT00267293|Ibuprofen|ibuprofen|mesh-list
56050536|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
55883768|NCT04500678|Metformin|metformin|mesh-list
55958545|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55958546|NCT00267293|Analgesics|analgesics|mesh-ancestor
55958547|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
55958548|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958549|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958550|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
55958551|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55958552|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958553|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958554|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55958555|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958556|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958557|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55958558|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
55958559|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958560|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55958561|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958562|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55958563|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55958564|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55883890|NCT02506140|Aspirin|aspirin|mesh-list
55883891|NCT02506140|Clopidogrel|clopidogrel|mesh-list
56000841|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
56000842|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56000843|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56000844|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56000845|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000847|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
56000848|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
55958565|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958566|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
55958567|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958568|NCT02579382|Vesatolimod|vesatolimod|mesh-list
55958569|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
55958570|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958571|NCT01774851|Paclitaxel|paclitaxel|mesh-list
55958572|NCT01774851|Trastuzumab|trastuzumab|mesh-list
55958573|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55958574|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958575|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
55958576|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
55958577|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
55958578|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050545|NCT02018627|Incretins|incretins|mesh-ancestor
55958579|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958580|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
55958581|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
55958582|NCT02990013|Povidone|povidone|mesh-list
55958583|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55958584|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958585|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
55958586|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
55958587|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
55958588|NCT03440112|Clarithromycin|clarithromycin|mesh-list
55958589|NCT03440112|Flumazenil|flumazenil|mesh-list
55958590|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55958591|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958592|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55958593|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958594|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958595|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55958596|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55958597|NCT03440112|Antidotes|antidotes|mesh-ancestor
55958598|NCT03440112|Protective Agents|protective agents|mesh-ancestor
55958599|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958600|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
55958601|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
55958602|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958603|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55958604|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
55958605|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56050568|NCT01717898|Dactolisib|dactolisib|mesh-list
55958606|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56050570|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
55958607|NCT01775865|Analgesics|analgesics|mesh-ancestor
55958608|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
55958609|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958611|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958612|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958613|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55958614|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958615|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958616|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55958617|NCT01419236|Testosterone|testosterone|mesh-list
55958618|NCT01419236|Androgens|androgens|mesh-ancestor
55958619|NCT01419236|Hormones|hormones|mesh-ancestor
55958620|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803029|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
55958621|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958623|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958624|NCT01443026|Lycopene|lycopene|mesh-list
55958625|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958626|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
56000849|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000850|NCT02551692|Nicotine|nicotine|mesh-list
56000851|NCT02551692|Varenicline|varenicline|mesh-list
55958627|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958628|NCT01443026|Protective Agents|protective agents|mesh-ancestor
55958629|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958630|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55958631|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55958633|NCT01879371|Ibuprofen|ibuprofen|mesh-list
55958634|NCT01879371|Caffeine|caffeine|mesh-list
55958635|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55958636|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55958637|NCT01879371|Analgesics|analgesics|mesh-ancestor
55958638|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
55958639|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958640|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884482|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884498|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
55958641|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958642|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958643|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55958644|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958645|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958646|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55958647|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55958648|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55958649|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55958650|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
55958651|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958652|NCT03276468|Atezolizumab|atezolizumab|mesh-list
55958653|NCT03276468|Venetoclax|venetoclax|mesh-list
55958654|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
55958655|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958656|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958657|NCT01442714|Lenalidomide|lenalidomide|mesh-list
55958658|NCT01442714|Azacitidine|azacitidine|mesh-list
55958659|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
55958660|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958661|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55958662|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55958663|NCT01442714|Growth Substances|growth substances|mesh-ancestor
55958664|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
55958665|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958666|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55958667|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
55958668|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958669|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958670|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
55958671|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
55958672|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
55958673|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
55958674|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958675|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958676|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
55958677|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958678|NCT05501574|Tacrolimus|tacrolimus|mesh-list
55958679|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55958680|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
55958681|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803040|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
55958686|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
55958687|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55958688|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958689|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55958690|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55884635|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
55958691|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55958692|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958693|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958694|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958695|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55958696|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55958697|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56000852|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56000853|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
56050673|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000854|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000855|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000856|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56000857|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55958698|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
55958699|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884774|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
55958700|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958701|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55958702|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55958703|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
55958704|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55958705|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55958706|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
55958707|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
55958708|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
55958709|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958710|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
55958711|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958712|NCT01828515|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55958713|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55958714|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55884926|NCT02493192|Meperidine|meperidine|mesh-list
55884927|NCT02493192|Haloperidol|haloperidol|mesh-list
55884928|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
55884987|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55958715|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958716|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958717|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
55958718|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958719|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55958720|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55958721|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
55958722|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55958723|NCT01828593|Antibodies|antibodies|mesh-list
55958724|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
55958725|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958726|NCT01781169|Vitamin D|vitamin d|mesh-list
55958727|NCT01781169|Vitamins|vitamins|mesh-ancestor
55958728|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
55958729|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958730|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55958731|NCT00216125|Docetaxel|docetaxel|mesh-list
55958732|NCT00216125|Etoposide|etoposide|mesh-list
55884988|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55958733|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958734|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
55958735|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
55958736|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
55958737|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958738|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55958739|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55958740|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55958741|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958742|NCT01781403|Capecitabine|capecitabine|mesh-list
55958743|NCT01781403|Temozolomide|temozolomide|mesh-list
55958744|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55958745|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
55958746|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958747|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958748|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55958749|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
55958751|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55958760|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958761|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958762|NCT01898585|Vemurafenib|vemurafenib|mesh-list
55958763|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958764|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55958765|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000858|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
55958766|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958767|NCT00220961|Pioglitazone|pioglitazone|mesh-list
55958768|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55958769|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958770|NCT00222131|Esomeprazole|esomeprazole|mesh-list
55958771|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55958772|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55958773|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56050776|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56050778|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56050779|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
56050780|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56050781|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050782|NCT00354965|Amoxicillin|amoxicillin|mesh-list
56050783|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
56050784|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
56050785|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56050786|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56050787|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050788|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56050801|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
55958774|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958775|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958776|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55958777|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55958778|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55958779|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55958780|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
55958781|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050857|NCT05718869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55958782|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958783|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55958784|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
55958785|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958786|NCT01782963|Dexamethasone|dexamethasone|mesh-list
55958787|NCT01782963|Lenalidomide|lenalidomide|mesh-list
55958788|NCT01782963|Bortezomib|bortezomib|mesh-list
55958789|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958790|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
55958791|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
55958792|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958793|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958794|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55958795|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
55958796|NCT01782963|Hormones|hormones|mesh-ancestor
55958797|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958798|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55958799|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958800|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
55958801|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55958802|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55958803|NCT01782963|Growth Substances|growth substances|mesh-ancestor
55958804|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
55958805|NCT01829217|Sunitinib|sunitinib|mesh-list
55958806|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958807|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56051029|NCT02314403|Rituximab|rituximab|mesh-list
56051030|NCT02314403|Abatacept|abatacept|mesh-list
55885662|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
55958808|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55958809|NCT01829217|Growth Substances|growth substances|mesh-ancestor
55958810|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958811|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
55958812|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55958813|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958814|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958815|NCT05327751|Celecoxib|celecoxib|mesh-list
55958816|NCT05327751|Capecitabine|capecitabine|mesh-list
55958817|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55885798|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55958818|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
55958820|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958821|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55958822|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55958824|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
55958825|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958826|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958827|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885872|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
55958828|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958829|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55958830|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55958831|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958832|NCT02096861|Infliximab|infliximab|mesh-list
55958833|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
55958834|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55958835|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958836|NCT01829919|Paroxetine|paroxetine|mesh-list
55958837|NCT01829919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55958838|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55958839|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56000859|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56000860|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958840|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958841|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958842|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
55958843|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958844|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55958845|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
55958846|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958847|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56051091|NCT01749956|Antidotes|antidotes|mesh-ancestor
55958848|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55958849|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958850|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
55958851|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55958852|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55958853|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
55958854|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
55958855|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958856|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958857|NCT00226577|Gemcitabine|gemcitabine|mesh-list
55958858|NCT00226577|Pemetrexed|pemetrexed|mesh-list
55958859|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55958860|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
55958861|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958862|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958863|NCT00226577|Antiviral Agents|antiviral agents|mesh-ancestor
55886268|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958864|NCT00226577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958865|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958866|NCT00226577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55958867|NCT00226577|Immunologic Factors|immunologic factors|mesh-ancestor
55958868|NCT00226577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958869|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55958870|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55958871|NCT01830699|Triamcinolone|triamcinolone|mesh-list
55958872|NCT01830699|Rilonacept|rilonacept|mesh-list
55958873|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958874|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
55958875|NCT01830699|Hormones|hormones|mesh-ancestor
55958876|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958877|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958878|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
55958879|NCT00280241|Rituximab|rituximab|mesh-list
55886328|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
55958880|NCT00280241|Fludarabine|fludarabine|mesh-list
55958881|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55958882|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
55958883|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958884|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958885|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55958886|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
55958887|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958888|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958889|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55958890|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958905|NCT00281021|Digoxin|digoxin|mesh-list
55958906|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958907|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55958908|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958909|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958911|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55958912|NCT00281021|Protective Agents|protective agents|mesh-ancestor
55958913|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958914|NCT01786161|Vancomycin|vancomycin|mesh-list
55958915|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55958916|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958917|NCT01786239|Risperidone|risperidone|mesh-list
55958918|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55958919|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
55958921|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958922|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958923|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55958924|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56000861|NCT00542542|Fentanyl|fentanyl|mesh-list
56000862|NCT00542542|Midazolam|midazolam|mesh-list
56000863|NCT00542542|Propofol|propofol|mesh-list
55958925|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55958926|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55958927|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55958928|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
55958929|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
55958930|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
55958931|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958932|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958933|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55958934|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
55958935|NCT01833741|Bimatoprost|bimatoprost|mesh-list
55958936|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55958937|NCT02261727|Prednisone|prednisone|mesh-list
55958938|NCT02261727|Cortisone|cortisone|mesh-list
55958939|NCT02261727|Theophylline|theophylline|mesh-list
55958940|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958941|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
55958942|NCT02261727|Hormones|hormones|mesh-ancestor
55958943|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958944|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958945|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886810|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
55886811|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
55958946|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958947|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55958948|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
55958949|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958950|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55958951|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
55958952|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55958956|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55958957|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55958958|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
55958959|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55958960|NCT02261805|Doxorubicin|doxorubicin|mesh-list
55958961|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55958962|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958963|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55958964|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55958965|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886940|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
55886943|NCT01783054|Antiviral Agents|antiviral agents|mesh-ancestor
55958966|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958967|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55958968|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55958969|NCT05300841|Estradiol|estradiol|mesh-list
55958970|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55958971|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
55958972|NCT05300841|Estrogens|estrogens|mesh-ancestor
55958973|NCT05300841|Hormones|hormones|mesh-ancestor
55958974|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958975|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958976|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55958977|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
55887092|NCT02470026|Yohimbine|yohimbine|mesh-list
55958978|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55958979|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55958980|NCT05300841|Progestins|progestins|mesh-ancestor
55958981|NCT00232505|Carboplatin|carboplatin|mesh-list
55958983|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958984|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958985|NCT00232583|Metformin|metformin|mesh-list
55958986|NCT00232583|Pioglitazone|pioglitazone|mesh-list
55958987|NCT00232583|Glyburide|glyburide|mesh-list
55958988|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55958989|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958990|NCT00232739|Sirolimus|sirolimus|mesh-list
55958991|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55958992|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958993|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55958994|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958995|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
55958996|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55958998|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958999|NCT01789905|Tigecycline|tigecycline|mesh-list
55887262|NCT01800838|Silicon|silicon|mesh-list
55959000|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55959001|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000865|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55959002|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55959003|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959004|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959005|NCT01790685|Dexamethasone|dexamethasone|mesh-list
55959006|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959007|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
55959008|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
55959009|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959010|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959011|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959012|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
55959013|NCT01790685|Hormones|hormones|mesh-ancestor
55959014|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56051356|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56051357|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051358|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
56051359|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
55959015|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55959016|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959017|NCT01838655|Nitisinone|nitisinone|mesh-list
55959018|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959019|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959020|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55959021|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
55803070|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
55959022|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959023|NCT00282971|Insulin|insulin|mesh-list
55959024|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55959025|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959026|NCT01791465|Exenatide|exenatide|mesh-list
55959027|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55959031|NCT01791465|Hormones|hormones|mesh-ancestor
55959032|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55959033|NCT04518319|Olanzapine|olanzapine|mesh-list
55959034|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
55959035|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
55959036|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959037|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959038|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959039|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55959040|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55887495|NCT05166876|Brequinar|brequinar|mesh-list
55959041|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959042|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55959043|NCT04518319|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55959044|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55887534|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
55959045|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55959046|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959047|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959048|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
55959049|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55959050|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55959051|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959052|NCT00285467|Vitamin D|vitamin d|mesh-list
55959053|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
55959054|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
55959055|NCT00285467|Vitamins|vitamins|mesh-ancestor
55959056|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
55887701|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
55959057|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959058|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55959059|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55887770|NCT05422534|Ubiquinone|ubiquinone|mesh-list
55959060|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55959061|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
55887838|NCT03303924|Sulbactam|sulbactam|mesh-list
55959062|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959063|NCT05261321|Dronabinol|dronabinol|mesh-list
55959064|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
55959065|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959066|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55959067|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55959068|NCT05261321|Analgesics|analgesics|mesh-ancestor
55959069|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
55887900|NCT05224336|Niacin|niacin|mesh-list
55959070|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959071|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55959072|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55959074|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959075|NCT05261321|Hormones|hormones|mesh-ancestor
55959076|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213219|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213220|NCT02567409|Antiviral Agents|antiviral agents|mesh-ancestor
55789915|NCT04881851|Inositol|inositol|mesh-list
55959077|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
55959078|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959079|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959080|NCT01794039|Dexamethasone|dexamethasone|mesh-list
55959081|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
55959082|NCT01794039|Lenalidomide|lenalidomide|mesh-list
55959083|NCT01794039|Pomalidomide|pomalidomide|mesh-list
55959084|NCT01794039|Ichthammol|ichthammol|mesh-list
55959085|NCT01794039|BB 1101|bb 1101|mesh-list
55959086|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959087|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
55959088|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
55959089|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959090|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959091|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959092|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
55959093|NCT01794039|Hormones|hormones|mesh-ancestor
55959094|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55959095|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55959096|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959097|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
55959098|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55959099|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55959100|NCT01794039|Growth Substances|growth substances|mesh-ancestor
55959111|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
55888265|NCT05707962|Sensory System Agents|sensory system agents|mesh-ancestor
55888266|NCT05707962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888267|NCT05707962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888268|NCT05707962|Anesthetics|anesthetics|mesh-ancestor
55959112|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959113|NCT00281827|Antiviral Agents|antiviral agents|mesh-ancestor
55959114|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959115|NCT00281827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959116|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959117|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
55959118|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959119|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
55959120|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55959121|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55959122|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55959123|NCT00281827|Growth Substances|growth substances|mesh-ancestor
55959124|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
55959125|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
55959126|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55959127|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959128|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051654|NCT01312922|Dexetimide|dexetimide|mesh-list
56051746|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
56051747|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959129|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55959130|NCT01898819|Analgesics|analgesics|mesh-ancestor
55959131|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
55959132|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959133|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55959134|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55959135|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55959136|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
55959137|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888519|NCT04745130|Cetuximab|cetuximab|mesh-list
55959138|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959139|NCT01794741|Fluticasone|fluticasone|mesh-list
55959140|NCT01794741|Xhance|xhance|mesh-list
55959141|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959142|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55959143|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
55959144|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959145|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888577|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55959146|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55959147|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
55959148|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
55959149|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55959151|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888690|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55959152|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959153|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
55959154|NCT04085419|Denosumab|denosumab|mesh-list
55959155|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55959156|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213221|NCT02567409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213222|NCT02567409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959158|NCT02989623|Trace Elements|trace elements|mesh-ancestor
55959159|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
55959160|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959161|NCT00052429|Fluorouracil|fluorouracil|mesh-list
55959162|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959163|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
55959164|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959165|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55959166|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959177|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
55959178|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959179|NCT00287053|Valproic Acid|valproic acid|mesh-list
55959180|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
55959181|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959182|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959183|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
55959184|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959185|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959186|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
55959187|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55959188|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959189|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55959190|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55959191|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55959192|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55959193|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55959194|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55959195|NCT01435460|Analgesics|analgesics|mesh-ancestor
55959196|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
55959197|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959198|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959199|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959200|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959201|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55959202|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55959203|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
55959204|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
55959205|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959206|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959207|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
55959208|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55959209|NCT00236951|Hematinics|hematinics|mesh-ancestor
55959210|NCT00287287|Lenalidomide|lenalidomide|mesh-list
55959211|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
55959212|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959213|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55889046|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55959214|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55959215|NCT00287287|Growth Substances|growth substances|mesh-ancestor
55959216|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
55959217|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959219|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55959220|NCT04871061|Narcotics|narcotics|mesh-ancestor
55959221|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959222|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959223|NCT04871061|Analgesics|analgesics|mesh-ancestor
55959224|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
56052024|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
55959225|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959226|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55959227|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55959228|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
55959229|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
55959231|NCT00287989|Carboplatin|carboplatin|mesh-list
55959232|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55959233|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55889164|NCT03283605|Tremelimumab|tremelimumab|mesh-list
55889165|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55889166|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889167|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
55889168|NCT01896544|Vitamin D|vitamin d|mesh-list
55889169|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55959235|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
55959236|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
55959237|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
55959238|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959239|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213223|NCT02567409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56213224|NCT02567409|Immunologic Factors|immunologic factors|mesh-ancestor
55959240|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959241|NCT00288067|Rituximab|rituximab|mesh-list
55959242|NCT00288067|Fenretinide|fenretinide|mesh-list
55959243|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959244|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959245|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
55959246|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052046|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
56052047|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56052050|NCT00357305|Cytarabine|cytarabine|mesh-list
55959247|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959248|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55959249|NCT00288067|Protective Agents|protective agents|mesh-ancestor
55959250|NCT00285779|Etanercept|etanercept|mesh-list
55959251|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55959252|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55959253|NCT00285779|Analgesics|analgesics|mesh-ancestor
55959254|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
55959255|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959256|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959257|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959258|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959259|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959260|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959261|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
55959262|NCT04827537|Metronidazole|metronidazole|mesh-list
55959263|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959264|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55959265|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55959266|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55959267|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55959268|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
55959269|NCT04728087|Coagulants|coagulants|mesh-ancestor
55959270|NCT01435382|Bococizumab|bococizumab|mesh-list
55959271|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55959272|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55959273|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
55959274|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959275|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55959276|NCT01801449|Rilonacept|rilonacept|mesh-list
55959277|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959278|NCT00286325|Rituximab|rituximab|mesh-list
55959279|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959280|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959281|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
55959282|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889459|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
55959283|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959284|NCT00238355|Voriconazole|voriconazole|mesh-list
55959285|NCT00238355|Caspofungin|caspofungin|mesh-list
55959286|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
55959287|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959288|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55959289|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55959290|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959291|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959292|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55959294|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55959295|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959296|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55959297|NCT01791439|Lidocaine|lidocaine|mesh-list
55959298|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
55959299|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
55959300|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959301|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959302|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
55959303|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959304|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55959305|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55959306|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55889779|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959307|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55959308|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959310|NCT01650701|Lenalidomide|lenalidomide|mesh-list
55959311|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56213225|NCT02567409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213226|NCT02496663|Osimertinib|osimertinib|mesh-list
56213227|NCT02496663|Necitumumab|necitumumab|mesh-list
56213228|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55889838|NCT01915108|Analgesics|analgesics|mesh-ancestor
55959312|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959313|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959314|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
55959315|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959316|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959317|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55959318|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55959319|NCT01650701|Growth Substances|growth substances|mesh-ancestor
55959320|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
55959321|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55959322|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
55959323|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959324|NCT00290329|Vaccines|vaccines|mesh-list
55959325|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
55959326|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959327|NCT04058678|Danazol|danazol|mesh-list
55959328|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56052358|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
56052359|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052360|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
55959329|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
55959330|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55959331|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959332|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55959333|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55959334|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55959335|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55959336|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959337|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
55959338|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959339|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959340|NCT00287339|Esomeprazole|esomeprazole|mesh-list
55959341|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55959342|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959343|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55959344|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890249|NCT04273035|Midazolam|midazolam|mesh-list
55959345|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959346|NCT00291655|Levetiracetam|levetiracetam|mesh-list
55959347|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
55959348|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
55959349|NCT01846455|Promethazine|promethazine|mesh-list
55959350|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
55959351|NCT01846455|Buprenorphine|buprenorphine|mesh-list
55890412|NCT01730729|Cabergoline|cabergoline|mesh-list
55959352|NCT01846455|Naloxone|naloxone|mesh-list
55959353|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55959354|NCT01846455|Narcotics|narcotics|mesh-ancestor
55890546|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
55959355|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959356|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959357|NCT01846455|Analgesics|analgesics|mesh-ancestor
55959358|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
55959359|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959361|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
55959362|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
55890571|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959363|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55959364|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
55959365|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
55959366|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959367|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959368|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55959369|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55959370|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55890639|NCT04272567|Norepinephrine|norepinephrine|mesh-list
55959371|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
55959372|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
55959373|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
55959374|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
55959375|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959376|NCT03366415|Gemcitabine|gemcitabine|mesh-list
55959377|NCT03366415|Cisplatin|cisplatin|mesh-list
55959378|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959379|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56213229|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959380|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
55959381|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959382|NCT03366415|Antiviral Agents|antiviral agents|mesh-ancestor
55959384|NCT03366415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959385|NCT03366415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959386|NCT03366415|Immunologic Factors|immunologic factors|mesh-ancestor
55959387|NCT03366415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959388|NCT00292591|Vitamin D|vitamin d|mesh-list
55959389|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
55959390|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
55959391|NCT00292591|Vitamins|vitamins|mesh-list
55890908|NCT02611323|Venetoclax|venetoclax|mesh-list
55890911|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
55959392|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
55959393|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959394|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55959395|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55959396|NCT01847001|Paclitaxel|paclitaxel|mesh-list
55959397|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55959398|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
55959399|NCT01847001|Doxorubicin|doxorubicin|mesh-list
55959400|NCT01847001|Trastuzumab|trastuzumab|mesh-list
55959401|NCT01847001|Pertuzumab|pertuzumab|mesh-list
55959402|NCT01847001|Propranolol|propranolol|mesh-list
55890999|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891051|NCT01928290|Antidotes|antidotes|mesh-ancestor
55959403|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55959404|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959405|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
55891158|NCT05733286|Suvorexant|suvorexant|mesh-list
55959406|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
55891250|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55959407|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
55959408|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959409|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959410|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
55959411|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959412|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959413|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55959414|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
55891358|NCT02721537|Niacinamide|niacinamide|mesh-list
55891359|NCT02721537|Niacin|niacin|mesh-list
55959415|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55959416|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55959417|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55959418|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55959419|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959420|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959421|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55959422|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55959423|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
55959424|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959425|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55959426|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56052850|NCT02306694|Factor VIII|factor viii|mesh-list
55891378|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55959427|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
55959428|NCT01847469|Zonisamide|zonisamide|mesh-list
55959429|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
55959430|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55959431|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55891448|NCT02986906|Hormones|hormones|mesh-ancestor
55959432|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959433|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55959435|NCT01804101|Cytarabine|cytarabine|mesh-list
55959436|NCT01804101|Daunorubicin|daunorubicin|mesh-list
55959437|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55959438|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
55959439|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959440|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959441|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
55959442|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959443|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959444|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
55959445|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959446|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55959447|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55891612|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959448|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55959449|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959450|NCT00287729|Pirfenidone|pirfenidone|mesh-list
55959451|NCT00287729|Analgesics|analgesics|mesh-ancestor
55959452|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
55803107|NCT05678959|Immunologic Factors|immunologic factors|mesh-ancestor
55959453|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959454|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213230|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213231|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213232|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213233|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213234|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
55959455|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55959456|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55959457|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959458|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959461|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959462|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959464|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55959465|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
55959466|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
55959467|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891804|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55959468|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55959469|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959471|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959472|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55959473|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959474|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959475|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
55959476|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55959477|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
55959478|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959479|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959480|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55959481|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
55959482|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56052950|NCT04889664|Ketamine|ketamine|mesh-list
55959483|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
55959484|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959485|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959486|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55959487|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
55959488|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
55959489|NCT04069052|Protective Agents|protective agents|mesh-ancestor
55959490|NCT01727193|Azathioprine|azathioprine|mesh-list
55959491|NCT01727193|Leflunomide|leflunomide|mesh-list
55959492|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
55959493|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959494|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55959495|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959496|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959497|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
55959498|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959499|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959500|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959501|NCT00181701|Paclitaxel|paclitaxel|mesh-list
55959502|NCT00181701|Carboplatin|carboplatin|mesh-list
55959503|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55959504|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053085|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959505|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
55959506|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
55959507|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
55959508|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959509|NCT01849419|Oxytocin|oxytocin|mesh-list
55959510|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
55959511|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56053211|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959512|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959513|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
55959514|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55959515|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959516|NCT05098067|Ondansetron|ondansetron|mesh-list
55959517|NCT05098067|Metoclopramide|metoclopramide|mesh-list
55959518|NCT05098067|Capsaicin|capsaicin|mesh-list
55959519|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
55959520|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
56213235|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959521|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959522|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959523|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959524|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
55959525|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
55959526|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55959527|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
55959528|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959529|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959530|NCT05098067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55959531|NCT05098067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55959539|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55959540|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55959541|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55959542|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55959543|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959544|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959545|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959547|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
55959548|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959549|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
55959550|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55959551|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
55959552|NCT04272333|Nivolumab|nivolumab|mesh-list
55959553|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959554|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959555|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55959556|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959557|NCT02273115|Oxytocin|oxytocin|mesh-list
55959558|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
55959559|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55959560|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959561|NCT01853085|Bimatoprost|bimatoprost|mesh-list
55959562|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55959563|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55959564|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55959565|NCT02989467|Aprepitant|aprepitant|mesh-list
55959566|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
55959567|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
55959568|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959569|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959570|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959571|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55959572|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959573|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959574|NCT01853553|Spironolactone|spironolactone|mesh-list
55959575|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55959576|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
55959577|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55959578|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959579|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55959580|NCT01853553|Diuretics|diuretics|mesh-ancestor
55959581|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
55959582|NCT05748561|Methylprednisolone|methylprednisolone|mesh-list
55959583|NCT05748561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55959584|NCT05748561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55959586|NCT05748561|Prednisolone acetate|prednisolone acetate|mesh-list
55959587|NCT05748561|Epoetin Alfa|epoetin alfa|mesh-list
55959588|NCT05748561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55959589|NCT05748561|Prednisolone phosphate|prednisolone phosphate|mesh-list
55959590|NCT05748561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959591|NCT05748561|Antiemetics|antiemetics|mesh-ancestor
55959592|NCT05748561|Autonomic Agents|autonomic agents|mesh-ancestor
55959593|NCT05748561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959594|NCT05748561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959595|NCT05748561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959596|NCT05748561|Glucocorticoids|glucocorticoids|mesh-ancestor
56213238|NCT02420821|Atezolizumab|atezolizumab|mesh-list
55959598|NCT05748561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55959602|NCT05748561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959603|NCT05748561|Hematinics|hematinics|mesh-ancestor
55959604|NCT00290537|Paclitaxel|paclitaxel|mesh-list
55959605|NCT00290537|Carboplatin|carboplatin|mesh-list
55959606|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55959607|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959608|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
55959609|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
55959610|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
55959611|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959612|NCT05748483|Topiramate|topiramate|mesh-list
55959613|NCT05748483|Anticonvulsants|anticonvulsants|mesh-ancestor
55959614|NCT05748483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55959615|NCT05748483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959616|NCT00290615|Bevacizumab|bevacizumab|mesh-list
55959617|NCT00290615|Cetuximab|cetuximab|mesh-list
55959618|NCT00290615|Capecitabine|capecitabine|mesh-list
55959619|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
55959620|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959621|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959622|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55959623|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55893383|NCT03288402|Caffeine|caffeine|mesh-list
55959624|NCT00290615|Growth Substances|growth substances|mesh-ancestor
55959625|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959626|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
55959627|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55959628|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
55893602|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
55959629|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959630|NCT01854177|Aprepitant|aprepitant|mesh-list
55959631|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
55959632|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
55959633|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
55959634|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959635|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959636|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959637|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55959638|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959639|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959640|NCT01591577|Temozolomide|temozolomide|mesh-list
55959641|NCT01591577|Lapatinib|lapatinib|mesh-list
55959642|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55893785|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
56053686|NCT00552110|Phenylephrine|phenylephrine|mesh-list
55959643|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
55959644|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959645|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959646|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55959647|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959648|NCT03858231|Acetaminophen|acetaminophen|mesh-list
55959649|NCT03858231|Ibuprofen|ibuprofen|mesh-list
55959650|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55959651|NCT03858231|Analgesics|analgesics|mesh-ancestor
55959652|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
55959653|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959654|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959655|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
55959656|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55959657|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959658|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894094|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55894095|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894096|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959659|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55959660|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959661|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959662|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
55959663|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959664|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55959665|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959666|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959667|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
55959668|NCT00299221|Tacrolimus|tacrolimus|mesh-list
55959669|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959670|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
55959671|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894220|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
55959674|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959675|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56213239|NCT02420821|Antibodies|antibodies|mesh-list
56213240|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56213241|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959676|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959677|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55959678|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
55959679|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55959680|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959681|NCT03799731|Trifluridine|trifluridine|mesh-list
55959682|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
55959683|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959684|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
55959685|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959686|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
55959687|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959688|NCT00244985|Rituximab|rituximab|mesh-list
55959689|NCT00244985|Doxorubicin|doxorubicin|mesh-list
55894301|NCT01219257|Etanercept|etanercept|mesh-list
55959690|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55959691|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959692|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959693|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
55959694|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959695|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959696|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55959697|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55959698|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55959699|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959700|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894356|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
55894361|NCT01542879|Hematinics|hematinics|mesh-ancestor
55959701|NCT01857297|Vaccines|vaccines|mesh-list
55959702|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
55959703|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959704|NCT00300391|Haloperidol|haloperidol|mesh-list
55959705|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
55959706|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
55959707|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
55959708|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959709|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959710|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959711|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55959712|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55959713|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959714|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55959715|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55959716|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
55959717|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959718|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959719|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55959720|NCT01859013|Topiramate|topiramate|mesh-list
55959721|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
55959722|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55959723|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959724|NCT05748171|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56053886|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56053894|NCT04004481|Tramadol|tramadol|mesh-list
55959725|NCT05748171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959726|NCT05748171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959727|NCT05748171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55959728|NCT05748093|Cobicistat|cobicistat|mesh-list
55959729|NCT05748093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55959730|NCT05748093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55959731|NCT05748093|Antiviral Agents|antiviral agents|mesh-ancestor
55959732|NCT05748093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803116|NCT05678647|Trace Elements|trace elements|mesh-ancestor
55959734|NCT05748093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55959735|NCT05748093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959736|NCT05748093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959737|NCT00294515|Valganciclovir|valganciclovir|mesh-list
55959738|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
55959739|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959740|NCT00300469|Atorvastatin|atorvastatin|mesh-list
55959741|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55959742|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55959743|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
55894457|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959744|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213242|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213243|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55959748|NCT01543763|Abexinostat|abexinostat|mesh-list
55959749|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55959750|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959751|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959752|NCT01859637|Lenograstim|lenograstim|mesh-list
55959753|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55959754|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
55959755|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959756|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
55959757|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55959758|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
55959759|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959760|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959761|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55959762|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55959763|NCT02117141|Hydrocodone|hydrocodone|mesh-list
55959764|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55959765|NCT02117141|Narcotics|narcotics|mesh-ancestor
55959766|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959767|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959768|NCT02117141|Analgesics|analgesics|mesh-ancestor
55959769|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
55959770|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959771|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
55959772|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
55959774|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959775|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55959776|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55959777|NCT00299741|Growth Substances|growth substances|mesh-ancestor
55959778|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959779|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
55959780|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55959781|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959782|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959783|NCT00328861|Aldesleukin|aldesleukin|mesh-list
55959784|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
55959785|NCT00328861|Fludarabine|fludarabine|mesh-list
55959786|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55959787|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
55959788|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053973|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56053975|NCT02988440|Spartalizumab|spartalizumab|mesh-list
55959789|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959790|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55959791|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
55959792|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959793|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959795|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55959796|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55959797|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
55959798|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959799|NCT00248807|Enalaprilat|enalaprilat|mesh-list
55959801|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55959802|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
56053985|NCT00550550|Prednisone|prednisone|mesh-list
55959803|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959804|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959805|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55959807|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55959808|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
55959809|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959810|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959811|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55959812|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
55959813|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55959814|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894795|NCT03250962|Decitabine|decitabine|mesh-list
55959815|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959816|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55959817|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
55959818|NCT00330421|Sorafenib|sorafenib|mesh-list
56213244|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55894855|NCT03254784|BMS-986165|bms-986165|mesh-list
56213245|NCT02420821|Growth Substances|growth substances|mesh-ancestor
55959819|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959820|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55959821|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959822|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959823|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
55959824|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55959825|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55959826|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959827|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
55959828|NCT04350645|Coagulants|coagulants|mesh-ancestor
55959829|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55959830|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55894961|NCT03247413|Hormones|hormones|mesh-ancestor
55959831|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55959832|NCT00330733|Analgesics|analgesics|mesh-ancestor
55959833|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
55959834|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959835|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959836|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959837|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959838|NCT01861665|Bupivacaine|bupivacaine|mesh-list
55959839|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
55959840|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
55959841|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959842|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959843|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
55959844|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959845|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
55959846|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55959847|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959848|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55894989|NCT02025634|Analgesics|analgesics|mesh-ancestor
55959849|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55959850|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959851|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959852|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959853|NCT05185973|Micronutrients|micronutrients|mesh-list
55959854|NCT05185973|Trace Elements|trace elements|mesh-list
55959855|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959856|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
55959857|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55959858|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959859|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
55959860|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55959861|NCT00251225|Docetaxel|docetaxel|mesh-list
55895114|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959862|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
55959863|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959864|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
55959865|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
55895177|NCT03241914|Megestrol|megestrol|mesh-list
55959866|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
55959867|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959868|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55959869|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959870|NCT02979327|Adderall|adderall|mesh-list
55959871|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55959872|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959873|NCT00251303|Riluzole|riluzole|mesh-list
55959874|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
55959875|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55959876|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55959877|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959878|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959879|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959881|NCT00251303|Protective Agents|protective agents|mesh-ancestor
55959882|NCT05747625|Panitumumab|panitumumab|mesh-list
55959883|NCT05747625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959884|NCT05747625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959885|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
55959886|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
55959887|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959888|NCT00303823|Protective Agents|protective agents|mesh-ancestor
55895278|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
56213246|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213247|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
56213248|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
56213249|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213250|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213251|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213252|NCT02398773|Estradiol|estradiol|mesh-list
56213253|NCT02398773|Estrogens|estrogens|mesh-ancestor
56213254|NCT02398773|Hormones|hormones|mesh-ancestor
56213255|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213256|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213257|NCT02229084|Paclitaxel|paclitaxel|mesh-list
56213258|NCT02229084|Docetaxel|docetaxel|mesh-list
56213259|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
56213260|NCT02229084|Doxorubicin|doxorubicin|mesh-list
56213261|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56213262|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
56213263|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55959889|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959890|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55959898|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55959899|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895378|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55895386|NCT03238482|Hormones|hormones|mesh-ancestor
55895444|NCT02454426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56054204|NCT01882868|Protective Agents|protective agents|mesh-ancestor
56054205|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
56054206|NCT01882868|Vitamins|vitamins|mesh-ancestor
56054207|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
55959900|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959901|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55959902|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
55959903|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55959904|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959905|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55959906|NCT00559845|Paclitaxel|paclitaxel|mesh-list
55959907|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
55959908|NCT00559845|Bevacizumab|bevacizumab|mesh-list
55959909|NCT00559845|Fluorouracil|fluorouracil|mesh-list
55959910|NCT00559845|Epirubicin|epirubicin|mesh-list
55959911|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55959912|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959913|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
55959914|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
55959915|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
55959916|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959917|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054208|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
55959918|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
55959919|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959920|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55959921|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55959922|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
55959923|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55959924|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55959925|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55895489|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55895490|NCT03240120|Dalteparin|dalteparin|mesh-list
55895491|NCT03240120|Dabigatran|dabigatran|mesh-list
55895492|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
55959926|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55959927|NCT00559845|Growth Substances|growth substances|mesh-ancestor
55959928|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
55959929|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
55959930|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55959931|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55959932|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55959933|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55895508|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213264|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213265|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
55959934|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959935|NCT00304187|Erythromycin|erythromycin|mesh-list
55959936|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
55959937|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55959938|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
55959939|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55959940|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959941|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959942|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55959943|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895548|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
55895549|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55959944|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959945|NCT02261883|Treprostinil|treprostinil|mesh-list
55959946|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55959947|NCT00334633|Metronidazole|metronidazole|mesh-list
55959948|NCT00334633|Tinidazole|tinidazole|mesh-list
55959949|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959950|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55959951|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55959952|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55959953|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
55959954|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959955|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55959957|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
55959958|NCT01393964|Lenalidomide|lenalidomide|mesh-list
55959959|NCT01393964|Elotuzumab|elotuzumab|mesh-list
55959970|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55959971|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959972|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
55959973|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959974|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959975|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
55959976|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55959977|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55959978|NCT01393964|Growth Substances|growth substances|mesh-ancestor
55959979|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
55959981|NCT01790555|Dronabinol|dronabinol|mesh-list
55959982|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55959983|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
55959984|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
55959985|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
55959986|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959987|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959988|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959989|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55959990|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959991|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55959992|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55959993|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55959994|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55959995|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55959996|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55959997|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
55959998|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
55959999|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
55960000|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
55960001|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960002|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960003|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
55960004|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55960005|NCT01790555|Analgesics|analgesics|mesh-ancestor
55960006|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
55960007|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55960008|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55960009|NCT01790555|Hormones|hormones|mesh-ancestor
55960010|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960011|NCT00335725|Hormones|hormones|mesh-list
55960012|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55960013|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960014|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960015|NCT01393730|Prednisone|prednisone|mesh-list
55960016|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
55960017|NCT01393730|Dutasteride|dutasteride|mesh-list
55895771|NCT00061893|Analgesics|analgesics|mesh-ancestor
55960018|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56213266|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
56213267|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
56213268|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213269|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960019|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
55960020|NCT01393730|Hormones|hormones|mesh-ancestor
55960021|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960022|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960023|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55960024|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960026|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960027|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960028|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
55960029|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55960030|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55960031|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
55960032|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55960033|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895864|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
55960034|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55960035|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
55960036|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55803150|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
55960037|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960038|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960039|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960040|NCT00337987|Prednisone|prednisone|mesh-list
55960041|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
55960042|NCT00337987|Vincristine|vincristine|mesh-list
55960043|NCT00337987|Doxorubicin|doxorubicin|mesh-list
55960044|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55960045|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
55960046|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960047|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
55960048|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960049|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55960050|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55960051|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
55895927|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
55895931|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
55960052|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960053|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960054|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55960055|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55960056|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
55960057|NCT00337987|Hormones|hormones|mesh-ancestor
55960058|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960059|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55960060|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55960061|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
55895958|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960062|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
55960063|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
55960064|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55960065|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55960066|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55960067|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960068|NCT01393106|Idelalisib|idelalisib|mesh-list
55960069|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960070|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960071|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960072|NCT00553059|Dexamethasone|dexamethasone|mesh-list
55960073|NCT00553059|Dronabinol|dronabinol|mesh-list
55960074|NCT00553059|Palonosetron|palonosetron|mesh-list
55896023|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
55960075|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55960076|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
55960077|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
55960078|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960079|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960080|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55960081|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
55960082|NCT00553059|Hormones|hormones|mesh-ancestor
55960083|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054430|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054431|NCT02298192|Incretins|incretins|mesh-ancestor
56054432|NCT02298192|Hormones|hormones|mesh-ancestor
55960084|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56213270|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
56213271|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960085|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960086|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55960087|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55960089|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960090|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960091|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
55960092|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55960093|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55960094|NCT00553059|Analgesics|analgesics|mesh-ancestor
55960095|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
55960096|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55960097|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55960101|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960102|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960104|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55960105|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
55960106|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960107|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960108|NCT02989311|Iron|iron|mesh-list
55960109|NCT02989311|Trace Elements|trace elements|mesh-ancestor
55960110|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
55960111|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960112|NCT00325403|Treprostinil|treprostinil|mesh-list
55960113|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56054503|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054504|NCT01189071|Darifenacin|darifenacin|mesh-list
56054505|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56054506|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56054507|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
56054512|NCT02515851|Bupivacaine|bupivacaine|mesh-list
56054513|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
55960114|NCT02015611|Vitamin D|vitamin d|mesh-list
55960115|NCT02015611|Vitamins|vitamins|mesh-ancestor
55960116|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
55960117|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960118|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55960119|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
55960120|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55960121|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55960122|NCT01413542|Enalaprilat|enalaprilat|mesh-list
55960123|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55960124|NCT01413542|Bradykinin|bradykinin|mesh-list
55960125|NCT01413542|Glucagon|glucagon|mesh-list
55960126|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55960127|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55960128|NCT01413542|Substance P|substance p|mesh-list
55960129|NCT01413542|Neurokinin A|neurokinin a|mesh-list
55960130|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55960131|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960132|NCT01413542|Incretins|incretins|mesh-ancestor
55960133|NCT01413542|Hormones|hormones|mesh-ancestor
55960134|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960135|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
55960136|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960137|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960138|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55960139|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
55960140|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
55960141|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55960142|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960143|NCT01873989|Testosterone|testosterone|mesh-list
55960144|NCT01873989|Androgens|androgens|mesh-ancestor
55960145|NCT01873989|Hormones|hormones|mesh-ancestor
55960146|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960147|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960148|NCT01875159|Caffeine|caffeine|mesh-list
55960149|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
55960150|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960151|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55960152|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960153|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55960154|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960155|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55960156|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55960157|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
55960158|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960159|NCT01432574|Vaccines|vaccines|mesh-list
55960160|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
56213272|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213273|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55960161|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960162|NCT04413617|Tofacitinib|tofacitinib|mesh-list
55960163|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55960164|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896352|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55960165|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960166|NCT00339079|Fluoxetine|fluoxetine|mesh-list
55960167|NCT00339079|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55960169|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55960170|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960173|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960174|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55960175|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
55960176|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55960177|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55960178|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55960179|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960181|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55960182|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960183|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56054568|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56054578|NCT00378027|PENTA|penta|mesh-list
55960184|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960186|NCT00342355|Lopinavir|lopinavir|mesh-list
55960187|NCT00342355|Lamivudine|lamivudine|mesh-list
55960188|NCT00342355|Zidovudine|zidovudine|mesh-list
55960189|NCT00342355|Didanosine|didanosine|mesh-list
55960190|NCT00342355|Stavudine|stavudine|mesh-list
55960191|NCT00342355|Efavirenz|efavirenz|mesh-list
55960192|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55960193|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55960194|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
55960195|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960196|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960197|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55960198|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55960199|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
55960200|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960201|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55960202|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55960203|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55960204|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55960205|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
55960206|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55896440|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55896441|NCT03221166|Growth Substances|growth substances|mesh-ancestor
55896442|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
55960207|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55960208|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55960209|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55960210|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55960211|NCT00306163|Fluticasone|fluticasone|mesh-list
55960212|NCT00306163|Ciclesonide|ciclesonide|mesh-list
55960213|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55960214|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55960215|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
55960216|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960217|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960218|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55960219|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
55960220|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
55960221|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55960222|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
55960223|NCT00306163|Hormones|hormones|mesh-ancestor
55960224|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960225|NCT00330161|Vorinostat|vorinostat|mesh-list
55960226|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960227|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55960228|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960230|NCT00552279|Vaccines|vaccines|mesh-list
55960231|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
55960232|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213274|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
56213275|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56213276|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55960233|NCT00309751|Atorvastatin|atorvastatin|mesh-list
55960234|NCT00309751|Pitavastatin|pitavastatin|mesh-list
55960235|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55960236|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55960237|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
55960238|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960239|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55960240|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55960241|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896479|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
55960242|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55960243|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960244|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960245|NCT02988999|Erythritol|erythritol|mesh-list
55960246|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
55960247|NCT00313729|Temozolomide|temozolomide|mesh-list
55960248|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55960249|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
55960250|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960251|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960252|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55960253|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55960254|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960256|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
55896490|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55960257|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55960258|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55960259|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960260|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960261|NCT05266651|Urological Agents|urological agents|mesh-ancestor
55960262|NCT05746689|Sirolimus|sirolimus|mesh-list
55960263|NCT05746689|Prednisone|prednisone|mesh-list
55960264|NCT05746689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55960265|NCT05746689|Glucocorticoids|glucocorticoids|mesh-ancestor
55960266|NCT05746689|Hormones|hormones|mesh-ancestor
55896541|NCT03206658|Diuretics|diuretics|mesh-ancestor
55960267|NCT05746689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960268|NCT05746689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960269|NCT05746689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55960270|NCT05746689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960271|NCT05746689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55960272|NCT05746689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960273|NCT05746689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55960274|NCT05746689|Antifungal Agents|antifungal agents|mesh-ancestor
55960275|NCT05746689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960276|NCT05746689|Immunologic Factors|immunologic factors|mesh-ancestor
55960277|NCT01412060|Cariprazine|cariprazine|mesh-list
55896611|NCT00176865|Melphalan|melphalan|mesh-list
55960278|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55960279|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55960280|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960281|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960282|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55960283|NCT00345865|Cytarabine|cytarabine|mesh-list
55960284|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
55960285|NCT00345865|Carmustine|carmustine|mesh-list
55960286|NCT00345865|Etoposide|etoposide|mesh-list
55896657|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960287|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960288|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
55960289|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960290|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55960291|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55960292|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
55960293|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960294|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960295|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55960296|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55960297|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55960298|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55960299|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960300|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56213277|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56213278|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56213280|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56213281|NCT02188121|Losartan|losartan|mesh-list
56213282|NCT02188121|Simvastatin|simvastatin|mesh-list
56213283|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56213284|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56213285|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
55960301|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
55960302|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
55960303|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960304|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55960305|NCT00551421|Cetuximab|cetuximab|mesh-list
55960306|NCT00551421|Pertuzumab|pertuzumab|mesh-list
55960307|NCT00551421|Irinotecan|irinotecan|mesh-list
55960308|NCT00551421|Antibodies|antibodies|mesh-list
55960309|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
55960310|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55960311|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
55960312|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960313|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960314|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55960315|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55960316|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960317|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960318|NCT01791751|Clomiphene|clomiphene|mesh-list
55960319|NCT01791751|Enclomiphene|enclomiphene|mesh-list
55960338|NCT05266261|Antacids|antacids|mesh-ancestor
55960339|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960340|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55960341|NCT04830813|Chiauranib|chiauranib|mesh-list
56054798|NCT03539744|Hormones|hormones|mesh-ancestor
56054799|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054800|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56054801|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054802|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
56054803|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55896808|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960342|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960343|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55960344|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960345|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960346|NCT05266105|Palbociclib|palbociclib|mesh-list
55960347|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960348|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55960349|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960350|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896855|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
55960351|NCT01891643|Dexamethasone|dexamethasone|mesh-list
55960352|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
55960353|NCT01891643|Lenalidomide|lenalidomide|mesh-list
55960354|NCT01891643|Elotuzumab|elotuzumab|mesh-list
55960355|NCT01891643|BB 1101|bb 1101|mesh-list
55960356|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55960357|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
55896924|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960358|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
55960359|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896926|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
55960360|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960361|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55960362|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
55960363|NCT01891643|Hormones|hormones|mesh-ancestor
55960364|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960365|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55960366|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960367|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
55960368|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960369|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960370|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
55960371|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55960372|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55960373|NCT01891643|Growth Substances|growth substances|mesh-ancestor
55960374|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
55960375|NCT05265793|Apatinib|apatinib|mesh-list
55960376|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960377|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55960379|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213286|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213287|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55960386|NCT04005599|Remifentanil|remifentanil|mesh-list
55960387|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56054841|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55960388|NCT04005599|Narcotics|narcotics|mesh-ancestor
55960389|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789719|NCT04884503|Clonazepam|clonazepam|mesh-list
55960390|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960391|NCT04005599|Analgesics|analgesics|mesh-ancestor
55960392|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
55960393|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960394|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
55960395|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55960396|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
55960397|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55960398|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55897003|NCT02387554|Diuretics|diuretics|mesh-ancestor
55897004|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
55960399|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960400|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55960401|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
55960402|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55960404|NCT00330863|Risperidone|risperidone|mesh-list
55960405|NCT00330863|Aripiprazole|aripiprazole|mesh-list
55960406|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55960407|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55960408|NCT00330863|Ziprasidone|ziprasidone|mesh-list
55960409|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55960410|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
55960411|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960412|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897059|NCT01740089|Ribavirin|ribavirin|mesh-list
55897060|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55897061|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
55960413|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960414|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55960415|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55960416|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960417|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55960418|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55960419|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
55960420|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
55960421|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
55960422|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960423|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55960424|NCT00330863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55960425|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55960426|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55960427|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
55960428|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
55960429|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55960430|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55960431|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55960432|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55960433|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
55960434|NCT01899521|Astringents|astringents|mesh-ancestor
55960435|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960436|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
55960437|NCT01790009|Acetaminophen|acetaminophen|mesh-list
55960438|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897092|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897095|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
55960439|NCT01790009|Analgesics|analgesics|mesh-ancestor
55960440|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
55960441|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960442|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960443|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
55960444|NCT05737329|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55960445|NCT05737329|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55960447|NCT05737329|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55960448|NCT05737329|Estrogens|estrogens|mesh-ancestor
55960449|NCT05737329|Hormones|hormones|mesh-ancestor
55960450|NCT05737329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960451|NCT05737329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960452|NCT05737329|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55960453|NCT05737329|Contraceptive Agents|contraceptive agents|mesh-ancestor
55960454|NCT05737329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897125|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960455|NCT05737329|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55960456|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
55960458|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
55960459|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960460|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
55960461|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55960462|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960463|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55897180|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55960464|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55897181|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960465|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960466|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960467|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960468|NCT05266937|Paclitaxel|paclitaxel|mesh-list
55960469|NCT05266937|Carboplatin|carboplatin|mesh-list
55960470|NCT05266937|Atezolizumab|atezolizumab|mesh-list
55960471|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55897235|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55960472|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960473|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
55960474|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
55960475|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
55960476|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960477|NCT00332579|Naltrexone|naltrexone|mesh-list
55960478|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55960479|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55960480|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960481|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
55897291|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960482|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960483|NCT00318409|Bupropion|bupropion|mesh-list
55960484|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55960485|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
55960486|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55960487|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55960488|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55960489|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55960490|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960491|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
55960492|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960493|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960494|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55960495|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55960496|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960497|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
55960498|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55960499|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960500|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56054983|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960501|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
55960502|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55960503|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960504|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960505|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960507|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55960508|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
55960509|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
55960510|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960511|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960512|NCT00353119|Etanercept|etanercept|mesh-list
55960513|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55960514|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55960515|NCT00353119|Analgesics|analgesics|mesh-ancestor
55960516|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
55960517|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960518|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960519|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56055009|NCT03723447|Dexamethasone|dexamethasone|mesh-list
55960520|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55960521|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55960522|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960523|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
55960524|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
55960525|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55960526|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960527|NCT04971187|Cisplatin|cisplatin|mesh-list
55960528|NCT04971187|Carboplatin|carboplatin|mesh-list
55960529|NCT04971187|Pemetrexed|pemetrexed|mesh-list
55960530|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213288|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56213289|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213290|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55960543|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960545|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897422|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
55960546|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960547|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55960548|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960549|NCT01792375|Dinoprostone|dinoprostone|mesh-list
55960550|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
55960551|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55960552|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960553|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55960554|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
55960555|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960563|NCT00320671|Risperidone|risperidone|mesh-list
55960564|NCT00320671|Aripiprazole|aripiprazole|mesh-list
55897473|NCT04938232|Ipilimumab|ipilimumab|mesh-list
55960565|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55960566|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
55960567|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960568|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960569|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960570|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55960571|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55897535|NCT05718934|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55960572|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960573|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55960574|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55960575|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
55960576|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
55960577|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
55960578|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55960579|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55960580|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55960581|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55960582|NCT00320749|Gemcitabine|gemcitabine|mesh-list
56055061|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
55960583|NCT00320749|Capecitabine|capecitabine|mesh-list
55960584|NCT00320749|Docetaxel|docetaxel|mesh-list
55960585|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55960586|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
55960587|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960588|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960589|NCT00320749|Antiviral Agents|antiviral agents|mesh-ancestor
55960603|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960604|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
55960605|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55960606|NCT01432262|Vaccines|vaccines|mesh-list
55960607|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55960608|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
55960609|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960610|NCT00322309|Mirtazapine|mirtazapine|mesh-list
55960611|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
55960612|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55960613|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55960614|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
56055075|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055076|NCT03701295|Azacitidine|azacitidine|mesh-list
55960615|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
55960616|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960617|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960618|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960619|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55960620|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55960621|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960622|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55960623|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55960624|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55960625|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
55960626|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55960629|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55960630|NCT04046744|Lidocaine|lidocaine|mesh-list
55960631|NCT04046744|Analgesics|analgesics|mesh-list
56213291|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56213292|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56213293|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55960632|NCT04046744|Ropivacaine|ropivacaine|mesh-list
55960633|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
55960634|NCT04046744|Anesthetics|anesthetics|mesh-list
55960635|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960636|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960637|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
55960638|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960639|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55960640|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55960641|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55960642|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55960643|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960644|NCT01431950|Fluticasone|fluticasone|mesh-list
55960645|NCT01431950|Xhance|xhance|mesh-list
55960646|NCT01431950|Albuterol|albuterol|mesh-list
55960647|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55960648|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55960649|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
55960650|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960651|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960652|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55960653|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
55960655|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56055119|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56055123|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55897710|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960656|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
55960657|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55960658|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55960659|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55960660|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55960661|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
55960662|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960663|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960664|NCT00551031|Vaccines|vaccines|mesh-list
55897711|NCT04484844|Listerine|listerine|mesh-list
55960665|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
55960666|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960667|NCT01431716|Epoprostenol|epoprostenol|mesh-list
55960668|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55960669|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55960670|NCT00550953|Amlodipine|amlodipine|mesh-list
55960671|NCT00550953|Telmisartan|telmisartan|mesh-list
55960672|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
55960673|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55897772|NCT03200886|Triamcinolone|triamcinolone|mesh-list
55960674|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55960675|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55960676|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960677|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55960678|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960679|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
55960680|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55960681|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55960682|NCT00322465|Azithromycin|azithromycin|mesh-list
55960683|NCT00322465|Doxycycline|doxycycline|mesh-list
55960684|NCT00322465|Tinidazole|tinidazole|mesh-list
55960685|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55960686|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960687|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
55960688|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55960689|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55960690|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
55960691|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960692|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55960693|NCT05732883|Dexamethasone|dexamethasone|mesh-list
55897816|NCT03223506|Analgesics|analgesics|mesh-ancestor
55960694|NCT05732883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55960695|NCT05732883|Antiemetics|antiemetics|mesh-ancestor
55960696|NCT05732883|Autonomic Agents|autonomic agents|mesh-ancestor
55960697|NCT05732883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960698|NCT05732883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960699|NCT05732883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55960700|NCT05732883|Glucocorticoids|glucocorticoids|mesh-ancestor
56213294|NCT02066181|Sorafenib|sorafenib|mesh-list
56213295|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213296|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55960701|NCT05732883|Hormones|hormones|mesh-ancestor
55960702|NCT05732883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897859|NCT05225116|Lenvatinib|lenvatinib|mesh-list
55897864|NCT03838042|Nivolumab|nivolumab|mesh-list
55960703|NCT05732883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55960704|NCT05732883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960705|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55960706|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
55960707|NCT03021993|Nivolumab|nivolumab|mesh-list
55960708|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55960709|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960710|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55960711|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960712|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55960713|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
55960714|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960715|NCT00558753|Pregabalin|pregabalin|mesh-list
55960716|NCT00558753|Analgesics|analgesics|mesh-ancestor
55960717|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
55960718|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960719|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960720|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
55960721|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55897920|NCT05681260|Hormones|hormones|mesh-ancestor
55960722|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55960723|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960724|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55960725|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55960726|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55960728|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55960730|NCT00324259|Estrogens|estrogens|mesh-ancestor
55960731|NCT00324259|Hormones|hormones|mesh-ancestor
55960732|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960733|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960734|NCT04598451|Prednisone|prednisone|mesh-list
55960735|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55960736|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
55960737|NCT04598451|Hormones|hormones|mesh-ancestor
55960738|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960739|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960740|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55960741|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960742|NCT04600141|Heparin|heparin|mesh-list
55960743|NCT04600141|Calcium heparin|calcium heparin|mesh-list
55960744|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
55960745|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55960746|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55960747|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960748|NCT00324415|Fluorouracil|fluorouracil|mesh-list
55960749|NCT00324415|Cetuximab|cetuximab|mesh-list
55960750|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960751|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
55897965|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55897966|NCT05156632|Antacids|antacids|mesh-ancestor
55960752|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960753|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55960754|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960755|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
55960756|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960757|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55960758|NCT00390559|Nicotine|nicotine|mesh-list
55960759|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55960760|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
55960761|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960762|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960763|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55960764|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55960766|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960767|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960769|NCT02107339|Hydromorphone|hydromorphone|mesh-list
55960770|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55960771|NCT02107339|Narcotics|narcotics|mesh-ancestor
56213297|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213298|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213299|NCT02059265|Dasatinib|dasatinib|mesh-list
55960772|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960773|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960774|NCT02107339|Analgesics|analgesics|mesh-ancestor
55960775|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
55960776|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960777|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
55960778|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
55960779|NCT00392041|Eszopiclone|eszopiclone|mesh-list
55960780|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55960781|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960782|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960783|NCT01390844|Ribavirin|ribavirin|mesh-list
55960784|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55960785|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
55960786|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960787|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
55960788|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960789|NCT04035278|Vaccines|vaccines|mesh-list
55960790|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
55960791|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960792|NCT00395161|Selenium|selenium|mesh-list
55960793|NCT00395161|Metoclopramide|metoclopramide|mesh-list
55960794|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
55960795|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960796|NCT00395161|Protective Agents|protective agents|mesh-ancestor
55960797|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960798|NCT00395161|Trace Elements|trace elements|mesh-ancestor
55960799|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
55960800|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
55960801|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
55960802|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960803|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55960804|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55960806|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
55960807|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960808|NCT01409564|Cilostazol|cilostazol|mesh-list
55960809|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55960810|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
55960811|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960812|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960813|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55960814|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
55960815|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55960816|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55960817|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960818|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55960819|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
55960820|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55960821|NCT01409564|Protective Agents|protective agents|mesh-ancestor
55960822|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55960823|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55960824|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960825|NCT02009449|Leucovorin|leucovorin|mesh-list
55960826|NCT02009449|Gemcitabine|gemcitabine|mesh-list
55960827|NCT02009449|Paclitaxel|paclitaxel|mesh-list
55960828|NCT02009449|Docetaxel|docetaxel|mesh-list
55960829|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55960830|NCT02009449|Carboplatin|carboplatin|mesh-list
55960831|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
55960832|NCT02009449|Fluorouracil|fluorouracil|mesh-list
55960833|NCT02009449|Capecitabine|capecitabine|mesh-list
55960834|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
55960835|NCT02009449|Nivolumab|nivolumab|mesh-list
55960836|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
55898061|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55898062|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960837|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55960838|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960839|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
55960840|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
55960841|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
55960842|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213300|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960843|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55960844|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
55960845|NCT02009449|Antiviral Agents|antiviral agents|mesh-ancestor
55960846|NCT02009449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960847|NCT02009449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960848|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960849|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
55960850|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960851|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55960852|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55960853|NCT02009449|Antidotes|antidotes|mesh-ancestor
55960854|NCT02009449|Protective Agents|protective agents|mesh-ancestor
55960855|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
55960857|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
55960858|NCT01794091|Eplerenone|eplerenone|mesh-list
55960859|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55960860|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
55960861|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960862|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960863|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55960864|NCT01794091|Diuretics|diuretics|mesh-ancestor
55960865|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
55960866|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55960867|NCT01794169|Cytarabine|cytarabine|mesh-list
55960868|NCT01794169|Azacitidine|azacitidine|mesh-list
55960869|NCT01794169|Daunorubicin|daunorubicin|mesh-list
55960870|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55960871|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
55960872|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803236|NCT05051449|Ketamine|ketamine|mesh-list
55960873|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960874|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
55960875|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960876|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960877|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
55960878|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960881|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55960882|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55960883|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55960884|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
55960885|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960886|NCT01390220|Midazolam|midazolam|mesh-list
55960887|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55960888|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55960889|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960890|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960891|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55960892|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55960893|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55960894|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55960895|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
55960896|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
55960897|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
55960898|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
55898221|NCT03192618|Antidotes|antidotes|mesh-ancestor
55960899|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960900|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960901|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
55960902|NCT00357331|Diuretics|diuretics|mesh-ancestor
55960903|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
55960904|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960905|NCT00357331|Expectorants|expectorants|mesh-ancestor
55960906|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
55960907|NCT00550173|Pemetrexed|pemetrexed|mesh-list
55960908|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55960909|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960910|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055435|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960911|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055447|NCT01203371|Urological Agents|urological agents|mesh-ancestor
55960912|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55960913|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55960914|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55960915|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
55960916|NCT04163107|Dexamethasone|dexamethasone|mesh-list
55960917|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55960918|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
55960919|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
55960920|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960921|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960922|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55960923|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
55960924|NCT04163107|Hormones|hormones|mesh-ancestor
55960925|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960926|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56055451|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56055453|NCT01549977|Febuxostat|febuxostat|mesh-list
55960927|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960928|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
55960929|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55960930|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55960931|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960932|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960933|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960934|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55960935|NCT01429298|Hydromorphone|hydromorphone|mesh-list
55960936|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55960937|NCT01429298|Narcotics|narcotics|mesh-ancestor
55898410|NCT00357604|Hormones|hormones|mesh-ancestor
55960938|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960939|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960940|NCT01429298|Analgesics|analgesics|mesh-ancestor
55960941|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
55960942|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55960943|NCT01408628|Insulin|insulin|mesh-list
55960944|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55960945|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960946|NCT01389752|Charcoal|charcoal|mesh-list
55960947|NCT01389752|Antidotes|antidotes|mesh-ancestor
55898455|NCT00356824|Amodiaquine|amodiaquine|mesh-list
55960948|NCT01389752|Protective Agents|protective agents|mesh-ancestor
55960949|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960950|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
55960951|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960952|NCT00358501|Defibrotide|defibrotide|mesh-list
55960953|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55960956|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55960957|NCT01427972|Eplerenone|eplerenone|mesh-list
55960958|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55960959|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
55960960|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960961|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960962|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55960963|NCT01427972|Diuretics|diuretics|mesh-ancestor
55960964|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
55960965|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55960966|NCT00336323|Bevacizumab|bevacizumab|mesh-list
55960967|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55960968|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960969|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55898510|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55960970|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55960971|NCT00336323|Growth Substances|growth substances|mesh-ancestor
55960972|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960973|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
55960974|NCT01427738|Nystatin|nystatin|mesh-list
55960975|NCT01427738|Gentian Violet|gentian violet|mesh-list
55960976|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55960977|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960978|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
55960979|NCT01427738|Ionophores|ionophores|mesh-ancestor
55960980|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55960981|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960982|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55960983|NCT01426958|Ritonavir|ritonavir|mesh-list
55960984|NCT01426958|Afatinib|afatinib|mesh-list
55960985|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55960986|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55960987|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
55960988|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960989|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960990|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55960991|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55960992|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
55960993|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744147|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
56213301|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213302|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898632|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
56213303|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213304|NCT02039063|Quetmolimab|quetmolimab|mesh-list
56213305|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56213306|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213307|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
56213308|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213309|NCT01970410|Teriflunomide|teriflunomide|mesh-list
56213310|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56213311|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56213312|NCT01970410|Analgesics|analgesics|mesh-ancestor
55960994|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55960995|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55960996|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960997|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55960998|NCT00397813|Cyclosporine|cyclosporine|mesh-list
55960999|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
55961000|NCT00397813|Fludarabine|fludarabine|mesh-list
55961001|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
55961002|NCT00397813|Cyclosporins|cyclosporins|mesh-list
55961003|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961004|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961005|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
55961006|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961008|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
55961009|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961010|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961011|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
55961012|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055569|NCT05721755|Fluorouracil|fluorouracil|mesh-list
55961013|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
55961014|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961015|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55961016|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55961017|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55961018|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
55961019|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55961020|NCT00398983|Decitabine|decitabine|mesh-list
55961021|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961022|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
55961023|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961024|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961025|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961035|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898750|NCT03132532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55961036|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961037|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55961038|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55961039|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
55961040|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961041|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55961042|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
55961043|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
55961044|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
55961045|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55961046|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
56055642|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898775|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898776|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55898777|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55898779|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
55961047|NCT00358579|Coagulants|coagulants|mesh-ancestor
55961048|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55961049|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
55961050|NCT00338039|Gemcitabine|gemcitabine|mesh-list
55961051|NCT00338039|Capecitabine|capecitabine|mesh-list
55961052|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
55961053|NCT00338039|Cetuximab|cetuximab|mesh-list
55961054|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961055|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
55961056|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961057|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961058|NCT00338039|Antiviral Agents|antiviral agents|mesh-ancestor
55961059|NCT00338039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961060|NCT00338039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961061|NCT00338039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055648|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
55961062|NCT00338039|Immunologic Factors|immunologic factors|mesh-ancestor
55961063|NCT00338039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961064|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961065|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
55961066|NCT00358657|Sirolimus|sirolimus|mesh-list
55961067|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
55961068|NCT00358657|Fludarabine|fludarabine|mesh-list
55961069|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
55961070|NCT00358657|Tacrolimus|tacrolimus|mesh-list
55961071|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961072|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
55961073|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961074|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961075|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55961076|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
55898885|NCT05629702|Temozolomide|temozolomide|mesh-list
55961077|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961078|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961079|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55961080|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961081|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
55961082|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55961083|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961084|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55961085|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55961086|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
55961087|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55961088|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961089|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
55961090|NCT00340379|Haloperidol|haloperidol|mesh-list
55961091|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
55961092|NCT00340379|Ziprasidone|ziprasidone|mesh-list
55961093|NCT00340379|Sertraline|sertraline|mesh-list
55961094|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
55961095|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55961110|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55961111|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
55961112|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55961113|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55961114|NCT00342563|Mecamylamine|mecamylamine|mesh-list
55961115|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55961116|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
55961117|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
55961118|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961119|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961120|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55961121|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56055682|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055683|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
55961122|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
55961123|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961124|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961125|NCT00358735|Enoxaparin|enoxaparin|mesh-list
55961126|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
55961127|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55961128|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55961129|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961130|NCT01793519|Adalimumab|adalimumab|mesh-list
55961131|NCT01793519|Etanercept|etanercept|mesh-list
55961132|NCT01793519|Infliximab|infliximab|mesh-list
55961133|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55961134|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961135|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
55961136|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55961137|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55961138|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55961139|NCT01793519|Analgesics|analgesics|mesh-ancestor
55961140|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
55961141|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961142|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961143|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055722|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55961144|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
55961145|NCT03043872|Carboplatin|carboplatin|mesh-list
56213313|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
56213314|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213315|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789989|NCT04879511|Metformin|metformin|mesh-list
55961146|NCT03043872|Etoposide|etoposide|mesh-list
55961147|NCT03043872|Durvalumab|durvalumab|mesh-list
55961148|NCT03043872|Tremelimumab|tremelimumab|mesh-list
55961149|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961150|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55961151|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55961152|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55961153|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961154|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961155|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961172|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961173|NCT00345371|Topiramate|topiramate|mesh-list
55961174|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
55961175|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55961176|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961177|NCT03006276|Celecoxib|celecoxib|mesh-list
55961178|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55961179|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56055733|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055734|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055735|NCT00271011|Irinotecan|irinotecan|mesh-list
55961180|NCT03006276|Analgesics|analgesics|mesh-ancestor
55961181|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
55961182|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961183|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961184|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55961185|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961186|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55961187|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55961188|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961189|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961190|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
55961191|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56055741|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961192|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961193|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55961194|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55961195|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55961196|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55961197|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961198|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961199|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961200|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
55961201|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55961202|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961203|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961204|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55961205|NCT00351299|Analgesics|analgesics|mesh-ancestor
55961206|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
55961207|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961208|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55961209|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55961211|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
55961212|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961213|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961214|NCT00352001|Lenalidomide|lenalidomide|mesh-list
55961215|NCT00352001|Azacitidine|azacitidine|mesh-list
56055763|NCT05720273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55961217|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961219|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55961220|NCT00352001|Growth Substances|growth substances|mesh-ancestor
55961221|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
55961222|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961223|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961224|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
55961225|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961226|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961227|NCT00401401|Zalutumumab|zalutumumab|mesh-list
55961228|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961229|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055781|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
56213316|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56213317|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213318|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56213319|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
56213320|NCT01950520|Topiramate|topiramate|mesh-list
56213321|NCT01950520|Phentermine|phentermine|mesh-list
56213322|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
56213323|NCT01950520|Propranolol|propranolol|mesh-list
56213324|NCT01950520|Pindolol|pindolol|mesh-list
56213325|NCT01950520|Naltrexone|naltrexone|mesh-list
55961230|NCT00352781|Nicotine|nicotine|mesh-list
55961231|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55961232|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
55961233|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899381|NCT02097303|Prednisone|prednisone|mesh-list
55961234|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961235|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55961236|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55961237|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
55961238|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961239|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961240|NCT02812524|Ipilimumab|ipilimumab|mesh-list
55961241|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961242|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961243|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55961244|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961245|NCT01793753|Propofol|propofol|mesh-list
55899433|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55899434|NCT05513560|Protective Agents|protective agents|mesh-ancestor
55899436|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
55961246|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55961247|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961248|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961249|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55961250|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
55961251|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
55961252|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
55961254|NCT00360685|Tacrolimus|tacrolimus|mesh-list
55961255|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55899487|NCT00112593|Cyclosporins|cyclosporins|mesh-list
55899505|NCT05280106|Citric Acid|citric acid|mesh-list
55961256|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
55961257|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55961258|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961259|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961260|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
55961261|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961262|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961263|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
55961264|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961265|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55961266|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961267|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
55961268|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961269|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55961270|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55961271|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55961272|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55961273|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
55961274|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55961275|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961276|NCT05487456|Menthol|menthol|mesh-list
55961277|NCT05487456|Nicotine|nicotine|mesh-list
55961278|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55961279|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
55899604|NCT02437032|Menotropins|menotropins|mesh-list
55961280|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961281|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961282|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55961283|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55961284|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
55961285|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961286|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961287|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
56213326|NCT01950520|Caffeine|caffeine|mesh-list
56213327|NCT01950520|Dantrolene|dantrolene|mesh-list
56213328|NCT01950520|Mirabegron|mirabegron|mesh-list
55961288|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
55961293|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55961294|NCT00558519|Methotrexate|methotrexate|mesh-list
55961295|NCT00558519|Vincristine|vincristine|mesh-list
55961297|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
55961298|NCT00558519|Pegaspargase|pegaspargase|mesh-list
55961299|NCT00558519|Thioguanine|thioguanine|mesh-list
55961300|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961301|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
55961302|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961303|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961304|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55961305|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
55889472|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55961306|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961307|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961308|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55961309|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55961310|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
55961311|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
55961312|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961313|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55961315|NCT00558519|Hormones|hormones|mesh-ancestor
55961316|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889473|NCT03004287|Growth Substances|growth substances|mesh-ancestor
56055958|NCT00380133|Prednisolone|prednisolone|mesh-list
55961317|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55961318|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55961319|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55961320|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55961321|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961322|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55961323|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
55961324|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55961325|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961326|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
55961327|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
55961328|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55961329|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55961330|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
55961331|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961332|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55961333|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
55961334|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
55961335|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
55899817|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
55961336|NCT03239015|Trastuzumab|trastuzumab|mesh-list
55961337|NCT03239015|Everolimus|everolimus|mesh-list
55961338|NCT03239015|Olaparib|olaparib|mesh-list
55961339|NCT03239015|Gefitinib|gefitinib|mesh-list
55961340|NCT03239015|Palbociclib|palbociclib|mesh-list
55961341|NCT03239015|Afatinib|afatinib|mesh-list
55961342|NCT03239015|Vemurafenib|vemurafenib|mesh-list
55961343|NCT03239015|Dabrafenib|dabrafenib|mesh-list
55961344|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
55961345|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899877|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899886|NCT00227019|Vitamins|vitamins|mesh-list
55961346|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961347|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961348|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
55961349|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961350|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55961351|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961352|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961353|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55889474|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
55899928|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961354|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55961355|NCT03239015|Growth Substances|growth substances|mesh-ancestor
55961356|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
55961357|NCT05370885|Vancomycin|vancomycin|mesh-list
55961358|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55961359|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961360|NCT00403117|Naltrexone|naltrexone|mesh-list
55961361|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55961362|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55961363|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961364|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
55961372|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213329|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56213330|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56213331|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213332|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
56213333|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213334|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56213335|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56213336|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961373|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
55961374|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961375|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55961376|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961377|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056121|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
55961379|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55961380|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55961381|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55961382|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
55961383|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961384|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961385|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961387|NCT01389596|Analgesics|analgesics|mesh-ancestor
55961388|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
55961389|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961390|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900012|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55961392|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55961393|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55961394|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961395|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55961396|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55961397|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55961398|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961399|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55961400|NCT00558207|Gemcitabine|gemcitabine|mesh-list
55961401|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961402|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
55961403|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961404|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961405|NCT00558207|Antiviral Agents|antiviral agents|mesh-ancestor
55961406|NCT00558207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961407|NCT00558207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961408|NCT00558207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961409|NCT00558207|Immunologic Factors|immunologic factors|mesh-ancestor
55961410|NCT00558207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961411|NCT00407485|Aflibercept|aflibercept|mesh-list
56056151|NCT00000219|Buprenorphine|buprenorphine|mesh-list
55961412|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55961413|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55961414|NCT00407485|Growth Substances|growth substances|mesh-ancestor
55961415|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961416|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
55961417|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961418|NCT00354887|Capecitabine|capecitabine|mesh-list
55961419|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
55900112|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900113|NCT00255177|Mifepristone|mifepristone|mesh-list
55961420|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961421|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
55961422|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961423|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961424|NCT02111863|Aldesleukin|aldesleukin|mesh-list
55961425|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
55961426|NCT02111863|Fludarabine|fludarabine|mesh-list
55961427|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961428|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
55961429|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961430|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961431|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56056190|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
56056191|NCT01645176|Atorvastatin|atorvastatin|mesh-list
56056192|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56056193|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56056194|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
55900165|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900166|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900167|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55900168|NCT00702624|Hormones|hormones|mesh-list
55900169|NCT00702624|Progesterone|progesterone|mesh-list
55900170|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55900171|NCT00702624|Ganirelix|ganirelix|mesh-list
56213337|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213338|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56213340|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
55961432|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
55961433|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961436|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55961437|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55961438|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
55961439|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961441|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
55961442|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55961443|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55961444|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744153|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
55961445|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961446|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900287|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
55961447|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55961448|NCT03127267|Protective Agents|protective agents|mesh-ancestor
55961450|NCT02660411|Sevoflurane|sevoflurane|mesh-list
55961451|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55961452|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961453|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961454|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55961455|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
55961456|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
55900356|NCT03185988|Trastuzumab|trastuzumab|mesh-list
55961457|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55961458|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55961459|NCT02078492|Ketorolac|ketorolac|mesh-list
55961460|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55961461|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55961462|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55961463|NCT02078492|Analgesics|analgesics|mesh-ancestor
55961464|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
55961465|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961466|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961467|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55961468|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056251|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961469|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55961470|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961471|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961472|NCT02988921|Paclitaxel|paclitaxel|mesh-list
55961473|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55961474|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961475|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
55961476|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
55961477|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
56056295|NCT03360903|Caffeine|caffeine|mesh-list
55961478|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961479|NCT04528563|Ketorolac|ketorolac|mesh-list
55961480|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55961481|NCT04528563|Morphine|morphine|mesh-list
55961482|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55961483|NCT04528563|Narcotics|narcotics|mesh-ancestor
55961484|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961485|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961486|NCT04528563|Analgesics|analgesics|mesh-ancestor
55961487|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
55961488|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961489|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55961490|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55961491|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55961492|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900444|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55961493|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55961494|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961495|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961496|NCT00355199|Rituximab|rituximab|mesh-list
55961497|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961498|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961499|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
56213341|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213342|NCT01950520|Analgesics|analgesics|mesh-ancestor
55889475|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
55900492|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900493|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55900494|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
55900495|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55900496|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900497|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55900498|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900499|NCT00702234|Progesterone|progesterone|mesh-list
55900500|NCT00702234|Progestins|progestins|mesh-ancestor
55900501|NCT00702234|Hormones|hormones|mesh-ancestor
55961500|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961501|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961502|NCT01791647|Inositol|inositol|mesh-list
55961503|NCT01791647|Metformin|metformin|mesh-list
55961504|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55961505|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961506|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
55961508|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
55900534|NCT01682759|Glimepiride|glimepiride|mesh-list
55961510|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961511|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55900535|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55900536|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900537|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55900538|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55900539|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
55900540|NCT01682681|Topiramate|topiramate|mesh-list
55900541|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
55900542|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55961512|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961513|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961514|NCT00364819|Rituximab|rituximab|mesh-list
55961515|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961516|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961517|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
55961518|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961519|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961520|NCT04524351|Phenserine|phenserine|mesh-list
55961521|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55961522|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961523|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961524|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
55900597|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55900598|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900599|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900600|NCT02425254|Acetaminophen|acetaminophen|mesh-list
55900601|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55900602|NCT02425254|Analgesics|analgesics|mesh-ancestor
55900603|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
55900604|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900605|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900606|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
55900607|NCT02426736|Dexamethasone|dexamethasone|mesh-list
55961525|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961526|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961527|NCT04523961|Lidocaine|lidocaine|mesh-list
55961528|NCT04523961|Tetracaine|tetracaine|mesh-list
55961529|NCT04523961|Prilocaine|prilocaine|mesh-list
55961530|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55961531|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
55961532|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
55961533|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961534|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961535|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
55961536|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961537|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55961538|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55961539|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55961540|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900658|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900659|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
55900680|NCT03609580|Tamsulosin|tamsulosin|mesh-list
55961541|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961542|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55961543|NCT01792505|Imiquimod|imiquimod|mesh-list
55961544|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55961545|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
55961546|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961547|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961548|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
55961549|NCT00365053|Belinostat|belinostat|mesh-list
55961550|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961551|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55961552|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900718|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55900719|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900720|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900721|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
55900722|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55900723|NCT01703117|Riluzole|riluzole|mesh-list
55900724|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
55900725|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55900726|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55900727|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961553|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961554|NCT00555789|Tacrolimus|tacrolimus|mesh-list
55961555|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961556|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
55961557|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961558|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55961559|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961560|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900773|NCT01702025|Protective Agents|protective agents|mesh-ancestor
55900774|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55900775|NCT01702025|Diuretics|diuretics|mesh-ancestor
55900776|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
55900777|NCT01592747|Memantine|memantine|mesh-list
55900778|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55900779|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55900780|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
55900781|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900782|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900783|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900784|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55900785|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55900786|NCT02425488|Coal Tar|coal tar|mesh-list
55900787|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
55961561|NCT04288895|Vortioxetine|vortioxetine|mesh-list
55961562|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
55961563|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55961564|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55961565|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55961566|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961567|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961568|NCT04288895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55961569|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55961570|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55961571|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900826|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900827|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
55900828|NCT02423928|Ipilimumab|ipilimumab|mesh-list
55900829|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55900830|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
55900831|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900832|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900833|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56213343|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
56213344|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213345|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56213346|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
56213347|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56213348|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56213349|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56213350|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
56213351|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56213352|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56213353|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56213354|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
55790013|NCT03871049|Hormones|hormones|mesh-ancestor
56056435|NCT00001677|Methotrexate|methotrexate|mesh-list
56056436|NCT00001677|Fludarabine|fludarabine|mesh-list
56056437|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56056438|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
56056439|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56056440|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056441|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790014|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790015|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55961572|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961573|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
55961574|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55961575|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55961576|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55961577|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55961578|NCT05299125|Carboplatin|carboplatin|mesh-list
55961579|NCT05299125|Pemetrexed|pemetrexed|mesh-list
56056568|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56056569|NCT00000861|Indinavir|indinavir|mesh-list
56056570|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56056571|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56056572|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
56056573|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961581|NCT05299125|Lazertinib|lazertinib|mesh-list
55961582|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961583|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961584|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961585|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55961586|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55961587|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55961588|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961589|NCT00365209|Curcumin|curcumin|mesh-list
56056701|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961590|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55744157|NCT03120715|Tinzaparin|tinzaparin|mesh-list
55961591|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55961592|NCT00365209|Analgesics|analgesics|mesh-ancestor
55961593|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
55961594|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961595|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961596|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55961597|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961598|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961599|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961600|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961601|NCT04417257|Fenretinide|fenretinide|mesh-list
55900852|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55900853|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900854|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
55900855|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
55900856|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056773|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056774|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56056775|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056776|NCT05325515|Alendronate|alendronate|mesh-list
56056779|NCT00000939|Efavirenz|efavirenz|mesh-list
55961602|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961603|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55961604|NCT04417257|Protective Agents|protective agents|mesh-ancestor
55961605|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961606|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
55961607|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
55961608|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55961609|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
55961610|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55961611|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961612|NCT00409825|Progestins|progestins|mesh-ancestor
55961613|NCT00409825|Hormones|hormones|mesh-ancestor
56213355|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56213356|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
56213357|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55961614|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55961615|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961616|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55961617|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961618|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961619|NCT04749069|Remifentanil|remifentanil|mesh-list
55961620|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55961621|NCT04749069|Narcotics|narcotics|mesh-ancestor
56057007|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56057008|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56057021|NCT00001053|Antacids|antacids|mesh-ancestor
55961622|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961623|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961624|NCT04749069|Analgesics|analgesics|mesh-ancestor
55961625|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
55961626|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961627|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55961628|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
55961629|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55961630|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55961631|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55961632|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961633|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961634|NCT00356993|Nicotine|nicotine|mesh-list
55961635|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55961636|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
55961637|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961638|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057043|NCT00001059|Bleomycin|bleomycin|mesh-list
56057044|NCT00001059|Vincristine|vincristine|mesh-list
56057045|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56057046|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057047|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56057048|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55961639|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55961640|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55961641|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
55961642|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961643|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961644|NCT01793077|Leuprolide|leuprolide|mesh-list
55961645|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55961646|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
55961647|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55961648|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961649|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55961650|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961651|NCT00555477|Anastrozole|anastrozole|mesh-list
55961655|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55961656|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057162|NCT00359333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057163|NCT00359333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057164|NCT00359333|Immunologic Factors|immunologic factors|mesh-ancestor
56057165|NCT00359333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057181|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56057182|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961657|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961658|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55961659|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
55961660|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55961661|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961663|NCT00365599|Vorinostat|vorinostat|mesh-list
55961664|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961665|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56057301|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56057302|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
56057303|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057304|NCT05044637|Primaquine|primaquine|mesh-list
55961666|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
55961667|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55961668|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961669|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55961670|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961671|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55961672|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55961673|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55961674|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55961675|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961676|NCT00554619|Ambrisentan|ambrisentan|mesh-list
55961677|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55961679|NCT02104739|Saxagliptin|saxagliptin|mesh-list
55961680|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55961681|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961682|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55961683|NCT02104739|Incretins|incretins|mesh-ancestor
55961684|NCT02104739|Hormones|hormones|mesh-ancestor
56213358|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55790028|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
55961685|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55961686|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55961687|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
55961688|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961689|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961690|NCT00411619|Everolimus|everolimus|mesh-list
55961691|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961692|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961693|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
55961694|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961695|NCT00412087|Vitamin D|vitamin d|mesh-list
55961696|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
56057515|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961697|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
55961698|NCT00412087|Vitamins|vitamins|mesh-list
55961699|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
55961700|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961701|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55961702|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55961703|NCT03924401|Abatacept|abatacept|mesh-list
55961704|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56057589|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56057596|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961705|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961706|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961707|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961708|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
55961709|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961710|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961711|NCT00312923|Policosanol|policosanol|mesh-list
55961712|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55961713|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55961714|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
55961715|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961716|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55961717|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55961718|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
56057687|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961719|NCT00412243|Clofarabine|clofarabine|mesh-list
55961720|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961721|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
55961722|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961725|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
55961726|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961727|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961728|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55961729|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56057792|NCT00002163|Abacavir|abacavir|mesh-list
55961730|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
55961731|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55961732|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
55961733|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961734|NCT00315341|Buprenorphine|buprenorphine|mesh-list
55961736|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55961738|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55961739|NCT00315341|Narcotics|narcotics|mesh-ancestor
55961740|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961741|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961742|NCT00315341|Analgesics|analgesics|mesh-ancestor
55961743|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
55961744|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961745|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55961746|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
55961747|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
55961748|NCT02277249|Digoxin|digoxin|mesh-list
55961749|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55961750|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55961751|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961752|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057953|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55961753|NCT02277249|Protective Agents|protective agents|mesh-ancestor
55961754|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213359|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56213360|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56213361|NCT01950520|Urological Agents|urological agents|mesh-ancestor
55961760|NCT04767542|Acetaminophen|acetaminophen|mesh-list
55961761|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961762|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55961763|NCT04767542|Analgesics|analgesics|mesh-ancestor
55961764|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
55961765|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961766|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
55961768|NCT01794533|Epinephrine|epinephrine|mesh-list
55961769|NCT01794533|Racepinephrine|racepinephrine|mesh-list
55961770|NCT01794533|Fentanyl|fentanyl|mesh-list
55961771|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
55961772|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
55961773|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
56058051|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55961774|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961775|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961776|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
55961777|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961778|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55961779|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55961780|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55961781|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55961782|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961783|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55961784|NCT01794533|Narcotics|narcotics|mesh-ancestor
55961785|NCT01794533|Analgesics|analgesics|mesh-ancestor
55961786|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55961787|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55961788|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
55961789|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55961790|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55961791|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
55961792|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961793|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55961794|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55961795|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
55961796|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55961797|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
55961798|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
55744160|NCT03120715|Progesterone|progesterone|mesh-list
55961813|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961814|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058392|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
55961815|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
55961816|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
55961817|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961818|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
55961819|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961820|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961821|NCT01653223|Simvastatin|simvastatin|mesh-list
55961822|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55961823|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55961824|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
56058505|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058506|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
56058507|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058508|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058509|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058510|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
55961825|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961826|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55961827|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55961828|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961829|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
55961830|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55961831|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961832|NCT00414271|Docetaxel|docetaxel|mesh-list
55961833|NCT00414271|Capecitabine|capecitabine|mesh-list
55961834|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961835|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
55961836|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
55961837|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
55961838|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961839|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961840|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
55961841|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
56213362|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
56213363|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56213364|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
56213365|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
55961842|NCT00576979|Etoposide|etoposide|mesh-list
55961843|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
55961844|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961845|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
55961846|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961847|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961848|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55961849|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
55961850|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961851|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961852|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55961853|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55961854|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55961855|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55961856|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961857|NCT00360971|Cisplatin|cisplatin|mesh-list
55961858|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961859|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
55961861|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55961862|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55961863|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55961864|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961865|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
55961866|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961867|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961868|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55961869|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961871|NCT03636503|Avelumab|avelumab|mesh-list
55961872|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961873|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961875|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961876|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961877|NCT03448159|Fluoxetine|fluoxetine|mesh-list
55961878|NCT03448159|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55961879|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56058868|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
56058869|NCT00002571|Hormones|hormones|mesh-ancestor
56058873|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
55961880|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55961881|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961882|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961883|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
55961884|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961885|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55961886|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
55961887|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56058965|NCT02223871|Lumefantrine|lumefantrine|mesh-list
55961888|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55961889|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55961890|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961891|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
55961892|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55961893|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
55961894|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55961895|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
55961896|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55961897|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961898|NCT03438487|Vaccines|vaccines|mesh-list
55961899|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
55961900|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961901|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56059072|NCT00002637|Interferons|interferons|mesh-list
55961902|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961903|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961904|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
55961905|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55961906|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55961907|NCT01792037|Prednisolone|prednisolone|mesh-list
55961908|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
55961909|NCT01792037|Midazolam|midazolam|mesh-list
56213366|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56213367|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
56213368|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55961910|NCT01792037|Etomidate|etomidate|mesh-list
55961911|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55961912|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
55961913|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55961914|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55961915|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961916|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961917|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55961918|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55961919|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55961920|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55961921|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
55961922|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
55961923|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
55961924|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
55961925|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059336|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55961926|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961927|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55961928|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
55961929|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
55961930|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961931|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55961932|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
55961933|NCT01792037|Hormones|hormones|mesh-ancestor
55961936|NCT01792037|Protective Agents|protective agents|mesh-ancestor
55803340|NCT04964947|Tobramycin|tobramycin|mesh-list
55961937|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55961938|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961939|NCT00373399|Dronabinol|dronabinol|mesh-list
55961940|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
56059418|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
55961941|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961942|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55961943|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55961944|NCT00373399|Analgesics|analgesics|mesh-ancestor
55961945|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
55961946|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961947|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55961948|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55961949|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961950|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961951|NCT00373399|Hormones|hormones|mesh-ancestor
55961952|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55961953|NCT00318929|Valproic Acid|valproic acid|mesh-list
55961954|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
55961955|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961956|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961957|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
55961958|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961959|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961960|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
55961961|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55961962|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961963|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55961964|NCT00418093|Gemcitabine|gemcitabine|mesh-list
55961965|NCT00418093|Bevacizumab|bevacizumab|mesh-list
55961966|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
55961967|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55961968|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961969|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55961970|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55961971|NCT00418093|Growth Substances|growth substances|mesh-ancestor
56059735|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
56059736|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059737|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059738|NCT04248179|Sufentanil|sufentanil|mesh-list
55961972|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961973|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
55961974|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961975|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
55961976|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961977|NCT00418093|Antiviral Agents|antiviral agents|mesh-ancestor
55961978|NCT00418093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55961979|NCT00418093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059809|NCT05749575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55961980|NCT00418093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961981|NCT00418093|Immunologic Factors|immunologic factors|mesh-ancestor
56213369|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56213370|NCT01861314|Bortezomib|bortezomib|mesh-list
56213371|NCT01861314|Sorafenib|sorafenib|mesh-list
56213372|NCT01861314|Decitabine|decitabine|mesh-list
56213373|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961983|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
55961984|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961985|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
55961986|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961987|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961988|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961989|NCT03284723|Letrozole|letrozole|mesh-list
55961990|NCT03284723|Palbociclib|palbociclib|mesh-list
55961991|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961992|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55961993|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55961994|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55961995|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961996|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55961997|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
55961998|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55961999|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962000|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962001|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
55962002|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55962003|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962004|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55962005|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
56059981|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962007|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962008|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962009|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962010|NCT00418951|Voriconazole|voriconazole|mesh-list
55962011|NCT00418951|Amphotericin B|amphotericin b|mesh-list
55962012|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55962013|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
55962014|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962015|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56060045|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
55962016|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56060046|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
56060048|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56060049|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060050|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060051|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060052|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56060054|NCT05242965|Sargramostim|sargramostim|mesh-list
55962017|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962018|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962019|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55962020|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
55962021|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962022|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962023|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56060215|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962024|NCT00418951|Amebicides|amebicides|mesh-ancestor
55962025|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55962026|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55962027|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55962028|NCT00363077|Vaccines|vaccines|mesh-list
55962029|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
55962030|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962031|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55962032|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55962033|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55962034|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889476|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56060252|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962035|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962036|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962037|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962038|NCT00375973|Analgesics|analgesics|mesh-ancestor
55962039|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
55962040|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962041|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
55962042|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55901029|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962043|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
55962044|NCT00421603|Topiramate|topiramate|mesh-list
55962045|NCT00421603|Adderall|adderall|mesh-list
55962046|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
55962047|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55962048|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213374|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213375|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962049|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55962051|NCT00363779|Cyclosporins|cyclosporins|mesh-list
55962052|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962053|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962054|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962055|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
55962056|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962057|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
55962058|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962059|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
55962060|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962061|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56060380|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962063|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
55962064|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962065|NCT05287633|Esomeprazole|esomeprazole|mesh-list
55962066|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55962067|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55962068|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55962069|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962070|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962071|NCT01405742|Factor VIII|factor viii|mesh-list
55962072|NCT01405742|Coagulants|coagulants|mesh-ancestor
55962073|NCT01794767|Heparin|heparin|mesh-list
55962074|NCT01794767|Calcium heparin|calcium heparin|mesh-list
55962075|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
55962076|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55962077|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55962081|NCT02076152|Bevacizumab|bevacizumab|mesh-list
55962082|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962083|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962084|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962085|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962086|NCT02076152|Growth Substances|growth substances|mesh-ancestor
55962087|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962088|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962089|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
55962090|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56060437|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
55962091|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962092|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55962093|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962094|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962095|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962096|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962097|NCT01405508|Brivaracetam|brivaracetam|mesh-list
55962098|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
55962099|NCT00426283|Fluticasone|fluticasone|mesh-list
55962101|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55962102|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55962103|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
55962104|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962105|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962106|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55962107|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
55962108|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
55962109|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55962110|NCT00322439|Etanercept|etanercept|mesh-list
55962111|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55962112|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55962113|NCT00322439|Analgesics|analgesics|mesh-ancestor
55962114|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
55962115|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962116|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962117|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55962118|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962119|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55962120|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56060590|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55962121|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
55962122|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
55962123|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962124|NCT00365261|Eszopiclone|eszopiclone|mesh-list
56213376|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962125|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55962126|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060675|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060678|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
55962127|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962128|NCT00426517|Sirolimus|sirolimus|mesh-list
55962129|NCT00426517|Busulfan|busulfan|mesh-list
55962130|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
55962131|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55962132|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962133|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55962134|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962135|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
55962136|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962137|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
55962138|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060781|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55962139|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
55962140|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962141|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55962142|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55962143|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962144|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
55962145|NCT00365417|Bevacizumab|bevacizumab|mesh-list
55962146|NCT00365417|Docetaxel|docetaxel|mesh-list
55962147|NCT00365417|Doxorubicin|doxorubicin|mesh-list
55962148|NCT00365417|Capecitabine|capecitabine|mesh-list
55962149|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962150|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
55962151|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962155|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060879|NCT00000483|Niacin|niacin|mesh-list
55962156|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962157|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55962158|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962159|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962160|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962161|NCT00365417|Growth Substances|growth substances|mesh-ancestor
55962162|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962163|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
55962164|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
55962165|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
55962166|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55962167|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55962168|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55962169|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060924|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56060925|NCT01676311|Protective Agents|protective agents|mesh-ancestor
56060927|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55962170|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55962171|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
55962172|NCT02947685|Trastuzumab|trastuzumab|mesh-list
55962173|NCT02947685|Pertuzumab|pertuzumab|mesh-list
55962174|NCT02947685|Letrozole|letrozole|mesh-list
55962175|NCT02947685|Fulvestrant|fulvestrant|mesh-list
55962176|NCT02947685|Palbociclib|palbociclib|mesh-list
55962177|NCT02947685|Anastrozole|anastrozole|mesh-list
55962178|NCT02947685|Exemestane|exemestane|mesh-list
55962179|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962180|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962181|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56061004|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55962182|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55962183|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962184|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962185|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55962186|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
55962187|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962188|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962189|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962190|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55962191|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962192|NCT00427297|Ritonavir|ritonavir|mesh-list
55962193|NCT00427297|Lopinavir|lopinavir|mesh-list
55962194|NCT00427297|Tenofovir|tenofovir|mesh-list
55962195|NCT00427297|Lamivudine|lamivudine|mesh-list
55962196|NCT00427297|Zidovudine|zidovudine|mesh-list
55962197|NCT00427297|Nevirapine|nevirapine|mesh-list
55962198|NCT00427297|Abacavir|abacavir|mesh-list
55962199|NCT00427297|Didanosine|didanosine|mesh-list
55962200|NCT00427297|Stavudine|stavudine|mesh-list
55962201|NCT00427297|Efavirenz|efavirenz|mesh-list
55962202|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
55962203|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56213377|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55962204|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55962205|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
55962206|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962207|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962208|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55962209|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55962210|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
55962211|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962212|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56061102|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962213|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55962214|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55962215|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55962217|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55962218|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55962219|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55962220|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55962221|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55962222|NCT00427765|Melphalan|melphalan|mesh-list
55962223|NCT00427765|Busulfan|busulfan|mesh-list
55962224|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55962225|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
55962237|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55962239|NCT00384865|Analgesics|analgesics|mesh-ancestor
55962240|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
55962241|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962242|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744180|NCT03335293|Racepinephrine|racepinephrine|mesh-list
55962243|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55962244|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962245|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55962246|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55962247|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962248|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55962249|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55962250|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962251|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
55962252|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55962253|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55962254|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
55962255|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55962256|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55962257|NCT00367601|Bevacizumab|bevacizumab|mesh-list
55962258|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55962259|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962260|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962261|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962262|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962263|NCT00367601|Growth Substances|growth substances|mesh-ancestor
55962264|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962265|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962266|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962267|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962268|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962269|NCT00385801|Risperidone|risperidone|mesh-list
55962270|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55962271|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
55962272|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962273|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061393|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
55962274|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962275|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55962276|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55962277|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55962278|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55962279|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55962280|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
55962281|NCT00429403|Goserelin|goserelin|mesh-list
55962282|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962283|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962284|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
55962285|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56213378|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
56213379|NCT01746173|Gemcitabine|gemcitabine|mesh-list
56213380|NCT01746173|Plerixafor|plerixafor|mesh-list
56213381|NCT01746173|Prednisone|prednisone|mesh-list
55962286|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962287|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55962290|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962291|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962292|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55962293|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55962294|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55962295|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55962296|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
55962297|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962298|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962299|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55962300|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55962301|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55962302|NCT00429949|Dasatinib|dasatinib|mesh-list
55962303|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962304|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962305|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962306|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962307|NCT02078726|Glucagon|glucagon|mesh-list
55962308|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55962309|NCT02078726|Hormones|hormones|mesh-ancestor
55962310|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962311|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962312|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
55962313|NCT00431041|Oxybutynin|oxybutynin|mesh-list
55962314|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55962315|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55962316|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
55962317|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061554|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55962318|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962319|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962320|NCT00431041|Urological Agents|urological agents|mesh-ancestor
55962321|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
55962322|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
55962323|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962324|NCT00390611|Paclitaxel|paclitaxel|mesh-list
55962325|NCT00390611|Carboplatin|carboplatin|mesh-list
55962326|NCT00390611|Sorafenib|sorafenib|mesh-list
55962327|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55962328|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962329|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
55962330|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
55962331|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
55962332|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962333|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962334|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962335|NCT00391079|Nabiximols|nabiximols|mesh-list
55962336|NCT00391079|Analgesics|analgesics|mesh-ancestor
55962337|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
55962338|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962339|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962340|NCT00387751|Bevacizumab|bevacizumab|mesh-list
55962341|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55962342|NCT00387751|Sorafenib|sorafenib|mesh-list
55962343|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
55962344|NCT00387751|Antibodies|antibodies|mesh-list
55962345|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
55962346|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55962347|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
55962348|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962349|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962350|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962351|NCT00387751|Growth Substances|growth substances|mesh-ancestor
55803452|NCT05692297|Denosumab|denosumab|mesh-list
55962352|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962353|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962354|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
56213382|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
56213383|NCT01746173|Melphalan|melphalan|mesh-list
56213384|NCT01746173|Busulfan|busulfan|mesh-list
56213385|NCT01746173|Doxorubicin|doxorubicin|mesh-list
56061765|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55962355|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962356|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962357|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962358|NCT01795235|Atenolol|atenolol|mesh-list
55962359|NCT01795235|Glucagon|glucagon|mesh-list
55962360|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55962363|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962365|NCT01795235|Incretins|incretins|mesh-ancestor
55962366|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55962367|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55962368|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
55962369|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
55962370|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962371|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55962372|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55962373|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55962374|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
55962375|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962376|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962377|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55962378|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55962379|NCT00387829|Estradiol|estradiol|mesh-list
55962380|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55962381|NCT00387829|Estrogens|estrogens|mesh-ancestor
55962382|NCT00387829|Hormones|hormones|mesh-ancestor
55962383|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962384|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962385|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55962386|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
55962387|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55962388|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55962389|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
55962390|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962391|NCT00392951|Sirolimus|sirolimus|mesh-list
56062006|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962392|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55962393|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962394|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55962395|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962396|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
55962397|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962398|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
55962399|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962400|NCT01424930|Prednisone|prednisone|mesh-list
55962401|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55962402|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
55962403|NCT01424930|Hormones|hormones|mesh-ancestor
55962404|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962405|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962406|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962407|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962408|NCT00389857|Vaccines|vaccines|mesh-list
55962409|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
55962410|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962411|NCT01795183|Amisulpride|amisulpride|mesh-list
55962412|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56062186|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56062187|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56062188|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55962413|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55962414|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55962415|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962416|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55962417|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55962418|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
55962420|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962421|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55962422|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
55962423|NCT01424228|Prucalopride|prucalopride|mesh-list
55962424|NCT01424228|Laxatives|laxatives|mesh-ancestor
55962425|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55962426|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55962427|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55962428|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
55962429|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962430|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962431|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962432|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
55962434|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962435|NCT04750603|Fluticasone|fluticasone|mesh-list
55962436|NCT04750603|Xhance|xhance|mesh-list
55962437|NCT04750603|Albuterol|albuterol|mesh-list
55962438|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55962439|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55962440|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
55962441|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962442|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962443|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55962444|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
55962445|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
55962446|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55962447|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
56062359|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062362|NCT01710787|Tetracaine|tetracaine|mesh-list
55962448|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55962449|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55962450|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56062444|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962451|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55962452|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
55962453|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962454|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962455|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
55962456|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55962457|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962458|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55962459|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55962460|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744185|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962461|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962462|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962463|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
55962464|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55962465|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
55962466|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962467|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
55962468|NCT00436969|Protective Agents|protective agents|mesh-ancestor
55962470|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55962471|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
55962472|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55962473|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962474|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962475|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962476|NCT00394277|Ribavirin|ribavirin|mesh-list
55962477|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55962478|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
55962479|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
56062446|NCT02276040|Bupivacaine|bupivacaine|mesh-list
55962480|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962481|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
55962482|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962483|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
55962484|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962485|NCT00395057|Ranibizumab|ranibizumab|mesh-list
55962486|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962487|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962488|NCT00395057|Growth Substances|growth substances|mesh-ancestor
55962489|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962490|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962491|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962492|NCT00438451|Lamotrigine|lamotrigine|mesh-list
55962493|NCT00438451|Carbamazepine|carbamazepine|mesh-list
55962494|NCT00438451|Levetiracetam|levetiracetam|mesh-list
55962495|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
55962496|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
55962497|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55962498|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56213387|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
56213388|NCT01746173|Vincristine|vincristine|mesh-list
56213389|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56213390|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
55962499|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962500|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55962501|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962502|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55962503|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55962504|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55962505|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55962506|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55962507|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
55962509|NCT00438451|Analgesics|analgesics|mesh-ancestor
55962510|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
55962511|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962512|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55962513|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55962514|NCT00456625|Vaccines|vaccines|mesh-list
55962515|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
55962516|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962517|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55962518|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55962519|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55962520|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55962521|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55962522|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
55962523|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062759|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962524|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962525|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962526|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55962527|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
55962528|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55962529|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
55962530|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55962531|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962532|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55962533|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962535|NCT01423604|Capecitabine|capecitabine|mesh-list
55962536|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55962537|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
55962538|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962539|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962540|NCT01402544|Ranibizumab|ranibizumab|mesh-list
55962541|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962542|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962543|NCT01402544|Growth Substances|growth substances|mesh-ancestor
55962544|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962545|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962546|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962547|NCT00460993|Eszopiclone|eszopiclone|mesh-list
55962548|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55962549|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55962550|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962551|NCT00441883|Latanoprost|latanoprost|mesh-list
55962552|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55962553|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55962554|NCT00461773|Bevacizumab|bevacizumab|mesh-list
55962555|NCT00461773|Letrozole|letrozole|mesh-list
55962556|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962557|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962558|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962559|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56063077|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
55962560|NCT00461773|Growth Substances|growth substances|mesh-ancestor
55962561|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962562|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962563|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55962564|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55962565|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213391|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962566|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962568|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
56063078|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962569|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962570|NCT00461851|Gemcitabine|gemcitabine|mesh-list
55962571|NCT00461851|Carboplatin|carboplatin|mesh-list
55962572|NCT00461851|Sorafenib|sorafenib|mesh-list
55962573|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962574|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55962575|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
55962576|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962577|NCT00461851|Antiviral Agents|antiviral agents|mesh-ancestor
55962578|NCT00461851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962579|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962583|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962585|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55962586|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962587|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962588|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962589|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962590|NCT00442507|Growth Substances|growth substances|mesh-ancestor
55962591|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962592|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962593|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962594|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962595|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962596|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
56063155|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55962597|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962598|NCT01387022|Tenofovir|tenofovir|mesh-list
55962599|NCT01387022|Lamivudine|lamivudine|mesh-list
55962600|NCT01387022|Efavirenz|efavirenz|mesh-list
55962601|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
55962602|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962603|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55962604|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55962605|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962606|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962607|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55962608|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55962609|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56063240|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56063241|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962610|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55962611|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55962612|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55962613|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55962614|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55962615|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
55962616|NCT00374231|Prednisone|prednisone|mesh-list
55962617|NCT00374231|Tacrolimus|tacrolimus|mesh-list
55962618|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55962619|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
55962620|NCT00374231|Hormones|hormones|mesh-ancestor
55962621|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962622|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962623|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962624|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962625|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962626|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
55962627|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55962628|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962629|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962630|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55962631|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55962632|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
55962633|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56063326|NCT02348385|Amphetamine|amphetamine|mesh-list
55962634|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962635|NCT00400205|Docetaxel|docetaxel|mesh-list
55962636|NCT00400205|Fluorouracil|fluorouracil|mesh-list
55962637|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962638|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
55962639|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
56213392|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213393|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55962640|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
55962641|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962642|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
55962643|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55962644|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962645|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
55962646|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962647|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55962648|NCT01386554|Hormones|hormones|mesh-ancestor
55962649|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962650|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962653|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55962654|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
56063426|NCT05709301|Cholinergic Agents|cholinergic agents|mesh-ancestor
56063427|NCT05709301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063428|NCT05709301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063429|NCT05709301|Nootropic Agents|nootropic agents|mesh-ancestor
56063430|NCT00003117|Paclitaxel|paclitaxel|mesh-list
56063431|NCT00003117|Carboplatin|carboplatin|mesh-list
56063432|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063433|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063434|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063435|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063436|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063437|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063438|NCT02240329|Capsaicin|capsaicin|mesh-list
56063439|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
56063440|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
56063441|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
55962655|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962656|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55962658|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
55962659|NCT00448201|Fludarabine|fludarabine|mesh-list
55962660|NCT00448201|Busulfan|busulfan|mesh-list
55962661|NCT00448201|Tacrolimus|tacrolimus|mesh-list
55962662|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55962663|NCT00448201|Sargramostim|sargramostim|mesh-list
55962664|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55962665|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
55962666|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55962667|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962668|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55962669|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
55962670|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962671|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962672|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
56063502|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
55962673|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962674|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55962675|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962676|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
55962677|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962678|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55962679|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55962680|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
55962681|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55962682|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55962683|NCT05287607|Bilirubin|bilirubin|mesh-list
55962684|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
55962685|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962686|NCT05287607|Protective Agents|protective agents|mesh-ancestor
55962687|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962688|NCT00375713|Cetirizine|cetirizine|mesh-list
55962689|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
55962690|NCT00375713|Levocetirizine|levocetirizine|mesh-list
55962691|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55962692|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55962693|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56063642|NCT04860661|Esketamine|esketamine|mesh-list
55962694|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55962695|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
55962696|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
55962697|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962698|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962699|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962700|NCT00465595|Psilocybin|psilocybin|mesh-list
55962701|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
55962702|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
55962703|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962704|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55962705|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55962706|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
55962707|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962708|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962709|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55962710|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
55962711|NCT00376805|Fludarabine|fludarabine|mesh-list
55962712|NCT00376805|Interleukin-2|interleukin-2|mesh-list
55790056|NCT04878497|Edoxaban|edoxaban|mesh-list
55962713|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962714|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
55962715|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962716|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962717|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55962718|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
55962719|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063967|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
55962720|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962721|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55962722|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55962723|NCT00376805|Analgesics|analgesics|mesh-ancestor
55962724|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
55962725|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962736|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962737|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55962739|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962740|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962741|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
55962742|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962743|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56064104|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064105|NCT01783561|Caffeine|caffeine|mesh-list
56064106|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
56064107|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064116|NCT02452931|Leuprolide|leuprolide|mesh-list
55962744|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962745|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
55962746|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962747|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55962748|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55962749|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
55962750|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55962751|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55962752|NCT00450073|Vitamin D|vitamin d|mesh-list
55962753|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
55962754|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
55962755|NCT00450073|Vitamins|vitamins|mesh-list
55962756|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
55962757|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962758|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55962759|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55962760|NCT00467077|Interferons|interferons|mesh-list
55962761|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
55962762|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
55962763|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55962764|NCT00467077|Gefitinib|gefitinib|mesh-list
55962765|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962766|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
55962767|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962768|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
56064164|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064165|NCT02458235|Azacitidine|azacitidine|mesh-list
56064166|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55962769|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962770|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962771|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962772|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962773|NCT00467389|Donepezil|donepezil|mesh-list
55962774|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55962775|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962776|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962777|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
55962778|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962779|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962780|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
55962781|NCT00377741|Valganciclovir|valganciclovir|mesh-list
55962782|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
55962783|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064312|NCT00544115|Sirolimus|sirolimus|mesh-list
55962784|NCT00379145|Trabectedin|trabectedin|mesh-list
55962785|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55962786|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
55962787|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962788|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962789|NCT00382031|Zalutumumab|zalutumumab|mesh-list
55962790|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55962791|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962792|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962795|NCT00382265|Tamsulosin|tamsulosin|mesh-list
55962796|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55962797|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55962798|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56213394|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
56213395|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962799|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
55962800|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962801|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962802|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962803|NCT00382265|Urological Agents|urological agents|mesh-ancestor
55962804|NCT00383747|Nicotine|nicotine|mesh-list
55962805|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55962806|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
56064392|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55962807|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962808|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962809|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55962810|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55962811|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
55962812|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962813|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962814|NCT01421342|Aripiprazole|aripiprazole|mesh-list
55962816|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
55962817|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55962818|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55962819|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55962820|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55744198|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
55962821|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56064492|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
56064496|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
55962822|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962824|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962825|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962826|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55962827|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55962828|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962829|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55962830|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55962831|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55962832|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
55962833|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55962834|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55803581|NCT00352027|Prednisone|prednisone|mesh-list
55962836|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55962837|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55962838|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55962839|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55962840|NCT00403403|Bevacizumab|bevacizumab|mesh-list
55962841|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962842|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962843|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962844|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962845|NCT00403403|Growth Substances|growth substances|mesh-ancestor
55962846|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962847|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962848|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
55962849|NCT00405353|Testosterone|testosterone|mesh-list
55962850|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
55962851|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
55962852|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55962853|NCT00405353|Androgens|androgens|mesh-ancestor
55962854|NCT00405353|Hormones|hormones|mesh-ancestor
56064649|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
55962855|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064650|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55962856|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962857|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962858|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962859|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
55962860|NCT01384292|Naloxegol|naloxegol|mesh-list
55962861|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55962862|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962863|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
55962864|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962867|NCT00450463|Flutamide|flutamide|mesh-list
55962868|NCT00450463|Sargramostim|sargramostim|mesh-list
56213396|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962869|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
55962870|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962871|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962872|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962873|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55962874|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55962875|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55962876|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
55962877|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
55962878|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962879|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55962880|NCT00407381|Ranibizumab|ranibizumab|mesh-list
55962881|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962882|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962883|NCT00407381|Growth Substances|growth substances|mesh-ancestor
55962884|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962885|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962886|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962887|NCT00384449|Ranibizumab|ranibizumab|mesh-list
55962888|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56064795|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064820|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55962889|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962890|NCT00384449|Growth Substances|growth substances|mesh-ancestor
55962891|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962892|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962893|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962894|NCT00452335|Lubiprostone|lubiprostone|mesh-list
55962895|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55962896|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889477|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064921|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
55962897|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962898|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
55962899|NCT00386243|Analgesics|analgesics|mesh-list
55962900|NCT00386243|Narcotics|narcotics|mesh-ancestor
55962901|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55962902|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962903|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
55962904|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962905|NCT01400516|Vitamin D|vitamin d|mesh-list
55962906|NCT01400516|Teriparatide|teriparatide|mesh-list
55962907|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
55962908|NCT01400516|Calcium|calcium|mesh-list
55962909|NCT01400516|Vitamins|vitamins|mesh-ancestor
55962910|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
56065068|NCT01827475|Analgesics|analgesics|mesh-ancestor
55962911|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962912|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55962913|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55962914|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55962915|NCT01383356|Metformin|metformin|mesh-list
55962916|NCT01383356|Linagliptin|linagliptin|mesh-list
55962917|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55962918|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962919|NCT01383356|Incretins|incretins|mesh-ancestor
55962920|NCT01383356|Hormones|hormones|mesh-ancestor
55962921|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55962922|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55962923|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
55962924|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962925|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962926|NCT02111447|Propofol|propofol|mesh-list
55962927|NCT02111447|Sevoflurane|sevoflurane|mesh-list
55962928|NCT02111447|Isoflurane|isoflurane|mesh-list
55962929|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55889478|NCT04124913|Progesterone|progesterone|mesh-list
56065175|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
55962930|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55962931|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962932|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55962933|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
55962934|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
55962935|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55962936|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55962937|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
55962938|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55962940|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
56213397|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56213398|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56213399|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
55962941|NCT00453193|Pentostatin|pentostatin|mesh-list
55962942|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962943|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962944|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
55962945|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962946|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962947|NCT00387023|Rituximab|rituximab|mesh-list
55962948|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962949|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962950|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
55962951|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962952|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962953|NCT00472849|Cytarabine|cytarabine|mesh-list
55962954|NCT00472849|Rituximab|rituximab|mesh-list
55962955|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
55962956|NCT00472849|Fludarabine|fludarabine|mesh-list
55962957|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962958|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962959|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
55962960|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962961|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962962|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55962963|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
55962964|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962965|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962966|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
55962967|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55962969|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789881|NCT04882163|Hormones|hormones|mesh-ancestor
55962970|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962971|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962972|NCT00453895|Growth Substances|growth substances|mesh-ancestor
55962973|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962974|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962975|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55962976|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55962977|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962978|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
55962979|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55962980|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56065445|NCT01834261|Oxytocin|oxytocin|mesh-list
55962981|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55962982|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55962983|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962984|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
55962985|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55962986|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962987|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55962988|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55962989|NCT00409565|Bevacizumab|bevacizumab|mesh-list
55962990|NCT00409565|Cetuximab|cetuximab|mesh-list
55962991|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55962992|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962993|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55962994|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55962995|NCT00409565|Growth Substances|growth substances|mesh-ancestor
55962996|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962997|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
55962998|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
55962999|NCT00475501|Finasteride|finasteride|mesh-list
55963000|NCT00475501|Testosterone|testosterone|mesh-list
55963001|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
55963002|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
55963003|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55963004|NCT00475501|Androgens|androgens|mesh-ancestor
55963005|NCT00475501|Hormones|hormones|mesh-ancestor
55963006|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963007|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065536|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
55963008|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56213400|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
56213401|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213402|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963009|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963010|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
55963011|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55963012|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55963014|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963015|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
55963016|NCT00475501|Urological Agents|urological agents|mesh-ancestor
55963017|NCT00529555|Minocycline|minocycline|mesh-list
55963018|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55963019|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963020|NCT00387335|Sunitinib|sunitinib|mesh-list
55963021|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963022|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963023|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963024|NCT00387335|Growth Substances|growth substances|mesh-ancestor
55963025|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963026|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
55963027|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55963028|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963029|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963030|NCT01797757|Orlistat|orlistat|mesh-list
55963031|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065587|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065588|NCT05249153|Analgesics|analgesics|mesh-ancestor
55963032|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963033|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55963034|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55963036|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
55963037|NCT04410445|Nivolumab|nivolumab|mesh-list
55963038|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963039|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963040|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55963041|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963043|NCT00477451|Doxapram|doxapram|mesh-list
55963044|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55963045|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55963046|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963047|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55963048|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55963049|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55963050|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
55963051|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
55963052|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963053|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963054|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55963055|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
55963056|NCT00530803|Lidocaine|lidocaine|mesh-list
55963057|NCT00530803|Tetracaine|tetracaine|mesh-list
55963058|NCT00530803|Prilocaine|prilocaine|mesh-list
55963059|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55963060|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
55963061|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
55963062|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55963063|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963064|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
55963065|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065661|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
55963066|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55963067|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55963068|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55963069|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963070|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963071|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55963072|NCT04372927|Cisplatin|cisplatin|mesh-list
55963073|NCT04372927|Etoposide|etoposide|mesh-list
55963074|NCT04372927|Pemetrexed|pemetrexed|mesh-list
55963075|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
55963076|NCT04372927|Durvalumab|durvalumab|mesh-list
55963077|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
55963078|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
55963079|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56213403|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56213404|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56213405|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55963080|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
55963081|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963082|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55963083|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55963084|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55963085|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065706|NCT05627557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963086|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963087|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55963088|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55963102|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
55963103|NCT01381874|Exemestane|exemestane|mesh-list
55963104|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
55963105|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55963106|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
55963107|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55963108|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
55963109|NCT01381874|Hormones|hormones|mesh-ancestor
55963110|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963111|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963112|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55963113|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963114|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
55963115|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
55963116|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963117|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55963118|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55963119|NCT01381874|Protective Agents|protective agents|mesh-ancestor
55963120|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55963121|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55963122|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963123|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963124|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55963125|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
55963126|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55963127|NCT01399190|Bevacizumab|bevacizumab|mesh-list
55963128|NCT01399190|Capecitabine|capecitabine|mesh-list
55963129|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
55963130|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963131|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963132|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963133|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963134|NCT01399190|Growth Substances|growth substances|mesh-ancestor
55963135|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963136|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
55963137|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55963138|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
55963139|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963140|NCT01381718|Modafinil|modafinil|mesh-list
55963141|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55963142|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963143|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55963144|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55963145|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55963146|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963147|NCT05365178|Fulvestrant|fulvestrant|mesh-list
55963148|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56065820|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55963149|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963150|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55963152|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
55963153|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963154|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963155|NCT00479089|Dexamethasone|dexamethasone|mesh-list
55963157|NCT00479089|Gefitinib|gefitinib|mesh-list
55963158|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55963159|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
55963160|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
55963161|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213406|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56213407|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
55790069|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
55963162|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963163|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55963164|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
55963165|NCT00479089|Hormones|hormones|mesh-ancestor
55963166|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963167|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55963168|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963169|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
55963170|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
55963171|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
55963172|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963173|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55963174|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963175|NCT01398956|Levetiracetam|levetiracetam|mesh-list
55963176|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
55963177|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
55963178|NCT00410423|Cytarabine|cytarabine|mesh-list
55963179|NCT00410423|Etoposide|etoposide|mesh-list
55963180|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
55963181|NCT00410423|Bortezomib|bortezomib|mesh-list
56065967|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065978|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56065979|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56065980|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56065981|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56065982|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065983|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
56065984|NCT05592197|Lenvatinib|lenvatinib|mesh-list
56065985|NCT05592197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065986|NCT05592197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56065987|NCT05592197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065988|NCT05592197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065989|NCT02989207|Mitomycins|mitomycins|mesh-list
56065990|NCT02989207|Mitomycin|mitomycin|mesh-list
56065991|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55963182|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55963183|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963184|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55744209|NCT03340597|Olorofim|olorofim|mesh-list
55963185|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55963186|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963188|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56066029|NCT02608229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066030|NCT02608229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066031|NCT02608229|Immunologic Factors|immunologic factors|mesh-ancestor
56066033|NCT01642212|Budesonide|budesonide|mesh-list
55963189|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
55963190|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
55963191|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963192|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55963193|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
55963194|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963195|NCT00410423|Analgesics|analgesics|mesh-ancestor
55963196|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
55963197|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963198|NCT00387959|Cyclosporine|cyclosporine|mesh-list
55963199|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
55963200|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
55963201|NCT00387959|Rituximab|rituximab|mesh-list
55963202|NCT00387959|Fludarabine|fludarabine|mesh-list
55963203|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
55963204|NCT00387959|Cyclosporins|cyclosporins|mesh-list
55963205|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066168|NCT01848067|Prednisone|prednisone|mesh-list
56066169|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
56066170|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066171|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
56066172|NCT01848067|Hormones|hormones|mesh-ancestor
56066173|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56066178|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066206|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066207|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
56066208|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066210|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
56066211|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066212|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56066213|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56066214|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56066215|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56066216|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55963206|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
55963207|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963208|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55963209|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55963210|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
55963211|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963212|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963213|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55963214|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963215|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55963216|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
55963217|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963218|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
56066253|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55963219|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963220|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
55963221|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55963222|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55963223|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55963226|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
55963227|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55963228|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963229|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55963230|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56213409|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213410|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56213411|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56213412|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
55790073|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
55963231|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55963232|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55963233|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963234|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963235|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963236|NCT01381562|Meropenem|meropenem|mesh-list
55963237|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55963238|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963239|NCT01381016|Hormones|hormones|mesh-list
55963240|NCT01381016|Estradiol|estradiol|mesh-list
55963241|NCT01381016|Progesterone|progesterone|mesh-list
55963242|NCT01381016|Estrogens|estrogens|mesh-list
55963243|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963244|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963245|NCT01381016|Progestins|progestins|mesh-ancestor
55963246|NCT00412451|Plasminogen|plasminogen|mesh-list
55963247|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56066487|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55963248|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55963249|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963250|NCT01398410|Rabeprazole|rabeprazole|mesh-list
55963251|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55963252|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55963253|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55963254|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963255|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963256|NCT00412529|Entecavir|entecavir|mesh-list
55963257|NCT00412529|Telbivudine|telbivudine|mesh-list
55963259|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963260|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55963261|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963262|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963263|NCT00412841|Atorvastatin|atorvastatin|mesh-list
55963264|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55963265|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56066573|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55963266|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
55963267|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963268|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55963269|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55963270|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963271|NCT01796483|Clonidine|clonidine|mesh-list
55963272|NCT01796483|Analgesics|analgesics|mesh-ancestor
55963273|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
55963274|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963275|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963276|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55963277|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
55963278|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
55963279|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55963280|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55963281|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55963282|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
55963283|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963284|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963285|NCT00414167|Bupropion|bupropion|mesh-list
55963286|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55963287|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
55963288|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55963289|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55963290|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55963291|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963292|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963293|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
55963294|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213413|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
56213414|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
55963295|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963296|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55963310|NCT04245865|Capecitabine|capecitabine|mesh-list
55963311|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
55963312|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
55963313|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963314|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963315|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963316|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963317|NCT04245865|Growth Substances|growth substances|mesh-ancestor
55803643|NCT02576977|Hormones|hormones|mesh-ancestor
55963318|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963319|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
55963320|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
56066716|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066717|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55963321|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963322|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55963323|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55963324|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
55963325|NCT04245865|Antidotes|antidotes|mesh-ancestor
55963326|NCT04245865|Protective Agents|protective agents|mesh-ancestor
55963327|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
55963328|NCT04245865|Vitamins|vitamins|mesh-ancestor
56066781|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55963329|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
55963330|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
55963331|NCT00534001|Bupropion|bupropion|mesh-list
55963332|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55963333|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
55963334|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55963335|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55963336|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55963337|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963338|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963339|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
55963340|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963341|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963342|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55963343|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56066887|NCT05588219|Cisplatin|cisplatin|mesh-list
55963344|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963345|NCT00481351|Simvastatin|simvastatin|mesh-list
55963346|NCT00481351|Ezetimibe|ezetimibe|mesh-list
55963347|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55963348|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55963349|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
55963350|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963351|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55963352|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55963353|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963354|NCT00455975|Bevacizumab|bevacizumab|mesh-list
55963355|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963356|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963357|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963358|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963359|NCT00455975|Growth Substances|growth substances|mesh-ancestor
55963360|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963362|NCT05366192|Ritonavir|ritonavir|mesh-list
55963363|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55963364|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55963365|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
55963366|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963367|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963368|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55963369|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55963370|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
55963371|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963372|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55963373|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55963374|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
55963375|NCT04013672|Sargramostim|sargramostim|mesh-list
55963376|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55963377|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963378|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963379|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
56213415|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56213416|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56213417|NCT01694004|Benzocaine|benzocaine|mesh-list
56213418|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
56213419|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
56067153|NCT05044871|Paclitaxel|paclitaxel|mesh-list
55790080|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
55963380|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963381|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55963382|NCT02078882|Abatacept|abatacept|mesh-list
55963383|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55963384|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963385|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963386|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55963387|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
55963388|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963389|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55963390|NCT00458237|Trastuzumab|trastuzumab|mesh-list
55963391|NCT00458237|Everolimus|everolimus|mesh-list
55963392|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963393|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963394|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55963395|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
55963396|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963397|NCT00418457|Anesthetics|anesthetics|mesh-list
55963398|NCT00418457|Propofol|propofol|mesh-list
55963399|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55963400|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963401|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55963402|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55963403|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
55963404|NCT00482677|Temozolomide|temozolomide|mesh-list
55963405|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55963406|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
55963407|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067250|NCT01585805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963408|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963410|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
55963411|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55963412|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55963413|NCT01397552|Prednisolone|prednisolone|mesh-list
55963414|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
55963415|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55963416|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
55963417|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55963418|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
55963419|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
55963420|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963421|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963422|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55963423|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
55963424|NCT01397552|Hormones|hormones|mesh-ancestor
55963425|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963426|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56067324|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963427|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963428|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55963429|NCT01397552|Protective Agents|protective agents|mesh-ancestor
55963430|NCT05368376|Metoprolol|metoprolol|mesh-list
55963431|NCT05368376|Labetalol|labetalol|mesh-list
55963432|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55963433|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55963434|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
55963435|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
55963436|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963449|NCT00482911|Sunitinib|sunitinib|mesh-list
55963450|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55963451|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
55963452|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963453|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55963454|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55963455|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
55963456|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963457|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213420|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213421|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963458|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55963459|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963460|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963461|NCT00482911|Growth Substances|growth substances|mesh-ancestor
55963463|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55963464|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963465|NCT01397162|Fluticasone|fluticasone|mesh-list
55963467|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55963468|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55963469|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
55963470|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963471|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963472|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55963473|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
55963474|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
55963475|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55963476|NCT05362916|Letermovir|letermovir|mesh-list
55963477|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55963478|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963479|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963480|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963481|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
55963482|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963483|NCT00483223|Carboplatin|carboplatin|mesh-list
55963484|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963485|NCT01397084|Esomeprazole|esomeprazole|mesh-list
55963486|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55963487|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55963488|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55963489|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963490|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963491|NCT04221529|Atezolizumab|atezolizumab|mesh-list
55963492|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963493|NCT00420017|Amiodarone|amiodarone|mesh-list
55963494|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55963495|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
55963496|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55963497|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963499|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56067575|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
55963500|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55963501|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55963502|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963503|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55963504|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55963505|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55963506|NCT04092673|Trastuzumab|trastuzumab|mesh-list
55963507|NCT04092673|Fulvestrant|fulvestrant|mesh-list
55963508|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963509|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963510|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55963511|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55963512|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55963513|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
55963514|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963515|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963516|NCT00484393|Tetracaine|tetracaine|mesh-list
55963517|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
55963518|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
55963519|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55963520|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963521|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
55963522|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963523|NCT00485485|Docetaxel|docetaxel|mesh-list
55963524|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
55963525|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803663|NCT03908437|Buprenorphine|buprenorphine|mesh-list
55963526|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
56213422|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
56213423|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213425|NCT01545843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56213426|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55790083|NCT02614859|Metformin|metformin|mesh-list
55963527|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
55963528|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
55963529|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963530|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55963531|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963532|NCT00422201|Mifepristone|mifepristone|mesh-list
56067639|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55963533|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55963534|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
55963535|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55963536|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963537|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55963538|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55963539|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55963540|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
55963541|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55963542|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55963543|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
55963544|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963545|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
55963546|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55963547|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55963548|NCT01396148|Sunitinib|sunitinib|mesh-list
55963549|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963550|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963551|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963552|NCT01396148|Growth Substances|growth substances|mesh-ancestor
55963553|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963554|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
55963555|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55963556|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963557|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963558|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
55963559|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55963560|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963561|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963562|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55963563|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067724|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
55963564|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55963566|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55963567|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55963569|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
55963570|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963571|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963572|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55963573|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55963574|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55963576|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
55963577|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
55963578|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55963579|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963580|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
55963581|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963582|NCT04017962|Letermovir|letermovir|mesh-list
55963583|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55963584|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803668|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55963585|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963586|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963587|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
55963588|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213427|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963589|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55963590|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067835|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
55963591|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963592|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
55963593|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55963594|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55963595|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963596|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55963597|NCT02108171|Analgesics|analgesics|mesh-ancestor
55963598|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
55963599|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963600|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55963601|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55963602|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55963603|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
55963604|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963605|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067890|NCT04408625|Sirolimus|sirolimus|mesh-list
55963607|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55963608|NCT03940807|Estrogens|estrogens|mesh-ancestor
55963609|NCT03940807|Hormones|hormones|mesh-ancestor
55963610|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963611|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963612|NCT00535873|Lenalidomide|lenalidomide|mesh-list
55963613|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
55963614|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963615|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963616|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963617|NCT00535873|Growth Substances|growth substances|mesh-ancestor
55963618|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
55963619|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963620|NCT00487669|Paclitaxel|paclitaxel|mesh-list
55963621|NCT00487669|Pemetrexed|pemetrexed|mesh-list
55963622|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
55963623|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55963624|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963625|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
55963626|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
55963627|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
55744214|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
55963628|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963629|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963630|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55963631|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55963632|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
55963633|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
55963634|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
55963635|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55963636|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55963637|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963638|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55963639|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55963641|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963643|NCT02120287|Bevacizumab|bevacizumab|mesh-list
55963644|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963645|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068035|NCT02661971|Vitamins|vitamins|mesh-ancestor
55963646|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963647|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963648|NCT02120287|Growth Substances|growth substances|mesh-ancestor
55963649|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963650|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
55963651|NCT00536341|Rituximab|rituximab|mesh-list
55963652|NCT00536341|Fludarabine|fludarabine|mesh-list
55963653|NCT00536341|Lenalidomide|lenalidomide|mesh-list
55803692|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
55963654|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963655|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963656|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
55963657|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963658|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55963659|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963660|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963661|NCT00536341|Growth Substances|growth substances|mesh-ancestor
56213428|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213429|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213430|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
56213431|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213432|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56213433|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
56213434|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56213435|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55963662|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
55963663|NCT02122471|Plecanatide|plecanatide|mesh-list
55963664|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55963665|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
55963666|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963667|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55963668|NCT00461591|Apaziquone|apaziquone|mesh-list
55963669|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963670|NCT00533117|Fluoxetine|fluoxetine|mesh-list
55963671|NCT00533117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55963672|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55963673|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963674|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963675|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963676|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
55963677|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963678|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55963679|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
55963680|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55963681|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55963682|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55963683|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963684|NCT00423683|PENTA|penta|mesh-list
55963685|NCT00423683|Fondaparinux|fondaparinux|mesh-list
55963686|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55963687|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
55963688|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55963689|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
55963690|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963691|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963692|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
55963693|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55963694|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55963695|NCT00424619|Vitamin D|vitamin d|mesh-list
55963696|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
55963697|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
55963698|NCT00424619|Vitamins|vitamins|mesh-list
55963699|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
55963700|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963701|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55803699|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963702|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55963706|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963707|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068290|NCT05735197|Dapagliflozin|dapagliflozin|mesh-list
56068293|NCT05735197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55963708|NCT00427037|Vitamin D|vitamin d|mesh-list
55963709|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
55963710|NCT00427037|Vitamins|vitamins|mesh-ancestor
55963711|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
55963712|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963713|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55963714|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55963715|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
55963717|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963718|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55963719|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963720|NCT00427661|Cyclosporine|cyclosporine|mesh-list
55963721|NCT00427661|Fludarabine|fludarabine|mesh-list
56213436|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55963722|NCT00427661|Busulfan|busulfan|mesh-list
55963723|NCT00427661|Cyclosporins|cyclosporins|mesh-list
55963724|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068405|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963725|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963726|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55963727|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
55963728|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963729|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963730|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
55963731|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963732|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
55963733|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55963734|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55963735|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
55963736|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55963737|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55963738|NCT00427973|Cediranib|cediranib|mesh-list
55963739|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963740|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963741|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963742|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55963743|NCT01795703|Prednisolone|prednisolone|mesh-list
55963744|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55963745|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
55963746|NCT01795703|Hormones|hormones|mesh-ancestor
55963747|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963748|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068505|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56068510|NCT05062577|Buprenorphine|buprenorphine|mesh-list
55963749|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55963750|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963751|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
55963752|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
55963753|NCT00429143|Tacrolimus|tacrolimus|mesh-list
55963754|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55963755|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
55963756|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963757|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56068563|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
55963758|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55963759|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
55963760|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963761|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963762|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55963763|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55963764|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963765|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55963766|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55963767|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
55963768|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55963769|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963770|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
55963772|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55963773|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55963774|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963775|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963776|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
55963777|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963778|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963779|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55963780|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963781|NCT00433745|Vaccines|vaccines|mesh-list
55963782|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
56068717|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
55795916|NCT02521415|Ibuprofen|ibuprofen|mesh-list
55963783|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963784|NCT01395758|Gemcitabine|gemcitabine|mesh-list
55963785|NCT01395758|Docetaxel|docetaxel|mesh-list
55963786|NCT01395758|Pemetrexed|pemetrexed|mesh-list
55963787|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55963788|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55963798|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
55963799|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
55963800|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
55963801|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55963802|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56213437|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213438|NCT00843791|Pioglitazone|pioglitazone|mesh-list
56213439|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
55963803|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55963805|NCT00462605|Sargramostim|sargramostim|mesh-list
56068811|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
55963806|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55963807|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
55963808|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963809|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963810|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963811|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963812|NCT00534833|Vaccines|vaccines|mesh-list
55963813|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
55963814|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963815|NCT00434993|Albuterol|albuterol|mesh-list
55963816|NCT00434993|Dimercaprol|dimercaprol|mesh-list
55963817|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55963818|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
55963819|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55963820|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963821|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55963822|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
55963823|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
55963824|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55963825|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55963826|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55963827|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55963828|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
55963829|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963830|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963831|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
55963832|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
55963833|NCT01395524|Naloxegol|naloxegol|mesh-list
55963834|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55963835|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963836|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
55963839|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
55963840|NCT04338698|Oseltamivir|oseltamivir|mesh-list
55963841|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55963842|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963843|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
55963844|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55963845|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55963846|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963847|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963848|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55963849|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
55963850|NCT00435539|Plasminogen|plasminogen|mesh-list
55963851|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
55963852|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56068987|NCT05349071|Prednisolone|prednisolone|mesh-list
55963853|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55963861|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
55963862|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963863|NCT00464711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55963864|NCT00464711|Antidepressive Agents|antidepressive agents|mesh-ancestor
55963865|NCT00464711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55963866|NCT02078180|Bupropion|bupropion|mesh-list
55963867|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55963868|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
55963869|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55963870|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55963871|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55963872|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963873|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963874|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
55963875|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963876|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963877|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55963878|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56213440|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56213441|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069070|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963879|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963880|NCT00535613|Propofol|propofol|mesh-list
55963881|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55963882|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55963883|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963884|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55963885|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
55963886|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
55963887|NCT00466661|Acamprosate|acamprosate|mesh-list
55963888|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55963889|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55963890|NCT05360576|Etonogestrel|etonogestrel|mesh-list
55963891|NCT05360576|NuvaRing|nuvaring|mesh-list
55963892|NCT05360576|Estradiol|estradiol|mesh-list
55963893|NCT05360576|Estrogens|estrogens|mesh-ancestor
55963894|NCT05360576|Hormones|hormones|mesh-ancestor
55963895|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55963896|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963897|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55963898|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
56069161|NCT05691829|Pembrolizumab|pembrolizumab|mesh-list
55963899|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55963900|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55963901|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55963902|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55963903|NCT00535925|Aspirin|aspirin|mesh-list
55963904|NCT00535925|Atenolol|atenolol|mesh-list
55963905|NCT00535925|Amlodipine|amlodipine|mesh-list
55963906|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55963907|NCT00535925|Clonidine|clonidine|mesh-list
55963908|NCT00535925|Ramipril|ramipril|mesh-list
55963909|NCT00535925|Irbesartan|irbesartan|mesh-list
55963910|NCT00535925|Doxazosin|doxazosin|mesh-list
55963911|NCT00535925|Furosemide|furosemide|mesh-list
55963912|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
55963913|NCT00535925|Simvastatin|simvastatin|mesh-list
55963914|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963915|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55963916|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55963917|NCT00535925|Analgesics|analgesics|mesh-ancestor
55963918|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
55963919|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069232|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963920|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55963921|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55963922|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55963923|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55963924|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963925|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55963926|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55963927|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963929|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55963930|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55963931|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963932|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55963933|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
55963934|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55963935|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55963936|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
55963937|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55963938|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55963939|NCT00535925|Diuretics|diuretics|mesh-ancestor
55963940|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
55963941|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55963942|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55963943|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
55963944|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
55963945|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55963946|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55963947|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55963948|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
55963949|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963950|NCT00535925|Hematinics|hematinics|mesh-ancestor
55963951|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55963952|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
55963953|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55963954|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55963955|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55963956|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55963957|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55963958|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55963959|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55963960|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55963961|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55963962|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55963963|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
55963964|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963965|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963966|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963968|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55963969|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55963970|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963971|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963972|NCT01796093|Protective Agents|protective agents|mesh-ancestor
55963973|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963975|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
55963976|NCT00537511|Pomalidomide|pomalidomide|mesh-list
55963977|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963978|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55963979|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55963980|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55963981|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963982|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963983|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
55963984|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963985|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55963986|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55963987|NCT00537511|Growth Substances|growth substances|mesh-ancestor
55963988|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
55963989|NCT00435929|Ritonavir|ritonavir|mesh-list
55963990|NCT00435929|Saquinavir|saquinavir|mesh-list
55963991|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55963992|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55963993|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
55963995|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963996|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55963997|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55963998|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
55963999|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964000|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55964001|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55964003|NCT00436475|Vitamin D|vitamin d|mesh-list
55964004|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
55964005|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
55964006|NCT00436475|Vitamins|vitamins|mesh-list
55964007|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
55964008|NCT00436475|Calcium|calcium|mesh-list
55964009|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
55964010|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964011|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55964012|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55964013|NCT00436475|Antacids|antacids|mesh-ancestor
55964014|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964015|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55964016|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
55964017|NCT00210626|Hematinics|hematinics|mesh-ancestor
55964018|NCT03595514|Dexamethasone|dexamethasone|mesh-list
55964019|NCT03595514|Lidocaine|lidocaine|mesh-list
56069519|NCT04757675|Ketamine|ketamine|mesh-list
55964020|NCT03595514|Epinephrine|epinephrine|mesh-list
55964021|NCT03595514|Bupivacaine|bupivacaine|mesh-list
55964022|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964023|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
55964024|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
55964025|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213442|NCT03187769|Olanzapine|olanzapine|mesh-list
56213443|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
56213444|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
55964026|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964027|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55964028|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
55964029|NCT03595514|Hormones|hormones|mesh-ancestor
55964030|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964031|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55964032|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964033|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
55964034|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
55964035|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964036|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
55964037|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55964038|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55964039|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55964040|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55964041|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964042|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55964043|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55964044|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
55964045|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964046|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55964047|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55964048|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55964049|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
55964050|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
55964051|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
55964052|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55964053|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
55964054|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
55964055|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964056|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
55964057|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964058|NCT03595046|Dexamethasone|dexamethasone|mesh-list
55964059|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
55964060|NCT03595046|Ropivacaine|ropivacaine|mesh-list
55964061|NCT03595046|BB 1101|bb 1101|mesh-list
55964062|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964063|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
55964064|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
55964065|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964066|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964067|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55964068|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
55964069|NCT03595046|Hormones|hormones|mesh-ancestor
55964070|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964071|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55964072|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964074|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964075|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964076|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
55964077|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
55964078|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964079|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
55964080|NCT00217022|Budesonide|budesonide|mesh-list
55964081|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964082|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55964083|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
55964084|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964085|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964086|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55964087|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
55964088|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
55964089|NCT00217022|Hormones|hormones|mesh-ancestor
55964090|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964091|NCT03594968|Progesterone|progesterone|mesh-list
55964092|NCT03594968|Progestins|progestins|mesh-ancestor
55964093|NCT03594968|Hormones|hormones|mesh-ancestor
55964094|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964095|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213445|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213446|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213447|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55964097|NCT00538915|Antibodies|antibodies|mesh-list
55964098|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
55964099|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55964100|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56069832|NCT04265053|Ketorolac|ketorolac|mesh-list
55964101|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
55964102|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964103|NCT00490009|Acetaminophen|acetaminophen|mesh-list
55964104|NCT00490009|Iodine|iodine|mesh-list
55964105|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
55964106|NCT00490009|Promethazine|promethazine|mesh-list
55964107|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
55964108|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
55964109|NCT00490009|Lugol's solution|lugol's solution|mesh-list
55964110|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55964111|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55964112|NCT00490009|Analgesics|analgesics|mesh-ancestor
55803758|NCT03009019|Celecoxib|celecoxib|mesh-list
55964114|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964115|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964117|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55964118|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964119|NCT00490009|Trace Elements|trace elements|mesh-ancestor
55964120|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
55964121|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55964122|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55964123|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964124|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
55964125|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
55964126|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
55964127|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
55964128|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55964129|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55964130|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
55964131|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
56070011|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
55964132|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964133|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070020|NCT02316379|Xenon|xenon|mesh-list
55964134|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55964135|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
55964136|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
55964137|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964138|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
55964139|NCT00490009|Coagulants|coagulants|mesh-ancestor
55964140|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
55964141|NCT03769532|Azacitidine|azacitidine|mesh-list
55964142|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55964143|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964144|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55964145|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
55964146|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964147|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964149|NCT00490477|Polymyxin B|polymyxin b|mesh-list
55964150|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56070105|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964151|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964152|NCT03997370|Carboplatin|carboplatin|mesh-list
55964153|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964155|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
55964156|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55964157|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55964158|NCT00492973|Prednisolone|prednisolone|mesh-list
55964159|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
55964160|NCT00492973|Clonidine|clonidine|mesh-list
55964161|NCT00492973|Epinephrine|epinephrine|mesh-list
55964162|NCT00492973|Morphine|morphine|mesh-list
55964163|NCT00492973|Bupivacaine|bupivacaine|mesh-list
55964164|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56070199|NCT02895035|Protective Agents|protective agents|mesh-ancestor
55964165|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
55964166|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
55964167|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
55964168|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964169|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213448|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55964170|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
55964171|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964172|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55964173|NCT00492973|Narcotics|narcotics|mesh-ancestor
55964174|NCT00492973|Analgesics|analgesics|mesh-ancestor
55964175|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964176|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
55789918|NCT04881851|Vitamins|vitamins|mesh-ancestor
55964178|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55964179|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
55964180|NCT00492973|Hormones|hormones|mesh-ancestor
55964181|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964182|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55964183|NCT00492973|Protective Agents|protective agents|mesh-ancestor
55964184|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55964185|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964186|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55964187|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55964188|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
55964189|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964190|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964191|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55964192|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55964193|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55964194|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
55964195|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
55964196|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
55964197|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55964198|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55964199|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
55964200|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55964201|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55964202|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964203|NCT05630534|Minocycline|minocycline|mesh-list
55964204|NCT05630534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55964205|NCT05630534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964206|NCT00495079|Vincristine|vincristine|mesh-list
55964207|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55964208|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964209|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
55964210|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
55964211|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
55964212|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964213|NCT05630222|Acetaminophen|acetaminophen|mesh-list
55964214|NCT05630222|Ibuprofen|ibuprofen|mesh-list
55964215|NCT05630222|Morphine|morphine|mesh-list
55964216|NCT05630222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55964217|NCT05630222|Narcotics|narcotics|mesh-ancestor
55964218|NCT05630222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964219|NCT05630222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964220|NCT05630222|Analgesics|analgesics|mesh-ancestor
55964221|NCT05630222|Sensory System Agents|sensory system agents|mesh-ancestor
55964222|NCT05630222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964223|NCT05630222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55964224|NCT05630222|Antipyretics|antipyretics|mesh-ancestor
55964236|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964237|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55964238|NCT00539695|Analgesics|analgesics|mesh-ancestor
56070737|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
55964239|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
55964240|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964241|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964242|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55964243|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55964244|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
55964245|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964246|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
55964247|NCT03590054|Abexinostat|abexinostat|mesh-list
55964248|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55964249|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964250|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55964251|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964252|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964253|NCT03593954|Ritonavir|ritonavir|mesh-list
55964254|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56213449|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56213450|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213451|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56213452|NCT03187769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56213453|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56213454|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55790106|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55964255|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55964256|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
55964257|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964258|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964259|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55964260|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55964261|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
55964262|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964263|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55964264|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55964266|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55964267|NCT03590210|Nivolumab|nivolumab|mesh-list
55964268|NCT03590210|Trabectedin|trabectedin|mesh-list
55964269|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55964270|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964271|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56070890|NCT02014363|Analgesics|analgesics|mesh-ancestor
55964272|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964273|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55964274|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
55964275|NCT05632328|Gemcitabine|gemcitabine|mesh-list
55964276|NCT05632328|Paclitaxel|paclitaxel|mesh-list
55964277|NCT05632328|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55964278|NCT05632328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55964279|NCT05632328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964280|NCT05632328|Tubulin Modulators|tubulin modulators|mesh-ancestor
55964281|NCT05632328|Antimitotic Agents|antimitotic agents|mesh-ancestor
55964282|NCT05632328|Mitosis Modulators|mitosis modulators|mesh-ancestor
55964283|NCT05632328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964284|NCT05632328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55964285|NCT05632328|Antimetabolites|antimetabolites|mesh-ancestor
55964294|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
55964296|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55964297|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964298|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964299|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
55964300|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964301|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964302|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
55964303|NCT00466817|Valganciclovir|valganciclovir|mesh-list
55964304|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
55964305|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964306|NCT04406870|Sirolimus|sirolimus|mesh-list
55964307|NCT04406870|Propranolol|propranolol|mesh-list
55964308|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56070944|NCT02837237|Hormones|hormones|mesh-ancestor
55964309|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964310|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55964311|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964312|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
55964313|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55964314|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
55964315|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964316|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55964317|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55964318|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
55964319|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964320|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964321|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55964322|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56213455|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213456|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213457|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
56213458|NCT03161353|Tamoxifen|tamoxifen|mesh-list
56213459|NCT03161353|Carboplatin|carboplatin|mesh-list
56213460|NCT03161353|Docetaxel|docetaxel|mesh-list
56213461|NCT03161353|Trastuzumab|trastuzumab|mesh-list
56213462|NCT03161353|Letrozole|letrozole|mesh-list
56071032|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213463|NCT03161353|Pertuzumab|pertuzumab|mesh-list
56213464|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213465|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
56213466|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
56213467|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
56213468|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213469|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213470|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56213471|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56213472|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213473|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56213474|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
56213475|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964323|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
55964324|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55964325|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
55964326|NCT03985514|Tazobactam|tazobactam|mesh-list
55964327|NCT03985514|Piperacillin|piperacillin|mesh-list
55964328|NCT03985514|Metronidazole|metronidazole|mesh-list
55964329|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55964330|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55964331|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964332|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
55964333|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55964334|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55964335|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964336|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964337|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964338|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55964339|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55964340|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55964341|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55964342|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55964343|NCT00540007|Lenalidomide|lenalidomide|mesh-list
55964344|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
55964345|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964346|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55964347|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55964348|NCT00540007|Growth Substances|growth substances|mesh-ancestor
55964349|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
55964350|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964351|NCT02982889|Bupivacaine|bupivacaine|mesh-list
55964352|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
55964353|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
55964356|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964358|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071086|NCT02937623|Calcium|calcium|mesh-list
55964359|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56213476|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828842|NCT01534078|Vinblastine|vinblastine|mesh-list
56000866|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964361|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
55964362|NCT02982889|Protective Agents|protective agents|mesh-ancestor
55964363|NCT01867333|Metronidazole|metronidazole|mesh-list
55964364|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964365|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55964366|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55964367|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55964368|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55964369|NCT03592082|Bismuth|bismuth|mesh-list
55964370|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
55964371|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964372|NCT03592082|Antacids|antacids|mesh-ancestor
55964373|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964374|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55964375|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
55964376|NCT03598868|Vortioxetine|vortioxetine|mesh-list
55964377|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
55964378|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55964379|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55964380|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55964381|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964382|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071126|NCT02025439|Amantadine|amantadine|mesh-list
56071127|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56071128|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56071129|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
55798328|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071131|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
55964383|NCT03598868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55964384|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55964385|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55964386|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964387|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964388|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
55964389|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55964390|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55964391|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55964392|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55964393|NCT03974828|Anesthetics|anesthetics|mesh-list
55964394|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964395|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964396|NCT00501631|Naltrexone|naltrexone|mesh-list
55964397|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55964398|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56071193|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55964399|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964400|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
55964401|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964402|NCT05631704|Midazolam|midazolam|mesh-list
55964403|NCT05631704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55964404|NCT05631704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55964405|NCT05631704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964406|NCT05631704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964407|NCT05631704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55964408|NCT05631704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55964409|NCT05631704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55964410|NCT05631704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55964411|NCT05631704|Anesthetics, General|anesthetics, general|mesh-ancestor
55964412|NCT05631704|Anesthetics|anesthetics|mesh-ancestor
55964413|NCT05631704|GABA Modulators|gaba modulators|mesh-ancestor
56071357|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
55964414|NCT05631704|GABA Agents|gaba agents|mesh-ancestor
55964415|NCT05631704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964416|NCT05631704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964417|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
55964418|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55964419|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964420|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964421|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55964422|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55964423|NCT03591536|Protective Agents|protective agents|mesh-ancestor
55964424|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964427|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
55964428|NCT00501943|Interferons|interferons|mesh-list
56213478|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56213479|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56213480|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55964429|NCT00501943|Interferon-beta|interferon-beta|mesh-list
55964430|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
55964432|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964433|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
55964434|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964435|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
55964436|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964437|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55964438|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
55964439|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55964440|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55964441|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964442|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964443|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55964444|NCT00501943|Protective Agents|protective agents|mesh-ancestor
55964445|NCT03598634|Riboflavin|riboflavin|mesh-list
55964446|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
55964447|NCT03598634|Vitamins|vitamins|mesh-ancestor
55964448|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
55964449|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964450|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55964451|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
55964452|NCT03598556|Vitamin D|vitamin d|mesh-list
55964453|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
55964454|NCT03598556|Vitamins|vitamins|mesh-ancestor
55964455|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
55964456|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964457|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55964458|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55964459|NCT03024476|Olmesartan|olmesartan|mesh-list
55964460|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55964461|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55964462|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55964463|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964464|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
56071651|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55964466|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55964467|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
55964468|NCT03590912|Prednisolone|prednisolone|mesh-list
55964469|NCT03590912|Phenylephrine|phenylephrine|mesh-list
55964470|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
55964471|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
55964472|NCT03590912|Levocetirizine|levocetirizine|mesh-list
55964473|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
55964474|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55964475|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964476|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964477|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
55964478|NCT03590912|Hormones|hormones|mesh-ancestor
55803834|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964479|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964481|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55964482|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964483|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
55964484|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964485|NCT03590912|Protective Agents|protective agents|mesh-ancestor
55964486|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
55964487|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55964488|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55964489|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
55964490|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964491|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964492|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55964493|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55964494|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
55964495|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
55964496|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55964497|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
56213482|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
56213483|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213484|NCT03134196|Valacyclovir|valacyclovir|mesh-list
56071849|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56213485|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
55964498|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55964499|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
55964500|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55964515|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
55964516|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964517|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55964518|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964519|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55964520|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55964521|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55964524|NCT00504751|Etoposide|etoposide|mesh-list
55964525|NCT00504751|Bortezomib|bortezomib|mesh-list
55964526|NCT00504751|Ifosfamide|ifosfamide|mesh-list
55964527|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55964528|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964529|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
55964530|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071916|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
55964531|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56071917|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56071918|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55964532|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964533|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
55964534|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
55964535|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964536|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55964537|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
55964538|NCT00504751|Hormones|hormones|mesh-ancestor
55964539|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964540|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55964541|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55964542|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55964543|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55964544|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964545|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964546|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55964547|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
55964549|NCT01013779|Etoposide|etoposide|mesh-list
55964550|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071994|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55964551|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55964552|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55964553|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55964554|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964555|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964557|NCT05630846|Immunologic Factors|immunologic factors|mesh-ancestor
55964558|NCT05630846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964559|NCT05630768|Vitamin D|vitamin d|mesh-list
55964560|NCT05630768|Risedronic Acid|risedronic acid|mesh-list
55964561|NCT05630768|Calcium|calcium|mesh-list
55964562|NCT05630768|Vitamins|vitamins|mesh-ancestor
55964563|NCT05630768|Micronutrients|micronutrients|mesh-ancestor
55964565|NCT05630768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55964566|NCT05630768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55964567|NCT05630768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55964568|NCT05630768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072117|NCT03145259|Diclofenac|diclofenac|mesh-list
55964569|NCT05630768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964570|NCT00506155|Bevacizumab|bevacizumab|mesh-list
55964571|NCT00506155|Cisplatin|cisplatin|mesh-list
55964572|NCT00506155|Doxorubicin|doxorubicin|mesh-list
55964573|NCT00506155|Methotrexate|methotrexate|mesh-list
55964574|NCT00506155|Vinblastine|vinblastine|mesh-list
55964575|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55964576|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964577|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55964578|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55964579|NCT00506155|Growth Substances|growth substances|mesh-ancestor
55964580|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964581|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
56213486|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213487|NCT02956382|Venetoclax|venetoclax|mesh-list
56213488|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213489|NCT02939573|Dapsone|dapsone|mesh-list
55964582|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55964583|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55964584|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55964585|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964586|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964587|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55964588|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
55964589|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55964590|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55964591|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
55964592|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
55964593|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55964594|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55964595|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
55964596|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55964597|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55964598|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55964599|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
55964600|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
55964601|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
55964602|NCT03590444|Ranibizumab|ranibizumab|mesh-list
55964603|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55964604|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55964605|NCT03590444|Growth Substances|growth substances|mesh-ancestor
55964606|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964607|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
55964608|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964609|NCT00506857|Fludarabine|fludarabine|mesh-list
55964610|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
55964611|NCT00506857|Busulfan|busulfan|mesh-list
55964612|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964613|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55964614|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
55964615|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964616|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55964617|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
55964618|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964619|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
55964620|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55964621|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55964622|NCT04005170|Paclitaxel|paclitaxel|mesh-list
55964623|NCT04005170|Cisplatin|cisplatin|mesh-list
55964624|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55964625|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964626|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
55964627|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
55964628|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
55964629|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964630|NCT03597308|Acetaminophen|acetaminophen|mesh-list
55964631|NCT03597308|Ibuprofen|ibuprofen|mesh-list
55964632|NCT03597308|Oxycodone|oxycodone|mesh-list
55964633|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55964634|NCT03597308|Analgesics|analgesics|mesh-ancestor
55964635|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
55964644|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964645|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55964646|NCT03597308|Narcotics|narcotics|mesh-ancestor
55964647|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964648|NCT04750135|Metformin|metformin|mesh-list
55964649|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55964650|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964651|NCT04003922|Adalimumab|adalimumab|mesh-list
55964652|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964653|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55964654|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
55964655|NCT03781934|Lenvatinib|lenvatinib|mesh-list
55964656|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55964657|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964658|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55964659|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744242|NCT03334981|Analgesics|analgesics|mesh-ancestor
55889483|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964660|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964661|NCT00558571|Empagliflozin|empagliflozin|mesh-list
55964662|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55964663|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964664|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55964665|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964666|NCT03970382|Aldesleukin|aldesleukin|mesh-list
55964667|NCT03970382|Nivolumab|nivolumab|mesh-list
55964668|NCT03970382|Interleukin-2|interleukin-2|mesh-list
55964669|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55964670|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964671|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55964672|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964673|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55964674|NCT03970382|Analgesics|analgesics|mesh-ancestor
55964675|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
55964676|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964677|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964678|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55964679|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55964680|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
55964681|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964682|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55964683|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55964684|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964685|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
55964686|NCT01797913|Gemcitabine|gemcitabine|mesh-list
55964687|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55803892|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55964689|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964690|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964691|NCT01797913|Antiviral Agents|antiviral agents|mesh-ancestor
55964692|NCT01797913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964693|NCT01797913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072587|NCT04603937|Aflibercept|aflibercept|mesh-list
55964694|NCT01797913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55964695|NCT01797913|Immunologic Factors|immunologic factors|mesh-ancestor
55964696|NCT01797913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964697|NCT03596294|Rifampin|rifampin|mesh-list
55964698|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55964699|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
55964700|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55964701|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964705|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964706|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55964707|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55964708|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55964709|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55964710|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55964711|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55964712|NCT00537407|Ribavirin|ribavirin|mesh-list
55964713|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55964714|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
55964715|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964716|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
55964717|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964718|NCT00214916|Insulin|insulin|mesh-list
55964719|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55964720|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55964721|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964722|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55964723|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55964724|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55964725|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55964726|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964727|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964728|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964729|NCT00438971|Analgesics|analgesics|mesh-ancestor
55964730|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
55964731|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964732|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
55964733|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55964734|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
56213491|NCT02939573|Azathioprine|azathioprine|mesh-list
56213492|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
56213493|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213494|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
56213495|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
55964735|NCT00219284|Levodopa|levodopa|mesh-list
55964736|NCT00219284|Carbidopa|carbidopa|mesh-list
55964737|NCT00219284|Entacapone|entacapone|mesh-list
55964738|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55964739|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55964740|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55964741|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
55964742|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964743|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964744|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964745|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55964746|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964747|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55964748|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55964750|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
55964751|NCT00509041|Dasatinib|dasatinib|mesh-list
55964752|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964753|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55964754|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964755|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964756|NCT03781700|Prednisolone|prednisolone|mesh-list
55964757|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964758|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
55964759|NCT03781700|Hormones|hormones|mesh-ancestor
55964760|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55964761|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964762|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55964763|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964765|NCT00439673|Valproic Acid|valproic acid|mesh-list
55964766|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55964767|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
55964768|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964769|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964770|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964773|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964774|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964775|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
55964776|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55964777|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964778|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55964779|NCT03596060|Fentanyl|fentanyl|mesh-list
55964780|NCT03596060|Morphine|morphine|mesh-list
55964781|NCT03596060|Propofol|propofol|mesh-list
55964782|NCT03596060|Rocuronium|rocuronium|mesh-list
55964783|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55964784|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964785|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964786|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56072876|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964787|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
55964788|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
56072877|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56072878|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
56072879|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55964789|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55964790|NCT03596060|Narcotics|narcotics|mesh-ancestor
55964791|NCT03596060|Analgesics|analgesics|mesh-ancestor
55964792|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
55964793|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964794|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55964795|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55964796|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55964797|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55964798|NCT00473837|Chloroquine|chloroquine|mesh-list
55964799|NCT00473837|Amebicides|amebicides|mesh-ancestor
55964800|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55964801|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55964802|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964803|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
55964804|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55964805|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
55964806|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072967|NCT05637086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55964807|NCT00509197|Fluticasone|fluticasone|mesh-list
55964808|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964809|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55964810|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
55964811|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964812|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964813|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55964814|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
55964815|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
55964816|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55964817|NCT00442013|Lansoprazole|lansoprazole|mesh-list
55964818|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
55964819|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55964820|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55964821|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55964822|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964823|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964824|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
55964825|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55964826|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
55964827|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55964828|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964829|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55964830|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55964831|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55964832|NCT00509665|Gemcitabine|gemcitabine|mesh-list
55964833|NCT00509665|Doxorubicin|doxorubicin|mesh-list
55800363|NCT03048019|Tirofiban|tirofiban|mesh-list
55964834|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55964835|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55964836|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
55964837|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964838|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964839|NCT00509665|Antiviral Agents|antiviral agents|mesh-ancestor
55964840|NCT00509665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964841|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964842|NCT00509665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55964843|NCT00509665|Immunologic Factors|immunologic factors|mesh-ancestor
55964844|NCT00509665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964845|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55964846|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55964855|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55964856|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55964857|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964858|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964859|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55964860|NCT00216476|Risperidone|risperidone|mesh-list
55964861|NCT00216476|Aripiprazole|aripiprazole|mesh-list
55964862|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55964863|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55964864|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
55964865|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964866|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964867|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964868|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56073326|NCT02397265|Insulin|insulin|mesh-list
55964869|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55964870|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964871|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55964872|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55964873|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
55964874|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
55964875|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
55964876|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55964877|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55964878|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55964879|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55964880|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
55964881|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
55803925|NCT02392611|Fulvestrant|fulvestrant|mesh-list
55964882|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55964883|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55964884|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55964885|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55964886|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964887|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
55964888|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964889|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964890|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55964891|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964892|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55964893|NCT00216086|Capecitabine|capecitabine|mesh-list
55964894|NCT00216086|Irinotecan|irinotecan|mesh-list
55964895|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55964896|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
55964897|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964898|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964899|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55964900|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55964901|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964902|NCT00474851|Norethindrone|norethindrone|mesh-list
55964903|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
55964904|NCT00474851|Estrogens|estrogens|mesh-list
55964905|NCT00474851|Hormones|hormones|mesh-ancestor
55964906|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889484|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
56073539|NCT05721170|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55964907|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964908|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55964909|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55964910|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55964911|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
55964912|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55964913|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55964937|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55964938|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
55964939|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55964940|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
55964941|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073615|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55889485|NCT02962401|Idelalisib|idelalisib|mesh-list
55964942|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964943|NCT03023852|Oseltamivir|oseltamivir|mesh-list
55964944|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
55964945|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964946|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964947|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964948|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
55964949|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55964950|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964951|NCT00516217|Galiximab|galiximab|mesh-list
55964952|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964953|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964954|NCT04001504|Vaccines|vaccines|mesh-list
55964955|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
55964956|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964957|NCT00516919|Orlistat|orlistat|mesh-list
55964958|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964959|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964960|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55964961|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55964962|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55964963|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964964|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55964965|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964971|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
55964972|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964973|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964974|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55964975|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55964976|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
55964977|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964978|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964979|NCT04193774|Anesthetics|anesthetics|mesh-list
55964981|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55964982|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
55964983|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964984|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964985|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55964986|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
55964987|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
55964988|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964989|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
55964990|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55964991|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55964992|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55964993|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964994|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56073771|NCT00354757|Rabeprazole|rabeprazole|mesh-list
56073777|NCT02376283|Clopidogrel|clopidogrel|mesh-list
55964995|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55964996|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964997|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964998|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964999|NCT02985242|Empagliflozin|empagliflozin|mesh-list
55965000|NCT02985242|Glimepiride|glimepiride|mesh-list
55965001|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55965002|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965003|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55965004|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965005|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55965006|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965007|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
55965008|NCT03023774|Lenograstim|lenograstim|mesh-list
56073847|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
55965009|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55965010|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
55965011|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965013|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55965014|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965015|NCT00518713|Clobazam|clobazam|mesh-list
55965016|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
55965017|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55965018|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55965019|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965020|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965021|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55965022|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55965023|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
55965024|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
55965025|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965026|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965027|NCT03948464|Morphine|morphine|mesh-list
55965028|NCT03948464|Methadone|methadone|mesh-list
55965029|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55789952|NCT03046979|Apatinib|apatinib|mesh-list
55965031|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965032|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965033|NCT03948464|Analgesics|analgesics|mesh-ancestor
55965034|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
55965035|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965036|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
55965039|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
55965040|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
55965041|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965042|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073920|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965043|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
56073921|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55965044|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965045|NCT03948074|Dronabinol|dronabinol|mesh-list
55965046|NCT03948074|Cannabidiol|cannabidiol|mesh-list
55965047|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
55965048|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
55965049|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965050|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55965051|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55965052|NCT03948074|Analgesics|analgesics|mesh-ancestor
55965053|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
55965054|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965055|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55965056|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55965057|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965058|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965059|NCT03948074|Hormones|hormones|mesh-ancestor
56213497|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965060|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965062|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55965063|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965064|NCT00521989|Prednisolone|prednisolone|mesh-list
55965065|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55965066|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
55965067|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55965068|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
55965069|NCT00521989|Dipyridamole|dipyridamole|mesh-list
56074049|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965070|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55965071|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
55965072|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55965073|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
55965074|NCT00521989|Hormones|hormones|mesh-ancestor
55965075|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965076|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965077|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55965078|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965079|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
55965080|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
55965081|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965082|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55965083|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55965084|NCT00521989|Protective Agents|protective agents|mesh-ancestor
55965085|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55965086|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965087|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965088|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55965089|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
55965090|NCT04029350|Osimertinib|osimertinib|mesh-list
55965091|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965092|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55965093|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965094|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965095|NCT00548197|Bevacizumab|bevacizumab|mesh-list
55965096|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55965097|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965098|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55965099|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55965100|NCT00548197|Growth Substances|growth substances|mesh-ancestor
55965101|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965102|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
55965103|NCT04029272|Metformin|metformin|mesh-list
55965104|NCT04029272|Exenatide|exenatide|mesh-list
55965105|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55965106|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965107|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55965108|NCT04029272|Incretins|incretins|mesh-ancestor
55965109|NCT04029272|Hormones|hormones|mesh-ancestor
56074143|NCT05640674|Analgesics|analgesics|mesh-ancestor
55965110|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965118|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965119|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55965121|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
55965122|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55965123|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55965124|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
55965125|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965126|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55965127|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55965128|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965129|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965130|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
55965131|NCT04028804|Fluorides|fluorides|mesh-list
55965132|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
55965133|NCT04028804|Protective Agents|protective agents|mesh-ancestor
55965134|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965135|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
55965136|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965137|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
55965138|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965139|NCT00524017|Cetuximab|cetuximab|mesh-list
55965140|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213498|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213499|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
56074201|NCT05716256|Urinastatin|urinastatin|mesh-list
56213500|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55965141|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965143|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55965144|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965145|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55965146|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965147|NCT05560165|Listerine|listerine|mesh-list
55965148|NCT05560165|Anesthetics|anesthetics|mesh-list
55965149|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
55965150|NCT05560165|Fluorides|fluorides|mesh-list
55965151|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
55965152|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
55965153|NCT05560165|Protective Agents|protective agents|mesh-ancestor
55965154|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965155|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965156|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
55965157|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965158|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55965159|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965160|NCT00525421|Curcumin|curcumin|mesh-list
55965161|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55965162|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55965163|NCT00525421|Analgesics|analgesics|mesh-ancestor
55965164|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
55965165|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965166|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965167|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55965168|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55965169|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965170|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965171|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965173|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55965174|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55965175|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
55965176|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965177|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965187|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55965188|NCT00525733|Ritonavir|ritonavir|mesh-list
55965189|NCT00525733|Darunavir|darunavir|mesh-list
55965190|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
55965191|NCT00525733|Maraviroc|maraviroc|mesh-list
55965192|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55965193|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55965194|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
55965195|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965196|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965197|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55965198|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55965199|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
55965200|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965201|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55965202|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55965203|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55965204|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55965205|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55965206|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55965207|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55965208|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
55965209|NCT04025216|Fludarabine|fludarabine|mesh-list
55965210|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965211|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
56074411|NCT05715788|Vasodilator Agents|vasodilator agents|mesh-ancestor
55965212|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965213|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55965214|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55965215|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
55965216|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965217|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965218|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56213501|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56213502|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
55965220|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
55965221|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
55965222|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965223|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965224|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074500|NCT02265510|Hormones|hormones|mesh-ancestor
56074501|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074502|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56074503|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55801705|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
56074504|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
56074505|NCT02265510|Antiviral Agents|antiviral agents|mesh-ancestor
55965225|NCT04028024|Urinastatin|urinastatin|mesh-list
55965226|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55965227|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55965228|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
55965229|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965230|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965231|NCT00526591|Everolimus|everolimus|mesh-list
55965232|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965233|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965234|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
55965235|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965236|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
55965237|NCT05559619|Vitamin D|vitamin d|mesh-list
55965238|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
55965239|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
55965240|NCT05559619|Calcium|calcium|mesh-list
55965241|NCT05559619|Vitamins|vitamins|mesh-ancestor
55965242|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
55965243|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965244|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55965245|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55965246|NCT05559619|Antacids|antacids|mesh-ancestor
55965247|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965248|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55965250|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
55965251|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965252|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55965253|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55965254|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55965255|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55965256|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55965257|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965258|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965259|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55965260|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
56074730|NCT03279731|Liraglutide|liraglutide|mesh-list
55965261|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965262|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965263|NCT04021862|Antibodies|antibodies|mesh-list
55965264|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55965265|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
55965266|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965267|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
55965268|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55965269|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
55965270|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965271|NCT04023266|Expectorants|expectorants|mesh-ancestor
55965272|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
55965273|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55965274|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
55965275|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965276|NCT04023266|Protective Agents|protective agents|mesh-ancestor
55965277|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965278|NCT04023266|Antidotes|antidotes|mesh-ancestor
55965279|NCT00475085|Dexamethasone|dexamethasone|mesh-list
55965280|NCT00475085|Aprepitant|aprepitant|mesh-list
55965281|NCT00475085|Palonosetron|palonosetron|mesh-list
55965282|NCT00475085|Granisetron|granisetron|mesh-list
55965283|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
55965284|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55965285|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
55965286|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
55965287|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965288|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965289|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56213503|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213504|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213505|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
56213506|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55790155|NCT04874675|Acetaminophen|acetaminophen|mesh-list
55965290|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
55965291|NCT00475085|Hormones|hormones|mesh-ancestor
55965292|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965293|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55965294|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965295|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55965296|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889486|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55965297|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965298|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55965299|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55965300|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
55965301|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55965302|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55965303|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965304|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55965305|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55965306|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
55965307|NCT00551707|Prednisolone|prednisolone|mesh-list
55965308|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55965309|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
55965310|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55965311|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
55965312|NCT00551707|Dipyridamole|dipyridamole|mesh-list
55965313|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55965314|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
55965315|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55965316|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
55965317|NCT00551707|Hormones|hormones|mesh-ancestor
55965318|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965328|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55965329|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965330|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965331|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55965332|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
55965334|NCT04193930|Menotropins|menotropins|mesh-list
55965336|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55965337|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965338|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965339|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965340|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55965341|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55965342|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965343|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965344|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55965345|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
55965346|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55965347|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
55965348|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55965349|NCT00445211|Heparin|heparin|mesh-list
55965350|NCT00445211|Calcium heparin|calcium heparin|mesh-list
55965351|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
55965352|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55965353|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55965354|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965355|NCT04193852|Dienogest|dienogest|mesh-list
55965356|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55965357|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55965358|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55965359|NCT04193852|Estradiol|estradiol|mesh-list
55965360|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55965361|NCT04193852|Nandrolone|nandrolone|mesh-list
55965362|NCT04193852|Estrogens|estrogens|mesh-ancestor
55965363|NCT04193852|Hormones|hormones|mesh-ancestor
55965364|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213507|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56213508|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56213509|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213510|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
56213511|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56213512|NCT02891603|Sirolimus|sirolimus|mesh-list
56213513|NCT02891603|Tacrolimus|tacrolimus|mesh-list
56213514|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965365|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965366|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55965367|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
55965368|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55965369|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55965370|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55965371|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55965372|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55965373|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
55965374|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55965375|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965376|NCT04193852|Androgens|androgens|mesh-ancestor
55965377|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
55965378|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
55965379|NCT00552409|Vitamin D|vitamin d|mesh-list
55965380|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55965381|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965382|NCT00552409|Vitamins|vitamins|mesh-ancestor
55965383|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
55965384|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55965387|NCT03830918|Niraparib|niraparib|mesh-list
55965388|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55965389|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55965390|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
55965391|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965392|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965393|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
55965394|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965395|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55965396|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965397|NCT00553735|Cyclosporine|cyclosporine|mesh-list
55965398|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
55965399|NCT00553735|Cyclosporins|cyclosporins|mesh-list
55965400|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965401|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965402|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965403|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
55965404|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965405|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
55965406|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965407|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
55965408|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55965409|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55965410|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55965411|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55965412|NCT04027166|Methadone|methadone|mesh-list
55965413|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55965414|NCT04027166|Narcotics|narcotics|mesh-ancestor
55965415|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965416|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965417|NCT04027166|Analgesics|analgesics|mesh-ancestor
55965418|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
55965419|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965420|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
55965421|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
55965422|NCT00543101|Darunavir|darunavir|mesh-list
55965423|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55965424|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55965425|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
55965426|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965427|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965428|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55965429|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55965430|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
55965431|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965432|NCT00553969|Carvedilol|carvedilol|mesh-list
55965433|NCT00553969|Lisinopril|lisinopril|mesh-list
55965434|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55965435|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55965436|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
55965437|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965438|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965439|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965440|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55965441|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
55965442|NCT00553969|Protective Agents|protective agents|mesh-ancestor
55965443|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55965444|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55965445|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55965446|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
55965447|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55965448|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55965449|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55965450|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
55965451|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965452|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55965453|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55965454|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55965455|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965456|NCT05533567|Sufentanil|sufentanil|mesh-list
55965458|NCT05533567|Propofol|propofol|mesh-list
55965459|NCT05533567|Cisatracurium|cisatracurium|mesh-list
55965473|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55965474|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55965475|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55965476|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55965477|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55965478|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
55965479|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965480|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965481|NCT04026464|Acetaminophen|acetaminophen|mesh-list
55965482|NCT04026464|Ibuprofen|ibuprofen|mesh-list
55965483|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55965484|NCT04026464|Analgesics|analgesics|mesh-ancestor
55965485|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
55965486|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965487|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965488|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
55965489|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55965490|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55965491|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55965492|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55965493|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965494|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965495|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
55965496|NCT04192916|Apixaban|apixaban|mesh-list
55965497|NCT04192916|Edoxaban|edoxaban|mesh-list
55965498|NCT04192916|Dabigatran|dabigatran|mesh-list
55965499|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55965500|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
55965501|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55965502|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
55965503|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965504|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965505|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
55965506|NCT01797991|Dexamethasone|dexamethasone|mesh-list
55965507|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
55965508|NCT01797991|BB 1101|bb 1101|mesh-list
55965509|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55965510|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
55965511|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
55965512|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965513|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965515|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
56213515|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
55790157|NCT04874675|Diclofenac|diclofenac|mesh-list
55965517|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56075709|NCT04812470|Melphalan|melphalan|mesh-list
55965518|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55965519|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965520|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
55965521|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965522|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965523|NCT00475319|Rebamipide|rebamipide|mesh-list
55965534|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55965536|NCT04026074|Narcotics|narcotics|mesh-ancestor
55965537|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965538|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965539|NCT04026074|Analgesics|analgesics|mesh-ancestor
55965540|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
55965541|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965542|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55965543|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55965544|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
55965545|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
55965546|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55965547|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
55965548|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
55965549|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55965550|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55965551|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55965552|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
55965553|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965554|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965555|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
55965556|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55965557|NCT02704208|Nicotine|nicotine|mesh-list
56075871|NCT04329494|Mitomycins|mitomycins|mesh-list
55965558|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55965559|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
55965560|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965561|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965562|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55965563|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55965564|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
55965565|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965566|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965567|NCT00555997|Ziprasidone|ziprasidone|mesh-list
55965568|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55965569|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
55965570|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965571|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965572|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965573|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55965574|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56075985|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
55965575|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965576|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55965577|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55965578|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
55965579|NCT00446147|Pyridoxine|pyridoxine|mesh-list
55965580|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
55965581|NCT00446147|Vitamins|vitamins|mesh-ancestor
55965582|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
55965583|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965584|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55965585|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55965586|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55965587|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55965590|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965591|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
55965592|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55965593|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
55965594|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55965595|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
55965596|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55965597|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965598|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56213516|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213517|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55965599|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55965600|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55965601|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56076054|NCT04184999|Dexamethasone|dexamethasone|mesh-list
55965603|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55965604|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55965605|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965606|NCT04192292|Incretins|incretins|mesh-ancestor
55965607|NCT04192292|Hormones|hormones|mesh-ancestor
55965608|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965609|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
55965610|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965611|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965612|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55965613|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55965614|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55965615|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
55965616|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965617|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965618|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965619|NCT00448175|Urological Agents|urological agents|mesh-ancestor
55965621|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
55965622|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55965623|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965624|NCT00476645|Fulvestrant|fulvestrant|mesh-list
55965625|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55965626|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965627|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55965628|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55965629|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
55965630|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965631|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965632|NCT00477191|Etanercept|etanercept|mesh-list
55965633|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55965634|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55965635|NCT00477191|Analgesics|analgesics|mesh-ancestor
55965636|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
55965637|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076119|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
56076120|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56076121|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56076122|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
56076123|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965638|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965639|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55965640|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55965641|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55965642|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965643|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
55965644|NCT04025918|Phenylephrine|phenylephrine|mesh-list
55965645|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
55965646|NCT04025918|Ephedrine|ephedrine|mesh-list
55965647|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55965648|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55965649|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
55965650|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
55965651|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965652|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965653|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
55965654|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
55965655|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
55965656|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55965657|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55965658|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55965659|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
56076169|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076170|NCT04662242|Trace Elements|trace elements|mesh-ancestor
56076171|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
56076172|NCT04848792|Sulforaphane|sulforaphane|mesh-list
56076173|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56076174|NCT04848792|Protective Agents|protective agents|mesh-ancestor
56076193|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56076194|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56076195|NCT04160546|Analgesics|analgesics|mesh-ancestor
56076196|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
56076197|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076198|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076199|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076200|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56076201|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56076202|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56076207|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
55965660|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804046|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55965661|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965663|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55965665|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55965667|NCT05415397|Analgesics|analgesics|mesh-ancestor
55965668|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
55965669|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965670|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965671|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790160|NCT04874675|Analgesics|analgesics|mesh-ancestor
55965672|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55965673|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55965674|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55965675|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965676|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965677|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
55965678|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56076269|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56076270|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076271|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
56076272|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076273|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076274|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56076276|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
55965679|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965680|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
55965681|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55965682|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965683|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55965684|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965685|NCT02115581|Ubiquinone|ubiquinone|mesh-list
55965686|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
55965687|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
55965688|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965689|NCT02115581|Vitamins|vitamins|mesh-ancestor
55965690|NCT00477659|Donepezil|donepezil|mesh-list
55965691|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55965692|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076377|NCT04098575|Empagliflozin|empagliflozin|mesh-list
55965693|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965694|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
55965695|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965696|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965698|NCT04191278|Varenicline|varenicline|mesh-list
55965699|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55965700|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55965701|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
55965702|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889487|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965703|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965704|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965705|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
55965706|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55965707|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55965708|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965709|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965710|NCT03988387|Tenofovir|tenofovir|mesh-list
55965711|NCT03988387|Emtricitabine|emtricitabine|mesh-list
55965712|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
55965713|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965714|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55965715|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55965716|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965717|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965718|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55965719|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55965720|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
55965721|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55965722|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
55965723|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965724|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965725|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56076612|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965726|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
55965727|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55965728|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
55965729|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965730|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965731|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55965732|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
55965734|NCT03748082|Protective Agents|protective agents|mesh-ancestor
55965735|NCT00478361|Gemcitabine|gemcitabine|mesh-list
55965751|NCT00478361|Immunologic Factors|immunologic factors|mesh-ancestor
55965752|NCT00478361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965753|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55965754|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55965755|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55965756|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
55965757|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213519|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213520|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55965758|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
55965759|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55965760|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55965761|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965762|NCT02129725|Urological Agents|urological agents|mesh-ancestor
55965763|NCT00483509|Doxorubicin|doxorubicin|mesh-list
55965764|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55965765|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965766|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55744263|NCT03334513|Ranibizumab|ranibizumab|mesh-list
55965767|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55965768|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965769|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965770|NCT03840200|Rucaparib|rucaparib|mesh-list
55965771|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55965772|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965773|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965774|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965775|NCT03842839|Albuterol|albuterol|mesh-list
55965776|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
55965777|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55965778|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
55965779|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076788|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55965780|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965781|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55965782|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
55965783|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
55965784|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55965785|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
55965786|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965787|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965788|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
55965789|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55965790|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55965791|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55965792|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55965793|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
55965802|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965803|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55965805|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965806|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965807|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
55965808|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965809|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55965810|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965811|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
56076895|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56076900|NCT01638000|Mirabegron|mirabegron|mesh-list
55965812|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55965813|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55965814|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55965816|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55965817|NCT01796405|Clofarabine|clofarabine|mesh-list
55965818|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55965819|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
55965820|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965821|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965822|NCT03298295|Insulin|insulin|mesh-list
55965823|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55965824|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965825|NCT03649321|Gemcitabine|gemcitabine|mesh-list
55965826|NCT03649321|Paclitaxel|paclitaxel|mesh-list
55965827|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55965828|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55965829|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965830|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
55965831|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
55965832|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
55965833|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965834|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56213522|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56213523|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077008|NCT05722561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56077009|NCT05722561|Autonomic Agents|autonomic agents|mesh-ancestor
56213524|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
55965835|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
55965836|NCT03649321|Antiviral Agents|antiviral agents|mesh-ancestor
55965837|NCT03649321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965838|NCT03649321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965839|NCT03649321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965840|NCT03649321|Immunologic Factors|immunologic factors|mesh-ancestor
55965841|NCT03649321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965842|NCT04192370|Cannabidiol|cannabidiol|mesh-list
55965843|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
55965849|NCT04149938|Lidocaine|lidocaine|mesh-list
55965850|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
55965851|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
55965852|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965853|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965854|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
55965855|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965856|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55965857|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55965858|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55965859|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55965860|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965861|NCT01797601|Insulin|insulin|mesh-list
55965864|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965865|NCT02984930|Esomeprazole|esomeprazole|mesh-list
55965866|NCT02984930|Mosapride|mosapride|mesh-list
55965867|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55965868|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55965869|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55965870|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965871|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965872|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55965873|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
55965874|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965875|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965876|NCT02123017|Lactulose|lactulose|mesh-list
55965877|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55965878|NCT04149626|Midazolam|midazolam|mesh-list
55965879|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
55965880|NCT04149626|Remifentanil|remifentanil|mesh-list
55965881|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55965882|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965883|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965884|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55965885|NCT04149626|Analgesics|analgesics|mesh-ancestor
55965886|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
55965887|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965888|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55965889|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55965890|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55965891|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
55965892|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965893|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965894|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55965895|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55965896|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55965897|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55965898|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55965899|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
55965900|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
55965901|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
55965902|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
55965903|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55965904|NCT04149626|Narcotics|narcotics|mesh-ancestor
55965905|NCT00486863|Praziquantel|praziquantel|mesh-list
55965906|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
56077280|NCT03127592|Analgesics|analgesics|mesh-ancestor
55965907|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55965908|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965910|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
56213526|NCT02876107|Carboplatin|carboplatin|mesh-list
56213527|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56213528|NCT02876107|Panitumumab|panitumumab|mesh-list
56213529|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56213530|NCT02876107|Antibodies|antibodies|mesh-list
56213531|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
55965911|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55965912|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965913|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
55965914|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965915|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55965916|NCT05150587|Rifaximin|rifaximin|mesh-list
55965917|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55965918|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965919|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55965920|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
55965921|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55965922|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965923|NCT00452387|Prednisone|prednisone|mesh-list
55965924|NCT00452387|Sorafenib|sorafenib|mesh-list
55965925|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
55965926|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55965927|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
55965928|NCT00452387|Hormones|hormones|mesh-ancestor
55965929|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55965930|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965931|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55965932|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965933|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55965934|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965935|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965936|NCT00452387|Analgesics|analgesics|mesh-ancestor
55965937|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
56077358|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
55965940|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55965942|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55965943|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
55965944|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55965945|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965946|NCT00452543|Acamprosate|acamprosate|mesh-list
55965947|NCT00452543|Dexetimide|dexetimide|mesh-list
55965948|NCT00452543|Citalopram|citalopram|mesh-list
55965949|NCT00452543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55965950|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56077390|NCT05720455|Fexofenadine|fexofenadine|mesh-list
55965951|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55965952|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965953|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965954|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
55965955|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965956|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55965957|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
55965958|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55965959|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55965960|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55965961|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
55965962|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
55965963|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965964|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55965965|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55965966|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
55965967|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55965969|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
55965970|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965971|NCT05621707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55965972|NCT05621707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965973|NCT05621707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965974|NCT04765904|Fluorides|fluorides|mesh-list
55965975|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
55965976|NCT04765904|Protective Agents|protective agents|mesh-ancestor
55965977|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213532|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56213533|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56213534|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965978|NCT05621551|Dapagliflozin|dapagliflozin|mesh-list
55965979|NCT05621551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55965980|NCT05621551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965981|NCT05621551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55965982|NCT05621551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965983|NCT00565669|Cyclosporine|cyclosporine|mesh-list
55965984|NCT00565669|Cyclosporins|cyclosporins|mesh-list
55965985|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965986|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965987|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965988|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
55965989|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965990|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
55965991|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965992|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
55965993|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55965994|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55965996|NCT04165135|Coagulants|coagulants|mesh-ancestor
55965997|NCT02132533|Nifedipine|nifedipine|mesh-list
55965998|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55965999|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55966000|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966001|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55966002|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966003|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
55966004|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
55966005|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55966006|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
55966007|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077644|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55966008|NCT00567229|Rituximab|rituximab|mesh-list
55966009|NCT00567229|Lenalidomide|lenalidomide|mesh-list
55966010|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55966022|NCT04148846|Gabapentin|gabapentin|mesh-list
55966023|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966024|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
55966025|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
55966026|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966027|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966028|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55966029|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
55966030|NCT04148846|Hormones|hormones|mesh-ancestor
55966031|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55966032|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55966033|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966034|NCT04148846|Analgesics|analgesics|mesh-ancestor
55966035|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
55966036|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
55966037|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55966038|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55966039|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966040|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55966041|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55966042|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55966043|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804060|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55966044|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966045|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
55966046|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55966047|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55966048|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966049|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55966050|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966051|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55966052|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55966053|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
55966054|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55966055|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
55966056|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55966057|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55966058|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
55966059|NCT03939182|Abexinostat|abexinostat|mesh-list
55966060|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56077720|NCT05716009|Gemtuzumab|gemtuzumab|mesh-list
55966061|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966062|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966064|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55966065|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
55966066|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966067|NCT00568087|Expectorants|expectorants|mesh-ancestor
55966068|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
55966069|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55966070|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
55966071|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966072|NCT00568087|Protective Agents|protective agents|mesh-ancestor
55966073|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966074|NCT00568087|Antidotes|antidotes|mesh-ancestor
55966076|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
55966077|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966080|NCT03761030|Levodopa|levodopa|mesh-list
55966081|NCT03761030|Carbidopa|carbidopa|mesh-list
55966082|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55966083|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55966084|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55966085|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
55966086|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966087|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966088|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966089|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55966090|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966091|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55966092|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
55966093|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
55966094|NCT00568633|Cyclosporine|cyclosporine|mesh-list
55966095|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
55966096|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
55966097|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55966098|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55966099|NCT00568633|Prednisolone|prednisolone|mesh-list
55966100|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
55966101|NCT00568633|Cyclosporins|cyclosporins|mesh-list
55966102|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
55966103|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55966104|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55966105|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
55966106|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966107|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966108|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55966109|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
55966110|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966111|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
55966112|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966113|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
55966114|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966115|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55966116|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55966117|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966118|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55966119|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
55966120|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55966121|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966123|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
55966124|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966126|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
55966127|NCT00568633|Hormones|hormones|mesh-ancestor
55966128|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55966129|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55966130|NCT00568633|Protective Agents|protective agents|mesh-ancestor
55966131|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55966132|NCT03022838|Caffeine|caffeine|mesh-list
55966133|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55966134|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213536|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
56213537|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
56213538|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966135|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55966136|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966137|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966138|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55966139|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55966140|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
55966141|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966142|NCT05363449|Naftifine|naftifine|mesh-list
55966143|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
55966144|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966145|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
55966146|NCT00489281|Sirolimus|sirolimus|mesh-list
55966147|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
55966148|NCT00489281|Fludarabine|fludarabine|mesh-list
55966149|NCT00489281|Levetiracetam|levetiracetam|mesh-list
55966150|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
55966151|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55966152|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55966153|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
55966155|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966156|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55966157|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
55966158|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966159|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966160|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55966161|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55966162|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55966163|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
55966164|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55966165|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966166|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966167|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
55966168|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
55966169|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
55966170|NCT05362513|Ivermectin|ivermectin|mesh-list
55966171|NCT05362513|Permethrin|permethrin|mesh-list
55966172|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55966173|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966174|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966175|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966176|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55966177|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
55966178|NCT04146038|Azacitidine|azacitidine|mesh-list
55966179|NCT04146038|Decitabine|decitabine|mesh-list
55966180|NCT04146038|Venetoclax|venetoclax|mesh-list
55966181|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55966182|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
55966183|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966184|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966185|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966186|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55789977|NCT04550195|Famotidine|famotidine|mesh-list
55966187|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55966188|NCT04146038|Analgesics|analgesics|mesh-ancestor
55966189|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
55966190|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966191|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966192|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966193|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966194|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55966195|NCT04457297|Trifluridine|trifluridine|mesh-list
55966196|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
55966197|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966198|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
55966199|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966200|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
55966202|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
55966203|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
55966204|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55966205|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966206|NCT04145804|Insulin|insulin|mesh-list
56213539|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
55966207|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55966208|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966209|NCT02120261|Triamcinolone|triamcinolone|mesh-list
55966210|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55966211|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55966212|NCT02120261|Lidocaine|lidocaine|mesh-list
55966213|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55966214|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
55966215|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
56078077|NCT00359905|Silodosin|silodosin|mesh-list
56078092|NCT00358813|Casopitant|casopitant|mesh-list
55966216|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966217|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966218|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
55966219|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966220|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55966221|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55966222|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55966223|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55966224|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966225|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966226|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
55966227|NCT02120261|Hormones|hormones|mesh-ancestor
55966231|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966232|NCT03907046|Aspirin|aspirin|mesh-list
55966233|NCT03907046|Apixaban|apixaban|mesh-list
55889488|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966234|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55966235|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55966236|NCT03907046|Analgesics|analgesics|mesh-ancestor
55966237|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
55966238|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966239|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966240|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966241|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966242|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55966243|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55966244|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966245|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55966246|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55966247|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966248|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
55966249|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55966250|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
55966251|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55966252|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
55966253|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
55966254|NCT03840421|Gemcitabine|gemcitabine|mesh-list
55966255|NCT03840421|Cisplatin|cisplatin|mesh-list
55966256|NCT03840421|Fluorouracil|fluorouracil|mesh-list
55966257|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966258|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55966259|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
55966260|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966261|NCT03840421|Antiviral Agents|antiviral agents|mesh-ancestor
55966262|NCT03840421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078235|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55966263|NCT03840421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966264|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55966265|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
55966266|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966267|NCT00492089|Bevacizumab|bevacizumab|mesh-list
55966268|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55966269|NCT00492089|Antibodies|antibodies|mesh-list
55966270|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
55966271|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55966272|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966273|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55966274|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55966275|NCT00492089|Growth Substances|growth substances|mesh-ancestor
55966276|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966277|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
55966278|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
56213540|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213542|NCT02855229|Modafinil|modafinil|mesh-list
55966290|NCT01798537|Vancomycin|vancomycin|mesh-list
55966291|NCT01798537|Colistin|colistin|mesh-list
55966292|NCT01798537|Neomycin|neomycin|mesh-list
56078325|NCT03926299|Hormones|hormones|mesh-ancestor
55966293|NCT01798537|Nystatin|nystatin|mesh-list
55966294|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55966295|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966296|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55966297|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966298|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966299|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
55966301|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55966302|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55966303|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966304|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966305|NCT03805477|Nintedanib|nintedanib|mesh-list
55966306|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966307|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55966308|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966309|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966310|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55966311|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55966312|NCT01797341|Tacrolimus|tacrolimus|mesh-list
55966313|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55966314|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
55966315|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966316|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55966317|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966318|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966319|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55966320|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966321|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55966322|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966323|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966324|NCT04145492|Vitamin D|vitamin d|mesh-list
55966325|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
55966326|NCT04145492|Calcifediol|calcifediol|mesh-list
55966327|NCT04145492|Vitamins|vitamins|mesh-list
55966328|NCT04145492|Vitamin K|vitamin k|mesh-list
55966329|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
55966330|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
55966331|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966332|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55966333|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55966334|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55966335|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55966336|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966337|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
55966338|NCT04145492|Coagulants|coagulants|mesh-ancestor
55966339|NCT04147754|Morphine|morphine|mesh-list
55966340|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966341|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966342|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55966343|NCT04147754|Narcotics|narcotics|mesh-ancestor
55966344|NCT04147754|Analgesics|analgesics|mesh-ancestor
55966345|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
55966346|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966347|NCT05324449|Cannabidiol|cannabidiol|mesh-list
55966348|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
55966349|NCT00492401|Decitabine|decitabine|mesh-list
55966350|NCT00492401|Azacitidine|azacitidine|mesh-list
55966351|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55966352|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
55966353|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966354|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078450|NCT05616468|Fludarabine|fludarabine|mesh-list
55966355|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213543|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56213544|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790177|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55966357|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
55966358|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966359|NCT04147286|Atorvastatin|atorvastatin|mesh-list
55966360|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55966361|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55966362|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
55966363|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966364|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55966365|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55966366|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966367|NCT00493181|Oprelvekin|oprelvekin|mesh-list
55966368|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966369|NCT04147208|Ritonavir|ritonavir|mesh-list
55966370|NCT04147208|Entecavir|entecavir|mesh-list
55966371|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55966372|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55966373|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
55966374|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966375|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966379|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966380|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55966381|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55966382|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
55966383|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
55966384|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55966385|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
55966386|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55966387|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966388|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55966389|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55966390|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55966391|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55966397|NCT00493805|Interferons|interferons|mesh-list
55966398|NCT00493805|Ribavirin|ribavirin|mesh-list
55966399|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
55966400|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
55966401|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55966402|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966403|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
55966404|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966405|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
55966406|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966407|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
55966408|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966409|NCT04145102|Propolis|propolis|mesh-list
55966410|NCT04145102|Fluorides|fluorides|mesh-list
55966411|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
55966412|NCT04145102|Protective Agents|protective agents|mesh-ancestor
55966413|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966415|NCT05293249|Methylprednisolone|methylprednisolone|mesh-list
55966416|NCT05293249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55966417|NCT05293249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55966418|NCT05293249|Prednisolone|prednisolone|mesh-list
55966419|NCT05293249|Prednisolone acetate|prednisolone acetate|mesh-list
55966420|NCT05293249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55966422|NCT05293249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966423|NCT05293249|Antiemetics|antiemetics|mesh-ancestor
55966424|NCT05293249|Autonomic Agents|autonomic agents|mesh-ancestor
55966425|NCT05293249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966426|NCT05293249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966427|NCT05293249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55966428|NCT05293249|Glucocorticoids|glucocorticoids|mesh-ancestor
56213545|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56213546|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55966430|NCT05293249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55966431|NCT05293249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55966432|NCT05293249|Protective Agents|protective agents|mesh-ancestor
55966433|NCT05293249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55966434|NCT05293249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966435|NCT05581706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55966436|NCT05581706|Calcium|calcium|mesh-list
55966437|NCT05581706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55966438|NCT05581706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966439|NCT05581706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966440|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55966441|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
55966442|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966443|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55966444|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966445|NCT03588494|Endostar protein|endostar protein|mesh-list
55966446|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55966447|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55966448|NCT03588494|Growth Substances|growth substances|mesh-ancestor
55966468|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966469|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966471|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
55966472|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966473|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55966474|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966475|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55966476|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966477|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55966478|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55966479|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
55966480|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966481|NCT03588338|Acetaminophen|acetaminophen|mesh-list
55966482|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55966483|NCT03588338|Analgesics|analgesics|mesh-ancestor
55966484|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
55966485|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966486|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966487|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
55966488|NCT05099185|Trace Elements|trace elements|mesh-list
55966489|NCT05099185|Micronutrients|micronutrients|mesh-list
55966490|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966491|NCT05068609|Nivolumab|nivolumab|mesh-list
55966492|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55966493|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966494|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55966495|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966496|NCT00496379|Epothilones|epothilones|mesh-list
55966497|NCT00496379|Sagopilone|sagopilone|mesh-list
55966498|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
55966499|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
55966500|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
55966501|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966506|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
55966507|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55966508|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966509|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55966510|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
55966511|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55966512|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55966513|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55966514|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966515|NCT00497081|Mirtazapine|mirtazapine|mesh-list
55966516|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
55966517|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55966518|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55966519|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
55966520|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
56213547|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55966521|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966522|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966523|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966524|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56078705|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
55966525|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55966526|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966527|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55966528|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55966529|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55966530|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
55966531|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55966532|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55966533|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
55966534|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55966535|NCT01796951|Aspirin|aspirin|mesh-list
55966536|NCT01796951|Celecoxib|celecoxib|mesh-list
55966537|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55966538|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55966539|NCT01796951|Analgesics|analgesics|mesh-ancestor
55966540|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
55966541|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966542|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966543|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966544|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966545|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55966546|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55966547|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966548|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55966549|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55966550|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966551|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
55966552|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55966553|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
55966554|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966555|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55966556|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966557|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966558|NCT03895502|Edoxaban|edoxaban|mesh-list
55966559|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55966560|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
55966561|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55966562|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
55966563|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966564|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966565|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
55966566|NCT04704505|Androgens|androgens|mesh-list
55966567|NCT04704505|Hormones|hormones|mesh-ancestor
55966568|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55966569|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966570|NCT03905798|Lorazepam|lorazepam|mesh-list
55966571|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
55966572|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
55966573|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
55966575|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966576|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55966577|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55966578|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966579|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55966580|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56078821|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966581|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55966584|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966585|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966586|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
55966587|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55966588|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55966589|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55966590|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55966591|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966592|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
55966593|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213548|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213549|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
56213550|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213551|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56213552|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56213553|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56213554|NCT02829931|Bevacizumab|bevacizumab|mesh-list
56213555|NCT02829931|Nivolumab|nivolumab|mesh-list
56213556|NCT02829931|Ipilimumab|ipilimumab|mesh-list
56213557|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213558|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213559|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55790184|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
55966594|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966595|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55966596|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966597|NCT03587558|Flecainide|flecainide|mesh-list
55966598|NCT03587558|Carvedilol|carvedilol|mesh-list
55966599|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55966600|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55966601|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
55966602|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966603|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966604|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966605|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55966606|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
55966607|NCT03587558|Protective Agents|protective agents|mesh-ancestor
55966608|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55966609|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55966610|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55966611|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
55966612|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55966613|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55966614|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55966615|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55966616|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55966617|NCT04415905|Propofol|propofol|mesh-list
55966618|NCT04415905|Sevoflurane|sevoflurane|mesh-list
55966619|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55966620|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966621|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966622|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55966623|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
55966624|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
55966625|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55966626|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55966627|NCT01798459|Methylphenidate|methylphenidate|mesh-list
56078930|NCT00003435|Melphalan|melphalan|mesh-list
55966628|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55790003|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55966629|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966630|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55966631|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55966632|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55966633|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966634|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
55966635|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966637|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55966638|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55966639|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55966640|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
56213560|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56213561|NCT02829931|Growth Substances|growth substances|mesh-ancestor
55966641|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966642|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55966643|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55966644|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966645|NCT03587324|Clopidogrel|clopidogrel|mesh-list
55966647|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56078996|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
55966648|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55966650|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
55966651|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966652|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966653|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966654|NCT03919292|Valproic Acid|valproic acid|mesh-list
55966655|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
55966656|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966657|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966658|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
55966659|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966660|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966661|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
55966662|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55966663|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966664|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55966665|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
55966666|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55966667|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56079057|NCT00002823|Vindesine|vindesine|mesh-list
56079067|NCT00361621|Prednisone|prednisone|mesh-list
55966668|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966669|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
55966670|NCT01980355|Coagulants|coagulants|mesh-ancestor
55966671|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
55966672|NCT00555321|Abatacept|abatacept|mesh-list
55966673|NCT00555321|Tacrolimus|tacrolimus|mesh-list
55966674|NCT00555321|Basiliximab|basiliximab|mesh-list
55966675|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55966676|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
55966677|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966678|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55966679|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966680|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966681|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55966682|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966683|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55966684|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
55966685|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55966686|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966687|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55966688|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966689|NCT05583266|Pentoxifylline|pentoxifylline|mesh-list
55966690|NCT05583266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55966691|NCT05583266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966692|NCT05583266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966693|NCT05583266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55966694|NCT05583266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55966695|NCT05583266|Protective Agents|protective agents|mesh-ancestor
55966696|NCT05583266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966697|NCT05583266|Vasodilator Agents|vasodilator agents|mesh-ancestor
55966698|NCT05583266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55966699|NCT05583266|Antioxidants|antioxidants|mesh-ancestor
55966700|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
55966701|NCT04142840|Propofol|propofol|mesh-list
55966702|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55966703|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966704|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966705|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55966706|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
55966707|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
55966708|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55966709|NCT04142840|Analgesics|analgesics|mesh-ancestor
55966710|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
55966711|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966712|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56213562|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966713|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55966715|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
55966716|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966717|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966720|NCT04142762|Midazolam|midazolam|mesh-list
55966721|NCT04142762|Esomeprazole|esomeprazole|mesh-list
55966722|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
55966723|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55966724|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
55966725|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
55966726|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
55966727|NCT04142762|Estradiol|estradiol|mesh-list
55966728|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55966729|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55966730|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966731|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966732|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55966733|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55966734|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55966735|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55966736|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
55966737|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
55966738|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
55966739|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
55966740|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966741|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966742|NCT04142762|Estrogens|estrogens|mesh-ancestor
55966743|NCT04142762|Hormones|hormones|mesh-ancestor
55966744|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55966745|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55966746|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55966747|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55966748|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55966749|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55966750|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55966751|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966752|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
55966753|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966754|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55966755|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55966756|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55966757|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
55966758|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55966759|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55966760|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55966761|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
55966762|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55966763|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
55966764|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55966765|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55966766|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55966767|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55966768|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55966769|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55966770|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55966771|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55966772|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55966773|NCT05582876|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55966774|NCT05582876|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
55966775|NCT05582876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966776|NCT02139007|Alendronate|alendronate|mesh-list
55966777|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55966778|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966780|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55966781|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966782|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966783|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966784|NCT04221477|Acetaminophen|acetaminophen|mesh-list
56213563|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
56213564|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56213565|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966785|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
56079348|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
55966786|NCT04221477|Promethazine|promethazine|mesh-list
55966787|NCT04221477|Prednisone|prednisone|mesh-list
55966788|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
55966789|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
55966790|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966793|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744291|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55966795|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55966796|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966797|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55966798|NCT04221477|Analgesics|analgesics|mesh-ancestor
55966799|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
55966800|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966801|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
55966802|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
55966803|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
55966804|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55966805|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56079449|NCT03504241|Sirolimus|sirolimus|mesh-list
55966806|NCT04221477|Protective Agents|protective agents|mesh-ancestor
55966807|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55966808|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55966809|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55966810|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966811|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
55966812|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
55966813|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55966814|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
55966815|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
55966816|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966817|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966818|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55966819|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
55966820|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
55966821|NCT03586466|Buprenorphine|buprenorphine|mesh-list
55966822|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55966823|NCT03586466|Naloxone|naloxone|mesh-list
55966824|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55966825|NCT03586466|Narcotics|narcotics|mesh-ancestor
55966826|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966827|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966828|NCT03586466|Analgesics|analgesics|mesh-ancestor
55966829|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
55966830|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966831|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55966832|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
55966833|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55966834|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
55966835|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966836|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966837|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55966838|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
55966839|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55966840|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
55966841|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966842|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55966843|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55966844|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
55966845|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
55966846|NCT00570349|Protective Agents|protective agents|mesh-ancestor
55966847|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
55966848|NCT04157985|Nivolumab|nivolumab|mesh-list
55966849|NCT04157985|Ipilimumab|ipilimumab|mesh-list
55966850|NCT04157985|Cemiplimab|cemiplimab|mesh-list
55966851|NCT04157985|Atezolizumab|atezolizumab|mesh-list
55966852|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55966853|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55966854|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966855|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213566|NCT02815566|Tenofovir|tenofovir|mesh-list
56213567|NCT02815566|Emtricitabine|emtricitabine|mesh-list
56213568|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
55966856|NCT05605899|Prednisone|prednisone|mesh-list
55966857|NCT05605899|Cyclophosphamide|cyclophosphamide|mesh-list
55966858|NCT05605899|Rituximab|rituximab|mesh-list
55966859|NCT05605899|Doxorubicin|doxorubicin|mesh-list
55966860|NCT05605899|Fludarabine|fludarabine|mesh-list
55966861|NCT05605899|Etoposide|etoposide|mesh-list
55966862|NCT05605899|Vincristine|vincristine|mesh-list
55966863|NCT05605899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55966864|NCT05605899|Immunologic Factors|immunologic factors|mesh-ancestor
55966865|NCT05605899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966866|NCT05605899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966868|NCT05605899|Alkylating Agents|alkylating agents|mesh-ancestor
55966869|NCT05605899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966870|NCT05605899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966871|NCT05605899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55966872|NCT05605899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55966873|NCT05605899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55966874|NCT05605899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55966875|NCT05605899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55966876|NCT05605899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966877|NCT05605899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966878|NCT05605899|Glucocorticoids|glucocorticoids|mesh-ancestor
55966880|NCT05605899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55966881|NCT05605899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55966882|NCT05605899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55966883|NCT05605899|Tubulin Modulators|tubulin modulators|mesh-ancestor
55966884|NCT05605899|Antimitotic Agents|antimitotic agents|mesh-ancestor
55966885|NCT05605899|Mitosis Modulators|mitosis modulators|mesh-ancestor
55966886|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
55966887|NCT03889418|Narcotics|narcotics|mesh-ancestor
55966888|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55966889|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966890|NCT03889418|Analgesics|analgesics|mesh-ancestor
55966891|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
56079630|NCT00004833|Antibodies|antibodies|mesh-list
55966892|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966893|NCT00609739|Cytarabine|cytarabine|mesh-list
55966894|NCT00609739|Cyclosporine|cyclosporine|mesh-list
55966895|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
55966896|NCT00609739|Methotrexate|methotrexate|mesh-list
55966897|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
55966898|NCT00609739|Tretinoin|tretinoin|mesh-list
55966899|NCT00609739|Isotretinoin|isotretinoin|mesh-list
55966900|NCT00609739|Cyclosporins|cyclosporins|mesh-list
55966901|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55966902|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
55966903|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55966904|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966905|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55966906|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
55966907|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966908|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966909|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
55966910|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966911|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55966912|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55966913|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
55966914|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966915|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55966916|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
55966917|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966918|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
55966919|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55966920|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55966921|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
55966922|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
55966923|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966924|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55966925|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
55966926|NCT00609739|Hormones|hormones|mesh-ancestor
55966927|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55966928|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55966929|NCT00609739|Protective Agents|protective agents|mesh-ancestor
55966930|NCT00609739|Analgesics|analgesics|mesh-ancestor
56213569|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213570|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55790203|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
55966931|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
55966932|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55966933|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55966934|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
55966935|NCT03397004|Doxycycline|doxycycline|mesh-list
55966936|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55966937|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966938|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
55966939|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55966940|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55966941|NCT00610987|Cefazolin|cefazolin|mesh-list
55966942|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55966959|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55966960|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55966961|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55966962|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966963|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966964|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55966965|NCT00612235|Lamotrigine|lamotrigine|mesh-list
55966966|NCT00612235|Carbamazepine|carbamazepine|mesh-list
55966967|NCT00612235|Levetiracetam|levetiracetam|mesh-list
55966968|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
55966969|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
55966970|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55966971|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55966972|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966973|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55966974|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966975|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55966976|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55966977|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804081|NCT05012371|Everolimus|everolimus|mesh-list
55966978|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55966979|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55966980|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
55966981|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55966982|NCT00612235|Analgesics|analgesics|mesh-ancestor
55966983|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
55966984|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966985|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55966986|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55966987|NCT00575029|Megestrol|megestrol|mesh-list
55966988|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
55966989|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55966990|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55966991|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55966992|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
55966993|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55966994|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966995|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55966996|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55966997|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55966998|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966999|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
55967000|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55967001|NCT00499109|Gemcitabine|gemcitabine|mesh-list
55967002|NCT00499109|Carboplatin|carboplatin|mesh-list
55967003|NCT00499109|Docetaxel|docetaxel|mesh-list
55967006|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967007|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
55967008|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967009|NCT00499109|Antiviral Agents|antiviral agents|mesh-ancestor
55967010|NCT00499109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967011|NCT00499109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967012|NCT00499109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967013|NCT00499109|Immunologic Factors|immunologic factors|mesh-ancestor
55967014|NCT00499109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967015|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
55967016|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
55967017|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790204|NCT05256173|Melatonin|melatonin|mesh-list
55967018|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55967019|NCT03585530|Raltitrexed|raltitrexed|mesh-list
55967020|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967022|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967023|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967024|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55967025|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967026|NCT03021590|Amoxicillin|amoxicillin|mesh-list
55967027|NCT03021590|Clarithromycin|clarithromycin|mesh-list
55967028|NCT03021590|Levofloxacin|levofloxacin|mesh-list
55967030|NCT03021590|Tinidazole|tinidazole|mesh-list
55967031|NCT03021590|Esomeprazole|esomeprazole|mesh-list
55967032|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55967033|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967034|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55967035|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55967036|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55967037|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967038|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967039|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55967040|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55967041|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56079964|NCT00004029|Sargramostim|sargramostim|mesh-list
55967042|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55967043|NCT03021590|Renal Agents|renal agents|mesh-ancestor
55967044|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55967045|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55967046|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967047|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55967048|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
55967049|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55967050|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55967051|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55967052|NCT02125721|Penicillamine|penicillamine|mesh-list
55967053|NCT02125721|Antidotes|antidotes|mesh-ancestor
55967054|NCT02125721|Protective Agents|protective agents|mesh-ancestor
55967055|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967056|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
55967057|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
55967058|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967059|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967060|NCT00552695|Lidocaine|lidocaine|mesh-list
55967061|NCT00552695|Tetracaine|tetracaine|mesh-list
55967062|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
55967063|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
55967064|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967065|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967066|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
55967067|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967068|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56080017|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967069|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55967070|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55967071|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55967072|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967073|NCT00615433|Olanzapine|olanzapine|mesh-list
55967074|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55967075|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
55967076|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
55967077|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967079|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55967080|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55967081|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55967082|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967083|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55967084|NCT00615433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55967085|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55967086|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55967087|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967088|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967089|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
55967090|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55967091|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56213571|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56213572|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213573|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213574|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55967092|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55967093|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
55967094|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55967095|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55967096|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55967097|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55967098|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
55967099|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
56080078|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
55967100|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55967101|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967102|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55967103|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967104|NCT03585374|Acetaminophen|acetaminophen|mesh-list
55967105|NCT03585374|Ketoprofen|ketoprofen|mesh-list
55967106|NCT03585374|Morphine|morphine|mesh-list
55967107|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
55967108|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55967109|NCT03585374|Narcotics|narcotics|mesh-ancestor
55967110|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967111|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967113|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
55967114|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967115|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55967116|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
55967117|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55967118|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967119|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967120|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55967121|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889572|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967122|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967123|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55967124|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
55967125|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
55967126|NCT00499343|Rituximab|rituximab|mesh-list
55967127|NCT00499343|Etoposide|etoposide|mesh-list
55967128|NCT00499343|Ifosfamide|ifosfamide|mesh-list
55967129|NCT00499343|Sargramostim|sargramostim|mesh-list
55967130|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967131|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967132|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
55967133|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967134|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967135|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55967136|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55967137|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55967138|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967139|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967140|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967141|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
56080228|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56080263|NCT00005007|Etanercept|etanercept|mesh-list
55967142|NCT00615589|Fludarabine|fludarabine|mesh-list
55967143|NCT00615589|Busulfan|busulfan|mesh-list
55967144|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967145|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967146|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967147|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
55967148|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967149|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
55967150|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967153|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55967154|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967155|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55967156|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967157|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967158|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56213575|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56213576|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
56213577|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213578|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
56213579|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790210|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
55967159|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55967160|NCT00499655|Analgesics|analgesics|mesh-ancestor
55967161|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
55967162|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967163|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967164|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967165|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967166|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55967167|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55967169|NCT03585140|Adapalene|adapalene|mesh-list
55967170|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55967171|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967172|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
55967173|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55967174|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55967175|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56080426|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55967176|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55967177|NCT03585140|Analgesics|analgesics|mesh-ancestor
55967178|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
55967179|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967180|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967181|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967183|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
55967184|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55967185|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
55967186|NCT03584984|Coagulants|coagulants|mesh-ancestor
55967187|NCT00575887|Temozolomide|temozolomide|mesh-list
55967188|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967189|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
55967190|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967191|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967192|NCT00575965|Simvastatin|simvastatin|mesh-list
55967193|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56080519|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967194|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55967195|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
55967196|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967197|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55967198|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55967199|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967200|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
55967201|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967202|NCT03623828|Apomorphine|apomorphine|mesh-list
55967203|NCT03623828|Emetics|emetics|mesh-ancestor
55967204|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967205|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
55967206|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967207|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55967208|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
55967209|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
55967210|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967211|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967212|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
55967213|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967214|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
55967215|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967216|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967217|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967218|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
55967219|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967220|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967221|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55967222|NCT03589898|Gabapentin|gabapentin|mesh-list
55967223|NCT03589898|Analgesics|analgesics|mesh-ancestor
56213580|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213581|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55967224|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
56080594|NCT00003729|Cytarabine|cytarabine|mesh-list
55967226|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967227|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
55967228|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55967229|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55967230|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967231|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55967232|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55967233|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55967234|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967235|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967236|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
55967237|NCT00577135|Furosemide|furosemide|mesh-list
55967238|NCT00577135|Diuretics|diuretics|mesh-list
55967239|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
55967240|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
55967241|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804099|NCT02569957|Topotecan|topotecan|mesh-list
55967242|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55967243|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967246|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967247|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967248|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
55967249|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967250|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967251|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55967252|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
55967253|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55967254|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967255|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
55967256|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967257|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
55967258|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967259|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55967260|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080733|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080734|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
55967261|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55967262|NCT00617539|Irinotecan|irinotecan|mesh-list
55967263|NCT00617539|Temozolomide|temozolomide|mesh-list
55967264|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55967265|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55967266|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967267|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967268|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967269|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967270|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
55967271|NCT03620123|Docetaxel|docetaxel|mesh-list
55967272|NCT03620123|Nivolumab|nivolumab|mesh-list
55967273|NCT03620123|Ipilimumab|ipilimumab|mesh-list
55967274|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967275|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
55967276|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
55967277|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
55967278|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967279|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967280|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55967281|NCT00578071|Capecitabine|capecitabine|mesh-list
55967282|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
55967283|NCT00578071|Panitumumab|panitumumab|mesh-list
55967284|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080822|NCT00003783|Hormones|hormones|mesh-ancestor
55967285|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
55967286|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967287|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967288|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967290|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967291|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55967292|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213583|NCT02727803|Melphalan|melphalan|mesh-list
55967293|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967294|NCT00504023|Imiquimod|imiquimod|mesh-list
55967295|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55967296|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
55967297|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967300|NCT03589430|Protein C|protein c|mesh-list
55967301|NCT03589430|Antithrombins|antithrombins|mesh-list
55967302|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
55967303|NCT03589430|Protein S|protein s|mesh-list
55967304|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55967305|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
55967306|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967307|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967308|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
55967309|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55967310|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55967311|NCT05702762|Gentamicins|gentamicins|mesh-list
55967312|NCT05702762|Cephalexin|cephalexin|mesh-list
55967313|NCT05702762|Nitrofurantoin|nitrofurantoin|mesh-list
55967314|NCT05702762|Cefdinir|cefdinir|mesh-list
55967315|NCT05702762|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55967316|NCT05702762|Trimethoprim|trimethoprim|mesh-list
55967317|NCT05702762|Sulfamethoxazole|sulfamethoxazole|mesh-list
55967318|NCT05702762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55967319|NCT05702762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967320|NCT05702762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55967321|NCT05702762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967322|NCT05702762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967323|NCT05702762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55967324|NCT05702762|Renal Agents|renal agents|mesh-ancestor
55967325|NCT05702762|Antimalarials|antimalarials|mesh-ancestor
55967326|NCT05702762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55967327|NCT05702762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55967328|NCT05702762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55967329|NCT05702762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56080866|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967330|NCT05702762|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55967331|NCT05702762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55967332|NCT03580694|Cemiplimab|cemiplimab|mesh-list
55967333|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967334|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967335|NCT03583892|Gabapentin|gabapentin|mesh-list
55967336|NCT03583892|Analgesics|analgesics|mesh-ancestor
55967337|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
55967338|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967339|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967340|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
55967341|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55967342|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55967343|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967344|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55967345|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55967346|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55967347|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967348|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967349|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
55967350|NCT03589040|Darunavir|darunavir|mesh-list
55967351|NCT03589040|Rilpivirine|rilpivirine|mesh-list
55967352|NCT03589040|Etonogestrel|etonogestrel|mesh-list
55967353|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55967354|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55967355|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
55967356|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967357|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967358|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55967359|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55967360|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
55967361|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080925|NCT00004467|Antidotes|antidotes|mesh-ancestor
55967362|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55967363|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55967364|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55967365|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
55967366|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55967367|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967368|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55967370|NCT03583424|Etoposide|etoposide|mesh-list
55967371|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
55967372|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
55967384|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967385|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
55967386|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
55967387|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967388|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967390|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967391|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967392|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
55967393|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55967394|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
55967395|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
55967396|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
55967397|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
55967398|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
55967399|NCT00578305|Folic Acid|folic acid|mesh-list
55967400|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
55967401|NCT00578305|Rituximab|rituximab|mesh-list
55967402|NCT00578305|Methotrexate|methotrexate|mesh-list
55967403|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967404|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967405|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
55967406|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967407|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080986|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55967408|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55967409|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
55967410|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55967411|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967412|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
55967413|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967414|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
55967415|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967416|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55967417|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967418|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55967419|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967420|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
55967421|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
55967422|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967423|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55967424|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
55967425|NCT00578305|Hormones|hormones|mesh-ancestor
55967426|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55967427|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55967428|NCT00578305|Protective Agents|protective agents|mesh-ancestor
55967429|NCT00578305|Hematinics|hematinics|mesh-ancestor
55967430|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
55967431|NCT00578305|Vitamins|vitamins|mesh-ancestor
55967432|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
55967433|NCT00578461|Cytarabine|cytarabine|mesh-list
55967434|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
55967435|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967436|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
55967437|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967438|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967439|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55804180|NCT04999969|Paclitaxel|paclitaxel|mesh-list
55967444|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967446|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
55967447|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967448|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
55967449|NCT03156296|Bupivacaine|bupivacaine|mesh-list
55967450|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
55967451|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
56081063|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081064|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
55967452|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56081065|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081066|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081067|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56081068|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081074|NCT00363584|Capecitabine|capecitabine|mesh-list
55967453|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967454|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
55967455|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967456|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55967457|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55967458|NCT03156296|Analgesics|analgesics|mesh-ancestor
55967459|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56213584|NCT02727803|Busulfan|busulfan|mesh-list
56213585|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
56213586|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55967460|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55967461|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55967462|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
55967463|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967464|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967465|NCT00578539|Cytarabine|cytarabine|mesh-list
55967466|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
55967467|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
55967468|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967469|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
55967470|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967471|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967472|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967473|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
55967474|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967475|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967476|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55967477|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967479|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
55967480|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967481|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967482|NCT05688332|Metformin|metformin|mesh-list
55967483|NCT05688332|Glyburide|glyburide|mesh-list
55967484|NCT05688332|Voglibose|voglibose|mesh-list
55967485|NCT05688332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55967486|NCT05688332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967487|NCT05688332|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55967488|NCT05688332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967489|NCT05688332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967490|NCT00578617|Amiodarone|amiodarone|mesh-list
55967491|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967492|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55967493|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
55967494|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55967495|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55967496|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55967497|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55967498|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55967499|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967500|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55967501|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55967502|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56081153|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55967503|NCT00505895|Rituximab|rituximab|mesh-list
55967504|NCT00505895|Fludarabine|fludarabine|mesh-list
55967505|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
55967506|NCT00505895|Melphalan|melphalan|mesh-list
55967507|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967508|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967509|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
55967510|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967516|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967518|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55967519|NCT03582332|Indomethacin|indomethacin|mesh-list
55967520|NCT03582332|Etoricoxib|etoricoxib|mesh-list
55967521|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55967522|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55967523|NCT03582332|Analgesics|analgesics|mesh-ancestor
55967524|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
55967525|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967526|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967527|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967528|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967529|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
55967530|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
55967531|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55967532|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55967533|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967534|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213587|NCT02727803|Rituximab|rituximab|mesh-list
56213588|NCT02727803|Fludarabine|fludarabine|mesh-list
56213589|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
56213590|NCT02727803|Clofarabine|clofarabine|mesh-list
56213591|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56213592|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56213593|NCT02727803|Antibodies|antibodies|mesh-list
56213594|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
56213595|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56213596|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56213597|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
56213598|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213599|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213600|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55790222|NCT01669343|Letrozole|letrozole|mesh-list
55967535|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55967537|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55967538|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
55967539|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55967540|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
55967541|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967542|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55967543|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55967544|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
55967545|NCT03410615|Durvalumab|durvalumab|mesh-list
55967546|NCT03410615|Tremelimumab|tremelimumab|mesh-list
55967547|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967548|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967549|NCT03582098|Rituximab|rituximab|mesh-list
55967550|NCT03582098|Idelalisib|idelalisib|mesh-list
55967551|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967552|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967553|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
55967554|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967555|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967556|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967557|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081283|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
55967558|NCT00555893|Oseltamivir|oseltamivir|mesh-list
55967559|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
55967560|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967561|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967562|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967563|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55967564|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55967565|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55967566|NCT00578929|Analgesics|analgesics|mesh-ancestor
55967567|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
56081368|NCT00005673|Capravirine|capravirine|mesh-list
55967568|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967569|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967570|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967571|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967572|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55967573|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55967574|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55967575|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
55967576|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
55967577|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967578|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967579|NCT00556049|Gemcitabine|gemcitabine|mesh-list
55967581|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967582|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
56213601|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
55790233|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
55967583|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967584|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967585|NCT00556049|Antiviral Agents|antiviral agents|mesh-ancestor
55967586|NCT00556049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967587|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967588|NCT00556049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967589|NCT00556049|Immunologic Factors|immunologic factors|mesh-ancestor
55967590|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967591|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55967592|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55967593|NCT00556049|Growth Substances|growth substances|mesh-ancestor
55967594|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
55967595|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55967596|NCT01797107|Azithromycin|azithromycin|mesh-list
55967597|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55967598|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967599|NCT03155984|Antibodies|antibodies|mesh-list
55967600|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
55967601|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967602|NCT00620191|Metformin|metformin|mesh-list
55967603|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55967604|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967606|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967607|NCT03589976|Sirolimus|sirolimus|mesh-list
56081508|NCT01680939|Narcotics|narcotics|mesh-ancestor
55967608|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55967609|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967610|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55967611|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967612|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
55967613|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967614|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
55967615|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967616|NCT03581630|Naltrexone|naltrexone|mesh-list
55967617|NCT03581630|Bupropion|bupropion|mesh-list
55967618|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55967619|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55967620|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967622|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967623|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55967624|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
55967625|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55967626|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55967627|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56081631|NCT04824417|Voriconazole|voriconazole|mesh-list
55967628|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55967629|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967630|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
55967631|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967632|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55967633|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55967634|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967635|NCT00506675|Atropine|atropine|mesh-list
55967636|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55967637|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55967638|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55967639|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
55967640|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967641|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967642|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55967643|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
55967644|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
56081681|NCT02488070|Edetic Acid|edetic acid|mesh-list
55967645|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
55967646|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55967647|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55967648|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
55967649|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967650|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967651|NCT00507767|Dasatinib|dasatinib|mesh-list
55967652|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967653|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55967654|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967655|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213602|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967660|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967661|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967662|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55967663|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55967664|NCT00621049|Growth Substances|growth substances|mesh-ancestor
55967665|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967666|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
55967667|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
55967668|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
55967669|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
56081766|NCT00430183|Docetaxel|docetaxel|mesh-list
55967670|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967671|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55967672|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967674|NCT00508469|Travoprost|travoprost|mesh-list
55967675|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55967676|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55967677|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55967678|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55967679|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
55967680|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967681|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967682|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967683|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55967684|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55967685|NCT05702996|Eculizumab|eculizumab|mesh-list
55967686|NCT05702996|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55967687|NCT05702996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967688|NCT05702996|Immunologic Factors|immunologic factors|mesh-ancestor
55967689|NCT05702996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967690|NCT00580333|Paclitaxel|paclitaxel|mesh-list
55967691|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
55967692|NCT00580333|Bevacizumab|bevacizumab|mesh-list
55967693|NCT00580333|Doxorubicin|doxorubicin|mesh-list
56081847|NCT00363259|Ribavirin|ribavirin|mesh-list
55967694|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55967695|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967696|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
55967697|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
55967698|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
55967699|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967700|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967701|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
55967702|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967703|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967704|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967705|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
55967706|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55967707|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967708|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55967709|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56081906|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
55967710|NCT00580333|Growth Substances|growth substances|mesh-ancestor
55967711|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
55967712|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55967713|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55967715|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967716|NCT00580645|Varenicline|varenicline|mesh-list
55967717|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55967718|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55967719|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
55967720|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967721|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967722|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967723|NCT00580957|Trimethaphan|trimethaphan|mesh-list
55967724|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55967725|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55967726|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
55967727|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
55967729|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967730|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55967731|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55967732|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
55967733|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967734|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967735|NCT00509249|Aflibercept|aflibercept|mesh-list
55967736|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
55967737|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55967738|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55967739|NCT00509249|Growth Substances|growth substances|mesh-ancestor
55967740|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967741|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
55967742|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967743|NCT00624013|Sertraline|sertraline|mesh-list
55967744|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
55967745|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55967746|NCT00624013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55967747|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55967748|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55967749|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967750|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967751|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
55967752|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967753|NCT02121041|Losartan|losartan|mesh-list
55967754|NCT02121041|Amlodipine|amlodipine|mesh-list
55967755|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
55967756|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55967757|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55967758|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55967759|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967760|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55967761|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967762|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
55967763|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56082092|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55967764|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55967765|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55967766|NCT02121041|Diuretics|diuretics|mesh-ancestor
55967767|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
55967768|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55967769|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
55967770|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55967771|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55967772|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55967773|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967774|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55967775|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55967776|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967777|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967778|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967779|NCT02133781|Vaccines|vaccines|mesh-list
55967780|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
55967781|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967782|NCT01855451|Cetuximab|cetuximab|mesh-list
55967783|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967784|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967785|NCT02134951|Ketamine|ketamine|mesh-list
55967786|NCT02134951|Analgesics|analgesics|mesh-ancestor
55967787|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
55967788|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082182|NCT02525653|Gemcitabine|gemcitabine|mesh-list
55967789|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967790|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55967791|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55967792|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
55967793|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
55967794|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967795|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55967796|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55967797|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967798|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967799|NCT03029780|Nivolumab|nivolumab|mesh-list
55967801|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967802|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967803|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55967804|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967806|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55967807|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56213603|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213604|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56213605|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790236|NCT04722601|Venetoclax|venetoclax|mesh-list
55967808|NCT00624559|Analgesics|analgesics|mesh-ancestor
55967809|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
55967810|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967811|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967812|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967813|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967814|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55967815|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55967816|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967817|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967818|NCT00510809|Ethanol|ethanol|mesh-list
55967819|NCT00510809|Policosanol|policosanol|mesh-list
55967820|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55967821|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55967822|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967823|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967824|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967825|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55967826|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55967828|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967829|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967830|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55967831|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55967832|NCT00625729|Aldesleukin|aldesleukin|mesh-list
55967833|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
55967834|NCT00625729|Rituximab|rituximab|mesh-list
55967835|NCT00625729|Fludarabine|fludarabine|mesh-list
55967836|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
55967837|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967838|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
55967839|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967840|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967841|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55967842|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
55967843|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967844|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967845|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55967846|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55967847|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967848|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
55967849|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55967850|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55967851|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
55967852|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55967853|NCT00581971|Celecoxib|celecoxib|mesh-list
55967854|NCT00581971|Paclitaxel|paclitaxel|mesh-list
55967855|NCT00581971|Carboplatin|carboplatin|mesh-list
55967856|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55967857|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967858|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
55967859|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
55967860|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
55967861|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967862|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55967863|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55967864|NCT00581971|Analgesics|analgesics|mesh-ancestor
55967865|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
55967866|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967867|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967868|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967869|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967870|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55967871|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55967872|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967873|NCT03029234|Dexamethasone|dexamethasone|mesh-list
55967880|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
56213606|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
55967882|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55967883|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55967884|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967885|NCT01670318|Chromium|chromium|mesh-list
55967886|NCT01670318|Everolimus|everolimus|mesh-list
55967887|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967888|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967889|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
55967890|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082284|NCT02432456|Ibuprofen|ibuprofen|mesh-list
55967891|NCT01670318|Trace Elements|trace elements|mesh-ancestor
56082285|NCT02432456|Ketamine|ketamine|mesh-list
55967892|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
55967893|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
55967894|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55967895|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
55967896|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967897|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967898|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55967899|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
55967900|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
55967901|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55967902|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
55967903|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55967904|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967905|NCT03111992|Spartalizumab|spartalizumab|mesh-list
55967906|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55967907|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967908|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967909|NCT00626431|Leuprolide|leuprolide|mesh-list
55967910|NCT00626431|Hormones|hormones|mesh-list
55967911|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55967912|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082309|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55967913|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967914|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55967915|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
55967916|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55967917|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55967918|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967919|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55967920|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55967921|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55967922|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967924|NCT00582205|Cisplatin|cisplatin|mesh-list
55967925|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55967926|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967927|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
55967928|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
55967929|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
55967930|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967931|NCT00626743|Amlodipine|amlodipine|mesh-list
55967932|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55967933|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55967934|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55967935|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967936|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55967937|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967938|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
55967939|NCT03155048|Estradiol|estradiol|mesh-list
55967940|NCT03155048|Estrogens|estrogens|mesh-list
55967941|NCT03155048|Hormones|hormones|mesh-ancestor
55967942|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55967943|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082394|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55967945|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967946|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967947|NCT00627367|Hydromorphone|hydromorphone|mesh-list
55967948|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55967949|NCT00627367|Narcotics|narcotics|mesh-ancestor
55967950|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967951|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967952|NCT00627367|Analgesics|analgesics|mesh-ancestor
55967953|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
55967954|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967955|NCT00627679|Budesonide|budesonide|mesh-list
55967956|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967957|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55967958|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
55967959|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967960|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967961|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55967962|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
55967963|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
55967964|NCT00627679|Hormones|hormones|mesh-ancestor
55967965|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55967966|NCT00514709|Vaccines|vaccines|mesh-list
55967967|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
55967968|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967969|NCT03154814|Urinastatin|urinastatin|mesh-list
55967970|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55967971|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55967972|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
55967973|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967974|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967975|NCT00515021|Eplerenone|eplerenone|mesh-list
55967976|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55967977|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
55967978|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55967979|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967980|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55967981|NCT00515021|Diuretics|diuretics|mesh-ancestor
55967982|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
55967983|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55967984|NCT00515177|Eszopiclone|eszopiclone|mesh-list
55967985|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55967986|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967987|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967988|NCT01671410|Morphine|morphine|mesh-list
55967989|NCT01671410|Buprenorphine|buprenorphine|mesh-list
55967990|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55967991|NCT01671410|Narcotics|narcotics|mesh-ancestor
55967992|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55967993|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967994|NCT01671410|Analgesics|analgesics|mesh-ancestor
55967995|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
55967996|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967997|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55967998|NCT00630253|Cyclosporine|cyclosporine|mesh-list
55967999|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
55968000|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
55968001|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
55968002|NCT00630253|Fludarabine|fludarabine|mesh-list
55968003|NCT00630253|Cyclosporins|cyclosporins|mesh-list
55968004|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55968005|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55968006|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
55968007|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968008|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55968009|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56082508|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
56082509|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
55968010|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
55968011|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968012|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968013|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55968014|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968015|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
55968017|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
55968018|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55968019|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55968020|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55968021|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
55968022|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55968023|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55968025|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
55968026|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968027|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55968028|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
55968030|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55968031|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56213607|NCT02702492|Niacin|niacin|mesh-list
55968032|NCT00630253|Protective Agents|protective agents|mesh-ancestor
55968033|NCT01671722|Montelukast|montelukast|mesh-list
55968034|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55968035|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
55968036|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55968037|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
55968038|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55968039|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968040|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55968041|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55968042|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968044|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55968045|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
55968046|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968047|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968048|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968049|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55968050|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55968051|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968052|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55968053|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55968054|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
55968055|NCT00630409|Gemcitabine|gemcitabine|mesh-list
55968056|NCT00630409|Doxorubicin|doxorubicin|mesh-list
55968057|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55968058|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
55968059|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968060|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968061|NCT00630409|Antiviral Agents|antiviral agents|mesh-ancestor
55968062|NCT00630409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968063|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968064|NCT00630409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55968065|NCT00630409|Immunologic Factors|immunologic factors|mesh-ancestor
55968066|NCT00630409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968067|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55968068|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55968069|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55968071|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55968072|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55968073|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
55968074|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968075|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968076|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968077|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55968078|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55968079|NCT00584857|Paclitaxel|paclitaxel|mesh-list
55968080|NCT00584857|Carboplatin|carboplatin|mesh-list
55968081|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55968082|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968083|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
55968084|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
55968085|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
55968086|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968087|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
55968088|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55968089|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
55968090|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968091|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968092|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55968093|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
55968094|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55968095|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
56082869|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55968096|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968097|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968098|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55968099|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
55968100|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
55968101|NCT00585013|Protective Agents|protective agents|mesh-ancestor
55968102|NCT01672112|Oxycodone|oxycodone|mesh-list
55968103|NCT01672112|Codeine|codeine|mesh-list
55968104|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55968105|NCT01672112|Narcotics|narcotics|mesh-ancestor
56213608|NCT02702492|Nivolumab|nivolumab|mesh-list
56213609|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213610|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968106|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968107|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968108|NCT01672112|Analgesics|analgesics|mesh-ancestor
55968109|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
55968110|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968111|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
55968112|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
55968113|NCT00585637|Vitamin D|vitamin d|mesh-list
55968114|NCT00585637|Vitamins|vitamins|mesh-ancestor
55968115|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
55968116|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968117|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55968118|NCT03158792|Enoxaparin|enoxaparin|mesh-list
55968119|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
55968120|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
55968121|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55968122|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55968123|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968124|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55968125|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55968126|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
55968127|NCT00633919|Prednisone|prednisone|mesh-list
55968128|NCT00633919|Budesonide|budesonide|mesh-list
55968129|NCT00633919|Albuterol|albuterol|mesh-list
55968130|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
55968131|NCT00633919|Desloratadine|desloratadine|mesh-list
55968132|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55968133|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
55968134|NCT00633919|Hormones|hormones|mesh-ancestor
55968135|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55968136|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968137|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55968138|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968139|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55968140|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
55968141|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968143|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
55968144|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55968145|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55968146|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55968147|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
55968148|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968149|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968150|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
55968151|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55968152|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55968153|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
55968154|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55968155|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55968156|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
55968157|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
55968158|NCT03158246|Vitamin D|vitamin d|mesh-list
55968159|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
55968160|NCT03158246|Calcium|calcium|mesh-list
55968161|NCT03158246|Vitamins|vitamins|mesh-ancestor
55968162|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
55968163|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968164|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55968165|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55968166|NCT04459117|Acetaminophen|acetaminophen|mesh-list
55968167|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55968183|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
55968184|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55968185|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55968186|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
55968187|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968188|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968189|NCT00515411|Antidotes|antidotes|mesh-ancestor
55968190|NCT00515411|Protective Agents|protective agents|mesh-ancestor
56213611|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56213612|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968191|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
55968192|NCT00515411|Vitamins|vitamins|mesh-ancestor
55968193|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
55968194|NCT00586261|Pioglitazone|pioglitazone|mesh-list
55968195|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
55968197|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968198|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
55968199|NCT00515723|Olanzapine|olanzapine|mesh-list
55968200|NCT00515723|Risperidone|risperidone|mesh-list
55968201|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55968202|NCT00515723|Ziprasidone|ziprasidone|mesh-list
55968203|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55968204|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
55968205|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968206|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968207|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968208|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55968209|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55968210|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968211|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55968212|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55968213|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
55968214|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
55968215|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
55968216|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968217|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55968218|NCT00515723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55968219|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55968220|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55968221|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
55968223|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968224|NCT00586573|Memantine|memantine|mesh-list
55968225|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56082969|NCT05525858|Maytansine|maytansine|mesh-list
56082970|NCT05525858|Entrectinib|entrectinib|mesh-list
55968226|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55968227|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
55968228|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968229|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968230|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968231|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55968243|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968244|NCT03152942|Aminophylline|aminophylline|mesh-list
55968245|NCT03152942|Progesterone|progesterone|mesh-list
55968246|NCT03152942|Progestins|progestins|mesh-ancestor
55968247|NCT03152942|Hormones|hormones|mesh-ancestor
55968248|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55968249|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968250|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55968251|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
55968252|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968253|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55968254|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
55968255|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55968256|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55968257|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968258|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968259|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55968260|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55968261|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
55968262|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083009|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55968263|NCT03152942|Protective Agents|protective agents|mesh-ancestor
55968264|NCT00586729|Mafenide|mafenide|mesh-list
55968265|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55968266|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968267|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55968268|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55968269|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968270|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968271|NCT01672346|Adenosine|adenosine|mesh-list
55968272|NCT01672346|Analgesics|analgesics|mesh-ancestor
55968273|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
55968274|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968275|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968276|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55968277|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
55968278|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55968279|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
55968280|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
55968281|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968282|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968283|NCT00516503|Ketamine|ketamine|mesh-list
55968284|NCT00516503|Amitriptyline|amitriptyline|mesh-list
55968285|NCT00516503|Baclofen|baclofen|mesh-list
55968286|NCT00516503|Analgesics|analgesics|mesh-ancestor
55968287|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
55968288|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804257|NCT04295941|Trazodone|trazodone|mesh-list
55968289|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968290|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55968291|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55968292|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
55968294|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968297|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968298|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968299|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55968300|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55968301|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55968302|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
55968303|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
55968304|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55968305|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
55968306|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55968307|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55968308|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55968309|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55968310|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55968311|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
55968312|NCT03157310|Gefitinib|gefitinib|mesh-list
55968313|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968314|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55968315|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968316|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968317|NCT03157388|Vancomycin|vancomycin|mesh-list
55968318|NCT03157388|Gentamicins|gentamicins|mesh-list
55968319|NCT03157388|Meropenem|meropenem|mesh-list
55968320|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55968321|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968322|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55968323|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968324|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083114|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55968325|NCT03156920|Sumatriptan|sumatriptan|mesh-list
55968326|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55968327|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55968328|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55968329|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
55968330|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968331|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968332|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968333|NCT05247385|Ticagrelor|ticagrelor|mesh-list
55968334|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55968335|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55968336|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55968337|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55968338|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55968339|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
55968340|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968341|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968342|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968343|NCT03156842|Amlodipine|amlodipine|mesh-list
55968344|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55968345|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55968346|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56213613|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56213614|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
56213615|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56213616|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
56213617|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
55968347|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55968348|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968349|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55968350|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968351|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
55968352|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55968354|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
55968355|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55968356|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55968357|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968358|NCT01672580|Vitamins|vitamins|mesh-list
55968359|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
55968360|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968361|NCT00636649|Citalopram|citalopram|mesh-list
55968362|NCT00636649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55968363|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55968364|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55968371|NCT00636649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55968373|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55968374|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55968375|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
55968376|NCT00636805|Dexamethasone|dexamethasone|mesh-list
55968377|NCT00636805|Palonosetron|palonosetron|mesh-list
55968378|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55968379|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
55968380|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
55968381|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968382|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968383|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55968384|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
55968385|NCT00636805|Hormones|hormones|mesh-ancestor
55968386|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55968387|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55968388|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968389|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55968390|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55968391|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
55968392|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968393|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968394|NCT05247151|Oxytocin|oxytocin|mesh-list
55968395|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
55968396|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55968397|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968398|NCT01676246|Flupirtine|flupirtine|mesh-list
55968399|NCT01676246|Analgesics|analgesics|mesh-ancestor
56083229|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
55968400|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
55744322|NCT03342079|Analgesics|analgesics|mesh-ancestor
55968401|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968402|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968403|NCT00517595|Gemcitabine|gemcitabine|mesh-list
55968404|NCT00517595|Bevacizumab|bevacizumab|mesh-list
55968405|NCT00517595|Pemetrexed|pemetrexed|mesh-list
55968406|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968407|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968408|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55968409|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55968410|NCT00517595|Growth Substances|growth substances|mesh-ancestor
55968411|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968412|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
55968413|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55968414|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
55968415|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968416|NCT00517595|Antiviral Agents|antiviral agents|mesh-ancestor
55968417|NCT00517595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790246|NCT04383743|Doxorubicin|doxorubicin|mesh-list
55968418|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968419|NCT00517595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55968420|NCT00517595|Immunologic Factors|immunologic factors|mesh-ancestor
55968421|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55968422|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55968423|NCT01672814|Riboflavin|riboflavin|mesh-list
55968424|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55968425|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55968426|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
55968427|NCT01672814|Vitamins|vitamins|mesh-ancestor
55968428|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
56083276|NCT02630030|Ixazomib|ixazomib|mesh-list
55968429|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968430|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55968431|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
55968432|NCT00524225|Oprelvekin|oprelvekin|mesh-list
55968449|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55968450|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
55968451|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968452|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968453|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968454|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55968455|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55968456|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
55968457|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
56083318|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55968458|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968459|NCT05621915|Nadroparin|nadroparin|mesh-list
55968460|NCT05621915|Anticoagulants|anticoagulants|mesh-ancestor
55968461|NCT05621915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55968462|NCT05621915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55968463|NCT05621915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968464|NCT01673204|Calcitriol|calcitriol|mesh-list
55968465|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55968466|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968467|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55968468|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55968469|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968470|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55968471|NCT01673204|Vitamins|vitamins|mesh-ancestor
55968472|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
55968473|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55968474|NCT04393298|Leucovorin|leucovorin|mesh-list
55968475|NCT04393298|Trifluridine|trifluridine|mesh-list
55968476|NCT04393298|Fluorouracil|fluorouracil|mesh-list
55968477|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968478|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
55968479|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968480|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55968481|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968482|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55968483|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
55968484|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
55968485|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968486|NCT04393298|Antidotes|antidotes|mesh-ancestor
55968487|NCT04393298|Protective Agents|protective agents|mesh-ancestor
55968488|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
55968489|NCT04393298|Vitamins|vitamins|mesh-ancestor
55968490|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
55968491|NCT00641563|Midazolam|midazolam|mesh-list
55968504|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
55968505|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968506|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968507|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55968508|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55968509|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55968510|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55968511|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55968512|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
55968513|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
55968514|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
55968515|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
55968516|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55968517|NCT00641563|Narcotics|narcotics|mesh-ancestor
55968518|NCT05621759|Cyclophosphamide|cyclophosphamide|mesh-list
55968519|NCT05621759|Abatacept|abatacept|mesh-list
55968520|NCT05621759|Tacrolimus|tacrolimus|mesh-list
55968521|NCT05621759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55968522|NCT05621759|Immunologic Factors|immunologic factors|mesh-ancestor
56213618|NCT02702492|Vitamins|vitamins|mesh-ancestor
56213619|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
56213620|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213621|NCT02652455|Aldesleukin|aldesleukin|mesh-list
55968523|NCT05621759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968524|NCT05621759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55968525|NCT05621759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55968526|NCT05621759|Alkylating Agents|alkylating agents|mesh-ancestor
55968527|NCT05621759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968528|NCT05621759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968529|NCT05621759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55968530|NCT05621759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55968531|NCT05621759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968532|NCT05621759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55968533|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55968534|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55829120|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
56083539|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
55968535|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968537|NCT00641641|Emtricitabine|emtricitabine|mesh-list
55968538|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
55968539|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
55968540|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968541|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55968542|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55968543|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968544|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968545|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55968546|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55968547|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55968548|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55968549|NCT03152474|Vitamin A|vitamin a|mesh-list
55968550|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
55968551|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55968552|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56083631|NCT03678428|Floxuridine|floxuridine|mesh-list
55968553|NCT03152474|Prednisolone|prednisolone|mesh-list
55968554|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
55968556|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
55968558|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
55968559|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968560|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55968561|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
55968562|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
55968563|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968564|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55968565|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
55968566|NCT03152474|Hormones|hormones|mesh-ancestor
55968567|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55968568|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55968569|NCT03152474|Protective Agents|protective agents|mesh-ancestor
55968570|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55968571|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968572|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
55968573|NCT00641797|Promethazine|promethazine|mesh-list
55968574|NCT00641797|Meclizine|meclizine|mesh-list
55968575|NCT00641797|Lorazepam|lorazepam|mesh-list
55968576|NCT00641797|Ondansetron|ondansetron|mesh-list
55968577|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
55968578|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
55968579|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968580|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968581|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55968582|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
55968583|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
55968584|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55968585|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
55968586|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968587|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968588|NCT00641797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55968589|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55968590|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968591|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55968592|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55968593|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56213622|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
56213623|NCT02652455|Nivolumab|nivolumab|mesh-list
56213624|NCT02652455|Fludarabine|fludarabine|mesh-list
55968595|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
55968596|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
55968597|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
55968598|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55968599|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
55968600|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
55968601|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55968602|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
55968603|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
55968604|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
55968605|NCT04333459|Vaccines|vaccines|mesh-list
55968606|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
55968607|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968608|NCT00671515|Pioglitazone|pioglitazone|mesh-list
55968609|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55968610|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968611|NCT01893320|Decitabine|decitabine|mesh-list
55968612|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55968613|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
55968614|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968615|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968616|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968617|NCT04157725|Clomiphene|clomiphene|mesh-list
55968618|NCT04157725|Enclomiphene|enclomiphene|mesh-list
55968619|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
55968620|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55968621|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
55968622|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55968623|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968624|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55968625|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
55968626|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55968627|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55968628|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55968629|NCT04120766|Nicorandil|nicorandil|mesh-list
55968630|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55968631|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55968632|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
55968636|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968637|NCT00673075|Carvedilol|carvedilol|mesh-list
55968638|NCT00673075|Nebivolol|nebivolol|mesh-list
55968639|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55968640|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55968641|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
55968642|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968643|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968644|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968645|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55968646|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
55968647|NCT00673075|Protective Agents|protective agents|mesh-ancestor
55968648|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55968649|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55968650|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55968651|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
55968652|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55968653|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55968654|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55968655|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55968656|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55968657|NCT02250014|Sargramostim|sargramostim|mesh-list
55968658|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
55968659|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968660|NCT04022096|Lansoprazole|lansoprazole|mesh-list
55968661|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
55968662|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55968663|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55968664|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55968665|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968666|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968667|NCT00673153|Vorinostat|vorinostat|mesh-list
55968668|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
55968669|NCT00673153|Calicheamicins|calicheamicins|mesh-list
55968670|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968671|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55968672|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968673|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968674|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968675|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55968676|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55968677|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
56084014|NCT02495779|Emtricitabine|emtricitabine|mesh-list
56084015|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
56084016|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084017|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56084018|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56084019|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084020|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084021|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56084022|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56084023|NCT03241771|Naloxone|naloxone|mesh-list
56084024|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56084025|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084026|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
56084027|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084031|NCT02502487|Ropivacaine|ropivacaine|mesh-list
55968678|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55968680|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
55968681|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55968683|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968684|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55968686|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
55968687|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968688|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55968689|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55968690|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55968691|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
55968692|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889573|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56084092|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
56084093|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084094|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56084095|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55968693|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968694|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55968695|NCT00654511|Narcotics|narcotics|mesh-ancestor
55968696|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55968697|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55968698|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
55968699|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
55968700|NCT01670084|Leucovorin|leucovorin|mesh-list
55968701|NCT01670084|Cytarabine|cytarabine|mesh-list
55968702|NCT01670084|Dexamethasone|dexamethasone|mesh-list
55968703|NCT01670084|Prednisone|prednisone|mesh-list
55968704|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
55968705|NCT01670084|Rituximab|rituximab|mesh-list
55968706|NCT01670084|Doxorubicin|doxorubicin|mesh-list
55968708|NCT01670084|Methotrexate|methotrexate|mesh-list
55968709|NCT01670084|Vincristine|vincristine|mesh-list
55968710|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
55968712|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55968713|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
55968714|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968715|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55968716|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55968717|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
55968718|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968719|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968720|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55968721|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968722|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55968723|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
55968724|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
55968725|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968726|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55968727|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
55968728|NCT01670084|Hormones|hormones|mesh-ancestor
55968729|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55968730|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55968731|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55968732|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55968733|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55968734|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968735|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55968736|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
55968737|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55968738|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55968739|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
55968740|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
55968741|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55968742|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55968743|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
55968744|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968745|NCT01670084|Antidotes|antidotes|mesh-ancestor
56213625|NCT02652455|Interleukin-2|interleukin-2|mesh-list
56213626|NCT02652455|Antibodies|antibodies|mesh-list
56213627|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
56213628|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
56213629|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56213630|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
56213631|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213632|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213633|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56213634|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
55790254|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55790255|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55790256|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55968746|NCT01670084|Protective Agents|protective agents|mesh-ancestor
55968747|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
55968748|NCT01670084|Vitamins|vitamins|mesh-ancestor
55968749|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
55968750|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55968751|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
55968752|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
55968753|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
55968754|NCT01670162|Aflibercept|aflibercept|mesh-list
55968755|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55968756|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55968757|NCT01670162|Growth Substances|growth substances|mesh-ancestor
55968758|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968759|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
55968760|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968761|NCT04345783|Apatinib|apatinib|mesh-list
55968763|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55968764|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889575|NCT02987218|Desflurane|desflurane|mesh-list
56084405|NCT02600611|Vancomycin|vancomycin|mesh-list
55968765|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968766|NCT01670240|Adalimumab|adalimumab|mesh-list
55968767|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55968768|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55968769|NCT00675259|Paclitaxel|paclitaxel|mesh-list
55968770|NCT00675259|Bevacizumab|bevacizumab|mesh-list
55968771|NCT00675259|Carboplatin|carboplatin|mesh-list
55968772|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55968773|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968774|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
55968775|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
55968776|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
55968777|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968778|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968779|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55968780|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55968781|NCT00675259|Growth Substances|growth substances|mesh-ancestor
56084500|NCT02616523|Analgesics|analgesics|mesh-ancestor
55968784|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
55968785|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55968786|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968787|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55968788|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55968789|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968790|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968791|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968792|NCT04764344|Haloperidol|haloperidol|mesh-list
55968793|NCT04764344|Ondansetron|ondansetron|mesh-list
56213635|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213636|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213637|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56213638|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213639|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56213640|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56213641|NCT02652455|Analgesics|analgesics|mesh-ancestor
56213642|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
56213643|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084577|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
56084578|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
56084579|NCT05730907|Simendan|simendan|mesh-list
56084588|NCT05384665|Sufentanil|sufentanil|mesh-list
56213644|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55790257|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968794|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
55968795|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
55968796|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
55968797|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968798|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968799|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55968800|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
55968801|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
55968802|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55968803|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
55968804|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968805|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968806|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55968807|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55968808|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968809|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55968810|NCT04764344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56084675|NCT04143607|Gefitinib|gefitinib|mesh-list
56084676|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084678|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084693|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56084694|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56084695|NCT04622839|Analgesics|analgesics|mesh-ancestor
56084696|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
56084697|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968811|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55968812|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
55968813|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55968815|NCT04404686|Nifedipine|nifedipine|mesh-list
55968816|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55968817|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55968818|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968819|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55968820|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968821|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
55968822|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
55968823|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55968824|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55968825|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55968826|NCT04404686|Analgesics|analgesics|mesh-ancestor
55968827|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
55968828|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968829|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55968830|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55968831|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
55968832|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55968833|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968834|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
55968835|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55968836|NCT00658411|Deferoxamine|deferoxamine|mesh-list
55968837|NCT00658411|Siderophores|siderophores|mesh-ancestor
55968838|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55968839|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
55968840|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
55968841|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968842|NCT01674530|Lubiprostone|lubiprostone|mesh-list
55968843|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55968844|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55968845|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968846|NCT00676897|Simvastatin|simvastatin|mesh-list
55968848|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55968849|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
55968850|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968851|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55968852|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55968853|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968854|NCT02115074|Celecoxib|celecoxib|mesh-list
55968870|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55968871|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
55968872|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968873|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55968874|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55968875|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968876|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55968877|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55968878|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55968879|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55968880|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
55968881|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968882|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968883|NCT02082392|Citalopram|citalopram|mesh-list
55968884|NCT02082392|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55968885|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55968886|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55968887|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968888|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968889|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
55968890|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085071|NCT04781088|Paclitaxel|paclitaxel|mesh-list
55968891|NCT02082392|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55968892|NCT02082392|Antidepressive Agents|antidepressive agents|mesh-ancestor
55968893|NCT02082392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55968894|NCT03355976|Nivolumab|nivolumab|mesh-list
55968895|NCT03355976|Ipilimumab|ipilimumab|mesh-list
55968896|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968897|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968898|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55968899|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968900|NCT01674842|Cisplatin|cisplatin|mesh-list
55968901|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968902|NCT03845894|Bupivacaine|bupivacaine|mesh-list
55968903|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
55968904|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
55968905|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968906|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968907|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
55968908|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968909|NCT03161132|Doxorubicin|doxorubicin|mesh-list
55968910|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55968912|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55968926|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968928|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968929|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55968930|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55968931|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
56213646|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
56213647|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213648|NCT02578680|Folic Acid|folic acid|mesh-list
56213649|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
56213650|NCT02578680|Dexamethasone|dexamethasone|mesh-list
56085148|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56213652|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
56213653|NCT02578680|Pemetrexed|pemetrexed|mesh-list
56213654|NCT02578680|Vitamins|vitamins|mesh-ancestor
56213655|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
55968932|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55968933|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968934|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
55968935|NCT01675076|Apixaban|apixaban|mesh-list
55968936|NCT01675076|Dabigatran|dabigatran|mesh-list
55968937|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55968938|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
55968939|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55968940|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
55968941|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968942|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968943|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
55968944|NCT03018080|Paclitaxel|paclitaxel|mesh-list
55968945|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
55968946|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55968947|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968948|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
55968949|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
55968950|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
55968951|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968952|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968953|NCT03838796|Lenvatinib|lenvatinib|mesh-list
55968954|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968955|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55968956|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968957|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968958|NCT03719690|Tipifarnib|tipifarnib|mesh-list
55968959|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968960|NCT01675466|Anesthetics|anesthetics|mesh-list
55968961|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968962|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968963|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
55968964|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
55968965|NCT01676558|Rituximab|rituximab|mesh-list
55968966|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968967|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968968|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
55968969|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968970|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55968971|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
55968972|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55968973|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55968980|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968981|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55968982|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
55968983|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968984|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55968985|NCT00659737|Scopolamine|scopolamine|mesh-list
55968986|NCT00659737|Aprepitant|aprepitant|mesh-list
55968987|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
55968988|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55968989|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
55968990|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
55968991|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968992|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968993|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55968994|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56085422|NCT00367874|Narcotics|narcotics|mesh-ancestor
55968995|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213656|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968996|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968998|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
55968999|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55969000|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
55969001|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55969002|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
55969003|NCT04763876|Ketorolac|ketorolac|mesh-list
55969004|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55969005|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55969006|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55969007|NCT04763876|Analgesics|analgesics|mesh-ancestor
55969008|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
55969009|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969010|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969011|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969012|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969013|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55969014|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969015|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085516|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55969016|NCT00680797|Testosterone|testosterone|mesh-list
55969017|NCT00680797|Estrogens|estrogens|mesh-list
55969018|NCT00680797|Androgens|androgens|mesh-ancestor
55969019|NCT00680797|Hormones|hormones|mesh-ancestor
55969020|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969021|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969022|NCT02984852|Tenofovir|tenofovir|mesh-list
55969023|NCT02984852|Emtricitabine|emtricitabine|mesh-list
55969024|NCT02984852|Darunavir|darunavir|mesh-list
55969025|NCT02984852|Cobicistat|cobicistat|mesh-list
55969026|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
55969027|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969028|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55969029|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55969030|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969031|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969032|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55969033|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55969034|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55969035|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55969036|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
55969037|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55969038|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55969039|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
55969040|NCT00557193|Leucovorin|leucovorin|mesh-list
55969041|NCT00557193|Folic Acid|folic acid|mesh-list
55969042|NCT00557193|Cytarabine|cytarabine|mesh-list
55969043|NCT00557193|Dexamethasone|dexamethasone|mesh-list
55969044|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
55969045|NCT00557193|Prednisone|prednisone|mesh-list
55969046|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
55969048|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55969050|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
55969051|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
56085597|NCT00367315|Analgesics|analgesics|mesh-ancestor
55969052|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55969053|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55969054|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55969055|NCT00557193|Cortisone|cortisone|mesh-list
55969056|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
55969058|NCT00557193|Etoposide|etoposide|mesh-list
55969059|NCT00557193|Vincristine|vincristine|mesh-list
55969060|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
55969061|NCT00557193|Daunorubicin|daunorubicin|mesh-list
55969062|NCT00557193|Asparaginase|asparaginase|mesh-list
55969063|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
55969064|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
55969065|NCT00557193|Pegaspargase|pegaspargase|mesh-list
55969066|NCT00557193|Lenograstim|lenograstim|mesh-list
55969067|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55969068|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
55969069|NCT00557193|BB 1101|bb 1101|mesh-list
55969070|NCT00557193|Calcium|calcium|mesh-list
55969071|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
55969072|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085656|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55969073|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
55969074|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969075|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969076|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56213657|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56213658|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
56213659|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
56213660|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213661|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56213662|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
56213663|NCT02578680|Hormones|hormones|mesh-ancestor
56213664|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213665|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56213666|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213668|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213669|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213670|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56213671|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56213672|NCT02578680|Hematinics|hematinics|mesh-ancestor
56213673|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
55969077|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
55969078|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969079|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969080|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55969081|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969082|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
55969083|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
55969084|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969085|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55969086|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
55969088|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969089|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55969090|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
55969091|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969092|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55969093|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55969094|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55969095|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
55969096|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55969097|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55969098|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
55969099|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
55969100|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55969101|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55969102|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55969103|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55969104|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55969105|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
55969106|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969107|NCT00557193|Antidotes|antidotes|mesh-ancestor
55969108|NCT00557193|Protective Agents|protective agents|mesh-ancestor
55969109|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
55969110|NCT00557193|Vitamins|vitamins|mesh-ancestor
55969111|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
55969112|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55969113|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
55969114|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
55969115|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
56213674|NCT02520791|Antibodies|antibodies|mesh-list
56213675|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56213676|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
56213677|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213678|NCT02491983|Letrozole|letrozole|mesh-list
56213679|NCT02491983|Fulvestrant|fulvestrant|mesh-list
56213680|NCT02491983|Palbociclib|palbociclib|mesh-list
56213681|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213682|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55969116|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55969117|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55969118|NCT00557193|Hematinics|hematinics|mesh-ancestor
55969119|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
55969120|NCT00660517|Fluticasone|fluticasone|mesh-list
55969122|NCT00660517|Azelastine|azelastine|mesh-list
55969123|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969124|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55969125|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
55969137|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
55969138|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
55969139|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55969140|NCT02141581|Vaccines|vaccines|mesh-list
55969141|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
55969142|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969154|NCT03826628|Sirolimus|sirolimus|mesh-list
55969155|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55969156|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969157|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55969158|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969159|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
55969160|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969161|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
55969162|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969163|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55969164|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55969165|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969166|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969167|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55969168|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55969169|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969170|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
55969171|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55969172|NCT03751436|Venetoclax|venetoclax|mesh-list
55969173|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969174|NCT03819530|Micronutrients|micronutrients|mesh-list
55969175|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969176|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55969177|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
55969178|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55969179|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55969180|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55969181|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969186|NCT03750968|Carotenoids|carotenoids|mesh-list
55969187|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
55969188|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969189|NCT03750968|Protective Agents|protective agents|mesh-ancestor
56144757|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
55969190|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969191|NCT03818672|Rifaximin|rifaximin|mesh-list
55969192|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55969193|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969194|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55969195|NCT03749018|Prednisone|prednisone|mesh-list
55969196|NCT03749018|Cortisone|cortisone|mesh-list
55969197|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
56213683|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56213684|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969198|NCT03749018|Rituximab|rituximab|mesh-list
55969199|NCT03749018|Doxorubicin|doxorubicin|mesh-list
55969215|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
55969216|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969217|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969218|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55969219|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55969220|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55969221|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55969222|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969223|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969224|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
55969226|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969227|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55969228|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55969229|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55969230|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
55969231|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
55969232|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
55969235|NCT01931163|Everolimus|everolimus|mesh-list
55969236|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969237|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969238|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
55969239|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969240|NCT02974725|Trametinib|trametinib|mesh-list
55969241|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969242|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55969243|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969244|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969245|NCT04763486|Cefazolin|cefazolin|mesh-list
55969246|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55969247|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969248|NCT02988063|Polidocanol|polidocanol|mesh-list
55969249|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55969250|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55969251|NCT03877406|Empagliflozin|empagliflozin|mesh-list
55969252|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55969253|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55969254|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969255|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969279|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969281|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969282|NCT03802604|Atezolizumab|atezolizumab|mesh-list
55969283|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
55969284|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969285|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969286|NCT03869996|Cytarabine|cytarabine|mesh-list
55969287|NCT03869996|Methotrexate|methotrexate|mesh-list
55969288|NCT03869996|Etoposide|etoposide|mesh-list
55969289|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55969290|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
55969291|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969292|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969293|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
55969294|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969295|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969296|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
55969297|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969298|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55969299|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55969300|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55969301|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969302|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55969303|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
55969304|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55969305|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
55969306|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55969307|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213685|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969308|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55969309|NCT03869450|Lidocaine|lidocaine|mesh-list
55969310|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
55969311|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
55969312|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
55969313|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969314|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969315|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
55969316|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969317|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55969326|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
55969327|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
55969328|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969329|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
55969330|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086573|NCT02514278|Folfirinox|folfirinox|mesh-list
55969331|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969333|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969334|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
55969335|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969336|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55969337|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969338|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969339|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55969340|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56086637|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
55969341|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55969342|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55969343|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969344|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
55969345|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55969346|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969347|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55744366|NCT03332953|Nicotine|nicotine|mesh-list
55969348|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969349|NCT01101464|Asenapine|asenapine|mesh-list
55969350|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55969351|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55969352|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969353|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086748|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
56086749|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55969355|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
55969356|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55969357|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
55969358|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
55969359|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969360|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969361|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55969362|NCT03736538|Analgesics|analgesics|mesh-ancestor
55969363|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
55969364|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969365|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55969366|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
55969367|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969368|NCT03725930|Clonidine|clonidine|mesh-list
55969369|NCT03725930|Analgesics|analgesics|mesh-ancestor
55969370|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
55969371|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969372|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969373|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55969374|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
55969375|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
55969376|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55969377|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55969378|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55969379|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
55969380|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55969381|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969382|NCT03781388|Bupivacaine|bupivacaine|mesh-list
55969384|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
55969385|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969386|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213687|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
56213688|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969387|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
55969388|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969390|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55969391|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969392|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
55969393|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55969394|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
55969395|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
55969396|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969397|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
55969399|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969400|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
55969401|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
55969402|NCT03778580|Vitamins|vitamins|mesh-ancestor
55969403|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
55969404|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969405|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
55969406|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969407|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969408|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
55969409|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
55969410|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
55969411|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969412|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969413|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
55969414|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969415|NCT03722108|Irinotecan|irinotecan|mesh-list
55969416|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55969417|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55969418|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969419|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969420|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969421|NCT03775070|Simvastatin|simvastatin|mesh-list
55969422|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55969423|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55969424|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
55969425|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969426|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55969427|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55969428|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969429|NCT02083406|Artefenomel|artefenomel|mesh-list
55969430|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
55969431|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55969432|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55969433|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969434|NCT03773666|Durvalumab|durvalumab|mesh-list
55969435|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969436|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969437|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
55969438|NCT04762784|Hormones|hormones|mesh-ancestor
55969439|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969440|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969441|NCT00003644|Paclitaxel|paclitaxel|mesh-list
55969442|NCT00003644|Carboplatin|carboplatin|mesh-list
55969443|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55969444|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969445|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
55969446|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
55969447|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
55969448|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969449|NCT02142049|Lenalidomide|lenalidomide|mesh-list
55969450|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
55969451|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969452|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55969453|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55969454|NCT02142049|Growth Substances|growth substances|mesh-ancestor
55969455|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
55969456|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969457|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
56213689|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086910|NCT05451121|Analgesics|analgesics|mesh-ancestor
55969458|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56086911|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
55969459|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969461|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969463|NCT03716180|Trastuzumab|trastuzumab|mesh-list
55969464|NCT03716180|Pertuzumab|pertuzumab|mesh-list
55969465|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55969466|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969467|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
55804392|NCT02568397|Dabigatran|dabigatran|mesh-list
55969468|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
55969469|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
55969470|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969471|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969472|NCT03715244|Anesthetics|anesthetics|mesh-list
55969473|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
55969474|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969475|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969476|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
55969477|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969479|NCT03714620|Analgesics|analgesics|mesh-ancestor
55969480|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
55969481|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969482|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969483|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55969484|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55969485|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
55969486|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
55969487|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969488|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55969489|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55969490|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55969491|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969492|NCT03632720|Vaccines|vaccines|mesh-list
55969493|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
55969494|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969495|NCT03629288|Azithromycin|azithromycin|mesh-list
55969496|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55969497|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969498|NCT04763096|Tacrolimus|tacrolimus|mesh-list
55969499|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969500|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
55969501|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969502|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55969503|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969504|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969505|NCT00680953|Denosumab|denosumab|mesh-list
55969506|NCT00680953|Alendronate|alendronate|mesh-list
55969507|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55969508|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969509|NCT00660985|Adapalene|adapalene|mesh-list
55969510|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55969511|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55969512|NCT00660985|Analgesics|analgesics|mesh-ancestor
55969513|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
55969514|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969515|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969516|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969517|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969518|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
55969519|NCT03551522|Seladelpar|seladelpar|mesh-list
55969520|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55969521|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
55969522|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969523|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55969524|NCT03704714|Prednisone|prednisone|mesh-list
55969525|NCT03704714|Cortisone|cortisone|mesh-list
55969526|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
55969527|NCT03704714|Rituximab|rituximab|mesh-list
55969528|NCT03704714|Doxorubicin|doxorubicin|mesh-list
55969529|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55969530|NCT03704714|Nivolumab|nivolumab|mesh-list
56213690|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56213691|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55790291|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
55969531|NCT03704714|Vincristine|vincristine|mesh-list
55969532|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55969533|NCT03704714|Antibodies|antibodies|mesh-list
55969535|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55969536|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969537|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
55969538|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969539|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969540|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55969541|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
55969542|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969543|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969544|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55969545|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55969546|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55969547|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55969548|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969549|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969550|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
55969551|NCT03704714|Hormones|hormones|mesh-ancestor
55969552|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969553|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55969554|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56087062|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969555|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55969556|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
55969557|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
55969558|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
55969559|NCT00661141|Ethanol|ethanol|mesh-list
55969560|NCT00661141|Fomepizole|fomepizole|mesh-list
55969561|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55969562|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087136|NCT03233347|Daunorubicin|daunorubicin|mesh-list
55969563|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969564|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969565|NCT00661141|Antidotes|antidotes|mesh-ancestor
55969566|NCT00661141|Protective Agents|protective agents|mesh-ancestor
55969567|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969568|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969569|NCT03616574|Trifluridine|trifluridine|mesh-list
55969570|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
55969571|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969572|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
55969573|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969575|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55969576|NCT00681265|Protective Agents|protective agents|mesh-ancestor
55969577|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969578|NCT01677104|Liraglutide|liraglutide|mesh-list
55969579|NCT01677104|Exenatide|exenatide|mesh-list
55969580|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55969581|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55969582|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969583|NCT01677104|Incretins|incretins|mesh-ancestor
55969584|NCT01677104|Hormones|hormones|mesh-ancestor
55969585|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969586|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55969587|NCT00661453|Valproic Acid|valproic acid|mesh-list
55969588|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
55969589|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969590|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969591|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
55969592|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087233|NCT02626130|Tremelimumab|tremelimumab|mesh-list
55969593|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969594|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
55969595|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55969596|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969597|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55969598|NCT03547622|Galantamine|galantamine|mesh-list
55969599|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55969600|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213692|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213694|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55969601|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969602|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
55969603|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55969604|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969605|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55969606|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
55969607|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969608|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
55969611|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55969612|NCT00681889|Growth Substances|growth substances|mesh-ancestor
55969614|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
55969615|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969616|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
55969617|NCT03610490|Fludarabine|fludarabine|mesh-list
55969618|NCT03610490|Interleukin-2|interleukin-2|mesh-list
55969619|NCT03610490|Mitogens|mitogens|mesh-list
55969620|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969621|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
55969622|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969623|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969624|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55969625|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
55969626|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969627|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969628|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55969629|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55969630|NCT03610490|Analgesics|analgesics|mesh-ancestor
55969631|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
55969632|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969633|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
55969634|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
55969635|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56087361|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087362|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087363|NCT01265030|Sirolimus|sirolimus|mesh-list
56087364|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56087365|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087366|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56087367|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087368|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
56087369|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087370|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
55969636|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55969637|NCT00682357|Prednisolone|prednisolone|mesh-list
55969638|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
55969639|NCT00682357|Lidocaine|lidocaine|mesh-list
55969640|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55969641|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
55969642|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
55969643|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
55969644|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969645|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969646|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
55969647|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969648|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55969649|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55969650|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55969651|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55969652|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969653|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969654|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
55969655|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
55969656|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55969657|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
55969658|NCT00682357|Hormones|hormones|mesh-ancestor
55969659|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969660|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55969661|NCT00682357|Protective Agents|protective agents|mesh-ancestor
55969662|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55969663|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969664|NCT00662155|Zolpidem|zolpidem|mesh-list
55969665|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55969666|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55969667|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969668|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969669|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55969670|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
55969671|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
55969672|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213695|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213697|NCT02467478|Hormones|hormones|mesh-ancestor
55969673|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969674|NCT03546608|Tepotinib|tepotinib|mesh-list
55969675|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969676|NCT00662545|Tenofovir|tenofovir|mesh-list
55969677|NCT00662545|Lamivudine|lamivudine|mesh-list
55969678|NCT00662545|Emtricitabine|emtricitabine|mesh-list
55889576|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56087648|NCT05453851|Pancrelipase|pancrelipase|mesh-list
55969679|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55969680|NCT00662545|Entecavir|entecavir|mesh-list
55969681|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55969682|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
55969694|NCT00663169|Dexamethasone|dexamethasone|mesh-list
55969695|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
55969696|NCT00663169|BB 1101|bb 1101|mesh-list
55969697|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55969698|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969699|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
55969700|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
55969701|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969702|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969703|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55969704|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
55969706|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969707|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56087712|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
56087713|NCT03698461|Vitamins|vitamins|mesh-ancestor
55969708|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969709|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
55969710|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969711|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969712|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
55969713|NCT00663403|Daptomycin|daptomycin|mesh-list
55969714|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55969715|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969716|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
55969717|NCT00663793|Finasteride|finasteride|mesh-list
55969718|NCT00663793|Testosterone|testosterone|mesh-list
55969719|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
55969720|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
55969721|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55969722|NCT00663793|Acyline|acyline|mesh-list
55969723|NCT00663793|Androgens|androgens|mesh-ancestor
55969724|NCT00663793|Hormones|hormones|mesh-ancestor
55969725|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969726|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969727|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55969728|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969729|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
56087800|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087802|NCT00370669|Hormones|hormones|mesh-ancestor
55969730|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55969731|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55969732|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969733|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969734|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
55969735|NCT00663793|Urological Agents|urological agents|mesh-ancestor
55969736|NCT03690986|Nivolumab|nivolumab|mesh-list
55969737|NCT03690986|Ipilimumab|ipilimumab|mesh-list
55969738|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969739|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969740|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55969741|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969742|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
55969743|NCT03605654|Tacrolimus|tacrolimus|mesh-list
55969744|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55969760|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
55969761|NCT00667615|Rituximab|rituximab|mesh-list
55969762|NCT00667615|Etoposide|etoposide|mesh-list
55969763|NCT00667615|Vorinostat|vorinostat|mesh-list
55969764|NCT00667615|Lenograstim|lenograstim|mesh-list
55969765|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969766|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
55969767|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087861|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969768|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969769|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56213698|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790298|NCT01594931|Artesunate|artesunate|mesh-list
55969770|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
55969771|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969772|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969773|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55969774|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969775|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969776|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
55969777|NCT00667615|Hormones|hormones|mesh-ancestor
55969778|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969779|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55969780|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55969781|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55969782|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55969783|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969784|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55829124|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55969785|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55969786|NCT03532880|Olaparib|olaparib|mesh-list
55969787|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55969788|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969789|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969790|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969791|NCT03683810|Lactoferrin|lactoferrin|mesh-list
55969792|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
55969793|NCT03683810|Hematinics|hematinics|mesh-ancestor
55969794|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969795|NCT01587235|Simvastatin|simvastatin|mesh-list
55969796|NCT01587235|Ezetimibe|ezetimibe|mesh-list
55969797|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
55969798|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55969799|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55969800|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
55969801|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087909|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55969802|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55969803|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55969804|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969805|NCT03528902|Tamoxifen|tamoxifen|mesh-list
55969806|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55969807|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
55969808|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969809|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969810|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55969811|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969812|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55969813|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55969814|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55969815|NCT00705133|Treprostinil|treprostinil|mesh-list
55969816|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55969817|NCT00652717|Simvastatin|simvastatin|mesh-list
55969818|NCT00652717|Ezetimibe|ezetimibe|mesh-list
55969819|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55969820|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55969821|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
55969822|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969823|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55969824|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55969825|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087953|NCT05057689|Fentanyl|fentanyl|mesh-list
55969826|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
55969827|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969828|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
55969829|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55969830|NCT03600350|Nivolumab|nivolumab|mesh-list
55969831|NCT03600350|Sargramostim|sargramostim|mesh-list
55969832|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969833|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969834|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55969835|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969836|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
55969837|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969838|NCT00684775|Naltrexone|naltrexone|mesh-list
56213699|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56213700|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
55790299|NCT01594931|Pyronaridine|pyronaridine|mesh-list
55969839|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55969840|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55969841|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088020|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55969842|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
55969843|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969844|NCT03593408|Fentanyl|fentanyl|mesh-list
55969845|NCT03593408|Midazolam|midazolam|mesh-list
55969846|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
55969847|NCT03593408|Morphine|morphine|mesh-list
55969848|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55969849|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969850|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969851|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55969852|NCT03593408|Analgesics|analgesics|mesh-ancestor
55969853|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
55969854|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969855|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55969856|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55969857|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55969858|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
55969859|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55969860|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969861|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55969862|NCT03593408|Narcotics|narcotics|mesh-ancestor
55969863|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55969864|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55969865|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
55969866|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
55969867|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55969868|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55969869|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55969870|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
55969871|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
55969872|NCT00395473|Ezetimibe|ezetimibe|mesh-list
55969873|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55969874|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55969875|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
55969876|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969877|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55969878|NCT00393211|Etoricoxib|etoricoxib|mesh-list
56088086|NCT02958800|Olanzapine|olanzapine|mesh-list
55889577|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969879|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969881|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969882|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55969883|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55969884|NCT00393211|Analgesics|analgesics|mesh-ancestor
55969885|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
55969886|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969887|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969888|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55969889|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55969890|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969891|NCT03676556|Lidocaine|lidocaine|mesh-list
55969892|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
55969893|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
56088172|NCT04337606|Decitabine|decitabine|mesh-list
55969894|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969895|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969896|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
55969897|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969898|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55969899|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55969900|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55969901|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55969902|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969903|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
55969904|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969905|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
55969906|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
55969907|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
55969908|NCT03592472|Abexinostat|abexinostat|mesh-list
55969909|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56213701|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213702|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969910|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969911|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969912|NCT00269191|Ibuprofen|ibuprofen|mesh-list
55969913|NCT00269191|Etoricoxib|etoricoxib|mesh-list
55969914|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55969915|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55969916|NCT00269191|Analgesics|analgesics|mesh-ancestor
55969917|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
55969918|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969919|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969920|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55969921|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969922|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55969923|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052171|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969924|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969925|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55969926|NCT00690235|Pramlintide|pramlintide|mesh-list
55969927|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55969928|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969929|NCT00092833|Ezetimibe|ezetimibe|mesh-list
55969930|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55969931|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55969932|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
55969933|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969934|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55969935|NCT01799083|Decitabine|decitabine|mesh-list
56088443|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
55969936|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55969937|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
55969938|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969939|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969940|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969941|NCT01799161|Theophylline|theophylline|mesh-list
55969942|NCT01799161|Vaccines|vaccines|mesh-list
55969943|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
55969944|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969945|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55969946|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
55969947|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969948|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55969949|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
55969950|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55969951|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969953|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
55969954|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55969955|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55969956|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
55969957|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55969959|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
55969960|NCT00006110|Doxorubicin|doxorubicin|mesh-list
55969961|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55969962|NCT00006110|Trastuzumab|trastuzumab|mesh-list
55969963|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55969964|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969965|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
55969966|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
56088522|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55969967|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
55969968|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969969|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969970|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
55969971|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969972|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969973|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55969974|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
55969975|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55969976|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55969977|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55969978|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55969979|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088563|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55969980|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969981|NCT03591770|Vaccines|vaccines|mesh-list
56213703|NCT02466243|Lenabasum|lenabasum|mesh-list
56213704|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55969982|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
55969983|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969984|NCT00692185|Olanzapine|olanzapine|mesh-list
55969985|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
55969986|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
55969987|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969988|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969989|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55969990|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55969991|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55969992|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55969993|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55969994|NCT00692185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55969995|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55969996|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55969997|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969998|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55969999|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
55970000|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
55970001|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
55970002|NCT00692341|Axitinib|axitinib|mesh-list
55970003|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970004|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55970005|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829125|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
55970006|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088725|NCT03713437|Insulin|insulin|mesh-list
55970007|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
55970008|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970009|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970010|NCT03511976|Methylphenidate|methylphenidate|mesh-list
55970012|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55970013|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970014|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55970015|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55970016|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55970017|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970018|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
55970019|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970020|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
55970021|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
56088815|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55970022|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970023|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
55970024|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55970039|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970040|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55970041|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55970043|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
55970044|NCT03510884|Vitamins|vitamins|mesh-ancestor
55970045|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
55970046|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088907|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
56088908|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088909|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088912|NCT04900220|Hormones|hormones|mesh-ancestor
55970047|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
55970048|NCT00694603|Cetuximab|cetuximab|mesh-list
55970049|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970050|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970051|NCT03582722|Orlistat|orlistat|mesh-list
55970052|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970053|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970054|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55970055|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55970056|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
55970057|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55970058|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901143|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970059|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089010|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56089011|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970060|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55970061|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55970062|NCT00590161|Protective Agents|protective agents|mesh-ancestor
55970063|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970064|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
55970065|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55970066|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
55970067|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56213705|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56213706|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213707|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213709|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213710|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213711|NCT02321098|Amorolfine|amorolfine|mesh-list
56213712|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
56213713|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213714|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
56213715|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213716|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56213717|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
56213718|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56213719|NCT02185417|Diuretics|diuretics|mesh-ancestor
56213720|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
56213721|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213722|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56213723|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56213724|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213725|NCT02158234|Cisplatin|cisplatin|mesh-list
56213726|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
56213727|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790304|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970068|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
55970069|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970070|NCT00006170|Bupropion|bupropion|mesh-list
55829233|NCT02985736|Hormones|hormones|mesh-ancestor
55970071|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55970072|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
55970073|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55970074|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55970075|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55970076|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55970077|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970078|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
55970079|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970080|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970081|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56089113|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55970082|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55970083|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970084|NCT02123849|Aspirin|aspirin|mesh-list
55970085|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55970086|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55970087|NCT02123849|Analgesics|analgesics|mesh-ancestor
55970089|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970090|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089176|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55970091|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55970092|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55970093|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56213728|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213729|NCT02019641|beta-Aminoethyl Isothiourea|beta-aminoethyl isothiourea|mesh-list
56213730|NCT02019641|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56213731|NCT02019641|Protective Agents|protective agents|mesh-ancestor
56213732|NCT02019641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213733|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
56213734|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213735|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
56213736|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970094|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55970095|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089347|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089348|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
56089349|NCT02902081|Cannabidiol|cannabidiol|mesh-list
56089350|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
56089351|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
56089352|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55970096|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55970097|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55970098|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970099|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
55970100|NCT05347160|Calcium|calcium|mesh-list
55970101|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55970102|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970103|NCT00671528|Gentamicins|gentamicins|mesh-list
55970104|NCT00671528|Clotrimazole|clotrimazole|mesh-list
55970106|NCT00671528|Betamethasone|betamethasone|mesh-list
56089405|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56089406|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56089407|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56089408|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56089409|NCT02933372|Varenicline|varenicline|mesh-list
56089410|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56089411|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56089412|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
56089413|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089414|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970107|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
55970108|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55970109|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
55970110|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55970111|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55970112|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
55970113|NCT00671528|Hormones|hormones|mesh-ancestor
55970114|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970115|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970116|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55970117|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
55970118|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55970119|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970120|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55970121|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970122|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901238|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55901240|NCT00568672|Olanzapine|olanzapine|mesh-list
55970123|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55970124|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
55970125|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55970126|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55970127|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55970128|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
55970129|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55970130|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55970131|NCT00590863|Dexetimide|dexetimide|mesh-list
55970132|NCT00590863|Mirtazapine|mirtazapine|mesh-list
55970133|NCT00590863|Citalopram|citalopram|mesh-list
55970134|NCT00590863|Bupropion|bupropion|mesh-list
55970135|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55970136|NCT00590863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55970137|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55970138|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55970139|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970140|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970141|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
55970142|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970143|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55970144|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
55970145|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55970146|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55970147|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55970148|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
55970149|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
56213737|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970150|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970151|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55970152|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55970153|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
55970154|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55970155|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
55970156|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55970157|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55970158|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970159|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55970160|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55970161|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
55970162|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
55970163|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55970164|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55970165|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55970166|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55970167|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55970168|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55970169|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
55970170|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55970171|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55970172|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55970174|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55970175|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970176|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55970177|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55970178|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55970179|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970180|NCT02996695|Artesunate|artesunate|mesh-list
56089677|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089678|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55970181|NCT02996695|Chloroquine|chloroquine|mesh-list
55970182|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
55970183|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55970184|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55970185|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970186|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970187|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
55970188|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
55970189|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55970190|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
55901259|NCT00544414|Fluorouracil|fluorouracil|mesh-list
55901260|NCT00544414|Calcium|calcium|mesh-list
55901261|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
55901262|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901263|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55901264|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
55901266|NCT00544414|Antiviral Agents|antiviral agents|mesh-ancestor
55970191|NCT02996695|Amebicides|amebicides|mesh-ancestor
55970192|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55970193|NCT00359138|Cetirizine|cetirizine|mesh-list
55970194|NCT00359138|Loratadine|loratadine|mesh-list
55970195|NCT00359138|Levocetirizine|levocetirizine|mesh-list
55970196|NCT00359138|Desloratadine|desloratadine|mesh-list
55970197|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55970198|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55970199|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
55970200|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
55970201|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970202|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970203|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970204|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55970205|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55970206|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
55970207|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
55970208|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
55970209|NCT04738643|Varenicline|varenicline|mesh-list
55970210|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55970211|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56089851|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089852|NCT02956616|Ketorolac|ketorolac|mesh-list
56089853|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56089854|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56089855|NCT02956616|Analgesics|analgesics|mesh-ancestor
56089856|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
56089859|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55970212|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
55970213|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970214|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970215|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970217|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55970218|NCT05503979|Velpatasvir|velpatasvir|mesh-list
55970219|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
56213738|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56213739|NCT01953926|Trastuzumab|trastuzumab|mesh-list
55970220|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970221|NCT04703621|Daratumumab|daratumumab|mesh-list
55970222|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970223|NCT02996227|Bupivacaine|bupivacaine|mesh-list
55970224|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
55970225|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
55970226|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55970227|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970228|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
55970229|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970230|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
55970231|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56089899|NCT03043105|Hormones|hormones|mesh-ancestor
55970232|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55970233|NCT00698035|Testosterone|testosterone|mesh-list
55970234|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
55970235|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
55970236|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55970243|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55970244|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970245|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
55970246|NCT00698035|Estrogens|estrogens|mesh-ancestor
55970247|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55970248|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
55970249|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55970250|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55970253|NCT02129075|Poly I-C|poly i-c|mesh-list
55970254|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55970255|NCT02129075|Poly ICLC|poly iclc|mesh-list
55970256|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
55970257|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
55970258|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
55970259|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970260|NCT02129075|Laxatives|laxatives|mesh-ancestor
55970261|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55970262|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
55970263|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970264|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55970265|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55970266|NCT02129075|Protective Agents|protective agents|mesh-ancestor
55970267|NCT02775903|Azacitidine|azacitidine|mesh-list
55970268|NCT02775903|Durvalumab|durvalumab|mesh-list
55970269|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55970270|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
55970271|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970272|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970273|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970274|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970275|NCT01782443|Aflibercept|aflibercept|mesh-list
55970276|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55970277|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55970278|NCT01782443|Growth Substances|growth substances|mesh-ancestor
55970279|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970280|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
55970281|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970282|NCT01933425|Rocuronium|rocuronium|mesh-list
55970283|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56089943|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56089951|NCT02970032|Heparin|heparin|mesh-list
55970284|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55970286|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970287|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970288|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
55970289|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970290|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970291|NCT04239599|Leuprolide|leuprolide|mesh-list
55970292|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55970293|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
55970294|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55970295|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970296|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55970297|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970298|NCT03487016|Gemcitabine|gemcitabine|mesh-list
56213740|NCT01953926|Fulvestrant|fulvestrant|mesh-list
56213741|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213742|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790335|NCT04341467|Olanzapine|olanzapine|mesh-list
55970299|NCT03487016|Paclitaxel|paclitaxel|mesh-list
55970300|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
55970301|NCT03487016|Irinotecan|irinotecan|mesh-list
55970302|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55970303|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970304|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
55970305|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
55970306|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
55970307|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970309|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
55970310|NCT03487016|Antiviral Agents|antiviral agents|mesh-ancestor
55970311|NCT03487016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970312|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089982|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55970313|NCT03487016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55970314|NCT03487016|Immunologic Factors|immunologic factors|mesh-ancestor
55970315|NCT03487016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970316|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55970317|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55970318|NCT05346926|Calpastatin|calpastatin|mesh-list
55970319|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55970320|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
55970321|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970322|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970323|NCT05292209|Riluzole|riluzole|mesh-list
55970324|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
55970325|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55970326|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55970327|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970328|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970329|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970330|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56090020|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55970331|NCT05292209|Protective Agents|protective agents|mesh-ancestor
55970332|NCT03023319|Pemetrexed|pemetrexed|mesh-list
55970333|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970334|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970335|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970336|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55970337|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55970338|NCT02980653|Megestrol|megestrol|mesh-list
55970339|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
55970340|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55970341|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55970342|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55970343|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
55970344|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55970345|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090079|NCT02988050|Epinephrine|epinephrine|mesh-list
56090080|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
56090081|NCT02988050|Remifentanil|remifentanil|mesh-list
55970346|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55970347|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55970348|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55970349|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970350|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
55970351|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55970352|NCT05265065|Vaccines|vaccines|mesh-list
55970353|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
55970354|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970355|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
55970356|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55970357|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970358|NCT04125563|Capsaicin|capsaicin|mesh-list
55970359|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
55970360|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
55970361|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
55970362|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970363|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970364|NCT02168829|Aspirin|aspirin|mesh-list
55970365|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
55970366|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56213743|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56213744|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56213745|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55790338|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
55970367|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55970368|NCT02168829|Analgesics|analgesics|mesh-ancestor
55970369|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
55970370|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970371|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970372|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55970373|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55970374|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55970375|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55970376|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970377|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55970378|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56090235|NCT03075553|Nivolumab|nivolumab|mesh-list
55970379|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970380|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
55970383|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55970384|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
55970385|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
55970386|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
55970387|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
55970388|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970389|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55970390|NCT03990623|Liver Extracts|liver extracts|mesh-list
55970391|NCT03990623|Hematinics|hematinics|mesh-ancestor
55970392|NCT03087968|Prednisolone|prednisolone|mesh-list
55970393|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55970394|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
55970395|NCT03087968|Hormones|hormones|mesh-ancestor
55970396|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970397|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970398|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55970399|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970400|NCT03845049|Aflibercept|aflibercept|mesh-list
55970401|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55970402|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55970403|NCT03845049|Growth Substances|growth substances|mesh-ancestor
55970404|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970405|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
55970406|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970407|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55970408|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55970409|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970410|NCT03790839|Incretins|incretins|mesh-ancestor
55970411|NCT03790839|Hormones|hormones|mesh-ancestor
55970412|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970413|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55970414|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
55970416|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970417|NCT03088046|Progesterone|progesterone|mesh-list
55970418|NCT03088046|Progestins|progestins|mesh-ancestor
55970419|NCT03088046|Hormones|hormones|mesh-ancestor
56090433|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55970420|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970421|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970422|NCT01677884|Bevacizumab|bevacizumab|mesh-list
55970423|NCT01677884|Capecitabine|capecitabine|mesh-list
55970424|NCT01677884|Irinotecan|irinotecan|mesh-list
55970425|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970426|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970427|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55970428|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55970429|NCT01677884|Growth Substances|growth substances|mesh-ancestor
55970430|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970431|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
55970432|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55970433|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
55970434|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213746|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
56213747|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213748|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213749|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56213750|NCT01859026|Mitogens|mitogens|mesh-list
56213751|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213752|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213753|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213754|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970435|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55970436|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55970437|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970438|NCT02124083|Vorinostat|vorinostat|mesh-list
55970439|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970440|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55970441|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901393|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55970442|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970443|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
55970444|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55970445|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55970446|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970447|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
55970448|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
55970449|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970450|NCT00701389|Sumatriptan|sumatriptan|mesh-list
55970451|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55970452|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55970453|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55970454|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
55970463|NCT02152995|Trace Elements|trace elements|mesh-ancestor
56090597|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090598|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090599|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56090600|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
56090601|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090602|NCT03090620|Lorazepam|lorazepam|mesh-list
56090603|NCT03090620|Physostigmine|physostigmine|mesh-list
56090604|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
56090605|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
55901401|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55970464|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
55970465|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970466|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970467|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55970468|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970469|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970470|NCT02336594|Verinurad|verinurad|mesh-list
55970471|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
55970472|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55970473|NCT01799317|Vitamin D|vitamin d|mesh-list
55970474|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
55970475|NCT01799317|Vitamins|vitamins|mesh-ancestor
55970476|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
55970477|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970478|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55970481|NCT03925025|Nimodipine|nimodipine|mesh-list
55970482|NCT03925025|Analgesics|analgesics|mesh-ancestor
55970483|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
55970484|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970485|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970486|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
55970487|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55970488|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56090657|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
55970489|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
55970490|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55970491|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55970492|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970493|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55970494|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
55970495|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55970496|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55970497|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
55970498|NCT01677962|Poly ICLC|poly iclc|mesh-list
55970499|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
55970500|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
55970501|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970502|NCT00595153|Budesonide|budesonide|mesh-list
55970503|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55970504|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55970505|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
55970506|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090710|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55970507|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970508|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55970509|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
55970510|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
55970511|NCT00595153|Hormones|hormones|mesh-ancestor
55970512|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970513|NCT02995291|Phentolamine|phentolamine|mesh-list
55970514|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55970515|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55970516|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
55970517|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090853|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55970518|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970519|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970520|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55970521|NCT00595231|Rufinamide|rufinamide|mesh-list
55970523|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55970524|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55970525|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55970526|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970527|NCT02995057|Nickel|nickel|mesh-list
55970528|NCT02995057|Trace Elements|trace elements|mesh-ancestor
55970529|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
56090941|NCT03795350|Hormones|hormones|mesh-ancestor
56090942|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090943|NCT03118843|Velpatasvir|velpatasvir|mesh-list
55901424|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
55901425|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901426|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970530|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970531|NCT02474173|Paclitaxel|paclitaxel|mesh-list
55970532|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55970533|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55970534|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970535|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
55970536|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
55970537|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
55970538|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970539|NCT03482102|Durvalumab|durvalumab|mesh-list
55970540|NCT03482102|Tremelimumab|tremelimumab|mesh-list
55970541|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970542|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970543|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55970544|NCT02402270|Laxatives|laxatives|mesh-ancestor
55970545|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55970546|NCT00701935|Exenatide|exenatide|mesh-list
55970547|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55970548|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970549|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55970550|NCT00701935|Incretins|incretins|mesh-ancestor
55970551|NCT00701935|Hormones|hormones|mesh-ancestor
55970552|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970560|NCT02984696|Estradiol|estradiol|mesh-list
55970561|NCT02984696|Estrogens|estrogens|mesh-ancestor
55970562|NCT02984696|Hormones|hormones|mesh-ancestor
55970563|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970564|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970565|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55970566|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
55970567|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970568|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55970569|NCT00596167|Vancomycin|vancomycin|mesh-list
55970570|NCT00596167|Levofloxacin|levofloxacin|mesh-list
55970571|NCT00596167|Gentamicins|gentamicins|mesh-list
55970572|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970573|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55970574|NCT00596167|Renal Agents|renal agents|mesh-ancestor
55970575|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55970576|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55970577|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213755|NCT01859026|Mitosis Modulators|mitosis modulators|mesh-ancestor
56213756|NCT01843374|Tremelimumab|tremelimumab|mesh-list
56213757|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970578|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091059|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
56091060|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091061|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56091062|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
56091066|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56091086|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56091087|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55970579|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970580|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55970581|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55970582|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55970583|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
55970584|NCT03087032|Liraglutide|liraglutide|mesh-list
55970585|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55970586|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970587|NCT03087032|Incretins|incretins|mesh-ancestor
55970588|NCT03087032|Hormones|hormones|mesh-ancestor
55970589|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970590|NCT02994745|Atorvastatin|atorvastatin|mesh-list
55970591|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55970592|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55970593|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
55970594|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970595|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55970596|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55970597|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970598|NCT00703261|Atorvastatin|atorvastatin|mesh-list
55970599|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55970600|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55970601|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
55970608|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55970609|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970610|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970612|NCT04912115|Ketamine|ketamine|mesh-list
55970613|NCT04912115|Analgesics|analgesics|mesh-ancestor
55970614|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
55970615|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970616|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970617|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55970618|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55970619|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
55970620|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
55970621|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55970622|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55970623|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55970624|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970625|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970626|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55970627|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55970629|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55970630|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55970631|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
55970632|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
55970633|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
55970634|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970635|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56091137|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56091138|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
55970636|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970638|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
55970640|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
55970641|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
55970642|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
55970643|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970644|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55970645|NCT04200833|Golimumab|golimumab|mesh-list
55970646|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55970647|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55970648|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55970649|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
55970650|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970651|NCT01678352|Imiquimod|imiquimod|mesh-list
56213759|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970652|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55970653|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
55970654|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970655|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970656|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
55970657|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55970658|NCT01678430|Chlorambucil|chlorambucil|mesh-list
55970659|NCT01678430|Ofatumumab|ofatumumab|mesh-list
55970660|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55970661|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
55970662|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970663|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970664|NCT01678664|Doxorubicin|doxorubicin|mesh-list
55970665|NCT01678664|Everolimus|everolimus|mesh-list
55970666|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55970667|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970668|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55970669|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55970679|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901531|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
55970680|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970681|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55970682|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970683|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
55970685|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
55970686|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970687|NCT04402112|Pitavastatin|pitavastatin|mesh-list
55970688|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55970689|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55970690|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55970691|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
55970692|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970693|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970694|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55901573|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
55970695|NCT00597727|Glycerol|glycerol|mesh-list
55970696|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55970697|NCT00597727|Protective Agents|protective agents|mesh-ancestor
55970698|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970699|NCT03952403|Bevacizumab|bevacizumab|mesh-list
55970700|NCT03952403|Carboplatin|carboplatin|mesh-list
55970701|NCT03952403|Pemetrexed|pemetrexed|mesh-list
55970702|NCT03952403|Antibodies|antibodies|mesh-list
55970703|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970704|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970705|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55970706|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55970707|NCT03952403|Growth Substances|growth substances|mesh-ancestor
55970708|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970709|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
55970710|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
55970711|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970712|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091281|NCT03163303|Nicotine|nicotine|mesh-list
55970713|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55970714|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55970715|NCT03474770|Huperzine A|huperzine a|mesh-list
55970716|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55970717|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970718|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970719|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
55970720|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970721|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970722|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55970723|NCT03474770|Protective Agents|protective agents|mesh-ancestor
55970724|NCT02998645|Cyclosporine|cyclosporine|mesh-list
55970725|NCT02998645|Cyclosporins|cyclosporins|mesh-list
55970726|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970727|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970728|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55970729|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
55970730|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213760|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213761|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213762|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970731|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
55970732|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970733|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
55970734|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55970735|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55970738|NCT03450122|Interleukin-2|interleukin-2|mesh-list
55970739|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55970740|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
55970741|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970742|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55970743|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55970744|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
55970745|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970746|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970747|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55970748|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55970749|NCT03450122|Analgesics|analgesics|mesh-ancestor
55970750|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
55970751|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970752|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55970753|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55970754|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
55970755|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970756|NCT00707863|Citalopram|citalopram|mesh-list
55970757|NCT00707863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55970758|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55970759|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55970760|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970761|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970762|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
55970763|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970764|NCT00707863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55970765|NCT00707863|Antidepressive Agents|antidepressive agents|mesh-ancestor
55970766|NCT00707863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55970767|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55970768|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
55970769|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55970770|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
55970771|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970772|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
55970773|NCT00565643|Protective Agents|protective agents|mesh-ancestor
55970774|NCT00565643|Laxatives|laxatives|mesh-ancestor
55970775|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55970776|NCT01798277|Amiodarone|amiodarone|mesh-list
55970777|NCT01798277|Sotalol|sotalol|mesh-list
55970778|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55970779|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
55970780|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55970781|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55970782|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970783|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55970784|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55970785|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55970786|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970787|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55970788|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55970789|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56091555|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55970790|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55970791|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55970792|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
55970793|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970794|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970795|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
55970796|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
55970797|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970798|NCT00598507|Sagopilone|sagopilone|mesh-list
55970799|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970800|NCT00566813|Exenatide|exenatide|mesh-list
56091640|NCT03291080|Isotretinoin|isotretinoin|mesh-list
56213769|NCT01599572|Zinc|zinc|mesh-list
56213770|NCT01599572|Trace Elements|trace elements|mesh-ancestor
56213771|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
56213772|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213773|NCT01599598|Imidacloprid|imidacloprid|mesh-list
56213774|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
56213775|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790356|NCT04872881|Fentanyl|fentanyl|mesh-list
55970801|NCT00566813|Etanercept|etanercept|mesh-list
55970802|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55970803|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55970804|NCT00566813|Analgesics|analgesics|mesh-ancestor
55970805|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
55970806|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970807|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970808|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55970810|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55970811|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55970812|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
55970813|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55970814|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55970815|NCT00566813|Incretins|incretins|mesh-ancestor
55970816|NCT00566813|Hormones|hormones|mesh-ancestor
55970817|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970818|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
55970819|NCT00088166|Hormones|hormones|mesh-ancestor
55970820|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970821|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970822|NCT00566969|Carvedilol|carvedilol|mesh-list
55970823|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55970824|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55970825|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
55970826|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970827|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970828|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970829|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55970830|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
55970831|NCT00566969|Protective Agents|protective agents|mesh-ancestor
55970832|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55970833|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55970834|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56091739|NCT03189589|Nemiralisib|nemiralisib|mesh-list
55970835|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
55970836|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55970837|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55970843|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
55970844|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55970845|NCT03086564|Estrogens|estrogens|mesh-ancestor
55970846|NCT03086564|Hormones|hormones|mesh-ancestor
55970847|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970848|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970849|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55970850|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970851|NCT00598663|Insulin|insulin|mesh-list
56213776|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213777|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213778|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55970852|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55970853|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55970854|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970855|NCT03449108|Aldesleukin|aldesleukin|mesh-list
55970856|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
55970857|NCT03449108|Nivolumab|nivolumab|mesh-list
55970858|NCT03449108|Fludarabine|fludarabine|mesh-list
55970859|NCT03449108|Ipilimumab|ipilimumab|mesh-list
55970860|NCT03449108|Interleukin-2|interleukin-2|mesh-list
55970861|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55970862|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
55970863|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970864|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55970865|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55970866|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
55970867|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970868|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970869|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55970870|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970871|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55970872|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55970873|NCT03449108|Analgesics|analgesics|mesh-ancestor
55970874|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
55970875|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970876|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55970877|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55970878|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
55970879|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970881|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
55970882|NCT00704353|Hematinics|hematinics|mesh-ancestor
55970883|NCT00087698|Pemetrexed|pemetrexed|mesh-list
55970884|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970886|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970887|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55970888|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55970889|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
55970890|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970891|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970892|NCT05245721|Nalbuphine|nalbuphine|mesh-list
55970893|NCT05245721|Bupivacaine|bupivacaine|mesh-list
55970894|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
55970895|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
55970896|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55970897|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970898|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
55970899|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970900|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55970901|NCT05245721|Narcotics|narcotics|mesh-ancestor
55970902|NCT05245721|Analgesics|analgesics|mesh-ancestor
55970903|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
55970904|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
55970905|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55970906|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970907|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970908|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
55970909|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55970910|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55970911|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970912|NCT03472586|Nivolumab|nivolumab|mesh-list
55970913|NCT03472586|Ipilimumab|ipilimumab|mesh-list
55970914|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970915|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970916|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55970917|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970918|NCT02987985|Acetaminophen|acetaminophen|mesh-list
55970919|NCT02987985|Dexamethasone|dexamethasone|mesh-list
55970920|NCT02987985|Lidocaine|lidocaine|mesh-list
55970921|NCT02987985|Fentanyl|fentanyl|mesh-list
55970922|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
56091998|NCT03236168|Malathion|malathion|mesh-list
56091999|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55970923|NCT02987985|Ketamine|ketamine|mesh-list
55970924|NCT02987985|Gabapentin|gabapentin|mesh-list
56213779|NCT01599702|Hematinics|hematinics|mesh-ancestor
56213780|NCT01599728|Substance P|substance p|mesh-list
56213781|NCT01599728|Neurokinin A|neurokinin a|mesh-list
56213782|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970925|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
55970926|NCT02987985|Ondansetron|ondansetron|mesh-list
55970927|NCT02987985|Sevoflurane|sevoflurane|mesh-list
55970928|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55970929|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
55970930|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
55970931|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55970932|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970933|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55970934|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
55970935|NCT02987985|Hormones|hormones|mesh-ancestor
55970936|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970937|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55970938|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970939|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
55970940|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
55970941|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55970942|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
55970943|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55970944|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55901596|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
55970945|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55970946|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889625|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55970947|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970948|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55970949|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55970950|NCT02987985|Analgesics|analgesics|mesh-ancestor
55970951|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55970952|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55970953|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55970954|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
55970955|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970956|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55970957|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55970958|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
55970959|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55970965|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55970966|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
56092049|NCT03211117|Docetaxel|docetaxel|mesh-list
55970967|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55970968|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55970969|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55970970|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
55970971|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
55970972|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
55970973|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55970974|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
55970975|NCT02987985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55970976|NCT00708721|Clofarabine|clofarabine|mesh-list
55970977|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55970978|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
55970979|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970980|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970981|NCT00087152|Capecitabine|capecitabine|mesh-list
55970982|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
55970983|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55970984|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
55970985|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970986|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970987|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55970988|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970989|NCT05362799|Metformin|metformin|mesh-list
55970990|NCT05362799|Letrozole|letrozole|mesh-list
55970991|NCT05362799|Lactitol|lactitol|mesh-list
55970992|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55970993|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970994|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970995|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55970996|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55970997|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970998|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213783|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213784|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213785|NCT01599819|Factor VIII|factor viii|mesh-list
56213786|NCT01599819|BAX 855|bax 855|mesh-list
56213787|NCT01599819|Coagulants|coagulants|mesh-ancestor
56213788|NCT01599858|Omeprazole|omeprazole|mesh-list
56213789|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56213790|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56213791|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56213792|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213793|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971007|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971009|NCT01940523|Coagulants|coagulants|mesh-ancestor
55971010|NCT04403282|Eflornithine|eflornithine|mesh-list
56092230|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971011|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971012|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55971013|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55971014|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55971015|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971016|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
55971017|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971018|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971019|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
55971020|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55971021|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
55971022|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
55971023|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971024|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092319|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55971025|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55971026|NCT02994433|Analgesics|analgesics|mesh-ancestor
55971027|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
55971028|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971029|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55971030|NCT04388189|Bupropion|bupropion|mesh-list
55971031|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55971034|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55971035|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55971036|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55971037|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971038|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
55971039|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092508|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55971040|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971041|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56213797|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213798|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213799|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56213800|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
56213801|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56213802|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213803|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213804|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
56213805|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56213806|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55790372|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55971053|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55971054|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971055|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971057|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56092715|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
56092716|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092717|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092718|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
56092719|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
56092720|NCT03572972|Warfarin|warfarin|mesh-list
56092721|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
56092722|NCT03572972|Dabigatran|dabigatran|mesh-list
56092723|NCT03572972|Apixaban|apixaban|mesh-list
55971058|NCT05220917|Metformin|metformin|mesh-list
56213807|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
56213808|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213809|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
56213810|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56213811|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
56213812|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213813|NCT01599884|Expectorants|expectorants|mesh-ancestor
56213814|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
55790373|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56213815|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56213816|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
56213817|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213818|NCT01599884|Protective Agents|protective agents|mesh-ancestor
56213819|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213820|NCT01599884|Antidotes|antidotes|mesh-ancestor
56213821|NCT01599923|Antivenins|antivenins|mesh-list
56213822|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
56213823|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213824|NCT01599936|Antivenins|antivenins|mesh-list
56213825|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
56213826|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213827|NCT01599962|Cinacalcet|cinacalcet|mesh-list
55755233|NCT03069183|Ropivacaine|ropivacaine|mesh-list
56213828|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55790375|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55790376|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55829795|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
55971069|NCT05220917|Canagliflozin|canagliflozin|mesh-list
55971070|NCT05220917|Saxagliptin|saxagliptin|mesh-list
55971071|NCT05220917|Alogliptin|alogliptin|mesh-list
55971072|NCT05220917|Dulaglutide|dulaglutide|mesh-list
55971073|NCT05220917|Glyburide|glyburide|mesh-list
55971074|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
55971075|NCT05220917|Lixisenatide|lixisenatide|mesh-list
55971076|NCT05220917|Glipizide|glipizide|mesh-list
55971077|NCT05220917|Xultophy|xultophy|mesh-list
56213829|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213831|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
56213832|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213833|NCT01599975|Methylphenidate|methylphenidate|mesh-list
56213834|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56213835|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790377|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55790378|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
55971078|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55971079|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55971080|NCT05220917|Simvastatin|simvastatin|mesh-list
55971081|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
55971082|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55971083|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092781|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
55971084|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55971085|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55971086|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
55971087|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971088|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55971089|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55971090|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971092|NCT05220917|Hormones|hormones|mesh-ancestor
55971093|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971094|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
55971095|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55971096|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55971097|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56092851|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092852|NCT03225313|Bupivacaine|bupivacaine|mesh-list
56092853|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56092854|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
56092855|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
56092856|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901716|NCT03175926|Budesonide|budesonide|mesh-list
55971098|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
55971099|NCT00086996|Fluorouracil|fluorouracil|mesh-list
56213836|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55971100|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
55971101|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
55971102|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971103|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55971104|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971105|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55971106|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
55971107|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971108|NCT01943565|Hydromorphone|hydromorphone|mesh-list
55971122|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
55971123|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
55971124|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971125|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971126|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
55971127|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971128|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55971129|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55971130|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55971131|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55971132|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971133|NCT05362019|Norethindrone|norethindrone|mesh-list
55971134|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
55971135|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
55971136|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55971137|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55971138|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55901718|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55971139|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
55971140|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55971141|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971142|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55971143|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55971144|NCT03654105|Aspirin|aspirin|mesh-list
55971145|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55971146|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55971147|NCT03654105|Analgesics|analgesics|mesh-ancestor
55971148|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
55971149|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971150|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971151|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55971152|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55971153|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55971154|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55971155|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971156|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55971157|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55971159|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
55971160|NCT04388111|Morphine|morphine|mesh-list
55971161|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55971162|NCT04388111|Narcotics|narcotics|mesh-ancestor
55971163|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971164|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093021|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971165|NCT04388111|Analgesics|analgesics|mesh-ancestor
55971166|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
55971167|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971168|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
55971169|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55971170|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971175|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971176|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971177|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
55971178|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971179|NCT01944423|Cycloserine|cycloserine|mesh-list
55971180|NCT01944423|Nicotine|nicotine|mesh-list
55971181|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55971182|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
55971183|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971184|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971185|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55971186|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55971187|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
56213837|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56213838|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093077|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56093080|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
56213839|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971189|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971190|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55971191|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971192|NCT01944423|Renal Agents|renal agents|mesh-ancestor
55971193|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55971194|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
55971195|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55971196|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
55971197|NCT05305313|Propofol|propofol|mesh-list
55971198|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55971199|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971200|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971201|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55971202|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
55971203|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
55971204|NCT00600925|Gentamicins|gentamicins|mesh-list
55971205|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093164|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56093166|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55971206|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971207|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55971208|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971209|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971210|NCT02338973|Interferons|interferons|mesh-list
55971211|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
55971212|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971213|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
55971214|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971215|NCT00601627|Gemcitabine|gemcitabine|mesh-list
55971216|NCT00601627|Fluorouracil|fluorouracil|mesh-list
55971217|NCT00601627|Capecitabine|capecitabine|mesh-list
55971218|NCT00601627|Panitumumab|panitumumab|mesh-list
55971219|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55901723|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
55901724|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
55901725|NCT03175926|Hormones|hormones|mesh-ancestor
55901726|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55901727|NCT02524054|Furosemide|furosemide|mesh-list
55971220|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
55971221|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971222|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971223|NCT00601627|Antiviral Agents|antiviral agents|mesh-ancestor
55971224|NCT00601627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971225|NCT00601627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971226|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55971227|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
55971228|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971229|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55971230|NCT01947153|Metformin|metformin|mesh-list
55971231|NCT01947153|Linagliptin|linagliptin|mesh-list
55971232|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55971233|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971234|NCT01947153|Incretins|incretins|mesh-ancestor
55971235|NCT01947153|Hormones|hormones|mesh-ancestor
55971236|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971237|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56093339|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55971238|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
55971239|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971240|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971241|NCT02476409|Tolvaptan|tolvaptan|mesh-list
55971242|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55971251|NCT01269853|Growth Substances|growth substances|mesh-ancestor
55971252|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971253|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
55971254|NCT02993575|Floxacillin|floxacillin|mesh-list
55971255|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55971256|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971257|NCT00603187|Acyline|acyline|mesh-list
55971258|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
55971259|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971260|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971261|NCT01941641|Capecitabine|capecitabine|mesh-list
55971262|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56213840|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
55971263|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
55889626|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971264|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971265|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971266|NCT01886937|Phentermine|phentermine|mesh-list
55971267|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55971269|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
55971270|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55971271|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
55971272|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
55971273|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971274|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
55971275|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971276|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971277|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
55971278|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55971279|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55971280|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971281|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
55971282|NCT02993341|Coagulants|coagulants|mesh-ancestor
55971283|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
55971284|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55971285|NCT01219075|Estrogens|estrogens|mesh-ancestor
55971286|NCT01219075|Hormones|hormones|mesh-ancestor
55971287|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971288|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971289|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
55971290|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
55971291|NCT04560179|Tobramycin|tobramycin|mesh-list
55971292|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55971293|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55971294|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971295|NCT02987907|Dexamethasone|dexamethasone|mesh-list
55971296|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55971297|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
55971298|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
55971299|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971300|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971301|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55971302|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
55971303|NCT02987907|Hormones|hormones|mesh-ancestor
55971304|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971305|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55971306|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971307|NCT01887171|Tacrolimus|tacrolimus|mesh-list
56093603|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
55971308|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55971324|NCT03467750|Narcotics|narcotics|mesh-ancestor
55971325|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971326|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971327|NCT03467750|Analgesics|analgesics|mesh-ancestor
55971328|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
55971329|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971330|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55971331|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55971332|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55971333|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55971334|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55971335|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971336|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971337|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
55971338|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55971339|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55971340|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971341|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
55971342|NCT03085394|Coagulants|coagulants|mesh-ancestor
55971343|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
55971344|NCT04402580|Rituximab|rituximab|mesh-list
55971345|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55971346|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971347|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
55971348|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093666|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55971349|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55971350|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55971351|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55971352|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
55971353|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55971354|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971355|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971356|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971359|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971360|NCT02987751|Insulin|insulin|mesh-list
55971361|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
55971362|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55971363|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971364|NCT04385719|Remdesivir|remdesivir|mesh-list
55971365|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
55971366|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971367|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
55971368|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971369|NCT00082628|Hormones|hormones|mesh-list
55971370|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971371|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971372|NCT01275859|Letrozole|letrozole|mesh-list
55971373|NCT01275859|Lapatinib|lapatinib|mesh-list
55971374|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971375|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55971376|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55971377|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971378|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093739|NCT02614586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971379|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55971380|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
55971381|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971382|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971383|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55971384|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
55971385|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55971386|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971388|NCT01950039|Glycine|glycine|mesh-list
56093855|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093856|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56093857|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093858|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
56093865|NCT01139996|Analgesics|analgesics|mesh-ancestor
55971389|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
55971390|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971391|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971392|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971393|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55971394|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
55971395|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55971396|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
55971397|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55971398|NCT01275937|Esomeprazole|esomeprazole|mesh-list
55971399|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55971400|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55971401|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55971402|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971403|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971404|NCT02990455|Nicotine|nicotine|mesh-list
55971405|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56093905|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55971406|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
56093906|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56093907|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093908|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
55971407|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971408|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971409|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55971410|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55971411|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
55971412|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971413|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971414|NCT01889667|Insulin|insulin|mesh-list
55971415|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55971416|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55971417|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971418|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
55971419|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55971420|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55971421|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55971422|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55971423|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971424|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
55971425|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971426|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971427|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55971428|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971429|NCT02130635|Nemiralisib|nemiralisib|mesh-list
55971431|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971432|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971433|NCT01276093|Amiodarone|amiodarone|mesh-list
55971434|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55971435|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
55971436|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55971437|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55971438|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971439|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55971440|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56094164|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56094165|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
55971441|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55971442|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971443|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55971444|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55971445|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55971446|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
55971448|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55971449|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971450|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55971451|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971452|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55971454|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
55971455|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971456|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971458|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55971459|NCT01892709|Narcotics|narcotics|mesh-ancestor
55971460|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971461|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971462|NCT01892709|Analgesics|analgesics|mesh-ancestor
55971463|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
56094269|NCT00793520|Analgesics|analgesics|mesh-ancestor
55971464|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971465|NCT00726739|Aldesleukin|aldesleukin|mesh-list
55971466|NCT00726739|Interleukin-2|interleukin-2|mesh-list
55971467|NCT00726739|Vaccines|vaccines|mesh-list
55971468|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
55971469|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971470|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971471|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55971472|NCT00726739|Analgesics|analgesics|mesh-ancestor
55971473|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
55971474|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971475|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55971476|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55971477|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
55971478|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971479|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55971480|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
55971481|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971482|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
55971483|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55971484|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55971485|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
55971486|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971487|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971488|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971489|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55971490|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
55971491|NCT02991781|Varenicline|varenicline|mesh-list
55971492|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55971493|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56213841|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213843|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
55971494|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
55971495|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971496|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971497|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971498|NCT01893801|Gemcitabine|gemcitabine|mesh-list
55971499|NCT01893801|Paclitaxel|paclitaxel|mesh-list
55971500|NCT01893801|Cisplatin|cisplatin|mesh-list
55971501|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55971502|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971503|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
55971505|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
55971506|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971507|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55971508|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
55971509|NCT01893801|Antiviral Agents|antiviral agents|mesh-ancestor
55971510|NCT01893801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971511|NCT01893801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971512|NCT01893801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55971513|NCT01893801|Immunologic Factors|immunologic factors|mesh-ancestor
55971514|NCT01893801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971515|NCT00570089|Ranolazine|ranolazine|mesh-list
55971516|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55971517|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55971518|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971520|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
55971521|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55971522|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55971523|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971524|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971525|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
55971526|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971527|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55971528|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56094552|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56094553|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
56094554|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094555|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56094556|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
56094557|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
56094558|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
56094559|NCT00624650|Diuretics|diuretics|mesh-ancestor
56094560|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
56094561|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56094562|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901813|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901814|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
55901815|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55901816|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
55901817|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901818|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
55901819|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55901821|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971529|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55971530|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55971531|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55971532|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55971533|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55971534|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55971535|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
55971536|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55971537|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55971538|NCT00571259|Gentamicins|gentamicins|mesh-list
55971540|NCT00571259|Citric Acid|citric acid|mesh-list
55971541|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
55971542|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
55971543|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55971544|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
55971545|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
55971546|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971547|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55971548|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55971549|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55971550|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971551|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55971552|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971554|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55971555|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55971556|NCT01893879|Analgesics|analgesics|mesh-ancestor
55971557|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
55971558|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971559|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971560|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55971561|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55971562|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56213844|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
56213845|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971563|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971564|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971565|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
55971566|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55971567|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
55971568|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55971570|NCT00571493|Etoposide|etoposide|mesh-list
55971571|NCT00571493|Bortezomib|bortezomib|mesh-list
55971572|NCT00571493|Melphalan|melphalan|mesh-list
55971573|NCT00571493|Carmustine|carmustine|mesh-list
55971574|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55971575|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971576|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55971577|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55971578|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971579|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971580|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55971581|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
55971582|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
55971583|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971584|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55971585|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
55971586|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971587|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55971588|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
55971589|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55971590|NCT00571961|Ritonavir|ritonavir|mesh-list
55971591|NCT00571961|Lopinavir|lopinavir|mesh-list
55971592|NCT00571961|Buprenorphine|buprenorphine|mesh-list
55971602|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55971603|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55971604|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55971605|NCT00571961|Narcotics|narcotics|mesh-ancestor
55971606|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971607|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971608|NCT00571961|Analgesics|analgesics|mesh-ancestor
55971609|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
55971610|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971611|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55971613|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
55971614|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55971615|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971616|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
55971617|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55971618|NCT01895127|Antibodies|antibodies|mesh-list
55971619|NCT01895127|Eculizumab|eculizumab|mesh-list
56094783|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971620|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
55971621|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971622|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55971623|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55971624|NCT01953081|Metoclopramide|metoclopramide|mesh-list
55971625|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
55971626|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
55971627|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971628|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971629|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55971630|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55971631|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55971632|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
55971633|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971634|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971635|NCT00572897|Fludarabine|fludarabine|mesh-list
55971636|NCT00572897|Melphalan|melphalan|mesh-list
55971637|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971638|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971639|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55971640|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
55971641|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971642|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55971643|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
55971644|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56213846|NCT01600430|Vitamin D|vitamin d|mesh-list
56213847|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
56213848|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
56213849|NCT01600430|Vitamins|vitamins|mesh-list
55971645|NCT01276717|Vorinostat|vorinostat|mesh-list
55971646|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971647|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55971648|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971649|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971650|NCT02991157|Nimodipine|nimodipine|mesh-list
55971651|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55971652|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55971653|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55971654|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971655|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55971656|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971657|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
55971658|NCT04386499|Folic Acid|folic acid|mesh-list
55971672|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55971673|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
55971675|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971676|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971677|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55971678|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55971679|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971680|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55971681|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55971682|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
55971683|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
55971684|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
55971685|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
55971686|NCT01896921|Maraviroc|maraviroc|mesh-list
55971687|NCT01896921|Dolutegravir|dolutegravir|mesh-list
55971688|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55971689|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55971690|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
55971691|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971692|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55971693|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55971694|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971695|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971696|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55971697|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55971698|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55971699|NCT00749749|Bupivacaine|bupivacaine|mesh-list
55971700|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
55971701|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
55971702|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971703|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971704|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
55971705|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971706|NCT02991937|Tazobactam|tazobactam|mesh-list
55971707|NCT02991937|Piperacillin|piperacillin|mesh-list
55971708|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55971709|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55971710|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971711|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55971712|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971713|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971714|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55971715|NCT00420667|Enoxaparin|enoxaparin|mesh-list
55971716|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
55971717|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55971718|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55971719|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971720|NCT00620425|Sumatriptan|sumatriptan|mesh-list
55971721|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55971722|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55971738|NCT01277185|Calcium|calcium|mesh-list
55971739|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55971740|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213850|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
56213851|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213852|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56213853|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55971741|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55971742|NCT01274533|Lenalidomide|lenalidomide|mesh-list
55971743|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
55971744|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971745|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55971746|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55971747|NCT01274533|Growth Substances|growth substances|mesh-ancestor
55971748|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
55971749|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971750|NCT01277497|Calcium|calcium|mesh-list
55971751|NCT01277497|Sevelamer|sevelamer|mesh-list
55971752|NCT01277497|Calcium acetate|calcium acetate|mesh-list
55971753|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55971754|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971755|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
55971756|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
55971757|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971758|NCT05735535|Antiviral Agents|antiviral agents|mesh-list
55971759|NCT05735535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971761|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55971762|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55971764|NCT01958073|Estrogens|estrogens|mesh-list
55971765|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55971766|NCT01958073|Hormones|hormones|mesh-ancestor
55971767|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971768|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971769|NCT01270165|Telbivudine|telbivudine|mesh-list
55971770|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
55971771|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971772|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55971773|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095401|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56095402|NCT00000884|Protective Agents|protective agents|mesh-ancestor
56095403|NCT00000896|Lamivudine|lamivudine|mesh-list
56095404|NCT00000896|Zidovudine|zidovudine|mesh-list
56095405|NCT00000896|Nevirapine|nevirapine|mesh-list
56095406|NCT00000896|Stavudine|stavudine|mesh-list
55971774|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971775|NCT05740215|Lenvatinib|lenvatinib|mesh-list
55971776|NCT05740215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971777|NCT05740215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55971778|NCT05740215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971779|NCT05740215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971780|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
55971781|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55971782|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55971784|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
55971785|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55971786|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
55971787|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55971789|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
55971790|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971791|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971792|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55971793|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
55971794|NCT01277731|Hormones|hormones|mesh-ancestor
56095434|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
56095435|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095436|NCT00000902|Ritonavir|ritonavir|mesh-list
55971795|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971796|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55971797|NCT01277731|Protective Agents|protective agents|mesh-ancestor
55971798|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55971799|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971800|NCT05735379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55971801|NCT05735379|Cholinergic Antagonists|cholinergic antagonists|mesh-list
55971802|NCT05735379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971803|NCT05735379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971804|NCT05735379|Cholinergic Agents|cholinergic agents|mesh-ancestor
55971805|NCT05735379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971806|NCT05735379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971807|NCT05739981|Paclitaxel|paclitaxel|mesh-list
56213854|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
56213855|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55971808|NCT05739981|Bevacizumab|bevacizumab|mesh-list
55971809|NCT05739981|Carboplatin|carboplatin|mesh-list
55971810|NCT05739981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55971811|NCT05739981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971812|NCT05739981|Tubulin Modulators|tubulin modulators|mesh-ancestor
55971813|NCT05739981|Antimitotic Agents|antimitotic agents|mesh-ancestor
55971814|NCT05739981|Mitosis Modulators|mitosis modulators|mesh-ancestor
55971815|NCT05739981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971816|NCT05739981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55971817|NCT05739981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55971818|NCT05739981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55971819|NCT05739981|Growth Substances|growth substances|mesh-ancestor
55971820|NCT05739981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971821|NCT05739981|Growth Inhibitors|growth inhibitors|mesh-ancestor
55971822|NCT00751777|Vaccines|vaccines|mesh-list
55971823|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
55971824|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971825|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55971826|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
55971827|NCT01902459|Coagulants|coagulants|mesh-ancestor
55971828|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
55971829|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55971830|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55971831|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55971832|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55971833|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971834|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
55971835|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971836|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971837|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55971838|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971840|NCT05735145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55971841|NCT05735145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55971842|NCT05735145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971843|NCT05735145|Tubulin Modulators|tubulin modulators|mesh-ancestor
55971844|NCT05735145|Antimitotic Agents|antimitotic agents|mesh-ancestor
55971845|NCT05735145|Mitosis Modulators|mitosis modulators|mesh-ancestor
56095490|NCT00000914|Nelfinavir|nelfinavir|mesh-list
55971846|NCT05735145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971847|NCT01903005|Buprenorphine|buprenorphine|mesh-list
55971848|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55971849|NCT01903005|Naloxone|naloxone|mesh-list
55971850|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55971851|NCT01903005|Narcotics|narcotics|mesh-ancestor
55971852|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971853|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971854|NCT01903005|Analgesics|analgesics|mesh-ancestor
55971855|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
55971870|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
55971871|NCT01905423|Citric Acid|citric acid|mesh-list
55971872|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
55971873|NCT01905423|DMP 777|dmp 777|mesh-list
55971874|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
55971875|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55971876|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
55971877|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
55971878|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971879|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
55971880|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55971881|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971882|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
55971883|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55971884|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55971885|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
55971886|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
55971887|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
55971888|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971889|NCT01905423|Filaricides|filaricides|mesh-ancestor
55971890|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
55971891|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
55971892|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971893|NCT05734911|Niraparib|niraparib|mesh-list
56213856|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56213857|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213858|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
56213859|NCT01600599|Coagulants|coagulants|mesh-ancestor
56095528|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
55971894|NCT05734911|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55971895|NCT05734911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971896|NCT05734911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971897|NCT05734911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971898|NCT01906515|Chrysarobin|chrysarobin|mesh-list
55971899|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55971900|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55971901|NCT01906515|Analgesics|analgesics|mesh-ancestor
55971902|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
55971903|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971904|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971905|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55971906|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55971907|NCT00730483|Doxorubicin|doxorubicin|mesh-list
55971908|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55971909|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55971910|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971911|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55971912|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55971913|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971914|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971915|NCT01907607|Palbociclib|palbociclib|mesh-list
55971916|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971917|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55971918|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971932|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
55971933|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971934|NCT04385407|Ribavirin|ribavirin|mesh-list
55971935|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
55971936|NCT04385407|Simeprevir|simeprevir|mesh-list
55971937|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
55971938|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971939|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
55971940|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971941|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
55971942|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971943|NCT00573989|Pemetrexed|pemetrexed|mesh-list
55971944|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55971945|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971946|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971947|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971948|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55971949|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55971950|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55971951|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
55971952|NCT02286921|Testosterone|testosterone|mesh-list
55971953|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
55971954|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
55971955|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56095703|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971956|NCT02286921|Androgens|androgens|mesh-ancestor
55971957|NCT02286921|Hormones|hormones|mesh-ancestor
55971958|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55971959|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971960|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55971961|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971962|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
55971963|NCT00574067|Buprenorphine|buprenorphine|mesh-list
55971964|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55971965|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55971966|NCT00574067|Narcotics|narcotics|mesh-ancestor
55971967|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971968|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971969|NCT00574067|Analgesics|analgesics|mesh-ancestor
55971970|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
55971971|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971972|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55971973|NCT05734443|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56213860|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
56213861|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
56213862|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55971974|NCT05734443|Luteolytic Agents|luteolytic agents|mesh-ancestor
55971975|NCT05734443|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55971976|NCT05734443|Contraceptive Agents|contraceptive agents|mesh-ancestor
55971977|NCT05734443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56095799|NCT00001934|Daclizumab|daclizumab|mesh-list
55971978|NCT05734443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971979|NCT05734443|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55971980|NCT05734443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55971981|NCT05734443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971991|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971993|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971994|NCT00576251|Tobramycin|tobramycin|mesh-list
55971995|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
55971996|NCT00576251|Dexamethasone|dexamethasone|mesh-list
55971997|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55971998|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
55971999|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
55972000|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972001|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972002|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972003|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
55972004|NCT00576251|Hormones|hormones|mesh-ancestor
55972005|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972006|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55972007|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972008|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55972009|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972010|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55972011|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55972013|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55972014|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972015|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972016|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972017|NCT00578669|Fluoxetine|fluoxetine|mesh-list
55972018|NCT00578669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55972019|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55972020|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55972021|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972022|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972023|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
55972024|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972025|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55972026|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
55972027|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55972028|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55972029|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55972030|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972031|NCT04341311|Panobinostat|panobinostat|mesh-list
55972032|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972033|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55972034|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972035|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972036|NCT05733507|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55972037|NCT05733507|Tenecteplase|tenecteplase|mesh-list
55972038|NCT05733507|Tirofiban|tirofiban|mesh-list
55972039|NCT05733507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55972040|NCT05733507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55972041|NCT05733507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095886|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
55972042|NCT05733507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55972043|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
55972044|NCT00578903|Methotrexate|methotrexate|mesh-list
55972045|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
55972046|NCT00578903|Tacrolimus|tacrolimus|mesh-list
55972054|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972055|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55972056|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55972057|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
55972058|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56213863|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56213864|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213865|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213866|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213867|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213868|NCT01602029|Ondansetron|ondansetron|mesh-list
56213869|NCT01602029|Simvastatin|simvastatin|mesh-list
56213870|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56213871|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56213872|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
56213873|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213874|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56213875|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55972059|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55972060|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
55972061|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
55972062|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972063|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55972064|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55972065|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55972066|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55972068|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972069|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972070|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972071|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55972072|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55972078|NCT00579137|Fludarabine|fludarabine|mesh-list
55972079|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
55972080|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972081|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55972083|NCT00580073|Fluorouracil|fluorouracil|mesh-list
55972084|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
55972085|NCT00580073|Cetuximab|cetuximab|mesh-list
55972086|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
55972087|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972088|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55972089|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972090|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55972091|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
55972092|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972093|NCT00580073|Antidotes|antidotes|mesh-ancestor
55972094|NCT00580073|Protective Agents|protective agents|mesh-ancestor
55972095|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
55972096|NCT00580073|Vitamins|vitamins|mesh-ancestor
55972097|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
55972098|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56096037|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
55972099|NCT00580151|Clonidine|clonidine|mesh-list
55972100|NCT00580151|Analgesics|analgesics|mesh-ancestor
56096042|NCT03799783|Analgesics|analgesics|mesh-ancestor
55972101|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
55972102|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972103|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972104|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55972105|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
55972106|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
55972107|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55972108|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55972109|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55972110|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
55972111|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972112|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972113|NCT01919697|Plecanatide|plecanatide|mesh-list
56213876|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213877|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
56213878|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
55972114|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55972115|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
55972116|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972117|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972118|NCT00580229|Prednisone|prednisone|mesh-list
55972143|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
55972144|NCT05739045|Nivolumab|nivolumab|mesh-list
55972145|NCT05739045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55972146|NCT05739045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972147|NCT05739045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55972148|NCT05739045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972149|NCT00604019|Dopamine|dopamine|mesh-list
55972150|NCT00604019|Norepinephrine|norepinephrine|mesh-list
55972151|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55972152|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55972153|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
55972154|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972155|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972156|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972157|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
55972158|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
55972159|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972160|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55972161|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55972162|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
55972163|NCT00604019|Protective Agents|protective agents|mesh-ancestor
55972164|NCT01922115|Trospium chloride|trospium chloride|mesh-list
55972165|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
55972166|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
55972178|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55972179|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
55972180|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972181|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
55972182|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972183|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
55972184|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096258|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
55972185|NCT05731323|Cycloserine|cycloserine|mesh-list
55972187|NCT05731323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972188|NCT05731323|Renal Agents|renal agents|mesh-ancestor
55972189|NCT05731323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55972190|NCT05731323|Antitubercular Agents|antitubercular agents|mesh-ancestor
55972191|NCT05731323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55972192|NCT05731323|Antimetabolites|antimetabolites|mesh-ancestor
55972193|NCT05731323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972194|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
55972195|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55972196|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
55972197|NCT00605423|Hormones|hormones|mesh-ancestor
55972198|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972199|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972200|NCT01923129|Prazosin|prazosin|mesh-list
55972201|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55972202|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55972203|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55972205|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
55972206|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972207|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972208|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972209|NCT00581867|Insulin|insulin|mesh-list
55972210|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55972211|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
55972212|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55972213|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972214|NCT01925469|Benzocaine|benzocaine|mesh-list
55972215|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
55972216|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
55972217|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972218|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972219|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
56213879|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972220|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972221|NCT01925781|Nicotine|nicotine|mesh-list
55972222|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55972223|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
55972224|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901937|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972225|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972226|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55972227|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55972228|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
55972229|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972230|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972245|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972246|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55972247|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55972248|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972249|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55972250|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55972251|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
55972252|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972253|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972254|NCT01929291|Vaccines|vaccines|mesh-list
55972255|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
55972256|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972257|NCT01929759|Tenofovir|tenofovir|mesh-list
55972258|NCT01929759|Emtricitabine|emtricitabine|mesh-list
55972259|NCT01929759|Cobicistat|cobicistat|mesh-list
55972260|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55972261|NCT01929759|Elvitegravir|elvitegravir|mesh-list
55972262|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
55972263|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972264|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55972265|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55972266|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972267|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972268|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55972269|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55972270|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55972271|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55972272|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55972273|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
55972274|NCT03437330|Empagliflozin|empagliflozin|mesh-list
55972275|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55972276|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972277|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55972278|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972279|NCT01271803|Vemurafenib|vemurafenib|mesh-list
55972280|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972281|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55972282|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972283|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972284|NCT00585377|Bevacizumab|bevacizumab|mesh-list
55972285|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55972286|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55972287|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972288|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55972289|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55972297|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55972298|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972299|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55972300|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55972301|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55972302|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972304|NCT00610883|Methotrexate|methotrexate|mesh-list
55972305|NCT00610883|Asparaginase|asparaginase|mesh-list
55972306|NCT00610883|Daunorubicin|daunorubicin|mesh-list
55972307|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55972308|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
55972309|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213880|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213881|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56213882|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
55972310|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55972311|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55972312|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
55972313|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972314|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972315|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55972316|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55972317|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
55972318|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55972319|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55972320|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
55972321|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
55972322|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972323|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55972324|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55972325|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55972326|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55972327|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55972328|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
55972329|NCT03084380|Fludarabine|fludarabine|mesh-list
55972330|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55972331|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
55972332|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972333|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55972334|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55972335|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
55972336|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972337|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972338|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55972339|NCT00084344|Afimoxifene|afimoxifene|mesh-list
55972340|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972341|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55972342|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
55972343|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972344|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972345|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55972346|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55972347|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
55972348|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
55972350|NCT00611351|Tacrolimus|tacrolimus|mesh-list
55972351|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55972352|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55972353|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
55972360|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55972361|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55972362|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972363|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55972364|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55972365|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
55972366|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55972367|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096605|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55972368|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
55972369|NCT00611897|Ketamine|ketamine|mesh-list
55972370|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55972371|NCT00611897|Analgesics|analgesics|mesh-ancestor
55972372|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
55972373|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972374|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972375|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55972376|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55972377|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
55972378|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
55972379|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972380|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55972381|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55972382|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972383|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213883|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
56213884|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56213885|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
56213886|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213887|NCT01602029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56213888|NCT01602029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55972384|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
55972385|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972387|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
55972388|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55972389|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
55972390|NCT00611897|Protective Agents|protective agents|mesh-ancestor
55972391|NCT00611897|Antidotes|antidotes|mesh-ancestor
55972392|NCT05711823|Dexamethasone|dexamethasone|mesh-list
55972393|NCT05711823|Dexamethasone acetate|dexamethasone acetate|mesh-list
55972394|NCT05711823|Aprepitant|aprepitant|mesh-list
55972395|NCT05711823|Granisetron|granisetron|mesh-list
55972396|NCT05711823|BB 1101|bb 1101|mesh-list
55972397|NCT05711823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55972398|NCT05711823|Antiemetics|antiemetics|mesh-ancestor
55972399|NCT05711823|Autonomic Agents|autonomic agents|mesh-ancestor
55972400|NCT05711823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972401|NCT05711823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972402|NCT05711823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972403|NCT05711823|Glucocorticoids|glucocorticoids|mesh-ancestor
55972404|NCT05711823|Hormones|hormones|mesh-ancestor
55972405|NCT05711823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972406|NCT05711823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55972407|NCT05711823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972408|NCT05711823|Protease Inhibitors|protease inhibitors|mesh-ancestor
55972409|NCT05711823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972410|NCT05711823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972411|NCT05711823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55972412|NCT05711823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972413|NCT05711823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55972414|NCT05711823|Serotonin Agents|serotonin agents|mesh-ancestor
56096860|NCT00002186|Acyclovir|acyclovir|mesh-list
55972415|NCT03698162|Bevacizumab|bevacizumab|mesh-list
55972416|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55972417|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972418|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55972419|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55972420|NCT03698162|Growth Substances|growth substances|mesh-ancestor
55972421|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972431|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55972432|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55972433|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
55972434|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
55972435|NCT03083834|Cosyntropin|cosyntropin|mesh-list
55972437|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972439|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
55972440|NCT03404180|Propofol|propofol|mesh-list
55972441|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55972442|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972443|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972444|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55972445|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
55972446|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
55972447|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55972448|NCT03404180|Analgesics|analgesics|mesh-ancestor
55972449|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
55972450|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972451|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55972452|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55972453|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55972454|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
55972455|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972456|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972457|NCT02780609|Dexamethasone|dexamethasone|mesh-list
56213889|NCT01602029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972458|NCT02780609|Melphalan|melphalan|mesh-list
55972459|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
55972460|NCT02780609|Aprepitant|aprepitant|mesh-list
55972461|NCT02780609|Antiemetics|antiemetics|mesh-list
55972462|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55972463|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
55972464|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972465|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972466|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972467|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
55972468|NCT02780609|Hormones|hormones|mesh-ancestor
55889627|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55972469|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972470|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55972471|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972472|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55972473|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
55972474|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972475|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55972476|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55972477|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
55972478|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55972479|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972481|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55972482|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55972483|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972484|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972485|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972486|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55972487|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55972488|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55972504|NCT05346146|Gemcitabine|gemcitabine|mesh-list
55972505|NCT05346146|Paclitaxel|paclitaxel|mesh-list
55972506|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55972507|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972508|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
55972509|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
55972510|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
55972511|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972512|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55972513|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
55972514|NCT05346146|Antiviral Agents|antiviral agents|mesh-ancestor
55972515|NCT05346146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972516|NCT05346146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972517|NCT05346146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55972518|NCT05346146|Immunologic Factors|immunologic factors|mesh-ancestor
55972519|NCT05346146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972520|NCT00613379|Leronlimab|leronlimab|mesh-list
55972521|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
55972522|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55972523|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55972524|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972525|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55972526|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55972527|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
55972528|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972529|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
55972530|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972531|NCT01271725|Paclitaxel|paclitaxel|mesh-list
55972532|NCT01271725|Vinorelbine|vinorelbine|mesh-list
55972533|NCT01271725|Afatinib|afatinib|mesh-list
55972534|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55972535|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972536|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
55972537|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
55972538|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
55972539|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972540|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55972541|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972542|NCT00587483|Lidocaine|lidocaine|mesh-list
55972543|NCT00587483|Amiodarone|amiodarone|mesh-list
55972544|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
55972545|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
55972546|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972547|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972556|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55972557|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55972558|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55972559|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972560|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55972561|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55972562|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55972563|NCT03401060|Denosumab|denosumab|mesh-list
55972564|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55972565|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972566|NCT01270321|Everolimus|everolimus|mesh-list
55972567|NCT01270321|Pasireotide|pasireotide|mesh-list
55972568|NCT01270321|Somatostatin|somatostatin|mesh-list
55972569|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972570|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55972571|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
55972572|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972573|NCT01270321|Hormones|hormones|mesh-ancestor
55972574|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972575|NCT03400826|Simvastatin|simvastatin|mesh-list
55972576|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55972577|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55901954|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972578|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
55972579|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972580|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55972581|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55972582|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972584|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55972585|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972586|NCT03086486|Linezolid|linezolid|mesh-list
55972587|NCT03086486|Bedaquiline|bedaquiline|mesh-list
55972588|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55972589|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972590|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55972591|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972592|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972593|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
55972594|NCT02287779|Volixibat|volixibat|mesh-list
55972595|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55972596|NCT00732901|Citalopram|citalopram|mesh-list
55972597|NCT00732901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55972598|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55972599|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55972600|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097220|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972601|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972602|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
55972603|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972604|NCT00732901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55972605|NCT00732901|Antidepressive Agents|antidepressive agents|mesh-ancestor
55972606|NCT00732901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55972607|NCT03083210|Lanreotide|lanreotide|mesh-list
55972608|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972609|NCT00616109|Sunitinib|sunitinib|mesh-list
55972610|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097288|NCT00378547|Analgesics|analgesics|mesh-ancestor
55972611|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55972636|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972637|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
55972638|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55972639|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972640|NCT05737563|Capecitabine|capecitabine|mesh-list
55972641|NCT05737563|Irinotecan|irinotecan|mesh-list
55972642|NCT05737563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55972643|NCT05737563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55972644|NCT05737563|Antimetabolites|antimetabolites|mesh-ancestor
55972645|NCT05737563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972646|NCT05737563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213890|NCT01602029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56213891|NCT01602029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56213893|NCT01602874|Clarithromycin|clarithromycin|mesh-list
55972647|NCT05737563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55972648|NCT05737563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55972649|NCT05737563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972650|NCT03434678|Fentanyl|fentanyl|mesh-list
55972651|NCT03434678|Bupivacaine|bupivacaine|mesh-list
55972652|NCT03434678|Propofol|propofol|mesh-list
55972653|NCT03434678|Rocuronium|rocuronium|mesh-list
55972654|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
55972655|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
55972656|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972657|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972658|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
55972659|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972660|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55972661|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55972662|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
55972663|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55972664|NCT03434678|Narcotics|narcotics|mesh-ancestor
55972665|NCT03434678|Analgesics|analgesics|mesh-ancestor
55972666|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55972667|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55972668|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55972669|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55972670|NCT05445921|Mepivacaine|mepivacaine|mesh-list
55972671|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
55972672|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
55972688|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972690|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55972691|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
55972692|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972693|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972694|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55972696|NCT03389750|Morphine|morphine|mesh-list
55972697|NCT03389750|Oxycodone|oxycodone|mesh-list
55972698|NCT03389750|Hydromorphone|hydromorphone|mesh-list
55972699|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55972700|NCT03389750|Narcotics|narcotics|mesh-ancestor
55972701|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972702|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972703|NCT03389750|Analgesics|analgesics|mesh-ancestor
56097866|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
55972704|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
55972705|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972706|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55972707|NCT03837873|Cytarabine|cytarabine|mesh-list
55972708|NCT03837873|Dexamethasone|dexamethasone|mesh-list
55972709|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
55972710|NCT03837873|Rituximab|rituximab|mesh-list
55972711|NCT03837873|Doxorubicin|doxorubicin|mesh-list
55972712|NCT03837873|Etoposide|etoposide|mesh-list
55972713|NCT03837873|Vincristine|vincristine|mesh-list
55972714|NCT03837873|Lenalidomide|lenalidomide|mesh-list
55972715|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55972716|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
55972717|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972718|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55972719|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55972720|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
55972721|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972722|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972723|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55972724|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55972725|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55972726|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
55972727|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
55972728|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972729|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972730|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
55972731|NCT03837873|Hormones|hormones|mesh-ancestor
55972732|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213894|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
56213895|NCT01602874|Tigecycline|tigecycline|mesh-list
56213896|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213897|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56213898|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55972733|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55972734|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55972735|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55972736|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55972741|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
55972742|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972743|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
55972744|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
55972745|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
55972746|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55972747|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55972748|NCT03837873|Growth Substances|growth substances|mesh-ancestor
55972749|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
55972750|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55972751|NCT03082742|Furosemide|furosemide|mesh-list
55972752|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55972753|NCT03082742|Diuretics|diuretics|mesh-ancestor
55972754|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
55972755|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972756|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55972757|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55972758|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972759|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55972760|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
55972761|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55972762|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55972763|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972764|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
55972765|NCT05434533|Coagulants|coagulants|mesh-ancestor
55972766|NCT03432650|Dexamethasone|dexamethasone|mesh-list
55972767|NCT03432650|Bupivacaine|bupivacaine|mesh-list
55972768|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55972769|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
55972770|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
55972771|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972772|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972773|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972774|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
55972775|NCT03432650|Hormones|hormones|mesh-ancestor
55972776|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098563|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972777|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55972778|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972779|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
55972780|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
55972781|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972782|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
55972783|NCT00248833|Vaccines|vaccines|mesh-list
55972784|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
55972785|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972786|NCT00668525|Dexetimide|dexetimide|mesh-list
55972787|NCT00668525|Citalopram|citalopram|mesh-list
55972788|NCT00668525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55972789|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55972790|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55972791|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972792|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972794|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972795|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55972796|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
55972797|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55972798|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55972799|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55972800|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
55972801|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
55972802|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213900|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56213901|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213902|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213903|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56213904|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56213905|NCT01602887|Palbociclib|palbociclib|mesh-list
56213906|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213907|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56213908|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972803|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55972804|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55972805|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
55972806|NCT05736549|Dexamethasone|dexamethasone|mesh-list
55972807|NCT05736549|Methylprednisolone|methylprednisolone|mesh-list
55972809|NCT05736549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55972810|NCT05736549|Prednisolone|prednisolone|mesh-list
55972811|NCT05736549|Prednisolone acetate|prednisolone acetate|mesh-list
55972812|NCT05736549|Dexamethasone acetate|dexamethasone acetate|mesh-list
55972813|NCT05736549|Bupivacaine|bupivacaine|mesh-list
55972814|NCT05736549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56098880|NCT00002774|Cisplatin|cisplatin|mesh-list
55972815|NCT05736549|Prednisolone phosphate|prednisolone phosphate|mesh-list
55972816|NCT05736549|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55972818|NCT05736549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55972819|NCT05736549|Antiemetics|antiemetics|mesh-ancestor
55972820|NCT05736549|Autonomic Agents|autonomic agents|mesh-ancestor
55972821|NCT05736549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972822|NCT05736549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972823|NCT05736549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972824|NCT05736549|Glucocorticoids|glucocorticoids|mesh-ancestor
55972825|NCT05736549|Hormones|hormones|mesh-ancestor
56099059|NCT05594407|Sensory System Agents|sensory system agents|mesh-ancestor
55972826|NCT05736549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972827|NCT05736549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55972828|NCT05736549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972829|NCT05736549|Anesthetics, Local|anesthetics, local|mesh-ancestor
55972830|NCT05736549|Anesthetics|anesthetics|mesh-ancestor
55972831|NCT05736549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972832|NCT05736549|Sensory System Agents|sensory system agents|mesh-ancestor
55972833|NCT05736549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55972834|NCT05736549|Protective Agents|protective agents|mesh-ancestor
55972835|NCT05736549|Protease Inhibitors|protease inhibitors|mesh-ancestor
55972836|NCT05736549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972837|NCT05736549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972838|NCT05688488|Curcumin|curcumin|mesh-list
55972839|NCT05688488|Mitomycins|mitomycins|mesh-list
55972840|NCT05688488|Mitomycin|mitomycin|mesh-list
55972841|NCT05688488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55972842|NCT05688488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099313|NCT04796012|Irinotecan|irinotecan|mesh-list
56099314|NCT04796012|Vincristine|vincristine|mesh-list
55972843|NCT05688488|Alkylating Agents|alkylating agents|mesh-ancestor
55972844|NCT05688488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972845|NCT05688488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55972846|NCT05688488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972847|NCT05688488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55972848|NCT05688488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55972849|NCT05688488|Analgesics|analgesics|mesh-ancestor
55972850|NCT05688488|Sensory System Agents|sensory system agents|mesh-ancestor
55972851|NCT05688488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972852|NCT05688488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972853|NCT05688488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55972854|NCT05688488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55972855|NCT00669383|Betamethasone|betamethasone|mesh-list
55972856|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55972857|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
56213909|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213910|NCT01603264|Trastuzumab|trastuzumab|mesh-list
55972858|NCT00669383|Hormones|hormones|mesh-ancestor
55972860|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972861|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55972862|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
55972864|NCT00733993|Amphetamine|amphetamine|mesh-list
55972865|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55972866|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972867|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55972868|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972869|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972870|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55972871|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55972872|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
55972873|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972874|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
55972875|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
55972876|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972877|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
55972878|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
55972879|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55972880|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55972892|NCT05692869|Pseudoephedrine|pseudoephedrine|mesh-list
55972893|NCT05692869|Ephedrine|ephedrine|mesh-list
55972894|NCT05692869|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55972895|NCT05692869|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55972896|NCT05692869|Adrenergic Agents|adrenergic agents|mesh-ancestor
55972897|NCT05692869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972898|NCT05692869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972899|NCT05692869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972900|NCT05692869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55972901|NCT05692869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55972902|NCT05692869|Vasodilator Agents|vasodilator agents|mesh-ancestor
55972903|NCT05692869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55972904|NCT05692869|Autonomic Agents|autonomic agents|mesh-ancestor
55972905|NCT05692869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972906|NCT05692869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56099886|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
55972907|NCT05692869|Respiratory System Agents|respiratory system agents|mesh-ancestor
55972908|NCT05692869|Nasal Decongestants|nasal decongestants|mesh-ancestor
55972909|NCT05692869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55972910|NCT05692869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55972911|NCT05692869|Sympathomimetics|sympathomimetics|mesh-ancestor
55972912|NCT03082352|Metoprolol|metoprolol|mesh-list
55972913|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55972914|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55972915|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
55972916|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
55972917|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972918|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972919|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55972920|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55972921|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55972922|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
55972923|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972924|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972925|NCT03431168|Azithromycin|azithromycin|mesh-list
55972926|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55972927|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55972928|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972929|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55972930|NCT03431168|Renal Agents|renal agents|mesh-ancestor
55972931|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
56100054|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
55972932|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55972933|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55972937|NCT05667285|Sirolimus|sirolimus|mesh-list
55972938|NCT05667285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55972939|NCT05667285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972940|NCT05667285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55972941|NCT05667285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972942|NCT05667285|Antifungal Agents|antifungal agents|mesh-ancestor
55972943|NCT05667285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55972944|NCT05667285|Immunologic Factors|immunologic factors|mesh-ancestor
55972953|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972956|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
56100123|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
55972957|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55972958|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55972959|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55972960|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972961|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972962|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55972963|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
55972964|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972965|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972966|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55972968|NCT05688098|Irbesartan|irbesartan|mesh-list
55972969|NCT05688098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55972970|NCT05688098|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55972971|NCT05688098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55972972|NCT05688098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972973|NCT05688098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55972974|NCT05688098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972975|NCT05688098|Vasodilator Agents|vasodilator agents|mesh-ancestor
55972976|NCT05688098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55972977|NCT05688098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55972978|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55972979|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
55972980|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55972981|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
55972982|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972983|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
55972984|NCT03429140|Protective Agents|protective agents|mesh-ancestor
55972985|NCT03081494|Spartalizumab|spartalizumab|mesh-list
55972986|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55972987|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972988|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972989|NCT03081728|Acetaminophen|acetaminophen|mesh-list
55972990|NCT03081728|Diclofenac|diclofenac|mesh-list
55972991|NCT03081728|Ropivacaine|ropivacaine|mesh-list
55972992|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
55972993|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
55972994|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972995|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972996|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
55972997|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972998|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55972999|NCT03081728|Analgesics|analgesics|mesh-ancestor
55973000|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
55973001|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55973002|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973003|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55973004|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55973005|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973006|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973007|NCT05651217|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55973008|NCT05651217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973010|NCT05688020|Tranexamic Acid|tranexamic acid|mesh-list
55973011|NCT05688020|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55973012|NCT05688020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55973013|NCT05688020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973014|NCT05688020|Hemostatics|hemostatics|mesh-ancestor
55973015|NCT05688020|Coagulants|coagulants|mesh-ancestor
55973016|NCT05688020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55973017|NCT05688020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56213911|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56213912|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973018|NCT05688020|Adrenergic Agents|adrenergic agents|mesh-ancestor
55973019|NCT05688020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973020|NCT05688020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973021|NCT05688020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56100547|NCT04175600|Selexipag|selexipag|mesh-list
55973022|NCT05688020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55973023|NCT05688020|Autonomic Agents|autonomic agents|mesh-ancestor
55973024|NCT05688020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973025|NCT05688020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55973027|NCT05688020|Mydriatics|mydriatics|mesh-ancestor
55973028|NCT05688020|Sympathomimetics|sympathomimetics|mesh-ancestor
55973029|NCT05688020|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55973030|NCT00618917|Manganese|manganese|mesh-list
55973031|NCT00618917|Paclitaxel|paclitaxel|mesh-list
55973032|NCT00618917|Carboplatin|carboplatin|mesh-list
55973033|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
55973034|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55973035|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973036|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
55973037|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
55973038|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
55973039|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973040|NCT00618917|Trace Elements|trace elements|mesh-ancestor
55973041|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
55973042|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973043|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55973044|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
55973045|NCT00618917|Protective Agents|protective agents|mesh-ancestor
55973046|NCT05736081|Dexamethasone|dexamethasone|mesh-list
55973047|NCT05736081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973048|NCT05736081|Antiemetics|antiemetics|mesh-ancestor
55973049|NCT05736081|Autonomic Agents|autonomic agents|mesh-ancestor
55973050|NCT05736081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973051|NCT05736081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973052|NCT05736081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100882|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56100883|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56100884|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56100885|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56100886|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56100898|NCT00000685|Zidovudine|zidovudine|mesh-list
55973053|NCT05736081|Glucocorticoids|glucocorticoids|mesh-ancestor
55973054|NCT05736081|Hormones|hormones|mesh-ancestor
55973055|NCT05736081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55973056|NCT05736081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55973057|NCT05736081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973058|NCT00619073|Aspirin|aspirin|mesh-list
55973059|NCT00619073|Clopidogrel|clopidogrel|mesh-list
55973060|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55973061|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55973062|NCT00619073|Analgesics|analgesics|mesh-ancestor
55973063|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
55973064|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973065|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973066|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973067|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55973068|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55973069|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55973070|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973071|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55973072|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55973073|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973074|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
55973075|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55973076|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55973077|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55973078|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
55973079|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973086|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
55973088|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56101069|NCT00001015|Ribavirin|ribavirin|mesh-list
56101070|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
56101071|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101072|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
55973089|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
55973091|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56213913|NCT01603680|Anesthetics|anesthetics|mesh-list
56213914|NCT01603680|Mepivacaine|mepivacaine|mesh-list
55973092|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973093|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55973094|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
55973095|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
55973096|NCT03088670|Metformin|metformin|mesh-list
55973097|NCT03088670|Vildagliptin|vildagliptin|mesh-list
55973098|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55973099|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973100|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55973101|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
55973102|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973103|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973104|NCT03088358|Enoxaparin|enoxaparin|mesh-list
55973105|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
55973106|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55973108|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973109|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55973110|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55973111|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55973112|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973113|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101191|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56101192|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
55973114|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55973115|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55973116|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55973117|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55973118|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
55973119|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973120|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973121|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55973122|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55973123|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
55973124|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55973125|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55973126|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
55973127|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
55973128|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55973129|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55973130|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
55973131|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973132|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973133|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973134|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55973135|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
55973136|NCT00621179|Leuprolide|leuprolide|mesh-list
56101285|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
55973137|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55973138|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
55973139|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55973140|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973141|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55973142|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973143|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
55973144|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
55973145|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55973146|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55973147|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973148|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55973149|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973150|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55973151|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56101403|NCT00001339|Doxorubicin|doxorubicin|mesh-list
55973152|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
55973153|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55973179|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
55973180|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
55973192|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
55973193|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973194|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
56101558|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973195|NCT05039619|Hormones|hormones|mesh-ancestor
55973196|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55973197|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973198|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55973199|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973200|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55973201|NCT05039619|Analgesics|analgesics|mesh-ancestor
55973202|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
55973203|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973204|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
55973205|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56101854|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56101855|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101856|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55973206|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55973207|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
55973208|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55973209|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973210|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973211|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973212|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
55973213|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
55973214|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55973215|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55973216|NCT05039619|Protective Agents|protective agents|mesh-ancestor
55973217|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973218|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55973219|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55973220|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973221|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
55973222|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
55973223|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55973224|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
55973225|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
55973226|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973227|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55973228|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
55973229|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
55973230|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
55973231|NCT00622895|Fludarabine|fludarabine|mesh-list
55973232|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
55973233|NCT00622895|Tacrolimus|tacrolimus|mesh-list
55973234|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973235|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55973236|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
55973237|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973238|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973239|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
55973240|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973241|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55973242|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973243|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55973244|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55973245|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
55973246|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55973247|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973248|NCT03380546|Insulin|insulin|mesh-list
55973249|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55973250|NCT03380546|Acarbose|acarbose|mesh-list
55973251|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
55973253|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973254|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55973255|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973256|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973257|NCT00672737|Remifentanil|remifentanil|mesh-list
55973258|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55973259|NCT00672737|Narcotics|narcotics|mesh-ancestor
55973260|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973261|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973262|NCT00672737|Analgesics|analgesics|mesh-ancestor
55973263|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
55973264|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973265|NCT00673127|Ketoconazole|ketoconazole|mesh-list
55973266|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
55973267|NCT00673127|Dutasteride|dutasteride|mesh-list
55973268|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973269|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
55973270|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213915|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
56213916|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56213917|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213918|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
56213919|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213920|NCT01604213|Metformin|metformin|mesh-list
56213921|NCT01604213|Vildagliptin|vildagliptin|mesh-list
56213922|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55790448|NCT05304559|Ketamine|ketamine|mesh-list
55973271|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55973272|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55973273|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973274|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973275|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55973276|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
55973277|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55973278|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973279|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55973280|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55973281|NCT00246259|Risperidone|risperidone|mesh-list
55973282|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
55973293|NCT00673439|PENTA|penta|mesh-list
55973294|NCT00673439|Warfarin|warfarin|mesh-list
55973295|NCT00673439|Fondaparinux|fondaparinux|mesh-list
55973296|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
55973297|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55973298|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
55973299|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55973300|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
55973301|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973302|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973303|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55973304|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55973305|NCT03316118|Bupivacaine|bupivacaine|mesh-list
55973306|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
55973307|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
55973308|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973309|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973310|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
55973311|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973312|NCT03029013|Apatinib|apatinib|mesh-list
55973313|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973314|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55973315|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973316|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973317|NCT00674219|Memantine|memantine|mesh-list
55973318|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55973319|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55973320|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
55973321|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56102918|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
55973322|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973325|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56213923|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213924|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56213925|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
55790449|NCT05304559|Esketamine|esketamine|mesh-list
55973337|NCT00246025|Dabigatran|dabigatran|mesh-list
55973338|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
55973339|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55973340|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
55973341|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973342|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973343|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
55973344|NCT05256069|Propranolol|propranolol|mesh-list
55973345|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55973346|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55973347|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
55973348|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973349|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973350|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973351|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55973352|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55973353|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
55973354|NCT03311594|Ethanol|ethanol|mesh-list
55973355|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55973356|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973358|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973359|NCT05069051|Belimumab|belimumab|mesh-list
55973360|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973361|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
55973362|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973363|NCT05255601|Nivolumab|nivolumab|mesh-list
55973364|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973365|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973366|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55973367|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973368|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55973369|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
55973370|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55973371|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
55973372|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973373|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973374|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973375|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55973376|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
55973377|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55973378|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56103120|NCT00002581|Tamoxifen|tamoxifen|mesh-list
56103121|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
56103178|NCT00002593|Leucovorin|leucovorin|mesh-list
55973379|NCT00624923|Analgesics|analgesics|mesh-ancestor
55973380|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
55973381|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973382|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973383|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973384|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55973385|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55973386|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973387|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973388|NCT05593653|Suvorexant|suvorexant|mesh-list
55973389|NCT05593653|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55973390|NCT05593653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55973391|NCT05593653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973392|NCT05593653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973393|NCT05593653|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55973401|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213926|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213927|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213928|NCT01605240|Acetaminophen|acetaminophen|mesh-list
56213930|NCT01605240|Codeine|codeine|mesh-list
55973402|NCT03375788|Hormones|hormones|mesh-list
55973403|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
55973404|NCT03375788|Tesamorelin|tesamorelin|mesh-list
56103215|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55973405|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55973406|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973407|NCT03375788|Growth Substances|growth substances|mesh-ancestor
55973408|NCT00628589|Loxapine|loxapine|mesh-list
55973409|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55973410|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55973411|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973412|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973413|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55973414|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55973415|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
55973416|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973417|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973418|NCT04953897|Decitabine|decitabine|mesh-list
55973419|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55973420|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
55973421|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973422|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973423|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973424|NCT03375242|Crizotinib|crizotinib|mesh-list
55973425|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973426|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55973427|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973428|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973429|NCT01271569|Fospropofol|fospropofol|mesh-list
55973430|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55973431|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973434|NCT05589597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973435|NCT05589597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973436|NCT05589597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55973437|NCT05589597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973438|NCT05686772|Dopamine|dopamine|mesh-list
55973439|NCT05686772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55973440|NCT05686772|Sympathomimetics|sympathomimetics|mesh-ancestor
55973441|NCT05686772|Autonomic Agents|autonomic agents|mesh-ancestor
55973442|NCT05686772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973443|NCT05686772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973444|NCT05686772|Dopamine Agents|dopamine agents|mesh-ancestor
55973445|NCT05686772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973446|NCT05686772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973447|NCT05686772|Protective Agents|protective agents|mesh-ancestor
55973448|NCT04771871|Paclitaxel|paclitaxel|mesh-list
55973449|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
55973450|NCT04771871|Carboplatin|carboplatin|mesh-list
55973451|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55973452|NCT04771871|Epirubicin|epirubicin|mesh-list
55973453|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55973454|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973455|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
55973456|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
55973457|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
55973458|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973459|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973460|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
55973466|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55973467|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55973468|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55973469|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213931|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56213932|NCT01605240|Analgesics|analgesics|mesh-ancestor
56103636|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
56213933|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
55790457|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
55973470|NCT04386577|Vitamin D|vitamin d|mesh-list
55973471|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
55973472|NCT04386577|Vitamins|vitamins|mesh-ancestor
55973473|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
55973474|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973475|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55973476|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55973477|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
56103695|NCT00002665|Daunorubicin|daunorubicin|mesh-list
55973478|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55973479|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55973480|NCT04270669|Growth Substances|growth substances|mesh-ancestor
55973481|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973482|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
55973483|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973484|NCT05680454|Vaccines|vaccines|mesh-list
55973485|NCT05680454|Immunologic Factors|immunologic factors|mesh-ancestor
55973486|NCT05680454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973487|NCT04928703|Ketamine|ketamine|mesh-list
55973488|NCT04928703|Analgesics|analgesics|mesh-ancestor
55973489|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
55973490|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973491|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103794|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
55973492|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55973493|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55973494|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
55973495|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
55973496|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973497|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55973498|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55973499|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973500|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973501|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
55973502|NCT04278950|Povidone|povidone|mesh-list
55973503|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
55973504|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
55973505|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55973506|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973507|NCT00755755|Iron|iron|mesh-list
55973509|NCT00755755|Trace Elements|trace elements|mesh-ancestor
55973510|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
55973511|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973512|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55973513|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
55973514|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55973515|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55973517|NCT00674609|Analgesics|analgesics|mesh-ancestor
55973518|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
55973519|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103985|NCT00003578|Cytarabine|cytarabine|mesh-list
55973520|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973521|NCT05686616|Dapagliflozin|dapagliflozin|mesh-list
55973522|NCT05686616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55973523|NCT05686616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973524|NCT05686616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55973525|NCT05686616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973526|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55973527|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
55973528|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55973529|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55973530|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55973541|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55973542|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
55973543|NCT00755911|Coagulants|coagulants|mesh-ancestor
55973544|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
55973545|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55973546|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973548|NCT00737737|Oxycodone|oxycodone|mesh-list
55973549|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55973550|NCT00737737|Narcotics|narcotics|mesh-ancestor
55973551|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973552|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973553|NCT00737737|Analgesics|analgesics|mesh-ancestor
55973554|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
55973555|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973556|NCT05199051|Cytarabine|cytarabine|mesh-list
55973557|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
55973558|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55973559|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
55973560|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973561|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973562|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
55973563|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973564|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973565|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
55902116|NCT02407782|Ivermectin|ivermectin|mesh-list
55973566|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973567|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973568|NCT00245011|Ifosfamide|ifosfamide|mesh-list
55973569|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
55973570|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973571|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55973572|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
55973573|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973574|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973575|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55973576|NCT00245011|Analgesics|analgesics|mesh-ancestor
55973577|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
55973578|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973579|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
55973580|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973581|NCT00244933|Gemcitabine|gemcitabine|mesh-list
55973582|NCT00244933|Genistein|genistein|mesh-list
55973583|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55973584|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
55973585|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973586|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973587|NCT00244933|Antiviral Agents|antiviral agents|mesh-ancestor
56104247|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973588|NCT00244933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973589|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973590|NCT00244933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973591|NCT00244933|Immunologic Factors|immunologic factors|mesh-ancestor
55973592|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973593|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55973594|NCT00244933|Protective Agents|protective agents|mesh-ancestor
55973595|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55973608|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
55973609|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973610|NCT05539053|Protective Agents|protective agents|mesh-ancestor
55973611|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973612|NCT05539053|Antidotes|antidotes|mesh-ancestor
55973613|NCT00629525|Everolimus|everolimus|mesh-list
55973614|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973615|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973616|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
55973617|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973618|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56104281|NCT00003344|Irinotecan|irinotecan|mesh-list
55973619|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
55973620|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973621|NCT05364008|Protective Agents|protective agents|mesh-ancestor
55973622|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973623|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55973624|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55973625|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973626|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55973627|NCT00244855|Dexamethasone|dexamethasone|mesh-list
55973628|NCT00244855|Rituximab|rituximab|mesh-list
55973629|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973630|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973631|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
55973632|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973633|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55973634|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973635|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
55973636|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
56213934|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973637|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973638|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55973639|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
55973640|NCT00244855|Hormones|hormones|mesh-ancestor
55973641|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55973642|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55973643|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
55973644|NCT00737893|Hematinics|hematinics|mesh-ancestor
55973645|NCT00631319|Hydromorphone|hydromorphone|mesh-list
55973646|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55973647|NCT00631319|Narcotics|narcotics|mesh-ancestor
55973648|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973649|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973650|NCT00631319|Analgesics|analgesics|mesh-ancestor
55973651|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
55973652|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973653|NCT00244621|Candesartan|candesartan|mesh-list
55973654|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
55973655|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55973656|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55973657|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55973658|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973659|NCT00680225|Ranibizumab|ranibizumab|mesh-list
55973660|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55973664|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
55973665|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973666|NCT04603391|Cannabidiol|cannabidiol|mesh-list
55973667|NCT04603391|Methylphenidate|methylphenidate|mesh-list
55973668|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55973669|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104426|NCT00003650|Etoposide|etoposide|mesh-list
55973670|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55973671|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55973672|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55973673|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973674|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
55973675|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973676|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
55973677|NCT04575857|Atorvastatin|atorvastatin|mesh-list
55973678|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55973679|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55973680|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
55973681|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973682|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55973684|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973685|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
55973686|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55973687|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
55973688|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973689|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55973690|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902237|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55973691|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973692|NCT00738049|Darusentan|darusentan|mesh-list
55973693|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55973694|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973695|NCT04416633|Durvalumab|durvalumab|mesh-list
55973696|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973697|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973698|NCT05644340|Methamphetamine|methamphetamine|mesh-list
55973699|NCT05644340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55973700|NCT05644340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973701|NCT05644340|Sympathomimetics|sympathomimetics|mesh-ancestor
55973702|NCT05644340|Autonomic Agents|autonomic agents|mesh-ancestor
55973703|NCT05644340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973704|NCT05644340|Dopamine Agents|dopamine agents|mesh-ancestor
55973705|NCT05644340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973706|NCT05644340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973707|NCT05644340|Adrenergic Agents|adrenergic agents|mesh-ancestor
55973708|NCT05644340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56213935|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213936|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
55973709|NCT05644340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55973710|NCT05644340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56104539|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
55902284|NCT02701296|Ropivacaine|ropivacaine|mesh-list
56104540|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56104541|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56104542|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104543|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104544|NCT00382135|Urological Agents|urological agents|mesh-ancestor
56104546|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
56104547|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
56104548|NCT00003662|Melphalan|melphalan|mesh-list
56104549|NCT00003662|Busulfan|busulfan|mesh-list
56104550|NCT00003662|Cyclosporins|cyclosporins|mesh-list
56104551|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56104552|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104553|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
56104554|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104555|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104556|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104557|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
56104558|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973711|NCT05644340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55973712|NCT02291133|Bleomycin|bleomycin|mesh-list
55973713|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55973714|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973715|NCT00680459|Ethanol|ethanol|mesh-list
55973716|NCT00680459|Heparin|heparin|mesh-list
55973717|NCT00680459|Anticoagulants|anticoagulants|mesh-list
55973718|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55973719|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55973720|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973721|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55973722|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973723|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973724|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973725|NCT00632411|Nicotine|nicotine|mesh-list
55973726|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55973727|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
55973728|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104559|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104560|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55831593|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
56104561|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104562|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
56104563|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104564|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56104565|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56104566|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56104568|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
56104569|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104570|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56104571|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
56104572|NCT00003662|Hormones|hormones|mesh-ancestor
56104573|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104574|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56104575|NCT00003662|Protective Agents|protective agents|mesh-ancestor
56104576|NCT00004154|Fenretinide|fenretinide|mesh-list
56104577|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104578|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56104615|NCT00004160|Antiviral Agents|antiviral agents|mesh-ancestor
56104616|NCT00004160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104617|NCT00004160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104618|NCT00004160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104619|NCT00004160|Immunologic Factors|immunologic factors|mesh-ancestor
56104620|NCT00004160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973729|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973731|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55973732|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
55973733|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973734|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973735|NCT05685836|Bevacizumab|bevacizumab|mesh-list
55973736|NCT05685836|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
55973737|NCT05685836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973738|NCT05685836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973739|NCT05685836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55973740|NCT05685836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55973741|NCT05685836|Growth Substances|growth substances|mesh-ancestor
55973742|NCT05685836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973743|NCT05685836|Growth Inhibitors|growth inhibitors|mesh-ancestor
55973744|NCT05685836|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55973745|NCT05685836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973746|NCT00632489|Capecitabine|capecitabine|mesh-list
55973747|NCT00632489|Lapatinib|lapatinib|mesh-list
55973748|NCT00632489|Panobinostat|panobinostat|mesh-list
55973749|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55973750|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
55973751|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973752|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973753|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55973756|NCT05096481|Temozolomide|temozolomide|mesh-list
55973757|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55973758|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
56104622|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56104623|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104624|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104625|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104626|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104627|NCT00003674|Dalteparin|dalteparin|mesh-list
56104628|NCT00003674|Tinzaparin|tinzaparin|mesh-list
56104629|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56104630|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
56104631|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56104632|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56104633|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104634|NCT00003380|Doxorubicin|doxorubicin|mesh-list
56104635|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56104636|NCT00003380|Etoposide|etoposide|mesh-list
56104637|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104638|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831673|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
55973759|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973760|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973761|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
55973762|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
55973763|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973764|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
55973765|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973766|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973767|NCT01798979|Midazolam|midazolam|mesh-list
56104653|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104654|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104655|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
56104656|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104657|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56104658|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104659|NCT00003680|Tamoxifen|tamoxifen|mesh-list
56104660|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
56104661|NCT00003680|Thiotepa|thiotepa|mesh-list
56104662|NCT00003680|Fluorouracil|fluorouracil|mesh-list
56104698|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56104699|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56104700|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
56104701|NCT00002785|Methotrexate|methotrexate|mesh-list
56104702|NCT00002785|Etoposide|etoposide|mesh-list
55973768|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55973769|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55973770|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973771|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973772|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55973773|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55973774|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55973775|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55973776|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
55973778|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
55973779|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
56213937|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56213938|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973780|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56104743|NCT00002785|Protective Agents|protective agents|mesh-ancestor
56104744|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
56104745|NCT00002785|Vitamins|vitamins|mesh-ancestor
56104746|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
56104747|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104748|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104749|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104750|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
56104751|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56104752|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56104753|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104754|NCT00002785|Trace Elements|trace elements|mesh-ancestor
56104755|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56104756|NCT00004184|Antibodies|antibodies|mesh-list
56104757|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56104758|NCT00004184|Sargramostim|sargramostim|mesh-list
56104759|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
56104760|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
56104761|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973781|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973782|NCT00738361|Paclitaxel|paclitaxel|mesh-list
55973783|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55973784|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55973785|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973786|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
55973787|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
55973788|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
55973789|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973790|NCT05063565|Durvalumab|durvalumab|mesh-list
55973791|NCT05063565|Tremelimumab|tremelimumab|mesh-list
55973792|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
55973793|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973794|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973795|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973796|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55973797|NCT01279213|Clozapine|clozapine|mesh-list
55973798|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55973799|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56104762|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56104763|NCT00004184|Antacids|antacids|mesh-ancestor
56104764|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104765|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56104766|NCT05508061|Insulin|insulin|mesh-list
56104767|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56104768|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
56104769|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56104770|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104771|NCT00003386|Paclitaxel|paclitaxel|mesh-list
56104772|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
56104793|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56104794|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
56104795|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
56104796|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104797|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104798|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56104799|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56104800|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56104801|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
56104802|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56104803|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104804|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
56104805|NCT00384566|Protective Agents|protective agents|mesh-ancestor
55973800|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973801|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973802|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55973805|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
55973806|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973807|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973808|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55973809|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55973810|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
55973811|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
55973813|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55973814|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56104814|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56104815|NCT05501665|Carboplatin|carboplatin|mesh-list
56104816|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
56104817|NCT05501665|Pemetrexed|pemetrexed|mesh-list
56104818|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56104819|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104820|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104821|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104822|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104823|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104824|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104825|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56104826|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104830|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
55973815|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55973816|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55973817|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973818|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973819|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973820|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55973821|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
55973822|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55973823|NCT01279291|Gemcitabine|gemcitabine|mesh-list
55973824|NCT01279291|Paclitaxel|paclitaxel|mesh-list
55973825|NCT01279291|Carboplatin|carboplatin|mesh-list
55973826|NCT01279291|Doxorubicin|doxorubicin|mesh-list
56104903|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104904|NCT05495035|Dexamethasone|dexamethasone|mesh-list
56104905|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56104906|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
56104907|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
56104908|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104909|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104910|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56104911|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
56104912|NCT05495035|Hormones|hormones|mesh-ancestor
56104913|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104914|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104915|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104916|NCT00004856|Trastuzumab|trastuzumab|mesh-list
56104917|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56104918|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104919|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
56104920|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104921|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104922|NCT00004862|Cytarabine|cytarabine|mesh-list
56104923|NCT00004862|Fludarabine|fludarabine|mesh-list
56104924|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
56104925|NCT00004862|Oblimersen|oblimersen|mesh-list
55973827|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55973828|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55973829|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973830|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
55973831|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
55973832|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
55973833|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973834|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55973835|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
55973836|NCT01279291|Antiviral Agents|antiviral agents|mesh-ancestor
55973837|NCT01279291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104926|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105038|NCT00004874|Iodine|iodine|mesh-list
55973838|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973839|NCT01279291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973840|NCT01279291|Immunologic Factors|immunologic factors|mesh-ancestor
55973841|NCT01279291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973842|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55973843|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55973844|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55973845|NCT04367883|Amantadine|amantadine|mesh-list
55973846|NCT04367883|Histamine Antagonists|histamine antagonists|mesh-list
55973847|NCT04367883|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55973848|NCT04367883|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55973849|NCT04367883|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55973850|NCT04367883|Antiviral Agents|antiviral agents|mesh-ancestor
56213939|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56213940|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56213941|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56213942|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973851|NCT04367883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973852|NCT04367883|Dopamine Agents|dopamine agents|mesh-ancestor
55973853|NCT04367883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973854|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973855|NCT04367883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973856|NCT04367883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55973857|NCT04367883|Analgesics|analgesics|mesh-ancestor
55973858|NCT04367883|Sensory System Agents|sensory system agents|mesh-ancestor
55973859|NCT04367883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55973860|NCT04367883|Histamine Agents|histamine agents|mesh-ancestor
55973878|NCT04329039|Somatostatin|somatostatin|mesh-list
55973879|NCT04329039|Hormones|hormones|mesh-ancestor
55973880|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105061|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105062|NCT00004250|Dactinomycin|dactinomycin|mesh-list
56105063|NCT00004250|Melphalan|melphalan|mesh-list
56105065|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
56105073|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105074|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56105075|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56105076|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105077|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56105079|NCT00003728|Cytarabine|cytarabine|mesh-list
56105080|NCT00003728|Dexamethasone|dexamethasone|mesh-list
56105081|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
56105082|NCT00003728|Prednisolone|prednisolone|mesh-list
56105083|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
56105084|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55973881|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973882|NCT00635609|Doxycycline|doxycycline|mesh-list
55973883|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55973884|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973885|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
55973886|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55973887|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55973888|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
55973889|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55973890|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55973891|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56105104|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105105|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
55973893|NCT03298802|Diuretics|diuretics|mesh-ancestor
55973894|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
55973895|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973896|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55973897|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55973898|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973899|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55973900|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55973901|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
55973902|NCT05315336|Antibodies|antibodies|mesh-list
55973903|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
56105208|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56105209|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56105210|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55973904|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973905|NCT04746495|Eplerenone|eplerenone|mesh-list
55973906|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55973907|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
55973908|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55973909|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973910|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55973911|NCT04746495|Diuretics|diuretics|mesh-ancestor
55973912|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
55973913|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55973914|NCT03347786|Verapamil|verapamil|mesh-list
55973915|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55829954|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
55973916|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55973917|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55973918|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973919|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55973920|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973921|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
55973922|NCT03288974|Pomalidomide|pomalidomide|mesh-list
55973923|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
55973924|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973925|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55973926|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55973927|NCT03288974|Growth Substances|growth substances|mesh-ancestor
55973928|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
55973929|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973930|NCT03286634|Cytarabine|cytarabine|mesh-list
55973931|NCT03286634|Prednisolone|prednisolone|mesh-list
55973932|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
56105357|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105358|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105359|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56105360|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56105361|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105362|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105363|NCT00003776|Leucovorin|leucovorin|mesh-list
56105364|NCT00003776|Trimetrexate|trimetrexate|mesh-list
56105365|NCT00003776|Doxorubicin|doxorubicin|mesh-list
55973933|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
55973934|NCT03286634|Methotrexate|methotrexate|mesh-list
56213943|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56213944|NCT01605240|Narcotics|narcotics|mesh-ancestor
56213945|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973935|NCT03286634|Vincristine|vincristine|mesh-list
55973936|NCT03286634|Daunorubicin|daunorubicin|mesh-list
55973937|NCT03286634|Asparaginase|asparaginase|mesh-list
55973938|NCT03286634|Epirubicin|epirubicin|mesh-list
55973939|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
55973940|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973941|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
55973942|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973943|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55973944|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55973945|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
55973946|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973947|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973948|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55973949|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55973950|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
55973951|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55973952|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55973953|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
55973954|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
55973955|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973956|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55973957|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55973958|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
56105394|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
56105395|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105396|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
56105397|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
56105398|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105399|NCT00003788|Carmustine|carmustine|mesh-list
56105400|NCT00003788|Lomustine|lomustine|mesh-list
56105401|NCT00003788|Procarbazine|procarbazine|mesh-list
56105402|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56105403|NCT00003788|Trioxsalen|trioxsalen|mesh-list
56105404|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105405|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
56105406|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105407|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105408|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
56105409|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56105410|NCT00004340|Calcitriol|calcitriol|mesh-list
56105411|NCT00004340|Hormones|hormones|mesh-list
56105412|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105413|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973959|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973960|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55973961|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
55973962|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
55973963|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
55973964|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973965|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
55973966|NCT03286634|Hormones|hormones|mesh-ancestor
55973967|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55973969|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55973970|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55973971|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55973972|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55973973|NCT03286556|Autoantibodies|autoantibodies|mesh-list
55973974|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973975|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
55973976|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973977|NCT05000294|Atezolizumab|atezolizumab|mesh-list
55973978|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105414|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56105415|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56105416|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56105417|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105418|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56105419|NCT00004340|Vitamins|vitamins|mesh-ancestor
56105420|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
56105421|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56105422|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56105423|NCT00004346|Lovastatin|lovastatin|mesh-list
56105424|NCT00004346|L 647318|l 647318|mesh-list
56105425|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
56105426|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56105427|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56105428|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
56105429|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105430|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56105431|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56105432|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105433|NCT00004346|Cathartics|cathartics|mesh-ancestor
56105434|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56105435|NCT00384800|Thalidomide|thalidomide|mesh-list
56105436|NCT00384800|Tegafur|tegafur|mesh-list
56105466|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56105467|NCT02972762|Propofol|propofol|mesh-list
56105468|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56105469|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973979|NCT00637247|Gemcitabine|gemcitabine|mesh-list
55973980|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55973981|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
55973982|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973983|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973984|NCT00637247|Antiviral Agents|antiviral agents|mesh-ancestor
55973985|NCT00637247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973986|NCT00637247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973987|NCT00637247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55973988|NCT00637247|Immunologic Factors|immunologic factors|mesh-ancestor
55973989|NCT00637247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973993|NCT03267836|Avelumab|avelumab|mesh-list
55973994|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55973995|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973996|NCT04388033|Temozolomide|temozolomide|mesh-list
55973997|NCT04388033|Interleukin-12|interleukin-12|mesh-list
55973998|NCT04388033|Vaccines|vaccines|mesh-list
55973999|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
55974000|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105473|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
55974001|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55974002|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
55974003|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974004|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974005|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56213946|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
55790470|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
55974006|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55974007|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55974008|NCT04388033|Growth Substances|growth substances|mesh-ancestor
55974009|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
55974011|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
55974012|NCT03267680|Omeprazole|omeprazole|mesh-list
55974013|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974014|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
55974015|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974016|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55974017|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55832575|NCT01625611|Naltrexone|naltrexone|mesh-list
55974018|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
55974019|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974020|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974021|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55974022|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55974023|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55974024|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55974025|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974026|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56105623|NCT00004424|Fentanyl|fentanyl|mesh-list
56105624|NCT00004424|Midazolam|midazolam|mesh-list
56105625|NCT00004424|Propofol|propofol|mesh-list
56105626|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56105627|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56105628|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105629|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56105630|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
56105636|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105637|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56105638|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56105639|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56105640|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56105641|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
56105642|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
56105643|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105644|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105645|NCT00004430|Prednisolone|prednisolone|mesh-list
56105646|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56105647|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
55974027|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55974028|NCT03267680|Analgesics|analgesics|mesh-ancestor
55974029|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
55974030|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974031|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974032|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
55974033|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
55974034|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55974035|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55974036|NCT02980731|Venetoclax|venetoclax|mesh-list
55974037|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974038|NCT05564390|Cytarabine|cytarabine|mesh-list
55974039|NCT05564390|Azacitidine|azacitidine|mesh-list
56105648|NCT00004430|Hormones|hormones|mesh-ancestor
56105649|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105650|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105651|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56105652|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105653|NCT00003842|Interleukin-4|interleukin-4|mesh-list
56105654|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56105655|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
56105656|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105657|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105658|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55974040|NCT05564390|Daunorubicin|daunorubicin|mesh-list
55974065|NCT05563766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974066|NCT05563766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55974068|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55974069|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974070|NCT02980497|Ethanol|ethanol|mesh-list
55974071|NCT02980497|Listerine|listerine|mesh-list
55974072|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
55974073|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
55974074|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974075|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974076|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974077|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
56105659|NCT00005036|Leucovorin|leucovorin|mesh-list
56105660|NCT00005036|Fluorouracil|fluorouracil|mesh-list
56105661|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
56105662|NCT00005036|Irinotecan|irinotecan|mesh-list
56105663|NCT00005036|Calcium|calcium|mesh-list
56105664|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
56105665|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56105666|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105667|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
56105668|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105669|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56105670|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105671|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105672|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
56105673|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56105674|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105675|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105676|NCT00005036|Antidotes|antidotes|mesh-ancestor
56105677|NCT00005036|Protective Agents|protective agents|mesh-ancestor
56105678|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
56105693|NCT00004436|Leuprolide|leuprolide|mesh-list
56105694|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56105695|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
56105696|NCT00004436|Hormones|hormones|mesh-ancestor
56105697|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974078|NCT02980497|Protective Agents|protective agents|mesh-ancestor
55974079|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
55974080|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55974081|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
55974082|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974083|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974084|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55974085|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
55974086|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55974092|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
55974093|NCT02652429|Protective Agents|protective agents|mesh-ancestor
55974099|NCT02294253|Buprenorphine|buprenorphine|mesh-list
55974100|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55974102|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55974103|NCT02294253|Narcotics|narcotics|mesh-ancestor
55974104|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974105|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974106|NCT02294253|Analgesics|analgesics|mesh-ancestor
55974107|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
55974108|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974109|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55974110|NCT04926818|Ofatumumab|ofatumumab|mesh-list
55974111|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55974112|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56213947|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
56213948|NCT01605279|Dobutamine|dobutamine|mesh-list
56213949|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56213950|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
55755390|NCT04483505|Palbociclib|palbociclib|mesh-list
56105699|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56105700|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105701|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56105702|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
56105703|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56105704|NCT00005042|Semaxinib|semaxinib|mesh-list
56105705|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56105706|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56105707|NCT00005042|Growth Substances|growth substances|mesh-ancestor
56105708|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105709|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
56213951|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
56213952|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56213953|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213954|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55974113|NCT04926818|Siponimod|siponimod|mesh-list
55974114|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974115|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
55974116|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974117|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55974118|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974119|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974120|NCT00684983|Capecitabine|capecitabine|mesh-list
55974121|NCT00684983|Lapatinib|lapatinib|mesh-list
55974122|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56105710|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105711|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56105712|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105713|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105714|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56105715|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56105716|NCT00004442|Cholic Acids|cholic acids|mesh-list
56105717|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56105718|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56105719|NCT00004442|Cathartics|cathartics|mesh-ancestor
56105720|NCT05444569|Liraglutide|liraglutide|mesh-list
56105721|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56105722|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105723|NCT05444569|Incretins|incretins|mesh-ancestor
56105724|NCT05444569|Hormones|hormones|mesh-ancestor
56105725|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105726|NCT00004448|Prednisone|prednisone|mesh-list
56105727|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56105728|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
56105729|NCT00004448|Hormones|hormones|mesh-ancestor
56105730|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105731|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105732|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56105733|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105734|NCT00003860|Carboplatin|carboplatin|mesh-list
56105735|NCT00003860|Etoposide|etoposide|mesh-list
56105736|NCT00003860|Ifosfamide|ifosfamide|mesh-list
56105737|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105738|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56105739|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55974123|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55974124|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
55974125|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974126|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974127|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55974128|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974129|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
55974130|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974131|NCT05550194|Valacyclovir|valacyclovir|mesh-list
55974132|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
55974133|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974134|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
55974135|NCT03339596|Hematinics|hematinics|mesh-ancestor
55974136|NCT00638651|Imiquimod|imiquimod|mesh-list
55974137|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55974138|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
55974139|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974140|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105745|NCT05167825|Macitentan|macitentan|mesh-list
55974141|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
55974142|NCT02584647|Sirolimus|sirolimus|mesh-list
55974143|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55974144|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974145|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55974146|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974147|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
55974148|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974149|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
55974150|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974151|NCT00685139|Zonisamide|zonisamide|mesh-list
55974152|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
55974153|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55974154|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974155|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974156|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55974157|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974158|NCT00685295|Fentanyl|fentanyl|mesh-list
55974159|NCT00685295|Oxycodone|oxycodone|mesh-list
55974160|NCT00685295|Lansoprazole|lansoprazole|mesh-list
55974161|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
55974162|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55974164|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974165|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974166|NCT00685295|Analgesics|analgesics|mesh-ancestor
55974167|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
55974168|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974169|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55974170|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55974171|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
55974172|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
56213955|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56213956|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56213957|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
56213958|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974173|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55974174|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55974175|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55974176|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974177|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974178|NCT00686231|Lidocaine|lidocaine|mesh-list
55974179|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
55974180|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
55974181|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
55974182|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974183|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974184|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
55974185|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974186|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55974187|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55974188|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55974189|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974190|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974191|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
55974192|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55974193|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56105871|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
55974194|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974195|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
55974196|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55974197|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55974198|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55974199|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974200|NCT03335540|Nivolumab|nivolumab|mesh-list
55974201|NCT03335540|Ipilimumab|ipilimumab|mesh-list
55974202|NCT03335540|Linrodostat|linrodostat|mesh-list
55974203|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974204|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974205|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55974206|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974207|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974208|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
55974209|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55974210|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
55974211|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974212|NCT00643097|Temozolomide|temozolomide|mesh-list
56105889|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55974213|NCT00643097|Sargramostim|sargramostim|mesh-list
55974214|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55974215|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
55974216|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974217|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105890|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105891|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
56105892|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56105893|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56105930|NCT05122819|Anesthetics|anesthetics|mesh-list
55974218|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
55974219|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974220|NCT03333668|Guanfacine|guanfacine|mesh-list
55974221|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55974222|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55974223|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974224|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55974225|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55974226|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974227|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974228|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
55974229|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974230|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55974231|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55974232|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55974239|NCT04683315|Fluorouracil|fluorouracil|mesh-list
55974240|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55974241|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974242|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
55974243|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
55974244|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
55974245|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974246|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55974247|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
55974248|NCT04683315|Antiviral Agents|antiviral agents|mesh-ancestor
55974249|NCT04683315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974250|NCT04683315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974251|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974252|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
55974253|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974255|NCT05502146|Bupivacaine|bupivacaine|mesh-list
55974256|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
55974257|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
55974258|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974259|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974260|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
55974261|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105996|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105997|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105998|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56105999|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106000|NCT00005108|Estradiol|estradiol|mesh-list
56106001|NCT00005108|Progesterone|progesterone|mesh-list
56106002|NCT00005108|Estrogens|estrogens|mesh-ancestor
56106003|NCT00005108|Hormones|hormones|mesh-ancestor
56106004|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833018|NCT02062879|Ketamine|ketamine|mesh-list
56106005|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106006|NCT00005108|Progestins|progestins|mesh-ancestor
56106007|NCT00004652|Pimozide|pimozide|mesh-list
55974262|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55974263|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55974264|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974265|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974266|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974267|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
55974268|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
55974269|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55974270|NCT04033991|Sunitinib|sunitinib|mesh-list
55974271|NCT04033991|Axitinib|axitinib|mesh-list
55974272|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974273|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55974274|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55974275|NCT04033991|Growth Substances|growth substances|mesh-ancestor
56106008|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56106009|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56106010|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56106011|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106012|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56106013|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56106014|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
56106015|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106016|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106017|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56106018|NCT04641871|Irinotecan|irinotecan|mesh-list
56106019|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56106020|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56106021|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106042|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106043|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56106044|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56106045|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56106046|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106047|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
56106048|NCT00004682|Antibodies|antibodies|mesh-list
56106049|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
56106050|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56106051|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56106052|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
56106053|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748476|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55748477|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55748478|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748479|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
55748480|NCT03263689|Morphine|morphine|mesh-list
55748481|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55748482|NCT03263689|Narcotics|narcotics|mesh-ancestor
55748483|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974276|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974277|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
55974278|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55974279|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974280|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974281|NCT04027361|Amphetamine|amphetamine|mesh-list
55974282|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55974283|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974284|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
55974285|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
55974286|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974287|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
55974288|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974289|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106054|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
56106055|NCT00004688|Carmustine|carmustine|mesh-list
56106056|NCT00004688|Streptozocin|streptozocin|mesh-list
56106057|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
56106058|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106069|NCT00004694|Heparin|heparin|mesh-list
55974290|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974291|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55974292|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55974293|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974294|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55974295|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55974297|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55974298|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55974299|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
55974300|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
55974301|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
56106146|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106156|NCT04585477|Durvalumab|durvalumab|mesh-list
55974302|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974303|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974304|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
55974305|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974306|NCT03793439|Prednisone|prednisone|mesh-list
55974307|NCT03793439|Tofacitinib|tofacitinib|mesh-list
55974309|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
55974312|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213959|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974313|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55974314|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974315|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55974316|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106244|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55974317|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974318|NCT03729401|Aspirin|aspirin|mesh-list
55974319|NCT03729401|Clopidogrel|clopidogrel|mesh-list
55974320|NCT03729401|Ticagrelor|ticagrelor|mesh-list
55974321|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55974322|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55974323|NCT03729401|Analgesics|analgesics|mesh-ancestor
55974324|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
55974325|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106340|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55974326|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974327|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974328|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55974329|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55974330|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55974331|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974332|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55974333|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55974334|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974335|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
55974336|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55974337|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55974338|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55974339|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
55974340|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974341|NCT00687167|Zonisamide|zonisamide|mesh-list
55974342|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
56106478|NCT04456699|Vitamins|vitamins|mesh-ancestor
55974343|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55974344|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974345|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974346|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55974347|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974348|NCT00687713|Bupropion|bupropion|mesh-list
55974349|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55974350|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
55974351|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55974352|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55974353|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55974354|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974355|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974356|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
55974357|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974358|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974359|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56106566|NCT00005810|Carboplatin|carboplatin|mesh-list
55974360|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55974361|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974362|NCT02304159|Ribavirin|ribavirin|mesh-list
55974363|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
55974364|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
55974365|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974366|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
55974367|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974368|NCT04670679|Pembrolizumab|pembrolizumab|mesh-list
55974369|NCT04670679|Cetuximab|cetuximab|mesh-list
55974370|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974371|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974372|NCT02143973|Nalbuphine|nalbuphine|mesh-list
55974373|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55974374|NCT02143973|Narcotics|narcotics|mesh-ancestor
56106646|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55974375|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974376|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974377|NCT02143973|Analgesics|analgesics|mesh-ancestor
55974378|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
56213961|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56213962|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
55974380|NCT03028701|Budesonide|budesonide|mesh-list
55974384|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
55974385|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974386|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974387|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56106761|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56106762|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56106763|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
56106764|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106765|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106766|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
56106767|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106768|NCT04563962|Methamphetamine|methamphetamine|mesh-list
56106769|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56106782|NCT02211482|Lamivudine|lamivudine|mesh-list
55974388|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
55974389|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
55974390|NCT03028701|Hormones|hormones|mesh-ancestor
55974391|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974392|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55974393|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55974394|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55974395|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974396|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974397|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974398|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55974399|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56106817|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56106818|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
56106819|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56106820|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
56106821|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106822|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974400|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55974401|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55974402|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974403|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974404|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974405|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974406|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
55974407|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974408|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
55974409|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55974410|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
55974411|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974412|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974413|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55974414|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
55974415|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55974416|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
55974417|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974418|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974419|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55974420|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
55974421|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
55974422|NCT02267655|Protective Agents|protective agents|mesh-ancestor
55974423|NCT02209545|Pyridoxine|pyridoxine|mesh-list
55974424|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
55974425|NCT02209545|Misoprostol|misoprostol|mesh-list
55974426|NCT02209545|Vitamins|vitamins|mesh-ancestor
56106908|NCT04123717|Ibuprofen|ibuprofen|mesh-list
55974427|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
55974428|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974429|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55974430|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
55974431|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55974432|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55974433|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55974434|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
55974435|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
55974436|NCT00690833|Desonide|desonide|mesh-list
55974437|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974438|NCT05171816|Olaparib|olaparib|mesh-list
55974439|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
56106956|NCT04068103|Capecitabine|capecitabine|mesh-list
56106957|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
56106958|NCT04068103|Calcium|calcium|mesh-list
56106959|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
56106960|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56106961|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106962|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56106963|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
56106964|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106965|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56106966|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106967|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106968|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
56107004|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56107005|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107006|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56107007|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107008|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
56107009|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107010|NCT03194893|Crizotinib|crizotinib|mesh-list
56107011|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974440|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55974441|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974442|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974443|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974444|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55974445|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
55974446|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974447|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974448|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55974449|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
55974450|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
55974451|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56213963|NCT01606072|Coagulants|coagulants|mesh-ancestor
56213964|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55974453|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974456|NCT00644657|Clopidogrel|clopidogrel|mesh-list
55974457|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55974458|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55974459|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55974460|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55974461|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
55974462|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974463|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107073|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
56107074|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107075|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107076|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107077|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
56107078|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107079|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107080|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107081|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107082|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107083|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107084|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107085|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107086|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
56107087|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56107088|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56107089|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
56107090|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107091|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56107092|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56107093|NCT00002905|Analgesics|analgesics|mesh-ancestor
56107094|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
55974464|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974465|NCT04613024|Topiramate|topiramate|mesh-list
55974466|NCT04613024|Gabapentin|gabapentin|mesh-list
55974467|NCT04613024|Analgesics|analgesics|mesh-ancestor
55974468|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
55974469|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974470|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974471|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
55974472|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55974473|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55974474|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974475|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55974476|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56107120|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
56107121|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
56107122|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107123|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56107124|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56107125|NCT00383851|Growth Substances|growth substances|mesh-ancestor
56107126|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107127|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
56107128|NCT00002923|KRN 5500|krn 5500|mesh-list
56107129|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107130|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56107131|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107132|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107133|NCT03778957|Bevacizumab|bevacizumab|mesh-list
56107134|NCT03778957|Durvalumab|durvalumab|mesh-list
56107135|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56107136|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107137|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56107138|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56107139|NCT03778957|Growth Substances|growth substances|mesh-ancestor
56107140|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107141|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
56107142|NCT02636569|Diclofenac|diclofenac|mesh-list
56107143|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56107144|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56107145|NCT02636569|Analgesics|analgesics|mesh-ancestor
55974477|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55974478|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974479|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974480|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
55974481|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55974482|NCT02094261|Osimertinib|osimertinib|mesh-list
55974483|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974484|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55974485|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974486|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974487|NCT01933815|Bevacizumab|bevacizumab|mesh-list
55974488|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974489|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974490|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55974491|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55974492|NCT01933815|Growth Substances|growth substances|mesh-ancestor
55974493|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974494|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
55974495|NCT03239210|Ondansetron|ondansetron|mesh-list
55974496|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
55974497|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
55974498|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974499|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974500|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55974501|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
55974502|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107182|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107183|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56107184|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
56107187|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107188|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
56107189|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107190|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107191|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107192|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
56107193|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107194|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107195|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107196|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107197|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107198|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107199|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107200|NCT00002953|Paclitaxel|paclitaxel|mesh-list
56107201|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
56107202|NCT00002953|Epirubicin|epirubicin|mesh-list
56107203|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107204|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974503|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55974504|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
55974505|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974506|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974507|NCT03239210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55974508|NCT03239210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55974509|NCT03239210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974510|NCT03239210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55974511|NCT03239210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55974512|NCT04606316|Nivolumab|nivolumab|mesh-list
55974513|NCT04606316|Ipilimumab|ipilimumab|mesh-list
55974514|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974515|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974516|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55974517|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974519|NCT03480971|TEMPO|tempo|mesh-list
55974520|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
55974521|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974522|NCT03480971|Protective Agents|protective agents|mesh-ancestor
55974523|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974524|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56107205|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107206|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107207|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107208|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107209|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107210|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
56107211|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107212|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107213|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107214|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
56107215|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107216|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107217|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107218|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107219|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107220|NCT03693781|Colchicine|colchicine|mesh-list
56107221|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
56107222|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107223|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107224|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107225|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107226|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107228|NCT02283853|Interferons|interferons|mesh-list
55974525|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974536|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
55974537|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974539|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55974540|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55974542|NCT04023669|Antiviral Agents|antiviral agents|mesh-ancestor
55974543|NCT04023669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974544|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974545|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56107237|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
56107238|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107239|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56107240|NCT03668041|Gabapentin|gabapentin|mesh-list
56107241|NCT03668041|Trazodone|trazodone|mesh-list
56107242|NCT03668041|Eszopiclone|eszopiclone|mesh-list
56107243|NCT03668041|Analgesics|analgesics|mesh-ancestor
56107244|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
56107245|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56107246|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107247|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
56107248|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56107249|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56107250|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56107251|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55974547|NCT00646763|Sargramostim|sargramostim|mesh-list
55974548|NCT00646763|Mitogens|mitogens|mesh-list
55974549|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55974550|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
55974551|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974552|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
55974553|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974554|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
55974555|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974556|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974557|NCT02986347|Epinephrine|epinephrine|mesh-list
55974558|NCT02986347|Racepinephrine|racepinephrine|mesh-list
55974559|NCT02986347|Anesthetics|anesthetics|mesh-list
55974560|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
55974561|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974562|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974563|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55974564|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55974565|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974566|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974567|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107252|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56107253|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56107254|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56107255|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107320|NCT00003397|Hormones|hormones|mesh-ancestor
55974568|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55974569|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55974570|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
55974571|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974572|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55974573|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
55974574|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
55974575|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
55974576|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55974577|NCT00649961|Melatonin|melatonin|mesh-list
55974578|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
55974579|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974580|NCT00649961|Protective Agents|protective agents|mesh-ancestor
55974581|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974582|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974583|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55974584|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
55974585|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56107365|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107366|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
55974586|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55974587|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55974588|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974589|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974602|NCT00652145|Analgesics|analgesics|mesh-ancestor
55974603|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
55974604|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974605|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974606|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974607|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107439|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107440|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107441|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107442|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107443|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107444|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107445|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107446|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107447|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107448|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107449|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56107450|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
56107451|NCT00003421|Hormones|hormones|mesh-ancestor
56107452|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107453|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107454|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56107455|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107456|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
56107457|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
56107458|NCT00003427|Irinotecan|irinotecan|mesh-list
56107459|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107460|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56107461|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107462|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107463|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107464|NCT00003439|Interleukin-12|interleukin-12|mesh-list
56107465|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56107466|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
55974608|NCT03231722|Leucovorin|leucovorin|mesh-list
55974609|NCT03231722|Fluorouracil|fluorouracil|mesh-list
55974610|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
55974611|NCT03231722|Irinotecan|irinotecan|mesh-list
55974612|NCT03231722|Panitumumab|panitumumab|mesh-list
55974613|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
55974614|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
55974615|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974616|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55974617|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213965|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
56213966|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213967|NCT01606722|Ritonavir|ritonavir|mesh-list
55974618|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974619|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
55974620|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974621|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55974622|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55974626|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
55974627|NCT03231722|Vitamins|vitamins|mesh-ancestor
55974628|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
55974629|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974630|NCT02298933|Eculizumab|eculizumab|mesh-list
55974631|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55974632|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107474|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
55974633|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
55974634|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974635|NCT02959775|Vaccines|vaccines|mesh-list
55974636|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
55974637|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974638|NCT04761848|Cilostazol|cilostazol|mesh-list
55974639|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55974640|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
55974641|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974642|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974643|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55974644|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
55974645|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55974646|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55974647|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974648|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55974649|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
55974650|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55974651|NCT04761848|Protective Agents|protective agents|mesh-ancestor
55974661|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974663|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974664|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
55974665|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974666|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55974668|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974669|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55974670|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55974671|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55974672|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55974673|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55974674|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974675|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974676|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974677|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974678|NCT00693719|Irinotecan|irinotecan|mesh-list
55974679|NCT00693719|Etoposide|etoposide|mesh-list
55974680|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55974681|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55974682|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974683|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974684|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974685|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55974686|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55974687|NCT00653861|Lidocaine|lidocaine|mesh-list
55974688|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
55974689|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
55974690|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974691|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974692|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
55974693|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974694|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55974695|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55974696|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55974697|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974698|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974699|NCT00654329|Fentanyl|fentanyl|mesh-list
55974700|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
55974701|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55974702|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974703|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974704|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55974707|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974708|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55974709|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55974710|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55974711|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974712|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974722|NCT00695435|Dexamethasone|dexamethasone|mesh-list
55974723|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55974724|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974725|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
55974726|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
55974727|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974728|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974729|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55974730|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
55974731|NCT00695435|Hormones|hormones|mesh-ancestor
55974732|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974733|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55974734|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974735|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55974736|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55974737|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974738|NCT00654953|Gabapentin|gabapentin|mesh-list
55974739|NCT00654953|Sertraline|sertraline|mesh-list
55974740|NCT00654953|Analgesics|analgesics|mesh-ancestor
56107927|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107930|NCT00002839|Fluorouracil|fluorouracil|mesh-list
55974741|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
55974742|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974743|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974744|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
55974745|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55974746|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55974747|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974748|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55974749|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55974750|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55974751|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974752|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974753|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
55974754|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
55974755|NCT00654953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55974756|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56108045|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108063|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108064|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108065|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108066|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108067|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108068|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108070|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56108071|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108072|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
56108073|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108074|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108075|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108076|NCT00002881|Suramin|suramin|mesh-list
55755515|NCT02463929|Ketamine|ketamine|mesh-list
56108077|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
56108078|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56108079|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56108080|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56108082|NCT00002881|Goserelin|goserelin|mesh-list
55974757|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974758|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
55974759|NCT01790165|Terbinafine|terbinafine|mesh-list
55974760|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
55974761|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974762|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974763|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974764|NCT02299089|Octreotide|octreotide|mesh-list
55974765|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55974766|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55974767|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974768|NCT00655811|Capsaicin|capsaicin|mesh-list
55974769|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
55974770|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
55974771|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
55974772|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974773|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974774|NCT03931551|Trastuzumab|trastuzumab|mesh-list
55974775|NCT03931551|Olaparib|olaparib|mesh-list
55974776|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974777|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213968|NCT01606722|Darunavir|darunavir|mesh-list
56213969|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55974786|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974787|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974788|NCT00696293|Analgesics|analgesics|mesh-ancestor
56108083|NCT00002881|Flutamide|flutamide|mesh-list
56108084|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974789|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
55974790|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974791|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
55974792|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55974793|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
55974795|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55974796|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55974797|NCT00696449|Analgesics|analgesics|mesh-ancestor
55974798|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
56108159|NCT00003937|Methotrexate|methotrexate|mesh-list
56108161|NCT00003937|Ifosfamide|ifosfamide|mesh-list
56108162|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
56108163|NCT00003937|Razoxane|razoxane|mesh-list
56108164|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108165|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108166|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108167|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108168|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108169|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108170|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56108171|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
56108172|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56108173|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974799|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974800|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974801|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974802|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55974803|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
55974804|NCT03916263|Metformin|metformin|mesh-list
55974805|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55974806|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974807|NCT00696761|Alfuzosin|alfuzosin|mesh-list
55974808|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55974809|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55974810|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55974811|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974812|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56108279|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
55974813|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974814|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974815|NCT00696761|Urological Agents|urological agents|mesh-ancestor
55974816|NCT00656201|Progesterone|progesterone|mesh-list
55974817|NCT00656201|Progestins|progestins|mesh-ancestor
55974818|NCT00656201|Hormones|hormones|mesh-ancestor
55974819|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974820|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974821|NCT00759291|Acipimox|acipimox|mesh-list
55974822|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55974823|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
55974824|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974825|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55974826|NCT00756405|Antioxidants|antioxidants|mesh-list
55974827|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974828|NCT00756405|Protective Agents|protective agents|mesh-ancestor
55974829|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974830|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55974831|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55974832|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55974833|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55974834|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55974835|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55974836|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56108371|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
55974837|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974838|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974839|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974849|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974850|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974851|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55974852|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55974854|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
55974855|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
55974856|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974857|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
55974858|NCT00700661|Montelukast|montelukast|mesh-list
55974859|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55974860|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
55974861|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55974862|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
55974863|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974864|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56213970|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56213971|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
55974865|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55974866|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55974867|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974869|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55974870|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55974871|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
56108509|NCT00003697|Vadimezan|vadimezan|mesh-list
55974872|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974873|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55974874|NCT00652301|Simvastatin|simvastatin|mesh-list
55974875|NCT00652301|Ezetimibe|ezetimibe|mesh-list
55974877|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55974878|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
55974879|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974880|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55974881|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55974882|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974883|NCT01961271|Buprenorphine|buprenorphine|mesh-list
55974884|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55974885|NCT01961271|Narcotics|narcotics|mesh-ancestor
55974886|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55974887|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974888|NCT01961271|Analgesics|analgesics|mesh-ancestor
55974889|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
55974890|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55974891|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55974892|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
55974893|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56108575|NCT00003151|Metronidazole|metronidazole|mesh-list
55974894|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55974895|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
55974896|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974897|NCT03822351|Durvalumab|durvalumab|mesh-list
55974898|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55974899|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974900|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974901|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
55974902|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974903|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55974904|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55974912|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974914|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974915|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974916|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55974917|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974918|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55974919|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55974920|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55974921|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55974922|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55974923|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
56108667|NCT00004063|Interferons|interferons|mesh-list
56108668|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
56108669|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108679|NCT00003733|Paclitaxel|paclitaxel|mesh-list
55974924|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974925|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974926|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974927|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
55974928|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55974929|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
55974930|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974931|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974932|NCT03769155|Nivolumab|nivolumab|mesh-list
55974933|NCT03769155|Ipilimumab|ipilimumab|mesh-list
55974934|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974935|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974936|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55974937|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974938|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
55974939|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974940|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
56213973|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56213974|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55790489|NCT04858529|Docetaxel|docetaxel|mesh-list
55974941|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55974942|NCT03737643|Paclitaxel|paclitaxel|mesh-list
55974943|NCT03737643|Bevacizumab|bevacizumab|mesh-list
55974944|NCT03737643|Carboplatin|carboplatin|mesh-list
55974945|NCT03737643|Durvalumab|durvalumab|mesh-list
55974946|NCT03737643|Olaparib|olaparib|mesh-list
55974947|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55974948|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55974949|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974950|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
55974951|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
55974952|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
55974953|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974954|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974955|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55974956|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55974957|NCT03737643|Growth Substances|growth substances|mesh-ancestor
55974958|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974959|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
55974960|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
55974961|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55974962|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974963|NCT04277702|Montelukast|montelukast|mesh-list
55835794|NCT01959841|Valacyclovir|valacyclovir|mesh-list
56108820|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56108821|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56108822|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
56108823|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108824|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
56108825|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56108826|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56108828|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
56108829|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56108830|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56108831|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
56108832|NCT00003187|Hormones|hormones|mesh-ancestor
56108833|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56108834|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56108835|NCT00003187|Protective Agents|protective agents|mesh-ancestor
56108836|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
56108837|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108838|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108839|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748561|NCT04444193|Lenvatinib|lenvatinib|mesh-list
55748562|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55748563|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55748564|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748565|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
55748566|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748567|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55748568|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748569|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748570|NCT03984955|Mannitol|mannitol|mesh-list
55748571|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
55748572|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55748573|NCT03984955|Diuretics|diuretics|mesh-ancestor
55748574|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
55748575|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748576|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55748577|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
55748578|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
55748579|NCT03984955|Protective Agents|protective agents|mesh-ancestor
55748580|NCT03946969|Paclitaxel|paclitaxel|mesh-list
55974964|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55974965|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
55974966|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55974967|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
55974974|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974975|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
55974977|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974978|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974979|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55974980|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974981|NCT04695080|Cladribine|cladribine|mesh-list
55974982|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974983|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974984|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
55974985|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974986|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55974987|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974988|NCT03726879|Paclitaxel|paclitaxel|mesh-list
55974989|NCT03726879|Maytansine|maytansine|mesh-list
55974990|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55974991|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
55974992|NCT03726879|Doxorubicin|doxorubicin|mesh-list
55974993|NCT03726879|Trastuzumab|trastuzumab|mesh-list
55974994|NCT03726879|Atezolizumab|atezolizumab|mesh-list
55974995|NCT03726879|Pertuzumab|pertuzumab|mesh-list
55974996|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55974997|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974998|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
55974999|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
55975000|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
55975001|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108946|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108947|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108948|NCT00004159|Gemcitabine|gemcitabine|mesh-list
56108949|NCT00004159|Paclitaxel|paclitaxel|mesh-list
55975002|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975003|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
55975004|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975005|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975006|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55975007|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
55975008|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55975009|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55975010|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55975011|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55975012|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975013|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55975014|NCT03914300|Nivolumab|nivolumab|mesh-list
55975015|NCT03914300|Ipilimumab|ipilimumab|mesh-list
55975016|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55975017|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975018|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55975019|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975020|NCT00699491|Sirolimus|sirolimus|mesh-list
55975021|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55975022|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56109175|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109176|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
56109177|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109178|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109179|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
56109180|NCT00003859|Carboplatin|carboplatin|mesh-list
56109182|NCT00003859|Vincristine|vincristine|mesh-list
56109183|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109184|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
56109185|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109186|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109187|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109188|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
56109189|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109190|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109191|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109192|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109193|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109199|NCT00003865|Toremifene|toremifene|mesh-list
56109224|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56109225|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
56109226|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975023|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975024|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55975025|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975026|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
55975027|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975028|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
55975029|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975030|NCT04493216|Dolutegravir|dolutegravir|mesh-list
55975031|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55975032|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56109246|NCT00003883|Fluconazole|fluconazole|mesh-list
56109247|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
56109248|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109249|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56109250|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56109251|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109252|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975033|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975045|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975046|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55975047|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975049|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
55975050|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975051|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975052|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55975053|NCT03721965|Protective Agents|protective agents|mesh-ancestor
55975054|NCT04399148|Ketotifen|ketotifen|mesh-list
55975055|NCT04399148|Aprepitant|aprepitant|mesh-list
55975056|NCT04399148|Desloratadine|desloratadine|mesh-list
55975057|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
55975058|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
55975059|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975060|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975061|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975062|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55975063|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975064|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109310|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56109311|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109312|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
56109313|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109314|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109315|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109316|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
55975065|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55975066|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
55975067|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55975068|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55975069|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
55975070|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
55975071|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
55975072|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
55975073|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55975074|NCT04672382|Morphine|morphine|mesh-list
56109379|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56109380|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109381|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56109382|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
56109383|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
56109384|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109385|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975075|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55975076|NCT04672382|Narcotics|narcotics|mesh-ancestor
55975077|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55975078|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975079|NCT04672382|Analgesics|analgesics|mesh-ancestor
55975080|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
55975081|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975082|NCT00699803|Prednisone|prednisone|mesh-list
55975083|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
55975084|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55975085|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
55975086|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55975087|NCT00699803|Prednisolone|prednisolone|mesh-list
55975088|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55975089|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
55975090|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55975091|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
55975092|NCT00699803|Hormones|hormones|mesh-ancestor
55975093|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55975094|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975095|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55975096|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975097|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
55975098|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
55975111|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
55790491|NCT04858529|Pertuzumab|pertuzumab|mesh-list
55975112|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975113|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
55975114|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
55975115|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975116|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55975117|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
55975118|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
55975119|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975120|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975121|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55975122|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
55975123|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
55975124|NCT00551447|Simvastatin|simvastatin|mesh-list
55975125|NCT00551447|Ezetimibe|ezetimibe|mesh-list
55975126|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55975127|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55975128|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
55975129|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975131|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55975132|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975133|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
55975134|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975135|NCT01968057|Cyclosporine|cyclosporine|mesh-list
55975136|NCT01968057|Cyclosporins|cyclosporins|mesh-list
55975137|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975138|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109691|NCT00004981|Lamivudine|lamivudine|mesh-list
56109692|NCT00004981|Zidovudine|zidovudine|mesh-list
56109693|NCT00004981|Abacavir|abacavir|mesh-list
56109694|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
56109695|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56109696|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56109697|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56109698|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109699|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109700|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
56109701|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109705|NCT00004993|Hormones|hormones|mesh-list
55975139|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975140|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
55975141|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975142|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
55975143|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975144|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
55975145|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975146|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55975147|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
55975148|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
55975149|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55975150|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55975151|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975152|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55975153|NCT00658697|Bevacizumab|bevacizumab|mesh-list
55975154|NCT00658697|Docetaxel|docetaxel|mesh-list
55975155|NCT00658697|Bicalutamide|bicalutamide|mesh-list
55975156|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55975157|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975158|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55975159|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55975160|NCT00658697|Growth Substances|growth substances|mesh-ancestor
55975161|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975162|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
55975163|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
55975164|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
55975176|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55975177|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55975178|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975179|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55975180|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
55975182|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55975183|NCT04399226|Analgesics|analgesics|mesh-ancestor
55975184|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
55975185|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975186|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55975187|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55975188|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55975189|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
55975190|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975191|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975192|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55975193|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56213975|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56109756|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109757|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109758|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56109759|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109760|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109761|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109762|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56109763|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109764|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109765|NCT00005005|Alendronate|alendronate|mesh-list
56213976|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
55975194|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55975196|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55975197|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
55975198|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
55975199|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55975200|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975201|NCT00542087|Diclofenac|diclofenac|mesh-list
55975202|NCT00542087|Etoricoxib|etoricoxib|mesh-list
55975203|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55975204|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55975205|NCT00542087|Analgesics|analgesics|mesh-ancestor
55975206|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
55975207|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975208|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975209|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55975210|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975211|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55975212|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975213|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830054|NCT01502410|Sorafenib|sorafenib|mesh-list
55975217|NCT00541697|Ezetimibe|ezetimibe|mesh-list
55975218|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55975219|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55975220|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
56109775|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55975221|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975222|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55975223|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55975224|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975225|NCT03223376|Paclitaxel|paclitaxel|mesh-list
55975226|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55975228|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975229|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
55975230|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
55975231|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
55975232|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975233|NCT00395603|Atorvastatin|atorvastatin|mesh-list
55975234|NCT00395603|Simvastatin|simvastatin|mesh-list
55975235|NCT00395603|Ezetimibe|ezetimibe|mesh-list
55975236|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55975237|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55975238|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
55975239|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975240|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55975241|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55975242|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975252|NCT00659633|Lidocaine|lidocaine|mesh-list
55975253|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
55975254|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
55975255|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55975256|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975257|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
55975258|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975259|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55975260|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55975261|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55975262|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55975263|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975264|NCT00328523|Ezetimibe|ezetimibe|mesh-list
55975265|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55790494|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
55975266|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55975267|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
55975268|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975269|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55975270|NCT00701675|Sertraline|sertraline|mesh-list
55975271|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
55975272|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55975273|NCT00701675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55975274|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55975275|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55975276|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109870|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56109871|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56109872|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56109873|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56109874|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109875|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
56109876|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56109877|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109878|NCT00005059|Paclitaxel|paclitaxel|mesh-list
55836848|NCT01955707|Natalizumab|natalizumab|mesh-list
56109879|NCT00005059|Carboplatin|carboplatin|mesh-list
55975277|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975278|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
55975279|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975280|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
55975281|NCT03204188|Fludarabine|fludarabine|mesh-list
55975282|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55975283|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975284|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
55975285|NCT04445714|Saxagliptin|saxagliptin|mesh-list
55975286|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55975287|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975288|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55975289|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975290|NCT04445714|Incretins|incretins|mesh-ancestor
55975291|NCT04445714|Hormones|hormones|mesh-ancestor
55975292|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55975293|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55975294|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
56109886|NCT00005065|Paclitaxel|paclitaxel|mesh-list
55975295|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975296|NCT04639310|Ezogabine|ezogabine|mesh-list
55975297|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
55975298|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55975314|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55975315|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975316|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975317|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975318|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975319|NCT00250445|Diclofenac|diclofenac|mesh-list
55975320|NCT00250445|Etoricoxib|etoricoxib|mesh-list
55975321|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55975322|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55975323|NCT00250445|Analgesics|analgesics|mesh-ancestor
55975324|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
55975325|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975326|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975327|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55975328|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975329|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55975330|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975331|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975332|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55975334|NCT00242489|Etoricoxib|etoricoxib|mesh-list
55975335|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55975336|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55975337|NCT00242489|Analgesics|analgesics|mesh-ancestor
55975338|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
55975339|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975340|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975341|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55975342|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975343|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55975344|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109948|NCT00004489|Vitamins|vitamins|mesh-ancestor
56109949|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
56109950|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56109951|NCT00004489|Antacids|antacids|mesh-ancestor
56109952|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836931|NCT01970462|Incretins|incretins|mesh-ancestor
56109953|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109954|NCT00005593|Carboplatin|carboplatin|mesh-list
56109955|NCT00005593|Fludarabine|fludarabine|mesh-list
55975345|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975346|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55975347|NCT00659945|Ondansetron|ondansetron|mesh-list
55975348|NCT00659945|Aprepitant|aprepitant|mesh-list
55975349|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
55975350|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
56213977|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213978|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56213979|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55975351|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975352|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975353|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975354|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
55975355|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
55975356|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55975357|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
55975367|NCT04387565|Trace Elements|trace elements|mesh-ancestor
55975368|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
55975369|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975370|NCT02141555|Misoprostol|misoprostol|mesh-list
55975371|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55975372|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
55975373|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55975374|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975375|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55975376|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975377|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
55975378|NCT02600117|Tenofovir|tenofovir|mesh-list
55975379|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
55975380|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975381|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55975382|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55975383|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975384|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975385|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55975386|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55975387|NCT01799057|Metformin|metformin|mesh-list
55975388|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55975389|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975390|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55975391|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
55975392|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975393|NCT00588965|Propranolol|propranolol|mesh-list
55975394|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55975395|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55975396|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
55975397|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975398|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975399|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975400|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55975401|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55975402|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
55975403|NCT00702299|Paclitaxel|paclitaxel|mesh-list
55975404|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55975405|NCT00702299|Cisplatin|cisplatin|mesh-list
55975406|NCT00702299|Pemetrexed|pemetrexed|mesh-list
55975407|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56110063|NCT00005119|Calcium|calcium|mesh-list
55975408|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975409|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
55975410|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
55975411|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
55975412|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975413|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975414|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55975415|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55975416|NCT00661583|Ranibizumab|ranibizumab|mesh-list
55975417|NCT00661583|Mitomycins|mitomycins|mesh-list
55975418|NCT00661583|Mitomycin|mitomycin|mesh-list
55975419|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55975420|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55975421|NCT00661583|Growth Substances|growth substances|mesh-ancestor
55975422|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975423|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
55975434|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55975436|NCT00661895|Lisinopril|lisinopril|mesh-list
55975437|NCT00661895|Doxazosin|doxazosin|mesh-list
55975438|NCT00661895|Hydralazine|hydralazine|mesh-list
55975439|NCT00661895|Nifedipine|nifedipine|mesh-list
55975440|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55975441|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56213981|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55975442|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55975443|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975444|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55975445|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975446|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
55975447|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55975448|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55975449|NCT00661895|Diuretics|diuretics|mesh-ancestor
55975450|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
56110178|NCT00004705|Amiloride|amiloride|mesh-list
55975451|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55975452|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55975453|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
55975454|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
55975455|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975456|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55975457|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55975458|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55975459|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
55975460|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975461|NCT00661895|Analgesics|analgesics|mesh-ancestor
55975462|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
55975463|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55975464|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55975465|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55975466|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
55975467|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55975468|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55975469|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
55975470|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975471|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55975472|NCT00661895|Protective Agents|protective agents|mesh-ancestor
55975473|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55975474|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55975475|NCT02312258|Ixazomib|ixazomib|mesh-list
55975488|NCT02996825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975521|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
55975522|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55975523|NCT00591305|Protective Agents|protective agents|mesh-ancestor
55975524|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110223|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110224|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56110225|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110226|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56110227|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
56110228|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56110229|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
55975525|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975526|NCT01799603|Simeprevir|simeprevir|mesh-list
55975527|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
55975528|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975529|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
55975530|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975531|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975532|NCT03816176|Isavuconazole|isavuconazole|mesh-list
56213982|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
55975533|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
55975534|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975535|NCT00666029|Atorvastatin|atorvastatin|mesh-list
55975536|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55975537|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55975538|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
55975539|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975540|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55975541|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55975542|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975543|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
55975551|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975553|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975554|NCT03221426|Leucovorin|leucovorin|mesh-list
55975555|NCT03221426|Docetaxel|docetaxel|mesh-list
55975556|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
55975557|NCT03221426|Fluorouracil|fluorouracil|mesh-list
55975558|NCT03221426|Capecitabine|capecitabine|mesh-list
55975559|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
55975560|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975561|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
55975562|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
55975563|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
55975564|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975565|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55975566|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
55975567|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55975568|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975569|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
55804467|NCT05506501|Anesthetics|anesthetics|mesh-list
55975570|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975571|NCT03221426|Antidotes|antidotes|mesh-ancestor
55975572|NCT03221426|Protective Agents|protective agents|mesh-ancestor
55975573|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
55975574|NCT03221426|Vitamins|vitamins|mesh-ancestor
55975575|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
55975576|NCT01989195|Manganese|manganese|mesh-list
55975577|NCT01989195|Trace Elements|trace elements|mesh-ancestor
55975578|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
55975579|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975580|NCT00592943|Modafinil|modafinil|mesh-list
55975581|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55975582|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975583|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55975584|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55975585|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55975586|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975587|NCT01973205|Aspirin|aspirin|mesh-list
55975588|NCT01973205|Acetaminophen|acetaminophen|mesh-list
55975589|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55975590|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55975591|NCT01973205|Analgesics|analgesics|mesh-ancestor
55975592|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
55975593|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110341|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
56110343|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975594|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975595|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55975596|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975597|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55975598|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55975599|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975600|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55975601|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55975602|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975603|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
55975604|NCT01990677|Eplerenone|eplerenone|mesh-list
55975605|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55975606|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
55975607|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55975608|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975609|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55975610|NCT01990677|Diuretics|diuretics|mesh-ancestor
55975621|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975622|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213983|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975623|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
56110436|NCT02125734|Bromides|bromides|mesh-list
55975624|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975625|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975626|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
55975627|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975628|NCT03194126|Misoprostol|misoprostol|mesh-list
55975629|NCT03194126|Mifepristone|mifepristone|mesh-list
55975630|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55975631|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
55975632|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55975633|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110538|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110539|NCT02098746|Pioglitazone|pioglitazone|mesh-list
55755536|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
56110540|NCT02098746|Glimepiride|glimepiride|mesh-list
56110541|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56110542|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110543|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56110544|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110545|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
56110546|NCT02122770|Itraconazole|itraconazole|mesh-list
56110547|NCT02122770|Fluconazole|fluconazole|mesh-list
56110548|NCT02122770|Paclitaxel|paclitaxel|mesh-list
55975634|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55975635|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975636|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
55975637|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55975638|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55975639|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55975640|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55975641|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
55975642|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55975643|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55975644|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
55975645|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55975646|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
55975647|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55975648|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55975649|NCT02999087|Cetuximab|cetuximab|mesh-list
55975650|NCT02999087|Avelumab|avelumab|mesh-list
55975651|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975652|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55975653|NCT03219086|Bupivacaine|bupivacaine|mesh-list
55975654|NCT03219086|Prilocaine|prilocaine|mesh-list
55975655|NCT03219086|Anesthetics|anesthetics|mesh-list
55975656|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
55975657|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55975658|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975659|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
55975660|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975661|NCT02998385|Cisplatin|cisplatin|mesh-list
55975662|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975663|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
55975664|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55975665|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
55975666|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975667|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975668|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55975669|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
55975670|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55975671|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
55975672|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975673|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975674|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55975675|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
55975676|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
55975677|NCT04398290|Protective Agents|protective agents|mesh-ancestor
55975698|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
55975699|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55975700|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975701|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
55975702|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55975703|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
55975704|NCT02661035|Protective Agents|protective agents|mesh-ancestor
55975705|NCT04397510|Heparin|heparin|mesh-list
55975706|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
55975707|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55975708|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55975709|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975710|NCT00704717|Ribavirin|ribavirin|mesh-list
55975711|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55975712|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
55975713|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
55975714|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975715|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
55975716|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56213984|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975717|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
55975718|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975719|NCT03708224|Atezolizumab|atezolizumab|mesh-list
55975720|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975721|NCT03632642|Floxacillin|floxacillin|mesh-list
55975722|NCT03632642|Penicillin G|penicillin g|mesh-list
55975723|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
55975724|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
55975725|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55975726|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975727|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55975728|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55975729|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55975730|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
55975731|NCT04317404|Triamcinolone|triamcinolone|mesh-list
55975732|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55975733|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55975738|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55975739|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975740|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975741|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
55975742|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975743|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975744|NCT04399070|Ketamine|ketamine|mesh-list
55975745|NCT04399070|Esketamine|esketamine|mesh-list
55975746|NCT04399070|Analgesics|analgesics|mesh-ancestor
55975747|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
55975748|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975749|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975750|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55975751|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55975752|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
55975754|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55975755|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55975756|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55975757|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975758|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975759|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
55975760|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55975761|NCT03650114|Ofatumumab|ofatumumab|mesh-list
55975762|NCT03650114|Vaccines|vaccines|mesh-list
55975763|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55975764|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
55975765|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
55975766|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975767|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975768|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55975770|NCT00667589|Tazarotene|tazarotene|mesh-list
55975771|NCT00667589|Emollients|emollients|mesh-list
55975772|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
55975773|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
55975774|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110757|NCT02116530|Doxorubicin|doxorubicin|mesh-list
55975775|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
55975776|NCT00667589|Hormones|hormones|mesh-ancestor
55975777|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55975778|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975779|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55975780|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
55975781|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
55975782|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55975783|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975784|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975785|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
55975786|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55975787|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56110856|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975788|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975789|NCT03173612|Cytarabine|cytarabine|mesh-list
55975790|NCT03173612|Etoposide|etoposide|mesh-list
55975791|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
55975792|NCT03173612|Idarubicin|idarubicin|mesh-list
55975793|NCT03173612|Dasatinib|dasatinib|mesh-list
55975794|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
55975795|NCT03173612|Lenograstim|lenograstim|mesh-list
56213985|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56213986|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
55975796|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55975797|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975798|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55975799|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55975800|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975801|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975802|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55975803|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
55975804|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
55975805|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975807|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
55975808|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975809|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55975811|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
55975812|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975813|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55975814|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55975815|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
55975816|NCT03643796|Ketamine|ketamine|mesh-list
55975817|NCT03643796|Remifentanil|remifentanil|mesh-list
55975818|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55975819|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55975820|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975821|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55975822|NCT03643796|Analgesics|analgesics|mesh-ancestor
55975823|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
55975824|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975825|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55975826|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55975827|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55975828|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
55975829|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975830|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975831|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55975832|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55975833|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
55975835|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55975836|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55975837|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55975838|NCT03643796|Narcotics|narcotics|mesh-ancestor
55975839|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55975840|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55975841|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
55975842|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975843|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975844|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55975845|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
55975846|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55975847|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55975848|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55975849|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
55975850|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975851|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975852|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
55975853|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55975854|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111083|NCT04182984|Bromides|bromides|mesh-list
56111084|NCT04182984|Tacrolimus|tacrolimus|mesh-list
56111085|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56111086|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56111087|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111088|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
55975855|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55975856|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55975857|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975858|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975859|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975860|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55975861|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55975862|NCT00705107|Ribavirin|ribavirin|mesh-list
55975863|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55975864|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
55975865|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
56213987|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56213988|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
56111128|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56111129|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56111130|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111131|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56111132|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111133|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
56111134|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
56111135|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111136|NCT02062632|Doxepin|doxepin|mesh-list
56111137|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56111138|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56111139|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56111140|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111141|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56111142|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
56111143|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56111144|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
56111145|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
56111146|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111147|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111148|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
56111149|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
56213989|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975866|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975867|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
55975868|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975869|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
55975870|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975871|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55975872|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55975873|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55975874|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
55975875|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975876|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55975877|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55975879|NCT00240097|Carboplatin|carboplatin|mesh-list
55975880|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
55975881|NCT00240097|Irinotecan|irinotecan|mesh-list
55975882|NCT00240097|Etoposide|etoposide|mesh-list
55975883|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975884|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55975885|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55975886|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975887|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975888|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55975889|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55975890|NCT04270487|Octylonium|octylonium|mesh-list
55975891|NCT04270487|Bromides|bromides|mesh-list
55975892|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
55975893|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55975894|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55975895|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975896|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55975897|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111236|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975898|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975899|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
55975900|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
55975901|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975902|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55975903|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55975904|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
55975905|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975907|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55975908|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55975909|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
55975910|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975911|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56111444|NCT02011386|Golimumab|golimumab|mesh-list
55975912|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55975913|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975914|NCT02997995|Durvalumab|durvalumab|mesh-list
55975915|NCT02997995|Tremelimumab|tremelimumab|mesh-list
55975916|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55975917|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975918|NCT03620162|Vaccines|vaccines|mesh-list
55975919|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
55975920|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975921|NCT00248287|Carboplatin|carboplatin|mesh-list
55975922|NCT00248287|Irinotecan|irinotecan|mesh-list
55975923|NCT00248287|Cetuximab|cetuximab|mesh-list
55975924|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975925|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55975926|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55975927|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975928|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975929|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55975930|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
55975931|NCT00742573|Bupropion|bupropion|mesh-list
55975932|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55975933|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55975934|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56213990|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213991|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56213992|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
55975935|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975936|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975937|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975938|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55975939|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
55975940|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55975941|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55975942|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55975943|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975944|NCT03809923|Lidocaine|lidocaine|mesh-list
55975945|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
55975946|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
55975947|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
55975948|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55975949|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975950|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
55975951|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975953|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55975954|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55975955|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55975956|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975957|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55975958|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55975959|NCT03809923|Analgesics|analgesics|mesh-ancestor
55975960|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55975961|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55975962|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55975963|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
55975964|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975965|NCT01210625|Psyllium|psyllium|mesh-list
55975966|NCT01210625|Cathartics|cathartics|mesh-ancestor
55975967|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975968|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
55975969|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55975970|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975971|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
55975972|NCT00602225|Cytarabine|cytarabine|mesh-list
55975973|NCT00602225|Clofarabine|clofarabine|mesh-list
55975974|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55975975|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
55975976|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975977|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975978|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
55975979|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975980|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975981|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
55975982|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975983|NCT00602771|Etoposide|etoposide|mesh-list
55975984|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
55975985|NCT00602771|Tipifarnib|tipifarnib|mesh-list
55975986|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55975987|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975988|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55975989|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56111799|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
56111800|NCT01965834|Fenofibrate|fenofibrate|mesh-list
56111801|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
56111802|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56111803|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
56111804|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111805|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56111806|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56111807|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56111808|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111809|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56111810|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111811|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111812|NCT01987596|Lenograstim|lenograstim|mesh-list
55975990|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975991|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975992|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
55975993|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55975994|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975995|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55975996|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975997|NCT04248998|Metformin|metformin|mesh-list
55975998|NCT04248998|Paclitaxel|paclitaxel|mesh-list
55975999|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
55976000|NCT04248998|Doxorubicin|doxorubicin|mesh-list
55976001|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55976002|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56213993|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
56213994|NCT01607983|Protective Agents|protective agents|mesh-ancestor
56213995|NCT01608217|Acetaminophen|acetaminophen|mesh-list
56213996|NCT01608217|Dronabinol|dronabinol|mesh-list
55976003|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
55976004|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
55976005|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
55976006|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976007|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976008|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
55976009|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976010|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976011|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55976012|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
55976013|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55976014|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55976015|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55976016|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55976017|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55976018|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976019|NCT00714233|Metformin|metformin|mesh-list
55976020|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
55976021|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
55976022|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
55976023|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55976024|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55976025|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976030|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55976031|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976032|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
55976033|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
55976034|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55976035|NCT04205786|Vitamins|vitamins|mesh-ancestor
55976036|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
55976037|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976038|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
55976039|NCT04205786|Hematinics|hematinics|mesh-ancestor
55976040|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55976041|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976042|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111831|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111832|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56111833|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
56111834|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
56111835|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56111836|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
55976043|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55976044|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
55976045|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976046|NCT00719966|Letrozole|letrozole|mesh-list
55976048|NCT00719966|Exemestane|exemestane|mesh-list
55976049|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976050|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55976051|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55976052|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976053|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976054|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55976055|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
55976056|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976057|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976058|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55976059|NCT01276067|Donepezil|donepezil|mesh-list
55976060|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55976061|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976062|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976063|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
55976064|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976065|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976066|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
55976067|NCT00378482|Tremelimumab|tremelimumab|mesh-list
55976068|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976069|NCT02428205|Propranolol|propranolol|mesh-list
56111838|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111839|NCT01946412|Ivacaftor|ivacaftor|mesh-list
56111840|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56111841|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56111842|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111843|NCT01945866|Dexamethasone|dexamethasone|mesh-list
56111844|NCT01945866|Ranibizumab|ranibizumab|mesh-list
56111845|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111846|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
55976070|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55976071|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55976072|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
55976073|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56213997|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55976074|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976075|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976076|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55976077|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55976078|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
55976079|NCT04183868|Empagliflozin|empagliflozin|mesh-list
55976080|NCT04183868|Glimepiride|glimepiride|mesh-list
55976081|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55976082|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976083|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55976084|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976085|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55976086|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976087|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
55976088|NCT02997215|Lidocaine|lidocaine|mesh-list
55976089|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
55976090|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
55976091|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976092|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976093|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
55976094|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976095|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56111847|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
56111848|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111849|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111850|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56111851|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
56111852|NCT01945866|Hormones|hormones|mesh-ancestor
56111853|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111854|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56111855|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111856|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56111857|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56111858|NCT01945866|Growth Substances|growth substances|mesh-ancestor
56111878|NCT01945242|Alogliptin|alogliptin|mesh-list
56111905|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111906|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
56111907|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
56111908|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
56111909|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111910|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
56111912|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
55976099|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976100|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
55976101|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55976102|NCT02990507|Testosterone|testosterone|mesh-list
55976103|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
55976104|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
55976105|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55976106|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976107|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
55976108|NCT02990507|Hormones|hormones|mesh-ancestor
55976109|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976110|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976111|NCT02990507|Androgens|androgens|mesh-ancestor
55976112|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
55976113|NCT03331484|Ticagrelor|ticagrelor|mesh-list
55976114|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55976115|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55976116|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55976117|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55976118|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
55976119|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976120|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976124|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55976125|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
55976126|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976127|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
55976129|NCT00721513|Fluorouracil|fluorouracil|mesh-list
55976130|NCT00721513|Cetuximab|cetuximab|mesh-list
55976131|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976132|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
55976133|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
55976134|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
55976135|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976136|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
55976137|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55976138|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976139|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
55976140|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976141|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976142|NCT00706121|Vitamins|vitamins|mesh-list
55976143|NCT00706121|Vitamin E|vitamin e|mesh-list
55976144|NCT00706121|Tocopherols|tocopherols|mesh-list
55976145|NCT00706121|Tocotrienols|tocotrienols|mesh-list
55976146|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
55976148|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
55976149|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976150|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
55976151|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976152|NCT00706121|Protective Agents|protective agents|mesh-ancestor
55976153|NCT00706121|Trace Elements|trace elements|mesh-ancestor
55976154|NCT00746863|Bupivacaine|bupivacaine|mesh-list
55976155|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
55976156|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
55976157|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976158|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976159|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
55976160|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976161|NCT04115384|Insulin|insulin|mesh-list
55976162|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55976163|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55976164|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976165|NCT04385563|Docetaxel|docetaxel|mesh-list
55976166|NCT04385563|Trastuzumab|trastuzumab|mesh-list
55976167|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976168|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
55976177|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976178|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
55976179|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
55976180|NCT00726713|Vitamins|vitamins|mesh-ancestor
55976181|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
55976182|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976183|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
55976184|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55976185|NCT00759187|Triclosan|triclosan|mesh-list
55976186|NCT00759187|Fluorides|fluorides|mesh-list
55976187|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
55976188|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
55976189|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
55976190|NCT00759187|Protective Agents|protective agents|mesh-ancestor
55976191|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976192|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55976193|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976194|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
55976195|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
55976196|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55976197|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55976198|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
55976199|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976200|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55976201|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
55976202|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
55976203|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55976204|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55976205|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976206|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976207|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976208|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976209|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
55976210|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55976211|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
55976212|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976213|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976214|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55976215|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
55976216|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55976217|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
55976218|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976219|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976220|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55976221|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
55976222|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
56112072|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
56112073|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56112102|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112103|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56112104|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56112105|NCT01960140|Simvastatin|simvastatin|mesh-list
56112106|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56112107|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56112108|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
56112109|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976223|NCT00515281|Protective Agents|protective agents|mesh-ancestor
55976224|NCT01279915|Linaclotide|linaclotide|mesh-list
55976225|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55976226|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
55976227|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976228|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55976230|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55976231|NCT03809455|Narcotics|narcotics|mesh-ancestor
55976232|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976233|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976234|NCT03809455|Analgesics|analgesics|mesh-ancestor
55976235|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
55976236|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976251|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55976252|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976253|NCT02997059|Fluconazole|fluconazole|mesh-list
55976254|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
55976255|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976256|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55976257|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56112110|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56112111|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56112112|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112113|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
56112114|NCT01959672|Leucovorin|leucovorin|mesh-list
56112115|NCT01959672|Folic Acid|folic acid|mesh-list
56112116|NCT01959672|Gemcitabine|gemcitabine|mesh-list
56112117|NCT01959672|Nelfinavir|nelfinavir|mesh-list
56112118|NCT01959672|Fluorouracil|fluorouracil|mesh-list
56112119|NCT01959672|Oregovomab|oregovomab|mesh-list
56112120|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56112121|NCT01959672|Antibodies|antibodies|mesh-list
56112122|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
56112123|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56112124|NCT01959672|Calcium|calcium|mesh-list
56112125|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
56112126|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
56112127|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112128|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56112129|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
56112130|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112131|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112132|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
56112133|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112134|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112135|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976258|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976259|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976260|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55976261|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
55976262|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976263|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976264|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55976265|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55976266|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
55976267|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
55976268|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976269|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976270|NCT00759811|Methotrexate|methotrexate|mesh-list
55976271|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55976272|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
55976273|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55976274|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976275|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55976276|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
55976277|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976278|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976279|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
55976280|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976281|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55976282|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976283|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
55976284|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976285|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55976286|NCT03085628|Oxytocin|oxytocin|mesh-list
55976287|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
55976288|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55976289|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976290|NCT01276613|Gemcitabine|gemcitabine|mesh-list
55976291|NCT01276613|Losartan|losartan|mesh-list
55976292|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55976293|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
55976294|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976295|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976296|NCT01276613|Antiviral Agents|antiviral agents|mesh-ancestor
55976300|NCT01276613|Immunologic Factors|immunologic factors|mesh-ancestor
55976301|NCT01276613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976302|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55976303|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55976304|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55976305|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55976307|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55976308|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55976309|NCT01276691|Analgesics|analgesics|mesh-ancestor
56112262|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112263|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112264|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56112265|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56112269|NCT01932762|Ribavirin|ribavirin|mesh-list
55976310|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
55976311|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976312|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976313|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976314|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976315|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55976316|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56213999|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
56214000|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976317|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976318|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55976319|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55976320|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976321|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
55976322|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
55976323|NCT03081416|Dexamethasone|dexamethasone|mesh-list
56112383|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
56112384|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56112385|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112386|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
56112387|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112388|NCT03896633|Brinzolamide|brinzolamide|mesh-list
56112389|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56112390|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112391|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112392|NCT03888755|Icatibant|icatibant|mesh-list
56112393|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56112394|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56112395|NCT03888755|Analgesics|analgesics|mesh-ancestor
56112396|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
56112397|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112398|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112399|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112400|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112401|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56112402|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56112403|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112404|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56112405|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56112406|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
56112407|NCT00378755|Bortezomib|bortezomib|mesh-list
56112409|NCT00378833|Niacin|niacin|mesh-list
55976324|NCT03081416|Ketorolac|ketorolac|mesh-list
55976325|NCT03081416|Ketamine|ketamine|mesh-list
55976326|NCT03081416|Metoclopramide|metoclopramide|mesh-list
55976327|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976328|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
55976329|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
55976330|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976331|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976332|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55976333|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
55976334|NCT03081416|Hormones|hormones|mesh-ancestor
55976335|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976336|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55976337|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976338|NCT03081416|Analgesics|analgesics|mesh-ancestor
55976339|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
55976340|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55976341|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55976342|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
55976343|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
55976344|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976345|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55976346|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55976347|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976348|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976349|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55976350|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55976351|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976352|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55976353|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976354|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55976355|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55976356|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
55976357|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56112414|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112415|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56112416|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
56112417|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
56112418|NCT00378833|Vitamins|vitamins|mesh-ancestor
56112419|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
56112420|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112421|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
56112422|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56112423|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56112424|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56112425|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56112426|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112427|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
56112428|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112429|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112430|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56112435|NCT00377975|Ephedrine|ephedrine|mesh-list
55976358|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55976359|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
55976360|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55976361|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
55976362|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
55976363|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55976364|NCT00706589|Aripiprazole|aripiprazole|mesh-list
55976365|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
55976366|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55976367|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55976368|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55976387|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976388|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
55976389|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
55976390|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
55976391|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976392|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55976393|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55976394|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55976395|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976397|NCT01279681|Bevacizumab|bevacizumab|mesh-list
55976398|NCT01279681|Fluorouracil|fluorouracil|mesh-list
55976399|NCT01279681|Capecitabine|capecitabine|mesh-list
55976400|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
55976401|NCT01279681|Calcium|calcium|mesh-list
55976402|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
55976403|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976404|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976405|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55976406|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56112471|NCT02936999|Vitamin D|vitamin d|mesh-list
56214001|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214002|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
56214003|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
56214004|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56214005|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56214006|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56214007|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214008|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214009|NCT01608217|Hormones|hormones|mesh-ancestor
56000867|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976407|NCT01279681|Growth Substances|growth substances|mesh-ancestor
55976408|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976409|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
55976410|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55976411|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
55976412|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976413|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55976414|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976415|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
55976416|NCT01279681|Antidotes|antidotes|mesh-ancestor
55976417|NCT01279681|Protective Agents|protective agents|mesh-ancestor
55976418|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
55976419|NCT01279681|Vitamins|vitamins|mesh-ancestor
55976420|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
55976421|NCT01276925|Bupivacaine|bupivacaine|mesh-list
55976422|NCT01276925|Ropivacaine|ropivacaine|mesh-list
55976423|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
55976424|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
55976427|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
55976428|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976429|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
55976430|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55976431|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976432|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55976433|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976434|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
55976435|NCT00728507|Rifampin|rifampin|mesh-list
55976436|NCT00728507|Isoniazid|isoniazid|mesh-list
56112577|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55976437|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
55976438|NCT00728507|Ethambutol|ethambutol|mesh-list
55976439|NCT00728507|Rifapentine|rifapentine|mesh-list
55976440|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55976441|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976442|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55976443|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55976445|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976447|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55976448|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
55976449|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
55976450|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55976451|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55976452|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55976453|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55976454|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55976455|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55976456|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55976457|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55976458|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55976459|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
55976460|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55976461|NCT01279057|Fluticasone|fluticasone|mesh-list
55976462|NCT01279057|Xhance|xhance|mesh-list
56112638|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112639|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56112640|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56112641|NCT03860753|Pioglitazone|pioglitazone|mesh-list
56112642|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56112643|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112644|NCT02687165|Cycloserine|cycloserine|mesh-list
56112670|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56112671|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56112673|NCT02654639|Bevacizumab|bevacizumab|mesh-list
56112713|NCT00378911|Sunitinib|sunitinib|mesh-list
56112714|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112715|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56112716|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56112717|NCT00378911|Growth Substances|growth substances|mesh-ancestor
56112718|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112719|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
56112720|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56112721|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214010|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214011|NCT01608594|Ipilimumab|ipilimumab|mesh-list
56214012|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976463|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976464|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55976465|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
55976466|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976467|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976468|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55976469|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
55976470|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
55976471|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55976472|NCT03187106|Metronidazole|metronidazole|mesh-list
55976473|NCT03187106|Cephalexin|cephalexin|mesh-list
55976474|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976475|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55976476|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55976477|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55976478|NCT04384783|Hormones|hormones|mesh-list
55976479|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976480|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976481|NCT03186326|Bevacizumab|bevacizumab|mesh-list
55976482|NCT03186326|Cetuximab|cetuximab|mesh-list
55976483|NCT03186326|Avelumab|avelumab|mesh-list
55976484|NCT03186326|Panitumumab|panitumumab|mesh-list
55976485|NCT03186326|Aflibercept|aflibercept|mesh-list
55976486|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976487|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976488|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55976489|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56112727|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55976491|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976492|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
55976493|NCT02999633|Acetaminophen|acetaminophen|mesh-list
55976494|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
55976495|NCT02999633|Promethazine|promethazine|mesh-list
55976496|NCT02999633|Dexamethasone|dexamethasone|mesh-list
55976497|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
55976498|NCT02999633|Ranitidine|ranitidine|mesh-list
55976499|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
55976500|NCT02999633|BB 1101|bb 1101|mesh-list
55976501|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976502|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
55976503|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
55976504|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976505|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976506|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55976507|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
55976508|NCT02999633|Hormones|hormones|mesh-ancestor
55976509|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976510|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55976511|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976512|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
55976513|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976514|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976515|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55976516|NCT02999633|Analgesics|analgesics|mesh-ancestor
55976517|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
55976518|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
55976519|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55976520|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55976521|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976522|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
55976523|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
55976524|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55976525|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
55976526|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
55976527|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112870|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
56112871|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55976528|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55976529|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
55976530|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
55976531|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55976532|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56214013|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214014|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56214015|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214016|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55976533|NCT04749797|Bupivacaine|bupivacaine|mesh-list
55976534|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
55976535|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
55976536|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976537|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976538|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
55976539|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976540|NCT03036098|Gemcitabine|gemcitabine|mesh-list
55976541|NCT03036098|Carboplatin|carboplatin|mesh-list
55976542|NCT03036098|Nivolumab|nivolumab|mesh-list
55976543|NCT03036098|Ipilimumab|ipilimumab|mesh-list
55976544|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976545|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55976546|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
55976547|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976548|NCT03036098|Antiviral Agents|antiviral agents|mesh-ancestor
56112909|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56112910|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56112911|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56112912|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
56112913|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112914|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56112915|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56112916|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112917|NCT00957827|Cephalexin|cephalexin|mesh-list
56112918|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56112919|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112920|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
56112921|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
56112922|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112923|NCT00962429|Protective Agents|protective agents|mesh-ancestor
56112924|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112925|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
56112926|NCT00962429|Vitamins|vitamins|mesh-ancestor
55976549|NCT03036098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976550|NCT03036098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976551|NCT03036098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976552|NCT03036098|Immunologic Factors|immunologic factors|mesh-ancestor
55976553|NCT03036098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976554|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976555|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55976556|NCT02991599|Vaccines|vaccines|mesh-list
55976557|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
55976558|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976559|NCT02996513|Vitamin A|vitamin a|mesh-list
55976560|NCT02996513|Vitamins|vitamins|mesh-ancestor
55976561|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
55976562|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976563|NCT04276688|Interferons|interferons|mesh-list
55976564|NCT04276688|Ritonavir|ritonavir|mesh-list
55976565|NCT04276688|Ribavirin|ribavirin|mesh-list
55976566|NCT04276688|Lopinavir|lopinavir|mesh-list
55976567|NCT04276688|Interferon-beta|interferon-beta|mesh-list
55976568|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
55976569|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976571|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976572|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55976573|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55976574|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
55976575|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976576|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976577|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55976578|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55976579|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55976580|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55976581|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
55976582|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
55976583|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976584|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55976585|NCT01277627|Efavirenz|efavirenz|mesh-list
55976586|NCT01277627|Nevirapine|nevirapine|mesh-list
55976587|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
55976588|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
55976589|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55976590|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55976592|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976593|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
55976594|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976595|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55976596|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55976597|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55976598|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55976599|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55976600|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56214017|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214019|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
56214020|NCT01608958|Oxytocin|oxytocin|mesh-list
56214021|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
56214022|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214023|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214024|NCT01609153|Olanzapine|olanzapine|mesh-list
56214025|NCT01609153|Amisulpride|amisulpride|mesh-list
56214026|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
56214027|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
56214028|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214029|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214030|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214031|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56214032|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56214033|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976601|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55976602|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55976603|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55976604|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55976605|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55976606|NCT01270451|Insulin|insulin|mesh-list
55976607|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55976608|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976609|NCT00706979|Nicotine|nicotine|mesh-list
55976610|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55976611|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
55976612|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976613|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976614|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55976615|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55976616|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
55976617|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976618|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976619|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
55976620|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55976621|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976623|NCT00716963|Xhance|xhance|mesh-list
55976624|NCT00716963|Budesonide|budesonide|mesh-list
56112927|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
56112928|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56112929|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112930|NCT00920309|Sirolimus|sirolimus|mesh-list
56112931|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56112932|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112933|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56112934|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112935|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
56112936|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56112937|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
56112938|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112939|NCT02075411|Bupivacaine|bupivacaine|mesh-list
56112940|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
56112941|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
56112942|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56112943|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112944|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
56112945|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112946|NCT03753113|Minoxidil|minoxidil|mesh-list
56112947|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56112948|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
55976625|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976626|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55976627|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
55976628|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976629|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976630|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55976631|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
55976632|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
55976633|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55976634|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
55976635|NCT00716963|Hormones|hormones|mesh-ancestor
55976636|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976637|NCT01270997|Etanercept|etanercept|mesh-list
55976638|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55976639|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55976640|NCT01270997|Analgesics|analgesics|mesh-ancestor
55976641|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
55976642|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976643|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976645|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976646|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214034|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56214035|NCT01609153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55976647|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976648|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
55976651|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976652|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112949|NCT02075021|Paclitaxel|paclitaxel|mesh-list
56112950|NCT02075021|Lenalidomide|lenalidomide|mesh-list
56112951|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56112952|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112953|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
56112954|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
56112955|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
56112956|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112957|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
56112958|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112959|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56112960|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56112961|NCT02075021|Growth Substances|growth substances|mesh-ancestor
56112962|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
56112964|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56112965|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976653|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
55976654|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976655|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976656|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976657|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55976658|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976659|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976660|NCT02995655|Azacitidine|azacitidine|mesh-list
55976661|NCT02995655|Heparin|heparin|mesh-list
55976662|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55976663|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
55976664|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976665|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976666|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976667|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
55976668|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55976669|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55976670|NCT01271153|Dobutamine|dobutamine|mesh-list
55976671|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55976672|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
55976673|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
55976674|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976675|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976676|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55976677|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55976678|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55976679|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
55976680|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976681|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976682|NCT01271153|Protective Agents|protective agents|mesh-ancestor
55976683|NCT03809065|Labetalol|labetalol|mesh-list
55976684|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
55976685|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
55976686|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55976687|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55976688|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
55976689|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976690|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976691|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976692|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55976693|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
55976694|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
55976695|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976696|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55976697|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55976698|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
55976699|NCT03006926|Lenvatinib|lenvatinib|mesh-list
55976700|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976701|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976702|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56113007|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56113008|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113009|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56113010|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56113011|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56113012|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113013|NCT01978535|Iron|iron|mesh-list
56113014|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56113015|NCT01978535|Trace Elements|trace elements|mesh-ancestor
56113016|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
55976703|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976704|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976705|NCT02995187|Apatinib|apatinib|mesh-list
55976706|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976707|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55976708|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976709|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976710|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55976711|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55976712|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55976713|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55976714|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55976715|NCT01272089|Analgesics|analgesics|mesh-ancestor
55976716|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
55976727|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790547|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
55976728|NCT00748657|Bevacizumab|bevacizumab|mesh-list
55976729|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55976730|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
55976731|NCT00748657|Antibodies|antibodies|mesh-list
55976732|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
55976733|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55976734|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
55976735|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976736|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55976737|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55976738|NCT00748657|Growth Substances|growth substances|mesh-ancestor
55976739|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976740|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
55976741|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
55976742|NCT02994953|Avelumab|avelumab|mesh-list
55976743|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55976744|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976745|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976746|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
55976747|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976748|NCT01273051|Capecitabine|capecitabine|mesh-list
55976749|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55976750|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
55976751|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976752|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976753|NCT02890784|Dasatinib|dasatinib|mesh-list
55976754|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976755|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55976756|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976757|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976758|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
55976759|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55976760|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
55976761|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976762|NCT02994875|Expectorants|expectorants|mesh-ancestor
55976763|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
55976764|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55976765|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
55976766|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976767|NCT02994875|Protective Agents|protective agents|mesh-ancestor
55976768|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976769|NCT02994875|Antidotes|antidotes|mesh-ancestor
55976770|NCT03809143|Buprenorphine|buprenorphine|mesh-list
55976771|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55976772|NCT03809143|Narcotics|narcotics|mesh-ancestor
55976773|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976774|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976775|NCT03809143|Analgesics|analgesics|mesh-ancestor
55976776|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
55976777|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976778|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55976779|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
55976780|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
55976781|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55976782|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55976783|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976784|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976785|NCT02390960|Urological Agents|urological agents|mesh-ancestor
55976787|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
55976788|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55976789|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55976790|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976791|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55976792|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976793|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55976794|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55976795|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976796|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55976797|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55976798|NCT00637832|Prednisolone|prednisolone|mesh-list
55976799|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
55976800|NCT00637832|Rituximab|rituximab|mesh-list
55976801|NCT00637832|Doxorubicin|doxorubicin|mesh-list
55976802|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56214036|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56214037|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55790549|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
55976803|NCT00637832|Vincristine|vincristine|mesh-list
55976804|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976805|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
55976806|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976807|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976808|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55976809|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
55976810|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976811|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976812|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55976813|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976814|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55976815|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55976816|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55976817|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976818|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55976819|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
55976820|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
55976821|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
55976822|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976823|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
55976824|NCT00637832|Hormones|hormones|mesh-ancestor
55976825|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976826|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55976827|NCT00720629|Methotrexate|methotrexate|mesh-list
55976828|NCT00720629|Tacrolimus|tacrolimus|mesh-list
55976829|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
55976830|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55976831|NCT00720629|Visilizumab|visilizumab|mesh-list
55976832|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55976833|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
55976834|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55976835|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976836|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55976837|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
56113018|NCT01978535|Hematinics|hematinics|mesh-ancestor
56113019|NCT00808769|Omeprazole|omeprazole|mesh-list
56113020|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56113021|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55976838|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976839|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976840|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
55976841|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976842|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55976843|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976844|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
55976845|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976846|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55976847|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55976848|NCT01276327|Pioglitazone|pioglitazone|mesh-list
55976849|NCT01276327|Linagliptin|linagliptin|mesh-list
55976850|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55976851|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976852|NCT01276327|Incretins|incretins|mesh-ancestor
55976853|NCT01276327|Hormones|hormones|mesh-ancestor
55976854|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976855|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55976858|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976860|NCT05245760|Carboplatin|carboplatin|mesh-list
55976861|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55976862|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976863|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
55976864|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
55976865|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
56113022|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56113023|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56113024|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113025|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113026|NCT00379067|Tamsulosin|tamsulosin|mesh-list
55839993|NCT01738971|Progestins|progestins|mesh-list
56113027|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56113028|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56113029|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56113030|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
56113031|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113032|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113033|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113034|NCT00379067|Urological Agents|urological agents|mesh-ancestor
56113035|NCT00378287|Rabeprazole|rabeprazole|mesh-list
56113036|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56113037|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56113038|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56113039|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113040|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113042|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56113046|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
55976866|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976867|NCT02674958|Aspirin|aspirin|mesh-list
55976868|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55976869|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55976870|NCT02674958|Analgesics|analgesics|mesh-ancestor
55976871|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
55976872|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214038|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214039|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214040|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
55976873|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976874|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976875|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976876|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55976877|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55830202|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
55976879|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55976880|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55976881|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976883|NCT00760435|Infliximab|infliximab|mesh-list
55976884|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
55976885|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55976886|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976887|NCT03808129|Lidocaine|lidocaine|mesh-list
55976888|NCT03808129|Bupivacaine|bupivacaine|mesh-list
55976889|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
55976890|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
55976891|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976892|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976893|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
55976894|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976895|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55976896|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55976897|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55976898|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55976899|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976900|NCT00749125|Citalopram|citalopram|mesh-list
55976901|NCT00749125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55976902|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55976903|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55976904|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976905|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976906|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
56113050|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55976907|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976908|NCT00749125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55976909|NCT00749125|Antidepressive Agents|antidepressive agents|mesh-ancestor
55976910|NCT00749125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55976911|NCT02144675|Cytarabine|cytarabine|mesh-list
55976912|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
55976913|NCT02144675|Salicylates|salicylates|mesh-list
55976914|NCT02144675|Idarubicin|idarubicin|mesh-list
55976915|NCT02144675|Choline|choline|mesh-list
55976916|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55976917|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
55976918|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976919|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976920|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
55976921|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55976922|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976923|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
55976924|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976925|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55976926|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55976928|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976929|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
55976930|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55976931|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55976932|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55976934|NCT02144675|Analgesics|analgesics|mesh-ancestor
55976935|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
55976936|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976937|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55976938|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55976939|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976940|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976941|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56214041|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56214042|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
55976942|NCT00749515|Deferasirox|deferasirox|mesh-list
55976943|NCT00749515|Deferoxamine|deferoxamine|mesh-list
55976944|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55976945|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
55976946|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
55976947|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976948|NCT00749515|Siderophores|siderophores|mesh-ancestor
55976949|NCT01272557|Doxorubicin|doxorubicin|mesh-list
55976950|NCT01272557|Sorafenib|sorafenib|mesh-list
55976951|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55976952|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976953|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55976954|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55976955|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976956|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976957|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55976959|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976960|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
55976961|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
56113128|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55976962|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976963|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976964|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55976965|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
55976966|NCT00639002|Hormones|hormones|mesh-ancestor
55976967|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976968|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55976969|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976970|NCT00761137|Tropicamide|tropicamide|mesh-list
55976971|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
55976972|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
55976973|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976974|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976975|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55976976|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55976977|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
55976978|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976979|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976980|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55976981|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55976982|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976983|NCT01273493|Dexamethasone|dexamethasone|mesh-list
55976984|NCT01273493|Trabectedin|trabectedin|mesh-list
55976985|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976986|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
55976987|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
55976988|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976989|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976990|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55976991|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
55976992|NCT01273493|Hormones|hormones|mesh-ancestor
55976993|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55976994|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55976995|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976996|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55976997|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
55976998|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976999|NCT00638456|Budesonide|budesonide|mesh-list
55977002|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977003|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55977004|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
55977005|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977006|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977007|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55977008|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
55977009|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
55977010|NCT00638456|Hormones|hormones|mesh-ancestor
55977011|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977012|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55977013|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214043|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56214044|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
56214045|NCT01610141|Warfarin|warfarin|mesh-list
56214046|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
56214047|NCT01610310|Interferon-beta|interferon-beta|mesh-list
55977014|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55977015|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977016|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977017|NCT01273571|Metformin|metformin|mesh-list
55977018|NCT01273571|Canagliflozin|canagliflozin|mesh-list
55977019|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55977020|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977021|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55977023|NCT02147899|Secnidazole|secnidazole|mesh-list
55977024|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55977025|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55977026|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977027|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
55977028|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977029|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977030|NCT03132116|Gentamicins|gentamicins|mesh-list
55977031|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55977032|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977033|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55977034|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977035|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977036|NCT00762619|Triclosan|triclosan|mesh-list
55977037|NCT00762619|Fluorides|fluorides|mesh-list
56113282|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56113283|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
56113284|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113285|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56113286|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56113287|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
56113288|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113289|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113290|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56113291|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56113292|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56113293|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56113294|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113295|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56113296|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
56113297|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
56113298|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
55977038|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
55977039|NCT00762619|Protective Agents|protective agents|mesh-ancestor
55977040|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977041|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55977042|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977043|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55977044|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55977045|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
55977046|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977047|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55977048|NCT02520362|Denosumab|denosumab|mesh-list
55977049|NCT02520362|Diphosphonates|diphosphonates|mesh-list
55977050|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55977051|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977052|NCT00735449|Timolol|timolol|mesh-list
55977053|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55977054|NCT00735449|Latanoprost|latanoprost|mesh-list
55977055|NCT00735449|Maleic acid|maleic acid|mesh-list
55977056|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977057|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977058|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55977059|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55977060|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
55977061|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977062|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977063|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55977064|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55977065|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55977066|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55977067|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55977068|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55977069|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55977070|NCT01273831|Cisatracurium|cisatracurium|mesh-list
55977071|NCT01273831|Atracurium|atracurium|mesh-list
55977072|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55977085|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113300|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55977086|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977087|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977088|NCT00736073|Aprepitant|aprepitant|mesh-list
55977089|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
55977090|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
56214048|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214049|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
56214050|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214051|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
56214052|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214053|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
56214054|NCT01610362|Antibodies|antibodies|mesh-list
56214055|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
56214056|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56214057|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56214058|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
56214059|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
55790566|NCT03472573|Hormones|hormones|mesh-ancestor
55977091|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977092|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977093|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55977094|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55977095|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113406|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56113407|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56113408|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
56113409|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56113410|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56113411|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56113412|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56113413|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113414|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
56113415|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56113416|NCT00528437|Carboplatin|carboplatin|mesh-list
56113417|NCT00528437|Temozolomide|temozolomide|mesh-list
56113418|NCT00528437|Thiotepa|thiotepa|mesh-list
56113419|NCT00528437|Tretinoin|tretinoin|mesh-list
56113420|NCT00528437|Isotretinoin|isotretinoin|mesh-list
55977096|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977098|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55977099|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977100|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55977101|NCT00736229|Incretins|incretins|mesh-ancestor
55977102|NCT00736229|Hormones|hormones|mesh-ancestor
55977103|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977104|NCT00737243|Paclitaxel|paclitaxel|mesh-list
55977105|NCT00737243|Bevacizumab|bevacizumab|mesh-list
55977106|NCT00737243|Carboplatin|carboplatin|mesh-list
55977107|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55977108|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55977109|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977110|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
55977111|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
55977112|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
55977113|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977114|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977115|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55977116|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55977117|NCT00737243|Growth Substances|growth substances|mesh-ancestor
55977118|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977119|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
55977120|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56113487|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113488|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113489|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
56113490|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113491|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56113492|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56113493|NCT00379847|Conivaptan|conivaptan|mesh-list
56113494|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56113495|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113496|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
56113497|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113498|NCT00374543|Ziprasidone|ziprasidone|mesh-list
56113499|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56113500|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
56113501|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113502|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113503|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977121|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977122|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
55977123|NCT00707759|Prednisone|prednisone|mesh-list
55977124|NCT00707759|Prednisolone|prednisolone|mesh-list
55977125|NCT00707759|Tacrolimus|tacrolimus|mesh-list
55977126|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977127|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
55977128|NCT00707759|Hormones|hormones|mesh-ancestor
55977129|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977130|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977131|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55977132|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977133|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977135|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55977136|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977137|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977138|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55977139|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55977140|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
56214060|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214061|NCT01610401|Metformin|metformin|mesh-list
56214062|NCT01610401|Caffeine|caffeine|mesh-list
56214063|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55977141|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55977142|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977143|NCT01273727|Dexamethasone|dexamethasone|mesh-list
55977144|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
55977146|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977147|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
55977148|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
55977149|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977150|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977151|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55977152|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
55977153|NCT01273727|Hormones|hormones|mesh-ancestor
55977154|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56113519|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113520|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56113521|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56113522|NCT00299195|Sulindac|sulindac|mesh-list
56113523|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56113524|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56113525|NCT00299195|Analgesics|analgesics|mesh-ancestor
56113526|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
56113527|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113528|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113529|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56113530|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56113531|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113551|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56113552|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113559|NCT00281879|Melphalan|melphalan|mesh-list
55977155|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55977156|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977157|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
55977158|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977159|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977160|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55977161|NCT00708071|Thrombin|thrombin|mesh-list
55977162|NCT00708071|Aprotinin|aprotinin|mesh-list
55977163|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
55977164|NCT00708071|Coagulants|coagulants|mesh-ancestor
55977165|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55977166|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55977167|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
55977168|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830203|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
55977171|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55977172|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55977173|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
55977174|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977175|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55977176|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56113566|NCT00281879|Tacrolimus|tacrolimus|mesh-list
56113567|NCT00281879|Cyclosporins|cyclosporins|mesh-list
56113568|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56113569|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56113570|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
56113571|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113572|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56113573|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56113574|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
56113575|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113576|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113577|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56113578|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56113579|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
56113580|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56113581|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56113582|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
56113583|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
56113584|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113585|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56113586|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113587|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56113588|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56113589|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56113590|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
55977177|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977178|NCT02994173|Ketamine|ketamine|mesh-list
55977179|NCT02994173|Oxycodone|oxycodone|mesh-list
55977180|NCT02994173|Esketamine|esketamine|mesh-list
55977181|NCT02994173|Analgesics|analgesics|mesh-ancestor
55977182|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
55977183|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977184|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977185|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55977186|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55977187|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
55977188|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
55977189|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55977190|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55977191|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55977192|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977193|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977194|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55977195|NCT02994173|Narcotics|narcotics|mesh-ancestor
55977196|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
55977197|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55977198|NCT00723749|Buprenorphine|buprenorphine|mesh-list
55977199|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55977200|NCT00723749|Naloxone|naloxone|mesh-list
55977201|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55977202|NCT00723749|Narcotics|narcotics|mesh-ancestor
55977203|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55977204|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977205|NCT00723749|Analgesics|analgesics|mesh-ancestor
55977206|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
55977210|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55977211|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
55977212|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977213|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977214|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
55977215|NCT00779311|Bevacizumab|bevacizumab|mesh-list
55977217|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977218|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977219|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55977220|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55977221|NCT00779311|Growth Substances|growth substances|mesh-ancestor
55977222|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977223|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
55977224|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55977225|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977226|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977228|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
55977229|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55977230|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977231|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977232|NCT01274039|Diuretics|diuretics|mesh-ancestor
55977233|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
55977234|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977235|NCT01274195|Busulfan|busulfan|mesh-list
55977236|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
55977237|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977238|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977239|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
55977240|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977241|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55977242|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977243|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55977244|NCT00779701|Insulin|insulin|mesh-list
55977245|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55977246|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977247|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
55977248|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55977249|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55977250|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977251|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55977252|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55977253|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55977254|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55977255|NCT03809221|Hormones|hormones|mesh-list
55977256|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55977257|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977258|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977259|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
55977260|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55977261|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
55977262|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55977263|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56113786|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56113787|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56113788|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113789|NCT00000923|Lamivudine|lamivudine|mesh-list
56113790|NCT00000923|Zidovudine|zidovudine|mesh-list
56113791|NCT00000923|Didanosine|didanosine|mesh-list
56113792|NCT00000923|Stavudine|stavudine|mesh-list
56113793|NCT00000923|Aldesleukin|aldesleukin|mesh-list
56113794|NCT00000923|Indinavir|indinavir|mesh-list
56113795|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56113796|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113797|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113798|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113799|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
56113800|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113801|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55977264|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55977265|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977266|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
55977267|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977268|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977269|NCT02993159|Tamoxifen|tamoxifen|mesh-list
55977270|NCT02993159|Afimoxifene|afimoxifene|mesh-list
55977271|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55977272|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
55977273|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977274|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977275|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55977276|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977277|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55977279|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55977280|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55977281|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
55977282|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977283|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
55977284|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55977285|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214064|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141848|NCT04336488|Hormones|hormones|mesh-ancestor
55977286|NCT00762853|Triclosan|triclosan|mesh-list
55977287|NCT00762853|Fluorides|fluorides|mesh-list
55977288|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
55977289|NCT00762853|Protective Agents|protective agents|mesh-ancestor
55977290|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977291|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55977292|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977293|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55977294|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55977295|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
55977296|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113841|NCT00000935|Antibodies|antibodies|mesh-list
55977297|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55977298|NCT00724009|Clofarabine|clofarabine|mesh-list
55977299|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55977300|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
55977301|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977302|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977303|NCT01279499|Remifentanil|remifentanil|mesh-list
55977304|NCT01279499|Propofol|propofol|mesh-list
55977305|NCT01279499|Sevoflurane|sevoflurane|mesh-list
55977306|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55977307|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55977308|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977309|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55977310|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
55977311|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
55977312|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55977313|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55977314|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55977315|NCT01279499|Narcotics|narcotics|mesh-ancestor
55977316|NCT01279499|Analgesics|analgesics|mesh-ancestor
55977317|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
55977318|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977319|NCT02992925|Vaccines|vaccines|mesh-list
55977320|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
55977321|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977322|NCT00780715|Metformin|metformin|mesh-list
55977323|NCT00780715|Pioglitazone|pioglitazone|mesh-list
55977324|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55977325|NCT00780715|Gliclazide|gliclazide|mesh-list
55977326|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55977327|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977328|NCT00780715|Incretins|incretins|mesh-ancestor
55977329|NCT00780715|Hormones|hormones|mesh-ancestor
55977330|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977331|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55977332|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
55977333|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977334|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977335|NCT05318443|Paclitaxel|paclitaxel|mesh-list
55977336|NCT05318443|Carboplatin|carboplatin|mesh-list
55977337|NCT05318443|Bevacizumab|bevacizumab|mesh-list
55977338|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55977339|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977340|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
55977341|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
55977342|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
55977343|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977344|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977345|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56113995|NCT04038515|Nicotine|nicotine|mesh-list
55977346|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55977347|NCT05318443|Growth Substances|growth substances|mesh-ancestor
55977348|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977349|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
55977350|NCT05313529|Metformin|metformin|mesh-list
55977351|NCT05313529|Liraglutide|liraglutide|mesh-list
55977352|NCT05313529|Empagliflozin|empagliflozin|mesh-list
55977354|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55977355|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977356|NCT05313529|Incretins|incretins|mesh-ancestor
55977357|NCT05313529|Hormones|hormones|mesh-ancestor
55977358|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214065|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56214066|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55977359|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55977360|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977361|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55977362|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
55977363|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977364|NCT00740831|Leuprolide|leuprolide|mesh-list
55977365|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
55977366|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55977367|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
55977368|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55977369|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977370|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55977371|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977372|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55977373|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
55977374|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55977375|NCT01275287|Eculizumab|eculizumab|mesh-list
55977376|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55977377|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56114091|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
55977378|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
55977379|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977380|NCT01275443|Rilpivirine|rilpivirine|mesh-list
55977381|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55977382|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55977383|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977384|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977385|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
55977386|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977387|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55977388|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55977389|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55977390|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55977391|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977392|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55977393|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55977394|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55977395|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977396|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
55977397|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977398|NCT00741455|Cyclosporine|cyclosporine|mesh-list
55977399|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
55977400|NCT00741455|Methotrexate|methotrexate|mesh-list
55977401|NCT00741455|Fludarabine|fludarabine|mesh-list
55977402|NCT00741455|Cyclosporins|cyclosporins|mesh-list
55977403|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977404|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
55977405|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977406|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55977407|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55977408|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
55977409|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977410|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977411|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55977412|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55977413|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
55977414|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55977415|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55977416|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
55977417|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
55977418|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977419|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55977420|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55977421|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
55977422|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977423|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55977424|NCT00742313|Hemostatics|hemostatics|mesh-list
55977428|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977429|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55977431|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55977432|NCT01275599|Naloxone|naloxone|mesh-list
55977433|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55977434|NCT01275599|Narcotics|narcotics|mesh-ancestor
55977435|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55977436|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977437|NCT01275599|Analgesics|analgesics|mesh-ancestor
55977438|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
55977439|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977440|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55977441|NCT02992457|Interferons|interferons|mesh-list
55977442|NCT02992457|Ribavirin|ribavirin|mesh-list
55977443|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
55977444|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
55977445|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55977446|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
56114247|NCT00000311|Buprenorphine|buprenorphine|mesh-list
55977447|NCT02992457|Ledipasvir|ledipasvir|mesh-list
55977448|NCT02992457|Simeprevir|simeprevir|mesh-list
55977449|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55977450|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977451|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
55977452|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977453|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
55977456|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977457|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
55977458|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977459|NCT00782821|Rituximab|rituximab|mesh-list
55977460|NCT00782821|Bortezomib|bortezomib|mesh-list
55977461|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
55977462|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55977463|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977464|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977465|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
55977466|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977467|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55977468|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977469|NCT00743093|Acetaminophen|acetaminophen|mesh-list
55977470|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55977471|NCT00743093|Analgesics|analgesics|mesh-ancestor
55977472|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
55977473|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977474|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977475|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
55977476|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
55977477|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55977478|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55977479|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977480|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55977481|NCT03805945|Analgesics|analgesics|mesh-ancestor
55977482|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
55977483|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977484|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55977485|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55977486|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55977487|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
55977488|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977489|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977490|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55977491|NCT04270019|Laxatives|laxatives|mesh-ancestor
55977492|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55977493|NCT00743717|Cobalt|cobalt|mesh-list
55977494|NCT00743717|Trace Elements|trace elements|mesh-ancestor
55977495|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
55977496|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977497|NCT00744965|Glyburide|glyburide|mesh-list
55977498|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55977499|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977502|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55977504|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114342|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56114343|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56114344|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
56114345|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114346|NCT00000353|Buprenorphine|buprenorphine|mesh-list
55977505|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977506|NCT00763867|Urological Agents|urological agents|mesh-ancestor
55977507|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
55977508|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55977509|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
55977510|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977511|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
55977512|NCT00711347|Protective Agents|protective agents|mesh-ancestor
55977513|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
55977514|NCT01276223|Difluprednate|difluprednate|mesh-list
55977515|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
55977517|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977518|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977519|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977521|NCT00784225|Vitamin E|vitamin e|mesh-list
55977522|NCT00784225|Tocopherols|tocopherols|mesh-list
55977523|NCT00784225|Tocotrienols|tocotrienols|mesh-list
55977524|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
55977525|NCT00784225|Selenium|selenium|mesh-list
55977526|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
55977527|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977528|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
55977529|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977530|NCT00784225|Protective Agents|protective agents|mesh-ancestor
55977531|NCT00784225|Trace Elements|trace elements|mesh-ancestor
55977532|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
55977533|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55977535|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
55977536|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
55977537|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55977538|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55977539|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977540|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977541|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977542|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55977543|NCT01273181|Aldesleukin|aldesleukin|mesh-list
55977544|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
55977545|NCT01273181|Fludarabine|fludarabine|mesh-list
55977546|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977547|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
55977548|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977549|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748581|NCT03946969|Cisplatin|cisplatin|mesh-list
55748582|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55748583|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748584|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
55748585|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
55748586|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
55748587|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748588|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55748589|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55748590|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748591|NCT03277573|Analgesics|analgesics|mesh-ancestor
55844696|NCT05688436|(T,G)-A-L|(t,g)-a-l|mesh-list
55844697|NCT05688436|Siponimod|siponimod|mesh-list
55844698|NCT05688436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844699|NCT05688436|Antiviral Agents|antiviral agents|mesh-ancestor
55844700|NCT05688436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844701|NCT05688436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844702|NCT05688436|Immunologic Factors|immunologic factors|mesh-ancestor
55844703|NCT05688436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844704|NCT05688436|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55844705|NCT05688436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844706|NCT05688436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844707|NCT05688436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55844708|NCT05688436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844709|NCT03386578|Tenofovir|tenofovir|mesh-list
55844710|NCT03386578|Emtricitabine|emtricitabine|mesh-list
55844711|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55844712|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
55844713|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844714|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55844715|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55844716|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844717|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977550|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55977551|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
55977552|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977553|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977554|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55977555|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55977556|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55977557|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
55977558|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977559|NCT01272947|Diclofenac|diclofenac|mesh-list
55977560|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55977561|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55977562|NCT01272947|Analgesics|analgesics|mesh-ancestor
55977563|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
55977564|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977565|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977566|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977567|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55977568|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55977569|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977570|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977571|NCT01279343|Misoprostol|misoprostol|mesh-list
55977572|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55977573|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
55977574|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55977595|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55977596|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
55977597|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55977598|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
55977599|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977600|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
55977601|NCT01272635|Hormones|hormones|mesh-ancestor
55977602|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977603|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977604|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55977605|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214067|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214068|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977607|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
55977608|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977609|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55977610|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55977611|NCT01272635|Protective Agents|protective agents|mesh-ancestor
56114382|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114383|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
56114384|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56114385|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
56114386|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56114387|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56114388|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114389|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55977612|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55977613|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977614|NCT04387097|Remifentanil|remifentanil|mesh-list
55977615|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55977616|NCT04387097|Narcotics|narcotics|mesh-ancestor
55977617|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55977618|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977619|NCT04387097|Analgesics|analgesics|mesh-ancestor
55977620|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
55977621|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977622|NCT01270841|Enclomiphene|enclomiphene|mesh-list
55977623|NCT01270841|Clomiphene|clomiphene|mesh-list
55977624|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
55977625|NCT01270841|Testosterone|testosterone|mesh-list
55977626|NCT01270841|Androgens|androgens|mesh-ancestor
55977627|NCT01270841|Hormones|hormones|mesh-ancestor
55977628|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977629|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977645|NCT01278173|Vigabatrin|vigabatrin|mesh-list
55977646|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
55977647|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977648|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977649|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
55977650|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977651|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977652|NCT00784303|Lenvatinib|lenvatinib|mesh-list
55977653|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114403|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56114404|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56114405|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
56114407|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56114429|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114430|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56114431|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56114432|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56114435|NCT00000437|Naltrexone|naltrexone|mesh-list
55977654|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55977655|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977656|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977657|NCT00750815|Dexamethasone|dexamethasone|mesh-list
55977658|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
55977659|NCT00750815|Doxorubicin|doxorubicin|mesh-list
55977660|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55977661|NCT00750815|Bortezomib|bortezomib|mesh-list
55977662|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977663|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
55977664|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977665|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55977666|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55977667|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
55977668|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977669|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977670|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55977671|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977672|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
55977673|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
55977674|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977675|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55977676|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
55977677|NCT00750815|Hormones|hormones|mesh-ancestor
55977678|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977679|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55755601|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
56114495|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56114496|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114497|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114498|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56114499|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
56114500|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56114501|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114502|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56114503|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56114504|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56114505|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56114506|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114507|NCT04331327|Mitogens|mitogens|mesh-list
56114508|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
56114509|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114510|NCT00001955|Celecoxib|celecoxib|mesh-list
55977680|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55977681|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55977682|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55977683|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977684|NCT00784849|Methylene Blue|methylene blue|mesh-list
55977685|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977686|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977687|NCT00786019|Vitamins|vitamins|mesh-list
55977688|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
55977697|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55977698|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977699|NCT01277861|Analgesics|analgesics|mesh-ancestor
56214069|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56214070|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55977700|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
55977701|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977702|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55977703|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55977704|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
55977705|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
55977706|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55977707|NCT00786487|Glycerol|glycerol|mesh-list
55977708|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55977709|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55977710|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55977711|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55977712|NCT00786487|Protective Agents|protective agents|mesh-ancestor
55977713|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977714|NCT03805633|Pancrelipase|pancrelipase|mesh-list
55977715|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55977716|NCT01276847|Etanercept|etanercept|mesh-list
55977717|NCT01276847|Ustekinumab|ustekinumab|mesh-list
55977718|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55977719|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55977720|NCT01276847|Analgesics|analgesics|mesh-ancestor
55977721|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
55977722|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977723|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977724|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977725|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55977726|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55977727|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977728|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
55977729|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
55977730|NCT05743777|Pembrolizumab|pembrolizumab|mesh-list
55977731|NCT05743777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977732|NCT05743777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114511|NCT00001955|Etanercept|etanercept|mesh-list
56114512|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56114513|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56114515|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
56114516|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114517|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114518|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56114519|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56114520|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55977733|NCT00945269|Aldesleukin|aldesleukin|mesh-list
55977734|NCT00945269|Interleukin-2|interleukin-2|mesh-list
55977735|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
55977736|NCT00945269|Immunotoxins|immunotoxins|mesh-list
55977737|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977738|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55977739|NCT00945269|Analgesics|analgesics|mesh-ancestor
55977740|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
55977741|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977742|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977743|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55977744|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55977745|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
55977746|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977747|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
55977748|NCT01272791|Gemcitabine|gemcitabine|mesh-list
55977749|NCT01272791|Bavituximab|bavituximab|mesh-list
55977750|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55977751|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
55977752|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977753|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977754|NCT01272791|Antiviral Agents|antiviral agents|mesh-ancestor
55977755|NCT01272791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977756|NCT01272791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977790|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55977791|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55977792|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977793|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
55977796|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977797|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
55977798|NCT03804931|Hormones|hormones|mesh-ancestor
55977799|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55977800|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977801|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55977802|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977803|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55977804|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55977805|NCT03804931|Analgesics|analgesics|mesh-ancestor
56214071|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
56214072|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214073|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
55977806|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
55977807|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977808|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55977809|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
55977810|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55977811|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977812|NCT02991131|Linezolid|linezolid|mesh-list
55977813|NCT02991131|Tedizolid|tedizolid|mesh-list
55977814|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
55977815|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55977816|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977817|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55977818|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977819|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977820|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55977821|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
55977822|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55977824|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
55977825|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977826|NCT00767767|Thiopental|thiopental|mesh-list
55977827|NCT00767767|Propofol|propofol|mesh-list
55977828|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55977829|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55977830|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977831|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55977832|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
55977833|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
55977834|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
55977835|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
55977836|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
55977837|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977838|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977839|NCT00761345|Gemcitabine|gemcitabine|mesh-list
55977840|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55977841|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55977842|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
55977843|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977844|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977845|NCT00761345|Antiviral Agents|antiviral agents|mesh-ancestor
55977846|NCT00761345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977847|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977848|NCT00761345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977849|NCT00761345|Immunologic Factors|immunologic factors|mesh-ancestor
55977850|NCT00761345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977851|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55977852|NCT00762515|Triclosan|triclosan|mesh-list
55977853|NCT00762515|Fluorides|fluorides|mesh-list
55977854|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
55977855|NCT00762515|Protective Agents|protective agents|mesh-ancestor
55977856|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977857|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55977858|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977859|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55977860|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55977861|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
55977862|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977863|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55977864|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
55977865|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55977866|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55977867|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55977868|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55977870|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977871|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
55977872|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977873|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977874|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55977875|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977876|NCT00753935|Aspirin|aspirin|mesh-list
56214074|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214076|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55790576|NCT04288687|Niraparib|niraparib|mesh-list
55977877|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55977878|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55977879|NCT00753935|Analgesics|analgesics|mesh-ancestor
55977880|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
55977881|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977882|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977883|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55977884|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55977885|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55977886|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55977887|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977888|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55977889|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55977890|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977891|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
55977892|NCT00779285|Doxorubicin|doxorubicin|mesh-list
55977893|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55977894|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55977895|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977896|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55977897|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55977898|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977899|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977900|NCT00786643|Leucovorin|leucovorin|mesh-list
55977902|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
55977903|NCT00786643|Bevacizumab|bevacizumab|mesh-list
55977904|NCT00786643|Fluorouracil|fluorouracil|mesh-list
55977905|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
55977906|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977907|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977908|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55977909|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55977910|NCT00786643|Growth Substances|growth substances|mesh-ancestor
55977911|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977912|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
55977913|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
55977914|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977915|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55977916|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977917|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
55977918|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
55977919|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977920|NCT00786643|Antidotes|antidotes|mesh-ancestor
55977921|NCT00786643|Protective Agents|protective agents|mesh-ancestor
55977922|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
55977923|NCT00786643|Vitamins|vitamins|mesh-ancestor
55977924|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
55977925|NCT01276379|Leucovorin|leucovorin|mesh-list
55977926|NCT01276379|Folic Acid|folic acid|mesh-list
55977927|NCT01276379|Fluorouracil|fluorouracil|mesh-list
55977928|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
55977929|NCT01276379|Irinotecan|irinotecan|mesh-list
55977930|NCT01276379|Cetuximab|cetuximab|mesh-list
55977931|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
55977932|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
55977933|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977934|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55977935|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977936|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977937|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
55977938|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114686|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55977939|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56114688|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114689|NCT00002021|Foscarnet|foscarnet|mesh-list
56114690|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56114691|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
56114692|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114693|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114694|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114695|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977940|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55977941|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977942|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977943|NCT01276379|Antidotes|antidotes|mesh-ancestor
55977944|NCT01276379|Protective Agents|protective agents|mesh-ancestor
55977947|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
55977948|NCT01276379|Hematinics|hematinics|mesh-ancestor
55977949|NCT01275547|Midazolam|midazolam|mesh-list
56214077|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
56214078|NCT01610869|Nintedanib|nintedanib|mesh-list
55977950|NCT01275547|Ketamine|ketamine|mesh-list
55977951|NCT01275547|Morphine|morphine|mesh-list
55977952|NCT01275547|Esketamine|esketamine|mesh-list
55977953|NCT01275547|Analgesics|analgesics|mesh-ancestor
55977954|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
55977955|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977956|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977957|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55977958|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55977959|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
55977960|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
55977961|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55977962|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56114697|NCT00002027|Diclazuril|diclazuril|mesh-list
55977963|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55977964|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889710|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55977965|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977966|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55977967|NCT01275547|Narcotics|narcotics|mesh-ancestor
55977968|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55977969|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55977970|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55977971|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55977972|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55977973|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
55977974|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
55977975|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
55977984|NCT00789685|Interferons|interferons|mesh-list
55977985|NCT00789685|Interferon-beta|interferon-beta|mesh-list
55977986|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55977987|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
55977988|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977989|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
55977990|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977991|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
55977992|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55977993|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55977994|NCT03804229|Protective Agents|protective agents|mesh-ancestor
55977995|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977997|NCT05742607|Cisplatin|cisplatin|mesh-list
55977998|NCT05742607|Carboplatin|carboplatin|mesh-list
55977999|NCT05742607|Pemetrexed|pemetrexed|mesh-list
55978000|NCT05742607|Durvalumab|durvalumab|mesh-list
55978001|NCT05742607|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55978002|NCT05742607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55978003|NCT05742607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978004|NCT05742607|Tubulin Modulators|tubulin modulators|mesh-ancestor
55978005|NCT05742607|Antimitotic Agents|antimitotic agents|mesh-ancestor
55978006|NCT05742607|Mitosis Modulators|mitosis modulators|mesh-ancestor
55978007|NCT05742607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978008|NCT05742607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978009|NCT05742607|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55978010|NCT05742607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55978011|NCT05742607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55978012|NCT05742607|Immunologic Factors|immunologic factors|mesh-ancestor
55978013|NCT05742607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978014|NCT02149303|Dabigatran|dabigatran|mesh-list
55978015|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
55978016|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55978017|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
55978018|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978019|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978020|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
56114793|NCT00002051|Thymopentin|thymopentin|mesh-list
55978021|NCT03803449|Fentanyl|fentanyl|mesh-list
55978027|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56214079|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214080|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55978028|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
55978029|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
55978030|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55978031|NCT03803449|Narcotics|narcotics|mesh-ancestor
55978032|NCT03803449|Analgesics|analgesics|mesh-ancestor
55978033|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
55978034|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978035|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55978036|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55978037|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55978038|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55978039|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
55978040|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
55978041|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978042|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978043|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
55978044|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55978045|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978046|NCT00789997|Levofloxacin|levofloxacin|mesh-list
55978047|NCT00789997|Ofloxacin|ofloxacin|mesh-list
55978048|NCT00789997|Prednisone|prednisone|mesh-list
55978049|NCT00789997|Etanercept|etanercept|mesh-list
55978050|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978051|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
55978052|NCT00789997|Hormones|hormones|mesh-ancestor
55978053|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978054|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978055|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55978056|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978057|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55978058|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978059|NCT00789997|Analgesics|analgesics|mesh-ancestor
56114818|NCT00001535|Interleukin-2|interleukin-2|mesh-list
56114819|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114820|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56114821|NCT00001535|Analgesics|analgesics|mesh-ancestor
56114822|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
56114823|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114824|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114825|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
56114826|NCT00002303|Hematinics|hematinics|mesh-ancestor
56114827|NCT00002063|Zidovudine|zidovudine|mesh-list
56114828|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
56114829|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114830|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114831|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114832|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978060|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
55978061|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978062|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978063|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55978064|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978065|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
55978066|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55978068|NCT00789997|Renal Agents|renal agents|mesh-ancestor
55978069|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55978070|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55978071|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55978072|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978073|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978074|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55978075|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55978076|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
55978077|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55978078|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
55978079|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978080|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978081|NCT03803215|Theophylline|theophylline|mesh-list
55978082|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55978083|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
55978084|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978085|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978086|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55978087|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
55978088|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55978089|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978090|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978091|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
55978092|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55978094|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
55978095|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978096|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55978097|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55978098|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
55978099|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978100|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978101|NCT03802747|Durvalumab|durvalumab|mesh-list
55978102|NCT03802747|Tremelimumab|tremelimumab|mesh-list
55755640|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
56114833|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
56114834|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114835|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114836|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114837|NCT00002069|Ditiocarb|ditiocarb|mesh-list
56114838|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56114839|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
56114840|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114841|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
56114842|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114843|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
55978103|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55978104|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55978105|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978106|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
55978107|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978108|NCT00791323|Ketorolac|ketorolac|mesh-list
55978109|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55978110|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
55978111|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55978112|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55978113|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978114|NCT00791323|Analgesics|analgesics|mesh-ancestor
55978115|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
55978116|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978117|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978118|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978119|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978120|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55978121|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978122|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978123|NCT00772915|Dexamethasone|dexamethasone|mesh-list
55978124|NCT00772915|Lenalidomide|lenalidomide|mesh-list
55978125|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978126|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
55978127|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
55978128|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978129|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978130|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55978131|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
55978132|NCT00772915|Hormones|hormones|mesh-ancestor
55978133|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978134|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55978135|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978136|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
55978137|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56114844|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
56114845|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114846|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56114847|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114848|NCT00002309|Azithromycin|azithromycin|mesh-list
56114849|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55978138|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55978139|NCT00772915|Growth Substances|growth substances|mesh-ancestor
55978140|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
55978141|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55978142|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978143|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978145|NCT03801733|Atorvastatin|atorvastatin|mesh-list
55978146|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55978147|NCT03801733|Simvastatin|simvastatin|mesh-list
55978148|NCT03801733|Pravastatin|pravastatin|mesh-list
55978149|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55978150|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55978151|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
55978152|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978153|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55978154|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55978155|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978156|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978157|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55978158|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978159|NCT03801733|Analgesics|analgesics|mesh-ancestor
55978160|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
55978161|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978162|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978163|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978164|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978166|NCT00775411|Dexamethasone|dexamethasone|mesh-list
55978167|NCT00775411|Ranibizumab|ranibizumab|mesh-list
55978168|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978169|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
55978170|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
56214081|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214082|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214083|NCT01610921|Adenosine|adenosine|mesh-list
56214084|NCT01610921|Analgesics|analgesics|mesh-ancestor
55978171|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978172|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978173|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55978174|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
55978175|NCT00775411|Hormones|hormones|mesh-ancestor
56114914|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114915|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114916|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114917|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114918|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
56114919|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114920|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114921|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114922|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55978176|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978177|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55978178|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978179|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55978180|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55978181|NCT00775411|Growth Substances|growth substances|mesh-ancestor
55978182|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
55978183|NCT03801499|Lenvatinib|lenvatinib|mesh-list
55978184|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978185|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55978186|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978187|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978188|NCT00808405|Acyclovir|acyclovir|mesh-list
55978189|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
55978190|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978191|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
55978192|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
55978193|NCT00775645|Vitamins|vitamins|mesh-ancestor
55978194|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
55978195|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978196|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
55978197|NCT01974687|Itraconazole|itraconazole|mesh-list
55978198|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
55978199|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
55978200|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978201|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55978202|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55978203|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978204|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978205|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55978206|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
55978207|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978208|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978209|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55978210|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
55978211|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
55978212|NCT00795145|Linezolid|linezolid|mesh-list
55978214|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978215|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55978216|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55978217|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978218|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978219|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978220|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55978221|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
55978222|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55978223|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978224|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
55978225|NCT00809185|Everolimus|everolimus|mesh-list
55978226|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978227|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978228|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
55978229|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978230|NCT03800953|Avelumab|avelumab|mesh-list
55978231|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55978232|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978233|NCT04856215|Antibodies|antibodies|mesh-list
55978234|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55978235|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
55978236|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214085|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
55790585|NCT04481113|Niraparib|niraparib|mesh-list
55978237|NCT00795769|Ondansetron|ondansetron|mesh-list
55978238|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
55978239|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
55978240|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978241|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114924|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114925|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114926|NCT00002321|Aldesleukin|aldesleukin|mesh-list
56114927|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114928|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55978242|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55978243|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
55978244|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
55978245|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55978246|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
55978247|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978248|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978249|NCT00795769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55978250|NCT00795769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55978251|NCT00795769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978252|NCT00795769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55978253|NCT00795769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55978254|NCT01975935|Amlexanox|amlexanox|mesh-list
55978255|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55978256|NCT02305017|Acetaminophen|acetaminophen|mesh-list
55978257|NCT02305017|Opicapone|opicapone|mesh-list
55978258|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978259|NCT02305017|Analgesics|analgesics|mesh-ancestor
55978260|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
55978261|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978262|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978263|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
55978264|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55978265|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978266|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978267|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55978268|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55978269|NCT01976871|Rotigotine|rotigotine|mesh-list
55978270|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
55978271|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
55978272|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978273|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978274|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978275|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
55978276|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55978277|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
55978278|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978279|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978280|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55978281|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
55978282|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55978284|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978285|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978286|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55978288|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
55978289|NCT03602781|Protective Agents|protective agents|mesh-ancestor
55978290|NCT02280239|Acetaminophen|acetaminophen|mesh-list
55978291|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978292|NCT02280239|Analgesics|analgesics|mesh-ancestor
55978293|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
55978294|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978295|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978296|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
55978297|NCT01993875|Lubiprostone|lubiprostone|mesh-list
55978298|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55978299|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55978300|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978301|NCT00796705|Adalimumab|adalimumab|mesh-list
55978302|NCT00796705|Etanercept|etanercept|mesh-list
55978303|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978304|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889711|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55978305|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55978306|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978307|NCT00796705|Analgesics|analgesics|mesh-ancestor
55978308|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
55978309|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978310|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214086|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214087|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214088|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55978311|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55978312|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978313|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
55978314|NCT00809809|Zinc|zinc|mesh-list
55978315|NCT00809809|Trace Elements|trace elements|mesh-ancestor
55978316|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
55978317|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978318|NCT00248651|Amitriptyline|amitriptyline|mesh-list
55978321|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55978322|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55978323|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978324|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978325|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
55978326|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978327|NCT00248651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55978328|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
55978329|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55978330|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978331|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55978332|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978334|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
55978335|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55978336|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
55978337|NCT03800797|Loxoprofen|loxoprofen|mesh-list
55978338|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55978339|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978340|NCT03800797|Analgesics|analgesics|mesh-ancestor
55978341|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
55978342|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978343|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978344|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56115125|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115126|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115127|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115128|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115129|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115130|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
56115131|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115132|NCT00002381|Nevirapine|nevirapine|mesh-list
56115133|NCT00002381|Stavudine|stavudine|mesh-list
56115134|NCT00002381|Nelfinavir|nelfinavir|mesh-list
56115135|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55791636|NCT03038321|Levofloxacin|levofloxacin|mesh-list
55978345|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978346|NCT04383067|Aldesleukin|aldesleukin|mesh-list
55978347|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978348|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55978349|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55978350|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
55978351|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978352|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
55978353|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
55978354|NCT01994109|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55978355|NCT01994109|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55978356|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55978357|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55978358|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978359|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
55978360|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978361|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978362|NCT01994109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55978365|NCT04744831|Camptothecin|camptothecin|mesh-list
55978366|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
55978367|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55978368|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978369|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55978370|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55978371|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978372|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978373|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
55978374|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978376|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978377|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978378|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978379|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55978380|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56214089|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
55978381|NCT04739371|Insulin|insulin|mesh-list
55978382|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55978383|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56115136|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115137|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978384|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978385|NCT03809767|Antibodies|antibodies|mesh-list
55978386|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55978387|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
55978388|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978389|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
55978390|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55978397|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55978398|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55978400|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
55978401|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978402|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978403|NCT03807011|Fentanyl|fentanyl|mesh-list
55978404|NCT03807011|Remifentanil|remifentanil|mesh-list
55978405|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55978406|NCT03807011|Narcotics|narcotics|mesh-ancestor
55978407|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978408|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978409|NCT03807011|Analgesics|analgesics|mesh-ancestor
55978410|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
55978411|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978412|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55978413|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55978414|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
55978415|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
55978416|NCT02986503|Cisplatin|cisplatin|mesh-list
55978417|NCT02986503|Doxorubicin|doxorubicin|mesh-list
55978418|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55978419|NCT02986503|Methotrexate|methotrexate|mesh-list
55978420|NCT02986503|Ifosfamide|ifosfamide|mesh-list
55978421|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
55978422|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978423|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55978424|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55978425|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55978426|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978427|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978428|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55978429|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
55978430|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55978431|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978432|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55978433|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
55978434|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
55978435|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55978436|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978437|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
55978438|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978439|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55978440|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115183|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55978441|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
55978442|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
55978443|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55978444|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55978445|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
55978446|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978447|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55978448|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55978449|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978450|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978451|NCT00763061|Timolol|timolol|mesh-list
55978452|NCT00763061|Travoprost|travoprost|mesh-list
55978453|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55978454|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55978455|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55978456|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55978457|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
55978458|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978470|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56214090|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55978472|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
55978473|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978474|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55978475|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55978476|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55978477|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
55978478|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978479|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978480|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
55978481|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55978482|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978483|NCT00754247|Vitamin E|vitamin e|mesh-list
55978484|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
55978485|NCT00754247|Vitamins|vitamins|mesh-ancestor
55978486|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
55978487|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978488|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978489|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
55978490|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978491|NCT00754247|Protective Agents|protective agents|mesh-ancestor
55978492|NCT02305329|Opicapone|opicapone|mesh-list
55978493|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55978494|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978495|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978496|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55978497|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55978510|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55978511|NCT01979445|Cangrelor|cangrelor|mesh-list
55978512|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55978513|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55978514|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56115235|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115236|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115237|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978515|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55978516|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
55978517|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978518|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978519|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978520|NCT03802565|Tolperisone|tolperisone|mesh-list
55978521|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55978522|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978523|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55978524|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978525|NCT04382443|Colchicine|colchicine|mesh-list
55978526|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
55978527|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978528|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
55978529|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
55978530|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
55978531|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978532|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978533|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55978534|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55978536|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
55978537|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978538|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55978539|NCT04631029|Carboplatin|carboplatin|mesh-list
55978540|NCT04631029|Etoposide|etoposide|mesh-list
55978541|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
55978542|NCT04631029|Atezolizumab|atezolizumab|mesh-list
55978543|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
55978544|NCT04631029|Entinostat|entinostat|mesh-list
55978545|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55978546|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55978547|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978548|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115257|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115258|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
56115259|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56115260|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56115267|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
55978549|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55978550|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55978551|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978552|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978553|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
56214091|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
56214092|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
55790592|NCT04201873|Poly I-C|poly i-c|mesh-list
55978554|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978555|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
55978556|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
55978557|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
55978558|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
55978559|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
55978560|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
55978561|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55978562|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55978563|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978564|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
55978565|NCT01981863|Coagulants|coagulants|mesh-ancestor
55978566|NCT04564885|Meloxicam|meloxicam|mesh-list
55978567|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55978568|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56115298|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56115299|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56115300|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56115301|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56115302|NCT00002453|Tenofovir|tenofovir|mesh-list
55978569|NCT04564885|Analgesics|analgesics|mesh-ancestor
55978570|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
55978571|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978572|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978573|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978574|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978575|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55978576|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55978577|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978578|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978579|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
55889712|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
56115357|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56115358|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56115359|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55842318|NCT05701540|Esomeprazole|esomeprazole|mesh-list
56115360|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
56115361|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56115362|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56115363|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
56115364|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
56115365|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115366|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55978580|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978581|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
55978582|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978583|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978584|NCT01995045|Triamcinolone|triamcinolone|mesh-list
55978585|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55978586|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55978587|NCT01995045|Bupivacaine|bupivacaine|mesh-list
55978588|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55978589|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
55978590|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
55978591|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978592|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978593|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
55978594|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978595|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978596|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
55978597|NCT01995045|Hormones|hormones|mesh-ancestor
55978598|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978599|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978601|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978602|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978604|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
55978608|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
55978609|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978611|NCT01982643|Bupropion|bupropion|mesh-list
55978612|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55978613|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55978614|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978615|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
55978616|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978617|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55978618|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
55978619|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55978620|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55978621|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55978622|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55978623|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978624|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
56214093|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889713|NCT03313180|Nintedanib|nintedanib|mesh-list
56115367|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115368|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115369|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115370|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115371|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
56115372|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115373|NCT00002471|Antidotes|antidotes|mesh-ancestor
56115374|NCT00002471|Protective Agents|protective agents|mesh-ancestor
56115375|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
56115376|NCT00002471|Vitamins|vitamins|mesh-ancestor
56115377|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
56115378|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
56214094|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214095|NCT01610934|Liraglutide|liraglutide|mesh-list
55790595|NCT04201873|Vaccines|vaccines|mesh-list
55978625|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978626|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55978627|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55978628|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978629|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55978630|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55978631|NCT00797797|Milnacipran|milnacipran|mesh-list
55978632|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
55978633|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55978634|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55978635|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55978636|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978637|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56115379|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
56115380|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
56115381|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56115382|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115383|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
56115384|NCT00002477|Carboplatin|carboplatin|mesh-list
56115385|NCT00002477|Doxorubicin|doxorubicin|mesh-list
56115386|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56115387|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115388|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
56115389|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115390|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115391|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115392|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
56115393|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115394|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115395|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56115396|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115397|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115398|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115399|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115400|NCT00002489|Leucovorin|leucovorin|mesh-list
56115401|NCT00002489|Dactinomycin|dactinomycin|mesh-list
55978638|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978639|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978640|NCT00797797|Analgesics|analgesics|mesh-ancestor
55978641|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
55978642|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978643|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
55978644|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55978645|NCT03496233|Grazoprevir|grazoprevir|mesh-list
55978646|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55978647|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
55978648|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978649|NCT04482673|Vitamin D|vitamin d|mesh-list
55978650|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
55978651|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
55978652|NCT04482673|Vitamins|vitamins|mesh-list
56115417|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978653|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
55978654|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115418|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56115419|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115420|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115421|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115422|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115423|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56115424|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
56115425|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56115426|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56115427|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
56115428|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
56115429|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56115430|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115431|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115432|NCT00002489|Antidotes|antidotes|mesh-ancestor
56115433|NCT00002489|Protective Agents|protective agents|mesh-ancestor
55842395|NCT03158584|Analgesics|analgesics|mesh-ancestor
56115434|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
56115435|NCT00002489|Vitamins|vitamins|mesh-ancestor
56115436|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
56115437|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56115438|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56115468|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115469|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115470|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115471|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115473|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115474|NCT00002159|Itraconazole|itraconazole|mesh-list
55978655|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55978656|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55978657|NCT04760275|Fluoxetine|fluoxetine|mesh-list
55978658|NCT04760275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55978659|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55978660|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55978661|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978662|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978663|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
55978664|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978665|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55978666|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
55978667|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55978668|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55978669|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55978670|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978671|NCT00245063|Cediranib|cediranib|mesh-list
55978672|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978673|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978682|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
55978683|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
55978684|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978685|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978686|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55978687|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
55978688|NCT02151487|Hormones|hormones|mesh-ancestor
55978689|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978690|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55978691|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978692|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
55978693|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978694|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978695|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
55978696|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
56115488|NCT00002159|Amebicides|amebicides|mesh-ancestor
55978697|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214096|NCT01610934|Glimepiride|glimepiride|mesh-list
56214097|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56214098|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214099|NCT01610934|Incretins|incretins|mesh-ancestor
55790600|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978698|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
55978699|NCT02151487|Analgesics|analgesics|mesh-ancestor
55978700|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55978701|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
55978702|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55978703|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55978704|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55978705|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
55978706|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978707|NCT05318339|Trastuzumab|trastuzumab|mesh-list
55978708|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55978709|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978710|NCT04459273|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55978711|NCT04459273|FAPI-46|fapi-46|mesh-list
55978712|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55978713|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978714|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
55978715|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55978716|NCT00764309|Dasatinib|dasatinib|mesh-list
55978717|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978718|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55978719|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978720|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978721|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
55978722|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55978723|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
55978724|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978725|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978726|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55978727|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
55978728|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55978729|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
55978730|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978731|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978732|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55978733|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
55978734|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
55978735|NCT02151877|Protective Agents|protective agents|mesh-ancestor
55978736|NCT03970837|Tofacitinib|tofacitinib|mesh-list
55978737|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55978738|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978739|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978740|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55978741|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55978742|NCT00799435|Exenatide|exenatide|mesh-list
55978744|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978745|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55978746|NCT00799435|Incretins|incretins|mesh-ancestor
55978747|NCT00799435|Hormones|hormones|mesh-ancestor
55978748|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978749|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
55978750|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56115521|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55978751|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978752|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978753|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978754|NCT04329091|Analgesics|analgesics|mesh-ancestor
55978755|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
55978756|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978757|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55978758|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55978759|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55978760|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
55978761|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214101|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214102|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56214103|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978762|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978763|NCT04382209|Meperidine|meperidine|mesh-list
55978764|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55978765|NCT04382209|Narcotics|narcotics|mesh-ancestor
55978766|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978767|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978768|NCT04382209|Analgesics|analgesics|mesh-ancestor
55978769|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
55978770|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978771|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55978772|NCT04634071|Bupropion|bupropion|mesh-list
55978773|NCT04634071|Nicotine|nicotine|mesh-list
55978774|NCT04634071|Varenicline|varenicline|mesh-list
55978775|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55978776|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
55978777|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978778|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978779|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55978780|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55978781|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
56115538|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
56115539|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115540|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115541|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115542|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
56115543|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56115544|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
56115545|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115546|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115547|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115548|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115549|NCT00002189|Paclitaxel|paclitaxel|mesh-list
56115550|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115552|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
55978782|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55978783|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978784|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55978785|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
55978786|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55978787|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55978788|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55978789|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55978790|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
55978791|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55978792|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55978793|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978794|NCT03417921|Gemcitabine|gemcitabine|mesh-list
55978795|NCT03417921|Paclitaxel|paclitaxel|mesh-list
55978796|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55978797|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978798|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
55978799|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
55978800|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
55978801|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978802|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55978803|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
55978804|NCT03417921|Antiviral Agents|antiviral agents|mesh-ancestor
55978805|NCT03417921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978806|NCT03417921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978807|NCT03417921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978808|NCT03417921|Immunologic Factors|immunologic factors|mesh-ancestor
55978809|NCT03417921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978811|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55978812|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978813|NCT03378297|Aspirin|aspirin|mesh-list
55978814|NCT03378297|Metformin|metformin|mesh-list
55978815|NCT03378297|Letrozole|letrozole|mesh-list
56115587|NCT00002213|Efavirenz|efavirenz|mesh-list
55978816|NCT03378297|Olaparib|olaparib|mesh-list
55978817|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55978834|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978835|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55978836|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55978837|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55978838|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55978841|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55978842|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978843|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978844|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978845|NCT00243659|Factor VIII|factor viii|mesh-list
55978846|NCT00243659|Coagulants|coagulants|mesh-ancestor
55978847|NCT04501705|Apatinib|apatinib|mesh-list
56214104|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
56214105|NCT01610947|Adalimumab|adalimumab|mesh-list
56214106|NCT01610947|Etanercept|etanercept|mesh-list
56214107|NCT01610947|Golimumab|golimumab|mesh-list
55978848|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978849|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55978850|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978851|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978852|NCT00814177|Warfarin|warfarin|mesh-list
55978853|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
55978854|NCT00243347|Cediranib|cediranib|mesh-list
55978855|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978856|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55978857|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978858|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978859|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
55978860|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55978861|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55889714|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978862|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978863|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
55978864|NCT03364491|Coagulants|coagulants|mesh-ancestor
55978865|NCT04294069|Azithromycin|azithromycin|mesh-list
55978866|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55978867|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978868|NCT01997229|Eculizumab|eculizumab|mesh-list
55978869|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55978870|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978871|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
55978872|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978873|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
55978877|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55978878|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
55978879|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978880|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978881|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55978882|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
55978883|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978884|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978885|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55978886|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55978887|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
55978888|NCT00814255|Adalimumab|adalimumab|mesh-list
55978889|NCT00814255|Losartan|losartan|mesh-list
55978890|NCT00814255|Lisinopril|lisinopril|mesh-list
55978891|NCT00814255|Atorvastatin|atorvastatin|mesh-list
55978892|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55978893|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55978894|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
55978895|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978896|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55978897|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55978898|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978899|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978900|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978901|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55978902|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55978903|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55978904|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55978905|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55978906|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
55978907|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55978908|NCT00814255|Protective Agents|protective agents|mesh-ancestor
55978909|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978910|NCT02000973|Lidocaine|lidocaine|mesh-list
55978911|NCT02000973|Bupivacaine|bupivacaine|mesh-list
55978912|NCT02000973|Ropivacaine|ropivacaine|mesh-list
55978913|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
55978914|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
55978915|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978916|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978917|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
55978918|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978919|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56214108|NCT01610947|Infliximab|infliximab|mesh-list
56214109|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56214110|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214111|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978920|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55978921|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55978922|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55978923|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978924|NCT02002767|Velpatasvir|velpatasvir|mesh-list
55978925|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
55978926|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55978927|NCT01985685|Thiamine|thiamine|mesh-list
55978928|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
55978929|NCT01985685|Vitamins|vitamins|mesh-ancestor
55978930|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
55978931|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978932|NCT00815347|Bosentan|bosentan|mesh-list
55978933|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55978934|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55978935|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978936|NCT01985763|Genistein|genistein|mesh-list
55978937|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55978938|NCT01985763|Protective Agents|protective agents|mesh-ancestor
55978939|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978940|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978941|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55978942|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978943|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978944|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
55978945|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55978946|NCT01985763|Estrogens|estrogens|mesh-ancestor
55978955|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
55978956|NCT02061969|Linagliptin|linagliptin|mesh-list
56115786|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
56115787|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
56115788|NCT00002531|Analgesics|analgesics|mesh-ancestor
56115789|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
56115790|NCT00002537|Topotecan|topotecan|mesh-list
55978957|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55978958|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978959|NCT02061969|Incretins|incretins|mesh-ancestor
55978960|NCT02061969|Hormones|hormones|mesh-ancestor
55978961|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978962|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55978963|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
55978964|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978965|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978966|NCT02003625|Meloxicam|meloxicam|mesh-list
55978967|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55978968|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978969|NCT02003625|Analgesics|analgesics|mesh-ancestor
55978970|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
55978971|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978972|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978973|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978974|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55978975|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55978976|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55978977|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978978|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978979|NCT04037683|Misoprostol|misoprostol|mesh-list
55978980|NCT04037683|Oxytocin|oxytocin|mesh-list
55978981|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
55978982|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55978983|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978984|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55978985|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
56115791|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56115792|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115793|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115794|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115795|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115796|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
56115797|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56115798|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115799|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115800|NCT00002291|Pentamidine|pentamidine|mesh-list
56115801|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
56115802|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115803|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56115804|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56115805|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56115806|NCT00002549|Cytarabine|cytarabine|mesh-list
56115808|NCT00002549|Busulfan|busulfan|mesh-list
55978986|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55978987|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55978988|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
55978989|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55978990|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55978991|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978992|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
55978993|NCT04251247|Coagulants|coagulants|mesh-ancestor
55978994|NCT02396511|Bevacizumab|bevacizumab|mesh-list
55978995|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56214112|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
56214113|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214114|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55978996|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978997|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55978998|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55978999|NCT02396511|Growth Substances|growth substances|mesh-ancestor
55979000|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979001|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
55979002|NCT00816751|Lidocaine|lidocaine|mesh-list
55979003|NCT00816751|Vasopressins|vasopressins|mesh-list
55979004|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
56115849|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115850|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
56115851|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115852|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
56115853|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
56115854|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
56115856|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115857|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979005|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
55979006|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
55979007|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979008|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979009|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
55979010|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979011|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55979012|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55979013|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55979014|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55979029|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55979030|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
55979031|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979032|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55979033|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55979034|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
55979035|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979036|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979037|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55979038|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55979039|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55979040|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
55979041|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979043|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
55979044|NCT02397291|Vitamins|vitamins|mesh-ancestor
56115858|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115859|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115860|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115861|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115862|NCT05751629|Bevacizumab|bevacizumab|mesh-list
56115863|NCT05751629|Niraparib|niraparib|mesh-list
56115874|NCT00002579|Tamoxifen|tamoxifen|mesh-list
55979045|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
55979046|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979047|NCT00816907|Metformin|metformin|mesh-list
55979048|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55979049|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979050|NCT00817219|Betamethasone|betamethasone|mesh-list
55979051|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
55979052|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55979053|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
55979054|NCT00817219|Calcipotriene|calcipotriene|mesh-list
55979055|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55979056|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979057|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
55979058|NCT00817219|Hormones|hormones|mesh-ancestor
55979059|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56115903|NCT00002585|NSC 366140|nsc 366140|mesh-list
55979060|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979061|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55979062|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
55979063|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
55979064|NCT00817843|Simvastatin|simvastatin|mesh-list
55979065|NCT00817843|Ezetimibe|ezetimibe|mesh-list
55979066|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55979067|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55979068|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
56116068|NCT05671991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55979069|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979070|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55979071|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55979072|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979074|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55979075|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55979076|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55979086|NCT02008617|Bupivacaine|bupivacaine|mesh-list
55979087|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
55979088|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
55979089|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979090|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979091|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
55979092|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979093|NCT03839251|Aripiprazole|aripiprazole|mesh-list
55979094|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
55979095|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55979096|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55979097|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55979098|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979099|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979100|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
55979101|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
55979102|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979103|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979104|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55979105|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55979106|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
55979107|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55979108|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55979109|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55979110|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55979111|NCT00819403|Simvastatin|simvastatin|mesh-list
55979112|NCT00819403|Ezetimibe|ezetimibe|mesh-list
55979113|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
55979114|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55979115|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55979116|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
55979117|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979118|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55979119|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55979120|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979121|NCT02010021|Letrozole|letrozole|mesh-list
55979122|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979123|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55979124|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55979125|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979126|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979127|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55979128|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
55979129|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979130|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979131|NCT02062905|Dexamethasone|dexamethasone|mesh-list
55979132|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979133|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
55979134|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
55979135|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979136|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979137|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55979138|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
55979139|NCT02062905|Hormones|hormones|mesh-ancestor
55979148|NCT00820573|Hormones|hormones|mesh-ancestor
55979149|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979150|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55979151|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
55979152|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979153|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979154|NCT05240755|Cannabidiol|cannabidiol|mesh-list
55979155|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
56116179|NCT05645393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116180|NCT05645393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116181|NCT00002735|Cobalt|cobalt|mesh-list
56116182|NCT00002735|Cisplatin|cisplatin|mesh-list
56116183|NCT00002735|Fluorouracil|fluorouracil|mesh-list
56116184|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116185|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
56116186|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116193|NCT00002747|Cobalt|cobalt|mesh-list
55979156|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
55979157|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55979158|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55979159|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55979160|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55979161|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979162|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
55979163|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979164|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979165|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55979166|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214115|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56214116|NCT01610947|Analgesics|analgesics|mesh-ancestor
56214117|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
56214118|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979167|NCT02010645|Decitabine|decitabine|mesh-list
55979168|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55979169|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
55979170|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979173|NCT02065479|Ticagrelor|ticagrelor|mesh-list
55979174|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55979175|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55979176|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55979177|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55979178|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55979179|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
55979180|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979181|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979182|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979183|NCT05236621|Dexamethasone|dexamethasone|mesh-list
55979184|NCT05236621|Pomalidomide|pomalidomide|mesh-list
55979185|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979186|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
55979187|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
55979188|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979189|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979190|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55979191|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
55979192|NCT05236621|Hormones|hormones|mesh-ancestor
55979193|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979194|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55979195|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979196|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
55979197|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55979198|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56116238|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56116239|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56116241|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979199|NCT05236621|Growth Substances|growth substances|mesh-ancestor
55979200|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
55979201|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
55979202|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55979203|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979204|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979205|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55979206|NCT02066727|Analgesics|analgesics|mesh-ancestor
55979207|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
55979208|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979209|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55979210|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55979211|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55979212|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
55979213|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979214|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979216|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
56116322|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
55979217|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979218|NCT02812615|Micronutrients|micronutrients|mesh-list
55979219|NCT02812615|Trace Elements|trace elements|mesh-list
55979220|NCT02812615|Albendazole|albendazole|mesh-list
55979221|NCT02812615|Pyrantel|pyrantel|mesh-list
55979222|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
55979223|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
55979224|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55979225|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979226|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
55979227|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55979228|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55979229|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
55979230|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
55979231|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
55979232|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979233|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979234|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979235|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
56214119|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214120|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214121|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
56214122|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55979237|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55979238|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55979239|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979240|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
55979241|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
55979242|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979243|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55979244|NCT02665117|Diuretics|diuretics|mesh-ancestor
55979245|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
55979246|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116452|NCT05523869|Topotecan|topotecan|mesh-list
55979247|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55979248|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55979250|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55979251|NCT02151253|Modafinil|modafinil|mesh-list
55979252|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55979253|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979254|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55979255|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55979256|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55979257|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979258|NCT02069847|Budesonide|budesonide|mesh-list
55979259|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979260|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55979261|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
55979262|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979263|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979264|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55979265|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
55979266|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
55979267|NCT02069847|Hormones|hormones|mesh-ancestor
55979268|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979269|NCT02070237|Enoxaparin|enoxaparin|mesh-list
55979270|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
55979271|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55979272|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55979273|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979274|NCT02071095|Poly I-C|poly i-c|mesh-list
55979275|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55979276|NCT02071095|Poly ICLC|poly iclc|mesh-list
55979277|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
55979278|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
55979279|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979280|NCT02071095|Laxatives|laxatives|mesh-ancestor
55979281|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55979298|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979299|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
55979300|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
55979301|NCT02408445|Testosterone|testosterone|mesh-list
55979302|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
55979303|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
55979304|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55979305|NCT02408445|Androgens|androgens|mesh-ancestor
55979306|NCT02408445|Hormones|hormones|mesh-ancestor
55889715|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56116555|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116556|NCT04331093|Apatinib|apatinib|mesh-list
56116557|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116558|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56116559|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116560|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116561|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
55979307|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979308|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979309|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55979310|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979311|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
55979312|NCT00388921|Vitamin A|vitamin a|mesh-list
55979313|NCT00388921|Vitamins|vitamins|mesh-ancestor
55979314|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
55979315|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979316|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
55979317|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55979318|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55979319|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56214124|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56214125|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55979320|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
55979321|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979322|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979323|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979324|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
55979325|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55979326|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979328|NCT00142285|Astringents|astringents|mesh-ancestor
55979329|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979330|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
55979331|NCT02342379|Bevacizumab|bevacizumab|mesh-list
55979332|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55979333|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979334|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55979335|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55979336|NCT02342379|Growth Substances|growth substances|mesh-ancestor
55979337|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979338|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
55979339|NCT02019069|Cytarabine|cytarabine|mesh-list
55979340|NCT02019069|Daunorubicin|daunorubicin|mesh-list
55979341|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55979342|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
55979366|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979367|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
55979368|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979369|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979370|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55979371|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979372|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
55979373|NCT02410707|Propofol|propofol|mesh-list
55979374|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55979375|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979376|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979377|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55979378|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
55979379|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
55979380|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55979381|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55979382|NCT02410707|Analgesics|analgesics|mesh-ancestor
55979383|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
55979384|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979385|NCT02343081|Temozolomide|temozolomide|mesh-list
55979386|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55979387|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
55979388|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979389|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979390|NCT00823303|Calcitriol|calcitriol|mesh-list
56116599|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56116600|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116601|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
56116602|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
56116603|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
56116604|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56116605|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56116606|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56116607|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
56116608|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56116609|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56116610|NCT05343455|Doxycycline|doxycycline|mesh-list
56116611|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56116612|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116613|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
55979391|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55979392|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979396|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55979397|NCT00823303|Vitamins|vitamins|mesh-ancestor
55979398|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
55979399|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55979400|NCT00823459|Everolimus|everolimus|mesh-list
55979401|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979402|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55979403|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
55979404|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979405|NCT04994431|Tamsulosin|tamsulosin|mesh-list
55979406|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56116655|NCT05015621|Leucovorin|leucovorin|mesh-list
56116656|NCT05015621|Fluorouracil|fluorouracil|mesh-list
56116658|NCT05015621|Calcium|calcium|mesh-list
56116659|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
56116660|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56116661|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116662|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
56116663|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116664|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116665|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116666|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116667|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
56116668|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56116669|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56116670|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116671|NCT05015621|Antidotes|antidotes|mesh-ancestor
56116672|NCT05015621|Protective Agents|protective agents|mesh-ancestor
56116673|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
56116674|NCT05015621|Vitamins|vitamins|mesh-ancestor
56116675|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
56116676|NCT05007509|Vaccines|vaccines|mesh-list
56116677|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
56116678|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116679|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
56116680|NCT05289167|Bortezomib|bortezomib|mesh-list
56116681|NCT05289167|Abatacept|abatacept|mesh-list
56116682|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116683|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
56116684|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116685|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55979407|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55979408|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55979409|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
55979410|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979411|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979412|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979413|NCT04994431|Urological Agents|urological agents|mesh-ancestor
55979414|NCT00825565|Allantoin|allantoin|mesh-list
56214126|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
56214127|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214128|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
55979415|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
55979416|NCT00803647|Leucovorin|leucovorin|mesh-list
55979417|NCT00803647|Fluorouracil|fluorouracil|mesh-list
55979418|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
55979419|NCT00803647|Cetuximab|cetuximab|mesh-list
55979420|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
55979421|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979422|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55979423|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979424|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55979425|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
55979426|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979427|NCT00803647|Antidotes|antidotes|mesh-ancestor
55979428|NCT00803647|Protective Agents|protective agents|mesh-ancestor
55979429|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
55979430|NCT00803647|Vitamins|vitamins|mesh-ancestor
55979431|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
55979432|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55979433|NCT00827983|Progesterone|progesterone|mesh-list
55979434|NCT00827983|Progestins|progestins|mesh-ancestor
55979435|NCT00827983|Hormones|hormones|mesh-ancestor
55979436|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979437|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979438|NCT02346903|Capsaicin|capsaicin|mesh-list
55979439|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
55979440|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
55979441|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
55979442|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979443|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116827|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
56116828|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
56116829|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116830|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56116831|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116832|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
56116833|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
56116834|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
56116835|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116836|NCT04328285|Ritonavir|ritonavir|mesh-list
55979444|NCT02347605|Nicotine|nicotine|mesh-list
55979445|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55979446|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
55979447|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979448|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979449|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55979450|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55979451|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
55979452|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979453|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979454|NCT02153671|Vaccines|vaccines|mesh-list
55979455|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
55979456|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979457|NCT02413203|Celecoxib|celecoxib|mesh-list
55979458|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55979459|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55979460|NCT02413203|Analgesics|analgesics|mesh-ancestor
55979461|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
55979462|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979463|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979464|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979465|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55979488|NCT02348775|Protective Agents|protective agents|mesh-ancestor
56116905|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
56116906|NCT04882241|Vitamins|vitamins|mesh-ancestor
56116907|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
56116908|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56116909|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
56116910|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116911|NCT04207931|Fluocinonide|fluocinonide|mesh-list
56116912|NCT04207931|Triamcinolone|triamcinolone|mesh-list
56116913|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56116914|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56116915|NCT04207931|Betamethasone|betamethasone|mesh-list
56116916|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
56116918|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
55979489|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979490|NCT02348775|Antidotes|antidotes|mesh-ancestor
55979491|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
55979492|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979493|NCT00828061|Prednisone|prednisone|mesh-list
55979494|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979495|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
55979496|NCT00828061|Hormones|hormones|mesh-ancestor
55979497|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979498|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116966|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
56116967|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116968|NCT00002903|Docetaxel|docetaxel|mesh-list
56116969|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116970|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
56116971|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
56116972|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
56116973|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116974|NCT03375203|Zolpidem|zolpidem|mesh-list
56116975|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56116976|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56116977|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56116978|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116979|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56116980|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
56116981|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
56116982|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56116983|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116984|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56116985|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116986|NCT00002915|Penclomedine|penclomedine|mesh-list
56116987|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116988|NCT00002921|Suramin|suramin|mesh-list
56116989|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
56116990|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56116991|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56116992|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55979499|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55979500|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979501|NCT00849121|Vaccines|vaccines|mesh-list
55979502|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
55979503|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979504|NCT02023125|Esomeprazole|esomeprazole|mesh-list
55979505|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55979506|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55979507|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55979508|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979509|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979510|NCT02349477|Gabapentin|gabapentin|mesh-list
55979511|NCT02349477|Analgesics|analgesics|mesh-ancestor
56117023|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55979512|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
56117024|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56117025|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
56117026|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
56117027|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
56117028|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
56117029|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56117030|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117031|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
56117032|NCT00002933|Irinotecan|irinotecan|mesh-list
56117033|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56117034|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117036|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117068|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
56117069|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117070|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117071|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117081|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
55979513|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979514|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979515|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
55979516|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55979517|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55979518|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979519|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55979535|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979537|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56117098|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56117099|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
56117101|NCT03058289|Antibodies|antibodies|mesh-list
56117102|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
56117103|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
56117106|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979538|NCT02350569|Ledipasvir|ledipasvir|mesh-list
55979539|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
55979540|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979541|NCT02351037|Azacitidine|azacitidine|mesh-list
55979542|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55979543|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
55979544|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979545|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979546|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979547|NCT02351115|Alprazolam|alprazolam|mesh-list
55979548|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55979549|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979550|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979551|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55979552|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55979553|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55979554|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
55979555|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
55979556|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889716|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979557|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979558|NCT02025075|Rocuronium|rocuronium|mesh-list
55979559|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55979560|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55979561|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55979562|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979563|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979564|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
55979565|NCT00242567|Androgens|androgens|mesh-list
55979566|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55979567|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979568|NCT00242567|Hormones|hormones|mesh-ancestor
55979569|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979570|NCT00241631|Fluticasone|fluticasone|mesh-list
55979571|NCT00241631|Xhance|xhance|mesh-list
55979572|NCT00241631|Theophylline|theophylline|mesh-list
55979573|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979574|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55979575|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
55979576|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979577|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979586|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55979587|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55979588|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
55979589|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979590|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
55979591|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
55979592|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56117314|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
55979593|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979594|NCT00240071|Tamoxifen|tamoxifen|mesh-list
55979595|NCT00240071|Bevacizumab|bevacizumab|mesh-list
55979596|NCT00240071|Letrozole|letrozole|mesh-list
55979597|NCT00240071|Exemestane|exemestane|mesh-list
55979598|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55979599|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979600|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55979601|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55979602|NCT00240071|Growth Substances|growth substances|mesh-ancestor
55979603|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979604|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
55979605|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55979606|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55979607|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979608|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979609|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55979610|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
55979611|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979612|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117387|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
56117388|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117389|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
56117390|NCT00003113|Lomustine|lomustine|mesh-list
56117391|NCT00003113|Etoposide|etoposide|mesh-list
56117392|NCT00003113|Procarbazine|procarbazine|mesh-list
56117393|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117394|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
56117395|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117396|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117397|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117398|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
56117399|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117400|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117401|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117402|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117403|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117406|NCT01545557|Lidocaine|lidocaine|mesh-list
55979613|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55979614|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55979615|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55979618|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55979619|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
55979620|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979621|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979622|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979623|NCT00765947|Amlodipine|amlodipine|mesh-list
55979624|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55979625|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55979626|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55979627|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55979628|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117436|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117437|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117438|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117439|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117440|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117441|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117442|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117444|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117445|NCT00003401|Gemcitabine|gemcitabine|mesh-list
56117446|NCT00003401|Dexamethasone|dexamethasone|mesh-list
56117447|NCT00003401|Paclitaxel|paclitaxel|mesh-list
56117448|NCT00003401|Etoposide|etoposide|mesh-list
56117449|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
56117450|NCT00003401|Melphalan|melphalan|mesh-list
56117451|NCT00003401|Carmustine|carmustine|mesh-list
56117452|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117453|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117454|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117455|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117456|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117457|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117458|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117459|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
56117460|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117461|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117462|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55979629|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55979630|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979631|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
55979632|NCT00765947|Diuretics|diuretics|mesh-ancestor
55979633|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
55979634|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55979635|NCT05743907|Dapagliflozin|dapagliflozin|mesh-list
55979636|NCT05743907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55979637|NCT05743907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979638|NCT05743907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55979639|NCT05743907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979640|NCT00766649|Sirolimus|sirolimus|mesh-list
55979641|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55979642|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979648|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979650|NCT02352831|Tosedostat|tosedostat|mesh-list
55979651|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55979652|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
55979653|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979654|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979655|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979656|NCT02353299|Zolpidem|zolpidem|mesh-list
55979657|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55979658|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55979659|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979660|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979661|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55979662|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
55979663|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
55979664|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979665|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979666|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56117487|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55979667|NCT00756977|Laxatives|laxatives|mesh-ancestor
55979668|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55979669|NCT03808961|Vitamins|vitamins|mesh-list
55979670|NCT03808961|Niacin|niacin|mesh-list
55979671|NCT03808961|Niacinamide|niacinamide|mesh-list
55979672|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
55979673|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
55979674|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
55979675|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979676|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55979677|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
55979678|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979679|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55979680|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
55979681|NCT00783965|Tazarotene|tazarotene|mesh-list
55979682|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
55979683|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
55979684|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
56214130|NCT01611038|Protective Agents|protective agents|mesh-ancestor
56214131|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214132|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214133|NCT01611077|Amlodipine|amlodipine|mesh-list
55979685|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55804508|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55979686|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979688|NCT00421551|Ritonavir|ritonavir|mesh-list
55979689|NCT00421551|Darunavir|darunavir|mesh-list
55979690|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56117545|NCT00330551|Risperidone|risperidone|mesh-list
55979691|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55979693|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979694|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979695|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55979696|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55979697|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
55979698|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979699|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55979700|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55979701|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
55979702|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55979703|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
55979704|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55979706|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56117627|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117628|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
56117629|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
56117630|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56117631|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56117632|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
56117633|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117634|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117635|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117636|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117637|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117638|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
56117639|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56117640|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
56117641|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117671|NCT00002801|Calcium|calcium|mesh-list
56117672|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
56117673|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56117674|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117675|NCT00002801|Antidotes|antidotes|mesh-ancestor
56117676|NCT00002801|Protective Agents|protective agents|mesh-ancestor
56117677|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
56117678|NCT00002801|Vitamins|vitamins|mesh-ancestor
56117679|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
56117680|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117681|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
56117682|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117683|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117684|NCT00002813|Vinorelbine|vinorelbine|mesh-list
55844721|NCT05688202|Lidocaine|lidocaine|mesh-list
55844730|NCT05688202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55844731|NCT05688202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55979707|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55979708|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55979709|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55979710|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
55979711|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979712|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979718|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
55979719|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979720|NCT03804749|Suramin|suramin|mesh-list
55979721|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
55979722|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
55979723|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55979724|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979725|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979726|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55979727|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55979728|NCT02312739|Ketorolac|ketorolac|mesh-list
55979729|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55979730|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
55979731|NCT02312739|Analgesics|analgesics|mesh-list
55979732|NCT02312739|Lorazepam|lorazepam|mesh-list
56117685|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117686|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117687|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117688|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117689|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117690|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117691|NCT00002819|Paclitaxel|paclitaxel|mesh-list
56117692|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
56117693|NCT00002819|Carboplatin|carboplatin|mesh-list
56117694|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
56117695|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117696|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117697|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117698|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117699|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117700|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979733|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55979734|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55979735|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
55979736|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979737|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979738|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979739|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55979740|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55979741|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979742|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979743|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55979744|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
56117748|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
55979745|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
55979746|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979747|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
55979748|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
55979749|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
55979750|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55979751|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55979752|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55979753|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55979754|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55979755|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
55979756|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
55979757|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214135|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
56214136|NCT01611077|Olmesartan|olmesartan|mesh-list
56214137|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56117856|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117857|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117858|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56117859|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
56117860|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56117861|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56117862|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56117863|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
56117864|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56117865|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117866|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56117867|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56117868|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56117869|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117870|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117871|NCT00003539|Paclitaxel|paclitaxel|mesh-list
56117872|NCT00003539|Trastuzumab|trastuzumab|mesh-list
56117873|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117874|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117875|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117876|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117877|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117878|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117879|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56117880|NCT00002879|Cladribine|cladribine|mesh-list
56117881|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117882|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214138|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55979758|NCT05718609|Amoxicillin|amoxicillin|mesh-list
55979759|NCT05718609|Clarithromycin|clarithromycin|mesh-list
55979760|NCT05718609|Furazolidone|furazolidone|mesh-list
55979761|NCT05718609|Rabeprazole|rabeprazole|mesh-list
55979762|NCT05718609|Bismuth|bismuth|mesh-list
55979763|NCT05718609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55979764|NCT05718609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830204|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
55979766|NCT05718609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979767|NCT05718609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979768|NCT05718609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55979769|NCT05718609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55979770|NCT05718609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55979771|NCT05718609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55979772|NCT05718609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55979774|NCT05718609|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55979775|NCT05718609|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55755734|NCT02463383|Ibuprofen|ibuprofen|mesh-list
56117889|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117890|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117891|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117892|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
56117893|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117894|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117895|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117896|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
56117897|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117898|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117899|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117900|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117901|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117902|NCT00003935|Etoposide|etoposide|mesh-list
56117903|NCT00003935|Vincristine|vincristine|mesh-list
56117904|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117905|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117906|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117907|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117908|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117909|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117913|NCT00003191|Fenretinide|fenretinide|mesh-list
55979776|NCT05718609|Renal Agents|renal agents|mesh-ancestor
55979777|NCT05718609|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55979778|NCT05718609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55979779|NCT05718609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55979780|NCT05718609|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55979781|NCT02359305|Acetaminophen|acetaminophen|mesh-list
55979782|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55979783|NCT02359305|Analgesics|analgesics|mesh-ancestor
56117923|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117924|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117925|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117926|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117927|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117928|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
56117929|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117930|NCT00384527|Vancomycin|vancomycin|mesh-list
56117931|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
56117932|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56117933|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117934|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56117935|NCT00003569|Paclitaxel|paclitaxel|mesh-list
56117936|NCT00003569|Cisplatin|cisplatin|mesh-list
56117937|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117938|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117939|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117940|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117941|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117942|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117963|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117964|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117965|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117966|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
56117967|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117968|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56117969|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
56117970|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55791730|NCT03039257|Vitamins|vitamins|mesh-ancestor
55979784|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
55979785|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979788|NCT02360319|Aripiprazole|aripiprazole|mesh-list
55979789|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
55979790|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
55979791|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55979792|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55979793|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979794|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979795|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
55979796|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
55979797|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56117971|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
56117972|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56117973|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56117974|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56117975|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
56117976|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117977|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117978|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56117979|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56117980|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56117981|NCT00003959|Sargramostim|sargramostim|mesh-list
56117982|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
56117983|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117984|NCT02972723|Metformin|metformin|mesh-list
56117985|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56117986|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117987|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
56117988|NCT00003203|Cisplatin|cisplatin|mesh-list
55979798|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979799|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55979800|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55979801|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
55979802|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55979803|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55979804|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55979805|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55979806|NCT05718531|Aspirin|aspirin|mesh-list
56118083|NCT00003215|Methotrexate|methotrexate|mesh-list
56118084|NCT00003215|Etoposide|etoposide|mesh-list
56118085|NCT00003215|Vincristine|vincristine|mesh-list
56118086|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
56118087|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
56118088|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118089|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
56118090|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118091|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118092|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118093|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
56118094|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118095|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118096|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56118103|NCT00003215|Hormones|hormones|mesh-ancestor
55979807|NCT05718531|Rivaroxaban|rivaroxaban|mesh-list
55979808|NCT05718531|Clopidogrel|clopidogrel|mesh-list
55979809|NCT05718531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55979810|NCT05718531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55979811|NCT05718531|Analgesics|analgesics|mesh-ancestor
55979812|NCT05718531|Sensory System Agents|sensory system agents|mesh-ancestor
55979813|NCT05718531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979814|NCT05718531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118136|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55979815|NCT05718531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979816|NCT05718531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55979817|NCT05718531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55979818|NCT05718531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55979819|NCT05718531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979820|NCT05718531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55979821|NCT05718531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55979822|NCT05718531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979823|NCT05718531|Antipyretics|antipyretics|mesh-ancestor
55979824|NCT05718531|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55979825|NCT05718531|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55979826|NCT05718531|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55979827|NCT05718531|Purinergic Agents|purinergic agents|mesh-ancestor
56118137|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118138|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118139|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118140|NCT00004001|Prednisone|prednisone|mesh-list
56118141|NCT00004001|Docetaxel|docetaxel|mesh-list
56118142|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
56118143|NCT00004001|Estramustine|estramustine|mesh-list
56118144|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118145|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118146|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118147|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118148|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118149|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56118150|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
56118151|NCT00004001|Hormones|hormones|mesh-ancestor
56118152|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56118153|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118154|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56118155|NCT00004001|Analgesics|analgesics|mesh-ancestor
55979828|NCT05718531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979829|NCT05718531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55979830|NCT05718531|Antithrombins|antithrombins|mesh-ancestor
55979831|NCT05718531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55979832|NCT05718531|Protease Inhibitors|protease inhibitors|mesh-ancestor
55979833|NCT05718531|Anticoagulants|anticoagulants|mesh-ancestor
55979834|NCT02360631|Varenicline|varenicline|mesh-list
55979835|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55979836|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55979837|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
55979838|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979839|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979840|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979842|NCT00355095|Hematinics|hematinics|mesh-ancestor
55979843|NCT02366871|Enoxaparin|enoxaparin|mesh-list
55979844|NCT02366871|Apixaban|apixaban|mesh-list
55979845|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
55979846|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55979847|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55979848|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979849|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55979850|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
55979851|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55979852|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
55979853|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979855|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
55979856|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56118189|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979857|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55979858|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979859|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55979861|NCT03836651|Antioxidants|antioxidants|mesh-list
55979862|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979863|NCT03836651|Protective Agents|protective agents|mesh-ancestor
55979864|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979865|NCT02037555|Antithrombins|antithrombins|mesh-list
55979866|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
55979867|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55979868|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
56118258|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118259|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118260|NCT00004043|Calcitriol|calcitriol|mesh-list
56118281|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
56118282|NCT00004061|Ifosfamide|ifosfamide|mesh-list
56118283|NCT00004061|Etoposide|etoposide|mesh-list
56118284|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118285|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
56118286|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118287|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118288|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118289|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
56118290|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118291|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118292|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55979869|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979870|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979871|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
55979872|NCT03804359|Rituximab|rituximab|mesh-list
55979873|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55979874|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979875|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
55979876|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979877|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55979878|NCT02369211|Acetaminophen|acetaminophen|mesh-list
55979879|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55979880|NCT02369211|Analgesics|analgesics|mesh-ancestor
55979881|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
55979882|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979883|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979884|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
55979885|NCT02038023|Iron|iron|mesh-list
55979886|NCT02038023|Dextrans|dextrans|mesh-list
55979887|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
55979888|NCT02038023|Trace Elements|trace elements|mesh-ancestor
56118293|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118320|NCT00004073|Suramin|suramin|mesh-list
55979889|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
55979890|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979891|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
55979892|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
55979893|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
55979894|NCT02038023|Hematinics|hematinics|mesh-ancestor
55979895|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
55979896|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55979897|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
55979898|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979899|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979900|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55979901|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214139|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55790630|NCT02838745|Pemetrexed|pemetrexed|mesh-list
55979902|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55979903|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
55979904|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979905|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979906|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55979907|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
56118412|NCT00004127|Vitamins|vitamins|mesh-ancestor
55979908|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
55979909|NCT04384133|Protective Agents|protective agents|mesh-ancestor
55979910|NCT02038179|Allopurinol|allopurinol|mesh-list
55979911|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
55979912|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979913|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979914|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
55979915|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55979916|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55979918|NCT02038179|Protective Agents|protective agents|mesh-ancestor
55979919|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979920|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
55979921|NCT02369835|Eusol|eusol|mesh-list
55979922|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55979923|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
55979924|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979925|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55979926|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55979927|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55979928|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
55979929|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979930|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979931|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979932|NCT00768521|Urological Agents|urological agents|mesh-ancestor
55979933|NCT00768599|Econazole|econazole|mesh-list
55979934|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
55979935|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979936|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55979938|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979939|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979940|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55979941|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
55979942|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979943|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979944|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
55979946|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55979947|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979948|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55979949|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
55979950|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55979951|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979952|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979953|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979954|NCT02039115|Prednisone|prednisone|mesh-list
55979955|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55979956|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
55979957|NCT02039115|Hormones|hormones|mesh-ancestor
55979958|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979959|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979960|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55979961|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979962|NCT00759473|Cycloserine|cycloserine|mesh-list
55979963|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55979964|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979965|NCT00759473|Renal Agents|renal agents|mesh-ancestor
55979966|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55979967|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
55979968|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55979969|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
55979970|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979971|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
55979972|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979973|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979974|NCT03809273|Trimetazidine|trimetazidine|mesh-list
56214140|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56214141|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790632|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979975|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
55979976|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55979977|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55979979|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55979980|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55979981|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979982|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979983|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
55979984|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979985|NCT00770861|Nebivolol|nebivolol|mesh-list
55979986|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55979987|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
55979988|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55979989|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55979992|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979993|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979994|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979995|NCT03808805|Aprepitant|aprepitant|mesh-list
55979996|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
55979997|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
55979998|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
56118845|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
55979999|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
55980000|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980001|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980002|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55980003|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55980004|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980005|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980006|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
55980007|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
55980009|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
55980010|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
55980011|NCT03803267|Fentanyl|fentanyl|mesh-list
55980012|NCT03803267|Propofol|propofol|mesh-list
55980013|NCT03803267|Atracurium|atracurium|mesh-list
55980014|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
55980015|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980016|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980017|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55980018|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55980019|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
55980020|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980021|NCT03803267|Narcotics|narcotics|mesh-ancestor
55980022|NCT03803267|Analgesics|analgesics|mesh-ancestor
55980023|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
55980024|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980025|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55980026|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55980027|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55980028|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55980029|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55980030|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55980031|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
55980032|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980033|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980034|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55980035|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
55980036|NCT03808649|Mannitol|mannitol|mesh-list
55980037|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55980038|NCT03808649|Diuretics|diuretics|mesh-ancestor
55980039|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
55980040|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980041|NCT00788255|Oxytocin|oxytocin|mesh-list
55980042|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
55980043|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55980044|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980045|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55980046|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
55980047|NCT02379195|Fludarabine|fludarabine|mesh-list
55980048|NCT02379195|Interleukin-2|interleukin-2|mesh-list
55980049|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55980050|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
55980051|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980052|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980053|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55980054|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
55980055|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980056|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980057|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55980058|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980059|NCT02379195|Analgesics|analgesics|mesh-ancestor
55980060|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
55980061|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980062|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
55980063|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980064|NCT00771875|Acetaminophen|acetaminophen|mesh-list
55980065|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
55980066|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
55980067|NCT00771875|Rituximab|rituximab|mesh-list
55980068|NCT00771875|Bortezomib|bortezomib|mesh-list
55980069|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
55980070|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55980071|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55980072|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
55980073|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980074|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980075|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
55980076|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980077|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118944|NCT00004931|Leucovorin|leucovorin|mesh-list
55980078|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980079|NCT00771875|Analgesics|analgesics|mesh-ancestor
55980080|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
55980081|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980082|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
55980083|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980084|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
55980085|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
55980086|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55980087|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
55980088|NCT00771875|Hormones|hormones|mesh-ancestor
55980089|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980090|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55980091|NCT00771875|Protective Agents|protective agents|mesh-ancestor
55980092|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55980093|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55980094|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55980095|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980096|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
55980097|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
55980098|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
55980099|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980100|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980101|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55980102|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55980103|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55980104|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980105|NCT00760019|Analgesics|analgesics|mesh-ancestor
55980106|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
55980107|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980108|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980109|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56119189|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
55980110|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980111|NCT00789113|Lamotrigine|lamotrigine|mesh-list
55980112|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
55980113|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55980114|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55980115|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980116|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55980117|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980118|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55980119|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56214142|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56214143|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980120|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980121|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55980122|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55980123|NCT03808259|Ketamine|ketamine|mesh-list
56119299|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119300|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119301|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56119302|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56119303|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
56119304|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
56119305|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119306|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119307|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
56119309|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119310|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119311|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56119312|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
56119313|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56119314|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119315|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
56119316|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
56119317|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119318|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56119319|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119321|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119367|NCT00005603|Dexamethasone|dexamethasone|mesh-list
56119368|NCT00005603|Prednisone|prednisone|mesh-list
56119369|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
56119370|NCT00005603|Doxorubicin|doxorubicin|mesh-list
56119371|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56119372|NCT00005603|Methotrexate|methotrexate|mesh-list
56119373|NCT00005603|Vincristine|vincristine|mesh-list
56119374|NCT00005603|Daunorubicin|daunorubicin|mesh-list
55980124|NCT03808259|Esketamine|esketamine|mesh-list
55980125|NCT03808259|Analgesics|analgesics|mesh-ancestor
55980126|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
55980127|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980128|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980129|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55980130|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55980131|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
55980132|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
55980133|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980134|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56119376|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
56119377|NCT00005603|Thioguanine|thioguanine|mesh-list
56119378|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119379|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
56119380|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119381|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56119382|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119383|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
56119384|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119385|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119386|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56119387|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56119388|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
56119389|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
56119390|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119391|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119392|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
56119393|NCT00005603|Hormones|hormones|mesh-ancestor
55980135|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55980136|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980137|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980138|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
55980139|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55980141|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55980142|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980143|NCT05742503|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55980144|NCT05742503|Medroxyprogesterone|medroxyprogesterone|mesh-list
55980145|NCT05742503|Etonogestrel|etonogestrel|mesh-list
55980146|NCT05742503|Norgestrel|norgestrel|mesh-list
55980147|NCT05742503|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55980148|NCT05742503|Contraceptive Agents|contraceptive agents|mesh-ancestor
55980149|NCT05742503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55980150|NCT05742503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980151|NCT05742503|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55980152|NCT05742503|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55980153|NCT05742503|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55742233|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119394|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119395|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119396|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56119397|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56119398|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119399|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119400|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56119401|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
56119402|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56119403|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119404|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
56119405|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
56119406|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55980154|NCT05742503|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55980155|NCT05742503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55980156|NCT05742503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980157|NCT05742503|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55980158|NCT02388321|Fentanyl|fentanyl|mesh-list
55980159|NCT02388321|Ketamine|ketamine|mesh-list
55980160|NCT02388321|Analgesics|analgesics|mesh-ancestor
55980163|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980164|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55980165|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55980166|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
55980167|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
55980168|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980169|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55980170|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55980171|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980172|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980173|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980174|NCT02388321|Narcotics|narcotics|mesh-ancestor
55980175|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55980176|NCT05742425|Bevacizumab|bevacizumab|mesh-list
55980177|NCT05742425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980178|NCT05742425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980179|NCT05742425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55980180|NCT05742425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55980181|NCT05742425|Growth Substances|growth substances|mesh-ancestor
55980182|NCT05742425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980183|NCT05742425|Growth Inhibitors|growth inhibitors|mesh-ancestor
55980184|NCT02313675|Acetaminophen|acetaminophen|mesh-list
55980185|NCT02313675|Ketorolac|ketorolac|mesh-list
55980186|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55980187|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980188|NCT02313675|Analgesics|analgesics|mesh-ancestor
55980189|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
55980190|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980191|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980192|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
56214144|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
56214145|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56214146|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55980193|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55980194|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980195|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980196|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55980197|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119490|NCT00386399|Mitomycins|mitomycins|mesh-list
55980198|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980199|NCT05742347|Protective Agents|protective agents|mesh-list
55980200|NCT05742347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980204|NCT05568797|Vaccines|vaccines|mesh-list
55980205|NCT05568797|Immunologic Factors|immunologic factors|mesh-ancestor
55980206|NCT05568797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980207|NCT03801629|Morphine|morphine|mesh-list
55980208|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980209|NCT03801629|Narcotics|narcotics|mesh-ancestor
56119492|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56119493|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119494|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
56119495|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119496|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119497|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119498|NCT00005807|Epothilones|epothilones|mesh-list
56119499|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119500|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119501|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119502|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980210|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980211|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980212|NCT03801629|Analgesics|analgesics|mesh-ancestor
55980213|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
55980214|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980215|NCT05741021|Paclitaxel|paclitaxel|mesh-list
55980216|NCT05741021|Carboplatin|carboplatin|mesh-list
55980217|NCT05741021|Pemetrexed|pemetrexed|mesh-list
55980221|NCT05741021|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119608|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119609|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119610|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
55980222|NCT05741021|Mitosis Modulators|mitosis modulators|mesh-ancestor
55980223|NCT05741021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980224|NCT05741021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980225|NCT05741021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55980226|NCT05741021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55980227|NCT04383977|Etoposide|etoposide|mesh-list
55980228|NCT04383977|Apatinib|apatinib|mesh-list
55980229|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55980230|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980231|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56119688|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119689|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56119690|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119691|NCT00003797|Gemcitabine|gemcitabine|mesh-list
56119692|NCT00003797|Trastuzumab|trastuzumab|mesh-list
56119693|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119694|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
55980232|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55980233|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980234|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980236|NCT02389959|Bevacizumab|bevacizumab|mesh-list
55980237|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980238|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980239|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55980240|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55980241|NCT02389959|Growth Substances|growth substances|mesh-ancestor
55980242|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980243|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
56119781|NCT00003851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119782|NCT00003851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119783|NCT00003851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119784|NCT00003851|Immunologic Factors|immunologic factors|mesh-ancestor
56119785|NCT00003851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119786|NCT00003881|Paclitaxel|paclitaxel|mesh-list
56119787|NCT00003881|Carboplatin|carboplatin|mesh-list
56119788|NCT00003881|Trastuzumab|trastuzumab|mesh-list
56119789|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119790|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119791|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119792|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119793|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119794|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119795|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56119796|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
56119797|NCT00003893|Doxorubicin|doxorubicin|mesh-list
56119798|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56119799|NCT00003893|Fluorouracil|fluorouracil|mesh-list
56119800|NCT00003893|Methotrexate|methotrexate|mesh-list
56119801|NCT00003893|Epirubicin|epirubicin|mesh-list
56119802|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
56119838|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119839|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119840|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
56119841|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119842|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980244|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
55980245|NCT00775931|Busulfan|busulfan|mesh-list
55980246|NCT00775931|Fludarabine|fludarabine|mesh-list
55980247|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
55980248|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
55980249|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55980250|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
55980251|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980252|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980253|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55980254|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
55980255|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980256|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980257|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55980258|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55980259|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
55980260|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980261|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55980262|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55980263|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55980264|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
55980265|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980266|NCT05734235|Vitamins|vitamins|mesh-list
55980267|NCT05734235|Vitamin E|vitamin e|mesh-list
55980268|NCT05734235|Micronutrients|micronutrients|mesh-ancestor
55980269|NCT05734235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980270|NCT05734235|Antioxidants|antioxidants|mesh-ancestor
56119844|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
55980271|NCT05734235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980272|NCT05734235|Protective Agents|protective agents|mesh-ancestor
55980273|NCT05732129|Irinotecan|irinotecan|mesh-list
55980274|NCT05732129|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55980275|NCT05732129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55980276|NCT05732129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980277|NCT05732129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980278|NCT05732129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980279|NCT02394951|Pregabalin|pregabalin|mesh-list
55980280|NCT02394951|Analgesics|analgesics|mesh-ancestor
55980281|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
55980282|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980283|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980284|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
55980285|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55980286|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55980287|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980288|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55980289|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55980290|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55980291|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980292|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55980293|NCT03838367|Leronlimab|leronlimab|mesh-list
55980294|NCT03838367|Carboplatin|carboplatin|mesh-list
55980295|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
55980296|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980297|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55980298|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55980299|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980300|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55980301|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55980302|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
55980303|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980304|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
55980305|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980306|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
55980307|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55980308|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
55980310|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
55980311|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55980312|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55980314|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
55980315|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55980316|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
55980317|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980318|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
55980319|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
55980320|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980321|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980322|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56120139|NCT01968954|Bococizumab|bococizumab|mesh-list
55980323|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
55980325|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980326|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55980327|NCT04345445|Protective Agents|protective agents|mesh-ancestor
55980328|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55980329|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980330|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
55980331|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55980332|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980333|NCT05713877|Melatonin|melatonin|mesh-list
55980334|NCT05713877|Antioxidants|antioxidants|mesh-ancestor
55980335|NCT05713877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980336|NCT05713877|Protective Agents|protective agents|mesh-ancestor
55980337|NCT05713877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214148|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214149|NCT01611311|BI 409306|bi 409306|mesh-list
56214150|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55980338|NCT05713877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980339|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55980340|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55980341|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980342|NCT00795275|Incretins|incretins|mesh-ancestor
55980343|NCT00795275|Hormones|hormones|mesh-ancestor
55980344|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120359|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980345|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55980346|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
55980347|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980348|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980349|NCT00777335|Panobinostat|panobinostat|mesh-list
55980350|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980351|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55980352|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980353|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980354|NCT04896645|Albuterol|albuterol|mesh-list
55980355|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55980356|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
55980357|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980358|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980359|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55980360|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
55980361|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
55980362|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55980363|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55830899|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56120470|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56120471|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120472|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
56120473|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56120474|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56120475|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56120476|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
56120477|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120478|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
56120479|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56120480|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56120481|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120482|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120485|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
56120495|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120496|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56120497|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56120498|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56120499|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56120500|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56120501|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56120502|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55748754|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
55748755|NCT03350321|Hematinics|hematinics|mesh-ancestor
55748756|NCT03352349|Terlipressin|terlipressin|mesh-list
55748757|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55748758|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55748759|NCT03265171|Plasminogen|plasminogen|mesh-list
55748760|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55748761|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55980364|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55980365|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55980366|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
55980367|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980368|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980369|NCT05644587|Buprenorphine|buprenorphine|mesh-list
55980370|NCT05644587|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55980371|NCT05644587|Naloxone|naloxone|mesh-list
55980372|NCT05644587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980373|NCT05644587|Narcotics|narcotics|mesh-ancestor
55980374|NCT05644587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980375|NCT05644587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980376|NCT05644587|Analgesics|analgesics|mesh-ancestor
55980377|NCT05644587|Sensory System Agents|sensory system agents|mesh-ancestor
55980378|NCT05644587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980379|NCT05644587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55980380|NCT03801863|Ropivacaine|ropivacaine|mesh-list
56144793|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847432|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
56120503|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56120504|NCT01856790|Liraglutide|liraglutide|mesh-list
56120505|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56120506|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120507|NCT01856790|Incretins|incretins|mesh-ancestor
56120508|NCT01856790|Hormones|hormones|mesh-ancestor
56120509|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120510|NCT01856322|Sulindac|sulindac|mesh-list
56120511|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56120512|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56120513|NCT01856322|Analgesics|analgesics|mesh-ancestor
56120514|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
56120515|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120516|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120517|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120518|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56120519|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120520|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55980381|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
55980382|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
55980383|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980384|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980385|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
55980386|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980387|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
55980388|NCT00355407|Hematinics|hematinics|mesh-ancestor
55980389|NCT00355251|Atorvastatin|atorvastatin|mesh-list
55980390|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55980391|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55980392|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
55980393|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120521|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120522|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120523|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56120524|NCT01871532|Hormones|hormones|mesh-ancestor
56120525|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120526|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120527|NCT01855074|Risperidone|risperidone|mesh-list
56120528|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56120529|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
56120530|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120531|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120532|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120533|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56120534|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56120535|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120536|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56120537|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55980394|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55980395|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55980396|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980397|NCT03832127|Fludarabine|fludarabine|mesh-list
55980398|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980399|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55980400|NCT04876131|Gentamicins|gentamicins|mesh-list
55980401|NCT04876131|Cephalexin|cephalexin|mesh-list
55980402|NCT04876131|Penicillin G|penicillin g|mesh-list
55980403|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
55980404|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
55980405|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980406|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56214151|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790645|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
55980407|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980408|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980409|NCT04825275|Posaconazole|posaconazole|mesh-list
55980410|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
55980411|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980412|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55980413|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55980414|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55980415|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56120721|NCT04414956|Agglutinins|agglutinins|mesh-list
56120722|NCT04414956|Vitamins|vitamins|mesh-ancestor
56120723|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
55847658|NCT04390984|Apatinib|apatinib|mesh-list
56120724|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120725|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56120726|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56120727|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120728|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
56120729|NCT04414956|Coagulants|coagulants|mesh-ancestor
56120730|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
56120731|NCT01848990|Insulin|insulin|mesh-list
56120732|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56120733|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
56120779|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120780|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
56120781|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
56120782|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
56120783|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120784|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56120785|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55980416|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55980417|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980418|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980419|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55980420|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
55980421|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980422|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980423|NCT00791219|Itraconazole|itraconazole|mesh-list
55980424|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
55980425|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
55980426|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980427|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55980428|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56120786|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56120787|NCT01803282|Growth Substances|growth substances|mesh-ancestor
56120788|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120789|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
56120790|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56120791|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
56120792|NCT01803282|Antiviral Agents|antiviral agents|mesh-ancestor
56120793|NCT01803282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120794|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120795|NCT01803282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56120796|NCT01803282|Immunologic Factors|immunologic factors|mesh-ancestor
56120797|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55980429|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980430|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980431|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55980432|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
55980433|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980434|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980435|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55980438|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980439|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
55980440|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
55980441|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
55980442|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120799|NCT01803282|Antidotes|antidotes|mesh-ancestor
56120800|NCT01803282|Protective Agents|protective agents|mesh-ancestor
55980443|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980444|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
55980445|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55980446|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
55980447|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980448|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
55980449|NCT00797459|Protective Agents|protective agents|mesh-ancestor
55980451|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980452|NCT03831113|Narcotics|narcotics|mesh-ancestor
55980453|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980454|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980455|NCT03831113|Analgesics|analgesics|mesh-ancestor
55980456|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
55980460|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55980461|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55980462|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980463|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980464|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55980465|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55980466|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55980467|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55980468|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
55980469|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
55980470|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
55980471|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
55980472|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980473|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980474|NCT00355953|Genistein|genistein|mesh-list
55980475|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55980476|NCT00355953|Protective Agents|protective agents|mesh-ancestor
55980477|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980478|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980479|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56214152|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214153|NCT01611324|Epinephrine|epinephrine|mesh-list
56214154|NCT01611324|Mepivacaine|mepivacaine|mesh-list
56214155|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56214156|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56120907|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
56120908|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818933|NCT01816984|Cetuximab|cetuximab|mesh-list
55980480|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980481|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980482|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
55980483|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55980484|NCT00355953|Estrogens|estrogens|mesh-ancestor
55980485|NCT00355953|Hormones|hormones|mesh-ancestor
55980486|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980487|NCT05419193|Propranolol|propranolol|mesh-list
55980488|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55980489|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55980490|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
55980491|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120909|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120910|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56120911|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56120912|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56120914|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120915|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120916|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
56120917|NCT01798992|Protective Agents|protective agents|mesh-ancestor
56120918|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56120919|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56120920|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56120921|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
56120922|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56120923|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56120924|NCT01798056|Vaccines|vaccines|mesh-list
55980492|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980493|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980494|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55980495|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55980496|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
55980497|NCT05416073|Sufentanil|sufentanil|mesh-list
55980498|NCT05416073|Esketamine|esketamine|mesh-list
55980499|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980500|NCT05416073|Narcotics|narcotics|mesh-ancestor
55980501|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980502|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980503|NCT05416073|Analgesics|analgesics|mesh-ancestor
55980504|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
55980505|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980506|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55980507|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55980508|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
55980509|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
55980511|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55980512|NCT05664971|Paclitaxel|paclitaxel|mesh-list
55980513|NCT05664971|Etoposide|etoposide|mesh-list
55980514|NCT05664971|Docetaxel|docetaxel|mesh-list
55980515|NCT05664971|Carboplatin|carboplatin|mesh-list
55980516|NCT05664971|Pemetrexed|pemetrexed|mesh-list
55980517|NCT05664971|Antibodies|antibodies|mesh-list
55980518|NCT05664971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55980519|NCT05664971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55980520|NCT05664971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980521|NCT05664971|Tubulin Modulators|tubulin modulators|mesh-ancestor
55980522|NCT05664971|Antimitotic Agents|antimitotic agents|mesh-ancestor
55980523|NCT05664971|Mitosis Modulators|mitosis modulators|mesh-ancestor
55980524|NCT05664971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980525|NCT05664971|Immunologic Factors|immunologic factors|mesh-ancestor
55980526|NCT05664971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980527|NCT05664971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55980528|NCT05664971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55980529|NCT05664971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980530|NCT05664971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55980532|NCT05594667|Psilocybin|psilocybin|mesh-list
56121079|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55980533|NCT05594667|Hallucinogens|hallucinogens|mesh-ancestor
55980534|NCT05594667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980535|NCT05594667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55980536|NCT05590299|Immunologic Factors|immunologic factors|mesh-list
55980537|NCT05590299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980538|NCT04812509|Denosumab|denosumab|mesh-list
55980539|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55980540|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980541|NCT05446623|Sufentanil|sufentanil|mesh-list
55980542|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
55980543|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55980544|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121166|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121167|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121168|NCT01836276|Varenicline|varenicline|mesh-list
56121169|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56121170|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56121171|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
56121172|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121173|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121174|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121175|NCT01790568|Methotrexate|methotrexate|mesh-list
56121176|NCT01790568|Vorinostat|vorinostat|mesh-list
56121177|NCT01790568|Tacrolimus|tacrolimus|mesh-list
56121178|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56121179|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
56121180|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56121181|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121182|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56121183|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
55980545|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980546|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56214157|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
56214158|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980548|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
55980549|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980550|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55980551|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55980552|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55980553|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
55980554|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980555|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980556|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980557|NCT05446623|Narcotics|narcotics|mesh-ancestor
55980558|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56121232|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56121233|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56121234|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56121235|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121236|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
56121237|NCT01789320|Hormones|hormones|mesh-ancestor
56121238|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121239|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121240|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121241|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
56121242|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121243|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121244|NCT01788228|Vaccines|vaccines|mesh-list
56121245|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
55980559|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55980560|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
55980561|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
55980562|NCT00792077|Lenalidomide|lenalidomide|mesh-list
55980563|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
55980564|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980565|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55980566|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55980567|NCT00792077|Growth Substances|growth substances|mesh-ancestor
55980568|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
55980569|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980573|NCT04647435|Tramadol|tramadol|mesh-list
55804521|NCT02372799|Fluoxetine|fluoxetine|mesh-list
55980574|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980575|NCT04647435|Narcotics|narcotics|mesh-ancestor
55980576|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980577|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980578|NCT04647435|Analgesics|analgesics|mesh-ancestor
55980579|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
55980580|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980582|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55980583|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980584|NCT04637529|Analgesics|analgesics|mesh-ancestor
55980585|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
55980586|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980587|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980588|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980589|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980590|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55980591|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980592|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980593|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55980594|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
55980595|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55980596|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980597|NCT00799643|Analgesics|analgesics|mesh-ancestor
55980598|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
55980599|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980600|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980601|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980602|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980603|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55980604|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980605|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980606|NCT03835013|Exenatide|exenatide|mesh-list
55980607|NCT03835013|Glucagon|glucagon|mesh-list
55980610|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980612|NCT03835013|Incretins|incretins|mesh-ancestor
55980613|NCT03835013|Hormones|hormones|mesh-ancestor
55980614|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980615|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55980616|NCT05555823|Repaglinide|repaglinide|mesh-list
55980617|NCT05555823|Celecoxib|celecoxib|mesh-list
55980618|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56121337|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
56121341|NCT01811238|Oxycodone|oxycodone|mesh-list
55980619|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980620|NCT05555823|Analgesics|analgesics|mesh-ancestor
55980621|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
55980622|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980623|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214159|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214160|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790653|NCT00136435|Hormones|hormones|mesh-ancestor
55980624|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980625|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980626|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55980627|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55980628|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980629|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980630|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55980631|NCT00800345|Topotecan|topotecan|mesh-list
55980632|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55980633|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55980634|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980635|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980636|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980637|NCT03806751|Acetazolamide|acetazolamide|mesh-list
55980638|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
55980639|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55980640|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804528|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
55980643|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
55980644|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980645|NCT04383275|Capecitabine|capecitabine|mesh-list
55980646|NCT04383275|Trastuzumab|trastuzumab|mesh-list
55980647|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55980648|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
55980649|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980650|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980651|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980652|NCT03973229|Estradiol|estradiol|mesh-list
55980653|NCT03973229|Estrogens|estrogens|mesh-ancestor
55980654|NCT03973229|Hormones|hormones|mesh-ancestor
55980655|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980656|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980657|NCT03782103|Ethanol|ethanol|mesh-list
55980658|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
55980659|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55980660|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55980661|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980662|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121544|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56121588|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56121589|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
56121590|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121591|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121592|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56121593|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
56121594|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121595|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56121596|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
56121597|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56121598|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
56121599|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121600|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121601|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56121602|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55755924|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980663|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980664|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
55980665|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
55980666|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
55980667|NCT05319015|Lenvatinib|lenvatinib|mesh-list
55980668|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980669|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980670|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55980671|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980672|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980673|NCT00810719|Gemcitabine|gemcitabine|mesh-list
55980674|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55980675|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55980676|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
55980677|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980678|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980679|NCT00810719|Antiviral Agents|antiviral agents|mesh-ancestor
55980680|NCT00810719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980681|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980682|NCT00810719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55980683|NCT00810719|Immunologic Factors|immunologic factors|mesh-ancestor
55980684|NCT00810719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980685|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55980686|NCT03761277|Morphine|morphine|mesh-list
55980687|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980688|NCT03761277|Narcotics|narcotics|mesh-ancestor
55980689|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980690|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980691|NCT03761277|Analgesics|analgesics|mesh-ancestor
56214161|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56214162|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56214163|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
56214164|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980692|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
56121603|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56121604|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
56121605|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
56121606|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
56121608|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121609|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
56121610|NCT04562532|Sirolimus|sirolimus|mesh-list
56121611|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56121612|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980693|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980694|NCT00810797|Exemestane|exemestane|mesh-list
55980695|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980696|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55980697|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55980698|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980699|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980700|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55980701|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
55980702|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980703|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980704|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
55980705|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980706|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
55980708|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980709|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980711|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
55980712|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121614|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121615|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
56121616|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121617|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
56121618|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121619|NCT01778010|Cocaine|cocaine|mesh-list
56121620|NCT01778010|Modafinil|modafinil|mesh-list
56121621|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56121622|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121623|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56121624|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56121625|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56121626|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121627|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
56121628|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
56121629|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121630|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
56121669|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121670|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
56121671|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748840|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
55748841|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
55748842|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748843|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748844|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
55748845|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748846|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55748849|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55748850|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55748851|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55748852|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
55748853|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748854|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980714|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55980715|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980716|NCT04693715|Analgesics|analgesics|mesh-ancestor
55980717|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
55980718|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980719|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980720|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980721|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980722|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55980723|NCT00355641|Ropinirole|ropinirole|mesh-list
55980724|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55980725|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55980726|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
55980727|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
55980728|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980729|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980730|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980731|NCT05268237|Liraglutide|liraglutide|mesh-list
55980732|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55980733|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980734|NCT05268237|Incretins|incretins|mesh-ancestor
55980735|NCT05268237|Hormones|hormones|mesh-ancestor
55980736|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980737|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
55980738|NCT00356733|Hematinics|hematinics|mesh-ancestor
56121672|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121673|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56121674|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
56121675|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121676|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121677|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56121678|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56121679|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56121680|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56121684|NCT01777152|Hormones|hormones|mesh-ancestor
55980739|NCT04591925|Insulin|insulin|mesh-list
55980740|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55980741|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55980742|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980743|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55980744|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55980745|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55980746|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
55980747|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55980748|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55980749|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55980750|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55980751|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980752|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
55980753|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980754|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980758|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55980759|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55980760|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
56214165|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56214166|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
55980761|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980762|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980763|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980765|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
55980766|NCT04112823|BB 1101|bb 1101|mesh-list
55980767|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980768|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
55980769|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
55980770|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980771|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121802|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56121803|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121804|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121805|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56121806|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
55980772|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55980773|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
55980775|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980776|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55980777|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980778|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
55980779|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980780|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980781|NCT00802685|Ibuprofen|ibuprofen|mesh-list
55980782|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55980783|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980784|NCT00802685|Analgesics|analgesics|mesh-ancestor
55980785|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
55980786|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980787|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980788|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980789|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980790|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55980791|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980792|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980794|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55980795|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55980796|NCT00802919|Varenicline|varenicline|mesh-list
55980797|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55980798|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55980799|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
55980800|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980801|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980802|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980803|NCT04467905|Etripamil|etripamil|mesh-list
55980804|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55980805|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55980806|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980807|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55980808|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980809|NCT00803543|Valacyclovir|valacyclovir|mesh-list
55980810|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
55980811|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980812|NCT05071937|Talazoparib|talazoparib|mesh-list
55980813|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55980814|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980815|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980816|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980817|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
55980818|NCT04099641|Bavituximab|bavituximab|mesh-list
55980819|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980820|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980821|NCT05051735|Acetaminophen|acetaminophen|mesh-list
55980822|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55980823|NCT05051735|Analgesics|analgesics|mesh-ancestor
55980824|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
55980825|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980828|NCT04098237|Pancrelipase|pancrelipase|mesh-list
55980829|NCT04098237|Pancreatin|pancreatin|mesh-list
55980830|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55980831|NCT04095221|Irinotecan|irinotecan|mesh-list
55980832|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56214168|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
56214169|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56121985|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121986|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121987|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
56121988|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
56121989|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980833|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55980834|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980835|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980836|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980837|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
55980838|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980839|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980840|NCT04045431|Hylan|hylan|mesh-list
55980841|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
55980842|NCT04045431|Protective Agents|protective agents|mesh-ancestor
55980843|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980844|NCT04923893|Dexamethasone|dexamethasone|mesh-list
55980845|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
55980846|NCT04923893|Fludarabine|fludarabine|mesh-list
55980847|NCT04923893|Lenalidomide|lenalidomide|mesh-list
55980848|NCT04923893|Bortezomib|bortezomib|mesh-list
55980849|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121990|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121991|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56121992|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56121993|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
56121994|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56121995|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56121996|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56121997|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56121998|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56121999|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
56122000|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56122010|NCT01725126|Hormones|hormones|mesh-ancestor
55980850|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
55980851|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980852|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980853|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55980854|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
55980855|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980856|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980857|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55980858|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55980859|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
55980860|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
55980861|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980862|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56122099|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980863|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
55980865|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55980866|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55980867|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55980868|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55980869|NCT04923893|Growth Substances|growth substances|mesh-ancestor
55980870|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
55980871|NCT03357627|Venetoclax|venetoclax|mesh-list
55980872|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980873|NCT03713645|Tacrolimus|tacrolimus|mesh-list
55980874|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55980875|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
55980876|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980877|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55980878|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980879|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122212|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55980880|NCT03932409|Paclitaxel|paclitaxel|mesh-list
55980881|NCT03932409|Carboplatin|carboplatin|mesh-list
55980882|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
55980883|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55980884|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980885|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
55980886|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
55980887|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
55980888|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980889|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980890|NCT04923113|Amoxicillin|amoxicillin|mesh-list
55980891|NCT04923113|Minocycline|minocycline|mesh-list
55980892|NCT04923113|Rabeprazole|rabeprazole|mesh-list
55980893|NCT04923113|Bismuth|bismuth|mesh-list
55980894|NCT04923113|Antibodies|antibodies|mesh-list
55980895|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
55980896|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980897|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55980898|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980899|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55980900|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55980903|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980904|NCT04923113|Antacids|antacids|mesh-ancestor
55980905|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
55980906|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
55980907|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214170|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
56214171|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
55980908|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
55980909|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980910|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55980911|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55980912|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
55980913|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980914|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980915|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55980916|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980917|NCT02499328|Durvalumab|durvalumab|mesh-list
55980918|NCT02499328|Tremelimumab|tremelimumab|mesh-list
55980919|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980920|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980921|NCT03250923|Acemannan|acemannan|mesh-list
55980922|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55980923|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
55980924|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980925|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980926|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
55980927|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980928|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55980929|NCT00805493|Riluzole|riluzole|mesh-list
55980930|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
55980931|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55980932|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55980933|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980934|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980935|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980936|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55980937|NCT00805493|Protective Agents|protective agents|mesh-ancestor
55980938|NCT03236649|Sorafenib|sorafenib|mesh-list
55830900|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55980939|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980940|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55980941|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980942|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980943|NCT00807209|Fentanyl|fentanyl|mesh-list
55980944|NCT00807209|Bupivacaine|bupivacaine|mesh-list
55980945|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
55980946|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
55980947|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980948|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980949|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
55980950|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980951|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55980952|NCT00807209|Narcotics|narcotics|mesh-ancestor
55980953|NCT00807209|Analgesics|analgesics|mesh-ancestor
55980954|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55980955|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55980956|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
55980957|NCT03220035|Vemurafenib|vemurafenib|mesh-list
55980958|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980959|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55980960|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980961|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980962|NCT00807989|Lamotrigine|lamotrigine|mesh-list
55980963|NCT00807989|Carbamazepine|carbamazepine|mesh-list
56122353|NCT01696032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122354|NCT01696032|Immunologic Factors|immunologic factors|mesh-ancestor
56122355|NCT01696032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980964|NCT00807989|Valproic Acid|valproic acid|mesh-list
55980965|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
55980966|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55980967|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55980968|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980969|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55980970|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980971|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55980972|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55980973|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55980975|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56122529|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56122530|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
56122531|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56122532|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56122533|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56122534|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56122535|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
56122536|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122537|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122538|NCT01568892|Dolutegravir|dolutegravir|mesh-list
56122539|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56122540|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56122541|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122542|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122543|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56122544|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56122545|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
56122546|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122548|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56122549|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56122550|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56122551|NCT01568112|Analgesics|analgesics|mesh-ancestor
56122552|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
56122553|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122554|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122555|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56122556|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56122557|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56122558|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56122574|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980976|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55980977|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
55980978|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55980979|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
55980980|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56214172|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214173|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
56214174|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
56214175|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56214176|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980981|NCT00807989|Analgesics|analgesics|mesh-ancestor
55980982|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
55980983|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980984|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55980985|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55980986|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55980987|NCT05723055|Nivolumab|nivolumab|mesh-list
55980988|NCT05723055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55980989|NCT05723055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55980990|NCT05723055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55980991|NCT05723055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55980992|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
55980993|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55980994|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55980995|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
55980996|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55980997|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55980998|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55980999|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981000|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981001|NCT04845490|Mitomycins|mitomycins|mesh-list
55981002|NCT04845490|Mitomycin|mitomycin|mesh-list
55981003|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55981004|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981005|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
55981006|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981007|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55981008|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981009|NCT00357045|Paroxetine|paroxetine|mesh-list
55981010|NCT00357045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55981011|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55981012|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981013|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122683|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122684|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
56122685|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122686|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56122687|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56122688|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
56122689|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56122691|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55981014|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981015|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
55981016|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981017|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55981018|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
55981019|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981020|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55981021|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55981022|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981023|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
55981024|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55981025|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55981026|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981027|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981028|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55981029|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981030|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981031|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
55981032|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981033|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55981034|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55981035|NCT04819360|Urological Agents|urological agents|mesh-ancestor
55981036|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55981037|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55981038|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55981039|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
55981040|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981041|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56214177|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56214178|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214179|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
56122738|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122739|NCT01564758|Linezolid|linezolid|mesh-list
56122740|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56122741|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122742|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56122743|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122744|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122745|NCT01589094|Gemcitabine|gemcitabine|mesh-list
56122746|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122747|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56214180|NCT01611415|Furosemide|furosemide|mesh-list
56214181|NCT01611415|Diuretics|diuretics|mesh-ancestor
56214182|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
56214183|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214184|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56214185|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56214186|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214187|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56214188|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55981042|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55981043|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981044|NCT04436458|Niclosamide|niclosamide|mesh-list
55981045|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
55981048|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55981049|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981050|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
55981051|NCT03834753|Bevacizumab|bevacizumab|mesh-list
55981052|NCT03834753|Ranibizumab|ranibizumab|mesh-list
55981053|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55981054|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981055|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55981056|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55981057|NCT03834753|Growth Substances|growth substances|mesh-ancestor
55981058|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981059|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
55981060|NCT00845039|Irinotecan|irinotecan|mesh-list
55981061|NCT00845039|Cetuximab|cetuximab|mesh-list
55981062|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55981063|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55981064|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55981065|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981066|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981067|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981068|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55981069|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
55981070|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981071|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55981072|NCT00845195|Azelastine|azelastine|mesh-list
55981073|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55981074|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55981075|NCT00845195|Analgesics|analgesics|mesh-ancestor
55981076|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
55981077|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981078|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981079|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55981080|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981081|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55981082|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55981083|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55981084|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
55981085|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
55981086|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981087|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981088|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55981089|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
55981090|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55981091|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
55981092|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56214189|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
56214190|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55981093|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981094|NCT00845507|Exenatide|exenatide|mesh-list
55981095|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55981096|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981097|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56122748|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
56122749|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122750|NCT01589094|Antiviral Agents|antiviral agents|mesh-ancestor
56122751|NCT01589094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122752|NCT01589094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122753|NCT01589094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122755|NCT01589094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122756|NCT01563354|Everolimus|everolimus|mesh-list
56122757|NCT01563354|Pasireotide|pasireotide|mesh-list
56122758|NCT01563354|Somatostatin|somatostatin|mesh-list
56122759|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981098|NCT00845507|Incretins|incretins|mesh-ancestor
55981099|NCT00845507|Hormones|hormones|mesh-ancestor
55981100|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55981101|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
55981102|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55981103|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981104|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
55981105|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981106|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
55981107|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122813|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122814|NCT04767828|Capecitabine|capecitabine|mesh-list
56122815|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56122816|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
56122817|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122818|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122819|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
56122820|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122821|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122822|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56122823|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56122824|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56122825|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55849770|NCT02209636|Protective Agents|protective agents|mesh-ancestor
56122826|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122827|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122828|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122829|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
56122830|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56122831|NCT01585428|Aldesleukin|aldesleukin|mesh-list
56122832|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
56122833|NCT01585428|Fludarabine|fludarabine|mesh-list
55981108|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981109|NCT03500380|Capecitabine|capecitabine|mesh-list
55981110|NCT03500380|Lapatinib|lapatinib|mesh-list
55981111|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55981112|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
55981113|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981114|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981115|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55981116|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981117|NCT00534430|Cyclosporine|cyclosporine|mesh-list
55981118|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
55981119|NCT00534430|Etoposide|etoposide|mesh-list
55981123|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981124|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55981125|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55981126|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981127|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122834|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122835|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
56122836|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122837|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56122838|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56122839|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
56122840|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122841|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122842|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56122843|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56122844|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56122845|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
56122846|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122847|NCT01585272|Rivastigmine|rivastigmine|mesh-list
56122848|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56122849|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122850|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122851|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
56122852|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122853|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981128|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981129|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
55981130|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981131|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
55981132|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981133|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
55981134|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981135|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55981136|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55981137|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55981138|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
55981139|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55981140|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
55981141|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55981142|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55981143|NCT03092895|Apatinib|apatinib|mesh-list
55981144|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981145|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55981146|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981147|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981148|NCT03839771|Ivosidenib|ivosidenib|mesh-list
55981149|NCT03839771|Glycine|glycine|mesh-list
55981150|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981151|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981152|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981153|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
55981154|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981155|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981156|NCT03033225|Verteporfin|verteporfin|mesh-list
55981157|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55981158|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
55981159|NCT02593396|Bupropion|bupropion|mesh-list
55981160|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55981161|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
55981162|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981163|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55981164|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55981165|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981166|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214191|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214192|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56214193|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214194|NCT01611480|Imiquimod|imiquimod|mesh-list
56214195|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55981167|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
55981168|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981169|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981170|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55981171|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55981172|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981173|NCT00848783|Capecitabine|capecitabine|mesh-list
55981174|NCT00848783|Irinotecan|irinotecan|mesh-list
55981175|NCT00848783|Floxuridine|floxuridine|mesh-list
55981176|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981177|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55981178|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
55981179|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981180|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55981181|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55981182|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981183|NCT05372536|Cytarabine|cytarabine|mesh-list
55981184|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55981185|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
55981186|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981187|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981188|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
55981189|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981190|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981191|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
55981194|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
55981195|NCT00849251|Doxorubicin|doxorubicin|mesh-list
55981196|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56122960|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
56122961|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122962|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122963|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122964|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56122965|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56122966|NCT01534962|Ranolazine|ranolazine|mesh-list
56122970|NCT01582152|Bevacizumab|bevacizumab|mesh-list
56123000|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56123002|NCT01534182|Interferon-beta|interferon-beta|mesh-list
56123003|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
56123004|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56123005|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
56123006|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123007|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
56123008|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123009|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
56123010|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123011|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56123012|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123013|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123014|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56123015|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123016|NCT01579812|Metformin|metformin|mesh-list
56123017|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55981197|NCT00849251|Bortezomib|bortezomib|mesh-list
55981198|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981199|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
55981200|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981201|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981203|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
55981204|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981205|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981206|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55981207|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55981208|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
55981209|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
55981210|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981211|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55981212|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
55981214|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55981215|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55981216|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55981217|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55981218|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56123018|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123019|NCT01579578|Paclitaxel|paclitaxel|mesh-list
56123035|NCT01555164|Metformin|metformin|mesh-list
55981219|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981220|NCT05323396|Metronidazole|metronidazole|mesh-list
55981221|NCT05323396|Albendazole|albendazole|mesh-list
55981222|NCT05323396|Praziquantel|praziquantel|mesh-list
55981223|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
55981224|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981225|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55981226|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55981227|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
55981228|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
55981229|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55981230|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
55981231|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
55981232|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
55981233|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981234|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214196|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
56214197|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214198|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214199|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
55981235|NCT00850889|Lidocaine|lidocaine|mesh-list
55981236|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
55981237|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
55981238|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
55981239|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981240|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981241|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
56123129|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123130|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56123131|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123132|NCT01529346|Ibuprofen|ibuprofen|mesh-list
56123133|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55981242|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981243|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55981244|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55981245|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55981246|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981247|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981248|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55981249|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
55981250|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
55981251|NCT00850889|Protective Agents|protective agents|mesh-ancestor
55981252|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
55981253|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55981254|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981255|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
55981256|NCT00851357|Nicotine|nicotine|mesh-list
56123183|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
56123184|NCT01525602|Paclitaxel|paclitaxel|mesh-list
56123185|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56123186|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123187|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
56123188|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
56123189|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
56123190|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123191|NCT01549002|Fentanyl|fentanyl|mesh-list
56123192|NCT01549002|Morphine|morphine|mesh-list
56123193|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56123194|NCT01549002|Narcotics|narcotics|mesh-ancestor
56123195|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850153|NCT01639690|Busulfan|busulfan|mesh-list
56123196|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123197|NCT01549002|Analgesics|analgesics|mesh-ancestor
56123198|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
56123199|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123200|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56123201|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56123239|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123240|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55742345|NCT04038489|Analgesics|analgesics|mesh-ancestor
56123242|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
56123243|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56123244|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56123245|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
55981257|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55981258|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
55981259|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981260|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981261|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55981262|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55981263|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
55981264|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981265|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981266|NCT05105074|Morphine|morphine|mesh-list
55981269|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981270|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981271|NCT05105074|Analgesics|analgesics|mesh-ancestor
55981272|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
55981273|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981274|NCT04932382|Misoprostol|misoprostol|mesh-list
55981276|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
55981277|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55981278|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981279|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55981280|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55981281|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
55981282|NCT04882774|Treprostinil|treprostinil|mesh-list
55981283|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55981284|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55981285|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981286|NCT00364702|Methylphenidate|methylphenidate|mesh-list
55981287|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55981288|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981289|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55981290|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55981291|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981292|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981293|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
55981294|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981295|NCT04395196|Choline|choline|mesh-list
55981296|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
55981297|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55981298|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
55981299|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981300|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55981301|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55981302|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
55981303|NCT00852761|Clobetasol|clobetasol|mesh-list
55981304|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55981305|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
55981306|NCT00852761|Hormones|hormones|mesh-ancestor
55981307|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55981308|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981309|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
55981310|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
55981311|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55981312|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
55981313|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981314|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981315|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55981316|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
55981317|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55981318|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
55981319|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981320|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981321|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56123350|NCT03911466|Buprenorphine|buprenorphine|mesh-list
56123380|NCT01517802|Hormones|hormones|mesh-ancestor
55981322|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
55981323|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
55981324|NCT03839537|Protective Agents|protective agents|mesh-ancestor
55981325|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
55981326|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
55981327|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55981328|NCT04223765|Fludarabine|fludarabine|mesh-list
55981329|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981330|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
55981331|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981332|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981333|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55981334|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
55981335|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981336|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981337|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55981339|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
55981340|NCT02646839|Vitamins|vitamins|mesh-ancestor
55981341|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
55981342|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981343|NCT04082806|Trazodone|trazodone|mesh-list
55981344|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55981345|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55981346|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981347|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981348|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981349|NCT04082806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55981351|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981352|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981353|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981354|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
55981355|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56123396|NCT04714710|Diuretics|diuretics|mesh-ancestor
55981356|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
55981357|NCT05635786|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55981358|NCT05635786|Tenecteplase|tenecteplase|mesh-list
55981360|NCT05635786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55981361|NCT05635786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981362|NCT00365950|Warfarin|warfarin|mesh-list
55981363|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
55981364|NCT02487797|Oxytocin|oxytocin|mesh-list
55981365|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
55981366|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55981367|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981368|NCT01733693|Buprenorphine|buprenorphine|mesh-list
55981369|NCT01733693|Methadone|methadone|mesh-list
55981370|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55981371|NCT01733693|Narcotics|narcotics|mesh-ancestor
55981372|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981373|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981374|NCT01733693|Analgesics|analgesics|mesh-ancestor
55981375|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
55981376|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981377|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55981378|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
55981379|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214201|NCT01611506|Cetuximab|cetuximab|mesh-list
55790686|NCT04864379|Sargramostim|sargramostim|mesh-list
55981380|NCT05608252|Fulvestrant|fulvestrant|mesh-list
55981381|NCT05608252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55981382|NCT05608252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981383|NCT05608252|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55981384|NCT05608252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55981385|NCT05608252|Hormone Antagonists|hormone antagonists|mesh-ancestor
55981386|NCT05608252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55981387|NCT05608252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981388|NCT00855413|Ritonavir|ritonavir|mesh-list
55981389|NCT00855413|Darunavir|darunavir|mesh-list
55981390|NCT00855413|Etravirine|etravirine|mesh-list
55981391|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55981392|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55981393|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
55981394|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981395|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981396|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55981397|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55981398|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
56123499|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123500|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123501|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123502|NCT01513590|Insulin|insulin|mesh-list
56123503|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
55981399|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981400|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55981401|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55981402|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55981403|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55981404|NCT05599984|Carboplatin|carboplatin|mesh-list
55981405|NCT05599984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981406|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
55981407|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55981408|NCT05536414|Citalopram|citalopram|mesh-list
55981409|NCT05536414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55981410|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55981411|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981412|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981413|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981414|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
55981415|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981416|NCT05536414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55981418|NCT05536414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981419|NCT00366262|Naproxen|naproxen|mesh-list
55981420|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55981421|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55981422|NCT00366262|Analgesics|analgesics|mesh-ancestor
55981423|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
55981424|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981425|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981426|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55981427|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981428|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
55981429|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55981430|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981431|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981432|NCT00818363|Bupivacaine|bupivacaine|mesh-list
55981434|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
55981435|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981436|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981437|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
55981438|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981439|NCT00828841|Gemcitabine|gemcitabine|mesh-list
55981440|NCT00828841|Paclitaxel|paclitaxel|mesh-list
55981441|NCT00828841|Carboplatin|carboplatin|mesh-list
55981442|NCT00828841|Cetuximab|cetuximab|mesh-list
55981443|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55981444|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981445|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
55981446|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
55981447|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
55981448|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981449|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55981450|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
55981451|NCT00828841|Antiviral Agents|antiviral agents|mesh-ancestor
55790688|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981452|NCT00828841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981453|NCT00828841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981454|NCT00828841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981455|NCT00828841|Immunologic Factors|immunologic factors|mesh-ancestor
55981456|NCT00828841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981457|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55981458|NCT00858689|Minocycline|minocycline|mesh-list
55981459|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55981460|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981461|NCT00821795|Insulin|insulin|mesh-list
55981462|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
55981463|NCT00821795|Protamines|protamines|mesh-list
55981464|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56123504|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56123505|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123507|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55981465|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981466|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
55981467|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981468|NCT00821795|Coagulants|coagulants|mesh-ancestor
55981469|NCT00833365|Ibuprofen|ibuprofen|mesh-list
55981470|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55981471|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55981472|NCT00833365|Analgesics|analgesics|mesh-ancestor
55981473|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
55981474|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981475|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981476|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55981477|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981478|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55981479|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981480|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981481|NCT00821951|Vorinostat|vorinostat|mesh-list
55981482|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981483|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55981484|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981485|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981486|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55981487|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
55981488|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981489|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55981490|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55764049|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
55981491|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56123511|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123512|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55748935|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
55748937|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
55748938|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748940|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
55748941|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748942|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55748943|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
55748945|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55748946|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
55748947|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748948|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748949|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55748950|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
55748951|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55748953|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748954|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748955|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55748956|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
55748957|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
55748958|NCT05505617|Protective Agents|protective agents|mesh-ancestor
55748959|NCT04504877|Cannabidiol|cannabidiol|mesh-list
55748960|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
55748961|NCT02518295|Sulfalene|sulfalene|mesh-list
55748962|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748963|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55748964|NCT02518295|Renal Agents|renal agents|mesh-ancestor
55748965|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
55748966|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55748967|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55748968|NCT03257683|Ranolazine|ranolazine|mesh-list
55748969|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55748970|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55748971|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748972|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
55748973|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55748974|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55748975|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748976|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
55748977|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752866|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
55981492|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981494|NCT00860015|Pemetrexed|pemetrexed|mesh-list
55981495|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55981496|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
55981497|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981498|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981500|NCT00860015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981501|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981502|NCT00860015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981503|NCT00860015|Immunologic Factors|immunologic factors|mesh-ancestor
55981504|NCT00860015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981505|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55981506|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55981507|NCT00853333|Midazolam|midazolam|mesh-list
55981508|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
55981509|NCT00853333|Propofol|propofol|mesh-list
55981510|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56123513|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123515|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56123516|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123517|NCT01512108|Incretins|incretins|mesh-ancestor
56123518|NCT01512108|Hormones|hormones|mesh-ancestor
56123519|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123520|NCT01486758|Azithromycin|azithromycin|mesh-list
56123521|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56123522|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123523|NCT01463982|Capecitabine|capecitabine|mesh-list
56123524|NCT01463982|Irinotecan|irinotecan|mesh-list
56123525|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56123526|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
56123563|NCT01462344|Xhance|xhance|mesh-list
55981511|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981512|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981513|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55981514|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
55981515|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
55981516|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55981517|NCT00853333|Analgesics|analgesics|mesh-ancestor
55981518|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
55981519|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981520|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55981521|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55981522|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56214202|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214203|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56214204|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
56214205|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790689|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
55981523|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
55981524|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981525|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981526|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55981527|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55981528|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55981529|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981530|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
55981531|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
55981532|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
55981533|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
55981534|NCT05231980|Clomiphene|clomiphene|mesh-list
55981535|NCT05231980|Enclomiphene|enclomiphene|mesh-list
55981536|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
56123571|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
56123572|NCT01462344|Hormones|hormones|mesh-ancestor
56123573|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123574|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
56123575|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123576|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
56123577|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56123608|NCT01508676|Diclofenac|diclofenac|mesh-list
56123609|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56123610|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56123611|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56123612|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56123613|NCT01508676|Analgesics|analgesics|mesh-ancestor
56123614|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
56123615|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123616|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981537|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981538|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55981539|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981540|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55981541|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55981542|NCT05231980|Protective Agents|protective agents|mesh-ancestor
55981543|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981544|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
55981545|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55981546|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
55981547|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
55981548|NCT05231980|Vitamins|vitamins|mesh-ancestor
55981549|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
55981550|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55981551|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
55981552|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55981553|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55981554|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
55981555|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55981556|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55981557|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55981558|NCT05227612|Psilocybin|psilocybin|mesh-list
55981559|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
55981560|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981561|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981562|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55981563|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55981564|NCT00822107|Diuretics|diuretics|mesh-ancestor
55981566|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981567|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55981568|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123617|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123618|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56123619|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123620|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123621|NCT02985372|Cytarabine|cytarabine|mesh-list
56123622|NCT02985372|Decitabine|decitabine|mesh-list
56123623|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56123624|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
56123625|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123626|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123627|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
56123628|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123629|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123630|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
56123631|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123632|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749059|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
55749061|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55749062|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
55749063|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749064|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749065|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55749066|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
55749067|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55749068|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
55749069|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981569|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981572|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55981573|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55981574|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981575|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981576|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55981577|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55981578|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981579|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55981580|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
55981581|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
55981583|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
55981584|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981585|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981586|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
55981587|NCT05236907|Protective Agents|protective agents|mesh-ancestor
55981588|NCT05217706|Ketamine|ketamine|mesh-list
55981589|NCT05217706|Analgesics|analgesics|mesh-ancestor
55981590|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
56214206|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56214207|NCT01611675|Vemurafenib|vemurafenib|mesh-list
56214208|NCT01611675|Leflunomide|leflunomide|mesh-list
56214209|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981591|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981592|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981593|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55981594|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55981595|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
55981596|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
55981597|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981598|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55981599|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55981600|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981601|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981602|NCT00833443|Bupropion|bupropion|mesh-list
55981603|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55981604|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
55981605|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981606|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55981607|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55981608|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981609|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981610|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
55981611|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981612|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981613|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55981614|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55981615|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981616|NCT05207722|Aldesleukin|aldesleukin|mesh-list
55981617|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
55981618|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
55981619|NCT05207722|Trastuzumab|trastuzumab|mesh-list
55981620|NCT05207722|Fludarabine|fludarabine|mesh-list
55981621|NCT05207722|Interleukin-2|interleukin-2|mesh-list
55981622|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981623|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
55981624|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981625|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981626|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55981627|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
55981628|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981629|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981630|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55981631|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56123679|NCT01505634|Cilastatin|cilastatin|mesh-list
56123680|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56123681|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123682|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56123683|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56123684|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123685|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123686|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123687|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56123688|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56123707|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56123708|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
56123709|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123710|NCT01459614|Antiviral Agents|antiviral agents|mesh-ancestor
56123711|NCT01459614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123712|NCT01459614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123713|NCT01459614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123714|NCT01459614|Immunologic Factors|immunologic factors|mesh-ancestor
56123715|NCT01459614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981632|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55981633|NCT05207722|Analgesics|analgesics|mesh-ancestor
55981634|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
55981635|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981636|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55981637|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55981638|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
55981639|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981640|NCT00860171|Iodine|iodine|mesh-list
55981641|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
55981642|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55981644|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
55981645|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55981646|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
55981647|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981648|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981649|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55981650|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981651|NCT00860171|Trace Elements|trace elements|mesh-ancestor
55981652|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
55981653|NCT00366418|Rituximab|rituximab|mesh-list
55981654|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55981655|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981656|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
56214210|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56214211|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214212|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214213|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981657|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981658|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981660|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981661|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55981662|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55981663|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
56123716|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
56123717|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
56123718|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
56123720|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
56123721|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
56123722|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56123723|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56123724|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123725|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123726|NCT03026946|Cyclosporine|cyclosporine|mesh-list
56123727|NCT03026946|Alitretinoin|alitretinoin|mesh-list
56123728|NCT03026946|Cyclosporins|cyclosporins|mesh-list
56123729|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123730|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123731|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123732|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
56123733|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123734|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
56123735|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981664|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981665|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981666|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55981667|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55981668|NCT00862745|Fesoterodine|fesoterodine|mesh-list
55981669|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55981670|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55981671|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
55981672|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981673|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981674|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981675|NCT00862745|Urological Agents|urological agents|mesh-ancestor
55981676|NCT02150759|Fentanyl|fentanyl|mesh-list
55981677|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
55981678|NCT02150759|Ketamine|ketamine|mesh-list
55981679|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55981680|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981681|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981682|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55981683|NCT02150759|Analgesics|analgesics|mesh-ancestor
55981684|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
55981685|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981686|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55981687|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56123736|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56123737|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123738|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56123739|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123740|NCT01458366|Carboplatin|carboplatin|mesh-list
56123741|NCT01458366|Etoposide|etoposide|mesh-list
56123742|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
56123743|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56123744|NCT01458366|Ofatumumab|ofatumumab|mesh-list
56123745|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123746|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56123761|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56123762|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123763|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123764|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981688|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55981689|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
55981690|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981691|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981692|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55981693|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55981694|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
55981695|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
55981696|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55981697|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55981698|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55981699|NCT02150759|Narcotics|narcotics|mesh-ancestor
56123786|NCT01501110|Protective Agents|protective agents|mesh-ancestor
56123787|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123788|NCT01501110|Antidotes|antidotes|mesh-ancestor
56123789|NCT01500720|Topotecan|topotecan|mesh-list
56123790|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56123791|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56123792|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123793|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123794|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123795|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56123796|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56123797|NCT01455012|Rotigotine|rotigotine|mesh-list
55981700|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55981705|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
55981706|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981707|NCT04991350|Bevacizumab|bevacizumab|mesh-list
55981708|NCT04991350|Ranibizumab|ranibizumab|mesh-list
55981709|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55981710|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981711|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55981712|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55981713|NCT04991350|Growth Substances|growth substances|mesh-ancestor
55981714|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981715|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
55981718|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981720|NCT04952194|Carbidopa|carbidopa|mesh-list
55981721|NCT04952194|Entacapone|entacapone|mesh-list
55981722|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55981723|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55981724|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
55981725|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981726|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214214|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
56214215|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214216|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56214217|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
56214218|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214219|NCT01611727|Cisplatin|cisplatin|mesh-list
55981727|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981728|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55981729|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981730|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55981731|NCT00835159|Rivastigmine|rivastigmine|mesh-list
55981732|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55981733|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981734|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981735|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
55981736|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981737|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981738|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55981739|NCT00835159|Protective Agents|protective agents|mesh-ancestor
55981740|NCT04860856|Ropivacaine|ropivacaine|mesh-list
55981741|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
55981742|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
55981743|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981744|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981745|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
55981746|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981747|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
55981748|NCT00827099|Fludarabine|fludarabine|mesh-list
55981749|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
55981750|NCT00827099|Melphalan|melphalan|mesh-list
55981751|NCT00827099|Tacrolimus|tacrolimus|mesh-list
55981752|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55981753|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981754|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55981755|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
56123798|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
56123799|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
56123800|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123801|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123802|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123803|NCT01454934|Gemcitabine|gemcitabine|mesh-list
56123804|NCT01454934|Docetaxel|docetaxel|mesh-list
56123805|NCT01454934|Pemetrexed|pemetrexed|mesh-list
55981756|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981757|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981758|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
55981759|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981760|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55981761|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981762|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55981763|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55981764|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
55981765|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55981766|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981767|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55981768|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
55981769|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55981770|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55981771|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55981772|NCT00366652|Desipramine|desipramine|mesh-list
55981773|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55981774|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55981775|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981776|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981777|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981778|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981779|NCT00366652|Analgesics|analgesics|mesh-ancestor
55981780|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
55981781|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981782|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
55981783|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55981784|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
55981785|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55981786|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981787|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56214220|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214221|NCT01611896|Selenium|selenium|mesh-list
56214222|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
56214223|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214224|NCT01611896|Protective Agents|protective agents|mesh-ancestor
55981791|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981792|NCT02617888|Bismuth|bismuth|mesh-list
55981793|NCT02617888|Antacids|antacids|mesh-ancestor
55981794|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981795|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55981796|NCT02620774|Tazobactam|tazobactam|mesh-list
55981797|NCT02620774|Ceftolozane|ceftolozane|mesh-list
55981798|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55981799|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55981800|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981801|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55981802|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981803|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981804|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55981805|NCT02620774|Renal Agents|renal agents|mesh-ancestor
55981806|NCT02625298|Pemetrexed|pemetrexed|mesh-list
55981807|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981808|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889787|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123999|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56124000|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124001|NCT01450800|Renal Agents|renal agents|mesh-ancestor
56124002|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56124003|NCT01474512|Ixekizumab|ixekizumab|mesh-list
56124004|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
56124005|NCT02985606|Caffeine|caffeine|mesh-list
56124006|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56124007|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124009|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124033|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56124034|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
56124035|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124036|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56124037|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
56124038|NCT01450098|Protective Agents|protective agents|mesh-ancestor
56124039|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124041|NCT01449630|LY3031207|ly3031207|mesh-list
56124042|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56124043|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56124044|NCT01449630|Analgesics|analgesics|mesh-ancestor
55981809|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981810|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55981811|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55981812|NCT00858013|Glimepiride|glimepiride|mesh-list
55981813|NCT00858013|Nateglinide|nateglinide|mesh-list
55981814|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55981815|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55981816|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981817|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981818|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
55981819|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
55981820|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981821|NCT00835861|Insulin|insulin|mesh-list
55981822|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55981823|NCT00835861|Metformin|metformin|mesh-list
55981824|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
55981825|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
55981826|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55981827|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981828|NCT00804973|Sumatriptan|sumatriptan|mesh-list
55981829|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55981830|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55981831|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55981832|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
55981833|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981834|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981835|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981836|NCT02628106|Alprostadil|alprostadil|mesh-list
55981837|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55981838|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
55755993|NCT03108287|Bismuth|bismuth|mesh-list
56124109|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124110|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
56124111|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124112|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124113|NCT01471782|Blinatumomab|blinatumomab|mesh-list
56124114|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124115|NCT01490580|Atropine|atropine|mesh-list
56124116|NCT01490580|Sufentanil|sufentanil|mesh-list
56124117|NCT01490580|Propofol|propofol|mesh-list
56124118|NCT01490580|Atracurium|atracurium|mesh-list
56124119|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56124120|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56124121|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124122|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56124123|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
56124124|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
56124125|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56124126|NCT01490580|Narcotics|narcotics|mesh-ancestor
56124127|NCT01490580|Analgesics|analgesics|mesh-ancestor
56124128|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
56124129|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124130|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56124164|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55981839|NCT02628106|Urological Agents|urological agents|mesh-ancestor
55981840|NCT02629354|Ibuprofen|ibuprofen|mesh-list
55981841|NCT02629354|Caffeine|caffeine|mesh-list
55981842|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55981843|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55981844|NCT02629354|Analgesics|analgesics|mesh-ancestor
55981845|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
55981846|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981847|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804541|NCT02566993|Topotecan|topotecan|mesh-list
55981848|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55981849|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55981850|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55981851|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981852|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981853|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55981854|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55981855|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56214226|NCT01611896|Trace Elements|trace elements|mesh-ancestor
56214227|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
56214228|NCT01611909|Terpin|terpin|mesh-list
56214229|NCT01611909|Expectorants|expectorants|mesh-ancestor
56214230|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214231|NCT01611961|Docetaxel|docetaxel|mesh-list
55981856|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55981857|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
55981858|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981859|NCT02834247|Nivolumab|nivolumab|mesh-list
55981860|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55981861|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981862|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55981863|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981864|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
55981865|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
55981866|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55981867|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55981868|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981869|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55981870|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981871|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55981872|NCT02630992|Amoxicillin|amoxicillin|mesh-list
55981873|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
55981874|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
55981875|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55981876|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55981877|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981878|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55981879|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981880|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981881|NCT00836407|Ipilimumab|ipilimumab|mesh-list
55981882|NCT00836407|Vaccines|vaccines|mesh-list
55981883|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
55981884|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981885|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55981886|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981887|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55981888|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981889|NCT02631772|Ribavirin|ribavirin|mesh-list
55981890|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
55981891|NCT02631772|Ledipasvir|ledipasvir|mesh-list
55981892|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
56124224|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124225|NCT01470144|Epoprostenol|epoprostenol|mesh-list
55981893|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981894|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
55981895|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981896|NCT02633488|Metformin|metformin|mesh-list
55981897|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55981898|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981899|NCT00859339|Gemcitabine|gemcitabine|mesh-list
55981900|NCT00859339|Sunitinib|sunitinib|mesh-list
55981901|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981902|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55981903|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
55981904|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981905|NCT00859339|Antiviral Agents|antiviral agents|mesh-ancestor
55981906|NCT00859339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981907|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981908|NCT00859339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55981909|NCT00859339|Immunologic Factors|immunologic factors|mesh-ancestor
55981910|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981911|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55981912|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55981913|NCT00859339|Growth Substances|growth substances|mesh-ancestor
55981914|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
55981915|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55981916|NCT00859495|Doxorubicin|doxorubicin|mesh-list
55981918|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981919|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55981920|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55981921|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55981922|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981923|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981924|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55981925|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55981926|NCT00355719|Ritonavir|ritonavir|mesh-list
55981927|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55981928|NCT00355719|Nevirapine|nevirapine|mesh-list
55981929|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55981930|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55981931|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
55981932|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981933|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981934|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55981935|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55981938|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55981939|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55981940|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55981941|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55981942|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55981943|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55981944|NCT00859651|Vitamin D|vitamin d|mesh-list
55981945|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
55981946|NCT00859651|Vitamins|vitamins|mesh-ancestor
55981947|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
55981948|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981949|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55981950|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55981951|NCT02633956|Atorvastatin|atorvastatin|mesh-list
55981952|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55981953|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55981954|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
55981955|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981956|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55981957|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55981958|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981959|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55981960|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
55981961|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981962|NCT00806221|Emollients|emollients|mesh-list
55981963|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
55981964|NCT02635828|Promethazine|promethazine|mesh-list
55981965|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
55981966|NCT02635828|Dexamethasone|dexamethasone|mesh-list
55981967|NCT02635828|Palonosetron|palonosetron|mesh-list
55981968|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55981969|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
55981970|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
55981971|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55981972|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981973|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55981974|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
55981975|NCT02635828|Hormones|hormones|mesh-ancestor
55981976|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124342|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124343|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
56124344|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
56124345|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
56124346|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981977|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55981978|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55981979|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55981980|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55981981|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
55981982|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55981983|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55981984|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
55981985|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
55981986|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55981987|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
55981988|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
55981989|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55981990|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56214233|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
56214234|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
56214235|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
56214236|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214237|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56214238|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55981991|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55981992|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55981993|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
55981994|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
55981995|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
55981996|NCT02638168|Methylphenidate|methylphenidate|mesh-list
55981997|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55981998|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981999|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55982000|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55982001|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55982002|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982003|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
55982004|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982005|NCT04986579|Trastuzumab|trastuzumab|mesh-list
55982006|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55982008|NCT00837031|Gemcitabine|gemcitabine|mesh-list
55982009|NCT00837031|Lenalidomide|lenalidomide|mesh-list
55982010|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55982011|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
55982012|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982013|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982014|NCT00837031|Antiviral Agents|antiviral agents|mesh-ancestor
55982015|NCT00837031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982016|NCT00837031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982017|NCT00837031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55982018|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
55982019|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982021|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55982022|NCT00837031|Growth Substances|growth substances|mesh-ancestor
55982023|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
55982024|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55982025|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55982026|NCT04344483|Lidocaine|lidocaine|mesh-list
55982027|NCT04344483|Epinephrine|epinephrine|mesh-list
55982028|NCT04344483|Racepinephrine|racepinephrine|mesh-list
55982029|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
55982030|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
55982032|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982033|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982034|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
55982035|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982036|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55982037|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55982038|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55982039|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55982040|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982041|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55982042|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55982043|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
55982044|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982045|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55982046|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55982047|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
55982048|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55982049|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
55982050|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
55982051|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
55982052|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55982053|NCT02154763|Ropivacaine|ropivacaine|mesh-list
55982054|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
55982055|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
56214239|NCT01612065|Misoprostol|misoprostol|mesh-list
56214240|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56214241|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
56214242|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214243|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214244|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56214245|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214246|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
56214247|NCT01612078|Droxidopa|droxidopa|mesh-list
56214248|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56214249|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56214250|NCT01612247|Aspirin|aspirin|mesh-list
56214251|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
56214252|NCT01612247|Methotrexate|methotrexate|mesh-list
56214253|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214254|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
56214255|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214256|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56214257|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55982056|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982057|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982058|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
55982059|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982060|NCT02641522|Siltuximab|siltuximab|mesh-list
55982061|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982062|NCT04964427|Methylphenidate|methylphenidate|mesh-list
55982063|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55982064|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982065|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55982066|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55982067|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55982068|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982069|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
55982070|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982071|NCT00357669|Brivaracetam|brivaracetam|mesh-list
55982072|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
55982073|NCT00357747|Docetaxel|docetaxel|mesh-list
55982074|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982075|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
55982076|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
55982077|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
55982078|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982079|NCT00863551|Trospium chloride|trospium chloride|mesh-list
55982080|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
55982081|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
55982082|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982084|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55982085|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55982086|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
55982087|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982088|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982089|NCT00863551|Urological Agents|urological agents|mesh-ancestor
55982091|NCT03838575|Gentamicins|gentamicins|mesh-list
55982092|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
55982093|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55982094|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55982095|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
56214258|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
56214259|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214260|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214261|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56214262|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56214263|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
56214264|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214265|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56214266|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
55790715|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55790716|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55790717|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55790718|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56124469|NCT01435122|Axitinib|axitinib|mesh-list
55790719|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790720|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
55790721|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55790722|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55790723|NCT02439385|Curcumin|curcumin|mesh-list
55790724|NCT02439385|Bevacizumab|bevacizumab|mesh-list
55982096|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55982097|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982098|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982099|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55982100|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55982101|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55982102|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
55982104|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55982105|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55982106|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982108|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
55982109|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55982110|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982111|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
55982112|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55982113|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55982114|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982115|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982116|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55982117|NCT05588908|Betamethasone|betamethasone|mesh-list
55982118|NCT05588908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55982119|NCT05588908|Antibodies|antibodies|mesh-list
55982120|NCT05588908|Immunoglobulins|immunoglobulins|mesh-list
55982121|NCT05588908|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55982122|NCT05588908|Immunologic Factors|immunologic factors|mesh-ancestor
55982123|NCT05588908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982124|NCT05588908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982125|NCT05588908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55982126|NCT05588908|Glucocorticoids|glucocorticoids|mesh-ancestor
55982127|NCT05588908|Hormones|hormones|mesh-ancestor
55982128|NCT05588908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55982129|NCT05588908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56124559|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56124560|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56124561|NCT01391130|Growth Substances|growth substances|mesh-ancestor
56124562|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124563|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
56124564|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124565|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124566|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124567|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
56124568|NCT04046094|Vitamins|vitamins|mesh-ancestor
56124569|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
56124570|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124571|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
56124572|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124573|NCT04046094|Protective Agents|protective agents|mesh-ancestor
56124574|NCT01410240|Hemostatics|hemostatics|mesh-list
56124575|NCT01410240|Coagulants|coagulants|mesh-ancestor
55982130|NCT05588908|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214268|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982131|NCT05588830|Belimumab|belimumab|mesh-list
55982132|NCT05588830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55982133|NCT05588830|Immunologic Factors|immunologic factors|mesh-ancestor
55982134|NCT05588830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982135|NCT04740190|Carboplatin|carboplatin|mesh-list
55982136|NCT04740190|Talazoparib|talazoparib|mesh-list
55982137|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982138|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55982139|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982140|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982141|NCT00865969|Belinostat|belinostat|mesh-list
55982142|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982143|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55982144|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982145|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982146|NCT05588518|Propolis|propolis|mesh-list
55982147|NCT05588518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982148|NCT00866749|Cytarabine|cytarabine|mesh-list
55982149|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
55982150|NCT00866749|Doxorubicin|doxorubicin|mesh-list
55982151|NCT00866749|Methotrexate|methotrexate|mesh-list
55982152|NCT00866749|Vincristine|vincristine|mesh-list
55982153|NCT00866749|Daunorubicin|daunorubicin|mesh-list
55982154|NCT00866749|Asparaginase|asparaginase|mesh-list
55982155|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
55982156|NCT00866749|Thioguanine|thioguanine|mesh-list
55982157|NCT00866749|Pegaspargase|pegaspargase|mesh-list
55982160|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982161|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55982162|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55982163|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
55982164|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982165|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982166|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55982167|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55982168|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55982169|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55982170|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982171|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55982173|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55982174|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55982175|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
55982176|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
55982177|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55982178|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55982179|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
55982180|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982181|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55982182|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
55982183|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
55982184|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
55982185|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
55982186|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55982187|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
55982188|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982189|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55982190|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55982191|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
55982192|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982193|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982194|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55982195|NCT05587426|Iproplatin|iproplatin|mesh-list
55982196|NCT05587426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982197|NCT00867139|Oseltamivir|oseltamivir|mesh-list
55982198|NCT00867139|Ribavirin|ribavirin|mesh-list
55982199|NCT00867139|Zanamivir|zanamivir|mesh-list
55982200|NCT00867139|Amantadine|amantadine|mesh-list
55982201|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
55982202|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
55982203|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982204|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982205|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982206|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
55982207|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55982208|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55982209|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
55982210|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982211|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982212|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55982213|NCT00867139|Analgesics|analgesics|mesh-ancestor
55982214|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
55982215|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982216|NCT05342818|Ondansetron|ondansetron|mesh-list
55902296|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55902298|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
55982217|NCT05342818|Metoclopramide|metoclopramide|mesh-list
55982218|NCT05342818|Neostigmine|neostigmine|mesh-list
55982219|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
55982220|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
55982221|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982222|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982223|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55982224|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
55982225|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
55982226|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55982227|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
55982228|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982229|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982230|NCT05342818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55982232|NCT05342818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982233|NCT05342818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55982234|NCT05342818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55982235|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55982237|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
55982238|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55982239|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55982240|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55982241|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
55982243|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
55982244|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
55982246|NCT00867217|Letrozole|letrozole|mesh-list
55982247|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
55982248|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902384|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982249|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55982250|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55982251|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982252|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55982253|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55982254|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982255|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982256|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55982257|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
55982258|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55982259|NCT00867451|Melatonin|melatonin|mesh-list
55982260|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
55982261|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982262|NCT00867451|Protective Agents|protective agents|mesh-ancestor
55982263|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982264|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982265|NCT00867529|Rituximab|rituximab|mesh-list
55982266|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55982267|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982268|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
55982269|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982270|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55982271|NCT05219266|Midostaurin|midostaurin|mesh-list
55982272|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982273|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55982274|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982275|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982276|NCT02456857|Bevacizumab|bevacizumab|mesh-list
55982277|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55982278|NCT02456857|Doxorubicin|doxorubicin|mesh-list
55982279|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55982280|NCT02456857|Everolimus|everolimus|mesh-list
56214269|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56214270|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55982281|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
55982282|NCT02456857|Antibodies|antibodies|mesh-list
55982283|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
55982284|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55982285|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
55982286|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982287|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55982288|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55982289|NCT02456857|Growth Substances|growth substances|mesh-ancestor
55982290|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982291|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
55982292|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
55982293|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55982294|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55982295|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55982296|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982297|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982298|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55982299|NCT05197270|Aflibercept|aflibercept|mesh-list
55982300|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55982301|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55982302|NCT05197270|Growth Substances|growth substances|mesh-ancestor
55982303|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982304|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
55982305|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982307|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55982308|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
55982309|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982311|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55982312|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55982313|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
55982314|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982315|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982317|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
55982318|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982319|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55982320|NCT00889915|Methylphenidate|methylphenidate|mesh-list
55982321|NCT00889915|Amphetamine|amphetamine|mesh-list
55982322|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55982323|NCT00889915|Adderall|adderall|mesh-list
55982324|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55982325|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982326|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55982327|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55982328|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55982329|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902616|NCT02696850|Budesonide|budesonide|mesh-list
55982330|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
55982331|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982332|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
55982333|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
55982334|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982335|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
55982336|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55982338|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55982339|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
55982340|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
55982341|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55982342|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982343|NCT02685436|Domperidone|domperidone|mesh-list
55982344|NCT02685436|Omeprazole|omeprazole|mesh-list
55982345|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55982346|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55982347|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55982348|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982349|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982350|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
55982351|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
55982352|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982353|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982354|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56214271|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56214272|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56214273|NCT01612247|Analgesics|analgesics|mesh-ancestor
56214274|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
56214275|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214276|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214277|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56214278|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56214279|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55790729|NCT02439385|Growth Substances|growth substances|mesh-ancestor
55982355|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
55982356|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982357|NCT00841555|Temozolomide|temozolomide|mesh-list
55982358|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55982359|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
55982360|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982361|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982362|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55982363|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
55982364|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
55982365|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
55982366|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982367|NCT00868309|Antivenins|antivenins|mesh-list
55982368|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
55982369|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982370|NCT00368134|Vildagliptin|vildagliptin|mesh-list
55982371|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55982372|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982373|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55982374|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
55982375|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982376|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982378|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55982379|NCT02697292|Antibodies|antibodies|mesh-list
55982380|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
55982381|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55982384|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
55982385|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55982386|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982387|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55982388|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982389|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55982390|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55982391|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55982392|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982393|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982394|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55982395|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55982396|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55982397|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55982398|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
55982399|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982400|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982401|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55982402|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55982403|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
55982404|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55982405|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55982406|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
55982407|NCT02701582|Phenylephrine|phenylephrine|mesh-list
55982408|NCT02701582|Epinephrine|epinephrine|mesh-list
55982409|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
55982410|NCT02701582|Synephrine|synephrine|mesh-list
56214280|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56214281|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
56214282|NCT01612273|Aspirin|aspirin|mesh-list
55982411|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55982412|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55982413|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
55982414|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982415|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982416|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982417|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55982418|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55982419|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
55982420|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982421|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55982422|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
55982423|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
55982424|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
55982425|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55982426|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55982427|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
55982428|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55982429|NCT02701582|Protective Agents|protective agents|mesh-ancestor
55982430|NCT00869791|Levodopa|levodopa|mesh-list
55982431|NCT00869791|Carbidopa|carbidopa|mesh-list
55982432|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55982433|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55982434|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55982435|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
55982436|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982437|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982438|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982439|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55982440|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982441|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55982442|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
55982443|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
55982444|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55982445|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55982446|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55982447|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
55982448|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982449|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55982450|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55982451|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982453|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
55982455|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982456|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55982457|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
55982458|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55982459|NCT01622335|Analgesics|analgesics|mesh-ancestor
55982460|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
55982461|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982462|NCT00895531|Morphine|morphine|mesh-list
55982463|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55982464|NCT00895531|Narcotics|narcotics|mesh-ancestor
55982465|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982466|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982467|NCT00895531|Analgesics|analgesics|mesh-ancestor
55982468|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
55982469|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982470|NCT03215875|Torsemide|torsemide|mesh-list
55982471|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55982472|NCT03215875|Diuretics|diuretics|mesh-ancestor
55982473|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
55982474|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982475|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55982476|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55982477|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982478|NCT02710630|Dabigatran|dabigatran|mesh-list
55982479|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
55902761|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55982480|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55982481|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
56214283|NCT01612273|Triflusal|triflusal|mesh-list
56214284|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55982482|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982483|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982484|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
55982485|NCT02715700|Methadone|methadone|mesh-list
55982486|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55982487|NCT02715700|Narcotics|narcotics|mesh-ancestor
55982488|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982489|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982490|NCT02715700|Analgesics|analgesics|mesh-ancestor
55982491|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
55982492|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982493|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
55982494|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
55982495|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
55982496|NCT00338377|Fludarabine|fludarabine|mesh-list
55982497|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
55982498|NCT00338377|Interleukin-2|interleukin-2|mesh-list
55982500|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55982501|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
55982502|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982503|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55982504|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55982505|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
55982506|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982507|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982508|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55982509|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55982510|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
55982511|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55982512|NCT00338377|Analgesics|analgesics|mesh-ancestor
55982513|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
55982514|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982515|NCT00338377|Protective Agents|protective agents|mesh-ancestor
55982516|NCT00895921|Olanzapine|olanzapine|mesh-list
55982517|NCT00895921|Aripiprazole|aripiprazole|mesh-list
55982518|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
55982519|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
55982520|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982521|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982522|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55982523|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55982524|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55982525|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982526|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55982527|NCT00895921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55982528|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55982530|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982532|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
55982533|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
55982534|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
55982536|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55982537|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55902810|NCT05730634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55982538|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55982539|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55982540|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55982541|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55982543|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55982544|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55982545|NCT05315479|Analgesics|analgesics|mesh-ancestor
55982546|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
55982547|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982548|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982549|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55982550|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55982551|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55982552|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55982553|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982554|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982555|NCT05312671|Cisplatin|cisplatin|mesh-list
55982556|NCT05312671|Carboplatin|carboplatin|mesh-list
55982557|NCT05312671|Etoposide|etoposide|mesh-list
55982558|NCT05312671|Atezolizumab|atezolizumab|mesh-list
55982559|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
55982560|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982561|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55982562|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55982563|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55982564|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982565|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982566|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
55982567|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
55982568|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
55982569|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
55982570|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
55902862|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55902863|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
55902864|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902865|NCT03167268|Protective Agents|protective agents|mesh-ancestor
55902866|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902867|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55902868|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55902869|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902870|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55902871|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55982571|NCT00883675|Carboplatin|carboplatin|mesh-list
55982572|NCT00883675|Docetaxel|docetaxel|mesh-list
55982573|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982574|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
55982575|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
55982576|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
55982577|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982578|NCT03215407|Betamethasone|betamethasone|mesh-list
55982579|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55982580|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
55982581|NCT03215407|Hormones|hormones|mesh-ancestor
55982582|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55982583|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982584|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55982585|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
55982586|NCT05310331|Paclitaxel|paclitaxel|mesh-list
55982587|NCT05310331|Antibodies|antibodies|mesh-list
55982588|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55982589|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982590|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
55982591|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
55982592|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
55982593|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982594|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
55982595|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982596|NCT00885079|Rebamipide|rebamipide|mesh-list
55982597|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55982598|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55982599|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55982600|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55982601|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
55902925|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55902926|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55902927|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
55902928|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902929|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
55902930|NCT04024462|Docetaxel|docetaxel|mesh-list
55902931|NCT04024462|Doxorubicin|doxorubicin|mesh-list
55902932|NCT04024462|Trastuzumab|trastuzumab|mesh-list
55902933|NCT04024462|Pertuzumab|pertuzumab|mesh-list
55902934|NCT04024462|Hormones|hormones|mesh-list
55902935|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55902936|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
55902937|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831525|NCT02196701|Methotrexate|methotrexate|mesh-list
55982602|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982605|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982607|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55982608|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55982609|NCT00896779|Growth Substances|growth substances|mesh-ancestor
55982610|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982612|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982613|NCT02722564|Ethanol|ethanol|mesh-list
55982614|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55982615|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982616|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982617|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982618|NCT03376477|Lenalidomide|lenalidomide|mesh-list
55982619|NCT03376477|Molgramostim|molgramostim|mesh-list
55982620|NCT03376477|Vaccines|vaccines|mesh-list
55982621|NCT03376477|Sargramostim|sargramostim|mesh-list
55982622|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55982623|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
55982624|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982625|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55982626|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55982627|NCT03376477|Growth Substances|growth substances|mesh-ancestor
55982628|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
55982629|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982630|NCT02726620|Lidocaine|lidocaine|mesh-list
55982631|NCT02726620|Atropine|atropine|mesh-list
55982632|NCT02726620|Terlipressin|terlipressin|mesh-list
56214287|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
56142076|NCT03035214|Hormones|hormones|mesh-ancestor
56214288|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790745|NCT03104959|Expectorants|expectorants|mesh-ancestor
55982633|NCT02726620|Phenylephrine|phenylephrine|mesh-list
55982634|NCT02726620|Dobutamine|dobutamine|mesh-list
55982635|NCT02726620|Dopamine|dopamine|mesh-list
55982636|NCT02726620|Milrinone|milrinone|mesh-list
55982638|NCT02726620|Vasopressins|vasopressins|mesh-list
55982639|NCT02726620|Arginine Vasopressin|arginine vasopressin|mesh-list
55982640|NCT02726620|Epinephrine|epinephrine|mesh-list
55982641|NCT02726620|Norepinephrine|norepinephrine|mesh-list
55982642|NCT02726620|Ephedrine|ephedrine|mesh-list
55982643|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
55982644|NCT02726620|Bupivacaine|bupivacaine|mesh-list
55982645|NCT02726620|Ropivacaine|ropivacaine|mesh-list
55982646|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
55982647|NCT02726620|Tetracaine|tetracaine|mesh-list
55982648|NCT02726620|Prilocaine|prilocaine|mesh-list
55982649|NCT02726620|Mepivacaine|mepivacaine|mesh-list
55982650|NCT02726620|Benzocaine|benzocaine|mesh-list
55982651|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
55982652|NCT02726620|Procaine|procaine|mesh-list
55982653|NCT02726620|Anesthetics|anesthetics|mesh-list
55982654|NCT02726620|Propofol|propofol|mesh-list
55982655|NCT02726620|Sevoflurane|sevoflurane|mesh-list
55982656|NCT02726620|Desflurane|desflurane|mesh-list
55982657|NCT02726620|Isoflurane|isoflurane|mesh-list
55982658|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55982659|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
55982660|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
55982661|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982662|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982663|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
55982664|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982665|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55982666|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55982667|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55982668|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55982669|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982670|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55982671|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55982672|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
55982673|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55982674|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55982675|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55982676|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55982677|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
55982678|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982679|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55982680|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55982681|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
55982682|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55982684|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
55982685|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
55982686|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55982687|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55982688|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
55982689|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55982690|NCT02726620|Protective Agents|protective agents|mesh-ancestor
55982691|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55982692|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
55982693|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55982694|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55982695|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
55982696|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
55982697|NCT02726620|Coagulants|coagulants|mesh-ancestor
55982698|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55982699|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
55982700|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55982701|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55982702|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55982703|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
55982704|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
55982705|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56214289|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214290|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55982706|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55982707|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982708|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55982709|NCT00887575|Paclitaxel|paclitaxel|mesh-list
55982710|NCT00887575|Carboplatin|carboplatin|mesh-list
55982711|NCT00887575|Sunitinib|sunitinib|mesh-list
55982712|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55982713|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982714|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
55982715|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
55982716|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
55982717|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982718|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55982719|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55982720|NCT00887575|Growth Substances|growth substances|mesh-ancestor
55982721|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982722|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
55982723|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55982724|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982725|NCT03352843|Primaquine|primaquine|mesh-list
55982726|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
55982727|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55982728|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55982729|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982730|NCT03238027|Durvalumab|durvalumab|mesh-list
55982731|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55982732|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982733|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
55982734|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55982735|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55982736|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
55982737|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982738|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55982739|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55982740|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982741|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982742|NCT00887965|Denosumab|denosumab|mesh-list
55982743|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55982744|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982745|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
55982746|NCT05311813|Enoxaparin|enoxaparin|mesh-list
55982747|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
55982748|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55982749|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55982750|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982751|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982752|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982753|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55982754|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
55982755|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55982756|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55982757|NCT03214627|Iron|iron|mesh-list
55982759|NCT03214627|Hematinics|hematinics|mesh-list
55982760|NCT03214627|Trace Elements|trace elements|mesh-ancestor
55982761|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
55982765|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55982766|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982767|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982768|NCT03214393|Antibodies|antibodies|mesh-list
55982769|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
55982770|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982771|NCT00888979|Nicotine|nicotine|mesh-list
55982772|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55982773|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
55982774|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982775|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982776|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55982777|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55982778|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
55982779|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982780|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982781|NCT03214003|Cisplatin|cisplatin|mesh-list
56214291|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55982782|NCT03214003|Etoposide|etoposide|mesh-list
55982783|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
55982784|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982785|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55982786|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55982787|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55982788|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982789|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982790|NCT03214159|Ritonavir|ritonavir|mesh-list
55982791|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55982792|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55982793|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
55982794|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982795|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982796|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55982797|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55982798|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
55982799|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982800|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55982801|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55982802|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
55982803|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
55982804|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55982805|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55982806|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982807|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982808|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982809|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55982810|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55982811|NCT02879695|Nivolumab|nivolumab|mesh-list
55982812|NCT02879695|Ipilimumab|ipilimumab|mesh-list
55982813|NCT02879695|Blinatumomab|blinatumomab|mesh-list
55982814|NCT02879695|Antibodies|antibodies|mesh-list
55982815|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
55982816|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55902981|NCT02397486|Protective Agents|protective agents|mesh-ancestor
55902982|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55902983|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902984|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55902985|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55902986|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
55902987|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55902988|NCT02393586|Amoxicillin|amoxicillin|mesh-list
55902989|NCT02393586|Rifampin|rifampin|mesh-list
55902990|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55902991|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
55902992|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
55982817|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
55982818|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55982819|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
55982820|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982821|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982822|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55982823|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982824|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55982825|NCT02737072|Durvalumab|durvalumab|mesh-list
55982826|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55982827|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982828|NCT02669173|Bevacizumab|bevacizumab|mesh-list
55982829|NCT02669173|Capecitabine|capecitabine|mesh-list
55982830|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55982831|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982832|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55831644|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
55831645|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
55831646|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982839|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982841|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55982842|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
55982843|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982844|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982845|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982846|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55982847|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55982848|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
55982849|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
55982850|NCT03213145|Rifampin|rifampin|mesh-list
55982851|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55982852|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
55982853|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55982854|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982855|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
55982856|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55982857|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982858|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214292|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56214293|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55982859|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55982860|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55982861|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55982862|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55982863|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55982864|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55982865|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
55982866|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55982867|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
55982868|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55982869|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982871|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
55982872|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55982873|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
55982874|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982875|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982876|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55982877|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
55982878|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
55982879|NCT05446090|Protective Agents|protective agents|mesh-ancestor
55982880|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55982881|NCT05445076|Antibodies|antibodies|mesh-list
55982882|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
55982883|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55982884|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
55982885|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982886|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982887|NCT05444998|Paclitaxel|paclitaxel|mesh-list
55982888|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55982889|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982890|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
55982891|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
55982892|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
55982893|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982894|NCT05444842|Insulin|insulin|mesh-list
55982895|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55982896|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55982897|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982898|NCT04381741|Antibodies|antibodies|mesh-list
55982899|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55982900|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
55982901|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982902|NCT05444452|Sirolimus|sirolimus|mesh-list
55982903|NCT05444452|Everolimus|everolimus|mesh-list
55982906|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
55982907|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982908|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55982909|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982910|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55982912|NCT05444374|Bevacizumab|bevacizumab|mesh-list
55982913|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55982914|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982915|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55982916|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55982917|NCT05444374|Growth Substances|growth substances|mesh-ancestor
55982918|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982919|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
55982921|NCT05444218|Metronidazole|metronidazole|mesh-list
55982922|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55982923|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902993|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55902994|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902995|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55902996|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
55902997|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
55902998|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55902999|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903000|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903001|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55982924|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55982925|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55982926|NCT01830361|Midostaurin|midostaurin|mesh-list
55982927|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982928|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55982929|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982930|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982932|NCT01830517|Amlodipine|amlodipine|mesh-list
56214294|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214295|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56214296|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55982933|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55982934|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55982935|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55982936|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982937|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55982938|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982939|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
55982940|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55982941|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55982942|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55982943|NCT03212833|Insulin|insulin|mesh-list
55982944|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55982945|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982946|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
55982947|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
55982948|NCT05443360|Calcium|calcium|mesh-list
55982949|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55982950|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982951|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55982952|NCT05443360|Antacids|antacids|mesh-ancestor
55982953|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982954|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55982955|NCT05443282|Hormones|hormones|mesh-list
55982956|NCT05443282|Estradiol|estradiol|mesh-list
55982957|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55982958|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55982959|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982960|NCT05443282|Estrogens|estrogens|mesh-ancestor
55982961|NCT00904345|Cetuximab|cetuximab|mesh-list
55982962|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55982963|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982964|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
55982965|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55982966|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982967|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55982968|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55982969|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982970|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903002|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55903003|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55903004|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55903005|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55903006|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55982971|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982972|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55982973|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55982974|NCT01830829|Tamsulosin|tamsulosin|mesh-list
55982975|NCT01830829|Dutasteride|dutasteride|mesh-list
55982978|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55982979|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
55982980|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982981|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55982982|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982984|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55982985|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55982986|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55982987|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
55982988|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55982989|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
55982990|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55982991|NCT03212755|Antibodies|antibodies|mesh-list
55982992|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
55982993|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
55982994|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982995|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
55982996|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55982997|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55982998|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214297|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214298|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
56214299|NCT01612286|Endostatins|endostatins|mesh-list
56214300|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56214301|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56214302|NCT01612286|Growth Substances|growth substances|mesh-ancestor
55982999|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
55983000|NCT05437822|Coagulants|coagulants|mesh-ancestor
55983001|NCT03212599|Disulfiram|disulfiram|mesh-list
55983002|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55983003|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
55983004|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983005|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983006|NCT03212053|Hemostatics|hemostatics|mesh-list
55983007|NCT03212053|Coagulants|coagulants|mesh-ancestor
55983008|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
55983009|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55983010|NCT05311189|Trastuzumab|trastuzumab|mesh-list
55983011|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55983012|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983013|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
55983014|NCT00369772|Hematinics|hematinics|mesh-ancestor
55983015|NCT03211897|Midazolam|midazolam|mesh-list
55983016|NCT03211897|Haloperidol|haloperidol|mesh-list
55983017|NCT03211897|Olanzapine|olanzapine|mesh-list
55983019|NCT03211897|Ziprasidone|ziprasidone|mesh-list
55983020|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55983021|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55983022|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983023|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983024|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55983025|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55983026|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55983027|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55983028|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
55756028|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55714995|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
55983029|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
55983030|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
55983031|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
55983032|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983033|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983034|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
55983035|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
55983036|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983037|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55983038|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55983039|NCT03211897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55983040|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55983041|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983042|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
55983043|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55983044|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
55983045|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55983046|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55983047|NCT01831687|Etodolac|etodolac|mesh-list
55983048|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55983049|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55983050|NCT01831687|Analgesics|analgesics|mesh-ancestor
55983052|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983053|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983054|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55983055|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983056|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55983057|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55983058|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983059|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983061|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55983062|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903008|NCT02393430|Rebamipide|rebamipide|mesh-list
55903009|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55903010|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55903011|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
55903012|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903013|NCT02393430|Protective Agents|protective agents|mesh-ancestor
55903014|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903015|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903016|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
55983063|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
55983064|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
55983065|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
55983066|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214303|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214304|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
56214305|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214306|NCT01612299|Everolimus|everolimus|mesh-list
55983068|NCT00369148|Mitiglinide|mitiglinide|mesh-list
55983069|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55983070|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983071|NCT03816982|Bupivacaine|bupivacaine|mesh-list
55983072|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
55983073|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
55983074|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983075|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983076|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
55983077|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983078|NCT01832467|Cetuximab|cetuximab|mesh-list
55983079|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55983080|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983081|NCT03211351|Dextrans|dextrans|mesh-list
55983082|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
55983083|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
55983084|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
55983085|NCT01832623|Vitamin D|vitamin d|mesh-list
55983086|NCT01832623|Vitamins|vitamins|mesh-ancestor
55983087|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
55983088|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983089|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55983090|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55983091|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55983092|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983093|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55983094|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983095|NCT05316493|Megestrol|megestrol|mesh-list
55983096|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
55983097|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
55983098|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
55983099|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55983100|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983101|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55983102|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55983103|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55983104|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55983105|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55983106|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55983107|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983108|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
55983109|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55983110|NCT02470390|Fentanyl|fentanyl|mesh-list
55983111|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55756052|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
55715088|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
55983112|NCT02470390|Narcotics|narcotics|mesh-ancestor
55983113|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983114|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983115|NCT02470390|Analgesics|analgesics|mesh-ancestor
55983116|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
55983117|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983118|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55983119|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55983120|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
55983121|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
55983122|NCT00363532|Calcitonin|calcitonin|mesh-list
55983123|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
55983125|NCT00363532|Katacalcin|katacalcin|mesh-list
55983126|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55983127|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983128|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55983130|NCT00363610|Pegaspargase|pegaspargase|mesh-list
55983131|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983132|NCT00363688|Penicillins|penicillins|mesh-list
55983133|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55983134|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983135|NCT01832935|Insulin|insulin|mesh-list
55983136|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56214307|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214308|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214309|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
56214310|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214311|NCT01612377|Prednisone|prednisone|mesh-list
56214312|NCT01612377|Prednisolone|prednisolone|mesh-list
56214313|NCT01612377|Dipyridamole|dipyridamole|mesh-list
56214314|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214315|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
56214316|NCT01612377|Hormones|hormones|mesh-ancestor
56214317|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214318|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214319|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56214320|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214321|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56214322|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214323|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983137|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
55983138|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
55983139|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
55983140|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
55983141|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55903017|NCT03453892|Nivolumab|nivolumab|mesh-list
55903018|NCT03453892|Ipilimumab|ipilimumab|mesh-list
55903019|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55903020|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903021|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55903022|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903023|NCT00367120|Amoxicillin|amoxicillin|mesh-list
55903024|NCT00367120|Azithromycin|azithromycin|mesh-list
55983142|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983143|NCT03216733|Sirolimus|sirolimus|mesh-list
55983144|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55983145|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983146|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55983147|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983148|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
55983149|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983150|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
55983151|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983152|NCT03216343|Chiauranib|chiauranib|mesh-list
55983153|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983154|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55983155|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983156|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983157|NCT03333616|Nivolumab|nivolumab|mesh-list
55983158|NCT03333616|Ipilimumab|ipilimumab|mesh-list
55983159|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55983160|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983161|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55983162|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983163|NCT04380181|Milrinone|milrinone|mesh-list
55983164|NCT04380181|Epinephrine|epinephrine|mesh-list
55983165|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55983166|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55983167|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983168|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983169|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983170|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983171|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55983172|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55983173|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
55983174|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983175|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55983176|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214324|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56214325|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
56214326|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
56214327|NCT01612403|Astringents|astringents|mesh-ancestor
56214328|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214329|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
56214330|NCT01612468|Liraglutide|liraglutide|mesh-list
56214331|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56214332|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214333|NCT01612468|Incretins|incretins|mesh-ancestor
56214335|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214337|NCT01612507|Cephalosporins|cephalosporins|mesh-list
56214338|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56214339|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214340|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56214341|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55983177|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
55983178|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
55983179|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55983180|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55983181|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55983182|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
55983183|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55983184|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55983185|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983186|NCT04380181|Protective Agents|protective agents|mesh-ancestor
55983187|NCT01833559|Insulin|insulin|mesh-list
55983188|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55983189|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
55983190|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55983191|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983192|NCT05394142|Metformin|metformin|mesh-list
55983193|NCT05394142|Pioglitazone|pioglitazone|mesh-list
55983194|NCT05394142|Spironolactone|spironolactone|mesh-list
55983195|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55983196|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983197|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55983198|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
55983199|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55983201|NCT05394142|Diuretics|diuretics|mesh-ancestor
55983202|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
55983203|NCT00901225|Plerixafor|plerixafor|mesh-list
55983204|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55983205|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55983206|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
55983207|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983208|NCT01833715|Morphine|morphine|mesh-list
55983209|NCT01833715|Methadone|methadone|mesh-list
55983210|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55983211|NCT01833715|Narcotics|narcotics|mesh-ancestor
55983212|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983213|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983214|NCT01833715|Analgesics|analgesics|mesh-ancestor
55983215|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
55983216|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983217|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
55983218|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214342|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214343|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214344|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55983219|NCT05393050|Methotrexate|methotrexate|mesh-list
55983220|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55983221|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
55983222|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55983223|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983224|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55983225|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
55889788|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55903093|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903094|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55983226|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983227|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983228|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
55983229|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983230|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55983231|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983232|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
55983233|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983234|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55983235|NCT03166228|Glycine|glycine|mesh-list
55983236|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
55983237|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983238|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983239|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983240|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
55983241|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55983242|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
55983243|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55983244|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983245|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55983246|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55983247|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55983248|NCT03216187|Pregabalin|pregabalin|mesh-list
55983249|NCT03216187|Analgesics|analgesics|mesh-ancestor
55983250|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
55983251|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983252|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983253|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
55983254|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55983255|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983256|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983257|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55983258|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55983259|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55983260|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983261|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55983262|NCT03154996|Topotecan|topotecan|mesh-list
55983263|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55983264|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55983265|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983266|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983267|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715279|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
55983268|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
55983269|NCT02475070|Vildagliptin|vildagliptin|mesh-list
55983270|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55983271|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983274|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55983276|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983277|NCT00902161|Propranolol|propranolol|mesh-list
55983278|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55983279|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55983280|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983281|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983282|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983283|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983284|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55983285|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55983286|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
55983287|NCT01834183|Gemcitabine|gemcitabine|mesh-list
56214345|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
56214346|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214347|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983288|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55983289|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
55983290|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983291|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983292|NCT01834183|Antiviral Agents|antiviral agents|mesh-ancestor
55983293|NCT01834183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983294|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983295|NCT01834183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983296|NCT01834183|Immunologic Factors|immunologic factors|mesh-ancestor
55983297|NCT01834183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983298|NCT02478580|Modafinil|modafinil|mesh-list
55983299|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55983300|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983301|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55983302|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55983303|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55889790|NCT02916771|Hormones|hormones|mesh-ancestor
55903127|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903128|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903129|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55903130|NCT00367276|Diuretics|diuretics|mesh-ancestor
55903131|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
55903132|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
55903133|NCT02546986|Azacitidine|azacitidine|mesh-list
55903135|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55903136|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903137|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55903138|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
55903139|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903140|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903141|NCT02689206|Glycine|glycine|mesh-list
55903142|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
55903143|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715331|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
55983304|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983305|NCT02994784|Melphalan|melphalan|mesh-list
55983306|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55983307|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
55983308|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983309|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983310|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55983311|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983312|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
55831655|NCT01456936|Bupropion|bupropion|mesh-list
55983314|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55983315|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
55983316|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983317|NCT03210025|Methyldopa|methyldopa|mesh-list
55983318|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55983319|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
55983320|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
55983321|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983322|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983323|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55983324|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55983325|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55983326|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983327|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983328|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983329|NCT03219853|Selenium|selenium|mesh-list
55983330|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
55983331|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983332|NCT03219853|Protective Agents|protective agents|mesh-ancestor
55983333|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983334|NCT03219853|Trace Elements|trace elements|mesh-ancestor
55983335|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
55903144|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903145|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903146|NCT01695239|Adalimumab|adalimumab|mesh-list
55903147|NCT01695239|Ixekizumab|ixekizumab|mesh-list
55903148|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903149|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55903150|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
55903151|NCT02163694|Paclitaxel|paclitaxel|mesh-list
55903152|NCT02163694|Carboplatin|carboplatin|mesh-list
55903153|NCT02163694|Veliparib|veliparib|mesh-list
55742455|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
55983336|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
55983337|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55983338|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
55983339|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983340|NCT02480998|Vaccines|vaccines|mesh-list
55983341|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
55983342|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983346|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983347|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
55983348|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983349|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55983350|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983351|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983352|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
55983353|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983354|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
55983355|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983356|NCT03215797|Phenylephrine|phenylephrine|mesh-list
55983357|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
56214348|NCT01612741|Acarbose|acarbose|mesh-list
56214349|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56214350|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790792|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
55983358|NCT03215797|Norepinephrine|norepinephrine|mesh-list
55983359|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
55983360|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55983361|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
55983362|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
55983363|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983364|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983365|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
55983366|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55983367|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
55983368|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
55983369|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55983370|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55983371|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983372|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983373|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983374|NCT03215797|Protective Agents|protective agents|mesh-ancestor
55983375|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55983376|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
55983377|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983378|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55983379|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
55983380|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983381|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983382|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55983383|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55983384|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983385|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983386|NCT02485834|Docetaxel|docetaxel|mesh-list
55983387|NCT02485834|Capecitabine|capecitabine|mesh-list
55983388|NCT02485834|Irinotecan|irinotecan|mesh-list
55983389|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983390|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
55983391|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
55983392|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
55983393|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983394|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55983395|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
55983396|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55983397|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55983398|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983399|NCT01834885|Fluticasone|fluticasone|mesh-list
55983400|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55983401|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55983402|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55983403|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55983404|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
55983405|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983406|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983407|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55983408|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
55983409|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
55983410|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55983411|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55983412|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55983413|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55983414|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983415|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983416|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983418|NCT01834885|Hormones|hormones|mesh-ancestor
55983419|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55983420|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
55983421|NCT01834963|Interferons|interferons|mesh-list
55983422|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
55983423|NCT01834963|Cisplatin|cisplatin|mesh-list
55983424|NCT01834963|Fluorouracil|fluorouracil|mesh-list
55983425|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214351|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214352|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56214353|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983426|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
55983427|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983428|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55983429|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983430|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
55903166|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903167|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903168|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903169|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55903170|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
55903171|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
55903172|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
55903188|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55903189|NCT00703222|Analgesics|analgesics|mesh-ancestor
55903190|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
55983431|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983432|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
55983433|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983434|NCT04380103|Bevacizumab|bevacizumab|mesh-list
55983435|NCT04380103|Capecitabine|capecitabine|mesh-list
55983436|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
55983437|NCT04380103|Irinotecan|irinotecan|mesh-list
55983438|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55983439|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983440|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55983441|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55983442|NCT04380103|Growth Substances|growth substances|mesh-ancestor
55983443|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983444|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
55983445|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55983446|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
55983447|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983448|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55983449|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55983450|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983452|NCT01954966|Progestins|progestins|mesh-ancestor
55983453|NCT01954966|Hormones|hormones|mesh-ancestor
55983454|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55983455|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983456|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55983457|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55983458|NCT03836599|Allopurinol|allopurinol|mesh-list
55983459|NCT03836599|Verinurad|verinurad|mesh-list
55983460|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
55983461|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983462|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983463|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
55983464|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983465|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55983466|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
55983467|NCT03836599|Protective Agents|protective agents|mesh-ancestor
55983468|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983469|NCT01839097|Prednisone|prednisone|mesh-list
55983470|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
55983471|NCT01839097|Doxorubicin|doxorubicin|mesh-list
55983472|NCT01839097|Vincristine|vincristine|mesh-list
55983473|NCT01839097|Belinostat|belinostat|mesh-list
55983474|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983475|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
55983476|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983477|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983478|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55983479|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
55983480|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983481|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983482|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55983483|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55983484|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55983485|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55983486|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983487|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55983488|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
55903210|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55983489|NCT01839097|Hormones|hormones|mesh-ancestor
55983490|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55983491|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55983493|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
55983494|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
55983495|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
56214355|NCT01612832|Analgesics|analgesics|mesh-ancestor
56214356|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
56214357|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214358|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983496|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55983498|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55983499|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55983500|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983501|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983502|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55983503|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983504|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
55983505|NCT01839175|Vaccines|vaccines|mesh-list
55983506|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55983507|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
55983508|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983509|NCT01839253|Atenolol|atenolol|mesh-list
55983510|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55983511|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55983512|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55983513|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
55983514|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
55983515|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983516|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983517|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55983518|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55983519|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55983520|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
55804572|NCT02311881|Acetaminophen|acetaminophen|mesh-list
55804573|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55804574|NCT02311881|Analgesics|analgesics|mesh-ancestor
55804575|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
55983521|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983522|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983523|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
55983524|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983525|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
55983526|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983527|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
55983528|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983529|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983530|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55983531|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
55983532|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983533|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983534|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55983535|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55983536|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
55983537|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983538|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55983539|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
55983540|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983541|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983542|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55903211|NCT03821272|Vaccines|vaccines|mesh-list
55983543|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55983544|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983545|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983546|NCT01839643|Meloxicam|meloxicam|mesh-list
55983547|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55983548|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55983549|NCT01839643|Analgesics|analgesics|mesh-ancestor
55983550|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
55983551|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983552|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983553|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55983554|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983555|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55983556|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55983557|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214359|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
56214360|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56214361|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983558|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983559|NCT04380025|Pycnogenols|pycnogenols|mesh-list
55983560|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55983562|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983563|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
55983564|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983565|NCT04380025|Protective Agents|protective agents|mesh-ancestor
55983566|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55983567|NCT01836679|Paclitaxel|paclitaxel|mesh-list
55983568|NCT01836679|Carboplatin|carboplatin|mesh-list
55983569|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55983570|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983571|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
55983572|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
55983573|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
55983574|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983575|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55983576|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
55983577|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983578|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55983579|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
55983580|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983581|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983582|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55983583|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55983584|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983585|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983586|NCT00369538|Losartan|losartan|mesh-list
55983587|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55983588|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55983589|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55983591|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55983592|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983593|NCT00369538|Diuretics|diuretics|mesh-ancestor
55983594|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
55983595|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903223|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55715631|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
55983596|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55983597|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983598|NCT05177848|Nicotine|nicotine|mesh-list
55983599|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55983600|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
55983601|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983602|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983603|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55983604|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55983605|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
55983606|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983607|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983608|NCT02489734|Sevoflurane|sevoflurane|mesh-list
55983609|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55983610|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55983611|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
55983612|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
55983613|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983614|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983615|NCT02490670|Cephalexin|cephalexin|mesh-list
55983616|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55983617|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983618|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
55983619|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55983620|NCT05451472|Calcium|calcium|mesh-list
55983621|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
55983622|NCT05451472|Hormones|hormones|mesh-list
55983623|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55983624|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983625|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214362|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214363|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55983626|NCT03218059|Methotrexate|methotrexate|mesh-list
55983627|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55983628|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
55983629|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55983630|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983631|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55983632|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
55983634|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983635|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
55983636|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983637|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55983638|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983639|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
55983640|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983641|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55983643|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55983644|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983645|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55983646|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983647|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983648|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
55983649|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55983650|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
55983651|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55983652|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983653|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
55983654|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55983655|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
55983656|NCT02494102|Modafinil|modafinil|mesh-list
55983657|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55983658|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983659|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55983660|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55983661|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55983662|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983664|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55983665|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55983666|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55983667|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983668|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983669|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
55983670|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983671|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983672|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55983673|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983674|NCT01838395|Cytarabine|cytarabine|mesh-list
55983675|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55983676|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
55903225|NCT03189706|Irinotecan|irinotecan|mesh-list
55903226|NCT03189706|Temozolomide|temozolomide|mesh-list
55903227|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55903228|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55903229|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903230|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903231|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983677|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983678|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983679|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
55983680|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983681|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983682|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
55983683|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983684|NCT00422578|Tadalafil|tadalafil|mesh-list
55983685|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
55983686|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55983687|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55983688|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983689|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983690|NCT00422578|Urological Agents|urological agents|mesh-ancestor
55983691|NCT02494180|Fentanyl|fentanyl|mesh-list
55983692|NCT02494180|Midazolam|midazolam|mesh-list
55983693|NCT02494180|Diazepam|diazepam|mesh-list
55983694|NCT02494180|Meperidine|meperidine|mesh-list
55983695|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55983696|NCT02494180|Narcotics|narcotics|mesh-ancestor
56214364|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56214365|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56214366|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214367|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56214368|NCT01612871|Tamoxifen|tamoxifen|mesh-list
56214369|NCT01612871|Letrozole|letrozole|mesh-list
56214370|NCT01612871|Anastrozole|anastrozole|mesh-list
56214371|NCT01612871|Exemestane|exemestane|mesh-list
55983697|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983698|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983699|NCT02494180|Analgesics|analgesics|mesh-ancestor
55983700|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
55983701|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983702|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55983703|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55983704|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
55983705|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
55983708|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55983709|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55983710|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
55983711|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
55983712|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983713|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983714|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
55983715|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
55983716|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
55983717|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55983718|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55983719|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55983720|NCT02494336|Ropivacaine|ropivacaine|mesh-list
55983721|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
55983722|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
55983723|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983724|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983725|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
55983726|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983728|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
55983729|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55983730|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55983731|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
55983732|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
55983733|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983735|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55983736|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55983737|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55983738|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983739|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983740|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983741|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
55983742|NCT02495038|Rocuronium|rocuronium|mesh-list
55983743|NCT02495038|Atracurium|atracurium|mesh-list
55983744|NCT02495038|Cisatracurium|cisatracurium|mesh-list
55983745|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55983746|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55983747|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55983748|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983749|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983750|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55983751|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55983752|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
55983753|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983754|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983755|NCT01720303|Insulin|insulin|mesh-list
55983756|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55983757|NCT01720303|Repaglinide|repaglinide|mesh-list
55983758|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
55983759|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
55983760|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
56214372|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214373|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56214374|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56214375|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214376|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983761|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55983762|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983763|NCT04956484|Belimumab|belimumab|mesh-list
55983764|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55983765|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
55983766|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983767|NCT05450458|Sorbitol|sorbitol|mesh-list
55983768|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
55983769|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55983770|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
55983771|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983772|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
55983773|NCT05450458|Protective Agents|protective agents|mesh-ancestor
55983774|NCT05450458|Cathartics|cathartics|mesh-ancestor
55983775|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55983776|NCT01720615|Remifentanil|remifentanil|mesh-list
55715828|NCT05262413|Lenvatinib|lenvatinib|mesh-list
55983777|NCT01720615|Propofol|propofol|mesh-list
55983778|NCT01720615|Sevoflurane|sevoflurane|mesh-list
55983779|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55983780|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983781|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983785|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55983786|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55983787|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55983788|NCT01720615|Narcotics|narcotics|mesh-ancestor
55983789|NCT01720615|Analgesics|analgesics|mesh-ancestor
55983790|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
55983791|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983792|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
55983793|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
55983794|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55983795|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
55983796|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983797|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983798|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55983799|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
55983800|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
55983801|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55983803|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983804|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983805|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55983806|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55983807|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
55983809|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983811|NCT02504554|Omeprazole|omeprazole|mesh-list
55983812|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55983813|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983814|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55983815|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55983816|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55983817|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983818|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983819|NCT01838473|Lobeline|lobeline|mesh-list
55983820|NCT01838473|Nicotine|nicotine|mesh-list
55983821|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55983822|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
55983823|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983824|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983825|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55983826|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55983827|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
55983828|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983829|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903281|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55903282|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55903283|NCT01581281|Analgesics|analgesics|mesh-ancestor
55903284|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
55903285|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903286|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55903287|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55903288|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903289|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903290|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
55715878|NCT05262335|Paclitaxel|paclitaxel|mesh-list
55983830|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214377|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56214378|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
55790814|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55983831|NCT04937452|Rotigotine|rotigotine|mesh-list
55983832|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
55983833|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
55983834|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983835|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983836|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983837|NCT01838707|Fentanyl|fentanyl|mesh-list
55983838|NCT01838707|Morphine|morphine|mesh-list
55983839|NCT01838707|Bupivacaine|bupivacaine|mesh-list
55983840|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
55983841|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
55983842|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983843|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983844|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
55983845|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983846|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55983847|NCT01838707|Narcotics|narcotics|mesh-ancestor
55983848|NCT01838707|Analgesics|analgesics|mesh-ancestor
55983849|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55983850|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55983851|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
55983853|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55983854|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983855|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55983856|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983860|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983861|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
55983862|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
55983863|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
55983864|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983865|NCT04920994|Bupivacaine|bupivacaine|mesh-list
55983866|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
55983867|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
55983868|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983869|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983870|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
55983871|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983872|NCT02506660|Dexamethasone|dexamethasone|mesh-list
55983873|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
55983874|NCT02506660|Bupivacaine|bupivacaine|mesh-list
55983875|NCT02506660|BB 1101|bb 1101|mesh-list
55983876|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55983878|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
55983879|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983880|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983881|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55983882|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
55983883|NCT02506660|Hormones|hormones|mesh-ancestor
55983884|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55983885|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55983886|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983887|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
55983888|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983889|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983890|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
55983891|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
55983892|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983893|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
55983894|NCT02509624|Selonsertib|selonsertib|mesh-list
55983895|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55983896|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983897|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983898|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55983899|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55983900|NCT01726075|Somatostatin|somatostatin|mesh-list
55983901|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55983902|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55983903|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55983904|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56214379|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214380|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214381|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55790817|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
55983905|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55983906|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
55983907|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55983908|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983909|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983910|NCT01726075|Hormones|hormones|mesh-ancestor
55983911|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55983912|NCT00369694|Terlipressin|terlipressin|mesh-list
55983913|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55983914|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55983915|NCT01721707|Latanoprost|latanoprost|mesh-list
55983916|NCT01721707|Brinzolamide|brinzolamide|mesh-list
55983917|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55983918|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55983919|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55983920|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55983921|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983923|NCT05448586|Narcotics|narcotics|mesh-ancestor
55983924|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55983925|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983926|NCT05448586|Analgesics|analgesics|mesh-ancestor
55983927|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
55983928|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983929|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
55983930|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
55983932|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55903342|NCT03167112|Protective Agents|protective agents|mesh-ancestor
55903343|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
55903344|NCT03167112|Vitamins|vitamins|mesh-ancestor
55903345|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
55903346|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
55983934|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
55983935|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55983936|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
55983937|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55983938|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55983939|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
55983940|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
55983941|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55983942|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983943|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55983944|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
55983945|NCT01726465|Hormones|hormones|mesh-ancestor
55983946|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55983947|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55983948|NCT01726465|Protective Agents|protective agents|mesh-ancestor
55983949|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55983950|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983951|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
55983952|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55983953|NCT01726465|Expectorants|expectorants|mesh-ancestor
55983954|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
55983955|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55983956|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
55983957|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983958|NCT01726465|Antidotes|antidotes|mesh-ancestor
55983959|NCT02733042|Rituximab|rituximab|mesh-list
55983960|NCT02733042|Durvalumab|durvalumab|mesh-list
55983961|NCT02733042|Lenalidomide|lenalidomide|mesh-list
55983962|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55983963|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55983964|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55983965|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
55983966|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983967|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55983968|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55983969|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55983970|NCT02733042|Growth Substances|growth substances|mesh-ancestor
55983971|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
55983972|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55983973|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
56214382|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56214383|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56214384|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56052227|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55903368|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
55903369|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
55983974|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983975|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
55983976|NCT00912301|Cathartics|cathartics|mesh-ancestor
55983977|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55983978|NCT04850638|Furosemide|furosemide|mesh-list
55983979|NCT04850638|Diuretics|diuretics|mesh-ancestor
55983980|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
55983981|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983982|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55983983|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55983984|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983985|NCT05326776|Oxytocin|oxytocin|mesh-list
55983986|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
55983987|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55983988|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983989|NCT01726777|Vitamin D|vitamin d|mesh-list
55983990|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
55983991|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
55983992|NCT01726777|Vitamins|vitamins|mesh-list
55983993|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
55983994|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983995|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55983996|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55983998|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
55983999|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984000|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
55984001|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984002|NCT05602038|Morphine|morphine|mesh-list
55984003|NCT05602038|Bupivacaine|bupivacaine|mesh-list
55984004|NCT05602038|Anesthetics, Local|anesthetics, local|mesh-ancestor
55984005|NCT05602038|Anesthetics|anesthetics|mesh-ancestor
55984006|NCT05602038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984007|NCT05602038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984008|NCT05602038|Sensory System Agents|sensory system agents|mesh-ancestor
55984009|NCT05602038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984010|NCT05602038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55984011|NCT05602038|Narcotics|narcotics|mesh-ancestor
55984012|NCT05602038|Analgesics|analgesics|mesh-ancestor
55984013|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
55984014|NCT01722409|Sevoflurane|sevoflurane|mesh-list
55984015|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55984016|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984017|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984018|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55984019|NCT01722409|Analgesics|analgesics|mesh-ancestor
55984020|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
55984021|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984022|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55984023|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55984024|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55984025|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
55984026|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984027|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984028|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55984029|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55984031|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
55984032|NCT04307238|Anesthetics|anesthetics|mesh-list
55984033|NCT04307238|Propofol|propofol|mesh-list
55984034|NCT04307238|Sevoflurane|sevoflurane|mesh-list
55984035|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984036|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984037|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55984038|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55984039|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
55984040|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55984041|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55984042|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55984043|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
55984044|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214385|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
56214386|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56214387|NCT01612910|Protective Agents|protective agents|mesh-ancestor
55984045|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
55984046|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984048|NCT01727401|Fondaparinux|fondaparinux|mesh-list
55984049|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55984050|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
55984051|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55984052|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
55984053|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984054|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984055|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
55984056|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55984057|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55984058|NCT02513212|Fluorides|fluorides|mesh-list
55984059|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
55984060|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
55984061|NCT02513212|Protective Agents|protective agents|mesh-ancestor
55984062|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984063|NCT02513446|Itraconazole|itraconazole|mesh-list
55984064|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
55984065|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984066|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55984067|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55984068|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984069|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984070|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55984071|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
55984072|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55984073|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984074|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55984075|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55984076|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55984077|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984078|NCT00363844|Incretins|incretins|mesh-ancestor
55984079|NCT00363844|Hormones|hormones|mesh-ancestor
55984080|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55984081|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55984082|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
55984084|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984085|NCT04687800|Dexamethasone|dexamethasone|mesh-list
55984086|NCT04687800|Difluprednate|difluprednate|mesh-list
55984087|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55984088|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
55984089|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
55984090|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984091|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984092|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55984093|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
55984094|NCT04687800|Hormones|hormones|mesh-ancestor
55984095|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55984096|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55984097|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984098|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
55984099|NCT00864383|Rifampin|rifampin|mesh-list
55984100|NCT00864383|Isoniazid|isoniazid|mesh-list
55984101|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
55984102|NCT00864383|Ethambutol|ethambutol|mesh-list
55984103|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55984104|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984105|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55984106|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55984107|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984108|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984109|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984110|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55984111|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
55984112|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
55984113|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55984114|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56214388|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214389|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984115|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55984116|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55984117|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55984118|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55984119|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55984120|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55984121|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55984122|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
55984123|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55984124|NCT05532072|Sirolimus|sirolimus|mesh-list
55984125|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
55984126|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55984127|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55984128|NCT05532072|Prednisolone|prednisolone|mesh-list
55984129|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
55984130|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55984131|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
55984132|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55984133|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984134|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55903540|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
55903541|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903542|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984135|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984136|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
55984137|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55984138|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
55984139|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984140|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55984141|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
55984142|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
55984143|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984144|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55984145|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
55984146|NCT05532072|Hormones|hormones|mesh-ancestor
55984147|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55984148|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55984149|NCT05532072|Protective Agents|protective agents|mesh-ancestor
55984150|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55984151|NCT05531994|Montelukast|montelukast|mesh-list
55984152|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55984153|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
55984154|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55984155|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
55984156|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55984159|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55984160|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984161|NCT00864539|Vitamin D|vitamin d|mesh-list
55984162|NCT00864539|Calcium|calcium|mesh-list
55984163|NCT00864539|Vitamins|vitamins|mesh-ancestor
55984164|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
55984165|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984166|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55984167|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55984171|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984173|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
55984174|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984175|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
55984176|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984177|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
55984178|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984179|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55984181|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55984182|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
55984183|NCT04458610|Antibodies|antibodies|mesh-list
55984184|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
55984185|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55984186|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
55984187|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984188|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984189|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984190|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55984191|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984192|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984193|NCT02153489|Bromides|bromides|mesh-list
55984194|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
55984195|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
55984196|NCT04627012|Lenvatinib|lenvatinib|mesh-list
55984197|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55984198|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984199|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984200|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55984201|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984202|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
55984203|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984204|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55984205|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984206|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984207|NCT00866879|Sirolimus|sirolimus|mesh-list
55984208|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55984209|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984210|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55984211|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984212|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
55984213|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55984214|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
55984215|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984216|NCT02426658|Pemetrexed|pemetrexed|mesh-list
55984217|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984218|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984219|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984220|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55984221|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55984223|NCT02311920|Ipilimumab|ipilimumab|mesh-list
55984224|NCT02311920|Temozolomide|temozolomide|mesh-list
55984225|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55984226|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984227|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55984228|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984229|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55984232|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
55984233|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55984234|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
55984235|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984236|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55984237|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984238|NCT02955940|Capecitabine|capecitabine|mesh-list
55984239|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55984240|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
55984241|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984242|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984243|NCT00828191|Progesterone|progesterone|mesh-list
55984246|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55984247|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984248|NCT00867659|Cetrorelix|cetrorelix|mesh-list
55984249|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55984250|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
55984251|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55984252|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984253|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
55984254|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55984255|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
55984256|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55984257|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55984258|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984260|NCT04560010|Coagulants|coagulants|mesh-ancestor
55984261|NCT05531058|Vaccines|vaccines|mesh-list
56214390|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56214391|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56214392|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214393|NCT01612975|Naproxen|naproxen|mesh-list
56214394|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56214395|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56214396|NCT01612975|Analgesics|analgesics|mesh-ancestor
55984262|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
55984263|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984264|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
55984265|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55984266|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55984267|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984268|NCT00828347|Vitamins|vitamins|mesh-ancestor
55984269|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
55984270|NCT02939872|Aspirin|aspirin|mesh-list
55984271|NCT02939872|Clopidogrel|clopidogrel|mesh-list
55984272|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55984273|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55984274|NCT02939872|Analgesics|analgesics|mesh-ancestor
55984275|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
55984276|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984277|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984278|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55984279|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984280|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55984281|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55984282|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984283|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55984284|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55984285|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984286|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
55984287|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55984288|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55984289|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55984290|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
55984291|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984292|NCT00829049|Adapalene|adapalene|mesh-list
55984293|NCT00829049|Tazarotene|tazarotene|mesh-list
55984294|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55984295|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55984296|NCT00829049|Analgesics|analgesics|mesh-ancestor
55984297|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
55984298|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984299|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984300|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55984301|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984302|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
55984303|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
55984304|NCT02859064|Lanreotide|lanreotide|mesh-list
55984306|NCT04303702|Oxytocin|oxytocin|mesh-list
55984307|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
55984308|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55984309|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984310|NCT01727557|Anesthetics|anesthetics|mesh-list
55984311|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984312|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984315|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55984316|NCT00913003|Lidocaine|lidocaine|mesh-list
55984317|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
55984318|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
55984319|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903543|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55903544|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
55903545|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
55984320|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984321|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
55984322|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984323|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56214397|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
56214398|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790832|NCT03841201|Nivolumab|nivolumab|mesh-list
55984324|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55984325|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55984326|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55984327|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984328|NCT00869141|Timolol|timolol|mesh-list
55984329|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55984330|NCT00869141|Dorzolamide|dorzolamide|mesh-list
55984331|NCT00869141|Brinzolamide|brinzolamide|mesh-list
55984332|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55984333|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55984334|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
55984335|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984336|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984337|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984338|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55984339|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55984340|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55984341|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55984342|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55984343|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55984344|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984345|NCT01722799|Paclitaxel|paclitaxel|mesh-list
55984346|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55984347|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984348|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
55984349|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
55984350|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
55984351|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984352|NCT04260022|Blinatumomab|blinatumomab|mesh-list
55984353|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984354|NCT01606176|Nabiximols|nabiximols|mesh-list
55984355|NCT01606176|Analgesics|analgesics|mesh-ancestor
55984356|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
55984357|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984358|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984359|NCT00913081|Quercetin|quercetin|mesh-list
55984360|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
55984361|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984362|NCT00913081|Protective Agents|protective agents|mesh-ancestor
55984363|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984364|NCT04077424|Vaccines|vaccines|mesh-list
55984365|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
55984366|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
55984367|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984368|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
55984369|NCT01727869|Cetuximab|cetuximab|mesh-list
55984370|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55984371|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55984372|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984373|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55984374|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984375|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984376|NCT00371020|Heparin|heparin|mesh-list
55984379|NCT00371020|Dalteparin|dalteparin|mesh-list
55984380|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
55984381|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55984382|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55984383|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984384|NCT01512888|Busulfan|busulfan|mesh-list
55984385|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
55984386|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984387|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55984388|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
55984389|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984390|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55984391|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984392|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55984394|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214399|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214401|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56214402|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
56214403|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56214404|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984395|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55984396|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
55984397|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984398|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984399|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55984400|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
55984401|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
55984402|NCT04476628|Hormones|hormones|mesh-ancestor
55984403|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903619|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55903620|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903621|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903622|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55903624|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55903643|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903644|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55903645|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903646|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55903647|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
55903648|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903649|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
55903650|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903651|NCT00121251|Gemcitabine|gemcitabine|mesh-list
55903652|NCT00121251|Capecitabine|capecitabine|mesh-list
55903654|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55984404|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55984405|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984406|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55984407|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984408|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984409|NCT04378231|Amoxicillin|amoxicillin|mesh-list
55984410|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
55984411|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
55984412|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55984413|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55984414|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984415|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55984416|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984417|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984418|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
55984419|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55984420|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
55984421|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984422|NCT01728571|Vitamin D|vitamin d|mesh-list
55984423|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
55984424|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
55984425|NCT01728571|Vitamins|vitamins|mesh-list
55984426|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
55984427|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984428|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55984429|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55984430|NCT00832637|Gemcitabine|gemcitabine|mesh-list
55984431|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55984432|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984433|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55984434|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
55984435|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984436|NCT00832637|Antiviral Agents|antiviral agents|mesh-ancestor
55984437|NCT00832637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984438|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984439|NCT00832637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55984440|NCT00832637|Immunologic Factors|immunologic factors|mesh-ancestor
55984441|NCT00832637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984442|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55984443|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55984444|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984445|NCT00370240|Ropivacaine|ropivacaine|mesh-list
55984446|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
55984447|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
55984448|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984449|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984450|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
55984453|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55984454|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
55984455|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984456|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
55984457|NCT03408145|Protective Agents|protective agents|mesh-ancestor
55984458|NCT02475772|Cisplatin|cisplatin|mesh-list
55984459|NCT02475772|Doxorubicin|doxorubicin|mesh-list
56214405|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214406|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
56214407|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56214408|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56214409|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214410|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55984460|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55984461|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984462|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55984463|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55984464|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55984465|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984466|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984468|NCT00915655|Darunavir|darunavir|mesh-list
55984469|NCT00915655|Lamivudine|lamivudine|mesh-list
55984470|NCT00915655|Zidovudine|zidovudine|mesh-list
55984471|NCT00915655|Abacavir|abacavir|mesh-list
55984472|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55984473|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55984474|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
55984475|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984476|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984477|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55984478|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55984479|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
55984480|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984481|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55984482|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55984483|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55984484|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55984485|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
55984486|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
55984487|NCT03835507|Hematinics|hematinics|mesh-ancestor
55984488|NCT05524974|Paclitaxel|paclitaxel|mesh-list
55984489|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
55984490|NCT05524974|Apatinib|apatinib|mesh-list
55984491|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55984492|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984493|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
55984494|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
55984495|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
55984496|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984497|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55984498|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984499|NCT00870467|Adalimumab|adalimumab|mesh-list
55984500|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55984501|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984502|NCT00370318|Acetaminophen|acetaminophen|mesh-list
55984503|NCT00370318|Vaccines|vaccines|mesh-list
55903655|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
55903656|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903657|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903658|NCT00121251|Antiviral Agents|antiviral agents|mesh-ancestor
55903659|NCT00121251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984504|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55984505|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
55984506|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984507|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55984508|NCT00370318|Analgesics|analgesics|mesh-ancestor
55984509|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
55984510|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984511|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
55984512|NCT01728961|Lumefantrine|lumefantrine|mesh-list
55984513|NCT01728961|Artemether|artemether|mesh-list
55984514|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55984515|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
55984516|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55984517|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55984518|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984519|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
55984520|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55984521|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984532|NCT00872027|Antidepressive Agents|antidepressive agents|mesh-ancestor
55984533|NCT00872027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55984534|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
55984535|NCT01854814|Losartan|losartan|mesh-list
55984536|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55984537|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984538|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55984539|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
55984540|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55984541|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984542|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984543|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984544|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55984545|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55984546|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55984547|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55984548|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
55984549|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55984550|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984551|NCT02576652|Tetracycline|tetracycline|mesh-list
55984552|NCT02576652|Demeclocycline|demeclocycline|mesh-list
55984553|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55984554|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984555|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55984556|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984557|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984558|NCT01743742|Vitamins|vitamins|mesh-list
55984559|NCT01743742|Vitamin E|vitamin e|mesh-list
55984560|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
55984561|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984562|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
55984563|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214415|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55984570|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984571|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55984573|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
55984574|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984575|NCT04640376|Acetaminophen|acetaminophen|mesh-list
55984576|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55984577|NCT04640376|Analgesics|analgesics|mesh-ancestor
55984578|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
55984579|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984580|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984581|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
55984582|NCT00832871|Mifepristone|mifepristone|mesh-list
55984583|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55984584|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
55984585|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55984586|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984587|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55984588|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55984589|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55984590|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
55984591|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55984592|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55984593|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
55984594|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55984595|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
55984596|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55984597|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55984598|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55984599|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984600|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984601|NCT01729663|Interferons|interferons|mesh-list
55984602|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
55984603|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
55984604|NCT01729663|Molgramostim|molgramostim|mesh-list
55984605|NCT01729663|Sargramostim|sargramostim|mesh-list
55984606|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
55984607|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984608|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
55984609|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984610|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
55984611|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984612|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55984613|NCT05530122|Adalimumab|adalimumab|mesh-list
55984614|NCT05530122|Golimumab|golimumab|mesh-list
55984615|NCT05530122|Infliximab|infliximab|mesh-list
55984616|NCT05530122|Ustekinumab|ustekinumab|mesh-list
55984617|NCT05530122|Vedolizumab|vedolizumab|mesh-list
55984618|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55984619|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984620|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
55984621|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55984622|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56214419|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56214421|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55903828|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903842|NCT05339542|Hormones|hormones|mesh-ancestor
55903849|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55903850|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903851|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55903852|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55903853|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903854|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903855|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903856|NCT05335252|Dronabinol|dronabinol|mesh-list
55903857|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
55903858|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903859|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55903860|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55903861|NCT05335252|Analgesics|analgesics|mesh-ancestor
55903862|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
55716580|NCT02231333|Protective Agents|protective agents|mesh-ancestor
56214422|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
55984623|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55984624|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
55984625|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984628|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984629|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
55984630|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
55984631|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55984632|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55984633|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984634|NCT05529888|Isotretinoin|isotretinoin|mesh-list
55984635|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
55984636|NCT04262206|Atorvastatin|atorvastatin|mesh-list
55984637|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55984638|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55984639|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
55984640|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984641|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55984642|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55984644|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
55984645|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55984646|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984647|NCT05518578|Huperzine A|huperzine a|mesh-list
55984648|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55984649|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984650|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984651|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
55984652|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984653|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984654|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55984655|NCT05518578|Protective Agents|protective agents|mesh-ancestor
55984656|NCT05518500|Vaccines|vaccines|mesh-list
55903863|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903864|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55903865|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55903866|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903867|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903868|NCT05335252|Hormones|hormones|mesh-ancestor
55903869|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903870|NCT05257018|Doxorubicin|doxorubicin|mesh-list
55903871|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55903872|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903873|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55903874|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55903875|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716620|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
55984657|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
55984658|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984659|NCT04196530|Atezolizumab|atezolizumab|mesh-list
55984660|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984661|NCT03058978|Etonogestrel|etonogestrel|mesh-list
55984662|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55984663|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
55984664|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55984665|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984666|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55984667|NCT00212134|Dipivefrin|dipivefrin|mesh-list
55984668|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55984669|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
55984670|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984671|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984672|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984673|NCT00913627|Ibuprofen|ibuprofen|mesh-list
55984674|NCT00913627|Naproxen|naproxen|mesh-list
55984675|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55984676|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55984677|NCT00913627|Analgesics|analgesics|mesh-ancestor
55984678|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
55984679|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984680|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984681|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55984682|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984683|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55984684|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984685|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984686|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
55984687|NCT04297254|Lenvatinib|lenvatinib|mesh-list
55984688|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214423|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214424|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56214425|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214426|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214427|NCT01613079|Methotrexate|methotrexate|mesh-list
56214428|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56214429|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
56214430|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214431|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984689|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55984690|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984691|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984692|NCT04297176|Vancomycin|vancomycin|mesh-list
55984693|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55984694|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984695|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
55984696|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55984697|NCT02425306|Poly ICLC|poly iclc|mesh-list
55984698|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
55984699|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903877|NCT05248984|Ketorolac|ketorolac|mesh-list
55984700|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55984701|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984702|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55984703|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
55984704|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984705|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984706|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55984707|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55984708|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
55984709|NCT04052698|Factor VIII|factor viii|mesh-list
55984710|NCT04052698|Coagulants|coagulants|mesh-ancestor
55984711|NCT05523102|Acetaminophen|acetaminophen|mesh-list
55984712|NCT05523102|Ketorolac|ketorolac|mesh-list
55984713|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55984714|NCT05523102|Analgesics|analgesics|mesh-ancestor
55984715|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
55984716|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984719|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55984720|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55984721|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984722|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55984723|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984724|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984725|NCT05528718|Midazolam|midazolam|mesh-list
55984726|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
55984727|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55984728|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55984729|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984730|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984731|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55984732|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55984733|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55984734|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55984735|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
55984736|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
55984737|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
55984738|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
55984739|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984740|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984741|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55984742|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55984743|NCT05528718|Analgesics|analgesics|mesh-ancestor
55984744|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
55984745|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984746|NCT03407209|Anesthetics|anesthetics|mesh-list
56214432|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56214433|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
55984747|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
55984748|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984749|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984750|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
55903913|NCT05145400|Dexamethasone|dexamethasone|mesh-list
55984751|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984752|NCT04141020|Sirolimus|sirolimus|mesh-list
55984753|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55984754|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984755|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55984756|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984757|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
55984758|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55984759|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
55984760|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984761|NCT02740114|Oxycodone|oxycodone|mesh-list
55984762|NCT02740114|Bupivacaine|bupivacaine|mesh-list
55984763|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
55984764|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
55984765|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984768|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984769|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55984770|NCT02740114|Narcotics|narcotics|mesh-ancestor
55984771|NCT02740114|Analgesics|analgesics|mesh-ancestor
55984772|NCT03999268|Insulin|insulin|mesh-list
55984773|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55984774|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984775|NCT05517330|Afatinib|afatinib|mesh-list
55984776|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984777|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55984778|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984779|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984780|NCT05517174|Vaccines|vaccines|mesh-list
55984781|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
55984782|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984783|NCT01729897|Fentanyl|fentanyl|mesh-list
55984784|NCT01729897|Propofol|propofol|mesh-list
55984785|NCT01729897|Etomidate|etomidate|mesh-list
55984786|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55984787|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984788|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984789|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55984790|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
55984791|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
55984792|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55984794|NCT01729897|Analgesics|analgesics|mesh-ancestor
55984795|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
55984796|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984797|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55984798|NCT01048177|Lidocaine|lidocaine|mesh-list
55984799|NCT01048177|Heparin|heparin|mesh-list
55984800|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
55984801|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
55984802|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984803|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984804|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
55984805|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984806|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55984807|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55984808|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55984809|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55984810|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984811|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
55984812|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55984813|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55984814|NCT02740582|Tolcapone|tolcapone|mesh-list
55984815|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55984816|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55984817|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56214434|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214435|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142218|NCT03017430|Ketorolac|ketorolac|mesh-list
56214436|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
55984818|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984819|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984820|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
55984821|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55984822|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55984823|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55984824|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904072|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
55904073|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55904074|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
55904075|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
55904076|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
55904077|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55904078|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
55904079|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904080|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904081|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55904082|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
55904083|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55904084|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55984825|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
55984826|NCT05453266|Coagulants|coagulants|mesh-ancestor
55984827|NCT02740660|Caffeine|caffeine|mesh-list
55984828|NCT02740660|Albuterol|albuterol|mesh-list
55984829|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55984830|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984831|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55984832|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984833|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984834|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55984835|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55984836|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
55984838|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55984839|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
55984840|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984841|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55984842|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
55984843|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
55984844|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55984845|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55984846|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55984847|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55984848|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
55984849|NCT05516862|Camphor|camphor|mesh-list
55984850|NCT05516862|Salicylates|salicylates|mesh-list
55984851|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
55984852|NCT05516862|Menthol|menthol|mesh-list
55984853|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55984854|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984855|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
55984856|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
55984857|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55984858|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55984859|NCT05516862|Analgesics|analgesics|mesh-ancestor
55984860|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
55984861|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904085|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55904086|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
55904087|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904088|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904089|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904090|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
55904091|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55904093|NCT03417388|Losartan|losartan|mesh-list
55904094|NCT03417388|Lisinopril|lisinopril|mesh-list
55904095|NCT03417388|Atorvastatin|atorvastatin|mesh-list
55984862|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984863|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55984864|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55984865|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55984866|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984867|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984869|NCT03929068|Carbidopa|carbidopa|mesh-list
55984870|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55984871|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55984872|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55984873|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
55984874|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984875|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984877|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55984878|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984879|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55984880|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
55984881|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
55984882|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55984884|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
55984885|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214438|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55984886|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55984887|NCT03910972|Antacids|antacids|mesh-ancestor
55984888|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984889|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55984890|NCT05516784|Clopidogrel|clopidogrel|mesh-list
55984891|NCT05516784|Ticagrelor|ticagrelor|mesh-list
55984892|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55984893|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55984894|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55984895|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55984896|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
55984897|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984898|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984899|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984900|NCT03871036|Paclitaxel|paclitaxel|mesh-list
55984901|NCT03871036|Durvalumab|durvalumab|mesh-list
55984902|NCT03871036|Tremelimumab|tremelimumab|mesh-list
55984903|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55984904|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984905|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
55984906|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
55984907|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
55984908|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984909|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55984910|NCT03746080|Plerixafor|plerixafor|mesh-list
55984911|NCT03746080|Temozolomide|temozolomide|mesh-list
55984912|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55984914|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984915|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984916|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55984917|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55984918|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
55984919|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984920|NCT03462719|Venetoclax|venetoclax|mesh-list
55984921|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
55984922|NCT03462719|Chlorambucil|chlorambucil|mesh-list
55984923|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984924|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55984925|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55984926|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
55984927|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984928|NCT02571972|Timolol|timolol|mesh-list
55984929|NCT02571972|Dorzolamide|dorzolamide|mesh-list
55984930|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55984931|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55984932|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
55984933|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984934|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984935|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984936|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55984937|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55984938|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55984939|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984940|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55984941|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
55984942|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984943|NCT04996134|Domperidone|domperidone|mesh-list
55984944|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
55984945|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
55984946|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984947|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984948|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55984949|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55984950|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
55984951|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984952|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984954|NCT03772613|Calcium heparin|calcium heparin|mesh-list
55984955|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
56214439|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214440|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
56214441|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56214442|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56214443|NCT01613092|Vancomycin|vancomycin|mesh-list
56214444|NCT01613092|Clindamycin|clindamycin|mesh-list
55984956|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55984957|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55984958|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984959|NCT00371332|Minocycline|minocycline|mesh-list
55984960|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55984961|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55984962|NCT00842075|Pramlintide|pramlintide|mesh-list
55984963|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55984964|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984965|NCT00879359|Paclitaxel|paclitaxel|mesh-list
55984966|NCT00879359|Bevacizumab|bevacizumab|mesh-list
55984967|NCT00879359|Carboplatin|carboplatin|mesh-list
55984968|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55984969|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984970|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
55984971|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
55984972|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
55984973|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984974|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55984975|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55984976|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55984977|NCT00879359|Growth Substances|growth substances|mesh-ancestor
55984978|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984979|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
55984980|NCT05100160|Gabapentin|gabapentin|mesh-list
55984981|NCT05100160|Analgesics|analgesics|mesh-ancestor
55790602|NCT04201873|Laxatives|laxatives|mesh-ancestor
55984982|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
55984983|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984984|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984985|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
55984986|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55984987|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55984988|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55984989|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55984990|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55984991|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55984992|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984993|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55984994|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
55984995|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55984996|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
55984997|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55984998|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55984999|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55985000|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985001|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985002|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
55985003|NCT05064280|Lenvatinib|lenvatinib|mesh-list
55985004|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985005|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985006|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55985007|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985008|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985009|NCT00880997|Doxazosin|doxazosin|mesh-list
55985010|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55985011|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55985012|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55985013|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55985014|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985015|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985016|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985017|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985019|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55985020|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985021|NCT00883103|Lidocaine|lidocaine|mesh-list
55985022|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
55985023|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
55985024|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985025|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985026|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
55985027|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985028|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55985029|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55985030|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55985031|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55985032|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985033|NCT02742532|Oxytocin|oxytocin|mesh-list
55985034|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
55985035|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55985036|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985037|NCT05521386|Caffeine|caffeine|mesh-list
55985038|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55985039|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985040|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55985041|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985042|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985043|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55985044|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55985045|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
55985046|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985047|NCT00370630|Triamcinolone|triamcinolone|mesh-list
55985048|NCT00370630|Bevacizumab|bevacizumab|mesh-list
55985049|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985050|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985051|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55985052|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55985053|NCT00370630|Growth Substances|growth substances|mesh-ancestor
55985055|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
55985056|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985057|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
55985058|NCT00370630|Hormones|hormones|mesh-ancestor
55985059|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55985060|NCT04984980|Gemcitabine|gemcitabine|mesh-list
55985061|NCT04984980|Bevacizumab|bevacizumab|mesh-list
55985062|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
55985063|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985064|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985065|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55985066|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55985067|NCT04984980|Growth Substances|growth substances|mesh-ancestor
55985068|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985069|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
55985070|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55985071|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
55985072|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985073|NCT04984980|Antiviral Agents|antiviral agents|mesh-ancestor
55985074|NCT04984980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985075|NCT04984980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985076|NCT04984980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55985077|NCT04984980|Immunologic Factors|immunologic factors|mesh-ancestor
55985078|NCT00370786|Bevacizumab|bevacizumab|mesh-list
55985079|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985080|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985081|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55985082|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55985083|NCT00370786|Growth Substances|growth substances|mesh-ancestor
55985084|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985085|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
55985086|NCT04981158|Anesthetics|anesthetics|mesh-list
55985087|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
55985089|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985090|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55985091|NCT03387670|Simvastatin|simvastatin|mesh-list
56214446|NCT01613092|Cephalexin|cephalexin|mesh-list
56214447|NCT01613092|Bacitracin|bacitracin|mesh-list
56214448|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56214449|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214450|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56214451|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214452|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214453|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55985092|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55985093|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55985094|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
55985095|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985096|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55985097|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55985098|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985099|NCT04979832|Metronidazole|metronidazole|mesh-list
55985100|NCT04979832|Fosfomycin|fosfomycin|mesh-list
55985101|NCT04979832|Molgramostim|molgramostim|mesh-list
55985102|NCT04979832|Sargramostim|sargramostim|mesh-list
55985103|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985104|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55985105|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55985106|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55985107|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
55985108|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985109|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985110|NCT05521152|Norepinephrine|norepinephrine|mesh-list
55985111|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55985112|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55985113|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985114|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985115|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985116|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985117|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
55985118|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
55985119|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985120|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55985121|NCT04906096|GDC-0084|gdc-0084|mesh-list
55985123|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985124|NCT00371410|Triamcinolone|triamcinolone|mesh-list
55985125|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55985126|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55985127|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55985128|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985129|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
55985130|NCT00371410|Hormones|hormones|mesh-ancestor
55985131|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55985132|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985133|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55985134|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
55985135|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985136|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985137|NCT04659616|Cytarabine|cytarabine|mesh-list
55985138|NCT04659616|Daunorubicin|daunorubicin|mesh-list
55985139|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55985140|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
55985141|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985142|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985143|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
55985144|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985145|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55985146|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
55985147|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985148|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55985149|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55985150|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55985151|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985152|NCT04295850|Aspirin|aspirin|mesh-list
55985153|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55985154|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55985155|NCT04295850|Analgesics|analgesics|mesh-ancestor
55985156|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
55985157|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985158|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985159|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985160|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985161|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55985163|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985164|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55985165|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55985166|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985169|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55985170|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55985171|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55985172|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
55985173|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985174|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985175|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985176|NCT02166905|Poly I-C|poly i-c|mesh-list
55985177|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55985178|NCT02166905|Poly ICLC|poly iclc|mesh-list
55985179|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
55985180|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
55985181|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985182|NCT02166905|Laxatives|laxatives|mesh-ancestor
55985183|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55985184|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
55985185|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985186|NCT02743078|Bevacizumab|bevacizumab|mesh-list
55985187|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985188|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985189|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55985190|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55985191|NCT02743078|Growth Substances|growth substances|mesh-ancestor
55985192|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985193|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
55985194|NCT03323398|Durvalumab|durvalumab|mesh-list
55985195|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985196|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985197|NCT00890981|Denosumab|denosumab|mesh-list
55831656|NCT01456936|Nicotine|nicotine|mesh-list
55985198|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55985199|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985201|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55985202|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55985203|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985204|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985205|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55985206|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55985207|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
55985208|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985209|NCT04480138|Interferons|interferons|mesh-list
55985210|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985211|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
55985212|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985219|NCT00371488|Lapatinib|lapatinib|mesh-list
55985220|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985221|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55985222|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985223|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985224|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
55985225|NCT00883415|Hematinics|hematinics|mesh-ancestor
55985226|NCT05526690|Metformin|metformin|mesh-list
55985227|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55985228|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985229|NCT03751709|Blinatumomab|blinatumomab|mesh-list
55985230|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985231|NCT04337632|Paclitaxel|paclitaxel|mesh-list
55985232|NCT04337632|Carboplatin|carboplatin|mesh-list
55985233|NCT04337632|Doxorubicin|doxorubicin|mesh-list
56214455|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56214456|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214457|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985234|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55985235|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55985236|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985237|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
55985238|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
55985239|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
55985240|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985241|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55985242|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55985243|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55985246|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985247|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985248|NCT05348980|Phenylephrine|phenylephrine|mesh-list
55985249|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
55985250|NCT05348980|Synephrine|synephrine|mesh-list
55985251|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55985252|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
55985253|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
55985254|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985255|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985256|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
55985257|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55985258|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
55985259|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985260|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55985261|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55985262|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55985263|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985264|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985265|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985266|NCT05348980|Protective Agents|protective agents|mesh-ancestor
55985267|NCT00884585|Cyclosporine|cyclosporine|mesh-list
55985268|NCT00884585|Cyclosporins|cyclosporins|mesh-list
55985269|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985270|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985271|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55985272|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
55985273|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985274|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
55985275|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985276|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
55985277|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790612|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
55985278|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55985280|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
55985281|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55985282|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904704|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904705|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55904706|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55904708|NCT01582009|Panobinostat|panobinostat|mesh-list
55904709|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55904710|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904711|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904712|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
55904713|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904714|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985283|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
55985284|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55985285|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55985286|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55985287|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55985288|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985289|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
55985290|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985291|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985292|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55985293|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985294|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
55985295|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55985296|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985297|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985298|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55985299|NCT03384563|Analgesics|analgesics|mesh-ancestor
55985300|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
55985301|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985302|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56214458|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56214459|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214460|NCT01613170|Estrogens|estrogens|mesh-list
56214461|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56214462|NCT01613170|Hormones|hormones|mesh-ancestor
56214463|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790881|NCT01799629|Protective Agents|protective agents|mesh-ancestor
55985303|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55985304|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55985305|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985306|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985307|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985308|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
55985309|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
55985310|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985311|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55985312|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985313|NCT02748070|Fluticasone|fluticasone|mesh-list
55985314|NCT02748070|Prednisone|prednisone|mesh-list
55985315|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985316|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
55985318|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55985319|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985320|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55985321|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985322|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55985323|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
55985324|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985325|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55904715|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904716|NCT01553591|Eluxadoline|eluxadoline|mesh-list
55904717|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55904718|NCT01581931|Metformin|metformin|mesh-list
55904719|NCT01581931|Linagliptin|linagliptin|mesh-list
55904720|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55904721|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756168|NCT01670721|Antidotes|antidotes|mesh-ancestor
55985326|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985327|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
55985328|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55985329|NCT05310305|Antibodies|antibodies|mesh-list
55985330|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
55985331|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985332|NCT05149638|Cosyntropin|cosyntropin|mesh-list
55985333|NCT05149638|Hormones|hormones|mesh-ancestor
55985334|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55985335|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985336|NCT05519670|Niraparib|niraparib|mesh-list
55985337|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55985338|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985339|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985340|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985341|NCT05519592|Ropivacaine|ropivacaine|mesh-list
55985342|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
55985343|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
55985344|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985345|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985347|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985348|NCT05519514|Budesonide|budesonide|mesh-list
55985349|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985350|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55985351|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
55985352|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985353|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985354|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55985355|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985356|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
55985357|NCT05519514|Hormones|hormones|mesh-ancestor
55985358|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55985359|NCT02756572|Cytarabine|cytarabine|mesh-list
55985360|NCT02756572|Cyclosporine|cyclosporine|mesh-list
55985361|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
55904722|NCT01581931|Incretins|incretins|mesh-ancestor
55904724|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904725|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55904726|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
55904727|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904728|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904729|NCT01581307|Leucovorin|leucovorin|mesh-list
55904730|NCT01581307|Folic Acid|folic acid|mesh-list
55904731|NCT01581307|Fluorouracil|fluorouracil|mesh-list
55904732|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
55904733|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
55904744|NCT01581307|Vitamins|vitamins|mesh-ancestor
55904786|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55904788|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
55904789|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904790|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55904791|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55985362|NCT02756572|Sirolimus|sirolimus|mesh-list
55985363|NCT02756572|Fludarabine|fludarabine|mesh-list
56214464|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985364|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
55985365|NCT02756572|Melphalan|melphalan|mesh-list
55985366|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
55985367|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
55985368|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55985369|NCT02756572|Cladribine|cladribine|mesh-list
55985370|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
55985371|NCT02756572|Cyclosporins|cyclosporins|mesh-list
55985372|NCT02756572|Lenograstim|lenograstim|mesh-list
55985373|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985374|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55985375|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
55985376|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985377|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55985378|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
55985379|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985380|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
55985381|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985382|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55985383|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985384|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
55985385|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
55985386|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985387|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55985388|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55985389|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55985390|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
55985391|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55985392|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55985394|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55985396|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
55985397|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985398|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55985399|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55985400|NCT01049035|Vaccines|vaccines|mesh-list
55985401|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55985402|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
55904796|NCT01549613|Vancomycin|vancomycin|mesh-list
55985403|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985404|NCT05131698|Lenvatinib|lenvatinib|mesh-list
55985405|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985406|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55985407|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985408|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985409|NCT01724983|Fentanyl|fentanyl|mesh-list
55985410|NCT01724983|Ketamine|ketamine|mesh-list
55985411|NCT01724983|Analgesics|analgesics|mesh-ancestor
55985412|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
55985413|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985414|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985415|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55985416|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55985417|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
55985418|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
55985419|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985420|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55985421|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55985422|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985423|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985424|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55985426|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55985427|NCT05126784|Denosumab|denosumab|mesh-list
55985428|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55985429|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985430|NCT02973958|Acetaminophen|acetaminophen|mesh-list
55985431|NCT02973958|Ibuprofen|ibuprofen|mesh-list
55985432|NCT02973958|Ketorolac|ketorolac|mesh-list
55985433|NCT02973958|Bupivacaine|bupivacaine|mesh-list
55985434|NCT02973958|Sevoflurane|sevoflurane|mesh-list
55985435|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
55985436|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
55985437|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985438|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214466|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
56214467|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214468|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
55904858|NCT01543685|Analgesics|analgesics|mesh-ancestor
55904892|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
55904893|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904894|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55904895|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55904896|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55904897|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55904898|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904899|NCT01539083|Thalidomide|thalidomide|mesh-list
56214469|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985439|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
55985440|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985441|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55985442|NCT02973958|Analgesics|analgesics|mesh-ancestor
55985443|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
55985444|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55985445|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985446|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985447|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55985448|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985449|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985450|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55985451|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55985452|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
55985453|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
55985454|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55985455|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55985456|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
55985457|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985458|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985459|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55985460|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985461|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55985462|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55985463|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55985464|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985465|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985466|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985468|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
55985469|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985470|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
55985471|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55985472|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55985473|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
55985474|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985475|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55985476|NCT05348434|Ether|ether|mesh-list
55985477|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55985478|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
55985479|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
55985480|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985481|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985482|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
55985483|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985484|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
55904920|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904921|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55904922|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
55904923|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55904924|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904925|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55904926|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55749231|NCT04487743|Hormones|hormones|mesh-ancestor
55985485|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55985486|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
55985487|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985488|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
55985489|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55985490|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
55985491|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985492|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985493|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55985494|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985495|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55985496|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55985497|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55985498|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985499|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985500|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985501|NCT05715411|Methamphetamine|methamphetamine|mesh-list
55985502|NCT05715411|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55985503|NCT05715411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985504|NCT05715411|Sympathomimetics|sympathomimetics|mesh-ancestor
56214471|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
56214472|NCT01613209|Olmesartan|olmesartan|mesh-list
56214473|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56214474|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56214475|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56214476|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214477|NCT01613300|Ofatumumab|ofatumumab|mesh-list
56214478|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214479|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
56214480|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55985505|NCT05715411|Autonomic Agents|autonomic agents|mesh-ancestor
55985506|NCT05715411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985507|NCT05715411|Dopamine Agents|dopamine agents|mesh-ancestor
55985508|NCT05715411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985509|NCT05715411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985510|NCT05715411|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985511|NCT05715411|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55985512|NCT05715411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55985513|NCT05715411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55985514|NCT05715411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55985515|NCT05040360|Capecitabine|capecitabine|mesh-list
55985516|NCT05040360|Temozolomide|temozolomide|mesh-list
55985517|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55985518|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
55985519|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985520|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904941|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
55904942|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904943|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904944|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55904945|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
55904970|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904971|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904983|NCT02655016|Niraparib|niraparib|mesh-list
55985521|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55985522|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
55985523|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
55985524|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55985525|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55985526|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55985527|NCT02760862|Mannitol|mannitol|mesh-list
55985528|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985529|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55985530|NCT02760862|Diuretics|diuretics|mesh-ancestor
55985531|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
55985532|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985533|NCT05720637|Serotonin|serotonin|mesh-list
55985534|NCT05720637|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55985535|NCT05720637|Serotonin Agents|serotonin agents|mesh-ancestor
55985536|NCT05720637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985537|NCT05720637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985538|NCT05720637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985540|NCT05720559|Vitamin A|vitamin a|mesh-list
55985541|NCT05720559|Metronidazole|metronidazole|mesh-list
55985542|NCT05720559|Capecitabine|capecitabine|mesh-list
55985543|NCT05720559|Oxaliplatin|oxaliplatin|mesh-list
55985544|NCT05720559|Cetuximab|cetuximab|mesh-list
55985546|NCT05720559|Micronutrients|micronutrients|mesh-ancestor
55985547|NCT05720559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985548|NCT05720559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55985549|NCT05720559|Antimetabolites|antimetabolites|mesh-ancestor
55985550|NCT05720559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985551|NCT05720559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985552|NCT05720559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985554|NCT05720559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55985555|NCT05720559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55985556|NCT05720559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55985557|NCT05720559|Hematinics|hematinics|mesh-ancestor
55985558|NCT05720559|Vitamin B Complex|vitamin b complex|mesh-ancestor
55985559|NCT02761252|Montelukast|montelukast|mesh-list
55985560|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56214481|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56214482|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214484|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
56214485|NCT01613469|Leucovorin|leucovorin|mesh-list
56214486|NCT01613469|Antidotes|antidotes|mesh-ancestor
56214487|NCT01613469|Protective Agents|protective agents|mesh-ancestor
56214488|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214489|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
56214490|NCT01613469|Vitamins|vitamins|mesh-ancestor
56214491|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
56214492|NCT01613482|Trastuzumab|trastuzumab|mesh-list
56214493|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985561|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985562|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55985563|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
55985564|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55985565|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985566|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55985567|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55985568|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717496|NCT02343393|Isosorbide|isosorbide|mesh-list
55985569|NCT05714475|Pancrelipase|pancrelipase|mesh-list
55985570|NCT05714475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55985571|NCT01047007|Cisplatin|cisplatin|mesh-list
55985572|NCT01047007|Adavosertib|adavosertib|mesh-list
55985573|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985574|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985575|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985576|NCT05443984|Esomeprazole|esomeprazole|mesh-list
55985577|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55985578|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55985579|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55985580|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985581|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985582|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
55985583|NCT01725607|Anesthetics|anesthetics|mesh-list
55985584|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985585|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985586|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55985587|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55985588|NCT01725607|Analgesics|analgesics|mesh-ancestor
55985589|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
55985590|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985591|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55985592|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55985593|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55985594|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985595|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985596|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985597|NCT03304379|Celecoxib|celecoxib|mesh-list
55985598|NCT03304379|Diclofenac|diclofenac|mesh-list
55985599|NCT03304379|Fasinumab|fasinumab|mesh-list
55985600|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55985601|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55985602|NCT03304379|Analgesics|analgesics|mesh-ancestor
55985603|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
55985604|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904984|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55904985|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904986|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904987|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904988|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
55904989|NCT01533935|Olodaterol|olodaterol|mesh-list
55904990|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55904991|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
55904992|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904993|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904994|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55904995|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
55904996|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
55904997|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55904998|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
55904999|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905001|NCT02570542|Cytarabine|cytarabine|mesh-list
55905042|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55905043|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55985605|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985606|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985607|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985608|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55985609|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56214494|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214495|NCT01613534|Sucralfate|sucralfate|mesh-list
56214496|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55985610|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985611|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831657|NCT01456936|Varenicline|varenicline|mesh-list
55985615|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
55985616|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
55985619|NCT01044745|Fludarabine|fludarabine|mesh-list
55985620|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
55985621|NCT01044745|Tacrolimus|tacrolimus|mesh-list
55985622|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
55985623|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55985624|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55985625|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
55985626|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985627|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985628|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55985629|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
55985630|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985631|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985632|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55985633|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985634|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55985635|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
55985636|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55985637|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985638|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55985639|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55985640|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
55985641|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55985642|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985643|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55985644|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985645|NCT05031078|Lidocaine|lidocaine|mesh-list
55985646|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985647|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
55985648|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
55985649|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985650|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
55985651|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985652|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55985653|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55985654|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55985655|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55985656|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985657|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55985658|NCT03270059|Hematinics|hematinics|mesh-ancestor
55985659|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55985660|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55985661|NCT05513664|Osimertinib|osimertinib|mesh-list
55985662|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985663|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55985664|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985665|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985666|NCT03216395|Epinephrine|epinephrine|mesh-list
55985667|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55985668|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55985669|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985670|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985671|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985672|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985673|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55985674|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55985675|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
55985676|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985677|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55985678|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985679|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
55985680|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
56214497|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214499|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56214500|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214501|NCT01613573|Hormones|hormones|mesh-list
55985681|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55985682|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55985683|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985684|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
55985686|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55985688|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55985689|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
55985690|NCT01044433|Capecitabine|capecitabine|mesh-list
55985691|NCT01044433|Lapatinib|lapatinib|mesh-list
55985692|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55985693|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
55985694|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905110|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55905111|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905112|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55905113|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905114|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
55905151|NCT05676216|Dermatologic Agents|dermatologic agents|mesh-ancestor
55905153|NCT03163914|Epinephrine|epinephrine|mesh-list
55905154|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
55985695|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985696|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55985697|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985698|NCT03400969|Glycerol|glycerol|mesh-list
55985699|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55985700|NCT03400969|Protective Agents|protective agents|mesh-ancestor
55985701|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985702|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
55985703|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985704|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985705|NCT04334512|Vitamin D|vitamin d|mesh-list
55985706|NCT04334512|Vitamins|vitamins|mesh-list
55985707|NCT04334512|Azithromycin|azithromycin|mesh-list
55985708|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
55985709|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
55985710|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985711|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55985712|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55985713|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985714|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
55985715|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55985716|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55985717|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985718|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985719|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985720|NCT05518812|Carboprost|carboprost|mesh-list
55985721|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
55985722|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55985723|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
55985724|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55985725|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985726|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
55985727|NCT01043185|Lesogaberan|lesogaberan|mesh-list
55985728|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55985729|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55985730|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
55985731|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
55985732|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052228|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905169|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
55905170|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55905171|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55905172|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
55905173|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55905174|NCT03163914|Protective Agents|protective agents|mesh-ancestor
55905175|NCT03160872|Hormones|hormones|mesh-list
55985733|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985734|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985735|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55985736|NCT01042093|Clonidine|clonidine|mesh-list
55985737|NCT01042093|Epinephrine|epinephrine|mesh-list
55985738|NCT01042093|Ropivacaine|ropivacaine|mesh-list
55985739|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
55985740|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
55985741|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985742|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985743|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
55985744|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985745|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55985746|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55985747|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985748|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214502|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214503|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214504|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55985749|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985750|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55985751|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55985752|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
55985753|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55985754|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985755|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
55985756|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
55985757|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55985758|NCT01042093|Analgesics|analgesics|mesh-ancestor
55985759|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55985760|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
55985761|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55985763|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55985764|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985765|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985766|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55985767|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985769|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55985770|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985771|NCT05100628|Doxorubicin|doxorubicin|mesh-list
55985772|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55985773|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985774|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55985775|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55985776|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985777|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985778|NCT04737928|Latanoprost|latanoprost|mesh-list
55985779|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55985780|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55985782|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55985783|NCT01041859|Narcotics|narcotics|mesh-ancestor
55985784|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985785|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985786|NCT01041859|Analgesics|analgesics|mesh-ancestor
55985787|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
55985788|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985789|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55985790|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55985791|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55985792|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985793|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
55985794|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985795|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55985796|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
55985797|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985798|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55985799|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
55985800|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985801|NCT03400423|Caffeine|caffeine|mesh-list
55985802|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55985803|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985804|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55985805|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985806|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985807|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55985808|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55985809|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
55985810|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985811|NCT01040845|Colchicine|colchicine|mesh-list
55985812|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55985813|NCT01040845|Norethindrone|norethindrone|mesh-list
55985814|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
55985815|NCT01040845|Estradiol|estradiol|mesh-list
55985816|NCT01040845|Estrogens|estrogens|mesh-ancestor
55985817|NCT01040845|Hormones|hormones|mesh-ancestor
56214505|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
56214506|NCT01613664|Coagulants|coagulants|mesh-ancestor
56214507|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
55985818|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55985819|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985820|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55985821|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
55985822|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55985823|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55985824|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
55985825|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985826|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
55985827|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
55985828|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
55985829|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985830|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985831|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55985833|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55985835|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55985836|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
55985837|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55985838|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985839|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55985840|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55985841|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55985842|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
55985844|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55985845|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
55985846|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985847|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985848|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55985849|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985850|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
55985851|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55985852|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
55985853|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985854|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985856|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
55985858|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985859|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985860|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
55985861|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985862|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55985863|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55985864|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55985865|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55985866|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985867|NCT03400189|Sulthiame|sulthiame|mesh-list
55985868|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
55985869|NCT04098874|Bupropion|bupropion|mesh-list
55985870|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55985871|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
55985872|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55985873|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55985874|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55985875|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55985876|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985877|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
55985878|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55985879|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985880|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55985881|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55985882|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985883|NCT01043029|Pioglitazone|pioglitazone|mesh-list
55985884|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55985885|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985886|NCT04066348|Etanercept|etanercept|mesh-list
56214508|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56214509|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56214510|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55985887|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55985888|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55985889|NCT04066348|Analgesics|analgesics|mesh-ancestor
55985890|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
55985891|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985892|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985893|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985894|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55985895|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55985896|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55985897|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
55985898|NCT04282954|Esomeprazole|esomeprazole|mesh-list
55985899|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55985900|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55985901|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55985902|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985903|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985904|NCT05337436|Calcium|calcium|mesh-list
55985905|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55985908|NCT04755712|Morphine|morphine|mesh-list
55985909|NCT04755712|Bupivacaine|bupivacaine|mesh-list
55985910|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
55985911|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
55985912|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985913|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905355|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
55905356|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905357|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55905358|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55905359|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55905360|NCT02135874|Cytarabine|cytarabine|mesh-list
55905361|NCT02135874|Dexamethasone|dexamethasone|mesh-list
55905362|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
55905363|NCT02135874|Rituximab|rituximab|mesh-list
55905364|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55905365|NCT02135874|Vincristine|vincristine|mesh-list
55905366|NCT02135874|Sorafenib|sorafenib|mesh-list
55905367|NCT02135874|Idarubicin|idarubicin|mesh-list
55905368|NCT02135874|Clofarabine|clofarabine|mesh-list
55905369|NCT02135874|Antibodies|antibodies|mesh-list
55905370|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
55905371|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55985914|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
55985915|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985916|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55985917|NCT04755712|Narcotics|narcotics|mesh-ancestor
55985918|NCT04755712|Analgesics|analgesics|mesh-ancestor
55985919|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55985920|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55985921|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
55985922|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
55985923|NCT04751812|Narcotics|narcotics|mesh-ancestor
55985924|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985925|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985926|NCT04751812|Analgesics|analgesics|mesh-ancestor
55985927|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
55985928|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985929|NCT00372736|Docetaxel|docetaxel|mesh-list
55985930|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985931|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
55985932|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
55985933|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
55985934|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985935|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
55985936|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55985937|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55985938|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
55985939|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985940|NCT03241732|Expectorants|expectorants|mesh-ancestor
55985941|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
55985942|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55985943|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
55985944|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985945|NCT03241732|Protective Agents|protective agents|mesh-ancestor
55985946|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985947|NCT03241732|Antidotes|antidotes|mesh-ancestor
55985948|NCT02415712|Fomepizole|fomepizole|mesh-list
55985949|NCT02415712|Antidotes|antidotes|mesh-ancestor
55985950|NCT02415712|Protective Agents|protective agents|mesh-ancestor
55985951|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985952|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985953|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55985954|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55985955|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55985956|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55985957|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55985980|NCT02973724|Remifentanil|remifentanil|mesh-list
55985981|NCT02973724|Propofol|propofol|mesh-list
56214511|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
56214512|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214513|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790907|NCT01553071|Safingol|safingol|mesh-list
55985982|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
55985983|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985984|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985985|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55985986|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55985987|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
55985988|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55985989|NCT02973724|Narcotics|narcotics|mesh-ancestor
55905487|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905488|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55905489|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55905491|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
55905492|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905493|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55905494|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
55905495|NCT01527149|Hormones|hormones|mesh-ancestor
55905496|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905497|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55985990|NCT02973724|Analgesics|analgesics|mesh-ancestor
55985991|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
55985992|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985993|NCT05456542|Dexamethasone|dexamethasone|mesh-list
55985994|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55985995|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
55985996|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
55985997|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55985998|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831824|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
55985999|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55986000|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
55986002|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55986006|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986007|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55986008|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986009|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986010|NCT05455918|Paclitaxel|paclitaxel|mesh-list
55986011|NCT05455918|Ifosfamide|ifosfamide|mesh-list
55986012|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55986013|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986014|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
55986015|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
55986016|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
55986017|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986018|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55986019|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
55986020|NCT00889187|Capecitabine|capecitabine|mesh-list
55986021|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55986022|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
55986023|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986024|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986025|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
55986026|NCT04231708|Yohimbine|yohimbine|mesh-list
55986027|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986028|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
55986029|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
55986030|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986031|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986032|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55986033|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55986034|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55986035|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
55986036|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986037|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986038|NCT04231708|Urological Agents|urological agents|mesh-ancestor
55905498|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55905499|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55905500|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55905501|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905506|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
55986039|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55986040|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55986041|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55986042|NCT04334824|Diuretics|diuretics|mesh-ancestor
55986043|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
55986044|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986045|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55986046|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55986047|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986048|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
55986049|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214514|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214515|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56214516|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56214517|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56214519|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214520|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56214521|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56214522|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214523|NCT01613755|Metformin|metformin|mesh-list
56214524|NCT01613755|Dipyridamole|dipyridamole|mesh-list
55986050|NCT05314127|Fluorouracil|fluorouracil|mesh-list
55986051|NCT05314127|Imiquimod|imiquimod|mesh-list
55986052|NCT05314127|Tazarotene|tazarotene|mesh-list
55986053|NCT05314127|Petrolatum|petrolatum|mesh-list
55986054|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
55986055|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986056|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55986057|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986058|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986059|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
55986060|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986061|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55986062|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
55986063|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
55986064|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
55986065|NCT05314127|Emollients|emollients|mesh-ancestor
55986066|NCT03130127|Terlipressin|terlipressin|mesh-list
55986067|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55986068|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55986069|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
55986070|NCT04225078|Loperamide|loperamide|mesh-list
55986071|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
55986072|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55986073|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986074|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55986075|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55986077|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986079|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55986080|NCT00373048|Mefloquine|mefloquine|mesh-list
55986081|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
55986082|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55986083|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55986084|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986085|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
55986086|NCT03056339|Fludarabine|fludarabine|mesh-list
55986087|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
55986088|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986089|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
55905521|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905522|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55905524|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905525|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55905526|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905528|NCT01525901|Mitogens|mitogens|mesh-list
55986090|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986091|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986092|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55986093|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
55986094|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986095|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986096|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55986097|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55986098|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
55986099|NCT00372892|Rituximab|rituximab|mesh-list
55986100|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55986101|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986102|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
55986103|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986104|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986105|NCT00895817|Fluticasone|fluticasone|mesh-list
56214525|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56214526|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214527|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56214528|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986106|NCT00895817|Esomeprazole|esomeprazole|mesh-list
55986107|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986108|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55986109|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
55986110|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986111|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905533|NCT01525901|Growth Substances|growth substances|mesh-ancestor
55905534|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
55905535|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55905536|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55905537|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986112|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55986113|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
55986114|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
55986115|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55986116|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55986117|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55986118|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55986119|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986120|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986121|NCT03020303|Spironolactone|spironolactone|mesh-list
55986122|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55986123|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
55986124|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55986125|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986127|NCT03020303|Diuretics|diuretics|mesh-ancestor
55986128|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
55986129|NCT04825522|Vancomycin|vancomycin|mesh-list
55986130|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55986131|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986132|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
55986133|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986134|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55986135|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
55986137|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55986138|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55986139|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55986140|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986141|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
55986142|NCT00373282|Hormones|hormones|mesh-ancestor
55986143|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55986144|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986145|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986146|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
55986147|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986148|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986149|NCT04033354|Paclitaxel|paclitaxel|mesh-list
55986150|NCT04033354|Carboplatin|carboplatin|mesh-list
55986151|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55718062|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986152|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986153|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
55986154|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
55986155|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
55986156|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986157|NCT04382027|Vitamins|vitamins|mesh-list
55986158|NCT04382027|Vitamin K|vitamin k|mesh-list
55986159|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
55986160|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
55986161|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986162|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55986163|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55986164|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986165|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
55986166|NCT04382027|Coagulants|coagulants|mesh-ancestor
55986167|NCT00896441|Citalopram|citalopram|mesh-list
55986168|NCT00896441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55986169|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55986170|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55986171|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214529|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214530|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56214531|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
56214532|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56214533|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56214534|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56214535|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
56214536|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214537|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56214538|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55790927|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
55986172|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986173|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
55986174|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986175|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55986176|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
55986177|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55986179|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
55986180|NCT02790515|Melphalan|melphalan|mesh-list
55986181|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
55986182|NCT02790515|Thiotepa|thiotepa|mesh-list
55986183|NCT02790515|Rituximab|rituximab|mesh-list
55986184|NCT02790515|Fludarabine|fludarabine|mesh-list
55986185|NCT02790515|Blinatumomab|blinatumomab|mesh-list
55986186|NCT02790515|Tacrolimus|tacrolimus|mesh-list
55986187|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
55986188|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55986189|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986190|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
55986191|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986192|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986193|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55986194|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
55986195|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986196|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986197|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55986198|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55986199|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55986201|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55986202|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986203|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55986204|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
55986205|NCT03400111|Acetaminophen|acetaminophen|mesh-list
55986206|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55986207|NCT03400111|Analgesics|analgesics|mesh-ancestor
55986208|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
55986209|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986210|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986211|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
55986212|NCT03404791|Gemcitabine|gemcitabine|mesh-list
55986213|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55986214|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
55986215|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986216|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986217|NCT03404791|Antiviral Agents|antiviral agents|mesh-ancestor
55986218|NCT03404791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986219|NCT03404791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986220|NCT03404791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986221|NCT03404791|Immunologic Factors|immunologic factors|mesh-ancestor
55986222|NCT03404791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986223|NCT00918931|Obatoclax|obatoclax|mesh-list
55986224|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214539|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214541|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56214542|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
55986225|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986226|NCT03404011|Glycerol|glycerol|mesh-list
55986227|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55986228|NCT03404011|Protective Agents|protective agents|mesh-ancestor
55986229|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986230|NCT01830491|Aspirin|aspirin|mesh-list
55986231|NCT01830491|Clopidogrel|clopidogrel|mesh-list
55986232|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55986233|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55986234|NCT01830491|Analgesics|analgesics|mesh-ancestor
55986235|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
55986236|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986237|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986238|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986239|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986240|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55986241|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55986242|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986243|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55986244|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55986245|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986246|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
55986247|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55986248|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55986249|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55986250|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
55986251|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986252|NCT00200200|Bevacizumab|bevacizumab|mesh-list
55986253|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55986254|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986255|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55986256|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55986257|NCT00200200|Growth Substances|growth substances|mesh-ancestor
55986258|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905632|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55905633|NCT00266799|Capecitabine|capecitabine|mesh-list
55905642|NCT00249249|Atorvastatin|atorvastatin|mesh-list
55986259|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
55986260|NCT02778880|Fentanyl|fentanyl|mesh-list
55986261|NCT02778880|Ketamine|ketamine|mesh-list
55986262|NCT02778880|Analgesics|analgesics|mesh-ancestor
55986263|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
55986264|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986265|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986266|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55986267|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55986268|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
55986269|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
55986270|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986271|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55986273|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986274|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986275|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55986277|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55986278|NCT05310929|Labetalol|labetalol|mesh-list
55986279|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
55986280|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
55986281|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55986282|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55986283|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
55986284|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986285|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986286|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986287|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55986288|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
55986289|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
55986290|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986291|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55905697|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
55905698|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905699|NCT01520987|Opicapone|opicapone|mesh-list
55905700|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55905701|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905702|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905703|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55905704|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55905705|NCT00130923|Risperidone|risperidone|mesh-list
55905706|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55905707|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
55905708|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905709|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905710|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905711|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55905712|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56214543|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
55986292|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55986293|NCT00891995|Insulin|insulin|mesh-list
55986294|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55986295|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986296|NCT02781454|Mexiletine|mexiletine|mesh-list
55986297|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55986298|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55986299|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55986300|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55986301|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986303|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55986304|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
55986305|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986306|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
55986307|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986308|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55986309|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986310|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55986311|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986312|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986313|NCT01831193|Curcumin|curcumin|mesh-list
55986314|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55986315|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55986316|NCT01831193|Analgesics|analgesics|mesh-ancestor
55986317|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
55986318|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986319|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986320|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986321|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986322|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986323|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986324|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986325|NCT01831505|Prednisolone|prednisolone|mesh-list
55986326|NCT01831505|Rituximab|rituximab|mesh-list
55986327|NCT01831505|Doxorubicin|doxorubicin|mesh-list
55986328|NCT01831505|Vincristine|vincristine|mesh-list
55986329|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55986330|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55986331|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986332|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
55986333|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986334|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986335|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55986336|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55986337|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55986338|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986339|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986340|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55986341|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
55986342|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
55905713|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905714|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55905715|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55905716|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
55986343|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
55986344|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986345|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
55986348|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55986349|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55986350|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
55986351|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55986352|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986354|NCT03214055|Diuretics|diuretics|mesh-list
55986355|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55986356|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
55986357|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986358|NCT03405337|Factor VIII|factor viii|mesh-list
55986359|NCT03405337|Coagulants|coagulants|mesh-ancestor
55986360|NCT01831661|Metformin|metformin|mesh-list
55986361|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55986362|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986363|NCT03213977|Prednisone|prednisone|mesh-list
56214546|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214547|NCT01613820|Scopolamine|scopolamine|mesh-list
56214548|NCT01613820|Ketamine|ketamine|mesh-list
56214549|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56214550|NCT01613820|Analgesics|analgesics|mesh-ancestor
56214551|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
56214552|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214553|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214554|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55790945|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
55986364|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
55986365|NCT03213977|Doxorubicin|doxorubicin|mesh-list
55986366|NCT03213977|Etoposide|etoposide|mesh-list
55986367|NCT03213977|Vincristine|vincristine|mesh-list
55986368|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986369|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
55986370|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986371|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986372|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55986373|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
55986374|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986375|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986376|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55986378|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55986379|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55986380|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986381|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55986382|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986383|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
55986384|NCT03213977|Hormones|hormones|mesh-ancestor
55986385|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55986386|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55986387|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
55986388|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
55986389|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
55986390|NCT05311085|Nicotine|nicotine|mesh-list
55986391|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55986392|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
55986393|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986394|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986395|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55986396|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55986397|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
55986398|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986399|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986400|NCT03400267|Acetaminophen|acetaminophen|mesh-list
55986401|NCT03400267|Fentanyl|fentanyl|mesh-list
55986402|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55986403|NCT03400267|Narcotics|narcotics|mesh-ancestor
55986404|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986405|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986406|NCT03400267|Analgesics|analgesics|mesh-ancestor
55986407|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
55986408|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986409|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55986410|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55986411|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
55986412|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
55986414|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
55986415|NCT01832051|Trastuzumab|trastuzumab|mesh-list
55986416|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55986417|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214555|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56214556|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
56214557|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
56214558|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214559|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55986418|NCT01832129|Vitamins|vitamins|mesh-list
55986419|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
55986420|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
55986421|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
55986422|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
55986423|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986424|NCT01832129|Hematinics|hematinics|mesh-ancestor
55986425|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
55986426|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
55986427|NCT03219359|Vedolizumab|vedolizumab|mesh-list
55986428|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
55986429|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986430|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
55986431|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986432|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986433|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55986434|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
55986435|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986436|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986437|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55986438|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986439|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
55986440|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
55986441|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986442|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55986443|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
55986444|NCT03219359|Hormones|hormones|mesh-ancestor
55986445|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55986446|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55986447|NCT03219359|Protective Agents|protective agents|mesh-ancestor
55986448|NCT04380857|Dexamethasone|dexamethasone|mesh-list
55986449|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986450|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
55986451|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
55986452|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986454|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55986457|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55986458|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55986459|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986460|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55986461|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55986462|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986463|NCT02903446|Denosumab|denosumab|mesh-list
55986464|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55986465|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986466|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
55986467|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55986468|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55986469|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986470|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986471|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55986472|NCT01832285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55986473|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55986474|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55986475|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986476|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986477|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
55986478|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55986479|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
55986480|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55986481|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55986482|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986483|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55986484|NCT01832363|Xenon|xenon|mesh-list
56214560|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55905827|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56214561|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986485|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55986486|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
55986488|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986489|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986490|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
55986491|NCT02903836|Nafithromycin|nafithromycin|mesh-list
55986492|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55986493|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986494|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55986495|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55986496|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986497|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986498|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986499|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55986500|NCT00014911|Sirolimus|sirolimus|mesh-list
55986501|NCT00014911|Pentamidine|pentamidine|mesh-list
55986502|NCT00014911|Trimethoprim|trimethoprim|mesh-list
55986503|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
55986504|NCT00014911|Ganciclovir|ganciclovir|mesh-list
55986505|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
55986506|NCT00014911|Tacrolimus|tacrolimus|mesh-list
55986507|NCT00014911|Daclizumab|daclizumab|mesh-list
55986508|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986509|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
55986510|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986511|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55986512|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986513|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986514|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55986515|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986516|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55986517|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986518|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
55986519|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55986520|NCT00014911|Renal Agents|renal agents|mesh-ancestor
55986521|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
55986522|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55986523|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55905828|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55905829|NCT01561963|Analgesics|analgesics|mesh-ancestor
55905830|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
55905831|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905832|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905833|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55905834|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55905835|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55905836|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55905837|NCT04852003|Morphine|morphine|mesh-list
55905838|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55905839|NCT04852003|Narcotics|narcotics|mesh-ancestor
55905840|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905841|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905842|NCT04852003|Analgesics|analgesics|mesh-ancestor
55986524|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55986525|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55986528|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
55986529|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55986530|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55986531|NCT01832675|Bupivacaine|bupivacaine|mesh-list
55986532|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
55986533|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
55986534|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986535|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986536|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
55986537|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986538|NCT03213587|Apatinib|apatinib|mesh-list
55986539|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986540|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55986541|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986542|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986543|NCT00013897|Lamivudine|lamivudine|mesh-list
55986544|NCT00013897|Zidovudine|zidovudine|mesh-list
55986545|NCT00013897|Efavirenz|efavirenz|mesh-list
55986546|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
55986547|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55986548|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55986549|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55986550|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986551|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986552|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
55986553|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986554|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55986555|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55986556|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
55986557|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56214562|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214563|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55986558|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55986559|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55986560|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55986561|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55986562|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55905850|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
55905851|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905852|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905853|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905854|NCT01534351|Urological Agents|urological agents|mesh-ancestor
55905855|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55905856|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55905857|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986563|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55986564|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55986565|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
55986566|NCT03219983|Bupivacaine|bupivacaine|mesh-list
55986567|NCT03219983|Ropivacaine|ropivacaine|mesh-list
55986568|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
55986569|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
55986570|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986571|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986572|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
55986573|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986574|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55986575|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55986576|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55986577|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55986578|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986579|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986580|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986581|NCT04347577|Analgesics|analgesics|mesh-ancestor
55986582|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
55986583|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986584|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
55986585|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55986586|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
55986587|NCT03213353|Acetaminophen|acetaminophen|mesh-list
55986588|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
55986589|NCT03213353|Phenylephrine|phenylephrine|mesh-list
55986590|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
55986591|NCT03213353|Guaifenesin|guaifenesin|mesh-list
55986592|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
55986593|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55986594|NCT03213353|Analgesics|analgesics|mesh-ancestor
55986595|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
55986596|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986598|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
55986599|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55986600|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
55986601|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
55986602|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
55986603|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55986604|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
55986605|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
55986606|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55986607|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55986608|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55986609|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
55986610|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986611|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986612|NCT03213353|Protective Agents|protective agents|mesh-ancestor
55986613|NCT03213353|Expectorants|expectorants|mesh-ancestor
55986614|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
55986615|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55986616|NCT02240017|Gemcitabine|gemcitabine|mesh-list
55986617|NCT02240017|Carboplatin|carboplatin|mesh-list
55986618|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986619|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55986620|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
55986621|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986622|NCT02240017|Antiviral Agents|antiviral agents|mesh-ancestor
55986623|NCT02240017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986624|NCT02240017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986625|NCT02240017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905858|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
55905859|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905860|NCT02120352|Rilpivirine|rilpivirine|mesh-list
55905861|NCT02120352|Cabotegravir|cabotegravir|mesh-list
55905862|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55905863|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55986626|NCT02240017|Immunologic Factors|immunologic factors|mesh-ancestor
56214565|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
56214566|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55986627|NCT02240017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986628|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
55986629|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986630|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
55986632|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
55986633|NCT03219593|Apatinib|apatinib|mesh-list
55986634|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986635|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55986636|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986637|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986638|NCT04375267|Olaparib|olaparib|mesh-list
55986639|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55986640|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55986641|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986642|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986643|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986644|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55986645|NCT03836807|Ketoprofen|ketoprofen|mesh-list
55986646|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
55986647|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55986648|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55986649|NCT03836807|Analgesics|analgesics|mesh-ancestor
55986650|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
55986651|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986652|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986653|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986654|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986655|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55986656|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986657|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986658|NCT02240173|Haloperidol|haloperidol|mesh-list
55986659|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
55986660|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
55986661|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
55986662|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986663|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986664|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55986665|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55986666|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55986667|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986668|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55986669|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55986670|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
55986671|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986672|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986674|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
55986675|NCT02240641|Lacidipine|lacidipine|mesh-list
55986676|NCT02240641|Diuretics|diuretics|mesh-list
55986677|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55986678|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55986679|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55986680|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
55986681|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
55986682|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986683|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55986684|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
55986685|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986686|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986687|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
55986688|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55986689|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55718555|NCT02338089|Oxytocin|oxytocin|mesh-list
55986690|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55986691|NCT03219671|Nivolumab|nivolumab|mesh-list
55986692|NCT03219671|Ipilimumab|ipilimumab|mesh-list
55986693|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55986694|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986695|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55986696|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214568|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56214569|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
55986697|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
55986698|NCT03404635|Apixaban|apixaban|mesh-list
55986699|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55986700|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
55986701|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55986702|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
55986703|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986705|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
55986706|NCT01832987|Trimethoprim|trimethoprim|mesh-list
55986707|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55986708|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
55986709|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55986710|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986711|NCT01832987|Renal Agents|renal agents|mesh-ancestor
55986712|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
55986713|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55986714|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55986715|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55986716|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986717|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986718|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55986719|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55986720|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55986721|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55986722|NCT03404479|Celecoxib|celecoxib|mesh-list
55986723|NCT03404479|Diacetylrhein|diacetylrhein|mesh-list
55986724|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55986725|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55986726|NCT03404479|Analgesics|analgesics|mesh-ancestor
55986727|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
55986728|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986729|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756262|NCT03290417|Vitamin D|vitamin d|mesh-list
55905865|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905867|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905868|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55905869|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55905870|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55905871|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55905872|NCT01534195|Prednisolone|prednisolone|mesh-list
55905873|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55986730|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986731|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986732|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55986733|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55986734|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986735|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986736|NCT04380467|Vitamin D|vitamin d|mesh-list
55986737|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
55986738|NCT04380467|Vitamins|vitamins|mesh-ancestor
55986739|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
55986740|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986741|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55986742|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55986743|NCT03218657|Cyclosporine|cyclosporine|mesh-list
55986744|NCT03218657|Levamisole|levamisole|mesh-list
55986745|NCT03218657|Cyclosporins|cyclosporins|mesh-list
55986748|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986749|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986750|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
55986751|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986752|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
55986753|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986754|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
55986755|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986756|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55986757|NCT03218657|Hormones|hormones|mesh-ancestor
55986758|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55986759|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55986760|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
55986761|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
55986762|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55986763|NCT02240719|Everolimus|everolimus|mesh-list
55986764|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55986765|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986766|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986767|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
55986768|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986769|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56214570|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56214571|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
56214572|NCT01613846|Sorafenib|sorafenib|mesh-list
56214573|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986770|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
55986771|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986772|NCT01833299|Sorafenib|sorafenib|mesh-list
55986773|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
55986774|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986775|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55986776|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986777|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986778|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55986779|NCT01833299|Estrogens|estrogens|mesh-ancestor
55986780|NCT01833299|Hormones|hormones|mesh-ancestor
56052229|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55905874|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
55905875|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55905876|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
55905877|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55905878|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55986781|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55986782|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986783|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55986784|NCT03213041|Carboplatin|carboplatin|mesh-list
55986785|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
55986787|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55986788|NCT01833611|Entecavir|entecavir|mesh-list
55986789|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
55986790|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986791|NCT02240953|Warfarin|warfarin|mesh-list
55986792|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
55986793|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
55986794|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55986795|NCT02241031|Oprelvekin|oprelvekin|mesh-list
55986796|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986797|NCT03212807|Lenalidomide|lenalidomide|mesh-list
55986798|NCT03212807|Durvalumab|durvalumab|mesh-list
55986799|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
55986800|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986801|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55986802|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55986803|NCT03212807|Growth Substances|growth substances|mesh-ancestor
55986804|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
55986805|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986806|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55986807|NCT04373941|Lenograstim|lenograstim|mesh-list
55986808|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55986809|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
55986810|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986811|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
55986812|NCT01833767|Interleukin-2|interleukin-2|mesh-list
55986813|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986814|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
55986815|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986816|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986817|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55986818|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
55986819|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986820|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986823|NCT01833767|Analgesics|analgesics|mesh-ancestor
55986824|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
55986825|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986826|NCT01834235|Gemcitabine|gemcitabine|mesh-list
55986827|NCT01834235|Paclitaxel|paclitaxel|mesh-list
55986828|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55986829|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986830|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
55986831|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
55986832|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
55986833|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986834|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55986835|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
55986836|NCT01834235|Antiviral Agents|antiviral agents|mesh-ancestor
55986837|NCT01834235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986838|NCT01834235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986839|NCT01834235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986840|NCT01834235|Immunologic Factors|immunologic factors|mesh-ancestor
55986841|NCT01834235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214574|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56214575|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749469|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
55749470|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749471|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749472|NCT03248791|Protective Agents|protective agents|mesh-ancestor
55749473|NCT03254173|Mirtazapine|mirtazapine|mesh-list
55749474|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
55749475|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55749476|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55749477|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
55749478|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
55749479|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749480|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749481|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749482|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55749483|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56214576|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986842|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
55986843|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55986844|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986845|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986846|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55986847|NCT03211871|Analgesics|analgesics|mesh-ancestor
55986848|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
55986849|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986850|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55986851|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55986854|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986855|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986856|NCT03838133|Bupivacaine|bupivacaine|mesh-list
55986857|NCT03838133|Ropivacaine|ropivacaine|mesh-list
55986858|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
55986859|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
55986860|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986861|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986862|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
55986863|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986864|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55986865|NCT03217409|Ezetimibe|ezetimibe|mesh-list
55986866|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55986867|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55986868|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
55986869|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986870|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55986871|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55986872|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986873|NCT00895193|Aspirin|aspirin|mesh-list
55986874|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55986875|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55986876|NCT00895193|Analgesics|analgesics|mesh-ancestor
55986877|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
55986878|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986879|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986880|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55986881|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55986882|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55986883|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55986884|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986885|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55986886|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55986887|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986888|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
55986889|NCT01834547|Caffeine|caffeine|mesh-list
55986890|NCT01834547|Methylphenidate|methylphenidate|mesh-list
55986891|NCT01834547|Modafinil|modafinil|mesh-list
55986892|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55986895|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986896|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905879|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55905880|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
55905881|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55905882|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
55905883|NCT01534195|Hormones|hormones|mesh-ancestor
55905884|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55718763|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55986897|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55986898|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55986900|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986901|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55986902|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55986903|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55986904|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
55986905|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55986906|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55986907|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55986908|NCT03216941|Ketamine|ketamine|mesh-list
55986909|NCT03216941|Olanzapine|olanzapine|mesh-list
56214579|NCT01613963|Cyclosporine|cyclosporine|mesh-list
56214580|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
55986910|NCT03216941|Analgesics|analgesics|mesh-ancestor
55986911|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
55986912|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986913|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986914|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55986915|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55986916|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
55986917|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
55986918|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986919|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55986920|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55986921|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55986922|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986923|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
55986924|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
55986925|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55986926|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55986927|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55986928|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55986929|NCT03216941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55986930|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55986931|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55986932|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
55986933|NCT03216707|Capsaicin|capsaicin|mesh-list
55986934|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
55986935|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
55986936|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
55986937|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986938|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986939|NCT01838993|Lidocaine|lidocaine|mesh-list
55986940|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
55986941|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
55986942|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55986943|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986944|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
55986945|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55986946|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55986947|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55986948|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55986949|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55986950|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986951|NCT03211013|Oxytocin|oxytocin|mesh-list
55986952|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
55986953|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55986954|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986955|NCT01835561|Thalidomide|thalidomide|mesh-list
55986956|NCT01835561|Pomalidomide|pomalidomide|mesh-list
55986957|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
55905888|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
55986958|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986959|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55986960|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55986961|NCT01835561|Growth Substances|growth substances|mesh-ancestor
55986962|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
55986963|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986964|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55986965|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
55986966|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55986967|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55986969|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
55986970|NCT01835639|Vitamins|vitamins|mesh-ancestor
55986971|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
55986972|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986973|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55986974|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55986976|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
55986977|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214581|NCT01613963|Prednisolone|prednisolone|mesh-list
56214582|NCT01613963|Adalimumab|adalimumab|mesh-list
56214583|NCT01613963|Etanercept|etanercept|mesh-list
56214584|NCT01613963|Methotrexate|methotrexate|mesh-list
55986978|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986981|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55986982|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986983|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55986984|NCT00901199|Deferasirox|deferasirox|mesh-list
55986985|NCT00901199|Deferoxamine|deferoxamine|mesh-list
55986986|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55986987|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
55986988|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
55986989|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986990|NCT00901199|Siderophores|siderophores|mesh-ancestor
55986991|NCT01836341|Carboplatin|carboplatin|mesh-list
55986992|NCT01836341|Pemetrexed|pemetrexed|mesh-list
55986993|NCT01836341|Afatinib|afatinib|mesh-list
55986994|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986995|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986996|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55986997|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55986998|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55986999|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55987000|NCT00906503|Dexamethasone|dexamethasone|mesh-list
55987001|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55987002|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987003|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
55987004|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
55987005|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987006|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987007|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55987009|NCT00906503|Hormones|hormones|mesh-ancestor
55987010|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987011|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55987012|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987013|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55987014|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987015|NCT01836575|Carboplatin|carboplatin|mesh-list
55987016|NCT01836575|Pemetrexed|pemetrexed|mesh-list
55987017|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987018|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987019|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987020|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55987021|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55987022|NCT01836653|Bevacizumab|bevacizumab|mesh-list
55987023|NCT01836653|Cetuximab|cetuximab|mesh-list
55987024|NCT01836653|Fluorouracil|fluorouracil|mesh-list
55987025|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
55987026|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55987027|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987028|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55987029|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55987030|NCT01836653|Growth Substances|growth substances|mesh-ancestor
55987031|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987032|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
55987033|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
55987034|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987035|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55987036|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987037|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
55987038|NCT03836885|Apremilast|apremilast|mesh-list
55987039|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55987041|NCT03836885|Analgesics|analgesics|mesh-ancestor
55987042|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
55987043|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987044|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987045|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987046|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56214585|NCT01613963|Azathioprine|azathioprine|mesh-list
56214586|NCT01613963|Infliximab|infliximab|mesh-list
55987047|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55987048|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55987049|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987050|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987051|NCT01837043|Cyclosporine|cyclosporine|mesh-list
55987052|NCT01837043|Abatacept|abatacept|mesh-list
55987053|NCT01837043|Tacrolimus|tacrolimus|mesh-list
55987054|NCT01837043|Cyclosporins|cyclosporins|mesh-list
55987055|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55987056|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987057|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
55987058|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987059|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987060|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987061|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
55987062|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987063|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
55987064|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987065|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55987066|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987067|NCT01839773|Paclitaxel|paclitaxel|mesh-list
55987068|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55987069|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55987070|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987071|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
55987072|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
55987073|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
55987074|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987075|NCT00909155|Fluoxetine|fluoxetine|mesh-list
55987076|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55987077|NCT00909155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55987078|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55987079|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987080|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987081|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987082|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
55987083|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987084|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55987085|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
55987086|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55987087|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55987088|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55987089|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987090|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55987091|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
55987092|NCT01839851|Hormones|hormones|mesh-ancestor
55987093|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987094|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987095|NCT01839929|Tacrolimus|tacrolimus|mesh-list
55987096|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987097|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
55987098|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987099|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55987100|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987101|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987102|NCT04373083|Cemiplimab|cemiplimab|mesh-list
55987103|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55987104|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987105|NCT03210545|Betamethasone|betamethasone|mesh-list
55987106|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987107|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
55987108|NCT03210545|Hormones|hormones|mesh-ancestor
55987109|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987110|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987112|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
55987114|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55987115|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987116|NCT03403777|Avelumab|avelumab|mesh-list
55987117|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56214588|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56214589|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214590|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
55987118|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987119|NCT02241421|Amoxicillin|amoxicillin|mesh-list
55987120|NCT02241421|Vancomycin|vancomycin|mesh-list
55987121|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55987122|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987123|NCT01837199|Amoxicillin|amoxicillin|mesh-list
55987124|NCT01837199|Metronidazole|metronidazole|mesh-list
55906058|NCT05661552|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55906061|NCT03534102|Narcotics|narcotics|mesh-ancestor
55906076|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
55906077|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906078|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906079|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
55906080|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906081|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55906082|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55906083|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55906084|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55906085|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906086|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55906087|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
55906088|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
55906089|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906090|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
55906137|NCT05549154|Vitamin D|vitamin d|mesh-list
55906138|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
55906139|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
55906140|NCT05549154|Vitamins|vitamins|mesh-list
55987125|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55987126|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987127|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55987128|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55987129|NCT00926185|Lifitegrast|lifitegrast|mesh-list
55987130|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55987131|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55987132|NCT02241499|Fluorouracil|fluorouracil|mesh-list
55987133|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
55987134|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
55987135|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987136|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55987137|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987138|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987139|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
55987140|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987141|NCT01837667|Docetaxel|docetaxel|mesh-list
55987142|NCT01837667|LB100|lb100|mesh-list
55987143|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987144|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
55987145|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
55987146|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
55987147|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987148|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987149|NCT03833947|Dexamethasone|dexamethasone|mesh-list
55987150|NCT03833947|Lidocaine|lidocaine|mesh-list
55987151|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987152|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
55987153|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
55987154|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987155|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987156|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55987157|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
55987158|NCT03833947|Hormones|hormones|mesh-ancestor
55987159|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987160|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55987161|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987162|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
55987163|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
55987164|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987165|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
55987166|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55987167|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55987168|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55987169|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987170|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987171|NCT03219437|Methotrexate|methotrexate|mesh-list
55987172|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55987173|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
55987174|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55987175|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987176|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55987177|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
55987178|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987179|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719050|NCT02305615|Growth Substances|growth substances|mesh-ancestor
55987180|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
55987181|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987182|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55987183|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987184|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
56214591|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214592|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56214593|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56214594|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
55987186|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55987187|NCT03212963|Clobetasol|clobetasol|mesh-list
55987188|NCT03212963|Halobetasol|halobetasol|mesh-list
55987189|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55987190|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987191|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
55987192|NCT03212963|Hormones|hormones|mesh-ancestor
55987193|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987194|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987195|NCT03218969|Ecopipam|ecopipam|mesh-list
55987196|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55987197|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55987198|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987199|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987200|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55987201|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55987202|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
55987203|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987204|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987205|NCT01830101|Temozolomide|temozolomide|mesh-list
55987206|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55987207|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
55987208|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987209|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987210|NCT01830335|Indomethacin|indomethacin|mesh-list
55987211|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55987212|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55987213|NCT01830335|Analgesics|analgesics|mesh-ancestor
55987214|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
55987215|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987216|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987217|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987218|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987219|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
55987220|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
55987221|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55987222|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55987223|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987224|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987225|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
55987226|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55987227|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55987228|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987229|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55987230|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55987231|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987232|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906149|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55906150|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906151|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
55906152|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906153|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987233|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987234|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987235|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
55987237|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55987238|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
55987239|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987240|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987241|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55987242|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
55987243|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
55987244|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55987245|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
55987246|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987247|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987248|NCT04371757|Doxazosin|doxazosin|mesh-list
55987249|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
55987250|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55987251|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56214595|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214596|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56214597|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
55790979|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
55987252|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55987253|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55987254|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987255|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987256|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987257|NCT04371601|Oseltamivir|oseltamivir|mesh-list
55987258|NCT04371601|Hormones|hormones|mesh-list
55987261|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
55987262|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987263|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987264|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987265|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
55987266|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
55987267|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55987268|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55987269|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987270|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987271|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987272|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987274|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55987275|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55987276|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55987277|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987278|NCT03409835|Ramosetron|ramosetron|mesh-list
55987279|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
55987280|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
55987281|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987282|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987283|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55987284|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55987285|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
55987286|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987287|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987288|NCT02242513|Lidocaine|lidocaine|mesh-list
55987289|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
55987290|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
55987291|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987292|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987293|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
55987294|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987295|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55987296|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55987297|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55987298|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987299|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987300|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55987301|NCT03409679|Murepavadin|murepavadin|mesh-list
55987302|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987303|NCT04371367|Avdoralimab|avdoralimab|mesh-list
55987304|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987305|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
55987306|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987307|NCT02242591|Ropivacaine|ropivacaine|mesh-list
55987308|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
55987309|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
55987310|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987311|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987312|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
55987313|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987314|NCT02982577|Pilocarpine|pilocarpine|mesh-list
55987315|NCT02982577|Miotics|miotics|mesh-ancestor
55987316|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
55987317|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987318|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987319|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55987320|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55987321|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
56214598|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214599|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
55987322|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987323|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987325|NCT03409367|Petrolatum|petrolatum|mesh-list
55987326|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
55987327|NCT01726205|Pregabalin|pregabalin|mesh-list
55987328|NCT01726205|Ropivacaine|ropivacaine|mesh-list
55987329|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
55987330|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
55987332|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987333|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
55987334|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987335|NCT01726205|Analgesics|analgesics|mesh-ancestor
55987336|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
55987337|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55987338|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987339|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987340|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55987341|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55987342|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55987343|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55987344|NCT02242825|Telmisartan|telmisartan|mesh-list
55987345|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
55987347|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55987348|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55987349|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987350|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55987351|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987352|NCT02242825|Diuretics|diuretics|mesh-ancestor
55987353|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
55987354|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987355|NCT04370977|Artesunate|artesunate|mesh-list
55987356|NCT04370977|Lumefantrine|lumefantrine|mesh-list
55987357|NCT04370977|Artemether|artemether|mesh-list
55987358|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55987359|NCT04370977|Amodiaquine|amodiaquine|mesh-list
55987360|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
55987361|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55987362|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55987363|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987364|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987365|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
55987366|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
55987367|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55987368|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
55987369|NCT01726283|Riboflavin|riboflavin|mesh-list
55987370|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
55987371|NCT01726283|Vitamins|vitamins|mesh-ancestor
55987372|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
55987373|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987374|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55987375|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
55987376|NCT04370431|Edaravone|edaravone|mesh-list
55987377|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55987378|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
55987379|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987380|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55987381|NCT04370431|Protective Agents|protective agents|mesh-ancestor
55987382|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987383|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
55987384|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987385|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987386|NCT03835871|Beclomethasone|beclomethasone|mesh-list
55987387|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987388|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
55987389|NCT03835871|Hormones|hormones|mesh-ancestor
55987390|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987391|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987392|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56214600|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214601|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56214602|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55906158|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
55906159|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55906160|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749565|NCT03345797|Androgens|androgens|mesh-ancestor
55749566|NCT03345797|Hormones|hormones|mesh-ancestor
55749567|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749568|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749570|NCT04500743|Dienogest|dienogest|mesh-list
55749571|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55749572|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
55749573|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55749574|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749575|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55749576|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749578|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
55749579|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55749580|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55749581|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55749582|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55749583|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
55749584|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749586|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749587|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55749588|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749589|NCT03239353|Entecavir|entecavir|mesh-list
55749590|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
55749591|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749592|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
55749593|NCT03347591|Hemostatics|hemostatics|mesh-list
55749594|NCT03347591|Coagulants|coagulants|mesh-ancestor
55749595|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55749596|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
55749597|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987393|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
55987394|NCT03402295|Thalidomide|thalidomide|mesh-list
55987395|NCT03402295|Dexamethasone|dexamethasone|mesh-list
55987396|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
55987398|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987399|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
55987400|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987401|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987402|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55987403|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
55987404|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987405|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987408|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
55987409|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
55987410|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987411|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55987412|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
55987413|NCT03402295|Hormones|hormones|mesh-ancestor
55987414|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987415|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55987416|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
55987417|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55987418|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987419|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55987420|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55987421|NCT03402295|Growth Substances|growth substances|mesh-ancestor
55987422|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
55987423|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
55987424|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55987425|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987426|NCT02244073|Insulin|insulin|mesh-list
55987427|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55987428|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55987429|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987430|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55987431|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
55987432|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55987433|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
55987434|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55987435|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987436|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55987437|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55987438|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987439|NCT03401827|Gemcitabine|gemcitabine|mesh-list
55987440|NCT03401827|Paclitaxel|paclitaxel|mesh-list
55987441|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55987442|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987443|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
55987444|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
55987445|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
55987446|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987447|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55987448|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
55987449|NCT03401827|Antiviral Agents|antiviral agents|mesh-ancestor
55987450|NCT03401827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987451|NCT03401827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987452|NCT03401827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987453|NCT03401827|Immunologic Factors|immunologic factors|mesh-ancestor
55987454|NCT03401827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987456|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55987457|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55987458|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987459|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987460|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55987461|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987462|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
56214603|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
56214604|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214605|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56214606|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55987463|NCT02244229|Tamsulosin|tamsulosin|mesh-list
55987464|NCT02244229|Finasteride|finasteride|mesh-list
55987465|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55987466|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55987467|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55987468|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
55987469|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987470|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987471|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987472|NCT02244229|Urological Agents|urological agents|mesh-ancestor
55987473|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55987474|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55987475|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987476|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
55987478|NCT02157103|Bevacizumab|bevacizumab|mesh-list
55987480|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987481|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55987482|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55987483|NCT02157103|Growth Substances|growth substances|mesh-ancestor
55987484|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987485|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
55987486|NCT00924001|Aldesleukin|aldesleukin|mesh-list
55987487|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
55987488|NCT00924001|Fludarabine|fludarabine|mesh-list
55987489|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987490|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
55987491|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987492|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987493|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55987494|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
55987495|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987496|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987497|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55987498|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55906227|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
55987499|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55987500|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
55987501|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987502|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
55987503|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
55987504|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
55987505|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987506|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987507|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987508|NCT03401593|Fentanyl|fentanyl|mesh-list
55987509|NCT03401593|Midazolam|midazolam|mesh-list
55987510|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55987511|NCT03401593|Narcotics|narcotics|mesh-ancestor
55987512|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987513|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987514|NCT03401593|Analgesics|analgesics|mesh-ancestor
55987515|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
55987516|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987517|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55987518|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55987519|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
55987520|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
55987521|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55987522|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55987523|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55987524|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55987525|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
55987526|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
55987527|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987528|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214607|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56214608|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
55790991|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
55987529|NCT03401515|Propranolol|propranolol|mesh-list
55987530|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55987531|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55987532|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
55987533|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987534|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987535|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987536|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55987537|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55987538|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
55987539|NCT01726829|Pancrelipase|pancrelipase|mesh-list
55987540|NCT01726829|Pancreatin|pancreatin|mesh-list
55987541|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55987542|NCT03408587|Ipilimumab|ipilimumab|mesh-list
55987543|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55987544|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987545|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55906240|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906257|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906258|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55906259|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906260|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55906261|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906262|NCT01528735|Ribavirin|ribavirin|mesh-list
55906263|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
55906264|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906265|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
55987546|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987547|NCT03834233|Nivolumab|nivolumab|mesh-list
55987548|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55987549|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987550|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55987551|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987553|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55987554|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55987555|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987556|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
55987557|NCT04367155|Coagulants|coagulants|mesh-ancestor
55987558|NCT01727453|Warfarin|warfarin|mesh-list
55987559|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
55987560|NCT01727531|Chloroquine|chloroquine|mesh-list
55987561|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
55987562|NCT01727531|Amebicides|amebicides|mesh-ancestor
55987563|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55987564|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55987565|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987566|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
55987567|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987568|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55987569|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55987571|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
55987572|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987573|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987574|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987575|NCT01727531|Filaricides|filaricides|mesh-ancestor
55987576|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
55987577|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
55987578|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
55987579|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55987580|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55987581|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987582|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55987583|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55987584|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987585|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987586|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987587|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55987588|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
55987589|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55987590|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987591|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55987592|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55987593|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55987594|NCT00929071|Lidocaine|lidocaine|mesh-list
55987595|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
55987596|NCT00929071|Anesthetics|anesthetics|mesh-list
55987597|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987598|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987599|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
56214609|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56214610|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214611|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
56214612|NCT01613963|Hormones|hormones|mesh-ancestor
55719454|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214613|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987600|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987601|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55987602|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55987603|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55987604|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987605|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987606|NCT01721525|Ribavirin|ribavirin|mesh-list
55987607|NCT01721525|Paclitaxel|paclitaxel|mesh-list
55987608|NCT01721525|Carboplatin|carboplatin|mesh-list
55987609|NCT01721525|Afatinib|afatinib|mesh-list
55987610|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55987611|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987612|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
55987613|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
55987614|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
55987615|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987616|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
55987617|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
55987618|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987619|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55987620|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987622|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55906266|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906268|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
55906269|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55906270|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55906271|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55906272|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906273|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906274|NCT02386488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55906275|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55906276|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55906277|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906278|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906279|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
55906280|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55906281|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55906282|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55906283|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55906284|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
55906285|NCT02661594|Amisulpride|amisulpride|mesh-list
55906286|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55906316|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55987623|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55987624|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987625|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
55987626|NCT01727843|Coagulants|coagulants|mesh-ancestor
55987627|NCT01721915|Vitamin D|vitamin d|mesh-list
55987630|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987631|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55987632|NCT04357483|Thrombin|thrombin|mesh-list
55987633|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
55987634|NCT04357483|Coagulants|coagulants|mesh-ancestor
55987635|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
55987636|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55987637|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987638|NCT04366609|Methylphenidate|methylphenidate|mesh-list
55987639|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55987640|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987641|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55987642|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55987643|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987644|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987645|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
55987646|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987647|NCT03407105|Ipilimumab|ipilimumab|mesh-list
55987648|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55987649|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987650|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55987651|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987652|NCT01722227|Liraglutide|liraglutide|mesh-list
55987653|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55987654|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987655|NCT01722227|Incretins|incretins|mesh-ancestor
55987656|NCT01722227|Hormones|hormones|mesh-ancestor
55987657|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987658|NCT01722305|Dexamethasone|dexamethasone|mesh-list
55987659|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
55987660|NCT01722305|Pomalidomide|pomalidomide|mesh-list
55987661|NCT01722305|Ichthammol|ichthammol|mesh-list
55987662|NCT01722305|BB 1101|bb 1101|mesh-list
55987663|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987664|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
55987665|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
55987666|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214614|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56214615|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214616|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55987667|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987668|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55987669|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
55987670|NCT01722305|Hormones|hormones|mesh-ancestor
55987671|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987672|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55987673|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987674|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
55987675|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987676|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987677|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
55987678|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55987679|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55987680|NCT01722305|Growth Substances|growth substances|mesh-ancestor
55987681|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
55987682|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
55987683|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55987684|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55987685|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987686|NCT04365517|Incretins|incretins|mesh-ancestor
55987687|NCT04365517|Hormones|hormones|mesh-ancestor
55987688|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987689|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55987690|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
55987691|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987692|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987693|NCT03406871|Nivolumab|nivolumab|mesh-list
55987694|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55987695|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987696|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55987697|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987698|NCT04357093|Listerine|listerine|mesh-list
55987699|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
55987700|NCT04357093|Fluorides|fluorides|mesh-list
55987703|NCT04357093|Protective Agents|protective agents|mesh-ancestor
55987704|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987705|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55987706|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987707|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55987708|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987709|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
55987710|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987712|NCT03406793|Zinc|zinc|mesh-list
55987713|NCT03406793|Trace Elements|trace elements|mesh-ancestor
55987714|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
55987715|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987716|NCT04365127|Progesterone|progesterone|mesh-list
55715034|NCT02207387|Rasagiline|rasagiline|mesh-list
55987717|NCT04365127|Progestins|progestins|mesh-ancestor
55987718|NCT04365127|Hormones|hormones|mesh-ancestor
55987719|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987720|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987721|NCT00929383|Hemostatics|hemostatics|mesh-list
55987722|NCT00929383|Coagulants|coagulants|mesh-ancestor
55987723|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
55987724|NCT01722539|Piperaquine|piperaquine|mesh-list
55906372|NCT01510769|Lesinurad|lesinurad|mesh-list
55906373|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
55906374|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906375|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
55906376|NCT01510769|Renal Agents|renal agents|mesh-ancestor
55906377|NCT02382354|Remifentanil|remifentanil|mesh-list
55987725|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
55987726|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55987727|NCT01722539|Albendazole|albendazole|mesh-list
55987728|NCT01722539|Praziquantel|praziquantel|mesh-list
55987729|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
55987730|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55987731|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55987732|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987733|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55987734|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987735|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987736|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55987737|NCT01722539|Renal Agents|renal agents|mesh-ancestor
56214617|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56214618|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56214619|NCT01613963|Analgesics|analgesics|mesh-ancestor
56214620|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
55987738|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
55987739|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
55987740|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55987741|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
55987742|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
55987743|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
55987744|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987745|NCT04765111|Rituximab|rituximab|mesh-list
55987746|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55987747|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
55987748|NCT04765111|Antibodies|antibodies|mesh-list
55987749|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
55987750|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55987751|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
55987752|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987753|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987754|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987755|NCT03406403|Anesthetics|anesthetics|mesh-list
55987756|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987757|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987758|NCT04378283|Lidocaine|lidocaine|mesh-list
55987759|NCT04378283|Epinephrine|epinephrine|mesh-list
55987760|NCT04378283|Tetracaine|tetracaine|mesh-list
55987761|NCT04378283|Anesthetics|anesthetics|mesh-list
55719630|NCT02234921|Vaccines|vaccines|mesh-list
55987762|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
55987763|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987764|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987765|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
55987766|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987767|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55987768|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55987769|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55987770|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55987771|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987772|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55987773|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55987774|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
55987775|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987778|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
55987779|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55987780|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
55987781|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
55987782|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
55987783|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55987784|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
55987785|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
55987786|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
55987787|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55987788|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55987789|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987790|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987791|NCT03406169|Urological Agents|urological agents|mesh-ancestor
55987792|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55987793|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55987794|NCT03406169|Protective Agents|protective agents|mesh-ancestor
55987795|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987796|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55987797|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
55987798|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
55987799|NCT04357015|Carbetocin|carbetocin|mesh-list
55987800|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55987801|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55906430|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906431|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55906432|NCT02382432|Narcotics|narcotics|mesh-ancestor
55906433|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55906434|NCT00145587|Antibodies|antibodies|mesh-list
55906435|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
55906436|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906437|NCT04298463|Vancomycin|vancomycin|mesh-list
55906438|NCT04298463|Daptomycin|daptomycin|mesh-list
55906439|NCT04298463|Teicoplanin|teicoplanin|mesh-list
55906440|NCT04298463|Dalbavancin|dalbavancin|mesh-list
55906441|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55906442|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906443|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
55906444|NCT02381964|Vitamins|vitamins|mesh-ancestor
55906445|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
55906446|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906447|NCT01509053|Aripiprazole|aripiprazole|mesh-list
55906448|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
55987802|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987803|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
55987804|NCT04357015|Coagulants|coagulants|mesh-ancestor
55987805|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
55987806|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55987807|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987808|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56214621|NCT01613976|Panobinostat|panobinostat|mesh-list
56214622|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987809|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55987810|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55987811|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987812|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
55987813|NCT03406091|Plerixafor|plerixafor|mesh-list
55987814|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55987815|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55987816|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
55987817|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987818|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
55987819|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
55987820|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55987821|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55987822|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987823|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987824|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987825|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987826|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
55987827|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
55987828|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987829|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55987830|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55987831|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
55987832|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987833|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987834|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55987835|NCT01728935|Tenofovir|tenofovir|mesh-list
55987836|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
55987837|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987838|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55987839|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55987840|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987841|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987842|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55987843|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55987844|NCT04609111|Aspirin|aspirin|mesh-list
55987845|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55987846|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55906450|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55906451|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55906452|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906453|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906455|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
55906483|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
55906484|NCT02390700|Golimumab|golimumab|mesh-list
55906485|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55906486|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987847|NCT04609111|Analgesics|analgesics|mesh-ancestor
55987848|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
55987849|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987851|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55987852|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987853|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55987854|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55987855|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987856|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55987857|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55987858|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987860|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
55987861|NCT02904226|Nivolumab|nivolumab|mesh-list
55987862|NCT02904226|Ipilimumab|ipilimumab|mesh-list
55987863|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55987864|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987865|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55987866|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987867|NCT03833999|Ondansetron|ondansetron|mesh-list
55987868|NCT03833999|Lactulose|lactulose|mesh-list
55987869|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
55715182|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
55987870|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
55987871|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987872|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987873|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55987874|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
55987875|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
55987876|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55987877|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
55987878|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987879|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987880|NCT03833999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55987881|NCT03833999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56214623|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56214624|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987882|NCT03833999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987883|NCT03833999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55987884|NCT03833999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55987885|NCT04379219|Methotrexate|methotrexate|mesh-list
55987886|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55987887|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
55987888|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55987889|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987890|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55987892|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987893|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987894|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
55987895|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987896|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55987897|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987898|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
55987899|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987900|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55987901|NCT04347031|Azithromycin|azithromycin|mesh-list
55987902|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
55987903|NCT04347031|Mefloquine|mefloquine|mesh-list
55987904|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55987905|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987906|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
55987907|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55987908|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55987909|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052230|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55987910|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987911|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55987912|NCT02906566|Vitamin A|vitamin a|mesh-list
55987913|NCT02906566|Vitamins|vitamins|mesh-ancestor
55987914|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
55987915|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987916|NCT00913133|Desirudin|desirudin|mesh-list
55987917|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
55987918|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55987919|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55987920|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987921|NCT00373126|Nicotine|nicotine|mesh-list
55987922|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55987923|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
55987924|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987926|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55987927|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55987928|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
55987929|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987930|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987931|NCT04355845|Sumatriptan|sumatriptan|mesh-list
55987932|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55987933|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55987934|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55987935|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
55987936|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987937|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987938|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987939|NCT02789410|Morphine|morphine|mesh-list
55987940|NCT02789410|Hydromorphone|hydromorphone|mesh-list
55987941|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55987942|NCT02789410|Narcotics|narcotics|mesh-ancestor
55987943|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987944|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987945|NCT02789410|Analgesics|analgesics|mesh-ancestor
55987946|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
55987947|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987948|NCT01729481|Leucovorin|leucovorin|mesh-list
55987949|NCT01729481|Folic Acid|folic acid|mesh-list
55906497|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
55906498|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906499|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906500|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55906501|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
55906502|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906503|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906504|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55906505|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
55906506|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
55906507|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
55906508|NCT05030298|Temozolomide|temozolomide|mesh-list
55987950|NCT01729481|Gemcitabine|gemcitabine|mesh-list
55987951|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
55987952|NCT01729481|Irinotecan|irinotecan|mesh-list
55987953|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
55987954|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55987955|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
55987956|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214625|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214626|NCT01614041|Tandospirone|tandospirone|mesh-list
56214627|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56214628|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55987957|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55987958|NCT01729481|Antiviral Agents|antiviral agents|mesh-ancestor
55987959|NCT01729481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55987960|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55987961|NCT01729481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55987962|NCT01729481|Immunologic Factors|immunologic factors|mesh-ancestor
55987963|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987964|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55987965|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55987966|NCT01729481|Antidotes|antidotes|mesh-ancestor
55987967|NCT01729481|Protective Agents|protective agents|mesh-ancestor
55987968|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
55987969|NCT01729481|Vitamins|vitamins|mesh-ancestor
55987970|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
55987971|NCT01729481|Hematinics|hematinics|mesh-ancestor
55987972|NCT02790736|Propranolol|propranolol|mesh-list
55987973|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55987974|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55987975|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
55987976|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55987977|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987978|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987979|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55987980|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55987981|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
55987982|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
55987983|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55987984|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
55987985|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55987986|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987987|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55987988|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
55987989|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
55987990|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55987991|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
55987992|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831907|NCT02168387|Expectorants|expectorants|mesh-ancestor
55987993|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55987994|NCT02793154|Exenatide|exenatide|mesh-list
55987995|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
55987996|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55987997|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987998|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55987999|NCT02793154|Incretins|incretins|mesh-ancestor
55988000|NCT02793154|Hormones|hormones|mesh-ancestor
55988003|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988004|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55988005|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55988006|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55988007|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906513|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
55988008|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988009|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55988010|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55988011|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988012|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
55988013|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988014|NCT02909140|Lidocaine|lidocaine|mesh-list
55988015|NCT02909140|Phenylephrine|phenylephrine|mesh-list
55988016|NCT02909140|Epinephrine|epinephrine|mesh-list
55988017|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
55988018|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
55988019|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
55988020|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
55988021|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988022|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988023|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
55988024|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988025|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55988026|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56214629|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214630|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988027|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55988028|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55988029|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988030|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55988032|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
55988033|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988034|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55988035|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55988036|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
55988037|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55988038|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
55988039|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
55988040|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
55988041|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55988042|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55988043|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
55988044|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55988045|NCT02909140|Protective Agents|protective agents|mesh-ancestor
55988046|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
55988047|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55988048|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55988049|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
55988050|NCT01724879|Dasatinib|dasatinib|mesh-list
55988051|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988052|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55988053|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988054|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988055|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
55988056|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988057|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
55988058|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988059|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988060|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55988061|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
55988062|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988063|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988064|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55988065|NCT03403985|Calcium|calcium|mesh-list
55988066|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55988067|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988068|NCT04364425|Triamcinolone|triamcinolone|mesh-list
55988069|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55988070|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55988071|NCT04364425|Lidocaine|lidocaine|mesh-list
55988072|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55988073|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
55988075|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988076|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988077|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
55988078|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988079|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55988080|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55988081|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55988082|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55988083|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988084|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988085|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
55988086|NCT04364425|Hormones|hormones|mesh-ancestor
55988087|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988088|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988089|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
55988090|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988091|NCT02911324|Nabilone|nabilone|mesh-list
55988092|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
55988093|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
55988094|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988095|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988096|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214631|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56214632|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55988097|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55988098|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55988099|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988100|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55988101|NCT01729403|Metformin|metformin|mesh-list
55988102|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55988103|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988104|NCT04364581|Letrozole|letrozole|mesh-list
55988105|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988106|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55988107|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55988108|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988109|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988110|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55988111|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
55988112|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988113|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988114|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56052231|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988115|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988117|NCT04355455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55988118|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55988119|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55988120|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988121|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988122|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
55906601|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
55988123|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988124|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55988125|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
55988126|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55988127|NCT04182373|Antithrombins|antithrombins|mesh-list
55988128|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
55988129|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55988130|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
55988131|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988132|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988133|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
55988134|NCT00913913|Bevacizumab|bevacizumab|mesh-list
55988135|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988136|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988137|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55988138|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55988139|NCT00913913|Growth Substances|growth substances|mesh-ancestor
55988140|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988141|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
55988142|NCT00373594|Rituximab|rituximab|mesh-list
55988143|NCT00373594|Fludarabine|fludarabine|mesh-list
55988144|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988145|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988146|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
55988148|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988149|NCT03403829|Gemcitabine|gemcitabine|mesh-list
55988150|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55988151|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
55988152|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988153|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988154|NCT03403829|Antiviral Agents|antiviral agents|mesh-ancestor
55988155|NCT03403829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988156|NCT03403829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988157|NCT03403829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988158|NCT03403829|Immunologic Factors|immunologic factors|mesh-ancestor
55988159|NCT03403829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988160|NCT04364113|Benzocaine|benzocaine|mesh-list
55988161|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
55988162|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
55988163|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988164|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988165|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
55988166|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988167|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
55988168|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56214633|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
56214634|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791011|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55988169|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988170|NCT03197194|Aspirin|aspirin|mesh-list
55988171|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55988172|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55906753|NCT01504841|Etravirine|etravirine|mesh-list
55988173|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55988174|NCT03197194|Analgesics|analgesics|mesh-ancestor
55988175|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
55988176|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988177|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988178|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988179|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988180|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55988181|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55988182|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988183|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55988184|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55988185|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988186|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
55988187|NCT04031833|Amphotericin B|amphotericin b|mesh-list
55988188|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55988189|NCT04031833|Amebicides|amebicides|mesh-ancestor
55988190|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55988191|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55988192|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988193|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55988194|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
55988195|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
55988196|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55988197|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55988198|NCT03834935|Analgesics|analgesics|mesh-ancestor
55988199|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
55988200|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988201|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988202|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988203|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988204|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
55988205|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988206|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
55988207|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55988208|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988209|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988210|NCT02796352|Interleukin-2|interleukin-2|mesh-list
55988211|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988212|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55988214|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
55988215|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988216|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988217|NCT00939367|Zolpidem|zolpidem|mesh-list
55988218|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55988219|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55988236|NCT04347187|Anticoagulants|anticoagulants|mesh-list
55715579|NCT04467931|Terazosin|terazosin|mesh-list
55988253|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55988254|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906789|NCT04861584|Immunologic Factors|immunologic factors|mesh-ancestor
55906790|NCT04861584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906791|NCT02388750|Palonosetron|palonosetron|mesh-list
55906792|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
55906793|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
55906794|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906795|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988255|NCT04364035|Vesatolimod|vesatolimod|mesh-list
55988256|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
55988257|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988258|NCT03403439|Itraconazole|itraconazole|mesh-list
55988259|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
55988260|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988261|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55988262|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55988263|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988264|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988265|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55988266|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
55988267|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756311|NCT04156581|Dexamethasone|dexamethasone|mesh-list
55906796|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906797|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55906798|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55906799|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
55906800|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906801|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906802|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
55906803|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55906804|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
55906805|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906806|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906807|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55906808|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
55906809|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906810|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906811|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55906812|NCT01500317|Oxycodone|oxycodone|mesh-list
55906813|NCT01500317|Tapentadol|tapentadol|mesh-list
55906814|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55906815|NCT01500317|Narcotics|narcotics|mesh-ancestor
55906816|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906817|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906818|NCT01500317|Analgesics|analgesics|mesh-ancestor
55906846|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
55906848|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906849|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906850|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214635|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988268|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988269|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55988270|NCT04346797|Eculizumab|eculizumab|mesh-list
55988271|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55988272|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988273|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
55988274|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988275|NCT01049009|Metoprolol|metoprolol|mesh-list
55988276|NCT01049009|Nebivolol|nebivolol|mesh-list
55988277|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55988278|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55988279|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
55988280|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
55988281|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988282|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988283|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55988284|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55988285|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55988286|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
55988287|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988288|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988289|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
55988290|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55988291|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55988293|NCT02850874|Gemcitabine|gemcitabine|mesh-list
55988294|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55988295|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
55988296|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988297|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988298|NCT02850874|Antiviral Agents|antiviral agents|mesh-ancestor
55988299|NCT02850874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988300|NCT02850874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988301|NCT02850874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988302|NCT02850874|Immunologic Factors|immunologic factors|mesh-ancestor
55988303|NCT02850874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988304|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
55988305|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55988306|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55988307|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55988308|NCT02920918|Canagliflozin|canagliflozin|mesh-list
55988309|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55988310|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988311|NCT02920918|Incretins|incretins|mesh-ancestor
55988312|NCT02920918|Hormones|hormones|mesh-ancestor
55988313|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988314|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55988315|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
55988316|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715658|NCT03522649|Antidotes|antidotes|mesh-ancestor
55988317|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988318|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55988319|NCT03403049|Gemcitabine|gemcitabine|mesh-list
55988320|NCT03403049|Capecitabine|capecitabine|mesh-list
55988321|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55988322|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988323|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55988324|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
55988325|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988326|NCT03403049|Antiviral Agents|antiviral agents|mesh-ancestor
55988327|NCT03403049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988328|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988329|NCT03403049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988330|NCT03403049|Immunologic Factors|immunologic factors|mesh-ancestor
55988331|NCT03403049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988332|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55988333|NCT00944047|Paclitaxel|paclitaxel|mesh-list
55988334|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
55988335|NCT00944047|Doxorubicin|doxorubicin|mesh-list
55988336|NCT00944047|Trastuzumab|trastuzumab|mesh-list
55988337|NCT00944047|Mitogens|mitogens|mesh-list
55988338|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55988339|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214637|NCT01614132|Vincristine|vincristine|mesh-list
56214638|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791016|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
55988340|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
55988341|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
55988342|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
55988343|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988344|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988345|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
55988346|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988347|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988348|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55988349|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
55988350|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55988351|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55988352|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55988353|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55988354|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988355|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988356|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
55988357|NCT02921386|Testosterone|testosterone|mesh-list
55988358|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
55988359|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
55988360|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55988361|NCT02921386|Androgens|androgens|mesh-ancestor
55988362|NCT02921386|Hormones|hormones|mesh-ancestor
55988363|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988364|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988366|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988367|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
55988369|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55988370|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55988371|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988372|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55988373|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55988374|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
55988375|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988376|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55988377|NCT02245555|Tamsulosin|tamsulosin|mesh-list
55988378|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55988379|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55988380|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55988381|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
55988382|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988383|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988384|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988385|NCT02245555|Urological Agents|urological agents|mesh-ancestor
55988386|NCT03941587|Aflibercept|aflibercept|mesh-list
55988387|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55988388|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55988389|NCT03941587|Growth Substances|growth substances|mesh-ancestor
55988390|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715724|NCT05373433|Ritonavir|ritonavir|mesh-list
55988391|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
55988392|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988393|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
55988394|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
55988395|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55988396|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55988397|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988398|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988399|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988400|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988401|NCT02802514|Exenatide|exenatide|mesh-list
55988402|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
55988403|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55988404|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55988405|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988406|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55988408|NCT02802514|Hormones|hormones|mesh-ancestor
55988409|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214639|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214640|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56214641|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
55988410|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
55988411|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
55988412|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55988413|NCT00944671|Famotidine|famotidine|mesh-list
55988414|NCT00944671|Calcium|calcium|mesh-list
55988415|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55988416|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988417|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55988418|NCT00944671|Antacids|antacids|mesh-ancestor
55988419|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988420|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55988421|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55988422|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55988423|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
55988424|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
55988425|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988426|NCT00944749|Cyclosporine|cyclosporine|mesh-list
55988427|NCT00944749|Cyclosporins|cyclosporins|mesh-list
55988428|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988429|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988430|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988431|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
55988432|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988433|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
55988434|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988435|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
55988436|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988437|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55988438|NCT01047293|Leucovorin|leucovorin|mesh-list
55988439|NCT01047293|Bevacizumab|bevacizumab|mesh-list
55988443|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988444|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55988445|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55988446|NCT01047293|Growth Substances|growth substances|mesh-ancestor
55988447|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988448|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
55988449|NCT01047293|Antidotes|antidotes|mesh-ancestor
55988450|NCT01047293|Protective Agents|protective agents|mesh-ancestor
55988451|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
55988452|NCT01047293|Vitamins|vitamins|mesh-ancestor
55988453|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
55988454|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988455|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
55988456|NCT01045967|Lansoprazole|lansoprazole|mesh-list
55988457|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
55988458|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55988459|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55988460|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55988461|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988462|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988463|NCT02808052|Minocycline|minocycline|mesh-list
55907010|NCT00198315|Bleomycin|bleomycin|mesh-list
55715791|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55988464|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55832108|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988465|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988466|NCT02924350|Fluorides|fluorides|mesh-list
55988467|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
55988468|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
55988469|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
55988470|NCT02924350|Protective Agents|protective agents|mesh-ancestor
55988471|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988472|NCT02344498|Tenofovir|tenofovir|mesh-list
55988473|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
55988474|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988475|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55988476|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55988477|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988478|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988479|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55988481|NCT00945139|Bevacizumab|bevacizumab|mesh-list
55988482|NCT00945139|Doxorubicin|doxorubicin|mesh-list
56214643|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
56214644|NCT01614197|Cytarabine|cytarabine|mesh-list
56214645|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
56214646|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56214647|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56214648|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56214649|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
56214650|NCT01614197|Methotrexate|methotrexate|mesh-list
56214651|NCT01614197|Etoposide|etoposide|mesh-list
56214652|NCT01614197|Etoposide phosphate|etoposide phosphate|mesh-list
56214653|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214654|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
56214655|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214656|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55791024|NCT04847687|Hormones|hormones|mesh-ancestor
55988483|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988484|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988485|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55988486|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55988487|NCT00945139|Growth Substances|growth substances|mesh-ancestor
55988488|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988489|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
55988490|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55988491|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55988492|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55988493|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988494|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988495|NCT02812342|Tofacitinib|tofacitinib|mesh-list
55988496|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55988497|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988498|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988499|NCT03871465|Triamcinolone|triamcinolone|mesh-list
55988500|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55988501|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55988502|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55988503|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988504|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
55988505|NCT03871465|Hormones|hormones|mesh-ancestor
55988506|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988507|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988508|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988509|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
55988510|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988511|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988512|NCT00931489|Ranibizumab|ranibizumab|mesh-list
55988514|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55988515|NCT00931489|Growth Substances|growth substances|mesh-ancestor
55988516|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988517|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
55988518|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988519|NCT04363255|Cisplatin|cisplatin|mesh-list
55988520|NCT04363255|Carboplatin|carboplatin|mesh-list
55988521|NCT04363255|Etoposide|etoposide|mesh-list
55988522|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
55988523|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988524|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55988525|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55988526|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55988527|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214657|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56214658|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
56214659|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214660|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214661|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56214662|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56214663|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
55988528|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988530|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
55988531|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988532|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
55988533|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55988534|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55988535|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55988536|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55988537|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988538|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
55988539|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988540|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988541|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55988542|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988544|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
55988545|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988546|NCT03490825|Protective Agents|protective agents|mesh-ancestor
55988547|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988548|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988549|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55988550|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988551|NCT03317899|Lenograstim|lenograstim|mesh-list
55988552|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55988553|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
55988555|NCT04353505|Dexamethasone|dexamethasone|mesh-list
55988556|NCT04353505|Ketorolac|ketorolac|mesh-list
55988557|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988558|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
55988559|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
55988560|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988561|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988562|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55988563|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
55988564|NCT04353505|Hormones|hormones|mesh-ancestor
55988565|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988566|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55988567|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988568|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55988569|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55988570|NCT04353505|Analgesics|analgesics|mesh-ancestor
55988571|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
55988572|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988573|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55988574|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988575|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988576|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
55988577|NCT02929927|Eusol|eusol|mesh-list
55988578|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
55988579|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988580|NCT02427451|Venetoclax|venetoclax|mesh-list
55988581|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
55988582|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988583|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988584|NCT04362241|Prednisolone|prednisolone|mesh-list
55988585|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55988586|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
55988587|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55988588|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
56142473|NCT03005340|Vitamin D|vitamin d|mesh-list
56214664|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214665|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56214666|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
56214667|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
56214668|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214669|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56214670|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56214672|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56214673|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56214674|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
56214675|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214676|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214677|NCT01614223|Betamethasone|betamethasone|mesh-list
55988593|NCT04362241|Hormones|hormones|mesh-ancestor
55988594|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988595|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988596|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55988597|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988598|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
55988599|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
55988600|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988601|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55988602|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55988603|NCT04362241|Protective Agents|protective agents|mesh-ancestor
55988604|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
55988605|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
55988606|NCT01384513|Busulfan|busulfan|mesh-list
55988607|NCT01384513|Fludarabine|fludarabine|mesh-list
55988608|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
55988609|NCT01384513|Tacrolimus|tacrolimus|mesh-list
55988610|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988611|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
55988612|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988613|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988614|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55988615|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
55988616|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988617|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988618|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55988619|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55988620|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
55988621|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988622|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55988623|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988624|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55988625|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55988626|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
55988627|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55988628|NCT03035617|Bupivacaine|bupivacaine|mesh-list
55988629|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
55988630|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
55988631|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988632|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988633|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
55988634|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214678|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214680|NCT01614223|Hormones|hormones|mesh-ancestor
56214681|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988636|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988637|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988638|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
55988639|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988640|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988641|NCT05563675|Cholinergic Agents|cholinergic agents|mesh-list
55988642|NCT05563675|Muscarinic Antagonists|muscarinic antagonists|mesh-list
55988643|NCT05563675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988644|NCT05563675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988645|NCT05563675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988646|NCT05563675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55988647|NCT05555251|Trastuzumab|trastuzumab|mesh-list
55988648|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988649|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988650|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
55907208|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55907209|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
55907210|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907211|NCT01524991|Antiviral Agents|antiviral agents|mesh-ancestor
55907212|NCT01524991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907213|NCT01524991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907214|NCT01524991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55907215|NCT01524991|Immunologic Factors|immunologic factors|mesh-ancestor
55907216|NCT01524991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907217|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988651|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
55988652|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55988653|NCT03035305|Amodiaquine|amodiaquine|mesh-list
55988654|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
55988655|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55988656|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55988657|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988658|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55988659|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988660|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988661|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55988663|NCT03034759|Insulin|insulin|mesh-list
55988664|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55988665|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988666|NCT02158273|Fenofibrate|fenofibrate|mesh-list
55988667|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55988668|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
55988669|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988670|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55988671|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55988672|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55988673|NCT04361461|Azithromycin|azithromycin|mesh-list
55988674|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
55988675|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55988676|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988677|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
55988678|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55988679|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55988680|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988681|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907218|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55907219|NCT04039230|Talazoparib|talazoparib|mesh-list
55907220|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55907221|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907222|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907223|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907224|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
55907225|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55907226|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
55907227|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907228|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
55907229|NCT01524913|Protective Agents|protective agents|mesh-ancestor
55907230|NCT02376192|Phenylephrine|phenylephrine|mesh-list
55907231|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
55907232|NCT02376192|Ephedrine|ephedrine|mesh-list
55907233|NCT02376192|Bupivacaine|bupivacaine|mesh-list
55907234|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
55907235|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
55907236|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907237|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988682|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988683|NCT03002506|Tazobactam|tazobactam|mesh-list
55988684|NCT03002506|Ceftolozane|ceftolozane|mesh-list
55988685|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55988686|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55988687|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988688|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55988689|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988690|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988691|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55988692|NCT03002506|Renal Agents|renal agents|mesh-ancestor
55988693|NCT02822950|Ceftazidime|ceftazidime|mesh-list
55988694|NCT02822950|Avibactam|avibactam|mesh-list
55988695|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55988696|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55988697|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988698|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55988699|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988700|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988701|NCT02935738|Prednisolone|prednisolone|mesh-list
55988702|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988703|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
56214682|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214683|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56214684|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214686|NCT01614236|Analgesics|analgesics|mesh-ancestor
56214687|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
56214688|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214689|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791052|NCT05579769|Busulfan|busulfan|mesh-list
55988705|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988706|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988707|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55907238|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
55907239|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907241|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
55907242|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
55907243|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
55907244|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55907269|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55907270|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
55907271|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
55907272|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907273|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907274|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55907275|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
55907276|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
55907277|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
55907278|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55907279|NCT02375880|Gemcitabine|gemcitabine|mesh-list
55907280|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907281|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55907282|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
55756320|NCT04156581|Hormones|hormones|mesh-ancestor
55988708|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988709|NCT05435677|Insulin|insulin|mesh-list
55988710|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55988711|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988712|NCT00939991|Bevacizumab|bevacizumab|mesh-list
55988713|NCT00939991|Temozolomide|temozolomide|mesh-list
55988714|NCT00939991|Vorinostat|vorinostat|mesh-list
55988715|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988716|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988717|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55988718|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55988719|NCT00939991|Growth Substances|growth substances|mesh-ancestor
55988720|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988721|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
55988722|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55988723|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
55988724|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832232|NCT02068495|Candesartan|candesartan|mesh-list
55988725|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55988727|NCT04361305|Tadalafil|tadalafil|mesh-list
55988728|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
55988729|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55988730|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55988731|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988732|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988733|NCT04361305|Urological Agents|urological agents|mesh-ancestor
55988734|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
55988735|NCT02245321|Hematinics|hematinics|mesh-ancestor
55988736|NCT04361149|Capsaicin|capsaicin|mesh-list
55988739|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
55988740|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988741|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988742|NCT05332483|Megestrol|megestrol|mesh-list
55988743|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
55988744|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55988745|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55988746|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55988747|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
55988748|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55988749|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988750|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55988751|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55988752|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55988753|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988754|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
55907283|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907284|NCT02375880|Antiviral Agents|antiviral agents|mesh-ancestor
55907285|NCT02375880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907286|NCT02375880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749678|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
55749679|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
55749680|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749681|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749682|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749683|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
55789038|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749685|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749686|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55749687|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749688|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
55749689|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749690|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749692|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55749693|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55749694|NCT03952091|Growth Substances|growth substances|mesh-ancestor
55749695|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
55749696|NCT03246919|Oxytocin|oxytocin|mesh-list
55749697|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
55749698|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55988755|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55988756|NCT03033589|Bupivacaine|bupivacaine|mesh-list
55988757|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55988758|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
55988759|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
55988760|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988761|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988762|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
56214690|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
56214691|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56214692|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55988763|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988764|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55988765|NCT00947167|Pertuzumab|pertuzumab|mesh-list
55988766|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988767|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55716093|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55988768|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988769|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988770|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988772|NCT04360759|Chloroquine|chloroquine|mesh-list
55988773|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
55988774|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55988775|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55988776|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988777|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988778|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988779|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988780|NCT04360759|Amebicides|amebicides|mesh-ancestor
55988781|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55988782|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55988783|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55988784|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
55988785|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988786|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988787|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55988788|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55988789|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
55988790|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988791|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
55988792|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55988793|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55988794|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55988795|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55988796|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988797|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
55988799|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988800|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55988801|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988802|NCT03033121|Hormones|hormones|mesh-list
55988803|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988804|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988805|NCT03033199|Dexamethasone|dexamethasone|mesh-list
55988806|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988807|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
55988810|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988811|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55988812|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
55988813|NCT03033199|Hormones|hormones|mesh-ancestor
55988814|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988815|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55988816|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988817|NCT00940927|Albuterol|albuterol|mesh-list
55988818|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55988819|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
55988820|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988821|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988822|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55988823|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
55988824|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
55988825|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55988826|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55988827|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55988828|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55988829|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
55988830|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214693|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214694|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56214695|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55988831|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988833|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55988834|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988835|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988836|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
55988837|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988838|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988839|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
55988840|NCT03002974|Triamcinolone|triamcinolone|mesh-list
55716170|NCT02290717|Fluticasone|fluticasone|mesh-list
55988841|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55988842|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55988843|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55988844|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55988845|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988846|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
55988847|NCT03002974|Hormones|hormones|mesh-ancestor
55988848|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988849|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988850|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55907303|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55907304|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55907305|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
55907306|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907307|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55907308|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55907333|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907335|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55907336|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55907337|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
55907338|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988851|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
55988852|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988853|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988854|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988855|NCT02245477|Mitogens|mitogens|mesh-list
55988856|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
55988857|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
55988858|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988859|NCT02245477|Growth Substances|growth substances|mesh-ancestor
55988860|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988861|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
55988862|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55988863|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55988864|NCT02825212|Ledipasvir|ledipasvir|mesh-list
55988865|NCT02825212|Velpatasvir|velpatasvir|mesh-list
55988866|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
55988867|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988868|NCT00373672|Modafinil|modafinil|mesh-list
55988869|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55988870|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988871|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55988872|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55988873|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55988874|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988875|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
55988876|NCT04941703|Cathartics|cathartics|mesh-ancestor
55988877|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55988878|NCT04359823|Lovastatin|lovastatin|mesh-list
55988880|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
55988881|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55988882|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55988883|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
55988884|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988885|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55988886|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55907350|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
55907351|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907352|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55907353|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907354|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
55907355|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55988887|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988888|NCT03008590|Naltrexone|naltrexone|mesh-list
55988889|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55988890|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55988891|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988892|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
55988893|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988894|NCT04359511|Prednisone|prednisone|mesh-list
55988895|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
55988896|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988897|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
56214696|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56214697|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214698|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56214700|NCT01614301|Sirolimus|sirolimus|mesh-list
55988898|NCT04359511|Hormones|hormones|mesh-ancestor
55988899|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988900|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988901|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55988902|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988903|NCT03032419|Vaccines|vaccines|mesh-list
55988904|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
55988905|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988906|NCT00373906|Bortezomib|bortezomib|mesh-list
55988907|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988908|NCT00955513|Diclofenac|diclofenac|mesh-list
55988909|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55988910|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55988911|NCT00955513|Analgesics|analgesics|mesh-ancestor
55988912|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
55988913|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988914|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988915|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988916|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988917|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55988918|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988919|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988921|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55988922|NCT00935311|Hydrocodone|hydrocodone|mesh-list
55988923|NCT00935311|Oxycodone|oxycodone|mesh-list
55988924|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55988925|NCT00935311|Analgesics|analgesics|mesh-ancestor
55988926|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
55988927|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988928|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988929|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
55988930|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55988931|NCT00935311|Narcotics|narcotics|mesh-ancestor
55988932|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988933|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
55988934|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
55988935|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55988936|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988937|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55988938|NCT02946034|Ribavirin|ribavirin|mesh-list
55988939|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
55907356|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55988940|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988941|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
55988942|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55988944|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55988945|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
55988946|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
55988947|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988948|NCT02946892|Carvedilol|carvedilol|mesh-list
55988949|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55988950|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55988951|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
55988952|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988953|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988954|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988957|NCT02946892|Protective Agents|protective agents|mesh-ancestor
55988958|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55988959|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55988960|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55988961|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
55988962|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55988963|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55988964|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
55988965|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
56214702|NCT01614301|Dacarbazine|dacarbazine|mesh-list
56214703|NCT01614301|Trofosfamide|trofosfamide|mesh-list
56214704|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55988966|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55988967|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55988968|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55988969|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988970|NCT03402191|Urological Agents|urological agents|mesh-ancestor
55988971|NCT03402113|Midazolam|midazolam|mesh-list
55988972|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
55988973|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55988974|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55988975|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988976|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55988977|NCT03402113|Analgesics|analgesics|mesh-ancestor
55988978|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
55988979|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988980|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55988981|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55988982|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55988983|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
55988984|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988985|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988986|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55988987|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55988988|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55716357|NCT02226341|Hormones|hormones|mesh-ancestor
55988989|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55988990|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55988991|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
55988992|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
55988993|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
55988994|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
55988996|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55988997|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988998|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55988999|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989000|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989001|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55989002|NCT01725113|Vitamins|vitamins|mesh-ancestor
55989003|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
55989004|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55989005|NCT03031405|Oxytocin|oxytocin|mesh-list
55989006|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
55989007|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55989008|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989009|NCT03031249|Cytarabine|cytarabine|mesh-list
55989010|NCT03031249|Tretinoin|tretinoin|mesh-list
55989011|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
55989012|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55989013|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
55989014|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989015|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989016|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
55989017|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989018|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55989019|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
55989020|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989021|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
55989022|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
55989023|NCT01042535|Tryptophan|tryptophan|mesh-list
55989024|NCT01042535|Vaccines|vaccines|mesh-list
55989025|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
55989026|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989027|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55989028|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
55989030|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55989031|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
55989032|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55989033|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55989034|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
56214705|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214706|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56214707|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214708|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55989035|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989036|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
55989037|NCT03031327|Protective Agents|protective agents|mesh-ancestor
55989038|NCT03401957|Cetuximab|cetuximab|mesh-list
55989039|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55989040|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989041|NCT04358965|Misoprostol|misoprostol|mesh-list
55907459|NCT02375022|Endostatins|endostatins|mesh-list
55907460|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55907461|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55907462|NCT02375022|Growth Substances|growth substances|mesh-ancestor
55907463|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989042|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
55989043|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55989044|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55989045|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989046|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
55989047|NCT04358965|Coagulants|coagulants|mesh-ancestor
55989048|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55989049|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
55989050|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55989051|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989052|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55989053|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55989054|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
55989055|NCT01041287|Metoprolol|metoprolol|mesh-list
55989056|NCT01041287|Nebivolol|nebivolol|mesh-list
55989057|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55989058|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55989059|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
55989060|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
55989061|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989062|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989063|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55989064|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55989065|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55989066|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
55989067|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989068|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989069|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
55989070|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55989071|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55989072|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55989074|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
55989075|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55989076|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
55989077|NCT03016741|Hormones|hormones|mesh-ancestor
55989078|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55989079|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989080|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55989081|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989082|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55989084|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989086|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55989087|NCT01042925|Paclitaxel|paclitaxel|mesh-list
55989088|NCT01042925|Trastuzumab|trastuzumab|mesh-list
55989089|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55989090|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989091|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
55989092|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
55989093|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
55989094|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989095|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55989096|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
55989097|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55989098|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
55989099|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989100|NCT03400709|Expectorants|expectorants|mesh-ancestor
55989101|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214710|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
55989102|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55989103|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
55989105|NCT03400709|Protective Agents|protective agents|mesh-ancestor
55720934|NCT02289898|Gemcitabine|gemcitabine|mesh-list
55989106|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989108|NCT02049957|Fulvestrant|fulvestrant|mesh-list
55989109|NCT02049957|Exemestane|exemestane|mesh-list
55989110|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55989111|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989112|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55989113|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55989114|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
55989115|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55989116|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989117|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55989118|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55989119|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989120|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989121|NCT03030937|Irinotecan|irinotecan|mesh-list
55989122|NCT03030937|Apatinib|apatinib|mesh-list
55989123|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55989124|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55907468|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55907469|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
55907470|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907471|NCT01497275|Rituximab|rituximab|mesh-list
55907472|NCT01497275|Bortezomib|bortezomib|mesh-list
55907473|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55907474|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907475|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
55907476|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907477|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907478|NCT01557517|Clobetasol|clobetasol|mesh-list
55907479|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55907480|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
55907481|NCT01557517|Hormones|hormones|mesh-ancestor
55907482|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907484|NCT02363556|Misoprostol|misoprostol|mesh-list
55989125|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989126|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989127|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989128|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55989129|NCT00950365|Pemetrexed|pemetrexed|mesh-list
55989130|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55989131|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989132|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989133|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989134|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55716460|NCT02223299|Tryptophan|tryptophan|mesh-list
55989140|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
55989141|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989142|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989143|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989144|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55989145|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
55989146|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989147|NCT02246023|Propofol|propofol|mesh-list
55989148|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55989149|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989150|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989151|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55989152|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
55989153|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
55989159|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55989160|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989161|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55989162|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989163|NCT00357825|Reboxetine|reboxetine|mesh-list
55989164|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
55989170|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
55989171|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989172|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989173|NCT03400241|Bromides|bromides|mesh-list
55989174|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
55989175|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55989176|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
55989177|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989178|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989179|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56214711|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214712|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
56214713|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56214714|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
56214715|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214716|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56214717|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56214718|NCT01614301|Analgesics|analgesics|mesh-ancestor
56214719|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
56214720|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214721|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214722|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56214723|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56214724|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56214725|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214726|NCT01614366|Amlodipine|amlodipine|mesh-list
56214727|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56214728|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56214729|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56214730|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791071|NCT05579769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55989180|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
55989181|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
55989182|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55989183|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
55989185|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989187|NCT05706987|Lidocaine|lidocaine|mesh-list
55989188|NCT05706987|Anesthetics, Local|anesthetics, local|mesh-ancestor
55989189|NCT05706987|Anesthetics|anesthetics|mesh-ancestor
55989190|NCT05706987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989191|NCT05706987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989192|NCT05706987|Sensory System Agents|sensory system agents|mesh-ancestor
55989193|NCT05706987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989194|NCT05706987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55989195|NCT05706987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55989196|NCT05706987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55989197|NCT05706987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989198|NCT05706987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989205|NCT00729573|Tenofovir|tenofovir|mesh-list
55989206|NCT00729573|Emtricitabine|emtricitabine|mesh-list
55989207|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55989208|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
55989209|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214731|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56214732|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214733|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
56214734|NCT01614405|Ritonavir|ritonavir|mesh-list
56214735|NCT01614405|Lopinavir|lopinavir|mesh-list
56214736|NCT01614405|Tenofovir|tenofovir|mesh-list
56214737|NCT01614405|Emtricitabine|emtricitabine|mesh-list
55989210|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55832233|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
55989211|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55989212|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989213|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989215|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55989217|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55989218|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989219|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989220|NCT03403205|Choline|choline|mesh-list
55989221|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
55989222|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55989223|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
55989224|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989225|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55989226|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55989227|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
55989228|NCT02959359|Ribavirin|ribavirin|mesh-list
55989229|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
55989230|NCT02959359|Ledipasvir|ledipasvir|mesh-list
55989231|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
55989232|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989233|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
55989234|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989235|NCT02829034|Ranolazine|ranolazine|mesh-list
55989236|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55989237|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989238|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989239|NCT00924209|Gemcitabine|gemcitabine|mesh-list
55989240|NCT00924209|Bevacizumab|bevacizumab|mesh-list
55989241|NCT00924209|Etoposide|etoposide|mesh-list
55989242|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55989243|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989244|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55989245|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55989246|NCT00924209|Growth Substances|growth substances|mesh-ancestor
55989247|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989248|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
55989249|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55989250|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
55989251|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989252|NCT00924209|Antiviral Agents|antiviral agents|mesh-ancestor
55989253|NCT00924209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989254|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989255|NCT00924209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55989258|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55989259|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55989260|NCT05719467|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55989261|NCT05719467|Parasympatholytics|parasympatholytics|mesh-ancestor
55989262|NCT05719467|Autonomic Agents|autonomic agents|mesh-ancestor
55989263|NCT05719467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989264|NCT05719467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989265|NCT05719467|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55989266|NCT05719467|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55907637|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
55907638|NCT02881086|Cytarabine|cytarabine|mesh-list
55907639|NCT02881086|Dexamethasone|dexamethasone|mesh-list
55989267|NCT05719467|Cholinergic Agents|cholinergic agents|mesh-ancestor
55989268|NCT05719467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989269|NCT05719467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989270|NCT03408119|Vitamin D|vitamin d|mesh-list
55989271|NCT03408119|Calcium|calcium|mesh-list
55989272|NCT03408119|Vitamins|vitamins|mesh-ancestor
55989273|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
55989274|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214738|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56214739|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56214740|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56214741|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
56214742|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214743|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214744|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56214745|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56214746|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
55989275|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55989276|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55989277|NCT03405155|Nivolumab|nivolumab|mesh-list
55989278|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55989279|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989280|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55989281|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989282|NCT03406247|Nivolumab|nivolumab|mesh-list
55989283|NCT03406247|Ipilimumab|ipilimumab|mesh-list
55989284|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55989285|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989286|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55989287|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989288|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55989290|NCT04374929|Hormones|hormones|mesh-ancestor
55989291|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55989292|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989293|NCT05717361|Lidocaine|lidocaine|mesh-list
55989294|NCT05717361|Ketamine|ketamine|mesh-list
55989295|NCT05717361|Remifentanil|remifentanil|mesh-list
55989296|NCT05717361|Anesthetics, Local|anesthetics, local|mesh-ancestor
55989297|NCT05717361|Anesthetics|anesthetics|mesh-ancestor
55989298|NCT05717361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989299|NCT05717361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989300|NCT05717361|Sensory System Agents|sensory system agents|mesh-ancestor
55989301|NCT05717361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989302|NCT05717361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55989303|NCT05717361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55989304|NCT05717361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55989305|NCT05717361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989306|NCT05717361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989307|NCT05717361|Analgesics|analgesics|mesh-ancestor
55989308|NCT05717361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55989309|NCT05717361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55989310|NCT05717361|Anesthetics, General|anesthetics, general|mesh-ancestor
55989311|NCT05717361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55989312|NCT05717361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55989313|NCT05717361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989314|NCT05717361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55989315|NCT05717361|Narcotics|narcotics|mesh-ancestor
55989316|NCT02951884|Bupivacaine|bupivacaine|mesh-list
55989317|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
55989318|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
55989319|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989320|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989321|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
55989322|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989323|NCT05574387|Metformin|metformin|mesh-list
55989324|NCT05574387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55989325|NCT05574387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989326|NCT02978001|Glycerol|glycerol|mesh-list
55989327|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55989328|NCT02978001|Protective Agents|protective agents|mesh-ancestor
55989331|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56214747|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214748|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56214749|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55989332|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989333|NCT05685225|Acetaminophen|acetaminophen|mesh-list
55989335|NCT05685225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55989336|NCT05685225|Analgesics|analgesics|mesh-ancestor
55989337|NCT05685225|Sensory System Agents|sensory system agents|mesh-ancestor
55989338|NCT05685225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989339|NCT05685225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989340|NCT05685225|Antipyretics|antipyretics|mesh-ancestor
55989341|NCT05685225|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55989342|NCT05685225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55989343|NCT05716503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55989344|NCT05716503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989345|NCT00014495|Cytarabine|cytarabine|mesh-list
55989346|NCT00014495|Bismuth|bismuth|mesh-list
55989347|NCT00014495|Antibodies|antibodies|mesh-list
55989348|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55989349|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
55989350|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989351|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55989352|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
55989353|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989354|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989358|NCT00014495|Antacids|antacids|mesh-ancestor
55989359|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55989360|NCT05566041|Carboplatin|carboplatin|mesh-list
55989361|NCT05566041|Etoposide|etoposide|mesh-list
55989362|NCT05566041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716687|NCT02259179|Naltrexone|naltrexone|mesh-list
55989363|NCT05566041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55989364|NCT05566041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55989365|NCT05566041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55989366|NCT05566041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989367|NCT05566041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989368|NCT05565105|Cyclophosphamide|cyclophosphamide|mesh-list
55989369|NCT05565105|Melphalan|melphalan|mesh-list
55989370|NCT05565105|Busulfan|busulfan|mesh-list
55989371|NCT05565105|Thiotepa|thiotepa|mesh-list
55989372|NCT05565105|Fludarabine|fludarabine|mesh-list
55989373|NCT05565105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55989374|NCT05565105|Immunologic Factors|immunologic factors|mesh-ancestor
55989375|NCT05565105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989376|NCT05565105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55989377|NCT05565105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55989378|NCT05565105|Alkylating Agents|alkylating agents|mesh-ancestor
55989379|NCT05565105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989380|NCT05565105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989381|NCT05565105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55989382|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
55721234|NCT05340764|Infliximab|infliximab|mesh-list
55989383|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55989384|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55989385|NCT04374071|Prednisolone|prednisolone|mesh-list
55989386|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
55989387|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55989388|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
55989389|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55989390|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
55989391|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
55989392|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989393|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989394|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55989395|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
55989396|NCT04374071|Hormones|hormones|mesh-ancestor
55989397|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55989398|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55989399|NCT04374071|Protective Agents|protective agents|mesh-ancestor
55989400|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55989401|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989402|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
55989403|NCT00357981|Ortho Evra|ortho evra|mesh-list
55989405|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989406|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55989408|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
55989409|NCT03030703|Vitamins|vitamins|mesh-ancestor
55989410|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
55989411|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989412|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55989413|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55989414|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
55989415|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
55989416|NCT03030469|Analgesics|analgesics|mesh-list
55989417|NCT03030469|Narcotics|narcotics|mesh-ancestor
55989418|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989419|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989420|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
55989421|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989422|NCT00952081|Clevidipine|clevidipine|mesh-list
55989423|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55989424|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989425|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989426|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55989427|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989428|NCT05716347|Vaccines|vaccines|mesh-list
55989429|NCT05716347|Immunologic Factors|immunologic factors|mesh-ancestor
55989430|NCT05716347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989431|NCT02959840|Ondansetron|ondansetron|mesh-list
55989432|NCT02959840|Metoclopramide|metoclopramide|mesh-list
55989433|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
55989434|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
55989435|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989436|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989437|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55989438|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
55989440|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55989441|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
55989442|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989443|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989444|NCT02959840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55989445|NCT02959840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55907709|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
55907710|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55907711|NCT02362308|Hormones|hormones|mesh-ancestor
55907712|NCT02366208|Adefovir|adefovir|mesh-list
55907713|NCT02366208|Thymalfasin|thymalfasin|mesh-list
55907714|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
55907715|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907716|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55721285|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
55989446|NCT02959840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989447|NCT02959840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55989448|NCT02959840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55989449|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55989450|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55989451|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
55989452|NCT04358341|Doxorubicin|doxorubicin|mesh-list
55989453|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55989454|NCT04358341|Fluorouracil|fluorouracil|mesh-list
55989455|NCT04358341|Irinotecan|irinotecan|mesh-list
55989456|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55989457|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989458|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55989459|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55989460|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989461|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989462|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
55989463|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55989464|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55989465|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
55989466|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989467|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55989468|NCT02978547|Metformin|metformin|mesh-list
55989469|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55989470|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989471|NCT02959996|Bupivacaine|bupivacaine|mesh-list
55989472|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
55989473|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
55989474|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989475|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214750|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56214751|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55989476|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
55989477|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989478|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
55989479|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55989480|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55989481|NCT00929981|Prednisolone|prednisolone|mesh-list
55989482|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
55989483|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55989484|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
55989485|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55989486|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
55989487|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
55989488|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989489|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989490|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55989491|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
55989492|NCT00929981|Hormones|hormones|mesh-ancestor
55989493|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55989494|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55989495|NCT00929981|Protective Agents|protective agents|mesh-ancestor
55989496|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55989497|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989498|NCT00961441|Levetiracetam|levetiracetam|mesh-list
55989499|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
55989500|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
55989501|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
55989503|NCT02240459|Fesoterodine|fesoterodine|mesh-list
55989504|NCT02240459|Oxybutynin|oxybutynin|mesh-list
55989505|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55721340|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
55989506|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55989507|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
55989508|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989509|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989510|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989511|NCT02240459|Urological Agents|urological agents|mesh-ancestor
55989513|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
55989514|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989515|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55989516|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55989517|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55989518|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55989519|NCT02240537|Sargramostim|sargramostim|mesh-list
55989520|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55989521|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
55989522|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989523|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55989524|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55989525|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55989526|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989527|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55989528|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989529|NCT02240927|Enoxaparin|enoxaparin|mesh-list
55989530|NCT02240927|Warfarin|warfarin|mesh-list
55989531|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
55989532|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
55989533|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55989534|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55989535|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989536|NCT03038308|Ropinirole|ropinirole|mesh-list
55989537|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55989538|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55989539|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
55989540|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
55989541|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989542|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989543|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989544|NCT04358497|Ibuprofen|ibuprofen|mesh-list
55989545|NCT04358497|Polidocanol|polidocanol|mesh-list
56214752|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
56214753|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56214754|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
56214755|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214756|NCT01614431|Expectorants|expectorants|mesh-ancestor
56214757|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214758|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56214759|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
56214760|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214761|NCT01614431|Protective Agents|protective agents|mesh-ancestor
56214762|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989546|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55989547|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55989548|NCT04358497|Analgesics|analgesics|mesh-ancestor
55989549|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
55989550|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989551|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756333|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
55989552|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55989562|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
55989563|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55989564|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55989565|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989566|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989567|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989568|NCT00930293|Dexetimide|dexetimide|mesh-list
55989569|NCT00930293|Citalopram|citalopram|mesh-list
55989570|NCT00930293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55989571|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55989572|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989573|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989574|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989575|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
55989576|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989577|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55989578|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
55989579|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55989580|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55989581|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55989582|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
55989583|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
55989584|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989585|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55989586|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55989587|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
55989588|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
55989589|NCT04364945|Remifentanil|remifentanil|mesh-list
55989590|NCT04364945|Sevoflurane|sevoflurane|mesh-list
55989591|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55989592|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989593|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989594|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55989595|NCT04364945|Analgesics|analgesics|mesh-ancestor
55989596|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
55989597|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989598|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55989599|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55989600|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55989601|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
55989602|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989603|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989604|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55989605|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55989606|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
56214763|NCT01614431|Antidotes|antidotes|mesh-ancestor
56214764|NCT01614496|Insulin|insulin|mesh-list
56214765|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56214766|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214767|NCT01614535|Remifentanil|remifentanil|mesh-list
55989607|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
55989608|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55989609|NCT04364945|Narcotics|narcotics|mesh-ancestor
55989610|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55989611|NCT02855086|Cetuximab|cetuximab|mesh-list
55989612|NCT02855086|Antibodies|antibodies|mesh-list
55989613|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
55989614|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55989615|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
55989616|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989617|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989618|NCT05368857|Afamelanotide|afamelanotide|mesh-list
55989619|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
55989620|NCT04347005|Allopurinol|allopurinol|mesh-list
55989622|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
55989623|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989624|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989625|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
55989626|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55989627|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55989628|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
55989629|NCT04347005|Protective Agents|protective agents|mesh-ancestor
55989630|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989632|NCT00358293|Analgesics|analgesics|mesh-ancestor
55989633|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
55989634|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989635|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989636|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
55989637|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55989638|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55989639|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
55989640|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
55989641|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55989642|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55989643|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55989644|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
55989645|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989646|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989647|NCT02241083|Dopamine|dopamine|mesh-list
55907717|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55907719|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907720|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55907721|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
55907722|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907723|NCT02373462|Olmesartan|olmesartan|mesh-list
55907724|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
55989649|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55989650|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55989651|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
55989652|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989653|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989654|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989655|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
55989656|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
55989657|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989658|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55989659|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55989660|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
55989661|NCT02241083|Protective Agents|protective agents|mesh-ancestor
55989663|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
55716986|NCT03149913|Paclitaxel|paclitaxel|mesh-list
55989664|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55989665|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55989666|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989667|NCT04364399|Vaccines|vaccines|mesh-list
55989668|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
55989669|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989670|NCT02982551|Insulin|insulin|mesh-list
55989671|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55989672|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989673|NCT02965924|Phenylephrine|phenylephrine|mesh-list
55989674|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
55989675|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55989676|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
55989677|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
56214768|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56214769|NCT01614535|Narcotics|narcotics|mesh-ancestor
56214770|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214771|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214772|NCT01614535|Analgesics|analgesics|mesh-ancestor
56214773|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
56214774|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214775|NCT01614938|Cisplatin|cisplatin|mesh-list
56214776|NCT01614938|Docetaxel|docetaxel|mesh-list
56214777|NCT01614938|Cetuximab|cetuximab|mesh-list
56214778|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214779|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
56214780|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
55791126|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55989678|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989679|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989680|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
55989681|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55989682|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
55989683|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
55989684|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55989685|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55989686|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55989687|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
55989688|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989689|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989690|NCT02965924|Protective Agents|protective agents|mesh-ancestor
55989691|NCT05344833|Lenalidomide|lenalidomide|mesh-list
55989692|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
55989693|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989694|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55989695|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55989696|NCT05344833|Growth Substances|growth substances|mesh-ancestor
55989697|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
55989698|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989699|NCT04364321|Diazepam|diazepam|mesh-list
55989700|NCT04364321|Clonazepam|clonazepam|mesh-list
55989701|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55989702|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
55989703|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
55989704|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
55989705|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989706|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989707|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55989708|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55989709|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989710|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55989711|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55989712|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55989713|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55989714|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55989715|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55989716|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
55989717|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
55989718|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
55989719|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
55989720|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989721|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989722|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
55989723|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55989724|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
55989725|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989726|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214781|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
56214782|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214783|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56214784|NCT01614964|Lumefantrine|lumefantrine|mesh-list
56214786|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56214787|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
55989727|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989728|NCT05528913|Benralizumab|benralizumab|mesh-list
55989729|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55989730|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
55989731|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55989732|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55989733|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
55989734|NCT04371965|Povidone|povidone|mesh-list
55989735|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
55989736|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
55989737|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55989738|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989740|NCT02959125|Trace Elements|trace elements|mesh-list
55989741|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989742|NCT05644353|Mirikizumab|mirikizumab|mesh-list
55989743|NCT05644353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55989744|NCT05644353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55989745|NCT05644353|Analgesics|analgesics|mesh-ancestor
55989746|NCT05644353|Sensory System Agents|sensory system agents|mesh-ancestor
55989747|NCT05644353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989748|NCT05644353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989749|NCT05644353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55989750|NCT05644353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55989751|NCT05644353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55989752|NCT05644353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55989753|NCT02972554|Propranolol|propranolol|mesh-list
55989754|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55989755|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55989756|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
55989757|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989758|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989759|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989760|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55989761|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55989762|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
55989763|NCT02241941|Daptomycin|daptomycin|mesh-list
55989764|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55989765|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989766|NCT05316129|Hormones|hormones|mesh-list
55989767|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55989768|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55989769|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989770|NCT00359151|Celecoxib|celecoxib|mesh-list
55989771|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55989772|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55989773|NCT00359151|Analgesics|analgesics|mesh-ancestor
55989774|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
55989775|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989776|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989777|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55989778|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832426|NCT01830543|Coagulants|coagulants|mesh-ancestor
55989779|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55989780|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55989781|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989782|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989783|NCT00374686|Valganciclovir|valganciclovir|mesh-list
55989784|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
55989785|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989786|NCT04371575|Carbamazepine|carbamazepine|mesh-list
56214788|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56214789|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56214790|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214791|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56214792|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214793|NCT01615042|Lenalidomide|lenalidomide|mesh-list
56214794|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
56214795|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214796|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55989787|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
55989788|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
55989789|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
55989790|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55989791|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989792|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989793|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55989794|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55989795|NCT04371575|Analgesics|analgesics|mesh-ancestor
55989796|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
55989797|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989798|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55989799|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989800|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989801|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55989802|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55989803|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55989804|NCT00359229|Zolpidem|zolpidem|mesh-list
55989805|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55989806|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55989807|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989808|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989809|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55989810|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
55989812|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989813|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989814|NCT05513391|Vaccines|vaccines|mesh-list
55989815|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
55989816|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989817|NCT04371341|Bupivacaine|bupivacaine|mesh-list
55989818|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
55989819|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
55989820|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989821|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989822|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
55989823|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989824|NCT00374764|Risperidone|risperidone|mesh-list
55989825|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55989826|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
55989827|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989828|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989829|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989830|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55989831|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55989832|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989833|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55989834|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55989835|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
55989836|NCT04371185|Ustekinumab|ustekinumab|mesh-list
55989837|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
55989838|NCT01005355|Ramucirumab|ramucirumab|mesh-list
55989839|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989840|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
55989841|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55989842|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55989843|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
55989844|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214797|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56214798|NCT01615042|Growth Substances|growth substances|mesh-ancestor
56214799|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
56214800|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989845|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989846|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55989847|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
55989848|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
55989851|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989852|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989853|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55989854|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55989855|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55989856|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
55989857|NCT05285943|Betamethasone|betamethasone|mesh-list
55989858|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
55989859|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55989860|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
55989861|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55989862|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55989863|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
55907801|NCT01493531|Renal Agents|renal agents|mesh-ancestor
55989865|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55989866|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989867|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55989868|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
55989869|NCT03030001|Antibodies|antibodies|mesh-list
55989870|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
55989871|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989872|NCT02242331|Telmisartan|telmisartan|mesh-list
55989873|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55989874|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55989875|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55989876|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989877|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55989878|NCT05495061|Latanoprost|latanoprost|mesh-list
55989879|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55989880|NCT03030157|Pirarubicin|pirarubicin|mesh-list
55989881|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55989882|NCT00359385|Alendronate|alendronate|mesh-list
55989883|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55989884|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989886|NCT03029455|VX-659|vx-659|mesh-list
55989887|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55989888|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989889|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989890|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
55989891|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989892|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989893|NCT02245789|Remifentanil|remifentanil|mesh-list
55989895|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
55989896|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989897|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989898|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55989899|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55989900|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
55989901|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55989902|NCT02245789|Narcotics|narcotics|mesh-ancestor
55989903|NCT02245789|Analgesics|analgesics|mesh-ancestor
55989904|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
55989905|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989906|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
55989907|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
55989908|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55989909|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55989910|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989911|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989912|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989913|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55989914|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
56214802|NCT01615055|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56214803|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56214804|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989915|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55989916|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989917|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989918|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
55989919|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
55989920|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55989921|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55989922|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55989923|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989926|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55989927|NCT02242877|Telmisartan|telmisartan|mesh-list
55989928|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55989929|NCT02242877|Diuretics|diuretics|mesh-ancestor
55989930|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
55989931|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989932|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55989933|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55989934|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989935|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55989936|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55989937|NCT01007071|Hormones|hormones|mesh-list
55989938|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55989939|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989940|NCT05475639|Diclofenac|diclofenac|mesh-list
55989941|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55989942|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55989943|NCT05475639|Analgesics|analgesics|mesh-ancestor
55989944|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
55989945|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989946|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989947|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55989948|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55989949|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55989950|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989951|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989952|NCT02242955|Diazepam|diazepam|mesh-list
55989953|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55989954|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
55989955|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
55989956|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
55989957|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55989958|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989959|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55989960|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55989961|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55989962|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55989963|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55989964|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55717287|NCT02233049|Everolimus|everolimus|mesh-list
55989965|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55989966|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55989967|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55989968|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
55989969|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
55989970|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
55989971|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
55989972|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989973|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989974|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
55989975|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55989976|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989977|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55989978|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989979|NCT01008319|Citric Acid|citric acid|mesh-list
55989980|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
56214805|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214806|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214807|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
56214808|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989982|NCT01008319|Enclomiphene|enclomiphene|mesh-list
55989983|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
55989984|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
55989985|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55989986|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
55989987|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
55989988|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989989|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55989990|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
55989991|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55989992|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989993|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55989995|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55989996|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55989997|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55989998|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
55989999|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55990000|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990001|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55990002|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55990003|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990004|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990005|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990006|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
55990007|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55990008|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
55990009|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990010|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990011|NCT00967369|Carboplatin|carboplatin|mesh-list
55990013|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
55990014|NCT00967369|Bortezomib|bortezomib|mesh-list
55990015|NCT00967369|Ifosfamide|ifosfamide|mesh-list
55990016|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
55990017|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
55990018|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990019|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55990020|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55990021|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55990022|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990023|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990024|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55990025|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
55990026|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
55990027|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
55990028|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
55990029|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
55990030|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
55990031|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
55990032|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55990033|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990034|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990035|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55990036|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55990037|NCT02245295|Anesthetics|anesthetics|mesh-list
55990038|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990039|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990040|NCT05238207|Psyllium|psyllium|mesh-list
55990041|NCT05238207|Cathartics|cathartics|mesh-ancestor
55990042|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55990043|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
55990044|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990045|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
55990046|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55990047|NCT00968071|Decitabine|decitabine|mesh-list
55990048|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
55990049|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55990050|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
56214809|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56214810|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
56214811|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55791161|NCT01660971|Antiviral Agents|antiviral agents|mesh-ancestor
55990051|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990052|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990053|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990054|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990055|NCT05462613|Aspirin|aspirin|mesh-list
55990056|NCT05462613|Bevacizumab|bevacizumab|mesh-list
55990057|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990058|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990059|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55990060|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55990061|NCT05462613|Growth Substances|growth substances|mesh-ancestor
55990062|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990063|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
55990064|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55990065|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990066|NCT05462613|Analgesics|analgesics|mesh-ancestor
55990067|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
55990068|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990070|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990071|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55990072|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55990073|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990074|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55990075|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55990076|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990077|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
55990078|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
55990079|NCT00971737|Trastuzumab|trastuzumab|mesh-list
55990080|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55990081|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
55990082|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990083|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990084|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55990085|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
55990086|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990087|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990088|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55990089|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990090|NCT04368377|Aspirin|aspirin|mesh-list
55990091|NCT04368377|PENTA|penta|mesh-list
55990092|NCT04368377|Tirofiban|tirofiban|mesh-list
55990093|NCT04368377|Fondaparinux|fondaparinux|mesh-list
55990094|NCT04368377|Clopidogrel|clopidogrel|mesh-list
55990095|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55990096|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55990097|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55990098|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55990099|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
55990100|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990101|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990102|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990103|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55990104|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990105|NCT04368377|Analgesics|analgesics|mesh-ancestor
55990106|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
55990107|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990108|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990109|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990110|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55990111|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55990112|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55990113|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990114|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
55990115|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55990116|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
55990117|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56214812|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56214813|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56214814|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214815|NCT01615081|Insulin|insulin|mesh-list
55990118|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
55990119|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
55990120|NCT04361513|Triamcinolone|triamcinolone|mesh-list
55990121|NCT04361513|Bupivacaine|bupivacaine|mesh-list
55990122|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
55990123|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
55990124|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990125|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990126|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
55990127|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990128|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990129|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
55990131|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55990132|NCT05595993|Cilostazol|cilostazol|mesh-list
55990133|NCT05595993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55990134|NCT05595993|Autonomic Agents|autonomic agents|mesh-ancestor
55990135|NCT05595993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990136|NCT05595993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990137|NCT05595993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55990138|NCT05595993|Respiratory System Agents|respiratory system agents|mesh-ancestor
55990139|NCT05595993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55990140|NCT05595993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55990141|NCT05595993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990142|NCT05595993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55990143|NCT05595993|Vasodilator Agents|vasodilator agents|mesh-ancestor
55990146|NCT05595993|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55990147|NCT05595993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55990148|NCT05595993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990149|NCT05593341|Analgesics, Opioid|analgesics, opioid|mesh-list
55990150|NCT05593341|Narcotics|narcotics|mesh-ancestor
55990151|NCT05593341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990152|NCT05593341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990153|NCT05593341|Analgesics|analgesics|mesh-ancestor
55990154|NCT05593341|Sensory System Agents|sensory system agents|mesh-ancestor
55990155|NCT05593341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990156|NCT00972205|Paclitaxel|paclitaxel|mesh-list
55990157|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
55990158|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55990159|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990160|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
55990161|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
55990162|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
55990163|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990164|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55990165|NCT00928421|Polidocanol|polidocanol|mesh-list
55990166|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55990167|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55990168|NCT03051256|Methadone|methadone|mesh-list
55990169|NCT03051256|D-methadone|d-methadone|mesh-list
55990170|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55990171|NCT03051256|Narcotics|narcotics|mesh-ancestor
55990172|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990173|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990174|NCT03051256|Analgesics|analgesics|mesh-ancestor
55990175|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
55990176|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990177|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
55990178|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
55990179|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990180|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55990181|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55990182|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55990183|NCT00932321|Norethindrone|norethindrone|mesh-list
55990184|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
55990185|NCT00932321|Estradiol|estradiol|mesh-list
55990186|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55990187|NCT00932321|Estrogens|estrogens|mesh-ancestor
55990188|NCT00932321|Hormones|hormones|mesh-ancestor
56214816|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56214817|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214818|NCT01615107|Oxytocin|oxytocin|mesh-list
56214819|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
56214820|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214821|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214822|NCT01615185|Amisulpride|amisulpride|mesh-list
56214823|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56214824|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55791168|NCT04853615|Empagliflozin|empagliflozin|mesh-list
55990189|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55990190|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990191|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55990192|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
55990193|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55990194|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55990195|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55990197|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55990199|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990200|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990201|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55990202|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990203|NCT01011829|Varenicline|varenicline|mesh-list
55990204|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55990205|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55990206|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
55990207|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990208|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990209|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990210|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55907989|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
55907990|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55907991|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55990211|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
55990212|NCT00932477|Glycerol|glycerol|mesh-list
55990213|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55990214|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55990215|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55990216|NCT00932477|Protective Agents|protective agents|mesh-ancestor
55990217|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990218|NCT00932477|Laxatives|laxatives|mesh-ancestor
55990220|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
55990221|NCT00972439|Norinyl|norinyl|mesh-list
55990222|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
55990223|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55990224|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990225|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55990226|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55990227|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55990228|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55990229|NCT00358371|Floxacillin|floxacillin|mesh-list
55990230|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55990231|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990232|NCT02989714|Nivolumab|nivolumab|mesh-list
55990233|NCT02989714|Interleukin-2|interleukin-2|mesh-list
55990234|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990235|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990236|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55990237|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990238|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990239|NCT02989714|Analgesics|analgesics|mesh-ancestor
55990240|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
55990241|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990242|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990243|NCT04361279|Rituximab|rituximab|mesh-list
55990244|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990245|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214825|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214826|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214827|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55791174|NCT05573607|Trace Elements|trace elements|mesh-ancestor
55990246|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
55990247|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990248|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990249|NCT05585229|Psilocybin|psilocybin|mesh-list
55990250|NCT05585229|Hallucinogens|hallucinogens|mesh-ancestor
55990251|NCT05585229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990252|NCT05585229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55990253|NCT05582499|Paclitaxel|paclitaxel|mesh-list
55990254|NCT05582499|Cyclophosphamide|cyclophosphamide|mesh-list
55990255|NCT05582499|Carboplatin|carboplatin|mesh-list
55990256|NCT05582499|Trastuzumab|trastuzumab|mesh-list
55990257|NCT05582499|Letrozole|letrozole|mesh-list
55990258|NCT05582499|Epirubicin|epirubicin|mesh-list
55990259|NCT05582499|Pertuzumab|pertuzumab|mesh-list
55990260|NCT05582499|Goserelin|goserelin|mesh-list
55990261|NCT05582499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55990262|NCT05582499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990264|NCT05582499|Antimitotic Agents|antimitotic agents|mesh-ancestor
55990265|NCT05582499|Mitosis Modulators|mitosis modulators|mesh-ancestor
55990266|NCT05582499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990267|NCT05582499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55990268|NCT05582499|Immunologic Factors|immunologic factors|mesh-ancestor
55990269|NCT05582499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990270|NCT05582499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990271|NCT05582499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55990272|NCT05582499|Alkylating Agents|alkylating agents|mesh-ancestor
55990273|NCT05582499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55908010|NCT02372604|Cetirizine|cetirizine|mesh-list
55990274|NCT05582499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990275|NCT05582499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55990276|NCT05582499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55990277|NCT05582499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990278|NCT05582499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55990279|NCT05582499|Hormone Antagonists|hormone antagonists|mesh-ancestor
55990280|NCT05582499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55990281|NCT05582499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55990282|NCT05582499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55990283|NCT05582499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55990284|NCT05582499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55990285|NCT02881996|Acetaminophen|acetaminophen|mesh-list
55990286|NCT02881996|Ketorolac|ketorolac|mesh-list
55990287|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990288|NCT02881996|Analgesics|analgesics|mesh-ancestor
55990289|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
55990290|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990291|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990292|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
55990293|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55990295|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990296|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55990297|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990298|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990300|NCT04367831|Calcium heparin|calcium heparin|mesh-list
55990301|NCT04367831|Enoxaparin|enoxaparin|mesh-list
55990302|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
55990303|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
55990304|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55990305|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55990306|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990307|NCT03051646|Aspirin|aspirin|mesh-list
55990308|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55990309|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990310|NCT03051646|Analgesics|analgesics|mesh-ancestor
55990311|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
55990312|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990313|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990314|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990315|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56214828|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56214829|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
56214830|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990316|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55990317|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55990318|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990319|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55990320|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55990321|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990322|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
55990323|NCT04344405|Vitamin D|vitamin d|mesh-list
55990324|NCT04344405|Vitamins|vitamins|mesh-ancestor
55990325|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
55908023|NCT02358642|Lisinopril|lisinopril|mesh-list
55990326|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990327|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55990328|NCT05187429|Nivolumab|nivolumab|mesh-list
55990329|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990331|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55990332|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990333|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
55804674|NCT02310789|Miotics|miotics|mesh-ancestor
55990334|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
55990335|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55990336|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990337|NCT02993302|Vitamins|vitamins|mesh-ancestor
55990338|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
55990339|NCT00359853|Norfloxacin|norfloxacin|mesh-list
55990340|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55990341|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990342|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55990343|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55990344|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990345|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990346|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990347|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55990348|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55990349|NCT05168709|Vaccines|vaccines|mesh-list
55990350|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
55990351|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990352|NCT04367051|Spironolactone|spironolactone|mesh-list
55990353|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55990354|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
55990355|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55990356|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990357|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55990358|NCT04367051|Diuretics|diuretics|mesh-ancestor
55990359|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
55990360|NCT03111316|Dinoprostone|dinoprostone|mesh-list
55990361|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
55990362|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55990363|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990364|NCT03054844|Lidocaine|lidocaine|mesh-list
55990365|NCT03054844|Midazolam|midazolam|mesh-list
55990366|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
55990367|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
55990368|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990370|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
55990371|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990372|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55990373|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55990374|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55990375|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55990376|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990377|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55990378|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55990379|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55990380|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55990381|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55990382|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55990383|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
55990384|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
55990385|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
55990386|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214831|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908098|NCT04438980|Hormones|hormones|mesh-ancestor
56214832|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55990387|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
55990388|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990389|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990391|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55990392|NCT00359697|Diuretics|diuretics|mesh-ancestor
55990393|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
55990394|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990395|NCT03111628|Omalizumab|omalizumab|mesh-list
55990396|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55990397|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55990398|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
55990399|NCT05120505|Metformin|metformin|mesh-list
55990400|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55990401|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990402|NCT02977533|Acyclovir|acyclovir|mesh-list
55990403|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
55990404|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990405|NCT01012297|Gemcitabine|gemcitabine|mesh-list
55990406|NCT01012297|Bevacizumab|bevacizumab|mesh-list
55804675|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
55990407|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55990408|NCT01012297|Docetaxel|docetaxel|mesh-list
55990409|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
55990410|NCT01012297|Antibodies|antibodies|mesh-list
55990411|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
55990412|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55990413|NCT01012297|Lenograstim|lenograstim|mesh-list
55990414|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
55990415|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990416|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55990417|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55990418|NCT01012297|Growth Substances|growth substances|mesh-ancestor
55990419|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990420|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
55990421|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
55990422|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55990423|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
55990424|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990425|NCT01012297|Antiviral Agents|antiviral agents|mesh-ancestor
55990426|NCT01012297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990427|NCT01012297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990428|NCT01012297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55990429|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
55990430|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
55990431|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
55990432|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55990433|NCT00923117|Sunitinib|sunitinib|mesh-list
55990434|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990435|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55990436|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55990437|NCT00923117|Growth Substances|growth substances|mesh-ancestor
55990438|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990439|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
55990440|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55990441|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990442|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990443|NCT05108259|Adalimumab|adalimumab|mesh-list
55990444|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990447|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55990448|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55990449|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55990450|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
55990451|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990452|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990453|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990454|NCT02244281|Urological Agents|urological agents|mesh-ancestor
55990456|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55990457|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55990458|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55990459|NCT02977611|Hematinics|hematinics|mesh-ancestor
55990460|NCT04360655|Antibodies|antibodies|mesh-list
56214834|NCT01615211|Letrozole|letrozole|mesh-list
56214835|NCT01615211|Trilostane|trilostane|mesh-list
55791185|NCT03040817|Mosapride|mosapride|mesh-list
55990461|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55990462|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
55990463|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990464|NCT00375232|Montelukast|montelukast|mesh-list
55990465|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55990466|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
55990467|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55990468|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
55990469|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55990470|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990471|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55990472|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55990473|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990474|NCT00975637|Brodalumab|brodalumab|mesh-list
55990475|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55990476|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
55990477|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
55990478|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990479|NCT02244437|Acetaminophen|acetaminophen|mesh-list
55990480|NCT02244437|Ibuprofen|ibuprofen|mesh-list
55990481|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990482|NCT02244437|Analgesics|analgesics|mesh-ancestor
55990483|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
55990484|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990485|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990486|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
55990487|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55990488|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990489|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990490|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55990491|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990492|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990493|NCT03023527|Dexamethasone|dexamethasone|mesh-list
55990495|NCT03023527|Pomalidomide|pomalidomide|mesh-list
55990496|NCT03023527|Elotuzumab|elotuzumab|mesh-list
55990497|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990498|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
55990499|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
55990500|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990501|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990502|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55990503|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
55990504|NCT03023527|Hormones|hormones|mesh-ancestor
55990505|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55990506|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55990507|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990508|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990509|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55990510|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990511|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
55990512|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55990513|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55990514|NCT03023527|Growth Substances|growth substances|mesh-ancestor
55990515|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
55990516|NCT04878627|Cannabidiol|cannabidiol|mesh-list
55990517|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
55990521|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990522|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990523|NCT02244515|Analgesics|analgesics|mesh-ancestor
55990524|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
55990525|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990526|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55990527|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55990528|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55990529|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
55990530|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990531|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990532|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
55990533|NCT04360031|Tacrolimus|tacrolimus|mesh-list
56214836|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214837|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56214838|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55990534|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55990535|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
55990536|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990537|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55990538|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990539|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990540|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55990541|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990542|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55990543|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
55990544|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55990545|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990546|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
55990547|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
55990548|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
55990549|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990550|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990551|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55990552|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55990553|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55804678|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55990554|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990555|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55908208|NCT02352714|Lidocaine|lidocaine|mesh-list
55990556|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55990557|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
55990558|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990559|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990560|NCT03023059|Levodopa|levodopa|mesh-list
55990561|NCT03023059|Carbidopa|carbidopa|mesh-list
55990562|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55990563|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55990564|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55990565|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
55990566|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990567|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990568|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990569|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55990570|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990571|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55990572|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
55990573|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
55990574|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
55990575|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55990576|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990577|NCT04359485|Glycolic acid|glycolic acid|mesh-list
55990578|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
55990579|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
55990580|NCT05376579|Siponimod|siponimod|mesh-list
55990581|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55990582|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990583|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55990584|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
55990585|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990586|NCT04868565|Caffeine|caffeine|mesh-list
55990587|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
55990588|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990589|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55990590|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990591|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55990592|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990593|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55990594|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55990595|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
55990596|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990598|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
55990599|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990600|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990601|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990602|NCT00361413|Alefacept|alefacept|mesh-list
56214839|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214840|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214841|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55990603|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
55990604|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
55990605|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990606|NCT03062488|Acetaminophen|acetaminophen|mesh-list
55990607|NCT03062488|Fentanyl|fentanyl|mesh-list
55990608|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55990609|NCT03062488|Narcotics|narcotics|mesh-ancestor
55990610|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990611|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990612|NCT03062488|Analgesics|analgesics|mesh-ancestor
55990613|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
55990614|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990615|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55990616|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55990617|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
55990618|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
55990619|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990620|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
55990621|NCT00936299|Bupropion|bupropion|mesh-list
55990622|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55990623|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
55990625|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55990626|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55990627|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55990628|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990629|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
55990630|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990631|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990632|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55990633|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55990634|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990635|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55990636|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55990637|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990638|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990639|NCT03117634|Aflibercept|aflibercept|mesh-list
55990640|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55990641|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55990642|NCT03117634|Growth Substances|growth substances|mesh-ancestor
55990643|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990644|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
55990646|NCT00937235|Varenicline|varenicline|mesh-list
55990647|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55990648|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55990649|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
55990650|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990651|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990652|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990653|NCT01014403|Enoxaparin|enoxaparin|mesh-list
55990654|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
55990655|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55990656|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55990657|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990658|NCT05405608|Ondansetron|ondansetron|mesh-list
55990659|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
55990660|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
55990661|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990662|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990663|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55990664|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
55990665|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
55990666|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55990667|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
55990668|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990669|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990670|NCT05405608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56214842|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
56214843|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55990671|NCT05405608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55990672|NCT05405608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990673|NCT05405608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55990674|NCT05405608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55990675|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
55990676|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55990677|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55990678|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55990679|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55990680|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990681|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
55990682|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990683|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990684|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55990685|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990686|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
55990687|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55990688|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55990689|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990690|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
55990691|NCT00375466|Coagulants|coagulants|mesh-ancestor
55990693|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990694|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55990695|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990696|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990697|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
55990698|NCT04357535|Giapreza|giapreza|mesh-list
55990699|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55990700|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
55990701|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55990702|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55990703|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990704|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55990705|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55990706|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
55990707|NCT01015807|Clonidine|clonidine|mesh-list
55990708|NCT01015807|Bupivacaine|bupivacaine|mesh-list
55990709|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
55990710|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
55990711|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990712|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990713|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
55990714|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990715|NCT01015807|Analgesics|analgesics|mesh-ancestor
55990716|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55990717|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
55990718|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
55718050|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
55990719|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55990720|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55990721|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55990722|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
55990723|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990724|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990725|NCT01575925|Thalidomide|thalidomide|mesh-list
55990726|NCT01575925|Dexamethasone|dexamethasone|mesh-list
55990727|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
55990728|NCT01575925|Pomalidomide|pomalidomide|mesh-list
55990729|NCT01575925|BB 1101|bb 1101|mesh-list
55990730|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990731|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
55990732|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
55990733|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990734|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990735|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55990736|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
55990737|NCT01575925|Hormones|hormones|mesh-ancestor
55990738|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55990739|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56214844|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214845|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55990740|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990741|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
55990742|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990743|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990744|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
55990745|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55990746|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55990747|NCT01575925|Growth Substances|growth substances|mesh-ancestor
55990748|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
55990749|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55990750|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
55804695|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
55990751|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55990752|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990754|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55990755|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990756|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990757|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990759|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
55990760|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990761|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55990762|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55990763|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55990764|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
55990765|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990766|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990767|NCT04471233|Pregabalin|pregabalin|mesh-list
55990768|NCT04471233|Analgesics|analgesics|mesh-ancestor
55990769|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
55990770|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990771|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990772|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
55990773|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55990774|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55990775|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990776|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55990777|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55990778|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55990779|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990780|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55990781|NCT04359095|Tenofovir|tenofovir|mesh-list
55990782|NCT04359095|Emtricitabine|emtricitabine|mesh-list
55990783|NCT04359095|Colchicine|colchicine|mesh-list
55990784|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55990785|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
55990786|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990787|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55990788|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55990789|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990790|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990791|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55990792|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55718153|NCT02300623|Lamivudine|lamivudine|mesh-list
55990794|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55990795|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
55990796|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55990797|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55990798|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
55990799|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990800|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
55990801|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
55990802|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
55990803|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990804|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
55990805|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55990806|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55990807|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990808|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
55990809|NCT04803747|Coagulants|coagulants|mesh-ancestor
56214846|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
56214847|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214848|NCT01615224|Misoprostol|misoprostol|mesh-list
56214849|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56214850|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
56214851|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214852|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791195|NCT04853069|Estradiol|estradiol|mesh-list
55990810|NCT02163421|Vedolizumab|vedolizumab|mesh-list
55990811|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55990812|NCT02982395|Ethanol|ethanol|mesh-list
55990813|NCT02982395|Docetaxel|docetaxel|mesh-list
55990814|NCT02982395|Mitomycins|mitomycins|mesh-list
55990815|NCT02982395|Mitomycin|mitomycin|mesh-list
55804700|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
55990816|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990817|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
55990818|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
55908556|NCT04478526|Norepinephrine|norepinephrine|mesh-list
55990819|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
55990820|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990821|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55990822|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
55990823|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55990824|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990825|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55990826|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990827|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990828|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990829|NCT02982005|Brodalumab|brodalumab|mesh-list
55990830|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
55990831|NCT04736836|Rifaximin|rifaximin|mesh-list
55990832|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55990833|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990834|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55990835|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55990836|NCT03126370|Emtricitabine|emtricitabine|mesh-list
55990837|NCT03126370|Tenofovir|tenofovir|mesh-list
55990838|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
55990839|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
55990840|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55990841|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55990842|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990843|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990844|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
55990845|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990846|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55990847|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55990848|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55990849|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55990850|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55990851|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55990852|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55990853|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990854|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
55990855|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990856|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990857|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55990858|NCT00979615|Azelastine|azelastine|mesh-list
55990859|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55990860|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55990861|NCT00979615|Analgesics|analgesics|mesh-ancestor
55990862|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
55990863|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990864|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990865|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990866|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990867|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56214854|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56214855|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
55990868|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55990869|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55990870|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
55990871|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
55990872|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990873|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990874|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55990875|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
55990876|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55990877|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
55990878|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
55990879|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990880|NCT03126682|Bupropion|bupropion|mesh-list
55990881|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55990883|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55990884|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55990885|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55990888|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
55990889|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990890|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990891|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55990892|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55990893|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990894|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55990895|NCT05236738|Cobicistat|cobicistat|mesh-list
55990896|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55990897|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55990898|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
55990899|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990900|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990901|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55990902|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55990903|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
55990904|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990905|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55990906|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55990907|NCT00980395|Rituximab|rituximab|mesh-list
55990908|NCT00980395|Bortezomib|bortezomib|mesh-list
55990909|NCT00980395|Cladribine|cladribine|mesh-list
55990910|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55990911|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990912|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
55990913|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990914|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990915|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55990916|NCT02976597|Morphine|morphine|mesh-list
55990917|NCT02976597|Bupivacaine|bupivacaine|mesh-list
55990919|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
55990920|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990921|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990922|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
55990923|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990924|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55990925|NCT02976597|Narcotics|narcotics|mesh-ancestor
55990926|NCT02976597|Analgesics|analgesics|mesh-ancestor
55990927|NCT03020329|Paclitaxel|paclitaxel|mesh-list
55908661|NCT00323739|Bevacizumab|bevacizumab|mesh-list
55990928|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55990929|NCT03020329|Cisplatin|cisplatin|mesh-list
55990930|NCT03020329|Fluorouracil|fluorouracil|mesh-list
55990931|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55990932|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990933|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
55990934|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
55990935|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
55990936|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990937|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
55990938|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56214856|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56214857|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56214858|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
55990939|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55990940|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
55990941|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990942|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
55990943|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55990944|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990945|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55990946|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55990947|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990948|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990949|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55990950|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55990951|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55990952|NCT00980785|Ramipril|ramipril|mesh-list
55990953|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55990954|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
55990955|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990956|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990957|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55990958|NCT04772547|Vigabatrin|vigabatrin|mesh-list
55990960|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55990961|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990963|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990964|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990965|NCT05028153|Azithromycin|azithromycin|mesh-list
55990966|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55990967|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55990968|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55990969|NCT03126760|Hormones|hormones|mesh-ancestor
55990970|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55990971|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990972|NCT05027919|Lofexidine|lofexidine|mesh-list
55990973|NCT05027919|Clonidine|clonidine|mesh-list
55990974|NCT05027919|Morphine|morphine|mesh-list
55990975|NCT05027919|Naloxone|naloxone|mesh-list
55990976|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55990977|NCT05027919|Narcotics|narcotics|mesh-ancestor
55908681|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
55990978|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990979|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990980|NCT05027919|Analgesics|analgesics|mesh-ancestor
55990981|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
55990982|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55990983|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55990984|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55990985|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55990986|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55990987|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55990988|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
55990989|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55990990|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990991|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
55990992|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
55990993|NCT05026905|Leucovorin|leucovorin|mesh-list
55990994|NCT05026905|Gemcitabine|gemcitabine|mesh-list
55990995|NCT05026905|Paclitaxel|paclitaxel|mesh-list
55990996|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55990997|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
55990998|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55990999|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991000|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
55991001|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
55991002|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
55991003|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991004|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55991005|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
55991006|NCT05026905|Antiviral Agents|antiviral agents|mesh-ancestor
55991007|NCT05026905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214859|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55991008|NCT05026905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991009|NCT05026905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991010|NCT05026905|Immunologic Factors|immunologic factors|mesh-ancestor
55991011|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991012|NCT05026905|Antidotes|antidotes|mesh-ancestor
55991013|NCT05026905|Protective Agents|protective agents|mesh-ancestor
55991014|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
55991015|NCT05026905|Vitamins|vitamins|mesh-ancestor
55991016|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
55991017|NCT00982189|Lisinopril|lisinopril|mesh-list
55718350|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
55991018|NCT00982189|Pravastatin|pravastatin|mesh-list
55991019|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55991020|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55991021|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
55991022|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991023|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55991024|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55991025|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991026|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55991027|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
55991028|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55991029|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55991030|NCT00982189|Protective Agents|protective agents|mesh-ancestor
55991031|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991033|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55991035|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991036|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991037|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
55908753|NCT02349282|Vitamin D|vitamin d|mesh-list
55991038|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991039|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55991041|NCT03128008|Carboplatin|carboplatin|mesh-list
55991042|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55991043|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991044|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
55991045|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
55991046|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
55991047|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991048|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55991049|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
55991050|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55991051|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55991052|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55991053|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991054|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991055|NCT05017311|Citalopram|citalopram|mesh-list
55991056|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
55991057|NCT05017311|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55991058|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55991059|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991060|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991061|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991062|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
55991063|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991064|NCT05017311|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55991065|NCT05017311|Antidepressive Agents|antidepressive agents|mesh-ancestor
55991066|NCT05017311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55991067|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
55991068|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
55991069|NCT00360087|Bosentan|bosentan|mesh-list
55991070|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55991071|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55991072|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991073|NCT00982423|Furosemide|furosemide|mesh-list
55991074|NCT00982423|Diuretics|diuretics|mesh-ancestor
55991075|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
55991076|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991077|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55991078|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991079|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214860|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
56214861|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56214862|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791207|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
55991080|NCT04719819|Anesthetics|anesthetics|mesh-list
55991081|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991082|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908768|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991083|NCT02981719|Gemcitabine|gemcitabine|mesh-list
55991084|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55991085|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
55991086|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991087|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991088|NCT02981719|Antiviral Agents|antiviral agents|mesh-ancestor
55991089|NCT02981719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991090|NCT02981719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991091|NCT02981719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991092|NCT02981719|Immunologic Factors|immunologic factors|mesh-ancestor
55991093|NCT02981719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991094|NCT03073876|Donepezil|donepezil|mesh-list
55991095|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55991096|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991097|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991098|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
55991099|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991100|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991101|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
55991102|NCT04718961|Volixibat|volixibat|mesh-list
55991103|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55991108|NCT03130738|Miconazole|miconazole|mesh-list
55991109|NCT03130738|Clotrimazole|clotrimazole|mesh-list
55991110|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
55991111|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991112|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55991113|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55991114|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991115|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991116|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55991117|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
55991118|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55991119|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991120|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55991121|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55991122|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55991123|NCT04996251|Bupivacaine|bupivacaine|mesh-list
55991124|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
55991125|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
55991126|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991127|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991128|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
55991129|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991130|NCT00984139|Vaccines|vaccines|mesh-list
55991131|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
55991132|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991133|NCT04672395|Vaccines|vaccines|mesh-list
55908853|NCT02345148|Esketamine|esketamine|mesh-list
55991134|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
55991135|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
55991136|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991137|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55991138|NCT05394493|Avelumab|avelumab|mesh-list
55991139|NCT05394493|Axitinib|axitinib|mesh-list
55991140|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991141|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991142|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55991143|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991144|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991145|NCT00985543|Ritonavir|ritonavir|mesh-list
55991146|NCT00985543|Lopinavir|lopinavir|mesh-list
55991147|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56214863|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56214864|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55991148|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55991149|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
55991150|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991151|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991152|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55991153|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55991154|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
55991155|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991156|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55991157|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55991158|NCT05394415|Paclitaxel|paclitaxel|mesh-list
55991159|NCT05394415|Carboplatin|carboplatin|mesh-list
55991160|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55991161|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991162|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
55991163|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
55991164|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
55991165|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991166|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
55991167|NCT04977453|Lenvatinib|lenvatinib|mesh-list
55991168|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991169|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991170|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55991171|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991172|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991173|NCT04352959|Betadex|betadex|mesh-list
55991174|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
55991175|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991176|NCT00360945|Temozolomide|temozolomide|mesh-list
55991177|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991178|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55991181|NCT03019237|Omalizumab|omalizumab|mesh-list
55991182|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55991183|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55991184|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
55908865|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55908866|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55908867|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55908868|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55908869|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
55908870|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908871|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908872|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908873|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
55908874|NCT00394329|Hormones|hormones|mesh-ancestor
55766361|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
55723085|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
55991185|NCT00361023|Losartan|losartan|mesh-list
55991186|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55991187|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55991188|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55991189|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55991190|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991191|NCT04659369|Nivolumab|nivolumab|mesh-list
55991192|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991193|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991194|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55991195|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991196|NCT03019081|Isoproterenol|isoproterenol|mesh-list
55991197|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55991198|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55991199|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
55991200|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991201|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991202|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991203|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55991204|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
55991205|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991206|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55991207|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
55991208|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55991209|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
55782931|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765795|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765796|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
55765797|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
55765798|NCT02100514|Bococizumab|bococizumab|mesh-list
55765799|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55765800|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55765801|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
55765802|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214866|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56214867|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55791212|NCT05244811|Progestins|progestins|mesh-list
55765803|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55765805|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55765806|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
55765807|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765808|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765809|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55765810|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55765811|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
55765812|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765813|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765814|NCT02573493|Paclitaxel|paclitaxel|mesh-list
55765815|NCT02573493|Cisplatin|cisplatin|mesh-list
55765816|NCT02573493|Cetuximab|cetuximab|mesh-list
55765817|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55765818|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765819|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
55765820|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
55765821|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
55765822|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765823|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55765824|NCT05522361|Risdiplam|risdiplam|mesh-list
55765825|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55765826|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765827|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765828|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
55765829|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55765830|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765841|NCT02046616|Methotrexate|methotrexate|mesh-list
55765842|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55765843|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
55765844|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55765845|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765846|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55765847|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
55765848|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765849|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765850|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
55765851|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765852|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55765853|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765854|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
55765855|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765856|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55765857|NCT05525481|Tamoxifen|tamoxifen|mesh-list
55765858|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55765859|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
55765860|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765861|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765862|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55765863|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782932|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55782933|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55765864|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55765865|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56214868|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56214869|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55765866|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55765867|NCT04706026|Anesthetics|anesthetics|mesh-list
55765868|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765869|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765870|NCT02068222|Ritonavir|ritonavir|mesh-list
55765871|NCT02068222|Ribavirin|ribavirin|mesh-list
55765872|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55908875|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765873|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55765874|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
55765875|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765876|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765877|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55765879|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
55765880|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765881|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55765882|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55765883|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
55765884|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
55765885|NCT05517213|Etoposide|etoposide|mesh-list
55765886|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765887|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
55765888|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765889|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765890|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55765891|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
55765892|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765893|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765894|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55765895|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55765896|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55765897|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55765898|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765899|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
55765901|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55765902|NCT05516589|Afatinib|afatinib|mesh-list
55765903|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55765904|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765906|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
55765907|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
55765908|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765909|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55765910|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765911|NCT02099110|Metformin|metformin|mesh-list
55765912|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
55765913|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55765914|NCT02099110|Glimepiride|glimepiride|mesh-list
55765915|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
55765916|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55765917|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765919|NCT02099110|Hormones|hormones|mesh-ancestor
55765920|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765921|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55765922|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
55765923|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765924|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765925|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55908951|NCT00360399|Citalopram|citalopram|mesh-list
55765926|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765927|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
55765928|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55765929|NCT02098876|Everolimus|everolimus|mesh-list
55765930|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765931|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765932|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
55782934|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
55782935|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782936|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
55782937|NCT05008523|Narcotics|narcotics|mesh-ancestor
56214870|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56214872|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
56214873|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782938|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782939|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765933|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765934|NCT01624090|Plicamycin|plicamycin|mesh-list
55765935|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55765936|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765937|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55765938|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765939|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55765940|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765941|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765942|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55765943|NCT02571777|Fluticasone|fluticasone|mesh-list
55765944|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55765945|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765946|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55765947|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
55765948|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765949|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765950|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55765951|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
55765952|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
55765953|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55765954|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55765955|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55765956|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55765957|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
55765958|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804724|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
55765959|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765960|NCT05511831|Ketotifen|ketotifen|mesh-list
55765961|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
55765962|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
55765963|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55765964|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
55765965|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
55765966|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765967|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765968|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765969|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55765970|NCT02705105|Nivolumab|nivolumab|mesh-list
55765971|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
55765974|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55765975|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765976|NCT05521347|Caffeine|caffeine|mesh-list
55765977|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55765978|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908987|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
55765979|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55765980|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765981|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765982|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55765983|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55765984|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
55765985|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765986|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55765987|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
55765988|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765989|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
55782940|NCT05008523|Analgesics|analgesics|mesh-ancestor
55765990|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765991|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
55765992|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
55765993|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
56214875|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214876|NCT01615445|Resveratrol|resveratrol|mesh-list
56214877|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
56214878|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214879|NCT01615445|Protective Agents|protective agents|mesh-ancestor
56214880|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214881|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214882|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55765994|NCT05093517|Volagidemab|volagidemab|mesh-list
55765995|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55765996|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765997|NCT02420171|Insulin|insulin|mesh-list
55765998|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55765999|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766000|NCT03180593|Valsartan|valsartan|mesh-list
55766001|NCT03180593|Nebivolol|nebivolol|mesh-list
55766002|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55766003|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55766004|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55766005|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766006|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
55766007|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55766008|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55766009|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55766010|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
55766011|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766012|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766013|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
55766014|NCT02423759|Gentamicins|gentamicins|mesh-list
55766015|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55766016|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766017|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55766018|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55766020|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766021|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766022|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55766023|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55766024|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55766025|NCT01623310|Fluticasone|fluticasone|mesh-list
55766027|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766028|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55766029|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
55766030|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766031|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766032|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55766033|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
55766034|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
55766035|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55766037|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
55766038|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
55766039|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
55766042|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
55766043|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766044|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55766045|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55766046|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55766047|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55766048|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766049|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55766051|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
55766052|NCT03180125|Protective Agents|protective agents|mesh-ancestor
55766053|NCT02423603|Paclitaxel|paclitaxel|mesh-list
56214884|NCT01615601|Darunavir|darunavir|mesh-list
56142673|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56214885|NCT01615601|Etravirine|etravirine|mesh-list
55766054|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55766055|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766056|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
55766057|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
55766058|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
55766059|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766060|NCT03178409|Liver Extracts|liver extracts|mesh-list
55766061|NCT03178409|Hematinics|hematinics|mesh-ancestor
55782941|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
55766062|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55766063|NCT03180281|Glimepiride|glimepiride|mesh-list
55766064|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55766065|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766066|NCT03180281|Incretins|incretins|mesh-ancestor
55766068|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766069|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55766070|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
55766071|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766072|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766073|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55766074|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766075|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
55766076|NCT03116945|Gallium citrate|gallium citrate|mesh-list
55766077|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766078|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55766079|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
55766080|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55766081|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766082|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766083|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55766084|NCT03117023|Analgesics|analgesics|mesh-ancestor
55766085|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
55766086|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766087|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55766088|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55766089|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55766090|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
55766091|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766092|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766093|NCT02097238|Halichondrin B|halichondrin b|mesh-list
55766094|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
55766095|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
55766096|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
55766097|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766098|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766100|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766101|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
55766102|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55766103|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766104|NCT02419859|Insulin|insulin|mesh-list
55766105|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55766106|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55766107|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766108|NCT02419235|Ethanol|ethanol|mesh-list
55766109|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55766111|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766112|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766113|NCT02422823|Epinephrine|epinephrine|mesh-list
55766114|NCT02422823|Carticaine|carticaine|mesh-list
55766115|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55766116|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55766117|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
55766118|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766119|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766120|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766121|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56214886|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56214887|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56214888|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56214889|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
55766122|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55766124|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766125|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55766126|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
55766127|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
55766128|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
55766129|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55766130|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
55766131|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
55766132|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766133|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
55766134|NCT02422589|Ceritinib|ceritinib|mesh-list
55782942|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782943|NCT02342977|Lacosamide|lacosamide|mesh-list
55766135|NCT02422589|Midazolam|midazolam|mesh-list
55766136|NCT02422589|Warfarin|warfarin|mesh-list
55766137|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55766138|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55766139|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766140|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766141|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55766142|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55766143|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55766144|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55766145|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
55766146|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
55766147|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
55766148|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
55766149|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766150|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766151|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
55909085|NCT02340936|Growth Substances|growth substances|mesh-ancestor
55766152|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766153|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55766154|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766155|NCT02422199|Capecitabine|capecitabine|mesh-list
55766156|NCT02422199|Lapatinib|lapatinib|mesh-list
55766157|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55766158|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
55766159|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766160|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804736|NCT05093959|Metformin|metformin|mesh-list
55766161|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55766162|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766165|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
55766166|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
55766167|NCT02416739|Vitamins|vitamins|mesh-ancestor
55766168|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
55766169|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766170|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55766171|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
55766172|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766173|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55766174|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
55766175|NCT02416583|Oxytocin|oxytocin|mesh-list
55766176|NCT02416583|Dinoprostone|dinoprostone|mesh-list
55766177|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
55766178|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55766179|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766181|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55766182|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55766183|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
55766184|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766186|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55766188|NCT02416271|Vitamin D|vitamin d|mesh-list
55766189|NCT02416271|Alendronate|alendronate|mesh-list
55766190|NCT02416271|Teriparatide|teriparatide|mesh-list
55766191|NCT02416271|Calcium|calcium|mesh-list
55766192|NCT02416271|Vitamins|vitamins|mesh-ancestor
56214890|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214891|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214892|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56214893|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
56214894|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214895|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56214896|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56214897|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56214898|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56214899|NCT01615614|Rilpivirine|rilpivirine|mesh-list
55766193|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
55766194|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766195|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55766196|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55766197|NCT02416115|Morphine|morphine|mesh-list
55766198|NCT02416115|Ramosetron|ramosetron|mesh-list
55766199|NCT02416115|Naloxone|naloxone|mesh-list
55766200|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55766201|NCT02416115|Narcotics|narcotics|mesh-ancestor
55766202|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766203|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766204|NCT02416115|Analgesics|analgesics|mesh-ancestor
55766205|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
55766206|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766207|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55782944|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
55782945|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55766208|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
55766209|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
55766210|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55766211|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55766212|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
55766213|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766214|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766216|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766217|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766219|NCT02415803|Ticagrelor|ticagrelor|mesh-list
55766220|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55766221|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55766222|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55766223|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55766224|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
55766225|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766226|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766227|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766229|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55766230|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55766232|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55766233|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
55766234|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55766235|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766236|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55766237|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55766238|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
55766239|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55766240|NCT04482881|Diuretics|diuretics|mesh-ancestor
55766241|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
55766242|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
55766243|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55766244|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766245|NCT03176693|Doxazosin|doxazosin|mesh-list
56214901|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56214902|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56214903|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214904|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214905|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
56214906|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214907|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56214908|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56214909|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56214910|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56214911|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
56214912|NCT01615627|Treprostinil|treprostinil|mesh-list
56214913|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55791237|NCT05564403|Protective Agents|protective agents|mesh-ancestor
55766246|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
55766247|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55766248|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55766249|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55766250|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55766251|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
55766252|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766253|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766254|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766255|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
55766259|NCT02415569|Laxatives|laxatives|mesh-ancestor
55766260|NCT02415335|Dexamethasone|dexamethasone|mesh-list
55766261|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
55766262|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55766263|NCT02415335|BB 1101|bb 1101|mesh-list
55766264|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766265|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
55766266|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
55766267|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766268|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766269|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55766270|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
55766271|NCT02415335|Hormones|hormones|mesh-ancestor
55766272|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766273|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55766274|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766275|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
55766276|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766277|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766278|NCT02415257|Gentamicins|gentamicins|mesh-list
55782946|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55766279|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55766280|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766281|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55766282|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766283|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766284|NCT02415179|Fluticasone|fluticasone|mesh-list
55766285|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
55766286|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
55766287|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55766288|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56214914|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56214915|NCT01615757|Cytarabine|cytarabine|mesh-list
55791252|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55766289|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766290|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55766293|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766294|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55766295|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
55766296|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
55766297|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55766298|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55766299|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55766300|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55766301|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
55766302|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766303|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766304|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
55766305|NCT02415179|Hormones|hormones|mesh-ancestor
55766306|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766307|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
55766308|NCT02415023|Paclitaxel|paclitaxel|mesh-list
55766309|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55766310|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55766311|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766312|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
55766313|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
55766314|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
55766315|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766316|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
55766317|NCT02414945|Fludarabine|fludarabine|mesh-list
55766318|NCT02414945|Interleukin-2|interleukin-2|mesh-list
55766319|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766320|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
55766321|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766322|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55766323|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55766324|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
55766325|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766326|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766330|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
55766331|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766332|NCT02414555|Phenylephrine|phenylephrine|mesh-list
55766333|NCT02414555|Norepinephrine|norepinephrine|mesh-list
55766334|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55766335|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55766336|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
55766337|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
55766338|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766339|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766340|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
55766341|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
55766342|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
55766343|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55766344|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55766345|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55766346|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
55766347|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782947|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55782948|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782949|NCT03090269|Methylphenidate|methylphenidate|mesh-list
55766348|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766349|NCT02414555|Protective Agents|protective agents|mesh-ancestor
55766350|NCT02414399|Azithromycin|azithromycin|mesh-list
55766351|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55909294|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
55909295|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
55909296|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55909297|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909313|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909316|NCT04270929|Folfirinox|folfirinox|mesh-list
55909317|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909318|NCT00401817|Bevacizumab|bevacizumab|mesh-list
55909319|NCT00401817|Rituximab|rituximab|mesh-list
55909320|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55909321|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909322|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55909323|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55909324|NCT00401817|Growth Substances|growth substances|mesh-ancestor
55909325|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909326|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
55909327|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
55909328|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909329|NCT04417179|Bupivacaine|bupivacaine|mesh-list
55909330|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
55909331|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
55766352|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766353|NCT02046070|Dexamethasone|dexamethasone|mesh-list
55766354|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
55766355|NCT02046070|Ixazomib|ixazomib|mesh-list
55766356|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214916|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56214917|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
56214918|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214919|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766357|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
55766358|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766359|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55766360|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55766362|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766363|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766364|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55766365|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766366|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
55766367|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
55766368|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766369|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55766370|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
55766371|NCT02046070|Hormones|hormones|mesh-ancestor
55766372|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766373|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55766374|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
55766375|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766376|NCT04992065|Evolocumab|evolocumab|mesh-list
55766377|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55766378|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55766379|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
55766380|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766381|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55766382|NCT01663857|Gemcitabine|gemcitabine|mesh-list
55766383|NCT01663857|Carboplatin|carboplatin|mesh-list
55766384|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766385|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55766386|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
55766387|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766388|NCT01663857|Antiviral Agents|antiviral agents|mesh-ancestor
55766389|NCT01663857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766390|NCT01663857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766391|NCT01663857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766392|NCT01663857|Immunologic Factors|immunologic factors|mesh-ancestor
55766393|NCT01663857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766394|NCT02414165|Flucytosine|flucytosine|mesh-list
55766395|NCT02414165|Bevacizumab|bevacizumab|mesh-list
55766396|NCT02414165|Temozolomide|temozolomide|mesh-list
55766397|NCT02414165|Lomustine|lomustine|mesh-list
55766398|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766399|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766400|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55766401|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55766402|NCT02414165|Growth Substances|growth substances|mesh-ancestor
55766403|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766404|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
55766405|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55766406|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
55909335|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909337|NCT02330796|Colchicine|colchicine|mesh-list
55909338|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
55909339|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909340|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
55909341|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
55766427|NCT04887831|Avelumab|avelumab|mesh-list
55766407|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766408|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
55766409|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766410|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
55766411|NCT02094898|Ketamine|ketamine|mesh-list
55766412|NCT02094898|Analgesics|analgesics|mesh-ancestor
55766413|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
55766414|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766415|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782950|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55766416|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55766417|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55766418|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
55766419|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
56214920|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
56214921|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214922|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766420|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766421|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55766422|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55766423|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766424|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766425|NCT04887831|Gemcitabine|gemcitabine|mesh-list
55766426|NCT04887831|Carboplatin|carboplatin|mesh-list
55766428|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766429|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55766430|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
55766431|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766432|NCT04887831|Antiviral Agents|antiviral agents|mesh-ancestor
55766433|NCT04887831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766436|NCT04887831|Immunologic Factors|immunologic factors|mesh-ancestor
55766437|NCT04887831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766438|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766439|NCT02414009|Leucovorin|leucovorin|mesh-list
55766440|NCT02414009|Fluorouracil|fluorouracil|mesh-list
55766441|NCT02414009|Capecitabine|capecitabine|mesh-list
55766442|NCT02414009|Irinotecan|irinotecan|mesh-list
55766443|NCT02414009|Temozolomide|temozolomide|mesh-list
55766445|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766446|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55766447|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766448|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766450|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766451|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55766452|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55766453|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766454|NCT02414009|Antidotes|antidotes|mesh-ancestor
55766455|NCT02414009|Protective Agents|protective agents|mesh-ancestor
55766456|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
55766457|NCT02414009|Vitamins|vitamins|mesh-ancestor
55766458|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
55766459|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55766460|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
55766461|NCT02413853|Leucovorin|leucovorin|mesh-list
55766462|NCT02413853|Bevacizumab|bevacizumab|mesh-list
55766463|NCT02413853|Fluorouracil|fluorouracil|mesh-list
55766464|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
55766465|NCT02413853|Calcium|calcium|mesh-list
55766466|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
55766467|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766468|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766469|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55766470|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55766471|NCT02413853|Growth Substances|growth substances|mesh-ancestor
55766475|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
55766476|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766477|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55766478|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766479|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
55766480|NCT02413853|Antidotes|antidotes|mesh-ancestor
55766481|NCT02413853|Protective Agents|protective agents|mesh-ancestor
55766482|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
55766484|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
55766485|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
55766486|NCT00704483|Sevelamer|sevelamer|mesh-list
55766487|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
55766488|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
55766489|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766491|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
55782951|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782952|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56214923|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
56214924|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214925|NCT01615913|Ketoconazole|ketoconazole|mesh-list
56214926|NCT01615913|Terbinafine|terbinafine|mesh-list
56214927|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
56214928|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56214929|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56214930|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56214931|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000868|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55782953|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55766492|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766493|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
55766494|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55766495|NCT03176537|Testosterone|testosterone|mesh-list
55766496|NCT03176537|Androgens|androgens|mesh-ancestor
55766498|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766499|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766500|NCT05511441|Aspirin|aspirin|mesh-list
55766501|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55766502|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55766503|NCT05511441|Analgesics|analgesics|mesh-ancestor
55766504|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
55766505|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766506|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766507|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766508|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55766509|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55909402|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
55766510|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55766511|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766512|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55766513|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55766514|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766516|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55766517|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55766518|NCT02413541|Polymyxins|polymyxins|mesh-list
55766519|NCT02413541|Polymyxin B|polymyxin b|mesh-list
55766520|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55766521|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766522|NCT02045836|Vaccines|vaccines|mesh-list
55766523|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55766524|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
55766525|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766526|NCT02412917|Valacyclovir|valacyclovir|mesh-list
55766527|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
55766528|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766529|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
55766530|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766531|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
55766532|NCT04588311|Hematinics|hematinics|mesh-ancestor
55766533|NCT02569437|Fluticasone|fluticasone|mesh-list
55766534|NCT02569437|Doxycycline|doxycycline|mesh-list
55766535|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
55766536|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55766537|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55766538|NCT02569437|Prednisolone|prednisolone|mesh-list
55766539|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
55766540|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55766541|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
55766542|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766543|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
55766544|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
55766545|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766549|NCT02569437|Hormones|hormones|mesh-ancestor
55766550|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766551|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56214932|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214933|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56214934|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
55766552|NCT02569437|Protective Agents|protective agents|mesh-ancestor
55766553|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55766554|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766555|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55766556|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766557|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
55766558|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55766559|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55766560|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55782954|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55766561|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55766562|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
55766563|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
55766564|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55766565|NCT02412449|Glycine|glycine|mesh-list
55766566|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
55766567|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766568|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766569|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766570|NCT02412059|Prednisolone|prednisolone|mesh-list
55766571|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55766572|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
55766574|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
55766575|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55766576|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
55766577|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766578|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
55766579|NCT02412059|Hormones|hormones|mesh-ancestor
55766580|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766581|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766582|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55766583|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766584|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
55766585|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
55766586|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766587|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55766588|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55766589|NCT02412059|Protective Agents|protective agents|mesh-ancestor
55766591|NCT05090085|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55766592|NCT05090085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55766593|NCT05090085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766594|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766595|NCT05090085|Hormone Antagonists|hormone antagonists|mesh-ancestor
55766596|NCT05090085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766597|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766598|NCT03175679|Interleukin-2|interleukin-2|mesh-list
55766599|NCT03175679|Tegafur|tegafur|mesh-list
55766600|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766601|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55766602|NCT03175679|Analgesics|analgesics|mesh-ancestor
55766603|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
55766604|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766605|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766606|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55766607|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
55766608|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766610|NCT05520645|Etomidate|etomidate|mesh-list
55766611|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55766612|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766613|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766614|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55766615|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
55766616|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
55766617|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55766619|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55766620|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
56000869|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
55766621|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766622|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55766623|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55766624|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766625|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
55766626|NCT05515185|Fludarabine|fludarabine|mesh-list
55766627|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766628|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
55766629|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766630|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55766631|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55766632|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
55766635|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55766636|NCT02044822|Rituximab|rituximab|mesh-list
55766637|NCT02044822|Idelalisib|idelalisib|mesh-list
55766638|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766639|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766640|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
55766641|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766642|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55766643|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766644|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766645|NCT03116555|Irinotecan|irinotecan|mesh-list
55766646|NCT03116555|Apatinib|apatinib|mesh-list
55766647|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55766648|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55766649|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766650|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766651|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766652|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55766653|NCT04871529|Gemcitabine|gemcitabine|mesh-list
55766654|NCT04871529|Carboplatin|carboplatin|mesh-list
55766655|NCT04871529|Avelumab|avelumab|mesh-list
55766656|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
55766657|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
55766658|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55766659|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766660|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55909633|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909634|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909635|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909636|NCT05076942|Cisplatin|cisplatin|mesh-list
55724036|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
55766661|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
55766662|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766664|NCT04871529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766665|NCT04871529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766666|NCT04871529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766667|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
55766668|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766669|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766670|NCT02044510|Mirabegron|mirabegron|mesh-list
55766671|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55766672|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55766673|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55766674|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
55766675|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766676|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766677|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766678|NCT02044510|Urological Agents|urological agents|mesh-ancestor
55766679|NCT02411903|Clopidogrel|clopidogrel|mesh-list
55766680|NCT02411903|Atorvastatin|atorvastatin|mesh-list
55766681|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55766682|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55766683|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55766684|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
55766685|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766686|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55766687|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55766688|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766689|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55766690|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55766691|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55766692|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55766693|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
55766695|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766696|NCT02411825|Metformin|metformin|mesh-list
56214935|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214936|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214937|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56214938|NCT01615978|Liraglutide|liraglutide|mesh-list
55766697|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55766698|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789062|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55766715|NCT04424901|Dipyridamole|dipyridamole|mesh-list
55766716|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55766717|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766718|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766719|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55766720|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
55766721|NCT05510895|Cetuximab|cetuximab|mesh-list
55766722|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766723|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766724|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
55766725|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55766726|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55766727|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
55766728|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766730|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55766731|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766732|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766734|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55766735|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766736|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766737|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55766738|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
55766739|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
55766740|NCT02410655|Oxytocin|oxytocin|mesh-list
55766741|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
55766742|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55766743|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766744|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55766745|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
55766746|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766747|NCT05510505|Antibodies|antibodies|mesh-list
55766748|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55766749|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
55766750|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766751|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
55766752|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55766753|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
55766754|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766756|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
55766757|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55766758|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
55766759|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766760|NCT04987775|Protective Agents|protective agents|mesh-ancestor
55766761|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766762|NCT04987775|Antidotes|antidotes|mesh-ancestor
55766763|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
55766764|NCT05514015|Rituximab|rituximab|mesh-list
56214939|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55766765|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766766|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
55766767|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766768|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55766769|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55766770|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
55766771|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766772|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766773|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55766774|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766776|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55766777|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55766778|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766779|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
55766780|NCT05520021|Nifedipine|nifedipine|mesh-list
55766781|NCT05520021|Analgesics|analgesics|mesh-ancestor
55909637|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909638|NCT03143946|Vitamins|vitamins|mesh-list
55909639|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
55909640|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766782|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
55766783|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782955|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782956|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
55782957|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782958|NCT05008679|Oseltamivir|oseltamivir|mesh-list
55782959|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
55766784|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766785|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
55766786|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766787|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55766788|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
55766789|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55766790|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55766791|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766792|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55766793|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
55766794|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55766795|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
55766796|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
55766797|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55766798|NCT02410031|Cyproterone|cyproterone|mesh-list
55766799|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
55766800|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55766801|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55766802|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55766803|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
55766804|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55766805|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766806|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55766809|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766810|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
55766811|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
55766812|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766813|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55766815|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766816|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766817|NCT05513625|Pritelivir|pritelivir|mesh-list
55766818|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
55766819|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766820|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766821|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766822|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55766823|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55766824|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55766825|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55766826|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
55766827|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766828|NCT02067676|Antacids|antacids|mesh-ancestor
55766829|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766830|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55766831|NCT05510115|Empagliflozin|empagliflozin|mesh-list
55766832|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56214940|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214941|NCT01615978|Incretins|incretins|mesh-ancestor
55766833|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766834|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55766835|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909693|NCT02327754|FYX-051|fyx-051|mesh-list
55766836|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55766837|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55766838|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766839|NCT02409407|Alprostadil|alprostadil|mesh-list
55766840|NCT02409407|Misoprostol|misoprostol|mesh-list
55766843|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55766844|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766845|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55782960|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766846|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55766847|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
55766848|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55766849|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
55766850|NCT02409407|Urological Agents|urological agents|mesh-ancestor
55766851|NCT02409563|Budesonide|budesonide|mesh-list
55766852|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766853|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55766854|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
55766855|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766856|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766857|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55766858|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
55766859|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
55766860|NCT02409563|Hormones|hormones|mesh-ancestor
55766861|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766862|NCT02409017|Insulin|insulin|mesh-list
55766863|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55766864|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766877|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
55766878|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766879|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55766880|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766881|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766882|NCT02065570|Adalimumab|adalimumab|mesh-list
55766883|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766884|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55766885|NCT02408705|Acetaminophen|acetaminophen|mesh-list
55766886|NCT02408705|Liraglutide|liraglutide|mesh-list
55766887|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55766889|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
55766890|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766891|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766892|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
55766893|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55766894|NCT02408705|Incretins|incretins|mesh-ancestor
55766895|NCT02408705|Hormones|hormones|mesh-ancestor
55766896|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766897|NCT05509569|Icatibant|icatibant|mesh-list
55766898|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55766899|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55766900|NCT05509569|Analgesics|analgesics|mesh-ancestor
55766901|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
55766902|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766903|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766904|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56214942|NCT01615978|Hormones|hormones|mesh-ancestor
55909705|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909706|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55909707|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55909708|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55909709|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909710|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55909711|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909712|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55909713|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214943|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56214944|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
56214945|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56214946|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
55766905|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55766906|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55766907|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55766908|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766909|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55766910|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55766911|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
55766913|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55766914|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766915|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
55766916|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
55766917|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766918|NCT05507697|Protective Agents|protective agents|mesh-ancestor
55766919|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782961|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782962|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766920|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
55766921|NCT05507697|Vitamins|vitamins|mesh-ancestor
55766922|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
55766923|NCT04292223|Pimavanserin|pimavanserin|mesh-list
55766924|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55766925|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55766926|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55766927|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55766928|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766929|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766930|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55766931|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55766932|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55766933|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
55766934|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766935|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766936|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55766937|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
55766938|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55766939|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55766940|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55766941|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766942|NCT03174041|Itraconazole|itraconazole|mesh-list
55766943|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
55909714|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909715|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55909716|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55909717|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55909718|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55909719|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
55909720|NCT03110952|Vaccines|vaccines|mesh-list
55909723|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
55766944|NCT03174041|Midazolam|midazolam|mesh-list
55766945|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55766946|NCT03174041|Simvastatin|simvastatin|mesh-list
55766947|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55766948|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55766949|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766950|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766951|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55766952|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55766953|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55766954|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55766955|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
55766956|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
55766957|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
55766958|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
55766959|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766960|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766961|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55766962|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55766963|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
55766964|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55766965|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55766966|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000870|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
55766967|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
55766968|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766969|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55766970|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55766971|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55766972|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
55766973|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55766974|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55766975|NCT02566005|Misoprostol|misoprostol|mesh-list
55766976|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55766977|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
55766978|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55766979|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766980|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55766982|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
55766983|NCT02408393|Ropivacaine|ropivacaine|mesh-list
55766984|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
55766985|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
55766986|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782963|NCT03090035|Interferons|interferons|mesh-list
55782964|NCT03090035|Ribavirin|ribavirin|mesh-list
55782965|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782966|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
55766987|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766988|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
55766989|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55766990|NCT05041335|Heparin|heparin|mesh-list
55766992|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55766993|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55766994|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766995|NCT03173963|Empagliflozin|empagliflozin|mesh-list
55766996|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55766997|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766998|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55766999|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767001|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
55767002|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767003|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
55767004|NCT03173417|Fludarabine|fludarabine|mesh-list
55767005|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55767006|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
55767007|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767008|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767009|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55767010|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
55767011|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767012|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767013|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55767014|NCT03173339|Remifentanil|remifentanil|mesh-list
55767015|NCT03173339|Sevoflurane|sevoflurane|mesh-list
55767016|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55767017|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55767018|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
55767019|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
55832427|NCT02109445|Gemcitabine|gemcitabine|mesh-list
55767021|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767022|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55767023|NCT03173339|Narcotics|narcotics|mesh-ancestor
55767024|NCT03173339|Analgesics|analgesics|mesh-ancestor
55767025|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
55767026|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767027|NCT03172871|Aripiprazole|aripiprazole|mesh-list
55767028|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
55767029|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55767030|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55767031|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55767032|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767033|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767034|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
55767035|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
56214948|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56000871|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
55767036|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767037|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767038|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55767039|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55767040|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
55767041|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55767042|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55767043|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55767044|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55767045|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
55767046|NCT02065336|Entecavir|entecavir|mesh-list
55767047|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
55767048|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767049|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
55767050|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767051|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55767052|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
55767055|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782967|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767056|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767057|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55767058|NCT02408003|Simendan|simendan|mesh-list
55767059|NCT02408003|Milrinone|milrinone|mesh-list
55767060|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55767061|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
55767062|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55767063|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55767065|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767066|NCT02408003|Protective Agents|protective agents|mesh-ancestor
55767067|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767068|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55767069|NCT05518929|Propofol|propofol|mesh-list
55767070|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55767071|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767072|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767073|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55767074|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
55767075|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
55767076|NCT02406911|Ticagrelor|ticagrelor|mesh-list
55767077|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55767078|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55767079|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55767080|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55767081|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
55767082|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767083|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767084|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767085|NCT03172793|Telavancin|telavancin|mesh-list
55767086|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55767087|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767088|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
55767089|NCT03116087|Testosterone|testosterone|mesh-list
55767090|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
55767091|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
55767092|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55767093|NCT03116087|Androgens|androgens|mesh-ancestor
55767095|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767096|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767097|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55767099|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
55767100|NCT02701985|Petesicatib|petesicatib|mesh-list
55767101|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767102|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767103|NCT02406521|Sorafenib|sorafenib|mesh-list
55767104|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55767105|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767106|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56214949|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214950|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56214951|NCT01616004|Analgesics|analgesics|mesh-ancestor
55767107|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767108|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767109|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55767110|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55767111|NCT02406053|Antioxidants|antioxidants|mesh-list
55767112|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767113|NCT02406053|Protective Agents|protective agents|mesh-ancestor
55767114|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767115|NCT02064166|Insulin|insulin|mesh-list
55767116|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55767117|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767118|NCT03171623|Globalagliatin|globalagliatin|mesh-list
55767119|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
55767120|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767121|NCT03171389|Ponatinib|ponatinib|mesh-list
55767122|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767123|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55767124|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767127|NCT05508633|Alverine|alverine|mesh-list
55767128|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
55782969|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782970|NCT05008367|Dexamethasone|dexamethasone|mesh-list
55782971|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782972|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
55782973|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
55767129|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
55909789|NCT01488487|Everolimus|everolimus|mesh-list
55767130|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767131|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767132|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
55767133|NCT04482257|Irinotecan|irinotecan|mesh-list
55767134|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55767135|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55767136|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767137|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767138|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767139|NCT05502705|Lidocaine|lidocaine|mesh-list
55767140|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
55767141|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
55767142|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767143|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767144|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
55767145|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767146|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55767147|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55767148|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55767149|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55767150|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767153|NCT04591431|Ipilimumab|ipilimumab|mesh-list
55767154|NCT04591431|Pertuzumab|pertuzumab|mesh-list
55767155|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55767156|NCT04591431|Everolimus|everolimus|mesh-list
55767157|NCT04591431|Atezolizumab|atezolizumab|mesh-list
55767158|NCT04591431|Lapatinib|lapatinib|mesh-list
55767159|NCT04591431|Palbociclib|palbociclib|mesh-list
55767160|NCT04591431|Vemurafenib|vemurafenib|mesh-list
55767161|NCT04591431|Maytansine|maytansine|mesh-list
55767162|NCT04591431|Ponatinib|ponatinib|mesh-list
55767163|NCT04591431|Entrectinib|entrectinib|mesh-list
55767164|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55767165|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767166|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55767168|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55767169|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
55767170|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767171|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55767172|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767173|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55767174|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
56214952|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
56214953|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214954|NCT01616069|Simendan|simendan|mesh-list
55767175|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
55767176|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
55767177|NCT05506137|Pilocarpine|pilocarpine|mesh-list
55767178|NCT05506137|Miotics|miotics|mesh-ancestor
55767179|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
55767180|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767181|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767182|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55767183|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55767184|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
55767185|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767186|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767187|NCT04742283|Timolol|timolol|mesh-list
55767188|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55767189|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55767190|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767191|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55767192|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55782974|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909827|NCT01515865|Midodrine|midodrine|mesh-list
55782975|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782978|NCT05008367|Hormones|hormones|mesh-ancestor
55782979|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782980|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55782981|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782982|NCT02342587|Lapatinib|lapatinib|mesh-list
55782983|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782984|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55782985|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782986|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767193|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
55767194|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767195|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767196|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55767197|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55767198|NCT04289805|Letrozole|letrozole|mesh-list
55767199|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767200|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55767201|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55767202|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767203|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767204|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55767205|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
55767206|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767207|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767208|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
55767209|NCT05508009|Melphalan|melphalan|mesh-list
55767210|NCT05508009|Rituximab|rituximab|mesh-list
55767211|NCT05508009|Fludarabine|fludarabine|mesh-list
55767212|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55767213|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
55767214|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767215|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767216|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55767217|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
55767218|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767219|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767220|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55767221|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55767222|NCT05505591|Cangrelor|cangrelor|mesh-list
55767223|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55767224|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55767225|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55767227|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
55767228|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767229|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214955|NCT01616069|Epinephrine|epinephrine|mesh-list
56214956|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56214957|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55767230|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767231|NCT05448807|Phentolamine|phentolamine|mesh-list
55767232|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55767233|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55767234|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
55767235|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767236|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767237|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767238|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55767239|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
55767240|NCT01662999|Saxagliptin|saxagliptin|mesh-list
55767241|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55767242|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767243|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55767244|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767245|NCT01662999|Incretins|incretins|mesh-ancestor
55767247|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767248|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55767249|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
55767250|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767251|NCT05366283|Sargramostim|sargramostim|mesh-list
55767253|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767254|NCT02565381|Nicotine|nicotine|mesh-list
55767255|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55767256|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
55767257|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767258|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767259|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55767260|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55767261|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
55767262|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767263|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767264|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
55767265|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
55767266|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55767267|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55767268|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767269|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55767270|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767271|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55767272|NCT02063698|Auranofin|auranofin|mesh-list
55767273|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767274|NCT04701333|Cabergoline|cabergoline|mesh-list
55767275|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55767276|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55909912|NCT04409431|Epinephrine|epinephrine|mesh-list
55767277|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
55767278|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
55767279|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767280|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767281|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767282|NCT04701034|Prednisolone|prednisolone|mesh-list
55767283|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
55767284|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55767285|NCT04701034|Antibodies|antibodies|mesh-list
55767286|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
55767287|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55767288|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767289|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
55767290|NCT04701034|Hormones|hormones|mesh-ancestor
55767291|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767292|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767293|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55767294|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767295|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
55767296|NCT01663623|Azathioprine|azathioprine|mesh-list
55767297|NCT01663623|Belimumab|belimumab|mesh-list
55767298|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
56214958|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
56214959|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56214960|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767299|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767300|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55767301|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767302|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55767303|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
55767304|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767305|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767307|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55767308|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767309|NCT05504967|Dexamethasone|dexamethasone|mesh-list
55767310|NCT05504967|Ropivacaine|ropivacaine|mesh-list
55767311|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767312|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
55782987|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55782988|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767313|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
55767314|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767315|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767316|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55767317|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
55767319|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767320|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55767321|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909922|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55909923|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
55909924|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909925|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55909926|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
55909927|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
55909928|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
55909929|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55909930|NCT01794507|Dexamethasone|dexamethasone|mesh-list
55909931|NCT01794507|Bortezomib|bortezomib|mesh-list
55909932|NCT01794507|Venetoclax|venetoclax|mesh-list
55909933|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767322|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
55767323|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
55767324|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767327|NCT02565147|Bivalirudin|bivalirudin|mesh-list
55767328|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
55767329|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55767330|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55767331|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767332|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
55767333|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55767334|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
55767335|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767336|NCT02061280|Fluticasone|fluticasone|mesh-list
55767338|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55767339|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55767340|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767341|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55767342|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
55767343|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767344|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767345|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55767346|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
55767347|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767348|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55767349|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55767350|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55767351|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55767352|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
55767353|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767354|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767355|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
55767356|NCT02061280|Hormones|hormones|mesh-ancestor
55767357|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767358|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
55767359|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
55767360|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767361|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767362|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55767364|NCT04664361|Niacin|niacin|mesh-list
55767365|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
55767366|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
55767367|NCT04664361|Vitamins|vitamins|mesh-ancestor
55767368|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
56214961|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214962|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55767369|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767370|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55767371|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
55767372|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767373|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55767374|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
55767375|NCT04698850|Ranibizumab|ranibizumab|mesh-list
55767376|NCT04698850|Aflibercept|aflibercept|mesh-list
55767377|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55767378|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55767379|NCT04698850|Growth Substances|growth substances|mesh-ancestor
55767380|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767381|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
55767382|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767383|NCT04698226|Temazepam|temazepam|mesh-list
55767384|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55782989|NCT02342509|Sevoflurane|sevoflurane|mesh-list
55782990|NCT02342509|Desflurane|desflurane|mesh-list
55782991|NCT02342509|Isoflurane|isoflurane|mesh-list
55767385|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767386|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767387|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55767388|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55767389|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55767390|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
55767391|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
55767392|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767393|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767394|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
55767395|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
55767396|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55767419|NCT05504265|Analgesics|analgesics|mesh-ancestor
55767420|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
55767421|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767422|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767423|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55767424|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55767425|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767426|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767427|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55767428|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767429|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767430|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
55767431|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
55767432|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767433|NCT04916613|Androgens|androgens|mesh-list
55767434|NCT04916613|Hormones|hormones|mesh-ancestor
55767435|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767436|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782992|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55767459|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55767460|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767461|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
55767462|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767463|NCT02560389|Levodopa|levodopa|mesh-list
55767464|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55767465|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55767466|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
55767467|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767468|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767469|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767470|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55767471|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
55767473|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767474|NCT02564211|Incretins|incretins|mesh-ancestor
55767475|NCT02564211|Hormones|hormones|mesh-ancestor
55910049|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55910050|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55910051|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55910052|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55910053|NCT00420771|Gabapentin|gabapentin|mesh-list
55910054|NCT00420771|Analgesics|analgesics|mesh-ancestor
55767476|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767477|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55767478|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
56214963|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55767479|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767480|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767481|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55767482|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
55767483|NCT04639245|Fludarabine|fludarabine|mesh-list
55767484|NCT04639245|Atezolizumab|atezolizumab|mesh-list
55767485|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55767486|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55767487|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55767488|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
55767489|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767490|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767491|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55767492|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
55767493|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767494|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767495|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55767497|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
55767498|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767499|NCT04465383|Propofol|propofol|mesh-list
55767500|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55767501|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767502|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767503|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55767504|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
55767505|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
55767506|NCT05500677|Lidocaine|lidocaine|mesh-list
55767507|NCT05500677|Fentanyl|fentanyl|mesh-list
55767508|NCT05500677|Tramadol|tramadol|mesh-list
55767509|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
55767510|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
55767511|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767512|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767513|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
55767514|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767515|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55767516|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55767517|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55767518|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55767519|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767520|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55767521|NCT05500677|Narcotics|narcotics|mesh-ancestor
55767522|NCT05500677|Analgesics|analgesics|mesh-ancestor
55767523|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55767524|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55767525|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
55767526|NCT04511013|Nivolumab|nivolumab|mesh-list
55767527|NCT04511013|Ipilimumab|ipilimumab|mesh-list
55767528|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55767529|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782993|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55767530|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55767531|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767532|NCT02093026|Folic Acid|folic acid|mesh-list
55767533|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
55767534|NCT02093026|Rituximab|rituximab|mesh-list
55767535|NCT02093026|Methotrexate|methotrexate|mesh-list
55767536|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55767537|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767538|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
55767539|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767540|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767541|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55767542|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
55767543|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55767544|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55767546|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767548|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767549|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55767550|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214964|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
56214965|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214966|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56214967|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
56214969|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
56214970|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56214971|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56214972|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
56214973|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55791302|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
55756385|NCT04854837|Remdesivir|remdesivir|mesh-list
55910132|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910133|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55910134|NCT04088305|Vancomycin|vancomycin|mesh-list
55910135|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55910136|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910137|NCT00427791|Rituximab|rituximab|mesh-list
55910138|NCT00427791|Etoposide|etoposide|mesh-list
55910139|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55910140|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910141|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
55767552|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767553|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
55767554|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
55767555|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767556|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55767557|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
55767558|NCT02093026|Hormones|hormones|mesh-ancestor
55767559|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767560|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55767561|NCT02093026|Protective Agents|protective agents|mesh-ancestor
55767562|NCT02093026|Hematinics|hematinics|mesh-ancestor
55767563|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
55767564|NCT02093026|Vitamins|vitamins|mesh-ancestor
55767565|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
55767566|NCT04697602|Colchicine|colchicine|mesh-list
55767568|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
55767569|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767570|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
55767571|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
55767572|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
55767573|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767574|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767575|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
55767576|NCT02059174|MK-1293|mk-1293|mesh-list
55767577|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55767578|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767579|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55767580|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
55767581|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767582|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55767583|NCT04417582|Liraglutide|liraglutide|mesh-list
55767584|NCT04417582|Orlistat|orlistat|mesh-list
55767585|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55767586|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767587|NCT04417582|Incretins|incretins|mesh-ancestor
55767588|NCT04417582|Hormones|hormones|mesh-ancestor
55767589|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767590|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767591|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767592|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55767593|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55767594|NCT02040766|Beclomethasone|beclomethasone|mesh-list
55767595|NCT02040766|Albuterol|albuterol|mesh-list
55767596|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
55767597|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
55767598|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767599|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767600|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55767601|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
55767603|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55767604|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55782994|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
55782995|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
55767605|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56214974|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56214975|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56214976|NCT01616069|Protective Agents|protective agents|mesh-ancestor
56214977|NCT01616108|Bupivacaine|bupivacaine|mesh-list
56214978|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
55767606|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55767607|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
55767608|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767609|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767610|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767611|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
55767612|NCT02040766|Hormones|hormones|mesh-ancestor
55767613|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767614|NCT02040532|Gabapentin|gabapentin|mesh-list
55767615|NCT02040532|Analgesics|analgesics|mesh-ancestor
55767616|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
55767617|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767618|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767621|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55767622|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767623|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55767624|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55767625|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55767626|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767627|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767628|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
55767629|NCT02039908|Methylphenidate|methylphenidate|mesh-list
55767630|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55767631|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767632|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55767633|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55767634|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55767635|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767636|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
55767637|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767638|NCT04417348|Tretinoin|tretinoin|mesh-list
55767639|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767640|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
55767641|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767642|NCT02058940|Exenatide|exenatide|mesh-list
55767643|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55767644|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767645|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55767646|NCT02058940|Incretins|incretins|mesh-ancestor
55767647|NCT02058940|Hormones|hormones|mesh-ancestor
55767648|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767650|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
55767651|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
55767652|NCT02058628|Azelaic acid|azelaic acid|mesh-list
55767653|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55767654|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767655|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55767656|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767657|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767658|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767659|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767660|NCT02058160|Insulin|insulin|mesh-list
55767661|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55767662|NCT02058160|Metformin|metformin|mesh-list
55767663|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
55767664|NCT02058160|Lixisenatide|lixisenatide|mesh-list
55767665|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55767666|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767667|NCT02088034|Metformin|metformin|mesh-list
55767668|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55767669|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767670|NCT02037256|Bortezomib|bortezomib|mesh-list
55767671|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214980|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56214981|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214982|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
56214983|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56214984|NCT01616186|Everolimus|everolimus|mesh-list
56214985|NCT01616186|Sorafenib|sorafenib|mesh-list
56214986|NCT01616186|Sunitinib|sunitinib|mesh-list
56214987|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56214988|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56214989|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
56214990|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56214991|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56214992|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000872|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
55767672|NCT02035696|Vaccines|vaccines|mesh-list
55767673|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
55767674|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767675|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
55782996|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767676|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
55767677|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55767678|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55767679|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767680|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767681|NCT02057458|Urological Agents|urological agents|mesh-ancestor
55767682|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
55767684|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767685|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767686|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
55767687|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767689|NCT02056288|Ropivacaine|ropivacaine|mesh-list
55767690|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
55767691|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
55767693|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767695|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767697|NCT02056288|Narcotics|narcotics|mesh-ancestor
55767698|NCT02056288|Analgesics|analgesics|mesh-ancestor
55767699|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55767700|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55767701|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
55767702|NCT03115697|Rifaximin|rifaximin|mesh-list
55767703|NCT03115697|Lactulose|lactulose|mesh-list
55767704|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55767705|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767706|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55767707|NCT03115775|Vitamin D|vitamin d|mesh-list
55767708|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
55767709|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
55767710|NCT03115775|Vitamins|vitamins|mesh-list
55767711|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
55767712|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767713|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55767714|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55767715|NCT02404259|Ritonavir|ritonavir|mesh-list
55767716|NCT02404259|Lopinavir|lopinavir|mesh-list
55767717|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55767718|NCT02404259|Tenofovir|tenofovir|mesh-list
55767719|NCT02404259|Efavirenz|efavirenz|mesh-list
55767720|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55767721|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55767722|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
56214993|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56214994|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56214995|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55767723|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767724|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767726|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55767727|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
55767728|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767729|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55767730|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55767731|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55767732|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55767733|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55767734|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55767735|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55767736|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55767737|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55767738|NCT03170687|Calpastatin|calpastatin|mesh-list
55767739|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55767740|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
55767741|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767742|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767743|NCT03169751|Caffeine|caffeine|mesh-list
55767744|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55767745|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767746|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55767747|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910289|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767748|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767749|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55767750|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55767751|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
55767752|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767753|NCT02403713|Fluticasone|fluticasone|mesh-list
55767754|NCT02403713|Xhance|xhance|mesh-list
55767755|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
55767756|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767757|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55767758|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
55767759|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767760|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767763|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767764|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55767767|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55767768|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
55767769|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767770|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767771|NCT02700815|Diclofenac|diclofenac|mesh-list
55767772|NCT02700815|Capsaicin|capsaicin|mesh-list
55767773|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55767774|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55767775|NCT02700815|Analgesics|analgesics|mesh-ancestor
55767776|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
55767777|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767778|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767779|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767780|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767781|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55767782|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767783|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767784|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
55767785|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767786|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
55767787|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55767788|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
56214997|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
56214998|NCT01616225|Hormones|hormones|mesh-list
56214999|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215000|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215001|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56215002|NCT01616355|Eusol|eusol|mesh-list
56215003|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
56215004|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215005|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
55791336|NCT04850417|Aspirin|aspirin|mesh-list
55767789|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55767790|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767791|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55767792|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55767793|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55767794|NCT02402621|Fentanyl|fentanyl|mesh-list
55767795|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55767796|NCT02402621|Narcotics|narcotics|mesh-ancestor
55767797|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767798|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767799|NCT02402621|Analgesics|analgesics|mesh-ancestor
55767800|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
55767801|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767802|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55767803|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55767804|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
55767805|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
55767806|NCT04481789|Furosemide|furosemide|mesh-list
55767807|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
55767808|NCT04481789|Edaravone|edaravone|mesh-list
55767809|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55767810|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55767811|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55767812|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
55767813|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767814|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55767815|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55767816|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767817|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
55767818|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55767819|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55767820|NCT04481789|Urological Agents|urological agents|mesh-ancestor
55782997|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782998|NCT03079271|Benzocaine|benzocaine|mesh-list
55782999|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
55783000|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
55767821|NCT04481789|Diuretics|diuretics|mesh-ancestor
55767822|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
55767823|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767824|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55767825|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55767826|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55767828|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55767829|NCT04481789|Protective Agents|protective agents|mesh-ancestor
55767830|NCT02402465|Fluticasone|fluticasone|mesh-list
55767832|NCT02402465|Azelastine|azelastine|mesh-list
55767833|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767834|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55767835|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
55767836|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767838|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55767839|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
55767840|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767841|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55767842|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
55767843|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215006|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
56215007|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56215008|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55767844|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767845|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55767846|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55767847|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
55767848|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
55767849|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767850|NCT02402231|Omalizumab|omalizumab|mesh-list
55767851|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55767853|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
55767854|NCT02402543|Acetaminophen|acetaminophen|mesh-list
55767855|NCT02402543|Dexamethasone|dexamethasone|mesh-list
55767856|NCT02402543|Ketamine|ketamine|mesh-list
55767857|NCT02402543|Gabapentin|gabapentin|mesh-list
55767858|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767859|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
55767860|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
55767861|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767862|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767863|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55767864|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
55767865|NCT02402543|Hormones|hormones|mesh-ancestor
55767866|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767867|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55767868|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767869|NCT02402543|Analgesics|analgesics|mesh-ancestor
55767870|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
55767871|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55767873|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
55767874|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
55767875|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767876|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55767877|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55767878|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767879|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767880|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55767881|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
55767882|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
55767883|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55767884|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55767885|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55767886|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
55767887|NCT02401295|Itraconazole|itraconazole|mesh-list
55767888|NCT02401295|Celecoxib|celecoxib|mesh-list
55767889|NCT02401295|Tretinoin|tretinoin|mesh-list
55767890|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55767891|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55783001|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767892|NCT02401295|Analgesics|analgesics|mesh-ancestor
55767893|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
55910387|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910388|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910389|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
55910390|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910391|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
55910392|NCT00383643|Zolpidem|zolpidem|mesh-list
55910393|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55767894|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767895|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767896|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767897|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767898|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55767899|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55767900|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767901|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767902|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
55767903|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767904|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55767905|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55767906|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55767907|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
55767908|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767909|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55767910|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215009|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215010|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215011|NCT01616381|Urological Agents|urological agents|mesh-ancestor
56215012|NCT01616407|Methylphenidate|methylphenidate|mesh-list
56215013|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56215014|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56215015|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215016|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56215017|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56215018|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55791344|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767911|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
55767912|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767927|NCT00708305|Listerine|listerine|mesh-list
55767928|NCT00708305|Fluorides|fluorides|mesh-list
55767929|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
55767930|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
55767931|NCT00708305|Protective Agents|protective agents|mesh-ancestor
55767932|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767933|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55767934|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767935|NCT03169127|Ibuprofen|ibuprofen|mesh-list
55767936|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55767937|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55767938|NCT03169127|Analgesics|analgesics|mesh-ancestor
55767939|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
55767940|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767941|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767942|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55767943|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767944|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55767945|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767946|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767947|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55767948|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
55767949|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55767950|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
55767951|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55767952|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767953|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55767954|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55767955|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767956|NCT02418533|Menotropins|menotropins|mesh-list
55767957|NCT02418533|Hormones|hormones|mesh-list
55767958|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55767959|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215019|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767960|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767961|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55767962|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
55767963|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55767964|NCT02418065|Testosterone|testosterone|mesh-list
55767965|NCT02418065|Androgens|androgens|mesh-ancestor
55767966|NCT02418065|Hormones|hormones|mesh-ancestor
55767967|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767968|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767969|NCT05058443|Denosumab|denosumab|mesh-list
55767970|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55767971|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767972|NCT02400281|Cytarabine|cytarabine|mesh-list
55767973|NCT02400281|Fludarabine|fludarabine|mesh-list
55767974|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
55767975|NCT02400281|Etoposide|etoposide|mesh-list
55767976|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
55767977|NCT02400281|Azacitidine|azacitidine|mesh-list
55767978|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
55767979|NCT02400281|Idarubicin|idarubicin|mesh-list
55767980|NCT02400281|Crenolanib|crenolanib|mesh-list
55767981|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55767982|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55767983|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
55767985|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55767986|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
55767987|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767988|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
55767989|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767990|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55767991|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55767992|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55767993|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767994|NCT02400281|Analgesics|analgesics|mesh-ancestor
55767995|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
55767996|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767997|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55767998|NCT02055976|Ezetimibe|ezetimibe|mesh-list
55767999|NCT02055976|Bococizumab|bococizumab|mesh-list
55768000|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55768001|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55768002|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
55768003|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768004|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55768005|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
55768006|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55768007|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55768008|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
55768009|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
55768010|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768011|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768012|NCT04406259|Verapamil|verapamil|mesh-list
55768013|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55768014|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55768015|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55768016|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768017|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55768018|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768019|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
55768020|NCT04603911|Dexamethasone|dexamethasone|mesh-list
55768021|NCT04603911|Clonidine|clonidine|mesh-list
55768022|NCT04603911|Epinephrine|epinephrine|mesh-list
55768023|NCT04603911|Bupivacaine|bupivacaine|mesh-list
55768024|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55768025|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
55768026|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
55768027|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768028|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768029|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55768030|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
55768031|NCT04603911|Hormones|hormones|mesh-ancestor
55768032|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768033|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55768034|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783002|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783003|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
55768035|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
55768037|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768038|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
55768039|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55768040|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55768041|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
55768042|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768043|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768044|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55768045|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55768046|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55768047|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
55768048|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
55768049|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
55768050|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55768051|NCT04603911|Analgesics|analgesics|mesh-ancestor
55768052|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55768053|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
55768054|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55768058|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768059|NCT02699099|Vitamin A|vitamin a|mesh-list
55768060|NCT02699099|Vaccines|vaccines|mesh-list
55768061|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
55768062|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768063|NCT02699099|Vitamins|vitamins|mesh-ancestor
55768064|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
55768065|NCT04088409|Adalimumab|adalimumab|mesh-list
55768066|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55768067|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768068|NCT02400047|Dexamethasone|dexamethasone|mesh-list
55768069|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
55768070|NCT02400047|Ketoprofen|ketoprofen|mesh-list
55768071|NCT02400047|BB 1101|bb 1101|mesh-list
55768072|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55768073|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
55768074|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
55768075|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768076|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768077|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55768078|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
55768079|NCT02400047|Hormones|hormones|mesh-ancestor
55768080|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768081|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55768082|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768083|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
55768084|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768085|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768086|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55768087|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55768088|NCT02400047|Analgesics|analgesics|mesh-ancestor
55768089|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
55768090|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768091|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55768093|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55768094|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
55768095|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768096|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
55768097|NCT02698865|Protective Agents|protective agents|mesh-ancestor
55768098|NCT05499897|Anesthetics|anesthetics|mesh-list
55768099|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768100|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768101|NCT05497323|Adapalene|adapalene|mesh-list
55768102|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55768103|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55768104|NCT05497323|Analgesics|analgesics|mesh-ancestor
55768105|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
55768106|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768107|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215021|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215022|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
56215023|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215024|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
56215025|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55783004|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783005|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55783006|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768108|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55768109|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768110|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
55768111|NCT02417207|Entecavir|entecavir|mesh-list
55768112|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
55768113|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768114|NCT02698475|Ustekinumab|ustekinumab|mesh-list
55768115|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
55768116|NCT02399657|Dexamethasone|dexamethasone|mesh-list
55768117|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55768118|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
55768119|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
55768120|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768121|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768122|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55768124|NCT02399657|Hormones|hormones|mesh-ancestor
55768125|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768126|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55768127|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768130|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768131|NCT04278729|Apixaban|apixaban|mesh-list
55768132|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55768133|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
55768134|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55768135|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
55768136|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768137|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768138|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
55768139|NCT03177317|Dexamethasone|dexamethasone|mesh-list
55768140|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55768141|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
55768142|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
55768143|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768144|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768145|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55768146|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
55768147|NCT03177317|Hormones|hormones|mesh-ancestor
55768148|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768149|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55768150|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768151|NCT03177239|Nivolumab|nivolumab|mesh-list
55768152|NCT03177239|Ipilimumab|ipilimumab|mesh-list
55768153|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768154|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768155|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55768156|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768157|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
55768158|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55768159|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55768160|NCT04480775|Prednisolone|prednisolone|mesh-list
55768161|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
55768162|NCT04480775|Triamcinolone|triamcinolone|mesh-list
55768163|NCT04480775|Bupivacaine|bupivacaine|mesh-list
55768164|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55768165|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
55768166|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
55768167|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
55768168|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768169|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768170|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
55768171|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768172|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215026|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
56215027|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
56215028|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
55791361|NCT04843943|Bevacizumab|bevacizumab|mesh-list
55768173|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
55768174|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
55768175|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55768176|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
55783007|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55783008|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768178|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768179|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55768180|NCT04480775|Protective Agents|protective agents|mesh-ancestor
55768181|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55768182|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768183|NCT02416817|Thrombin|thrombin|mesh-list
55768184|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
55768185|NCT02416817|Coagulants|coagulants|mesh-ancestor
55768186|NCT02399189|Methotrexate|methotrexate|mesh-list
55768187|NCT02399189|Temozolomide|temozolomide|mesh-list
55768188|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768189|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
55768190|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768191|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768192|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55768193|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
55768194|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55768195|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55768196|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
55768197|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768198|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
55768199|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768201|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768202|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55768203|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55768204|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
55768205|NCT03176849|Vitamin D|vitamin d|mesh-list
55768206|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
55768207|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
55768208|NCT03176849|Vitamins|vitamins|mesh-list
55768209|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
55768210|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768211|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55768212|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55768213|NCT03106571|Methamphetamine|methamphetamine|mesh-list
55768214|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55768215|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768216|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
55768217|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
55768218|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768219|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
55768220|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768221|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768222|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
55768223|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55768224|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55768225|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55768226|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55768227|NCT03177083|Interferons|interferons|mesh-list
55768228|NCT03177083|Interferon-beta|interferon-beta|mesh-list
55910612|NCT01473953|Hormones|hormones|mesh-ancestor
55768229|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
55768230|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
55768231|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768233|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768234|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
55768235|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768236|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55768237|NCT03629925|Gemcitabine|gemcitabine|mesh-list
55768238|NCT03629925|Carboplatin|carboplatin|mesh-list
55768239|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768240|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55768242|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768243|NCT03629925|Antiviral Agents|antiviral agents|mesh-ancestor
55783009|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768244|NCT03629925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768245|NCT03629925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768246|NCT03629925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768247|NCT03629925|Immunologic Factors|immunologic factors|mesh-ancestor
55768248|NCT03629925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768250|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55768252|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768253|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768254|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55768255|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55768256|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
55768257|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768258|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768259|NCT02697617|Pioglitazone|pioglitazone|mesh-list
55768260|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55768261|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768262|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
55768263|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55768264|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55768265|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768267|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
55768268|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768269|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55768270|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55768271|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768272|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768274|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
55768275|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768276|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768277|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55768279|NCT04272801|Letrozole|letrozole|mesh-list
55768280|NCT04272801|Anastrozole|anastrozole|mesh-list
55768281|NCT04272801|Exemestane|exemestane|mesh-list
55768282|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768283|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55768284|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55768285|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768286|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910728|NCT01472081|Nivolumab|nivolumab|mesh-list
55768287|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55768288|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
55768289|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768290|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768291|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55768292|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55768293|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55768294|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55768295|NCT02396303|Carbetocin|carbetocin|mesh-list
55768296|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
55768297|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55768298|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768299|NCT01918527|Capecitabine|capecitabine|mesh-list
55768300|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
55768301|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55768302|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
55768303|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768304|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768305|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55768306|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768307|NCT02397863|Cannabidiol|cannabidiol|mesh-list
55768308|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
55768309|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
55768310|NCT04357587|Capecitabine|capecitabine|mesh-list
55768311|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768312|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768313|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56215029|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215030|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
56215031|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55768314|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
55768315|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768316|NCT04058717|Nicotine|nicotine|mesh-list
55768317|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55768318|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
55768319|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768320|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768322|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55768323|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
55768324|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768325|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768327|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768328|NCT02397395|Simeprevir|simeprevir|mesh-list
55768329|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
55768330|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768331|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
55768332|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768333|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768334|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55768335|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55768336|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768337|NCT03168191|Menthol|menthol|mesh-list
55768338|NCT03168191|Nicotine|nicotine|mesh-list
55768339|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55768340|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
55768341|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768342|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768343|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55768344|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55768345|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
55768347|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768348|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
55768349|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
55768350|NCT05496075|Orlistat|orlistat|mesh-list
55768351|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768352|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768353|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55768354|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55768355|NCT04280055|Psilocybin|psilocybin|mesh-list
55768356|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
55768357|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804798|NCT05497843|Chiauranib|chiauranib|mesh-list
55768358|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55768359|NCT05499117|Fluoxetine|fluoxetine|mesh-list
55768360|NCT05499117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55768361|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55768362|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55768363|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768364|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768365|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
55768366|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768367|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55768368|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
55768369|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55768370|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55768371|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55768372|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768373|NCT05494593|Rituximab|rituximab|mesh-list
55768374|NCT05494593|Methotrexate|methotrexate|mesh-list
55768375|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
55768376|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55768377|NCT05494593|Antibodies|antibodies|mesh-list
55768378|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
55768379|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55768380|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768381|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768382|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
56215032|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56215033|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215034|NCT01616485|Urological Agents|urological agents|mesh-ancestor
56215035|NCT01616615|Aspirin|aspirin|mesh-list
55791366|NCT04843943|Growth Substances|growth substances|mesh-ancestor
55768383|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768384|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768385|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55768386|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
55768387|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783011|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55783012|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55768388|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55768389|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
55768390|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768391|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
55768392|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768393|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55768394|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768395|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55768396|NCT04311723|Anesthetics|anesthetics|mesh-list
55768397|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768398|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768399|NCT05498337|Calcium|calcium|mesh-list
55768400|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55768401|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768402|NCT01663233|Amlodipine|amlodipine|mesh-list
55768403|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55768404|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55768405|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55768406|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55768407|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768408|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55768409|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768410|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
55768411|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55768412|NCT05494281|Anesthetics|anesthetics|mesh-list
55768413|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
55768414|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768415|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768416|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
55768417|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768418|NCT05494047|Vaccines|vaccines|mesh-list
55768419|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
55768420|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768421|NCT05493969|Lamivudine|lamivudine|mesh-list
55768423|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55768424|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55768425|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768426|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768427|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
55768428|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768429|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55768430|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55768431|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55768432|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55768434|NCT05493657|Clopidogrel|clopidogrel|mesh-list
55768435|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55768436|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55768437|NCT05493657|Analgesics|analgesics|mesh-ancestor
55768438|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
55768439|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768440|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768441|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215036|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56215037|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55768442|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768443|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55768444|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55910859|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768445|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768446|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55768447|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55768448|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768449|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
55768450|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55768451|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55768452|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55783013|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783014|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768453|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
55768454|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768455|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
55768456|NCT05493267|Interleukin-2|interleukin-2|mesh-list
55768457|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768458|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55768459|NCT05493267|Analgesics|analgesics|mesh-ancestor
55768460|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
55768461|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768462|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768463|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55768464|NCT05492565|Tenofovir|tenofovir|mesh-list
55768465|NCT05492565|Emtricitabine|emtricitabine|mesh-list
55768466|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
55768467|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768468|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55768469|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55768470|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768471|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768472|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55768473|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55768474|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
55768475|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
55768476|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55768477|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
55768478|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55768479|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768480|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55768481|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55768483|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55768493|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
55768494|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768495|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768496|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
55768497|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768498|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55768499|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55910902|NCT00527943|Vorapaxar|vorapaxar|mesh-list
55768500|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55768501|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55768502|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768503|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55768504|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
55768505|NCT04176705|Hormones|hormones|mesh-ancestor
55768506|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768507|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768508|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
55768509|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768510|NCT05492019|Doxycycline|doxycycline|mesh-list
55768511|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55768512|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768513|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
55768514|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56215040|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215041|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768515|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55768516|NCT05491785|Oxycodone|oxycodone|mesh-list
55768517|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55768518|NCT05491785|Narcotics|narcotics|mesh-ancestor
55768519|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768520|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768521|NCT05491785|Analgesics|analgesics|mesh-ancestor
55783015|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
55768522|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
55910938|NCT00460551|Zalutumumab|zalutumumab|mesh-list
55768523|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768524|NCT05484687|Anesthetics|anesthetics|mesh-list
55768525|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768526|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768527|NCT05484375|Capecitabine|capecitabine|mesh-list
55768528|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55768529|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
55768530|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768531|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768532|NCT05480007|Metformin|metformin|mesh-list
55768533|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55768534|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55768535|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768536|NCT05480007|Incretins|incretins|mesh-ancestor
55768537|NCT05480007|Hormones|hormones|mesh-ancestor
55768538|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768539|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55768540|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
55768541|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768542|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768543|NCT05489601|Oxycodone|oxycodone|mesh-list
55768544|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55768545|NCT05489601|Narcotics|narcotics|mesh-ancestor
55768546|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768547|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768548|NCT05489601|Analgesics|analgesics|mesh-ancestor
55768549|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
55768552|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
55768553|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768561|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768563|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
55768564|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768565|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
55768566|NCT05483439|Carboplatin|carboplatin|mesh-list
55768567|NCT05483439|Docetaxel|docetaxel|mesh-list
55768568|NCT05483439|Trastuzumab|trastuzumab|mesh-list
55768569|NCT05483439|Epirubicin|epirubicin|mesh-list
55768570|NCT05483439|Pertuzumab|pertuzumab|mesh-list
55768571|NCT05483439|Antibodies|antibodies|mesh-list
55768572|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55768573|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768574|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
55768575|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768576|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768577|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55768578|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
55768579|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768580|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768581|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55768582|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
55768583|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
55768584|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
55768585|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56215042|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215043|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56215044|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56215045|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55791374|NCT04843553|Niacinamide|niacinamide|mesh-list
55768586|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55768587|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55768588|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55768589|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768590|NCT03748095|Tazobactam|tazobactam|mesh-list
55768591|NCT03748095|Piperacillin|piperacillin|mesh-list
55768592|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55768593|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768594|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55783016|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768595|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768596|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768598|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768599|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768600|NCT05478291|Vitamin D|vitamin d|mesh-list
55768601|NCT05478291|Vitamins|vitamins|mesh-ancestor
55768602|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
55768603|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768604|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55768605|NCT04543071|Gemcitabine|gemcitabine|mesh-list
55768607|NCT04543071|Cemiplimab|cemiplimab|mesh-list
55768608|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55768609|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768610|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
55768611|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
55768612|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
55768613|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768614|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55768615|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
55768616|NCT04543071|Antiviral Agents|antiviral agents|mesh-ancestor
55768617|NCT04543071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768618|NCT04543071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768619|NCT04543071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768620|NCT04543071|Immunologic Factors|immunologic factors|mesh-ancestor
55768621|NCT04543071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768622|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768623|NCT05487963|Tofacitinib|tofacitinib|mesh-list
55911083|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768624|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768627|NCT05487885|Ketamine|ketamine|mesh-list
55768628|NCT05487885|Analgesics|analgesics|mesh-ancestor
55768629|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
55768630|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768631|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768632|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55768633|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55768634|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
55768635|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
55768636|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768637|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55768638|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55768639|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768640|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768641|NCT03605901|Methadone|methadone|mesh-list
55768642|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55768643|NCT03605901|Narcotics|narcotics|mesh-ancestor
55768644|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768645|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768647|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
55768648|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768649|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
55768650|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
55768651|NCT05487807|Nicotine|nicotine|mesh-list
55768652|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55768653|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
55791377|NCT04843553|Vitamins|vitamins|mesh-ancestor
55768654|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768655|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768656|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55768657|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55768658|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
55768659|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768660|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768661|NCT05487261|Valsartan|valsartan|mesh-list
55768662|NCT05487261|Enalapril|enalapril|mesh-list
55768663|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55768664|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55768665|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55768666|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55768667|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768668|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55768669|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
55768670|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768671|NCT03602859|Niraparib|niraparib|mesh-list
55768672|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55768673|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768674|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768675|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768676|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55768677|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
55911096|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55911097|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
55911098|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55911099|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
55911100|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55911101|NCT01588496|Evolocumab|evolocumab|mesh-list
55768678|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768679|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
55768680|NCT05476731|Clotrimazole|clotrimazole|mesh-list
55768681|NCT05476731|Miconazole|miconazole|mesh-list
55768682|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768683|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55768684|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55768685|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55768687|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768688|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55768689|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
55768690|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55768691|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768692|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55768693|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55768694|NCT05482113|Bupivacaine|bupivacaine|mesh-list
55768695|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
55768696|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
55768697|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768698|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768700|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768701|NCT05481957|Vortioxetine|vortioxetine|mesh-list
55768702|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
55768703|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55768704|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55768705|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55768707|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768708|NCT05481957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55768709|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55768710|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55768711|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768712|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768713|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
55768714|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55768715|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55768716|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55768717|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55768719|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
55768720|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
55768721|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768722|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768723|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
55768724|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768725|NCT05476341|Bevacizumab|bevacizumab|mesh-list
55768726|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56215046|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215047|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56215048|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55768727|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768729|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55768730|NCT05476341|Growth Substances|growth substances|mesh-ancestor
55768731|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768732|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
55768733|NCT05481723|Norepinephrine|norepinephrine|mesh-list
55768734|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55768735|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55768736|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
55768737|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783017|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55783018|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55768738|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768739|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768740|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
55768741|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
55768742|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768743|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55768744|NCT05481645|Paclitaxel|paclitaxel|mesh-list
55768745|NCT05481645|Carboplatin|carboplatin|mesh-list
55768746|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55768747|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768748|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
55768749|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
55768750|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
55768751|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768752|NCT04272021|Methylphenidate|methylphenidate|mesh-list
55768753|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55768754|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768755|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55768756|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55768757|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55768758|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768759|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
55768760|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768761|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
55804838|NCT02559505|Vaccines|vaccines|mesh-list
55768762|NCT03434769|Fludarabine|fludarabine|mesh-list
55768763|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768764|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
55768765|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768766|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768767|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55768770|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768771|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55768774|NCT03426891|Vorinostat|vorinostat|mesh-list
55768775|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55768776|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768777|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768778|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55768779|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
55768780|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768781|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768782|NCT02697773|Tanezumab|tanezumab|mesh-list
55768783|NCT02697773|Analgesics|analgesics|mesh-ancestor
55768784|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
55768785|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768786|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768787|NCT02394821|Metronidazole|metronidazole|mesh-list
55768788|NCT02394821|Polihexanide|polihexanide|mesh-list
55768789|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768790|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55768791|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55768792|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55768793|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
56215050|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
56215051|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56215052|NCT01616680|Antibodies|antibodies|mesh-list
56215053|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
55768794|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55768795|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55768796|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768797|NCT05745857|Bevacizumab|bevacizumab|mesh-list
55768798|NCT05745857|Cetuximab|cetuximab|mesh-list
55768799|NCT05745857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768800|NCT05745857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768801|NCT05745857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55768802|NCT05745857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55768803|NCT05745857|Growth Substances|growth substances|mesh-ancestor
55768804|NCT05745857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768805|NCT05745857|Growth Inhibitors|growth inhibitors|mesh-ancestor
55768807|NCT05745779|Vitamins|vitamins|mesh-list
55768808|NCT05745779|Vitamin B 12|vitamin b 12|mesh-list
55768809|NCT05745779|Hydroxocobalamin|hydroxocobalamin|mesh-list
55783019|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
55768810|NCT05745779|Micronutrients|micronutrients|mesh-ancestor
55768811|NCT05745779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768812|NCT05745779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55768813|NCT05745779|Vitamin B Complex|vitamin b complex|mesh-ancestor
55768814|NCT05745779|Hematinics|hematinics|mesh-ancestor
55768815|NCT02394197|Chloroquine|chloroquine|mesh-list
55768816|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
55768818|NCT02394197|Amebicides|amebicides|mesh-ancestor
55768819|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55768820|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55768821|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768822|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
55768823|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768824|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55768825|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55768826|NCT02394197|Analgesics|analgesics|mesh-ancestor
55768827|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
55768828|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768829|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768830|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55768831|NCT02394197|Filaricides|filaricides|mesh-ancestor
55768832|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
55768833|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
55768835|NCT02394119|Ofatumumab|ofatumumab|mesh-list
55768836|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768837|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768838|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
55911211|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55911212|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55911215|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768839|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768840|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768841|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
55768842|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55768843|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
55768844|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768848|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55768849|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55768850|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768851|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
55768852|NCT02393963|Coagulants|coagulants|mesh-ancestor
55768853|NCT03115619|Pirfenidone|pirfenidone|mesh-list
55768854|NCT03115619|Analgesics|analgesics|mesh-ancestor
55768855|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
55768856|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768857|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768858|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55768859|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55768860|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55768861|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768862|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768864|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55768865|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215054|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56215055|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
56215056|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
56215057|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215058|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56215059|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215061|NCT01616732|Androgens|androgens|mesh-ancestor
56215062|NCT01616732|Hormones|hormones|mesh-ancestor
56215063|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215064|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215065|NCT01616784|Insulin|insulin|mesh-list
56215066|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56215067|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
56215068|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215069|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215070|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
56215071|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791384|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55768866|NCT05745467|Povidone-Iodine|povidone-iodine|mesh-list
55768867|NCT05745467|Povidone|povidone|mesh-list
55768868|NCT05745467|Plasma Substitutes|plasma substitutes|mesh-ancestor
55768869|NCT05745467|Blood Substitutes|blood substitutes|mesh-ancestor
55768870|NCT05745467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55768871|NCT05745467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768872|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
55768873|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55768874|NCT02693171|Dinutuximab|dinutuximab|mesh-list
55768875|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768876|NCT05745233|Pembrolizumab|pembrolizumab|mesh-list
55768877|NCT05745233|Nivolumab|nivolumab|mesh-list
55768878|NCT05745233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768879|NCT05745233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768880|NCT05745233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55768881|NCT05745233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768882|NCT02392793|Irinotecan|irinotecan|mesh-list
55768883|NCT02392793|Temozolomide|temozolomide|mesh-list
55768884|NCT02392793|Talazoparib|talazoparib|mesh-list
55768885|NCT02392793|Lenograstim|lenograstim|mesh-list
55783020|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768886|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55768887|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55768888|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768889|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768890|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768891|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55768892|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
55768893|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768894|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55768895|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
55768896|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55768897|NCT03167177|Leucovorin|leucovorin|mesh-list
55768898|NCT03167177|Paclitaxel|paclitaxel|mesh-list
55768899|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
55768900|NCT03167177|Bevacizumab|bevacizumab|mesh-list
55768901|NCT03167177|Fluorouracil|fluorouracil|mesh-list
55768902|NCT03167177|Capecitabine|capecitabine|mesh-list
55768903|NCT03167177|Nivolumab|nivolumab|mesh-list
55768904|NCT03167177|Avelumab|avelumab|mesh-list
56215072|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56215073|NCT01616875|Cisplatin|cisplatin|mesh-list
56215074|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215075|NCT01616888|Paclitaxel|paclitaxel|mesh-list
55768905|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55768906|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768907|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
55768908|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
55768909|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
55768910|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911271|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911272|NCT00463437|Vaccines|vaccines|mesh-list
55911273|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55911274|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
55911275|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911276|NCT01466153|Rituximab|rituximab|mesh-list
55911277|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55911278|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911279|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911280|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
55911281|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726244|NCT02288741|Melphalan|melphalan|mesh-list
55768911|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768912|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
55768913|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768914|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768915|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55768916|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
55768917|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55768926|NCT03167177|Antidotes|antidotes|mesh-ancestor
55768927|NCT03167177|Protective Agents|protective agents|mesh-ancestor
55768928|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
55768929|NCT03167177|Vitamins|vitamins|mesh-ancestor
55768930|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
55768931|NCT02392169|Methylphenidate|methylphenidate|mesh-list
55768932|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55768933|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768934|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55768935|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55768936|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55768937|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768938|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
55768939|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768940|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
55768941|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55768942|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
55768943|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768944|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
55768945|NCT03166865|Protective Agents|protective agents|mesh-ancestor
55768946|NCT03166787|Tadalafil|tadalafil|mesh-list
55768947|NCT03166787|Charcoal|charcoal|mesh-list
55768948|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
55768949|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768950|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768951|NCT03166787|Protective Agents|protective agents|mesh-ancestor
55768952|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
55768953|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55768954|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55768955|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768956|NCT03166787|Urological Agents|urological agents|mesh-ancestor
55768957|NCT03166787|Antidotes|antidotes|mesh-ancestor
55768958|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
55768959|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
55789063|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55768960|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768969|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
55768970|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768971|NCT03167957|Amphotericin B|amphotericin b|mesh-list
55768973|NCT03167957|Amebicides|amebicides|mesh-ancestor
55768974|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55768975|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55768976|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768977|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55768978|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
55768979|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
56215076|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56215077|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215078|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
55768980|NCT03166397|Nivolumab|nivolumab|mesh-list
55768981|NCT03166397|Fludarabine|fludarabine|mesh-list
55768982|NCT03166397|Ipilimumab|ipilimumab|mesh-list
55768983|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55768984|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
55768985|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768986|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55768987|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55768988|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
55768989|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768990|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768991|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55768992|NCT03166397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768993|NCT03166397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55768995|NCT05745935|Oxytocics|oxytocics|mesh-ancestor
55768996|NCT05745935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55768997|NCT05745935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768998|NCT05232227|Primaquine|primaquine|mesh-list
55768999|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
55769000|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55769001|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55769002|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769003|NCT05744375|Trastuzumab|trastuzumab|mesh-list
55769004|NCT05744375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769005|NCT05744375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769006|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
55769007|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769008|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769009|NCT02552355|Metformin|metformin|mesh-list
55769010|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55769011|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769012|NCT02551731|Cannabidiol|cannabidiol|mesh-list
55769013|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
55769014|NCT04479657|Cefuroxime|cefuroxime|mesh-list
55769015|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
55769016|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55769017|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769018|NCT05475873|Ondansetron|ondansetron|mesh-list
55769019|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
55769020|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
55769021|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769022|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769023|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55769024|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
55769025|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
55769026|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55769027|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
55769028|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769029|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769030|NCT05475873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55769031|NCT05475873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55769032|NCT05475873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55769033|NCT05475873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55769034|NCT05475873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55769037|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55769038|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55769039|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769041|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
56052263|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
55769042|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769043|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
55769044|NCT02542605|Erenumab|erenumab|mesh-list
55769045|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55769046|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769047|NCT02542605|Analgesics|analgesics|mesh-ancestor
55769050|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215080|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
55769051|NCT02542605|Growth Substances|growth substances|mesh-ancestor
55769052|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
55769053|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769054|NCT02723955|Gemcitabine|gemcitabine|mesh-list
55769055|NCT02723955|Paclitaxel|paclitaxel|mesh-list
55769056|NCT02723955|Docetaxel|docetaxel|mesh-list
55769057|NCT02723955|Carboplatin|carboplatin|mesh-list
55769058|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
55769059|NCT02723955|Fluorouracil|fluorouracil|mesh-list
55769060|NCT02723955|Pemetrexed|pemetrexed|mesh-list
55769061|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55769062|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769064|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
55769065|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
55769066|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769067|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55769068|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
55769069|NCT02723955|Antiviral Agents|antiviral agents|mesh-ancestor
55769070|NCT02723955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769071|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769072|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769073|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
55769074|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769075|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769076|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55769077|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55769078|NCT03299049|Rilpivirine|rilpivirine|mesh-list
55769079|NCT03299049|Cabotegravir|cabotegravir|mesh-list
55769080|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55769081|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55769082|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769083|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769084|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
55769086|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55769087|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55769088|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55769089|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55769090|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
55769092|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769093|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769094|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55769095|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769096|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769097|NCT02550795|Dexamethasone|dexamethasone|mesh-list
55769098|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
55769099|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769100|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
55769101|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
55769102|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911602|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
55911603|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55911604|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55911605|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55911606|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55911607|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55911664|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769103|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769104|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55769105|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
55769106|NCT02550795|Hormones|hormones|mesh-ancestor
55769107|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769108|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55769109|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769110|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55783021|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783022|NCT05007587|Leucovorin|leucovorin|mesh-list
55783023|NCT05007587|Fluorouracil|fluorouracil|mesh-list
55783024|NCT05007587|Raltitrexed|raltitrexed|mesh-list
55769111|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55769112|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55769113|NCT02550795|Analgesics|analgesics|mesh-ancestor
55769114|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
55769115|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55769116|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55769117|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55769118|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
55769119|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215081|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215083|NCT01616927|Somatostatin|somatostatin|mesh-list
56215084|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769120|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769121|NCT02541903|Afatinib|afatinib|mesh-list
55769122|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769123|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55769124|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769125|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769126|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55769127|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55769128|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55769129|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769130|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55769131|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55769134|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55769135|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55769136|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769137|NCT02688647|Belumosudil|belumosudil|mesh-list
55769138|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55769139|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769140|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769141|NCT05453799|Antibodies|antibodies|mesh-list
55769142|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
55769143|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55769144|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
55726469|NCT03475459|Melatonin|melatonin|mesh-list
55769145|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769146|NCT05453487|Vaccines|vaccines|mesh-list
55769147|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
55769148|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769149|NCT05646719|Phentolamine|phentolamine|mesh-list
55769150|NCT05646719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55769151|NCT05646719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55769152|NCT05646719|Pilocarpine|pilocarpine|mesh-list
55769153|NCT05646719|Miotics|miotics|mesh-ancestor
55769154|NCT05646719|Autonomic Agents|autonomic agents|mesh-ancestor
55769155|NCT05646719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769156|NCT05646719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769157|NCT05646719|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55769158|NCT05646719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55769159|NCT05646719|Cholinergic Agents|cholinergic agents|mesh-ancestor
55769160|NCT05646719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769161|NCT05646719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769162|NCT05646719|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55769163|NCT05646719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55769164|NCT05646719|Adrenergic Agents|adrenergic agents|mesh-ancestor
55769165|NCT05646719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55769167|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
55769168|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769169|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
55769170|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55911666|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55911667|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55911668|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55911669|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911670|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911671|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
55911672|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911673|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911674|NCT00477087|Molgramostim|molgramostim|mesh-list
55911675|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
55911676|NCT00477087|Sargramostim|sargramostim|mesh-list
55911677|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
55911687|NCT01473589|Vitamin D|vitamin d|mesh-list
55726535|NCT00701623|Heparin|heparin|mesh-list
55769171|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
55769172|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55769173|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769174|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55769175|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55769176|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55783025|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
55769177|NCT05451615|Abatacept|abatacept|mesh-list
55769178|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
55769179|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55769180|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769181|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769182|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769183|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
55769184|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769185|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769186|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56215085|NCT01616927|Hormones|hormones|mesh-ancestor
56215086|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215087|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215088|NCT01616966|Remifentanil|remifentanil|mesh-list
55769187|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769188|NCT05727527|Anesthetics|anesthetics|mesh-list
55769189|NCT05727527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55769190|NCT05727527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769192|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55769193|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
55769194|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55769195|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769196|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55769197|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55769198|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
55769199|NCT05626439|Alprazolam|alprazolam|mesh-list
55769200|NCT05626439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55769201|NCT05626439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55769202|NCT05626439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769203|NCT05626439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55769204|NCT05626439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55769205|NCT05626439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55769207|NCT05626439|GABA Agents|gaba agents|mesh-ancestor
55769208|NCT05626439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769209|NCT05626439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769210|NCT02547987|Carboplatin|carboplatin|mesh-list
55769211|NCT02547987|Docetaxel|docetaxel|mesh-list
55769212|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769213|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
55769214|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
55769215|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
55769216|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769217|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
55769218|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769219|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769220|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
55769221|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769222|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769223|NCT02540265|Meloxicam|meloxicam|mesh-list
55769224|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55769225|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55769226|NCT02540265|Analgesics|analgesics|mesh-ancestor
55769227|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
55769228|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769229|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769230|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769231|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769232|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55769233|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55769234|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769235|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769236|NCT02684357|Ustekinumab|ustekinumab|mesh-list
55769237|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55769238|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
55769239|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
55769240|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769241|NCT03115073|Clotrimazole|clotrimazole|mesh-list
55769242|NCT03115073|Miconazole|miconazole|mesh-list
55769243|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55769244|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769245|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
55769246|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55769247|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55769248|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783027|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
55769249|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769250|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55769251|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
55769252|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215090|NCT01616966|Sevoflurane|sevoflurane|mesh-list
55769253|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769254|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55769255|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55769257|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55769258|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769259|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
55769260|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
55769261|NCT03165929|Analgesics|analgesics|mesh-ancestor
55769262|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
55769263|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769264|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769265|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55769266|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55769267|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55911740|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55911741|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911742|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55911743|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55769268|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769269|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55769270|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769271|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769273|NCT03206073|Tremelimumab|tremelimumab|mesh-list
55769274|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769275|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769276|NCT03190941|Aldesleukin|aldesleukin|mesh-list
55769277|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
55769278|NCT03190941|Fludarabine|fludarabine|mesh-list
55769280|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
55769281|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769283|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55769284|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
55769285|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769286|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769287|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55769288|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55769289|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55769290|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
55769291|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769293|NCT03142893|Dexamethasone|dexamethasone|mesh-list
55769294|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
55769295|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
55769296|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55769297|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55769298|NCT03142893|Hormones|hormones|mesh-list
55769299|NCT03142893|Cosyntropin|cosyntropin|mesh-list
55769300|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55769301|NCT03142893|BB 1101|bb 1101|mesh-list
55769302|NCT03142893|Ganirelix|ganirelix|mesh-list
55769303|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769304|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
55769305|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
55769306|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769307|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769308|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55769309|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
55769310|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769311|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55769312|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769313|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
55769314|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769315|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769316|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
55769317|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769318|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55769319|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55769320|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55769322|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55769323|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55769324|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55769326|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55769327|NCT05428215|Estrogens|estrogens|mesh-ancestor
55769328|NCT05428215|Hormones|hormones|mesh-ancestor
56215091|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56215092|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215093|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215094|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56215095|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
56215096|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
55911755|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55911756|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55911757|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
56215097|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56215098|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56215099|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56215100|NCT01616966|Narcotics|narcotics|mesh-ancestor
55769329|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769330|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769331|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55769332|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
55769333|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55769334|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55769336|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55769337|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769338|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
55769339|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
55769340|NCT03073785|Fluorouracil|fluorouracil|mesh-list
55769341|NCT03073785|Capecitabine|capecitabine|mesh-list
55769342|NCT03073785|Imidazole|imidazole|mesh-list
55769343|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
55769344|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769345|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55769346|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769347|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769348|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
55769349|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769350|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55769351|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769352|NCT02420613|Sirolimus|sirolimus|mesh-list
55769353|NCT02420613|Vorinostat|vorinostat|mesh-list
55769354|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55769355|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769357|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769358|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
55769359|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769360|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
55769361|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769362|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55769363|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769364|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769365|NCT02546193|Misoprostol|misoprostol|mesh-list
55769366|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55769367|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
55769368|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55769369|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769370|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55769371|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55769372|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
55769373|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
55769374|NCT01661595|Tadalafil|tadalafil|mesh-list
55769375|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
55769376|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55769377|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55769379|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769380|NCT01661595|Urological Agents|urological agents|mesh-ancestor
55769381|NCT03004443|Infliximab|infliximab|mesh-list
55769382|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
55769383|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55769384|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56215101|NCT01616966|Analgesics|analgesics|mesh-ancestor
56215102|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
56215103|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215104|NCT01616992|Bupivacaine|bupivacaine|mesh-list
55791421|NCT03594175|Reteplase|reteplase|mesh-list
55769385|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
55769386|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55769387|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769388|NCT02957097|Gabapentin|gabapentin|mesh-list
55769389|NCT02957097|Analgesics|analgesics|mesh-ancestor
55769390|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
55769391|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769392|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769393|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
55769394|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55769395|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55769396|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55769397|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55783028|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769398|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55769399|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55769401|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769402|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
55769403|NCT03165383|Morphine|morphine|mesh-list
55769404|NCT03165383|Bupivacaine|bupivacaine|mesh-list
55769405|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
55769406|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
55769407|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55769408|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769409|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
55769410|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769411|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55769412|NCT03165383|Narcotics|narcotics|mesh-ancestor
55769413|NCT03165383|Analgesics|analgesics|mesh-ancestor
55769414|NCT03162185|Citalopram|citalopram|mesh-list
55769415|NCT03162185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55769416|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55769417|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55769418|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769419|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911810|NCT04082767|Analgesics|analgesics|mesh-ancestor
55769420|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
55769421|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769422|NCT03162185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55769424|NCT03162185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55769425|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55769426|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55769427|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769428|NCT05324501|Lomustine|lomustine|mesh-list
55769431|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769433|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
55769434|NCT05286437|Letrozole|letrozole|mesh-list
55769435|NCT05286437|Lenvatinib|lenvatinib|mesh-list
55769436|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769437|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769438|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55769439|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55769440|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769441|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769442|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55769443|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
55769444|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769445|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769446|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55769447|NCT05426031|Protamines|protamines|mesh-list
55769448|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
55769449|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769450|NCT05426031|Coagulants|coagulants|mesh-ancestor
55769451|NCT05265299|Aspirin|aspirin|mesh-list
56215105|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
55769452|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55769453|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55769454|NCT05265299|Analgesics|analgesics|mesh-ancestor
55769455|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
55769456|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769457|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769458|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769459|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769460|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55769461|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55769462|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769463|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55769464|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55769465|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769466|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
55769467|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
55769468|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55769469|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55769470|NCT05464173|Fulvestrant|fulvestrant|mesh-list
55769471|NCT05464173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55769472|NCT05464173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769473|NCT05464173|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55769474|NCT05464173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55769475|NCT05464173|Hormone Antagonists|hormone antagonists|mesh-ancestor
55832428|NCT02109445|Paclitaxel|paclitaxel|mesh-list
55769476|NCT05464173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769477|NCT05464173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769478|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55769479|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55769480|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769482|NCT02683187|Hormones|hormones|mesh-ancestor
55769483|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769484|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55769485|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
55769486|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052264|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
55911884|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55769487|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769488|NCT05515601|Mirikizumab|mirikizumab|mesh-list
55769489|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55769490|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55769491|NCT05515601|Analgesics|analgesics|mesh-ancestor
55769492|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
55769493|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769494|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769495|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769496|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769497|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55769499|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
55769500|NCT02683109|Olodaterol|olodaterol|mesh-list
55769501|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55769502|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
55769503|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769504|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769505|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55769506|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
55769507|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
55769508|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55769509|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
55769510|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769511|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769512|NCT02544321|Bromocriptine|bromocriptine|mesh-list
55769513|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55769514|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55769515|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
55769516|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769517|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769518|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
55769519|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
55769520|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769521|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769522|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
56215106|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
56215107|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215108|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215109|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
55791426|NCT03103399|Carbidopa|carbidopa|mesh-list
55769523|NCT02533401|Rituximab|rituximab|mesh-list
55769524|NCT02533401|Fludarabine|fludarabine|mesh-list
55769525|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769526|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
55769527|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769528|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769529|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55769531|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769532|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769533|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55769534|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769535|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
55769536|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55769537|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769538|NCT05178173|Ethanol|ethanol|mesh-list
55769545|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55769547|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769548|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769549|NCT02536833|Lorecivivint|lorecivivint|mesh-list
55769550|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769551|NCT02680847|Naltrexone|naltrexone|mesh-list
55769552|NCT02680847|Oxycodone|oxycodone|mesh-list
55769555|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55769557|NCT02680847|Analgesics|analgesics|mesh-ancestor
55769558|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
55769559|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769560|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55769561|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55769569|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
55769570|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
55769571|NCT03959241|Methotrexate|methotrexate|mesh-list
55769572|NCT03959241|Tacrolimus|tacrolimus|mesh-list
55769573|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769574|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
55769575|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769576|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769577|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55769578|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
55769579|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769580|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769581|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55769582|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55769583|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
55769584|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55769585|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55769586|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
55769588|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769589|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55769590|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55769591|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55769592|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55769593|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55769594|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
55769595|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55769596|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769597|NCT05127395|Acyclovir|acyclovir|mesh-list
55769598|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
55769599|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769600|NCT02532855|Metformin|metformin|mesh-list
55769601|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55769602|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
55769603|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55769604|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911885|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911886|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55911887|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55911888|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911889|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911890|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55911891|NCT00485433|Epinephrine|epinephrine|mesh-list
55911892|NCT00485433|Bupivacaine|bupivacaine|mesh-list
55911893|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
55911894|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
56215110|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769605|NCT02532855|Incretins|incretins|mesh-ancestor
55769606|NCT02532855|Hormones|hormones|mesh-ancestor
55769607|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769608|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55769609|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
55769610|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769611|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769612|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55783029|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55783030|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783031|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55783032|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
55769613|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
55769614|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
55769615|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769616|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
55769617|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769618|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769619|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55769620|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
55769621|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769622|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769623|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55769624|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769625|NCT02530125|Pidilizumab|pidilizumab|mesh-list
55769626|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769627|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769628|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55769629|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55769630|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769633|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
55769634|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
55769635|NCT05421819|Vitamins|vitamins|mesh-list
55769636|NCT05421819|Calcium|calcium|mesh-list
55769637|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
55769638|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769639|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55769640|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55769641|NCT02055820|Prednisone|prednisone|mesh-list
55769642|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
55769643|NCT02055820|Rituximab|rituximab|mesh-list
55769644|NCT02055820|Doxorubicin|doxorubicin|mesh-list
55769645|NCT02055820|Vincristine|vincristine|mesh-list
55769646|NCT02055820|Venetoclax|venetoclax|mesh-list
55769647|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
55769648|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769649|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
55769650|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769651|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769652|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55769653|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
55769654|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769655|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769656|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55769657|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769658|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55769662|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769664|NCT02055820|Hormones|hormones|mesh-ancestor
55769665|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769666|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55769667|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55769668|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
55769669|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
55769670|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
55769671|NCT05408559|Sulforaphane|sulforaphane|mesh-list
55769672|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55769673|NCT05408559|Protective Agents|protective agents|mesh-ancestor
55769674|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769675|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769676|NCT05435547|Dexamethasone|dexamethasone|mesh-list
56215112|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56215113|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769677|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769678|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
55769679|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
55769680|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769681|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769682|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55769683|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
55769684|NCT05435547|Hormones|hormones|mesh-ancestor
56052265|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
55769685|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769686|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55769687|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769688|NCT02055352|Fluticasone|fluticasone|mesh-list
55769689|NCT02055352|Budesonide|budesonide|mesh-list
55769690|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55769691|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769692|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55769693|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
55769694|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769695|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769696|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55769697|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
55769698|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
55769699|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55769700|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
55769701|NCT02055352|Hormones|hormones|mesh-ancestor
55769702|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769703|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55769704|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55769705|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55769706|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
55769707|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769708|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769710|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55769711|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769712|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769713|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769714|NCT04693156|Bupivacaine|bupivacaine|mesh-list
55769715|NCT04693156|Prilocaine|prilocaine|mesh-list
55769716|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
55769717|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
55769718|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55769719|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769720|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
55769721|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769722|NCT01374425|Leucovorin|leucovorin|mesh-list
55769723|NCT01374425|Bevacizumab|bevacizumab|mesh-list
55769724|NCT01374425|Fluorouracil|fluorouracil|mesh-list
55769725|NCT01374425|Capecitabine|capecitabine|mesh-list
55769726|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
55769727|NCT01374425|Irinotecan|irinotecan|mesh-list
55769728|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769729|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769733|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769734|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
55769735|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
55769736|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769737|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55769739|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
55769740|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55769741|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55769742|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769743|NCT01374425|Antidotes|antidotes|mesh-ancestor
55769744|NCT01374425|Protective Agents|protective agents|mesh-ancestor
55769745|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
55769746|NCT01374425|Vitamins|vitamins|mesh-ancestor
55769747|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
55769748|NCT02085460|Rebamipide|rebamipide|mesh-list
55769749|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55769750|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56215114|NCT01617135|Levodopa|levodopa|mesh-list
56215115|NCT01617135|Carbidopa|carbidopa|mesh-list
55912095|NCT01451645|Colchicine|colchicine|mesh-list
55912096|NCT01451645|Allopurinol|allopurinol|mesh-list
55791432|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55769751|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
55769752|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769753|NCT02085460|Protective Agents|protective agents|mesh-ancestor
55769754|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783033|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783034|NCT05007587|Antidotes|antidotes|mesh-ancestor
55769755|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769756|NCT03164291|Rifabutin|rifabutin|mesh-list
55769757|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55769758|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769759|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55769760|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
55769761|NCT02084134|Dexamethasone|dexamethasone|mesh-list
55769762|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
55769763|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
55769764|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55769765|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55769766|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55769767|NCT02084134|BB 1101|bb 1101|mesh-list
55769768|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55769769|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
55769770|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
55769771|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769772|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769773|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55769775|NCT02084134|Hormones|hormones|mesh-ancestor
55769776|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769777|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55769778|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769779|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
55769780|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769781|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769782|NCT01374269|Acetaminophen|acetaminophen|mesh-list
55769784|NCT01374269|Naproxen|naproxen|mesh-list
55769785|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55769787|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55769788|NCT01374269|Analgesics|analgesics|mesh-ancestor
55769789|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
55769790|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769791|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769792|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
55769793|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769794|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55769795|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55769796|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769797|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769798|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
55769799|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
55769800|NCT05036681|Futibatinib|futibatinib|mesh-list
55769801|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769802|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769805|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769806|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
55769807|NCT03163589|Hematinics|hematinics|mesh-ancestor
55769808|NCT03163277|Emtricitabine|emtricitabine|mesh-list
55769809|NCT03163277|Maraviroc|maraviroc|mesh-list
55769810|NCT03163277|Darunavir|darunavir|mesh-list
55769811|NCT03163277|Cobicistat|cobicistat|mesh-list
55769812|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
55769813|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
55769814|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769815|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55769816|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55769817|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769818|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769819|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55769820|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55769821|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55769822|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55769823|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55791434|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769824|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55769825|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55769826|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
55769827|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55769828|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55783035|NCT05007587|Protective Agents|protective agents|mesh-ancestor
55783036|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
55769829|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
55769830|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769831|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769832|NCT05401097|Azacitidine|azacitidine|mesh-list
55769833|NCT05401097|Venetoclax|venetoclax|mesh-list
55769834|NCT05401097|Ivosidenib|ivosidenib|mesh-list
55769835|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55769836|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
55769837|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769838|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769839|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769840|NCT05676749|Aldesleukin|aldesleukin|mesh-list
55769841|NCT05676749|Pembrolizumab|pembrolizumab|mesh-list
55769842|NCT05676749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769843|NCT05676749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769844|NCT05676749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55769845|NCT05676749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55769846|NCT05676749|Antiviral Agents|antiviral agents|mesh-ancestor
55769847|NCT05676749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769848|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55769849|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55769850|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769851|NCT02679755|Letrozole|letrozole|mesh-list
55769852|NCT02679755|Palbociclib|palbociclib|mesh-list
55769853|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769854|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55769855|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55769856|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769857|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769858|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55769859|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
55769860|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769861|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769864|NCT02675231|Fulvestrant|fulvestrant|mesh-list
55769865|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769866|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769867|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55769868|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55727191|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
55769869|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55769870|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
55769871|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769872|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769873|NCT03163121|Vaccines|vaccines|mesh-list
55769874|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
55769875|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769876|NCT03114371|Oxytocin|oxytocin|mesh-list
55769877|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
55769878|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55769879|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769880|NCT04905407|Azacitidine|azacitidine|mesh-list
55769881|NCT04905407|Venetoclax|venetoclax|mesh-list
55769882|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55769883|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
55769884|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769885|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769886|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769887|NCT03162653|Allopurinol|allopurinol|mesh-list
55769888|NCT03162653|Mannitol|mannitol|mesh-list
55769889|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
55769890|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769891|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769892|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
55769893|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769894|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56215116|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56215117|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56215118|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56215119|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
56215120|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791437|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769895|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
55769896|NCT03162653|Protective Agents|protective agents|mesh-ancestor
55769897|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769898|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55769899|NCT03162653|Diuretics|diuretics|mesh-ancestor
55769900|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
55783037|NCT05007587|Vitamins|vitamins|mesh-ancestor
55783038|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
55769901|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
55769902|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769903|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769904|NCT04708067|Atezolizumab|atezolizumab|mesh-list
55912108|NCT01451645|Protective Agents|protective agents|mesh-ancestor
55912109|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912110|NCT01450007|Dexamethasone|dexamethasone|mesh-list
55912111|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
55912112|NCT01450007|Ropivacaine|ropivacaine|mesh-list
55912113|NCT01450007|BB 1101|bb 1101|mesh-list
55912114|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55912115|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
55912116|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
55912117|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769905|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769906|NCT03114215|Biotin|biotin|mesh-list
55769907|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
55769908|NCT03114215|Vitamins|vitamins|mesh-ancestor
55769909|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
55769910|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769911|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
55769912|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55769913|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769914|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769915|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55769916|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55769917|NCT05675813|Azacitidine|azacitidine|mesh-list
55769918|NCT05675813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55769919|NCT05675813|Antimetabolites|antimetabolites|mesh-ancestor
55769920|NCT05675813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769921|NCT05675813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769922|NCT05675813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769924|NCT03158129|Carboplatin|carboplatin|mesh-list
55769925|NCT03158129|Docetaxel|docetaxel|mesh-list
55769926|NCT03158129|Nivolumab|nivolumab|mesh-list
55769927|NCT03158129|Pemetrexed|pemetrexed|mesh-list
55769928|NCT03158129|Ipilimumab|ipilimumab|mesh-list
55769929|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769930|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
55769932|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
55769933|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769934|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769935|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55769937|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55769938|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55769939|NCT02397083|Everolimus|everolimus|mesh-list
55769940|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
55769941|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769942|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769943|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
55769944|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769945|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55769946|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
55769947|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55769948|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55769949|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55769950|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55769955|NCT05675579|Pembrolizumab|pembrolizumab|mesh-list
55912153|NCT01687712|Hormones|hormones|mesh-ancestor
55769960|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769961|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769962|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55769963|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55769964|NCT01932125|Growth Substances|growth substances|mesh-ancestor
55769965|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769966|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
55769967|NCT01740557|Aldesleukin|aldesleukin|mesh-list
55769968|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
56215121|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215122|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215123|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56215124|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215125|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55769969|NCT01740557|Fludarabine|fludarabine|mesh-list
55769970|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
55769971|NCT01740557|Interleukin-2|interleukin-2|mesh-list
55769972|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769973|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
55769974|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769975|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55769976|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55769977|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
55769978|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769979|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769980|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55769981|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55769982|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
55769983|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55769984|NCT01740557|Analgesics|analgesics|mesh-ancestor
55769985|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
55769986|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769987|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55769988|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55769989|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
55769990|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55769991|NCT01738139|Ipilimumab|ipilimumab|mesh-list
55769992|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
55769993|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769994|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769995|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55769996|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912171|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912172|NCT01453153|Antiviral Agents|antiviral agents|mesh-ancestor
55912173|NCT01453153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912174|NCT01453153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769997|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55769998|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769999|NCT01729091|Lenalidomide|lenalidomide|mesh-list
55770000|NCT01729091|Melphalan|melphalan|mesh-list
55770001|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
55770002|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55770003|NCT01729091|Elotuzumab|elotuzumab|mesh-list
55770004|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
55770005|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770006|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55770007|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55770008|NCT01729091|Growth Substances|growth substances|mesh-ancestor
55770009|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
55770010|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770011|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55770012|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
55770013|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770014|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55770015|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770017|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55770018|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55770019|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770020|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
55770021|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
55770023|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770024|NCT01515527|Cytarabine|cytarabine|mesh-list
55770025|NCT01515527|Decitabine|decitabine|mesh-list
55770027|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55770030|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770031|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
55770032|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770033|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770034|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
56215126|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
56215127|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
56215128|NCT01617200|Olanzapine|olanzapine|mesh-list
56215129|NCT01617200|Asenapine|asenapine|mesh-list
56215130|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
56215131|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
56215132|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215133|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770035|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770036|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770037|NCT05675501|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55770038|NCT05675501|Dermatologic Agents|dermatologic agents|mesh-ancestor
55770039|NCT02670551|Cariprazine|cariprazine|mesh-list
55770040|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55770041|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55770042|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770043|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770044|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55770045|NCT01430351|Metformin|metformin|mesh-list
55770046|NCT01430351|Mefloquine|mefloquine|mesh-list
55770047|NCT01430351|Temozolomide|temozolomide|mesh-list
55770048|NCT01430351|Memantine|memantine|mesh-list
55770049|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55770050|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770051|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55770052|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
55770053|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770054|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770055|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55912206|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
55770056|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55770057|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
55770058|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770059|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55770060|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55770061|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
55770062|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55770063|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55770064|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770065|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
55770066|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55770067|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770068|NCT05675033|Bevacizumab|bevacizumab|mesh-list
55770069|NCT05675033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55770070|NCT05675033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770071|NCT05675033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55804858|NCT05497063|Renal Agents|renal agents|mesh-ancestor
55770072|NCT05675033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55770073|NCT05675033|Growth Substances|growth substances|mesh-ancestor
55770074|NCT05675033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770075|NCT05675033|Growth Inhibitors|growth inhibitors|mesh-ancestor
55770077|NCT05674877|Ketamine|ketamine|mesh-list
55770078|NCT05674877|Analgesics, Opioid|analgesics, opioid|mesh-list
55770079|NCT05674877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55770080|NCT05674877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770081|NCT05674877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770082|NCT05674877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55770083|NCT05674877|Analgesics|analgesics|mesh-ancestor
55770084|NCT05674877|Sensory System Agents|sensory system agents|mesh-ancestor
55770085|NCT05674877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770086|NCT05674877|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55770087|NCT05674877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55770088|NCT05674877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55770089|NCT05674877|Adrenergic Agents|adrenergic agents|mesh-ancestor
55770090|NCT05674877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770091|NCT05674877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770092|NCT05674877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55770093|NCT05674877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55770094|NCT05674877|Anesthetics, General|anesthetics, general|mesh-ancestor
55770095|NCT05674877|Anesthetics|anesthetics|mesh-ancestor
55770096|NCT05674877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55770097|NCT05674877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55770098|NCT05674877|Narcotics|narcotics|mesh-ancestor
55770100|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55770103|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770104|NCT04479527|Apatinib|apatinib|mesh-list
55770105|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770106|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55770107|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770108|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770110|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
55770111|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
55770112|NCT02391077|Povidone|povidone|mesh-list
55770113|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770114|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55770115|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
55770116|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
55770117|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
55770118|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55770119|NCT02390921|Hematinics|hematinics|mesh-ancestor
55770120|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
55770121|NCT02390843|Topotecan|topotecan|mesh-list
55770122|NCT02390843|Simvastatin|simvastatin|mesh-list
55770123|NCT02390843|Lenograstim|lenograstim|mesh-list
55770124|NCT02390843|Mitogens|mitogens|mesh-list
55783040|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770126|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
55770127|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770128|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55770129|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55770130|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
55770131|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770132|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770133|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55770135|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55770136|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
55770137|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56215134|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56215135|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56215136|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56215137|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770138|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55770139|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770140|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55770141|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55770142|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
55770143|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55770144|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55770145|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55770146|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55770147|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
55770148|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770149|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55770150|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55770151|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770152|NCT03806309|Leucovorin|leucovorin|mesh-list
55770153|NCT03806309|Fluorouracil|fluorouracil|mesh-list
55770154|NCT03806309|Irinotecan|irinotecan|mesh-list
55770155|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
55770156|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770157|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55770158|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770159|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770160|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
55770161|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770162|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55770163|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55770164|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770166|NCT03806309|Protective Agents|protective agents|mesh-ancestor
55770167|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
55770168|NCT03806309|Vitamins|vitamins|mesh-ancestor
55770169|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
55770170|NCT05656235|Pembrolizumab|pembrolizumab|mesh-list
55770171|NCT05656235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55770172|NCT05656235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770173|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
55770174|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55770175|NCT03489629|Minocycline|minocycline|mesh-list
55770176|NCT03489629|Trimethoprim|trimethoprim|mesh-list
55770177|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
55770186|NCT03489629|Renal Agents|renal agents|mesh-ancestor
55770187|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
55770188|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55770189|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55770190|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55770191|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770192|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770193|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55770194|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55770195|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55770196|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55770198|NCT02389751|Carboplatin|carboplatin|mesh-list
55770199|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55783041|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55783042|NCT04148911|Paclitaxel|paclitaxel|mesh-list
55783043|NCT04148911|Atezolizumab|atezolizumab|mesh-list
55770200|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55770201|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770202|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
55770203|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
55770204|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
55770205|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770206|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
55770207|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770208|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
55770209|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770210|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55770211|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56215138|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215139|NCT01617200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56215140|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56215141|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215142|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215143|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215144|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
56215145|NCT01617213|Lenalidomide|lenalidomide|mesh-list
56215146|NCT01617213|Melphalan|melphalan|mesh-list
56215147|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
56215148|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215149|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56215150|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56215151|NCT01617213|Growth Substances|growth substances|mesh-ancestor
56215152|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
56215153|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215154|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55770212|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
55770213|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770214|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770215|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55770216|NCT02388035|Cefotaxime|cefotaxime|mesh-list
55770217|NCT02388035|Cefoxitin|cefoxitin|mesh-list
55770218|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55770219|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770220|NCT02389439|Artesunate|artesunate|mesh-list
55770221|NCT02389439|Pyronaridine|pyronaridine|mesh-list
55770222|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
55912250|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912251|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55912252|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
55912255|NCT01468207|Adalimumab|adalimumab|mesh-list
55912260|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912261|NCT01686152|Imiquimod|imiquimod|mesh-list
55770223|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55770224|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55770225|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770226|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770227|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
55770228|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
55770229|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55770230|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
55770231|NCT02663687|Complement C1s|complement c1s|mesh-list
55770232|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55770233|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
55770234|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
55770235|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770236|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55770237|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770238|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55770239|NCT05283395|Latanoprost|latanoprost|mesh-list
55770240|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55770241|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55770242|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55770244|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55770245|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
55770246|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55770247|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55770248|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770249|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
55770250|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215155|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
56215156|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770251|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770253|NCT02388581|Metronidazole|metronidazole|mesh-list
55770254|NCT02388581|Clarithromycin|clarithromycin|mesh-list
55770255|NCT02388581|Lansoprazole|lansoprazole|mesh-list
55770256|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
55770257|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55770258|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770259|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55770260|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55770261|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55770262|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770263|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770264|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55770265|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55770267|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55770268|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55770269|NCT02387567|Lidocaine|lidocaine|mesh-list
55770270|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
55783044|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55770271|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
55770272|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770273|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770274|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
55770275|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770276|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55770277|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55770278|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55770279|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55770280|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770282|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
55770283|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
55770284|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770285|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770286|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55770287|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55770288|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55770289|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55770290|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
55770291|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770292|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770293|NCT02387021|Ropivacaine|ropivacaine|mesh-list
55770294|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
55770295|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
55770296|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770297|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770298|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
55770299|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770300|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55770301|NCT02386943|Saxagliptin|saxagliptin|mesh-list
55770302|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55770303|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770304|NCT02386943|Incretins|incretins|mesh-ancestor
55770305|NCT02386943|Hormones|hormones|mesh-ancestor
55770306|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770307|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55770308|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
55770309|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770310|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770311|NCT02084056|Metformin|metformin|mesh-list
55770313|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55770314|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770315|NCT02084056|Incretins|incretins|mesh-ancestor
55770317|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770318|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55770319|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
56215157|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56215158|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770320|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770321|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770323|NCT04714372|Fludarabine|fludarabine|mesh-list
55770324|NCT04714372|Daratumumab|daratumumab|mesh-list
55770325|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770326|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
55770327|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770328|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55770329|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55770330|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
55770331|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770332|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770333|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55770334|NCT04787471|Riboflavin|riboflavin|mesh-list
55770335|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
55770336|NCT04787471|Vitamins|vitamins|mesh-ancestor
55770337|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
55770338|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770339|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55770340|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
55770341|NCT02386397|Gemcitabine|gemcitabine|mesh-list
55783045|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783046|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
55770343|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55770344|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
55770345|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770346|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770347|NCT02386397|Antiviral Agents|antiviral agents|mesh-ancestor
55770348|NCT02386397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770349|NCT02386397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770350|NCT02386397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770351|NCT02386397|Immunologic Factors|immunologic factors|mesh-ancestor
55770352|NCT02386397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770353|NCT02386475|Dexetimide|dexetimide|mesh-list
55770354|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55770355|NCT02386475|Citalopram|citalopram|mesh-list
55770356|NCT02386475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55770357|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55770358|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55770359|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770360|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770361|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
55770362|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770363|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55770364|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
55770365|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55770366|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55770367|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55770368|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
55770369|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
55770370|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770371|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55770372|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55770373|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
55770374|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55770375|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
55770376|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
55770377|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
55770378|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55770379|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55770380|NCT02382653|Piroxicam|piroxicam|mesh-list
55770381|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55770382|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55770383|NCT02382653|Analgesics|analgesics|mesh-ancestor
55770384|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
55770385|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770386|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770387|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55770388|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55770390|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912269|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55912270|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912271|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912272|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55912274|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56215160|NCT01617226|Vorinostat|vorinostat|mesh-list
56215161|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56215162|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
56215163|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791477|NCT05258851|Colistin|colistin|mesh-list
55770391|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770392|NCT02382263|Gemcitabine|gemcitabine|mesh-list
55770393|NCT02382263|Paclitaxel|paclitaxel|mesh-list
55770394|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55770395|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55770396|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770397|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
55770398|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
55770399|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
55770400|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770401|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55770402|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
55770403|NCT02382263|Antiviral Agents|antiviral agents|mesh-ancestor
55770404|NCT02382263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770405|NCT02382263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770406|NCT02382263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770407|NCT02382263|Immunologic Factors|immunologic factors|mesh-ancestor
55770410|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
55770411|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
55770412|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
55783047|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
55783048|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
55770413|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770414|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770415|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770416|NCT02385617|Octreotide|octreotide|mesh-list
55770417|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55770418|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55770419|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770420|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
55770421|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
55770422|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
55770423|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770424|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770425|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
55770426|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770427|NCT02385461|Heparin|heparin|mesh-list
55770428|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55770429|NCT02385461|Tinzaparin|tinzaparin|mesh-list
55770430|NCT02385461|Dalteparin|dalteparin|mesh-list
55770431|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
55770432|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55770433|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55770434|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770435|NCT02381717|Morphine|morphine|mesh-list
55770436|NCT02381717|Bupivacaine|bupivacaine|mesh-list
55770437|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
55770438|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
55770439|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770440|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770441|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
55770442|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770443|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55770444|NCT02381717|Narcotics|narcotics|mesh-ancestor
55770445|NCT02381717|Analgesics|analgesics|mesh-ancestor
55770446|NCT02385305|Anesthetics|anesthetics|mesh-list
55770447|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770448|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770449|NCT02385227|Nicotine|nicotine|mesh-list
55770450|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55770451|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
55770452|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770453|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215164|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215165|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770454|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55770455|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55770456|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
55770457|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770458|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770459|NCT02381249|Octreotide|octreotide|mesh-list
55770460|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55770461|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55770462|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770466|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
55770467|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770468|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770470|NCT02384915|Mepivacaine|mepivacaine|mesh-list
55770471|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
55770472|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770473|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770475|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
55770476|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770477|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
55770478|NCT04895735|Pemetrexed|pemetrexed|mesh-list
55770479|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55770480|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770481|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770482|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770483|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55770484|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55770486|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789065|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770487|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770488|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55770489|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770490|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
55770491|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770492|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
55770493|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770494|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
55770495|NCT03105791|Narcotics|narcotics|mesh-ancestor
55770496|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770497|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770498|NCT03105791|Analgesics|analgesics|mesh-ancestor
55770499|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
55770500|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770501|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
55770502|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55770503|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55912342|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55912343|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
55912344|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912345|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912346|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55912347|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55770504|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770505|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
55770506|NCT02384135|Coagulants|coagulants|mesh-ancestor
55770507|NCT02380625|Azithromycin|azithromycin|mesh-list
55770508|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55770509|NCT02380625|Sunitinib|sunitinib|mesh-list
55770510|NCT02380625|Irbesartan|irbesartan|mesh-list
55770511|NCT02380625|Atorvastatin|atorvastatin|mesh-list
55770512|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55770513|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55770514|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
55770515|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770516|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55770517|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55770518|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770519|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770520|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55770521|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55770522|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770523|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55770524|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55770525|NCT02380625|Growth Substances|growth substances|mesh-ancestor
55770526|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215166|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56215167|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
56215168|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55770527|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
55770528|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55770529|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55770530|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55770531|NCT02380313|Prednisone|prednisone|mesh-list
55770532|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55770534|NCT02380313|Hormones|hormones|mesh-ancestor
55770535|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770536|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770538|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770539|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55770540|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55770541|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770542|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770544|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770545|NCT02383901|Methotrexate|methotrexate|mesh-list
55770546|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55770547|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
55770548|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55770549|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770550|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55770552|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770553|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770554|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
55770555|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770556|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55770558|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
55770559|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55783049|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770560|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55770561|NCT02383823|Estradiol|estradiol|mesh-list
55770562|NCT02383823|Estrogens|estrogens|mesh-list
55770563|NCT02383823|Hormones|hormones|mesh-ancestor
55770564|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770565|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770566|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55770567|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55770568|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55770569|NCT02380001|Analgesics|analgesics|mesh-ancestor
55770570|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
55770571|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770572|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770573|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55770574|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55770575|NCT02379767|Harmine|harmine|mesh-list
55770576|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
55770577|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770578|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55770579|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55770580|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770581|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770582|NCT02661815|Paclitaxel|paclitaxel|mesh-list
55770583|NCT02661815|Bevacizumab|bevacizumab|mesh-list
55770584|NCT02661815|Ricolinostat|ricolinostat|mesh-list
55770585|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55770586|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770587|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
55770588|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
55770589|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
55770590|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770591|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55770592|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55770593|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55770594|NCT02661815|Growth Substances|growth substances|mesh-ancestor
56215169|NCT01617317|Antibodies|antibodies|mesh-list
56215170|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
55770595|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770596|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
55770597|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55770598|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770599|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
55770600|NCT02377193|Tacrolimus|tacrolimus|mesh-list
55770601|NCT02377193|Basiliximab|basiliximab|mesh-list
55770602|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770603|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
55770604|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770605|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55770606|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770607|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770608|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55770611|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
55770612|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55770613|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770614|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55770615|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
55770616|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770617|NCT04688021|Cytarabine|cytarabine|mesh-list
55770618|NCT04688021|Cyclosporine|cyclosporine|mesh-list
55770619|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
55770620|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
55770621|NCT04688021|Busulfan|busulfan|mesh-list
55770622|NCT04688021|Cyclosporins|cyclosporins|mesh-list
55770623|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55912352|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912353|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912354|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55912355|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
55912356|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
55912357|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55912358|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55912359|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55912360|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
55770624|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
55770625|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770626|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
55770627|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770628|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55770629|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55770630|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
55783050|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
55770631|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770632|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770633|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55770634|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55770635|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
55770636|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
55770637|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770638|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770639|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
55770640|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
55770641|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55770642|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55770643|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55770644|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
55770645|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55770647|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55770648|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
55770649|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55770650|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55770651|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55770652|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
55770653|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770654|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770655|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770656|NCT04678661|Insulin|insulin|mesh-list
55770657|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55770658|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770659|NCT02379299|Hormones|hormones|mesh-list
55770660|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770661|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770663|NCT02376881|Hematinics|hematinics|mesh-ancestor
55770664|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
55770665|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
55770666|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770667|NCT02376803|Warfarin|warfarin|mesh-list
55770668|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
56215171|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56215172|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
56215173|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770669|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55770670|NCT04210427|Laxatives|laxatives|mesh-ancestor
55770671|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55770672|NCT04132427|Vancomycin|vancomycin|mesh-list
55770673|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
55770674|NCT04132427|Citric Acid|citric acid|mesh-list
55770675|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
55770676|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
55770677|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55770678|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
55770679|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
55770680|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770681|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55912363|NCT01451827|Tolvaptan|tolvaptan|mesh-list
55912364|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55912365|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912366|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
55912367|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912368|NCT01557920|Propofol|propofol|mesh-list
55912369|NCT01557920|Sevoflurane|sevoflurane|mesh-list
55770682|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770686|NCT02031640|Albuterol|albuterol|mesh-list
55770687|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
55770688|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
55770689|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770690|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770691|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55770692|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
55770694|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55770696|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55770697|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55770698|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
55770699|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770700|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770701|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55770702|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
55770703|NCT02031640|Hormones|hormones|mesh-ancestor
55770704|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770705|NCT02376413|Trastuzumab|trastuzumab|mesh-list
55783051|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55770706|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55770707|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770708|NCT02378441|Metformin|metformin|mesh-list
55770709|NCT02378441|Atorvastatin|atorvastatin|mesh-list
55770710|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55770711|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770712|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55770713|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55770714|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
55770715|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770716|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55770717|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55770718|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770719|NCT04072445|Trifluridine|trifluridine|mesh-list
55770720|NCT04072445|Irinotecan|irinotecan|mesh-list
55770721|NCT04072445|Camptothecin|camptothecin|mesh-list
55770722|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55770723|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55770724|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770725|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770726|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770727|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55770728|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
55770729|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
55770730|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770731|NCT04600427|Anesthetics|anesthetics|mesh-list
55770732|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770733|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770734|NCT04595981|Cisplatin|cisplatin|mesh-list
55770735|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770736|NCT02378129|Methamphetamine|methamphetamine|mesh-list
55770737|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55770738|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770739|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
55770740|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
55770741|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215174|NCT01617356|Lidocaine|lidocaine|mesh-list
56215175|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
56215176|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
55770742|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
55770743|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770744|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770745|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
55770746|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55770747|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55770748|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55770749|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55770750|NCT02376335|Rituximab|rituximab|mesh-list
55770751|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55770752|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770753|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
55770754|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770757|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55770758|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55770759|NCT02375867|Prednisolone|prednisolone|mesh-list
55770760|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
55770761|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55770762|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
55770763|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55770764|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
55770765|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
55770766|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770768|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55770769|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
55770771|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770772|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55770773|NCT02375867|Protective Agents|protective agents|mesh-ancestor
55770774|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55770775|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770776|NCT04540133|Dexamethasone|dexamethasone|mesh-list
55770777|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
55770778|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55770779|NCT04540133|BB 1101|bb 1101|mesh-list
55770780|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55770781|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
55770782|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
55770783|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770784|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770785|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55770786|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
55770787|NCT04540133|Hormones|hormones|mesh-ancestor
55770788|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770789|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55770790|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770791|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
55770792|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770793|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770794|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
55770795|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55770796|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770797|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770798|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55770799|NCT02375243|Analgesics|analgesics|mesh-ancestor
55912370|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55742970|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55912371|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912372|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912373|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55912374|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
55912375|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
55912376|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55770800|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
55770801|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770802|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55770803|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55770804|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55770805|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
55770806|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770807|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770808|NCT02374931|Estradiol|estradiol|mesh-list
55770809|NCT02374931|Estrogens|estrogens|mesh-ancestor
55770810|NCT02374931|Hormones|hormones|mesh-ancestor
55770811|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215177|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215178|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215179|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
55770812|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770813|NCT02377661|Amlodipine|amlodipine|mesh-list
55770814|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55770815|NCT02377661|Olmesartan|olmesartan|mesh-list
55770816|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55770817|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55770818|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55770819|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55770820|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770821|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55770822|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770823|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
55770824|NCT02377661|Diuretics|diuretics|mesh-ancestor
55770825|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
55770828|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55770829|NCT02372357|Posaconazole|posaconazole|mesh-list
55770830|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
55770831|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770832|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55770833|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55770834|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55770835|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55770836|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55770837|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770838|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770839|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55770840|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
55770841|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770842|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770843|NCT03672773|Temozolomide|temozolomide|mesh-list
55770844|NCT03672773|Talazoparib|talazoparib|mesh-list
55770845|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55783052|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55770846|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
55912381|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
55912382|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55912383|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
55912384|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912385|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750414|NCT02507843|Vitamins|vitamins|mesh-ancestor
55750415|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
55750416|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750417|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55750418|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55750419|NCT02425891|Paclitaxel|paclitaxel|mesh-list
55750420|NCT02425891|Atezolizumab|atezolizumab|mesh-list
55750421|NCT02425891|Antibodies|antibodies|mesh-list
55750422|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55750423|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55750424|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750425|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
55750426|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
55750427|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
55770847|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770848|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770849|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55770850|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770851|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
55770852|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770853|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770854|NCT02371577|Lenalidomide|lenalidomide|mesh-list
55770855|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
55770856|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770857|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55770858|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55770859|NCT02371577|Growth Substances|growth substances|mesh-ancestor
55770860|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
55770861|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770862|NCT02373449|Ketamine|ketamine|mesh-list
55770863|NCT02373449|Analgesics|analgesics|mesh-ancestor
55770864|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
55770865|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770866|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770867|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55770868|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55770869|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
55770870|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
55770871|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770872|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55770873|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55770874|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770875|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770876|NCT02371421|Allopurinol|allopurinol|mesh-list
55770877|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
56215180|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215181|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56000873|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770878|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770879|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770880|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
55770881|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55770882|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55770883|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
55770884|NCT02371421|Protective Agents|protective agents|mesh-ancestor
55770885|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770886|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
55770887|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
55770888|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770889|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770890|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770891|NCT03959891|Letrozole|letrozole|mesh-list
55770892|NCT03959891|Fulvestrant|fulvestrant|mesh-list
55770893|NCT03959891|Palbociclib|palbociclib|mesh-list
55770894|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55770895|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770898|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770900|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
55770901|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770902|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770903|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55770904|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55770905|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55770907|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55770908|NCT02373215|Narcotics|narcotics|mesh-ancestor
55770909|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770910|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770911|NCT02373215|Analgesics|analgesics|mesh-ancestor
55770912|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
55770913|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770914|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
55770915|NCT03785249|Cetuximab|cetuximab|mesh-list
55783053|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770916|NCT03785249|Afatinib|afatinib|mesh-list
55770917|NCT03785249|Adagrasib|adagrasib|mesh-list
55770918|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55770919|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770920|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55770921|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770922|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770923|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55770924|NCT03773237|SMOFlipid|smoflipid|mesh-list
55770925|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55770926|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55770927|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55770928|NCT03765983|Trastuzumab|trastuzumab|mesh-list
55770929|NCT03765983|GDC-0084|gdc-0084|mesh-list
55770930|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55770931|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770932|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770933|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770934|NCT02372903|Palmidrol|palmidrol|mesh-list
55770935|NCT02372903|Analgesics|analgesics|mesh-ancestor
55770936|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
55770937|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770938|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770939|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55770940|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55770941|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55770942|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55770943|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
55770944|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770945|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55770946|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56215182|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56215183|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55770947|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770948|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770949|NCT02372903|Hormones|hormones|mesh-ancestor
55756437|NCT04971759|Fentanyl|fentanyl|mesh-list
55912386|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
55912387|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55912388|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55912389|NCT01576718|Fluticasone|fluticasone|mesh-list
55912390|NCT01576718|Xhance|xhance|mesh-list
55912391|NCT01576718|Albuterol|albuterol|mesh-list
55770950|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770951|NCT02372591|Buprenorphine|buprenorphine|mesh-list
55770952|NCT02372591|Hydromorphone|hydromorphone|mesh-list
55770953|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55770954|NCT02372591|Narcotics|narcotics|mesh-ancestor
55770955|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55770956|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770957|NCT02372591|Analgesics|analgesics|mesh-ancestor
55770958|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
55770959|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770960|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55770961|NCT02372669|Chitosan|chitosan|mesh-list
55770962|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55770963|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55770964|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
55770968|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
55770969|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
55770970|NCT02372669|Coagulants|coagulants|mesh-ancestor
55770971|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55770972|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
55770973|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55770974|NCT02369939|Fluorouracil|fluorouracil|mesh-list
55770976|NCT02369939|Mitomycin|mitomycin|mesh-list
55770977|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
55770978|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770979|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55770980|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770981|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770982|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
55770983|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770984|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55770985|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
55770986|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55770987|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770989|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55783054|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783055|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55783056|NCT03953677|Analgesics|analgesics|mesh-ancestor
55770990|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55770991|NCT02369549|Analgesics|analgesics|mesh-ancestor
55770992|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
55770993|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770994|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770995|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55770996|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55770997|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770998|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770999|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771001|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
55771002|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771003|NCT02365415|Sirolimus|sirolimus|mesh-list
55771004|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55771005|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771006|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55771007|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771008|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
55771009|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771010|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
55771011|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912453|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55912454|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
55912455|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912456|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55912457|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55912458|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55771012|NCT02369081|Bisoprolol|bisoprolol|mesh-list
55771013|NCT02369081|Doxazosin|doxazosin|mesh-list
55771014|NCT02369081|Spironolactone|spironolactone|mesh-list
55771015|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55771016|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
55771017|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771018|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142980|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
56215184|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215185|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215186|NCT01617538|Atorvastatin|atorvastatin|mesh-list
56215187|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56215188|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56215189|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
56215190|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000874|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55771019|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55771020|NCT02369081|Diuretics|diuretics|mesh-ancestor
55771021|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
55771022|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55771023|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
55771024|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
55771025|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771026|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55771027|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55771028|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55771029|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
55771030|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771031|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771032|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55912463|NCT01451515|Prednisolone|prednisolone|mesh-list
55912464|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
55912465|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
55912466|NCT01451515|Doxorubicin|doxorubicin|mesh-list
55912467|NCT01451515|Methotrexate|methotrexate|mesh-list
55912468|NCT01451515|Etoposide|etoposide|mesh-list
55912469|NCT01451515|Vincristine|vincristine|mesh-list
55912470|NCT01451515|Daunorubicin|daunorubicin|mesh-list
55912471|NCT01451515|Asparaginase|asparaginase|mesh-list
55912472|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
55912473|NCT01451515|Clofarabine|clofarabine|mesh-list
55912474|NCT01451515|Pegaspargase|pegaspargase|mesh-list
55771033|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55771034|NCT02365493|Cefazolin|cefazolin|mesh-list
55771035|NCT02365493|Lactams|lactams|mesh-list
55771039|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55771040|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771041|NCT02365181|Ropivacaine|ropivacaine|mesh-list
55771042|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
55771043|NCT02365181|Anesthetics|anesthetics|mesh-list
55771044|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771045|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771046|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
55771047|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771048|NCT05653895|Metformin|metformin|mesh-list
55771049|NCT05653895|Resveratrol|resveratrol|mesh-list
55771050|NCT05653895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55771051|NCT05653895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771052|NCT05653895|Antioxidants|antioxidants|mesh-ancestor
55771053|NCT05653895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771054|NCT05653895|Protective Agents|protective agents|mesh-ancestor
55771055|NCT05653895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771056|NCT05653895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55771057|NCT02364479|Etanercept|etanercept|mesh-list
55771058|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55783058|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771059|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55771060|NCT02364479|Analgesics|analgesics|mesh-ancestor
55771061|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
55771062|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771063|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771064|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771065|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55912475|NCT01451515|Thioguanine|thioguanine|mesh-list
55912476|NCT01451515|Antimetabolites|antimetabolites|mesh-list
55912477|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55912478|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
55912479|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912526|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55912528|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55912529|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912530|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912531|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
55912532|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55771066|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771067|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771068|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
55771069|NCT05653817|Paclitaxel|paclitaxel|mesh-list
55771070|NCT05653817|Apatinib|apatinib|mesh-list
55771071|NCT05653817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55771072|NCT05653817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55771073|NCT05653817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771074|NCT05653817|Tubulin Modulators|tubulin modulators|mesh-ancestor
55771075|NCT05653817|Antimitotic Agents|antimitotic agents|mesh-ancestor
55771076|NCT05653817|Mitosis Modulators|mitosis modulators|mesh-ancestor
56215191|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56215192|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55771077|NCT05653817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771078|NCT05653817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55771079|NCT05653817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771080|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
55771081|NCT02052310|Hematinics|hematinics|mesh-ancestor
55771082|NCT02368379|Metyrapone|metyrapone|mesh-list
55771083|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
55771084|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771085|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771086|NCT02051296|Minocycline|minocycline|mesh-list
55771087|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55771088|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771089|NCT02367755|Lorazepam|lorazepam|mesh-list
55771090|NCT02367755|Propofol|propofol|mesh-list
55771091|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55771092|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771093|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771094|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55771095|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
55771096|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
55771097|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
55771098|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
55771099|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
55771100|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771101|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771102|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55771103|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55771104|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55771105|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
55771106|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
55771107|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771108|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771109|NCT02364089|Epinephrine|epinephrine|mesh-list
55771112|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55771113|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55771114|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
55771115|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771116|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771117|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771118|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55771119|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55912564|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55912565|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912566|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912567|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912568|NCT01540838|Acetaminophen|acetaminophen|mesh-list
55912569|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55912570|NCT01540838|Analgesics|analgesics|mesh-ancestor
55912571|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
55771120|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
55771121|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771122|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55771123|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
55771125|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
55771126|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55771127|NCT02363699|Lidocaine|lidocaine|mesh-list
55771128|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
55771129|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
55771130|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771131|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783059|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55783060|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55783061|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55771132|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
55771133|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771134|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55771135|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55771136|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55771137|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55771138|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771139|NCT02049814|Metformin|metformin|mesh-list
55771140|NCT02049814|Acarbose|acarbose|mesh-list
55771141|NCT02049814|Voglibose|voglibose|mesh-list
55771142|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55771143|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771144|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55771145|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771146|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771147|NCT03344159|Spironolactone|spironolactone|mesh-list
56215193|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215194|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56215195|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771148|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55771149|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
55771150|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771151|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771152|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55771153|NCT03344159|Diuretics|diuretics|mesh-ancestor
55771154|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
55771155|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
55771156|NCT03324113|Promethazine|promethazine|mesh-list
55771157|NCT03324113|Dexamethasone|dexamethasone|mesh-list
55771158|NCT03324113|Naphazoline|naphazoline|mesh-list
55771159|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55771160|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771161|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
55771162|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
55771163|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771164|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771165|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771166|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
55771167|NCT03324113|Hormones|hormones|mesh-ancestor
55771168|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771169|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55771170|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771171|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55771172|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55771173|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55771174|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771175|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
55771176|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
55771177|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
55771178|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55771179|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
55771180|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
55771181|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771182|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771183|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55771184|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
55771185|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
55771186|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55771187|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55771188|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
55771189|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
55771190|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55771191|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
55771192|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
55771193|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55771194|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771195|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771196|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55771197|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
55783063|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771198|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55771199|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771200|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55771201|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55771202|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55771203|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771204|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
55771205|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771206|NCT02367053|Glucagon|glucagon|mesh-list
55771207|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771208|NCT02367053|Hormones|hormones|mesh-ancestor
55771209|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771210|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771211|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55771213|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55771214|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
56215196|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771215|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771216|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55771217|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55771218|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771219|NCT02366975|Testosterone|testosterone|mesh-list
55771220|NCT02366975|Androgens|androgens|mesh-ancestor
55771221|NCT02366975|Hormones|hormones|mesh-ancestor
55771222|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771223|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771224|NCT04479371|Bupivacaine|bupivacaine|mesh-list
55771225|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
55771226|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
55750506|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
55750507|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
55750508|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750509|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55750510|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55750511|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750512|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750513|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55750514|NCT02499341|Narcotics|narcotics|mesh-ancestor
55750515|NCT02495285|Polygeline|polygeline|mesh-list
55750516|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
55750517|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
55750518|NCT02495363|Bupivacaine|bupivacaine|mesh-list
55750519|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
55771227|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771228|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771229|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
55771230|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771231|NCT02029846|Metformin|metformin|mesh-list
55771232|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55771233|NCT02029846|Incretins|incretins|mesh-list
55771234|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55771235|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771236|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
55771237|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771238|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771239|NCT02029846|Hormones|hormones|mesh-ancestor
55771240|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771241|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
55771242|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55771243|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
55771244|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55771245|NCT02366585|Cyclosporine|cyclosporine|mesh-list
55771246|NCT02366585|Cyclosporins|cyclosporins|mesh-list
55771247|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771248|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771250|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
55771251|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771254|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
55771255|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771256|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55771257|NCT02079532|Rituximab|rituximab|mesh-list
55771258|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55771259|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771260|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
55771261|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771262|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771264|NCT02958917|Analgesics|analgesics|mesh-ancestor
55771265|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
55771266|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771267|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771268|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55771269|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55912572|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912573|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912574|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
55912575|NCT01451203|Methotrexate|methotrexate|mesh-list
55912576|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
55912577|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55912578|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
55912579|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55912580|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912581|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55912582|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
55912584|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771270|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771271|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771272|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771273|NCT02362529|Minocycline|minocycline|mesh-list
55771275|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55771276|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55771277|NCT02362529|Analgesics|analgesics|mesh-ancestor
55771278|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
55771279|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771280|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771281|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771282|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771283|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55771284|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55771285|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771286|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771287|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55771288|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771289|NCT02794571|Paclitaxel|paclitaxel|mesh-list
56215197|NCT01617564|Bupivacaine|bupivacaine|mesh-list
56215198|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
56215199|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
55771290|NCT02794571|Etoposide|etoposide|mesh-list
55771291|NCT02794571|Bevacizumab|bevacizumab|mesh-list
55771292|NCT02794571|Carboplatin|carboplatin|mesh-list
55771293|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
55771294|NCT02794571|Capecitabine|capecitabine|mesh-list
55771295|NCT02794571|Pemetrexed|pemetrexed|mesh-list
55771296|NCT02794571|Atezolizumab|atezolizumab|mesh-list
55771297|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55771298|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771299|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
55771300|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
55771301|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
55771302|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771303|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55771304|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55771305|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55771306|NCT02794571|Growth Substances|growth substances|mesh-ancestor
55771307|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771308|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
55771309|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55771310|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
55771311|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55771312|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55771313|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771314|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55771315|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55771316|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
55771317|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55771318|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55771319|NCT02769689|Prednisolone|prednisolone|mesh-list
55771320|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
55771321|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55771322|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
55771323|NCT02769689|Natalizumab|natalizumab|mesh-list
55771324|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771325|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
55912633|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912634|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
55912635|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55912636|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912637|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912638|NCT01450813|Bromides|bromides|mesh-list
55912639|NCT01450813|Rocuronium|rocuronium|mesh-list
55771326|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
55771327|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771331|NCT02769689|Hormones|hormones|mesh-ancestor
55804902|NCT04352101|Bupropion|bupropion|mesh-list
55771332|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771334|NCT02769689|Protective Agents|protective agents|mesh-ancestor
55771335|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55771337|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
55771338|NCT02365571|Itraconazole|itraconazole|mesh-list
55771339|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
55771340|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771341|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55771342|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55771343|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771344|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771345|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55771346|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
55771347|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771348|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771349|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55771350|NCT02365727|Clonidine|clonidine|mesh-list
55771351|NCT02365727|Epinephrine|epinephrine|mesh-list
55771352|NCT02365727|Bupivacaine|bupivacaine|mesh-list
55771353|NCT02365727|Ropivacaine|ropivacaine|mesh-list
55771354|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
55771355|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
55771356|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771357|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771358|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
55771359|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771360|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55771361|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55771363|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771364|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215200|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215201|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215202|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
56215203|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771365|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55771366|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55771367|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
55771368|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55771369|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
55771370|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
55771371|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
55771372|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55771373|NCT02365727|Analgesics|analgesics|mesh-ancestor
55771374|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55771375|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
55771376|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55771377|NCT02365805|Paclitaxel|paclitaxel|mesh-list
55771378|NCT02365805|Docetaxel|docetaxel|mesh-list
55771379|NCT02365805|Fluorouracil|fluorouracil|mesh-list
55771380|NCT02365805|Epirubicin|epirubicin|mesh-list
55771381|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
55771382|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55771383|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771384|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
55771385|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
55771386|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
55771387|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771388|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
55771389|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55771390|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771391|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
55771392|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771393|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55771394|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55771395|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55771396|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771397|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771398|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55771399|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
55771400|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55771401|NCT03112889|Valproic Acid|valproic acid|mesh-list
55771404|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771405|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
55771406|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771407|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771408|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
55771409|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55771410|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771411|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55771412|NCT03112577|Fluticasone|fluticasone|mesh-list
55771414|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771415|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55771416|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
55771417|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771418|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783064|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783065|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
55771419|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55771420|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
55771421|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
55771422|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55771423|NCT02361905|Leuprolide|leuprolide|mesh-list
55771424|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
55771425|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55771426|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
55771427|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55771428|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771429|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55912642|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55912643|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55912644|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912645|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912646|NCT01539512|Rituximab|rituximab|mesh-list
55912647|NCT01539512|Idelalisib|idelalisib|mesh-list
55912648|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55912649|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912650|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
55912651|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912705|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55728834|NCT04167111|Vitamin D|vitamin d|mesh-list
55771430|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771431|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56215204|NCT01617590|Methotrexate|methotrexate|mesh-list
56215205|NCT01617590|Leflunomide|leflunomide|mesh-list
56215206|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56215207|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
55771432|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
55771433|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55771434|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
55771435|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55771436|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55771437|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771438|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
55771439|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771440|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771441|NCT04372433|Azacitidine|azacitidine|mesh-list
55771443|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55771444|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
55771445|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771446|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771447|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771448|NCT02359331|Amoxicillin|amoxicillin|mesh-list
55771449|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
55771450|NCT02359331|Metronidazole|metronidazole|mesh-list
55771451|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55771452|NCT02359331|Tetracycline|tetracycline|mesh-list
55771453|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
55771454|NCT02359331|Bismuth|bismuth|mesh-list
55771455|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55771456|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55771457|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55771458|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771459|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771460|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771461|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55771462|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55771463|NCT02359331|Antacids|antacids|mesh-ancestor
55771464|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771465|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55771466|NCT02358707|Ibuprofen|ibuprofen|mesh-list
55771467|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55771468|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55771469|NCT02358707|Analgesics|analgesics|mesh-ancestor
55771470|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
55771471|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771472|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771475|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55771477|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771478|NCT02360501|Docetaxel|docetaxel|mesh-list
55771479|NCT02360501|Capecitabine|capecitabine|mesh-list
55771480|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771481|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
55771482|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
55771483|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
55771484|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771485|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55771486|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
55771487|NCT02360423|Sirolimus|sirolimus|mesh-list
55771488|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55783066|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
55771489|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771490|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55771491|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771492|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
55771493|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771494|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
55771495|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771496|NCT02358161|Gemcitabine|gemcitabine|mesh-list
55771497|NCT02358161|Paclitaxel|paclitaxel|mesh-list
55771498|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55771499|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771500|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
56215208|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56215209|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215210|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56215211|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
55771501|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
55771502|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
55771503|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771504|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55771505|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
55771506|NCT02358161|Antiviral Agents|antiviral agents|mesh-ancestor
55771507|NCT02358161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771508|NCT02358161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771509|NCT02358161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771510|NCT02358161|Immunologic Factors|immunologic factors|mesh-ancestor
55771511|NCT02358161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771512|NCT02357849|Aripiprazole|aripiprazole|mesh-list
55771513|NCT02357849|Fluoxetine|fluoxetine|mesh-list
55771514|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
55771515|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55771516|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55771517|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55771518|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771519|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771520|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
55771521|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
55771522|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771523|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771524|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55771525|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55771526|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
55771527|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55771528|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55771529|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55771530|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55771531|NCT02357849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55728928|NCT02294357|Hormones|hormones|mesh-ancestor
55771532|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55771533|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55771534|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55771535|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55771536|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55771537|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771538|NCT02357693|Aprepitant|aprepitant|mesh-list
55771539|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
55771540|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
55771541|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771542|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771543|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771545|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771546|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771547|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55771548|NCT02357615|Nifedipine|nifedipine|mesh-list
55771549|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55771550|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55771551|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771552|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55771553|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771554|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
55771555|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
55771556|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55771557|NCT03160001|Niclosamide|niclosamide|mesh-list
55771558|NCT03160001|Etanercept|etanercept|mesh-list
55771559|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55783067|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55771560|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55771561|NCT03160001|Analgesics|analgesics|mesh-ancestor
55771562|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
55771563|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771564|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215212|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215213|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771565|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771566|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771567|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771568|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771569|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
55771570|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
55771571|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55771572|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
55771573|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55771574|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771575|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
55912720|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912721|NCT01553318|Ketotifen|ketotifen|mesh-list
55912722|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
55912723|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
55912724|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55912725|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
55912726|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
55912727|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912728|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912729|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912730|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55912731|NCT01572740|Liraglutide|liraglutide|mesh-list
55912732|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55771577|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55771578|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55771579|NCT02359643|Analgesics|analgesics|mesh-ancestor
55771580|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
55771581|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771582|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771583|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771584|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771585|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55771586|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55771587|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771588|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55771589|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55771590|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771591|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
55771592|NCT02359721|Clarithromycin|clarithromycin|mesh-list
55771593|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55771594|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771595|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55771596|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771597|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771598|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55771600|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
55771601|NCT02357303|Simethicone|simethicone|mesh-list
55771602|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55771603|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
55771604|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771605|NCT02357303|Expectorants|expectorants|mesh-ancestor
55771606|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
55771607|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55771608|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
55771609|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771610|NCT02357303|Protective Agents|protective agents|mesh-ancestor
55771611|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771612|NCT02357303|Antidotes|antidotes|mesh-ancestor
55771613|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
55771614|NCT02357303|Emollients|emollients|mesh-ancestor
55771615|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
55771616|NCT02357225|Bromides|bromides|mesh-list
55833110|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
55771619|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55771620|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771621|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771622|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
55771623|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771624|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771626|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55771627|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55771628|NCT02357069|Analgesics|analgesics|mesh-ancestor
55771629|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
55771630|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771631|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783068|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55771632|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771633|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771634|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771635|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771636|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
56215214|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
56215215|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215216|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56215217|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791527|NCT04839653|Amebicides|amebicides|mesh-ancestor
55771638|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55771639|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
55771640|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771641|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771642|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55771643|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55771644|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
55771645|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771646|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771647|NCT02352545|Montelukast|montelukast|mesh-list
55771648|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55771649|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
55771650|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55771651|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
55771652|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771653|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771654|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55771655|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55771656|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771657|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
55771658|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55771659|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
55771660|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771661|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771662|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55771663|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
55771664|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55771666|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771667|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771668|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55771669|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
55771670|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
55771671|NCT02356835|Protective Agents|protective agents|mesh-ancestor
55771672|NCT02352701|Amoxicillin|amoxicillin|mesh-list
55771673|NCT02352701|Levofloxacin|levofloxacin|mesh-list
55771674|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55771675|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771676|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55771677|NCT02352701|Renal Agents|renal agents|mesh-ancestor
55771678|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55771679|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55771680|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771681|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771682|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771683|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55771684|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55771685|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55771686|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771690|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55771691|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
55771692|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55771693|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771694|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55771695|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
55771696|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771697|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771698|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
55771699|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771700|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55771701|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771702|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
55771703|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56215218|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
56215219|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55791531|NCT04842383|Peppermint oil|peppermint oil|mesh-list
55771704|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55771705|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771707|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55771708|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771709|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771710|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771711|NCT02352155|Epinephrine|epinephrine|mesh-list
55771712|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55771713|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55771714|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
55771715|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771716|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771717|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771718|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55771719|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55771720|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
55771721|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771722|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55771723|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
55771724|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
55771725|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
55771726|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55771727|NCT02352311|Tadalafil|tadalafil|mesh-list
55771728|NCT02352311|Dutasteride|dutasteride|mesh-list
55771729|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
55771730|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55771731|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55771732|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771733|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771734|NCT02352311|Urological Agents|urological agents|mesh-ancestor
55771735|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55771736|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55771737|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
55771738|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912794|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55771739|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771740|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55771741|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771742|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55771743|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771744|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771745|NCT02351765|Cisplatin|cisplatin|mesh-list
55771746|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771747|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
55771748|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
55771749|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55771750|NCT02351687|Albendazole|albendazole|mesh-list
55771751|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
55771752|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55771753|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55771754|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771755|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55771756|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804908|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
55771757|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771758|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55771762|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55771763|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
55771764|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
55771765|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
55771766|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771767|NCT02355509|Acarbose|acarbose|mesh-list
55771768|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55771769|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771770|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771771|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55771772|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771773|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
55783070|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215220|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56215221|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
55783071|NCT03945643|Urological Agents|urological agents|mesh-ancestor
55783072|NCT02039323|Tenofovir|tenofovir|mesh-list
55783073|NCT02039323|Maraviroc|maraviroc|mesh-list
55783074|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
55783075|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783076|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55783077|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55783078|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771774|NCT02355197|Vitamins|vitamins|mesh-ancestor
55771775|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
55771776|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771777|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
55771778|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771779|NCT02355197|Protective Agents|protective agents|mesh-ancestor
55771780|NCT02351297|Caseins|caseins|mesh-list
55771781|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
55771782|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
55771783|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771784|NCT02355119|Gemcitabine|gemcitabine|mesh-list
55771785|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55771786|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
55771787|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771788|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771789|NCT02355119|Antiviral Agents|antiviral agents|mesh-ancestor
55771790|NCT02355119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771791|NCT02355119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771792|NCT02355119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771793|NCT02355119|Immunologic Factors|immunologic factors|mesh-ancestor
55771794|NCT02355119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771795|NCT03149939|Febuxostat|febuxostat|mesh-list
55771796|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
55771797|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771798|NCT03149783|Ropivacaine|ropivacaine|mesh-list
55771799|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
55771800|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
55771801|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771802|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771803|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
55771804|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771805|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
55771806|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55771807|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55771808|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771809|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
55771810|NCT02354885|Coagulants|coagulants|mesh-ancestor
55771812|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55771813|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55771814|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55771815|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
55771816|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771817|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771818|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771819|NCT02354807|Urological Agents|urological agents|mesh-ancestor
55771820|NCT03159845|Levofloxacin|levofloxacin|mesh-list
55771821|NCT03159845|Ofloxacin|ofloxacin|mesh-list
55771822|NCT03159845|Fluconazole|fluconazole|mesh-list
55771824|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
55771825|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55771826|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771827|NCT03159845|Renal Agents|renal agents|mesh-ancestor
55771828|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55771829|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55771830|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55912806|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
55912807|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912808|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912809|NCT04108676|Omeprazole|omeprazole|mesh-list
55912810|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55912811|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55912812|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55912813|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912814|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912815|NCT01552772|Aripiprazole|aripiprazole|mesh-list
55912816|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
55912817|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55912818|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55912819|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55912820|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912821|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912822|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
55912824|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912825|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912826|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55783079|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771832|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771833|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771834|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55771835|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56215222|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56215223|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771836|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
55771837|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55771838|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55771839|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
55771840|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771841|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771842|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55771843|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55771844|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
55771845|NCT03159845|Astringents|astringents|mesh-ancestor
55771846|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
55771847|NCT02350751|MEDI8852|medi8852|mesh-list
55771848|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
55771849|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771850|NCT02350985|Propranolol|propranolol|mesh-list
55771851|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55771852|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55771853|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55771854|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
55771855|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771856|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771857|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771858|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55771859|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55771860|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
55771861|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55771862|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55771863|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55771864|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55771865|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
55771867|NCT02354261|Itraconazole|itraconazole|mesh-list
55771868|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
55771869|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771870|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55771871|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55771872|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771873|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771874|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55771875|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
55771876|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771877|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771878|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55771880|NCT02350439|Analgesics|analgesics|mesh-ancestor
55771881|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
55771882|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771883|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771884|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55771885|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
55771886|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55771887|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
55771888|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
55771889|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771890|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771891|NCT02350673|Atezolizumab|atezolizumab|mesh-list
55771892|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771893|NCT02350361|Endostatins|endostatins|mesh-list
55771895|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55771896|NCT02350361|Growth Substances|growth substances|mesh-ancestor
55771897|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771898|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
55771899|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771901|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55771902|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771903|NCT02354027|Metformin|metformin|mesh-list
55771904|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215224|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215225|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56215227|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
56215228|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215229|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56215230|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56215231|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56215232|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
56215233|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215234|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215235|NCT01617707|Midazolam|midazolam|mesh-list
56215236|NCT01617707|Propofol|propofol|mesh-list
56215237|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56000875|NCT00542542|Narcotics|narcotics|mesh-ancestor
55771905|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771906|NCT03149393|Mosapride|mosapride|mesh-list
55771907|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771908|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771909|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55771910|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
55771911|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771912|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771913|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
55771914|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771915|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55771916|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771917|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771918|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
55771919|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55771920|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771921|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55771922|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
55771923|NCT02353325|Fesoterodine|fesoterodine|mesh-list
55771924|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
55771925|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771926|NCT02353325|Protective Agents|protective agents|mesh-ancestor
55771927|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771928|NCT02353325|Vitamins|vitamins|mesh-ancestor
55771929|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
55771930|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55912885|NCT00490269|Dronabinol|dronabinol|mesh-list
55912886|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
55912887|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912890|NCT00490269|Analgesics|analgesics|mesh-ancestor
55771931|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55771932|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
55771933|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55771934|NCT02353325|Urological Agents|urological agents|mesh-ancestor
55771935|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
55771936|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771937|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
55771938|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55771939|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
55834116|NCT01823289|Itraconazole|itraconazole|mesh-list
55771940|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771941|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
55771942|NCT03157193|Protective Agents|protective agents|mesh-ancestor
55771943|NCT03149159|Nivolumab|nivolumab|mesh-list
55771944|NCT03149159|Ipilimumab|ipilimumab|mesh-list
55771945|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55771946|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771947|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56215238|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215239|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215240|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56215241|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
56215242|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
56215243|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55771948|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771949|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
55771951|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55771952|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771953|NCT03155477|Vitamins|vitamins|mesh-ancestor
55771954|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
55771955|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55771956|NCT02349581|Bupivacaine|bupivacaine|mesh-list
55771957|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
55771958|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
55771959|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771960|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771961|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
55771962|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55771963|NCT03154385|Rituximab|rituximab|mesh-list
55771964|NCT03154385|Belimumab|belimumab|mesh-list
55771965|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55771966|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771969|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771970|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55771972|NCT03112187|Trace Elements|trace elements|mesh-ancestor
55771973|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
55771974|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771975|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
55783080|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55783081|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55771976|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55771977|NCT03147677|Irbesartan|irbesartan|mesh-list
55771978|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55771979|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55771980|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55771981|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771982|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55771983|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771984|NCT03147677|Vitamins|vitamins|mesh-ancestor
55771985|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
55771986|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
55771987|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
55771988|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55771989|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771990|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55771991|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
55771992|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55771993|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55771994|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771995|NCT03147599|Mebeverine|mebeverine|mesh-list
55771996|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
55771997|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
55771998|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
55771999|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772000|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772001|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55772002|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55772003|NCT02349113|Estrogens|estrogens|mesh-list
55772004|NCT02349113|Estradiol|estradiol|mesh-list
55772005|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55772006|NCT02349113|Hormones|hormones|mesh-ancestor
55772007|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772008|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772009|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55772011|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56215244|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56215245|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56215246|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772012|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55772013|NCT04183205|Sertraline|sertraline|mesh-list
55772014|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
55772015|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772016|NCT04183205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55772017|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55772018|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772019|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772020|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772021|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
55772022|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772023|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55772024|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772025|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55772026|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772027|NCT02348177|Ritonavir|ritonavir|mesh-list
55772028|NCT02348177|Lopinavir|lopinavir|mesh-list
55772029|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55772030|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55772031|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
55772032|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772033|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772034|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55772035|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55772036|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
55772037|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772040|NCT02348255|Bevacizumab|bevacizumab|mesh-list
55772041|NCT02348255|Carmustine|carmustine|mesh-list
55772042|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55772043|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772044|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55783082|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55783083|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55772045|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55772046|NCT02348255|Growth Substances|growth substances|mesh-ancestor
55772047|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772048|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
55772049|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55772050|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
55772051|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772053|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
55772054|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
55772055|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55772056|NCT02348333|Renal Agents|renal agents|mesh-ancestor
55772057|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
55772058|NCT02343419|Miotics|miotics|mesh-ancestor
55772059|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
55772060|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772061|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772062|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55772063|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
55772064|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
55772065|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55772066|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55772067|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
55772068|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772069|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772070|NCT02342717|Itraconazole|itraconazole|mesh-list
55772071|NCT02342717|BI 425809|bi 425809|mesh-list
55772072|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
55772073|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772074|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55772075|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55772076|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772077|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772078|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55772079|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
56215247|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
56215248|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
56215250|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215251|NCT01617733|Pasireotide|pasireotide|mesh-list
56215253|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215254|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215255|NCT01617746|Bosentan|bosentan|mesh-list
56215256|NCT01617746|Ambrisentan|ambrisentan|mesh-list
56143057|NCT00582894|Fludarabine|fludarabine|mesh-list
56215257|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56215258|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56215259|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215260|NCT01617772|Atorvastatin|atorvastatin|mesh-list
56215261|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56215262|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56215263|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
56215264|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215265|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56215266|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56215267|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215268|NCT01617798|Metolazone|metolazone|mesh-list
56215269|NCT01617798|Furosemide|furosemide|mesh-list
56215270|NCT01617798|Diuretics|diuretics|mesh-ancestor
56215271|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
56215272|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215273|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56215274|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215275|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215276|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56000876|NCT00542542|Analgesics|analgesics|mesh-ancestor
55772080|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772081|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772082|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55772083|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
55772084|NCT04478357|Fesoterodine|fesoterodine|mesh-list
55772085|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55772086|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55772087|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
56215277|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56215279|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215280|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215281|NCT01617824|Linagliptin|linagliptin|mesh-list
56215282|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215283|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215284|NCT01617824|Incretins|incretins|mesh-ancestor
56215285|NCT01617824|Hormones|hormones|mesh-ancestor
56215286|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215287|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56215288|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
56215289|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215290|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215291|NCT01617928|Paclitaxel|paclitaxel|mesh-list
56215292|NCT01617928|Carboplatin|carboplatin|mesh-list
56215293|NCT01617928|Veliparib|veliparib|mesh-list
55791590|NCT02514031|Paclitaxel|paclitaxel|mesh-list
55772089|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772090|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772091|NCT04478357|Urological Agents|urological agents|mesh-ancestor
55772092|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
55772093|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55772094|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55772095|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772096|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772097|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772098|NCT04478513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55772099|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55772100|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772101|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772102|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772103|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
55772104|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55772105|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
55772107|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55912936|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
55912937|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912938|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55729567|NCT03510533|Hormones|hormones|mesh-ancestor
55772109|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55772111|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55772112|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
55783084|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55783085|NCT03079115|Atorvastatin|atorvastatin|mesh-list
55783086|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55772113|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772114|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772115|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55772116|NCT02342093|Diuretics|diuretics|mesh-ancestor
55772117|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
55772118|NCT02347319|Silymarin|silymarin|mesh-list
55772119|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
55772120|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772121|NCT02347319|Protective Agents|protective agents|mesh-ancestor
55772122|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772123|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
55772124|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56215294|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56215295|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215296|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
55772125|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772127|NCT02341703|Pioglitazone|pioglitazone|mesh-list
55772128|NCT02341703|Letrozole|letrozole|mesh-list
55772129|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55772130|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772131|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772132|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55772133|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55772134|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772135|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772136|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55772137|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
55772138|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772139|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
55772140|NCT02341547|Hematinics|hematinics|mesh-ancestor
55772141|NCT02341079|Bupivacaine|bupivacaine|mesh-list
55772142|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
55772143|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
55772144|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772145|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772146|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
55772147|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772148|NCT02346539|Nicotine|nicotine|mesh-list
55912939|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55912940|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772149|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55772150|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
55772151|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772152|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772153|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55772154|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55772155|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
55772156|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772157|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772158|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55772159|NCT02340455|Pregabalin|pregabalin|mesh-list
55772160|NCT02340455|Analgesics|analgesics|mesh-ancestor
55772161|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
55772162|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772163|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772164|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
55772165|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55772166|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772167|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772168|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55772169|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55772170|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55772171|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772172|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772174|NCT02345837|Enclomiphene|enclomiphene|mesh-list
55772175|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
55772176|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55772177|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
55772180|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55772181|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
55772182|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783087|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55772183|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55772184|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55772186|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
55772187|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55772188|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
55772189|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772190|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772191|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55729674|NCT03510221|Antioxidants|antioxidants|mesh-list
55772192|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
55772193|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55772194|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56215297|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
56215298|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
56215299|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791613|NCT04622917|Prednisolone|prednisolone|mesh-list
55772195|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55772196|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
55772197|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772198|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772199|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55772200|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
55772202|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772203|NCT02345681|Furosemide|furosemide|mesh-list
55772204|NCT02345681|Diuretics|diuretics|mesh-ancestor
55772205|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
55772206|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772207|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55772208|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772209|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772210|NCT02340611|Olaparib|olaparib|mesh-list
55772211|NCT02340611|Cediranib|cediranib|mesh-list
55772212|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55772213|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772214|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772215|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772216|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55772217|NCT03145649|Insulin|insulin|mesh-list
55772218|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55772219|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772220|NCT02345213|Donepezil|donepezil|mesh-list
55772221|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55772222|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772223|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772224|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
55772225|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772226|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772227|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
55772228|NCT02339753|Carboplatin|carboplatin|mesh-list
55772229|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772230|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
55772231|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
55772232|NCT02339441|Methotrexate|methotrexate|mesh-list
55772233|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55772234|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
55772235|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772236|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55772237|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55772238|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
55772239|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772240|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772241|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55772242|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55772243|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
55772244|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55772245|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55772246|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
55772253|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
55772255|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772256|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
55772257|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
55772258|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55772259|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55772260|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772261|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772262|NCT02344823|Urological Agents|urological agents|mesh-ancestor
55772263|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
55772264|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55772265|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215300|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56215301|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772266|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
55772267|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
55772268|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772271|NCT02344511|Dalbavancin|dalbavancin|mesh-list
55772273|NCT02344511|Nafcillin|nafcillin|mesh-list
55772274|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55772275|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772276|NCT02344589|Lidocaine|lidocaine|mesh-list
55772277|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
55772278|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
55772279|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772280|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772281|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
55772282|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772283|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55772284|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55772285|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55772286|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772287|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772296|NCT02338115|Paclitaxel|paclitaxel|mesh-list
55772297|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55772298|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772299|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
55772300|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
55772301|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
55772302|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772303|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
55772304|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
55772305|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55772306|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55772307|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772308|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772309|NCT02337881|Urological Agents|urological agents|mesh-ancestor
55772310|NCT02337257|Vitamin D|vitamin d|mesh-list
55772311|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
55772312|NCT02337257|Vitamins|vitamins|mesh-ancestor
55772313|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
55772314|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772315|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55772316|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55772317|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55772323|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55772324|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55912993|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912994|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55772326|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772327|NCT04850495|Prednisone|prednisone|mesh-list
55772328|NCT04850495|Cortisone|cortisone|mesh-list
55772329|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
55772330|NCT04850495|Rituximab|rituximab|mesh-list
55772332|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55772333|NCT04850495|Vincristine|vincristine|mesh-list
55772334|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
55772335|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55772336|NCT04850495|Antibodies|antibodies|mesh-list
55772337|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
55772338|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55772339|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55772341|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772342|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55772343|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55772344|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
55772345|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772346|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772347|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55772348|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55772349|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55772350|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55772351|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772352|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55772353|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
55772354|NCT04850495|Hormones|hormones|mesh-ancestor
55772355|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772356|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55772357|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55772358|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
55772359|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
55772360|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
55772361|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55772362|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
55772363|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55772364|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772365|NCT04477811|Vitamins|vitamins|mesh-list
55772366|NCT04477811|Vitamin K|vitamin k|mesh-list
55772367|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
55772368|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
55772369|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
55772370|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772371|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55772372|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55772373|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772374|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
55772375|NCT04477811|Coagulants|coagulants|mesh-ancestor
55772376|NCT02332031|Sorafenib|sorafenib|mesh-list
55772377|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772378|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55772379|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772380|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772381|NCT03112031|Tamoxifen|tamoxifen|mesh-list
55772382|NCT03112031|Fluconazole|fluconazole|mesh-list
55772383|NCT03112031|Amphotericin B|amphotericin b|mesh-list
55772384|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55772385|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55772387|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772389|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55772390|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772391|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55772392|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55913006|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772393|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55772394|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
55783092|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772395|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772396|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55772397|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55772398|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772399|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772400|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55772401|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55772402|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55772403|NCT03112031|Amebicides|amebicides|mesh-ancestor
55772404|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55772405|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55772406|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55772407|NCT03111797|Morphine|morphine|mesh-list
55772408|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55772409|NCT03111797|Narcotics|narcotics|mesh-ancestor
55772410|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772411|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772413|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
55772415|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
55772416|NCT02938013|Velpatasvir|velpatasvir|mesh-list
55772417|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55772418|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
55772419|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772420|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
55772421|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55772422|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772423|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55772424|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55772425|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772426|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215303|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55772428|NCT02336633|Resveratrol|resveratrol|mesh-list
55772429|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
55772430|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772431|NCT02336633|Protective Agents|protective agents|mesh-ancestor
55772432|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772433|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772434|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55772435|NCT02336477|Mexiletine|mexiletine|mesh-list
55772436|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55772437|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55772438|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55772439|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772440|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772441|NCT04624451|Dalbavancin|dalbavancin|mesh-list
55772442|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55772443|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772444|NCT02642315|Gabapentin|gabapentin|mesh-list
55772445|NCT02642315|Analgesics|analgesics|mesh-ancestor
55772446|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
55772447|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772448|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772449|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
55772450|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55772451|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55772452|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772453|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772454|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55772455|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55772457|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772459|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
55772460|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55772461|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
55772462|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772463|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772464|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55772465|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
55783094|NCT03078725|Glyburide|glyburide|mesh-list
55772466|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
55772467|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55772468|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
55772469|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772470|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772471|NCT02709889|Dexamethasone|dexamethasone|mesh-list
55772472|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55772473|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
55772474|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
55772475|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772476|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772477|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55772478|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
55772479|NCT02709889|Hormones|hormones|mesh-ancestor
55772480|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772481|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55772482|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772484|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55772485|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
55772486|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55772487|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55772488|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772489|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772490|NCT03189901|Protective Agents|protective agents|mesh-ancestor
55772491|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772492|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55772493|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
55772494|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55772495|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772496|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772497|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
56215304|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55772498|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772499|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772500|NCT02711995|Laxatives|laxatives|mesh-ancestor
55772501|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55772502|NCT03193723|Anesthetics|anesthetics|mesh-list
55772503|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772504|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913042|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
55913043|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55913044|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55913045|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55913046|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55913047|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
55913049|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55772506|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55772507|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55772508|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772509|NCT03512197|Midostaurin|midostaurin|mesh-list
55772510|NCT03512197|Staurosporine|staurosporine|mesh-list
55772511|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772512|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55772513|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772514|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772515|NCT02442817|Linagliptin|linagliptin|mesh-list
55772516|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55772517|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772518|NCT02442817|Incretins|incretins|mesh-ancestor
55772519|NCT02442817|Hormones|hormones|mesh-ancestor
55772520|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772521|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55772522|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
55772523|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772524|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772525|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
55772526|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55772527|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772528|NCT02442739|Ketamine|ketamine|mesh-list
55772529|NCT02442739|Analgesics|analgesics|mesh-ancestor
55772530|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
55772531|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772532|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772533|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55772534|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55772535|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
55772537|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783095|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55783096|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783097|NCT02341963|Ketamine|ketamine|mesh-list
55783098|NCT02341963|Analgesics|analgesics|mesh-ancestor
55783099|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
55783100|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783101|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783102|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55783103|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55783104|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
55783105|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
55783106|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772538|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55772539|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55772540|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772541|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772542|NCT02437045|Meropenem|meropenem|mesh-list
55772543|NCT02437045|Tazobactam|tazobactam|mesh-list
55772544|NCT02437045|Piperacillin|piperacillin|mesh-list
55772545|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55772546|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55913055|NCT00502905|Fludarabine|fludarabine|mesh-list
55913056|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
55913057|NCT00502905|Busulfan|busulfan|mesh-list
55772548|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55772549|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772550|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772551|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55772552|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55772553|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
55772555|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
55772556|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772557|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
55772558|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55772559|NCT05233735|Betamethasone|betamethasone|mesh-list
56215307|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772560|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55772561|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
55772562|NCT05233735|Hormones|hormones|mesh-ancestor
55772563|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772564|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772565|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55772566|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
55772567|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
55772568|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55772569|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55772570|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55772571|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772572|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772573|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
55772574|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772575|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772576|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55772577|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772578|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
55772580|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
55772581|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
55772582|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772583|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772584|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
55772585|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772586|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55772587|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55772588|NCT02331563|Analgesics|analgesics|mesh-ancestor
55772589|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55783107|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55783108|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55772591|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55913140|NCT00511173|Warfarin|warfarin|mesh-list
55772592|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
55772593|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772594|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772595|NCT02441803|Cytarabine|cytarabine|mesh-list
55772596|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
55772597|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
55772598|NCT02441803|Busulfan|busulfan|mesh-list
55772599|NCT02441803|Fludarabine|fludarabine|mesh-list
55772600|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
55772601|NCT02441803|Decitabine|decitabine|mesh-list
55772602|NCT02441803|Idarubicin|idarubicin|mesh-list
55772603|NCT02441803|Clofarabine|clofarabine|mesh-list
55772604|NCT02441803|Tacrolimus|tacrolimus|mesh-list
55772605|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
55772606|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55772607|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55772608|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
55772609|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772610|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55772611|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55772612|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
55772613|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772614|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772615|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55772616|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55772617|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
55772618|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
55772619|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772620|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55772621|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772622|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55772623|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55772624|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
55772625|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55772626|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55772627|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55772628|NCT02331173|Dorzolamide|dorzolamide|mesh-list
55772629|NCT02331173|Brinzolamide|brinzolamide|mesh-list
55772630|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55772631|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215308|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215309|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215311|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56215312|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56215313|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913151|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913152|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
55913153|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913154|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913155|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55913156|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
55913157|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913159|NCT00514137|Sunitinib|sunitinib|mesh-list
56215314|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56215315|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56215316|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215317|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
56215318|NCT01618136|Paclitaxel|paclitaxel|mesh-list
56215319|NCT01618136|Carboplatin|carboplatin|mesh-list
56215320|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56215321|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215322|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
56215323|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
56215324|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
55791623|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
55772632|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772633|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55772634|NCT02709109|Ivacaftor|ivacaftor|mesh-list
55772635|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55772636|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772637|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772638|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
55772639|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55772640|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55772641|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772642|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
55772643|NCT04233749|Coagulants|coagulants|mesh-ancestor
55772644|NCT03117595|Fentanyl|fentanyl|mesh-list
55772645|NCT03117595|Morphine|morphine|mesh-list
55772646|NCT03117595|Bupivacaine|bupivacaine|mesh-list
55772647|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
55772648|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
55772649|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772650|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772651|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
55772652|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772653|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55772654|NCT03117595|Narcotics|narcotics|mesh-ancestor
55772655|NCT03117595|Analgesics|analgesics|mesh-ancestor
55772656|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55772657|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55772658|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
55772659|NCT02039531|Mitogens|mitogens|mesh-list
55772660|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
55772661|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
55772662|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783109|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772663|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55772664|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
55772667|NCT02039531|Protective Agents|protective agents|mesh-ancestor
55772668|NCT02331251|Gemcitabine|gemcitabine|mesh-list
55772669|NCT02331251|Paclitaxel|paclitaxel|mesh-list
55772670|NCT02331251|Vinorelbine|vinorelbine|mesh-list
55772671|NCT02331251|Docetaxel|docetaxel|mesh-list
55772672|NCT02331251|Doxorubicin|doxorubicin|mesh-list
56215325|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215326|NCT01618188|Insulin|insulin|mesh-list
55772673|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55772674|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
55772675|NCT02331251|Irinotecan|irinotecan|mesh-list
55772676|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55772677|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772678|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
55772679|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
55772680|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
55730141|NCT03942887|Rituximab|rituximab|mesh-list
55772681|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772682|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55772683|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
55772684|NCT02331251|Antiviral Agents|antiviral agents|mesh-ancestor
55772696|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55772697|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55772698|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
55772699|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
55772700|NCT02435797|Vitamins|vitamins|mesh-ancestor
55772701|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
55772702|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772703|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55772704|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55772705|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772706|NCT02330783|Bevacizumab|bevacizumab|mesh-list
55772707|NCT02330783|Sorafenib|sorafenib|mesh-list
55772708|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55772709|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772710|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55772711|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55772712|NCT02330783|Growth Substances|growth substances|mesh-ancestor
55772713|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772714|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
55772715|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55772716|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772717|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772730|NCT02335151|Desflurane|desflurane|mesh-list
55772731|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55772732|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
55772733|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
55772734|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772735|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772736|NCT02709655|Vortioxetine|vortioxetine|mesh-list
55772738|NCT02709655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55772739|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55772740|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772743|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
55772744|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772745|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55772746|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
56215327|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56215329|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
55772747|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772748|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55772749|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55772750|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772751|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55772752|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55772753|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772754|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55772755|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55772756|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55772757|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55772758|NCT02334605|Capsaicin|capsaicin|mesh-list
55772759|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
55772760|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
55772761|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
55772762|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772763|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772764|NCT02329535|Progesterone|progesterone|mesh-list
55772765|NCT02329535|Progestins|progestins|mesh-ancestor
55772766|NCT02329535|Hormones|hormones|mesh-ancestor
55772767|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772768|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772769|NCT03187795|Mirabegron|mirabegron|mesh-list
55772770|NCT03187795|Oxybutynin|oxybutynin|mesh-list
55772771|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55772772|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55772773|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55772774|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
55772776|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772777|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772779|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
55772780|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
55772781|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772782|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55772783|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55772784|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
55772785|NCT02435563|Ritonavir|ritonavir|mesh-list
55772786|NCT02435563|Ticagrelor|ticagrelor|mesh-list
55772787|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55772788|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55772789|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
55772790|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772791|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772792|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55772793|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55772794|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
55772795|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772796|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55772797|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55772798|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55772799|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55772800|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55772801|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55772802|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
55772803|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772804|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772805|NCT04031729|Aspirin|aspirin|mesh-list
55772806|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55772807|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55772808|NCT04031729|Analgesics|analgesics|mesh-ancestor
55772809|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
55772810|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772811|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772812|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55772814|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55772815|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55772816|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143125|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215330|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56215331|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55772817|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55772818|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55772819|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772820|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
55772822|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55913233|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
55913234|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730264|NCT03505151|BI 409306|bi 409306|mesh-list
55750520|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
55750521|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750522|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750523|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
55750524|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750525|NCT03121079|Interferons|interferons|mesh-list
55750526|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
55750527|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750528|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
55750529|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772823|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55772824|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
55772825|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772826|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772827|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772828|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
55772829|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55772830|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772831|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772832|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772834|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55772835|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55772836|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
55772837|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
55772838|NCT02328521|Vitamins|vitamins|mesh-ancestor
55772839|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
55772840|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772841|NCT03831503|Antibodies|antibodies|mesh-list
55772842|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
55772843|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772844|NCT03187093|Vortioxetine|vortioxetine|mesh-list
55772845|NCT03187093|Citalopram|citalopram|mesh-list
55772846|NCT03187093|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55772847|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55772848|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772849|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772850|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772851|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
55772852|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772853|NCT03187093|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55772854|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
55772855|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772856|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55772857|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55772858|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772859|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55772860|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55772861|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55772862|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55772863|NCT02039999|Citric Acid|citric acid|mesh-list
55772864|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
55772865|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55772866|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
55772867|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55772868|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
55772869|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
55772870|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772871|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
55772872|NCT02434861|Digoxin|digoxin|mesh-list
55772873|NCT02434861|Rolapitant|rolapitant|mesh-list
55772874|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55772875|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55772876|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772877|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772878|NCT02434861|Protective Agents|protective agents|mesh-ancestor
55913235|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913252|NCT00525057|Dalteparin|dalteparin|mesh-list
55772879|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772880|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772881|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55772882|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55772883|NCT02434861|Analgesics|analgesics|mesh-ancestor
55772884|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
55783110|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215332|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215333|NCT01618253|Sorafenib|sorafenib|mesh-list
56215334|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772885|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772887|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55772888|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55772889|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55772890|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772892|NCT03187015|Midazolam|midazolam|mesh-list
55772893|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55772894|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55772895|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55772896|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772897|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55772898|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55772899|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772900|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55772901|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
55772902|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
55772903|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
55772904|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
55772905|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772906|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772907|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772908|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55772909|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772910|NCT02328053|Voriconazole|voriconazole|mesh-list
55772911|NCT02328053|Natamycin|natamycin|mesh-list
55772912|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
55772913|NCT02328053|Clotrimazole|clotrimazole|mesh-list
55772914|NCT02328053|Miconazole|miconazole|mesh-list
55772915|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772916|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55772917|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55772918|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772919|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772920|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55772921|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
55772922|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772923|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772924|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55772925|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55772926|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55772927|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55772928|NCT02022748|Ticagrelor|ticagrelor|mesh-list
55772929|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55772930|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55772931|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55913256|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55913257|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55913258|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913260|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
55913261|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913263|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
55913280|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913281|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
55772932|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55772933|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
55772934|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772935|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772936|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772937|NCT02333513|Vincristine|vincristine|mesh-list
55772938|NCT02333513|Lomustine|lomustine|mesh-list
55772939|NCT02333513|Procarbazine|procarbazine|mesh-list
55772940|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55772941|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772942|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
55772943|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
55772944|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
55772945|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756523|NCT02711137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730428|NCT02660229|Narcotics|narcotics|mesh-ancestor
55750530|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
55750531|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750533|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750534|NCT02494895|Aspirin|aspirin|mesh-list
55750535|NCT02494895|Ticagrelor|ticagrelor|mesh-list
55750536|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55750537|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750538|NCT02494895|Analgesics|analgesics|mesh-ancestor
55750539|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
55779896|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
55750540|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750541|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750542|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750543|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55750544|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55750545|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55789042|NCT03520231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55750546|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750547|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55750548|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55750549|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750550|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
55750551|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55750552|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55750553|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55750554|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
55750555|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750556|NCT03341741|Tobramycin|tobramycin|mesh-list
55750557|NCT03341741|Colistin|colistin|mesh-list
55750558|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55750559|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750561|NCT01597245|Ixekizumab|ixekizumab|mesh-list
55750562|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55750563|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750564|NCT01597245|Analgesics|analgesics|mesh-ancestor
55750565|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
55750566|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750567|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750568|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750569|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55750570|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55750571|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55750572|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
55750573|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
55750574|NCT03341429|Liraglutide|liraglutide|mesh-list
55750575|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55750576|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750577|NCT03341429|Incretins|incretins|mesh-ancestor
55750579|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750580|NCT04494659|Rifampin|rifampin|mesh-list
55750581|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55750582|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
55750583|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55750584|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750585|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
55752950|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
55772946|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55772947|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
55772948|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55772949|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55772950|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55772951|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772952|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
55772953|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215335|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56215336|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215337|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772954|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772955|NCT02328209|Ranibizumab|ranibizumab|mesh-list
55783111|NCT05014685|Amoxicillin|amoxicillin|mesh-list
55783112|NCT05014685|Metronidazole|metronidazole|mesh-list
55783113|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
55772956|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55772957|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55772958|NCT02328209|Growth Substances|growth substances|mesh-ancestor
55772959|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772960|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
55772961|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772963|NCT02328443|Itraconazole|itraconazole|mesh-list
55772964|NCT02328443|Rifampin|rifampin|mesh-list
55772965|NCT02328443|Midazolam|midazolam|mesh-list
55772966|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55772967|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55772969|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772970|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55772971|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55772972|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55772973|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55772974|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
55772975|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
55772976|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
55772977|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
55772978|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772979|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772980|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
55772981|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772982|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55772983|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55772984|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772985|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55772986|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
55772987|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772988|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55772989|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55772990|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
55772991|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55772992|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
55772993|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55772994|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55772995|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55772997|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55772998|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55772999|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55913282|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913283|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55773000|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55773001|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55773002|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55773003|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55773004|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55773005|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
55773006|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773007|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773008|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773009|NCT03191539|Apremilast|apremilast|mesh-list
55773010|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55773011|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55773012|NCT03191539|Analgesics|analgesics|mesh-ancestor
55773013|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
55773014|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773015|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773016|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215338|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56215339|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215340|NCT01618396|Midazolam|midazolam|mesh-list
56215341|NCT01618396|Propofol|propofol|mesh-list
56215342|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55773017|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55773018|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55773019|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55773020|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773021|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913296|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913298|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55913299|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55730499|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
55773022|NCT02433925|Resveratrol|resveratrol|mesh-list
55783115|NCT05014685|Bismuth|bismuth|mesh-list
55783116|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783118|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783119|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55783120|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55783121|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55773023|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
55773024|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773025|NCT02433925|Protective Agents|protective agents|mesh-ancestor
55773026|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773027|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773028|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55773029|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
55773030|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773031|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773032|NCT02327663|Emtricitabine|emtricitabine|mesh-list
55773033|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
55773034|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773035|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55773036|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55773037|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773038|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773039|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55773040|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55773042|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55773043|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55773044|NCT02333123|Analgesics|analgesics|mesh-ancestor
55773045|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
55773046|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773047|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773048|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773049|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55773050|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55773051|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55773052|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773053|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55773054|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55773055|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773056|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
55773057|NCT02332811|Sevelamer|sevelamer|mesh-list
55773058|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
55773059|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
55773060|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773061|NCT02433457|Omeprazole|omeprazole|mesh-list
55773062|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55773063|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773064|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55773065|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773066|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773067|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
55773068|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55773069|NCT02021656|Ledipasvir|ledipasvir|mesh-list
55773070|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
55773071|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773072|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
55773073|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773074|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
55773075|NCT03145025|Hormones|hormones|mesh-ancestor
56215343|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773076|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773077|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773078|NCT03144947|Docetaxel|docetaxel|mesh-list
55773080|NCT03144947|Pertuzumab|pertuzumab|mesh-list
55773081|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773082|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
55773083|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
55773084|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
55773085|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773086|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55773087|NCT02433535|Simvastatin|simvastatin|mesh-list
55773088|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55773089|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55773090|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
55773091|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773092|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55773095|NCT03144713|Terlipressin|terlipressin|mesh-list
55773096|NCT03144713|Midodrine|midodrine|mesh-list
55773097|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
55773098|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
55773099|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773100|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773101|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55773102|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55773103|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55773104|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55773105|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
55773106|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773107|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773108|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55773110|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
55913312|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913313|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
55913314|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55913315|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55913316|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55913317|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55913318|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913319|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
55913320|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913321|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913322|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55913323|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913324|NCT00525837|Varenicline|varenicline|mesh-list
55913325|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55913326|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55913327|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
55913328|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913329|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913330|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913332|NCT00527475|Verteporfin|verteporfin|mesh-list
55913333|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55773111|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773112|NCT04682158|Paclitaxel|paclitaxel|mesh-list
55773113|NCT04682158|Carboplatin|carboplatin|mesh-list
55773114|NCT04682158|Propranolol|propranolol|mesh-list
55773115|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55773116|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773117|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
55773118|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
55773119|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
55773120|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773121|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55773122|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55773123|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
55773124|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773125|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773126|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55773127|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55773128|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
55773129|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
55773130|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773131|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
55773132|NCT02075632|Hormones|hormones|mesh-ancestor
55773133|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773134|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773135|NCT02430259|Isoniazid|isoniazid|mesh-list
55773136|NCT02430259|Rifapentine|rifapentine|mesh-list
55773137|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
55773138|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55773139|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773140|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55773141|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55773142|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
55773143|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773145|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55773146|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
55773147|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
55773148|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56215344|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215345|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56215346|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
56215347|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
56215348|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56215349|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55773149|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773150|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55773151|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773152|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
55773153|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55773154|NCT03142607|Metronidazole|metronidazole|mesh-list
55773155|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55773156|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773157|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
55783122|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773158|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
55773159|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55773160|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55773161|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55773162|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
55773163|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55773164|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55773167|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773168|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
55773169|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773170|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773171|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55773172|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773173|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
55756554|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55913334|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913335|NCT00527475|Growth Substances|growth substances|mesh-ancestor
55913336|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913337|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913338|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913339|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55913340|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
55913341|NCT01798251|Capecitabine|capecitabine|mesh-list
55913342|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
55773174|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
55773175|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
55773176|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773177|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773179|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
55773180|NCT02326727|Propofol|propofol|mesh-list
55773181|NCT02326727|Ropivacaine|ropivacaine|mesh-list
55773182|NCT02326727|Isoflurane|isoflurane|mesh-list
55773183|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55773184|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773185|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773186|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55773187|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
55773188|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
55773189|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
55773190|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
55773191|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773192|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55773193|NCT02326727|Narcotics|narcotics|mesh-ancestor
55773194|NCT02326727|Analgesics|analgesics|mesh-ancestor
55773195|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55773196|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55773197|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55773198|NCT02432911|Cytarabine|cytarabine|mesh-list
55773199|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
55773200|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55773201|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
55773202|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773203|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773204|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
55773205|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773206|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55773207|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
55773208|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773209|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55773210|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55913343|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55913344|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
55913345|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913346|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913347|NCT02121483|Empagliflozin|empagliflozin|mesh-list
55913348|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55913349|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913350|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55913351|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913352|NCT01572038|Paclitaxel|paclitaxel|mesh-list
55913353|NCT01572038|Docetaxel|docetaxel|mesh-list
55913354|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55913356|NCT01572038|Pertuzumab|pertuzumab|mesh-list
55773212|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
55773213|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
55773214|NCT03588767|Vitamins|vitamins|mesh-list
55773215|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
56215350|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56215351|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215352|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
55773216|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
55773217|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773218|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55773219|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55773221|NCT03588767|Hormones|hormones|mesh-ancestor
55773222|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773223|NCT02440399|Acetaminophen|acetaminophen|mesh-list
55773224|NCT02440399|Diclofenac|diclofenac|mesh-list
55773225|NCT02440399|Morphine|morphine|mesh-list
55773226|NCT02440399|Oxycodone|oxycodone|mesh-list
55773227|NCT02440399|Tramadol|tramadol|mesh-list
55773228|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55773229|NCT02440399|Narcotics|narcotics|mesh-ancestor
55773230|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773231|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773232|NCT02440399|Analgesics|analgesics|mesh-ancestor
55773233|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
55783123|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55783124|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783125|NCT05014685|Antacids|antacids|mesh-ancestor
55773234|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773235|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55773236|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
55773237|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55773238|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773240|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55773241|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773242|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773243|NCT03574571|Docetaxel|docetaxel|mesh-list
55773244|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773245|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
55773246|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
55773247|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
55773248|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773249|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
55773250|NCT03565445|Nivolumab|nivolumab|mesh-list
55756568|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55913369|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
55913370|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55913371|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
55913372|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55913373|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
55913374|NCT01448213|Hormones|hormones|mesh-ancestor
55913375|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55913376|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773251|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55773252|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773253|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55773254|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773255|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
55773256|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55773257|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55773258|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
55773259|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773260|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773261|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773262|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
55773263|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
55773264|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773265|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
55773266|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55773267|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
55773268|NCT03191305|Warfarin|warfarin|mesh-list
55773269|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
55773270|NCT03144401|Misoprostol|misoprostol|mesh-list
55773271|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55773272|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
55773273|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55773274|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773275|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55773276|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773277|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
55773278|NCT04483765|Anesthetics|anesthetics|mesh-list
55773279|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773280|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773281|NCT03186313|Ribavirin|ribavirin|mesh-list
55773282|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
55773283|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
55773284|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215353|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
56215354|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773285|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
55773286|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773287|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
55773288|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55773289|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773291|NCT04996199|Carbamazepine|carbamazepine|mesh-list
55773292|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
55773293|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
55773294|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
55773295|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55773296|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773297|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773299|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55773300|NCT04996199|Analgesics|analgesics|mesh-ancestor
55773301|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
55773302|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773303|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55783127|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
55783128|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773304|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55773305|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773306|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55773307|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55773308|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55773309|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55773335|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55773336|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773337|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773338|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773339|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55773340|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55773342|NCT04984733|Temozolomide|temozolomide|mesh-list
55773343|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55773344|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773345|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55773346|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773347|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55773348|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
55773349|NCT02707861|Ibalizumab|ibalizumab|mesh-list
55773350|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55773351|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
55773352|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773353|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55773354|NCT02432599|Choline|choline|mesh-list
55773355|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
55773356|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55773357|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
55773358|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773359|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773360|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55773362|NCT03185143|Acetaminophen|acetaminophen|mesh-list
55773363|NCT03185143|Sumatriptan|sumatriptan|mesh-list
55773364|NCT03185143|Naltrexone|naltrexone|mesh-list
55913513|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913514|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913515|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
55913516|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
55913517|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55913518|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
55913519|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55913520|NCT03357159|Antibodies|antibodies|mesh-list
55913521|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913522|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
55913523|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913524|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55773365|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55773366|NCT03185143|Analgesics|analgesics|mesh-ancestor
55773367|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
55773368|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773369|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773370|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
55773371|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55783129|NCT05014685|Expectorants|expectorants|mesh-ancestor
55783130|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
55783131|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
55773372|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55773373|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55773374|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55773375|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55773376|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
56215355|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773377|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773378|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773379|NCT05076773|Morphine|morphine|mesh-list
55773380|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55773381|NCT05076773|Narcotics|narcotics|mesh-ancestor
55773382|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773383|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773384|NCT05076773|Analgesics|analgesics|mesh-ancestor
55773385|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
55773387|NCT02432677|Remifentanil|remifentanil|mesh-list
55773388|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55773389|NCT02432677|Narcotics|narcotics|mesh-ancestor
55913525|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55773390|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773391|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773392|NCT02432677|Analgesics|analgesics|mesh-ancestor
55773393|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
55773394|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773395|NCT03442673|Gemcitabine|gemcitabine|mesh-list
55773396|NCT03442673|Vinorelbine|vinorelbine|mesh-list
55773397|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55773398|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
55773399|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773400|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773401|NCT03442673|Antiviral Agents|antiviral agents|mesh-ancestor
55773402|NCT03442673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773403|NCT03442673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773404|NCT03442673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55773405|NCT03442673|Immunologic Factors|immunologic factors|mesh-ancestor
55773406|NCT03442673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773407|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55773408|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
55773409|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
55773410|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
55773412|NCT02432365|Cisplatin|cisplatin|mesh-list
55773413|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55773414|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773415|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
55773416|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
55773417|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
55773418|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773419|NCT05076695|Trastuzumab|trastuzumab|mesh-list
55773420|NCT05076695|Fulvestrant|fulvestrant|mesh-list
55773421|NCT05076695|Palbociclib|palbociclib|mesh-list
55773422|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55773423|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773424|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55773425|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55773426|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55773427|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
55773428|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773430|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55773431|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773432|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773433|NCT03143933|Fentanyl|fentanyl|mesh-list
55773434|NCT03143933|Propofol|propofol|mesh-list
55773435|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55773436|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773437|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773438|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55773439|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
55783132|NCT03111901|Interleukin-2|interleukin-2|mesh-list
55783133|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55783134|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773440|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
55773441|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56215357|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56215358|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215359|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
55773442|NCT03143933|Narcotics|narcotics|mesh-ancestor
55773443|NCT03143933|Analgesics|analgesics|mesh-ancestor
55773444|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
55773445|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773446|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55773448|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
55773449|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773450|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
55773451|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55773452|NCT05076461|Ondansetron|ondansetron|mesh-list
55773453|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
55913574|NCT03072771|Blinatumomab|blinatumomab|mesh-list
55773454|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
55773455|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773456|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773457|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773458|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
55773459|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
55773460|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55773461|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
55773462|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773463|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773464|NCT05076461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55773465|NCT05076461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55773466|NCT05076461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773467|NCT05076461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55773468|NCT05076461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55773469|NCT02428933|Bromocriptine|bromocriptine|mesh-list
55773470|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55773471|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55773472|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
55773473|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773474|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773475|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
55773476|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
55773477|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773478|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773480|NCT02428777|Tramadol|tramadol|mesh-list
55773481|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55773482|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55773483|NCT02428777|Analgesics|analgesics|mesh-ancestor
55913581|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55913582|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
55913583|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
55913584|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913585|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55773484|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
55773485|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773486|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773487|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773488|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55773489|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55773490|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773491|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773492|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55773493|NCT02428777|Narcotics|narcotics|mesh-ancestor
55773494|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773495|NCT02432053|Tacrolimus|tacrolimus|mesh-list
55773496|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55773497|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
55773499|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55773500|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773501|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773502|NCT03141827|Insulin|insulin|mesh-list
55773503|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55773504|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773505|NCT03190681|Methylphenidate|methylphenidate|mesh-list
55773506|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55783135|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55783136|NCT03111901|Analgesics|analgesics|mesh-ancestor
56215360|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215362|NCT01618474|Capecitabine|capecitabine|mesh-list
55783137|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
55783138|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783139|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783140|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55783141|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55783142|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
55773507|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773508|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55773509|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55773510|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55773511|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773512|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
55773513|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773514|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55773515|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55773516|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55773517|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55773518|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773519|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
55913732|NCT00574587|Vorinostat|vorinostat|mesh-list
55773521|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773522|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55773523|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773525|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
55773526|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773527|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55773528|NCT04551911|Calcifediol|calcifediol|mesh-list
55773529|NCT04551911|Vitamins|vitamins|mesh-ancestor
55773530|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
55773531|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773532|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55773533|NCT02431975|Ritonavir|ritonavir|mesh-list
55773534|NCT02431975|Lopinavir|lopinavir|mesh-list
55773535|NCT02431975|Lamivudine|lamivudine|mesh-list
55773536|NCT02431975|Zidovudine|zidovudine|mesh-list
55773537|NCT02431975|Nevirapine|nevirapine|mesh-list
55773538|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55773539|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55773540|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
55773541|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773542|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773543|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55913793|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913794|NCT04417569|Estrogens|estrogens|mesh-ancestor
55913795|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55913796|NCT04417569|Progestins|progestins|mesh-ancestor
55913797|NCT01550744|Ustekinumab|ustekinumab|mesh-list
55773544|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55773545|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
55773546|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773547|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55773548|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55773549|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55773550|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55773551|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
55773552|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55773553|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55773554|NCT03143465|Calcitonin|calcitonin|mesh-list
55773555|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
55773556|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
55773557|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55773558|NCT03143465|Katacalcin|katacalcin|mesh-list
55773559|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
55773560|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55773561|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55773562|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773563|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783143|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783144|NCT02341729|Ticagrelor|ticagrelor|mesh-list
55773566|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773567|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55773568|NCT05034809|Melatonin|melatonin|mesh-list
55773569|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
55773570|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215363|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215364|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
56215365|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
55773571|NCT05034809|Protective Agents|protective agents|mesh-ancestor
55773572|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773573|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773574|NCT02428543|Cytarabine|cytarabine|mesh-list
55773575|NCT02428543|Ponatinib|ponatinib|mesh-list
55773576|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55773577|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
55773578|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773579|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773580|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
55773581|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773582|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55773583|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
55773584|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773585|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55773586|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773587|NCT04428203|Cannabidiol|cannabidiol|mesh-list
55773588|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
55773589|NCT02431663|Ketamine|ketamine|mesh-list
55773590|NCT02431663|Analgesics|analgesics|mesh-ancestor
55773591|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
55773592|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773593|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913849|NCT00579111|Busulfan|busulfan|mesh-list
55773594|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55773595|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55773596|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
55773598|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773599|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55773600|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55773601|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773602|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773604|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
55773605|NCT03182803|Antibodies|antibodies|mesh-list
55773606|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
55773607|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773608|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55773609|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773610|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773611|NCT03185611|Rifaximin|rifaximin|mesh-list
55773612|NCT03185611|Azathioprine|azathioprine|mesh-list
55773613|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55773614|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773615|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773616|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
55773617|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773618|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55773619|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773620|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55773621|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
55913906|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55913907|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
55913908|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55913909|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55913910|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
55913911|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913912|NCT04233567|Infigratinib|infigratinib|mesh-list
55913913|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913914|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
55913915|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55913916|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55913917|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
55913918|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913919|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913920|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913921|NCT00581061|Urological Agents|urological agents|mesh-ancestor
55913922|NCT01549652|Morphine|morphine|mesh-list
55913923|NCT01549652|Ondansetron|ondansetron|mesh-list
55913924|NCT01549652|Naloxone|naloxone|mesh-list
55913925|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55913926|NCT01549652|Narcotics|narcotics|mesh-ancestor
55913927|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773622|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773623|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55783145|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55773624|NCT03547973|Gemcitabine|gemcitabine|mesh-list
55773625|NCT03547973|Carboplatin|carboplatin|mesh-list
56215366|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
56215367|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791658|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
55773626|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
55773627|NCT03547973|Avelumab|avelumab|mesh-list
55773628|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773629|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55773630|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
55773631|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773632|NCT03547973|Antiviral Agents|antiviral agents|mesh-ancestor
55773633|NCT03547973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773634|NCT03547973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773635|NCT03547973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55773636|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
55773637|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773638|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55773639|NCT02431429|Miltefosine|miltefosine|mesh-list
55773640|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
55773641|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773642|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773643|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55773644|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55773645|NCT02027428|Paclitaxel|paclitaxel|mesh-list
55773646|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55773647|NCT02027428|Carboplatin|carboplatin|mesh-list
55773648|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55773649|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773650|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
55773651|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
55773652|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
55773653|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773654|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55773655|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55773656|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55773657|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773658|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773659|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55773660|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55773661|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773662|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
55773663|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773664|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55773665|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773666|NCT01995136|Travoprost|travoprost|mesh-list
55773667|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55773668|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55773669|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55773671|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
55773672|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
55773673|NCT03141593|Vitamins|vitamins|mesh-list
55773674|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
55773675|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773676|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55773677|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55773678|NCT04102241|Hemay005|hemay005|mesh-list
55773679|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
55773680|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55773681|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55773682|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773683|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773684|NCT03576443|Idelalisib|idelalisib|mesh-list
55783146|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55773685|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773686|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215368|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56215370|NCT01618513|Octreotide|octreotide|mesh-list
56215371|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773687|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773690|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773691|NCT04667572|Riboflavin|riboflavin|mesh-list
55773692|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
55773693|NCT04667572|Vitamins|vitamins|mesh-ancestor
55773694|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
55773696|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55773697|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
55773698|NCT04438733|Anastrozole|anastrozole|mesh-list
55773699|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55773700|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773701|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55773702|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55773703|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773704|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773705|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55773706|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
55773707|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773708|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773709|NCT04438811|Anesthetics|anesthetics|mesh-list
55773710|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773711|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773712|NCT02427295|Octreotide|octreotide|mesh-list
55773713|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773714|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55773715|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773716|NCT01994590|Prednisone|prednisone|mesh-list
55773717|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
55773718|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773719|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
55773720|NCT01994590|Hormones|hormones|mesh-ancestor
55773721|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773722|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773723|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55773724|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773725|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55914111|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
55914112|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914113|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914114|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914115|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914116|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55914117|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55914118|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914119|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55914145|NCT00617097|Lidocaine|lidocaine|mesh-list
55914146|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
55773726|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773727|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773728|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
55773729|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55773730|NCT05387603|Capecitabine|capecitabine|mesh-list
55773731|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
55773732|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55773733|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
55783147|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55783148|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55773734|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773735|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215373|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215374|NCT01618539|Propofol|propofol|mesh-list
56215375|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56215376|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791663|NCT03042377|Calcium|calcium|mesh-list
55773738|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55773739|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773740|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55773741|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55773754|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
55773755|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773756|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773757|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
55773758|NCT03117439|Clotrimazole|clotrimazole|mesh-list
55773759|NCT03117439|Miconazole|miconazole|mesh-list
55773760|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773761|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55773762|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55773763|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55773764|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773765|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773766|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55773767|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
55773768|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773769|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773770|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55773771|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55773772|NCT02426905|Trientine|trientine|mesh-list
55773773|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
55773774|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
55773775|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773776|NCT02421289|Efavirenz|efavirenz|mesh-list
55773777|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55773778|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55773779|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773780|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773781|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
55773782|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773783|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55773784|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55773785|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55773786|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55773787|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55773788|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55773789|NCT02389517|Dexamethasone|dexamethasone|mesh-list
55773790|NCT02389517|Lenalidomide|lenalidomide|mesh-list
55773791|NCT02389517|Ixazomib|ixazomib|mesh-list
55773792|NCT02389517|Glycine|glycine|mesh-list
55773793|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
55783149|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
56215377|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215378|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56215379|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
56215380|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
55773794|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773795|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
55773796|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
55773797|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773798|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773799|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773800|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
55773801|NCT02389517|Hormones|hormones|mesh-ancestor
55773802|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773803|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55773804|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773805|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
55773806|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55773807|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55773808|NCT02389517|Growth Substances|growth substances|mesh-ancestor
55773809|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
55773810|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773811|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
55773812|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773814|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773815|NCT03141125|Ethanol|ethanol|mesh-list
55773816|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55914204|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55914205|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55914206|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773817|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773818|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773819|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773820|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
55773821|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
55773822|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
55773823|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55773824|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55773825|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773826|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773827|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773828|NCT03142763|Choline|choline|mesh-list
55773829|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
55773830|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55773831|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
55773832|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773833|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773834|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55773835|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
55773836|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
55773837|NCT03511391|Nivolumab|nivolumab|mesh-list
55773838|NCT03511391|Atezolizumab|atezolizumab|mesh-list
55773839|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55773840|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55783151|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773841|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773842|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773843|NCT05081765|Olaparib|olaparib|mesh-list
55773846|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773848|NCT05078177|Rituximab|rituximab|mesh-list
55773849|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55773850|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215382|NCT01618591|Levofloxacin|levofloxacin|mesh-list
56215383|NCT01618591|Ofloxacin|ofloxacin|mesh-list
56215384|NCT01618591|Rifaximin|rifaximin|mesh-list
55773851|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
55773852|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773853|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55773854|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
55773855|NCT05081687|Irinotecan|irinotecan|mesh-list
55773856|NCT05081687|Folfirinox|folfirinox|mesh-list
55773857|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773858|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55914220|NCT04122443|Oxycodone|oxycodone|mesh-list
55773859|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55773860|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773861|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773862|NCT05080985|Bupivacaine|bupivacaine|mesh-list
55773863|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
55773864|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
55773865|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773866|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773867|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
55773868|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773869|NCT05275205|Aflibercept|aflibercept|mesh-list
55773870|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55773871|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55773872|NCT05275205|Growth Substances|growth substances|mesh-ancestor
55773873|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773874|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
55773875|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773876|NCT03139487|Dalteparin|dalteparin|mesh-list
55773877|NCT03139487|Tinzaparin|tinzaparin|mesh-list
55773878|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55773879|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
55773880|NCT03139487|Apixaban|apixaban|mesh-list
55773881|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55773882|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
55773883|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55773884|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
55773886|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773887|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
55773888|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55773889|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55773891|NCT04976387|Ibuprofen|ibuprofen|mesh-list
55773892|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55773893|NCT04976387|Hydrocodone|hydrocodone|mesh-list
55773894|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55773895|NCT04976387|Analgesics|analgesics|mesh-ancestor
55773896|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
55773897|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773898|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773899|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
55773900|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55773901|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773902|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55773903|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55773904|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773905|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773906|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55773907|NCT04976387|Narcotics|narcotics|mesh-ancestor
55773908|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783152|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783153|NCT05014373|Favipiravir|favipiravir|mesh-list
55773909|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
55773910|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
56215385|NCT01618591|Loperamide|loperamide|mesh-list
56215386|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
56215387|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56215388|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215389|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56215390|NCT01618591|Renal Agents|renal agents|mesh-ancestor
55773911|NCT03139253|Amoxicillin|amoxicillin|mesh-list
55773912|NCT03139253|Clarithromycin|clarithromycin|mesh-list
55773913|NCT03139253|Levofloxacin|levofloxacin|mesh-list
55773914|NCT03139253|Ofloxacin|ofloxacin|mesh-list
55773915|NCT03139253|Tetracycline|tetracycline|mesh-list
55773916|NCT03139253|Tinidazole|tinidazole|mesh-list
55773917|NCT03139253|Furazolidone|furazolidone|mesh-list
55773918|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55773919|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773920|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55773921|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773922|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773923|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55773924|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55773925|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55773926|NCT03139253|Renal Agents|renal agents|mesh-ancestor
55914409|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55773927|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55773928|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55773929|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773930|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55773931|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55773932|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55773933|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55773934|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55773935|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55773936|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
55773937|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
55773938|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55773939|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773940|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
55773941|NCT02019472|Adalimumab|adalimumab|mesh-list
55773942|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55773943|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773944|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55773945|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
55773946|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773947|NCT00157937|Theophylline|theophylline|mesh-list
55773948|NCT00157937|Montelukast|montelukast|mesh-list
55773949|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773950|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804994|NCT04080895|Artemether|artemether|mesh-list
55773951|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773953|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773954|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
55773955|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55773956|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55773957|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
55773958|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773959|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55773960|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55773961|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55773962|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55773963|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773964|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
56215391|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56215392|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55773965|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55773966|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55783154|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
55783155|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783157|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773967|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
55773968|NCT03139565|Vaccines|vaccines|mesh-list
55773969|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
55773973|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55773974|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55773975|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773976|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773977|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773978|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55773979|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
55773980|NCT04423601|Itraconazole|itraconazole|mesh-list
55773981|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
55773982|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773983|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55773984|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55773985|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773986|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773987|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55773988|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
55773989|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773990|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773991|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55773992|NCT05022563|Warfarin|warfarin|mesh-list
55773993|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
55773994|NCT05022563|Dabigatran|dabigatran|mesh-list
55773995|NCT05022563|Apixaban|apixaban|mesh-list
55773996|NCT05022563|Anticoagulants|anticoagulants|mesh-list
55773997|NCT05022563|Edoxaban|edoxaban|mesh-list
55773998|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55773999|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
55774000|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55914588|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55914589|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55774001|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
55774002|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774003|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774004|NCT04983095|Hormones|hormones|mesh-list
55774005|NCT04983095|Androgens|androgens|mesh-list
55774006|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
55774007|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774008|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774009|NCT03281369|Leucovorin|leucovorin|mesh-list
55774010|NCT03281369|Linagliptin|linagliptin|mesh-list
55774011|NCT03281369|Paclitaxel|paclitaxel|mesh-list
55774012|NCT03281369|Fluorouracil|fluorouracil|mesh-list
55774013|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
55774014|NCT03281369|Atezolizumab|atezolizumab|mesh-list
55774015|NCT03281369|Ramucirumab|ramucirumab|mesh-list
55774016|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55774017|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55774018|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774019|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
55914643|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914644|NCT01439867|Cinacalcet|cinacalcet|mesh-list
55914645|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55914646|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914647|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
55914648|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
55914649|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55914650|NCT00637923|Ribavirin|ribavirin|mesh-list
55914651|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55914652|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
55914653|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
55914654|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914655|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
55914656|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914657|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55914658|NCT01439711|Letrozole|letrozole|mesh-list
55914659|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914660|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55914661|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55774020|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
55774021|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
55774022|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774023|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
55783158|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774024|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55774025|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56215393|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215394|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215395|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791676|NCT04860011|Diuretics|diuretics|mesh-ancestor
55774026|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
55774027|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774028|NCT03281369|Antidotes|antidotes|mesh-ancestor
55774029|NCT03281369|Protective Agents|protective agents|mesh-ancestor
55774030|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
55774031|NCT03281369|Vitamins|vitamins|mesh-ancestor
55774032|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
55774035|NCT03281369|Hormones|hormones|mesh-ancestor
55774036|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774037|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55774038|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
55774039|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774040|NCT02936687|Ambrisentan|ambrisentan|mesh-list
55774041|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55774042|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
55774043|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55774044|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55774045|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774046|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
55774047|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774048|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774049|NCT05083793|Pregabalin|pregabalin|mesh-list
55774050|NCT05083793|Analgesics|analgesics|mesh-ancestor
55774051|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
55756629|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
55914678|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
55914679|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914680|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914681|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
55914682|NCT00675909|Midazolam|midazolam|mesh-list
55914683|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55914684|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55774052|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774053|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774054|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
55774055|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55774056|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55774057|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774058|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55774059|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55774060|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55774061|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774062|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55774063|NCT05083013|Chrysarobin|chrysarobin|mesh-list
55774064|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55774065|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55774066|NCT05083013|Analgesics|analgesics|mesh-ancestor
55774067|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
55774068|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774069|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774070|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55774071|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55774072|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55774073|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55774074|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774075|NCT03223883|Curcumin|curcumin|mesh-list
55774076|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55774077|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55774078|NCT03223883|Analgesics|analgesics|mesh-ancestor
55774079|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
55774080|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774081|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774082|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55774083|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55774084|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774085|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914755|NCT04120961|Hirudins|hirudins|mesh-list
55774086|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774087|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55774088|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55774089|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55774090|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
55774091|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215396|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56215397|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56215398|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56215399|NCT01618643|Acetic Acid|acetic acid|mesh-list
56215400|NCT01618643|Retinol acetate|retinol acetate|mesh-list
56215401|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56215402|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215403|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56215404|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
56143203|NCT00590226|Insulin|insulin|mesh-list
56215405|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215406|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56215407|NCT01618643|Protective Agents|protective agents|mesh-ancestor
56215408|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215409|NCT01618760|Risperidone|risperidone|mesh-list
56215410|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56215411|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
56215412|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215413|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215414|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791680|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
55774092|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55774093|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55774094|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774095|NCT05048069|Rebamipide|rebamipide|mesh-list
55774096|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55774097|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55774098|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
55774099|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774100|NCT05048069|Protective Agents|protective agents|mesh-ancestor
55774101|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774102|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774103|NCT03194165|Ritonavir|ritonavir|mesh-list
55774104|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55774105|NCT03194165|Darunavir|darunavir|mesh-list
55774106|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
55774107|NCT03194165|Nevirapine|nevirapine|mesh-list
55774108|NCT03194165|Dolutegravir|dolutegravir|mesh-list
55774109|NCT03194165|Rilpivirine|rilpivirine|mesh-list
55774110|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55774111|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55774112|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
55774113|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774114|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774115|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55774116|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55774117|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
55774118|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914789|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
55774119|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55774120|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55774121|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56215415|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56215416|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56215417|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215418|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215419|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56215420|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
56215421|NCT01618773|Adapalene|adapalene|mesh-list
56215422|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56215423|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
56215424|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56215425|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56215426|NCT01618773|Analgesics|analgesics|mesh-ancestor
56215427|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
56215428|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215429|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215430|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215431|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56215432|NCT01618799|Lamotrigine|lamotrigine|mesh-list
55774122|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55774123|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55774124|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55774125|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55774126|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55774127|NCT04065113|Ethanol|ethanol|mesh-list
55774128|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55774129|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774130|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774131|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774132|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
55774133|NCT03366155|Irinotecan|irinotecan|mesh-list
55774134|NCT03366155|Cetuximab|cetuximab|mesh-list
55774135|NCT03366155|Panitumumab|panitumumab|mesh-list
55774136|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774137|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55774138|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55774139|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774140|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774141|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55774142|NCT03116737|Benzocaine|benzocaine|mesh-list
55774143|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55774144|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
55774145|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
55774146|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774147|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774148|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
55774149|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774150|NCT03116659|Doxycycline|doxycycline|mesh-list
55774151|NCT03116659|Imiquimod|imiquimod|mesh-list
55774152|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55774153|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774154|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
55774155|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55774156|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55774157|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55774158|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
55774159|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215434|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56215435|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215436|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215437|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56215438|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215439|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56215440|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56215441|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215442|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215443|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56215444|NCT01618825|Lamotrigine|lamotrigine|mesh-list
56215445|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
56215446|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56215447|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215448|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215449|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56215450|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215451|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56215452|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55791719|NCT03037775|Nicotine|nicotine|mesh-list
55774160|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774161|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
55774162|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55774163|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
55774164|NCT01993888|Coagulants|coagulants|mesh-ancestor
55774165|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
55774166|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55783159|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783160|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55783161|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55783162|NCT03078569|Testosterone|testosterone|mesh-list
55774167|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55774168|NCT02425813|Prednisolone|prednisolone|mesh-list
55774169|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
55774170|NCT02425813|Budesonide|budesonide|mesh-list
55774171|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55774172|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
55774173|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55774174|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
55774175|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
55914964|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55914965|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55914966|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55914967|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55914968|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914969|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914970|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
55914971|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55914972|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914973|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914974|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914975|NCT01438957|Analgesics|analgesics|mesh-ancestor
55914976|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
55914977|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914978|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55774176|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774177|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774178|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55774179|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
55774180|NCT02425813|Hormones|hormones|mesh-ancestor
55774181|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774182|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55774183|NCT02425813|Protective Agents|protective agents|mesh-ancestor
55774184|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55774185|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774186|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56215453|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215454|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215455|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56215456|NCT01618877|Levetiracetam|levetiracetam|mesh-list
56215457|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
56215458|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
56215459|NCT01618890|Propranolol|propranolol|mesh-list
56215460|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55774187|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55774188|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
55774189|NCT03106831|Norepinephrine|norepinephrine|mesh-list
55774190|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55774191|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55774192|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
55774193|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774194|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774195|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774196|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
55774197|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
55774198|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774199|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55774200|NCT03138785|Itraconazole|itraconazole|mesh-list
55774201|NCT03138785|Voriconazole|voriconazole|mesh-list
55774202|NCT03138785|Levofloxacin|levofloxacin|mesh-list
55774203|NCT03138785|Ofloxacin|ofloxacin|mesh-list
55774204|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
55774205|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774206|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55774207|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55774208|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774209|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774210|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55774211|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
55774212|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774213|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774214|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55774215|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55774216|NCT03138785|Renal Agents|renal agents|mesh-ancestor
55774217|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55774218|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55774219|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55774220|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774221|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55774222|NCT03106597|Amlodipine|amlodipine|mesh-list
55774223|NCT03106597|Manidipine|manidipine|mesh-list
55774224|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55774225|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55774226|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55774227|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774228|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55774229|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774230|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
55783163|NCT03078569|Androgens|androgens|mesh-ancestor
55783164|NCT03078569|Hormones|hormones|mesh-ancestor
55783165|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774231|NCT02018458|Paclitaxel|paclitaxel|mesh-list
55774232|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55774233|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
55774234|NCT02018458|Carboplatin|carboplatin|mesh-list
55774236|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56215461|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56215462|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
55774239|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774240|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55774241|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774242|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
55774243|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
55774244|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
55774245|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915013|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55743016|NCT04163419|Analgesics|analgesics|mesh-ancestor
55774246|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55774247|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55774248|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55774249|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
55774250|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55774251|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55774252|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55774253|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55774254|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915085|NCT00655083|MEN 11420|men 11420|mesh-list
55774256|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55774257|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55774258|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55774259|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55774260|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
55774261|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774262|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774263|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774266|NCT02423863|Durvalumab|durvalumab|mesh-list
55774267|NCT02423863|Cemiplimab|cemiplimab|mesh-list
55774268|NCT02423863|Atezolizumab|atezolizumab|mesh-list
55774269|NCT02423863|Poly ICLC|poly iclc|mesh-list
55774270|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55774271|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774272|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55774273|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774274|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
55774275|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
55774276|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774278|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774279|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774280|NCT03519893|Losartan|losartan|mesh-list
55774281|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55774282|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55774283|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55774284|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55774285|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774286|NCT05392673|Bilirubin|bilirubin|mesh-list
55774287|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
55774288|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774289|NCT05392673|Protective Agents|protective agents|mesh-ancestor
55774290|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774291|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
55774292|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
55774293|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774294|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
55783166|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915164|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
55783167|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55774295|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774296|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774297|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
55774298|NCT03178591|Vildagliptin|vildagliptin|mesh-list
55774299|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55774300|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774301|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55774302|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774303|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55774304|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
55774305|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774306|NCT01993186|Glycerol|glycerol|mesh-list
56215463|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215464|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215465|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215467|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56215468|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
56215469|NCT01618903|Levetiracetam|levetiracetam|mesh-list
56215470|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
56215471|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
56215472|NCT01618929|Montelukast|montelukast|mesh-list
56215473|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56215474|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
56215475|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56215476|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
56215477|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215478|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215479|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56215480|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56215481|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215482|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
56215483|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56215484|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
55791749|NCT05069779|Diazepam|diazepam|mesh-list
55774307|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55774310|NCT03181243|Anesthetics|anesthetics|mesh-list
55774311|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774312|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774313|NCT03196427|Vedolizumab|vedolizumab|mesh-list
55774319|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774320|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55774321|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
55774322|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915320|NCT01414855|Hormones|hormones|mesh-ancestor
55774323|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55774324|NCT02420665|Protective Agents|protective agents|mesh-ancestor
55774325|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774326|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55774327|NCT02016898|Mitomycins|mitomycins|mesh-list
55774328|NCT02016898|Mitomycin|mitomycin|mesh-list
55774329|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55774330|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774331|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
55774332|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774333|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55774334|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774335|NCT04482907|Hormones|hormones|mesh-list
55774336|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774337|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774338|NCT02420509|Leucovorin|leucovorin|mesh-list
55774339|NCT02420509|Capecitabine|capecitabine|mesh-list
55774340|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215485|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56215486|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
56215487|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215488|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215489|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
56215490|NCT01619046|Factor VIII|factor viii|mesh-list
56215491|NCT01619046|Coagulants|coagulants|mesh-ancestor
56215492|NCT01619072|Misoprostol|misoprostol|mesh-list
56215493|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56215494|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
55791780|NCT03251911|Ivacaftor|ivacaftor|mesh-list
55774341|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774342|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55774343|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
55774344|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774345|NCT02420509|Antidotes|antidotes|mesh-ancestor
55774346|NCT02420509|Protective Agents|protective agents|mesh-ancestor
55774347|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
55774348|NCT02420509|Vitamins|vitamins|mesh-ancestor
55774349|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
55774350|NCT03193853|Paclitaxel|paclitaxel|mesh-list
55774351|NCT03193853|Serabelisib|serabelisib|mesh-list
55774352|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55774353|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774354|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
55774355|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
55774356|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
55774357|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774358|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774359|NCT02416531|Clobetasol|clobetasol|mesh-list
55774360|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55774361|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
55774362|NCT02416531|Hormones|hormones|mesh-ancestor
55774363|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774364|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774365|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
55774366|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55774367|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55774368|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774369|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
55783169|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55783170|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
55774370|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
55774371|NCT02416141|Tramadol|tramadol|mesh-list
55774372|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55774373|NCT02416141|Narcotics|narcotics|mesh-ancestor
55774374|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774375|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774376|NCT02416141|Analgesics|analgesics|mesh-ancestor
55774377|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
55774378|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774379|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55774380|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55774381|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774382|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
55774383|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55774387|NCT02416063|Analgesics|analgesics|mesh-ancestor
55774388|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
55774389|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774390|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55774391|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55774392|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55774393|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
55774394|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215495|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56215496|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215497|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56215498|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56215500|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
56215501|NCT01619137|Povidone|povidone|mesh-list
56215502|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
56215503|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
56215504|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56215505|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215506|NCT01619150|Etoricoxib|etoricoxib|mesh-list
56215507|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56215508|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56215509|NCT01619150|Analgesics|analgesics|mesh-ancestor
56215510|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
56215511|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215512|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215513|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215514|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56215515|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56215516|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56215517|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215518|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774395|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774396|NCT01828697|Enoxaparin|enoxaparin|mesh-list
55915456|NCT01418339|Aripiprazole|aripiprazole|mesh-list
55915457|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
55915458|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55915459|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55915460|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55774397|NCT01828697|Dalteparin|dalteparin|mesh-list
55774398|NCT01828697|Tinzaparin|tinzaparin|mesh-list
55774399|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55774400|NCT01828697|Nadroparin|nadroparin|mesh-list
55774401|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
55774402|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
55774403|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55774404|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55774405|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774406|NCT02415985|Lopinavir|lopinavir|mesh-list
55774407|NCT02415985|Rifabutin|rifabutin|mesh-list
55774408|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55774409|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55774410|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
55774411|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834117|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
55774412|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774413|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55774414|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55774415|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
55774416|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774417|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55774418|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55774419|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55774420|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55774421|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
56215519|NCT01619163|Prednisolone|prednisolone|mesh-list
56215520|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215521|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
56215523|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215524|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215525|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56215526|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215527|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56215528|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56215529|NCT01619176|Methotrexate|methotrexate|mesh-list
56215530|NCT01619176|Leflunomide|leflunomide|mesh-list
56215531|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56215532|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
56215533|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56215534|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215535|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56215536|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
56215537|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791812|NCT03036605|BB 1101|bb 1101|mesh-list
55774422|NCT02415829|Capecitabine|capecitabine|mesh-list
55774423|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
55774424|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55774425|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
55774426|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774427|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774428|NCT04631393|Alfentanil|alfentanil|mesh-list
55774429|NCT04631393|Propofol|propofol|mesh-list
55774430|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55774431|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774432|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774433|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55774434|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
55774435|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
55774436|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55915461|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915462|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915463|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
55774437|NCT04631393|Narcotics|narcotics|mesh-ancestor
55774438|NCT04631393|Analgesics|analgesics|mesh-ancestor
55774439|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
55774440|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774441|NCT03180775|Glycine|glycine|mesh-list
55783171|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774442|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
55774443|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774444|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774445|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774446|NCT03137927|Vaccines|vaccines|mesh-list
55774447|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
55804998|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55774448|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774449|NCT04482985|Meclizine|meclizine|mesh-list
55774450|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
55774451|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
55774452|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774453|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774454|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56215538|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215539|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
56215540|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215541|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56215542|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56215543|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
56215544|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56215545|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56215546|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55774455|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55774457|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
55774458|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774459|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774460|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55774462|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55774463|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774464|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55774465|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774466|NCT03180229|Granisetron|granisetron|mesh-list
55774467|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
55774468|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
55774469|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774470|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774471|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55774472|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55774473|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
55774474|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774475|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774476|NCT05091619|Vaccines|vaccines|mesh-list
55774477|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
55774478|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774479|NCT03178123|Interferons|interferons|mesh-list
55774480|NCT03178123|Antibodies|antibodies|mesh-list
55774481|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55774482|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
55774483|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774484|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774485|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
55774486|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774488|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55774489|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774490|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55774491|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
55774492|NCT05106517|Denosumab|denosumab|mesh-list
55774493|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55774494|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783172|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783173|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55783175|NCT03078257|Tirofiban|tirofiban|mesh-list
55774495|NCT03140033|Misoprostol|misoprostol|mesh-list
55774497|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
55774498|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55774499|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
55774500|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55774501|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774502|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55774503|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55774504|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
55774505|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55774506|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
55774507|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
55774508|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774509|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215548|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
56215549|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215550|NCT01619280|Nitroprusside|nitroprusside|mesh-list
56215551|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56215552|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
56215553|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56215554|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215556|NCT01619436|Analgesics|analgesics|mesh-ancestor
56215557|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
56215558|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215559|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215560|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56215561|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
56215562|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
55774510|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
55774511|NCT05338931|Gossypol|gossypol|mesh-list
55774512|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55774513|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774514|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55774515|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
55774516|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55774517|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774518|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
55774519|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
55774520|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55774521|NCT02706691|Infigratinib|infigratinib|mesh-list
55774522|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774523|NCT02419729|Estrogens|estrogens|mesh-list
55774524|NCT02419729|Hormones|hormones|mesh-ancestor
55774526|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774527|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55774528|NCT03697031|Hormones|hormones|mesh-ancestor
55774529|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774530|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774531|NCT02419651|Diclofenac|diclofenac|mesh-list
55774532|NCT02419651|Tramadol|tramadol|mesh-list
55774533|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55774534|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55774535|NCT02419651|Analgesics|analgesics|mesh-ancestor
55774536|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
55774537|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774538|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774539|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55774540|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55774541|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55774542|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915482|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774543|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774544|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55774545|NCT02419651|Narcotics|narcotics|mesh-ancestor
55774546|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774547|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56215563|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56215564|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56215565|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56215566|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
56215567|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215568|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215569|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56215570|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
56215571|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215573|NCT01619527|Cobicistat|cobicistat|mesh-list
56215574|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56215575|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56215576|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
56215577|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215578|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215579|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56215580|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56215581|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
56215582|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215583|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56215584|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56215585|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56215586|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56215587|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56215588|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215589|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791849|NCT03099031|Dalteparin|dalteparin|mesh-list
55774548|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774549|NCT02419261|Analgesics|analgesics|mesh-list
55774550|NCT02419261|Ropivacaine|ropivacaine|mesh-list
55774551|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
55774552|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
55774553|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774554|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774555|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
55774556|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774557|NCT02414503|Oxytocin|oxytocin|mesh-list
55783176|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
55783177|NCT03078257|Clopidogrel|clopidogrel|mesh-list
55783178|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55774558|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
55774559|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56215590|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215591|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215592|NCT01619566|Analgesics|analgesics|mesh-ancestor
56215593|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
56215594|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215595|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
56215596|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215597|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
56215598|NCT01619644|Valproic Acid|valproic acid|mesh-list
56215599|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
56215600|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889843|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915494|NCT01435577|Narcotics|narcotics|mesh-ancestor
56215601|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215602|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
56215603|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791878|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
55774560|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774561|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
55774562|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55774563|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774564|NCT03137615|Anesthetics|anesthetics|mesh-list
55774565|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
55774566|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774567|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774568|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
55774569|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774570|NCT03415061|Insulin|insulin|mesh-list
55774571|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55774572|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55774573|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774574|NCT05088083|Paclitaxel|paclitaxel|mesh-list
55774575|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55774576|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774577|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
55774578|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
55774579|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
55774580|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774581|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55774582|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55774583|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
55774584|NCT05087693|Albuterol|albuterol|mesh-list
55774585|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55774586|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
55774587|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774588|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774589|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55774590|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
55774591|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
55774592|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55774593|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55774594|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55774595|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55774596|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
55774597|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774598|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774599|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
55774600|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55774601|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55774602|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774603|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
55774604|NCT01990768|Coagulants|coagulants|mesh-ancestor
55774605|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
56215604|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215605|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
56215607|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215608|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215609|NCT01619683|Enclomiphene|enclomiphene|mesh-list
55915508|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56215611|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
56215612|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56215613|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
56215614|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215615|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215616|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56215617|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
56215618|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56215619|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56215620|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56215621|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
56215622|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
56215623|NCT01619761|Melphalan|melphalan|mesh-list
56215624|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
56215659|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215660|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
56215661|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
56215662|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
56215663|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215664|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215665|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
56215667|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215668|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215669|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56215670|NCT01619891|Vitamin D|vitamin d|mesh-list
56215671|NCT01619891|Vitamins|vitamins|mesh-ancestor
56215672|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
56215673|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774606|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774607|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
55774608|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
55774609|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
55774610|NCT02624765|Digoxin|digoxin|mesh-list
55774611|NCT02624765|Sotalol|sotalol|mesh-list
55774612|NCT02624765|Flecainide|flecainide|mesh-list
55774613|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55774614|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55774615|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774616|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774617|NCT02624765|Protective Agents|protective agents|mesh-ancestor
55774618|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774619|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55774620|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55774621|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
55774622|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774623|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
55774624|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
55774625|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774626|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55774627|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55783179|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55783180|NCT03078257|Analgesics|analgesics|mesh-ancestor
55774628|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55774629|NCT05085587|Fluticasone|fluticasone|mesh-list
55774630|NCT05085587|Xhance|xhance|mesh-list
55774631|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55774632|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55774633|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55774634|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55774635|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
55774636|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774637|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774638|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55774639|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
55774640|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
55774641|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55774642|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55774643|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55774644|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55774645|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
55774646|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774647|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215674|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56215675|NCT01620112|Lidocaine|lidocaine|mesh-list
56215676|NCT01620112|Clonidine|clonidine|mesh-list
56215677|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
56215678|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
56215679|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215680|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215681|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
56215682|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215683|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56215684|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56215685|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56215686|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215687|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215688|NCT01620112|Analgesics|analgesics|mesh-ancestor
56215689|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56215690|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
56215691|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
56215692|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56215693|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56215694|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56215695|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
56215696|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215697|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56215698|NCT01620229|Antibodies|antibodies|mesh-list
56215699|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
55774648|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
55774649|NCT05085587|Hormones|hormones|mesh-ancestor
55774650|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774651|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
55774652|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55774653|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55774654|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774655|NCT05084573|Bupivacaine|bupivacaine|mesh-list
55774656|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
55774657|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
55774658|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774659|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774660|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
55774661|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774662|NCT05088707|Misoprostol|misoprostol|mesh-list
55774663|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55774664|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
55774665|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55774666|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774667|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55774668|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55774669|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
55774670|NCT05028257|Vaccines|vaccines|mesh-list
55774671|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
55774672|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774673|NCT01990300|Pioglitazone|pioglitazone|mesh-list
55774675|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55915615|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774676|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774677|NCT01990300|Incretins|incretins|mesh-ancestor
55774678|NCT01990300|Hormones|hormones|mesh-ancestor
55774679|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774680|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55774681|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
55774682|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774683|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774684|NCT03135977|Etoposide|etoposide|mesh-list
55774685|NCT03135977|Apatinib|apatinib|mesh-list
55774686|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55774687|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774688|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55774689|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55774690|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774691|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774692|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55774693|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55774694|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55774695|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
55774697|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
55774698|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774699|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55774700|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55774701|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774702|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774703|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55774704|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
55774705|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774706|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774707|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55774708|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55774709|NCT04837235|Hemay005|hemay005|mesh-list
55774710|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
55774711|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55774712|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55774713|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774714|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774715|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
55774716|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55774717|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774718|NCT05738057|Gemcitabine|gemcitabine|mesh-list
55774720|NCT05738057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774721|NCT05738057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55774722|NCT05738057|Antimetabolites|antimetabolites|mesh-ancestor
55774723|NCT05738057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774724|NCT05738057|Antiviral Agents|antiviral agents|mesh-ancestor
55774725|NCT05738057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774726|NCT05738057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774727|NCT05738057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55774728|NCT05738057|Immunologic Factors|immunologic factors|mesh-ancestor
55774729|NCT05738057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774730|NCT03116971|Etoposide|etoposide|mesh-list
55774733|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55774734|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55774735|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55774736|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774737|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774738|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55774739|NCT02414581|Ethanol|ethanol|mesh-list
55774740|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
55774741|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56215700|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56215701|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
56215702|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
56143498|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
56215703|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215704|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56215705|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215706|NCT01620268|Leflunomide|leflunomide|mesh-list
56215707|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215708|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215709|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56215710|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
56215711|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215712|NCT01620307|Sirolimus|sirolimus|mesh-list
56215713|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56215714|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215715|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56215716|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215717|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
56215718|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791989|NCT02603393|Fluticasone|fluticasone|mesh-list
55805024|NCT05493709|Leuprolide|leuprolide|mesh-list
55774742|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55774743|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774744|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774745|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774747|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
55774748|NCT02419105|Vitamin D|vitamin d|mesh-list
55774749|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
55774750|NCT02419105|Testosterone|testosterone|mesh-list
55774751|NCT02419105|Vitamins|vitamins|mesh-ancestor
55774752|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
55774753|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774754|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55774755|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55774756|NCT02419105|Androgens|androgens|mesh-ancestor
55774757|NCT02419105|Hormones|hormones|mesh-ancestor
55774758|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774759|NCT04643249|Repaglinide|repaglinide|mesh-list
55774760|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
55774761|NCT04643249|Midazolam|midazolam|mesh-list
55774762|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
55774763|NCT04643249|Caffeine|caffeine|mesh-list
55774764|NCT04643249|Bupropion|bupropion|mesh-list
55774765|NCT04643249|Omeprazole|omeprazole|mesh-list
55783182|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774766|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55774767|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55774768|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774769|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774770|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55774771|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55774772|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55774773|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55774774|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
55774775|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
56215719|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
56215720|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215721|NCT01620320|Dobutamine|dobutamine|mesh-list
56215722|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56215723|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
56215724|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
56215725|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215726|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215727|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56215728|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56215729|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56215730|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
56215731|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215732|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215733|NCT01620320|Protective Agents|protective agents|mesh-ancestor
56215734|NCT01620333|Insulin|insulin|mesh-list
55915731|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215735|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56215736|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
55774776|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
55774777|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
55774778|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774779|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774780|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55774781|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55774782|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774783|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55774784|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55774785|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
55774786|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55774787|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55774788|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55774789|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55774790|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
55774791|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55774792|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55774793|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55774794|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
55774795|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55774796|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55774797|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
55774798|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
55774799|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55774800|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55774801|NCT04643249|Analgesics|analgesics|mesh-ancestor
55774802|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
55774803|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774804|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55774805|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55774806|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55774807|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55774808|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55774809|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55774810|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
56215737|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
56215738|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56215739|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
56215740|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215741|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215742|NCT01620424|Insulin|insulin|mesh-list
56215743|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56215744|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
56215745|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
56215746|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56215747|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
56215748|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56215749|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215750|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215751|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
56215752|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
56215753|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215754|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215755|NCT01620450|Insulin|insulin|mesh-list
56215756|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56215757|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215758|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215759|NCT01620463|Liraglutide|liraglutide|mesh-list
56215760|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215761|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215762|NCT01620463|Incretins|incretins|mesh-ancestor
56215763|NCT01620463|Hormones|hormones|mesh-ancestor
55792035|NCT05363631|Selenium|selenium|mesh-list
55774811|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55774812|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55774813|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55774814|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55774815|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774816|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
55774817|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774818|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774819|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55774820|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774821|NCT03116893|Itraconazole|itraconazole|mesh-list
55774822|NCT03116893|Rifampin|rifampin|mesh-list
55774823|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
55774824|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774825|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55774826|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55774827|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774828|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774829|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56215764|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215765|NCT01620476|Liraglutide|liraglutide|mesh-list
55774830|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
55774831|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774832|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783183|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783184|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783186|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55783187|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55774833|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55774834|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55774836|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55774837|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
55774838|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55915892|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55774839|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55774840|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55774841|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55774842|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55774843|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55774844|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55774845|NCT05737511|Diazepam|diazepam|mesh-list
55774846|NCT05737511|Gabapentin|gabapentin|mesh-list
55774847|NCT05737511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55774848|NCT05737511|Milnacipran|milnacipran|mesh-list
55774849|NCT05737511|Levetiracetam|levetiracetam|mesh-list
55774850|NCT05737511|Lorazepam|lorazepam|mesh-list
55774851|NCT05737511|Clonazepam|clonazepam|mesh-list
55774852|NCT05737511|Dexetimide|dexetimide|mesh-list
55774853|NCT05737511|Olanzapine|olanzapine|mesh-list
55774854|NCT05737511|Alprazolam|alprazolam|mesh-list
55774855|NCT05737511|Mirtazapine|mirtazapine|mesh-list
55774856|NCT05737511|Fluvoxamine|fluvoxamine|mesh-list
55774857|NCT05737511|Tranylcypromine|tranylcypromine|mesh-list
55774858|NCT05737511|Risperidone|risperidone|mesh-list
55774859|NCT05737511|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55774860|NCT05737511|Citalopram|citalopram|mesh-list
55774861|NCT05737511|Bupropion|bupropion|mesh-list
55774862|NCT05737511|Sertraline|sertraline|mesh-list
55774863|NCT05737511|Fluoxetine|fluoxetine|mesh-list
55774865|NCT05737511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55774866|NCT05737511|Reboxetine|reboxetine|mesh-list
55774867|NCT05737511|Imipramine|imipramine|mesh-list
55774868|NCT05737511|Clomipramine|clomipramine|mesh-list
55774869|NCT05737511|Phenelzine|phenelzine|mesh-list
55774870|NCT05737511|Moclobemide|moclobemide|mesh-list
55774871|NCT05737511|Hydroxyzine|hydroxyzine|mesh-list
55774873|NCT05737511|Sensory System Agents|sensory system agents|mesh-ancestor
55774874|NCT05737511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55774875|NCT05737511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774876|NCT05737511|Anticonvulsants|anticonvulsants|mesh-ancestor
55774877|NCT05737511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55774878|NCT05737511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55774879|NCT05737511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774880|NCT05737511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55774881|NCT05737511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55774882|NCT05737511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55774883|NCT05737511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774884|NCT05737511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774885|NCT05737511|Antimanic Agents|antimanic agents|mesh-ancestor
55774886|NCT05737511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55774887|NCT05737511|Serotonin Agents|serotonin agents|mesh-ancestor
55774888|NCT05737511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55774889|NCT05737511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56215767|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215768|NCT01620476|Incretins|incretins|mesh-ancestor
56215769|NCT01620476|Hormones|hormones|mesh-ancestor
56215770|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215771|NCT01620684|Metyrapone|metyrapone|mesh-list
56215772|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
56215773|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215774|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215775|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
56215776|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56215777|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56215778|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
56215779|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215780|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56215781|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56215782|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215783|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215784|NCT01620814|Misoprostol|misoprostol|mesh-list
56215785|NCT01620814|Dinoprostone|dinoprostone|mesh-list
56215786|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56215787|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
56215788|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55774890|NCT05737511|Dopamine Agents|dopamine agents|mesh-ancestor
55783188|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774891|NCT05737511|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55834596|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55774892|NCT05737511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55774893|NCT05737511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55774894|NCT05737511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55774895|NCT05737511|Antidepressive Agents|antidepressive agents|mesh-ancestor
55774896|NCT05737511|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55774897|NCT05737511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55774898|NCT05737511|Parasympatholytics|parasympatholytics|mesh-ancestor
55774899|NCT05737511|Autonomic Agents|autonomic agents|mesh-ancestor
55774900|NCT05737511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55774901|NCT05737511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55774902|NCT05737511|Cholinergic Agents|cholinergic agents|mesh-ancestor
55774903|NCT05737511|Antiemetics|antiemetics|mesh-ancestor
55774904|NCT05737511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55774905|NCT05737511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55774906|NCT05737511|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55774907|NCT05737511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55774908|NCT05737511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774909|NCT05737511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55774910|NCT05737511|Nootropic Agents|nootropic agents|mesh-ancestor
55774911|NCT05737511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55774912|NCT05737511|GABA Modulators|gaba modulators|mesh-ancestor
55774913|NCT05737511|GABA Agents|gaba agents|mesh-ancestor
55774914|NCT05737511|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55774915|NCT05737511|Histamine Antagonists|histamine antagonists|mesh-ancestor
55774916|NCT05737511|Histamine Agents|histamine agents|mesh-ancestor
56215789|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215790|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56215791|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56215792|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
56215793|NCT01620840|Lacosamide|lacosamide|mesh-list
56215794|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
56215795|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56215796|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56215797|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215798|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792077|NCT04822649|Adenosine|adenosine|mesh-list
55774917|NCT05737511|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55774918|NCT05737511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55774919|NCT05737511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55774920|NCT05737511|Adrenergic Agents|adrenergic agents|mesh-ancestor
55774921|NCT05737511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55774922|NCT05737511|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55774923|NCT05737511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55916186|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
55774924|NCT05737511|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55774925|NCT05737511|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55774926|NCT05737511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55774927|NCT05737511|Anesthetics, General|anesthetics, general|mesh-ancestor
55774928|NCT05737511|Anesthetics|anesthetics|mesh-ancestor
55774929|NCT05737511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55774930|NCT05737511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55774931|NCT05737511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55774932|NCT05737511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55774933|NCT05737511|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55774934|NCT05737511|Antipruritics|antipruritics|mesh-ancestor
55774937|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
55774939|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
55774940|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55774941|NCT03179839|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55774942|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55774943|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55774944|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774945|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55774946|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
55774947|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774948|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55774949|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55774950|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774951|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55774952|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55774953|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55774954|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774955|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55774956|NCT05736887|Acetylcysteine|acetylcysteine|mesh-list
55774957|NCT05736887|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55774958|NCT05736887|Antiviral Agents|antiviral agents|mesh-ancestor
55774959|NCT05736887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783189|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55774960|NCT05736887|Expectorants|expectorants|mesh-ancestor
55774961|NCT05736887|Respiratory System Agents|respiratory system agents|mesh-ancestor
55774962|NCT05736887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55774963|NCT05736887|Antioxidants|antioxidants|mesh-ancestor
55774964|NCT05736887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774965|NCT05736887|Protective Agents|protective agents|mesh-ancestor
55774966|NCT05736887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774967|NCT05736887|Antidotes|antidotes|mesh-ancestor
55774968|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
55774969|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215799|NCT01620944|Ritonavir|ritonavir|mesh-list
56215800|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56215801|NCT01620944|Tenofovir|tenofovir|mesh-list
56215802|NCT01620944|Lamivudine|lamivudine|mesh-list
56215803|NCT01620944|Emtricitabine|emtricitabine|mesh-list
56215804|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56215805|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56215806|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
56215807|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215808|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215809|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56215810|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56215811|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
56215812|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215813|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56215814|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56215815|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55792089|NCT04822415|Mepivacaine|mepivacaine|mesh-list
55774970|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774971|NCT05735639|Enoxaparin|enoxaparin|mesh-list
55774972|NCT05735639|Dalteparin|dalteparin|mesh-list
55774973|NCT05735639|Tinzaparin|tinzaparin|mesh-list
55774974|NCT05735639|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55774975|NCT05735639|Rivaroxaban|rivaroxaban|mesh-list
55774976|NCT05735639|Apixaban|apixaban|mesh-list
55774977|NCT05735639|Enoxaparin sodium|enoxaparin sodium|mesh-list
55774978|NCT05735639|Dabigatran|dabigatran|mesh-list
55774979|NCT05735639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55774980|NCT05735639|Antithrombins|antithrombins|mesh-ancestor
55774981|NCT05735639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55774982|NCT05735639|Protease Inhibitors|protease inhibitors|mesh-ancestor
55774983|NCT05735639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55774984|NCT05735639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55774985|NCT05735639|Anticoagulants|anticoagulants|mesh-ancestor
55774986|NCT05735639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55774987|NCT05735639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55774988|NCT04483219|Antibodies|antibodies|mesh-list
55774989|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
55774990|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774991|NCT03176563|Fosfomycin|fosfomycin|mesh-list
55774992|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55774993|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774994|NCT03827447|Vancomycin|vancomycin|mesh-list
55774995|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55774996|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55774997|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
55774998|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55774999|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
55775002|NCT01680497|Protective Agents|protective agents|mesh-ancestor
55775003|NCT02423395|Orphenadrine|orphenadrine|mesh-list
55775004|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775005|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56215816|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56215817|NCT01621022|Bupropion|bupropion|mesh-list
56215818|NCT01621022|Nicotine|nicotine|mesh-list
56215819|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56215820|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
56215821|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215822|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215823|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56215824|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56215825|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
56215826|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215827|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215828|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56215830|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56215831|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55775006|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55775007|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55775008|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55775009|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775010|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
55775011|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
55775012|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55775013|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55775014|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
55775015|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775016|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775017|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
55775018|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55775019|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775020|NCT05694689|Vitamin D|vitamin d|mesh-list
55775021|NCT05694689|Cholecalciferol|cholecalciferol|mesh-list
55775022|NCT05694689|Vitamins|vitamins|mesh-ancestor
55775023|NCT05694689|Micronutrients|micronutrients|mesh-ancestor
55775024|NCT05694689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775025|NCT05694689|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55775026|NCT05694689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55775027|NCT02423239|Gemcitabine|gemcitabine|mesh-list
55783190|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55775028|NCT02423239|Paclitaxel|paclitaxel|mesh-list
55775029|NCT02423239|Sorafenib|sorafenib|mesh-list
55775030|NCT02423239|HU 211|hu 211|mesh-list
55775031|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55775032|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775033|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
55775034|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
55775035|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
55775036|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775037|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55775038|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
55775039|NCT02423239|Antiviral Agents|antiviral agents|mesh-ancestor
55775040|NCT02423239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775041|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775042|NCT02423239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775043|NCT02423239|Immunologic Factors|immunologic factors|mesh-ancestor
55775044|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775045|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55775046|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55775047|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
56215832|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56215833|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215834|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
56215835|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56215836|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56215837|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215838|NCT01621100|Hydromorphone|hydromorphone|mesh-list
56215839|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56215840|NCT01621100|Narcotics|narcotics|mesh-ancestor
56215841|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215842|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215843|NCT01621100|Analgesics|analgesics|mesh-ancestor
56215844|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
56215845|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215846|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
56215847|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56215848|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215849|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215850|NCT01621165|Prazosin|prazosin|mesh-list
56215851|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56215852|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56215853|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56215854|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56215855|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
55775048|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
55775049|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775050|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55775051|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55775052|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55775053|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775054|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55775056|NCT02449733|Tenofovir|tenofovir|mesh-list
55775057|NCT02449733|Emtricitabine|emtricitabine|mesh-list
55775058|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55775059|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
55775060|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775061|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55775062|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55775063|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775064|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215856|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215857|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215858|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215859|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
56215860|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56215861|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
56215862|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56215863|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
56215864|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215865|NCT01621217|Cetuximab|cetuximab|mesh-list
56215866|NCT01621217|Mitomycins|mitomycins|mesh-list
56215867|NCT01621217|Mitomycin|mitomycin|mesh-list
56215868|NCT01621217|Fluorouracil|fluorouracil|mesh-list
56215869|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56215870|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215871|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55775065|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55775066|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55775067|NCT02417467|Nicotine|nicotine|mesh-list
55775068|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55775069|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
55775070|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775071|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775072|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55775073|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55775074|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
55775075|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775076|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775077|NCT02417389|Alendronate|alendronate|mesh-list
55775078|NCT02417389|Cinacalcet|cinacalcet|mesh-list
55775079|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55775080|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775081|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55775082|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
55775083|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
55775084|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775086|NCT02413021|Deferasirox|deferasirox|mesh-list
55775087|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55775088|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
55775089|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775090|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775091|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
55775092|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775093|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775094|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
55775095|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775096|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55775097|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
55775098|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
55775099|NCT01680341|Insulin|insulin|mesh-list
55775100|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55775101|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
55775102|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
55775103|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55775104|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55775105|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775106|NCT03177811|Acetazolamide|acetazolamide|mesh-list
55775107|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
55775108|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56215872|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
56215873|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215874|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56215875|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215876|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
56215877|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56215878|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56215879|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
56215880|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215882|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
56215883|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56215884|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56215885|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215886|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56215887|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56215888|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215889|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56215890|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
56215891|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215892|NCT01621308|Insulin|insulin|mesh-list
56215893|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56215894|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215895|NCT01621321|Voriconazole|voriconazole|mesh-list
56215896|NCT01621321|Prednisolone|prednisolone|mesh-list
56215897|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792163|NCT05056519|Vaccines|vaccines|mesh-list
55775109|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775110|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775111|NCT03177811|Diuretics|diuretics|mesh-ancestor
55775112|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
55775113|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775114|NCT03175939|Fluorouracil|fluorouracil|mesh-list
55775115|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775116|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
55889844|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775117|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215898|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
56215899|NCT01621321|Hormones|hormones|mesh-ancestor
56215900|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215901|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215902|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56215903|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215904|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
56215905|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56215906|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56215907|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56215908|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215909|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215910|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56215911|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
55775118|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55775119|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775120|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
55775121|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775122|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
55775123|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55775124|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55775125|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55775126|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55775127|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775128|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775129|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55775130|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55775137|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
55775138|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55775139|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
55775140|NCT02412475|Cytarabine|cytarabine|mesh-list
55775141|NCT02412475|Fludarabine|fludarabine|mesh-list
55775142|NCT02412475|Sorafenib|sorafenib|mesh-list
55775143|NCT02412475|Decitabine|decitabine|mesh-list
55775144|NCT02412475|Vorinostat|vorinostat|mesh-list
55775145|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775146|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55775147|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
55775148|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775149|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775150|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
55775151|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775152|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
55775153|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775154|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55775155|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775156|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55775157|NCT04543643|Carvedilol|carvedilol|mesh-list
55783192|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
55783193|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55783194|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55783195|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55775158|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56215912|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56215913|NCT01621373|Propofol|propofol|mesh-list
56215914|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56215915|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215916|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215917|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56215918|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
56215919|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
56215920|NCT01621386|Prednisone|prednisone|mesh-list
56215921|NCT01621386|Montelukast|montelukast|mesh-list
56215922|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215923|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
56215924|NCT01621386|Hormones|hormones|mesh-ancestor
56215925|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56215926|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215927|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56215928|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215929|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56215930|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
56215931|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56215932|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
56215933|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56215934|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56215935|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215937|NCT01621451|Clopidogrel|clopidogrel|mesh-list
56215938|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56215939|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56215940|NCT01621451|Analgesics|analgesics|mesh-ancestor
56215941|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
56215942|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792205|NCT03097003|Apremilast|apremilast|mesh-list
55775159|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55775160|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
55775161|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775162|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775163|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775164|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55775165|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
55775166|NCT04543643|Protective Agents|protective agents|mesh-ancestor
55775167|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55775168|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55775169|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56215943|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215944|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56215945|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775170|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
55775171|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55775172|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55775173|NCT00720785|Bortezomib|bortezomib|mesh-list
55775174|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775175|NCT05377619|Buspirone|buspirone|mesh-list
55775176|NCT05377619|Prucalopride|prucalopride|mesh-list
55775177|NCT05377619|Laxatives|laxatives|mesh-ancestor
55775178|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55775179|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55775180|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55775181|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
55775182|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775183|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775184|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775186|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55775187|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775188|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55775189|NCT03199157|Fentanyl|fentanyl|mesh-list
55775190|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55775191|NCT03199157|Narcotics|narcotics|mesh-ancestor
55775192|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775193|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775194|NCT03199157|Analgesics|analgesics|mesh-ancestor
55775195|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
55775197|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55775198|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55775200|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
55775201|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
55775202|NCT00641381|Carmustine|carmustine|mesh-list
55916425|NCT04655586|Protein C|protein c|mesh-list
55916426|NCT04655586|Anticoagulants|anticoagulants|mesh-list
55916427|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55916428|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55916429|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775203|NCT00641381|Etoposide|etoposide|mesh-list
55775204|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775205|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
55775206|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775207|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775208|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55775209|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
55775210|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775211|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775212|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55775213|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55775214|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55775215|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55775216|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783196|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
55783197|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775217|NCT02416999|Bevacizumab|bevacizumab|mesh-list
55775218|NCT02416999|Temozolomide|temozolomide|mesh-list
55775219|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55775220|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775221|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55775222|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55775223|NCT02416999|Growth Substances|growth substances|mesh-ancestor
55775224|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775225|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
55775226|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55775227|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
55775228|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775230|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55775231|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775232|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775233|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
55775234|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775235|NCT01679405|Gemcitabine|gemcitabine|mesh-list
55775236|NCT01679405|Cisplatin|cisplatin|mesh-list
55775237|NCT01679405|Afatinib|afatinib|mesh-list
55775238|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775239|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55775240|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
55775241|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775242|NCT01679405|Antiviral Agents|antiviral agents|mesh-ancestor
55775243|NCT01679405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775244|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775245|NCT01679405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775246|NCT01679405|Immunologic Factors|immunologic factors|mesh-ancestor
55775247|NCT01679405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775248|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55775250|NCT03175705|Tegafur|tegafur|mesh-list
55775251|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775252|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55775253|NCT03175705|Analgesics|analgesics|mesh-ancestor
55775254|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
55775255|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775256|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775257|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55775259|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775260|NCT00301457|Anastrozole|anastrozole|mesh-list
55775262|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775263|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55775264|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55775265|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775266|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775267|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55775268|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
55775269|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775270|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775272|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
55775273|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
55775274|NCT03177109|Protective Agents|protective agents|mesh-ancestor
55775275|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783198|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
55783199|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55775279|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
55775280|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55775281|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
55775282|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775283|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775284|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775285|NCT02421913|Ketamine|ketamine|mesh-list
55775286|NCT02421913|Analgesics|analgesics|mesh-ancestor
55775287|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
55775288|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775289|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775290|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55775291|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55775292|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
55775293|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
55775294|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775295|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55775296|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56215949|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56215950|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56215951|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56215952|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
56215953|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56215954|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56215955|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56215956|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
56215957|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775297|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775298|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775300|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55775301|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775302|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775303|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55775304|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
55775305|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
55775306|NCT02416765|Glucagon|glucagon|mesh-list
55775307|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775308|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55775309|NCT02416765|Hormones|hormones|mesh-ancestor
55784098|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916456|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55916457|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55916458|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55916459|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55916460|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
55916461|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916462|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
55775310|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775311|NCT02703259|Acetaminophen|acetaminophen|mesh-list
55775312|NCT02703259|Celecoxib|celecoxib|mesh-list
55775313|NCT02703259|Gabapentin|gabapentin|mesh-list
55775314|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55775315|NCT02703259|Analgesics|analgesics|mesh-ancestor
55775316|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
55775317|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775318|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775319|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
55775320|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55775321|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775322|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775323|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55775324|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55775325|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775326|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775329|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55775330|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775331|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55775332|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55775333|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55775334|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775335|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
55775336|NCT02416687|Etonogestrel|etonogestrel|mesh-list
55775337|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55775338|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
55775339|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55775340|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775341|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55775342|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
55775343|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
55775344|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775345|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775346|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775347|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
55783200|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
55916464|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55916465|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
55916467|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775348|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
55775349|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
55775350|NCT05093231|Olaparib|olaparib|mesh-list
55775351|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55775352|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56215959|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
56215960|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
56215961|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215962|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215963|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55775353|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55775354|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775355|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775356|NCT02411149|Epinephrine|epinephrine|mesh-list
55775357|NCT02411149|Racepinephrine|racepinephrine|mesh-list
55775358|NCT02411149|Morphine|morphine|mesh-list
55775359|NCT02411149|Ropivacaine|ropivacaine|mesh-list
55775360|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
55775361|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55775362|NCT02411149|Narcotics|narcotics|mesh-ancestor
55775363|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775364|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775365|NCT02411149|Analgesics|analgesics|mesh-ancestor
55775366|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
55775367|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775368|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
55775369|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
55775370|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55775371|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55775372|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
55775373|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775374|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775375|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55775377|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
55775378|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55775379|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
55775380|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
55775381|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
55775382|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55775383|NCT04413227|Docetaxel|docetaxel|mesh-list
55775384|NCT04413227|Endostatins|endostatins|mesh-list
55775385|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775386|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
55775387|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
55775388|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
55775389|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775390|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55775391|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55775392|NCT04413227|Growth Substances|growth substances|mesh-ancestor
55775393|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775394|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
55775395|NCT02410135|Mirabegron|mirabegron|mesh-list
55775396|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55775397|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55775398|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55775399|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
55775400|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775401|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775403|NCT02410135|Urological Agents|urological agents|mesh-ancestor
55775404|NCT02410759|Carbetocin|carbetocin|mesh-list
55775405|NCT02410759|Ergonovine|ergonovine|mesh-list
55775406|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
55775407|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55775408|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775409|NCT03175081|Ropivacaine|ropivacaine|mesh-list
55775410|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
55775411|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
55775412|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775413|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775414|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
55775415|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775416|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
55775417|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55775418|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56215964|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56215965|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56215966|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
56215967|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56215968|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215969|NCT01621620|Urological Agents|urological agents|mesh-ancestor
56215971|NCT01621698|Bupivacaine|bupivacaine|mesh-list
56215972|NCT01621698|Propofol|propofol|mesh-list
56215973|NCT01621698|Atracurium|atracurium|mesh-list
56215974|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
56215975|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
56215976|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775419|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775420|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55775421|NCT02401477|Amoxicillin|amoxicillin|mesh-list
55775427|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
55775428|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55775429|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775431|NCT02409433|Phenytoin|phenytoin|mesh-list
55775432|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
55775433|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55775434|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55775435|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55775436|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775437|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55775438|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55775439|NCT01989754|Canagliflozin|canagliflozin|mesh-list
55775440|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55775441|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775442|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55775443|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775444|NCT01619878|Lumefantrine|lumefantrine|mesh-list
55775445|NCT01619878|Artemether|artemether|mesh-list
55775446|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55775447|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
55916567|NCT00691665|Analgesics|analgesics|mesh-ancestor
55775448|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55775449|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55775450|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775451|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
55775452|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55775453|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
55775454|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775455|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
55775456|NCT01989208|Cathartics|cathartics|mesh-ancestor
55775457|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55775458|NCT01619410|Clindamycin|clindamycin|mesh-list
55775459|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
55775460|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
55775461|NCT01619410|Linezolid|linezolid|mesh-list
55775462|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55775463|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775464|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55775465|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775466|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775467|NCT04666714|Pregabalin|pregabalin|mesh-list
55775468|NCT04666714|Analgesics|analgesics|mesh-ancestor
55775469|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
55775470|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775471|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775472|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
55775473|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55775474|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56215977|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56215978|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
56215979|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56215980|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56215981|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56215982|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
56215983|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56215984|NCT01621698|Narcotics|narcotics|mesh-ancestor
56215985|NCT01621698|Analgesics|analgesics|mesh-ancestor
56215986|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56215987|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55792272|NCT05035381|Leucovorin|leucovorin|mesh-list
55775475|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775476|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55775477|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55775478|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55775479|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775481|NCT01668719|Dexamethasone|dexamethasone|mesh-list
55775482|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
55775483|NCT01668719|Lenalidomide|lenalidomide|mesh-list
55775484|NCT01668719|Bortezomib|bortezomib|mesh-list
55775485|NCT01668719|Elotuzumab|elotuzumab|mesh-list
55775486|NCT01668719|Ichthammol|ichthammol|mesh-list
55775487|NCT01668719|BB 1101|bb 1101|mesh-list
55783201|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
55783202|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783203|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775488|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775489|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
55775490|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
55775491|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775492|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775493|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55775494|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
55775495|NCT01668719|Hormones|hormones|mesh-ancestor
55775496|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775497|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55775498|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775499|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
55775500|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55775501|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55775502|NCT01668719|Growth Substances|growth substances|mesh-ancestor
55775503|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
55775504|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
55775505|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775506|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775507|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
55775508|NCT01261247|Panobinostat|panobinostat|mesh-list
55775509|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55775510|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775511|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775512|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775513|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55775514|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55775515|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55775516|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
55775517|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775518|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56215988|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56215989|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56215990|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56215991|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56215992|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
56215993|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784099|NCT04654429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56215994|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56215995|NCT01621750|Clopidogrel|clopidogrel|mesh-list
56215996|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56215997|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56215998|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56216000|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
56216001|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143798|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
56216002|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216003|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216004|NCT01621763|Clopidogrel|clopidogrel|mesh-list
56216005|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56216006|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56216007|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56216008|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56216009|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
56216010|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216011|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775519|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55775520|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775521|NCT02449655|Paclitaxel|paclitaxel|mesh-list
55775522|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55916778|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
55775523|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55775524|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775525|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
55775526|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
55775527|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
55775528|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775529|NCT04254731|Methadone|methadone|mesh-list
55775530|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55775531|NCT04254731|Narcotics|narcotics|mesh-ancestor
55775532|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216012|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216013|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
56216014|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56216015|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56216016|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216017|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56216019|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56216020|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792308|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
55775533|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775534|NCT04254731|Analgesics|analgesics|mesh-ancestor
55775535|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
55775536|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775537|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
55775538|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
55775539|NCT01603277|Antibodies|antibodies|mesh-list
55775540|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55775541|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
55775542|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775544|NCT01678313|Doxazosin|doxazosin|mesh-list
55783204|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
55783205|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55783206|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775545|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55775546|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55775547|NCT01678313|Analgesics|analgesics|mesh-ancestor
55775548|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
55775549|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775550|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775551|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775552|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775553|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55775554|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55775555|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775556|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775557|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55775558|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55775559|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55775560|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55775561|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
55775562|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775563|NCT03197207|Camphor|camphor|mesh-list
55775564|NCT03197207|Salicylates|salicylates|mesh-list
55775565|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
55775566|NCT03197207|Menthol|menthol|mesh-list
55775567|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55775568|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775570|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
55775571|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55775572|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55775573|NCT03197207|Analgesics|analgesics|mesh-ancestor
55775574|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
55775575|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775576|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775577|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775578|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775579|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55775580|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775581|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775582|NCT01603121|Lisofylline|lisofylline|mesh-list
55775583|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55775584|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
56216021|NCT01621971|Milrinone|milrinone|mesh-list
56216022|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56216023|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56216024|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
56216025|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56216026|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55775585|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775586|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55775587|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55775588|NCT01603121|Analgesics|analgesics|mesh-ancestor
55775589|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
55775590|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775591|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775592|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775593|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775594|NCT02449265|Prednisone|prednisone|mesh-list
55775595|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
55775596|NCT02449265|Doxorubicin|doxorubicin|mesh-list
55775597|NCT02449265|Vincristine|vincristine|mesh-list
55775598|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775599|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
55775600|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775601|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775602|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55775603|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
55775604|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775605|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775606|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55775607|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55775608|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55775609|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55733633|NCT03645863|Iron|iron|mesh-list
55783208|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55775614|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775615|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55775616|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55775617|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
55775618|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
55775619|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
55775620|NCT03196817|Betamethasone|betamethasone|mesh-list
55775621|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
55775622|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55775623|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
55775624|NCT03196817|Lidocaine|lidocaine|mesh-list
55775625|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55775626|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
55775627|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
55775628|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775629|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775630|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
55775631|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775632|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55775633|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55775634|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55775635|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55775636|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775637|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775638|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
55775639|NCT03196817|Hormones|hormones|mesh-ancestor
55775640|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775641|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55775642|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
55775643|NCT05091359|Calcium|calcium|mesh-list
55775644|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55775645|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775646|NCT03593759|Prednisone|prednisone|mesh-list
55775647|NCT03593759|Prednisolone|prednisolone|mesh-list
55775648|NCT03593759|Methotrexate|methotrexate|mesh-list
56216027|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216028|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216029|NCT01621971|Protective Agents|protective agents|mesh-ancestor
56216030|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216031|NCT01622075|Paclitaxel|paclitaxel|mesh-list
56216032|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56216033|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56216034|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916942|NCT02960568|Primaquine|primaquine|mesh-list
56216035|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
56216036|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
56216037|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
56216038|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216039|NCT01622283|Cetirizine|cetirizine|mesh-list
55775649|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775650|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
55775651|NCT03593759|Hormones|hormones|mesh-ancestor
55775652|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775653|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775654|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55775655|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775656|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55775657|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
55775658|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55775659|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55775660|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
55775661|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775662|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
55775663|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775664|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55775665|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775666|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
55775667|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775668|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55775669|NCT03564821|Ivosidenib|ivosidenib|mesh-list
55775670|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775671|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775672|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775673|NCT02014402|Thrombin|thrombin|mesh-list
55775674|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
55775675|NCT02014402|Coagulants|coagulants|mesh-ancestor
55775676|NCT01988662|Ranibizumab|ranibizumab|mesh-list
55775677|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55775681|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
55775682|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775683|NCT00127673|Sertraline|sertraline|mesh-list
55775684|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
55775685|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55775686|NCT00127673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55775687|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55775688|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56216040|NCT01622283|Levocetirizine|levocetirizine|mesh-list
56216041|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56216042|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56216043|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56216044|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
56216045|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
56216046|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216047|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216048|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216049|NCT01622361|Tamoxifen|tamoxifen|mesh-list
56216050|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
56216051|NCT01622361|Docetaxel|docetaxel|mesh-list
56216052|NCT01622361|Doxorubicin|doxorubicin|mesh-list
56216053|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56216054|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216055|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
56216056|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775689|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775690|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775691|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
55775692|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775693|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
55775694|NCT02449187|Metformin|metformin|mesh-list
55775695|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55775696|NCT02449187|Calcium|calcium|mesh-list
55775697|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55775698|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775699|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55775700|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55775701|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55775702|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55775703|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
55775704|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775705|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55775706|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55775707|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775711|NCT05095571|Niacinamide|niacinamide|mesh-list
55775713|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
55775714|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
55775715|NCT05095571|Vitamins|vitamins|mesh-ancestor
55775716|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
55775717|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775718|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55775719|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
55775720|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775721|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55775722|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
55775723|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
55775725|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
55775726|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55775727|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
55775728|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55775729|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775730|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55775731|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
55775732|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775733|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775734|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
56216057|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56216058|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56216059|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
56216060|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216061|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216062|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56216063|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
55917040|NCT01517100|Sensory System Agents|sensory system agents|mesh-ancestor
56216064|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
56216065|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
56216066|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56216067|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56216068|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56216069|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216070|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56216071|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
56000877|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55775735|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775736|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55775737|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775738|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
55775739|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775740|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55775744|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55783210|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
55783211|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775745|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775746|NCT05095025|Bupivacaine|bupivacaine|mesh-list
55775747|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
55775748|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
55775749|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775750|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775751|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
55775752|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775753|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55775754|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55775755|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775756|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
55775757|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
55775758|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775759|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775760|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775761|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
55775762|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
55775763|NCT05084027|Fludarabine|fludarabine|mesh-list
55775764|NCT05084027|Melphalan|melphalan|mesh-list
55775765|NCT05084027|Venetoclax|venetoclax|mesh-list
55775766|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775767|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775768|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775769|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
55775770|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775771|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55775772|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
55775773|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55775774|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
55775775|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
55775776|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216072|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216073|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56216074|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56216075|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55784100|NCT04654429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56216076|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56216077|NCT01622439|Prednisone|prednisone|mesh-list
56216078|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
56216079|NCT01622439|Rituximab|rituximab|mesh-list
56216080|NCT01622439|Doxorubicin|doxorubicin|mesh-list
56216081|NCT01622439|Vincristine|vincristine|mesh-list
56216082|NCT01622439|Valproic Acid|valproic acid|mesh-list
56216083|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216084|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
56216085|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216086|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56216087|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56216088|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
56216089|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216090|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216091|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56216092|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55792368|NCT04816253|Prednisolone|prednisolone|mesh-list
55775777|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775778|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775779|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
55775780|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
55775781|NCT02448797|Vinorelbine|vinorelbine|mesh-list
55775782|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55775783|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775784|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
55775785|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
55775786|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
55775787|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775788|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
55775789|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55775790|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55775791|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
55775792|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55775793|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55775794|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
55775795|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
55775796|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55775797|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
56216093|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56216094|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56216095|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56216096|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216097|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56216099|NCT01622439|Hormones|hormones|mesh-ancestor
56216100|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216101|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56216102|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56216103|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
56216104|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
56216105|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
56216106|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
56216107|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
56216108|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216109|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
56216110|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55775798|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775799|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
55775802|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55775803|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55775804|NCT04438577|Lidocaine|lidocaine|mesh-list
55783212|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55783214|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55783215|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
55775805|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
55775806|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
55775807|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775808|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775809|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
55917188|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
55775810|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775811|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55775812|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55775813|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55775814|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55775815|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775816|NCT05087615|Ondansetron|ondansetron|mesh-list
55775817|NCT05087615|Metoclopramide|metoclopramide|mesh-list
55775818|NCT05087615|Granisetron|granisetron|mesh-list
55775819|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
55775820|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
55775821|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775822|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775823|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55775824|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
55775825|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
55775826|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55775827|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
55775828|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775829|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775830|NCT05087615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56216111|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216112|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56216114|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56216115|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216116|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
56216117|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216118|NCT01622556|Fludarabine|fludarabine|mesh-list
56216119|NCT01622556|Busulfan|busulfan|mesh-list
56216120|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
56216121|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216122|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792410|NCT05042635|Ixekizumab|ixekizumab|mesh-list
55775831|NCT05087615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55775832|NCT05087615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775833|NCT05087615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55775834|NCT05087615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55775835|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55775836|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55775838|NCT01987102|Leucovorin|leucovorin|mesh-list
55775839|NCT01987102|Calcium|calcium|mesh-list
55775840|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
55775841|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55775842|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775843|NCT01987102|Antidotes|antidotes|mesh-ancestor
55775844|NCT01987102|Protective Agents|protective agents|mesh-ancestor
55775845|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
55775846|NCT01987102|Vitamins|vitamins|mesh-ancestor
55775847|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
55775848|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55775849|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55775850|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
55775851|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775852|NCT05374499|Epinephrine|epinephrine|mesh-list
55775853|NCT05374499|Bupivacaine|bupivacaine|mesh-list
55775854|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
55775855|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
55775856|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775857|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775858|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
55775859|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775860|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55775861|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55775863|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775864|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775865|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55775866|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55775867|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
55775868|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55775869|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
55775870|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
55775871|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
55775872|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55775873|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
55775874|NCT03968939|Promethazine|promethazine|mesh-list
55775875|NCT03968939|Melatonin|melatonin|mesh-list
55775876|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
56216123|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216124|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
56216125|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775877|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775878|NCT03968939|Protective Agents|protective agents|mesh-ancestor
55775879|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775880|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55775881|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55775882|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55775883|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
55775884|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
55775885|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
55775886|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775887|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
55775888|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
55775889|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55775890|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55775891|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
55775892|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
55775893|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775894|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55775895|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
55775896|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
55775897|NCT03856619|Teriflunomide|teriflunomide|mesh-list
55775898|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55775899|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55775900|NCT03856619|Analgesics|analgesics|mesh-ancestor
55775901|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
55775902|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775903|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775904|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775905|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775906|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775907|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
55775908|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
55775909|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55775910|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
55775911|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775912|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
55775913|NCT02448407|Protective Agents|protective agents|mesh-ancestor
55775914|NCT05099471|Dexamethasone|dexamethasone|mesh-list
55775915|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
55775916|NCT05099471|Rituximab|rituximab|mesh-list
55775917|NCT05099471|Venetoclax|venetoclax|mesh-list
55775918|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775919|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
55775920|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775921|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55775922|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55775923|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
55775924|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775925|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775926|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55775927|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55775928|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775929|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
55775930|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
55775931|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775932|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55775933|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
55775934|NCT05099471|Hormones|hormones|mesh-ancestor
55775936|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55783216|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775937|NCT05098847|Lenvatinib|lenvatinib|mesh-list
55775938|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775939|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55775940|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775941|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216126|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
55889845|NCT03825471|Narcotics|narcotics|mesh-ancestor
56216127|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56216128|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56216129|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56216130|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56216131|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55775943|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775944|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55775945|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775946|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775947|NCT02012296|Mifepristone|mifepristone|mesh-list
55775948|NCT02012296|Androgens|androgens|mesh-list
55775949|NCT02012296|Hormones|hormones|mesh-ancestor
55775950|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775951|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775952|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55775953|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
55775954|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55775955|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55775956|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55775957|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55775958|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
55775959|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55775960|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55775961|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
55917576|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775962|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
55775963|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55775964|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55775965|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
55775966|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
55775967|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775968|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775969|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775970|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
55775971|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
55775972|NCT04177498|ON 01910|on 01910|mesh-list
55775973|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55775974|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55775975|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917758|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55775976|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775977|NCT04658836|Triamcinolone|triamcinolone|mesh-list
55775978|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55775979|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55775980|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55775981|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775983|NCT04658836|Hormones|hormones|mesh-ancestor
55775984|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775985|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775986|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55775987|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
55775988|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775989|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775990|NCT01677377|Risperidone|risperidone|mesh-list
55775991|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55775992|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
55775993|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775994|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775995|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775996|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55775998|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216132|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
56216133|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917939|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56216134|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56216135|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56216136|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216137|NCT01622790|Lamivudine|lamivudine|mesh-list
56216138|NCT01622790|Abacavir|abacavir|mesh-list
56216139|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
56216140|NCT01622790|Dolutegravir|dolutegravir|mesh-list
56216141|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56216142|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56216143|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000878|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55775999|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55783217|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776000|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55776002|NCT05097911|Bevacizumab|bevacizumab|mesh-list
55776003|NCT05097911|Atezolizumab|atezolizumab|mesh-list
55776004|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55776005|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918054|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
55776006|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55776007|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55776008|NCT05097911|Growth Substances|growth substances|mesh-ancestor
55776009|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776010|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
55776011|NCT05097365|Folic Acid|folic acid|mesh-list
55776012|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
55776013|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
55776014|NCT05097365|Vitamins|vitamins|mesh-ancestor
55776015|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
55776016|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776017|NCT05097365|Hematinics|hematinics|mesh-ancestor
55776018|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
55776019|NCT01964716|Vaccines|vaccines|mesh-list
55776020|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55776021|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
55776022|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776023|NCT01964560|Lacosamide|lacosamide|mesh-list
55776024|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
55776025|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55776026|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55776027|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55776028|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776029|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
55776030|NCT02659943|Fludarabine|fludarabine|mesh-list
55776031|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55776032|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
55776033|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776035|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55776036|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
55776037|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776038|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776039|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55776040|NCT05083325|Oseltamivir|oseltamivir|mesh-list
55776041|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
55776042|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776043|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776044|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776045|NCT01677299|Metformin|metformin|mesh-list
55776046|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55776047|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776048|NCT04999631|Ethanol|ethanol|mesh-list
56216144|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776049|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
55776050|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55776051|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889846|NCT03825471|Analgesics|analgesics|mesh-ancestor
55776052|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776053|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776054|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55776055|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
55776056|NCT02718833|Dexamethasone|dexamethasone|mesh-list
55776057|NCT02718833|Bortezomib|bortezomib|mesh-list
55776058|NCT02718833|Pomalidomide|pomalidomide|mesh-list
55776059|NCT02718833|Elotuzumab|elotuzumab|mesh-list
55776060|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55776061|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
55776062|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
55776063|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776064|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776065|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55776066|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
55776067|NCT02718833|Hormones|hormones|mesh-ancestor
55776068|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55776069|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55776070|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776071|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
55776072|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55783221|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776073|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55776074|NCT02718833|Growth Substances|growth substances|mesh-ancestor
55776075|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
55776076|NCT04908293|Listerine|listerine|mesh-list
55776077|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
55918390|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55776079|NCT04908293|Protective Agents|protective agents|mesh-ancestor
55776080|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776081|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55776082|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776083|NCT01964326|Atorvastatin|atorvastatin|mesh-list
55776084|NCT01964326|Calcium|calcium|mesh-list
55776085|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55776086|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776087|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55776088|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55776089|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
55776090|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776091|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55776092|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55776093|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776094|NCT05102045|Memantine|memantine|mesh-list
55918472|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918473|NCT01427933|Ramucirumab|ramucirumab|mesh-list
55918474|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918475|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
55918476|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918477|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
55918478|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55918479|NCT03780127|Fenfluramine|fenfluramine|mesh-list
55918480|NCT03780127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55776095|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
55776096|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55776097|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55776098|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
55776099|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776100|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776101|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776102|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55776103|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55776104|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776105|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
55776106|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
55776107|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
55918544|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55776108|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55776109|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55776110|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776111|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776112|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776113|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776114|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
55776115|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
55776116|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
55776117|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776118|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776119|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
55776121|NCT05101811|Vitamin D|vitamin d|mesh-list
56216145|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
56216146|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216147|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56216148|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56216149|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56216150|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56216151|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
55918654|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
55918655|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743088|NCT01868451|Doxorubicin|doxorubicin|mesh-list
55918705|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918706|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55918707|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
55918708|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918709|NCT04197349|Sumatriptan|sumatriptan|mesh-list
55918710|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55918711|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55918712|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55918713|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
55918722|NCT03422094|Nivolumab|nivolumab|mesh-list
55918767|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
55918768|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
55918769|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55918770|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55918775|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
56216152|NCT01622881|Nefopam|nefopam|mesh-list
56216153|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56216154|NCT01622881|Analgesics|analgesics|mesh-ancestor
56216155|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
56216156|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216157|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216158|NCT01622933|Interferons|interferons|mesh-list
56216159|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
55776122|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
55776123|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
55776124|NCT05101811|Vitamins|vitamins|mesh-list
55776125|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
55776126|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776127|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55776128|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55776129|NCT04088123|Ticagrelor|ticagrelor|mesh-list
55776130|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55776131|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55918794|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55918796|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
55918797|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
55918798|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55776132|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55776133|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55776134|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
55776135|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776136|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776137|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776138|NCT05164367|Atropine|atropine|mesh-list
55776139|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55776140|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55776141|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55776142|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
55783222|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776143|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776146|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
55776148|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
55776149|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55776150|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55776151|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
55776152|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776153|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776154|NCT03847181|Vitamin K|vitamin k|mesh-list
55776155|NCT03847181|Warfarin|warfarin|mesh-list
55776156|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
55776157|NCT03847181|Apixaban|apixaban|mesh-list
55776158|NCT03847181|Anticoagulants|anticoagulants|mesh-list
55776159|NCT03847181|Vitamins|vitamins|mesh-ancestor
55776160|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
55776161|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776162|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55776163|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
55776164|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55776165|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
55918987|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55918989|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776166|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216160|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216161|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
56216162|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216163|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
56216164|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216165|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
56216166|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56216167|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56216168|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216169|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
56216170|NCT01622946|Coagulants|coagulants|mesh-ancestor
56216171|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56216172|NCT01622972|Laxatives|laxatives|mesh-ancestor
56216173|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56216174|NCT01623024|Vitamin D|vitamin d|mesh-list
56216175|NCT01623024|Vitamins|vitamins|mesh-ancestor
56216176|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
56216177|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216178|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56216180|NCT01623102|Bevacizumab|bevacizumab|mesh-list
56216181|NCT01623102|Cisplatin|cisplatin|mesh-list
56000879|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55776167|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776168|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55776169|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55776170|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
55776171|NCT03847181|Coagulants|coagulants|mesh-ancestor
55776172|NCT03477851|Tramadol|tramadol|mesh-list
55776173|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55776174|NCT03477851|Narcotics|narcotics|mesh-ancestor
55776175|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776176|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776177|NCT03477851|Analgesics|analgesics|mesh-ancestor
55776178|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
55776179|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776180|NCT02409199|Docetaxel|docetaxel|mesh-list
55776181|NCT02409199|Apatinib|apatinib|mesh-list
55776182|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776183|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
55919030|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776184|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
55776185|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
55776186|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776187|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55776188|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776189|NCT03115489|Ketamine|ketamine|mesh-list
55776191|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55776192|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776193|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776194|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55776195|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
55776196|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
55776197|NCT03115489|Analgesics|analgesics|mesh-ancestor
56216182|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56216183|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216184|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55776198|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
55776199|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776200|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55776201|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55776202|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55776203|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776204|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776206|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55776207|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55776208|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
55776209|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776210|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776211|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919181|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919182|NCT04026841|Antibodies|antibodies|mesh-list
55919183|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
55919184|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919185|NCT04128774|Dexamethasone|dexamethasone|mesh-list
55919186|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
55919187|NCT04128774|BB 1101|bb 1101|mesh-list
55919188|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55919189|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
55919190|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
55776212|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55783223|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55776215|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55776216|NCT03171727|Tinzaparin|tinzaparin|mesh-list
55776217|NCT03171727|Dalteparin|dalteparin|mesh-list
55776218|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
55776219|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55776220|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55776221|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776222|NCT02400931|Rocuronium|rocuronium|mesh-list
55776223|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55776224|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55776225|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55776226|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776227|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776228|NCT03116269|Aspirin|aspirin|mesh-list
55776229|NCT03116269|Cilostazol|cilostazol|mesh-list
55776230|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55776231|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55776232|NCT03116269|Analgesics|analgesics|mesh-ancestor
55776233|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
55776234|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776235|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776237|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776238|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55776239|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55919217|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
55919218|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919219|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919220|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
55919221|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55919231|NCT00751179|Bromides|bromides|mesh-list
55776240|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776241|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55776242|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55776243|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776245|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55776246|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
55776247|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55776248|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919296|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55919298|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
55919299|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
55919300|NCT01276587|Vitamins|vitamins|mesh-list
55919301|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
55919302|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919303|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55919304|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55919305|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55919306|NCT01275105|Phenylephrine|phenylephrine|mesh-list
55919307|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
55776249|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
55776250|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55776251|NCT03116269|Protective Agents|protective agents|mesh-ancestor
55776252|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55776253|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55776254|NCT03174067|Clonidine|clonidine|mesh-list
55776255|NCT03174067|Buprenorphine|buprenorphine|mesh-list
56216185|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56216186|NCT01623102|Growth Substances|growth substances|mesh-ancestor
56216187|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216188|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
56216189|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56216190|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
56216191|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216192|NCT01623102|Antiviral Agents|antiviral agents|mesh-ancestor
55919428|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216193|NCT01623102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216194|NCT01623102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216195|NCT01623102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216196|NCT01623102|Immunologic Factors|immunologic factors|mesh-ancestor
56216197|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56216198|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
55776256|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55776257|NCT03174067|Narcotics|narcotics|mesh-ancestor
55776258|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776259|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776260|NCT03174067|Analgesics|analgesics|mesh-ancestor
55776261|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
55776262|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776263|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55776264|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55776265|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
55776266|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
55783225|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
55783226|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783227|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
55783228|NCT05005637|Prednisone|prednisone|mesh-list
55783229|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783230|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
55783231|NCT05005637|Hormones|hormones|mesh-ancestor
55783232|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919594|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
55783233|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783239|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55783240|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783241|NCT02336659|Incretins|incretins|mesh-ancestor
55783242|NCT02336659|Hormones|hormones|mesh-ancestor
55776267|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55776268|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55776269|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55776270|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
55776271|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919752|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55776272|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776273|NCT02408185|Colistin|colistin|mesh-list
55776274|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55776275|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776276|NCT02408419|Bupivacaine|bupivacaine|mesh-list
55776277|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
55776278|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
55776279|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776280|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776281|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
55776282|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776283|NCT00708097|Fluorides|fluorides|mesh-list
55776284|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
55776285|NCT00708097|Protective Agents|protective agents|mesh-ancestor
55776286|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776287|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55920061|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
55776288|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56216200|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56216201|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
56216202|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216203|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56216204|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56216205|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216206|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56216207|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56216208|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
56216209|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
56216210|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216211|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
56216212|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216213|NCT01623349|Olaparib|olaparib|mesh-list
56216214|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55792502|NCT03094663|Hormones|hormones|mesh-ancestor
55776289|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55776290|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776291|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
55776292|NCT02405689|Remifentanil|remifentanil|mesh-list
55776293|NCT02405689|Sevoflurane|sevoflurane|mesh-list
55776294|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55776295|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776296|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776297|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55776298|NCT02405689|Analgesics|analgesics|mesh-ancestor
55776299|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
55776300|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776301|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55776302|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55776303|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55776304|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
55783243|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783244|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55783246|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776305|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776306|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776307|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55776308|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55776309|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
55776310|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
55776311|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55776312|NCT02405689|Narcotics|narcotics|mesh-ancestor
55776313|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
55776314|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55776315|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55776316|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55776318|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776319|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
55776320|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216215|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216216|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216217|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920223|NCT05076786|Carboplatin|carboplatin|mesh-list
55920224|NCT05076786|Etoposide|etoposide|mesh-list
55920225|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920227|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55920268|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55920269|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920270|NCT05068752|Sorafenib|sorafenib|mesh-list
56216218|NCT01623362|Fluorides|fluorides|mesh-list
55776321|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776322|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55776323|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776324|NCT05083949|Metformin|metformin|mesh-list
55776325|NCT05083949|Empagliflozin|empagliflozin|mesh-list
55776326|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55776327|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776328|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55776329|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776330|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55776331|NCT02699125|Guanfacine|guanfacine|mesh-list
55776332|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55776333|NCT02699125|Diuretics|diuretics|mesh-ancestor
55776334|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
55776335|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776336|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55776337|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55776338|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776339|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55776340|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55776341|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55776342|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
55776343|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776344|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
55776345|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
55776346|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776347|NCT04279535|Protective Agents|protective agents|mesh-ancestor
55920526|NCT04405921|Azithromycin|azithromycin|mesh-list
55920527|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
55920528|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55920529|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920530|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
55920531|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55920532|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55920533|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920535|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920574|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55920575|NCT04765267|Astringents|astringents|mesh-ancestor
55920576|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
55920577|NCT05583409|Osimertinib|osimertinib|mesh-list
55920578|NCT05583409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920579|NCT05583409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55920580|NCT05583409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920581|NCT05583409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776348|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776349|NCT04279535|Vitamins|vitamins|mesh-ancestor
55776350|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
55776351|NCT02400151|Vitamin D|vitamin d|mesh-list
55776352|NCT02400151|Vitamins|vitamins|mesh-ancestor
55776353|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
55776354|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776355|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55783247|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776356|NCT02400385|Nivolumab|nivolumab|mesh-list
55776357|NCT02400385|Sunitinib|sunitinib|mesh-list
55920624|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920625|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55920626|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55920627|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
55920628|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55920629|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55920630|NCT03580681|Vitamin E|vitamin e|mesh-list
55920631|NCT03580681|Vitamins|vitamins|mesh-ancestor
55920632|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
55920633|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920634|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
55920635|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920636|NCT03580681|Protective Agents|protective agents|mesh-ancestor
55776358|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55776359|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776360|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55776361|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776362|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55776363|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55776364|NCT02400385|Growth Substances|growth substances|mesh-ancestor
55776365|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776366|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
55776367|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55776368|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776369|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55776370|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55776371|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55776372|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55776373|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55920823|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
55920827|NCT01602510|Lamotrigine|lamotrigine|mesh-list
55776374|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
55776375|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776376|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776377|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776378|NCT05100719|Mebeverine|mebeverine|mesh-list
55776379|NCT05100719|Simethicone|simethicone|mesh-list
56216219|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
56216220|NCT01623362|Protective Agents|protective agents|mesh-ancestor
56216221|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216222|NCT01623375|Insulin|insulin|mesh-list
56216223|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56216224|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
56216225|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56216226|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216227|NCT01623401|Tedizolid|tedizolid|mesh-list
56216228|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
56216229|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56216230|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216232|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56216233|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56216234|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216235|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
56216236|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216237|NCT01623505|Varenicline|varenicline|mesh-list
56216238|NCT01623505|Nicotine|nicotine|mesh-list
56216239|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56216240|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56216241|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
55776380|NCT05100719|Citric Acid|citric acid|mesh-list
55776381|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
55776382|NCT05100719|Alverine|alverine|mesh-list
55776383|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
55776384|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55921228|NCT04510194|Metformin|metformin|mesh-list
55776386|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
55776387|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776388|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
55776389|NCT05100719|Emollients|emollients|mesh-ancestor
55776390|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
55776391|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
55776392|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
55776393|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776394|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776395|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
55776396|NCT05100563|Naltrexone|naltrexone|mesh-list
55776397|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55776398|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55776399|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776400|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
55776401|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776402|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
55776403|NCT05100329|Analgesics|analgesics|mesh-ancestor
55776404|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
55776405|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776406|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776407|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776408|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55776409|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55776410|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776411|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776412|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
55776413|NCT04530539|Melatonin|melatonin|mesh-list
55776414|NCT04530539|Vitamins|vitamins|mesh-ancestor
55776415|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
56216242|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216243|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216244|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216245|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56216246|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
56216247|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216248|NCT01623570|Menotropins|menotropins|mesh-list
56216249|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55921430|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56216250|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
56216251|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56216252|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216253|NCT01623609|Naloxegol|naloxegol|mesh-list
56216254|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56216255|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216256|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
56216257|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216258|NCT01623635|Ropivacaine|ropivacaine|mesh-list
56216259|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
56216260|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
56216261|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216262|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216263|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
56216264|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216265|NCT01623713|Risperidone|risperidone|mesh-list
56216266|NCT01623713|Iloperidone|iloperidone|mesh-list
56216267|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56216268|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
56216269|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216270|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921549|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
55921550|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921551|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55921552|NCT04080908|Hematinics|hematinics|mesh-ancestor
55921553|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55921554|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55921555|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
55921556|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55921557|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921558|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55921559|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792550|NCT04819217|Charcoal|charcoal|mesh-list
55776416|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776417|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
55776418|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776419|NCT04530539|Protective Agents|protective agents|mesh-ancestor
55776420|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776421|NCT02698891|Paclitaxel|paclitaxel|mesh-list
55776422|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55776423|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776424|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
55921596|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
55921597|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921598|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55921599|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55921600|NCT01671709|Montelukast|montelukast|mesh-list
55921601|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55921602|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
55921603|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55921604|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
55921605|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921606|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921607|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55776425|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
55776426|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
55776435|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55776436|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776437|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216271|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216272|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56216273|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56216274|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216275|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56216276|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56216277|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
56216278|NCT01623778|Interferons|interferons|mesh-list
56216279|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
56216280|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
56216281|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216282|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
56216283|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216284|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
56216285|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216286|NCT01623817|Vancomycin|vancomycin|mesh-list
56216287|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56216288|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216289|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
56216290|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56216291|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216292|NCT01623921|Celecoxib|celecoxib|mesh-list
55921804|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55921805|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
55921806|NCT03243175|Apixaban|apixaban|mesh-list
55921807|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55921808|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
55921809|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55921810|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
55921811|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921813|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
55921836|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
55921837|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921838|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921840|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55921841|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55921842|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55921843|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55921844|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
56216293|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56216294|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56216295|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56216296|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
56216297|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216298|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56216299|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56216300|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216301|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56216302|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56216303|NCT01623921|Analgesics|analgesics|mesh-ancestor
56216304|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
56216305|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776438|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55776439|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776440|NCT05108051|Oseltamivir|oseltamivir|mesh-list
55776441|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
55776442|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216306|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216307|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56216308|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55921982|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921983|NCT04404751|Folic Acid|folic acid|mesh-list
55921984|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
55921985|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
55921987|NCT04404751|Vitamins|vitamins|mesh-ancestor
55922016|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922017|NCT03841357|Abatacept|abatacept|mesh-list
55922018|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55922019|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922020|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216309|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56216310|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56216313|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216314|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
56216315|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
56216316|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
56216317|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216318|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56216319|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56216320|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56216321|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216322|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
56216323|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216324|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
56216325|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216326|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216327|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56216328|NCT01624051|Cisplatin|cisplatin|mesh-list
56216329|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216330|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
56216331|NCT01624064|Enalapril|enalapril|mesh-list
56216332|NCT01624064|Calcium|calcium|mesh-list
55805046|NCT05489731|Osimertinib|osimertinib|mesh-list
55922306|NCT03807037|Vitamins|vitamins|mesh-ancestor
56216333|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56216334|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56216335|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56216336|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216337|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56216338|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
56216339|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216340|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56216341|NCT01624103|Lidocaine|lidocaine|mesh-list
56216342|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
56216343|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
56216345|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216346|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216347|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
56216348|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216349|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56216350|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56216351|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56216352|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55776443|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776444|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776445|NCT03765359|Metformin|metformin|mesh-list
55776446|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55776447|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776448|NCT04351295|Chloroquine|chloroquine|mesh-list
55776449|NCT04351295|Favipiravir|favipiravir|mesh-list
55776450|NCT04351295|Amebicides|amebicides|mesh-ancestor
55776451|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55776452|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55776453|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776454|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
55776455|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776456|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
55776458|NCT02399137|Paclitaxel|paclitaxel|mesh-list
55776459|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55776460|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776461|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
55776462|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
55776463|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
55776464|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776465|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55776466|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
55776467|NCT02399137|Antiviral Agents|antiviral agents|mesh-ancestor
55776469|NCT02399137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776470|NCT02399137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55776471|NCT02399137|Immunologic Factors|immunologic factors|mesh-ancestor
55776472|NCT02399137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776473|NCT05093387|Carboplatin|carboplatin|mesh-list
55776474|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
55776475|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776476|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55776477|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
55776478|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55776479|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776480|NCT02850263|Aflibercept|aflibercept|mesh-list
55776481|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55776482|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55776483|NCT02850263|Growth Substances|growth substances|mesh-ancestor
55776484|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776485|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
55776486|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776487|NCT04481815|Rituximab|rituximab|mesh-list
55776488|NCT04481815|Methotrexate|methotrexate|mesh-list
55776489|NCT04481815|Lenalidomide|lenalidomide|mesh-list
55805057|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
55776490|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55776491|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776492|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
55776493|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783249|NCT03081923|Tremelimumab|tremelimumab|mesh-list
55783250|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55776494|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776495|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55776496|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
55776497|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56216353|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216354|NCT01624116|Metformin|metformin|mesh-list
55776499|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
55776500|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776501|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
55776502|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776503|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55922897|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776504|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55776505|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55776506|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55776507|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55776508|NCT04481815|Growth Substances|growth substances|mesh-ancestor
55776509|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
55776510|NCT05106803|Amoxicillin|amoxicillin|mesh-list
55776511|NCT05106803|Vancomycin|vancomycin|mesh-list
55776512|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
55776513|NCT05106803|Clindamycin|clindamycin|mesh-list
55923048|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
55776514|NCT05106803|Gentamicins|gentamicins|mesh-list
55776515|NCT05106803|Tetracycline|tetracycline|mesh-list
55776516|NCT05106803|Penicillins|penicillins|mesh-list
55776517|NCT05106803|Erythromycin|erythromycin|mesh-list
55776518|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
55776519|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
55776520|NCT05106803|Ampicillin|ampicillin|mesh-list
55776521|NCT05106803|Cefepime|cefepime|mesh-list
55776522|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55776523|NCT05106803|Norfloxacin|norfloxacin|mesh-list
55776524|NCT05106803|Oxacillin|oxacillin|mesh-list
55776525|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
55776526|NCT05106803|Trimethoprim|trimethoprim|mesh-list
55776527|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
55776528|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55776529|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776530|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55776531|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55776532|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776533|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776534|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776535|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55776536|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55776537|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55776538|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55776539|NCT05106803|Renal Agents|renal agents|mesh-ancestor
55776540|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
55776541|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55776542|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55923352|NCT00758667|Mesna|mesna|mesh-list
55776543|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55776544|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55776545|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55776546|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55776547|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55776548|NCT02398357|Nadroparin|nadroparin|mesh-list
55776549|NCT02398357|Warfarin|warfarin|mesh-list
55776550|NCT02398357|Calcium|calcium|mesh-list
55776551|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55776552|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776553|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
55776554|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55776555|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55923422|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923423|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55923424|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
55923426|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776557|NCT02398201|Bezafibrate|bezafibrate|mesh-list
55776558|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55776559|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
55776560|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776561|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55776562|NCT05106179|Propranolol|propranolol|mesh-list
56216355|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56216356|NCT01624116|Acarbose|acarbose|mesh-list
56216357|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56216358|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216359|NCT01624116|Incretins|incretins|mesh-ancestor
56216360|NCT01624116|Hormones|hormones|mesh-ancestor
55776563|NCT05106179|Atenolol|atenolol|mesh-list
55776564|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55923517|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55776565|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55776566|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
55776567|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776568|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776569|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776570|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55776571|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55776572|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
55776573|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
55776574|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
55776575|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923610|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55923622|NCT04700514|Analgesics|analgesics|mesh-ancestor
55776576|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55776577|NCT04670471|Remifentanil|remifentanil|mesh-list
55776578|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55776579|NCT04670471|Narcotics|narcotics|mesh-ancestor
55776580|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776581|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776582|NCT04670471|Analgesics|analgesics|mesh-ancestor
55776583|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
55776584|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776585|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
55776586|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
55776587|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55776588|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776589|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55776590|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
55923769|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55776591|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776592|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776593|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55776594|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
55776595|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776596|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55776597|NCT05106023|Temozolomide|temozolomide|mesh-list
55776598|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55776599|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
55776600|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776601|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776602|NCT02398123|Bupivacaine|bupivacaine|mesh-list
55776603|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
55776604|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
55776605|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923878|NCT04405674|Carboplatin|carboplatin|mesh-list
55923879|NCT04405674|Pemetrexed|pemetrexed|mesh-list
55923880|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55923881|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776606|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776608|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776609|NCT04486625|Aztreonam|aztreonam|mesh-list
55776610|NCT04486625|Avibactam|avibactam|mesh-list
55776611|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55776612|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776613|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55776614|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776615|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776616|NCT02404363|Clopidogrel|clopidogrel|mesh-list
55923973|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55923974|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55923975|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55923976|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
55923977|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
55923978|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
55923979|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
55923980|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923981|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923982|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55923983|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55923984|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
55923985|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923986|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55923987|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55776617|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55783251|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783252|NCT02341105|Amiodarone|amiodarone|mesh-list
55783253|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55783254|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
55783255|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55783256|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55783257|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783258|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55783259|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56216361|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216362|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55783260|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55783261|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783262|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55924067|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924068|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55924097|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55924098|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55924099|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
55924100|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924101|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
55924102|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924103|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924104|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924105|NCT00794313|Analgesics|analgesics|mesh-ancestor
55924106|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
55924107|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924108|NCT05743101|Levofloxacin|levofloxacin|mesh-list
55924109|NCT05743101|Ofloxacin|ofloxacin|mesh-list
55924112|NCT05743101|Renal Agents|renal agents|mesh-ancestor
55783263|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55776618|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55776619|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55776620|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55776621|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
55776622|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776623|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776624|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776625|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
55776626|NCT02404519|Vitamin K|vitamin k|mesh-list
55776627|NCT02404519|Vitamin MK 7|vitamin mk 7|mesh-list
55776628|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55776629|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55776630|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776631|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
55776632|NCT02404519|Coagulants|coagulants|mesh-ancestor
55776633|NCT02404519|Vitamins|vitamins|mesh-ancestor
55776634|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
55776635|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776636|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
55776637|NCT03173131|Narcotics|narcotics|mesh-ancestor
55776638|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776639|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776640|NCT03173131|Analgesics|analgesics|mesh-ancestor
55776641|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
55776642|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776643|NCT04524611|Ustekinumab|ustekinumab|mesh-list
55776644|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55776645|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
55776646|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
55924137|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924138|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
55924139|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55924140|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55924141|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55924142|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
55924143|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924144|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55924145|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55924146|NCT00087139|Epothilones|epothilones|mesh-list
55924147|NCT00087139|Epothilone B|epothilone b|mesh-list
55924148|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
55924149|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
55924150|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
55924151|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776647|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776648|NCT02658149|Ketorolac|ketorolac|mesh-list
55776649|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55776650|NCT02658149|Epinephrine|epinephrine|mesh-list
55776651|NCT02658149|Morphine|morphine|mesh-list
55776652|NCT02658149|Ropivacaine|ropivacaine|mesh-list
55776653|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55776654|NCT02658149|Narcotics|narcotics|mesh-ancestor
55776655|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776656|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776657|NCT02658149|Analgesics|analgesics|mesh-ancestor
55776658|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
55783265|NCT03078101|Empagliflozin|empagliflozin|mesh-list
55783266|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55776660|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
55776662|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55776663|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55776664|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
55924166|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
55924167|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924168|NCT00786825|Somatostatin|somatostatin|mesh-list
55924169|NCT00786825|Hormones|hormones|mesh-ancestor
55924170|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924171|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924172|NCT00768261|Memantine|memantine|mesh-list
55924173|NCT00768261|Donepezil|donepezil|mesh-list
55924174|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55924175|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924176|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924177|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
55924178|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924179|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924180|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
55924181|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55924182|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55924183|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
55924186|NCT03804723|Prednisone|prednisone|mesh-list
55776665|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776666|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776667|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55776668|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56216363|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
56216364|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000880|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55776669|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
55776670|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55924206|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55924207|NCT00797277|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55924208|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55924209|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55924211|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924228|NCT05742789|Isoflurane|isoflurane|mesh-list
55924229|NCT05742789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55924230|NCT05742789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924231|NCT05742789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924232|NCT05742789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55776671|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
55776672|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
55776673|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
55776674|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55776675|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55776676|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55776677|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55776678|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776679|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55776680|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776681|NCT03701711|Lenalidomide|lenalidomide|mesh-list
55776682|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
55776683|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776684|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55924302|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55924303|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
55924304|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924305|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55924306|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55924307|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776685|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55776686|NCT03701711|Growth Substances|growth substances|mesh-ancestor
55776687|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
55776688|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776690|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55776691|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
55776692|NCT04481971|Hormones|hormones|mesh-ancestor
55834597|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
55776693|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55776694|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776695|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55776696|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776698|NCT03172741|Cannabidiol|cannabidiol|mesh-list
55776699|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
55776700|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
55776701|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776702|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55776703|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55776704|NCT03172741|Analgesics|analgesics|mesh-ancestor
55776705|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
55776706|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776707|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55776708|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55776709|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776710|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776711|NCT03172741|Hormones|hormones|mesh-ancestor
55776712|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55776713|NCT02702011|Empagliflozin|empagliflozin|mesh-list
55784101|NCT04654429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756715|NCT05233579|Protective Agents|protective agents|mesh-ancestor
55743210|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
55924458|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924459|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55924460|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
55924461|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
55924463|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924464|NCT03439267|Calcium|calcium|mesh-list
55924465|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55924466|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924467|NCT00770133|Ketotifen|ketotifen|mesh-list
55776714|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55783268|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55783269|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783270|NCT02345239|Pantoprazole|pantoprazole|mesh-list
55783271|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55783272|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55783273|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55776715|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776717|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776718|NCT03170713|Ibuprofen|ibuprofen|mesh-list
55776719|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55776720|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55776721|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55776722|NCT03170713|Analgesics|analgesics|mesh-ancestor
55776723|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
55776724|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776725|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776726|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55776727|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776728|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55776729|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776730|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924514|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56000881|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
55776731|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
55776733|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
55776734|NCT04959175|Fludarabine|fludarabine|mesh-list
55776735|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55776736|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
55776737|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776738|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776739|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55776740|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
55776741|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776742|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776743|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55776744|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55776745|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55776746|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
55776747|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55776748|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776752|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776753|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55776754|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776755|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776756|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
55776757|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55776758|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776759|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55776760|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776761|NCT04952779|Insulin|insulin|mesh-list
55776762|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55776763|NCT04952779|Liraglutide|liraglutide|mesh-list
55776764|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
55776765|NCT04952779|Xultophy|xultophy|mesh-list
55776766|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55776767|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776768|NCT04952779|Incretins|incretins|mesh-ancestor
55776769|NCT04952779|Hormones|hormones|mesh-ancestor
55776770|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55776771|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
55783274|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783275|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924673|NCT03159000|Bupivacaine|bupivacaine|mesh-list
55783276|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
55783277|NCT04688203|Labetalol|labetalol|mesh-list
55783278|NCT04688203|Analgesics|analgesics|mesh-ancestor
55783279|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
55776772|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55776773|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
55776774|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776775|NCT04832009|Protective Agents|protective agents|mesh-ancestor
55776777|NCT04832009|Vitamins|vitamins|mesh-ancestor
55776778|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
55776779|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55776780|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55776781|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55776782|NCT03129113|Metformin|metformin|mesh-list
55776783|NCT03129113|Maraviroc|maraviroc|mesh-list
55776784|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55776785|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776786|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55776787|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56216365|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216366|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56216367|NCT01624129|Fluticasone|fluticasone|mesh-list
56216368|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56216369|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55776788|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776789|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55776790|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55776791|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
55776792|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776793|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55776794|NCT05105009|Furosemide|furosemide|mesh-list
55776795|NCT05105009|Diuretics|diuretics|mesh-ancestor
55776796|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
55776797|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784102|NCT04654429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55776798|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55776799|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55776800|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776801|NCT05104931|Piroxicam|piroxicam|mesh-list
55776802|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55776803|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55776804|NCT05104931|Analgesics|analgesics|mesh-ancestor
55924861|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924862|NCT05136534|Anesthetics|anesthetics|mesh-list
55924863|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924864|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924866|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924867|NCT05130684|Paclitaxel|paclitaxel|mesh-list
55924868|NCT05130684|Cisplatin|cisplatin|mesh-list
55924869|NCT05130684|Nivolumab|nivolumab|mesh-list
55924870|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55924871|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924872|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
55924873|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
55924874|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
55924875|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776805|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
55776806|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776807|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776808|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55776809|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776810|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55776811|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776812|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776813|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55776814|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55776815|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
55776816|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776817|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776818|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55776819|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
55776820|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55776821|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55776822|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55776823|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
55776824|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776825|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776826|NCT02406703|Mepivacaine|mepivacaine|mesh-list
55776827|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
55783280|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783281|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783282|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
55783283|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783284|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55783285|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
55783286|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55783287|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55783288|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783289|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55783290|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
55784103|NCT04654429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55925004|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
55783291|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783292|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55783293|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55783300|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55783302|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
55783303|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783304|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783305|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776828|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
56216371|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216372|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216373|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56216374|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
56216375|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
56216376|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56216377|NCT01624207|Atorvastatin|atorvastatin|mesh-list
56216378|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56216379|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56216380|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
56216381|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216382|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56216383|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56216384|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216385|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56216386|NCT01624246|Avibactam|avibactam|mesh-list
56216387|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56216388|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216389|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56216390|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216391|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792666|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
55792671|NCT05028907|Hormones|hormones|mesh-ancestor
55776829|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
55776830|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925145|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55925146|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55925147|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925148|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925149|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55925152|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55776831|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776832|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
55776833|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776835|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55776836|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776837|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
55776838|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776839|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776840|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
55776841|NCT05110469|Meperidine|meperidine|mesh-list
55925203|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925204|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925205|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925206|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
55925207|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925208|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
55925209|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55925210|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55925212|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55925213|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925214|NCT00791973|Fluticasone|fluticasone|mesh-list
55925215|NCT00791973|Xhance|xhance|mesh-list
55925216|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925217|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55776842|NCT05110469|Analgesics|analgesics|mesh-ancestor
55776843|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
55776844|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776845|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776846|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
55776847|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776848|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55776849|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
55783306|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
55783307|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
55783308|NCT04509973|Dexamethasone|dexamethasone|mesh-list
55783309|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783310|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
55783311|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
55776850|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56216393|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
56216394|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55776851|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55776852|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776853|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55776855|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55925274|NCT04460352|Fluorouracil|fluorouracil|mesh-list
55925275|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
55925276|NCT04460352|Calcium|calcium|mesh-list
55925277|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
55925278|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55925279|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925280|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
55925281|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
55925282|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
55925283|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925284|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55925285|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776856|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55776857|NCT05110469|Narcotics|narcotics|mesh-ancestor
55776858|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55776859|NCT02404051|Everolimus|everolimus|mesh-list
55776860|NCT02404051|Fulvestrant|fulvestrant|mesh-list
55776861|NCT02404051|Exemestane|exemestane|mesh-list
55776862|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776863|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55776864|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
55776865|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776866|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55776867|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55776868|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55776869|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
55925319|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
55925320|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925321|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925322|NCT03703375|Antiviral Agents|antiviral agents|mesh-ancestor
55925323|NCT03703375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776870|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55776871|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55776872|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55776873|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776874|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776875|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55776876|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
55776877|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776878|NCT05094323|Bupivacaine|bupivacaine|mesh-list
55776881|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776882|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776883|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
55776884|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776885|NCT03170323|Cyclosporine|cyclosporine|mesh-list
55776886|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
55776887|NCT03170323|Cyclosporins|cyclosporins|mesh-list
55925419|NCT05688631|Protective Agents|protective agents|mesh-ancestor
55925420|NCT05688631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925421|NCT04348032|Apatinib|apatinib|mesh-list
55925422|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743222|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
55776888|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776889|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776890|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55776891|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
55776892|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776893|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
55776894|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776895|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
55776896|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55776897|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55925487|NCT04970901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55776898|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55776899|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776900|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55776901|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
55776902|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55776903|NCT02396563|Ropivacaine|ropivacaine|mesh-list
55776904|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
55776905|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
55776906|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776907|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776908|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
55776909|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776910|NCT05109377|Tadalafil|tadalafil|mesh-list
55776911|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
55925553|NCT05665387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55925554|NCT03361735|Leuprolide|leuprolide|mesh-list
55925556|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55925557|NCT03361735|Hormones|hormones|mesh-list
55925558|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925559|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925560|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55925561|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
55925562|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55925563|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55776912|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55783312|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783313|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783314|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55776913|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55776914|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776915|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776916|NCT05109377|Urological Agents|urological agents|mesh-ancestor
55776918|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
55776919|NCT05109299|Protective Agents|protective agents|mesh-ancestor
56216395|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55776920|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776921|NCT05108597|Misoprostol|misoprostol|mesh-list
55776922|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55776923|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
55776924|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55776925|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776926|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55776927|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55776928|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
55776929|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
55776930|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
55776931|NCT02396329|Povidone|povidone|mesh-list
55776932|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55776933|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776934|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
55776935|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
55776936|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
55776937|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
55776938|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55925615|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55925616|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55925617|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776939|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776940|NCT02395783|Melatonin|melatonin|mesh-list
55776941|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
55776942|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776943|NCT02395783|Protective Agents|protective agents|mesh-ancestor
55776944|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776945|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55776946|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
55776947|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55776948|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55776949|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776950|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
55776953|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925681|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925682|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
55925683|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55925684|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55925685|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
55925686|NCT01459796|Protective Agents|protective agents|mesh-ancestor
55925687|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925689|NCT05043714|Nivolumab|nivolumab|mesh-list
55776954|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776955|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55776957|NCT04383119|Trabectedin|trabectedin|mesh-list
55776958|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55776959|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
55776960|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776961|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776962|NCT04383119|Antiviral Agents|antiviral agents|mesh-ancestor
55776963|NCT04383119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776964|NCT04383119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776965|NCT04383119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55776966|NCT04383119|Immunologic Factors|immunologic factors|mesh-ancestor
55776967|NCT04383119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776968|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55925763|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55925764|NCT04663347|Rituximab|rituximab|mesh-list
55925765|NCT04663347|Carboplatin|carboplatin|mesh-list
55925766|NCT04663347|Doxorubicin|doxorubicin|mesh-list
55925767|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55925768|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
55925769|NCT04663347|Vincristine|vincristine|mesh-list
55925770|NCT04663347|Lenalidomide|lenalidomide|mesh-list
55925839|NCT02900976|Rituximab|rituximab|mesh-list
55776969|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
55776970|NCT04522739|Spironolactone|spironolactone|mesh-list
55776971|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55776972|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
55783315|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
55783316|NCT04509973|Hormones|hormones|mesh-ancestor
55783317|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783318|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55783319|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776973|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55776974|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776975|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55776976|NCT04522739|Diuretics|diuretics|mesh-ancestor
55776977|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
55776978|NCT04309877|Theophylline|theophylline|mesh-list
55776979|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55776980|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
55784104|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
55925851|NCT05602597|Rabeprazole|rabeprazole|mesh-list
55925852|NCT05602597|Antifungal Agents|antifungal agents|mesh-ancestor
55925853|NCT05602597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925854|NCT05602597|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55925879|NCT04608201|Nicotine|nicotine|mesh-list
55776981|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216396|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216397|NCT01624428|Varenicline|varenicline|mesh-list
56216398|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55776982|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55776983|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55776984|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
55776985|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55776986|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776987|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776988|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
55776989|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55776990|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55776991|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
55925910|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
55776992|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776993|NCT04367909|Carboplatin|carboplatin|mesh-list
55776994|NCT04367909|Docetaxel|docetaxel|mesh-list
55776995|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
55776996|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55776997|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
55776998|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
55776999|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
55777000|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777001|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55777002|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
55777003|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55777004|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
55777005|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55777006|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777007|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55777011|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777012|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55926104|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
55926105|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777013|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777014|NCT04196075|Analgesics|analgesics|mesh-ancestor
55777015|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
55777016|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777017|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777018|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777019|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55777020|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55777021|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777022|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
55777023|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55777024|NCT03863483|Docetaxel|docetaxel|mesh-list
55777025|NCT03863483|Pemetrexed|pemetrexed|mesh-list
55777026|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777027|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
55926171|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55926172|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55926173|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
55926174|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
55926176|NCT00814671|Rifapentine|rifapentine|mesh-list
55926177|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55926178|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
55926179|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55926180|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926181|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
55926182|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55926183|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926184|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926185|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55926186|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55926187|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55926188|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55926189|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55926190|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55926191|NCT05686993|Nifedipine|nifedipine|mesh-list
55926192|NCT05686993|Cinnarizine|cinnarizine|mesh-list
55926193|NCT05686993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55926194|NCT05686993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55926195|NCT05686993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926196|NCT05686993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55926197|NCT05686993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926198|NCT05686993|Vasodilator Agents|vasodilator agents|mesh-ancestor
55926199|NCT05686993|Tocolytic Agents|tocolytic agents|mesh-ancestor
55777028|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
55777029|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
55777030|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777031|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777032|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55777033|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55777034|NCT03830411|Docetaxel|docetaxel|mesh-list
55777035|NCT03830411|Pemetrexed|pemetrexed|mesh-list
55783320|NCT02336347|Quinidine|quinidine|mesh-list
55783321|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
55783322|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
55783323|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
55783324|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55777036|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777037|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
55777038|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
55777039|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
55784105|NCT03111121|Neostigmine|neostigmine|mesh-list
55926200|NCT05686993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55926201|NCT05686993|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55926203|NCT05686993|Histamine Agents|histamine agents|mesh-ancestor
55777040|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777041|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777042|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55777043|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55777044|NCT03300479|Urapidil|urapidil|mesh-list
55777045|NCT03300479|Clevidipine|clevidipine|mesh-list
55777046|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56216399|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56216400|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
55777047|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55777048|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777049|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55777050|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777051|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55777052|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
55777053|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55777055|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777056|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55777057|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55777058|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55777059|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
55777060|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
55777061|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777062|NCT03540875|Remifentanil|remifentanil|mesh-list
55777063|NCT03540875|Propofol|propofol|mesh-list
55926419|NCT01473602|Vitamin D|vitamin d|mesh-list
55777064|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
55777065|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777066|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777067|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55777068|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55777069|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
55777070|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55777071|NCT03540875|Narcotics|narcotics|mesh-ancestor
55777072|NCT03540875|Analgesics|analgesics|mesh-ancestor
55777075|NCT03536507|Acetazolamide|acetazolamide|mesh-list
55777076|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
55777077|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55777078|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777079|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777080|NCT03536507|Diuretics|diuretics|mesh-ancestor
55777081|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
55777082|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926467|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55777083|NCT04765787|Acetaminophen|acetaminophen|mesh-list
55777084|NCT04765787|Orphenadrine|orphenadrine|mesh-list
55777085|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777086|NCT04765787|Analgesics|analgesics|mesh-ancestor
55777087|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
55777088|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777089|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777090|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
55777091|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55777092|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55777093|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55926554|NCT05237115|Bismuth|bismuth|mesh-list
55926555|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55926556|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926557|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55926558|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55926559|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55777094|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55777095|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
55777096|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
55777097|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55777098|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55783325|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55783326|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783327|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783328|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783329|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55777099|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
55777100|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777101|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926631|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55926632|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55926633|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
55926634|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926635|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926636|NCT00824733|Trastuzumab|trastuzumab|mesh-list
55926637|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55926638|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926639|NCT02150499|Albuterol|albuterol|mesh-list
55926640|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55926641|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
55926642|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777102|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
55777103|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55777104|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777106|NCT02944799|Alendronate|alendronate|mesh-list
55777107|NCT02944799|Calcium|calcium|mesh-list
55777108|NCT02944799|Vitamins|vitamins|mesh-ancestor
55777109|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
55777110|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216402|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216403|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216404|NCT01624441|Epirubicin|epirubicin|mesh-list
56216405|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56216406|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216407|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55926679|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56216408|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56216409|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777111|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55777112|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55777113|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
55777114|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
55777115|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777117|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777118|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55777120|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
55777121|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777122|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
55777123|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
55777124|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55777125|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55777126|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777127|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
55926758|NCT02155257|Modafinil|modafinil|mesh-list
55926759|NCT02155257|Analgesics|analgesics|mesh-ancestor
55926760|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
55926761|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926762|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926763|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
55926764|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55777128|NCT04521881|Coagulants|coagulants|mesh-ancestor
55777129|NCT04305899|BMS-986165|bms-986165|mesh-list
55777130|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
55777131|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55777132|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777133|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777134|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
55777135|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55777136|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
55777137|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777138|NCT01675661|Expectorants|expectorants|mesh-ancestor
55777139|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
55777140|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55777157|NCT04014803|Analgesics|analgesics|mesh-ancestor
55777158|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
55777159|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926826|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55926827|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
55926828|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
55926829|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926830|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926831|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926832|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55926833|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55926835|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
55926836|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
55926837|NCT04278937|Azithromycin|azithromycin|mesh-list
55926838|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55926839|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756742|NCT03284645|Lamivudine|lamivudine|mesh-list
55926840|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
55926841|NCT04278547|Valganciclovir|valganciclovir|mesh-list
55926842|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
55926843|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926844|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
55926845|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55926846|NCT05261269|Niraparib|niraparib|mesh-list
55735590|NCT04771689|Naloxone|naloxone|mesh-list
55777160|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777161|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783330|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55783331|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
55777162|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777163|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55777164|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55777165|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777166|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55777167|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55777168|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777169|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
55777170|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55777171|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55777172|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55777173|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
55777174|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777175|NCT05113511|Bevacizumab|bevacizumab|mesh-list
55777176|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55777177|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777178|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56216410|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777179|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55777181|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777182|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
55777198|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55777199|NCT03169985|Ezetimibe|ezetimibe|mesh-list
55777200|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55777201|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55777202|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
55777203|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777204|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55926847|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55926848|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926849|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926850|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926851|NCT00863109|Ribavirin|ribavirin|mesh-list
55926852|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55926853|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
55926854|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926855|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
55926856|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926857|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55926858|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55926859|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926860|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
55926861|NCT05246371|Propofol|propofol|mesh-list
55926862|NCT05246371|Desflurane|desflurane|mesh-list
55777205|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55777206|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777207|NCT04161989|Progesterone|progesterone|mesh-list
55777208|NCT04161989|Progestins|progestins|mesh-ancestor
55777209|NCT04161989|Hormones|hormones|mesh-ancestor
55777210|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777211|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777212|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
55777213|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55777214|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
55926882|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55926883|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
55926884|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926885|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55926886|NCT00831675|Vaccines|vaccines|mesh-list
55926887|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
55926888|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926889|NCT01397825|Rituximab|rituximab|mesh-list
55926890|NCT01397825|Vincristine|vincristine|mesh-list
55926891|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55926892|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926893|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
55926894|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926895|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926896|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55926897|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
55926898|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
55926901|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
55777215|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777217|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777218|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55777220|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
55777221|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55777223|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777224|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777225|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55777226|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777227|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
55777228|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777229|NCT04160117|Colchicine|colchicine|mesh-list
55777230|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
55777231|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777232|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
55777233|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
55777234|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
55777235|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926933|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926934|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55926935|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55926936|NCT01397201|Fluticasone|fluticasone|mesh-list
55926937|NCT01397201|Xhance|xhance|mesh-list
55926938|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926939|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55926940|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
55926941|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926942|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926943|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55926944|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
55926945|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
55926946|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55926947|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55926948|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55777236|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777237|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55777238|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55777239|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777240|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
55777241|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777242|NCT03115255|Ranibizumab|ranibizumab|mesh-list
55777243|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55777244|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55777245|NCT03115255|Growth Substances|growth substances|mesh-ancestor
55777246|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777247|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
55777248|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777249|NCT02009878|Tolvaptan|tolvaptan|mesh-list
55777250|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55777251|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777252|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
55777253|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926979|NCT00864123|Cycloserine|cycloserine|mesh-list
55926980|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55926981|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926982|NCT00864123|Renal Agents|renal agents|mesh-ancestor
55926983|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55926984|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
55926985|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55926986|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
55926987|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926988|NCT03858465|Phenylephrine|phenylephrine|mesh-list
55926989|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
55926990|NCT03858465|Ephedrine|ephedrine|mesh-list
55926991|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55926992|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
55926993|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
55926994|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926995|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777254|NCT02009722|Morphine|morphine|mesh-list
55777255|NCT02009722|Hydromorphone|hydromorphone|mesh-list
55777256|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55777257|NCT02009722|Narcotics|narcotics|mesh-ancestor
55777258|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777259|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777260|NCT02009722|Analgesics|analgesics|mesh-ancestor
55777261|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
55777262|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777263|NCT02655419|Metronidazole|metronidazole|mesh-list
55777264|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777265|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56216412|NCT01624493|Carboplatin|carboplatin|mesh-list
56216413|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216414|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55926996|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
55926997|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55926998|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
55926999|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
55927000|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55927001|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55927002|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55927003|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927004|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927005|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927006|NCT03858465|Protective Agents|protective agents|mesh-ancestor
55927007|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55756764|NCT03284177|Calcium|calcium|mesh-list
55927008|NCT05155579|Vaccines|vaccines|mesh-list
55927009|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
55927010|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927011|NCT00867789|Trimethoprim|trimethoprim|mesh-list
55927012|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55927013|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
55927014|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55927015|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927016|NCT00867789|Renal Agents|renal agents|mesh-ancestor
55927017|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
55927018|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55927019|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55927020|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55927021|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927022|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216415|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
56216416|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216417|NCT01624493|Antiviral Agents|antiviral agents|mesh-ancestor
56216418|NCT01624493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216419|NCT01624493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216420|NCT01624493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216421|NCT01624493|Immunologic Factors|immunologic factors|mesh-ancestor
56216422|NCT01624493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216423|NCT01624649|Methylphenidate|methylphenidate|mesh-list
56216424|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56216425|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56216426|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216427|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55927023|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55927024|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55927025|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55927026|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55927027|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
55927028|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
55927029|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927030|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927031|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751063|NCT03094533|Sevoflurane|sevoflurane|mesh-list
55751064|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55751065|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751066|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751067|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55751068|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
55751069|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
55751070|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55751071|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55751072|NCT03335579|Sufentanil|sufentanil|mesh-list
55751073|NCT03335579|Remifentanil|remifentanil|mesh-list
55751074|NCT03335579|Propofol|propofol|mesh-list
55751075|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
55751076|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751077|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751078|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55751079|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55751080|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
55751081|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55751082|NCT03335579|Narcotics|narcotics|mesh-ancestor
55751083|NCT03335579|Analgesics|analgesics|mesh-ancestor
55751084|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
55751085|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751086|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55751087|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
55751088|NCT05050071|Calcium|calcium|mesh-list
55751089|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55751090|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751091|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55751093|NCT03335501|Hormones|hormones|mesh-list
55751094|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751095|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751096|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55751097|NCT02492945|Lidocaine|lidocaine|mesh-list
55751098|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55751099|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
55751100|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
55751101|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751102|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751103|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
55751104|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216428|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56216429|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56216430|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216431|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
56216432|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216433|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56216434|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
55792704|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55777266|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55777267|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55777268|NCT01962922|Tacrolimus|tacrolimus|mesh-list
55927032|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
55927034|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55927035|NCT04797013|Plasminogen|plasminogen|mesh-list
55927036|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55927037|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55927038|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927039|NCT00838695|Phenylephrine|phenylephrine|mesh-list
55927040|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
55927041|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55927042|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
55927043|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
55927044|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927045|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927046|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
55927047|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55927048|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
55777269|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777270|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
55777271|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777272|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55777273|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777274|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777275|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
55777276|NCT04198961|Narcotics|narcotics|mesh-ancestor
55777277|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777278|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777279|NCT04198961|Analgesics|analgesics|mesh-ancestor
55777280|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
55777281|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777282|NCT01984684|Vancomycin|vancomycin|mesh-list
55777283|NCT01984684|Aztreonam|aztreonam|mesh-list
55777284|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55777286|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
55777287|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55927089|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55927090|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927091|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55927092|NCT04760431|Paclitaxel|paclitaxel|mesh-list
55927093|NCT04760431|Docetaxel|docetaxel|mesh-list
55927094|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55927095|NCT04760431|Trastuzumab|trastuzumab|mesh-list
55927096|NCT04760431|Pertuzumab|pertuzumab|mesh-list
55927097|NCT04760431|Taxane|taxane|mesh-list
55927098|NCT04760431|Tucatinib|tucatinib|mesh-list
55927099|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55927100|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927101|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
55777288|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
55777289|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56216435|NCT01624675|Risperidone|risperidone|mesh-list
56216436|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55777290|NCT04585841|Cannabidiol|cannabidiol|mesh-list
55777291|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
55777292|NCT02694523|Adalimumab|adalimumab|mesh-list
55777293|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55777294|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777295|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777296|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
55777297|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777298|NCT05038475|Antibodies|antibodies|mesh-list
55777299|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
55777300|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927130|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55927131|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927132|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927133|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927134|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55927135|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55927136|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
55927137|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55927138|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55927139|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
55927140|NCT02647866|KHK4083|khk4083|mesh-list
55927141|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
55927142|NCT02246127|Everolimus|everolimus|mesh-list
55927143|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927144|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927145|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
55927146|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927147|NCT04277923|SMOFlipid|smoflipid|mesh-list
55927186|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927187|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927188|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55743242|NCT03218137|Analgesics|analgesics|mesh-ancestor
55927189|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
55927190|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55927191|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55927192|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55927193|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927194|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927195|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927196|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
55927197|NCT03224767|Vemurafenib|vemurafenib|mesh-list
55927198|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927199|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55927200|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777301|NCT02009332|Gemcitabine|gemcitabine|mesh-list
55777302|NCT02009332|Sirolimus|sirolimus|mesh-list
55777303|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55777304|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
55777305|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777306|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777307|NCT02009332|Antiviral Agents|antiviral agents|mesh-ancestor
55777308|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777309|NCT02009332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783332|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55783333|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
55783334|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55927244|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
55927245|NCT02084797|Tolvaptan|tolvaptan|mesh-list
55927246|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
55927247|NCT02084797|Coagulants|coagulants|mesh-ancestor
55927248|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55927249|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55927250|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
55927251|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927252|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55927253|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927254|NCT00873327|Tazobactam|tazobactam|mesh-list
55927255|NCT00873327|Piperacillin|piperacillin|mesh-list
55927256|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55927257|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55927258|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927259|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55927260|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927261|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927262|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
55927263|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55927264|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927269|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927270|NCT00841971|Fluconazole|fluconazole|mesh-list
55927271|NCT00841971|Anidulafungin|anidulafungin|mesh-list
55927272|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
55927273|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927274|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55927275|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55927276|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777310|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777311|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
55777312|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777313|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55777314|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55777315|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
55777316|NCT04518293|Amlodipine|amlodipine|mesh-list
55777317|NCT04518293|Telmisartan|telmisartan|mesh-list
55777318|NCT04518293|Indapamide|indapamide|mesh-list
55777319|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55777320|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55777321|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55927277|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927278|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55927279|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
55927280|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927281|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927282|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55927283|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55927284|NCT00842751|Finasteride|finasteride|mesh-list
55927285|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55927286|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55927287|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927288|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927289|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
55927290|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55735754|NCT05114499|Donepezil|donepezil|mesh-list
55777322|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777323|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55777324|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777325|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
55777326|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55777327|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55777328|NCT04518293|Diuretics|diuretics|mesh-ancestor
55777329|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
55777330|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55927291|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927292|NCT00842751|Urological Agents|urological agents|mesh-ancestor
55927293|NCT03104010|Hormones|hormones|mesh-list
55927294|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927295|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927296|NCT03907969|AZD7648|azd7648|mesh-list
55927297|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55927298|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927299|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927300|NCT04399213|Histamine|histamine|mesh-list
55927301|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
55927302|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
55927303|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
55927304|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927305|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756787|NCT03193957|Etanercept|etanercept|mesh-list
55927306|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927307|NCT02154243|Midodrine|midodrine|mesh-list
55777331|NCT01984294|Ribavirin|ribavirin|mesh-list
55777332|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
55777333|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777334|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
55777335|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777336|NCT03170479|Vitamin D|vitamin d|mesh-list
55777337|NCT03170479|Vitamins|vitamins|mesh-ancestor
55777338|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
55777339|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777340|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55777342|NCT01962298|Neostigmine|neostigmine|mesh-list
55777343|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55777344|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55777345|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55927308|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
55927309|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
55927310|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927311|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927312|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55927313|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55927314|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55927315|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55927316|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927317|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927318|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927319|NCT03995004|Dexamethasone|dexamethasone|mesh-list
55927320|NCT03995004|Melatonin|melatonin|mesh-list
55927321|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
55927322|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55927323|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
55927324|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
55927325|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927326|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927327|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55927328|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
55927329|NCT03995004|Hormones|hormones|mesh-ancestor
55927330|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927355|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927356|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
55777346|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777347|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777348|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55777349|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777350|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777351|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
55777352|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777353|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55777354|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
55777355|NCT03169933|Androgens|androgens|mesh-list
55777356|NCT03169933|Hormones|hormones|mesh-ancestor
55777357|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777358|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927367|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
55927368|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927369|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55927370|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55927371|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55927372|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927373|NCT03837925|Atorvastatin|atorvastatin|mesh-list
55927374|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55927375|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55927376|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
55927377|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927378|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55927379|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55777360|NCT04416334|Colchicine|colchicine|mesh-list
56216437|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
56216438|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216439|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777361|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777363|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
55777364|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777365|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777366|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
55777367|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
55777368|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777369|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
55777370|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
55777371|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
55927380|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927381|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
55927382|NCT04398589|Ropivacaine|ropivacaine|mesh-list
55927383|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55927384|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55927385|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927386|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55927387|NCT04398589|Analgesics|analgesics|mesh-ancestor
55927388|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
55777372|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777373|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777374|NCT02403349|Atenolol|atenolol|mesh-list
55777375|NCT02403349|Valsartan|valsartan|mesh-list
55777376|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55777377|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55777378|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55777379|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783335|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55777380|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55777381|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
55777382|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
55777383|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927389|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927390|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55927391|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55927392|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55927393|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927394|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927395|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927396|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
55927397|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
55927398|NCT03892044|Nivolumab|nivolumab|mesh-list
55735802|NCT03691311|Denosumab|denosumab|mesh-list
55777384|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777385|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55777386|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55777387|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55777389|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777390|NCT04735822|Belumosudil|belumosudil|mesh-list
55777391|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55777392|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777393|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777394|NCT01984138|Estradiol|estradiol|mesh-list
55777395|NCT01984138|Estrogens|estrogens|mesh-ancestor
55927399|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55927400|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927401|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55927402|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927404|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
55927406|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55927407|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55927408|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927409|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55927410|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55927411|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927412|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927413|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927414|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
55927415|NCT03882060|Hematinics|hematinics|mesh-ancestor
55927416|NCT01376505|Vaccines|vaccines|mesh-list
55927417|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
55927418|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927419|NCT00875277|Betamethasone|betamethasone|mesh-list
55927420|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
55927421|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55927422|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
55777396|NCT01984138|Hormones|hormones|mesh-ancestor
55777397|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777398|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777399|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55777400|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
55777401|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777402|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55777403|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
55777404|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777405|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777406|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55927423|NCT00875277|Calcipotriene|calcipotriene|mesh-list
55927424|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55927425|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55927426|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
55927427|NCT00875277|Hormones|hormones|mesh-ancestor
55927428|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927429|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927430|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55927431|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
55927432|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
55927433|NCT04634539|Gemcitabine|gemcitabine|mesh-list
55927434|NCT04634539|Paclitaxel|paclitaxel|mesh-list
55927435|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55927436|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927437|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
55927438|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
55927439|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
55927440|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777407|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55777408|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55777409|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
55777410|NCT04299113|Vinorelbine|vinorelbine|mesh-list
55777411|NCT04299113|Mocetinostat|mocetinostat|mesh-list
55777412|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55777413|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777414|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
55777415|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
55777416|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
55777417|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777418|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55777419|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777421|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
55777422|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
55777423|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
55777424|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55927470|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55927471|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927472|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927473|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
55927474|NCT03299088|Trametinib|trametinib|mesh-list
55927475|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55927476|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777425|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777426|NCT03906617|Dexamethasone|dexamethasone|mesh-list
55777427|NCT03906617|Epinephrine|epinephrine|mesh-list
55777428|NCT03906617|Bupivacaine|bupivacaine|mesh-list
56216440|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216441|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56216442|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56216443|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777429|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777430|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
55756871|NCT04977843|Dimercaprol|dimercaprol|mesh-list
55927477|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55927478|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927479|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927480|NCT03235986|Poractant alfa|poractant alfa|mesh-list
55927481|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
55927482|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
55927483|NCT03657342|Cyclosporine|cyclosporine|mesh-list
55927484|NCT03657342|Cyclosporins|cyclosporins|mesh-list
55927485|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927486|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927487|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927488|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
55927489|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927490|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
55927491|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927492|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
55927493|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735860|NCT03443141|Vitamins|vitamins|mesh-ancestor
55777431|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
55777432|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777435|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
55777437|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777438|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55777439|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777440|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
55777441|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
55777442|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777443|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
55777444|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55777445|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55777446|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927496|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55927497|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
55927498|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927499|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927500|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927501|NCT03600090|Paclitaxel|paclitaxel|mesh-list
55927502|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55927503|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927504|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
55927505|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
55927506|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
55927507|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735863|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
55777447|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777448|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777449|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55777450|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55777451|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55777452|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
55783336|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783338|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55783339|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55783340|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
55777453|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
55777454|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
55777455|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55777456|NCT04655482|Aflibercept|aflibercept|mesh-list
55777457|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55777458|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55777459|NCT04655482|Growth Substances|growth substances|mesh-ancestor
55777460|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777461|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
55777462|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777463|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
55777464|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756914|NCT03269591|Diclofenac|diclofenac|mesh-list
55777466|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55777467|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55777468|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777469|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777470|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55777471|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55777472|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
55777473|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777474|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777475|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
55777476|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55777477|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55777478|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
55777479|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777480|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777481|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777482|NCT01981954|Urological Agents|urological agents|mesh-ancestor
55777483|NCT03727139|Rasagiline|rasagiline|mesh-list
55777484|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55735899|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55777485|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777486|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777487|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55777488|NCT03727139|Protective Agents|protective agents|mesh-ancestor
55777489|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777490|NCT05120687|Cyclosporine|cyclosporine|mesh-list
55777491|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
55777492|NCT05120687|Adalimumab|adalimumab|mesh-list
55777493|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
55777494|NCT05120687|Methotrexate|methotrexate|mesh-list
56216444|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56216445|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56216446|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
56216447|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
56216448|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56216449|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216450|NCT01624766|Denosumab|denosumab|mesh-list
55927536|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927537|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55927538|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
55927539|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927540|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927541|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
55927542|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55927543|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55927544|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55927545|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927546|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
55927547|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927548|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927550|NCT00876915|Tinzaparin|tinzaparin|mesh-list
55927551|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55927552|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
55927553|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55927554|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55927558|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216451|NCT01624766|Everolimus|everolimus|mesh-list
56144251|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56216452|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56216453|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216454|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777495|NCT05120687|Cyclosporins|cyclosporins|mesh-list
55777496|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777497|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
55777498|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777499|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55927574|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55927575|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55927576|NCT00876993|Growth Substances|growth substances|mesh-ancestor
55927577|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927578|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
55927579|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55927580|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55927581|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927582|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927583|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55927584|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
55927585|NCT00896181|Carboplatin|carboplatin|mesh-list
55927586|NCT00896181|Docetaxel|docetaxel|mesh-list
55927587|NCT00896181|Fluorouracil|fluorouracil|mesh-list
55927588|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927589|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
55927590|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
55927591|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
55735924|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55777500|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55777501|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
55777512|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55777513|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55777515|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777516|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55783341|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55783342|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55777517|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55777518|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55777519|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
55777520|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55777521|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777523|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
55777524|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55777525|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777527|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55777528|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777529|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55777530|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55777531|NCT04224545|Colchicine|colchicine|mesh-list
55927592|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927593|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
55927594|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55927595|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927596|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
55927597|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927598|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55927599|NCT02647320|Firuglipel|firuglipel|mesh-list
55927600|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55927601|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927602|NCT02647320|Incretins|incretins|mesh-ancestor
55927603|NCT02647320|Hormones|hormones|mesh-ancestor
55927604|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927605|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55927606|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
55927607|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927608|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927609|NCT03457896|Trastuzumab|trastuzumab|mesh-list
55927610|NCT03457896|Cetuximab|cetuximab|mesh-list
55927611|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55927612|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927613|NCT04380597|Betamethasone|betamethasone|mesh-list
55927614|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
55777532|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
55777533|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777534|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
55777535|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
55777536|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
55777537|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777538|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777539|NCT03096041|Analgesics|analgesics|mesh-list
55777540|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
55777541|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777542|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777543|NCT05121233|Diclofenac|diclofenac|mesh-list
55777544|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55777545|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777546|NCT05121233|Analgesics|analgesics|mesh-ancestor
55777547|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
55777548|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777549|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777550|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55927622|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927623|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927624|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55927625|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
55927627|NCT03214731|Artesunate|artesunate|mesh-list
55927628|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
55927629|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55927630|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55927631|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927632|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927633|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
55927634|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
55927635|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55927636|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
55927637|NCT04424862|Cyclosporine|cyclosporine|mesh-list
55927638|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
55927639|NCT04424862|Prednisone|prednisone|mesh-list
55927640|NCT04424862|Cyclosporins|cyclosporins|mesh-list
55927641|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55927642|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
55927643|NCT04424862|Hormones|hormones|mesh-ancestor
55927644|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927645|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927646|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55927647|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927648|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927649|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777551|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777552|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55777553|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777554|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777555|NCT05745259|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55777556|NCT05745259|Tenecteplase|tenecteplase|mesh-list
56216455|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
55834844|NCT01843023|Analgesics|analgesics|mesh-ancestor
56216456|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216457|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56216458|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56216459|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56000882|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
55777557|NCT05745259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55777558|NCT05745259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55784106|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55927651|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
55927652|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
55927653|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927654|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
55927655|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55927656|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55927657|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55927658|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55927659|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
55927660|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55927661|NCT00882687|Lifitegrast|lifitegrast|mesh-list
55927662|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55927663|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55927664|NCT04313166|Copper|copper|mesh-list
55927665|NCT04313166|Trace Elements|trace elements|mesh-ancestor
55927666|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
55927667|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927668|NCT00883233|Adapalene|adapalene|mesh-list
55927669|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55927670|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777559|NCT05745259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777561|NCT02893241|Theodrenaline|theodrenaline|mesh-list
55777585|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
55777587|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
55783343|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55783344|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55783345|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55783346|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
55777588|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55777589|NCT05021861|Estradiol|estradiol|mesh-list
55777590|NCT05021861|Cyproterone|cyproterone|mesh-list
55777591|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
55927691|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
55927692|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55927693|NCT02288377|Lanreotide|lanreotide|mesh-list
55927694|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927695|NCT04133532|Metoprolol|metoprolol|mesh-list
55927696|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55927697|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55927698|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
55777592|NCT05021861|Estrogens|estrogens|mesh-ancestor
55777593|NCT05021861|Hormones|hormones|mesh-ancestor
55777594|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777595|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777596|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55777597|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
55777598|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55777599|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55777600|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55777601|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55777602|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
55777603|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
55777604|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784107|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927760|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
55927761|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927762|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927763|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55927764|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55927765|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
55927766|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
55927767|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55927768|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55927769|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55927770|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927771|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927772|NCT03358875|Docetaxel|docetaxel|mesh-list
55927773|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927774|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
55927775|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
55927776|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
55777618|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777619|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55777620|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777621|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
55777622|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777623|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777624|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
55777625|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55777626|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927802|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55927803|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55927804|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927805|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927806|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927808|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927809|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927810|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55927811|NCT00888459|Nicotine|nicotine|mesh-list
55927812|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55927813|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
55927814|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927815|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927816|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55927817|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55927818|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
55927819|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927820|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927821|NCT05312541|Bupivacaine|bupivacaine|mesh-list
55927822|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
55927823|NCT05312541|Anesthetics|anesthetics|mesh-list
55927824|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777627|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55777628|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55777629|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
55777630|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777631|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
55777632|NCT04480333|Remdesivir|remdesivir|mesh-list
55777633|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
55777634|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777635|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
55777636|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777637|NCT04480333|Protective Agents|protective agents|mesh-ancestor
55777638|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777639|NCT03166891|Chiauranib|chiauranib|mesh-list
55927825|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927826|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
55927827|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927828|NCT04398823|Polidocanol|polidocanol|mesh-list
55927829|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55927830|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55927831|NCT04410913|Psilocybin|psilocybin|mesh-list
55927832|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
55927833|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927834|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55927835|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
55927836|NCT02013336|Irinotecan|irinotecan|mesh-list
55927837|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927842|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
55927843|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927844|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927845|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55927846|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55927847|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55927848|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927849|NCT04397653|Ezetimibe|ezetimibe|mesh-list
55927850|NCT04397653|Evolocumab|evolocumab|mesh-list
55927851|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55927852|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55927854|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777640|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777641|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55777642|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777643|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777644|NCT01980940|Etoricoxib|etoricoxib|mesh-list
55777645|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
55777646|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55777647|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777648|NCT01980940|Analgesics|analgesics|mesh-ancestor
55777649|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
55777650|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777651|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783348|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783349|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783350|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55783351|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55783352|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55783353|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55927870|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55927871|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55927872|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55927873|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927874|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927875|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55927876|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
55927877|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
55927878|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55927879|NCT04412538|Vaccines|vaccines|mesh-list
55927880|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
55927881|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927882|NCT04397341|Docetaxel|docetaxel|mesh-list
55927883|NCT04397341|Fluorouracil|fluorouracil|mesh-list
55927884|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927885|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
55927886|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
55927887|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
55927888|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783354|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
55783355|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
55783356|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55783357|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777652|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777653|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777654|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55777655|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55777656|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777662|NCT01960114|Acetaminophen|acetaminophen|mesh-list
55777663|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777664|NCT01960114|Analgesics|analgesics|mesh-ancestor
55777665|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
55777666|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777667|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777668|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
55777671|NCT04752527|Venetoclax|venetoclax|mesh-list
55777672|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777673|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55777674|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889847|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
55927906|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55927907|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
55927908|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
55927909|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55927910|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55927911|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927912|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927913|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927914|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777675|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777676|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55777677|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
55777678|NCT05229497|Carboplatin|carboplatin|mesh-list
55777679|NCT05229497|Fluorouracil|fluorouracil|mesh-list
55777680|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777681|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
55777682|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777683|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55777684|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777685|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
55777686|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777687|NCT03169777|Leucovorin|leucovorin|mesh-list
55777688|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
55777689|NCT03169777|Bevacizumab|bevacizumab|mesh-list
55777690|NCT03169777|Fluorouracil|fluorouracil|mesh-list
55777691|NCT03169777|Capecitabine|capecitabine|mesh-list
55777692|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
55777693|NCT03169777|Nivolumab|nivolumab|mesh-list
55777694|NCT03169777|Cetuximab|cetuximab|mesh-list
55777695|NCT03169777|Fulvestrant|fulvestrant|mesh-list
55927915|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
55927916|NCT01473524|Cathartics|cathartics|mesh-ancestor
55927917|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55927918|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55927919|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
55927920|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927921|NCT03696355|GDC-0084|gdc-0084|mesh-list
55757118|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
55777696|NCT03169777|Avelumab|avelumab|mesh-list
55777697|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777698|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777699|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777700|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
55777701|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777702|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777703|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55777704|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
55777705|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55927922|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927923|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927924|NCT03882996|Atorvastatin|atorvastatin|mesh-list
55927925|NCT03882996|Ezetimibe|ezetimibe|mesh-list
55927926|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55927927|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55927928|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
55927929|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927930|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55927931|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55927932|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927933|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55927934|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55927935|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55927936|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55927937|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927938|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55927939|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55927940|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55927941|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55783358|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783359|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
55783360|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55783361|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783362|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783363|NCT02340481|Simethicone|simethicone|mesh-list
55783364|NCT02340481|Loperamide|loperamide|mesh-list
55783365|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
55783366|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55783367|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
55783368|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783369|NCT02340481|Emollients|emollients|mesh-ancestor
55783370|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
55783371|NCT03077633|Progesterone|progesterone|mesh-list
55783372|NCT03077633|Progestins|progestins|mesh-ancestor
56216460|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56216461|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56216462|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
56216463|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216464|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56216465|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56216466|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216467|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56216468|NCT01625026|Cathartics|cathartics|mesh-ancestor
55783373|NCT03077633|Hormones|hormones|mesh-ancestor
55783374|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777706|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55927942|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927943|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927944|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927945|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55927946|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55777707|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55777708|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55777709|NCT03169777|Growth Substances|growth substances|mesh-ancestor
55777719|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55777720|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55777721|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55777722|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
55777723|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777725|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55777726|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777727|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55777728|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777729|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55777730|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
55777732|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777733|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777734|NCT02092571|Progesterone|progesterone|mesh-list
55777735|NCT02092571|Progestins|progestins|mesh-ancestor
55777736|NCT02092571|Hormones|hormones|mesh-ancestor
55777737|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777738|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777739|NCT02402725|Dexamethasone|dexamethasone|mesh-list
55777740|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
55777741|NCT02402725|BB 1101|bb 1101|mesh-list
55777742|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777743|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
55777744|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
55927947|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
55927948|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55927949|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55927950|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
55927951|NCT05070468|Dexamethasone|dexamethasone|mesh-list
55927952|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55927953|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
55927954|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
55927955|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927956|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927957|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55927958|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
55927959|NCT05070468|Hormones|hormones|mesh-ancestor
55751185|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
55751186|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
55751187|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751188|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751189|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55751190|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
55751191|NCT03334487|Hormones|hormones|mesh-ancestor
55751192|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751193|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55751194|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751195|NCT05038449|Colchicine|colchicine|mesh-list
55751196|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
55751197|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751198|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
55751199|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
55751200|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
55751201|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751203|NCT05038059|Acetic Acid|acetic acid|mesh-list
55751204|NCT05038059|Retinol acetate|retinol acetate|mesh-list
55751205|NCT05038059|Ethylene|ethylene|mesh-list
55751206|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55751207|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751208|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55777745|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777746|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783375|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783376|NCT05253781|Aspirin|aspirin|mesh-list
55783377|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55783378|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55783379|NCT05253781|Analgesics|analgesics|mesh-ancestor
55783380|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
55783381|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783382|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783383|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783384|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55783385|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55783386|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55783387|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783388|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55777747|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55777748|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
55777749|NCT02402725|Hormones|hormones|mesh-ancestor
55777750|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777751|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56216469|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55927960|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927961|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55927962|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927963|NCT01390181|Losartan|losartan|mesh-list
55927964|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55927965|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55927966|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55927967|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55736182|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
56216471|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56216472|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216473|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56216474|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216475|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
56216476|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216477|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
56216478|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216479|NCT01625260|Gemcitabine|gemcitabine|mesh-list
56216480|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56216481|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
56216482|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216483|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792764|NCT02528253|Tramadol|tramadol|mesh-list
55777752|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777753|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
55777754|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757139|NCT03266159|Trametinib|trametinib|mesh-list
55927968|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927969|NCT02641080|Aspirin|aspirin|mesh-list
55927970|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55927971|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55927972|NCT02641080|Analgesics|analgesics|mesh-ancestor
55927973|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
55927974|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927975|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927976|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55927977|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55927978|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55777755|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777756|NCT02394145|Clopidogrel|clopidogrel|mesh-list
55777757|NCT02394145|Ticagrelor|ticagrelor|mesh-list
55777758|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55835881|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55777759|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55777760|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55777761|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55777762|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
55777763|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777764|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927980|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927981|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55927982|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55927983|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927984|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
55927985|NCT03101280|Atezolizumab|atezolizumab|mesh-list
55927986|NCT03101280|Rucaparib|rucaparib|mesh-list
55927987|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927988|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55927989|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927990|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927991|NCT03672487|Benzonidazole|benzonidazole|mesh-list
55927992|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927993|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
55927994|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927995|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55927996|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55927997|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55927998|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927999|NCT04015739|Bevacizumab|bevacizumab|mesh-list
55928000|NCT04015739|Durvalumab|durvalumab|mesh-list
55928001|NCT04015739|Olaparib|olaparib|mesh-list
55928002|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928003|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928004|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55777765|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777767|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55777768|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777769|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
55777770|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55777771|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777772|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
55777773|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55777774|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55777775|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
55777776|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
55777777|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55777778|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55777779|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
55928005|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55928006|NCT04015739|Growth Substances|growth substances|mesh-ancestor
55928007|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928008|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
55928009|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55928010|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928011|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928012|NCT03867318|Atorvastatin|atorvastatin|mesh-list
55928013|NCT03867318|Ezetimibe|ezetimibe|mesh-list
55928014|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55928016|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
55928017|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928018|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55928019|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55928020|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928021|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55928022|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928023|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55928025|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55928026|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928027|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55928028|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928029|NCT04381377|Bromides|bromides|mesh-list
55928030|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
55928031|NCT01457846|Paclitaxel|paclitaxel|mesh-list
55928032|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55928033|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777780|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
55777781|NCT04255277|Charcoal|charcoal|mesh-list
55777782|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55777783|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777784|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55777785|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55777786|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777787|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777788|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928034|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
55928035|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
55928036|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
55928037|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928038|NCT04032119|Epinephrine|epinephrine|mesh-list
55928039|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55928040|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55928041|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
55928042|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928043|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928044|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777789|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55777790|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783389|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55783391|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
55783392|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
55777791|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777792|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56216485|NCT01625260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216486|NCT01625260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216487|NCT01625260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216488|NCT01625260|Immunologic Factors|immunologic factors|mesh-ancestor
56216489|NCT01625260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216490|NCT01625351|Sirolimus|sirolimus|mesh-list
56216491|NCT01625351|Fludarabine|fludarabine|mesh-list
56216492|NCT01625351|Melphalan|melphalan|mesh-list
56216493|NCT01625351|Busulfan|busulfan|mesh-list
56216494|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
56216495|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
56216496|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216497|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216498|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216499|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
56216500|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216501|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56216502|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55777793|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55777794|NCT04255277|Antidotes|antidotes|mesh-ancestor
55777795|NCT04255277|Protective Agents|protective agents|mesh-ancestor
55777796|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55777797|NCT04255277|Estrogens|estrogens|mesh-ancestor
55777798|NCT04255277|Hormones|hormones|mesh-ancestor
55777799|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777800|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55777801|NCT04435925|Fentanyl|fentanyl|mesh-list
55777802|NCT04435925|Remifentanil|remifentanil|mesh-list
55777803|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55777804|NCT04435925|Narcotics|narcotics|mesh-ancestor
55777805|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777806|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777807|NCT04435925|Analgesics|analgesics|mesh-ancestor
55777808|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
55777809|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928193|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55928194|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55928195|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55928208|NCT03518203|Eculizumab|eculizumab|mesh-list
55928217|NCT00882895|Prednisolone|prednisolone|mesh-list
55928218|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
55928219|NCT00882895|Tacrolimus|tacrolimus|mesh-list
55928220|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
55928221|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55928222|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55928223|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
55928224|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928225|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
55928226|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928227|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55928228|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928229|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928230|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55928231|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928232|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55928233|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
55777810|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55777811|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55777812|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
55777813|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
55777814|NCT04649476|Cisplatin|cisplatin|mesh-list
55777815|NCT04649476|Docetaxel|docetaxel|mesh-list
55777816|NCT04649476|Fluorouracil|fluorouracil|mesh-list
55777817|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777818|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
55777819|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
55777820|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
55928255|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55928256|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
55928257|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928258|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928259|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55928260|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55928261|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
55928262|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928263|NCT05367245|Butyric Acid|butyric acid|mesh-list
55928264|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928265|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
55928266|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
55928267|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928268|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928269|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55928270|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
55928271|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
55777821|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777822|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
55777823|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55777824|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777825|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
55777826|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777827|NCT05117957|Sorafenib|sorafenib|mesh-list
55777828|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777835|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56216503|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55777837|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
55777838|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928272|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55928273|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55928274|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55928275|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928276|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55928277|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55928278|NCT00893997|Vaccines|vaccines|mesh-list
55928279|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
55928280|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928281|NCT00512317|Ganaxolone|ganaxolone|mesh-list
55928282|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
55928283|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928284|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928286|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
55928296|NCT01494506|Fluorouracil|fluorouracil|mesh-list
55928297|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
55928298|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928299|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55928300|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928301|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928302|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
55928303|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736303|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55777839|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777840|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55777841|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
55777843|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777844|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55777845|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777846|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
55777847|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55777848|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55777849|NCT02969837|Growth Substances|growth substances|mesh-ancestor
55928305|NCT01494506|Protective Agents|protective agents|mesh-ancestor
55928306|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
55928307|NCT01494506|Vitamins|vitamins|mesh-ancestor
55928308|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
55928309|NCT03024905|Misoprostol|misoprostol|mesh-list
55928310|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55928311|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
55928312|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55928313|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928314|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55928315|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55928316|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
55928317|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
55928318|NCT02643420|Docetaxel|docetaxel|mesh-list
55928319|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928320|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
55928321|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928322|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928323|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55777850|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
55777851|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
55777852|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55777853|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777854|NCT04507919|Dabrafenib|dabrafenib|mesh-list
55777855|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783393|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55783394|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55777856|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55777857|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777858|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777859|NCT03251729|Progesterone|progesterone|mesh-list
55777860|NCT03251729|Progestins|progestins|mesh-ancestor
55777861|NCT03251729|Hormones|hormones|mesh-ancestor
55777862|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777863|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777864|NCT02696785|Adalimumab|adalimumab|mesh-list
55928358|NCT01456130|Secretagogues|secretagogues|mesh-list
55928359|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55928360|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928361|NCT01456130|Incretins|incretins|mesh-ancestor
55928362|NCT01456130|Hormones|hormones|mesh-ancestor
55928363|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55928364|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55928365|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
55928366|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928367|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928368|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55928369|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55928370|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55928371|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55928372|NCT03219645|Aspirin|aspirin|mesh-list
55928373|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55777865|NCT02696785|Ixekizumab|ixekizumab|mesh-list
55777866|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777867|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777868|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
55777869|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
55777870|NCT02004262|Pancrelipase|pancrelipase|mesh-list
55777871|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777872|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
55777873|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777874|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777875|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55928398|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928399|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
55928400|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55928401|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55928402|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928403|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55928404|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55928405|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55928406|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928407|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55928408|NCT05069454|Vaccines|vaccines|mesh-list
55928409|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
55928410|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928411|NCT05069688|Rifampin|rifampin|mesh-list
55928412|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55928413|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
55928414|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55928415|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928416|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
55928417|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55928418|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928419|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928420|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55928421|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55928422|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55928423|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55928424|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55928425|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55928426|NCT01830777|Cytarabine|cytarabine|mesh-list
55777876|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
55777877|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777878|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777879|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55777880|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55777881|NCT02393599|Cocaine|cocaine|mesh-list
55777882|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
55777884|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777885|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777886|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
55777887|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777888|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55928427|NCT01830777|Etoposide|etoposide|mesh-list
55928428|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
55928429|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55928430|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55928431|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928432|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55928433|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55928434|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928435|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928436|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55928438|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
55928439|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928440|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928441|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
55928442|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928443|NCT01830777|Analgesics|analgesics|mesh-ancestor
55928444|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
55928447|NCT04479306|Osimertinib|osimertinib|mesh-list
55777889|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55777890|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55777891|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55777892|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777905|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55777906|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55777907|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777908|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55777909|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55777910|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777911|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
55928480|NCT03451045|Analgesics|analgesics|mesh-ancestor
55928481|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
55928482|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928483|NCT01831011|Aspirin|aspirin|mesh-list
55928484|NCT01831011|Cinepazide|cinepazide|mesh-list
55928485|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
55928486|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55928487|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55928488|NCT01831011|Analgesics|analgesics|mesh-ancestor
55928489|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
55928490|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928491|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928492|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55928493|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928494|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55928495|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55928496|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736373|NCT02384577|Hormones|hormones|mesh-ancestor
55777912|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55777913|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55777914|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
55777915|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777916|NCT02402413|Androgens|androgens|mesh-list
55777917|NCT02402413|Hormones|hormones|mesh-ancestor
55777918|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777919|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777920|NCT02393443|Oxytocin|oxytocin|mesh-list
55777921|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
55928497|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55928498|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55928499|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928500|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
55928501|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
55928502|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55928503|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
55928504|NCT03218709|Vitamins|vitamins|mesh-list
55928505|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
55928506|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928507|NCT03218553|Dexamethasone|dexamethasone|mesh-list
55928508|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55928510|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
55928511|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928512|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928513|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55928514|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
55928515|NCT03218553|Hormones|hormones|mesh-ancestor
55928516|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55928517|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55928518|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928519|NCT03430843|Paclitaxel|paclitaxel|mesh-list
55928520|NCT03430843|Docetaxel|docetaxel|mesh-list
55928521|NCT03430843|Irinotecan|irinotecan|mesh-list
55928522|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55777922|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55777923|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783395|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783396|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777925|NCT05744635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777926|NCT05744635|Immunologic Factors|immunologic factors|mesh-ancestor
55777927|NCT05744635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777928|NCT05744635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55777929|NCT05744635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928540|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928541|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
55928542|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
55928543|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
55928544|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928545|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55928546|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
55928547|NCT03415854|Antiviral Agents|antiviral agents|mesh-ancestor
55928548|NCT03415854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928549|NCT03415854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928550|NCT03415854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928551|NCT03415854|Immunologic Factors|immunologic factors|mesh-ancestor
55928552|NCT03415854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928553|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55928554|NCT01831323|Rifaximin|rifaximin|mesh-list
55928555|NCT01831323|Mesalamine|mesalamine|mesh-list
55928556|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55928557|NCT01831323|Psyllium|psyllium|mesh-list
55736386|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
55751209|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
55751211|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55751212|NCT05038059|Protective Agents|protective agents|mesh-ancestor
55751213|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751214|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
55751215|NCT05038059|Growth Substances|growth substances|mesh-ancestor
55751216|NCT01236547|Paclitaxel|paclitaxel|mesh-list
55751217|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55751218|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55751219|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751220|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
55751221|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
55751222|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
55751223|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751224|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
55751225|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
55751226|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751227|NCT03329339|Protective Agents|protective agents|mesh-ancestor
55751228|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751229|NCT03329339|Vitamins|vitamins|mesh-ancestor
55751230|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
55751231|NCT05048901|Lanreotide|lanreotide|mesh-list
55751232|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751233|NCT03329261|Clopidogrel|clopidogrel|mesh-list
55751234|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55751235|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55751236|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55751237|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55777930|NCT05744635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777931|NCT01977898|Morphine|morphine|mesh-list
55777932|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55777933|NCT01977898|Narcotics|narcotics|mesh-ancestor
55777934|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777935|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777936|NCT01977898|Analgesics|analgesics|mesh-ancestor
55777937|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
55777938|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777939|NCT05744479|Metformin|metformin|mesh-list
55777940|NCT05744479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55777941|NCT05744479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777942|NCT02003638|Niacin|niacin|mesh-list
55777943|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55777944|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
55928558|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928559|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55928560|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55928561|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55757227|NCT02456129|Itraconazole|itraconazole|mesh-list
55928563|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
55928564|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928565|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736398|NCT03432767|Chrysarobin|chrysarobin|mesh-list
55777945|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777946|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55777947|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
55777948|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
55777949|NCT02003638|Vitamins|vitamins|mesh-ancestor
55777950|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
55777951|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777952|NCT04649398|Nimodipine|nimodipine|mesh-list
55777953|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55777954|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55777975|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
55777976|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
55777977|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777978|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777979|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
55777980|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777981|NCT03166111|Lidocaine|lidocaine|mesh-list
55777982|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
55777983|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
55777984|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777985|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777986|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
55777987|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777988|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55777990|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55777991|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55783397|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783398|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55783399|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
55783400|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55777992|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777993|NCT05117021|Bupivacaine|bupivacaine|mesh-list
55777994|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
55777995|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
55777996|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777997|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928630|NCT03025295|Analgesics|analgesics|mesh-ancestor
55928631|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
55928632|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928633|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55928634|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55928635|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55928636|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
55928637|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928638|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928639|NCT01471574|Interferons|interferons|mesh-list
55928640|NCT01471574|Ribavirin|ribavirin|mesh-list
55928641|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
55928642|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
55928643|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55928644|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928645|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
55928646|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928647|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
55928648|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928651|NCT01383707|Leucovorin|leucovorin|mesh-list
55777998|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
55777999|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778000|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55778001|NCT02392117|Insulin|insulin|mesh-list
55778002|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55778003|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778004|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
56216504|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
56216505|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56216506|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
55778012|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
55778013|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
55778014|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55778015|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55778016|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55778017|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
55778018|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
55778019|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778020|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778021|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778022|NCT03106363|Ethanol|ethanol|mesh-list
55778023|NCT03106363|Dronabinol|dronabinol|mesh-list
55778024|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55778025|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778026|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778027|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778028|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
55778029|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55778030|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55778031|NCT03106363|Analgesics|analgesics|mesh-ancestor
55778032|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
55778033|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928754|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55928755|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55928756|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
55928757|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928758|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55778034|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55778035|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55778036|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778037|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778038|NCT03106363|Hormones|hormones|mesh-ancestor
55778039|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778041|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
55778042|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
55778043|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778044|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778045|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
55778046|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778047|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
55928806|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928807|NCT03799445|Nivolumab|nivolumab|mesh-list
55928808|NCT03799445|Ipilimumab|ipilimumab|mesh-list
55928809|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928810|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928811|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55928812|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928813|NCT04009109|Dexamethasone|dexamethasone|mesh-list
55928814|NCT04009109|Lenalidomide|lenalidomide|mesh-list
55928815|NCT04009109|Daratumumab|daratumumab|mesh-list
55928816|NCT04009109|Ixazomib|ixazomib|mesh-list
55928817|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55928818|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
55928819|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
55928820|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928821|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928822|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55928823|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
55928824|NCT04009109|Hormones|hormones|mesh-ancestor
55928825|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55928826|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55736479|NCT05112471|Erythritol|erythritol|mesh-list
55778048|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55778049|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778050|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55805095|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55778051|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778052|NCT02687815|Vitamin D|vitamin d|mesh-list
55778053|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
55778054|NCT02687815|Vitamins|vitamins|mesh-ancestor
55783401|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55783402|NCT02340247|Cathartics|cathartics|mesh-ancestor
55778055|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
55778056|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778057|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55778058|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55778059|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
55928827|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928828|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
55928829|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55928830|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55928831|NCT04009109|Growth Substances|growth substances|mesh-ancestor
55928832|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
55928833|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
55928834|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928835|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928836|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55928837|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55928838|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55778060|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55778061|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778062|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
55778063|NCT01959334|Glucagon|glucagon|mesh-list
55778064|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55778065|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55778066|NCT01959334|Hormones|hormones|mesh-ancestor
55778067|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778068|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778070|NCT01958476|Morphine|morphine|mesh-list
55928839|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928840|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928841|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
55928842|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928843|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55928844|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55928845|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55928846|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55928847|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928848|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928849|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
55928850|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928851|NCT04007393|Topiramate|topiramate|mesh-list
55928852|NCT04007393|Phentermine|phentermine|mesh-list
55928853|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
55928854|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55928855|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928856|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55928857|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
55928858|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55928859|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
55928860|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
55928861|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928862|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
55928863|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778080|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778081|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
55778082|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
55778083|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
55778084|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55778085|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55778086|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55778087|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216507|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55928864|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928865|NCT05368805|Dabigatran|dabigatran|mesh-list
55928866|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55928867|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55928868|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55928869|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
55928870|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928871|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55928872|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55928873|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928874|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
55928875|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55928876|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
55928877|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
55928878|NCT03138720|Gemcitabine|gemcitabine|mesh-list
55928879|NCT03138720|Paclitaxel|paclitaxel|mesh-list
55928880|NCT03138720|Cisplatin|cisplatin|mesh-list
55928881|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55928882|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55928883|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928884|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
55928885|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
55928886|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
55928887|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928888|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55928905|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55928906|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
55928907|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
55928908|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928909|NCT01839981|Protective Agents|protective agents|mesh-ancestor
55928910|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928911|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
55928912|NCT01839981|Vitamins|vitamins|mesh-ancestor
55928913|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
55928914|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
55928915|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
55928916|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55928917|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
55928918|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928919|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928920|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55928921|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
55928922|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55928923|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55928924|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56216508|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56216509|NCT01625429|Paclitaxel|paclitaxel|mesh-list
56216510|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56216511|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216512|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
56216513|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
56216514|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
55928949|NCT03258385|Hematinics|hematinics|mesh-ancestor
55928950|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
55928951|NCT03024515|Narcotics|narcotics|mesh-ancestor
55928952|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928953|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928955|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
55928956|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928957|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
55928958|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55928959|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55751238|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
55751239|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751240|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751241|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751242|NCT03329183|Irinotecan|irinotecan|mesh-list
55751244|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55751245|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751246|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751247|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751250|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
55751251|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751252|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55751253|NCT02167945|Ritonavir|ritonavir|mesh-list
55751254|NCT02167945|Ribavirin|ribavirin|mesh-list
55751255|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55751256|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55751257|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
55751258|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751259|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751260|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55751261|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55751263|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751264|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55751265|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55751266|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
55751267|NCT03328481|Anesthetics|anesthetics|mesh-list
55751269|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751270|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
55751271|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55751272|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55751273|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
55751274|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751275|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751276|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751277|NCT02452879|Urological Agents|urological agents|mesh-ancestor
55751278|NCT01191697|Bevacizumab|bevacizumab|mesh-list
55751279|NCT01191697|Trastuzumab|trastuzumab|mesh-list
55751280|NCT01191697|Capecitabine|capecitabine|mesh-list
55751281|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
55751282|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55751283|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751284|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55751285|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55751286|NCT01191697|Growth Substances|growth substances|mesh-ancestor
55751287|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751288|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
55889848|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889849|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55889850|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55889851|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889852|NCT01450215|Lenalidomide|lenalidomide|mesh-list
55889853|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
55889854|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889855|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55928960|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55928961|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928962|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
55928963|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928964|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928965|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
55928966|NCT04287829|Lenvatinib|lenvatinib|mesh-list
55928967|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928968|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928969|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55928970|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928971|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216515|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216516|NCT01625494|Amlodipine|amlodipine|mesh-list
56216517|NCT01625494|Irbesartan|irbesartan|mesh-list
56216518|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56216519|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56216520|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56216521|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216522|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56216523|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778088|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778089|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
55778090|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
55778091|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55778092|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55778093|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55929020|NCT03836157|Growth Substances|growth substances|mesh-ancestor
55929021|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929022|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929023|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55929024|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
55929025|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
55929026|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
55929027|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929028|NCT03080545|Calcitriol|calcitriol|mesh-list
55929029|NCT03080545|Betamethasone|betamethasone|mesh-list
55929030|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55929031|NCT03080545|Calcipotriene|calcipotriene|mesh-list
55929032|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55929033|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
55929034|NCT03080545|Hormones|hormones|mesh-ancestor
55929035|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929036|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929037|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55778094|NCT04809181|Azacitidine|azacitidine|mesh-list
55778095|NCT04809181|Venetoclax|venetoclax|mesh-list
55778096|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55778097|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
55778098|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778099|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778100|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778101|NCT05734807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
55778102|NCT05734807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55778103|NCT05734807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778104|NCT05734807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778105|NCT05734807|Antiviral Agents|antiviral agents|mesh-ancestor
55778106|NCT05734807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778107|NCT01057121|Lenalidomide|lenalidomide|mesh-list
55778108|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
55778109|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778110|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55778111|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55778112|NCT01057121|Growth Substances|growth substances|mesh-ancestor
55778113|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929067|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55929068|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929069|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
55929070|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
55929071|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
55929072|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929073|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55929074|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55929075|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55929076|NCT05247619|Growth Substances|growth substances|mesh-ancestor
55929077|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929078|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929079|NCT04018937|Fludarabine|fludarabine|mesh-list
55929080|NCT04018937|Melphalan|melphalan|mesh-list
55778114|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778115|NCT02695537|Cannabidiol|cannabidiol|mesh-list
55778116|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
55778117|NCT04620941|Chrysarobin|chrysarobin|mesh-list
55778118|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55778119|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55778120|NCT04620941|Analgesics|analgesics|mesh-ancestor
55778121|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
55778122|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778123|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778124|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778125|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55778126|NCT04210349|Vaccines|vaccines|mesh-list
56216524|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
55929118|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929119|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929120|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
55929121|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929122|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55929123|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929124|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55929125|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55929126|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55929127|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55929128|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929129|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
55929130|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929131|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929133|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55929134|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
55929135|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929136|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929137|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929138|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55929139|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55929140|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
55929141|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
55929142|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
56144325|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
56216525|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56216526|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56216528|NCT01625520|Pasireotide|pasireotide|mesh-list
56216529|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216530|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216531|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
56216532|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216533|NCT01625520|Hormones|hormones|mesh-ancestor
56000883|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792811|NCT05021887|Fluticasone|fluticasone|mesh-list
55778127|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
55778128|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778129|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
55778130|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778131|NCT04746989|Allopurinol|allopurinol|mesh-list
55778132|NCT04746989|Probenecid|probenecid|mesh-list
55929157|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929158|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55929159|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55929160|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55929161|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929162|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55929163|NCT05243251|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55929164|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55929165|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55778133|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
55778134|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778135|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778136|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
55778153|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55778154|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55778155|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778156|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55778157|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55778158|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778159|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
55778160|NCT04393103|Atropine|atropine|mesh-list
55929166|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929167|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929168|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
55929169|NCT05242705|Cystatins|cystatins|mesh-list
55929170|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55929171|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
55929172|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929173|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929175|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55929176|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
55929177|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929178|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929179|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929180|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55929181|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55929182|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929183|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55929184|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55929185|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
55929186|NCT05245669|Denosumab|denosumab|mesh-list
55929187|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55757338|NCT03257423|Renal Agents|renal agents|mesh-ancestor
55929188|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929190|NCT00783354|Desloratadine|desloratadine|mesh-list
55929191|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55929192|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
55929193|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929194|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778161|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55778162|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55778163|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55778164|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55778165|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
55778166|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778167|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778168|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55778169|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
55778170|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
55778171|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
55778172|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55929199|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
55929200|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
55929201|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
55929202|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55929203|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
55929204|NCT01833663|Estrogens|estrogens|mesh-list
55929205|NCT01833663|Hormones|hormones|mesh-ancestor
55929206|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929207|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929208|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55929209|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55929210|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
55736607|NCT03431285|Narcotics|narcotics|mesh-ancestor
55778173|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55778174|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
55778175|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778176|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778177|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55778178|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55778179|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55778180|NCT04671953|Metformin|metformin|mesh-list
55778181|NCT04671953|BMS-986165|bms-986165|mesh-list
55778182|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55778183|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778184|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
55778185|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55778186|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778187|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778188|NCT04585061|Lidocaine|lidocaine|mesh-list
55778189|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
55778190|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
55929211|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929212|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929213|NCT01833663|Urological Agents|urological agents|mesh-ancestor
55929214|NCT01720875|Dexamethasone|dexamethasone|mesh-list
55929215|NCT01720875|Bortezomib|bortezomib|mesh-list
55929216|NCT01720875|Vorinostat|vorinostat|mesh-list
55929217|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55929218|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
55929219|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
55929220|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929221|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929222|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55929223|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
55929224|NCT01720875|Hormones|hormones|mesh-ancestor
55929225|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929226|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55929227|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929228|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55929229|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929230|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929231|NCT04277143|Daptomycin|daptomycin|mesh-list
55736615|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
55778191|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792820|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
55778194|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778195|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55778213|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778215|NCT03874091|Racepinephrine|racepinephrine|mesh-list
55778216|NCT03874091|Morphine|morphine|mesh-list
55778217|NCT03874091|Bupivacaine|bupivacaine|mesh-list
55778218|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
55778219|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
55778220|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
55778221|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778222|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929235|NCT00750750|Amoxicillin|amoxicillin|mesh-list
55778223|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
55778224|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778225|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55778226|NCT03874091|Narcotics|narcotics|mesh-ancestor
55778227|NCT03874091|Analgesics|analgesics|mesh-ancestor
55778228|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55778229|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55778230|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
55778231|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778232|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778233|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55778234|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55778235|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
55778236|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55778237|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
55778238|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
55778239|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
55778240|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55778241|NCT01362491|Ibuprofen|ibuprofen|mesh-list
55778242|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55778243|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55778244|NCT01362491|Analgesics|analgesics|mesh-ancestor
55778245|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
55778246|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778247|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778248|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778249|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55778253|NCT03560297|Nitrazepam|nitrazepam|mesh-list
55778254|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
55778255|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55778256|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778257|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778258|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55778259|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55778260|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55929301|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55929302|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929303|NCT01833819|Lidocaine|lidocaine|mesh-list
55929304|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
55929305|NCT01833819|Remifentanil|remifentanil|mesh-list
55929306|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
55929307|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
55929308|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929309|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929310|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
55929311|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929312|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55929313|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55929314|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55929315|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55736654|NCT03861611|Ibuprofen|ibuprofen|mesh-list
55778261|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
55778262|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
55778263|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778264|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783410|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
55783411|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55783412|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55783413|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55783414|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
55783415|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55757364|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
55929316|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929317|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55929318|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55929319|NCT01833819|Analgesics|analgesics|mesh-ancestor
55929320|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55929321|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55929322|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55929323|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
55929324|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929325|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55929326|NCT01833819|Narcotics|narcotics|mesh-ancestor
55929327|NCT05244109|Antibodies|antibodies|mesh-list
55929328|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
55929329|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
55751367|NCT03093597|Petrolatum|petrolatum|mesh-list
55751368|NCT03093597|Emollients|emollients|mesh-ancestor
55751369|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
55751370|NCT05465135|Artenimol|artenimol|mesh-list
55751371|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
55751372|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55751373|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55751374|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751375|NCT03327155|Tenofovir|tenofovir|mesh-list
55751376|NCT03327155|Emtricitabine|emtricitabine|mesh-list
55751377|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
55751378|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751379|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55751380|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55751381|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751382|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751383|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55751384|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55751385|NCT05024877|Stanozolol|stanozolol|mesh-list
55751386|NCT05024877|Androgens|androgens|mesh-ancestor
55751387|NCT05024877|Hormones|hormones|mesh-ancestor
55751388|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751389|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751390|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
55751391|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
55751392|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55751393|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55751394|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55751395|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751396|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751397|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
55751398|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751399|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751401|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751402|NCT03230851|Aspirin|aspirin|mesh-list
55783416|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783417|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55778265|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55778266|NCT04122287|Levofloxacin|levofloxacin|mesh-list
55778267|NCT04122287|Ofloxacin|ofloxacin|mesh-list
55778268|NCT04122287|Tinidazole|tinidazole|mesh-list
55778269|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55778270|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778271|NCT04122287|Renal Agents|renal agents|mesh-ancestor
55778272|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55778273|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55778274|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55778275|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778276|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778277|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929330|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929331|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55929332|NCT00651144|Ezetimibe|ezetimibe|mesh-list
55929333|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55929334|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55929335|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
55929336|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216534|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216536|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56216537|NCT01625572|Narcotics|narcotics|mesh-ancestor
55792822|NCT05021731|Rifampin|rifampin|mesh-list
55778278|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55778279|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55778280|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
55778281|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55778282|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55778283|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55778284|NCT05746351|Fentanyl|fentanyl|mesh-list
55778285|NCT05746351|Dexmedetomidine|dexmedetomidine|mesh-list
55929391|NCT00904995|Voriconazole|voriconazole|mesh-list
55929392|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
55929393|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929394|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55929395|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55929396|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929397|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929398|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55929399|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
55929400|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929401|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929402|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55929403|NCT05249725|Irsogladine|irsogladine|mesh-list
55929404|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
55929405|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929406|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55929407|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55929408|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778286|NCT05746351|Nalbuphine|nalbuphine|mesh-list
55778287|NCT05746351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55778288|NCT05746351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778289|NCT05746351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778290|NCT05746351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55778291|NCT05746351|Analgesics|analgesics|mesh-ancestor
55778292|NCT05746351|Sensory System Agents|sensory system agents|mesh-ancestor
55778293|NCT05746351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778294|NCT05746351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55929409|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55929410|NCT05249725|Protective Agents|protective agents|mesh-ancestor
55929411|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929412|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55929413|NCT05249725|Antacids|antacids|mesh-ancestor
55929414|NCT01834209|Prednisone|prednisone|mesh-list
55929415|NCT01834209|Prednisolone|prednisolone|mesh-list
55929416|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
55929417|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55929418|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
55929419|NCT01834209|Hormones|hormones|mesh-ancestor
55929420|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929421|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929422|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55929423|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929424|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55929425|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929426|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929427|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
55929428|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55929429|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
55929430|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929431|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778295|NCT05746351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55778296|NCT05746351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55778297|NCT05746351|Adrenergic Agents|adrenergic agents|mesh-ancestor
55778298|NCT05746351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778299|NCT05746351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778300|NCT05746351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55778301|NCT05746351|Narcotics|narcotics|mesh-ancestor
55778302|NCT05746351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55778303|NCT05746351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55778304|NCT05746351|Anesthetics, General|anesthetics, general|mesh-ancestor
55778305|NCT05746351|Anesthetics|anesthetics|mesh-ancestor
55778306|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55929451|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929452|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55929453|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55929454|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55929455|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929456|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
55929457|NCT05243706|Loratadine|loratadine|mesh-list
55929458|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
55929459|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
55929460|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55929461|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55929462|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55929463|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
55929464|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
55929465|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929466|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929467|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929468|NCT01728051|Melphalan|melphalan|mesh-list
55929469|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55929470|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
55778307|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
55778308|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55778309|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778310|NCT05403281|Incretins|incretins|mesh-ancestor
55778311|NCT05403281|Hormones|hormones|mesh-ancestor
55778312|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778316|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778317|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55778319|NCT03115099|Liraglutide|liraglutide|mesh-list
55778320|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55783418|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55783419|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55783420|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55783421|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778321|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778323|NCT03115099|Hormones|hormones|mesh-ancestor
55778324|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778325|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55778326|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
55736742|NCT03429179|Butorphanol|butorphanol|mesh-list
55778327|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778328|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778329|NCT03165097|ACT-709478|act-709478|mesh-list
55778330|NCT03165097|Midazolam|midazolam|mesh-list
55778331|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55778332|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55778333|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778334|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778335|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55778336|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55778337|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55778338|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55778339|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
55778340|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
55778342|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
55778343|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216538|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216539|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216540|NCT01625572|Analgesics|analgesics|mesh-ancestor
56216541|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
56216542|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216543|NCT01625715|Ketotifen|ketotifen|mesh-list
56216544|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
55929475|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
56216545|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
56216546|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56216547|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
55778344|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778345|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55778346|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55778347|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55778348|NCT03165409|Nivolumab|nivolumab|mesh-list
55929541|NCT05059782|Coal Tar|coal tar|mesh-list
55929542|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
55929543|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
55929544|NCT05242081|Sufentanil|sufentanil|mesh-list
55929545|NCT05242081|Ketamine|ketamine|mesh-list
55929546|NCT05242081|Esketamine|esketamine|mesh-list
55929547|NCT05242081|Analgesics|analgesics|mesh-ancestor
55929548|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
55929549|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929550|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929551|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55929552|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55929553|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
55929554|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
55929555|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929556|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55929557|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55929558|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929559|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929560|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55929561|NCT05242081|Narcotics|narcotics|mesh-ancestor
55929562|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55929563|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
55929564|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55929565|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
55929566|NCT03149029|Trametinib|trametinib|mesh-list
55929567|NCT03149029|Dabrafenib|dabrafenib|mesh-list
55929568|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55929569|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929570|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55929571|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929572|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778349|NCT03165409|Ipilimumab|ipilimumab|mesh-list
55778350|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55778351|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778352|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55778353|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778354|NCT05403125|Listerine|listerine|mesh-list
55778355|NCT05403125|Fluorides|fluorides|mesh-list
55778356|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
55778357|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
55929573|NCT04412304|Dalteparin|dalteparin|mesh-list
55929574|NCT04412304|Tinzaparin|tinzaparin|mesh-list
55929575|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55929576|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
55929577|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55929578|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55929579|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929580|NCT05063838|Anesthetics|anesthetics|mesh-list
55929581|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929582|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929583|NCT00915603|Paclitaxel|paclitaxel|mesh-list
55929584|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55929585|NCT00915603|Bevacizumab|bevacizumab|mesh-list
55929586|NCT00915603|Everolimus|everolimus|mesh-list
55929587|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55929588|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929589|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
55929590|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
55929591|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
55929592|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929593|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55929594|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55778358|NCT05403125|Protective Agents|protective agents|mesh-ancestor
55778359|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778360|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55778361|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778362|NCT05701423|Natalizumab|natalizumab|mesh-list
55778363|NCT05701423|Immunologic Factors|immunologic factors|mesh-ancestor
55778364|NCT05701423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778365|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
55929595|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55929596|NCT00915603|Growth Substances|growth substances|mesh-ancestor
55929597|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929598|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929599|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929600|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
55929601|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55929602|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55929603|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
55929604|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929605|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929606|NCT01929421|Gemcitabine|gemcitabine|mesh-list
55929607|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55778366|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
55778367|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55778368|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55778369|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778370|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778371|NCT02795351|Urological Agents|urological agents|mesh-ancestor
55778372|NCT05403047|Tenofovir|tenofovir|mesh-list
55778373|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
55778374|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778375|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55778376|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55778377|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929608|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
56144591|NCT00801138|Bupivacaine|bupivacaine|mesh-list
55929609|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929610|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929611|NCT01929421|Antiviral Agents|antiviral agents|mesh-ancestor
55929612|NCT01929421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929613|NCT01929421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929614|NCT01929421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55751403|NCT03230851|Indobufen|indobufen|mesh-list
55751404|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55751405|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55751406|NCT03230851|Analgesics|analgesics|mesh-ancestor
55751407|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
55751408|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751409|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751410|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751411|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751412|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55751413|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55751414|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751415|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55751416|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55751417|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751418|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
55751419|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
55751420|NCT05464433|Analgesics|analgesics|mesh-ancestor
55751421|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
55751422|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751423|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751424|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751425|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55751426|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55751428|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751429|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55751430|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751431|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55751432|NCT05024565|Lactams|lactams|mesh-list
55751433|NCT05024565|beta-Lactams|beta-lactams|mesh-list
55751434|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751435|NCT03228901|Oxytocin|oxytocin|mesh-list
55751436|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
55751437|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55751438|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751439|NCT03228823|Amiodarone|amiodarone|mesh-list
55751440|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55751441|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
55751442|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55751443|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751444|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751445|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55751446|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55751448|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751449|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55778378|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778379|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55778380|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55778384|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55778385|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55778386|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783422|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
55783423|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
55778387|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778388|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778389|NCT03927443|Bimatoprost|bimatoprost|mesh-list
55778390|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55778391|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
55778392|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55778393|NCT05124353|Protective Agents|protective agents|mesh-ancestor
55778394|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778395|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
55778396|NCT03913247|Metronidazole|metronidazole|mesh-list
55778397|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778398|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929615|NCT01929421|Immunologic Factors|immunologic factors|mesh-ancestor
55929616|NCT01929421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929617|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
56216548|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
56216549|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216550|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216551|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778399|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55778400|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55778401|NCT03805841|Bromides|bromides|mesh-list
55778402|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
55778403|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
55778404|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55778405|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929618|NCT04474002|Cathartics|cathartics|mesh-ancestor
55929619|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55929620|NCT01929577|Peficitinib|peficitinib|mesh-list
55929621|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929622|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929623|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929624|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
55929625|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929626|NCT03142321|Vedolizumab|vedolizumab|mesh-list
55929627|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55736836|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
55778406|NCT01999972|Axitinib|axitinib|mesh-list
55778407|NCT01999972|Crizotinib|crizotinib|mesh-list
55778408|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778409|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55778410|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778411|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778412|NCT04055389|Antithrombins|antithrombins|mesh-list
55778413|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
55778415|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
55778416|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778417|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778418|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
55778420|NCT05697055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55778421|NCT05697055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55778422|NCT05697055|Protease Inhibitors|protease inhibitors|mesh-ancestor
55778423|NCT05697055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778424|NCT05697055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778425|NCT05697055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55778426|NCT05697055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55778427|NCT05697055|Antiviral Agents|antiviral agents|mesh-ancestor
55778428|NCT05697055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778429|NCT05697055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55778430|NCT05697055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55778431|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
55929628|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55929629|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929631|NCT03836703|Trace Elements|trace elements|mesh-ancestor
55778432|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
55778433|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55778434|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778435|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55778436|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55778437|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
55778438|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55778439|NCT01999894|Memantine|memantine|mesh-list
55778440|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55778441|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55778442|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
55778443|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778444|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778445|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778446|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55778447|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55778448|NCT01976806|Aspirin|aspirin|mesh-list
55778449|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55778450|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55929692|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
55929693|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55929694|NCT05061732|Renal Agents|renal agents|mesh-ancestor
55929695|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55929696|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55929697|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929698|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55929699|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55929700|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55929701|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55929703|NCT05061732|Diuretics|diuretics|mesh-ancestor
55929704|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
55929705|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929706|NCT05061732|Expectorants|expectorants|mesh-ancestor
55929707|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
55929708|NCT02391571|Naltrexone|naltrexone|mesh-list
55929709|NCT02391571|Oxycodone|oxycodone|mesh-list
55929710|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55929711|NCT02391571|Narcotics|narcotics|mesh-ancestor
55929712|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929713|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778451|NCT01976806|Analgesics|analgesics|mesh-ancestor
55778452|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
55778455|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778456|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55778457|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55783425|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
55783426|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
55778458|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55778459|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778460|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55778461|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55778462|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778463|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
55778464|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55876623|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216552|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55778466|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778467|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929714|NCT02391571|Analgesics|analgesics|mesh-ancestor
55929715|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
55929716|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929717|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55929718|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55929719|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
55929720|NCT01728987|Vitamin D|vitamin d|mesh-list
55929721|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55929722|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929723|NCT01728987|Vitamins|vitamins|mesh-ancestor
55929724|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
55929725|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55929726|NCT01834989|Mitogens|mitogens|mesh-list
55929727|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
55929735|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929736|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929737|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929738|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55929739|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55929740|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929741|NCT03100422|Armin|armin|mesh-list
55929742|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55929743|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929744|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929745|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
55929746|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778468|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55778469|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55778470|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778472|NCT03165253|Clarithromycin|clarithromycin|mesh-list
55778473|NCT03165253|Omeprazole|omeprazole|mesh-list
55778474|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55778475|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778476|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55778477|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55778478|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55757502|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55929747|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778479|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778480|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778481|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55778482|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55778483|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55778484|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55778485|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55778486|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778487|NCT04718389|Benralizumab|benralizumab|mesh-list
55778488|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55929748|NCT00639769|Cisplatin|cisplatin|mesh-list
55929749|NCT00639769|Irinotecan|irinotecan|mesh-list
55929750|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929751|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55778489|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
55778490|NCT03161977|Mannitol|mannitol|mesh-list
55778491|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55778492|NCT03161977|Diuretics|diuretics|mesh-ancestor
55778493|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
55778494|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778495|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55778496|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55778497|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778498|NCT02683525|Incretins|incretins|mesh-ancestor
55929752|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55929753|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929754|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929755|NCT02553642|Nivolumab|nivolumab|mesh-list
55929756|NCT02553642|Ipilimumab|ipilimumab|mesh-list
55929757|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55929758|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929759|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55736929|NCT03425747|Antacids|antacids|mesh-ancestor
55778500|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778501|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55778502|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
55778503|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778504|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778505|NCT01976338|Ranibizumab|ranibizumab|mesh-list
55778506|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55778507|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55778508|NCT01976338|Growth Substances|growth substances|mesh-ancestor
55778509|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929760|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929761|NCT01723371|Carvedilol|carvedilol|mesh-list
55929762|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55929763|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55929765|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929766|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929767|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929768|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55929769|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
55929770|NCT01723371|Protective Agents|protective agents|mesh-ancestor
55929771|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55929772|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55929773|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55929774|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
55929775|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55929776|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55929777|NCT00639457|Pioglitazone|pioglitazone|mesh-list
55929778|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55736938|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
55778510|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
55778511|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778513|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778514|NCT05115773|Anesthetics|anesthetics|mesh-list
55778515|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778516|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778517|NCT02506517|Afatinib|afatinib|mesh-list
55778518|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778519|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55778520|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778521|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778522|NCT04657939|Pioglitazone|pioglitazone|mesh-list
55778523|NCT04657939|Liraglutide|liraglutide|mesh-list
55778524|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55783430|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929779|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929780|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
55929781|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55783431|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
55783432|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
55783433|NCT03105583|Vitamins|vitamins|mesh-list
55783434|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
55778528|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778529|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
55778530|NCT01999114|Naltrexone|naltrexone|mesh-list
55778531|NCT01999114|Buprenorphine|buprenorphine|mesh-list
55778532|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55778533|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55778534|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778535|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55778536|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55757546|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
55929783|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55929784|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929785|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
55929786|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929787|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929788|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55929789|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929790|NCT01723527|Buprenorphine|buprenorphine|mesh-list
55929791|NCT01723527|Methadone|methadone|mesh-list
55929792|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55929793|NCT01723527|Narcotics|narcotics|mesh-ancestor
55929794|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929795|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929796|NCT01723527|Analgesics|analgesics|mesh-ancestor
55929797|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
55929798|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929799|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55929800|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
55929801|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
55929802|NCT00639223|Pravastatin|pravastatin|mesh-list
55929803|NCT00639223|Red yeast rice|red yeast rice|mesh-list
55929804|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55929805|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55929806|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
55778537|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216553|NCT01625741|Rituximab|rituximab|mesh-list
56216554|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56216555|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778538|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778539|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778540|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55778541|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
55929807|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929808|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55929809|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55929810|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929811|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55929812|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
55836488|NCT01986751|Analgesics|analgesics|mesh-ancestor
55778542|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55778543|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778544|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55778545|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55778546|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55778547|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55778548|NCT01999114|Narcotics|narcotics|mesh-ancestor
55778549|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778550|NCT01999114|Analgesics|analgesics|mesh-ancestor
55778551|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
55778552|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778553|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55778554|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55929813|NCT03519984|Cytarabine|cytarabine|mesh-list
55929814|NCT03519984|Vincristine|vincristine|mesh-list
55929815|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55929816|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
55929817|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929818|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929819|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
55929820|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929821|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929822|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
55929823|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929824|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55929825|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
55929826|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
55929827|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
55929828|NCT05056896|Aspirin|aspirin|mesh-list
55778555|NCT04500275|Vancomycin|vancomycin|mesh-list
55778556|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55778557|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778558|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55778559|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55778560|NCT04503161|Estradiol|estradiol|mesh-list
55778561|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55778562|NCT04503161|Estrogens|estrogens|mesh-ancestor
55778563|NCT04503161|Hormones|hormones|mesh-ancestor
55929829|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
55929830|NCT05056896|Salicylates|salicylates|mesh-list
55929831|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55929832|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55929833|NCT05056896|Analgesics|analgesics|mesh-ancestor
55757590|NCT03254927|Cetuximab|cetuximab|mesh-list
55736978|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751612|NCT03331445|Protective Agents|protective agents|mesh-ancestor
55751614|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751615|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751616|NCT05008263|Liver Extracts|liver extracts|mesh-list
55751617|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
55751618|NCT05008263|Hematinics|hematinics|mesh-ancestor
55751619|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55751620|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751621|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55751622|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751624|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
55751625|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751626|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751627|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55751628|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
55751629|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751630|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751631|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55751633|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55751634|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
55751635|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55751636|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
55751638|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751639|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55751640|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751641|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55751642|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
55751643|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751644|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751645|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55751646|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
55751647|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
55751648|NCT03078933|Protective Agents|protective agents|mesh-ancestor
55751649|NCT03092193|Naproxen|naproxen|mesh-list
55751650|NCT03092193|Esomeprazole|esomeprazole|mesh-list
55751651|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55751652|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55751653|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55751654|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751655|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751656|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55751657|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55751658|NCT03092193|Analgesics|analgesics|mesh-ancestor
55751659|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
55751660|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751661|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751662|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751663|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751664|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
55751665|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55751667|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
55778564|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778565|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778566|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55778567|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
55778568|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55778569|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55778570|NCT02214407|Decitabine|decitabine|mesh-list
55778571|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
55778572|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55778573|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
55778574|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778575|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778576|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778577|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
55778578|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55778579|NCT01899989|Carboplatin|carboplatin|mesh-list
55778580|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778581|NCT02261285|Nivolumab|nivolumab|mesh-list
55778582|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55778583|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778584|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55778585|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783440|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778587|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55929834|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
55757618|NCT03259529|Gemcitabine|gemcitabine|mesh-list
55736999|NCT03444025|Goserelin|goserelin|mesh-list
55778588|NCT01288625|Protective Agents|protective agents|mesh-ancestor
55778589|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778590|NCT04968899|Dexamethasone|dexamethasone|mesh-list
55778591|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
55778592|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55778593|NCT04968899|Antibodies|antibodies|mesh-list
55778594|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
55778595|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55778596|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778597|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
55778598|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
55778599|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778600|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778601|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55778602|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
55778603|NCT04968899|Hormones|hormones|mesh-ancestor
55778604|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778605|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55778606|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216556|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
55778607|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
55778608|NCT01374451|Everolimus|everolimus|mesh-list
55778609|NCT01374451|Pasireotide|pasireotide|mesh-list
55778610|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778611|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55778612|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
55778613|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778614|NCT01374451|Hormones|hormones|mesh-ancestor
55778615|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778616|NCT02674399|Hylan|hylan|mesh-list
55778617|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
55778618|NCT02674399|Protective Agents|protective agents|mesh-ancestor
55778619|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929835|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929836|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929837|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55929838|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55929839|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55929840|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55929841|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929842|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55929843|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55929844|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929845|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
55929846|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929847|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
55929848|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
55929849|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
55929850|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55778620|NCT03161509|Acetaminophen|acetaminophen|mesh-list
55778621|NCT03161509|Lamotrigine|lamotrigine|mesh-list
55778622|NCT03161509|Carbamazepine|carbamazepine|mesh-list
55778623|NCT03161509|Phenytoin|phenytoin|mesh-list
55778624|NCT03161509|Valproic Acid|valproic acid|mesh-list
55778625|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
55778626|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55778627|NCT03161509|Analgesics|analgesics|mesh-ancestor
55778628|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
55778629|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778630|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778631|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
55778632|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55778633|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55778634|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778635|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55778636|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55778637|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55778638|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778639|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55778640|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55778641|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778643|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778644|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
55778645|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55929851|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
55929852|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929853|NCT01835691|Vitamin D|vitamin d|mesh-list
55929854|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
55929855|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
55929856|NCT01835691|Vitamins|vitamins|mesh-list
55929857|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
55929858|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929859|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55929860|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55929861|NCT01729767|Acyclovir|acyclovir|mesh-list
55929862|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
55929863|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929864|NCT00913263|Flutamide|flutamide|mesh-list
55929865|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
55751668|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
55751669|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751670|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751671|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
55751672|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751673|NCT05015595|Memantine|memantine|mesh-list
55751674|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55751675|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55751676|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
55751677|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751678|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751679|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751680|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55751682|NCT05015829|Dobutamine|dobutamine|mesh-list
55751683|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55751684|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
55751685|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
55751686|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751687|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751688|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55751689|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55751690|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55778646|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55778647|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55778648|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55778649|NCT02676895|Vaccines|vaccines|mesh-list
55778650|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
55778651|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778652|NCT04440085|Midodrine|midodrine|mesh-list
55783441|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783442|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
55783443|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778655|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778656|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778657|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55778658|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55778659|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55778660|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55929866|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
55929867|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
55929868|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929869|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929870|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55929871|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929872|NCT04377867|Abatacept|abatacept|mesh-list
55929873|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55929874|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929875|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929876|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929877|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
55737068|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778661|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
55778662|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778663|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778664|NCT05129033|Omalizumab|omalizumab|mesh-list
55778665|NCT05129033|Itraconazole|itraconazole|mesh-list
55778666|NCT05129033|Prednisone|prednisone|mesh-list
55778667|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778668|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
55778669|NCT05129033|Hormones|hormones|mesh-ancestor
55778670|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778671|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778672|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55778673|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778674|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
55778675|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778676|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55778677|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55778678|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876624|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
56216557|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216558|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56216560|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
56216561|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216562|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
55778679|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778680|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55778681|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
55751691|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
55751692|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751693|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780042|NCT03962855|Ifetroban|ifetroban|mesh-list
55751694|NCT05015829|Protective Agents|protective agents|mesh-ancestor
55751697|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751698|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751699|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55751700|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
55751701|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
55751702|NCT01375075|Atorvastatin|atorvastatin|mesh-list
55751703|NCT01375075|Evacetrapib|evacetrapib|mesh-list
55751704|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55751705|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55751706|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
55751707|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751708|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55751709|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55751710|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751711|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55751712|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55751713|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
55751714|NCT03240055|Etomidate|etomidate|mesh-list
55751715|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
55751716|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751717|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751718|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55751719|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55751720|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
55751721|NCT03087201|Nabiximols|nabiximols|mesh-list
55751722|NCT03087201|Analgesics|analgesics|mesh-ancestor
55751723|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
55751724|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751725|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751726|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
55751727|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55751728|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
55751729|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55751730|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751731|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55751733|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55751734|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55751735|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751736|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751737|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55751738|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55751739|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55751740|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55751741|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
55751742|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
55751743|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
55751744|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
55751745|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751746|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751747|NCT03239821|Codeine|codeine|mesh-list
55751748|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55751749|NCT03239821|Narcotics|narcotics|mesh-ancestor
55751750|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751751|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751752|NCT03239821|Analgesics|analgesics|mesh-ancestor
55751753|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
55778682|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55778683|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55778684|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55778685|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
55778686|NCT03113851|Molgramostim|molgramostim|mesh-list
55778687|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778688|NCT05128721|Vaccines|vaccines|mesh-list
55778689|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
55778690|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778691|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
55778692|NCT04546399|Leucovorin|leucovorin|mesh-list
55778693|NCT04546399|Folic Acid|folic acid|mesh-list
55778694|NCT04546399|Cytarabine|cytarabine|mesh-list
55778695|NCT04546399|Dexamethasone|dexamethasone|mesh-list
55805106|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
55778697|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
55778698|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55778699|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55778700|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55778701|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
55778702|NCT04546399|Methotrexate|methotrexate|mesh-list
55778703|NCT04546399|Nivolumab|nivolumab|mesh-list
55778704|NCT04546399|Etoposide|etoposide|mesh-list
55778705|NCT04546399|Vincristine|vincristine|mesh-list
55778706|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
55778707|NCT04546399|Asparaginase|asparaginase|mesh-list
55929878|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929880|NCT00637273|Pioglitazone|pioglitazone|mesh-list
55929881|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55929882|NCT00637273|Exenatide|exenatide|mesh-list
55929883|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55929884|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929885|NCT00637273|Incretins|incretins|mesh-ancestor
55929886|NCT00637273|Hormones|hormones|mesh-ancestor
55929887|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929888|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55929889|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
55929890|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929891|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929892|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55778708|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
55778709|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
55778710|NCT04546399|Pegaspargase|pegaspargase|mesh-list
55778711|NCT04546399|Thioguanine|thioguanine|mesh-list
55778712|NCT04546399|Blinatumomab|blinatumomab|mesh-list
55778713|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55778714|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
55778715|NCT04546399|Antibodies|antibodies|mesh-list
55778716|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
55778717|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55778718|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55778719|NCT04546399|BB 1101|bb 1101|mesh-list
55778720|NCT04546399|Calcium|calcium|mesh-list
55778721|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
55778722|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
55778723|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55778724|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
55778725|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783444|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55783445|NCT03105115|Narcotics|narcotics|mesh-ancestor
55783446|NCT03105115|Analgesics|analgesics|mesh-ancestor
55783447|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55783448|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55783449|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
55783450|NCT03105349|Ribavirin|ribavirin|mesh-list
55783451|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
55778727|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55778728|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
55778729|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778730|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778731|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55778732|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778733|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
55778734|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
55778735|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778736|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55778737|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
55778738|NCT04546399|Hormones|hormones|mesh-ancestor
55778739|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778740|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55778741|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
56216563|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216564|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
56216565|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216566|NCT01625806|Ketoconazole|ketoconazole|mesh-list
56216567|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
56216568|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216569|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56216570|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56216571|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778742|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778743|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55778744|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55778745|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55778746|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
55778747|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55778748|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55778749|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
55778750|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
55778751|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55778752|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55778753|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55778754|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55778755|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55778756|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55778757|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
55737187|NCT03436303|Hormones|hormones|mesh-ancestor
55778758|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778759|NCT04546399|Antidotes|antidotes|mesh-ancestor
55778760|NCT04546399|Protective Agents|protective agents|mesh-ancestor
55778761|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
55778762|NCT04546399|Vitamins|vitamins|mesh-ancestor
55778763|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
55778764|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
55778765|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
55778766|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
55778767|NCT04546399|Hematinics|hematinics|mesh-ancestor
55778768|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
55778769|NCT05128175|Levodopa|levodopa|mesh-list
55778770|NCT05128175|Carbidopa|carbidopa|mesh-list
55778771|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55778772|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55778773|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55778774|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
55778775|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778776|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778777|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778778|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55778779|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778780|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55778781|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
55783454|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
55783455|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783456|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
55783457|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783458|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55783459|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55783460|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55783461|NCT03077555|Estradiol|estradiol|mesh-list
55783462|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55783463|NCT03077555|Estrogens|estrogens|mesh-ancestor
55783464|NCT03077555|Hormones|hormones|mesh-ancestor
55778782|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
55929893|NCT01923259|Donepezil|donepezil|mesh-list
55929894|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55929895|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929896|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929897|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
55929898|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929899|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737212|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
55778783|NCT04184453|Deferiprone|deferiprone|mesh-list
55778784|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55778785|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
55778796|NCT05205109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56216572|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216573|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56216574|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
55792850|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55778797|NCT05205109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778798|NCT02207465|Paclitaxel|paclitaxel|mesh-list
55778799|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55778800|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55778801|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778802|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
55778803|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
55778804|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
55778805|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778807|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55778808|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778809|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778810|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55778811|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
55778812|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778813|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55778814|NCT05134337|Itraconazole|itraconazole|mesh-list
55778815|NCT05134337|Rifampin|rifampin|mesh-list
55778816|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
55778817|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778818|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55778819|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55778820|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889856|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55929900|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
55929901|NCT01923337|Irinotecan|irinotecan|mesh-list
55929902|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55929903|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55929904|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929905|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929906|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929907|NCT03098160|Ipilimumab|ipilimumab|mesh-list
55929908|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55778821|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778822|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55778823|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
55778824|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778825|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778826|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55778827|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55778828|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
55778829|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55778830|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
55778831|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55778832|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55929909|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929910|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55929911|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929912|NCT01720563|Leucovorin|leucovorin|mesh-list
55929913|NCT01720563|Tegafur|tegafur|mesh-list
55929914|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929915|NCT01720563|Antidotes|antidotes|mesh-ancestor
55929916|NCT01720563|Protective Agents|protective agents|mesh-ancestor
55929917|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929918|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
55929919|NCT01720563|Vitamins|vitamins|mesh-ancestor
55778833|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55783465|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783466|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783467|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55783468|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
55778834|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55778835|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55757721|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929920|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
55929921|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55929922|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
55929923|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929924|NCT01724385|Bevacizumab|bevacizumab|mesh-list
55929925|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55929926|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929927|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55929928|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55929929|NCT01724385|Growth Substances|growth substances|mesh-ancestor
55929930|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929931|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929932|NCT04377789|Quercetin|quercetin|mesh-list
55929933|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
55929934|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778836|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55778837|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55778838|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
55778839|NCT04499495|Mesalamine|mesalamine|mesh-list
55778840|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55778841|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55778845|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778846|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778847|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55778848|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
55778849|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55778850|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778852|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
55778853|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
55778854|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778855|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778856|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
55778857|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778858|NCT05279963|Amitriptyline|amitriptyline|mesh-list
56216575|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216576|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216577|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56216578|NCT01625871|Lumefantrine|lumefantrine|mesh-list
55778859|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55778860|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
55778861|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55778862|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55778863|NCT05279963|Analgesics|analgesics|mesh-ancestor
55778864|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
55778865|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778866|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778867|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55778868|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55778869|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889857|NCT01450215|Growth Substances|growth substances|mesh-ancestor
55929935|NCT04377789|Protective Agents|protective agents|mesh-ancestor
55929936|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929937|NCT00988117|Rivastigmine|rivastigmine|mesh-list
55929938|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55778870|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778871|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
55778872|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778874|NCT04310995|Diltiazem|diltiazem|mesh-list
55778875|NCT04310995|Isosorbide|isosorbide|mesh-list
55778876|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55778877|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55778878|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55778879|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55778880|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55778881|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778882|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55778883|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778884|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
55778885|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55778887|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
55778888|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55778889|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55778890|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
55778892|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
55778893|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
55778894|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55929939|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778895|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55783470|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55783471|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55783472|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55783473|NCT02335255|Naftifine|naftifine|mesh-list
55783474|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
55783475|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783476|NCT05012033|Prednisolone|prednisolone|mesh-list
55783477|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783478|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
55778896|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778897|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
55778898|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778899|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778900|NCT05133791|Annexin A5|annexin a5|mesh-list
55778901|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778902|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778903|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
55778904|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55778908|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55778909|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
55778910|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778911|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
55778912|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
55778913|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778914|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778915|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55778916|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
55778917|NCT05133635|Hormones|hormones|mesh-ancestor
55778918|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216579|NCT01625871|Artemether|artemether|mesh-list
56216580|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56216581|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
56216582|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55778919|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55778920|NCT05133635|Protective Agents|protective agents|mesh-ancestor
55929940|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929941|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
55929942|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929943|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929944|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55929945|NCT00988117|Protective Agents|protective agents|mesh-ancestor
55929946|NCT01728753|Favipiravir|favipiravir|mesh-list
55929947|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
55929948|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929949|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
55929950|NCT01724619|Androgens|androgens|mesh-ancestor
55929951|NCT01724619|Hormones|hormones|mesh-ancestor
55929952|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929953|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929954|NCT05045508|Varenicline|varenicline|mesh-list
55929955|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55929956|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55929957|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
55929958|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737348|NCT03438955|Telmisartan|telmisartan|mesh-list
55778921|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55778922|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778923|NCT04094675|Sirolimus|sirolimus|mesh-list
55778924|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55778925|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778926|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55778927|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778928|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
55778929|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55778930|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
55778931|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778932|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
55929959|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929960|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929961|NCT00637195|Vaccines|vaccines|mesh-list
55929962|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
55929963|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929964|NCT05045274|Aspirin|aspirin|mesh-list
55929965|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
55929966|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
55929967|NCT05045274|Giapreza|giapreza|mesh-list
55929968|NCT05045274|Clopidogrel|clopidogrel|mesh-list
55929969|NCT05045274|Ticagrelor|ticagrelor|mesh-list
55929970|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55929971|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55929972|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
55929973|NCT05045274|Diuretics|diuretics|mesh-list
55929978|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
55929982|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
55929983|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929984|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929985|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55929987|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55757758|NCT02454881|Narcotics|narcotics|mesh-ancestor
55778933|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55778934|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55778935|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778936|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
55778937|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
55778938|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778939|NCT05132777|Osimertinib|osimertinib|mesh-list
55778940|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778941|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55778942|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778943|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778944|NCT05422027|Dexamethasone|dexamethasone|mesh-list
55778945|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
55778947|NCT05422027|Bortezomib|bortezomib|mesh-list
55778948|NCT05422027|BB 1101|bb 1101|mesh-list
55778949|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778950|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
55783479|NCT05012033|Hormones|hormones|mesh-ancestor
55783480|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783481|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783482|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55778951|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
55778952|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778953|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778954|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55778955|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
55778956|NCT05422027|Hormones|hormones|mesh-ancestor
55778957|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778958|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55778959|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778960|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
55778961|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889858|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929988|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55929989|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929990|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55929991|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55929992|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
55929993|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55929994|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55929995|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55929996|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
55929997|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929998|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55929999|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55930000|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55930001|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55930002|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
55930003|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55930004|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
55930005|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55778962|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778963|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
55778964|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55778965|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55778966|NCT05422027|Growth Substances|growth substances|mesh-ancestor
55778967|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
55778969|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55778970|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55778971|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55778972|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55778973|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778976|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778978|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778979|NCT04140487|Azacitidine|azacitidine|mesh-list
55930009|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
55930010|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
55778980|NCT04140487|Venetoclax|venetoclax|mesh-list
55778981|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55778982|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
55778983|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778984|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55778985|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216583|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56216584|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216585|NCT01625936|Bevacizumab|bevacizumab|mesh-list
56216586|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56000895|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000896|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56000897|NCT05471544|Renal Agents|renal agents|mesh-ancestor
56000898|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
56000899|NCT03333486|Fludarabine|fludarabine|mesh-list
56000900|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
56000901|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56000902|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
56000903|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000904|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55778986|NCT01674725|Ribavirin|ribavirin|mesh-list
55778987|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
55778988|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778989|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
55778990|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778991|NCT05404061|Hormones|hormones|mesh-list
55778992|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778993|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778994|NCT05051293|Testosterone|testosterone|mesh-list
55778995|NCT05051293|Estrogens|estrogens|mesh-list
55778996|NCT05051293|Androgens|androgens|mesh-ancestor
55778997|NCT05051293|Hormones|hormones|mesh-ancestor
55778998|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55778999|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779000|NCT03161041|Bevacizumab|bevacizumab|mesh-list
55779001|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
55779002|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55779003|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779004|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55779005|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55779006|NCT03161041|Growth Substances|growth substances|mesh-ancestor
55779007|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779008|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
55779010|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55779011|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779012|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
55779013|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55779014|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779015|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779016|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55779017|NCT03163693|Analgesics|analgesics|mesh-ancestor
55783483|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783484|NCT03895099|Desogestrel|desogestrel|mesh-list
55783485|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55757820|NCT04961307|Trastuzumab|trastuzumab|mesh-list
56000905|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56000906|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
56000907|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000908|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000909|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56000910|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56000911|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
56000912|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
56000913|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55783486|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55783487|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55783488|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
55783489|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783490|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783491|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55783492|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55783494|NCT03895099|Hormones|hormones|mesh-ancestor
55779018|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
55779019|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779020|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55779021|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55779022|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55779023|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
55779024|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779025|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779026|NCT05030545|Eplerenone|eplerenone|mesh-list
55779027|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
55779028|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
55779029|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
55779030|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56000914|NCT02598778|Listerine|listerine|mesh-list
56000915|NCT02598778|Fluorides|fluorides|mesh-list
56000916|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
56000917|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
56000918|NCT02598778|Protective Agents|protective agents|mesh-ancestor
56000919|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000920|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56000921|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000922|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
56000923|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
56000924|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
55737485|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
55779031|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779032|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55779033|NCT05030545|Diuretics|diuretics|mesh-ancestor
55779038|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779039|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779040|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779041|NCT00754949|Azithromycin|azithromycin|mesh-list
55779042|NCT00754949|Dexamethasone|dexamethasone|mesh-list
55779043|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
55779044|NCT00754949|BB 1101|bb 1101|mesh-list
56216587|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216588|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56216589|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56216591|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216592|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
56216593|NCT01626222|Everolimus|everolimus|mesh-list
56216594|NCT01626222|Exemestane|exemestane|mesh-list
55779045|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779046|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
55779047|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
55779048|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779049|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779050|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779051|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
55779052|NCT00754949|Hormones|hormones|mesh-ancestor
55779053|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779054|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779055|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779056|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
55779057|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779058|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779059|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55779060|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779061|NCT03160807|Levofloxacin|levofloxacin|mesh-list
55779062|NCT03160807|Ofloxacin|ofloxacin|mesh-list
55779063|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55779064|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779065|NCT03160807|Renal Agents|renal agents|mesh-ancestor
56000925|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56000926|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
56000927|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000928|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
56000929|NCT00642382|Protective Agents|protective agents|mesh-ancestor
56000931|NCT05476380|Cisplatin|cisplatin|mesh-list
56000932|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56000933|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000934|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
56000935|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
56000936|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
56000937|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000938|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56000939|NCT00634972|Ketorolac|ketorolac|mesh-list
56000940|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56000941|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55779066|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55779067|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55779068|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55779069|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779070|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779071|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779072|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55779073|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55779074|NCT01674569|Ranibizumab|ranibizumab|mesh-list
55779075|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55779076|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55779077|NCT01674569|Growth Substances|growth substances|mesh-ancestor
55779078|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779079|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
55779081|NCT03160729|Dexamethasone|dexamethasone|mesh-list
55779082|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779083|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
55779084|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
55779085|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000947|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56000948|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56000949|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000950|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000951|NCT00529282|Vancomycin|vancomycin|mesh-list
56000952|NCT00529282|Cefepime|cefepime|mesh-list
56000953|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
56000954|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
56000955|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56000956|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000957|NCT00623974|Teriparatide|teriparatide|mesh-list
56000958|NCT00623974|Calcitriol|calcitriol|mesh-list
56000959|NCT00623974|Calcium|calcium|mesh-list
56000960|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
56000961|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56000962|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000963|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56000964|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55779086|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779087|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779088|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
55779089|NCT03160729|Hormones|hormones|mesh-ancestor
55779090|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779091|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779092|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779094|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779095|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55779096|NCT05131841|Vinorelbine|vinorelbine|mesh-list
55779097|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55779098|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779099|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
55779100|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
55779101|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
55779102|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779103|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
55779104|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
56216595|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216596|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216597|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
55792873|NCT04294459|Acetaminophen|acetaminophen|mesh-list
55779105|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757863|NCT00700817|Metformin|metformin|mesh-list
56000965|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56000966|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000967|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56000968|NCT00623974|Vitamins|vitamins|mesh-ancestor
56000969|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
56000970|NCT02550288|Atorvastatin|atorvastatin|mesh-list
56000971|NCT02550288|Ezetimibe|ezetimibe|mesh-list
56000972|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56000973|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56000974|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
56000975|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000976|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56000977|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56000978|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000979|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
56000980|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
56000981|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55779106|NCT03163381|Apatinib|apatinib|mesh-list
55779107|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779108|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55779110|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779111|NCT05131295|Dapsone|dapsone|mesh-list
55779112|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55779113|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779114|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
55779115|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55779116|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55779117|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55779118|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779119|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779120|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
55779121|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55779122|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55779123|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
56000998|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56000999|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001000|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001001|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
56001002|NCT00500890|Carboplatin|carboplatin|mesh-list
56001003|NCT00500890|Etoposide|etoposide|mesh-list
56001004|NCT00500890|Vincristine|vincristine|mesh-list
56001005|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001006|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
55779124|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779125|NCT05131295|Antacids|antacids|mesh-ancestor
55779126|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779127|NCT01374217|Clarithromycin|clarithromycin|mesh-list
55779128|NCT01374217|Dexamethasone|dexamethasone|mesh-list
55779129|NCT01374217|Lenalidomide|lenalidomide|mesh-list
55779130|NCT01374217|Tadalafil|tadalafil|mesh-list
55779131|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779132|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
55779133|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
55779134|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779136|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779137|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
55779138|NCT01374217|Hormones|hormones|mesh-ancestor
55779139|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779140|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779141|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779142|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
55779143|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55783495|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779144|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55779145|NCT01374217|Growth Substances|growth substances|mesh-ancestor
55779146|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
55779147|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56001007|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001008|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56001009|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56001010|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
56001011|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001012|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001013|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56001014|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56145274|NCT00886236|Gabapentin|gabapentin|mesh-list
56145275|NCT00886236|Analgesics|analgesics|mesh-ancestor
56145276|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
55854507|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145277|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145278|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145279|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
56145280|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56145281|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56145282|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145283|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56145285|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56145286|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145287|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145288|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
56145289|NCT00886626|Exenatide|exenatide|mesh-list
55854544|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854545|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56145291|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145292|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56145293|NCT00886626|Incretins|incretins|mesh-ancestor
56145294|NCT00886626|Hormones|hormones|mesh-ancestor
56145295|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145296|NCT00887562|Ubiquinone|ubiquinone|mesh-list
56145297|NCT00887562|Idebenone|idebenone|mesh-list
56145298|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
56145299|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145300|NCT00887562|Protective Agents|protective agents|mesh-ancestor
56145301|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145302|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
56145303|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
56145305|NCT00887640|Sirolimus|sirolimus|mesh-list
56145306|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55779148|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779149|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55779150|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779151|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779152|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55779153|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55779154|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
55779155|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55779156|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55779157|NCT01374217|Urological Agents|urological agents|mesh-ancestor
55779159|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55779160|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779161|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
55779162|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779163|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55779164|NCT04941937|Thalidomide|thalidomide|mesh-list
55779165|NCT04941937|Dexamethasone|dexamethasone|mesh-list
55779166|NCT04941937|Lenalidomide|lenalidomide|mesh-list
55779167|NCT04941937|Pomalidomide|pomalidomide|mesh-list
55779168|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779169|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
55779170|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
55779171|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779172|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779173|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779174|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
55779175|NCT04941937|Hormones|hormones|mesh-ancestor
56216598|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216599|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56216600|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56216601|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216602|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216603|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56001015|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56001016|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56001017|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779176|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779177|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779178|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779179|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
55779180|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55779181|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55779183|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
55779185|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
55779186|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55779187|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779188|NCT02959619|Ensartinib|ensartinib|mesh-list
55779189|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779190|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55779191|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001018|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56001019|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56001020|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
55742405|NCT05131893|Capecitabine|capecitabine|mesh-list
55742406|NCT05131893|Trastuzumab|trastuzumab|mesh-list
56145382|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145384|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56145385|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
56145386|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145387|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145388|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
55855286|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56145390|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56145391|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56145392|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56145393|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56145394|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145395|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
56145396|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145397|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145398|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56145399|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145401|NCT00902226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56145402|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56145403|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56145404|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145405|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145406|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
55855459|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
55855460|NCT00452374|Cytarabine|cytarabine|mesh-list
55855461|NCT00452374|Rituximab|rituximab|mesh-list
56145407|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145408|NCT00902226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56145409|NCT00902226|Antidepressive Agents|antidepressive agents|mesh-ancestor
56145410|NCT00902226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56145411|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
56145412|NCT00903162|Letrozole|letrozole|mesh-list
56145413|NCT00903162|Leuprolide|leuprolide|mesh-list
56145414|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855535|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145415|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56145416|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56145418|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145419|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56145420|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
56145421|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145423|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56145424|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56145425|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
56145426|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56145427|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56145428|NCT00904488|Metolazone|metolazone|mesh-list
56145429|NCT00904488|Furosemide|furosemide|mesh-list
56145430|NCT00904488|Diuretics|diuretics|mesh-ancestor
55855627|NCT02334813|Dexamethasone|dexamethasone|mesh-list
56145431|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
55779192|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779193|NCT04935931|Naltrexone|naltrexone|mesh-list
55779194|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55779195|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55779196|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779197|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
55779198|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779199|NCT05124431|Everolimus|everolimus|mesh-list
55779200|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779201|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55757906|NCT02455115|Antidotes|antidotes|mesh-ancestor
56001021|NCT00000736|Zidovudine|zidovudine|mesh-list
56001022|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
56001023|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001024|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001025|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001026|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001027|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
56001028|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779202|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
55779203|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779204|NCT04877275|Dexamethasone|dexamethasone|mesh-list
55779205|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
55779206|NCT04877275|Doxorubicin|doxorubicin|mesh-list
55779207|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55779208|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779209|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
55779210|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001029|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001030|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001031|NCT00379522|Vasopressins|vasopressins|mesh-list
56001032|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
56001033|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
56001034|NCT00379522|Coagulants|coagulants|mesh-ancestor
56001035|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56001036|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56001037|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
56001038|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001039|NCT00421954|Ziprasidone|ziprasidone|mesh-list
55779211|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55779212|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55779213|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
55779214|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779215|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779216|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55779217|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783496|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
55783497|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55779218|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
55779219|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
55779220|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779221|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779222|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
55779223|NCT04877275|Hormones|hormones|mesh-ancestor
56001040|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56001042|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001043|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001044|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001045|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56001046|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56001047|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001048|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55737701|NCT03421717|Chitosan|chitosan|mesh-list
55779224|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779225|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779226|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55779227|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55779228|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55779229|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779230|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
56001049|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56001050|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
56001051|NCT01662336|Ritonavir|ritonavir|mesh-list
56001052|NCT01662336|Lopinavir|lopinavir|mesh-list
56001053|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56001055|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
56001056|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001057|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001058|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001059|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001060|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
55779231|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55779232|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779233|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779234|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55779236|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
56216604|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
56216605|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216606|NCT01626339|Bevacizumab|bevacizumab|mesh-list
56216607|NCT01626339|Ranibizumab|ranibizumab|mesh-list
55779237|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779238|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55779239|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55779240|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55779241|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
55779242|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779243|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779244|NCT05676463|Ascorbic Acid|ascorbic acid|mesh-list
55779245|NCT05676463|Methyltestosterone|methyltestosterone|mesh-list
55779247|NCT05676463|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55779248|NCT05676463|Androgens|androgens|mesh-list
55779249|NCT05676463|Androgen Antagonists|androgen antagonists|mesh-list
55779250|NCT05676463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779251|NCT05676463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779252|NCT05676463|Antioxidants|antioxidants|mesh-ancestor
55779253|NCT05676463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779254|NCT05676463|Protective Agents|protective agents|mesh-ancestor
55779255|NCT05676463|Vitamins|vitamins|mesh-ancestor
55779256|NCT05676463|Micronutrients|micronutrients|mesh-ancestor
55779257|NCT05676463|Estrogens|estrogens|mesh-ancestor
55779258|NCT05676463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779259|NCT05676463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779260|NCT05676463|Anabolic Agents|anabolic agents|mesh-ancestor
55779261|NCT05676463|Hormone Antagonists|hormone antagonists|mesh-ancestor
55779262|NCT03114085|Capecitabine|capecitabine|mesh-list
55779264|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55779265|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
55779266|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779267|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779268|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55779269|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779270|NCT04886453|Morphine|morphine|mesh-list
55779272|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779273|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001061|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001062|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56001063|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56001064|NCT00000766|Ganciclovir|ganciclovir|mesh-list
56001065|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56001066|NCT00000766|Foscarnet|foscarnet|mesh-list
56001067|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56001068|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
56001069|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001070|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001071|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001072|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001073|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001074|NCT00000772|Ribavirin|ribavirin|mesh-list
56001075|NCT00000772|Didanosine|didanosine|mesh-list
56001076|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
56001077|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001078|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
56001079|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001080|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55737752|NCT01004029|Hormones|hormones|mesh-ancestor
55779274|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55779275|NCT04886453|Narcotics|narcotics|mesh-ancestor
55779276|NCT04886453|Analgesics|analgesics|mesh-ancestor
55779277|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
55779278|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779279|NCT05136521|Trazodone|trazodone|mesh-list
55779280|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55779281|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55779282|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779283|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779284|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56001081|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001082|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001083|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001084|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001085|NCT00572260|Daptomycin|daptomycin|mesh-list
56001086|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56001087|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001088|NCT00000778|Pyridoxine|pyridoxine|mesh-list
56001089|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
56001090|NCT00000778|Levofloxacin|levofloxacin|mesh-list
56001091|NCT00000778|Ofloxacin|ofloxacin|mesh-list
56001092|NCT00000778|Isoniazid|isoniazid|mesh-list
56001093|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56001094|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001095|NCT00000778|Renal Agents|renal agents|mesh-ancestor
56001096|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56001097|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56001098|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56001099|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001100|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001101|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001102|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56001103|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56001104|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
56001105|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56001106|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56001107|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
56001108|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55779285|NCT05136521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55779286|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55779287|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55779288|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779289|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783498|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783499|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55779290|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
55779291|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55779292|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
55779293|NCT05343013|Trifluridine|trifluridine|mesh-list
56001130|NCT05600686|Vincristine|vincristine|mesh-list
56001131|NCT05600686|Etoposide phosphate|etoposide phosphate|mesh-list
56001132|NCT05600686|Daunorubicin|daunorubicin|mesh-list
56001133|NCT05600686|Podophyllotoxin|podophyllotoxin|mesh-list
56001134|NCT05600686|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
56001135|NCT05600686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56001136|NCT05600686|Antibodies|antibodies|mesh-list
56001137|NCT05600686|Immunoglobulins|immunoglobulins|mesh-list
56001138|NCT05600686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55779294|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
55779295|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779296|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
55779297|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779298|NCT02388373|Fluticasone|fluticasone|mesh-list
55779300|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
55779301|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55779302|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779303|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55779304|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
56216608|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56216609|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792884|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
55779305|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779306|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779307|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55779308|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
55779309|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
55779310|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55779311|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55779312|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55779313|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55779314|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
55779315|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779316|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779317|NCT01674647|Vitamin K|vitamin k|mesh-list
55779318|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
55779319|NCT01674647|Vitamins|vitamins|mesh-ancestor
55779320|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
55779321|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779322|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55779323|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
55779324|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55779325|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
55779326|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779327|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779328|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
55779329|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55779331|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
55779332|NCT01674647|Coagulants|coagulants|mesh-ancestor
55779333|NCT02669407|Lidocaine|lidocaine|mesh-list
55779334|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
55779336|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779337|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779338|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
55779339|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779340|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55737804|NCT03420703|Morphine|morphine|mesh-list
55857450|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857451|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
56145767|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56145768|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
56145769|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145770|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56145771|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56145772|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
56145773|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55857452|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
56145774|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56145775|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56145776|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56145777|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145778|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
56145779|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145780|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145781|NCT00955266|Calcium|calcium|mesh-list
55857530|NCT03595371|Dapansutrile|dapansutrile|mesh-list
56145782|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56145783|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145784|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56145785|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
56145786|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56145787|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56145788|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56145789|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145790|NCT00961662|Tagatose|tagatose|mesh-list
56145791|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56145792|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
56145793|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
56145794|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145795|NCT00964548|Dantrolene|dantrolene|mesh-list
56145796|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56145797|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145798|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56145799|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145800|NCT00967044|Everolimus|everolimus|mesh-list
56145801|NCT00967044|Panobinostat|panobinostat|mesh-list
56145802|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145803|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145804|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
56145805|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145806|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55779341|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55779342|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55779343|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55779344|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779345|NCT04909853|Ritonavir|ritonavir|mesh-list
55779346|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55779347|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55779348|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
55779349|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779350|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779351|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55779352|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55779353|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
55779354|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779355|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55779356|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55779357|NCT04637555|Valsartan|valsartan|mesh-list
55779358|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55779359|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55779360|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55779361|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55779362|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779364|NCT02388061|Plasminogen|plasminogen|mesh-list
55779365|NCT02388061|Tenecteplase|tenecteplase|mesh-list
55779366|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55779367|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55779368|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779369|NCT04556357|Phenylephrine|phenylephrine|mesh-list
55779370|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
55779371|NCT04556357|Norepinephrine|norepinephrine|mesh-list
55779372|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56216610|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56216611|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56216612|NCT01626339|Growth Substances|growth substances|mesh-ancestor
55792886|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
56001139|NCT05600686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001140|NCT05600686|Immunologic Factors|immunologic factors|mesh-ancestor
56001141|NCT05600686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001142|NCT05600686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56001143|NCT05600686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56001144|NCT05600686|Alkylating Agents|alkylating agents|mesh-ancestor
56001145|NCT05600686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001146|NCT05600686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001147|NCT05600686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56001148|NCT05600686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56001149|NCT05600686|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56001150|NCT05600686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56001151|NCT05600686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001152|NCT05600686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56001153|NCT05600686|Glucocorticoids|glucocorticoids|mesh-ancestor
55779373|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55779374|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
55779375|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
55779376|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779377|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779378|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
55779379|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
55779380|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
55779381|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55779382|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55779383|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55779384|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
55779385|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779386|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779387|NCT04556357|Protective Agents|protective agents|mesh-ancestor
55779388|NCT04553939|Gemcitabine|gemcitabine|mesh-list
55779389|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55779390|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
55779391|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779392|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001154|NCT05600686|Hormones|hormones|mesh-ancestor
56001155|NCT05600686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001156|NCT05600686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55737869|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55779393|NCT04553939|Antiviral Agents|antiviral agents|mesh-ancestor
55779394|NCT04553939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779395|NCT04553939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779396|NCT04553939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779397|NCT04553939|Immunologic Factors|immunologic factors|mesh-ancestor
55779398|NCT04553939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779399|NCT02790853|Proflavine|proflavine|mesh-list
55779400|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55779401|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001157|NCT05600686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56001158|NCT05600686|Tubulin Modulators|tubulin modulators|mesh-ancestor
56001159|NCT05600686|Antimitotic Agents|antimitotic agents|mesh-ancestor
56001160|NCT05600686|Mitosis Modulators|mitosis modulators|mesh-ancestor
56001161|NCT05600686|Keratolytic Agents|keratolytic agents|mesh-ancestor
56001162|NCT05600686|Dermatologic Agents|dermatologic agents|mesh-ancestor
56001164|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
56001165|NCT00000796|Levofloxacin|levofloxacin|mesh-list
56001166|NCT00000796|Cycloserine|cycloserine|mesh-list
56001167|NCT00000796|Rifampin|rifampin|mesh-list
56001168|NCT00000796|Isoniazid|isoniazid|mesh-list
56001169|NCT00000796|Amikacin|amikacin|mesh-list
56001170|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
56001171|NCT00000796|Ethambutol|ethambutol|mesh-list
56001172|NCT00000796|Clofazimine|clofazimine|mesh-list
56001173|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
56001174|NCT00000796|Streptomycin|streptomycin|mesh-list
56001175|NCT00000796|Ethionamide|ethionamide|mesh-list
56001176|NCT00000796|Capreomycin|capreomycin|mesh-list
56001177|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56001178|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001179|NCT00000796|Renal Agents|renal agents|mesh-ancestor
56001180|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55779402|NCT03113773|Aldesleukin|aldesleukin|mesh-list
55779420|NCT05122169|Trace Elements|trace elements|mesh-ancestor
55779421|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
55779422|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779423|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
55779424|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
55779425|NCT04359329|Estradiol|estradiol|mesh-list
55779426|NCT04359329|Estrogens|estrogens|mesh-ancestor
55779427|NCT04359329|Hormones|hormones|mesh-ancestor
55779428|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779429|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779430|NCT05403749|Aflibercept|aflibercept|mesh-list
55779431|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56001181|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56001182|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56001183|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001184|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001185|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001186|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56001187|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56001188|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56001189|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
56001190|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
56001191|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001192|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56001193|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56001194|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56001195|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56001196|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56001197|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56001198|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56001200|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
56001201|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56001202|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
56001203|NCT00000796|Vitamins|vitamins|mesh-ancestor
56001204|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
56001205|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001206|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56001207|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55779432|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55779433|NCT05403749|Growth Substances|growth substances|mesh-ancestor
55779434|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779435|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
55779436|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779437|NCT04745351|Remdesivir|remdesivir|mesh-list
55779438|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
55783500|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55783501|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001208|NCT00000802|Dapsone|dapsone|mesh-list
56001209|NCT00000802|Atovaquone|atovaquone|mesh-list
56001210|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001211|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
56001212|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56001213|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56001214|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56001215|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001216|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001217|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
56001218|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56001219|NCT02389946|Sirolimus|sirolimus|mesh-list
56001220|NCT02389946|Everolimus|everolimus|mesh-list
56001221|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001222|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001223|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
56001224|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001225|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56001226|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001227|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55779439|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779440|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
55779441|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779442|NCT04203875|Abatacept|abatacept|mesh-list
55779443|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55779444|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779445|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779446|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779447|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
55779448|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779449|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55779450|NCT04491383|Tocovid|tocovid|mesh-list
55779451|NCT04491383|Vitamins|vitamins|mesh-ancestor
55779452|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
55779453|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779454|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
56216613|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001228|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
56001229|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
56001230|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001231|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56001232|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001233|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001234|NCT00268450|Gemcitabine|gemcitabine|mesh-list
56001235|NCT00268450|Paclitaxel|paclitaxel|mesh-list
56001236|NCT00268450|Bevacizumab|bevacizumab|mesh-list
56001237|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56001238|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001239|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
56001240|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
56001241|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
56001242|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001243|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56001244|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56001245|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56001246|NCT00268450|Growth Substances|growth substances|mesh-ancestor
56001247|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001248|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
56001249|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56001250|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
55779455|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779456|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779457|NCT04576325|Voriconazole|voriconazole|mesh-list
55779458|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
55779459|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779460|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55779461|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55779462|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779472|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779473|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55779475|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55779476|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779478|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779479|NCT04422743|Tramiprosate|tramiprosate|mesh-list
55779480|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55779481|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
55779482|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
55779483|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
55779484|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
55779485|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779486|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779487|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779488|NCT02535221|Epirubicin|epirubicin|mesh-list
55779489|NCT02535221|Goserelin|goserelin|mesh-list
55779490|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56001251|NCT00268450|Antiviral Agents|antiviral agents|mesh-ancestor
56001252|NCT00268450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001253|NCT00268450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001254|NCT00268450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001255|NCT00268450|Immunologic Factors|immunologic factors|mesh-ancestor
56001256|NCT00000808|Nevirapine|nevirapine|mesh-list
56001257|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001258|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001259|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001260|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758058|NCT04939779|Delpazolid|delpazolid|mesh-list
55779491|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779492|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55779493|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55779494|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779495|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779496|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779497|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
55779498|NCT00000587|Hematinics|hematinics|mesh-ancestor
55779499|NCT04592159|Nabiximols|nabiximols|mesh-list
55779500|NCT04592159|Analgesics|analgesics|mesh-ancestor
55779501|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
55779502|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779503|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779504|NCT05137145|Linaclotide|linaclotide|mesh-list
55779505|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55779506|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
56001261|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
56001262|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001263|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55728519|NCT02819141|Analgesics|analgesics|mesh-ancestor
56001264|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001265|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56001266|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56001267|NCT01892384|BI 409306|bi 409306|mesh-list
56001268|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56001269|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001270|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001271|NCT00000814|Zidovudine|zidovudine|mesh-list
56001272|NCT00000814|Nevirapine|nevirapine|mesh-list
56001273|NCT00000814|Didanosine|didanosine|mesh-list
56001274|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
56001275|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001276|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001277|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001278|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001279|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
56001280|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001281|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001282|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001283|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55779507|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779508|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55783502|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783503|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783504|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
55779509|NCT04419389|Rituximab|rituximab|mesh-list
55779510|NCT04419389|Venetoclax|venetoclax|mesh-list
55779511|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
55779512|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55779513|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779514|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
55779515|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001284|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56001285|NCT02661932|Letrozole|letrozole|mesh-list
55737972|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55779516|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55779517|NCT05304845|Aspirin|aspirin|mesh-list
55779518|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55779519|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55779520|NCT05304845|Analgesics|analgesics|mesh-ancestor
55779521|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
55779522|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779523|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779533|NCT05303597|Lidocaine|lidocaine|mesh-list
55779534|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
55779535|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
55779536|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779537|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779538|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
56001286|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001287|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56001288|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56001289|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001290|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779539|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779540|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55779541|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55779542|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55779543|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55779544|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779545|NCT04892459|Vaccines|vaccines|mesh-list
55779546|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
55779547|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779548|NCT04881539|Cannabidiol|cannabidiol|mesh-list
55779549|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
56001291|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55758094|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
56001292|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
56001293|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55738006|NCT02639065|Durvalumab|durvalumab|mesh-list
55779550|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55779551|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
55779552|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779553|NCT04280939|Anesthetics|anesthetics|mesh-list
55779554|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779555|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779556|NCT05302817|Xenon|xenon|mesh-list
55779557|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55779558|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
55779559|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
56001294|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001296|NCT02658890|Ipilimumab|ipilimumab|mesh-list
56001297|NCT02658890|Linrodostat|linrodostat|mesh-list
56001298|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56001299|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001300|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56001301|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001302|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001303|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
56001304|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56001305|NCT00177970|Antibodies|antibodies|mesh-list
56001306|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
56001307|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
56001308|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56001309|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
55758106|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
56001310|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001311|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56001312|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
56001313|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001314|NCT00088972|Celecoxib|celecoxib|mesh-list
56001315|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56001316|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56001317|NCT00088972|Analgesics|analgesics|mesh-ancestor
56001318|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
56001319|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001320|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001321|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56001322|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56001323|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55779560|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779561|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779562|NCT04489589|Midodrine|midodrine|mesh-list
55779563|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
55779564|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
55779565|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779566|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779567|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55779568|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55779569|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55779570|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55779571|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
56001324|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56001325|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001326|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779572|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779573|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779574|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
55779575|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55779577|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779578|NCT04314713|Scopolamine|scopolamine|mesh-list
55779579|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55779580|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55779581|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
55779582|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
55779583|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779584|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779585|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779586|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
55779587|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55779603|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779604|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55779605|NCT04719221|Evolocumab|evolocumab|mesh-list
55779606|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55779607|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55779608|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
55779609|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001327|NCT00089128|Gemcitabine|gemcitabine|mesh-list
55779610|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55779611|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
55779612|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55779613|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55779614|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
55779615|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
55779616|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779617|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779618|NCT03790397|Osimertinib|osimertinib|mesh-list
55779619|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779620|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55779621|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779622|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779624|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55779625|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55779626|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
55779627|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55779629|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779630|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779631|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
56001328|NCT00089128|Irinotecan|irinotecan|mesh-list
56001329|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56001330|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
56001331|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001332|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001333|NCT00089128|Antiviral Agents|antiviral agents|mesh-ancestor
56001334|NCT00089128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001335|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001336|NCT00089128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001337|NCT00089128|Immunologic Factors|immunologic factors|mesh-ancestor
56001338|NCT00089128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001339|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56001340|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56001341|NCT00000838|Lamivudine|lamivudine|mesh-list
56001342|NCT00000838|Zidovudine|zidovudine|mesh-list
56001343|NCT00000838|Didanosine|didanosine|mesh-list
56001344|NCT00000838|Stavudine|stavudine|mesh-list
55738063|NCT02735707|Analgesics|analgesics|mesh-ancestor
55779632|NCT04684589|Tadalafil|tadalafil|mesh-list
55779633|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
55779634|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56216614|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
56216615|NCT01626443|Folic Acid|folic acid|mesh-list
56216616|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
56216617|NCT01626443|Inositol|inositol|mesh-list
55779635|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55779636|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779637|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779638|NCT04684589|Urological Agents|urological agents|mesh-ancestor
56001345|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001346|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001347|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001348|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001349|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
56001350|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001351|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001352|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001353|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
56001354|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
56001355|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56001356|NCT00001768|Antibodies|antibodies|mesh-list
56001357|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
56001358|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56001359|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
56001360|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001361|NCT00000844|Interferons|interferons|mesh-list
56001362|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
56001363|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001364|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
56001365|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001366|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
56001367|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001368|NCT00014560|Antibodies|antibodies|mesh-list
56001369|NCT00014560|Sargramostim|sargramostim|mesh-list
56001370|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55779639|NCT01228331|Cytarabine|cytarabine|mesh-list
55779640|NCT01228331|Dexamethasone|dexamethasone|mesh-list
55779641|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
55779642|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
55779643|NCT01228331|Doxorubicin|doxorubicin|mesh-list
55779644|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55779645|NCT01228331|Methotrexate|methotrexate|mesh-list
55779646|NCT01228331|Etoposide|etoposide|mesh-list
55779647|NCT01228331|Vincristine|vincristine|mesh-list
55779648|NCT01228331|Daunorubicin|daunorubicin|mesh-list
55779649|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
55779650|NCT01228331|Clofarabine|clofarabine|mesh-list
55779651|NCT01228331|Pegaspargase|pegaspargase|mesh-list
55783506|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55779653|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
55779654|NCT01228331|Amsacrine|amsacrine|mesh-list
55779655|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779656|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
55779657|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779658|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56001371|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
55758155|NCT03244319|Warfarin|warfarin|mesh-list
55779659|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55779660|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
55779661|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779662|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779663|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55779664|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779665|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
55779666|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
55779667|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779668|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779669|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
55779670|NCT01228331|Hormones|hormones|mesh-ancestor
55779671|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001372|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001373|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
56001374|NCT00020722|Ifosfamide|ifosfamide|mesh-list
56001375|NCT00020722|Thiotepa|thiotepa|mesh-list
56001376|NCT00020722|Carboplatin|carboplatin|mesh-list
56001377|NCT00020722|Etoposide|etoposide|mesh-list
56001378|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
56001379|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001380|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
56001381|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001382|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56001383|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56001384|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
56001385|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001386|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001387|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56001388|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56001389|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56001390|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56001391|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001392|NCT02649764|Cytarabine|cytarabine|mesh-list
56001393|NCT02649764|Fludarabine|fludarabine|mesh-list
56001394|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
56001395|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001396|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56001397|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
55779672|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779673|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55779674|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55779675|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55779676|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779677|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55779678|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
55779679|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55779680|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55779681|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
56001408|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001409|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001410|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56001411|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56001412|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
56001413|NCT02126878|Hormones|hormones|mesh-ancestor
56001414|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001415|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001416|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001417|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
56001418|NCT02634008|Ritonavir|ritonavir|mesh-list
56001419|NCT02634008|Ribavirin|ribavirin|mesh-list
56001420|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56001421|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56001423|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001424|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001425|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001426|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001427|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
56001428|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001429|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56001430|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56001431|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
56001432|NCT00000850|Indinavir|indinavir|mesh-list
56001433|NCT00000850|Sargramostim|sargramostim|mesh-list
56001434|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
55779682|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
55779683|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55779684|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55779685|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55779687|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779688|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
55779689|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
55779690|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
55779691|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55779692|NCT01228331|Protective Agents|protective agents|mesh-ancestor
56001435|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001436|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56001437|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56001438|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
56001439|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001440|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001442|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001443|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
56001444|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001445|NCT00000856|Ganciclovir|ganciclovir|mesh-list
56001446|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56001447|NCT00000856|Foscarnet|foscarnet|mesh-list
56001448|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56001449|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
56001450|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001451|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001452|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001453|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779693|NCT01171937|Risperidone|risperidone|mesh-list
55779694|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55779695|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
55779696|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779697|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779698|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779699|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55779700|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55779701|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779702|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55779703|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56216618|NCT01626443|Hematinics|hematinics|mesh-ancestor
56216619|NCT01626443|Vitamins|vitamins|mesh-ancestor
56216620|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
55758197|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
56001454|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001455|NCT00001810|Voriconazole|voriconazole|mesh-list
56001456|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
56001457|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001458|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56001459|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56001460|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001461|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001462|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56001463|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
56001464|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001465|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001466|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56001467|NCT00000862|Zidovudine|zidovudine|mesh-list
56001468|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
56001469|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001470|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001471|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001472|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779705|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
55779706|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55779707|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55779708|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779709|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
55779710|NCT03136445|Coagulants|coagulants|mesh-ancestor
55779711|NCT02867267|Thymalfasin|thymalfasin|mesh-list
55779712|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55779713|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
55779714|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779715|NCT00887783|Vinorelbine|vinorelbine|mesh-list
55779716|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55779717|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001473|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
56001474|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001475|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001476|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001478|NCT02344472|Vinorelbine|vinorelbine|mesh-list
56001479|NCT02344472|Docetaxel|docetaxel|mesh-list
56001480|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56001481|NCT02344472|Capecitabine|capecitabine|mesh-list
56001482|NCT02344472|Trastuzumab|trastuzumab|mesh-list
56001483|NCT02344472|Letrozole|letrozole|mesh-list
56001484|NCT02344472|Fulvestrant|fulvestrant|mesh-list
56001485|NCT02344472|Anastrozole|anastrozole|mesh-list
56001486|NCT02344472|Pertuzumab|pertuzumab|mesh-list
56001487|NCT02344472|Exemestane|exemestane|mesh-list
56001488|NCT02344472|Goserelin|goserelin|mesh-list
56001489|NCT02344472|Leuprolide|leuprolide|mesh-list
56001490|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56001491|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001492|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56001493|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56001494|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
55779718|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
55779719|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
55779720|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
55783507|NCT02334475|Prednisolone|prednisolone|mesh-list
55783508|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
55779729|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779730|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779731|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779732|NCT03199547|Azithromycin|azithromycin|mesh-list
55779733|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55779734|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779735|NCT03189641|Cilostazol|cilostazol|mesh-list
55779736|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55779737|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
55779738|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001495|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001496|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56001497|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
56001498|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56001499|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56001500|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56001501|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001502|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56001503|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
56001504|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001505|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001506|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56001507|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56001508|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56001509|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
55779739|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779740|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55779741|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
55779742|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55779743|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55779744|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779745|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55779746|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
55779747|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55779748|NCT03189641|Protective Agents|protective agents|mesh-ancestor
55779749|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55779750|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55779751|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779752|NCT00416351|Clofarabine|clofarabine|mesh-list
55779753|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55779754|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
55779755|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779756|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001511|NCT02338232|Telmisartan|telmisartan|mesh-list
56001512|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56001513|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56001514|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56001515|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001516|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
56001517|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56001518|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56001519|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001520|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
56001521|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001522|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001523|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55758217|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001524|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56001525|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
56001526|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001527|NCT00000868|Antacids|antacids|mesh-ancestor
55779757|NCT03938831|Fentanyl|fentanyl|mesh-list
55779758|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
55779759|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55779760|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779761|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779762|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55779763|NCT03938831|Analgesics|analgesics|mesh-ancestor
55779764|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
55779765|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779766|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55779767|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55779768|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55779769|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
55779770|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779771|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779772|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55779774|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55779775|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55779776|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
55779777|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
55779778|NCT02592707|Dexamethasone|dexamethasone|mesh-list
55779779|NCT02592707|Ondansetron|ondansetron|mesh-list
55779780|NCT02592707|Antiemetics|antiemetics|mesh-list
56001528|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001529|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56001530|NCT02628626|Clonidine|clonidine|mesh-list
56001531|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56001532|NCT02628626|Analgesics|analgesics|mesh-ancestor
56001533|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
56001534|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001535|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001536|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56001537|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
56001538|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
56001539|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55744375|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758218|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55779781|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
55779782|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779783|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
55779784|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779785|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779789|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783510|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
56001540|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56001541|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56001542|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
56001543|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001544|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001545|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56001546|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56001547|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
56001548|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56001549|NCT05586464|Bismuth|bismuth|mesh-list
56001550|NCT05586464|Antacids|antacids|mesh-ancestor
56001551|NCT05586464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001552|NCT05586464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56001553|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
56001554|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56001555|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001556|NCT02627846|Lidocaine|lidocaine|mesh-list
56001557|NCT02627846|Epinephrine|epinephrine|mesh-list
56001558|NCT02627846|Racepinephrine|racepinephrine|mesh-list
56001559|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56001560|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
56001561|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
56001562|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
56001563|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
56001564|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001565|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001566|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
56001567|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001568|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55728827|NCT03967288|Procaine|procaine|mesh-list
55779790|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779791|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779792|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779793|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
55779794|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
55779795|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55779796|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
55779797|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779798|NCT02592707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55779799|NCT02592707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56001569|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56001570|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56001571|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56001572|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001573|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56001575|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
56001576|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001577|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56001578|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56001579|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
56001580|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56001581|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
56001582|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
56145807|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145808|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145810|NCT00973752|Prednisone|prednisone|mesh-list
56145811|NCT00973752|Doxorubicin|doxorubicin|mesh-list
56145812|NCT00973752|Methotrexate|methotrexate|mesh-list
56145813|NCT00973752|Vincristine|vincristine|mesh-list
56145814|NCT00973752|Asparaginase|asparaginase|mesh-list
56145815|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
56145816|NCT00973752|Clofarabine|clofarabine|mesh-list
56145817|NCT00973752|Pegaspargase|pegaspargase|mesh-list
56145818|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56145819|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145820|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56145821|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56145822|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145823|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145824|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742416|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145825|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
56145826|NCT00973752|Hormones|hormones|mesh-ancestor
56145827|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145828|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145829|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56145830|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56145831|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
56145832|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56145833|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56145834|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
56145835|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145836|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56145837|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145838|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
56145839|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145840|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56145841|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
56145842|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752146|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
55779800|NCT02592707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779801|NCT02592707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55779802|NCT02592707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55779803|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
55779804|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
55779805|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
55779806|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
55779807|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779808|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55779809|NCT03104855|Calcifediol|calcifediol|mesh-list
55779811|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
55779812|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779813|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55779814|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
55779815|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55779816|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779817|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
55779818|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55779819|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779820|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779821|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55779822|NCT03102359|Analgesics|analgesics|mesh-ancestor
55779823|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
55779824|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779825|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56001583|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
56001584|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56001585|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56001586|NCT02608268|Decitabine|decitabine|mesh-list
56001587|NCT02608268|Spartalizumab|spartalizumab|mesh-list
56001588|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55779826|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55779828|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
55779829|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779830|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779831|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
55779832|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55779833|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
55779834|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55779835|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779836|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55779837|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55779838|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55779839|NCT03832049|Vaccines|vaccines|mesh-list
55779840|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
56001589|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
56001590|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001591|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001592|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001593|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55779841|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779843|NCT02102477|Hormones|hormones|mesh-ancestor
55779844|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779846|NCT03103685|Clopidogrel|clopidogrel|mesh-list
55779847|NCT03103685|Ticagrelor|ticagrelor|mesh-list
55779848|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55779849|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55779850|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55779851|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55779852|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55779853|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
55779854|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779855|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779856|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779864|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56216621|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216622|NCT01626469|Captopril|captopril|mesh-list
56216623|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56216624|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
55779866|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55779867|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55779868|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779869|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779870|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
55758265|NCT03241043|Tacrolimus|tacrolimus|mesh-list
55779871|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779872|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
55779873|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779874|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55779875|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55779876|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
55779877|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
55779878|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
55779879|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
55779880|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
55779881|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55779882|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
55779883|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779884|NCT05103215|Lidocaine|lidocaine|mesh-list
55779885|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
55779886|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
55779887|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779888|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779889|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
55779890|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779891|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56001606|NCT00000880|Cyclosporine|cyclosporine|mesh-list
56001607|NCT00000880|Cyclosporins|cyclosporins|mesh-list
56001608|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001609|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001610|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001611|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
56001612|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001613|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
56001614|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001615|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
56001616|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56001617|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56001618|NCT02308280|Bortezomib|bortezomib|mesh-list
56001619|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001620|NCT02795156|Afatinib|afatinib|mesh-list
56001621|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001622|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55779892|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55779893|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55779894|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55779895|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779897|NCT05033483|Trace Elements|trace elements|mesh-ancestor
55779898|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
55779899|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779900|NCT05001815|Insulin|insulin|mesh-list
55779901|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55779902|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55779903|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779904|NCT02644967|Ipilimumab|ipilimumab|mesh-list
55779905|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55779906|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779907|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55779908|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001645|NCT02780024|Metformin|metformin|mesh-list
56001646|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56001647|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001648|NCT02268656|Propofol|propofol|mesh-list
56001649|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56001650|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001651|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001652|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56001653|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
56001654|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
56001655|NCT02564978|Minocycline|minocycline|mesh-list
56001656|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56001657|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001658|NCT02554890|Valsartan|valsartan|mesh-list
56001659|NCT02554890|Enalapril|enalapril|mesh-list
56001660|NCT02554890|Enalaprilat|enalaprilat|mesh-list
56001661|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56001662|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56001663|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56001664|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56001665|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001666|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56001667|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
56001668|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738321|NCT03413371|Analgesics|analgesics|mesh-ancestor
55779909|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
55779910|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55779911|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779912|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779913|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55779914|NCT04771637|Analgesics|analgesics|mesh-ancestor
55779915|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
55779916|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001670|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56001671|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55779917|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55779918|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55779929|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
55779930|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783514|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783515|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779932|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55779933|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55779934|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55779935|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779936|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
55779938|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001672|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56001673|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
56001674|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001675|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001676|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56001677|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
56001678|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
56001679|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
55738347|NCT03677115|Analgesics|analgesics|mesh-ancestor
56216625|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216626|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779939|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779940|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779941|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
55779942|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779943|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779944|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55779945|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55779946|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779947|NCT04552847|Octreotide|octreotide|mesh-list
55779948|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
55779949|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779950|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55779951|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779952|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55779953|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779954|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
55779955|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55779956|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
55779957|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
55779958|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001680|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56001681|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56001682|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
56001683|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001684|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001685|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
56001686|NCT02232152|Fluorouracil|fluorouracil|mesh-list
56001687|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
56001688|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001689|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56001690|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001691|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001692|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
56001693|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001694|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
56001696|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
56001697|NCT02232152|Vitamins|vitamins|mesh-ancestor
56001698|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
56001699|NCT02229656|Olaparib|olaparib|mesh-list
56146130|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
56146131|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146132|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55859715|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
55859716|NCT00588406|Hormones|hormones|mesh-ancestor
56146133|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146134|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
56146135|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146136|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146137|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56146138|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56146140|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56146141|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56146142|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55779959|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779960|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55779961|NCT05167331|Analgesics|analgesics|mesh-ancestor
55779962|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
55779963|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779964|NCT04509401|Vitamins|vitamins|mesh-list
55779965|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
55779966|NCT04509401|Pyridoxal|pyridoxal|mesh-list
55779967|NCT04509401|Pyridoxine|pyridoxine|mesh-list
55779968|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
55779970|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001700|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56001701|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001702|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001703|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779971|NCT05155007|Cyclosporine|cyclosporine|mesh-list
55779972|NCT05155007|Cyclosporins|cyclosporins|mesh-list
55779973|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779974|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779975|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779976|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
55779977|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779978|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
55779979|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001704|NCT00001870|Acetylcholine|acetylcholine|mesh-list
56001705|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
56001706|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56001707|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
56001708|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001709|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001710|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001711|NCT03252600|Dexamethasone|dexamethasone|mesh-list
56001712|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
56001713|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
56001714|NCT03252600|Lenalidomide|lenalidomide|mesh-list
56001715|NCT03252600|Elotuzumab|elotuzumab|mesh-list
56001716|NCT03252600|Ichthammol|ichthammol|mesh-list
56001717|NCT03252600|BB 1101|bb 1101|mesh-list
55758383|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
56001718|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001719|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
56001720|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001721|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56001722|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56001723|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
55744376|NCT02491723|Azithromycin|azithromycin|mesh-list
55779980|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
55779989|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779990|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55779991|NCT03101423|Analgesics|analgesics|mesh-ancestor
55779992|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
55779993|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779994|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779995|NCT05073029|Vitamin D|vitamin d|mesh-list
55779996|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
55779997|NCT05073029|Vitamins|vitamins|mesh-ancestor
55779998|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
55779999|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783516|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55783517|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
55783518|NCT02334475|Hormones|hormones|mesh-ancestor
55780000|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55805158|NCT03879109|Folfirinox|folfirinox|mesh-list
55780001|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55780002|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55780003|NCT04268849|Hematinics|hematinics|mesh-ancestor
55780004|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55780005|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55780006|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
55780008|NCT02642159|Niacinamide|niacinamide|mesh-list
55780009|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55780010|NCT02642159|Ezetimibe|ezetimibe|mesh-list
55780011|NCT02642159|Fenofibrate|fenofibrate|mesh-list
55780012|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55780013|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780014|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
55780015|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780016|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780017|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
55780018|NCT02642159|Vitamins|vitamins|mesh-ancestor
55780019|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
55780020|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780021|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
55780022|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
55758407|NCT03237533|Ionophores|ionophores|mesh-ancestor
56146143|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146144|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
56146145|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56146146|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56146147|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56146148|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56146149|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
56146150|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56146151|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
56146152|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146153|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
56146154|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
56146155|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
56146156|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56146158|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55853510|NCT00149734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56146159|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146160|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
56146161|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146162|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146163|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
56146164|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146165|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56146167|NCT01011816|Coagulants|coagulants|mesh-ancestor
56146168|NCT01011894|Lenalidomide|lenalidomide|mesh-list
56146169|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
55859882|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146170|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146171|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56146172|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56146173|NCT01011894|Growth Substances|growth substances|mesh-ancestor
56146174|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
56146175|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146176|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56146178|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
56146179|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146180|NCT01015170|Bupropion|bupropion|mesh-list
56146181|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56146182|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
55853622|NCT01608308|Analgesics|analgesics|mesh-ancestor
56146185|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56146186|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56146187|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146188|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
55859994|NCT01799356|Metronidazole|metronidazole|mesh-list
55859996|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55860001|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146189|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780023|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55780024|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55780025|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780026|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
55780027|NCT05072873|Coagulants|coagulants|mesh-ancestor
55780028|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55780029|NCT05072405|Simvastatin|simvastatin|mesh-list
55780030|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55780031|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780032|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
55780033|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780034|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780035|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55780036|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780043|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55780044|NCT03101579|Folic Acid|folic acid|mesh-list
55780045|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
55780046|NCT03101579|Dexamethasone|dexamethasone|mesh-list
55780055|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55780056|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
55780057|NCT03101579|Hormones|hormones|mesh-ancestor
55780058|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001724|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001725|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001726|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56001727|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758429|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738434|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55780059|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55780060|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780061|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780062|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780063|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55780064|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55780065|NCT03101579|Hematinics|hematinics|mesh-ancestor
55780066|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
55780067|NCT05071781|Hormones|hormones|mesh-list
55780068|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55784108|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001729|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
56001730|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001731|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56001732|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
56124621|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124622|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56124623|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56124624|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56124625|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56124626|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55780069|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783519|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783521|NCT02334475|Protective Agents|protective agents|mesh-ancestor
55780070|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780071|NCT03882905|Ezetimibe|ezetimibe|mesh-list
55780072|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55780073|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780074|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
55780075|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780076|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780077|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
55780078|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55780079|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780080|NCT04479865|Donepezil|donepezil|mesh-list
55780081|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55780082|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780083|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780084|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
55780085|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780086|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780087|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
55780088|NCT03491059|Nicotine|nicotine|mesh-list
56124627|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56124629|NCT04044222|Etoposide|etoposide|mesh-list
56124630|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
56124632|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
56124634|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56124635|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56124636|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56124637|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124638|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124639|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55780089|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55780090|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
55780092|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780093|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55780094|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55780095|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
55780096|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216628|NCT01626534|Clopidogrel|clopidogrel|mesh-list
55780097|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780099|NCT02668393|Nintedanib|nintedanib|mesh-list
55780100|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780101|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
56124640|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
56124642|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
56001734|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001735|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56001736|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56001737|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56001738|NCT03252600|Growth Substances|growth substances|mesh-ancestor
56001739|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
56001740|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
56001741|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001742|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
55780102|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
55780103|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
55780104|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780105|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780106|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780107|NCT05251129|Atorvastatin|atorvastatin|mesh-list
55780108|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55780109|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780110|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
55780111|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780112|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780113|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55780147|NCT01226563|Calcium|calcium|mesh-list
55780148|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55780149|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780150|NCT02382757|Insulin|insulin|mesh-list
55780152|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55780153|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780155|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
55780156|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780157|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
55780158|NCT00916747|Pravastatin|pravastatin|mesh-list
55780159|NCT00916747|Lonafarnib|lonafarnib|mesh-list
55780160|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55780161|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780162|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55780163|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780164|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
56001744|NCT02749526|Endostar protein|endostar protein|mesh-list
56001745|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001746|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56001747|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
55780165|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780166|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780167|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55780168|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780169|NCT02391883|Clopidogrel|clopidogrel|mesh-list
55780170|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55780171|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55780172|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55780173|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55780174|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
56001748|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001749|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56001750|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56001752|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001753|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
56001754|NCT00000916|Lamivudine|lamivudine|mesh-list
56001755|NCT00000916|Zidovudine|zidovudine|mesh-list
56001756|NCT00000916|Didanosine|didanosine|mesh-list
56001757|NCT00000916|Stavudine|stavudine|mesh-list
56001758|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56001759|NCT00000916|Indinavir|indinavir|mesh-list
56001760|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
55738529|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780175|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780176|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780177|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780178|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55780180|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780181|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780182|NCT02391805|Tenofovir|tenofovir|mesh-list
55780183|NCT02391805|Entecavir|entecavir|mesh-list
55780184|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
55780185|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780186|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55780187|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55780188|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780189|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780190|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55780191|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55780192|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55780193|NCT02391181|Hematinics|hematinics|mesh-ancestor
55780194|NCT02381899|Rituximab|rituximab|mesh-list
55780195|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55780196|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56001761|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55780199|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780200|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55780201|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55780202|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
56216629|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56216630|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55780203|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780204|NCT01998958|Esketamine|esketamine|mesh-list
55780205|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
55783524|NCT02334631|Simethicone|simethicone|mesh-list
55780206|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55780207|NCT02386111|Sunitinib|sunitinib|mesh-list
55780208|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780209|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55780210|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55780211|NCT02386111|Growth Substances|growth substances|mesh-ancestor
56001762|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001763|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001764|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780212|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780213|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
55780214|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780215|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780216|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780217|NCT02386033|Atorvastatin|atorvastatin|mesh-list
55780218|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55780219|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780220|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
55780221|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780229|NCT02381275|Tenofovir|tenofovir|mesh-list
56001766|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001767|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001768|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001769|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
56001770|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001771|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
56001772|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56001773|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56001774|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
56001775|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56001776|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56001777|NCT02744612|Antibodies|antibodies|mesh-list
56001778|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
55780230|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
55780231|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780232|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55780233|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55780234|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780235|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780236|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55780237|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55780240|NCT04743505|Osimertinib|osimertinib|mesh-list
55780241|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780242|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780243|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784109|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
56001779|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56001780|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
56001781|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
55780244|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780245|NCT04693507|Antarelix|antarelix|mesh-list
55780246|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
55780247|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780248|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780249|NCT03105661|Atenolol|atenolol|mesh-list
55780250|NCT03105661|Labetalol|labetalol|mesh-list
55780251|NCT03105661|Nifedipine|nifedipine|mesh-list
55780252|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55780253|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55780254|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780255|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55780256|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780257|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
55780258|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
55780259|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55780260|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55780261|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55780262|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
55780263|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
55780264|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780265|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55780266|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55780267|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55780268|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
55780269|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780270|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
55780271|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55780272|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55780273|NCT05482789|Exenatide|exenatide|mesh-list
55780274|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55780275|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216631|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56216632|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56216633|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
56216634|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780276|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55783525|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
55780278|NCT05482789|Hormones|hormones|mesh-ancestor
55780279|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780287|NCT01998880|Rituximab|rituximab|mesh-list
55780288|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
55780289|NCT01998880|Chlorambucil|chlorambucil|mesh-list
55780293|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780294|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56001782|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001783|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001784|NCT02548364|Vitamin D|vitamin d|mesh-list
56001785|NCT02548364|Calcifediol|calcifediol|mesh-list
56001786|NCT02548364|Vitamins|vitamins|mesh-ancestor
56001787|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
56001788|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146255|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
56146257|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56146258|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56146259|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146260|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55860644|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
55860664|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146264|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56146265|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742422|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56146266|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56146267|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742423|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55742424|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
55742425|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55780295|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55780296|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
55780297|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780298|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55780299|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55780300|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780301|NCT02380417|Ropivacaine|ropivacaine|mesh-list
55780302|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
55780303|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
55780304|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780306|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
55780307|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780308|NCT02390089|Capsaicin|capsaicin|mesh-list
55780309|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
55780310|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
55780311|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
55780312|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780313|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780314|NCT02379793|Mineral Oil|mineral oil|mesh-list
55780315|NCT02379793|Emollients|emollients|mesh-ancestor
55780316|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
55780317|NCT01975246|Amlodipine|amlodipine|mesh-list
56001789|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56001790|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56001791|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001792|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
55729042|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
56001793|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56001794|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001795|NCT00000160|Xenon|xenon|mesh-list
56001796|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56001797|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
56001798|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
56001799|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001800|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001801|NCT00000178|Prednisone|prednisone|mesh-list
56001802|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56001803|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
56001804|NCT00000178|Hormones|hormones|mesh-ancestor
56001805|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56001806|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001807|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56001808|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001810|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55758511|NCT04922151|Growth Substances|growth substances|mesh-ancestor
55780318|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55780319|NCT01975246|Telmisartan|telmisartan|mesh-list
55780320|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
55780321|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55780322|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55780323|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55780324|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780325|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55780326|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780328|NCT01975246|Diuretics|diuretics|mesh-ancestor
55780329|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
55780330|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55780331|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55780332|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55780333|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56001811|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
56001812|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001813|NCT05480280|Leucovorin|leucovorin|mesh-list
56001814|NCT05480280|Fluorouracil|fluorouracil|mesh-list
56001815|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
56001816|NCT05480280|Calcium|calcium|mesh-list
56001817|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
56001818|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56001819|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001820|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
56001821|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001822|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56001823|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001824|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001825|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
56001826|NCT05480280|Antidotes|antidotes|mesh-ancestor
56001827|NCT05480280|Protective Agents|protective agents|mesh-ancestor
56001828|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
56001829|NCT05480280|Vitamins|vitamins|mesh-ancestor
56001830|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
56001831|NCT00001906|Interleukin-12|interleukin-12|mesh-list
55860696|NCT02990884|Ketamine|ketamine|mesh-list
55860697|NCT02990884|Analgesics|analgesics|mesh-ancestor
55860698|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
55742426|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55742427|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55742428|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742429|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55742430|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
55742431|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742432|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55742433|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55742434|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55742435|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742436|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55742438|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55742439|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
55742440|NCT02889237|Vitamin D|vitamin d|mesh-list
55742441|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
55780334|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55780335|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780336|NCT02379715|Remifentanil|remifentanil|mesh-list
55780337|NCT02379715|Desflurane|desflurane|mesh-list
55780338|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55780339|NCT02379715|Narcotics|narcotics|mesh-ancestor
55780340|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780341|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780342|NCT02379715|Analgesics|analgesics|mesh-ancestor
55780343|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
55780344|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780345|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55780346|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
56216635|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216638|NCT01626560|Daptomycin|daptomycin|mesh-list
56216639|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56216640|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780347|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
56001832|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56001833|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56001834|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
56001835|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001836|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56001837|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56001838|NCT00001906|Growth Substances|growth substances|mesh-ancestor
56001839|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
56001840|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001841|NCT00001906|Antacids|antacids|mesh-ancestor
56124643|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124644|NCT01429584|Bupivacaine|bupivacaine|mesh-list
56124645|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
56001842|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001843|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758527|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55780348|NCT04439773|Lidocaine|lidocaine|mesh-list
55780349|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
55780350|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
55783526|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780351|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780352|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780353|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
55780354|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780355|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55780356|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55780357|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55780358|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55780359|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780365|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780366|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780367|NCT02383927|Tipifarnib|tipifarnib|mesh-list
55780368|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780369|NCT02383771|Aspirin|aspirin|mesh-list
55780370|NCT02383771|Ticagrelor|ticagrelor|mesh-list
55780371|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56001845|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56001847|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001848|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
56124646|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
56001849|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001850|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
56001851|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56001852|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
56001853|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001854|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56001855|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001856|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
55738715|NCT04448015|Analgesics|analgesics|mesh-ancestor
55780372|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55780374|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
55780375|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780376|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780377|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780378|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55780379|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55780380|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55780381|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780382|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55780383|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55780384|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780385|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
55780386|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55780387|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55780388|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55780389|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
55780390|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780392|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56001857|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001858|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
56001859|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56001860|NCT00000946|Protective Agents|protective agents|mesh-ancestor
56001861|NCT02543346|Cetirizine|cetirizine|mesh-list
56001862|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56001863|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56001864|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56001865|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
56001866|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
56001867|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001868|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001869|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001870|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56001871|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
55729116|NCT04542993|Protective Agents|protective agents|mesh-ancestor
55780393|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
55780394|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55780395|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
55780396|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780397|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780398|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
55780399|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
55780400|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55780401|NCT02372149|Antibodies|antibodies|mesh-list
55780402|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
55780403|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55780404|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
55780405|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780406|NCT02661061|Midazolam|midazolam|mesh-list
55780407|NCT02661061|Ketamine|ketamine|mesh-list
55780408|NCT02661061|Analgesics|analgesics|mesh-ancestor
55780409|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
55780410|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780411|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780412|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55780413|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55780414|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
56216641|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
56216642|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56216643|NCT01626651|Ketoconazole|ketoconazole|mesh-list
56216644|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
55780415|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
55780416|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001872|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56001873|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
56001874|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001875|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
56001876|NCT04390100|Protective Agents|protective agents|mesh-ancestor
56001879|NCT00000202|Buprenorphine|buprenorphine|mesh-list
56001880|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56001881|NCT00000202|Narcotics|narcotics|mesh-ancestor
56001882|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001883|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001884|NCT00000202|Analgesics|analgesics|mesh-ancestor
56001885|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
56001886|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001888|NCT00000208|Buprenorphine|buprenorphine|mesh-list
56001889|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56001890|NCT00000208|Narcotics|narcotics|mesh-ancestor
56001891|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001892|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738747|NCT05228925|Vitamin D|vitamin d|mesh-list
55780417|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55780418|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55780419|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780420|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780421|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55783527|NCT02334631|Emollients|emollients|mesh-ancestor
55783528|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
55780422|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55780423|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56001894|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
56001895|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001896|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56001898|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56001899|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56001901|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001902|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
56001903|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001904|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001905|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001906|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56001907|NCT00001930|Analgesics|analgesics|mesh-ancestor
55780424|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55780425|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55780426|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
55780427|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
55780428|NCT02376985|Everolimus|everolimus|mesh-list
55780429|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780430|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55780431|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
55780432|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780436|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
55780437|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780438|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55780439|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780440|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
55780441|NCT02371603|Pioglitazone|pioglitazone|mesh-list
55780442|NCT02371603|Trimethoprim|trimethoprim|mesh-list
55780444|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55780445|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780446|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
55780447|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780448|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780449|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56001908|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
56001909|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001910|NCT00000964|Foscarnet|foscarnet|mesh-list
56001911|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56001912|NCT00000964|Ranitidine|ranitidine|mesh-list
56001913|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56001914|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56001915|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56001916|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56001917|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
56001918|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
56001919|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001920|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001921|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001923|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001924|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001925|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001926|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001927|NCT00000976|Zidovudine|zidovudine|mesh-list
56001928|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
56001929|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
56124647|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56124648|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001930|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001931|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55780450|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780451|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55780452|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780453|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55780454|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780455|NCT02371603|Renal Agents|renal agents|mesh-ancestor
55780456|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
55780457|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55780458|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55780459|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56001934|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
55780460|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55780461|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55780462|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55780463|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
55780464|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55780465|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780466|NCT04175431|Prednisone|prednisone|mesh-list
55780467|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
55780468|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780469|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
55780470|NCT04175431|Hormones|hormones|mesh-ancestor
56001935|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001936|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001937|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001938|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
56001939|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001940|NCT00000226|Buprenorphine|buprenorphine|mesh-list
56001941|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56001942|NCT00000226|Narcotics|narcotics|mesh-ancestor
56001943|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001944|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001946|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
56001947|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001948|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56001949|NCT00000982|Zidovudine|zidovudine|mesh-list
56001950|NCT00000982|Didanosine|didanosine|mesh-list
56001951|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
56001952|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001953|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001954|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55742442|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
55742444|NCT02889237|Calcium|calcium|mesh-list
55742445|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
55742446|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742447|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55742448|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55742450|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742451|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55742452|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55742453|NCT02689167|Growth Substances|growth substances|mesh-ancestor
55742454|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742456|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55742457|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742458|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742462|NCT02582697|Bleomycin|bleomycin|mesh-list
55742463|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742464|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55742465|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55742466|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55742467|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742468|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742469|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55742470|NCT01503489|Norepinephrine|norepinephrine|mesh-list
55742471|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
55860903|NCT02992912|Antibodies|antibodies|mesh-list
55780471|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780472|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780473|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55780474|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780475|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55780476|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780477|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780478|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
55780479|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55780480|NCT04149145|Niraparib|niraparib|mesh-list
55780481|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55780482|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780483|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216645|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216646|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56216647|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55780484|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780486|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780487|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
55780488|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
55780489|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
55780490|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780491|NCT02376595|Bromides|bromides|mesh-list
55780493|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
55780494|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55780495|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55780496|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55780497|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780498|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780499|NCT02370745|Insulin|insulin|mesh-list
55780500|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56001956|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
56001957|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001958|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56001959|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001960|NCT02549196|Donepezil|donepezil|mesh-list
56001961|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
56001962|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56001963|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001964|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001965|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
56001966|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001967|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001969|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56001970|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55758634|NCT04924647|Hormones|hormones|mesh-ancestor
56001971|NCT02549196|Urological Agents|urological agents|mesh-ancestor
56124649|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
55780501|NCT02370745|Incretins|incretins|mesh-list
55780502|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55780503|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780504|NCT02370745|Hormones|hormones|mesh-ancestor
55780505|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780513|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55780514|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780515|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
55780516|NCT02376049|Hormones|hormones|mesh-ancestor
56124650|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124652|NCT01405950|Tizanidine|tizanidine|mesh-list
55780517|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780518|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780519|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55780520|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
55780521|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55780522|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55780523|NCT02376049|Analgesics|analgesics|mesh-ancestor
55780524|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
55780525|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780526|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55780527|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
55780528|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55780529|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
55780530|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55780531|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780532|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780533|NCT02376205|Bupivacaine|bupivacaine|mesh-list
55738873|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780534|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55780535|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
55780536|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
55780537|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780538|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780539|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
55780540|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780541|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
55780542|NCT02370433|Neostigmine|neostigmine|mesh-list
55780543|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55780544|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780545|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780546|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
56124653|NCT01405950|Analgesics|analgesics|mesh-ancestor
56001974|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001975|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56001976|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56001977|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001978|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
56001979|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001981|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56001982|NCT00000232|Buprenorphine|buprenorphine|mesh-list
56001983|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56001984|NCT00000232|Narcotics|narcotics|mesh-ancestor
56001985|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001986|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001987|NCT00000232|Analgesics|analgesics|mesh-ancestor
56001988|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
56001989|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001990|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56001991|NCT00000238|Buprenorphine|buprenorphine|mesh-list
56001993|NCT00000238|Narcotics|narcotics|mesh-ancestor
55738893|NCT03411941|Growth Substances|growth substances|mesh-ancestor
55780547|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780548|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780549|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55780550|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
55780551|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780552|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55780553|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55780554|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55780555|NCT01957150|Fluticasone|fluticasone|mesh-list
55780556|NCT01957150|Xhance|xhance|mesh-list
55780557|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780558|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56216648|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216649|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216650|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56216651|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
56216652|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780559|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
55780560|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001994|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56001995|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001996|NCT00000238|Analgesics|analgesics|mesh-ancestor
56001997|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
56001998|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56001999|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56002000|NCT00000244|Dynorphins|dynorphins|mesh-list
56002001|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002002|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002003|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002004|NCT00000994|Zidovudine|zidovudine|mesh-list
56002005|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
56002006|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002007|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002008|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002009|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002010|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
55780561|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780562|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55780563|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
55780564|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
55780565|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55783530|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55783534|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
55783535|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783536|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56002011|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002012|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002013|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56002014|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
56002015|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56002016|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
56002017|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002018|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002019|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56002020|NCT00001006|Protective Agents|protective agents|mesh-ancestor
56002021|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002022|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002023|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002024|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002025|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
56002026|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002028|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56002030|NCT00001954|Analgesics|analgesics|mesh-ancestor
56002031|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
56002032|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002033|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002034|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002035|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55783537|NCT02334163|Metronidazole|metronidazole|mesh-list
55783538|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
55783539|NCT02334163|Lactulose|lactulose|mesh-list
55783540|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783542|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55780567|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55780568|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780569|NCT01973218|Vaccines|vaccines|mesh-list
55780570|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
56002036|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56002037|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56002038|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
56002039|NCT02904954|Durvalumab|durvalumab|mesh-list
56002040|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56002041|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55780571|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780572|NCT01946152|Dexamethasone|dexamethasone|mesh-list
55780573|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
55780574|NCT01946152|Pomalidomide|pomalidomide|mesh-list
55780575|NCT01946152|Ichthammol|ichthammol|mesh-list
55780576|NCT01946152|Lenograstim|lenograstim|mesh-list
55780577|NCT01946152|BB 1101|bb 1101|mesh-list
55780578|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780579|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
55744378|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002042|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002043|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
56002044|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002045|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
56002046|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56002047|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
56002048|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
56002049|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002050|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002051|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56002052|NCT00000250|Analgesics|analgesics|mesh-ancestor
56002053|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
56002054|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002055|NCT03244020|Aspirin|aspirin|mesh-list
56002056|NCT03244020|Enoxaparin|enoxaparin|mesh-list
56002057|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55738944|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
55780580|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
55780581|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780582|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780583|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55780584|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
55780585|NCT01946152|Hormones|hormones|mesh-ancestor
55780586|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780588|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780589|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55780590|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
55780591|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
55780592|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780593|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780594|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55780595|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55780596|NCT01946152|Growth Substances|growth substances|mesh-ancestor
55780597|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
55780598|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
55780599|NCT01971346|Etanercept|etanercept|mesh-list
55780600|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55780601|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55780602|NCT01971346|Analgesics|analgesics|mesh-ancestor
55780603|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
55780604|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780605|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780606|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002058|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56002059|NCT03244020|Analgesics|analgesics|mesh-ancestor
56002060|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
56002061|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002062|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002063|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002064|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56002065|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56002066|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56002067|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002068|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56002069|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56002070|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002071|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
56002072|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
56002074|NCT00000262|Sevoflurane|sevoflurane|mesh-list
56002075|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56002076|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56002077|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
56002078|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
56002079|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780607|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55780608|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55780609|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55780610|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
55780612|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55780613|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780614|NCT01945216|Incretins|incretins|mesh-ancestor
55780615|NCT01945216|Hormones|hormones|mesh-ancestor
56216653|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216654|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56002085|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56002086|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
56002087|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758751|NCT02157376|Cimetidine|cimetidine|mesh-list
56002088|NCT02891538|Protective Agents|protective agents|mesh-ancestor
56002089|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002090|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56002091|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56002092|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002093|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56002094|NCT00001024|Zidovudine|zidovudine|mesh-list
56002095|NCT00001024|Didanosine|didanosine|mesh-list
56002096|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
56002097|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002098|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002099|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002100|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002101|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
56002102|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216656|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55780616|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780617|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55780618|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
55783543|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55783544|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55780619|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784110|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002103|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002104|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55758767|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
55738990|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
55780620|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780621|NCT02641379|Ribavirin|ribavirin|mesh-list
55780622|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55780623|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
55780624|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780625|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
55780626|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780627|NCT02660983|Donepezil|donepezil|mesh-list
55780628|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55780629|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780630|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780631|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
55780632|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780633|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780634|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
55780635|NCT05070221|Axitinib|axitinib|mesh-list
55780636|NCT05070221|Antibodies|antibodies|mesh-list
55780637|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55780638|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
55780641|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780642|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780643|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780644|NCT04404439|Topiramate|topiramate|mesh-list
55780645|NCT04404439|Verapamil|verapamil|mesh-list
55780646|NCT04404439|Paroxetine|paroxetine|mesh-list
55780647|NCT04404439|Nortriptyline|nortriptyline|mesh-list
55780648|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
55780649|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55780650|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780651|NCT04404439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55780652|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55780653|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55780654|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780655|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780656|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
55780657|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55780658|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
55780659|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56002105|NCT00000268|Bupropion|bupropion|mesh-list
55739007|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55780660|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55780661|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55780662|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780663|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55780664|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55780665|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55780666|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
55780667|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55780668|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55780669|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
55780670|NCT01953328|Atorvastatin|atorvastatin|mesh-list
55780672|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55780673|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55780674|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780675|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
55780676|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780677|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780678|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55780679|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780680|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
55780681|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780682|NCT03100955|Cisplatin|cisplatin|mesh-list
56216658|NCT01626911|Dalteparin|dalteparin|mesh-list
56216659|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
56216660|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56216661|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56216662|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780683|NCT03100955|Etoposide|etoposide|mesh-list
55780684|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
55780685|NCT03100955|Apatinib|apatinib|mesh-list
55780686|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002106|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56002107|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
55780687|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55780688|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55783545|NCT02332057|Diclofenac|diclofenac|mesh-list
55783546|NCT02332057|Lidocaine|lidocaine|mesh-list
55780689|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55780690|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780691|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780692|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780693|NCT02377609|Tacrolimus|tacrolimus|mesh-list
55780694|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55780695|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
56002108|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56002109|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56002110|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56002111|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002112|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002113|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
56002114|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002115|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860904|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
55860905|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860906|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742472|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
55742474|NCT01503489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55742475|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55742476|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55742477|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
55742480|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860932|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55742481|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
55742482|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
55742483|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742484|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55742485|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55742486|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55742487|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
55742488|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55742489|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55742490|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55742491|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55861067|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
55861068|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55742492|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742493|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742494|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55742495|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55861186|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742496|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742497|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
55742498|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742499|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
55742500|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55742502|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55742503|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742505|NCT05185167|Anesthetics|anesthetics|mesh-list
55742506|NCT05185167|Desflurane|desflurane|mesh-list
55742507|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
55742508|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55742509|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742510|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742511|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55742512|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55780696|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780697|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55780698|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780699|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780701|NCT02369965|Lopinavir|lopinavir|mesh-list
55780702|NCT02369965|Tenofovir|tenofovir|mesh-list
55780703|NCT02369965|Lamivudine|lamivudine|mesh-list
55780704|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55780705|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55780706|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
55780707|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780708|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780709|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55780710|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55780737|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
55744380|NCT03332719|Methotrexate|methotrexate|mesh-list
56002116|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56002117|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56002118|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002119|NCT02847624|Tolvaptan|tolvaptan|mesh-list
56002120|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56002121|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002122|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
55715642|NCT03705559|Analgesics|analgesics|mesh-ancestor
56002123|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739075|NCT03612921|Amantadine|amantadine|mesh-list
55739076|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55739077|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55739088|NCT03393481|Enoxaparin|enoxaparin|mesh-list
55742513|NCT05133453|Pirfenidone|pirfenidone|mesh-list
55742514|NCT05133453|Analgesics|analgesics|mesh-ancestor
55742515|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
55742516|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742520|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742521|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55742522|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742523|NCT05125185|Insulin|insulin|mesh-list
55742524|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55742525|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742526|NCT04244877|Rifaximin|rifaximin|mesh-list
55742527|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55742528|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742529|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742532|NCT05128617|Epirubicin|epirubicin|mesh-list
55742533|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55742534|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742535|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
55861392|NCT00724594|Antidotes|antidotes|mesh-ancestor
55742536|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
55742537|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
55742538|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742539|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55742540|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
55742541|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742542|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55742543|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55742544|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
55742545|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55742546|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55861462|NCT04141995|Protective Agents|protective agents|mesh-ancestor
55861464|NCT04141995|Vitamins|vitamins|mesh-ancestor
55780738|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55780739|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780740|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55780741|NCT02375503|Vitamin D|vitamin d|mesh-list
55780742|NCT02375503|Calcium|calcium|mesh-list
55780743|NCT02375503|Vitamins|vitamins|mesh-ancestor
55780744|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
55780745|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780746|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55780747|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55780749|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55780750|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
56002125|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
56002126|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
56002127|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56002128|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
56002129|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002130|NCT00001042|Antacids|antacids|mesh-ancestor
56002131|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002132|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56002133|NCT00982865|Niacinamide|niacinamide|mesh-list
56002134|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
56002135|NCT00982865|Vitamins|vitamins|mesh-ancestor
56002136|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
56002137|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715738|NCT02363127|Hormones|hormones|mesh-ancestor
56002138|NCT00001054|Valacyclovir|valacyclovir|mesh-list
56002139|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
56002140|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002141|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
55739093|NCT01936857|Buprenorphine|buprenorphine|mesh-list
55780751|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780752|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780753|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780754|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55780759|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780760|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
55783547|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
55783549|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783550|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783551|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
55783552|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783553|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55783554|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56002142|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56002143|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002144|NCT01226719|Leucovorin|leucovorin|mesh-list
56002145|NCT01226719|Fluorouracil|fluorouracil|mesh-list
56002146|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
56002147|NCT01226719|Irinotecan|irinotecan|mesh-list
56002148|NCT01226719|Panitumumab|panitumumab|mesh-list
56002149|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
56002150|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716004|NCT02358993|Renal Agents|renal agents|mesh-ancestor
55716060|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716140|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
55716214|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
55716428|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55716506|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
56002151|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55716652|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55716800|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55716875|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
55716952|NCT02347839|Gefitinib|gefitinib|mesh-list
55717026|NCT03146481|Aceclofenac|aceclofenac|mesh-list
55783555|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55783556|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55783557|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783558|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55783559|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55783560|NCT02332057|Analgesics|analgesics|mesh-ancestor
55783561|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56216664|NCT01627041|Decitabine|decitabine|mesh-list
56216665|NCT01627041|Daunorubicin|daunorubicin|mesh-list
55783562|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55783563|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55783564|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780761|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55780762|NCT02299141|Nintedanib|nintedanib|mesh-list
55780763|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780764|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780765|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780766|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780767|NCT02643251|Clonidine|clonidine|mesh-list
55780768|NCT02643251|Analgesics|analgesics|mesh-ancestor
56002152|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002153|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56002154|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
56002155|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002156|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56002157|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56002158|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002160|NCT01226719|Protective Agents|protective agents|mesh-ancestor
56002161|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
56002162|NCT01226719|Vitamins|vitamins|mesh-ancestor
56002163|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
56002164|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56002165|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
56002166|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56002167|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
56002168|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717387|NCT02233205|Gemcitabine|gemcitabine|mesh-list
56002169|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55717763|NCT02342067|Pioglitazone|pioglitazone|mesh-list
55717842|NCT05230797|Zinc|zinc|mesh-list
56002170|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002171|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
55739117|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55780769|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
55780770|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780771|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780772|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55780773|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
55780774|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
55780775|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55780776|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55780777|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55780778|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
55780779|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002172|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002173|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
55718521|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55718607|NCT02304289|Artesunate|artesunate|mesh-list
55718743|NCT03508999|Metronidazole|metronidazole|mesh-list
55718817|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002174|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56002175|NCT00001072|Protective Agents|protective agents|mesh-ancestor
56002176|NCT04331470|Ritonavir|ritonavir|mesh-list
56002177|NCT04331470|Lopinavir|lopinavir|mesh-list
56002178|NCT04331470|Chloroquine|chloroquine|mesh-list
56002179|NCT04331470|Levamisole|levamisole|mesh-list
56002180|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
56002181|NCT04331470|Budesonide|budesonide|mesh-list
56002182|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
56002183|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55719939|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55720013|NCT01590719|Antidotes|antidotes|mesh-ancestor
55720240|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
55720321|NCT02266511|Tamsulosin|tamsulosin|mesh-list
56002184|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56002185|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
55720768|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
56002186|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721064|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721292|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56124655|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002187|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002189|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56002190|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
56002191|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739135|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742625|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
55742627|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55742628|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742630|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002199|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56002200|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
56002201|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
56002202|NCT04331470|Hormones|hormones|mesh-ancestor
56002203|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002204|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55722624|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002205|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55722858|NCT00835367|Amlodipine|amlodipine|mesh-list
55780780|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780782|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
55780783|NCT02375191|Ropivacaine|ropivacaine|mesh-list
55780784|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55780785|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780786|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780787|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55780788|NCT02375191|Analgesics|analgesics|mesh-ancestor
55780789|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
55780790|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002225|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56002227|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56002228|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002229|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55724905|NCT02260492|Xhance|xhance|mesh-list
56002230|NCT01147627|Incretins|incretins|mesh-ancestor
56002231|NCT01147627|Hormones|hormones|mesh-ancestor
55725261|NCT02257372|Albuterol|albuterol|mesh-list
55725336|NCT00489203|Hormones|hormones|mesh-ancestor
56124656|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124657|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
55725559|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725631|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55725929|NCT00355355|Talaporfin|talaporfin|mesh-list
56002232|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55726083|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
56002233|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
55726227|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56002234|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726376|NCT03951025|Melatonin|melatonin|mesh-list
55726458|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
56002235|NCT01147627|Coagulants|coagulants|mesh-ancestor
56002238|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002239|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
56002240|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
56002241|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780791|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55780792|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55780794|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
55780795|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780796|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780797|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
55780799|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55780800|NCT02375191|Narcotics|narcotics|mesh-ancestor
55780801|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55780802|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55780803|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
55780804|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
55780805|NCT03100877|Melphalan|melphalan|mesh-list
55780806|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
55780807|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55780808|NCT03100877|Lenalidomide|lenalidomide|mesh-list
56002242|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002243|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56002244|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
55726822|NCT04984798|Protective Agents|protective agents|mesh-ancestor
56002246|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002247|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56002248|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002249|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
56002250|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56002251|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56002252|NCT02548962|Growth Substances|growth substances|mesh-ancestor
56002253|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
56002254|NCT00000274|Flupenthixol|flupenthixol|mesh-list
56002255|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
56002257|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56002258|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002259|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002269|NCT02743598|Hormones|hormones|mesh-ancestor
55780809|NCT03100877|Lenograstim|lenograstim|mesh-list
55780811|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55780812|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
55780815|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55780816|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
55780817|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780818|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780819|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55780820|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55780821|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56002283|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002284|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002285|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002286|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56002287|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
56002288|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55728433|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728507|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55728579|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
55780822|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55780823|NCT03100877|Growth Substances|growth substances|mesh-ancestor
55780824|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
55780825|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
55780826|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
55780827|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780828|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780829|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728656|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56002289|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56002290|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55728974|NCT03521063|Budesonide|budesonide|mesh-list
56002291|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
56002292|NCT01188577|Epinephrine|epinephrine|mesh-list
56002293|NCT01188577|Racepinephrine|racepinephrine|mesh-list
55729414|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
56002294|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
56002295|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56002296|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56002297|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
56002298|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729853|NCT03309007|Metformin|metformin|mesh-list
55729928|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
56124658|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56002299|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002300|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002301|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56002302|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56002303|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
55739183|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742631|NCT05303961|Protective Agents|protective agents|mesh-ancestor
55742632|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862003|NCT03586947|Vitamin D|vitamin d|mesh-list
55742633|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742634|NCT03122353|Calcitriol|calcitriol|mesh-list
55742635|NCT03122353|Betamethasone|betamethasone|mesh-list
55742636|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
55742637|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55742638|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
55742639|NCT03122353|Calcipotriene|calcipotriene|mesh-list
55742640|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55742641|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742642|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
55742643|NCT03122353|Hormones|hormones|mesh-ancestor
55742644|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742645|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742646|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55742647|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
55742648|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
55742649|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55742650|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55742651|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55742652|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742653|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55780830|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780832|NCT00794495|Desloratadine|desloratadine|mesh-list
55780833|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55780834|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55780835|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55780836|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
55780838|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780839|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780840|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780842|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
55780843|NCT04157075|Bupivacaine|bupivacaine|mesh-list
55780844|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
55780845|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
56002304|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002305|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56002306|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
56002307|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
56002308|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
56002309|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56002310|NCT02507336|Thalidomide|thalidomide|mesh-list
56002311|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56002312|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
56002313|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002314|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
56002315|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56002316|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002317|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56002318|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56002320|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
56002321|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002322|NCT00000292|Cocaine|cocaine|mesh-list
56002323|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
56002324|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
56002325|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002326|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002327|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
55739200|NCT03343197|Ivosidenib|ivosidenib|mesh-list
55780846|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780847|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780848|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
55780849|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780850|NCT00763529|Fluticasone|fluticasone|mesh-list
55780851|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
55780852|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780853|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55780854|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
55780855|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780856|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780857|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55780858|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
55780859|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
55780860|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55780861|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
56002328|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002330|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56002331|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56002332|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002333|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739201|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780862|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55780863|NCT03105505|Permethrin|permethrin|mesh-list
55780864|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55780865|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780866|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780867|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55780868|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780869|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55780870|NCT03105193|Lidocaine|lidocaine|mesh-list
55780871|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
55780872|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
56002335|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002336|NCT00000298|Buprenorphine|buprenorphine|mesh-list
56124659|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56124660|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
55730966|NCT05160727|Irinotecan|irinotecan|mesh-list
55731032|NCT02476786|Tamoxifen|tamoxifen|mesh-list
55731174|NCT02738879|Metformin|metformin|mesh-list
56124662|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56124663|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56124664|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56124665|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
55731762|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
56124666|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731985|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
55732062|NCT02325245|Metformin|metformin|mesh-list
55732589|NCT03466567|Cyclosporine|cyclosporine|mesh-list
56002337|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56002338|NCT00000298|Naloxone|naloxone|mesh-list
56002339|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55742728|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742729|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742730|NCT04943679|Interferons|interferons|mesh-list
55742731|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
55742732|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742733|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
55742734|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742735|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
55742736|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742737|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
55742738|NCT04507165|Anesthetics|anesthetics|mesh-list
55742739|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742741|NCT04507165|Narcotics|narcotics|mesh-ancestor
55742742|NCT04507165|Analgesics|analgesics|mesh-ancestor
55742743|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
55742744|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742746|NCT04475991|Favipiravir|favipiravir|mesh-list
55742747|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55742748|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55742749|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862679|NCT03806062|Domperidone|domperidone|mesh-list
55742750|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55742751|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55742752|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
55742753|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742754|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55742755|NCT03387475|Deferasirox|deferasirox|mesh-list
55742756|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55742757|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
55742758|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
55780873|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780874|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780875|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
55783565|NCT02331745|Lenograstim|lenograstim|mesh-list
55780876|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780877|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55780878|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55780880|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55780881|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780882|NCT05066633|Metoprolol|metoprolol|mesh-list
55780883|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55780884|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55780894|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780895|NCT04439305|Dasatinib|dasatinib|mesh-list
55780896|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780897|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780898|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780899|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002340|NCT00000298|Narcotics|narcotics|mesh-ancestor
56002341|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002342|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002343|NCT00000298|Analgesics|analgesics|mesh-ancestor
56002344|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
56002345|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002346|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56002347|NCT00000304|Amphetamine|amphetamine|mesh-list
56002348|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
55733473|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
55733543|NCT03990077|Docetaxel|docetaxel|mesh-list
56002349|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56002350|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002351|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
55734302|NCT05579249|Incretins|incretins|mesh-ancestor
56002352|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
55734375|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
55734449|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
56002353|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002354|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
56002355|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734677|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55780900|NCT02368795|Indomethacin|indomethacin|mesh-list
55780901|NCT02368795|Isosorbide|isosorbide|mesh-list
55780902|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55780903|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55780904|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55780905|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55780906|NCT02368795|Analgesics|analgesics|mesh-ancestor
55780907|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
55780908|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780909|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780910|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780911|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56002356|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734752|NCT04073615|Trifluridine|trifluridine|mesh-list
56002357|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
56002358|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55735053|NCT01677741|Dabrafenib|dabrafenib|mesh-list
56002359|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56002360|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002361|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56002362|NCT02548650|Aspirin|aspirin|mesh-list
56002363|NCT02548650|Clopidogrel|clopidogrel|mesh-list
55735882|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
56002364|NCT02548650|Vorapaxar|vorapaxar|mesh-list
55736093|NCT04418895|Vitamins|vitamins|mesh-ancestor
55736322|NCT03433001|Dexamethasone|dexamethasone|mesh-list
55736619|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736691|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55736778|NCT02732639|Interferons|interferons|mesh-list
55736994|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
55737292|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
55737363|NCT04219735|Minocycline|minocycline|mesh-list
55744398|NCT03332719|Analgesics|analgesics|mesh-ancestor
55780912|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
55780913|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
55780914|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55780915|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55780916|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780917|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780918|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56216666|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56216667|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
55737588|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002365|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56002366|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56002367|NCT02548650|Analgesics|analgesics|mesh-ancestor
55737961|NCT03425929|Oxytocin|oxytocin|mesh-list
55738116|NCT01092143|Fluticasone|fluticasone|mesh-list
56002368|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
55738345|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738422|NCT02654145|Omalizumab|omalizumab|mesh-list
56002369|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738566|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
55738643|NCT04814745|Analgesics|analgesics|mesh-ancestor
56002370|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002371|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002372|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56002373|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56002374|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56002375|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002376|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56002377|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56002378|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002380|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56002381|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56002382|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55739253|NCT03397069|Midazolam|midazolam|mesh-list
56216668|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216669|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216670|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
56216671|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780920|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
55780921|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
55780922|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55780923|NCT00650663|Simvastatin|simvastatin|mesh-list
56002383|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
56002384|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002385|NCT00000310|Risperidone|risperidone|mesh-list
56002386|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56002387|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
56002388|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002389|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002390|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002391|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56002392|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56002393|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002394|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56002395|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56002396|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
56002397|NCT02734004|Bevacizumab|bevacizumab|mesh-list
56002399|NCT02734004|Olaparib|olaparib|mesh-list
56002400|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56002401|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002402|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56002403|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56002404|NCT02734004|Growth Substances|growth substances|mesh-ancestor
56002406|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
55780924|NCT00650663|Ezetimibe|ezetimibe|mesh-list
55780925|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55780926|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780927|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
55780928|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780929|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780930|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55780931|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780932|NCT02368717|Mesalamine|mesalamine|mesh-list
55780933|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55780934|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55780935|NCT02368717|Analgesics|analgesics|mesh-ancestor
55780936|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
55780937|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002479|NCT00001108|Nevirapine|nevirapine|mesh-list
56002480|NCT00001108|Didanosine|didanosine|mesh-list
56002481|NCT00001108|Stavudine|stavudine|mesh-list
56002482|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56002483|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56002484|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
56002485|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002486|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002487|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002488|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56002489|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
56002490|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002491|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56002492|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56002493|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002494|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002498|NCT02157974|Exenatide|exenatide|mesh-list
56002537|NCT00002002|Trimethoprim|trimethoprim|mesh-list
56002538|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
56002539|NCT00002002|Calcium|calcium|mesh-list
56002540|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
56002541|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56002542|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002543|NCT00002002|Antidotes|antidotes|mesh-ancestor
56002544|NCT00002002|Protective Agents|protective agents|mesh-ancestor
56002545|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
56002546|NCT00002002|Vitamins|vitamins|mesh-ancestor
56002547|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
55780938|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780939|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780940|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55780941|NCT04231565|Tenofovir|tenofovir|mesh-list
55780942|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
55780943|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780944|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55780945|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55780946|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780947|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783566|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55780948|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55780958|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55780959|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55780960|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55780961|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780963|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
55780964|NCT05035277|Apixaban|apixaban|mesh-list
56002555|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002556|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002557|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56002558|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56002559|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56002560|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56002561|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56002562|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56002563|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002564|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002565|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002566|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002567|NCT02535000|Analgesics|analgesics|mesh-ancestor
56002568|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
56002569|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002570|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
56002571|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56002572|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
56002573|NCT00380380|Vildagliptin|vildagliptin|mesh-list
56002574|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56002575|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780965|NCT05035277|Edoxaban|edoxaban|mesh-list
55780966|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55780967|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
55780968|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55780969|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
55780970|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780971|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780972|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
55780973|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55780974|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55780975|NCT05035277|Analgesics|analgesics|mesh-ancestor
55780976|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
55780977|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759009|NCT04908813|Capecitabine|capecitabine|mesh-list
56002586|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56002587|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
56002588|NCT01228903|Protective Agents|protective agents|mesh-ancestor
56002589|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002590|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56002591|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56002592|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56002593|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738791|NCT03814317|Treprostinil|treprostinil|mesh-list
56002594|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002595|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56002596|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002597|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002598|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
56002599|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002600|NCT00001126|Cidofovir|cidofovir|mesh-list
56002601|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
56002602|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002603|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002604|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002605|NCT00002008|Sargramostim|sargramostim|mesh-list
56002606|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
56002607|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002608|NCT00001132|Abacavir|abacavir|mesh-list
56002609|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002610|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55780978|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780979|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780980|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55780981|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55780982|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55780983|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55780984|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55780985|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
56002611|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002612|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002613|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
56002614|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002615|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002616|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56002617|NCT01149733|Tamsulosin|tamsulosin|mesh-list
56002618|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56002619|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56002620|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56002621|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
56002622|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002623|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002624|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002625|NCT01149733|Urological Agents|urological agents|mesh-ancestor
55729871|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
56002626|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
56002627|NCT02498912|Fludarabine|fludarabine|mesh-list
56002628|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56002629|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
56002630|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002631|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56002632|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56002633|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
56002634|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002635|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780986|NCT02374645|Gefitinib|gefitinib|mesh-list
55780987|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780988|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780989|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216672|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56216673|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
56144482|NCT00790062|Oxytocin|oxytocin|mesh-list
56216674|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780990|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780991|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
55780993|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55780994|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
56002636|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56002637|NCT00002014|Zidovudine|zidovudine|mesh-list
56002638|NCT00002014|Didanosine|didanosine|mesh-list
56002639|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
56002640|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002641|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002642|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002643|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002644|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
56002645|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002646|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002647|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56002648|NCT00000334|Buprenorphine|buprenorphine|mesh-list
56002649|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56002650|NCT00000334|Narcotics|narcotics|mesh-ancestor
56002651|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002652|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002653|NCT00000334|Analgesics|analgesics|mesh-ancestor
56002654|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
56002655|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002656|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55780995|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780996|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
55780997|NCT02368561|Protective Agents|protective agents|mesh-ancestor
55780999|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55781000|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781001|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781002|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
55781003|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781004|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781005|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56002679|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002680|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002682|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56002683|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002684|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56002685|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
56002686|NCT01229527|Meperidine|meperidine|mesh-list
56002687|NCT01229527|Remifentanil|remifentanil|mesh-list
56002688|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56002689|NCT01229527|Narcotics|narcotics|mesh-ancestor
56002690|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56002691|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002692|NCT01229527|Analgesics|analgesics|mesh-ancestor
56002693|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
56002694|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002695|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56002696|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
56002697|NCT02723162|Varenicline|varenicline|mesh-list
56002698|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56002699|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56002700|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56002701|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
56002702|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002703|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002704|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002705|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
56002706|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002707|NCT02723162|Expectorants|expectorants|mesh-ancestor
56002708|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
56002709|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56002710|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
55781006|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
55781007|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781008|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
55781009|NCT02374489|Ceritinib|ceritinib|mesh-list
55781010|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781011|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55781012|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781013|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781014|NCT02374567|Topiramate|topiramate|mesh-list
55781017|NCT02374567|Pregabalin|pregabalin|mesh-list
55781018|NCT02374567|Lamotrigine|lamotrigine|mesh-list
56002711|NCT02723162|Protective Agents|protective agents|mesh-ancestor
56002712|NCT02723162|Antidotes|antidotes|mesh-ancestor
56002713|NCT00000358|Lofexidine|lofexidine|mesh-list
56002714|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56002715|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56002716|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002717|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
56002718|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002719|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56002720|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55739339|NCT03392623|Niacinamide|niacinamide|mesh-list
55781019|NCT02374567|Lacosamide|lacosamide|mesh-list
55783568|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783570|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
55781020|NCT02374567|Carbamazepine|carbamazepine|mesh-list
55781021|NCT02374567|Phenytoin|phenytoin|mesh-list
55781022|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
55781023|NCT02374567|Nicergoline|nicergoline|mesh-list
55781024|NCT02374567|Midazolam|midazolam|mesh-list
55781025|NCT02374567|Diazepam|diazepam|mesh-list
55781026|NCT02374567|Triazolam|triazolam|mesh-list
55781027|NCT02374567|Acamprosate|acamprosate|mesh-list
55781028|NCT02374567|Gabapentin|gabapentin|mesh-list
55781029|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55781030|NCT02374567|Amitriptyline|amitriptyline|mesh-list
55781031|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
55781034|NCT02374567|Lorazepam|lorazepam|mesh-list
55781035|NCT02374567|Clonazepam|clonazepam|mesh-list
55781036|NCT02374567|Phenobarbital|phenobarbital|mesh-list
55781037|NCT02374567|Clobazam|clobazam|mesh-list
56002721|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56002722|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
56002723|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002724|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002725|NCT00000376|Desipramine|desipramine|mesh-list
56002726|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56002727|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
56002728|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56002729|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002730|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002731|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55781038|NCT02374567|Zaleplon|zaleplon|mesh-list
55781039|NCT02374567|Nitrazepam|nitrazepam|mesh-list
55781040|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
55781041|NCT02374567|Memantine|memantine|mesh-list
55781042|NCT02374567|Biperiden|biperiden|mesh-list
55781043|NCT02374567|Haloperidol|haloperidol|mesh-list
55781044|NCT02374567|Pimozide|pimozide|mesh-list
55781045|NCT02374567|Olanzapine|olanzapine|mesh-list
55781046|NCT02374567|Zolpidem|zolpidem|mesh-list
55781047|NCT02374567|Alprazolam|alprazolam|mesh-list
55781048|NCT02374567|Zopiclone|zopiclone|mesh-list
55781050|NCT02374567|Doxepin|doxepin|mesh-list
56002768|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
56002769|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002770|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002771|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56002772|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56002774|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
55730024|NCT03511703|Apatinib|apatinib|mesh-list
56002775|NCT01894334|Urinastatin|urinastatin|mesh-list
56002776|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56002777|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56002778|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002779|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
56002780|NCT01894334|Coagulants|coagulants|mesh-ancestor
56002781|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56002782|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
56002783|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56002784|NCT01894334|Protective Agents|protective agents|mesh-ancestor
56002785|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002786|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55759081|NCT04897269|Hormones|hormones|mesh-ancestor
55739364|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781051|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
55781052|NCT02374567|Oxazepam|oxazepam|mesh-list
55781053|NCT02374567|Temazepam|temazepam|mesh-list
55781054|NCT02374567|Brotizolam|brotizolam|mesh-list
55781055|NCT02374567|Lormetazepam|lormetazepam|mesh-list
55781056|NCT02374567|Flurazepam|flurazepam|mesh-list
55781057|NCT02374567|Mirtazapine|mirtazapine|mesh-list
55781058|NCT02374567|Buspirone|buspirone|mesh-list
55781059|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
55781060|NCT02374567|Trazodone|trazodone|mesh-list
55781061|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
55781062|NCT02374567|Bromazepam|bromazepam|mesh-list
55781063|NCT02374567|Risperidone|risperidone|mesh-list
55781064|NCT02374567|Melatonin|melatonin|mesh-list
55781065|NCT02374567|Aripiprazole|aripiprazole|mesh-list
55781066|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55781067|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55781068|NCT02374567|Ziprasidone|ziprasidone|mesh-list
55781069|NCT02374567|Clozapine|clozapine|mesh-list
55781070|NCT02374567|Amisulpride|amisulpride|mesh-list
55781071|NCT02374567|Flupenthixol|flupenthixol|mesh-list
55781072|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
56216675|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56216676|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55781073|NCT02374567|Perphenazine|perphenazine|mesh-list
55781074|NCT02374567|Sertindole|sertindole|mesh-list
55781075|NCT02374567|Fluphenazine|fluphenazine|mesh-list
56002787|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56002788|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
56002789|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002790|NCT00002044|Zidovudine|zidovudine|mesh-list
56002791|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
56002792|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002793|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002794|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002795|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002796|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
56002797|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002798|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002799|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56002800|NCT00001282|Zidovudine|zidovudine|mesh-list
56002801|NCT00001282|Interleukin-2|interleukin-2|mesh-list
56002802|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002803|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56002804|NCT00001282|Analgesics|analgesics|mesh-ancestor
56002805|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
56002806|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002807|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002808|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
56002809|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002810|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002811|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55781076|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
55781077|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
55781078|NCT02374567|Sulpiride|sulpiride|mesh-list
55781079|NCT02374567|Thioridazine|thioridazine|mesh-list
55781080|NCT02374567|Pipamperone|pipamperone|mesh-list
55781081|NCT02374567|Clopenthixol|clopenthixol|mesh-list
55781082|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
55781083|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
55781084|NCT02374567|Fluspirilene|fluspirilene|mesh-list
55781085|NCT02374567|Perazine|perazine|mesh-list
55781086|NCT02374567|Bromperidol|bromperidol|mesh-list
55781087|NCT02374567|Benperidol|benperidol|mesh-list
55781088|NCT02374567|Rivastigmine|rivastigmine|mesh-list
55781089|NCT02374567|Piracetam|piracetam|mesh-list
55781090|NCT02374567|Donepezil|donepezil|mesh-list
55781091|NCT02374567|Galantamine|galantamine|mesh-list
55781092|NCT02374567|Citalopram|citalopram|mesh-list
55781093|NCT02374567|Bupropion|bupropion|mesh-list
55781094|NCT02374567|Sertraline|sertraline|mesh-list
56002812|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002813|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
56002814|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002815|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002816|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56002818|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002819|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56002820|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002821|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002822|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
56002823|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56002824|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002825|NCT00001300|Doxorubicin|doxorubicin|mesh-list
56002826|NCT00001300|Ifosfamide|ifosfamide|mesh-list
56002827|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56002828|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002829|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56002830|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56002831|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002832|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002833|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56002834|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
56002835|NCT00000400|Alendronate|alendronate|mesh-list
56002836|NCT00000400|Teriparatide|teriparatide|mesh-list
56002837|NCT00000400|Hormones|hormones|mesh-list
56002838|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
55759089|NCT04896177|Sirolimus|sirolimus|mesh-list
55781095|NCT02374567|Fluoxetine|fluoxetine|mesh-list
55781096|NCT02374567|Paroxetine|paroxetine|mesh-list
55781097|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55781098|NCT02374567|Nortriptyline|nortriptyline|mesh-list
55781099|NCT02374567|Reboxetine|reboxetine|mesh-list
55781100|NCT02374567|Imipramine|imipramine|mesh-list
55781101|NCT02374567|Clomipramine|clomipramine|mesh-list
55781102|NCT02374567|Moclobemide|moclobemide|mesh-list
55781104|NCT02374567|Opipramol|opipramol|mesh-list
55781105|NCT02374567|Trimipramine|trimipramine|mesh-list
55781106|NCT02374567|Maprotiline|maprotiline|mesh-list
55781107|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
55781108|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55781109|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55781124|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781125|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
55781126|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55781127|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814923|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002839|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002840|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002841|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56002842|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56002843|NCT01195597|Nicotine|nicotine|mesh-list
56002844|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55739405|NCT04647643|Paclitaxel|paclitaxel|mesh-list
55781128|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55781129|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55781130|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55781131|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
55781132|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55781133|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
55781134|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55781135|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55781136|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
55781138|NCT02374567|Protective Agents|protective agents|mesh-ancestor
55781139|NCT02374567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55781140|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55781141|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55781142|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
56002845|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
56002846|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002847|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730094|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
56002848|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56002849|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56002850|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
56002851|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002852|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002853|NCT00002050|Thymopentin|thymopentin|mesh-list
56002854|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56002855|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
56002856|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002857|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
56002858|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56002859|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
56002860|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002861|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
56002862|NCT04389866|Protective Agents|protective agents|mesh-ancestor
56002863|NCT00000412|Alendronate|alendronate|mesh-list
56002865|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56002866|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002867|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56002868|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56002869|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002870|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002871|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56002872|NCT00000412|Vitamins|vitamins|mesh-ancestor
55781143|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55781144|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55781145|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
55781146|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
55781147|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55781148|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55781149|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
55781150|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
55781151|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781152|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55781153|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55781154|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55781155|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781156|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
55781157|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55781158|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56002876|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002877|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56002878|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56002879|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56002880|NCT03110562|Dexamethasone|dexamethasone|mesh-list
56002881|NCT03110562|Bortezomib|bortezomib|mesh-list
56002882|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002883|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
56002884|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
55781159|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55781160|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55781161|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55781162|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55781163|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
55781164|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56216677|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56216678|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781165|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55781166|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55781187|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55781188|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55781189|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
55781190|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55781191|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55781192|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55781193|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55781194|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55781195|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55781196|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55781197|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55781198|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
55781199|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
56002885|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002886|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002888|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
56002889|NCT03110562|Hormones|hormones|mesh-ancestor
56002890|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002891|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56002892|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002893|NCT00380614|Lamivudine|lamivudine|mesh-list
56002894|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002895|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002896|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781202|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55781203|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
55781204|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55781206|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781207|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781208|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
55781209|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
55781210|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
55781211|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55781212|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
55781213|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781214|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781215|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55781216|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
55781217|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56002897|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002898|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
56002899|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002900|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002901|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56002902|NCT00000430|Alendronate|alendronate|mesh-list
56002903|NCT00000430|Estrogens|estrogens|mesh-list
56002904|NCT00000430|Progestins|progestins|mesh-list
56002905|NCT00000430|Hormones|hormones|mesh-ancestor
56002906|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002907|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002908|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56002909|NCT00380770|Lamivudine|lamivudine|mesh-list
56002910|NCT00380770|Stavudine|stavudine|mesh-list
56002911|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
56002912|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56002913|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002914|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002915|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002916|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
56002917|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002918|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002919|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55781218|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
55781219|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781220|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781221|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55781222|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
55781228|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55781230|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
55814924|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56002934|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002935|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56002936|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
56002937|NCT01231399|Antidotes|antidotes|mesh-ancestor
56002938|NCT01231399|Protective Agents|protective agents|mesh-ancestor
56002939|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
56002940|NCT01231399|Vitamins|vitamins|mesh-ancestor
56002941|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
56002942|NCT00002062|Spiramycin|spiramycin|mesh-list
55781231|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781232|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55781233|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55781234|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55781235|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
55781237|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781238|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781239|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781240|NCT02364583|Primaquine|primaquine|mesh-list
55781241|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
56002943|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56002944|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002946|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56002947|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56002948|NCT01231633|Dexamethasone|dexamethasone|mesh-list
56002949|NCT01231633|Bevacizumab|bevacizumab|mesh-list
56002950|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56002951|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002952|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55781242|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55781243|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55781244|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781245|NCT02368015|Cefazolin|cefazolin|mesh-list
55781246|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55781247|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781248|NCT02373943|Carotenoids|carotenoids|mesh-list
55781249|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
55781250|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781252|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781253|NCT04632433|Cemiplimab|cemiplimab|mesh-list
55781254|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56002953|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56002954|NCT01231633|Growth Substances|growth substances|mesh-ancestor
56002955|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002956|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
56002957|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56002958|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
56002959|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
56002960|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002961|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56002963|NCT01231633|Hormones|hormones|mesh-ancestor
56002964|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002965|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56002966|NCT00000442|Naltrexone|naltrexone|mesh-list
56002967|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56002968|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56002969|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002970|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
56002971|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56002972|NCT00002068|Fluconazole|fluconazole|mesh-list
56002973|NCT00002068|Amphotericin B|amphotericin b|mesh-list
56002974|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56002975|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
56002976|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002977|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56002978|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56002979|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002980|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002981|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56002982|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
55739490|NCT03396523|Losartan|losartan|mesh-list
55781255|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781256|NCT02368249|Terlipressin|terlipressin|mesh-list
55781257|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55781258|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55781259|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
55783572|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55783573|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
55781260|NCT02367937|Midazolam|midazolam|mesh-list
55781261|NCT02367937|Omeprazole|omeprazole|mesh-list
55781262|NCT02367937|Simvastatin|simvastatin|mesh-list
55781263|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56216679|NCT01627106|Amiodarone|amiodarone|mesh-list
56216680|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56216681|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
56216682|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56216683|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55781264|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55781265|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781266|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781267|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56002983|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002984|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002985|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56002986|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56002987|NCT00002068|Amebicides|amebicides|mesh-ancestor
56002988|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56002989|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56002990|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56002991|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56002992|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56002993|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56002994|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
56002995|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002996|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002997|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56002998|NCT00000448|Naltrexone|naltrexone|mesh-list
55781268|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55781269|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55781270|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55781271|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
55781272|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
55781273|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
55781274|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
55781275|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781276|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781277|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55781278|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55781279|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
55781280|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56003021|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003022|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56003023|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56003024|NCT00002074|Amebicides|amebicides|mesh-ancestor
56003025|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56003026|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56003027|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56003028|NCT00001354|Zidovudine|zidovudine|mesh-list
56003029|NCT00001354|Interleukin-2|interleukin-2|mesh-list
56003030|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003031|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56003032|NCT00001354|Analgesics|analgesics|mesh-ancestor
56003033|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
56003034|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003035|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003036|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
56003037|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003038|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003039|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003040|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003041|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
56003042|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781281|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55781282|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781283|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55781284|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781285|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55781286|NCT02367937|Analgesics|analgesics|mesh-ancestor
55781287|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
55781288|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781289|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55781290|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55781291|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55781293|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55781295|NCT05011487|Osimertinib|osimertinib|mesh-list
55781296|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003043|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003044|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003045|NCT00000454|Nicotine|nicotine|mesh-list
56003046|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56003047|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
56003048|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003049|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003050|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55759130|NCT03051087|Ganirelix|ganirelix|mesh-list
56003051|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56003052|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
56003053|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56003054|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003055|NCT00002080|Rifabutin|rifabutin|mesh-list
56003056|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56003057|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003058|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56003059|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
56003060|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
56003061|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56003062|NCT00000484|Diuretics|diuretics|mesh-ancestor
56003063|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
56003064|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003065|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56003066|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56003067|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003068|NCT00000496|Aspirin|aspirin|mesh-list
56003069|NCT00000496|Dipyridamole|dipyridamole|mesh-list
56003070|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55781299|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55781300|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55781301|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55781302|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55781303|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55781304|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55781305|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
55781306|NCT05061641|Progesterone|progesterone|mesh-list
55781307|NCT05061641|Progestins|progestins|mesh-ancestor
55781308|NCT05061641|Hormones|hormones|mesh-ancestor
55781309|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781310|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781311|NCT03100019|Resveratrol|resveratrol|mesh-list
55781312|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
55781313|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781314|NCT03100019|Protective Agents|protective agents|mesh-ancestor
55781315|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781316|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003074|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003075|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003076|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56003077|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003078|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56003079|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56003080|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003081|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56003082|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56003083|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003085|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56003086|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
56003087|NCT00002086|Interferons|interferons|mesh-list
56003088|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
56003089|NCT00002086|Zidovudine|zidovudine|mesh-list
56003090|NCT00002086|Zalcitabine|zalcitabine|mesh-list
56003091|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003092|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
56003093|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781317|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55781318|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
55781319|NCT05047055|Rifampin|rifampin|mesh-list
55781320|NCT05047055|Isoniazid|isoniazid|mesh-list
55781321|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
55781322|NCT05047055|Ethambutol|ethambutol|mesh-list
55781323|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55781324|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781325|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55781326|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55781327|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781328|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781329|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781330|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56216684|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216685|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56003113|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
56003114|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
56003115|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003116|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003117|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
56003118|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003119|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55783575|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
55783576|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783577|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783579|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
55783580|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55783581|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783582|NCT02334007|Dalteparin|dalteparin|mesh-list
55783583|NCT02334007|Tinzaparin|tinzaparin|mesh-list
55783584|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55781331|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
55781332|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
56003120|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56003121|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
56003122|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56003123|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56003124|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56003125|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56003126|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003129|NCT01151761|Carboplatin|carboplatin|mesh-list
56003130|NCT01151761|Fluorouracil|fluorouracil|mesh-list
56003131|NCT01151761|Capecitabine|capecitabine|mesh-list
56003132|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003133|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56003134|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
56003135|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003136|NCT01151761|Antiviral Agents|antiviral agents|mesh-ancestor
56003137|NCT01151761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003138|NCT01151761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003139|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003140|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
56003141|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003142|NCT00002092|Cimetidine|cimetidine|mesh-list
56003143|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56003144|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56003145|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56003146|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
56003147|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
56003148|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56003149|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781333|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55781334|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55781335|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55781336|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55781337|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55781338|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55781339|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55781340|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55781341|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55781342|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
55781343|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55805189|NCT05484817|Hormones|hormones|mesh-list
55781344|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55781345|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781346|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781347|NCT05046041|Misoprostol|misoprostol|mesh-list
55781348|NCT05046041|Mifepristone|mifepristone|mesh-list
55781349|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55781350|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
55781351|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55781352|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003150|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003151|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56003152|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56003153|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003154|NCT02122562|Ketamine|ketamine|mesh-list
56003155|NCT02122562|Analgesics|analgesics|mesh-ancestor
56003156|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
56003157|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003158|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781353|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55781354|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781355|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
55781356|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55781357|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55781359|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55781360|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
55781361|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55781362|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55781363|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
55781364|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56003193|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003194|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56003195|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003196|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003197|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
56003198|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56003199|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56003200|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003201|NCT02705300|Antidotes|antidotes|mesh-ancestor
56003202|NCT02705300|Protective Agents|protective agents|mesh-ancestor
56003203|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
56003204|NCT02705300|Vitamins|vitamins|mesh-ancestor
56003205|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
56003206|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
56003207|NCT01196377|Albuterol|albuterol|mesh-list
56003208|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56003209|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
56003212|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55781366|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55781367|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55781368|NCT01970878|Bromides|bromides|mesh-list
55781369|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
55781370|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55781371|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
55781372|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781373|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781374|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55781375|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
55781376|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
55781377|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55781378|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
55781379|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781380|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003241|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
56003242|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003243|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
56003244|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56003245|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003246|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56003247|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56003248|NCT00002104|Growth Substances|growth substances|mesh-ancestor
56003249|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
56003250|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003251|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
56003252|NCT00001438|Tretinoin|tretinoin|mesh-list
56003253|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003254|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
56003255|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
56003256|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
56003257|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003258|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56003259|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003260|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55781381|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
55783585|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
55783586|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55783587|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55783588|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783589|NCT02637323|Triamcinolone|triamcinolone|mesh-list
55783590|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55783591|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55783593|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56216686|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56216687|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56216688|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783594|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783595|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
55783596|NCT02637323|Hormones|hormones|mesh-ancestor
56003261|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003262|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003263|NCT00000574|Ibuprofen|ibuprofen|mesh-list
56003264|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56003265|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56003266|NCT00000574|Analgesics|analgesics|mesh-ancestor
56003267|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
56003268|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003269|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003270|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56003271|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003272|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56003273|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003274|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003275|NCT00002110|Zidovudine|zidovudine|mesh-list
56003322|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003323|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56003324|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
56003325|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56003326|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56003338|NCT00001498|Antidotes|antidotes|mesh-ancestor
55783597|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783598|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783599|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55783600|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
55783601|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783602|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783603|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
55783604|NCT02331823|Isoniazid|isoniazid|mesh-list
55783605|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
55781382|NCT05045651|Cimetidine|cimetidine|mesh-list
55781383|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55781384|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781385|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56003347|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
56003348|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
56003349|NCT02688140|Cytarabine|cytarabine|mesh-list
56003350|NCT02688140|Methotrexate|methotrexate|mesh-list
56003351|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
56003352|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
56003353|NCT02688140|Idarubicin|idarubicin|mesh-list
56003354|NCT02688140|Tretinoin|tretinoin|mesh-list
56003355|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
56003356|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56003357|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
56003358|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56003359|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003360|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56003361|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
55759172|NCT04890561|Lemborexant|lemborexant|mesh-list
55781386|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
55781387|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
55781388|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781389|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781390|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781391|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55781392|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55781393|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781394|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
55781395|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56003362|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003363|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003364|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
56003365|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003366|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56003367|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003368|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
56003369|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003370|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003371|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
56003372|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003373|NCT02688140|Analgesics|analgesics|mesh-ancestor
56003374|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
56003375|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003376|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56003377|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56003378|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56003379|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
56003380|NCT05456490|Bupivacaine|bupivacaine|mesh-list
56003381|NCT05456490|Anesthetics, Local|anesthetics, local|mesh-ancestor
56003382|NCT05456490|Anesthetics|anesthetics|mesh-ancestor
56003383|NCT05456490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781396|NCT05059145|Fluconazole|fluconazole|mesh-list
55781397|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55781398|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781399|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
55781400|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
55781401|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
55781402|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55781403|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55781404|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781405|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781406|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55781407|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
55781408|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781409|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781412|NCT05058677|Lidocaine|lidocaine|mesh-list
55781413|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
55781414|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
55781415|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781416|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781417|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
55781418|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781419|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55781420|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55781421|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55781422|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55781423|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781424|NCT01970488|Adalimumab|adalimumab|mesh-list
56003384|NCT05456490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003385|NCT05456490|Sensory System Agents|sensory system agents|mesh-ancestor
56003386|NCT05456490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003388|NCT00002122|Rifabutin|rifabutin|mesh-list
56003389|NCT00002122|Fluconazole|fluconazole|mesh-list
56003390|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56003391|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003392|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
56003393|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56003394|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56003395|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003396|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003397|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56003398|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
56003399|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56003400|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003401|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56003402|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56003403|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56003404|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
56003405|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56003406|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56003407|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
55739669|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
55781425|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55781426|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55781427|NCT03097835|Anesthetics|anesthetics|mesh-list
55781428|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781429|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781430|NCT03097601|Sunitinib|sunitinib|mesh-list
55781431|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781432|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55781433|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55781434|NCT03097601|Growth Substances|growth substances|mesh-ancestor
55781435|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781436|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
55781437|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56216689|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56216690|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56003409|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56003410|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56003411|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56003412|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56003413|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003414|NCT01027559|Sertraline|sertraline|mesh-list
56003415|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
56003416|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56003417|NCT01027559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56003418|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56003419|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56003420|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003421|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56003422|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
56003423|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003424|NCT00002128|Adefovir|adefovir|mesh-list
56003425|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56003426|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
56003427|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003428|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003429|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003430|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003431|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003432|NCT00001570|Vinblastine|vinblastine|mesh-list
56003433|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56003434|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003435|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
55781438|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781439|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781440|NCT05058755|Etoposide|etoposide|mesh-list
55781442|NCT05058755|Azacitidine|azacitidine|mesh-list
55781443|NCT05058755|Pegaspargase|pegaspargase|mesh-list
55781444|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55781445|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781446|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55781447|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55781448|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781449|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781450|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
56003436|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
56003437|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
56003438|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003439|NCT00000628|Zidovudine|zidovudine|mesh-list
56003440|NCT00000628|L-697661|l-697661|mesh-list
56003441|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
56003442|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003443|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003444|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003445|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003447|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003448|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003449|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003450|NCT00000634|Nevirapine|nevirapine|mesh-list
56003451|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003452|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003453|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730690|NCT05095467|Paclitaxel|paclitaxel|mesh-list
56003455|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
56003456|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003457|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003458|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55739695|NCT03398837|Lenabasum|lenabasum|mesh-list
55781451|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781452|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55781453|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55781454|NCT05058755|Growth Substances|growth substances|mesh-ancestor
55781455|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
55781456|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55781457|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
55781458|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
55781459|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55781460|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
56003459|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56003460|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56003461|NCT01661790|Bevacizumab|bevacizumab|mesh-list
55739700|NCT03398837|Hormones|hormones|mesh-ancestor
55781461|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781462|NCT05058209|Triamcinolone|triamcinolone|mesh-list
55781463|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55781464|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55781465|NCT05058209|Betamethasone|betamethasone|mesh-list
55781466|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
55781467|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55781469|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
55781470|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55781471|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56003462|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56003463|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003464|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56003465|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56003466|NCT01661790|Growth Substances|growth substances|mesh-ancestor
56003467|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003468|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
56003470|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56003471|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
56003472|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003473|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003474|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003475|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003476|NCT00985907|Bortezomib|bortezomib|mesh-list
56003477|NCT00985907|Melphalan|melphalan|mesh-list
56003478|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56003479|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003480|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56003481|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
56003482|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003483|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56003484|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55781472|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55781473|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
55781474|NCT05058209|Hormones|hormones|mesh-ancestor
55781475|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781476|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781477|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55781478|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
55781479|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781480|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781481|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55781482|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
55781492|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55781494|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55781495|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
55781496|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781497|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781498|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56003485|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
56003486|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003487|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56003488|NCT00002140|Azithromycin|azithromycin|mesh-list
56003489|NCT00002140|Clarithromycin|clarithromycin|mesh-list
55781499|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55781500|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
55781501|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781502|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781503|NCT05057351|Glycerol|glycerol|mesh-list
55781504|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55781505|NCT05057351|Protective Agents|protective agents|mesh-ancestor
55781506|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781507|NCT03097211|Levodopa|levodopa|mesh-list
55781508|NCT03097211|Benserazide|benserazide|mesh-list
55781509|NCT03097211|Resveratrol|resveratrol|mesh-list
55781510|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
55781511|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55781512|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55781513|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
55781514|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781515|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781516|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781517|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
55781518|NCT03097211|Protective Agents|protective agents|mesh-ancestor
55781519|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216691|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56216692|NCT01627132|Dasatinib|dasatinib|mesh-list
56216693|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216694|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56003490|NCT00002140|Ethambutol|ethambutol|mesh-list
56003491|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56003492|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003493|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56003494|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003495|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003496|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56003497|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56003498|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
56003499|NCT02444546|Sargramostim|sargramostim|mesh-list
56003500|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
56003501|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003502|NCT00000658|Leucovorin|leucovorin|mesh-list
56003503|NCT00000658|Cytarabine|cytarabine|mesh-list
56003504|NCT00000658|Dexamethasone|dexamethasone|mesh-list
56003505|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
56003506|NCT00000658|Doxorubicin|doxorubicin|mesh-list
56003507|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55781520|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55781521|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
55781522|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55781523|NCT05056337|Lenvatinib|lenvatinib|mesh-list
55781524|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781525|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55781526|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781527|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781528|NCT05056025|Vitamins|vitamins|mesh-list
55781529|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
55781530|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781531|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55759220|NCT04906161|Vitamin D|vitamin d|mesh-list
56003508|NCT00000658|Methotrexate|methotrexate|mesh-list
56003509|NCT00000658|Vincristine|vincristine|mesh-list
56003511|NCT00000658|Allopurinol|allopurinol|mesh-list
56003512|NCT00000658|Sargramostim|sargramostim|mesh-list
56003513|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
56003514|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003515|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
56003516|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003517|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003518|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56003519|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
56003520|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003521|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003522|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56003523|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56003524|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
55781532|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55781533|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791729|NCT03039257|Vitamin A|vitamin a|mesh-list
55781534|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55781535|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781536|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781537|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781538|NCT01952080|Teduglutide|teduglutide|mesh-list
55781541|NCT01952080|Protective Agents|protective agents|mesh-ancestor
55781542|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781544|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55781545|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
55781546|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003525|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
56003526|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003527|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781547|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781548|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55781549|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
55781550|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
55781551|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783611|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55783612|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55783613|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783614|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783615|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783616|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55783617|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
55783618|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55783619|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55783620|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
55783621|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55783622|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55783623|NCT02890459|Denatonium|denatonium|mesh-list
55783624|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
55783625|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003529|NCT00000658|Hormones|hormones|mesh-ancestor
56003530|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56003531|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56003532|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56003533|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56003534|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56003535|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003536|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56003537|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
56003538|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56003539|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56003540|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
56003541|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
56003542|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56003543|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55783626|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
55781552|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55781553|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55781554|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55781555|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
55781556|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781557|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781558|NCT03359863|Pirfenidone|pirfenidone|mesh-list
55781559|NCT03359863|Analgesics|analgesics|mesh-ancestor
55781560|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
55781561|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781562|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781563|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55781564|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55781565|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55781566|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55781567|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781568|NCT05043233|Methimazole|methimazole|mesh-list
55781569|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
56216695|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216696|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216697|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
56216698|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55781570|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
55781571|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781572|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781573|NCT03258853|Pancrelipase|pancrelipase|mesh-list
55781574|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781575|NCT05054465|Venetoclax|venetoclax|mesh-list
55781576|NCT05054465|Navitoclax|navitoclax|mesh-list
55781577|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781578|NCT03860233|Oxytocin|oxytocin|mesh-list
55781579|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
55781580|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55781581|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781582|NCT04154189|Etoposide|etoposide|mesh-list
55781583|NCT04154189|Ifosfamide|ifosfamide|mesh-list
55781584|NCT04154189|Lenvatinib|lenvatinib|mesh-list
55781585|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55781586|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781587|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55781588|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55781589|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781590|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783627|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783628|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
55783629|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783640|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781591|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55781593|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55781594|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55781595|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
55781597|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
55781598|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781599|NCT01361009|Protective Agents|protective agents|mesh-ancestor
55781600|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781601|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55781602|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55781603|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
55781604|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
55781605|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781606|NCT02373163|Amlodipine|amlodipine|mesh-list
55781607|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56003544|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
55781608|NCT02373163|Telmisartan|telmisartan|mesh-list
55781609|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55781611|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55781612|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781613|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55781614|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781615|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
55781616|NCT02373163|Diuretics|diuretics|mesh-ancestor
55781617|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
55781618|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55781619|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55781620|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55781621|NCT02366377|Metformin|metformin|mesh-list
55781622|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55781623|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781624|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
55781626|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55781627|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781628|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781629|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55781630|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
55781631|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
55781632|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55781633|NCT02366299|Analgesics|analgesics|mesh-ancestor
55781634|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
56216699|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56216700|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
55781635|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781636|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55781637|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55781638|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55783641|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
55783642|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783643|NCT03079973|Calcipotriene|calcipotriene|mesh-list
55783644|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
55783645|NCT03861871|Fenfluramine|fenfluramine|mesh-list
55783646|NCT03861871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55783647|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55781648|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781650|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55781651|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
55781652|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
55781653|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
55781654|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781655|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805205|NCT05479747|Analgesics|analgesics|mesh-list
55781656|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781657|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55781658|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781659|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55781660|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55781661|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55781662|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55781663|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55781664|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55781665|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
55781666|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
55781667|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
55781668|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
55781669|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781670|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781672|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55781673|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781674|NCT02372461|Amoxicillin|amoxicillin|mesh-list
55781675|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55781676|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781677|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
55781678|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55781679|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
55781680|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55781681|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781682|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55781683|NCT04499131|Progesterone|progesterone|mesh-list
55781684|NCT04499131|Progestins|progestins|mesh-ancestor
55781685|NCT04499131|Hormones|hormones|mesh-ancestor
55781686|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781687|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781688|NCT02366065|Acetaminophen|acetaminophen|mesh-list
55781689|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55781690|NCT02366065|Analgesics|analgesics|mesh-ancestor
55781691|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
55781692|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781693|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781694|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
55781696|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
55781698|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781699|NCT02365909|Bupivacaine|bupivacaine|mesh-list
55781700|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
55781701|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
55783649|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781702|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781703|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781704|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
55781709|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55781710|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
55781711|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781712|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55781713|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
56216701|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216702|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216703|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216704|NCT01627145|Urological Agents|urological agents|mesh-ancestor
56216705|NCT01627158|Budesonide|budesonide|mesh-list
56216706|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
55792971|NCT05380947|Rabeprazole|rabeprazole|mesh-list
55781714|NCT02365675|Petrolatum|petrolatum|mesh-list
55781715|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55781716|NCT02365675|Laxatives|laxatives|mesh-ancestor
55781717|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781718|NCT02365675|Emollients|emollients|mesh-ancestor
55781719|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
55781720|NCT05052437|Capecitabine|capecitabine|mesh-list
55781721|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55781722|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
55781723|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003545|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003546|NCT00000658|Antidotes|antidotes|mesh-ancestor
56003547|NCT00000658|Protective Agents|protective agents|mesh-ancestor
56003548|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
55781724|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781725|NCT05052359|Lectins|lectins|mesh-list
55781726|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
55781727|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
55781728|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781729|NCT05052359|Coagulants|coagulants|mesh-ancestor
55781730|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
55781731|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55781732|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55781733|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
55781734|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55781735|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781736|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55781737|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55781738|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55781739|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55781741|NCT02362711|Hormones|hormones|mesh-ancestor
55781742|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781743|NCT01944046|Oxytocin|oxytocin|mesh-list
55781744|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
55781745|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55781746|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781747|NCT00773695|Paclitaxel|paclitaxel|mesh-list
55781748|NCT00773695|Docetaxel|docetaxel|mesh-list
55781749|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
55781750|NCT00773695|Bevacizumab|bevacizumab|mesh-list
55781751|NCT00773695|Fluorouracil|fluorouracil|mesh-list
55781752|NCT00773695|Epirubicin|epirubicin|mesh-list
55781754|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55781755|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781756|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
55781757|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
55781758|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
55781759|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781760|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55781761|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
55781762|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781763|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55781764|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55781765|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
55781766|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55781767|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55781768|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55781769|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55781770|NCT00773695|Growth Substances|growth substances|mesh-ancestor
55781771|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
55781772|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
55781773|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55781774|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55781775|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781776|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55781777|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
55783650|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783651|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
55781780|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55781781|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55781782|NCT01969084|Linagliptin|linagliptin|mesh-list
55781783|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55781784|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781785|NCT01969084|Incretins|incretins|mesh-ancestor
55781786|NCT01969084|Hormones|hormones|mesh-ancestor
55781787|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781788|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55781789|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
55781790|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781791|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781792|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
55781793|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781794|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
55781795|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55781796|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55781797|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781798|NCT02362399|Urological Agents|urological agents|mesh-ancestor
55781800|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55781801|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781802|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781803|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781804|NCT02358499|Posaconazole|posaconazole|mesh-list
55781805|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
55781806|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781807|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55781808|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55781809|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55781810|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55781811|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55781812|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781813|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781814|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55781815|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
55781816|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781817|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781819|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
55781820|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
55781821|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781822|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55781823|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
55781824|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
55781825|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781826|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781827|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781828|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55781829|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
55781830|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55781831|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
55781832|NCT01968694|Promethazine|promethazine|mesh-list
55781833|NCT01968694|Lidocaine|lidocaine|mesh-list
55781834|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
55781835|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
55781836|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781837|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781838|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
55781839|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781840|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55781841|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55781842|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55781843|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55740014|NCT03388463|Omeprazole|omeprazole|mesh-list
55781844|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781845|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55781846|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55783652|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783653|NCT05004545|Propofol|propofol|mesh-list
55781850|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55781851|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
55781852|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
55781853|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216707|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56216708|NCT01627158|Charcoal|charcoal|mesh-list
56216709|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55781854|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55781855|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
55781856|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
55781857|NCT04639414|Empagliflozin|empagliflozin|mesh-list
55781858|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55781859|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781860|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55781861|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781862|NCT05038007|Bupivacaine|bupivacaine|mesh-list
55781863|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
55781864|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
55781865|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781866|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781867|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
55781868|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781869|NCT02362165|Dexamethasone|dexamethasone|mesh-list
55781870|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
55781871|NCT02362165|Doxorubicin|doxorubicin|mesh-list
55781873|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55781874|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
55781875|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781876|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55781877|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55781878|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
55781879|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781880|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781881|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55781882|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55781883|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
55781884|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
55781885|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781886|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781887|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
55781888|NCT02362165|Hormones|hormones|mesh-ancestor
55781889|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781890|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55781891|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55781892|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55781893|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55781895|NCT05049473|Cytarabine|cytarabine|mesh-list
55781896|NCT05049473|Dexamethasone|dexamethasone|mesh-list
55781897|NCT05049473|Prednisone|prednisone|mesh-list
55781898|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
55781899|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
55781900|NCT05049473|Rituximab|rituximab|mesh-list
55781901|NCT05049473|Doxorubicin|doxorubicin|mesh-list
55781902|NCT05049473|Methotrexate|methotrexate|mesh-list
55781903|NCT05049473|Etoposide|etoposide|mesh-list
55781904|NCT05049473|Vincristine|vincristine|mesh-list
55781905|NCT05049473|Vindesine|vindesine|mesh-list
55781906|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55781907|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
55781908|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781909|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55781910|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55781911|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
55781912|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781913|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781914|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55781915|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55781916|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55781917|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
55781918|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
55781919|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781920|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55783654|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55781921|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
55781930|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
55781931|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55781932|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56216711|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
56216712|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216713|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216714|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56216715|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
55781933|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
55781934|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
55781935|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55805243|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
55781936|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55781937|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55781938|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
55781939|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781940|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
55781941|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
55781942|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
55781944|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
55781945|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55781946|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55781947|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55781948|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781949|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781950|NCT02357797|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55781951|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55781952|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55781953|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781954|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781955|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
55781956|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55781957|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55781958|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55781959|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56003549|NCT00000658|Vitamins|vitamins|mesh-ancestor
56003550|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
56003551|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56003552|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
56003553|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
56003554|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
56003555|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
56003556|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55781960|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
55781961|NCT02361931|Hematinics|hematinics|mesh-ancestor
55781962|NCT05037695|Empagliflozin|empagliflozin|mesh-list
55781963|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55781964|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781965|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55781966|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781967|NCT02357563|Leuprolide|leuprolide|mesh-list
55781968|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
55781969|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55781970|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
55781971|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55781972|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781973|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55781974|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781975|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55781976|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
55781977|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55781978|NCT02640053|Paclitaxel|paclitaxel|mesh-list
55781979|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55781980|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55781981|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781982|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
55781983|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
55781984|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
55781985|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781986|NCT03160261|Exenatide|exenatide|mesh-list
55781988|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781989|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55781990|NCT03160261|Incretins|incretins|mesh-ancestor
55781991|NCT03160261|Hormones|hormones|mesh-ancestor
55783655|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783656|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783657|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55783658|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
56216716|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
56216717|NCT01627158|Hormones|hormones|mesh-ancestor
56216718|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216719|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56216720|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56216721|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55781992|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781993|NCT04478617|Metronidazole|metronidazole|mesh-list
55781994|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781995|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55781996|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55781997|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55781998|NCT02361775|Ropivacaine|ropivacaine|mesh-list
55781999|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
55782000|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
55782001|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782002|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782003|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
55782004|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782005|NCT02361619|Clarithromycin|clarithromycin|mesh-list
55782007|NCT02361619|Metoprolol|metoprolol|mesh-list
55782008|NCT02361619|Midazolam|midazolam|mesh-list
55782009|NCT02361619|Caffeine|caffeine|mesh-list
56003557|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
56003558|NCT02684474|HBOC 201|hboc 201|mesh-list
56003559|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
56003560|NCT01027793|Tretinoin|tretinoin|mesh-list
56003561|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003562|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
56003563|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
56003564|NCT00002146|Foscarnet|foscarnet|mesh-list
56003565|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56003566|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
55782010|NCT02361619|Esomeprazole|esomeprazole|mesh-list
55782011|NCT02361619|Dabigatran|dabigatran|mesh-list
55782012|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55782013|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55782014|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782015|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782016|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55782017|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55782018|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782019|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55782020|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
55782021|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
55782022|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
55782023|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
55782024|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782025|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782026|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55782027|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782028|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55782029|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782030|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55782031|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55782032|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55782033|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55782034|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
55782035|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55782036|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55782037|NCT02361619|Analgesics|analgesics|mesh-ancestor
55782038|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
55782039|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782040|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782041|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782042|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55782043|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55782044|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782045|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55782046|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55782047|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55782048|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
55782049|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55782050|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
55782051|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
55782052|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55782053|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55782054|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
56216722|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56216723|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792991|NCT05016349|Alitretinoin|alitretinoin|mesh-list
55782056|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55782057|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55782061|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
55782062|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55782063|NCT02352025|Estrogens|estrogens|mesh-ancestor
55782064|NCT02352025|Hormones|hormones|mesh-ancestor
55782065|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782066|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782067|NCT01950364|Rifampin|rifampin|mesh-list
55782068|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55782069|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55782070|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55782071|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782072|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
55782073|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782074|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55782075|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
55782076|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55782077|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782078|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
55782079|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55782080|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782081|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782082|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55782083|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55782084|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55782085|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55782086|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55782087|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55782088|NCT05047991|Leucovorin|leucovorin|mesh-list
55782089|NCT05047991|Gemcitabine|gemcitabine|mesh-list
55782090|NCT05047991|Paclitaxel|paclitaxel|mesh-list
55782091|NCT05047991|Fluorouracil|fluorouracil|mesh-list
55782092|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
55782093|NCT05047991|Irinotecan|irinotecan|mesh-list
55782094|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55782095|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782096|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
55782097|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
55782098|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
55782099|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782100|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55782101|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
55782102|NCT05047991|Antiviral Agents|antiviral agents|mesh-ancestor
56003567|NCT00002146|Analgesics|analgesics|mesh-ancestor
56003568|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
56003569|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003570|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003571|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
56003572|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56003573|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56003574|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
56003575|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56003576|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56003577|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003578|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56003579|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
56003580|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56003581|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
56003582|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003583|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55782103|NCT05047991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782104|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782105|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55782106|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
55782107|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782108|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55782109|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55782110|NCT05047991|Antidotes|antidotes|mesh-ancestor
55782111|NCT05047991|Protective Agents|protective agents|mesh-ancestor
55782112|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
55782113|NCT05047991|Vitamins|vitamins|mesh-ancestor
55782114|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
55782115|NCT00014443|Thalidomide|thalidomide|mesh-list
55782116|NCT00014443|Topotecan|topotecan|mesh-list
55782117|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55782118|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55782119|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782120|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782121|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782122|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55782123|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
55782124|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782126|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55782127|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782128|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55782129|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55782130|NCT00014443|Growth Substances|growth substances|mesh-ancestor
55782131|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
55783662|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
55783663|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783664|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783665|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55783666|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55783667|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
55783668|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783669|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783670|NCT04463615|Leflunomide|leflunomide|mesh-list
55783671|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783672|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783673|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55782134|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55782135|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55782136|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782137|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782138|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55782139|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55782140|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782141|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55782142|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
55782143|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
55782144|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
55782145|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
55782146|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782147|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782148|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55782149|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55782150|NCT02351869|Analgesics|analgesics|mesh-ancestor
55782151|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
55782152|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782153|NCT05035745|Talazoparib|talazoparib|mesh-list
55740272|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
55782154|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55782155|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782156|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782157|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782158|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
55782159|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55782160|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55782161|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782162|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
55782163|NCT05047133|Coagulants|coagulants|mesh-ancestor
55782164|NCT04334863|Tyrphostins|tyrphostins|mesh-list
55782165|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782166|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782167|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782168|NCT05047211|Dextrans|dextrans|mesh-list
55782169|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
55782170|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
55782171|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
55782172|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
55782173|NCT05047211|Hematinics|hematinics|mesh-ancestor
55782174|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
55782175|NCT02357407|Ofloxacin|ofloxacin|mesh-list
55782176|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55782177|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782178|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55782179|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55782180|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782181|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782182|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783674|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
55783675|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783676|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
55783677|NCT05003765|Buprenorphine|buprenorphine|mesh-list
55783678|NCT05003765|Bupivacaine|bupivacaine|mesh-list
55783679|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55783680|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
55783681|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
55783682|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783683|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783699|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
56216724|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216725|NCT01627158|Antidotes|antidotes|mesh-ancestor
56216726|NCT01627158|Protective Agents|protective agents|mesh-ancestor
56216727|NCT01627171|Bisacodyl|bisacodyl|mesh-list
56216728|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
56216729|NCT01627171|Cathartics|cathartics|mesh-ancestor
56216730|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56216731|NCT01627171|Laxatives|laxatives|mesh-ancestor
56216732|NCT01627223|Lamivudine|lamivudine|mesh-list
56216733|NCT01627223|Entecavir|entecavir|mesh-list
56216734|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56216735|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55782183|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55782184|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55782185|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55782186|NCT02357407|Renal Agents|renal agents|mesh-ancestor
55782187|NCT02038699|TIC10 compound|tic10 compound|mesh-list
55782188|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782189|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
55782190|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55782191|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55782192|NCT03160651|Prednisolone|prednisolone|mesh-list
55782193|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
55782194|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55782195|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
55782196|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782197|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
55782198|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
55782199|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782200|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782201|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782202|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
55782203|NCT03160651|Hormones|hormones|mesh-ancestor
55782204|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782205|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55782206|NCT03160651|Protective Agents|protective agents|mesh-ancestor
55783701|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55782207|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55782208|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782210|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55782211|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
55782212|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782213|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
55782214|NCT05034965|Protective Agents|protective agents|mesh-ancestor
55782215|NCT03160339|Vaccines|vaccines|mesh-list
55782216|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
55782217|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782218|NCT05034887|Trastuzumab|trastuzumab|mesh-list
55782219|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55782220|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782221|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
55782222|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55782223|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
55782224|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782237|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55782238|NCT05024825|Analgesics|analgesics|mesh-ancestor
55782239|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
55782240|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782241|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782242|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
55782243|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55782244|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782245|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782246|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55782247|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782248|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782249|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
55782250|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55782251|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55782252|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782253|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782254|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55782255|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55805267|NCT04274335|Coagulants|coagulants|mesh-ancestor
55782257|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
55782258|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55782259|NCT05024825|Narcotics|narcotics|mesh-ancestor
55782260|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
55782261|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
55782262|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55782263|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
55782264|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
55782265|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
55782266|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
55782267|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782268|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55782269|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782270|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782272|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55782273|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55782274|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55782275|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
55782276|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55783702|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782278|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
55782279|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782280|NCT05024357|Dasatinib|dasatinib|mesh-list
55782281|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782282|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55782283|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782284|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782285|NCT03095105|Resveratrol|resveratrol|mesh-list
55782286|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
55782288|NCT03095105|Protective Agents|protective agents|mesh-ancestor
55782289|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782290|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782291|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55782292|NCT01968070|Celecoxib|celecoxib|mesh-list
55782293|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55782294|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55782295|NCT01968070|Analgesics|analgesics|mesh-ancestor
55782296|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
55782297|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782298|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782299|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782300|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782301|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55782302|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55782303|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782304|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782305|NCT01949662|Lorazepam|lorazepam|mesh-list
55782306|NCT01949662|Haloperidol|haloperidol|mesh-list
55782307|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
55782308|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
55782309|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
55782310|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782311|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782312|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782313|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55782314|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55782315|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782316|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782317|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55782318|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
55782319|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782320|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216736|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216737|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782321|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55782322|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
55782323|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55782324|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55782325|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
55782326|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
55782327|NCT03093389|Resveratrol|resveratrol|mesh-list
55782328|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
55782329|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782330|NCT03093389|Protective Agents|protective agents|mesh-ancestor
55782331|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782332|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782333|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55782334|NCT01949116|Folic Acid|folic acid|mesh-list
55782335|NCT01949116|Methotrexate|methotrexate|mesh-list
55782336|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55782337|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
55782338|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55782339|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782340|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55782341|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
55782342|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782343|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782344|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
55782345|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782346|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55782347|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55782348|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
55782349|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782350|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55782351|NCT01949116|Hematinics|hematinics|mesh-ancestor
55782352|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
55782353|NCT01949116|Vitamins|vitamins|mesh-ancestor
55782354|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
55782355|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
55782356|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782357|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55782358|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782359|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782360|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
55782365|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782366|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782367|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
55782368|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
55782369|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782370|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
55782371|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55782372|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
55782373|NCT02350543|Aspirin|aspirin|mesh-list
55782374|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55782375|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55782376|NCT02350543|Analgesics|analgesics|mesh-ancestor
55782377|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
55782378|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782379|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782380|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782381|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782382|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55782383|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55782384|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782385|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55782386|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55782387|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782388|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
55782389|NCT05023577|Metronidazole|metronidazole|mesh-list
55782390|NCT05023577|Clarithromycin|clarithromycin|mesh-list
55782391|NCT05023577|Levofloxacin|levofloxacin|mesh-list
55782392|NCT05023577|Ofloxacin|ofloxacin|mesh-list
55782393|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
55782394|NCT05023577|Rabeprazole|rabeprazole|mesh-list
55782395|NCT05023577|Bismuth|bismuth|mesh-list
55876625|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216738|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
56216739|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216740|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55782396|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782397|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782398|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55782399|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55782400|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55782401|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55782402|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782403|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55782404|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55782405|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55782406|NCT05023577|Renal Agents|renal agents|mesh-ancestor
55782407|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55782408|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55782409|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782410|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55782411|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55782412|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782413|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55782414|NCT05023577|Antacids|antacids|mesh-ancestor
55782415|NCT05023577|Diuretics|diuretics|mesh-ancestor
55782416|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
55782417|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782418|NCT05023577|Expectorants|expectorants|mesh-ancestor
55782419|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
55783703|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
55783704|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55783705|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783706|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
55783707|NCT02333305|Vitamins|vitamins|mesh-ancestor
55783708|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
55782420|NCT03149419|Paroxetine|paroxetine|mesh-list
55782421|NCT03149419|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55782422|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55782423|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55782424|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782425|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782426|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
55782429|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
55782430|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782431|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55782432|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55782433|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782434|NCT03092765|Quetmolimab|quetmolimab|mesh-list
55782435|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782437|NCT01939366|Analgesics|analgesics|mesh-ancestor
55782438|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
55782439|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782440|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782441|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
55782442|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55782443|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55782444|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782445|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55782446|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55782447|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55782448|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782449|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782450|NCT04434365|Aspirin|aspirin|mesh-list
55782451|NCT04434365|Clopidogrel|clopidogrel|mesh-list
55782452|NCT04434365|Atorvastatin|atorvastatin|mesh-list
55782453|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55782454|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55782455|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55782456|NCT04434365|Analgesics|analgesics|mesh-ancestor
55782457|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
55782458|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782459|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216741|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56216742|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
56216743|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55793011|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55782460|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782461|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782462|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55782463|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55782464|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782465|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55782466|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55782467|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782469|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56003607|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003608|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
56003609|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782470|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55782471|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
55782472|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55782473|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55782474|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55782475|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55782476|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55782477|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
55782478|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782479|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
55782480|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55783709|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783710|NCT02326987|Pregabalin|pregabalin|mesh-list
55783711|NCT02326987|Analgesics|analgesics|mesh-ancestor
55783712|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
55783713|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783714|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783715|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
55783716|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55783717|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55783718|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783719|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55782481|NCT03149575|Carboplatin|carboplatin|mesh-list
55782482|NCT03149575|Temozolomide|temozolomide|mesh-list
55782483|NCT03149575|Lomustine|lomustine|mesh-list
55782484|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
55782485|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782486|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55782487|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
55782490|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55782491|NCT05032001|Biguanides|biguanides|mesh-list
55782492|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782493|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55782494|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782495|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
55782496|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782497|NCT03147859|Vedolizumab|vedolizumab|mesh-list
55782498|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782499|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
55782500|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55782501|NCT05031689|Protective Agents|protective agents|mesh-ancestor
55782502|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782503|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
55782504|NCT02350231|Progesterone|progesterone|mesh-list
55782505|NCT02350231|Progestins|progestins|mesh-ancestor
55782506|NCT02350231|Hormones|hormones|mesh-ancestor
55782507|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782508|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782509|NCT01918306|Cisplatin|cisplatin|mesh-list
55782510|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782511|NCT05031143|Triamcinolone|triamcinolone|mesh-list
55782512|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55782513|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55782514|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55782515|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782516|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
55782517|NCT05031143|Hormones|hormones|mesh-ancestor
55782518|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216744|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56216745|NCT01627236|Prednisolone|prednisolone|mesh-list
56216746|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
55782519|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782520|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55782521|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
55782522|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782523|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782524|NCT01916980|Desloratadine|desloratadine|mesh-list
55782525|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55782526|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
55782527|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814925|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
55782528|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782529|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782530|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55782531|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55783720|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55783721|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55783722|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783723|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55783724|NCT02331511|Aspirin|aspirin|mesh-list
55783726|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55783727|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55783728|NCT02331511|Analgesics|analgesics|mesh-ancestor
55783729|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
55783730|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783731|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783732|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783733|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55783734|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55783735|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55783736|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783737|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55783738|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55783739|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783740|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
55783741|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55783742|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55783743|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55783744|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
55783745|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783746|NCT02326441|KX2-361|kx2-361|mesh-list
55783749|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783751|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
55783752|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
55783753|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783754|NCT02039791|Paclitaxel|paclitaxel|mesh-list
55783755|NCT02039791|Carboplatin|carboplatin|mesh-list
55782532|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
55782533|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
55783756|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
55783757|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55783758|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783759|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
55783760|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
55783761|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
55783762|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783763|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55783764|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
55783765|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55783766|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
55783767|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783768|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783769|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55783770|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
55783771|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55783772|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55783773|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55783774|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
56216747|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56003610|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003611|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003612|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003613|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
56003614|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003615|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003616|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003617|NCT00000670|Zidovudine|zidovudine|mesh-list
56003618|NCT00000670|Probenecid|probenecid|mesh-list
56003619|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
56003620|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003621|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003622|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003623|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216748|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
56216749|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56216751|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
55783775|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783776|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783777|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
55783778|NCT03111511|Drospirenone|drospirenone|mesh-list
55783779|NCT03111511|Midazolam|midazolam|mesh-list
55782534|NCT02348281|Bicalutamide|bicalutamide|mesh-list
55782535|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
55782536|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
55782537|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782538|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782539|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782540|NCT04638400|Simvastatin|simvastatin|mesh-list
55782541|NCT04638400|Ezetimibe|ezetimibe|mesh-list
55782542|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55782543|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55782544|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
55782545|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782546|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55782547|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55782548|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782549|NCT02349919|Procaterol|procaterol|mesh-list
55782552|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782553|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782554|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55782555|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
55782556|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
55782557|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55783780|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55783781|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
55783783|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55783784|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55783785|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783786|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782558|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55782559|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55782560|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
55782561|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782563|NCT02349763|Dexamethasone|dexamethasone|mesh-list
55782564|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
55782565|NCT02349763|BB 1101|bb 1101|mesh-list
55782566|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782567|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
55782568|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
55782569|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782570|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782571|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782572|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
55782573|NCT02349763|Hormones|hormones|mesh-ancestor
55782574|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782575|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55782576|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782577|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
55782578|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782579|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782580|NCT02349841|Amoxicillin|amoxicillin|mesh-list
55782581|NCT02349841|Meropenem|meropenem|mesh-list
55782582|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
55782583|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
55782584|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55782585|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782586|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782587|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876626|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56216752|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793019|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
55782588|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55782589|NCT02354053|Triumeq|triumeq|mesh-list
55782590|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55782591|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55782592|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
55782594|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55782595|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782596|NCT03094481|Epinephrine|epinephrine|mesh-list
55782597|NCT03094481|Bupivacaine|bupivacaine|mesh-list
55782598|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
55782599|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
55782600|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782601|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782602|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
55782603|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782604|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55782605|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55782606|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
55782607|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782608|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782609|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55782610|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55782611|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
55782612|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55782613|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
55782614|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
55782615|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
55782616|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55783787|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55783788|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55783789|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55783790|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55783791|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
55783792|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
55783793|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
55783794|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
55783795|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783796|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783797|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55783798|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55783799|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55783800|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
55783801|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783802|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55783803|NCT03111511|Estrogens|estrogens|mesh-ancestor
55783807|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
55783808|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55782619|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55782620|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55782621|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782622|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782623|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782624|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782625|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
55782626|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
55782627|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782628|NCT02348125|Protective Agents|protective agents|mesh-ancestor
55782629|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782630|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
55782631|NCT02348125|Vitamins|vitamins|mesh-ancestor
55782632|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
55782633|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
55782634|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55782635|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782636|NCT03094403|Azelaic acid|azelaic acid|mesh-list
55782637|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782638|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
55782639|NCT02347891|Belimumab|belimumab|mesh-list
55782640|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55782641|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
56216753|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216754|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56216755|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
55782642|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782643|NCT03147157|Tacrolimus|tacrolimus|mesh-list
55782644|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55782645|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
55782646|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782647|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55782648|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782649|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783809|NCT03111511|Diuretics|diuretics|mesh-ancestor
55783810|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
55783811|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
55783812|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783813|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
55783814|NCT03144115|Oxytocin|oxytocin|mesh-list
55783815|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
55783816|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783817|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783818|NCT02326285|Docetaxel|docetaxel|mesh-list
55783819|NCT02326285|Gefitinib|gefitinib|mesh-list
55783820|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783821|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
55783822|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
56003631|NCT00000670|Renal Agents|renal agents|mesh-ancestor
56003633|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56003634|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003635|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56003636|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003637|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
56003638|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56003639|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003640|NCT00000694|Interferons|interferons|mesh-list
56003641|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
56003642|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
56003643|NCT00000694|Zidovudine|zidovudine|mesh-list
56003644|NCT00000694|Sargramostim|sargramostim|mesh-list
56003645|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003646|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
55783823|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
55783824|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783825|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55783826|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783827|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
55783828|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55783829|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55783830|NCT02332603|Prednisolone|prednisolone|mesh-list
55783831|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
55783832|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55783833|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
55783834|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783835|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
55783836|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
55783837|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783838|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783839|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55783840|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
55783841|NCT02332603|Hormones|hormones|mesh-ancestor
55783842|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783843|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55783844|NCT02332603|Protective Agents|protective agents|mesh-ancestor
55783845|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55783846|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782650|NCT03091595|Drospirenone|drospirenone|mesh-list
55783847|NCT02332447|Naloxone|naloxone|mesh-list
55783848|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55783849|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783850|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
55783851|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783852|NCT05077813|Vitamin D|vitamin d|mesh-list
55783853|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
55783854|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
55783855|NCT05077813|Vitamins|vitamins|mesh-list
55783856|NCT05077813|Minocycline|minocycline|mesh-list
55783857|NCT05077813|Tretinoin|tretinoin|mesh-list
55783858|NCT05077813|Alitretinoin|alitretinoin|mesh-list
55783859|NCT05077813|Isotretinoin|isotretinoin|mesh-list
55783860|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
55783861|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003647|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003648|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
56003649|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003650|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
56003651|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783862|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55783863|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55783864|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55783865|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783866|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783867|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
55783868|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
55783869|NCT02326051|Enoxaparin|enoxaparin|mesh-list
55783870|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
55783871|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
55783872|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56216756|NCT01627236|Hormones|hormones|mesh-ancestor
56216757|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216758|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55783873|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55783874|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783875|NCT05076955|Vancomycin|vancomycin|mesh-list
55783876|NCT05076955|Tobramycin|tobramycin|mesh-list
55783877|NCT05076955|Itraconazole|itraconazole|mesh-list
55782652|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55782653|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55782654|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55782655|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
55782656|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55782657|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782658|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55782659|NCT03091595|Estrogens|estrogens|mesh-ancestor
55782660|NCT03091595|Hormones|hormones|mesh-ancestor
55782661|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782662|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55782663|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
55782664|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55782665|NCT03091595|Diuretics|diuretics|mesh-ancestor
55782666|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
55782667|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55782668|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55782669|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783878|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55783879|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783880|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
55783881|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55783882|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55783883|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782670|NCT02347501|Incretins|incretins|mesh-ancestor
55782671|NCT02347501|Hormones|hormones|mesh-ancestor
55782672|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782673|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55782674|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
55782675|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782676|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782678|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55782679|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
56003652|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003653|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003654|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003655|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003656|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003657|NCT01894412|Etanercept|etanercept|mesh-list
56003658|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56003659|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56003660|NCT01894412|Analgesics|analgesics|mesh-ancestor
55782680|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55782681|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782682|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55782683|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782684|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
55782685|NCT02349607|Ibuprofen|ibuprofen|mesh-list
55782686|NCT02349607|Pregabalin|pregabalin|mesh-list
55782687|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55782688|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55782689|NCT02349607|Analgesics|analgesics|mesh-ancestor
55782695|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55782696|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782697|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782699|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55782700|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55782701|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55782702|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55782703|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55782704|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782705|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782706|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
55782707|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
55782708|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782709|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782711|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55782712|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
55782713|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782714|NCT04108481|Durvalumab|durvalumab|mesh-list
56216759|NCT01627236|Protective Agents|protective agents|mesh-ancestor
56216760|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56216761|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216763|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56216764|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56216765|NCT01627262|Analgesics|analgesics|mesh-ancestor
56216766|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
56216767|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793025|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
55782715|NCT04108481|Methamphetamine|methamphetamine|mesh-list
55782716|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55782717|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55782718|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782719|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
55782720|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782721|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55782722|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
55782723|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
55782724|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782725|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
55782726|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782727|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783884|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783885|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55783886|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
55783887|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782728|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
55782729|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55782730|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55782731|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55782732|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55782733|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55782734|NCT02353507|Laxatives|laxatives|mesh-ancestor
55782735|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782736|NCT03148561|Misoprostol|misoprostol|mesh-list
55782738|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
55782739|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55782740|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782741|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55782742|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782743|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
55782744|NCT02353429|Toremifene|toremifene|mesh-list
55782745|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55782746|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782747|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55782748|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55782749|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
55782750|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782751|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782752|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55782753|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55782759|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782761|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782762|NCT03112135|Epinephrine|epinephrine|mesh-list
56003664|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56003665|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003666|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56003667|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003668|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
56003669|NCT00000700|Zidovudine|zidovudine|mesh-list
56003670|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
55741039|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55782763|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
55782764|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55782765|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55782766|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782767|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
55782768|NCT03112135|Coagulants|coagulants|mesh-ancestor
55782769|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56216768|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216769|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56216771|NCT01627353|Dexamethasone|dexamethasone|mesh-list
56216772|NCT01627353|Lidocaine|lidocaine|mesh-list
56216773|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
55782770|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55782771|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
55782772|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782773|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782774|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55782775|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55782776|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
55782777|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782778|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55782779|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
55782780|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
55782782|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55782783|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
55782784|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55782785|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782786|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782787|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
55782788|NCT03146533|Fludarabine|fludarabine|mesh-list
55782789|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55782790|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
55783888|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783889|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55783890|NCT05077111|Anesthetics|anesthetics|mesh-list
55783891|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782791|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782792|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782793|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55782794|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
55782795|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782796|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782797|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55782798|NCT03090971|Diclofenac|diclofenac|mesh-list
55782799|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55782800|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55782801|NCT03090971|Analgesics|analgesics|mesh-ancestor
55782802|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
55782803|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782804|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782805|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782806|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782807|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55782808|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782809|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782810|NCT03146689|Ibuprofen|ibuprofen|mesh-list
55782811|NCT03146689|Capsaicin|capsaicin|mesh-list
55782812|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55782813|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55782814|NCT03146689|Analgesics|analgesics|mesh-ancestor
55782815|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
55782816|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782817|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782820|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55782822|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782823|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
55782824|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
55782826|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55782827|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782828|NCT05026229|Cytarabine|cytarabine|mesh-list
55782829|NCT05026229|Prednisone|prednisone|mesh-list
55782831|NCT05026229|Vincristine|vincristine|mesh-list
55782832|NCT05026229|Dasatinib|dasatinib|mesh-list
55782833|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782834|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
55782835|NCT05026229|Hormones|hormones|mesh-ancestor
56216774|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56216775|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
56216776|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
56216777|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782836|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55782837|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782838|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55782839|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782840|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55782842|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55782843|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55782844|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
55782845|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782846|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
55782847|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782848|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55782849|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55782850|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
55782851|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782852|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55782853|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
55782854|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782855|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55783892|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783894|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783895|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55783896|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55783897|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782856|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
55782857|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
55782858|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
55782859|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55782860|NCT02343679|Ceritinib|ceritinib|mesh-list
55782861|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782862|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55782863|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782864|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782865|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55782866|NCT02348905|Hormones|hormones|mesh-ancestor
55789060|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782867|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789061|NCT03171805|Propranolol|propranolol|mesh-list
55782869|NCT02347033|Sertraline|sertraline|mesh-list
55782870|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
55782871|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782872|NCT02347033|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55782873|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55782874|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55782875|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782876|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782877|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
55782878|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782879|NCT04949633|Oxytocin|oxytocin|mesh-list
55782880|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
55782881|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55782882|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782883|NCT03146377|Capecitabine|capecitabine|mesh-list
55782885|NCT03146377|Irinotecan|irinotecan|mesh-list
55782890|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55782891|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55782892|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782893|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
55782894|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55782895|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782896|NCT03079505|Dasatinib|dasatinib|mesh-list
55782897|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782898|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55782899|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216778|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216779|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56216780|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
55782900|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782902|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55782903|NCT02343211|Antibodies|antibodies|mesh-list
55782904|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
55782905|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782906|NCT03090503|Risperidone|risperidone|mesh-list
55782907|NCT03090503|Aripiprazole|aripiprazole|mesh-list
55782908|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55782909|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
55782910|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782911|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782912|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782913|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55782914|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55783898|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783899|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55782915|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55782916|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55782917|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55782918|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
55782919|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
55782920|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
55782921|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55782922|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55782923|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55782924|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55782925|NCT02343289|Clarithromycin|clarithromycin|mesh-list
55782926|NCT02343289|Esketamine|esketamine|mesh-list
55782927|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55782928|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55782929|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55782930|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791913|NCT03098407|Narcotics|narcotics|mesh-ancestor
55791914|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791915|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791916|NCT03098407|Analgesics|analgesics|mesh-ancestor
55791917|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
56003671|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003672|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003673|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55791918|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791919|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55791920|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
55791921|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
55791923|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
55791924|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
55791925|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791926|NCT04836143|Growth Substances|growth substances|mesh-ancestor
55791927|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791929|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55791930|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
55791931|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791932|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
55791933|NCT00751075|Amoxicillin|amoxicillin|mesh-list
55791934|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55791935|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791936|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791937|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
55791939|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
55791940|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791941|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
55791942|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55791944|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55791945|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791946|NCT00651391|Simvastatin|simvastatin|mesh-list
55791947|NCT00651391|Ezetimibe|ezetimibe|mesh-list
55793462|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55793463|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793464|NCT05294835|Ketamine|ketamine|mesh-list
55793465|NCT05294835|Analgesics|analgesics|mesh-ancestor
55793466|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
55793467|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216781|NCT01627353|Hormones|hormones|mesh-ancestor
56216782|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216783|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56216784|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793048|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793468|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793469|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55793470|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55793471|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
55793472|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
55793473|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793474|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55793475|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55793476|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793477|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793478|NCT02522325|Cocaine|cocaine|mesh-list
55793479|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
55795500|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795501|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783900|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
55783901|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783902|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783903|NCT02330419|Naltrexone|naltrexone|mesh-list
55783904|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55783905|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55783906|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783907|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
55783908|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783909|NCT05068141|Paclitaxel|paclitaxel|mesh-list
55783910|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55783911|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783912|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
55783913|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
55783914|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
55795502|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55795503|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55795505|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
55795506|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795507|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55795508|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55795509|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795510|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795511|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
55797048|NCT04425707|Ivermectin|ivermectin|mesh-list
55797049|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
55797050|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55797756|NCT02577107|Ranibizumab|ranibizumab|mesh-list
55797757|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55797758|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55797759|NCT02577107|Growth Substances|growth substances|mesh-ancestor
55799073|NCT02453841|Protective Agents|protective agents|mesh-ancestor
55799074|NCT03081689|Paclitaxel|paclitaxel|mesh-list
55799075|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55799076|NCT03081689|Carboplatin|carboplatin|mesh-list
55799077|NCT03081689|Nivolumab|nivolumab|mesh-list
55799078|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55799079|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799080|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
55799081|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
55799082|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
55799083|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799084|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55799484|NCT05529095|Apomorphine|apomorphine|mesh-list
55799485|NCT05529095|Emetics|emetics|mesh-ancestor
55799486|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799487|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
55799761|NCT05171777|Atezolizumab|atezolizumab|mesh-list
55799762|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216785|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216786|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
56216787|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
56216788|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216789|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
56216790|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56216791|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55799763|NCT04112095|Norgestrel|norgestrel|mesh-list
55799764|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55799765|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55799766|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55799767|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
55799768|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55799769|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799770|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55799771|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55799772|NCT05257993|Gemcitabine|gemcitabine|mesh-list
55783915|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783916|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
55783917|NCT03142165|Promethazine|promethazine|mesh-list
55783918|NCT03142165|Famotidine|famotidine|mesh-list
55783919|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55783920|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55783921|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783922|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783923|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
55783924|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
55783925|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
55783926|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783927|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
55783928|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
55783929|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55783930|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55783931|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
55783932|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
55783933|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783934|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783935|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55783936|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
55799773|NCT05257993|Paclitaxel|paclitaxel|mesh-list
55800161|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
55800162|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800163|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800164|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
55800165|NCT05531591|Aripiprazole|aripiprazole|mesh-list
55800166|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
55800167|NCT05531591|Bupropion|bupropion|mesh-list
55800662|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55800663|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56003675|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
56003676|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003677|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55800664|NCT05503667|Growth Substances|growth substances|mesh-ancestor
55800665|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800666|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
55800668|NCT05512481|Apatinib|apatinib|mesh-list
55800750|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55800751|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800752|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
55800753|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800754|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55800756|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800757|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55800759|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800760|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800761|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55800762|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
55800763|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
56216792|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56216793|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56216794|NCT01627353|Analgesics|analgesics|mesh-ancestor
55800764|NCT04342039|Hormones|hormones|mesh-ancestor
55800765|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800766|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
55800767|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
55783937|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
55783938|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55783939|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55783942|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55783943|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783944|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55783945|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783946|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
55783947|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
55800768|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55800769|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800770|NCT04338529|Vitamins|vitamins|mesh-ancestor
55800771|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
55800772|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55800773|NCT04338529|Antacids|antacids|mesh-ancestor
55800774|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800775|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800776|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
55800777|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
55800778|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55800779|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55800780|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800781|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800782|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800783|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800784|NCT03043495|Dexamethasone|dexamethasone|mesh-list
55801141|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55801142|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55801143|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55801202|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
55801203|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
55801205|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55801206|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
55801207|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55801208|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55801209|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55801210|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
55801211|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801212|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801213|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801214|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
55801215|NCT03040765|Denosumab|denosumab|mesh-list
55801216|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55801217|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801218|NCT01668667|Gabapentin|gabapentin|mesh-list
55801219|NCT01668667|Analgesics|analgesics|mesh-ancestor
55801220|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
55801221|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801222|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801223|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
55801224|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55801225|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55801226|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801227|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55801228|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55801229|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55801230|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801231|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801232|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
55801233|NCT03040219|Folic Acid|folic acid|mesh-list
55801234|NCT03040219|Hematinics|hematinics|mesh-ancestor
55783948|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783949|NCT05076019|Atorvastatin|atorvastatin|mesh-list
56216795|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
55783950|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55783951|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55783952|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
55783953|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783954|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55783955|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55783956|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783957|NCT04988971|Corticosterone|corticosterone|mesh-list
55783958|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
55783959|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801235|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
55801236|NCT03040219|Vitamins|vitamins|mesh-ancestor
55801237|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
55801238|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801239|NCT03038503|Terlipressin|terlipressin|mesh-list
55801240|NCT03038503|Methylene Blue|methylene blue|mesh-list
55801241|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801338|NCT04842487|Vincristine|vincristine|mesh-list
55801339|NCT04842487|Lenalidomide|lenalidomide|mesh-list
55801340|NCT04842487|Doxorubicin|doxorubicin|mesh-list
55801341|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55801342|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55801343|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
55801344|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801413|NCT04312243|Protective Agents|protective agents|mesh-ancestor
55801414|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
55801415|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55801416|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55801418|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
55801465|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801466|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801467|NCT03036085|Epinephrine|epinephrine|mesh-list
55801468|NCT03036085|Bupivacaine|bupivacaine|mesh-list
55801469|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
55801470|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
55801471|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801472|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801473|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
55801474|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801475|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55801476|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55801477|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
55801478|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801479|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801480|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55801481|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55801482|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
55801483|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55801484|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
55801485|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
55801486|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
55801488|NCT04831255|Triamcinolone|triamcinolone|mesh-list
55801489|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55801490|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55801491|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55801543|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55801544|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
55801545|NCT02412657|Hormones|hormones|mesh-ancestor
55801546|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801547|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55801548|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801549|NCT02412111|Ivacaftor|ivacaftor|mesh-list
55801550|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55801551|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55801552|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801553|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
55801554|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55801555|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801556|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55803078|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
56216797|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56216798|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
55803079|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803080|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
55803081|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
55803082|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55803083|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55803084|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
55803237|NCT05051449|Analgesics|analgesics|mesh-ancestor
55803238|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
55803239|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803371|NCT02343939|Azacitidine|azacitidine|mesh-list
55803372|NCT02343939|Decitabine|decitabine|mesh-list
55803373|NCT02343939|Daunorubicin|daunorubicin|mesh-list
55803374|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55803375|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
55803396|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55803397|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
55803398|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803399|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55803400|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
55803401|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55803402|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
55803403|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803404|NCT02395653|Fentanyl|fentanyl|mesh-list
55803405|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55803406|NCT02395653|Narcotics|narcotics|mesh-ancestor
55803407|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803408|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803409|NCT02395653|Analgesics|analgesics|mesh-ancestor
55803410|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
55803411|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803412|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55803413|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55803414|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
55803415|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
55803416|NCT01664923|Bicalutamide|bicalutamide|mesh-list
55803417|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
55803418|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
55803419|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803420|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803421|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803422|NCT04778527|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55803423|NCT04778527|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55803424|NCT04778527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55803425|NCT04778527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803426|NCT04778527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783963|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783964|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783966|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55783967|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
55803478|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55803479|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803480|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803481|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803482|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55803483|NCT02581345|Adalimumab|adalimumab|mesh-list
55803484|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55803485|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55803486|NCT05579509|Fentanyl|fentanyl|mesh-list
55803487|NCT05579509|Midazolam|midazolam|mesh-list
55803488|NCT05579509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55803489|NCT05579509|Narcotics|narcotics|mesh-ancestor
55803490|NCT05579509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803491|NCT05579509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803492|NCT05579509|Analgesics|analgesics|mesh-ancestor
55803493|NCT05579509|Sensory System Agents|sensory system agents|mesh-ancestor
55803494|NCT05579509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216799|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56216800|NCT01627379|Panitumumab|panitumumab|mesh-list
55803495|NCT05579509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55803496|NCT05579509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55803497|NCT05579509|Anesthetics, General|anesthetics, general|mesh-ancestor
55803500|NCT05579509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55803501|NCT05579509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55803502|NCT05579509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55803503|NCT05579509|GABA Modulators|gaba modulators|mesh-ancestor
55803504|NCT05579509|GABA Agents|gaba agents|mesh-ancestor
55803505|NCT05579509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55803506|NCT05579509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803507|NCT05696431|Fluorides|fluorides|mesh-list
55803508|NCT05696431|Cariostatic Agents|cariostatic agents|mesh-ancestor
55803509|NCT05696431|Protective Agents|protective agents|mesh-ancestor
55803510|NCT05696431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803511|NCT05628883|Cyclophosphamide|cyclophosphamide|mesh-list
55803512|NCT05628883|Fludarabine|fludarabine|mesh-list
55803513|NCT05628883|Interleukin-2|interleukin-2|mesh-list
55803514|NCT05628883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55803515|NCT05628883|Immunologic Factors|immunologic factors|mesh-ancestor
55803516|NCT05628883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803517|NCT05628883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55803518|NCT05628883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55803519|NCT05628883|Alkylating Agents|alkylating agents|mesh-ancestor
55803520|NCT05628883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803521|NCT05628883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803589|NCT00352027|Bleomycin|bleomycin|mesh-list
55803590|NCT00352027|Vinblastine|vinblastine|mesh-list
55803591|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55803592|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
55803593|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803594|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55803595|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55803596|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
55803597|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803598|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803599|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55803600|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55803601|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55803602|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55803672|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803674|NCT04425187|Bevacizumab|bevacizumab|mesh-list
55803675|NCT04425187|Gefitinib|gefitinib|mesh-list
55803676|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803677|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759333|NCT04569045|Lidocaine|lidocaine|mesh-list
55741587|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55783968|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783969|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783970|NCT02329561|Tramadol|tramadol|mesh-list
55783971|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55783972|NCT02329561|Narcotics|narcotics|mesh-ancestor
55783973|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783974|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783975|NCT02329561|Analgesics|analgesics|mesh-ancestor
55783976|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
55783977|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783978|NCT03143491|Paclitaxel|paclitaxel|mesh-list
55783979|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55783980|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783981|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
55783982|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
55783983|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
55803678|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55803679|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55803680|NCT04425187|Growth Substances|growth substances|mesh-ancestor
55803681|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803682|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
55803683|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55803684|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803685|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216802|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56216803|NCT01627431|Aspirin|aspirin|mesh-list
56216804|NCT01627431|Clopidogrel|clopidogrel|mesh-list
55793062|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
55803686|NCT05519839|Vaccines|vaccines|mesh-list
55803687|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
55803688|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803719|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55803720|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
55803721|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803722|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803727|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
55803784|NCT04302181|Ropivacaine|ropivacaine|mesh-list
55803785|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
55803786|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
55803787|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803788|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803789|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
55803790|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803791|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
55803792|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803793|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803794|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
55803795|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55803796|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55803797|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
55803798|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55803799|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803800|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803801|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
55803802|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
55783984|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783985|NCT05002673|Anesthetics|anesthetics|mesh-list
55783986|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55783987|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783988|NCT03076151|Tacrolimus|tacrolimus|mesh-list
55783989|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55783990|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
55783991|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783992|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55783993|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783994|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783995|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
55803803|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803855|NCT01606189|Analgesics|analgesics|mesh-ancestor
55803856|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
55803857|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803858|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803859|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
55803860|NCT05525065|Hormones|hormones|mesh-ancestor
55803861|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803862|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803863|NCT01663987|Bromides|bromides|mesh-list
55803864|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
55803865|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55803866|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
55803867|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803868|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803869|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55803870|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
55803871|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
55803872|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55803873|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
55803874|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56003678|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55730957|NCT02874430|Metformin|metformin|mesh-list
56003680|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56003681|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56003682|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
56003683|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003684|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003685|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003686|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003687|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
56003688|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003689|NCT00000706|Zidovudine|zidovudine|mesh-list
56003690|NCT00000706|Quinine|quinine|mesh-list
56003691|NCT00000706|Probenecid|probenecid|mesh-list
56003692|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
56003693|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803938|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
55803939|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55803940|NCT02378961|Velpatasvir|velpatasvir|mesh-list
55803941|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
55803942|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803943|NCT05140525|Macitentan|macitentan|mesh-list
56216805|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56216806|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56216807|NCT01627431|Analgesics|analgesics|mesh-ancestor
55803944|NCT05140525|Riociguat|riociguat|mesh-list
55803945|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55803946|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55803947|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803948|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55803949|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
55803950|NCT05518513|Bupivacaine|bupivacaine|mesh-list
55804003|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804004|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
55804005|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55804006|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804007|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804008|NCT05522491|Olaparib|olaparib|mesh-list
55804009|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55804010|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783996|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55783997|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55783998|NCT05002517|Prednisolone|prednisolone|mesh-list
55783999|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
55784000|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55784001|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
55784002|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784003|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
55784004|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
55784005|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784006|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784007|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784008|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
55784009|NCT05002517|Hormones|hormones|mesh-ancestor
55784010|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784011|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55804011|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804012|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804013|NCT02340975|Durvalumab|durvalumab|mesh-list
55804014|NCT02340975|Tremelimumab|tremelimumab|mesh-list
55804015|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55804016|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804017|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804122|NCT05521633|Metformin|metformin|mesh-list
55804123|NCT05521633|Pioglitazone|pioglitazone|mesh-list
55804124|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55804125|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804126|NCT04411693|Dexamethasone|dexamethasone|mesh-list
55804127|NCT04411693|Aflibercept|aflibercept|mesh-list
55804128|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55804129|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
55804130|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
55804131|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804132|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804133|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804134|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
55804135|NCT04411693|Hormones|hormones|mesh-ancestor
55804136|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804137|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55804138|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804139|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55804167|NCT02336607|Protective Agents|protective agents|mesh-ancestor
55804168|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55805306|NCT05487001|Dexamethasone|dexamethasone|mesh-list
55804169|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55804170|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
55804171|NCT02569801|Fulvestrant|fulvestrant|mesh-list
55804172|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55804173|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804174|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55804175|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55804176|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
55804177|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804184|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
56216808|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
56216809|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216810|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804185|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
55804186|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
55804247|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55804248|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55804249|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55804250|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
55804251|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804300|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55804301|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
55804302|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
55804304|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
55804305|NCT04847947|Vitamins|vitamins|mesh-ancestor
55804306|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
55804307|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804308|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55804309|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55804310|NCT05514925|Bevacizumab|bevacizumab|mesh-list
55804311|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804312|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804313|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55804314|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55804315|NCT05514925|Growth Substances|growth substances|mesh-ancestor
55804316|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804317|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
55804318|NCT05514847|Aspirin|aspirin|mesh-list
55804319|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55804320|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55804321|NCT05514847|Analgesics|analgesics|mesh-ancestor
55805223|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
55805224|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55805225|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55805226|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55805227|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
55805228|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805229|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805230|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55805231|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
55805232|NCT05479357|Oxytocin|oxytocin|mesh-list
55805233|NCT05479357|Carbetocin|carbetocin|mesh-list
55805346|NCT05475379|Vaccines|vaccines|mesh-list
55805347|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
55805348|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805349|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
55805350|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
55805351|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805352|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
55805446|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
55805447|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805448|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805482|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55805483|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
55805484|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742923|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
55742924|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
55742925|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742926|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742927|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742930|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742931|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742932|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863450|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805485|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55805486|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805487|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55805488|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805489|NCT02554279|Menotropins|menotropins|mesh-list
55806208|NCT02545075|Dacarbazine|dacarbazine|mesh-list
55806209|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806210|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806211|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55806518|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55806519|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806521|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806522|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806524|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55806525|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55806526|NCT05487521|Prednisolone|prednisolone|mesh-list
55806527|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
55806528|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55806529|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
55806530|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806610|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806611|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806614|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806615|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55806616|NCT05492669|Lidocaine|lidocaine|mesh-list
55806617|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
55806618|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
55806619|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806620|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806621|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
55806622|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806623|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55806624|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55806731|NCT02551991|Fluorouracil|fluorouracil|mesh-list
55806732|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
55806733|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
55806734|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806735|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55806912|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806913|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55806914|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55806915|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55806916|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806917|NCT02542631|Insulin|insulin|mesh-list
55806918|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55806919|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55806920|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806921|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
55806922|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806923|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806924|NCT02549573|Apomorphine|apomorphine|mesh-list
55806925|NCT02549573|Emetics|emetics|mesh-ancestor
55806926|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806927|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
55806928|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807164|NCT03029351|Exenatide|exenatide|mesh-list
55807165|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55807166|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807167|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55807168|NCT03029351|Incretins|incretins|mesh-ancestor
55807169|NCT03029351|Hormones|hormones|mesh-ancestor
56003698|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003699|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003700|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55784016|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784017|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
55784018|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
55784019|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784020|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784021|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784022|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
56216814|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56216815|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216816|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56216817|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55784024|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784025|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55807170|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807171|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55807172|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
55807289|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807290|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807291|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807292|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55807293|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55807441|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
55807442|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807443|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807444|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807445|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807446|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55807447|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807448|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55807711|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807712|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55807921|NCT05610085|GABA Modulators|gaba modulators|mesh-ancestor
55807922|NCT05610085|GABA Agents|gaba agents|mesh-ancestor
55807923|NCT05610085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55807955|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55807956|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
55807957|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
55807958|NCT05509933|Hormones|hormones|mesh-ancestor
55807959|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807960|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55807961|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55807962|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
55807963|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807964|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55807965|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55807966|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
55808577|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55808578|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55808580|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808581|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55808682|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55808683|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
55808684|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55808685|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808859|NCT05123131|Lenalidomide|lenalidomide|mesh-list
55808860|NCT05123131|Bortezomib|bortezomib|mesh-list
55808861|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55808862|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
55808863|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
55808864|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808865|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808895|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
55808896|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808897|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55808898|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55808899|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
55808900|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55808901|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
55808902|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808903|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
55808904|NCT01364467|Guaifenesin|guaifenesin|mesh-list
56216818|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216819|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
55808905|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
55808906|NCT01364467|Expectorants|expectorants|mesh-ancestor
55808907|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
55808908|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55808909|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55808910|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808968|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55808969|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55808970|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
55808971|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
55808972|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
55808973|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
55808974|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808975|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808976|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
55808977|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
55808978|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
55808979|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
55809330|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809331|NCT04966585|Posaconazole|posaconazole|mesh-list
55809332|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
55809333|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809334|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55809335|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55809336|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55809337|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55809338|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55809339|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809340|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809341|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55809386|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
55809854|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809856|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55809857|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
55809858|NCT02447887|Ixazomib|ixazomib|mesh-list
55809859|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809860|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
55809861|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809889|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
55809890|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
55809891|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809892|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809893|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
55809894|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809895|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55809896|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55809899|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809901|NCT02469961|Propofol|propofol|mesh-list
55809902|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55809903|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809904|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809942|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55784026|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003709|NCT00000706|Analgesics|analgesics|mesh-ancestor
56003710|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
56003711|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
56003712|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
56003713|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003714|NCT00000706|Renal Agents|renal agents|mesh-ancestor
56003715|NCT00988325|Oseltamivir|oseltamivir|mesh-list
55784028|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55784029|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
55784030|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55784031|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784032|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
55784033|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55784034|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809943|NCT02415127|Interferons|interferons|mesh-list
55809980|NCT01651039|Hormones|hormones|mesh-ancestor
55809981|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809982|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55810048|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216820|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56216821|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56216822|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56216823|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
56216824|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216825|NCT01627587|Ketoconazole|ketoconazole|mesh-list
56216826|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
55810049|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810051|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55810052|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
55810053|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810054|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810055|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55810118|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55810119|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55810120|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
55810121|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810122|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55810123|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55810319|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810320|NCT04256213|Nivolumab|nivolumab|mesh-list
55810321|NCT04256213|Ipilimumab|ipilimumab|mesh-list
55810322|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810323|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810324|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55810325|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810326|NCT02268045|Rituximab|rituximab|mesh-list
55810327|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810328|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810417|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55810418|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810419|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55810420|NCT04909333|Incretins|incretins|mesh-ancestor
55810421|NCT04909333|Hormones|hormones|mesh-ancestor
55810422|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810423|NCT04909021|Vaccines|vaccines|mesh-list
55810424|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
55810425|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810426|NCT02460991|Sorafenib|sorafenib|mesh-list
55810428|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55810429|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810430|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814926|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55810431|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55810432|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55810636|NCT05640375|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55810637|NCT05640375|Prednisolone phosphate|prednisolone phosphate|mesh-list
55810638|NCT05640375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810639|NCT05640375|Antiemetics|antiemetics|mesh-ancestor
55810640|NCT05640375|Autonomic Agents|autonomic agents|mesh-ancestor
55810641|NCT05640375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810673|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810675|NCT01639131|Antiviral Agents|antiviral agents|mesh-ancestor
55810676|NCT01639131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784035|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784036|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55784037|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55810677|NCT01639131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810678|NCT01639131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55810679|NCT01639131|Immunologic Factors|immunologic factors|mesh-ancestor
55810680|NCT01639131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810681|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
55810682|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
55810683|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
55810685|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56216827|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216828|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56216829|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56216830|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216831|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216832|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56216833|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
55793082|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810686|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55810687|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810733|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55810734|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810735|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810736|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55810737|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55810738|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810740|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55810741|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
55810742|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810743|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810744|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55810746|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
55810747|NCT05369091|Simvastatin|simvastatin|mesh-list
55810748|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56003716|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
56003717|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003718|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003719|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003720|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
56003721|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56003722|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
56003723|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003724|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
56003725|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810749|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55810993|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
55810994|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
55810995|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810996|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55811120|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811122|NCT02817633|Docetaxel|docetaxel|mesh-list
55811123|NCT02817633|Nivolumab|nivolumab|mesh-list
55811124|NCT02817633|Pemetrexed|pemetrexed|mesh-list
55811125|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811126|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
55811127|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
55811128|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
55811129|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811130|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811131|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55811132|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811133|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55811316|NCT05180097|Antiviral Agents|antiviral agents|mesh-ancestor
55811317|NCT05180097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811318|NCT05180097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811319|NCT05180097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811320|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
55811321|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811322|NCT01635153|Micronutrients|micronutrients|mesh-list
55811323|NCT01635153|Trace Elements|trace elements|mesh-list
55811324|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811325|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55811326|NCT04446039|Vortioxetine|vortioxetine|mesh-list
55811327|NCT04446039|Mirtazapine|mirtazapine|mesh-list
55811328|NCT04446039|Citalopram|citalopram|mesh-list
55811329|NCT04446039|Bupropion|bupropion|mesh-list
55811330|NCT04446039|Fluoxetine|fluoxetine|mesh-list
55811331|NCT04446039|Paroxetine|paroxetine|mesh-list
55811332|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55811334|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55811335|NCT04446039|Tianeptine|tianeptine|mesh-list
55811336|NCT04446039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55811337|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55812799|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
56216834|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216835|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216836|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55812800|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784038|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55784039|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55784040|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55812801|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55812802|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55812803|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
55812804|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55812805|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55813253|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813254|NCT05381753|Sunitinib|sunitinib|mesh-list
55813255|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
55813256|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813257|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55813258|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55813259|NCT05381753|Growth Substances|growth substances|mesh-ancestor
55813260|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813261|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
55813262|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55813263|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813264|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003731|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
56003732|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813265|NCT02527421|Betamethasone|betamethasone|mesh-list
55813391|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55813392|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55813394|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55813395|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
55813396|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813397|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813398|NCT05305859|Azacitidine|azacitidine|mesh-list
55813399|NCT05305859|Venetoclax|venetoclax|mesh-list
55813400|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55813401|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
55813402|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813564|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813565|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813566|NCT04422275|Budesonide|budesonide|mesh-list
55813567|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813568|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55813569|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
55813609|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55813610|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
55813611|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813612|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813613|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55813614|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55813615|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
55813616|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55813617|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
55813618|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55813619|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55813620|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55813621|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55813622|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55813623|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55813624|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55813626|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55813627|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55813658|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55813659|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
55813660|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55813662|NCT02524145|Protective Agents|protective agents|mesh-ancestor
55813663|NCT05357417|Bevacizumab|bevacizumab|mesh-list
56216837|NCT01627626|Pilocarpine|pilocarpine|mesh-list
56216838|NCT01627626|Miotics|miotics|mesh-ancestor
56216839|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
56216840|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216841|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216842|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55813664|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55813665|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813666|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55813667|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55813668|NCT05357417|Growth Substances|growth substances|mesh-ancestor
55784041|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55784042|NCT02329171|Imiquimod|imiquimod|mesh-list
55784043|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55784044|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
55784045|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784048|NCT04498741|Midazolam|midazolam|mesh-list
55784049|NCT04498741|Dabigatran|dabigatran|mesh-list
55784050|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55784051|NCT04498741|Tacrolimus|tacrolimus|mesh-list
55784052|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55784053|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
55784054|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784055|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55784056|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813669|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813818|NCT04895917|Pomalidomide|pomalidomide|mesh-list
55813819|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813820|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
55813821|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813822|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55813823|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55813824|NCT04895917|Growth Substances|growth substances|mesh-ancestor
55813825|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
55813827|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55813828|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55813829|NCT02161575|Growth Substances|growth substances|mesh-ancestor
55813830|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813831|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
55813832|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813833|NCT02161185|Midazolam|midazolam|mesh-list
55813834|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55813835|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55813836|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813837|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813838|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55813839|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55813840|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55813841|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55813842|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
55813843|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
55813844|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
55813845|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
55813846|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813847|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813848|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
55813849|NCT02159469|Testosterone|testosterone|mesh-list
55813850|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
55813851|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
55813852|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55813853|NCT02159469|Androgens|androgens|mesh-ancestor
55813854|NCT02159469|Hormones|hormones|mesh-ancestor
55813855|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813856|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813857|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55813858|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813859|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
55813860|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
55876627|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56003733|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003734|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003735|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003736|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
56003737|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003738|NCT00002308|Stavudine|stavudine|mesh-list
56003739|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
55742933|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742934|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742935|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55742937|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55742939|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55742940|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55742941|NCT03351517|Tapentadol|tapentadol|mesh-list
55742942|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55742943|NCT03351517|Narcotics|narcotics|mesh-ancestor
55742944|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742945|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742946|NCT03351517|Analgesics|analgesics|mesh-ancestor
55784057|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784059|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55784060|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784061|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55784062|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55784063|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55784064|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55784065|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
55784066|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
55784067|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
55784068|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
55784069|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813861|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55813862|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
55813863|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813864|NCT02123511|Expectorants|expectorants|mesh-ancestor
55813865|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
55813967|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813971|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
55814099|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55814100|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
55814184|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
55814185|NCT05157971|Hormones|hormones|mesh-ancestor
55814186|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814187|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55814188|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55814189|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
55814190|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55814191|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55814192|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
55814193|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814194|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814195|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55814196|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55814197|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
55814198|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814199|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55814200|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814201|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814202|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
55814203|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55814204|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55814205|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55814206|NCT05250791|Lidocaine|lidocaine|mesh-list
55814207|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
55814241|NCT02175771|Hormones|hormones|mesh-ancestor
55814242|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814243|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
55814244|NCT01657799|Veliparib|veliparib|mesh-list
55814245|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55814246|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814272|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
55814273|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814274|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
55814276|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814277|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814278|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55784070|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55814279|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814280|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
55814281|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
56003740|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003741|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55814282|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814283|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55814284|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55814285|NCT05248139|Protective Agents|protective agents|mesh-ancestor
55814286|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814287|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
55814288|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55814289|NCT05247905|Capecitabine|capecitabine|mesh-list
55814290|NCT05247905|Temozolomide|temozolomide|mesh-list
55814291|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55814292|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55814293|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
55814294|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216844|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
56216845|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216846|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814331|NCT02367781|Carboplatin|carboplatin|mesh-list
55814332|NCT02367781|Pemetrexed|pemetrexed|mesh-list
55814333|NCT02367781|Atezolizumab|atezolizumab|mesh-list
55814334|NCT02367781|Antibodies|antibodies|mesh-list
55814353|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55814354|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55814355|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55814356|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55814357|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814358|NCT05239091|Lidocaine|lidocaine|mesh-list
55814359|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
55814360|NCT05239091|Anesthetics|anesthetics|mesh-list
55814361|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814362|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814363|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
55814364|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814365|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55814366|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55814367|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55814368|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814369|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814370|NCT02152371|Metformin|metformin|mesh-list
55814371|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
55814372|NCT02152371|Dulaglutide|dulaglutide|mesh-list
55814373|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55814374|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814375|NCT02332291|Citalopram|citalopram|mesh-list
55814376|NCT02332291|Bupropion|bupropion|mesh-list
55814377|NCT02332291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55814378|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55814379|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814380|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814381|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814382|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
55814383|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814384|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55814385|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
55814386|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814387|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55814388|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
55814389|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55814419|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
55814420|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814421|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55814422|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55814423|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814424|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55814425|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55814426|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814427|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814428|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
55814429|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814430|NCT05182151|Istradefylline|istradefylline|mesh-list
55814431|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
55784071|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55784072|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
55784073|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55784074|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55784075|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
55814455|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814457|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814458|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
56216848|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
56216849|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56216850|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216851|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216852|NCT01627639|Diuretics|diuretics|mesh-ancestor
55814459|NCT02300311|Vitamins|vitamins|mesh-ancestor
55814460|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
55814461|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55814462|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814463|NCT05140499|Bupivacaine|bupivacaine|mesh-list
55814464|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
55814465|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
55814466|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814467|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814468|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
55814469|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814470|NCT04229381|Coal Tar|coal tar|mesh-list
55814471|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
55814472|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814474|NCT05178485|Bupivacaine|bupivacaine|mesh-list
55814475|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
55814476|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
55814477|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56003752|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56003753|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738833|NCT03408847|Hormones|hormones|mesh-ancestor
56003754|NCT00000724|Antidotes|antidotes|mesh-ancestor
56003755|NCT00000724|Protective Agents|protective agents|mesh-ancestor
56003756|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
56003757|NCT00000724|Vitamins|vitamins|mesh-ancestor
56003758|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
56003759|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
56003760|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003761|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55742388|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55814478|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814479|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
55814480|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814481|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814482|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
55814483|NCT05178485|Hormones|hormones|mesh-ancestor
55814597|NCT04881799|Topiramate|topiramate|mesh-list
55814598|NCT04881799|Phentermine|phentermine|mesh-list
55814599|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
55814600|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55814601|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814602|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55814603|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
55814604|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55814639|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55814641|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55814642|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814643|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
55814728|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814730|NCT05093621|Torsemide|torsemide|mesh-list
55814731|NCT05093621|Furosemide|furosemide|mesh-list
55814732|NCT05093621|Diuretics|diuretics|mesh-ancestor
55814733|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
55814734|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814735|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55814736|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814737|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814738|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55814739|NCT02112045|Melphalan|melphalan|mesh-list
55814740|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55814741|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
55814769|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55814770|NCT05090657|Methylene Blue|methylene blue|mesh-list
55814771|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55814772|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814773|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
55814774|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814775|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814776|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814777|NCT05048849|Somatomedin B|somatomedin b|mesh-list
55814778|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55814779|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55784076|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55784077|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
56216853|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
56216854|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216855|NCT01627678|Molgramostim|molgramostim|mesh-list
56216856|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56216857|NCT01627678|Sargramostim|sargramostim|mesh-list
55784078|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
55784080|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55784081|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
55784082|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55784083|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
55784084|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814780|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
55814781|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814782|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814783|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55814784|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
55814785|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55814786|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
55814817|NCT05075993|Paclitaxel|paclitaxel|mesh-list
56003763|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003764|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003765|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56003766|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814818|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55814819|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
55814820|NCT05075993|Bevacizumab|bevacizumab|mesh-list
55814821|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55805375|NCT03678025|Bicalutamide|bicalutamide|mesh-list
55814822|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814823|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814824|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814825|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
55814826|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814827|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814828|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
55814829|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814830|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55814861|NCT02147067|Ranolazine|ranolazine|mesh-list
55814862|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55814863|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814864|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814865|NCT02107131|Ranibizumab|ranibizumab|mesh-list
55814866|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55814868|NCT02107131|Growth Substances|growth substances|mesh-ancestor
55814869|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814870|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
55814871|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814872|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
55814874|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
55814875|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814901|NCT02520011|Growth Substances|growth substances|mesh-ancestor
55814902|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55814903|NCT05037539|Fentanyl|fentanyl|mesh-list
55814904|NCT05037539|Morphine|morphine|mesh-list
55814905|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55814906|NCT05037539|Narcotics|narcotics|mesh-ancestor
55814907|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814908|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814909|NCT05037539|Analgesics|analgesics|mesh-ancestor
55814910|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
55814911|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814912|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55814913|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55814914|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
55814915|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
55814916|NCT02519231|Naproxen|naproxen|mesh-list
55814917|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55814918|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55814919|NCT02519231|Analgesics|analgesics|mesh-ancestor
55814920|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
55814921|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814922|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784085|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784086|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
55784088|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
56216858|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
56216859|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216860|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784089|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
55784090|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784091|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784092|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784093|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
55784094|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
55784095|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55784096|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
55784097|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744044|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
55744045|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
55744046|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
55744047|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55744048|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
55744049|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744050|NCT03341845|Avelumab|avelumab|mesh-list
55744051|NCT03341845|Axitinib|axitinib|mesh-list
55744052|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860048|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
55744058|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
55744059|NCT02498977|Azathioprine|azathioprine|mesh-list
55744061|NCT02498977|Cyclosporins|cyclosporins|mesh-list
55814959|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55814960|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55814961|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814962|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814964|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55814965|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55814966|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784111|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784112|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55784113|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
55814967|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814968|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814969|NCT05060627|Dexamethasone|dexamethasone|mesh-list
55814970|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814971|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
55814972|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
55814973|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814974|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814975|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55814976|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
55815007|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815008|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815009|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55815010|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55815011|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
55815012|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815013|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815015|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815016|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815017|NCT05022329|Vaccines|vaccines|mesh-list
56216861|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56216863|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216864|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56216865|NCT01627717|Maraviroc|maraviroc|mesh-list
55815018|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
55815019|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815052|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
55815053|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55815054|NCT04949867|Glucagon|glucagon|mesh-list
55815055|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55815056|NCT04949867|Hormones|hormones|mesh-ancestor
55815057|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815058|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815059|NCT04989491|Rituximab|rituximab|mesh-list
55815060|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55815061|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815062|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
55815063|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815098|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815099|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55815100|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815101|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
55815102|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55815104|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815105|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
55815106|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815153|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55815155|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815156|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
55815157|NCT02141295|Antidotes|antidotes|mesh-ancestor
55815158|NCT02141295|Protective Agents|protective agents|mesh-ancestor
55815159|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
55815160|NCT02141295|Vitamins|vitamins|mesh-ancestor
55815161|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
55815162|NCT02141295|Hematinics|hematinics|mesh-ancestor
55815163|NCT02514551|Paclitaxel|paclitaxel|mesh-list
55815164|NCT02514551|Ramucirumab|ramucirumab|mesh-list
55815165|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55815166|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815167|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
55815168|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
55815169|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
55815261|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
55815262|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
55815263|NCT02068443|Metformin|metformin|mesh-list
55815264|NCT02068443|Alogliptin|alogliptin|mesh-list
55815265|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815266|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815267|NCT02068443|Incretins|incretins|mesh-ancestor
55815268|NCT02068443|Hormones|hormones|mesh-ancestor
55815269|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784114|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784115|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55784116|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55784117|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55784118|NCT02328469|Doxycycline|doxycycline|mesh-list
55784119|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
55784120|NCT02328469|Acyclovir|acyclovir|mesh-list
55784121|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55784122|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784123|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
55784124|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55784125|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55784126|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
55815271|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
55815272|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815273|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815274|NCT04978649|Amlodipine|amlodipine|mesh-list
55815275|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56216866|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55815276|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55815277|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55815278|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815279|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55815280|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815281|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
55815282|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55815283|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55815284|NCT02508935|Narcotics|narcotics|mesh-ancestor
55805387|NCT03678025|Hormones|hormones|mesh-ancestor
55815285|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815286|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815287|NCT02508935|Analgesics|analgesics|mesh-ancestor
55815564|NCT02100657|Bortezomib|bortezomib|mesh-list
55815565|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815566|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
55815567|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
55815568|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815569|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815570|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55815571|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
55815572|NCT02100657|Hormones|hormones|mesh-ancestor
55815573|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815574|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55815575|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815576|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
55815577|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55815578|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
55815579|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55815580|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815581|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55815582|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55815583|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55815584|NCT01909804|Ribavirin|ribavirin|mesh-list
55815585|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
55815586|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815587|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
55815588|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815589|NCT01880086|Clomiphene|clomiphene|mesh-list
55815590|NCT01880086|Enclomiphene|enclomiphene|mesh-list
55815623|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
55815624|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
55815625|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55815626|NCT01878292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55815627|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55815628|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784127|NCT04998071|Bupivacaine|bupivacaine|mesh-list
55784128|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
55784129|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
55784130|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784131|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784132|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
55815629|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815630|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815631|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
55815656|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815660|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
55815661|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815662|NCT02500901|Niraparib|niraparib|mesh-list
55815663|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55815664|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815665|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815666|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815667|NCT01877668|Adalimumab|adalimumab|mesh-list
55815668|NCT01877668|Tofacitinib|tofacitinib|mesh-list
55815669|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815670|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815671|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55815672|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815673|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815674|NCT04629196|Ustekinumab|ustekinumab|mesh-list
55815675|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
55815676|NCT01906372|Hormones|hormones|mesh-list
56216867|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56216868|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216870|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56216871|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
55793118|NCT05018923|Antacids|antacids|mesh-ancestor
56003781|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56003782|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
56003783|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
56003784|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003785|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56003786|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
56003787|NCT00000730|Hormones|hormones|mesh-ancestor
55815677|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55815678|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55815679|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
55815680|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815681|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815682|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815710|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
55815711|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
55815712|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
55815713|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815714|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
55815715|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55815716|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815717|NCT01875250|Metronidazole|metronidazole|mesh-list
55815718|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815719|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55815720|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55815721|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55815722|NCT01904032|Vitamin D|vitamin d|mesh-list
55815723|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
55815724|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
55815725|NCT01904032|Vitamins|vitamins|mesh-list
55815726|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
55815727|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815728|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55815788|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815790|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815791|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
55815792|NCT04415476|Sirolimus|sirolimus|mesh-list
55815793|NCT04415476|Prednisone|prednisone|mesh-list
55815794|NCT04415476|Tacrolimus|tacrolimus|mesh-list
55815795|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815796|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
55815797|NCT04415476|Hormones|hormones|mesh-ancestor
55815798|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815799|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815800|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55815801|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784135|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784136|NCT03073343|Betaine|betaine|mesh-list
55784137|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784138|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
55784139|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55784140|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
55784141|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784142|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55784143|NCT03073265|Apixaban|apixaban|mesh-list
55784144|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55784145|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
55784146|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55784147|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
55784149|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784150|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
55784152|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
55784153|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55784154|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784155|NCT04997837|Capecitabine|capecitabine|mesh-list
55815802|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55815803|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
55815804|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55815805|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876628|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216872|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56216873|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56216874|NCT01627834|Ropinirole|ropinirole|mesh-list
56216875|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56216876|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56216877|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
56216878|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
56216879|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216880|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216881|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216882|NCT01627847|Ropinirole|ropinirole|mesh-list
56216883|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56216884|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55815806|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815807|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55815808|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55815879|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816014|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816015|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55816017|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55816018|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55816019|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
55816020|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816021|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816022|NCT02294773|Letrozole|letrozole|mesh-list
55816023|NCT02294773|Clomiphene|clomiphene|mesh-list
55816024|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816025|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55816026|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55805544|NCT02307513|Analgesics|analgesics|mesh-ancestor
55816073|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
55816074|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55816075|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55816076|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816077|NCT01645111|Clevidipine|clevidipine|mesh-list
55816078|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55816079|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55816080|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784156|NCT04997837|Tegafur|tegafur|mesh-list
55816147|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55816148|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
55816149|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816150|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816151|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55816152|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816153|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
55816304|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55816306|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55816307|NCT01612156|Lidocaine|lidocaine|mesh-list
55816308|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
55816309|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
55816310|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816311|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816312|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
55816313|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816314|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55816315|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55816316|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55816317|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56216886|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
56216887|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56216888|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216889|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216890|NCT01627873|Fentanyl|fentanyl|mesh-list
56216891|NCT01627873|Remifentanil|remifentanil|mesh-list
56216892|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55816318|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816319|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
55816320|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55816384|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
55816385|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
55816386|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
55816387|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816388|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816389|NCT02358343|Sertraline|sertraline|mesh-list
55805563|NCT02305797|Lorazepam|lorazepam|mesh-list
55816390|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
55816391|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55816392|NCT02358343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55816393|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55816394|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55816395|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816469|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55816471|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816472|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816473|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816474|NCT04965701|Osimertinib|osimertinib|mesh-list
55816511|NCT02060487|Urological Agents|urological agents|mesh-ancestor
55816512|NCT04696029|Eflornithine|eflornithine|mesh-list
55816513|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816514|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55816515|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55816516|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55816517|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816518|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
55816519|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816520|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816521|NCT02059239|Cytarabine|cytarabine|mesh-list
55816522|NCT02059239|Rituximab|rituximab|mesh-list
55816523|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
55816524|NCT02059239|Etoposide|etoposide|mesh-list
55816525|NCT02059239|Melphalan|melphalan|mesh-list
55816526|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55816527|NCT02059239|Carmustine|carmustine|mesh-list
55816528|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55816529|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816530|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
55816531|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816532|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816533|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55816534|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55816535|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55816536|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816572|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816573|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816574|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
55816575|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784157|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
55784158|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55816576|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816653|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55816654|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816655|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816656|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216893|NCT01627873|Narcotics|narcotics|mesh-ancestor
56216894|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216895|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216896|NCT01627873|Analgesics|analgesics|mesh-ancestor
56216897|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
56216898|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216899|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56216900|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56216901|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
56216902|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
56216903|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
56216904|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56216905|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216906|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
56216907|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
56216908|NCT01627938|Razoxane|razoxane|mesh-list
56216909|NCT01627938|Analgesics|analgesics|mesh-ancestor
56216910|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
56216911|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216912|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216913|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216914|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56216915|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56216916|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216917|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216918|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56216919|NCT01627938|Protective Agents|protective agents|mesh-ancestor
55816657|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
55816658|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
55816659|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816660|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55816661|NCT01896700|Methylphenidate|methylphenidate|mesh-list
55816662|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55816663|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816664|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55816665|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55816666|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55816667|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816668|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
55816669|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816671|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55816717|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55816718|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816719|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55816720|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55816721|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
55816722|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
56216920|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
56216921|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
56216922|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
56216923|NCT01628055|Antibodies|antibodies|mesh-list
56216924|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
56216925|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56216926|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56216927|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
56216928|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
56216929|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216930|NCT01628341|Insulin|insulin|mesh-list
56216931|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56216932|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216933|NCT01628354|Ranibizumab|ranibizumab|mesh-list
56216934|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55816723|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55816724|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816725|NCT02491463|Vaccines|vaccines|mesh-list
55816726|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
55816727|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816728|NCT02038881|Vaccines|vaccines|mesh-list
55816815|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
55816816|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
55816817|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
55817058|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55817060|NCT02485691|Hormones|hormones|mesh-ancestor
55817061|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817062|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791959|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
55763758|NCT04062201|Clofazimine|clofazimine|mesh-list
55763759|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55763760|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763761|NCT04062201|Renal Agents|renal agents|mesh-ancestor
55817063|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55817064|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817065|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55817066|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817067|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817068|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
55817069|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55817071|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55817072|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55817105|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817106|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
55817108|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817109|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55817110|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817111|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55817112|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55817113|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55817114|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55817115|NCT02484911|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55817212|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817213|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
55817214|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817215|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
55817216|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817217|NCT01852942|Losartan|losartan|mesh-list
55817218|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55817219|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55817220|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55817325|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216935|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56216936|NCT01628354|Growth Substances|growth substances|mesh-ancestor
56216937|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817326|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817327|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55817328|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817329|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55817351|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817352|NCT02366468|Ranibizumab|ranibizumab|mesh-list
55817353|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55817354|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55817355|NCT02366468|Growth Substances|growth substances|mesh-ancestor
55817356|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817357|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
55817358|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817359|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55817360|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55817361|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55817362|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55817363|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817364|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817365|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817366|NCT02335346|Analgesics|analgesics|mesh-ancestor
55817367|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
55817368|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817369|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
55817370|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55817371|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
55817372|NCT02403674|Tenofovir|tenofovir|mesh-list
55817373|NCT02403674|Lamivudine|lamivudine|mesh-list
55817374|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55817375|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
55817376|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817377|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55817379|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817380|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817381|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55805701|NCT05284643|Bevacizumab|bevacizumab|mesh-list
55817383|NCT02401256|Efavirenz|efavirenz|mesh-list
55817384|NCT02401256|Bupropion|bupropion|mesh-list
55817385|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55817386|NCT02401256|Montelukast|montelukast|mesh-list
55817387|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55817388|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55817389|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
55817390|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817391|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55817392|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55817393|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817394|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55817395|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
55817396|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55817398|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55817399|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55817400|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
55817401|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817402|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817403|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55817404|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55817405|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55817406|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
55817407|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55817408|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
55817409|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817410|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55817411|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55817412|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56216938|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
56216939|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216940|NCT01628445|Liraglutide|liraglutide|mesh-list
55793176|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
55784159|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55784160|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
55784161|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784162|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784163|NCT04202263|Minocycline|minocycline|mesh-list
55784164|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55784165|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784166|NCT04996979|Ropivacaine|ropivacaine|mesh-list
55784167|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
55817413|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55817414|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
55817415|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817416|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55817417|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55817418|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55817419|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55817510|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55817511|NCT04906382|Paclitaxel|paclitaxel|mesh-list
55817512|NCT04906382|Carboplatin|carboplatin|mesh-list
55817513|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55817556|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
55817557|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55817558|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817559|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817560|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817562|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817563|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817564|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
55817565|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55817566|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55817567|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817568|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
55817569|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
55817570|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55817571|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55817574|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817575|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817576|NCT04860505|Doxycycline|doxycycline|mesh-list
55817577|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55817578|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817579|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
55817580|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55817581|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55817582|NCT05650099|Cimetidine|cimetidine|mesh-list
55817583|NCT05650099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55817584|NCT05650099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817585|NCT05650099|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55817586|NCT05650099|Histamine Antagonists|histamine antagonists|mesh-ancestor
55817587|NCT05650099|Histamine Agents|histamine agents|mesh-ancestor
55817588|NCT05650099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817589|NCT05650099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817590|NCT05650099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817591|NCT05650099|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56003838|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56003839|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56003840|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
56003841|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56003842|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003843|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56003844|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56003845|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56003846|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003847|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
56003848|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56003849|NCT00002320|Lamivudine|lamivudine|mesh-list
56003850|NCT00002320|Zidovudine|zidovudine|mesh-list
55817592|NCT05650099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55817593|NCT05650099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817594|NCT02278471|Losartan|losartan|mesh-list
55817595|NCT02278471|Amlodipine|amlodipine|mesh-list
55817596|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55817597|NCT02278471|Atorvastatin|atorvastatin|mesh-list
55817598|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55817599|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55817600|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
55817601|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817602|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55784168|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
55784169|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56216941|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56216942|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216943|NCT01628445|Incretins|incretins|mesh-ancestor
56216944|NCT01628445|Hormones|hormones|mesh-ancestor
55793180|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55784170|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784171|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
55784172|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784173|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
55784174|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784175|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55784176|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784177|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784178|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
55817603|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55817604|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817605|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55817606|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55817607|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55817608|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55817609|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817610|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
55817646|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
55817647|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
55817648|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817649|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55817650|NCT04876027|Dulaglutide|dulaglutide|mesh-list
55817707|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817708|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55817709|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55817710|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55817711|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55817713|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
55817714|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817715|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817716|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817717|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55817718|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
55817719|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817720|NCT04856761|Capecitabine|capecitabine|mesh-list
55817721|NCT04856761|Tegafur|tegafur|mesh-list
55817722|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55817774|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817776|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
55817777|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55817778|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55817779|NCT02324270|Analgesics|analgesics|mesh-ancestor
55817780|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
55817813|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55817814|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
55817815|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
55817816|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817817|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
55817818|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55817819|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817820|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55817821|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55817859|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
55817860|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784179|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784180|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784181|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55784182|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
55784183|NCT04997291|Razoxane|razoxane|mesh-list
55784184|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216945|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216946|NCT01628471|Decitabine|decitabine|mesh-list
56216947|NCT01628471|Genistein|genistein|mesh-list
56216948|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56216949|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
55784185|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55784186|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55784187|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55784188|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784189|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817861|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817862|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
55817863|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817864|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55817865|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55817866|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
55817867|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805818|NCT04282109|Nivolumab|nivolumab|mesh-list
55817868|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817870|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
55817871|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
55817872|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55817873|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
55817874|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55817875|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
55817876|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55817877|NCT01844830|Protective Agents|protective agents|mesh-ancestor
55817878|NCT02323334|Itraconazole|itraconazole|mesh-list
55817879|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
55817880|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817881|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55817958|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55818057|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
55818058|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
55818059|NCT02319668|Protective Agents|protective agents|mesh-ancestor
55818060|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818061|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55818062|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818063|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
55818064|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
55818065|NCT02092467|Adalimumab|adalimumab|mesh-list
55818148|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818150|NCT02461745|Ritonavir|ritonavir|mesh-list
55818151|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
55818152|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818153|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
55818154|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818155|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55818156|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55818157|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
55818193|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55818194|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818195|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818196|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
55818338|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818339|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55818340|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818341|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818342|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55818343|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55818344|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
55784190|NCT04997291|Protective Agents|protective agents|mesh-ancestor
55784191|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784192|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
55784193|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
55792054|NCT03036995|Apremilast|apremilast|mesh-list
55784194|NCT02328079|Acyclovir|acyclovir|mesh-list
55784195|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
55784196|NCT02328079|Prednisolone|prednisolone|mesh-list
55784197|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55784198|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
56216950|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784199|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55818345|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818346|NCT02088957|Phenytoin|phenytoin|mesh-list
55818347|NCT02088957|Brivaracetam|brivaracetam|mesh-list
55818348|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55818349|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
55818350|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55818351|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55818352|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818353|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818354|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55818413|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55818415|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
55818416|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818417|NCT04730037|Warfarin|warfarin|mesh-list
55818418|NCT04730037|Edoxaban|edoxaban|mesh-list
55818419|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
55818420|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55818421|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
55818422|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55818423|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
55818424|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818425|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818426|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55818427|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55818479|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55818480|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818481|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818483|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55818515|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
55818516|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818517|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55818518|NCT01652729|Exenatide|exenatide|mesh-list
55818519|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55818520|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818521|NCT01652729|Incretins|incretins|mesh-ancestor
55818522|NCT01652729|Hormones|hormones|mesh-ancestor
55818523|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818524|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55818525|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
55818526|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818655|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818657|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55818659|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
55818660|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818661|NCT02083653|Fluorouracil|fluorouracil|mesh-list
55818666|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55818667|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818668|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818669|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
55805863|NCT05563571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55818670|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818671|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
55818672|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
55818673|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55784200|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
55784202|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
55784203|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784204|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
55818674|NCT02436239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55818675|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55818676|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818677|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818678|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818680|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818681|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55818682|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55818683|NCT02026011|Naltrexone|naltrexone|mesh-list
56216951|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56216952|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216953|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56216954|NCT01628471|Protective Agents|protective agents|mesh-ancestor
55818684|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55818685|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55818686|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818687|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
55818688|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818689|NCT02456909|Morphine|morphine|mesh-list
55818690|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55818691|NCT02456909|Narcotics|narcotics|mesh-ancestor
55818692|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55818693|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818694|NCT02456909|Analgesics|analgesics|mesh-ancestor
55818695|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
55818696|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818697|NCT02025621|Simendan|simendan|mesh-list
55818698|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55818699|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
55818700|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55818701|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55818702|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818703|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818704|NCT02025621|Protective Agents|protective agents|mesh-ancestor
55818705|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818706|NCT04729023|Temazepam|temazepam|mesh-list
55818707|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55818708|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55818709|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818710|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56003851|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003852|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003853|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003854|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003855|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
55818711|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55818712|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55818713|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
55818714|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
55818715|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818716|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818717|NCT02020941|Dexamethasone|dexamethasone|mesh-list
55818718|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55818719|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
55818720|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
55818721|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818722|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818723|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55818724|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
55818725|NCT02020941|Hormones|hormones|mesh-ancestor
55818726|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818727|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55818728|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818729|NCT01823224|Acetaminophen|acetaminophen|mesh-list
55818730|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55818731|NCT01823224|Analgesics|analgesics|mesh-ancestor
55818836|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55818837|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55818838|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55818839|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55818840|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818841|NCT02435147|Denosumab|denosumab|mesh-list
55818843|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784205|NCT02328079|Hormones|hormones|mesh-ancestor
55784206|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784207|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818844|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55818845|NCT02435069|Glycerol|glycerol|mesh-list
55818846|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55818848|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818849|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
55818850|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55818851|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56216955|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818852|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55818853|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818854|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818855|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
55818856|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818857|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818858|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55818859|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818918|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
55818919|NCT01817530|Estradiol|estradiol|mesh-list
55818920|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55818921|NCT01817530|Estrogens|estrogens|mesh-ancestor
55818922|NCT01817530|Hormones|hormones|mesh-ancestor
55818923|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818924|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818925|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55818926|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
55818927|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55818928|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55819040|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
55819041|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819042|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819043|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819044|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
55819045|NCT01612702|Hormones|hormones|mesh-ancestor
55819046|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819047|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55819048|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819049|NCT02431559|Doxorubicin|doxorubicin|mesh-list
55819050|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55819051|NCT02431559|Durvalumab|durvalumab|mesh-list
55819052|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55819053|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819054|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55819055|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55819056|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819082|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55819083|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819084|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55819085|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
55819086|NCT02388191|Naproxen|naproxen|mesh-list
55819087|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55819088|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55819089|NCT02388191|Analgesics|analgesics|mesh-ancestor
55819090|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
55819091|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819092|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819093|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819094|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819095|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
55819096|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55819097|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819098|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819099|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55819100|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
55819101|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784209|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784210|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
55784211|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
55819134|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
55819135|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55819136|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819137|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55819138|NCT04902131|Menotropins|menotropins|mesh-list
55819139|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55819172|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819173|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
56216956|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56216957|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
56216958|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56216959|NCT01628471|Estrogens|estrogens|mesh-ancestor
55819174|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55819175|NCT01814878|Narcotics|narcotics|mesh-ancestor
55819176|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819177|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
55819178|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
55819179|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819180|NCT02407223|Ustekinumab|ustekinumab|mesh-list
55819181|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
56003872|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
56003873|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56003874|NCT02427620|BB 1101|bb 1101|mesh-list
56003875|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819182|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
55819183|NCT04602754|Empagliflozin|empagliflozin|mesh-list
55819184|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55819186|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55819218|NCT02383589|Rituximab|rituximab|mesh-list
55819219|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55819220|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819221|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
55819222|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819223|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819224|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55819225|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55819226|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
55819227|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819228|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819229|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805883|NCT02489903|Gemcitabine|gemcitabine|mesh-list
55819230|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819262|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819264|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819265|NCT02383433|Gemcitabine|gemcitabine|mesh-list
55819266|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55819267|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
55819268|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819269|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819270|NCT02383433|Antiviral Agents|antiviral agents|mesh-ancestor
55819271|NCT02383433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819272|NCT02383433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819273|NCT02383433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819274|NCT02383433|Immunologic Factors|immunologic factors|mesh-ancestor
55819331|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
55819332|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
55819333|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
55819334|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
55819335|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819336|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819337|NCT02402933|Glucagon|glucagon|mesh-list
55819338|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55819339|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819340|NCT02402933|Hormones|hormones|mesh-ancestor
55819341|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819342|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819343|NCT02402933|Incretins|incretins|mesh-ancestor
55819370|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
55819371|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
55819372|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819373|NCT01867294|Doxycycline|doxycycline|mesh-list
55819374|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
55819375|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55819376|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55819377|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55819378|NCT01867294|Spironolactone|spironolactone|mesh-list
55784212|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784213|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784214|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55784215|NCT02328079|Protective Agents|protective agents|mesh-ancestor
55784216|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784217|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
55784218|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55784219|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55784220|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
55819379|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
56216960|NCT01628471|Hormones|hormones|mesh-ancestor
55763838|NCT05390307|Incretins|incretins|mesh-ancestor
55763839|NCT05390307|Hormones|hormones|mesh-ancestor
55763840|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763841|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55763842|NCT05319249|Talazoparib|talazoparib|mesh-list
55763843|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55763844|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763845|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763846|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763847|NCT05318469|Ivermectin|ivermectin|mesh-list
55763848|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55763849|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763850|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56216961|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56216962|NCT01628562|Remifentanil|remifentanil|mesh-list
55819380|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819381|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819383|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
55819384|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55819385|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55819386|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55819387|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
55819388|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819389|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819390|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55819391|NCT01867294|Diuretics|diuretics|mesh-ancestor
55819392|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
55819393|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55819419|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819420|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819422|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
55819423|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
55819424|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819425|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819426|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55819427|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55819428|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
55819429|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819430|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819431|NCT04600336|Urological Agents|urological agents|mesh-ancestor
55819432|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
55819433|NCT01865812|Cathartics|cathartics|mesh-ancestor
55819434|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819435|NCT01808092|Meropenem|meropenem|mesh-list
55819436|NCT01808092|Ceftazidime|ceftazidime|mesh-list
56003876|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
56003877|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003878|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003879|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56003880|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
56003881|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003882|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003883|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56003884|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56003886|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
56003887|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003888|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56003889|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
56003890|NCT02427620|Hormones|hormones|mesh-ancestor
56003891|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56003892|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56003893|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
56003894|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003895|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56003896|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55819437|NCT01808092|Avibactam|avibactam|mesh-list
55819438|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55819439|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819440|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819441|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55819442|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819443|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819444|NCT01807234|Ketorolac|ketorolac|mesh-list
55819445|NCT01807234|Sumatriptan|sumatriptan|mesh-list
55819459|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55819460|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
55819461|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819462|NCT02421887|Antioxidants|antioxidants|mesh-list
55819463|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819464|NCT02421887|Protective Agents|protective agents|mesh-ancestor
55819465|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819466|NCT01789606|Ibuprofen|ibuprofen|mesh-list
55819467|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55819468|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55819469|NCT01789606|Analgesics|analgesics|mesh-ancestor
55819470|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
55819471|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819472|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819473|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819474|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784221|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784222|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805919|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
55784223|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784224|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
55784225|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
55819475|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55819476|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819477|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819478|NCT01788358|Candesartan|candesartan|mesh-list
55819479|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
55819480|NCT01788358|Nifedipine|nifedipine|mesh-list
55819481|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55819482|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56216963|NCT01628562|Esmolol|esmolol|mesh-list
56216964|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56216965|NCT01628562|Narcotics|narcotics|mesh-ancestor
56216966|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819483|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55819484|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819485|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55819486|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55819487|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55819490|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
55819491|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55819492|NCT01773070|Ritonavir|ritonavir|mesh-list
55819493|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55819494|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55819495|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
55819496|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819497|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819498|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55819499|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55819500|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
55819501|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805955|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55819513|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819514|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819515|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55819516|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
55819518|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55819519|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55819520|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55819521|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
55819522|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819523|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819524|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
55819525|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55819526|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
55819527|NCT01772368|Hormones|hormones|mesh-ancestor
55819528|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819529|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
55819530|NCT01806298|Hormones|hormones|mesh-list
55819531|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819532|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819533|NCT01772134|Fluticasone|fluticasone|mesh-list
55819534|NCT01772134|Xhance|xhance|mesh-list
55819535|NCT01772134|Bromides|bromides|mesh-list
55819536|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55819537|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819538|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55819539|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
55819540|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819541|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819542|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55819543|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
55819544|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
55819545|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55819546|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55819547|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55784226|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784227|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
55784228|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55784229|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
55784231|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55784232|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784233|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55784234|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819548|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55819549|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
55819550|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819551|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216967|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56216968|NCT01628562|Analgesics|analgesics|mesh-ancestor
56216969|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
55819552|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
55819553|NCT02017899|Vaccines|vaccines|mesh-list
55819554|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
55819555|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819556|NCT01993329|Mitomycin|mitomycin|mesh-list
55819557|NCT01993329|Cisplatin|cisplatin|mesh-list
55819558|NCT01993329|Ifosfamide|ifosfamide|mesh-list
55819560|NCT01993329|Protective Agents|protective agents|mesh-ancestor
55819561|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819562|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
55819563|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819565|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819566|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55819584|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55819585|NCT02421419|BB 1101|bb 1101|mesh-list
55819586|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819587|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
55819588|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
55819589|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819590|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819591|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819592|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
55819594|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819595|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55819596|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819597|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
55819598|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
55819599|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819600|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
55819601|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55819602|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55819603|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55819604|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56032490|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
55819605|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819606|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
55819607|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819608|NCT02420717|Leucovorin|leucovorin|mesh-list
55819609|NCT02420717|Cytarabine|cytarabine|mesh-list
55819610|NCT02420717|Dexamethasone|dexamethasone|mesh-list
55819611|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
55819612|NCT02420717|Prednisone|prednisone|mesh-list
55819613|NCT02420717|Cortisone|cortisone|mesh-list
55819614|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
55819615|NCT02420717|Rituximab|rituximab|mesh-list
55819616|NCT02420717|Doxorubicin|doxorubicin|mesh-list
55819617|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55819618|NCT02420717|Methotrexate|methotrexate|mesh-list
55819619|NCT02420717|Vincristine|vincristine|mesh-list
55819620|NCT02420717|Daunorubicin|daunorubicin|mesh-list
55819621|NCT02420717|Dasatinib|dasatinib|mesh-list
55819622|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
55819623|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55819624|NCT02420717|Antibodies|antibodies|mesh-list
55784235|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
55784236|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55784237|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
55784238|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784239|NCT03074825|Chiauranib|chiauranib|mesh-list
55784240|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784241|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55784242|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819625|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
55819642|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
55819643|NCT02420717|Hormones|hormones|mesh-ancestor
55819644|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819645|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55819646|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
55819647|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216970|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56216971|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56216972|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56216973|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55819648|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55819649|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55819651|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55819652|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
55819653|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55819654|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55819655|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
55819656|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
55819657|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55819658|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55819659|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
55819660|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819661|NCT02420717|Antidotes|antidotes|mesh-ancestor
55819662|NCT02420717|Protective Agents|protective agents|mesh-ancestor
55819665|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
55819666|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55819667|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
55819668|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
55819669|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
55819670|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55819671|NCT02016105|Adalimumab|adalimumab|mesh-list
55819672|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819673|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819674|NCT02400749|Apremilast|apremilast|mesh-list
55819675|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55819676|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55819677|NCT02400749|Analgesics|analgesics|mesh-ancestor
55819678|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
55819679|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819680|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819681|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819682|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819683|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55819709|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55819710|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
55819711|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819712|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819713|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819715|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819716|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819717|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
55819718|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
55819719|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55819720|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
55819721|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819722|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819723|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55819724|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
55784243|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784245|NCT03072485|Sirolimus|sirolimus|mesh-list
55784246|NCT03072485|Diclofenac|diclofenac|mesh-list
55784247|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55784248|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784249|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55784250|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784251|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55784252|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784253|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
55784254|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55784255|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
55784256|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55819725|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55819726|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56216974|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
56216975|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819727|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55819728|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
55819729|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819730|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819731|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55819732|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55819733|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55819744|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819745|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55819746|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55819747|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55819748|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55819749|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819750|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819751|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819752|NCT01621191|Analgesics|analgesics|mesh-ancestor
55819753|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
55819754|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819755|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
55819756|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55819759|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55819760|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
55819761|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
55819762|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819763|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819764|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
56003897|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56003898|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56003899|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
56003900|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56003901|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56003902|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
56003903|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
55819765|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819766|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
55819767|NCT02343263|Coagulants|coagulants|mesh-ancestor
55819768|NCT02342639|Rifaximin|rifaximin|mesh-list
55819769|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819770|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819771|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819772|NCT01625091|Naltrexone|naltrexone|mesh-list
55819773|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55819774|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55819775|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819776|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
55819777|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819778|NCT02396537|Lidocaine|lidocaine|mesh-list
55819779|NCT02396537|Midazolam|midazolam|mesh-list
55784257|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55784258|NCT03072485|Analgesics|analgesics|mesh-ancestor
55784259|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
55784260|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784261|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784262|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784263|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55784264|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784265|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784266|NCT05080543|Terlipressin|terlipressin|mesh-list
55784267|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55784268|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55784269|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
55784270|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55784271|NCT03074591|Hematinics|hematinics|mesh-ancestor
55784272|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
55784273|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55784274|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
55819780|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
55819781|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
55819782|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819783|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819784|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
55819785|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819786|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55819787|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55819788|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55819789|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55876629|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56216976|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819790|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819791|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55819792|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55819794|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55819795|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55819796|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55819797|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
55819798|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
55819820|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819821|NCT01993017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55819822|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
55819823|NCT01988493|Sorafenib|sorafenib|mesh-list
55819824|NCT01988493|Tepotinib|tepotinib|mesh-list
55819825|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819826|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55819827|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003908|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56003909|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
56003910|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
56003911|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
56003912|NCT02167217|Prednisolone|prednisolone|mesh-list
56003913|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56003914|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
55819828|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819829|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
55819830|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55819831|NCT02081079|Ledipasvir|ledipasvir|mesh-list
55819832|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
55819833|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819834|NCT02081001|Glucagon|glucagon|mesh-list
55819835|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784275|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55784278|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
55784279|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784280|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
55784281|NCT03111433|Vitamins|vitamins|mesh-ancestor
55784282|NCT03915613|Insulin|insulin|mesh-list
55784283|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55784284|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55784285|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784286|NCT03143023|Fluorides|fluorides|mesh-list
55784287|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
55784288|NCT03143023|Protective Agents|protective agents|mesh-ancestor
55784289|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784290|NCT03074435|Ivermectin|ivermectin|mesh-list
55784291|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55784292|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784293|NCT03142789|Cerivastatin|cerivastatin|mesh-list
55784294|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55784295|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55784296|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55784297|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
55784298|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784299|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784300|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55784301|NCT03072329|Bupivacaine|bupivacaine|mesh-list
55784302|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
55784303|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
55784304|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784305|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784306|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
55784308|NCT02327689|Emtricitabine|emtricitabine|mesh-list
55784309|NCT02327689|Adefovir|adefovir|mesh-list
55784311|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
55784312|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784313|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55819840|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
55784314|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55784315|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784316|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784317|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55784318|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55784319|NCT02327923|Ketorolac|ketorolac|mesh-list
55784320|NCT02327923|Lidocaine|lidocaine|mesh-list
55784321|NCT02327923|Atropine|atropine|mesh-list
55784322|NCT02327923|Ephedrine|ephedrine|mesh-list
55784323|NCT02327923|Fentanyl|fentanyl|mesh-list
55784324|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
55784325|NCT02327923|Morphine|morphine|mesh-list
55784326|NCT02327923|Tramadol|tramadol|mesh-list
55784327|NCT02327923|Ondansetron|ondansetron|mesh-list
55784328|NCT02327923|Bupivacaine|bupivacaine|mesh-list
56216978|NCT01628666|Cefazolin|cefazolin|mesh-list
56216979|NCT01628666|Cephalexin|cephalexin|mesh-list
56216980|NCT01628666|Bacitracin|bacitracin|mesh-list
55784329|NCT02327923|Propofol|propofol|mesh-list
55784330|NCT02327923|Neostigmine|neostigmine|mesh-list
55819841|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819842|NCT02080221|Antidotes|antidotes|mesh-ancestor
55819843|NCT02080221|Protective Agents|protective agents|mesh-ancestor
55819844|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819845|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
55819846|NCT02080221|Vitamins|vitamins|mesh-ancestor
55819847|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
55819848|NCT04677387|Naloxone|naloxone|mesh-list
55819849|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55819850|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759378|NCT04885803|Vitamin D|vitamin d|mesh-list
55819851|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
55819852|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819853|NCT02014467|Vitamin D|vitamin d|mesh-list
55819854|NCT02014467|Denosumab|denosumab|mesh-list
55819855|NCT02014467|Calcium|calcium|mesh-list
55819879|NCT01988103|Apremilast|apremilast|mesh-list
55819881|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55819882|NCT01988103|Analgesics|analgesics|mesh-ancestor
55819883|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
55819884|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819885|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819886|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819887|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819888|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55819889|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55819890|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819891|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819892|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819893|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
55819894|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
55819895|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819896|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819897|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55819898|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55819899|NCT01988103|Growth Substances|growth substances|mesh-ancestor
55819900|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
55819901|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819902|NCT02013375|Sirolimus|sirolimus|mesh-list
55819903|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
55806068|NCT04273607|Heparin|heparin|mesh-list
55819904|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
55819905|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819939|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819940|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819941|NCT02011113|Dexamethasone|dexamethasone|mesh-list
55819942|NCT02011113|Pomalidomide|pomalidomide|mesh-list
55784332|NCT02327923|Esmolol|esmolol|mesh-list
55784333|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
55784334|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
55784335|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784336|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784337|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
55784338|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784339|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55819943|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819944|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
55820011|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820012|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55820013|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
55820014|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820015|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820016|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55820017|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55820018|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
55820019|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55820020|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55820021|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56216981|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56216982|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793215|NCT05006911|Analgesics|analgesics|mesh-ancestor
55820022|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820023|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820041|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55820042|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55820043|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55820044|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820045|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55820047|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55820048|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55820049|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55820050|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55820051|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55820052|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820053|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
55820054|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55820055|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55820056|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
55820057|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820058|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55820059|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55820060|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820061|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820062|NCT01736176|Levodopa|levodopa|mesh-list
55820063|NCT01736176|Carbidopa|carbidopa|mesh-list
55820064|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55820065|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55820066|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55820067|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
55820068|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820069|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820070|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820071|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55820072|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820073|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55820074|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
55820075|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
55820076|NCT01735630|Inositol|inositol|mesh-list
55820077|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
55820078|NCT01735630|Vitamins|vitamins|mesh-ancestor
55820102|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55820103|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784340|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55784341|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55784342|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784343|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784344|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55784345|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55784347|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55784348|NCT02327923|Narcotics|narcotics|mesh-ancestor
55784349|NCT02327923|Analgesics|analgesics|mesh-ancestor
55784350|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55820104|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55820105|NCT01766050|Abatacept|abatacept|mesh-list
55820106|NCT01766050|Losartan|losartan|mesh-list
55820107|NCT01766050|Midazolam|midazolam|mesh-list
55820108|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
55820109|NCT01766050|Caffeine|caffeine|mesh-list
55820110|NCT01766050|Omeprazole|omeprazole|mesh-list
55820111|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55820112|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55820113|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820114|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820115|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55820116|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55820117|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55820118|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55820119|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
55820120|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
56216984|NCT01628731|Furosemide|furosemide|mesh-list
56216985|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
55820121|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
55820122|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
55820123|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820124|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820125|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55820126|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55792267|NCT04428437|Lenvatinib|lenvatinib|mesh-list
55820127|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55820142|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55820143|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820144|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820145|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
55820146|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820147|NCT02341625|Nivolumab|nivolumab|mesh-list
55820148|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820149|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820150|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55820151|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820152|NCT02370095|Treprostinil|treprostinil|mesh-list
55820153|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55820154|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55820155|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
55820156|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
55820157|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820158|NCT01734772|Dabigatran|dabigatran|mesh-list
55820159|NCT01734772|Ticagrelor|ticagrelor|mesh-list
55820160|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55820162|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55820163|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55820164|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
55820165|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820166|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820167|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820168|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
55820169|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55784351|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55784352|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
55784353|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
55784354|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784355|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
55784356|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
55784357|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55784358|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
55784359|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820170|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
55820171|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820172|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
55820173|NCT02340221|Fulvestrant|fulvestrant|mesh-list
55820174|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55820175|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820176|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55820177|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55820178|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
55820179|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820180|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820182|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55820183|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820184|NCT02369159|Oseltamivir|oseltamivir|mesh-list
55820185|NCT02369159|Peramivir|peramivir|mesh-list
55820186|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
55820187|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820212|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55820213|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
55820214|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820215|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820216|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820217|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
55820218|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820219|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55820220|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55820221|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216986|NCT01628731|Diuretics|diuretics|mesh-ancestor
56216987|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
55793220|NCT05339295|Ofloxacin|ofloxacin|mesh-list
55806117|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
56003916|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
56003917|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56003918|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
55820223|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
55820224|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820226|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55820227|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820228|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55820229|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820230|NCT01608724|Saxagliptin|saxagliptin|mesh-list
55820231|NCT01608724|Incretins|incretins|mesh-ancestor
55820232|NCT01608724|Hormones|hormones|mesh-ancestor
55820233|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820234|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820235|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55820257|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55820258|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55820259|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
55820260|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820261|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
55820262|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55820263|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55820264|NCT02364947|Nalmefene|nalmefene|mesh-list
55820265|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55820266|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820267|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
55784362|NCT02327923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55784363|NCT02327923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55784364|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55820271|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820272|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820273|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55820274|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55820275|NCT02337491|Growth Substances|growth substances|mesh-ancestor
55820276|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820277|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
55820280|NCT01765582|Bevacizumab|bevacizumab|mesh-list
55820281|NCT01765582|Fluorouracil|fluorouracil|mesh-list
55820282|NCT01765582|Capecitabine|capecitabine|mesh-list
55820283|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
55820284|NCT01765582|Irinotecan|irinotecan|mesh-list
55820285|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
55820286|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820287|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820288|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55820316|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55820317|NCT01648283|Narcotics|narcotics|mesh-ancestor
55820318|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820319|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820320|NCT01648283|Analgesics|analgesics|mesh-ancestor
55820321|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
55820322|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820323|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
55820324|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
55820325|NCT01649297|Empagliflozin|empagliflozin|mesh-list
55820326|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55820327|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820328|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55820329|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820330|NCT01648205|Ranolazine|ranolazine|mesh-list
55820331|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55820332|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55820333|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820334|NCT02391545|Rituximab|rituximab|mesh-list
55820335|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
55820363|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55820364|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55820365|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216988|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820366|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820367|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820369|NCT01607476|Flutemetamol|flutemetamol|mesh-list
55820370|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55820371|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55820372|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820373|NCT01765192|Montelukast|montelukast|mesh-list
55820374|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55820375|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
55820376|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55820377|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
55820378|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820379|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820380|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55820381|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55820409|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55820410|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
55820411|NCT04887506|Hormones|hormones|mesh-ancestor
55820412|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820413|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820415|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784365|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784366|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784367|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55820416|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55820417|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820418|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820419|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
55820420|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55820421|NCT02336165|Bevacizumab|bevacizumab|mesh-list
55820422|NCT02336165|Durvalumab|durvalumab|mesh-list
55820423|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820424|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820425|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55820426|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55820458|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55820459|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820460|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820461|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55820463|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
55820464|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55820465|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820466|NCT02311478|Trace Elements|trace elements|mesh-ancestor
55820467|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
55820468|NCT02281760|Trametinib|trametinib|mesh-list
55820469|NCT02281760|Dabrafenib|dabrafenib|mesh-list
55820470|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
55820497|NCT02334215|Analgesics|analgesics|mesh-ancestor
55820498|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
55820499|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820500|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
55820501|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
55820503|NCT02359877|Interferon-beta|interferon-beta|mesh-list
55820504|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
55820505|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820506|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
55820507|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820508|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
55820509|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820510|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55820511|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
55820512|NCT02389829|Promethazine|promethazine|mesh-list
55820513|NCT02389829|Hydromorphone|hydromorphone|mesh-list
55820514|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
55820515|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55820516|NCT02389829|Narcotics|narcotics|mesh-ancestor
55820517|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820518|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820519|NCT02389829|Analgesics|analgesics|mesh-ancestor
55876630|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
56216989|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56216990|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55793222|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820553|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820554|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55820555|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
55820556|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55820557|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55820558|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820559|NCT02358863|Antidotes|antidotes|mesh-ancestor
55820560|NCT02358863|Protective Agents|protective agents|mesh-ancestor
55820561|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820562|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
55820563|NCT02358863|Vitamins|vitamins|mesh-ancestor
55820564|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
55820565|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55820566|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55820567|NCT02358473|Docetaxel|docetaxel|mesh-list
55820594|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820595|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
55820596|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
55820597|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820598|NCT02357147|Pemetrexed|pemetrexed|mesh-list
55820599|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820600|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784368|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820601|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820602|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55820603|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55820604|NCT02332655|Cannabidiol|cannabidiol|mesh-list
55820605|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
55820606|NCT02388737|Lansoprazole|lansoprazole|mesh-list
55820607|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
55820608|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55820609|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820610|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55820611|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820612|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820613|NCT02355665|Nicotine|nicotine|mesh-list
55820614|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55820615|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
55820616|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820639|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820640|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55820641|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820642|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820643|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55820644|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
55820645|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
55820646|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820647|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
55820648|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55820649|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
55820650|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820651|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56003943|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56003944|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55820652|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
55820653|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
55820654|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55820655|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820656|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55820657|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55820658|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
55820659|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820660|NCT01620177|Ethanol|ethanol|mesh-list
55820661|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55820662|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820663|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820664|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820665|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
55806176|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820666|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55820667|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820668|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56216991|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216992|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56216993|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55820701|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820702|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55820703|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
55820704|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820705|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820706|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
55820707|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820738|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820739|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820740|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55820741|NCT02353169|Analgesics|analgesics|mesh-ancestor
55820742|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
55820743|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820744|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55820745|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55820746|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55820747|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
55820748|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820749|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820750|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55820751|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55820775|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820776|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820777|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
55820779|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820780|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56003945|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003946|NCT01152697|Haloperidol|haloperidol|mesh-list
56003947|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
56003948|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
56003949|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
56003950|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003951|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003958|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
55820781|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55820782|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
55820783|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820784|NCT01983969|Antiviral Agents|antiviral agents|mesh-ancestor
55820785|NCT01983969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820786|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820787|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820788|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55820789|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
55820790|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55820791|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55820792|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
55820793|NCT01983969|Vitamins|vitamins|mesh-ancestor
55820794|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
55820795|NCT02008773|Valacyclovir|valacyclovir|mesh-list
55820796|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
55820797|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820798|NCT02257567|Rituximab|rituximab|mesh-list
55820799|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
55820800|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55820801|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55820802|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
55820803|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820804|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820805|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
55820840|NCT05644873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820841|NCT05644873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55820843|NCT05644873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55820844|NCT05302297|Cemiplimab|cemiplimab|mesh-list
55820876|NCT04198649|Azithromycin|azithromycin|mesh-list
55820877|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55820878|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820879|NCT02348723|Warfarin|warfarin|mesh-list
55820880|NCT02348723|Dabigatran|dabigatran|mesh-list
55820881|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
55820882|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
55820883|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55820884|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
55820885|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820886|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56216994|NCT01628770|Hematinics|hematinics|mesh-ancestor
56216995|NCT01628783|Citalopram|citalopram|mesh-list
56216996|NCT01628783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56003962|NCT00002188|Alitretinoin|alitretinoin|mesh-list
56003963|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003964|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
56003965|NCT00002332|Thymopentin|thymopentin|mesh-list
56216997|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56216998|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56216999|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217000|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217001|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
55793232|NCT02637037|Metformin|metformin|mesh-list
55820887|NCT02006667|Gemcitabine|gemcitabine|mesh-list
55820921|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
55820922|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
55820923|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55820924|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
55820925|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820926|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820927|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
55820928|NCT02348489|Guadecitabine|guadecitabine|mesh-list
55820929|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820930|NCT01966107|Bromides|bromides|mesh-list
55820931|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
55820954|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820955|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820956|NCT02005887|Letrozole|letrozole|mesh-list
55820957|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55820958|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820959|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55820960|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55820961|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820962|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820963|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55820964|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
55820965|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820966|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820967|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
55820968|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55784372|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
55784373|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
55784374|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55784375|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55784378|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55784379|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55784380|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55820969|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
55820970|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55820971|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55820972|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55820973|NCT01981473|Infliximab|infliximab|mesh-list
55820974|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
55820975|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820976|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820977|NCT02005029|Erythromycin|erythromycin|mesh-list
55820978|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
55820979|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55820980|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
55820981|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55820982|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820983|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56003966|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56003967|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
56003968|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003969|NCT05571644|Leucovorin|leucovorin|mesh-list
56003970|NCT05571644|Fluorouracil|fluorouracil|mesh-list
56003971|NCT05571644|Oxaliplatin|oxaliplatin|mesh-list
56003972|NCT05571644|Irinotecan|irinotecan|mesh-list
56003973|NCT05571644|Levoleucovorin|levoleucovorin|mesh-list
55821015|NCT04416399|Budesonide|budesonide|mesh-list
55821016|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55821017|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55821018|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
55821019|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821020|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821021|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56217002|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217003|NCT01628783|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56217004|NCT01628783|Antidepressive Agents|antidepressive agents|mesh-ancestor
55821022|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
55821023|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
55821024|NCT04416399|Hormones|hormones|mesh-ancestor
55821025|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821026|NCT02282345|Talazoparib|talazoparib|mesh-list
55821027|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55821028|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821029|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821049|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
55821050|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821051|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55821052|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
55821053|NCT02004093|Antiviral Agents|antiviral agents|mesh-ancestor
55821054|NCT02004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821055|NCT02004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821056|NCT02004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821057|NCT02004093|Immunologic Factors|immunologic factors|mesh-ancestor
55821058|NCT02004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821059|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55821061|NCT01641367|Emtricitabine|emtricitabine|mesh-list
55821062|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
55821063|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55821064|NCT01641367|Darunavir|darunavir|mesh-list
55821065|NCT01641367|Etravirine|etravirine|mesh-list
55821066|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
55821067|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
55821068|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
55821069|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821070|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55821071|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55821072|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821073|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821074|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55784381|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55784382|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
55784383|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55784384|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
55784385|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55784386|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55784387|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55784388|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55784389|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55784390|NCT04991207|Bosentan|bosentan|mesh-list
55784391|NCT04991207|Zamicastat|zamicastat|mesh-list
55784392|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55784400|NCT03074123|Cosyntropin|cosyntropin|mesh-list
55784401|NCT03074123|Hormones|hormones|mesh-ancestor
55784402|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784403|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784404|NCT02327299|Fesoterodine|fesoterodine|mesh-list
55784405|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55759420|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
55763851|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
55763852|NCT02577315|Metformin|metformin|mesh-list
55763853|NCT02577315|Empagliflozin|empagliflozin|mesh-list
55763854|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763855|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763856|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55763857|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763858|NCT05529069|Venetoclax|venetoclax|mesh-list
55763859|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763860|NCT03569085|Sevoflurane|sevoflurane|mesh-list
55763861|NCT03569085|Isoflurane|isoflurane|mesh-list
55784406|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55784407|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
55784408|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821075|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55821076|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55821077|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55821078|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55821079|NCT02325713|Praziquantel|praziquantel|mesh-list
55821080|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
55821081|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55821082|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821083|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
55821084|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55821085|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821101|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821102|NCT02324699|Prednisone|prednisone|mesh-list
55821103|NCT02324699|Vedolizumab|vedolizumab|mesh-list
56217005|NCT01628783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56217006|NCT01628952|Curare|curare|mesh-list
56217007|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55821104|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55821105|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
55821106|NCT02324699|Hormones|hormones|mesh-ancestor
55821107|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821108|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821109|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55784409|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784410|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784411|NCT02327299|Urological Agents|urological agents|mesh-ancestor
55784412|NCT03494569|Fludarabine|fludarabine|mesh-list
55784413|NCT03494569|Melphalan|melphalan|mesh-list
55784414|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
55784415|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55784416|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821110|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821111|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821112|NCT01979523|Trametinib|trametinib|mesh-list
55821113|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821114|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55821115|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821116|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821117|NCT02255461|Palbociclib|palbociclib|mesh-list
55821118|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821119|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55821120|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821121|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821122|NCT01764022|Paclitaxel|paclitaxel|mesh-list
55821123|NCT01764022|Trastuzumab|trastuzumab|mesh-list
55821124|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55821125|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821126|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
55821127|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
55821128|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
55821129|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821130|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55821131|NCT02003391|Timolol|timolol|mesh-list
55821132|NCT02003391|Travoprost|travoprost|mesh-list
55821133|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55821135|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55821136|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55821137|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
55821138|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821139|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821140|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821141|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55821142|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55821143|NCT02254681|Gemcitabine|gemcitabine|mesh-list
55821171|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821172|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55821175|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55821176|NCT01639729|Narcotics|narcotics|mesh-ancestor
55821177|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821178|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821179|NCT01639729|Analgesics|analgesics|mesh-ancestor
55821180|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
55821181|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821182|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55821183|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55821184|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
55821185|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
55821186|NCT02002221|Metformin|metformin|mesh-list
55821187|NCT02002221|Vildagliptin|vildagliptin|mesh-list
55821188|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55821189|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821190|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55821191|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
55821192|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821193|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217008|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56217009|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55821208|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821209|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821210|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784417|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784418|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55784419|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
55784420|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003974|NCT05571644|Antimetabolites|antimetabolites|mesh-ancestor
56003975|NCT05571644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003976|NCT05571644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56003977|NCT05571644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003978|NCT05571644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003979|NCT05571644|Immunologic Factors|immunologic factors|mesh-ancestor
56003980|NCT05571644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003981|NCT05571644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55784421|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55784422|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
55784423|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55784425|NCT03071549|Salicylates|salicylates|mesh-list
55784426|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821211|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55821212|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55821213|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821214|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55821215|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55821216|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55821217|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
55821218|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55821219|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55821221|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55821222|NCT05243797|Lenalidomide|lenalidomide|mesh-list
55821223|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
55821224|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821225|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55821226|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55821227|NCT05243797|Growth Substances|growth substances|mesh-ancestor
55821228|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
55821229|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821230|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55821231|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55821232|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55821233|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821234|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821235|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55821236|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55821237|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821238|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
55821239|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821241|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55821242|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
55821243|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55821244|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821245|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55821246|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
55821247|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821248|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821249|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
55821250|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821251|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55821252|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821288|NCT01639339|Belimumab|belimumab|mesh-list
55821289|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821290|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
55821291|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821320|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55821321|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821323|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
55821324|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
55821325|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821326|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784427|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
55784428|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
55784429|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
55784430|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55784431|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217010|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217011|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784432|NCT03071549|Analgesics|analgesics|mesh-ancestor
55784433|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
55784434|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784435|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784436|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784437|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784438|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55784439|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784440|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784441|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
55784442|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55784443|NCT04994951|Triamcinolone|triamcinolone|mesh-list
55784444|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55784445|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55784446|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55784447|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784448|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
55784449|NCT04994951|Hormones|hormones|mesh-ancestor
55784450|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784451|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784452|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821327|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821328|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
55821329|NCT04662073|Camostat|camostat|mesh-list
55821330|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
55821331|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821332|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821333|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55821334|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55821335|NCT01600885|Guanfacine|guanfacine|mesh-list
55821369|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55821370|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
55821371|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55821372|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
55821373|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
55821374|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821375|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821401|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821402|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821403|NCT01637077|Pregabalin|pregabalin|mesh-list
55821404|NCT01637077|Analgesics|analgesics|mesh-ancestor
55821405|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
55821406|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821407|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784453|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
55784454|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784455|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784456|NCT03073889|Ropivacaine|ropivacaine|mesh-list
55784457|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
55784458|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
55784459|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784460|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784461|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
55784462|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784463|NCT03071705|Metformin|metformin|mesh-list
55784464|NCT03071705|Gefitinib|gefitinib|mesh-list
55784465|NCT03071705|Afatinib|afatinib|mesh-list
55784466|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55784467|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792635|NCT05029453|Apatinib|apatinib|mesh-list
55784469|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55784470|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784471|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784472|NCT03351439|Celecoxib|celecoxib|mesh-list
55784473|NCT03351439|Naproxen|naproxen|mesh-list
55784474|NCT03351439|Gabapentin|gabapentin|mesh-list
55784475|NCT03351439|Zopiclone|zopiclone|mesh-list
55784476|NCT03351439|Analgesics|analgesics|mesh-ancestor
55784477|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
55784478|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784479|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217012|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56217013|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56217014|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
56217015|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217016|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784480|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
55784481|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55784482|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55784483|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821408|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
55821409|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55821410|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55821411|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821412|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55821413|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55821414|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55821415|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821416|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55821417|NCT02308163|Etanercept|etanercept|mesh-list
55821418|NCT02308163|Peficitinib|peficitinib|mesh-list
55821419|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55821420|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55821421|NCT02308163|Analgesics|analgesics|mesh-ancestor
55821422|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
55784484|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55784485|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55784486|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55784487|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784488|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784489|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
55784490|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55784491|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55784492|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784493|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784494|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55784495|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55784496|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821423|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821451|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821453|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55821454|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
55821455|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55821456|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55821457|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
55821458|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821459|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
55821461|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
55821462|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55821463|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55821464|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
55806265|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
55821465|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821468|NCT04907851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55821469|NCT04907851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821471|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821472|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
55821473|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55821474|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821505|NCT01999179|Heparin|heparin|mesh-list
55821506|NCT01999179|Enoxaparin|enoxaparin|mesh-list
55821507|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55821508|NCT01999179|Tinzaparin|tinzaparin|mesh-list
55821509|NCT01999179|Dalteparin|dalteparin|mesh-list
55821510|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
55821511|NCT01999179|Dabigatran|dabigatran|mesh-list
55821512|NCT01999179|Apixaban|apixaban|mesh-list
55821513|NCT01999179|Anticoagulants|anticoagulants|mesh-list
55821514|NCT01999179|Edoxaban|edoxaban|mesh-list
55821515|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56217017|NCT01629082|Lenalidomide|lenalidomide|mesh-list
56217018|NCT01629082|Clofarabine|clofarabine|mesh-list
56217019|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
56217020|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217021|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56217022|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56217023|NCT01629082|Growth Substances|growth substances|mesh-ancestor
56217024|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
56217025|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217026|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217027|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
56217028|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217029|NCT01629173|Ethylene|ethylene|mesh-list
56217030|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56217031|NCT01629173|Growth Substances|growth substances|mesh-ancestor
56217032|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217033|NCT01629199|Mitogens|mitogens|mesh-list
56217034|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
56217035|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217036|NCT01629212|Octylonium|octylonium|mesh-list
56217037|NCT01629212|Bromides|bromides|mesh-list
56217038|NCT01629212|Tiropramide|tiropramide|mesh-list
56217039|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
56217040|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
56217041|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
56217042|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217043|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217044|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56217045|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217046|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217047|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217048|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55793267|NCT05013697|Paclitaxel|paclitaxel|mesh-list
55821516|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55821517|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821518|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55821519|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
55821520|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55821521|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
55821522|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003986|NCT05571644|Vitamin B Complex|vitamin b complex|mesh-ancestor
56003987|NCT05571644|Vitamins|vitamins|mesh-ancestor
56003988|NCT05571644|Micronutrients|micronutrients|mesh-ancestor
56003989|NCT03011281|Tofacitinib|tofacitinib|mesh-list
56003990|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56003991|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003998|NCT00002194|Nevirapine|nevirapine|mesh-list
55821538|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
55821539|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217049|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56217050|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56217051|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
56217052|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821540|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821541|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821543|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55821544|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821545|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784497|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
55784498|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55784499|NCT03139747|Everolimus|everolimus|mesh-list
55784500|NCT03139747|Lenvatinib|lenvatinib|mesh-list
55784501|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784502|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55784503|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
55784504|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784505|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55784506|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821547|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
55821548|NCT01731886|Melphalan|melphalan|mesh-list
55821549|NCT01731886|Lenalidomide|lenalidomide|mesh-list
55821550|NCT01731886|Lenograstim|lenograstim|mesh-list
55821551|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821552|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
55821553|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821554|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821555|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55821556|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
55821557|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821558|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821560|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55821562|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
55821563|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821564|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821565|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
55821566|NCT01731886|Hormones|hormones|mesh-ancestor
55821567|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821568|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55821569|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55821570|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55821571|NCT01731886|Growth Substances|growth substances|mesh-ancestor
55821572|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
55821573|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55821574|NCT01759420|Ondansetron|ondansetron|mesh-list
55821575|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
55821576|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
55821577|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821578|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821579|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821580|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
55821610|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821611|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821612|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55821613|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55821614|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821615|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
55821616|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55821617|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
55821618|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821619|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821620|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821621|NCT01975701|Infigratinib|infigratinib|mesh-list
55821622|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821623|NCT01962987|Diclofenac|diclofenac|mesh-list
56217053|NCT01629225|Candesartan|candesartan|mesh-list
56217054|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56217055|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56217056|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55821692|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821693|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821694|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
55821695|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821696|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
55806357|NCT05495945|Propofol|propofol|mesh-list
55821698|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
55784507|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784508|NCT02037919|Etonogestrel|etonogestrel|mesh-list
55784509|NCT02037919|Desogestrel|desogestrel|mesh-list
55784510|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55784511|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
55784512|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55784513|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784514|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55784515|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55821699|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821700|NCT04419025|Expectorants|expectorants|mesh-ancestor
55821701|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
55821702|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55821770|NCT05221021|Estradiol|estradiol|mesh-list
55821771|NCT05221021|Estrogens|estrogens|mesh-list
55821772|NCT05221021|Hormones|hormones|mesh-ancestor
55821773|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821774|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821775|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55821776|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55821777|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55821778|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
55821779|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821780|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821781|NCT05221021|Urological Agents|urological agents|mesh-ancestor
55821782|NCT03167437|Vorinostat|vorinostat|mesh-list
55821810|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821811|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821813|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821814|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55821815|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821816|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
55821817|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821818|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55821819|NCT04193215|Vaccines|vaccines|mesh-list
55821820|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
55821821|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821822|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55821823|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
55821824|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821825|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
55821826|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55821827|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821828|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
55821857|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
55821858|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821859|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55821860|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55821861|NCT05652751|Mitogens|mitogens|mesh-list
55821863|NCT05652751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821865|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
55821866|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821867|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
55821869|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
55821870|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56217057|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821871|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55821873|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
55821874|NCT02909335|Everolimus|everolimus|mesh-list
55821877|NCT02909335|Tacrolimus|tacrolimus|mesh-list
55821878|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784516|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55784517|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55784518|NCT02037919|Progestins|progestins|mesh-ancestor
55784519|NCT02037919|Hormones|hormones|mesh-ancestor
55784520|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784521|NCT03139591|Dexamethasone|dexamethasone|mesh-list
55784522|NCT03139591|Lidocaine|lidocaine|mesh-list
55821879|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
55821880|NCT02909335|Hormones|hormones|mesh-ancestor
55821881|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821882|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821883|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55821884|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821885|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821886|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
55821887|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55821888|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821889|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821890|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55821891|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55821892|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
55821893|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55821894|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821895|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
55821896|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
55821897|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821898|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821899|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55821900|NCT02909335|Protective Agents|protective agents|mesh-ancestor
55821901|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
55821902|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821903|NCT05652517|Ethanol|ethanol|mesh-list
55821904|NCT05652517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55821905|NCT05652517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821906|NCT05652517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821907|NCT05652517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821908|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55821909|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55821910|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55821911|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821912|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
55821913|NCT02619253|Vorinostat|vorinostat|mesh-list
55821915|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821916|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55821917|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821918|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821919|NCT03998293|Somatostatin|somatostatin|mesh-list
55821920|NCT03998293|Hormones|hormones|mesh-ancestor
55821921|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821922|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821923|NCT01606306|Fluticasone|fluticasone|mesh-list
55821924|NCT01606306|Xhance|xhance|mesh-list
55821925|NCT01606306|Montelukast|montelukast|mesh-list
55821926|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55821927|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55821928|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
55821929|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821930|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821931|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55821932|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
55821935|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55821936|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
55821937|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784523|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217058|NCT01629251|Insulin|insulin|mesh-list
56217059|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56217060|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217061|NCT01629277|Insulin|insulin|mesh-list
56217062|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55784524|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
55784525|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
55784526|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784527|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784528|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784529|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
55784530|NCT03139591|Hormones|hormones|mesh-ancestor
55789066|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821938|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55821939|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55821940|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821941|NCT04567108|Benzocaine|benzocaine|mesh-list
55821942|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
55821943|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
55821944|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821945|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821946|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
55821968|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
55821969|NCT01777282|Incretins|incretins|mesh-ancestor
55821970|NCT01777282|Hormones|hormones|mesh-ancestor
55821971|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821972|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821973|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55821974|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821975|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821976|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
55821977|NCT04571632|Ipilimumab|ipilimumab|mesh-list
55821978|NCT04571632|Avelumab|avelumab|mesh-list
55821979|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55821980|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821981|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55821982|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821983|NCT01975389|Bococizumab|bococizumab|mesh-list
55821984|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55821985|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55821986|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
55821987|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821988|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55821989|NCT01974141|Dapsone|dapsone|mesh-list
55821990|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821991|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
55821992|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55821993|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55821994|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55821995|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821996|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821997|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
55821998|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56004039|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
56004040|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004041|NCT00002200|Abacavir|abacavir|mesh-list
55821999|NCT01945593|Factor VIII|factor viii|mesh-list
55822020|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822021|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822022|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55822023|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
55822024|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
55822025|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55822026|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55822027|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55822028|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
55822029|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
55822030|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822031|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822032|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822033|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
55822034|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
56217063|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217065|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
56217066|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
56217067|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56217068|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806432|NCT05482763|Ciclopirox|ciclopirox|mesh-list
55784531|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784534|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
55784535|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
55784536|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822036|NCT04661397|Emtricitabine|emtricitabine|mesh-list
55822037|NCT04661397|Darunavir|darunavir|mesh-list
55822038|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55822039|NCT04661397|Cobicistat|cobicistat|mesh-list
55822040|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55822041|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
55822042|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
55822043|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822044|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55822045|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55822046|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822047|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822048|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55822049|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55822050|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55822051|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55822052|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
55822053|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55822054|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55822085|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
55822086|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822087|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822089|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822090|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55822091|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
55822092|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55822093|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55822094|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822095|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55822096|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
55822097|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55822098|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
55822134|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55822135|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55822167|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822169|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
55822170|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822171|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55822172|NCT01970475|Adalimumab|adalimumab|mesh-list
55822173|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56004042|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004043|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004044|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004045|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004046|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
56004047|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004048|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004049|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004050|NCT00002356|Fomivirsen|fomivirsen|mesh-list
56004051|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
56004052|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004053|NCT00994175|Pioglitazone|pioglitazone|mesh-list
56004054|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56004055|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004056|NCT00002206|Adefovir|adefovir|mesh-list
56004057|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56004058|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
56004059|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004060|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004061|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55822174|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822175|NCT04653831|Pirfenidone|pirfenidone|mesh-list
55822176|NCT04653831|Analgesics|analgesics|mesh-ancestor
55822177|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
55822178|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822215|NCT02488759|Daratumumab|daratumumab|mesh-list
55822216|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822217|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822249|NCT05651347|Protective Agents|protective agents|mesh-ancestor
55822250|NCT05651347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822251|NCT05651347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822252|NCT05651269|Gemcitabine|gemcitabine|mesh-list
55822253|NCT05651269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217069|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217070|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56217071|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217073|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
56217074|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822254|NCT05651269|Antimetabolites|antimetabolites|mesh-ancestor
55822255|NCT05651269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784537|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
55784538|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55784539|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55784540|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55784541|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784542|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784544|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55784545|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784547|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784548|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55784549|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55784550|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784551|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784552|NCT03139513|Vemurafenib|vemurafenib|mesh-list
55759482|NCT03047265|Paclitaxel|paclitaxel|mesh-list
56004062|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004063|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004064|NCT02403986|Lidocaine|lidocaine|mesh-list
56004065|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
56004066|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
56004067|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731297|NCT03468829|Gontivimab|gontivimab|mesh-list
56004068|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004069|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
56004070|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004071|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56004072|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56004073|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56004074|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56004075|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004076|NCT00002212|Bexarotene|bexarotene|mesh-list
55822256|NCT05651269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822257|NCT05651269|Antiviral Agents|antiviral agents|mesh-ancestor
55822258|NCT05651269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822259|NCT05651269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822292|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55822294|NCT01939197|Ribavirin|ribavirin|mesh-list
55822295|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55822296|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55822297|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
55822298|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822299|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822300|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55822301|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55822302|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
55822303|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822304|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55822336|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822337|NCT01938573|Gemcitabine|gemcitabine|mesh-list
55822338|NCT01938573|Sirolimus|sirolimus|mesh-list
55822339|NCT01938573|Cisplatin|cisplatin|mesh-list
55822340|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822341|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55822342|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
55822343|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822344|NCT01938573|Antiviral Agents|antiviral agents|mesh-ancestor
55822345|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822346|NCT01938573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822347|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822348|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
55822349|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822419|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822420|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55822445|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55822446|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55822447|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822448|NCT01287091|Rabeprazole|rabeprazole|mesh-list
55822449|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55822450|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55822451|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55784553|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784554|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55784555|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784556|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784557|NCT04986995|Opicapone|opicapone|mesh-list
56217075|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56217076|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784558|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55784559|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822452|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822453|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822454|NCT01269463|Methylphenidate|methylphenidate|mesh-list
55822455|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55822456|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822457|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55822458|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55822459|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55822460|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822461|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
55822462|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822463|NCT01258933|Ofatumumab|ofatumumab|mesh-list
55822464|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822465|NCT02539459|Everolimus|everolimus|mesh-list
55822467|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822468|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
55822469|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822513|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822514|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55822515|NCT01916967|Desloratadine|desloratadine|mesh-list
55822516|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55822517|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
55822518|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822519|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822520|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822521|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55822522|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55822523|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
55822524|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
55822525|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55822526|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55822527|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55822528|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55822529|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55822530|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55822531|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55822532|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
55822533|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822534|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822535|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822536|NCT01916109|Gemcitabine|gemcitabine|mesh-list
55822537|NCT01916109|Carboplatin|carboplatin|mesh-list
55822538|NCT01916109|Panitumumab|panitumumab|mesh-list
55822539|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822540|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55822541|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
55822542|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822543|NCT01916109|Antiviral Agents|antiviral agents|mesh-ancestor
55822544|NCT01916109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822545|NCT01916109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822576|NCT00942331|Growth Substances|growth substances|mesh-ancestor
55822577|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822578|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
55822579|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
55822580|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55822581|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
55784560|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784561|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55784562|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55784563|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55784564|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55784565|NCT03971929|Diuretics|diuretics|mesh-ancestor
55784566|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
55784567|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217077|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217078|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56217079|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55822582|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004082|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
56004083|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004084|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004085|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004086|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822583|NCT00942331|Antiviral Agents|antiviral agents|mesh-ancestor
55822584|NCT00942331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822585|NCT00942331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822586|NCT00942331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822588|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822589|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822590|NCT00630565|Dexamethasone|dexamethasone|mesh-list
55822591|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
55822619|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55822620|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822621|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822622|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55822623|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55822624|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55822625|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55822626|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
55822627|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822628|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822630|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55822632|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55822633|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55822634|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
55822637|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
55822638|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
55822695|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55822696|NCT02244619|Analgesics|analgesics|mesh-ancestor
55822697|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
55822698|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822699|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822700|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
55822701|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
55822703|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
55822704|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822705|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822706|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822707|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55822708|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
55822709|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822710|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822711|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55822712|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822713|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55822714|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55822715|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56004087|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004088|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004089|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004090|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56004091|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56004092|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56004093|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56004094|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56004095|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56004096|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
55822716|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55822717|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55822718|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822719|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822720|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784568|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55784569|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784570|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784571|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
55784572|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55784573|NCT04986371|Niraparib|niraparib|mesh-list
55784574|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55784575|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822721|NCT01931475|Analgesics|analgesics|mesh-ancestor
55822722|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
55822723|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217080|NCT01629394|Neostigmine|neostigmine|mesh-list
56217081|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56004097|NCT02168309|Labetalol|labetalol|mesh-list
56004098|NCT02168309|Nifedipine|nifedipine|mesh-list
56004099|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56004100|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56004101|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004102|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56004103|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004104|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
56004105|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
56004106|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56004107|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56004108|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56004109|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
56004110|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004111|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56004112|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
56004113|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
56004114|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004115|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56004116|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56004118|NCT00002368|Nevirapine|nevirapine|mesh-list
56004119|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56217082|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822724|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
55822725|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55822726|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
55822727|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
55822729|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
55822730|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822763|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822764|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822765|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55822766|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55822767|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
55822768|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55822769|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55822770|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
55822771|NCT02324153|Riboflavin|riboflavin|mesh-list
55822772|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
55822773|NCT02324153|Vitamins|vitamins|mesh-ancestor
55822800|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
55822801|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822802|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822803|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55822804|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822805|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
55822807|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55822808|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55822810|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822812|NCT01928433|Finafloxacin|finafloxacin|mesh-list
55822813|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
55822814|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56004152|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004153|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56004154|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
56004155|NCT00995501|Hormones|hormones|mesh-ancestor
56004156|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56004157|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56004158|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004159|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004160|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004161|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004162|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56004163|NCT00995501|Cathartics|cathartics|mesh-ancestor
55822815|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822816|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55822817|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55822818|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822819|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822820|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822821|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55822822|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55822859|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55822860|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55822861|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55822862|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
55822896|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55822898|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55822899|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822900|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
55822921|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55822922|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
55822923|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55822924|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
56004185|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55764098|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
55764099|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
55764100|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55764101|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764102|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764103|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55764104|NCT02439905|Analgesics|analgesics|mesh-ancestor
55764105|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
55764106|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764107|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55764108|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55764109|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55764110|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
55764111|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764112|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764113|NCT03192371|Vaccines|vaccines|mesh-list
55764114|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
55764115|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764116|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
55764117|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55764118|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764119|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
55764120|NCT05663073|Amlodipine|amlodipine|mesh-list
55764121|NCT05663073|Irbesartan|irbesartan|mesh-list
55764122|NCT05663073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55764123|NCT05663073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55764124|NCT05663073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55764125|NCT05663073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764126|NCT05663073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55764127|NCT05663073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764128|NCT05663073|Vasodilator Agents|vasodilator agents|mesh-ancestor
55764129|NCT05663073|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55764130|NCT05663073|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55764131|NCT02442791|Exenatide|exenatide|mesh-list
55764132|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55764133|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764137|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764139|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
55764140|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
55764141|NCT04756557|Protective Agents|protective agents|mesh-ancestor
55764142|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764143|NCT04742673|Guanfacine|guanfacine|mesh-list
55764144|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55764145|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55764146|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55764147|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55764148|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
55764149|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764339|NCT05562999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784576|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784577|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784578|NCT04988945|Durvalumab|durvalumab|mesh-list
55784579|NCT04988945|Tremelimumab|tremelimumab|mesh-list
55784580|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55784581|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822925|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
55822926|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
55822927|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55822928|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55822929|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55822930|NCT02242201|Analgesics|analgesics|mesh-ancestor
55822931|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55822932|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822933|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55822934|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822935|NCT02242045|Idelalisib|idelalisib|mesh-list
55822936|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217083|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217084|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
56217085|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217086|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217087|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56217088|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
56217089|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822937|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822938|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822939|NCT02241889|Pancrelipase|pancrelipase|mesh-list
56004186|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004187|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004188|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004189|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004190|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004191|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
56004192|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004193|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56004194|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56004195|NCT00002386|Lamivudine|lamivudine|mesh-list
56004196|NCT00002386|Zidovudine|zidovudine|mesh-list
55822941|NCT02241187|Cetuximab|cetuximab|mesh-list
55822942|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822943|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822944|NCT02249767|Tretinoin|tretinoin|mesh-list
55822945|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822946|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
55822947|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
55822948|NCT04783675|Rituximab|rituximab|mesh-list
55822949|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822950|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822951|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
55822952|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822953|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822954|NCT04892953|Gemcitabine|gemcitabine|mesh-list
55822955|NCT04892953|Paclitaxel|paclitaxel|mesh-list
55822956|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55822957|NCT04892953|Carboplatin|carboplatin|mesh-list
55822958|NCT04892953|Pemetrexed|pemetrexed|mesh-list
55822992|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822993|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55822994|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55822995|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55822996|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
55822997|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
55822998|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822999|NCT02207413|Vaccines|vaccines|mesh-list
55823030|NCT02308748|Mexiletine|mexiletine|mesh-list
56004197|NCT00002386|Didanosine|didanosine|mesh-list
55823031|NCT02308748|Dofetilide|dofetilide|mesh-list
55823032|NCT02308748|Diltiazem|diltiazem|mesh-list
55823033|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
55823034|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
56004198|NCT00002386|Stavudine|stavudine|mesh-list
56004199|NCT00002386|Zalcitabine|zalcitabine|mesh-list
56004200|NCT00002386|Indinavir|indinavir|mesh-list
56004201|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004202|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004203|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004204|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004205|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
56004206|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004207|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004208|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004209|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
56004210|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56004211|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56004212|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
55823035|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823036|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823037|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
55823038|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823039|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55823040|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55823041|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55823042|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55823043|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823044|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55823045|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823074|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55823075|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55823076|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55823077|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
55823078|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784583|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55823079|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823080|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55823081|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823082|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
55823083|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55823084|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56217091|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55823085|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823086|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823087|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
55806566|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
55823088|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823089|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
55823090|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
55823091|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55823115|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823116|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55759529|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
56004214|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
56004215|NCT01942694|Vitamins|vitamins|mesh-ancestor
56004216|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
56004217|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004218|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56004219|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56004220|NCT01153711|Ketoconazole|ketoconazole|mesh-list
56004221|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
56004222|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004223|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56004224|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55823117|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
55823118|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823119|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823120|NCT02230891|Carvedilol|carvedilol|mesh-list
55823121|NCT02230891|Spironolactone|spironolactone|mesh-list
55823122|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55823123|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
55823124|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823125|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823126|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55823127|NCT02230891|Diuretics|diuretics|mesh-ancestor
55823128|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
55823129|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55823130|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55823131|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
55823132|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823133|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823134|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55823135|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
55823136|NCT02230891|Protective Agents|protective agents|mesh-ancestor
55823137|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55823138|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55823139|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55823140|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
55823172|NCT02279732|Paclitaxel|paclitaxel|mesh-list
55823173|NCT02279732|Carboplatin|carboplatin|mesh-list
55823174|NCT02279732|Ipilimumab|ipilimumab|mesh-list
55823175|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55823176|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823177|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
55823178|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
56004225|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004226|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004275|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004276|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004277|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56004278|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56004279|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56004280|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56004281|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004282|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56004283|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56004284|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004285|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
55823179|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
55823180|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823181|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55823245|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
55823246|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
55823247|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55823248|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55823249|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
55823250|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823251|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823252|NCT02304302|Memantine|memantine|mesh-list
55823253|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55823254|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55823255|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
55823256|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823257|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806581|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823259|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55823260|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55784584|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55784585|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784586|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
55784587|NCT03070847|Coagulants|coagulants|mesh-ancestor
55784588|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
55784589|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55784590|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55784591|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55784592|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217092|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56217093|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004286|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56217094|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
55784593|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823261|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55823262|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55823263|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55823264|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
55823298|NCT02275052|Albuterol|albuterol|mesh-list
55823299|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55823300|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
55823301|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823302|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004287|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
56004288|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56004289|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004290|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
56004291|NCT00002230|Efavirenz|efavirenz|mesh-list
56004292|NCT00002230|Didanosine|didanosine|mesh-list
56004293|NCT00002230|Stavudine|stavudine|mesh-list
56004294|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
56004295|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55731519|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55823303|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55823304|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
55823305|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
55823306|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55823328|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55823329|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823330|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55823331|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823332|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823333|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55823334|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
55823335|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55823337|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55823338|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55823339|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55823340|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55823341|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823342|NCT02274038|Pemetrexed|pemetrexed|mesh-list
55823343|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823344|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823345|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823346|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55823347|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55823348|NCT01646021|Sirolimus|sirolimus|mesh-list
55823349|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55823350|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823351|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55823352|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823353|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
55823354|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823355|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
55823356|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823390|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55823391|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
55823392|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823393|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823394|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55823395|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55823396|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
55823397|NCT02269943|Azacitidine|azacitidine|mesh-list
55784594|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
55784595|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784596|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784597|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55784598|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784600|NCT04989257|Ticagrelor|ticagrelor|mesh-list
55823399|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55823419|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55823420|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55823421|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55823422|NCT01605136|Afamelanotide|afamelanotide|mesh-list
55823423|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
55823424|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
55823425|NCT01706146|Apixaban|apixaban|mesh-list
55823426|NCT01706146|Dabigatran|dabigatran|mesh-list
56217095|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217096|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56217097|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55823427|NCT01706146|Anticoagulants|anticoagulants|mesh-list
55823428|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55823429|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
55823430|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55823431|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
55823432|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823433|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823434|NCT02269241|Drospirenone|drospirenone|mesh-list
55823435|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55823436|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
55823437|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56004296|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004297|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004298|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004299|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
55823438|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823439|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55823440|NCT02269241|Diuretics|diuretics|mesh-ancestor
55823441|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
55823442|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
55823443|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55823444|NCT01750294|Diuretics|diuretics|mesh-ancestor
55823445|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
55823446|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823447|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55823448|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55823449|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823450|NCT01749982|Choline|choline|mesh-list
55823451|NCT01749982|Betaine|betaine|mesh-list
55823452|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
55823453|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55823454|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
55823455|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823482|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
55823483|NCT01724866|Docetaxel|docetaxel|mesh-list
55823484|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823485|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
55823486|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823487|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55823488|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55823489|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
55823490|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823491|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823492|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55823493|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
55823494|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
55823495|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
55823496|NCT02266433|Dexamethasone|dexamethasone|mesh-list
55823497|NCT02266433|Ketorolac|ketorolac|mesh-list
55823498|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55823499|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
55823500|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
55823501|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823502|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823503|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784601|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55784602|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55784604|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55784605|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
55784606|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784607|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784608|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784611|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55784612|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784613|NCT03140449|Calcitriol|calcitriol|mesh-list
55784614|NCT03140449|Sirolimus|sirolimus|mesh-list
55784615|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55784616|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784617|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56217098|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56217099|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
55784618|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784619|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
55784620|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55784621|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
55784622|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784623|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55784624|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55784625|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784626|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784627|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55784628|NCT03140449|Vitamins|vitamins|mesh-ancestor
55784629|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
55784630|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55784631|NCT02659813|Copper|copper|mesh-list
55784632|NCT02659813|Nickel|nickel|mesh-list
55784633|NCT02659813|Trace Elements|trace elements|mesh-ancestor
55784634|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
55784635|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784636|NCT04985435|Adalimumab|adalimumab|mesh-list
55784637|NCT04985435|Etanercept|etanercept|mesh-list
55784638|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784639|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784640|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55784641|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55784643|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
55784644|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784645|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004300|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004301|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56004302|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56004303|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56004304|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56004305|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55784646|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784647|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55784648|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
55784650|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55784651|NCT05084365|Protective Agents|protective agents|mesh-ancestor
55784652|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823504|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
55823505|NCT02266433|Hormones|hormones|mesh-ancestor
55823506|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823507|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55823508|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823509|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55823510|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55823511|NCT02266433|Analgesics|analgesics|mesh-ancestor
55823538|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823540|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823541|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55823542|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55823543|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
55823544|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823545|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823546|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
55823547|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
55823548|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
56004324|NCT03009877|Analgesics|analgesics|mesh-ancestor
56004325|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
56004326|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004327|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56004328|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56004329|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56004330|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56004331|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
56004332|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
56004333|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004334|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004335|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56004336|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56004337|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56004338|NCT00002392|Thalidomide|thalidomide|mesh-list
56004339|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56004340|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
56004341|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004342|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
56004343|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55823549|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55823550|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
55823551|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55823552|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
55823554|NCT01745380|Protective Agents|protective agents|mesh-ancestor
55823556|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55823557|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823558|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823559|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823561|NCT05648318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55823562|NCT01703260|Pioglitazone|pioglitazone|mesh-list
55823581|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55823582|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55823583|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
55823584|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
55823585|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823586|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56217101|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217102|NCT01629511|Gemcitabine|gemcitabine|mesh-list
56217103|NCT01629511|Methotrexate|methotrexate|mesh-list
55759579|NCT02119156|Belimumab|belimumab|mesh-list
56004344|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004345|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56217104|NCT01629511|Clofarabine|clofarabine|mesh-list
55823587|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55823588|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823589|NCT01909791|Aflibercept|aflibercept|mesh-list
55823590|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55823591|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55823592|NCT01909791|Growth Substances|growth substances|mesh-ancestor
55823593|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823594|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
55823595|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784654|NCT03070613|Lectins|lectins|mesh-list
55784655|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
55784656|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
55784657|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784658|NCT03070613|Coagulants|coagulants|mesh-ancestor
55784659|NCT03441139|Analgesics|analgesics|mesh-list
55784660|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
55823596|NCT02202499|Varenicline|varenicline|mesh-list
55823597|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55823598|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55823599|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
55823600|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823601|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004346|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56004347|NCT00002392|Growth Substances|growth substances|mesh-ancestor
56004348|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
56004349|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004350|NCT00002398|Adefovir|adefovir|mesh-list
56004351|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56004352|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
56004353|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004354|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004355|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55823602|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823603|NCT02227849|Canagliflozin|canagliflozin|mesh-list
55823604|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55823605|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823606|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55823607|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823608|NCT02169271|Aspirin|aspirin|mesh-list
55823609|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55823610|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55823611|NCT02169271|Analgesics|analgesics|mesh-ancestor
55823612|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
55823613|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823614|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823615|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55823616|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55823617|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55823618|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55823619|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823620|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55823649|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55823650|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55823651|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823652|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004356|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004357|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004358|NCT00997139|Polymyxins|polymyxins|mesh-list
56004359|NCT00997139|Neomycin|neomycin|mesh-list
56004360|NCT00997139|Bacitracin|bacitracin|mesh-list
56004361|NCT00997139|Polymyxin B|polymyxin b|mesh-list
56004362|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
56004363|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56004364|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004365|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56004366|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004367|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823653|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55823654|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55823655|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55823656|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55823657|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
55823659|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
55823660|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
55823661|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823662|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823663|NCT02168803|Evacetrapib|evacetrapib|mesh-list
55823664|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55823665|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55823667|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823703|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55823704|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55823705|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
55823706|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823735|NCT02296112|Trametinib|trametinib|mesh-list
56217105|NCT01629511|Busulfan|busulfan|mesh-list
56217106|NCT01629511|Tacrolimus|tacrolimus|mesh-list
56217107|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
56217108|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56217109|NCT01629511|Lenograstim|lenograstim|mesh-list
55823736|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823737|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55823738|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823739|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823740|NCT02269670|Tamoxifen|tamoxifen|mesh-list
55823741|NCT02269670|Everolimus|everolimus|mesh-list
56004368|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56004369|NCT00002236|Zidovudine|zidovudine|mesh-list
56004370|NCT00002236|Delavirdine|delavirdine|mesh-list
56004371|NCT00002236|Indinavir|indinavir|mesh-list
56004372|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
56004373|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004374|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004375|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004376|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792679|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
55823742|NCT02269670|Letrozole|letrozole|mesh-list
55823743|NCT02269670|Fulvestrant|fulvestrant|mesh-list
55784661|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806759|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
55784662|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784664|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55784665|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784666|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
55784667|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
55784668|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
55784669|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784670|NCT04985669|Prucalopride|prucalopride|mesh-list
55784671|NCT04985669|Laxatives|laxatives|mesh-ancestor
55784672|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784673|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55784674|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55784675|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
55784676|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823744|NCT02269670|Anastrozole|anastrozole|mesh-list
55823745|NCT02269670|Megestrol|megestrol|mesh-list
55823746|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
55823747|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823748|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823749|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823750|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
55823751|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823752|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56004377|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
56004378|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004379|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004380|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55823776|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823777|NCT01641926|Interferons|interferons|mesh-list
55823778|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
55823779|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
55823780|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55823781|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55823782|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823783|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
55823784|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823785|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
55823786|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823787|NCT02294786|Capecitabine|capecitabine|mesh-list
55823788|NCT02294786|Lapatinib|lapatinib|mesh-list
55823789|NCT02294786|Octreotide|octreotide|mesh-list
55823790|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55823791|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
55823792|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823793|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823794|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55823795|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823796|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55823797|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55823798|NCT04880876|Eluxadoline|eluxadoline|mesh-list
55823799|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55823800|NCT01927341|Panitumumab|panitumumab|mesh-list
55823801|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55823836|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55823837|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
55823838|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56004381|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56004382|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56004383|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004384|NCT01241539|Dabigatran|dabigatran|mesh-list
56004385|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
56004386|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56004387|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004388|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004389|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004390|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
56004391|NCT04998617|Curcumin|curcumin|mesh-list
56004392|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55823839|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55823840|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823841|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55784678|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784679|NCT04753957|Progesterone|progesterone|mesh-list
55784680|NCT04753957|Progestins|progestins|mesh-ancestor
56217110|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217111|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
55784682|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784683|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784684|NCT03070379|Lidocaine|lidocaine|mesh-list
55806762|NCT02880293|Thiotepa|thiotepa|mesh-list
55823862|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55823864|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
55823865|NCT02196259|Anesthetics|anesthetics|mesh-list
55823866|NCT02196259|Analgesics|analgesics|mesh-ancestor
55823867|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
55823868|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823869|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823870|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55823871|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
55823872|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823873|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55823874|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55823875|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823876|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823877|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
55823878|NCT02294396|Mirabegron|mirabegron|mesh-list
55823879|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55823880|NCT02294396|Propiverine|propiverine|mesh-list
55823881|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55823882|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55823883|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
55823884|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823885|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823886|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823887|NCT02294396|Urological Agents|urological agents|mesh-ancestor
55759618|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
55764305|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
55764306|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55764307|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55764308|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55764309|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55764310|NCT03192059|Analgesics|analgesics|mesh-ancestor
55764311|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
55764312|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764313|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764314|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55764315|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55764316|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55764317|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55764318|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764319|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
55764320|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55764321|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55764322|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55764323|NCT00587067|Floxuridine|floxuridine|mesh-list
55764324|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55764325|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
55764326|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764327|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764328|NCT02441075|Ethanol|ethanol|mesh-list
55764329|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55764330|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764331|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764332|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764333|NCT05562999|Bromides|bromides|mesh-list
55764334|NCT05562999|Rocuronium|rocuronium|mesh-list
55764335|NCT05562999|Anticonvulsants|anticonvulsants|mesh-ancestor
55764336|NCT05562999|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55764337|NCT05562999|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55764338|NCT05562999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55823888|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55823889|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55823890|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55823891|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
55823892|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
55823893|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
55823920|NCT02263547|Teriflunomide|teriflunomide|mesh-list
55823921|NCT02263547|Colestipol|colestipol|mesh-list
55823922|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55823923|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55823924|NCT02263547|Analgesics|analgesics|mesh-ancestor
55823925|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
55823926|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823927|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823928|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55823929|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55823930|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823931|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
55823932|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55823933|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
55823934|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823935|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55823936|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
55823938|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
55823939|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
55823940|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823961|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
55823962|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823963|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
55823964|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823965|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55784685|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
55784686|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
55784687|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56004393|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55759637|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
55784688|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784689|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
55784690|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784691|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55784692|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55784693|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56217112|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217113|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784694|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784695|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784697|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55784698|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784699|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55784700|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55784701|NCT03227263|Growth Substances|growth substances|mesh-ancestor
56004394|NCT04998617|Analgesics|analgesics|mesh-ancestor
56004395|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
56004396|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004397|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004398|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56004399|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784702|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784703|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
55784705|NCT04985201|Simvastatin|simvastatin|mesh-list
55784706|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55784707|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55784708|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784709|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784710|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784711|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55784712|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55784713|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
55784714|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55784715|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55784716|NCT02031601|Carboplatin|carboplatin|mesh-list
55784717|NCT02031601|Docetaxel|docetaxel|mesh-list
55784718|NCT02031601|Pemetrexed|pemetrexed|mesh-list
55784719|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55784720|NCT02031601|Gefitinib|gefitinib|mesh-list
55823966|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55823967|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784721|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784722|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
55784723|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
55784724|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
55784725|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784726|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784727|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55784728|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55784729|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55784730|NCT04984577|Edaravone|edaravone|mesh-list
55823968|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823969|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55823970|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55823972|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
55823973|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55823974|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
55823975|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823976|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55823977|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55823978|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
55823979|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55823980|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823982|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
55823983|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823984|NCT01954251|Vaccines|vaccines|mesh-list
55823985|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
55823986|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823987|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55823988|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55823989|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823990|NCT02257385|Albuterol|albuterol|mesh-list
56004400|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004401|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004402|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004403|NCT00002404|Valacyclovir|valacyclovir|mesh-list
56004404|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
56004405|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004406|NCT05593757|Quinidine|quinidine|mesh-list
56004407|NCT05593757|Verapamil|verapamil|mesh-list
56004408|NCT05593757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56004409|NCT05593757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56004410|NCT05593757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56004411|NCT05593757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004412|NCT05593757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56004413|NCT05593757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004414|NCT05593757|Vasodilator Agents|vasodilator agents|mesh-ancestor
56004415|NCT05593757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56004416|NCT05593757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55823991|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
55823992|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55823993|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
55823994|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823995|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823996|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55824042|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55824043|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824044|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55824045|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824048|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55824049|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55824050|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824051|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
55824052|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
55824053|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824054|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824055|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824056|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
55824057|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
56004420|NCT05593757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56004421|NCT05593757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56004422|NCT05593757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004423|NCT05593757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004424|NCT05593757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55824058|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
55824091|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55824092|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
55824094|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55824095|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
55824096|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824097|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824098|NCT02255279|Vaccines|vaccines|mesh-list
55824099|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
55824100|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784731|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55784732|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
55784733|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784734|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55784735|NCT04984577|Protective Agents|protective agents|mesh-ancestor
55824129|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55824130|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55824131|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
55824132|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
55824133|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824134|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
55824135|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55824136|NCT02264990|Paclitaxel|paclitaxel|mesh-list
55824137|NCT02264990|Carboplatin|carboplatin|mesh-list
55824138|NCT02264990|Pemetrexed|pemetrexed|mesh-list
55824139|NCT02264990|Veliparib|veliparib|mesh-list
55824140|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55824141|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824142|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
55824143|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
55824144|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
55824145|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824146|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824147|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55824148|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55824149|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55824168|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56004425|NCT05593757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56004426|NCT05593757|Cholinergic Agents|cholinergic agents|mesh-ancestor
56004427|NCT05593757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56004428|NCT05593757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56004429|NCT05593757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56004430|NCT05593757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56004431|NCT01242241|Propofol|propofol|mesh-list
56004432|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56004433|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56004434|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004435|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56004436|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
56004437|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
56004438|NCT02393690|Iodine|iodine|mesh-list
56004439|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
56004440|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56004441|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004442|NCT02393690|Trace Elements|trace elements|mesh-ancestor
55824169|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55824170|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
55824171|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
55824172|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
55824173|NCT05650775|Methylphenidate|methylphenidate|mesh-list
55824174|NCT05650775|Adderall|adderall|mesh-list
55824175|NCT05650775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55824176|NCT05650775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824177|NCT05650775|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55824178|NCT05650775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55824179|NCT05650775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55824180|NCT05650775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824181|NCT05650775|Dopamine Agents|dopamine agents|mesh-ancestor
55824182|NCT05650775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824184|NCT02194465|Tadalafil|tadalafil|mesh-list
55824185|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
55824186|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
55824187|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
55824188|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55824189|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55824190|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824191|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217115|NCT01629511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217116|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217117|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56217118|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
56217119|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217120|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56217121|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
55793343|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824192|NCT02194465|Urological Agents|urological agents|mesh-ancestor
55824193|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
55824194|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824196|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55824197|NCT02194465|Diuretics|diuretics|mesh-ancestor
55824198|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
55824199|NCT02194465|Hormones|hormones|mesh-ancestor
55824200|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55824201|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55824202|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824203|NCT01720264|Incretins|incretins|mesh-ancestor
55824204|NCT01720264|Hormones|hormones|mesh-ancestor
55824205|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824234|NCT01719172|Coagulants|coagulants|mesh-ancestor
55824235|NCT02285855|Metformin|metformin|mesh-list
55824236|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55824237|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824238|NCT02285153|Aspirin|aspirin|mesh-list
55824239|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
55784736|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784737|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
56004445|NCT01928576|Nivolumab|nivolumab|mesh-list
55784738|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55784739|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55824240|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55824241|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824242|NCT02285153|Analgesics|analgesics|mesh-ancestor
55824243|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
55824244|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824245|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824246|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824247|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824248|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55824249|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55824250|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824273|NCT01740388|Besifloxacin|besifloxacin|mesh-list
55824274|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55824275|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824276|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56004446|NCT01928576|Azacitidine|azacitidine|mesh-list
56004447|NCT01928576|Entinostat|entinostat|mesh-list
56004448|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56004450|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56004451|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004452|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56004453|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
56004454|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004455|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56004456|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
56004457|NCT01200433|Propofol|propofol|mesh-list
56004458|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56004459|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824277|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55824278|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824279|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824280|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824281|NCT01740154|Sunitinib|sunitinib|mesh-list
55824282|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824283|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55824284|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55824285|NCT01740154|Growth Substances|growth substances|mesh-ancestor
55824286|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824287|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
55824288|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55824289|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824290|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824291|NCT02287610|Prednisone|prednisone|mesh-list
55824292|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824293|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
55824294|NCT02287610|Hormones|hormones|mesh-ancestor
55824295|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56217122|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56217123|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
56217124|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56217125|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824296|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824297|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55824298|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824300|NCT02262728|Simeprevir|simeprevir|mesh-list
55824301|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
55824302|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824303|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
55824312|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
55824313|NCT02260934|Promethazine|promethazine|mesh-list
55824314|NCT02260934|Prednisone|prednisone|mesh-list
56004460|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004461|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56004462|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
56004463|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
56004464|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56004465|NCT01200433|Analgesics|analgesics|mesh-ancestor
56004466|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
56004467|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004468|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55824315|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
55824316|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55824317|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55824318|NCT02260934|Prednisolone|prednisolone|mesh-list
55824319|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
55824320|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
55824321|NCT02260934|Rituximab|rituximab|mesh-list
55824322|NCT02260934|Belimumab|belimumab|mesh-list
55824325|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824326|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
55824327|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824328|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824329|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55824330|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
55824331|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824332|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824333|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55824334|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824335|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824336|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
55784741|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784742|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784743|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55784744|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
55784745|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
55784746|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55784747|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
55784748|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032491|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004469|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56004470|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56004471|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
56004472|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004473|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004474|NCT04416269|Insulin|insulin|mesh-list
55784749|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784750|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55784751|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55784752|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55784753|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
55824337|NCT02260934|Hormones|hormones|mesh-ancestor
55824338|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824339|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55824340|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824341|NCT02260934|Analgesics|analgesics|mesh-ancestor
55824342|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
55824343|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824344|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
55824345|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
55824346|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
55824347|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55824348|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55824349|NCT02260934|Protective Agents|protective agents|mesh-ancestor
55824350|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55824351|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55824352|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824353|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
55824354|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
55824355|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55824356|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
55824357|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
55824358|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824359|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55824360|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
55824361|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
56217126|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55824363|NCT02260388|Pregabalin|pregabalin|mesh-list
55824364|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55824365|NCT02260388|Nortriptyline|nortriptyline|mesh-list
55824366|NCT02260388|Analgesics|analgesics|mesh-ancestor
55824367|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
55824368|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824369|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824370|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
55824371|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55824372|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55824385|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55824386|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
55824387|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55824388|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55824389|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55824390|NCT02260154|Mebeverine|mebeverine|mesh-list
55824392|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
55824393|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
55824394|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
55824395|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824397|NCT01643408|Asparaginase|asparaginase|mesh-list
55824398|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824399|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
55824400|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55824401|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55824402|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824403|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56004475|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56004476|NCT04416269|Metformin|metformin|mesh-list
56004477|NCT04416269|Pioglitazone|pioglitazone|mesh-list
56004478|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56004479|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56004480|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004481|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004482|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004483|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004484|NCT00002410|Lamivudine|lamivudine|mesh-list
56004485|NCT00002410|Zidovudine|zidovudine|mesh-list
56004486|NCT00002410|Indinavir|indinavir|mesh-list
56004487|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004488|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004489|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004490|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004491|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
56004492|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004493|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004494|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55824404|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55824405|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824406|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824407|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824408|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
55824409|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55824410|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55824411|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55824412|NCT01739764|Vemurafenib|vemurafenib|mesh-list
55824413|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824414|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55824415|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824416|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824417|NCT01700530|Simvastatin|simvastatin|mesh-list
55824418|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55824419|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55824420|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55824421|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
55824422|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824423|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55824424|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824426|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
55824427|NCT01717456|Laxatives|laxatives|mesh-list
55824428|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55824429|NCT01716754|Omalizumab|omalizumab|mesh-list
55824430|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55824431|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55824432|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
55824520|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824521|NCT01716052|Analgesics|analgesics|mesh-ancestor
55824522|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
55824523|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806952|NCT02710097|Ethanol|ethanol|mesh-list
55824525|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824526|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824527|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55824528|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824529|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824531|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55824532|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
55824533|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824534|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217127|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56217128|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56217129|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
56217130|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56217131|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56217132|NCT01629628|Adalimumab|adalimumab|mesh-list
55824535|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55824536|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
55824537|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
55824538|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56004495|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
56004496|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55824539|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55824540|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55824541|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55824542|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
55824543|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806992|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
55824544|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824546|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824547|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824548|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
55824549|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824550|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824551|NCT04863716|Fentanyl|fentanyl|mesh-list
55824552|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55824553|NCT04863716|Narcotics|narcotics|mesh-ancestor
55824554|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784755|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55784756|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56004497|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56004498|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004499|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
56004500|NCT01243333|Alovudine|alovudine|mesh-list
56004501|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
56004502|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56004503|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56004504|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004505|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
56004506|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
56004507|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004508|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004509|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004510|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784757|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
55824556|NCT04863716|Analgesics|analgesics|mesh-ancestor
55824594|NCT05544734|Ibuprofen|ibuprofen|mesh-list
55824595|NCT05544734|Hydrocodone|hydrocodone|mesh-list
55824596|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824597|NCT05544734|Analgesics|analgesics|mesh-ancestor
55824598|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
55824623|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824624|NCT05640596|Betamethasone|betamethasone|mesh-list
55824625|NCT05640596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824626|NCT05640596|Glucocorticoids|glucocorticoids|mesh-ancestor
55824627|NCT05640596|Hormones|hormones|mesh-ancestor
55824628|NCT05640596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824629|NCT05640596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824630|NCT05640596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55824631|NCT05640596|Respiratory System Agents|respiratory system agents|mesh-ancestor
55824632|NCT05651126|Psilocybin|psilocybin|mesh-list
55824633|NCT05651126|Hallucinogens|hallucinogens|mesh-ancestor
56004512|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56004513|NCT01924052|Katacalcin|katacalcin|mesh-list
56004514|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56004515|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004516|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56004517|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
56004518|NCT00002416|Lamivudine|lamivudine|mesh-list
56004519|NCT00002416|Emtricitabine|emtricitabine|mesh-list
56004520|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004521|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004522|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004523|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004524|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
56004525|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004526|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004527|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004528|NCT00002254|Alovudine|alovudine|mesh-list
56004529|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
56004530|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004531|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
56004532|NCT01897454|Leucovorin|leucovorin|mesh-list
55824634|NCT05651126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824635|NCT05651126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55824636|NCT01696942|Mesalamine|mesalamine|mesh-list
55824637|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824638|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824639|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55824640|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824641|NCT01696942|Analgesics|analgesics|mesh-ancestor
55824642|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
55824643|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824644|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824645|NCT05493566|Aldesleukin|aldesleukin|mesh-list
55824646|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
55824647|NCT05493566|Interleukin-2|interleukin-2|mesh-list
55824665|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55824666|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55824667|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824669|NCT05625776|Antipruritics|antipruritics|mesh-ancestor
55824670|NCT05625776|Dermatologic Agents|dermatologic agents|mesh-ancestor
55824671|NCT05625776|Sensory System Agents|sensory system agents|mesh-ancestor
56004533|NCT01897454|Folic Acid|folic acid|mesh-list
56004534|NCT01897454|Gemcitabine|gemcitabine|mesh-list
56004535|NCT01897454|Fluorouracil|fluorouracil|mesh-list
56004536|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
56004538|NCT01897454|Camptothecin|camptothecin|mesh-list
56004539|NCT01897454|Calcium|calcium|mesh-list
56004540|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
56004541|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56004542|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
56004543|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004544|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004545|NCT01897454|Antiviral Agents|antiviral agents|mesh-ancestor
56004546|NCT01897454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004547|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004548|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56004549|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
56004550|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004551|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56004552|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56004553|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55824672|NCT05625776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824673|NCT05625776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824674|NCT05615948|Ketamine|ketamine|mesh-list
55824675|NCT05615948|Analgesics|analgesics|mesh-ancestor
56217134|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217135|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217136|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
55824676|NCT05615948|Sensory System Agents|sensory system agents|mesh-ancestor
55824677|NCT05615948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824678|NCT05615948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824679|NCT05615948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824680|NCT05615948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55824681|NCT05615948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55824682|NCT05615948|Anesthetics, General|anesthetics, general|mesh-ancestor
55824683|NCT05615948|Anesthetics|anesthetics|mesh-ancestor
55792663|NCT05028907|BB 1101|bb 1101|mesh-list
55824684|NCT05615948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824685|NCT05615948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55824686|NCT05615948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55824687|NCT05615948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824688|NCT05650268|Vitamin D|vitamin d|mesh-list
55824689|NCT05650268|Ergocalciferols|ergocalciferols|mesh-list
55824690|NCT05650268|Cholecalciferol|cholecalciferol|mesh-list
55824691|NCT05650268|Vitamins|vitamins|mesh-list
55824692|NCT05650268|Micronutrients|micronutrients|mesh-ancestor
55824693|NCT05650268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824694|NCT05650268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55824695|NCT05650268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55824696|NCT05438264|Donepezil|donepezil|mesh-list
55824697|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55824698|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824699|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824700|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
55824701|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824702|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824723|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824724|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824725|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
55824727|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824728|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55824729|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55824730|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
55824731|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
55824732|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
55824733|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55824734|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55824735|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
55824736|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824738|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824739|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
55824740|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824741|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55824742|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824743|NCT04834310|Clindamycin|clindamycin|mesh-list
55824744|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
55824745|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
55824746|NCT04834310|Cefazolin|cefazolin|mesh-list
55824747|NCT04834310|Cephalexin|cephalexin|mesh-list
55824748|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55824749|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824750|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55824751|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824752|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824753|NCT04848116|Nivolumab|nivolumab|mesh-list
55824754|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824755|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824756|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55824757|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824775|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
56004572|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004573|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56004574|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56004575|NCT01001195|Bimatoprost|bimatoprost|mesh-list
56004577|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55807033|NCT02301975|Fluticasone|fluticasone|mesh-list
55824777|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824778|NCT05031494|Gemcitabine|gemcitabine|mesh-list
55824779|NCT05031494|Paclitaxel|paclitaxel|mesh-list
56217137|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217138|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217139|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217140|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56217141|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
56217142|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217143|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56217144|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824780|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55824781|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824782|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
55824783|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
55824784|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
55824785|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824786|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55824787|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
55824788|NCT05031494|Antiviral Agents|antiviral agents|mesh-ancestor
55824789|NCT05031494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824790|NCT05031494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824791|NCT05031494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824792|NCT05031494|Immunologic Factors|immunologic factors|mesh-ancestor
55824793|NCT05031494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824794|NCT04844216|Lidocaine|lidocaine|mesh-list
55824795|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
55824796|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
55824797|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
55824798|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56004612|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56004613|NCT01459484|Methotrexate|methotrexate|mesh-list
56004614|NCT01459484|Ifosfamide|ifosfamide|mesh-list
56004615|NCT01459484|Mifamurtide|mifamurtide|mesh-list
56004616|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
56004617|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004618|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56004619|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56004620|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56004621|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004622|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824799|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824800|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
55824801|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824802|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55824803|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55824804|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55824805|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55824806|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824807|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55824808|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
55824809|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
55824810|NCT04844216|Protective Agents|protective agents|mesh-ancestor
55824811|NCT05345678|Durvalumab|durvalumab|mesh-list
55824812|NCT05345678|Tremelimumab|tremelimumab|mesh-list
55807047|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55824813|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55784759|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55784760|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55784761|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784762|NCT03068429|Sertraline|sertraline|mesh-list
55784763|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
55784764|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55784765|NCT03068429|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55784766|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55784767|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784768|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784769|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784770|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
56004623|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56004624|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
55784771|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784772|NCT03068351|Daratumumab|daratumumab|mesh-list
55784773|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784774|NCT03140293|Lidocaine|lidocaine|mesh-list
55784775|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
55784776|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
55784777|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
55784778|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784779|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217146|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
56217147|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
55784780|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
55784781|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784782|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55784783|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55759853|NCT02453009|Prednisone|prednisone|mesh-list
56004625|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56004626|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004627|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56004628|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
56004629|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56004630|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56004631|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56004632|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
56004633|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56004634|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004635|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56004636|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
56004637|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56004638|NCT00002260|Alovudine|alovudine|mesh-list
56004639|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
55784784|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55784785|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784786|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784787|NCT04982861|Cefixime|cefixime|mesh-list
55824814|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824815|NCT05327738|Atezolizumab|atezolizumab|mesh-list
55824848|NCT04621526|Analgesics|analgesics|mesh-ancestor
55824849|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
55824850|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824851|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55824852|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55824853|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55824854|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
55824855|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824856|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824857|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55824858|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55824959|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55824961|NCT04513184|Hormones|hormones|mesh-ancestor
55784788|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55784789|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784790|NCT04572217|Topiramate|topiramate|mesh-list
55784791|NCT04572217|Phentermine|phentermine|mesh-list
55784792|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
55784793|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55784794|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784795|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55784796|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
55784797|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55784798|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
55784799|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
56004640|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004642|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55784800|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784801|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
55784802|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784803|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784804|NCT05635955|Propofol|propofol|mesh-list
55784806|NCT05635955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55824962|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824963|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55824964|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824999|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825001|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
55825002|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825003|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55825004|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55825005|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55825006|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
55825007|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
55825031|NCT04827446|Methamphetamine|methamphetamine|mesh-list
55825032|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55825033|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825034|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
55825035|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
55825036|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825037|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
55825038|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825039|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825040|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
55825041|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55744381|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55764593|NCT02435459|Calcium|calcium|mesh-list
55764594|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55764595|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764596|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
55764597|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764598|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55764599|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764600|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764601|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
55764602|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
55764603|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55764605|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764606|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764607|NCT02435303|Urological Agents|urological agents|mesh-ancestor
55764608|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55764610|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764611|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764612|NCT03189329|Lidocaine|lidocaine|mesh-list
55764613|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
55764614|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
55764615|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
55764616|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764617|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764618|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
55764619|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764620|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55764621|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55764622|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55764623|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55764624|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764625|NCT02575833|Erenumab|erenumab|mesh-list
55764626|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55764627|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764628|NCT02575833|Analgesics|analgesics|mesh-ancestor
55764629|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
55764630|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764631|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764632|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
55764633|NCT02709083|Dasatinib|dasatinib|mesh-list
55825042|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55825043|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825044|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55825045|NCT02191579|Topiramate|topiramate|mesh-list
55825046|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
55825047|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56217148|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217149|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217151|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
56217152|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825048|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55825049|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55825050|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825051|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825052|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
55825053|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825054|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825055|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55784807|NCT05635955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784808|NCT05635955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784809|NCT05635955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55784810|NCT05635955|Anesthetics, General|anesthetics, general|mesh-ancestor
55825056|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825057|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
55825058|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55825059|NCT05324462|Xultophy|xultophy|mesh-list
55825060|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55825061|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825062|NCT05324462|Incretins|incretins|mesh-ancestor
55825094|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55825095|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825096|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825097|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
55825098|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
55825101|NCT04838288|Tacrolimus|tacrolimus|mesh-list
56004643|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
56004644|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56004645|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
56004646|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004647|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004648|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56004649|NCT00002266|Protective Agents|protective agents|mesh-ancestor
56004650|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004651|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004652|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004653|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004654|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
56004655|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004656|NCT05751304|Dexmedetomidine|dexmedetomidine|mesh-list
56004657|NCT05751304|Ketamine|ketamine|mesh-list
56004658|NCT05751304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56004659|NCT05751304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55825102|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55825103|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
55825104|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825136|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
55825138|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55825139|NCT04307576|Thioguanine|thioguanine|mesh-list
55825140|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825141|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
55825142|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
55825143|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825144|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825145|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56004663|NCT05751304|Sensory System Agents|sensory system agents|mesh-ancestor
56004664|NCT05751304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004665|NCT05751304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56004666|NCT05751304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56004667|NCT05751304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56004668|NCT05751304|Adrenergic Agents|adrenergic agents|mesh-ancestor
56004669|NCT05751304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004670|NCT05751304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004671|NCT05751304|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56004672|NCT05751304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56004673|NCT05751304|Anesthetics, General|anesthetics, general|mesh-ancestor
56004674|NCT05751304|Anesthetics|anesthetics|mesh-ancestor
56004675|NCT05751304|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56004676|NCT05751304|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56004677|NCT01202071|Rabeprazole|rabeprazole|mesh-list
56004678|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56004679|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56004680|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56004681|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004682|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825146|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
55825147|NCT04307576|Hormones|hormones|mesh-ancestor
55825148|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825169|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825170|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825171|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825172|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55825173|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55825174|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
55825175|NCT04129502|Carboplatin|carboplatin|mesh-list
55825176|NCT04129502|Pemetrexed|pemetrexed|mesh-list
55825177|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825178|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825179|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825180|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55825181|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55825182|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
55744382|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
56004683|NCT00002428|Vaccines|vaccines|mesh-list
56004684|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
56004685|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004686|NCT01422746|Metformin|metformin|mesh-list
56004687|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56004688|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004689|NCT00002272|Foscarnet|foscarnet|mesh-list
56004690|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56004691|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
56004692|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004693|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004694|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004695|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004696|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004697|NCT01002755|Lenalidomide|lenalidomide|mesh-list
56004698|NCT01002755|Ofatumumab|ofatumumab|mesh-list
56004699|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56004700|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
56004701|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004702|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56004703|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56004707|NCT00002434|Leucovorin|leucovorin|mesh-list
55825183|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825185|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
55825186|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825187|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
55825188|NCT01637402|Hormones|hormones|mesh-ancestor
56217153|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
56217154|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217155|NCT01629758|Nivolumab|nivolumab|mesh-list
56217156|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56217157|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217158|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55793370|NCT05554965|Propofol|propofol|mesh-list
55825189|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825190|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825191|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825192|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825193|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56004729|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56004730|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004731|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
56004732|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
56004733|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
56004734|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004735|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004736|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56004737|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56004738|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
56004739|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
56004740|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004741|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004742|NCT01003301|Omalizumab|omalizumab|mesh-list
56004743|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56004744|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56004745|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
56004746|NCT00002440|Ritonavir|ritonavir|mesh-list
56004747|NCT00002440|Nelfinavir|nelfinavir|mesh-list
55731979|NCT05096143|Valsartan|valsartan|mesh-list
56004748|NCT00002440|Indinavir|indinavir|mesh-list
56004749|NCT00002440|Saquinavir|saquinavir|mesh-list
56004750|NCT00002440|Amprenavir|amprenavir|mesh-list
56004751|NCT00002440|Abacavir|abacavir|mesh-list
56004752|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56004753|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56004754|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004755|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004756|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825194|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825195|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825196|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
55825197|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55825198|NCT04419038|Mitomycins|mitomycins|mesh-list
55825199|NCT04419038|Mitomycin|mitomycin|mesh-list
55825200|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55825201|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825234|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
55825235|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825236|NCT01601132|Colchicine|colchicine|mesh-list
55825237|NCT01601132|Theophylline|theophylline|mesh-list
55825238|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
55825239|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56004761|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56004762|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56004763|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004764|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004765|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56004766|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
56004767|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56004768|NCT01421810|Dexamethasone|dexamethasone|mesh-list
56004769|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56004770|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
56004771|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
55825240|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
55825241|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
55825242|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
55825243|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825244|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825245|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55825268|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825269|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
55825270|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
55825271|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825272|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825273|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825274|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
55825275|NCT04836962|Hormones|hormones|mesh-ancestor
55825276|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825277|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825278|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825279|NCT05289440|Esketamine|esketamine|mesh-list
55825280|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
55825281|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55825282|NCT04016090|Folic Acid|folic acid|mesh-list
55825283|NCT04016090|Hematinics|hematinics|mesh-ancestor
55825284|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
55825285|NCT04016090|Vitamins|vitamins|mesh-ancestor
55825286|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
55825287|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825288|NCT04809974|Niacinamide|niacinamide|mesh-list
55825289|NCT04809974|Vitamins|vitamins|mesh-ancestor
55825290|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
55744383|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55759857|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
56004772|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004773|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825291|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825292|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
55825293|NCT04691960|Metformin|metformin|mesh-list
55825294|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55825295|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825296|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
55825297|NCT04809038|Analgesics|analgesics|mesh-ancestor
55825298|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
55825334|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807148|NCT02553629|Rocuronium|rocuronium|mesh-list
55825368|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55825369|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825370|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
55825371|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55825372|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56217159|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217160|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56217161|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56217162|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55793376|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
55825373|NCT03029000|Lenograstim|lenograstim|mesh-list
55825374|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55825375|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
55825448|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
55825450|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004774|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56004775|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
56004776|NCT01421810|Hormones|hormones|mesh-ancestor
55744384|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825451|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55825452|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825453|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55825454|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55825483|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55825484|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825485|NCT04192136|Niacinamide|niacinamide|mesh-list
55825487|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
55825488|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
55825489|NCT04192136|Vitamins|vitamins|mesh-ancestor
55825490|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
55825491|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825492|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55825493|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
55825494|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825495|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55825525|NCT01636934|Minocycline|minocycline|mesh-list
55825526|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55825527|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825529|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55825530|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55784812|NCT05635955|Antidepressive Agents|antidepressive agents|mesh-ancestor
55784813|NCT05635955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55784814|NCT04452461|Leucovorin|leucovorin|mesh-list
55784815|NCT04452461|Gemcitabine|gemcitabine|mesh-list
55784816|NCT04452461|Paclitaxel|paclitaxel|mesh-list
55784817|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
55784818|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55784819|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784820|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
55784821|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
55784822|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
55784823|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004777|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56004778|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56004779|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004780|NCT00002284|Zidovudine|zidovudine|mesh-list
56004781|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
56004782|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004783|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004784|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004785|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004786|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
55784824|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55784825|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
55784826|NCT04452461|Antiviral Agents|antiviral agents|mesh-ancestor
55825531|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55825532|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
55825533|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807154|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
55825534|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825535|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55825564|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825565|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825566|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825567|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
55825569|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825570|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825571|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825572|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
55759862|NCT02453009|Hormones|hormones|mesh-ancestor
55825573|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55825574|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55825575|NCT02159365|Growth Substances|growth substances|mesh-ancestor
55825576|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
55825577|NCT02072200|Prednisone|prednisone|mesh-list
55825578|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825579|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
55825580|NCT02072200|Hormones|hormones|mesh-ancestor
56217163|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807186|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
56217164|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217165|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56004787|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217166|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56004789|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55825581|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56004790|NCT01243957|Fluoxetine|fluoxetine|mesh-list
56004791|NCT01243957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56004792|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56004793|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825582|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825583|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825601|NCT02158975|Ixazomib|ixazomib|mesh-list
55825602|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825603|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
55825604|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825605|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825606|NCT02158039|Ethanol|ethanol|mesh-list
55825607|NCT02158039|Lidocaine|lidocaine|mesh-list
55825608|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
55825609|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
55825610|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55825613|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825614|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55825615|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55825616|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55825617|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825618|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825619|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55825620|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784827|NCT04452461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784828|NCT04452461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784829|NCT04452461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55784830|NCT04452461|Immunologic Factors|immunologic factors|mesh-ancestor
55784831|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784832|NCT04452461|Antidotes|antidotes|mesh-ancestor
55784833|NCT04452461|Protective Agents|protective agents|mesh-ancestor
55784834|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
55784836|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
55825621|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55825622|NCT03563222|SMOFlipid|smoflipid|mesh-list
55825623|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55825624|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55825625|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55825627|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55825628|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
55825629|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825630|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825631|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55825632|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
55825633|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
55825634|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55825635|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55825636|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55825637|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56004794|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004795|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004796|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
56004797|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004798|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56004799|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
56004800|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56004801|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56004802|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55792785|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55792786|NCT03093883|Hematinics|hematinics|mesh-ancestor
55825638|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
55825639|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825677|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825696|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825697|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825698|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55825699|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55825700|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217167|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217168|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
56217169|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217170|NCT01630018|Topotecan|topotecan|mesh-list
55825701|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55825703|NCT05195918|Protective Agents|protective agents|mesh-ancestor
55825704|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55825705|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55825706|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55825707|NCT04511078|Panitumumab|panitumumab|mesh-list
55825708|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825709|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825710|NCT02158052|Tacrolimus|tacrolimus|mesh-list
56004803|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004805|NCT00002446|Posaconazole|posaconazole|mesh-list
55825711|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55825712|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55825713|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
55825714|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825715|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55825716|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825717|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784845|NCT03137017|Acetaminophen|acetaminophen|mesh-list
55784846|NCT03137017|Hydrocodone|hydrocodone|mesh-list
55825718|NCT01635218|Fluoxetine|fluoxetine|mesh-list
55825719|NCT01635218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55825720|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55825721|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825722|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825723|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825724|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
55825725|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744385|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56004806|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
56004807|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004808|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56004809|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56004810|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004811|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004812|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56004813|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
56004814|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56004815|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004816|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56004817|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55765183|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55765184|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765185|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55765186|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55765187|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55765188|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765189|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
55765190|NCT03186131|Vitamin D|vitamin d|mesh-list
55765191|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
55765192|NCT03186131|Vitamins|vitamins|mesh-ancestor
55765193|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
55765194|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765195|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55765196|NCT03184649|Acetaminophen|acetaminophen|mesh-list
55765197|NCT03184649|Ibuprofen|ibuprofen|mesh-list
55765199|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55765200|NCT03184649|Analgesics|analgesics|mesh-ancestor
55765201|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
55765202|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765203|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765204|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765205|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765206|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55765207|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765208|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765209|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
55765210|NCT05105841|Venetoclax|venetoclax|mesh-list
55825726|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55825727|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
55825728|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55825729|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55825730|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55825731|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825732|NCT05351684|Dolutegravir|dolutegravir|mesh-list
55825755|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
55825756|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
55825757|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
55825758|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825759|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825760|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
55825762|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825763|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825764|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825765|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
55825766|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
55825767|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825768|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825769|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55825770|NCT04787744|Protective Agents|protective agents|mesh-ancestor
55825771|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55825772|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
55825773|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55825774|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
55825775|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
56004818|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56004819|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56004820|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56004821|NCT01884740|Bevacizumab|bevacizumab|mesh-list
56004822|NCT01884740|Cetuximab|cetuximab|mesh-list
56004823|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56004824|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004825|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55825776|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
55825777|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55825778|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
55825779|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55825780|NCT05180942|Atorvastatin|atorvastatin|mesh-list
55825781|NCT05180942|Calcium|calcium|mesh-list
55825782|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55825783|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825784|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55825785|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55825786|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
55825787|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217172|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56217173|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56217174|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825788|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55825819|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
55825820|NCT04269200|Paclitaxel|paclitaxel|mesh-list
55825821|NCT04269200|Carboplatin|carboplatin|mesh-list
55825822|NCT04269200|Durvalumab|durvalumab|mesh-list
55825823|NCT04269200|Olaparib|olaparib|mesh-list
55825824|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55825825|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55825826|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825827|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
55825828|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56004826|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56004827|NCT01884740|Growth Substances|growth substances|mesh-ancestor
56004828|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004829|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
56004830|NCT00002290|Zidovudine|zidovudine|mesh-list
56004831|NCT00002290|Acyclovir|acyclovir|mesh-list
56004832|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
56004833|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825829|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
55825830|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825831|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825832|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
55825833|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825834|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55825871|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784848|NCT03137017|Analgesics|analgesics|mesh-ancestor
55784850|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784851|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784852|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
55784853|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55784855|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55784856|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
55784857|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
55784859|NCT03019003|Decitabine|decitabine|mesh-list
55784860|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55784861|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784862|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55784863|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
55825872|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825907|NCT03965468|Paclitaxel|paclitaxel|mesh-list
55825908|NCT03965468|Carboplatin|carboplatin|mesh-list
55825909|NCT03965468|Durvalumab|durvalumab|mesh-list
55825910|NCT03965468|Tremelimumab|tremelimumab|mesh-list
55825945|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825946|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825986|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825987|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55825988|NCT04776980|Hematinics|hematinics|mesh-ancestor
55826015|NCT00119366|Fludarabine|fludarabine|mesh-list
55826016|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
55826017|NCT00119366|Antibodies|antibodies|mesh-list
55826018|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
55826019|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55826020|NCT00119366|Cyclosporins|cyclosporins|mesh-list
55826021|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
55826022|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826023|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826024|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55826025|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
55826026|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826027|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826028|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826029|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
55826030|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826031|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
55826032|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55826033|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55826034|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55826035|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55826036|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
55826037|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56217175|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217176|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217177|NCT01630057|Zonisamide|zonisamide|mesh-list
56217178|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
55826067|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826068|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826069|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
55826070|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826071|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55826072|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55826073|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55826074|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55826075|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
55784864|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784865|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784867|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55784868|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55784870|NCT03013933|Antibodies|antibodies|mesh-list
55784871|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
55784872|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55784873|NCT03013933|Cyclosporins|cyclosporins|mesh-list
55784874|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
55784875|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
55826076|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
55826077|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826078|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55826079|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55826080|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
55826081|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55826083|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55826084|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55826085|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55826086|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826110|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55826111|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
55826112|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56004873|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
56004874|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004875|NCT01004393|Bromides|bromides|mesh-list
56004876|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
56004877|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
56004878|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56004879|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826113|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826114|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55826115|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
55826116|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826117|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826118|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
55826119|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826120|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55826121|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826122|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
55826123|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55826124|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55826125|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826126|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
55826127|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55826128|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
55826129|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55826130|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826131|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826132|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
55826133|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826134|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55826135|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55826136|NCT03455270|Palbociclib|palbociclib|mesh-list
55826173|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55826174|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
55826209|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826211|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826245|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217179|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56217180|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217181|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826247|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
55826248|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55826249|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
55826250|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
55826251|NCT01709578|Methotrexate|methotrexate|mesh-list
56004897|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004899|NCT00002476|Cobalt|cobalt|mesh-list
56004900|NCT00002476|Fluorouracil|fluorouracil|mesh-list
56004901|NCT00002476|Methotrexate|methotrexate|mesh-list
56004902|NCT00002476|Vincristine|vincristine|mesh-list
56004903|NCT00002476|Bleomycin|bleomycin|mesh-list
56004904|NCT00002476|Calcium|calcium|mesh-list
56004905|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
56004906|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56004907|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004908|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
56004909|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004910|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56004911|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826252|NCT01709578|Leflunomide|leflunomide|mesh-list
55784876|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784877|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784878|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784879|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784880|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55784881|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
55784882|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784883|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
55784884|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55784885|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55784886|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55784887|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55784888|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784889|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55784890|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
56004912|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56004914|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56004915|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
56004916|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55759913|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
56004917|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
56004918|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004919|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56004920|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56004921|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004922|NCT00002476|Antidotes|antidotes|mesh-ancestor
56004923|NCT00002476|Protective Agents|protective agents|mesh-ancestor
56004924|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
56004925|NCT00002476|Vitamins|vitamins|mesh-ancestor
56004926|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
56004927|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56004928|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
56004929|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
56004930|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
56004931|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56004932|NCT00002476|Trace Elements|trace elements|mesh-ancestor
56004933|NCT01876628|Clindamycin|clindamycin|mesh-list
55784891|NCT05214911|Loratadine|loratadine|mesh-list
55784892|NCT05214911|Prednisolone|prednisolone|mesh-list
55784893|NCT05214911|Desloratadine|desloratadine|mesh-list
55826277|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826278|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55826279|NCT02132767|Digoxin|digoxin|mesh-list
55826280|NCT02132767|Amiodarone|amiodarone|mesh-list
55826281|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
55826282|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55826283|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826284|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55826285|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55826286|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826287|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826288|NCT02132767|Protective Agents|protective agents|mesh-ancestor
55826289|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
55826291|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55826293|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55826294|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55826295|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55826296|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55826297|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55826298|NCT02153905|Aldesleukin|aldesleukin|mesh-list
55826299|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
55826300|NCT02153905|Fludarabine|fludarabine|mesh-list
55826333|NCT02244944|Ezetimibe|ezetimibe|mesh-list
55826334|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55826336|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
55826337|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826338|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55826339|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56004934|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
56004935|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
56004936|NCT01876628|Floxacillin|floxacillin|mesh-list
56004937|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56004938|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826340|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
55826395|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
55826396|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826397|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55826398|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55826399|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784895|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
55784896|NCT05214911|Hormones|hormones|mesh-ancestor
55784897|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784898|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784899|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55784900|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784901|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56217182|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217183|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217184|NCT01630070|Paclitaxel|paclitaxel|mesh-list
55784902|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
55784903|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784904|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784905|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55826400|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826401|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55826402|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
55826403|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55826404|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826405|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55826406|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55826407|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55826432|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826433|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
55826434|NCT02152345|Abatacept|abatacept|mesh-list
55826435|NCT02152345|Tacrolimus|tacrolimus|mesh-list
56004939|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56004940|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004941|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004942|NCT01004705|Aspirin|aspirin|mesh-list
56004943|NCT01004705|Ramipril|ramipril|mesh-list
56004944|NCT01004705|Simvastatin|simvastatin|mesh-list
56004945|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56004946|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56004947|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
56004948|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004949|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55826436|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55826437|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
55826438|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826439|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
55826440|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826441|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55826442|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826443|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826444|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826445|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826446|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
55826447|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
55826448|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826449|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55826450|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
55826451|NCT02152345|Hormones|hormones|mesh-ancestor
55826452|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55826453|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55826454|NCT02152345|Protective Agents|protective agents|mesh-ancestor
56004950|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56004951|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004952|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56004953|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56004954|NCT01004705|Analgesics|analgesics|mesh-ancestor
56004955|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
56004956|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759922|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55765211|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
55765212|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765213|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55765214|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
55765215|NCT02432261|ST 1435|st 1435|mesh-list
55765217|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
55765218|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
55765219|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55765220|NCT02432261|Androgens|androgens|mesh-ancestor
55765221|NCT02432261|Hormones|hormones|mesh-ancestor
55765222|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765224|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55765225|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765226|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
55765227|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55765228|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
55765229|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55765230|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55765231|NCT02428283|Remifentanil|remifentanil|mesh-list
55765232|NCT02428283|Ropivacaine|ropivacaine|mesh-list
55765233|NCT02428283|Sevoflurane|sevoflurane|mesh-list
55765234|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
55765235|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
55765236|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765237|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765238|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
55765239|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765240|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55765241|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55765242|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
55765243|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55765244|NCT02428283|Narcotics|narcotics|mesh-ancestor
55765245|NCT02428283|Analgesics|analgesics|mesh-ancestor
55765246|NCT02427893|Vemurafenib|vemurafenib|mesh-list
55765247|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765248|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55765249|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765250|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826455|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55826456|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55826457|NCT02180659|Buprenorphine|buprenorphine|mesh-list
55826458|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55826496|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55826529|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55826530|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55826531|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826532|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826533|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55826534|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55826535|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55826536|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55826572|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
55784906|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55784907|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
55784908|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
55784909|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
55784910|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
55784911|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55784912|NCT05635253|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55784913|NCT05635253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55784914|NCT05635253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784916|NCT04262479|Vitamins|vitamins|mesh-ancestor
55784917|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
55784918|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784919|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55784920|NCT04133311|Latanoprost|latanoprost|mesh-list
55784921|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55826573|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826574|NCT02203838|Risperidone|risperidone|mesh-list
56004957|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004958|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56004959|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56004960|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56004961|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56004962|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56004963|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56004964|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
56004965|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56004966|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004967|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56004968|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
56004969|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
56004970|NCT00002482|Antibodies|antibodies|mesh-list
56004971|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56004972|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
56004973|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004974|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56004975|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55826575|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56217185|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56217186|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217187|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
56217188|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
56217189|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
55826598|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
55826599|NCT02178709|Vitamins|vitamins|mesh-ancestor
55826600|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
55826601|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
55826602|NCT02238080|Hematinics|hematinics|mesh-ancestor
55826603|NCT02178553|Bupivacaine|bupivacaine|mesh-list
55826604|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
55826605|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
55826606|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826607|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826608|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
55826609|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826610|NCT01627327|Fluticasone|fluticasone|mesh-list
55826611|NCT01627327|Xhance|xhance|mesh-list
55826612|NCT01627327|Bromides|bromides|mesh-list
55826613|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
55826614|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826615|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55826616|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
55826617|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826618|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807378|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
55826619|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55826620|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
55826621|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
55826622|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55826623|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
55826624|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55826625|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
55826626|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826627|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826629|NCT01627249|Bevacizumab|bevacizumab|mesh-list
55826630|NCT01627249|Ranibizumab|ranibizumab|mesh-list
55826631|NCT01627249|Aflibercept|aflibercept|mesh-list
55826666|NCT01588990|Irinotecan|irinotecan|mesh-list
55826667|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56004976|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
56004977|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004978|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004979|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56004980|NCT05750992|Fentanyl|fentanyl|mesh-list
56004981|NCT05750992|Meperidine|meperidine|mesh-list
56004982|NCT05750992|Bupivacaine|bupivacaine|mesh-list
56004984|NCT05750992|Anesthetics|anesthetics|mesh-ancestor
55826668|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826669|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55826670|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55826671|NCT01588990|Growth Substances|growth substances|mesh-ancestor
55826705|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826707|NCT02125279|Calcitriol|calcitriol|mesh-list
55826708|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55826709|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826710|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55784924|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55784925|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55784926|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55784927|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55826711|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55826742|NCT02176291|Buprenorphine|buprenorphine|mesh-list
55826743|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55826744|NCT02176291|Narcotics|narcotics|mesh-ancestor
56005007|NCT05750758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56005008|NCT05750758|Antithrombins|antithrombins|mesh-ancestor
56005009|NCT05750758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56005010|NCT05750758|Protease Inhibitors|protease inhibitors|mesh-ancestor
56005011|NCT05750758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005012|NCT05750758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005013|NCT05750758|Anticoagulants|anticoagulants|mesh-ancestor
56005014|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
56005016|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005017|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
56005018|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005019|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005020|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56005021|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
56005022|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005023|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005024|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56005025|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56005026|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56005027|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56005028|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005029|NCT01245595|Aminophylline|aminophylline|mesh-list
56005030|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55826745|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826746|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826747|NCT02176291|Analgesics|analgesics|mesh-ancestor
55826748|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
55826749|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826750|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55826751|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
55826752|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
55826753|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826754|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217190|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217191|NCT01630083|Capecitabine|capecitabine|mesh-list
56217192|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
56217193|NCT01630083|Epirubicin|epirubicin|mesh-list
55826755|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826789|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55826790|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55826791|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826792|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
55826793|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826794|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826795|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
55826796|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
56005031|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
56005032|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005033|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005034|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56005035|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
56005036|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56005037|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56005038|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005039|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005040|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56005041|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56005042|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
55826823|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55826824|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
55826826|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55826827|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55826828|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55826829|NCT01587118|Asenapine|asenapine|mesh-list
55826830|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55826831|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55826832|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826833|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826834|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55826835|NCT01905657|Docetaxel|docetaxel|mesh-list
55826836|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
55826837|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826838|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
55826839|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
55826840|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
55807408|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
55826841|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826842|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55826843|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
55826844|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
55826912|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55826913|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826914|NCT04769414|Gemcitabine|gemcitabine|mesh-list
55826915|NCT04769414|Fluorouracil|fluorouracil|mesh-list
55826916|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55826917|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
55826918|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826950|NCT02236130|Hydrocodone|hydrocodone|mesh-list
55826952|NCT02236130|Anesthetics|anesthetics|mesh-list
55826953|NCT02236130|Ropivacaine|ropivacaine|mesh-list
55826954|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
56005043|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005044|NCT01245595|Protective Agents|protective agents|mesh-ancestor
56005045|NCT01864772|Cetuximab|cetuximab|mesh-list
56005046|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56005047|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005048|NCT00002494|Leucovorin|leucovorin|mesh-list
56005049|NCT00002494|Cobalt|cobalt|mesh-list
56005050|NCT00002494|Cytarabine|cytarabine|mesh-list
55826955|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826956|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826957|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55826958|NCT02236130|Narcotics|narcotics|mesh-ancestor
55826959|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
55784928|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784929|NCT04035187|Itraconazole|itraconazole|mesh-list
55784930|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
55784931|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55784932|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
55784934|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55784935|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55784936|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784937|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784938|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55826960|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826961|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55826962|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
55826991|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826993|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55826994|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55826995|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56217194|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217195|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
56217196|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217197|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005051|NCT00002494|Dexamethasone|dexamethasone|mesh-list
56005052|NCT00002494|Prednisone|prednisone|mesh-list
56005053|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
56005054|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56005055|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56005056|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55759961|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
56005057|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
56005059|NCT00002494|Doxorubicin|doxorubicin|mesh-list
56005060|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56005061|NCT00002494|Methotrexate|methotrexate|mesh-list
56005063|NCT00002494|Vincristine|vincristine|mesh-list
56005064|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
56005075|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
55826996|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55826997|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55826998|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55826999|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55827000|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55827001|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55827002|NCT01632566|Celecoxib|celecoxib|mesh-list
55827003|NCT01632566|Simvastatin|simvastatin|mesh-list
55827004|NCT01632566|LY3031207|ly3031207|mesh-list
55827005|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55827006|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55827007|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
55827033|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55827035|NCT05650151|Vitamins|vitamins|mesh-ancestor
55827036|NCT05650151|Micronutrients|micronutrients|mesh-ancestor
55827037|NCT05650151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827038|NCT05650151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55827039|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
55827040|NCT02174731|Hematinics|hematinics|mesh-ancestor
55827041|NCT01922037|Omalizumab|omalizumab|mesh-list
55827042|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55827043|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55827044|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
55827045|NCT02282813|Calcitriol|calcitriol|mesh-list
55827046|NCT02282813|Calcifediol|calcifediol|mesh-list
56005131|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005132|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
56005133|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56005134|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56005135|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56005136|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56005137|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005138|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
56005139|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005140|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005141|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56005142|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005143|NCT01357772|Tamoxifen|tamoxifen|mesh-list
56005144|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56005145|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
56005146|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005147|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827047|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
55827048|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55827049|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827050|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55827051|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827052|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827053|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55827054|NCT02282813|Vitamins|vitamins|mesh-ancestor
55827085|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55827086|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55827087|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55827088|NCT02121847|Laxatives|laxatives|mesh-ancestor
55827089|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55827090|NCT01586806|Dexamethasone|dexamethasone|mesh-list
55827091|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
55827092|NCT01586806|Bupivacaine|bupivacaine|mesh-list
55827093|NCT01586806|BB 1101|bb 1101|mesh-list
55827094|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55827095|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
55827096|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
55784939|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
55784940|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55784941|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784942|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55784943|NCT00157963|Losartan|losartan|mesh-list
55784944|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55784945|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55784946|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55827097|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827098|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827125|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55827126|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827127|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827128|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827129|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
55827133|NCT05619653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55827134|NCT05619653|Glucocorticoids|glucocorticoids|mesh-ancestor
56005148|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56005149|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005150|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56005151|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56005152|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56005153|NCT03866837|Micronutrients|micronutrients|mesh-list
56005154|NCT03866837|Trace Elements|trace elements|mesh-list
56005155|NCT03866837|Lactoferrin|lactoferrin|mesh-list
56005156|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005157|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005158|NCT05750446|Riociguat|riociguat|mesh-list
56005159|NCT05750446|Enzyme Activators|enzyme activators|mesh-ancestor
56005160|NCT05750446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005161|NCT05750290|Irinotecan|irinotecan|mesh-list
56005162|NCT05750290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56005163|NCT05750290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56005164|NCT05750290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827136|NCT05619653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827137|NCT05619653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827138|NCT05619653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55827139|NCT05619653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217198|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56217199|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56217200|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55793414|NCT05331573|Apomorphine|apomorphine|mesh-list
55827140|NCT05619653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55827141|NCT05619653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55827142|NCT05619653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55827143|NCT05619653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55827144|NCT05619653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827145|NCT02143843|Bimatoprost|bimatoprost|mesh-list
55827182|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55827183|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
55827184|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032492|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56005165|NCT05750290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005166|NCT05750290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005167|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
56005168|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005169|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
56005170|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
56005171|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
56005172|NCT04456517|Ranolazine|ranolazine|mesh-list
56005173|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56005174|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56005175|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005176|NCT01840046|Interleukin-2|interleukin-2|mesh-list
56005177|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005178|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56005179|NCT01840046|Analgesics|analgesics|mesh-ancestor
56005180|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
55827185|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827186|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827219|NCT02252042|Docetaxel|docetaxel|mesh-list
55827220|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
55827221|NCT02252042|Methotrexate|methotrexate|mesh-list
55827222|NCT02252042|Cetuximab|cetuximab|mesh-list
55827223|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827224|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
55827225|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
55827226|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
55827227|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827262|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
55827263|NCT02199080|Coagulants|coagulants|mesh-ancestor
55827265|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55827334|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827335|NCT05417165|Vaccines|vaccines|mesh-list
55827336|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55827337|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
55827338|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827339|NCT04660643|Tirzepatide|tirzepatide|mesh-list
55827340|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55827341|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827342|NCT04660643|Incretins|incretins|mesh-ancestor
55827343|NCT04660643|Hormones|hormones|mesh-ancestor
55827344|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827345|NCT04659317|Oxycodone|oxycodone|mesh-list
55827346|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55827347|NCT04659317|Narcotics|narcotics|mesh-ancestor
55827348|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827349|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827350|NCT04659317|Analgesics|analgesics|mesh-ancestor
55784947|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55784948|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55784949|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784950|NCT00157963|Diuretics|diuretics|mesh-ancestor
55784951|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
55784952|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784953|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55784954|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55784955|NCT05087797|Nicorandil|nicorandil|mesh-list
55784956|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56005181|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005182|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005184|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56005185|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
55827386|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827387|NCT02120833|Decanoic acid|decanoic acid|mesh-list
55827388|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
55827424|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55827425|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55827426|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827427|NCT04577417|Methylphenidate|methylphenidate|mesh-list
55827428|NCT04577417|Amphetamine|amphetamine|mesh-list
55827430|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
55827449|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55827450|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827451|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827455|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827456|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55827458|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
55827459|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56217201|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217202|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55793415|NCT05331573|Emetics|emetics|mesh-ancestor
55827460|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56005186|NCT00437216|Hormones|hormones|mesh-ancestor
56005187|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827461|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55827462|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55827463|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
55827464|NCT02193776|Rifampin|rifampin|mesh-list
55827465|NCT02193776|Isoniazid|isoniazid|mesh-list
55827466|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
55827467|NCT02193776|Ethambutol|ethambutol|mesh-list
55827468|NCT02193776|Bedaquiline|bedaquiline|mesh-list
55827469|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55827470|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827471|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55827472|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55827473|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827474|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827475|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827476|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55827477|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
55827478|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
55827479|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55827480|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55827481|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55827482|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55827483|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55827484|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55827511|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827512|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827513|NCT04562285|Antibodies|antibodies|mesh-list
55827514|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
55827515|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827516|NCT05344625|Ketamine|ketamine|mesh-list
55827517|NCT05344625|Analgesics|analgesics|mesh-ancestor
55827518|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
55784957|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55784958|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
55827519|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827520|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827521|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55827522|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55827523|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
55827524|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
56005188|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005189|NCT00002524|Leucovorin|leucovorin|mesh-list
56005190|NCT00002524|Cytarabine|cytarabine|mesh-list
56005191|NCT00002524|Zidovudine|zidovudine|mesh-list
56005192|NCT00002524|Trimethoprim|trimethoprim|mesh-list
55765252|NCT03184493|Celecoxib|celecoxib|mesh-list
55765253|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55765254|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765255|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55765256|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55765257|NCT03184493|Analgesics|analgesics|mesh-ancestor
55765258|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
55765259|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765260|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765261|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765262|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55765263|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55765264|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765265|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765266|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
55765267|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765268|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55765269|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765270|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765271|NCT02431325|Teduglutide|teduglutide|mesh-list
55765272|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55765273|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55765274|NCT02431325|Protective Agents|protective agents|mesh-ancestor
55765275|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765276|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
55765277|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
55827525|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827526|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55827527|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55827528|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827552|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827553|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
55827556|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55827557|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827558|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55889863|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759996|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55827559|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827560|NCT04530149|Acetaminophen|acetaminophen|mesh-list
55827561|NCT04530149|Bupivacaine|bupivacaine|mesh-list
55827562|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
55827563|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
55827564|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827565|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827566|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
55827567|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827568|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55827569|NCT04530149|Analgesics|analgesics|mesh-ancestor
55827570|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
55827574|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827575|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827576|NCT04524689|Carboplatin|carboplatin|mesh-list
55827577|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
55827600|NCT02119819|Incretins|incretins|mesh-ancestor
55827601|NCT02119819|Hormones|hormones|mesh-ancestor
56217204|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56217206|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
56217207|NCT01630187|Carbetocin|carbetocin|mesh-list
56217208|NCT01630187|Oxytocin|oxytocin|mesh-list
56217209|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
55827602|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005194|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56005195|NCT00002524|Pentamidine|pentamidine|mesh-list
56005196|NCT00002524|Prednisone|prednisone|mesh-list
56005197|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
56005198|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56005199|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55827603|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
55827604|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55827605|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
55827606|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827607|NCT04766450|Expectorants|expectorants|mesh-ancestor
55827608|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
55827609|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55827610|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
55827611|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827612|NCT04766450|Protective Agents|protective agents|mesh-ancestor
55827613|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827614|NCT04766450|Antidotes|antidotes|mesh-ancestor
55827615|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
55827616|NCT02168816|Metronidazole|metronidazole|mesh-list
55827617|NCT02168816|Vancomycin|vancomycin|mesh-list
55827618|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
55827619|NCT02168816|Clindamycin|clindamycin|mesh-list
56005200|NCT00002524|Prednisolone|prednisolone|mesh-list
56005201|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
56005202|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
56005203|NCT00002524|Ifosfamide|ifosfamide|mesh-list
56005204|NCT00002524|Doxorubicin|doxorubicin|mesh-list
56005205|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56005206|NCT00002524|Fluorouracil|fluorouracil|mesh-list
56005207|NCT00002524|Methotrexate|methotrexate|mesh-list
56005208|NCT00002524|Etoposide|etoposide|mesh-list
55732409|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005210|NCT00002524|Bleomycin|bleomycin|mesh-list
56005211|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56005212|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
56005213|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
55827620|NCT02168816|Meropenem|meropenem|mesh-list
55827621|NCT02168816|Tazobactam|tazobactam|mesh-list
55827622|NCT02168816|Linezolid|linezolid|mesh-list
55827623|NCT02168816|Piperacillin|piperacillin|mesh-list
55827624|NCT02168816|Daptomycin|daptomycin|mesh-list
55827625|NCT02168816|Cefepime|cefepime|mesh-list
55827626|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55827627|NCT02168816|Aztreonam|aztreonam|mesh-list
55827628|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55827629|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55827630|NCT02168816|Trimethoprim|trimethoprim|mesh-list
55827631|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
55827632|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827633|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55827668|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55827669|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
55827670|NCT04481009|Antiviral Agents|antiviral agents|mesh-ancestor
55827671|NCT04481009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55784959|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
55784960|NCT05087797|Vitamins|vitamins|mesh-ancestor
55784961|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
55827672|NCT04481009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827701|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55827703|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
55827704|NCT02168270|Temozolomide|temozolomide|mesh-list
55827705|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55827706|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
55827707|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827708|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827709|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
55827710|NCT02168270|Protective Agents|protective agents|mesh-ancestor
55827711|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827712|NCT02168270|Vitamins|vitamins|mesh-ancestor
55827713|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
55827714|NCT02167256|Saracatinib|saracatinib|mesh-list
55827715|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827716|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827717|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827718|NCT05323955|Trastuzumab|trastuzumab|mesh-list
55827719|NCT05323955|Pertuzumab|pertuzumab|mesh-list
55827749|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56005214|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005215|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
56005216|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005217|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005218|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56005219|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
56005220|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005221|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005222|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56005223|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56005224|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56005225|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56005226|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005227|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
56005228|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56005229|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55827750|NCT02166476|Levofloxacin|levofloxacin|mesh-list
55827751|NCT02166476|Ofloxacin|ofloxacin|mesh-list
55827752|NCT02166476|Meropenem|meropenem|mesh-list
55827753|NCT02166476|Tazobactam|tazobactam|mesh-list
55827754|NCT02166476|Piperacillin|piperacillin|mesh-list
55827755|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55827756|NCT02166476|Vaborbactam|vaborbactam|mesh-list
55827757|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
55827807|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827808|NCT04791059|Sufentanil|sufentanil|mesh-list
56005230|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
56005231|NCT00002524|Hormones|hormones|mesh-ancestor
56005232|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760028|NCT04873479|Ketamine|ketamine|mesh-list
55827809|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
56217210|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56217211|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217212|NCT01630226|Cisplatin|cisplatin|mesh-list
56217213|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217214|NCT01630278|Ibuprofen|ibuprofen|mesh-list
56217215|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56217216|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217217|NCT01630278|Analgesics|analgesics|mesh-ancestor
56217218|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
56217219|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217220|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217221|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56005233|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56005234|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56005235|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
56005236|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56005237|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
56005238|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56005239|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56005240|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56005241|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
56005242|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005243|NCT00002524|Antidotes|antidotes|mesh-ancestor
56005244|NCT00002524|Protective Agents|protective agents|mesh-ancestor
56005245|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
56005246|NCT00002524|Vitamins|vitamins|mesh-ancestor
56005247|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
55827810|NCT04791059|Ketamine|ketamine|mesh-list
55827811|NCT04791059|Esketamine|esketamine|mesh-list
55827812|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55827826|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55827827|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
55827828|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
55827829|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55827830|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55827831|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55827832|NCT04791059|Narcotics|narcotics|mesh-ancestor
55827833|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55827834|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
55827835|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55827836|NCT05402111|Olanzapine|olanzapine|mesh-list
55827837|NCT05402111|Risperidone|risperidone|mesh-list
55827838|NCT05402111|Aripiprazole|aripiprazole|mesh-list
55827839|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55827840|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
55827841|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55827842|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
55827843|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005248|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
56005249|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
56005250|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
56005251|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
56005252|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
56005253|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005254|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005255|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56005256|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56005257|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56005258|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56005259|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56005260|NCT00002524|Renal Agents|renal agents|mesh-ancestor
56005261|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
56005262|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56005263|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56005264|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56005265|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55827844|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784962|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784963|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
55784964|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55784965|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
55784966|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784967|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
55784968|NCT03906877|Protective Agents|protective agents|mesh-ancestor
55784969|NCT03867799|Nivolumab|nivolumab|mesh-list
55784970|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55784971|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784972|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55827845|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827846|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55827847|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827853|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827854|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55827855|NCT05402111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55827856|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55827857|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827858|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
55827860|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55827861|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56005266|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56005267|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56005268|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
55765278|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
55765279|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765280|NCT02103478|Decitabine|decitabine|mesh-list
55765281|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55765282|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
55765283|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765284|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765285|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765287|NCT02431013|Simvastatin|simvastatin|mesh-list
55765288|NCT02431013|Pravastatin|pravastatin|mesh-list
55765289|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55765290|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55765291|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
55765292|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765294|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55765296|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55765297|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
55765298|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765299|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765300|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55765301|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
55765302|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55765304|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55765305|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
55765306|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55765307|NCT02431013|Protective Agents|protective agents|mesh-ancestor
55765308|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55765309|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55765310|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
55765311|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
55765312|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765313|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765314|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765315|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55765317|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765318|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765319|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55765320|NCT02430545|Rifampin|rifampin|mesh-list
55765321|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55765322|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
55765323|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55765324|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827862|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55827863|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55827864|NCT05398913|Rimonabant|rimonabant|mesh-list
55827865|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55827866|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
55827867|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55827868|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217222|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217223|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56217224|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217225|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217226|NCT01630343|Acetaminophen|acetaminophen|mesh-list
56217227|NCT01630343|Tramadol|tramadol|mesh-list
56217228|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217229|NCT01630343|Analgesics|analgesics|mesh-ancestor
56217230|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
56217231|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217232|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217233|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
56217234|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56217235|NCT01630343|Narcotics|narcotics|mesh-ancestor
56217236|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217237|NCT01630369|Insulin|insulin|mesh-list
56217238|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56217239|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56217240|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217241|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
56217242|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56217243|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
56005269|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56005270|NCT01824836|Anastrozole|anastrozole|mesh-list
56005271|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56005272|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005273|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56005274|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56005275|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005276|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005277|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56005278|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
56005279|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005280|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005281|NCT00002536|Vincristine|vincristine|mesh-list
56005282|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005283|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56005284|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
56217244|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217245|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217246|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56217247|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
55807587|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
56217269|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217270|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217271|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217272|NCT01630655|Felodipine|felodipine|mesh-list
56217273|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56217274|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56217275|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56217276|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827869|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827870|NCT05398913|Hormones|hormones|mesh-ancestor
55827871|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827892|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
55827893|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
55827894|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55827895|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827896|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55827897|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55827898|NCT01583374|Growth Substances|growth substances|mesh-ancestor
55827899|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
55827900|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827901|NCT04245215|Ustekinumab|ustekinumab|mesh-list
55827902|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827903|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
55827905|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56005285|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
56005287|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005288|NCT01203319|Vaccines|vaccines|mesh-list
56005289|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
56005290|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005291|NCT01344200|Celecoxib|celecoxib|mesh-list
56005292|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56005293|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56005294|NCT01344200|Analgesics|analgesics|mesh-ancestor
56005295|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
56005296|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005297|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005298|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56005299|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005300|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56005301|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56005302|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827906|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827907|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55827908|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55827909|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827910|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827911|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827912|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827913|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55827914|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
55827915|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827916|NCT04721015|Docetaxel|docetaxel|mesh-list
55827917|NCT04721015|Osimertinib|osimertinib|mesh-list
55784973|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784975|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55784976|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55827918|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827919|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
55827920|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
55827921|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
55827922|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827923|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55827955|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827956|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55827957|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55827958|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827959|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827960|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
55827961|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55827964|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55827967|NCT04060277|Letermovir|letermovir|mesh-list
55827968|NCT04060277|Vaccines|vaccines|mesh-list
55827969|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
55827970|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828037|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
55828038|NCT02975999|Coagulants|coagulants|mesh-ancestor
55828039|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55828086|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828087|NCT02220920|Canagliflozin|canagliflozin|mesh-list
56217277|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217278|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217279|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217280|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
56217281|NCT01630720|Vitamin D|vitamin d|mesh-list
56217282|NCT01630720|Vitamins|vitamins|mesh-list
56217283|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
56217284|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217285|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56217286|NCT01630733|Docetaxel|docetaxel|mesh-list
56217287|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217288|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
56217289|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
56217290|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
56217291|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217292|NCT01630902|Felodipine|felodipine|mesh-list
56005303|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005305|NCT01204255|Promethazine|promethazine|mesh-list
56005306|NCT01204255|Lorazepam|lorazepam|mesh-list
56005307|NCT01204255|Haloperidol|haloperidol|mesh-list
56005308|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
56217293|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56217294|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55793491|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
55828088|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55828089|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828090|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55828091|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828092|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
55828093|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
55828094|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
55828095|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828096|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828097|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828226|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828227|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828228|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
56005309|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56005310|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56005311|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760063|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
55765325|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
55765326|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55765327|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765328|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765329|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55765330|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55765331|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55765332|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55765333|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55765334|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55765335|NCT03117725|Melatonin|melatonin|mesh-list
55765336|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
55765337|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765338|NCT03117725|Protective Agents|protective agents|mesh-ancestor
55765339|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765340|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765342|NCT03185351|Bupivacaine|bupivacaine|mesh-list
55765343|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
55765344|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
55765345|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765346|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765347|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
55765348|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765349|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55765350|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55765351|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55765352|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55765353|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55765354|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55765355|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
55765357|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
55765358|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765359|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765360|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
55765361|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55765362|NCT02707601|Ledipasvir|ledipasvir|mesh-list
55765363|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55765364|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
55765365|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765366|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55765367|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55765368|NCT02425865|Golimumab|golimumab|mesh-list
55765369|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55765370|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765371|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765372|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
55828229|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828315|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55828363|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828364|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828365|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
55828366|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828367|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828368|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
55828369|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828370|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828371|NCT03774641|Lamotrigine|lamotrigine|mesh-list
55828372|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
55828373|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55828374|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828375|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828401|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828403|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
55828404|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
55828405|NCT02074631|Pamidronate|pamidronate|mesh-list
55828406|NCT02074631|Calcium|calcium|mesh-list
55828407|NCT02074631|Vitamins|vitamins|mesh-ancestor
55828408|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
55828409|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217295|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56217296|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828410|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55784977|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55784978|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55784980|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
55784981|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784982|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005315|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
56005316|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005317|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
56005318|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
56005319|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005320|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55784983|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784984|NCT04873297|Metoclopramide|metoclopramide|mesh-list
55784985|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
55784986|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
55784987|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828411|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55828412|NCT04813991|Ibuprofen|ibuprofen|mesh-list
55828413|NCT04813991|Oxycodone|oxycodone|mesh-list
55828414|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55828415|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55828416|NCT04813991|Analgesics|analgesics|mesh-ancestor
55828417|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
55828418|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828419|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828420|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55828423|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828522|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55828523|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55828524|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
55828525|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
55828526|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
55828527|NCT01562548|Guaifenesin|guaifenesin|mesh-list
55829181|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829182|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55829183|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55829184|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56005321|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
56005322|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
56005323|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005324|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005325|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56005326|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
56005327|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
56005328|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56005329|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56005330|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56005331|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56005332|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
56005334|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
56005335|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56005336|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
56005337|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
56005338|NCT00002542|Tamoxifen|tamoxifen|mesh-list
56005339|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
56005340|NCT00002542|Doxorubicin|doxorubicin|mesh-list
56005341|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56005342|NCT00002542|Fluorouracil|fluorouracil|mesh-list
56005343|NCT00002542|Methotrexate|methotrexate|mesh-list
56005344|NCT00002542|Epirubicin|epirubicin|mesh-list
56005345|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005346|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
55829185|NCT02209454|Analgesics|analgesics|mesh-ancestor
55829186|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
55829187|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829188|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829189|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829190|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829191|NCT01557166|Liraglutide|liraglutide|mesh-list
55829192|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55829193|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829194|NCT01557166|Incretins|incretins|mesh-ancestor
55829195|NCT01557166|Hormones|hormones|mesh-ancestor
55829196|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829598|NCT01545388|Incretins|incretins|mesh-ancestor
55829599|NCT01545388|Hormones|hormones|mesh-ancestor
55829636|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830066|NCT02132312|Phenylephrine|phenylephrine|mesh-list
55830067|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
55830068|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55830069|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
55830070|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
55830071|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830072|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830073|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
55830074|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55830075|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
55784988|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55784989|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55784990|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55784991|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55784992|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
55784993|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55784994|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784995|NCT05634473|Methacholine Chloride|methacholine chloride|mesh-list
55784996|NCT05634473|Miotics|miotics|mesh-ancestor
55784997|NCT05634473|Autonomic Agents|autonomic agents|mesh-ancestor
56217297|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217298|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217299|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217300|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
56217301|NCT01630915|Clopidogrel|clopidogrel|mesh-list
56217302|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55830076|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
55830077|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55830078|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55830079|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55830080|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
55830081|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830082|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830083|NCT02132312|Protective Agents|protective agents|mesh-ancestor
55830085|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
55830086|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55830087|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830088|NCT04188392|Pimavanserin|pimavanserin|mesh-list
56005347|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830089|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55830090|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56005348|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005349|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56005350|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
56005351|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005352|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005353|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56005354|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56005355|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56005356|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56005357|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005358|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
56005359|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56005360|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56005361|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
56005362|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56005363|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
56005364|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56005365|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56005366|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56005367|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
55830091|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55830092|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55830093|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830094|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830095|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55830096|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55830097|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55830098|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
55830099|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830121|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55830122|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55830124|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55830125|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55830126|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830127|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55830128|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
55830129|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830130|NCT04748822|Ethanol|ethanol|mesh-list
55830131|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55830132|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807646|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830133|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830134|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830135|NCT04739150|Nintedanib|nintedanib|mesh-list
56005369|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55830136|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830137|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55830138|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830139|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830140|NCT02147132|Nicotine|nicotine|mesh-list
55830141|NCT02147132|Varenicline|varenicline|mesh-list
56005370|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56005372|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56005374|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56005375|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005376|NCT05503511|Bumetanide|bumetanide|mesh-list
56005377|NCT05503511|Diuretics|diuretics|mesh-ancestor
56005378|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
56005379|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005380|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56005381|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56005382|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005383|NCT01823198|Aldesleukin|aldesleukin|mesh-list
56005384|NCT01823198|Fludarabine|fludarabine|mesh-list
56005385|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
56005386|NCT01823198|Busulfan|busulfan|mesh-list
56005387|NCT01823198|Interleukin-2|interleukin-2|mesh-list
56005388|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760081|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55830142|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55830143|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
55830144|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830145|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830146|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55830147|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55830148|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
55784998|NCT05634473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55784999|NCT05634473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785000|NCT05634473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55785001|NCT05634473|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
55785002|NCT05634473|Respiratory System Agents|respiratory system agents|mesh-ancestor
55830149|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830150|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830151|NCT02146430|Pregabalin|pregabalin|mesh-list
55830152|NCT02146430|Analgesics|analgesics|mesh-ancestor
56217303|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56217304|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56217305|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56217306|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
56217307|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217308|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217309|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830153|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
55830419|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55830420|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830421|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
55830422|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830479|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55830480|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830482|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
55830483|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830484|NCT02241551|Gemcitabine|gemcitabine|mesh-list
55830485|NCT02241551|Paclitaxel|paclitaxel|mesh-list
55830486|NCT02241551|Fluorouracil|fluorouracil|mesh-list
55830487|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
55830488|NCT02241551|Irinotecan|irinotecan|mesh-list
55830489|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55830490|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830491|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
55830492|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
55830493|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
56005390|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
56005391|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005392|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005393|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
56005394|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005395|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
55830494|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830495|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55830496|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
55830497|NCT02241551|Antiviral Agents|antiviral agents|mesh-ancestor
55830498|NCT02241551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830499|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830500|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830501|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
55830502|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830503|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55830504|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55830505|NCT02207621|Timolol|timolol|mesh-list
55830508|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830509|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55830510|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55830511|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
55830512|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830513|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830514|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55830515|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55830516|NCT02240693|BI 409306|bi 409306|mesh-list
55830544|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
55830545|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55830547|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
55830548|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
55830549|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830550|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005396|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56005397|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56005398|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56005399|NCT01823198|Analgesics|analgesics|mesh-ancestor
55830551|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830552|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55830553|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55830554|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55830555|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
55830556|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830557|NCT03836105|Cemiplimab|cemiplimab|mesh-list
55830558|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55830559|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830560|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
56217310|NCT01630941|Denosumab|denosumab|mesh-list
56217311|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56217312|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217313|NCT01631058|Prednisone|prednisone|mesh-list
55785003|NCT05634473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55830561|NCT02123108|Tacrolimus|tacrolimus|mesh-list
56005400|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
56005401|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005402|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56005403|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56005404|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
56005405|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005406|NCT05750056|Lidocaine|lidocaine|mesh-list
56005407|NCT05750056|Sufentanil|sufentanil|mesh-list
56005408|NCT05750056|Dsuvia|dsuvia|mesh-list
56005409|NCT05750056|Propofol|propofol|mesh-list
56005410|NCT05750056|Anesthetics, Local|anesthetics, local|mesh-ancestor
56005411|NCT05750056|Anesthetics|anesthetics|mesh-ancestor
56005412|NCT05750056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56005413|NCT05750056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005414|NCT05750056|Sensory System Agents|sensory system agents|mesh-ancestor
56005415|NCT05750056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005416|NCT05750056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56005417|NCT05750056|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56005418|NCT05750056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55830562|NCT02123108|Basiliximab|basiliximab|mesh-list
55830563|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830564|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
55830565|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807693|NCT02292771|Vasotocin|vasotocin|mesh-list
55830566|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55830567|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830568|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830569|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55830570|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830571|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55830572|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
55830573|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55830864|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830865|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
55830866|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55830867|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55830869|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55830870|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55830871|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
55830872|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830873|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
55830874|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831060|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831061|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55831062|NCT01881789|Dexamethasone|dexamethasone|mesh-list
55831063|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
55831064|NCT01881789|Lenalidomide|lenalidomide|mesh-list
55831065|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831066|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
56005419|NCT05750056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831067|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831068|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831069|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55831070|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
55831071|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831072|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831073|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55831074|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831102|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831103|NCT01500226|Dexamethasone|dexamethasone|mesh-list
55831104|NCT01500226|Granisetron|granisetron|mesh-list
55831105|NCT01500226|Rolapitant|rolapitant|mesh-list
55831106|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831109|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831110|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831111|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55831112|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
55831113|NCT01500226|Hormones|hormones|mesh-ancestor
55831114|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831115|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55831116|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831117|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55831118|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
55831119|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831120|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831121|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55831122|NCT02075047|Ziprasidone|ziprasidone|mesh-list
55831123|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55831223|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55831224|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
55831225|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
55831226|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831227|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55831228|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
55831229|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
56217314|NCT01631058|Everolimus|everolimus|mesh-list
56217315|NCT01631058|Lactitol|lactitol|mesh-list
55807724|NCT02291679|Linaclotide|linaclotide|mesh-list
56217316|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217318|NCT01631058|Hormones|hormones|mesh-ancestor
56217319|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005424|NCT05750056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56005425|NCT05750056|Narcotics|narcotics|mesh-ancestor
56005426|NCT05750056|Analgesics|analgesics|mesh-ancestor
56005427|NCT05750056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56005428|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
56005429|NCT03011125|Lansoprazole|lansoprazole|mesh-list
56005430|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56005431|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005432|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56005433|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005434|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005435|NCT05686564|Choline|choline|mesh-list
55831230|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55831231|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
55831232|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55831233|NCT02229383|Exenatide|exenatide|mesh-list
55831234|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55785004|NCT05634473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55785005|NCT05634473|Cholinergic Agents|cholinergic agents|mesh-ancestor
55785006|NCT05634473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785007|NCT05634473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785009|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55785010|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55785011|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785012|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55785013|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785014|NCT04858711|Lidocaine|lidocaine|mesh-list
55831235|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831236|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55831237|NCT02229383|Incretins|incretins|mesh-ancestor
55831238|NCT02229383|Hormones|hormones|mesh-ancestor
55831239|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831240|NCT01499368|Omeprazole|omeprazole|mesh-list
55831241|NCT01499368|Famotidine|famotidine|mesh-list
55831242|NCT01499368|Lafutidine|lafutidine|mesh-list
55831243|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55831244|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55831245|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56005436|NCT05686564|Lipotropic Agents|lipotropic agents|mesh-ancestor
56005437|NCT05686564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56005438|NCT05686564|Antimetabolites|antimetabolites|mesh-ancestor
56005439|NCT05686564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760127|NCT03222089|Vitamins|vitamins|mesh-ancestor
55792875|NCT04294459|Promethazine|promethazine|mesh-list
55831246|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831247|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831248|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55831249|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
55831250|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
55831251|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831252|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831253|NCT01835145|Temozolomide|temozolomide|mesh-list
55831254|NCT01835145|Dacarbazine|dacarbazine|mesh-list
55831255|NCT01835145|Imidazole|imidazole|mesh-list
55831256|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55831257|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
55831258|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831259|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831260|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831261|NCT02229227|Insulin|insulin|mesh-list
55831262|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
55831575|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
55831576|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831577|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831578|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831579|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831580|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55831582|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
55831583|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55831584|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55831585|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831586|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831587|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
55765531|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
55765532|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
55765534|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55765535|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765536|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765537|NCT02422277|Urological Agents|urological agents|mesh-ancestor
55765538|NCT02422121|RNS60|rns60|mesh-list
55765539|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55765540|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55765541|NCT02422121|Analgesics|analgesics|mesh-ancestor
55765542|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
55765543|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765544|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765545|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765546|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765547|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55765548|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
55765549|NCT02424461|Ofloxacin|ofloxacin|mesh-list
55765550|NCT02424461|Levofloxacin|levofloxacin|mesh-list
55765551|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55765552|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765553|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55765554|NCT02424461|Renal Agents|renal agents|mesh-ancestor
55765559|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765560|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55765561|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55765562|NCT02072824|Pregabalin|pregabalin|mesh-list
55765563|NCT02072824|Analgesics|analgesics|mesh-ancestor
55765564|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
55765565|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765566|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765567|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
55765568|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55765569|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55765570|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765571|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55765572|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55765573|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55765574|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765575|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55765576|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55765577|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
55765578|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831588|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831589|NCT02219477|Ritonavir|ritonavir|mesh-list
55831590|NCT02219477|Ribavirin|ribavirin|mesh-list
55831591|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55831592|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55831594|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217320|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217321|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56217322|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217323|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56217324|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
56217325|NCT01631058|Cathartics|cathartics|mesh-ancestor
56217326|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56217327|NCT01631136|Gemcitabine|gemcitabine|mesh-list
56217328|NCT01631136|Cisplatin|cisplatin|mesh-list
56217329|NCT01631136|Pemetrexed|pemetrexed|mesh-list
55831595|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831596|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55831597|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55831598|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
55785015|NCT04858711|Fentanyl|fentanyl|mesh-list
55785016|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
56005440|NCT05686564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55785017|NCT04858711|Ketamine|ketamine|mesh-list
55785018|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
55785019|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
55785020|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56005441|NCT05686564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56005442|NCT05686564|Nootropic Agents|nootropic agents|mesh-ancestor
56005443|NCT05749900|Gemcitabine|gemcitabine|mesh-list
56005444|NCT05749900|Nivolumab|nivolumab|mesh-list
55760142|NCT03222167|Grazoprevir|grazoprevir|mesh-list
55785021|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785022|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
55785023|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785024|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55831599|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831600|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55831601|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55831602|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
55831603|NCT02093390|Fluconazole|fluconazole|mesh-list
55831604|NCT02093390|Atorvastatin|atorvastatin|mesh-list
55831605|NCT02093390|Relugolix|relugolix|mesh-list
55831606|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55831607|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55831608|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
55831609|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831610|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55831611|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55831612|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831613|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
55831614|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831615|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55831647|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831648|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55831649|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55831651|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55831652|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55831653|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55831654|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55831805|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831806|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55831807|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55831808|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
55831809|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55831810|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
55831811|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55831812|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55831813|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831814|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831815|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55831816|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55831817|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
55831818|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56005446|NCT05749900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005447|NCT05749900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55765579|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55765580|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
55765581|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765582|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765583|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55765584|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55765585|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55765586|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
55765587|NCT03117257|Cisplatin|cisplatin|mesh-list
55765588|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765589|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
55765590|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55765591|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
55765592|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55765593|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
55765594|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765595|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765596|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
55765597|NCT03181685|Cetrorelix|cetrorelix|mesh-list
55765598|NCT03181685|Progesterone|progesterone|mesh-list
55765599|NCT03181685|Progestins|progestins|mesh-ancestor
55765600|NCT03181685|Hormones|hormones|mesh-ancestor
55765601|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765602|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765603|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55765604|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
55765605|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55832019|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217330|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217331|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217332|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
56217333|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217334|NCT01631136|Antiviral Agents|antiviral agents|mesh-ancestor
56217335|NCT01631136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217336|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793546|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
55832020|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55832021|NCT02070991|Macitentan|macitentan|mesh-list
55832022|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55832023|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55832025|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55832026|NCT01490086|Aripiprazole|aripiprazole|mesh-list
55832028|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
55832029|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55832030|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55832031|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55832032|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55832033|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785026|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55785027|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55785028|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785029|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55785030|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55785031|NCT04858711|Analgesics|analgesics|mesh-ancestor
55785032|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55785033|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55785034|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55785035|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
55785036|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785037|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55785038|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55785039|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
55785040|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55785041|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55785042|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55785043|NCT04858711|Narcotics|narcotics|mesh-ancestor
55832034|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
55832035|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
56005448|NCT05749900|Antimetabolites|antimetabolites|mesh-ancestor
56005449|NCT05749900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005450|NCT05749900|Antiviral Agents|antiviral agents|mesh-ancestor
56005451|NCT05749900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005452|NCT05749900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005453|NCT05749900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005454|NCT05749900|Immunologic Factors|immunologic factors|mesh-ancestor
55832036|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832037|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832038|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55832039|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55832040|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
55832041|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55832042|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55832043|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55832044|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55832074|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
55832075|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832076|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832077|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832079|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55832080|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55832081|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832082|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55832083|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55832084|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832085|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
55832086|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55832087|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
56217338|NCT01631136|Immunologic Factors|immunologic factors|mesh-ancestor
56217339|NCT01631136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217340|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56217341|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56217342|NCT01631201|Azithromycin|azithromycin|mesh-list
56217343|NCT01631201|KRM 1648|krm 1648|mesh-list
56005455|NCT05749900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005456|NCT05749900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56005457|NCT05749900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56005458|NCT03442751|Riboflavin|riboflavin|mesh-list
56005459|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56005460|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56005461|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
56005462|NCT03442751|Vitamins|vitamins|mesh-ancestor
56005463|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
56005464|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005465|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56005466|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
56005467|NCT05749666|Prednisolone|prednisolone|mesh-list
56005468|NCT05749666|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56005469|NCT05749666|Methylprednisolone|methylprednisolone|mesh-list
56005470|NCT05749666|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56005471|NCT05749666|Prednisolone acetate|prednisolone acetate|mesh-list
56005472|NCT05749666|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55765606|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
55765607|NCT02424071|Melatonin|melatonin|mesh-list
55765609|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765610|NCT02424071|Protective Agents|protective agents|mesh-ancestor
55765611|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765612|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765613|NCT03178955|Etanercept|etanercept|mesh-list
55765616|NCT03178955|Analgesics|analgesics|mesh-ancestor
55765617|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
55765618|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217344|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56217345|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217346|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56217347|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
56217348|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
56217349|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
56217350|NCT01631305|Calcium|calcium|mesh-list
56217351|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55832088|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55832089|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
55832090|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
55832091|NCT02070757|Meropenem|meropenem|mesh-list
55832118|NCT01473940|Ipilimumab|ipilimumab|mesh-list
55832119|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55832120|NCT01473940|Antibodies|antibodies|mesh-list
55832121|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
55832122|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55785044|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55785045|NCT03068975|Alvimopan|alvimopan|mesh-list
55785046|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55785047|NCT02034331|Acetylcholine|acetylcholine|mesh-list
55832123|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
55832124|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832125|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55832126|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
55832127|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832128|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832131|NCT01473940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832132|NCT01473940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832133|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55832134|NCT01832727|Dexamethasone|dexamethasone|mesh-list
56005473|NCT05749666|Prednisolone phosphate|prednisolone phosphate|mesh-list
56005474|NCT05749666|Tofacitinib|tofacitinib|mesh-list
56005475|NCT05749666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56005476|NCT05749666|Glucocorticoids|glucocorticoids|mesh-ancestor
56005477|NCT05749666|Hormones|hormones|mesh-ancestor
56005478|NCT05749666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005479|NCT05749666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005480|NCT05749666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56005481|NCT05749666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005482|NCT05749666|Antiemetics|antiemetics|mesh-ancestor
56005483|NCT05749666|Autonomic Agents|autonomic agents|mesh-ancestor
56005484|NCT05749666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005485|NCT05749666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005486|NCT05749666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56005487|NCT05749666|Protective Agents|protective agents|mesh-ancestor
56005488|NCT05749666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56005489|NCT05749666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005490|NCT05749666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005491|NCT05449535|Omalizumab|omalizumab|mesh-list
56005492|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56005493|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56005495|NCT04253561|Trastuzumab|trastuzumab|mesh-list
55832135|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832136|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
55832137|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
55832138|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832164|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
55832165|NCT01449682|BB 1101|bb 1101|mesh-list
55832166|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832167|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
55832168|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
55832169|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832170|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832171|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55832172|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
55832173|NCT01449682|Hormones|hormones|mesh-ancestor
55832174|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832175|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55832176|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832177|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
55832178|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832179|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832180|NCT01831791|Dutasteride|dutasteride|mesh-list
55832181|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55832182|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56217352|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217354|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217355|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56217356|NCT01631357|Gemcitabine|gemcitabine|mesh-list
56217357|NCT01631357|Cisplatin|cisplatin|mesh-list
56217358|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217359|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217360|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
56217361|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832183|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005497|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56005498|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005499|NCT05663866|Dexamethasone|dexamethasone|mesh-list
56005500|NCT05663866|Methotrexate|methotrexate|mesh-list
56005501|NCT05663866|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56005502|NCT05663866|Montelukast|montelukast|mesh-list
56005503|NCT05663866|Lazertinib|lazertinib|mesh-list
56005504|NCT05663866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56005505|NCT05663866|Antiemetics|antiemetics|mesh-ancestor
56005506|NCT05663866|Autonomic Agents|autonomic agents|mesh-ancestor
56005507|NCT05663866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732719|NCT04108897|Ivermectin|ivermectin|mesh-list
56005508|NCT05663866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005509|NCT05663866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005511|NCT05663866|Hormones|hormones|mesh-ancestor
56005512|NCT05663866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005513|NCT05663866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56005514|NCT05663866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005515|NCT05663866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55832184|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832219|NCT02111785|Dexamethasone|dexamethasone|mesh-list
55832220|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832221|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
55832222|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
55832223|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832224|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832225|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55832258|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832259|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
55832260|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55832262|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55832263|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
55832265|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
55832390|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832391|NCT01830543|Aspirin|aspirin|mesh-list
55832392|NCT01830543|Vitamin K|vitamin k|mesh-list
55832393|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
55832394|NCT01830543|Clopidogrel|clopidogrel|mesh-list
55832395|NCT01830543|Ticagrelor|ticagrelor|mesh-list
55832396|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55832397|NCT01830543|Vitamins|vitamins|mesh-ancestor
55832398|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
55832399|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832400|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55832401|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55832402|NCT01830543|Analgesics|analgesics|mesh-ancestor
55832403|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
55832404|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832405|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832406|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832407|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56005520|NCT05663866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005521|NCT05663866|Dermatologic Agents|dermatologic agents|mesh-ancestor
55785048|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785049|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
55785050|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55785051|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
55785052|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785053|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785054|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55785055|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
55785056|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785057|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
55785058|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785060|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55785061|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55832408|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55832409|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832410|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55832411|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55832412|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832413|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
55832414|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55832415|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55832416|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56217363|NCT01631357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217364|NCT01631357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217365|NCT01631357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56217366|NCT01631357|Immunologic Factors|immunologic factors|mesh-ancestor
56217367|NCT01631357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217368|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
56217369|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56217370|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56217371|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56217372|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217373|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217374|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217375|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217376|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56217377|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56217378|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217379|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56217380|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56217381|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
56217382|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217383|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
56217384|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217385|NCT01631383|Analgesics|analgesics|mesh-ancestor
56005522|NCT05663866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005523|NCT05663866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56005524|NCT05663866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005525|NCT05663866|Immunologic Factors|immunologic factors|mesh-ancestor
56217386|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
56217387|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217388|NCT01631396|Neostigmine|neostigmine|mesh-list
55832417|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
55832418|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832419|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55832453|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832454|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832455|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
55832456|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832457|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55832458|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
55832459|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55832460|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55832461|NCT01623271|Gabapentin|gabapentin|mesh-list
55832462|NCT01623271|Analgesics|analgesics|mesh-ancestor
55832479|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55832480|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832481|NCT02095873|Resveratrol|resveratrol|mesh-list
55832482|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
55832483|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832484|NCT02095873|Protective Agents|protective agents|mesh-ancestor
56217389|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56217390|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217391|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217392|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
56217393|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217394|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217395|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56217396|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
55832485|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832486|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832487|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55832490|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832491|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55832492|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
55832493|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832494|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832495|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55832496|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
55832497|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
55866798|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
55866799|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55866800|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55866801|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866802|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866803|NCT01720030|Protective Agents|protective agents|mesh-ancestor
55866804|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866805|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
55866806|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55866807|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
55866808|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55866809|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
55866810|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866811|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866812|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
55866813|NCT04380220|Protein C|protein c|mesh-list
55866814|NCT04380220|Antithrombins|antithrombins|mesh-list
55866815|NCT04380220|Protein S|protein s|mesh-list
55866816|NCT04380220|Factor VIII|factor viii|mesh-list
55866817|NCT04380220|Complement C3|complement c3|mesh-list
55789094|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55789095|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
55866818|NCT04380220|Coagulants|coagulants|mesh-ancestor
55866819|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55866820|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866821|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55866822|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
55866823|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866824|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
55866825|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55866826|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
55866827|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866828|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55866829|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
55785066|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55785067|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
55785068|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785069|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55832498|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55832499|NCT04724629|Aldesleukin|aldesleukin|mesh-list
55832500|NCT04724629|Colchicine|colchicine|mesh-list
55832501|NCT04724629|Ixekizumab|ixekizumab|mesh-list
55832502|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832503|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55832504|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55832505|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
55832506|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832507|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
55832508|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832509|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
55832510|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
55832511|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
55832512|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832513|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
55832514|NCT02186015|Vitamin D|vitamin d|mesh-list
55832515|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
55832516|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
55832517|NCT02186015|Vitamins|vitamins|mesh-list
55832518|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
55832519|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832520|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55832521|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55832540|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832541|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832543|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55832545|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
55832546|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55832547|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55832548|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55832549|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832550|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832551|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55832552|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55832553|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
55832554|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
56005527|NCT05663866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56005528|NCT05663866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56005529|NCT05663866|Respiratory System Agents|respiratory system agents|mesh-ancestor
56005530|NCT05663866|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56005531|NCT05663866|Hormone Antagonists|hormone antagonists|mesh-ancestor
56005532|NCT05663866|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55832555|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
55832556|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55832557|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55832558|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
55832559|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
55832560|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56217397|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217398|NCT01631409|Aspirin|aspirin|mesh-list
56217399|NCT01631409|Atenolol|atenolol|mesh-list
56217400|NCT01631409|Enalapril|enalapril|mesh-list
56217401|NCT01631409|Enalaprilat|enalaprilat|mesh-list
56217402|NCT01631409|Amlodipine|amlodipine|mesh-list
56217403|NCT01631409|Isosorbide|isosorbide|mesh-list
56217404|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56217405|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56217406|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
56217408|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217409|NCT01631409|Analgesics|analgesics|mesh-ancestor
55793612|NCT03079687|Olaparib|olaparib|mesh-list
55832561|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
55832562|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
55832563|NCT02184611|Bromides|bromides|mesh-list
55832564|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
55832565|NCT02066311|Nelfinavir|nelfinavir|mesh-list
55832566|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55832567|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55832568|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
55832569|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832570|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832571|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55832572|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55832573|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
55832574|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832576|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55832577|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55832578|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832579|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
55832580|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832581|NCT02159807|Fentanyl|fentanyl|mesh-list
55832582|NCT02159807|Bupivacaine|bupivacaine|mesh-list
55832694|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55832695|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
55832696|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55832697|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55832698|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
55832699|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832700|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
55832701|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832799|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832800|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
55832801|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
55832802|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
55832803|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832804|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55832805|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55832806|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
55832807|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55832808|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
55832982|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832983|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832984|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55832985|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55832986|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832987|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55832988|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55832989|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832990|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
55832991|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
55832992|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832993|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
56217410|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
56217411|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005533|NCT05663866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56005534|NCT05663866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56005535|NCT05663866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56005536|NCT05749276|Daratumumab|daratumumab|mesh-list
56005537|NCT05749276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005538|NCT05749042|Cisplatin|cisplatin|mesh-list
56005539|NCT05749042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005540|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
56005541|NCT02940509|Ketamine|ketamine|mesh-list
56005542|NCT02940509|Analgesics|analgesics|mesh-ancestor
56217412|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217413|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217414|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217415|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56217416|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56217417|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217418|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56217419|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56217420|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217421|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
56217422|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56005543|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
56005544|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005545|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005546|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56005547|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56005548|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
56005550|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56005551|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56005552|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56005553|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005554|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005555|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56005556|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
56005557|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56005558|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56005559|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56005560|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
56005561|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56005562|NCT02530697|Miltefosine|miltefosine|mesh-list
56005563|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
56005564|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
56005565|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56005566|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005567|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217423|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
56217424|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56217425|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56217426|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
56217427|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
55793618|NCT04997707|Sevoflurane|sevoflurane|mesh-list
55832994|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
55833000|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
55833001|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
55807926|NCT05341609|Ritonavir|ritonavir|mesh-list
55833002|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833003|NCT01598987|Cyclosporine|cyclosporine|mesh-list
55833004|NCT01598987|Everolimus|everolimus|mesh-list
55833005|NCT01598987|Tacrolimus|tacrolimus|mesh-list
55833175|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55833176|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
55833177|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833178|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55833179|NCT02176421|Lidocaine|lidocaine|mesh-list
55833180|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
55833181|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
55833182|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833183|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833184|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
55833185|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833186|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55833187|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55833188|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56005568|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56005569|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56005570|NCT02530697|Protective Agents|protective agents|mesh-ancestor
56005571|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005572|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
56005573|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56005574|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
56005575|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
56005576|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005577|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005578|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56005579|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56005580|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56005582|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56005583|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56005584|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56005585|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005586|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
56005587|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56005588|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005589|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005590|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55833189|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55833190|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833191|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
55833192|NCT02042443|Leucovorin|leucovorin|mesh-list
55833193|NCT02042443|Folic Acid|folic acid|mesh-list
55833194|NCT02042443|Fluorouracil|fluorouracil|mesh-list
55833195|NCT02042443|Capecitabine|capecitabine|mesh-list
55833196|NCT02042443|Trametinib|trametinib|mesh-list
55833197|NCT02042443|Calcium|calcium|mesh-list
55833198|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
55833199|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55833200|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833201|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55833202|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
55833203|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217428|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56217429|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56217430|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56217431|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
56217432|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217433|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55833204|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55833205|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005592|NCT04094207|Protective Agents|protective agents|mesh-ancestor
56005593|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005594|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
56005595|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56005596|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
56005597|NCT02144831|Aspirin|aspirin|mesh-list
56005598|NCT02144831|Clopidogrel|clopidogrel|mesh-list
56005599|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56005600|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55868303|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55868304|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55868305|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868306|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
55868307|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55868308|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55868311|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
55868312|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868313|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868314|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55868315|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
55868316|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55868317|NCT03153111|Macitentan|macitentan|mesh-list
55868318|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55868319|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55868320|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789132|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
55789133|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789134|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789135|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
55789136|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55789137|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55789138|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55789139|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55868321|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55868322|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
55868323|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55868324|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55868327|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868337|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
55868338|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868339|NCT02242864|Telmisartan|telmisartan|mesh-list
55833206|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55833207|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
55785070|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55785072|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55785073|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55785074|NCT02936843|Analgesics|analgesics|mesh-ancestor
55785075|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
55785076|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785077|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785078|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785079|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55785080|NCT03285763|Atezolizumab|atezolizumab|mesh-list
55785081|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785082|NCT05047601|Ritonavir|ritonavir|mesh-list
55785083|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55785084|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55785085|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
55785086|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785087|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785088|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55807974|NCT04248595|Azacitidine|azacitidine|mesh-list
55833208|NCT02042443|Antidotes|antidotes|mesh-ancestor
55833209|NCT02042443|Protective Agents|protective agents|mesh-ancestor
55833210|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
55833238|NCT04723862|Spironolactone|spironolactone|mesh-list
55833239|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56005601|NCT02144831|Analgesics|analgesics|mesh-ancestor
56005602|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
56005603|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005604|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005605|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56005606|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005607|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56005608|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56005609|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005610|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56005611|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56005612|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005613|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
56005614|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56005615|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56005616|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56005617|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
56005618|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005619|NCT05644600|Nintedanib|nintedanib|mesh-list
55833240|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
55833241|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833243|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55833244|NCT04723862|Diuretics|diuretics|mesh-ancestor
55833245|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
55833246|NCT02092220|Pancrelipase|pancrelipase|mesh-list
55833247|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55833249|NCT02066402|Tedizolid|tedizolid|mesh-list
55833250|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
55833251|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55833252|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833253|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55833254|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833255|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833256|NCT02060383|Metformin|metformin|mesh-list
55833375|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833376|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
56005620|NCT05644600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005621|NCT05644600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56005622|NCT05644600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005623|NCT05644600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005624|NCT05276219|Furosemide|furosemide|mesh-list
56005625|NCT05276219|Isosorbide|isosorbide|mesh-list
56005626|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56005627|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56005628|NCT05276219|Diuretics|diuretics|mesh-ancestor
55833377|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
55833378|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833379|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833380|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55833381|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
55833382|NCT02150213|Hormones|hormones|mesh-ancestor
55833383|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833384|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55833385|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833386|NCT02091362|Metformin|metformin|mesh-list
55833387|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55833388|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833389|NCT02091206|Cannabidiol|cannabidiol|mesh-list
55833390|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
55833391|NCT02062658|Ketamine|ketamine|mesh-list
55833392|NCT02062658|Analgesics|analgesics|mesh-ancestor
56217434|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217435|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56005630|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005631|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56217436|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
56217437|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56217438|NCT01631409|Diuretics|diuretics|mesh-ancestor
55833393|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
55833394|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833395|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833396|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55833397|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55833398|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
55833399|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
55833400|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833464|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833467|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833468|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
55833469|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833470|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833471|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
55833472|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55833473|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
55833474|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833475|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
55833476|NCT02110238|Protective Agents|protective agents|mesh-ancestor
55760250|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
55833477|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55833478|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
55833479|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833480|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
55833481|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55833482|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55833483|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55833484|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833485|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
55833486|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833487|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833488|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56005632|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56005633|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005634|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56005635|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
56005636|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56005637|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
56005638|NCT05232461|Celecoxib|celecoxib|mesh-list
56005639|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56005640|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56005641|NCT05232461|Analgesics|analgesics|mesh-ancestor
56005642|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
55833489|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833490|NCT02107274|Azithromycin|azithromycin|mesh-list
55833491|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55833492|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833493|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
55833494|NCT02173769|Olodaterol|olodaterol|mesh-list
55833495|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55833496|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
55833497|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833498|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833502|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55833503|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
55833504|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833505|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833540|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55833541|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
55833542|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833543|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005643|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005644|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005645|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833544|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
55833545|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55833647|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833648|NCT04726592|Ketoprofen|ketoprofen|mesh-list
55833649|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
55833650|NCT04726592|Metoclopramide|metoclopramide|mesh-list
55833651|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
55833652|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
55833678|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55833679|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
55833680|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833681|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833682|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
55833683|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217439|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
56217440|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55833684|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55833685|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
55785090|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
55785091|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833686|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833687|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55833688|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55833689|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55833690|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833691|NCT02080832|Dexetimide|dexetimide|mesh-list
55833692|NCT02080832|Citalopram|citalopram|mesh-list
55833693|NCT02080832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55833694|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55833695|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55833696|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833697|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833698|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
55833699|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833700|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55833701|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
55833739|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
55833740|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833741|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833742|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55833743|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55833744|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
55833745|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55833746|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55833747|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56005646|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005647|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56005648|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56005649|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005650|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833748|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55833749|NCT02044094|Buprenorphine|buprenorphine|mesh-list
55833750|NCT02044094|Hydromorphone|hydromorphone|mesh-list
55833751|NCT02044094|Naloxone|naloxone|mesh-list
55833752|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55833753|NCT02044094|Narcotics|narcotics|mesh-ancestor
55833754|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833755|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833756|NCT02044094|Analgesics|analgesics|mesh-ancestor
55833757|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
55833758|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833759|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55833760|NCT02053610|Rituximab|rituximab|mesh-list
55833761|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
55833762|NCT02053610|Chlorambucil|chlorambucil|mesh-list
55833763|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55833764|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833766|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833767|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833768|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55833769|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
55833770|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833771|NCT02075606|Lanreotide|lanreotide|mesh-list
55833772|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833773|NCT04701008|Ketamine|ketamine|mesh-list
55833774|NCT04701008|Analgesics|analgesics|mesh-ancestor
55833775|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
55833797|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55833798|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833799|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55833800|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
55833801|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
55833802|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833803|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833804|NCT02049944|Cefazolin|cefazolin|mesh-list
55833805|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55833806|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833808|NCT01621880|Bevacizumab|bevacizumab|mesh-list
55833809|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55833810|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833811|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56005651|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56005652|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005653|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56005654|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56005655|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005656|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56005657|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56005658|NCT01804790|Capecitabine|capecitabine|mesh-list
56005659|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56005660|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
56005661|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005663|NCT05623774|Imatinib Mesylate|imatinib mesylate|mesh-list
56005664|NCT05623774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005665|NCT05623774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56217441|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56217442|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
56217443|NCT01631448|Coagulants|coagulants|mesh-ancestor
56217445|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56217446|NCT01631513|Narcotics|narcotics|mesh-ancestor
56217447|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217448|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217449|NCT01631513|Analgesics|analgesics|mesh-ancestor
56217450|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
56217451|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217452|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56217453|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56217454|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55833812|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55833813|NCT01621880|Growth Substances|growth substances|mesh-ancestor
55833814|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005666|NCT05623774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785092|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55785093|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56005667|NCT05623774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005669|NCT05746546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56005670|NCT05746546|Autonomic Agents|autonomic agents|mesh-ancestor
56005671|NCT05746546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005672|NCT05746546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005673|NCT05746546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56005674|NCT05746546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56005675|NCT05746546|Cholinergic Agents|cholinergic agents|mesh-ancestor
56005676|NCT05746546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005677|NCT05746546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005678|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
56005679|NCT01804634|Melphalan|melphalan|mesh-list
56005680|NCT01804634|Fludarabine|fludarabine|mesh-list
56005681|NCT01804634|Tacrolimus|tacrolimus|mesh-list
56005682|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005683|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
56005684|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005685|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005686|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56005687|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
55785094|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55785095|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55785096|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785097|NCT04705727|Budesonide|budesonide|mesh-list
55785098|NCT04705727|Terbutaline|terbutaline|mesh-list
55785099|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
55785100|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55785101|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785102|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55785103|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
55785104|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785105|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785106|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55785107|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
55785108|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
55785109|NCT04705727|Hormones|hormones|mesh-ancestor
55785110|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833815|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
55833816|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833817|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
55833818|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
55833819|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833820|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55833821|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
55833822|NCT01621880|Hormones|hormones|mesh-ancestor
55833823|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833824|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55833825|NCT01621880|Protective Agents|protective agents|mesh-ancestor
55833826|NCT01621568|Sunitinib|sunitinib|mesh-list
56005688|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005690|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56005691|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56005692|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005693|NCT01313702|Atenolol|atenolol|mesh-list
56005694|NCT01313702|Lisinopril|lisinopril|mesh-list
56005695|NCT01313702|Simvastatin|simvastatin|mesh-list
56005696|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56005697|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56005698|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
56005699|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005700|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56005701|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56005702|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005703|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56005704|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
56005705|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56005706|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56005707|NCT01313702|Protective Agents|protective agents|mesh-ancestor
56005708|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005709|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56005710|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
55833827|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833893|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55833895|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
55833896|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833897|NCT02079805|Telmisartan|telmisartan|mesh-list
55833898|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55833899|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55833900|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55833901|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55833902|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833903|NCT02037295|Vancomycin|vancomycin|mesh-list
55833904|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56217455|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217456|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
56217457|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217458|NCT01631526|Vitamin D|vitamin d|mesh-list
56217459|NCT01631526|Vitamins|vitamins|mesh-ancestor
56217460|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
56217463|NCT01631539|Irinotecan|irinotecan|mesh-list
56217464|NCT01631539|Cetuximab|cetuximab|mesh-list
56217465|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56217466|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56217467|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217468|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217469|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217470|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56217471|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
56217472|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55833905|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833930|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
55833931|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833932|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833933|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55833934|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785111|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55785112|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55785113|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55785114|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
55785115|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785116|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785117|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
55785118|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
55785119|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55785120|NCT03114865|Dexamethasone|dexamethasone|mesh-list
55833935|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
55833936|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55833937|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
55833938|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55833939|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833940|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
55833941|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55833942|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005712|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005713|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56005714|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56005715|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55833943|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55833944|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
55833945|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833946|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55833947|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
55833948|NCT02034799|Coagulants|coagulants|mesh-ancestor
55833949|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55833950|NCT02057575|Latanoprost|latanoprost|mesh-list
55833951|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55833952|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55833953|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
55833954|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833956|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55833957|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
56217473|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217474|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217475|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
56217476|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217477|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217479|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55833958|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55833959|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
55833960|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833961|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833983|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
55833984|NCT02021318|Hematinics|hematinics|mesh-ancestor
55833985|NCT02020616|Metformin|metformin|mesh-list
55833986|NCT02020616|Exenatide|exenatide|mesh-list
55833987|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55833988|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833989|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55833990|NCT02020616|Incretins|incretins|mesh-ancestor
55833991|NCT02020616|Hormones|hormones|mesh-ancestor
55833992|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833993|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55833994|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55833995|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833997|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
55833998|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833999|NCT01622660|Gemcitabine|gemcitabine|mesh-list
55834000|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55834001|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
55834002|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834003|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834004|NCT01622660|Antiviral Agents|antiviral agents|mesh-ancestor
55834005|NCT01622660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834006|NCT01622660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834007|NCT01622660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005716|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
56005717|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005718|NCT05742958|Morphine|morphine|mesh-list
56005719|NCT05742958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56005720|NCT05742958|Narcotics|narcotics|mesh-ancestor
56005721|NCT05742958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56005722|NCT05742958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005723|NCT05742958|Analgesics|analgesics|mesh-ancestor
56005724|NCT05742958|Sensory System Agents|sensory system agents|mesh-ancestor
56005725|NCT05742958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005727|NCT04868708|Bevacizumab|bevacizumab|mesh-list
56005728|NCT04868708|Carboplatin|carboplatin|mesh-list
56005729|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55834008|NCT01622660|Immunologic Factors|immunologic factors|mesh-ancestor
55834009|NCT01622660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785122|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55785123|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785125|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
55785126|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785127|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785128|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55785129|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
55785130|NCT03114865|Hormones|hormones|mesh-ancestor
55785131|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785132|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55785133|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785134|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
55785135|NCT03085771|Deferoxamine|deferoxamine|mesh-list
55785136|NCT03085771|Siderophores|siderophores|mesh-ancestor
55834011|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834012|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834013|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
55834055|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834056|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834057|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834058|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55834060|NCT02053753|Denosumab|denosumab|mesh-list
55834061|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55834062|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834063|NCT02019979|Metformin|metformin|mesh-list
56217480|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217481|NCT01631669|Analgesics|analgesics|mesh-ancestor
56217482|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
56217483|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793686|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
55834064|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834065|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834066|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
55834067|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55834068|NCT02019667|Protective Agents|protective agents|mesh-ancestor
55834069|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834070|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
55834071|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
55834072|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834123|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55834124|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
55834125|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55834126|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834127|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55834128|NCT01822899|Fluticasone|fluticasone|mesh-list
55834130|NCT01822899|Bromides|bromides|mesh-list
55834131|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56005730|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005732|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56005733|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
55732938|NCT02249182|Ribavirin|ribavirin|mesh-list
56005734|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005735|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56005736|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56005737|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56005738|NCT04868708|Growth Substances|growth substances|mesh-ancestor
56005739|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005740|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
55834132|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834133|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55834134|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
55834135|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834136|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834137|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55834138|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
55834139|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
55834140|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55834141|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55834142|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55834143|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55834144|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
55834145|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834146|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834147|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
55834148|NCT01822821|Acetaminophen|acetaminophen|mesh-list
55834149|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55834150|NCT01822821|Analgesics|analgesics|mesh-ancestor
55834151|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
55834172|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
55834173|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834174|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834176|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55834177|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55834178|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
55834179|NCT04588233|Melatonin|melatonin|mesh-list
55834180|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
55834181|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834182|NCT04588233|Protective Agents|protective agents|mesh-ancestor
55834183|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834184|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834185|NCT01821963|Interferons|interferons|mesh-list
55834186|NCT01821963|Ribavirin|ribavirin|mesh-list
55834187|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
55834188|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
55834189|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55834190|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834191|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
55834192|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834193|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
55834194|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834195|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
55834196|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834197|NCT01821729|Leucovorin|leucovorin|mesh-list
55834198|NCT01821729|Fluorouracil|fluorouracil|mesh-list
55834199|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
56217484|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217485|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217486|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217487|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56217488|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56217489|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217490|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217491|NCT01631838|Tocotrienols|tocotrienols|mesh-list
56217493|NCT01631838|Tocopherols|tocopherols|mesh-list
56217494|NCT01631838|Tocovid|tocovid|mesh-list
56005742|NCT05732272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56005743|NCT05732272|Antidepressive Agents|antidepressive agents|mesh-ancestor
56005744|NCT05732272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56217495|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
56217496|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217497|NCT01631838|Protective Agents|protective agents|mesh-ancestor
56217498|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217499|NCT01631838|Vitamins|vitamins|mesh-ancestor
56217500|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
56217501|NCT01631877|Enoxaparin|enoxaparin|mesh-list
56217502|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
56217503|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
56217504|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56217505|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56217506|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217507|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55834200|NCT01821729|Folfirinox|folfirinox|mesh-list
55834201|NCT01821729|Losartan|losartan|mesh-list
55834202|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
55834203|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834204|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55834205|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834206|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834207|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
55834241|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834242|NCT01818141|Vancomycin|vancomycin|mesh-list
55834243|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
55834244|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55834245|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834246|NCT01849497|Evolocumab|evolocumab|mesh-list
55834247|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55834248|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55834249|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55834250|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
55834284|NCT01847313|Incretins|incretins|mesh-ancestor
55834285|NCT01847313|Hormones|hormones|mesh-ancestor
55834286|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55834287|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55834288|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55834290|NCT02117687|Glycerol|glycerol|mesh-list
55834291|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56005745|NCT05732272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56005746|NCT05732272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56005747|NCT05732272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56005748|NCT05732272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005750|NCT05732272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005751|NCT05732272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005752|NCT05732272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56005753|NCT05732272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56005754|NCT05732272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005755|NCT05513872|Nicotine|nicotine|mesh-list
56005756|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56005757|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
55834292|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
55834293|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834342|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55834343|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
55834344|NCT01846611|Hormones|hormones|mesh-ancestor
56217508|NCT01631968|Colistin|colistin|mesh-list
56217509|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217510|NCT01631994|Metoclopramide|metoclopramide|mesh-list
56217511|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
56217512|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
56217513|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217514|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217515|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56217516|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56217517|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56217518|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
56217519|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217520|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217521|NCT01632007|Alogliptin|alogliptin|mesh-list
56217522|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834345|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55834346|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55834347|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834348|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55834349|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55834350|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55834351|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834352|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834353|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55834354|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
55834355|NCT01846299|Ranibizumab|ranibizumab|mesh-list
55834356|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55834357|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55834358|NCT01846299|Growth Substances|growth substances|mesh-ancestor
55834359|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834360|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
55834361|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834363|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55834364|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834367|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834369|NCT01846221|Fentanyl|fentanyl|mesh-list
55834370|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55834371|NCT01846221|Narcotics|narcotics|mesh-ancestor
55834372|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834373|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834374|NCT01846221|Analgesics|analgesics|mesh-ancestor
55834375|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
55834376|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834377|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55834378|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55834379|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
55834380|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
55834381|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55834382|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
55834383|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
55834384|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56005758|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005759|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005760|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56005761|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56005762|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
56005763|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56005764|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005765|NCT05498272|Olaparib|olaparib|mesh-list
56005766|NCT05498272|Leuprolide|leuprolide|mesh-list
56005767|NCT05498272|Goserelin|goserelin|mesh-list
55834385|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55834386|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55834387|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
55834388|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834389|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834390|NCT01845831|Metformin|metformin|mesh-list
55834391|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
56217523|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217525|NCT01632007|Hormones|hormones|mesh-ancestor
56217526|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005768|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56005769|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56005770|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005771|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005772|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005773|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56005774|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
56005775|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56005776|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005777|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56005778|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
56005779|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56005780|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
56005781|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56005782|NCT05445856|Fentanyl|fentanyl|mesh-list
56005783|NCT05445856|Methadone|methadone|mesh-list
56005784|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56005785|NCT05445856|Narcotics|narcotics|mesh-ancestor
56005786|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217527|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56217528|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
56217529|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793728|NCT03073057|Budesonide|budesonide|mesh-list
55834392|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55834406|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834407|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
55834408|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834409|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834410|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
55834411|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55834412|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55834413|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55834414|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55834415|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834416|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
55834417|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834418|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834419|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55834420|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834422|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
55834423|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
55834424|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
55834425|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56005787|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005788|NCT05445856|Analgesics|analgesics|mesh-ancestor
56005789|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
56005790|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005791|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56005792|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56005793|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
56005794|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
56005795|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
56005796|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
56005797|NCT05481112|Buprenorphine|buprenorphine|mesh-list
56005798|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56005799|NCT05481112|Narcotics|narcotics|mesh-ancestor
56005800|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56005801|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005802|NCT05481112|Analgesics|analgesics|mesh-ancestor
55834426|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834427|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
55834428|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834429|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55834430|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55834431|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55834432|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55834433|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834434|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55834435|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
55834436|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
55834437|NCT04594239|Protective Agents|protective agents|mesh-ancestor
55834438|NCT04585737|Tenofovir|tenofovir|mesh-list
55834439|NCT04585737|Lamivudine|lamivudine|mesh-list
55785138|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
55785139|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
55785140|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834440|NCT04585737|Emtricitabine|emtricitabine|mesh-list
55834441|NCT04585737|Dolutegravir|dolutegravir|mesh-list
55834442|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55834443|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
55834444|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005803|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
56005804|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005805|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56005806|NCT05543278|Amiodarone|amiodarone|mesh-list
56005807|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56005808|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
56005809|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56005810|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56005811|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005812|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56005813|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56005814|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56005815|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005816|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56005817|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56005818|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56005819|NCT00382330|Ciclopirox|ciclopirox|mesh-list
56005820|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
56005821|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834445|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55834446|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55834447|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834448|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834449|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55834476|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55834477|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55834478|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55834479|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55834480|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55834481|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55834482|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55834484|NCT04742075|Olaparib|olaparib|mesh-list
55834485|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55834486|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55834487|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834488|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
55834489|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834490|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55834491|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834492|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834494|NCT02115113|Tacrolimus|tacrolimus|mesh-list
55834495|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834496|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
55834497|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005822|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
56005823|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56005825|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
56005826|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56005827|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
56005828|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005829|NCT05397964|Calcium|calcium|mesh-list
56005830|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56005831|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005832|NCT00002548|Interferons|interferons|mesh-list
56005833|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
56005834|NCT00002548|Dexamethasone|dexamethasone|mesh-list
56005835|NCT00002548|Prednisone|prednisone|mesh-list
56005836|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
56005837|NCT00002548|Melphalan|melphalan|mesh-list
56005838|NCT00002548|Carmustine|carmustine|mesh-list
56005839|NCT00002548|Doxorubicin|doxorubicin|mesh-list
56005840|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56005841|NCT00002548|Vincristine|vincristine|mesh-list
56005842|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005843|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
56005844|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005845|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005846|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55834498|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55834499|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834500|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834501|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834502|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
55834503|NCT02114177|Simeprevir|simeprevir|mesh-list
55834559|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834560|NCT01844505|Nivolumab|nivolumab|mesh-list
55834561|NCT01844505|Ipilimumab|ipilimumab|mesh-list
55834562|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55834563|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834564|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55834565|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834566|NCT01994720|Aspirin|aspirin|mesh-list
55834567|NCT01994720|Ticagrelor|ticagrelor|mesh-list
55762553|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55834568|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55834569|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55834570|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55834571|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55834572|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
55834573|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834574|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834575|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834576|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55834577|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55834578|NCT01994720|Analgesics|analgesics|mesh-ancestor
55834579|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
55834580|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834581|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834582|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834583|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55785141|NCT05619965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55834584|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55834585|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55834586|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834589|NCT01814397|Anastrozole|anastrozole|mesh-list
55834590|NCT01814397|Exemestane|exemestane|mesh-list
55834591|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834592|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55834593|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55834631|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
55834632|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55834633|NCT02029417|Cytarabine|cytarabine|mesh-list
55834634|NCT02029417|Decitabine|decitabine|mesh-list
55834635|NCT02029417|Azacitidine|azacitidine|mesh-list
55834636|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
55834637|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55834639|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834641|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
55834642|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834643|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834644|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
55834645|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834646|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834647|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55834648|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55834649|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55834650|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
55834651|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834652|NCT04694846|Bupropion|bupropion|mesh-list
55834653|NCT04694846|Nicotine|nicotine|mesh-list
55834654|NCT04694846|Varenicline|varenicline|mesh-list
56217530|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217531|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
56217532|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56217533|NCT01632163|Lixisenatide|lixisenatide|mesh-list
56217534|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56217535|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217536|NCT01632189|Varenicline|varenicline|mesh-list
56217537|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56217538|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56217539|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
56217540|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217541|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217542|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217543|NCT01632371|Paclitaxel|paclitaxel|mesh-list
56217544|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56217545|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56217546|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217547|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
56217548|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
55834655|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55834656|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
55834657|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834658|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834659|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55834660|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55834661|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
55834662|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834663|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834664|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55808072|NCT05351593|Growth Substances|growth substances|mesh-ancestor
55834665|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
55834666|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55834667|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55834686|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
55834687|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
55834688|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
55834689|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834690|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55834691|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
55834692|NCT02017015|Antiviral Agents|antiviral agents|mesh-ancestor
55834693|NCT02017015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834694|NCT02017015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834695|NCT02017015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834696|NCT02017015|Immunologic Factors|immunologic factors|mesh-ancestor
55834697|NCT02017015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834699|NCT02016625|Tacrolimus|tacrolimus|mesh-list
55834700|NCT02016625|Cyclosporins|cyclosporins|mesh-list
55834701|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834702|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
55834703|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834704|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55834705|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834706|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834707|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
55834708|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217549|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
56217550|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217551|NCT01632436|Pixantrone|pixantrone|mesh-list
56217552|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56217553|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56217554|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793755|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
55834709|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
55834710|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834711|NCT02016482|Adalimumab|adalimumab|mesh-list
55834712|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834713|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55785142|NCT05619965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869160|NCT03705429|Docetaxel|docetaxel|mesh-list
55869161|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55869162|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
55869163|NCT03705429|Trastuzumab|trastuzumab|mesh-list
55869164|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55869165|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869166|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
55869167|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
55869168|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
55869169|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869170|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55869171|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
55869172|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869183|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869184|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
55869185|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55869186|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55869187|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869188|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869189|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869190|NCT04370782|Astringents|astringents|mesh-ancestor
55869202|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869204|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55869205|NCT04376086|Anesthetics|anesthetics|mesh-list
55869206|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869207|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869208|NCT03703167|Rituximab|rituximab|mesh-list
55869209|NCT03703167|Lenalidomide|lenalidomide|mesh-list
55869210|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869211|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869212|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
55725826|NCT00429923|Hormones|hormones|mesh-ancestor
55785143|NCT05619965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785144|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
55785145|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55785146|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785147|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
55785148|NCT02998567|Guadecitabine|guadecitabine|mesh-list
55785149|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55785150|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785151|NCT02985619|Triamcinolone|triamcinolone|mesh-list
55785152|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55834714|NCT02028871|Insulin|insulin|mesh-list
55834715|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834716|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834717|NCT02028715|Acetaminophen|acetaminophen|mesh-list
55834718|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55834719|NCT02028715|Analgesics|analgesics|mesh-ancestor
55834722|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834723|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
55834724|NCT02016170|Ticagrelor|ticagrelor|mesh-list
55834784|NCT02047513|Gemcitabine|gemcitabine|mesh-list
55834785|NCT02047513|Paclitaxel|paclitaxel|mesh-list
55834786|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55834787|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55834788|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834789|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
55834790|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
55834791|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
55834792|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834793|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55834794|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
55834795|NCT02047513|Antiviral Agents|antiviral agents|mesh-ancestor
55834796|NCT02047513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834797|NCT02047513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834798|NCT02047513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834799|NCT02047513|Immunologic Factors|immunologic factors|mesh-ancestor
55834800|NCT02047513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834801|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
55834802|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55834993|NCT01993927|Voglibose|voglibose|mesh-list
55834994|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55869878|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55869882|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55869883|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55869884|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869885|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869886|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
55869887|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55869888|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55869889|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
55869890|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
55869892|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
55869893|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55869894|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55869895|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869896|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869897|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869898|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869899|NCT04355026|Expectorants|expectorants|mesh-ancestor
55869900|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
55869901|NCT03548571|Temozolomide|temozolomide|mesh-list
55869902|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55869903|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
55869904|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869905|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869906|NCT00939562|Doxycycline|doxycycline|mesh-list
55869907|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55869908|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869909|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
55869910|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55869911|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55869912|NCT03542175|Rucaparib|rucaparib|mesh-list
55869927|NCT03568383|Pyridoxine|pyridoxine|mesh-list
55869928|NCT03568383|Pyridoxal|pyridoxal|mesh-list
55869929|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
55869930|NCT03568383|Isoniazid|isoniazid|mesh-list
55869931|NCT03568383|Vitamins|vitamins|mesh-ancestor
55869932|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
55869933|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834995|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834996|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55834997|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834998|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834999|NCT02012959|Tolvaptan|tolvaptan|mesh-list
55835000|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55835001|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835002|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
55835003|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835004|NCT02012491|Misoprostol|misoprostol|mesh-list
55835031|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835032|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55835033|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
55835034|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
55835035|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
56217555|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835036|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835037|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
55835038|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835039|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785153|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55785155|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55785156|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869934|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
55869935|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
55869936|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55869937|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869938|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55789155|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55789156|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
55789157|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55789158|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55789159|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55789160|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55789161|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55789162|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789163|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
55789164|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789165|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789166|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55789167|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789168|NCT04917497|Simendan|simendan|mesh-list
55789169|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55869939|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55869940|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
55869941|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869943|NCT04366726|Abaloparatide|abaloparatide|mesh-list
55869944|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55869945|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869946|NCT04366960|Enoxaparin|enoxaparin|mesh-list
55869948|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55869949|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55869950|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869951|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
55869952|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55869953|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55869954|NCT03539445|Protective Agents|protective agents|mesh-ancestor
55869955|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869956|NCT04360876|Dexamethasone|dexamethasone|mesh-list
55869957|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
55869958|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869959|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
55869960|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
55869961|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869962|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869963|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55869964|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
55869965|NCT04360876|Hormones|hormones|mesh-ancestor
55869966|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55869967|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55869968|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785157|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785158|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55785159|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55785160|NCT02985619|Growth Substances|growth substances|mesh-ancestor
55785161|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785162|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
55785163|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785164|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
55785166|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785167|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785168|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
55785169|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785170|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785171|NCT03110653|Remifentanil|remifentanil|mesh-list
55785172|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55835041|NCT04678154|Tobramycin|tobramycin|mesh-list
55835042|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55835043|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835044|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
55835045|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835046|NCT01989572|Sargramostim|sargramostim|mesh-list
55835047|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
55760736|NCT04839237|Metformin|metformin|mesh-list
55835048|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835049|NCT01988402|Allopurinol|allopurinol|mesh-list
55835078|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835079|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55835080|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55835081|NCT02013830|Growth Substances|growth substances|mesh-ancestor
55835082|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835083|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
55835084|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55835085|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
55835086|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835087|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
55835088|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55835089|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55835090|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55835091|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835092|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835093|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
55835094|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835095|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835096|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55835119|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835120|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55835121|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835122|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835123|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
55835124|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55785173|NCT03110653|Narcotics|narcotics|mesh-ancestor
55785174|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785175|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785176|NCT03110653|Analgesics|analgesics|mesh-ancestor
55785177|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
55785178|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785179|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
55785180|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785182|NCT02037529|Halichondrin B|halichondrin b|mesh-list
55785183|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55785184|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55785185|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785186|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
55785187|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
56217557|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
56217558|NCT01632514|Vitamin D|vitamin d|mesh-list
56217559|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217560|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785188|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
55835125|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55835126|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835127|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55835128|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835129|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835131|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55835132|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835133|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835134|NCT01966003|Paclitaxel|paclitaxel|mesh-list
55835135|NCT01966003|Bevacizumab|bevacizumab|mesh-list
55835136|NCT01966003|Carboplatin|carboplatin|mesh-list
55835137|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55835138|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835139|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
55835140|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
55835141|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
55835142|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835143|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835144|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55835145|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55835146|NCT01966003|Growth Substances|growth substances|mesh-ancestor
55835147|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835235|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55835236|NCT01990573|Narcotics|narcotics|mesh-ancestor
55835237|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55835238|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835239|NCT01990573|Analgesics|analgesics|mesh-ancestor
55835240|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
55835241|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835245|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
55835246|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55835247|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55835248|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55835249|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835250|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835251|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55835252|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55835253|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55785189|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785190|NCT04450199|Vitamin D|vitamin d|mesh-list
55785191|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
55785192|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
55785193|NCT04450199|Vitamins|vitamins|mesh-list
55785194|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
55785195|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785196|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55785197|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55785198|NCT01884259|Docetaxel|docetaxel|mesh-list
55835254|NCT02007577|Analgesics|analgesics|mesh-ancestor
55835255|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
55835256|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835257|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835258|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55835259|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835260|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55835261|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835262|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55835263|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835264|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835265|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
55835266|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55835267|NCT01962493|Listerine|listerine|mesh-list
56217562|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
56217563|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56217564|NCT01632540|Beclomethasone|beclomethasone|mesh-list
56217565|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217566|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
56217567|NCT01632540|Hormones|hormones|mesh-ancestor
56217568|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56217569|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217570|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55762587|NCT02176018|Quinidine|quinidine|mesh-list
56217571|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
56217572|NCT01632592|Tesamorelin|tesamorelin|mesh-list
56217573|NCT01632592|Growth Substances|growth substances|mesh-ancestor
56217574|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217576|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56217577|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217578|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55835268|NCT01962493|Fluorides|fluorides|mesh-list
55835269|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
55835270|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
55835271|NCT01962493|Protective Agents|protective agents|mesh-ancestor
55835272|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835273|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55835274|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835275|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
55835276|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835301|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835302|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835303|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55835304|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55835305|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55835306|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55835307|NCT01987232|Carboplatin|carboplatin|mesh-list
55835308|NCT01987232|Etoposide|etoposide|mesh-list
55835309|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835310|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55835311|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55835312|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55835313|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835314|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835315|NCT04676204|Teriflunomide|teriflunomide|mesh-list
55835316|NCT04676204|Cladribine|cladribine|mesh-list
55835317|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55835318|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55835319|NCT04676204|Ozanimod|ozanimod|mesh-list
55835320|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835321|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55835322|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
55835323|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835324|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55835325|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835326|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835327|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55835405|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835406|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835407|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55835409|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
56217579|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217580|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
56217581|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56217582|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
55808151|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56217583|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217585|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56217586|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217587|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56217588|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56217589|NCT01632722|Growth Substances|growth substances|mesh-ancestor
55835410|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55835411|NCT02031458|Atezolizumab|atezolizumab|mesh-list
55835412|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835413|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55835414|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
55835415|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835416|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
55835417|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55835418|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
55835571|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835572|NCT01607073|Verapamil|verapamil|mesh-list
55835573|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55835574|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55835575|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835576|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835577|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55835578|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835579|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
55835580|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55835581|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
55835582|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835583|NCT01801917|Siponimod|siponimod|mesh-list
55835584|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55835585|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835586|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55835587|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
55835588|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835589|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55835590|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
55835591|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835592|NCT01772823|Tenofovir|tenofovir|mesh-list
55835593|NCT01772823|Emtricitabine|emtricitabine|mesh-list
55835594|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55835595|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
55835633|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55835634|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
55835766|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55835767|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
55835769|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
55835770|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55835771|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
55835772|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835773|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55835774|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55835775|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55835776|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
55835777|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
55835778|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55835779|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55835780|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
55835781|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56217590|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217591|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
56217592|NCT01632761|Vitamin D|vitamin d|mesh-list
56217593|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
56217594|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
55835783|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
55835784|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835785|NCT01959919|Factor VIII|factor viii|mesh-list
55835786|NCT01959919|Coagulants|coagulants|mesh-ancestor
55835787|NCT01986907|Ranibizumab|ranibizumab|mesh-list
55835788|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55835789|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55835790|NCT01986907|Growth Substances|growth substances|mesh-ancestor
55835791|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835792|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
55835793|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835795|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
55835796|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835797|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
55835798|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835800|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55835828|NCT02104505|Tocotrienols|tocotrienols|mesh-list
55835829|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
55835830|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
55835831|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
55835832|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835833|NCT02104505|Protective Agents|protective agents|mesh-ancestor
55835834|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835836|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
55835837|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
55835838|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55835839|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55835840|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
55835841|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835842|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55835843|NCT02111369|Propranolol|propranolol|mesh-list
55835844|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
55835845|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55835846|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835847|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835848|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
55835849|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835850|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835851|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55835852|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55835853|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
55835854|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55835855|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55835856|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
55835857|NCT02069093|Dexamethasone|dexamethasone|mesh-list
55835858|NCT02069093|Everolimus|everolimus|mesh-list
55835859|NCT02069093|Exemestane|exemestane|mesh-list
55835860|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55835861|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
55835862|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
55835863|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808173|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836182|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55836184|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
55836185|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
55836186|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
55836187|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836188|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55836189|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55836190|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55836191|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
55836192|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836193|NCT02005484|Trastuzumab|trastuzumab|mesh-list
55836194|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55836195|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836196|NCT01597973|Meropenem|meropenem|mesh-list
55836197|NCT01597973|Colistin|colistin|mesh-list
56217595|NCT01632761|Vitamins|vitamins|mesh-list
56217596|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
55836198|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55836199|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836200|NCT02047253|Acyclovir|acyclovir|mesh-list
55836201|NCT02047253|Dexamethasone|dexamethasone|mesh-list
55836202|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836203|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
55836204|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
55836205|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836206|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836207|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55836208|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
55836209|NCT02047253|Hormones|hormones|mesh-ancestor
55836210|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836211|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55836212|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836213|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
55836214|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836252|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836253|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55836254|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
55836255|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836368|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55836369|NCT02056301|Narcotics|narcotics|mesh-ancestor
55836371|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836372|NCT02056301|Analgesics|analgesics|mesh-ancestor
55836373|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
55836374|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836376|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836377|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55836378|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836379|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836380|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55836381|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55836382|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55836383|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55760825|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55836498|NCT01438060|Aripiprazole|aripiprazole|mesh-list
55836499|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
55836500|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55836501|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55836502|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55836503|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55836504|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836505|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
55836506|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
55836507|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836508|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836509|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55836510|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55836511|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
55836806|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836808|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55836809|NCT01964378|Narcotics|narcotics|mesh-ancestor
55836810|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762614|NCT05611827|Antioxidants|antioxidants|mesh-ancestor
55836811|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836812|NCT01964378|Analgesics|analgesics|mesh-ancestor
55836813|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
55836814|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836815|NCT01442038|Ranolazine|ranolazine|mesh-list
55836816|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55836817|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55836818|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836819|NCT01998919|Gemcitabine|gemcitabine|mesh-list
55836820|NCT01998919|Carboplatin|carboplatin|mesh-list
55836821|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55836822|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836823|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55836824|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
55836825|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836951|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55836953|NCT01968434|Expectorants|expectorants|mesh-ancestor
56217597|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836954|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
55836956|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
55836957|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836958|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
55836959|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
55836960|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
55836961|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836962|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836963|NCT01917656|Metformin|metformin|mesh-list
55836964|NCT01917656|Liraglutide|liraglutide|mesh-list
55836965|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836966|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762663|NCT05612451|Calcium|calcium|mesh-list
55836967|NCT01917656|Incretins|incretins|mesh-ancestor
55836968|NCT01917656|Hormones|hormones|mesh-ancestor
55836969|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836970|NCT02018861|Rituximab|rituximab|mesh-list
55836971|NCT02018861|Carboplatin|carboplatin|mesh-list
55836972|NCT02018861|Etoposide|etoposide|mesh-list
55836973|NCT02018861|Ifosfamide|ifosfamide|mesh-list
55836974|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55836975|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836976|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
55837032|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837036|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55837037|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55785201|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785202|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
55837038|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55837039|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
55837040|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837041|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837108|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55837110|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837112|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
55837113|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837114|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837116|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837152|NCT02015819|Leucovorin|leucovorin|mesh-list
55837153|NCT02015819|Flucytosine|flucytosine|mesh-list
55837154|NCT02015819|Calcium|calcium|mesh-list
55837547|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837548|NCT04675931|Artesunate|artesunate|mesh-list
55837549|NCT04675931|Lumefantrine|lumefantrine|mesh-list
55837550|NCT04675931|Artemether|artemether|mesh-list
55837552|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
55837553|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55837554|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55837555|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837556|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837557|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
55837558|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
55837559|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55837560|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
55837561|NCT04667039|Ranibizumab|ranibizumab|mesh-list
55837562|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55837563|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55837660|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55837661|NCT01931150|Dapsone|dapsone|mesh-list
55837662|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837663|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
55762667|NCT02151682|Morphine|morphine|mesh-list
55837664|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55837665|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55837666|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55837668|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837991|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55837992|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
55837993|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
55837994|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55837995|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55837996|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217598|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55837997|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837998|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
55837999|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838000|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838001|NCT04767178|Acetaminophen|acetaminophen|mesh-list
55838002|NCT04767178|Ibuprofen|ibuprofen|mesh-list
55838090|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
55838091|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55838092|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55838093|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55838094|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
55838095|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838096|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838097|NCT01413958|Protective Agents|protective agents|mesh-ancestor
55838098|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
55838099|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
55838100|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55838101|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55838102|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55838103|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
55838104|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
55838106|NCT01413178|Busulfan|busulfan|mesh-list
55785203|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
55785204|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
55789067|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838140|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838142|NCT01798485|Docetaxel|docetaxel|mesh-list
55838143|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838174|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808219|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
55838175|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838176|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55838177|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838178|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55838179|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838180|NCT01765569|Vemurafenib|vemurafenib|mesh-list
55838181|NCT01765569|Digoxin|digoxin|mesh-list
55838182|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55838183|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55838184|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838185|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838223|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55838224|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55838255|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
55838256|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838257|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838258|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55838259|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55838260|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
55838261|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838262|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838263|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
55838264|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838265|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55838266|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838268|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
55838269|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838339|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838340|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838341|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
55838342|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838343|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
55838344|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838345|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
55838346|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838347|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55838348|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838349|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56217599|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217600|NCT01632826|Pomalidomide|pomalidomide|mesh-list
56217601|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
56217602|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217603|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56217604|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56217605|NCT01632826|Growth Substances|growth substances|mesh-ancestor
56217606|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
56217607|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217608|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
56217609|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56217610|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
56217611|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217612|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217613|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55838350|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55838351|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
55838352|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55838353|NCT04037176|Omalizumab|omalizumab|mesh-list
55838354|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55838355|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55838356|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
55838357|NCT01430104|Teriparatide|teriparatide|mesh-list
55838358|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55838359|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838360|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55838361|NCT01990859|Ipilimumab|ipilimumab|mesh-list
55838362|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838363|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838364|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55838365|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838366|NCT02093897|Factor VIII|factor viii|mesh-list
55838367|NCT02093897|Coagulants|coagulants|mesh-ancestor
55838368|NCT01976845|Midazolam|midazolam|mesh-list
55838369|NCT01976845|Propofol|propofol|mesh-list
55838370|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55838371|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55838372|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838373|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55785205|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785207|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55785208|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785209|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
55838376|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55838377|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55838378|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55838379|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838380|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
55838381|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
55838382|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838383|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838384|NCT01989689|Etanercept|etanercept|mesh-list
55838385|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55744388|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838386|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55838387|NCT01989689|Analgesics|analgesics|mesh-ancestor
55838388|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
55838389|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838417|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
56217614|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
55838418|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838419|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838420|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838421|NCT01390948|Bevacizumab|bevacizumab|mesh-list
55838422|NCT01390948|Temozolomide|temozolomide|mesh-list
55838423|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838424|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838425|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55838426|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55838427|NCT01390948|Growth Substances|growth substances|mesh-ancestor
55838428|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838429|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
55838430|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55838431|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
55838432|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838433|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
55838467|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838468|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55838469|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55838470|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55838471|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838472|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55838473|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
55838474|NCT01925612|Hormones|hormones|mesh-ancestor
55838475|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838503|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
55838504|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838505|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838506|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838507|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55838508|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55838509|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
55838510|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
55838511|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
55838512|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55838513|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55838514|NCT01390402|Aldesleukin|aldesleukin|mesh-list
55838515|NCT01390402|Methotrexate|methotrexate|mesh-list
55838516|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
55838517|NCT01390402|Fludarabine|fludarabine|mesh-list
55838519|NCT01390402|Interleukin-2|interleukin-2|mesh-list
55838520|NCT01390402|Tacrolimus|tacrolimus|mesh-list
55838521|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
55838522|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55838523|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55838524|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
55838595|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838596|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
55838597|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
55838598|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
55838630|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838631|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
55838632|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838633|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
55838634|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838635|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
55838636|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
55838637|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
55838639|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
55838640|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838641|NCT01975285|Dexamethasone|dexamethasone|mesh-list
55838642|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55838643|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
55838644|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
55838645|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838715|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55838716|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
55838717|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55838718|NCT01914757|Benralizumab|benralizumab|mesh-list
55838744|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55838745|NCT01789047|Topiramate|topiramate|mesh-list
55838746|NCT01789047|Amantadine|amantadine|mesh-list
55838747|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
56217615|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56217616|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
55838748|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55869969|NCT03537495|Linezolid|linezolid|mesh-list
55869970|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55869971|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869972|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55869973|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869985|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869986|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869987|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869988|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55869989|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55869990|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869991|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869993|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55789170|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
55789171|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55869994|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55869995|NCT00942448|Analgesics|analgesics|mesh-ancestor
55869996|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
55869997|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869998|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869999|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870000|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870001|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55870002|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870003|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870004|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55870005|NCT02982148|Methylene Blue|methylene blue|mesh-list
55838749|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838750|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55838751|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55838752|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
55838753|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838754|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
55838755|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838756|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838757|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55838758|NCT01789047|Analgesics|analgesics|mesh-ancestor
55838759|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
55838760|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838761|NCT01617187|Olanzapine|olanzapine|mesh-list
55838762|NCT01617187|Asenapine|asenapine|mesh-list
55838763|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
55838764|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
55838765|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838766|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838767|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55838800|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838802|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
55838803|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838816|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55838817|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
55838818|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838819|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838820|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55838821|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55838822|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838823|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838824|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
55838825|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838827|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55838828|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838829|NCT01786551|Eplerenone|eplerenone|mesh-list
55838830|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55838831|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
55838832|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838833|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838834|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55838835|NCT01786551|Diuretics|diuretics|mesh-ancestor
55838836|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
55838837|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55838838|NCT01973569|Denosumab|denosumab|mesh-list
55838839|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55785211|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55785212|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
55789068|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55838840|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838841|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
55838842|NCT01951586|Denosumab|denosumab|mesh-list
55838843|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55838844|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838845|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55838846|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838847|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
55838848|NCT04641728|Olaparib|olaparib|mesh-list
55838849|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838850|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838851|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55838852|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838853|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838854|NCT01756833|Doxycycline|doxycycline|mesh-list
55838855|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55838856|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838857|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
55838858|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56217617|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217618|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217619|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55762721|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
56217620|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
56217621|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
56217622|NCT01633086|Protective Agents|protective agents|mesh-ancestor
56217624|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217625|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
56217626|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217627|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217630|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
55838859|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55838860|NCT01785615|Atorvastatin|atorvastatin|mesh-list
55838861|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55838862|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55838894|NCT01783821|Hormones|hormones|mesh-ancestor
55838895|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838896|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55838897|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55838898|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55838899|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
55838900|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789054|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870006|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870007|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870008|NCT04359316|Azithromycin|azithromycin|mesh-list
55870009|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
55870010|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55870011|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870012|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
55870013|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55870014|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55870015|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870016|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870017|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870018|NCT03558867|Metformin|metformin|mesh-list
55870019|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55870020|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870021|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
55870022|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55870023|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55870024|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
55870025|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870026|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55870027|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55870028|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870029|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870030|NCT03557385|Adenosine|adenosine|mesh-list
55870031|NCT03557385|Analgesics|analgesics|mesh-ancestor
55870032|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
55870034|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870035|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55870036|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
55870052|NCT04601350|Anesthetics, General|anesthetics, general|mesh-ancestor
55870053|NCT04601350|GABA Modulators|gaba modulators|mesh-ancestor
55870054|NCT04601350|GABA Agents|gaba agents|mesh-ancestor
55870055|NCT04601350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870056|NCT04601350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870057|NCT05346861|Trastuzumab|trastuzumab|mesh-list
55870058|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870059|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870061|NCT04358614|Lopinavir|lopinavir|mesh-list
55870062|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55870063|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55870064|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
55870065|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870066|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870067|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55870068|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55870069|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
55870070|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870071|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55870072|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55870073|NCT01670409|Cisplatin|cisplatin|mesh-list
55870074|NCT01670409|Fluorouracil|fluorouracil|mesh-list
55870075|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838901|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838902|NCT01608087|Bevacizumab|bevacizumab|mesh-list
55838903|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838924|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838925|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838926|NCT01912807|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55838927|NCT01912807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55838928|NCT01912807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55838929|NCT01912807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838930|NCT01912807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55838931|NCT01782885|Acetaminophen|acetaminophen|mesh-list
55838932|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55838933|NCT01782885|Analgesics|analgesics|mesh-ancestor
55838934|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
55838935|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838936|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762726|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
55838937|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
55838938|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55838939|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55838940|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55838941|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55838942|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838943|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838944|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838945|NCT01754493|Analgesics|analgesics|mesh-ancestor
55838946|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
55838947|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838948|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
55838949|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838950|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
55838951|NCT01972789|Ranibizumab|ranibizumab|mesh-list
55838952|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55838953|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56217631|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
56217632|NCT01633177|Vitamins|vitamins|mesh-list
56217633|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
55808276|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217634|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217635|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56217636|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217637|NCT01633203|Capecitabine|capecitabine|mesh-list
56217638|NCT01633203|Epirubicin|epirubicin|mesh-list
56217639|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217640|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217641|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
56217642|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217643|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56217644|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56217645|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56217646|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217647|NCT01633294|Gentamicins|gentamicins|mesh-list
56217648|NCT01633294|Ampicillin|ampicillin|mesh-list
56217649|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56217650|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217651|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55838954|NCT01972789|Growth Substances|growth substances|mesh-ancestor
55785213|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55785214|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785216|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785218|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55785219|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
55838955|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838956|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
55838957|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839016|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55839017|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55839018|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839019|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
55839020|NCT01408030|Coagulants|coagulants|mesh-ancestor
55839021|NCT01408030|Hormones|hormones|mesh-ancestor
55839022|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839023|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55839024|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55839025|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839026|NCT01897532|Linagliptin|linagliptin|mesh-list
55839027|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55760871|NCT04843449|Rifampin|rifampin|mesh-list
55839028|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839029|NCT01897532|Incretins|incretins|mesh-ancestor
55839030|NCT01897532|Hormones|hormones|mesh-ancestor
55839031|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839032|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55839033|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
55839034|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839035|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839036|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
55839037|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217652|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217653|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217654|NCT01633359|Atorvastatin|atorvastatin|mesh-list
56217655|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56217656|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56217657|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56217658|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
55839038|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55839039|NCT04641026|Protective Agents|protective agents|mesh-ancestor
55839040|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839041|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
55839042|NCT04173416|Narcotics|narcotics|mesh-ancestor
55839043|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839044|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839045|NCT04173416|Analgesics|analgesics|mesh-ancestor
55839046|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
55839047|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839066|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
55839067|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
55839068|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839069|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839070|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839071|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
55762749|NCT02149264|Hormones|hormones|mesh-ancestor
55839072|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
55839073|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55839074|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
55839075|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839076|NCT01405924|Dexamethasone|dexamethasone|mesh-list
55839077|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
55839078|NCT01405924|Aprepitant|aprepitant|mesh-list
55839079|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839080|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
55839081|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
55839082|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839083|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839084|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55839085|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
55839086|NCT01405924|Hormones|hormones|mesh-ancestor
55839087|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839088|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55785220|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55785221|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55839089|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839090|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55839091|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839092|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839093|NCT01426438|Aspirin|aspirin|mesh-list
55839094|NCT01426438|Niacin|niacin|mesh-list
55839095|NCT01426438|Fenofibrate|fenofibrate|mesh-list
55839096|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55839097|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55839098|NCT01426438|Analgesics|analgesics|mesh-ancestor
55839101|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839102|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839130|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55839131|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
55839132|NCT01922102|Ranibizumab|ranibizumab|mesh-list
55839133|NCT01922102|Verteporfin|verteporfin|mesh-list
55839134|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55839135|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55839136|NCT01922102|Growth Substances|growth substances|mesh-ancestor
55839137|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839138|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
55839139|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839140|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55839141|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
55839142|NCT01405768|Lidocaine|lidocaine|mesh-list
55839143|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
55808313|NCT04243837|Analgesics|analgesics|mesh-ancestor
56217659|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217660|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56217661|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217663|NCT01633450|Trace Elements|trace elements|mesh-ancestor
56217664|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
55839144|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
55839145|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839146|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839147|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
55839148|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839149|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55839150|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55839151|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55839180|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
55839181|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
55839182|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839184|NCT01896050|Letrozole|letrozole|mesh-list
55839185|NCT01896050|Anastrozole|anastrozole|mesh-list
55839186|NCT01896050|Exemestane|exemestane|mesh-list
55839187|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839188|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55839189|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55839190|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839191|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839192|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55839193|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
55839194|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839210|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839212|NCT01424566|Analgesics|analgesics|mesh-ancestor
55839213|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
55839214|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839215|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839216|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
55839217|NCT01403116|Testosterone|testosterone|mesh-list
55839218|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
55839219|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
55839220|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55839221|NCT01403116|Androgens|androgens|mesh-ancestor
55839222|NCT01403116|Hormones|hormones|mesh-ancestor
55839223|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839224|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839225|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55839226|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839227|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
55839228|NCT01753401|Prednisone|prednisone|mesh-list
55839229|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55839230|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839231|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
55839233|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839234|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839235|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55839236|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839237|NCT01894568|Insulin|insulin|mesh-list
55839238|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55839239|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
55839240|NCT01894568|Pioglitazone|pioglitazone|mesh-list
55839241|NCT01894568|Biguanides|biguanides|mesh-list
55839242|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55839243|NCT01894568|Meglitinide|meglitinide|mesh-list
55839244|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839246|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55839247|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
55839248|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839249|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
55839250|NCT01920152|Protective Agents|protective agents|mesh-ancestor
55839251|NCT01752933|Guadecitabine|guadecitabine|mesh-list
55808327|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
55839288|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55839289|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839290|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55839291|NCT01422382|Diltiazem|diltiazem|mesh-list
55839292|NCT01422382|Pitavastatin|pitavastatin|mesh-list
55839293|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55839294|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55839295|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839312|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
55839313|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839314|NCT01401010|Doripenem|doripenem|mesh-list
55839315|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55839316|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839317|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55839318|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
55839319|NCT01890746|Cytarabine|cytarabine|mesh-list
55839320|NCT01890746|Daunorubicin|daunorubicin|mesh-list
55839321|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55839322|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
55839323|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839324|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839325|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
55839326|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839327|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55839328|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
55839329|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839330|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55839331|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55839332|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55839333|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839334|NCT01422304|Atropine|atropine|mesh-list
55839335|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
55839336|NCT01422304|Neostigmine|neostigmine|mesh-list
55839337|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55839338|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55839339|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55839340|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
55839341|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839342|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839343|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55839344|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
55839345|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
55839346|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
55839347|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55839348|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55839349|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
55839350|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839351|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839352|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55839353|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839377|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55839378|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55839379|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
55785222|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785223|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55785224|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785225|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55808335|NCT05254171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785226|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785227|NCT03067727|Dinoprostone|dinoprostone|mesh-list
55785228|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
55839380|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55839381|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55839382|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
55839383|NCT01894022|Ambrisentan|ambrisentan|mesh-list
55839384|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55839385|NCT01386970|Lamivudine|lamivudine|mesh-list
55839391|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839392|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
55839393|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839394|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55839395|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55839396|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
55839398|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
55839399|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217665|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217666|NCT01633476|Valacyclovir|valacyclovir|mesh-list
56217667|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
56217668|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217669|NCT01633593|Donepezil|donepezil|mesh-list
56217670|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56217671|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839400|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
55839401|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
55839402|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839403|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
55839419|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839421|NCT01780389|Analgesics|analgesics|mesh-ancestor
55839422|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
55839423|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839424|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
55839425|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55839426|NCT01778985|Estrogens|estrogens|mesh-list
55839427|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55839428|NCT01778985|Hormones|hormones|mesh-ancestor
55839429|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839430|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839431|NCT01865084|Tadalafil|tadalafil|mesh-list
55839432|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
55839433|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55839434|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55839435|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839436|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839437|NCT01865084|Urological Agents|urological agents|mesh-ancestor
55839438|NCT01399372|Cytarabine|cytarabine|mesh-list
55839439|NCT01399372|Rituximab|rituximab|mesh-list
55839440|NCT01399372|Methotrexate|methotrexate|mesh-list
55839441|NCT01399372|Vincristine|vincristine|mesh-list
55839442|NCT01399372|Procarbazine|procarbazine|mesh-list
55839443|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55839444|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839445|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
55839446|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839447|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55839448|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55839449|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
55839450|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55839451|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55839452|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
55839453|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839454|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
55839455|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839456|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55839457|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785229|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55785230|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839458|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55839459|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
55839460|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839489|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839490|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
55839491|NCT03025282|Hormones|hormones|mesh-ancestor
55839492|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839493|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839494|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55839495|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
55839500|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55839501|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839502|NCT01778049|Incretins|incretins|mesh-ancestor
55839504|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839505|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55839506|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
55870076|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
55870077|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870078|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55870079|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870080|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
55789172|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55789173|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870081|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870082|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55870084|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55870085|NCT04358770|Clocortolone|clocortolone|mesh-list
55870095|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870096|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870117|NCT05620498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870118|NCT05620498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870119|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
55870120|NCT01670565|Belimumab|belimumab|mesh-list
55870121|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55870123|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55870124|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
55870125|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55870127|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870128|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870129|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870130|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
55870131|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870132|NCT01670799|Ketorolac|ketorolac|mesh-list
55870133|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55870134|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55870135|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55870136|NCT01670799|Analgesics|analgesics|mesh-ancestor
55870137|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
55870138|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870139|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870140|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870141|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870142|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55870143|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870144|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870145|NCT02404935|Cetuximab|cetuximab|mesh-list
55870146|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870147|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870148|NCT04320940|Phenobarbital|phenobarbital|mesh-list
55870160|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55870161|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55870163|NCT03422523|Rituximab|rituximab|mesh-list
55870164|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
55870165|NCT03422523|Atezolizumab|atezolizumab|mesh-list
55870166|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870167|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870173|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870174|NCT03422523|Antiviral Agents|antiviral agents|mesh-ancestor
55870175|NCT03422523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870176|NCT03422523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870177|NCT03422523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870178|NCT03032536|Tenofovir|tenofovir|mesh-list
55870180|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
55870181|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217672|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217673|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
56217674|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217675|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217676|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
56217677|NCT01633645|Gemcitabine|gemcitabine|mesh-list
56217678|NCT01633645|Bortezomib|bortezomib|mesh-list
56217679|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217680|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55839535|NCT01890122|Incretins|incretins|mesh-ancestor
55839537|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839538|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55839539|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
55839540|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839541|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839542|NCT01397890|Budesonide|budesonide|mesh-list
55839543|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
55839544|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
55839545|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55839546|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839547|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55839548|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
55839549|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839550|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839551|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55839552|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
55839553|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
55839586|NCT01775787|Menthol|menthol|mesh-list
55839587|NCT01775787|Nicotine|nicotine|mesh-list
55839588|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55839589|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
55760980|NCT04428879|Topotecan|topotecan|mesh-list
55839590|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839591|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839592|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55839620|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839621|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839622|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
55839623|NCT01775475|Hormones|hormones|mesh-ancestor
55839624|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839625|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55839626|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55839627|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
55839628|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
55839629|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
55839630|NCT01774929|Fentanyl|fentanyl|mesh-list
55839631|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55839632|NCT01774929|Narcotics|narcotics|mesh-ancestor
55839633|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839634|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839635|NCT01774929|Analgesics|analgesics|mesh-ancestor
55839636|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
55839637|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839638|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55839639|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55785232|NCT01794793|Pasireotide|pasireotide|mesh-list
55785233|NCT01794793|Somatostatin|somatostatin|mesh-list
55785234|NCT01794793|Hormones|hormones|mesh-ancestor
55839640|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
55839675|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839676|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839677|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55839678|NCT01747629|Albuterol|albuterol|mesh-list
55839679|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55839680|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
56217681|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
55839711|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839713|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55839716|NCT01885208|Incretins|incretins|mesh-ancestor
55839717|NCT01885208|Hormones|hormones|mesh-ancestor
55839718|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839719|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
55839720|NCT01859702|Dexamethasone|dexamethasone|mesh-list
55839721|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55839722|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839723|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
55839724|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
55839755|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
55839756|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55839757|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55839758|NCT01747551|Growth Substances|growth substances|mesh-ancestor
55839759|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
55839761|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839762|NCT01859390|Protective Agents|protective agents|mesh-ancestor
55839763|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839764|NCT01746225|Paclitaxel|paclitaxel|mesh-list
55839765|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55839766|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839767|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
55839768|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
55839794|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839795|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
55839796|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
55839797|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839798|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839799|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55839800|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
55839801|NCT01383928|Hormones|hormones|mesh-ancestor
55839802|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839803|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55839804|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839805|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
55839806|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55839807|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55839808|NCT01383928|Growth Substances|growth substances|mesh-ancestor
55839809|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
55839810|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
55839811|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839812|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839813|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55839814|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839815|NCT05368012|Dexamethasone|dexamethasone|mesh-list
55839816|NCT05368012|Bupivacaine|bupivacaine|mesh-list
55808369|NCT05216653|Capecitabine|capecitabine|mesh-list
55839817|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839878|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
55839879|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839880|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55839881|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55839882|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55839883|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55839884|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55839885|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55839887|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
55839888|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839889|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839890|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785235|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785236|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839891|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55839892|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55839893|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55839894|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55839895|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
55839896|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
55839897|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839923|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56217682|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217683|NCT01633645|Antiviral Agents|antiviral agents|mesh-ancestor
56217684|NCT01633645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839926|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839927|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839929|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
55839930|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839931|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839932|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55839933|NCT01741545|Interferons|interferons|mesh-list
55839934|NCT01741545|Ribavirin|ribavirin|mesh-list
55839935|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839936|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
55839937|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839938|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
55839939|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839940|NCT01884350|Apixaban|apixaban|mesh-list
55839941|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55839942|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
55791327|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
55791328|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
55791329|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791331|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55791577|NCT04880785|Dolutegravir|dolutegravir|mesh-list
55791578|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55791579|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55791580|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791581|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791582|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
55791583|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791584|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55791585|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55791586|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55791587|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55791588|NCT02514031|Gemcitabine|gemcitabine|mesh-list
55791589|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
55791591|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55791592|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791593|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
55791594|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
55791595|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
55791596|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791597|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55791598|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
55791599|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
55791600|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791601|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791602|NCT02514031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791603|NCT02514031|Immunologic Factors|immunologic factors|mesh-ancestor
55791604|NCT02514031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791605|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55791606|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55818914|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818915|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55818916|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55818917|NCT01817530|Norethindrone|norethindrone|mesh-list
55818929|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55818931|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55818932|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55818934|NCT01816984|Antibodies|antibodies|mesh-list
55818935|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
55818936|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55818937|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
55819080|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55839943|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55839944|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
55839945|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839946|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839947|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
55839971|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55839972|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55839973|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839974|NCT01834274|Incretins|incretins|mesh-ancestor
55839975|NCT01834274|Hormones|hormones|mesh-ancestor
55839976|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839977|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55839978|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
55839979|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839980|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839981|NCT01739595|Enclomiphene|enclomiphene|mesh-list
55839982|NCT01739595|Clomiphene|clomiphene|mesh-list
55839983|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
55839984|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55839985|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
55839986|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839987|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839988|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55839989|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
55839990|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55839991|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55839992|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55839994|NCT01738971|Hormones|hormones|mesh-ancestor
55839995|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839996|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839997|NCT01738503|Buprenorphine|buprenorphine|mesh-list
55839998|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55839999|NCT01738503|Narcotics|narcotics|mesh-ancestor
55840029|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55840030|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55840032|NCT04563273|Vaccines|vaccines|mesh-list
55840033|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
55840034|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
55840035|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840036|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55840037|NCT01726023|Metronidazole|metronidazole|mesh-list
55785237|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55840038|NCT01726023|Meropenem|meropenem|mesh-list
55840039|NCT01726023|Ceftazidime|ceftazidime|mesh-list
55840040|NCT01726023|Avibactam|avibactam|mesh-list
55840041|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55840077|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55840078|NCT03361436|Halichondrin B|halichondrin b|mesh-list
55840079|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
55819102|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55819129|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819130|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819131|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55819132|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55819133|NCT01799590|Topiramate|topiramate|mesh-list
55819142|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819143|NCT01815424|Tofacitinib|tofacitinib|mesh-list
55819144|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55819145|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819200|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819201|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820753|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55820754|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55820755|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55820756|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822190|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55822201|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55822202|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
55822204|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
55822273|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822274|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
55822275|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822276|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55714989|NCT04416451|Venetoclax|venetoclax|mesh-list
55714990|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55714991|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55714992|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
55714993|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55714994|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55714996|NCT04348747|Vaccines|vaccines|mesh-list
55714997|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
55714998|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55714999|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55715000|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715001|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
55715002|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55715003|NCT02257697|Mizoribine|mizoribine|mesh-list
55715004|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
55715005|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55715006|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
55715007|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840087|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55840088|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840089|NCT01857206|Vaccines|vaccines|mesh-list
56217685|NCT01633645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217686|NCT01633645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56217687|NCT01633645|Immunologic Factors|immunologic factors|mesh-ancestor
56217688|NCT01633645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217690|NCT01633658|Vitamin D|vitamin d|mesh-list
56217691|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217692|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217693|NCT01633658|Vitamins|vitamins|mesh-ancestor
56217694|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
56217695|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56217696|NCT01633749|Vaccines|vaccines|mesh-list
56217697|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
56217698|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217699|NCT01633762|Vancomycin|vancomycin|mesh-list
55793883|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55793885|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
55840090|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
55840091|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840092|NCT01882088|Psyllium|psyllium|mesh-list
55840093|NCT01882088|Cathartics|cathartics|mesh-ancestor
55840107|NCT01722669|Quercetin|quercetin|mesh-list
55840108|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
55840109|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840110|NCT01722669|Protective Agents|protective agents|mesh-ancestor
55840111|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840112|NCT01707147|Linagliptin|linagliptin|mesh-list
55840113|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55840114|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840115|NCT01707147|Incretins|incretins|mesh-ancestor
55840116|NCT01707147|Hormones|hormones|mesh-ancestor
55840117|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840118|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55840119|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
55840120|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840121|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840122|NCT01876251|Docetaxel|docetaxel|mesh-list
55840123|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840124|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
55840125|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
55840126|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
55840127|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840128|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
55840129|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55840130|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55840131|NCT01875237|Prednisolone|prednisolone|mesh-list
55840132|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
55840133|NCT01875237|Methotrexate|methotrexate|mesh-list
55840134|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
55840135|NCT01875237|Fludarabine|fludarabine|mesh-list
55840136|NCT01875237|Melphalan|melphalan|mesh-list
55840137|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
55840138|NCT01875237|Tacrolimus|tacrolimus|mesh-list
55840139|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55840140|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
55840141|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55840142|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
55840143|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55840144|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840145|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55840146|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
56217701|NCT01633762|Meropenem|meropenem|mesh-list
56217702|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56217703|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217704|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56217705|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217706|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217707|NCT01633957|Warfarin|warfarin|mesh-list
56217708|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
56217709|NCT01633970|Leucovorin|leucovorin|mesh-list
56217710|NCT01633970|Paclitaxel|paclitaxel|mesh-list
56217711|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56217712|NCT01633970|Bevacizumab|bevacizumab|mesh-list
56217713|NCT01633970|Carboplatin|carboplatin|mesh-list
56217714|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
56217715|NCT01633970|Pemetrexed|pemetrexed|mesh-list
56217716|NCT01633970|Atezolizumab|atezolizumab|mesh-list
56217717|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56217718|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217719|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
56217720|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
56217721|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
56217722|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217723|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56217724|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56217725|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56217726|NCT01633970|Growth Substances|growth substances|mesh-ancestor
56217727|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217728|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
56217729|NCT01633970|Antidotes|antidotes|mesh-ancestor
56217730|NCT01633970|Protective Agents|protective agents|mesh-ancestor
56217731|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
56217732|NCT01633970|Vitamins|vitamins|mesh-ancestor
55840147|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840170|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55840171|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55840172|NCT01874535|Esomeprazole|esomeprazole|mesh-list
55840173|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55840174|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55785238|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55840175|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55840176|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840177|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217733|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
56217734|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808392|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
56217735|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56217736|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56217737|NCT01633983|Methotrexate|methotrexate|mesh-list
56217738|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56217739|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
56217740|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56217741|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217742|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217743|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
56217744|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217745|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217746|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
56217747|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217748|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56217749|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56217750|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
56217751|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217752|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56217753|NCT01634061|Dactolisib|dactolisib|mesh-list
56217754|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840178|NCT01722045|Aflibercept|aflibercept|mesh-list
55840179|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55840180|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55840181|NCT01722045|Growth Substances|growth substances|mesh-ancestor
55841918|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
55841919|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840182|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840183|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
55840184|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840185|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55840186|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55840187|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55840188|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
55840189|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840190|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
55840191|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
55840192|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55840193|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
55840194|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840195|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840196|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55840197|NCT04415385|Apatinib|apatinib|mesh-list
55840198|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840199|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55840223|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
55840224|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840225|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55840228|NCT01881230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840229|NCT01881230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840230|NCT01881230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840231|NCT01881230|Immunologic Factors|immunologic factors|mesh-ancestor
56217755|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
56217756|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217757|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
56217758|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217759|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217760|NCT01634295|Niacin|niacin|mesh-list
56217761|NCT01634295|Amlodipine|amlodipine|mesh-list
56217762|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55840232|NCT01881230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840233|NCT01856114|Fentanyl|fentanyl|mesh-list
55840234|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55840235|NCT01856114|Narcotics|narcotics|mesh-ancestor
55840236|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840237|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840238|NCT01856114|Analgesics|analgesics|mesh-ancestor
55840239|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
55840240|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840241|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55840242|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55840244|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
55840285|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840286|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55840287|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55840289|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840290|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840291|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840292|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55840320|NCT01853696|Hormones|hormones|mesh-ancestor
55840321|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840322|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840323|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55840324|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785241|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785242|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785243|NCT03067103|Ketamine|ketamine|mesh-list
55785244|NCT03067103|Tramadol|tramadol|mesh-list
55785245|NCT03067103|Analgesics|analgesics|mesh-ancestor
55785246|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
55785247|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785248|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840325|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
55840326|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
55840327|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840328|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55840329|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55840330|NCT01853696|Protective Agents|protective agents|mesh-ancestor
55840331|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55840332|NCT01719861|Desipramine|desipramine|mesh-list
55840333|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55840334|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
55840335|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55840336|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840337|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840338|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55840339|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55840340|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55840368|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56217763|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56217764|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217765|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217766|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217767|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217768|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
56217769|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56217770|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
56217771|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56217772|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
56217774|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
56217775|NCT01634321|Leuprolide|leuprolide|mesh-list
56217776|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56217777|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
56217778|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56217779|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217780|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56217781|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217782|NCT01634347|Propranolol|propranolol|mesh-list
56217783|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56217784|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56217785|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
56217786|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217787|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217788|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217789|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56217790|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56217791|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
56217792|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56217793|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
56217794|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56217795|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55840369|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55840371|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
55840372|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55840373|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840374|NCT01719003|Metformin|metformin|mesh-list
55840375|NCT01719003|Empagliflozin|empagliflozin|mesh-list
55840376|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55840377|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217796|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56217797|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217798|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217799|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56217800|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
56217801|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55840378|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55840379|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840381|NCT01853228|Decitabine|decitabine|mesh-list
55840382|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55840383|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
55840384|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840385|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840386|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
55840387|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840403|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55840404|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
55840405|NCT01853072|Nepafenac|nepafenac|mesh-list
55840406|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55840407|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
55840408|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55840409|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
55840410|NCT01853072|Hormones|hormones|mesh-ancestor
55840411|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840412|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840413|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55840414|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840415|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
55840416|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
55840417|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840418|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55840419|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55840420|NCT01853072|Protective Agents|protective agents|mesh-ancestor
55840421|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55840422|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55840423|NCT01853072|Analgesics|analgesics|mesh-ancestor
55840424|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
55785249|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55785250|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55785251|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
55785252|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
55785253|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785254|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55785255|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55785256|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785257|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785258|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55785259|NCT03067103|Narcotics|narcotics|mesh-ancestor
55785260|NCT05492123|Cisplatin|cisplatin|mesh-list
55785261|NCT05492123|Nivolumab|nivolumab|mesh-list
55785262|NCT05492123|Ipilimumab|ipilimumab|mesh-list
55761054|NCT03038919|Androgens|androgens|mesh-ancestor
55785263|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785264|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55840425|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55840426|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
55840427|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55840428|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55840429|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
55840430|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840431|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55840432|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55840433|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840434|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840436|NCT04605393|Cannabidiol|cannabidiol|mesh-list
55840437|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
55840438|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
55840439|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217802|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56217803|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56217804|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217805|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217806|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56217807|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
56217808|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56217809|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56217810|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56217811|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840440|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55840441|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55840443|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
55840444|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840445|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55840446|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55840474|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55840475|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
55840476|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55840477|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840478|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55840479|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
55840480|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840481|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840482|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
55840483|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840484|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55840485|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840486|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
55840487|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55840488|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55840489|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55840490|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
55840524|NCT04594772|Fluorouracil|fluorouracil|mesh-list
55840525|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
55840526|NCT04594772|Irinotecan|irinotecan|mesh-list
55840527|NCT04594772|Folfirinox|folfirinox|mesh-list
55785265|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55840528|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55840529|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840530|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
55840531|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
55840532|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
55840598|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55840599|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840600|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840601|NCT03997786|Etanercept|etanercept|mesh-list
55840602|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55840603|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55840604|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55840605|NCT03997786|Analgesics|analgesics|mesh-ancestor
55840606|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
55840607|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840608|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840609|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55840610|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55840611|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55840612|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840613|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
55840614|NCT05630638|Dolutegravir|dolutegravir|mesh-list
55840615|NCT05630638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56217812|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217813|NCT01634412|Amitriptyline|amitriptyline|mesh-list
56217814|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
56217815|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56217816|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
56217817|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56217818|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56217819|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217820|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56217821|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217822|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56217823|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217824|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217825|NCT01634412|Analgesics|analgesics|mesh-ancestor
56217826|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
56217827|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56217828|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55840649|NCT03989362|Ipilimumab|ipilimumab|mesh-list
55840650|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55840651|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840652|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55840653|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840654|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
55840655|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
55840656|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55840657|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
55840684|NCT05630872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55840685|NCT05630872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55840687|NCT05630872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840688|NCT05630872|Antiviral Agents|antiviral agents|mesh-ancestor
55840689|NCT05630872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840690|NCT05630872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55840691|NCT05630872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55840692|NCT05630872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55840693|NCT05630872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55840694|NCT04006522|Atezolizumab|atezolizumab|mesh-list
55840695|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840696|NCT03024814|Acetaminophen|acetaminophen|mesh-list
55840697|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55840698|NCT03024814|Analgesics|analgesics|mesh-ancestor
55840699|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
55840700|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840701|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840702|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
55840705|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55840712|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55840713|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840714|NCT03024502|Clotrimazole|clotrimazole|mesh-list
55840715|NCT03024502|Miconazole|miconazole|mesh-list
55840716|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55840717|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840718|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
55840719|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55840720|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55840721|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840722|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217829|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217830|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217831|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
56217832|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217833|NCT01634438|Heparin|heparin|mesh-list
56217834|NCT01634438|Calcium heparin|calcium heparin|mesh-list
56217835|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
55840723|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55840724|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
55840725|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840726|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840727|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55785266|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785267|NCT01398319|Ethanol|ethanol|mesh-list
55840728|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55840729|NCT03024580|Tamoxifen|tamoxifen|mesh-list
55840730|NCT03024580|Letrozole|letrozole|mesh-list
55840731|NCT03024580|Fulvestrant|fulvestrant|mesh-list
55840732|NCT03024580|Anastrozole|anastrozole|mesh-list
55840734|NCT03024580|Megestrol|megestrol|mesh-list
55840735|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
55840736|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840737|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55840738|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55840739|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840740|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840741|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55840742|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
55840743|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840744|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840745|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55840746|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55840747|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55840748|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55840749|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55840750|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55840751|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55840752|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55840753|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
55840754|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55840755|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55840756|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55840757|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
55840758|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55840759|NCT01851590|Terbinafine|terbinafine|mesh-list
55840760|NCT01851590|Amorolfine|amorolfine|mesh-list
55840761|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
55840762|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840763|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840764|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840765|NCT03598816|Durvalumab|durvalumab|mesh-list
55840766|NCT03598816|Tremelimumab|tremelimumab|mesh-list
55840767|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55840768|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840769|NCT05633758|Metolazone|metolazone|mesh-list
55840770|NCT05633758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55840771|NCT05633758|Diuretics|diuretics|mesh-ancestor
55840772|NCT05633758|Natriuretic Agents|natriuretic agents|mesh-ancestor
55808440|NCT04239313|Vaccines|vaccines|mesh-list
55840786|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840787|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840788|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55840789|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55840790|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840793|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55840794|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55840795|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840796|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840797|NCT03594214|Vitamin D|vitamin d|mesh-list
55840798|NCT03594214|Vitamins|vitamins|mesh-ancestor
55840799|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
55840800|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840801|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55840802|NCT04003948|Ibogaine|ibogaine|mesh-list
55840803|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
55840804|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840805|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55840806|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55840807|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55840808|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840809|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840811|NCT03598582|Hematinics|hematinics|mesh-ancestor
55840812|NCT03593668|Metformin|metformin|mesh-list
55785268|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55840813|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55840814|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840815|NCT03598348|Capecitabine|capecitabine|mesh-list
55840816|NCT03598348|Apatinib|apatinib|mesh-list
55840817|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55840818|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
55840819|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840820|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840821|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55840822|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840823|NCT03976258|Naltrexone|naltrexone|mesh-list
55840824|NCT03976258|Buprenorphine|buprenorphine|mesh-list
55840825|NCT03976258|Methadone|methadone|mesh-list
55840826|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55840827|NCT03976258|Heroin|heroin|mesh-list
55840828|NCT03976258|Naloxone|naloxone|mesh-list
55840829|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55840830|NCT03976258|Narcotics|narcotics|mesh-ancestor
55840831|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840832|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840833|NCT03976258|Analgesics|analgesics|mesh-ancestor
55840834|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
55840852|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55761105|NCT03036501|Risdiplam|risdiplam|mesh-list
55840853|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55840855|NCT04003246|Durvalumab|durvalumab|mesh-list
55840856|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55840857|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55840858|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840859|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
55840860|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840861|NCT00218296|Lobeline|lobeline|mesh-list
55840862|NCT00218296|Nicotine|nicotine|mesh-list
55840863|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55840864|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
55840865|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840866|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840867|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55840868|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55840869|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
55840870|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840871|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808443|NCT05209867|Cannabidiol|cannabidiol|mesh-list
55840872|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
55840874|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
55761125|NCT04365933|Interferons|interferons|mesh-list
55840875|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55840876|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55840877|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840878|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840879|NCT01824290|Urological Agents|urological agents|mesh-ancestor
55840880|NCT00217672|Bevacizumab|bevacizumab|mesh-list
55840881|NCT00217672|Docetaxel|docetaxel|mesh-list
55840882|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55840883|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840891|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
55840892|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840893|NCT00216736|Dexamethasone|dexamethasone|mesh-list
55840914|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55840915|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
56217837|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55715008|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715009|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55715010|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
55715011|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715012|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715013|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55715015|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55715016|NCT02257697|Analgesics|analgesics|mesh-ancestor
55715017|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
55715018|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715019|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55715020|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715021|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715022|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55715023|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
55715024|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55715025|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55715026|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715027|NCT04468711|Vitamin D|vitamin d|mesh-list
55715029|NCT04468711|Vitamins|vitamins|mesh-ancestor
55715030|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
55715031|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715032|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55715033|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55715035|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55715036|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715037|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715038|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55715039|NCT02207387|Protective Agents|protective agents|mesh-ancestor
55715040|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715041|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
55715042|NCT03528421|Fludarabine|fludarabine|mesh-list
55715043|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55715044|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
55715045|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715046|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715047|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55715048|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
55715049|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715050|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715051|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55715052|NCT02374047|Atorvastatin|atorvastatin|mesh-list
55715053|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55715054|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55715055|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
55715056|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715057|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55715058|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55715059|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715060|NCT02203253|Thalidomide|thalidomide|mesh-list
55715061|NCT02203253|Dexamethasone|dexamethasone|mesh-list
55715062|NCT02203253|Palonosetron|palonosetron|mesh-list
55715063|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55715064|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
55715065|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
55715066|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715067|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726433|NCT03478423|Hydromorphone|hydromorphone|mesh-list
56217838|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217839|NCT01634594|Nicardipine|nicardipine|mesh-list
56217840|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
55840916|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840917|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55840918|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55840919|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55840920|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840921|NCT00213148|Anastrozole|anastrozole|mesh-list
55840922|NCT00213148|Citric Acid|citric acid|mesh-list
55840923|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
55840925|NCT00213148|Enclomiphene|enclomiphene|mesh-list
55785269|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840926|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
55840927|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
55840928|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55840929|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
55840930|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
55840931|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840932|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55840933|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840934|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55840935|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55840936|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840937|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55840938|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
55840939|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840940|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840941|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55840942|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
55840943|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55840944|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55840945|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55840946|NCT01704261|Metformin|metformin|mesh-list
55840947|NCT01704261|Glimepiride|glimepiride|mesh-list
55840948|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55840949|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840975|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
55840976|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55840977|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55840978|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840979|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
55840980|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55840981|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55840982|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55840983|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55840984|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840985|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840986|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840987|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55840988|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55840989|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55840991|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55840992|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840993|NCT04414995|Acetaminophen|acetaminophen|mesh-list
55840994|NCT04414995|Ibuprofen|ibuprofen|mesh-list
55840995|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55840997|NCT04414995|Analgesics|analgesics|mesh-ancestor
55840998|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
55840999|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841024|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841025|NCT01875848|Buprenorphine|buprenorphine|mesh-list
55841026|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55841027|NCT01875848|Naloxone|naloxone|mesh-list
55841028|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55841029|NCT01875848|Narcotics|narcotics|mesh-ancestor
56217841|NCT01634594|Remifentanil|remifentanil|mesh-list
56217842|NCT01634594|Sevoflurane|sevoflurane|mesh-list
56217843|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56217844|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217845|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217846|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217847|NCT01634594|Analgesics|analgesics|mesh-ancestor
56217848|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
56217849|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841030|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841031|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841032|NCT01875848|Analgesics|analgesics|mesh-ancestor
55841033|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
55761174|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
55841034|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841035|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55841036|NCT03591172|Propolis|propolis|mesh-list
55841037|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841038|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55841039|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55841040|NCT04197622|Diuretics|diuretics|mesh-ancestor
55841041|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
55841042|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841043|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55841044|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55841045|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785270|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785271|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841046|NCT03595930|Fluticasone|fluticasone|mesh-list
55841047|NCT03595930|Xhance|xhance|mesh-list
55841048|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55841049|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55841050|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
55841080|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841081|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55841082|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55841083|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841084|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841085|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55841086|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55841087|NCT04196452|Ipilimumab|ipilimumab|mesh-list
55841088|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55841089|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841090|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55841091|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841092|NCT03956056|Poly I-C|poly i-c|mesh-list
55841093|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55841094|NCT03956056|Poly ICLC|poly iclc|mesh-list
55841095|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
55841096|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
55841109|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841111|NCT04196608|Imipenem|imipenem|mesh-list
55841112|NCT04196608|Ceftolozane|ceftolozane|mesh-list
55841113|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55841114|NCT04196608|Relebactam|relebactam|mesh-list
55841115|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55841116|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841117|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55841118|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841119|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841120|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55841121|NCT04196608|Renal Agents|renal agents|mesh-ancestor
55841122|NCT04022200|Paclitaxel|paclitaxel|mesh-list
55841123|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55715657|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715659|NCT03522649|Protective Agents|protective agents|mesh-ancestor
55715660|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
55715662|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
55715663|NCT02366481|Vitamins|vitamins|mesh-list
55715664|NCT02366481|Vitamin K|vitamin k|mesh-list
55715665|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
55715666|NCT02366481|Vitamin MK 7|vitamin mk 7|mesh-list
55715667|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
55715668|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715669|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55715670|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55715671|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715672|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
55715673|NCT02366481|Coagulants|coagulants|mesh-ancestor
55715674|NCT02366247|Adefovir|adefovir|mesh-list
55715675|NCT02366247|Thymalfasin|thymalfasin|mesh-list
55715676|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
55715677|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715678|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55715679|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55715680|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715681|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715682|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55715683|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
55715684|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715686|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55715688|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
55715689|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715690|NCT03526315|Fluorides|fluorides|mesh-list
55715691|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
55715692|NCT03526315|Protective Agents|protective agents|mesh-ancestor
55715693|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715694|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
55715695|NCT03112551|Analgesics|analgesics|mesh-ancestor
55715696|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
55715697|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715699|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
55715700|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715701|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55715702|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
55715703|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55715704|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55715705|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715706|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55715707|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
55715708|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55715709|NCT04466917|Paclitaxel|paclitaxel|mesh-list
55715710|NCT04466917|Bevacizumab|bevacizumab|mesh-list
55715711|NCT04466917|Carboplatin|carboplatin|mesh-list
55715712|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56217850|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56217851|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56217853|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
56217854|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217855|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217856|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56217857|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56217858|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
56217859|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
56217860|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56217861|NCT01634594|Narcotics|narcotics|mesh-ancestor
56217862|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56217863|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56217864|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56217865|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56217866|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
56217867|NCT01634685|Capecitabine|capecitabine|mesh-list
56217868|NCT01634685|Bavituximab|bavituximab|mesh-list
55794047|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
55841124|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841125|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
55841126|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
55841127|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
55841128|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841129|NCT04552743|Plerixafor|plerixafor|mesh-list
55841130|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55841131|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55841132|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
55841134|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
55841135|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55841136|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55841137|NCT03590080|Prednisolone|prednisolone|mesh-list
55841138|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
55841139|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55841140|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
55841141|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55841142|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
55841143|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
55841144|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841145|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841146|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841147|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
55841148|NCT03590080|Hormones|hormones|mesh-ancestor
55841149|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841150|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55841151|NCT03590080|Protective Agents|protective agents|mesh-ancestor
55841152|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55841153|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841154|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
55841155|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55841156|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
55841157|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841158|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
55785273|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
56217869|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217870|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
56217871|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217872|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217873|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56217874|NCT01634698|Vitamin A|vitamin a|mesh-list
56217875|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
56217876|NCT01634698|Vitamins|vitamins|mesh-ancestor
55794072|NCT04982809|Dexamethasone|dexamethasone|mesh-list
55785274|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55841159|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55841184|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
55841185|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841186|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841187|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841188|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55841189|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55841190|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
55841191|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841192|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841193|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55841194|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55841195|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841196|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
55841198|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841199|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55841200|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55841201|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841202|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841203|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55841204|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
55841205|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841239|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841240|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841241|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
55841242|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55841243|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841244|NCT04027192|Midazolam|midazolam|mesh-list
55841245|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55841246|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55841247|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841280|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841281|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55841283|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
55841284|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55841285|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55841286|NCT03828292|Growth Substances|growth substances|mesh-ancestor
55841287|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
55841288|NCT04191694|Ondansetron|ondansetron|mesh-list
55841289|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
55841290|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
55841291|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841325|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841326|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55841330|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55841331|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
55841332|NCT04020094|Atezolizumab|atezolizumab|mesh-list
55841355|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841356|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55841357|NCT04029610|Lidocaine|lidocaine|mesh-list
55841358|NCT04029610|Epinephrine|epinephrine|mesh-list
55841359|NCT04029610|Racepinephrine|racepinephrine|mesh-list
55841360|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
55841361|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
56217877|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
56217878|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217879|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
56217880|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217881|NCT01634698|Protective Agents|protective agents|mesh-ancestor
55841362|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
55841363|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841364|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841365|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
55841366|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841367|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55841368|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55841369|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55841370|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55841371|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841372|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55841373|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55841374|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808458|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
55841376|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55841377|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55841378|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
55841379|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55841380|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
55841381|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
55841382|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
55841383|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55841384|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
55841391|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841392|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841393|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55841394|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841396|NCT04024384|Daratumumab|daratumumab|mesh-list
55841397|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841398|NCT01849562|Ribavirin|ribavirin|mesh-list
55841399|NCT01849562|Odalasvir|odalasvir|mesh-list
55841400|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
55841401|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841402|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
55841403|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841404|NCT04023760|Apixaban|apixaban|mesh-list
55841405|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55841406|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
55841407|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55841408|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
55841409|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841410|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841411|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
55841412|NCT04026958|Clarithromycin|clarithromycin|mesh-list
55841413|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55841414|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841415|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55841416|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841417|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841418|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55841419|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55841420|NCT04020718|Nicotine|nicotine|mesh-list
55841421|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55841422|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
55841423|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841424|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841425|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55841426|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55841427|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
55841429|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841430|NCT04027348|Dexamethasone|dexamethasone|mesh-list
55841432|NCT04027348|Metoclopramide|metoclopramide|mesh-list
55841433|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217882|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55715783|NCT02365857|Bupivacaine|bupivacaine|mesh-list
55715784|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
55715785|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
55715786|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715787|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715788|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
55715789|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715790|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55715792|NCT02365857|Analgesics|analgesics|mesh-ancestor
55715793|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55715794|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55715795|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55715796|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
55715797|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715798|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715799|NCT02365935|Paclitaxel|paclitaxel|mesh-list
55715800|NCT02365935|Cisplatin|cisplatin|mesh-list
55715801|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55715802|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715803|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
55715804|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
55715805|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
55715806|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715807|NCT02365623|Bedaquiline|bedaquiline|mesh-list
55715808|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
55715809|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
55715810|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715811|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715812|NCT03112707|Aspirin|aspirin|mesh-list
55715813|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56217883|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217884|NCT01634763|Ceritinib|ceritinib|mesh-list
56217885|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217886|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56217887|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217888|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217889|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
56217890|NCT01634789|Estrogens|estrogens|mesh-list
56217891|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56217892|NCT01634789|Hormones|hormones|mesh-ancestor
56217893|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56217894|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217895|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56217896|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56217897|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
56217898|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56217899|NCT01634880|Panitumumab|panitumumab|mesh-list
56217900|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56217901|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217902|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
56217903|NCT01634893|Sorafenib|sorafenib|mesh-list
56217904|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217905|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56217906|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794082|NCT04982809|Hormones|hormones|mesh-ancestor
55841434|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
55841435|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
55841436|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841437|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841438|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841439|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
55841440|NCT04027348|Hormones|hormones|mesh-ancestor
55841441|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841442|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55841443|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841444|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55841445|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55841446|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
55841447|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841448|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841449|NCT04195204|Tropisetron|tropisetron|mesh-list
55841450|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
55841451|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
55785275|NCT01305889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55841452|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841453|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217907|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217908|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
56217909|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56217910|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56217911|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217912|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217913|NCT01634906|Atorvastatin|atorvastatin|mesh-list
56217914|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56217915|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56217916|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56217917|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
56217918|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841459|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841461|NCT04023292|Letrozole|letrozole|mesh-list
55841462|NCT04023292|Exemestane|exemestane|mesh-list
55841463|NCT04023292|Anastrozole|anastrozole|mesh-list
55841464|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841465|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55841466|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55841467|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841468|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841469|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55841470|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
55841471|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841472|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841473|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55841474|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55841475|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55841476|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55841477|NCT03022240|Ondansetron|ondansetron|mesh-list
55841478|NCT03022240|Propofol|propofol|mesh-list
55841479|NCT03022240|Sevoflurane|sevoflurane|mesh-list
55841480|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55841481|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841482|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841483|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55841484|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
55841485|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
55841486|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55841487|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55841488|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
55841489|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
55841490|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841491|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841492|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
55841493|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
55841494|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55841495|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
55841496|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841497|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841498|NCT03022240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55841499|NCT03022240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55841500|NCT03022240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55841501|NCT03022240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55841502|NCT02704390|Methylphenidate|methylphenidate|mesh-list
55841503|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55841505|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55841506|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55841507|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55841508|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217919|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56217920|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56217921|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217923|NCT01634932|Trace Elements|trace elements|mesh-ancestor
56217924|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
56217925|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217926|NCT01634945|Amodiaquine|amodiaquine|mesh-list
55841509|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
55841510|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841511|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
55841513|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55841514|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
55841515|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841516|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55841517|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841518|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841519|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55841520|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841521|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55841522|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
55841535|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55841536|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841537|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55785276|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55785277|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55841538|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841540|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841541|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
55841542|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
55841543|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
55841544|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841545|NCT01611974|Maribavir|maribavir|mesh-list
55841546|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
55841547|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841548|NCT01871870|Pancrelipase|pancrelipase|mesh-list
55841549|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841550|NCT02080780|Clarithromycin|clarithromycin|mesh-list
55841551|NCT02080780|Diltiazem|diltiazem|mesh-list
55841552|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55841553|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841554|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55841555|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841556|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841557|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55841558|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55841559|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55841560|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55841561|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55841562|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55841563|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841564|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
55841565|NCT01871558|Metformin|metformin|mesh-list
55841566|NCT01871558|Vildagliptin|vildagliptin|mesh-list
55841567|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55841568|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841569|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55841570|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
55841571|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841572|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841573|NCT01711359|Folic Acid|folic acid|mesh-list
55841574|NCT01711359|Methotrexate|methotrexate|mesh-list
55841575|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55841576|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
55841577|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55841578|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217927|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
56217928|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56217929|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56217930|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217931|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56217932|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55841579|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55841580|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
55841581|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841582|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841583|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
55841584|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841611|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55841612|NCT04140136|Tocotrienols|tocotrienols|mesh-list
55841614|NCT04140136|Tocopherols|tocopherols|mesh-list
55841615|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
55841616|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841617|NCT04140136|Protective Agents|protective agents|mesh-ancestor
55841618|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841619|NCT04140136|Vitamins|vitamins|mesh-ancestor
55841620|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
55841621|NCT04146532|Aspirin|aspirin|mesh-list
55841622|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55841623|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55841624|NCT04146532|Analgesics|analgesics|mesh-ancestor
55841625|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
55785278|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841626|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841627|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841628|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55841629|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55841630|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55841631|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55841632|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841633|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55841634|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55841635|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841636|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
55841638|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55841639|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841640|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55841641|NCT03928288|Cabergoline|cabergoline|mesh-list
55841642|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55841643|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55841644|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
55841645|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
55841666|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55841667|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55841669|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
55841670|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841671|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841672|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55841673|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55841674|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
55841675|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55841676|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841677|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841678|NCT03021772|Dexamethasone|dexamethasone|mesh-list
55841679|NCT03021772|Neostigmine|neostigmine|mesh-list
55841680|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55841681|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
55841682|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
55841683|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841684|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841685|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841686|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
55841687|NCT03021772|Hormones|hormones|mesh-ancestor
56217933|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
56217934|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217935|NCT01634958|Antacids|antacids|mesh-ancestor
56217936|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217937|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56217938|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
56217939|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217940|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
55841688|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841689|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55841691|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55841692|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841693|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841694|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
55841695|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841696|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55841697|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
55841698|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55841713|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841714|NCT04405960|Vitamins|vitamins|mesh-ancestor
55841715|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
55841716|NCT03945604|Apatinib|apatinib|mesh-list
55841717|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841718|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55841719|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841720|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841721|NCT03944434|Leuprolide|leuprolide|mesh-list
55841722|NCT03944434|Goserelin|goserelin|mesh-list
55841723|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55841724|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55841725|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55841726|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
55841727|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55841728|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841729|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55841730|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785280|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
55785281|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841731|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55841732|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841733|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841734|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55841735|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
55841736|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841737|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
55841738|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55841739|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
55841740|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55841741|NCT03944356|Trametinib|trametinib|mesh-list
55841742|NCT03944356|Dabrafenib|dabrafenib|mesh-list
55841743|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841744|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55841745|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841746|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841747|NCT01701063|Ribavirin|ribavirin|mesh-list
55841748|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55841749|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
55841750|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841751|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
55841752|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841753|NCT03920722|Rituximab|rituximab|mesh-list
55841754|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55841755|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841756|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
55841757|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217942|NCT01635114|Resveratrol|resveratrol|mesh-list
56217943|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
56217944|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217945|NCT01635114|Protective Agents|protective agents|mesh-ancestor
56217946|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217947|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217948|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56217949|NCT01635205|Anesthetics|anesthetics|mesh-list
55794136|NCT05392933|Lidocaine|lidocaine|mesh-list
55841758|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55841759|NCT05580094|Anesthetics|anesthetics|mesh-list
55841794|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808576|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841796|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841798|NCT05583058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841799|NCT05583058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841800|NCT01700829|Midazolam|midazolam|mesh-list
55841801|NCT01700829|Ketamine|ketamine|mesh-list
55841802|NCT01700829|Analgesics|analgesics|mesh-ancestor
55841803|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
55841826|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841827|NCT04144192|Lidocaine|lidocaine|mesh-list
55841828|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
55841829|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
55841830|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841831|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841832|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
55841834|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55841835|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55841836|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55841837|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55841838|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841839|NCT01710345|Sufentanil|sufentanil|mesh-list
55841840|NCT01710345|Dsuvia|dsuvia|mesh-list
55841841|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55841842|NCT01710345|Narcotics|narcotics|mesh-ancestor
55841843|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841844|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841845|NCT01710345|Analgesics|analgesics|mesh-ancestor
55841846|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
55841847|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841848|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55841849|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55841850|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
55841851|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
55841852|NCT03022006|Grazoprevir|grazoprevir|mesh-list
55841853|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
55841854|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841855|NCT04143256|Menthol|menthol|mesh-list
55841892|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785283|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
55785284|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841893|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
55841920|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841922|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55841923|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841924|NCT01821560|Baclofen|baclofen|mesh-list
55841925|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55841926|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841927|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55841928|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841929|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55841930|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
56217950|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56217951|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217952|NCT01635296|Cytarabine|cytarabine|mesh-list
55841931|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
55841932|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841933|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841934|NCT03896230|Ketamine|ketamine|mesh-list
55841935|NCT03896230|Analgesics|analgesics|mesh-ancestor
55841936|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
55841937|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841938|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841960|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841962|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55841963|NCT01709721|Narcotics|narcotics|mesh-ancestor
55841964|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841965|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841966|NCT01709721|Analgesics|analgesics|mesh-ancestor
55808655|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841967|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
55841968|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841969|NCT01866657|Phenylephrine|phenylephrine|mesh-list
55841970|NCT01866657|Dopamine|dopamine|mesh-list
55841971|NCT01866657|Ephedrine|ephedrine|mesh-list
55841972|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55841973|NCT01866657|Propofol|propofol|mesh-list
55841974|NCT01866657|Sevoflurane|sevoflurane|mesh-list
55841975|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
55841976|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841977|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841978|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55841979|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55841980|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
55841981|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55841982|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55841983|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55841984|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
55841985|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
55841986|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841987|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
55841988|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
55841989|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
55841990|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55841991|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55842022|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55842023|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842025|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
55842026|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842027|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842028|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842029|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842030|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55842031|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55842032|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842033|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842035|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842067|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842068|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842069|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842070|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55842071|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785285|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
55785286|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55785287|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
55785288|NCT00223171|Androgens|androgens|mesh-list
55785289|NCT00223171|Hormones|hormones|mesh-ancestor
55842072|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842073|NCT03891706|Interleukin-2|interleukin-2|mesh-list
55842074|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842075|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842076|NCT03891706|Analgesics|analgesics|mesh-ancestor
55842077|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
55842078|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217953|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56217954|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
55794148|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
55842079|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842090|NCT05702944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55842091|NCT05702944|Vasodilator Agents|vasodilator agents|mesh-ancestor
55842093|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
55842094|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842095|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55842096|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762809|NCT04225221|Leuprolide|leuprolide|mesh-list
55842097|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842098|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
55842099|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842100|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842101|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
55842102|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842103|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842104|NCT03153280|Capecitabine|capecitabine|mesh-list
55842105|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
55842106|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55842107|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
55842108|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842109|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842110|NCT03585556|Prednisolone|prednisolone|mesh-list
55842111|NCT03585556|Ranibizumab|ranibizumab|mesh-list
55842112|NCT03585556|Aflibercept|aflibercept|mesh-list
55842113|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842114|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55842115|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55842116|NCT03585556|Growth Substances|growth substances|mesh-ancestor
55842117|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842118|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
55842119|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842120|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
55842121|NCT03585556|Hormones|hormones|mesh-ancestor
55842122|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842123|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55842124|NCT05702398|Vitamins|vitamins|mesh-list
55842125|NCT05702398|Vitamin A|vitamin a|mesh-list
55842126|NCT05702398|Niacin|niacin|mesh-list
55842127|NCT05702398|Niacinamide|niacinamide|mesh-list
55842128|NCT05702398|Nicotinic Acids|nicotinic acids|mesh-list
55842129|NCT05702398|Micronutrients|micronutrients|mesh-ancestor
55842130|NCT05702398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842131|NCT05702398|Vitamin B Complex|vitamin b complex|mesh-ancestor
55842133|NCT05702398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55842134|NCT05702398|Antimetabolites|antimetabolites|mesh-ancestor
55842135|NCT05702398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55842136|NCT05702398|Vasodilator Agents|vasodilator agents|mesh-ancestor
55842137|NCT01709409|Poractant alfa|poractant alfa|mesh-list
55842138|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
55842139|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
55842140|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
55842141|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842142|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842143|NCT02335294|Morphine|morphine|mesh-list
55842144|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55842145|NCT02335294|Narcotics|narcotics|mesh-ancestor
55842164|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
55785290|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842166|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55842167|NCT01698801|Growth Substances|growth substances|mesh-ancestor
55842170|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842171|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842172|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55842173|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842174|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55842175|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55842176|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
55842177|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
55842178|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56217955|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217957|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
56217958|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56217959|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56217960|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
55794149|NCT04796675|Fludarabine|fludarabine|mesh-list
55842179|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55842180|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842181|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
55842182|NCT03580018|Coagulants|coagulants|mesh-ancestor
55842183|NCT03584854|Carboprost|carboprost|mesh-list
55842184|NCT03584854|Dinoprost|dinoprost|mesh-list
55842185|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
55842186|NCT03584854|Methylergonovine|methylergonovine|mesh-list
55842187|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55842188|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
55842189|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55842190|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842191|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
55842192|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
55842193|NCT03584698|Misoprostol|misoprostol|mesh-list
55842194|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55842195|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
55842196|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55842197|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842198|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55842199|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842200|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
55842201|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55842202|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842203|NCT03584698|Analgesics|analgesics|mesh-ancestor
55842233|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842234|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55842235|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55842236|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
55842237|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808741|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
55842239|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55842240|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55842241|NCT03020056|Antioxidants|antioxidants|mesh-list
55842242|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55842243|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842244|NCT03020056|Protective Agents|protective agents|mesh-ancestor
55842245|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842247|NCT03026062|Ipilimumab|ipilimumab|mesh-list
55842248|NCT03026062|Tremelimumab|tremelimumab|mesh-list
55842282|NCT03583138|Narcotics|narcotics|mesh-ancestor
55842283|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842284|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842285|NCT03583138|Analgesics|analgesics|mesh-ancestor
55842288|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55842309|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55842310|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
55842311|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55842312|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55842313|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55842314|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55842315|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
55842316|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55842317|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
55842319|NCT05701540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55842320|NCT05701540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842321|NCT05701540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55785291|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842322|NCT05701540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842323|NCT05701540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842325|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217961|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217962|NCT01635400|Irinotecan|irinotecan|mesh-list
56217963|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56217964|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56217965|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217966|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217967|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56217968|NCT01635426|Aspirin|aspirin|mesh-list
56217969|NCT01635426|Clopidogrel|clopidogrel|mesh-list
56217970|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56217971|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56217972|NCT01635426|Analgesics|analgesics|mesh-ancestor
56217973|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
56217974|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56217975|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56217976|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56217977|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56217978|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55842326|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55842327|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
55842328|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
55842329|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842330|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842331|NCT01818752|Prednisone|prednisone|mesh-list
55842332|NCT01818752|Bortezomib|bortezomib|mesh-list
55842333|NCT01818752|Melphalan|melphalan|mesh-list
55842334|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842335|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
55842336|NCT01818752|Hormones|hormones|mesh-ancestor
55842337|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842338|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842339|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55842340|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842341|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55842342|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
55842343|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842370|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55842371|NCT05701384|Lazertinib|lazertinib|mesh-list
55842372|NCT05701384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55842373|NCT05701384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842374|NCT05701384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842375|NCT01362608|Triamcinolone|triamcinolone|mesh-list
55842376|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55842377|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55842378|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55842379|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842380|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
55842381|NCT01362608|Hormones|hormones|mesh-ancestor
55842382|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842383|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842384|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842385|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
55842386|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842387|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842388|NCT03581968|Pancrelipase|pancrelipase|mesh-list
56217979|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56217980|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56217981|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56217982|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56217983|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56217984|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
55842389|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842390|NCT03158584|Morphine|morphine|mesh-list
55842391|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55842421|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55842422|NCT04140448|Growth Substances|growth substances|mesh-ancestor
55842423|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842424|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
55842425|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842426|NCT03156322|Fentanyl|fentanyl|mesh-list
55842427|NCT03156322|Bupivacaine|bupivacaine|mesh-list
55842428|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
55842429|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
55842430|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842431|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842432|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
55842433|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842467|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842468|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55842469|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
55842470|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842471|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842472|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55842474|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842475|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842476|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55842493|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842494|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842495|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55785292|NCT03138031|Ethanol|ethanol|mesh-list
55785293|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55785294|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842496|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842497|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842498|NCT04536298|Vitamin D|vitamin d|mesh-list
55842499|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
55842500|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
55842501|NCT04536298|Vitamins|vitamins|mesh-list
55842502|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
55842503|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842504|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55842505|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55842506|NCT01923298|Estradiol|estradiol|mesh-list
55842507|NCT01923298|Estrogens|estrogens|mesh-ancestor
55842508|NCT01923298|Hormones|hormones|mesh-ancestor
55842509|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842510|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842511|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
55842512|NCT04417192|Olaparib|olaparib|mesh-list
55842513|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842514|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842515|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55842516|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842517|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842518|NCT05212246|Imiquimod|imiquimod|mesh-list
55842519|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55842520|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
55842521|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842522|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842523|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
55842524|NCT04297618|Lifitegrast|lifitegrast|mesh-list
55842525|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56217985|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56217986|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56217987|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56217988|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
56217989|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56217990|NCT01635530|Doxycycline|doxycycline|mesh-list
56217991|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
56217992|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55808805|NCT01365091|Saxagliptin|saxagliptin|mesh-list
56217994|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
56217995|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56217996|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56217997|NCT01635608|Acetaminophen|acetaminophen|mesh-list
56217998|NCT01635608|Amoxicillin|amoxicillin|mesh-list
56217999|NCT01635608|Talinolol|talinolol|mesh-list
56218000|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56218001|NCT01635608|Analgesics|analgesics|mesh-ancestor
55794181|NCT05226429|Vaccines|vaccines|mesh-list
55842526|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55842527|NCT03154918|Gemcitabine|gemcitabine|mesh-list
55842528|NCT03154918|Dexamethasone|dexamethasone|mesh-list
55842529|NCT03154918|Etoposide|etoposide|mesh-list
55842530|NCT03154918|Ifosfamide|ifosfamide|mesh-list
55842531|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842532|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
55842533|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
55842534|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808823|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
55842535|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842562|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842564|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55842565|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
55842566|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842567|NCT01671982|Tenofovir|tenofovir|mesh-list
55842568|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
55842569|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842570|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55842571|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55842572|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842573|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842574|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55842575|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55842576|NCT04040452|Ketorolac|ketorolac|mesh-list
55842577|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55842581|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842582|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842646|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842648|NCT03732352|Osimertinib|osimertinib|mesh-list
55842649|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55842650|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55842651|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842652|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842653|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55842655|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
55842656|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
55842657|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842658|NCT01854268|Capsaicin|capsaicin|mesh-list
55842659|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
55842660|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
55842661|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
56218003|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218004|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218005|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
56218006|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56218007|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218010|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
55794186|NCT04785755|Spironolactone|spironolactone|mesh-list
55794187|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55794188|NCT04785755|Diuretics|diuretics|mesh-list
55794189|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
55794190|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794191|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55794192|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55794193|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842662|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842663|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842664|NCT01672606|Rocuronium|rocuronium|mesh-list
55842665|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55842666|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55842667|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55842696|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842697|NCT03526900|Atezolizumab|atezolizumab|mesh-list
55842698|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842699|NCT03420742|Midazolam|midazolam|mesh-list
55842700|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55842701|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55842702|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842703|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842704|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55842705|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55842706|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55842707|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55842708|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
55842710|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
55842711|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
55842712|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842727|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842728|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842730|NCT05418010|Natalizumab|natalizumab|mesh-list
55842731|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
55842732|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842733|NCT03025594|Ketorolac|ketorolac|mesh-list
55842734|NCT03025594|Epinephrine|epinephrine|mesh-list
55842735|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
56218011|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218012|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218013|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56218014|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56218016|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56218017|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56218018|NCT01635686|Analgesics|analgesics|mesh-ancestor
56218019|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
56218020|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218021|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218022|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56218023|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56218024|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56218025|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218026|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
56218027|NCT01635751|Pregabalin|pregabalin|mesh-list
56218028|NCT01635751|Analgesics|analgesics|mesh-ancestor
56218029|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
55794194|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55794195|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
55794196|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794197|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55842736|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55842737|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55842738|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
55842739|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842740|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842741|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842742|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55842743|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55842744|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
55842745|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842746|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55842747|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
55842748|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
55842749|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
55842750|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55842751|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56218030|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218031|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218032|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
56218033|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56218034|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55794199|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55842752|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842753|NCT03025594|Analgesics|analgesics|mesh-ancestor
55842754|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
55842755|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842756|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842758|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842759|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
55842760|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
55842761|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842762|NCT04404946|Phenylephrine|phenylephrine|mesh-list
55842763|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
55842764|NCT04404946|Norepinephrine|norepinephrine|mesh-list
55842765|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55842766|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
55842767|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
55842768|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842769|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842770|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
55842772|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
55842773|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
55785295|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785296|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785297|NCT02735057|Paclitaxel|paclitaxel|mesh-list
55785298|NCT02735057|Carboplatin|carboplatin|mesh-list
55842774|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55842775|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55842776|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55842797|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842798|NCT01610492|Belimumab|belimumab|mesh-list
55842799|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842800|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
55842801|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842802|NCT02738866|Fulvestrant|fulvestrant|mesh-list
55842803|NCT02738866|Palbociclib|palbociclib|mesh-list
55842804|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55842805|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842806|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55842807|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55842808|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
55842809|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842810|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842811|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55842812|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842813|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842814|NCT04587128|Irinotecan|irinotecan|mesh-list
55842815|NCT04587128|Cetuximab|cetuximab|mesh-list
55842816|NCT04587128|Panitumumab|panitumumab|mesh-list
55842817|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55842818|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55842819|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842820|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842821|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842822|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842823|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55842824|NCT01817582|Cyclosporine|cyclosporine|mesh-list
55842825|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55842826|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
55842827|NCT01817582|Cyclosporins|cyclosporins|mesh-list
55842828|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842848|NCT01592409|Dronabinol|dronabinol|mesh-list
55842849|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
55842850|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842851|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56218035|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218036|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56218037|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56218038|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56218039|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218040|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56218041|NCT01635777|Miltefosine|miltefosine|mesh-list
56218042|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
56218043|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218044|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218045|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56218046|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55842852|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842853|NCT01592409|Analgesics|analgesics|mesh-ancestor
55842854|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
55842855|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842856|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55842857|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55842858|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842859|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842860|NCT01592409|Hormones|hormones|mesh-ancestor
55842861|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842862|NCT02081638|Aspirin|aspirin|mesh-list
55842863|NCT02081638|Atorvastatin|atorvastatin|mesh-list
55842864|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55842867|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
55842868|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842869|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842870|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842871|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842872|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55842873|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55842874|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842875|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55842876|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55785299|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55785300|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785301|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
55842877|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842878|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
55842879|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55842880|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55842881|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
55842882|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55842906|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842907|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842908|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842909|NCT02235688|Gemcitabine|gemcitabine|mesh-list
55842910|NCT02235688|Doxorubicin|doxorubicin|mesh-list
55842911|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55842912|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
55842913|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842914|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842915|NCT02235688|Antiviral Agents|antiviral agents|mesh-ancestor
55842916|NCT02235688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842918|NCT02235688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842919|NCT02235688|Immunologic Factors|immunologic factors|mesh-ancestor
55842920|NCT02235688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842921|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56218047|NCT01635790|Bevacizumab|bevacizumab|mesh-list
56218048|NCT01635790|Ranibizumab|ranibizumab|mesh-list
56218049|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56218050|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218051|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56218052|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56218053|NCT01635790|Growth Substances|growth substances|mesh-ancestor
56218054|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218055|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
56218056|NCT01635803|Bevacizumab|bevacizumab|mesh-list
56218057|NCT01635803|Ranibizumab|ranibizumab|mesh-list
56218058|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56218059|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218060|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56218061|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56218062|NCT01635803|Growth Substances|growth substances|mesh-ancestor
55842922|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55842923|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55842924|NCT03152578|Capsaicin|capsaicin|mesh-list
55842925|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
55842926|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
55842927|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
55842928|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842929|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761234|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842930|NCT01065532|Paclitaxel|paclitaxel|mesh-list
55842931|NCT01065532|Everolimus|everolimus|mesh-list
55842932|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55842933|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842966|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55842967|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
55842968|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55842969|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55842970|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55842971|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842972|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
55842973|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
55842974|NCT01674946|Cathartics|cathartics|mesh-ancestor
55842991|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842992|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842994|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
55842995|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
55842996|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55842997|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55842998|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842999|NCT01675648|Lofexidine|lofexidine|mesh-list
55843000|NCT01675648|Clonidine|clonidine|mesh-list
55843001|NCT01675648|Diazepam|diazepam|mesh-list
55843002|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55843003|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
55843004|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
55843005|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
55843006|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843007|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843009|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55843010|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843011|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55843012|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55843013|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55843014|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55843015|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56218063|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218064|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
56218065|NCT01635816|Vaccines|vaccines|mesh-list
55843016|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55843017|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
55843018|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
55785302|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
55785303|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
55785304|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785305|NCT04439357|Trametinib|trametinib|mesh-list
55785306|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
55785307|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843019|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
55843020|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
55843021|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843022|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843023|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55843024|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55843025|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
55843026|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55843027|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55843028|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55843029|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
55843030|NCT01675648|Analgesics|analgesics|mesh-ancestor
55843031|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
55843032|NCT03871348|Cemiplimab|cemiplimab|mesh-list
55843033|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843034|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843035|NCT01566435|Paclitaxel|paclitaxel|mesh-list
55843055|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843056|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55843057|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55843058|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55843059|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843060|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
55843061|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843062|NCT01696695|Capecitabine|capecitabine|mesh-list
55843063|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843064|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
55843065|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843066|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843067|NCT05261386|Betadex|betadex|mesh-list
55843068|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
55843069|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843070|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
55843071|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843072|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843073|NCT04768023|Vitamin D|vitamin d|mesh-list
55843074|NCT04768023|Vitamins|vitamins|mesh-ancestor
55843075|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
55843076|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843077|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55843078|NCT03861988|Ketamine|ketamine|mesh-list
55843080|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
55843081|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843082|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843083|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55843084|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55843085|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
55843086|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
55843087|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843088|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55843089|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55843117|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55843118|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
55843119|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843120|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55843128|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55843129|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
55843130|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
56218066|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
56218067|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218069|NCT01635829|Phenytoin|phenytoin|mesh-list
56218070|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
56218071|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
56218072|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56218073|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218074|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218075|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56218076|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56218077|NCT01635829|Analgesics|analgesics|mesh-ancestor
55843131|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55843132|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
55843133|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843134|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843135|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
55843136|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55843169|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
55843170|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843171|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55843172|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55843173|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
55843174|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843175|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843176|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55843177|NCT03844048|Venetoclax|venetoclax|mesh-list
55843178|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843179|NCT03833440|Docetaxel|docetaxel|mesh-list
55843180|NCT03833440|Durvalumab|durvalumab|mesh-list
55843181|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843182|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
55843216|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843217|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55843219|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843220|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
55843221|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55843222|NCT01590771|Metformin|metformin|mesh-list
55843223|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55843261|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55843292|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
55843293|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843294|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843295|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
55843296|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843297|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55843298|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55843299|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55843300|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843301|NCT03824938|Aspirin|aspirin|mesh-list
55843302|NCT03824938|Acetaminophen|acetaminophen|mesh-list
55843303|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55843304|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55843305|NCT03824938|Analgesics|analgesics|mesh-ancestor
55843306|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
55843307|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843333|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55843334|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55843335|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
55843336|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843337|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843338|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843339|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56218078|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
56218079|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218080|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56218081|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56218082|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218083|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56218084|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56218085|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56218086|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56218087|NCT01635946|Isavuconazole|isavuconazole|mesh-list
56218088|NCT01635946|Atorvastatin|atorvastatin|mesh-list
56218089|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56218090|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56218091|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
56218092|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218093|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56218094|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56218095|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218096|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
56218097|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218098|NCT01635972|Isavuconazole|isavuconazole|mesh-list
56218099|NCT01635972|Bupropion|bupropion|mesh-list
55843340|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55843341|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
55843346|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
55843347|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55843348|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
55843349|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55843350|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55843351|NCT03813160|Dronabinol|dronabinol|mesh-list
55843352|NCT03813160|Lenabasum|lenabasum|mesh-list
55843353|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55843354|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55785308|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55785309|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843355|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843356|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843379|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843380|NCT03807856|Dabigatran|dabigatran|mesh-list
55843381|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
55843382|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55843383|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
55843384|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843385|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843386|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
55843387|NCT03806530|Gabapentin|gabapentin|mesh-list
55843388|NCT03806530|Ropinirole|ropinirole|mesh-list
55843389|NCT03806530|Analgesics|analgesics|mesh-ancestor
55843390|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
55843391|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843392|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218100|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56218101|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
56218102|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56218103|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56218104|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56218105|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55761247|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
55715885|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
55715886|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
55715887|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715888|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55715889|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
55715890|NCT02361645|Ketorolac|ketorolac|mesh-list
55715891|NCT02361645|Indomethacin|indomethacin|mesh-list
55715892|NCT02361645|Nepafenac|nepafenac|mesh-list
55715893|NCT02361645|Bromfenac|bromfenac|mesh-list
55715894|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55715895|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55715896|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55715899|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715900|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715901|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55715902|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715903|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55715904|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824842|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824843|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824844|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55824845|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
55824846|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
55824847|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824859|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55824860|NCT04589546|Niacinamide|niacinamide|mesh-list
55824861|NCT04589546|Niacin|niacin|mesh-list
55824862|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
55824863|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
55715905|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715906|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
55715907|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
55715908|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55715909|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55715910|NCT03522181|Insulin|insulin|mesh-list
55715911|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55715912|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55715913|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715915|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
55715916|NCT02373033|Hematinics|hematinics|mesh-ancestor
55715917|NCT02373033|Vitamins|vitamins|mesh-ancestor
55715918|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
55726434|NCT03478423|Codeine|codeine|mesh-list
56218106|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218107|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
56218108|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218109|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218110|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55809120|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56218111|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56218112|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218113|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
56218114|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218117|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56218118|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56218119|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56218120|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
56218121|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218122|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218123|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218124|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56218125|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218126|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56218127|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
56218128|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
56218129|NCT01636128|Eflornithine|eflornithine|mesh-list
56218130|NCT01636128|Sulindac|sulindac|mesh-list
56218131|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218132|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56218133|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55843393|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
55843394|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55843395|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55843396|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218134|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56218135|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218136|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56218137|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218138|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218139|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55794302|NCT04988191|Irinotecan|irinotecan|mesh-list
55794303|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55794304|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794305|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55794306|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55794307|NCT04988191|Growth Substances|growth substances|mesh-ancestor
55843397|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55843398|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55843399|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55843400|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843401|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843402|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
55843403|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55843404|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55843405|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
55843406|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
55843407|NCT00003820|Rituximab|rituximab|mesh-list
55843432|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
55843434|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55715989|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
55715990|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
55715991|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
55715992|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
55715993|NCT02358993|Methenamine|methenamine|mesh-list
55715994|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715995|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715996|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55715997|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55715998|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715999|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716000|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716001|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55716002|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55716003|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55716005|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
55716006|NCT04059445|Calcium|calcium|mesh-list
55843435|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55843436|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55843437|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
55843438|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55843439|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843440|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
55843441|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
55843442|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843443|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55843444|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55843445|NCT01561989|Vitamin D|vitamin d|mesh-list
55843446|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
55843448|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
55843449|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843450|NCT01561989|Vitamins|vitamins|mesh-ancestor
55843451|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
55843452|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55843453|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55843454|NCT00004054|Paclitaxel|paclitaxel|mesh-list
55843455|NCT00004054|Etoposide|etoposide|mesh-list
55843459|NCT00004054|Warfarin|warfarin|mesh-list
55843460|NCT00004054|Hormones|hormones|mesh-list
55843461|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55843495|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843496|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843497|NCT01587651|Ticagrelor|ticagrelor|mesh-list
55843498|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55843499|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55843500|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55843531|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843533|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
55843534|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56218140|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56218142|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
56218143|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218144|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793104|NCT05018923|Tetracycline|tetracycline|mesh-list
56218145|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56218146|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56218147|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56218148|NCT01636141|Dapansutrile|dapansutrile|mesh-list
56218149|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55794310|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55794311|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55794312|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794313|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794314|NCT03069001|Ribavirin|ribavirin|mesh-list
55794315|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
55794316|NCT03069001|Simeprevir|simeprevir|mesh-list
55794317|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
55794318|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794319|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
55785310|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843537|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55843538|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
55843539|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843540|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843541|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55843542|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55843543|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55843577|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55843578|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55843579|NCT01691781|Protective Agents|protective agents|mesh-ancestor
55843580|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843582|NCT04112043|Niacin|niacin|mesh-list
55843583|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
55843584|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
55843585|NCT04112043|Vitamins|vitamins|mesh-ancestor
55843621|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55843622|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
55843623|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843624|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843625|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56218150|NCT01636180|Clopidogrel|clopidogrel|mesh-list
56218151|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56218152|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56218153|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56218154|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56218155|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
56218156|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809210|NCT02512861|Bupivacaine|bupivacaine|mesh-list
56218168|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
55794320|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843652|NCT03684538|Trace Elements|trace elements|mesh-ancestor
55843653|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
55843654|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843656|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55843657|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843658|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55843659|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843660|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55843661|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
55843662|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
56218169|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218170|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218171|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56218172|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56218173|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
56218174|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218175|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843663|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843664|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843665|NCT03676192|Bevacizumab|bevacizumab|mesh-list
55843666|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843667|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843668|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55843669|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55843670|NCT03676192|Growth Substances|growth substances|mesh-ancestor
55843671|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843673|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
55843694|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843695|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843696|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55843697|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
55843698|NCT03775096|Protective Agents|protective agents|mesh-ancestor
55843699|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55843700|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55843701|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55843702|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
55843703|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55843704|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55843705|NCT03774394|Clopidogrel|clopidogrel|mesh-list
55843706|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55843707|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55843708|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55843709|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55843710|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
55843711|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843713|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843715|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55843716|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843717|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55843718|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55785312|NCT04439357|Protective Agents|protective agents|mesh-ancestor
55785313|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843719|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55843720|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843721|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
55843722|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843723|NCT03675256|Vaccines|vaccines|mesh-list
55843754|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843755|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843756|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
55843757|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843758|NCT03674242|Antiviral Agents|antiviral agents|mesh-ancestor
55843759|NCT03674242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843760|NCT03674242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843761|NCT03674242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843762|NCT03674242|Immunologic Factors|immunologic factors|mesh-ancestor
55843763|NCT03674242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843764|NCT04761952|Azathioprine|azathioprine|mesh-list
55843765|NCT04761952|Infliximab|infliximab|mesh-list
55843766|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
55843801|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843802|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218177|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56218178|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
56218179|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218180|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218181|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56218182|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56218183|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
56218184|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218185|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843803|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843804|NCT01690299|Etanercept|etanercept|mesh-list
55843805|NCT01690299|Apremilast|apremilast|mesh-list
55843806|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55843807|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55843841|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762918|NCT05549583|Metformin|metformin|mesh-list
55716449|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716450|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716451|NCT02220335|Protective Agents|protective agents|mesh-ancestor
55716452|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716453|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
55716454|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
55716455|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
55716456|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716457|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55716458|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55716459|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55716461|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55716462|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
55716463|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55716464|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55716465|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55716466|NCT02223377|Morphine|morphine|mesh-list
55716467|NCT02223377|Hydromorphone|hydromorphone|mesh-list
55716468|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55716469|NCT02223377|Narcotics|narcotics|mesh-ancestor
55716470|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716471|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716472|NCT02223377|Analgesics|analgesics|mesh-ancestor
55716473|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
55716474|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716475|NCT02291887|Ranibizumab|ranibizumab|mesh-list
55716476|NCT02291887|Aflibercept|aflibercept|mesh-list
55716477|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55716478|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55716479|NCT02291887|Growth Substances|growth substances|mesh-ancestor
55716480|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716481|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
55716482|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716483|NCT02352285|Tolvaptan|tolvaptan|mesh-list
55825159|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
55843842|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55843843|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55843844|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
55843845|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
55843846|NCT00305344|Vaccines|vaccines|mesh-list
55843847|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
55843848|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843882|NCT04403776|Tofacitinib|tofacitinib|mesh-list
55843883|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55843884|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843885|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843887|NCT03662074|Nivolumab|nivolumab|mesh-list
55843888|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843889|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
55843925|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843926|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843928|NCT01559259|Ibuprofen|ibuprofen|mesh-list
55843929|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55843930|NCT01559259|Analgesics|analgesics|mesh-ancestor
55843965|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55843966|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55843967|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55843968|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
55843969|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
55843970|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55843971|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844000|NCT01677754|Donepezil|donepezil|mesh-list
55844001|NCT01677754|Galantamine|galantamine|mesh-list
55844002|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55844003|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844004|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844005|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
55844006|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844007|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825256|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
55825257|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825258|NCT04207190|Talazoparib|talazoparib|mesh-list
55825259|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
55825260|NCT04207190|Calicheamicins|calicheamicins|mesh-list
55825262|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716542|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55716543|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716544|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716545|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
55716546|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716547|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55716548|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
55716549|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55716550|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
55716551|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
55716552|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716553|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716555|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
55716556|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716557|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55716558|NCT02292121|Mannitol|mannitol|mesh-list
55716559|NCT02292121|Lactitol|lactitol|mesh-list
55716560|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55716561|NCT02292121|Diuretics|diuretics|mesh-ancestor
55716562|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
55716563|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716564|NCT02292121|Cathartics|cathartics|mesh-ancestor
55716565|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55716566|NCT02223611|Cisplatin|cisplatin|mesh-list
55716568|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716569|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55716570|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
55716571|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
55716572|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
55716573|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716574|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
55716575|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55716576|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716577|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716579|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55844010|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55844011|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
55844012|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55844013|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55844014|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55844015|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
55785314|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55844016|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844017|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55844018|NCT01677754|Protective Agents|protective agents|mesh-ancestor
55844019|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
55844047|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
55844048|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
56218186|NCT01636336|Nicotine|nicotine|mesh-list
56218187|NCT01636336|Progesterone|progesterone|mesh-list
56218188|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56218189|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
56218190|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218191|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218192|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56218193|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56218194|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
56218195|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218196|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218197|NCT01636336|Progestins|progestins|mesh-ancestor
56218198|NCT01636336|Hormones|hormones|mesh-ancestor
55809265|NCT05010421|Hormones|hormones|mesh-ancestor
55809269|NCT02504827|Ceftazidime|ceftazidime|mesh-list
56218199|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56218200|NCT01636401|Bromides|bromides|mesh-list
56218201|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
56218202|NCT01636505|Cetrorelix|cetrorelix|mesh-list
56218203|NCT01636505|Buserelin|buserelin|mesh-list
56218204|NCT01636505|Ganirelix|ganirelix|mesh-list
55844049|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844050|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844051|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55844052|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55844053|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55844054|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844055|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844056|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
55844057|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
55844058|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
55844059|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
55844060|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
55844061|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55844062|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55844063|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844064|NCT02405260|Incretins|incretins|mesh-ancestor
55844065|NCT02405260|Hormones|hormones|mesh-ancestor
55844066|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55844067|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55844068|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
55844069|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844100|NCT01689519|Vemurafenib|vemurafenib|mesh-list
55844101|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844102|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55844103|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844104|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844105|NCT01689363|Histamine|histamine|mesh-list
55844106|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
55844107|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
55844108|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844109|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844110|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844111|NCT04761861|Vildagliptin|vildagliptin|mesh-list
55844112|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55844113|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844114|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55844115|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
55844116|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218205|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56218206|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
55794356|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
55844117|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844118|NCT03455140|BCT-100|bct-100|mesh-list
55844119|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844120|NCT03502018|Bupivacaine|bupivacaine|mesh-list
55844121|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
55844122|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
55844123|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844124|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844125|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
55844126|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844127|NCT01689207|Aztreonam|aztreonam|mesh-list
55844128|NCT01689207|Avibactam|avibactam|mesh-list
55844129|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55844130|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844131|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55844132|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844133|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844134|NCT00089284|Rituximab|rituximab|mesh-list
55844135|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
55844136|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844141|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55844142|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
55844143|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55844144|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844145|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55844146|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844147|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844148|NCT00087646|Ribavirin|ribavirin|mesh-list
55844149|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55844150|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
55844151|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
55844152|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844153|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
55844154|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844155|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
55844156|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844157|NCT03492658|Methotrexate|methotrexate|mesh-list
55844158|NCT03492658|Abatacept|abatacept|mesh-list
55844159|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55844160|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
55844161|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55844162|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844163|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55844164|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
55844165|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844166|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844167|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
55844168|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844169|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55844170|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844171|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
55844172|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844173|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55844174|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55844175|NCT03085654|Oxytocin|oxytocin|mesh-list
55844176|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
55844177|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55844178|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844179|NCT00087568|Ribavirin|ribavirin|mesh-list
55844180|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55844181|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
55844182|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844183|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
55844184|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844185|NCT05346562|Cannabidiol|cannabidiol|mesh-list
55844186|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
55844187|NCT04402762|Enoxaparin|enoxaparin|mesh-list
55844188|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
55844189|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
55844190|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55794358|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794359|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55794360|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55794361|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56218207|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56218208|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218209|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
56218210|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56218211|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56218212|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
56218213|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218215|NCT01636557|Midazolam|midazolam|mesh-list
56218216|NCT01636557|Caffeine|caffeine|mesh-list
56218217|NCT01636557|Omeprazole|omeprazole|mesh-list
56218220|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
56218221|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218222|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56218223|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56218224|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218225|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56218226|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56218227|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56218228|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56218229|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
56218230|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
55794362|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
55844191|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55844230|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55844231|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
55844232|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844233|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844264|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55844266|NCT01558089|Methotrexate|methotrexate|mesh-list
55844267|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55844268|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
55844269|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55844270|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844271|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55844272|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
55844273|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844274|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844275|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
55844276|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218231|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
56218232|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
56218233|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218234|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218235|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
56218236|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56218237|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56218238|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218239|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55794381|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55844291|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844293|NCT01556997|Perindopril|perindopril|mesh-list
55844294|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55844295|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55844296|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55844297|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809398|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
55844298|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55844299|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844300|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
55844301|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55844302|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
55844303|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844305|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844306|NCT03409588|Riociguat|riociguat|mesh-list
55844307|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
55844308|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844309|NCT03085186|Crizotinib|crizotinib|mesh-list
55844310|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844311|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55844312|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844313|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844314|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
55844315|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55844316|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55844317|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844318|NCT00082810|Fulvestrant|fulvestrant|mesh-list
55844319|NCT00082810|Tipifarnib|tipifarnib|mesh-list
55844320|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55844321|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844322|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55844323|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55844324|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
55844325|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55844326|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844327|NCT03480334|Nivolumab|nivolumab|mesh-list
55844328|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844329|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844330|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55844331|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844332|NCT03085030|Antioxidants|antioxidants|mesh-list
55844333|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844334|NCT03085030|Protective Agents|protective agents|mesh-ancestor
55844335|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844336|NCT03443128|Vinorelbine|vinorelbine|mesh-list
55844359|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55844360|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55844361|NCT03437746|Protective Agents|protective agents|mesh-ancestor
55844362|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55844363|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218240|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56218241|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
56218242|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55844364|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844366|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55844367|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844368|NCT00080938|Temozolomide|temozolomide|mesh-list
55844369|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55844370|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
55844371|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844372|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844373|NCT03084250|Tenofovir|tenofovir|mesh-list
55844374|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55844375|NCT03084250|Entecavir|entecavir|mesh-list
55844376|NCT03084250|Adefovir|adefovir|mesh-list
55844377|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
55844378|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844379|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55844380|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55844381|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844382|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844383|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55844384|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55844387|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55844419|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55844421|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785318|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785319|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844423|NCT01678690|Antiviral Agents|antiviral agents|mesh-ancestor
55844424|NCT01678690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844425|NCT01678690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716659|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
55716660|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55716661|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
55716662|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716663|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
55716664|NCT02227745|Protective Agents|protective agents|mesh-ancestor
55716665|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55716666|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55716667|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716668|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716669|NCT03517033|Nebivolol|nebivolol|mesh-list
55716671|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
55716672|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55716673|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55716674|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55716675|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
55716676|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716677|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716678|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716679|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55716680|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55844426|NCT01678690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844427|NCT01678690|Immunologic Factors|immunologic factors|mesh-ancestor
55844428|NCT01678690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844429|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
55844503|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55844504|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
55844505|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
55844506|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
55844507|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55844508|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
55844546|NCT05346952|Pemetrexed|pemetrexed|mesh-list
55844571|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844572|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844573|NCT03080740|Metronidazole|metronidazole|mesh-list
55844574|NCT03080740|Clindamycin|clindamycin|mesh-list
55844575|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
55844576|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
55844577|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844578|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55844579|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55844580|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55844581|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55844582|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844583|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844584|NCT03081832|Oxytocin|oxytocin|mesh-list
55844585|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
55844586|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55844587|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844588|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
55844589|NCT05345938|Analgesics|analgesics|mesh-ancestor
55844590|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
55844591|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844592|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844593|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844594|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56218243|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56218244|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56218245|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56218246|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56218247|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
56218248|NCT01636557|Coagulants|coagulants|mesh-ancestor
56218249|NCT01636570|Vitamin D|vitamin d|mesh-list
56218250|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
56218251|NCT01636570|Vitamins|vitamins|mesh-ancestor
56218252|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
56218253|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218254|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56218255|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56218256|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
56218257|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56218258|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218259|NCT01636609|Cytarabine|cytarabine|mesh-list
56218260|NCT01636609|Azacitidine|azacitidine|mesh-list
56218261|NCT01636609|Tosedostat|tosedostat|mesh-list
56218262|NCT01636609|Glycine|glycine|mesh-list
56218263|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56218264|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
56218265|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218266|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218267|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
56218268|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218269|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218270|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
56218271|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844595|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55844628|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844629|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
55844630|NCT03323866|Budesonide|budesonide|mesh-list
55844631|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55844632|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55844633|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
55844634|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844635|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844636|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55844663|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844664|NCT03366766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844665|NCT03366766|Immunologic Factors|immunologic factors|mesh-ancestor
55844666|NCT03366766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844667|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55716681|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55844668|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55716682|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
55844669|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55716683|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716684|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55716685|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55716686|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716688|NCT02259179|Bupropion|bupropion|mesh-list
55716689|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55716690|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55716691|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844670|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218273|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
56218274|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218275|NCT01636622|Paclitaxel|paclitaxel|mesh-list
56218276|NCT01636622|Carboplatin|carboplatin|mesh-list
56218277|NCT01636622|Vemurafenib|vemurafenib|mesh-list
56218278|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55844672|NCT03366298|Racepinephrine|racepinephrine|mesh-list
55844673|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
55844674|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55844675|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55844676|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
55844677|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844678|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844679|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844680|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55844681|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55844683|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844684|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55844685|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
55844686|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
55844718|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55844719|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55844720|NCT05688202|Acetaminophen|acetaminophen|mesh-list
55844722|NCT05688202|Prilocaine|prilocaine|mesh-list
55844723|NCT05688202|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55844724|NCT05688202|Anesthetics, Local|anesthetics, local|mesh-ancestor
55844725|NCT05688202|Anesthetics|anesthetics|mesh-ancestor
55844726|NCT05688202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844727|NCT05688202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844728|NCT05688202|Sensory System Agents|sensory system agents|mesh-ancestor
55844729|NCT05688202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844760|NCT05665270|Autonomic Agents|autonomic agents|mesh-ancestor
55844761|NCT05665270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844762|NCT05665270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55844763|NCT05665270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55844764|NCT05665270|Protective Agents|protective agents|mesh-ancestor
55793173|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793174|NCT05339529|Glycine|glycine|mesh-list
55844766|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55844767|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844768|NCT05687500|Glyburide|glyburide|mesh-list
55844769|NCT05687500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55844770|NCT05687500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844771|NCT05687344|Nifedipine|nifedipine|mesh-list
55844772|NCT05687344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55844808|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844809|NCT01842308|Melphalan|melphalan|mesh-list
55844810|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
55844836|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55844837|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
55844838|NCT03301636|Nivolumab|nivolumab|mesh-list
55844839|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844840|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844841|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55844842|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844843|NCT04760860|Prazosin|prazosin|mesh-list
55844844|NCT04760860|Terazosin|terazosin|mesh-list
55844845|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55844846|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55844847|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55844848|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
55844849|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844850|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844851|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844852|NCT04760860|Urological Agents|urological agents|mesh-ancestor
55844853|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55844854|NCT04602494|Varenicline|varenicline|mesh-list
55844855|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55844856|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55844857|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
55844878|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844880|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
55844882|NCT04348006|Bortezomib|bortezomib|mesh-list
55844883|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844884|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
55844885|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844886|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844887|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55844888|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
55844889|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844890|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785321|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55785322|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
55844895|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844896|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55844897|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
55844898|NCT04348006|Hormones|hormones|mesh-ancestor
55844899|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55844900|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55844901|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55844902|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55844903|NCT04348006|Growth Substances|growth substances|mesh-ancestor
55844904|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
55844905|NCT04621435|Copper|copper|mesh-list
55844906|NCT04621435|Trace Elements|trace elements|mesh-ancestor
55844907|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
55844908|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844909|NCT04171700|Rucaparib|rucaparib|mesh-list
55844935|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844936|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55844937|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55844938|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844939|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844940|NCT05567458|Luspatercept|luspatercept|mesh-list
55844941|NCT05567458|Hematinics|hematinics|mesh-ancestor
55844942|NCT05305924|Fulvestrant|fulvestrant|mesh-list
55844943|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55844944|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844945|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55844946|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55844947|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
55844948|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55844949|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844954|NCT05548582|Acetaminophen|acetaminophen|mesh-list
55844955|NCT05548582|Ibuprofen|ibuprofen|mesh-list
55844956|NCT05548582|Oxycodone|oxycodone|mesh-list
55844957|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55844958|NCT05548582|Analgesics|analgesics|mesh-ancestor
55844959|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
55844960|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809497|NCT02482129|Hormones|hormones|mesh-ancestor
55844992|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
55844993|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844994|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
55844996|NCT05223088|Tegafur|tegafur|mesh-list
55844997|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844998|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55844999|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845000|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845001|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55845002|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
55845003|NCT01838876|Cariprazine|cariprazine|mesh-list
55845004|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
55845031|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55845032|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55845033|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
55845034|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55845035|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55845036|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845037|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
56218280|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
56218281|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
56218282|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
56218283|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218284|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56218285|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218286|NCT01636700|Tramadol|tramadol|mesh-list
56218287|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55845038|NCT01813058|Coagulants|coagulants|mesh-ancestor
55845039|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
55845040|NCT03330028|Promethazine|promethazine|mesh-list
55845041|NCT03330028|Dexamethasone|dexamethasone|mesh-list
55845043|NCT03330028|Cisplatin|cisplatin|mesh-list
55845044|NCT03330028|Mitomycins|mitomycins|mesh-list
55845045|NCT03330028|Mitomycin|mitomycin|mesh-list
55845046|NCT03330028|Famotidine|famotidine|mesh-list
55845047|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55845048|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785323|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55785324|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785325|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55845051|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
55845052|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845076|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845078|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
55845079|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
55845080|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55845081|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55845083|NCT04415060|Isoflurane|isoflurane|mesh-list
55845084|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55845085|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55845086|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
55845087|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
55845088|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845089|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845090|NCT05491330|Ritonavir|ritonavir|mesh-list
55845091|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55845092|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55845093|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
55845094|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845095|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845096|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55845097|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55845098|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
55845099|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845100|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55845101|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55845102|NCT04601402|Avelumab|avelumab|mesh-list
55845103|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55845138|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845139|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55845140|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
55845141|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845142|NCT01866098|Naltrexone|naltrexone|mesh-list
55845143|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55845144|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55845145|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845146|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
55845147|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845167|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845169|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55845170|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
55845171|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845172|NCT03238300|Expectorants|expectorants|mesh-ancestor
55845173|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
55845174|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55845175|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
55845176|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218289|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218290|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218291|NCT01636700|Analgesics|analgesics|mesh-ancestor
56218292|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
56218293|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218294|NCT01636869|Bupivacaine|bupivacaine|mesh-list
56218295|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
56218296|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
56218297|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218298|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845177|NCT03238300|Protective Agents|protective agents|mesh-ancestor
55845178|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845179|NCT03238300|Antidotes|antidotes|mesh-ancestor
55845180|NCT03236428|Daratumumab|daratumumab|mesh-list
55845181|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845182|NCT03985540|Methamphetamine|methamphetamine|mesh-list
55845183|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55845184|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845185|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
55845186|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
55845187|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845188|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
55845189|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845190|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845191|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
55845192|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55845193|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55845194|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55845195|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55845196|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55785327|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785328|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
55845197|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
55845198|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
55845199|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845200|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845201|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
55845220|NCT01809314|Hematinics|hematinics|mesh-ancestor
55845221|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55845222|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55845223|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845225|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
55845226|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845228|NCT05185024|Trace Elements|trace elements|mesh-ancestor
55845229|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
55845230|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845231|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
55845232|NCT04591210|Giapreza|giapreza|mesh-list
55845233|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55845234|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
55845235|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55845236|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55845237|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845238|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55845239|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55845240|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
55845241|NCT01808690|Metformin|metformin|mesh-list
55845242|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55845243|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218299|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
56218300|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218301|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
56218302|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56218303|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
56218304|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
56218305|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56218306|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56218307|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845244|NCT04583618|Vaccines|vaccines|mesh-list
55845245|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55845246|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
55845247|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845248|NCT04413734|Gemcitabine|gemcitabine|mesh-list
55845249|NCT04413734|Cisplatin|cisplatin|mesh-list
55845250|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845251|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55845252|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
55845253|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845254|NCT04413734|Antiviral Agents|antiviral agents|mesh-ancestor
55845255|NCT04413734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845256|NCT04413734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845257|NCT04413734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55845258|NCT04413734|Immunologic Factors|immunologic factors|mesh-ancestor
55845259|NCT04413734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845288|NCT03229174|Droxidopa|droxidopa|mesh-list
55845289|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55845290|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55845291|NCT03227926|Panitumumab|panitumumab|mesh-list
55845292|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55845293|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845294|NCT03615742|Budesonide|budesonide|mesh-list
55845295|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845296|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55845297|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
55845298|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845299|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845300|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55845301|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
55845302|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
55845303|NCT03615742|Hormones|hormones|mesh-ancestor
55845304|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845305|NCT04558918|Eculizumab|eculizumab|mesh-list
55845306|NCT04558918|Ravulizumab|ravulizumab|mesh-list
55845341|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55845342|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55845343|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55845344|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845380|NCT03642028|Suvorexant|suvorexant|mesh-list
55845381|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55845382|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55845383|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845384|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845385|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55845410|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845411|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845412|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
55845414|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845415|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55845416|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845417|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
55845418|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218308|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56218309|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218310|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218311|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56218312|NCT01636895|Renal Agents|renal agents|mesh-ancestor
56218313|NCT01636908|Everolimus|everolimus|mesh-list
56218314|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56218315|NCT01636908|Sorafenib|sorafenib|mesh-list
56218316|NCT01636908|Sunitinib|sunitinib|mesh-list
56218317|NCT01636908|Dasatinib|dasatinib|mesh-list
56218318|NCT01636908|Lapatinib|lapatinib|mesh-list
56218319|NCT01636908|Vemurafenib|vemurafenib|mesh-list
56218320|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218321|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218322|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
56218323|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218324|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56218325|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845419|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845420|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55845421|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
55845422|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
55845423|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
55845424|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845425|NCT03197662|Oxytocin|oxytocin|mesh-list
55845426|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
55845427|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55845428|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845429|NCT03194542|Luspatercept|luspatercept|mesh-list
55845430|NCT03194542|Hematinics|hematinics|mesh-ancestor
55845431|NCT03247582|Edoxaban|edoxaban|mesh-list
55845432|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55845433|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
55845434|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55845435|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
55845436|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845437|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845438|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
55845439|NCT01808612|Fluoxetine|fluoxetine|mesh-list
55845440|NCT01808612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55845441|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55845477|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
55845506|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845507|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845509|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
55845510|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55845511|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55845512|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55809611|NCT02493751|Avelumab|avelumab|mesh-list
55845518|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55845519|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
55845520|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845521|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845556|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55845557|NCT04305106|Dexamethasone|dexamethasone|mesh-list
55845558|NCT04305106|Dexamethasone acetate|dexamethasone acetate|mesh-list
55845559|NCT04305106|Bevacizumab|bevacizumab|mesh-list
55845561|NCT04305106|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55845562|NCT04305106|Tinzaparin|tinzaparin|mesh-list
55845563|NCT04305106|Dalteparin|dalteparin|mesh-list
55845564|NCT04305106|Anticoagulants|anticoagulants|mesh-list
55845565|NCT04305106|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55845566|NCT04305106|BB 1101|bb 1101|mesh-list
55845594|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
55845595|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55845596|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845597|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845598|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55845599|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55845600|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55845601|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55845602|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55845603|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55845604|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845605|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55845606|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
55845607|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55845608|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55845609|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55845610|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55845646|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
55845648|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845682|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55845683|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55845684|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55845685|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
55845686|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55845720|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
55845721|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845722|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845723|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55845724|NCT04226248|Protective Agents|protective agents|mesh-ancestor
55845725|NCT01892722|Interferons|interferons|mesh-list
55845754|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
56218326|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218327|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56218328|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56218329|NCT01636908|Growth Substances|growth substances|mesh-ancestor
56218330|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
56218331|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
56218338|NCT01636999|Analgesics|analgesics|mesh-ancestor
56218339|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
56218340|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218382|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218383|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56218384|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56218385|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218386|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
56218387|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56218388|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56218389|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56218390|NCT01637259|Ritonavir|ritonavir|mesh-list
56218391|NCT01637259|Lopinavir|lopinavir|mesh-list
56218392|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56218393|NCT01637259|Darunavir|darunavir|mesh-list
56218394|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
56218395|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56218396|NCT01637259|Tenofovir|tenofovir|mesh-list
56218397|NCT01637259|Lamivudine|lamivudine|mesh-list
56218398|NCT01637259|Zidovudine|zidovudine|mesh-list
56218399|NCT01637259|Emtricitabine|emtricitabine|mesh-list
56218400|NCT01637259|Maraviroc|maraviroc|mesh-list
56218401|NCT01637259|Abacavir|abacavir|mesh-list
56218402|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
56218403|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56218404|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
56218405|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56218406|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845755|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845756|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55845758|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55845759|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845760|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55845761|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845762|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55845763|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
55845764|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55845765|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845766|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
55845767|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845768|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
55845769|NCT01801280|Pantoprazole|pantoprazole|mesh-list
55845835|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55845836|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55845837|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
55845838|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845839|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55845840|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55845841|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845842|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845843|NCT01930045|Antacids|antacids|mesh-ancestor
55845844|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845845|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
55845846|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55845847|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
55845848|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845849|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
55845892|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55845894|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845895|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55785331|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55845920|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55845921|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55845922|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55845923|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845924|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845925|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55845926|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55845927|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55845928|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55845929|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
55845930|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845931|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845932|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55845933|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55845934|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
55845935|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55845936|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55845937|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
55845938|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
55845939|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56218407|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218408|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56218409|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56218410|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
56218411|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218412|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56218413|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56218414|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218415|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
56218416|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56218417|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56218418|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56218419|NCT01637376|Temoporfin|temoporfin|mesh-list
56218420|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218421|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56218422|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
55845940|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845973|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55845974|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55845975|NCT01609790|Growth Substances|growth substances|mesh-ancestor
55845976|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845977|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
55845978|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
55845979|NCT01767116|Ribavirin|ribavirin|mesh-list
55845980|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
55845981|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845982|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
55845983|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846000|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55846001|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55846002|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
55846003|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55846004|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55846005|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846006|NCT01686633|Fluticasone|fluticasone|mesh-list
55846008|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846009|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55846010|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
55846011|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846012|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846013|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55846014|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
55846015|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
55846016|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55846017|NCT02511106|Osimertinib|osimertinib|mesh-list
55846018|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846019|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55846020|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846021|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846022|NCT03180034|Vaccines|vaccines|mesh-list
55846023|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
55846024|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846025|NCT03141424|Fluticasone|fluticasone|mesh-list
55846026|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
55846027|NCT03141424|Ciclesonide|ciclesonide|mesh-list
55846028|NCT03141424|Budesonide|budesonide|mesh-list
55846029|NCT03141424|Beclomethasone|beclomethasone|mesh-list
55846030|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56218424|NCT01637454|Norepinephrine|norepinephrine|mesh-list
56218425|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56218426|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55809649|NCT02491411|BB 1101|bb 1101|mesh-list
56218427|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56218428|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56218429|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56218430|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218431|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218432|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218434|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
56218435|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218436|NCT01637532|Interferons|interferons|mesh-list
56218437|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
56218438|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
56218439|NCT01637532|Carboplatin|carboplatin|mesh-list
56218440|NCT01637532|Doxorubicin|doxorubicin|mesh-list
56218441|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218442|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56218443|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55794514|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846031|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55846032|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
55846033|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846034|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846035|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55846036|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
55846037|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
55846038|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55846039|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
55846042|NCT03614494|Piroxicam|piroxicam|mesh-list
55846043|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
55846073|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846074|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846076|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
55846077|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
55846078|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846079|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846080|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
55846081|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846083|NCT01573767|Xhance|xhance|mesh-list
55846084|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846085|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55846086|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
55846087|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846119|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55846120|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846121|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846122|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55846123|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
55846125|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846126|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846127|NCT05241028|Ensartinib|ensartinib|mesh-list
56218444|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56218445|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218446|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218447|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
56218448|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218449|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
56218450|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218453|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
55794531|NCT05204667|Acetaminophen|acetaminophen|mesh-list
55846128|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846129|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55846158|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846159|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55846160|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55846161|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809666|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55846162|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846163|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55846164|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
55846165|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846166|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846167|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55846168|NCT01908205|Oxytocin|oxytocin|mesh-list
55846169|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
55846170|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846171|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846195|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846196|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55846197|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846198|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846199|NCT01548573|Thalidomide|thalidomide|mesh-list
55846200|NCT01548573|Dexamethasone|dexamethasone|mesh-list
55846201|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
55846202|NCT01548573|Melphalan|melphalan|mesh-list
55846203|NCT01548573|Doxorubicin|doxorubicin|mesh-list
55846204|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55846205|NCT01548573|Etoposide|etoposide|mesh-list
55846206|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
55846207|NCT01548573|Bortezomib|bortezomib|mesh-list
55846208|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55763035|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
55846209|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
55846210|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846211|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846212|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55846213|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
55846214|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846215|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846216|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55846217|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846218|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
55846219|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
55846220|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846221|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55846222|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
55846223|NCT01548573|Hormones|hormones|mesh-ancestor
55846224|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846225|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55846259|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
55846260|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846261|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55846262|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55846263|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55846264|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
55846265|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56218454|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218455|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218456|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56218457|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56218458|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
56218459|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218460|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218461|NCT01637558|Ritonavir|ritonavir|mesh-list
56218462|NCT01637558|Lopinavir|lopinavir|mesh-list
55846266|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55846298|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846300|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55846301|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55846302|NCT01546857|Gabapentin|gabapentin|mesh-list
55846303|NCT01546857|Analgesics|analgesics|mesh-ancestor
55846304|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
55846305|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846306|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846332|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846333|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55846334|NCT01515189|Ipilimumab|ipilimumab|mesh-list
55809676|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
55846335|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55846336|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846337|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55846338|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846340|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55846341|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
55846342|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846343|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846344|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55846345|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846346|NCT00636610|Bevacizumab|bevacizumab|mesh-list
55846347|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55846348|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846349|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55846350|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55846351|NCT00636610|Growth Substances|growth substances|mesh-ancestor
55846352|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846353|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
55846354|NCT00635050|Paclitaxel|paclitaxel|mesh-list
55846372|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55846373|NCT00635050|Growth Substances|growth substances|mesh-ancestor
55846374|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
55846376|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55846377|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55846379|NCT05245786|Copper|copper|mesh-list
55846380|NCT05245786|Antibodies|antibodies|mesh-list
55846381|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55846382|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
55846383|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809683|NCT02490475|Docetaxel|docetaxel|mesh-list
55846390|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
55846391|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846392|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846393|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55846394|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
55846395|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846396|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218464|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56218465|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56218466|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
56218467|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218468|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218469|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56218470|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56218471|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
55846397|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
55846398|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846399|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55846400|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846401|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
55846402|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846403|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55846404|NCT00634504|Antidotes|antidotes|mesh-ancestor
55846405|NCT00634504|Protective Agents|protective agents|mesh-ancestor
55846406|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
55785336|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55785337|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785339|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785340|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
55785341|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55785342|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55785343|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785344|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
55785345|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
55785346|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785347|NCT05391451|Anesthetics|anesthetics|mesh-list
55785348|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785349|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785350|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
55785351|NCT03110341|Hematinics|hematinics|mesh-ancestor
55785353|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55785354|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846407|NCT00634504|Vitamins|vitamins|mesh-ancestor
55846408|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
55846409|NCT03101254|Vemurafenib|vemurafenib|mesh-list
55846410|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846411|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55846412|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846413|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846443|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846445|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846447|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55846448|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846449|NCT04410081|Lazertinib|lazertinib|mesh-list
55846450|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55846451|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846452|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846453|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56218472|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218473|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56218474|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56218475|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56218476|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218477|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56218478|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56218479|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
56218480|NCT01637571|Lansoprazole|lansoprazole|mesh-list
56218481|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55846455|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
55846456|NCT01924000|Minoxidil|minoxidil|mesh-list
55846457|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55846492|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
55846493|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846494|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
55846495|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846496|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846497|NCT01927198|Verinurad|verinurad|mesh-list
55846498|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
55846499|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846526|NCT01924624|Thalidomide|thalidomide|mesh-list
55846527|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846528|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
55846529|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785356|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55785357|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55785358|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785359|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785360|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55846530|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
55846531|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55846532|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846533|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55846534|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55846535|NCT01924624|Growth Substances|growth substances|mesh-ancestor
55846536|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
55846537|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846538|NCT01929382|Interferons|interferons|mesh-list
55846539|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
55846540|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846541|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
55846542|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846543|NCT00989950|Methylphenidate|methylphenidate|mesh-list
55846582|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846583|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846584|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55846585|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55846611|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55846612|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55846613|NCT01920334|Zolpidem|zolpidem|mesh-list
55846614|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55846615|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55763039|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846616|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846617|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846618|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55846619|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
55846620|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
55846621|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846622|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846623|NCT03096418|Paclitaxel|paclitaxel|mesh-list
55846624|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56218483|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56218484|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218485|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846625|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846626|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
55846627|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
55846628|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
55846629|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846631|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55846632|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
55846633|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846634|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55846635|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
55846638|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
55846639|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846640|NCT01928719|Nicotine|nicotine|mesh-list
55846641|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55846642|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
55846643|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846644|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846645|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55846646|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55846647|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
55846648|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809788|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846649|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846650|NCT00986674|Paclitaxel|paclitaxel|mesh-list
55846651|NCT00986674|Carboplatin|carboplatin|mesh-list
55846652|NCT00986674|Cetuximab|cetuximab|mesh-list
55846653|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55846654|NCT00986674|Antibodies|antibodies|mesh-list
55846655|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
55846656|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55846657|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55846658|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846659|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
55846660|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
55846661|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
55846662|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846663|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
55846664|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846665|NCT00986440|Efatutazone|efatutazone|mesh-list
55846666|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846667|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
55846668|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
55846669|NCT03118492|Melphalan|melphalan|mesh-list
55846670|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
55846671|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55846672|NCT03118492|Fludarabine|fludarabine|mesh-list
55846674|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846675|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
55846676|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846677|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846678|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55846679|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
55846680|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846681|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846682|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55846683|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55846684|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846685|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55846686|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55846687|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
55846688|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55846689|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846690|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55846692|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55846693|NCT01904149|Narcotics|narcotics|mesh-ancestor
55846694|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218487|NCT01637636|Ketoconazole|ketoconazole|mesh-list
56218488|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56218489|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
56218490|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56218491|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218492|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
56218493|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218494|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794555|NCT04801199|Hormones|hormones|mesh-ancestor
55794556|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794557|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55794558|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
55794559|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794560|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794561|NCT04340141|Leucovorin|leucovorin|mesh-list
55794563|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
55846695|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846696|NCT01904149|Analgesics|analgesics|mesh-ancestor
55846697|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
55846698|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846700|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55846701|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846702|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846703|NCT04629547|Suvorexant|suvorexant|mesh-list
55846704|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55846705|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55846706|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846707|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846708|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55846709|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846710|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846711|NCT01925638|Ketoconazole|ketoconazole|mesh-list
55846739|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846740|NCT00985504|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55846741|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
55846743|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846744|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55846745|NCT00985504|Analgesics|analgesics|mesh-ancestor
55846746|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
55846747|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
55846748|NCT01921192|Folic Acid|folic acid|mesh-list
55846749|NCT01921192|Hematinics|hematinics|mesh-ancestor
55846750|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
55846751|NCT01921192|Vitamins|vitamins|mesh-ancestor
55846773|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
55846775|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785361|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55785362|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55785363|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55846776|NCT01921426|Protective Agents|protective agents|mesh-ancestor
55846777|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846778|NCT01921582|Methylphenidate|methylphenidate|mesh-list
55846779|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55846780|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218495|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218496|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56218497|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56218498|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56218499|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56218500|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56218501|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56218502|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
56218503|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56218504|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56218505|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56218506|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
55794566|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
55794567|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55794568|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794569|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
55794570|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794571|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55794572|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794573|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55794574|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
55794575|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55794576|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55794577|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794578|NCT04340141|Antidotes|antidotes|mesh-ancestor
55794579|NCT04340141|Protective Agents|protective agents|mesh-ancestor
55794580|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
55846781|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55846782|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55846783|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55846784|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846785|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
55846786|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846787|NCT00985426|Vaccines|vaccines|mesh-list
55846788|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
55846789|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846790|NCT00985192|Everolimus|everolimus|mesh-list
55846793|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
55763079|NCT04757740|Prednisolone|prednisolone|mesh-list
55846794|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218507|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56218508|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218509|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56218510|NCT01637675|Tanshinone|tanshinone|mesh-list
56218511|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
56218512|NCT01637675|Citric Acid|citric acid|mesh-list
56218513|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
56218514|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
56218515|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56218516|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
56218517|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
56218518|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218519|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
56218520|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56218521|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56218522|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218523|NCT01637675|Urological Agents|urological agents|mesh-ancestor
56218524|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218525|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55794581|NCT04340141|Vitamins|vitamins|mesh-ancestor
55794582|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
55794583|NCT05445791|Metformin|metformin|mesh-list
55794584|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55794585|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794586|NCT05201547|Paclitaxel|paclitaxel|mesh-list
55846795|NCT03390010|Misoprostol|misoprostol|mesh-list
55846796|NCT03390010|Carboprost|carboprost|mesh-list
55846797|NCT03390010|Oxytocin|oxytocin|mesh-list
55846798|NCT03390010|Methylergonovine|methylergonovine|mesh-list
55846799|NCT03390010|Carboprost tromethamine|carboprost tromethamine|mesh-list
55846800|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55846801|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
55846802|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846803|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846804|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55846805|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55846828|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55846829|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55846830|NCT00984568|Analgesics|analgesics|mesh-ancestor
55846831|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
55846832|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
55846833|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55846834|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846835|NCT02984176|Simethicone|simethicone|mesh-list
55846836|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
55846837|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846838|NCT02984176|Emollients|emollients|mesh-ancestor
55846839|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
55846840|NCT01921738|Azithromycin|azithromycin|mesh-list
55846841|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55846842|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218527|NCT01637675|Analgesics|analgesics|mesh-ancestor
56218528|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
56218529|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218530|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218531|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56218532|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56218533|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56218534|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846843|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
55846844|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55846845|NCT00984256|Atovaquone|atovaquone|mesh-list
55846846|NCT00984256|Proguanil|proguanil|mesh-list
55846847|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
55846848|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846849|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
55846850|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55846851|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55846852|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846853|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846854|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
55846855|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55846856|NCT00984022|Laxatives|laxatives|mesh-ancestor
55846857|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55846858|NCT01890265|Pirfenidone|pirfenidone|mesh-list
55846884|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55846885|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846886|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
55846887|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55846888|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55846889|NCT03110926|Leucovorin|leucovorin|mesh-list
55846890|NCT03110926|Paclitaxel|paclitaxel|mesh-list
55846891|NCT03110926|Carboplatin|carboplatin|mesh-list
55846892|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
55846893|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55785364|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
55785365|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
55785366|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
55785367|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
55785368|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785369|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785370|NCT04405063|Paclitaxel|paclitaxel|mesh-list
55785371|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55785372|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785373|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
55785374|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
55785375|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
55785376|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785377|NCT05090449|Losartan|losartan|mesh-list
55785378|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
55846894|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846895|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
55846896|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
55846897|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
55846899|NCT03110926|Antidotes|antidotes|mesh-ancestor
55846900|NCT03110926|Protective Agents|protective agents|mesh-ancestor
55846901|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846902|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
55846904|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
55846905|NCT01928329|Exenatide|exenatide|mesh-list
55846906|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55846907|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846908|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55846909|NCT01928329|Incretins|incretins|mesh-ancestor
55846922|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55846923|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55846925|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56218535|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218536|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
56218537|NCT01637753|Carmustine|carmustine|mesh-list
56218538|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56218539|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
56218540|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218541|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218542|NCT01637766|Melphalan|melphalan|mesh-list
56218543|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56218544|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
56218545|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218546|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846926|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846927|NCT03088540|Gemcitabine|gemcitabine|mesh-list
55846928|NCT03088540|Paclitaxel|paclitaxel|mesh-list
55846929|NCT03088540|Carboplatin|carboplatin|mesh-list
55846930|NCT03088540|Pemetrexed|pemetrexed|mesh-list
55846931|NCT03088540|Cemiplimab|cemiplimab|mesh-list
55846932|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55846933|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846934|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
55846935|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
55846936|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
55846937|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846938|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55846939|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
55846940|NCT03088540|Antiviral Agents|antiviral agents|mesh-ancestor
55846941|NCT03088540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846942|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846943|NCT03088540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846944|NCT03088540|Immunologic Factors|immunologic factors|mesh-ancestor
55846945|NCT03088540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846946|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55846947|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55846948|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55846950|NCT01903993|Atezolizumab|atezolizumab|mesh-list
55846951|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846952|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
55846953|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
55846954|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
55785379|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55785380|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55785381|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55785382|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55846955|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846956|NCT00980044|Tramadol|tramadol|mesh-list
55846957|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55846958|NCT00980044|Narcotics|narcotics|mesh-ancestor
55846959|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846960|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846961|NCT00980044|Analgesics|analgesics|mesh-ancestor
55846962|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
55846963|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846964|NCT03049306|Propranolol|propranolol|mesh-list
55846965|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55846966|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55846967|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
55846968|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846969|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846970|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218547|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55847000|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55847001|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
55847002|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55847003|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847004|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847005|NCT05601466|Cytarabine|cytarabine|mesh-list
55847006|NCT05601466|Cyclophosphamide|cyclophosphamide|mesh-list
55847007|NCT05601466|Fludarabine|fludarabine|mesh-list
55847008|NCT05601466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55847009|NCT05601466|Immunologic Factors|immunologic factors|mesh-ancestor
55847011|NCT05601466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847012|NCT05601466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55847013|NCT05601466|Alkylating Agents|alkylating agents|mesh-ancestor
55847014|NCT05601466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847015|NCT05601466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847016|NCT05601466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55847049|NCT00982696|Analgesics|analgesics|mesh-ancestor
55847050|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
55847051|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847052|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
55809993|NCT02349633|Avelumab|avelumab|mesh-list
55847053|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847054|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847056|NCT00981526|Olanzapine|olanzapine|mesh-list
55847057|NCT00981526|Clozapine|clozapine|mesh-list
55847058|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
55847059|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
55847060|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847061|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847062|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55847094|NCT05607940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55847095|NCT05607940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847096|NCT05607940|Analgesics|analgesics|mesh-ancestor
55847097|NCT05607940|Sensory System Agents|sensory system agents|mesh-ancestor
55847098|NCT05607940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847099|NCT05607940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847100|NCT05607940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847101|NCT05607940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847102|NCT04394728|Trabectedin|trabectedin|mesh-list
55847137|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847138|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847139|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55847140|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
55847141|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
55847176|NCT03036904|Doxorubicin|doxorubicin|mesh-list
55847177|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55847178|NCT03036904|Etoposide|etoposide|mesh-list
55847179|NCT03036904|Vincristine|vincristine|mesh-list
55847180|NCT03036904|Venetoclax|venetoclax|mesh-list
55847181|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789069|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55847182|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
55847183|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847204|NCT05604898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55847206|NCT05604898|Immunoglobulins|immunoglobulins|mesh-list
55847207|NCT05604898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55847208|NCT05604898|Immunologic Factors|immunologic factors|mesh-ancestor
55847209|NCT05604898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847210|NCT05604898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847211|NCT05606692|Propofol|propofol|mesh-list
55847212|NCT05606692|Sevoflurane|sevoflurane|mesh-list
55847213|NCT05606692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55847214|NCT05606692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847215|NCT05606692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847216|NCT05606692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55847217|NCT05606692|Anesthetics, General|anesthetics, general|mesh-ancestor
55847218|NCT05606692|Anesthetics|anesthetics|mesh-ancestor
55847219|NCT05606692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55847220|NCT05606692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55847221|NCT04392700|Tenofovir|tenofovir|mesh-list
55847222|NCT04392700|Entecavir|entecavir|mesh-list
55847223|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
55847224|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847225|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55847226|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218548|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218549|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
56218550|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218551|NCT01637818|Acetaminophen|acetaminophen|mesh-list
56218552|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56218553|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56218554|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56218555|NCT01637818|Analgesics|analgesics|mesh-ancestor
56218556|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
56218557|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218558|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218559|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
56218560|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56218561|NCT01637844|Telbivudine|telbivudine|mesh-list
56218562|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
56218563|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218564|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218565|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218566|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218567|NCT01637883|Benzydamine|benzydamine|mesh-list
56218568|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56218570|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55847227|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847228|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847229|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55847230|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55847231|NCT03828058|Tacrolimus|tacrolimus|mesh-list
55847232|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55847233|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
55847234|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847235|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55847236|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847269|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55847272|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55847273|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55847274|NCT01513473|Insulin|insulin|mesh-list
55847310|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
55847311|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55847334|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
55847335|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
55847336|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847337|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847338|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
55847339|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847340|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55847341|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55847342|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55847343|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847344|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218571|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218572|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56218573|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
56218574|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56218575|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
56218576|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56218577|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218578|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56218579|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56218580|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218581|NCT01638078|Thalidomide|thalidomide|mesh-list
56218582|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218583|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
56218584|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218585|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
55847345|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55847346|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847347|NCT03825016|Analgesics|analgesics|mesh-ancestor
55847348|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847349|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847350|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55847351|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847352|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
55847354|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55847355|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
55847356|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55847357|NCT03043924|Estradiol|estradiol|mesh-list
55847358|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55847359|NCT03043924|Cyproterone|cyproterone|mesh-list
55847360|NCT03043924|Estrogens|estrogens|mesh-ancestor
55847361|NCT03043924|Hormones|hormones|mesh-ancestor
55847362|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847363|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847364|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55847365|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
55785383|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847391|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55847392|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
55847393|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
55847394|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847395|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847396|NCT03824002|Insulin|insulin|mesh-list
55847397|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55847398|NCT03824002|Metformin|metformin|mesh-list
55847399|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
55847400|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
55847401|NCT03824002|Dulaglutide|dulaglutide|mesh-list
55847402|NCT03824002|Repaglinide|repaglinide|mesh-list
55847403|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
55847404|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55847405|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55847406|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847407|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
55847408|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
55847409|NCT03823846|Parecoxib|parecoxib|mesh-list
55847410|NCT03823846|Dezocine|dezocine|mesh-list
55847411|NCT03823846|Analgesics|analgesics|mesh-ancestor
55847412|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
55847413|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847414|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847415|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56218586|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56218587|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218588|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56218589|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56218590|NCT01638078|Growth Substances|growth substances|mesh-ancestor
56218591|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
56218592|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218593|NCT01638182|Vitamins|vitamins|mesh-list
56218594|NCT01638182|Vitamin K|vitamin k|mesh-list
56218595|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
56218596|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
56218597|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
56218598|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794657|NCT04798313|Denosumab|denosumab|mesh-list
55847416|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847417|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847445|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847446|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847447|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847449|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55810106|NCT02442349|Osimertinib|osimertinib|mesh-list
55847450|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55847451|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847452|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55847453|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55847454|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847455|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
55847456|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
55847457|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55847458|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
55847459|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55847460|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
55847461|NCT02735902|Aspirin|aspirin|mesh-list
55847462|NCT02735902|Vitamin K|vitamin k|mesh-list
55847463|NCT02735902|Anticoagulants|anticoagulants|mesh-list
55847464|NCT02735902|Vitamins|vitamins|mesh-ancestor
55847488|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847490|NCT04273282|Dexamethasone|dexamethasone|mesh-list
55847491|NCT04273282|Prednisolone|prednisolone|mesh-list
55847492|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55847493|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
55847494|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55847495|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
55847496|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55847497|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
55847498|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847499|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
55847500|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
55847501|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847502|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847503|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55847504|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
55847505|NCT04273282|Hormones|hormones|mesh-ancestor
55847506|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847507|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55847508|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847509|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55847510|NCT04273282|Protective Agents|protective agents|mesh-ancestor
55847511|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55847512|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847513|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55847514|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55847515|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847553|NCT01455532|Immunologic Factors|immunologic factors|mesh-ancestor
56218599|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56218600|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56218601|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810140|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
55785385|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
55789070|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
55847554|NCT01455532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847555|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55847556|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55847592|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
55847593|NCT01456546|Proguanil|proguanil|mesh-list
55847594|NCT01456546|Clopidogrel|clopidogrel|mesh-list
55847595|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55847596|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55847597|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55847598|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55847599|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
55847620|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847621|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55847622|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
55847623|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
55847625|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847626|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55847627|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55847628|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55847629|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
55847630|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847631|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847632|NCT02880982|Vitamin D|vitamin d|mesh-list
55847633|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
55847634|NCT02880982|Vitamins|vitamins|mesh-ancestor
55847635|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
55847636|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847637|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55847638|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55847639|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55847640|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
55847682|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55847683|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847684|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55847685|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55847686|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847687|NCT01890772|Vitamin D|vitamin d|mesh-list
55847688|NCT01890772|Ribavirin|ribavirin|mesh-list
55847689|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55847690|NCT01890772|Vitamins|vitamins|mesh-ancestor
55847691|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
55847692|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847693|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55847694|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
55847695|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847696|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
55847697|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847698|NCT01891084|Acetaminophen|acetaminophen|mesh-list
55847699|NCT01891084|Ibuprofen|ibuprofen|mesh-list
55847700|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847701|NCT01891084|Analgesics|analgesics|mesh-ancestor
55847702|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
55847703|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847704|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847705|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
55785386|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785387|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55785388|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55785389|NCT05090137|Diuretics|diuretics|mesh-list
55785390|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
55785391|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785392|NCT05431049|Anesthetics|anesthetics|mesh-list
55794669|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794670|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55794671|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55794672|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794673|NCT05624359|Ropivacaine|ropivacaine|mesh-list
55794674|NCT05624359|Anesthetics, Local|anesthetics, local|mesh-ancestor
55794675|NCT05624359|Anesthetics|anesthetics|mesh-ancestor
55785395|NCT03067415|Latanoprost|latanoprost|mesh-list
55785396|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55785397|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55785398|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
55785399|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55785400|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
55785401|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785402|NCT05089981|Expectorants|expectorants|mesh-ancestor
56218614|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56218615|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
56218616|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56218617|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218618|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56218619|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810179|NCT02463331|Analgesics|analgesics|mesh-ancestor
56218620|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56218621|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56218622|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55785403|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
55785404|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55785405|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
55785406|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785407|NCT05089981|Protective Agents|protective agents|mesh-ancestor
55785408|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785409|NCT05089981|Antidotes|antidotes|mesh-ancestor
55847740|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55847741|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55847742|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55847743|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847744|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847745|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55847746|NCT01892332|Narcotics|narcotics|mesh-ancestor
55847747|NCT01892332|Analgesics|analgesics|mesh-ancestor
55847748|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55847749|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55847750|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
55847751|NCT01892488|Sultamicillin|sultamicillin|mesh-list
55847752|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
55847753|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55847780|NCT01615939|Bupivacaine|bupivacaine|mesh-list
55847781|NCT01615939|Ropivacaine|ropivacaine|mesh-list
55847782|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
55785413|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55785414|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847784|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847785|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847786|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
55847787|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847789|NCT02789878|Goserelin|goserelin|mesh-list
55847790|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847791|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
55847792|NCT02789878|Hormones|hormones|mesh-ancestor
55847793|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847794|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847795|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55847796|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847797|NCT01901185|Etanercept|etanercept|mesh-list
55847798|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55847799|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847800|NCT01901185|Analgesics|analgesics|mesh-ancestor
55847801|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
55847802|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847829|NCT02788708|Paclitaxel|paclitaxel|mesh-list
55847830|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55847831|NCT02788708|Lenvatinib|lenvatinib|mesh-list
55847832|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55847833|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847834|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
55847835|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
55847836|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
55847837|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847838|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56218623|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56218624|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56218625|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218626|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218627|NCT01638247|Hormones|hormones|mesh-ancestor
56218628|NCT01638260|Liraglutide|liraglutide|mesh-list
56218629|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56218630|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218631|NCT01638260|Incretins|incretins|mesh-ancestor
56218632|NCT01638260|Hormones|hormones|mesh-ancestor
55794685|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847839|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847840|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
55847841|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55847842|NCT01888003|Hematinics|hematinics|mesh-ancestor
55847843|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
55847844|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55847845|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847846|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847847|NCT02780128|Ceritinib|ceritinib|mesh-list
55847848|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847849|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55847850|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847851|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847884|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
55847885|NCT02720068|Fluorouracil|fluorouracil|mesh-list
55847886|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
55847887|NCT02720068|Irinotecan|irinotecan|mesh-list
55847888|NCT02720068|Lenvatinib|lenvatinib|mesh-list
55847889|NCT02720068|Calcium|calcium|mesh-list
55847890|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
55847891|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55847892|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847893|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55847894|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847895|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
55810652|NCT01641237|Fluorides|fluorides|mesh-list
55847990|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847991|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847992|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55847993|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55847994|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55847996|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
55847997|NCT02388178|Protective Agents|protective agents|mesh-ancestor
55847998|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848000|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
55848001|NCT02384668|Vitamins|vitamins|mesh-ancestor
55848002|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
55848035|NCT05604586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848036|NCT05604586|Expectorants|expectorants|mesh-ancestor
55848037|NCT05604586|Respiratory System Agents|respiratory system agents|mesh-ancestor
55848038|NCT05604586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55848039|NCT05604586|Antioxidants|antioxidants|mesh-ancestor
55785415|NCT04271189|Incretins|incretins|mesh-ancestor
55785416|NCT04271189|Hormones|hormones|mesh-ancestor
55789071|NCT04918433|Anesthetics|anesthetics|mesh-list
55848040|NCT05604586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848041|NCT05604586|Protective Agents|protective agents|mesh-ancestor
55848042|NCT05604586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848077|NCT05603884|Antimetabolites|antimetabolites|mesh-ancestor
55848078|NCT05603884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848079|NCT05603884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848080|NCT05603884|Antiviral Agents|antiviral agents|mesh-ancestor
55848081|NCT05603884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848082|NCT05603884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848083|NCT05603884|Immunologic Factors|immunologic factors|mesh-ancestor
56218633|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56218635|NCT01638273|Analgesics|analgesics|mesh-ancestor
55810935|NCT04390581|Lidocaine|lidocaine|mesh-list
56218636|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
56218637|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218638|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218639|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
56218640|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56218641|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56218642|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218643|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56218644|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56218645|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56218646|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218647|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56218648|NCT01638299|Insulin|insulin|mesh-list
56218649|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56218650|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218651|NCT01638325|Insulin|insulin|mesh-list
56218652|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56218653|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
56218654|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56218655|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218656|NCT01638364|Ethanol|ethanol|mesh-list
56218657|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56218658|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218659|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218660|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218661|NCT01638377|Naltrexone|naltrexone|mesh-list
56218662|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55811180|NCT03905889|Sunitinib|sunitinib|mesh-list
56218664|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848084|NCT05603884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848108|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848110|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
55848111|NCT04393792|Povidone|povidone|mesh-list
55848112|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
55848113|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
55848114|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55848115|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848116|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
56218665|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
56218666|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218667|NCT01638403|Modafinil|modafinil|mesh-list
56218668|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56218669|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218670|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55794730|NCT02633059|Dexamethasone|dexamethasone|mesh-list
55794732|NCT02633059|Ixazomib|ixazomib|mesh-list
55848117|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55848118|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55848119|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55848120|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55848121|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55848122|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848123|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
55848124|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848125|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848126|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55848127|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848128|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55848129|NCT02315872|Hormones|hormones|mesh-ancestor
55848130|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848131|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848132|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
55848156|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55848157|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
55848158|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848159|NCT03017326|Antiviral Agents|antiviral agents|mesh-ancestor
55848160|NCT03017326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848162|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848163|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
55848164|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848165|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55848166|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55848167|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55848168|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55848169|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55848170|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
55848172|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
55848173|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55848174|NCT03012880|Dexamethasone|dexamethasone|mesh-list
55848175|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
55848176|NCT03012880|Lenalidomide|lenalidomide|mesh-list
55848177|NCT03012880|Daratumumab|daratumumab|mesh-list
55848178|NCT03012880|Ixazomib|ixazomib|mesh-list
55848179|NCT03012880|Ichthammol|ichthammol|mesh-list
55848180|NCT03012880|BB 1101|bb 1101|mesh-list
55848181|NCT03012880|Glycine|glycine|mesh-list
55848182|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848183|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
55848184|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
55848185|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848186|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848187|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55848188|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
55848223|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55848224|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55785417|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785418|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55848225|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848226|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
55848227|NCT03007732|Prednisone|prednisone|mesh-list
55848228|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
55848229|NCT03007732|Leuprolide|leuprolide|mesh-list
55848266|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56218671|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56218672|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56218673|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848301|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55848302|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
55848303|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
55848304|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848305|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848306|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55848307|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55848308|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55848309|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55848345|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
55848346|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
55848347|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848348|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55848349|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55848350|NCT01884571|Protective Agents|protective agents|mesh-ancestor
55848351|NCT01884337|Apixaban|apixaban|mesh-list
55848368|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848369|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55848370|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55848371|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848372|NCT04121416|Sufentanil|sufentanil|mesh-list
55848373|NCT04121416|Oxycodone|oxycodone|mesh-list
55848374|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55848375|NCT04121416|Narcotics|narcotics|mesh-ancestor
55848376|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55848377|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848378|NCT04121416|Analgesics|analgesics|mesh-ancestor
55848379|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
55848380|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848381|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55848382|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55848383|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
55848384|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
55848385|NCT04121338|Bupivacaine|bupivacaine|mesh-list
55848386|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
55848387|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
55848388|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761296|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55848390|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
55848391|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848392|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
55848393|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
55848394|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848395|NCT01922011|Vancomycin|vancomycin|mesh-list
55848396|NCT01922011|Daptomycin|daptomycin|mesh-list
55848397|NCT01922011|Nafcillin|nafcillin|mesh-list
55848398|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55848399|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848400|NCT04127968|Vitamin A|vitamin a|mesh-list
55848401|NCT04127968|Vitamins|vitamins|mesh-ancestor
55848402|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
55848403|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848404|NCT01921387|Cytarabine|cytarabine|mesh-list
55848405|NCT01921387|Etoposide|etoposide|mesh-list
55848406|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
55848407|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
55848408|NCT01921387|Melphalan|melphalan|mesh-list
55848409|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
55848410|NCT01921387|Carmustine|carmustine|mesh-list
55848411|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55848412|NCT01921387|Antibodies|antibodies|mesh-list
55848413|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55848427|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55848429|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55848430|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
55848431|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
55785419|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
55785420|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848432|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
55848433|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
55848434|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
55848435|NCT04129996|Paclitaxel|paclitaxel|mesh-list
55848436|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56218675|NCT01638442|Glycine|glycine|mesh-list
56218676|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218677|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218678|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
56218679|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218680|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218681|NCT01638624|Propofol|propofol|mesh-list
56218682|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56218683|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56218684|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848437|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848438|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
55848439|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
55848440|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
55848441|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848442|NCT04129216|Tamoxifen|tamoxifen|mesh-list
55848443|NCT04129216|Letrozole|letrozole|mesh-list
55848444|NCT04129216|Exemestane|exemestane|mesh-list
55848445|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848446|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848447|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55848448|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55848449|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848450|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55848451|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
55848452|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848453|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848454|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55848455|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55848456|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55848457|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55848458|NCT04124614|Sertraline|sertraline|mesh-list
55848459|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
55848460|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
55848461|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55848462|NCT04124614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55848463|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55848464|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55848465|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848466|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848467|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
55848468|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848469|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
55848470|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
55848471|NCT01895335|Teriflunomide|teriflunomide|mesh-list
55848472|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55848501|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55848502|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
55848503|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55848504|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848505|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
55848509|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55848510|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
55848511|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55848512|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848513|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55848514|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55848515|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
55848516|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55848517|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55848518|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56218685|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56218686|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
56218689|NCT01638650|Saquinavir|saquinavir|mesh-list
56218690|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56218691|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56218692|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56218693|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
56218694|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218695|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218696|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56218697|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56218698|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
55716769|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
55716770|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716771|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716772|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716773|NCT02228135|Dexamethasone|dexamethasone|mesh-list
55716774|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55716775|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
55716776|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
55716777|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716778|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716779|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55716780|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
55716781|NCT02228135|Hormones|hormones|mesh-ancestor
55716782|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716783|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55716784|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716785|NCT03152877|Bupivacaine|bupivacaine|mesh-list
55716786|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
55716787|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
55716788|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726435|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56218699|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218700|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55794752|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848519|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55848520|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
55848521|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55848522|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55848523|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
55848554|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848555|NCT02965768|Naltrexone|naltrexone|mesh-list
55848556|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55848557|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55848558|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848559|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
55785421|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785422|NCT05730413|Bisoprolol|bisoprolol|mesh-list
55785423|NCT05730413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55785424|NCT05730413|Sympatholytics|sympatholytics|mesh-ancestor
55848560|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848561|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
55848562|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55848563|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55848564|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848565|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
55848566|NCT01895101|Coagulants|coagulants|mesh-ancestor
55848567|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
55848601|NCT03483649|Growth Substances|growth substances|mesh-ancestor
55848602|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848603|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
55848604|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
55848605|NCT03822520|Celecoxib|celecoxib|mesh-list
55848606|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55848607|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848608|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55848609|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55848639|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848640|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55848641|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55848642|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55848643|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
55848644|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
55793268|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55848645|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55848646|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
55848647|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
56218702|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218704|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56218705|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218706|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
56218707|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218708|NCT01638676|Metformin|metformin|mesh-list
56218709|NCT01638676|Vemurafenib|vemurafenib|mesh-list
56218710|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56218711|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218712|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218713|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56218714|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218715|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218716|NCT01638689|Citalopram|citalopram|mesh-list
56218717|NCT01638689|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56218718|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56218719|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56218720|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218721|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56218722|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
56218723|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218724|NCT01638689|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56218725|NCT01638689|Antidepressive Agents|antidepressive agents|mesh-ancestor
56218726|NCT01638689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55848648|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
55848649|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848650|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848652|NCT03820180|Xhance|xhance|mesh-list
55848653|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55848654|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55848690|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
55848691|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848692|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55848720|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848721|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
55848722|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
55848723|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
55848724|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848725|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848726|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
56218727|NCT01638715|Rituximab|rituximab|mesh-list
56218728|NCT01638715|Abatacept|abatacept|mesh-list
56218729|NCT01638715|Infliximab|infliximab|mesh-list
56218730|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56218731|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218732|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
56218733|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218734|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56218735|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
56218736|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56218737|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56218738|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218739|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218740|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
56218741|NCT01638767|NuvaRing|nuvaring|mesh-list
56218742|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
55848727|NCT02913196|Hormones|hormones|mesh-ancestor
55848729|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848730|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55848731|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55848733|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
55848734|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55848736|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
55848737|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848772|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848773|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848774|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55848775|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848776|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
55848777|NCT02638090|Vorinostat|vorinostat|mesh-list
55848778|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55848801|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55848802|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55848803|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848804|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
55848805|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
55848806|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848807|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
55848808|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
55848809|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
55848810|NCT01452724|Lansoprazole|lansoprazole|mesh-list
55848811|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
55848812|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55848813|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55848814|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55848815|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848816|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848817|NCT02620072|Insulin|insulin|mesh-list
55848818|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55848819|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848820|NCT01452880|Remifentanil|remifentanil|mesh-list
55848821|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55848822|NCT01452880|Narcotics|narcotics|mesh-ancestor
55848823|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55848824|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848825|NCT01452880|Analgesics|analgesics|mesh-ancestor
55848826|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
55848827|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218743|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56218744|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218745|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56218746|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56218748|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
56218749|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218750|NCT01638780|Protective Agents|protective agents|mesh-ancestor
56218751|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218752|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218753|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55848828|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
55848829|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55848830|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55848867|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848868|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848870|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55848871|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55848902|NCT02864914|Empagliflozin|empagliflozin|mesh-list
55848903|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55889864|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55848904|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55848905|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848906|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55848907|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848908|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
55848909|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848910|NCT04840264|Docetaxel|docetaxel|mesh-list
55848911|NCT04840264|Fluorouracil|fluorouracil|mesh-list
55848912|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
55848913|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848943|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55848944|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848945|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55848946|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848947|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
55848948|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55848949|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
55848950|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848952|NCT04840342|Diuretics|diuretics|mesh-ancestor
55848953|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
55848954|NCT02849470|Complement Factor H|complement factor h|mesh-list
55848955|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55848992|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55848993|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55849030|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849031|NCT02819596|Durvalumab|durvalumab|mesh-list
55849032|NCT02819596|Tremelimumab|tremelimumab|mesh-list
55849059|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55849060|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849061|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849062|NCT05586568|Itraconazole|itraconazole|mesh-list
55763880|NCT03496779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849063|NCT05586568|Rifampin|rifampin|mesh-list
55849064|NCT05586568|Esomeprazole|esomeprazole|mesh-list
55849065|NCT05586568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55849066|NCT05586568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55849067|NCT05586568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55849068|NCT05586568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849069|NCT05586568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849070|NCT05586568|Antifungal Agents|antifungal agents|mesh-ancestor
56218754|NCT01638858|Ranibizumab|ranibizumab|mesh-list
56218755|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56218756|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56218757|NCT01638858|Growth Substances|growth substances|mesh-ancestor
56218758|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218759|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
56218760|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218761|NCT01638936|Maytansine|maytansine|mesh-list
56218762|NCT01638936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849071|NCT05586568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849072|NCT05586568|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55849073|NCT05586568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55849074|NCT05586568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55849075|NCT05586568|Hormone Antagonists|hormone antagonists|mesh-ancestor
55849076|NCT05586568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849100|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849101|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849102|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849103|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849104|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55849105|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
55849106|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
55849107|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849108|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849109|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
55849110|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849111|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849112|NCT02632708|Analgesics|analgesics|mesh-ancestor
55849113|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
55849114|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849115|NCT02624908|Canagliflozin|canagliflozin|mesh-list
55849116|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55849117|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849118|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55811768|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849120|NCT02614534|Mitomycins|mitomycins|mesh-list
55849121|NCT02614534|Mitomycin|mitomycin|mesh-list
55849122|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849123|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849124|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
55849125|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849157|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849158|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
55849159|NCT02556424|Dexamethasone|dexamethasone|mesh-list
55849160|NCT02556424|Triamcinolone|triamcinolone|mesh-list
55849161|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849162|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
55849163|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
55849164|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849165|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849166|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55849167|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
55849168|NCT02556424|Hormones|hormones|mesh-ancestor
55849169|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849170|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849171|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849174|NCT02543944|Buprenorphine|buprenorphine|mesh-list
55849176|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55849177|NCT02543944|Narcotics|narcotics|mesh-ancestor
55849178|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55849179|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849180|NCT02543944|Analgesics|analgesics|mesh-ancestor
55849181|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
55849182|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849183|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55849184|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
55849185|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55849186|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55849187|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55849188|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55849189|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55849190|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849191|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849192|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
55849193|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55849194|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55849195|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
55849196|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
55849197|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55785425|NCT05730413|Autonomic Agents|autonomic agents|mesh-ancestor
55785426|NCT05730413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849198|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55849199|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55849200|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
55849201|NCT02538484|Letrozole|letrozole|mesh-list
55849202|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849203|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55849204|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55849205|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849206|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849207|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55849208|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
55849209|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849210|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849211|NCT02531308|Metformin|metformin|mesh-list
55849212|NCT02531308|Prednisone|prednisone|mesh-list
55849213|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
55849214|NCT02531308|Rituximab|rituximab|mesh-list
55849215|NCT02531308|Doxorubicin|doxorubicin|mesh-list
55849216|NCT02531308|Vincristine|vincristine|mesh-list
55849217|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849218|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
55849219|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811773|NCT01632345|Efavirenz|efavirenz|mesh-list
55849221|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55849223|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849224|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849225|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55849226|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849227|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55849228|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849229|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849230|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849231|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849232|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849233|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
55849234|NCT02531308|Hormones|hormones|mesh-ancestor
55849235|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849236|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849237|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849238|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
55849239|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849240|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
55849241|NCT02523976|Cytarabine|cytarabine|mesh-list
55849242|NCT02523976|Dexamethasone|dexamethasone|mesh-list
55849243|NCT02523976|Prednisone|prednisone|mesh-list
55849244|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
55849277|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55849279|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849280|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849281|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849282|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
55849283|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849284|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
56218763|NCT01638936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218764|NCT01638936|Tubulin Modulators|tubulin modulators|mesh-ancestor
56218765|NCT01638936|Antimitotic Agents|antimitotic agents|mesh-ancestor
56218766|NCT01638936|Mitosis Modulators|mitosis modulators|mesh-ancestor
56218767|NCT01638936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218768|NCT01638962|Acetaminophen|acetaminophen|mesh-list
56218769|NCT01638962|Aspirin|aspirin|mesh-list
56218770|NCT01638962|Ibuprofen|ibuprofen|mesh-list
56218771|NCT01638962|Celecoxib|celecoxib|mesh-list
56218772|NCT01638962|Diclofenac|diclofenac|mesh-list
56218773|NCT01638962|Naproxen|naproxen|mesh-list
56218774|NCT01638962|Indomethacin|indomethacin|mesh-list
56218775|NCT01638962|Etoricoxib|etoricoxib|mesh-list
56218776|NCT01638962|Meloxicam|meloxicam|mesh-list
56218777|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56218778|NCT01638962|Etodolac|etodolac|mesh-list
56218779|NCT01638962|Lornoxicam|lornoxicam|mesh-list
56218780|NCT01638962|Nabumetone|nabumetone|mesh-list
55849285|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849286|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
55849287|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849288|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55849315|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
55849316|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849317|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849318|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
55849319|NCT02495896|Gemcitabine|gemcitabine|mesh-list
55849320|NCT02495896|Paclitaxel|paclitaxel|mesh-list
55849321|NCT02495896|Docetaxel|docetaxel|mesh-list
55849322|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55849324|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849325|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849326|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
55849327|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849328|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
55849329|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849330|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55849331|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
55849332|NCT02495896|Antiviral Agents|antiviral agents|mesh-ancestor
55849333|NCT02495896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849334|NCT02495896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849335|NCT02495896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849336|NCT02495896|Immunologic Factors|immunologic factors|mesh-ancestor
55849337|NCT02495896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849338|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55849340|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55849370|NCT02466334|Calcitonin|calcitonin|mesh-list
55849371|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
55849372|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55849373|NCT02466334|Katacalcin|katacalcin|mesh-list
55849374|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55849375|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849376|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55849377|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
55849378|NCT02460874|Glyburide|glyburide|mesh-list
55849379|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55849380|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849381|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
55849382|NCT02443324|Ramucirumab|ramucirumab|mesh-list
55849383|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849408|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
55849409|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849410|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
56218781|NCT01638962|Tenoxicam|tenoxicam|mesh-list
56218782|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
56218783|NCT01638962|Analgesics|analgesics|mesh-list
55849411|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849412|NCT02420314|Vitamins|vitamins|mesh-ancestor
55849413|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
55849414|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849415|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
55849416|NCT02420314|Protective Agents|protective agents|mesh-ancestor
55849417|NCT02403778|Ipilimumab|ipilimumab|mesh-list
55849418|NCT02403778|Tretinoin|tretinoin|mesh-list
55849419|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849420|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849421|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55849422|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849423|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
55849424|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
55849425|NCT01539291|Idelalisib|idelalisib|mesh-list
55849426|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849427|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849428|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849429|NCT04746040|Fluticasone|fluticasone|mesh-list
55849430|NCT04746040|Xhance|xhance|mesh-list
55849431|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55849432|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55849436|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849437|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849438|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55849465|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849467|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849468|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849469|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849470|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849471|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849472|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849473|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
55849474|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849475|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
55849477|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
55849478|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55849479|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55849480|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55849481|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849482|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785427|NCT05730413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849483|NCT02363374|Leucovorin|leucovorin|mesh-list
55849484|NCT02363374|Folic Acid|folic acid|mesh-list
55849485|NCT02363374|Fluorouracil|fluorouracil|mesh-list
55849486|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
55849487|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
55849488|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
55849517|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849518|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849519|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849520|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849521|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849522|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849523|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55849524|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55849526|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55849527|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55849528|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55849529|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849530|NCT02297698|Trastuzumab|trastuzumab|mesh-list
55849531|NCT02297698|Sargramostim|sargramostim|mesh-list
55849532|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849533|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849534|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
55849535|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849536|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
55849537|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849571|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218785|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
56218786|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218787|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218788|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
55849572|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55849573|NCT02285140|Vancomycin|vancomycin|mesh-list
55849596|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849597|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55849598|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
55849599|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55849600|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849601|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849602|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849603|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849604|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849605|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849606|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
55849607|NCT04767633|Analgesics|analgesics|mesh-ancestor
55849608|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
55849609|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849610|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849611|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
55849612|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55849613|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55849615|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55849616|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55849617|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849618|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55849619|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
55849620|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55849622|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55849623|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
55849624|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849655|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849656|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
55849657|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849658|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55849659|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849660|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55849661|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55849662|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55849663|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
55849664|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849665|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55849666|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55785428|NCT05730413|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55785429|NCT05730413|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55785430|NCT05730413|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55849667|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849668|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
55849669|NCT01536561|Antibodies|antibodies|mesh-list
55849701|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
55849702|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849703|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849704|NCT04409691|Sirolimus|sirolimus|mesh-list
55849705|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55849706|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849707|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849708|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849709|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
55849745|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55849746|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55849747|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849748|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
55849749|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
55849750|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56218789|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56218790|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56218791|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56218792|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55849785|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849786|NCT01514344|Rituximab|rituximab|mesh-list
55849787|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849788|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849789|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
55849790|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849817|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849818|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849819|NCT01536015|Rotigotine|rotigotine|mesh-list
55849820|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
55849821|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
55849822|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849823|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849824|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849825|NCT01865110|Prednisone|prednisone|mesh-list
55849826|NCT01865110|Rituximab|rituximab|mesh-list
55849827|NCT01865110|Lenalidomide|lenalidomide|mesh-list
55849828|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
55849829|NCT01865110|Vincristine|vincristine|mesh-list
55849830|NCT01865110|Doxorubicin|doxorubicin|mesh-list
55849831|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849832|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849833|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
55849834|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849835|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849836|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55849837|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55849838|NCT01865110|Growth Substances|growth substances|mesh-ancestor
55849868|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849871|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849872|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
55849873|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
55849874|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849875|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849876|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55849877|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
55849878|NCT01464034|Hormones|hormones|mesh-ancestor
55849879|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849880|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849881|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849882|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
55849912|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55849913|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55849915|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
55849916|NCT01810588|Rituximab|rituximab|mesh-list
55849917|NCT01810588|Fludarabine|fludarabine|mesh-list
55785432|NCT05730413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849918|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
55849919|NCT01810588|Melphalan|melphalan|mesh-list
55849920|NCT01810588|Tacrolimus|tacrolimus|mesh-list
55849921|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55849922|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
55849923|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849924|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849925|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
55849926|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849960|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55849961|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
55849962|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849963|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849964|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
55849965|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849985|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55849986|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
55849987|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849988|NCT01894360|Belimumab|belimumab|mesh-list
56218793|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218794|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218795|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56218796|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
55849989|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849990|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
55849991|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849993|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849994|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849995|NCT01407562|Paclitaxel|paclitaxel|mesh-list
55849996|NCT01407562|Carboplatin|carboplatin|mesh-list
55849997|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849998|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849999|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
55850000|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
55850001|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
55850002|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850003|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55850004|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
55850005|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850006|NCT01393522|Milnacipran|milnacipran|mesh-list
55850007|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
55850008|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55850009|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55850010|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55850011|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850012|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850013|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850014|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55850015|NCT01393522|Analgesics|analgesics|mesh-ancestor
55850016|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
55850017|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850018|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
55850019|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55850020|NCT02086786|Risperidone|risperidone|mesh-list
55850021|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55850056|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55850058|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55850059|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55850060|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55850061|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55850062|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850063|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
55850077|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
55850078|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55850079|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55850080|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55850081|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55850082|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
55850083|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850084|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850086|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850087|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785433|NCT05730413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785435|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55850088|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850089|NCT01895296|Pasireotide|pasireotide|mesh-list
55850090|NCT01895296|Hormones|hormones|mesh-ancestor
55850091|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850092|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850093|NCT01276600|Tenofovir|tenofovir|mesh-list
55850094|NCT01276600|Emtricitabine|emtricitabine|mesh-list
55850095|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
55850096|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850097|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56218797|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56218798|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56218799|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56218800|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
56218801|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56218802|NCT01638988|Metformin|metformin|mesh-list
56218803|NCT01638988|Clomiphene|clomiphene|mesh-list
56218804|NCT01638988|Enclomiphene|enclomiphene|mesh-list
56218805|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
55850098|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55850099|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850100|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850101|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55850102|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55850103|NCT02040376|Metformin|metformin|mesh-list
55850104|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55850105|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850106|NCT04755868|Talazoparib|talazoparib|mesh-list
55850107|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55850108|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850109|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850110|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850111|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55850112|NCT05228314|Vaccines|vaccines|mesh-list
55793315|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
55850113|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
55850114|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
55850115|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850116|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55850117|NCT05228314|Antacids|antacids|mesh-ancestor
55850118|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850119|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850120|NCT01659658|Thalidomide|thalidomide|mesh-list
55850121|NCT01659658|Dexamethasone|dexamethasone|mesh-list
55850122|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
55850123|NCT01659658|Melphalan|melphalan|mesh-list
55850158|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850159|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55850160|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850161|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55850162|NCT01621906|Alovudine|alovudine|mesh-list
55850163|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
55850200|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55850225|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850226|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850227|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850229|NCT01209364|Hormones|hormones|mesh-ancestor
55850230|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850231|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55850232|NCT01209364|Protective Agents|protective agents|mesh-ancestor
55850235|NCT05080192|Fenofibrate|fenofibrate|mesh-list
55850236|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55850237|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
55850238|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850239|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55850240|NCT00479128|Gemcitabine|gemcitabine|mesh-list
55850241|NCT00479128|Doxorubicin|doxorubicin|mesh-list
55850242|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55850243|NCT00479128|Bortezomib|bortezomib|mesh-list
55850244|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850246|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850247|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850248|NCT00479128|Antiviral Agents|antiviral agents|mesh-ancestor
55850249|NCT00479128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850250|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785436|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785437|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218806|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56218807|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218808|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56218809|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
56218810|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56218811|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56218812|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
56218813|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55850286|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850288|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850289|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850327|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
55850328|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850351|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850352|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850353|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55850354|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55850355|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55850356|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55850357|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850358|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850359|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850360|NCT00425230|Analgesics|analgesics|mesh-ancestor
55850361|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
55850362|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850363|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
55850364|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55850365|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
55850367|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55850369|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
55850370|NCT00412594|Antibodies|antibodies|mesh-list
55850371|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
55850372|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55850373|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
55850374|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850375|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850376|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55850377|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850378|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850379|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
55850380|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850381|NCT00410956|Dexamethasone|dexamethasone|mesh-list
55850406|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55850407|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850408|NCT04634578|Bevacizumab|bevacizumab|mesh-list
55850409|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55850410|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850411|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55850412|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55850413|NCT04634578|Growth Substances|growth substances|mesh-ancestor
55850414|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850415|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
55850416|NCT04564612|Itraconazole|itraconazole|mesh-list
55850417|NCT04564612|Rabeprazole|rabeprazole|mesh-list
55850418|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
55850419|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850420|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55850423|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850424|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55850425|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
55850426|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56218814|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55794870|NCT03066427|Growth Substances|growth substances|mesh-ancestor
55850427|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850428|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55850429|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55850430|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850461|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850462|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850464|NCT01506609|Carboplatin|carboplatin|mesh-list
55850465|NCT01506609|Temozolomide|temozolomide|mesh-list
55850466|NCT01506609|Veliparib|veliparib|mesh-list
55850467|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55850468|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850469|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
55850470|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
55850471|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
55850472|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850473|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55850474|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
55850475|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55850476|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850500|NCT04389580|Isotretinoin|isotretinoin|mesh-list
55850501|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55850502|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
55850503|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850504|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850505|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55850506|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850507|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55850508|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55850509|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55850510|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
55850511|NCT00199108|Dexamethasone|dexamethasone|mesh-list
55850512|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55850513|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
55850514|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
55850515|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850516|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850517|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850520|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850521|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55850522|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850523|NCT01504971|Rabeprazole|rabeprazole|mesh-list
55850524|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55850525|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850526|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55850527|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850556|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
55850557|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850558|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850559|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850560|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850561|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
55850562|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55850563|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55850564|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850565|NCT00936832|Antidotes|antidotes|mesh-ancestor
55850566|NCT00936832|Protective Agents|protective agents|mesh-ancestor
55850567|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
55850568|NCT00936832|Vitamins|vitamins|mesh-ancestor
55850569|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
55850570|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55850571|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55850572|NCT00936832|Growth Substances|growth substances|mesh-ancestor
55850573|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
55811797|NCT02205333|Rituximab|rituximab|mesh-list
55850603|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55850605|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55850607|NCT02319304|Fluorouracil|fluorouracil|mesh-list
55850608|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
56218815|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56218817|NCT01639027|Analgesics|analgesics|mesh-ancestor
56218818|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
56218819|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218820|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218821|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
56218822|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
56218823|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
56218824|NCT01639066|Tenofovir|tenofovir|mesh-list
56218825|NCT01639066|Entecavir|entecavir|mesh-list
56218826|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
56218827|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218828|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56218829|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218830|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218831|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218832|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56218833|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56218834|NCT01639092|Tenofovir|tenofovir|mesh-list
56218835|NCT01639092|Entecavir|entecavir|mesh-list
56218836|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
56218837|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218838|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56218839|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218840|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218841|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218842|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56218843|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56218844|NCT01639261|Interferons|interferons|mesh-list
56218845|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
56218846|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850609|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
55850610|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850611|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850612|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850613|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850614|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
55850615|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850616|NCT02319304|Antidotes|antidotes|mesh-ancestor
55850617|NCT02319304|Protective Agents|protective agents|mesh-ancestor
55850618|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
55850619|NCT02319304|Vitamins|vitamins|mesh-ancestor
55850620|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
55785439|NCT04206059|Analgesics|analgesics|mesh-ancestor
56218848|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218849|NCT01639326|Irinotecan|irinotecan|mesh-list
56218850|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56218851|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56218852|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218853|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218854|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218855|NCT01639456|Aldesleukin|aldesleukin|mesh-list
56218856|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
56218857|NCT01639456|Fludarabine|fludarabine|mesh-list
56218858|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218859|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
56218860|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218861|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56218862|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56218863|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
56218864|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218865|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218866|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56218867|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56218868|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56218869|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
56218870|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218871|NCT01639521|Gemcitabine|gemcitabine|mesh-list
56218872|NCT01639521|Doxorubicin|doxorubicin|mesh-list
56218873|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56218874|NCT01639521|Methotrexate|methotrexate|mesh-list
56218875|NCT01639521|Vinblastine|vinblastine|mesh-list
56218876|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218877|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56218878|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
56218879|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218880|NCT01639521|Antiviral Agents|antiviral agents|mesh-ancestor
56218881|NCT01639521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850621|NCT00885664|Ritonavir|ritonavir|mesh-list
55850622|NCT00885664|Lopinavir|lopinavir|mesh-list
55850623|NCT00885664|Tenofovir|tenofovir|mesh-list
55850624|NCT00885664|Emtricitabine|emtricitabine|mesh-list
55850659|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55850660|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
56218882|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218883|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56218884|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
56218885|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218886|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56218887|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56218888|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56218889|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56218890|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
56218891|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55794942|NCT05115513|Dronabinol|dronabinol|mesh-list
55850662|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
55850680|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850681|NCT00878254|Leucovorin|leucovorin|mesh-list
55850682|NCT00878254|Cytarabine|cytarabine|mesh-list
55850683|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
55850684|NCT00878254|Ifosfamide|ifosfamide|mesh-list
55850685|NCT00878254|Rituximab|rituximab|mesh-list
55850686|NCT00878254|Doxorubicin|doxorubicin|mesh-list
55850687|NCT00878254|Methotrexate|methotrexate|mesh-list
55850688|NCT00878254|Etoposide|etoposide|mesh-list
55850689|NCT00878254|Vincristine|vincristine|mesh-list
55850690|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850691|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
55850692|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850693|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55850694|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55850695|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
55850696|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850697|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850698|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55850699|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55850700|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55850701|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55850702|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55850703|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850704|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55850705|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
55850706|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55850707|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850708|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
55850709|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
55850710|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55850711|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55850712|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55850713|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
55850714|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850715|NCT00878254|Antidotes|antidotes|mesh-ancestor
55850716|NCT00878254|Protective Agents|protective agents|mesh-ancestor
55850717|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
55850718|NCT00878254|Vitamins|vitamins|mesh-ancestor
55850736|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850737|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850739|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
55850740|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850741|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55850742|NCT03364348|Trastuzumab|trastuzumab|mesh-list
55850743|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55850745|NCT03364348|Antibodies|antibodies|mesh-list
55850746|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
55850747|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55850748|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
55850749|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
55850750|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
56218892|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
56218893|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56218894|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55850751|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850752|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850753|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55850754|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
55850755|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
55850756|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
55850757|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850758|NCT04782622|Apatinib|apatinib|mesh-list
55850759|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850760|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55850761|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850762|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785440|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
55785441|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785442|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55785443|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55850763|NCT04775212|Sevoflurane|sevoflurane|mesh-list
55850764|NCT04775212|Desflurane|desflurane|mesh-list
55850765|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55850766|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55850767|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
55850768|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
55850769|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850770|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850771|NCT04306900|Gemcitabine|gemcitabine|mesh-list
55850772|NCT04306900|Paclitaxel|paclitaxel|mesh-list
55850773|NCT04306900|Docetaxel|docetaxel|mesh-list
55850774|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55850775|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
55850776|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55850777|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850778|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
55850779|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
55850780|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
55850806|NCT04782076|Dabigatran|dabigatran|mesh-list
55850807|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
55850808|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55850809|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
55850810|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850811|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850812|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
55850813|NCT04782310|Pregabalin|pregabalin|mesh-list
55850814|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55850815|NCT04782310|Analgesics|analgesics|mesh-ancestor
55850816|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
55850817|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850818|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850819|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
55850820|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55850821|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55850822|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850823|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55850824|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55850825|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55850826|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850827|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55850853|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
55850854|NCT03300544|Vitamins|vitamins|mesh-ancestor
55850855|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
55850856|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55850857|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
55850858|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55850859|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55850860|NCT03249844|Prednisolone|prednisolone|mesh-list
55850861|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
55850862|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55850863|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
56218895|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218896|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56218897|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
56218898|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
56218899|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
56218900|NCT01639547|Ribavirin|ribavirin|mesh-list
56218902|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
56218903|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218904|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
56218905|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218906|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
56218907|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56218908|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218909|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
56218910|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55794954|NCT05115513|Hormones|hormones|mesh-ancestor
55850864|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55850867|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889865|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761348|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
55850868|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850869|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850870|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
55850871|NCT03249844|Hormones|hormones|mesh-ancestor
55850872|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850873|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55850874|NCT03249844|Protective Agents|protective agents|mesh-ancestor
55850875|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55850876|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850877|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
55850878|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55850880|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850881|NCT00637624|Expectorants|expectorants|mesh-ancestor
55850882|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
55850883|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55850884|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
55850885|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850886|NCT00637624|Protective Agents|protective agents|mesh-ancestor
55850887|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850888|NCT00637624|Antidotes|antidotes|mesh-ancestor
55850889|NCT01479465|Leucovorin|leucovorin|mesh-list
55850890|NCT01479465|Fluorouracil|fluorouracil|mesh-list
55850891|NCT01479465|Irinotecan|irinotecan|mesh-list
55850892|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
55850893|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850894|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850895|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850896|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850897|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
55850898|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850899|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55850900|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55850901|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850902|NCT01479465|Antidotes|antidotes|mesh-ancestor
55850903|NCT01479465|Protective Agents|protective agents|mesh-ancestor
55850904|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
55850905|NCT01479465|Vitamins|vitamins|mesh-ancestor
55850906|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
55850907|NCT02428192|Nivolumab|nivolumab|mesh-list
55850908|NCT02428192|Ipilimumab|ipilimumab|mesh-list
56052266|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
55850909|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55850910|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218911|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56218912|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
56218913|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794956|NCT01672801|Nimodipine|nimodipine|mesh-list
55850911|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55850912|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850913|NCT04781686|Docetaxel|docetaxel|mesh-list
55850914|NCT04781686|Apatinib|apatinib|mesh-list
55850915|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850916|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
55850917|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
55850918|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
55850919|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850920|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55850921|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850922|NCT02390284|Timolol|timolol|mesh-list
55850923|NCT02390284|Bimatoprost|bimatoprost|mesh-list
55850924|NCT02390284|Travoprost|travoprost|mesh-list
55850925|NCT02390284|Dorzolamide|dorzolamide|mesh-list
55850926|NCT02390284|Acetazolamide|acetazolamide|mesh-list
55850927|NCT02390284|Methazolamide|methazolamide|mesh-list
55850928|NCT02390284|Latanoprost|latanoprost|mesh-list
55850929|NCT02390284|Brinzolamide|brinzolamide|mesh-list
55850930|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55850931|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55850932|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
55850933|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850934|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850935|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850936|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55850937|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55850938|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55850939|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55850940|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
55850941|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55850942|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850944|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
55850946|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850947|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
55850948|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
55850949|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
55850950|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850951|NCT04780984|Bromides|bromides|mesh-list
55850952|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
55850953|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55850954|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
55850955|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850956|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785445|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
55785446|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850985|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850986|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55850987|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850989|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
55850990|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850991|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55850992|NCT04389424|Tamoxifen|tamoxifen|mesh-list
55850993|NCT04389424|Anastrozole|anastrozole|mesh-list
55850994|NCT04389424|Exemestane|exemestane|mesh-list
55850995|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55850996|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
55850997|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850998|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850999|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55851000|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851001|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55851002|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55851003|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55851004|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55851040|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811825|NCT02230527|Ticagrelor|ticagrelor|mesh-list
55851042|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55851075|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55851076|NCT00058240|Alvocidib|alvocidib|mesh-list
56218914|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218915|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218916|NCT01639794|Urological Agents|urological agents|mesh-ancestor
56218917|NCT01639807|Latanoprost|latanoprost|mesh-list
56218918|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56218919|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55851077|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851078|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851079|NCT00058240|Growth Substances|growth substances|mesh-ancestor
55851080|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851081|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851082|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851083|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851084|NCT00060346|Prednisone|prednisone|mesh-list
55851085|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
55851086|NCT00060346|Rituximab|rituximab|mesh-list
55851101|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55851102|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55851104|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851105|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
55851106|NCT00060346|Hormones|hormones|mesh-ancestor
55851107|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851108|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55851109|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55851110|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
55851111|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
55851112|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
55851113|NCT03026907|Azathioprine|azathioprine|mesh-list
55851114|NCT03026907|Alitretinoin|alitretinoin|mesh-list
55851115|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851116|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
55851117|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
55851118|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851119|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851120|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851121|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
55851122|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851123|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851124|NCT00060424|Cyclosporine|cyclosporine|mesh-list
55851125|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
55851126|NCT00060424|Fludarabine|fludarabine|mesh-list
55851130|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851131|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
55851132|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851133|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851134|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
55851135|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851136|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851137|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
55851138|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785447|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785448|NCT04132817|Paclitaxel|paclitaxel|mesh-list
55785449|NCT04132817|Nivolumab|nivolumab|mesh-list
55851139|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
55851140|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851141|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55851142|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55851143|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55851144|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
55851168|NCT05605756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851169|NCT05605756|Cholinergic Agents|cholinergic agents|mesh-ancestor
55851170|NCT05605756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851171|NCT00153166|Pioglitazone|pioglitazone|mesh-list
55851172|NCT00153166|Atorvastatin|atorvastatin|mesh-list
55851173|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55851174|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55851175|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
55851176|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851177|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55851178|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55851179|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851180|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55851181|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851182|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
55851183|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55851184|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55851185|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55851186|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55851187|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851188|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
55851189|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851190|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851191|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55851192|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851193|NCT01475721|Fluticasone|fluticasone|mesh-list
55851195|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55851196|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55851202|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
55851204|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851205|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
55851206|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851207|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
55851208|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55851209|NCT00065806|Atorvastatin|atorvastatin|mesh-list
55851210|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55851211|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55851212|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
55851213|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851214|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55851215|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55851216|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851217|NCT05152888|Evolocumab|evolocumab|mesh-list
55851218|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55851219|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55851220|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
55851221|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851222|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55851223|NCT00068770|Celecoxib|celecoxib|mesh-list
55851225|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55851226|NCT00068770|Analgesics|analgesics|mesh-ancestor
55851227|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
55851228|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851229|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851230|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851231|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56052267|NCT03351933|Antibodies|antibodies|mesh-list
55851232|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55851233|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55851234|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785451|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55785452|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785453|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
55785454|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
55851235|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851236|NCT01475331|Ethanol|ethanol|mesh-list
55851237|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55851238|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851239|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851240|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851241|NCT01500213|Dexamethasone|dexamethasone|mesh-list
55851242|NCT01500213|Granisetron|granisetron|mesh-list
55851243|NCT01500213|Rolapitant|rolapitant|mesh-list
55851244|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851245|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
55851246|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
55851247|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851248|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851249|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55851250|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
55851251|NCT01500213|Hormones|hormones|mesh-ancestor
56218920|NCT01639885|Interferons|interferons|mesh-list
56218921|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
56218922|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
56218923|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218924|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
56218925|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218926|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
56218927|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218928|NCT01639898|Dexamethasone|dexamethasone|mesh-list
56218929|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
56218930|NCT01639898|Lenalidomide|lenalidomide|mesh-list
56218931|NCT01639898|BB 1101|bb 1101|mesh-list
56218932|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56218933|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
56218934|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
56218935|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851252|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851253|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55851254|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851255|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55851256|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
55851257|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851258|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851259|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55851260|NCT00069160|Docetaxel|docetaxel|mesh-list
55851261|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
55851262|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851263|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
55851264|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
55851265|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
55851281|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
55851282|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
55851283|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851284|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851285|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
55851286|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851287|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55851288|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55851289|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55851290|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55851291|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851292|NCT00072514|Gemcitabine|gemcitabine|mesh-list
55851293|NCT00072514|Dexamethasone|dexamethasone|mesh-list
55851294|NCT00072514|Rituximab|rituximab|mesh-list
55851295|NCT00072514|Carboplatin|carboplatin|mesh-list
55851296|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851297|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851298|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
55851299|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851300|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851301|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851302|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
55851303|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
55851304|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851305|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55851306|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
55851307|NCT00072514|Hormones|hormones|mesh-ancestor
55851308|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851310|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851311|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
56218936|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218938|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
56218939|NCT01639898|Hormones|hormones|mesh-ancestor
56218940|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56218941|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56218942|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218943|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
55851312|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851313|NCT00072514|Antiviral Agents|antiviral agents|mesh-ancestor
55785455|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
55789072|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851314|NCT00072514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851315|NCT00072514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851316|NCT00072514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851317|NCT00074308|Bevacizumab|bevacizumab|mesh-list
55851318|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55851319|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
55851320|NCT00074308|Antibodies|antibodies|mesh-list
55851321|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
55851322|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55851323|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851324|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55851351|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851352|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55851353|NCT01474551|Vemurafenib|vemurafenib|mesh-list
55851354|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851355|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851356|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851357|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851358|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55851359|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55851360|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851361|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851362|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
55851363|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851364|NCT00168298|Dexamethasone|dexamethasone|mesh-list
55851365|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
55851366|NCT00168298|BB 1101|bb 1101|mesh-list
55851367|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851368|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
55851369|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
55851370|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851387|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851388|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851389|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
55851390|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851391|NCT00078754|Valproic Acid|valproic acid|mesh-list
55851392|NCT00078754|Fluoxetine|fluoxetine|mesh-list
55851393|NCT00078754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55851394|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55851395|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55851396|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851397|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851398|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
55851399|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851400|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55851401|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
55851402|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55851403|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55851404|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55851405|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851406|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
55851407|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
56218944|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218945|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218946|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
56218947|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56218948|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56218949|NCT01639898|Growth Substances|growth substances|mesh-ancestor
55794990|NCT05169957|Nivolumab|nivolumab|mesh-list
55851408|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
55851409|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55851410|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851411|NCT00081328|Metformin|metformin|mesh-list
55851412|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
55851413|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55811830|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
55851414|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851415|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
55851416|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55851417|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851418|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55851419|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
55851421|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851422|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851423|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851424|NCT00083122|Cisplatin|cisplatin|mesh-list
55785456|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851425|NCT00083122|Alvocidib|alvocidib|mesh-list
55851426|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851455|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55851456|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55851457|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
55851458|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
55851459|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851460|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55851461|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55851462|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
55851463|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55851464|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55851465|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
55851466|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55851467|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55851468|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55851469|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55851470|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851505|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55851507|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
55851508|NCT01898182|Growth Substances|growth substances|mesh-ancestor
55851509|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851510|NCT01499199|Dolutegravir|dolutegravir|mesh-list
55851541|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
55851542|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851544|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851545|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55851546|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
55851547|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55851548|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
55851549|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55851550|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851551|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55851552|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55851553|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851554|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55851555|NCT01897012|Romidepsin|romidepsin|mesh-list
55851579|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55851580|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851581|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
55851582|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851584|NCT01472835|Midazolam|midazolam|mesh-list
56218950|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
56218951|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
56218952|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56218953|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56218954|NCT01640743|Prednisolone|prednisolone|mesh-list
55851585|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55851586|NCT01472835|Narcotics|narcotics|mesh-ancestor
55761362|NCT05619315|Antidotes|antidotes|mesh-ancestor
55851587|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851588|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851589|NCT01472835|Analgesics|analgesics|mesh-ancestor
55851590|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
55851591|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851592|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55851593|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55851594|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
55851596|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55851597|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55851598|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55851599|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55851601|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
55851602|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851603|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851604|NCT00185692|Acetaminophen|acetaminophen|mesh-list
55851635|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
55851636|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55851637|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851638|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55851639|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
55851640|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55851641|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851642|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
55851643|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
55851644|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55785457|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851645|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
55851647|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851648|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55851649|NCT00185692|Protective Agents|protective agents|mesh-ancestor
55851650|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55851683|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851684|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56052268|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
55851685|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55851686|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55851687|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55851688|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55851689|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55851691|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
55851692|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55851693|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851694|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55851695|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851696|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
55851724|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
55851725|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
55851727|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55851728|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851729|NCT00006244|Interferons|interferons|mesh-list
55851730|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
55851731|NCT00006244|Aldesleukin|aldesleukin|mesh-list
55851732|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
55851733|NCT00006244|Melphalan|melphalan|mesh-list
55851734|NCT00006244|Interleukin-2|interleukin-2|mesh-list
55851735|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851736|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
55851737|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851738|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55851739|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
55851740|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851741|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56218955|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
56218956|NCT01640743|Everolimus|everolimus|mesh-list
56218957|NCT01640743|Tacrolimus|tacrolimus|mesh-list
56218958|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56218959|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
56218960|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55794996|NCT05611463|Docetaxel|docetaxel|mesh-list
55851742|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851743|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
55851744|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851745|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55851746|NCT00006244|Analgesics|analgesics|mesh-ancestor
55851765|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
55851766|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851767|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
55851768|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851769|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851770|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55851771|NCT01496469|Febuxostat|febuxostat|mesh-list
55851772|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
55851773|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851774|NCT00189436|Budesonide|budesonide|mesh-list
55851775|NCT00189436|Albuterol|albuterol|mesh-list
55851776|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764018|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55851777|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55851778|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
55851779|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851780|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851781|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55851782|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
55851783|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
55851784|NCT00189436|Hormones|hormones|mesh-ancestor
55851785|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851786|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
55851787|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55851788|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55851789|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55851790|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55851791|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
55851792|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851796|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851797|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
55785458|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55785460|NCT04118387|Zolpidem|zolpidem|mesh-list
55785461|NCT04118387|Buspirone|buspirone|mesh-list
55851798|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851799|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851800|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851801|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851802|NCT01525407|Atorvastatin|atorvastatin|mesh-list
55851803|NCT01525407|Calcium|calcium|mesh-list
55851834|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55851835|NCT00011986|Topotecan|topotecan|mesh-list
55851836|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55851837|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851838|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
55851839|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
55851840|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
55851841|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851842|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851843|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
55851844|NCT00011986|Antiviral Agents|antiviral agents|mesh-ancestor
55851845|NCT00011986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851846|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851901|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
55851902|NCT01469637|Mesalamine|mesalamine|mesh-list
55851903|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851904|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55851905|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55851906|NCT01469637|Analgesics|analgesics|mesh-ancestor
55851907|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
56218961|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
56218962|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56218963|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56218964|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218965|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218966|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218967|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56218968|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
56218969|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
56218970|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56218971|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56218972|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
55851908|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717141|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55851909|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717142|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55717143|NCT03519061|Budesonide|budesonide|mesh-list
55717144|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717145|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55717146|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
55717147|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717148|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717149|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55717150|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
55717151|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
55717152|NCT03519061|Hormones|hormones|mesh-ancestor
55717153|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55717154|NCT02229773|Pravastatin|pravastatin|mesh-list
55717155|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55851910|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851911|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851912|NCT04409223|Sunitinib|sunitinib|mesh-list
55851913|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851914|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55851915|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55851916|NCT04409223|Growth Substances|growth substances|mesh-ancestor
55851917|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851918|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851919|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851920|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851921|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851922|NCT00012298|Rituximab|rituximab|mesh-list
55851923|NCT00012298|Oprelvekin|oprelvekin|mesh-list
55851924|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55851925|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851926|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851927|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
55851928|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851929|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851930|NCT00193258|Bevacizumab|bevacizumab|mesh-list
55851931|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55851932|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
55851933|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851934|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851935|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55851936|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55851966|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
55851967|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55851968|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851969|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55851970|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
55851971|NCT02096458|Lansoprazole|lansoprazole|mesh-list
55851972|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55851973|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55851974|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55851975|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851978|NCT00194896|Glyburide|glyburide|mesh-list
55851979|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55785462|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55785463|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55785464|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785465|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851980|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851981|NCT04348474|Azithromycin|azithromycin|mesh-list
55851982|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
55851983|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55852017|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56218973|NCT01640743|Hormones|hormones|mesh-ancestor
56218974|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56218975|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56218976|NCT01640743|Protective Agents|protective agents|mesh-ancestor
56218977|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56218979|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56218980|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56218981|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56218982|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218983|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
56218984|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56218985|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55795016|NCT05475041|Liver Extracts|liver extracts|mesh-list
55852019|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55852020|NCT00200902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55852021|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55852022|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55852043|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852044|NCT00201760|Antiviral Agents|antiviral agents|mesh-ancestor
55852045|NCT00201760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852046|NCT00201760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852047|NCT00201760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852048|NCT00201760|Immunologic Factors|immunologic factors|mesh-ancestor
55852049|NCT00201760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852050|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852052|NCT00201838|Etanercept|etanercept|mesh-list
55852053|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852054|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
55852055|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852056|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852057|NCT00201838|Antiviral Agents|antiviral agents|mesh-ancestor
55852058|NCT00201838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852059|NCT00201838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852060|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852061|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
55852062|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717156|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55717157|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
55717158|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717159|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55717160|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55717161|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717162|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
55717163|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
55717164|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55717165|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717166|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717167|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
55717168|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55717169|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717170|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717171|NCT03515707|Etoposide|etoposide|mesh-list
55717172|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
55717173|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
55717174|NCT03515707|Busulfan|busulfan|mesh-list
55717175|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55717176|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717181|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
55717182|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717183|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
55717184|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717185|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55717186|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55717187|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
55717188|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
55717189|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
55717190|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
55717191|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
55717192|NCT02298205|Beclomethasone|beclomethasone|mesh-list
55717193|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717195|NCT02298205|Hormones|hormones|mesh-ancestor
55717196|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55852063|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55852064|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55852065|NCT00201838|Analgesics|analgesics|mesh-ancestor
55852066|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
55852067|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852068|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55852069|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852070|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55852071|NCT00040846|Cyclosporine|cyclosporine|mesh-list
55852072|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
55852073|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55852074|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
55852076|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
55852077|NCT00040846|Antibodies|antibodies|mesh-list
55852078|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
55852079|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55852080|NCT00040846|Cyclosporins|cyclosporins|mesh-list
55852081|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
55852082|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852083|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852084|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852085|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
55852086|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218986|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56218987|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56218988|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55852087|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852088|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852089|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
55852090|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852091|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
55852092|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852093|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55852094|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55852095|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55852096|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
55852097|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55852098|NCT00041938|Aspirin|aspirin|mesh-list
55785466|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55785467|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
55785468|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
55852100|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55852101|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55852102|NCT00041938|Analgesics|analgesics|mesh-ancestor
55852103|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
55852104|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852105|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852106|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55852107|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852108|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55852109|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55852110|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852111|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55852112|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55852113|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852114|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
55852115|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
55852116|NCT00202930|Rituximab|rituximab|mesh-list
55852117|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852118|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852119|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
55852120|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852121|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852122|NCT00044044|Haloperidol|haloperidol|mesh-list
55852123|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
55852124|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55852125|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
55852126|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
55852127|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852128|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852129|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55852130|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55852131|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55852132|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852133|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852134|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55852135|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
55852136|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852137|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852138|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55852139|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55852140|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55852141|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55852142|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
55852143|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55852144|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55852145|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
55852146|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55852147|NCT00112918|Leucovorin|leucovorin|mesh-list
55852148|NCT00112918|Bevacizumab|bevacizumab|mesh-list
55852149|NCT00112918|Fluorouracil|fluorouracil|mesh-list
55852150|NCT00112918|Capecitabine|capecitabine|mesh-list
55852178|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55852179|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56218989|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56218990|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56218991|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56218992|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
56218993|NCT01641718|Coagulants|coagulants|mesh-ancestor
56218994|NCT01642771|Docetaxel|docetaxel|mesh-list
56218995|NCT01642771|Fluorouracil|fluorouracil|mesh-list
56218996|NCT01642771|Capecitabine|capecitabine|mesh-list
55852181|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55852182|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55852183|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
55852184|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55852185|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852186|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55852187|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55852188|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55852189|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55852190|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852191|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55852192|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55852193|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852194|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785469|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852233|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55852234|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55852235|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55852237|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
55852238|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
55852239|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
55852240|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
55852241|NCT00049504|Fludarabine|fludarabine|mesh-list
55852242|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
55852268|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
55852269|NCT04499950|Naltrexone|naltrexone|mesh-list
55852270|NCT04499950|Bupropion|bupropion|mesh-list
55852271|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55852272|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55852273|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852274|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
55852275|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852276|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55852277|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
55852278|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852279|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55852280|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55852281|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55852282|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852283|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
55852284|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852285|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55852286|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55852287|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852288|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55852321|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852322|NCT00052078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55852323|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55852324|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55852325|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852326|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852327|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
55852328|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852329|NCT00119158|Fluticasone|fluticasone|mesh-list
55852331|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
55852357|NCT00119392|Cyclosporins|cyclosporins|mesh-list
56218997|NCT01642771|Epirubicin|epirubicin|mesh-list
56218998|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56218999|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
56219000|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
56219001|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
56219002|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219003|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
56219004|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219005|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219006|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
56219007|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219008|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56219009|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56219010|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56219011|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219012|NCT01642979|Cyclosporine|cyclosporine|mesh-list
56219013|NCT01642979|Levamisole|levamisole|mesh-list
56219014|NCT01642979|Cyclosporins|cyclosporins|mesh-list
56219015|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
56219016|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219017|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219018|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219019|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
55852358|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55852359|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852360|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852361|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
55852362|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852363|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852364|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852365|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
55852366|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852367|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852368|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852369|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
55852370|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852371|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
55852372|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55852373|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55852374|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55811870|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
55852375|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
55852376|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55852379|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
55852380|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55852381|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852382|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55852398|NCT00121186|Fludarabine|fludarabine|mesh-list
55852399|NCT00121186|Melphalan|melphalan|mesh-list
55852400|NCT00121186|Tacrolimus|tacrolimus|mesh-list
55852401|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55852402|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
55852403|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56219020|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219021|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
56219022|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219023|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
56219024|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219025|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56219026|NCT01642979|Hormones|hormones|mesh-ancestor
56219027|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219028|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56219029|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
56219030|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
56219031|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56219032|NCT01643031|Clopidogrel|clopidogrel|mesh-list
56219033|NCT01643031|Ticagrelor|ticagrelor|mesh-list
56219034|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56219035|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56219036|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56219037|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55852404|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852405|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852406|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
55852407|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852408|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852409|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
55852410|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852411|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55852412|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852413|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
55852414|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852415|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55852416|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55852417|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55852418|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
55852419|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55852420|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
55852421|NCT00121810|Sirolimus|sirolimus|mesh-list
55852422|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55852423|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55852424|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852425|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55852426|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
55852427|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55852428|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852429|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852430|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852431|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
55852432|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852433|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
55852434|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852435|NCT00053014|Cyclosporine|cyclosporine|mesh-list
55852436|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
55852437|NCT00053014|Fludarabine|fludarabine|mesh-list
55852438|NCT00053014|Cyclosporins|cyclosporins|mesh-list
55852439|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852440|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852441|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219038|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
56219039|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219040|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219041|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219042|NCT01643434|Clonidine|clonidine|mesh-list
56219043|NCT01643434|Spironolactone|spironolactone|mesh-list
55852458|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
55852459|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
55852460|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852461|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852462|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55852463|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55852464|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55852465|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
55852466|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852467|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852468|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
55852469|NCT00123604|Protective Agents|protective agents|mesh-ancestor
55852470|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55852471|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55852472|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55852473|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
55852474|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55852475|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55852477|NCT00221338|Analgesics|analgesics|mesh-ancestor
55852478|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
55852479|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852480|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785470|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852482|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55852483|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55852484|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852485|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852486|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55852487|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55852488|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852489|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852490|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
55852491|NCT00223678|Sirolimus|sirolimus|mesh-list
55852492|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55852493|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852494|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55852495|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852496|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
55852497|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852498|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
55852499|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852500|NCT00053482|Vaccines|vaccines|mesh-list
55852526|NCT00225784|Immunologic Factors|immunologic factors|mesh-ancestor
55852527|NCT00225784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852528|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852529|NCT02092168|Opicapone|opicapone|mesh-list
55852530|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55852531|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852532|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852533|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55852534|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55852535|NCT00133978|Selenium|selenium|mesh-list
55852536|NCT00133978|Antioxidants|antioxidants|mesh-list
55852537|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852538|NCT00133978|Protective Agents|protective agents|mesh-ancestor
55852539|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852540|NCT00133978|Trace Elements|trace elements|mesh-ancestor
55852541|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
56219044|NCT01643434|Analgesics|analgesics|mesh-ancestor
55852542|NCT01897324|Hormones|hormones|mesh-list
55852543|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55852544|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852545|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
55852546|NCT00254410|Rituximab|rituximab|mesh-list
55852547|NCT00254410|Fludarabine|fludarabine|mesh-list
55852548|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
55852549|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852550|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
55852606|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852607|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852608|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
55852609|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852610|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852611|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
55852612|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852613|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55852614|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852615|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
55852616|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852617|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55852618|NCT01493427|Travoprost|travoprost|mesh-list
55852619|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55852620|NCT01523457|Folfirinox|folfirinox|mesh-list
55852621|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852622|NCT01523301|Rotigotine|rotigotine|mesh-list
55852623|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
55852624|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
55852625|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852626|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852627|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852628|NCT01609556|Maytansine|maytansine|mesh-list
55852637|NCT01766336|Vitamins|vitamins|mesh-ancestor
55852638|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
55785472|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55785474|NCT04118387|Diuretics|diuretics|mesh-ancestor
55852641|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
55852642|NCT01797302|Vitamins|vitamins|mesh-ancestor
55852643|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
55852644|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852645|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55852646|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55852647|NCT01804946|Oseltamivir|oseltamivir|mesh-list
55852648|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
55852649|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852650|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852651|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852652|NCT01795898|Fentanyl|fentanyl|mesh-list
55852653|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55852654|NCT01795898|Narcotics|narcotics|mesh-ancestor
55852655|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852656|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852657|NCT01795898|Analgesics|analgesics|mesh-ancestor
55852658|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
55852659|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852660|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55852661|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55852662|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
55852663|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
55852664|NCT01736696|Tofacitinib|tofacitinib|mesh-list
55852665|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55852666|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852667|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852668|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
55852669|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55852670|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
55852671|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55852672|NCT01764464|Gabapentin|gabapentin|mesh-list
55852673|NCT01764464|Analgesics|analgesics|mesh-ancestor
55852674|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
55852675|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852676|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852677|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
55852678|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56219045|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
56219046|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219047|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852679|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55852680|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852681|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852682|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55852683|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55852684|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930024|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930025|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930026|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55930027|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930028|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55930029|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
55930030|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55930031|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
55930032|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930033|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930034|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55930035|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55930036|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
55930037|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
55930038|NCT01726725|Desflurane|desflurane|mesh-list
55852685|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852686|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
55852688|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
55852689|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852690|NCT01763918|Evolocumab|evolocumab|mesh-list
55852691|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55852692|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55852693|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
55852694|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852695|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55852696|NCT01606748|Gemcitabine|gemcitabine|mesh-list
55852697|NCT01606748|Necitumumab|necitumumab|mesh-list
55852724|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852725|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55852726|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
55852727|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55852728|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852729|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852730|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
55852731|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55852732|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55852733|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
55852734|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785475|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
55785476|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55785477|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55785478|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55785479|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55785481|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
55785482|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55785483|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55852736|NCT01759862|Protective Agents|protective agents|mesh-ancestor
55852737|NCT01790828|Factor VIII|factor viii|mesh-list
55852738|NCT01790828|Coagulants|coagulants|mesh-ancestor
55852739|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
55852740|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
55852741|NCT01790594|Abatacept|abatacept|mesh-list
55852742|NCT01790594|Tacrolimus|tacrolimus|mesh-list
55852743|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
55852744|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55852745|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852746|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
55852747|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852774|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
55852775|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
55852776|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
55852777|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55852778|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852779|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55930039|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55852780|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55852781|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852782|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55852783|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852784|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
55852785|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55852786|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
55852787|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55852788|NCT01734902|Scopolamine|scopolamine|mesh-list
55852789|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55852790|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55852791|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
55852792|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
55852793|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219049|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
56219050|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
56219051|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56219052|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55795086|NCT03067597|Dinoprostone|dinoprostone|mesh-list
55852794|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852795|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55852796|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
55852799|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852800|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852801|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55930040|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
55930041|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
55930042|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930043|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930044|NCT05044728|Paclitaxel|paclitaxel|mesh-list
55930045|NCT05044728|Carboplatin|carboplatin|mesh-list
55930046|NCT05044728|Antibodies|antibodies|mesh-list
55930047|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55930048|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930049|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
55930050|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
55930051|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
55930052|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852802|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
55852803|NCT01789970|Hydrocodone|hydrocodone|mesh-list
55852804|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55852805|NCT01789970|Narcotics|narcotics|mesh-ancestor
55852806|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852807|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852808|NCT01789970|Analgesics|analgesics|mesh-ancestor
55852809|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
55852810|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852811|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
55852812|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
55852813|NCT01788566|Gemcitabine|gemcitabine|mesh-list
55852814|NCT01788566|Necitumumab|necitumumab|mesh-list
55852815|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852816|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852817|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
55852818|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852819|NCT01788566|Antiviral Agents|antiviral agents|mesh-ancestor
55852820|NCT01788566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852821|NCT01788566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852822|NCT01788566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852823|NCT01788566|Immunologic Factors|immunologic factors|mesh-ancestor
55785484|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55785485|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55785486|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852824|NCT01788566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852825|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852826|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55852827|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
55852830|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
55852831|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852832|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
55852833|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852834|NCT01732640|Paclitaxel|paclitaxel|mesh-list
55852835|NCT01732640|Cisplatin|cisplatin|mesh-list
55852836|NCT01732640|Carboplatin|carboplatin|mesh-list
55852837|NCT01732640|Afatinib|afatinib|mesh-list
55852838|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55852839|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852840|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
55930053|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
55930054|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930056|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930057|NCT01041807|Losartan|losartan|mesh-list
55930058|NCT01041807|Amlodipine|amlodipine|mesh-list
55930059|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55930060|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55930061|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55930062|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852841|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
55852842|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
55852843|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852844|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55852845|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852846|NCT04560686|Atezolizumab|atezolizumab|mesh-list
55852847|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852848|NCT01757288|Paclitaxel|paclitaxel|mesh-list
55852849|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55852850|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55852851|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852852|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
55852853|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
55852854|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
55852855|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852856|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55852857|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
56219054|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
56219055|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219056|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795090|NCT02518971|Tamsulosin|tamsulosin|mesh-list
55852858|NCT01731938|Coagulants|coagulants|mesh-ancestor
55852859|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55852860|NCT01731002|Latanoprost|latanoprost|mesh-list
55852861|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55852862|NCT01783886|Aflibercept|aflibercept|mesh-list
55852863|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55852864|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55852865|NCT01783886|Growth Substances|growth substances|mesh-ancestor
55852866|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852867|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
55852868|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852869|NCT00234832|Sibutramine|sibutramine|mesh-list
55852870|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
55852871|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852906|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852907|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852908|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55852909|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55930081|NCT01725087|Narcotics|narcotics|mesh-ancestor
55930082|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930083|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930084|NCT01725087|Analgesics|analgesics|mesh-ancestor
55930085|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
55930091|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
55930092|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930093|NCT04151082|Prednisone|prednisone|mesh-list
55930094|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
55930095|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55930096|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55930097|NCT04151082|Prednisolone|prednisolone|mesh-list
55930098|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
55930099|NCT04151082|Cortisone|cortisone|mesh-list
55930100|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55930101|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
55930102|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930103|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
55930104|NCT04151082|Hormones|hormones|mesh-ancestor
55852910|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55852911|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852912|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852913|NCT00260962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55852914|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55852915|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55852944|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
55852945|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
55852946|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852947|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
55852948|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852949|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
55852950|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55852951|NCT00240526|Antibodies|antibodies|mesh-list
55852952|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
55852953|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785487|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
55785488|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785489|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852955|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55852956|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55852957|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
55852958|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852959|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852960|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852961|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55852985|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55852986|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852989|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852990|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55852991|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
55852992|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852993|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55852994|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55852995|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852996|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55852997|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852998|NCT00248560|Gemcitabine|gemcitabine|mesh-list
55852999|NCT00248560|Docetaxel|docetaxel|mesh-list
55853000|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55853001|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
55853002|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853003|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853004|NCT00248560|Antiviral Agents|antiviral agents|mesh-ancestor
55930106|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930107|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55930108|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219057|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55853005|NCT00248560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853006|NCT00248560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853007|NCT00248560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55853008|NCT00248560|Immunologic Factors|immunologic factors|mesh-ancestor
55853009|NCT00248560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853010|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
55853011|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
55853012|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
55853013|NCT00268762|Argatroban|argatroban|mesh-list
55853041|NCT00270790|Carboplatin|carboplatin|mesh-list
55853042|NCT00270790|Amifostine|amifostine|mesh-list
55853043|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853044|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55853045|NCT00270790|Protective Agents|protective agents|mesh-ancestor
55853046|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853047|NCT00271570|Infliximab|infliximab|mesh-list
55853048|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
55853049|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55853051|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
55853052|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55853053|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
55853054|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853055|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
55853056|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55853057|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853058|NCT05237596|Acetaminophen|acetaminophen|mesh-list
55853059|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55853090|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853091|NCT00273910|Imiquimod|imiquimod|mesh-list
55853092|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55853093|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55853094|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
55853095|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853096|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853097|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
55853098|NCT00274768|Capecitabine|capecitabine|mesh-list
55853099|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55853100|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
55785490|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55785491|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785492|NCT03136237|Cyclosporine|cyclosporine|mesh-list
55785493|NCT03136237|Digoxin|digoxin|mesh-list
56052269|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55930109|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
55930110|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
55930111|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930112|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55930113|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55930114|NCT04151082|Protective Agents|protective agents|mesh-ancestor
55930115|NCT00634543|Acetaminophen|acetaminophen|mesh-list
55930116|NCT00634543|Gabapentin|gabapentin|mesh-list
55930117|NCT00634543|Tramadol|tramadol|mesh-list
55930118|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55930119|NCT00634543|Analgesics|analgesics|mesh-ancestor
55930120|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
55930121|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930122|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930123|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
55853101|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853121|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
55853122|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853123|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55853124|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55853125|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55853126|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853127|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853128|NCT01790542|Iron|iron|mesh-list
55853131|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853132|NCT01899820|Lumefantrine|lumefantrine|mesh-list
55853133|NCT01899820|Artemether|artemether|mesh-list
55853134|NCT01899820|Piperaquine|piperaquine|mesh-list
55853135|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55853136|NCT01899820|Artenimol|artenimol|mesh-list
55853137|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
55853138|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55853139|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55853140|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853141|NCT02100748|Morphine|morphine|mesh-list
55853142|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55853143|NCT02100748|Narcotics|narcotics|mesh-ancestor
55853144|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55853145|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853146|NCT02100748|Analgesics|analgesics|mesh-ancestor
55853147|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
55853148|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853149|NCT04445662|Varenicline|varenicline|mesh-list
55853150|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55853151|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55853152|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
56219058|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
56219059|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219060|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56219061|NCT01643434|Diuretics|diuretics|mesh-ancestor
56219062|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
55930124|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
55930125|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55930126|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55930127|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930128|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55930129|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55930130|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55930131|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930132|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930133|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
55930134|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55930136|NCT05054322|Fluticasone|fluticasone|mesh-list
55930137|NCT05054322|Xhance|xhance|mesh-list
56219064|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
56219065|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853153|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853154|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853155|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853156|NCT00283504|Omalizumab|omalizumab|mesh-list
55853182|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853183|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
55853184|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55853185|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55853186|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811887|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55853187|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853188|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
55853189|NCT00287716|Pirfenidone|pirfenidone|mesh-list
55853190|NCT00287716|Analgesics|analgesics|mesh-ancestor
55853191|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
55853192|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853193|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853194|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55853195|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55853196|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55853197|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853198|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853199|NCT00287872|Thalidomide|thalidomide|mesh-list
55853201|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853202|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55853203|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
55853204|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853205|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
55853234|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55853235|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
55853236|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55853237|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55853239|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
55853240|NCT04061590|Pemetrexed|pemetrexed|mesh-list
55785494|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55785495|NCT03136237|Cyclosporins|cyclosporins|mesh-list
55785496|NCT03136237|Berotralstat|berotralstat|mesh-list
55785497|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785498|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785499|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785500|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
55853241|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853242|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55853243|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853244|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853245|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55853246|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55853247|NCT01791088|Sirolimus|sirolimus|mesh-list
55853266|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55853267|NCT00291694|Analgesics|analgesics|mesh-ancestor
55853275|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853276|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853277|NCT00292162|Metoprolol|metoprolol|mesh-list
55853278|NCT00292162|Carvedilol|carvedilol|mesh-list
55853279|NCT00292162|Ramipril|ramipril|mesh-list
55853280|NCT00292162|Enalapril|enalapril|mesh-list
55853281|NCT00292162|Lisinopril|lisinopril|mesh-list
55853282|NCT00292162|Bisoprolol|bisoprolol|mesh-list
55853283|NCT00292162|Perindopril|perindopril|mesh-list
55853284|NCT00292162|Captopril|captopril|mesh-list
56219067|NCT01643980|Progestins|progestins|mesh-ancestor
56219068|NCT01643980|Hormones|hormones|mesh-ancestor
56219069|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219070|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219071|NCT01645228|Calcium|calcium|mesh-list
56219072|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55795098|NCT02518971|Urological Agents|urological agents|mesh-ancestor
55853285|NCT00292162|Spironolactone|spironolactone|mesh-list
55853286|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55853287|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
55853288|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55853289|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55853290|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55853291|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
55853292|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
55853293|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853294|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853295|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55853296|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55853297|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
55853298|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853299|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853300|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
55853301|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853302|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55853303|NCT00292162|Diuretics|diuretics|mesh-ancestor
55853304|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
55853331|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
55930138|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930139|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55930140|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
55930141|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930142|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930143|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55930144|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
55930145|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
55930146|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55930147|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55930148|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
55930149|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930150|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
55853332|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
55853333|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853334|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853335|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55853336|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55853337|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55853338|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
55853339|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853340|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853341|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55853342|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55853343|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55853344|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
55853351|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
55853352|NCT00300430|Atorvastatin|atorvastatin|mesh-list
55853353|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55853354|NCT00300430|Simvastatin|simvastatin|mesh-list
55853387|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55853388|NCT02100826|Cephalexin|cephalexin|mesh-list
55853389|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853390|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853391|NCT03587272|Sirolimus|sirolimus|mesh-list
55853392|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
55853393|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853394|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853395|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55853396|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853425|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853426|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853427|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
55853428|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853429|NCT00302848|Drospirenone|drospirenone|mesh-list
55853430|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
55853431|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
55853432|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
55853433|NCT00302848|Progestins|progestins|mesh-list
55853434|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55853435|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853436|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55853437|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55853438|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55761392|NCT04826679|Cisplatin|cisplatin|mesh-list
55930151|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55930152|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
55853439|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55853440|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
55853441|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853472|NCT02578732|Antidotes|antidotes|mesh-ancestor
55853473|NCT02578732|Protective Agents|protective agents|mesh-ancestor
55853474|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853475|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
55853476|NCT02578732|Vitamins|vitamins|mesh-ancestor
55853477|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
55853478|NCT02501434|Heparin|heparin|mesh-list
55853479|NCT02501434|Calcium heparin|calcium heparin|mesh-list
55853480|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
55853481|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55853482|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55853483|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853484|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55853485|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55853486|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55853487|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853488|NCT00148798|Cisplatin|cisplatin|mesh-list
55853489|NCT00148798|Cetuximab|cetuximab|mesh-list
55853519|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55853520|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55853521|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
55853522|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853523|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853524|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853525|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55853526|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55853527|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
55853528|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853529|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55930153|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930154|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930155|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55930156|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
55930157|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
55930158|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55930159|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
55930162|NCT04759729|Vitamin D|vitamin d|mesh-list
55853530|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55853531|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853532|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853598|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55853599|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
55853600|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853601|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785501|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785502|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
55853602|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55853603|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853605|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55853606|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853607|NCT01790308|Incretins|incretins|mesh-ancestor
55853608|NCT01790308|Hormones|hormones|mesh-ancestor
55853609|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853610|NCT01609010|Interferons|interferons|mesh-list
55853612|NCT01609010|Rituximab|rituximab|mesh-list
55853613|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55853614|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853615|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
55853616|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853617|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853618|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
55853619|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853620|NCT01608308|Acetaminophen|acetaminophen|mesh-list
55853649|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55853650|NCT01755416|Liraglutide|liraglutide|mesh-list
55853651|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55853652|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853653|NCT01755416|Incretins|incretins|mesh-ancestor
55853657|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55930188|NCT03096990|Analgesics|analgesics|mesh-ancestor
55930189|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
55930190|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930191|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853658|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853660|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
55853661|NCT00333814|BB 1101|bb 1101|mesh-list
55853662|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55853663|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
55853664|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
56219073|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219074|NCT01645839|Cytarabine|cytarabine|mesh-list
56219075|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219076|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
56219077|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219078|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219079|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
56219080|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219081|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219082|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
56219083|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219084|NCT01646437|Aspirin|aspirin|mesh-list
56219085|NCT01646437|Vitamin D|vitamin d|mesh-list
55853665|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853666|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853667|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55853691|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55853692|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
55853693|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
55853694|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
55853695|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55853696|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55853697|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
55853698|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853699|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853700|NCT01522443|Prednisone|prednisone|mesh-list
55853701|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
55853702|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55853703|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
55853704|NCT01522443|Hormones|hormones|mesh-ancestor
55853705|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853706|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853707|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55853709|NCT01522443|Analgesics|analgesics|mesh-ancestor
55853710|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
55853711|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930241|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930242|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853712|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55853713|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55853714|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853715|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853716|NCT00336232|Vitamin K|vitamin k|mesh-list
55853717|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
55853718|NCT00336232|Vitamins|vitamins|mesh-ancestor
55853752|NCT01754402|Hormones|hormones|mesh-ancestor
55853753|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853754|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55853755|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853756|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55853757|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
56052270|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55930243|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
55930244|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930245|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55930246|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
55930247|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55930248|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930249|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55930250|NCT01360866|Analgesics|analgesics|mesh-ancestor
55930251|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
55930252|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
55930253|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55930254|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55930255|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930256|NCT00984061|Clarithromycin|clarithromycin|mesh-list
55930257|NCT00984061|Colchicine|colchicine|mesh-list
55930258|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55930259|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930260|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55930261|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930262|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853758|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785503|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785504|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
55785505|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55785506|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55853759|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
55853760|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55853789|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55853790|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55853791|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56219086|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
56219087|NCT01646437|Vitamins|vitamins|mesh-ancestor
56219088|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
56219089|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219090|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56219091|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56219092|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56219093|NCT01646437|Analgesics|analgesics|mesh-ancestor
56219094|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
56219095|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219096|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56219097|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219098|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56219099|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56219100|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219101|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56219102|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56219103|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219104|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
56052271|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
55930282|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930283|NCT00983905|Colchicine|colchicine|mesh-list
55930284|NCT00983905|Theophylline|theophylline|mesh-list
55930285|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
55930286|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930287|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
55930288|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
55930289|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
55930301|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55930302|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55930303|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
55930304|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930305|NCT01046565|Adapalene|adapalene|mesh-list
55930306|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55930307|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55930308|NCT01046565|Analgesics|analgesics|mesh-ancestor
55930309|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
55930310|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930311|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930312|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56219105|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56219106|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
56219107|NCT01646619|Analgesics|analgesics|mesh-ancestor
56219108|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
56219109|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219110|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853792|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853793|NCT01490697|Renal Agents|renal agents|mesh-ancestor
55853794|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55853795|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
55853796|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853797|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
55853798|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853799|NCT01728194|Citalopram|citalopram|mesh-list
55853800|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55853801|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55853802|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853803|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853826|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
55853827|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55853828|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55853829|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55853830|NCT01466673|Desogestrel|desogestrel|mesh-list
55853831|NCT01466673|Norgestimate|norgestimate|mesh-list
56052272|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930313|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930314|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
55930315|NCT01046253|Lansoprazole|lansoprazole|mesh-list
55930316|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
55930317|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55930318|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55930319|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55930320|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930321|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930322|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55930323|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55930324|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55930325|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55930326|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930327|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930328|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930329|NCT05050656|Analgesics|analgesics|mesh-ancestor
55930330|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
55930331|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853832|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55853833|NCT01466673|Estradiol|estradiol|mesh-list
55853834|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55853835|NCT01466673|Estrogens|estrogens|mesh-ancestor
55853836|NCT01466673|Hormones|hormones|mesh-ancestor
56219111|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
56219112|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56219113|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56219114|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
56219115|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56219116|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56219117|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219118|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56219119|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
56219120|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56219121|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56219122|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56219123|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219124|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219125|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
56219126|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795145|NCT04716413|Dsuvia|dsuvia|mesh-list
55853837|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853838|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853839|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55853840|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
55853841|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55853842|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55853843|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55853844|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55853845|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55853846|NCT01466673|Progestins|progestins|mesh-ancestor
55930332|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
55930333|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55930334|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
55930335|NCT00983515|Ritonavir|ritonavir|mesh-list
55930336|NCT00983515|Colchicine|colchicine|mesh-list
55930337|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55930338|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55930339|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
55930340|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930349|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930350|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
55930351|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
55930352|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
55930353|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930355|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930356|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930357|NCT04471818|Ketamine|ketamine|mesh-list
55930358|NCT04471818|Analgesics|analgesics|mesh-ancestor
55930359|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
55930360|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853847|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853848|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853849|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55853850|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55853851|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853852|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853853|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853854|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55853855|NCT01753856|Vitamin D|vitamin d|mesh-list
55853856|NCT01753856|Denosumab|denosumab|mesh-list
55853857|NCT01753856|Teriparatide|teriparatide|mesh-list
55853858|NCT01753856|Tetracycline|tetracycline|mesh-list
55853895|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55853930|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55853931|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55853967|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55853968|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853969|NCT01519791|Methotrexate|methotrexate|mesh-list
55853970|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
55853971|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55854000|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55854001|NCT01461369|Analgesics|analgesics|mesh-ancestor
55854002|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
55854003|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854004|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219133|NCT01648218|Protamines|protamines|mesh-list
55785507|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55785508|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55785510|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55785511|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55785512|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55785513|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55854005|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55854006|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55854007|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55854008|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930363|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55930364|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
55930366|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930367|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55930368|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55854009|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854010|NCT01727258|Fluorides|fluorides|mesh-list
55854011|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
55854012|NCT01727258|Protective Agents|protective agents|mesh-ancestor
55854013|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854014|NCT01781234|Insulin|insulin|mesh-list
55854015|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55854016|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854049|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854051|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55854052|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55854053|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854054|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
55854055|NCT01519245|Coagulants|coagulants|mesh-ancestor
55854056|NCT01519167|Fentanyl|fentanyl|mesh-list
55854176|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854178|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
55854179|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854180|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
55854204|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55854205|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854206|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55854207|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55854208|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55854209|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
55854210|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854211|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854212|NCT00392392|Paclitaxel|paclitaxel|mesh-list
55854213|NCT00392392|Bevacizumab|bevacizumab|mesh-list
55854214|NCT00392392|Trastuzumab|trastuzumab|mesh-list
55854215|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55854216|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854217|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854218|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854219|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854220|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854221|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55930369|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930370|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930372|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
55930373|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55930374|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55930375|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55930376|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930378|NCT04434378|Tamsulosin|tamsulosin|mesh-list
55854222|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55785514|NCT03136237|Protective Agents|protective agents|mesh-ancestor
55785515|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
55854223|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854224|NCT00392392|Growth Substances|growth substances|mesh-ancestor
55854225|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854226|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854227|NCT01519089|Tofacitinib|tofacitinib|mesh-list
56219134|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56219135|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219136|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
56219137|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219139|NCT01648465|Everolimus|everolimus|mesh-list
56219140|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219141|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219142|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
56219143|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219144|NCT01648777|Bupivacaine|bupivacaine|mesh-list
56219145|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
56219146|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
56219147|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56219148|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795177|NCT04401553|Vancomycin|vancomycin|mesh-list
55854228|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854229|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854230|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854266|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55854267|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
55854268|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55854269|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55930436|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55930437|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55930438|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930439|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55930440|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55930441|NCT01045161|Bromides|bromides|mesh-list
55930442|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
55930443|NCT05032248|Tacrolimus|tacrolimus|mesh-list
55930444|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55930445|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
55930449|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930450|NCT00633217|Fluticasone|fluticasone|mesh-list
55930451|NCT00633217|Xhance|xhance|mesh-list
55930452|NCT00633217|Norflurane|norflurane|mesh-list
55930453|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55930454|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55930455|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930456|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55930457|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
55930458|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930459|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854294|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854295|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854298|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854299|NCT01458951|Tofacitinib|tofacitinib|mesh-list
55854300|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854301|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854302|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052273|NCT03594045|Apixaban|apixaban|mesh-list
55930462|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
55930463|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55930464|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55930465|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55930466|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55930467|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
55930468|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854304|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55854305|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
55854306|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
55854307|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854308|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854309|NCT00393796|Sunitinib|sunitinib|mesh-list
55854310|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854311|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854312|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854313|NCT00393796|Growth Substances|growth substances|mesh-ancestor
55854314|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854315|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854316|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854317|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854349|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854350|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
55854351|NCT01457703|Letrozole|letrozole|mesh-list
55854352|NCT01457703|Cetrorelix|cetrorelix|mesh-list
55854353|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55930469|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930470|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
55930471|NCT00633217|Hormones|hormones|mesh-ancestor
55930472|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854354|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854355|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55854356|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55854357|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854358|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854394|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219149|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
56219150|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219151|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
56219152|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56219153|NCT01649024|Tremelimumab|tremelimumab|mesh-list
56219154|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219155|NCT01649960|Sirolimus|sirolimus|mesh-list
55795187|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
55854395|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854396|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
55854397|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854427|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854428|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854429|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
55854430|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854431|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56052274|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55930473|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
55930474|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
55930475|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930476|NCT01673490|Tamsulosin|tamsulosin|mesh-list
55930477|NCT01673490|Dutasteride|dutasteride|mesh-list
55854432|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55854433|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55854434|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55854435|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854436|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854437|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854438|NCT00360724|Analgesics|analgesics|mesh-ancestor
55854439|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
55854440|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854441|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
55854442|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55785517|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
55785518|NCT04021381|Cathartics|cathartics|mesh-ancestor
55785519|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55785520|NCT03066791|Curcumin|curcumin|mesh-list
55854474|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55854476|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55854477|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55854478|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55854479|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854480|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55854481|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55854482|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55854483|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
55854484|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
55854508|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854509|NCT02109640|Analgesics|analgesics|mesh-ancestor
55854510|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
55854511|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854512|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55854513|NCT01454739|Factor VIII|factor viii|mesh-list
55854514|NCT01454739|Coagulants|coagulants|mesh-ancestor
55854515|NCT00366106|Dexamethasone|dexamethasone|mesh-list
55854516|NCT00366106|Doxorubicin|doxorubicin|mesh-list
55854517|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55854519|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55854521|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
55854522|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854523|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854524|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55854525|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
55854526|NCT00366106|Hormones|hormones|mesh-ancestor
55854527|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854528|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55854529|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854530|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55854531|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55854532|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55854533|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219156|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56219157|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219158|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55930478|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55930479|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55930480|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55930481|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
55930482|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930483|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219159|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219160|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
56219161|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219162|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
56219163|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219164|NCT01650012|Eplerenone|eplerenone|mesh-list
56219165|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56219166|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
56219167|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219168|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219169|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56219170|NCT01650012|Diuretics|diuretics|mesh-ancestor
56219171|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
56219172|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56219173|NCT01650090|Cisplatin|cisplatin|mesh-list
56219174|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795190|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
55854534|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854572|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55854573|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854574|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854575|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
55854576|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
55854577|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854578|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854606|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854607|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854608|NCT00408070|Growth Substances|growth substances|mesh-ancestor
55854609|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854610|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854611|NCT00408460|Paclitaxel|paclitaxel|mesh-list
55854612|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
55930484|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930485|NCT01673490|Urological Agents|urological agents|mesh-ancestor
55930486|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55930487|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55930488|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930489|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
55854613|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55854614|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854615|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854616|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854617|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854618|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854619|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854620|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854621|NCT03675412|Caffeine|caffeine|mesh-list
55785521|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55854622|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55854623|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854624|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55854625|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854663|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55854664|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
56219175|NCT01650129|Insulin|insulin|mesh-list
56219176|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56219177|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
56219178|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
56219179|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56219180|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219181|NCT01650181|Selenium|selenium|mesh-list
56219182|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
56219183|NCT01650181|Metformin|metformin|mesh-list
56219184|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56219185|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219186|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
56219187|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219188|NCT01650181|Protective Agents|protective agents|mesh-ancestor
56219189|NCT01650181|Trace Elements|trace elements|mesh-ancestor
56219190|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
56219191|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
56219192|NCT01650181|Vitamins|vitamins|mesh-ancestor
56219193|NCT01650272|Minoxidil|minoxidil|mesh-list
56219194|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56219195|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56219196|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
56219197|NCT01650376|Paclitaxel|paclitaxel|mesh-list
56219198|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56219199|NCT01650376|Carboplatin|carboplatin|mesh-list
56219200|NCT01650376|Olaparib|olaparib|mesh-list
56219201|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56219202|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219203|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
56219204|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
56219205|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854732|NCT02845882|Vincristine|vincristine|mesh-list
55854733|NCT02845882|Daunorubicin|daunorubicin|mesh-list
55854734|NCT02845882|Asparaginase|asparaginase|mesh-list
55854735|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
55854736|NCT02845882|Vindesine|vindesine|mesh-list
55854737|NCT02845882|Pegaspargase|pegaspargase|mesh-list
55854738|NCT02845882|BB 1101|bb 1101|mesh-list
55854739|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55854740|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
55854741|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854742|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55854743|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55854744|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
55854770|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55854772|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854773|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854774|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854775|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854776|NCT03509584|Nivolumab|nivolumab|mesh-list
55761467|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
55930490|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930492|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
55930493|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55930494|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55930495|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930496|NCT00632827|Leucovorin|leucovorin|mesh-list
55930497|NCT00632827|Gemcitabine|gemcitabine|mesh-list
55930498|NCT00632827|Cytarabine|cytarabine|mesh-list
55930499|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
55930500|NCT00632827|Carmustine|carmustine|mesh-list
55930502|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55930503|NCT00632827|Methotrexate|methotrexate|mesh-list
55930504|NCT00632827|Etoposide|etoposide|mesh-list
55930505|NCT00632827|Vincristine|vincristine|mesh-list
55930506|NCT00632827|Vinorelbine|vinorelbine|mesh-list
55930507|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
55930508|NCT00632827|Lenograstim|lenograstim|mesh-list
55930509|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55930510|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
55930511|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930512|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930513|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55930514|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
55930515|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854777|NCT03509584|Ipilimumab|ipilimumab|mesh-list
56219206|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219207|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56219208|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219210|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56219211|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
56219212|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219213|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
55854778|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854779|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854780|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55854781|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854782|NCT00417274|Quinacrine|quinacrine|mesh-list
55930517|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55930518|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55930519|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
55930520|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
55930521|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930522|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854783|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
55854786|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55854787|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854788|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
55854789|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55854790|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
55854791|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854825|NCT00424840|Bevacizumab|bevacizumab|mesh-list
55854827|NCT00424840|Bortezomib|bortezomib|mesh-list
55854828|NCT00424840|Docetaxel|docetaxel|mesh-list
55854829|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854830|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854831|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854850|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854851|NCT01164202|Sunitinib|sunitinib|mesh-list
55854852|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854853|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854854|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854855|NCT01164202|Growth Substances|growth substances|mesh-ancestor
55930523|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55930524|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55930525|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55930526|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55930527|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
55930528|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55930529|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
55930530|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55930531|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55854856|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854857|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854858|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854859|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854860|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854861|NCT02112370|Epinephrine|epinephrine|mesh-list
55854862|NCT02112370|Racepinephrine|racepinephrine|mesh-list
55854863|NCT02112370|Ropivacaine|ropivacaine|mesh-list
55854864|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
55854865|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
55761505|NCT04807569|Tamsulosin|tamsulosin|mesh-list
55930532|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55930533|NCT00632827|Antidotes|antidotes|mesh-ancestor
55930534|NCT00632827|Protective Agents|protective agents|mesh-ancestor
55930535|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
55930536|NCT00632827|Vitamins|vitamins|mesh-ancestor
55930537|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
55930538|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
55930539|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
55930540|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
55930541|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55854866|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
55854867|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854868|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854869|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
55854870|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854871|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55854872|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55854873|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
55854874|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785522|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55785523|NCT03066791|Analgesics|analgesics|mesh-ancestor
55785524|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
55785525|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785526|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785527|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785528|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55785529|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930542|NCT00214019|Fluticasone|fluticasone|mesh-list
55930543|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55930544|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55930545|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930546|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55930547|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
55930548|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930549|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930550|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55785530|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785531|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785532|NCT05729555|Diphenhydramine|diphenhydramine|mesh-list
55785533|NCT05729555|Promethazine|promethazine|mesh-list
55785534|NCT05729555|Ibuprofen|ibuprofen|mesh-list
55854875|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219214|NCT01650415|Hematinics|hematinics|mesh-ancestor
56219215|NCT01650428|Bevacizumab|bevacizumab|mesh-list
56219216|NCT01650428|Fluorouracil|fluorouracil|mesh-list
56219217|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
55854876|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55854877|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55854878|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
55854879|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55854880|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
55854881|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
55854882|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
55854883|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55854884|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
55854885|NCT00427336|Fludarabine|fludarabine|mesh-list
55854886|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
55854921|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
55854922|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854923|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
55854924|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930551|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
55854925|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
55854958|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
55854959|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
55930552|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
55930553|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55930554|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55930555|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55930556|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55930557|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
55854960|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854961|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55854962|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55854964|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55811918|NCT02404441|Spartalizumab|spartalizumab|mesh-list
55854965|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55854966|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855001|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
55855002|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930558|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930559|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930560|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
55930561|NCT00214019|Hormones|hormones|mesh-ancestor
55930562|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930563|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
55717345|NCT02293525|Narcotics|narcotics|mesh-ancestor
55717346|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717347|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717348|NCT02293525|Analgesics|analgesics|mesh-ancestor
55717349|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
55717350|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717351|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
55717352|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
55717353|NCT02298595|Cetuximab|cetuximab|mesh-list
55717354|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717355|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55717356|NCT02345343|Apixaban|apixaban|mesh-list
55717357|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55717358|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
55717359|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55717360|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
55717361|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717363|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
55717364|NCT03949673|Celecoxib|celecoxib|mesh-list
55717365|NCT03949673|Diclofenac|diclofenac|mesh-list
55717366|NCT03949673|Naproxen|naproxen|mesh-list
55717367|NCT03949673|Fasinumab|fasinumab|mesh-list
55717368|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55717369|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717370|NCT03949673|Analgesics|analgesics|mesh-ancestor
55717371|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
55717372|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717373|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717375|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717376|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55717377|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55717378|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717379|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717380|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
55717381|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
55717382|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55717383|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55717384|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717385|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
55717386|NCT02350179|Coagulants|coagulants|mesh-ancestor
55717388|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55717389|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
55717390|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717391|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717392|NCT02233205|Antiviral Agents|antiviral agents|mesh-ancestor
55717393|NCT02233205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717394|NCT02233205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717395|NCT02233205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717396|NCT02233205|Immunologic Factors|immunologic factors|mesh-ancestor
55717397|NCT02233205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717398|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55717399|NCT02293681|Infliximab|infliximab|mesh-list
55855003|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855004|NCT00376948|Antiviral Agents|antiviral agents|mesh-ancestor
55855005|NCT00376948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55855006|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855007|NCT00376948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855038|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55855039|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
55855040|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
55855041|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55855042|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55855043|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55855044|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855045|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855046|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
55855047|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
55855048|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855049|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855050|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55855051|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
55855078|NCT00458848|Idarubicin|idarubicin|mesh-list
55855079|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855080|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
55761522|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
55930565|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930566|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55930567|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930568|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930569|NCT05047848|Fulvestrant|fulvestrant|mesh-list
55930570|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55930571|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717400|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
55717401|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55717402|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717403|NCT02259491|Calcium|calcium|mesh-list
55717405|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717406|NCT05255523|Capecitabine|capecitabine|mesh-list
55717407|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55717408|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
55717409|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717410|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717411|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
55717412|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717413|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
55717414|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717415|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717416|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55717417|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
55717418|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717419|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717420|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55717421|NCT02298985|Curcumin|curcumin|mesh-list
55717422|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
55717423|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55717424|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717425|NCT02298985|Analgesics|analgesics|mesh-ancestor
55717426|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
55717427|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717428|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717429|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717430|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717431|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717432|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717433|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717434|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55717435|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717436|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55785535|NCT05729555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55785536|NCT05729555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55785537|NCT05729555|Analgesics|analgesics|mesh-ancestor
55855081|NCT00458848|Hormones|hormones|mesh-ancestor
55855082|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855083|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855084|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55855085|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855086|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55855087|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
55855088|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55855089|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855090|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
55855091|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855092|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
55855093|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855094|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55855095|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55761528|NCT04807413|Protective Agents|protective agents|mesh-ancestor
55930572|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55930573|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55930574|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
55855096|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
55855097|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219218|NCT01650428|Irinotecan|irinotecan|mesh-list
56219219|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56219220|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219221|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56219222|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56219223|NCT01650428|Growth Substances|growth substances|mesh-ancestor
56219224|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219225|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
56219226|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
56219227|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219228|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219229|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219230|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
56219231|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56219232|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56219233|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219234|NCT01650441|Beclomethasone|beclomethasone|mesh-list
55795254|NCT01672723|Naltrexone|naltrexone|mesh-list
55855098|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55855099|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55855100|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55855101|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55855102|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
55855103|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
55855132|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855134|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855135|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
55855136|NCT00378352|Hematinics|hematinics|mesh-ancestor
55855137|NCT00462280|Lovastatin|lovastatin|mesh-list
55855138|NCT00462280|L 647318|l 647318|mesh-list
55855139|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
55855140|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55855141|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55855142|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
55855143|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855144|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55855145|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55855146|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855147|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
55855148|NCT00381004|Rituximab|rituximab|mesh-list
55855149|NCT00381004|Fludarabine|fludarabine|mesh-list
55855150|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
55855151|NCT00381004|Sargramostim|sargramostim|mesh-list
55930575|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930576|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930577|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
55930578|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855161|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55855162|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855165|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
55855166|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855167|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855168|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
55855169|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855170|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855171|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
55855172|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855173|NCT00440830|Nicotine|nicotine|mesh-list
55855174|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55855175|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
55855176|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219236|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56219237|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
56219238|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219239|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930579|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55930580|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930581|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930583|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
55930584|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
55930585|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
55930586|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
55930587|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930588|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219240|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56219241|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
56219242|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56219243|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56219244|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56219245|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
56219246|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219247|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219248|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56219249|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
56219250|NCT01650441|Hormones|hormones|mesh-ancestor
55855177|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855178|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55855179|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55855180|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
55855181|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855182|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855183|NCT00381862|Leucovorin|leucovorin|mesh-list
55855184|NCT00381862|Dexamethasone|dexamethasone|mesh-list
55855185|NCT00381862|Fluorouracil|fluorouracil|mesh-list
55930589|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55785538|NCT05729555|Sensory System Agents|sensory system agents|mesh-ancestor
55855186|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
55855187|NCT00381862|Irinotecan|irinotecan|mesh-list
55930590|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55930591|NCT01837329|Growth Substances|growth substances|mesh-ancestor
55930592|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930593|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
55930594|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930595|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
55930596|NCT03993353|Tadalafil|tadalafil|mesh-list
55855188|NCT00381862|Camptothecin|camptothecin|mesh-list
55855189|NCT00381862|Aprepitant|aprepitant|mesh-list
55855190|NCT00381862|Palonosetron|palonosetron|mesh-list
55855191|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
55855192|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855193|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
55855194|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
55855195|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855196|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855197|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855198|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
55855199|NCT00381862|Hormones|hormones|mesh-ancestor
55855200|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855201|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55855202|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855203|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
55855204|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855205|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855206|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855207|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
55855208|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55855209|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55855210|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855211|NCT00381862|Antidotes|antidotes|mesh-ancestor
55855212|NCT00381862|Protective Agents|protective agents|mesh-ancestor
55855213|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
55855214|NCT00381862|Vitamins|vitamins|mesh-ancestor
55855215|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
55855216|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55855217|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855218|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55855219|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56219251|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219252|NCT01650493|Listerine|listerine|mesh-list
56219253|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
56219254|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
56219255|NCT01650493|Protective Agents|protective agents|mesh-ancestor
56219256|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219257|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56219258|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219259|NCT01650506|Metformin|metformin|mesh-list
56219260|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56219261|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56219262|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219263|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219264|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55795293|NCT04982367|Sirolimus|sirolimus|mesh-list
55855220|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
55855245|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55855247|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
55855248|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
55855249|NCT00465088|Vitamins|vitamins|mesh-ancestor
55855250|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
55855251|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855252|NCT01796782|Capecitabine|capecitabine|mesh-list
55855253|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855254|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
55855255|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855256|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855257|NCT00466960|Paclitaxel|paclitaxel|mesh-list
55855258|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55855260|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55855261|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855262|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
55855263|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
55855264|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
55855265|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855266|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
55855267|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930597|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55930598|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930599|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
55930600|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55930601|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55930602|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930603|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855268|NCT00383266|Carboplatin|carboplatin|mesh-list
55855304|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855305|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
55855306|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855307|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855308|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55855334|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55855335|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55855337|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
55855338|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855339|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855340|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855342|NCT00446290|Capecitabine|capecitabine|mesh-list
55855343|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
55855344|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855345|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
55785539|NCT05729555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855346|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
55855347|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
55930604|NCT03993353|Urological Agents|urological agents|mesh-ancestor
55930605|NCT05040906|Rituximab|rituximab|mesh-list
55930606|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55930607|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930608|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
55930609|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717437|NCT03149445|Metoprolol|metoprolol|mesh-list
55717438|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55717439|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55717440|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
55717441|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
55717442|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717443|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717444|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55717445|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55717446|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55717447|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
55717448|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717449|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826216|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55826217|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
55826218|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826219|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826220|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55826221|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
55826222|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
55826223|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55826224|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
55717451|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55717452|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55717453|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717455|NCT02345187|Trace Elements|trace elements|mesh-list
55717456|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717457|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
55717458|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55717459|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717460|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717461|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717463|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
55717464|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717465|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55717466|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55717467|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55717468|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
55717469|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717470|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855348|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855349|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219266|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219267|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
56219268|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219269|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219270|NCT01650649|Lofexidine|lofexidine|mesh-list
56219271|NCT01650649|Clonidine|clonidine|mesh-list
56219272|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56219273|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56219274|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219275|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
56219276|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219277|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56219279|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56219280|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
56219281|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219282|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219283|NCT01650649|Analgesics|analgesics|mesh-ancestor
56219284|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
55855350|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
55855351|NCT00385216|Nicotine|nicotine|mesh-list
55855352|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55855353|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
55855354|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855355|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855356|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55855390|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55855391|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55855392|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855393|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855394|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855395|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855428|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
55855429|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855431|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
55855433|NCT00389818|Doxorubicin|doxorubicin|mesh-list
55855434|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55855435|NCT00389818|Vincristine|vincristine|mesh-list
55855436|NCT00389818|Sargramostim|sargramostim|mesh-list
55855437|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855438|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
55855439|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855440|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855474|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
55855475|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55855476|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
55855477|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55855478|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855479|NCT00476242|Naltrexone|naltrexone|mesh-list
55855480|NCT00476242|Memantine|memantine|mesh-list
55855510|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55855511|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855512|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855514|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219285|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
56219286|NCT01650662|Cyclosporine|cyclosporine|mesh-list
56219287|NCT01650662|Cyclosporins|cyclosporins|mesh-list
56219288|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219289|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219290|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219291|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
56219292|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219293|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
56219294|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219295|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56219296|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219297|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56219298|NCT01650727|Rituximab|rituximab|mesh-list
56219299|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56219300|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219301|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
55795315|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930610|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930611|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
55930612|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55930613|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930614|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55855515|NCT00453388|Cyclosporine|cyclosporine|mesh-list
55855516|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
55855517|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
55855518|NCT00453388|Fludarabine|fludarabine|mesh-list
55855519|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
55855520|NCT00453388|Cyclosporins|cyclosporins|mesh-list
55855521|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855553|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855554|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55855555|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55855556|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55855557|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
55855558|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855559|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855560|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55855562|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55855563|NCT00389974|Sunitinib|sunitinib|mesh-list
55855564|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855565|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55855566|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55855567|NCT00389974|Growth Substances|growth substances|mesh-ancestor
55855568|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855569|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
55855570|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55855603|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
55855604|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
55855605|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
55855606|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
55855607|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785540|NCT05729555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785541|NCT05729555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785542|NCT05729555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55785543|NCT05729555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55785544|NCT05729555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855608|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855609|NCT01415349|Omeprazole|omeprazole|mesh-list
55855610|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55855611|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855612|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55855613|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219302|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219303|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219304|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56219305|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56219306|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56219307|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56219308|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855643|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55855644|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55855645|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855646|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
55855648|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855649|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855650|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55855651|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855652|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855653|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855654|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55855678|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855680|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
55855681|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
55855682|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55855684|NCT01452789|Buprenorphine|buprenorphine|mesh-list
55855685|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55855686|NCT01452789|Narcotics|narcotics|mesh-ancestor
55855687|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855688|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855689|NCT01452789|Analgesics|analgesics|mesh-ancestor
55855690|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
55855691|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930615|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
55930616|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55930617|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930618|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930619|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930620|NCT05040828|Montelukast|montelukast|mesh-list
55930621|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55930622|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
55930623|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55930624|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
55930625|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930626|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930627|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55930628|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55930629|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855692|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55855693|NCT00478192|Conivaptan|conivaptan|mesh-list
55855694|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55855695|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855696|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
55855697|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855698|NCT01414257|Methotrexate|methotrexate|mesh-list
55855700|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
55855701|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55855702|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855703|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855704|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
55855705|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855706|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855707|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
55855739|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
55855740|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55855741|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
55855742|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
55855743|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
55855744|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55855746|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55855747|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855748|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55855749|NCT00529204|Incretins|incretins|mesh-ancestor
55855750|NCT00529204|Hormones|hormones|mesh-ancestor
55855783|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
55855784|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930630|NCT00983437|Modafinil|modafinil|mesh-list
55930631|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55930632|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930633|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55930634|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55930635|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55930636|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930637|NCT05031234|Morphine|morphine|mesh-list
55930638|NCT05031234|Anesthetics|anesthetics|mesh-list
55930639|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930640|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855785|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
55855786|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55855787|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
56219309|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219310|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219312|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
56219313|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219314|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
56219315|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56219316|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
56219317|NCT01650870|Lactulose|lactulose|mesh-list
56219318|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56219319|NCT01650883|Vitamin D|vitamin d|mesh-list
55785545|NCT05729555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785546|NCT05729555|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55855788|NCT00483262|Bortezomib|bortezomib|mesh-list
55855823|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55855824|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55855825|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55855826|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855827|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855828|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55855829|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55855830|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
55855860|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855861|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855862|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55855863|NCT01433055|Minocycline|minocycline|mesh-list
55855864|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55855865|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55855866|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
55855867|NCT01450137|Hormones|hormones|mesh-ancestor
55855868|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855869|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855870|NCT04075149|Spironolactone|spironolactone|mesh-list
55855871|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55855872|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
55855900|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55855901|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855902|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855903|NCT01411215|Etanercept|etanercept|mesh-list
55855904|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55855905|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55855906|NCT01411215|Analgesics|analgesics|mesh-ancestor
55855907|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
55855908|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855909|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855910|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855911|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855912|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855913|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855914|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
55855915|NCT01449279|Ipilimumab|ipilimumab|mesh-list
55855916|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55855917|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855918|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55855951|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855953|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855954|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
55855955|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
56219321|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
56219322|NCT01650883|Vitamins|vitamins|mesh-list
55855956|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
55855957|NCT00542308|Zalutumumab|zalutumumab|mesh-list
55855958|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55855992|NCT00494494|Analgesics|analgesics|mesh-ancestor
55855993|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
55930641|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55930642|NCT05031234|Narcotics|narcotics|mesh-ancestor
55930643|NCT05031234|Analgesics|analgesics|mesh-ancestor
55930644|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
55930645|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930646|NCT03599609|Simvastatin|simvastatin|mesh-list
55930647|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55930648|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55930649|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
55793559|NCT02524665|Analgesics|analgesics|mesh-ancestor
55855994|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855995|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855996|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855997|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855998|NCT03145558|Doxorubicin|doxorubicin|mesh-list
55855999|NCT03145558|Tirapazamine|tirapazamine|mesh-list
55856000|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55856064|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
55856065|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856066|NCT00500578|Ribavirin|ribavirin|mesh-list
55856067|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
55856068|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856069|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
55856070|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856071|NCT01430559|Meloxicam|meloxicam|mesh-list
55856072|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55856073|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55856074|NCT01430559|Analgesics|analgesics|mesh-ancestor
55856075|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
55856076|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856077|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856078|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856079|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856080|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55856081|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55856082|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761657|NCT01667679|Sumatriptan|sumatriptan|mesh-list
55930650|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930651|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55930652|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55930653|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930654|NCT05040594|Lidocaine|lidocaine|mesh-list
55930655|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
55930656|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
55930657|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930658|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930659|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
55930660|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930661|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55856083|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856084|NCT00500656|Icatibant|icatibant|mesh-list
55856085|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
55856086|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55856114|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55856115|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55856116|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55836978|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856117|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55856118|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856119|NCT00502216|Naltrexone|naltrexone|mesh-list
55856120|NCT00502216|Varenicline|varenicline|mesh-list
55856121|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55856122|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55856123|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856124|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
55856125|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856126|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55856127|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55856128|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
55856129|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856161|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856162|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856163|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
55856164|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856165|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55856166|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55856167|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55856168|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
55856169|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856211|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856212|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55856213|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55856214|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55856215|NCT00512278|Infliximab|infliximab|mesh-list
55856216|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
55856217|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55795353|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
55795354|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
55795355|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795356|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795357|NCT05029401|Ibogaine|ibogaine|mesh-list
56219323|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
56219324|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219325|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56219326|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56219327|NCT01650961|Palonosetron|palonosetron|mesh-list
56219328|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
56219329|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
56219330|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219331|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219332|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56219333|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56219334|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56219335|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
56219336|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219337|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219338|NCT01651130|Carbetocin|carbetocin|mesh-list
55856220|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
55856221|NCT01445535|Rituximab|rituximab|mesh-list
55856222|NCT01445535|Doxorubicin|doxorubicin|mesh-list
55856223|NCT01445535|Etoposide|etoposide|mesh-list
55856224|NCT01445535|Vincristine|vincristine|mesh-list
55856225|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856226|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
55856227|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856228|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856229|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55856230|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
55856231|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856232|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856233|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55856234|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55856235|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55856236|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55856237|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55856238|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856239|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785547|NCT05729555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55785548|NCT05729555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785549|NCT05729555|Anesthetics, Local|anesthetics, local|mesh-ancestor
55785550|NCT05729555|Anesthetics|anesthetics|mesh-ancestor
55785551|NCT05729555|Antiemetics|antiemetics|mesh-ancestor
55785552|NCT05729555|Autonomic Agents|autonomic agents|mesh-ancestor
55785553|NCT05729555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55785554|NCT05729555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55785555|NCT05729555|Histamine Antagonists|histamine antagonists|mesh-ancestor
55785556|NCT05729555|Histamine Agents|histamine agents|mesh-ancestor
55785557|NCT05729555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785558|NCT05729555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55785559|NCT05729555|Antipruritics|antipruritics|mesh-ancestor
55785560|NCT05729555|Dermatologic Agents|dermatologic agents|mesh-ancestor
55795376|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55795377|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795378|NCT04033237|Nicotine|nicotine|mesh-list
55795379|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56219339|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
56219340|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56219341|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219342|NCT01651156|Tolvaptan|tolvaptan|mesh-list
56052335|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
55930662|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55930663|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55930664|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55930665|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930667|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55930668|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930669|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55930670|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219343|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56219344|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219345|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
56219346|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219347|NCT01651169|Methylphenidate|methylphenidate|mesh-list
56219348|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56219349|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219350|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56219351|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55795380|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
55795383|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55785561|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55856240|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
55856242|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856243|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55856244|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55856246|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
55856247|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
55856248|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
55856249|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
55856250|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55856251|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55856252|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856253|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856254|NCT01409031|Urological Agents|urological agents|mesh-ancestor
55856255|NCT01430403|Fluticasone|fluticasone|mesh-list
55856257|NCT01430403|Omalizumab|omalizumab|mesh-list
55856258|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55856259|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856260|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55856261|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
55856262|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930672|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55930673|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
55930674|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55930675|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55930676|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55793584|NCT02638129|Naltrexone|naltrexone|mesh-list
55717471|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
55717473|NCT05624801|Vitamin D|vitamin d|mesh-list
55717474|NCT05624801|Vitamins|vitamins|mesh-ancestor
55717475|NCT05624801|Micronutrients|micronutrients|mesh-ancestor
55717476|NCT05624801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717477|NCT05624801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55717478|NCT05255211|Propofol|propofol|mesh-list
55717479|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55717480|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717481|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717482|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55717483|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
55717484|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
55717485|NCT03514381|Doxorubicin|doxorubicin|mesh-list
55717486|NCT03514381|Ifosfamide|ifosfamide|mesh-list
55717487|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55717488|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717489|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55717490|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55717491|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826243|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55826244|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826246|NCT02133001|Esketamine|esketamine|mesh-list
55826253|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55826254|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
55826255|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55826256|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717492|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717493|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55856263|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856264|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55856265|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
55856266|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
55856267|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55856300|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856301|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
55856302|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
55856303|NCT04407975|Betamethasone|betamethasone|mesh-list
55856304|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856305|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
56219352|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56219353|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856306|NCT04407975|Hormones|hormones|mesh-ancestor
55856307|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856308|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856310|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
55856375|NCT00561418|Vorinostat|vorinostat|mesh-list
55856377|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55856378|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856379|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856380|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55856381|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
55856382|NCT00514852|Glycerol|glycerol|mesh-list
55856383|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55785562|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55785563|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785564|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856384|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55856385|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55856386|NCT00514852|Protective Agents|protective agents|mesh-ancestor
55856387|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856388|NCT00514852|Laxatives|laxatives|mesh-ancestor
55856389|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55856391|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
55856392|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
55856393|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856394|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856395|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55856449|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55856451|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55856452|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856453|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856454|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856455|NCT05560516|Analgesics|analgesics|mesh-ancestor
55856456|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
55856457|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930677|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
55930678|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930681|NCT05039580|Dexamethasone|dexamethasone|mesh-list
55856458|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
55856459|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55856460|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
55856461|NCT05559268|Denosumab|denosumab|mesh-list
55856462|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55856463|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856464|NCT02121418|Cytarabine|cytarabine|mesh-list
55856465|NCT02121418|Decitabine|decitabine|mesh-list
55856466|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55856467|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
55856505|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
55856506|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55856507|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856539|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55856541|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55856542|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55856543|NCT01427751|Growth Substances|growth substances|mesh-ancestor
55856544|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
55856545|NCT01920061|Docetaxel|docetaxel|mesh-list
55856546|NCT01920061|Gedatolisib|gedatolisib|mesh-list
55856547|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856548|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
55856549|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
55856550|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
55856586|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55856587|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
55856588|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856589|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856590|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856591|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55856607|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856609|NCT01405911|Hormones|hormones|mesh-ancestor
55856610|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219355|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219356|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
56219357|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56219358|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55811957|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856611|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55856612|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
55930701|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930702|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
55930703|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
55930704|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930705|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
55930706|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930707|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930708|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55930709|NCT05024604|Progesterone|progesterone|mesh-list
55930710|NCT05024604|Progestins|progestins|mesh-ancestor
55930711|NCT05024604|Hormones|hormones|mesh-ancestor
55930712|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856613|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856614|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856616|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55856617|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
55856618|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856619|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856621|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
55856622|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
55856623|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55856624|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55856625|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55856627|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
55856628|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856629|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856630|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
55856631|NCT02076243|Paclitaxel|paclitaxel|mesh-list
55856632|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55856633|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856634|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
55856635|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
55856636|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
55856637|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856638|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
55856639|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55856640|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55856641|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55856642|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55856643|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856644|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
55856645|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856646|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856647|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55856648|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856649|NCT01392573|Insulin|insulin|mesh-list
55930725|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930726|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930727|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55930728|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930729|NCT03596957|Tolvaptan|tolvaptan|mesh-list
55793617|NCT04997707|Propofol|propofol|mesh-list
55856681|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
55856682|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856683|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55856684|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55856685|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856686|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
55856687|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
55856688|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
55856689|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856690|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
55856691|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
55856692|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55856725|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
55856726|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55856727|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856728|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856729|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55856730|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
55856731|NCT01402869|Lidocaine|lidocaine|mesh-list
55856752|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55856753|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
55856754|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
55856755|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
55856756|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55856757|NCT01391793|Dexamethasone|dexamethasone|mesh-list
55856758|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856759|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
55856760|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
55856761|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219359|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219361|NCT01651182|Coagulants|coagulants|mesh-ancestor
56219362|NCT01651312|Mirabegron|mirabegron|mesh-list
56219363|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55856762|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856763|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55856764|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
55856766|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856767|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55856768|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856769|NCT01422915|Colestipol|colestipol|mesh-list
55856770|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55856771|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
55856772|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856773|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55856774|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
55856775|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
55856776|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55856778|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856779|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856780|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55856781|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
55785565|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55856782|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
55856783|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55856784|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
55856785|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856816|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55856817|NCT01390857|Valacyclovir|valacyclovir|mesh-list
55856818|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
55856819|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856820|NCT04036305|Lidocaine|lidocaine|mesh-list
55856821|NCT04036305|Bupivacaine|bupivacaine|mesh-list
55856822|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
55856823|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
55856824|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856825|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856826|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
55856860|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
55856861|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
55856862|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930730|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55930731|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930732|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
55930733|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930734|NCT03408015|Lifitegrast|lifitegrast|mesh-list
55930735|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55930736|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55793622|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55856864|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55856895|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
55856896|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
55856897|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
55856898|NCT04033575|Protective Agents|protective agents|mesh-ancestor
55856899|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856900|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55856901|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856902|NCT03842085|Antibodies|antibodies|mesh-list
55856903|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55856904|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55856905|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
55856906|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856907|NCT01390389|Ubiquinone|ubiquinone|mesh-list
55856908|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
55856909|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
55856910|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856977|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55856978|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55856979|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
55857009|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857010|NCT01400139|Analgesics|analgesics|mesh-ancestor
55857011|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
55857012|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857013|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
55857014|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
55857015|NCT01399905|Carbidopa|carbidopa|mesh-list
55857016|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56219364|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56219365|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56219366|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
56219367|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219368|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219369|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219370|NCT01651312|Urological Agents|urological agents|mesh-ancestor
56219371|NCT01651325|Isavuconazole|isavuconazole|mesh-list
56219372|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
56219373|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
56219374|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
55857017|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55857018|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
55857019|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857020|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857021|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857022|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55857023|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857024|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55857041|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857043|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
55857044|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55857045|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857046|NCT01880437|Cytarabine|cytarabine|mesh-list
55857047|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55857048|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
55857049|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857050|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857051|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
55857052|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857053|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857054|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
55857055|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857057|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857058|NCT01834729|Alfuzosin|alfuzosin|mesh-list
55857059|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55857060|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55785566|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55857061|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55857062|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
55857063|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857064|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857065|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857066|NCT01834729|Urological Agents|urological agents|mesh-ancestor
55857067|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
55857068|NCT01860703|Deferiprone|deferiprone|mesh-list
55857069|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55857070|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857071|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55857072|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55857073|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857074|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857075|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857076|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55857077|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
55857078|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
55857080|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55857081|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857082|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
55857083|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930737|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
55930738|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55930739|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
55930740|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55930741|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55857084|NCT01388985|Vaccines|vaccines|mesh-list
55857085|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
55857158|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857160|NCT01831765|Insulin|insulin|mesh-list
55857161|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55857162|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
55857163|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
55857210|NCT04766775|Protective Agents|protective agents|mesh-ancestor
55857211|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857212|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
55857213|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55857214|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
55857215|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857216|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857217|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55857218|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
55857219|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
55857220|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55857221|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
55857243|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857244|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857245|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55857247|NCT05365035|Azacitidine|azacitidine|mesh-list
55857248|NCT05365035|Venetoclax|venetoclax|mesh-list
55857249|NCT05365035|Cladribine|cladribine|mesh-list
55857250|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55857251|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
55857252|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857253|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857254|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
55857255|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857256|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857257|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
55857258|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857259|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857260|NCT01396395|Nicorandil|nicorandil|mesh-list
55857261|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55857262|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55857263|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
55857264|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
55857265|NCT01396395|Vitamins|vitamins|mesh-ancestor
55857266|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
55857267|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857268|NCT01396083|Dexamethasone|dexamethasone|mesh-list
55857269|NCT01396083|Ranibizumab|ranibizumab|mesh-list
55857270|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857271|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
55857273|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857308|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857309|NCT01396005|Buprenorphine|buprenorphine|mesh-list
55785567|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857311|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55857376|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55857377|NCT01829425|Oxybutynin|oxybutynin|mesh-list
55857378|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
55857379|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55857380|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
55857381|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857382|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857383|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857384|NCT01829425|Urological Agents|urological agents|mesh-ancestor
55857385|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
55857386|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
55857387|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857388|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
55857389|NCT01394991|Hematinics|hematinics|mesh-ancestor
55857407|NCT01857583|Fondaparinux|fondaparinux|mesh-list
55857408|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55857409|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
55857410|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55857411|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
55857412|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857413|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857414|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
55857415|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55857416|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56219375|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56219376|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56219377|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930742|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930743|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55930744|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930745|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55930746|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717494|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
55717495|NCT02343393|Hydralazine|hydralazine|mesh-list
55717497|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55717498|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55717499|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55717500|NCT02343393|Diuretics|diuretics|mesh-ancestor
55717501|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
55717502|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717503|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
55717504|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55717505|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717506|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55717509|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55717510|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717511|NCT03896009|Analgesics|analgesics|mesh-ancestor
55717512|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
55717513|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717514|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717515|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717516|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717517|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55717518|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55717519|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717520|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717521|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55717522|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
55717523|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717524|NCT02344875|Dotinurad|dotinurad|mesh-list
55717525|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
55717526|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
55717527|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717528|NCT02344875|Renal Agents|renal agents|mesh-ancestor
55717529|NCT03145623|Grazoprevir|grazoprevir|mesh-list
55717530|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55717531|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
55717532|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219378|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219379|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219380|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
56219381|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219382|NCT01651364|Cabergoline|cabergoline|mesh-list
55857417|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55857418|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
55857419|NCT00211185|Prednisone|prednisone|mesh-list
55857420|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
55857421|NCT00211185|Doxorubicin|doxorubicin|mesh-list
55857422|NCT00211185|Vincristine|vincristine|mesh-list
55857423|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
55857424|NCT00211185|Lenograstim|lenograstim|mesh-list
55857425|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857426|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
55857427|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857428|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857429|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55857430|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
55857431|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857432|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857433|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55857434|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55857435|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55857436|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55930747|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55930748|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930749|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857437|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857438|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857439|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
55857440|NCT00211185|Hormones|hormones|mesh-ancestor
55857441|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857442|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55857443|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55857444|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857445|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
55857446|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
55857447|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55857448|NCT00219297|Epothilone B|epothilone b|mesh-list
55857471|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857472|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857473|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
55857474|NCT01721408|Imipenem|imipenem|mesh-list
55857475|NCT01721408|Tigecycline|tigecycline|mesh-list
55857476|NCT01721408|Cilastatin|cilastatin|mesh-list
55857477|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55857478|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857479|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55857480|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857481|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857482|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
55930750|NCT03596099|Acetic Acid|acetic acid|mesh-list
55930751|NCT03596099|Retinol acetate|retinol acetate|mesh-list
55930752|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55930753|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930754|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55930755|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
55930756|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930757|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55857485|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857487|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55857488|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55857489|NCT03998709|Hormones|hormones|mesh-ancestor
55857490|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857491|NCT01744496|Rotigotine|rotigotine|mesh-list
55857492|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
55857493|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
55857494|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857495|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857496|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857497|NCT05631405|Dexamethasone|dexamethasone|mesh-list
55857498|NCT05631405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56219383|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56219384|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55857499|NCT05631405|Antiemetics|antiemetics|mesh-ancestor
55857531|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857533|NCT05634057|Heparin|heparin|mesh-list
55857534|NCT05634057|Calcium heparin|calcium heparin|mesh-list
55857535|NCT05634057|Anticoagulants|anticoagulants|mesh-ancestor
55857536|NCT05634057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55857537|NCT05634057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55857538|NCT05634057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857567|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
55857568|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
55857569|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857570|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857571|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55857572|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55857573|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
55857574|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857575|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857576|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
55857577|NCT03596385|Protective Agents|protective agents|mesh-ancestor
55857578|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55857579|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55857580|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55857581|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
55857582|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55857583|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55761853|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55857584|NCT01828099|Carboplatin|carboplatin|mesh-list
55857585|NCT01828099|Pemetrexed|pemetrexed|mesh-list
55857586|NCT01828099|Ceritinib|ceritinib|mesh-list
55857587|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857672|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
55857673|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857674|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857675|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55857676|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55857677|NCT00217581|Growth Substances|growth substances|mesh-ancestor
55857678|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857679|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
55930758|NCT03596099|Protective Agents|protective agents|mesh-ancestor
55930759|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930760|NCT01041417|Molgramostim|molgramostim|mesh-list
55930761|NCT01041417|Sargramostim|sargramostim|mesh-list
55930762|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
55930763|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930764|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930765|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
55930766|NCT03595397|Fentanyl|fentanyl|mesh-list
55930767|NCT03595397|Bupivacaine|bupivacaine|mesh-list
55930768|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
55930769|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
55930770|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857680|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857681|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
55857682|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
55857683|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857684|NCT00217425|Prednisone|prednisone|mesh-list
55857685|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
55857686|NCT00217425|Bevacizumab|bevacizumab|mesh-list
55857687|NCT00217425|Doxorubicin|doxorubicin|mesh-list
55857688|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55857689|NCT00217425|Vincristine|vincristine|mesh-list
55857690|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857691|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
55857728|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857729|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857760|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
55857761|NCT00215943|Hormones|hormones|mesh-ancestor
55857762|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857764|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857765|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55857766|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55785569|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857767|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55857768|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857769|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857770|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55857771|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857772|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
55857773|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
55857774|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857804|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
55857805|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55857806|NCT01827163|Paclitaxel|paclitaxel|mesh-list
55857807|NCT01827163|Trastuzumab|trastuzumab|mesh-list
55857808|NCT01827163|Lapatinib|lapatinib|mesh-list
56219385|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
55857809|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55930771|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930772|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
55930773|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930774|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55930775|NCT03595397|Narcotics|narcotics|mesh-ancestor
55930776|NCT03595397|Analgesics|analgesics|mesh-ancestor
55930777|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55930778|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55930779|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
55930780|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55930781|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
55930782|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55930783|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55930784|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930785|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55930786|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
55930787|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55857810|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857811|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857812|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
55857813|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
55857814|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857815|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857816|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55857817|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857818|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55857819|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
55857820|NCT00214461|Vaccines|vaccines|mesh-list
55857821|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
55857846|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
55857847|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857848|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857849|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55811974|NCT02434939|Ketamine|ketamine|mesh-list
55857850|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
55857851|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857852|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55857853|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857854|NCT03592485|Acetaminophen|acetaminophen|mesh-list
55857856|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857857|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857858|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55857859|NCT03592485|Analgesics|analgesics|mesh-ancestor
55857860|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
55857861|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857862|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
55857863|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55857864|NCT03592485|Narcotics|narcotics|mesh-ancestor
55857865|NCT04199013|Fentanyl|fentanyl|mesh-list
55857866|NCT04199013|Ropivacaine|ropivacaine|mesh-list
55857867|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
55930792|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
55930793|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930794|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930795|NCT01040871|Prednisone|prednisone|mesh-list
55930796|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
55930797|NCT01040871|Rituximab|rituximab|mesh-list
55930798|NCT01040871|Doxorubicin|doxorubicin|mesh-list
55930799|NCT01040871|Vincristine|vincristine|mesh-list
55930800|NCT01040871|Bortezomib|bortezomib|mesh-list
55930801|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55930802|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
55930803|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930804|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857868|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
55857869|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857870|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857871|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
55857872|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857905|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55857906|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857907|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55857908|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
55857909|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857910|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857911|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
55857912|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857913|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55857950|NCT03591471|Benazepril|benazepril|mesh-list
55857951|NCT03591471|Heparin|heparin|mesh-list
55857952|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55857953|NCT03591471|Tinzaparin|tinzaparin|mesh-list
55857954|NCT03591471|Dalteparin|dalteparin|mesh-list
55857955|NCT03591471|Calcium heparin|calcium heparin|mesh-list
55857956|NCT03591471|Dipyridamole|dipyridamole|mesh-list
55857985|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
55857986|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785570|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
55785571|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55857988|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55857989|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55857990|NCT01875991|Analgesics|analgesics|mesh-ancestor
55857991|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
55857992|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857993|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857994|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857995|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857996|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857997|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857998|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
55857999|NCT04203927|Empagliflozin|empagliflozin|mesh-list
55858000|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56219386|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
55930805|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55930806|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
55930807|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930808|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930809|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55930810|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55930811|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55930812|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55930813|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55717533|NCT02294071|Acetaminophen|acetaminophen|mesh-list
55826274|NCT01709578|Analgesics|analgesics|mesh-ancestor
55826275|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
55826276|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826301|NCT02153905|Interleukin-2|interleukin-2|mesh-list
55826302|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826303|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
55826304|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826305|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55826306|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55826307|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
55826308|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826309|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826310|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55826311|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55826312|NCT02153905|Analgesics|analgesics|mesh-ancestor
56219387|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219388|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219389|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219390|NCT01651377|Pramipexole|pramipexole|mesh-list
56219391|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
56219392|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219393|NCT01651377|Protective Agents|protective agents|mesh-ancestor
56219394|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219395|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56219396|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56219397|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
56219398|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
56219399|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219400|NCT01651390|Sirolimus|sirolimus|mesh-list
55795411|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55858028|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
55858029|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858030|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
55858031|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
55858032|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858033|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858034|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858035|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
55858036|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
55858037|NCT01824823|Afatinib|afatinib|mesh-list
55858038|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858039|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55858040|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858041|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858042|NCT03598725|Prednisone|prednisone|mesh-list
55858043|NCT03598725|Rituximab|rituximab|mesh-list
55858044|NCT03598725|Factor VIII|factor viii|mesh-list
55858045|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55858046|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858047|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
55858080|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55858081|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
55858082|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858083|NCT04191135|Antiviral Agents|antiviral agents|mesh-ancestor
55930814|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930815|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930816|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
55930817|NCT01040871|Hormones|hormones|mesh-ancestor
55930818|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930819|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55930820|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55858084|NCT04191135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858085|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858086|NCT04191135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55858087|NCT04191135|Immunologic Factors|immunologic factors|mesh-ancestor
55858088|NCT04191135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858089|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55858090|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55858145|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55858147|NCT03597867|Analgesics|analgesics|mesh-ancestor
55858148|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
55858149|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858150|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858151|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858152|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858153|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55858154|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219402|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56219403|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219404|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
56219405|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
56219406|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
56219407|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219408|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56219409|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219410|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56219411|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
56219412|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219413|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
56219414|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219416|NCT01651416|Artemether|artemether|mesh-list
56219417|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
56219418|NCT01651416|Piperaquine|piperaquine|mesh-list
56219419|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
56219420|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55930822|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
55930823|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
55930824|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
55930825|NCT01040169|Calcium|calcium|mesh-list
56219421|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56219422|NCT01651416|Amodiaquine|amodiaquine|mesh-list
56219423|NCT01651416|Artenimol|artenimol|mesh-list
56219424|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
55795426|NCT05165251|Amlodipine|amlodipine|mesh-list
55858155|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858156|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
55858157|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
55858158|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55858159|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
55858160|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55858161|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55858162|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
55858163|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
55858164|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55858166|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
55858167|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55858168|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785572|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55785573|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55785574|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
55785575|NCT03136003|Coagulants|coagulants|mesh-ancestor
55785576|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55858197|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858198|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55858199|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
55858200|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858201|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858202|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
55858203|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219425|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56219426|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56219427|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219428|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56219429|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826363|NCT01599806|Ceftazidime|ceftazidime|mesh-list
55826364|NCT01599806|Avibactam|avibactam|mesh-list
55826365|NCT01599806|Doripenem|doripenem|mesh-list
55717617|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717618|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55717619|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55717620|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
55717621|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717622|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55717623|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55717624|NCT03766295|Gemcitabine|gemcitabine|mesh-list
55717625|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55717626|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
55717627|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717628|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717629|NCT03766295|Antiviral Agents|antiviral agents|mesh-ancestor
55717630|NCT03766295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717631|NCT03766295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717632|NCT03766295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717633|NCT03766295|Immunologic Factors|immunologic factors|mesh-ancestor
55717634|NCT03766295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717636|NCT03761225|Docetaxel|docetaxel|mesh-list
55717637|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717638|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
55717639|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
55717640|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
55717641|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717642|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717643|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
55717644|NCT03761225|Hormones|hormones|mesh-ancestor
55717645|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55717646|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717647|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55717648|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55717649|NCT02349945|Hormones|hormones|mesh-ancestor
55717650|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55717651|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717652|NCT02302495|Prednisone|prednisone|mesh-list
55717653|NCT02302495|Melphalan|melphalan|mesh-list
56219430|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219431|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56219432|NCT01651416|Renal Agents|renal agents|mesh-ancestor
56219433|NCT01651481|Montelukast|montelukast|mesh-list
56219434|NCT01651481|Levocetirizine|levocetirizine|mesh-list
56219435|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56219436|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
56219437|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56219438|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
56219439|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219440|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219441|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56219442|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55930826|NCT01040169|Fluorides|fluorides|mesh-list
55930827|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55930828|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930829|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
55761955|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
55858204|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55858205|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55858206|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
55858207|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858208|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55858241|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858243|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858245|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55858246|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
55858247|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55858248|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
55858249|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858280|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858281|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55858282|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55858284|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
55858285|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858286|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858287|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858288|NCT04344951|Filaricides|filaricides|mesh-ancestor
55858289|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
55858290|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
55858291|NCT01822561|Eplerenone|eplerenone|mesh-list
55858292|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55858293|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
55858327|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55858328|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55858329|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55858365|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55858366|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858367|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
55858368|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219443|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219444|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56219445|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56219446|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
55930830|NCT01040169|Protective Agents|protective agents|mesh-ancestor
55930831|NCT01040169|Antacids|antacids|mesh-ancestor
55930832|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930833|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55930834|NCT01044381|Luliconazole|luliconazole|mesh-list
56219447|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
56219448|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219449|NCT01651520|Flumazenil|flumazenil|mesh-list
56219450|NCT01651520|Antidotes|antidotes|mesh-ancestor
56219451|NCT01651520|Protective Agents|protective agents|mesh-ancestor
56219452|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219453|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
56219454|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
56219455|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219456|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219457|NCT01651572|Rocuronium|rocuronium|mesh-list
56219458|NCT01651572|Cisatracurium|cisatracurium|mesh-list
56219459|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56219460|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56219461|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56219462|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219463|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219464|NCT01651585|Valacyclovir|valacyclovir|mesh-list
56219465|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
56219466|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219467|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56219468|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
56219469|NCT01651715|Antibodies|antibodies|mesh-list
56219470|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
56219471|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219472|NCT01651728|Simvastatin|simvastatin|mesh-list
56219473|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56219474|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56219486|NCT01651962|Fentanyl|fentanyl|mesh-list
56219487|NCT01651962|Terbutaline|terbutaline|mesh-list
56219488|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56219489|NCT01651962|Narcotics|narcotics|mesh-ancestor
55930835|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
55930836|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930837|NCT03594461|Aflibercept|aflibercept|mesh-list
55930838|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55930839|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55930840|NCT03594461|Growth Substances|growth substances|mesh-ancestor
55930841|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930842|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
55761967|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55717808|NCT02232581|Alovudine|alovudine|mesh-list
55717809|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
55717810|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
55717811|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717812|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
55717813|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717814|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55717815|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55717817|NCT02341833|Sevoflurane|sevoflurane|mesh-list
55717818|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55717819|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55717820|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
55717821|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
55717822|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717824|NCT02337231|Borage oil|borage oil|mesh-list
55717825|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717826|NCT03507751|Meropenem|meropenem|mesh-list
55717827|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55717828|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717829|NCT02306629|Epratuzumab|epratuzumab|mesh-list
55717830|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55717831|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717832|NCT03510793|Anesthetics|anesthetics|mesh-list
55717833|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717834|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717835|NCT05039177|Cetuximab|cetuximab|mesh-list
55717836|NCT05039177|Palbociclib|palbociclib|mesh-list
56219490|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56219491|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219492|NCT01651962|Analgesics|analgesics|mesh-ancestor
56219493|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
56219494|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219495|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55812022|NCT02457247|Antacids|antacids|mesh-ancestor
56219496|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56219497|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
56219499|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56219500|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
56219501|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56219502|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
56219503|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
56219504|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
56219505|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56219506|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55858401|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858403|NCT04024527|Metronidazole|metronidazole|mesh-list
55858404|NCT04024527|Esomeprazole|esomeprazole|mesh-list
55858405|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55858406|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858407|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55858408|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55858409|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55858410|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55858411|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55858477|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930843|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930844|NCT03407703|Grazoprevir|grazoprevir|mesh-list
55930845|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55930846|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
55930847|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930848|NCT03594149|Levofloxacin|levofloxacin|mesh-list
55930849|NCT03594149|Ofloxacin|ofloxacin|mesh-list
55930850|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55930851|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930852|NCT03594149|Renal Agents|renal agents|mesh-ancestor
55930853|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55858479|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858480|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55858481|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
55858482|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858483|NCT04145193|Antidotes|antidotes|mesh-ancestor
55858484|NCT04145193|Protective Agents|protective agents|mesh-ancestor
55858485|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
55858486|NCT04145193|Vitamins|vitamins|mesh-ancestor
55858487|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
55858488|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55858490|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55858491|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55858492|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55858520|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858523|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858524|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55858525|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
55858526|NCT01849783|Hormones|hormones|mesh-ancestor
55858527|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858528|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55858529|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55858530|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55858531|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56219507|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56219508|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56219509|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
56219510|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219511|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219512|NCT01651988|Propofol|propofol|mesh-list
56219513|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56219514|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56219515|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219516|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56219517|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
56219518|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
56219519|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
56219520|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
56219521|NCT01652014|Fludarabine|fludarabine|mesh-list
55930854|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55930855|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55930856|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930857|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930858|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219522|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
55795534|NCT03763305|Analgesics|analgesics|mesh-ancestor
55858532|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858533|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55858534|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
55858535|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55858536|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858537|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55858538|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55858539|NCT01849783|Growth Substances|growth substances|mesh-ancestor
55858540|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
55858566|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
55858567|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858568|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55858569|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55858570|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55858571|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55858572|NCT01870999|Aripiprazole|aripiprazole|mesh-list
55858573|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
55858574|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55858575|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55858576|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55858577|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55858578|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858579|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
55858580|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
55858581|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858582|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858583|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55858584|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55858585|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
55858586|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55858587|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55858588|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55858654|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858655|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858656|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
55858657|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858658|NCT01870843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55858659|NCT01870843|Antidepressive Agents|antidepressive agents|mesh-ancestor
55858660|NCT01870843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55858661|NCT01816477|Ropivacaine|ropivacaine|mesh-list
55858662|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
56219523|NCT01652014|Tacrolimus|tacrolimus|mesh-list
56219524|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219525|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
56219526|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219527|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219528|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56219529|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
56219530|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219531|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219532|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56219533|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219534|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
56219535|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56219536|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219537|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56219538|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56219539|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
56219540|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56219541|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219542|NCT01652118|Clarithromycin|clarithromycin|mesh-list
56219543|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56219544|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858663|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
55858664|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55858665|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858691|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858693|NCT01846507|Coagulants|coagulants|mesh-ancestor
55858694|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
55858695|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55858696|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
55858697|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858698|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
55858699|NCT01846039|Protective Agents|protective agents|mesh-ancestor
55858700|NCT04699240|Clotrimazole|clotrimazole|mesh-list
55858701|NCT04699240|Miconazole|miconazole|mesh-list
55858702|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55858703|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858704|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
55858706|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55858707|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761985|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
55930859|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55930860|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55930861|NCT00916539|Calpastatin|calpastatin|mesh-list
55930862|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55930863|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
55858708|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858709|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55858710|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
55858711|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858712|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858734|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858735|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55858736|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55858737|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
55858738|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
56219545|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56219546|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219547|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219548|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56219549|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56219550|NCT01652157|Pancrelipase|pancrelipase|mesh-list
56219551|NCT01652157|Pancreatin|pancreatin|mesh-list
56219552|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56219553|NCT01652183|Acetaminophen|acetaminophen|mesh-list
55858739|NCT05576896|Hydroxychloroquine|hydroxychloroquine|mesh-list
55858740|NCT05576896|Cetuximab|cetuximab|mesh-list
55858741|NCT05576896|Panitumumab|panitumumab|mesh-list
55858742|NCT05576896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55858743|NCT05576896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858744|NCT05576896|Antimalarials|antimalarials|mesh-ancestor
55858745|NCT05576896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55858746|NCT05576896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55858747|NCT05576896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858748|NCT05576896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858749|NCT05576896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858750|NCT05576896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858751|NCT01845805|Azacitidine|azacitidine|mesh-list
55858752|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55858753|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
55858754|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858755|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858756|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858757|NCT05575804|Capecitabine|capecitabine|mesh-list
55858758|NCT05575804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55858759|NCT05575804|Antimetabolites|antimetabolites|mesh-ancestor
55858760|NCT05575804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858761|NCT05575804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858762|NCT01845025|Fluticasone|fluticasone|mesh-list
55858763|NCT01845025|Xhance|xhance|mesh-list
55858764|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
55858765|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858766|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55858767|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
55858790|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
55858791|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
55858792|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55858793|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858794|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
55858795|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858796|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55858797|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55858798|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55858799|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55858800|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858802|NCT05193994|Abacavir|abacavir|mesh-list
55858803|NCT05193994|Dolutegravir|dolutegravir|mesh-list
55858804|NCT05193994|Triumeq|triumeq|mesh-list
55858805|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55858806|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55858807|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858808|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930864|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930865|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930866|NCT03593447|Ribavirin|ribavirin|mesh-list
55858809|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
55858810|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858811|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55858812|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55858813|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55858814|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55858815|NCT04847440|Tenofovir|tenofovir|mesh-list
55858816|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
55858817|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219554|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56219555|NCT01652183|Analgesics|analgesics|mesh-ancestor
56219556|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
56219557|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858837|NCT01870297|Liraglutide|liraglutide|mesh-list
55858838|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55858839|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858840|NCT01870297|Incretins|incretins|mesh-ancestor
55858841|NCT01870297|Hormones|hormones|mesh-ancestor
55858842|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858843|NCT01814761|Bimatoprost|bimatoprost|mesh-list
55858844|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55858845|NCT04616248|Poly I-C|poly i-c|mesh-list
55858846|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55858847|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55858848|NCT04616248|Antibodies|antibodies|mesh-list
55858849|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
55858850|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55858851|NCT04616248|Poly ICLC|poly iclc|mesh-list
55858852|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
55858853|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
55858854|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858855|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858856|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
55858857|NCT04616248|Laxatives|laxatives|mesh-ancestor
55858858|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55858859|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
55858860|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858861|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55858862|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55858863|NCT04616248|Protective Agents|protective agents|mesh-ancestor
55858864|NCT01798030|Vitamin D|vitamin d|mesh-list
55858865|NCT01798030|Vitamins|vitamins|mesh-ancestor
55858866|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
55858867|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858868|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55858869|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
55858870|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55858871|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858872|NCT01814371|Mupirocin|mupirocin|mesh-list
55858873|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55858874|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858875|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55858876|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858877|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858879|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55858903|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
55858904|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858905|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858906|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858907|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858908|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55858909|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55858910|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858911|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55858912|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55858913|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858914|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
55858915|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55858916|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55858917|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55858918|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
55858919|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858920|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
55858921|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55858922|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
55858924|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
55858925|NCT01798498|Protective Agents|protective agents|mesh-ancestor
55858926|NCT04934800|Cladribine|cladribine|mesh-list
55858927|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858928|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785582|NCT04945213|Biperiden|biperiden|mesh-list
56219558|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219559|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
56219560|NCT01652196|Leucovorin|leucovorin|mesh-list
55785583|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55785584|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55858929|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
55858930|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858931|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55858932|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55858961|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55858962|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
55858963|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
55858964|NCT01033552|Cyclosporine|cyclosporine|mesh-list
55858965|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
55858966|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
55930867|NCT03593447|Yimitasvir|yimitasvir|mesh-list
55930868|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
55930869|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930870|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
55930871|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930872|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55858967|NCT01033552|Fludarabine|fludarabine|mesh-list
55858968|NCT01033552|Cyclosporins|cyclosporins|mesh-list
55858969|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55858970|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55858971|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
55858972|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858973|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858974|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55858975|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
55858976|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858977|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859002|NCT00997906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859003|NCT00997906|Immunologic Factors|immunologic factors|mesh-ancestor
55859004|NCT00997906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859005|NCT05246644|Acetaminophen|acetaminophen|mesh-list
55859006|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55859007|NCT05246644|Analgesics|analgesics|mesh-ancestor
55859008|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
55859009|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859010|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859011|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
55859012|NCT01798576|Interferons|interferons|mesh-list
55859013|NCT01798576|Ribavirin|ribavirin|mesh-list
55859014|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
55859015|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
55859016|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55859017|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859018|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
55762020|NCT03195569|Bevacizumab|bevacizumab|mesh-list
55930873|NCT03593291|Dalteparin|dalteparin|mesh-list
55930874|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
55859019|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859020|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
55859021|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859022|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
55859023|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859024|NCT00565084|Ibuprofen|ibuprofen|mesh-list
55859025|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55859026|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55859028|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
55859029|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859030|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859057|NCT05362942|Azacitidine|azacitidine|mesh-list
55859058|NCT05362942|Decitabine|decitabine|mesh-list
55859059|NCT05362942|Venetoclax|venetoclax|mesh-list
55859060|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55859061|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
55859062|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859063|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859064|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
55859065|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859066|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859067|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
55859068|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859069|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859070|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
55859071|NCT01868893|Chlorambucil|chlorambucil|mesh-list
55859072|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55859073|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859074|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55859076|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859078|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56219561|NCT01652196|Fluorouracil|fluorouracil|mesh-list
56219562|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
56219563|NCT01652196|Aflibercept|aflibercept|mesh-list
56219564|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
56219565|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56219566|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
56219567|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219568|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219569|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795585|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
55795587|NCT03064633|BB 1101|bb 1101|mesh-list
55859148|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55785586|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
55785587|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785588|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859149|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859151|NCT02958514|Dexamethasone|dexamethasone|mesh-list
55859152|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859153|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
55859154|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
55859155|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930875|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55930876|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55859156|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859157|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55859186|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55859187|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859188|NCT05236894|Nicotine|nicotine|mesh-list
55859189|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55859190|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
55859191|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859192|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859193|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55859194|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55859195|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
55859196|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859197|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859198|NCT04507204|Methylphenidate|methylphenidate|mesh-list
55859199|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55859200|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859201|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55859233|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
55859234|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859235|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859236|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859237|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55859238|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55859239|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859240|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859241|NCT05076292|Glucagon|glucagon|mesh-list
55859270|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
55859271|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859272|NCT04483102|Liver Extracts|liver extracts|mesh-list
55859273|NCT04483102|Hematinics|hematinics|mesh-ancestor
55859274|NCT04387786|Albuterol|albuterol|mesh-list
55859275|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55859276|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
55859277|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859278|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859279|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55859280|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859281|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
55859282|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55859283|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56219570|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219571|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
56219572|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219573|NCT01652196|Antidotes|antidotes|mesh-ancestor
56219574|NCT01652196|Protective Agents|protective agents|mesh-ancestor
55859284|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55859286|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
55859287|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859314|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859316|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55859317|NCT00574834|Ramipril|ramipril|mesh-list
55859318|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55859319|NCT00574834|Diuretics|diuretics|mesh-ancestor
55859320|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
55859321|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930877|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930878|NCT03593135|Metformin|metformin|mesh-list
55930879|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55930880|NCT03593135|Acetic Acid|acetic acid|mesh-list
55859322|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55859323|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55859324|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859325|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55859326|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
55859327|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859328|NCT03934840|Prednisone|prednisone|mesh-list
55859329|NCT03934840|Carboplatin|carboplatin|mesh-list
55859330|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859331|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859332|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
55859333|NCT03934840|Hormones|hormones|mesh-ancestor
55859365|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859366|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55859367|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859368|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
55859369|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55859370|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
55859371|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859372|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859373|NCT00579280|Valproic Acid|valproic acid|mesh-list
55859374|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55859375|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
55859439|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55859440|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55859441|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859442|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
55859443|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930881|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55930882|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930883|NCT03593135|Incretins|incretins|mesh-ancestor
55930884|NCT03593135|Hormones|hormones|mesh-ancestor
55930885|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930886|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55930887|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
55930888|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930889|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930890|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55930891|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930892|NCT03592901|Anesthetics|anesthetics|mesh-list
55930893|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930894|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930895|NCT03830385|Carboplatin|carboplatin|mesh-list
55930897|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930898|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55930899|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
55930900|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
55930901|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55859444|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859445|NCT01802437|Fluoxetine|fluoxetine|mesh-list
55859446|NCT01802437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55859447|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55859448|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55859449|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859450|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859451|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
55859452|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859489|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55859490|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55859491|NCT01801735|Analgesics|analgesics|mesh-ancestor
55859561|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55859562|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859563|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55859564|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
55859565|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859597|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55859598|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
55859599|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
55859600|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55859601|NCT00615472|Narcotics|narcotics|mesh-ancestor
55859602|NCT00615472|Analgesics|analgesics|mesh-ancestor
56219575|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
56219576|NCT01652196|Vitamins|vitamins|mesh-ancestor
56219577|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
56219578|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56219579|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56219580|NCT01652196|Growth Substances|growth substances|mesh-ancestor
56219581|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
56219582|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56219583|NCT01652313|Rasagiline|rasagiline|mesh-list
56219584|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56219585|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219586|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219587|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56219588|NCT01652313|Protective Agents|protective agents|mesh-ancestor
56219589|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219590|NCT01652326|Diazepam|diazepam|mesh-list
56219591|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56219592|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
56219593|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
56219594|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
56219595|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219596|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859603|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
55859604|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859605|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55859606|NCT00615784|Bexarotene|bexarotene|mesh-list
55859631|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55930902|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55930903|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930904|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930905|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930906|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930907|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
55859632|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55859633|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55859634|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859635|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
55859636|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859637|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55859638|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
55859639|NCT00489346|Fluticasone|fluticasone|mesh-list
55859640|NCT00489346|Xhance|xhance|mesh-list
55859641|NCT00489346|Montelukast|montelukast|mesh-list
55859642|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859643|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55859644|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
55859645|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859646|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859647|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55859648|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859649|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
55859650|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55859651|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859671|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56052336|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762080|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
55762081|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55859672|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859673|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55859674|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55859676|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
56219597|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56219598|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56219599|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56219600|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56219601|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56219602|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56219603|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56219604|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55812060|NCT04929379|Fenofibrate|fenofibrate|mesh-list
55859677|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55859678|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
55859679|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859680|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55859681|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
55859682|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
55859684|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
55859685|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859686|NCT05247424|Heparin|heparin|mesh-list
55859687|NCT05247424|Calcium heparin|calcium heparin|mesh-list
55859688|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
55859689|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55859690|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55859691|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859692|NCT00092716|Atorvastatin|atorvastatin|mesh-list
55859693|NCT00092716|Ezetimibe|ezetimibe|mesh-list
55859694|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55859695|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55859696|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
55859697|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859698|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55859699|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55859700|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859701|NCT00619684|Lenalidomide|lenalidomide|mesh-list
55859702|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
55859703|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859704|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55859729|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55859730|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55859731|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55930921|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930922|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930923|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930924|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55930926|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55930927|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
55930928|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
55930929|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930930|NCT03406533|Fentanyl|fentanyl|mesh-list
55930931|NCT03406533|Midazolam|midazolam|mesh-list
55930932|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
55930933|NCT03406533|Remifentanil|remifentanil|mesh-list
55930934|NCT03406533|Propofol|propofol|mesh-list
55930935|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55930936|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859732|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
55859733|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859734|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859735|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55859736|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
55859737|NCT00668434|Prednisone|prednisone|mesh-list
55859738|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859739|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
55859740|NCT00668434|Hormones|hormones|mesh-ancestor
55859741|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859742|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859743|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55859744|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859745|NCT00668902|Pantoprazole|pantoprazole|mesh-list
55859746|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55859747|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55859748|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55859749|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859750|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859751|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55859752|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55859753|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55859754|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55859755|NCT00621946|Dexetimide|dexetimide|mesh-list
55859756|NCT00621946|Citalopram|citalopram|mesh-list
55859787|NCT02139358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859788|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55859790|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
56219605|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56219606|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
56219608|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
56219609|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
56219610|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219611|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219612|NCT01652339|Amlodipine|amlodipine|mesh-list
56219613|NCT01652339|Valsartan|valsartan|mesh-list
56219614|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56219615|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56219616|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56219617|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56219618|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219619|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56219620|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219621|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
55859791|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55859792|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
55859793|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
55859794|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
55859795|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859796|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859834|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859835|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859836|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
55859837|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859838|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55859876|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55859893|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55859894|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55859895|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859896|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55859897|NCT00629122|Clotrimazole|clotrimazole|mesh-list
55859899|NCT00629122|Nystatin|nystatin|mesh-list
55859900|NCT00629122|Tacrolimus|tacrolimus|mesh-list
55859901|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859902|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
55859903|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859904|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55859905|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859906|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859907|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55859908|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859909|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
55859910|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55859911|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55859912|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55859913|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
55859914|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859915|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55859916|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56219622|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56219623|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56219624|NCT01652378|Lidocaine|lidocaine|mesh-list
56219625|NCT01652378|Ondansetron|ondansetron|mesh-list
56219626|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
56219627|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
56219628|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56219629|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219630|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
56219631|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219632|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55930940|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
55930941|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55930942|NCT03406533|Analgesics|analgesics|mesh-ancestor
55930943|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
55930944|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930945|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55930946|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55930947|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55930948|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
56219633|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56219634|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56219635|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56219636|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859917|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55859918|NCT00629122|Ionophores|ionophores|mesh-ancestor
55859919|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55859920|NCT00596440|Nicotine|nicotine|mesh-list
55859921|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55859922|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
55859923|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859924|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859925|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55859926|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55859927|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
55859928|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859929|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859930|NCT00632632|Cycloserine|cycloserine|mesh-list
55859931|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55859932|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859933|NCT00632632|Renal Agents|renal agents|mesh-ancestor
55859934|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55859935|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
55859965|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55859966|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55859967|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859968|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859969|NCT00678418|Naltrexone|naltrexone|mesh-list
55859970|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55859971|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55859972|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859973|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
55859974|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859975|NCT00600340|Paclitaxel|paclitaxel|mesh-list
55859976|NCT00600340|Bevacizumab|bevacizumab|mesh-list
55859977|NCT00600340|Capecitabine|capecitabine|mesh-list
55859978|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55859979|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859980|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
55930949|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859981|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
55860006|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55860008|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55785591|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
55785592|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860009|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55860010|NCT00602290|Methylphenidate|methylphenidate|mesh-list
56219637|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
56219638|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
56219639|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56219640|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
56219641|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
56219642|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56219643|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
56219644|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219645|NCT01652378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56219646|NCT01652378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56219647|NCT01652378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55860011|NCT00602290|Citalopram|citalopram|mesh-list
55860012|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55860013|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860014|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55860015|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55860016|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860017|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860018|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
55860019|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860020|NCT00602290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55860021|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
55860022|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55860023|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
55860024|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55860025|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
55860026|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860027|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55860028|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55860029|NCT00637780|Analgesics|analgesics|mesh-ancestor
55860030|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
55860031|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860076|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860077|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860078|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55860079|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860080|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55930950|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930951|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55930952|NCT03406533|Narcotics|narcotics|mesh-ancestor
55930953|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55930954|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55930955|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55930956|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55930957|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
55930958|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
55930959|NCT03591341|Melatonin|melatonin|mesh-list
55930960|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
55930961|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930962|NCT03591341|Protective Agents|protective agents|mesh-ancestor
55860081|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55860082|NCT00602836|Growth Substances|growth substances|mesh-ancestor
55860083|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
55860084|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
55860085|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860086|NCT00683332|Tigecycline|tigecycline|mesh-list
55860087|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55860088|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860089|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55860116|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860117|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
55860118|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860119|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55860120|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860121|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860122|NCT00642694|Dexetimide|dexetimide|mesh-list
55860123|NCT00642694|Citalopram|citalopram|mesh-list
55860124|NCT00642694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55860125|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55860126|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55930963|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930964|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55930966|NCT04377399|Vitamins|vitamins|mesh-ancestor
55930967|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
55930968|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930969|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55930970|NCT03400995|Ziresovir|ziresovir|mesh-list
55930971|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
55860127|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860128|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860129|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
55860130|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860131|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55860132|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
56219649|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
56219650|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56219651|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56219653|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
56219654|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56219655|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
56219656|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56219657|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
56219658|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
56219659|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219660|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219661|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55795679|NCT01697527|Analgesics|analgesics|mesh-ancestor
55860133|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55860134|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55860135|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55860148|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860149|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860150|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55860151|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55860152|NCT00705874|Growth Substances|growth substances|mesh-ancestor
55860153|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860154|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
55860157|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860159|NCT00705874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785593|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860160|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860161|NCT00705874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55930973|NCT03406299|Leucovorin|leucovorin|mesh-list
55930974|NCT03406299|Gemcitabine|gemcitabine|mesh-list
55930975|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
55860162|NCT00705874|Immunologic Factors|immunologic factors|mesh-ancestor
55860163|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
55860164|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
55860165|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
55860167|NCT00705874|Protective Agents|protective agents|mesh-ancestor
55860168|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
55860169|NCT00705874|Vitamins|vitamins|mesh-ancestor
55860170|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
55860171|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55860172|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
55860173|NCT00647998|Hematinics|hematinics|mesh-ancestor
55860174|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
55860175|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55860176|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860177|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860178|NCT00687076|Aspirin|aspirin|mesh-list
55860179|NCT00687076|Niacin|niacin|mesh-list
55860180|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
55860181|NCT00687076|Clopidogrel|clopidogrel|mesh-list
55860182|NCT00687076|Ezetimibe|ezetimibe|mesh-list
55860183|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55860184|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55860185|NCT00687076|Analgesics|analgesics|mesh-ancestor
55860186|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
55860187|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860188|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860189|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55860190|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860191|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55860192|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56219662|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
56219664|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219665|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56219666|NCT01652417|Protective Agents|protective agents|mesh-ancestor
56219667|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56219668|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219669|NCT01652534|Amantadine|amantadine|mesh-list
56219670|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55860193|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860194|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55860195|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55860196|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930976|NCT03406299|Tegafur|tegafur|mesh-list
55930977|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860197|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
55860198|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55860199|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55860237|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
55860238|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860239|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860272|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860273|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55860274|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860275|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55860276|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
55860277|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55762093|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930978|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55930979|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
55930980|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930981|NCT03406299|Antiviral Agents|antiviral agents|mesh-ancestor
55930982|NCT03406299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930983|NCT03406299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860278|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55860279|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
55860280|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860281|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
55860282|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860304|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
55860305|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55860306|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55860307|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55860308|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860309|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860310|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55860311|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55860312|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55860313|NCT00655642|Promethazine|promethazine|mesh-list
55860314|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
55860315|NCT00655642|Ondansetron|ondansetron|mesh-list
55860316|NCT00655642|Metoclopramide|metoclopramide|mesh-list
55860317|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
55860318|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
55860319|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860320|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860321|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55860322|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
55785595|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55785596|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860323|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
55860324|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55860325|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
55860326|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860327|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860328|NCT00655642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55860329|NCT00655642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55860330|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860331|NCT00655642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55860332|NCT00655642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55860333|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55860334|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56219671|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55860336|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55860337|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
55860365|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860366|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
55860367|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
55860368|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860369|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
55860370|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860371|NCT00656968|Esomeprazole|esomeprazole|mesh-list
55860372|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55860373|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55860374|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55860375|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860376|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860377|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55860378|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55860379|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860380|NCT00657280|Incretins|incretins|mesh-ancestor
55860381|NCT00657280|Hormones|hormones|mesh-ancestor
55860382|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55860383|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55860384|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
55860385|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860405|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
55860406|NCT00695188|Methotrexate|methotrexate|mesh-list
55860407|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55860408|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
55860409|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55860410|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860411|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55860412|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
55860413|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860414|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860415|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
55860416|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860417|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55860418|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860419|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
55860420|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860421|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55860422|NCT00706264|Silicon|silicon|mesh-list
55860423|NCT00706264|Trace Elements|trace elements|mesh-ancestor
55860424|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
55860425|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860426|NCT01154920|Paclitaxel|paclitaxel|mesh-list
55860427|NCT01154920|Docetaxel|docetaxel|mesh-list
55930985|NCT03406299|Immunologic Factors|immunologic factors|mesh-ancestor
55930986|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930987|NCT03406299|Antidotes|antidotes|mesh-ancestor
55930988|NCT03406299|Protective Agents|protective agents|mesh-ancestor
55930989|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
55930990|NCT03406299|Vitamins|vitamins|mesh-ancestor
55930991|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
55762095|NCT03195257|Glucagon|glucagon|mesh-list
55860428|NCT01154920|Cisplatin|cisplatin|mesh-list
55860429|NCT01154920|Carboplatin|carboplatin|mesh-list
55860430|NCT01154920|Fluorouracil|fluorouracil|mesh-list
55860431|NCT01154920|Cetuximab|cetuximab|mesh-list
55860432|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55860433|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860434|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
55860435|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
55860436|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
55860437|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860439|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55785597|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
55930993|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
55930994|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930995|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
55930996|NCT03590873|Coagulants|coagulants|mesh-ancestor
55860440|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860441|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
55860466|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860467|NCT02996734|Denosumab|denosumab|mesh-list
55860468|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55860469|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860470|NCT00699010|Oxycodone|oxycodone|mesh-list
55860471|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55860472|NCT00699010|Narcotics|narcotics|mesh-ancestor
55860473|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860474|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860475|NCT00699010|Analgesics|analgesics|mesh-ancestor
55860476|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
55860477|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860478|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
56219672|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
56219673|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219674|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
56219675|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219676|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860479|NCT00706810|Verapamil|verapamil|mesh-list
55860480|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860481|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
55860482|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860483|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930997|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55860484|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55930998|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55930999|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
55931000|NCT02155335|Golimumab|golimumab|mesh-list
55931001|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55931002|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55860485|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55860486|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55860487|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860488|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55860489|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860490|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
55860491|NCT00661960|Efavirenz|efavirenz|mesh-list
55860492|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
55860514|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860515|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
55860516|NCT00699556|Nicotine|nicotine|mesh-list
55860517|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55860518|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
55860519|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860520|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860521|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55860522|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55860523|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
55860524|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860525|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860526|NCT00700336|Cisplatin|cisplatin|mesh-list
55860527|NCT00700336|Pemetrexed|pemetrexed|mesh-list
55860528|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860529|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860530|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860531|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55860532|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55860533|NCT00701896|Nicotine|nicotine|mesh-list
55860534|NCT00701896|Varenicline|varenicline|mesh-list
55860535|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55860536|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
55860537|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860538|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860539|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55860540|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55860541|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
55860542|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860543|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860578|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
55860579|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860580|NCT00666406|Factor VIII|factor viii|mesh-list
55860581|NCT00666406|Coagulants|coagulants|mesh-ancestor
55860582|NCT02995954|Amlodipine|amlodipine|mesh-list
55860583|NCT02995954|Perindopril|perindopril|mesh-list
55860584|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55860585|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55860586|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860645|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860646|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785598|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
55785599|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
55860649|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55860650|NCT02995720|Amlodipine|amlodipine|mesh-list
55860651|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55860652|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55860653|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56219677|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219678|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56219679|NCT01652534|Analgesics|analgesics|mesh-ancestor
56219680|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
56219681|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219682|NCT01652547|Pasireotide|pasireotide|mesh-list
56219683|NCT01652547|Somatostatin|somatostatin|mesh-list
56219684|NCT01652547|Hormones|hormones|mesh-ancestor
55812092|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219685|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219686|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860654|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860655|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860656|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55860657|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860658|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
55931003|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931004|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931005|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
55931006|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931007|NCT05024526|Edaravone|edaravone|mesh-list
55931008|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55931009|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
55931010|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931011|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55931012|NCT05024526|Protective Agents|protective agents|mesh-ancestor
55931013|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931014|NCT03597035|Spironolactone|spironolactone|mesh-list
55931015|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55931016|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
55860659|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55860660|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55860661|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
55860662|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55860663|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55860705|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860706|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55860707|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55860709|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860710|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
55860711|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860712|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860713|NCT02999776|Etanercept|etanercept|mesh-list
55860714|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55860715|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55860716|NCT02999776|Analgesics|analgesics|mesh-ancestor
55860717|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
55860718|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860719|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860720|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55860721|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860722|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55860723|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860724|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
55860725|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
55860726|NCT02996656|Cefazolin|cefazolin|mesh-list
55860727|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55860728|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860729|NCT04387630|Metformin|metformin|mesh-list
55860730|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55931017|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931018|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931019|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55931020|NCT03597035|Diuretics|diuretics|mesh-ancestor
55826636|NCT01627249|Growth Substances|growth substances|mesh-ancestor
55826637|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717912|NCT04771923|Racepinephrine|racepinephrine|mesh-list
55717913|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
55717914|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
55717915|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55717916|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55717917|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717918|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
55717919|NCT04771923|Coagulants|coagulants|mesh-ancestor
55717920|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55717921|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55717922|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
55717923|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717924|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717925|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55717926|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55717927|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
55717928|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717929|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55717930|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
55717931|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
55717932|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
55717933|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55717934|NCT04718415|Paclitaxel|paclitaxel|mesh-list
55717935|NCT04718415|Carboplatin|carboplatin|mesh-list
55717936|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55717937|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717938|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
55717939|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
55717940|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
55717941|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717942|NCT03971253|Peficitinib|peficitinib|mesh-list
55717943|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717944|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860731|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860732|NCT04270318|Pemetrexed|pemetrexed|mesh-list
55860733|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860734|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860735|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860736|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55860737|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55860738|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
55860739|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860760|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860761|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860762|NCT00704938|Aldesleukin|aldesleukin|mesh-list
55860763|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
55860764|NCT00704938|Fludarabine|fludarabine|mesh-list
55860765|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
56219688|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56219689|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219690|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56219691|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56219692|NCT01652560|Growth Substances|growth substances|mesh-ancestor
56219693|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795712|NCT05556005|Trimetazidine|trimetazidine|mesh-list
55860766|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860767|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
55860768|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860769|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860770|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55860771|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
55860772|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860773|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860774|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55860775|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55860776|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
55860777|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55860778|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55785600|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785601|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
55785602|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55785603|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55785604|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55785605|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55931021|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
55931022|NCT03400683|Letrozole|letrozole|mesh-list
55931023|NCT03400683|Misoprostol|misoprostol|mesh-list
55931024|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931025|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55931026|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55931027|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931028|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762123|NCT04792515|Apatinib|apatinib|mesh-list
55785606|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785607|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
55785608|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785609|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785610|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55785611|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785613|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
55785614|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55785615|NCT03726749|Hormones|hormones|mesh-ancestor
55785616|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785617|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785618|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55785619|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785620|NCT03136705|Niacinamide|niacinamide|mesh-list
55860779|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
55860780|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860781|NCT02994082|Bupropion|bupropion|mesh-list
55860782|NCT02994082|Nicotine|nicotine|mesh-list
55860783|NCT02994082|Varenicline|varenicline|mesh-list
55860784|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55860785|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
55860786|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860787|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860788|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55860789|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55860970|NCT00717574|Sevoflurane|sevoflurane|mesh-list
55860971|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55860972|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931029|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55931030|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
55931031|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931032|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931033|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55931034|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
55931035|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55860973|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860974|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55860975|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
55860976|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
55860977|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55860978|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55860979|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55860980|NCT00717574|Analgesics|analgesics|mesh-ancestor
55860981|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
55860982|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860983|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
55860984|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56219694|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
56219695|NCT01652586|Midazolam|midazolam|mesh-list
56219696|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
56219697|NCT01652586|Remifentanil|remifentanil|mesh-list
56219698|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56219699|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860985|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860986|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860987|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55860988|NCT04385602|Analgesics|analgesics|mesh-ancestor
55860989|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
55785622|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
55785623|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
55785624|NCT03136705|Vitamins|vitamins|mesh-ancestor
55785625|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
55785626|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785627|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55785628|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
55860990|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860991|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55860992|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55860993|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55860994|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
55860995|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860996|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860997|NCT00719134|Rizatriptan|rizatriptan|mesh-list
55860998|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55860999|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
55861000|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861001|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861003|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
55861004|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55861005|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
55861006|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861024|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55861025|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
55861026|NCT01772719|Simvastatin|simvastatin|mesh-list
55861027|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55861028|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55861029|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
55861030|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861031|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55861032|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55861033|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861034|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55861035|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861037|NCT05582265|Cisplatin|cisplatin|mesh-list
55861038|NCT05582265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55861039|NCT05582265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861040|NCT05582265|Tubulin Modulators|tubulin modulators|mesh-ancestor
55861041|NCT05582265|Antimitotic Agents|antimitotic agents|mesh-ancestor
55861042|NCT05582265|Mitosis Modulators|mitosis modulators|mesh-ancestor
55861043|NCT05582265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861044|NCT04144101|Etoricoxib|etoricoxib|mesh-list
55861045|NCT04144101|Aceclofenac|aceclofenac|mesh-list
55861046|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55861047|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55861048|NCT04144101|Analgesics|analgesics|mesh-ancestor
55861049|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
55861050|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861051|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861052|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55861053|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861054|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55861055|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55861056|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219700|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219702|NCT01652586|Analgesics|analgesics|mesh-ancestor
55931036|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55931037|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55931038|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
55931039|NCT05037240|Quercetin|quercetin|mesh-list
55931040|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
55931041|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931042|NCT05037240|Protective Agents|protective agents|mesh-ancestor
55931043|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219703|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
56219704|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219705|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56219706|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56219707|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56219708|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
56219709|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219710|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219711|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56219712|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56219713|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56219714|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56219715|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56219716|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
56219717|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
55861057|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861058|NCT01278004|Ethosuximide|ethosuximide|mesh-list
55861059|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
55861060|NCT01278238|Phenylephrine|phenylephrine|mesh-list
55861061|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
55861062|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55861063|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
55861064|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
55861080|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55785629|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785630|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55785631|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
55785632|NCT04540861|Siponimod|siponimod|mesh-list
55861081|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861082|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861083|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55931044|NCT05037006|Anesthetics|anesthetics|mesh-list
55931045|NCT05037006|Sevoflurane|sevoflurane|mesh-list
55931046|NCT05037006|Neostigmine|neostigmine|mesh-list
55931047|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931048|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718175|NCT04463953|Dexamethasone|dexamethasone|mesh-list
55718177|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
55718178|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718179|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
55718180|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
55718181|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718182|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718183|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718184|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
55718185|NCT04463953|Hormones|hormones|mesh-ancestor
55718186|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55718187|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55718188|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718189|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
55718190|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718191|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718192|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55718193|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
55718194|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
55718195|NCT02307955|Protective Agents|protective agents|mesh-ancestor
55718196|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718198|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718199|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
55718200|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
55718201|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
55718202|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718203|NCT02348307|Dotinurad|dotinurad|mesh-list
55718204|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
55718205|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
55826920|NCT04769414|Antiviral Agents|antiviral agents|mesh-ancestor
55826921|NCT04769414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826922|NCT04769414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826923|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826924|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
55861084|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55861085|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861086|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
55861087|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861088|NCT01272310|Interferons|interferons|mesh-list
55861089|NCT01272310|Ribavirin|ribavirin|mesh-list
55861090|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
55861091|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
55861092|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55861093|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
55861094|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861095|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
55861096|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861097|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
55861098|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861099|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
55861100|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861101|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
55861102|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55861103|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55861104|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861105|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219718|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
56219719|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
56219720|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56219721|NCT01652586|Narcotics|narcotics|mesh-ancestor
56219722|NCT01652599|Dexamethasone|dexamethasone|mesh-list
56219723|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56219724|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
56219725|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
56219726|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219727|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219728|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56219729|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
56219730|NCT01652599|Hormones|hormones|mesh-ancestor
55861106|NCT05586477|Diphenhydramine|diphenhydramine|mesh-list
55861107|NCT05586477|Promethazine|promethazine|mesh-list
55861108|NCT05586477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55861109|NCT05586477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55861110|NCT05586477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861111|NCT05586477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861112|NCT05586477|Anesthetics, Local|anesthetics, local|mesh-ancestor
55861113|NCT05586477|Anesthetics|anesthetics|mesh-ancestor
55861114|NCT05586477|Sensory System Agents|sensory system agents|mesh-ancestor
55861115|NCT05586477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861116|NCT05586477|Antiemetics|antiemetics|mesh-ancestor
55861117|NCT05586477|Autonomic Agents|autonomic agents|mesh-ancestor
55861118|NCT05586477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55861119|NCT05586477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55861120|NCT05586477|Histamine Antagonists|histamine antagonists|mesh-ancestor
55861121|NCT05586477|Histamine Agents|histamine agents|mesh-ancestor
55861122|NCT05586477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861123|NCT05586477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861155|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861158|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
55861159|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861160|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861161|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55861162|NCT01273246|Vaccines|vaccines|mesh-list
55861163|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
55861164|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861165|NCT00730522|Vigabatrin|vigabatrin|mesh-list
55861166|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
55861167|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861265|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
55861266|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861267|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931049|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55931051|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
55931052|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55931053|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931054|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931055|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
55827019|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55827020|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55827021|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55827022|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
55827023|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
55827024|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827025|NCT02254304|Interferons|interferons|mesh-list
55718267|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55718268|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
55718269|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718270|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718271|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55718272|NCT03117933|Paclitaxel|paclitaxel|mesh-list
55718273|NCT03117933|Olaparib|olaparib|mesh-list
55718275|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55718276|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718277|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
55718278|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
55718279|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
55718280|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718281|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55718282|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718283|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55718284|NCT02309281|Aflibercept|aflibercept|mesh-list
55718285|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55718286|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55718287|NCT02309281|Growth Substances|growth substances|mesh-ancestor
55718289|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
55765625|NCT01598506|Hydromorphone|hydromorphone|mesh-list
55861268|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861269|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55861301|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55861302|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55861303|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55861304|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55861305|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55861306|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
55931056|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931057|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55931058|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
55931059|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931060|NCT03093090|Furosemide|furosemide|mesh-list
55931061|NCT03093090|Diuretics|diuretics|mesh-ancestor
55785633|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55785634|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785635|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785636|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
55785637|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785638|NCT03066557|Apatinib|apatinib|mesh-list
55785639|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
56219731|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219732|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56219733|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219734|NCT01652638|Heparin|heparin|mesh-list
56219735|NCT01652638|Calcium heparin|calcium heparin|mesh-list
56219736|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
55861307|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861308|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861309|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
55861310|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861311|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861312|NCT00734500|Anidulafungin|anidulafungin|mesh-list
55861359|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55861361|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861362|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55861363|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052337|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55931062|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
55931063|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861364|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861365|NCT03916341|Nicotine|nicotine|mesh-list
55861366|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55861367|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
55861368|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861369|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861370|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55861371|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55861372|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
55861373|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861374|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861375|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55861376|NCT01276054|Methylene Blue|methylene blue|mesh-list
55861377|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
55861378|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861379|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861380|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55861382|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55861383|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
55861384|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861385|NCT00724594|Expectorants|expectorants|mesh-ancestor
55861386|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
55861387|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55861388|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
55861389|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861390|NCT00724594|Protective Agents|protective agents|mesh-ancestor
55861391|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861419|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55861420|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861421|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55861422|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55861423|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861424|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55861425|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55861426|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861428|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55931064|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55931065|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55931066|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931067|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
55931068|NCT03093168|Fludarabine|fludarabine|mesh-list
55861429|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55861430|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55861431|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
55861432|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861433|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55861434|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55861435|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55861436|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
55861501|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55861502|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861503|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
55785640|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785641|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56219737|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56219738|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56219739|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219740|NCT01652781|Azacitidine|azacitidine|mesh-list
56219741|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219742|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
56219743|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795759|NCT02519595|Analgesics|analgesics|mesh-ancestor
55785642|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785643|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785644|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55861504|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861505|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
55861506|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55861507|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55861508|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861509|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
55861510|NCT04149171|Coagulants|coagulants|mesh-ancestor
55861511|NCT04140591|Propranolol|propranolol|mesh-list
55861512|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55861513|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55861514|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55861515|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
55861570|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55861571|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55861572|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
55861573|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55931069|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931070|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
55861574|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861576|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861577|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861578|NCT05587881|Vaccines|vaccines|mesh-list
55861579|NCT05587881|Immunologic Factors|immunologic factors|mesh-ancestor
55861580|NCT05587881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861581|NCT05582421|Diclofenac|diclofenac|mesh-list
55861582|NCT05582421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55861583|NCT05582421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55861584|NCT05582421|Analgesics|analgesics|mesh-ancestor
55861585|NCT05582421|Sensory System Agents|sensory system agents|mesh-ancestor
55861586|NCT05582421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861587|NCT05582421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861588|NCT05582421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55861589|NCT05582421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861590|NCT05582421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55861591|NCT05582421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861592|NCT05582421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861593|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
55861594|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55861595|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55861596|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861597|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
55861598|NCT03897621|Coagulants|coagulants|mesh-ancestor
55861599|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
55861600|NCT03580473|Dexamethasone|dexamethasone|mesh-list
55861601|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55861602|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55861603|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
55861604|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
55861605|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861606|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861607|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55861608|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
55861609|NCT03580473|Hormones|hormones|mesh-ancestor
55861625|NCT03581487|Durvalumab|durvalumab|mesh-list
55861626|NCT03581487|Ipilimumab|ipilimumab|mesh-list
55861627|NCT03581487|Tremelimumab|tremelimumab|mesh-list
56219744|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219745|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931071|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219746|NCT01652794|Gemcitabine|gemcitabine|mesh-list
56219747|NCT01652794|Carboplatin|carboplatin|mesh-list
56219748|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219749|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219750|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
56219751|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219752|NCT01652794|Antiviral Agents|antiviral agents|mesh-ancestor
56219753|NCT01652794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219754|NCT01652794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219755|NCT01652794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219756|NCT01652794|Immunologic Factors|immunologic factors|mesh-ancestor
56219757|NCT01652794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219758|NCT01652820|Gemcitabine|gemcitabine|mesh-list
56219759|NCT01652820|Carboplatin|carboplatin|mesh-list
56219760|NCT01652820|Docetaxel|docetaxel|mesh-list
56219761|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219762|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219763|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
55861628|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
55861629|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55861630|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
55861631|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55931072|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931073|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55931074|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
55931075|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931076|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861632|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861633|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
55861634|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861635|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55861636|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785645|NCT03066557|Estrogens|estrogens|mesh-ancestor
55785646|NCT03066557|Hormones|hormones|mesh-ancestor
55785647|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55861637|NCT03897309|Vaccines|vaccines|mesh-list
55861638|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
55861639|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861640|NCT03588429|Sevoflurane|sevoflurane|mesh-list
55861641|NCT03588429|Isoflurane|isoflurane|mesh-list
55861642|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55861643|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55861645|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
55861646|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861647|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861648|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
55861649|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
55861650|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
55861651|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
55861652|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55861653|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861654|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
55861655|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55861656|NCT03588351|Chitosan|chitosan|mesh-list
55861657|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55861658|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861659|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
55861660|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
56219764|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219766|NCT01652820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219767|NCT01652820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219768|NCT01652820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219769|NCT01652820|Immunologic Factors|immunologic factors|mesh-ancestor
56219770|NCT01652820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219771|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
56219772|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
56219773|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
56219774|NCT01652859|Amphotericin B|amphotericin b|mesh-list
56219775|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56219776|NCT01652859|Amebicides|amebicides|mesh-ancestor
56219777|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56219778|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56219779|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219780|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56219781|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
56219782|NCT01652898|Esmolol|esmolol|mesh-list
56219783|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56219784|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56219785|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56219786|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
56219787|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219788|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219789|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219790|NCT01652924|Anesthetics|anesthetics|mesh-list
56219791|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931077|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55931078|NCT04377321|Colchicine|colchicine|mesh-list
55931079|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
56219792|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219793|NCT01653015|Vaccines|vaccines|mesh-list
55861661|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55861662|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55861663|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
55861664|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861665|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55861722|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55861724|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861725|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55861726|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55861727|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55861728|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
55861729|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219794|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
56219795|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219796|NCT01653041|Everolimus|everolimus|mesh-list
56219797|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219798|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219799|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
56219800|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219801|NCT01653067|Cytarabine|cytarabine|mesh-list
56219802|NCT01653067|Sirolimus|sirolimus|mesh-list
56219804|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
56219805|NCT01653067|Rituximab|rituximab|mesh-list
55861730|NCT03935451|Apixaban|apixaban|mesh-list
55861732|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
55861733|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55861734|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
55861735|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861736|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861737|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
55861738|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55861739|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55861740|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55861741|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55861742|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861743|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
55931080|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931081|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
55931082|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
55931083|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
55931084|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931085|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931086|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
55931087|NCT05018364|Hematinics|hematinics|mesh-ancestor
55861744|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861745|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861746|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55861747|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861806|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861807|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55861808|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
55861809|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55861810|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55861811|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55861812|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55861813|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861814|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861815|NCT03586791|Anesthetics|anesthetics|mesh-list
55861816|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861817|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785648|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861818|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
55861819|NCT01795495|Remifentanil|remifentanil|mesh-list
55861820|NCT01795495|Methadone|methadone|mesh-list
55861821|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55861822|NCT01795495|Narcotics|narcotics|mesh-ancestor
55861823|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861824|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861825|NCT01795495|Analgesics|analgesics|mesh-ancestor
55861826|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
55861827|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861828|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
55861829|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55861830|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
55861831|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55861832|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55861833|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861834|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55861835|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
55861836|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55861837|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
55861862|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
55861863|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
55861864|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
56219806|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56219807|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219808|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
56219809|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795826|NCT05612711|Analgesics|analgesics|mesh-ancestor
55861865|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861866|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861867|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55861868|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55861869|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861870|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55861871|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55931089|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55931090|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55931091|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931092|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861872|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55861873|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55861874|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55861875|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55861876|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
55861877|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
55861878|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
55861879|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
55861880|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861881|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861882|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55861883|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55861885|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55861886|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55861923|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861924|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55861925|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
55861926|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55861952|NCT05702151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55861953|NCT05702151|Narcotics|narcotics|mesh-ancestor
55861954|NCT05702151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931093|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55931094|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
55931095|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55931096|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
55931097|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861955|NCT05702151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861956|NCT05702151|Analgesics|analgesics|mesh-ancestor
55861957|NCT05702151|Sensory System Agents|sensory system agents|mesh-ancestor
55861958|NCT05702151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861959|NCT05702073|Insulin Glargine|insulin glargine|mesh-list
55861960|NCT05702073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55861961|NCT05702073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861963|NCT05701995|Dermatologic Agents|dermatologic agents|mesh-ancestor
55861964|NCT05701995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55861965|NCT05701995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861966|NCT05701995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861967|NCT01985321|Ethanol|ethanol|mesh-list
55861968|NCT01985321|Glycolic acid|glycolic acid|mesh-list
55861969|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55861970|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861971|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861972|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861973|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
55861974|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
55861975|NCT03584919|Doxycycline|doxycycline|mesh-list
55861976|NCT03584919|Cefuroxime|cefuroxime|mesh-list
55861977|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
55862092|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55862094|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
55862095|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862096|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862097|NCT01984229|Posaconazole|posaconazole|mesh-list
55862098|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
55862099|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862100|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55862101|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55862102|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55862103|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55862104|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56219810|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219811|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56219812|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
56219813|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
56219814|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56219815|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56219816|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
56219817|NCT01653067|Hormones|hormones|mesh-ancestor
56219818|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219819|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56219820|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219821|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219822|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
56219823|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
56219824|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219825|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219826|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56219827|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56219828|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
56219829|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55862105|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862106|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862107|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55862108|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
55862109|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862110|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862111|NCT01274026|Verapamil|verapamil|mesh-list
55862112|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55862113|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55862114|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762188|NCT02445989|NuvaRing|nuvaring|mesh-list
55862115|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862116|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55862174|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862175|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55862176|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55862177|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55862178|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55862179|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862180|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55862181|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55862182|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862183|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55931098|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931099|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931101|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
55931102|NCT03595163|Propofol|propofol|mesh-list
55862184|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55862185|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
55862189|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862190|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862191|NCT05701215|Venetoclax|venetoclax|mesh-list
55862192|NCT05701215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862211|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55862212|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862213|NCT03154983|Docetaxel|docetaxel|mesh-list
55862214|NCT03154983|Apatinib|apatinib|mesh-list
56219831|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56219832|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
56219833|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219834|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56219835|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56219836|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219837|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
56219838|NCT01653171|Simethicone|simethicone|mesh-list
56219839|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56219840|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
56219841|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219842|NCT01653171|Expectorants|expectorants|mesh-ancestor
56219843|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
55931103|NCT03595163|Sevoflurane|sevoflurane|mesh-list
55931104|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55931105|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931106|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931107|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55931108|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
55931109|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
56219844|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56219845|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
56219846|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219847|NCT01653171|Protective Agents|protective agents|mesh-ancestor
56219848|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219849|NCT01653171|Antidotes|antidotes|mesh-ancestor
56219850|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
56219851|NCT01653171|Emollients|emollients|mesh-ancestor
56219852|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
56219853|NCT01653236|Ribavirin|ribavirin|mesh-list
55795848|NCT05701007|Docetaxel|docetaxel|mesh-list
55862215|NCT03154983|Tegafur|tegafur|mesh-list
55862216|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862217|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
55862218|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
55862219|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
55862220|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862221|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55862222|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862223|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55862224|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
55862225|NCT01983683|Vancomycin|vancomycin|mesh-list
55862226|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
55862227|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55862228|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862229|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55862230|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862231|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862232|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
55862233|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
55862234|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862235|NCT03158025|Zolpidem|zolpidem|mesh-list
55862236|NCT03158025|Suvorexant|suvorexant|mesh-list
55785649|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55862237|NCT03158025|Lemborexant|lemborexant|mesh-list
55862238|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55862239|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55862240|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56219854|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56219855|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
56219856|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219857|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
56219858|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219859|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
55795874|NCT02630563|Cyclosporine|cyclosporine|mesh-list
55862241|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862242|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55862243|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
55862244|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
55862245|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862246|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862247|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55862248|NCT01998893|Rituximab|rituximab|mesh-list
55862249|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55862250|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862265|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55862267|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55862268|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931110|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55931112|NCT03595163|Hematinics|hematinics|mesh-ancestor
55931113|NCT03595163|Vitamins|vitamins|mesh-ancestor
55931114|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
55931115|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55862269|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55862270|NCT03154281|Everolimus|everolimus|mesh-list
55862271|NCT03154281|Niraparib|niraparib|mesh-list
55862272|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862273|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55862274|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
55862275|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862276|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55862277|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862278|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862279|NCT03157791|Simethicone|simethicone|mesh-list
55862280|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
55862281|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862282|NCT03157791|Emollients|emollients|mesh-ancestor
55862283|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
55862284|NCT05701059|Meloxicam|meloxicam|mesh-list
55862285|NCT05701059|Cimetidine|cimetidine|mesh-list
55862286|NCT05701059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55862287|NCT05701059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862288|NCT05701059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55862289|NCT05701059|Histamine Antagonists|histamine antagonists|mesh-ancestor
55862290|NCT05701059|Histamine Agents|histamine agents|mesh-ancestor
55862292|NCT05701059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862293|NCT05701059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862294|NCT05701059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55862295|NCT05701059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55862296|NCT05701059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862297|NCT05701059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55862298|NCT05701059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55862299|NCT05701059|Analgesics|analgesics|mesh-ancestor
55862300|NCT05701059|Sensory System Agents|sensory system agents|mesh-ancestor
55931116|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55931118|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
55931119|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931120|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
55862301|NCT05701059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862302|NCT05701059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862303|NCT05701059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862304|NCT05701059|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55862305|NCT05701059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55812157|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
55862364|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55862365|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55862367|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
55862368|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862369|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862370|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862371|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219860|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219861|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55862372|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55862373|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052338|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55931121|NCT00918723|Rituximab|rituximab|mesh-list
55931122|NCT00918723|Fludarabine|fludarabine|mesh-list
55862374|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862375|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
55862376|NCT01670955|Folic Acid|folic acid|mesh-list
55862377|NCT01670955|Hematinics|hematinics|mesh-ancestor
55862378|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
55862379|NCT01670955|Vitamins|vitamins|mesh-ancestor
55862380|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
55862381|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862382|NCT01275274|Tretinoin|tretinoin|mesh-list
55862383|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862384|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
55862385|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
55862386|NCT01997333|Capecitabine|capecitabine|mesh-list
55862387|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55862388|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
55862389|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862390|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862391|NCT01271920|Trastuzumab|trastuzumab|mesh-list
55862434|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55862435|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55862437|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862438|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
55862439|NCT00746512|Hormones|hormones|mesh-ancestor
55862440|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862441|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862442|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55862443|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862444|NCT05409027|Cortisone|cortisone|mesh-list
55862445|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55931123|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
55931124|NCT00918723|Vorinostat|vorinostat|mesh-list
55931125|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931126|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
55931127|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862446|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
55862447|NCT05409027|Hormones|hormones|mesh-ancestor
55862448|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862449|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862450|NCT01982435|Ranibizumab|ranibizumab|mesh-list
55862451|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55862452|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55862453|NCT01982435|Growth Substances|growth substances|mesh-ancestor
55862454|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862455|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
55862456|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862457|NCT00747214|Prednisolone|prednisolone|mesh-list
55862458|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
55862459|NCT00747214|Dipyridamole|dipyridamole|mesh-list
55862460|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862461|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
55862462|NCT00747214|Hormones|hormones|mesh-ancestor
55862483|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
55862484|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55862485|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55862486|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862487|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
55862488|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
55862489|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55862490|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
55862491|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862492|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862493|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55862494|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
55862495|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862496|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862497|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55862498|NCT01279954|Abatacept|abatacept|mesh-list
55862499|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55862500|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931128|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931129|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55862502|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55862503|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
55862504|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219863|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219865|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56219866|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56219867|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
56219868|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56219869|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219870|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219871|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56219872|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55862505|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862506|NCT00763048|Triclosan|triclosan|mesh-list
55862507|NCT00763048|Fluorides|fluorides|mesh-list
55862508|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
55862509|NCT00763048|Protective Agents|protective agents|mesh-ancestor
55862510|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862511|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55862512|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862513|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55785652|NCT05738161|Magrolimab|magrolimab|mesh-list
55785653|NCT05738161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785654|NCT05738161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55862514|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55862544|NCT01736917|Dexamethasone|dexamethasone|mesh-list
55862545|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
55862546|NCT01736917|Aprepitant|aprepitant|mesh-list
55862547|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862548|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
55862549|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
55862550|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862551|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862552|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862553|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
55862554|NCT01736917|Hormones|hormones|mesh-ancestor
55862555|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052339|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55862556|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55862557|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862558|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55862559|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862560|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862561|NCT01277302|Ranibizumab|ranibizumab|mesh-list
55862614|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55862615|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862616|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55862617|NCT00248170|Letrozole|letrozole|mesh-list
55862618|NCT00248170|Anastrozole|anastrozole|mesh-list
55862619|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862620|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55862621|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55862622|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862623|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862624|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55862625|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
55862626|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862627|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862628|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55862630|NCT01764997|Etanercept|etanercept|mesh-list
55862631|NCT01764997|Methotrexate|methotrexate|mesh-list
55862635|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862636|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55862637|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
56219873|NCT01653470|Leucovorin|leucovorin|mesh-list
56219874|NCT01653470|Paclitaxel|paclitaxel|mesh-list
56219875|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56219876|NCT01653470|Carboplatin|carboplatin|mesh-list
55931130|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
55931131|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931132|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931133|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55931134|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55931135|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56219877|NCT01653470|Fluorouracil|fluorouracil|mesh-list
56219878|NCT01653470|Irinotecan|irinotecan|mesh-list
56219879|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56219880|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219882|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
56219883|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
56219884|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219885|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
56219886|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55795892|NCT05700695|Lactulose|lactulose|mesh-list
55862638|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862639|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862640|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
55862641|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862642|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55862680|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
55862681|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
55862682|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862736|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862738|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862739|NCT03806374|Lidocaine|lidocaine|mesh-list
55862740|NCT03806374|Fentanyl|fentanyl|mesh-list
55862741|NCT03806374|Ketamine|ketamine|mesh-list
55862742|NCT03806374|Propofol|propofol|mesh-list
55862743|NCT03806374|Cisatracurium|cisatracurium|mesh-list
55862744|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
55862745|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
55862746|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55862747|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862748|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
55862749|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862750|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55931136|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
55931137|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55931138|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931139|NCT04192331|Paclitaxel|paclitaxel|mesh-list
55931140|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55862751|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55785655|NCT05738161|Antimetabolites|antimetabolites|mesh-ancestor
55785656|NCT05738161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785657|NCT05738161|Antiviral Agents|antiviral agents|mesh-ancestor
55785658|NCT05738161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785659|NCT05738161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785660|NCT05738161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55785661|NCT05738161|Immunologic Factors|immunologic factors|mesh-ancestor
55785662|NCT05738161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785663|NCT05738161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55862752|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55862753|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55862754|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862755|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55862756|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55862757|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
55862758|NCT03806374|Analgesics|analgesics|mesh-ancestor
55862759|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55862760|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55862761|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55862762|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862763|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55862764|NCT03806374|Narcotics|narcotics|mesh-ancestor
55862765|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55862766|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56219887|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219888|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
56219889|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219890|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56219891|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56219892|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219893|NCT01653470|Antidotes|antidotes|mesh-ancestor
56219894|NCT01653470|Protective Agents|protective agents|mesh-ancestor
56219895|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
55931141|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55931142|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931143|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
56219896|NCT01653470|Vitamins|vitamins|mesh-ancestor
56219897|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
56219898|NCT01653522|Doxycycline|doxycycline|mesh-list
56219899|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56219900|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56219901|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
55862892|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55862893|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862894|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
55862895|NCT03830164|Protective Agents|protective agents|mesh-ancestor
55862896|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55862897|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55862898|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55862899|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
55862984|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862985|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862987|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
55862988|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55862989|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
55862990|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862991|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862992|NCT00757822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55862993|NCT00757822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55862994|NCT00757822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55862995|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55862996|NCT00757822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55862997|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
55862998|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55862999|NCT00757822|Analgesics|analgesics|mesh-ancestor
55863000|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
55863001|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55863002|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55863003|NCT00757822|Hormones|hormones|mesh-ancestor
55863004|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863005|NCT00758836|Acetaminophen|acetaminophen|mesh-list
55863006|NCT00758836|Ibuprofen|ibuprofen|mesh-list
55863007|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55863008|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863009|NCT00758836|Analgesics|analgesics|mesh-ancestor
55863032|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931144|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
55931145|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
55931146|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931147|NCT00919035|Sirolimus|sirolimus|mesh-list
55931148|NCT00919035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55931149|NCT00919035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931150|NCT00919035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55863034|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55863035|NCT03809650|Macitentan|macitentan|mesh-list
55863036|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55863037|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55785665|NCT05728775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55785666|NCT05728775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55785667|NCT05728775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863038|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863039|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55863041|NCT03809260|Vancomycin|vancomycin|mesh-list
56219902|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56219903|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56219904|NCT01653561|Apatinib|apatinib|mesh-list
56219905|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219906|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56219907|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219908|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219909|NCT01653639|Factor VIII|factor viii|mesh-list
56219910|NCT01653639|Coagulants|coagulants|mesh-ancestor
56219911|NCT01653665|Sargramostim|sargramostim|mesh-list
56219912|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
56219913|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219914|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
56219915|NCT01653717|Fludarabine|fludarabine|mesh-list
56219916|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
56219917|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219918|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
56219919|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219920|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56219921|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56219922|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
56219923|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219924|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219925|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56219926|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55762262|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
56219927|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
56219929|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
56219930|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56219931|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55795926|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
55863042|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55863043|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863044|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55863045|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863046|NCT01763905|Ezetimibe|ezetimibe|mesh-list
55863047|NCT01763905|Evolocumab|evolocumab|mesh-list
55863048|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55863049|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55863050|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55863051|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
55863052|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863053|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55863054|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
56219932|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052340|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55931151|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931152|NCT00919035|Antifungal Agents|antifungal agents|mesh-ancestor
55931153|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931154|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
55931155|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219933|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56219934|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56219935|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863055|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863056|NCT05743504|Paclitaxel|paclitaxel|mesh-list
55863057|NCT05743504|Cisplatin|cisplatin|mesh-list
55863058|NCT05743504|Atezolizumab|atezolizumab|mesh-list
55863083|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
55863084|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55863085|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55762305|NCT04790331|Verapamil|verapamil|mesh-list
55931157|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55931158|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
55931159|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55931160|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
55931161|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931162|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863086|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55863087|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863088|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863089|NCT00759772|Teriparatide|teriparatide|mesh-list
55863090|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55863091|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863092|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55863093|NCT01977677|Plerixafor|plerixafor|mesh-list
55863094|NCT01977677|Temozolomide|temozolomide|mesh-list
55863095|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55863096|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
55863097|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863098|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863099|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55863100|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55863101|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
55863102|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863103|NCT04384744|Hormones|hormones|mesh-list
55863104|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863105|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863106|NCT05743270|Paclitaxel|paclitaxel|mesh-list
55863178|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863210|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
55863211|NCT00774202|Hormones|hormones|mesh-ancestor
55863212|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931163|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
55931164|NCT04374981|Celecoxib|celecoxib|mesh-list
55931165|NCT04374981|Montelukast|montelukast|mesh-list
55931166|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55931167|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863214|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55863215|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
55863216|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
55863217|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
55863219|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863220|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863222|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863223|NCT03802162|Memantine|memantine|mesh-list
55863275|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55863276|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863277|NCT01784965|Incretins|incretins|mesh-ancestor
55863278|NCT01784965|Hormones|hormones|mesh-ancestor
55863279|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863280|NCT05742724|Dronabinol|dronabinol|mesh-list
55785668|NCT05728775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55785669|NCT05728775|Anesthetics, General|anesthetics, general|mesh-ancestor
55785670|NCT05728775|Anesthetics|anesthetics|mesh-ancestor
55785671|NCT05737693|Midazolam|midazolam|mesh-list
55863281|NCT05742724|Nabiximols|nabiximols|mesh-list
55863282|NCT05742724|Cannabidiol|cannabidiol|mesh-list
55931168|NCT04374981|Analgesics|analgesics|mesh-ancestor
55931169|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
55931170|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931171|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931172|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931173|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931174|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55931175|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55863283|NCT05742724|Anticonvulsants|anticonvulsants|mesh-ancestor
55863284|NCT05742724|Hallucinogens|hallucinogens|mesh-ancestor
55863285|NCT05742724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863286|NCT05742724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55863287|NCT05742724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863288|NCT05742724|Analgesics|analgesics|mesh-ancestor
55863289|NCT05742724|Sensory System Agents|sensory system agents|mesh-ancestor
55863290|NCT05742724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863291|NCT05742724|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55863292|NCT05742724|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55863293|NCT05742724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863294|NCT05742724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219936|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219937|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219938|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56219939|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
55744387|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931176|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931177|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219940|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56219941|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219942|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56219943|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56219944|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56219945|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56219946|NCT01654081|Irinotecan|irinotecan|mesh-list
56219947|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56219948|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56219949|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219950|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219951|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219952|NCT01654120|Liraglutide|liraglutide|mesh-list
55863295|NCT05742724|Hormones|hormones|mesh-ancestor
55863296|NCT05742724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863297|NCT01784419|Ivacaftor|ivacaftor|mesh-list
55931178|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55931179|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
55931180|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55863298|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55863299|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55863300|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863301|NCT01784029|Vitamin D|vitamin d|mesh-list
55863302|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
55863303|NCT01784029|Vitamins|vitamins|mesh-ancestor
55863304|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
55863305|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863306|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55863307|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55863308|NCT00789256|Bortezomib|bortezomib|mesh-list
55863309|NCT00789256|Melphalan|melphalan|mesh-list
55863310|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863311|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55863312|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
55863348|NCT05742568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55863349|NCT05742568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55863350|NCT05742568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55863351|NCT05742568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863352|NCT05742568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863396|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
55863397|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863398|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55863399|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55863400|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863401|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863402|NCT01755091|Hormones|hormones|mesh-ancestor
55863403|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863404|NCT00789802|Naproxen|naproxen|mesh-list
55863405|NCT00789802|Estradiol|estradiol|mesh-list
55863406|NCT00789802|Estrogens|estrogens|mesh-ancestor
55863407|NCT00789802|Hormones|hormones|mesh-ancestor
55863408|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219953|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56219954|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56219956|NCT01654120|Hormones|hormones|mesh-ancestor
56219957|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56219958|NCT01654146|Paclitaxel|paclitaxel|mesh-list
55931182|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931183|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55931184|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55931185|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55931186|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
55931187|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56219959|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56219960|NCT01654146|Carboplatin|carboplatin|mesh-list
56219961|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56219962|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219963|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
56219964|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
56219965|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
56219966|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56219967|NCT01654185|Letrozole|letrozole|mesh-list
56219968|NCT01654185|Exemestane|exemestane|mesh-list
56219969|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56219970|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56219971|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56219972|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56219973|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863409|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863410|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55863411|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863412|NCT00789802|Analgesics|analgesics|mesh-ancestor
55863413|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
55863414|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863415|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55863416|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55863417|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
55863418|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55863419|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863420|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863421|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
55863422|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55863423|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785673|NCT05737693|Analgesics|analgesics|mesh-ancestor
56052341|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
55931189|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931190|NCT03090516|Donepezil|donepezil|mesh-list
55931192|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931193|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931194|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
55931195|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785674|NCT05737693|Sensory System Agents|sensory system agents|mesh-ancestor
55785675|NCT05737693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785676|NCT05737693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863424|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55863425|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55863426|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55863427|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
55863428|NCT05574712|Leuprolide|leuprolide|mesh-list
55863429|NCT05574712|Abiraterone Acetate|abiraterone acetate|mesh-list
55863430|NCT05574712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55863431|NCT05574712|Fertility Agents|fertility agents|mesh-ancestor
55863432|NCT05574712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55863433|NCT05574712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863434|NCT05574712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55863435|NCT05574712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863436|NCT05574712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55863437|NCT05574712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863583|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863584|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55863585|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
55863586|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863587|NCT05709184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55863588|NCT05709184|Vancomycin|vancomycin|mesh-list
55863589|NCT05709184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863590|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56220053|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762376|NCT02444585|Denosumab|denosumab|mesh-list
55793905|NCT03072121|Diuretics|diuretics|mesh-ancestor
56220054|NCT01654718|Pantoprazole|pantoprazole|mesh-list
55812201|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55785707|NCT04710199|Maraviroc|maraviroc|mesh-list
56220163|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
56220164|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220165|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220166|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56220167|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
56220169|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
56220170|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220171|NCT01655303|Propranolol|propranolol|mesh-list
56220172|NCT01655303|Metoprolol|metoprolol|mesh-list
56220173|NCT01655303|Verapamil|verapamil|mesh-list
56220174|NCT01655303|Diltiazem|diltiazem|mesh-list
56220175|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56220176|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56220177|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
56220178|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220179|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220180|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220181|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55796219|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
55785723|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
55785724|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
55785725|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785726|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55785727|NCT05737069|Ibuprofen|ibuprofen|mesh-list
56220245|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56220246|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55931196|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931197|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
55931198|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55931199|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55931200|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220247|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56220248|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56220249|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
56220250|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
56220251|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56220252|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56220253|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56220289|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
56220290|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56220291|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56220292|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56220293|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56220294|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220295|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
56220296|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220297|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220298|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56220299|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220300|NCT01655875|Plerixafor|plerixafor|mesh-list
56220301|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56220302|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56220303|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
56220304|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220305|NCT01655888|Tremelimumab|tremelimumab|mesh-list
55931201|NCT03092310|Pancrelipase|pancrelipase|mesh-list
55931202|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55931203|NCT03405207|Vitamin D|vitamin d|mesh-list
55931204|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
55931205|NCT03405207|Vitamins|vitamins|mesh-ancestor
55931206|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
55931207|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931208|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55931209|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55931210|NCT04197323|Alprostadil|alprostadil|mesh-list
55931211|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55931212|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
55931213|NCT04197323|Urological Agents|urological agents|mesh-ancestor
55931214|NCT03092466|Ropivacaine|ropivacaine|mesh-list
56220306|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220307|NCT01655914|Flumazenil|flumazenil|mesh-list
56220308|NCT01655914|Antidotes|antidotes|mesh-ancestor
56220309|NCT01655914|Protective Agents|protective agents|mesh-ancestor
56220310|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220311|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
56220312|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
56220313|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56220314|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220315|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
55785769|NCT03073525|Atezolizumab|atezolizumab|mesh-list
55785770|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785771|NCT02563015|Vitamin D|vitamin d|mesh-list
55785772|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
55785773|NCT02563015|Vitamins|vitamins|mesh-ancestor
55785774|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
56220382|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220383|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56220384|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56220385|NCT01656057|Acetaminophen|acetaminophen|mesh-list
56220386|NCT01656057|Metformin|metformin|mesh-list
56220387|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
56220388|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56220389|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56220390|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220391|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56220392|NCT01656057|Analgesics|analgesics|mesh-ancestor
56220393|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
56220394|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220395|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
56220396|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56220397|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56220398|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
56220399|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220400|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56220401|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56220402|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220403|NCT01656070|Vitamin D|vitamin d|mesh-list
56220404|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
56220405|NCT01656070|Vitamins|vitamins|mesh-ancestor
56220406|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
56220407|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220408|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56220409|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56220410|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56220411|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56220412|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56220413|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
56220414|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220415|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785833|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785834|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56220441|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56220442|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
56220443|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220444|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785836|NCT04821869|Albuterol|albuterol|mesh-list
55785837|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55785838|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
55785839|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785840|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785841|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55785842|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
55785843|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55785844|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55785845|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55785846|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
55785847|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55785848|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785849|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
55785850|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56220462|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
56220463|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785851|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
55785852|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55785853|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
55785854|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220540|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56220542|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
56220543|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220544|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220566|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220567|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220568|NCT01657201|Voriconazole|voriconazole|mesh-list
56220569|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
56220570|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56220571|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56220572|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56220573|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796568|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55796569|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
56220755|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55931215|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
55931217|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931218|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220756|NCT01657955|Chlorambucil|chlorambucil|mesh-list
55796754|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
56220757|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56220758|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
55796771|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55785964|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
55785965|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785966|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55785967|NCT05090761|Narcotics|narcotics|mesh-ancestor
55785968|NCT05090761|Analgesics|analgesics|mesh-ancestor
55785969|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55785970|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56220778|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
56220779|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56220780|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
56220781|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220782|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220783|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
56220784|NCT01658007|Sirolimus|sirolimus|mesh-list
56220785|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56220786|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796783|NCT04213885|Vitamins|vitamins|mesh-ancestor
55785988|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55785989|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56220915|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56220916|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220918|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220919|NCT01658891|Beclomethasone|beclomethasone|mesh-list
56220920|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
56220921|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56220922|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
56220923|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56220924|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56220925|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56220926|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
55796910|NCT02725177|Hormones|hormones|mesh-ancestor
55785997|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
55785998|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
55785999|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786000|NCT04074785|Bevacizumab|bevacizumab|mesh-list
56052342|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
55796943|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55786001|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56220961|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
56220962|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56220963|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786009|NCT04533841|Misoprostol|misoprostol|mesh-list
55786010|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55786011|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
55786012|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55786013|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786014|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55786015|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56220964|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56220965|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56220966|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56220967|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56220968|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56220969|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56220970|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56220971|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
56220972|NCT01659099|Hormones|hormones|mesh-ancestor
56220973|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56220974|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56220975|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56220976|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
55931219|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
55931220|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931222|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56220977|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
55796982|NCT02447991|Rizatriptan|rizatriptan|mesh-list
56221002|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56221003|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56221004|NCT01659242|Analgesics|analgesics|mesh-ancestor
56221005|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
56221006|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221007|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56221008|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56221010|NCT01659281|Mefloquine|mefloquine|mesh-list
56221011|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
56221012|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56221013|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56221014|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221015|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56221016|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
56221017|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
56221018|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56221019|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
56221020|NCT01659346|Carvedilol|carvedilol|mesh-list
56221021|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56221022|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56221023|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
56221024|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221025|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221026|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221027|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56221028|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
56221029|NCT01659346|Protective Agents|protective agents|mesh-ancestor
56221030|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56221034|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56221035|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56221037|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
56221038|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
55762435|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55718367|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
55718368|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718369|NCT03107871|Valganciclovir|valganciclovir|mesh-list
55718370|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
55718371|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718372|NCT03064113|Ipratropium|ipratropium|mesh-list
55718373|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55827076|NCT02121847|Cyclosporins|cyclosporins|mesh-list
55718374|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
55718375|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718376|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718377|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55718378|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
55718379|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55718380|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
55718381|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718382|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718383|NCT02301715|Oxytocin|oxytocin|mesh-list
55718384|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
55718385|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55718386|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718387|NCT03509545|Torsemide|torsemide|mesh-list
55718388|NCT03509545|Furosemide|furosemide|mesh-list
55718389|NCT03509545|Diuretics|diuretics|mesh-ancestor
55718390|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
55718391|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718392|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55718393|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55718394|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718395|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55718396|NCT02301949|Thalidomide|thalidomide|mesh-list
55718397|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55718398|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
55718399|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718400|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
55718401|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55718402|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718403|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55718404|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56221039|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56221040|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221041|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
56221042|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221043|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55797051|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55786041|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221044|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56221045|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56221046|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56221047|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221049|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56221050|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56221051|NCT01659372|Analgesics|analgesics|mesh-ancestor
56221052|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
55797061|NCT05697185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55786042|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221060|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221062|NCT01659437|Streptomycin|streptomycin|mesh-list
55762458|NCT02152384|Insulin|insulin|mesh-list
56221063|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56221064|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221065|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56221066|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221067|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221068|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56221069|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56221070|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
56221071|NCT01659476|Miotics|miotics|mesh-ancestor
56221072|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
56221073|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221074|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221075|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56221076|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56221077|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
56221078|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56221079|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56221080|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
56221081|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221092|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56221093|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56221094|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221095|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
56221096|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56221097|NCT01659684|Antibodies|antibodies|mesh-list
56221098|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
56221099|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55797101|NCT05591417|Analgesics|analgesics|mesh-ancestor
55786047|NCT03063359|Fentanyl|fentanyl|mesh-list
55786048|NCT03063359|Morphine|morphine|mesh-list
56221100|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
56221101|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221102|NCT01659775|Ondansetron|ondansetron|mesh-list
56221103|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
55786087|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931223|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931224|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55931225|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
55931226|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55931227|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55931228|NCT04196309|Heparin|heparin|mesh-list
55931229|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55786088|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56221190|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56221191|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56221201|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221203|NCT01660373|Ticagrelor|ticagrelor|mesh-list
56221204|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56221238|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56221350|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
56221351|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
56221352|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56221353|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
56221354|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56221355|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56221356|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
56221357|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797364|NCT03059719|Hormones|hormones|mesh-ancestor
55786114|NCT04262869|Carboplatin|carboplatin|mesh-list
56221387|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221388|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55786152|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
55786153|NCT04884035|Rituximab|rituximab|mesh-list
55786154|NCT04884035|Doxorubicin|doxorubicin|mesh-list
55786155|NCT04884035|Vincristine|vincristine|mesh-list
55786156|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55786157|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
55786158|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931230|NCT04196309|Tinzaparin|tinzaparin|mesh-list
55931231|NCT04196309|Dalteparin|dalteparin|mesh-list
55931232|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
55786159|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786208|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221680|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56221681|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221746|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56221747|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56221748|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
56221749|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56221750|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221751|NCT01664650|Genistein|genistein|mesh-list
56221752|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56221753|NCT01664650|Protective Agents|protective agents|mesh-ancestor
56221754|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221758|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221759|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
56221760|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55813471|NCT05367401|Magrolimab|magrolimab|mesh-list
56221804|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221806|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56221807|NCT01664871|Fluorides|fluorides|mesh-list
55931233|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56221808|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
56221809|NCT01664871|Protective Agents|protective agents|mesh-ancestor
56221810|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221811|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56221812|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56221813|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221814|NCT01665066|Nicotine|nicotine|mesh-list
56221815|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56221816|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
56221817|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56221818|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56221819|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56221820|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56221821|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
56221822|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797817|NCT05587673|Glucocorticoids|glucocorticoids|mesh-ancestor
56221977|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56221978|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56221980|NCT01665742|Vitamin E|vitamin e|mesh-list
56221981|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
56221982|NCT01665742|Lycopene|lycopene|mesh-list
56221983|NCT01665742|Vitamins|vitamins|mesh-ancestor
55931234|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55931235|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931237|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55931238|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55794019|NCT02593097|Metformin|metformin|mesh-list
56222151|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56222152|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222153|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222154|NCT01666769|Micafungin|micafungin|mesh-list
56222155|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
56222156|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222157|NCT01667094|Meropenem|meropenem|mesh-list
56222158|NCT01667094|Tazobactam|tazobactam|mesh-list
56222159|NCT01667094|Piperacillin|piperacillin|mesh-list
56222160|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
56222161|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
56222162|NCT01667094|Ceftazidime|ceftazidime|mesh-list
56222163|NCT01667094|Cefepime|cefepime|mesh-list
56222164|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56222165|NCT01667094|Ticarcillin|ticarcillin|mesh-list
56222166|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
56222167|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56222168|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56222169|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56222170|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814132|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55814133|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56222171|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222172|NCT01667211|Paclitaxel|paclitaxel|mesh-list
55786399|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931239|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931240|NCT03090048|Vitamin A|vitamin a|mesh-list
55931241|NCT03090048|Azithromycin|azithromycin|mesh-list
55931242|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
55931243|NCT03090048|Vitamins|vitamins|mesh-ancestor
55931244|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
55786401|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55786402|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786403|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55786404|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55786405|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55786406|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55786418|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55786419|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55786420|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786421|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
55786422|NCT04625530|Coagulants|coagulants|mesh-ancestor
55786423|NCT04625530|Hematinics|hematinics|mesh-ancestor
55786424|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55786425|NCT01916824|Mirtazapine|mirtazapine|mesh-list
55786426|NCT01916824|Citalopram|citalopram|mesh-list
55786427|NCT01916824|Bupropion|bupropion|mesh-list
55786428|NCT01916824|Fluoxetine|fluoxetine|mesh-list
55786429|NCT01916824|Paroxetine|paroxetine|mesh-list
55786434|NCT01916824|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56222355|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222417|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56222418|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56222419|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222421|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
56222422|NCT01668927|Amoxicillin|amoxicillin|mesh-list
56222423|NCT01668927|Metronidazole|metronidazole|mesh-list
55786463|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55786464|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55786465|NCT01915732|Clindamycin|clindamycin|mesh-list
55931245|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931246|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55931247|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786466|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
55786467|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
55786468|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56222594|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
56222595|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222596|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222597|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
56222598|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222599|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56222600|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56222601|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56222602|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56222603|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222604|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55798564|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
56222677|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56222678|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56222679|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798635|NCT02495883|Ethanol|ethanol|mesh-list
56222740|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
56222741|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
56222742|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
56222743|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222744|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56222745|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56222746|NCT01676987|Budesonide|budesonide|mesh-list
56222747|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
56222748|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56222749|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56222750|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
55762509|NCT04787289|Bevacizumab|bevacizumab|mesh-list
56222751|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222752|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222753|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55786573|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
55786575|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786576|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56222755|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
56222756|NCT01676987|Hormones|hormones|mesh-ancestor
56222765|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56222766|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786578|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786579|NCT02875223|Itraconazole|itraconazole|mesh-list
55786580|NCT02875223|Rifampin|rifampin|mesh-list
55786581|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
55786582|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
55786583|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786584|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55786585|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56222890|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
56222891|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222892|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56222893|NCT05597215|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
56222894|NCT05597215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56222895|NCT05597215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222896|NCT05596981|Sorafenib|sorafenib|mesh-list
56222897|NCT05596981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56222898|NCT05596981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56222899|NCT05596981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56222947|NCT05596552|Anesthetics|anesthetics|mesh-ancestor
56222948|NCT05596552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56222949|NCT05596552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56222950|NCT05596552|Sensory System Agents|sensory system agents|mesh-ancestor
56222951|NCT05596552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56222952|NCT05596552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56222953|NCT05596552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56222954|NCT05596552|Analgesics|analgesics|mesh-ancestor
56222955|NCT05596552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56222956|NCT05596552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56222957|NCT05596552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56222958|NCT05596552|Adrenergic Agents|adrenergic agents|mesh-ancestor
56222959|NCT05596552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56222960|NCT05596552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56222961|NCT05596552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56222962|NCT05596552|Narcotics|narcotics|mesh-ancestor
56222963|NCT05596552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56223020|NCT05596071|Ropivacaine|ropivacaine|mesh-list
55786668|NCT04389775|Hormones|hormones|mesh-ancestor
56223021|NCT05596071|Anesthetics, Local|anesthetics, local|mesh-ancestor
56223022|NCT05596071|Anesthetics|anesthetics|mesh-ancestor
56223023|NCT05596071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223024|NCT05596071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223025|NCT05596071|Sensory System Agents|sensory system agents|mesh-ancestor
56223026|NCT05596071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223128|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56223129|NCT05488847|Narcotics|narcotics|mesh-ancestor
56223244|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55786691|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931248|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
55931249|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931250|NCT03090048|Protective Agents|protective agents|mesh-ancestor
55931251|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55931252|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931253|NCT04195997|Heparin|heparin|mesh-list
55786692|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56223245|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56223246|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
56223247|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56223248|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793651|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
56223312|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
56223313|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223315|NCT05291156|Avelumab|avelumab|mesh-list
56223316|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223317|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223318|NCT05253118|Pemetrexed|pemetrexed|mesh-list
56223319|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223320|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223321|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223322|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56223323|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56223324|NCT05226923|Meropenem|meropenem|mesh-list
56223325|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55786698|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
55786699|NCT02102789|Antidotes|antidotes|mesh-ancestor
55815457|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
56223403|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56223404|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
56223405|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56223406|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56223407|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56223408|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56223409|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56223462|NCT04810793|Renal Agents|renal agents|mesh-ancestor
56223463|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56223464|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56223465|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223466|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56223467|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56223468|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56223469|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56223470|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56223471|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56223472|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56223473|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56223474|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
56223475|NCT04797832|Hematinics|hematinics|mesh-ancestor
56223479|NCT04684511|Rofecoxib|rofecoxib|mesh-list
56223480|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56223481|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56223482|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799411|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56223500|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56223501|NCT04624854|Analgesics|analgesics|mesh-ancestor
56223502|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
56223503|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56223504|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223505|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56223506|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223507|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56223508|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56223509|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223510|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56223511|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56223512|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223513|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
56223514|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56223515|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56223516|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56223517|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
56223518|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223519|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
55931254|NCT04195997|Bivalirudin|bivalirudin|mesh-list
55931255|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
55931256|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55931257|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56223520|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223521|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56223522|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223523|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223524|NCT04565171|Yimitasvir|yimitasvir|mesh-list
56223525|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
56223532|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223533|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56223534|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223535|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56223536|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56223537|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55815555|NCT04171726|Edoxaban|edoxaban|mesh-list
56223650|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56223651|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56223652|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56223653|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
56223654|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56223655|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
56223656|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56223657|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223658|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223659|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56223660|NCT03928093|Pregabalin|pregabalin|mesh-list
56223661|NCT03928093|Analgesics|analgesics|mesh-ancestor
56223662|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
56223663|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799590|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787009|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787010|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
55787011|NCT05092555|Coagulants|coagulants|mesh-ancestor
55787031|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787107|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
55787108|NCT05164081|Gentamicins|gentamicins|mesh-list
55787109|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55787110|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787111|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
55787112|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55787113|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787114|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787115|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55787116|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55787117|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56223671|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56223672|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223673|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56223674|NCT03907800|Paclitaxel|paclitaxel|mesh-list
56223675|NCT03907800|Carboplatin|carboplatin|mesh-list
56223676|NCT03907800|Trastuzumab|trastuzumab|mesh-list
56223677|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56223678|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223679|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
56223680|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
56223681|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
55787118|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787119|NCT04437017|Dexamethasone|dexamethasone|mesh-list
55787120|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
55787121|NCT04437017|Olanzapine|olanzapine|mesh-list
55787122|NCT04437017|Serotonin|serotonin|mesh-list
55787123|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55787124|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
55787125|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
55787126|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787127|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787128|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787129|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
55787130|NCT04437017|Hormones|hormones|mesh-ancestor
55789085|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787131|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787133|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787147|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787148|NCT03061253|Nicotine|nicotine|mesh-list
55787149|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56223682|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223683|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223684|NCT03894904|Heparin|heparin|mesh-list
56223685|NCT03894904|Papaverine|papaverine|mesh-list
56223686|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
56223687|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56223688|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56223689|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223690|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56223691|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223692|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
56223693|NCT03894904|Urological Agents|urological agents|mesh-ancestor
56223694|NCT03797833|Anesthetics|anesthetics|mesh-list
56223695|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787150|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
55787151|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787152|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787153|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56223696|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223698|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56223699|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223700|NCT03722927|Bupivacaine|bupivacaine|mesh-list
55931258|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931259|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
55931260|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56223714|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56223715|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223716|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223717|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
55799647|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223718|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223719|NCT03671525|Nimodipine|nimodipine|mesh-list
56223720|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56223721|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56223722|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56223723|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223724|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56223725|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223726|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
56223727|NCT03600155|Nivolumab|nivolumab|mesh-list
56223728|NCT03600155|Ipilimumab|ipilimumab|mesh-list
55787162|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787163|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56223729|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223731|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56223732|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223734|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223735|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223736|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
56223737|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223738|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223739|NCT03571308|Prednisolone|prednisolone|mesh-list
56223740|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
56223741|NCT03571308|Doxorubicin|doxorubicin|mesh-list
56223742|NCT03571308|Vincristine|vincristine|mesh-list
56223743|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
56223744|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223745|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
56223746|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223747|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56223748|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56223749|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
56223750|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223751|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56223752|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56223753|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56223754|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55799680|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799681|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799683|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
55799685|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56223791|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
56223792|NCT03517176|Antiviral Agents|antiviral agents|mesh-ancestor
56223793|NCT03517176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223794|NCT03517176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223795|NCT03517176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223796|NCT03517176|Immunologic Factors|immunologic factors|mesh-ancestor
56223797|NCT03517176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223798|NCT03512964|Tenofovir|tenofovir|mesh-list
56223799|NCT03512964|Emtricitabine|emtricitabine|mesh-list
56223800|NCT03512964|Dolutegravir|dolutegravir|mesh-list
56223801|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56223802|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
56223803|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56223804|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55718405|NCT02301949|Growth Substances|growth substances|mesh-ancestor
55718406|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
55718407|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827105|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
55827106|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827107|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827108|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
55827109|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
55827110|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827111|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
55827112|NCT05631041|Silymarin|silymarin|mesh-list
55718408|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55718409|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
55718410|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56223805|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56223806|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56223807|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223808|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56223812|NCT03507608|Flutamide|flutamide|mesh-list
56223823|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
56223824|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56223825|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
56223826|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56223827|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
56223828|NCT03463499|Protective Agents|protective agents|mesh-ancestor
56223829|NCT03404193|Decitabine|decitabine|mesh-list
55787171|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55787172|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
55787173|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787174|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
55787175|NCT05106751|Protective Agents|protective agents|mesh-ancestor
55787177|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
55787178|NCT04977557|Vitamins|vitamins|mesh-ancestor
56223882|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56223883|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799810|NCT04050553|Hormones|hormones|mesh-ancestor
56223906|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787195|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787196|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787197|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
55787198|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787199|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55787200|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56223907|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56223908|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56223909|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
56223910|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56223911|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56223912|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56223913|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56223914|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
56223915|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56223948|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
55787305|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224013|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224015|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224017|NCT02812862|Olodaterol|olodaterol|mesh-list
56224018|NCT02812862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56224019|NCT02812862|Autonomic Agents|autonomic agents|mesh-ancestor
56224112|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224114|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224115|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56224116|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224117|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224118|NCT01517451|Androgens|androgens|mesh-list
56224119|NCT01517451|Hormones|hormones|mesh-ancestor
55800053|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
55787320|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
55787321|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
55787322|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
55787323|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787324|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787325|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800072|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55787326|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55787327|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55787328|NCT03060005|Dextrans|dextrans|mesh-list
55787353|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
55787354|NCT02615119|Protective Agents|protective agents|mesh-ancestor
55787355|NCT02598349|Capecitabine|capecitabine|mesh-list
55787356|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55787357|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
56224121|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224122|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
56224123|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56224124|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56224125|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56224126|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55800074|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
55787358|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787359|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787360|NCT02555293|Rifaximin|rifaximin|mesh-list
55787361|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55787362|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787363|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787364|NCT05104255|Anesthetics|anesthetics|mesh-list
55787365|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787366|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787367|NCT03293017|Diazepam|diazepam|mesh-list
55787368|NCT03293017|Baclofen|baclofen|mesh-list
55787369|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55787370|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224152|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224154|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56224155|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
56224156|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224157|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224158|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56224160|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
56224161|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224162|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56224163|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55787388|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56224184|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224185|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224187|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224188|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56224189|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224190|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56224191|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
56224192|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
56224193|NCT01685489|Docetaxel|docetaxel|mesh-list
56224194|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224195|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
56224196|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
56224197|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
56224198|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224199|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56224200|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
56224201|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224202|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56224203|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
56224204|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224205|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
56224207|NCT01685489|Protective Agents|protective agents|mesh-ancestor
56224213|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
56224214|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56224215|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56224216|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56224217|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56224218|NCT01686386|Dexamethasone|dexamethasone|mesh-list
56224219|NCT01686386|Lenalidomide|lenalidomide|mesh-list
56224220|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56224221|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224222|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
56224223|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
56224224|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224225|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224227|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
56224228|NCT01686386|Hormones|hormones|mesh-ancestor
56224229|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224230|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56224231|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224232|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
56224233|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56224234|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56224235|NCT01686386|Growth Substances|growth substances|mesh-ancestor
56224236|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
56224237|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56224238|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
56224239|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224240|NCT01686594|Methoxsalen|methoxsalen|mesh-list
56224241|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56224242|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
56224253|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
56224254|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224255|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56224256|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56224257|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56224258|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
56224259|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224260|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224261|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56224262|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56224263|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56224264|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56224265|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56224266|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
55800195|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56224268|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
56224269|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
56224270|NCT01688362|Dexamethasone|dexamethasone|mesh-list
56224271|NCT01688362|Bupivacaine|bupivacaine|mesh-list
56224272|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224273|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
56224274|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
56224275|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931261|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
56224276|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224277|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56224278|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
56224279|NCT01688362|Hormones|hormones|mesh-ancestor
56224280|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224281|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56224282|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224283|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
56224284|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
56224285|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224286|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
55794341|NCT03068065|Hormones|hormones|mesh-ancestor
56224315|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56224316|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800239|NCT05519813|Pioglitazone|pioglitazone|mesh-list
56224343|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
56224344|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224345|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224346|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56224347|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
56224348|NCT01690325|Bevacizumab|bevacizumab|mesh-list
56224349|NCT01690325|Docetaxel|docetaxel|mesh-list
56224350|NCT01690325|Trastuzumab|trastuzumab|mesh-list
56224351|NCT01690325|Epirubicin|epirubicin|mesh-list
56224352|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224353|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
56224354|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224355|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56224356|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56224357|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
56224358|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224359|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224360|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56224361|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56224362|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56224363|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56224364|NCT01690325|Growth Substances|growth substances|mesh-ancestor
56224365|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
56224366|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
56224367|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
56224368|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
56224369|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56224370|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56224371|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56224372|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224373|NCT01690338|Bromides|bromides|mesh-list
56224374|NCT01690338|Rocuronium|rocuronium|mesh-list
56224375|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
56224376|NCT01690338|Cisatracurium|cisatracurium|mesh-list
56224377|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
56224378|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56224379|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56224380|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56224381|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224382|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224383|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56224384|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55815928|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224385|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
56224386|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787401|NCT02625623|Irinotecan|irinotecan|mesh-list
55787402|NCT02625623|Avelumab|avelumab|mesh-list
55787403|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55787404|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787405|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
55787406|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
55787407|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
55787408|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787409|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56224395|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931262|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224396|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56224397|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56224416|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224418|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
56224433|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224434|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224435|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56224436|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
56224437|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56224438|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224439|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56224440|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56224441|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56224442|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
56224443|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56224459|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224460|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56224461|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
56224462|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224463|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
56224464|NCT01690572|Protective Agents|protective agents|mesh-ancestor
56224466|NCT01690598|Veliparib|veliparib|mesh-list
56224467|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56224468|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56224469|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224470|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224471|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224472|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56224473|NCT01690637|Oseltamivir|oseltamivir|mesh-list
56224474|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
56224475|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224476|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224477|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224478|NCT01690702|Paclitaxel|paclitaxel|mesh-list
56224479|NCT01690702|Docetaxel|docetaxel|mesh-list
56224480|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
56224481|NCT01690702|Epirubicin|epirubicin|mesh-list
55787430|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
55787431|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
55787432|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
55787433|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787434|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
56224524|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56224525|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224526|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224528|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56224529|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
56224530|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
56224531|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
56224532|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224533|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224534|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224536|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224537|NCT01690884|Adenosine|adenosine|mesh-list
56224538|NCT01690884|Analgesics|analgesics|mesh-ancestor
56224539|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
56224540|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224541|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787435|NCT05110339|Ropivacaine|ropivacaine|mesh-list
55787436|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55787437|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787438|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787439|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55787440|NCT05110339|Analgesics|analgesics|mesh-ancestor
55787441|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
55787442|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787443|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55787444|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56224542|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56224543|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
56224544|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56224545|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
56224546|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
56224547|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224548|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224549|NCT01690962|Vitamins|vitamins|mesh-list
56224550|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
56224551|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
56224552|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
56224553|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
56224554|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224563|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56224564|NCT01691001|Analgesics|analgesics|mesh-ancestor
56224565|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
56224566|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224567|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56224568|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55787445|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55787446|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
55787447|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787448|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787449|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
55787450|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
55787451|NCT04965545|Copper|copper|mesh-list
55787452|NCT04965545|Trace Elements|trace elements|mesh-ancestor
55787453|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
55787454|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787455|NCT05105347|Prednisone|prednisone|mesh-list
55787456|NCT05105347|Adalimumab|adalimumab|mesh-list
55787457|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55787458|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
55787459|NCT05105347|Hormones|hormones|mesh-ancestor
56224569|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56224570|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
56224571|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224572|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224574|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55787465|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
55787466|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
55787467|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56224582|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
56224583|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224584|NCT01691365|Vitamins|vitamins|mesh-list
56224585|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
56224586|NCT01691365|Antioxidants|antioxidants|mesh-list
56224587|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
56224588|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224589|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224590|NCT01691365|Protective Agents|protective agents|mesh-ancestor
56224591|NCT01691404|Quercetin|quercetin|mesh-list
56224592|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
56224593|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224594|NCT01691404|Protective Agents|protective agents|mesh-ancestor
56224595|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224596|NCT01691456|Montelukast|montelukast|mesh-list
56224597|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56224598|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
56224599|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56224600|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
56224601|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224602|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224603|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56224604|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55787468|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56224605|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224607|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56224608|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
56224609|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56224635|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224636|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56224637|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224638|NCT01691677|Beclomethasone|beclomethasone|mesh-list
56224639|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224640|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
56224642|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224643|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224644|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56224645|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
56224646|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56224647|NCT01691742|Laxatives|laxatives|mesh-list
55798056|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55931268|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931269|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55931270|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55931271|NCT04195373|Flucytosine|flucytosine|mesh-list
55931272|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
55931273|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931274|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
55931275|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931276|NCT04194827|Adalimumab|adalimumab|mesh-list
55931277|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931278|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931279|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55931280|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56224648|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56224649|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56224650|NCT01691807|Ofatumumab|ofatumumab|mesh-list
56224651|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56224652|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
56224653|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224654|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224655|NCT01691872|Ezogabine|ezogabine|mesh-list
56224656|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
56224657|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56224658|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224659|NCT01691937|Sufentanil|sufentanil|mesh-list
56224660|NCT01691937|Ropivacaine|ropivacaine|mesh-list
56224661|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
56224662|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
55800583|NCT04667663|Hormones|hormones|mesh-ancestor
56224663|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224664|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224665|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
56224666|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224667|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56224668|NCT01691937|Narcotics|narcotics|mesh-ancestor
56224669|NCT01691937|Analgesics|analgesics|mesh-ancestor
56224670|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56224671|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56224672|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
56224673|NCT01691976|Estrogens|estrogens|mesh-list
56224674|NCT01691976|Hormones|hormones|mesh-ancestor
56224675|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224676|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224677|NCT01692132|Prucalopride|prucalopride|mesh-list
56224678|NCT01692132|Laxatives|laxatives|mesh-ancestor
56224679|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56224680|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56224681|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56224682|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
56224683|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224684|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800607|NCT05513729|Pioglitazone|pioglitazone|mesh-list
56224701|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56224702|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224703|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224704|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
56224705|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224706|NCT01692483|Prednisone|prednisone|mesh-list
56224707|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
55798072|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
56224708|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224709|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
56224710|NCT01692483|Hormones|hormones|mesh-ancestor
56224711|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224712|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224713|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56224714|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224715|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56224716|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224722|NCT01692678|Dacarbazine|dacarbazine|mesh-list
56224724|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56224725|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
56224726|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224727|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224728|NCT01692704|Gemcitabine|gemcitabine|mesh-list
56224729|NCT01692704|Floxuridine|floxuridine|mesh-list
56224730|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224731|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56224732|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
56224733|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224734|NCT01692704|Antiviral Agents|antiviral agents|mesh-ancestor
56224735|NCT01692704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224736|NCT01692704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224737|NCT01692704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224738|NCT01692704|Immunologic Factors|immunologic factors|mesh-ancestor
56224739|NCT01692704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224740|NCT01692808|Vitamin D|vitamin d|mesh-list
56224741|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
55787494|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55787495|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55787496|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55787497|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55787498|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224791|NCT01693276|Gemcitabine|gemcitabine|mesh-list
56224792|NCT01693276|Paclitaxel|paclitaxel|mesh-list
56224793|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56224794|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56224795|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224796|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
56224797|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
56224798|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
56224799|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224800|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56224801|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
56224802|NCT01693276|Antiviral Agents|antiviral agents|mesh-ancestor
56224803|NCT01693276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224804|NCT01693276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224805|NCT01693276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224806|NCT01693276|Immunologic Factors|immunologic factors|mesh-ancestor
56224807|NCT01693276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224808|NCT01693289|Metformin|metformin|mesh-list
56224809|NCT01693289|Letrozole|letrozole|mesh-list
56224848|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
56224849|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56224850|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56224851|NCT01693419|Gemcitabine|gemcitabine|mesh-list
56224852|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56224853|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56224854|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
56224855|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224856|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224857|NCT01693419|Antiviral Agents|antiviral agents|mesh-ancestor
56224858|NCT01693419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224859|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224860|NCT01693419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224861|NCT01693419|Immunologic Factors|immunologic factors|mesh-ancestor
56224862|NCT01693419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224863|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56224864|NCT01693432|Docetaxel|docetaxel|mesh-list
56224865|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224866|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
56224867|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
56224868|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
56224869|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224870|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
56224871|NCT01693445|Irinotecan|irinotecan|mesh-list
56224872|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224873|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56224874|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55787499|NCT05108545|Amphotericin B|amphotericin b|mesh-list
55787500|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55787501|NCT05108545|Amebicides|amebicides|mesh-ancestor
56224883|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56224897|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
56224898|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56224899|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56224900|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56224902|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
56224903|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56224904|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
56224905|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224906|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56224907|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224908|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
56224909|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224910|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
56224911|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56224937|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55800846|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
55787514|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
55787515|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
55787516|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787517|NCT04952129|Protective Agents|protective agents|mesh-ancestor
55787518|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787519|NCT04952129|Trace Elements|trace elements|mesh-ancestor
55787520|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
56224949|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
56224950|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56224951|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56224952|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224953|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56224954|NCT05288738|Analgesics|analgesics|mesh-ancestor
56224955|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
56224956|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56224957|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56224958|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56224959|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56224960|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
56224961|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56224962|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56224963|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56224964|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56224965|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
56224966|NCT05288725|Hormones|hormones|mesh-ancestor
55798132|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
56224967|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56224968|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56224969|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56224970|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
56225020|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225021|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225022|NCT05288127|Talazoparib|talazoparib|mesh-list
55800940|NCT04856371|Letrozole|letrozole|mesh-list
55787630|NCT01675765|Pemetrexed|pemetrexed|mesh-list
55787631|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
55787633|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787634|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787635|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55787636|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
55787637|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225029|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
56225030|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56225031|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56225032|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56225033|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225034|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56225035|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225036|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225037|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55787663|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787664|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55798179|NCT04921111|Vaccines|vaccines|mesh-list
55798180|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
55798181|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931337|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787665|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55787666|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55816335|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225086|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225087|NCT05291039|Adalimumab|adalimumab|mesh-list
56225088|NCT05291039|Infliximab|infliximab|mesh-list
56225116|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225117|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
56225118|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225119|NCT05290857|Hemostatics|hemostatics|mesh-list
56225120|NCT05290857|Coagulants|coagulants|mesh-ancestor
56225121|NCT05290506|Linagliptin|linagliptin|mesh-list
56225122|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56225123|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56225124|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225125|NCT05290506|Incretins|incretins|mesh-ancestor
56225127|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56225128|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
56225129|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225130|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225131|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
56225132|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225133|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55801024|NCT04856137|Paclitaxel|paclitaxel|mesh-list
56225134|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225135|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225136|NCT05290324|Midazolam|midazolam|mesh-list
56225137|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56225138|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56225139|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225140|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225141|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56225142|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56225143|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55787712|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55787714|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787715|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
55787716|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787717|NCT04000555|Vancomycin|vancomycin|mesh-list
55931371|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931373|NCT03404037|Endostatins|endostatins|mesh-list
56225150|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225151|NCT05290090|Rituximab|rituximab|mesh-list
56225152|NCT05290090|Lenalidomide|lenalidomide|mesh-list
56225153|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
56225154|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56225155|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225156|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
56225157|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225158|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225159|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56225160|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56225161|NCT05290090|Growth Substances|growth substances|mesh-ancestor
56225162|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
56225163|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56225164|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225165|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225166|NCT05292742|Capecitabine|capecitabine|mesh-list
56225167|NCT05292742|Trastuzumab|trastuzumab|mesh-list
56225168|NCT05292742|Pertuzumab|pertuzumab|mesh-list
56225179|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787719|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225181|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56225182|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56225183|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225184|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
56225185|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
56225186|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
56225187|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225188|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
56225189|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56225190|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56225191|NCT05291793|Prednisolone|prednisolone|mesh-list
56225192|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
56225193|NCT05291793|Tenoxicam|tenoxicam|mesh-list
56225194|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56225195|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
55931394|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
55798204|NCT05421065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798205|NCT05421065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55798206|NCT05421065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56225196|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56225197|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
56225198|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
56225199|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225200|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225201|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56225202|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
56225203|NCT05291793|Hormones|hormones|mesh-ancestor
56225204|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56225205|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56225206|NCT05291793|Protective Agents|protective agents|mesh-ancestor
56225207|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56225208|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225209|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56225210|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56225211|NCT05291793|Analgesics|analgesics|mesh-ancestor
56225212|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
56225213|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225214|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56225215|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225219|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56225220|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56225247|NCT05294744|Expectorants|expectorants|mesh-ancestor
56225248|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
56225249|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56225250|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
56225251|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225252|NCT05294744|Protective Agents|protective agents|mesh-ancestor
56225253|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225254|NCT05294744|Antidotes|antidotes|mesh-ancestor
56225325|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225326|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
56225327|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225328|NCT05294393|Analgesics|analgesics|mesh-ancestor
56225329|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55801249|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
55787732|NCT03540901|Diuretics|diuretics|mesh-ancestor
55787733|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
55787734|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787735|NCT03517735|Remifentanil|remifentanil|mesh-list
55787736|NCT03517735|Propofol|propofol|mesh-list
55787737|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55787738|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787739|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787740|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55787741|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
55787742|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
55787743|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55787744|NCT03517735|Narcotics|narcotics|mesh-ancestor
55787745|NCT03517735|Analgesics|analgesics|mesh-ancestor
55787746|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
55787747|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787748|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
55787749|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55787750|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
55787751|NCT04941131|Povidone|povidone|mesh-list
55787752|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55787753|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787754|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
56225346|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931417|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931418|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931419|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931420|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
56225347|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225348|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56225349|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56225350|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225351|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56225352|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56225353|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225354|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
56225355|NCT05293704|Mizoribine|mizoribine|mesh-list
56225356|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56225357|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55787797|NCT04938713|Analgesics|analgesics|mesh-ancestor
55787798|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
55787799|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787800|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787801|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55787802|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55787803|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
55787804|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
55787805|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787806|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55787807|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55787808|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787809|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225414|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56225415|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
56225416|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225417|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225418|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56225419|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
56225420|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225421|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225422|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56225423|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56225424|NCT05296564|Analgesics|analgesics|mesh-ancestor
56225425|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
56225426|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225427|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56225428|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56225429|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
56225430|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225431|NCT05296369|Folic Acid|folic acid|mesh-list
56225432|NCT05296369|Hematinics|hematinics|mesh-ancestor
56225433|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
56225434|NCT05296369|Vitamins|vitamins|mesh-ancestor
56225435|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
56225436|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225437|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
56225438|NCT05296317|Epirubicin|epirubicin|mesh-list
55931427|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55931428|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931429|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
55931430|NCT03962465|Hormones|hormones|mesh-ancestor
55931431|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931432|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931433|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55931434|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931435|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55931436|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
55931437|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55931438|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56225439|NCT05296317|Lenograstim|lenograstim|mesh-list
56225440|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56225441|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
56225442|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225449|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56225450|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56225451|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56225452|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56225453|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225455|NCT05296005|Docetaxel|docetaxel|mesh-list
56225456|NCT05296005|Fluorouracil|fluorouracil|mesh-list
56225457|NCT05296005|Capecitabine|capecitabine|mesh-list
56225458|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
55787830|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787831|NCT03572413|Bromides|bromides|mesh-list
55787832|NCT03572413|Rocuronium|rocuronium|mesh-list
55787833|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
55787834|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55787835|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55787836|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55787837|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787838|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787839|NCT04956419|Fluconazole|fluconazole|mesh-list
56225483|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
56225484|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
56225485|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225486|NCT05280405|Infliximab|infliximab|mesh-list
56225487|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
56225488|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56225489|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225490|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56225491|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56225492|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787840|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
55787841|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225530|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55787862|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787864|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55787865|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787866|NCT03100045|Artesunate|artesunate|mesh-list
55787867|NCT03100045|Artemisinins|artemisinins|mesh-list
55787868|NCT03100045|Artemisinin|artemisinin|mesh-list
55787869|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
55787870|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55787871|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55787872|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787873|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225657|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56225658|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225659|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225660|NCT05203705|Enoxaparin|enoxaparin|mesh-list
56225661|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
56225662|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56225663|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56225664|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225665|NCT05202561|Vaccines|vaccines|mesh-list
56225666|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
55931439|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
56225667|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225668|NCT05192629|Midazolam|midazolam|mesh-list
56225669|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
56225670|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56225671|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225672|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225673|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56225765|NCT05110898|Diuretics|diuretics|mesh-ancestor
56225766|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
56225767|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225768|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56225769|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56225770|NCT05103696|Propofol|propofol|mesh-list
56225846|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225847|NCT04989621|Rituximab|rituximab|mesh-list
56225848|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56225849|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225850|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
56225851|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225852|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801688|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
55864027|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
55864029|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864030|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864031|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
55864032|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788025|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
55788026|NCT04332445|Protective Agents|protective agents|mesh-ancestor
55788028|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55788029|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788030|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864033|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55864034|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55864035|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55864036|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864037|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864038|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55864039|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55864040|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
55864041|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864042|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55864043|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55864044|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
55864045|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55864046|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
55864047|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
55864068|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864070|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864071|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56225860|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
56225861|NCT04984044|Vitamins|vitamins|mesh-ancestor
56225862|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
56225863|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225864|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56225865|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55801701|NCT03035695|Hemostatics|hemostatics|mesh-list
55864072|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55864073|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
55798235|NCT04939675|Lamotrigine|lamotrigine|mesh-list
55864074|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55864075|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55864081|NCT01905436|Ivermectin|ivermectin|mesh-list
55864082|NCT01905436|Albendazole|albendazole|mesh-list
55864083|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55864084|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864085|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
55864086|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
55864087|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55864088|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55864089|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
55864090|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
55864091|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
55864092|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864093|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864094|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
55864095|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55864096|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
55864097|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864098|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864099|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55864120|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55864121|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
55864122|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864123|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
55864124|NCT01972841|Mirabegron|mirabegron|mesh-list
55788031|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788032|NCT03890887|Itraconazole|itraconazole|mesh-list
55864125|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55864126|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55864127|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
55864128|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864129|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864130|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864131|NCT01972841|Urological Agents|urological agents|mesh-ancestor
55864133|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56225873|NCT04975802|Caffeine|caffeine|mesh-list
56225874|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55864134|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55864135|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
55864137|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55864138|NCT01774903|Narcotics|narcotics|mesh-ancestor
55864139|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864140|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864141|NCT01774903|Analgesics|analgesics|mesh-ancestor
55864142|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
55864143|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864144|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55798247|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931463|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931464|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931465|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55931466|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
55931467|NCT05021406|Protective Agents|protective agents|mesh-ancestor
55931468|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55931469|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798249|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55798250|NCT04939441|Tenofovir|tenofovir|mesh-list
55798251|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
55931470|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55931471|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
55864145|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55864146|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
55864147|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
55864148|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55864149|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55864150|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55864177|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
55864178|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864179|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864180|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
55864181|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55864182|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864183|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864184|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55864185|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55864186|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55864187|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864188|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55864190|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55864191|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55864192|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
55864193|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
55864194|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864195|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864196|NCT04656041|Paclitaxel|paclitaxel|mesh-list
55864197|NCT04656041|Carboplatin|carboplatin|mesh-list
55817783|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55864198|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55864199|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864231|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55864232|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864233|NCT01969721|Fluticasone|fluticasone|mesh-list
55864235|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
55864236|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55864237|NCT01969721|Olodaterol|olodaterol|mesh-list
55864238|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55864239|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55864240|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
55864241|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864242|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864243|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55864276|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
55864277|NCT01746901|Naltrexone|naltrexone|mesh-list
55864278|NCT01746901|Oxycodone|oxycodone|mesh-list
55864279|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55864280|NCT01746901|Narcotics|narcotics|mesh-ancestor
55864281|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864282|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931472|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55864283|NCT01746901|Analgesics|analgesics|mesh-ancestor
55864284|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
55864285|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788034|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788035|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55788036|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55788037|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788038|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788039|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55788040|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
55789087|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56225875|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225876|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56225877|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225878|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225879|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56225880|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56225881|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
56225882|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864321|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864322|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
55864374|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55864375|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864377|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55864378|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55864379|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864380|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55864382|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55864383|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864384|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55864385|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864386|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
55864387|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55864388|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
55864389|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864390|NCT01704079|Calcifediol|calcifediol|mesh-list
55864391|NCT01704079|Vitamins|vitamins|mesh-ancestor
55864392|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
55864393|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864394|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55864396|NCT01703845|Olodaterol|olodaterol|mesh-list
55864397|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55864398|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
55864399|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864400|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864401|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55864424|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864426|NCT01703221|Hormones|hormones|mesh-ancestor
55864427|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864428|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55864429|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
55864430|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864431|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864432|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
55864433|NCT00803686|Calcitonin|calcitonin|mesh-list
55864434|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55864435|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864436|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55864437|NCT00823966|Delavirdine|delavirdine|mesh-list
55864438|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55864439|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55864440|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864441|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864442|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
55864443|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864444|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55864445|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55864446|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
55864447|NCT01702987|Atorvastatin|atorvastatin|mesh-list
55788041|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788042|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864448|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55864449|NCT01702987|Simvastatin|simvastatin|mesh-list
55931516|NCT05015322|Bupivacaine|bupivacaine|mesh-list
55931517|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55931520|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
55864450|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55864451|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55864511|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
55864512|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864513|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864514|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55864515|NCT03879538|Analgesics|analgesics|mesh-ancestor
55864516|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
55864517|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864518|NCT00824824|Timolol|timolol|mesh-list
55864519|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55864520|NCT00824824|Dorzolamide|dorzolamide|mesh-list
55864521|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55864522|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55864523|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
55864525|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864526|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864527|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55864528|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55864529|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55864530|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55864532|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55864533|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864556|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
55864557|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864558|NCT01721317|Ezogabine|ezogabine|mesh-list
55864559|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
55864560|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864561|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864562|NCT05014438|Branebrutinib|branebrutinib|mesh-list
55864563|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55864564|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864565|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931539|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931540|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55864566|NCT00828412|Desonide|desonide|mesh-list
55864567|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55864568|NCT01959035|Aripiprazole|aripiprazole|mesh-list
55864569|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
55864570|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55864571|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55864572|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55864573|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864574|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864575|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
55864576|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
55864577|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864578|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864579|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55864580|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55864581|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
55864582|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55864583|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55864608|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55864609|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
55864610|NCT01737931|Hormones|hormones|mesh-ancestor
55864611|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864612|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55864613|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864614|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55864615|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55864616|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864617|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
55864618|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
55864619|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
55864620|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
55788043|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55788044|NCT04516993|Aspirin|aspirin|mesh-list
55788045|NCT04516993|Plasminogen|plasminogen|mesh-list
55788046|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55798310|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788047|NCT04516993|Tenecteplase|tenecteplase|mesh-list
55788048|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55864622|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864623|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55864624|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
55864625|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
55864626|NCT01958489|Pravastatin|pravastatin|mesh-list
55864627|NCT01958489|Evacetrapib|evacetrapib|mesh-list
55864628|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55864629|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55864630|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
55864631|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864632|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55864633|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55864634|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864687|NCT01943435|Mirtazapine|mirtazapine|mesh-list
55864688|NCT01943435|Trazodone|trazodone|mesh-list
55864689|NCT01943435|Sertraline|sertraline|mesh-list
55864690|NCT01943435|Nortriptyline|nortriptyline|mesh-list
55864691|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
55864692|NCT01943435|Misoprostol|misoprostol|mesh-list
55864693|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55864694|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
55864695|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864696|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864697|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
55864698|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55864699|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55864700|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55864701|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55864702|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864703|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864704|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55864725|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
55864726|NCT01943435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55864727|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
55864728|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55864729|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
55864730|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
55864731|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55864732|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55864733|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55864734|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
55864735|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55864736|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55864737|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55864738|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55864739|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55864740|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55864741|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
55864742|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
55864743|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864744|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798336|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
55864745|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864746|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
55864747|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
55864748|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55864749|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55864750|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
55864751|NCT00807586|Prednisolone|prednisolone|mesh-list
55864752|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
55788049|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55864753|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55864754|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
55864755|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55864756|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
55864797|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56225896|NCT04964700|Natalizumab|natalizumab|mesh-list
56225897|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
55864798|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55864799|NCT01941095|Analgesics|analgesics|mesh-ancestor
55864800|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
55864801|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864802|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55864803|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55864804|NCT00831766|Cytarabine|cytarabine|mesh-list
55864805|NCT00831766|Lenalidomide|lenalidomide|mesh-list
55864806|NCT00831766|Idarubicin|idarubicin|mesh-list
55864807|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
55864808|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55864809|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
55864810|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864811|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
55864812|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864813|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55864814|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
55864841|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55864842|NCT04644029|Islatravir|islatravir|mesh-list
55864843|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
55864844|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864845|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55864847|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864848|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864849|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55864850|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55798349|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798350|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798351|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
55931587|NCT02979665|Ranibizumab|ranibizumab|mesh-list
55864851|NCT00844090|Methylphenidate|methylphenidate|mesh-list
55864852|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55864853|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864854|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55864855|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55864856|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864857|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864858|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
55864859|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864860|NCT00844714|Rituximab|rituximab|mesh-list
55864861|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55864881|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864882|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864883|NCT00834808|Analgesics|analgesics|mesh-ancestor
55864884|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
55864885|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864886|NCT00850096|Insulin|insulin|mesh-list
55864887|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55864888|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864889|NCT00834886|Melatonin|melatonin|mesh-list
55864890|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
55864891|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864892|NCT00834886|Protective Agents|protective agents|mesh-ancestor
55864893|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864913|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55864914|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55864915|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55864916|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864917|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864918|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55864919|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
55864920|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864921|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864922|NCT00835900|Varenicline|varenicline|mesh-list
55864923|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55864924|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55788051|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
55788052|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788053|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788123|NCT01698307|Adalimumab|adalimumab|mesh-list
56225898|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931609|NCT04374279|Bicalutamide|bicalutamide|mesh-list
55798366|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225899|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55864925|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
55864926|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864927|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864928|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864929|NCT03856216|Rituximab|rituximab|mesh-list
55864930|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55864931|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55864932|NCT03856216|Methotrexate|methotrexate|mesh-list
55864933|NCT03856216|Fludarabine|fludarabine|mesh-list
55864934|NCT03856216|Melphalan|melphalan|mesh-list
55864935|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55864936|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
55864937|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55864938|NCT03856216|Antibodies|antibodies|mesh-list
55864939|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
55864940|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55864941|NCT03856216|Tacrolimus|tacrolimus|mesh-list
55864942|NCT03856216|Lenograstim|lenograstim|mesh-list
55864943|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55864944|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
55864945|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864946|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864947|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55864948|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55864949|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
55864950|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55864951|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55865018|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55865020|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55865021|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55865022|NCT00841204|Analgesics|analgesics|mesh-ancestor
55865023|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
55865024|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865025|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865026|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865027|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865028|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865029|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55865030|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931627|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55931628|NCT05014464|Crizotinib|crizotinib|mesh-list
55931629|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865031|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865032|NCT00853840|Maraviroc|maraviroc|mesh-list
55865033|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
55865034|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55865035|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55865036|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865037|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55865072|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865073|NCT00842608|Haloperidol|haloperidol|mesh-list
55865074|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
55865075|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
55865076|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
55865077|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
55865078|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865079|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865101|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55865102|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865103|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
55865104|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865105|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798410|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
55798411|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
55798414|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55865106|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55865107|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865108|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
55865109|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55865110|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865111|NCT00857272|Bisacodyl|bisacodyl|mesh-list
55865112|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55788199|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788200|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55865113|NCT00857272|Cathartics|cathartics|mesh-ancestor
55865114|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55865115|NCT00857272|Laxatives|laxatives|mesh-ancestor
56225900|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
56225901|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865116|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
55865117|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55865118|NCT03696784|Fludarabine|fludarabine|mesh-list
55865119|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865120|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
55865121|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865122|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865123|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55865124|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
55865125|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865126|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865127|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55865128|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
55865129|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55865130|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55865131|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55865132|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
55865133|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865160|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55865161|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55865162|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
55865163|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931657|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931664|NCT04022057|Ropivacaine|ropivacaine|mesh-list
55865164|NCT04400890|Protective Agents|protective agents|mesh-ancestor
55865165|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865166|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55865167|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
55865168|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865169|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865170|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865171|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55865173|NCT04351438|Citric Acid|citric acid|mesh-list
55865174|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
55865175|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
55865176|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55865177|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
55865178|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
55865179|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865180|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55865181|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55865182|NCT00890656|Dexamethasone|dexamethasone|mesh-list
55865183|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
55865184|NCT00890656|Doxorubicin|doxorubicin|mesh-list
55931690|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55931691|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
55931692|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
55931693|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865185|NCT00890656|Methotrexate|methotrexate|mesh-list
55865186|NCT00890656|Vincristine|vincristine|mesh-list
55865187|NCT00890656|Asparaginase|asparaginase|mesh-list
55865188|NCT00890656|Pegaspargase|pegaspargase|mesh-list
55865189|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865190|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
55865191|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865192|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865193|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55865194|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
55865195|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865223|NCT00814138|Methotrexate|methotrexate|mesh-list
55865224|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55865225|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
55865226|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55788202|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
55788203|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55865227|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865228|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55865229|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
55865230|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865231|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865232|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
55865233|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865234|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55865235|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865236|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
55865237|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865238|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56225902|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56225903|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56225904|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225905|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225906|NCT04940767|Minocycline|minocycline|mesh-list
56225907|NCT04940767|Isotretinoin|isotretinoin|mesh-list
56225908|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55931717|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
55931718|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
55931719|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
55931720|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931721|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56225909|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56225910|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
56225911|NCT04921527|Paclitaxel|paclitaxel|mesh-list
56225912|NCT04921527|Chiauranib|chiauranib|mesh-list
56225913|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56225914|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225915|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
56225916|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
56225917|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
56225918|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225919|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56225920|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865264|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55865265|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865266|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55865267|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55865268|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55865269|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865270|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
55865271|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865272|NCT01857934|Aldesleukin|aldesleukin|mesh-list
55865273|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
55865277|NCT01857934|Doxorubicin|doxorubicin|mesh-list
55865278|NCT01857934|Etoposide|etoposide|mesh-list
55865279|NCT01857934|Vincristine|vincristine|mesh-list
55865280|NCT01857934|Topotecan|topotecan|mesh-list
55865281|NCT01857934|Interleukin-2|interleukin-2|mesh-list
55865282|NCT01857934|Molgramostim|molgramostim|mesh-list
55865283|NCT01857934|Dinutuximab|dinutuximab|mesh-list
55865284|NCT01857934|Levetiracetam|levetiracetam|mesh-list
55865285|NCT01857934|Isotretinoin|isotretinoin|mesh-list
55865286|NCT01857934|Antibodies|antibodies|mesh-list
55865287|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
55865288|NCT01857934|Sargramostim|sargramostim|mesh-list
55865289|NCT01857934|Lenograstim|lenograstim|mesh-list
55865290|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865291|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
55865325|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55865326|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865327|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865329|NCT01604785|Propofol|propofol|mesh-list
55865330|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
55865331|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55865332|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798485|NCT03056599|Nivolumab|nivolumab|mesh-list
55798486|NCT03056599|Bortezomib|bortezomib|mesh-list
55865364|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
55865365|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865366|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55865367|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
55865368|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
55865369|NCT00863434|Cytarabine|cytarabine|mesh-list
55865370|NCT00863434|Clofarabine|clofarabine|mesh-list
56225921|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
56225922|NCT04899843|Astringents|astringents|mesh-ancestor
56225923|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225924|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
56225925|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
56225926|NCT04899687|Fluoxetine|fluoxetine|mesh-list
56225927|NCT04899687|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56225928|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56225929|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56225930|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225931|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225932|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
55801767|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
55865371|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55865372|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
55865373|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865374|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865375|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
55865376|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865401|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865402|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55865403|NCT01716715|Paclitaxel|paclitaxel|mesh-list
55865404|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55865405|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55865406|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865407|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
55865408|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
55865409|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
55788204|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788205|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
55865410|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865411|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
55865412|NCT01696279|Calcium|calcium|mesh-list
55865413|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55865414|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865415|NCT01696279|Antacids|antacids|mesh-ancestor
55865416|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865417|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55865418|NCT01936181|Infliximab|infliximab|mesh-list
55865419|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
55931764|NCT03402087|Protective Agents|protective agents|mesh-ancestor
55931765|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
55931766|NCT03402087|Vitamins|vitamins|mesh-ancestor
55865420|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55865421|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865422|NCT01696045|Ipilimumab|ipilimumab|mesh-list
55865423|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55865424|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865425|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55865426|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865451|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55865452|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55865454|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865455|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55865457|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865458|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865459|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55865461|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
55865462|NCT02986321|Hormones|hormones|mesh-ancestor
55865463|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55865464|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56225933|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225934|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56225935|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
56225936|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865465|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55865466|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865467|NCT01951157|Gemcitabine|gemcitabine|mesh-list
55865468|NCT01951157|Docetaxel|docetaxel|mesh-list
55865469|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55865470|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
55865471|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865472|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865473|NCT01951157|Antiviral Agents|antiviral agents|mesh-ancestor
55865474|NCT01951157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865475|NCT01951157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865476|NCT01951157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865506|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865507|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55865508|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865509|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865510|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
55865511|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865512|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931783|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931784|NCT05008068|Simvastatin|simvastatin|mesh-list
55931785|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55931787|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
55865513|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55865514|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55865515|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865516|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865517|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865518|NCT01933919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55865519|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55865520|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55865521|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865550|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55865551|NCT01692301|Olmesartan|olmesartan|mesh-list
55865552|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55865553|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55865554|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55865555|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55865556|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55865557|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788206|NCT05406999|Hormones|hormones|mesh-ancestor
55865558|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55865559|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865560|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
55865561|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55865562|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55865611|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865612|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865613|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
55865616|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55865617|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55865618|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865619|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
55865620|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931803|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743341|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55931804|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931805|NCT04020809|Atezolizumab|atezolizumab|mesh-list
55931806|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931807|NCT04027751|Tropisetron|tropisetron|mesh-list
55931808|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
55931818|NCT05018988|Vitamin D|vitamin d|mesh-list
55865621|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55865622|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
55865623|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865624|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55865625|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55865626|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55865627|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865628|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
55865629|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225937|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56225938|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56225939|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225940|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
56225941|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
56225942|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56225943|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56225944|NCT04897802|Exenatide|exenatide|mesh-list
56225945|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56225946|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225947|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56225948|NCT04897802|Incretins|incretins|mesh-ancestor
56225949|NCT04897802|Hormones|hormones|mesh-ancestor
56225950|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56225951|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
56225952|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225953|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
56225954|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
56225955|NCT04882332|Vitamins|vitamins|mesh-ancestor
56225956|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
56225957|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225958|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
56225959|NCT04882332|Hematinics|hematinics|mesh-ancestor
56225960|NCT04882202|Acetaminophen|acetaminophen|mesh-list
56225961|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56225962|NCT04882202|Analgesics|analgesics|mesh-ancestor
56225963|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
56225964|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225965|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225966|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
55801779|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801780|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
55801781|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55801782|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801783|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225967|NCT04871425|Fentanyl|fentanyl|mesh-list
56225968|NCT04871425|Ketamine|ketamine|mesh-list
56225969|NCT04871425|Analgesics|analgesics|mesh-ancestor
56225970|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
55801809|NCT04818931|Cefazolin|cefazolin|mesh-list
55865630|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55865631|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55865633|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55865634|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
55865635|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
55865636|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865637|NCT04768075|Paclitaxel|paclitaxel|mesh-list
55865638|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55865639|NCT04768075|Carboplatin|carboplatin|mesh-list
55865640|NCT04768075|Pemetrexed|pemetrexed|mesh-list
55865641|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55865642|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865643|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
55865644|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
55865645|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
55865646|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865647|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865648|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55865649|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55865650|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55865681|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55865683|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55865684|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
55865685|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55865687|NCT00891436|Fluticasone|fluticasone|mesh-list
55798529|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55931871|NCT04027283|Erythritol|erythritol|mesh-list
55865688|NCT00891436|Xhance|xhance|mesh-list
55865689|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865690|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55865691|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
55865692|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865693|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865694|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55865695|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
55865696|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
55865753|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55865754|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865755|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865756|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
55865757|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
55865758|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865759|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865760|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55865761|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55865762|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
55788207|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798549|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798551|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
55788208|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788209|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55788210|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788211|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55788213|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788214|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
55788215|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55788216|NCT04930211|Dexamethasone|dexamethasone|mesh-list
55788217|NCT04930211|Lidocaine|lidocaine|mesh-list
55788218|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788219|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
55788220|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
55788221|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788222|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788223|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788224|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
55865763|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55865764|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55865765|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56225971|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225972|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225973|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56225974|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56225975|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
56225976|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
56225977|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56225978|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55865766|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55865768|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
55865769|NCT01709695|Guanfacine|guanfacine|mesh-list
55865770|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55865771|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55865772|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55865773|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55865774|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
55865775|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865777|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865778|NCT05236504|Melatonin|melatonin|mesh-list
55865779|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
55798594|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55798595|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55865806|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
55865807|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865808|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55865809|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55865811|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
55865812|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865813|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865814|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865815|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55865816|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55865817|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865818|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865820|NCT00875212|Fluorides|fluorides|mesh-list
55865821|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
55865822|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55865823|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865824|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
55865825|NCT00875212|Protective Agents|protective agents|mesh-ancestor
55788226|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788227|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55788228|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788229|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
55788230|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
55788231|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788232|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
55788233|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55788234|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55788235|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55788236|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55788237|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788238|NCT04912271|Dexamethasone|dexamethasone|mesh-list
55788239|NCT04912271|Aprepitant|aprepitant|mesh-list
55788240|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
55788241|NCT04912271|Palonosetron|palonosetron|mesh-list
55788242|NCT04912271|Granisetron|granisetron|mesh-list
55788243|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865826|NCT00875836|Buspirone|buspirone|mesh-list
55865835|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865836|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
55865837|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
55865838|NCT05312398|Irinotecan|irinotecan|mesh-list
55865839|NCT05312398|Cetuximab|cetuximab|mesh-list
55865840|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55865841|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56225979|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56225980|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56225981|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225982|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56225983|NCT04871425|Narcotics|narcotics|mesh-ancestor
56225984|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56225985|NCT04869605|Chrysarobin|chrysarobin|mesh-list
56225986|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56225987|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56225988|NCT04869605|Analgesics|analgesics|mesh-ancestor
56225989|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
56225990|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56225991|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56225992|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56225993|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56225994|NCT04835584|Dasatinib|dasatinib|mesh-list
56225995|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56225996|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55801820|NCT02406261|Midazolam|midazolam|mesh-list
55865842|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865843|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865844|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865845|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55865846|NCT01685203|Ribavirin|ribavirin|mesh-list
55798636|NCT02495883|Propranolol|propranolol|mesh-list
55798637|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55865847|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
55865848|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865849|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
55865850|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865851|NCT01928771|Benralizumab|benralizumab|mesh-list
55865852|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55865853|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
55865854|NCT01589653|Insulin|insulin|mesh-list
55865855|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55865856|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
55865857|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
55865858|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55865859|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
55865860|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
55865861|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
55865862|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55865882|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
55865883|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55865885|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55865886|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55865887|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55788244|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
55788245|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
55788246|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788247|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788248|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788249|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
55788250|NCT04912271|Hormones|hormones|mesh-ancestor
55788251|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788252|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56225997|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56225998|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56225999|NCT04800107|Curcumin|curcumin|mesh-list
56226000|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56226001|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56226002|NCT04800107|Analgesics|analgesics|mesh-ancestor
56226003|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
56226004|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226005|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226006|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56226007|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931938|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55931939|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931940|NCT03022409|Olaparib|olaparib|mesh-list
55931941|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56226008|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226009|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801838|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55788253|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788254|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55788255|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788256|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788257|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55788258|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55788259|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
55865888|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55865889|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55865890|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55865891|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55865892|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
55865893|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55865894|NCT01928381|Pregabalin|pregabalin|mesh-list
55865895|NCT01928381|Analgesics|analgesics|mesh-ancestor
55865896|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
55865897|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865898|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865899|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
55865900|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55865901|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55865902|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865903|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55931958|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55931959|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55865904|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55865907|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865909|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
55865910|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865911|NCT01927757|Etanercept|etanercept|mesh-list
55865912|NCT01927757|Methotrexate|methotrexate|mesh-list
55865913|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55865914|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
55865915|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55865916|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865917|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55865925|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
55865926|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865927|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55865928|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55865929|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55865931|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
55865932|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226010|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226011|NCT04793867|Xenon|xenon|mesh-list
56226012|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56226013|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
56226014|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
56226015|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226016|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226017|NCT04774315|Omalizumab|omalizumab|mesh-list
55801851|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
55865933|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865934|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788260|NCT02807779|Dexamethasone|dexamethasone|mesh-list
55788261|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788262|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
55788263|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
55788264|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788265|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788266|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788267|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
55932000|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798696|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788268|NCT02807779|Hormones|hormones|mesh-ancestor
55788269|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798697|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55788270|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55798698|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55798700|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
55788271|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788275|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
55788276|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788277|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788278|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
55788279|NCT02680561|Fluticasone|fluticasone|mesh-list
55788280|NCT02680561|Xhance|xhance|mesh-list
55788281|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55788282|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55788283|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788284|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55788285|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
55788286|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788287|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788288|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55865935|NCT01913639|Leucovorin|leucovorin|mesh-list
55865936|NCT01913639|Fluorouracil|fluorouracil|mesh-list
55865937|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
55865938|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
55865939|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865940|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55865941|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865942|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865943|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
55865944|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798720|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
55798722|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798723|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865945|NCT01913639|Antidotes|antidotes|mesh-ancestor
55865946|NCT01913639|Protective Agents|protective agents|mesh-ancestor
55798724|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55798725|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55865947|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
55865948|NCT01913639|Vitamins|vitamins|mesh-ancestor
55865949|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
55865950|NCT01913483|Heparin|heparin|mesh-list
55865951|NCT01913483|Calcium heparin|calcium heparin|mesh-list
55788289|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
55788290|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
55788291|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55788292|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55788293|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55788294|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55788295|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
55788296|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788297|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788298|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
55788299|NCT02680561|Hormones|hormones|mesh-ancestor
55788300|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788301|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
56226018|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56226019|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56226020|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
56226021|NCT04767503|Propofol|propofol|mesh-list
56226022|NCT04767503|Desflurane|desflurane|mesh-list
56226023|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56226024|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226025|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226026|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55788302|NCT05071183|Trametinib|trametinib|mesh-list
55788303|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788304|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55788305|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932029|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
55932030|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932031|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55798752|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55798753|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55798754|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
55798755|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798756|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798757|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55798758|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55798759|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
55865952|NCT01913483|Bivalirudin|bivalirudin|mesh-list
55865953|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
55865954|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55865955|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55865956|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865957|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
55865958|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55865959|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
55865960|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865961|NCT01913405|Factor VIII|factor viii|mesh-list
55865962|NCT01913405|BAX 855|bax 855|mesh-list
55865963|NCT01913405|Coagulants|coagulants|mesh-ancestor
55865964|NCT01927055|Mannitol|mannitol|mesh-list
55865965|NCT01927055|Droxidopa|droxidopa|mesh-list
55865966|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55865967|NCT01927055|Diuretics|diuretics|mesh-ancestor
55865968|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
55865969|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865970|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55865971|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55865972|NCT01913327|Risperidone|risperidone|mesh-list
55865973|NCT01913327|Aripiprazole|aripiprazole|mesh-list
55865974|NCT01913327|Modafinil|modafinil|mesh-list
55865975|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55865976|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
55865978|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865979|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865981|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55865982|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865983|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865984|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55865985|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
55865986|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
55865987|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
55866005|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
55866006|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55866007|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866008|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
55866009|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866010|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
55866011|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866012|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
55798771|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798772|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
55866013|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866015|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
55866016|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866017|NCT01910441|Metformin|metformin|mesh-list
55866018|NCT01910441|Glimepiride|glimepiride|mesh-list
55866019|NCT01910441|Vildagliptin|vildagliptin|mesh-list
55866020|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55866021|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866022|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55866023|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866024|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
55866025|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55866026|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
56226027|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
56226028|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
56226029|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56226030|NCT04763564|Liraglutide|liraglutide|mesh-list
56226031|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55866027|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866028|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866029|NCT01923467|Nicotine|nicotine|mesh-list
55866030|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55866031|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
55866032|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866033|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866034|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55866035|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55866036|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
55866037|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866038|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866039|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
55866040|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55866041|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
55866042|NCT01908803|Dexamethasone|dexamethasone|mesh-list
55866043|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866044|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
55866045|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
55866063|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
55866064|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
55866065|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
55866066|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932062|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932063|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55932064|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
55932065|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55932066|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932067|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
55932068|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55932070|NCT02242851|Telmisartan|telmisartan|mesh-list
55866067|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866068|NCT01588951|Cytarabine|cytarabine|mesh-list
55866069|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55866070|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
55866071|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866072|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866073|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
55866074|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866075|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866076|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
55866077|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866078|NCT01588405|Treprostinil|treprostinil|mesh-list
55866079|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55866080|NCT01923311|Elvitegravir|elvitegravir|mesh-list
55866081|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55866082|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55866083|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
55866084|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866086|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866087|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866088|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
55866089|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55866090|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55866091|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55798802|NCT03053167|Raltitrexed|raltitrexed|mesh-list
55798803|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55798804|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55866092|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55866093|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866094|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
55866095|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866096|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866097|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55866098|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866099|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
55788306|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788307|NCT05025163|Fluorides|fluorides|mesh-list
55788308|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
55788309|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
55788310|NCT05025163|Protective Agents|protective agents|mesh-ancestor
55788311|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788312|NCT02592031|Goserelin|goserelin|mesh-list
55788313|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55788314|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226032|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226033|NCT04763564|Incretins|incretins|mesh-ancestor
56226034|NCT04763564|Hormones|hormones|mesh-ancestor
56226035|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226036|NCT04760496|Oxytocin|oxytocin|mesh-list
56226037|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
56226038|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55801869|NCT04826497|Nicorandil|nicorandil|mesh-list
55788316|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
55788317|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
55788318|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788319|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788320|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
55788321|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866100|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55866110|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866111|NCT01921829|Diuretics|diuretics|mesh-list
55866112|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
55866113|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866114|NCT01904903|Trastuzumab|trastuzumab|mesh-list
55866115|NCT01904903|Pertuzumab|pertuzumab|mesh-list
55866116|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55866117|NCT01904903|Maytansine|maytansine|mesh-list
55866118|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866119|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798832|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55798833|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
55798834|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798835|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55798836|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55932095|NCT04999878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932096|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866120|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55866121|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
55866122|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
55866123|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
55866124|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866125|NCT01921205|Lacosamide|lacosamide|mesh-list
55866126|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
55866127|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55866128|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55866129|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55866130|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866131|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
55866132|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55866133|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866134|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
55866135|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55866136|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
55866137|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866139|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55866140|NCT01709305|Glimepiride|glimepiride|mesh-list
55866141|NCT01709305|Acarbose|acarbose|mesh-list
55866142|NCT01709305|Repaglinide|repaglinide|mesh-list
55866143|NCT01709305|Gliclazide|gliclazide|mesh-list
55866144|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55866145|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866146|NCT01709305|Incretins|incretins|mesh-ancestor
55866147|NCT01709305|Hormones|hormones|mesh-ancestor
55866148|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866149|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55866150|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
55866151|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866152|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866153|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55866154|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866155|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
55866156|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55866157|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
55866158|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55866159|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
55866160|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55866161|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
55866162|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866163|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226040|NCT04750967|Lidocaine|lidocaine|mesh-list
56226041|NCT04750967|Amitriptyline|amitriptyline|mesh-list
56226042|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
56226043|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
56226044|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226045|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226046|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
56226047|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226048|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55798840|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798841|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798842|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55798848|NCT02438787|Golimumab|golimumab|mesh-list
56226049|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56226050|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56226051|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56226052|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226053|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56226054|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
56226055|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56226056|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866164|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
55866165|NCT01709227|Furosemide|furosemide|mesh-list
55866166|NCT01709227|Diuretics|diuretics|mesh-ancestor
55866167|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
55866189|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866190|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55866191|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
55866192|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866193|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866194|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55866195|NCT00879190|Gentamicins|gentamicins|mesh-list
55866196|NCT00879190|Ampicillin|ampicillin|mesh-list
55866197|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55866198|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866199|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55866200|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866201|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866202|NCT01903811|Dexamethasone|dexamethasone|mesh-list
55866203|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
55866204|NCT01903811|Ichthammol|ichthammol|mesh-list
55866205|NCT01903811|BB 1101|bb 1101|mesh-list
55866206|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866207|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
55866208|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
55866209|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866210|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866211|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55866212|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
55866213|NCT01903811|Hormones|hormones|mesh-ancestor
55866214|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866215|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55866216|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866217|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
55866218|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866227|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866228|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866229|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226057|NCT04750967|Analgesics|analgesics|mesh-ancestor
56226058|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56226059|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56226060|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
56226061|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798851|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56226062|NCT04733547|Furosemide|furosemide|mesh-list
56226063|NCT04733547|Diuretics|diuretics|mesh-ancestor
56226064|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
55866230|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55866231|NCT01709149|Protective Agents|protective agents|mesh-ancestor
55866232|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
55866233|NCT05214196|Povidone|povidone|mesh-list
55866234|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
55866235|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
55866236|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55866237|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866238|NCT05311228|Azithromycin|azithromycin|mesh-list
55866239|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55866240|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866242|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55866243|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866244|NCT04382014|Analgesics|analgesics|mesh-ancestor
55866245|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
55866246|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932136|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932137|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55932138|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55798865|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55866247|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866248|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866249|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55788325|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55789088|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
55866252|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866254|NCT00892606|Methadone|methadone|mesh-list
55866255|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55866256|NCT00892606|Narcotics|narcotics|mesh-ancestor
55866257|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866258|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866259|NCT00892606|Analgesics|analgesics|mesh-ancestor
55866260|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
55866261|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866262|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
55866263|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
55866264|NCT04416035|Paclitaxel|paclitaxel|mesh-list
55866265|NCT04416035|Bevacizumab|bevacizumab|mesh-list
55866266|NCT04416035|Carboplatin|carboplatin|mesh-list
55866267|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55866268|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866269|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
55866270|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
55866271|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
55866272|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866273|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866274|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55866275|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55866276|NCT04416035|Growth Substances|growth substances|mesh-ancestor
55866277|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866278|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
55866279|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
55866280|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55866281|NCT04381858|Antibodies|antibodies|mesh-list
55866282|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
55866283|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866284|NCT01903031|Ritonavir|ritonavir|mesh-list
55866285|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55866297|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866298|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55866299|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55866300|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
55866301|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226065|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932180|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
55932181|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55932182|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56226066|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55866302|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55866303|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55866304|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55866305|NCT01903031|Estrogens|estrogens|mesh-ancestor
55866307|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866308|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866309|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55866310|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
55866311|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55866312|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55866313|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55866314|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55866315|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55866316|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55866317|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55866318|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55866319|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55866320|NCT00883168|Fluticasone|fluticasone|mesh-list
55866322|NCT00883168|Azelastine|azelastine|mesh-list
55866323|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866324|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55866325|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
55866326|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866327|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866328|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55866329|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
55866330|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
55788326|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788327|NCT02333149|Melatonin|melatonin|mesh-list
55866331|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55866332|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
55866333|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866334|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866335|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55866336|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55866337|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
55866338|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
55866339|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866340|NCT01616693|Zinc|zinc|mesh-list
55866341|NCT01616693|Vaccines|vaccines|mesh-list
55866342|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
55866343|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866344|NCT01616693|Trace Elements|trace elements|mesh-ancestor
55866345|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
55866346|NCT00893074|Dronabinol|dronabinol|mesh-list
55866347|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
55866348|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866349|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55866350|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866351|NCT00893074|Analgesics|analgesics|mesh-ancestor
55866361|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55866362|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55866363|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866365|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
55866366|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
55866367|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866368|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55866369|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55866370|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866371|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866372|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55866373|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
55866374|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866375|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866376|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55866377|NCT04062448|Rituximab|rituximab|mesh-list
56226067|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56226068|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226069|NCT04722679|Anticoagulants|anticoagulants|mesh-list
56226070|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
56226071|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226072|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
56226073|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801910|NCT04357795|Cyclosporine|cyclosporine|mesh-list
55866378|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866379|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866380|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
55866381|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866382|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866383|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55866384|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
55866385|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866386|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
55866387|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55866388|NCT03216304|Calcium|calcium|mesh-list
55866389|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55866390|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866391|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55798907|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798908|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866392|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55866393|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55866394|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
55866395|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866396|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55866397|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55866398|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866399|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
55866400|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55866401|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
55866402|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866403|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866404|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55866405|NCT03216538|Protective Agents|protective agents|mesh-ancestor
55866406|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55866407|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55788329|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788330|NCT02333149|Protective Agents|protective agents|mesh-ancestor
55788331|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788333|NCT02144857|Cyclosporine|cyclosporine|mesh-list
55788335|NCT02144857|Apremilast|apremilast|mesh-list
55788336|NCT02144857|Ustekinumab|ustekinumab|mesh-list
55788337|NCT02144857|Cyclosporins|cyclosporins|mesh-list
55788338|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789089|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
55866408|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866409|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866410|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
55866411|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866412|NCT03218722|Thrombin|thrombin|mesh-list
55866413|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
55866449|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55866450|NCT03175432|Growth Substances|growth substances|mesh-ancestor
55866451|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866452|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
55866463|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866464|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55866465|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866466|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55932225|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55932226|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55932227|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
55798936|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866467|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
55866468|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866470|NCT03215446|Propofol|propofol|mesh-list
55866471|NCT03215446|Sevoflurane|sevoflurane|mesh-list
56226074|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226075|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56226077|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56226078|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
56226079|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226080|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226081|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56226082|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56226083|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
55866472|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866473|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866474|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55866475|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55866476|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
55866477|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55866478|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55866479|NCT00896038|Aprepitant|aprepitant|mesh-list
55866480|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
55866481|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
55866482|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866483|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866484|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55866485|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55866486|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866487|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866488|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
55798964|NCT04393207|Hormones|hormones|mesh-ancestor
55798966|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55866489|NCT04381234|Citric Acid|citric acid|mesh-list
55866490|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
55866491|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
55866492|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
55866493|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55866494|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
55866495|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
55866496|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866497|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55866498|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
55866499|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55866502|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866503|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866504|NCT01616459|Vaccines|vaccines|mesh-list
55866505|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55866506|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
55788339|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788340|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55788341|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
55788342|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788343|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
55788344|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866507|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866508|NCT03218254|Methylphenidate|methylphenidate|mesh-list
55866509|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55866510|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866511|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55866512|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55866514|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866515|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
55866528|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226084|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226085|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226086|NCT04672772|Paclitaxel|paclitaxel|mesh-list
56226087|NCT04672772|Cetuximab|cetuximab|mesh-list
56226088|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56226089|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226090|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
56226091|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
56226092|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
56226093|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226094|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56226095|NCT04671082|Tolperisone|tolperisone|mesh-list
56226096|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56226097|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226098|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56226099|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798989|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798990|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798991|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
55798992|NCT04812535|Vilobelimab|vilobelimab|mesh-list
56226100|NCT04669587|Palbociclib|palbociclib|mesh-list
56226101|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866529|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55866530|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866531|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
55866533|NCT01919723|Eptifibatide|eptifibatide|mesh-list
55866534|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55866535|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55866536|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55866537|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55866538|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
55866539|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866540|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866541|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866542|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
55866543|NCT01919489|Liraglutide|liraglutide|mesh-list
55866544|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55866545|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866546|NCT01919489|Incretins|incretins|mesh-ancestor
55866547|NCT01919489|Hormones|hormones|mesh-ancestor
55866548|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866549|NCT01919411|Amoxicillin|amoxicillin|mesh-list
55866550|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
55866551|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
55866552|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55866553|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55866554|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866555|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55866556|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932273|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866557|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866558|NCT01901393|Ibuprofen|ibuprofen|mesh-list
55866559|NCT01901393|Ketorolac|ketorolac|mesh-list
55866560|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55866561|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55866562|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866563|NCT01901393|Analgesics|analgesics|mesh-ancestor
55866564|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
55866565|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866566|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226102|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56226103|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226104|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866567|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866568|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866569|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55866570|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866571|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866572|NCT01890707|Anesthetics|anesthetics|mesh-list
55866573|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866574|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866575|NCT01890473|Abatacept|abatacept|mesh-list
55866593|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55866594|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
55788345|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
55788346|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55788347|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55788348|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55788349|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55788350|NCT02144857|Analgesics|analgesics|mesh-ancestor
55788351|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
55788352|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788353|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788354|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789090|NCT03055793|Hormones|hormones|mesh-ancestor
55866595|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866596|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866597|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55866598|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866599|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55866600|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55866601|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55866604|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
55866605|NCT01889069|Hormones|hormones|mesh-ancestor
55866606|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866607|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55866608|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55866609|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
55866610|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
55866611|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
55866612|NCT00898222|Aspirin|aspirin|mesh-list
55799052|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55866613|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55866614|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866615|NCT00898222|Analgesics|analgesics|mesh-ancestor
55866616|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
55866617|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866618|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866619|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866620|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866621|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55866622|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55866623|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866624|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55866625|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55866626|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866627|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
55932328|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
55866628|NCT01830556|Cetuximab|cetuximab|mesh-list
55866629|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55799101|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55799103|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
55866630|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866631|NCT03214354|Sirolimus|sirolimus|mesh-list
55866632|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
55866633|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55866634|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866646|NCT00903448|Lansoprazole|lansoprazole|mesh-list
55866647|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55866648|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55866649|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56226105|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
56226106|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56226107|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
55866650|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866651|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866652|NCT00895180|Ramucirumab|ramucirumab|mesh-list
55866653|NCT00895180|Olaratumab|olaratumab|mesh-list
55866654|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866655|NCT01830868|Zonisamide|zonisamide|mesh-list
55866656|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
56124672|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124673|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
56124674|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124676|NCT01428882|Propofol|propofol|mesh-list
56124677|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56124678|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56124679|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124680|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56124681|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
56124682|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
56124683|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56124684|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56124685|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56124686|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56124687|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
56124688|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
56124689|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124690|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124691|NCT01428258|Coal Tar|coal tar|mesh-list
56124692|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
56124693|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
56124694|NCT03814200|Rifampin|rifampin|mesh-list
56124695|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55851646|NCT00185692|Hormones|hormones|mesh-ancestor
56124696|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
56124697|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56124698|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124699|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
56124700|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56124701|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124702|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124716|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124717|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124719|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56124720|NCT04051320|Leuprolide|leuprolide|mesh-list
56124721|NCT04051320|Estradiol|estradiol|mesh-list
56124722|NCT04051320|Progesterone|progesterone|mesh-list
56124723|NCT04051320|Estrogens|estrogens|mesh-ancestor
56124724|NCT04051320|Hormones|hormones|mesh-ancestor
56124725|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124726|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124727|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56124728|NCT04051320|Progestins|progestins|mesh-ancestor
56124729|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56124730|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
56124731|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56124732|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124733|NCT01403610|Bevacizumab|bevacizumab|mesh-list
56124734|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
56124735|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56124736|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124737|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56124738|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56124739|NCT01403610|Growth Substances|growth substances|mesh-ancestor
56124740|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124741|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
56124742|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56124743|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
56124744|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124745|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56124746|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
56124747|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124748|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56124749|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56226108|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226110|NCT04659382|Atezolizumab|atezolizumab|mesh-list
56226111|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56124750|NCT01389102|Estradiol|estradiol|mesh-list
56124751|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56124752|NCT01389102|Estrogens|estrogens|mesh-ancestor
55799206|NCT04887649|Narcotics|narcotics|mesh-ancestor
55799207|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799208|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799209|NCT04887649|Analgesics|analgesics|mesh-ancestor
55799210|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
55799211|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799212|NCT03050437|Pemetrexed|pemetrexed|mesh-list
55799213|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799214|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799215|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799216|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55799217|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56124753|NCT01389102|Hormones|hormones|mesh-ancestor
56124754|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124755|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124756|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56124757|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
56124758|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56124759|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56124760|NCT01402284|Dexamethasone|dexamethasone|mesh-list
55932397|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932398|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
55932399|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55932400|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55932401|NCT04363203|Azithromycin|azithromycin|mesh-list
55932402|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
55932403|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55932404|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932405|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
55932406|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56124762|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124763|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
56124764|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
56124765|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124766|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124767|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56124768|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
56124769|NCT01402284|Hormones|hormones|mesh-ancestor
55851726|NCT00187720|Metformin|metformin|mesh-list
56124770|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799254|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799255|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55799256|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
55799257|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799258|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55799259|NCT02419755|Cytarabine|cytarabine|mesh-list
55799260|NCT02419755|Dexamethasone|dexamethasone|mesh-list
55799261|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
55799262|NCT02419755|Doxorubicin|doxorubicin|mesh-list
55799263|NCT02419755|Methotrexate|methotrexate|mesh-list
55799274|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799275|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55799276|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
55799278|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799279|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55799280|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932430|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124771|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56124772|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124773|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
56124774|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56124775|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56124776|NCT01402284|Growth Substances|growth substances|mesh-ancestor
56124777|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
56124778|NCT01388790|Cetuximab|cetuximab|mesh-list
56124779|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124780|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56124781|NCT01388478|Pramipexole|pramipexole|mesh-list
56124782|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
56124783|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124784|NCT01388478|Protective Agents|protective agents|mesh-ancestor
56124785|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124786|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56124787|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56124788|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
56124789|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
56124790|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124791|NCT01423812|Ritonavir|ritonavir|mesh-list
56124792|NCT01423812|Darunavir|darunavir|mesh-list
56124793|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56124794|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56124795|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
56124796|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124797|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124798|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56124799|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56124800|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
55932468|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124801|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124802|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56124803|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56124804|NCT01400958|Modafinil|modafinil|mesh-list
56124805|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56124806|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124807|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56124808|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56124809|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56124810|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124811|NCT01400412|Ritonavir|ritonavir|mesh-list
56124812|NCT01400412|Darunavir|darunavir|mesh-list
56124813|NCT01400412|Tenofovir|tenofovir|mesh-list
56124814|NCT01400412|Emtricitabine|emtricitabine|mesh-list
56124815|NCT01400412|Maraviroc|maraviroc|mesh-list
56124816|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56124817|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56226112|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226113|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55801953|NCT04797949|Analgesics|analgesics|mesh-ancestor
56124818|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
56124819|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124820|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124821|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56124822|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56124823|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
56124824|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124825|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56124826|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56124827|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56124828|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55799299|NCT02419755|Analgesics|analgesics|mesh-ancestor
55799300|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
55799301|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55799303|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56124829|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56124830|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56124831|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56124832|NCT03829410|Bevacizumab|bevacizumab|mesh-list
56124833|NCT03829410|Onvansertib|onvansertib|mesh-list
56124835|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124836|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56124837|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56124838|NCT03829410|Growth Substances|growth substances|mesh-ancestor
56124839|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124840|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
56124841|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124842|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124843|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124844|NCT01422876|Linagliptin|linagliptin|mesh-list
56124845|NCT01422876|Empagliflozin|empagliflozin|mesh-list
56124846|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56124847|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124848|NCT01422876|Incretins|incretins|mesh-ancestor
56124849|NCT01422876|Hormones|hormones|mesh-ancestor
56124850|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124851|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56124852|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
56124853|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124854|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124855|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56124856|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56124857|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
56124858|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56124859|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56124860|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56124861|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124862|NCT01387932|Doxorubicin|doxorubicin|mesh-list
55799324|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55799326|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56124863|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
56124864|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56124865|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124866|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56124867|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56124868|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124869|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124870|NCT04413786|Oxytocin|oxytocin|mesh-list
56124871|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
56124872|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56124873|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124874|NCT01422408|Fluocinonide|fluocinonide|mesh-list
56124875|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124876|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
56124877|NCT01422408|Hormones|hormones|mesh-ancestor
56124878|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124879|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124880|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56124881|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55799358|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
55799365|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
56124882|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56124883|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56124884|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226114|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56226115|NCT04659382|Growth Substances|growth substances|mesh-ancestor
56226116|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226117|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
56226118|NCT04658823|Vitamin E|vitamin e|mesh-list
56226119|NCT04658823|Tocopherols|tocopherols|mesh-list
56226120|NCT04658823|Tocotrienols|tocotrienols|mesh-list
56226121|NCT04658823|Tocovid|tocovid|mesh-list
56226122|NCT04658823|Vitamins|vitamins|mesh-ancestor
55801954|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
56124885|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124886|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56124887|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56124888|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56124889|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
56124890|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932563|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
55932564|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
56124891|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124892|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56124893|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56124894|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
56124895|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
56124896|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56124897|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56124898|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56124899|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56124900|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124901|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
56124902|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124903|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124904|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56124906|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
56124907|NCT01386606|Enclomiphene|enclomiphene|mesh-list
56124908|NCT01386606|Clomiphene|clomiphene|mesh-list
56124909|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
56124910|NCT01386606|Testosterone|testosterone|mesh-list
56124911|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
56124912|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
56124913|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56124914|NCT01386606|Androgens|androgens|mesh-ancestor
56124915|NCT01386606|Hormones|hormones|mesh-ancestor
56124916|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124917|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124918|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56124919|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124920|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
55932604|NCT04023617|Docetaxel|docetaxel|mesh-list
55932605|NCT04023617|Nivolumab|nivolumab|mesh-list
56124921|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56124922|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
56124923|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56124924|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
56124925|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56124926|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56124927|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56124928|NCT01385748|Clonidine|clonidine|mesh-list
56124929|NCT01385748|Analgesics|analgesics|mesh-ancestor
56124930|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
56124931|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124932|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124933|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56124934|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
56124935|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
56124936|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56124937|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56124938|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56124939|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
56124940|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124941|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124942|NCT01397448|Rabeprazole|rabeprazole|mesh-list
56226124|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226125|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
56124943|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56124944|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56124945|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56124946|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788363|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124947|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124948|NCT01384734|Ritonavir|ritonavir|mesh-list
56124949|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56124950|NCT01384734|Tenofovir|tenofovir|mesh-list
56124951|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
56124952|NCT01384734|Fostemsavir|fostemsavir|mesh-list
56124953|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56124954|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56124955|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
56124956|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124957|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124958|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56124959|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56124960|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
56124961|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124962|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56124963|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56124964|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56124965|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56124966|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56124967|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56124968|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56124969|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56124970|NCT01396512|Vaccines|vaccines|mesh-list
56124971|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
56124972|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124973|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56124974|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
56124975|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124976|NCT01383954|Diclofenac|diclofenac|mesh-list
56124977|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56124979|NCT01383954|Analgesics|analgesics|mesh-ancestor
56124980|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
56124981|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124982|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124983|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124984|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799460|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
55799461|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55799462|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56124985|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56124986|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124987|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124988|NCT05365464|Progesterone|progesterone|mesh-list
56124989|NCT05365464|Progestins|progestins|mesh-ancestor
56124990|NCT05365464|Hormones|hormones|mesh-ancestor
56124991|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851949|NCT00193492|Rituximab|rituximab|mesh-list
56124992|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124994|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56124995|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56124996|NCT01383486|Analgesics|analgesics|mesh-ancestor
56124997|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
56124998|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124999|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125000|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125001|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125002|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
56125003|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56125004|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125005|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125006|NCT04766736|Antibodies|antibodies|mesh-list
55932650|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55932651|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55932652|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932653|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932654|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
55932655|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55932656|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55932657|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932658|NCT04148885|Paclitaxel|paclitaxel|mesh-list
55932659|NCT04148885|Carboplatin|carboplatin|mesh-list
55932660|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55932661|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932662|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
55932663|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
56125007|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
56125008|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125009|NCT01396278|Fluticasone|fluticasone|mesh-list
56125010|NCT01396278|Xhance|xhance|mesh-list
56226126|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226127|NCT04658823|Protective Agents|protective agents|mesh-ancestor
56226128|NCT04648241|Vaccines|vaccines|mesh-list
56226129|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
56226130|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226131|NCT04640818|Rituximab|rituximab|mesh-list
56226132|NCT04640818|Cladribine|cladribine|mesh-list
56226133|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
56226134|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56226135|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226136|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
56226137|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226138|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56226139|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56226140|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
56226141|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56226142|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226143|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56226144|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801965|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
56125011|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125012|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56125013|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
56125014|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125015|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125016|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56125017|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
56125018|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
56125019|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56125020|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
56125021|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
56125022|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
56125023|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125024|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125025|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
56125026|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125027|NCT01383096|Artefenomel|artefenomel|mesh-list
56125028|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56125029|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
56125030|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56125031|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56125032|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125033|NCT01382940|Acetaminophen|acetaminophen|mesh-list
56125034|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
56125035|NCT01382940|Rituximab|rituximab|mesh-list
56125036|NCT01382940|Methotrexate|methotrexate|mesh-list
56125037|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
56125038|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
56125039|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125040|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125041|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
56125042|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125043|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125044|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56125045|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
56226145|NCT04602078|Gemcitabine|gemcitabine|mesh-list
56226146|NCT04602078|Atezolizumab|atezolizumab|mesh-list
56226147|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226148|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56226149|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
56226150|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226151|NCT04602078|Antiviral Agents|antiviral agents|mesh-ancestor
56226152|NCT04602078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226153|NCT04602078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226154|NCT04602078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56226155|NCT04602078|Immunologic Factors|immunologic factors|mesh-ancestor
56226156|NCT04602078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226157|NCT04588857|Dexamethasone|dexamethasone|mesh-list
56226158|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125046|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56125047|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55799542|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55799543|NCT04895137|Growth Substances|growth substances|mesh-ancestor
56125048|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
56125049|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125050|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
56125051|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125052|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56125054|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56125055|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56125056|NCT01382940|Analgesics|analgesics|mesh-ancestor
56125057|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
56125058|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125059|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
56125060|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125061|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
56125062|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
56125063|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56125064|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
56125065|NCT01382940|Hormones|hormones|mesh-ancestor
56125066|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125067|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56125068|NCT01382940|Protective Agents|protective agents|mesh-ancestor
56125069|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
56125070|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125072|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56125073|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125074|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56125075|NCT01381926|Incretins|incretins|mesh-ancestor
56125076|NCT01381926|Hormones|hormones|mesh-ancestor
55932709|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932710|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55932711|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55932712|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
56125077|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125078|NCT01395888|Fluticasone|fluticasone|mesh-list
56125079|NCT01395888|Xhance|xhance|mesh-list
56125080|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
56125081|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125082|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56125083|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
56125084|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125085|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125086|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56125087|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
56125088|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
56125089|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55932742|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
55932743|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55932744|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55932745|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932746|NCT04361721|Erenumab|erenumab|mesh-list
55932747|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55932748|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932749|NCT04361721|Analgesics|analgesics|mesh-ancestor
56125090|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
56125091|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56125092|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
56125093|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125094|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125095|NCT05366166|Cisplatin|cisplatin|mesh-list
56226159|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
56226160|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
56226161|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226162|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125096|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
56125097|NCT05366166|Olaparib|olaparib|mesh-list
56125098|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125099|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125100|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56125101|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125102|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125103|NCT01381692|Sirolimus|sirolimus|mesh-list
56125104|NCT01381692|Dexamethasone|dexamethasone|mesh-list
56125105|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
56125106|NCT01381692|Rituximab|rituximab|mesh-list
56125107|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56125108|NCT01381692|Bortezomib|bortezomib|mesh-list
56125109|NCT01381692|Antibodies|antibodies|mesh-list
56125110|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
56125111|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56125112|NCT01381692|BB 1101|bb 1101|mesh-list
56125113|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
56125114|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125115|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125116|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125117|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125118|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
56125119|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
56125120|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125121|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56125122|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
56125123|NCT01381692|Hormones|hormones|mesh-ancestor
56125124|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125125|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56125126|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
56125127|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125128|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932785|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55932786|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55932787|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55932788|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55932789|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
56125129|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56125132|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
56125133|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125134|NCT01395030|Choline|choline|mesh-list
56125135|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
56125136|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56125137|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
56125138|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125139|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56125140|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56125141|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
56125142|NCT01394952|Dulaglutide|dulaglutide|mesh-list
56125143|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56125144|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125145|NCT01394718|Acetaminophen|acetaminophen|mesh-list
56125146|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56125148|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
56125149|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125150|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125151|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
56125152|NCT01394250|Lidocaine|lidocaine|mesh-list
56125153|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
56125154|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
56125155|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125156|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125157|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
56125158|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125159|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56125160|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56125161|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56125162|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55788382|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125163|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125165|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
56125166|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226163|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226164|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
56226165|NCT04588857|Hormones|hormones|mesh-ancestor
56226166|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125167|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125168|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
56125169|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932816|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55932817|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
55932818|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
55932819|NCT04368585|TEMPO|tempo|mesh-list
55932820|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55932821|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55932822|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55932823|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932824|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125170|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56125171|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125172|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56125173|NCT05369676|Ritonavir|ritonavir|mesh-list
56125174|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56125175|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56125176|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
56125177|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125178|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125179|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56125180|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56125181|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
56125182|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125183|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56125184|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56125185|NCT05361330|Fluoxetine|fluoxetine|mesh-list
56125186|NCT05361330|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56125187|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56125188|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56125189|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125190|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125191|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
56125192|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125193|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56125194|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
56125195|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56125196|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56125197|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56125198|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125199|NCT00214968|Modafinil|modafinil|mesh-list
56125200|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56125201|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125203|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55932837|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932838|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932840|NCT04990830|Enoxaparin|enoxaparin|mesh-list
55932841|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55932842|NCT04990830|Tinzaparin|tinzaparin|mesh-list
55932843|NCT04990830|Dalteparin|dalteparin|mesh-list
55932844|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
55932845|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
55932846|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55932847|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55932848|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932849|NCT04361409|Gemcitabine|gemcitabine|mesh-list
55932883|NCT05620641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932884|NCT05620641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932885|NCT05620641|Anticonvulsants|anticonvulsants|mesh-ancestor
55932886|NCT05620641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55932887|NCT05620641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55932888|NCT05620641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932889|NCT05620641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56125204|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56125205|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125206|NCT03999216|Diuretics|diuretics|mesh-list
56125207|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56125208|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56125209|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
56125210|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125211|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56125212|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125213|NCT03592212|Albuterol|albuterol|mesh-list
56125214|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56125215|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
56125216|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125217|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125218|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56125219|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
56125220|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
55788388|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
55932892|NCT05620641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932893|NCT05620641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932894|NCT05620641|Antimanic Agents|antimanic agents|mesh-ancestor
55932895|NCT05620641|Antiemetics|antiemetics|mesh-ancestor
55932896|NCT05620641|Autonomic Agents|autonomic agents|mesh-ancestor
55932897|NCT05620641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55932898|NCT05620641|Antipruritics|antipruritics|mesh-ancestor
55932899|NCT05620641|Dermatologic Agents|dermatologic agents|mesh-ancestor
56125221|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56125222|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56125223|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56125224|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56125225|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56125226|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125227|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125228|NCT03024450|Trastuzumab|trastuzumab|mesh-list
56226167|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56226168|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226170|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226171|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56226172|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56226173|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226174|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226175|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56226176|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
56226177|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226178|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226179|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
56125229|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125230|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125231|NCT03997968|Gemcitabine|gemcitabine|mesh-list
56125232|NCT03997968|Rituximab|rituximab|mesh-list
56125233|NCT03997968|Capecitabine|capecitabine|mesh-list
55932951|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55932952|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
55932953|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
55932954|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55932955|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55932956|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55932957|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
56125234|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56125235|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125236|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125237|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
56125238|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125239|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125240|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56125241|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
56125242|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125243|NCT03997968|Antiviral Agents|antiviral agents|mesh-ancestor
56125244|NCT03997968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125245|NCT03997968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125246|NCT03997968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125247|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56125248|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
56125249|NCT04263090|Nivolumab|nivolumab|mesh-list
56125250|NCT04263090|ON 01910|on 01910|mesh-list
56125251|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125252|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125253|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56125254|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125255|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56125256|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125257|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
56125258|NCT03596424|Ketamine|ketamine|mesh-list
56125259|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56125260|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125261|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125262|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56125263|NCT03596424|Analgesics|analgesics|mesh-ancestor
56125264|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
56125265|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125266|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56125267|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56125268|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56125269|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
56125270|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125271|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125275|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
56125276|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55933010|NCT03924947|Pancrelipase|pancrelipase|mesh-list
55933011|NCT03924947|Pancreatin|pancreatin|mesh-list
55933012|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55933013|NCT00934635|Risperidone|risperidone|mesh-list
55933014|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55933015|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55933016|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
55933017|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125277|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56125278|NCT03997266|Gentamicins|gentamicins|mesh-list
56226180|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
56226181|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226182|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226183|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226184|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
56226185|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
56226186|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
56226187|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226188|NCT04562831|Niacinamide|niacinamide|mesh-list
56226190|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
56226191|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
56125280|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56125281|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125282|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56125283|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125284|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125285|NCT05630274|Moxifloxacin|moxifloxacin|mesh-list
56125286|NCT05630274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56125287|NCT05630274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125288|NCT05630274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56125289|NCT05630274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56125290|NCT05630274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125291|NCT05630274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125292|NCT05630274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125293|NCT05632692|Menthol|menthol|mesh-list
56125294|NCT05632692|Antipruritics|antipruritics|mesh-ancestor
56125295|NCT05632692|Dermatologic Agents|dermatologic agents|mesh-ancestor
56125296|NCT03590652|Dexamethasone|dexamethasone|mesh-list
56125297|NCT03590652|Daratumumab|daratumumab|mesh-list
56125298|NCT03590652|Pomalidomide|pomalidomide|mesh-list
56125299|NCT03590652|Ixazomib|ixazomib|mesh-list
56125300|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125301|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
56125302|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
56125303|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125304|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125305|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56125306|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
56125307|NCT03590652|Hormones|hormones|mesh-ancestor
56125308|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125309|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56125310|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125311|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
56125312|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56125313|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56125314|NCT03590652|Growth Substances|growth substances|mesh-ancestor
56125315|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
56125316|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
55933042|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55933043|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55933044|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933045|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55933046|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55933047|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933048|NCT04355949|Vitamin D|vitamin d|mesh-list
55933083|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
56125317|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125318|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125319|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
56125320|NCT03594162|Fludarabine|fludarabine|mesh-list
56125321|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125322|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
56125323|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125324|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125325|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56125326|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
56125327|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125328|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125329|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56125330|NCT04407312|Aspirin|aspirin|mesh-list
56125331|NCT04407312|Cilostazol|cilostazol|mesh-list
56125332|NCT04407312|Clopidogrel|clopidogrel|mesh-list
56125333|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56226192|NCT04562831|Vitamins|vitamins|mesh-ancestor
56226193|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
56226194|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226195|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56226196|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
56226197|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226198|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56226199|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
56226200|NCT04545242|Dexamethasone|dexamethasone|mesh-list
56226201|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56226202|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
56125334|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56125335|NCT04407312|Analgesics|analgesics|mesh-ancestor
56125336|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
56125337|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125338|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125339|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125340|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125341|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55933095|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933096|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55933097|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933098|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933099|NCT04144439|Butyric Acid|butyric acid|mesh-list
55933100|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
55933101|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
55933102|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933103|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933104|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933105|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
56125342|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56125343|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125344|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56125345|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56125346|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125347|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
55788415|NCT04513639|Daratumumab|daratumumab|mesh-list
56125348|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56125349|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56125350|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56125351|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
56125352|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125353|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56125354|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
56125355|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56125356|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
56125357|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
56125358|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56125359|NCT04407312|Protective Agents|protective agents|mesh-ancestor
56125360|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56125361|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56125363|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125364|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125365|NCT04326738|Midazolam|midazolam|mesh-list
56125366|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56125367|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55933120|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55933121|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
55933122|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933123|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125368|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125369|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125370|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56125371|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56125372|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56125373|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56125374|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
56125375|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
56125376|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
56125377|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
56125378|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125379|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125380|NCT04347486|Atropine|atropine|mesh-list
56125381|NCT04347486|Neostigmine|neostigmine|mesh-list
56125382|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56125383|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56125384|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56125385|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
56125386|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125387|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226203|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
56226204|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226205|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226206|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226207|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
56226208|NCT04545242|Hormones|hormones|mesh-ancestor
56226209|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226210|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55933164|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799591|NCT04884997|Temozolomide|temozolomide|mesh-list
55799592|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55933173|NCT04355247|Prednisolone|prednisolone|mesh-list
56226211|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226212|NCT04542980|Autoantibodies|autoantibodies|mesh-list
56226213|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
56226214|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226215|NCT04529499|Favipiravir|favipiravir|mesh-list
56226216|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
56226217|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226218|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
56125388|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56125389|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
56125390|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
56125391|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
56125392|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56125393|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56125394|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
56125395|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125396|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125397|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56125398|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125399|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56125400|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
56125401|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125402|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125404|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
56125405|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
56125406|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125407|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125408|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125409|NCT04407234|Acetaminophen|acetaminophen|mesh-list
56125410|NCT04407234|Tirzepatide|tirzepatide|mesh-list
56125411|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56125412|NCT04407234|Analgesics|analgesics|mesh-ancestor
56125413|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
56125414|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125415|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125416|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
56125417|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56125418|NCT04407234|Incretins|incretins|mesh-ancestor
56125419|NCT04407234|Hormones|hormones|mesh-ancestor
55788420|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
55933212|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55933214|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
55933215|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933216|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55933217|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55933218|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933219|NCT00936663|Incretins|incretins|mesh-ancestor
55933220|NCT00936663|Hormones|hormones|mesh-ancestor
56125420|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125423|NCT03597594|Thiotepa|thiotepa|mesh-list
56125424|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
56125425|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56125426|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125427|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125428|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125429|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
56125430|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125431|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
56226219|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56226220|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56226221|NCT04526132|Analgesics|analgesics|mesh-ancestor
56226222|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
56226223|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226224|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226225|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56226226|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56226227|NCT04523428|Venetoclax|venetoclax|mesh-list
56226228|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
56226229|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226230|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56226231|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56226232|NCT04521920|Narcotics|narcotics|mesh-ancestor
55802056|NCT04814485|Paclitaxel|paclitaxel|mesh-list
56125432|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56125433|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56125434|NCT05632224|Aprepitant|aprepitant|mesh-list
55933251|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
55933252|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
56125435|NCT05632224|Granisetron|granisetron|mesh-list
56125436|NCT05632224|Antiemetics|antiemetics|mesh-ancestor
56125437|NCT05632224|Autonomic Agents|autonomic agents|mesh-ancestor
56125438|NCT05632224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125439|NCT05632224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125440|NCT05632224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56125441|NCT05632224|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56125442|NCT05632224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125443|NCT05632224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125444|NCT05632224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56125445|NCT05632224|Serotonin Agents|serotonin agents|mesh-ancestor
56125446|NCT05631912|Cyclophosphamide|cyclophosphamide|mesh-list
56125447|NCT05631912|Fludarabine|fludarabine|mesh-list
56125448|NCT05631912|Fludarabine phosphate|fludarabine phosphate|mesh-list
56125449|NCT05631912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125450|NCT05631912|Immunologic Factors|immunologic factors|mesh-ancestor
56125451|NCT05631912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125452|NCT05631912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125453|NCT05631912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55933306|NCT05582837|Adrenergic Agents|adrenergic agents|mesh-ancestor
55933307|NCT05582837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933308|NCT04728633|Carmustine|carmustine|mesh-list
56125454|NCT05631912|Alkylating Agents|alkylating agents|mesh-ancestor
56125455|NCT05631912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125456|NCT05631912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125457|NCT05631912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56125458|NCT05631912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56125459|NCT05631912|Antimetabolites|antimetabolites|mesh-ancestor
56125460|NCT03024840|Propofol|propofol|mesh-list
56125461|NCT03024840|Sevoflurane|sevoflurane|mesh-list
56125462|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56125463|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125464|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125465|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56125466|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
56125467|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
56125468|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56125469|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56125470|NCT05631678|Itraconazole|itraconazole|mesh-list
56125471|NCT05631678|Rifampin|rifampin|mesh-list
56125472|NCT05631678|Antifungal Agents|antifungal agents|mesh-ancestor
56125473|NCT05631678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125474|NCT05631678|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55933351|NCT05582135|Analgesics|analgesics|mesh-ancestor
55933352|NCT05582135|Sensory System Agents|sensory system agents|mesh-ancestor
55933353|NCT05582135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933356|NCT03070704|Liraglutide|liraglutide|mesh-list
56125475|NCT05631678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56125476|NCT05631678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125477|NCT05631678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226233|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226234|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226235|NCT04521920|Analgesics|analgesics|mesh-ancestor
56226236|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
56125478|NCT05631678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56125479|NCT05631678|Hormone Antagonists|hormone antagonists|mesh-ancestor
56125480|NCT05631678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125481|NCT05631678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125482|NCT05631678|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56125483|NCT05631678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56125484|NCT05631678|Antitubercular Agents|antitubercular agents|mesh-ancestor
56125485|NCT05631678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56125486|NCT05631678|Leprostatic Agents|leprostatic agents|mesh-ancestor
56125487|NCT05631678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56125488|NCT05631678|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56125489|NCT05631678|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56125490|NCT05631678|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56125491|NCT05631678|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56125492|NCT05631678|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56125495|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125496|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56125497|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125498|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125499|NCT04008264|Scopolamine|scopolamine|mesh-list
56125500|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56125501|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56125502|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
56125503|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
56125504|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125505|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933413|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
55933414|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933415|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933416|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933418|NCT03021317|Hormones|hormones|mesh-ancestor
56125506|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56125507|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
56125508|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56125509|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
56125510|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125511|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125512|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56125513|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
56125514|NCT03595254|Nicotine|nicotine|mesh-list
55852476|NCT00221338|Gabapentin|gabapentin|mesh-list
56125516|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
56125517|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125518|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125519|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56125520|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56125521|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
56125522|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125523|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125524|NCT03599466|Lisinopril|lisinopril|mesh-list
55933444|NCT05002686|Paclitaxel|paclitaxel|mesh-list
55933445|NCT05002686|Capecitabine|capecitabine|mesh-list
55933446|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
56125525|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56125526|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
56125527|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125528|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125529|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56125530|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56125531|NCT03599466|Protective Agents|protective agents|mesh-ancestor
56125532|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125533|NCT03986970|Tenofovir|tenofovir|mesh-list
56125534|NCT03986970|Emtricitabine|emtricitabine|mesh-list
56125535|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
55933495|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933496|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55933497|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55933498|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55933499|NCT04354545|Lifitegrast|lifitegrast|mesh-list
55933500|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55933501|NCT03587285|Goserelin|goserelin|mesh-list
56125536|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125537|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56125538|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56125539|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125540|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125541|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56125542|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56226237|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226238|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56226239|NCT04508504|Ropivacaine|ropivacaine|mesh-list
56226240|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
56226241|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
56125543|NCT03594396|Durvalumab|durvalumab|mesh-list
56125544|NCT03594396|Olaparib|olaparib|mesh-list
56125545|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55788433|NCT04675333|Carboplatin|carboplatin|mesh-list
56125546|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125547|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56125548|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125549|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125550|NCT03594240|Folic Acid|folic acid|mesh-list
56125551|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
56125552|NCT03594240|Vitamins|vitamins|mesh-ancestor
56125553|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
56125554|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125555|NCT03594240|Hematinics|hematinics|mesh-ancestor
56125556|NCT03976362|Paclitaxel|paclitaxel|mesh-list
56125557|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56125558|NCT03976362|Carboplatin|carboplatin|mesh-list
56125559|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
56125560|NCT03976362|Olaparib|olaparib|mesh-list
56125561|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56125562|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933528|NCT03586817|Palonosetron|palonosetron|mesh-list
55933529|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
55933530|NCT03586817|Aprepitant|aprepitant|mesh-list
56125563|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
56125564|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
56125565|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
56125568|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56125569|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125570|NCT03598374|Folic Acid|folic acid|mesh-list
56125571|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
56125572|NCT03598374|Inositol|inositol|mesh-list
56125573|NCT03598374|Hematinics|hematinics|mesh-ancestor
56125574|NCT03598374|Vitamins|vitamins|mesh-ancestor
56125575|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
56125576|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125577|NCT04407078|Neostigmine|neostigmine|mesh-list
56125578|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56125579|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125580|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799712|NCT04389073|Growth Substances|growth substances|mesh-ancestor
55799713|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
55799714|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56125581|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
56125582|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56125583|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125584|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56125585|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
56125586|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125587|NCT00217620|Sorafenib|sorafenib|mesh-list
56125588|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125589|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56125590|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125591|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125593|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56125594|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125595|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56125596|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56125597|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
56125598|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125599|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125600|NCT03597282|Nivolumab|nivolumab|mesh-list
56125601|NCT03597282|Ipilimumab|ipilimumab|mesh-list
56125602|NCT03597282|Poly ICLC|poly iclc|mesh-list
55799781|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55799782|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
55799783|NCT05257993|Antiviral Agents|antiviral agents|mesh-ancestor
55799789|NCT05533073|Etoricoxib|etoricoxib|mesh-list
56125603|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125604|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125605|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56125606|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125607|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
56125608|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
56125609|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125610|NCT03593304|Vitamins|vitamins|mesh-list
56125611|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
56226242|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226243|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226244|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
56226245|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226246|NCT04490707|Lenalidomide|lenalidomide|mesh-list
55933579|NCT03584087|Terlipressin|terlipressin|mesh-list
55933582|NCT03834363|Fentanyl|fentanyl|mesh-list
56226247|NCT04490707|Azacitidine|azacitidine|mesh-list
56226248|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
56226249|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226250|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56226251|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56226252|NCT04490707|Growth Substances|growth substances|mesh-ancestor
56226253|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
56226254|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226255|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56226256|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
56226257|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125612|NCT03593304|Pyridoxine|pyridoxine|mesh-list
56125613|NCT03593304|Pyridoxal|pyridoxal|mesh-list
56125614|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
56125615|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
56125616|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
56125617|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125618|NCT00211536|Insulin|insulin|mesh-list
55799862|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799863|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125619|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56125620|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55788444|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56125621|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125622|NCT03596970|Everolimus|everolimus|mesh-list
56125623|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125624|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125625|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
56125626|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125627|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
56125628|NCT03596892|Busulfan|busulfan|mesh-list
56125629|NCT03596892|Decitabine|decitabine|mesh-list
56125630|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125631|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
56125632|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125633|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125634|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56125635|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
56125636|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125637|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125638|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56125639|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56125641|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125642|NCT03592992|Morphine|morphine|mesh-list
56125643|NCT03592992|Hydromorphone|hydromorphone|mesh-list
56125644|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56125645|NCT03592992|Narcotics|narcotics|mesh-ancestor
55933603|NCT05702957|Letrozole|letrozole|mesh-list
55933604|NCT05702957|Clomiphene|clomiphene|mesh-list
56125646|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125647|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125648|NCT03592992|Analgesics|analgesics|mesh-ancestor
56125649|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
56125650|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125651|NCT03592836|Furosemide|furosemide|mesh-list
56125652|NCT03592836|Diuretics|diuretics|mesh-list
56125653|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56226259|NCT04464577|Itraconazole|itraconazole|mesh-list
56226260|NCT04464577|Fluconazole|fluconazole|mesh-list
56226261|NCT04464577|Bupropion|bupropion|mesh-list
56226262|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56226263|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
56226264|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56226265|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56226266|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56226267|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56226268|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226269|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
56226270|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226271|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226272|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56125654|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
56125655|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125656|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56052343|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933628|NCT03580733|Caspofungin|caspofungin|mesh-list
55933629|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
55799957|NCT04877509|Copper|copper|mesh-list
56125657|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125658|NCT03596502|Warfarin|warfarin|mesh-list
56125659|NCT03596502|Anticoagulants|anticoagulants|mesh-list
56125660|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
56125661|NCT04197570|Analgesics|analgesics|mesh-list
56125662|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56125663|NCT04197570|Anesthetics|anesthetics|mesh-list
56125664|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125665|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125667|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
56125668|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125669|NCT04197882|Molgramostim|molgramostim|mesh-list
56125670|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933669|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
55799959|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
56125671|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56125672|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56125673|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
56125674|NCT03024216|Atezolizumab|atezolizumab|mesh-list
56125675|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125676|NCT03981744|Ustekinumab|ustekinumab|mesh-list
56125677|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56125678|NCT03591900|Insulin|insulin|mesh-list
56125679|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56125680|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125681|NCT03591744|Dexamethasone|dexamethasone|mesh-list
56125682|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
56125683|NCT03591744|Doxorubicin|doxorubicin|mesh-list
56125684|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56125685|NCT03591744|Lenalidomide|lenalidomide|mesh-list
56125686|NCT03591744|Bortezomib|bortezomib|mesh-list
56125687|NCT03591744|Daratumumab|daratumumab|mesh-list
56125688|NCT03591744|Ichthammol|ichthammol|mesh-list
56125689|NCT03591744|BB 1101|bb 1101|mesh-list
56125690|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125691|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
56125692|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
56125693|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125694|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125695|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56125696|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
56125697|NCT03591744|Hormones|hormones|mesh-ancestor
56125698|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125699|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56125700|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125701|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56226273|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55933694|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55933695|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55933696|NCT00951561|Analgesics|analgesics|mesh-ancestor
55933697|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
55933698|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226274|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226275|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
56226276|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226277|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56226278|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56226279|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
56226280|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226281|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56226282|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56226283|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56226284|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
56226285|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226286|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226288|NCT04430517|Niacin|niacin|mesh-list
56226289|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
56226290|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
56226291|NCT04430517|Vitamins|vitamins|mesh-ancestor
56226292|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
56226293|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226294|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56226295|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
56226296|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226297|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56226298|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
56226299|NCT04402658|Albuterol|albuterol|mesh-list
55800017|NCT05521997|Cisplatin|cisplatin|mesh-list
56226300|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56226301|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
56226302|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226303|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125702|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56125703|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56125704|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125705|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125706|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
56125707|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56125708|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56125709|NCT03591744|Growth Substances|growth substances|mesh-ancestor
56125710|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
56125711|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
56125712|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
56226304|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56226305|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
56226306|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
56226307|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56226308|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56226309|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55933740|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933741|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226310|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56226311|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
56226312|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226313|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226314|NCT04391179|Dipyridamole|dipyridamole|mesh-list
56226315|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56226316|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226317|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226318|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56125714|NCT04196946|Alfentanil|alfentanil|mesh-list
56125715|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56125716|NCT04196946|Narcotics|narcotics|mesh-ancestor
56125717|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125720|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
56125721|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125722|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56125723|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56125724|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
56125725|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
56125726|NCT04194528|Acetaminophen|acetaminophen|mesh-list
56125727|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56125728|NCT04194528|Oxycodone|oxycodone|mesh-list
56125729|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56125730|NCT04194528|Analgesics|analgesics|mesh-ancestor
56125731|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
56125732|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125733|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125734|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
56125735|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56125736|NCT04194528|Narcotics|narcotics|mesh-ancestor
56125737|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125738|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56125739|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125740|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125741|NCT03023904|Nivolumab|nivolumab|mesh-list
56125742|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125743|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125744|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56125745|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125746|NCT04196010|Cytarabine|cytarabine|mesh-list
56125747|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56125748|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
56125749|NCT04196010|Cladribine|cladribine|mesh-list
56125750|NCT04196010|Lenograstim|lenograstim|mesh-list
56125751|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56125752|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
56125753|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125754|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125755|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
56125756|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125757|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125758|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
56226319|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
56226320|NCT04375683|HH-GV-678|hh-gv-678|mesh-list
56226321|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56226322|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125759|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125760|NCT04196010|Analgesics|analgesics|mesh-ancestor
56125761|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
56125762|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125763|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56125764|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56125765|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125766|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56125767|NCT04196400|Betamethasone|betamethasone|mesh-list
56125768|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125769|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
56125770|NCT04196400|Hormones|hormones|mesh-ancestor
56125771|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125772|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125773|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56125774|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
55800199|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56125775|NCT03742986|Paclitaxel|paclitaxel|mesh-list
56125776|NCT03742986|Docetaxel|docetaxel|mesh-list
56125777|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56125778|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
56125779|NCT03742986|Doxorubicin|doxorubicin|mesh-list
56125780|NCT03742986|Nivolumab|nivolumab|mesh-list
56125781|NCT03742986|Trastuzumab|trastuzumab|mesh-list
56125782|NCT03742986|Pertuzumab|pertuzumab|mesh-list
56125783|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56125784|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125785|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
56125786|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
56125787|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
56125788|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125789|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125790|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
56125791|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125792|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125794|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
56125795|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56125796|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56125797|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56125798|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56125799|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125800|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125801|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56125802|NCT03023436|Fluorouracil|fluorouracil|mesh-list
56125803|NCT03023436|Capecitabine|capecitabine|mesh-list
56125804|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125805|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
56125806|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125807|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56125808|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55933795|NCT05104866|Antiviral Agents|antiviral agents|mesh-ancestor
56125809|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
56125810|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125811|NCT04195074|Tenofovir|tenofovir|mesh-list
56125812|NCT04195074|Entecavir|entecavir|mesh-list
56125813|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
55800240|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55800241|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800242|NCT05519579|Methotrexate|methotrexate|mesh-list
55800243|NCT05519579|Blinatumomab|blinatumomab|mesh-list
55800244|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56125814|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125815|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56125816|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56125817|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125818|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125819|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56125820|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56125821|NCT03590262|Metformin|metformin|mesh-list
56125822|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56125823|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125824|NCT04029636|Xenon|xenon|mesh-list
56125825|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56125826|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
56125827|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
56125828|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226323|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226324|NCT04356742|Metformin|metformin|mesh-list
56226325|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
56226326|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55802160|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
56125829|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125830|NCT04194684|Paclitaxel|paclitaxel|mesh-list
55800265|NCT02613403|Ribavirin|ribavirin|mesh-list
56125831|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56125832|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125833|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
56125834|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
56125835|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
56125836|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125837|NCT04194294|Lidocaine|lidocaine|mesh-list
56125838|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
56125839|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
56125840|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56125841|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125842|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
56125843|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125844|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56125845|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56125846|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56125847|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56125848|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125849|NCT04029090|Edaravone|edaravone|mesh-list
56125850|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56125851|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
56125852|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125853|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56125854|NCT04029090|Protective Agents|protective agents|mesh-ancestor
56125855|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125856|NCT04194216|Clindamycin|clindamycin|mesh-list
56125857|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
56125858|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
56125859|NCT04194216|Cephalexin|cephalexin|mesh-list
56125860|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56125861|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125862|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56125863|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125864|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125865|NCT04193982|Vitamin E|vitamin e|mesh-list
56125866|NCT04193982|Vitamins|vitamins|mesh-ancestor
56125869|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
56125870|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125871|NCT04193982|Protective Agents|protective agents|mesh-ancestor
56125872|NCT04028778|Gefitinib|gefitinib|mesh-list
56125873|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125874|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56125875|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125876|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125877|NCT04028856|Interferons|interferons|mesh-list
56125878|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125879|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
56125880|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125881|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56125882|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
56125883|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56125884|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56125885|NCT04193592|Pirfenidone|pirfenidone|mesh-list
56125886|NCT04193592|Analgesics|analgesics|mesh-ancestor
56125887|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
56125888|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125889|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125890|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56125891|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56125892|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125893|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125894|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125895|NCT03933384|Tenofovir|tenofovir|mesh-list
56125896|NCT03933384|Entecavir|entecavir|mesh-list
56226327|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226332|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
56226333|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226334|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226335|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56226336|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56226337|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
56226338|NCT04348864|Antibodies|antibodies|mesh-list
56125897|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
55852890|NCT01898728|Iodine|iodine|mesh-list
56125898|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125899|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56125900|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56125901|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890126|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56125902|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125903|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56125904|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56125905|NCT04028466|Omeprazole|omeprazole|mesh-list
56125906|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56125907|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56125908|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56125909|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818082|NCT04951115|Carboplatin|carboplatin|mesh-list
56125910|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125911|NCT04027764|Paclitaxel|paclitaxel|mesh-list
56125912|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56125913|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125914|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
56125915|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
56125916|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
56125917|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125918|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
56125919|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56125920|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125921|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56125922|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125923|NCT03023358|Prednisone|prednisone|mesh-list
56125924|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
56125925|NCT03023358|Doxorubicin|doxorubicin|mesh-list
56125926|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56125927|NCT03023358|Vincristine|vincristine|mesh-list
56125928|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125929|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
56125930|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125931|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56125932|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56125933|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
56125934|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800355|NCT04868227|Vitamin D|vitamin d|mesh-list
55800357|NCT04868227|Vitamins|vitamins|mesh-ancestor
56125935|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125936|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56125937|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56125938|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56125940|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125941|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125942|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
56125943|NCT03023358|Hormones|hormones|mesh-ancestor
56125944|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125945|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56125946|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56125947|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56125948|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56125949|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56125950|NCT04192812|Leuprolide|leuprolide|mesh-list
56125951|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56125952|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
56125953|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56125954|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226339|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
56226340|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226341|NCT04328012|Losartan|losartan|mesh-list
56226342|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56226343|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56226344|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56226345|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56125955|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56125956|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125957|NCT04407000|Favipiravir|favipiravir|mesh-list
56125958|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
56125959|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125960|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
56125961|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56125962|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56125963|NCT04192656|Prednisolone|prednisolone|mesh-list
56125964|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
56125965|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56125966|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
56125967|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56125968|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
56125969|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
56125970|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125971|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125972|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56125973|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
56125974|NCT04192656|Hormones|hormones|mesh-ancestor
56125975|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56125976|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56125977|NCT04192656|Protective Agents|protective agents|mesh-ancestor
56125978|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56125979|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56125980|NCT04191954|Fasudil|fasudil|mesh-list
56125981|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56125982|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
56125983|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56125984|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56125985|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56125986|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125987|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56125988|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125989|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
56125990|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56125991|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56125992|NCT04192032|Nicotine|nicotine|mesh-list
56125993|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56125994|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
55788515|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
56125995|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56125996|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125997|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56125998|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56125999|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
56126000|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934086|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56126001|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126003|NCT03023982|Bupivacaine|bupivacaine|mesh-list
56126004|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
56126005|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
56126006|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126007|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126008|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
56126009|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126010|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56126011|NCT03023982|Narcotics|narcotics|mesh-ancestor
56126012|NCT03023982|Analgesics|analgesics|mesh-ancestor
56126013|NCT04192110|Diuretics|diuretics|mesh-list
56126017|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56126018|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56226346|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226348|NCT04310150|Coagulants|coagulants|mesh-ancestor
56226349|NCT04305444|Everolimus|everolimus|mesh-list
56226350|NCT04305444|Pomalidomide|pomalidomide|mesh-list
56226351|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126019|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126021|NCT04025736|Coagulants|coagulants|mesh-ancestor
56126022|NCT04190160|Xultophy|xultophy|mesh-list
55934389|NCT04265651|Infigratinib|infigratinib|mesh-list
56126023|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56126024|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126025|NCT04190160|Incretins|incretins|mesh-ancestor
56126026|NCT04190160|Hormones|hormones|mesh-ancestor
56126027|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56126028|NCT04190004|Vasopressins|vasopressins|mesh-list
56126029|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
56126030|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
56126031|NCT04190004|Coagulants|coagulants|mesh-ancestor
56126032|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56126033|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56126034|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
56126035|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126036|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
56126037|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55934795|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56126039|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
56126040|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126041|NCT04406376|Prednisone|prednisone|mesh-list
56126042|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126043|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
56126044|NCT04406376|Hormones|hormones|mesh-ancestor
56126045|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56126046|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126047|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56126048|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126049|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
56126050|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56126051|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126052|NCT04198662|Epinephrine|epinephrine|mesh-list
56126053|NCT04198662|Ropivacaine|ropivacaine|mesh-list
56126054|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
56126055|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
56126056|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126057|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126058|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
56126059|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126060|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56126061|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56126062|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
56126063|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935645|NCT00981825|Listerine|listerine|mesh-list
56126064|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126065|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56126066|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56126067|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
56126068|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56126069|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
56126070|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
56126071|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
56126072|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56126073|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
56126074|NCT04023630|Clopidogrel|clopidogrel|mesh-list
56126075|NCT04023630|Ticagrelor|ticagrelor|mesh-list
56126076|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56126077|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56126078|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56126079|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56126080|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
56126081|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126082|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226352|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56226353|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
56226354|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226355|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56226356|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56226357|NCT04305444|Growth Substances|growth substances|mesh-ancestor
56126083|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126084|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56126085|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
56126086|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56126088|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126089|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
56126091|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56126092|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126093|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56126094|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56126095|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126096|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126097|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940455|NCT05604859|Hormones|hormones|mesh-ancestor
56126098|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56126099|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56126100|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
55941064|NCT04120519|Hormones|hormones|mesh-ancestor
56126101|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56126102|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126103|NCT04020666|Kallikreins|kallikreins|mesh-list
56126104|NCT04020666|Coagulants|coagulants|mesh-ancestor
56126105|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
56126106|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
56126107|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56126108|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126109|NCT03929640|Acetaminophen|acetaminophen|mesh-list
56126110|NCT03929640|Ibuprofen|ibuprofen|mesh-list
56126111|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56126112|NCT03929640|Analgesics|analgesics|mesh-ancestor
56126113|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
56126114|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126115|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126116|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
56126117|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56126118|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126119|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56126120|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56126121|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126122|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126123|NCT04021992|Gemcitabine|gemcitabine|mesh-list
56126124|NCT04021992|Rituximab|rituximab|mesh-list
56126125|NCT04021992|Doxorubicin|doxorubicin|mesh-list
56126127|NCT04021992|Vinorelbine|vinorelbine|mesh-list
56126128|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56126129|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126130|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
56126131|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944244|NCT02384083|Hormones|hormones|mesh-ancestor
56126132|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56126133|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126134|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
56126135|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126136|NCT04021992|Antiviral Agents|antiviral agents|mesh-ancestor
56126137|NCT04021992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126138|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126139|NCT04021992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944482|NCT03056274|Metformin|metformin|mesh-list
56126140|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56126141|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56126142|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56126143|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56126144|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56126145|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56126146|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56126147|NCT03926130|Mirikizumab|mirikizumab|mesh-list
55944871|NCT01391013|Ritonavir|ritonavir|mesh-list
56126148|NCT03926130|Ustekinumab|ustekinumab|mesh-list
56226358|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
56226363|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56226364|NCT04294147|Erenumab|erenumab|mesh-list
56126149|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
56126150|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56126151|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56126152|NCT03926130|Analgesics|analgesics|mesh-ancestor
56126153|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
56126154|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126155|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126156|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126157|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56126158|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56126159|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56126160|NCT04020588|Minocycline|minocycline|mesh-list
56126161|NCT04020588|Celecoxib|celecoxib|mesh-list
56126164|NCT04020588|Analgesics|analgesics|mesh-ancestor
56126165|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
56126166|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126167|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126168|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126169|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56126170|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56126171|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56126172|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126173|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126174|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56126175|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126176|NCT04145856|Simethicone|simethicone|mesh-list
56126177|NCT04145856|Alverine|alverine|mesh-list
56126178|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
56126179|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126180|NCT04145856|Emollients|emollients|mesh-ancestor
56126181|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
56126182|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
56126183|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
56126184|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126185|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126186|NCT04140786|Gentamicins|gentamicins|mesh-list
56126187|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56126188|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126189|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56126190|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126191|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126192|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56126193|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56126194|NCT04022226|Ketamine|ketamine|mesh-list
56126195|NCT04022226|Methohexital|methohexital|mesh-list
56126196|NCT04022226|Analgesics|analgesics|mesh-ancestor
56126197|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
56126198|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126199|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788543|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56126200|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56126201|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56126202|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
56126203|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
56126204|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126205|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56126206|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55945872|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56126207|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126208|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126209|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
56126210|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56126211|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
56126212|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
56126213|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126214|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126215|NCT04025658|Oxytocin|oxytocin|mesh-list
56126216|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
56126217|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56126218|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126219|NCT05586438|Colistin|colistin|mesh-list
56226365|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56126220|NCT05586438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56126221|NCT05586438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126222|NCT04145232|Nivolumab|nivolumab|mesh-list
56126224|NCT04145232|Atezolizumab|atezolizumab|mesh-list
56126225|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56126226|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126227|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56126228|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126229|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
56126230|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56126231|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56126232|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
56126233|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126234|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126235|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126236|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
56126237|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
56126238|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126239|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
56126240|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56126241|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
56126242|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56126243|NCT04026282|Hormones|hormones|mesh-ancestor
56126244|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56126245|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126246|NCT04144218|Lacosamide|lacosamide|mesh-list
56126247|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
56126248|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55947350|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
56126249|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56126250|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56126251|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126252|NCT05580822|Tenecteplase|tenecteplase|mesh-list
56126253|NCT05580822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56126254|NCT05580822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56126255|NCT05580822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126256|NCT04024254|Folic Acid|folic acid|mesh-list
56126257|NCT04024254|Hematinics|hematinics|mesh-ancestor
56126258|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
56126259|NCT04024254|Vitamins|vitamins|mesh-ancestor
56126260|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
56126261|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126262|NCT05580666|Azithromycin|azithromycin|mesh-list
56126263|NCT05580666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56126264|NCT05580666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126265|NCT04143906|Gemcitabine|gemcitabine|mesh-list
56126266|NCT04143906|Carboplatin|carboplatin|mesh-list
56126267|NCT04143906|Vinorelbine|vinorelbine|mesh-list
56126268|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126269|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126270|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
56126271|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126272|NCT04143906|Antiviral Agents|antiviral agents|mesh-ancestor
55947893|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
56126273|NCT04143906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126274|NCT04143906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948528|NCT05606341|1018 oligonucleotide|1018 oligonucleotide|mesh-list
55948529|NCT05606341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55948530|NCT05606341|Immunologic Factors|immunologic factors|mesh-ancestor
55948531|NCT05606341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948532|NCT04778917|Heparin|heparin|mesh-list
55948534|NCT04778917|Tinzaparin|tinzaparin|mesh-list
56126275|NCT04143906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56126276|NCT04143906|Immunologic Factors|immunologic factors|mesh-ancestor
56126277|NCT04143906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126278|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56126279|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
56126280|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
56126281|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
56126282|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
56126283|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56126284|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
56126285|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126286|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
56126287|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56126288|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
56126289|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126290|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
56126291|NCT02708706|Protective Agents|protective agents|mesh-ancestor
56226366|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226368|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
55948974|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56226369|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226370|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126293|NCT05587608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126294|NCT05587608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126295|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
56126296|NCT02703714|Sargramostim|sargramostim|mesh-list
56126297|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56126298|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126299|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
56126300|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126301|NCT05583552|Imetelstat|imetelstat|mesh-list
56126302|NCT05583552|Motesanib diphosphate|motesanib diphosphate|mesh-list
56126303|NCT05583552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126304|NCT05583552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126305|NCT05583552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56126306|NCT05583474|Carteolol|carteolol|mesh-list
55949210|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56126307|NCT05583474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56126308|NCT05583474|Latanoprost|latanoprost|mesh-list
56126309|NCT05583474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56126310|NCT05583474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56126313|NCT05583474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126314|NCT05583474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126315|NCT05583474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126316|NCT05583474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56126317|NCT05583474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56126319|NCT05583474|Autonomic Agents|autonomic agents|mesh-ancestor
56126320|NCT05583474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126321|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
56126322|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56126323|NCT03904446|Methylergonovine|methylergonovine|mesh-list
56126324|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
56126325|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56126326|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126327|NCT03916068|Vitamin E|vitamin e|mesh-list
56126328|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
56126329|NCT03916068|Vitamins|vitamins|mesh-ancestor
56126330|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
56126331|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126332|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
56126333|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126334|NCT03916068|Protective Agents|protective agents|mesh-ancestor
56126335|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56126336|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126337|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56126338|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56126339|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
56126340|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56126341|NCT04143282|Metformin|metformin|mesh-list
56126342|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56126343|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126345|NCT04149678|Cyclosporins|cyclosporins|mesh-list
56126346|NCT04149678|Ozanimod|ozanimod|mesh-list
56126347|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126348|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126349|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56126350|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
56126351|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853316|NCT00296296|Cyclosporine|cyclosporine|mesh-list
56126352|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
56126353|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126354|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
56126355|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56126356|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56126357|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56126359|NCT05581992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56126360|NCT05581992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56126361|NCT05581992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56226371|NCT04292873|Vitamin D|vitamin d|mesh-list
56226372|NCT04292873|Vitamins|vitamins|mesh-ancestor
56226373|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
56226374|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126362|NCT05581992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126363|NCT05581992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126364|NCT03020940|Cefuroxime|cefuroxime|mesh-list
56126365|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
56126366|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56126367|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126368|NCT03645408|Exenatide|exenatide|mesh-list
56126369|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55951110|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951111|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55951147|NCT04772729|Insulin|insulin|mesh-list
56126370|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126371|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56126372|NCT03645408|Incretins|incretins|mesh-ancestor
56126373|NCT03645408|Hormones|hormones|mesh-ancestor
56126374|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56126375|NCT04141410|Simendan|simendan|mesh-list
56126376|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56126377|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
56126378|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56126379|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56126380|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126381|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126382|NCT04141410|Protective Agents|protective agents|mesh-ancestor
56126383|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126384|NCT05586204|Vaccines|vaccines|mesh-list
56126385|NCT05586204|Immunologic Factors|immunologic factors|mesh-ancestor
56126387|NCT04149444|Trifluridine|trifluridine|mesh-list
56126388|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
56126389|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126390|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
56126391|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951696|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56126392|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
56126393|NCT03020706|Analgesics|analgesics|mesh-ancestor
55952007|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
56126394|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
56126395|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126396|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126397|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
56126398|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126399|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56126400|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
56126401|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56126402|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56126403|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818188|NCT04594018|Minoxidil|minoxidil|mesh-list
56126404|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56126405|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
56126406|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56126407|NCT03900624|Dexamethasone|dexamethasone|mesh-list
56126408|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126409|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
56126410|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
56126411|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953242|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56126412|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126413|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56126414|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
56126415|NCT03900624|Hormones|hormones|mesh-ancestor
55788553|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126416|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56126417|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56126418|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126419|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
56126420|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56126421|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
56126422|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126423|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126424|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56126425|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
56126426|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56126427|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
56126428|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126429|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226375|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56226376|NCT04264637|Azelastine|azelastine|mesh-list
56126430|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56126431|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
56126432|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
56126433|NCT04149132|Protective Agents|protective agents|mesh-ancestor
56126434|NCT03908892|Tetracycline|tetracycline|mesh-list
56126435|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55955297|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
56126436|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126437|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55955744|NCT00141739|Etanercept|etanercept|mesh-list
56126438|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126439|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126440|NCT04140318|Paclitaxel|paclitaxel|mesh-list
56126441|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56126442|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126443|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
56126444|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
56126445|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
56126446|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126447|NCT03021330|Cytarabine|cytarabine|mesh-list
55956442|NCT04476511|Vitamins|vitamins|mesh-ancestor
56126448|NCT03021330|Daunorubicin|daunorubicin|mesh-list
56126449|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126450|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
56126451|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126452|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126453|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
56126454|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126455|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56126456|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
55956829|NCT01736943|Bortezomib|bortezomib|mesh-list
56126457|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126460|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56126461|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126462|NCT04140006|Alendronate|alendronate|mesh-list
56126463|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56126464|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126465|NCT04140396|Lidocaine|lidocaine|mesh-list
56126466|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
55957361|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55957650|NCT00186875|Hormones|hormones|mesh-ancestor
56126467|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
56126468|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126469|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126470|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
56126471|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126472|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55958465|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
56126473|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56126474|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56126475|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56126476|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126477|NCT04146324|Nivolumab|nivolumab|mesh-list
56126478|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56126479|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126480|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56126481|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126482|NCT03588936|Nivolumab|nivolumab|mesh-list
56126483|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56126484|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126485|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56126486|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126487|NCT03022500|Durvalumab|durvalumab|mesh-list
56126488|NCT03022500|Tremelimumab|tremelimumab|mesh-list
55961371|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55963097|NCT01381874|Prednisone|prednisone|mesh-list
55964286|NCT05632328|Antiviral Agents|antiviral agents|mesh-ancestor
56126489|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56126490|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126491|NCT04148898|Bevacizumab|bevacizumab|mesh-list
56126492|NCT04148898|Osimertinib|osimertinib|mesh-list
55968447|NCT00670267|Nadolol|nadolol|mesh-list
56126493|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56126494|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126495|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56126496|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56126497|NCT04148898|Growth Substances|growth substances|mesh-ancestor
56126498|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126499|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
56126500|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56126501|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226377|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56226378|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
56226379|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226380|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969130|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
55969202|NCT03749018|Etoposide|etoposide|mesh-list
56126502|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126503|NCT04148820|Aspirin|aspirin|mesh-list
56126504|NCT04148820|Perindopril|perindopril|mesh-list
56126505|NCT04148820|Atorvastatin|atorvastatin|mesh-list
56126506|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56126507|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56126508|NCT04148820|Analgesics|analgesics|mesh-ancestor
56126509|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
56126510|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126511|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126512|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126513|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56126514|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56126515|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56126516|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969745|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
56126517|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56126518|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56126519|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126520|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
56126521|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56126522|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56126523|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
56126524|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56126525|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56126526|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56126527|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
56126528|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55970676|NCT00597493|Sorafenib|sorafenib|mesh-list
56126530|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56126532|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56126533|NCT03941730|Estrogens|estrogens|mesh-ancestor
56126534|NCT03941730|Hormones|hormones|mesh-ancestor
56126535|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56126536|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126537|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56126538|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
56126539|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56126540|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56126541|NCT03941496|Azacitidine|azacitidine|mesh-list
56126542|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126543|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
56126544|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126545|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126546|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126547|NCT03580980|Acetaminophen|acetaminophen|mesh-list
56126548|NCT03580980|Ketamine|ketamine|mesh-list
56126549|NCT03580980|Morphine|morphine|mesh-list
56126550|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
56126551|NCT03580980|Analgesics|analgesics|mesh-ancestor
56126552|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
56126553|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126554|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126555|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56126556|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56126557|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
56126558|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
56126559|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126560|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56126561|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56126562|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126563|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126564|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56126566|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56126567|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
56126568|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
56126569|NCT03587220|Lidocaine|lidocaine|mesh-list
56126570|NCT03587220|Capsaicin|capsaicin|mesh-list
56226381|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56226382|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
56226383|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56226384|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226385|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226386|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56226387|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56226388|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56226389|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
56226390|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
56226391|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226392|NCT04262687|Bevacizumab|bevacizumab|mesh-list
56226393|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
56226394|NCT04262687|Capecitabine|capecitabine|mesh-list
56226395|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
56226396|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56226397|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226398|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56226399|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56226400|NCT04262687|Growth Substances|growth substances|mesh-ancestor
55802208|NCT04789915|Memantine|memantine|mesh-list
56126571|NCT03587220|Histamine|histamine|mesh-list
56126572|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
56126573|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
55972296|NCT00080288|Modafinil|modafinil|mesh-list
55972423|NCT03080324|Fentanyl|fentanyl|mesh-list
56126574|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126575|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126576|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
56126577|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126578|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56126579|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56126580|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56126581|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56126582|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126584|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
56126585|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
56126586|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
56126587|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126588|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56126589|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56126590|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
56126591|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55972634|NCT00249769|Vaccines|vaccines|mesh-list
56126592|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
56126593|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126594|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126595|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56126596|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
56126597|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
56126598|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56126599|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
56126600|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126601|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126602|NCT04147806|Dexamethasone|dexamethasone|mesh-list
56126603|NCT04147806|Tamsulosin|tamsulosin|mesh-list
56226401|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226410|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973188|NCT05039619|Promethazine|promethazine|mesh-list
56226411|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
56226412|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56226413|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
56226414|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226415|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56226416|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226417|NCT04233801|Empagliflozin|empagliflozin|mesh-list
56226418|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56226419|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226420|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56226421|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226422|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
56226423|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56226424|NCT04223570|Levulinic acid|levulinic acid|mesh-list
56226425|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56226426|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
55974067|NCT04725591|Insulin|insulin|mesh-list
56226427|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226428|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226437|NCT04180085|Abatacept|abatacept|mesh-list
56226438|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56226439|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226440|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226441|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974662|NCT04056962|Tacrolimus|tacrolimus|mesh-list
56226442|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
56226443|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226444|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56226445|NCT04169451|Letrozole|letrozole|mesh-list
56126604|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126605|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
56126606|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
56126607|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126608|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126609|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56126610|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
55890127|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
55975109|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
55975110|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
55975165|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
55975167|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
55975544|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55975545|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55975546|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975547|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
56126612|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56126613|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56126614|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126615|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56126616|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56226446|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226447|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56226448|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56226449|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226450|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977578|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
56226451|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56226452|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
56226453|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802257|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
56126617|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56126618|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
56126619|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126620|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126621|NCT04147806|Urological Agents|urological agents|mesh-ancestor
56126622|NCT03580590|Diltiazem|diltiazem|mesh-list
56126623|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
56126624|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56126625|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56126626|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126627|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
56126628|NCT03580590|Coagulants|coagulants|mesh-ancestor
56126629|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56126630|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56126631|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56126632|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56126633|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126634|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
56126635|NCT03891576|Niraparib|niraparib|mesh-list
56126636|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55983783|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
55983784|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
56126637|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126638|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126639|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126640|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56126641|NCT03586674|Fenofibrate|fenofibrate|mesh-list
56126642|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56126643|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
56126644|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126645|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56126646|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56126647|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56126648|NCT03346668|Gabapentin|gabapentin|mesh-list
56126649|NCT03346668|Analgesics|analgesics|mesh-ancestor
55853611|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
56126651|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126652|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126653|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
56126654|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56126655|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56126656|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126657|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56126658|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56126659|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56126660|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126661|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768490|NCT04176705|Lidocaine|lidocaine|mesh-list
56126662|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
56126663|NCT03585738|Folic Acid|folic acid|mesh-list
56126664|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
56126665|NCT03585738|Inositol|inositol|mesh-list
56126666|NCT03585738|Hematinics|hematinics|mesh-ancestor
56126667|NCT03585738|Vitamins|vitamins|mesh-ancestor
56126668|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
56126669|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126670|NCT03583164|Olorofim|olorofim|mesh-list
56126671|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
56126672|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126673|NCT03589326|Cytarabine|cytarabine|mesh-list
56226454|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226455|NCT04169438|Petrolatum|petrolatum|mesh-list
56226456|NCT04169438|Emollients|emollients|mesh-ancestor
56226457|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
56226458|NCT04159818|Doxorubicin|doxorubicin|mesh-list
56226459|NCT04159818|Nivolumab|nivolumab|mesh-list
55772270|NCT02344511|Cefazolin|cefazolin|mesh-list
56226460|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226461|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56226462|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56226463|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56226464|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226465|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226466|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56126674|NCT03589326|Dexamethasone|dexamethasone|mesh-list
56126675|NCT03589326|Prednisone|prednisone|mesh-list
56126676|NCT03589326|Methotrexate|methotrexate|mesh-list
56126677|NCT03589326|Vincristine|vincristine|mesh-list
56126678|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
56126679|NCT03589326|Ponatinib|ponatinib|mesh-list
56126680|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126681|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
56126690|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126691|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56126692|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
56126693|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56126694|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126695|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
56126696|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126697|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
56126698|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126699|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56126700|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56126701|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
56126702|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56126703|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56126704|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
55775741|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56126705|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126706|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56126707|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56126708|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56126709|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56126710|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56126711|NCT05701956|Tenecteplase|tenecteplase|mesh-list
56126712|NCT05701956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56126713|NCT05701956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56126714|NCT05701956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126715|NCT03156036|Capecitabine|capecitabine|mesh-list
56126716|NCT03156036|Temozolomide|temozolomide|mesh-list
56126717|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126718|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
56126719|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126720|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126721|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56126722|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
56126723|NCT03583866|Candesartan|candesartan|mesh-list
56126724|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56126725|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56126726|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56126727|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126736|NCT03585426|Vancomycin|vancomycin|mesh-list
55778205|NCT04512365|Analgesics|analgesics|mesh-ancestor
56126737|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56126738|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126739|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
56226467|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56226468|NCT04157881|Rabeprazole|rabeprazole|mesh-list
56226469|NCT04157881|Dabigatran|dabigatran|mesh-list
56226470|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
56226471|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56226472|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
56226473|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226474|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226475|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
56226476|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55779411|NCT05122169|Iodine|iodine|mesh-list
56226477|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226478|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56226479|NCT04151563|Docetaxel|docetaxel|mesh-list
56226480|NCT04151563|Nivolumab|nivolumab|mesh-list
56226481|NCT04151563|Ipilimumab|ipilimumab|mesh-list
56226482|NCT04151563|Ramucirumab|ramucirumab|mesh-list
56226483|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226484|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
56226485|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
56226486|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
56226487|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802279|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
56126740|NCT03585036|Tramadol|tramadol|mesh-list
56126741|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56126742|NCT03585036|Narcotics|narcotics|mesh-ancestor
56126743|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126744|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126745|NCT03585036|Analgesics|analgesics|mesh-ancestor
56126746|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
56126747|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126748|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56126749|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56126750|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126751|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56126752|NCT03309150|Paclitaxel|paclitaxel|mesh-list
56126753|NCT03309150|Carboplatin|carboplatin|mesh-list
56126754|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56126757|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
56126758|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
55820462|NCT02311478|Copper|copper|mesh-list
56126759|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126761|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
56126762|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
56126763|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126764|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126765|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
56126766|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126767|NCT03159702|Fludarabine|fludarabine|mesh-list
56126768|NCT03159702|Melphalan|melphalan|mesh-list
55823555|NCT04550104|Olaparib|olaparib|mesh-list
56126769|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126770|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126771|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56126772|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
56126773|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126774|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56126775|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
56226488|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56226489|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56226491|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56226492|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
56226493|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56226494|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226495|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56226496|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
56226497|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226498|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226499|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
56226500|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830123|NCT02130284|Insulin|insulin|mesh-list
56226501|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56226502|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56226503|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
56226504|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56226505|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56126776|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56126777|NCT03155646|Clonidine|clonidine|mesh-list
56126778|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
56126779|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
56126780|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56126781|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126782|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126783|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56126784|NCT03155646|Analgesics|analgesics|mesh-ancestor
56126785|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
56126786|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126787|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56126788|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56126789|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56126790|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
56126791|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126792|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847788|NCT02789878|Prednisone|prednisone|mesh-list
56126793|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56126794|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
56126795|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
56126796|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
56126797|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
56126798|NCT03584178|Budesonide|budesonide|mesh-list
56126799|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126800|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56126801|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
56126802|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126803|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126804|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55854303|NCT01458639|Xenon|xenon|mesh-list
56126805|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
56126806|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
56126807|NCT03584178|Hormones|hormones|mesh-ancestor
56126808|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56126809|NCT04405206|Capecitabine|capecitabine|mesh-list
56126810|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
56126811|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126812|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
55862632|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55862634|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55863213|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55785672|NCT05737693|Ketamine|ketamine|mesh-list
55785688|NCT05737693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56226507|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56226508|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226509|NCT04115059|Dasatinib|dasatinib|mesh-list
56226510|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226511|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56226512|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226513|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226514|NCT04114890|Tenofovir|tenofovir|mesh-list
56226515|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
56226516|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226517|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55802324|NCT04810585|Aflibercept|aflibercept|mesh-list
56126813|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126814|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126815|NCT03101046|Docetaxel|docetaxel|mesh-list
56126816|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55785892|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
55785898|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
55785995|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55785996|NCT02819479|Diuretics|diuretics|mesh-ancestor
56126817|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
56126818|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
56126819|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
56126820|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126821|NCT03159936|Tofacitinib|tofacitinib|mesh-list
56126822|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126823|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55786002|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786093|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55786094|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56126824|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126825|NCT03156816|Colchicine|colchicine|mesh-list
56126826|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
56126827|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56126830|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
56126831|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126832|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126833|NCT03583476|Amoxicillin|amoxicillin|mesh-list
56126834|NCT03583476|Metronidazole|metronidazole|mesh-list
56126835|NCT03583476|Clarithromycin|clarithromycin|mesh-list
56126836|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56126837|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56126838|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126839|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55789074|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55786121|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56126840|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56126841|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56126842|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126843|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126844|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56126845|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56126846|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56126847|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56126848|NCT03583242|Growth Substances|growth substances|mesh-ancestor
56126849|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126850|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56126851|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126852|NCT05701488|Durvalumab|durvalumab|mesh-list
56126853|NCT05701488|Tremelimumab|tremelimumab|mesh-list
56126854|NCT05701488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55786213|NCT01117441|Ifosfamide|ifosfamide|mesh-list
56126855|NCT05701488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126856|NCT02728050|Cytarabine|cytarabine|mesh-list
56126857|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56126858|NCT02728050|Sorafenib|sorafenib|mesh-list
56126859|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
56126860|NCT02728050|Cladribine|cladribine|mesh-list
56126861|NCT02728050|Lenograstim|lenograstim|mesh-list
56126862|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126863|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
56126864|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126865|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226518|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56226519|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226520|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226522|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56226523|NCT04096066|Dexamethasone|dexamethasone|mesh-list
56226524|NCT04096066|Lenalidomide|lenalidomide|mesh-list
56226525|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56126866|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
56126867|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126868|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56126869|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
56126870|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786352|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126871|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56126872|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56126873|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126874|NCT02728050|Analgesics|analgesics|mesh-ancestor
56126875|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
56126876|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126877|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56126878|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56126879|NCT05703126|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
56126880|NCT05703126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890128|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55786353|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55786476|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
55786481|NCT01618708|Hylan|hylan|mesh-list
56126881|NCT05703126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126882|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
56126883|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126884|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
56126885|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126886|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126887|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
56126888|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56126889|NCT03582306|Protective Agents|protective agents|mesh-ancestor
56126890|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126891|NCT03159234|Epinephrine|epinephrine|mesh-list
56126892|NCT03159234|Racepinephrine|racepinephrine|mesh-list
56126893|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
56126894|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56126895|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56126896|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
56126897|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795775|NCT04278755|Estradiol|estradiol|mesh-list
56126898|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126899|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126900|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56126901|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56126903|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126904|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56126905|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
56126906|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
56126907|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
56126908|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56126909|NCT05701332|Gemcitabine|gemcitabine|mesh-list
56126910|NCT05701332|BCG Vaccine|bcg vaccine|mesh-list
56126911|NCT05701332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56126912|NCT05701332|Antimetabolites|antimetabolites|mesh-ancestor
56126913|NCT05701332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126914|NCT05701332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126915|NCT05701332|Antiviral Agents|antiviral agents|mesh-ancestor
56126916|NCT05701332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786569|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55786574|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786586|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126917|NCT05701332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126918|NCT05701332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56126919|NCT05701332|Immunologic Factors|immunologic factors|mesh-ancestor
56126920|NCT05701332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126921|NCT05701332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56126922|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
56126923|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56226527|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
56226528|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226529|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226530|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226531|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
56226532|NCT04096066|Hormones|hormones|mesh-ancestor
56226533|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226534|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56226535|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226536|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
56126924|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126925|NCT05703048|Dexmedetomidine|dexmedetomidine|mesh-list
55795795|NCT04277975|Analgesics|analgesics|mesh-ancestor
56126926|NCT05703048|Esmolol|esmolol|mesh-list
56126927|NCT05703048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56126928|NCT05703048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126929|NCT05703048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126930|NCT05703048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56126931|NCT05703048|Analgesics|analgesics|mesh-ancestor
56126932|NCT05703048|Sensory System Agents|sensory system agents|mesh-ancestor
56126933|NCT05703048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126934|NCT05703048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56126935|NCT05703048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56126936|NCT05703048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56126937|NCT05703048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56126938|NCT05703048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126939|NCT05703048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126940|NCT05703048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56126941|NCT05703048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56126942|NCT05703048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56126943|NCT05702970|Vitamin D|vitamin d|mesh-list
56126944|NCT05702970|Vitamins|vitamins|mesh-ancestor
56126945|NCT05702970|Micronutrients|micronutrients|mesh-ancestor
56126946|NCT05702970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126947|NCT05702970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56126948|NCT03158142|Atropine|atropine|mesh-list
56126949|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56126950|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56126951|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56126952|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
55786817|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
55786818|NCT04432415|Protective Agents|protective agents|mesh-ancestor
55786821|NCT01402271|Carboplatin|carboplatin|mesh-list
55786825|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
55786831|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786832|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786846|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
55786994|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
55786995|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
56126953|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126954|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126955|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56126956|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
56126957|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
56126958|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
56126959|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56126960|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55787524|NCT05007769|Ramucirumab|ramucirumab|mesh-list
55787525|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787526|NCT04952051|Folic Acid|folic acid|mesh-list
55787599|NCT03059537|Cathartics|cathartics|mesh-ancestor
55787632|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55787654|NCT04285255|Lidocaine|lidocaine|mesh-list
55787699|NCT04121299|Protective Agents|protective agents|mesh-ancestor
56126961|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
56126962|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126963|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126964|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
56126965|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56126966|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126967|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56126968|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55787756|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
55787757|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
55787908|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787909|NCT04936295|Fulvestrant|fulvestrant|mesh-list
55787964|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864021|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55864022|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864024|NCT03839134|Epinephrine|epinephrine|mesh-list
55864132|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55864136|NCT01774903|Fentanyl|fentanyl|mesh-list
55864372|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
55864373|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55864531|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55864686|NCT01943435|Analgesics|analgesics|mesh-list
55864846|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55864985|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55864987|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
55864988|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864989|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864990|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865019|NCT00841204|Sulindac|sulindac|mesh-list
55865154|NCT04400890|Vitamin D|vitamin d|mesh-list
55865155|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
55865156|NCT04400890|Resveratrol|resveratrol|mesh-list
55865157|NCT04400890|Vitamins|vitamins|mesh-ancestor
55865158|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
55865159|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865172|NCT04351438|Heparin|heparin|mesh-list
55865274|NCT01857934|Melphalan|melphalan|mesh-list
55865275|NCT01857934|Busulfan|busulfan|mesh-list
55865276|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
55865460|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
56126969|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
56126970|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56126971|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
56126972|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56126973|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
56126974|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56126975|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226537|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56226538|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56226539|NCT04096066|Growth Substances|growth substances|mesh-ancestor
55802349|NCT04786795|Pancreatin|pancreatin|mesh-list
56126977|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56126978|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56126979|NCT01671384|Valproic Acid|valproic acid|mesh-list
56126980|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
56126981|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56126982|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56126983|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
56126984|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56126985|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126986|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
56126987|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56126988|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56126989|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56126990|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
56126991|NCT01671774|Interleukin-2|interleukin-2|mesh-list
56126992|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126993|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56126994|NCT01671774|Analgesics|analgesics|mesh-ancestor
56126995|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
56126996|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126997|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126998|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56126999|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
56127000|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127001|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56127002|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56127003|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
56127004|NCT01672086|Antacids|antacids|mesh-ancestor
56127005|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127006|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127007|NCT04472598|Navitoclax|navitoclax|mesh-list
56127008|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127009|NCT05153304|Nivolumab|nivolumab|mesh-list
56127010|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127011|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127012|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56127013|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127014|NCT05547750|Vitamin K|vitamin k|mesh-list
56127015|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
56127016|NCT05547750|Vitamins|vitamins|mesh-ancestor
56127017|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
56127018|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127019|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56127020|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56127021|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127022|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
56127023|NCT05547750|Coagulants|coagulants|mesh-ancestor
56127024|NCT04296006|Amphetamine|amphetamine|mesh-list
56127025|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
56127026|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56127027|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127029|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
56127030|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127031|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
56127032|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127033|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127034|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
56127035|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56127036|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56127037|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56127038|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56127039|NCT01672476|Valsartan|valsartan|mesh-list
56127040|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56127041|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56127345|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
55818247|NCT02461589|Incretins|incretins|mesh-ancestor
56127042|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56127043|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127044|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56226540|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
56226541|NCT04082676|Bupivacaine|bupivacaine|mesh-list
56226542|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
56226543|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
56226544|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226545|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226546|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
56226547|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226548|NCT04012177|Niacinamide|niacinamide|mesh-list
56226549|NCT04012177|Niacin|niacin|mesh-list
56127045|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
56127046|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56127047|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56127048|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56127049|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127051|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
56127052|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127053|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127054|NCT05033808|Epirubicin|epirubicin|mesh-list
56127055|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56127056|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141855|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141925|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56141926|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56142014|NCT05417100|Methadone|methadone|mesh-list
56127057|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56127058|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56127059|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127060|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127061|NCT04026984|Rifamycins|rifamycins|mesh-list
56127062|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
56127063|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56127064|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127065|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56127066|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56127067|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
56127068|NCT03989466|Antibodies|antibodies|mesh-list
56127069|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
55745731|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56127070|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56127071|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
56127072|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127073|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127074|NCT03805932|Rituximab|rituximab|mesh-list
56127075|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
56127076|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127077|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127078|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
55745757|NCT05067699|Vitamins|vitamins|mesh-ancestor
56144543|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
55745761|NCT05067153|Heparin|heparin|mesh-list
55745764|NCT05067153|Dalteparin|dalteparin|mesh-list
55795893|NCT05700695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55795897|NCT05555147|Ropivacaine|ropivacaine|mesh-list
55795899|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
55718411|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55718412|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55718413|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
55718414|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55718415|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718416|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55718417|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55718418|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55718419|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55718420|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718421|NCT02303899|Gemcitabine|gemcitabine|mesh-list
55718422|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
55718423|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55718424|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
55718425|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718426|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718427|NCT02303899|Antiviral Agents|antiviral agents|mesh-ancestor
55718428|NCT02303899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718429|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718430|NCT02303899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55718431|NCT02303899|Immunologic Factors|immunologic factors|mesh-ancestor
55718432|NCT02303899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718433|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55718434|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55718435|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55718436|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718438|NCT03510871|Ipilimumab|ipilimumab|mesh-list
55718439|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55718440|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718441|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55718442|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718443|NCT02331771|Donepezil|donepezil|mesh-list
55718444|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55718445|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718446|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718447|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
55718448|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718449|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718450|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
55718451|NCT02322814|Paclitaxel|paclitaxel|mesh-list
55718452|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55718453|NCT02322814|Atezolizumab|atezolizumab|mesh-list
55718454|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55718455|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718456|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
55718457|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
55718458|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
55718459|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718460|NCT02334501|Lansoprazole|lansoprazole|mesh-list
55718461|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
55718462|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55718463|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127079|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127080|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56127081|NCT04764396|Heparin|heparin|mesh-list
56127082|NCT04764396|Calcium heparin|calcium heparin|mesh-list
56127083|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
56127084|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56127085|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56127086|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127087|NCT04903314|Cenobamate|cenobamate|mesh-list
56127088|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
56127089|NCT03153072|Amiodarone|amiodarone|mesh-list
56127090|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56127091|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
56127092|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56127093|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55760573|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
56144544|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745779|NCT02474563|Prednisone|prednisone|mesh-list
56144545|NCT00796302|Risperidone|risperidone|mesh-list
55760593|NCT04847895|Ranibizumab|ranibizumab|mesh-list
55745790|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
56127094|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127095|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56127096|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56127097|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56127098|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127099|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56127100|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56226551|NCT04012177|Azithromycin|azithromycin|mesh-list
56226552|NCT04012177|Choline|choline|mesh-list
56226553|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56226554|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226555|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
56226556|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56226557|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
56226558|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226559|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226560|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56226561|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
56226562|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
56226563|NCT04012177|Vitamins|vitamins|mesh-ancestor
56144546|NCT00796302|Methylphenidate|methylphenidate|mesh-list
56144547|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56144548|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
55795933|NCT02521415|Narcotics|narcotics|mesh-ancestor
56226564|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
56226565|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226566|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
56226567|NCT04007289|Apixaban|apixaban|mesh-list
56226568|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56226569|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
56226570|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56226571|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
56226572|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226573|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226574|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
56226575|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
56127101|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56127103|NCT01673724|Bromocriptine|bromocriptine|mesh-list
56127104|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
56127105|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127106|NCT01673724|Protective Agents|protective agents|mesh-ancestor
56127107|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127108|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56127109|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56127110|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
56127111|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
56127112|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127113|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
56127114|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127115|NCT04765098|Tamoxifen|tamoxifen|mesh-list
56127116|NCT04765098|Etoposide|etoposide|mesh-list
56127117|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127118|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127119|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56127120|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56144549|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127121|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127122|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127123|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56127125|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127127|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56226577|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56226578|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56226579|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
56226580|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226581|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226582|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56226583|NCT04002518|Cimetidine|cimetidine|mesh-list
56226584|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56226585|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226586|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56226587|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
56226588|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
56226589|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226590|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745891|NCT02725411|Celecoxib|celecoxib|mesh-list
55718542|NCT03450343|Azacitidine|azacitidine|mesh-list
55718543|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55718544|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
55718545|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718546|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718549|NCT02321800|Cilastatin|cilastatin|mesh-list
55718550|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55718551|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718552|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
55718553|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718554|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718556|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
55718557|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55718558|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718559|NCT02338245|Capecitabine|capecitabine|mesh-list
55718560|NCT02338245|Lapatinib|lapatinib|mesh-list
55718561|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55718562|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
55718563|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718564|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718565|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55718566|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718567|NCT02332005|Choline|choline|mesh-list
55718568|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
55718569|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55718570|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
55718571|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718572|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718573|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55718574|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
55718575|NCT02304211|Insulin|insulin|mesh-list
55718576|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55718577|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718578|NCT02311777|Pregabalin|pregabalin|mesh-list
55718579|NCT02311777|Ketamine|ketamine|mesh-list
55718580|NCT02311777|Analgesics|analgesics|mesh-ancestor
55718581|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
55718582|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718583|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718584|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55718585|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55718586|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
55718587|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
55718588|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718589|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55718590|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55718591|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718592|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718593|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
55718594|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55718595|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55745921|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
55745924|NCT03099213|Ramipril|ramipril|mesh-list
56226591|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802387|NCT04023019|Thrombin|thrombin|mesh-list
56127128|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56127129|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56127130|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56127132|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
56127133|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127134|NCT03032328|Vitamin D|vitamin d|mesh-list
56127135|NCT03032328|Vitamins|vitamins|mesh-ancestor
56127136|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
56127137|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127138|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56127139|NCT04747392|Teriparatide|teriparatide|mesh-list
56127140|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56127141|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127142|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56127143|NCT01674192|Prucalopride|prucalopride|mesh-list
56127144|NCT01674192|Laxatives|laxatives|mesh-ancestor
56127145|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127146|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56127147|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56127148|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
55745939|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
55795972|NCT01752491|Protective Agents|protective agents|mesh-ancestor
56127149|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127150|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127151|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127152|NCT01674270|Bicalutamide|bicalutamide|mesh-list
56127153|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
56127154|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
56127155|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745950|NCT02127970|Teicoplanin|teicoplanin|mesh-list
56144568|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127156|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127157|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127158|NCT01674504|Montelukast|montelukast|mesh-list
56127159|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56127160|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
56127161|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56127162|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
56127163|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127164|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226592|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56226593|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56127165|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55746304|NCT02038777|Cytarabine|cytarabine|mesh-list
56127166|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56127167|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127169|NCT05353062|Hemostatics|hemostatics|mesh-list
56127170|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56127171|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56127172|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
56127173|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127174|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871456|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55871461|NCT00812032|Aspirin|aspirin|mesh-list
55827588|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
56127175|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127176|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56127177|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56127178|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
56127179|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127180|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56127181|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
56127182|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
56127183|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
56127184|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55747942|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
56127185|NCT05353062|Coagulants|coagulants|mesh-ancestor
56127186|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
56127187|NCT04675710|Trametinib|trametinib|mesh-list
56127188|NCT04675710|Dabrafenib|dabrafenib|mesh-list
56127189|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127190|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127191|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56127192|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127193|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127194|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56127196|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56127197|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127198|NCT03152370|Leucovorin|leucovorin|mesh-list
56127199|NCT03152370|Folic Acid|folic acid|mesh-list
56127200|NCT03152370|Capecitabine|capecitabine|mesh-list
56127201|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
56127202|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
56127203|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56127204|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
56127205|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127206|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127207|NCT03152370|Antidotes|antidotes|mesh-ancestor
56127208|NCT03152370|Protective Agents|protective agents|mesh-ancestor
56127209|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127210|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
56127211|NCT03152370|Vitamins|vitamins|mesh-ancestor
56127212|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
56127213|NCT03152370|Hematinics|hematinics|mesh-ancestor
56127214|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
55788643|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
56127215|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56127216|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56127217|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127218|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
56127219|NCT02187120|Coagulants|coagulants|mesh-ancestor
56127220|NCT01674738|Bevacizumab|bevacizumab|mesh-list
56127221|NCT01674738|Pemetrexed|pemetrexed|mesh-list
56127222|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127223|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127224|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56127225|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56127226|NCT01674738|Growth Substances|growth substances|mesh-ancestor
55718668|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
55718669|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718670|NCT03505411|Protective Agents|protective agents|mesh-ancestor
55718671|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718672|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718673|NCT02292238|Benphothiamine|benphothiamine|mesh-list
55718674|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55718675|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
55718676|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718677|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
55718678|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
55718679|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718680|NCT02631447|Nivolumab|nivolumab|mesh-list
55718681|NCT02631447|Ipilimumab|ipilimumab|mesh-list
55718682|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55718683|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718684|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55718685|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718686|NCT03867123|Temozolomide|temozolomide|mesh-list
55718687|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55718688|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
55718689|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718691|NCT03504475|Paroxetine|paroxetine|mesh-list
55765745|NCT02139046|Naproxen|naproxen|mesh-list
55718692|NCT03504475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55718693|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55718694|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55718695|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718696|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718697|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
55718698|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718699|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55718700|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
55718701|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55827297|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718702|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55718703|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55718704|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718706|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55718707|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55718708|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55718709|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55718710|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718711|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55718712|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718713|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
55718714|NCT03505255|Neostigmine|neostigmine|mesh-list
55718715|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55718716|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718717|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718718|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
55718719|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718720|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718721|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55718722|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
55718723|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718725|NCT02333799|Bedaquiline|bedaquiline|mesh-list
55718726|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55718727|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718728|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55718729|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719016|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127227|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127228|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
56127229|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127230|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127231|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56127232|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56127233|NCT01675206|Vitamin K|vitamin k|mesh-list
56127234|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
56127235|NCT01675206|Vitamins|vitamins|mesh-ancestor
55871492|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
55871493|NCT00417664|Propofol|propofol|mesh-list
56127236|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
56226594|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226595|NCT03993249|Nivolumab|nivolumab|mesh-list
56226596|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56226597|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226598|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56226599|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226600|NCT03990883|Lidocaine|lidocaine|mesh-list
56226601|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
56226602|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
56226603|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226604|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226605|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
56226606|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226607|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56226608|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56226609|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55818300|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
56226610|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56226611|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226612|NCT03984890|Vitamin D|vitamin d|mesh-list
55871547|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
55871548|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871621|NCT05623995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55871622|NCT05623995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55871623|NCT05623995|Antimetabolites|antimetabolites|mesh-ancestor
55871694|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55871708|NCT01025830|Lamivudine|lamivudine|mesh-list
55871767|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
55871768|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55871769|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871770|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55871771|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871772|NCT03322995|Fluorouracil|fluorouracil|mesh-list
56226613|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
56226614|NCT03984890|Vitamins|vitamins|mesh-ancestor
56226615|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
56226616|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127237|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127238|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56127239|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56127240|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127241|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
56127242|NCT01675206|Coagulants|coagulants|mesh-ancestor
56127243|NCT03150576|Paclitaxel|paclitaxel|mesh-list
56127244|NCT03150576|Carboplatin|carboplatin|mesh-list
56127245|NCT03150576|Olaparib|olaparib|mesh-list
56127246|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127247|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127248|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
56127249|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
56127250|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56127251|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127252|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56127253|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127254|NCT01059786|Rituximab|rituximab|mesh-list
56127255|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56127256|NCT01059786|Pentostatin|pentostatin|mesh-list
56127257|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127258|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127259|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
56127260|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127261|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56127262|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56127263|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
56226617|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56226618|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56226619|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
56226620|NCT03926091|Docetaxel|docetaxel|mesh-list
56226621|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56226622|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
56226623|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226624|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56226625|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56226626|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
56226627|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226628|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226629|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56226630|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
56226631|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
56226632|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
56226633|NCT03924427|BMS-986165|bms-986165|mesh-list
56226634|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
55802429|NCT05611879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127264|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127265|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56127266|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127267|NCT04747080|Dexamethasone|dexamethasone|mesh-list
56127268|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
56127269|NCT04747080|BB 1101|bb 1101|mesh-list
56127270|NCT04747080|Tacrolimus|tacrolimus|mesh-list
56127272|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
56127273|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
56127274|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127275|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874030|NCT04224766|Bupivacaine|bupivacaine|mesh-list
56127276|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127277|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
56127278|NCT04747080|Hormones|hormones|mesh-ancestor
56127279|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127280|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56127281|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127282|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
56127283|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127284|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127285|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56127286|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
56127287|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56127288|NCT01675362|Selenium|selenium|mesh-list
56127289|NCT01675362|Losartan|losartan|mesh-list
56127290|NCT01675362|Verapamil|verapamil|mesh-list
56127291|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
56127292|NCT01675362|Calcium|calcium|mesh-list
56127293|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56127294|NCT01675362|Antioxidants|antioxidants|mesh-list
56127295|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56127296|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127297|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56127298|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56127299|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55880955|NCT03383406|Cytarabine|cytarabine|mesh-list
56127300|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226635|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56226636|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226637|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226639|NCT03922451|Tazobactam|tazobactam|mesh-list
56226640|NCT03922451|Piperacillin|piperacillin|mesh-list
56226641|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56127301|NCT01675362|Protective Agents|protective agents|mesh-ancestor
56127302|NCT01675362|Trace Elements|trace elements|mesh-ancestor
56127303|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
56127304|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56127305|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
56127306|NCT01675518|ASP7991|asp7991|mesh-list
55882400|NCT04119180|Midazolam|midazolam|mesh-list
56127307|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56127308|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
56127309|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127310|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127311|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
56127312|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
56127313|NCT04657692|Anesthetics|anesthetics|mesh-list
56127314|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127315|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127316|NCT03879798|Irinotecan|irinotecan|mesh-list
56127317|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56127318|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56127319|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127320|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127321|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127322|NCT03878316|Oxytocin|oxytocin|mesh-list
56127323|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
56127324|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56127325|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127326|NCT01675986|Pregabalin|pregabalin|mesh-list
56127327|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
56127328|NCT01675986|Analgesics|analgesics|mesh-ancestor
56127329|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
56127330|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127331|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127332|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
56127333|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56127334|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56127335|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127336|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56127337|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56127338|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56127339|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127340|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56127341|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
56127342|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
56127343|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56127344|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
56127346|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127347|NCT03875664|Bupivacaine|bupivacaine|mesh-list
56127348|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
56127349|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
56127350|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127351|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127352|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
56127353|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127354|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
56127355|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
56127356|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56127358|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127359|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127360|NCT01670136|Urological Agents|urological agents|mesh-ancestor
56127361|NCT03861390|Prednisone|prednisone|mesh-list
56127362|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127363|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
56127364|NCT03861390|Hormones|hormones|mesh-ancestor
56226642|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56226643|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226644|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56226645|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885297|NCT03329898|Estradiol|estradiol|mesh-list
56226646|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226647|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56127365|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127366|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127367|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56127368|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127369|NCT03873480|Epinephrine|epinephrine|mesh-list
56127370|NCT03873480|Bupivacaine|bupivacaine|mesh-list
56127371|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56127372|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56127373|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
56127374|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127375|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127376|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127377|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56127378|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56127379|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
56127380|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127381|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56127382|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
56127383|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
56127384|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
56127385|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56127386|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
56127387|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
56127388|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127389|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
56127390|NCT04764084|Niraparib|niraparib|mesh-list
56127391|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56127392|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127393|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127394|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127396|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56127397|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
56127398|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56127399|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127400|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56127401|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127402|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
56127403|NCT03866538|Budesonide|budesonide|mesh-list
56127404|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127405|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56127406|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
56127407|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127408|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127409|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56127410|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
55887224|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
56127411|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
56127412|NCT03866538|Hormones|hormones|mesh-ancestor
56127413|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127414|NCT03865992|Curcumin|curcumin|mesh-list
56127415|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56127416|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56127417|NCT03865992|Analgesics|analgesics|mesh-ancestor
56127418|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
56127419|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127421|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127422|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56127423|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127424|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127425|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226648|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
56226649|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226650|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56226651|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56226652|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56226653|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
56226654|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226655|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56226656|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56226657|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226658|NCT03870880|Risperidone|risperidone|mesh-list
56127426|NCT03865212|Interferons|interferons|mesh-list
56127427|NCT03865212|Interferon-beta|interferon-beta|mesh-list
56127428|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127429|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
56127430|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127431|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
56127432|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127433|NCT01677390|Everolimus|everolimus|mesh-list
56127434|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127435|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56127436|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
56127437|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127438|NCT03749460|Nivolumab|nivolumab|mesh-list
56127439|NCT03749460|Ipilimumab|ipilimumab|mesh-list
56127440|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127441|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127442|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56127443|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127444|NCT03749070|Silymarin|silymarin|mesh-list
56127445|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
56127446|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127447|NCT03749070|Protective Agents|protective agents|mesh-ancestor
56127448|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127449|NCT03748134|Paclitaxel|paclitaxel|mesh-list
56127450|NCT03748134|Fluorouracil|fluorouracil|mesh-list
56127451|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127452|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127453|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
56127454|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
56127455|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
55892525|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56127456|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127457|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
56127458|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56127459|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56127460|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
56127461|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127462|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
56127463|NCT03747432|Propofol|propofol|mesh-list
56127464|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56127465|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127466|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127467|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56127468|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
56127469|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
56127470|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56127471|NCT03747432|Analgesics|analgesics|mesh-ancestor
56127472|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
56127473|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892966|NCT00003270|Hormones|hormones|mesh-ancestor
56127474|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56127475|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56127476|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56127477|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
56127478|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226659|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56226661|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127479|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127481|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
56127482|NCT03747120|Trastuzumab|trastuzumab|mesh-list
56127483|NCT03747120|Pertuzumab|pertuzumab|mesh-list
56127484|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127485|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127486|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
56127487|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
56127488|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
56127489|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127490|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127491|NCT01345656|Spironolactone|spironolactone|mesh-list
56127492|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56127493|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
55896850|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56127495|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127496|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56127498|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
56127499|NCT04763616|Cemiplimab|cemiplimab|mesh-list
56127500|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127501|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127502|NCT03652974|Valproic Acid|valproic acid|mesh-list
56127503|NCT03652974|Clozapine|clozapine|mesh-list
56127504|NCT03652974|Amisulpride|amisulpride|mesh-list
56127505|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
56127506|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127507|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127508|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
56127509|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127510|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127511|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
56127512|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56127513|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127514|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56127515|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56127516|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
56127517|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56127518|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
56127519|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56127520|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
56127521|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56127522|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
56127523|NCT03649152|Proxigermanium|proxigermanium|mesh-list
56127524|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127525|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
56127526|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
56127527|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127528|NCT03646188|Doxorubicin|doxorubicin|mesh-list
55901344|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901345|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55901346|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55901347|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901349|NCT01696955|Cetuximab|cetuximab|mesh-list
55901414|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901416|NCT02458690|Dopamine|dopamine|mesh-list
55901489|NCT02974426|Pemetrexed|pemetrexed|mesh-list
55901490|NCT02974426|Vinorelbine|vinorelbine|mesh-list
55901491|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901492|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755573|NCT02462915|Lidocaine|lidocaine|mesh-list
56127529|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56127530|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56127531|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127532|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56127533|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56127534|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127535|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127536|NCT03727776|Hormones|hormones|mesh-list
56127537|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56127538|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56127539|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
56127540|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127541|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127542|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127543|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127544|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
56127545|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56127546|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
56127547|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56127548|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226662|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226663|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127549|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56127550|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55788762|NCT02124187|Nicotine|nicotine|mesh-list
56127551|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56127552|NCT02082678|Ondansetron|ondansetron|mesh-list
56127553|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
56127554|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
56127555|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127556|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127557|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127558|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
56127559|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
56127560|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56127561|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
56127562|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127563|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127564|NCT02082678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56127565|NCT02082678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56127568|NCT02082678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56127569|NCT03843528|Azacitidine|azacitidine|mesh-list
56127570|NCT03843528|Vorinostat|vorinostat|mesh-list
56127571|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56127572|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
56127573|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127574|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127575|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127576|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56127577|NCT03843294|Nivolumab|nivolumab|mesh-list
56127578|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127579|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127580|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56127581|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127582|NCT03834948|Paclitaxel|paclitaxel|mesh-list
56127583|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
56127584|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127585|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127586|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
56127587|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
56127588|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
56127589|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127590|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127591|NCT01677468|Doxorubicin|doxorubicin|mesh-list
56127592|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56127593|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55842988|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
55718881|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
55718882|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
55718883|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
55718884|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55718885|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55718887|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
55718888|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55718889|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55718890|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718891|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718892|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55718893|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55718894|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55718895|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
55718896|NCT02305069|Pioglitazone|pioglitazone|mesh-list
55718897|NCT02305069|Octreotide|octreotide|mesh-list
55718898|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55718899|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718900|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718901|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55718902|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718903|NCT02330991|Temozolomide|temozolomide|mesh-list
55718904|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55718905|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
55718906|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718907|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718908|NCT02317237|Anesthetics|anesthetics|mesh-list
55718909|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718910|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718911|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55718912|NCT02332473|Molgramostim|molgramostim|mesh-list
55718913|NCT02332473|Sargramostim|sargramostim|mesh-list
55718914|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
55718915|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718916|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
55718917|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718918|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718921|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
55718922|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
55718923|NCT03501433|Vitamins|vitamins|mesh-ancestor
55718924|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
55718925|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718926|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55718927|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
55718928|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718929|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55718930|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
55718931|NCT02383251|Paclitaxel|paclitaxel|mesh-list
55718932|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55827390|NCT04615949|Cannabidiol|cannabidiol|mesh-list
55718933|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718934|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
55718935|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
55718936|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
55718937|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718938|NCT02313103|Lofexidine|lofexidine|mesh-list
55718939|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55718940|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55718941|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718942|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
55718943|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718944|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55718945|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56127594|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56127595|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127596|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56127597|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56127598|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127599|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127600|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
56127601|NCT01677468|Coagulants|coagulants|mesh-ancestor
56127602|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
56127603|NCT00003816|Melphalan|melphalan|mesh-list
56127604|NCT00003816|Busulfan|busulfan|mesh-list
56127605|NCT00003816|Thiotepa|thiotepa|mesh-list
56127606|NCT00003816|Carboplatin|carboplatin|mesh-list
56127607|NCT00003816|Fludarabine|fludarabine|mesh-list
56127608|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
56127610|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56127611|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56127612|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
56127613|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127614|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56127615|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56127616|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
56127617|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127618|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127619|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56127620|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56127621|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
56226664|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56226665|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56226666|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226667|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56226668|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56226669|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
56226670|NCT03861377|Remifentanil|remifentanil|mesh-list
56226671|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56226672|NCT03861377|Narcotics|narcotics|mesh-ancestor
56226673|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226674|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226675|NCT03861377|Analgesics|analgesics|mesh-ancestor
56226676|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
55757811|NCT04950933|Riluzole|riluzole|mesh-list
55796303|NCT02629861|Calcitonin|calcitonin|mesh-list
56226677|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127622|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127623|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56127624|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56127625|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127626|NCT03618654|Metformin|metformin|mesh-list
56127627|NCT03618654|Durvalumab|durvalumab|mesh-list
56127628|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
56127629|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56127630|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
56127631|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56127632|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127633|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127634|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127635|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
56127636|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
56127637|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
56127638|NCT03712878|Tacrolimus|tacrolimus|mesh-list
56127639|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55796318|NCT05545475|Enoxaparin|enoxaparin|mesh-list
55758329|NCT03238625|Lidocaine|lidocaine|mesh-list
55758681|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127640|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
56127641|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127643|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56127644|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
56127645|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127646|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127647|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56127648|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56127649|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744377|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55744379|NCT03332719|Etanercept|etanercept|mesh-list
56127650|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56127651|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56127652|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
56127653|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56127654|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127656|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56127657|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127658|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56127659|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56127660|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796347|NCT01665911|Listerine|listerine|mesh-list
56127661|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127662|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127663|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56127664|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56127665|NCT03611556|Leucovorin|leucovorin|mesh-list
56127666|NCT03611556|Gemcitabine|gemcitabine|mesh-list
56127667|NCT03611556|Paclitaxel|paclitaxel|mesh-list
56127668|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
56127669|NCT03611556|Fluorouracil|fluorouracil|mesh-list
56127670|NCT03611556|Durvalumab|durvalumab|mesh-list
56127671|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
56226678|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56226679|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56226680|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226681|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
56226682|NCT03836144|Diuretics|diuretics|mesh-ancestor
56226683|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
56226684|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226685|NCT03836144|Expectorants|expectorants|mesh-ancestor
56226686|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
56127672|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127673|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127674|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
55788789|NCT04930133|Afatinib|afatinib|mesh-list
56127675|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
55759641|NCT04875819|Vaccines|vaccines|mesh-list
56127676|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56127677|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127678|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56127679|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
56127680|NCT03611556|Antiviral Agents|antiviral agents|mesh-ancestor
56127681|NCT03611556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127682|NCT03611556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127683|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56127684|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
56127685|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127686|NCT03611556|Antidotes|antidotes|mesh-ancestor
56127687|NCT03611556|Protective Agents|protective agents|mesh-ancestor
56127688|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
56127689|NCT03611556|Vitamins|vitamins|mesh-ancestor
56127690|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
56127691|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127692|NCT03609060|Dexamethasone|dexamethasone|mesh-list
56127693|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127694|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
56127695|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
56127696|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127697|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127698|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127699|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
56127700|NCT03609060|Hormones|hormones|mesh-ancestor
56127701|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744386|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
56127702|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56127703|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127704|NCT04762992|Enoxaparin|enoxaparin|mesh-list
56127705|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
56127706|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56127707|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56127708|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127710|NCT03704766|Defensins|defensins|mesh-list
56127711|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127712|NCT03826992|Cytarabine|cytarabine|mesh-list
55760363|NCT03043443|Melatonin|melatonin|mesh-list
56127713|NCT03826992|Daunorubicin|daunorubicin|mesh-list
56127714|NCT03826992|Venetoclax|venetoclax|mesh-list
56127715|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56127716|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
56127717|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127720|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127721|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56127722|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
56127723|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127724|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56127725|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56127726|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56127727|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127728|NCT00004092|Paclitaxel|paclitaxel|mesh-list
56127729|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
56127730|NCT00004092|Carboplatin|carboplatin|mesh-list
56127731|NCT00004092|Doxorubicin|doxorubicin|mesh-list
56127732|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56226687|NCT03825536|Methamphetamine|methamphetamine|mesh-list
56226688|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56226689|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796365|NCT03063073|Analgesics|analgesics|mesh-ancestor
56226690|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
56226691|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
56226692|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226693|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
56226694|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226695|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226696|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
55718946|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55718947|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
55718948|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718949|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718951|NCT01959633|Vemurafenib|vemurafenib|mesh-list
55718952|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718953|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
55718954|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718955|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55718956|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718957|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718958|NCT02326623|Anesthetics|anesthetics|mesh-list
55718959|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
55718960|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718961|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718962|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
55718963|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718965|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718966|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
55718967|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55718968|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55718969|NCT02332629|Prednisolone|prednisolone|mesh-list
55718970|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
55718971|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55718972|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
55718973|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718974|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
55718975|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
55718976|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718977|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718978|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718979|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
55718980|NCT02332629|Hormones|hormones|mesh-ancestor
55718981|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55718982|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55718983|NCT02332629|Protective Agents|protective agents|mesh-ancestor
55718984|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55718985|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718987|NCT02313337|Midazolam|midazolam|mesh-list
55718989|NCT02313337|Propofol|propofol|mesh-list
55718990|NCT02313337|Atracurium|atracurium|mesh-list
55718991|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718992|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718993|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55718994|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55718995|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
55718996|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55718997|NCT02313337|Narcotics|narcotics|mesh-ancestor
55718998|NCT02313337|Analgesics|analgesics|mesh-ancestor
55718999|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
55719000|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719001|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55719002|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55719003|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55719004|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55719005|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
55719006|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
55719007|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719008|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719009|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55719010|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55719011|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55719012|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55719013|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55719014|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
55719015|NCT01767675|Carboplatin|carboplatin|mesh-list
56226697|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56226698|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56226699|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55802494|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127733|NCT00004092|Thiotepa|thiotepa|mesh-list
56127734|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127735|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127736|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
56127737|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
56127738|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
56127739|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127740|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56127741|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
56127742|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127743|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56127744|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56127745|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
56127746|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56127747|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56127748|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56127749|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56127750|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127751|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
56127752|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127753|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56127754|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56127755|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127756|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56127757|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127758|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56127759|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56127760|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56127761|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56127762|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127763|NCT03825198|Dexamethasone|dexamethasone|mesh-list
56127764|NCT03825198|Ketorolac|ketorolac|mesh-list
56127765|NCT03825198|Sufentanil|sufentanil|mesh-list
56127766|NCT03825198|Morphine|morphine|mesh-list
56127767|NCT03825198|Bromides|bromides|mesh-list
56127768|NCT03825198|Propofol|propofol|mesh-list
56127769|NCT03825198|Sevoflurane|sevoflurane|mesh-list
56127770|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
56127771|NCT03825198|Rocuronium|rocuronium|mesh-list
56127772|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127773|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
56127774|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
56127775|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127776|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127777|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127778|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
56226705|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56226706|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
56226707|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56226708|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226709|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56226710|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226711|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
56226712|NCT03785106|Vitamins|vitamins|mesh-list
56226713|NCT03785106|Pyridoxine|pyridoxine|mesh-list
56226714|NCT03785106|Pyridoxal|pyridoxal|mesh-list
56226715|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
56226716|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
56226717|NCT03785106|Isoniazid|isoniazid|mesh-list
56226718|NCT03785106|Rifapentine|rifapentine|mesh-list
56226719|NCT03785106|Rifampin|rifampin|mesh-list
56226720|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
56226721|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226722|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
56226723|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56127780|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127781|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56127782|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127783|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56127784|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127785|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56127786|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
56127787|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
56127788|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56127789|NCT03825198|Narcotics|narcotics|mesh-ancestor
56127790|NCT03825198|Analgesics|analgesics|mesh-ancestor
56127791|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
56127792|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56127795|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56127796|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56127797|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56127798|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127799|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127800|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
56127801|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56127802|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56127803|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56127804|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56127805|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
56127807|NCT03824106|Vitamins|vitamins|mesh-ancestor
56127808|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
55760697|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
55798055|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798146|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798147|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798148|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56127809|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127810|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56127811|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
56127812|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
56127813|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127814|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226725|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56226726|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56226727|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
56226728|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226729|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56226730|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56226731|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
56226732|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56226733|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226734|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56226735|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55802526|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
56127815|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56127816|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127817|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127818|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
56127819|NCT03820986|Lenvatinib|lenvatinib|mesh-list
56127820|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127821|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127822|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56127823|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127824|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127825|NCT03817320|Leucovorin|leucovorin|mesh-list
56127826|NCT03817320|Cytarabine|cytarabine|mesh-list
56127827|NCT03817320|Dexamethasone|dexamethasone|mesh-list
55798740|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55798741|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55798742|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798743|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798744|NCT04893733|Folic Acid|folic acid|mesh-list
56127828|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
56127829|NCT03817320|Doxorubicin|doxorubicin|mesh-list
56127830|NCT03817320|Methotrexate|methotrexate|mesh-list
56127831|NCT03817320|Vincristine|vincristine|mesh-list
56127832|NCT03817320|Asparaginase|asparaginase|mesh-list
56127833|NCT03817320|Ixazomib|ixazomib|mesh-list
56127834|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127835|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
56127836|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
56127837|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127838|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127839|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127840|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
56127841|NCT03817320|Hormones|hormones|mesh-ancestor
55799228|NCT02420223|Propranolol|propranolol|mesh-list
56127842|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127843|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56127844|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127845|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56127846|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56127847|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56127848|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127849|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127850|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56127851|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
56127852|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55799667|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56127853|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56127854|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
56127855|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
56127856|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56127857|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56127858|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
56127859|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56127860|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56127861|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
55800590|NCT02570711|Gemcitabine|gemcitabine|mesh-list
56127862|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127863|NCT03817320|Antidotes|antidotes|mesh-ancestor
56226736|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56226737|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56226738|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56226739|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56226740|NCT03782142|Tenofovir|tenofovir|mesh-list
56226741|NCT03782142|Dolutegravir|dolutegravir|mesh-list
55800649|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
56226742|NCT03782142|Rilpivirine|rilpivirine|mesh-list
56127864|NCT03817320|Protective Agents|protective agents|mesh-ancestor
56127865|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
56127866|NCT03817320|Vitamins|vitamins|mesh-ancestor
56127867|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
56127870|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
56127871|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
56127872|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
56127873|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56127874|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
56127875|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127876|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56127877|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56127878|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127879|NCT03583086|Nivolumab|nivolumab|mesh-list
56127880|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56127881|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800993|NCT04866355|Scopolamine|scopolamine|mesh-list
56127882|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56127883|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127884|NCT03580356|Omalizumab|omalizumab|mesh-list
56127885|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56127886|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55788809|NCT04165993|Docetaxel|docetaxel|mesh-list
56127887|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
56127888|NCT03575052|Pimavanserin|pimavanserin|mesh-list
56127889|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56127890|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56127891|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56127892|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56127893|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127894|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127895|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56127896|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56127897|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56127898|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
56127899|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127900|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127901|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
56127902|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
56127903|NCT01473108|Eplerenone|eplerenone|mesh-list
56127904|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56127905|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
56127906|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127907|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127908|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56127909|NCT01473108|Diuretics|diuretics|mesh-ancestor
56127910|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
56127911|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56127912|NCT01677546|Insulin|insulin|mesh-list
56127913|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56127914|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56127915|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127916|NCT04403724|Fentanyl|fentanyl|mesh-list
55801196|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
55801197|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56127917|NCT04403724|Morphine|morphine|mesh-list
56127918|NCT04403724|Bupivacaine|bupivacaine|mesh-list
56127919|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
56127920|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
56127921|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810293|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
56127922|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127923|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
56127924|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127925|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56127926|NCT04403724|Narcotics|narcotics|mesh-ancestor
56226743|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56226744|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
56226745|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226746|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56226747|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55801325|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
56226748|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226749|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226750|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56226751|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56226752|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56226753|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56127928|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56127929|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56127930|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
56127931|NCT03567876|Venetoclax|venetoclax|mesh-list
56127932|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127933|NCT04403568|Ursolic acid|ursolic acid|mesh-list
56127934|NCT04403568|Curcumin|curcumin|mesh-list
56127935|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56127936|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56127937|NCT04403568|Analgesics|analgesics|mesh-ancestor
56127938|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
55818393|NCT02087943|Thalidomide|thalidomide|mesh-list
56127939|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127940|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127941|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127943|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127944|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127945|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127946|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810872|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55810873|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56127947|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127948|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56127949|NCT03550794|Thiamine|thiamine|mesh-list
56127950|NCT03550794|Vitamins|vitamins|mesh-ancestor
56127951|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
56127952|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127953|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
56127954|NCT03798678|Dexamethasone|dexamethasone|mesh-list
56127955|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
56127956|NCT03798678|Ichthammol|ichthammol|mesh-list
56127957|NCT03798678|BB 1101|bb 1101|mesh-list
56127958|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127959|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
56127960|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
55811213|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56127961|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56127962|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127963|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127964|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
56127965|NCT03798678|Hormones|hormones|mesh-ancestor
56127966|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127967|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811295|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811296|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811297|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811298|NCT05180097|Gemcitabine|gemcitabine|mesh-list
55811299|NCT05180097|Dexamethasone|dexamethasone|mesh-list
55811300|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
55811301|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55811302|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811303|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
55811304|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
55811305|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811306|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811307|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811309|NCT05180097|Hormones|hormones|mesh-ancestor
56127968|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127969|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
56127970|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127971|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127972|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
56127973|NCT04762134|Doxycycline|doxycycline|mesh-list
56127974|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56127975|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127976|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
55811378|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56127977|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56127978|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56127979|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
56127980|NCT03564756|Vitamins|vitamins|mesh-ancestor
56127981|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
56226754|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
56226755|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56226756|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56226757|NCT03770299|Gemcitabine|gemcitabine|mesh-list
56226758|NCT03770299|Paclitaxel|paclitaxel|mesh-list
56226759|NCT03770299|Vinorelbine|vinorelbine|mesh-list
56226760|NCT03770299|Docetaxel|docetaxel|mesh-list
56226761|NCT03770299|Carboplatin|carboplatin|mesh-list
56226762|NCT03770299|Nivolumab|nivolumab|mesh-list
56226763|NCT03770299|Pemetrexed|pemetrexed|mesh-list
56127982|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127983|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
56127984|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127985|NCT03564756|Protective Agents|protective agents|mesh-ancestor
56127986|NCT03462966|Rifaximin|rifaximin|mesh-list
56127987|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56127988|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56127989|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127990|NCT03531762|Tepotinib|tepotinib|mesh-list
56127991|NCT03531762|Omeprazole|omeprazole|mesh-list
56127993|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56127994|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56127995|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56127996|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56127997|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127998|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
56127999|NCT03458598|Narcotics|narcotics|mesh-ancestor
56128000|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811519|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55811520|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811521|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811522|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
55811523|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811524|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55811525|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55811526|NCT04191447|Budesonide|budesonide|mesh-list
55811527|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
55811528|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55811529|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811530|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55811531|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
55811532|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811533|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811534|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55811535|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
55811536|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
55811537|NCT04191447|Hormones|hormones|mesh-ancestor
55811546|NCT04274361|Analgesics|analgesics|mesh-ancestor
56128001|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128002|NCT03458598|Analgesics|analgesics|mesh-ancestor
56128003|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
56128004|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128005|NCT03791736|Octreotide|octreotide|mesh-list
56128006|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56128007|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56128008|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128009|NCT03528408|Nivolumab|nivolumab|mesh-list
56128010|NCT03528408|Ipilimumab|ipilimumab|mesh-list
55854973|NCT00455962|Estradiol|estradiol|mesh-list
56128011|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811548|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811549|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811550|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55811551|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55811552|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
55811553|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
55811554|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811555|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55811556|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55811557|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811558|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811559|NCT04251819|Baclofen|baclofen|mesh-list
55811560|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55811561|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811562|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55811563|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811564|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55811565|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
55811566|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
55811567|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811568|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811569|NCT03462459|Vancomycin|vancomycin|mesh-list
55811570|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55811571|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811572|NCT02243631|Probenecid|probenecid|mesh-list
55811573|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
55811574|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
55811575|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55811577|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
55796551|NCT05697809|Hormones|hormones|mesh-ancestor
56128012|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128013|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56128014|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128015|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56128016|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128018|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
56128020|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56128021|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
56128022|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128023|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56128024|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56128025|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128026|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128027|NCT03524898|Gemcitabine|gemcitabine|mesh-list
55811578|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55811579|NCT03401073|Antibodies|antibodies|mesh-list
55811580|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
55811581|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55811582|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
55801425|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55801426|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
55811584|NCT02242305|Scopolamine|scopolamine|mesh-list
55811585|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55811586|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55811587|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
55811588|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
55811618|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811619|NCT03856515|Nicotine|nicotine|mesh-list
55811620|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55801439|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55801440|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55801441|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
55801442|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55811621|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
55811622|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811623|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811624|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55811625|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55811626|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
55811627|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811628|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811629|NCT02238483|AZD7624|azd7624|mesh-list
55811630|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55811631|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811632|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811633|NCT01632891|Ritonavir|ritonavir|mesh-list
56128028|NCT03524898|Paclitaxel|paclitaxel|mesh-list
56128029|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56128030|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128031|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
56128032|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
56128033|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
56128034|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801457|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801458|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801459|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55801460|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55801462|NCT04824937|Talazoparib|talazoparib|mesh-list
55801463|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55801464|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811643|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55811644|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
55811645|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811646|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811647|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55811649|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
55811650|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811651|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55811652|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55811653|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55811654|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55811655|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55811656|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55811657|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56128035|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56128036|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
56128037|NCT03524898|Antiviral Agents|antiviral agents|mesh-ancestor
56128038|NCT03524898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128039|NCT03524898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226764|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56226765|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226766|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
56226767|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
56226768|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
56226769|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226770|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56226771|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
56226772|NCT03770299|Antiviral Agents|antiviral agents|mesh-ancestor
56226773|NCT03770299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226774|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226775|NCT03770299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56226776|NCT03770299|Immunologic Factors|immunologic factors|mesh-ancestor
56226777|NCT03770299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128040|NCT03524898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128041|NCT03524898|Immunologic Factors|immunologic factors|mesh-ancestor
56128042|NCT03524898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128044|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128045|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128046|NCT03524508|Fluorouracil|fluorouracil|mesh-list
56128047|NCT03524508|Irinotecan|irinotecan|mesh-list
56128048|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
56128049|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128050|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56128051|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128052|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811741|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55811742|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55811743|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
55811744|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801574|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
55801576|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55801578|NCT02424591|Analgesics|analgesics|mesh-ancestor
55801579|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
55801580|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801581|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801582|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55801583|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55801584|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
55801586|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801587|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55801588|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55801589|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801590|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801592|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55801593|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55801594|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801595|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
55801596|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801597|NCT02408523|Lacosamide|lacosamide|mesh-list
55801599|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
56128053|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
56128054|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128055|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56128056|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56128057|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128058|NCT03522168|Risperidone|risperidone|mesh-list
56128059|NCT03522168|Aripiprazole|aripiprazole|mesh-list
56128060|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56128061|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
56128062|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56128063|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128064|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128065|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56128066|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56128067|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801788|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55801789|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55801790|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55801791|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
55801792|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801793|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801795|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128068|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56128069|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56128070|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
55816290|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
55816433|NCT02473913|Silymarin|silymarin|mesh-list
55816577|NCT04732065|Protective Agents|protective agents|mesh-ancestor
55817030|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55817050|NCT01892020|Insulin|insulin|mesh-list
55817137|NCT04616014|Insulin|insulin|mesh-list
55801904|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55801905|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
55818047|NCT02320058|Nivolumab|nivolumab|mesh-list
55801948|NCT04807543|Cathartics|cathartics|mesh-ancestor
55801949|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55801950|NCT04797949|Aspirin|aspirin|mesh-list
55801951|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55715014|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55715260|NCT05488405|Mesalamine|mesalamine|mesh-list
55715951|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
55801952|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55716229|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55716307|NCT02294617|Nicotine|nicotine|mesh-list
56128071|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
56128072|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
56128073|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56128074|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56128075|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56128076|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56128077|NCT03457818|Denosumab|denosumab|mesh-list
56128078|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56128079|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128080|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56128081|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
56128082|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
55720159|NCT01449071|Epratuzumab|epratuzumab|mesh-list
55720308|NCT01348919|Hormones|hormones|mesh-ancestor
55720377|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
55801999|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
55802000|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802001|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56128083|NCT01676844|Protective Agents|protective agents|mesh-ancestor
56128084|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128085|NCT03456102|Pravastatin|pravastatin|mesh-list
56226778|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56226779|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56226780|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56226781|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56226782|NCT03760835|Dexamethasone|dexamethasone|mesh-list
56128086|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56128087|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56128088|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
56128089|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128090|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56128091|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56128093|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
56128094|NCT04403334|Levofloxacin|levofloxacin|mesh-list
56128095|NCT04403334|Ofloxacin|ofloxacin|mesh-list
56128096|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56128097|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128098|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56128099|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56128100|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128101|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128102|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128103|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56128104|NCT04403334|Renal Agents|renal agents|mesh-ancestor
56128105|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56128106|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55802221|NCT04789915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55802222|NCT04789915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56128107|NCT03779646|Bisoprolol|bisoprolol|mesh-list
56128108|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56128109|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
56128110|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
55818446|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56128111|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128112|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128113|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56128114|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56128115|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56128117|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56128118|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128119|NCT03774732|Paclitaxel|paclitaxel|mesh-list
56128120|NCT03774732|Cisplatin|cisplatin|mesh-list
56128121|NCT03774732|Carboplatin|carboplatin|mesh-list
56128122|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
56128123|NCT03774732|Pemetrexed|pemetrexed|mesh-list
56128124|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56128125|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128126|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
56128127|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
55802277|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128128|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
56128129|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128130|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128131|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128132|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56128133|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56128134|NCT03503058|Chloroquine|chloroquine|mesh-list
56128135|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56128136|NCT03503058|Amebicides|amebicides|mesh-ancestor
56128137|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56128138|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56128139|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128140|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
56128141|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128142|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56128143|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748745|NCT03265795|Ether|ether|mesh-list
56128144|NCT03503058|Analgesics|analgesics|mesh-ancestor
56128145|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
56128146|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128147|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128148|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128149|NCT03503058|Filaricides|filaricides|mesh-ancestor
56128150|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
56128151|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
56226783|NCT03760835|Prednisone|prednisone|mesh-list
56226784|NCT03760835|Prednisolone|prednisolone|mesh-list
56226785|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
56226786|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56226787|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56226788|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56226789|NCT03760835|Cortisone|cortisone|mesh-list
56226790|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
56226791|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56226792|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
56226793|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
56128152|NCT05347134|Gemcitabine|gemcitabine|mesh-list
56128153|NCT05347134|Capecitabine|capecitabine|mesh-list
56128154|NCT05347134|Vinorelbine|vinorelbine|mesh-list
56128155|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56128156|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
56128157|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128158|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802608|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55802610|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
56128159|NCT05347134|Antiviral Agents|antiviral agents|mesh-ancestor
56128160|NCT05347134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128161|NCT05347134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128162|NCT05347134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128163|NCT05347134|Immunologic Factors|immunologic factors|mesh-ancestor
56128164|NCT05347134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128165|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56128167|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
56128168|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
56128169|NCT00089778|Aldesleukin|aldesleukin|mesh-list
56128170|NCT00089778|Interleukin-2|interleukin-2|mesh-list
56128172|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128173|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56128174|NCT00089778|Analgesics|analgesics|mesh-ancestor
56128175|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
56128176|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128177|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128178|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56128179|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128180|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56128181|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55762813|NCT04225221|Hormones|hormones|mesh-ancestor
56128182|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
56128183|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128184|NCT00089544|Thalidomide|thalidomide|mesh-list
56128185|NCT00089544|Doxorubicin|doxorubicin|mesh-list
56128186|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56128187|NCT00089544|Ifosfamide|ifosfamide|mesh-list
56128188|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
56128189|NCT00089544|Dacarbazine|dacarbazine|mesh-list
56128190|NCT00089544|Imidazole|imidazole|mesh-list
56128191|NCT00089544|Lenograstim|lenograstim|mesh-list
56128192|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56128193|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128194|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56128195|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56128196|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128197|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128198|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56128199|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
56128200|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128201|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56128202|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
56128203|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128204|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
56128205|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56128206|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128207|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56128208|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56226794|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226795|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802766|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226796|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226797|NCT03760835|Hormones|hormones|mesh-ancestor
56226798|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226799|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56226800|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226801|NCT03759496|Durvalumab|durvalumab|mesh-list
55802593|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
56128209|NCT00089544|Growth Substances|growth substances|mesh-ancestor
56128210|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
56128211|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56128212|NCT00089076|Ipilimumab|ipilimumab|mesh-list
56128213|NCT00089076|Antibodies|antibodies|mesh-list
56128214|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
56128215|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56128216|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
56128217|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128218|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802821|NCT05700721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802822|NCT05700721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802823|NCT05700721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802824|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
55802825|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128219|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56128220|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128221|NCT03773562|Erenumab|erenumab|mesh-list
55890129|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56128222|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56128223|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128224|NCT03773562|Analgesics|analgesics|mesh-ancestor
55789519|NCT05281549|Tenecteplase|tenecteplase|mesh-list
56128225|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
56128226|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128227|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128228|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56128229|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56128230|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128231|NCT00087594|Ribavirin|ribavirin|mesh-list
56128232|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56128233|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
55789618|NCT01596335|Antibodies|antibodies|mesh-list
56128234|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128235|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
56128236|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128237|NCT03770286|Fluorides|fluorides|mesh-list
56128238|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
56128239|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
56128240|NCT03770286|Protective Agents|protective agents|mesh-ancestor
56128241|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128242|NCT00087516|Metformin|metformin|mesh-list
56128243|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56128244|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56128245|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128246|NCT00087516|Incretins|incretins|mesh-ancestor
56128247|NCT00087516|Hormones|hormones|mesh-ancestor
56128248|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128249|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56128250|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
56128251|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128252|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128253|NCT03768960|Daratumumab|daratumumab|mesh-list
55803044|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56128254|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128255|NCT00087126|Topotecan|topotecan|mesh-list
56128256|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56128257|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56128258|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128259|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803097|NCT05679037|Vitamins|vitamins|mesh-ancestor
56128260|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128261|NCT00086346|Cyclosporine|cyclosporine|mesh-list
56128262|NCT00086346|Sirolimus|sirolimus|mesh-list
56128263|NCT00086346|Tacrolimus|tacrolimus|mesh-list
56128264|NCT00086346|Cyclosporins|cyclosporins|mesh-list
56128265|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56226802|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56226803|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226804|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
56226805|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128266|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
56128267|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128268|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56128269|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128270|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128271|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
56128272|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128273|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
55789709|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
56128274|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128275|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56128276|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56128277|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128279|NCT00085566|Gefitinib|gefitinib|mesh-list
56128280|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128281|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128282|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
56128283|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128284|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56128285|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128286|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128287|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
56128288|NCT00085098|Cisplatin|cisplatin|mesh-list
56128289|NCT00085098|Carboplatin|carboplatin|mesh-list
56128290|NCT00085098|Etoposide|etoposide|mesh-list
56128291|NCT00085098|Lenograstim|lenograstim|mesh-list
56128292|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128294|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128295|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128296|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56128297|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
56128298|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128299|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128300|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55803271|NCT05678257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55803272|NCT05678257|Growth Substances|growth substances|mesh-ancestor
55803274|NCT05678257|Growth Inhibitors|growth inhibitors|mesh-ancestor
56128301|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56128302|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56128303|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56128304|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128305|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56128306|NCT00084864|Calcitriol|calcitriol|mesh-list
56128307|NCT00084864|Dexamethasone|dexamethasone|mesh-list
55789778|NCT03050177|Gefitinib|gefitinib|mesh-list
56128308|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128309|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
56128310|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
56128311|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128312|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128313|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56128314|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
56128315|NCT00084864|Hormones|hormones|mesh-ancestor
55890130|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55803357|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
55803358|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803359|NCT05677633|Sargramostim|sargramostim|mesh-list
55803360|NCT05677633|Immunologic Factors|immunologic factors|mesh-ancestor
55789792|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789793|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803361|NCT05677633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803362|NCT05677555|Colchicine|colchicine|mesh-list
55803363|NCT05677555|Gout Suppressants|gout suppressants|mesh-ancestor
55803364|NCT05677555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890131|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
56128316|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128317|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56128319|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56128321|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56128322|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128323|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56128324|NCT00084864|Vitamins|vitamins|mesh-ancestor
56128325|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
56128326|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56128327|NCT01677702|Lactoferrin|lactoferrin|mesh-list
56128328|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128329|NCT00084318|Docetaxel|docetaxel|mesh-list
56128330|NCT00084318|Cetuximab|cetuximab|mesh-list
56128331|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128332|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
55803538|NCT05575219|Adrenergic Agents|adrenergic agents|mesh-ancestor
56128333|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
56128334|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
56128335|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226806|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226807|NCT03748784|Aflibercept|aflibercept|mesh-list
56226808|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56226809|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56226810|NCT03748784|Growth Substances|growth substances|mesh-ancestor
56226811|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128336|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128337|NCT00083616|Panitumumab|panitumumab|mesh-list
56128338|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128339|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128340|NCT00083226|Doxorubicin|doxorubicin|mesh-list
56128341|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56128343|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56128344|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128345|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56128346|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55803641|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55803642|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
56128347|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128348|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128349|NCT00082758|Interleukin-2|interleukin-2|mesh-list
56128351|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128352|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56128353|NCT00082758|Analgesics|analgesics|mesh-ancestor
56128354|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
56128355|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128356|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128357|NCT03483012|Atezolizumab|atezolizumab|mesh-list
55803777|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
56128358|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128359|NCT03438318|Atezolizumab|atezolizumab|mesh-list
56128360|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128361|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
56128362|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56128363|NCT03087942|Growth Substances|growth substances|mesh-ancestor
56128364|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128365|NCT01678092|Omalizumab|omalizumab|mesh-list
56128366|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56128367|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56128368|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
56128369|NCT04402320|Midazolam|midazolam|mesh-list
56128370|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56128371|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56128372|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128373|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128374|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56128375|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56128376|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55789929|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55789930|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
55803896|NCT02380287|Antibodies|antibodies|mesh-list
56128377|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56128378|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
56128379|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
56128380|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
56128381|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
56128382|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56128383|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128384|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
55804020|NCT02392377|Leucovorin|leucovorin|mesh-list
56128385|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128386|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128387|NCT03088176|Trametinib|trametinib|mesh-list
56128388|NCT03088176|Dabrafenib|dabrafenib|mesh-list
55855341|NCT00446290|Docetaxel|docetaxel|mesh-list
56128389|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56128390|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128391|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56128392|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128393|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128394|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128395|NCT01678404|Rituximab|rituximab|mesh-list
56128399|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128400|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128401|NCT03087864|Paclitaxel|paclitaxel|mesh-list
56128402|NCT03087864|Carboplatin|carboplatin|mesh-list
56128403|NCT03087864|Atezolizumab|atezolizumab|mesh-list
56226812|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
56226813|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226814|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
56226815|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56226816|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226817|NCT03724409|Octreotide|octreotide|mesh-list
56226818|NCT03724409|Edotreotide|edotreotide|mesh-list
56226819|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56128404|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56226824|NCT03715829|PF-06700841|pf-06700841|mesh-list
56226825|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56226826|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226827|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226828|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
56128406|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
56128407|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
56128409|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128411|NCT01678716|Trace Elements|trace elements|mesh-list
56128412|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128413|NCT00081510|Anastrozole|anastrozole|mesh-list
56128414|NCT00081510|Lonafarnib|lonafarnib|mesh-list
56128415|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56128416|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128417|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56128418|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55804454|NCT05513209|Anesthetics|anesthetics|mesh-list
55804455|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804456|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804457|NCT05513131|Azacitidine|azacitidine|mesh-list
55804458|NCT05513131|Venetoclax|venetoclax|mesh-list
55804459|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
55804460|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55804461|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
55804462|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804463|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804464|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804465|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55804466|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55804468|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804469|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804470|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55804471|NCT05502913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55790322|NCT04969237|Vitamin D|vitamin d|mesh-list
55804472|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804473|NCT05502913|Antitubercular Agents|antitubercular agents|mesh-ancestor
55804474|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
56128419|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128420|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128421|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56128422|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
56128423|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128424|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128425|NCT00088452|Lamotrigine|lamotrigine|mesh-list
56128426|NCT00088452|Valproic Acid|valproic acid|mesh-list
56128427|NCT00088452|Ethosuximide|ethosuximide|mesh-list
56128428|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
56128429|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56128430|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804495|NCT04584853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55804496|NCT04584853|Hormone Antagonists|hormone antagonists|mesh-ancestor
55804497|NCT04584853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804498|NCT04584853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804499|NCT04584853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55804500|NCT04584853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55804501|NCT04584853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55804502|NCT04584853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55804503|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
55804504|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804505|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804506|NCT02336451|Ceritinib|ceritinib|mesh-list
55804507|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804509|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804510|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804512|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
55804513|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804514|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128431|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128432|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56128433|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128434|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56128435|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56128436|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128437|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56128438|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56128439|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128440|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
56128441|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56128442|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
56128443|NCT01679106|Fentanyl|fentanyl|mesh-list
56128444|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56128445|NCT01679106|Narcotics|narcotics|mesh-ancestor
56128446|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128447|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128448|NCT01679106|Analgesics|analgesics|mesh-ancestor
56128449|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
56128450|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804537|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55804538|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
55804539|NCT02566993|Doxorubicin|doxorubicin|mesh-list
55804540|NCT02566993|Vincristine|vincristine|mesh-list
55804542|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55804543|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
55804544|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804545|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55804546|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55804547|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
55804548|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804549|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804550|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55804551|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55804552|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55804553|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55804554|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128451|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56128452|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56128453|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
56128454|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
56128455|NCT04403100|Ritonavir|ritonavir|mesh-list
56128456|NCT04403100|Lopinavir|lopinavir|mesh-list
56128457|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
56128458|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56128459|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56128460|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
56128461|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226829|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
56226830|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56226831|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804590|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55804591|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804592|NCT05505253|Vitamins|vitamins|mesh-ancestor
55804593|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
55804594|NCT04697719|Aspirin|aspirin|mesh-list
55804595|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55804596|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55818536|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56226832|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226833|NCT03704441|Bupivacaine|bupivacaine|mesh-list
56226834|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
56226835|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
56226836|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56226837|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226838|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
55804645|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
55804646|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55804647|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55804649|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
55804650|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
55804651|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
55804652|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55804668|NCT02310789|Ivacaftor|ivacaftor|mesh-list
56226839|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226840|NCT03693677|Gemcitabine|gemcitabine|mesh-list
56226842|NCT03693677|Irinotecan|irinotecan|mesh-list
56226843|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56128462|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128463|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56128464|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56128465|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
55804709|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55804710|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55804711|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
55804712|NCT02559817|Linaclotide|linaclotide|mesh-list
55804713|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55804714|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
55804715|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804716|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804717|NCT05504083|Benzbromarone|benzbromarone|mesh-list
55804718|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
55804719|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
55804720|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55804721|NCT05504083|Renal Agents|renal agents|mesh-ancestor
55804722|NCT04577443|Adenosine|adenosine|mesh-list
55804723|NCT04577443|Analgesics|analgesics|mesh-ancestor
56128466|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128467|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55788903|NCT04929509|Listerine|listerine|mesh-list
56128468|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56128469|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
56128470|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56128471|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56128472|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128473|NCT03086538|Pemetrexed|pemetrexed|mesh-list
56128474|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56128475|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128476|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128477|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128478|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56128479|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56128480|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56128482|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128484|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55804767|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804768|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128485|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128486|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
56128487|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
56128488|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
56128489|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128490|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
56128491|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128492|NCT01679574|Metformin|metformin|mesh-list
56128493|NCT01679574|Letrozole|letrozole|mesh-list
56128494|NCT01679574|Clomiphene|clomiphene|mesh-list
56128495|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56128496|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128497|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128498|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56128499|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56128500|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128501|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128502|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56128503|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
55804824|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804825|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
55804826|NCT04277845|Hormones|hormones|mesh-ancestor
55804827|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804828|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55804829|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804830|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
55804831|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128504|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128505|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56128506|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
56226844|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226845|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
56226846|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
56226847|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
56226848|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226849|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56226850|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
56226851|NCT03693677|Antiviral Agents|antiviral agents|mesh-ancestor
56226852|NCT03693677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128507|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55804877|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804878|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55804879|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55804880|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
55804881|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804882|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804889|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128508|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56128509|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56128510|NCT01679652|Nebivolol|nebivolol|mesh-list
56128511|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56128512|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
56128513|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56128514|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55804932|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55804933|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55804934|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804935|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804936|NCT05494567|Urological Agents|urological agents|mesh-ancestor
55804937|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55804938|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55804939|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55804940|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
55804941|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804942|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804943|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55804944|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55804945|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
55804947|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
56128515|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56128516|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
56128517|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56128518|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128519|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128520|NCT04761744|Nivolumab|nivolumab|mesh-list
56128521|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128522|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128523|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55805004|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805005|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
55805006|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
55805007|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
55805010|NCT04279561|Edetic Acid|edetic acid|mesh-list
56128524|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128525|NCT03089658|Avelumab|avelumab|mesh-list
56128526|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128527|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128528|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
56128529|NCT03417492|Citric Acid|citric acid|mesh-list
56128530|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
56128531|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
56128532|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56128533|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
55805066|NCT05492851|Hylan|hylan|mesh-list
55805067|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
55805068|NCT05492851|Protective Agents|protective agents|mesh-ancestor
55805069|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805070|NCT04139395|Citric Acid|citric acid|mesh-list
55805071|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
55805072|NCT04139395|Gallium citrate|gallium citrate|mesh-list
55805073|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
55805074|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55805075|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
55805076|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
55805084|NCT05485519|Midazolam|midazolam|mesh-list
56128534|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
56128535|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128536|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
56128537|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56128538|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56128539|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128540|NCT03417492|Urological Agents|urological agents|mesh-ancestor
56128541|NCT03395184|PF-06700841|pf-06700841|mesh-list
56128542|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56128543|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805125|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55805126|NCT02556775|Antibodies|antibodies|mesh-list
55805127|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
55805128|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55805129|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
55805130|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805131|NCT04080739|Ropivacaine|ropivacaine|mesh-list
55805132|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
55805133|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
55805182|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
55805183|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
55805184|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55805185|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55805186|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805187|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
56128544|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128545|NCT03080766|Decitabine|decitabine|mesh-list
56128546|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56128547|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
56128548|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128549|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128550|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128551|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
56128552|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56128554|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
55855513|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
56128556|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128557|NCT03088254|Amlodipine|amlodipine|mesh-list
56128558|NCT03088254|Telmisartan|telmisartan|mesh-list
56128559|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56128560|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56128561|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56226853|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128562|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56128563|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805263|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55805264|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55805265|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805266|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
55791872|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
56128564|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56128565|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128566|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
56128567|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56128568|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56128569|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
56128570|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56128571|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56128572|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128573|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56128574|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56128575|NCT05685342|Acetaminophen|acetaminophen|mesh-list
56128576|NCT05685342|Ibuprofen|ibuprofen|mesh-list
56128577|NCT05685342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56128578|NCT05685342|Analgesics|analgesics|mesh-ancestor
56128579|NCT05685342|Sensory System Agents|sensory system agents|mesh-ancestor
56128580|NCT05685342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128581|NCT05685342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128582|NCT05685342|Antipyretics|antipyretics|mesh-ancestor
56128583|NCT05685342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56128584|NCT05685342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128585|NCT05685342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128586|NCT05685342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56128587|NCT05685342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805492|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56128588|NCT05685342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128589|NCT05684718|Itraconazole|itraconazole|mesh-list
56128591|NCT05684718|Antifungal Agents|antifungal agents|mesh-ancestor
56128592|NCT05684718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128593|NCT05684718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56128594|NCT05684718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56128595|NCT05684718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128596|NCT05684718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128597|NCT05684718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56128598|NCT05684718|Hormone Antagonists|hormone antagonists|mesh-ancestor
56128599|NCT05684718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128600|NCT05684718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128601|NCT05684718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56128602|NCT05684718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55805558|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128603|NCT05684718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56128604|NCT05684718|Antitubercular Agents|antitubercular agents|mesh-ancestor
56128605|NCT05684484|Salicylic Acid|salicylic acid|mesh-list
56128606|NCT05684484|Salicylates|salicylates|mesh-list
56128607|NCT05684484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128608|NCT05684484|Antifungal Agents|antifungal agents|mesh-ancestor
56128609|NCT05684484|Keratolytic Agents|keratolytic agents|mesh-ancestor
55805711|NCT05092373|Atezolizumab|atezolizumab|mesh-list
56128610|NCT05684484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56128611|NCT05684484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56128612|NCT05684484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56128613|NCT05684484|Analgesics|analgesics|mesh-ancestor
56128614|NCT05684484|Sensory System Agents|sensory system agents|mesh-ancestor
56128615|NCT05684484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128616|NCT05684484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128617|NCT05684484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128618|NCT05684484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128619|NCT05684484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56128620|NCT05684484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128621|NCT05684484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128622|NCT03086382|Lacosamide|lacosamide|mesh-list
56128623|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
56128624|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56128627|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128628|NCT03086226|Itraconazole|itraconazole|mesh-list
56128629|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
56128630|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128631|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56128632|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56226854|NCT03693677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56226855|NCT03693677|Immunologic Factors|immunologic factors|mesh-ancestor
56226856|NCT03693677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226857|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56226858|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56226859|NCT03673826|Dexamethasone|dexamethasone|mesh-list
56128633|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128634|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128635|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56128636|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
56128637|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128638|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128639|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56128640|NCT03085992|Bevacizumab|bevacizumab|mesh-list
56128641|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128642|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128643|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56128644|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56128645|NCT03085992|Growth Substances|growth substances|mesh-ancestor
55806060|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806061|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55806126|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806127|NCT02336815|Dexamethasone|dexamethasone|mesh-list
56128646|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128647|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
56128649|NCT05679492|Antiviral Agents|antiviral agents|mesh-ancestor
56128650|NCT05679492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128651|NCT03086070|Omeprazole|omeprazole|mesh-list
56128652|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56128653|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56128654|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56128655|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128656|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128657|NCT05688306|Oprelvekin|oprelvekin|mesh-list
56128658|NCT05688306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806200|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55806201|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56128659|NCT05667324|Dexamethasone|dexamethasone|mesh-list
56128660|NCT05667324|Ropivacaine|ropivacaine|mesh-list
56128661|NCT05667324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128662|NCT05667324|Antiemetics|antiemetics|mesh-ancestor
56128663|NCT05667324|Autonomic Agents|autonomic agents|mesh-ancestor
56128664|NCT05667324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128665|NCT05667324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128666|NCT05667324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56128667|NCT05667324|Glucocorticoids|glucocorticoids|mesh-ancestor
56128668|NCT05667324|Hormones|hormones|mesh-ancestor
56128669|NCT05667324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128670|NCT05667324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56128671|NCT05667324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128672|NCT05667324|Anesthetics, Local|anesthetics, local|mesh-ancestor
56128673|NCT05667324|Anesthetics|anesthetics|mesh-ancestor
56128674|NCT05667324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128675|NCT05667324|Sensory System Agents|sensory system agents|mesh-ancestor
56128676|NCT03086148|Ketamine|ketamine|mesh-list
56128677|NCT03086148|Analgesics|analgesics|mesh-ancestor
56128678|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
56128679|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128680|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128681|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56128682|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56128684|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
56128685|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806333|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55806334|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806335|NCT05484401|Analgesics|analgesics|mesh-ancestor
55806336|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
55806337|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806338|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128686|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56128687|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56128688|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56128689|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128690|NCT03359538|Sirolimus|sirolimus|mesh-list
56128691|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56128692|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128693|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56128694|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128695|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
56128696|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806395|NCT05488925|Piroxicam|piroxicam|mesh-list
55806396|NCT05488925|Tramadol|tramadol|mesh-list
55806397|NCT05488925|Vitamins|vitamins|mesh-ancestor
55806398|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
55806399|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806400|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56226861|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56226862|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
56226863|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
55806463|NCT05494307|Terbutaline|terbutaline|mesh-list
56226864|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226865|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226866|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56128697|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
56128698|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128699|NCT05345808|Triamcinolone|triamcinolone|mesh-list
55855656|NCT00478036|Analgesics|analgesics|mesh-ancestor
56128700|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56128701|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56128702|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56128703|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128704|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
56128705|NCT05345808|Hormones|hormones|mesh-ancestor
56128706|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806702|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55806703|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
55806776|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55806777|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55806778|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
55806779|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55806780|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806781|NCT02865551|Anesthetics|anesthetics|mesh-list
55806782|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806784|NCT05478083|Leuprolide|leuprolide|mesh-list
56128707|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128708|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128709|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
56128710|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128711|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128712|NCT02336958|Ropivacaine|ropivacaine|mesh-list
56128713|NCT02336958|Prilocaine|prilocaine|mesh-list
56128714|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
55806843|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55806867|NCT05459285|Dulaglutide|dulaglutide|mesh-list
55806868|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55806869|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806870|NCT02542943|Fluorides|fluorides|mesh-list
55806871|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
55806872|NCT02542943|Protective Agents|protective agents|mesh-ancestor
55806873|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806874|NCT03284957|Everolimus|everolimus|mesh-list
55806875|NCT03284957|Palbociclib|palbociclib|mesh-list
55806876|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806877|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806878|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
55806879|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806880|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55806881|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806883|NCT05469893|Dexamethasone|dexamethasone|mesh-list
56128715|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
56128716|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128717|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128718|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
56128719|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128720|NCT03085368|Trastuzumab|trastuzumab|mesh-list
56128721|NCT03085368|Lapatinib|lapatinib|mesh-list
56128722|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128723|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806939|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806940|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56128724|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56128725|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128726|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128727|NCT05638932|Tofacitinib|tofacitinib|mesh-list
56128728|NCT05638932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56128729|NCT05638932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128730|NCT05638932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128753|NCT05687760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56128754|NCT05687760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128755|NCT03084978|Anesthetics|anesthetics|mesh-list
56128756|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128757|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128758|NCT03084588|Methadone|methadone|mesh-list
55807006|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55807007|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807008|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
55807009|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
55807010|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
55807011|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807012|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55807013|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55807014|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807015|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55792660|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
55792661|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55807051|NCT04882839|Psilocybin|psilocybin|mesh-list
56128759|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56128760|NCT03084588|Narcotics|narcotics|mesh-ancestor
56128761|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128762|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128763|NCT03084588|Analgesics|analgesics|mesh-ancestor
56128764|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
56128765|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128766|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
56128767|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
56128768|NCT05687136|Peposertib|peposertib|mesh-list
56128769|NCT05687136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56128770|NCT05687136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128771|NCT05687136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128772|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
55807053|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807056|NCT02300259|Diltiazem|diltiazem|mesh-list
56128773|NCT05345574|Remifentanil|remifentanil|mesh-list
56128774|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56128775|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128776|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128777|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56226868|NCT03673826|Hormones|hormones|mesh-ancestor
56226869|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226870|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55807117|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56226871|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226872|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
56128778|NCT05345574|Analgesics|analgesics|mesh-ancestor
56128779|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
56128780|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128781|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56128782|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56128783|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56128784|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
56128785|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56128786|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128787|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56128788|NCT05345574|Narcotics|narcotics|mesh-ancestor
56128789|NCT05598606|Zoledronic Acid|zoledronic acid|mesh-list
56128790|NCT05598606|Denosumab|denosumab|mesh-list
56128791|NCT05598606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56128792|NCT05598606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128794|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128795|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128796|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
55807265|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55807266|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128797|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56128798|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56128799|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128800|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
56128801|NCT04400916|Coagulants|coagulants|mesh-ancestor
56128802|NCT05582538|Paclitaxel|paclitaxel|mesh-list
56128803|NCT05582538|Durvalumab|durvalumab|mesh-list
56128804|NCT05582538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56128805|NCT05582538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807330|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55807331|NCT05401279|Gemcitabine|gemcitabine|mesh-list
56128806|NCT05582538|Tubulin Modulators|tubulin modulators|mesh-ancestor
56128807|NCT05582538|Antimitotic Agents|antimitotic agents|mesh-ancestor
56128808|NCT05582538|Mitosis Modulators|mitosis modulators|mesh-ancestor
56128809|NCT05582538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128810|NCT05582538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128811|NCT03406650|Durvalumab|durvalumab|mesh-list
56128812|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128813|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128814|NCT05571072|Analgesics, Opioid|analgesics, opioid|mesh-list
56128815|NCT05571072|Narcotics|narcotics|mesh-ancestor
56128816|NCT05571072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128817|NCT05571072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128818|NCT05571072|Analgesics|analgesics|mesh-ancestor
56128819|NCT05571072|Sensory System Agents|sensory system agents|mesh-ancestor
56128820|NCT05571072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128821|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
56128822|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
56128823|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56128824|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807396|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807397|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807398|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807399|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807400|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56128825|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56128826|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56128827|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128828|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128829|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128830|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
56128831|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56128832|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
56128833|NCT05553132|Coagulants|coagulants|mesh-ancestor
56128834|NCT04279938|Rituximab|rituximab|mesh-list
56128835|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
56128836|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128837|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128838|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
56128839|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128840|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56226873|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56226874|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56226875|NCT03673826|Growth Substances|growth substances|mesh-ancestor
56128841|NCT05686434|Osimertinib|osimertinib|mesh-list
56128842|NCT05686434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128843|NCT05686434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56128844|NCT05686434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128845|NCT05686434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128846|NCT05686356|Acetylcysteine|acetylcysteine|mesh-list
56128847|NCT05686356|Bedaquiline|bedaquiline|mesh-list
56128848|NCT05686356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56128849|NCT05686356|Antiviral Agents|antiviral agents|mesh-ancestor
55807457|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807458|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56128850|NCT05686356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128851|NCT05686356|Expectorants|expectorants|mesh-ancestor
56128852|NCT05686356|Respiratory System Agents|respiratory system agents|mesh-ancestor
56128853|NCT05686356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56128854|NCT05686356|Antioxidants|antioxidants|mesh-ancestor
56128855|NCT05686356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128856|NCT05686356|Protective Agents|protective agents|mesh-ancestor
56128857|NCT05686356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128858|NCT05686356|Antidotes|antidotes|mesh-ancestor
56128859|NCT05686356|Antitubercular Agents|antitubercular agents|mesh-ancestor
56128860|NCT05686356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56128861|NCT03083184|Ethanol|ethanol|mesh-list
56128862|NCT03083184|Enoxaparin|enoxaparin|mesh-list
56128863|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
56128864|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56128865|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56128866|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128867|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56128868|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128869|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128870|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128872|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56128873|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128874|NCT05512962|Triamcinolone|triamcinolone|mesh-list
56128875|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56128876|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56128877|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56128878|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128879|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
56128880|NCT05512962|Hormones|hormones|mesh-ancestor
55807504|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807506|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
55807507|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
55807508|NCT04262843|Fludarabine|fludarabine|mesh-list
56128881|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128882|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128883|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128884|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
56128885|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128886|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128887|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
56128888|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55807556|NCT01660711|Vitamins|vitamins|mesh-ancestor
56128889|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56128890|NCT03082092|Prednisolone|prednisolone|mesh-list
56128891|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
56128892|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56128893|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
56128894|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128895|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
56128896|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
56128897|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128898|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128899|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56128900|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
56128901|NCT03082092|Hormones|hormones|mesh-ancestor
56128902|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128903|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56128904|NCT03082092|Protective Agents|protective agents|mesh-ancestor
56128905|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55807618|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55807619|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807620|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
55807621|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
56128906|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128907|NCT05498220|Gemcitabine|gemcitabine|mesh-list
56128908|NCT05498220|Dexamethasone|dexamethasone|mesh-list
56128909|NCT05498220|Rituximab|rituximab|mesh-list
56226876|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
56226878|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
56226879|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
56226880|NCT03660839|Artefenomel|artefenomel|mesh-list
56226881|NCT03660839|Ferroquine|ferroquine|mesh-list
56226882|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
56226883|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56226884|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56226885|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226886|NCT03660241|Abrocitinib|abrocitinib|mesh-list
56226887|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56226888|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226889|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226890|NCT03651102|Thalidomide|thalidomide|mesh-list
56226891|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
56226892|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807746|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
55807747|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807748|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226893|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
56226894|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226895|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
56226896|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56128910|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128911|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128912|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
56128913|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128914|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128915|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128916|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
56128917|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
56128918|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128919|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56128920|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
56128921|NCT05498220|Hormones|hormones|mesh-ancestor
56128922|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56128923|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56128924|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56128925|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
56128926|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128927|NCT05498220|Antiviral Agents|antiviral agents|mesh-ancestor
56128928|NCT05498220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128929|NCT05498220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128930|NCT05498220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128931|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
56128933|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
56128934|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128935|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128936|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
56128937|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56128938|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56128939|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
56128940|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56128941|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56128942|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128946|NCT03318900|Aldesleukin|aldesleukin|mesh-list
56128947|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
55792730|NCT05023915|Hormones|hormones|mesh-ancestor
55808026|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808027|NCT05332717|Melatonin|melatonin|mesh-list
55808028|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808029|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
55808030|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808031|NCT05332717|Protective Agents|protective agents|mesh-ancestor
55808032|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808033|NCT05300269|Capecitabine|capecitabine|mesh-list
55808034|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
55808035|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55808036|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
55808039|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
56226897|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226898|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56226899|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56226900|NCT03651102|Growth Substances|growth substances|mesh-ancestor
56226901|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
56226902|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226903|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
56226904|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226905|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808075|NCT05321875|Candesartan|candesartan|mesh-list
55808076|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55808078|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56226907|NCT03649802|Vitamin D|vitamin d|mesh-list
56226908|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
56226909|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
56128948|NCT03318900|Interleukin-2|interleukin-2|mesh-list
56128949|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56128950|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
56128951|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128952|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
56128953|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128954|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128955|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56128956|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
56128957|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128958|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128959|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56128960|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808138|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55808139|NCT02522377|Midazolam|midazolam|mesh-list
55808140|NCT02522377|Ketamine|ketamine|mesh-list
55808141|NCT02522377|Analgesics|analgesics|mesh-ancestor
56128961|NCT03318900|Analgesics|analgesics|mesh-ancestor
56128962|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
56128963|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56128964|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56128965|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56128966|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
56128967|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56128968|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
56128969|NCT03328104|Etoposide|etoposide|mesh-list
55808200|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
55808205|NCT05314621|Analgesics|analgesics|mesh-ancestor
56128970|NCT03328104|Everolimus|everolimus|mesh-list
56128971|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56128972|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
56128973|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128974|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128975|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56128976|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
55808268|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808269|NCT05256823|Celecoxib|celecoxib|mesh-list
56128977|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128978|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128979|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56128980|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56128981|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56128982|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56128983|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128984|NCT03399318|Acetaminophen|acetaminophen|mesh-list
56128985|NCT03399318|Ibuprofen|ibuprofen|mesh-list
56128986|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56128987|NCT03399318|Analgesics|analgesics|mesh-ancestor
56128988|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
56128989|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808339|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55808340|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55808341|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808342|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808343|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808345|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56128990|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128991|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
56128992|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56128993|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56128994|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128995|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56128996|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226910|NCT03649802|Vitamins|vitamins|mesh-list
56226911|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
56226912|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226913|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56226914|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56128997|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56128998|NCT03082482|Nicotine|nicotine|mesh-list
56128999|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56129000|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
55808464|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55808465|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55808466|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55808467|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808468|NCT05243563|Clobetasol|clobetasol|mesh-list
55808469|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56129001|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129002|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129004|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56129005|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
56129006|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129007|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129009|NCT03308916|Hematinics|hematinics|mesh-ancestor
56129010|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
56129011|NCT03081702|Itraconazole|itraconazole|mesh-list
56129012|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
56129013|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56129014|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56129015|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129016|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129021|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56129022|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55808525|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55808526|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
56129023|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
56129024|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129025|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129026|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56129027|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
56129028|NCT03308448|Hematinics|hematinics|mesh-ancestor
56129029|NCT04399434|Insulin|insulin|mesh-list
56129030|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56129031|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129032|NCT04760574|Testosterone|testosterone|mesh-list
56129033|NCT04760574|Androgens|androgens|mesh-ancestor
56129034|NCT04760574|Hormones|hormones|mesh-ancestor
56129035|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129036|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129037|NCT03237390|Gemcitabine|gemcitabine|mesh-list
56129038|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55808585|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56129039|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
56129040|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129041|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129042|NCT03237390|Antiviral Agents|antiviral agents|mesh-ancestor
55788941|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
56129043|NCT03237390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129044|NCT03237390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129045|NCT03237390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56129046|NCT03237390|Immunologic Factors|immunologic factors|mesh-ancestor
56129047|NCT03237390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129048|NCT03302910|Torsemide|torsemide|mesh-list
56129049|NCT03302910|Furosemide|furosemide|mesh-list
56129050|NCT03302910|Bumetanide|bumetanide|mesh-list
56129051|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
56129052|NCT03302910|Diuretics|diuretics|mesh-list
55808643|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
55808646|NCT05148949|Vaccines|vaccines|mesh-list
56129053|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56129054|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
56129055|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129056|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56129057|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129058|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
56129059|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55808710|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
55808711|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808712|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129060|NCT03301896|Spartalizumab|spartalizumab|mesh-list
56129061|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56129062|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129063|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129064|NCT03292926|Dexamethasone|dexamethasone|mesh-list
56129065|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
56129066|NCT03292926|Bupivacaine|bupivacaine|mesh-list
56226916|NCT03643198|Metronidazole|metronidazole|mesh-list
56226917|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
56226918|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226919|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56226920|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55808776|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
55808777|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226921|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56226922|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56226923|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226924|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226926|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56226927|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56226928|NCT03606980|Dexamethasone|dexamethasone|mesh-list
56226929|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
56226930|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56226932|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56226933|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
55808840|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
55808843|NCT05079763|Monolaurin|monolaurin|mesh-list
56226934|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
56226935|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802712|NCT05347459|Hormones|hormones|mesh-ancestor
56129067|NCT03292926|BB 1101|bb 1101|mesh-list
56129068|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56129069|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
56129070|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
56129071|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129072|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129073|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56129074|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
55856039|NCT00499408|Vitamin D|vitamin d|mesh-list
56129075|NCT03292926|Hormones|hormones|mesh-ancestor
56129076|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129077|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56129078|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129079|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
56129080|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129081|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129082|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
56129083|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
56129084|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129085|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
56129087|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
56129088|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56129089|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56129090|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56129091|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129092|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808929|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
56129093|NCT04990284|Levodopa|levodopa|mesh-list
56129094|NCT04990284|Opicapone|opicapone|mesh-list
56129095|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56129096|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56129097|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
56129098|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129099|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129100|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226936|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226937|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56226938|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
56226939|NCT03606980|Hormones|hormones|mesh-ancestor
55808985|NCT04216693|Digoxin|digoxin|mesh-list
55808986|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55808987|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55808992|NCT01364389|Prednisone|prednisone|mesh-list
56226940|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56226941|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56226942|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129101|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56129102|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129103|NCT04962126|Atezolizumab|atezolizumab|mesh-list
56129104|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
55809059|NCT04983121|Antibodies|antibodies|mesh-list
55809131|NCT02357901|Buprenorphine|buprenorphine|mesh-list
56129105|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55788943|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56129106|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129107|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129108|NCT05338086|Vitamin D|vitamin d|mesh-list
56129109|NCT05338086|Denosumab|denosumab|mesh-list
56129110|NCT05338086|Calcium|calcium|mesh-list
56129111|NCT05338086|Vitamins|vitamins|mesh-ancestor
56129112|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
56129113|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129114|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56129115|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56129116|NCT04858854|Sulforaphane|sulforaphane|mesh-list
56129117|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56129118|NCT04858854|Protective Agents|protective agents|mesh-ancestor
55809195|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55809196|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129119|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129120|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809258|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55809343|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809344|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809345|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
56129122|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56129123|NCT04582968|Capecitabine|capecitabine|mesh-list
56129124|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56129125|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
56129126|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129127|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129128|NCT03261570|Digoxin|digoxin|mesh-list
56129129|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55809416|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809417|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
55809419|NCT02286843|Pertuzumab|pertuzumab|mesh-list
55809420|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129130|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56129131|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56129132|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129133|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129134|NCT03261570|Protective Agents|protective agents|mesh-ancestor
56129135|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129136|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56129137|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
56129138|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129139|NCT03227562|Risperidone|risperidone|mesh-list
56129140|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56129141|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
56129142|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129143|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129144|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809552|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
55809553|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55809554|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809555|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
55809556|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
55809557|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55809558|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55809559|NCT02495077|Protective Agents|protective agents|mesh-ancestor
55809560|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
55809561|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55809562|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55809563|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55809564|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129145|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56129146|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56129147|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129148|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56129149|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56129150|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
56129151|NCT04278378|Folic Acid|folic acid|mesh-list
56129152|NCT04278378|Riboflavin|riboflavin|mesh-list
55809607|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55809608|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
55809609|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55809610|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809612|NCT02493751|Axitinib|axitinib|mesh-list
56129153|NCT04278378|Hematinics|hematinics|mesh-ancestor
56129154|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
56129155|NCT04278378|Vitamins|vitamins|mesh-ancestor
56129156|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
56129157|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129158|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56129159|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
56129160|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
56129161|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56226943|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
56226944|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226945|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226946|NCT03576417|Nivolumab|nivolumab|mesh-list
56226947|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226948|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809678|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809679|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809738|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
56226949|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55809817|NCT02472847|Dronabinol|dronabinol|mesh-list
56226950|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226951|NCT03573115|Adapalene|adapalene|mesh-list
56226952|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56226953|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
55809909|NCT02469961|Analgesics|analgesics|mesh-ancestor
55809988|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
55809989|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55809990|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809991|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810071|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810072|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226954|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56226955|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56226956|NCT03573115|Analgesics|analgesics|mesh-ancestor
56226957|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
56226958|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226959|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810507|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810508|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56226960|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56226961|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56226962|NCT03569475|Milnacipran|milnacipran|mesh-list
56226963|NCT03569475|Fluoxetine|fluoxetine|mesh-list
55810916|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810922|NCT05147415|Metoprolol|metoprolol|mesh-list
56226964|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
56226965|NCT03569475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56129162|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56129163|NCT04551144|Estradiol|estradiol|mesh-list
56129164|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56129165|NCT04551144|Testosterone|testosterone|mesh-list
56129166|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
56129167|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
56129168|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56129169|NCT04551144|Estrogens|estrogens|mesh-ancestor
55811004|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811005|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
55811006|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811016|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
55811174|NCT05651373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811175|NCT05651373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811406|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55811407|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55811408|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
55811409|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55811410|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811411|NCT04800471|Insulin|insulin|mesh-list
55811412|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55811413|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811414|NCT01582191|Everolimus|everolimus|mesh-list
56129170|NCT04551144|Hormones|hormones|mesh-ancestor
56129171|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129172|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129173|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56129174|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
56129175|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56129176|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56129177|NCT04551144|Androgens|androgens|mesh-ancestor
55811794|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811795|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811796|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55811798|NCT02205333|Durvalumab|durvalumab|mesh-list
55811799|NCT02205333|Tremelimumab|tremelimumab|mesh-list
55811805|NCT04776369|Lidocaine|lidocaine|mesh-list
56129178|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56129179|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129180|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
56129181|NCT04785924|Imipenem|imipenem|mesh-list
56129182|NCT04785924|Relebactam|relebactam|mesh-list
56129183|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56129184|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129185|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56129186|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811859|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55811860|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55811861|NCT02202837|Analgesics|analgesics|mesh-ancestor
55811862|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
55811863|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811864|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811865|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811866|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129187|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129188|NCT04774380|Carboplatin|carboplatin|mesh-list
56129189|NCT04774380|Etoposide|etoposide|mesh-list
56129190|NCT04774380|Durvalumab|durvalumab|mesh-list
56129191|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226966|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56226967|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55802756|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56129192|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55811928|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
55811929|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811930|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55811931|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55811933|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129193|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56129194|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56129195|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129196|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129197|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129198|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
56129199|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
55811994|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811995|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811996|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
55811998|NCT02434081|Nivolumab|nivolumab|mesh-list
56129200|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56129201|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56129202|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129203|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812065|NCT02217501|Aspirin|aspirin|mesh-list
56129204|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129205|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129206|NCT05167734|Dextrans|dextrans|mesh-list
56129207|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
56129208|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
56129209|NCT05167734|Hematinics|hematinics|mesh-ancestor
56129210|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
56129211|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
55812142|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812143|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55812144|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55812145|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
55812146|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
56129212|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
56129213|NCT04451772|Upadacitinib|upadacitinib|mesh-list
56129214|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56129215|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56129216|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129217|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129218|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129219|NCT03831984|Bromfenac|bromfenac|mesh-list
55812208|NCT02395081|Vitamins|vitamins|mesh-list
55812209|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
55812210|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812211|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55792908|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
55812213|NCT04905277|Atenolol|atenolol|mesh-list
55812214|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55812215|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56129220|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
56129221|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56129222|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
56129223|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856201|NCT00557362|Natamycin|natamycin|mesh-list
56129224|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
56129225|NCT03831984|Protective Agents|protective agents|mesh-ancestor
56129226|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56129227|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56129228|NCT03831984|Analgesics|analgesics|mesh-ancestor
56129229|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
56129230|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129231|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56129232|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129233|NCT02084706|Triamcinolone|triamcinolone|mesh-list
56129234|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55812340|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812341|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55812342|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55812343|NCT01649791|Growth Substances|growth substances|mesh-ancestor
55812344|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
55812345|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812347|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55812348|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55812362|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56129235|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56129237|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56129238|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
56129239|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
56129241|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129242|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
56129243|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129244|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56129245|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56129246|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55812412|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
55812413|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812414|NCT02379637|Protective Agents|protective agents|mesh-ancestor
55812415|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129247|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56129248|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129249|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56129250|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
56129251|NCT02084706|Hormones|hormones|mesh-ancestor
56129252|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129253|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56129254|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
56129255|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129256|NCT04704024|Tenofovir|tenofovir|mesh-list
56129257|NCT04704024|Lamivudine|lamivudine|mesh-list
56129258|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
56129259|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812483|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812484|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55812485|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55812486|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55812487|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812488|NCT02213055|Permethrin|permethrin|mesh-list
55812489|NCT02213055|Malathion|malathion|mesh-list
55812490|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812491|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812492|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55812493|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
55812494|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812496|NCT02309515|Lenalidomide|lenalidomide|mesh-list
55812536|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
55812537|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812538|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812539|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55812541|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55812542|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
55812543|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56129260|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56226968|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226969|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56226970|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
56226971|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56226972|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55812604|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812605|NCT01618162|Liraglutide|liraglutide|mesh-list
55812606|NCT01618162|Xultophy|xultophy|mesh-list
55812607|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55812608|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812609|NCT01618162|Incretins|incretins|mesh-ancestor
55812610|NCT01618162|Hormones|hormones|mesh-ancestor
56226973|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
56129261|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56129262|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812751|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
55812752|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
55812753|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
55812754|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
55812756|NCT02135445|Relugolix|relugolix|mesh-list
56129263|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129264|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56129265|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56129266|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
56129267|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56129268|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129269|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812830|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55812831|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55812832|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55812834|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55812835|NCT01648699|Narcotics|narcotics|mesh-ancestor
55812896|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812898|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
56129270|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56129271|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56129272|NCT04433988|Protective Agents|protective agents|mesh-ancestor
56129273|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129274|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
56129275|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56129276|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
56129277|NCT04685538|Tetracaine|tetracaine|mesh-list
55812979|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
55812980|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55812981|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55812982|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56129278|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
56129279|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
56129280|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
56129281|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129282|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129283|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
56129284|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129285|NCT03252756|Cannabidiol|cannabidiol|mesh-list
56129286|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
56129287|NCT05121246|Palivizumab|palivizumab|mesh-list
56129288|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
55813198|NCT05412875|Nicotine|nicotine|mesh-list
55813284|NCT05610371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129289|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129290|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
56129291|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129292|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
56129293|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56129294|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56129295|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129296|NCT04344678|Urological Agents|urological agents|mesh-ancestor
55813520|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
55813521|NCT05365451|Metformin|metformin|mesh-list
55813522|NCT05365451|Probenecid|probenecid|mesh-list
56129297|NCT04075110|Montelukast|montelukast|mesh-list
56129298|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56129299|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56129300|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56129301|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
56129302|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129303|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856245|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
56129304|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56129305|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55813698|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56129306|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129308|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56129309|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56129310|NCT03249558|Narcotics|narcotics|mesh-ancestor
56129311|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129314|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
56129315|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813776|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55813777|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813784|NCT02335411|Capecitabine|capecitabine|mesh-list
55813892|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813988|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813989|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56129316|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56129317|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56129318|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56129319|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129320|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129321|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
56226974|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814066|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
55814067|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814068|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55814069|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
55814070|NCT05218889|Antiviral Agents|antiviral agents|mesh-ancestor
55814071|NCT05218889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814072|NCT05218889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814073|NCT05218889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814074|NCT05218889|Immunologic Factors|immunologic factors|mesh-ancestor
55814075|NCT05218889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814076|NCT05554367|Palbociclib|palbociclib|mesh-list
55814077|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814078|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55814079|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226975|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56226976|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56226977|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226978|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56226979|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56226980|NCT03569475|Analgesics|analgesics|mesh-ancestor
56226981|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
56226982|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56226983|NCT03546556|Alovudine|alovudine|mesh-list
55814121|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814122|NCT05254925|Emollients|emollients|mesh-ancestor
55814123|NCT05205473|Lidocaine|lidocaine|mesh-list
55814124|NCT05205473|Anesthetics|anesthetics|mesh-list
55814125|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
55814126|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814127|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814128|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
56226984|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
56226985|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
56226986|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56226987|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
56226988|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56226989|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55802765|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55814183|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814208|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
55814209|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814210|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814211|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
55814212|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129322|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56129323|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
56129324|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
56129325|NCT03220776|Gabapentin|gabapentin|mesh-list
56129326|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56129327|NCT03220776|Analgesics|analgesics|mesh-ancestor
56129328|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
56129329|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129330|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129331|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
56129332|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55814298|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55814299|NCT05247125|Melatonin|melatonin|mesh-list
55814300|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814301|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
55814302|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814303|NCT05247125|Protective Agents|protective agents|mesh-ancestor
55814304|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129333|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56129334|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129335|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56129336|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56129337|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56129338|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129339|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129340|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
55814399|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55814400|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55814401|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814402|NCT02114931|Adalimumab|adalimumab|mesh-list
55814403|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814404|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55814405|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
55814406|NCT05185739|Lenvatinib|lenvatinib|mesh-list
55814407|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55814408|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793092|NCT05014711|Narcotics|narcotics|mesh-ancestor
55793093|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793094|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793095|NCT05014711|Analgesics|analgesics|mesh-ancestor
55814409|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55814410|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814411|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814413|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55814414|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814415|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55814416|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814417|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
55814418|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814432|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55814433|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55814435|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814436|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814447|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
55814448|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814449|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55814450|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
55814451|NCT02300311|Capsaicin|capsaicin|mesh-list
55814452|NCT02300311|Nonivamide|nonivamide|mesh-list
55814453|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
55814454|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814503|NCT05227937|Amikacin|amikacin|mesh-list
56129341|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
56129342|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129343|NCT03220776|Expectorants|expectorants|mesh-ancestor
56129344|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
56129345|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56129346|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
56129347|NCT03220776|Protective Agents|protective agents|mesh-ancestor
56129348|NCT03220776|Antidotes|antidotes|mesh-ancestor
56129349|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
56129350|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
56129351|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
56129352|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129353|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56129354|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129355|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56129356|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
56129357|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129358|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129359|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56129360|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129361|NCT03246828|Gliclazide|gliclazide|mesh-list
56226991|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56226992|NCT03533712|Folic Acid|folic acid|mesh-list
56226993|NCT03533712|Hematinics|hematinics|mesh-ancestor
55814698|NCT05096663|Antiviral Agents|antiviral agents|mesh-ancestor
55814699|NCT05096663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814706|NCT05096663|Hematinics|hematinics|mesh-ancestor
55814797|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814798|NCT05078879|Empagliflozin|empagliflozin|mesh-list
55814799|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55814801|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55814944|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
55814945|NCT04738149|Bimatoprost|bimatoprost|mesh-list
55814946|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55814947|NCT04218539|Psilocybin|psilocybin|mesh-list
55815072|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
55815073|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815074|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815075|NCT05016869|Capecitabine|capecitabine|mesh-list
55815076|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55815077|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
55815079|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56226994|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
56226995|NCT03533712|Vitamins|vitamins|mesh-ancestor
56226996|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
56226997|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802781|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129362|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56129363|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129364|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
55815170|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815171|NCT02141217|Amoxicillin|amoxicillin|mesh-list
55815172|NCT02141217|Clindamycin|clindamycin|mesh-list
55815173|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
55815174|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
55815175|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
56129365|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
56129366|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129367|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
56129368|NCT03918798|Procaine|procaine|mesh-list
56129369|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56129370|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
56129371|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
56129372|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815328|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55815329|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56129373|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129374|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
56129375|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129377|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
56129378|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
56129380|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56129381|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56129382|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
55815401|NCT02480621|Bupivacaine|bupivacaine|mesh-list
55815402|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
55815403|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
55815444|NCT02101359|Mydriatics|mydriatics|mesh-list
56129383|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129384|NCT03204396|Dulaglutide|dulaglutide|mesh-list
56129385|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56129390|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
56129391|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
56129392|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815467|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56129393|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56129394|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129395|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56129396|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
56129397|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129398|NCT02008656|Antidotes|antidotes|mesh-ancestor
56129399|NCT02008656|Protective Agents|protective agents|mesh-ancestor
56129400|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
55815540|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815541|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55815542|NCT01614886|Protective Agents|protective agents|mesh-ancestor
55815543|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
55815544|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55815545|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55815546|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55815547|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55815548|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55815635|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55815636|NCT01907854|Liraglutide|liraglutide|mesh-list
55815637|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815638|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815640|NCT01907854|Hormones|hormones|mesh-ancestor
55815641|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129401|NCT02008656|Vitamins|vitamins|mesh-ancestor
56129402|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
56129403|NCT04300140|Nivolumab|nivolumab|mesh-list
56129404|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129405|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129406|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56129407|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129408|NCT03174132|Lidocaine|lidocaine|mesh-list
56129409|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
56129410|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
56129411|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
56129412|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129413|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129414|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
56129415|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129416|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55815757|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
55815758|NCT02366689|Fluorides|fluorides|mesh-list
55815759|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
55815760|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
55815761|NCT02366689|Protective Agents|protective agents|mesh-ancestor
55815762|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815763|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55815764|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129417|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56129418|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56129419|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56129420|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129421|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56129422|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
56227023|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815831|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
55815832|NCT01920568|Denosumab|denosumab|mesh-list
55815833|NCT01920568|Calcium|calcium|mesh-list
55815834|NCT01920568|Vitamins|vitamins|mesh-ancestor
56227024|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
56227025|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227026|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56227027|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
56227028|NCT03518242|Capecitabine|capecitabine|mesh-list
56227029|NCT03518242|Methotrexate|methotrexate|mesh-list
56227030|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227031|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
56227032|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227033|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56227034|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56129423|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
56129424|NCT03174132|Protective Agents|protective agents|mesh-ancestor
55815893|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815894|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815895|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55815896|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
55815898|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55815899|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55815900|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55815901|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
55815902|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55815903|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55815904|NCT02065713|Golimumab|golimumab|mesh-list
55815905|NCT02065713|Methotrexate|methotrexate|mesh-list
55815906|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55815907|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
55815908|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55815909|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815910|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55815911|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
55815912|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815913|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815914|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
55815915|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815916|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55815917|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55815918|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
55815919|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129425|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
56129426|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56129427|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129429|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56129430|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129431|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815994|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
56129432|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129433|NCT01812252|Azacitidine|azacitidine|mesh-list
56129434|NCT01812252|Decitabine|decitabine|mesh-list
56129435|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56129436|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
56129437|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129438|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129439|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129440|NCT04217694|Memantine|memantine|mesh-list
56129441|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56129442|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56129443|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
56129444|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129445|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816111|NCT01864174|Metformin|metformin|mesh-list
56129446|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129447|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56129448|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56129449|NCT03818802|Niacinamide|niacinamide|mesh-list
56129450|NCT03818802|Niacin|niacin|mesh-list
56129451|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
56227035|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
56227036|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227037|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227038|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56227039|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227040|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
56227041|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56227042|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
56227043|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56227044|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
56227045|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227046|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56227047|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56227048|NCT03500549|Eculizumab|eculizumab|mesh-list
56227049|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55816178|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56227050|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227051|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
56227052|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227115|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56227116|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55816337|NCT01613326|Albuterol|albuterol|mesh-list
56129452|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
56129453|NCT03818802|Vitamins|vitamins|mesh-ancestor
56129454|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
56129455|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129456|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56129457|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
56129458|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129460|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
55816488|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56129462|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129463|NCT01625286|Paclitaxel|paclitaxel|mesh-list
56129464|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55816596|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129465|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56129466|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129467|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
56129468|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
56129469|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
56129470|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129471|NCT01583322|Nintedanib|nintedanib|mesh-list
56129472|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129473|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56129474|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129475|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129476|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
56129477|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56129478|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129479|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56129480|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56129481|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129482|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227117|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56227118|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56227119|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227121|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
56227122|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56129484|NCT05158062|Paclitaxel|paclitaxel|mesh-list
56129485|NCT05158062|Docetaxel|docetaxel|mesh-list
56129486|NCT05158062|Bevacizumab|bevacizumab|mesh-list
56129487|NCT05158062|Carboplatin|carboplatin|mesh-list
56129488|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
56129489|NCT05158062|Olaparib|olaparib|mesh-list
56129490|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56129491|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129492|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
56129493|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
56129494|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
56129495|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129496|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129497|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56129498|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56129499|NCT05158062|Growth Substances|growth substances|mesh-ancestor
56129500|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129501|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
55816750|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816751|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56129502|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56129503|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129504|NCT01176474|Nivolumab|nivolumab|mesh-list
56129505|NCT01176474|Ipilimumab|ipilimumab|mesh-list
56129506|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56129507|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
56129508|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129509|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129510|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129511|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56129512|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129513|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56129514|NCT01076868|Primaquine|primaquine|mesh-list
56129515|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
56129516|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55816966|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55817033|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
55817134|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817141|NCT02451917|Insulin|insulin|mesh-list
56129518|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129519|NCT03193866|Interferons|interferons|mesh-list
56129520|NCT03193866|Interferon-beta|interferon-beta|mesh-list
56129521|NCT03193866|Rituximab|rituximab|mesh-list
56129522|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
56129523|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
56129524|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56129525|NCT03193866|Natalizumab|natalizumab|mesh-list
56129526|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56129527|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
56129528|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129529|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129530|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
55856478|NCT01441635|Norethindrone|norethindrone|mesh-list
56129531|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129532|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817223|NCT01852162|Dabigatran|dabigatran|mesh-list
55817299|NCT02405780|Adalimumab|adalimumab|mesh-list
56129534|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129535|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56129536|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129538|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
56129539|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56129540|NCT01064466|Etoposide|etoposide|mesh-list
56129541|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
55817622|NCT05565235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129542|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56129543|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129544|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56129545|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56129546|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129547|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129548|NCT04198116|Guanfacine|guanfacine|mesh-list
56129549|NCT04198116|Varenicline|varenicline|mesh-list
56129550|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56129551|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56227123|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55794979|NCT05078463|Protective Agents|protective agents|mesh-ancestor
56227124|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129552|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
56129553|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129554|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795006|NCT05611385|Autonomic Agents|autonomic agents|mesh-ancestor
56129555|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129556|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56129557|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56129558|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56129559|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56129560|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
56129561|NCT04195776|Tenofovir|tenofovir|mesh-list
56129562|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
56129563|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129564|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56129565|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56129566|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129567|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129568|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56129569|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56129570|NCT03708588|Ticagrelor|ticagrelor|mesh-list
56129571|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56129572|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56129573|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56129574|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56129575|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
56129576|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129577|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129578|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129579|NCT04130802|Dexamethasone|dexamethasone|mesh-list
56129580|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56129581|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
56129582|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
56129583|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129584|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129585|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56129586|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
56129587|NCT04130802|Hormones|hormones|mesh-ancestor
56129588|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129589|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56129590|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129591|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
56129592|NCT03087162|Lansoprazole|lansoprazole|mesh-list
56129593|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56129594|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56129595|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55817906|NCT02356562|Ritonavir|ritonavir|mesh-list
56129596|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890132|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818048|NCT02320058|Ipilimumab|ipilimumab|mesh-list
55890198|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129597|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129598|NCT03165942|Ethanol|ethanol|mesh-list
56129599|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56129600|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129601|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129602|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129603|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
56129604|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129606|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
56129607|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
56129609|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56129610|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129611|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129612|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129613|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129614|NCT04098744|Artesunate|artesunate|mesh-list
56129615|NCT04098744|Artemisinins|artemisinins|mesh-list
56129616|NCT04098744|Artemisinin|artemisinin|mesh-list
56129617|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
56129618|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56129619|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56129620|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227126|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56227127|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227128|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56227129|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227130|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
56227131|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227132|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
56227133|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227134|NCT03325439|Brivaracetam|brivaracetam|mesh-list
56227135|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
56227136|NCT03242772|Amphetamine|amphetamine|mesh-list
56227137|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56129621|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129622|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
56129623|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
56129624|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56129625|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
56129626|NCT03162432|Vitamin D|vitamin d|mesh-list
56129627|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
56129628|NCT03162432|Vitamins|vitamins|mesh-ancestor
55818447|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56129629|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
56129630|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129631|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56129632|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56129633|NCT04084314|Erenumab|erenumab|mesh-list
56129634|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56129635|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129636|NCT04084314|Analgesics|analgesics|mesh-ancestor
55818510|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55818511|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
55818512|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818513|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818514|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55818527|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818528|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55818529|NCT02083965|Factor VIII|factor viii|mesh-list
55818530|NCT02083965|Coagulants|coagulants|mesh-ancestor
55818531|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55818532|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818533|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818534|NCT04683627|Diclofenac|diclofenac|mesh-list
55818535|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55818537|NCT04683627|Analgesics|analgesics|mesh-ancestor
55818538|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
55818539|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818540|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818541|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55818542|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55818543|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55818544|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818545|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818546|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
55818547|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55818548|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55818549|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
55818551|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
56129637|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
56129638|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129639|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129640|NCT03392376|Haloperidol|haloperidol|mesh-list
56129641|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
56129642|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
56129643|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
56129644|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129645|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129646|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56129647|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56129648|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55764082|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719684|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719685|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719687|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
55719688|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
55719689|NCT03490123|Azithromycin|azithromycin|mesh-list
55719690|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55719691|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719692|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
55719693|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55719694|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719696|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55719697|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55719698|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719699|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55719701|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719702|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719703|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55719704|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55719705|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55719706|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719707|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55719708|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55719709|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55719710|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55719711|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55719712|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55719713|NCT01388491|Desogestrel|desogestrel|mesh-list
55719714|NCT01388491|Estradiol|estradiol|mesh-list
55719715|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55719716|NCT01388491|Estrogens|estrogens|mesh-ancestor
55719717|NCT01388491|Hormones|hormones|mesh-ancestor
55719718|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719719|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719720|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55719722|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55719723|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55719724|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55719725|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55719726|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55719727|NCT01388491|Progestins|progestins|mesh-ancestor
55719728|NCT02236169|Bromides|bromides|mesh-list
55719729|NCT02236169|Norflurane|norflurane|mesh-list
55719730|NCT02236169|Ipratropium|ipratropium|mesh-list
55719731|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
55719732|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55719733|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
55719734|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719735|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719736|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55719737|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
55719738|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55719739|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
55719740|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719741|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719742|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
55719743|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719744|NCT02749799|Betamethasone|betamethasone|mesh-list
55719745|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
55726436|NCT03478423|Narcotics|narcotics|mesh-ancestor
56129649|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129650|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56129651|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56129652|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
56129653|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129654|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129655|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56129656|NCT05243628|Insulin|insulin|mesh-list
56129657|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56129658|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56129659|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797525|NCT05595083|Analgesics|analgesics|mesh-ancestor
55844253|NCT00084838|Protective Agents|protective agents|mesh-ancestor
56129660|NCT05249478|Fentanyl|fentanyl|mesh-list
56129663|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
56129664|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129665|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129666|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
56129667|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129668|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56129669|NCT05249478|Narcotics|narcotics|mesh-ancestor
56129670|NCT05249478|Analgesics|analgesics|mesh-ancestor
56129671|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56129672|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56129673|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
56227138|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227139|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
56227140|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
56227141|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227142|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
56227143|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227144|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796334|NCT05545397|Propofol|propofol|mesh-list
55797537|NCT04959721|Bupivacaine|bupivacaine|mesh-list
56227145|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
56227146|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56227147|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56227148|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56227149|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56227150|NCT03236311|Adenosine|adenosine|mesh-list
56227151|NCT03236311|Regadenoson|regadenoson|mesh-list
56227152|NCT03236311|Analgesics|analgesics|mesh-ancestor
56227153|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
56227154|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227155|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227156|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56227157|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
56227158|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55802850|NCT05548465|Narcotics|narcotics|mesh-ancestor
56129674|NCT05244252|Bupivacaine|bupivacaine|mesh-list
56129675|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
56129676|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
55856626|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56129677|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129678|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129679|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
56129681|NCT03286842|Olaparib|olaparib|mesh-list
56129682|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56129683|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129684|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129686|NCT03269994|Tazobactam|tazobactam|mesh-list
56129687|NCT03269994|Piperacillin|piperacillin|mesh-list
56129688|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56129689|NCT03269994|Cefoxitin|cefoxitin|mesh-list
56129690|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56129691|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129692|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56129693|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129694|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129695|NCT05240274|Metformin|metformin|mesh-list
56129696|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56129697|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129698|NCT05244018|Vitamin D|vitamin d|mesh-list
56129699|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
56129700|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
55796376|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55796428|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55764152|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
56227159|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
56227160|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
56227161|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227162|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227163|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56227165|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56227167|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
55802875|NCT05541757|Heparin|heparin|mesh-list
56129701|NCT05244018|Vitamins|vitamins|mesh-list
56129702|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
56129703|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129704|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56129705|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56129706|NCT02398500|Ranibizumab|ranibizumab|mesh-list
56129707|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56129708|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56129709|NCT02398500|Growth Substances|growth substances|mesh-ancestor
56129710|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129711|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
56129712|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129713|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
56129714|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
56129715|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129716|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
56129717|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129718|NCT04276428|Insulin|insulin|mesh-list
55797573|NCT05575427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56129719|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56129720|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129721|NCT05248932|Norepinephrine|norepinephrine|mesh-list
56129722|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56129723|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56129724|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
56129725|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129726|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129727|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129728|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
55764212|NCT02439125|Eltoprazine|eltoprazine|mesh-list
56129729|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
56129730|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129731|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56129732|NCT03026790|Buprenorphine|buprenorphine|mesh-list
56129733|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56129734|NCT03026790|Naloxone|naloxone|mesh-list
56129735|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56129736|NCT03026790|Narcotics|narcotics|mesh-ancestor
56129737|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764219|NCT02441933|Taxane|taxane|mesh-list
56129738|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129739|NCT03026790|Analgesics|analgesics|mesh-ancestor
56129740|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
56129741|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129742|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56129743|NCT02392026|Metronidazole|metronidazole|mesh-list
56129744|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129745|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56129746|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56129747|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56129748|NCT03003546|Paclitaxel|paclitaxel|mesh-list
56129749|NCT03003546|Rituximab|rituximab|mesh-list
55796614|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55764254|NCT02438657|Epinephrine|epinephrine|mesh-list
56129750|NCT03003546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56129751|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56129752|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129753|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
56129754|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
56129755|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
56129756|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227168|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227169|NCT03223974|Paclitaxel|paclitaxel|mesh-list
55796637|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
55797612|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
56227170|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56227171|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227172|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
56129757|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129758|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
56129770|NCT02395614|Bacitracin|bacitracin|mesh-list
56129771|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
56129772|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796700|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796746|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56129773|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56129774|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
56129775|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56129776|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129777|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129778|NCT04396938|Lamotrigine|lamotrigine|mesh-list
56129779|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
56129780|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56129781|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56129782|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129783|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56129784|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129785|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56129786|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56129787|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129788|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56129789|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56129790|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56129791|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
56129792|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129794|NCT02914158|Leuprolide|leuprolide|mesh-list
56129795|NCT02914158|Goserelin|goserelin|mesh-list
56129796|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56129797|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56129798|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
56129799|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129800|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129801|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56129802|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890199|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56129803|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56129804|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56129805|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56129806|NCT02914158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56129807|NCT02914158|Fertility Agents|fertility agents|mesh-ancestor
56129808|NCT02914158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56129809|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56129810|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129811|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129812|NCT03136146|Dexamethasone|dexamethasone|mesh-list
55796881|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129813|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
56129814|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
56129815|NCT03136146|Rituximab|rituximab|mesh-list
56129816|NCT03136146|Etoposide|etoposide|mesh-list
56129817|NCT03136146|Vincristine|vincristine|mesh-list
56129818|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
56129819|NCT03136146|Bortezomib|bortezomib|mesh-list
56129820|NCT03136146|Clofarabine|clofarabine|mesh-list
56129821|NCT03136146|Ofatumumab|ofatumumab|mesh-list
56129822|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
55890200|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
55797039|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797040|NCT05536193|Analgesics|analgesics|mesh-ancestor
55797041|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
55797042|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797043|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797044|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797045|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56129823|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56129824|NCT03136146|Antibodies|antibodies|mesh-list
56129825|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
56129826|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56129827|NCT03136146|Lenograstim|lenograstim|mesh-list
56129828|NCT03136146|BB 1101|bb 1101|mesh-list
56129831|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129832|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129833|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56129834|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
55797650|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
55797141|NCT05678933|Hormones|hormones|mesh-ancestor
56129835|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129836|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129837|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56129838|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56129840|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
56129841|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129842|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56129843|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
56129844|NCT03136146|Hormones|hormones|mesh-ancestor
56129845|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56129846|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56129847|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
56129848|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129849|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56129850|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56129851|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56129852|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56129853|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
56129854|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
56129855|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
56129856|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56129857|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
56129858|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
56129859|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
56129860|NCT05241132|Paclitaxel|paclitaxel|mesh-list
56129861|NCT05241132|Cisplatin|cisplatin|mesh-list
56129862|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56129863|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129864|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
56129866|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
56129867|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129868|NCT05241054|Acetaminophen|acetaminophen|mesh-list
56129869|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
56129870|NCT05241054|Fentanyl|fentanyl|mesh-list
55797181|NCT05678621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56129871|NCT05241054|Bupivacaine|bupivacaine|mesh-list
56129872|NCT05241054|Propofol|propofol|mesh-list
56129873|NCT05241054|Sevoflurane|sevoflurane|mesh-list
56129874|NCT05241054|Atracurium|atracurium|mesh-list
56129875|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
56129876|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
56129877|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129878|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129879|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
56129880|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129881|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56129882|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56129883|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
56129884|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56129885|NCT05241054|Narcotics|narcotics|mesh-ancestor
56129886|NCT05241054|Analgesics|analgesics|mesh-ancestor
56129887|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56129888|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56129889|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
56129890|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56129891|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56129892|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
55828069|NCT04013555|Tryptophan|tryptophan|mesh-list
55828070|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55828071|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
55828072|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828073|NCT04013555|Expectorants|expectorants|mesh-ancestor
55828074|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
55828075|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55828076|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
55828077|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828078|NCT04013555|Protective Agents|protective agents|mesh-ancestor
55719830|NCT02934529|Hematinics|hematinics|mesh-ancestor
55719831|NCT02638805|Metformin|metformin|mesh-list
55719832|NCT02638805|Liraglutide|liraglutide|mesh-list
55719833|NCT02638805|Exenatide|exenatide|mesh-list
55719834|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55719835|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719836|NCT02638805|Incretins|incretins|mesh-ancestor
55719837|NCT02638805|Hormones|hormones|mesh-ancestor
55719838|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719839|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55719840|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
55719841|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55719842|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719843|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719844|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719845|NCT02261675|Analgesics|analgesics|mesh-ancestor
55719846|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
55719847|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719848|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55719849|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55719850|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55719851|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
55719852|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719853|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719854|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55719856|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55719857|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55719858|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
55719859|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719860|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55719861|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55719862|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719863|NCT02620553|Insulin|insulin|mesh-list
55719864|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55719865|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55719866|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719867|NCT04588727|Aspirin|aspirin|mesh-list
55719868|NCT04588727|Ticagrelor|ticagrelor|mesh-list
55719869|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55719870|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719871|NCT04588727|Analgesics|analgesics|mesh-ancestor
55719872|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
55719873|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726695|NCT01601626|Lopinavir|lopinavir|mesh-list
56129893|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56129894|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56129895|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56129896|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56129897|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56129898|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
56129899|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56129900|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129901|NCT00638508|Ketorolac|ketorolac|mesh-list
56129902|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56129903|NCT00638508|Ropivacaine|ropivacaine|mesh-list
56129904|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
56129905|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
56129906|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129908|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
56129909|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856850|NCT01421667|Rituximab|rituximab|mesh-list
56129910|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56129911|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56129912|NCT00638508|Analgesics|analgesics|mesh-ancestor
56227173|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
56227174|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
56227175|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227176|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
55764423|NCT05534685|Budesonide|budesonide|mesh-list
55720335|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720336|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720337|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720338|NCT01298687|Travoprost|travoprost|mesh-list
55720339|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55720341|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55720342|NCT02267057|Acetaminophen|acetaminophen|mesh-list
55720344|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55720345|NCT02267057|Analgesics|analgesics|mesh-ancestor
55720346|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
55720347|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720348|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720349|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
55720350|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55720351|NCT02267057|Narcotics|narcotics|mesh-ancestor
55720352|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720353|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55720354|NCT05260541|Pramoxine|pramoxine|mesh-list
55720355|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
55720356|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
55720357|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720358|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720359|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
55720360|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720361|NCT01262261|Buprenorphine|buprenorphine|mesh-list
55720362|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55720363|NCT01262261|Narcotics|narcotics|mesh-ancestor
55720364|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720365|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720368|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720369|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55720370|NCT02267681|Fentanyl|fentanyl|mesh-list
55720371|NCT02267681|Alfentanil|alfentanil|mesh-list
55720372|NCT02267681|Propofol|propofol|mesh-list
55720373|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55720374|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720375|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720376|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55720378|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
55720379|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55720380|NCT02267681|Narcotics|narcotics|mesh-ancestor
55720381|NCT02267681|Analgesics|analgesics|mesh-ancestor
55720382|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
55720383|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720384|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55720385|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
55720386|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55720387|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55720388|NCT05177939|Prednisolone|prednisolone|mesh-list
55720389|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
55720390|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55720391|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
55720392|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
55720393|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55720394|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
55720395|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55720396|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720398|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
55720399|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720400|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720401|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55720402|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
55720403|NCT05177939|Hormones|hormones|mesh-ancestor
55720519|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
56227177|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56227178|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227179|NCT03190369|Hylan|hylan|mesh-list
56227180|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
56227181|NCT03190369|Protective Agents|protective agents|mesh-ancestor
56227182|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227183|NCT05438316|Ramipril|ramipril|mesh-list
56227184|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56227185|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
56227186|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797414|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56227187|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227188|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56227189|NCT05438108|Bevacizumab|bevacizumab|mesh-list
56227190|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227191|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227192|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56227193|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56129913|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56129914|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129915|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56129916|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129917|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129918|NCT00637806|Megestrol|megestrol|mesh-list
56129919|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
56129920|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56129921|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56129922|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56129923|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
56129924|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56129925|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129926|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55797474|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797718|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56129927|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56129928|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56129929|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129930|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
56129931|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56129932|NCT00637728|Megestrol|megestrol|mesh-list
56129933|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
56129934|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56129936|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56129937|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
56129938|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55789020|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56129939|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129940|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56129941|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56129942|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56227194|NCT05438108|Growth Substances|growth substances|mesh-ancestor
56227195|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227196|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
56129943|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129945|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56129947|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56129948|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56129949|NCT01922466|Analgesics|analgesics|mesh-ancestor
56129950|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
56129951|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56129952|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129953|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56129954|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129955|NCT00637572|Megestrol|megestrol|mesh-list
56129956|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
56129957|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56129958|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56129959|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55797547|NCT04959721|Hormones|hormones|mesh-ancestor
56129960|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
56129961|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56129962|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129963|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56129964|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56129965|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56129966|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129967|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
56129968|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56129969|NCT00637416|Lansoprazole|lansoprazole|mesh-list
56129970|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
56129971|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56129972|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56129973|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56129974|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56129975|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129976|NCT00636792|Rituximab|rituximab|mesh-list
56129977|NCT00636792|Bortezomib|bortezomib|mesh-list
56129978|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56129979|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56129980|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129981|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
56129982|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866658|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56129983|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129984|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56129985|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
56129986|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129987|NCT00636636|Gabapentin|gabapentin|mesh-list
56129988|NCT00636636|Analgesics|analgesics|mesh-ancestor
55744456|NCT03324685|Estradiol|estradiol|mesh-list
56129989|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
56129990|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797678|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
55797680|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
56129991|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129992|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
56129993|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56129994|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56129995|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129996|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56129997|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56129998|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56129999|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130000|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130001|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
56130002|NCT05244954|Chloroquine|chloroquine|mesh-list
56130003|NCT05244954|Piperaquine|piperaquine|mesh-list
56130004|NCT05244954|Artenimol|artenimol|mesh-list
56130005|NCT05244954|Amebicides|amebicides|mesh-ancestor
56130006|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56130007|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56130008|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130009|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
56227197|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56227198|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227199|NCT05437783|Azithromycin|azithromycin|mesh-list
56227200|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56227201|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227202|NCT05437718|Ropivacaine|ropivacaine|mesh-list
56227203|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
56227204|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
56227205|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56227206|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227207|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
56227208|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227209|NCT05437497|Propofol|propofol|mesh-list
56227210|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56227211|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56227212|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227213|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56130010|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130011|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
56130012|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
56130013|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56130014|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720485|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
55720486|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
55720487|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720488|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55720489|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55720490|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720491|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720492|NCT01235039|Insulin|insulin|mesh-list
55720493|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
55720494|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55720495|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55720496|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720498|NCT01234025|Docetaxel|docetaxel|mesh-list
55720499|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720500|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
55720501|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
55720502|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
55720503|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720504|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720505|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
55720506|NCT01234025|Hormones|hormones|mesh-ancestor
55720507|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720508|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720509|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55720510|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55720511|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720512|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55720513|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720514|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720515|NCT01207115|Naproxen|naproxen|mesh-list
55720516|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55720517|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55720518|NCT01207115|Analgesics|analgesics|mesh-ancestor
56130015|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130016|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56130017|NCT01929252|Analgesics|analgesics|mesh-ancestor
56130018|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
56130019|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130020|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56130021|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56130022|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55797717|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56130023|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
56130024|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130025|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130026|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
56130027|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
56130028|NCT04275960|Selitrectinib|selitrectinib|mesh-list
56130029|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130030|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130031|NCT00634920|Cyclosporine|cyclosporine|mesh-list
56130032|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
56130033|NCT00634920|Prednisolone|prednisolone|mesh-list
56130034|NCT00634920|Everolimus|everolimus|mesh-list
56130035|NCT00634920|Cyclosporins|cyclosporins|mesh-list
55797786|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
56130036|NCT00634920|Basiliximab|basiliximab|mesh-list
56130037|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130038|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130039|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56130040|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
56130041|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130042|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
56130043|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130044|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
56130046|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56130047|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130048|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56130049|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56130050|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
56130051|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56227214|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
56227215|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
56227216|NCT05437471|Letrozole|letrozole|mesh-list
56227217|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
56227218|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800400|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55800401|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55800419|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55797892|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797893|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56227219|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55802929|NCT05540431|Charcoal|charcoal|mesh-list
56130053|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
56130054|NCT00634920|Hormones|hormones|mesh-ancestor
56130055|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130056|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56130057|NCT01923012|Vitamin K|vitamin k|mesh-list
55856997|NCT01400451|Ipilimumab|ipilimumab|mesh-list
56130058|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
56130059|NCT01923012|Vitamins|vitamins|mesh-ancestor
56130060|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
56130061|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145002|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
56130062|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56130063|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56130064|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130065|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
56130066|NCT01923012|Coagulants|coagulants|mesh-ancestor
56130067|NCT01923090|Finasteride|finasteride|mesh-list
56130068|NCT01923090|Dutasteride|dutasteride|mesh-list
56130069|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56130070|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56130071|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130072|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130073|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
56130074|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130075|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130076|NCT01923090|Urological Agents|urological agents|mesh-ancestor
56130077|NCT01929330|Dutasteride|dutasteride|mesh-list
56130078|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56130079|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56130080|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130081|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130082|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
56130083|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130084|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130085|NCT00634842|Insulin|insulin|mesh-list
56130086|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56130087|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
56130088|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56130089|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130090|NCT04396548|Midodrine|midodrine|mesh-list
56130091|NCT04396548|Anesthetics|anesthetics|mesh-list
56130092|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130093|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130094|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
56130095|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
56130096|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130097|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56130098|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56130099|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56130101|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
56130102|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744479|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56130103|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130105|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56130106|NCT00633984|Cycloserine|cycloserine|mesh-list
56130107|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56130108|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130109|NCT00633984|Renal Agents|renal agents|mesh-ancestor
56130110|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56130111|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
56130112|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56130113|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
56130114|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227220|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56227221|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227222|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227223|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56227224|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
56130115|NCT04395612|Niraparib|niraparib|mesh-list
56130116|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56130117|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145284|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56130118|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130119|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130120|NCT01923558|Donepezil|donepezil|mesh-list
56130121|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56130122|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130123|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130125|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130126|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130127|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
56130128|NCT01921218|Cyclosporine|cyclosporine|mesh-list
56130129|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
56130130|NCT01921218|Prednisone|prednisone|mesh-list
56130131|NCT01921218|Abatacept|abatacept|mesh-list
56130132|NCT01921218|Tacrolimus|tacrolimus|mesh-list
55857079|NCT01399593|Eculizumab|eculizumab|mesh-list
56130133|NCT01921218|Cyclosporins|cyclosporins|mesh-list
56130134|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56145338|NCT00892710|Pemetrexed|pemetrexed|mesh-list
56145373|NCT00896064|Vaccines|vaccines|mesh-list
56130135|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56130136|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
56130137|NCT01921218|Hormones|hormones|mesh-ancestor
56145400|NCT00902226|Citalopram|citalopram|mesh-list
56130138|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130139|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130140|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56130141|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130142|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56130143|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
56130144|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130145|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130146|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
56130147|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130148|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
56130149|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130150|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56130151|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56130152|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
56130153|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56130154|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56130155|NCT03129828|Bortezomib|bortezomib|mesh-list
56130156|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130157|NCT01922076|Adavosertib|adavosertib|mesh-list
56130158|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130159|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130160|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56130161|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130162|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56145457|NCT00908466|Sirolimus|sirolimus|mesh-list
56130163|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130164|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130165|NCT00633360|Drospirenone|drospirenone|mesh-list
56130166|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56130167|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56130168|NCT00633360|Estradiol|estradiol|mesh-list
56130169|NCT00633360|Estrogens|estrogens|mesh-ancestor
56130170|NCT00633360|Hormones|hormones|mesh-ancestor
56130171|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130172|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130173|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56130174|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
56130175|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56130176|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56227225|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56227226|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227228|NCT05437471|Hormones|hormones|mesh-ancestor
56227229|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
56227230|NCT05437432|Methamphetamine|methamphetamine|mesh-list
56227231|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56227232|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227233|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
56130177|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56130178|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55890356|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56130179|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56130180|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
56130181|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56130182|NCT00633360|Diuretics|diuretics|mesh-ancestor
56130183|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
56130184|NCT00988260|Ganirelix|ganirelix|mesh-list
56130185|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
56130186|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130187|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130188|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56130189|NCT00633126|Cephalosporins|cephalosporins|mesh-list
56130190|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56130191|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130192|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
56130193|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130194|NCT01923870|Enclomiphene|enclomiphene|mesh-list
56130195|NCT01923870|Clomiphene|clomiphene|mesh-list
56130196|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
56130197|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56130200|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130201|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56130202|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
56130203|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56130204|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56130205|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56130206|NCT00632736|Ropinirole|ropinirole|mesh-list
55857148|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
56130207|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56130208|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56130209|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
56130210|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
56130211|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130212|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130213|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130215|NCT01923948|Analgesics|analgesics|mesh-ancestor
56130216|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
56130217|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130218|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130219|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
56130220|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56130221|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56130222|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130223|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56130224|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56145719|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130225|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56130226|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130227|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56130228|NCT00989196|Factor VIII|factor viii|mesh-list
56130229|NCT00989196|Coagulants|coagulants|mesh-ancestor
56130231|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56130232|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56130233|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130235|NCT00631488|Hormones|hormones|mesh-ancestor
56130236|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56227234|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
56227235|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890357|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130237|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56130238|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
56130239|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130240|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130241|NCT01924104|Aspirin|aspirin|mesh-list
56130242|NCT01924104|Heparin|heparin|mesh-list
56130243|NCT01924104|Calcium heparin|calcium heparin|mesh-list
56130244|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56130245|NCT01924104|Tinzaparin|tinzaparin|mesh-list
56130246|NCT01924104|Dalteparin|dalteparin|mesh-list
56130247|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56130248|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56130249|NCT01924104|Analgesics|analgesics|mesh-ancestor
56145902|NCT00987480|Busulfan|busulfan|mesh-list
56130250|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
56130251|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130252|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130253|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56130254|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130255|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56130256|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56130257|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130258|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56130259|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56130260|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130261|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
56130262|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
56130263|NCT00987402|Ethanol|ethanol|mesh-list
56130264|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56130265|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130266|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130267|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130268|NCT00630786|Panitumumab|panitumumab|mesh-list
56130270|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56130274|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130276|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56130277|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56130278|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130279|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
56130280|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
56130281|NCT00630552|Conatumumab|conatumumab|mesh-list
56130282|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56145968|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
56130283|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130284|NCT04347720|Acetaminophen|acetaminophen|mesh-list
56130285|NCT04347720|Ibuprofen|ibuprofen|mesh-list
56130286|NCT04347720|Indomethacin|indomethacin|mesh-list
56130287|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56130288|NCT04347720|Analgesics|analgesics|mesh-ancestor
56130289|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
56130290|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130291|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130292|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
56130293|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56130294|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56130295|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130296|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56130297|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130298|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130299|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
56130300|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
56130301|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56130302|NCT01925352|Mitogens|mitogens|mesh-list
56130303|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
56130304|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130305|NCT03095352|Carboplatin|carboplatin|mesh-list
56130306|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
56130307|NCT03095352|Trastuzumab|trastuzumab|mesh-list
56130308|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130309|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227236|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
56227237|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227238|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227239|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
56227240|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56227241|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56227242|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56227243|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56227244|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
56227245|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56227246|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227247|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
56227248|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56227249|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56227250|NCT05437224|Ambrisentan|ambrisentan|mesh-list
56227251|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56227252|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
56227253|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55802955|NCT01666951|Tacrolimus|tacrolimus|mesh-list
56130310|NCT03092856|Axitinib|axitinib|mesh-list
56130311|NCT03092856|Antibodies|antibodies|mesh-list
56130312|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
56130313|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130314|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130315|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56130316|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130317|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130318|NCT01920204|Midostaurin|midostaurin|mesh-list
56130319|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130320|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56130321|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130322|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130323|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
56130324|NCT04275258|Narcotics|narcotics|mesh-ancestor
56130325|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130326|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130327|NCT04275258|Analgesics|analgesics|mesh-ancestor
56130328|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
56130329|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130330|NCT03474744|Rituximab|rituximab|mesh-list
56130331|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56130332|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130333|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
56130334|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130335|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130336|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56130337|NCT01925820|Entecavir|entecavir|mesh-list
56130338|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
56130339|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130340|NCT01925898|Midazolam|midazolam|mesh-list
56130341|NCT01925898|Ketamine|ketamine|mesh-list
56130342|NCT01925898|Analgesics|analgesics|mesh-ancestor
56130343|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
56130345|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130346|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56130347|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56227254|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227256|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56227257|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56227258|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227259|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56227260|NCT05436964|Analgesics|analgesics|mesh-ancestor
56227261|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
56227262|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146029|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56227263|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56227264|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56227265|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56227266|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
56227267|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227268|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227275|NCT05426811|Raltitrexed|raltitrexed|mesh-list
56227276|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227278|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227279|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227280|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56227281|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227282|NCT05357859|Vitamin D|vitamin d|mesh-list
55802964|NCT05546359|Amisulpride|amisulpride|mesh-list
56130348|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
56130349|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
56130350|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130351|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56130352|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56130353|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130354|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130355|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56130356|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56130357|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56130358|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56130359|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56130360|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
56130361|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
56130362|NCT00983580|Aspirin|aspirin|mesh-list
56130363|NCT00983580|Eflornithine|eflornithine|mesh-list
56130364|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56130365|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56130366|NCT00983580|Analgesics|analgesics|mesh-ancestor
56130367|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
56227283|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
56227284|NCT05357859|Vitamins|vitamins|mesh-ancestor
56227285|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
56227286|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227287|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56227288|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56227289|NCT05265286|Factor VIII|factor viii|mesh-list
56227290|NCT05265286|Coagulants|coagulants|mesh-ancestor
56227291|NCT05239169|Capecitabine|capecitabine|mesh-list
56227292|NCT05239169|Durvalumab|durvalumab|mesh-list
56227293|NCT05239169|Tremelimumab|tremelimumab|mesh-list
56227294|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227295|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
56227296|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227297|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227298|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227299|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
56227300|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227301|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227302|NCT05006079|Morphine|morphine|mesh-list
56227303|NCT05006079|Alprazolam|alprazolam|mesh-list
56227304|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56227305|NCT05006079|Narcotics|narcotics|mesh-ancestor
56227306|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56227307|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227308|NCT05006079|Analgesics|analgesics|mesh-ancestor
56227309|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
56227310|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802994|NCT05550415|Simvastatin|simvastatin|mesh-list
56130368|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130369|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130370|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56130371|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130372|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56130373|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56130374|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130375|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56130376|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56130378|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
56130379|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130380|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56130381|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56130382|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56130383|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227311|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56227312|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56227313|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56227314|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56227315|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
56227317|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227318|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227319|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
56227320|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56227321|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
56227322|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56227323|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
56227324|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227325|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227326|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
56227327|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
56227328|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
56227329|NCT04950270|Coagulants|coagulants|mesh-ancestor
56227330|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56227331|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56227332|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
56227333|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227334|NCT04895046|Niraparib|niraparib|mesh-list
56227335|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56227336|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227337|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130384|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56130385|NCT00982878|Maraviroc|maraviroc|mesh-list
56130386|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56130387|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56130388|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130389|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56130390|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56130391|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
56130392|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130393|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56130394|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
56130395|NCT00982488|Dasatinib|dasatinib|mesh-list
56130396|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130397|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56130398|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130399|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130400|NCT00982020|Olanzapine|olanzapine|mesh-list
56130401|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
56130402|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
56130403|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130404|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227338|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227340|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56227341|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
56227342|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227343|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227344|NCT04590586|Thalidomide|thalidomide|mesh-list
56227345|NCT04590586|Apremilast|apremilast|mesh-list
56227346|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56227347|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56227348|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56227349|NCT04590586|Analgesics|analgesics|mesh-ancestor
56227350|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
56227351|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227352|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227354|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56227355|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56227356|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56227357|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227358|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227359|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227360|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
56227361|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
56227362|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56227363|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227364|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56227365|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56227366|NCT04590586|Growth Substances|growth substances|mesh-ancestor
56227367|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
56227368|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227369|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
56227370|NCT04427293|Lenvatinib|lenvatinib|mesh-list
56227379|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56227380|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56227381|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227382|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
56227383|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
56227384|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227385|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227386|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227387|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
56227388|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
56227389|NCT03850483|PF-06700841|pf-06700841|mesh-list
56227390|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56227391|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227392|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227393|NCT03819296|Prednisone|prednisone|mesh-list
56130405|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56130406|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56130407|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56130408|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130409|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56130410|NCT00982020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56130411|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56130412|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56130413|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130414|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130415|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
56130416|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
56130417|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
56130418|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130419|NCT01926132|Protective Agents|protective agents|mesh-ancestor
56130420|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130421|NCT01926132|Vitamins|vitamins|mesh-ancestor
56130422|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
56130423|NCT01926210|Letrozole|letrozole|mesh-list
56130424|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130425|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56130426|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56130427|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130428|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130429|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56130430|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
56130431|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130432|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130434|NCT01926288|Maleic acid|maleic acid|mesh-list
56130435|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130436|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130437|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
56130438|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130440|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56130441|NCT03118674|Ledipasvir|ledipasvir|mesh-list
56130442|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
56130443|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130444|NCT00981084|Modafinil|modafinil|mesh-list
56130445|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56130446|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130447|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56227394|NCT03819296|Cortisone|cortisone|mesh-list
56227395|NCT03819296|Infliximab|infliximab|mesh-list
56227396|NCT03819296|Vedolizumab|vedolizumab|mesh-list
56227397|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
56227398|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
56227399|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56227400|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
56227401|NCT03819296|Hormones|hormones|mesh-ancestor
56227402|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56227403|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227404|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56227405|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130448|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56130449|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56130450|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130451|NCT03117816|Interferons|interferons|mesh-list
56130452|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
56130453|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
56130454|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130455|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
56130456|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130457|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
56130458|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130459|NCT00980148|Azithromycin|azithromycin|mesh-list
56130460|NCT00980148|Doxycycline|doxycycline|mesh-list
56130461|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56130462|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130463|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
56130464|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56130465|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56130466|NCT04275492|Pramipexole|pramipexole|mesh-list
56130467|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
56130468|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130469|NCT04275492|Protective Agents|protective agents|mesh-ancestor
56130470|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130471|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56130472|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56130473|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
56130474|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
56130475|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130476|NCT03064854|Gemcitabine|gemcitabine|mesh-list
56130478|NCT03064854|Carboplatin|carboplatin|mesh-list
56130479|NCT03064854|Pemetrexed|pemetrexed|mesh-list
56130480|NCT03064854|Spartalizumab|spartalizumab|mesh-list
56130481|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56146091|NCT01005888|Complement C1s|complement c1s|mesh-list
56130482|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130483|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
56130484|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
56130485|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
56130486|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130487|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56130488|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
56130489|NCT03064854|Antiviral Agents|antiviral agents|mesh-ancestor
56130490|NCT03064854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130491|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130492|NCT03064854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56130493|NCT03064854|Immunologic Factors|immunologic factors|mesh-ancestor
56130495|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56130496|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56130497|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56130498|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
56130499|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56130500|NCT00983814|Carbidopa|carbidopa|mesh-list
56130501|NCT00983814|Droxidopa|droxidopa|mesh-list
56130502|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56227406|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
56227407|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
56227408|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56227409|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56227411|NCT03563742|Lamivudine|lamivudine|mesh-list
56227412|NCT03563742|Rilpivirine|rilpivirine|mesh-list
56227413|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
56227414|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227415|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56227416|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56227417|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227418|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227419|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56227420|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56227421|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56146103|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
56227422|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
56227423|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227424|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56227425|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
56227426|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227427|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227428|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56227429|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56130503|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56130504|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
56130505|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130506|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130507|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130508|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56130509|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130510|NCT01921920|Omeprazole|omeprazole|mesh-list
56130511|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56130512|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56130513|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56130514|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130515|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130516|NCT03087708|Naloxegol|naloxegol|mesh-list
56130517|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56130518|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130519|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
56130520|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130521|NCT04275414|Bevacizumab|bevacizumab|mesh-list
56130522|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56130523|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130524|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56130525|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56130526|NCT04275414|Growth Substances|growth substances|mesh-ancestor
56227430|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56227431|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
56227432|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56227433|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
56227434|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227435|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56227436|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
56227437|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227438|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227439|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56227440|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56227441|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56227442|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
56227443|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
56227444|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227445|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227446|NCT03424122|Rituximab|rituximab|mesh-list
56227447|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56227448|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227450|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
56227451|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227452|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56227453|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56227454|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
56227455|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227456|NCT03230097|BI 409306|bi 409306|mesh-list
56227457|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56130527|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130528|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
56130529|NCT04395768|Vitamin D|vitamin d|mesh-list
56130530|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
56130531|NCT04395768|Vitamins|vitamins|mesh-list
56130532|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
56130533|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
56130534|NCT04395768|Azithromycin|azithromycin|mesh-list
56130535|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
56130536|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
56130537|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130538|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56130539|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130540|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56130541|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56130542|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130543|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
56130544|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56130545|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56227458|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227459|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227460|NCT03065621|Palbociclib|palbociclib|mesh-list
56227461|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227462|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56227463|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227464|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227465|NCT02968940|Avelumab|avelumab|mesh-list
56227466|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227467|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227468|NCT02679144|Eflornithine|eflornithine|mesh-list
56227469|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227471|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56227472|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56227473|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227474|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56130546|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130547|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130548|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
56130549|NCT04395768|Protective Agents|protective agents|mesh-ancestor
56130550|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
56130551|NCT01927224|Nifurtimox|nifurtimox|mesh-list
56130552|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56130553|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56130554|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56130555|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130556|NCT04556370|Norepinephrine|norepinephrine|mesh-list
56130557|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56130558|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56130559|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
56130560|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130561|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130562|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130563|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
56130564|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
56130565|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130566|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56130567|NCT01922154|Ranibizumab|ranibizumab|mesh-list
56130568|NCT01922154|Mitomycin|mitomycin|mesh-list
56130569|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56130570|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56130571|NCT01922154|Growth Substances|growth substances|mesh-ancestor
56130572|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130573|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
56130574|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130575|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
56130576|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130577|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56130578|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56130579|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130581|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
56130582|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56130583|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
56130584|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130585|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130586|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56130587|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56227475|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227476|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227478|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56227479|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
56227480|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56227481|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227482|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56227483|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227484|NCT02333292|Ritonavir|ritonavir|mesh-list
56227485|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
56227486|NCT02333292|Grazoprevir|grazoprevir|mesh-list
56227487|NCT02333292|Ledipasvir|ledipasvir|mesh-list
56130588|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
56130589|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130590|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130591|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
56130592|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
56130594|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56130595|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130596|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130597|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130598|NCT03423342|Niacinamide|niacinamide|mesh-list
56130599|NCT03423342|Niacin|niacin|mesh-list
56130601|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
56130602|NCT03423342|Vitamins|vitamins|mesh-ancestor
56130603|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
56130604|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130605|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56130606|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
56130607|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130608|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56130609|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
56130610|NCT01928160|Carboplatin|carboplatin|mesh-list
56130611|NCT01928160|Pemetrexed|pemetrexed|mesh-list
56130612|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56130613|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130614|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130615|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130616|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56130617|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56130618|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56130619|NCT01928316|Mizolastine|mizolastine|mesh-list
56130620|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56130621|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56130622|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
56130623|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
56130624|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130625|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130626|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130627|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
56130628|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56130629|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
56130630|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130631|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130633|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56130634|NCT04559646|Coagulants|coagulants|mesh-ancestor
56130635|NCT04550520|Glucagon|glucagon|mesh-list
56130636|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56130637|NCT04550520|Hormones|hormones|mesh-ancestor
56130638|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130639|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227489|NCT02333292|Simeprevir|simeprevir|mesh-list
56227490|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56227491|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56227492|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
56227493|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227494|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227495|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56227496|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56227497|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
56227498|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227499|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56227500|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56227501|NCT02203773|Posaconazole|posaconazole|mesh-list
56227502|NCT02203773|Azacitidine|azacitidine|mesh-list
56227503|NCT02203773|Decitabine|decitabine|mesh-list
56227504|NCT02203773|Venetoclax|venetoclax|mesh-list
56227505|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227506|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
56227507|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227508|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227509|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227510|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
56227511|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227512|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56227520|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227522|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
56227528|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56227529|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56227530|NCT02175030|Trace Elements|trace elements|mesh-ancestor
56227531|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
56227532|NCT02017717|Bevacizumab|bevacizumab|mesh-list
56227533|NCT02017717|Nivolumab|nivolumab|mesh-list
56227534|NCT02017717|Ipilimumab|ipilimumab|mesh-list
56227535|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227536|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227537|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56227538|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56227539|NCT02017717|Growth Substances|growth substances|mesh-ancestor
56227540|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227541|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
56227542|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56227543|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227544|NCT01734512|Everolimus|everolimus|mesh-list
56227545|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227546|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227547|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
56227548|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227549|NCT01555541|Cytarabine|cytarabine|mesh-list
56227550|NCT01555541|Etoposide|etoposide|mesh-list
56227551|NCT01555541|Ofatumumab|ofatumumab|mesh-list
56227552|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56227553|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227554|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56227555|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56227556|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130640|NCT01928628|Valsartan|valsartan|mesh-list
56130641|NCT01928628|Lercanidipine|lercanidipine|mesh-list
56130642|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56130643|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56130645|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130646|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56130647|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56130648|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56130649|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130650|NCT01929096|Edaravone|edaravone|mesh-list
56130651|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56130652|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
56130653|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130654|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56130655|NCT01929096|Protective Agents|protective agents|mesh-ancestor
56130656|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130657|NCT03059004|TEMPO|tempo|mesh-list
56227557|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227558|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227559|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
56227560|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
56227561|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227562|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227563|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
56227564|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227565|NCT01398852|Riboflavin|riboflavin|mesh-list
56227566|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
56227567|NCT01398852|Vitamins|vitamins|mesh-ancestor
56227568|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
56227569|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227570|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56227571|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
56227572|NCT01398839|Riboflavin|riboflavin|mesh-list
56227573|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
56227574|NCT01398839|Vitamins|vitamins|mesh-ancestor
56227575|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
56227576|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227577|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56227578|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
56227579|NCT00496795|Docetaxel|docetaxel|mesh-list
56227580|NCT00496795|Epirubicin|epirubicin|mesh-list
56227581|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227582|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
56227583|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
56227584|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
56227585|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227586|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56227587|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56227588|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56227589|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227590|NCT00316888|Cisplatin|cisplatin|mesh-list
56227591|NCT00316888|Fluorouracil|fluorouracil|mesh-list
56227592|NCT00316888|Cetuximab|cetuximab|mesh-list
56227593|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227594|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
56227595|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227596|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227597|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227598|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
56227599|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146184|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55859995|NCT01799356|Ofloxacin|ofloxacin|mesh-list
56227600|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227601|NCT03164889|Entecavir|entecavir|mesh-list
56227602|NCT03164889|Molgramostim|molgramostim|mesh-list
56227603|NCT03164889|Sargramostim|sargramostim|mesh-list
56227604|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
56227605|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803297|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130658|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
56130659|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130660|NCT03059004|Protective Agents|protective agents|mesh-ancestor
56130661|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130662|NCT04554888|Doxepin|doxepin|mesh-list
56130663|NCT04554888|Histamine|histamine|mesh-list
56130664|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
56130665|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
56130666|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130667|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130668|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130669|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56130670|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56130671|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130672|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56130673|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
56130674|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56130675|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
56130676|NCT05601960|Sunscreening Agents|sunscreening agents|mesh-list
56130677|NCT05601960|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56130678|NCT05601960|Protective Agents|protective agents|mesh-ancestor
56130679|NCT05601960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130680|NCT05601960|Dermatologic Agents|dermatologic agents|mesh-ancestor
56130681|NCT05605002|Serotonin|serotonin|mesh-list
56130682|NCT05605002|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56130683|NCT05605002|Serotonin Agents|serotonin agents|mesh-ancestor
56130684|NCT05605002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130685|NCT05605002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130686|NCT05605002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130687|NCT03238248|Azacitidine|azacitidine|mesh-list
56130688|NCT03238248|Pevonedistat|pevonedistat|mesh-list
56130689|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56130690|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
56130691|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130692|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130693|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130694|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
56130695|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56130696|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130697|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
56130698|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130699|NCT04124016|Protective Agents|protective agents|mesh-ancestor
56130700|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130701|NCT04124094|Fluticasone|fluticasone|mesh-list
56130702|NCT04124094|Xhance|xhance|mesh-list
56130703|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56130704|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56130705|NCT04124094|Charcoal|charcoal|mesh-list
56130706|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56130707|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56130708|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
56130709|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130710|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227607|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227608|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227609|NCT03133260|Aspirin|aspirin|mesh-list
56227610|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56227611|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56227612|NCT03133260|Analgesics|analgesics|mesh-ancestor
56227613|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
56227614|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227615|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227616|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56227617|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56227618|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56227619|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56227620|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227621|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56227622|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56227623|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227624|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
56227625|NCT03126812|Paclitaxel|paclitaxel|mesh-list
56227626|NCT03126812|Carboplatin|carboplatin|mesh-list
56227627|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
56227628|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56227629|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227630|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56227631|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56227632|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56227633|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227634|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227635|NCT03096834|Erenumab|erenumab|mesh-list
56227636|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55803310|NCT02579863|Hormones|hormones|mesh-ancestor
56130711|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56130712|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
56130713|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
56130714|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56130715|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56130716|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56130718|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
56130719|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130720|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227637|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227638|NCT03096834|Analgesics|analgesics|mesh-ancestor
56227639|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
56227640|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227641|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227642|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
56227643|NCT03089203|Fludarabine|fludarabine|mesh-list
56227644|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227645|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
56227646|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227647|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56227648|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56227649|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
56227650|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227651|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227652|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56227653|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
56227654|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56227655|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
56227656|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227657|NCT03056014|Expectorants|expectorants|mesh-ancestor
56227658|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
56227659|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56227660|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
56227661|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227662|NCT03056014|Protective Agents|protective agents|mesh-ancestor
56227663|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227664|NCT03056014|Antidotes|antidotes|mesh-ancestor
56227665|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
56227666|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
56227667|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227668|NCT03026972|Vaccines|vaccines|mesh-list
56227669|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
56227672|NCT03012815|Gabapentin|gabapentin|mesh-list
56227679|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
56227680|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56227681|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56227682|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56227683|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56227684|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56227685|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56227686|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227687|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227688|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
56227689|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
56227690|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
56227691|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56227692|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56227693|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
56227694|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
56227695|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227696|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56227698|NCT03006432|Folic Acid|folic acid|mesh-list
56227699|NCT03006432|Docetaxel|docetaxel|mesh-list
56227700|NCT03006432|Fluorouracil|fluorouracil|mesh-list
56227701|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
56227738|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227739|NCT02978716|Antiviral Agents|antiviral agents|mesh-ancestor
56227740|NCT02978716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227741|NCT02978716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227742|NCT02978716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227743|NCT02978716|Immunologic Factors|immunologic factors|mesh-ancestor
56227744|NCT02978716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227746|NCT02973321|Liraglutide|liraglutide|mesh-list
56227747|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56227748|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227749|NCT02973321|Incretins|incretins|mesh-ancestor
56227750|NCT02973321|Hormones|hormones|mesh-ancestor
56227751|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56227752|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56227753|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56227754|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56227755|NCT02943785|Edoxaban|edoxaban|mesh-list
56227757|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
56227758|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56227759|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
56227760|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227761|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227762|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
56227763|NCT02908334|Sertraline|sertraline|mesh-list
56227764|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
56227765|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56227766|NCT02908334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56227767|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56227768|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56227769|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227770|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227772|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130721|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
56130722|NCT04124094|Hormones|hormones|mesh-ancestor
56130723|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130724|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
56130725|NCT04124094|Antidotes|antidotes|mesh-ancestor
56130726|NCT04124094|Protective Agents|protective agents|mesh-ancestor
56227773|NCT02901067|Aspirin|aspirin|mesh-list
56227774|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56227775|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56227776|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56227777|NCT02901067|Analgesics|analgesics|mesh-ancestor
56227778|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
56227779|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56227780|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227781|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56227782|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56227783|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56227784|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56227785|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227786|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56227787|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56227795|NCT02886286|Fentanyl|fentanyl|mesh-list
56227833|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56227834|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56227835|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227836|NCT02736656|Viloxazine|viloxazine|mesh-list
56227837|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56227838|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
56227839|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56227840|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56227841|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56227842|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56227843|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227844|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
56227845|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56227846|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227847|NCT02735044|Insulin|insulin|mesh-list
56227848|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56227849|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
56227850|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56227851|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227852|NCT02692651|Vancomycin|vancomycin|mesh-list
56227853|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
56227854|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56227855|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227856|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
56227857|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227858|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227859|NCT02654314|Melatonin|melatonin|mesh-list
56227860|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
56227861|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227862|NCT02654314|Protective Agents|protective agents|mesh-ancestor
56227863|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227864|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56227865|NCT02626962|Nivolumab|nivolumab|mesh-list
56227866|NCT02626962|Ipilimumab|ipilimumab|mesh-list
55803522|NCT05628883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56130728|NCT05601336|Dapagliflozin|dapagliflozin|mesh-list
56130729|NCT05601336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56227867|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227868|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227869|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56227870|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227871|NCT02623998|Metformin|metformin|mesh-list
56227872|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
56227873|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56227874|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56227875|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227876|NCT02623998|Incretins|incretins|mesh-ancestor
56227877|NCT02623998|Hormones|hormones|mesh-ancestor
56227878|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146229|NCT05395962|Bleomycin|bleomycin|mesh-list
56227879|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56227880|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
56227881|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227882|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227883|NCT02608684|Gemcitabine|gemcitabine|mesh-list
56227884|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
56227885|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227886|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227887|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
56227888|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227889|NCT02608684|Antiviral Agents|antiviral agents|mesh-ancestor
56227890|NCT02608684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227891|NCT02608684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227892|NCT02608684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227893|NCT02608684|Immunologic Factors|immunologic factors|mesh-ancestor
56227894|NCT02608684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227899|NCT02587520|Vaccines|vaccines|mesh-list
56227911|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227912|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
56227913|NCT02559856|Apixaban|apixaban|mesh-list
56227914|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56227915|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
56227916|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56227917|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
56227918|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227919|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227920|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
56227921|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
56130730|NCT05601336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130731|NCT05601336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56130732|NCT05601336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130733|NCT03033576|Nivolumab|nivolumab|mesh-list
56130734|NCT03033576|Ipilimumab|ipilimumab|mesh-list
56130735|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56130736|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130737|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56130738|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130740|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
56130741|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
56130742|NCT04123392|Busulfan|busulfan|mesh-list
56130743|NCT04123392|Decitabine|decitabine|mesh-list
56130744|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55744597|NCT04492813|Propofol|propofol|mesh-list
56130745|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
56130746|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130747|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130748|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56130750|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130751|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130752|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56130753|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56130754|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
56130755|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130756|NCT04760262|Remifentanil|remifentanil|mesh-list
56130757|NCT04760262|Propofol|propofol|mesh-list
56130758|NCT04760262|Sevoflurane|sevoflurane|mesh-list
56130759|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56130760|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130761|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130762|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56130763|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
56130764|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
56130765|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56130766|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56130767|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56130768|NCT04760262|Narcotics|narcotics|mesh-ancestor
56130769|NCT04760262|Analgesics|analgesics|mesh-ancestor
56130770|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
56130771|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130772|NCT03047928|Nivolumab|nivolumab|mesh-list
56130773|NCT03047928|Vaccines|vaccines|mesh-list
56130774|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
56130775|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130776|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56130777|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130778|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56130779|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130780|NCT05607810|Aflibercept|aflibercept|mesh-list
56130781|NCT05607810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56130782|NCT05607810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56130783|NCT05607810|Growth Substances|growth substances|mesh-ancestor
56227922|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227923|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227924|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
56227925|NCT02512172|Azacitidine|azacitidine|mesh-list
56227926|NCT02512172|Romidepsin|romidepsin|mesh-list
56227927|NCT02512172|Cc-486|cc-486|mesh-list
56227928|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227929|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227930|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56227931|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
56227932|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227933|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227934|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56227935|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
56227936|NCT02499367|Doxorubicin|doxorubicin|mesh-list
56227937|NCT02499367|Nivolumab|nivolumab|mesh-list
56227938|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56227939|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
56227940|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227941|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56227942|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56227943|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
56227944|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56227945|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227946|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56227947|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56227948|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56227949|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56227950|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56227951|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227952|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56130784|NCT05607810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130785|NCT05607810|Growth Inhibitors|growth inhibitors|mesh-ancestor
56130786|NCT05607810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130788|NCT04126278|Cortisone|cortisone|mesh-list
56130789|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56130790|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
56130791|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
56130792|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130794|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56130796|NCT04126278|Hormones|hormones|mesh-ancestor
56130797|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56227953|NCT02497612|Artefenomel|artefenomel|mesh-list
56227954|NCT02497612|Ferroquine|ferroquine|mesh-list
56227955|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
56227956|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56227957|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56227958|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227959|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56227960|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227961|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227962|NCT02491333|Metformin|metformin|mesh-list
56227963|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56227964|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227965|NCT02469987|Bevacizumab|bevacizumab|mesh-list
56227966|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56227967|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56227968|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56227969|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56227970|NCT02469987|Growth Substances|growth substances|mesh-ancestor
56227971|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56227972|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
56227973|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56227974|NCT02439307|Rifaximin|rifaximin|mesh-list
56227975|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56227976|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56227977|NCT02381652|Triamcinolone|triamcinolone|mesh-list
56227978|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56227979|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56227980|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
56227981|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56227982|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56227999|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
56228000|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228001|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228002|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228003|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
56228004|NCT02368301|Hormones|hormones|mesh-ancestor
56228005|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228006|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228007|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228008|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
56228010|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56228011|NCT02368301|Growth Substances|growth substances|mesh-ancestor
56228012|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
56228013|NCT02367794|Paclitaxel|paclitaxel|mesh-list
56228014|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56228015|NCT02367794|Carboplatin|carboplatin|mesh-list
56228016|NCT02367794|Atezolizumab|atezolizumab|mesh-list
56228017|NCT02367794|Antibodies|antibodies|mesh-list
56228018|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56228019|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228020|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
56228021|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
56228022|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
56228023|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228024|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
56228025|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228026|NCT02363998|Lofexidine|lofexidine|mesh-list
56228027|NCT02363998|Clonidine|clonidine|mesh-list
56228028|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56228029|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56228031|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
56228044|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56228045|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
56228046|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228047|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228048|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146263|NCT04098432|Nivolumab|nivolumab|mesh-list
56228049|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
56228050|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228051|NCT02325466|Aspirin|aspirin|mesh-list
56228052|NCT02325466|Ticagrelor|ticagrelor|mesh-list
56228053|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56228054|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56228055|NCT02325466|Analgesics|analgesics|mesh-ancestor
56228056|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
56228057|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228058|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228059|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228060|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228061|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56228062|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56228063|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228064|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56228065|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56228066|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228067|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
56228068|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56130798|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56130799|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130800|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56130801|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130802|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
56130803|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
56130804|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130805|NCT04121910|Itraconazole|itraconazole|mesh-list
56130806|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
56130807|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130808|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56130809|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56130810|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130811|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130812|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56130814|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130815|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130816|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56130817|NCT04129788|Bisacodyl|bisacodyl|mesh-list
56130818|NCT04129788|Cathartics|cathartics|mesh-ancestor
56130819|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228069|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56228070|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56228071|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
56228072|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228073|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56228074|NCT02323100|Glycerol|glycerol|mesh-list
56228075|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56228076|NCT02323100|Protective Agents|protective agents|mesh-ancestor
56228077|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228078|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228079|NCT02322710|Petrolatum|petrolatum|mesh-list
56228080|NCT02322710|Emollients|emollients|mesh-ancestor
56228081|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56228082|NCT02283281|Dronabinol|dronabinol|mesh-list
56228083|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
56228084|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860694|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55860695|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
56228085|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56228086|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56228087|NCT02283281|Analgesics|analgesics|mesh-ancestor
56228088|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
56228089|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228090|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56228091|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56228092|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228093|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228094|NCT02283281|Hormones|hormones|mesh-ancestor
56228095|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228117|NCT02185820|Pomalidomide|pomalidomide|mesh-list
56228118|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228119|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
56228120|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
56228121|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228122|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228123|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228124|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
56228125|NCT02185820|Hormones|hormones|mesh-ancestor
56228126|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228127|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228128|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228129|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
56228130|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56228131|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56228132|NCT02185820|Growth Substances|growth substances|mesh-ancestor
56228133|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
56228134|NCT02162563|Leucovorin|leucovorin|mesh-list
56228135|NCT02162563|Bevacizumab|bevacizumab|mesh-list
56228136|NCT02162563|Panitumumab|panitumumab|mesh-list
56228137|NCT02162563|Fluorouracil|fluorouracil|mesh-list
56228138|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
56228139|NCT02162563|Irinotecan|irinotecan|mesh-list
56130820|NCT04129788|Laxatives|laxatives|mesh-ancestor
56130821|NCT03831126|Betamethasone|betamethasone|mesh-list
56130822|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
56130823|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56130824|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
56130825|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56130826|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
56130827|NCT03831126|Hormones|hormones|mesh-ancestor
56130828|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130829|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130830|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56130831|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56130832|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
56130834|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56130835|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
56130836|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130837|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130838|NCT04073784|Antiviral Agents|antiviral agents|mesh-ancestor
56130839|NCT04073784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130840|NCT04073784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130841|NCT04073784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56130842|NCT04073784|Immunologic Factors|immunologic factors|mesh-ancestor
56130843|NCT04073784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130844|NCT05606796|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56130845|NCT05606796|Latanoprost|latanoprost|mesh-list
56130846|NCT05606796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56130847|NCT04129710|Rituximab|rituximab|mesh-list
56130848|NCT04129710|Methotrexate|methotrexate|mesh-list
56130849|NCT04129710|Etoposide|etoposide|mesh-list
56130850|NCT04129710|Lenalidomide|lenalidomide|mesh-list
56228141|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55742437|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56228142|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228143|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56228144|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56228145|NCT02162563|Growth Substances|growth substances|mesh-ancestor
56228146|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228147|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
56228148|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
56228149|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228150|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56228151|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228152|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
56228153|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56228154|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56228155|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228156|NCT02162563|Antidotes|antidotes|mesh-ancestor
56228157|NCT02162563|Protective Agents|protective agents|mesh-ancestor
56228158|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
56228159|NCT02162563|Vitamins|vitamins|mesh-ancestor
56228160|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
56228161|NCT02127086|Analgesics|analgesics|mesh-list
56228162|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
56228163|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228164|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228165|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56228166|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56228186|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56228187|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228188|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56228189|NCT02075177|Protective Agents|protective agents|mesh-ancestor
56228191|NCT02050919|Epirubicin|epirubicin|mesh-list
56228192|NCT02050919|Ifosfamide|ifosfamide|mesh-list
56228193|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
56228194|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228195|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56228196|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228197|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228198|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56228199|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56228200|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56228201|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56228202|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
56228204|NCT02040857|Letrozole|letrozole|mesh-list
56228205|NCT02040857|Palbociclib|palbociclib|mesh-list
56228206|NCT02040857|Anastrozole|anastrozole|mesh-list
56228207|NCT02040857|Exemestane|exemestane|mesh-list
56228208|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56228209|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228210|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56228211|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228212|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228213|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56228214|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
56228215|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228216|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228217|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228218|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55803876|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
56130851|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56130852|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130853|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
56130854|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228219|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56228220|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56228221|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56228222|NCT01997463|Albuterol|albuterol|mesh-list
55742449|NCT02689167|Sunitinib|sunitinib|mesh-list
56228223|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56228224|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
56228225|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228226|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228227|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56228228|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
56228229|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
56228230|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56228231|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56228232|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56228233|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56228234|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
56228235|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228236|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228237|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
56228238|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56228239|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228240|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228241|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56228242|NCT01976754|Analgesics|analgesics|mesh-ancestor
56228243|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
56228244|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228245|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56228246|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56228263|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56228264|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56228265|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228279|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228280|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
56130855|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130856|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56130857|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
56130858|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56130859|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56130860|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
56130861|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130862|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56130863|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130864|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56130865|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56130866|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56130867|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56130868|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56130870|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56130871|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56130872|NCT04129710|Growth Substances|growth substances|mesh-ancestor
56130873|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
56130874|NCT03200808|Methylene Blue|methylene blue|mesh-list
56130875|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130876|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742460|NCT02582697|Etoposide|etoposide|mesh-list
55742461|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
56130877|NCT04129008|Aspirin|aspirin|mesh-list
56130878|NCT04129008|Indobufen|indobufen|mesh-list
56130879|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56130880|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56130881|NCT04129008|Analgesics|analgesics|mesh-ancestor
56130882|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
56130883|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130884|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130885|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56130886|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130887|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56130888|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56130889|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130890|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56130891|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56228281|NCT01913730|Hormones|hormones|mesh-ancestor
56228282|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228283|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228284|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228285|NCT01904123|Tyrphostins|tyrphostins|mesh-list
56228286|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228287|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228288|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228289|NCT01863186|Lofexidine|lofexidine|mesh-list
56228290|NCT01863186|Clonidine|clonidine|mesh-list
56228291|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56228292|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56228293|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228294|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
56228295|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742478|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742479|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228296|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56228297|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56228298|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56228299|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
56228300|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228301|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228302|NCT01863186|Analgesics|analgesics|mesh-ancestor
56228303|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
56228304|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
56228305|NCT01828840|Fentanyl|fentanyl|mesh-list
56228306|NCT01828840|Morphine|morphine|mesh-list
56228307|NCT01828840|Methadone|methadone|mesh-list
56228308|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56228329|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56228331|NCT01817751|Urological Agents|urological agents|mesh-ancestor
56228332|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
56228333|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
56228334|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228335|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742517|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742518|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55742519|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56228336|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
56228337|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56228338|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228339|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56228340|NCT01817426|Infliximab|infliximab|mesh-list
56228341|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
56228342|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228343|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228344|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56228345|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56228346|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228347|NCT01741103|Incretins|incretins|mesh-ancestor
56228348|NCT01741103|Hormones|hormones|mesh-ancestor
55804018|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
56130892|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130893|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
56130894|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
56130895|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56130896|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
56130897|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742570|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742571|NCT05305131|Antiviral Agents|antiviral agents|mesh-ancestor
56130898|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130899|NCT04120350|Rituximab|rituximab|mesh-list
56130900|NCT04120350|Methotrexate|methotrexate|mesh-list
56130901|NCT04120350|Lenalidomide|lenalidomide|mesh-list
56130902|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56130903|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130904|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
56130905|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130906|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56130907|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56130908|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
56130909|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56130910|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56130912|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130913|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
56130914|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130915|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56130916|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56130917|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56130918|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56130919|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56130920|NCT04120350|Growth Substances|growth substances|mesh-ancestor
56130921|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
56130922|NCT04394598|Capecitabine|capecitabine|mesh-list
56130923|NCT04394598|Irinotecan|irinotecan|mesh-list
56130924|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56130925|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
56130926|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228349|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228351|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
56228352|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228353|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228354|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56228355|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
55804038|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
56130927|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130928|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56130929|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56130930|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130931|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56130932|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742621|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55742622|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55742629|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
56130933|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56130934|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
56130935|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130936|NCT04129086|Ketamine|ketamine|mesh-list
56130937|NCT04129086|Analgesics|analgesics|mesh-ancestor
56130938|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
56130939|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130940|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130941|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56130942|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56130943|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
56130944|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
56130945|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130946|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56130947|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56130948|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56130949|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130950|NCT05602428|Anesthetics|anesthetics|mesh-list
56130951|NCT05602428|Esketamine|esketamine|mesh-list
56130952|NCT05602428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130953|NCT05602428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130954|NCT05602428|Antidepressive Agents|antidepressive agents|mesh-ancestor
56130955|NCT05602428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56130956|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56130957|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
56130958|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130960|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56130961|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56130962|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130963|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130964|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56130965|NCT05602194|Asparaginase|asparaginase|mesh-list
56130966|NCT05602194|Pegaspargase|pegaspargase|mesh-list
56130967|NCT05602194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130968|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
56130969|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
56130971|NCT03012360|Imipenem|imipenem|mesh-list
56130972|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56130973|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56130974|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56130975|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56130976|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130977|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130978|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130979|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56130980|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56130981|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56130982|NCT04120974|Insulin|insulin|mesh-list
56130983|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56228356|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742655|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
56228357|NCT01630590|Androgens|androgens|mesh-list
56228358|NCT01630590|Hormones|hormones|mesh-ancestor
56228359|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228360|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228361|NCT01619085|Nintedanib|nintedanib|mesh-list
56228362|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228363|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56228364|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228365|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228366|NCT01499095|Insulin|insulin|mesh-list
56228367|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56228368|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
56228369|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55804062|NCT04903509|Hormones|hormones|mesh-ancestor
56130984|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130985|NCT04126668|Vorolanib|vorolanib|mesh-list
56130986|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56130987|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56130988|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56130989|NCT03043950|Panitumumab|panitumumab|mesh-list
56130990|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56130991|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56130992|NCT04758936|Clonidine|clonidine|mesh-list
56130993|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
56130994|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56130995|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56130996|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130997|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56130998|NCT04758936|Analgesics|analgesics|mesh-ancestor
56130999|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
56131000|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131001|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56131002|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56131003|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56131004|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
56131005|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131006|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131007|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56131008|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
56131009|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
56131010|NCT04126044|Bevacizumab|bevacizumab|mesh-list
56131011|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131012|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131013|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56131016|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131017|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
56131018|NCT04758858|Glucagon|glucagon|mesh-list
56131019|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131020|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56131021|NCT04758858|Hormones|hormones|mesh-ancestor
56131022|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131023|NCT02975310|Anesthetics|anesthetics|mesh-list
56131024|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131025|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131026|NCT04394208|Silymarin|silymarin|mesh-list
56131027|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
56131028|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131029|NCT04394208|Protective Agents|protective agents|mesh-ancestor
56131030|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131031|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
56131032|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56131033|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56131034|NCT03829566|Prednisolone|prednisolone|mesh-list
56131035|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
56131036|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
56131037|NCT03829566|Rituximab|rituximab|mesh-list
56131038|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
56131039|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56131040|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56131041|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
56131042|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131043|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
56131044|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131045|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131046|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56131047|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
56131048|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131049|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131050|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56131051|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131052|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56131053|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
56131054|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
56131055|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131056|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56131057|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
56131058|NCT03829566|Hormones|hormones|mesh-ancestor
56131059|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131060|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56131061|NCT03829566|Protective Agents|protective agents|mesh-ancestor
56131062|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56131063|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
56131064|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56131065|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131066|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131067|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56131068|NCT03933306|Analgesics|analgesics|mesh-ancestor
56131069|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
56131070|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131071|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56131072|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56131073|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56131074|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
56131075|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742686|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131076|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131077|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
56131078|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
56131079|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56131080|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56131081|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131082|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131083|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131084|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131085|NCT02972424|Teriparatide|teriparatide|mesh-list
56131086|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56131088|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56131089|NCT05608590|Ethiodized Oil|ethiodized oil|mesh-list
56131090|NCT05608590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131092|NCT04393584|Docetaxel|docetaxel|mesh-list
56131093|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
56131094|NCT04393584|Irinotecan|irinotecan|mesh-list
56131095|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131096|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
56131097|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
56131098|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
56131099|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131100|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56131101|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56131102|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131103|NCT04393584|Antidotes|antidotes|mesh-ancestor
56131104|NCT04393584|Protective Agents|protective agents|mesh-ancestor
56228370|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228372|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56228373|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
56228374|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56228375|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228376|NCT01488890|Vaccines|vaccines|mesh-list
56228377|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
56228378|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228379|NCT01436396|Vaccines|vaccines|mesh-list
56228380|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
56228381|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228382|NCT01414777|Ondansetron|ondansetron|mesh-list
56228383|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
56131105|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131106|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
56131107|NCT04393584|Vitamins|vitamins|mesh-ancestor
56131108|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
56131109|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
56131110|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131111|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
56131112|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131113|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131114|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56131115|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
56131116|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131117|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131118|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56131119|NCT05608200|Lenvatinib|lenvatinib|mesh-list
56131120|NCT05608200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131121|NCT05608200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56131122|NCT05608200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131123|NCT05608200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131124|NCT03828474|Acetazolamide|acetazolamide|mesh-list
56131125|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
56131126|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56131127|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131128|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131129|NCT03828474|Diuretics|diuretics|mesh-ancestor
56131130|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
56131131|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131132|NCT05604300|Vitamin E|vitamin e|mesh-list
56131133|NCT05604300|Vitamins|vitamins|mesh-ancestor
56131134|NCT05604300|Micronutrients|micronutrients|mesh-ancestor
56131135|NCT05604300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131136|NCT05604300|Antioxidants|antioxidants|mesh-ancestor
56131137|NCT05604300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131138|NCT05604300|Protective Agents|protective agents|mesh-ancestor
56131139|NCT02921256|Leucovorin|leucovorin|mesh-list
56131140|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
56131141|NCT02921256|Fluorouracil|fluorouracil|mesh-list
56131142|NCT02921256|Capecitabine|capecitabine|mesh-list
56131143|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
56131144|NCT02921256|Veliparib|veliparib|mesh-list
56131145|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131146|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131147|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
56131148|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131149|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56131150|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131151|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
56131152|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131153|NCT02921256|Antidotes|antidotes|mesh-ancestor
56131154|NCT02921256|Protective Agents|protective agents|mesh-ancestor
56131155|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
56228384|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
56228385|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228386|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228387|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228388|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
56228389|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
56228390|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56228391|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
56228392|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228393|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228394|NCT01414777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56228395|NCT01414777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56228396|NCT01414777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228397|NCT01414777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56228398|NCT01414777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56228399|NCT01411241|Vaccines|vaccines|mesh-list
56228400|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56228401|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
56228402|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131156|NCT02921256|Vitamins|vitamins|mesh-ancestor
56131157|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
56131158|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56131159|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131160|NCT03828084|Decitabine|decitabine|mesh-list
56131161|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
56131162|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56131163|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
56131164|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131165|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131166|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131167|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56131168|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
56131169|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131172|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
56131173|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56131174|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131175|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
56131176|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
56131177|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
56131178|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131179|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56131180|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
56131181|NCT03884556|Antiviral Agents|antiviral agents|mesh-ancestor
56131182|NCT03884556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131183|NCT03884556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131184|NCT03884556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131185|NCT03884556|Immunologic Factors|immunologic factors|mesh-ancestor
56131186|NCT03884556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131187|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131189|NCT02959164|Decitabine|decitabine|mesh-list
56131190|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56131191|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
56131192|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131193|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131194|NCT02959164|Antiviral Agents|antiviral agents|mesh-ancestor
56228404|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56228405|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
56228406|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
56228407|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228408|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
56228409|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228410|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
56228411|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228412|NCT01374516|Vaccines|vaccines|mesh-list
56228413|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
56228414|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228415|NCT01373281|Vaccines|vaccines|mesh-list
56228416|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
56228417|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228418|NCT01346787|Dexamethasone|dexamethasone|mesh-list
56228419|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
56228420|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228421|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
56228422|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228423|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228424|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56228425|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
56228426|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228427|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228428|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56228429|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228430|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
56228431|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
56228450|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56228451|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56228452|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228453|NCT01187433|Vaccines|vaccines|mesh-list
56228454|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
56228455|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228456|NCT01166113|Prednisone|prednisone|mesh-list
56228457|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
56228458|NCT01166113|Pomalidomide|pomalidomide|mesh-list
56228459|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228460|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
56228461|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742740|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228462|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228463|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56228464|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
56228465|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228466|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228467|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56228468|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228469|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
56228470|NCT01166113|Hormones|hormones|mesh-ancestor
56228471|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228472|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228473|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56228474|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56228475|NCT01166113|Growth Substances|growth substances|mesh-ancestor
56228476|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
56228497|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228498|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56228499|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228500|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228501|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
56228502|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228503|NCT01150045|Antidotes|antidotes|mesh-ancestor
56228504|NCT01150045|Protective Agents|protective agents|mesh-ancestor
56228505|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
56228506|NCT01150045|Vitamins|vitamins|mesh-ancestor
56228507|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
56228508|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56228509|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56228510|NCT01150045|Analgesics|analgesics|mesh-ancestor
56144565|NCT00798018|Tetracaine|tetracaine|mesh-list
56228511|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
56228512|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228513|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228514|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228515|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56228516|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56228517|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228518|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
56228519|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
56228520|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228521|NCT01098032|Expectorants|expectorants|mesh-ancestor
56228522|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
56131195|NCT02959164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131196|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131197|NCT02959164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131198|NCT02959164|Immunologic Factors|immunologic factors|mesh-ancestor
56131199|NCT02959164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131200|NCT02983734|Cycloserine|cycloserine|mesh-list
56131201|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56131202|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131203|NCT02983734|Renal Agents|renal agents|mesh-ancestor
56131204|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56131205|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
56131206|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56131207|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
56131208|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131209|NCT03827070|Afatinib|afatinib|mesh-list
56131210|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131211|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56131212|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131213|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131214|NCT03821454|Capecitabine|capecitabine|mesh-list
56131215|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56131216|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
56228523|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56228524|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
56228525|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228526|NCT01098032|Protective Agents|protective agents|mesh-ancestor
56228527|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228528|NCT01093196|Dexamethasone|dexamethasone|mesh-list
56228530|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
56228531|NCT01093196|Melphalan|melphalan|mesh-list
56228532|NCT01093196|Lenalidomide|lenalidomide|mesh-list
56228533|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228534|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
56228535|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228536|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228537|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56228538|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
56228539|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228540|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228541|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56228542|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228543|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
56228544|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
56228545|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228546|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228547|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
56228548|NCT01093196|Hormones|hormones|mesh-ancestor
56228549|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228550|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228551|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56228552|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56228553|NCT01093196|Growth Substances|growth substances|mesh-ancestor
56228554|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
56228555|NCT00945009|Dactinomycin|dactinomycin|mesh-list
56228556|NCT00945009|Cactinomycin|cactinomycin|mesh-list
56228557|NCT00945009|Doxorubicin|doxorubicin|mesh-list
56228563|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56228564|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228565|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228566|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56228567|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
56228568|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
56228569|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
56228570|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56228571|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228572|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56228573|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56228574|NCT00942877|Cediranib|cediranib|mesh-list
56228575|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228576|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56228577|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228578|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228579|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56228580|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56228581|NCT00896389|Diuretics|diuretics|mesh-ancestor
56228582|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
56228583|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228584|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56131217|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131218|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131219|NCT02956590|Pitavastatin|pitavastatin|mesh-list
56131220|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56131221|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56131222|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56131223|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
56131224|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131225|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131226|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56131227|NCT03820518|Calcitriol|calcitriol|mesh-list
55744639|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131228|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56131230|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56131231|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56131232|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131233|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56131234|NCT03820518|Vitamins|vitamins|mesh-ancestor
56131235|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
56131236|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56131238|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56131239|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56131240|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131241|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
56131242|NCT03820206|Coagulants|coagulants|mesh-ancestor
56131243|NCT02955654|Aripiprazole|aripiprazole|mesh-list
56228585|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56228586|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228587|NCT00887146|Vincristine|vincristine|mesh-list
56228588|NCT00887146|Temozolomide|temozolomide|mesh-list
56228589|NCT00887146|Procarbazine|procarbazine|mesh-list
56228590|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56228591|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228592|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
56228593|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
56228594|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
56228595|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228596|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56228597|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
56228598|NCT00880893|Vaccines|vaccines|mesh-list
56228599|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
56228600|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228601|NCT00579527|Cyclosporine|cyclosporine|mesh-list
56228602|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
56228603|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
56228604|NCT00579527|Prednisolone|prednisolone|mesh-list
56228605|NCT00579527|Tacrolimus|tacrolimus|mesh-list
56228606|NCT00579527|Cyclosporins|cyclosporins|mesh-list
56228607|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
56228608|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56228609|NCT00579527|Daclizumab|daclizumab|mesh-list
56228610|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
56228611|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228634|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56228635|NCT00579527|Protective Agents|protective agents|mesh-ancestor
56228636|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228637|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56228638|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
56228639|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56228640|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228642|NCT00551928|Lenalidomide|lenalidomide|mesh-list
56228643|NCT00551928|Melphalan|melphalan|mesh-list
56228644|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228645|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
56228646|NCT00551928|Hormones|hormones|mesh-ancestor
56228647|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228648|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228649|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228650|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228651|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
56228652|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56228653|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56228654|NCT00551928|Growth Substances|growth substances|mesh-ancestor
56228655|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
56228656|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56228657|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
56228658|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228659|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56228660|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228661|NCT00531232|Clofarabine|clofarabine|mesh-list
56228662|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56228663|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
56228664|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228665|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228666|NCT00379340|Dactinomycin|dactinomycin|mesh-list
56228667|NCT00379340|Cactinomycin|cactinomycin|mesh-list
56228668|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
55804353|NCT05510323|Hormones|hormones|mesh-ancestor
56131244|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
56228670|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56228672|NCT00379340|Vincristine|vincristine|mesh-list
56228673|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
56228674|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228675|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
56228676|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228677|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228678|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56228679|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
56228680|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228681|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228682|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56228683|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56228684|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56228685|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56228686|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228687|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56228688|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
56228689|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
56228690|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
56228691|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56228692|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228693|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56228694|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56228695|NCT00304070|Doxorubicin|doxorubicin|mesh-list
56228696|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56228697|NCT00304070|Etoposide|etoposide|mesh-list
56228698|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
56228699|NCT00304070|Mitotane|mitotane|mesh-list
56228700|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228701|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55804372|NCT04843579|Hormones|hormones|mesh-ancestor
56131245|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56131246|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56131247|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56131248|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131249|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131250|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
56131251|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
56131252|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131253|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228702|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56228703|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56228704|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228705|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228706|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56228707|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228708|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
56228709|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56228710|NCT00066950|Fluorides|fluorides|mesh-list
56228711|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
56228712|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
56228713|NCT00066950|Protective Agents|protective agents|mesh-ancestor
56228714|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131254|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56131255|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55742780|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742787|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
56131256|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
56131257|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56131258|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56131259|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56131260|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56131262|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
56131263|NCT04392648|Bortezomib|bortezomib|mesh-list
56131264|NCT04392648|Pomalidomide|pomalidomide|mesh-list
56131265|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131266|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
56131267|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131268|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131269|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56131270|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
56131271|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131272|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131273|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56131274|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56131275|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
56131276|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
56131277|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131278|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56131279|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
56131280|NCT04392648|Hormones|hormones|mesh-ancestor
56131281|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131282|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56131283|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56131284|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56131285|NCT04392648|Growth Substances|growth substances|mesh-ancestor
56131286|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
56131287|NCT03826602|Metformin|metformin|mesh-list
56131288|NCT03826602|Tucatinib|tucatinib|mesh-list
56131289|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56131290|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131291|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131292|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56131293|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131294|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131295|NCT01453920|Ranibizumab|ranibizumab|mesh-list
56131296|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56131297|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56131298|NCT01453920|Growth Substances|growth substances|mesh-ancestor
56131299|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131300|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
56131301|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228716|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228717|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
55742814|NCT04488315|Hormones|hormones|mesh-ancestor
56228718|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
56228719|NCT00004935|Trastuzumab|trastuzumab|mesh-list
56228720|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56228721|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228722|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56228723|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
56228724|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56228725|NCT01694134|Prednisolone|prednisolone|mesh-list
56228726|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
56228727|NCT01694134|Lidocaine|lidocaine|mesh-list
56228728|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56228729|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
56228730|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
56228731|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
56228732|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228733|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228734|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
56228735|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228736|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56228737|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56228738|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55742822|NCT00709735|Propranolol|propranolol|mesh-list
56228739|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56228740|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228741|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228743|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
56228744|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228745|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
56131303|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56131304|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131305|NCT02953548|Cannabidiol|cannabidiol|mesh-list
56131306|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
56131307|NCT03826524|Epinephrine|epinephrine|mesh-list
56131308|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56131309|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56131310|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
56131311|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131312|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131313|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131314|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56131315|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56131317|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228747|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228748|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56228749|NCT01694134|Protective Agents|protective agents|mesh-ancestor
56228750|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228751|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228752|NCT01694212|Diclofenac|diclofenac|mesh-list
56228753|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56228754|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56228755|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56131318|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56131319|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
56131320|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
56131321|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
56131322|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56131323|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
56131324|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56131325|NCT03112044|Velpatasvir|velpatasvir|mesh-list
56131326|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
56131327|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131328|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
56131329|NCT02952222|Propofol|propofol|mesh-list
56131330|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56131331|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742877|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55742878|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55742879|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56131332|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131333|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56131334|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
56131335|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
56131336|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56131337|NCT02952222|Analgesics|analgesics|mesh-ancestor
56131338|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
56131339|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131340|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56131341|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56131342|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56131343|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
56131344|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890358|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55742905|NCT05576155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55742906|NCT05576155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55742907|NCT05576155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742908|NCT05576155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742910|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
55742911|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742913|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131345|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131346|NCT03826368|Cannabidiol|cannabidiol|mesh-list
56131347|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
56131348|NCT04391478|Milrinone|milrinone|mesh-list
56131349|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
56131350|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
56131351|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56131352|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56131353|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131354|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131355|NCT04391478|Urological Agents|urological agents|mesh-ancestor
55764256|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
56131357|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56131358|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56131359|NCT04391478|Protective Agents|protective agents|mesh-ancestor
56131360|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131361|NCT03828006|Red yeast rice|red yeast rice|mesh-list
56131362|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56131363|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56131364|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56131365|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
56131366|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131367|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131368|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56131369|NCT01454154|Glyburide|glyburide|mesh-list
56131370|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56131371|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131372|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
56228756|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56228757|NCT01694212|Analgesics|analgesics|mesh-ancestor
56228758|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
56228759|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131373|NCT04391868|Citric Acid|citric acid|mesh-list
56131374|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
56131375|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
56131376|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56131377|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
56131378|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
56131379|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131380|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
56131381|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56131382|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56131383|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131384|NCT04391868|Urological Agents|urological agents|mesh-ancestor
56131385|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
56131387|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131389|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55742959|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55742960|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742961|NCT05060523|Tolvaptan|tolvaptan|mesh-list
55742962|NCT05060523|Midodrine|midodrine|mesh-list
55742966|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131390|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131391|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131392|NCT03071406|Nivolumab|nivolumab|mesh-list
56131393|NCT03071406|Ipilimumab|ipilimumab|mesh-list
56131394|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131395|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131396|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56131397|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131398|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
56131399|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56131400|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131401|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131402|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56131403|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56131404|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
56131405|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56131406|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56131407|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56131408|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56131409|NCT01450176|Analgesics|analgesics|mesh-ancestor
56131410|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
56131411|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131412|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131413|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56131414|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131415|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56131416|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56131417|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56131418|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
56131420|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131421|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131422|NCT01454622|Metformin|metformin|mesh-list
56131423|NCT01454622|Canagliflozin|canagliflozin|mesh-list
56131424|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56131425|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131426|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56131427|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131428|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
56131430|NCT01450410|Niacinamide|niacinamide|mesh-list
56131431|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
56131432|NCT01450410|Vitamins|vitamins|mesh-ancestor
56131433|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
56131434|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131435|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56131436|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
56131437|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744655|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
56228760|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228761|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228762|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228763|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56228764|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228765|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228766|NCT01694264|Entecavir|entecavir|mesh-list
56228767|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
56228768|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228769|NCT01694355|Vitamin D|vitamin d|mesh-list
56228770|NCT01694355|Vitamins|vitamins|mesh-ancestor
56228771|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
56228772|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131438|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55742987|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742988|NCT05555797|Betamethasone|betamethasone|mesh-list
56131439|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
56131441|NCT02905110|Etoposide|etoposide|mesh-list
56131442|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56131443|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
56131444|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56131445|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131446|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56131447|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
56131448|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131449|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131450|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
56131451|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131452|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56131453|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131454|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
56131455|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131456|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56131457|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56131458|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56131459|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56131460|NCT01450566|Lidocaine|lidocaine|mesh-list
56131461|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
56131462|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
56131463|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131464|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131465|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
56131466|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131467|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56131468|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56131469|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56131470|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56131471|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131473|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
56131474|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131475|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131476|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56131477|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131478|NCT03043014|Misoprostol|misoprostol|mesh-list
56131479|NCT03043014|Mifepristone|mifepristone|mesh-list
56131480|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56131481|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
56131482|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56131483|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131484|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56131485|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56131486|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
56228773|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56228774|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56228775|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56131487|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56131488|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56131489|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56131490|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56131491|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
56131492|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56131493|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56131494|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
56131495|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131496|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
56131497|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56131498|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56131499|NCT02983344|Fentanyl|fentanyl|mesh-list
56131500|NCT02983344|Ropivacaine|ropivacaine|mesh-list
56131501|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
56131502|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
56131503|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131504|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131505|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
56131506|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131507|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56131508|NCT02983344|Narcotics|narcotics|mesh-ancestor
56131509|NCT02983344|Analgesics|analgesics|mesh-ancestor
56131510|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56131511|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56131512|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
56131513|NCT02964078|Aldesleukin|aldesleukin|mesh-list
56131514|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
56131515|NCT02964078|Interleukin-2|interleukin-2|mesh-list
56131516|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131517|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131518|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56131519|NCT02964078|Analgesics|analgesics|mesh-ancestor
56131520|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
56131521|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131522|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131523|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56131524|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56131525|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
56131526|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131527|NCT03824340|Doxycycline|doxycycline|mesh-list
56131528|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56131529|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131530|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
56131531|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56131532|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56131533|NCT01455246|Meropenem|meropenem|mesh-list
56131534|NCT01455246|Daptomycin|daptomycin|mesh-list
56131535|NCT01455246|Ceftazidime|ceftazidime|mesh-list
56131536|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56131537|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131538|NCT02934282|HBOC 201|hboc 201|mesh-list
56131539|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
56131540|NCT03823950|Lenograstim|lenograstim|mesh-list
56131541|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56131542|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
56131543|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131544|NCT01451268|Panobinostat|panobinostat|mesh-list
56131545|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131546|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56131547|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131548|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743004|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
55743005|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55743006|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743009|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131549|NCT03823638|Mannitol|mannitol|mesh-list
56131550|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56131551|NCT03823638|Diuretics|diuretics|mesh-ancestor
56131552|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
56131553|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131554|NCT02884908|Pregabalin|pregabalin|mesh-list
56131555|NCT02884908|Analgesics|analgesics|mesh-ancestor
56131556|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
56131557|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228776|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228777|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
56228778|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131558|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131559|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
56131560|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56131561|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56131562|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131563|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56131564|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56131565|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56131566|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131567|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56131568|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56131569|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56131570|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131571|NCT01451658|Propranolol|propranolol|mesh-list
56131572|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56131573|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56131574|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
56131575|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131576|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131577|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131578|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56131579|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56131580|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
56131581|NCT02861898|Cetuximab|cetuximab|mesh-list
56131582|NCT02861898|Mannitol|mannitol|mesh-list
56131583|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131584|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131585|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56131586|NCT02861898|Diuretics|diuretics|mesh-ancestor
56131587|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
56131588|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131589|NCT02851056|Lenograstim|lenograstim|mesh-list
56131590|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56131591|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
56131592|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131593|NCT02935374|Amoxicillin|amoxicillin|mesh-list
56131594|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
56131595|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
56131596|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56131597|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131598|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56131599|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131600|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131601|NCT01452750|Lansoprazole|lansoprazole|mesh-list
56131602|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
56131603|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56131604|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56131605|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56131606|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131607|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131608|NCT01452828|Tedizolid|tedizolid|mesh-list
55743043|NCT03351205|Progestins|progestins|mesh-ancestor
56131609|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
56131610|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
56131611|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56131612|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131613|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56131614|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131615|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131616|NCT01452906|Omeprazole|omeprazole|mesh-list
56131617|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56131618|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56131619|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56131620|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131621|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131622|NCT02781090|Nicotine|nicotine|mesh-list
56131623|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56131624|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
56131625|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131626|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228779|NCT01694407|Tenofovir|tenofovir|mesh-list
56228780|NCT01694407|Emtricitabine|emtricitabine|mesh-list
56228781|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
56228782|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228783|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56228784|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56228785|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228786|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228787|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56228788|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56131627|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56131628|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56131629|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
56131630|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131631|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131632|NCT03823248|Folic Acid|folic acid|mesh-list
56131633|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
56131634|NCT03823248|Hematinics|hematinics|mesh-ancestor
56131635|NCT03823248|Vitamins|vitamins|mesh-ancestor
56131636|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
56131637|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131638|NCT03822936|Fluorouracil|fluorouracil|mesh-list
56131639|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
56131640|NCT03822936|Irinotecan|irinotecan|mesh-list
56131641|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
56131642|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131643|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56131644|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131645|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131646|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
56131647|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131648|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56131649|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56131650|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131652|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56131654|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131655|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131656|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56131657|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56131658|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
56131659|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131660|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131661|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
56131662|NCT01453686|Clobetasol|clobetasol|mesh-list
56131663|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55743052|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56131664|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
56131665|NCT01453686|Hormones|hormones|mesh-ancestor
56131666|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131667|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131668|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56131669|NCT01455870|Exenatide|exenatide|mesh-list
56131670|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56131671|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131672|NCT01455870|Incretins|incretins|mesh-ancestor
56131673|NCT01455870|Hormones|hormones|mesh-ancestor
56131674|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131675|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56131676|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
56131677|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131678|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131679|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56131680|NCT01456260|Lansoprazole|lansoprazole|mesh-list
56131681|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
56131682|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56131683|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228789|NCT01694459|Heparin|heparin|mesh-list
56228790|NCT01694459|Calcium heparin|calcium heparin|mesh-list
56228791|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
56228792|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56228793|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56228794|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228795|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56228796|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
56228797|NCT01694498|Coagulants|coagulants|mesh-ancestor
56228798|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56228799|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
56228800|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131684|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56131685|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131686|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131687|NCT01890408|Ropivacaine|ropivacaine|mesh-list
56131688|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
56131689|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
56131692|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
56131693|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131694|NCT04849650|Amisulpride|amisulpride|mesh-list
56131695|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56131696|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56131697|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131698|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131699|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56131700|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56131701|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
56131702|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131703|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131704|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56131706|NCT04272372|Ketoprofen|ketoprofen|mesh-list
56131707|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56131708|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56131709|NCT04272372|Analgesics|analgesics|mesh-ancestor
56131710|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
56131711|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131712|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131713|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56131714|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131715|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56131716|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131717|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131718|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
56131719|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56131720|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
56131721|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131722|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131723|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55743069|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56131724|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56131725|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56131726|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
56131727|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131728|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131729|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56131730|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
56131731|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
56131732|NCT01891500|Protective Agents|protective agents|mesh-ancestor
56131733|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
56131734|NCT02439450|Nivolumab|nivolumab|mesh-list
56131735|NCT02439450|Pemetrexed|pemetrexed|mesh-list
56131736|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56228801|NCT01694576|Paclitaxel|paclitaxel|mesh-list
56228802|NCT01694576|Nedaplatin|nedaplatin|mesh-list
56228803|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56228804|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228805|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
56228806|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
56228807|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
56228808|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228809|NCT01694693|Abatacept|abatacept|mesh-list
56228810|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56228811|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228813|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228814|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
56228815|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228816|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131737|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131738|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56131739|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131740|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131741|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56131742|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56131743|NCT02862132|Vedolizumab|vedolizumab|mesh-list
56131744|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56131745|NCT02859402|Fludarabine|fludarabine|mesh-list
56131746|NCT02859402|Busulfan|busulfan|mesh-list
56131747|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131748|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131749|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131750|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
56131751|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131752|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
56131753|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56131754|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56131755|NCT04844268|Vaccines|vaccines|mesh-list
56131756|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
56131757|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131758|NCT04842552|Hydralazine|hydralazine|mesh-list
56131759|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56131760|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
56131761|NCT02535312|Cisplatin|cisplatin|mesh-list
56131764|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131765|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131766|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56131767|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56131768|NCT02811510|Dronabinol|dronabinol|mesh-list
56131769|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
56131770|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131771|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56131772|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56131773|NCT02811510|Analgesics|analgesics|mesh-ancestor
56131774|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
56131775|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131776|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56131777|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56131778|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131779|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228817|NCT01694732|Varenicline|varenicline|mesh-list
56228818|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56228819|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56131781|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131782|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
56131783|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56131784|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
56131785|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
56131786|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131787|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131788|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56131789|NCT01891812|Analgesics|analgesics|mesh-ancestor
56131790|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
56131791|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131792|NCT04840602|Rituximab|rituximab|mesh-list
56131793|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56131794|NCT04840602|Venetoclax|venetoclax|mesh-list
56131795|NCT04840602|Antibodies|antibodies|mesh-list
56131796|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
56131797|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56131798|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
56131799|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131800|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131801|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131802|NCT04390464|Ravulizumab|ravulizumab|mesh-list
56131803|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56131804|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131805|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
56131806|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131807|NCT01892748|Vitamin D|vitamin d|mesh-list
56131808|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
56131809|NCT01892748|Vitamins|vitamins|mesh-ancestor
56131810|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
56131811|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131812|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56131813|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56131814|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
56131815|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56131816|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
56131817|NCT01893060|Povidone|povidone|mesh-list
56131818|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56131819|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131820|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
56131821|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
56131822|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
56131823|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
56131824|NCT02344290|Pitavastatin|pitavastatin|mesh-list
56131825|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56131826|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56131827|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56131828|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
55743075|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55743076|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743078|NCT04065009|Ropivacaine|ropivacaine|mesh-list
55743079|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
55743080|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
56131829|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131830|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131831|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56131832|NCT02848560|Xenon|xenon|mesh-list
56131833|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56131834|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
56131835|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
56131836|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131838|NCT02846376|Nivolumab|nivolumab|mesh-list
56131839|NCT02846376|Ipilimumab|ipilimumab|mesh-list
56131840|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56131841|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131842|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56131843|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131844|NCT01457820|Allopurinol|allopurinol|mesh-list
56131845|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
56131846|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131847|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131849|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131850|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56131851|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
56228821|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228822|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228823|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228824|NCT01694797|Metoprolol|metoprolol|mesh-list
56228825|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56228826|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56228827|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
56228828|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
56131852|NCT01457820|Protective Agents|protective agents|mesh-ancestor
56131853|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131854|NCT02794428|Eflornithine|eflornithine|mesh-list
56131855|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131856|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56131857|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56131858|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56131859|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131860|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56131861|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131862|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131863|NCT05020782|Belimumab|belimumab|mesh-list
55858801|NCT05193994|Lamivudine|lamivudine|mesh-list
56131864|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56131865|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
56131866|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131867|NCT05022342|Fulvestrant|fulvestrant|mesh-list
56131868|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56131869|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131870|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56131871|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56131872|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
56131873|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131874|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131875|NCT01893294|Gemcitabine|gemcitabine|mesh-list
56131876|NCT01893294|Fluorouracil|fluorouracil|mesh-list
56131877|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56131878|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
56131879|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131880|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131881|NCT01893294|Antiviral Agents|antiviral agents|mesh-ancestor
56131882|NCT01893294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131883|NCT01893294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131884|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55743112|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743114|NCT02517619|Prednisolone|prednisolone|mesh-list
56131885|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
56131886|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131888|NCT01458054|Omeprazole|omeprazole|mesh-list
56131889|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56131890|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56131891|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
56131892|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131893|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131894|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56131895|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56131896|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
56131897|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131898|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56131899|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56131900|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56131901|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56131902|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56131903|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
56131904|NCT01893450|Bromocriptine|bromocriptine|mesh-list
56131905|NCT01893450|Methimazole|methimazole|mesh-list
56131906|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56131907|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131908|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228829|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228830|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228832|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56131909|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56131910|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56131911|NCT01893450|Protective Agents|protective agents|mesh-ancestor
56131912|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131913|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
56131914|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56131915|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
56131916|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56131917|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56131918|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
56131919|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131920|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
56131922|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131923|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
56131925|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56131926|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56131927|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131928|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131929|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131930|NCT05024214|Sunitinib|sunitinib|mesh-list
56131931|NCT05024214|Lenvatinib|lenvatinib|mesh-list
56131932|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131933|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56131934|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56131935|NCT05024214|Growth Substances|growth substances|mesh-ancestor
56131936|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131937|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
55858878|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
56131938|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56131939|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131940|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131941|NCT01458600|Diclofenac|diclofenac|mesh-list
56131942|NCT01458600|Propranolol|propranolol|mesh-list
56131943|NCT01458600|Metoprolol|metoprolol|mesh-list
56131944|NCT01458600|Methimazole|methimazole|mesh-list
56131945|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56131946|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56131947|NCT01458600|Analgesics|analgesics|mesh-ancestor
56131948|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
56131949|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56131950|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131951|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56131952|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56131953|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55743123|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56131954|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56131955|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131956|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56131957|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56131958|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
56131959|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56131960|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56131961|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56131962|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
56131963|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
56131964|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
56131965|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56131966|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
56131967|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
56131968|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56131969|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
56131970|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
56131971|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56131972|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56131973|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228833|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56228834|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
56228835|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743127|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743128|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55743129|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
55743130|NCT02517619|Hormones|hormones|mesh-ancestor
55743131|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55743132|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55743134|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55743135|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55743136|NCT02517619|Protective Agents|protective agents|mesh-ancestor
55743138|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228836|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228837|NCT01695005|Prednisone|prednisone|mesh-list
56228838|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228839|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
56228840|NCT01695005|Hormones|hormones|mesh-ancestor
56228841|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228842|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228843|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56228844|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228845|NCT01695057|Vorinostat|vorinostat|mesh-list
56228846|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228847|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56228848|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228849|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228850|NCT01695070|Melatonin|melatonin|mesh-list
56228851|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
56228852|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228853|NCT01695070|Protective Agents|protective agents|mesh-ancestor
56228854|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131974|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56131975|NCT02832570|Urological Agents|urological agents|mesh-ancestor
56131976|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
56131977|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
56131978|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56131979|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
56131980|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56131981|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
56131982|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131983|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131984|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
56131985|NCT02730546|Leucovorin|leucovorin|mesh-list
56131986|NCT02730546|Folic Acid|folic acid|mesh-list
56131987|NCT02730546|Paclitaxel|paclitaxel|mesh-list
56131991|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
56131992|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56131993|NCT02730546|Calcium|calcium|mesh-list
56131994|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
56131995|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56131996|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131997|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
56131998|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
56131999|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132000|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132001|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56132002|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56132003|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132004|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56132006|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56228855|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228856|NCT01695109|Liraglutide|liraglutide|mesh-list
56228857|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56228858|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228859|NCT01695109|Incretins|incretins|mesh-ancestor
56228860|NCT01695109|Hormones|hormones|mesh-ancestor
55743184|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55743185|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56228861|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56228862|NCT01695122|Valproic Acid|valproic acid|mesh-list
56132007|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132008|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
56132009|NCT02730546|Antidotes|antidotes|mesh-ancestor
56132010|NCT02730546|Protective Agents|protective agents|mesh-ancestor
56132011|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
56132012|NCT02730546|Vitamins|vitamins|mesh-ancestor
56132013|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
56132014|NCT02730546|Hematinics|hematinics|mesh-ancestor
56132015|NCT01459146|Lumefantrine|lumefantrine|mesh-list
56132016|NCT01459146|Artemether|artemether|mesh-list
56132017|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56132018|NCT01459146|Albendazole|albendazole|mesh-list
56132019|NCT01459146|Praziquantel|praziquantel|mesh-list
56132020|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
56132021|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56132022|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56132023|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132024|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
56132025|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
56132026|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56132027|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132028|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132029|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132030|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132031|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132032|NCT05026398|Fenfluramine|fenfluramine|mesh-list
56132033|NCT05026398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56132034|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56132035|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56132036|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132037|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132038|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
56132039|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132040|NCT05586750|Atorvastatin|atorvastatin|mesh-list
56132041|NCT05586750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56132042|NCT05586750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56132043|NCT05586750|Antimetabolites|antimetabolites|mesh-ancestor
56132044|NCT05586750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132045|NCT05586750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56132046|NCT05586750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56132047|NCT05586750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132048|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56132049|NCT02720094|Cabotegravir|cabotegravir|mesh-list
56132050|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56132051|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56132052|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132053|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132054|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
56132055|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132056|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56132057|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56132058|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56132059|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56132061|NCT02716974|Leuprolide|leuprolide|mesh-list
56132063|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132064|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132065|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132066|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
55890359|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55743206|NCT01285557|Cisplatin|cisplatin|mesh-list
55743213|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55743214|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
56132067|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228863|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
56228864|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228865|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228866|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
56228867|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228868|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228869|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
56228870|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56228871|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56228872|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56228873|NCT01695148|Carotenoids|carotenoids|mesh-list
56228874|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
56228875|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132068|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56132069|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
56132070|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56132071|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132072|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56132073|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
56132074|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
56132075|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132076|NCT01459380|Bevacizumab|bevacizumab|mesh-list
56132077|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56132078|NCT01459380|Carboplatin|carboplatin|mesh-list
56132079|NCT01459380|Doxorubicin|doxorubicin|mesh-list
56132080|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56132082|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
56132083|NCT01459380|Antibodies|antibodies|mesh-list
56132084|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
56132085|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56132086|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
56132087|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132088|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56132089|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55859027|NCT00565084|Analgesics|analgesics|mesh-ancestor
56132090|NCT01459380|Growth Substances|growth substances|mesh-ancestor
56132091|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132092|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
56132093|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
56132094|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56132095|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56132096|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56132097|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132098|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132099|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56132100|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56132101|NCT04346004|Hematinics|hematinics|mesh-ancestor
56132102|NCT02680314|Methotrexate|methotrexate|mesh-list
56132103|NCT02680314|Misoprostol|misoprostol|mesh-list
56132104|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56132105|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
56132106|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56132107|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743226|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
55743227|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
55743228|NCT03083067|Hormones|hormones|mesh-ancestor
55743229|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55743230|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55743231|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55743232|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55743233|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
56132108|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56132109|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
56132110|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132111|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132113|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132114|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56132115|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56228876|NCT01695148|Protective Agents|protective agents|mesh-ancestor
56228877|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228879|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56228880|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228881|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228882|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
56228883|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
56228884|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228885|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228886|NCT01695226|Celecoxib|celecoxib|mesh-list
56228887|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56228888|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56132116|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
56132117|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132118|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56132119|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56132120|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56132121|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
56132122|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56132123|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
56132124|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132125|NCT02706678|Tacrolimus|tacrolimus|mesh-list
56132126|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132127|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
56132128|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132129|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56132130|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132131|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132132|NCT02705196|Gemcitabine|gemcitabine|mesh-list
56132133|NCT02705196|Paclitaxel|paclitaxel|mesh-list
56132134|NCT02705196|Atezolizumab|atezolizumab|mesh-list
56132135|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56132138|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132139|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132140|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132141|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56132142|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
56132143|NCT02705196|Antiviral Agents|antiviral agents|mesh-ancestor
56132144|NCT02705196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132145|NCT02705196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132146|NCT02705196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132147|NCT02705196|Immunologic Factors|immunologic factors|mesh-ancestor
56132148|NCT02705196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132149|NCT02703948|Lidocaine|lidocaine|mesh-list
56132150|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
56132151|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
56132152|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56132153|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132154|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
56132155|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132156|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56132157|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56132158|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56132159|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56132160|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132166|NCT02677038|Olaparib|olaparib|mesh-list
55743238|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
56132167|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56132168|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228890|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
56228891|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132169|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132170|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132172|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
56132173|NCT02666742|Edoxaban|edoxaban|mesh-list
56132174|NCT02666742|Dabigatran|dabigatran|mesh-list
56132175|NCT02666742|Anticoagulants|anticoagulants|mesh-list
56132176|NCT02666742|Coagulants|coagulants|mesh-list
56132177|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56132178|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56132179|NCT02666742|Analgesics|analgesics|mesh-ancestor
56132180|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
56132181|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132182|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132183|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56132184|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132185|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56132186|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56132187|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132188|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56132189|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56132190|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132191|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
56132192|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56132193|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
56132194|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56132195|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
56132196|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
56132197|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56132198|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56132199|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132200|NCT05586516|Gemcitabine|gemcitabine|mesh-list
56132201|NCT05586516|Paclitaxel|paclitaxel|mesh-list
56132202|NCT05586516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56132203|NCT05586516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132204|NCT05586516|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132205|NCT05586516|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132206|NCT05586516|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132207|NCT05586516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132208|NCT05586516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56132209|NCT05586516|Antimetabolites|antimetabolites|mesh-ancestor
56132210|NCT05586516|Antiviral Agents|antiviral agents|mesh-ancestor
56132211|NCT05586516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132212|NCT05586516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132213|NCT05586516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132217|NCT04390854|Miconazole|miconazole|mesh-list
56132218|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56132219|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132220|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
56132221|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56132222|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56132223|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132224|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132225|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56132226|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
55743251|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743252|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743253|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56132227|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132228|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132229|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56132230|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56132231|NCT02465736|Cisplatin|cisplatin|mesh-list
56132232|NCT02465736|Docetaxel|docetaxel|mesh-list
56132233|NCT02465736|Vinorelbine|vinorelbine|mesh-list
56132234|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859181|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56132235|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132236|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132237|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132238|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228892|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228893|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56228894|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56228895|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56228896|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56228897|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228898|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228899|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
56228900|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
56228901|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
56228902|NCT01695356|Avobenzone|avobenzone|mesh-list
56228903|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
56132239|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56132240|NCT02630316|Treprostinil|treprostinil|mesh-list
56132241|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56132242|NCT02369484|Afatinib|afatinib|mesh-list
56132243|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132244|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56132245|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132246|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132247|NCT02359968|Paclitaxel|paclitaxel|mesh-list
56132248|NCT02359968|Fluorouracil|fluorouracil|mesh-list
56132249|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
56132250|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56132251|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132252|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
55743265|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
55743266|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743267|NCT02507479|Thiotepa|thiotepa|mesh-list
55743268|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55743269|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
55743273|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55743274|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
55743275|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743276|NCT02512315|Cisplatin|cisplatin|mesh-list
55743277|NCT02512315|Docetaxel|docetaxel|mesh-list
56132253|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132254|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132255|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132256|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
56132257|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56132258|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132259|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
56132260|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132261|NCT04757376|Denosumab|denosumab|mesh-list
56132262|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56132263|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132264|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
56132265|NCT02625480|Fludarabine|fludarabine|mesh-list
56132266|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132267|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
56132268|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132269|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132270|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56132271|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
56132272|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132273|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132274|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56132276|NCT02624544|Esomeprazole|esomeprazole|mesh-list
56132277|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56132278|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56132279|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56132280|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132281|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132282|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56132283|NCT02603328|Atorvastatin|atorvastatin|mesh-list
56132285|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56132286|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
56132287|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132288|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56132289|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56228905|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56228906|NCT01695356|Protective Agents|protective agents|mesh-ancestor
56228907|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228908|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
56228909|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56228910|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
56228911|NCT01695460|Vitamins|vitamins|mesh-list
56228912|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
56228913|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228914|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56228915|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56228916|NCT01695707|Pioglitazone|pioglitazone|mesh-list
56228917|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56132290|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132292|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56132293|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132294|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56132295|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132296|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132297|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56132298|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56132299|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
56132300|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132301|NCT02598726|Curcumin|curcumin|mesh-list
56132302|NCT02598726|Piperine|piperine|mesh-list
56132303|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56132304|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56132305|NCT02598726|Analgesics|analgesics|mesh-ancestor
56132306|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
56132307|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132308|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743295|NCT05431413|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55743299|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132309|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56132310|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132311|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132312|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132313|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132314|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56132315|NCT01451736|Risperidone|risperidone|mesh-list
56132316|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56132317|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56132318|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
56132319|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132320|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132321|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132322|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56132323|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56132324|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56132325|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56132326|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56132327|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
56132328|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56132329|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56132330|NCT02589600|Vitamin D|vitamin d|mesh-list
56132331|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
56132332|NCT02589600|Calcium|calcium|mesh-list
56132333|NCT02589600|Vitamins|vitamins|mesh-ancestor
56132334|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
56132335|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132336|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56132337|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56228918|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228920|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
56228921|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228922|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
56228923|NCT01695759|Hematinics|hematinics|mesh-ancestor
56228924|NCT01695798|Vaccines|vaccines|mesh-list
56228925|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
56132338|NCT04758000|Metformin|metformin|mesh-list
56132339|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56132340|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132341|NCT01450956|Sevoflurane|sevoflurane|mesh-list
56132342|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56132343|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56132344|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
56132345|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
56132346|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56132347|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132348|NCT02300922|Antibodies|antibodies|mesh-list
56132349|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
56132350|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132351|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
56132352|NCT01453530|Neostigmine|neostigmine|mesh-list
56132353|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56132354|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132355|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132356|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
56132357|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132358|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132359|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56132361|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132362|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56132363|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56132364|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55743300|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
55743303|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
56132365|NCT02983422|Aminophylline|aminophylline|mesh-list
56132366|NCT02983422|Furosemide|furosemide|mesh-list
56132367|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56132368|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
56132369|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132370|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132371|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56132372|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
56132373|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56132374|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56132375|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132376|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132377|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56132378|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56132379|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
56132380|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132381|NCT02983422|Protective Agents|protective agents|mesh-ancestor
56132382|NCT02983422|Diuretics|diuretics|mesh-ancestor
56132383|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
56132384|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56132385|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56132386|NCT05585814|Bevacizumab|bevacizumab|mesh-list
56132388|NCT05585814|Capecitabine|capecitabine|mesh-list
56132389|NCT05585814|Oxaliplatin|oxaliplatin|mesh-list
56132390|NCT05585814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56132391|NCT05585814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132392|NCT05585814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56132393|NCT05585814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56132394|NCT05585814|Growth Substances|growth substances|mesh-ancestor
56132395|NCT05585814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132396|NCT05585814|Growth Inhibitors|growth inhibitors|mesh-ancestor
56132397|NCT05585814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56132398|NCT05585814|Antimetabolites|antimetabolites|mesh-ancestor
56132399|NCT05585814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132400|NCT02013648|Cytarabine|cytarabine|mesh-list
56228926|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228927|NCT01695824|Warfarin|warfarin|mesh-list
56228928|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
56228929|NCT01695850|Sennosides|sennosides|mesh-list
56228930|NCT01695850|Laxatives|laxatives|mesh-ancestor
56228931|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56228932|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
56228933|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56228934|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
56228935|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56132401|NCT02013648|Daunorubicin|daunorubicin|mesh-list
56132402|NCT02013648|Dasatinib|dasatinib|mesh-list
56132403|NCT02013648|Idarubicin|idarubicin|mesh-list
56132404|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56132405|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
56132406|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132407|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132408|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
56132409|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132410|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132411|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
56132412|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132413|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56132414|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56132415|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56132416|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132417|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56132418|NCT05585736|Mydriatics|mydriatics|mesh-list
56132419|NCT05585736|Autonomic Agents|autonomic agents|mesh-ancestor
56132420|NCT05585736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743312|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55743313|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743315|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56132421|NCT05585736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132422|NCT01989780|Paclitaxel|paclitaxel|mesh-list
56132423|NCT01989780|Bevacizumab|bevacizumab|mesh-list
56132424|NCT01989780|Letrozole|letrozole|mesh-list
56132425|NCT01989780|Fulvestrant|fulvestrant|mesh-list
56132426|NCT01989780|Anastrozole|anastrozole|mesh-list
56132427|NCT01989780|Exemestane|exemestane|mesh-list
56132428|NCT01989780|Goserelin|goserelin|mesh-list
56132429|NCT01989780|Leuprolide|leuprolide|mesh-list
56132430|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56132431|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132432|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132433|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132434|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132435|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132436|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56132438|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56132439|NCT01989780|Growth Substances|growth substances|mesh-ancestor
56132440|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132441|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
56132442|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56132443|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56132444|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132445|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56132446|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
56132447|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132448|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56132449|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56132450|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56132451|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
56132453|NCT02270814|Paclitaxel|paclitaxel|mesh-list
56132454|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56132455|NCT02270814|Cisplatin|cisplatin|mesh-list
56132456|NCT02270814|Carboplatin|carboplatin|mesh-list
56132457|NCT02270814|Cetuximab|cetuximab|mesh-list
56132458|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55859406|NCT02134210|Etanercept|etanercept|mesh-list
56132459|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228936|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228937|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56228938|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56228939|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56228940|NCT01696110|Heparin|heparin|mesh-list
56228941|NCT01696110|Calcium heparin|calcium heparin|mesh-list
56132460|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132461|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132462|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132463|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132464|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56132465|NCT02549898|Cilostazol|cilostazol|mesh-list
56132467|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56132468|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
56132469|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132470|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132471|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56132472|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
56132473|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56132474|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56132475|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132476|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56132477|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
56132478|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56132479|NCT02549898|Protective Agents|protective agents|mesh-ancestor
55743320|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132480|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56132481|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56132482|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132483|NCT02549898|Hematinics|hematinics|mesh-ancestor
56132484|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56132485|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56132486|NCT02538198|Lenalidomide|lenalidomide|mesh-list
56132487|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
56132488|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132489|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56132490|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56132491|NCT02538198|Growth Substances|growth substances|mesh-ancestor
56132492|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
56132493|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132494|NCT05585580|Paclitaxel|paclitaxel|mesh-list
56132495|NCT05585580|Lenvatinib|lenvatinib|mesh-list
56132496|NCT05585580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56132497|NCT05585580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132498|NCT05585580|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132499|NCT05585580|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132500|NCT05585580|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132501|NCT05585580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132502|NCT05585580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56132503|NCT05585580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132504|NCT02516670|Vitamins|vitamins|mesh-list
56132505|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
56132506|NCT02516670|Docetaxel|docetaxel|mesh-list
56132507|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
56132508|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132509|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132510|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132511|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132513|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132515|NCT02516670|Protective Agents|protective agents|mesh-ancestor
56132516|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
56132517|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56132518|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56132519|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132520|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
56132521|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
56132522|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
56132523|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56132524|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56132525|NCT02283996|Prednisolone|prednisolone|mesh-list
56132526|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
56228942|NCT01696110|Tirofiban|tirofiban|mesh-list
55743332|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743333|NCT03136029|Protective Agents|protective agents|mesh-ancestor
55743334|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743335|NCT02507167|Rifampin|rifampin|mesh-list
55743340|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
56228943|NCT01696110|Bivalirudin|bivalirudin|mesh-list
56228944|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
56228945|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56228946|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56228947|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228948|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
56228949|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56228950|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
56228951|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228952|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56228953|NCT01696240|Udenafil|udenafil|mesh-list
56228954|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56228955|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56228956|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56228957|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228958|NCT01696370|Trimetazidine|trimetazidine|mesh-list
56228959|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
56228960|NCT01696383|Timolol|timolol|mesh-list
55804614|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56132527|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56132528|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
56132529|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56132531|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
56132532|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132533|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132534|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56132535|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
56132536|NCT02283996|Hormones|hormones|mesh-ancestor
56132537|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132538|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56132539|NCT02283996|Protective Agents|protective agents|mesh-ancestor
56132540|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56132543|NCT04390152|Lopinavir|lopinavir|mesh-list
56132544|NCT04390152|Azithromycin|azithromycin|mesh-list
56132545|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
56132546|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56132547|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56132548|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
56132549|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132550|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132551|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56132552|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56132553|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
56132554|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132555|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56132556|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56132557|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56132558|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
56132559|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56132560|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56132561|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132562|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56132563|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
56132564|NCT02227992|Coagulants|coagulants|mesh-ancestor
56132565|NCT02496780|Insulin|insulin|mesh-list
56228961|NCT01696383|Travoprost|travoprost|mesh-list
56228962|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56228963|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56228964|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
56228965|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56228966|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56228967|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743351|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
55743352|NCT01376167|Primaquine|primaquine|mesh-list
55743353|NCT01376167|Tafenoquine|tafenoquine|mesh-list
55743354|NCT01376167|Amebicides|amebicides|mesh-ancestor
56228968|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56228969|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56228970|NCT01696409|Vitamin D|vitamin d|mesh-list
56228971|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
56228972|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
56228973|NCT01696409|Vitamins|vitamins|mesh-list
56228974|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
56228975|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228976|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56132566|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56132567|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
56132568|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
56132569|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56132570|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132590|NCT01953588|Fulvestrant|fulvestrant|mesh-list
56132591|NCT01953588|Anastrozole|anastrozole|mesh-list
56132592|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56132593|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132594|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56132595|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56132596|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
56132597|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132598|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132599|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56132600|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56132601|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132602|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132603|NCT01953510|Vaccines|vaccines|mesh-list
56132604|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56132605|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
56132606|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132610|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56132611|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
56132612|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132613|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132614|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56132615|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56132617|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132618|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132619|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
56132620|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56132621|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56132622|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
56132623|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56132624|NCT02456532|Zolpidem|zolpidem|mesh-list
56132625|NCT02456532|Eszopiclone|eszopiclone|mesh-list
56132626|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56132627|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56132628|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56132629|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132630|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56228977|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56228978|NCT01696422|Vaccines|vaccines|mesh-list
56228979|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
56228980|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228981|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
56228982|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
55804648|NCT02335983|Growth Substances|growth substances|mesh-ancestor
56132631|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
55743365|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743366|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55743367|NCT01376167|Filaricides|filaricides|mesh-ancestor
56132632|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
56132633|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132634|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132635|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
56132636|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56132637|NCT02153580|Fludarabine|fludarabine|mesh-list
56132638|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
56132639|NCT02153580|Etoposide|etoposide|mesh-list
56132640|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
56132641|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
56132642|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132643|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
56132644|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132645|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132646|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56132647|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
56132648|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132649|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132650|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56132651|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56132652|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
56132653|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56132654|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56132655|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56132656|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132657|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
56132658|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
56132659|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132660|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132661|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132662|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56132664|NCT05578950|Terbinafine|terbinafine|mesh-list
56132665|NCT05578950|Antifungal Agents|antifungal agents|mesh-ancestor
56132666|NCT05578950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132667|NCT05578950|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56132668|NCT05578950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56132669|NCT05578950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132670|NCT05578950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132671|NCT05578950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56132672|NCT05578950|Hormone Antagonists|hormone antagonists|mesh-ancestor
56132673|NCT05578950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132674|NCT05578950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132675|NCT05578950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56132676|NCT05586126|Sevoflurane|sevoflurane|mesh-list
56132677|NCT05586126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56132678|NCT05586126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56132679|NCT05586126|Anesthetics, General|anesthetics, general|mesh-ancestor
56132680|NCT05586126|Anesthetics|anesthetics|mesh-ancestor
56132681|NCT05586126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56132683|NCT01893996|Adalimumab|adalimumab|mesh-list
56132684|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56132685|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132686|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
56132687|NCT02442180|Prednisolone|prednisolone|mesh-list
56132688|NCT02442180|Lenograstim|lenograstim|mesh-list
56132689|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56132690|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
56132691|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132692|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56132693|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
56228983|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743381|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55743382|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55743383|NCT02511613|Protective Agents|protective agents|mesh-ancestor
56228984|NCT01696448|Protective Agents|protective agents|mesh-ancestor
56228985|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56228986|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
56228987|NCT01696448|Vitamins|vitamins|mesh-ancestor
56228988|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
56132694|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
56132695|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132696|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56132697|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
56132698|NCT02442180|Hormones|hormones|mesh-ancestor
56132699|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132700|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56132701|NCT02442180|Protective Agents|protective agents|mesh-ancestor
56132702|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56132703|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132704|NCT01924260|Gemcitabine|gemcitabine|mesh-list
56132705|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56132706|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
56132707|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132708|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132709|NCT01924260|Antiviral Agents|antiviral agents|mesh-ancestor
56132710|NCT01924260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132711|NCT01924260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132712|NCT01924260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132713|NCT01924260|Immunologic Factors|immunologic factors|mesh-ancestor
56132714|NCT01924260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132715|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
56132716|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56132717|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
56132718|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132719|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
56132720|NCT02432742|Protective Agents|protective agents|mesh-ancestor
56132721|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
56132722|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56132723|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56132724|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132725|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
56132726|NCT02086500|Coagulants|coagulants|mesh-ancestor
56132728|NCT02104986|Ifosfamide|ifosfamide|mesh-list
56132729|NCT02104986|Bleomycin|bleomycin|mesh-list
56132730|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132731|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56132732|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
56132733|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132734|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56132735|NCT02425566|Trimethaphan|trimethaphan|mesh-list
56132736|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
56132737|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
56132738|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
56132739|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56132740|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56132741|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56132742|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
56132743|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132744|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132745|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56132746|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56132747|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
56132748|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743394|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
56132749|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132750|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
56132751|NCT04757532|Anastrozole|anastrozole|mesh-list
56132752|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
56132753|NCT04757532|Bupropion|bupropion|mesh-list
56132754|NCT04757532|Testosterone|testosterone|mesh-list
56132755|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
56132756|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
56132757|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56132758|NCT04757532|Danazol|danazol|mesh-list
56132759|NCT04757532|Androgens|androgens|mesh-ancestor
56228989|NCT01696461|Plerixafor|plerixafor|mesh-list
56132761|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132763|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56132764|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132765|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
56132766|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56132767|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
56132769|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56132770|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56132771|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56132772|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132773|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
56132774|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132775|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56132776|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56132777|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132778|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56132779|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56132780|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56132781|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
56132782|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56132783|NCT04757532|Diuretics|diuretics|mesh-ancestor
56132784|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
56132785|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56132786|NCT02392572|TIC10 compound|tic10 compound|mesh-list
56132787|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132788|NCT02069730|Androgens|androgens|mesh-list
56132789|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
56132790|NCT02069730|Hormones|hormones|mesh-ancestor
56132791|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132792|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132793|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
56132794|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
56132795|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132796|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
56132797|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132798|NCT02068092|Protective Agents|protective agents|mesh-ancestor
56132799|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132800|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56132801|NCT02063022|Dactinomycin|dactinomycin|mesh-list
56132802|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
56132803|NCT02063022|Melphalan|melphalan|mesh-list
56132804|NCT02063022|Busulfan|busulfan|mesh-list
56132805|NCT02063022|Ifosfamide|ifosfamide|mesh-list
56132806|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
56132807|NCT02063022|Doxorubicin|doxorubicin|mesh-list
56132808|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56132809|NCT02063022|Etoposide|etoposide|mesh-list
56132810|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
56132811|NCT02063022|Vincristine|vincristine|mesh-list
56132812|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56132813|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
56132814|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132815|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132816|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56132817|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
55743410|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
55743411|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55743413|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56132818|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132819|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132820|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56132821|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56132822|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56132823|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56132824|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132825|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56132826|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132827|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132828|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132829|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56132830|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132831|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56132832|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56132833|NCT01895010|Tropisetron|tropisetron|mesh-list
56132835|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
56132836|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56228990|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56228991|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56228992|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
56228993|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56228994|NCT01696474|Bortezomib|bortezomib|mesh-list
56228995|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56228996|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
56228997|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56228998|NCT01696500|Antibodies|antibodies|mesh-list
56228999|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
56229000|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56229001|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
56229002|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229003|NCT01696526|Vitamin D|vitamin d|mesh-list
56229004|NCT01696526|Vitamins|vitamins|mesh-ancestor
56229005|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
56229006|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229007|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56229008|NCT01696552|Cimetidine|cimetidine|mesh-list
56229009|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56229010|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55743418|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743419|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55743420|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743421|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743422|NCT02506855|Ropivacaine|ropivacaine|mesh-list
55743423|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
55743424|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
55743425|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743426|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743427|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
56229011|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56229012|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
56229013|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
56229014|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229015|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229016|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229017|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56229018|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56229019|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229020|NCT01696617|Aripiprazole|aripiprazole|mesh-list
56229021|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
56229022|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56229023|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56229024|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56229025|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229026|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132837|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132838|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229028|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
56229029|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229030|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229031|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56229032|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56229033|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
56229034|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56229035|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56229036|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56229037|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56229038|NCT01696630|Desflurane|desflurane|mesh-list
56229039|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56229040|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
56132839|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56132840|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56132841|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
56132842|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132843|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132844|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56132845|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56132846|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
56132847|NCT02030028|Hormones|hormones|mesh-ancestor
56132848|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132849|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132850|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132851|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132852|NCT01896336|Zolpidem|zolpidem|mesh-list
56132853|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56132854|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56132855|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56132856|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132857|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56132858|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
56132859|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
56132860|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132861|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132862|NCT00575718|Nicotine|nicotine|mesh-list
56132863|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56132864|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
56132865|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743448|NCT02506231|Protective Agents|protective agents|mesh-ancestor
55743457|NCT02505997|Midazolam|midazolam|mesh-list
56132866|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132868|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56132869|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
56132870|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132871|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132872|NCT02087748|Diclofenac|diclofenac|mesh-list
56132873|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56132874|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56132875|NCT02087748|Analgesics|analgesics|mesh-ancestor
56132876|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
56132877|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132878|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132879|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56132880|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132881|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56229041|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
56229042|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229043|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229044|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56229045|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
56229046|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229047|NCT01696799|Econazole|econazole|mesh-list
56229048|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
56229049|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229050|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56229051|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56229052|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229053|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229054|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56229055|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
56229056|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229057|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229058|NCT01696825|Diazepam|diazepam|mesh-list
56229059|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56229060|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
56229061|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
56229062|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
56132882|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132883|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132884|NCT01490502|Vitamin D|vitamin d|mesh-list
56132885|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
56132886|NCT01490502|Vitamins|vitamins|mesh-ancestor
56132887|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
56132888|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132889|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56132890|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56132891|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
56132892|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56132893|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
56132894|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132895|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
56132896|NCT01428024|Protective Agents|protective agents|mesh-ancestor
56132897|NCT01424982|Cytarabine|cytarabine|mesh-list
56132898|NCT01424982|Dexamethasone|dexamethasone|mesh-list
56132899|NCT01424982|Prednisone|prednisone|mesh-list
56132900|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
56132901|NCT01424982|Cortisone|cortisone|mesh-list
56132902|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
56132903|NCT01424982|Rituximab|rituximab|mesh-list
56132904|NCT01424982|Doxorubicin|doxorubicin|mesh-list
56132905|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56132906|NCT01424982|Methotrexate|methotrexate|mesh-list
56132907|NCT01424982|Vincristine|vincristine|mesh-list
56132908|NCT01424982|Daunorubicin|daunorubicin|mesh-list
56132909|NCT01424982|Ponatinib|ponatinib|mesh-list
56132910|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56132913|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55743462|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55743463|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56132914|NCT01424982|BB 1101|bb 1101|mesh-list
56132915|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229063|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229064|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229065|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229066|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56229067|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229068|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56229069|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56229070|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56229071|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56229072|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56229073|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56229074|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
56229075|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
55804734|NCT04572763|Venetoclax|venetoclax|mesh-list
56132916|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
56132917|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132918|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56132919|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56132920|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
56132921|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56132922|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132923|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56132924|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56132926|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
56132927|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132928|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56132929|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
56132930|NCT01424982|Hormones|hormones|mesh-ancestor
56132931|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56132932|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56132933|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56132934|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56132935|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56132936|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56132937|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56132938|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
56132939|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56132940|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56132941|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
56132942|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
56132943|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56132944|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56132945|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
56132946|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56132947|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56132948|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132949|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
56132950|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132951|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
56132952|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56132953|NCT01419834|Antibodies|antibodies|mesh-list
56132954|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56132955|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
56132956|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132957|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
56132958|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56132959|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
56132960|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132961|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
56132962|NCT01412190|Protective Agents|protective agents|mesh-ancestor
56229076|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
56229077|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
56229078|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229079|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229080|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
56229081|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
56229082|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229083|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55804751|NCT04630171|Anesthetics|anesthetics|mesh-list
56132964|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
56132965|NCT01331148|Vitamins|vitamins|mesh-ancestor
56132966|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
56132967|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132968|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56132969|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56132970|NCT04839042|Cloricromen|cloricromen|mesh-list
56132971|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56132972|NCT00273624|Olanzapine|olanzapine|mesh-list
56132973|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
56132974|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
56132975|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56132976|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132977|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56132978|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56132979|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56132980|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56132981|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56132982|NCT00273624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56132983|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56132984|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55744916|NCT02483767|Goserelin|goserelin|mesh-list
56132986|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56132987|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
56132988|NCT00262470|Indomethacin|indomethacin|mesh-list
56132989|NCT00262470|Octreotide|octreotide|mesh-list
56132990|NCT00262470|Propranolol|propranolol|mesh-list
56132991|NCT00262470|Clonidine|clonidine|mesh-list
56132992|NCT00262470|Mecamylamine|mecamylamine|mesh-list
56132993|NCT00262470|Acetazolamide|acetazolamide|mesh-list
56132994|NCT00262470|Isosorbide|isosorbide|mesh-list
56132995|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56132996|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56132997|NCT00262470|Midodrine|midodrine|mesh-list
56132998|NCT00262470|Memantine|memantine|mesh-list
56132999|NCT00262470|Entacapone|entacapone|mesh-list
56133000|NCT00262470|Melatonin|melatonin|mesh-list
56133001|NCT00262470|Modafinil|modafinil|mesh-list
56133002|NCT00262470|Sertraline|sertraline|mesh-list
56133003|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56133004|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
56133005|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133006|NCT00262470|Protective Agents|protective agents|mesh-ancestor
56133007|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133008|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133009|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56133010|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56133011|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
56133012|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133013|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56133014|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56133015|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
56133016|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
56133017|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56133018|NCT00262470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56133019|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56133020|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56133021|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
56133022|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56229084|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229085|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133023|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56133025|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56133026|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56133027|NCT00262470|Analgesics|analgesics|mesh-ancestor
56133028|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
56133029|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133030|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
56133031|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
56133032|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56133033|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56133034|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56133035|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56133036|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56133037|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133038|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56133039|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56133040|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56133041|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56133042|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56133043|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56133045|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133046|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56133047|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
56133048|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
56133049|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56133050|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56133051|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133052|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
56133053|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56133054|NCT00262470|Diuretics|diuretics|mesh-ancestor
56133055|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
56133056|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
56133057|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56133058|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56133059|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56133060|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56133063|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56133064|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56133065|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
56133066|NCT01851642|Albuterol|albuterol|mesh-list
56133067|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56133068|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
56133069|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133070|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133071|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56133072|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
56133073|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
56133074|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56133075|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56133076|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56133077|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56133078|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
56133079|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133080|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133081|NCT01253070|Cytarabine|cytarabine|mesh-list
56133082|NCT01253070|Sorafenib|sorafenib|mesh-list
56133083|NCT01253070|Daunorubicin|daunorubicin|mesh-list
56133084|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133085|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
56133086|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133087|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133088|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
56133089|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133090|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133091|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
56133092|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133093|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133094|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229086|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
56229087|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229088|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56229089|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229090|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56229091|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
56229092|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56229093|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56229094|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229095|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229096|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
56229097|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229098|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56229099|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56229100|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56229101|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56229102|NCT01697059|Amoxicillin|amoxicillin|mesh-list
56229103|NCT01697059|Piperacillin|piperacillin|mesh-list
56229104|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56229105|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56229106|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229107|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56229108|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229109|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229110|NCT01697098|Dexamethasone|dexamethasone|mesh-list
56133095|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56133096|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56133097|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56133098|NCT01212822|Leucovorin|leucovorin|mesh-list
56133099|NCT01212822|Bevacizumab|bevacizumab|mesh-list
56133100|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56133101|NCT01212822|Fluorouracil|fluorouracil|mesh-list
56133102|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
56133103|NCT01212822|Antibodies|antibodies|mesh-list
56133104|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
56133105|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56133106|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
56133107|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133108|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56133109|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56133110|NCT01212822|Growth Substances|growth substances|mesh-ancestor
56133111|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743522|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
55743523|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743524|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133112|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
56133113|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
56133114|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
56133115|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133116|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56229111|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
56229112|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
56229113|NCT01697098|BB 1101|bb 1101|mesh-list
56229114|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229115|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
56229116|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
56229117|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229118|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229119|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229120|NCT01697098|Hormones|hormones|mesh-ancestor
56229121|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229122|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56229123|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229124|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
56229125|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229126|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229127|NCT01697111|Dienogest|dienogest|mesh-list
56229128|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56229129|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
56229130|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56229131|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229132|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56229133|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56229134|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56229135|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56229136|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
56229137|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133117|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133118|NCT01212822|Antidotes|antidotes|mesh-ancestor
56133119|NCT01212822|Protective Agents|protective agents|mesh-ancestor
56133120|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
56133121|NCT01212822|Vitamins|vitamins|mesh-ancestor
56133122|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
56133123|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
56133124|NCT00163566|Androgens|androgens|mesh-ancestor
56133125|NCT00163566|Hormones|hormones|mesh-ancestor
56133126|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133127|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133128|NCT04705662|Lactulose|lactulose|mesh-list
56133129|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56133130|NCT04782960|Bupivacaine|bupivacaine|mesh-list
56133131|NCT04782960|Anesthetics|anesthetics|mesh-list
55743532|NCT02505295|Selenium|selenium|mesh-list
56133132|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
56133133|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133134|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133135|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
56133137|NCT04634604|Bevacizumab|bevacizumab|mesh-list
56229138|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56229139|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229140|NCT01697150|Pancrelipase|pancrelipase|mesh-list
56229141|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229142|NCT01697228|Vitamin D|vitamin d|mesh-list
56229143|NCT01697228|Vitamins|vitamins|mesh-ancestor
56229144|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
56229145|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229146|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56229147|NCT01697293|Paclitaxel|paclitaxel|mesh-list
56229148|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
56229149|NCT01697293|Doxorubicin|doxorubicin|mesh-list
56229150|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56229151|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56229152|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56229153|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229154|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
56229155|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
56229156|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
56133138|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56133139|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133140|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56133141|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56133142|NCT04634604|Growth Substances|growth substances|mesh-ancestor
56133143|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133144|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
56133145|NCT01026012|Regadenoson|regadenoson|mesh-list
56133146|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56133147|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56133148|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
56133149|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
56133150|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133151|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133152|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133153|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
56133154|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56133155|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
56133156|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133157|NCT02088216|Expectorants|expectorants|mesh-ancestor
56133158|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
56133159|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56133160|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
56133161|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133162|NCT02088216|Protective Agents|protective agents|mesh-ancestor
56133163|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133164|NCT02088216|Antidotes|antidotes|mesh-ancestor
56133165|NCT01014936|Tepotinib|tepotinib|mesh-list
56133166|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133167|NCT01896180|Latanoprost|latanoprost|mesh-list
56133168|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56133169|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56133170|NCT00981162|Everolimus|everolimus|mesh-list
56133171|NCT00981162|Sorafenib|sorafenib|mesh-list
56133172|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133173|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133174|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
56133175|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133176|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55743560|NCT03121807|Protective Agents|protective agents|mesh-ancestor
55743561|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
55743562|NCT03121807|Vitamins|vitamins|mesh-ancestor
56133177|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229157|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229158|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229159|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
56229160|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229161|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56229162|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56229163|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
56229164|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56229165|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56229166|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56229167|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56229168|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229169|NCT01697306|Gemcitabine|gemcitabine|mesh-list
56229170|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
56229171|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56229172|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
56229173|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229174|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229175|NCT01697306|Antiviral Agents|antiviral agents|mesh-ancestor
56229176|NCT01697306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229177|NCT01697306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229178|NCT01697306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229179|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
56133178|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133180|NCT04756050|Racepinephrine|racepinephrine|mesh-list
56133181|NCT04756050|Bupivacaine|bupivacaine|mesh-list
56133182|NCT04756050|Prilocaine|prilocaine|mesh-list
56133183|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56133184|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
56133185|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
56133186|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
56133187|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133188|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133189|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
56133190|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133191|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56133193|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
56133194|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133195|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133196|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56133197|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56133198|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
56133199|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56133200|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56133201|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
56133202|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
56133203|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56133204|NCT00877500|Epothilones|epothilones|mesh-list
56133205|NCT00877500|Epothilone B|epothilone b|mesh-list
56133206|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
56133207|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
56229180|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229181|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56229182|NCT01697410|Terlipressin|terlipressin|mesh-list
56229183|NCT01697410|Norepinephrine|norepinephrine|mesh-list
56229184|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56133208|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
56133209|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133210|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133211|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
56133212|NCT00875004|Hematinics|hematinics|mesh-ancestor
56133215|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
56133216|NCT00869232|Melphalan|melphalan|mesh-list
56133217|NCT00869232|Doxorubicin|doxorubicin|mesh-list
56133218|NCT00869232|Etoposide|etoposide|mesh-list
56133219|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56133220|NCT00869232|Bortezomib|bortezomib|mesh-list
56133221|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133222|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
56133223|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133224|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56133225|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56133226|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
56133227|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133228|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133229|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56133230|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133232|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
56133233|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133234|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56133235|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
56133236|NCT00869232|Hormones|hormones|mesh-ancestor
56133237|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133238|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56133239|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56133240|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56133241|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56133242|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133243|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56133244|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
56133245|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133246|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133247|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56133248|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56133249|NCT00869232|Growth Substances|growth substances|mesh-ancestor
56133250|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
56133251|NCT05320692|Apatinib|apatinib|mesh-list
56133252|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
56133253|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133254|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133255|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133256|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133257|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56133258|NCT05320692|Estrogens|estrogens|mesh-ancestor
56133259|NCT05320692|Hormones|hormones|mesh-ancestor
56133260|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133261|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133262|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56133263|NCT01763580|Prednisolone|prednisolone|mesh-list
56133264|NCT01763580|Tacrolimus|tacrolimus|mesh-list
56133265|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133266|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
56133267|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133268|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56133269|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133270|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743588|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
56133271|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133272|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
56133273|NCT01763580|Hormones|hormones|mesh-ancestor
56133274|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133275|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56229185|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56229186|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
56229187|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229188|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229189|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229190|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
56229191|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
56229192|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229193|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56229194|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56229196|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
56229197|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229198|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
56133276|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133277|NCT04780854|Metformin|metformin|mesh-list
56133278|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56133279|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133280|NCT03969420|Cytarabine|cytarabine|mesh-list
56133281|NCT03969420|Alvocidib|alvocidib|mesh-list
56133282|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133283|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
56133284|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133285|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133286|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
56133287|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133290|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133301|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56133302|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
56133303|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
56133304|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133305|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56133306|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56133308|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133310|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
56133311|NCT04780152|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56133312|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56133313|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56133314|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133315|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133316|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
56133317|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133318|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56133319|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56133320|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56133321|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56133322|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133323|NCT00644280|Ranibizumab|ranibizumab|mesh-list
56133324|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56133325|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56133326|NCT00644280|Growth Substances|growth substances|mesh-ancestor
56133327|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743614|NCT02515435|Apatinib|apatinib|mesh-list
56133328|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
56133329|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133330|NCT04779762|Ustekinumab|ustekinumab|mesh-list
56133331|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
55744999|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
56133346|NCT04777968|Protective Agents|protective agents|mesh-ancestor
56133347|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133348|NCT01722708|Metronidazole|metronidazole|mesh-list
56133349|NCT01722708|Clindamycin|clindamycin|mesh-list
56229199|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229200|NCT01697605|Infigratinib|infigratinib|mesh-list
56229201|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229203|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56229204|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
56229205|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
56229206|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56229207|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56229208|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229209|NCT01697631|Insulin|insulin|mesh-list
56229210|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56229211|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
56229212|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
56229213|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56229214|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
55804869|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56133350|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
56133351|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
56133352|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133353|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133354|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56133355|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56133356|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56133357|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133358|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133359|NCT01711632|Vemurafenib|vemurafenib|mesh-list
56133360|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133361|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133362|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133363|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133364|NCT04756206|Dutasteride|dutasteride|mesh-list
56133365|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56133366|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56133367|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133368|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133369|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
56133370|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133371|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133372|NCT04779060|Dexamethasone|dexamethasone|mesh-list
56133373|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133374|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
56133375|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
56133376|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133377|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133378|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56133379|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
56133380|NCT04779060|Hormones|hormones|mesh-ancestor
56133381|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133383|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133384|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
56133385|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
56133386|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56133387|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56133388|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133389|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56133390|NCT04777110|Esketamine|esketamine|mesh-list
56032493|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56229215|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56229216|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56229217|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229218|NCT01697657|Insulin|insulin|mesh-list
56229219|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56229220|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
56229221|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
56229222|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
56229223|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
56229224|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
56229225|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56229226|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229227|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55743636|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55743637|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743638|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743640|NCT02504359|Methotrexate|methotrexate|mesh-list
55743641|NCT02504359|Etoposide|etoposide|mesh-list
55743642|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
55743643|NCT02504359|Melphalan|melphalan|mesh-list
56229228|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56229229|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
56229230|NCT01697722|Beclomethasone|beclomethasone|mesh-list
56133391|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
56133392|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56133393|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
56133394|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56133395|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133396|NCT01895400|Cilostazol|cilostazol|mesh-list
56133397|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56133398|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
56133399|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133400|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133401|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56133402|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
56133403|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56133404|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55743702|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743704|NCT02504125|Coagulants|coagulants|mesh-ancestor
55743706|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55743707|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
55743708|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
55743709|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55743711|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55743712|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743714|NCT02509273|Midazolam|midazolam|mesh-list
56133405|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133406|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56133407|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
56133408|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56133409|NCT01895400|Protective Agents|protective agents|mesh-ancestor
56133410|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56133411|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56133412|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133413|NCT05171946|Vaccines|vaccines|mesh-list
56133414|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
56133415|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133416|NCT05605314|Cyclosporine|cyclosporine|mesh-list
56133417|NCT05605314|Cyclosporins|cyclosporins|mesh-list
56133418|NCT05605314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133419|NCT05605314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133420|NCT05605314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133421|NCT05605314|Immunologic Factors|immunologic factors|mesh-ancestor
56133422|NCT05605314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133424|NCT05605314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133425|NCT05605314|Dermatologic Agents|dermatologic agents|mesh-ancestor
56133426|NCT05605314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56133427|NCT05605314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56133428|NCT05605158|Pioglitazone|pioglitazone|mesh-list
56133429|NCT05605158|Empagliflozin|empagliflozin|mesh-list
56133430|NCT05605158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56133431|NCT05605158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133432|NCT05605158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56133433|NCT05605158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229232|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
56229233|NCT01697722|Hormones|hormones|mesh-ancestor
56229234|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229235|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229236|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56229237|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
56229238|NCT01697735|Atorvastatin|atorvastatin|mesh-list
56229239|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56229240|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56229241|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56229242|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
55890360|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
55743762|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
55743763|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743764|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55743767|NCT02514421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229243|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804901|NCT04352101|Citalopram|citalopram|mesh-list
56133434|NCT05605080|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56133435|NCT05605080|Hemostatics|hemostatics|mesh-ancestor
56133436|NCT05605080|Coagulants|coagulants|mesh-ancestor
56133437|NCT01653678|Vitamin D|vitamin d|mesh-list
56133438|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
56133439|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
56133440|NCT01653678|Vitamins|vitamins|mesh-list
56133441|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
56133442|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133443|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56133444|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56133445|NCT04775238|Copper|copper|mesh-list
56133446|NCT04775238|Trace Elements|trace elements|mesh-ancestor
56133447|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
56133448|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133449|NCT05580042|Tofacitinib|tofacitinib|mesh-list
56133450|NCT05580042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133451|NCT05580042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133452|NCT05580042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133453|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
56133454|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
55743793|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743794|NCT02513875|Vitamin D|vitamin d|mesh-list
55743795|NCT02513875|Vitamins|vitamins|mesh-ancestor
55743797|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743798|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55743799|NCT02509351|Misoprostol|misoprostol|mesh-list
55743800|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55743801|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
55743802|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55743803|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743804|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55743805|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55743806|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
55743807|NCT02509195|Lamivudine|lamivudine|mesh-list
55743808|NCT02509195|Abacavir|abacavir|mesh-list
56133455|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133456|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
56133457|NCT03012984|Morphine|morphine|mesh-list
56133461|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56133462|NCT03012984|Analgesics|analgesics|mesh-ancestor
56133463|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
56133464|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133465|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56133466|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55743838|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
55743839|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55743840|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55743841|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55743842|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
55743843|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743844|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55743845|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55743846|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55743847|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743856|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
56133467|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56133468|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
56133469|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133470|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133471|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56133472|NCT03012984|Narcotics|narcotics|mesh-ancestor
56133473|NCT02744430|Mirabegron|mirabegron|mesh-list
56133474|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56133475|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56133476|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56133477|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
56133478|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133479|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133480|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133481|NCT02744430|Urological Agents|urological agents|mesh-ancestor
56133483|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
56133484|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229244|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56229245|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56229246|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229247|NCT01697787|Artesunate|artesunate|mesh-list
56229248|NCT01697787|Lumefantrine|lumefantrine|mesh-list
56229249|NCT01697787|Artemether|artemether|mesh-list
56229250|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56229251|NCT01697787|Amodiaquine|amodiaquine|mesh-list
56229252|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
56229253|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56229254|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56229255|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229256|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229257|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
56229258|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
56229259|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56229260|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
56229261|NCT01697826|Clindamycin|clindamycin|mesh-list
56229262|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
56229263|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
56229264|NCT01697826|Clotrimazole|clotrimazole|mesh-list
56229265|NCT01697826|Miconazole|miconazole|mesh-list
56229266|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133485|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133486|NCT01896960|Fentanyl|fentanyl|mesh-list
56133487|NCT01896960|Bupivacaine|bupivacaine|mesh-list
56133488|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
56133489|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
55743892|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55743893|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743894|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133490|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133491|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133492|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
56133493|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133494|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56133495|NCT01896960|Narcotics|narcotics|mesh-ancestor
56133496|NCT01896960|Analgesics|analgesics|mesh-ancestor
56133497|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56133498|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55743922|NCT02501941|Ketamine|ketamine|mesh-list
55743923|NCT02501941|Analgesics|analgesics|mesh-ancestor
55743924|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
55743930|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
56133499|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
56133500|NCT03013998|Cytarabine|cytarabine|mesh-list
56133501|NCT03013998|Azacitidine|azacitidine|mesh-list
56133502|NCT03013998|Decitabine|decitabine|mesh-list
56133503|NCT03013998|Daunorubicin|daunorubicin|mesh-list
56133504|NCT03013998|Venetoclax|venetoclax|mesh-list
56133505|NCT03013998|AZD5991|azd5991|mesh-list
56133506|NCT03013998|Pevonedistat|pevonedistat|mesh-list
56133507|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133508|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
56133509|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743988|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
55743989|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
55743991|NCT03344029|Vaccines|vaccines|mesh-list
56133510|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133511|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
56133512|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133513|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133514|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
56133515|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133516|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133517|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56229267|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229268|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56229269|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229270|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229271|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56133518|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56133519|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56133520|NCT00055692|Bevacizumab|bevacizumab|mesh-list
56133521|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56133522|NCT00055692|Antibodies|antibodies|mesh-list
56133523|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
56133524|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56133525|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860451|NCT00695578|Bacitracin|bacitracin|mesh-list
56133526|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56133527|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56133528|NCT00055692|Growth Substances|growth substances|mesh-ancestor
56133529|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133532|NCT04772352|Febuxostat|febuxostat|mesh-list
56133533|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
56133534|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56133535|NCT00056472|Olanzapine|olanzapine|mesh-list
56133536|NCT00056472|Sertraline|sertraline|mesh-list
56133537|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
56133538|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
56133539|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133540|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744053|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744054|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744055|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744056|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744057|NCT02498977|Cyclosporine|cyclosporine|mesh-list
55744060|NCT02498977|Tacrolimus|tacrolimus|mesh-list
56133541|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56133542|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56133543|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56133544|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133545|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56133546|NCT00056472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56133547|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56133548|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56133549|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133550|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133551|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
56133552|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
56133553|NCT00056550|Antithrombins|antithrombins|mesh-list
56133554|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
56133555|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56133556|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
56133557|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133558|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133559|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
56133560|NCT04771728|Metronidazole|metronidazole|mesh-list
56133561|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133562|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133563|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56133564|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56133565|NCT04771884|Vancomycin|vancomycin|mesh-list
56133566|NCT04771884|Meropenem|meropenem|mesh-list
56133567|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
56133568|NCT04771884|Linezolid|linezolid|mesh-list
56133569|NCT04771884|Ceftazidime|ceftazidime|mesh-list
56133570|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
56133571|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133572|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133573|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56133574|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133575|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133577|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56133578|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
56133579|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
56133580|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55744089|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55744090|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
56133581|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133582|NCT02538744|Doxazosin|doxazosin|mesh-list
56133583|NCT02538744|Cocaine|cocaine|mesh-list
56133584|NCT02538744|Modafinil|modafinil|mesh-list
56229272|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
56229273|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56229274|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56229275|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56229276|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
56229277|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229278|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229279|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56229280|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56229281|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56229282|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56229284|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56229285|NCT01698164|Progesterone|progesterone|mesh-list
56229286|NCT01698164|Estrogens|estrogens|mesh-ancestor
56229287|NCT01698164|Hormones|hormones|mesh-ancestor
55744122|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744123|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
56229288|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229289|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229290|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56229291|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
56229292|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56229293|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56229294|NCT01698164|Progestins|progestins|mesh-ancestor
56229295|NCT01698177|Vaccines|vaccines|mesh-list
56229296|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
56229297|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229298|NCT01698203|Ropivacaine|ropivacaine|mesh-list
56229299|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
56229300|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
56229301|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804946|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
56133585|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56133586|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133587|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56133588|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56133589|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56133590|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133591|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
55744181|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
56133592|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
56133593|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133594|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
56133595|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229302|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229303|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
56229304|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229305|NCT01698476|Vitamin D|vitamin d|mesh-list
56229306|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
56229307|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56229308|NCT01698476|Vitamins|vitamins|mesh-ancestor
56229309|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
56229310|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229311|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56229312|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55804972|NCT05494411|Mitomycins|mitomycins|mesh-list
56133596|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56133597|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56133598|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56133599|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56133600|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
56133601|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133602|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56133603|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56133604|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56133606|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
56133609|NCT00060528|Sargramostim|sargramostim|mesh-list
56133610|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
56133611|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133613|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133614|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133615|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56133616|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56133617|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
56133618|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56133619|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56133620|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133621|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
56133622|NCT04696224|Coagulants|coagulants|mesh-ancestor
56133623|NCT04753008|Dopamine|dopamine|mesh-list
56133624|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56133625|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
56133626|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
56133627|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133628|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133629|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
56133630|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133631|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133632|NCT04753008|Protective Agents|protective agents|mesh-ancestor
55744236|NCT03334981|Buprenorphine|buprenorphine|mesh-list
55744237|NCT03334981|Methadone|methadone|mesh-list
55744238|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55744239|NCT03334981|Narcotics|narcotics|mesh-ancestor
55744240|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744241|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744243|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
55744244|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744245|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55744248|NCT02492503|Paclitaxel|paclitaxel|mesh-list
56133633|NCT04771026|Dexamethasone|dexamethasone|mesh-list
56133634|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133635|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
56133636|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
56133637|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133638|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133639|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56133640|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
56133641|NCT04771026|Hormones|hormones|mesh-ancestor
56133642|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133643|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56133644|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133645|NCT00063570|Gemcitabine|gemcitabine|mesh-list
56133646|NCT00063570|Pemetrexed|pemetrexed|mesh-list
56133647|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133648|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
56133649|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133650|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133651|NCT00063570|Antiviral Agents|antiviral agents|mesh-ancestor
55804993|NCT04080895|Lumefantrine|lumefantrine|mesh-list
55744255|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
55744256|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744257|NCT03334591|Apatinib|apatinib|mesh-list
55744258|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744259|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744260|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744261|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744262|NCT03334513|Bevacizumab|bevacizumab|mesh-list
55744264|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55744265|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744266|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56229313|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229314|NCT01698541|Tacrolimus|tacrolimus|mesh-list
56229315|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229316|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
56229317|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229318|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56229319|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229320|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229321|NCT01698567|Antithrombins|antithrombins|mesh-list
56229322|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
56229323|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56229324|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
56229325|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229326|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229327|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
56229328|NCT01698593|Epinephrine|epinephrine|mesh-list
56229329|NCT01698593|Bupivacaine|bupivacaine|mesh-list
56229330|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
56133652|NCT00063570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133653|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133654|NCT00063570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133655|NCT00063570|Immunologic Factors|immunologic factors|mesh-ancestor
56133656|NCT00063570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133657|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56133658|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56133666|NCT01897038|Sorafenib|sorafenib|mesh-list
56133667|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133668|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133669|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133670|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229331|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
56229332|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229333|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229334|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
56133671|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
56133672|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56133673|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56133674|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133675|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
56133676|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
56133677|NCT00064038|Dexamethasone|dexamethasone|mesh-list
56133678|NCT00064038|Lenalidomide|lenalidomide|mesh-list
56133679|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133680|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
56133681|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
55744300|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55744301|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55744302|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56133684|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56133686|NCT00064038|Hormones|hormones|mesh-ancestor
56133687|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133688|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56133689|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133690|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
56133691|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56133692|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56133693|NCT00064038|Growth Substances|growth substances|mesh-ancestor
56133694|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
56133695|NCT01960530|Dexamethasone|dexamethasone|mesh-list
56133696|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
56133697|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56133698|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56133699|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56133700|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133701|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
56133702|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
56133703|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133704|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133705|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55744329|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744331|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55744332|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
55744333|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
55744334|NCT02162758|Lansoprazole|lansoprazole|mesh-list
55744335|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55744336|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55744337|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55744338|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744339|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744340|NCT03333499|Trimetazidine|trimetazidine|mesh-list
55744341|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
56133706|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
56133707|NCT01960530|Hormones|hormones|mesh-ancestor
56133708|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133709|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56133710|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133711|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
56133712|NCT01897428|Salicylates|salicylates|mesh-list
56133713|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56133714|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56133715|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56133716|NCT01897428|Analgesics|analgesics|mesh-ancestor
56133717|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
56133718|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133719|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133720|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133721|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56133722|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56133723|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133724|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133725|NCT00024102|Doxorubicin|doxorubicin|mesh-list
56133726|NCT00024102|Capecitabine|capecitabine|mesh-list
56133728|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133729|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56133730|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56133731|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133732|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133733|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133734|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
56133735|NCT00074802|Paroxetine|paroxetine|mesh-list
56133736|NCT00074802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56133737|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56133738|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56229335|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229336|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56229337|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56229338|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
56229339|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229340|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229341|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56229342|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56229343|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
56229344|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56229345|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
56229346|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
56229347|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
56229348|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56229349|NCT01698645|Fentanyl|fentanyl|mesh-list
56229350|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55860594|NCT01799941|Quinidine|quinidine|mesh-list
56229351|NCT01698645|Narcotics|narcotics|mesh-ancestor
56133739|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133740|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133741|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
56133742|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133743|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56133744|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
56133745|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56133746|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56133747|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56133748|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133750|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133751|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
56133752|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133756|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56133757|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
56133758|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56133759|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133760|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133761|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
56133762|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133763|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133764|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
56133765|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133766|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56133767|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133768|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
56133769|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56133770|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56133771|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56133772|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
56133773|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
56133774|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
56133775|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
56133777|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
56133778|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56133779|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56133780|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229352|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229353|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229355|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
56229356|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229357|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56229358|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56229359|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
56229360|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
56229361|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
56229362|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56229363|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229364|NCT01698723|Ribavirin|ribavirin|mesh-list
56229365|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
55805015|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
56133781|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133782|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133783|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890361|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55776498|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133784|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133785|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133786|NCT00036738|Cyclosporine|cyclosporine|mesh-list
56133787|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
56133788|NCT00036738|Fludarabine|fludarabine|mesh-list
56133789|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
56133790|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
56133792|NCT00036738|Cyclosporins|cyclosporins|mesh-list
56133793|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133794|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133795|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
56133796|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133797|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133798|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
56133799|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133800|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133801|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
56133802|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133803|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
56133804|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56133805|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56133806|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56133807|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56133808|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
56133809|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133810|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133811|NCT00038610|Cytarabine|cytarabine|mesh-list
56133812|NCT00038610|Dexamethasone|dexamethasone|mesh-list
56133814|NCT00038610|Doxorubicin|doxorubicin|mesh-list
56133815|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56133816|NCT00038610|Methotrexate|methotrexate|mesh-list
56133817|NCT00038610|Vincristine|vincristine|mesh-list
56133818|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
56133819|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133820|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
56133821|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133822|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56133823|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56133824|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
56133825|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133826|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133827|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56133830|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
56133831|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229366|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229367|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
56229368|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229370|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229371|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
55805031|NCT05489887|Ceritinib|ceritinib|mesh-list
56133832|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56133833|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
56133834|NCT00038610|Hormones|hormones|mesh-ancestor
56133835|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55786856|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786858|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55786859|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
55786860|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55786861|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
55786862|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786863|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786864|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55776749|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55776750|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
56133836|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56133837|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56133838|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56133839|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56133840|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133841|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56133842|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
56133843|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56133844|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56133845|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
55786887|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786888|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55787050|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787051|NCT04834063|Trace Elements|trace elements|mesh-ancestor
55787052|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
55787053|NCT04794205|Caryophyllene|caryophyllene|mesh-list
55787056|NCT04794205|Analgesics|analgesics|mesh-ancestor
56133846|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
56133847|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56133848|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56133849|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
56133850|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133851|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56133852|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56133853|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56133854|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56133855|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56133856|NCT00156936|Naltrexone|naltrexone|mesh-list
56133857|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56133858|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56133859|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133860|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
56133861|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133862|NCT00046566|Caseins|caseins|mesh-list
56133863|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
56133864|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
56133865|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133866|NCT00079326|Trastuzumab|trastuzumab|mesh-list
56133867|NCT00079326|Epothilone B|epothilone b|mesh-list
56133868|NCT00079326|Epothilones|epothilones|mesh-list
56133869|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56133870|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133871|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56133872|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56133873|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56133874|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133875|NCT02187354|Blinatumomab|blinatumomab|mesh-list
56133876|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787219|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787220|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133877|NCT01898052|Anesthetics|anesthetics|mesh-list
56133878|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
56133879|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133881|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
56133882|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
56133883|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133885|NCT04531176|Topiramate|topiramate|mesh-list
56133886|NCT04531176|Orlistat|orlistat|mesh-list
56133887|NCT04531176|Phentermine|phentermine|mesh-list
56133888|NCT04531176|Naltrexone|naltrexone|mesh-list
56133889|NCT04531176|Bupropion|bupropion|mesh-list
56133890|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56133891|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56133892|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133893|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
56133894|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133895|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56229372|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
56229373|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229374|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229375|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229376|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
56229377|NCT01698749|Hormones|hormones|mesh-ancestor
56229378|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229379|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56229380|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787263|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55787532|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55787533|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55787583|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787584|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787585|NCT03059303|Simeprevir|simeprevir|mesh-list
55787586|NCT03059303|Odalasvir|odalasvir|mesh-list
55787587|NCT03059303|Omeprazole|omeprazole|mesh-list
55787588|NCT03059303|Lansoprazole|lansoprazole|mesh-list
55787589|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
55787590|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55788054|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133896|NCT04531176|Incretins|incretins|mesh-ancestor
56133897|NCT04531176|Hormones|hormones|mesh-ancestor
56133898|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133899|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56133900|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
56133901|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56133902|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56133904|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56133905|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860819|NCT01270438|Leucovorin|leucovorin|mesh-list
55788111|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
55788112|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
55788113|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788114|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788116|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56133907|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133908|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56133909|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56133911|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
56133912|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56133913|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56133914|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56133915|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
56133916|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
56133917|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
56133918|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
55788175|NCT04423107|Oxycodone|oxycodone|mesh-list
55788176|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55788177|NCT04423107|Analgesics|analgesics|mesh-ancestor
55788178|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
55788179|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788180|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788181|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
55788182|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55788391|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55788392|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788393|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
55788394|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788395|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788396|NCT05112211|Doxycycline|doxycycline|mesh-list
55788397|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133919|NCT00051168|Travoprost|travoprost|mesh-list
56133920|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56133921|NCT00083382|Pamidronate|pamidronate|mesh-list
56133922|NCT00083382|Thalidomide|thalidomide|mesh-list
56133923|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133924|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
56133925|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133926|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
56133927|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56133928|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56133929|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56133930|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56133931|NCT00083382|Growth Substances|growth substances|mesh-ancestor
56133932|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
56133933|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133934|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56133935|NCT04526730|Nivolumab|nivolumab|mesh-list
55788466|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55788467|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55788468|NCT04418479|Analgesics|analgesics|mesh-ancestor
55788469|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
55788473|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55788519|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55788520|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788522|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788523|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55788524|NCT01675141|Lenalidomide|lenalidomide|mesh-list
55788525|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
55788526|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788527|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56133936|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56133937|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133938|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56133939|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133940|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
56133942|NCT00167934|Valproic Acid|valproic acid|mesh-list
56133943|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
56133944|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133945|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133946|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
56133947|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133948|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133949|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
56133950|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56133951|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133952|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56229381|NCT01698788|Dexamethasone|dexamethasone|mesh-list
56229382|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
56229383|NCT01698788|BB 1101|bb 1101|mesh-list
56229384|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229385|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
55788594|NCT03490903|Narcotics|narcotics|mesh-ancestor
55788595|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788596|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788597|NCT03490903|Analgesics|analgesics|mesh-ancestor
55788598|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
55788599|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788600|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55788601|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55788602|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
55788603|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
55788608|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
56229386|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
56229387|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229388|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229389|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229390|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
56229391|NCT01698788|Hormones|hormones|mesh-ancestor
56229392|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229393|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56229394|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229395|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
55788637|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55788638|NCT03954613|Memantine|memantine|mesh-list
55788639|NCT03954613|Donepezil|donepezil|mesh-list
55788640|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56229396|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229397|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229398|NCT01698931|Glyburide|glyburide|mesh-list
56229399|NCT01698931|Repaglinide|repaglinide|mesh-list
56229400|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56229401|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229402|NCT01699113|Rabeprazole|rabeprazole|mesh-list
56229403|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56229404|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229405|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56229406|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788702|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788703|NCT03554707|Bevacizumab|bevacizumab|mesh-list
55788704|NCT03554707|Irinotecan|irinotecan|mesh-list
55788705|NCT03554707|Temozolomide|temozolomide|mesh-list
55777119|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788706|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55788707|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788708|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55788709|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55788710|NCT03554707|Growth Substances|growth substances|mesh-ancestor
55788711|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788712|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
55788713|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55788714|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55788715|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788719|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
56229407|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133953|NCT00168324|Dexamethasone|dexamethasone|mesh-list
56133954|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
56133955|NCT00168324|BB 1101|bb 1101|mesh-list
56133956|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133957|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
56133958|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
56133959|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133960|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133961|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56133962|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
56133963|NCT00168324|Hormones|hormones|mesh-ancestor
56133964|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56133965|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56133966|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133967|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
56133968|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56133969|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133970|NCT02091882|Aripiprazole|aripiprazole|mesh-list
55788753|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788754|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55788755|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788756|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
55788757|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
55788758|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788759|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788760|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56133971|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
56133972|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56133973|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56133974|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56229408|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56229409|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56229410|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56229411|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
56229412|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229413|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56229414|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55788804|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
55788805|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
55788806|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55788807|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788808|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788810|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788811|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
55788812|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
55788813|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
55788814|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788815|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
55788816|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55788817|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55788819|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
56229416|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
56229417|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56229418|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
56229419|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229420|NCT01699204|Expectorants|expectorants|mesh-ancestor
56229421|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
56229422|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56229423|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
56133975|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133976|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133977|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
56133978|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
56133979|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56133980|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133981|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56133982|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56133983|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
55788856|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55788857|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55788859|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
56133984|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56133985|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56133986|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56133987|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56133988|NCT00085254|Temozolomide|temozolomide|mesh-list
56133989|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56133990|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
56133991|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133992|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133993|NCT00253890|Trazodone|trazodone|mesh-list
56133994|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56133995|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56133996|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133997|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133998|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56133999|NCT00253890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56134000|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56134001|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56134002|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134003|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134004|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
56134005|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56134006|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
56134007|NCT00254592|Paclitaxel|paclitaxel|mesh-list
56134008|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56134009|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
56134010|NCT00254592|Bevacizumab|bevacizumab|mesh-list
56134011|NCT00254592|Carboplatin|carboplatin|mesh-list
56134012|NCT00254592|Doxorubicin|doxorubicin|mesh-list
56134013|NCT00254592|Trastuzumab|trastuzumab|mesh-list
56134014|NCT00254592|Sargramostim|sargramostim|mesh-list
55788913|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55788914|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55777180|NCT05113511|Growth Substances|growth substances|mesh-ancestor
55788915|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55788916|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788917|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55788918|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788919|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
55788920|NCT04910165|Ropivacaine|ropivacaine|mesh-list
55788921|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
56229424|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229425|NCT01699204|Protective Agents|protective agents|mesh-ancestor
56229426|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229427|NCT01699204|Antidotes|antidotes|mesh-ancestor
56229428|NCT01699282|Antivitamins K|antivitamins k|mesh-list
56229429|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
56229430|NCT01699347|Picibanil|picibanil|mesh-list
56229431|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229432|NCT01699360|Cyclosporine|cyclosporine|mesh-list
56229433|NCT01699360|Sirolimus|sirolimus|mesh-list
56229434|NCT01699360|Tacrolimus|tacrolimus|mesh-list
56229435|NCT01699360|Cyclosporins|cyclosporins|mesh-list
56229436|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229437|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
56229438|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229439|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56229440|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229441|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788947|NCT04928495|Protective Agents|protective agents|mesh-ancestor
55788948|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
55788949|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788951|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
55788952|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55788953|NCT04928495|Antidotes|antidotes|mesh-ancestor
55788954|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55788955|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55788956|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55788957|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788958|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788959|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55788960|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56229442|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
56229443|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229444|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
56229445|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56229446|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55805085|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
55788994|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134015|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56134016|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134017|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
56134018|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
56134019|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
56134020|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134021|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134022|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
55744480|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55744481|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744482|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55744483|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
55744484|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55744485|NCT03324139|Heparin|heparin|mesh-list
55744486|NCT03324139|Calcium heparin|calcium heparin|mesh-list
56134023|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134024|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134025|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56134026|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
56134027|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56134028|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56134029|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56134030|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56134031|NCT00254592|Growth Substances|growth substances|mesh-ancestor
56134032|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
56134033|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56134034|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56134035|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56134036|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134037|NCT00255684|Cyclosporine|cyclosporine|mesh-list
56134038|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
56134039|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
56134040|NCT00255684|Fludarabine|fludarabine|mesh-list
56134041|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
56134042|NCT00255684|Cyclosporins|cyclosporins|mesh-list
56134043|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229447|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55744540|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744541|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55744542|NCT03327727|Voriconazole|voriconazole|mesh-list
55744543|NCT03327727|Amphotericin B|amphotericin b|mesh-list
55744544|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55744545|NCT03327727|Isavuconazole|isavuconazole|mesh-list
55744586|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744587|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744588|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
55744589|NCT02499003|Pixantrone|pixantrone|mesh-list
55744590|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55744591|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744592|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55744593|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55744594|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744595|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744596|NCT04492813|Remifentanil|remifentanil|mesh-list
55744598|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55744599|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744600|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744603|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
56229448|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229449|NCT01699412|Dexamethasone|dexamethasone|mesh-list
56229450|NCT01699412|Clobetasol|clobetasol|mesh-list
56229451|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229452|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
56229453|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
56229454|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229455|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229456|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229457|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
55744649|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744650|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55744651|NCT02488291|Narcotics|narcotics|mesh-ancestor
55744652|NCT02488291|Analgesics|analgesics|mesh-ancestor
55744653|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55744654|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55744656|NCT03323047|Acetaminophen|acetaminophen|mesh-list
56229458|NCT01699412|Hormones|hormones|mesh-ancestor
56229459|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229460|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56229461|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229462|NCT01699438|Mesalamine|mesalamine|mesh-list
56229463|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56229464|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56134044|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
56134045|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134047|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56134048|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
56134049|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134051|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56134052|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56134053|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
56134054|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134055|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
55860968|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
55744735|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55744736|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55744737|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
55744740|NCT03318835|Thalidomide|thalidomide|mesh-list
56134056|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134057|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
56134058|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56134059|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56134060|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56134061|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
56134062|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56134063|NCT00256776|Thalidomide|thalidomide|mesh-list
56134064|NCT00256776|Dexamethasone|dexamethasone|mesh-list
56134066|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134067|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
56134068|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
56134069|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134070|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134071|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134072|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
56134073|NCT00256776|Hormones|hormones|mesh-ancestor
56134074|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56134075|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56134076|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134077|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134078|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
56134079|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
56134080|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56134081|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134082|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56134083|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56229465|NCT01699438|Analgesics|analgesics|mesh-ancestor
56229466|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
56229467|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229468|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229469|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229470|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56229471|NCT01699490|Valsartan|valsartan|mesh-list
56229472|NCT01699490|Fluoxetine|fluoxetine|mesh-list
55744788|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744789|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744790|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
56229473|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56229474|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56229475|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56229476|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229477|NCT01699490|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56229478|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56229479|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56229480|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229481|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
56229482|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229483|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56229484|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
56229485|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56229486|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56229487|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56229488|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229490|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
56229491|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56229492|NCT01699594|Diuretics|diuretics|mesh-ancestor
56229493|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
56134084|NCT00256776|Growth Substances|growth substances|mesh-ancestor
56134085|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
56134086|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
56134087|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134088|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
56134089|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134090|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744825|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55744828|NCT03321955|Ziconotide|ziconotide|mesh-list
56134091|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56134092|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
56134093|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134094|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134095|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56134096|NCT00176202|Valproic Acid|valproic acid|mesh-list
56134097|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
56134098|NCT00176202|Risperidone|risperidone|mesh-list
56229494|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229495|NCT01699594|Miotics|miotics|mesh-ancestor
56229496|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
56229497|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229498|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56229499|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56229500|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
55744874|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
56229501|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56229502|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56134099|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
56134100|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56134101|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
56134102|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134103|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134104|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134105|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56134106|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56134107|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56134108|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56134109|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
56134110|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134111|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
56134112|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
56134113|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
56134114|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
56134115|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
56134116|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56134117|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
56134118|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134119|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134120|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134121|NCT00176826|Busulfan|busulfan|mesh-list
56134122|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
56134123|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134124|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134125|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
56134126|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134127|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56134129|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56134130|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
56134131|NCT00176904|Busulfan|busulfan|mesh-list
56134132|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56134133|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134134|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
56134135|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134136|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744935|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744936|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
56134137|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56134138|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
56134139|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134140|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134141|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56134143|NCT00179478|Interferon-beta|interferon-beta|mesh-list
56134144|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
56134145|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134146|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
56134147|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134148|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
56134149|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134150|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56134151|NCT00182754|Octreotide|octreotide|mesh-list
56134152|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134153|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56134154|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134155|NCT00085410|Bortezomib|bortezomib|mesh-list
56134156|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134157|NCT00186498|Memantine|memantine|mesh-list
56134158|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56134159|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56229503|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
56229504|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229505|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229506|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56229507|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
55744974|NCT05001555|Analgesics|analgesics|mesh-ancestor
55744975|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
55744976|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744977|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229508|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229509|NCT01699711|Protective Agents|protective agents|mesh-ancestor
56229510|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229511|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56229512|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56229513|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229514|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56229515|NCT01699724|Sertraline|sertraline|mesh-list
56229516|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
56229517|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56229518|NCT01699724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56229519|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56229520|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56229521|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229522|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229523|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
56229524|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229525|NCT01699776|Digoxin|digoxin|mesh-list
56229526|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56229527|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56229528|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229529|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229530|NCT01699776|Protective Agents|protective agents|mesh-ancestor
56134160|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
56134161|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134162|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134163|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134164|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56134165|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56134167|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56134168|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134169|NCT00087672|Lenalidomide|lenalidomide|mesh-list
56134170|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
56134171|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134172|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56134173|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55745091|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56134174|NCT00087672|Growth Substances|growth substances|mesh-ancestor
56229531|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229532|NCT01699802|Anesthetics|anesthetics|mesh-list
56229533|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229534|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229535|NCT01699828|Buspirone|buspirone|mesh-list
56229536|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56229537|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56229538|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229539|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229540|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56229541|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56229542|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
56229543|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229544|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229545|NCT01699854|Capsaicin|capsaicin|mesh-list
56229546|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
56229547|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
56229548|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
56229549|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229550|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229551|NCT01699919|Lidocaine|lidocaine|mesh-list
56229552|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
56229553|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
56229554|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229555|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229556|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
56229557|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229558|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56229559|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56229560|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56229563|NCT01699932|Metformin|metformin|mesh-list
56229573|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229574|NCT01700010|Paclitaxel|paclitaxel|mesh-list
56229575|NCT01700010|Lapatinib|lapatinib|mesh-list
56229576|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56229577|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229578|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
56229579|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
56229580|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
56229581|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229582|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56229583|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229584|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
55745138|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745140|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55745143|NCT02485873|Coagulants|coagulants|mesh-ancestor
56229585|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56229586|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56229587|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229588|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229589|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56229590|NCT01700270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56229591|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56229592|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56229593|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229594|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229595|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
56229596|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56229598|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56229599|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56229600|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229601|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56229602|NCT01700322|Clopidogrel|clopidogrel|mesh-list
56229603|NCT01700322|Ticagrelor|ticagrelor|mesh-list
55805234|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
56134175|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
56134176|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134177|NCT00088218|Cytarabine|cytarabine|mesh-list
56134178|NCT00088218|Clofarabine|clofarabine|mesh-list
56134179|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56134180|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
55745168|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
55745170|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745220|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55745221|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
55745222|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
56134181|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134182|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229604|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56229605|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56229606|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56134183|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
56134184|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134185|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134186|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
56134187|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134188|NCT00189228|Omalizumab|omalizumab|mesh-list
56134189|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56134190|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56134191|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
56134192|NCT00091260|Dexamethasone|dexamethasone|mesh-list
56134193|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
56134194|NCT00091260|Lenalidomide|lenalidomide|mesh-list
56134195|NCT00091260|BB 1101|bb 1101|mesh-list
56134196|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134197|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
56134198|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
56134199|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745377|NCT02481193|Cisatracurium|cisatracurium|mesh-list
56134200|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134201|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134202|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
56134204|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56134205|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56134206|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134207|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
56134208|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134209|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134210|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
56134211|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56134212|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56134213|NCT00091260|Growth Substances|growth substances|mesh-ancestor
56134214|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
56134215|NCT00193128|Docetaxel|docetaxel|mesh-list
56134216|NCT00193128|Capecitabine|capecitabine|mesh-list
56134217|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
56134218|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134219|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
56134220|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
56134221|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
56134222|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134223|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56134224|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
56134225|NCT00193596|Gemcitabine|gemcitabine|mesh-list
56134226|NCT00193596|Paclitaxel|paclitaxel|mesh-list
56134227|NCT00193596|Etoposide|etoposide|mesh-list
56134228|NCT00193596|Carboplatin|carboplatin|mesh-list
56134229|NCT00193596|Irinotecan|irinotecan|mesh-list
55745496|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
56134230|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56134231|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134232|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
56134233|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
56134234|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
56134235|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134236|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56134237|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
56134238|NCT00193596|Antiviral Agents|antiviral agents|mesh-ancestor
56134239|NCT00193596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134240|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134241|NCT00193596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134242|NCT00193596|Immunologic Factors|immunologic factors|mesh-ancestor
56134243|NCT00193596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134244|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56134245|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56134246|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56134247|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
56134248|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
56134249|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
56134250|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56134251|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745139|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
56134252|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56134253|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56229607|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56229608|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56229609|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
56229610|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229611|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229612|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229613|NCT01700400|Bevacizumab|bevacizumab|mesh-list
56229614|NCT01700400|Carboplatin|carboplatin|mesh-list
56229616|NCT01700400|Everolimus|everolimus|mesh-list
56229617|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56229618|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229619|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56229620|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56229621|NCT01700400|Growth Substances|growth substances|mesh-ancestor
56229622|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229623|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
56134254|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134255|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134256|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134257|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56134258|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56134259|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
56134260|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56134261|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55745622|NCT05070195|Midazolam|midazolam|mesh-list
56134262|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56134265|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134266|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134268|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134269|NCT00093756|Paclitaxel|paclitaxel|mesh-list
56134270|NCT00093756|Carboplatin|carboplatin|mesh-list
56134271|NCT00093756|Bortezomib|bortezomib|mesh-list
56134272|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56134273|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134274|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
56134275|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
56134277|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134279|NCT04118556|Etanercept|etanercept|mesh-list
56134280|NCT04118556|Everolimus|everolimus|mesh-list
56134281|NCT04118556|Infliximab|infliximab|mesh-list
56134282|NCT04118556|Vedolizumab|vedolizumab|mesh-list
56134283|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134284|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134285|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
56134287|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56134288|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134289|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56134290|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
56134291|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
56134292|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134293|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134294|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55745169|NCT02485249|Hormones|hormones|mesh-ancestor
56134295|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56134296|NCT04118556|Analgesics|analgesics|mesh-ancestor
56229624|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229625|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229626|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56229627|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56229628|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229629|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
56229630|NCT01700413|Idarubicin|idarubicin|mesh-list
56229631|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56229632|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229633|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56229634|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56229635|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229636|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229637|NCT01700426|Vitamins|vitamins|mesh-list
56229638|NCT01700426|Vitamin E|vitamin e|mesh-list
56229639|NCT01700426|Tocopherols|tocopherols|mesh-list
56229640|NCT01700426|Tocotrienols|tocotrienols|mesh-list
56229641|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
56229642|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
56229643|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229644|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
56229645|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229646|NCT01700426|Protective Agents|protective agents|mesh-ancestor
56229647|NCT01700478|Vasopressins|vasopressins|mesh-list
56229648|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
56229649|NCT01700478|Misoprostol|misoprostol|mesh-list
56229650|NCT01700478|Diuretics|diuretics|mesh-list
55805286|NCT05479123|Timolol|timolol|mesh-list
56134297|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
56134298|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134299|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134300|NCT00267696|Gemcitabine|gemcitabine|mesh-list
56134301|NCT00267696|Bevacizumab|bevacizumab|mesh-list
56134302|NCT00267696|Carboplatin|carboplatin|mesh-list
56134303|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56134304|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134305|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56134306|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56134307|NCT00267696|Growth Substances|growth substances|mesh-ancestor
56134308|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134309|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
56134310|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56134311|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
56134312|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134313|NCT00267696|Antiviral Agents|antiviral agents|mesh-ancestor
56134314|NCT00267696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134315|NCT00267696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229651|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229652|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56229653|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
56229654|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56229655|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56229656|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229657|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
56229658|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
56229659|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
56229660|NCT01700478|Coagulants|coagulants|mesh-ancestor
56229661|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56229662|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56229663|NCT01700491|Ropivacaine|ropivacaine|mesh-list
56229664|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
56229665|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
56229666|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229667|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229668|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
56229669|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229670|NCT01700504|Gentamicins|gentamicins|mesh-list
56229671|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56229672|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229673|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56229674|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745719|NCT05249569|Axitinib|axitinib|mesh-list
55745725|NCT05244577|Olanzapine|olanzapine|mesh-list
56229675|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229676|NCT01700608|Plerixafor|plerixafor|mesh-list
56229677|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56229678|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56229679|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
56229680|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229681|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56229682|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56229683|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229694|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229695|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56229696|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55745737|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56229697|NCT01700803|Iodine|iodine|mesh-list
56229698|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
56229699|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
56229700|NCT01700803|Povidone|povidone|mesh-list
56229701|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56229702|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229703|NCT01700803|Trace Elements|trace elements|mesh-ancestor
56229704|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
56229705|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229706|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
56229707|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
56229708|NCT01700881|Vitamin E|vitamin e|mesh-list
55745804|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56229709|NCT01700881|Vitamins|vitamins|mesh-ancestor
56229710|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
56229711|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229712|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
56229713|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229714|NCT01700881|Protective Agents|protective agents|mesh-ancestor
56229716|NCT01701076|Lenalidomide|lenalidomide|mesh-list
56229717|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56229718|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134316|NCT00267696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134317|NCT00267696|Immunologic Factors|immunologic factors|mesh-ancestor
56134318|NCT00195624|Cyclosporine|cyclosporine|mesh-list
56134319|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
56134320|NCT00195624|Cyclosporins|cyclosporins|mesh-list
56134321|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134322|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134323|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134324|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
56134325|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134326|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
56134327|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134328|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
56134329|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134330|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56134331|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56134332|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134333|NCT00195702|Adalimumab|adalimumab|mesh-list
56134334|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134335|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134336|NCT00197184|Vaccines|vaccines|mesh-list
56134337|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
56134338|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134339|NCT00098670|Rituximab|rituximab|mesh-list
56134340|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56134341|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
56134342|NCT00098670|Fludarabine|fludarabine|mesh-list
56229719|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
56229720|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
56229721|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229722|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229723|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229724|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
56229725|NCT01701076|Hormones|hormones|mesh-ancestor
56229726|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229727|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56134343|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
56134344|NCT00098670|Antibodies|antibodies|mesh-list
56134345|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
56134346|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56134347|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
56134348|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134349|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134350|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134351|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56134352|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
56134355|NCT00201864|Fulvestrant|fulvestrant|mesh-list
56134356|NCT00201864|Exemestane|exemestane|mesh-list
56134357|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55745903|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134358|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134359|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56134360|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56134361|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
56134362|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56134363|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134364|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56134365|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56134366|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134367|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134370|NCT00202722|Narcotics|narcotics|mesh-ancestor
56134371|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56134372|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134373|NCT00202722|Analgesics|analgesics|mesh-ancestor
56134374|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
56134375|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134376|NCT00100698|Hormones|hormones|mesh-list
56134377|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56134378|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134379|NCT00103116|Vaccines|vaccines|mesh-list
56134380|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
56134381|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134382|NCT00205374|Cidofovir|cidofovir|mesh-list
56134383|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
56134384|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134385|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134386|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134387|NCT00103194|Lapatinib|lapatinib|mesh-list
56134388|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134389|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56134390|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134391|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134392|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
56134393|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55745961|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
56134394|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56134395|NCT00208026|Analgesics|analgesics|mesh-ancestor
56134396|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
56134397|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134398|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134399|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134400|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134401|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
56229728|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746002|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229729|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229730|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
56229731|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56229732|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56229733|NCT01701076|Growth Substances|growth substances|mesh-ancestor
56229734|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
56229735|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56229736|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
55746070|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56229737|NCT01701089|Selegiline|selegiline|mesh-list
56229738|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
56229739|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56229740|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56229741|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56229742|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56229743|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229744|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229745|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56229746|NCT01701089|Protective Agents|protective agents|mesh-ancestor
56229747|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229748|NCT01701180|Oxytocin|oxytocin|mesh-list
56229749|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
56229750|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56134402|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134403|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
56134404|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56134405|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134406|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134407|NCT00106392|Tacrolimus|tacrolimus|mesh-list
56134408|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134409|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
56134410|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134411|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56134412|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134413|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134414|NCT00211692|Interferons|interferons|mesh-list
56134415|NCT00211692|Ribavirin|ribavirin|mesh-list
56134416|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
56134417|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
56134418|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134419|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
56134420|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134421|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
56134422|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134423|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
56134424|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134429|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56134430|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134431|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134432|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56229751|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229752|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56229753|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56229754|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229755|NCT01701232|Rituximab|rituximab|mesh-list
56229756|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56229757|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229758|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
56229759|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229760|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56229761|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56229762|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56229763|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229764|NCT01701297|Renal Agents|renal agents|mesh-ancestor
56229765|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56229766|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
56229767|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56229768|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56229769|NCT01701323|Cytarabine|cytarabine|mesh-list
56229770|NCT01701323|Fludarabine|fludarabine|mesh-list
56229771|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
56229772|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229773|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56229774|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
56229775|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229776|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229777|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
56229778|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229780|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229781|NCT01701336|Cloricromen|cloricromen|mesh-list
56229782|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56229783|NCT01701349|Paclitaxel|paclitaxel|mesh-list
56229784|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
56229785|NCT01701349|Combretastatin|combretastatin|mesh-list
56229786|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56229790|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
56229791|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
56229792|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
56229793|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229794|NCT01701453|Clopidogrel|clopidogrel|mesh-list
56229795|NCT01701453|Ticagrelor|ticagrelor|mesh-list
56229796|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56229797|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55746143|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55746144|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229798|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56229799|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56229800|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56229801|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
56229802|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229803|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229804|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229805|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56229806|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56229807|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229808|NCT01701479|Aldesleukin|aldesleukin|mesh-list
56229809|NCT01701479|Interleukin-2|interleukin-2|mesh-list
56229810|NCT01701479|Dinutuximab|dinutuximab|mesh-list
56229811|NCT01701479|Isotretinoin|isotretinoin|mesh-list
56229812|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229813|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56229814|NCT01701479|Analgesics|analgesics|mesh-ancestor
56229815|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
56229816|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229817|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229818|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56229819|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56229820|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
56229821|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032494|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56229832|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229833|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56229834|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229835|NCT01701583|Omalizumab|omalizumab|mesh-list
56229836|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56229837|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56229838|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
56229839|NCT01701739|Digoxin|digoxin|mesh-list
56229840|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56229841|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56229842|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229843|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229844|NCT01701739|Protective Agents|protective agents|mesh-ancestor
56229845|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229846|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
56229847|NCT01701778|Sevoflurane|sevoflurane|mesh-list
56229848|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
56229849|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56134433|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56134434|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56134436|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56134437|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134438|NCT01899846|Progestins|progestins|mesh-ancestor
56134439|NCT01899846|Hormones|hormones|mesh-ancestor
56134440|NCT00214890|Tenofovir|tenofovir|mesh-list
56134441|NCT00214890|Abacavir|abacavir|mesh-list
56134442|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
56134443|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134444|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56134445|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56134446|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134447|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134448|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56134449|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56134450|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
56134451|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56134452|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56134453|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134454|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56134455|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746331|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
56134456|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56134457|NCT00282282|Sirolimus|sirolimus|mesh-list
56134458|NCT00282282|Fludarabine|fludarabine|mesh-list
56134459|NCT00282282|Busulfan|busulfan|mesh-list
56134460|NCT00282282|Tacrolimus|tacrolimus|mesh-list
56134461|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134462|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134463|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134464|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
56134465|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134466|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55745229|NCT02480335|Bosentan|bosentan|mesh-list
56134467|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134468|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56134469|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134470|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56229851|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229852|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56229853|NCT01701778|Analgesics|analgesics|mesh-ancestor
56229854|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
56229855|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229856|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56229857|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56229858|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56229859|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
56229860|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229861|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229862|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56229863|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56229864|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
56229865|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
56229866|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
56229867|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
56229868|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56229869|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
56229870|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229871|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229872|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56229873|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
56229874|NCT01701856|Interferons|interferons|mesh-list
56229875|NCT01701856|Interferon-beta|interferon-beta|mesh-list
56229876|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
56229877|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229878|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
56229879|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134471|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
56134472|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
56134473|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56134474|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56134475|NCT00282828|Clonazepam|clonazepam|mesh-list
56134476|NCT00282828|Sertraline|sertraline|mesh-list
56134477|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56134478|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
56134479|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56134480|NCT00282828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56134481|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56134482|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56134483|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134484|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56229881|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229882|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56229883|NCT01701882|Tenofovir|tenofovir|mesh-list
56229884|NCT01701882|Emtricitabine|emtricitabine|mesh-list
56229885|NCT01701882|Rilpivirine|rilpivirine|mesh-list
56229886|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
56229887|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229888|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56229889|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56229890|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229891|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805538|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56134485|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
55746403|NCT03174847|Hormones|hormones|mesh-ancestor
56134486|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134487|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56134488|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56134489|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
56134490|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
56134491|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
56134492|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56134493|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56134494|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
56134497|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56134498|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56134499|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
56134500|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134501|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134502|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134503|NCT00223236|Choline|choline|mesh-list
56134504|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56134505|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
56134506|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56134507|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
55861442|NCT04141995|Leucovorin|leucovorin|mesh-list
56134508|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134509|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134510|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56134512|NCT00223704|Icatibant|icatibant|mesh-list
56134513|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
56134514|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56134515|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56134516|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134517|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
56134518|NCT00223704|Coagulants|coagulants|mesh-ancestor
56134519|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56134520|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56134521|NCT00223704|Analgesics|analgesics|mesh-ancestor
56134522|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
56134523|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134524|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134525|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134526|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134527|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55746461|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
55746462|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746463|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134528|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55745258|NCT05245227|Misoprostol|misoprostol|mesh-list
56134529|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56134530|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134531|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
56134533|NCT00224952|Valproic Acid|valproic acid|mesh-list
56134534|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
56134535|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229892|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56229893|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56229895|NCT01701921|Analgesics|analgesics|mesh-ancestor
56229896|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
56229897|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229898|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229899|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
56229900|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56229901|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56229902|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229903|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56229904|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56134536|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134537|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
56134538|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134539|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134540|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
56134541|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56134542|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56134543|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56134544|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56134545|NCT00224952|Analgesics|analgesics|mesh-ancestor
56134546|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
56134547|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134548|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56134549|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56134550|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56134551|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56134552|NCT00225420|Docetaxel|docetaxel|mesh-list
56134553|NCT00225420|Leuprolide|leuprolide|mesh-list
56134554|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134555|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
56134556|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
56134557|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
56134558|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134559|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56134560|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
56134561|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56134562|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134563|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56134564|NCT00225498|Olanzapine|olanzapine|mesh-list
56134565|NCT00225498|Risperidone|risperidone|mesh-list
56134566|NCT00225498|Ziprasidone|ziprasidone|mesh-list
56134567|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56134568|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
55746534|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
56134569|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134570|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134571|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134572|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56134573|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56134574|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56134575|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56134576|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56134577|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
56134578|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
56134579|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
56134580|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134581|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134582|NCT00225498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56134583|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56229905|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56229906|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229907|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56229909|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56229910|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229911|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
56229912|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229913|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56229914|NCT01702090|Ritonavir|ritonavir|mesh-list
56229915|NCT01702090|Darunavir|darunavir|mesh-list
56229916|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56229917|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56229918|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
56229919|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229920|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229921|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56229922|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56229923|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
56229924|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229925|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56229926|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56229927|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
56229928|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56229929|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
56229930|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56229931|NCT01702129|Doxorubicin|doxorubicin|mesh-list
56229932|NCT01702129|Cetuximab|cetuximab|mesh-list
56229933|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56229934|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229935|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56229936|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56229937|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229938|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229939|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56229940|NCT01702181|Tacrolimus|tacrolimus|mesh-list
56229941|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229942|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
56229943|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229944|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56229946|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229948|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56229949|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
56229950|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229951|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56229952|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229953|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229954|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
56229955|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56229956|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229957|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56229958|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56229959|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56229960|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805602|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
56134584|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56134585|NCT00225732|Ibuprofen|ibuprofen|mesh-list
56134586|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56134587|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56134588|NCT00225732|Analgesics|analgesics|mesh-ancestor
56134589|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
56134590|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745267|NCT02479867|Cefadroxil|cefadroxil|mesh-list
56134591|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134592|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134593|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134594|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56134595|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134596|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746795|NCT04804735|Anesthetics|anesthetics|mesh-list
56134598|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134599|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56134600|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134601|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134602|NCT02097732|Ipilimumab|ipilimumab|mesh-list
56134603|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56134604|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134605|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56134606|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134607|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
56134608|NCT00286182|Hematinics|hematinics|mesh-ancestor
56134609|NCT00226590|Gemcitabine|gemcitabine|mesh-list
56134610|NCT00226590|Paclitaxel|paclitaxel|mesh-list
56134611|NCT00226590|Carboplatin|carboplatin|mesh-list
56134612|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56134613|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134614|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
56134615|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
56134616|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
56134617|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134618|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56229961|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229962|NCT01702389|Remifentanil|remifentanil|mesh-list
56229963|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56229964|NCT01702389|Narcotics|narcotics|mesh-ancestor
56229965|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56229966|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229967|NCT01702389|Analgesics|analgesics|mesh-ancestor
56229968|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
56229969|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56229970|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
56229971|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56229972|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56229973|NCT01702506|Antacids|antacids|mesh-list
56229974|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229975|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56229976|NCT01702610|Temozolomide|temozolomide|mesh-list
56229977|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56229978|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
56229979|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229980|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56229981|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
56229982|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
56229983|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56229984|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56229985|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56229986|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229987|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56229988|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56229989|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
56229990|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56134619|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
56134620|NCT00226590|Antiviral Agents|antiviral agents|mesh-ancestor
56134621|NCT00226590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134622|NCT00226590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134623|NCT00226590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134624|NCT00226590|Immunologic Factors|immunologic factors|mesh-ancestor
56134625|NCT00226590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134626|NCT00114114|Goserelin|goserelin|mesh-list
56134627|NCT00114114|Testosterone|testosterone|mesh-list
56134628|NCT00114114|Androgens|androgens|mesh-ancestor
56134629|NCT00114114|Hormones|hormones|mesh-ancestor
56134630|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56229991|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56229992|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56229993|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
56229994|NCT01702636|Coagulants|coagulants|mesh-ancestor
56229995|NCT01702649|Biapenem|biapenem|mesh-list
56229996|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56229997|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
56229998|NCT01702688|Giapreza|giapreza|mesh-list
56229999|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
56230000|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56134631|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134632|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56134633|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134634|NCT00227760|Cediranib|cediranib|mesh-list
56134635|NCT00227760|Maleic acid|maleic acid|mesh-list
56134636|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134637|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134638|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134639|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56134640|NCT00227994|Donepezil|donepezil|mesh-list
56134641|NCT00227994|Galantamine|galantamine|mesh-list
56134642|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56134643|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134646|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134647|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134648|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
56134649|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56134650|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
56134651|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134652|NCT00114504|Simvastatin|simvastatin|mesh-list
56134653|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56134654|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56134655|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
56134656|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134657|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56134658|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56134659|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134660|NCT01898676|Valproic Acid|valproic acid|mesh-list
56134661|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
56134662|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134663|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134664|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
56134665|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134666|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134667|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
56134668|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56134669|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56134670|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55747065|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134671|NCT00288366|Aripiprazole|aripiprazole|mesh-list
56134672|NCT00288366|Ziprasidone|ziprasidone|mesh-list
56134673|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
56134674|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56134675|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56134676|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56134677|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56134678|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134679|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
56134680|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
56134681|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134682|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134683|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56134684|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56134685|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
56134686|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56134687|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56134688|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56134689|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56230001|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56230002|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
56230003|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230004|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230005|NCT01702701|Fluticasone|fluticasone|mesh-list
56230006|NCT01702701|Montelukast|montelukast|mesh-list
56230007|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56230008|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56230009|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
56230010|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230011|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230012|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56230013|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
56230014|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56230015|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56230016|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56230017|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
56230018|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230019|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56230020|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56230021|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230022|NCT01702714|Gemcitabine|gemcitabine|mesh-list
56230023|NCT01702714|Paclitaxel|paclitaxel|mesh-list
56230024|NCT01702714|Carboplatin|carboplatin|mesh-list
56230025|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56230026|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230027|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
56230028|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
56230029|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
56230030|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230031|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56230032|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
56230033|NCT01702714|Antiviral Agents|antiviral agents|mesh-ancestor
56134690|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56134691|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
56134692|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56134693|NCT00288600|Antibodies|antibodies|mesh-list
56134694|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
56230034|NCT01702714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230035|NCT01702714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230036|NCT01702714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56230037|NCT01702714|Immunologic Factors|immunologic factors|mesh-ancestor
56230038|NCT01702714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230039|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56230040|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56230041|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
56230042|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230043|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56230044|NCT01702857|Vaccines|vaccines|mesh-list
56230045|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
55805688|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134695|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56134696|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
56134698|NCT00290472|Sirolimus|sirolimus|mesh-list
56134699|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56134700|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56134701|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56134702|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134703|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
56134704|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134705|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
56134706|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134707|NCT04752852|Dexamethasone|dexamethasone|mesh-list
56134708|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134709|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
56134710|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
56134711|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134712|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134713|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134714|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
56134715|NCT04752852|Hormones|hormones|mesh-ancestor
56134716|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56134717|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56134718|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134720|NCT01899144|Procaterol|procaterol|mesh-list
56134721|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56134722|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
56134723|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134724|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134725|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56134726|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
56134727|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
56134728|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56134729|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56134730|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56134731|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56134732|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
56134733|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134734|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134735|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
56134736|NCT00234078|Rebamipide|rebamipide|mesh-list
56134737|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56134738|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134739|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
56134740|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134741|NCT00234078|Protective Agents|protective agents|mesh-ancestor
56134742|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134743|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134744|NCT00118404|Fluoxetine|fluoxetine|mesh-list
56230046|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
56230047|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230048|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56230049|NCT01702857|Antacids|antacids|mesh-ancestor
56230050|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230051|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134745|NCT00118404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56134746|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55747249|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56134747|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56134748|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134749|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134751|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134752|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56134753|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
56134754|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56134755|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56134756|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56134757|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134758|NCT00121836|Bevacizumab|bevacizumab|mesh-list
56134759|NCT00121836|Capecitabine|capecitabine|mesh-list
56134760|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56134761|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134762|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56134763|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56134764|NCT00121836|Growth Substances|growth substances|mesh-ancestor
56134765|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134766|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
56134767|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56134768|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
56134769|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134770|NCT00237666|Ziprasidone|ziprasidone|mesh-list
56134771|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56134772|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
56134773|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134774|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134775|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134776|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56134777|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56134778|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56134779|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56134780|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56134781|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
56134783|NCT00296322|Mitomycin|mitomycin|mesh-list
56134784|NCT00296322|Doxifluridine|doxifluridine|mesh-list
56134785|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134786|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56134787|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
56134788|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134791|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56134792|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
56134793|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134794|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
56134795|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134796|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
56134797|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56134798|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
56134799|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134800|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
56134801|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56134802|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56134804|NCT00123162|Urological Agents|urological agents|mesh-ancestor
56134805|NCT00123630|Omalizumab|omalizumab|mesh-list
56134806|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56134807|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56230053|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
56230054|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56230055|NCT01702974|Vitamins|vitamins|mesh-ancestor
56230056|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
56230057|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230058|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56230059|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56230060|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230061|NCT01703104|Folic Acid|folic acid|mesh-list
56230062|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
56230063|NCT01703104|Proguanil|proguanil|mesh-list
56230064|NCT01703104|Hematinics|hematinics|mesh-ancestor
56230065|NCT01703104|Vitamins|vitamins|mesh-ancestor
56230066|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
56230067|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230068|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
56230069|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56230070|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56230071|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230072|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
56230073|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230074|NCT01703130|Ropivacaine|ropivacaine|mesh-list
56230075|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
56230076|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
56230077|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230078|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230079|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
56230080|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230081|NCT01703234|Ramipril|ramipril|mesh-list
56230082|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56230083|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
56230084|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747329|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56230085|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230086|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56230087|NCT01703312|Omalizumab|omalizumab|mesh-list
56230088|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56230089|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55805709|NCT05092373|Paclitaxel|paclitaxel|mesh-list
56230090|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
56230091|NCT01703325|Triamcinolone|triamcinolone|mesh-list
56230092|NCT01703325|Clobetasol|clobetasol|mesh-list
56230093|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56230094|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
56230095|NCT01703325|Hormones|hormones|mesh-ancestor
56230096|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230097|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230098|NCT01703351|Fentanyl|fentanyl|mesh-list
56230099|NCT01703351|Ropivacaine|ropivacaine|mesh-list
56230100|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
56230101|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
55805745|NCT04524455|Dexamethasone|dexamethasone|mesh-list
56134808|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
56134809|NCT00124176|Albuterol|albuterol|mesh-list
56134810|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56134811|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
56134812|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134813|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134814|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56134815|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
56134816|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
56134817|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56134818|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56134819|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56134820|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56134821|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
56134822|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134823|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134824|NCT00240162|Vatalanib|vatalanib|mesh-list
56134825|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56134826|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134827|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134828|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
56134829|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56134830|NCT00299988|Antibodies|antibodies|mesh-list
56134831|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
56134832|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56134833|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
56134834|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134835|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
56134836|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
56134837|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
56134838|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56134839|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56134840|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134841|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134842|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134843|NCT00300456|Simvastatin|simvastatin|mesh-list
56134844|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56134845|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56134846|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
56134847|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134848|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56134849|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56134850|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134851|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
56134852|NCT00125034|Cetuximab|cetuximab|mesh-list
56134853|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134854|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56134855|NCT02100930|Molgramostim|molgramostim|mesh-list
56134856|NCT02100930|Isotretinoin|isotretinoin|mesh-list
55747389|NCT03294967|Vitamin E|vitamin e|mesh-list
56230102|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230103|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230104|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
56230105|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230106|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56230107|NCT01703351|Narcotics|narcotics|mesh-ancestor
56230108|NCT01703351|Analgesics|analgesics|mesh-ancestor
56230109|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56230110|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56230111|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
56230112|NCT01703364|Lenalidomide|lenalidomide|mesh-list
56230113|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
56230114|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230115|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56230116|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56230117|NCT01703364|Growth Substances|growth substances|mesh-ancestor
56230118|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
56230119|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230121|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56230122|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230123|NCT01703455|Sorafenib|sorafenib|mesh-list
56230124|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230125|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56230126|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230127|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230128|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
56230129|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
56230130|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56230131|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56230132|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56230133|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230134|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56230135|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56230136|NCT01703559|Phentolamine|phentolamine|mesh-list
56230137|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55805759|NCT04411901|Vitamin D|vitamin d|mesh-list
56134857|NCT02100930|Antibodies|antibodies|mesh-list
56230138|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56230139|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56230140|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56230141|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
56230142|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230143|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230144|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230145|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56230146|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
56230147|NCT01703624|Bromides|bromides|mesh-list
56230148|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
56230149|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56230150|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56230151|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56230152|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
56230153|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230154|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230155|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134858|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56134859|NCT02100930|Sargramostim|sargramostim|mesh-list
56134860|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
56134861|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134863|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134864|NCT02101008|Disulfiram|disulfiram|mesh-list
56134865|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55747551|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747552|NCT02730455|Natalizumab|natalizumab|mesh-list
55747614|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134866|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56134867|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134868|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134869|NCT00241176|Aripiprazole|aripiprazole|mesh-list
56134870|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
56134871|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56134872|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56134873|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56134874|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56134875|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134876|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
56134879|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134880|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56134881|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56134882|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
56134883|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56134884|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56134885|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56134886|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56134888|NCT02102100|Nicotine|nicotine|mesh-list
56134889|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56134890|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
56134891|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134892|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134893|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55745339|NCT05196945|Amoxicillin|amoxicillin|mesh-list
56134894|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56134895|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
56230156|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56230157|NCT01703637|Vildagliptin|vildagliptin|mesh-list
56230158|NCT01703637|Saxagliptin|saxagliptin|mesh-list
55747701|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
56230159|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56230160|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230161|NCT01703637|Incretins|incretins|mesh-ancestor
56230162|NCT01703637|Hormones|hormones|mesh-ancestor
56230163|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230164|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56230165|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
56230166|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805809|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56134896|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56134897|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134898|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
56134899|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
55747734|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55747735|NCT03363815|Vitamin K|vitamin k|mesh-list
56134900|NCT02094534|Insulin|insulin|mesh-list
56134901|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56134902|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134903|NCT00242502|Bevacizumab|bevacizumab|mesh-list
56134904|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56134905|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56134906|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134907|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56134908|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56134909|NCT00242502|Growth Substances|growth substances|mesh-ancestor
56134910|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134911|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
56134912|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56134913|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134915|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
55747800|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56134916|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56134917|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134919|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134920|NCT04389060|Protective Agents|protective agents|mesh-ancestor
56134921|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134922|NCT01899066|Carboplatin|carboplatin|mesh-list
56134923|NCT01899066|Etoposide|etoposide|mesh-list
56134924|NCT01899066|Vincristine|vincristine|mesh-list
56134925|NCT01899066|Ranibizumab|ranibizumab|mesh-list
56134926|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134927|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56134928|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56134929|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56134930|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134931|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134932|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56134933|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56134934|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56134937|NCT01899066|Growth Substances|growth substances|mesh-ancestor
56134938|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134939|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
56134940|NCT00127218|Niacin|niacin|mesh-list
56134941|NCT00127218|Atorvastatin|atorvastatin|mesh-list
56134942|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56134943|NCT00127218|Simvastatin|simvastatin|mesh-list
56134944|NCT00127218|Pravastatin|pravastatin|mesh-list
56134945|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56134946|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56134947|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
56230167|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230168|NCT01703728|Menotropins|menotropins|mesh-list
56230169|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56230170|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
56230171|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56230172|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230173|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
56230175|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56230176|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
56230177|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230178|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230179|NCT01703910|Gemcitabine|gemcitabine|mesh-list
56230180|NCT01703910|Paclitaxel|paclitaxel|mesh-list
56230181|NCT01703910|Etoposide|etoposide|mesh-list
56230182|NCT01703910|Vinorelbine|vinorelbine|mesh-list
56230183|NCT01703910|Docetaxel|docetaxel|mesh-list
56230184|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56230185|NCT01703910|Cisplatin|cisplatin|mesh-list
56230186|NCT01703910|Doxorubicin|doxorubicin|mesh-list
56230187|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56230188|NCT01703910|Fluorouracil|fluorouracil|mesh-list
56230189|NCT01703910|Capecitabine|capecitabine|mesh-list
56230190|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
56230191|NCT01703910|Irinotecan|irinotecan|mesh-list
56230192|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
56230193|NCT01703910|Pemetrexed|pemetrexed|mesh-list
56230194|NCT01703910|Cetuximab|cetuximab|mesh-list
56230195|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56230196|NCT01703910|Sorafenib|sorafenib|mesh-list
56230197|NCT01703910|Topotecan|topotecan|mesh-list
56230198|NCT01703910|Dasatinib|dasatinib|mesh-list
56230199|NCT01703910|Mitomycins|mitomycins|mesh-list
56230200|NCT01703910|Mitomycin|mitomycin|mesh-list
56230201|NCT01703910|Raltitrexed|raltitrexed|mesh-list
56230202|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56230203|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230204|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
56134948|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134949|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56134950|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56134951|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134952|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
56134953|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
56230205|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
56230206|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
56230207|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230208|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56230209|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
56230210|NCT01703910|Antiviral Agents|antiviral agents|mesh-ancestor
56230211|NCT01703910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805856|NCT05563571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134955|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
55779093|NCT04439929|Adalimumab|adalimumab|mesh-list
56134956|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134957|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
56134958|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56134959|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56134960|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134961|NCT00250926|Dexamethasone|dexamethasone|mesh-list
56134962|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
56134963|NCT00250926|Rituximab|rituximab|mesh-list
56134964|NCT00250926|Bortezomib|bortezomib|mesh-list
56134965|NCT00250926|BB 1101|bb 1101|mesh-list
56134966|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56134967|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134968|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
56134969|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134970|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56134971|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56134972|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
56134973|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
56134974|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56134975|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56134976|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
56134977|NCT00250926|Hormones|hormones|mesh-ancestor
56134978|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56134979|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56134980|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
56134981|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134982|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134983|NCT00303966|Sorafenib|sorafenib|mesh-list
56134984|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134985|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56134986|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134987|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134988|NCT00304746|Testosterone|testosterone|mesh-list
56134989|NCT00304746|Androgens|androgens|mesh-ancestor
56134990|NCT00304746|Hormones|hormones|mesh-ancestor
56134991|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56134992|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56134993|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
56134994|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
56134995|NCT00134004|Fludarabine|fludarabine|mesh-list
56134996|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
56134997|NCT00134004|Tacrolimus|tacrolimus|mesh-list
56134998|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134999|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
56135000|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135001|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135002|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56135003|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
56135004|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135005|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135006|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56135007|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56135008|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
56135018|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135019|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
56135020|NCT02103114|Antithrombins|antithrombins|mesh-list
56135021|NCT02103114|Thrombin|thrombin|mesh-list
56135022|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
56135023|NCT02103114|Coagulants|coagulants|mesh-ancestor
56230212|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230213|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56230214|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
56230215|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135024|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56135025|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
56135026|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748045|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
56135027|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135028|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
56135029|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
56135030|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56135031|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56135032|NCT01790022|Prednisolone|prednisolone|mesh-list
56135033|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
56135034|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55861946|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135035|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
56135036|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56135037|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
56135038|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
56135039|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135040|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135041|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56135042|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
56135043|NCT01790022|Hormones|hormones|mesh-ancestor
56135044|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56135045|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56135046|NCT01790022|Protective Agents|protective agents|mesh-ancestor
56135047|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56135048|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135049|NCT00140556|Bevacizumab|bevacizumab|mesh-list
56135050|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56135051|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135052|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135053|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135054|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135055|NCT00140556|Growth Substances|growth substances|mesh-ancestor
56135056|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135057|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135058|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56135059|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135060|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135069|NCT00142116|Thalidomide|thalidomide|mesh-list
56135070|NCT00142116|Rituximab|rituximab|mesh-list
56135071|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135072|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135073|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
56135074|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135075|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135076|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135077|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
56135078|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56135079|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135080|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135081|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135082|NCT00142116|Growth Substances|growth substances|mesh-ancestor
56135083|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135084|NCT05201430|Capecitabine|capecitabine|mesh-list
56135087|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56135088|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
56135089|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135090|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135091|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56135092|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56135093|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135094|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
56135095|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135096|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
56135097|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56135098|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56230216|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56230217|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56230218|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56230219|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56230220|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56230221|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56230222|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56230223|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56230224|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
56230225|NCT01704027|Androgens|androgens|mesh-list
56230226|NCT01704027|Hormones|hormones|mesh-ancestor
56135099|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135100|NCT00142506|Urological Agents|urological agents|mesh-ancestor
56135101|NCT05266794|Selenium|selenium|mesh-list
56135102|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
56135103|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
56135104|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135105|NCT05266794|Protective Agents|protective agents|mesh-ancestor
56135106|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135107|NCT05266794|Trace Elements|trace elements|mesh-ancestor
56135108|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
56135109|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
56135110|NCT05266794|Vitamins|vitamins|mesh-ancestor
56135111|NCT00142818|Naltrexone|naltrexone|mesh-list
56135112|NCT00142818|Modafinil|modafinil|mesh-list
56135113|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56135114|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56135115|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135116|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
56135117|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135118|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56135119|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56135120|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56135121|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56135122|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135123|NCT05266716|Methamphetamine|methamphetamine|mesh-list
56135124|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56135125|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135126|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
56135127|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
56135128|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135129|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
56135130|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135131|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135132|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
56135133|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56135134|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56135135|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56135136|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56135137|NCT05266560|Propofol|propofol|mesh-list
56135138|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56135139|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135140|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135141|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56135142|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
56135143|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
56135144|NCT05117034|Morphine|morphine|mesh-list
56135145|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56135146|NCT05117034|Narcotics|narcotics|mesh-ancestor
56135147|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135148|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135149|NCT05117034|Analgesics|analgesics|mesh-ancestor
56135150|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
56230227|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230228|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230229|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
56230230|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56230231|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230232|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230233|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56230234|NCT01704092|Analgesics|analgesics|mesh-ancestor
56230235|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
56230236|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230237|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56230238|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56135151|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135152|NCT00147966|Rituximab|rituximab|mesh-list
56135153|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135154|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135155|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
56135156|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135157|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135158|NCT04528212|Glimepiride|glimepiride|mesh-list
56135159|NCT04528212|Curcumin|curcumin|mesh-list
56135160|NCT04528212|Fenofibrate|fenofibrate|mesh-list
56135161|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56135162|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56135163|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135164|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135165|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
56135166|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56135167|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56135168|NCT04528212|Analgesics|analgesics|mesh-ancestor
56135169|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
56135170|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135171|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56135172|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135173|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135174|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135175|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135176|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56135177|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
56135178|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56135179|NCT00148668|Carboplatin|carboplatin|mesh-list
56135180|NCT00148668|Docetaxel|docetaxel|mesh-list
56135181|NCT00148668|Trastuzumab|trastuzumab|mesh-list
56135182|NCT00148668|Vinorelbine|vinorelbine|mesh-list
56135183|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135184|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
56135185|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
56135186|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
56135187|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135188|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135191|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56135192|NCT00324870|Bevacizumab|bevacizumab|mesh-list
56135193|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56135195|NCT00324870|Antibodies|antibodies|mesh-list
56135196|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
56135197|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56135198|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135199|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135200|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135201|NCT00324870|Growth Substances|growth substances|mesh-ancestor
56230239|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56230240|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
56230241|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230242|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230243|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56230244|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56230245|NCT01704339|Capsaicin|capsaicin|mesh-list
56230246|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
56230247|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
56230248|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
56230249|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230250|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230251|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
56230252|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
56230253|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56230254|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230255|NCT01704417|Insulin|insulin|mesh-list
55805894|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
56135202|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135203|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135204|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
56135205|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56135206|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135207|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135208|NCT00151320|Rituximab|rituximab|mesh-list
56135209|NCT00151320|Bortezomib|bortezomib|mesh-list
56135210|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135211|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135212|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
56135213|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135214|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135215|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
56135216|NCT00328614|Goserelin|goserelin|mesh-list
56135217|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
56135218|NCT00328614|Bicalutamide|bicalutamide|mesh-list
56135219|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
56135220|NCT00328614|Androgens|androgens|mesh-list
56135221|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56135222|NCT00328614|Ethylene|ethylene|mesh-list
56135223|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56135224|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135225|NCT00328614|Hormones|hormones|mesh-ancestor
56135226|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56135227|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135228|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
56135229|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135230|NCT00328614|Protective Agents|protective agents|mesh-ancestor
56135231|NCT00328614|Vitamins|vitamins|mesh-ancestor
56135232|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
56135233|NCT00328614|Estrogens|estrogens|mesh-ancestor
56135234|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
56135235|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
56135236|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
56135237|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
55748238|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748239|NCT03264547|Paclitaxel|paclitaxel|mesh-list
55748240|NCT03264547|Docetaxel|docetaxel|mesh-list
56135239|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56135240|NCT00328614|Analgesics|analgesics|mesh-ancestor
56135241|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
56230256|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56230258|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56230259|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230260|NCT01704469|Anesthetics|anesthetics|mesh-list
56230261|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
56230262|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230263|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230264|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
55805909|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56135242|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135243|NCT00328770|Sirolimus|sirolimus|mesh-list
56135244|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56135245|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135246|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56135247|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135248|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
56135249|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135250|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
56135251|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135252|NCT04177758|Vitamin D|vitamin d|mesh-list
56135253|NCT04177758|Vitamins|vitamins|mesh-ancestor
56135254|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
56135255|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135256|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56135257|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56135258|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56135259|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56135260|NCT00330564|Sunitinib|sunitinib|mesh-list
55862171|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56135261|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135262|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135263|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135264|NCT00330564|Growth Substances|growth substances|mesh-ancestor
56135265|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135266|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135267|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56135268|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135269|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135270|NCT00330876|Pitavastatin|pitavastatin|mesh-list
56135271|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56135272|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56135273|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56135274|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
56135275|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135276|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135277|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56135278|NCT00334074|Cytarabine|cytarabine|mesh-list
56135279|NCT00334074|Clofarabine|clofarabine|mesh-list
56135280|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56135282|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135283|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135284|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
56135285|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135286|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135287|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
56135288|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135289|NCT00335478|Daptomycin|daptomycin|mesh-list
56135290|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56135291|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135292|NCT04345926|Propofol|propofol|mesh-list
56135293|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56135294|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135295|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230265|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230266|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
56230267|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56230268|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
56230269|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230270|NCT01704482|Expectorants|expectorants|mesh-ancestor
56230271|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
55748380|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
55748383|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
56230272|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56230273|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
56230274|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230275|NCT01704482|Protective Agents|protective agents|mesh-ancestor
56230276|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230277|NCT01704482|Antidotes|antidotes|mesh-ancestor
56230278|NCT01704508|Lumefantrine|lumefantrine|mesh-list
56230279|NCT01704508|Artemether|artemether|mesh-list
56230280|NCT01704508|Piperaquine|piperaquine|mesh-list
56230281|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56230282|NCT01704508|Artenimol|artenimol|mesh-list
56230283|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
56230284|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56230285|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56230286|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230287|NCT01704534|Ustekinumab|ustekinumab|mesh-list
56230288|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
56230289|NCT01704612|Ropivacaine|ropivacaine|mesh-list
56230290|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
56230291|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
56230292|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230293|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230294|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
56230295|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230296|NCT01704638|Digoxin|digoxin|mesh-list
56230297|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
56230298|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56135296|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56135297|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
56135298|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
56135299|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
56135300|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56135301|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135303|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
56135304|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135305|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135306|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135307|NCT00338988|Capecitabine|capecitabine|mesh-list
56230299|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56230300|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230301|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230303|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230304|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56230305|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56230306|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230307|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56230308|NCT01704638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56230309|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56230310|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56230311|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230312|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
56230313|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56230314|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
56230315|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56230316|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56230317|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56230318|NCT01704690|Paclitaxel|paclitaxel|mesh-list
56230319|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56230320|NCT01704690|Cisplatin|cisplatin|mesh-list
56230321|NCT01704690|Fluorouracil|fluorouracil|mesh-list
56230322|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56230323|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230324|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56230325|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56135308|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
56135309|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56135310|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
56135311|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135312|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135315|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135316|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135317|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135318|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135319|NCT00343044|Growth Substances|growth substances|mesh-ancestor
55748453|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
56135320|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135321|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135322|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56135323|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56135324|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135325|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135326|NCT00344370|Atorvastatin|atorvastatin|mesh-list
56135327|NCT00344370|Pitavastatin|pitavastatin|mesh-list
56230326|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56230327|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230328|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
56230329|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56230330|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56230331|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
56230332|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230333|NCT01704703|Panitumumab|panitumumab|mesh-list
56230334|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56230335|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230336|NCT01704716|Aldesleukin|aldesleukin|mesh-list
56230337|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
56230339|NCT01704716|Busulfan|busulfan|mesh-list
56230340|NCT01704716|Carboplatin|carboplatin|mesh-list
56230341|NCT01704716|Doxorubicin|doxorubicin|mesh-list
56230342|NCT01704716|Etoposide|etoposide|mesh-list
56230343|NCT01704716|Vincristine|vincristine|mesh-list
56230344|NCT01704716|Interleukin-2|interleukin-2|mesh-list
56230345|NCT01704716|Dinutuximab|dinutuximab|mesh-list
56230346|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56230347|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
56135328|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56135329|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56135330|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
56135331|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135332|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56135333|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56135334|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135335|NCT00344682|Memantine|memantine|mesh-list
56135336|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56135337|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56135338|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
56135339|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135340|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135341|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135342|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56135343|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56135344|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
56135345|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56135346|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135347|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135348|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56135349|NCT00345384|Analgesics|analgesics|mesh-ancestor
56135350|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
56135351|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135352|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56135353|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56135354|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56135355|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
56135356|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135357|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135358|NCT01791114|Propranolol|propranolol|mesh-list
56135359|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56135360|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56135361|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
56230348|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230349|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56230350|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56230351|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
56230352|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230353|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230354|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56135362|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745399|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56135363|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135364|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135365|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56135366|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56135367|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
56135368|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56135369|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56135370|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135371|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135372|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
56135373|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135374|NCT00350142|Gemcitabine|gemcitabine|mesh-list
56135375|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56135376|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
56135377|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135378|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135379|NCT00350142|Antiviral Agents|antiviral agents|mesh-ancestor
56135380|NCT00350142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135381|NCT00350142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135382|NCT00350142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135383|NCT00350142|Immunologic Factors|immunologic factors|mesh-ancestor
56135384|NCT00350142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135386|NCT00350532|Analgesics|analgesics|mesh-ancestor
56135387|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
56135388|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135389|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135390|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56135391|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
56135392|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
56135393|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56135394|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56135395|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56135396|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
56135397|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135398|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135399|NCT00351000|Ziprasidone|ziprasidone|mesh-list
55748603|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
56135400|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56135401|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
56135402|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135403|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135404|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135405|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56135406|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56135407|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135408|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56135409|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56135410|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
56135411|NCT00351936|Aripiprazole|aripiprazole|mesh-list
56135412|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
56135413|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56135414|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56135415|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56135416|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135417|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135418|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
56135419|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
56230355|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56230356|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56230357|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56230358|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230359|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56230360|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
56230361|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
56230362|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
56230363|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56230364|NCT01704716|Analgesics|analgesics|mesh-ancestor
55748644|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230365|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
56230366|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748646|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55748647|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55748648|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55748649|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
55748650|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748651|NCT02458963|Menotropins|menotropins|mesh-list
55748652|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55748653|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
55748654|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55748655|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748656|NCT04507607|Tenofovir|tenofovir|mesh-list
55748657|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
56230367|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56230368|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56230369|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
56230370|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230371|NCT01704794|Folic Acid|folic acid|mesh-list
56230372|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
56230373|NCT01704794|Proguanil|proguanil|mesh-list
56230374|NCT01704794|Hematinics|hematinics|mesh-ancestor
55806006|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
56135420|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135421|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135422|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56135423|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56135424|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
56135425|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56135426|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56135427|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56135428|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56135429|NCT00352794|Prednisone|prednisone|mesh-list
56135430|NCT00352794|Lenalidomide|lenalidomide|mesh-list
56135431|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56135432|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
56135433|NCT00352794|Hormones|hormones|mesh-ancestor
55745403|NCT03101319|Vitamin D|vitamin d|mesh-list
56135434|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56135435|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135436|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56135437|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135438|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
56135439|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55748677|NCT04511195|Diclofenac|diclofenac|mesh-list
56135440|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135441|NCT00352794|Growth Substances|growth substances|mesh-ancestor
56135442|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135443|NCT00353418|Ribavirin|ribavirin|mesh-list
56135444|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56135445|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
56135446|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135447|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
56135448|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135449|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
56135450|NCT00353652|Spironolactone|spironolactone|mesh-list
56135451|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56135452|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
56135453|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230375|NCT01704794|Vitamins|vitamins|mesh-ancestor
56230376|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
56230377|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230378|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
56230379|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56230380|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56230381|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230382|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
56230383|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230384|NCT01704872|Dinutuximab|dinutuximab|mesh-list
56230385|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806031|NCT05498441|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56135454|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135455|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56135458|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56135459|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56135460|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56135461|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135462|NCT02982798|Metformin|metformin|mesh-list
56135463|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56135464|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56135465|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135466|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56135467|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56135468|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
56135469|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135470|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56135471|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56135473|NCT03709914|Fosfomycin|fosfomycin|mesh-list
56135474|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56135475|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135476|NCT01794078|Ambrisentan|ambrisentan|mesh-list
56135477|NCT01794078|Aminophylline|aminophylline|mesh-list
56135478|NCT01794078|Theophylline|theophylline|mesh-list
56135479|NCT01794078|Ethylene|ethylene|mesh-list
56135480|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56135481|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
56135482|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135483|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135484|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56135485|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
56135486|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56135487|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135488|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135489|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
56135490|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56135491|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56135492|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
56135493|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135494|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56135495|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56135496|NCT01794078|Protective Agents|protective agents|mesh-ancestor
56135497|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56135498|NCT01794078|Growth Substances|growth substances|mesh-ancestor
56135499|NCT00354978|Leucovorin|leucovorin|mesh-list
56135500|NCT00354978|Bevacizumab|bevacizumab|mesh-list
56135501|NCT00354978|Fluorouracil|fluorouracil|mesh-list
56135502|NCT00354978|Irinotecan|irinotecan|mesh-list
56135503|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135504|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135505|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135506|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135507|NCT00354978|Growth Substances|growth substances|mesh-ancestor
56230386|NCT01704898|Efavirenz|efavirenz|mesh-list
56230387|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56230388|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56230389|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230390|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806038|NCT05491187|Fentanyl|fentanyl|mesh-list
56135508|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135509|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135510|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
56135511|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135512|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56135513|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135514|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
56135515|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56135516|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56135517|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135518|NCT00354978|Antidotes|antidotes|mesh-ancestor
56135519|NCT00354978|Protective Agents|protective agents|mesh-ancestor
56135520|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
56135521|NCT00354978|Vitamins|vitamins|mesh-ancestor
56135522|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
56135523|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
56135524|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135525|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135526|NCT00357162|Belinostat|belinostat|mesh-list
56135527|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135528|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56135529|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135531|NCT03549000|Spartalizumab|spartalizumab|mesh-list
56135532|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56032495|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55748816|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
56135533|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135534|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135535|NCT03984240|Midazolam|midazolam|mesh-list
56135536|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
56135537|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56135538|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135539|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135540|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56135541|NCT03984240|Analgesics|analgesics|mesh-ancestor
56135542|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
56135543|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135544|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56135545|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56135546|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56135547|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
56135548|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135549|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135550|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56135551|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56135552|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56135553|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56135554|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56135555|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
56135556|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
56135557|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
56135558|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
56135559|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
56135560|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
56135561|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56135562|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56135563|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135564|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135565|NCT00359736|Urological Agents|urological agents|mesh-ancestor
56135566|NCT00360126|Lamotrigine|lamotrigine|mesh-list
56135567|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
56135568|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56135569|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56135570|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230391|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
56230392|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230393|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56230394|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56230395|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56230396|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56230397|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56230398|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56230399|NCT01705002|Bevacizumab|bevacizumab|mesh-list
56230400|NCT01705002|Capecitabine|capecitabine|mesh-list
56230401|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55748847|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56230402|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748848|NCT02455609|Analgesics|analgesics|mesh-ancestor
56230403|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56230404|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56230405|NCT01705002|Growth Substances|growth substances|mesh-ancestor
56230406|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230407|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
56230408|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56230409|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
55806040|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
56135571|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56135572|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135573|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56135574|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56135575|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135576|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56135577|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56135578|NCT00360360|Paclitaxel|paclitaxel|mesh-list
56135579|NCT00360360|Bevacizumab|bevacizumab|mesh-list
55748871|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135581|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56135582|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56135583|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135584|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
56135585|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
56135586|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
56135587|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135588|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135589|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135590|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135591|NCT00360360|Growth Substances|growth substances|mesh-ancestor
56135592|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135593|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135594|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56135595|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135596|NCT01552590|Tolvaptan|tolvaptan|mesh-list
56135597|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56135598|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135599|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
56135600|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135601|NCT00549978|Cilostazol|cilostazol|mesh-list
56135602|NCT00549978|Probucol|probucol|mesh-list
55748936|NCT05513807|Vitamins|vitamins|mesh-ancestor
56135605|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230410|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230411|NCT01705041|Liver Extracts|liver extracts|mesh-list
56230412|NCT01705041|Hematinics|hematinics|mesh-ancestor
56135606|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135607|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56135608|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
56135609|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56135610|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56135611|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135612|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56135613|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
56135614|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56135615|NCT00549978|Protective Agents|protective agents|mesh-ancestor
56135616|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56135617|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56135618|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135619|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56135620|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56135621|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
56135622|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56135623|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
56135624|NCT03983226|Gemcitabine|gemcitabine|mesh-list
56135625|NCT03983226|Carboplatin|carboplatin|mesh-list
56135626|NCT03983226|Doxorubicin|doxorubicin|mesh-list
56135627|NCT03983226|Niraparib|niraparib|mesh-list
56135629|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135630|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56135631|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
56135632|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135633|NCT03983226|Antiviral Agents|antiviral agents|mesh-ancestor
56135634|NCT03983226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135635|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135636|NCT03983226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135637|NCT03983226|Immunologic Factors|immunologic factors|mesh-ancestor
56135638|NCT03983226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135639|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56135640|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56135641|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56135642|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56135643|NCT00360672|Lenalidomide|lenalidomide|mesh-list
56135644|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
56135645|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135646|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135647|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135648|NCT00360672|Growth Substances|growth substances|mesh-ancestor
56135649|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135650|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135652|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56135653|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56135655|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135656|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135657|NCT00361140|Fludarabine|fludarabine|mesh-list
56135658|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
56135659|NCT00361140|Busulfan|busulfan|mesh-list
56135660|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135661|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56135662|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
55748984|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
56135663|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135664|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135665|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
56135666|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135667|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
56135668|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56135669|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56135670|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
56135671|NCT00362466|Dasatinib|dasatinib|mesh-list
56135672|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135673|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56135674|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135675|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230413|NCT01705158|Carboplatin|carboplatin|mesh-list
56230414|NCT01705158|Doxorubicin|doxorubicin|mesh-list
56230415|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56230416|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230417|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56230418|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56230419|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56230420|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230421|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230422|NCT01705223|Vaccines|vaccines|mesh-list
56230423|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
56230424|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230425|NCT01705249|Norethindrone|norethindrone|mesh-list
56230426|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
56135676|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
56135677|NCT00305682|Sirolimus|sirolimus|mesh-list
56135679|NCT00305682|Fludarabine|fludarabine|mesh-list
56135680|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56135681|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135682|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
56135683|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749003|NCT03251365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749004|NCT03251365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135684|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135685|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56135686|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
56135687|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135688|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135689|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56135690|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56135691|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56135692|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
56135693|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56135694|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135695|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135696|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
56135697|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
56135698|NCT00305760|Cetuximab|cetuximab|mesh-list
56135699|NCT00305760|Vaccines|vaccines|mesh-list
56135700|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
56135701|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135702|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135703|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135704|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56135705|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
56135706|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135707|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135708|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56135709|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55862629|NCT01764997|Adalimumab|adalimumab|mesh-list
56135711|NCT00309738|Pitavastatin|pitavastatin|mesh-list
56135712|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56135713|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56135714|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
56135715|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135716|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56135717|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56135718|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135719|NCT00310050|Pemetrexed|pemetrexed|mesh-list
56135720|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135721|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135722|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135723|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56230428|NCT01705249|Estrogens|estrogens|mesh-ancestor
56230429|NCT01705249|Hormones|hormones|mesh-ancestor
56230430|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230431|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230432|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56230433|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
56230434|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56230435|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56230436|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56230437|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56230438|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56230439|NCT01705314|Vitamin D|vitamin d|mesh-list
56230440|NCT01705314|Vitamins|vitamins|mesh-ancestor
56230441|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
56230442|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230443|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56230444|NCT01705340|Trastuzumab|trastuzumab|mesh-list
56230445|NCT01705340|Lapatinib|lapatinib|mesh-list
56230446|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56230447|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230448|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56230449|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230450|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135724|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56135725|NCT00363168|Ranibizumab|ranibizumab|mesh-list
56135726|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135727|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135728|NCT00363168|Growth Substances|growth substances|mesh-ancestor
56135729|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135730|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135731|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135732|NCT00365274|Prednisone|prednisone|mesh-list
56135733|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
56135734|NCT00365274|Doxorubicin|doxorubicin|mesh-list
55749060|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
56135735|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56135736|NCT00365274|Vincristine|vincristine|mesh-list
56135737|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56135738|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135739|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
56135740|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135741|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135742|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56135743|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
56135744|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135745|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135746|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56135747|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56135748|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56135749|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56230451|NCT01705379|Lactitol|lactitol|mesh-list
56230452|NCT01705379|Cathartics|cathartics|mesh-ancestor
56230453|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56230454|NCT01705392|Bevacizumab|bevacizumab|mesh-list
56230455|NCT01705392|Dacarbazine|dacarbazine|mesh-list
56230456|NCT01705392|Propranolol|propranolol|mesh-list
56230457|NCT01705392|Enalapril|enalapril|mesh-list
56230458|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56230459|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230460|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135750|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135751|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56135753|NCT00365274|Hormones|hormones|mesh-ancestor
56135754|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56135755|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56135756|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56135757|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
56135758|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
56135759|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
56135760|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135761|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
56135762|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56135763|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55749120|NCT03434041|Analgesics|analgesics|mesh-ancestor
55749121|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
56135764|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56135765|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56135766|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135767|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
56135768|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135769|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135770|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56135771|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135772|NCT02104830|Lenograstim|lenograstim|mesh-list
56135773|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56135774|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
56135775|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135776|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56135777|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135778|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56135779|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135780|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135782|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
56135783|NCT00314106|Fludarabine|fludarabine|mesh-list
56135784|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135785|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
56135786|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135787|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135788|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56135789|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
56135790|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135791|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135792|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56135793|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56135794|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56135795|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
56135796|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135797|NCT00318708|Fluticasone|fluticasone|mesh-list
56135799|NCT00318708|Clarithromycin|clarithromycin|mesh-list
56135800|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56135801|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56135802|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
56135803|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135804|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135805|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56135806|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
56135807|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
56230461|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56230462|NCT01705392|Growth Substances|growth substances|mesh-ancestor
56230463|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230464|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
56230465|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56230466|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56230467|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
56230468|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230469|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230470|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56230471|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56230472|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
56230473|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56230474|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
55806110|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
56135808|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56135809|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56135810|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135811|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56135812|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135813|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135814|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56135815|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56135816|NCT00319644|Dimercaprol|dimercaprol|mesh-list
56135817|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
56135818|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
56135819|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135820|NCT02448420|Trastuzumab|trastuzumab|mesh-list
56135821|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56135822|NCT02448420|Palbociclib|palbociclib|mesh-list
56135823|NCT02448420|Antibodies|antibodies|mesh-list
56135824|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
56135826|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135827|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135828|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135829|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56135830|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135831|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135832|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
56135833|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
56135834|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
56135835|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56135836|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56135837|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56135839|NCT02405676|Prednisone|prednisone|mesh-list
56135840|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
56135841|NCT02405676|Ifosfamide|ifosfamide|mesh-list
56135842|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
56135843|NCT02405676|Rituximab|rituximab|mesh-list
56135844|NCT02405676|Methotrexate|methotrexate|mesh-list
56135845|NCT02405676|Etoposide|etoposide|mesh-list
56135846|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
56135847|NCT02405676|Vincristine|vincristine|mesh-list
55749178|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135848|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135849|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
56135850|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135851|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56135852|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56230475|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56230476|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
56230477|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230478|NCT01705457|Vitamin A|vitamin a|mesh-list
56230479|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
56230480|NCT01705457|Vitamins|vitamins|mesh-ancestor
56230481|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
56230482|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230483|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
56230484|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230485|NCT01705457|Protective Agents|protective agents|mesh-ancestor
56230486|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56230487|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135853|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
56135854|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135855|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135856|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55862774|NCT00756106|Temozolomide|temozolomide|mesh-list
56135857|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56135858|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56135859|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
56135860|NCT02405676|Hormones|hormones|mesh-ancestor
56135861|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56135862|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56135863|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56135864|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
56135865|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56135866|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56135867|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
56135868|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
56135869|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135870|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56135871|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56135872|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56135873|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56135875|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
56135876|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135877|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
56135878|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
56135879|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
56135880|NCT00321594|Belinostat|belinostat|mesh-list
56135881|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135882|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56135883|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135884|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135885|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
56135886|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56135887|NCT04751136|Protective Agents|protective agents|mesh-ancestor
56135888|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135889|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
56135890|NCT00390234|Aflibercept|aflibercept|mesh-list
56135891|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
56135892|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56135893|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135894|NCT00390234|Growth Substances|growth substances|mesh-ancestor
56135895|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135896|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135897|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135898|NCT00391716|Gabapentin|gabapentin|mesh-list
56135899|NCT00391716|Analgesics|analgesics|mesh-ancestor
56135901|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56135902|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230489|NCT01705470|Diuretics|diuretics|mesh-ancestor
56230490|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
56230491|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230492|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56230493|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56230494|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230495|NCT01705483|Paclitaxel|paclitaxel|mesh-list
56230496|NCT01705483|Docetaxel|docetaxel|mesh-list
56135903|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
56135904|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56135905|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56135906|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135907|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56135908|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56135909|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56135910|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135911|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135912|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
56135914|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135915|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55749302|NCT04767191|Piperaquine|piperaquine|mesh-list
56135916|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135917|NCT00392496|Growth Substances|growth substances|mesh-ancestor
56135918|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135919|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
56135920|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56135921|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135922|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135923|NCT01958190|Sirolimus|sirolimus|mesh-list
56135924|NCT01958190|Tacrolimus|tacrolimus|mesh-list
56135925|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135926|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
56135927|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135928|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56135929|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135930|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135931|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56135932|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135933|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56135934|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135935|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
56135936|NCT00638898|Melphalan|melphalan|mesh-list
56135937|NCT00638898|Busulfan|busulfan|mesh-list
56135938|NCT00638898|Topotecan|topotecan|mesh-list
56135939|NCT00638898|Lenograstim|lenograstim|mesh-list
56135940|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56135941|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
56135942|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135943|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56135944|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
56135945|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135946|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135947|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56135948|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56135949|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56135950|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56135951|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135952|NCT00393978|Topiramate|topiramate|mesh-list
56135953|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56135954|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
56135955|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56135956|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56135957|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56135958|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135959|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135960|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
56230497|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56230498|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230499|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
56230500|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
56230501|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
56230502|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230504|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
55749337|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56230505|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230506|NCT01705639|Protective Agents|protective agents|mesh-ancestor
55806155|NCT05466175|Prednisone|prednisone|mesh-list
56135961|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56135962|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
56135963|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56135964|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135965|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135966|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56135967|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56135968|NCT00397020|Valproic Acid|valproic acid|mesh-list
56135969|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56135970|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
56135971|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56135972|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56135973|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56135975|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135976|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
56135977|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135978|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135979|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
56135980|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56135981|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
56135982|NCT00397878|Saracatinib|saracatinib|mesh-list
56135983|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56135984|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135985|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135986|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
56135987|NCT00400686|Hematinics|hematinics|mesh-ancestor
56135988|NCT05220462|Midazolam|midazolam|mesh-list
56135989|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56135990|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56135991|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56135992|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56135993|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56135994|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56135995|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56135996|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56135997|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
56135998|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
56135999|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
56136000|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
56136001|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136002|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136004|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136005|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136006|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
56136007|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56136008|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
56136009|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136010|NCT00374088|Expectorants|expectorants|mesh-ancestor
56136011|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
55749417|NCT04663997|Docetaxel|docetaxel|mesh-list
55749418|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
55749419|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136012|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56136013|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
56136014|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136015|NCT00374088|Protective Agents|protective agents|mesh-ancestor
56230507|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230508|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230509|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
56230510|NCT01705743|Sevoflurane|sevoflurane|mesh-list
56230511|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56230512|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56230513|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
56230514|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
56230515|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230516|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230517|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56230518|NCT01705743|Analgesics|analgesics|mesh-ancestor
56230519|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
56230520|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230521|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56230522|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56230523|NCT01705769|Micronutrients|micronutrients|mesh-list
56230524|NCT01705769|Trace Elements|trace elements|mesh-list
55749493|NCT03248401|Aspirin|aspirin|mesh-list
56230525|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230527|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
56230528|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230529|NCT01705808|Protein C|protein c|mesh-list
56230530|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
56230531|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56136016|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136017|NCT00374088|Antidotes|antidotes|mesh-ancestor
56136018|NCT00374244|Pimozide|pimozide|mesh-list
56136019|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56136020|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56136021|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136022|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136023|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55749534|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
56136024|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56136025|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
56136026|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136027|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136028|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56136029|NCT00377832|Acetaminophen|acetaminophen|mesh-list
56136030|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56136031|NCT00377832|Analgesics|analgesics|mesh-ancestor
56136032|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
56136033|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136034|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136035|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
56136036|NCT00401778|Everolimus|everolimus|mesh-list
56136037|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136038|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136039|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
56136040|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230532|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56230533|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230534|NCT01705938|Dolcanatide|dolcanatide|mesh-list
56230535|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56230536|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
56230537|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230538|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56230539|NCT01705951|Nicotine|nicotine|mesh-list
56230540|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56230541|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
56230542|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230543|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230544|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56230545|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56230546|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
56230547|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230548|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230549|NCT01706055|Interferons|interferons|mesh-list
56230550|NCT01706055|Interferon-beta|interferon-beta|mesh-list
56230551|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
56230552|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230554|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230555|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
56230556|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230557|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56230558|NCT01706172|Lidocaine|lidocaine|mesh-list
56230559|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
56230560|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
56230561|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230562|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230563|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
56230570|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
56230572|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230573|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56230574|NCT01706354|Anesthetics|anesthetics|mesh-list
56230575|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
55749676|NCT03952091|BB 1101|bb 1101|mesh-list
56230576|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230577|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230578|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
56230579|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230580|NCT01706367|Vaccines|vaccines|mesh-list
56230581|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
56230582|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230583|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
56230584|NCT01706471|Everolimus|everolimus|mesh-list
56230585|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230586|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56230587|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
56230588|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230589|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56230590|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56230591|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
56230592|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56230593|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749703|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55749705|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749707|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56230594|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230595|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230597|NCT01706510|Ticagrelor|ticagrelor|mesh-list
56230598|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55806215|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
56136043|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136044|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56136045|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136046|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136047|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56136048|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136050|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56136051|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56136052|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56136054|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136055|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
56136056|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
56136057|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136058|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136059|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
56136060|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136061|NCT00381810|Acetaminophen|acetaminophen|mesh-list
56136062|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
55749763|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230599|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56230600|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56230601|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56136063|NCT00381810|Promethazine|promethazine|mesh-list
56136064|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
56136065|NCT00381810|Rituximab|rituximab|mesh-list
56136066|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136067|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136068|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
56136069|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136070|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136071|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56136072|NCT00381810|Analgesics|analgesics|mesh-ancestor
56136073|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
56136074|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136075|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
56136076|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136077|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
56136078|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
56136079|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136080|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
55749818|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136081|NCT00381810|Hormones|hormones|mesh-ancestor
56136082|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136083|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56136084|NCT00381810|Protective Agents|protective agents|mesh-ancestor
56136085|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56136086|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56136087|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136089|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
56136090|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56136091|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
56136092|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
56136093|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136094|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136095|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56136096|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
56136097|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136098|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56136099|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136100|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136101|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136102|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56136103|NCT00459732|Zinc|zinc|mesh-list
56136104|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
56136105|NCT00459732|Trace Elements|trace elements|mesh-ancestor
56136106|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
56136107|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136108|NCT00459732|Astringents|astringents|mesh-ancestor
56136109|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136110|NCT00459810|Paclitaxel|paclitaxel|mesh-list
56136111|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
56136112|NCT00459810|Estradiol|estradiol|mesh-list
56136113|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56136114|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136115|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56136116|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56136117|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56136118|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136119|NCT00459810|Estrogens|estrogens|mesh-ancestor
56136120|NCT00459810|Hormones|hormones|mesh-ancestor
56136121|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136122|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136123|NCT00405522|Remifentanil|remifentanil|mesh-list
56136124|NCT00405522|Propofol|propofol|mesh-list
56136125|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56136138|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56136139|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56136140|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56136141|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136142|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
56136143|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136144|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230602|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
56230603|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230604|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230605|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230606|NCT01706562|Itraconazole|itraconazole|mesh-list
56136145|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56136146|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136147|NCT00382590|Cytarabine|cytarabine|mesh-list
56136148|NCT00382590|Azacitidine|azacitidine|mesh-list
56136149|NCT00382590|Valproic Acid|valproic acid|mesh-list
56136150|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136151|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
56136152|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136153|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136154|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
56136155|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136156|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136157|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
56136158|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136159|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136160|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
56136161|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
56136162|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136163|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
56136164|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56136165|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750013|NCT02511665|Metformin|metformin|mesh-list
56136166|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56136168|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
56136169|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
56136170|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136171|NCT00382824|Vitamins|vitamins|mesh-ancestor
56136172|NCT00462072|Infliximab|infliximab|mesh-list
56136173|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136174|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136175|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136176|NCT00462228|Memantine|memantine|mesh-list
56136177|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56136178|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56136179|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
56136180|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136181|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136182|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136183|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56136184|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56136185|NCT00408564|Gemcitabine|gemcitabine|mesh-list
56136186|NCT00408564|Capecitabine|capecitabine|mesh-list
56136187|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
56136188|NCT00408564|Cetuximab|cetuximab|mesh-list
56136189|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136190|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
56136191|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136193|NCT00408564|Antiviral Agents|antiviral agents|mesh-ancestor
56136194|NCT00408564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136195|NCT00408564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136196|NCT00408564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136197|NCT00408564|Immunologic Factors|immunologic factors|mesh-ancestor
56136198|NCT00408564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136199|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136200|NCT00383448|Cyclosporine|cyclosporine|mesh-list
56136201|NCT00383448|Melphalan|melphalan|mesh-list
56136202|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
56136203|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
56136204|NCT00383448|Clofarabine|clofarabine|mesh-list
56136205|NCT00383448|Cyclosporins|cyclosporins|mesh-list
56136206|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136207|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136208|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136209|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
56136210|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136211|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
56136212|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230607|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
56230608|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230609|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56230610|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56230611|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230612|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230613|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56230614|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
55806252|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56136213|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136214|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136215|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56136216|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56136217|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
56136218|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136219|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56136220|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136221|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
56136222|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56136223|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136224|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
56136226|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56136227|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
56136228|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136229|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136230|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136231|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56136232|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136233|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56136234|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745430|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
56136235|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136237|NCT00464646|Bevacizumab|bevacizumab|mesh-list
56136238|NCT00464646|Docetaxel|docetaxel|mesh-list
56136239|NCT00464646|Trastuzumab|trastuzumab|mesh-list
56136240|NCT00464646|Epirubicin|epirubicin|mesh-list
56136241|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136242|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
56136243|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136244|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136245|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56136246|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
56136247|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136248|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136249|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56136250|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136251|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56136252|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56136253|NCT00464646|Growth Substances|growth substances|mesh-ancestor
56136254|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
56136255|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
56136256|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
56136257|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
56136258|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56136259|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56136260|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56136261|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136262|NCT00385008|Naproxen|naproxen|mesh-list
56136263|NCT00385008|Sumatriptan|sumatriptan|mesh-list
56136264|NCT00385008|Eletriptan|eletriptan|mesh-list
56136265|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56136267|NCT00385008|Analgesics|analgesics|mesh-ancestor
56136268|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
56136269|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230615|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230616|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136270|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136271|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136272|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136273|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
56136274|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56136275|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136276|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136277|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56136278|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56136279|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56136280|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
56136281|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136283|NCT00410904|Cediranib|cediranib|mesh-list
56136284|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136285|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136286|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750152|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750153|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
56136287|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56136288|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56136289|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56136290|NCT00385788|Gemcitabine|gemcitabine|mesh-list
56136291|NCT00385788|Methotrexate|methotrexate|mesh-list
56136292|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
56136293|NCT00385788|Fludarabine|fludarabine|mesh-list
56136294|NCT00385788|Melphalan|melphalan|mesh-list
56136295|NCT00385788|Tacrolimus|tacrolimus|mesh-list
56136296|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
56136297|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56136298|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136299|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
56136300|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136301|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136302|NCT00385788|Antiviral Agents|antiviral agents|mesh-ancestor
56136303|NCT00385788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136304|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136305|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136306|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
56136307|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136308|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56136309|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
55745433|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
56136310|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56136311|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136312|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56136313|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136314|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56136315|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56136316|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55863221|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56136317|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
56136318|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56136319|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
56136320|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56136321|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
56136322|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56136323|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136324|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56136325|NCT00412074|Vitamin D|vitamin d|mesh-list
56136326|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
56136327|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
56136328|NCT00412074|Vitamins|vitamins|mesh-list
56136329|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
56136330|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136331|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56136332|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56136334|NCT00412464|Fondaparinux|fondaparinux|mesh-list
56136335|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56136336|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
55750325|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56136337|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56136338|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
56230617|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56230618|NCT01706627|Melatonin|melatonin|mesh-list
56230619|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
56230620|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230621|NCT01706627|Protective Agents|protective agents|mesh-ancestor
56230622|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230623|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230625|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56230626|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230627|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56230628|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56230629|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136339|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136340|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136341|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
56136342|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56136343|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56136344|NCT00466752|Sorafenib|sorafenib|mesh-list
56136345|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136346|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56136347|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136348|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750386|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136349|NCT02115750|Etanercept|etanercept|mesh-list
56136350|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56136351|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56136352|NCT02115750|Analgesics|analgesics|mesh-ancestor
56136353|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
56136354|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136355|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136356|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136357|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136358|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136359|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136360|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
56136361|NCT00413166|Idarubicin|idarubicin|mesh-list
56136362|NCT00413166|Tretinoin|tretinoin|mesh-list
56136363|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
56136364|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
55750443|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
56136365|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56136366|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136367|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56136368|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56136369|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136370|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136371|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
55750578|NCT03341429|Hormones|hormones|mesh-ancestor
56136372|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136373|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136374|NCT00413400|Etanercept|etanercept|mesh-list
56136375|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56136376|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56136377|NCT00413400|Analgesics|analgesics|mesh-ancestor
56136378|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
56136379|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136380|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136381|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136382|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136383|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136384|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136385|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
56136386|NCT00413478|Azacitidine|azacitidine|mesh-list
56136387|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136388|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
56230630|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230631|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230632|NCT01706874|Listerine|listerine|mesh-list
56230633|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56230634|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230635|NCT01706887|Amiloride|amiloride|mesh-list
56230636|NCT01706887|Diuretics|diuretics|mesh-ancestor
56230637|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
56230638|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230639|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56230640|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56230641|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56230642|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230643|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56230644|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56230645|NCT01707082|Midazolam|midazolam|mesh-list
56230646|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56230647|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56230648|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230649|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230650|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56230651|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56230652|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55750702|NCT02494349|Tamsulosin|tamsulosin|mesh-list
56230653|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56230654|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
56230655|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
56230656|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
56230657|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
56230658|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230659|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230660|NCT01707134|Insulin|insulin|mesh-list
56230661|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56230662|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
56230663|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
56230664|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
56230665|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
56230668|NCT01707160|Insulin|insulin|mesh-list
56230669|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56230670|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
56230671|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
56230672|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56230673|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56230674|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230675|NCT01707199|Artesunate|artesunate|mesh-list
56230676|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
56230677|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
56230678|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56230679|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
55750757|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
55750765|NCT02497157|Antidotes|antidotes|mesh-ancestor
56230680|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56230681|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56230682|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230683|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230684|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
56230685|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
56230686|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56230687|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
56230688|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56230689|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230690|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230691|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56230692|NCT01707199|Renal Agents|renal agents|mesh-ancestor
56230694|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56230696|NCT01707251|Analgesics|analgesics|mesh-ancestor
56230697|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
56230698|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230699|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806315|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
56136389|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136390|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136391|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136392|NCT00413634|Anagrelide|anagrelide|mesh-list
56136393|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56136394|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55750810|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
56136395|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136396|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56230700|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56230701|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56230702|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56230703|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230704|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230705|NCT01707316|Canagliflozin|canagliflozin|mesh-list
56230706|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56230707|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230708|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56230709|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230710|NCT01707342|Simeprevir|simeprevir|mesh-list
56230711|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
56230712|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230713|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
56230714|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230715|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230716|NCT01707394|Apixaban|apixaban|mesh-list
56230717|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56230718|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
56230719|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56230720|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
56136397|NCT00387036|Fluticasone|fluticasone|mesh-list
56136398|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136399|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56136400|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
56136401|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136402|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136403|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56136404|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
56136405|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136406|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56136407|NCT04388904|Tenofovir|tenofovir|mesh-list
56136408|NCT04388904|Emtricitabine|emtricitabine|mesh-list
56136409|NCT04388904|Darunavir|darunavir|mesh-list
56136410|NCT04388904|Cobicistat|cobicistat|mesh-list
56136411|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56136412|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56136413|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
56136414|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136415|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56136417|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136418|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136419|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56136420|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56136421|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56136422|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56136423|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
56136424|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56136425|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56136426|NCT00387660|Carboplatin|carboplatin|mesh-list
56136427|NCT00387660|Irinotecan|irinotecan|mesh-list
56136428|NCT00387660|Camptothecin|camptothecin|mesh-list
56136429|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136430|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56230721|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230722|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230723|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
56230724|NCT01707407|Ketoconazole|ketoconazole|mesh-list
56230725|NCT01707407|Pomalidomide|pomalidomide|mesh-list
56230726|NCT01707407|Carbamazepine|carbamazepine|mesh-list
56230727|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
55750909|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230728|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
55750910|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230729|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230730|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56230731|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56230732|NCT01707407|Growth Substances|growth substances|mesh-ancestor
56230733|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
56230734|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230735|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
56230736|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230737|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56136431|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56136432|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136433|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136434|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56136435|NCT00472056|Cytarabine|cytarabine|mesh-list
56136436|NCT00472056|Rituximab|rituximab|mesh-list
56136437|NCT00472056|Etoposide|etoposide|mesh-list
56136438|NCT00472056|Melphalan|melphalan|mesh-list
56136439|NCT00472056|Carmustine|carmustine|mesh-list
56136440|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136441|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136442|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
56136443|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136444|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136445|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56136446|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56136447|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56136448|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136449|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136450|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136452|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
56136453|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136454|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136455|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55750948|NCT05052879|Urological Agents|urological agents|mesh-ancestor
56136456|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
56136457|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56136458|NCT00415506|Rituximab|rituximab|mesh-list
56136459|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136460|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136461|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
56136462|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136463|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136464|NCT03531918|Cytarabine|cytarabine|mesh-list
56136465|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56136466|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
56136467|NCT03531918|Cladribine|cladribine|mesh-list
56136468|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
56136469|NCT03531918|Calicheamicins|calicheamicins|mesh-list
56136471|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136472|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
56136473|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230738|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56230739|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230740|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230741|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56230742|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
56230743|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230744|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56230745|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
56230746|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
56230747|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56230748|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230749|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56230750|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56230751|NCT01707407|Analgesics|analgesics|mesh-ancestor
56230752|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
56230753|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230754|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56230755|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56230756|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56230757|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56230758|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56136474|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136475|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
56136476|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136477|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136478|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
56136479|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136480|NCT03531918|Analgesics|analgesics|mesh-ancestor
56136481|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
56136482|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136483|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56136484|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56136485|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136486|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56136487|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136488|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56136489|NCT00389532|Vaccines|vaccines|mesh-list
56136490|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
55751048|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56136492|NCT03520686|Paclitaxel|paclitaxel|mesh-list
56136493|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56136494|NCT03520686|Cisplatin|cisplatin|mesh-list
56136495|NCT03520686|Carboplatin|carboplatin|mesh-list
56136496|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
56136497|NCT03520686|Pemetrexed|pemetrexed|mesh-list
56136498|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56136499|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136500|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
56136501|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
56136502|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
56136503|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136504|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56230759|NCT01707407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56230760|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56230761|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230762|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
56230763|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56230764|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
56230765|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56230766|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56230767|NCT01707537|Vaccines|vaccines|mesh-list
56230768|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
55751092|NCT03335501|Pancrelipase|pancrelipase|mesh-list
56230769|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230770|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
56230771|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
56230772|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230773|NCT01707615|Protective Agents|protective agents|mesh-ancestor
56230774|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230775|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56230776|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56230777|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230778|NCT01707732|Enoxaparin|enoxaparin|mesh-list
56230779|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
56230780|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56230781|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56230782|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230783|NCT01707745|Bevacizumab|bevacizumab|mesh-list
56230784|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56230785|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230786|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56230787|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56230788|NCT01707745|Growth Substances|growth substances|mesh-ancestor
56230789|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230790|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
56230791|NCT01707823|Aspirin|aspirin|mesh-list
56230792|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56230797|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230798|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56230799|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56230800|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56230801|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56230802|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230803|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56230804|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56230805|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230806|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
56230807|NCT01707849|Everolimus|everolimus|mesh-list
56230808|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136505|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136506|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56136507|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56136508|NCT01957956|Temozolomide|temozolomide|mesh-list
56136509|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56136510|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
56136511|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136512|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136513|NCT00475878|Citalopram|citalopram|mesh-list
56136514|NCT00475878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56136515|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56136516|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56136517|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136518|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136519|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
56136520|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751210|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136521|NCT00475878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56136522|NCT00475878|Antidepressive Agents|antidepressive agents|mesh-ancestor
56136523|NCT00475878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56136524|NCT01795170|Pyridoxine|pyridoxine|mesh-list
56136525|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
56136526|NCT01795170|Vitamins|vitamins|mesh-ancestor
56136527|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
56136528|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136529|NCT00477204|Simvastatin|simvastatin|mesh-list
56136530|NCT00477204|Ezetimibe|ezetimibe|mesh-list
56136531|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56136532|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56136533|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56136534|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
56136535|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136536|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56136537|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56136538|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136539|NCT00528450|Idarubicin|idarubicin|mesh-list
56136540|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
56136541|NCT00528450|Tretinoin|tretinoin|mesh-list
56136542|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56136543|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136544|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56136545|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56136546|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136547|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136548|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
56136549|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136550|NCT00478218|Dexamethasone|dexamethasone|mesh-list
56136551|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
56136552|NCT00478218|Lenalidomide|lenalidomide|mesh-list
56136553|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136554|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
56230809|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56230810|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
56230811|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230812|NCT01707940|Ketoconazole|ketoconazole|mesh-list
56230813|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
56230814|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230815|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56230816|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56230817|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230818|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230819|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56230820|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
56230821|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230822|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230823|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56230824|NCT01707953|Midodrine|midodrine|mesh-list
56230825|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
56230826|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
55751243|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56230827|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230828|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230829|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56230830|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56230831|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56230832|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56230833|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
56230834|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230835|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230836|NCT01708005|Vitamin D|vitamin d|mesh-list
56230837|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
56230838|NCT01708005|Vitamins|vitamins|mesh-ancestor
56136555|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136556|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136557|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56136558|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
56136559|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136560|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136561|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55751268|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136562|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136563|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
56136564|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
56136567|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
56136568|NCT00478218|Hormones|hormones|mesh-ancestor
56230839|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
56230840|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230841|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56230842|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56230843|NCT01708044|Pramlintide|pramlintide|mesh-list
56230844|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56230845|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230846|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
56230847|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56230848|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56230849|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230850|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
56230851|NCT01708239|Coagulants|coagulants|mesh-ancestor
56230852|NCT01708330|Lidocaine|lidocaine|mesh-list
56230853|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
55751322|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230854|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
56230855|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230856|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230857|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
56230858|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230859|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56230860|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56230861|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56230862|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56230863|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230864|NCT01708369|Aspirin|aspirin|mesh-list
56230865|NCT01708369|Ethanol|ethanol|mesh-list
56230866|NCT01708369|Oseltamivir|oseltamivir|mesh-list
56230867|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56230868|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56230869|NCT01708369|Analgesics|analgesics|mesh-ancestor
56230881|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
56230882|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56230883|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56230884|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230885|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
56230886|NCT01708447|Lidocaine|lidocaine|mesh-list
56230887|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
56230888|NCT01708447|Anesthetics|anesthetics|mesh-list
56230889|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136569|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136570|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56136571|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56136572|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56136573|NCT00478218|Growth Substances|growth substances|mesh-ancestor
56136574|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
56136575|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
56136576|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56136577|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56136578|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56136579|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56136580|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136581|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
56136582|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136583|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136584|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56136585|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136586|NCT04270656|Insulin|insulin|mesh-list
56136587|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56136588|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136589|NCT00424554|Temozolomide|temozolomide|mesh-list
56136590|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56136591|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
56136592|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136593|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136594|NCT00425802|Cyclosporine|cyclosporine|mesh-list
56136595|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
55751355|NCT03333083|Lamivudine|lamivudine|mesh-list
56136596|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
56136597|NCT00425802|Rituximab|rituximab|mesh-list
56136598|NCT00425802|Fludarabine|fludarabine|mesh-list
56136599|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
56136600|NCT00425802|Cyclosporins|cyclosporins|mesh-list
56136601|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56136602|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136603|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
56136604|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136605|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136606|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56136607|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
56136608|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136609|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136610|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56136611|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136612|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136613|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
56136614|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136615|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
56136616|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136617|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136618|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56136619|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55863517|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136620|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56136621|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
55751400|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56136622|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56136623|NCT00530634|Gemcitabine|gemcitabine|mesh-list
56136624|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230890|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230891|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
56230892|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230893|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56230894|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56230895|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56230896|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56230897|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230898|NCT01708616|Risperidone|risperidone|mesh-list
56230899|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56230900|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
56230901|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230902|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136625|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136626|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
56136627|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136628|NCT00530634|Antiviral Agents|antiviral agents|mesh-ancestor
56136629|NCT00530634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136630|NCT00530634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136631|NCT00530634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136632|NCT00530634|Immunologic Factors|immunologic factors|mesh-ancestor
56136633|NCT00530634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136634|NCT00531882|Pioglitazone|pioglitazone|mesh-list
56136635|NCT00531882|Ibuprofen|ibuprofen|mesh-list
55751447|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56136636|NCT00531882|Simvastatin|simvastatin|mesh-list
56136639|NCT00531882|Analgesics|analgesics|mesh-ancestor
56136640|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
56136641|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136642|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136643|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136644|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136645|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56136646|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136647|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136648|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56136649|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56136650|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
56136651|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56136652|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56136653|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56136654|NCT00428298|Valacyclovir|valacyclovir|mesh-list
56136655|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
56136656|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136657|NCT00486018|Ranibizumab|ranibizumab|mesh-list
56136658|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56136659|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56136660|NCT00486018|Growth Substances|growth substances|mesh-ancestor
56136661|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136662|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
56136663|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136664|NCT00486642|Bicalutamide|bicalutamide|mesh-list
56136665|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
56136666|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
55751497|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
56136667|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136668|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136669|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136670|NCT00428922|Bevacizumab|bevacizumab|mesh-list
56136671|NCT00428922|Trastuzumab|trastuzumab|mesh-list
56136672|NCT00428922|Docetaxel|docetaxel|mesh-list
56230903|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230904|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56230905|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56230906|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751545|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55751546|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230907|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56230908|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56230909|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
56230910|NCT01708642|Epinephrine|epinephrine|mesh-list
56230911|NCT01708642|Racepinephrine|racepinephrine|mesh-list
56230912|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
56230913|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56230914|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56230915|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
56136673|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136674|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136675|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56136676|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56136677|NCT00428922|Growth Substances|growth substances|mesh-ancestor
56136678|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136679|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
56136680|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
56136681|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
56136682|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
56136683|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136684|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
56136685|NCT00533442|Sirolimus|sirolimus|mesh-list
56136686|NCT00533442|Tacrolimus|tacrolimus|mesh-list
56136687|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136688|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
56136689|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136690|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56136691|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136692|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136693|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55863599|NCT03831334|Minoxidil|minoxidil|mesh-list
56136694|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136695|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56136697|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55751609|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55751610|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
55751611|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
55751613|NCT05008029|Anesthetics|anesthetics|mesh-list
56136698|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136699|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
56136700|NCT00533910|Rifaximin|rifaximin|mesh-list
56136701|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56136702|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136703|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136704|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
56136705|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
56136706|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56136707|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56136708|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136709|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136714|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136715|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136716|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56136717|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56136718|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56136719|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
56136720|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136721|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136722|NCT00535002|Urological Agents|urological agents|mesh-ancestor
56136723|NCT02117934|Vaccines|vaccines|mesh-list
56136724|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
56136725|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230916|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56230917|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230918|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230919|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56230920|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56230921|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
56230922|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230923|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56230924|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
56230925|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
56230926|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
56230927|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56230928|NCT01708707|Morphine|morphine|mesh-list
56230929|NCT01708707|Buprenorphine|buprenorphine|mesh-list
56230930|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56230931|NCT01708707|Narcotics|narcotics|mesh-ancestor
56230932|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136726|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
56136727|NCT00429702|Promethazine|promethazine|mesh-list
56136728|NCT00429702|Dexamethasone|dexamethasone|mesh-list
56136729|NCT00429702|Lorazepam|lorazepam|mesh-list
56136731|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136732|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
56136733|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
56136734|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136735|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136736|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136737|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
56136738|NCT00429702|Hormones|hormones|mesh-ancestor
56136739|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136740|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56136741|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136742|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136743|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
56136744|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136745|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56136746|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
56136747|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136748|NCT00429702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56136749|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56136750|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136751|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56136752|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56136753|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56136754|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56136755|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
56136756|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
56136757|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
56136758|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56136759|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
56136760|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
56136761|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56136762|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
56136763|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
56136764|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
56136765|NCT00535392|Levetiracetam|levetiracetam|mesh-list
56136766|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
56136767|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
56136768|NCT00535782|Methotrexate|methotrexate|mesh-list
55863666|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
56230933|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230934|NCT01708707|Analgesics|analgesics|mesh-ancestor
56230935|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
56230936|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230937|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56230938|NCT01708720|Vaccines|vaccines|mesh-list
56230939|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
56230940|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230941|NCT01708798|Eplerenone|eplerenone|mesh-list
56230942|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56230943|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
56230944|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56230945|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230946|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55751808|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751809|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
56230947|NCT01708798|Diuretics|diuretics|mesh-ancestor
56230948|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
56230949|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56230950|NCT01708837|Propofol|propofol|mesh-list
56230951|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56230952|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56230953|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230954|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56230955|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
56230956|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
56230957|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
56230958|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56230959|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
56230960|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56230961|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
56230962|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230980|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56230981|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56230982|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56230984|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
56230985|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56230986|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56230987|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56230988|NCT01708876|Filaricides|filaricides|mesh-ancestor
56230989|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
56230990|NCT01708993|Docetaxel|docetaxel|mesh-list
56230991|NCT01708993|Pemetrexed|pemetrexed|mesh-list
56230992|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56230993|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56230994|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
56230995|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56230996|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56230997|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56230998|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56230999|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56231000|NCT01709019|Vaccines|vaccines|mesh-list
56231001|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
56231002|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231003|NCT01709071|Vaccines|vaccines|mesh-list
56231004|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
56231005|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231006|NCT01709292|Vemurafenib|vemurafenib|mesh-list
56231007|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231008|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56231009|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751914|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56231010|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231011|NCT01709370|Letrozole|letrozole|mesh-list
56231012|NCT01709370|Palbociclib|palbociclib|mesh-list
56231013|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231014|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56136769|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56136770|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
56136771|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56136772|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136773|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136774|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
56231015|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56231016|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231017|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231018|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56231019|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
56231020|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56231021|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231022|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56231023|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
56231024|NCT01709630|Analgesics|analgesics|mesh-ancestor
56231025|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
56231026|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231027|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231028|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
56231029|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231030|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55751961|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231031|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
56231032|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56231033|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231034|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231035|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56231036|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
56231037|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231038|NCT01709656|Celecoxib|celecoxib|mesh-list
56231039|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56231040|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56231041|NCT01709656|Analgesics|analgesics|mesh-ancestor
56231042|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
56231043|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231044|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231045|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231046|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56231047|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56231048|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56231050|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231052|NCT01709682|Sotalol|sotalol|mesh-list
56231053|NCT01709682|Flecainide|flecainide|mesh-list
56231054|NCT01709682|Propafenone|propafenone|mesh-list
56136775|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136776|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136777|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136778|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136779|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56136780|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136781|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
56136782|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136785|NCT00431184|Lorazepam|lorazepam|mesh-list
56136786|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
56136787|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
56136788|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
56136789|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136790|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136791|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136792|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56136793|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136794|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56136795|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56136796|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56136797|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
56136798|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
56136799|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136800|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136801|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56136802|NCT00431184|Narcotics|narcotics|mesh-ancestor
56136803|NCT00431184|Analgesics|analgesics|mesh-ancestor
56136804|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
56136805|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56136806|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56136807|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
56136808|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56136809|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56136810|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56136811|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56136812|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136814|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136815|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136816|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56136817|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136818|NCT01795794|Omeprazole|omeprazole|mesh-list
56136819|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56136820|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136821|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56136822|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136823|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136824|NCT01796028|Metformin|metformin|mesh-list
56136825|NCT01796028|Docetaxel|docetaxel|mesh-list
56136826|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56136827|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752044|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
56136828|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136829|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
56136830|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
56136831|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
56136832|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136833|NCT00491244|Interferons|interferons|mesh-list
56136834|NCT00491244|Ribavirin|ribavirin|mesh-list
56136835|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
56136836|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
56136837|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56136838|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136839|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
56136840|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136841|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
56136842|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136843|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
56136844|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231055|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56231056|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
56231057|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56231058|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231059|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231060|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56231061|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56231062|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56231063|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231064|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56231065|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56231066|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56231067|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56231068|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56231069|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
56231070|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231071|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231072|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
56231073|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
56231074|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231075|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56231076|NCT01709760|Methotrexate|methotrexate|mesh-list
56231077|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56231078|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
56231079|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231080|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231081|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56231082|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
56231083|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231084|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231085|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
56231092|NCT01709825|Sulfalene|sulfalene|mesh-list
56231093|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231094|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56231096|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
56231097|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56231098|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56231099|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
55752174|NCT03221569|Ketorolac|ketorolac|mesh-list
56231100|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56231101|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231102|NCT01709942|Cetrorelix|cetrorelix|mesh-list
56231103|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56231104|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
56231105|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231106|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231107|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
56231108|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56231109|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
56231110|NCT01709955|Cathartics|cathartics|mesh-ancestor
56231111|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231112|NCT01709994|Aspirin|aspirin|mesh-list
55863742|NCT01743560|Everolimus|everolimus|mesh-list
56136845|NCT00492336|Rasagiline|rasagiline|mesh-list
56136846|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56136848|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136849|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56136850|NCT00492336|Protective Agents|protective agents|mesh-ancestor
56136851|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136852|NCT00538434|Reslizumab|reslizumab|mesh-list
56136853|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56136854|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
56136855|NCT00538824|Thalidomide|thalidomide|mesh-list
56136856|NCT00538824|Dexamethasone|dexamethasone|mesh-list
56136857|NCT00538824|Lenalidomide|lenalidomide|mesh-list
56136858|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136862|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136864|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
56136865|NCT00538824|Hormones|hormones|mesh-ancestor
56136866|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136867|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55752192|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752194|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136868|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136869|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
56136870|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56136871|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56136872|NCT00538824|Growth Substances|growth substances|mesh-ancestor
56136873|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
56136874|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136875|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
56136876|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56136877|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136878|NCT00539526|Bimatoprost|bimatoprost|mesh-list
56136879|NCT00539526|Travoprost|travoprost|mesh-list
56136880|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56136881|NCT00539526|Latanoprost|latanoprost|mesh-list
56136882|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56136883|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56136884|NCT01796106|Fluorides|fluorides|mesh-list
56136885|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
56136886|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
56231113|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56231114|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56231115|NCT01709994|Analgesics|analgesics|mesh-ancestor
56231116|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
56231117|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806757|NCT05478785|Cisplatin|cisplatin|mesh-list
56136887|NCT01796106|Protective Agents|protective agents|mesh-ancestor
55752236|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
56136888|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136889|NCT00541242|Bimatoprost|bimatoprost|mesh-list
56136890|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56136891|NCT00541242|Latanoprost|latanoprost|mesh-list
56136892|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56136893|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56136894|NCT00438204|Gemcitabine|gemcitabine|mesh-list
56136895|NCT00438204|Bevacizumab|bevacizumab|mesh-list
56136896|NCT00438204|Pemetrexed|pemetrexed|mesh-list
56136897|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136898|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136899|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56136900|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56136901|NCT00438204|Growth Substances|growth substances|mesh-ancestor
56136902|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136903|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
56136904|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136905|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
56136906|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136907|NCT00438204|Antiviral Agents|antiviral agents|mesh-ancestor
56136908|NCT00438204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136909|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136910|NCT00438204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136911|NCT00438204|Immunologic Factors|immunologic factors|mesh-ancestor
56136912|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56136913|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56136914|NCT00439296|Cytarabine|cytarabine|mesh-list
56136915|NCT00439296|Dexamethasone|dexamethasone|mesh-list
56136916|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
56136917|NCT00439296|Doxorubicin|doxorubicin|mesh-list
56136918|NCT00439296|Methotrexate|methotrexate|mesh-list
56136919|NCT00439296|Asparaginase|asparaginase|mesh-list
56136920|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
55863819|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
56136921|NCT00439296|Thioguanine|thioguanine|mesh-list
56136922|NCT00439296|Pegaspargase|pegaspargase|mesh-list
56136923|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56136924|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
56136925|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136926|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56136927|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56136928|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
56136929|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136930|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136931|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56136932|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56136934|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
56136935|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136936|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136937|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
56136938|NCT00439296|Hormones|hormones|mesh-ancestor
56136939|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136940|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56136941|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56136942|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56136943|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56136944|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56136945|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56136946|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
56136947|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56136948|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56136949|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
56136950|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
56136951|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56231118|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231119|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231120|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56231121|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56231122|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56231123|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231124|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56231125|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56231126|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231127|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
56136952|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56136953|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
56136954|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56136955|NCT03117660|Vitamin A|vitamin a|mesh-list
55752294|NCT04493099|Growth Substances|growth substances|mesh-ancestor
55752295|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136956|NCT03117660|Vitamins|vitamins|mesh-ancestor
56136957|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
56136958|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136959|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56136960|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56136961|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56136962|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
56136963|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56136964|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136965|NCT00439374|Progestins|progestins|mesh-ancestor
56136966|NCT00439374|Hormones|hormones|mesh-ancestor
56136967|NCT00439608|Paclitaxel|paclitaxel|mesh-list
56136968|NCT00439608|Carboplatin|carboplatin|mesh-list
56136969|NCT00439608|Cetuximab|cetuximab|mesh-list
56136970|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56136971|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136972|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
56136973|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
56136974|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
56136975|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136976|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136977|NCT04750122|Carboplatin|carboplatin|mesh-list
56136978|NCT04750122|Docetaxel|docetaxel|mesh-list
56136979|NCT04750122|Trastuzumab|trastuzumab|mesh-list
56136980|NCT04750122|Pertuzumab|pertuzumab|mesh-list
56136981|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136982|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
56136983|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
56136984|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
56136985|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136986|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56136987|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56136988|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56136989|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56136990|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56136991|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56136992|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56136993|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136994|NCT00443352|Analgesics|analgesics|mesh-ancestor
56136995|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
56136996|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136997|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
55863889|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56136999|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
56137000|NCT00445302|Plerixafor|plerixafor|mesh-list
56137001|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56137002|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56137003|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
56137004|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137005|NCT00504504|Rituximab|rituximab|mesh-list
56137006|NCT00504504|Doxorubicin|doxorubicin|mesh-list
56231128|NCT01710007|Atorvastatin|atorvastatin|mesh-list
56231129|NCT01710007|Pitavastatin|pitavastatin|mesh-list
56231130|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56231131|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56231132|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
56231133|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231134|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56231135|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56231136|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231137|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
56231138|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
56231139|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231140|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231141|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231142|NCT01710072|Aspirin|aspirin|mesh-list
56231143|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56231144|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56231145|NCT01710072|Analgesics|analgesics|mesh-ancestor
56231146|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
56231147|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231148|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231149|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231150|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56231151|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56231152|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56231153|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231154|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56231155|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56231156|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231157|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
56231158|NCT01710163|Aripiprazole|aripiprazole|mesh-list
56137007|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56137012|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137013|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
56137014|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137015|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56137016|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56137017|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56137018|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56137019|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137020|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231160|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56231161|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56231162|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56231163|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231164|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231165|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
56231166|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
56231167|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231168|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231169|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56231170|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56231171|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
56231172|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56231173|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56137021|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56137022|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
55752440|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137023|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56137024|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
56137025|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
56137026|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
56137027|NCT00504660|Celecoxib|celecoxib|mesh-list
56137028|NCT00504660|Capecitabine|capecitabine|mesh-list
56137029|NCT00504660|Thioguanine|thioguanine|mesh-list
56137030|NCT00504660|Temozolomide|temozolomide|mesh-list
56137031|NCT00504660|Lomustine|lomustine|mesh-list
56137032|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137033|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
56137034|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137035|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137036|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56137037|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
56137038|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56137039|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56137040|NCT00504660|Analgesics|analgesics|mesh-ancestor
56137041|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
56137042|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137043|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137044|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56137045|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56137046|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56137047|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56137048|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137049|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
56137051|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137052|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56137053|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137054|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137055|NCT00447330|Bevacizumab|bevacizumab|mesh-list
56137056|NCT00447330|Capecitabine|capecitabine|mesh-list
56137057|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
56137058|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137059|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137060|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56137061|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56137062|NCT00447330|Growth Substances|growth substances|mesh-ancestor
56137063|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137064|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
56231174|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56231176|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
56231177|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231178|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
56231179|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56231180|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56231181|NCT01710228|Prednisolone|prednisolone|mesh-list
56231182|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
56231183|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56231184|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
56231185|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231186|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
56231187|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
56231188|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231189|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231190|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231191|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
56231192|NCT01710228|Hormones|hormones|mesh-ancestor
56231193|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56231194|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56231195|NCT01710228|Protective Agents|protective agents|mesh-ancestor
56231196|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56231197|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231198|NCT01710384|Betamethasone|betamethasone|mesh-list
56231199|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231200|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
56231201|NCT01710384|Hormones|hormones|mesh-ancestor
56231202|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56231203|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231204|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56231205|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
56231206|NCT01710462|Domperidone|domperidone|mesh-list
56231207|NCT01710462|Pantoprazole|pantoprazole|mesh-list
56231216|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231217|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56231218|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
56231219|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231221|NCT01710488|Ofloxacin|ofloxacin|mesh-list
56231222|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
56231223|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56231224|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231225|NCT01710488|Renal Agents|renal agents|mesh-ancestor
56231226|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56231227|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55752513|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56137065|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137066|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
56137067|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137068|NCT02115048|Letrozole|letrozole|mesh-list
56137069|NCT02115048|Afatinib|afatinib|mesh-list
56137070|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137071|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55863965|NCT02151994|Zamicastat|zamicastat|mesh-list
56137072|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55752559|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
56137073|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137074|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137075|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56137076|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
56137077|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137078|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137082|NCT00546156|Bevacizumab|bevacizumab|mesh-list
56137083|NCT00546156|Doxorubicin|doxorubicin|mesh-list
56137084|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56137085|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137086|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
56137087|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
56137088|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
56137089|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137090|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137091|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
56137092|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137093|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56137094|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56137095|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
56137096|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56137097|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137098|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56137099|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56137100|NCT00546156|Growth Substances|growth substances|mesh-ancestor
56137101|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
56137102|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56137103|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56137104|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56137105|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137106|NCT00449046|Fluticasone|fluticasone|mesh-list
56137107|NCT00449046|Xhance|xhance|mesh-list
56137108|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56137109|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56137110|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56137111|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
56137112|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752619|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
56137113|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137114|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56137115|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
56137116|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
56137117|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56231228|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56231229|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231230|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231231|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231232|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56231233|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56231234|NCT01710540|Metformin|metformin|mesh-list
56231235|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56231236|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231237|NCT01710553|Metformin|metformin|mesh-list
56231238|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56231239|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231240|NCT01710566|Misoprostol|misoprostol|mesh-list
56137118|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56137119|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56137120|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56137121|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
56137122|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137123|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137125|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137126|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137127|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
56137128|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137129|NCT00509496|Aldesleukin|aldesleukin|mesh-list
56137130|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
56137131|NCT00509496|Fludarabine|fludarabine|mesh-list
56137132|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
56137133|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137134|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
56137135|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137136|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56137137|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56137138|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
56137139|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137140|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137141|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56137142|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137144|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56137145|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56137146|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
56137147|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137148|NCT00548418|Bevacizumab|bevacizumab|mesh-list
56137150|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137151|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137152|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56137153|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56137155|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137156|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
55752654|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56137157|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56137158|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56137159|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137160|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137161|NCT00511992|Paclitaxel|paclitaxel|mesh-list
56137162|NCT00511992|Bevacizumab|bevacizumab|mesh-list
56137163|NCT00511992|Cisplatin|cisplatin|mesh-list
56137164|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56137165|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137166|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56137167|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56137168|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56231241|NCT01710566|Oxytocin|oxytocin|mesh-list
56231242|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
56231243|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231244|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231245|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56231246|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
56231247|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56231248|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231249|NCT01710592|Docetaxel|docetaxel|mesh-list
56231250|NCT01710592|Capecitabine|capecitabine|mesh-list
56231251|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
56231252|NCT01710592|Epirubicin|epirubicin|mesh-list
56231253|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231254|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
56231255|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
56231256|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
56231257|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231258|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56231259|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
56231260|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56231261|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56231262|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56231263|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231264|NCT01710631|Eszopiclone|eszopiclone|mesh-list
55780327|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
56231265|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56231266|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231267|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231268|NCT01710670|Ethanol|ethanol|mesh-list
56231269|NCT01710670|Brivaracetam|brivaracetam|mesh-list
56231289|NCT01710722|Caffeine|caffeine|mesh-list
56231290|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56231291|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231292|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56231293|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231294|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231295|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56231296|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56231297|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
56231298|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231299|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
56231300|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
56231301|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231302|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56231303|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
55752720|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231304|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56231305|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56231306|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
56231307|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
56231308|NCT01710748|Everolimus|everolimus|mesh-list
56137169|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137170|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137171|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56137172|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56137173|NCT00511992|Growth Substances|growth substances|mesh-ancestor
56137174|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137175|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
56137176|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
56137177|NCT00451698|Hematinics|hematinics|mesh-ancestor
56137178|NCT00549042|Hydromorphone|hydromorphone|mesh-list
56137179|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56137180|NCT00549042|Narcotics|narcotics|mesh-ancestor
56137181|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56137182|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137183|NCT00549042|Analgesics|analgesics|mesh-ancestor
56137184|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
56137185|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137186|NCT00452868|Donepezil|donepezil|mesh-list
56137187|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56137188|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137189|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137190|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
55752777|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56137191|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752778|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137192|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137194|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56137195|NCT00453336|Trioxsalen|trioxsalen|mesh-list
56137196|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137197|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
56137198|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56137199|NCT00549822|Letrozole|letrozole|mesh-list
56137200|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137201|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56137202|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56137203|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231309|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231310|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56231311|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
56231312|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231313|NCT01710761|Caffeine|caffeine|mesh-list
56231314|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56231315|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231316|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56231317|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231318|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231319|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56231320|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56231321|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
56231322|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231323|NCT01710904|Oxycodone|oxycodone|mesh-list
56231324|NCT01710904|Naloxone|naloxone|mesh-list
56231325|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56231326|NCT01710904|Narcotics|narcotics|mesh-ancestor
56231327|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231328|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231329|NCT01710904|Analgesics|analgesics|mesh-ancestor
56231330|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
56231331|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231332|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56231333|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56231334|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56231335|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231336|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231338|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
56231339|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231340|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231341|NCT01711073|Plerixafor|plerixafor|mesh-list
56231342|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56231343|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56231344|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
56231347|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56231348|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
56231349|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231350|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231351|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56231352|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
56231353|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56231354|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56231355|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56231356|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
56231357|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231358|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231359|NCT01711112|Docetaxel|docetaxel|mesh-list
56231360|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231361|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
56231362|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
56231363|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
56231364|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231365|NCT01711125|Baclofen|baclofen|mesh-list
56231366|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55752883|NCT03316469|Enclomiphene|enclomiphene|mesh-list
55752884|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
56231367|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231368|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56231369|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231370|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56231371|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
56231372|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
56137204|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137205|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56137206|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
56137207|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137208|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137209|NCT00550290|Cefazolin|cefazolin|mesh-list
56137210|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56137211|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137212|NCT01797198|Repaglinide|repaglinide|mesh-list
56137213|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
56137214|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56137215|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137216|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56137217|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
56137218|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137219|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56137220|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56137221|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56137222|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137223|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
56137224|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55752972|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231373|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231374|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231375|NCT01711229|Acetaminophen|acetaminophen|mesh-list
56231376|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56231377|NCT01711229|Analgesics|analgesics|mesh-ancestor
55752975|NCT02484209|Metformin|metformin|mesh-list
56231378|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
56231379|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231380|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231381|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
56231382|NCT01711320|Omeprazole|omeprazole|mesh-list
55807016|NCT02327013|Vortioxetine|vortioxetine|mesh-list
56137225|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
56137226|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137227|NCT00552786|Expectorants|expectorants|mesh-ancestor
56137228|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
56137229|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56137230|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
56137231|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137232|NCT00552786|Protective Agents|protective agents|mesh-ancestor
56137233|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137234|NCT00552786|Antidotes|antidotes|mesh-ancestor
56137235|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
56137236|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137237|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137238|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56137239|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56137240|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137241|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137242|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
56137243|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137244|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137245|NCT00553098|Cyclosporine|cyclosporine|mesh-list
56137246|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
56137247|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56137248|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
56137249|NCT00553098|Fludarabine|fludarabine|mesh-list
56137250|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
56137252|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
56137253|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56137254|NCT00553098|Cyclosporins|cyclosporins|mesh-list
56137255|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
56137256|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137257|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137258|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137259|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
55753039|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56137260|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137261|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137262|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137263|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
56137264|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137265|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
56137266|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56137267|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56137268|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56137269|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56137270|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
56137271|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56137273|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137274|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56137275|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56137276|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137277|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137278|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56137279|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
56231383|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56231384|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231385|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56231386|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231387|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231388|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
56231389|NCT01711437|Simethicone|simethicone|mesh-list
56231390|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
56231391|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
56231392|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56231393|NCT01711437|Citric Acid|citric acid|mesh-list
56231394|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
56231395|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56231396|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
56231397|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56231398|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
56231399|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
55753076|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
56231400|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231401|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
56231402|NCT01711437|Protective Agents|protective agents|mesh-ancestor
56231403|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231404|NCT01711437|Vitamins|vitamins|mesh-ancestor
56231405|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
56137280|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137281|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137282|NCT00554970|Budesonide|budesonide|mesh-list
56137283|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56137284|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56137285|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
55797969|NCT02577029|Tenofovir|tenofovir|mesh-list
56137286|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137287|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137288|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56137289|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
56137290|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
56137291|NCT00554970|Hormones|hormones|mesh-ancestor
56137292|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137293|NCT00524472|Insulin|insulin|mesh-list
56137294|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56137295|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56137296|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137297|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
56137298|NCT00555048|Busulfan|busulfan|mesh-list
56137299|NCT00555048|Methotrexate|methotrexate|mesh-list
56137300|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
56137301|NCT00555048|Tacrolimus|tacrolimus|mesh-list
56137302|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137303|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
56137304|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137305|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753111|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55753112|NCT05429489|Narcotics|narcotics|mesh-ancestor
55753115|NCT05429489|Analgesics|analgesics|mesh-ancestor
56137306|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56137307|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
56137309|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137310|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56137311|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56137312|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
56231406|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
56231407|NCT01711437|Emollients|emollients|mesh-ancestor
56231408|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
56231409|NCT01711437|Cathartics|cathartics|mesh-ancestor
56231410|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231411|NCT01711437|Antacids|antacids|mesh-ancestor
56231412|NCT01711437|Laxatives|laxatives|mesh-ancestor
56231413|NCT01711463|Fluticasone|fluticasone|mesh-list
56231414|NCT01711463|Xhance|xhance|mesh-list
56231415|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231416|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56231417|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
56231418|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231419|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231420|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56231421|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
56231422|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
56231423|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56231424|NCT01711476|Complement Factor H|complement factor h|mesh-list
56231425|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56231426|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56231427|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
55753155|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56231428|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231429|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
55753156|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231430|NCT01711489|Isavuconazole|isavuconazole|mesh-list
56231431|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56231432|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231433|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56231434|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
56231435|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56231436|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137313|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56137314|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137315|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
56137316|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
56137317|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137318|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56137319|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56137320|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56137321|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137323|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
56137324|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56137325|NCT00525798|Katacalcin|katacalcin|mesh-list
56137326|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56137327|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231437|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231438|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231439|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
56231441|NCT01711515|Ipilimumab|ipilimumab|mesh-list
56231442|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231443|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56231444|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56231445|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231446|NCT01711528|Dexamethasone|dexamethasone|mesh-list
55807083|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
56137328|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56137329|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
56137330|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
56137331|NCT00525876|Rituximab|rituximab|mesh-list
56137332|NCT00525876|Fludarabine|fludarabine|mesh-list
56137333|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
56137334|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
56137335|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137336|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
56137337|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137338|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56137339|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56137340|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
56137341|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137342|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753251|NCT03199261|Exenatide|exenatide|mesh-list
56137343|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56137344|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137345|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137346|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
56137347|NCT00555750|Eszopiclone|eszopiclone|mesh-list
56137348|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56137349|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56137350|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137351|NCT00556140|Aripiprazole|aripiprazole|mesh-list
56137352|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
56137353|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56137354|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56137355|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56137356|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56137357|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137358|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
56137359|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
56137360|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137361|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137362|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56137363|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56137364|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
56137365|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56137366|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56137367|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56137368|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56137370|NCT00527124|Docetaxel|docetaxel|mesh-list
56137371|NCT00527124|Cediranib|cediranib|mesh-list
56137372|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137373|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
56137374|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
56137375|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
56137376|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137377|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56137378|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
56137379|NCT00527124|Hormones|hormones|mesh-ancestor
56137380|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56231447|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
56231448|NCT01711528|Bortezomib|bortezomib|mesh-list
56231449|NCT01711528|Ichthammol|ichthammol|mesh-list
56231450|NCT01711528|BB 1101|bb 1101|mesh-list
56231451|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231452|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
56231453|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
56231454|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753369|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
56231455|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231456|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231457|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
56231459|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56231460|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56231461|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231462|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
56231463|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231464|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231465|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
56231466|NCT01711567|Tenofovir|tenofovir|mesh-list
56231467|NCT01711567|Entecavir|entecavir|mesh-list
56231468|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
56231469|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231470|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56231471|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56231472|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231473|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231474|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56231475|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56231476|NCT01711593|Dimercaprol|dimercaprol|mesh-list
56231477|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
56231478|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
56231479|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231480|NCT01711671|Dexamethasone|dexamethasone|mesh-list
56231481|NCT01711671|Lenalidomide|lenalidomide|mesh-list
56231482|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231483|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
56231484|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
55807087|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231485|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231486|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231487|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231488|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
56231489|NCT01711671|Hormones|hormones|mesh-ancestor
56231490|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56231491|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56231492|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753418|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
56231493|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
56137382|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56137383|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137384|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56137386|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56137387|NCT00527592|Latanoprost|latanoprost|mesh-list
56137388|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56137389|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56137390|NCT00556452|Busulfan|busulfan|mesh-list
56137391|NCT00556452|Clofarabine|clofarabine|mesh-list
56137392|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
56137393|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137394|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137395|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
56137396|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137397|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56137398|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137399|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56137400|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137401|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
56137402|NCT03158376|Gabapentin|gabapentin|mesh-list
56137403|NCT03158376|Analgesics|analgesics|mesh-ancestor
56137404|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
56137405|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137406|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137407|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
56137408|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56137409|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56137410|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753456|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55753457|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137411|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56137412|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56137413|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56137414|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137415|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137416|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
56137417|NCT01797900|Paclitaxel|paclitaxel|mesh-list
56137418|NCT01797900|Cisplatin|cisplatin|mesh-list
56137419|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56137420|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137421|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
56137422|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
56137423|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
56137424|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137425|NCT03572790|Prucalopride|prucalopride|mesh-list
56137426|NCT03572790|Laxatives|laxatives|mesh-ancestor
56137427|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56137428|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56137429|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56137430|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
56137431|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137432|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137433|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137434|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
56137435|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137436|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137437|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56137438|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231494|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56231495|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56231496|NCT01711671|Growth Substances|growth substances|mesh-ancestor
55753570|NCT02449603|Incretins|incretins|mesh-ancestor
56231497|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
56231498|NCT01711697|Paclitaxel|paclitaxel|mesh-list
56231499|NCT01711697|Carboplatin|carboplatin|mesh-list
56231500|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56231501|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231502|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
56231503|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
56231504|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
56231505|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231506|NCT01711723|Darapladib|darapladib|mesh-list
56231507|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56231508|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231509|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231510|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56231511|NCT01711749|Calcium|calcium|mesh-list
56231512|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56231513|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231514|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56231515|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56231516|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
56231517|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231518|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56231519|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56231520|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231521|NCT01711814|Peficitinib|peficitinib|mesh-list
56231522|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231523|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231528|NCT01711827|Prednisone|prednisone|mesh-list
56231536|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
55753623|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753624|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
55753625|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231537|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231538|NCT01711905|Vitamin D|vitamin d|mesh-list
56231539|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
56231540|NCT01711905|Vitamins|vitamins|mesh-ancestor
56231541|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
56231542|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231543|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56231544|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56231545|NCT01711931|Everolimus|everolimus|mesh-list
56231546|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231547|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56231548|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
56137439|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
56137440|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55753666|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55753667|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56137441|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137442|NCT02319486|Carboplatin|carboplatin|mesh-list
56137443|NCT02319486|Etoposide|etoposide|mesh-list
56137444|NCT02319486|Vincristine|vincristine|mesh-list
56137445|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137446|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56137447|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56137448|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56137449|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137450|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137451|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
56137452|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
56137453|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
56137454|NCT03117972|Leucovorin|leucovorin|mesh-list
56137457|NCT03117972|Capecitabine|capecitabine|mesh-list
56137458|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
56137459|NCT03117972|Irinotecan|irinotecan|mesh-list
56137460|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
55753727|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55753728|NCT02477267|Naloxone|naloxone|mesh-list
55753729|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55753730|NCT02477267|Narcotics|narcotics|mesh-ancestor
56137461|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137462|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137463|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56137464|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56137465|NCT03117972|Growth Substances|growth substances|mesh-ancestor
56137466|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137467|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
56137468|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
56137469|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137470|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137471|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137472|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
55753783|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56137473|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56137474|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56137475|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137476|NCT03117972|Antidotes|antidotes|mesh-ancestor
56137477|NCT03117972|Protective Agents|protective agents|mesh-ancestor
56137478|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
56137479|NCT03117972|Vitamins|vitamins|mesh-ancestor
56137480|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
56137481|NCT05622162|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
56137482|NCT05622162|18F-JK-PSMA-7|18f-jk-psma-7|mesh-list
56137483|NCT05622162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137484|NCT01330446|Modafinil|modafinil|mesh-list
56137485|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56137486|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137487|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56137488|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56137489|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56137490|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231549|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231550|NCT01711957|Liver Extracts|liver extracts|mesh-list
56231551|NCT01711957|Hematinics|hematinics|mesh-ancestor
56231552|NCT01711970|Paclitaxel|paclitaxel|mesh-list
56231553|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56231554|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231555|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
55753846|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
56231556|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
56231557|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
56231558|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231559|NCT01712100|Irbesartan|irbesartan|mesh-list
56231560|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56231561|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56231562|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56231563|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231564|NCT01712113|Irbesartan|irbesartan|mesh-list
56231565|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56231566|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56231567|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56231568|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231569|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56231570|NCT01712126|Irbesartan|irbesartan|mesh-list
56231571|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56231572|NCT01712126|Diuretics|diuretics|mesh-ancestor
56231573|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
56231574|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753897|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231575|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56231576|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231577|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231578|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56231579|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56231580|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56231581|NCT01712139|Irbesartan|irbesartan|mesh-list
56231582|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56137492|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
56137493|NCT00558012|Calcium|calcium|mesh-list
56137494|NCT00558012|Vitamins|vitamins|mesh-ancestor
56137495|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
56231584|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
56231585|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231586|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55753957|NCT02475317|Volixibat|volixibat|mesh-list
56231587|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231588|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231589|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56231590|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56231591|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
56231592|NCT01712295|Salicylates|salicylates|mesh-list
56231593|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56231594|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56231595|NCT01712295|Analgesics|analgesics|mesh-ancestor
56231596|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
56231597|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231598|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231599|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231600|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56231601|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56231602|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754009|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56231603|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231604|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231605|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
56231606|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
56231607|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
56231608|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56231609|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
56231610|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56231611|NCT01712321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56231612|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56137496|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137497|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56137498|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56137499|NCT00561834|Ranibizumab|ranibizumab|mesh-list
56137500|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55754065|NCT04983849|Metronidazole|metronidazole|mesh-list
55754066|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754067|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56137501|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56137502|NCT00561834|Growth Substances|growth substances|mesh-ancestor
56231613|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231614|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231615|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231616|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
56231617|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231618|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56231619|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56231620|NCT01712347|Bevacizumab|bevacizumab|mesh-list
56231621|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56231622|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231623|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56231624|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56231625|NCT01712347|Growth Substances|growth substances|mesh-ancestor
56231626|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231627|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
56231628|NCT01712464|Oxytocin|oxytocin|mesh-list
55754123|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754124|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754125|NCT04359017|Lidocaine|lidocaine|mesh-list
55754126|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
55754127|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
55754128|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754129|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231629|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
56231630|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231631|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231632|NCT01712477|Midazolam|midazolam|mesh-list
56231633|NCT01712477|Propofol|propofol|mesh-list
56231634|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56231635|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231636|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231637|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56231638|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
56231639|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
56231640|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56231641|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56231642|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56231643|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56231644|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
56231645|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
56231646|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231653|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231654|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231655|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231656|NCT01712646|Oxytocin|oxytocin|mesh-list
56231657|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
56231658|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231659|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231660|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
56231661|NCT01712828|Promethazine|promethazine|mesh-list
56231662|NCT01712828|Sirolimus|sirolimus|mesh-list
56137503|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137504|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
56137505|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137506|NCT04388202|Citalopram|citalopram|mesh-list
56137507|NCT04388202|Sertraline|sertraline|mesh-list
56137508|NCT04388202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56137509|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56137510|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137511|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137512|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137513|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
56137514|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137515|NCT04388202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56137516|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
56137517|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56137518|NCT02128230|Thalidomide|thalidomide|mesh-list
56137519|NCT02128230|Dexamethasone|dexamethasone|mesh-list
56137520|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
56137521|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
56137522|NCT02128230|Melphalan|melphalan|mesh-list
56137547|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137549|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
56137550|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137551|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56137552|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56137553|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56137554|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56137555|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56137556|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56137557|NCT02128230|Growth Substances|growth substances|mesh-ancestor
56137558|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
56137559|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
56137560|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55754221|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
56231664|NCT01712828|Lenalidomide|lenalidomide|mesh-list
56231665|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
56231666|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231667|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56231668|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56231669|NCT01712828|Growth Substances|growth substances|mesh-ancestor
56231670|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
56231671|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231672|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56231673|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231674|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56231675|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
56231676|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56231677|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56231678|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56231679|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231680|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
56231681|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
56231682|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
56231683|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231684|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
56231685|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
56231686|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55807309|NCT05447065|Vitamin D|vitamin d|mesh-list
56137561|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137562|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56137563|NCT03416244|Nivolumab|nivolumab|mesh-list
56137564|NCT03416244|Ipilimumab|ipilimumab|mesh-list
56137565|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137566|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137567|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56137568|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137569|NCT05560620|Caffeine|caffeine|mesh-list
56137570|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56137571|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137572|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56137573|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137574|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137575|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56137576|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56137577|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
56137578|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137579|NCT04388124|Bosentan|bosentan|mesh-list
56137580|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56137581|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56137582|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137583|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
56137584|NCT03172416|Nivolumab|nivolumab|mesh-list
56231687|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56144965|NCT00830076|Metformin|metformin|mesh-list
56231688|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
56231690|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231691|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231692|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56231693|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
56231694|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
56231695|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56231696|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56231697|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
56231698|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56231699|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
56231700|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56231701|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56231702|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137585|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137586|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137587|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55754302|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
56137588|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137589|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
56137590|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56137591|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
56137592|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137593|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
56137594|NCT05559996|Protective Agents|protective agents|mesh-ancestor
56137595|NCT02812212|Diuretics|diuretics|mesh-list
56137596|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
56137597|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137598|NCT05559450|Blinatumomab|blinatumomab|mesh-list
56137599|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864497|NCT00824746|Gefitinib|gefitinib|mesh-list
56137600|NCT05615844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56137602|NCT00564954|Methylphenidate|methylphenidate|mesh-list
56137603|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
55754368|NCT03308357|Infliximab|infliximab|mesh-list
56137604|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56137605|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137606|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56137607|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56137608|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137609|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137610|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
56137611|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137612|NCT00565266|Beclomethasone|beclomethasone|mesh-list
56137613|NCT00565266|Bromides|bromides|mesh-list
56137614|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
56137615|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56137616|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56137617|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
56137618|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137619|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137620|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56137621|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
56137622|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
56137623|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56137624|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
56137625|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890362|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56137626|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231703|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56231704|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56231705|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
56231706|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56231707|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56231708|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231709|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56231710|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56231712|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56231713|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231714|NCT01712919|Paclitaxel|paclitaxel|mesh-list
56231715|NCT01712919|Cetuximab|cetuximab|mesh-list
56231716|NCT01712919|Nedaplatin|nedaplatin|mesh-list
56231717|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56231718|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231719|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
56231720|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
56231721|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
56231722|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231723|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56231724|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
56231725|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56231726|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137627|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56137628|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56137629|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56137630|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
56137631|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
56137632|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56137633|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
56137634|NCT00565266|Hormones|hormones|mesh-ancestor
56137635|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137636|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55754471|NCT03311789|Antiviral Agents|antiviral agents|mesh-ancestor
56137637|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
56137638|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56137639|NCT01797978|Methylene Blue|methylene blue|mesh-list
56137640|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137641|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137642|NCT05363202|Fluticasone|fluticasone|mesh-list
56137644|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56137645|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56137646|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
56137647|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137648|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137649|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56137650|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
56137651|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
56137652|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56137653|NCT05461092|Morphine|morphine|mesh-list
56137654|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
56231727|NCT01712997|Bosentan|bosentan|mesh-list
56231728|NCT01712997|Iloprost|iloprost|mesh-list
56231729|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56231730|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56231731|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231732|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56231733|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
56231734|NCT01713049|Alovudine|alovudine|mesh-list
56231735|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
55754512|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231736|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231737|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
56137655|NCT05461092|Bupivacaine|bupivacaine|mesh-list
56137656|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
56137657|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
56137658|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56137659|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137660|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
56137661|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137662|NCT05461092|Narcotics|narcotics|mesh-ancestor
56137663|NCT05461092|Analgesics|analgesics|mesh-ancestor
56137664|NCT02129478|Olanzapine|olanzapine|mesh-list
56137665|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
56137666|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
56137667|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137668|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137669|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56137670|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56137671|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56137672|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56137673|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56137674|NCT02129478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56137675|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56137679|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
56137680|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
56137681|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137682|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137683|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
56137684|NCT05362500|Glycolic acid|glycolic acid|mesh-list
56137685|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
56137686|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56137687|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56137688|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137689|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
56137690|NCT05362500|Coagulants|coagulants|mesh-ancestor
56137691|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
56137692|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56137693|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56137694|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137695|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56137696|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56137697|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56137698|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137699|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
56137700|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
56137701|NCT05161806|Aflibercept|aflibercept|mesh-list
56137702|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56137703|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56137705|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137706|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
56137707|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754564|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137708|NCT05362188|Niacinamide|niacinamide|mesh-list
56145018|NCT00834210|Dapsone|dapsone|mesh-list
56137711|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
56137713|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
56137714|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231738|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
56231739|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
56231740|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56231741|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231742|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
56231743|NCT01713101|Coagulants|coagulants|mesh-ancestor
56231744|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
56231745|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56231746|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56231747|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231748|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56231749|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56231750|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231751|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231752|NCT01713127|Remifentanil|remifentanil|mesh-list
56231753|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56231754|NCT01713127|Narcotics|narcotics|mesh-ancestor
56231755|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231756|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231757|NCT01713127|Analgesics|analgesics|mesh-ancestor
56231758|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
56231759|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231760|NCT01713153|Misoprostol|misoprostol|mesh-list
56137715|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56137716|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
56137717|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137718|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56137719|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
56137720|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
56137721|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137722|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137723|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
56137725|NCT05353374|Emollients|emollients|mesh-ancestor
56137726|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
56137727|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56137728|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137729|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56137730|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137731|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137732|NCT05214222|Paclitaxel|paclitaxel|mesh-list
56137733|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56137734|NCT05214222|Cisplatin|cisplatin|mesh-list
56137735|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56137736|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137737|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
56137738|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
56137739|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
56137740|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137741|NCT05290740|Norepinephrine|norepinephrine|mesh-list
56137742|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56231761|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56231762|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
55754587|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55754588|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754589|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754590|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754591|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231763|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56145021|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
56231764|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231765|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56231766|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56231768|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
56137743|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56137744|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56137745|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137746|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137747|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137748|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
56137749|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
56137750|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137751|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55864635|NCT01700179|Ribavirin|ribavirin|mesh-list
56137752|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
56137755|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137756|NCT05198232|Protective Agents|protective agents|mesh-ancestor
56137757|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137758|NCT05198232|Antacids|antacids|mesh-ancestor
56137759|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56137760|NCT04747236|Gemcitabine|gemcitabine|mesh-list
56137761|NCT04747236|Azacitidine|azacitidine|mesh-list
56137762|NCT04747236|Romidepsin|romidepsin|mesh-list
56137763|NCT04747236|Belinostat|belinostat|mesh-list
56137764|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137765|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
55890363|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55754602|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754603|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754604|NCT03303209|Analgesics|analgesics|mesh-ancestor
55754605|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
55754606|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754607|NCT03303053|Prednisolone|prednisolone|mesh-list
55754608|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
55754609|NCT03303053|Carbimazole|carbimazole|mesh-list
55754610|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55754611|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
55754612|NCT03303053|Hormones|hormones|mesh-ancestor
55754613|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754614|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754615|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55754624|NCT02467907|Paclitaxel|paclitaxel|mesh-list
56137766|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137767|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137768|NCT04747236|Antiviral Agents|antiviral agents|mesh-ancestor
56137769|NCT04747236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137770|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137771|NCT04747236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137772|NCT04747236|Immunologic Factors|immunologic factors|mesh-ancestor
56137773|NCT04747236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137774|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56137775|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56137776|NCT01797666|Pioglitazone|pioglitazone|mesh-list
56137777|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56137778|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137779|NCT05017194|Emodepside|emodepside|mesh-list
56137780|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56137781|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137782|NCT04501380|Rifamycins|rifamycins|mesh-list
56137783|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
56137784|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56137785|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137786|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56137787|NCT04465734|Sorafenib|sorafenib|mesh-list
56137788|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137789|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56137790|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137791|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137792|NCT03869034|Leucovorin|leucovorin|mesh-list
56137793|NCT03869034|Fluorouracil|fluorouracil|mesh-list
56137794|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
56137795|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
56137796|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137797|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56137798|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137799|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137800|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
56137801|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137802|NCT03869034|Antidotes|antidotes|mesh-ancestor
56137803|NCT03869034|Protective Agents|protective agents|mesh-ancestor
56231770|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56231773|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
56231774|NCT01713218|Gemcitabine|gemcitabine|mesh-list
56231775|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56231776|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
56231777|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231778|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231779|NCT01713218|Antiviral Agents|antiviral agents|mesh-ancestor
56231780|NCT01713218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231781|NCT01713218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231782|NCT01713218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56231783|NCT01713218|Immunologic Factors|immunologic factors|mesh-ancestor
56231784|NCT01713218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231785|NCT01713231|Vitamin D|vitamin d|mesh-list
56231786|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
56231787|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
56231788|NCT01713231|Vitamins|vitamins|mesh-list
56231789|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
56231790|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231791|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56231792|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56231793|NCT01713309|Lenograstim|lenograstim|mesh-list
56231794|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56231795|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
56231796|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754634|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56231797|NCT01713361|Enoxaparin|enoxaparin|mesh-list
56231798|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
56231799|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56231800|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56231801|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231802|NCT01713387|Gemcitabine|gemcitabine|mesh-list
56231803|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56231812|NCT01713387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231813|NCT01713426|Pregabalin|pregabalin|mesh-list
56231814|NCT01713426|Capsaicin|capsaicin|mesh-list
56231815|NCT01713426|Analgesics|analgesics|mesh-ancestor
56231816|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
56231817|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231818|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231819|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
56231820|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56231821|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231822|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231823|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56137804|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
56137805|NCT03869034|Vitamins|vitamins|mesh-ancestor
56137806|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
56137807|NCT03856632|Liraglutide|liraglutide|mesh-list
56137808|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56137809|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56137810|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137811|NCT03856632|Incretins|incretins|mesh-ancestor
56137812|NCT03856632|Hormones|hormones|mesh-ancestor
56137813|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137814|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
56137815|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
56137816|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137817|NCT04286178|Vitamins|vitamins|mesh-ancestor
56137818|NCT04655976|Docetaxel|docetaxel|mesh-list
56137819|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137820|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
56137821|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
56137822|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
56137823|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137824|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
56137825|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
56137826|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137827|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56137828|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56137829|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
56137831|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137833|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56137834|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56137835|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56137836|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
56137837|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754648|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
55754652|NCT05727761|Metformin|metformin|mesh-list
56137838|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56137839|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56137840|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137842|NCT02783430|Milnacipran|milnacipran|mesh-list
56137843|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
56137844|NCT02783430|Analgesics|analgesics|mesh-ancestor
56137845|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
56137846|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137847|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137848|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56137849|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56137850|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
56137851|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
56137852|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56137853|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56137854|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56137855|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231824|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56231825|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56231826|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231827|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56231829|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
56231830|NCT01713556|Propranolol|propranolol|mesh-list
56231831|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56231832|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56231833|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
56231834|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231835|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231836|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231837|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56231838|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56231839|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
56231840|NCT01713647|Losartan|losartan|mesh-list
56231841|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56231842|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56231843|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55754671|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56231844|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56231845|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231846|NCT01713725|Omalizumab|omalizumab|mesh-list
56231847|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56231848|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56231849|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
56137856|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137857|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56137858|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56137859|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137860|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56137861|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
56137862|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56137863|NCT03642366|Tadalafil|tadalafil|mesh-list
56137864|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
56137865|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56137866|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56137867|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137868|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137869|NCT03642366|Urological Agents|urological agents|mesh-ancestor
56137870|NCT00604968|Doxorubicin|doxorubicin|mesh-list
56137871|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56137872|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56137873|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137874|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56137875|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56137876|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231850|NCT01713738|Rituximab|rituximab|mesh-list
56231851|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56231852|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231853|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
56231854|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231855|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56231856|NCT01713777|Lamotrigine|lamotrigine|mesh-list
56231857|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
56231858|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56231859|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231860|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231861|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56231862|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231863|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56231864|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55807495|NCT05415709|Paclitaxel|paclitaxel|mesh-list
56137877|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137878|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56137879|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56137880|NCT00605202|Diuretics|diuretics|mesh-ancestor
55754712|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754713|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754714|NCT03302039|Protective Agents|protective agents|mesh-ancestor
55754715|NCT02721875|Azacitidine|azacitidine|mesh-list
55754716|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55754717|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
55754722|NCT02466503|Xhance|xhance|mesh-list
56137881|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
56137882|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137883|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56137884|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137885|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137886|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56137887|NCT03548454|Desipramine|desipramine|mesh-list
56137888|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56137889|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56137890|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137891|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137892|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137893|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137895|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
56137896|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137897|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
56137898|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56137899|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
56137901|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137902|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56137903|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56137904|NCT00605904|Acamprosate|acamprosate|mesh-list
56137906|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56137907|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
56137908|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
56137909|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137910|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137911|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56137912|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56137913|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56137914|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754740|NCT03301181|Rifampin|rifampin|mesh-list
56137915|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137916|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137917|NCT00605904|Urological Agents|urological agents|mesh-ancestor
56137918|NCT00606138|Ranibizumab|ranibizumab|mesh-list
56231865|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231866|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56231867|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56231868|NCT01713803|Buprenorphine|buprenorphine|mesh-list
56231869|NCT01713803|Naloxone|naloxone|mesh-list
56231870|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56231871|NCT01713803|Narcotics|narcotics|mesh-ancestor
56231872|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231873|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231874|NCT01713803|Analgesics|analgesics|mesh-ancestor
56231875|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
56231876|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231877|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56231878|NCT01713920|Amlodipine|amlodipine|mesh-list
56231879|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56231880|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56231881|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56231882|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231883|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56231884|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231885|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
56231886|NCT01713972|Dabrafenib|dabrafenib|mesh-list
56231887|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231888|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56231889|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231890|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231891|NCT01714011|Aripiprazole|aripiprazole|mesh-list
56231892|NCT01714011|Ziprasidone|ziprasidone|mesh-list
56231893|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
56231894|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56231895|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56231896|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56231897|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56231898|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231899|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
56231900|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
55807505|NCT04262843|Vidarabine|vidarabine|mesh-list
56145100|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
56137919|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56231901|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56231902|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231903|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56231904|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56231905|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
56231906|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56231907|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56231908|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56231909|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56231910|NCT01714037|Gemcitabine|gemcitabine|mesh-list
56231911|NCT01714037|Docetaxel|docetaxel|mesh-list
56231912|NCT01714037|Pemetrexed|pemetrexed|mesh-list
56231913|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231914|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56231915|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
56231916|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231917|NCT01714037|Antiviral Agents|antiviral agents|mesh-ancestor
56231918|NCT01714037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231919|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231920|NCT01714037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56231921|NCT01714037|Immunologic Factors|immunologic factors|mesh-ancestor
56231922|NCT01714037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754819|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
56231923|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
56231924|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
56231925|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
56231926|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56231927|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56231928|NCT01714089|Interferons|interferons|mesh-list
56231929|NCT01714089|Interferon-beta|interferon-beta|mesh-list
56231930|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
56231931|NCT01714089|RNS60|rns60|mesh-list
56231932|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231933|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
56137920|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56137921|NCT00606138|Growth Substances|growth substances|mesh-ancestor
56137922|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137923|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
56137924|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137925|NCT01798914|Insulin|insulin|mesh-list
56137926|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56137927|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137928|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
56231934|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231935|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
56231936|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231937|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56231938|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56231939|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56231940|NCT01714089|Analgesics|analgesics|mesh-ancestor
56231941|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
56231942|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231943|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56231944|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56231945|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56231946|NCT01714102|Resveratrol|resveratrol|mesh-list
56231947|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
56231948|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807571|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
55807582|NCT02543801|Ketorolac|ketorolac|mesh-list
56137929|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56137930|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56145112|NCT00849810|Metoprolol|metoprolol|mesh-list
56137931|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56137932|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137933|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137934|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
56137935|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137936|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137937|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56137938|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56137939|NCT05175768|Niacinamide|niacinamide|mesh-list
56137941|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
56137942|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
56137943|NCT05175768|Vitamins|vitamins|mesh-ancestor
56137944|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
56137945|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137946|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56137947|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
56137948|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754902|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56137949|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56137950|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
56137951|NCT05097846|Amoxicillin|amoxicillin|mesh-list
56137952|NCT05097846|Doxycycline|doxycycline|mesh-list
56137953|NCT05097846|Furazolidone|furazolidone|mesh-list
56137954|NCT05097846|Esomeprazole|esomeprazole|mesh-list
56137955|NCT05097846|Bismuth|bismuth|mesh-list
56137956|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56137957|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137958|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56137959|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56137960|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56137961|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754953|NCT03299621|Rocuronium|rocuronium|mesh-list
55754954|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56137962|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137963|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
56137964|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56137965|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56137966|NCT05097846|Antacids|antacids|mesh-ancestor
56137967|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56137968|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56137969|NCT05097846|Renal Agents|renal agents|mesh-ancestor
56137970|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56231950|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231951|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231952|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56231953|NCT01714115|Aflibercept|aflibercept|mesh-list
56231954|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56231955|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56231956|NCT01714115|Growth Substances|growth substances|mesh-ancestor
56231957|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231958|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
56231959|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56231960|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56231961|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56231963|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56137971|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56137972|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
56137973|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56137974|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56137975|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137976|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56137977|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56137979|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56137980|NCT03018366|Progesterone|progesterone|mesh-list
56137981|NCT03018366|Estrogens|estrogens|mesh-ancestor
56137982|NCT03018366|Hormones|hormones|mesh-ancestor
56137983|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56137984|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137985|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56137986|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
56137987|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56137988|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56137989|NCT03018366|Progestins|progestins|mesh-ancestor
56137990|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
56137991|NCT02897700|Doxorubicin|doxorubicin|mesh-list
56137992|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56137993|NCT02897700|Fluorouracil|fluorouracil|mesh-list
56137994|NCT02897700|Methotrexate|methotrexate|mesh-list
56137995|NCT02897700|Epirubicin|epirubicin|mesh-list
56137996|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137997|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
56137998|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137999|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56138000|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56138001|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
56138002|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138003|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138004|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56138005|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56138006|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56138007|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56138008|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138009|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
56138010|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138011|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56138012|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
56138013|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56138014|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
56231965|NCT01714128|Hormones|hormones|mesh-ancestor
56231966|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145140|NCT00858468|Vaccines|vaccines|mesh-list
56231967|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231968|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56231970|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231971|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56231972|NCT01714154|Ritonavir|ritonavir|mesh-list
56231973|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56231974|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56231975|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
55755066|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56231976|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231977|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231978|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56231979|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56231980|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
56231981|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56231982|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56231983|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56231984|NCT01714193|Canagliflozin|canagliflozin|mesh-list
56138015|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56138016|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56138017|NCT02889666|Gemcitabine|gemcitabine|mesh-list
56138018|NCT02889666|Cisplatin|cisplatin|mesh-list
56138019|NCT02889666|Carboplatin|carboplatin|mesh-list
56138020|NCT02889666|Docetaxel|docetaxel|mesh-list
56138021|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
56138022|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138023|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138024|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
56138025|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138026|NCT02889666|Antiviral Agents|antiviral agents|mesh-ancestor
56138027|NCT02889666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138028|NCT02889666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138029|NCT02889666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138030|NCT02889666|Immunologic Factors|immunologic factors|mesh-ancestor
56138031|NCT02889666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138032|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
56138033|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
56138034|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
56138035|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56138036|NCT00609804|Sorafenib|sorafenib|mesh-list
55755094|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138037|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138038|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56138039|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138040|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138041|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
56138042|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
56138043|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
56138044|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138045|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138046|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56138047|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56231985|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
56231986|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
56231987|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56231988|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56231989|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56231990|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231991|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56138048|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56138049|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138050|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56138052|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
56138053|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138054|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138055|NCT02446236|Rituximab|rituximab|mesh-list
56138056|NCT02446236|Lenalidomide|lenalidomide|mesh-list
56138057|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138058|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138059|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
56138060|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138061|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56138062|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56138063|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56138064|NCT02446236|Growth Substances|growth substances|mesh-ancestor
56138065|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
56138066|NCT00610740|Gemcitabine|gemcitabine|mesh-list
56138067|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138068|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
56138069|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138070|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138071|NCT00610740|Antiviral Agents|antiviral agents|mesh-ancestor
56138072|NCT00610740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138073|NCT00610740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138074|NCT00610740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138075|NCT00610740|Immunologic Factors|immunologic factors|mesh-ancestor
56138076|NCT00610740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138077|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56138078|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56138079|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
56138080|NCT00611442|Lubiprostone|lubiprostone|mesh-list
56138081|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56138082|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56138083|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138084|NCT02136420|Promethazine|promethazine|mesh-list
56138085|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
56138086|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
55755141|NCT05546411|Antidotes|antidotes|mesh-ancestor
56138087|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
56138088|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56138089|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
56138090|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
56138091|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138092|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138093|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138094|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56138095|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56138096|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56145188|NCT00869622|Vitamin D|vitamin d|mesh-list
56138097|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138098|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
56138099|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
56138100|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
56138101|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138102|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
56138103|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
56138104|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56138105|NCT02136498|Varenicline|varenicline|mesh-list
56138106|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56138107|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56138108|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
56231992|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56231993|NCT01714206|Canagliflozin|canagliflozin|mesh-list
56231994|NCT01714206|Digoxin|digoxin|mesh-list
56231995|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56231996|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56231997|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56231998|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56231999|NCT01714206|Protective Agents|protective agents|mesh-ancestor
56232000|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232001|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56232002|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56232003|NCT01714297|Dalteparin|dalteparin|mesh-list
55755157|NCT03069027|Racepinephrine|racepinephrine|mesh-list
56232004|NCT01714297|Tinzaparin|tinzaparin|mesh-list
56232005|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56232006|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
56232007|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56232008|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55807629|NCT02481635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138109|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138110|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138111|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138112|NCT00612222|Aldesleukin|aldesleukin|mesh-list
56138113|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
56138114|NCT00612222|Fludarabine|fludarabine|mesh-list
56138115|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
56138116|NCT00612222|Interleukin-2|interleukin-2|mesh-list
56138117|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138118|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
56138119|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138120|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56138121|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56138122|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
56138123|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138124|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138125|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56138128|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56138129|NCT00612222|Analgesics|analgesics|mesh-ancestor
56138130|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
56138131|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138132|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56138133|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56138134|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
56138135|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138136|NCT01711242|Capecitabine|capecitabine|mesh-list
56138137|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
56138138|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138139|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
56138140|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138141|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138142|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56138143|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
56138144|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
56138145|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56138146|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
56145202|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
56138147|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138149|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138150|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56138151|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56232009|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232011|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56232012|NCT01714388|Narcotics|narcotics|mesh-ancestor
56232013|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232014|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232015|NCT01714388|Analgesics|analgesics|mesh-ancestor
56232016|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
56232017|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232019|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56232020|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
56232021|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232022|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232023|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56232024|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
56232025|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
55755196|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232026|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56232027|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56232028|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56232029|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56232030|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
56232031|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232032|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232033|NCT01714414|Lamivudine|lamivudine|mesh-list
56232034|NCT01714414|Zidovudine|zidovudine|mesh-list
56232035|NCT01714414|Efavirenz|efavirenz|mesh-list
56232036|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55807647|NCT05411159|Narcotics|narcotics|mesh-ancestor
56138153|NCT04304274|Ropivacaine|ropivacaine|mesh-list
56138154|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56138155|NCT04304274|Narcotics|narcotics|mesh-ancestor
56138156|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138157|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138158|NCT04304274|Analgesics|analgesics|mesh-ancestor
56138159|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
56138160|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138161|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
56138162|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
56138163|NCT02132832|Buspirone|buspirone|mesh-list
56138164|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56138165|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56138166|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138167|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138168|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56138169|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56232037|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56232038|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232039|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232040|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
56232041|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232042|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56232043|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56232044|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
56232045|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56232046|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56232047|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56232048|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56232049|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56232050|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56232051|NCT01714427|Dexamethasone|dexamethasone|mesh-list
56232052|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56232053|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
56232054|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
56232055|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232056|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755209|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755210|NCT04552197|Tofacitinib|tofacitinib|mesh-list
55755211|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55755212|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755213|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232057|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56232058|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
56232060|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56232061|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56232062|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232063|NCT01714557|Tazobactam|tazobactam|mesh-list
56232064|NCT01714557|Piperacillin|piperacillin|mesh-list
56232065|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56232066|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56232067|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232068|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56232069|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232070|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232071|NCT01714570|Tazobactam|tazobactam|mesh-list
56232074|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56232075|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56232076|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232077|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56232078|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232079|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232080|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56232081|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232082|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56232083|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
56138170|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
56138171|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138172|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138174|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56138175|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56138176|NCT00614406|Analgesics|analgesics|mesh-ancestor
56138177|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
56138178|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138179|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138180|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56138181|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56138182|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56138183|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56138184|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138185|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138186|NCT00614484|Paclitaxel|paclitaxel|mesh-list
56138187|NCT00614484|Carboplatin|carboplatin|mesh-list
56138188|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56138189|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138190|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
56138191|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
56138192|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
56138193|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138195|NCT04159974|Tremelimumab|tremelimumab|mesh-list
56138196|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138197|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138198|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
56138199|NCT04142502|Propofol|propofol|mesh-list
56138200|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56138201|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138202|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138204|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
56138205|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
56138206|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56138207|NCT04142502|Analgesics|analgesics|mesh-ancestor
56138208|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
56138209|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138210|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56138211|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56138212|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56138213|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
56138214|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138215|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138216|NCT00569010|Cytarabine|cytarabine|mesh-list
56138217|NCT00569010|Azacitidine|azacitidine|mesh-list
56138218|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138219|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
56138220|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138222|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
56138223|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138224|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138225|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
56232084|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56232085|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
56232086|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56232087|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232088|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56232089|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56232090|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138226|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138227|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138228|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
56138229|NCT00616122|Methotrexate|methotrexate|mesh-list
56138230|NCT00616122|Sunitinib|sunitinib|mesh-list
56138231|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138232|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
56138233|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138234|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55755334|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
56138235|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56138236|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
56138237|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138238|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138239|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56138240|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56138241|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
56138242|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56138243|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138244|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
56138245|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
56138246|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138247|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56138249|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56138250|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56138251|NCT00616122|Growth Substances|growth substances|mesh-ancestor
56138252|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
56138253|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56138254|NCT00617058|Metformin|metformin|mesh-list
56138255|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56138256|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138257|NCT00618540|Fludarabine|fludarabine|mesh-list
56138258|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
56138259|NCT00618540|Melphalan|melphalan|mesh-list
56138260|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
56138261|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138262|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138263|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
56138264|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138265|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138266|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
56138267|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138268|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56138269|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
56138270|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56138271|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138272|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
56138273|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56138274|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138275|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138277|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56138278|NCT00570960|Dextrans|dextrans|mesh-list
56138279|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
56138280|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
56138281|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
56138282|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56138283|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
56138284|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56232092|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232093|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232094|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
56232095|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232096|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
56232098|NCT01714817|Abatacept|abatacept|mesh-list
56232099|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56232100|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
56232101|NCT01714817|Hormones|hormones|mesh-ancestor
56232102|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56232103|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232104|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56232105|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232106|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56232107|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56232108|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
56232109|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56232110|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232111|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232112|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232113|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56232114|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232115|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
56232116|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232117|NCT01714843|Linaclotide|linaclotide|mesh-list
56232118|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56138285|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
56138286|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138287|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138288|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56138289|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
56138290|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56138291|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56138292|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56138293|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
56138294|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138295|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138296|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56138297|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56138298|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
56138299|NCT00574236|Doxorubicin|doxorubicin|mesh-list
56138300|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56138301|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138302|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56232119|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
56232120|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232121|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56232123|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56232124|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56232125|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
56232126|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
56232127|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232128|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232129|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232130|NCT01714895|Insulin|insulin|mesh-list
56232131|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56232132|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56232133|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232134|NCT01714908|Etoposide|etoposide|mesh-list
56232135|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56232136|NCT01714908|Cisplatin|cisplatin|mesh-list
56232137|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56232138|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232139|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56232140|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56232141|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232142|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232143|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56232144|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56232145|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56232146|NCT01715077|Ipilimumab|ipilimumab|mesh-list
56232147|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56232148|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232149|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56232150|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232151|NCT01715090|Insulin|insulin|mesh-list
56232152|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56232153|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755442|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
56232154|NCT01715142|Gemcitabine|gemcitabine|mesh-list
56232155|NCT01715142|Paclitaxel|paclitaxel|mesh-list
56138303|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55755445|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
56232156|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56232157|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56232158|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232159|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
56232160|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
56232161|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
56232162|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232163|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56232164|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
56232166|NCT01715142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232167|NCT01715142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232168|NCT01715142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232169|NCT01715142|Immunologic Factors|immunologic factors|mesh-ancestor
56232170|NCT01715142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232171|NCT01715168|Doxorubicin|doxorubicin|mesh-list
56232172|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56232173|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56232174|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232175|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56232176|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56232177|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232178|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232179|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
56232180|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
56232181|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
56232182|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232183|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56232184|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232185|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232186|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
56232187|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56232188|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232189|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56232190|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
56138304|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232191|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56232192|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
56232193|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232194|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232195|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56232196|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
56232197|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
56232198|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56232199|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
56232200|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232201|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232202|NCT01715363|Leucovorin|leucovorin|mesh-list
56232203|NCT01715363|Folic Acid|folic acid|mesh-list
56232204|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
56232205|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
56232206|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232207|NCT01715363|Antidotes|antidotes|mesh-ancestor
56232208|NCT01715363|Protective Agents|protective agents|mesh-ancestor
56232209|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232210|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
56232211|NCT01715363|Vitamins|vitamins|mesh-ancestor
56232212|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
56232213|NCT01715363|Hematinics|hematinics|mesh-ancestor
56232214|NCT01715441|Irinotecan|irinotecan|mesh-list
56232215|NCT01715441|Sorafenib|sorafenib|mesh-list
56232216|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56232217|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56232218|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232219|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807828|NCT05004805|Methylene Blue|methylene blue|mesh-list
56138305|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138306|NCT00574548|Vaccines|vaccines|mesh-list
56138307|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56138308|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
56138309|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138310|NCT01168219|Methotrexate|methotrexate|mesh-list
56138311|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
55755542|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56138313|NCT01168219|Fludarabine|fludarabine|mesh-list
56138314|NCT01168219|Busulfan|busulfan|mesh-list
56138315|NCT01168219|Tacrolimus|tacrolimus|mesh-list
56138316|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56138317|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56138318|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
56138319|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56138320|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232220|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232221|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56232223|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232224|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56232225|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
56232226|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56232227|NCT01715519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55807854|NCT03929029|Nivolumab|nivolumab|mesh-list
56138321|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138322|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
56138323|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138324|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138325|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
56138326|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138327|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56138328|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138329|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
56138330|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56138331|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56138332|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56138333|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
56138334|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56138335|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56138336|NCT01115803|Everolimus|everolimus|mesh-list
56138337|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56138338|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138339|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138340|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
56138341|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138342|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56138343|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138344|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138345|NCT01115569|Hydrocodone|hydrocodone|mesh-list
56138346|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56138347|NCT01115569|Narcotics|narcotics|mesh-ancestor
56138348|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138349|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138367|NCT05767008|Sunscreening Agents|sunscreening agents|mesh-list
56138368|NCT05767008|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56138369|NCT05767008|Protective Agents|protective agents|mesh-ancestor
56138370|NCT05767008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138371|NCT05767008|Dermatologic Agents|dermatologic agents|mesh-ancestor
56138383|NCT05766670|Gentamicins|gentamicins|mesh-list
56138384|NCT05766670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56138385|NCT05766670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138386|NCT05766670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56138387|NCT05766670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138388|NCT05766670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138390|NCT05766631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56138391|NCT05766631|Narcotics|narcotics|mesh-ancestor
56138392|NCT05766631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138393|NCT05766631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138394|NCT05766631|Analgesics|analgesics|mesh-ancestor
56138395|NCT05766631|Sensory System Agents|sensory system agents|mesh-ancestor
56138396|NCT05766631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138397|NCT05766631|Antitussive Agents|antitussive agents|mesh-ancestor
56138398|NCT05766631|Respiratory System Agents|respiratory system agents|mesh-ancestor
56138399|NCT05766605|Leucovorin|leucovorin|mesh-list
56138400|NCT05766605|Doxorubicin|doxorubicin|mesh-list
56138401|NCT05766605|Fluorouracil|fluorouracil|mesh-list
56138402|NCT05766605|Oxaliplatin|oxaliplatin|mesh-list
56138403|NCT05766605|Raltitrexed|raltitrexed|mesh-list
56138404|NCT05766605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138405|NCT05766605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56138406|NCT05766605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56138407|NCT05766605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56232228|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56232229|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232230|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232231|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232232|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
56232233|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232234|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56232235|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56232236|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
56232237|NCT01715584|Sevoflurane|sevoflurane|mesh-list
56232238|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56232239|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56232240|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
56232241|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
56232242|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232243|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232244|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56232245|NCT01715584|Analgesics|analgesics|mesh-ancestor
56232246|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
56232247|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232248|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
56232249|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
55807861|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56138408|NCT05766605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138409|NCT05766605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138410|NCT05766605|Antimetabolites|antimetabolites|mesh-ancestor
56138411|NCT05766605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138412|NCT05766605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138413|NCT05766605|Immunologic Factors|immunologic factors|mesh-ancestor
56138414|NCT05766605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138415|NCT05766605|Antidotes|antidotes|mesh-ancestor
56138416|NCT05766605|Protective Agents|protective agents|mesh-ancestor
56138417|NCT05766605|Vitamin B Complex|vitamin b complex|mesh-ancestor
56138418|NCT05766605|Vitamins|vitamins|mesh-ancestor
56138420|NCT05766605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56138421|NCT05766553|Nicotine|nicotine|mesh-list
56138422|NCT05766553|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56138423|NCT05766553|Autonomic Agents|autonomic agents|mesh-ancestor
56138424|NCT05766553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138425|NCT05766553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138426|NCT05766553|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56138427|NCT05766553|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56138428|NCT05766553|Cholinergic Agents|cholinergic agents|mesh-ancestor
56138429|NCT05766553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145290|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56138430|NCT05766553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138432|NCT05766540|Aripiprazole|aripiprazole|mesh-list
55865318|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
56138433|NCT05766540|Clozapine|clozapine|mesh-list
56138434|NCT05766540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56138435|NCT05766540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138436|NCT05766540|Antidepressive Agents|antidepressive agents|mesh-ancestor
56232250|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807884|NCT05385367|Anesthetics|anesthetics|mesh-list
56138437|NCT05766540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56138438|NCT05766540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56138439|NCT05766540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55745489|NCT03100071|Apixaban|apixaban|mesh-list
56138440|NCT05766540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138441|NCT05766540|Dopamine Agonists|dopamine agonists|mesh-ancestor
56138443|NCT05766540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138444|NCT05766540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138445|NCT05766540|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56138446|NCT05766540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56138447|NCT05766540|Serotonin Agents|serotonin agents|mesh-ancestor
56138448|NCT05766540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56138449|NCT05766540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56138450|NCT05766540|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56138451|NCT05766540|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56138452|NCT05766540|GABA Antagonists|gaba antagonists|mesh-ancestor
56138453|NCT05766540|GABA Agents|gaba agents|mesh-ancestor
56138454|NCT05766514|Cytarabine|cytarabine|mesh-list
56138455|NCT05766514|Decitabine|decitabine|mesh-list
56138456|NCT05766514|Venetoclax|venetoclax|mesh-list
56138457|NCT05766514|Cladribine|cladribine|mesh-list
56138458|NCT05766514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138459|NCT05766514|Antimetabolites|antimetabolites|mesh-ancestor
56138460|NCT05766514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138461|NCT05766514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138462|NCT05766514|Antiviral Agents|antiviral agents|mesh-ancestor
56138463|NCT05766514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138464|NCT05766514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138465|NCT05766514|Immunologic Factors|immunologic factors|mesh-ancestor
56138466|NCT05766514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138467|NCT05766514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138468|NCT05766436|Dexmedetomidine|dexmedetomidine|mesh-list
56138469|NCT05766436|Melatonin|melatonin|mesh-list
56138470|NCT05766436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56138471|NCT05766436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138472|NCT05766436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138473|NCT05766436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56138474|NCT05766436|Analgesics|analgesics|mesh-ancestor
56138475|NCT05766436|Sensory System Agents|sensory system agents|mesh-ancestor
56138476|NCT05766436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138477|NCT05766436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56138478|NCT05766436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56138479|NCT05766436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56138480|NCT05766436|Adrenergic Agents|adrenergic agents|mesh-ancestor
56145304|NCT00887640|Promethazine|promethazine|mesh-list
56138482|NCT05766436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138483|NCT05766436|Antioxidants|antioxidants|mesh-ancestor
56138484|NCT05766436|Protective Agents|protective agents|mesh-ancestor
56138485|NCT05766397|Methoxyflurane|methoxyflurane|mesh-list
55755590|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
56138486|NCT05766397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56138487|NCT05766397|Anesthetics, General|anesthetics, general|mesh-ancestor
56138488|NCT05766397|Anesthetics|anesthetics|mesh-ancestor
56138489|NCT05766397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138490|NCT05766397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138492|NCT05766384|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56138493|NCT05766384|Anesthetics, General|anesthetics, general|mesh-ancestor
56138494|NCT05766384|Anesthetics|anesthetics|mesh-ancestor
56138496|NCT05766384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138497|NCT05766371|Pembrolizumab|pembrolizumab|mesh-list
56138498|NCT05766371|177Lu-PSMA-617|177lu-psma-617|mesh-list
56138499|NCT05766371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138500|NCT05766371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138501|NCT05766371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56138502|NCT05766371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138503|NCT05766345|BCG Vaccine|bcg vaccine|mesh-list
56138504|NCT05766345|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56138505|NCT05766345|Immunologic Factors|immunologic factors|mesh-ancestor
56138506|NCT05766345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138507|NCT05766267|Moxifloxacin|moxifloxacin|mesh-list
56138508|NCT05766267|Rifampin|rifampin|mesh-list
56232252|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232254|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
56232255|NCT01715610|Clindamycin|clindamycin|mesh-list
56232256|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
56232257|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
56232258|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56232259|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56232260|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232261|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56232262|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232263|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232264|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56232265|NCT01715636|Tenofovir|tenofovir|mesh-list
56232266|NCT01715636|Emtricitabine|emtricitabine|mesh-list
56232267|NCT01715636|Rilpivirine|rilpivirine|mesh-list
56232268|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
56232269|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232270|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56232271|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56232273|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232274|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56232275|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56232276|NCT01715688|Lidocaine|lidocaine|mesh-list
56232277|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
56232278|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
56232279|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232280|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232281|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
56232282|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232283|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56232284|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56232285|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56232286|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232288|NCT01715701|Iodine|iodine|mesh-list
56232290|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232291|NCT01715701|Trace Elements|trace elements|mesh-ancestor
56232292|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
56232293|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232294|NCT01715909|Oseltamivir|oseltamivir|mesh-list
56232295|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
56232296|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232297|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232298|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232299|NCT01715922|Fluconazole|fluconazole|mesh-list
56232300|NCT01715922|Flucytosine|flucytosine|mesh-list
56232301|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
56232302|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232303|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56232304|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56232305|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232306|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232307|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56232308|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
56232309|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56232310|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232311|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56232312|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56232313|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
56232314|NCT01715935|Everolimus|everolimus|mesh-list
56232315|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232316|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232317|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
56232318|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232319|NCT01715987|Tenofovir|tenofovir|mesh-list
56232320|NCT01715987|Entecavir|entecavir|mesh-list
56232333|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56232334|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232335|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
56232336|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232337|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56232338|NCT01716273|Laxatives|laxatives|mesh-ancestor
56232339|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56232340|NCT01716338|Glyburide|glyburide|mesh-list
56232341|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56232342|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232343|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56232344|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56232345|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56232346|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232347|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232348|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232349|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138509|NCT05766267|Isoniazid|isoniazid|mesh-list
56138510|NCT05766267|Pyrazinamide|pyrazinamide|mesh-list
56138511|NCT05766267|Ethambutol|ethambutol|mesh-list
56138512|NCT05766267|Rifabutin|rifabutin|mesh-list
56138513|NCT05766267|Bedaquiline|bedaquiline|mesh-list
56138514|NCT05766267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56138515|NCT05766267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138516|NCT05766267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56138517|NCT05766267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56138518|NCT05766267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138519|NCT05766267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138520|NCT05766267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138521|NCT05766267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56138522|NCT05766267|Antitubercular Agents|antitubercular agents|mesh-ancestor
56138523|NCT05766267|Leprostatic Agents|leprostatic agents|mesh-ancestor
56138524|NCT05766267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56145332|NCT00889200|Eszopiclone|eszopiclone|mesh-list
56138525|NCT05766267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56138526|NCT05766267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56138527|NCT05766267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56138528|NCT05766267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56138529|NCT05766267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56138530|NCT05766267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56138531|NCT05766267|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56138532|NCT05766267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56138533|NCT05766267|Antimetabolites|antimetabolites|mesh-ancestor
56138534|NCT05766267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56138535|NCT05766176|Antibodies|antibodies|mesh-list
56138536|NCT05766176|Immunoglobulins|immunoglobulins|mesh-list
56138537|NCT05766176|Immunologic Factors|immunologic factors|mesh-ancestor
56138538|NCT05766176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138539|NCT05766124|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56138540|NCT05766124|Plasminogen|plasminogen|mesh-list
56138541|NCT05766124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56138542|NCT05766124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56138543|NCT05766124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138544|NCT05766085|Dexamethasone|dexamethasone|mesh-list
56138545|NCT05766085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56138546|NCT05766085|Antiemetics|antiemetics|mesh-ancestor
56138547|NCT05766085|Autonomic Agents|autonomic agents|mesh-ancestor
56232350|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56232351|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
56232352|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56232353|NCT01716416|Cetuximab|cetuximab|mesh-list
56232354|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56232355|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232356|NCT01716442|Rituximab|rituximab|mesh-list
56232357|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56232358|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232359|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
56232360|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232361|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232362|NCT01716572|Erythromycin|erythromycin|mesh-list
56232363|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
56232364|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56232365|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
56232366|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56232367|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138548|NCT05766085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138549|NCT05766085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138550|NCT05766085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55755652|NCT04111419|Atorvastatin|atorvastatin|mesh-list
56138551|NCT05766085|Glucocorticoids|glucocorticoids|mesh-ancestor
56138552|NCT05766085|Hormones|hormones|mesh-ancestor
56138553|NCT05766085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56138554|NCT05766085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56138555|NCT05766085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138556|NCT05765851|Trastuzumab|trastuzumab|mesh-list
56138557|NCT05765851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138558|NCT05765851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138559|NCT05765825|Carboplatin|carboplatin|mesh-list
56138560|NCT05765825|Etoposide|etoposide|mesh-list
56138561|NCT05765825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138562|NCT05765825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56138563|NCT05765825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56138564|NCT05765825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56138565|NCT05765825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138566|NCT05765825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138567|NCT05765812|Temozolomide|temozolomide|mesh-list
56145351|NCT00894504|Carboplatin|carboplatin|mesh-list
56138568|NCT05765812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56138570|NCT05765812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138571|NCT05765812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138572|NCT05765747|Celecoxib|celecoxib|mesh-list
56138573|NCT05765747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56138574|NCT05765747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56138575|NCT05765747|Analgesics|analgesics|mesh-ancestor
56138576|NCT05765747|Sensory System Agents|sensory system agents|mesh-ancestor
56138577|NCT05765747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138578|NCT05765747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138579|NCT05765747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56138580|NCT05765747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56138581|NCT05765747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56138582|NCT05765747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56138583|NCT05765747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138584|NCT05765747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138586|NCT05765682|Mepivacaine|mepivacaine|mesh-list
56232368|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56232369|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56232370|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755673|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
56232371|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232372|NCT01716611|Tolvaptan|tolvaptan|mesh-list
56232373|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56232374|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232375|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
56232376|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232377|NCT01716624|Oxybutynin|oxybutynin|mesh-list
56232378|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
56232379|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56232380|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56232381|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56232382|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232383|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232384|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
56232385|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232386|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232387|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56232388|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232389|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
56138587|NCT05765682|Anesthetics, Local|anesthetics, local|mesh-ancestor
56138588|NCT05765682|Anesthetics|anesthetics|mesh-ancestor
56138589|NCT05765682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138590|NCT05765682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138591|NCT05765682|Sensory System Agents|sensory system agents|mesh-ancestor
56138592|NCT05765682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138593|NCT05765617|Calcitriol|calcitriol|mesh-list
55755707|NCT04072835|Etripamil|etripamil|mesh-list
56138594|NCT05765617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56138595|NCT05765617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138596|NCT05765617|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56138597|NCT05765617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56138598|NCT05765617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138599|NCT05765617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56138600|NCT05765617|Vitamins|vitamins|mesh-ancestor
56138601|NCT05765617|Micronutrients|micronutrients|mesh-ancestor
56138602|NCT05765617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56138603|NCT05765578|Vaccines|vaccines|mesh-list
56138604|NCT05765578|Immunologic Factors|immunologic factors|mesh-ancestor
56138605|NCT05765578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138606|NCT05765500|Leuprolide|leuprolide|mesh-list
56138607|NCT05765500|Relugolix|relugolix|mesh-list
56138608|NCT05765500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56138609|NCT05765500|Fertility Agents|fertility agents|mesh-ancestor
56138610|NCT05765500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56138611|NCT05765500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138612|NCT05765500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56138613|NCT05765500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138614|NCT05765500|Androgen Antagonists|androgen antagonists|mesh-ancestor
55755754|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232390|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
56232391|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56232392|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56232393|NCT01716624|Urological Agents|urological agents|mesh-ancestor
56138615|NCT05765500|Hormone Antagonists|hormone antagonists|mesh-ancestor
56138616|NCT05765500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56138617|NCT05765487|Sildenafil Citrate|sildenafil citrate|mesh-list
56138618|NCT05765487|Vasodilator Agents|vasodilator agents|mesh-ancestor
56138619|NCT05765487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56138620|NCT05765487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56138621|NCT05765487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138622|NCT05765487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138623|NCT05765487|Urological Agents|urological agents|mesh-ancestor
56138624|NCT05765357|Trastuzumab|trastuzumab|mesh-list
56138625|NCT05765357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138626|NCT05765357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138627|NCT05765266|Methylprednisolone|methylprednisolone|mesh-list
56138628|NCT05765266|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56138629|NCT05765266|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56138630|NCT05765266|Prednisolone|prednisolone|mesh-list
56138631|NCT05765266|Prednisolone acetate|prednisolone acetate|mesh-list
56138632|NCT05765266|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56138633|NCT05765266|Prednisolone phosphate|prednisolone phosphate|mesh-list
56138634|NCT05765266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56138635|NCT05765266|Antiemetics|antiemetics|mesh-ancestor
56138636|NCT05765266|Autonomic Agents|autonomic agents|mesh-ancestor
56138637|NCT05765266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138638|NCT05765266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138639|NCT05765266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56138640|NCT05765266|Glucocorticoids|glucocorticoids|mesh-ancestor
56138642|NCT05765266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56138643|NCT05765266|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56138652|NCT05765240|Protective Agents|protective agents|mesh-ancestor
56138653|NCT05765110|Dopamine|dopamine|mesh-list
56138654|NCT05765110|Dopamine Agonists|dopamine agonists|mesh-list
56138655|NCT05765110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55865539|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138656|NCT05765110|Sympathomimetics|sympathomimetics|mesh-ancestor
56138657|NCT05765110|Autonomic Agents|autonomic agents|mesh-ancestor
56138658|NCT05765110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138659|NCT05765110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138660|NCT05765110|Dopamine Agents|dopamine agents|mesh-ancestor
56138661|NCT05765110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138662|NCT05765110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138663|NCT05765110|Protective Agents|protective agents|mesh-ancestor
56138664|NCT05765097|Pancrelipase|pancrelipase|mesh-list
56138665|NCT05765097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56138673|NCT05765071|Botulinum Toxins|botulinum toxins|mesh-list
56138674|NCT05765071|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56138675|NCT05765071|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56138676|NCT05765071|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56138677|NCT05765071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56138678|NCT05765071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138679|NCT05765071|Cholinergic Agents|cholinergic agents|mesh-ancestor
56138680|NCT05765071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138681|NCT05765071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138682|NCT05765071|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56138683|NCT05765071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138684|NCT05764993|Immunoglobulins|immunoglobulins|mesh-list
56138685|NCT05764993|gamma-Globulins|gamma-globulins|mesh-list
56138686|NCT05764993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56138687|NCT05764993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56138688|NCT05764993|Immunologic Factors|immunologic factors|mesh-ancestor
56138689|NCT05764993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138690|NCT05764876|Azithromycin|azithromycin|mesh-list
56138691|NCT05764876|Linezolid|linezolid|mesh-list
56138692|NCT05764876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56138693|NCT05764876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138694|NCT05764876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56138695|NCT05764876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232394|NCT01716637|Etanercept|etanercept|mesh-list
56232395|NCT01716637|Curcumin|curcumin|mesh-list
56232396|NCT01716637|Resveratrol|resveratrol|mesh-list
56232397|NCT01716637|Quercetin|quercetin|mesh-list
56232398|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56138696|NCT05764876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138697|NCT05764811|Canagliflozin|canagliflozin|mesh-list
56138698|NCT05764811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56138699|NCT05764811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138700|NCT05764811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56138701|NCT05764811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138702|NCT05764798|Zolpidem|zolpidem|mesh-list
56138703|NCT05764798|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56138704|NCT05764798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56138705|NCT05764798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138706|NCT05764798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138707|NCT05764798|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56138708|NCT05764798|GABA Agonists|gaba agonists|mesh-ancestor
56138709|NCT05764798|GABA Agents|gaba agents|mesh-ancestor
56138710|NCT05764798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755853|NCT05223075|Lidocaine|lidocaine|mesh-list
56138711|NCT05764798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138712|NCT05764746|Artesunate|artesunate|mesh-list
56138713|NCT05764746|Lumefantrine|lumefantrine|mesh-list
56138714|NCT05764746|Artemether|artemether|mesh-list
56138715|NCT05764746|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56138716|NCT05764746|Amodiaquine|amodiaquine|mesh-list
56138717|NCT05764746|Antimalarials|antimalarials|mesh-ancestor
56138719|NCT05764746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56138720|NCT05764746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138721|NCT05764746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138722|NCT05764746|Antiviral Agents|antiviral agents|mesh-ancestor
56138723|NCT05764746|Schistosomicides|schistosomicides|mesh-ancestor
56138724|NCT05764746|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56138725|NCT05764746|Anthelmintics|anthelmintics|mesh-ancestor
56138726|NCT05764707|Acetaminophen|acetaminophen|mesh-list
56138727|NCT05764707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56138728|NCT05764707|Analgesics|analgesics|mesh-ancestor
56138729|NCT05764707|Sensory System Agents|sensory system agents|mesh-ancestor
56138730|NCT05764707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138731|NCT05764707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138732|NCT05764707|Antipyretics|antipyretics|mesh-ancestor
56138733|NCT05763602|Povidone-Iodine|povidone-iodine|mesh-list
56138734|NCT05763602|Povidone|povidone|mesh-list
56138735|NCT05763602|Plasma Substitutes|plasma substitutes|mesh-ancestor
56138736|NCT05763602|Blood Substitutes|blood substitutes|mesh-ancestor
56138737|NCT05763602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56138738|NCT05763602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138739|NCT05757622|Remifentanil|remifentanil|mesh-list
56138740|NCT05757622|Propofol|propofol|mesh-list
56138741|NCT05757622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56138742|NCT05757622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138743|NCT05757622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138744|NCT05757622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56138745|NCT05757622|Anesthetics, General|anesthetics, general|mesh-ancestor
56138746|NCT05757622|Anesthetics|anesthetics|mesh-ancestor
56138747|NCT05757622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56138748|NCT05757622|Narcotics|narcotics|mesh-ancestor
56138749|NCT05757622|Analgesics|analgesics|mesh-ancestor
56138750|NCT05757622|Sensory System Agents|sensory system agents|mesh-ancestor
56138751|NCT05757622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138752|NCT05746819|Antipyretics|antipyretics|mesh-list
56138753|NCT05746819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138754|NCT05746650|Hormones|hormones|mesh-list
56138755|NCT05746650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56138756|NCT05746650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138757|NCT05743400|Thymoglobulin|thymoglobulin|mesh-list
56138758|NCT05743400|Immunologic Factors|immunologic factors|mesh-ancestor
56138759|NCT05743400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138760|NCT05743400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138761|NCT05733689|Paclitaxel|paclitaxel|mesh-list
56138762|NCT05733689|Docetaxel|docetaxel|mesh-list
56138763|NCT05733689|Carboplatin|carboplatin|mesh-list
56138764|NCT05733689|Pembrolizumab|pembrolizumab|mesh-list
56138765|NCT05733689|Nivolumab|nivolumab|mesh-list
56138766|NCT05733689|Irinotecan|irinotecan|mesh-list
56232399|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56232400|NCT01716637|Analgesics|analgesics|mesh-ancestor
55755869|NCT03064035|Coagulants|coagulants|mesh-ancestor
55755870|NCT03719313|Interferons|interferons|mesh-list
56232401|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
56232402|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232403|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232404|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56232405|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232406|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56232407|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232408|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
56232409|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232410|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232411|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232412|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
56232413|NCT01716637|Protective Agents|protective agents|mesh-ancestor
56232414|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56232415|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
56232416|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232417|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
56232418|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232419|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232420|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56232421|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
56232422|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232423|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232424|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56232425|NCT01716767|Analgesics|analgesics|mesh-list
56138767|NCT05733689|Folfirinox|folfirinox|mesh-list
56138768|NCT05733689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56138769|NCT05733689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138770|NCT05733689|Tubulin Modulators|tubulin modulators|mesh-ancestor
56138771|NCT05733689|Antimitotic Agents|antimitotic agents|mesh-ancestor
56138772|NCT05733689|Mitosis Modulators|mitosis modulators|mesh-ancestor
56138773|NCT05733689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138774|NCT05733689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138775|NCT05733689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56138776|NCT05733689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56138777|NCT05733689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56138778|NCT05733689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138779|NCT05731726|Celecoxib|celecoxib|mesh-list
56138780|NCT05731726|Capecitabine|capecitabine|mesh-list
56138781|NCT05731726|Oxaliplatin|oxaliplatin|mesh-list
56138782|NCT05731726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138783|NCT05731726|Antimetabolites|antimetabolites|mesh-ancestor
56138784|NCT05731726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138785|NCT05731726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232426|NCT01716767|Menthol|menthol|mesh-list
56232427|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
56145389|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
56232428|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808058|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
56138786|NCT05731726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56138787|NCT05731726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56138788|NCT05731726|Analgesics|analgesics|mesh-ancestor
56138789|NCT05731726|Sensory System Agents|sensory system agents|mesh-ancestor
56138790|NCT05731726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138791|NCT05731726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138792|NCT05731726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755891|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
56138793|NCT05731726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56138794|NCT05731726|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56138795|NCT05731726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56138796|NCT05731726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138797|NCT05715931|Leucovorin|leucovorin|mesh-list
56138798|NCT05715931|Docetaxel|docetaxel|mesh-list
56138799|NCT05715931|Oxaliplatin|oxaliplatin|mesh-list
56138800|NCT05715931|Trastuzumab|trastuzumab|mesh-list
56138801|NCT05715931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138802|NCT05715931|Tubulin Modulators|tubulin modulators|mesh-ancestor
56138803|NCT05715931|Antimitotic Agents|antimitotic agents|mesh-ancestor
56138804|NCT05715931|Mitosis Modulators|mitosis modulators|mesh-ancestor
56138805|NCT05715931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138806|NCT05715931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55865686|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138807|NCT05715931|Antidotes|antidotes|mesh-ancestor
56138808|NCT05715931|Protective Agents|protective agents|mesh-ancestor
56138809|NCT05715931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138810|NCT05715931|Vitamin B Complex|vitamin b complex|mesh-ancestor
56138812|NCT05715931|Micronutrients|micronutrients|mesh-ancestor
56138813|NCT05714384|Calcium|calcium|mesh-list
56138814|NCT05714384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56138815|NCT05714384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138816|NCT05714007|Ferrous succinate|ferrous succinate|mesh-list
56138817|NCT05714007|Hematinics|hematinics|mesh-ancestor
56138818|NCT05708989|Dexmedetomidine|dexmedetomidine|mesh-list
56138819|NCT05708989|Ropivacaine|ropivacaine|mesh-list
56138820|NCT05708989|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56138821|NCT05708989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138822|NCT05708989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138823|NCT05708989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56138824|NCT05708989|Analgesics|analgesics|mesh-ancestor
56138825|NCT05708989|Sensory System Agents|sensory system agents|mesh-ancestor
56138826|NCT05708989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138827|NCT05708989|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56138828|NCT05708989|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56138829|NCT05708989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56138830|NCT05708989|Adrenergic Agents|adrenergic agents|mesh-ancestor
56138831|NCT05708989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56138832|NCT05708989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138833|NCT05708989|Anesthetics, Local|anesthetics, local|mesh-ancestor
56138834|NCT05708989|Anesthetics|anesthetics|mesh-ancestor
56138835|NCT05708183|Micronutrients|micronutrients|mesh-list
56138836|NCT05708183|Trace Elements|trace elements|mesh-list
56138837|NCT05708183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138838|NCT05705258|Aflibercept|aflibercept|mesh-list
56138839|NCT05705258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56138840|NCT05705258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56138841|NCT05705258|Growth Substances|growth substances|mesh-ancestor
56138842|NCT05705258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138843|NCT05705258|Growth Inhibitors|growth inhibitors|mesh-ancestor
56138844|NCT05705258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138845|NCT05687110|Novobiocin|novobiocin|mesh-list
56138846|NCT05687110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56138847|NCT05687110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138848|NCT05687110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138849|NCT05687110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138850|NCT05687110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56138851|NCT05661578|Atezolizumab|atezolizumab|mesh-list
55755956|NCT04436913|Fluorides|fluorides|mesh-list
56138852|NCT05661578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138853|NCT05656664|Folic Acid|folic acid|mesh-list
56232429|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232430|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
56232431|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
56232433|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56232434|NCT01716858|Protective Agents|protective agents|mesh-ancestor
56232435|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232436|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232437|NCT01716949|Fluorouracil|fluorouracil|mesh-list
56232438|NCT01716949|Capecitabine|capecitabine|mesh-list
55808060|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
56138854|NCT05656664|Hematinics|hematinics|mesh-ancestor
56138855|NCT05656664|Vitamin B Complex|vitamin b complex|mesh-ancestor
56138856|NCT05656664|Vitamins|vitamins|mesh-ancestor
56138857|NCT05656664|Micronutrients|micronutrients|mesh-ancestor
56138858|NCT05656664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138864|NCT05644041|Gemcitabine|gemcitabine|mesh-list
56138865|NCT05644041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138866|NCT05644041|Antimetabolites|antimetabolites|mesh-ancestor
56138867|NCT05644041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138868|NCT05644041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138869|NCT05644041|Antiviral Agents|antiviral agents|mesh-ancestor
56138870|NCT05644041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138871|NCT05644041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138872|NCT05644041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138873|NCT05644041|Immunologic Factors|immunologic factors|mesh-ancestor
56138874|NCT05644041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138875|NCT05643573|Apixaban|apixaban|mesh-list
56138878|NCT05643573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56138879|NCT05643573|Protease Inhibitors|protease inhibitors|mesh-ancestor
56138880|NCT05643573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138881|NCT05643573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138882|NCT05643573|Anticoagulants|anticoagulants|mesh-ancestor
56138883|NCT05640180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56138884|NCT05640180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865767|NCT05317546|Cannabidiol|cannabidiol|mesh-list
56138885|NCT05640180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56138886|NCT05640180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138888|NCT05628623|Azacitidine|azacitidine|mesh-list
56138889|NCT05628623|Daunorubicin|daunorubicin|mesh-list
56138890|NCT05628623|Venetoclax|venetoclax|mesh-list
56138891|NCT05628623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138892|NCT05628623|Antimetabolites|antimetabolites|mesh-ancestor
56138893|NCT05628623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138894|NCT05628623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138895|NCT05628623|Antiviral Agents|antiviral agents|mesh-ancestor
56138896|NCT05628623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138897|NCT05628623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56138898|NCT05628623|Immunologic Factors|immunologic factors|mesh-ancestor
55756007|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
56138899|NCT05628623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138900|NCT05628623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138901|NCT05628623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56138902|NCT05628623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56138903|NCT05628623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56138904|NCT05616013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56138905|NCT05616013|Antibodies, Blocking|antibodies, blocking|mesh-list
56138906|NCT05616013|Immunologic Factors|immunologic factors|mesh-ancestor
56138907|NCT05616013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138908|NCT05611905|Probenecid|probenecid|mesh-list
56138909|NCT05611905|Uricosuric Agents|uricosuric agents|mesh-ancestor
56138910|NCT05611905|Gout Suppressants|gout suppressants|mesh-ancestor
56138911|NCT05611905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56138912|NCT05611905|Renal Agents|renal agents|mesh-ancestor
56138913|NCT05603910|Pembrolizumab|pembrolizumab|mesh-list
56138914|NCT05603910|Lenvatinib|lenvatinib|mesh-list
56138915|NCT05603910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138916|NCT05603910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232440|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
56232441|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138917|NCT05603910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56138918|NCT05603910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138919|NCT05603910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138920|NCT05594823|Furosemide|furosemide|mesh-list
56138921|NCT05594823|Diuretics|diuretics|mesh-list
56138922|NCT05594823|Natriuretic Agents|natriuretic agents|mesh-ancestor
56138923|NCT05594823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138924|NCT05594823|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56138925|NCT05594823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56138926|NCT05594823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138927|NCT05581797|Psilocybin|psilocybin|mesh-list
56138928|NCT05581797|Hallucinogens|hallucinogens|mesh-ancestor
56138929|NCT05581797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138930|NCT05581797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56138931|NCT05581030|Rituximab|rituximab|mesh-list
56138932|NCT05581030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138933|NCT05581030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138934|NCT05581030|Immunologic Factors|immunologic factors|mesh-ancestor
56138935|NCT05581030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756037|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
55756038|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138936|NCT05581030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56138937|NCT05562947|Ranibizumab|ranibizumab|mesh-list
56138938|NCT05562947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56138939|NCT05562947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56138940|NCT05562947|Growth Substances|growth substances|mesh-ancestor
56138941|NCT05562947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138942|NCT05562947|Growth Inhibitors|growth inhibitors|mesh-ancestor
56138943|NCT05562947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138944|NCT05555706|Paclitaxel|paclitaxel|mesh-list
56138945|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56138946|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138947|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
56138948|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
56138950|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138951|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56138953|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56138954|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56138955|NCT05526157|Hormones|hormones|mesh-ancestor
56138956|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56138957|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138958|NCT05526157|Incretins|incretins|mesh-ancestor
56138959|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138960|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56138961|NCT05510544|Plerixafor|plerixafor|mesh-list
56138962|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56138963|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56138964|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
56138965|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138966|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56138967|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138968|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138969|NCT05500326|Ivermectin|ivermectin|mesh-list
56138970|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56138971|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56138972|NCT05486481|Dexamethasone|dexamethasone|mesh-list
56138973|NCT05486481|Venetoclax|venetoclax|mesh-list
56138974|NCT05486481|Daratumumab|daratumumab|mesh-list
56138975|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56138976|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56138977|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
56138978|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
56138979|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138980|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138981|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56138982|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
56138983|NCT05486481|Hormones|hormones|mesh-ancestor
56138984|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56138985|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56138986|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138987|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
56232442|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56232443|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232444|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232445|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
56232446|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232447|NCT01717027|Oxycodone|oxycodone|mesh-list
56232448|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56232449|NCT01717027|Narcotics|narcotics|mesh-ancestor
56232450|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232451|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232452|NCT01717027|Analgesics|analgesics|mesh-ancestor
56232453|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
56232454|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808070|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56138988|NCT05471830|Apixaban|apixaban|mesh-list
56138989|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56138990|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
56138991|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56138992|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
56138993|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138994|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138995|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
56138996|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
56138997|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56138998|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138999|NCT05442567|Vedolizumab|vedolizumab|mesh-list
56139000|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56139001|NCT05441215|Ritonavir|ritonavir|mesh-list
56139002|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56139003|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56139004|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
56139005|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139006|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139007|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56139008|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56139009|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
56139010|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139011|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56139012|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56139013|NCT05431777|Avelumab|avelumab|mesh-list
56139014|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139015|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139016|NCT05405166|Dexamethasone|dexamethasone|mesh-list
56139017|NCT05405166|Pomalidomide|pomalidomide|mesh-list
56139018|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56139019|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56139020|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
56139021|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
56139022|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139023|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139024|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56139025|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
56139026|NCT05405166|Hormones|hormones|mesh-ancestor
56139027|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139028|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56139029|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139030|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
56139031|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56139032|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56139033|NCT05405166|Growth Substances|growth substances|mesh-ancestor
56139034|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
56139035|NCT05372614|Trastuzumab|trastuzumab|mesh-list
56232455|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
56232456|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56232457|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232458|NCT01717118|Vaccines|vaccines|mesh-list
56139036|NCT05372614|Camptothecin|camptothecin|mesh-list
56139037|NCT05372614|Maleic acid|maleic acid|mesh-list
56139038|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
55865908|NCT01928225|Vaccines|vaccines|mesh-list
56139039|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139040|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139041|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139042|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139043|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139044|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56139045|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56139046|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
56139047|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139048|NCT05348577|Docetaxel|docetaxel|mesh-list
56139049|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139050|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139051|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139052|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139053|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139054|NCT05327647|Bicalutamide|bicalutamide|mesh-list
56139055|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
56139056|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
56139057|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
56139058|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139059|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139060|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139061|NCT05320380|Cytarabine|cytarabine|mesh-list
56139062|NCT05320380|Prednisolone|prednisolone|mesh-list
55756095|NCT00701129|Rituximab|rituximab|mesh-list
56139063|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56139064|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
56139065|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56139066|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
56139067|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
56139068|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56139069|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56139070|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56139071|NCT05320380|Cortisone|cortisone|mesh-list
56139072|NCT05320380|Methotrexate|methotrexate|mesh-list
56139073|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
56139074|NCT05320380|Fludarabine|fludarabine|mesh-list
56139075|NCT05320380|Daunorubicin|daunorubicin|mesh-list
56139076|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56139077|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
56139078|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56139079|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
56139080|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56139081|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139082|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139083|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
56145438|NCT00905268|Idebenone|idebenone|mesh-list
56139084|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139085|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139086|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
56139087|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139088|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56139089|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55756156|NCT01670721|Irinotecan|irinotecan|mesh-list
56139090|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
56139091|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56139092|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56139093|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
56139094|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139095|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56139096|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
56139097|NCT05320380|Hormones|hormones|mesh-ancestor
56139098|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139100|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
56139101|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
56139102|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139103|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56232459|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
56232460|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232461|NCT01717157|Fentanyl|fentanyl|mesh-list
56232462|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56232463|NCT01717157|Narcotics|narcotics|mesh-ancestor
56232464|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232465|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232466|NCT01717157|Analgesics|analgesics|mesh-ancestor
56232467|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
55756215|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756216|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756218|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56232468|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232469|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56232470|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56232471|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
56232472|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
56232473|NCT01717222|Lidocaine|lidocaine|mesh-list
56232474|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
56232475|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
56139104|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56139105|NCT05320380|Protective Agents|protective agents|mesh-ancestor
56139106|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56139107|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56139108|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56139109|NCT05303532|Durvalumab|durvalumab|mesh-list
56139110|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139111|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139112|NCT05297565|Nivolumab|nivolumab|mesh-list
56139113|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139114|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139115|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56139116|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756267|NCT03290417|Turmeric extract|turmeric extract|mesh-list
56139117|NCT05296798|Paclitaxel|paclitaxel|mesh-list
56139118|NCT05296798|Docetaxel|docetaxel|mesh-list
56139119|NCT05296798|Trastuzumab|trastuzumab|mesh-list
56139120|NCT05296798|Pertuzumab|pertuzumab|mesh-list
56139121|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139122|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139123|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139124|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139125|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139126|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139127|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139128|NCT05263908|Ritonavir|ritonavir|mesh-list
56139129|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56139130|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56139131|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
56139132|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139133|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139135|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56139136|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
56139137|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139138|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56139139|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56139140|NCT05259527|Vitamin D|vitamin d|mesh-list
56139141|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
56139142|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
56139143|NCT05259527|Vitamins|vitamins|mesh-list
56139144|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
56139145|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139146|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56232476|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232477|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232478|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
56232479|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232480|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56232481|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56232482|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56232483|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232484|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232485|NCT01717235|Ropinirole|ropinirole|mesh-list
56232486|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56232487|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55756325|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
56232488|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
56232489|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
56232490|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232491|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232492|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232493|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
56232494|NCT01717300|Anacetrapib|anacetrapib|mesh-list
56232495|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56232496|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56232497|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
56139147|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56139156|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
56139157|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139158|NCT05243342|Daratumumab|daratumumab|mesh-list
56139159|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139160|NCT05239741|Leucovorin|leucovorin|mesh-list
56139161|NCT05239741|Bevacizumab|bevacizumab|mesh-list
56139162|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
56139163|NCT05239741|Cetuximab|cetuximab|mesh-list
56139164|NCT05239741|Fluorouracil|fluorouracil|mesh-list
56139165|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
56139166|NCT05239741|Irinotecan|irinotecan|mesh-list
56139167|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139168|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139169|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56139170|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56139171|NCT05239741|Growth Substances|growth substances|mesh-ancestor
56139172|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139173|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
56139174|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
56139175|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139176|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139177|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139178|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
56139179|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56139180|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56139181|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139182|NCT05239741|Antidotes|antidotes|mesh-ancestor
56139184|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
56232498|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232499|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56232500|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232501|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55756369|NCT04973319|Trastuzumab|trastuzumab|mesh-list
56232502|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232503|NCT01717404|Mexiletine|mexiletine|mesh-list
56232504|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56232505|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56232506|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56232507|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232508|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232509|NCT01717599|Diclofenac|diclofenac|mesh-list
56232510|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56232511|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56232512|NCT01717599|Analgesics|analgesics|mesh-ancestor
56232513|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
56232514|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232515|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232516|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56232517|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232518|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56232519|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232520|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232521|NCT01717612|Thrombin|thrombin|mesh-list
56232522|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
56232523|NCT01717612|Coagulants|coagulants|mesh-ancestor
56232524|NCT01717625|Montelukast|montelukast|mesh-list
56232525|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56232526|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
56232527|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56232528|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
56139187|NCT05198843|Dasatinib|dasatinib|mesh-list
55756399|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56139188|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56139189|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139190|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56139191|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139192|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139193|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56139194|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56139196|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139197|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232529|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56232530|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232531|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56139198|NCT05177588|Metformin|metformin|mesh-list
56139199|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56139200|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139201|NCT05171660|Bevacizumab|bevacizumab|mesh-list
56139202|NCT05171660|Capecitabine|capecitabine|mesh-list
56139203|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
56139204|NCT05171660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139205|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139206|NCT05171660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56139207|NCT05171660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56139208|NCT05171660|Growth Substances|growth substances|mesh-ancestor
56139209|NCT05171660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139210|NCT05171660|Growth Inhibitors|growth inhibitors|mesh-ancestor
56139211|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139212|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
56139213|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139214|NCT05171075|Dalteparin|dalteparin|mesh-list
56139215|NCT05171075|Tinzaparin|tinzaparin|mesh-list
56139216|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56139217|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
56139218|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56139219|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56139220|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139221|NCT05171049|Apixaban|apixaban|mesh-list
56139222|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56139223|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
56139224|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56139225|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
56139226|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139227|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756445|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
55756446|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756447|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56139228|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
56139229|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
56139230|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139231|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139232|NCT05155709|Azacitidine|azacitidine|mesh-list
56139233|NCT05155709|Venetoclax|venetoclax|mesh-list
56139234|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139235|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
56139236|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139237|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139238|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139239|NCT05153239|Irinotecan|irinotecan|mesh-list
56139240|NCT05153239|Topotecan|topotecan|mesh-list
56139241|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55745523|NCT05714839|Immunologic Factors|immunologic factors|mesh-ancestor
56139242|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56139243|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139244|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139245|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139246|NCT05147662|Factor VIII|factor viii|mesh-list
56139247|NCT05147662|Coagulants|coagulants|mesh-ancestor
56139248|NCT05142241|Temozolomide|temozolomide|mesh-list
56139249|NCT05142241|Talazoparib|talazoparib|mesh-list
56139250|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56139251|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
56139252|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139253|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139254|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56139255|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139256|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
56145504|NCT00916032|Factor VIII|factor viii|mesh-list
56139257|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56139261|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
56139262|NCT05133258|Dexamethasone|dexamethasone|mesh-list
56139263|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56139264|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
56139265|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
56139266|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139267|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232532|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56232533|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232535|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56232536|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56232537|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232538|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
56232539|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
56232540|NCT01717729|Iodine|iodine|mesh-list
56232541|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56232542|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232543|NCT01717729|Trace Elements|trace elements|mesh-ancestor
56232544|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
55756473|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56232545|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139268|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56139269|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
56139270|NCT05133258|Hormones|hormones|mesh-ancestor
56139271|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139272|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56139273|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139274|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56139275|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139276|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56139277|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56139278|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139279|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139280|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56139281|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56139282|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
56139283|NCT05119140|Mesalamine|mesalamine|mesh-list
56139284|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
56139285|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56139286|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56139287|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139288|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890364|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56139289|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139290|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56139291|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56139292|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56139293|NCT05119140|Analgesics|analgesics|mesh-ancestor
56139294|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
56139295|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139296|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139297|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56139298|NCT05112965|Atezolizumab|atezolizumab|mesh-list
56139299|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139300|NCT05109234|Brivaracetam|brivaracetam|mesh-list
56139301|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
56139302|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56139303|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56139304|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56139305|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139312|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
56139314|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139315|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139316|NCT05091346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56139317|NCT05091346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139318|NCT05091346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139319|NCT05059873|Prednisone|prednisone|mesh-list
56232546|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56232547|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232548|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56232549|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232550|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232551|NCT01717846|Abatacept|abatacept|mesh-list
56232552|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56232553|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232554|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232555|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232556|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
56232557|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232558|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232559|NCT01717911|Metformin|metformin|mesh-list
56232560|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56232561|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
56232562|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56232563|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232564|NCT01717911|Incretins|incretins|mesh-ancestor
56232565|NCT01717911|Hormones|hormones|mesh-ancestor
56232566|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56232567|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56139320|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56139321|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
56139322|NCT05059873|Hormones|hormones|mesh-ancestor
56139323|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139324|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139325|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56139326|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139327|NCT05056727|Valsartan|valsartan|mesh-list
56139328|NCT05056727|Lisinopril|lisinopril|mesh-list
56139329|NCT05056727|Irbesartan|irbesartan|mesh-list
56139330|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56139331|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56139332|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56139333|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139334|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56139336|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139337|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56139338|NCT05056727|Protective Agents|protective agents|mesh-ancestor
56139339|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139340|NCT05055024|Mazindol|mazindol|mesh-list
56139341|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56139342|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139343|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56139344|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56139345|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56139346|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139347|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
56139348|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232568|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
56232569|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232570|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139349|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56139350|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
56139351|NCT05053971|Entinostat|entinostat|mesh-list
56139352|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56139353|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139354|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139355|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139356|NCT05047978|Caseins|caseins|mesh-list
56139357|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
56139358|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
56139359|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139360|NCT05047250|Gemcitabine|gemcitabine|mesh-list
56139361|NCT05047250|Paclitaxel|paclitaxel|mesh-list
56139362|NCT05047250|Carboplatin|carboplatin|mesh-list
56139363|NCT05047250|Pemetrexed|pemetrexed|mesh-list
56139364|NCT05047250|Atezolizumab|atezolizumab|mesh-list
56139365|NCT05047250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139366|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139367|NCT05047250|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139368|NCT05047250|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139369|NCT05047250|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139370|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139371|NCT05047250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139372|NCT05047250|Antimetabolites|antimetabolites|mesh-ancestor
56139373|NCT05047250|Antiviral Agents|antiviral agents|mesh-ancestor
56139374|NCT05047250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139375|NCT05047250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139376|NCT05047250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139377|NCT05047250|Immunologic Factors|immunologic factors|mesh-ancestor
56139378|NCT05047250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139379|NCT05047250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56139380|NCT05047250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56139381|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
56139382|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139386|NCT05028634|Vaccines|vaccines|mesh-list
56139387|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56139388|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
56139389|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139390|NCT05028075|Cobalt|cobalt|mesh-list
56139391|NCT05028075|Trace Elements|trace elements|mesh-ancestor
56139392|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
56139393|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139394|NCT05017012|Paclitaxel|paclitaxel|mesh-list
56139395|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56139396|NCT05017012|Carboplatin|carboplatin|mesh-list
56139397|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
56139398|NCT05017012|Pemetrexed|pemetrexed|mesh-list
56139399|NCT05017012|Axitinib|axitinib|mesh-list
56139400|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139401|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139402|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139403|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139404|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139405|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139406|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139407|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139408|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56139409|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56139410|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56139413|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56139414|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56139415|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56139416|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139418|NCT05009069|Capecitabine|capecitabine|mesh-list
56139419|NCT05009069|Atezolizumab|atezolizumab|mesh-list
56139420|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
56232571|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56232572|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56232573|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
56232574|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232575|NCT01717950|Antacids|antacids|mesh-ancestor
56232576|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232577|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56232578|NCT01717963|Naltrexone|naltrexone|mesh-list
56232579|NCT01717963|Buprenorphine|buprenorphine|mesh-list
56232580|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56232581|NCT01717963|Naloxone|naloxone|mesh-list
56232582|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56232583|NCT01717963|Narcotics|narcotics|mesh-ancestor
56232584|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232585|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232586|NCT01717963|Analgesics|analgesics|mesh-ancestor
56232587|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
56232588|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232589|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56232590|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56232591|NCT01718054|Chloroquine|chloroquine|mesh-list
56232592|NCT01718054|Amebicides|amebicides|mesh-ancestor
56232593|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56232594|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56232595|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232596|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
56139421|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139422|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139423|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139424|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139425|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
56139426|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139427|NCT04989218|Gemcitabine|gemcitabine|mesh-list
56139428|NCT04989218|Cisplatin|cisplatin|mesh-list
56139429|NCT04989218|Durvalumab|durvalumab|mesh-list
56139430|NCT04989218|Tremelimumab|tremelimumab|mesh-list
56139431|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139432|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139433|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
56139434|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139435|NCT04989218|Antiviral Agents|antiviral agents|mesh-ancestor
56139436|NCT04989218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139437|NCT04989218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139438|NCT04989218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139439|NCT04989218|Immunologic Factors|immunologic factors|mesh-ancestor
55756649|NCT00189319|Flecainide|flecainide|mesh-list
56139440|NCT04989218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139441|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139442|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56139443|NCT04964544|Calcium|calcium|mesh-list
56139444|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56139445|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232597|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232598|NCT01718093|Metformin|metformin|mesh-list
56232599|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56232600|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56232601|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232602|NCT01718093|Incretins|incretins|mesh-ancestor
56232603|NCT01718093|Hormones|hormones|mesh-ancestor
56232604|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56232605|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56232606|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
56232607|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232608|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232609|NCT01718223|Temoporfin|temoporfin|mesh-list
56232610|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232611|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56232612|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
56232613|NCT01718236|Rocuronium|rocuronium|mesh-list
56232614|NCT01718236|Succinylcholine|succinylcholine|mesh-list
56232615|NCT01718236|Neostigmine|neostigmine|mesh-list
56232616|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56232617|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56139446|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56139447|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56139448|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
56139449|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139450|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56139451|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56139452|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139453|NCT04954196|Amlodipine|amlodipine|mesh-list
56139454|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56139455|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56139456|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56139457|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139458|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56139459|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139460|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
56139461|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56139462|NCT04944290|Brinzolamide|brinzolamide|mesh-list
56139463|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56139464|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56139465|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55756670|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56139466|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56139467|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
56139468|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56139469|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139470|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139471|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56139472|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139475|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139476|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
56139477|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232618|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56232619|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232620|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232621|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56232622|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232623|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232624|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
56232625|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232626|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56232627|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
56232628|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56232629|NCT01718288|Aspirin|aspirin|mesh-list
56139478|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139479|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139480|NCT04931017|Metformin|metformin|mesh-list
56139481|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56139483|NCT04929223|Bevacizumab|bevacizumab|mesh-list
56139485|NCT04929223|Atezolizumab|atezolizumab|mesh-list
56139486|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866360|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
56139487|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139488|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56139489|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56139490|NCT04929223|Growth Substances|growth substances|mesh-ancestor
56139491|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139492|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
56139493|NCT04920032|Irinotecan|irinotecan|mesh-list
56139494|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56139495|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56139496|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139497|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139498|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139499|NCT04908176|Midazolam|midazolam|mesh-list
56139500|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56139501|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55756695|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56139502|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56139503|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139504|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56139505|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56139506|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56139507|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56139508|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
56139509|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
56139510|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
56139511|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
56139512|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56139513|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139514|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
56139515|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
56139516|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139517|NCT04898023|Protective Agents|protective agents|mesh-ancestor
56139518|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139519|NCT04898023|Vitamins|vitamins|mesh-ancestor
56139520|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
56139521|NCT04893109|Paclitaxel|paclitaxel|mesh-list
56139523|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56139524|NCT04893109|Trastuzumab|trastuzumab|mesh-list
56139525|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139526|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139527|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139528|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139529|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139530|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232630|NCT01718288|Iloprost|iloprost|mesh-list
56232631|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56232632|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56139531|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139532|NCT04883645|Imiquimod|imiquimod|mesh-list
56139533|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56139534|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
56139535|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139536|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139537|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
56139538|NCT04882540|Brivaracetam|brivaracetam|mesh-list
56139539|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
56139540|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
56139541|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56139542|NCT04859829|Antibodies|antibodies|mesh-list
56139543|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
56139544|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56139545|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
56139546|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139547|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56139548|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56139549|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139550|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
56139551|NCT04821856|Cannabidiol|cannabidiol|mesh-list
56139552|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
56139553|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56139554|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
56139555|NCT04788043|Magrolimab|magrolimab|mesh-list
56139556|NCT04788043|Antibodies|antibodies|mesh-list
56139557|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
56139558|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56139559|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
56139560|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139561|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139563|NCT04778267|Bupivacaine|bupivacaine|mesh-list
56139564|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56139565|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56139566|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
56139568|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139569|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139570|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56139571|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
56139572|NCT04778267|Hormones|hormones|mesh-ancestor
56139573|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139574|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56139575|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139576|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
56139577|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
56139578|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56139579|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
56139581|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
56139583|NCT04760691|Emtricitabine|emtricitabine|mesh-list
56139584|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56139585|NCT04760691|Leuprolide|leuprolide|mesh-list
56139586|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56139587|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56139588|NCT04760691|Estradiol|estradiol|mesh-list
56139589|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56139590|NCT04760691|Estrogens|estrogens|mesh-list
56139591|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
56139592|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756761|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56139593|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56139594|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56139595|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139596|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139597|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56139598|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56139599|NCT04760691|Hormones|hormones|mesh-ancestor
56139600|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139601|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139602|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56139603|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
56232633|NCT01718288|Analgesics|analgesics|mesh-ancestor
56232634|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
56232635|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232636|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232637|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56232638|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232639|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56232640|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56232641|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232642|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56232643|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56232644|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232645|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
56232646|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
55808260|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55808261|NCT01657903|Listerine|listerine|mesh-list
56139604|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56139605|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56139606|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56139607|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
56139608|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56139609|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139610|NCT04740671|Ranibizumab|ranibizumab|mesh-list
56145608|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139611|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56139612|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56139613|NCT04740671|Growth Substances|growth substances|mesh-ancestor
56139614|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139615|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
56139616|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139618|NCT04736199|Hormones|hormones|mesh-ancestor
56139619|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139620|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139621|NCT04736173|Paclitaxel|paclitaxel|mesh-list
56139622|NCT04736173|Carboplatin|carboplatin|mesh-list
56139623|NCT04736173|Pembrolizumab|pembrolizumab|mesh-list
56139624|NCT04736173|Pemetrexed|pemetrexed|mesh-list
56139625|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139626|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139627|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139628|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139629|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139630|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139631|NCT04736173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139632|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139633|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56139634|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56139638|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
56139639|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139640|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56139641|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56139642|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
56139643|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139644|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139645|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56139646|NCT04718181|Omeprazole|omeprazole|mesh-list
56232647|NCT01718301|Ribavirin|ribavirin|mesh-list
56232648|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56232649|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56232650|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
56232651|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232652|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
56232653|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232654|NCT01718314|Lidocaine|lidocaine|mesh-list
56232655|NCT01718314|Misoprostol|misoprostol|mesh-list
56232656|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
56232657|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
56232658|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232659|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232660|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
56232661|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232662|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56232663|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56232664|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56232665|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232666|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232667|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56232668|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
56139647|NCT04718181|Risdiplam|risdiplam|mesh-list
56139648|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56139649|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56139650|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56139651|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139652|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139653|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56139654|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139655|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139656|NCT04713735|Lactoferrin|lactoferrin|mesh-list
56139657|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139659|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139660|NCT04682366|Tamsulosin|tamsulosin|mesh-list
56139661|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56139662|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56139663|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56139664|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
56139665|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56139666|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139667|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139668|NCT04682366|Urological Agents|urological agents|mesh-ancestor
56139669|NCT04666610|Brivaracetam|brivaracetam|mesh-list
56139670|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
56139671|NCT04665570|Metformin|metformin|mesh-list
56139672|NCT04665570|Acarbose|acarbose|mesh-list
56139673|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56139674|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139675|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56139676|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232669|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56232670|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56232671|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56232672|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
56232673|NCT01718327|Sunitinib|sunitinib|mesh-list
56232674|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232675|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56232676|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56232677|NCT01718327|Growth Substances|growth substances|mesh-ancestor
56232678|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232679|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
56232680|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56232681|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232682|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232683|NCT01718340|Metformin|metformin|mesh-list
56232684|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56139677|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139678|NCT04656301|Psilocybin|psilocybin|mesh-list
56139679|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
56139680|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139681|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56139682|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56139683|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
56139684|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56139685|NCT04656184|Antibodies|antibodies|mesh-list
56139686|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
56139687|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56139688|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
56139689|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139690|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56139691|NCT04644068|Paclitaxel|paclitaxel|mesh-list
56139692|NCT04644068|Carboplatin|carboplatin|mesh-list
56139693|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139694|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139695|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139696|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139697|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139698|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139699|NCT04616560|Trastuzumab|trastuzumab|mesh-list
56139700|NCT04616560|Camptothecin|camptothecin|mesh-list
56139701|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
56139702|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139703|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139704|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139705|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56139706|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56139707|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139715|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139716|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56139717|NCT04573504|Clindamycin|clindamycin|mesh-list
56139718|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
56139719|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
56139720|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56139721|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56139722|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139723|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56139724|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745569|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139725|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232685|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232686|NCT01718366|Vitamin D|vitamin d|mesh-list
56232687|NCT01718366|Azacitidine|azacitidine|mesh-list
56232688|NCT01718366|Deferasirox|deferasirox|mesh-list
56232689|NCT01718366|Vitamins|vitamins|mesh-ancestor
56232690|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
56232691|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232692|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56232693|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56232694|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
56232695|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232696|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232697|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232698|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56139726|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56139727|NCT04560972|Carboplatin|carboplatin|mesh-list
56139728|NCT04560972|Etoposide|etoposide|mesh-list
56139729|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
56139730|NCT04560972|Atezolizumab|atezolizumab|mesh-list
56139731|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
56139732|NCT04560972|LB100|lb100|mesh-list
56139733|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56139734|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139735|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139736|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56139737|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56139738|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139739|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139740|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
56139741|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139742|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
56139743|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
56139744|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139745|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139746|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139749|NCT04521335|Trace Elements|trace elements|mesh-ancestor
56139750|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
56139751|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139752|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56139753|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56139754|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139755|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139756|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
56139757|NCT04515615|Tegafur|tegafur|mesh-list
56139758|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139759|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139760|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
56139761|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139762|NCT04505410|Infliximab|infliximab|mesh-list
56139763|NCT04505410|Ustekinumab|ustekinumab|mesh-list
56139764|NCT04505410|Tofacitinib|tofacitinib|mesh-list
56139765|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
56139766|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56139767|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56139768|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56139769|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139770|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139771|NCT04504669|Durvalumab|durvalumab|mesh-list
56139772|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139773|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139789|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
56232700|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
56232701|NCT01718379|Lenalidomide|lenalidomide|mesh-list
56232702|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
56232703|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232704|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56232705|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56232706|NCT01718379|Growth Substances|growth substances|mesh-ancestor
56139790|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139791|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139792|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56139793|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
56139794|NCT04477304|Narcotics|narcotics|mesh-ancestor
56139795|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56139796|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139798|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
56139799|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139800|NCT04458831|Dexamethasone|dexamethasone|mesh-list
56139801|NCT04458831|Pomalidomide|pomalidomide|mesh-list
56139802|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56139803|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
56139804|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
56139805|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139806|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139807|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56139808|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
56139809|NCT04458831|Hormones|hormones|mesh-ancestor
56139810|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139811|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56139812|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139813|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
56139814|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56139815|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55756904|NCT03269747|Hormones|hormones|mesh-ancestor
56139816|NCT04458831|Growth Substances|growth substances|mesh-ancestor
56139817|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
56139818|NCT04452747|Dinoprostone|dinoprostone|mesh-list
56139819|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
56139820|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56139821|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139822|NCT04439136|Afatinib|afatinib|mesh-list
56139823|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139824|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56139825|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139826|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139827|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
56139828|NCT04418661|Adagrasib|adagrasib|mesh-list
56139829|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139830|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139831|NCT04394546|Anticoagulants|anticoagulants|mesh-list
56139832|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
56139833|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
56139834|NCT04370301|Melphalan|melphalan|mesh-list
56139835|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
56139836|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56139837|NCT04370301|Fludarabine|fludarabine|mesh-list
56139838|NCT04370301|Tacrolimus|tacrolimus|mesh-list
56139839|NCT04370301|Lenograstim|lenograstim|mesh-list
56139840|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56139841|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139842|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
56139843|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139844|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56139845|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56139846|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
56139847|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232707|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
56232708|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232709|NCT01718496|Morphine|morphine|mesh-list
56232710|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56232711|NCT01718496|Narcotics|narcotics|mesh-ancestor
56232712|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232713|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232714|NCT01718496|Analgesics|analgesics|mesh-ancestor
56232715|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
56232716|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232717|NCT01718587|Lamivudine|lamivudine|mesh-list
56232718|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
56232719|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56232720|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56232721|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232722|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808336|NCT05254171|Immunologic Factors|immunologic factors|mesh-ancestor
56139848|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139849|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56139850|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56139851|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139852|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56139853|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56139855|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56139856|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139857|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55756912|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
55756915|NCT03269591|Progesterone|progesterone|mesh-list
56139858|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56139859|NCT04329325|Dexamethasone|dexamethasone|mesh-list
56139860|NCT04329325|Methotrexate|methotrexate|mesh-list
56139861|NCT04329325|Dasatinib|dasatinib|mesh-list
56139862|NCT04329325|Blinatumomab|blinatumomab|mesh-list
56139863|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56139864|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
56139865|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
56139866|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139867|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139868|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56139869|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
56139870|NCT04329325|Hormones|hormones|mesh-ancestor
56139871|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139872|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56139873|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139874|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56139875|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
56139876|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56139877|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139878|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
56139879|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139880|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
56139881|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139882|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56139883|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139884|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
56139885|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56139886|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56139887|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56139889|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56139890|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
56232723|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232724|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56232725|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56232727|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
56232728|NCT01718613|Norepinephrine|norepinephrine|mesh-list
56232729|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56232730|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56232731|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
56232732|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232733|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232734|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232735|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
56232736|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
56139891|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139892|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139893|NCT04280692|Lumefantrine|lumefantrine|mesh-list
56139894|NCT04280692|Artemether|artemether|mesh-list
56139895|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
56139896|NCT04280692|Primaquine|primaquine|mesh-list
56139897|NCT04280692|Piperaquine|piperaquine|mesh-list
56139898|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
56139899|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56139900|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56139901|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
56139902|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56139903|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56139904|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139905|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56139906|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139907|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139908|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56139913|NCT04248569|Ipilimumab|ipilimumab|mesh-list
56139914|NCT04248569|Poly ICLC|poly iclc|mesh-list
56139915|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139916|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139917|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55756931|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
56139918|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139919|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
56139920|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
56139921|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139922|NCT04247126|Gemcitabine|gemcitabine|mesh-list
56139923|NCT04247126|Paclitaxel|paclitaxel|mesh-list
56139924|NCT04247126|Fulvestrant|fulvestrant|mesh-list
56139925|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56139926|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139927|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
56139928|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
56139929|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139939|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56139940|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56139941|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56139942|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
56139943|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56139944|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
56139945|NCT04240093|Narcotics|narcotics|mesh-ancestor
56139946|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56139947|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232738|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56232739|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
56232740|NCT01718613|Coagulants|coagulants|mesh-ancestor
56232741|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56232742|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
56232743|NCT01718626|Docetaxel|docetaxel|mesh-list
56232744|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232745|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56232746|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56232747|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56232748|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232749|NCT01718652|Canagliflozin|canagliflozin|mesh-list
56232750|NCT01718652|Cyclosporine|cyclosporine|mesh-list
56232751|NCT01718652|Cyclosporins|cyclosporins|mesh-list
56232752|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808366|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56139948|NCT04240093|Analgesics|analgesics|mesh-ancestor
56139949|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
56139950|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56139951|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56139952|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139956|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
56139957|NCT04198766|Antibodies|antibodies|mesh-list
56139958|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
56139959|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139960|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56139961|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139962|NCT04191889|Apatinib|apatinib|mesh-list
56139963|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139964|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56139965|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139966|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139967|NCT04181996|Colchicine|colchicine|mesh-list
56139968|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
56139980|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139982|NCT04179162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139983|NCT04179162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139984|NCT04179162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139985|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
56139986|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139987|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56232753|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232754|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232755|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
56232756|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232757|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
56232758|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232759|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
56232760|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232761|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56232762|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56232763|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56232764|NCT01718678|Melatonin|melatonin|mesh-list
56140001|NCT04163432|Carboplatin|carboplatin|mesh-list
56140002|NCT04163432|Pemetrexed|pemetrexed|mesh-list
56140004|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140005|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140006|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140007|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56140008|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140009|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140010|NCT04161885|Azacitidine|azacitidine|mesh-list
56140011|NCT04161885|Venetoclax|venetoclax|mesh-list
56140012|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56140013|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
56140014|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140015|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140016|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140017|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
56140018|NCT04151706|Busulfan|busulfan|mesh-list
55866878|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
56140019|NCT04151706|Thiotepa|thiotepa|mesh-list
56140020|NCT04151706|Fludarabine|fludarabine|mesh-list
56140021|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140022|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
56140023|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140024|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56140025|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56140026|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
56140027|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140028|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140029|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56140030|NCT04151667|Dexamethasone|dexamethasone|mesh-list
56140031|NCT04151667|Lenalidomide|lenalidomide|mesh-list
56140032|NCT04151667|Bortezomib|bortezomib|mesh-list
56140033|NCT04151667|Daratumumab|daratumumab|mesh-list
56140034|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140035|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
56140036|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
56140037|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140038|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140039|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56140040|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
56140041|NCT04151667|Hormones|hormones|mesh-ancestor
56140042|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56232765|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
56232766|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232767|NCT01718678|Protective Agents|protective agents|mesh-ancestor
56232768|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232769|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232770|NCT01718717|Morphine|morphine|mesh-list
56232771|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56232772|NCT01718717|Narcotics|narcotics|mesh-ancestor
56232773|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232774|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232775|NCT01718717|Analgesics|analgesics|mesh-ancestor
56232777|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232778|NCT01718808|Capecitabine|capecitabine|mesh-list
56232779|NCT01718808|Cetuximab|cetuximab|mesh-list
56140043|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56140044|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140045|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
56140046|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56140047|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56140048|NCT04151667|Growth Substances|growth substances|mesh-ancestor
56140049|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
56140050|NCT04119453|Apatinib|apatinib|mesh-list
56140051|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140052|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56140053|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140054|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140055|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
56140056|NCT04109482|Fludarabine|fludarabine|mesh-list
56140057|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140058|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
56140059|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140060|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56140061|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56140062|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
56140063|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140064|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140065|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56140066|NCT04099251|Nivolumab|nivolumab|mesh-list
56140067|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140068|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140070|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140071|NCT04092270|Doxorubicin|doxorubicin|mesh-list
56140072|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56140073|NCT04092270|Peposertib|peposertib|mesh-list
56140074|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56140075|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140076|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56140077|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140078|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140079|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140080|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56140081|NCT04083235|Leucovorin|leucovorin|mesh-list
56140082|NCT04083235|Gemcitabine|gemcitabine|mesh-list
56140083|NCT04083235|Paclitaxel|paclitaxel|mesh-list
56140084|NCT04083235|Fluorouracil|fluorouracil|mesh-list
56140085|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
56140086|NCT04083235|Irinotecan|irinotecan|mesh-list
56140087|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140088|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140089|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
56232780|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56232781|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
56232782|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232783|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232784|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56232785|NCT01718834|Vaccines|vaccines|mesh-list
56232786|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
56232787|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140090|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140091|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140092|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140093|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56140094|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
56140095|NCT04083235|Antiviral Agents|antiviral agents|mesh-ancestor
56140096|NCT04083235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56140097|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140098|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140099|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
56140100|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140101|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56140102|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140103|NCT04083235|Antidotes|antidotes|mesh-ancestor
56140104|NCT04083235|Protective Agents|protective agents|mesh-ancestor
56140105|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
56140107|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
56140108|NCT04068610|Leucovorin|leucovorin|mesh-list
56140109|NCT04068610|Durvalumab|durvalumab|mesh-list
56140110|NCT04068610|Fluorouracil|fluorouracil|mesh-list
56140111|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
56140112|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140113|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140114|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140115|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
56140116|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140117|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56140118|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140119|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
56140120|NCT04068610|Antidotes|antidotes|mesh-ancestor
56140121|NCT04068610|Protective Agents|protective agents|mesh-ancestor
56140122|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
56140123|NCT04068610|Vitamins|vitamins|mesh-ancestor
56140124|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
56140137|NCT04028050|Carboplatin|carboplatin|mesh-list
56140138|NCT04028050|Etoposide|etoposide|mesh-list
56140139|NCT04028050|Atezolizumab|atezolizumab|mesh-list
56140140|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140141|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140142|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56140143|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140144|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140145|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756974|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
56140146|NCT04026113|Linaclotide|linaclotide|mesh-list
56140147|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56140148|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
56140149|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140150|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56140151|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56140152|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56140153|NCT04015180|Aflibercept|aflibercept|mesh-list
56140154|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56140155|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56140156|NCT04015180|Growth Substances|growth substances|mesh-ancestor
56140158|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
56140159|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140160|NCT04006119|Cemiplimab|cemiplimab|mesh-list
56140161|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56232788|NCT01718873|Leucovorin|leucovorin|mesh-list
56232789|NCT01718873|Folic Acid|folic acid|mesh-list
56232790|NCT01718873|Bevacizumab|bevacizumab|mesh-list
56232792|NCT01718873|Capecitabine|capecitabine|mesh-list
56232793|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
56232794|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
56232795|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56232796|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232798|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56232799|NCT01718873|Growth Substances|growth substances|mesh-ancestor
56232800|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232801|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
56232802|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
56232803|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232804|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56232805|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140162|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140163|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
56140164|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56140165|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745580|NCT03375645|Narcotics|narcotics|mesh-ancestor
56140166|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55757019|NCT03277391|Morphine|morphine|mesh-list
55757020|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56140167|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140168|NCT04002180|Vedolizumab|vedolizumab|mesh-list
56140169|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55867032|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
56140170|NCT04002011|Warfarin|warfarin|mesh-list
56140171|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
56140172|NCT04002011|Dabigatran|dabigatran|mesh-list
56140173|NCT04002011|Apixaban|apixaban|mesh-list
56140174|NCT04002011|Edoxaban|edoxaban|mesh-list
56140175|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
56140176|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56140177|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
56140178|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56140179|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
56140180|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140181|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140182|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
56140183|NCT03983850|Sirolimus|sirolimus|mesh-list
56140184|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
56140185|NCT03983850|Busulfan|busulfan|mesh-list
56140186|NCT03983850|Fludarabine|fludarabine|mesh-list
56140187|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140188|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
56140189|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140190|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145809|NCT00973752|Cytarabine|cytarabine|mesh-list
56140191|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56140193|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140194|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140195|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56140196|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56140197|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56140198|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
56140199|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56140200|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56140201|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140202|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
55757069|NCT03961919|Treosulfan|treosulfan|mesh-list
56232807|NCT01718873|Antidotes|antidotes|mesh-ancestor
56232808|NCT01718873|Protective Agents|protective agents|mesh-ancestor
56140203|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
56140204|NCT03969446|Decitabine|decitabine|mesh-list
56140205|NCT03969446|Venetoclax|venetoclax|mesh-list
56140206|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140207|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140208|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56140209|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
56140210|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140211|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140212|NCT03944772|Carboplatin|carboplatin|mesh-list
56140213|NCT03944772|Etoposide|etoposide|mesh-list
56140214|NCT03944772|Pemetrexed|pemetrexed|mesh-list
56140215|NCT03944772|Durvalumab|durvalumab|mesh-list
56140216|NCT03944772|Gefitinib|gefitinib|mesh-list
56140217|NCT03944772|Osimertinib|osimertinib|mesh-list
56140218|NCT03944772|Necitumumab|necitumumab|mesh-list
56140219|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140220|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140221|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56140222|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140223|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140224|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140225|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56140226|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140227|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140228|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56140229|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56140230|NCT03903692|Laxatives|laxatives|mesh-ancestor
56140233|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140234|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140235|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56140236|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140237|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
56140239|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140240|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56140241|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140242|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56140243|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
56140244|NCT03809624|Antibodies|antibodies|mesh-list
56140245|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
56140246|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140247|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140248|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140249|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
56140250|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140251|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
56140252|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140253|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140254|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140256|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56140257|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56140259|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
56140260|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140261|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140262|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140263|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56140264|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56140265|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56140266|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140267|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140268|NCT03775460|Prednisolone|prednisolone|mesh-list
56140269|NCT03775460|Methotrexate|methotrexate|mesh-list
56140270|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56140271|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
56140272|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56140273|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140274|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56232809|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
56232810|NCT01718873|Vitamins|vitamins|mesh-ancestor
56232811|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
56232812|NCT01718873|Hematinics|hematinics|mesh-ancestor
56232813|NCT01718899|Lenalidomide|lenalidomide|mesh-list
56232814|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
56232815|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232816|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56232817|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56140275|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
56140276|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140277|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140278|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
56140279|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140280|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56140281|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140282|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
56140283|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56140284|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140285|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140286|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
56140287|NCT03775460|Hormones|hormones|mesh-ancestor
56140288|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56140289|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56140290|NCT03768063|Atezolizumab|atezolizumab|mesh-list
56140291|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757110|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
55757111|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
55757112|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56140292|NCT03695380|Atezolizumab|atezolizumab|mesh-list
56140293|NCT03695380|Niraparib|niraparib|mesh-list
56140294|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140295|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56140296|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140297|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140298|NCT03653364|Baloxavir|baloxavir|mesh-list
56140299|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
56140300|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56140301|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140302|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140304|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56140306|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140307|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140308|NCT03605342|Buprenorphine|buprenorphine|mesh-list
56140309|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56140310|NCT03605342|Narcotics|narcotics|mesh-ancestor
56140311|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56140312|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140313|NCT03605342|Analgesics|analgesics|mesh-ancestor
56140314|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
56140315|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140316|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56232826|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56232827|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
56232828|NCT01718912|Ionophores|ionophores|mesh-ancestor
55808435|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56140335|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140336|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56140337|NCT03538691|Dexetimide|dexetimide|mesh-list
56140338|NCT03538691|Citalopram|citalopram|mesh-list
56140339|NCT03538691|Fluoxetine|fluoxetine|mesh-list
56140340|NCT03538691|Paroxetine|paroxetine|mesh-list
56140341|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56140342|NCT03538691|Sertraline|sertraline|mesh-list
56140343|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
56140344|NCT03538691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56140345|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56140346|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56140347|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140348|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56140349|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
56140350|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140351|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56140352|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
56140353|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56140354|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56140355|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56140356|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
56140357|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
56140358|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140359|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56140360|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56140361|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
56140362|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56140363|NCT03538691|Analgesics|analgesics|mesh-ancestor
56140364|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
56140365|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
55757149|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56140366|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56140367|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56140370|NCT03523585|Capecitabine|capecitabine|mesh-list
56140371|NCT03523585|Trastuzumab|trastuzumab|mesh-list
56140372|NCT03523585|Lapatinib|lapatinib|mesh-list
56140373|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56140374|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
56140375|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140376|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140377|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140379|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140380|NCT03509012|Paclitaxel|paclitaxel|mesh-list
56140381|NCT03509012|Etoposide|etoposide|mesh-list
56140382|NCT03509012|Cisplatin|cisplatin|mesh-list
56140383|NCT03509012|Carboplatin|carboplatin|mesh-list
56140384|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
56140385|NCT03509012|Pemetrexed|pemetrexed|mesh-list
56140386|NCT03509012|Durvalumab|durvalumab|mesh-list
56140387|NCT03509012|Tremelimumab|tremelimumab|mesh-list
56140388|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140389|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140390|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56232829|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232830|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232831|NCT01718951|Pamidronate|pamidronate|mesh-list
56232832|NCT01718951|Golimumab|golimumab|mesh-list
56232833|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56232834|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56232835|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232836|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
56232837|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140391|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140392|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140393|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140394|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56140395|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140396|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140397|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56140398|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140399|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140400|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56140402|NCT03497676|Cabotegravir|cabotegravir|mesh-list
56140403|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
56140404|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56140405|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56140406|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140407|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140408|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140409|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56140410|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55757164|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55757165|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56140411|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56140412|NCT03489018|Vaccines|vaccines|mesh-list
56140413|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56140414|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
56140415|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140416|NCT03469960|Nivolumab|nivolumab|mesh-list
56140417|NCT03469960|Ipilimumab|ipilimumab|mesh-list
56140418|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140419|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140420|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56140421|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140422|NCT03439033|Edetic Acid|edetic acid|mesh-list
56140423|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
56140424|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
56145874|NCT00976248|Everolimus|everolimus|mesh-list
56140425|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
56140426|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140427|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
56140428|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56140429|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
56140430|NCT03419234|Prednisone|prednisone|mesh-list
56140431|NCT03419234|Cortisone|cortisone|mesh-list
56140432|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
56140433|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
56140434|NCT03419234|Hormones|hormones|mesh-list
56140435|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56140436|NCT03419234|Androgens|androgens|mesh-list
56140437|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
56140438|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140439|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
56140440|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56140441|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140442|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56140443|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140444|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56140445|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232838|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56232839|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
56232840|NCT01718964|Mannitol|mannitol|mesh-list
56140446|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140447|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
56140448|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56140449|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
56140450|NCT03419234|Protective Agents|protective agents|mesh-ancestor
56140451|NCT03419234|Vitamins|vitamins|mesh-ancestor
55757187|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56140452|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
56140453|NCT03419234|Estrogens|estrogens|mesh-ancestor
56140455|NCT03330886|Atezolizumab|atezolizumab|mesh-list
56140456|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140457|NCT03282916|Valacyclovir|valacyclovir|mesh-list
56140458|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
56140459|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56140460|NCT03282799|Etonogestrel|etonogestrel|mesh-list
56140461|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56140462|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
56140463|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56140464|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140465|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56140466|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56140467|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56140468|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140470|NCT03188705|Clopidogrel|clopidogrel|mesh-list
56140471|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56140472|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56140473|NCT03188705|Analgesics|analgesics|mesh-ancestor
56140474|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
56140475|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140476|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140477|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140478|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56140479|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56145880|NCT00976404|Maraviroc|maraviroc|mesh-list
56140480|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56140481|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140482|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56140483|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56140484|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140485|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
56140486|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56140487|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56140488|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56140489|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
56140490|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56140491|NCT03125928|Paclitaxel|paclitaxel|mesh-list
56140492|NCT03125928|Trastuzumab|trastuzumab|mesh-list
56140493|NCT03125928|Atezolizumab|atezolizumab|mesh-list
56140494|NCT03125928|Pertuzumab|pertuzumab|mesh-list
56140495|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140496|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140497|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140498|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140499|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140500|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140501|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140502|NCT03114319|Nazartinib|nazartinib|mesh-list
56140503|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140504|NCT03085056|Paclitaxel|paclitaxel|mesh-list
56140505|NCT03085056|Trametinib|trametinib|mesh-list
56140506|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140507|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140508|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140509|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140510|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140511|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140512|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56140513|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140514|NCT03006705|Capecitabine|capecitabine|mesh-list
56140515|NCT03006705|Tegafur|tegafur|mesh-list
56140516|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
56140517|NCT03006705|Nivolumab|nivolumab|mesh-list
56140518|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56140519|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
56232841|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56232842|NCT01718964|Diuretics|diuretics|mesh-ancestor
56232843|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
56232844|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232845|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56232846|NCT01719042|Ondansetron|ondansetron|mesh-list
56232847|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
56232848|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
56232849|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232850|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232851|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56232852|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
56232853|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
56232854|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56232855|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
56232856|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232857|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232858|NCT01719042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56232859|NCT01719042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56232860|NCT01719042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232861|NCT01719042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56232862|NCT01719042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56232863|NCT01719133|Histamine|histamine|mesh-list
56232864|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
56140520|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140521|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140522|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140523|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56140524|NCT02987543|Olaparib|olaparib|mesh-list
56140525|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
56140526|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56140527|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140528|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140529|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140532|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56140533|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140534|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56140535|NCT02983045|Paclitaxel|paclitaxel|mesh-list
56140536|NCT02983045|Cisplatin|cisplatin|mesh-list
56140537|NCT02983045|Carboplatin|carboplatin|mesh-list
56140538|NCT02983045|Nivolumab|nivolumab|mesh-list
56140539|NCT02983045|Pemetrexed|pemetrexed|mesh-list
56140540|NCT02983045|Ipilimumab|ipilimumab|mesh-list
56140541|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140542|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140543|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140544|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140545|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140546|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232865|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
56232866|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
56232867|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232868|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232869|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232870|NCT01719159|Rituximab|rituximab|mesh-list
56232871|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56232872|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232873|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
55808456|NCT05209711|Lidocaine|lidocaine|mesh-list
56140547|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140548|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56140549|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140551|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140552|NCT02894398|Letrozole|letrozole|mesh-list
56140553|NCT02894398|Fulvestrant|fulvestrant|mesh-list
56140554|NCT02894398|Palbociclib|palbociclib|mesh-list
56140555|NCT02894398|Anastrozole|anastrozole|mesh-list
56140556|NCT02894398|Exemestane|exemestane|mesh-list
56140557|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140558|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56140559|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56140560|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140561|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140562|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56140563|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
56140564|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56140565|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140566|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56140567|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56140568|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56140569|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56140570|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56140571|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56140572|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
56140573|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140574|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140575|NCT02678052|Vedolizumab|vedolizumab|mesh-list
56140576|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56140577|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56140578|NCT02616965|Romidepsin|romidepsin|mesh-list
56140579|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140580|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140581|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56140582|NCT02576717|Ozanimod|ozanimod|mesh-list
56140583|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56140584|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140585|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140586|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
56140587|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140588|NCT02564263|Paclitaxel|paclitaxel|mesh-list
56140589|NCT02564263|Docetaxel|docetaxel|mesh-list
56140590|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
56140591|NCT02564263|Irinotecan|irinotecan|mesh-list
56140592|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140593|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140594|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140595|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140596|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140597|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140598|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140599|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56140600|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140601|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140602|NCT02540018|Paclitaxel|paclitaxel|mesh-list
56232874|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232875|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232876|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
56232877|NCT01719185|Phentermine|phentermine|mesh-list
56232878|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56232879|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232880|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
56232881|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56232882|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
56232883|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
56232884|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232885|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
56232886|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232887|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232888|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
55757300|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757301|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
56232889|NCT01719185|Vitamins|vitamins|mesh-ancestor
56232890|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
56232891|NCT01719302|Gemcitabine|gemcitabine|mesh-list
56232892|NCT01719302|Docetaxel|docetaxel|mesh-list
56232893|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56232894|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
56232895|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232896|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232897|NCT01719302|Antiviral Agents|antiviral agents|mesh-ancestor
56140605|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140606|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140607|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140608|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140610|NCT02496208|Ipilimumab|ipilimumab|mesh-list
56140611|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140612|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140613|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56140614|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140615|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
56140616|NCT02437136|Entinostat|entinostat|mesh-list
56140617|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140618|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140619|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56140620|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140621|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140622|NCT02423265|Ranolazine|ranolazine|mesh-list
56140623|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56140624|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56140625|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140627|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140628|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
56140629|NCT02368886|Hormones|hormones|mesh-ancestor
56140630|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56140631|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140632|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
56232898|NCT01719302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232899|NCT01719302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232900|NCT01719302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232901|NCT01719302|Immunologic Factors|immunologic factors|mesh-ancestor
56232902|NCT01719302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232903|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
56232904|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
56232905|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
56232907|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232908|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232909|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56232910|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56232911|NCT01719588|Tapentadol|tapentadol|mesh-list
56232912|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56232913|NCT01719588|Narcotics|narcotics|mesh-ancestor
56232914|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757322|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757326|NCT03257423|Ofloxacin|ofloxacin|mesh-list
56232915|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232916|NCT01719588|Analgesics|analgesics|mesh-ancestor
56232917|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
56232918|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232919|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56232920|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56232921|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55808486|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140633|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140634|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140635|NCT02301286|Aspirin|aspirin|mesh-list
56140636|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56140637|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56140638|NCT02301286|Analgesics|analgesics|mesh-ancestor
56140639|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
56140640|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140641|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140642|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140643|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56140644|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56140645|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56140646|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140647|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56140648|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56145932|NCT00987948|Maraviroc|maraviroc|mesh-list
56140650|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
56140651|NCT02231749|Nivolumab|nivolumab|mesh-list
56140652|NCT02231749|Ipilimumab|ipilimumab|mesh-list
56140653|NCT02231749|Sunitinib|sunitinib|mesh-list
56140654|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140655|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140656|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56232922|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232923|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
56232924|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232926|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56232927|NCT01719601|Narcotics|narcotics|mesh-ancestor
56232928|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232929|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232930|NCT01719601|Analgesics|analgesics|mesh-ancestor
56232931|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
56140657|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140658|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56140659|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56140660|NCT02231749|Growth Substances|growth substances|mesh-ancestor
56140661|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140662|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
56140663|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56140664|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140665|NCT02126969|Carboplatin|carboplatin|mesh-list
56140666|NCT02126969|Docetaxel|docetaxel|mesh-list
56140667|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140668|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140669|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140670|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140671|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140672|NCT02099188|Leucovorin|leucovorin|mesh-list
56140673|NCT02099188|Docetaxel|docetaxel|mesh-list
56140674|NCT02099188|Doxorubicin|doxorubicin|mesh-list
56140675|NCT02099188|Fluorouracil|fluorouracil|mesh-list
56140676|NCT02099188|Etoposide|etoposide|mesh-list
56140677|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56140678|NCT02099188|Ifosfamide|ifosfamide|mesh-list
56140679|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140680|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140681|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140682|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140683|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757347|NCT03262727|BMS-986165|bms-986165|mesh-list
56140684|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56140685|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56140686|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140687|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140688|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
56140689|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56140690|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140691|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
56140692|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140693|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140694|NCT02099188|Antidotes|antidotes|mesh-ancestor
56140695|NCT02099188|Protective Agents|protective agents|mesh-ancestor
56140696|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
56140697|NCT02099188|Vitamins|vitamins|mesh-ancestor
56140698|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
56140699|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56140700|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
56140701|NCT02099175|Leucovorin|leucovorin|mesh-list
56140702|NCT02099175|Docetaxel|docetaxel|mesh-list
56140703|NCT02099175|Doxorubicin|doxorubicin|mesh-list
56140704|NCT02099175|Fluorouracil|fluorouracil|mesh-list
56140705|NCT02099175|Etoposide|etoposide|mesh-list
56140706|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56140707|NCT02099175|Ifosfamide|ifosfamide|mesh-list
56140708|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140709|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140710|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140711|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140712|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140713|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56140714|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56232932|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232933|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56232934|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56232935|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232936|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232937|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
56232938|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56232939|NCT01719614|Metformin|metformin|mesh-list
56232940|NCT01719614|Rilpivirine|rilpivirine|mesh-list
56232941|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56232942|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232943|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56232944|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56232945|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56232946|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232947|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
56232948|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232950|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56232951|NCT01719627|Maraviroc|maraviroc|mesh-list
56232952|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56232953|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56232954|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232955|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56232956|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56232957|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
56140715|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140716|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140717|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
56140718|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55757354|NCT03262727|Hormones|hormones|mesh-ancestor
56140719|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140720|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
56140721|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140722|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140723|NCT02099175|Antidotes|antidotes|mesh-ancestor
56140724|NCT02099175|Protective Agents|protective agents|mesh-ancestor
56140725|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
56140726|NCT02099175|Vitamins|vitamins|mesh-ancestor
56140727|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
56140728|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56140729|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
56140730|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56140731|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
56140733|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140734|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140735|NCT02003222|Cytarabine|cytarabine|mesh-list
56140736|NCT02003222|Dexamethasone|dexamethasone|mesh-list
56140737|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
56232958|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56232959|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56232961|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56232962|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56232963|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
56232964|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232965|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56232966|NCT01719705|Pregabalin|pregabalin|mesh-list
56232967|NCT01719705|Analgesics|analgesics|mesh-ancestor
56232968|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
56232969|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232970|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232971|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
56232972|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56232973|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56232974|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232975|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56232976|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56232977|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56232978|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56232979|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56232980|NCT01719770|Rocuronium|rocuronium|mesh-list
56232981|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56232982|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56232983|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56232984|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56232985|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56232986|NCT01719835|Gemcitabine|gemcitabine|mesh-list
56232987|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
56232988|NCT01719835|Prednisolone|prednisolone|mesh-list
56232989|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
56232990|NCT01719835|Doxorubicin|doxorubicin|mesh-list
56232991|NCT01719835|Vincristine|vincristine|mesh-list
56232992|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56232997|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
56232998|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56232999|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233000|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55757369|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
56233001|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56233002|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
56233003|NCT01719835|Antiviral Agents|antiviral agents|mesh-ancestor
56233004|NCT01719835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233005|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233006|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56233007|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56233008|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56233009|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56233010|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
56233011|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
56233012|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
56233013|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233014|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
56233015|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
56233016|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233017|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233018|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
56233019|NCT01719835|Hormones|hormones|mesh-ancestor
56233020|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56233021|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56233022|NCT01719835|Protective Agents|protective agents|mesh-ancestor
56233023|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56233024|NCT01719926|Indomethacin|indomethacin|mesh-list
56233025|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56233026|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56140738|NCT02003222|Prednisone|prednisone|mesh-list
56140739|NCT02003222|Cortisone|cortisone|mesh-list
56140740|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
56140741|NCT02003222|Rituximab|rituximab|mesh-list
56140742|NCT02003222|Methotrexate|methotrexate|mesh-list
56140743|NCT02003222|Etoposide|etoposide|mesh-list
56140744|NCT02003222|Vincristine|vincristine|mesh-list
56140745|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
56140746|NCT02003222|Daunorubicin|daunorubicin|mesh-list
56140747|NCT02003222|Asparaginase|asparaginase|mesh-list
56140748|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
56140749|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
56140750|NCT02003222|Pegaspargase|pegaspargase|mesh-list
56140751|NCT02003222|Blinatumomab|blinatumomab|mesh-list
56140752|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56233027|NCT01719926|Analgesics|analgesics|mesh-ancestor
56233028|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
56233029|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233030|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233031|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233032|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233033|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
56233034|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
56233035|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56233036|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56233037|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233038|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233039|NCT01719952|Oxytocin|oxytocin|mesh-list
56233040|NCT01719952|Carbetocin|carbetocin|mesh-list
56233041|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
56233042|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56233043|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233044|NCT01719978|Epinephrine|epinephrine|mesh-list
56233045|NCT01719978|Racepinephrine|racepinephrine|mesh-list
56233046|NCT01719978|Mepivacaine|mepivacaine|mesh-list
56233047|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
56233048|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56233049|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56233050|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
56233051|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233052|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233053|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233054|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56233055|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56233056|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
56233057|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233058|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56233059|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
56233060|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
56233061|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
56233062|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56233063|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
55808617|NCT05225155|Enoxaparin|enoxaparin|mesh-list
56140753|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
56233064|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
56233065|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233066|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
56233067|NCT01720459|Resveratrol|resveratrol|mesh-list
56233068|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
56233069|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233070|NCT01720459|Protective Agents|protective agents|mesh-ancestor
56233071|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233072|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233073|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56233074|NCT01720537|Bococizumab|bococizumab|mesh-list
56233075|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56145991|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56233076|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56233077|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56233078|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
56233079|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233080|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56233081|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
56233082|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233083|NCT01720719|Vitamin E|vitamin e|mesh-list
56233084|NCT01720719|Atorvastatin|atorvastatin|mesh-list
56233085|NCT01720719|Vitamins|vitamins|mesh-ancestor
56233086|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
56233087|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233088|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56233089|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56233090|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
56233091|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233092|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56233093|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56233094|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233095|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
56233096|NCT01720719|Protective Agents|protective agents|mesh-ancestor
56233097|NCT01722214|Adalimumab|adalimumab|mesh-list
56233098|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140754|NCT02003222|Antibodies|antibodies|mesh-list
56233104|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233105|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233106|NCT01723852|Vitamin D|vitamin d|mesh-list
56233107|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
56233108|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
56233109|NCT01723852|Vitamins|vitamins|mesh-list
56233110|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
56233111|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233112|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56233113|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56233114|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
56233115|NCT01724229|Clotrimazole|clotrimazole|mesh-list
56233116|NCT01724229|Miconazole|miconazole|mesh-list
56233117|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233118|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56233119|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56233120|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56233121|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233122|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233123|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56233124|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
56233125|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56233126|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233127|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55808688|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
56140755|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
56140756|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56140757|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56140760|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
56140761|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140762|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56140763|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56140764|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
55757440|NCT03059979|Hormones|hormones|mesh-ancestor
55757446|NCT03256721|Docetaxel|docetaxel|mesh-list
56140765|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140766|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140767|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56140768|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140770|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
56140771|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140772|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56140773|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
56140775|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56140776|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56140777|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
56140778|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233128|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56233129|NCT01724450|Carvedilol|carvedilol|mesh-list
56233130|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56233131|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56233132|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
56233133|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233134|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233135|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233136|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56233137|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
56233138|NCT01724450|Protective Agents|protective agents|mesh-ancestor
56233139|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56233140|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56233141|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55808714|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140779|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56140780|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
56140781|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56140782|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56140783|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
56140784|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56140785|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56140786|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140787|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140788|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56140789|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56140790|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
56140791|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56140792|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140793|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140794|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140795|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56140796|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
56140797|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56140798|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56140799|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56140800|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
56140801|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140802|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140803|NCT01946074|Paclitaxel|paclitaxel|mesh-list
56140804|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140805|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140806|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140807|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140808|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140809|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140810|NCT01715285|Prednisone|prednisone|mesh-list
56140811|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
56140812|NCT01715285|Androgens|androgens|mesh-list
56140813|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140814|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
56140815|NCT01715285|Hormones|hormones|mesh-ancestor
56140816|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56140817|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140818|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56140819|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140820|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56140821|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233142|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
56233143|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56233144|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56233146|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
56233147|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233148|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56233149|NCT01724892|Dexamethasone|dexamethasone|mesh-list
56233150|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233151|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
56233152|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
55808735|NCT05175781|Ketamine|ketamine|mesh-list
56140822|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140823|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
56140824|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56140825|NCT01705184|Bevacizumab|bevacizumab|mesh-list
56140826|NCT01705184|Pemetrexed|pemetrexed|mesh-list
56140827|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140828|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140829|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56140830|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56140832|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140833|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
56140834|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140835|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140836|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56140837|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140840|NCT01285817|Methotrexate|methotrexate|mesh-list
56140841|NCT01285817|Vinblastine|vinblastine|mesh-list
56140842|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140843|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
56140844|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140845|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56140846|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56140847|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
56140848|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140849|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140850|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56140851|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56140852|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
56140853|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55867712|NCT03830086|Midazolam|midazolam|mesh-list
56140854|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56140855|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
56140856|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
56140857|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140858|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56140859|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140860|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56140861|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56140862|NCT01285817|Analgesics|analgesics|mesh-ancestor
56140863|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
56140864|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140865|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56140866|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56140867|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56140868|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140869|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140870|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140871|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140872|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56140873|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56233153|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233154|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233155|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233156|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
56233157|NCT01724892|Hormones|hormones|mesh-ancestor
56233158|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56233159|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56233160|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233161|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56233162|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56233163|NCT01726400|Interferons|interferons|mesh-list
56233164|NCT01726400|Ribavirin|ribavirin|mesh-list
56233165|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
56233166|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233167|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
56233168|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233169|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
56233170|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233171|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
56233172|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233173|NCT01726582|Leucovorin|leucovorin|mesh-list
56233174|NCT01726582|Gemcitabine|gemcitabine|mesh-list
56233175|NCT01726582|Paclitaxel|paclitaxel|mesh-list
56233176|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56233177|NCT01726582|Capecitabine|capecitabine|mesh-list
56140874|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140875|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140876|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
56140877|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140878|NCT01250496|Aminophylline|aminophylline|mesh-list
55757505|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757506|NCT04974723|Teriparatide|teriparatide|mesh-list
56140879|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56140880|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
56140881|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140882|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140883|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56140884|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
56140885|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56140886|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56140887|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140888|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140889|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56140890|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56140891|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
56140892|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56140893|NCT01250496|Protective Agents|protective agents|mesh-ancestor
56140894|NCT01105975|Atorvastatin|atorvastatin|mesh-list
56140895|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56140897|NCT01105975|Evacetrapib|evacetrapib|mesh-list
56140898|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56233178|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
56233179|NCT01726582|Irinotecan|irinotecan|mesh-list
56233180|NCT01726582|Cisplatin|cisplatin|mesh-list
56233181|NCT01726582|Folfirinox|folfirinox|mesh-list
56233182|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56233183|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233184|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56233185|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56233186|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56233187|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233188|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56233189|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
56140899|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56140900|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
56140901|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140902|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56140913|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55757541|NCT04963881|Antibodies|antibodies|mesh-list
56140914|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140915|NCT00819637|Albuterol|albuterol|mesh-list
56140916|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
56140917|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56140918|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
56140919|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56140920|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140921|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56140922|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
56140923|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56140924|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56140925|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56140926|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
56140927|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56140928|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140929|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
56140930|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56140931|NCT00651456|Bevacizumab|bevacizumab|mesh-list
56140932|NCT00651456|Cisplatin|cisplatin|mesh-list
56140933|NCT00651456|Pemetrexed|pemetrexed|mesh-list
56140934|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56140935|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140936|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56140937|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56140938|NCT00651456|Growth Substances|growth substances|mesh-ancestor
56140939|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140940|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
56140941|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140942|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140943|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56140944|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56140945|NCT00280202|Dimercaprol|dimercaprol|mesh-list
56140946|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
56140947|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
56140948|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140949|NCT00079417|Iodine|iodine|mesh-list
56140950|NCT00079417|Cadexomer iodine|cadexomer iodine|mesh-list
56140951|NCT00079417|Carboplatin|carboplatin|mesh-list
56140952|NCT00079417|Vincristine|vincristine|mesh-list
56140953|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140954|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140955|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140956|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140958|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140959|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56140960|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233190|NCT01726582|Antiviral Agents|antiviral agents|mesh-ancestor
56233191|NCT01726582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233192|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233193|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233194|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
56233195|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233196|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56233197|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56233198|NCT01726582|Antidotes|antidotes|mesh-ancestor
56233199|NCT01726582|Protective Agents|protective agents|mesh-ancestor
56233200|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
56233201|NCT01726582|Vitamins|vitamins|mesh-ancestor
56233202|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
56233203|NCT01727427|Aspirin|aspirin|mesh-list
56233204|NCT01727427|Vitamin K|vitamin k|mesh-list
56233205|NCT01727427|Heparin|heparin|mesh-list
56233206|NCT01727427|Enoxaparin|enoxaparin|mesh-list
56233207|NCT01727427|Dalteparin|dalteparin|mesh-list
56233208|NCT01727427|Tinzaparin|tinzaparin|mesh-list
56233209|NCT01727427|PENTA|penta|mesh-list
56233210|NCT01727427|Nadroparin|nadroparin|mesh-list
56233211|NCT01727427|Warfarin|warfarin|mesh-list
56233212|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
56233213|NCT01727427|Dabigatran|dabigatran|mesh-list
56233214|NCT01727427|Apixaban|apixaban|mesh-list
56233215|NCT01727427|Fondaparinux|fondaparinux|mesh-list
56233216|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
56233217|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
56233218|NCT01727427|Bemiparin|bemiparin|mesh-list
56233219|NCT01727427|Vitamins|vitamins|mesh-ancestor
56140961|NCT00079417|Trace Elements|trace elements|mesh-ancestor
56140962|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
56140963|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140964|NCT04387500|Axitinib|axitinib|mesh-list
56140965|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140966|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56140968|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140970|NCT04386876|Lopinavir|lopinavir|mesh-list
56140971|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56140972|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56140973|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
56140974|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140975|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140976|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56140977|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56140978|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
56140979|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56140980|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56140981|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56140982|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
55757580|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56140983|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56140984|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56140985|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140986|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
56140987|NCT04386642|Coagulants|coagulants|mesh-ancestor
56233221|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233222|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56233223|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56233224|NCT01727427|Analgesics|analgesics|mesh-ancestor
56233225|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
56233226|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233227|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233228|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233230|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56233231|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233232|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56233233|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56233234|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233235|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
56233236|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
56233237|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56233238|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
56233239|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56233240|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
55808804|NCT01365091|Metformin|metformin|mesh-list
56140988|NCT04385550|Paclitaxel|paclitaxel|mesh-list
56140989|NCT04385550|Docetaxel|docetaxel|mesh-list
56140990|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140991|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140992|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140993|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140994|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140995|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140996|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
56140997|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
56140998|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56140999|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141000|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757630|NCT03259529|Antiviral Agents|antiviral agents|mesh-ancestor
56141001|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141002|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141003|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141004|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141005|NCT04384458|Ivermectin|ivermectin|mesh-list
56141006|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
56141007|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141008|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141009|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141010|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141011|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141012|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141013|NCT04383990|Insulin|insulin|mesh-list
56141014|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56141015|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141016|NCT04381884|Ivermectin|ivermectin|mesh-list
56141017|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141018|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141019|NCT04381962|Azithromycin|azithromycin|mesh-list
56233241|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56233242|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
56233243|NCT01727427|Coagulants|coagulants|mesh-ancestor
56233244|NCT01727778|Antibodies|antibodies|mesh-list
56233245|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
56233246|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
56233247|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233248|NCT01728025|Ranolazine|ranolazine|mesh-list
56233249|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56233250|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56233251|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233252|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56233253|NCT01728363|Rifampin|rifampin|mesh-list
56233254|NCT01728363|Clindamycin|clindamycin|mesh-list
56233255|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
56233256|NCT01728363|Ticarcillin|ticarcillin|mesh-list
56233258|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233260|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
56233261|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
56233262|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56233263|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233264|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233265|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56233266|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56233267|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56233268|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56233269|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56233270|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56233271|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56233272|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56233273|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
56233283|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
56233284|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56233285|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233286|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56233287|NCT01730157|Ipilimumab|ipilimumab|mesh-list
56233288|NCT01730157|Antibodies|antibodies|mesh-list
56233289|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
56233290|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56233291|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
56233292|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233293|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233294|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56233295|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757670|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56233296|NCT01730209|Everolimus|everolimus|mesh-list
56233297|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233298|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233299|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
56233300|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233301|NCT01730222|Gemcitabine|gemcitabine|mesh-list
56233302|NCT01730222|Paclitaxel|paclitaxel|mesh-list
56233303|NCT01730222|Capecitabine|capecitabine|mesh-list
56233304|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56233305|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233306|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
56233307|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
56233308|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
56233309|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233310|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56233311|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
56233312|NCT01730222|Antiviral Agents|antiviral agents|mesh-ancestor
56233329|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233330|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
56233331|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56233332|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233333|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233334|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56233335|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233336|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233337|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233338|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56233339|NCT01730495|Etanercept|etanercept|mesh-list
56233340|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56233341|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56233342|NCT01730495|Analgesics|analgesics|mesh-ancestor
56233343|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
56233344|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233345|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233346|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233348|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233349|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233350|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
56233351|NCT01730508|Interferons|interferons|mesh-list
56233352|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
56233353|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233354|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
56141020|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56141021|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141022|NCT04381104|Acetaminophen|acetaminophen|mesh-list
56141023|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56141024|NCT04381104|Analgesics|analgesics|mesh-ancestor
56141025|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
56141026|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141027|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141028|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
56141029|NCT04380402|Atorvastatin|atorvastatin|mesh-list
56141030|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56141031|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56141032|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
56141033|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141034|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56141035|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56141036|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141037|NCT04380012|Trastuzumab|trastuzumab|mesh-list
56141038|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56141039|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141040|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
56233355|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233356|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
56233357|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233358|NCT01730612|Histamine|histamine|mesh-list
56233359|NCT01730612|Glycine|glycine|mesh-list
56233360|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
56233361|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
56233362|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233363|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233364|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233365|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
56233366|NCT01730664|Ertapenem|ertapenem|mesh-list
56233367|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56233368|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233369|NCT01730677|Vinorelbine|vinorelbine|mesh-list
56233370|NCT01730677|Lapatinib|lapatinib|mesh-list
56233371|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56233372|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233373|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
56233374|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
56233375|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
56233376|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233377|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56233378|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233379|NCT01730976|Vitamin D|vitamin d|mesh-list
56233380|NCT01730976|Vitamins|vitamins|mesh-list
56233381|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
56233382|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233383|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56233384|NCT01731067|Fexofenadine|fexofenadine|mesh-list
56233385|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
56233386|NCT01731067|Midazolam|midazolam|mesh-list
56233402|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
56146109|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
56233403|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233404|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233405|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56233406|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56233408|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56233409|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56233410|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
56233411|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56233412|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233413|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56233414|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56233415|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
56233416|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56233417|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56141043|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56141044|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141046|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141047|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781625|NCT02366299|Propofol|propofol|mesh-list
55757692|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56141048|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56141049|NCT04378608|Ribavirin|ribavirin|mesh-list
56141050|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
56141051|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141052|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
56141053|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141054|NCT04376970|Fluorometholone|fluorometholone|mesh-list
56141055|NCT04376970|Cyclosporine|cyclosporine|mesh-list
56141056|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56141057|NCT04376970|Cyclosporins|cyclosporins|mesh-list
56141058|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141059|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141060|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56141061|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
56141062|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141063|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
56141064|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141065|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
56141066|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141067|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56141068|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56141069|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141070|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
56141071|NCT04376970|Hormones|hormones|mesh-ancestor
56141072|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141073|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56141074|NCT04377048|Gemcitabine|gemcitabine|mesh-list
56141075|NCT04377048|Tegafur|tegafur|mesh-list
56141076|NCT04377048|Nivolumab|nivolumab|mesh-list
56141077|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56141078|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
56141079|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867936|NCT02241460|Lidocaine|lidocaine|mesh-list
56141080|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141081|NCT04377048|Antiviral Agents|antiviral agents|mesh-ancestor
56141082|NCT04377048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141083|NCT04377048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141084|NCT04377048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233418|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56233419|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
56233420|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56233421|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56233422|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
55809000|NCT05054881|Iodine|iodine|mesh-list
56141085|NCT04377048|Immunologic Factors|immunologic factors|mesh-ancestor
56141086|NCT04377048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141087|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56141088|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56141089|NCT04376814|Ritonavir|ritonavir|mesh-list
56141090|NCT04376814|Lopinavir|lopinavir|mesh-list
56141091|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141092|NCT04376814|Favipiravir|favipiravir|mesh-list
56141093|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56141094|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56141095|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141096|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141097|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141098|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56141099|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56141100|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
56141101|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141102|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56141103|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56141104|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
56141105|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141106|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141107|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141108|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141109|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
56141110|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141111|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141112|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141113|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141114|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141117|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56141118|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56141119|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141120|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56141121|NCT04374318|Analgesics|analgesics|mesh-ancestor
56141122|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
56141123|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141124|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56141126|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56141127|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
56141128|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56141129|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141130|NCT04374552|Azithromycin|azithromycin|mesh-list
56141131|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141132|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55757751|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55757752|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55757753|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56141133|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141134|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
56141135|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141136|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141137|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141138|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141139|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141140|NCT04374006|Propolis|propolis|mesh-list
56141141|NCT04374006|Dienogest|dienogest|mesh-list
56141142|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141143|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56141144|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
56141145|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56141146|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141147|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56141148|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56141149|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56141150|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56233423|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
56233424|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56233425|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56233426|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56233427|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56233428|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56233429|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
56233430|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
56233432|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
56233433|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233434|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56233435|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56233436|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233437|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233438|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56233439|NCT01731132|Copper|copper|mesh-list
56141151|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
56141152|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141153|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56141154|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141155|NCT04372836|Vasopressins|vasopressins|mesh-list
56141156|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
56141157|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
56141158|NCT04372836|Coagulants|coagulants|mesh-ancestor
56141159|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56141160|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56141161|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
55757783|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
56141162|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141163|NCT04371978|Linagliptin|linagliptin|mesh-list
56141164|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56141165|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141166|NCT04371978|Incretins|incretins|mesh-ancestor
56141167|NCT04371978|Hormones|hormones|mesh-ancestor
56141168|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141169|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56141170|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141171|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141172|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141173|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
56141174|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
56141175|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56141176|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
56141177|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141178|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141179|NCT04370262|Famotidine|famotidine|mesh-list
56141180|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56141181|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56141182|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56141183|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
56141184|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
56141185|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56141186|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141187|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141188|NCT04368546|Sunitinib|sunitinib|mesh-list
56141190|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56233443|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56233444|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233445|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56233446|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56233448|NCT01731132|Trace Elements|trace elements|mesh-ancestor
56233449|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
56233450|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
56233451|NCT01731158|Bevacizumab|bevacizumab|mesh-list
56233452|NCT01731158|Sunitinib|sunitinib|mesh-list
56233453|NCT01731158|Everolimus|everolimus|mesh-list
56233454|NCT01731158|Sorafenib|sorafenib|mesh-list
56233455|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56233456|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233457|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56233458|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56233459|NCT01731158|Growth Substances|growth substances|mesh-ancestor
56233460|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233461|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
56233462|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233463|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
56233464|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56233465|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233466|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141191|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56141192|NCT04368546|Growth Substances|growth substances|mesh-ancestor
56141193|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141194|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
56141195|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56141196|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141197|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141203|NCT04366596|Paclitaxel|paclitaxel|mesh-list
56141204|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56141205|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141206|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
56141207|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
56141208|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
56141209|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141210|NCT04366050|Ramipril|ramipril|mesh-list
56141211|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56141212|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
56233467|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
56233468|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233470|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56233471|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56233472|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233473|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233474|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56233475|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56233476|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56233477|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56233478|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
56233479|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
56233480|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
56233481|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
56233482|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233483|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233484|NCT01731275|Quetmolimab|quetmolimab|mesh-list
56233485|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56233486|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233487|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
56233488|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233489|NCT01731301|Ribavirin|ribavirin|mesh-list
56233490|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
56233491|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233492|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
56146157|NCT01010568|Ofatumumab|ofatumumab|mesh-list
56233493|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233494|NCT01731327|Tofacitinib|tofacitinib|mesh-list
56233495|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56233496|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233497|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233498|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
56233499|NCT01731340|Calcium|calcium|mesh-list
56233500|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56233501|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141213|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141214|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141215|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56141216|NCT04365582|Ritonavir|ritonavir|mesh-list
56141217|NCT04365582|Lopinavir|lopinavir|mesh-list
56141218|NCT04365582|Azithromycin|azithromycin|mesh-list
56233502|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56233504|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56233505|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233506|NCT01731457|Etanercept|etanercept|mesh-list
56233507|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56233508|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56233509|NCT01731457|Analgesics|analgesics|mesh-ancestor
56233510|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
56233511|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233512|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233513|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233514|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141219|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141220|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56141221|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56141222|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141223|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141224|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141225|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56141226|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56141227|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
56141228|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141229|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56141230|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56141231|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56141232|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
56141233|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141234|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141235|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141236|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
56141237|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56141238|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
56141239|NCT04365270|Chitosan|chitosan|mesh-list
56141240|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56141241|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141242|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
56141243|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
56146177|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
56141244|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56141245|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56141246|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
56141247|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141248|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56141249|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
56141250|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
55757865|NCT00700817|Liraglutide|liraglutide|mesh-list
56141251|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
56141252|NCT04365270|Coagulants|coagulants|mesh-ancestor
56141253|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
56141254|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56141255|NCT04365270|Protective Agents|protective agents|mesh-ancestor
56141256|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141257|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56141258|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
56141259|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
56141260|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56141261|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141262|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56141263|NCT04365036|Gemcitabine|gemcitabine|mesh-list
56141264|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
56141266|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56141268|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141269|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141270|NCT04365036|Antiviral Agents|antiviral agents|mesh-ancestor
56233515|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233516|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233517|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
56233518|NCT01731561|Rituximab|rituximab|mesh-list
56233519|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56233520|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233521|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
56233522|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233523|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233524|NCT01731574|Dapivirine|dapivirine|mesh-list
56233525|NCT01731574|Miconazole|miconazole|mesh-list
56233526|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56233527|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56233528|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
56233529|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233530|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
55757879|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233531|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56233532|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56233533|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233534|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233535|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56233536|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
56233537|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56233538|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233539|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56233540|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56233541|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
55809094|NCT02358369|Timolol|timolol|mesh-list
56141271|NCT04365036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141272|NCT04365036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141273|NCT04365036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56141274|NCT04365036|Immunologic Factors|immunologic factors|mesh-ancestor
56141276|NCT04364022|Ritonavir|ritonavir|mesh-list
56141277|NCT04364022|Lopinavir|lopinavir|mesh-list
56141278|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56141279|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56141280|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141281|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141282|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141283|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56141284|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56141285|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
56146194|NCT01017042|Colchicine|colchicine|mesh-list
56141286|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757923|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757924|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55757925|NCT03250481|Oxycodone|oxycodone|mesh-list
55757926|NCT03250481|Propofol|propofol|mesh-list
55757927|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55757928|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757929|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757931|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
56141287|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56141288|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56141289|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
56233542|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233543|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
56233544|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233545|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233546|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56233547|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
56233548|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233549|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233550|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56233551|NCT01731652|Imiquimod|imiquimod|mesh-list
56233552|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56233553|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
56233554|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233556|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
56233557|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
56233558|NCT01731756|Salicylates|salicylates|mesh-list
56233559|NCT01731756|Petrolatum|petrolatum|mesh-list
56233560|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233561|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
56233562|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
56233563|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
56233564|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56233565|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56233566|NCT01731756|Analgesics|analgesics|mesh-ancestor
56233567|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
56233568|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233569|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233570|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141290|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
56141291|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141292|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141293|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141294|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141295|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141296|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141297|NCT04362384|Vitamin E|vitamin e|mesh-list
55757965|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757966|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
55757967|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
55757983|NCT04947111|Antibodies|antibodies|mesh-list
56141298|NCT04362384|Prednisolone|prednisolone|mesh-list
56141299|NCT04362384|Vitamins|vitamins|mesh-ancestor
56141300|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
56141301|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141302|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141303|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
56141304|NCT04362384|Hormones|hormones|mesh-ancestor
55868176|NCT00919126|Xenon|xenon|mesh-list
56141305|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56233571|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233572|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56233573|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233574|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233575|NCT01731756|Emollients|emollients|mesh-ancestor
56233576|NCT01731795|Dexamethasone|dexamethasone|mesh-list
56233577|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
56233578|NCT01731795|BB 1101|bb 1101|mesh-list
56233579|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233580|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
56233581|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
56233582|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233583|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233584|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233585|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
56233586|NCT01731795|Hormones|hormones|mesh-ancestor
56233587|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809148|NCT02515279|Ribavirin|ribavirin|mesh-list
56141306|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56141307|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141308|NCT04362384|Protective Agents|protective agents|mesh-ancestor
56141309|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
56141310|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141311|NCT04361214|Leflunomide|leflunomide|mesh-list
55758004|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
56141312|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141313|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141314|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56141315|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
56141316|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141317|NCT04361370|Bevacizumab|bevacizumab|mesh-list
56141318|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
56141319|NCT04361370|Olaparib|olaparib|mesh-list
56141320|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56141321|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141322|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56141323|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56141324|NCT04361370|Growth Substances|growth substances|mesh-ancestor
56141325|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141326|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56141327|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56141328|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141329|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141330|NCT04361058|Nivolumab|nivolumab|mesh-list
56141331|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56141332|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141333|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56141334|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141335|NCT04359966|Amoxicillin|amoxicillin|mesh-list
56141336|NCT04359966|Metronidazole|metronidazole|mesh-list
56141337|NCT04359966|Clarithromycin|clarithromycin|mesh-list
56141338|NCT04359966|Levofloxacin|levofloxacin|mesh-list
56141339|NCT04359966|Ofloxacin|ofloxacin|mesh-list
56141342|NCT04359966|Bismuth|bismuth|mesh-list
56141343|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56141344|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141345|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141346|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55745610|NCT04492501|Remdesivir|remdesivir|mesh-list
56141347|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56233588|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56233589|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233590|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
56233591|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233592|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233593|NCT01731899|S 20098|s 20098|mesh-list
56233594|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56233595|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233596|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233598|NCT01731925|Lanreotide|lanreotide|mesh-list
56233599|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233600|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56233601|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56233602|NCT01731925|Growth Substances|growth substances|mesh-ancestor
56233603|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233604|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
56233605|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56233606|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233607|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233608|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
56233609|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56233610|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56233611|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
56233612|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56233613|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
56233614|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56233615|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233616|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56233617|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56233618|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233619|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56233620|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
56233621|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56233622|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
56141348|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56141349|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56141350|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233623|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56233624|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233625|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56233626|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56233627|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233628|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
56233629|NCT01732146|Hematinics|hematinics|mesh-ancestor
56233630|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56233631|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
56233632|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233633|NCT01732224|Tenofovir|tenofovir|mesh-list
56233634|NCT01732224|Telbivudine|telbivudine|mesh-list
56233635|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
56233636|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233637|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56233638|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56233639|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758088|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55758089|NCT04938297|Growth Substances|growth substances|mesh-ancestor
55758090|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
56233640|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233641|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56233642|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56233643|NCT01732250|Meropenem|meropenem|mesh-list
56233644|NCT01732250|Colistin|colistin|mesh-list
56233645|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56233646|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233647|NCT01732276|Gefitinib|gefitinib|mesh-list
56233648|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233649|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56233650|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233651|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233652|NCT01732328|Vitamin D|vitamin d|mesh-list
56233653|NCT01732328|Calcium|calcium|mesh-list
56233654|NCT01732328|Vitamins|vitamins|mesh-ancestor
56233655|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
56233656|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233657|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56233658|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56233659|NCT01732367|Tenofovir|tenofovir|mesh-list
56141351|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233661|NCT01732367|Adefovir|adefovir|mesh-list
56233662|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
56233663|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233664|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56233665|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56233666|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233667|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233668|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56233669|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56233670|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
56233671|NCT01732380|Raltitrexed|raltitrexed|mesh-list
56233672|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233673|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56233674|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
56233675|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233676|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56141352|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56141353|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56141354|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56141355|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56141356|NCT04359966|Renal Agents|renal agents|mesh-ancestor
56141357|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56141358|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56141359|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141360|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56141362|NCT04360122|Levamisole|levamisole|mesh-list
56141363|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
56141364|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56141365|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
56141366|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141367|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
56141368|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
56141369|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141370|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141371|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141372|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
56141373|NCT04360356|Ivermectin|ivermectin|mesh-list
56141374|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
56141375|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141376|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141377|NCT04359576|Hemostatics|hemostatics|mesh-list
56141378|NCT04359576|Coagulants|coagulants|mesh-ancestor
56141379|NCT04358796|Perflubron|perflubron|mesh-list
56141380|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56141381|NCT04358718|Anesthetics|anesthetics|mesh-list
56141382|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56141383|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141384|NCT04358562|Gefitinib|gefitinib|mesh-list
56141385|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141386|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56141387|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141388|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141389|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56141390|NCT04358016|Terlipressin|terlipressin|mesh-list
56141391|NCT04358016|Somatostatin|somatostatin|mesh-list
56141392|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56141393|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56141394|NCT04358016|Hormones|hormones|mesh-ancestor
56233677|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233678|NCT01732393|Quercetin|quercetin|mesh-list
56233679|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
56233680|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233681|NCT01732393|Protective Agents|protective agents|mesh-ancestor
56233682|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233683|NCT01732666|Remifentanil|remifentanil|mesh-list
56233684|NCT01732666|Nefopam|nefopam|mesh-list
56233685|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56233686|NCT01732666|Narcotics|narcotics|mesh-ancestor
56141395|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141396|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141397|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56141398|NCT04357392|Prednisone|prednisone|mesh-list
56141399|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141400|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141401|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
56141402|NCT04357392|Hormones|hormones|mesh-ancestor
56141403|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141404|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56141405|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141406|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
56141407|NCT04357002|Dinoprostone|dinoprostone|mesh-list
56141408|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56141409|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56141410|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141411|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
56141412|NCT04357002|Coagulants|coagulants|mesh-ancestor
56141413|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
56141414|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56141415|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141417|NCT04356222|Durvalumab|durvalumab|mesh-list
56141418|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56141419|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
56141420|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56141421|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141422|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56141423|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
55890365|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55758185|NCT02623959|Doxycycline|doxycycline|mesh-list
56141424|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141425|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141426|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56141427|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141428|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56141429|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56141430|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
56141431|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141432|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56141433|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56141434|NCT04356144|Thrombin|thrombin|mesh-list
56141435|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
56141436|NCT04356144|Coagulants|coagulants|mesh-ancestor
56141437|NCT04355598|Lidocaine|lidocaine|mesh-list
56141438|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
56141439|NCT04355598|Prilocaine|prilocaine|mesh-list
56141440|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56141441|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
56141442|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
56141443|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56141444|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141445|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
56141446|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141447|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56141448|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56141449|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56141450|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56233687|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233688|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233689|NCT01732666|Analgesics|analgesics|mesh-ancestor
56233690|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
56233691|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233692|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56233693|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56233694|NCT01732744|Eusol|eusol|mesh-list
56233695|NCT01732744|Castor Oil|castor oil|mesh-list
56233696|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56233697|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
56233698|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809261|NCT05010421|Clobetasol|clobetasol|mesh-list
56141451|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141452|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
56141453|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56141454|NCT04355520|Fulvestrant|fulvestrant|mesh-list
56141455|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56141456|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141457|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56141458|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56141459|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
56141460|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141461|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141462|NCT04355052|Azithromycin|azithromycin|mesh-list
56141463|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141464|NCT04355052|Camostat|camostat|mesh-list
56141465|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56141466|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141467|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
56141468|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141469|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141470|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141471|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141472|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141473|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141474|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56141475|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56141476|NCT04354662|Leucovorin|leucovorin|mesh-list
56141477|NCT04354662|Docetaxel|docetaxel|mesh-list
56141478|NCT04354662|Fluorouracil|fluorouracil|mesh-list
56141479|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
56141480|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141481|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
56141482|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
56141483|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
56141484|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141485|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
56141486|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56141487|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56141488|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
56141489|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141492|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
56141493|NCT04354662|Vitamins|vitamins|mesh-ancestor
56141494|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
56141495|NCT04354350|Telmisartan|telmisartan|mesh-list
56141496|NCT04354350|Ramipril|ramipril|mesh-list
56141497|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56141498|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56141499|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56141500|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141501|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56141502|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141503|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233700|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233701|NCT01732861|Lenalidomide|lenalidomide|mesh-list
56233702|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
56233703|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233704|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56233705|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56233706|NCT01732861|Growth Substances|growth substances|mesh-ancestor
56233707|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
56233708|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233709|NCT01733017|Lycopene|lycopene|mesh-list
56233710|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146256|NCT04147416|Propofol|propofol|mesh-list
56233711|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
56233712|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233713|NCT01733017|Protective Agents|protective agents|mesh-ancestor
56233714|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233715|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56233716|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56233717|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233718|NCT01733030|Cycloserine|cycloserine|mesh-list
56233719|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56233720|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233721|NCT01733030|Renal Agents|renal agents|mesh-ancestor
56233722|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56233723|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
56233724|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56233725|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
56233726|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233727|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
56233728|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56233729|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233730|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233731|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56233732|NCT01733043|Analgesics|analgesics|mesh-ancestor
56141504|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141505|NCT04353336|Chloroquine|chloroquine|mesh-list
56141506|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56141507|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
56141508|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141509|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141510|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233733|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
56233734|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233735|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56233736|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56233737|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56233738|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
56233739|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233740|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233741|NCT01733095|Ambrisentan|ambrisentan|mesh-list
56233742|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56233743|NCT01733108|Canagliflozin|canagliflozin|mesh-list
56233744|NCT01733108|Glyburide|glyburide|mesh-list
56233745|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56233746|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233747|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56233748|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233749|NCT01733134|Tolvaptan|tolvaptan|mesh-list
56233750|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56233751|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233752|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
56233753|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233754|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
56233755|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56233756|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56233757|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56233758|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56233759|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233760|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
56233765|NCT01733342|Anesthetics|anesthetics|mesh-list
56146261|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
56233774|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233776|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56233777|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233778|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56233779|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56233781|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56233782|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233783|NCT01733485|Aspirin|aspirin|mesh-list
56233784|NCT01733485|Indomethacin|indomethacin|mesh-list
55809342|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
56141511|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141512|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141513|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141514|NCT04353336|Amebicides|amebicides|mesh-ancestor
56141515|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56141516|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56141517|NCT04353336|Analgesics|analgesics|mesh-ancestor
56141518|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
56141519|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141520|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141521|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141522|NCT04353336|Filaricides|filaricides|mesh-ancestor
56141523|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
56141524|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
56141525|NCT04353180|Tretinoin|tretinoin|mesh-list
56141526|NCT04353180|Isotretinoin|isotretinoin|mesh-list
56141527|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141528|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
56141529|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
56141530|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141531|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
56141532|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141533|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55868386|NCT01709318|Etonogestrel|etonogestrel|mesh-list
56141534|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141535|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141536|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141537|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141538|NCT04352400|Nafamostat|nafamostat|mesh-list
56141539|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56141540|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56141541|NCT04352400|Analgesics|analgesics|mesh-ancestor
56141542|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
56141543|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141544|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141545|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141546|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141547|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
56141548|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141549|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141550|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141551|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56141552|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56141553|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56141554|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56141555|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
56141556|NCT04351308|Apatinib|apatinib|mesh-list
56141557|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141558|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56141559|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141560|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141562|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
56233785|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56233786|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56233787|NCT01733485|Analgesics|analgesics|mesh-ancestor
56233788|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
56233789|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233790|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233791|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233792|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233793|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56233794|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56233795|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233796|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56233797|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56233798|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233799|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
56233800|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
56233801|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
56233802|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56233803|NCT01733589|Etoposide|etoposide|mesh-list
56233804|NCT01733589|Cisplatin|cisplatin|mesh-list
56233805|NCT01733589|Endostatins|endostatins|mesh-list
56233806|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56233807|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233808|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56233809|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56233810|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233811|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758334|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
56233812|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56233813|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56233814|NCT01733589|Growth Substances|growth substances|mesh-ancestor
56233815|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233816|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
56233817|NCT01733706|Nicotine|nicotine|mesh-list
56233818|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56233819|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
56233820|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141563|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
56233822|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56233823|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56233824|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
56233825|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233826|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233828|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56233829|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56233830|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56233831|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233832|NCT01733836|Metformin|metformin|mesh-list
56233833|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56233834|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233835|NCT01733966|Amoxicillin|amoxicillin|mesh-list
56233836|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
56233837|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
56233838|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56233839|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
56233840|NCT01733966|Secnidazole|secnidazole|mesh-list
56233841|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56233842|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233843|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233844|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233845|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56233846|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56233847|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141564|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
56141576|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56141577|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56141578|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
56141581|NCT04350684|Ritonavir|ritonavir|mesh-list
56141582|NCT04350684|Lopinavir|lopinavir|mesh-list
56141583|NCT04350684|Interferon-beta|interferon-beta|mesh-list
56141584|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
56141585|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141586|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141587|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
56141588|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890366|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
55758349|NCT05387681|Growth Substances|growth substances|mesh-ancestor
56141589|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56141590|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56141591|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141592|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141593|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141594|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56141595|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56141596|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56141597|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56141598|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
56141599|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141600|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56233848|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56233849|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56233850|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233851|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56233852|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56233854|NCT01733979|Trace Elements|trace elements|mesh-ancestor
56233855|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
56233856|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233857|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56233858|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56233859|NCT01734044|Dexamethasone|dexamethasone|mesh-list
55809418|NCT02286843|Trastuzumab|trastuzumab|mesh-list
56141601|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141602|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
56141603|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141604|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56141605|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141606|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
56141607|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141608|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141609|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141610|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141611|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141612|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141613|NCT04349592|Azithromycin|azithromycin|mesh-list
56141614|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141615|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56141616|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141617|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
56141618|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141619|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141620|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141621|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141622|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141623|NCT04347252|Glucagon|glucagon|mesh-list
56141624|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56141625|NCT04347252|Hormones|hormones|mesh-ancestor
56141626|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141627|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141628|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
55742459|NCT02582697|Cisplatin|cisplatin|mesh-list
56141629|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
56141630|NCT04346862|Vitamins|vitamins|mesh-ancestor
56141632|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141633|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
56141634|NCT04345848|Heparin|heparin|mesh-list
56141635|NCT04345848|Enoxaparin|enoxaparin|mesh-list
56141636|NCT04345848|Calcium heparin|calcium heparin|mesh-list
56141637|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
56141638|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56141639|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56141640|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141641|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141642|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
56141643|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141644|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141645|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141646|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141647|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141648|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141649|NCT04345458|Etanercept|etanercept|mesh-list
56141650|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55758423|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141651|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56141652|NCT04345458|Analgesics|analgesics|mesh-ancestor
56141653|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
56233860|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
56233861|NCT01734044|BB 1101|bb 1101|mesh-list
56233862|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233863|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
56233864|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
56233865|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233866|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233867|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233868|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
56233869|NCT01734044|Hormones|hormones|mesh-ancestor
56233870|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56233871|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56233872|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233873|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
56233874|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233875|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233876|NCT01734057|Dexamethasone|dexamethasone|mesh-list
56233877|NCT01734057|Rituximab|rituximab|mesh-list
56233878|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56233879|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233880|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
56233881|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233882|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56233883|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56233884|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
56233885|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
56233886|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233887|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233888|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
56141654|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141655|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141656|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141657|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141658|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56141659|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56141660|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
56141661|NCT04344756|Heparin|heparin|mesh-list
56141662|NCT04344756|Calcium heparin|calcium heparin|mesh-list
56141663|NCT04344756|Tinzaparin|tinzaparin|mesh-list
56141664|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56141665|NCT04344756|Dalteparin|dalteparin|mesh-list
56141666|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
56141667|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56141668|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56141669|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141670|NCT04344288|Prednisone|prednisone|mesh-list
56141671|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141672|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
56233889|NCT01734057|Hormones|hormones|mesh-ancestor
56233890|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56233891|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56233893|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
56233894|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56233895|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56233896|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56233897|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233898|NCT01734252|Argatroban|argatroban|mesh-list
56233899|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
56233900|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56233901|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
56233902|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233903|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233904|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
56233905|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56141673|NCT04344288|Hormones|hormones|mesh-ancestor
56141674|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141675|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141676|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56141677|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141678|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
56141679|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
56141680|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
56141681|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141682|NCT04342728|Vitamins|vitamins|mesh-list
56141683|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
56141684|NCT04342728|Zinc|zinc|mesh-list
56141685|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
56141686|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141687|NCT04342728|Trace Elements|trace elements|mesh-ancestor
56141688|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
56141689|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141690|NCT04342728|Protective Agents|protective agents|mesh-ancestor
56141691|NCT04342650|Chloroquine|chloroquine|mesh-list
56141692|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56141693|NCT04342650|Amebicides|amebicides|mesh-ancestor
56141694|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141695|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141696|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141697|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
56141698|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141699|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56141700|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56141701|NCT04342650|Analgesics|analgesics|mesh-ancestor
56141702|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
56141703|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141704|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141705|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141706|NCT04342650|Filaricides|filaricides|mesh-ancestor
56141707|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
56141708|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
56141711|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56141712|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141713|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
56141714|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56233906|NCT01734330|Nicotine|nicotine|mesh-list
56233907|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56233908|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
56233909|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233910|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233911|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56233912|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56233913|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
56233914|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233915|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233917|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
56233918|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56233919|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
56233920|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233921|NCT01734408|Antacids|antacids|mesh-ancestor
56233922|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233923|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233924|NCT01734473|Caseins|caseins|mesh-list
56233925|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
56233926|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
56233927|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233928|NCT01734564|Poly I-C|poly i-c|mesh-list
56233929|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56233930|NCT01734564|Poly ICLC|poly iclc|mesh-list
56233931|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
56233932|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
56233933|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758539|NCT03056625|Vitamin A|vitamin a|mesh-list
56233934|NCT01734564|Laxatives|laxatives|mesh-ancestor
56233935|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56233936|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
56141715|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141716|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141717|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141718|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141719|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
56141720|NCT04341402|Clotrimazole|clotrimazole|mesh-list
56141721|NCT04341402|Miconazole|miconazole|mesh-list
56141722|NCT04341402|Diclofenac|diclofenac|mesh-list
56141723|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56141724|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56141725|NCT04341402|Analgesics|analgesics|mesh-ancestor
56141726|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
56141727|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141728|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233937|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233938|NCT01734694|Vancomycin|vancomycin|mesh-list
56233939|NCT01734694|Linezolid|linezolid|mesh-list
56233940|NCT01734694|Daptomycin|daptomycin|mesh-list
56233941|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56233942|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56233943|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233944|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56233945|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233946|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233947|NCT01734798|Gemcitabine|gemcitabine|mesh-list
56233948|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233949|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56233950|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
56233951|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233952|NCT01734798|Antiviral Agents|antiviral agents|mesh-ancestor
56233953|NCT01734798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56233954|NCT01734798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56233955|NCT01734798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56233956|NCT01734798|Immunologic Factors|immunologic factors|mesh-ancestor
56233957|NCT01734798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233958|NCT01734824|Denosumab|denosumab|mesh-list
56233959|NCT01734824|Teriparatide|teriparatide|mesh-list
56233960|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
55758561|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56233961|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56233962|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809500|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141729|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141730|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141731|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55742473|NCT01503489|Serotonin|serotonin|mesh-list
56141732|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141733|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141734|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141735|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56141736|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56141737|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56141738|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56141739|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
56141740|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141741|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56141742|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56141744|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
56141745|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141746|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141747|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141748|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141749|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233963|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56233965|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56233967|NCT01734954|Analgesics|analgesics|mesh-list
56233968|NCT01734954|Anesthetics|anesthetics|mesh-list
56233969|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
56233970|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
56233971|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233972|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233973|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56233974|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56233975|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56233976|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56233977|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56233978|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56233979|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
56233980|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
56233981|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
56233982|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56233983|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56233984|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
56233985|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56233986|NCT01735006|Vaccines|vaccines|mesh-list
56233987|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
56233988|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233989|NCT01735019|Remifentanil|remifentanil|mesh-list
56233990|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56233991|NCT01735019|Narcotics|narcotics|mesh-ancestor
56233992|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233993|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56233994|NCT01735019|Analgesics|analgesics|mesh-ancestor
56233995|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
56233996|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809523|NCT02495077|Promethazine|promethazine|mesh-list
56141750|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141751|NCT04340778|Lidocaine|lidocaine|mesh-list
56141752|NCT04340778|Prilocaine|prilocaine|mesh-list
56141753|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56141754|NCT04340778|Dinoprostone|dinoprostone|mesh-list
56141755|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
56141756|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
56141757|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56233997|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
56233998|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56233999|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
56234001|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
56234002|NCT01735058|Protective Agents|protective agents|mesh-ancestor
56234003|NCT01735071|Bevacizumab|bevacizumab|mesh-list
56234004|NCT01735071|Carboplatin|carboplatin|mesh-list
56234005|NCT01735071|Trabectedin|trabectedin|mesh-list
56234006|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56234007|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234008|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56234009|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56234011|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234012|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
56234013|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56234014|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
56234015|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234016|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56234017|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
56234018|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758612|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56234020|NCT01735097|Vitamins|vitamins|mesh-ancestor
55758613|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56234021|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
56234022|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234023|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
56234024|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234025|NCT01735097|Protective Agents|protective agents|mesh-ancestor
56234026|NCT01735123|Caseins|caseins|mesh-list
56234027|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
56141758|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141759|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
56141760|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141761|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56141762|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56141763|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56141764|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56141765|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141766|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
56141767|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56141768|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56141769|NCT04340388|Tenofovir|tenofovir|mesh-list
56141770|NCT04340388|Lamivudine|lamivudine|mesh-list
56234028|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
56234029|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234030|NCT01735227|Omeprazole|omeprazole|mesh-list
56234031|NCT01735227|Pantoprazole|pantoprazole|mesh-list
56234032|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56234033|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56234034|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56234035|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234036|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234037|NCT01735240|Ketoconazole|ketoconazole|mesh-list
55758659|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234038|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
56234039|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234040|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56141771|NCT04340388|Zidovudine|zidovudine|mesh-list
56141772|NCT04340388|Dolutegravir|dolutegravir|mesh-list
56141773|NCT04340388|Darunavir|darunavir|mesh-list
56141774|NCT04340388|Abacavir|abacavir|mesh-list
56141775|NCT04340388|Cobicistat|cobicistat|mesh-list
56141776|NCT04340388|Rilpivirine|rilpivirine|mesh-list
56141777|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56141778|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
56141779|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141780|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56141781|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56141782|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141786|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56141787|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56141788|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56141789|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56141790|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141791|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56141792|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56141793|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141794|NCT04338906|Camostat|camostat|mesh-list
56141795|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
56141796|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55758711|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
56141797|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141798|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141799|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745618|NCT03101085|Estrogens|estrogens|mesh-ancestor
56141800|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141801|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141802|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141803|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56141804|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56141805|NCT04338438|Apatinib|apatinib|mesh-list
56141806|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141807|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56141808|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141809|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141810|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
56141811|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56141812|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56141813|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141814|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
56141815|NCT04338126|Coagulants|coagulants|mesh-ancestor
56141816|NCT04337658|Capecitabine|capecitabine|mesh-list
56141817|NCT04337658|Trastuzumab|trastuzumab|mesh-list
56141818|NCT04337658|Fulvestrant|fulvestrant|mesh-list
56141819|NCT04337658|Pertuzumab|pertuzumab|mesh-list
56141820|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56141821|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
55758759|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
56141822|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234041|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56234042|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234043|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809603|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141823|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141824|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56141825|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56141826|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56141827|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56141828|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
56141829|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141830|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141831|NCT04337268|Glucagon|glucagon|mesh-list
56141832|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56141833|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56141834|NCT04337268|Hormones|hormones|mesh-ancestor
56141835|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141836|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141837|NCT04337268|Incretins|incretins|mesh-ancestor
56141838|NCT04336566|Melatonin|melatonin|mesh-list
56141839|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
56141840|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141841|NCT04336566|Protective Agents|protective agents|mesh-ancestor
56141842|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141843|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56141844|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56141845|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
55742504|NCT05185167|Propofol|propofol|mesh-list
56141846|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141849|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56141850|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141851|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56141852|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
56141853|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141856|NCT04335786|Valsartan|valsartan|mesh-list
56141857|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55758806|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56141858|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56141859|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56141860|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141861|NCT04335006|Paclitaxel|paclitaxel|mesh-list
56141862|NCT04335006|Apatinib|apatinib|mesh-list
56141863|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56141864|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56141865|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
56141866|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
56141867|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
56141868|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141869|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56141870|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141871|NCT04334928|Tenofovir|tenofovir|mesh-list
56141872|NCT04334928|Emtricitabine|emtricitabine|mesh-list
55866657|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56141873|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56141874|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141875|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
56141876|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141877|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56141878|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56141879|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141880|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141881|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56141882|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56141883|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
56141884|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141885|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56141886|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141887|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56141888|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234044|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56234045|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
56234046|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234047|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234048|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56234049|NCT01735318|Lisinopril|lisinopril|mesh-list
56234050|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56234051|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
56234052|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141889|NCT04334382|Azithromycin|azithromycin|mesh-list
56141890|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141891|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56141892|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56141893|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
56141894|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56141895|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55758842|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
56141896|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141897|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141898|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141899|NCT04333992|Remifentanil|remifentanil|mesh-list
56141900|NCT04333992|Propofol|propofol|mesh-list
56141901|NCT04333992|Sevoflurane|sevoflurane|mesh-list
56141902|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56141903|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56141904|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141905|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56141906|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
56141907|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
56141908|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56141909|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56141910|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56141911|NCT04333992|Narcotics|narcotics|mesh-ancestor
56141912|NCT04333992|Analgesics|analgesics|mesh-ancestor
56141913|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
56141914|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141915|NCT04332978|Fluticasone|fluticasone|mesh-list
56141916|NCT04332978|Xhance|xhance|mesh-list
56141917|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55868760|NCT03748953|Ixazomib|ixazomib|mesh-list
56141918|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56141919|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
56141920|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141921|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141922|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56141923|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
56141924|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56141927|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56141928|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
56141929|NCT04332276|Dopamine|dopamine|mesh-list
56141930|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56141931|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
56141932|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
56141933|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141934|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141935|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
56141936|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56141937|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141938|NCT04332276|Protective Agents|protective agents|mesh-ancestor
56141939|NCT04332042|Tofacitinib|tofacitinib|mesh-list
56141940|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56141941|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141942|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141943|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
56141944|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56141945|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234053|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234054|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56234055|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56234056|NCT01735318|Protective Agents|protective agents|mesh-ancestor
56234057|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234059|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56234060|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
55809618|NCT02493517|Lanreotide|lanreotide|mesh-list
56141946|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141947|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56141948|NCT04331418|Analgesics|analgesics|mesh-ancestor
56141949|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
56141950|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141951|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56141952|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56141953|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56141954|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
56141955|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56141956|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141957|NCT04330872|Aspirin|aspirin|mesh-list
56141958|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56141959|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55758902|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
55758903|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
56141960|NCT04330872|Analgesics|analgesics|mesh-ancestor
56141961|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
56141962|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141963|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141964|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56141965|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141966|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56141967|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56141968|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141969|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56141970|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56141971|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141972|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
56141973|NCT04330326|Sorbitol|sorbitol|mesh-list
56141974|NCT04330326|Cathartics|cathartics|mesh-ancestor
56141975|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56141976|NCT04329858|Methamphetamine|methamphetamine|mesh-list
56141977|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56141978|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141979|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
56141980|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
56141981|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141982|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
56141983|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56141984|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141985|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
56141986|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56141987|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56141988|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56141989|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56141990|NCT00704106|Entecavir|entecavir|mesh-list
56141991|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
56141992|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758949|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55758952|NCT04899765|Vaccines|vaccines|mesh-list
56141993|NCT05605470|Vaccines|vaccines|mesh-list
55868840|NCT00925756|Maraviroc|maraviroc|mesh-list
56141994|NCT05605470|Immunologic Factors|immunologic factors|mesh-ancestor
56141995|NCT05605470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141996|NCT05508594|Sufentanil|sufentanil|mesh-list
56141997|NCT05508594|Ketamine|ketamine|mesh-list
56142000|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142001|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142002|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56142003|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56234061|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234062|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234063|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56234064|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56234065|NCT01735344|Protective Agents|protective agents|mesh-ancestor
56234066|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234067|NCT01735370|Etodolac|etodolac|mesh-list
56234068|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56234069|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56234070|NCT01735370|Analgesics|analgesics|mesh-ancestor
56234071|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
56234072|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234073|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234074|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56234075|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234076|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56234077|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56234078|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234079|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234080|NCT01735383|Etodolac|etodolac|mesh-list
56234081|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56142004|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
56142005|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
55758994|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56142006|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142007|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56142008|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56142009|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142010|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142011|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56142012|NCT05508594|Narcotics|narcotics|mesh-ancestor
56142013|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56142015|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56142016|NCT05417100|Narcotics|narcotics|mesh-ancestor
56142017|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142018|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142020|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
56142021|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142022|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
56142023|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
56142024|NCT05278884|Anesthetics|anesthetics|mesh-list
56142025|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142026|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142027|NCT05136690|Nicotine|nicotine|mesh-list
56142028|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56142029|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
56142030|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142031|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142032|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56142033|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56142034|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
56142035|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759035|NCT04893993|Thiamine|thiamine|mesh-list
56234082|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56234084|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
56234085|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234086|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234087|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56234088|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234089|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56234090|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56234091|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234092|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234093|NCT01735487|Nicotine|nicotine|mesh-list
56234094|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56234095|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
56234096|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234097|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234098|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55809648|NCT02491411|Ichthammol|ichthammol|mesh-list
56142036|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142037|NCT05035680|Vaccines|vaccines|mesh-list
56142038|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
56142039|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142040|NCT04831320|Paclitaxel|paclitaxel|mesh-list
56142041|NCT04831320|Nivolumab|nivolumab|mesh-list
56142042|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56142043|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142044|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
56142045|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
56142046|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
56142047|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142048|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142049|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56142050|NCT03874884|Olaparib|olaparib|mesh-list
56142051|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56142052|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142053|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142054|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142055|NCT03063450|Nivolumab|nivolumab|mesh-list
56142056|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142057|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142058|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56142059|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142060|NCT02748018|Insulin|insulin|mesh-list
56142061|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56142062|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142063|NCT01326000|Cetuximab|cetuximab|mesh-list
56142064|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142065|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142066|NCT03035214|Dexamethasone|dexamethasone|mesh-list
56142067|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
56142068|NCT03035214|BB 1101|bb 1101|mesh-list
55868908|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
56142069|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142070|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
56142072|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142073|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142075|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
56142077|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234099|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56234100|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
56234101|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234102|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234103|NCT01735669|Remifentanil|remifentanil|mesh-list
56234104|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
56234105|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56234106|NCT01735669|Narcotics|narcotics|mesh-ancestor
56234107|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234108|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234109|NCT01735669|Analgesics|analgesics|mesh-ancestor
55809665|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
55809667|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
55759121|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
56142078|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56142079|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142080|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
56142081|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142082|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142083|NCT03035058|Vedolizumab|vedolizumab|mesh-list
56142084|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56142085|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
55742565|NCT05305131|Growth Substances|growth substances|mesh-ancestor
56142086|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56142087|NCT03033654|Protective Agents|protective agents|mesh-ancestor
56142088|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142089|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
56142090|NCT03033732|Buprenorphine|buprenorphine|mesh-list
56142091|NCT03033732|Methadone|methadone|mesh-list
56142092|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56142093|NCT03033732|Naloxone|naloxone|mesh-list
56142094|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56142095|NCT03033732|Narcotics|narcotics|mesh-ancestor
56142096|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142097|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142098|NCT03033732|Analgesics|analgesics|mesh-ancestor
56142099|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
56142100|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142101|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56142102|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
56142103|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
56142104|NCT03033264|Dinoprostone|dinoprostone|mesh-list
56142105|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
56142106|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56142107|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142108|NCT03033342|Omeprazole|omeprazole|mesh-list
56142109|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56142110|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56142111|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56142112|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142113|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142114|NCT03032484|Bevacizumab|bevacizumab|mesh-list
56142115|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142116|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142117|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56142118|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56142119|NCT03032484|Growth Substances|growth substances|mesh-ancestor
56142120|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142121|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
55759165|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
55759167|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56142122|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56142123|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56142124|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56142125|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142126|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234110|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
56234111|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234112|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56234113|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
56234115|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56234116|NCT01735747|Vincristine|vincristine|mesh-list
56234117|NCT01735747|Temozolomide|temozolomide|mesh-list
56234118|NCT01735747|Nedaplatin|nedaplatin|mesh-list
56234119|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56234120|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234121|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
56234122|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
56234123|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
56234124|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234125|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56234126|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
56234127|NCT01735864|Indirubin|indirubin|mesh-list
56234128|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55759198|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234129|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234130|NCT01735890|Amlodipine|amlodipine|mesh-list
56234131|NCT01735890|Valsartan|valsartan|mesh-list
56234132|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56234133|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56234134|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56234135|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55742576|NCT03122665|Nefopam|nefopam|mesh-list
56234136|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234137|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56234138|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234139|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
56234140|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56234141|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56234142|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
56234143|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
56234145|NCT01736020|Propofol|propofol|mesh-list
56234146|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56142127|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
56234147|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234148|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234149|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56234150|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
56234151|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
56234152|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56234153|NCT01736020|Analgesics|analgesics|mesh-ancestor
56234154|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
56234155|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234156|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56234157|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56142128|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142129|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56142130|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56142131|NCT03030690|Methamphetamine|methamphetamine|mesh-list
56142132|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56142133|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142134|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
56142135|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
56142136|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142137|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
56142138|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142139|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142140|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
56142141|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55868985|NCT03630315|Bevacizumab|bevacizumab|mesh-list
56142142|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56142143|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56142144|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56142146|NCT03030300|Pioglitazone|pioglitazone|mesh-list
56142147|NCT03030300|Insulin|insulin|mesh-list
56142148|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56142149|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142150|NCT03029442|Denosumab|denosumab|mesh-list
56142151|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56142152|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142153|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
56142154|NCT03023514|Progesterone|progesterone|mesh-list
56142155|NCT03023514|Progestins|progestins|mesh-ancestor
56142156|NCT03023514|Hormones|hormones|mesh-ancestor
56142157|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142158|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142159|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
56142160|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142161|NCT03023514|Protective Agents|protective agents|mesh-ancestor
56142162|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
56142163|NCT03023514|Vitamins|vitamins|mesh-ancestor
56142164|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
56142165|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
56142166|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
56142167|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55759312|NCT04880811|Afatinib|afatinib|mesh-list
56142168|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56142169|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142170|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142171|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142172|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142173|NCT03019848|Curcumin|curcumin|mesh-list
56142174|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56142175|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142176|NCT03019848|Analgesics|analgesics|mesh-ancestor
56142177|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
56142178|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142179|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234158|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56234159|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
56234160|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234161|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234162|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56234163|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56234164|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56234165|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56234166|NCT01736033|Tamsulosin|tamsulosin|mesh-list
56234167|NCT01736033|Finasteride|finasteride|mesh-list
56234168|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56234169|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56234170|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56234171|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
56234172|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234173|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234174|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234175|NCT01736033|Urological Agents|urological agents|mesh-ancestor
56234176|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56234177|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56234178|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234179|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
56234180|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234181|NCT01736150|Sevelamer|sevelamer|mesh-list
55759328|NCT02181634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234182|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
56234183|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
56234184|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234185|NCT01736163|Hormones|hormones|mesh-list
56234186|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234187|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142180|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142181|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142182|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142183|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142184|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142185|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
56142186|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142187|NCT03019536|Flutemetamol|flutemetamol|mesh-list
56142188|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56142189|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234188|NCT01736371|Propofol|propofol|mesh-list
56234189|NCT01736371|Sevoflurane|sevoflurane|mesh-list
56234190|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56234191|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234192|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234193|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56234194|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
56234195|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
56234196|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56234197|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56234198|NCT01736410|Trastuzumab|trastuzumab|mesh-list
56234199|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234200|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56234201|NCT01736423|Ramosetron|ramosetron|mesh-list
56234202|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
56234203|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
56234204|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234205|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234206|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56234207|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56234208|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
56234209|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234210|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234211|NCT01736449|Bevacizumab|bevacizumab|mesh-list
56234212|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56234213|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234214|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56234215|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56234216|NCT01736449|Growth Substances|growth substances|mesh-ancestor
56234217|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234218|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
56234219|NCT01736488|Atenolol|atenolol|mesh-list
56234220|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56234221|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55759369|NCT04886193|Vitamins|vitamins|mesh-ancestor
56142190|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56142191|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56142192|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142193|NCT03018990|Ethanol|ethanol|mesh-list
56142194|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56142195|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142196|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234223|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
56234224|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142197|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142198|NCT03018756|Fentanyl|fentanyl|mesh-list
56142199|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56142200|NCT03018756|Narcotics|narcotics|mesh-ancestor
56142201|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142202|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142203|NCT03018756|Analgesics|analgesics|mesh-ancestor
56142204|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
56142205|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142206|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56142207|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56142208|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
56142209|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
56142210|NCT03018444|Atorvastatin|atorvastatin|mesh-list
56142211|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56142212|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56142213|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
56142214|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142215|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56142216|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56142217|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142219|NCT03017430|Phenazepam|phenazepam|mesh-list
56142221|NCT03017430|Pregabalin|pregabalin|mesh-list
56142222|NCT03017430|Metoclopramide|metoclopramide|mesh-list
56142223|NCT03017430|Loperamide|loperamide|mesh-list
56142224|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
56142225|NCT03017430|Analgesics|analgesics|mesh-ancestor
56142226|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
56142227|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142228|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142229|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
56142230|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56142231|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56142232|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142233|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56142234|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56142235|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56142236|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142237|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56142238|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56142239|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142240|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142241|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142242|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56142243|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142244|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56142245|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
56142246|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
56142247|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56142248|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56142249|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56142250|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
56142251|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142252|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
56142253|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56142254|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56142255|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56142256|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
56142257|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56142258|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
56142259|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56142260|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
56142261|NCT03017352|Exenatide|exenatide|mesh-list
56142262|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56142263|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142264|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56142265|NCT03017352|Incretins|incretins|mesh-ancestor
56142266|NCT03017352|Hormones|hormones|mesh-ancestor
56142267|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142268|NCT03016884|Vaccines|vaccines|mesh-list
56142269|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
56234225|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234226|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56234227|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56234228|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56234229|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
56234230|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234231|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234232|NCT01736514|Allopurinol|allopurinol|mesh-list
56234233|NCT01736514|Febuxostat|febuxostat|mesh-list
56234234|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
56234235|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142270|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142271|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
56142272|NCT03016806|Melphalan|melphalan|mesh-list
56142273|NCT03016806|Busulfan|busulfan|mesh-list
55759488|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
55759490|NCT05256147|Ibuprofen|ibuprofen|mesh-list
55759506|NCT05214417|Ketamine|ketamine|mesh-list
56142274|NCT03016806|Fludarabine|fludarabine|mesh-list
56142276|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56142277|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
56142278|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142279|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142280|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56142281|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
56142282|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142283|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142284|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56142285|NCT03016806|Protective Agents|protective agents|mesh-ancestor
56142286|NCT03016650|Acetaminophen|acetaminophen|mesh-list
56142287|NCT03016650|Ibuprofen|ibuprofen|mesh-list
56142288|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142289|NCT03016650|Analgesics|analgesics|mesh-ancestor
56142290|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
56142291|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142292|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142293|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
56142294|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56142295|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142296|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142297|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56142298|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142299|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142301|NCT03016260|Etanercept|etanercept|mesh-list
56142302|NCT03016260|Golimumab|golimumab|mesh-list
56142303|NCT03016260|Infliximab|infliximab|mesh-list
56142304|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
56142305|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142306|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142307|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
56142308|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56142309|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56142310|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142312|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
56142313|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142314|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142315|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56142316|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
55759534|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
55759536|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142317|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56142318|NCT03015246|Morphine|morphine|mesh-list
56142319|NCT03015246|Buprenorphine|buprenorphine|mesh-list
56142320|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56142321|NCT03015246|Naloxone|naloxone|mesh-list
56142322|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56142323|NCT03015246|Narcotics|narcotics|mesh-ancestor
56142324|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142325|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234236|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234237|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
56234238|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234239|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56234240|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
56234241|NCT01736514|Protective Agents|protective agents|mesh-ancestor
56234242|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234243|NCT01736670|Triamcinolone|triamcinolone|mesh-list
56234244|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56234245|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56234246|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56234247|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56234248|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
56234249|NCT01736670|Hormones|hormones|mesh-ancestor
56234250|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234251|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234252|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56234253|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
55759590|NCT04865991|Propofol|propofol|mesh-list
56234254|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234256|NCT01736761|Ritonavir|ritonavir|mesh-list
56234257|NCT01736761|Darunavir|darunavir|mesh-list
56234258|NCT01736761|Rilpivirine|rilpivirine|mesh-list
56142326|NCT03015246|Analgesics|analgesics|mesh-ancestor
56142327|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
56142328|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142329|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56142330|NCT03015168|Capecitabine|capecitabine|mesh-list
56142331|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56142332|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
56142333|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142334|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142335|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
56142336|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56142337|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
56142338|NCT03014778|Povidone|povidone|mesh-list
56142339|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56142340|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142341|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
56142342|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
56142343|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
56142344|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
56142345|NCT03014076|Trastuzumab|trastuzumab|mesh-list
56142346|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142347|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142348|NCT03013140|Anesthetics|anesthetics|mesh-list
56142349|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142350|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142351|NCT03011970|Oxytocin|oxytocin|mesh-list
56142352|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
55759619|NCT04865211|Bupivacaine|bupivacaine|mesh-list
55759621|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
56142353|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56142354|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142355|NCT03010098|Remifentanil|remifentanil|mesh-list
56142356|NCT03010098|Propofol|propofol|mesh-list
56142357|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56234259|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56234260|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56234261|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
56234262|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234263|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234264|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56234265|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56234266|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
56234267|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234268|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56234269|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56234270|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56234271|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56234272|NCT01736800|Temozolomide|temozolomide|mesh-list
56234273|NCT01736800|Topotecan|topotecan|mesh-list
56234274|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56234275|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
55759668|NCT00700271|Amlodipine|amlodipine|mesh-list
56234276|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234277|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234278|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56234279|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56234280|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234281|NCT01736813|Maraviroc|maraviroc|mesh-list
56234282|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56234283|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56234284|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234285|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56234286|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56234287|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
56234288|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759721|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
55759722|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234289|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56234290|NCT01736878|Sorafenib|sorafenib|mesh-list
56234291|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234298|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234299|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56234300|NCT01736891|Protective Agents|protective agents|mesh-ancestor
56234301|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234302|NCT01737008|Cisplatin|cisplatin|mesh-list
56234303|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234304|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
56234305|NCT01737073|Narcotics|narcotics|mesh-ancestor
56234306|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234307|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234308|NCT01737073|Analgesics|analgesics|mesh-ancestor
56234309|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
56234310|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234311|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
56234312|NCT01737086|Astringents|astringents|mesh-ancestor
56234313|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234314|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
56234315|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
56234316|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56234317|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234318|NCT01737177|Rituximab|rituximab|mesh-list
56234319|NCT01737177|Lenalidomide|lenalidomide|mesh-list
56234320|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56234321|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56234322|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234323|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
56234324|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234325|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234344|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
56234345|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
56234346|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
56234347|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234348|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759784|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759785|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
56234349|NCT01737307|Fluorides|fluorides|mesh-list
56234350|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
56234351|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
56234352|NCT01737307|Protective Agents|protective agents|mesh-ancestor
56234353|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234354|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56234355|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56234356|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234357|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
56234358|NCT01737346|Lomustine|lomustine|mesh-list
56234359|NCT01737346|Procarbazine|procarbazine|mesh-list
55742666|NCT03121963|Celecoxib|celecoxib|mesh-list
56234360|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56234361|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
56234362|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234363|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234364|NCT01737359|Tenofovir|tenofovir|mesh-list
56234365|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
56234366|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234367|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56234368|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56234369|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234370|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234371|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56234372|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56234373|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
56234374|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56234375|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56234376|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
56234377|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234378|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234380|NCT01737411|Urological Agents|urological agents|mesh-ancestor
56234382|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56234383|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56234384|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56234385|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234386|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234387|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
56234388|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759823|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234389|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56234390|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
56234391|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56234392|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56234393|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56234394|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234395|NCT01737671|Leucovorin|leucovorin|mesh-list
56234396|NCT01737671|Methotrexate|methotrexate|mesh-list
56234397|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56234398|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
56234399|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56234400|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234401|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56234402|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
56234403|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234404|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234405|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
56234406|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234407|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56234408|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56234409|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
56234410|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234411|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56234412|NCT01737671|Antidotes|antidotes|mesh-ancestor
56234413|NCT01737671|Protective Agents|protective agents|mesh-ancestor
56234415|NCT01737671|Vitamins|vitamins|mesh-ancestor
56234420|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
56234421|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234422|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234423|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234424|NCT01737918|Urological Agents|urological agents|mesh-ancestor
56234425|NCT01738035|Budesonide|budesonide|mesh-list
56234426|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142358|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142359|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142360|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56142361|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
56142362|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
56142363|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56142364|NCT03010098|Narcotics|narcotics|mesh-ancestor
56142365|NCT03010098|Analgesics|analgesics|mesh-ancestor
56142366|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
56142367|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142368|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56142369|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56142370|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56142371|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56142372|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
56142373|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142374|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56142375|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56142377|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56142378|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
56142379|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
56142380|NCT03009006|Calcium|calcium|mesh-list
56142381|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56142382|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142383|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56142384|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56142385|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142386|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
56142388|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56142389|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
56142390|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142391|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142392|NCT03007992|Vinorelbine|vinorelbine|mesh-list
56142393|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56142394|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142395|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56142396|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
55759909|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
56142397|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56142398|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142399|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
56142400|NCT03007446|Apatinib|apatinib|mesh-list
56142401|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142402|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56142403|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142404|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142405|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
56142406|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56142407|NCT03007524|Calcium|calcium|mesh-list
56142408|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56142409|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142410|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56142411|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56142412|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56142414|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142415|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56142416|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56234427|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55759941|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234428|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
56234429|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234430|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234431|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56234432|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
56234433|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
56234434|NCT01738035|Hormones|hormones|mesh-ancestor
56234435|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234436|NCT01738087|Fluticasone|fluticasone|mesh-list
56234437|NCT01738087|Xhance|xhance|mesh-list
56234438|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
56234439|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56234440|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56234441|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
56234442|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234443|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234444|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56234445|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
56234446|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
56234447|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56234448|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56234449|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56234450|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56234451|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
56142417|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142418|NCT03006042|Bupivacaine|bupivacaine|mesh-list
56142419|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
56142420|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
56142421|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142422|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760003|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
56142423|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
56142424|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142425|NCT03005496|Vitamin D|vitamin d|mesh-list
56142426|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
56142427|NCT03005496|Beta Carotene|beta carotene|mesh-list
56142428|NCT03005496|Zinc|zinc|mesh-list
56142429|NCT03005496|Dexamethasone|dexamethasone|mesh-list
56142430|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
56142431|NCT03005496|Nifedipine|nifedipine|mesh-list
56142432|NCT03005496|BB 1101|bb 1101|mesh-list
56142433|NCT03005496|Carotenoids|carotenoids|mesh-list
56142434|NCT03005496|Picolinic acid|picolinic acid|mesh-list
56142435|NCT03005496|Vitamins|vitamins|mesh-ancestor
56142436|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
56142437|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142438|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142439|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
56142440|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
56142441|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142442|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56142443|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
56142444|NCT03005496|Hormones|hormones|mesh-ancestor
56234452|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234453|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234454|NCT01738100|Morphine|morphine|mesh-list
56234455|NCT01738100|Clopidogrel|clopidogrel|mesh-list
56234456|NCT01738100|Ticagrelor|ticagrelor|mesh-list
56234457|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56234458|NCT01738100|Narcotics|narcotics|mesh-ancestor
56234459|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234460|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234461|NCT01738100|Analgesics|analgesics|mesh-ancestor
56234462|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
56234463|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234464|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56234465|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56234466|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56234467|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56234468|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
56234469|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234470|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234471|NCT01738178|Caffeine|caffeine|mesh-list
56234472|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56234473|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234474|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56234475|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234476|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234477|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56234478|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56234479|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
56234480|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234481|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
56234485|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
56234492|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56234493|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
56234494|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
56234495|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234496|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234497|NCT01738295|Donepezil|donepezil|mesh-list
56234498|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56234499|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234500|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234501|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
56234502|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234503|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234504|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
56234505|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
56234506|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234507|NCT01738373|Plerixafor|plerixafor|mesh-list
55760077|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56234508|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56234509|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56234510|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
56234511|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234512|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
56234513|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
56234514|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234515|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234516|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234517|NCT01738451|Dabrafenib|dabrafenib|mesh-list
56234518|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810056|NCT05561361|Diuretics|diuretics|mesh-ancestor
55745639|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142445|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142446|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56142447|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142448|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
56142449|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869285|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
56142451|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56142452|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56142453|NCT03005496|Trace Elements|trace elements|mesh-ancestor
56142454|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56142455|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56142456|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
56142457|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
56142458|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56142459|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
56142460|NCT03005496|Protective Agents|protective agents|mesh-ancestor
56142461|NCT03005496|Provitamins|provitamins|mesh-ancestor
56142462|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56142463|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
56234519|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56234520|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234521|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234522|NCT01738542|Bosentan|bosentan|mesh-list
56234523|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
56234524|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56234525|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234526|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56234528|NCT01738607|Laxatives|laxatives|mesh-ancestor
56234529|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56234530|NCT01738607|Cathartics|cathartics|mesh-ancestor
56234531|NCT01738724|Goserelin|goserelin|mesh-list
56234532|NCT01738724|Dienogest|dienogest|mesh-list
56234533|NCT01738724|Desogestrel|desogestrel|mesh-list
56234534|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56234535|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234536|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56234537|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
56234538|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56234539|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234540|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56234541|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55760132|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
56234542|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56234543|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56234544|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
56234545|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234546|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56234547|NCT01738724|Progestins|progestins|mesh-ancestor
56234548|NCT01738724|Hormones|hormones|mesh-ancestor
56234549|NCT01738763|Inositol|inositol|mesh-list
56234550|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
56234551|NCT01738763|Vitamins|vitamins|mesh-ancestor
56234552|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
56234553|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234561|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
56234562|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234563|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234564|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
56234565|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234566|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234567|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
55760157|NCT03043521|Lansoprazole|lansoprazole|mesh-list
56234568|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56234569|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234570|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56234572|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56234573|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56142464|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
56142465|NCT03005808|Ropivacaine|ropivacaine|mesh-list
56142466|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
56142467|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
56142468|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142469|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142470|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
56142471|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142472|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
56142474|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
56142475|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56142476|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142477|NCT03005340|Vitamins|vitamins|mesh-ancestor
56142478|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
56142479|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56142480|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56142481|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56142482|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
56142483|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142484|NCT03005184|Icatibant|icatibant|mesh-list
56142485|NCT03005184|Valsartan|valsartan|mesh-list
56142486|NCT03005184|Enalapril|enalapril|mesh-list
56142487|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56142488|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56142489|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56142490|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56142491|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142492|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56142493|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
56142494|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142495|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56142496|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142497|NCT03005184|Analgesics|analgesics|mesh-ancestor
56142498|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
56142499|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142500|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142501|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142502|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142503|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55760211|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55760212|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
55760213|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
55760214|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
55760215|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760216|NCT02505581|Metronidazole|metronidazole|mesh-list
55760217|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
55760218|NCT02505581|Cefuroxime|cefuroxime|mesh-list
55760219|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
55760220|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760222|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56142504|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56142505|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56142506|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56142507|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
56142509|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56142510|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142511|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234574|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234575|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
56234576|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234577|NCT01738893|Gabapentin|gabapentin|mesh-list
56234578|NCT01738893|Analgesics|analgesics|mesh-ancestor
56234579|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
56234580|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234581|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234582|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
56234583|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56234584|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56234585|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234586|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56234587|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56234588|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56234589|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234590|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234591|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
56234592|NCT01738945|Amlodipine|amlodipine|mesh-list
56234593|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56234594|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56234595|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56234596|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234597|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56234598|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234599|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
56234600|NCT01739049|Liraglutide|liraglutide|mesh-list
56234601|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56234602|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234603|NCT01739049|Incretins|incretins|mesh-ancestor
56234604|NCT01739049|Hormones|hormones|mesh-ancestor
55810138|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
56142512|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56142513|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
56142514|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
56142515|NCT03002844|Gemcitabine|gemcitabine|mesh-list
56142516|NCT03002844|Carboplatin|carboplatin|mesh-list
56142517|NCT03002844|Pemetrexed|pemetrexed|mesh-list
56142518|NCT03002844|Gefitinib|gefitinib|mesh-list
56142519|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142520|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56142521|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
56234605|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234607|NCT01739127|Aripiprazole|aripiprazole|mesh-list
56234608|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56234609|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55760231|NCT02451293|Melatonin|melatonin|mesh-list
56234610|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
56234611|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234612|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234613|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234614|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56234615|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55810169|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56142522|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142525|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142526|NCT03002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56142527|NCT03002844|Immunologic Factors|immunologic factors|mesh-ancestor
56142528|NCT03002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142529|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56142530|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56142531|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56142532|NCT03002376|Cemiplimab|cemiplimab|mesh-list
56142533|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142534|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142535|NCT03002064|Docetaxel|docetaxel|mesh-list
56142536|NCT03002064|Fluorouracil|fluorouracil|mesh-list
56142537|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142538|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
56142539|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
56142540|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
56142541|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142542|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
55760256|NCT02504801|Hormones|hormones|mesh-ancestor
56142543|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56142544|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56142545|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
56142546|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142547|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56142548|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
56142549|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142550|NCT03000660|Dexamethasone|dexamethasone|mesh-list
56142551|NCT03000660|Venetoclax|venetoclax|mesh-list
56142552|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142553|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
56142554|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
56142555|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142556|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142557|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56142558|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
56142559|NCT03000660|Hormones|hormones|mesh-ancestor
56142560|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142561|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56142562|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142563|NCT03000036|Doxorubicin|doxorubicin|mesh-list
56142564|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56142565|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56142566|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142567|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56142568|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56142569|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142570|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142571|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
56234616|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234617|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56234618|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56234619|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
56234620|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
56234621|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
56234622|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56234623|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56234624|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56234625|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56234626|NCT01739192|Bupropion|bupropion|mesh-list
56234627|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56234628|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
56234629|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56234630|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56234631|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55760301|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56234632|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56234633|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234634|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
56234635|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234636|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234637|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56234638|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56234639|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234640|NCT01739218|Paclitaxel|paclitaxel|mesh-list
56234641|NCT01739218|Bevacizumab|bevacizumab|mesh-list
56142572|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
56142573|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
56142574|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56142575|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56142576|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
56142577|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142578|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56142579|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56142580|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142581|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142582|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
56142583|NCT02989272|Analgesics|analgesics|mesh-ancestor
56142584|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
56142585|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745660|NCT02472613|Fluoxetine|fluoxetine|mesh-list
56142586|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142587|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
56142588|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142589|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56142590|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
56142591|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56234643|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56234644|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234645|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
56234646|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
56234647|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
56234648|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234649|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56234650|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56234651|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56234652|NCT01739218|Growth Substances|growth substances|mesh-ancestor
56234653|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234654|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
56234655|NCT01739413|Anesthetics|anesthetics|mesh-list
56234656|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234657|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234658|NCT01739439|Gemcitabine|gemcitabine|mesh-list
56234659|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56234660|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
55810209|NCT02462473|Risperidone|risperidone|mesh-list
56142592|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56142593|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142594|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56142598|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56142599|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
56142600|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142601|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142602|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56142603|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56142604|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
56142605|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142606|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142607|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56142608|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56142609|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56142610|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56142611|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142612|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142613|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142614|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
56142615|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56142617|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56142618|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142619|NCT02987400|Venetoclax|venetoclax|mesh-list
56142620|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
56142621|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142622|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142623|NCT02987244|Prednisone|prednisone|mesh-list
56142624|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
56142625|NCT02987244|Etoposide|etoposide|mesh-list
56142626|NCT02987244|Epirubicin|epirubicin|mesh-list
56142627|NCT02987244|Vindesine|vindesine|mesh-list
56142628|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760358|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
56234661|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234662|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234663|NCT01739439|Antiviral Agents|antiviral agents|mesh-ancestor
56234664|NCT01739439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234665|NCT01739439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234666|NCT01739439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56234667|NCT01739439|Immunologic Factors|immunologic factors|mesh-ancestor
56234668|NCT01739439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234669|NCT01739504|Anesthetics|anesthetics|mesh-list
56234670|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234671|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234672|NCT01739556|Aspirin|aspirin|mesh-list
56234673|NCT01739556|Ticagrelor|ticagrelor|mesh-list
56234674|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56234675|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56234676|NCT01739556|Analgesics|analgesics|mesh-ancestor
56234678|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234679|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810237|NCT05405309|Olaparib|olaparib|mesh-list
56142629|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
56142630|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142631|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142632|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56142633|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
56142634|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142635|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142636|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56142637|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142638|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
56142639|NCT02987244|Hormones|hormones|mesh-ancestor
55760398|NCT04872231|Voriconazole|voriconazole|mesh-list
56142640|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142641|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56142642|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56142643|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56142644|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56142645|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142646|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56142647|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
56142648|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
56142649|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
56142650|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
56142651|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142652|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142653|NCT02982486|Nivolumab|nivolumab|mesh-list
56142654|NCT02982486|Ipilimumab|ipilimumab|mesh-list
56142655|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142656|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142657|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56142658|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142659|NCT02981784|Ponatinib|ponatinib|mesh-list
56142660|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142661|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56142662|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142663|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142664|NCT02980926|Bupivacaine|bupivacaine|mesh-list
56234680|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56234681|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234682|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56234683|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56142665|NCT02980926|Mepivacaine|mepivacaine|mesh-list
56142666|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
56142668|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142669|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142670|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
55760445|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56142671|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142672|NCT02980458|Deferiprone|deferiprone|mesh-list
55869510|NCT01696214|Hormones|hormones|mesh-ancestor
56142674|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
56142675|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
56142676|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142677|NCT02978976|Betamethasone|betamethasone|mesh-list
56142678|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142679|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
56142680|NCT02978976|Hormones|hormones|mesh-ancestor
56142681|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142682|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142683|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56142684|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
56142686|NCT02979132|Trace Elements|trace elements|mesh-ancestor
56142687|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
56142688|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142689|NCT02978040|Tirofiban|tirofiban|mesh-list
56142690|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56142691|NCT02978040|Cangrelor|cangrelor|mesh-list
56142692|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56142693|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56142694|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56142695|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142696|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56142697|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56142698|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56142699|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
56142700|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142701|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142702|NCT02976246|Vitamin K|vitamin k|mesh-list
56142703|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
56142704|NCT02976246|Vitamins|vitamins|mesh-ancestor
56142705|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
56142706|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142707|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56142708|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56142709|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760483|NCT04849533|Abatacept|abatacept|mesh-list
55760484|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
56142710|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
56142711|NCT02976246|Coagulants|coagulants|mesh-ancestor
56142712|NCT02976012|Aflibercept|aflibercept|mesh-list
56142713|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56142714|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56142715|NCT02976012|Growth Substances|growth substances|mesh-ancestor
56142716|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142717|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
56142718|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142719|NCT02975076|Aspirin|aspirin|mesh-list
56142720|NCT02975076|Clopidogrel|clopidogrel|mesh-list
56142721|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56142722|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142723|NCT02975076|Analgesics|analgesics|mesh-ancestor
56142724|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
56142725|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142726|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142727|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142728|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142729|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56142730|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56142731|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142732|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56142733|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56142735|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
56142736|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56142737|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56142738|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56142739|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
56142740|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142741|NCT02974920|Aspirin|aspirin|mesh-list
56142742|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
56142745|NCT02974920|Analgesics|analgesics|mesh-ancestor
56142746|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
56142747|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142748|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142749|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142750|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142751|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56142752|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56142753|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142754|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56142755|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56142756|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142757|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
56142758|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56142759|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
56142760|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56142761|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
56142762|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
56142763|NCT02973204|Everolimus|everolimus|mesh-list
56142764|NCT02973204|Sorafenib|sorafenib|mesh-list
56142765|NCT02973204|Octreotide|octreotide|mesh-list
56142766|NCT02973204|Lanreotide|lanreotide|mesh-list
56142767|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142768|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56142769|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
56142770|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142771|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56142772|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142773|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142774|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56142775|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56142776|NCT02959476|Ropivacaine|ropivacaine|mesh-list
56142777|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
56142778|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
56142779|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142780|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142781|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
56142782|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142783|NCT02958852|Letrozole|letrozole|mesh-list
56142784|NCT02958852|Fulvestrant|fulvestrant|mesh-list
56142785|NCT02958852|Atorvastatin|atorvastatin|mesh-list
56142786|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56142787|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56142788|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
56142789|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142790|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56142791|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56142792|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142793|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142794|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56142795|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56142796|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56142797|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
56142798|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142799|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142800|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56142801|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55760568|NCT04849299|Cyclosporine|cyclosporine|mesh-list
56142802|NCT02641782|Aldesleukin|aldesleukin|mesh-list
56142803|NCT02641782|Interleukin-2|interleukin-2|mesh-list
56142804|NCT02641782|Tretinoin|tretinoin|mesh-list
56142805|NCT02641782|Dinutuximab|dinutuximab|mesh-list
56142807|NCT02641782|Antibodies|antibodies|mesh-list
56142808|NCT02641782|Sargramostim|sargramostim|mesh-list
56142809|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
56142810|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142811|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142812|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142813|NCT02641782|Analgesics|analgesics|mesh-ancestor
56234684|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142814|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
56142815|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142816|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
56142817|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
56142820|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
56142821|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142822|NCT02641314|Celecoxib|celecoxib|mesh-list
56142823|NCT02641314|Propranolol|propranolol|mesh-list
56142824|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142825|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56142826|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142827|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56142828|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142829|NCT02641314|Analgesics|analgesics|mesh-ancestor
56142830|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
56142831|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142832|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142833|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56142834|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56142835|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142836|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56142837|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56142838|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
56142839|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142840|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56142841|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56142842|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
56142843|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
56142844|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142845|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142846|NCT04769778|Valsartan|valsartan|mesh-list
56142847|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56142848|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56142849|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56142850|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142851|NCT04769076|Paclitaxel|paclitaxel|mesh-list
56142852|NCT04769076|Cisplatin|cisplatin|mesh-list
56142853|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56142854|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56142855|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142856|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
56142857|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
56142858|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
56142859|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142860|NCT04768764|Bupivacaine|bupivacaine|mesh-list
56142861|NCT04768764|Anesthetics|anesthetics|mesh-list
55760625|NCT04857801|Protective Agents|protective agents|mesh-ancestor
56142862|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
56142863|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760626|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760627|NCT03208361|Amoxicillin|amoxicillin|mesh-list
55760628|NCT03208361|Penicillins|penicillins|mesh-list
55760629|NCT03208361|Penicillin V|penicillin v|mesh-list
55760630|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55760631|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142864|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142865|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
56142866|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56142867|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
56142868|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56142869|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142870|NCT04748562|Progesterone|progesterone|mesh-list
56142871|NCT04748562|Progestins|progestins|mesh-ancestor
56142872|NCT04748562|Hormones|hormones|mesh-ancestor
56142873|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142874|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142875|NCT04745286|Ketamine|ketamine|mesh-list
56142876|NCT04745286|Esketamine|esketamine|mesh-list
56142877|NCT04745286|Analgesics|analgesics|mesh-ancestor
55742833|NCT04800393|Sevoflurane|sevoflurane|mesh-list
56142878|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
56142879|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745665|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142880|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142881|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56142882|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56142883|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
56142884|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
56234685|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56234686|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56234687|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234688|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
56234689|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56234690|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56234691|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56234692|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
56234693|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234694|NCT01739582|Enclomiphene|enclomiphene|mesh-list
56234695|NCT01739582|Clomiphene|clomiphene|mesh-list
56234696|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
56142885|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56142886|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56142887|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55760677|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142888|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56142889|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142892|NCT04745442|Antithrombins|antithrombins|mesh-list
56142893|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
56142894|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56142895|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
56142896|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142897|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142898|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
55869735|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
56142899|NCT04743180|Paclitaxel|paclitaxel|mesh-list
56142900|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56142901|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142902|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
56142903|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
56142904|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
56142905|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142906|NCT04740840|Amlodipine|amlodipine|mesh-list
56142907|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56142908|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56142909|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56142910|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142911|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56142912|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142913|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
56142914|NCT04739826|HH-GV-678|hh-gv-678|mesh-list
56142915|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56142916|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142917|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142918|NCT04739202|Bevacizumab|bevacizumab|mesh-list
56142919|NCT04739202|Atezolizumab|atezolizumab|mesh-list
56142920|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56142921|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56142922|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142923|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56142924|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56142925|NCT04739202|Growth Substances|growth substances|mesh-ancestor
56142926|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142927|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
56142928|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
56142929|NCT04738188|Epirubicin|epirubicin|mesh-list
56142930|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56142931|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142932|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56142933|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56142934|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142935|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234697|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56234698|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
56142936|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56142937|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55760721|NCT04839549|Hormones|hormones|mesh-ancestor
56142938|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56142939|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
56142940|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142941|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56142942|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56142943|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142944|NCT05314140|Calcium|calcium|mesh-list
56142945|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56142946|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142947|NCT05313906|Cisplatin|cisplatin|mesh-list
56142948|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142949|NCT05313828|Fluorometholone|fluorometholone|mesh-list
56142950|NCT05313828|Tobramycin|tobramycin|mesh-list
56142951|NCT05313828|Acyclovir|acyclovir|mesh-list
56142953|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56142954|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142955|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56142956|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
56142957|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142958|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
56142959|NCT05313828|Protective Agents|protective agents|mesh-ancestor
56142960|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
56142961|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56142962|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
56142963|NCT05313828|Hormones|hormones|mesh-ancestor
56142965|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56142966|NCT05313750|Levofloxacin|levofloxacin|mesh-list
56142968|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
56142969|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
56142970|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56142971|NCT05313750|Renal Agents|renal agents|mesh-ancestor
56142972|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56142973|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56142974|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56142975|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142976|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142977|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142978|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56142979|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56142981|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56142982|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
56142983|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56142984|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
56142985|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142986|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142987|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
56142988|NCT04123470|Atezolizumab|atezolizumab|mesh-list
56142989|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56142990|NCT04706910|Furosemide|furosemide|mesh-list
56142991|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
56142992|NCT04706910|Diuretics|diuretics|mesh-ancestor
56142993|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
56142994|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56142995|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56142996|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56142997|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142998|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
56142999|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143000|NCT05139966|Fluorides|fluorides|mesh-list
56143001|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
56143002|NCT05139966|Protective Agents|protective agents|mesh-ancestor
56143003|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143004|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56143005|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56143006|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143007|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
56143008|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56143009|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56143010|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56143011|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56234699|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234700|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234701|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56143012|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143013|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
56143014|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143015|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143016|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56143017|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143018|NCT00577590|Metformin|metformin|mesh-list
56143019|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
55760767|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760771|NCT03040401|Aldesleukin|aldesleukin|mesh-list
56143020|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56143021|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143022|NCT00578214|Midazolam|midazolam|mesh-list
56143023|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
56143024|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56143025|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143026|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56143027|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56143028|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56143029|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56143030|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56143031|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56143032|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
56143034|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
56143035|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143036|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143037|NCT00580398|Varenicline|varenicline|mesh-list
56143040|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
56143041|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143042|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143043|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143045|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56143046|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56143047|NCT00582660|Analgesics|analgesics|mesh-ancestor
56143048|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
56143049|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143050|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143051|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143052|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56143053|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56143054|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56143055|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143056|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143058|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
56143059|NCT00582894|Busulfan|busulfan|mesh-list
56143060|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143061|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143062|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56143063|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
56143064|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143065|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143066|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
56143067|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56143068|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56143069|NCT00585780|Prazosin|prazosin|mesh-list
56143070|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56143071|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56143072|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56143073|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56143074|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
56143075|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143076|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143077|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143078|NCT00586482|Nicotine|nicotine|mesh-list
56143079|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56143080|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
56143081|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810264|NCT02272413|Growth Substances|growth substances|mesh-ancestor
56234702|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
56234703|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56234704|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56234705|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56234706|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
56234707|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
56234708|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56234709|NCT01739673|Riboflavin|riboflavin|mesh-list
56234710|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
56234711|NCT01739673|Vitamins|vitamins|mesh-ancestor
56234712|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
56234713|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760849|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
55760850|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760851|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55760852|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56234714|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56234715|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
56234716|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
56234717|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
56234718|NCT01739855|Calcium|calcium|mesh-list
56234719|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56234720|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234721|NCT01739855|Antacids|antacids|mesh-ancestor
56234722|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143082|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143083|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56143084|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56143085|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
56143086|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143087|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143088|NCT03708354|Tocotrienols|tocotrienols|mesh-list
56143089|NCT03708354|Vitamin E|vitamin e|mesh-list
56143090|NCT03708354|Tocopherols|tocopherols|mesh-list
56143091|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
56143092|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143093|NCT03708354|Protective Agents|protective agents|mesh-ancestor
56143094|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143095|NCT03708354|Vitamins|vitamins|mesh-ancestor
56143096|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
56143097|NCT03527472|Memantine|memantine|mesh-list
56143098|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56143099|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56143100|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
56143102|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143103|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143104|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56143105|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56143106|NCT03297684|Aflibercept|aflibercept|mesh-list
56143107|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56143108|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56143109|NCT03297684|Growth Substances|growth substances|mesh-ancestor
56143110|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143111|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
55760881|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143112|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143114|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56143115|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56234723|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56234724|NCT01739855|Vitamins|vitamins|mesh-ancestor
56234725|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
56234726|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56234727|NCT01739894|Paclitaxel|paclitaxel|mesh-list
56234728|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56234729|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234730|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
56234731|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
56234732|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
56234733|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234734|NCT01739907|Vitamin D|vitamin d|mesh-list
56234735|NCT01739907|Vitamins|vitamins|mesh-ancestor
56234736|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
56234737|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234738|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56234739|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
56234740|NCT01739920|Povidone|povidone|mesh-list
56234741|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
56234742|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
56234743|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56234744|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234745|NCT01739985|Dexamethasone|dexamethasone|mesh-list
56234746|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
56234747|NCT01739985|Droperidol|droperidol|mesh-list
56234748|NCT01739985|Ondansetron|ondansetron|mesh-list
56234749|NCT01739985|BB 1101|bb 1101|mesh-list
56234750|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56234751|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
56234752|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
56234753|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234754|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234755|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56234756|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
56234769|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56234770|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55760916|NCT04837131|Ixazomib|ixazomib|mesh-list
55760918|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
56234771|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234772|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56234773|NCT01739985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56234774|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56234775|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56234776|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56234777|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
56234778|NCT01740245|Biguanides|biguanides|mesh-list
56234779|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
56234780|NCT01740245|Polihexanide|polihexanide|mesh-list
56234781|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56234782|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234783|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
56234784|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56143116|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
56143117|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143118|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143119|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143120|NCT01740648|Fluorouracil|fluorouracil|mesh-list
56143121|NCT01740648|Trametinib|trametinib|mesh-list
56143122|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
56143123|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143124|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56143126|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56143127|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
56143128|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143129|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56143130|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143131|NCT01685424|Etoricoxib|etoricoxib|mesh-list
56143132|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56143134|NCT01685424|Analgesics|analgesics|mesh-ancestor
56143135|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
56143136|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143137|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143138|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143139|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56143140|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56143141|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56143142|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143143|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760954|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
56143144|NCT01327638|Etoricoxib|etoricoxib|mesh-list
56143145|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
56143146|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56143147|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56143148|NCT01327638|Analgesics|analgesics|mesh-ancestor
56143149|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
56143150|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143151|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143152|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143153|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56143154|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56143155|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143156|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143157|NCT00393354|Etoricoxib|etoricoxib|mesh-list
56234785|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234786|NCT01740271|Epirubicin|epirubicin|mesh-list
56143158|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143159|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143160|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143161|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56143162|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56143163|NCT00393354|Analgesics|analgesics|mesh-ancestor
56143164|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
56143165|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143166|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56143167|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56143168|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56143169|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143170|NCT00166530|Atorvastatin|atorvastatin|mesh-list
56143171|NCT00166530|Simvastatin|simvastatin|mesh-list
56143172|NCT00166530|Ezetimibe|ezetimibe|mesh-list
56143173|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56143174|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56143175|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
56143176|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143177|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56143178|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56143179|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143180|NCT00588900|Irinotecan|irinotecan|mesh-list
56143181|NCT00588900|Cediranib|cediranib|mesh-list
56143182|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55760989|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
56143183|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56143184|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143185|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143186|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143187|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56143189|NCT00589056|Etoposide|etoposide|mesh-list
56143190|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143191|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56143192|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56143193|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56143194|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143195|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761024|NCT04835259|Selenium|selenium|mesh-list
56143196|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56143197|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56143198|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
56143199|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56143200|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56143201|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
56143202|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56143204|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56143205|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
56143206|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
56143207|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
56143208|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
56143209|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56143210|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143211|NCT00590460|Fludarabine|fludarabine|mesh-list
56143212|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
56143213|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143214|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143215|NCT00590772|Montelukast|montelukast|mesh-list
56143216|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56143217|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
56143218|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56143219|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
56143220|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143221|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143222|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56143223|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56143224|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143225|NCT00592176|Bevacizumab|bevacizumab|mesh-list
56143226|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143227|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143228|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56234788|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143229|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56143230|NCT00592176|Growth Substances|growth substances|mesh-ancestor
56143231|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143232|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
56143233|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
56143234|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
56143235|NCT00592488|Vitamins|vitamins|mesh-ancestor
56143236|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
56143237|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143238|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
56143239|NCT00595530|Ketamine|ketamine|mesh-list
56143240|NCT00595530|Analgesics|analgesics|mesh-ancestor
56143241|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
56143242|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143243|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143244|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55761131|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
56143245|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56143246|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
56143248|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56143249|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56143250|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56143251|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143252|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143253|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
56143254|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
56143255|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56143256|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143257|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143258|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
56143259|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56143260|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56143261|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143262|NCT00597402|Bevacizumab|bevacizumab|mesh-list
56143265|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143266|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143267|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56143268|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56143269|NCT00597402|Growth Substances|growth substances|mesh-ancestor
56143270|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143271|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
56143272|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56143273|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56143274|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143275|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143276|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56143277|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
56143278|NCT00598806|Apaziquone|apaziquone|mesh-list
56143279|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143280|NCT00601926|Bevacizumab|bevacizumab|mesh-list
56143281|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143282|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143283|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56143284|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56143285|NCT00601926|Growth Substances|growth substances|mesh-ancestor
56143286|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143287|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
56143288|NCT00603018|Fluoxetine|fluoxetine|mesh-list
56143289|NCT00603018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56143290|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56143291|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56143292|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143293|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143294|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
56143295|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143296|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56143297|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
56143298|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56143299|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56234789|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56234790|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56234791|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234792|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234793|NCT01740336|Paclitaxel|paclitaxel|mesh-list
56234794|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56234795|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234796|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
56234797|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
56234799|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234800|NCT01740453|Ropivacaine|ropivacaine|mesh-list
56234801|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
56234802|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
56234803|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234804|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234805|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
56234806|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234807|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
56234808|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
56234809|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234810|NCT01740518|Protective Agents|protective agents|mesh-ancestor
56234811|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234812|NCT01740518|Vitamins|vitamins|mesh-ancestor
56234813|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
56234814|NCT01740921|Aspirin|aspirin|mesh-list
56143300|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56143301|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143302|NCT00603408|Cisplatin|cisplatin|mesh-list
56143303|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761220|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55761221|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143304|NCT00603720|Phenylephrine|phenylephrine|mesh-list
56143305|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
56143306|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
56143307|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56143308|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
56143309|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
56143310|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143311|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143312|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
56143313|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56143314|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
56143315|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
56143316|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56143317|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56143318|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56143319|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
56143320|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143321|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143322|NCT00603720|Protective Agents|protective agents|mesh-ancestor
56234815|NCT01740921|Liraglutide|liraglutide|mesh-list
56234816|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56234817|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56234818|NCT01740921|Analgesics|analgesics|mesh-ancestor
56234819|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
56234820|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234821|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234822|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56234823|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234824|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55810377|NCT02409355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143323|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143324|NCT00625404|Tenofovir|tenofovir|mesh-list
56143325|NCT00625404|Emtricitabine|emtricitabine|mesh-list
56143326|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56143327|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
56143328|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56143329|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56143330|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55761253|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143331|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143332|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143333|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56143334|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56143337|NCT00626340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56143338|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56143339|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56143340|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143341|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143342|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
56143343|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143344|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56143345|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
56143346|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56143347|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56143348|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56143349|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143350|NCT00626340|Hormones|hormones|mesh-ancestor
56143351|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143352|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
56143353|NCT00626574|Hematinics|hematinics|mesh-ancestor
56143354|NCT00626886|Bupivacaine|bupivacaine|mesh-list
56143355|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
56143356|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
56143357|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56143358|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143359|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
56143360|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143361|NCT00628134|Calfactant|calfactant|mesh-list
56143362|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56143363|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
56143364|NCT00632814|Factor VIII|factor viii|mesh-list
56143365|NCT00632814|Coagulants|coagulants|mesh-ancestor
56143366|NCT00632970|Ritonavir|ritonavir|mesh-list
56143367|NCT00632970|Lopinavir|lopinavir|mesh-list
56143368|NCT00632970|Tenofovir|tenofovir|mesh-list
56143369|NCT00632970|Emtricitabine|emtricitabine|mesh-list
56143370|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
56143371|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56143372|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56143373|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55761289|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761299|NCT03976245|Etanercept|etanercept|mesh-list
56143374|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
56143375|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234825|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56234826|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234827|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56234828|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56234833|NCT01740921|Hormones|hormones|mesh-ancestor
56234834|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234835|NCT01740947|Amphotericin B|amphotericin b|mesh-list
56234836|NCT01740947|Tobramycin|tobramycin|mesh-list
56234837|NCT01740947|Colistin|colistin|mesh-list
56234838|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56234839|NCT01740947|Amebicides|amebicides|mesh-ancestor
56234840|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56234841|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56234842|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234843|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56234844|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
56234845|NCT01740960|Dronabinol|dronabinol|mesh-list
56234846|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
56234847|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234848|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56234849|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56234850|NCT01740960|Analgesics|analgesics|mesh-ancestor
56234851|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
56234852|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234853|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56234857|NCT01740960|Hormones|hormones|mesh-ancestor
56234871|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743033|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56234872|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143376|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143377|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56143378|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56143379|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
55761322|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143380|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761323|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761324|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761325|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55761326|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
55761327|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55761328|NCT04828395|Paclitaxel|paclitaxel|mesh-list
55761329|NCT04828395|Etoposide|etoposide|mesh-list
55761330|NCT04828395|Cisplatin|cisplatin|mesh-list
55761331|NCT04828395|Carboplatin|carboplatin|mesh-list
55761332|NCT04828395|Pemetrexed|pemetrexed|mesh-list
55761333|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55761334|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143381|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56143382|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55743035|NCT03351205|Estrogens|estrogens|mesh-ancestor
55743036|NCT03351205|Hormones|hormones|mesh-ancestor
56143383|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56143384|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56143385|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56143386|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56143387|NCT00635232|Irbesartan|irbesartan|mesh-list
55743037|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55743038|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143389|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56143390|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56143391|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143392|NCT00637494|Mifepristone|mifepristone|mesh-list
56143393|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56143394|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
56143395|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55761351|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761352|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55761353|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761354|NCT05619315|Calcium Carbonate|calcium carbonate|mesh-list
55761355|NCT05619315|Calcium|calcium|mesh-list
55761356|NCT05619315|Charcoal|charcoal|mesh-list
55761357|NCT05619315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56143396|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143397|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56143398|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56143399|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56143400|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
56143401|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56143402|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56143403|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
56143404|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143405|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
56143408|NCT00638820|Busulfan|busulfan|mesh-list
56143409|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
56143410|NCT00638820|Clofarabine|clofarabine|mesh-list
56143411|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
56143412|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143413|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56143414|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
56143415|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143416|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56143417|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143418|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56143419|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143420|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56143421|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
56143422|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
56143423|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
56143424|NCT00641862|Vitamins|vitamins|mesh-ancestor
56143425|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
56143426|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143427|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
56143428|NCT00641862|Hematinics|hematinics|mesh-ancestor
56143429|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
56143430|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56143431|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
56143432|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143433|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143434|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56143435|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
56143436|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56143437|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56143438|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56143439|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
56143440|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143441|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143442|NCT00644592|Fenofibrate|fenofibrate|mesh-list
56143443|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56143444|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
56234874|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
56234875|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234876|NCT01741142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56234877|NCT01741142|Antidepressive Agents|antidepressive agents|mesh-ancestor
56234878|NCT01741142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56234879|NCT01741181|Vitamin D|vitamin d|mesh-list
56234880|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
56234881|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
56234882|NCT01741181|Vitamins|vitamins|mesh-list
56234883|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
55743059|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56234884|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234885|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55810435|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810436|NCT02436889|Mirabegron|mirabegron|mesh-list
56143445|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143446|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56143447|NCT00645450|Propranolol|propranolol|mesh-list
56143448|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56143449|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56143450|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
56143451|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143452|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143453|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143454|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56143455|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56143456|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
56143457|NCT00647400|Adalimumab|adalimumab|mesh-list
55745682|NCT01361607|Nabiximols|nabiximols|mesh-list
56143458|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143459|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56143461|NCT00648648|Carboplatin|carboplatin|mesh-list
56143462|NCT00648648|Adavosertib|adavosertib|mesh-list
56143463|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143464|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56143465|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
56143466|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143467|NCT00648648|Antiviral Agents|antiviral agents|mesh-ancestor
56143468|NCT00648648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761437|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56143469|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143470|NCT00648648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56143471|NCT00648648|Immunologic Factors|immunologic factors|mesh-ancestor
56143472|NCT00648648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143473|NCT00652314|Thrombin|thrombin|mesh-list
56143474|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
56143475|NCT00652314|Coagulants|coagulants|mesh-ancestor
56143476|NCT00654030|Vaccines|vaccines|mesh-list
56143477|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
56143478|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143479|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
56143480|NCT00656448|Hematinics|hematinics|mesh-ancestor
56143484|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56143485|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56143486|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56143487|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143488|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761472|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143489|NCT00661674|Palonosetron|palonosetron|mesh-list
56143490|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
56143491|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
56143492|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
55761473|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55761475|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
56143493|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143494|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870339|NCT03031756|Glycine|glycine|mesh-list
56234886|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56234887|NCT01741285|Fluticasone|fluticasone|mesh-list
56234888|NCT01741285|Beclomethasone|beclomethasone|mesh-list
56234889|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56234890|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56234891|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
56234892|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234893|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743064|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55743065|NCT04132791|Analgesics|analgesics|mesh-ancestor
56234894|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56234895|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
56234896|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
56234897|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56234898|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
55774719|NCT05738057|Cisplatin|cisplatin|mesh-list
55743066|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
56234900|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234901|NCT01741324|Vitamin D|vitamin d|mesh-list
56234902|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
56234903|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
56234904|NCT01741324|Vitamins|vitamins|mesh-list
56234905|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
56234906|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234907|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56234908|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56234909|NCT01741376|Progesterone|progesterone|mesh-list
56234910|NCT01741376|Progestins|progestins|mesh-ancestor
56234911|NCT01741376|Hormones|hormones|mesh-ancestor
56234912|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234913|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234914|NCT01741389|Melatonin|melatonin|mesh-list
56234915|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
56234916|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234917|NCT01741389|Protective Agents|protective agents|mesh-ancestor
56234918|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234919|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56234920|NCT01741493|Upadacitinib|upadacitinib|mesh-list
56143495|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56143496|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56143497|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56234921|NCT01741493|Tofacitinib|tofacitinib|mesh-list
56234922|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56234923|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234924|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234925|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56234926|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234927|NCT01741506|Dalteparin|dalteparin|mesh-list
56234928|NCT01741506|Tinzaparin|tinzaparin|mesh-list
56234929|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56234930|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
56234931|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56234932|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56234933|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234934|NCT01741519|Landiolol|landiolol|mesh-list
56234935|NCT01741519|Esmolol|esmolol|mesh-list
56234936|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56234937|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56234938|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56234939|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
56234940|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234941|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234942|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234943|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56234944|NCT01741558|Riboflavin|riboflavin|mesh-list
56234945|NCT01741558|Methotrexate|methotrexate|mesh-list
56234946|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56234947|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
56234948|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56143499|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143500|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743073|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143501|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
56143502|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
56143503|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56143504|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
56143505|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
56143506|NCT00662298|Prednisolone|prednisolone|mesh-list
56143507|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143508|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
56143509|NCT00662298|Hormones|hormones|mesh-ancestor
56143510|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143511|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143512|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56143513|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143514|NCT00666666|Acetic Acid|acetic acid|mesh-list
56143515|NCT00666666|Bicalutamide|bicalutamide|mesh-list
56143516|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
56143517|NCT00666666|Gossypol|gossypol|mesh-list
55761595|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234949|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234950|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56234951|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
56234952|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234953|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234954|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
56234955|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234956|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56234957|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56234958|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
56234959|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56234960|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56234961|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
56234963|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
56234964|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56234965|NCT01741623|Bisoprolol|bisoprolol|mesh-list
56234966|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56234967|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
56234968|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
56234969|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56234970|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234971|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56234972|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56234973|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56234974|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
56234975|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56234976|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234977|NCT01741649|Povidone|povidone|mesh-list
56234978|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
56234979|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
56234980|NCT01741753|Prednisone|prednisone|mesh-list
56234981|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143518|NCT00666666|Hormones|hormones|mesh-list
56143519|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143520|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143521|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
56143522|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
56143523|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143524|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56143525|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234983|NCT01741753|Hormones|hormones|mesh-ancestor
56234984|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56234985|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56234986|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56234987|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56234988|NCT01741831|Darunavir|darunavir|mesh-list
56234989|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56234990|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56234991|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
56234992|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56234993|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56234994|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56234995|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56234996|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
56234997|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56234998|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
56234999|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56235000|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235001|NCT01742247|Palmidrol|palmidrol|mesh-list
56235002|NCT01742247|Analgesics|analgesics|mesh-ancestor
56235003|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
55810548|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
56143526|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56143527|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56143528|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
56143529|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56143530|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56143531|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56143532|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56143533|NCT00666978|Bupropion|bupropion|mesh-list
56143534|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56143535|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
56143536|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56143537|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56143538|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56143539|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56143540|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143541|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
56143542|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143543|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761681|NCT04802967|Gabapentin|gabapentin|mesh-list
55761682|NCT04802967|Analgesics|analgesics|mesh-ancestor
56143544|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56143545|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56143546|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143547|NCT00670956|Betamethasone|betamethasone|mesh-list
56143548|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143549|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
56143550|NCT00670956|Hormones|hormones|mesh-ancestor
56143551|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143552|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143554|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
56143555|NCT00671502|Carisoprodol|carisoprodol|mesh-list
56235004|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235005|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235006|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56235007|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235008|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235009|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235010|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
56235011|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56143556|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56143557|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143558|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56143559|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143560|NCT00671970|Bevacizumab|bevacizumab|mesh-list
56143561|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56143562|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143563|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143564|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56143565|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56143566|NCT00671970|Growth Substances|growth substances|mesh-ancestor
56143567|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143568|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
56143569|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56143570|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143571|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743089|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55743090|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56143574|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56143575|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56143576|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56143577|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56143578|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143579|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
56143580|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56143581|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
56143582|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143583|NCT00672438|Alfentanil|alfentanil|mesh-list
56143584|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56143585|NCT00672438|Narcotics|narcotics|mesh-ancestor
56143586|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56143587|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143588|NCT00672438|Analgesics|analgesics|mesh-ancestor
56143589|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
56143590|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143591|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56143592|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
56143593|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
56143594|NCT00672594|Sunitinib|sunitinib|mesh-list
56143595|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143596|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56143597|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56143598|NCT00672594|Growth Substances|growth substances|mesh-ancestor
55743101|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
55743102|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55743103|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
55761728|NCT03206411|Hormones|hormones|mesh-list
56143599|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743104|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
55743105|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
56143603|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143604|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56143605|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
56143606|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56143607|NCT00675792|Bromides|bromides|mesh-list
56143608|NCT00675792|Rocuronium|rocuronium|mesh-list
56143609|NCT00675792|Neostigmine|neostigmine|mesh-list
56143610|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
56143611|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56143612|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56143613|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56143614|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235012|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56235013|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56235014|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143615|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143616|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56143617|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143618|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143619|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
56143620|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143621|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56143622|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
56143623|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
56143624|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55761735|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
56143625|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
55743142|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
56143626|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143627|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56143628|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56143630|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143631|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143632|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56143633|NCT00678834|Tocopherols|tocopherols|mesh-list
56143634|NCT00678834|Vitamin E|vitamin e|mesh-list
56143635|NCT00678834|Tocotrienols|tocotrienols|mesh-list
56143636|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
56143637|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
56143638|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143639|NCT00678834|Protective Agents|protective agents|mesh-ancestor
56143640|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143641|NCT00678834|Vitamins|vitamins|mesh-ancestor
56143642|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
56143643|NCT00679380|Budesonide|budesonide|mesh-list
56143644|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143645|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55761783|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
55761784|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55761785|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
55761786|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761787|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761788|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55761789|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
55761790|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143646|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
56143647|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143648|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143649|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56143650|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
55743143|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743144|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55743145|NCT04481451|Ropivacaine|ropivacaine|mesh-list
55743146|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
55743147|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
55743148|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743150|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
56143651|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
56143652|NCT00679380|Hormones|hormones|mesh-ancestor
56143653|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143654|NCT00680706|Thiamine|thiamine|mesh-list
56143655|NCT00680706|Vitamins|vitamins|mesh-ancestor
56143656|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
56143657|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143658|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
56143659|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
56143660|NCT00682734|Promethazine|promethazine|mesh-list
56143661|NCT00682734|Metoclopramide|metoclopramide|mesh-list
56143662|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56143663|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56143664|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56143665|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143666|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
56143667|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
56143668|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
56143669|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143670|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
56143671|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
55761832|NCT03204071|Metformin|metformin|mesh-list
56143672|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56143673|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56143674|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
56143675|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
56143676|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143677|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143678|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56143679|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
56143680|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
56143681|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56143682|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56143683|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
56143684|NCT00683046|Fludarabine|fludarabine|mesh-list
56143685|NCT00683046|Melphalan|melphalan|mesh-list
56235015|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235016|NCT01742247|Hormones|hormones|mesh-ancestor
56235017|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56235018|NCT01742273|Vitamin K|vitamin k|mesh-list
56235019|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
56235020|NCT01742273|Vitamins|vitamins|mesh-ancestor
56235021|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
56235022|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235023|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56235024|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56235025|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235026|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
56235027|NCT01742273|Coagulants|coagulants|mesh-ancestor
56235028|NCT01742338|Prednisone|prednisone|mesh-list
56235029|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
56235030|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56235031|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56235032|NCT01742338|Prednisolone|prednisolone|mesh-list
56235033|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
56235034|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56235035|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
56235036|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143686|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
56143687|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143688|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143689|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56143690|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
56143691|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143692|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56143693|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
56143694|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56143695|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143696|NCT00687102|Tamoxifen|tamoxifen|mesh-list
56143697|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56143698|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56143699|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
56143700|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143701|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143702|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56143703|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143704|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56143705|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56143706|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56143707|NCT00690924|Calcitriol|calcitriol|mesh-list
56143708|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56143709|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143710|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56143711|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56143712|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143713|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56143714|NCT00690924|Vitamins|vitamins|mesh-ancestor
56235037|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
56235038|NCT01742338|Hormones|hormones|mesh-ancestor
56235039|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56235040|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235041|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56143715|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
56143716|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56143717|NCT00691002|Calcitriol|calcitriol|mesh-list
56143718|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
56143719|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55870569|NCT04984330|Hormones|hormones|mesh-ancestor
56143720|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56143721|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56143722|NCT00691002|Calcipotriene|calcipotriene|mesh-list
56143723|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143724|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
56143725|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56143726|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143727|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56143728|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56143729|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143730|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56143731|NCT00691002|Vitamins|vitamins|mesh-ancestor
56143732|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
56143733|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56143734|NCT00695292|Carboplatin|carboplatin|mesh-list
56143735|NCT00695292|Irinotecan|irinotecan|mesh-list
56143736|NCT00695292|Sunitinib|sunitinib|mesh-list
56143737|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143738|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56143739|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56143740|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143741|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761956|NCT03231683|Analgesics|analgesics|mesh-ancestor
55761957|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
55761965|NCT03231683|Narcotics|narcotics|mesh-ancestor
56143742|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56143743|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56143744|NCT00695292|Growth Substances|growth substances|mesh-ancestor
56143745|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143746|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
56143747|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56143748|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
56143749|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56143750|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56143751|NCT00700440|Cetuximab|cetuximab|mesh-list
56143752|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143753|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143754|NCT00701376|Liver Extracts|liver extracts|mesh-list
56143755|NCT00701376|Hematinics|hematinics|mesh-ancestor
56143756|NCT00702468|Nabiximols|nabiximols|mesh-list
56143757|NCT00702468|Analgesics|analgesics|mesh-ancestor
56143758|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
56143759|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143761|NCT00702780|Citalopram|citalopram|mesh-list
56143762|NCT00702780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56143763|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56143764|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56143765|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143766|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143767|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
56143768|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143769|NCT00702780|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55762005|NCT04389411|Montelukast|montelukast|mesh-list
56143770|NCT00702780|Antidepressive Agents|antidepressive agents|mesh-ancestor
56143771|NCT00702780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56143772|NCT00704028|Dextrans|dextrans|mesh-list
56143773|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
56143774|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
56143775|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
56143776|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
56143778|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
56143779|NCT00704262|Calcipotriene|calcipotriene|mesh-list
56235042|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235043|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
56235044|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
56235045|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235046|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56235047|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56235048|NCT01742338|Protective Agents|protective agents|mesh-ancestor
56235049|NCT01742390|Risperidone|risperidone|mesh-list
56235050|NCT01742390|Aripiprazole|aripiprazole|mesh-list
56235051|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55743162|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55743163|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
55743164|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743165|NCT03322215|Capecitabine|capecitabine|mesh-list
56235052|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55743166|NCT03322215|Fulvestrant|fulvestrant|mesh-list
55743167|NCT03322215|Palbociclib|palbociclib|mesh-list
56235053|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
56235054|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235055|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235056|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235058|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56235059|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235060|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56235061|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56235062|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
56235063|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
56235064|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
56235065|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56235066|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56235067|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56235068|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56235069|NCT01742429|Amoxicillin|amoxicillin|mesh-list
56235070|NCT01742429|Metronidazole|metronidazole|mesh-list
56235071|NCT01742429|Levofloxacin|levofloxacin|mesh-list
56235072|NCT01742429|Ofloxacin|ofloxacin|mesh-list
56235073|NCT01742429|Tetracycline|tetracycline|mesh-list
56235074|NCT01742429|Bismuth|bismuth|mesh-list
55762103|NCT02447393|Cetirizine|cetirizine|mesh-list
55762104|NCT02447393|Levocetirizine|levocetirizine|mesh-list
56235075|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56235076|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56235082|NCT01742429|Renal Agents|renal agents|mesh-ancestor
56235084|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56235085|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235086|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235087|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235088|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56235089|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56235091|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56235092|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56235093|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
56235094|NCT01742533|Hormones|hormones|mesh-list
56235095|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56235096|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235097|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
56235098|NCT01742624|Tacrolimus|tacrolimus|mesh-list
56235099|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56235100|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
56235101|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235102|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56235103|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235104|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235105|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56235106|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235107|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55762164|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
55762165|NCT04791345|Deflazacort|deflazacort|mesh-list
56235108|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
56235109|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56235110|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235111|NCT01742637|Adapalene|adapalene|mesh-list
56235112|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56235127|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235128|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235129|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235130|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55743191|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
55743192|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235133|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235135|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56235136|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
56235137|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235138|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56235139|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235140|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235141|NCT01742689|Indomethacin|indomethacin|mesh-list
56235142|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55810688|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143780|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143781|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
56143782|NCT00706446|Fluticasone|fluticasone|mesh-list
56143784|NCT00706446|Budesonide|budesonide|mesh-list
56143785|NCT00706446|Bromides|bromides|mesh-list
56143786|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
56143787|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
56143788|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56143789|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143790|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55743207|NCT01285557|Fluorouracil|fluorouracil|mesh-list
55743208|NCT01285557|Tegafur|tegafur|mesh-list
55743209|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743211|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743212|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56143792|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143793|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143794|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56143795|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
56143796|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
56143797|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56143799|NCT00706446|Hormones|hormones|mesh-ancestor
56143800|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143801|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56143802|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56143803|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56143804|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
56143805|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143806|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143807|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
56143808|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56143809|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
56143810|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
56143811|NCT00706836|Pregabalin|pregabalin|mesh-list
56143812|NCT00706836|Analgesics|analgesics|mesh-ancestor
56143813|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
56143814|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143815|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143816|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
56143817|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56143818|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56143819|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143820|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56235143|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56235144|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235145|NCT01742689|Analgesics|analgesics|mesh-ancestor
56235146|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
56235147|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235148|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235149|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235150|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235151|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
56235152|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
56235153|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55743243|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
56235154|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56235156|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235157|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
56235158|NCT01742689|Coagulants|coagulants|mesh-ancestor
56235159|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56235160|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
56235161|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
56235162|NCT01742702|Bisoprolol|bisoprolol|mesh-list
56235163|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
56235164|NCT01742702|Albuterol|albuterol|mesh-list
56235165|NCT01742702|Caseins|caseins|mesh-list
56235166|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56235167|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
56235168|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235169|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235170|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55762308|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56235171|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
56235172|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
56235189|NCT01742767|Pemetrexed|pemetrexed|mesh-list
56235190|NCT01742767|Cisplatin|cisplatin|mesh-list
56235191|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235192|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235193|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235194|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56235195|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56235196|NCT01742793|Lenalidomide|lenalidomide|mesh-list
56235197|NCT01742793|Romidepsin|romidepsin|mesh-list
56235198|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
56235199|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235200|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56235201|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56235202|NCT01742793|Growth Substances|growth substances|mesh-ancestor
56235203|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
56235204|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235205|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56235206|NCT01742845|Ropivacaine|ropivacaine|mesh-list
56235207|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
56235208|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
56235209|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762354|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235210|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143821|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56143822|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56143823|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56143824|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56143825|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56143826|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56143827|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
56143828|NCT00711828|Dexamethasone|dexamethasone|mesh-list
56143829|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
56143830|NCT00711828|Rituximab|rituximab|mesh-list
56143831|NCT00711828|Bortezomib|bortezomib|mesh-list
56143832|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56143833|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
56143834|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143836|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55743270|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743271|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143837|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
56143838|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743272|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56143839|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143840|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56143841|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143842|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143843|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
56143844|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
56143845|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143846|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56143847|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
56143848|NCT00711828|Hormones|hormones|mesh-ancestor
56143849|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56143850|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56143851|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56143852|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
56143853|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235211|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
56235212|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235213|NCT01742988|Rituximab|rituximab|mesh-list
56235214|NCT01742988|Venetoclax|venetoclax|mesh-list
56235215|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56235216|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235217|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
56235218|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235219|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235220|NCT01743014|Ramipril|ramipril|mesh-list
56235221|NCT01743014|Clopidogrel|clopidogrel|mesh-list
56235222|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56235223|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56235224|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56235225|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56143854|NCT00715884|Sirolimus|sirolimus|mesh-list
56143855|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56143859|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
56143860|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56143861|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
56143862|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143863|NCT00716586|Dorzolamide|dorzolamide|mesh-list
56143864|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56143865|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56143866|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143867|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143868|NCT00716742|Bimatoprost|bimatoprost|mesh-list
56143869|NCT00716742|Travoprost|travoprost|mesh-list
56143870|NCT00716742|Latanoprost|latanoprost|mesh-list
56143871|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56143872|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56143873|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56143874|NCT00716820|Sunitinib|sunitinib|mesh-list
56143875|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143876|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56143877|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56143878|NCT00716820|Growth Substances|growth substances|mesh-ancestor
56143879|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143880|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
56143881|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56143882|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143883|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143884|NCT00717054|Scopolamine|scopolamine|mesh-list
56143885|NCT00717054|Aprepitant|aprepitant|mesh-list
56143886|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56143887|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
55762445|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143888|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
56143889|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143890|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143891|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56143892|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56143893|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56143894|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143895|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56143896|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
56143897|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56143898|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
56143899|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56143900|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
56143901|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
56143902|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56235226|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
56235227|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235228|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235229|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235230|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56235231|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
56235232|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235233|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56235235|NCT01743066|Vitamins|vitamins|mesh-ancestor
56235236|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
56235237|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235238|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
56235239|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235240|NCT01743066|Protective Agents|protective agents|mesh-ancestor
56235241|NCT01743079|Lamivudine|lamivudine|mesh-list
56143903|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143904|NCT00719160|Esomeprazole|esomeprazole|mesh-list
55762483|NCT05474937|Midazolam|midazolam|mesh-list
56143905|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56143906|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56143907|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56143908|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143909|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143911|NCT00720330|Ketamine|ketamine|mesh-list
56143912|NCT00720330|Ropivacaine|ropivacaine|mesh-list
56143913|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
56143914|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
56143915|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56143916|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143917|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
56143918|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143919|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56143920|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56143921|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56143922|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56143923|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143924|NCT00720330|Analgesics|analgesics|mesh-ancestor
56143925|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56143926|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56143927|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
56143928|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55762524|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
56143931|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56143932|NCT00721188|Hematinics|hematinics|mesh-ancestor
56143933|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
55762529|NCT02116972|Hormones|hormones|mesh-ancestor
56143934|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56143935|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56143936|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143937|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
56143938|NCT00722436|Coagulants|coagulants|mesh-ancestor
56143939|NCT00724464|Interferons|interferons|mesh-list
56143941|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
56143942|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
56143943|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56143944|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143945|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
56143946|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56143947|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
56143948|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235242|NCT01743079|Telbivudine|telbivudine|mesh-list
56235243|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56235244|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56235245|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235246|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810810|NCT04841343|Hormones|hormones|mesh-ancestor
56143949|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
56143950|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143951|NCT00726414|Quinine|quinine|mesh-list
56143952|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
56143953|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56143954|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56143955|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56143956|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56143957|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143958|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56143959|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143960|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56143961|NCT00726414|Analgesics|analgesics|mesh-ancestor
56143962|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
56143963|NCT00727740|Indomethacin|indomethacin|mesh-list
56143964|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56143965|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56143966|NCT00727740|Analgesics|analgesics|mesh-ancestor
56143967|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
56143968|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56143969|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143970|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56143971|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56143972|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
56143973|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
56143974|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56143975|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56143976|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143977|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143978|NCT00728910|Niacin|niacin|mesh-list
56143979|NCT00728910|Atorvastatin|atorvastatin|mesh-list
56143980|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56143981|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56143982|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
56143983|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56143984|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56143985|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56143986|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56143987|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
56143988|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
56143990|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
56143991|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56143992|NCT00729846|Bevacizumab|bevacizumab|mesh-list
56143993|NCT00729846|Verteporfin|verteporfin|mesh-list
56143994|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56143995|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143996|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56143997|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56143998|NCT00729846|Growth Substances|growth substances|mesh-ancestor
56143999|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762613|NCT05611827|Quercetin|quercetin|mesh-list
56144000|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
56144001|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56144002|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
56144003|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
56144004|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56144006|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
56144007|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144008|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56144009|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56144010|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144011|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144012|NCT00731874|Tacrolimus|tacrolimus|mesh-list
56144013|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56235248|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235249|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56144014|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
56144015|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144016|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56144017|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144018|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144019|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
56144020|NCT00732654|Caseins|caseins|mesh-list
56144021|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144022|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
56144023|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
56144024|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144025|NCT00733278|Copper|copper|mesh-list
56144026|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
56144027|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144028|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144029|NCT00733278|Trace Elements|trace elements|mesh-ancestor
56144030|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
56144031|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56144032|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56144033|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144034|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56144035|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56144036|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56144037|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144038|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
56144039|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144040|NCT00735306|Bevacizumab|bevacizumab|mesh-list
56144041|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56144042|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56144043|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144044|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56144045|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56144046|NCT00735306|Growth Substances|growth substances|mesh-ancestor
56144047|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144048|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
55745695|NCT05713045|Hemostatics|hemostatics|mesh-ancestor
56144049|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56144050|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762655|NCT05611593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56144051|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144052|NCT00735462|Imiquimod|imiquimod|mesh-list
56144053|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56144054|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
56144055|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144056|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144057|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
56144058|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56144059|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
56144060|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
56144061|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144062|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144064|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
56144065|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
56144066|NCT00736632|Vitamins|vitamins|mesh-list
56144067|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
56144068|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144069|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56144070|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56144071|NCT00737178|Copper|copper|mesh-list
56144072|NCT00737178|Trace Elements|trace elements|mesh-ancestor
56144073|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
56144074|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144075|NCT00741156|Enalaprilat|enalaprilat|mesh-list
56144076|NCT00741156|Enalapril|enalapril|mesh-list
55762677|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56144077|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56144078|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
56144079|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144080|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144081|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56235250|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56235251|NCT01743118|Calcipotriene|calcipotriene|mesh-list
56235252|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
56235253|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
56235254|NCT01743144|Analgesics|analgesics|mesh-ancestor
56235255|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
56235256|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235257|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235258|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
56235259|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810812|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144082|NCT00741468|Tolbutamide|tolbutamide|mesh-list
56144083|NCT00741468|Midazolam|midazolam|mesh-list
56144084|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
56144085|NCT00741468|Caffeine|caffeine|mesh-list
56144086|NCT00741468|Omeprazole|omeprazole|mesh-list
56144087|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56144088|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56144089|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144090|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144091|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56144092|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56144093|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56144094|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56144095|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
56144096|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
56144097|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
55870945|NCT03033472|Clindamycin|clindamycin|mesh-list
56144098|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
56144099|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144100|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144101|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56144102|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56144103|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144104|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56144105|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56144106|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
56144107|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56144108|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56144109|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56144110|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
56144111|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
56144112|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56144113|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56144114|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56144115|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56144116|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56144117|NCT00741858|Estradiol|estradiol|mesh-list
56144118|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56144119|NCT00741858|Estrogens|estrogens|mesh-ancestor
56144120|NCT00741858|Hormones|hormones|mesh-ancestor
55745700|NCT00653835|Simvastatin|simvastatin|mesh-list
56144121|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144122|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144123|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56144124|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
56144125|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144126|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56144127|NCT00742872|Mosapride|mosapride|mesh-list
56144128|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144129|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56144130|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56144131|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
56144132|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144133|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235260|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56235261|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
56235262|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56235263|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56235264|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235265|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56235266|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
56235267|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56235268|NCT01743157|Bevacizumab|bevacizumab|mesh-list
56235270|NCT01743157|Interleukin-2|interleukin-2|mesh-list
56235271|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56235272|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235273|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56235274|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56235275|NCT01743157|Growth Substances|growth substances|mesh-ancestor
56235276|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144134|NCT00743574|Vitamin D|vitamin d|mesh-list
56144135|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
56144136|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
56144137|NCT00743574|Vitamins|vitamins|mesh-list
56144138|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56144139|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
56144140|NCT00743574|Calcium|calcium|mesh-list
56144141|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
56144142|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144143|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55762829|NCT04425993|Indomethacin|indomethacin|mesh-list
56144144|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56144145|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56144146|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56144147|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56144148|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
56144149|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144150|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56144151|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56144152|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56144155|NCT00743730|Morphine|morphine|mesh-list
56144156|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56144157|NCT00743730|Narcotics|narcotics|mesh-ancestor
55743331|NCT03136029|Antioxidants|antioxidants|mesh-list
56144160|NCT00743730|Analgesics|analgesics|mesh-ancestor
56144161|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
56144162|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144163|NCT00745290|Bupivacaine|bupivacaine|mesh-list
56144164|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
56144165|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
56144166|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144167|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144168|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
56144169|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144170|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
56144171|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56144172|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56144173|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
56144174|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144175|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56144176|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56235277|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
56235278|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56235279|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235280|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235281|NCT01743157|Analgesics|analgesics|mesh-ancestor
56235282|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
56235283|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235284|NCT01743235|Buspirone|buspirone|mesh-list
56235285|NCT01743235|Testosterone|testosterone|mesh-list
56235286|NCT01743235|Androgens|androgens|mesh-ancestor
56235287|NCT01743235|Hormones|hormones|mesh-ancestor
56235288|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56235289|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810839|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144177|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144178|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144179|NCT00753636|Isradipine|isradipine|mesh-list
56144180|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56144181|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56144182|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56144183|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144184|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56144185|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144186|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
56144187|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56144188|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144189|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55762971|NCT01318317|Rituximab|rituximab|mesh-list
56144190|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144191|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144192|NCT00755040|Cyclosporine|cyclosporine|mesh-list
56144193|NCT00755040|Cyclosporins|cyclosporins|mesh-list
56144194|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144195|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144196|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144197|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
56144198|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144199|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
56144200|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144201|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
56144202|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56144203|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56144204|NCT00755274|Vaccines|vaccines|mesh-list
56144205|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
56144206|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144207|NCT00756600|Anesthetics|anesthetics|mesh-list
56144208|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144209|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144210|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56144211|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
56144212|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56144213|NCT00758784|Bromfenac|bromfenac|mesh-list
56144214|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56144215|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56144216|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56144217|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56144218|NCT00758784|Analgesics|analgesics|mesh-ancestor
56144219|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
56144220|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235290|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56235291|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56235292|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235293|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56235294|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56235295|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
56235296|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235297|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235298|NCT01743300|Sunitinib|sunitinib|mesh-list
56235299|NCT01743300|Midazolam|midazolam|mesh-list
56235300|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56235301|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56235302|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235303|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235304|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56235305|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56235306|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56235307|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56235308|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
56235309|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
56235310|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
56235311|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
56235312|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235313|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235314|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235315|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56235316|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56235317|NCT01743300|Growth Substances|growth substances|mesh-ancestor
56235318|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
56235319|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56235320|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235321|NCT01743326|Anesthetics|anesthetics|mesh-list
56235322|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235323|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235324|NCT01743365|Afatinib|afatinib|mesh-list
56235325|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763076|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
55810853|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235326|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56235327|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235328|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235330|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
56235331|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
56235332|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235333|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235334|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
56235335|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235336|NCT01743456|Anesthetics|anesthetics|mesh-list
56235337|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235338|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235339|NCT01743508|Misoprostol|misoprostol|mesh-list
56235340|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56235341|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
56235342|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56235343|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235344|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56235345|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56235346|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
56235347|NCT01743690|Nystatin|nystatin|mesh-list
56235348|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56235349|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235350|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
56235351|NCT01743690|Hormones|hormones|mesh-ancestor
56235352|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56235354|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56235355|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235356|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
56235357|NCT01743690|Ionophores|ionophores|mesh-ancestor
56235358|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56235359|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235360|NCT01743755|Dexamethasone|dexamethasone|mesh-list
56235361|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235363|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
56235364|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235365|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235366|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56235367|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
56235369|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56235370|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56235371|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235372|NCT01743794|Ropivacaine|ropivacaine|mesh-list
56235373|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
56235374|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
56235375|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235376|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235377|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
56235378|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235379|NCT01743820|Primaquine|primaquine|mesh-list
56235380|NCT01743820|Piperaquine|piperaquine|mesh-list
56235381|NCT01743820|Artenimol|artenimol|mesh-list
56235382|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
56235383|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56235384|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56235385|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235386|NCT01743885|Propranolol|propranolol|mesh-list
56235387|NCT01743885|Acebutolol|acebutolol|mesh-list
56235388|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56235389|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56235390|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
56235391|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235392|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235393|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235394|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56235395|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56235396|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
56144221|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144222|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56144223|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56144224|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
56144225|NCT00759330|Analgesics|analgesics|mesh-ancestor
56144226|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
56144227|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144228|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144229|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56235397|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
56235398|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
56235399|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235400|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56235401|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
56235402|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56235403|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
56235404|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56235405|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
56235406|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235407|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235408|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
56235409|NCT01743911|Tadalafil|tadalafil|mesh-list
56235410|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
55763213|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55763214|NCT02105272|Latanoprost|latanoprost|mesh-list
56235411|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56235412|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56235414|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235415|NCT01743911|Urological Agents|urological agents|mesh-ancestor
56235416|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
56235417|NCT01744106|Ephedrine|ephedrine|mesh-list
56235418|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56235419|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
56235420|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235421|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235422|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56235423|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
55763268|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56235424|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
56235425|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56235426|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56235427|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
56235428|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
56235429|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235430|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235437|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235438|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56235439|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56235440|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56235441|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56235442|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
56235443|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
56235444|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
56235445|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
56235446|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235447|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235448|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56235449|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235450|NCT01744184|Analgesics|analgesics|mesh-ancestor
56235451|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
56235452|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235453|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56235454|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56235455|NCT01744236|Liraglutide|liraglutide|mesh-list
56235456|NCT01744236|Exenatide|exenatide|mesh-list
56235457|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56144230|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56144231|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56144232|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56144233|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56144234|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144235|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144236|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56144237|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56144238|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56144239|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144241|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144242|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56144243|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144244|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144245|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
56144246|NCT00759798|Rituximab|rituximab|mesh-list
56144247|NCT00759798|Fludarabine|fludarabine|mesh-list
56144248|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144249|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
56144250|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144252|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56144253|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
56144254|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144255|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144256|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56144257|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56144258|NCT00760578|Pioglitazone|pioglitazone|mesh-list
56144259|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56144260|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144261|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56144262|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
56144263|NCT00761202|Glycerol|glycerol|mesh-list
56144264|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56235458|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235460|NCT01744236|Hormones|hormones|mesh-ancestor
56235461|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763367|NCT05547789|Analgesics|analgesics|mesh-ancestor
55763372|NCT05542095|Simvastatin|simvastatin|mesh-list
56235462|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56235463|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
56235464|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235465|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235466|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56235467|NCT01744249|Axitinib|axitinib|mesh-list
56235468|NCT01744249|Octreotide|octreotide|mesh-list
56235469|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235470|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56235471|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235472|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235473|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56235474|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56235475|NCT01744262|Anesthetics|anesthetics|mesh-list
56235476|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235477|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235478|NCT01744288|Clopidogrel|clopidogrel|mesh-list
56235479|NCT01744288|Ticagrelor|ticagrelor|mesh-list
56235480|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56235481|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56235482|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56235483|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56235484|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
56235485|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235486|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235487|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235488|NCT01744314|Indomethacin|indomethacin|mesh-list
56235489|NCT01744314|Pantoprazole|pantoprazole|mesh-list
56235490|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56235491|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56144265|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
56144266|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144267|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
56144268|NCT00761202|Protective Agents|protective agents|mesh-ancestor
56235492|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56235493|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235494|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235495|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56235496|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235497|NCT01744314|Analgesics|analgesics|mesh-ancestor
56235498|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
56235499|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235500|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235501|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235502|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235503|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
56235504|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
55743440|NCT02516059|Analgesics|analgesics|mesh-ancestor
56235505|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56235506|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55811067|NCT01636947|Dexamethasone|dexamethasone|mesh-list
56144269|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56144270|NCT00761202|Laxatives|laxatives|mesh-ancestor
55763428|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
56144271|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56144272|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
56144273|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56144274|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56144275|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56144276|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56144277|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144278|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
56144279|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144280|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144281|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56144282|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144284|NCT00762450|Fluorides|fluorides|mesh-list
56144285|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
56144286|NCT00762450|Protective Agents|protective agents|mesh-ancestor
56144287|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144288|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56144289|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144290|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56144291|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56144292|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
56144293|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144294|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55763555|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
56144295|NCT00762528|Triclosan|triclosan|mesh-list
56144296|NCT00762528|Fluorides|fluorides|mesh-list
56144297|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
56144298|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
56144299|NCT00762528|Protective Agents|protective agents|mesh-ancestor
56144300|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144301|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56144302|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144303|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56144304|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56144305|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
56144306|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144307|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56235508|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56235509|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235511|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
56235512|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235513|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
56235514|NCT01744379|Renal Agents|renal agents|mesh-ancestor
56144308|NCT00765648|Labetalol|labetalol|mesh-list
56144309|NCT00765648|Nicardipine|nicardipine|mesh-list
56144310|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56144311|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56144312|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
56144313|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144314|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144315|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144316|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56144317|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
56144318|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
56144319|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144320|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56144321|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56144322|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56144323|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56144324|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56144326|NCT00766116|Azacitidine|azacitidine|mesh-list
56144327|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
56144328|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56144329|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
56144330|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144331|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144332|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144333|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56144334|NCT00767364|Vaccines|vaccines|mesh-list
56144335|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
56144336|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144337|NCT00769314|Acyclovir|acyclovir|mesh-list
56144338|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
56144339|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144340|NCT00769392|Lidocaine|lidocaine|mesh-list
56144341|NCT00769392|Tetracaine|tetracaine|mesh-list
56144342|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
56144343|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
56144344|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
56144345|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144346|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144347|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
56144348|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144349|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56144350|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56144351|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56144352|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56144353|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144354|NCT00770874|Cisplatin|cisplatin|mesh-list
56144355|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144356|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
56144357|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56144358|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56144359|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
56144360|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144361|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56144362|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56144363|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144364|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144365|NCT00775944|Nicotine|nicotine|mesh-list
56144366|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56144367|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
56144368|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144369|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144370|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56144371|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56144372|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
56235516|NCT01744444|Memantine|memantine|mesh-list
56235517|NCT01744444|Analgesics|analgesics|mesh-ancestor
56235518|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
56235519|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235520|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235521|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
56235522|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56235523|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56235524|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235525|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55811078|NCT01636947|BB 1101|bb 1101|mesh-list
55811079|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56144373|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144374|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144375|NCT00780234|Pioglitazone|pioglitazone|mesh-list
56144376|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763685|NCT04677855|Prednisone|prednisone|mesh-list
56144378|NCT00784524|Aldesleukin|aldesleukin|mesh-list
56144379|NCT00784524|Interleukin-2|interleukin-2|mesh-list
56144380|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144381|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56144382|NCT00784524|Analgesics|analgesics|mesh-ancestor
56144383|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
56144384|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144385|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144386|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56144387|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56144388|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
56144389|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144390|NCT00785772|Gabapentin|gabapentin|mesh-list
56144391|NCT00785772|Analgesics|analgesics|mesh-ancestor
56144392|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
56144393|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144394|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144395|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
56144396|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56144397|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56144398|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144399|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56144400|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56144401|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56144402|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144403|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144404|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
56144405|NCT00787332|Desirudin|desirudin|mesh-list
56144406|NCT00787332|Argatroban|argatroban|mesh-list
56144407|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
56144408|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56144409|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
56144410|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144411|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144412|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
56144413|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56144414|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56144415|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56144416|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
56144417|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56144418|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56144419|NCT00787722|Prednisolone|prednisolone|mesh-list
56144420|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
56144421|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
56144422|NCT00787722|Rituximab|rituximab|mesh-list
56144423|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
56144424|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56144425|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56144426|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
56235526|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55763778|NCT02583477|Gemcitabine|gemcitabine|mesh-list
56235528|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235529|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235530|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
56235531|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56235532|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56235533|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
56235534|NCT01744470|Tacrolimus|tacrolimus|mesh-list
56235535|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56235536|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
56235537|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235538|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56235539|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235540|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235541|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56235542|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
56235543|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235544|NCT01744587|Protective Agents|protective agents|mesh-ancestor
56235545|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235546|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56235547|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56235548|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235549|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56235550|NCT01744756|Bevacizumab|bevacizumab|mesh-list
56235551|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56235552|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235553|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56235554|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56235569|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235570|NCT01744886|Benzocaine|benzocaine|mesh-list
56235571|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
56235572|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
56235573|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235574|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235575|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
56235576|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235577|NCT01744626|Rituximab|rituximab|mesh-list
56235578|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56235579|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235580|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
56235581|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235582|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235584|NCT01744964|Emetics|emetics|mesh-ancestor
56235585|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235586|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
56235587|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235588|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56235589|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
56235590|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
56235591|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235592|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235593|NCT01745081|Mannitol|mannitol|mesh-list
56235594|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56235595|NCT01745081|Diuretics|diuretics|mesh-ancestor
56235596|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
56235597|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235598|NCT01745159|Tacrolimus|tacrolimus|mesh-list
56235599|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811135|NCT05651607|Cannabidiol|cannabidiol|mesh-list
56144427|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144428|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
56144429|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144430|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56144431|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56144432|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
56144433|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144434|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144435|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56144436|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56144437|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235600|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
56235601|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235602|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56235603|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235604|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235606|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
56235607|NCT01745263|Vitamins|vitamins|mesh-ancestor
56235608|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
56235609|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235610|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56235611|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56235613|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235614|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56235615|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235616|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235617|NCT01745328|Amoxicillin|amoxicillin|mesh-list
56235618|NCT01745328|Levofloxacin|levofloxacin|mesh-list
56235619|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56235620|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235621|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56235622|NCT01745328|Renal Agents|renal agents|mesh-ancestor
56235623|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56235624|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56235625|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235626|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144438|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
56144439|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
56144440|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144441|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56144442|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
56144443|NCT00787722|Hormones|hormones|mesh-ancestor
56144444|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144445|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56144446|NCT00787722|Protective Agents|protective agents|mesh-ancestor
56144447|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56144448|NCT00788892|Cytarabine|cytarabine|mesh-list
55763972|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56144449|NCT00788892|Daunorubicin|daunorubicin|mesh-list
56144450|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56144451|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
56144455|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144456|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144457|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
56144458|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144459|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56235627|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235628|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56235629|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56235630|NCT01745549|Insulin|insulin|mesh-list
56235631|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56235632|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56235633|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235634|NCT01745562|Alprazolam|alprazolam|mesh-list
56235635|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56235636|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235637|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235638|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56235639|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56235640|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56235641|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
56235642|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
56235643|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235644|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235645|NCT01745575|Alprazolam|alprazolam|mesh-list
56235646|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56235647|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235648|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235649|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56235650|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56235651|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56235652|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
56235653|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
56144460|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56144461|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56144463|NCT00789672|Levodopa|levodopa|mesh-list
56144464|NCT00789672|Carbidopa|carbidopa|mesh-list
56144465|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56144466|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56144467|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
56144468|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144469|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144470|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890367|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764009|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
56144471|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56144472|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144473|NCT00789750|Pioglitazone|pioglitazone|mesh-list
56144474|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56144475|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56144476|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144477|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56144478|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56144479|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
56144480|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235654|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235655|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235656|NCT01745601|Dexetimide|dexetimide|mesh-list
56235657|NCT01745601|Citalopram|citalopram|mesh-list
56235658|NCT01745601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56235659|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56235660|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56235661|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235662|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235663|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
55811224|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
56144481|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56144483|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
56144484|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144485|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144486|NCT00793572|Cyclosporine|cyclosporine|mesh-list
56144487|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
56144488|NCT00793572|Fludarabine|fludarabine|mesh-list
56144489|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
56144490|NCT00793572|Bortezomib|bortezomib|mesh-list
56144491|NCT00793572|Melphalan|melphalan|mesh-list
56144492|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
56144493|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56144494|NCT00793572|Cyclosporins|cyclosporins|mesh-list
56144495|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144496|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56144497|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
56144498|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144499|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144500|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
56144501|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144502|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144503|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
56144504|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144505|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
56144506|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56144507|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56144508|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56144509|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56144510|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
56144513|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
56144514|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56144516|NCT00793650|Melphalan|melphalan|mesh-list
56144517|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764059|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
55764071|NCT03192449|Albendazole|albendazole|mesh-list
56144518|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56144519|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
56144520|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144521|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56144522|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144523|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
56144524|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144525|NCT00795210|Hormones|hormones|mesh-list
56144535|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56144537|NCT00795366|Vasopressins|vasopressins|mesh-list
56144538|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
56144539|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
56144540|NCT00795366|Coagulants|coagulants|mesh-ancestor
56235664|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235665|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56235666|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
56235667|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56235668|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56235669|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56235670|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
56235671|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
56235672|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235673|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56235674|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56235675|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
56235676|NCT01745614|Nimesulide|nimesulide|mesh-list
56235677|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56235678|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235679|NCT01745614|Analgesics|analgesics|mesh-ancestor
56235680|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
56235681|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235682|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235683|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235684|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235685|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55764084|NCT05691933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56235686|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235687|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235688|NCT01745640|Dexamethasone|dexamethasone|mesh-list
56235689|NCT01745640|Pomalidomide|pomalidomide|mesh-list
56235690|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235691|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
56235692|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
56235693|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235694|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235695|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56235696|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
56235697|NCT01745640|Hormones|hormones|mesh-ancestor
56235698|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56235699|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56235706|NCT01745666|Epinephrine|epinephrine|mesh-list
56235707|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56235708|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56235709|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
55811268|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55811270|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144541|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56235710|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235711|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235712|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235713|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56235714|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56235715|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
56235716|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235717|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56235718|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
56235719|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
56235720|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
56235721|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56235722|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
56235723|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56235724|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235725|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56235726|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56235727|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56235728|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235729|NCT01745770|Mesalamine|mesalamine|mesh-list
56235730|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56235731|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235732|NCT01745770|Analgesics|analgesics|mesh-ancestor
56235733|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
56235734|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235735|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235736|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235737|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235738|NCT01745809|Dimercaprol|dimercaprol|mesh-list
56235739|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
56235740|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
56235741|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235742|NCT01745835|Bisacodyl|bisacodyl|mesh-list
56235743|NCT01745835|Cathartics|cathartics|mesh-ancestor
56235744|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56235745|NCT01745835|Laxatives|laxatives|mesh-ancestor
56235746|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
56235747|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
56235748|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56235750|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
56235770|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
56235771|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
56235772|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
56235773|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235774|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235775|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56235776|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55743609|NCT02510287|Narcotics|narcotics|mesh-ancestor
56235779|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56235780|NCT01746563|Ranibizumab|ranibizumab|mesh-list
56235781|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56235782|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55811340|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235783|NCT01746563|Growth Substances|growth substances|mesh-ancestor
56235784|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235785|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
56235786|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235787|NCT01746602|Timolol|timolol|mesh-list
56235788|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56235789|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56235790|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
55811351|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235792|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235793|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235794|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56235795|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56235796|NCT01746641|Remifentanil|remifentanil|mesh-list
55764134|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55764135|NCT02442791|Incretins|incretins|mesh-ancestor
55764136|NCT02442791|Hormones|hormones|mesh-ancestor
55764138|NCT04756557|Fluorides|fluorides|mesh-list
56235797|NCT01746641|Propofol|propofol|mesh-list
56235798|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56235799|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56235800|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235801|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56235802|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
56235803|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
56235804|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56235805|NCT01746641|Narcotics|narcotics|mesh-ancestor
56235806|NCT01746641|Analgesics|analgesics|mesh-ancestor
56235807|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
56235808|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235809|NCT01746680|Methotrexate|methotrexate|mesh-list
56235811|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56235812|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
56235813|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56235814|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235815|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56235816|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
56235817|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235818|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235819|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56235820|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235821|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56235822|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56235823|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
56235824|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235825|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56235826|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56235827|NCT01746719|Etodolac|etodolac|mesh-list
56235828|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56235829|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235830|NCT01746719|Analgesics|analgesics|mesh-ancestor
56235831|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
56235832|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235833|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235834|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235835|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235836|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55743610|NCT02510287|Analgesics|analgesics|mesh-ancestor
56235840|NCT01746771|Paclitaxel|paclitaxel|mesh-list
56235841|NCT01746771|Trastuzumab|trastuzumab|mesh-list
56235842|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56235843|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235844|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
56235845|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
56235846|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
56235847|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235848|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56235849|NCT01746823|Cyclosporine|cyclosporine|mesh-list
56235850|NCT01746823|Cyclosporins|cyclosporins|mesh-list
56235851|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235852|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811383|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
56235853|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56235854|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
56235855|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235856|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
55811417|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
56235857|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235858|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
56235859|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235860|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56235862|NCT01746875|Verteporfin|verteporfin|mesh-list
56235863|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56235864|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56235865|NCT01746875|Growth Substances|growth substances|mesh-ancestor
56235866|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235867|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
56235868|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235869|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56235870|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
56235871|NCT01746992|Prednisone|prednisone|mesh-list
56235872|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
56235873|NCT01746992|Ifosfamide|ifosfamide|mesh-list
56235874|NCT01746992|Doxorubicin|doxorubicin|mesh-list
56235875|NCT01746992|Methotrexate|methotrexate|mesh-list
56235876|NCT01746992|Etoposide|etoposide|mesh-list
56235877|NCT01746992|Vincristine|vincristine|mesh-list
56235878|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
56144550|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235879|NCT01746992|Pirarubicin|pirarubicin|mesh-list
56235880|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56235881|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
56235882|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235883|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56235884|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56235885|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
55743626|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235886|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235887|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56235888|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56235889|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56235890|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56235891|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56235892|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235893|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56235894|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
56235895|NCT01746992|Hormones|hormones|mesh-ancestor
56235896|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56235897|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56235898|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56235899|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
56235900|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56235901|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56235902|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
56235903|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
56235904|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56235905|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56235906|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56235907|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56235908|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56235909|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56235910|NCT01747044|Milnacipran|milnacipran|mesh-list
56235911|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
56235912|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56235913|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56235914|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55811448|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811449|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56235915|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235916|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235917|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235918|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56235920|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
56235921|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235922|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
56235923|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56235924|NCT01747083|Metformin|metformin|mesh-list
56235925|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56235926|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811474|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
56235928|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
55811485|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
56235929|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235931|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
55811490|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
56235932|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235933|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
56235934|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56235935|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55764289|NCT03192059|Vitamin D|vitamin d|mesh-list
56235936|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235938|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235939|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235940|NCT01747174|Adenosine|adenosine|mesh-list
56235942|NCT01747174|Analgesics|analgesics|mesh-ancestor
56235943|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
56235944|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56235945|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235946|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56235948|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56235949|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
56235950|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
56235951|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235952|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235953|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56235954|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56235956|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
56235957|NCT01747226|Protective Agents|protective agents|mesh-ancestor
56235958|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235960|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
56235961|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764346|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55764347|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
56235963|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235964|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235965|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56235966|NCT01747278|Trimethoprim|trimethoprim|mesh-list
56235967|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
56235968|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56235969|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56235970|NCT01747278|Renal Agents|renal agents|mesh-ancestor
56235971|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
56235972|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56235973|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56235974|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56235975|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235976|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235977|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56235978|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56235979|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56235980|NCT01747564|Mirabegron|mirabegron|mesh-list
56235981|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56235982|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56235983|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56235984|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
55811515|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
56235985|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56235986|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235987|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235988|NCT01747564|Urological Agents|urological agents|mesh-ancestor
56235990|NCT01747590|Alprazolam|alprazolam|mesh-list
56235991|NCT01747590|Caffeine|caffeine|mesh-list
56235992|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56235993|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56235994|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56235995|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56235996|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56235997|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56235998|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56235999|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
56236000|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811543|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811545|NCT04274361|Ketamine|ketamine|mesh-list
55764444|NCT02437955|Trace Elements|trace elements|mesh-ancestor
56236001|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56236002|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56236003|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236004|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56236005|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
56236006|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
56236007|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56236008|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56236009|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236010|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
56236011|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
56236012|NCT01747616|Chitosan|chitosan|mesh-list
56236015|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56236016|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
56236017|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236018|NCT01747616|Expectorants|expectorants|mesh-ancestor
56236019|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
56236020|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56236021|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
56236022|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236023|NCT01747616|Protective Agents|protective agents|mesh-ancestor
56236024|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236025|NCT01747616|Antidotes|antidotes|mesh-ancestor
56236026|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56236027|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56236028|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
55811576|NCT02243631|Renal Agents|renal agents|mesh-ancestor
56236029|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56236030|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
56236031|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
56236032|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
55764528|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55764530|NCT02440841|Rifampin|rifampin|mesh-list
56236033|NCT01747616|Coagulants|coagulants|mesh-ancestor
56236034|NCT01747642|Sorafenib|sorafenib|mesh-list
56236035|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236036|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56236037|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236038|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236039|NCT01747668|Tocopherols|tocopherols|mesh-list
56236040|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
56236041|NCT01747668|Vitamin E|vitamin e|mesh-list
56236042|NCT01747668|Vitamins|vitamins|mesh-ancestor
56236043|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
56236044|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236045|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
56236046|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236047|NCT01747668|Protective Agents|protective agents|mesh-ancestor
56236048|NCT01747707|Docetaxel|docetaxel|mesh-list
56236049|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236050|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
56236051|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
55811583|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236052|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
56236053|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236054|NCT01747720|Vitamin D|vitamin d|mesh-list
56236055|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
56236056|NCT01747720|Vitamins|vitamins|mesh-ancestor
56236057|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
56236058|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764576|NCT02435537|Narcotics|narcotics|mesh-ancestor
56236059|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56236060|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56236061|NCT01747746|Enoxaparin|enoxaparin|mesh-list
56236062|NCT01747746|Warfarin|warfarin|mesh-list
56236063|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
56236064|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
56236065|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56236066|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
56236067|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56236068|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
56236069|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236070|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236071|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56236072|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56236073|NCT01747798|Auranofin|auranofin|mesh-list
56236074|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56236076|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55743668|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56236081|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236082|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236083|NCT01747993|Urological Agents|urological agents|mesh-ancestor
56236084|NCT01748019|Namitecan|namitecan|mesh-list
55746045|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236085|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56236086|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236087|NCT01748084|Rituximab|rituximab|mesh-list
55746050|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
56236088|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56236089|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236090|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
56236091|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236092|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56236093|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56236094|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
55789031|NCT03520231|Calcium|calcium|mesh-list
56236095|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56236096|NCT01748123|Diuretics|diuretics|mesh-ancestor
56236097|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
56236098|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811640|NCT01632891|Trimethoprim|trimethoprim|mesh-list
55746053|NCT03403621|Pentamidine|pentamidine|mesh-list
56236099|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56236100|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236101|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236103|NCT01748253|Telmisartan|telmisartan|mesh-list
55746056|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56236104|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56236105|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56236106|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56236107|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236108|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236109|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56236110|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236111|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
55811648|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56236112|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56236113|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56236114|NCT01748279|Atorvastatin|atorvastatin|mesh-list
56236115|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
56236116|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56236117|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56236118|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
56144551|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236119|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236120|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56236121|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56236122|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236123|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56236124|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
56236125|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236126|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743683|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56236127|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56236128|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
56236129|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56236130|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56236131|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56236132|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
56236133|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236134|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56236135|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56236136|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236137|NCT01748318|Renal Agents|renal agents|mesh-ancestor
56236138|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56144552|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56236139|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
56236140|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56236141|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56236142|NCT01748344|Cetirizine|cetirizine|mesh-list
55811686|NCT02207907|Listerine|listerine|mesh-list
56144553|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56236143|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56236144|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56236145|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56236146|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
56236147|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
55764640|NCT02709005|Protective Agents|protective agents|mesh-ancestor
55764641|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764642|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
56236148|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144554|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236149|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236152|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
56236153|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
56236154|NCT01748370|Vitamins|vitamins|mesh-list
56236155|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
56236156|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236157|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56236158|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56236159|NCT01748396|Calcitriol|calcitriol|mesh-list
56236160|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
56236161|NCT01748396|Calcium|calcium|mesh-list
56236162|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56236163|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236164|NCT01748396|Antacids|antacids|mesh-ancestor
56236165|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236166|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56236167|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56236168|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56236169|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56236170|NCT01748396|Vitamins|vitamins|mesh-ancestor
56236171|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
56236172|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56236173|NCT01748422|Capsaicin|capsaicin|mesh-list
56236174|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
56236175|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
56236176|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
56236177|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236178|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236179|NCT01748435|Capsaicin|capsaicin|mesh-list
56236180|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
56236181|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
55764675|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
56236182|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
56236183|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236184|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236185|NCT01748487|Dexamethasone|dexamethasone|mesh-list
56236186|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
56236187|NCT01748487|BB 1101|bb 1101|mesh-list
56236188|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56236190|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
56236191|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236192|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236193|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56236194|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
56236195|NCT01748487|Hormones|hormones|mesh-ancestor
56236196|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811727|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55746079|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
56236198|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236199|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
56236200|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890368|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55764721|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
56236201|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144555|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236203|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56236204|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56236205|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56236206|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236207|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236209|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56236210|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236211|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56236212|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144556|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56236213|NCT01748539|Brodalumab|brodalumab|mesh-list
56236214|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
56236215|NCT01748630|Fentanyl|fentanyl|mesh-list
56236216|NCT01748630|Midazolam|midazolam|mesh-list
56236217|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
56236218|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56144557|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
56144558|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56236219|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236220|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236221|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56236222|NCT01748630|Analgesics|analgesics|mesh-ancestor
56236223|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
56236224|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56236225|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56236226|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56236227|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56236228|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
56236229|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236230|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236231|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56236232|NCT01748630|Narcotics|narcotics|mesh-ancestor
55811752|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811753|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56236233|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56236234|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56236235|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
56236236|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
56236237|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56236238|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56236239|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56236240|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
56236241|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
56236242|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
56236243|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
56236245|NCT01748669|Protective Agents|protective agents|mesh-ancestor
56236246|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236247|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56236248|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236249|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56236250|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236251|NCT01748721|Antibodies|antibodies|mesh-list
56236252|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56236253|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
56236254|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236255|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56236256|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56236257|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
56236258|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236259|NCT01748773|Capecitabine|capecitabine|mesh-list
56236260|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
56236261|NCT01748773|Trastuzumab|trastuzumab|mesh-list
56236262|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56236264|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236265|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236266|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56236267|NCT01748838|Mannitol|mannitol|mesh-list
55746095|NCT03065335|Analgesics|analgesics|mesh-ancestor
56236268|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56236269|NCT01748838|Diuretics|diuretics|mesh-ancestor
56236270|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
56236271|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236272|NCT01748929|Albendazole|albendazole|mesh-list
56236273|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
56236274|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56236275|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236276|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
56236277|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56236278|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56236279|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
56236280|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
56236281|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
56236282|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236283|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236284|NCT01749072|Vinorelbine|vinorelbine|mesh-list
56236285|NCT01749072|Ifosfamide|ifosfamide|mesh-list
56236286|NCT01749072|Gefitinib|gefitinib|mesh-list
56236287|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56236288|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236289|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
56236291|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
56236292|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236293|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56236294|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
56236295|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56236296|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236297|NCT01749085|Ketoconazole|ketoconazole|mesh-list
56236298|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
56236299|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56236300|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56236301|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56236302|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811807|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
55811808|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
56236303|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236304|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56236306|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764917|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
56236308|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56236309|NCT01749098|Ketamine|ketamine|mesh-list
56236310|NCT01749098|Analgesics|analgesics|mesh-ancestor
56236311|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
56236312|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811829|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56144559|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56236313|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236314|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56236315|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56236316|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
56236317|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
56236318|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56236319|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56236320|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56236321|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56236322|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236323|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
56236324|NCT01749111|Methotrexate|methotrexate|mesh-list
56236325|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
56236326|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56236327|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
56236328|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56236329|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56236330|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56236331|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
56236332|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236333|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56236334|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56236335|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56236336|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
56236337|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56236338|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56236339|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
56236340|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
56236341|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56236342|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56236343|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55764960|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56236344|NCT01749150|Ritonavir|ritonavir|mesh-list
56236345|NCT01749150|Ribavirin|ribavirin|mesh-list
56236346|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56236347|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
56236348|NCT01749150|Lactams|lactams|mesh-list
56236349|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56237019|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237020|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237021|NCT01754324|Analgesics|analgesics|mesh-ancestor
56237022|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
56237023|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237024|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
56237025|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
56237026|NCT01754649|Misoprostol|misoprostol|mesh-list
56237027|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56237028|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
56237029|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55812466|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56237030|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237031|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56237032|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56237033|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
56237035|NCT01754701|Trace Elements|trace elements|mesh-ancestor
56237036|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
56237037|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237038|NCT01754792|Inositol|inositol|mesh-list
56237039|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
56237040|NCT01754792|Vitamins|vitamins|mesh-ancestor
56237041|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
56237042|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237043|NCT01754805|Methotrexate|methotrexate|mesh-list
56237044|NCT01754805|Peficitinib|peficitinib|mesh-list
56237045|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56237106|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237108|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
56237109|NCT01755078|Calcium|calcium|mesh-list
56237110|NCT01755078|Sevelamer|sevelamer|mesh-list
56237111|NCT01755078|Calcium acetate|calcium acetate|mesh-list
56237112|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56237113|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237114|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56237115|NCT01755078|Antacids|antacids|mesh-ancestor
56237116|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237117|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56237118|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
56237119|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
56237120|NCT01755117|Ropivacaine|ropivacaine|mesh-list
56237121|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
56237122|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
56237123|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237124|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237125|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
56237126|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237127|NCT01755182|Somatostatin|somatostatin|mesh-list
55812570|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787229|NCT03059849|Adalimumab|adalimumab|mesh-list
56237196|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237276|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237277|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
56237278|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56237279|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237280|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765117|NCT05518383|Hormones|hormones|mesh-ancestor
56237281|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56237282|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237283|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237284|NCT01755845|Paclitaxel|paclitaxel|mesh-list
56237285|NCT01755845|Cisplatin|cisplatin|mesh-list
56237286|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56237287|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237288|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
56237289|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
56237290|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
56237291|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237292|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56237346|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
56237347|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
56237348|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237349|NCT01756261|Aflibercept|aflibercept|mesh-list
56237350|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56237351|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56237352|NCT01756261|Growth Substances|growth substances|mesh-ancestor
56237353|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237354|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
55871459|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871460|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
55871462|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55871463|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55871464|NCT00812032|Analgesics|analgesics|mesh-ancestor
55871465|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
55871466|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871467|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871468|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55871469|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871470|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56237355|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237356|NCT01756404|Canagliflozin|canagliflozin|mesh-list
56237357|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56237358|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237359|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237360|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237361|NCT01756417|Metformin|metformin|mesh-list
56237362|NCT01756417|Canagliflozin|canagliflozin|mesh-list
56237363|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237364|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237372|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237373|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237374|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56237375|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
56237376|NCT01756430|Protective Agents|protective agents|mesh-ancestor
56237377|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56237378|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56237379|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56237380|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
56237381|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56237382|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56237383|NCT01756443|Lidocaine|lidocaine|mesh-list
56237384|NCT01756443|Epinephrine|epinephrine|mesh-list
56237385|NCT01756443|Racepinephrine|racepinephrine|mesh-list
56237386|NCT01756443|Bupivacaine|bupivacaine|mesh-list
56237387|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
56237395|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56237396|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56237397|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56237398|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237399|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56237400|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56237401|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
56237402|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237403|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56237404|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56237405|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
56237406|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56237407|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
56237408|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
56237409|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
56237410|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56237411|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
56237412|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56237413|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56237414|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56237415|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56237416|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56237417|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237418|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237419|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237420|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56237421|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
56237422|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56237423|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788096|NCT04574479|Narcotics|narcotics|mesh-ancestor
56237674|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
56237675|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
56237784|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
56237785|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55813188|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237786|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56237787|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56237789|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56237790|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
56237791|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237792|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237793|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237794|NCT01758380|Metformin|metformin|mesh-list
56237795|NCT01758380|Vildagliptin|vildagliptin|mesh-list
56237796|NCT01758380|Gliclazide|gliclazide|mesh-list
56237797|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56237798|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765198|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56237799|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56237800|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
56237801|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237802|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237803|NCT01758393|Prednisone|prednisone|mesh-list
56237804|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237805|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
56237873|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56237874|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237876|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56237877|NCT01758978|Narcotics|narcotics|mesh-ancestor
56237878|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237879|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237880|NCT01758978|Analgesics|analgesics|mesh-ancestor
56237881|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
56237882|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237883|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
56237884|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
56237885|NCT01759030|Rituximab|rituximab|mesh-list
56237886|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56237887|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237888|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
56237889|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237890|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237891|NCT01759108|Rebamipide|rebamipide|mesh-list
55788408|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56237944|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813335|NCT02302807|Paclitaxel|paclitaxel|mesh-list
56237946|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56237947|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56237948|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56237949|NCT01759589|Narcotics|narcotics|mesh-ancestor
56237950|NCT01759589|Analgesics|analgesics|mesh-ancestor
56237951|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
56237952|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237953|NCT01759706|Dexamethasone|dexamethasone|mesh-list
56237954|NCT01759706|Sufentanil|sufentanil|mesh-list
56237955|NCT01759706|Diazepam|diazepam|mesh-list
56237956|NCT01759706|Ondansetron|ondansetron|mesh-list
56237957|NCT01759706|Anesthetics|anesthetics|mesh-list
56237958|NCT01759706|Ropivacaine|ropivacaine|mesh-list
55765223|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237959|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56237961|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
56237962|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56237963|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237964|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56237965|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
56237966|NCT01759706|Hormones|hormones|mesh-ancestor
56237967|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56237968|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56237969|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56237970|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56237971|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
56237972|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
56237973|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56237974|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
56237975|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56237976|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56237977|NCT01759706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56237978|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56237991|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56237992|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56237993|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
56237994|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
56237996|NCT01759719|Trace Elements|trace elements|mesh-ancestor
56237997|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
56237998|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56237999|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
56238000|NCT01759732|Fludarabine|fludarabine|mesh-list
56238001|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56238002|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238003|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
56238004|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238005|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238006|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56238007|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
56238008|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238009|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238010|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56238011|NCT01759771|Vitamin D|vitamin d|mesh-list
56238012|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
56238013|NCT01759771|Vitamins|vitamins|mesh-ancestor
56238014|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
56238015|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238016|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56238017|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56238018|NCT01759810|Vaccines|vaccines|mesh-list
55813405|NCT05368415|Norepinephrine|norepinephrine|mesh-list
55747572|NCT03287011|Listerine|listerine|mesh-list
56238019|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
56238020|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238021|NCT01759875|Ritonavir|ritonavir|mesh-list
56238022|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56238023|NCT01759875|Rabeprazole|rabeprazole|mesh-list
56238024|NCT01759875|Betaine|betaine|mesh-list
56238025|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56238026|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56238027|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
56238028|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238029|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238030|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56238031|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56238105|NCT01760174|Ropivacaine|ropivacaine|mesh-list
56238106|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
56238107|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
56238131|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56238132|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238133|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238134|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
56238136|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238137|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55765293|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55765295|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238138|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56238139|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
56238140|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56238141|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56238142|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
56238143|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
56238144|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56238145|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56238146|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56238147|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
56238148|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
56238149|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
56238150|NCT01760252|Capecitabine|capecitabine|mesh-list
56238151|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
56238152|NCT01760252|Irinotecan|irinotecan|mesh-list
56238153|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56238154|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
56238156|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238162|NCT01760278|Progesterone|progesterone|mesh-list
56238163|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56238164|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238165|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238166|NCT01760278|Progestins|progestins|mesh-ancestor
56238167|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56238168|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
56238169|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56238170|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
56238194|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56238195|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238196|NCT01760564|Miglustat|miglustat|mesh-list
55765341|NCT03185351|Midazolam|midazolam|mesh-list
56238197|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238198|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238199|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56238200|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56238201|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
56238224|NCT01760642|Midazolam|midazolam|mesh-list
56238225|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56238226|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56238227|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56238228|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238229|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56238230|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56238231|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56238232|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56238233|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
56238234|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
56238235|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
56238236|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
56238237|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238238|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238239|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56238240|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
56238241|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238242|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238243|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
56238244|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56238245|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238246|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56238247|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56238248|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56238249|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56238250|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56238251|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56238252|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
56238253|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56238259|NCT01760694|Leucovorin|leucovorin|mesh-list
56238266|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238267|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238268|NCT01760694|Antidotes|antidotes|mesh-ancestor
56238269|NCT01760694|Protective Agents|protective agents|mesh-ancestor
56238270|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238271|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
56238272|NCT01760694|Vitamins|vitamins|mesh-ancestor
56238273|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
56238274|NCT01760746|Bevacizumab|bevacizumab|mesh-list
56238275|NCT01760746|Ranibizumab|ranibizumab|mesh-list
56238276|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56238277|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238278|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56238279|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56238280|NCT01760746|Growth Substances|growth substances|mesh-ancestor
56238281|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238282|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
56238283|NCT01760798|Teriparatide|teriparatide|mesh-list
56238284|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56238285|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238286|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56238287|NCT01760811|Cetuximab|cetuximab|mesh-list
56238288|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56238289|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238290|NCT01760824|Amoxicillin|amoxicillin|mesh-list
56238291|NCT01760824|Metronidazole|metronidazole|mesh-list
56238292|NCT01760824|Clarithromycin|clarithromycin|mesh-list
56238293|NCT01760824|Tetracycline|tetracycline|mesh-list
56238294|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56238295|NCT01760824|Esomeprazole|esomeprazole|mesh-list
56238297|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55788453|NCT05108155|Tacrine|tacrine|mesh-list
56238329|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56238330|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238547|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56238548|NCT01762306|Folic Acid|folic acid|mesh-list
56238549|NCT01762306|Diclofenac|diclofenac|mesh-list
56238550|NCT01762306|Hematinics|hematinics|mesh-ancestor
56238551|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
56238552|NCT01762306|Vitamins|vitamins|mesh-ancestor
56238553|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
56238554|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238555|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55765412|NCT03182855|Cangrelor|cangrelor|mesh-list
56238556|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238557|NCT01762306|Analgesics|analgesics|mesh-ancestor
56238558|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
56238559|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238560|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238561|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238562|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56238569|NCT01762319|Vitamins|vitamins|mesh-ancestor
56238648|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238649|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238650|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
56238651|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238652|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
56238653|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238654|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
56238655|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238656|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56238657|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56238658|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56238659|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56238660|NCT01762670|Metronidazole|metronidazole|mesh-list
56238680|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238681|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238682|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55765455|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238683|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56238684|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238685|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56238686|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56238687|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238688|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
56238689|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
56238691|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765457|NCT02426099|Diuretics|diuretics|mesh-ancestor
56238692|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56238693|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238694|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
56238695|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
56238696|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56238699|NCT01762826|Inositol|inositol|mesh-list
56238700|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
56238702|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
56238703|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238704|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
56238706|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238707|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238708|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56238709|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56238710|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238711|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238712|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238713|NCT01762852|Belimumab|belimumab|mesh-list
56238714|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238715|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
56238716|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238717|NCT01762878|Nemiralisib|nemiralisib|mesh-list
56238718|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56238719|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238720|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238721|NCT01762891|Acetaminophen|acetaminophen|mesh-list
56238722|NCT01762891|Celecoxib|celecoxib|mesh-list
56238723|NCT01762891|Rofecoxib|rofecoxib|mesh-list
56238724|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56238725|NCT01762891|Analgesics|analgesics|mesh-ancestor
56238726|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
56238727|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238728|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238729|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
56238730|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56238731|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238732|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56238733|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56238734|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56238735|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238736|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238737|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
56238738|NCT01762995|Dolutegravir|dolutegravir|mesh-list
56238739|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
56238740|NCT01762995|Calcium|calcium|mesh-list
56238741|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56238742|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238743|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56238744|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56238745|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238746|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238748|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56238749|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
56238750|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238751|NCT01762995|Antacids|antacids|mesh-ancestor
56238752|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56238753|NCT01762995|Trace Elements|trace elements|mesh-ancestor
56238754|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
56238755|NCT01763021|Rifampin|rifampin|mesh-list
56238756|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56238757|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
56238758|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238766|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56238767|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56238768|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56238769|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56238770|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
56238772|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238773|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238774|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56238775|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238776|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56238777|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238778|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238779|NCT01763424|Calcitriol|calcitriol|mesh-list
56238780|NCT01763424|Niacinamide|niacinamide|mesh-list
56238781|NCT01763424|Niacin|niacin|mesh-list
56238806|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56238808|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56238809|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56238810|NCT01763450|Growth Substances|growth substances|mesh-ancestor
56238811|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238812|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
56238813|NCT01763463|Fluticasone|fluticasone|mesh-list
56238814|NCT01763463|Xhance|xhance|mesh-list
56238815|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56238816|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56238817|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
56238818|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238819|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
56238820|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238821|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238822|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56238823|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
56238824|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
56238825|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55765522|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55765523|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56238826|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56238827|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56238828|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56238829|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
56238830|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238831|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238832|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
56238833|NCT01763463|Hormones|hormones|mesh-ancestor
56238834|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238835|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
56238836|NCT01763476|Paclitaxel|paclitaxel|mesh-list
56238837|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56238838|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238846|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238847|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56238848|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56238849|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238850|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238851|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56238852|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
56238853|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56238854|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238855|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56238856|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
56238857|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56238858|NCT01763658|Dexamethasone|dexamethasone|mesh-list
56238859|NCT01763658|Prednisolone|prednisolone|mesh-list
56238860|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56238861|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
56238862|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56238863|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
56238864|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56238865|NCT01763658|Antioxidants|antioxidants|mesh-list
56238866|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56238867|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
56238868|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
56238869|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56238870|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238872|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
56238892|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56238893|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56238894|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
56238895|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238896|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238897|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238898|NCT01763788|Gemcitabine|gemcitabine|mesh-list
55765555|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55765556|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56238899|NCT01763788|Necitumumab|necitumumab|mesh-list
55765557|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765558|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238900|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238901|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56238902|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
56238903|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238904|NCT01763788|Antiviral Agents|antiviral agents|mesh-ancestor
56238905|NCT01763788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238906|NCT01763788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238907|NCT01763788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56238908|NCT01763788|Immunologic Factors|immunologic factors|mesh-ancestor
56238909|NCT01763788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238910|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56238911|NCT01764087|Paclitaxel|paclitaxel|mesh-list
56238912|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
56238913|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56238914|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56238915|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
56238916|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
56238917|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
56238918|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238919|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238920|NCT01764126|Vaccines|vaccines|mesh-list
56238921|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
56238922|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238923|NCT01764139|Vitamin D|vitamin d|mesh-list
56238924|NCT01764139|Vitamins|vitamins|mesh-ancestor
56238925|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
56238926|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238928|NCT01764178|Valsartan|valsartan|mesh-list
56238931|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56238932|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56238933|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238934|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56238935|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56238936|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56238937|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
56238938|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56238939|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56238940|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56238941|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
56238942|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56238943|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
56238944|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56238945|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56238946|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56238949|NCT01764295|Olmesartan|olmesartan|mesh-list
56238986|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56238987|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56238988|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56238989|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238990|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
56238991|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56238992|NCT01764750|Vancomycin|vancomycin|mesh-list
56238993|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56238994|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56238995|NCT01764828|Gemcitabine|gemcitabine|mesh-list
56238996|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56238997|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
56238998|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56238999|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239000|NCT01764828|Antiviral Agents|antiviral agents|mesh-ancestor
56239001|NCT01764828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239002|NCT01764828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239003|NCT01764828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56239004|NCT01764828|Immunologic Factors|immunologic factors|mesh-ancestor
56239005|NCT01764828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239006|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56239007|NCT01764867|Dexetimide|dexetimide|mesh-list
56239008|NCT01764867|Mirtazapine|mirtazapine|mesh-list
56239009|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
56239010|NCT01764867|Trazodone|trazodone|mesh-list
56239011|NCT01764867|Citalopram|citalopram|mesh-list
56239012|NCT01764867|Bupropion|bupropion|mesh-list
56239013|NCT01764867|Fluoxetine|fluoxetine|mesh-list
56239014|NCT01764867|Paroxetine|paroxetine|mesh-list
56239015|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55765614|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56239016|NCT01764867|Sertraline|sertraline|mesh-list
55765615|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56239021|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239031|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239032|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56239033|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56239034|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
56239035|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56239036|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
56239037|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56239038|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56239039|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239040|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56239041|NCT01764867|Analgesics|analgesics|mesh-ancestor
56239042|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
56239043|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56239044|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
56239045|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
56239046|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56239047|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56239048|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239049|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56239050|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56239051|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56239052|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
56239054|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56239081|NCT01765023|Atorvastatin|atorvastatin|mesh-list
56239082|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56239083|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239084|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56239085|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56239086|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
56239109|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239110|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
56239111|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239112|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239114|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56239115|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239116|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
56239117|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239145|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56239146|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239147|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239148|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55788655|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
56239154|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56239155|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
56239156|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
55765668|NCT02140060|Travoprost|travoprost|mesh-list
56239157|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56239158|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239159|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239160|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56239161|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56239162|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56239163|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56239164|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56239165|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56239167|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
56239168|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
56239169|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239170|NCT01765829|Droperidol|droperidol|mesh-list
56239171|NCT01765829|Haloperidol|haloperidol|mesh-list
56239172|NCT01765829|Pimozide|pimozide|mesh-list
56239173|NCT01765829|Olanzapine|olanzapine|mesh-list
56239174|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
56239175|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
56239176|NCT01765829|Risperidone|risperidone|mesh-list
56239177|NCT01765829|Aripiprazole|aripiprazole|mesh-list
56239178|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56239179|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56239180|NCT01765829|Ziprasidone|ziprasidone|mesh-list
56239181|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
56239182|NCT01765829|Clozapine|clozapine|mesh-list
56239183|NCT01765829|Asenapine|asenapine|mesh-list
56239184|NCT01765829|Amisulpride|amisulpride|mesh-list
56239185|NCT01765829|Perphenazine|perphenazine|mesh-list
56239186|NCT01765829|Sertindole|sertindole|mesh-list
56239187|NCT01765829|Sulpiride|sulpiride|mesh-list
56239188|NCT01765829|Clopenthixol|clopenthixol|mesh-list
56239189|NCT01765829|Clothiapine|clothiapine|mesh-list
56239190|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56239191|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
56239192|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239200|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
56239201|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
56239202|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239203|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56239204|NCT01765829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56239205|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56239206|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239207|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
56239208|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
55765680|NCT02421029|Edetic Acid|edetic acid|mesh-list
56239209|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56239210|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56239211|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56239212|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56239213|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56239214|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
56239215|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
56239216|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56239217|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56239218|NCT01765842|Rituximab|rituximab|mesh-list
56239219|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56239220|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239221|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
56239222|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239223|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56239224|NCT01765855|Betrixaban|betrixaban|mesh-list
56239225|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56239226|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
56239227|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56239228|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
56239229|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239230|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239231|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
56239232|NCT01765868|Betrixaban|betrixaban|mesh-list
56239233|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56239234|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
56239239|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
56239240|NCT01765881|Misoprostol|misoprostol|mesh-list
56239241|NCT01765881|Dinoprostone|dinoprostone|mesh-list
56239242|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56239243|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
56239244|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56239245|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239246|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56239259|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239260|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56239261|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
56239262|NCT01766089|Remifentanil|remifentanil|mesh-list
56239263|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56239264|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239265|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239266|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56239267|NCT01766089|Analgesics|analgesics|mesh-ancestor
56239268|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
56239269|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239270|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55765767|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55765768|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55765769|NCT04735354|Valsartan|valsartan|mesh-list
55765770|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55765771|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55765772|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56239271|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56239272|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55814644|NCT05220293|Hormones|hormones|mesh-ancestor
55814662|NCT05096663|Vitamins|vitamins|mesh-list
56239274|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239275|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239276|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56239277|NCT01766089|Narcotics|narcotics|mesh-ancestor
56239278|NCT01766154|Tirofiban|tirofiban|mesh-list
56239279|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56239280|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56239281|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239282|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56239283|NCT01766180|Resveratrol|resveratrol|mesh-list
56239284|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
56239285|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239286|NCT01766180|Protective Agents|protective agents|mesh-ancestor
56239287|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239288|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814684|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
55788718|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
56239308|NCT01766375|Methotrexate|methotrexate|mesh-list
56239309|NCT01766375|Cyclosporins|cyclosporins|mesh-list
56239310|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56239311|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
56239312|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56239313|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239314|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56239315|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
56239316|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239332|NCT01766414|Complement C1s|complement c1s|mesh-list
56239333|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55788726|NCT04264663|Tinidazole|tinidazole|mesh-list
56239334|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56239335|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
55863756|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55863757|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
56239336|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239337|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56239338|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56239339|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
56239340|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56239341|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239342|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56239343|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
56239344|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239345|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239346|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239347|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239348|NCT01766583|Lenalidomide|lenalidomide|mesh-list
56239349|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
56239350|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239351|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56239352|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56239353|NCT01766583|Growth Substances|growth substances|mesh-ancestor
56239354|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
56239355|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239356|NCT01766609|Triamcinolone|triamcinolone|mesh-list
56239357|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56239358|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56239378|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239379|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56239380|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
56239381|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
56239382|NCT01766843|Hormones|hormones|mesh-ancestor
56239383|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239384|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
56239385|NCT01766843|Antidotes|antidotes|mesh-ancestor
56239386|NCT01766843|Protective Agents|protective agents|mesh-ancestor
56239387|NCT01766960|Morphine|morphine|mesh-list
56239388|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56239389|NCT01766960|Narcotics|narcotics|mesh-ancestor
56239390|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239391|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239392|NCT01766960|Analgesics|analgesics|mesh-ancestor
56239393|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
56239394|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239395|NCT01767025|Oxytocin|oxytocin|mesh-list
56239396|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
56239397|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56239398|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239399|NCT01767090|Leuprolide|leuprolide|mesh-list
56239400|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56239401|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
56239402|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56239403|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863795|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55863796|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55863797|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55863799|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
55863800|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863801|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863802|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239404|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56239405|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239406|NCT01767259|Valsartan|valsartan|mesh-list
56239407|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56239412|NCT01767259|Diuretics|diuretics|mesh-ancestor
56239423|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239424|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239425|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239426|NCT01767298|Valsartan|valsartan|mesh-list
56239427|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56239428|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56239429|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56239430|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56239431|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239432|NCT01767298|Diuretics|diuretics|mesh-ancestor
56239433|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
56239434|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239435|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56239436|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239437|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56239438|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
56239439|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56239440|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
56239441|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239442|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239443|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239444|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56239445|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239446|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
56239447|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239448|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56239449|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
56239465|NCT01767454|Trametinib|trametinib|mesh-list
56239466|NCT01767454|Dabrafenib|dabrafenib|mesh-list
56239467|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56239468|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239469|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56239470|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239471|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56239472|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239473|NCT01767532|Cephalexin|cephalexin|mesh-list
56239474|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239475|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239476|NCT01767545|Dexamethasone|dexamethasone|mesh-list
55863818|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55863820|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863821|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863822|NCT00811564|Timolol|timolol|mesh-list
55863823|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55863825|NCT00811564|Latanoprost|latanoprost|mesh-list
55863826|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55863827|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863829|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55863830|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
56239477|NCT01767545|Bevacizumab|bevacizumab|mesh-list
56239478|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56239479|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239480|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56239481|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56239482|NCT01767545|Growth Substances|growth substances|mesh-ancestor
56239483|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239484|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
56239485|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56239486|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
56239487|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
56239515|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56239516|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239517|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239518|NCT01767714|Plerixafor|plerixafor|mesh-list
56239519|NCT01767714|Lenograstim|lenograstim|mesh-list
56239520|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56239521|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
56239522|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239523|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56239524|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56239525|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
56239526|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239527|NCT01767896|Vaccines|vaccines|mesh-list
56239528|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
56239529|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239530|NCT01768039|Vitamin D|vitamin d|mesh-list
56239531|NCT01768039|Vitamins|vitamins|mesh-ancestor
56239532|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
56239533|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239534|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56239535|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56239536|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56239537|NCT01768078|Betamethasone|betamethasone|mesh-list
56239568|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863840|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863841|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
55863842|NCT04520776|Meloxicam|meloxicam|mesh-list
55863843|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55863844|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863846|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
55863847|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863848|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863849|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55863850|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55863851|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55863852|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55863853|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863854|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239570|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56239571|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56239572|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239574|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56239575|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56239576|NCT01768260|Analgesics|analgesics|mesh-ancestor
55788751|NCT04563559|Hormones|hormones|mesh-ancestor
56239577|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
56239578|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239579|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239580|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56239581|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56239582|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56239583|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56239584|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239585|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56239586|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56239587|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239588|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
56239589|NCT01768273|Midazolam|midazolam|mesh-list
56239590|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56239591|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56239592|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239593|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239594|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56239595|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56239596|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56239597|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56239598|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
56239611|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56239612|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
56239613|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56239614|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56239615|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56239616|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56239617|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
56239618|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56239619|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56239620|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
56239621|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239622|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
56239623|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55863868|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55863869|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55863870|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55863872|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55863874|NCT01776307|Cetuximab|cetuximab|mesh-list
55863875|NCT01776307|Panitumumab|panitumumab|mesh-list
55863876|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55863877|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
55863878|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863879|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863880|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863881|NCT01741532|Deferiprone|deferiprone|mesh-list
55863882|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56239624|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56239625|NCT01768312|Cyclosporine|cyclosporine|mesh-list
56239626|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56239627|NCT01768312|Cyclosporins|cyclosporins|mesh-list
56239628|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239629|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239630|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56239631|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
56239632|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239633|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
56239634|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239635|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
56239636|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56239637|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56239638|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56239639|NCT01768351|Calcitriol|calcitriol|mesh-list
56239640|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56239652|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56239654|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
56239655|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56239656|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56239657|NCT01768377|Lidocaine|lidocaine|mesh-list
56239678|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56239679|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56239680|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56239681|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
56239682|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
56239683|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239684|NCT01768390|Fluorides|fluorides|mesh-list
56239685|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
56239695|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56239696|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56239697|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
56239698|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239699|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56239700|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55863883|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
55863884|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
55863885|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863887|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
55863890|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55863891|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55863892|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863893|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
55863894|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
55863895|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863896|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863897|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55863899|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
56239701|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239702|NCT01768507|Resveratrol|resveratrol|mesh-list
56239703|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
56239704|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239705|NCT01768507|Protective Agents|protective agents|mesh-ancestor
56239706|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239707|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239708|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56239709|NCT01768663|Itraconazole|itraconazole|mesh-list
56239710|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
55815108|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
56239726|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56239727|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239728|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56239729|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56239730|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
56239732|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56239733|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56239734|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56239735|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56239736|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56239737|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56239741|NCT01768741|Liver Extracts|liver extracts|mesh-list
56239755|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866660|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55866661|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866662|NCT03213964|Interleukin-2|interleukin-2|mesh-list
55866665|NCT03213964|Analgesics|analgesics|mesh-ancestor
56239756|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239757|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
56239758|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56239759|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
56239760|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239761|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239762|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55788774|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
56239817|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239818|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56239819|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56239820|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56239821|NCT01769079|Isosorbide|isosorbide|mesh-list
56239822|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56239823|NCT01769079|Diuretics|diuretics|mesh-ancestor
56239824|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
56239825|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239826|NCT01769118|Caffeine|caffeine|mesh-list
55866718|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239827|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55815210|NCT02511431|Ritonavir|ritonavir|mesh-list
56239828|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239829|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56239830|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239831|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239832|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56239833|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56239834|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
56239835|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239836|NCT01769183|Squalamine|squalamine|mesh-list
56239837|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56239838|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56239839|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55866780|NCT01838200|Ipilimumab|ipilimumab|mesh-list
56239840|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56239841|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55866781|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
55866796|NCT01720030|Simendan|simendan|mesh-list
56239842|NCT01769183|Protective Agents|protective agents|mesh-ancestor
56239843|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239844|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239845|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56239846|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56239847|NCT01769183|Growth Substances|growth substances|mesh-ancestor
56239848|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
56239849|NCT01769235|Clindamycin|clindamycin|mesh-list
56239850|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
56239881|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239882|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239883|NCT01769651|Methadone|methadone|mesh-list
56239884|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56239885|NCT01769651|Narcotics|narcotics|mesh-ancestor
56239886|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239887|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239888|NCT01769651|Analgesics|analgesics|mesh-ancestor
56239892|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
56239893|NCT01769664|Clindamycin|clindamycin|mesh-list
56239894|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
56239895|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
56239896|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56239897|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56239898|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866851|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866852|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866853|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56239899|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56239900|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239901|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239902|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
56239903|NCT01769677|Hydrocodone|hydrocodone|mesh-list
56239904|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56239905|NCT01769677|Narcotics|narcotics|mesh-ancestor
56239906|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56239907|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239908|NCT01769677|Analgesics|analgesics|mesh-ancestor
56239909|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
56239910|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56239911|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
56239912|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
56239913|NCT01769703|Dabigatran|dabigatran|mesh-list
56239914|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
56239915|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56239916|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
56239917|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239918|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239919|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
56239920|NCT01769768|Bupropion|bupropion|mesh-list
56239921|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56239922|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
56239923|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56239924|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56239925|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56239926|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56239927|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239928|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
56239929|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56239930|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866910|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56239931|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56239932|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56239933|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239934|NCT01769781|Anastrozole|anastrozole|mesh-list
56239935|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56239936|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56239938|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56239939|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56239940|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56239941|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56239942|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
56239943|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56239944|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56239945|NCT01769820|Dexamethasone|dexamethasone|mesh-list
56239946|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56239947|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
56239948|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
55788831|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56240006|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240007|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240008|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
56240009|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240010|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56240011|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
56240012|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56240014|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
56240015|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56240016|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
56240017|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866950|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56240018|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240019|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56240020|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
56240021|NCT01770041|Acetaminophen|acetaminophen|mesh-list
56240022|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56240023|NCT01770041|Analgesics|analgesics|mesh-ancestor
56240024|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
56240025|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240026|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240027|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
56240028|NCT01770080|Peppermint oil|peppermint oil|mesh-list
56240029|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56240030|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
56240031|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
56240032|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240033|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240034|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240035|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
55867047|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55867048|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
55867079|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867080|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55867081|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55867082|NCT03215524|Growth Substances|growth substances|mesh-ancestor
55867083|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
56240036|NCT01770106|Denosumab|denosumab|mesh-list
56240037|NCT01770106|Alendronate|alendronate|mesh-list
56240038|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56240039|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240040|NCT01770132|Gemcitabine|gemcitabine|mesh-list
56240041|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56240042|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
56240043|NCT01770132|Trioxsalen|trioxsalen|mesh-list
56240044|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56240045|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
56240046|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240047|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240048|NCT01770132|Antiviral Agents|antiviral agents|mesh-ancestor
56240049|NCT01770132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240050|NCT01770132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240051|NCT01770132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240052|NCT01770132|Immunologic Factors|immunologic factors|mesh-ancestor
56240053|NCT01770132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240054|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
56240102|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
56240103|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240104|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56240105|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56240106|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56240107|NCT01770301|Growth Substances|growth substances|mesh-ancestor
56240108|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240109|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
56240111|NCT01770444|Thioguanine|thioguanine|mesh-list
56240112|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56240113|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
56240114|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240115|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747885|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240116|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
56240146|NCT01770769|Tinzaparin|tinzaparin|mesh-list
56240147|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56240148|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
56240149|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56240150|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56240151|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240152|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56240153|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240154|NCT01770795|Gemcitabine|gemcitabine|mesh-list
56240155|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56240156|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
56240157|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240158|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240161|NCT01770795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240162|NCT01770795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240163|NCT01770795|Immunologic Factors|immunologic factors|mesh-ancestor
56240190|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56240191|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56240192|NCT01771081|Growth Substances|growth substances|mesh-ancestor
56240193|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240194|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
56240195|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240196|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
56240197|NCT01771146|Irinotecan|irinotecan|mesh-list
56240198|NCT01771146|Folfirinox|folfirinox|mesh-list
56240199|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240200|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56240201|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56240202|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240203|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240204|NCT01771185|Metformin|metformin|mesh-list
56240205|NCT01771185|Gliclazide|gliclazide|mesh-list
56240206|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56240207|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240208|NCT01771198|Simvastatin|simvastatin|mesh-list
56240209|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56240210|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56240211|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
56240212|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240213|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55867242|NCT04378972|Vitamin D|vitamin d|mesh-list
56240214|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56240215|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240216|NCT01771289|Docetaxel|docetaxel|mesh-list
56240217|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240218|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
56240219|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
56240220|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
56240221|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240222|NCT01771302|Calcium|calcium|mesh-list
56240232|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56240233|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56240234|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56240235|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
56240236|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240237|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240238|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240239|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56240240|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240241|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56240242|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240243|NCT01771458|Tamoxifen|tamoxifen|mesh-list
56240244|NCT01771458|Trastuzumab|trastuzumab|mesh-list
56240245|NCT01771458|Everolimus|everolimus|mesh-list
56240246|NCT01771458|Sorafenib|sorafenib|mesh-list
56240247|NCT01771458|Letrozole|letrozole|mesh-list
56240248|NCT01771458|Dasatinib|dasatinib|mesh-list
56240249|NCT01771458|Lapatinib|lapatinib|mesh-list
56240250|NCT01771458|Vemurafenib|vemurafenib|mesh-list
56240251|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56240252|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240253|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240254|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
56240255|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240257|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240282|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240283|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240284|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240285|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56240305|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56240306|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
56240308|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56240327|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240328|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240329|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240330|NCT01772238|Amoxicillin|amoxicillin|mesh-list
56240331|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56240332|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
56240333|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
56240334|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56240335|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240336|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56240337|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240338|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240339|NCT01772251|Insulin|insulin|mesh-list
56240340|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56240341|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240342|NCT01772290|Itraconazole|itraconazole|mesh-list
56240343|NCT01772290|Fluconazole|fluconazole|mesh-list
56240344|NCT01772290|Rabeprazole|rabeprazole|mesh-list
56240345|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
56240346|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815729|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55815730|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55788939|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56240359|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56240360|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56240362|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240364|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
56240365|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240366|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240367|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240368|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
56240369|NCT01772381|Hormones|hormones|mesh-ancestor
56240370|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240371|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56240372|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240373|NCT01772420|Lenalidomide|lenalidomide|mesh-list
56240374|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
56240375|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240376|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56240377|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56240378|NCT01772420|Growth Substances|growth substances|mesh-ancestor
56240379|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
56240380|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240381|NCT01772563|Itraconazole|itraconazole|mesh-list
56240382|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
56240383|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240386|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240404|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56240405|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56240407|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56240408|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56240409|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
56240410|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240411|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240412|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240413|NCT01772797|Ceritinib|ceritinib|mesh-list
56240414|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240415|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56240416|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240417|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240418|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
56240419|NCT01772836|Biapenem|biapenem|mesh-list
56240420|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890369|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55867339|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
55867340|NCT01836406|Ketorolac|ketorolac|mesh-list
55867341|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56240421|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240422|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56240423|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240424|NCT01772940|Ritonavir|ritonavir|mesh-list
56240425|NCT01772940|Lopinavir|lopinavir|mesh-list
56240426|NCT01772940|Tenofovir|tenofovir|mesh-list
56240427|NCT01772940|Lamivudine|lamivudine|mesh-list
56240428|NCT01772940|Zidovudine|zidovudine|mesh-list
56240429|NCT01772940|Emtricitabine|emtricitabine|mesh-list
56240430|NCT01772940|Nevirapine|nevirapine|mesh-list
56240431|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56240432|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56240433|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
56240434|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240435|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240436|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56240437|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56240438|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
55788962|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
56240444|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
56240445|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56240446|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56240448|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56240449|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
56240450|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240451|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240452|NCT01772979|Trabectedin|trabectedin|mesh-list
56240453|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56240454|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
56240455|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240456|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240457|NCT01773005|Acetaminophen|acetaminophen|mesh-list
56240458|NCT01773005|Ibuprofen|ibuprofen|mesh-list
56240459|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56240460|NCT01773005|Analgesics|analgesics|mesh-ancestor
56240461|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
56240462|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240463|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240464|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
56240465|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56240466|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240467|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240468|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56240469|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240470|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240471|NCT01773044|Lidocaine|lidocaine|mesh-list
56240472|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
56240473|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
56240475|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240476|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
56240477|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240478|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56240479|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56240480|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56240481|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56240482|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240483|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
56240484|NCT01773096|Bisacodyl|bisacodyl|mesh-list
56240485|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56240486|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55815880|NCT02499029|Expectorants|expectorants|mesh-ancestor
56240546|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56240547|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
56240548|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56240549|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815929|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55789004|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
55815953|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240579|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240580|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240605|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
56240606|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240607|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240609|NCT01774396|Lidocaine|lidocaine|mesh-list
56240622|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
56240623|NCT01774474|Triamcinolone|triamcinolone|mesh-list
56240624|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56240625|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56240626|NCT01774474|Bromfenac|bromfenac|mesh-list
56240627|NCT01774474|Bevacizumab|bevacizumab|mesh-list
56240628|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56240629|NCT01774474|BB 1101|bb 1101|mesh-list
56240630|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56240631|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56240632|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240633|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56240634|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56240635|NCT01774474|Growth Substances|growth substances|mesh-ancestor
55816034|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
55747913|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816040|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56240636|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816041|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
55816042|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55816043|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55816044|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816045|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56240637|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
56240638|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240639|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
56240640|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
56240641|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240642|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56240643|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
56240644|NCT01774474|Hormones|hormones|mesh-ancestor
56240645|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240646|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56240647|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
56240648|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240649|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240650|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56240651|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240652|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
56240655|NCT01774474|Analgesics|analgesics|mesh-ancestor
56240679|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240681|NCT01774864|Udenafil|udenafil|mesh-list
56240682|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56240683|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56240684|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240685|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240686|NCT01774877|Leflunomide|leflunomide|mesh-list
56240687|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240688|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240689|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240690|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
56240691|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240692|NCT01775098|Allopurinol|allopurinol|mesh-list
56240693|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
56240694|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240695|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240696|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
56240697|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240698|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56240699|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
56240700|NCT01775098|Protective Agents|protective agents|mesh-ancestor
56240701|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240702|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56240703|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
56240704|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240705|NCT01775397|Vancomycin|vancomycin|mesh-list
56240706|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
56240719|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56240720|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56240721|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240723|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56240724|NCT01775579|Metformin|metformin|mesh-list
56240725|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56240726|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56240727|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240728|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56240729|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56240730|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
56240731|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240732|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56240733|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56240734|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240735|NCT01775618|Factor VIII|factor viii|mesh-list
56240736|NCT01775618|Coagulants|coagulants|mesh-ancestor
56240737|NCT01775631|Rituximab|rituximab|mesh-list
56240738|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56240739|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240740|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
56240741|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240742|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240751|NCT01775839|Aspirin|aspirin|mesh-list
56240752|NCT01775839|Digoxin|digoxin|mesh-list
56240753|NCT01775839|Clopidogrel|clopidogrel|mesh-list
56240754|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56240755|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56240756|NCT01775839|Analgesics|analgesics|mesh-ancestor
56240757|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
56240758|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240759|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240760|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56240761|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56240762|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56240763|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55867437|NCT01837498|Neostigmine|neostigmine|mesh-list
56240764|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240765|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56240766|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56240767|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240769|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56240770|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56240771|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56240772|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
56240773|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240774|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56240775|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56240776|NCT01775839|Protective Agents|protective agents|mesh-ancestor
56240777|NCT01775891|Flecainide|flecainide|mesh-list
56240778|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56240779|NCT01775891|Propafenone|propafenone|mesh-list
56240780|NCT01775891|Pilsicainide|pilsicainide|mesh-list
56240781|NCT01775891|Lidocaine|lidocaine|mesh-list
56240782|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56240783|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56240784|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56240785|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240786|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
56240787|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
55867480|NCT01725412|Thiamine|thiamine|mesh-list
56240788|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56240789|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240790|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
56240791|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240792|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56240793|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56240794|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56240795|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
56240796|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56240797|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56240798|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56240799|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
56240800|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56240801|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240802|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56240803|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56240804|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56240805|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56240806|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240807|NCT01776320|Alprostadil|alprostadil|mesh-list
56240808|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56240809|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
55816191|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240825|NCT01776515|Narcotics|narcotics|mesh-ancestor
56240826|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56240827|NCT01776567|Everolimus|everolimus|mesh-list
56240828|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240829|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56240830|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
56240831|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240833|NCT01776671|Analgesics|analgesics|mesh-ancestor
56240834|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
55867543|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
56240835|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240836|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240837|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
56240838|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55816221|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
56240840|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56240841|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56240842|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56240843|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56240844|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240845|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240846|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
56240847|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56240848|NCT01776684|Gefitinib|gefitinib|mesh-list
56240849|NCT01776684|Afatinib|afatinib|mesh-list
56240850|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240851|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56240852|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240853|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240854|NCT01776788|Insulin|insulin|mesh-list
56240855|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56240897|NCT01777477|Chloroquine|chloroquine|mesh-list
56240898|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56240899|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
56240900|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240901|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240902|NCT01777477|Antiviral Agents|antiviral agents|mesh-ancestor
56240920|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240921|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240922|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240923|NCT01777685|Sulpiride|sulpiride|mesh-list
56240924|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56240934|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
56240935|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56240936|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55867590|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867598|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
56240937|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56240939|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56240940|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
56240941|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56240942|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56240943|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
56240944|NCT01777867|Miotics|miotics|mesh-ancestor
56240945|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
56240946|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56240947|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240948|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56240949|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56240950|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
56240951|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56240952|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56240953|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
56240954|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56240955|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240956|NCT01777919|Copper|copper|mesh-list
56240957|NCT01777919|Temozolomide|temozolomide|mesh-list
56240958|NCT01777919|Disulfiram|disulfiram|mesh-list
56240959|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56240960|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
56240961|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56240962|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56240963|NCT01777919|Trace Elements|trace elements|mesh-ancestor
56240964|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
56240965|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56240966|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56240967|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56240968|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56240969|NCT01778075|Acetaminophen|acetaminophen|mesh-list
56240970|NCT01778075|Tramadol|tramadol|mesh-list
56241002|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
56241003|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241004|NCT01778192|Cathartics|cathartics|mesh-ancestor
56241005|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56241006|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
56241007|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
56241008|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241009|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
56241010|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241011|NCT01778244|Metformin|metformin|mesh-list
56241012|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241013|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241014|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
56241015|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56241016|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
56241017|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56241018|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
56241019|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241020|NCT01778309|Expectorants|expectorants|mesh-ancestor
56241021|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
56241022|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56241023|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
56241024|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241025|NCT01778309|Protective Agents|protective agents|mesh-ancestor
55867635|NCT01728064|Ubiquinone|ubiquinone|mesh-list
56241026|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241027|NCT01778309|Antidotes|antidotes|mesh-ancestor
56241028|NCT01778400|Ethanol|ethanol|mesh-list
56241029|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56241062|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241063|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56241064|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
56241065|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56241068|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
56241072|NCT01778803|Paclitaxel|paclitaxel|mesh-list
56241073|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56241074|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241075|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
56241076|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
56241077|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
56241078|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241079|NCT01778842|Clopidogrel|clopidogrel|mesh-list
56241080|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56241081|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56241082|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55816477|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241096|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241098|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56241099|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241100|NCT01779258|Desonide|desonide|mesh-list
56241101|NCT01779258|Glycerol|glycerol|mesh-list
56241102|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56241103|NCT01779258|Protective Agents|protective agents|mesh-ancestor
56241104|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241105|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56241106|NCT01779271|Loxoprofen|loxoprofen|mesh-list
56241109|NCT01779271|Analgesics|analgesics|mesh-ancestor
56241133|NCT01779362|Incretins|incretins|mesh-ancestor
56241134|NCT01779362|Hormones|hormones|mesh-ancestor
56241135|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241136|NCT01779401|Aspirin|aspirin|mesh-list
56241137|NCT01779401|Cilostazol|cilostazol|mesh-list
56241138|NCT01779401|Clopidogrel|clopidogrel|mesh-list
56241139|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56241140|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56241141|NCT01779401|Analgesics|analgesics|mesh-ancestor
56241142|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
56241143|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241144|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241145|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56241146|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867663|NCT03834610|Hormones|hormones|mesh-ancestor
56241147|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56241148|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56241149|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241150|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55744523|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
56241153|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
56241154|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56241155|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56241156|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56241157|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
56241158|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241159|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56241160|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
56241161|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56241162|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
56241163|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
56241164|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56241165|NCT01779401|Protective Agents|protective agents|mesh-ancestor
56241166|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56241173|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241175|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56241176|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241177|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
56241178|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
56241179|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
56241180|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241181|NCT01779492|Oxycodone|oxycodone|mesh-list
56241182|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56241183|NCT01779492|Narcotics|narcotics|mesh-ancestor
56241184|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241185|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241186|NCT01779492|Analgesics|analgesics|mesh-ancestor
56241187|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
56241188|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241189|NCT01779518|Interferons|interferons|mesh-list
56241190|NCT01779518|Ribavirin|ribavirin|mesh-list
56241191|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
56241192|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241193|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
56241194|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241195|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
56241196|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241197|NCT01779596|Bosentan|bosentan|mesh-list
56241198|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56241199|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56241200|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241201|NCT01779609|Bosentan|bosentan|mesh-list
56241202|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56241203|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56241204|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241205|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
56241206|NCT01779687|Atorvastatin|atorvastatin|mesh-list
56241207|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56241208|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56241209|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
56241210|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241211|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56241212|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56241213|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241214|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56241215|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56241216|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
56241217|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241218|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56241219|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56241221|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55816616|NCT02039505|Vedolizumab|vedolizumab|mesh-list
56241293|NCT01780233|Analgesics|analgesics|mesh-ancestor
56241294|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
56241295|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241296|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56241297|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56241298|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
56241299|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
56241300|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
56241301|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56241302|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
56241303|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
56241304|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241305|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56241306|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56241307|NCT01780259|Triazolam|triazolam|mesh-list
56241308|NCT01780259|Esketamine|esketamine|mesh-list
56241309|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
56241310|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56241311|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56241312|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56241313|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56241314|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241315|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241316|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
56241329|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241331|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
55867737|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56241332|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241333|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56241334|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56241335|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56241336|NCT01780467|Dopamine|dopamine|mesh-list
56241337|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56241338|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
56241339|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
56241340|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241341|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241342|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
56241343|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241344|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241345|NCT01780467|Protective Agents|protective agents|mesh-ancestor
56241346|NCT01780519|Lorazepam|lorazepam|mesh-list
56241347|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
56241348|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
56241349|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
55744574|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
56241395|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241397|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
56241398|NCT01780610|Progestins|progestins|mesh-ancestor
56241399|NCT01780740|Atorvastatin|atorvastatin|mesh-list
56241400|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56241401|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56241402|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
56241403|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241404|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56241405|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56241406|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241407|NCT01780753|Primaquine|primaquine|mesh-list
56241408|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
56241409|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55744601|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56241436|NCT01780948|Atorvastatin|atorvastatin|mesh-list
56241437|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56241438|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56241439|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
56241440|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241441|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56241442|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56241443|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241444|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241445|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241446|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
56241447|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241448|NCT01781052|Iloprost|iloprost|mesh-list
56241449|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56241450|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
56241451|NCT01781273|Ethanol|ethanol|mesh-list
56241452|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56241453|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241454|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241455|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241456|NCT01781377|Metoclopramide|metoclopramide|mesh-list
56241457|NCT01781377|Propofol|propofol|mesh-list
56241458|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56241459|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816857|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56241484|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56241485|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56241486|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
56241487|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
56241488|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241489|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241490|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241491|NCT01781663|Petrolatum|petrolatum|mesh-list
56241492|NCT01781663|Emollients|emollients|mesh-ancestor
56241493|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
56241494|NCT01781702|Celecoxib|celecoxib|mesh-list
55816864|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241497|NCT01781702|Analgesics|analgesics|mesh-ancestor
56241498|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
56241499|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867886|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
56241500|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241501|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56241502|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56241503|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56241504|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56241505|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241506|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241507|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56241508|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
56241509|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241510|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
56241511|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
56241512|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241513|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241514|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241516|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56241517|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56241518|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
56241519|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241520|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241521|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241522|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56241523|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56241524|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
56241525|NCT01781936|Hormones|hormones|mesh-ancestor
56241526|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241527|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241528|NCT01781988|Gemcitabine|gemcitabine|mesh-list
56241529|NCT01781988|Carboplatin|carboplatin|mesh-list
56241530|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241531|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56241532|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
56241533|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241534|NCT01781988|Antiviral Agents|antiviral agents|mesh-ancestor
56241535|NCT01781988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241536|NCT01781988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241537|NCT01781988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241538|NCT01781988|Immunologic Factors|immunologic factors|mesh-ancestor
56241539|NCT01781988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241540|NCT01782001|Vitamins|vitamins|mesh-list
56241610|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56241611|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
56241612|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241613|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241614|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56241615|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241616|NCT01782781|Epinephrine|epinephrine|mesh-list
56241617|NCT01782781|Ropivacaine|ropivacaine|mesh-list
56241618|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
56241619|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
56241623|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867923|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
56241624|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56241625|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56241626|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
56241627|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56241628|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241629|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56241630|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56241632|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56241633|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
56241634|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
56241635|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
56241636|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56241637|NCT01782846|Codeine|codeine|mesh-list
56241638|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56241639|NCT01782846|Narcotics|narcotics|mesh-ancestor
56241640|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56241641|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241642|NCT01782846|Analgesics|analgesics|mesh-ancestor
56241643|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
56241644|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241645|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
56241646|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
56241647|NCT01782911|Resveratrol|resveratrol|mesh-list
56241648|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
56241649|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241650|NCT01782911|Protective Agents|protective agents|mesh-ancestor
56241651|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241652|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241670|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56241671|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56241672|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56241673|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56241674|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56241675|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56241676|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56241677|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56241678|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
56241679|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56241681|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55867946|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56241682|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241683|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56241684|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56241685|NCT01782976|Growth Substances|growth substances|mesh-ancestor
56241686|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241687|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
56241688|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
56241689|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55744717|NCT02487823|Buserelin|buserelin|mesh-list
56241713|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56241714|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56241715|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241716|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56241717|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56241719|NCT01783197|Carboplatin|carboplatin|mesh-list
56241720|NCT01783197|Pemetrexed|pemetrexed|mesh-list
56241721|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56241722|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241723|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
56241724|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
56241725|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
56241726|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241727|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241728|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56241729|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56241730|NCT01783340|Azithromycin|azithromycin|mesh-list
56241731|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56241732|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241733|NCT01783379|Micafungin|micafungin|mesh-list
56241734|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
56241735|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241736|NCT01783431|Poly ICLC|poly iclc|mesh-list
56241737|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
56241738|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
56241739|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241741|NCT01783587|Afatinib|afatinib|mesh-list
56241742|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241743|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56241744|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56241745|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
55868003|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868013|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
56241746|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241747|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56241748|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241749|NCT01783717|Exenatide|exenatide|mesh-list
56241750|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241751|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241752|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56241753|NCT01783717|Incretins|incretins|mesh-ancestor
56241754|NCT01783717|Hormones|hormones|mesh-ancestor
56241755|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241756|NCT01783756|Capecitabine|capecitabine|mesh-list
56241757|NCT01783756|Everolimus|everolimus|mesh-list
56241758|NCT01783756|Lapatinib|lapatinib|mesh-list
56241768|NCT01783834|Pemetrexed|pemetrexed|mesh-list
56241769|NCT01783834|Gefitinib|gefitinib|mesh-list
56241770|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241771|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241772|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241773|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56241774|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56241775|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56241776|NCT01783925|Aflibercept|aflibercept|mesh-list
55817149|NCT02349451|Adalimumab|adalimumab|mesh-list
56241777|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56241778|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56241779|NCT01783925|Growth Substances|growth substances|mesh-ancestor
56241780|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241781|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
56241782|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241783|NCT01783951|Cisplatin|cisplatin|mesh-list
56241784|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241785|NCT01783964|Cytarabine|cytarabine|mesh-list
56241786|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56241787|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
56241788|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241789|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241790|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
56241791|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241792|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56241793|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
56241794|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241795|NCT01783977|Vaccines|vaccines|mesh-list
56241796|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
56241797|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241798|NCT01784107|Ifosfamide|ifosfamide|mesh-list
56241799|NCT01784107|Belotecan|belotecan|mesh-list
56241800|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56241801|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
56241802|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241803|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56241804|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56241805|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56241806|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241807|NCT01784120|Doxorubicin|doxorubicin|mesh-list
56241808|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56241818|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
56241827|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241828|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
55868051|NCT01702532|Nicotine|nicotine|mesh-list
56241829|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
56241830|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56241831|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56241832|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56241833|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
56241834|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56241835|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56241836|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
56241837|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241838|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56241839|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56241840|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241841|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56241842|NCT01784315|Chloroquine|chloroquine|mesh-list
56241843|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56241844|NCT01784315|Primaquine|primaquine|mesh-list
56241845|NCT01784315|Artemisinins|artemisinins|mesh-list
56241846|NCT01784315|Artemisinin|artemisinin|mesh-list
56241847|NCT01784315|Amebicides|amebicides|mesh-ancestor
56241848|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56241849|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56241850|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56241851|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
56241852|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56241853|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56241854|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56241857|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56241858|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56241859|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56241860|NCT01784315|Filaricides|filaricides|mesh-ancestor
56241861|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
56241862|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
56241863|NCT01784380|Metformin|metformin|mesh-list
56241864|NCT01784380|Clomiphene|clomiphene|mesh-list
56241865|NCT01784380|Enclomiphene|enclomiphene|mesh-list
56241866|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
56241867|NCT01784380|Menotropins|menotropins|mesh-list
56241868|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
56241869|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56241870|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868069|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
55868070|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
55868071|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
55868072|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868073|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55868074|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868075|NCT03405064|Linezolid|linezolid|mesh-list
55868076|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
55868077|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55868078|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868079|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55868080|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56241871|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55868082|NCT03404908|Acetaminophen|acetaminophen|mesh-list
56241872|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
56241873|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56241874|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56242059|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242060|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242061|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56242062|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56242063|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56242064|NCT01785693|Clonidine|clonidine|mesh-list
56242065|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
56242066|NCT01785693|Analgesics|analgesics|mesh-ancestor
56242067|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
56242068|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242069|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242070|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56242071|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
56242072|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
56242073|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56242074|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56242075|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56242076|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
56242077|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242078|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242079|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
56242080|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
56242081|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242082|NCT01785797|Silicon|silicon|mesh-list
56242083|NCT01785797|Trace Elements|trace elements|mesh-ancestor
56242084|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
55817447|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
56242085|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242086|NCT01785836|Dapsone|dapsone|mesh-list
56242087|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242088|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
56242089|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56242090|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55868093|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242091|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56242092|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242093|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242094|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
56242095|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56242096|NCT01785862|Ibuprofen|ibuprofen|mesh-list
56242097|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56242098|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242099|NCT01785862|Analgesics|analgesics|mesh-ancestor
56242100|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
56242101|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242102|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242103|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242104|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242105|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56242106|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242107|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242108|NCT01785979|Chloroquine|chloroquine|mesh-list
56242109|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56242110|NCT01785979|Prednisone|prednisone|mesh-list
56242111|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242112|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
56242113|NCT01785979|Hormones|hormones|mesh-ancestor
56242114|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242115|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242116|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56242117|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242118|NCT01785979|Amebicides|amebicides|mesh-ancestor
56242224|NCT01786538|Leucovorin|leucovorin|mesh-list
56242225|NCT01786538|Fluorouracil|fluorouracil|mesh-list
56242226|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
56242227|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
56242228|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242229|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56242230|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868136|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55868137|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
56242231|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56242232|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
56242233|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242234|NCT01786538|Antidotes|antidotes|mesh-ancestor
56242235|NCT01786538|Protective Agents|protective agents|mesh-ancestor
56242236|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
56242237|NCT01786538|Vitamins|vitamins|mesh-ancestor
56242238|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
56242262|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56242263|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
56242264|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242265|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242266|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56242267|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56242268|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
56242269|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56242270|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
56242271|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
56242272|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
56242273|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56242274|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56242275|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56242276|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56242277|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56242278|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56242279|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56242280|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
56242281|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56242282|NCT01787123|Protective Agents|protective agents|mesh-ancestor
56242283|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242284|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
56242285|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
55817653|NCT02358044|Ribavirin|ribavirin|mesh-list
55744837|NCT03321955|Analgesics|analgesics|mesh-ancestor
56242299|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
56242300|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242301|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242302|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55868188|NCT01710020|Tofacitinib|tofacitinib|mesh-list
56242303|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242304|NCT01787357|Canagliflozin|canagliflozin|mesh-list
56242305|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
56242306|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56242307|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242308|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56242309|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56242310|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242311|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242312|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242316|NCT01787396|Metformin|metformin|mesh-list
56242330|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
56242331|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242332|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56242333|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
56242334|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56242335|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
56242336|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242337|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
56242338|NCT01787630|Protective Agents|protective agents|mesh-ancestor
56242339|NCT01787669|Dexamethasone|dexamethasone|mesh-list
56242340|NCT01787669|Bevacizumab|bevacizumab|mesh-list
56242341|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56242342|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242343|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56242344|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56242345|NCT01787669|Growth Substances|growth substances|mesh-ancestor
56242346|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242347|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
55817725|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242353|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
56242355|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242356|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56242358|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56242359|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
56242360|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242361|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242362|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
56242363|NCT01788072|Oxytocin|oxytocin|mesh-list
56242364|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
56242365|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242366|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868255|NCT01700192|Epinephrine|epinephrine|mesh-list
56242367|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
56242368|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56242369|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242370|NCT01788189|Lenalidomide|lenalidomide|mesh-list
56242371|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
56242372|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242373|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56242374|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56242375|NCT01788189|Growth Substances|growth substances|mesh-ancestor
56242376|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
56242377|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242378|NCT01788254|Talinolol|talinolol|mesh-list
56242379|NCT01788254|Torsemide|torsemide|mesh-list
56242380|NCT01788254|Midazolam|midazolam|mesh-list
56242381|NCT01788254|Codeine|codeine|mesh-list
56242382|NCT01788254|Pravastatin|pravastatin|mesh-list
56242383|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56242390|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56242391|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
56242392|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
56242393|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
56242394|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
56242395|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242396|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242397|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56242398|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56242399|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
56242400|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56242401|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56242402|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242403|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56242404|NCT01788254|Narcotics|narcotics|mesh-ancestor
56242405|NCT01788254|Analgesics|analgesics|mesh-ancestor
56242406|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
56242407|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242408|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
56242409|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
56242410|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56242411|NCT01788254|Diuretics|diuretics|mesh-ancestor
56242494|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242495|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242496|NCT01788722|Dienogest|dienogest|mesh-list
56242497|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56242498|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
56242499|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242500|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242501|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55817883|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868310|NCT02242474|Analgesics|analgesics|mesh-ancestor
55744858|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56242536|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242538|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56242539|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242540|NCT01789086|Incretins|incretins|mesh-ancestor
56242541|NCT01789086|Hormones|hormones|mesh-ancestor
56242542|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242543|NCT01789099|Sargramostim|sargramostim|mesh-list
56242544|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
56242545|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242546|NCT01789125|Nicotine|nicotine|mesh-list
56242547|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56242548|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
56242549|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242550|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242551|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56242552|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56242553|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
56242554|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242555|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242556|NCT01789216|Ketorolac|ketorolac|mesh-list
56242557|NCT01789216|Meloxicam|meloxicam|mesh-list
56242558|NCT01789216|Pregabalin|pregabalin|mesh-list
56242559|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56242560|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242561|NCT01789216|Analgesics|analgesics|mesh-ancestor
56242562|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
56242563|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242564|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242565|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242566|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242567|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56242569|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242570|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
56242571|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56242572|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56242573|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56242574|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56242575|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55868325|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55868326|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
56242576|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242577|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56242578|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56242579|NCT01789242|Dexamethasone|dexamethasone|mesh-list
56242580|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242581|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
56242582|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
56242583|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242584|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242585|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56242607|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242608|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56242609|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56242610|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56242611|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
56242612|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242613|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242614|NCT01789437|Dexamethasone|dexamethasone|mesh-list
56242615|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242616|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
56242617|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
56242618|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242619|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744899|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242650|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
56242651|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56242652|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56242653|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242654|NCT01789723|Leucovorin|leucovorin|mesh-list
56242655|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
56242656|NCT01789723|Antidotes|antidotes|mesh-ancestor
56242657|NCT01789723|Protective Agents|protective agents|mesh-ancestor
56242658|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242659|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
56242660|NCT01789723|Vitamins|vitamins|mesh-ancestor
56242661|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
56242662|NCT01789827|Interleukin-2|interleukin-2|mesh-list
56242663|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242664|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242665|NCT01789827|Analgesics|analgesics|mesh-ancestor
56242666|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
56242677|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242678|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56242679|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56242680|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56242681|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56242682|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56242683|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56242684|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56242685|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
56242686|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242687|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242688|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55818066|NCT02092467|Etanercept|etanercept|mesh-list
56242718|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242719|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56242720|NCT01789957|Incretins|incretins|mesh-ancestor
56242721|NCT01789957|Hormones|hormones|mesh-ancestor
56242722|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242723|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56242724|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56242725|NCT01792063|Sevoflurane|sevoflurane|mesh-list
56242726|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56242727|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56242728|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
56242729|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
56242730|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242731|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242732|NCT01792570|Darunavir|darunavir|mesh-list
56242733|NCT01792570|Rilpivirine|rilpivirine|mesh-list
56242734|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56242735|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56242736|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
56242737|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242738|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242739|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56242740|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56242741|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
56242742|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242743|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56242744|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56242745|NCT01792804|Vancomycin|vancomycin|mesh-list
56242746|NCT01792804|Clindamycin|clindamycin|mesh-list
56242747|NCT01792804|Cefazolin|cefazolin|mesh-list
56242748|NCT01792804|Linezolid|linezolid|mesh-list
56242749|NCT01792804|Daptomycin|daptomycin|mesh-list
56242750|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56242751|NCT01792804|Floxacillin|floxacillin|mesh-list
56242752|NCT01792804|Cloxacillin|cloxacillin|mesh-list
56242753|NCT01792804|Trimethoprim|trimethoprim|mesh-list
56242754|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
56242755|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56242756|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56242757|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56242758|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242760|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56242771|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
56242772|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55868416|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
55890370|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55868417|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
55868419|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242773|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242774|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56242775|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
56242776|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242777|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242778|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56242779|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
56242780|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242781|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56242782|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56242783|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56242784|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242785|NCT01794182|Glyburide|glyburide|mesh-list
56242786|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56242787|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242788|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56242789|NCT01794208|Hormones|hormones|mesh-ancestor
56242790|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744947|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56242801|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56242806|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56242807|NCT01794247|Narcotics|narcotics|mesh-ancestor
56242808|NCT01794247|Analgesics|analgesics|mesh-ancestor
56242809|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56242810|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56242811|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
56242812|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
56242813|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56242814|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56242815|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
56242816|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56242817|NCT01794429|Exenatide|exenatide|mesh-list
56242818|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56242819|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242820|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56242821|NCT01794429|Incretins|incretins|mesh-ancestor
56242822|NCT01794429|Hormones|hormones|mesh-ancestor
56242823|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242824|NCT01795248|Liraglutide|liraglutide|mesh-list
56242825|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56242826|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242827|NCT01795248|Incretins|incretins|mesh-ancestor
56242828|NCT01795248|Hormones|hormones|mesh-ancestor
56242829|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242830|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56242831|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
56242832|NCT01796132|Citalopram|citalopram|mesh-list
56242833|NCT01796132|Fluoxetine|fluoxetine|mesh-list
56242834|NCT01796132|Paroxetine|paroxetine|mesh-list
56242835|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56242836|NCT01796132|Sertraline|sertraline|mesh-list
56242837|NCT01796132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56242838|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56242839|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56242840|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242841|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242842|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
56242843|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242844|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56242845|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
56242846|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56242847|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242848|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55744958|NCT05105139|Triclosan|triclosan|mesh-list
56242887|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56242888|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242889|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
56242890|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242891|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56242892|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56242893|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56242894|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56242895|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242896|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56242897|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56242898|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
56242899|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56242900|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56242901|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56242902|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
56242903|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56242904|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
56242905|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
56242906|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
56242907|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56242908|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
56242909|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56242910|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56242911|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242912|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
56242913|NCT01797289|Coagulants|coagulants|mesh-ancestor
56242914|NCT01797718|Letrozole|letrozole|mesh-list
56242915|NCT01797718|Testosterone|testosterone|mesh-list
56242916|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56242917|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56242918|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56242919|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242920|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56242921|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56242922|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
56242923|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56242924|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242925|NCT01797718|Androgens|androgens|mesh-ancestor
56242926|NCT01797718|Hormones|hormones|mesh-ancestor
56242927|NCT01797796|Capsaicin|capsaicin|mesh-list
56242973|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56242974|NCT01799863|Analgesics|analgesics|mesh-ancestor
56242975|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
56242976|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56242977|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56242978|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56242979|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56242980|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56242981|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56242982|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243008|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243009|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56243010|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56243011|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56243012|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243014|NCT01800227|Pioglitazone|pioglitazone|mesh-list
56243015|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56243016|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243017|NCT01800240|Metformin|metformin|mesh-list
56243018|NCT01800240|Pioglitazone|pioglitazone|mesh-list
56243019|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56243020|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243021|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
56243023|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
56243035|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868548|NCT01935921|Cetuximab|cetuximab|mesh-list
56243036|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56243037|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56243038|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56243039|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56243040|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243041|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56243042|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56243043|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243044|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
56243045|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56243046|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
56243047|NCT01800396|Caseins|caseins|mesh-list
56243048|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
56243049|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
56243050|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243051|NCT01800422|Progesterone|progesterone|mesh-list
56243052|NCT01800422|Progestins|progestins|mesh-ancestor
56243053|NCT01800422|Hormones|hormones|mesh-ancestor
55818429|NCT04709211|Bupivacaine|bupivacaine|mesh-list
56243054|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56243055|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243057|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
56243058|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56243059|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56243060|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243061|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
56243062|NCT01800435|Coagulants|coagulants|mesh-ancestor
56243063|NCT01800487|Silymarin|silymarin|mesh-list
56243064|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
56243065|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243066|NCT01800487|Protective Agents|protective agents|mesh-ancestor
56243067|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243068|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
56243069|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56243070|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
56243071|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243072|NCT01800526|Expectorants|expectorants|mesh-ancestor
56243073|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
56243074|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56243075|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
56243076|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243077|NCT01800526|Protective Agents|protective agents|mesh-ancestor
56243078|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243079|NCT01800526|Antidotes|antidotes|mesh-ancestor
56243080|NCT01800630|Gemcitabine|gemcitabine|mesh-list
56243081|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56243082|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
56243083|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243084|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243085|NCT01800630|Antiviral Agents|antiviral agents|mesh-ancestor
56243086|NCT01800630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243087|NCT01800630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243088|NCT01800630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243093|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243094|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243095|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
56243096|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868610|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
56243097|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56243098|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243099|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56243100|NCT01800695|Temozolomide|temozolomide|mesh-list
56243101|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56243102|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
56243103|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243104|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243105|NCT01800708|Prednisolone|prednisolone|mesh-list
56243106|NCT01800708|Triamcinolone|triamcinolone|mesh-list
56243107|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56243108|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56243109|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56243110|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56243111|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
56243112|NCT01800708|Hormones|hormones|mesh-ancestor
56243113|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56243114|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243115|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56243116|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243156|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243157|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
56243158|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243159|NCT01801046|Analgesics|analgesics|mesh-ancestor
56243160|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
56243161|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744997|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56243233|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
56243235|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
56243236|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
56243237|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243238|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243239|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56243240|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56243241|NCT01802268|Sirolimus|sirolimus|mesh-list
56243242|NCT01802268|Tacrolimus|tacrolimus|mesh-list
56243243|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243244|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
56243245|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243246|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56243247|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243248|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243249|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243250|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243251|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56243252|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243253|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
56243254|NCT01802450|Dasatinib|dasatinib|mesh-list
56243255|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243256|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56243257|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868627|NCT03401476|Morphine|morphine|mesh-list
56243258|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243259|NCT01802476|Palbociclib|palbociclib|mesh-list
56243260|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243261|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56243262|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243263|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243264|NCT01802489|Amiloride|amiloride|mesh-list
56243265|NCT01802489|Diuretics|diuretics|mesh-ancestor
56243266|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
56243267|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243272|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56243273|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56243274|NCT01802502|Rifampin|rifampin|mesh-list
56243275|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56243289|NCT01802593|Methotrexate|methotrexate|mesh-list
56243342|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56243343|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56243344|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243345|NCT01802645|Antidotes|antidotes|mesh-ancestor
56243346|NCT01802645|Protective Agents|protective agents|mesh-ancestor
56243347|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
56243348|NCT01802645|Vitamins|vitamins|mesh-ancestor
56243349|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
56243350|NCT01802645|Hematinics|hematinics|mesh-ancestor
56243351|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
56243352|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56243353|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243354|NCT01802684|Aflibercept|aflibercept|mesh-list
56243355|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56243356|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56243357|NCT01802684|Growth Substances|growth substances|mesh-ancestor
56243358|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243359|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
56243360|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243361|NCT01802814|Epratuzumab|epratuzumab|mesh-list
56243362|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56243363|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243364|NCT01802892|Plerixafor|plerixafor|mesh-list
55818738|NCT01840228|Hormones|hormones|mesh-ancestor
55745024|NCT03316963|Neostigmine|neostigmine|mesh-list
56243425|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243426|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243427|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56243428|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55745042|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
56243445|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243446|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243448|NCT01803503|Docetaxel|docetaxel|mesh-list
56243474|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56243475|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55868672|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
56243476|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
56243477|NCT01803828|Tadalafil|tadalafil|mesh-list
56243478|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
56243479|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56243480|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56243481|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243482|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243483|NCT01803828|Urological Agents|urological agents|mesh-ancestor
56243484|NCT01804127|Rituximab|rituximab|mesh-list
56243485|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56243486|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243487|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
56243488|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243489|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56243490|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
56243491|NCT01804205|Analgesics|analgesics|mesh-ancestor
56243492|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
56243493|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243494|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243495|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
56243496|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243497|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56243498|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
56243499|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56243512|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56243513|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56243514|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
56243515|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
56243516|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243517|NCT01804244|Rilpivirine|rilpivirine|mesh-list
56243518|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56243519|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56243520|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243521|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243522|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
56243523|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243524|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55868699|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55868700|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
55868702|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243525|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56243526|NCT01804335|Trifarotene|trifarotene|mesh-list
56243527|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
56243528|NCT01804361|Cyclosporine|cyclosporine|mesh-list
56243529|NCT01804361|Cyclosporins|cyclosporins|mesh-list
56243544|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
56243545|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243546|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56243547|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243548|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243549|NCT01804387|Lamivudine|lamivudine|mesh-list
56243550|NCT01804387|Adefovir|adefovir|mesh-list
56243551|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56243552|NCT01804387|Telbivudine|telbivudine|mesh-list
56243553|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56243554|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56243555|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243556|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243557|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
56243558|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243559|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56243560|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56243561|NCT01804400|Montelukast|montelukast|mesh-list
56243562|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56243563|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
56243564|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56243565|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
55818930|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56243587|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
56243588|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243589|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56243590|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56243592|NCT01804777|Diuretics|diuretics|mesh-ancestor
56243593|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
56243594|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243595|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56243596|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56243597|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56243598|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243599|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56243600|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56243601|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56243602|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56243603|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
56243604|NCT01804985|Dasatinib|dasatinib|mesh-list
56243605|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243606|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56243607|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243608|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243609|NCT01805115|Misoprostol|misoprostol|mesh-list
56243610|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56243611|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
56243612|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56243613|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243614|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56243615|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56243616|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
56243617|NCT01805232|Artesunate|artesunate|mesh-list
56243618|NCT01805232|Quinine|quinine|mesh-list
56243619|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
56243620|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56243621|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56243622|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243623|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243624|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
56243625|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
56243626|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56243627|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
56243628|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56243629|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243630|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56243631|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243632|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56243633|NCT01805232|Analgesics|analgesics|mesh-ancestor
56243634|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
56243635|NCT01805258|Efavirenz|efavirenz|mesh-list
56243636|NCT01805258|Nevirapine|nevirapine|mesh-list
56243637|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56243638|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56243639|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243640|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243641|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
56243642|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243643|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56243644|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56243645|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56243646|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56243647|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56243648|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56243649|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56243650|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56243651|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
56243652|NCT01805310|Cathartics|cathartics|mesh-ancestor
56243653|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56243656|NCT01807741|Asenapine|asenapine|mesh-list
56243671|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243672|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56243673|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56243674|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
56243675|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243676|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243678|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
55868785|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55868786|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
56243679|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
56243680|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
56243681|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243682|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243683|NCT01807910|Choline|choline|mesh-list
56243684|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
56243730|NCT01808300|Protective Agents|protective agents|mesh-ancestor
56243731|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
56243732|NCT01808300|Vitamins|vitamins|mesh-ancestor
56243733|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
56243734|NCT01808469|Antibodies|antibodies|mesh-list
56243735|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56243736|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
56243737|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243738|NCT01808495|Mitomycins|mitomycins|mesh-list
56243739|NCT01808495|Mitomycin|mitomycin|mesh-list
56243740|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56243741|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243742|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
56243743|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243744|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56243745|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243746|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
56243747|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56243748|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
56243749|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243750|NCT01808521|Expectorants|expectorants|mesh-ancestor
56243751|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
56243752|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56243753|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
56243764|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243765|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243766|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56243767|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
56243768|NCT01808586|Hormones|hormones|mesh-ancestor
55868820|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
56243769|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56243770|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56243771|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243772|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
56243773|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
56243774|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243775|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
56243776|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56243777|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56243778|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56243779|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56243780|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243781|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56243782|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
56243783|NCT01808638|Gemcitabine|gemcitabine|mesh-list
56243784|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56243785|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
56243786|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243787|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243788|NCT01808638|Antiviral Agents|antiviral agents|mesh-ancestor
56243789|NCT01808638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243790|NCT01808638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243794|NCT01808768|Alcaftadine|alcaftadine|mesh-list
56243805|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243806|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243807|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
56243808|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243809|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
56243810|NCT01808911|Rituximab|rituximab|mesh-list
56243811|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243812|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
56243813|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243814|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56243815|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56243816|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
56243817|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243818|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243819|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56243820|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56243821|NCT01809041|Remifentanil|remifentanil|mesh-list
56243822|NCT01809041|Propofol|propofol|mesh-list
56243823|NCT01809041|Sevoflurane|sevoflurane|mesh-list
56243824|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56243825|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243826|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243827|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56243828|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
56243829|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
56243830|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56243831|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56243832|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56243833|NCT01809041|Narcotics|narcotics|mesh-ancestor
56243834|NCT01809041|Analgesics|analgesics|mesh-ancestor
56243835|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
56243836|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243837|NCT01809158|Minocycline|minocycline|mesh-list
56243838|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243839|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243840|NCT01809171|Vitamin D|vitamin d|mesh-list
56243841|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
56243843|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
56243844|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243845|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56243846|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56243847|NCT01809184|Insulin|insulin|mesh-list
56243848|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56243849|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
56243850|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56243851|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243852|NCT01809301|Niacin|niacin|mesh-list
56243853|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
56243854|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56243855|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
56243856|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243857|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56243858|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
56243859|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
56243860|NCT01809301|Vitamins|vitamins|mesh-ancestor
56243861|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
56243862|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243867|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243868|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243869|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56243870|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56243871|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
56243873|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56243874|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56243875|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56243876|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243877|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243878|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243879|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243880|NCT01809392|Decitabine|decitabine|mesh-list
56243881|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55868953|NCT03721653|Vitamins|vitamins|mesh-ancestor
56243882|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
56243883|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243884|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243885|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243886|NCT01809444|Doxycycline|doxycycline|mesh-list
56243887|NCT01809444|Prednisone|prednisone|mesh-list
56243888|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56243889|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
56243890|NCT01809444|Hormones|hormones|mesh-ancestor
56243891|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56243892|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243893|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56243894|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243895|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243896|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243897|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
56243898|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56243899|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56243922|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243923|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56243924|NCT01809847|Ofatumumab|ofatumumab|mesh-list
56243925|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243926|NCT01809860|Sirolimus|sirolimus|mesh-list
56243927|NCT01809860|Isavuconazole|isavuconazole|mesh-list
56243928|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243929|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243930|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56243931|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243932|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
56243933|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243934|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
56243935|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243936|NCT01809886|Neostigmine|neostigmine|mesh-list
56243937|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56243938|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243939|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243940|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
56243941|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243942|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243943|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56243944|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
56243945|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56243959|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56243960|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
56243961|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243962|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243963|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
56243964|NCT01810315|Estradiol|estradiol|mesh-list
56243965|NCT01810315|Estrogens|estrogens|mesh-ancestor
56243966|NCT01810315|Hormones|hormones|mesh-ancestor
55868977|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
55868978|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56243967|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56243968|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56243969|NCT01810354|Cefazolin|cefazolin|mesh-list
56243970|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56243971|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243972|NCT01810367|Gemcitabine|gemcitabine|mesh-list
56243973|NCT01810367|Cisplatin|cisplatin|mesh-list
56243974|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56243975|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56243976|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
56243977|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56243978|NCT01810367|Antiviral Agents|antiviral agents|mesh-ancestor
56243979|NCT01810367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56243980|NCT01810367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56243981|NCT01810367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56243982|NCT01810367|Immunologic Factors|immunologic factors|mesh-ancestor
56243983|NCT01810367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244004|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56244005|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56244006|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244007|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56244008|NCT01810458|Narcotics|narcotics|mesh-ancestor
56244009|NCT01810458|Analgesics|analgesics|mesh-ancestor
56244010|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56244011|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56244012|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
56244013|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56244014|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56244015|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56244030|NCT01810458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56244031|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
56244032|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56244033|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244034|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244035|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56244036|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244037|NCT01810601|Progesterone|progesterone|mesh-list
56244038|NCT01810601|Progestins|progestins|mesh-ancestor
56244040|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244041|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244042|NCT01810640|Liver Extracts|liver extracts|mesh-list
56244043|NCT01810640|Hematinics|hematinics|mesh-ancestor
56244044|NCT01810731|Vaccines|vaccines|mesh-list
56244045|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
56244046|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244047|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56244048|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244049|NCT01810796|Ranolazine|ranolazine|mesh-list
56244050|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56244051|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56244052|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244053|NCT01810809|Hylan|hylan|mesh-list
55869024|NCT04371874|Analgesics|analgesics|mesh-ancestor
56244054|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
56244055|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
56244056|NCT01810809|Protective Agents|protective agents|mesh-ancestor
56244080|NCT01810926|Cyclosporine|cyclosporine|mesh-list
56244081|NCT01810926|Rituximab|rituximab|mesh-list
56244082|NCT01810926|Methotrexate|methotrexate|mesh-list
56244083|NCT01810926|Fludarabine|fludarabine|mesh-list
56244084|NCT01810926|Thiotepa|thiotepa|mesh-list
56244085|NCT01810926|Treosulfan|treosulfan|mesh-list
56244086|NCT01810926|Antibodies|antibodies|mesh-list
56244087|NCT01810926|Cyclosporins|cyclosporins|mesh-list
56244088|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
56244089|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244090|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56244091|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244092|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244093|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56244094|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
56244095|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56244096|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56244097|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
56244098|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244099|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
56244100|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244101|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56244102|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244103|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56244104|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
56244110|NCT01811056|Mifepristone|mifepristone|mesh-list
56244130|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244131|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244132|NCT01811251|Dexamethasone|dexamethasone|mesh-list
56244133|NCT01811251|Pregabalin|pregabalin|mesh-list
56244134|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244135|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
56244136|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
56244137|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244138|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244139|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244140|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
56244141|NCT01811251|Hormones|hormones|mesh-ancestor
56244142|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244143|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56244191|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244192|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244193|NCT01811667|Sirolimus|sirolimus|mesh-list
56244194|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55869042|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55869043|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
55869044|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55869056|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55869057|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869058|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55869059|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
55869060|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
56244195|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244196|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56244197|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244198|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
56244199|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244200|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
56244257|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56244258|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56244259|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56244260|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
56244261|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244262|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244263|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244264|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56244265|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
56244266|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56244267|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
56244268|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244269|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
56244270|NCT01812239|Progesterone|progesterone|mesh-list
56244271|NCT01812239|Progestins|progestins|mesh-list
56244272|NCT01812239|Hormones|hormones|mesh-ancestor
56244273|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244314|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
56244316|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56244317|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244319|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
56244320|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56244321|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56244322|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244323|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244324|NCT01812434|Urological Agents|urological agents|mesh-ancestor
56244325|NCT01812538|Diclofenac|diclofenac|mesh-list
56244326|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56244327|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56244328|NCT01812538|Analgesics|analgesics|mesh-ancestor
56244329|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
56244371|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244372|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244373|NCT01812954|Cyclosporine|cyclosporine|mesh-list
56244374|NCT01812954|Adalimumab|adalimumab|mesh-list
56244375|NCT01812954|Etanercept|etanercept|mesh-list
56244376|NCT01812954|Methotrexate|methotrexate|mesh-list
56244377|NCT01812954|Infliximab|infliximab|mesh-list
56244378|NCT01812954|Ustekinumab|ustekinumab|mesh-list
56244379|NCT01812954|Acitretin|acitretin|mesh-list
55869080|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244380|NCT01812954|Cyclosporins|cyclosporins|mesh-list
56244381|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56244382|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
56244383|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56244384|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244385|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56244386|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
56244387|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244388|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244389|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
56244390|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244391|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56244392|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244393|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
56244394|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244395|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56244396|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
56244422|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56244423|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56244424|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56244425|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56244426|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56244427|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244428|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
56244429|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
56244430|NCT01813201|Testosterone|testosterone|mesh-list
56244431|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
56244489|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
56244490|NCT01813565|Protective Agents|protective agents|mesh-ancestor
56244491|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56244492|NCT01813591|Hormones|hormones|mesh-ancestor
56244493|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244494|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244495|NCT01813604|Vaccines|vaccines|mesh-list
56244496|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
56244497|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244498|NCT01813617|Prednisone|prednisone|mesh-list
56244499|NCT01813617|Methotrexate|methotrexate|mesh-list
56244500|NCT01813617|Azathioprine|azathioprine|mesh-list
56244501|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56244502|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244503|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
56244504|NCT01813617|Hormones|hormones|mesh-ancestor
56244505|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244506|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244507|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56244508|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244543|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55745142|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
56244544|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56244545|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244546|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244547|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
56244548|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
56244549|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244550|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244551|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56244552|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56244553|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
56244554|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56244555|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56244556|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56244557|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56244558|NCT01813773|Aflibercept|aflibercept|mesh-list
56244559|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56244560|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56244561|NCT01813773|Growth Substances|growth substances|mesh-ancestor
56244562|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244563|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
56244564|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244593|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244594|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244595|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56244597|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56244598|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244599|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56244600|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244601|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
56244602|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244603|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
56244604|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244606|NCT01814085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56244607|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56244608|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56244609|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244610|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244611|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
56244612|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244613|NCT01814085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55869154|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55869155|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869159|NCT03705429|Paclitaxel|paclitaxel|mesh-list
56244614|NCT01814085|Antidepressive Agents|antidepressive agents|mesh-ancestor
56244615|NCT01814085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56244616|NCT01814098|Citalopram|citalopram|mesh-list
56244617|NCT01814098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56244618|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56244619|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56244620|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244621|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244622|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
56244623|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244624|NCT01814098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56244627|NCT01814163|Paclitaxel|paclitaxel|mesh-list
56244632|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
56244633|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
56244634|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
56244635|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244636|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56244637|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56244638|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56244639|NCT01814163|Growth Substances|growth substances|mesh-ancestor
56244640|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244641|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
56244642|NCT01814189|Promethazine|promethazine|mesh-list
56244643|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
56244644|NCT01814189|Sumatriptan|sumatriptan|mesh-list
56244645|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56244646|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56244647|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56244648|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
56244649|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869191|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869192|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
55869193|NCT03604653|Cisplatin|cisplatin|mesh-list
55869194|NCT03604653|Doxorubicin|doxorubicin|mesh-list
55869195|NCT03604653|Mitomycins|mitomycins|mesh-list
55869196|NCT03604653|Mitomycin|mitomycin|mesh-list
55869197|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869198|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55869199|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55869200|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55869201|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869203|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
56244650|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244652|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
56244653|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
56244654|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56244655|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
56244656|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
56244657|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56244658|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56244659|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56244660|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244661|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
56244662|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
56244663|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
56244664|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244665|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
56244666|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
56244667|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244669|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
56244670|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
56244671|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244672|NCT01814319|Renal Agents|renal agents|mesh-ancestor
56244673|NCT01814410|Ethanol|ethanol|mesh-list
56244674|NCT01814410|Nicotine|nicotine|mesh-list
56244675|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56244677|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244678|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244679|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56244680|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56244681|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
56244682|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244683|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244684|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56244685|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244686|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244687|NCT01814423|Chloroquine|chloroquine|mesh-list
56244688|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56244689|NCT01814423|Amebicides|amebicides|mesh-ancestor
56244690|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56244691|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56244692|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869227|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244693|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
56244694|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56244695|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56244696|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56244697|NCT01814423|Analgesics|analgesics|mesh-ancestor
56244698|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
56244699|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244714|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244716|NCT01814475|Fludarabine|fludarabine|mesh-list
56244717|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
56244718|NCT01814475|Busulfan|busulfan|mesh-list
56244719|NCT01814475|Thiotepa|thiotepa|mesh-list
56244720|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244721|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56244722|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
56244723|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244724|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244725|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
56244726|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244728|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244729|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
56244730|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56244731|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56244732|NCT01814501|Leucovorin|leucovorin|mesh-list
56244772|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
56244773|NCT01814618|Hormones|hormones|mesh-ancestor
56244774|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244775|NCT01814683|Primaquine|primaquine|mesh-list
56244776|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
56244777|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56244778|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56244779|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244780|NCT01814709|Itraconazole|itraconazole|mesh-list
56244781|NCT01814709|Rifampin|rifampin|mesh-list
56244782|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
56244783|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244784|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56244785|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56244786|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244787|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244788|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56244789|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
56244790|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244791|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244792|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56244793|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56244794|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
56244796|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
56244820|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56244821|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244822|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56244823|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244824|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244825|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56244826|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
56244827|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56244829|NCT01814891|Vitamins|vitamins|mesh-ancestor
56244830|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
56244831|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244832|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
56244833|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244837|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
56244880|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56244881|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
56244882|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56244883|NCT01815255|Tenofovir|tenofovir|mesh-list
56244884|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
56244885|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244886|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56244887|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56244888|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244889|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244890|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56244891|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56244892|NCT01815268|Vaccines|vaccines|mesh-list
56244893|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
56244894|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244895|NCT01815294|Doxorubicin|doxorubicin|mesh-list
56244896|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56244897|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56244898|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244899|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56244900|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56244901|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56244902|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244930|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56244931|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
56244932|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56244933|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
56244934|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244935|NCT01815892|Furosemide|furosemide|mesh-list
56244936|NCT01815892|Diuretics|diuretics|mesh-ancestor
56244937|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
56244938|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244939|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56244940|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56244941|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56244942|NCT01815944|Ropivacaine|ropivacaine|mesh-list
56244943|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
56244944|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
56244945|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56244946|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244947|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
56244948|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244949|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56244950|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56244982|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56244983|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
56244984|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56244985|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
56244986|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
56244987|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56244988|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56244989|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56244990|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
56244991|NCT01816334|Hormones|hormones|mesh-ancestor
56244992|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56244993|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56244994|NCT01816334|Protective Agents|protective agents|mesh-ancestor
56244995|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56244996|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56244997|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56244998|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56244999|NCT01816334|Analgesics|analgesics|mesh-ancestor
56245000|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
56245001|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869324|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
56245002|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56245003|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245004|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245005|NCT01816412|Paclitaxel|paclitaxel|mesh-list
56245006|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56245007|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245029|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56245030|NCT01816581|Morphine|morphine|mesh-list
56245031|NCT01816581|Naloxone|naloxone|mesh-list
56245032|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56245033|NCT01816581|Narcotics|narcotics|mesh-ancestor
56245034|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245035|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245036|NCT01816581|Analgesics|analgesics|mesh-ancestor
56245037|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
56245038|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245039|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56245040|NCT01816620|Dexamethasone|dexamethasone|mesh-list
56245041|NCT01816620|Lenalidomide|lenalidomide|mesh-list
56245042|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56245043|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
56245044|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
56245045|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245046|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245047|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56245050|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245051|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56245052|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245053|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
56245054|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56245055|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56245056|NCT01816620|Growth Substances|growth substances|mesh-ancestor
56245079|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245080|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245081|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56245082|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56245083|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
56245084|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
56245085|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245086|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56245087|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56245088|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245089|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245090|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56245091|NCT01816997|Pravastatin|pravastatin|mesh-list
56245092|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56245093|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56245094|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
56245095|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245096|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55890371|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55869351|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869352|NCT04369222|Acetaminophen|acetaminophen|mesh-list
55869353|NCT04369222|Aspirin|aspirin|mesh-list
55869354|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
56245097|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56245098|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245099|NCT01817023|Cisplatin|cisplatin|mesh-list
56245100|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245101|NCT01817036|Vitamin D|vitamin d|mesh-list
56245102|NCT01817036|Vitamins|vitamins|mesh-ancestor
56245103|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
56245104|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245105|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56245106|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
56245125|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56245126|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
56245127|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56245128|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56245129|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
56245130|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56245131|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
56245132|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245133|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245134|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
56245135|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
56245136|NCT01817322|Prednisolone|prednisolone|mesh-list
56245137|NCT01817322|Deflazacort|deflazacort|mesh-list
56245138|NCT01817322|Basiliximab|basiliximab|mesh-list
56245139|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56245140|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
56245141|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
56245142|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245143|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245144|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56245145|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
56245146|NCT01817322|Hormones|hormones|mesh-ancestor
56245147|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245148|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56245149|NCT01817322|Protective Agents|protective agents|mesh-ancestor
56245150|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56245151|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245152|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56245153|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56245154|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
56245155|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56245168|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56245169|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56245170|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55745176|NCT03320707|Daratumumab|daratumumab|mesh-list
56245171|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245172|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245173|NCT01817400|Aspirin|aspirin|mesh-list
56245174|NCT01817400|Pioglitazone|pioglitazone|mesh-list
56245175|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56245176|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56245177|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56245178|NCT01817400|Analgesics|analgesics|mesh-ancestor
56245179|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
56245180|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245181|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245182|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56245183|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56245184|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56245185|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56245186|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245187|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56245188|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56245189|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245190|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
56245191|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56245192|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56245215|NCT01817803|Spironolactone|spironolactone|mesh-list
56245216|NCT01817803|Diuretics|diuretics|mesh-ancestor
56245217|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
56245218|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245219|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56245220|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245221|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245222|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56245223|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
56245224|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245225|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56245226|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245227|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56245228|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56245229|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56245230|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56245231|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245232|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245233|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56245234|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245235|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245236|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
56245237|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245238|NCT01817829|Acetaminophen|acetaminophen|mesh-list
56245239|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56245240|NCT01817829|Analgesics|analgesics|mesh-ancestor
56245241|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
56245257|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
56245258|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
56245259|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245260|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56245261|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245262|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56245263|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
56245264|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245265|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56245266|NCT01817985|Velpatasvir|velpatasvir|mesh-list
56245267|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
56245268|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245269|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56245270|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
56245271|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245272|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56245273|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56245274|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245275|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56245278|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56245279|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245280|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56245282|NCT01818648|Hormones|hormones|mesh-ancestor
56245304|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245305|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56245306|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56245307|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
56245308|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245309|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56245310|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56245311|NCT01818869|Adenosine|adenosine|mesh-list
56245312|NCT01818869|Analgesics|analgesics|mesh-ancestor
56245313|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
56245314|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245315|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245316|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56245317|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245318|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56245319|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
56245320|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
56245321|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245322|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245323|NCT01818908|Prednisone|prednisone|mesh-list
56245324|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
56245356|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56245357|NCT01818973|Growth Substances|growth substances|mesh-ancestor
56245358|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245359|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
56245360|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56245361|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
56245362|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245363|NCT01819012|Isoflurane|isoflurane|mesh-list
56245364|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56245365|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
56245366|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
56245367|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245368|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245369|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
56245370|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56245387|NCT01819155|Vaccines|vaccines|mesh-list
56245388|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
56245389|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245390|NCT01819220|Amlodipine|amlodipine|mesh-list
56245391|NCT01819220|Valsartan|valsartan|mesh-list
56245392|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56245393|NCT01819220|Telmisartan|telmisartan|mesh-list
56245394|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
56245395|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
56245396|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245397|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56245398|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245399|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245400|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245401|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245402|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245403|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56245404|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56245406|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
56245407|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56245408|NCT01819259|Nicotine|nicotine|mesh-list
56245409|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56245410|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
56245411|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245412|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245413|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56245414|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56245415|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
56245416|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245417|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245418|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56245420|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245421|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245422|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
55869467|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
56245423|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245424|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56245440|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56245441|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245442|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245443|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56245444|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
56245445|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245446|NCT01819610|Ketorolac|ketorolac|mesh-list
56245447|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56245448|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56245449|NCT01819610|Analgesics|analgesics|mesh-ancestor
56245450|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
56245451|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245452|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245453|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56245454|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56245455|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56245456|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245457|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245458|NCT01819649|Selenium|selenium|mesh-list
56245459|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
56245461|NCT01819649|Protective Agents|protective agents|mesh-ancestor
56245492|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245493|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245494|NCT01819857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56245495|NCT01819857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56245496|NCT01819857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56245497|NCT01819857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56245498|NCT01819857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56245500|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56245501|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56245502|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
56245503|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245504|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245505|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245506|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245507|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
56245508|NCT01819870|Protective Agents|protective agents|mesh-ancestor
56245509|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56245510|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245511|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245512|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245513|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56245514|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56245515|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56245516|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56245517|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56245518|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56245519|NCT01820026|Amoxicillin|amoxicillin|mesh-list
56245520|NCT01820026|Azithromycin|azithromycin|mesh-list
56245521|NCT01820026|Vancomycin|vancomycin|mesh-list
56245522|NCT01820026|Imipenem|imipenem|mesh-list
55745188|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56245523|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56245524|NCT01820026|Cefotaxime|cefotaxime|mesh-list
56245525|NCT01820026|Cefoxitin|cefoxitin|mesh-list
56245526|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56245531|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
56245532|NCT01820091|Antidotes|antidotes|mesh-ancestor
56245533|NCT01820091|Protective Agents|protective agents|mesh-ancestor
56245534|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245535|NCT01820104|Lansoprazole|lansoprazole|mesh-list
56245536|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
56245537|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56245538|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56245539|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56245540|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245541|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245542|NCT01820143|Esomeprazole|esomeprazole|mesh-list
56245543|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56245544|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56245545|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56245546|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245547|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245548|NCT01820299|Vitamin D|vitamin d|mesh-list
56245549|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
56245550|NCT01820299|Vitamins|vitamins|mesh-ancestor
56245551|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
56245552|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245553|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56245554|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56245555|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245556|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
56245557|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245558|NCT01820299|Protective Agents|protective agents|mesh-ancestor
56245559|NCT01820312|Paclitaxel|paclitaxel|mesh-list
56245560|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56245561|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245562|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
56245566|NCT01820325|Paclitaxel|paclitaxel|mesh-list
56245574|NCT01820442|Lofexidine|lofexidine|mesh-list
56245575|NCT01820442|Clonidine|clonidine|mesh-list
56245576|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245577|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56245578|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245579|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
56245580|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245581|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56245582|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56245583|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56245584|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56245585|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245586|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245587|NCT01820442|Analgesics|analgesics|mesh-ancestor
56245588|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
56245589|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
56245590|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
56245591|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56245592|NCT01820455|Mupirocin|mupirocin|mesh-list
56245593|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56245594|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245595|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
56245596|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
56245597|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56245598|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56245599|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245600|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245601|NCT01820624|Tretinoin|tretinoin|mesh-list
56245602|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
55745191|NCT02476981|Ephedrine|ephedrine|mesh-list
56245603|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
56245604|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56245605|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245617|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56245618|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
56245619|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245620|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55869555|NCT04368598|Protective Agents|protective agents|mesh-ancestor
55869557|NCT05347641|Cytarabine|cytarabine|mesh-list
56245621|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56245622|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245623|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245624|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245626|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
56245627|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56245629|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56245630|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56245631|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
56245632|NCT01820832|Calcitriol|calcitriol|mesh-list
56245633|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245634|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245635|NCT01820832|Vitamins|vitamins|mesh-ancestor
56245636|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
56245637|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56245638|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56245669|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245670|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56245671|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56245672|NCT01821001|Bromocriptine|bromocriptine|mesh-list
56245673|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56245674|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56245675|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
56245676|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245677|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245678|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
56245679|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
56245680|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245681|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245682|NCT01821027|Canagliflozin|canagliflozin|mesh-list
56245683|NCT01821027|Simvastatin|simvastatin|mesh-list
56245684|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56245685|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56245686|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
56245687|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245688|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56245689|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56245690|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245691|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56245692|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56245693|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245694|NCT01821040|Prednisone|prednisone|mesh-list
56245695|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56245696|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
56245711|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56245712|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56245713|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56245714|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245715|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245716|NCT01821170|Methylphenidate|methylphenidate|mesh-list
56245717|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56245718|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245719|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56245720|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56245721|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869572|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745203|NCT02476981|Analgesics|analgesics|mesh-ancestor
56245722|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245724|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245725|NCT01821235|Gabapentin|gabapentin|mesh-list
56245726|NCT01821235|Analgesics|analgesics|mesh-ancestor
56245727|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
56245728|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245765|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245766|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245767|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245768|NCT01821404|Atorvastatin|atorvastatin|mesh-list
56245769|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56245770|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56245771|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
56245772|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245773|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56245774|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56245775|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245776|NCT01821430|Pregabalin|pregabalin|mesh-list
56245777|NCT01821430|Analgesics|analgesics|mesh-ancestor
56245778|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
56245781|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
56245825|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
56245826|NCT01821664|Heparin|heparin|mesh-list
56245827|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
56245828|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56245829|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56245830|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245831|NCT01821703|Spironolactone|spironolactone|mesh-list
56245832|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56245833|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
56245834|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245835|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245836|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56245837|NCT01821703|Diuretics|diuretics|mesh-ancestor
56245838|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
56245839|NCT01821846|Liraglutide|liraglutide|mesh-list
56245840|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56245841|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245842|NCT01821846|Incretins|incretins|mesh-ancestor
56245843|NCT01821846|Hormones|hormones|mesh-ancestor
56245844|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245845|NCT01821872|Acetaminophen|acetaminophen|mesh-list
56245846|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56245847|NCT01821872|Analgesics|analgesics|mesh-ancestor
56245848|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
56245849|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56245850|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245851|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
56245873|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56245874|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56245875|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56245876|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56245877|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245878|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
56245879|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56245880|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245881|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245882|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
56245883|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245884|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245885|NCT01822405|Tocopherols|tocopherols|mesh-list
56245932|NCT01822613|Paclitaxel|paclitaxel|mesh-list
56245935|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56245936|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56245937|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
56245938|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
56245939|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
56245940|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245941|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56245942|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56245943|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245945|NCT01822639|Enalapril|enalapril|mesh-list
56245946|NCT01822639|Enalaprilat|enalaprilat|mesh-list
56245947|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245948|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56245949|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245950|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245951|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56245952|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245953|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245954|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245955|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56245956|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
56245957|NCT01822730|Risperidone|risperidone|mesh-list
56245958|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56245959|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56245960|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
56245961|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56245962|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245963|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245964|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56245970|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56245971|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56245973|NCT01822808|Isosorbide|isosorbide|mesh-list
56245974|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56245975|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56245976|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56245977|NCT01822808|Diuretics|diuretics|mesh-ancestor
56245978|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
56245979|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245980|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
56245981|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56245982|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245983|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245984|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56245985|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
56245986|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56245987|NCT01822860|Diuretics|diuretics|mesh-ancestor
56245988|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
56245989|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56245990|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56245991|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56245992|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56245993|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
55869610|NCT03580317|Carbamazepine|carbamazepine|mesh-list
56245994|NCT01822951|Donepezil|donepezil|mesh-list
56245995|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56245996|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56245997|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246001|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
56246014|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246015|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55745354|NCT05196945|Antacids|antacids|mesh-ancestor
56246016|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246017|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56246018|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
56246019|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246020|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56246022|NCT01823081|Fasudil|fasudil|mesh-list
56246023|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56246024|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246025|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56246026|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56246027|NCT01823081|Growth Substances|growth substances|mesh-ancestor
56246028|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246029|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
56246030|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56246031|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246032|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246033|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56246034|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
56246035|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56246036|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246037|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56246038|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56246039|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56246040|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
56246041|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246042|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56246043|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55745393|NCT05434663|Granisetron|granisetron|mesh-list
56246044|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246045|NCT01823159|Ezogabine|ezogabine|mesh-list
56246049|NCT01823172|Methylene Blue|methylene blue|mesh-list
56246052|NCT01823185|Clopidogrel|clopidogrel|mesh-list
56246053|NCT01823185|Ticagrelor|ticagrelor|mesh-list
56246054|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56246055|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56246056|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56246057|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56246058|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56246059|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
56246060|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246061|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246062|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246063|NCT01823393|Heparin|heparin|mesh-list
56246064|NCT01823393|Calcium heparin|calcium heparin|mesh-list
56246065|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
56246066|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56246067|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56246068|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869683|NCT00938548|Pregabalin|pregabalin|mesh-list
56246069|NCT01823523|Clindamycin|clindamycin|mesh-list
56246070|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
56246071|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
56246072|NCT01823523|Cefazolin|cefazolin|mesh-list
56246073|NCT01823523|Cephalexin|cephalexin|mesh-list
56246074|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56246075|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246076|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56246077|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246102|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
56246104|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56246105|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56246106|NCT01823965|Growth Substances|growth substances|mesh-ancestor
56246107|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246108|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
56246109|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246110|NCT01824043|Ranibizumab|ranibizumab|mesh-list
56246111|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56246112|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56246113|NCT01824043|Growth Substances|growth substances|mesh-ancestor
56246114|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246115|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
56246116|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246117|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56246118|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56246119|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246120|NCT01824199|Omeprazole|omeprazole|mesh-list
56246121|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56246122|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56246123|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56246124|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246125|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246126|NCT01824225|Aflibercept|aflibercept|mesh-list
56246127|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56246151|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56246152|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246153|NCT01824264|Incretins|incretins|mesh-ancestor
56246154|NCT01824264|Hormones|hormones|mesh-ancestor
55745482|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56246155|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56246156|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56246157|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
56246158|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246159|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246160|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56246161|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
56246162|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56246163|NCT01824420|Oxybutynin|oxybutynin|mesh-list
56246164|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56246165|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56246166|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
56246167|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246168|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246169|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246170|NCT01824420|Urological Agents|urological agents|mesh-ancestor
56246171|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
56246173|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246174|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56246175|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246176|NCT01824420|Renal Agents|renal agents|mesh-ancestor
56246177|NCT01824433|Fluoxetine|fluoxetine|mesh-list
56246178|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56246179|NCT01824433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56246193|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
56246194|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246195|NCT01824524|Hydromorphone|hydromorphone|mesh-list
56246196|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56246197|NCT01824524|Narcotics|narcotics|mesh-ancestor
56246198|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246199|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246200|NCT01824524|Analgesics|analgesics|mesh-ancestor
56246201|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
56246202|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246203|NCT01824615|Sunitinib|sunitinib|mesh-list
56246204|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246205|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56246206|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56246207|NCT01824615|Growth Substances|growth substances|mesh-ancestor
56246208|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246209|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
56246252|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
56246253|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56246254|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56246255|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246256|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246257|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
56246258|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56246259|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56246260|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56246261|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
56246262|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56246263|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246264|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56246265|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56246266|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
56246267|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56246268|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56246269|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
56246270|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56246271|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
56246272|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56246273|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
56246274|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56246275|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56246276|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
56246277|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
56246278|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
56246279|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246296|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745742|NCT05710237|Psilocybin|psilocybin|mesh-list
56246297|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56246298|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56246299|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
56246300|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
56246301|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246302|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56246303|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56246304|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246305|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246306|NCT01825109|Vaccines|vaccines|mesh-list
56246307|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
56246308|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246309|NCT01825395|Amifampridine|amifampridine|mesh-list
56246311|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246312|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246313|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56246314|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246315|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246316|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56246317|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246318|NCT01825447|Naltrexone|naltrexone|mesh-list
56246319|NCT01825447|Oxycodone|oxycodone|mesh-list
56246320|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56246321|NCT01825447|Narcotics|narcotics|mesh-ancestor
56246322|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246323|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246324|NCT01825447|Analgesics|analgesics|mesh-ancestor
56246325|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
56246326|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246327|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56246328|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56246329|NCT01825473|Erythromycin|erythromycin|mesh-list
56246330|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
56246331|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56246332|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
56246333|NCT01825473|Phenobarbital|phenobarbital|mesh-list
56246334|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56246335|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246336|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56246337|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56246338|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246339|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246340|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
56246341|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56246342|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246343|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246344|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56246345|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56246346|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246347|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
56246349|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56246350|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56246351|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56246352|NCT01825551|Lenograstim|lenograstim|mesh-list
56246353|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56246354|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
56246355|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246356|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
56246357|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56246358|NCT01825603|Gemcitabine|gemcitabine|mesh-list
56246359|NCT01825603|Cisplatin|cisplatin|mesh-list
56246360|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246361|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56246362|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
56246363|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745844|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
56246376|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56246378|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56246379|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246380|NCT01825733|Palonosetron|palonosetron|mesh-list
56246381|NCT01825733|Ramosetron|ramosetron|mesh-list
56246382|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
56246383|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
56246384|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246385|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246387|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56246388|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56246389|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
56246390|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246391|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246392|NCT01825850|Irbesartan|irbesartan|mesh-list
56246393|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56246394|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56246395|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56246396|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246397|NCT01825863|Ropivacaine|ropivacaine|mesh-list
56246398|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
56246399|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
56246400|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246401|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246402|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
56246403|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246405|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56246406|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246407|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56246408|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56246409|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56246410|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821703|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
56246411|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246412|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56246413|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56246414|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56246415|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
56246416|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246417|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246418|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56246419|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56246420|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
56246421|NCT01825993|Morphine|morphine|mesh-list
56246422|NCT01825993|Bupivacaine|bupivacaine|mesh-list
56246423|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
56246424|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
56246425|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246426|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246427|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
56246428|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246429|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56246430|NCT01825993|Narcotics|narcotics|mesh-ancestor
56246431|NCT01825993|Analgesics|analgesics|mesh-ancestor
56246432|NCT01826149|Propofol|propofol|mesh-list
56246433|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56246434|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246435|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246436|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56246437|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
56246438|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
56246439|NCT01826175|Clopidogrel|clopidogrel|mesh-list
56246440|NCT01826175|Ticagrelor|ticagrelor|mesh-list
56246441|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56246455|NCT01826279|Protective Agents|protective agents|mesh-ancestor
56246456|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246457|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246458|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56246460|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55869813|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
56246461|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56246462|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246463|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246464|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246466|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246467|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56246468|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246470|NCT01826747|Progestins|progestins|mesh-ancestor
56246471|NCT01826747|Hormones|hormones|mesh-ancestor
56246472|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56246473|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246474|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
56246475|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246476|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246477|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
56246478|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246479|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246480|NCT01826864|Sargramostim|sargramostim|mesh-list
56246481|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
56246482|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246483|NCT01826916|Ecallantide|ecallantide|mesh-list
56246502|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246503|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56246504|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56246505|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56246506|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246507|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246508|NCT01827020|Analgesics|analgesics|mesh-ancestor
56246509|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56246510|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56246511|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
56246512|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56246513|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56246514|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246515|NCT01827059|Bosentan|bosentan|mesh-list
56246516|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56246517|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56246518|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246519|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
56246520|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
56246521|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246522|NCT01827124|Oxytocin|oxytocin|mesh-list
56246523|NCT01827124|Carbetocin|carbetocin|mesh-list
56246524|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
56246525|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56246526|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246527|NCT01827137|Lenalidomide|lenalidomide|mesh-list
56246528|NCT01827137|Molgramostim|molgramostim|mesh-list
56246548|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56246552|NCT01827293|Promethazine|promethazine|mesh-list
56246625|NCT01827722|BB 1101|bb 1101|mesh-list
56246626|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56246627|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
56246628|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
56246629|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246630|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246631|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56246632|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
56246633|NCT01827722|Hormones|hormones|mesh-ancestor
56246634|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56246635|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56246636|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246637|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
56246638|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246639|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246640|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56246641|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56246642|NCT01827722|Growth Substances|growth substances|mesh-ancestor
56246643|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
56246644|NCT01827735|Aldesleukin|aldesleukin|mesh-list
56246677|NCT01827878|Protective Agents|protective agents|mesh-ancestor
55869819|NCT04355416|Curcumin|curcumin|mesh-list
56246678|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56246680|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56246681|NCT01828125|Hormones|hormones|mesh-ancestor
56246682|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56246683|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246684|NCT01828203|Minocycline|minocycline|mesh-list
56246685|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56246686|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246687|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
56246688|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56246690|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
56246691|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246692|NCT01828346|Azacitidine|azacitidine|mesh-list
56246693|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56246694|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
56246696|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246731|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56246732|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
56246733|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56246735|NCT01828437|Hormones|hormones|mesh-ancestor
56246736|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56246737|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246738|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56246739|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246740|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
56246741|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
56246742|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246743|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56246744|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56246745|NCT01828437|Protective Agents|protective agents|mesh-ancestor
56246746|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
56246747|NCT01828437|Vitamins|vitamins|mesh-ancestor
56246748|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
56246749|NCT01828463|Nitisinone|nitisinone|mesh-list
56246750|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246751|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246752|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
56246753|NCT01828489|Analgesics|analgesics|mesh-ancestor
56246754|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
56246755|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246756|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246757|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246758|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56246759|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56246767|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
56246776|NCT01828736|Cisplatin|cisplatin|mesh-list
56246777|NCT01828736|Carboplatin|carboplatin|mesh-list
56246778|NCT01828736|Trastuzumab|trastuzumab|mesh-list
56246779|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246780|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56246781|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
56246782|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246783|NCT01828736|Antiviral Agents|antiviral agents|mesh-ancestor
56246784|NCT01828736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246785|NCT01828736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246786|NCT01828736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56246787|NCT01828736|Immunologic Factors|immunologic factors|mesh-ancestor
56246788|NCT01828736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246789|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56246790|NCT01828788|Ropivacaine|ropivacaine|mesh-list
56246791|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
56246792|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
56246793|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56246794|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246795|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
56246796|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246797|NCT01828879|Tacrolimus|tacrolimus|mesh-list
56246798|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56246799|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
56246800|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246801|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56246802|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246803|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246804|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56246806|NCT01828892|Meropenem|meropenem|mesh-list
56246807|NCT01828892|Ceftazidime|ceftazidime|mesh-list
56246808|NCT01828892|Cefotaxime|cefotaxime|mesh-list
56246809|NCT01828892|Cefoxitin|cefoxitin|mesh-list
56246810|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246811|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
56246812|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56246814|NCT01829178|Cisplatin|cisplatin|mesh-list
56246817|NCT01829178|Silymarin|silymarin|mesh-list
56246818|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246819|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
56246820|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
56246821|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
56246822|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246823|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
56246824|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56246825|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56246826|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
56246827|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246828|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
56246829|NCT01829178|Protective Agents|protective agents|mesh-ancestor
56246830|NCT01829334|Listerine|listerine|mesh-list
56246831|NCT01829334|Fluorides|fluorides|mesh-list
56246832|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
56246833|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
56246834|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
56246835|NCT01829334|Protective Agents|protective agents|mesh-ancestor
56246836|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246837|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56246838|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246839|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
56246840|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56246841|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
56246842|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246843|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
56246844|NCT01829451|Protective Agents|protective agents|mesh-ancestor
56246846|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56246847|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246848|NCT01829659|Ticagrelor|ticagrelor|mesh-list
56246849|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56246850|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56246862|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56246863|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246864|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246865|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56246866|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56246867|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56246868|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
56246869|NCT01829711|Protective Agents|protective agents|mesh-list
56246870|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246871|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246872|NCT01829802|Ritonavir|ritonavir|mesh-list
56246873|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56246874|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
56246875|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56246877|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
56246878|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246879|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246880|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56246881|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56246882|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
56246883|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246884|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56246885|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56246886|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56246887|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56246888|NCT01829841|Sunitinib|sunitinib|mesh-list
56246889|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246890|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55869879|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55869880|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869881|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56246891|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56246892|NCT01829841|Growth Substances|growth substances|mesh-ancestor
56246893|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246894|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
56246895|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56246900|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56246901|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56246902|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56246903|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
56246904|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56246905|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246906|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246907|NCT01829893|Urological Agents|urological agents|mesh-ancestor
56246908|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56246909|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56246910|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246911|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
56246912|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56246913|NCT01830153|Everolimus|everolimus|mesh-list
56246914|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246915|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56246916|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
56246917|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246918|NCT01830244|Paclitaxel|paclitaxel|mesh-list
56246919|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56246920|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746452|NCT03302845|Omeprazole|omeprazole|mesh-list
56246921|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
56246922|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
56246923|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
56246924|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246926|NCT01830270|Epirubicin|epirubicin|mesh-list
56246927|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56246928|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56246929|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
56246937|NCT01830530|Telmisartan|telmisartan|mesh-list
56246941|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56246942|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246943|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56246944|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246945|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56246946|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246947|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
56246948|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
56246949|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56246951|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
56246952|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246953|NCT01831050|Vaccines|vaccines|mesh-list
56246954|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
56246955|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246956|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
56246957|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56246958|NCT01832311|Ketorolac|ketorolac|mesh-list
56246959|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56246960|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56246961|NCT01832311|Analgesics|analgesics|mesh-ancestor
56246962|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
56246963|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56246964|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56246965|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56246966|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56246967|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56246968|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246969|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56246983|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
56246984|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56246985|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56246986|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56246987|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56246988|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56246989|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56246990|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
56246991|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56246992|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56246993|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56246994|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56246995|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56246997|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
56246998|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
56246999|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247000|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247001|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
56247002|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247003|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55869947|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
56247004|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56247005|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56247006|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247007|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247025|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247026|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56247027|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56247028|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56247029|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
56247030|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
56247031|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
56247032|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56247033|NCT01835197|Abrocitinib|abrocitinib|mesh-list
56247034|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56247035|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247036|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247037|NCT01835418|Amlodipine|amlodipine|mesh-list
56247038|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56247039|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56247040|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247041|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247042|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56247043|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247044|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
56247045|NCT01835678|Linagliptin|linagliptin|mesh-list
56247046|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56247047|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247048|NCT01835678|Incretins|incretins|mesh-ancestor
56247049|NCT01835678|Hormones|hormones|mesh-ancestor
56247050|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247051|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56247052|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
56247053|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247054|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247055|NCT01836614|Lidocaine|lidocaine|mesh-list
56247056|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
55746567|NCT03301207|Midazolam|midazolam|mesh-list
56247060|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
56247061|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247062|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56247063|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56247064|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56247065|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247066|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247068|NCT01837251|Carboplatin|carboplatin|mesh-list
56247069|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56247070|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247071|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56247072|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56247073|NCT01837251|Growth Substances|growth substances|mesh-ancestor
56247074|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247075|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
56247077|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
56247078|NCT01837290|Bupivacaine|bupivacaine|mesh-list
56247079|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
56247080|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
56247081|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247082|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247083|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
56247084|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247085|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56247086|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56247088|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56247089|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56247090|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56247091|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
56247092|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247094|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56247095|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56247096|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56247097|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56247098|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56247099|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
56247100|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
56247101|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
56247102|NCT01837433|Prednisone|prednisone|mesh-list
56247103|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
56247104|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56247105|NCT01837433|Hormones|hormones|mesh-ancestor
56247106|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247107|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247108|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56247109|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247110|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
56247111|NCT01837446|Promethazine|promethazine|mesh-list
56247112|NCT01837446|Lidocaine|lidocaine|mesh-list
56247113|NCT01837446|Morphine|morphine|mesh-list
56247114|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56247115|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
56247116|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
56247117|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
55746680|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
56247164|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56247165|NCT01839994|Androgens|androgens|mesh-list
56247166|NCT01839994|Hormones|hormones|mesh-ancestor
56247167|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247168|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822475|NCT01634113|Bromides|bromides|mesh-list
56247178|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56247179|NCT01840254|Analgesics|analgesics|mesh-ancestor
56247180|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
56247181|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746764|NCT02466373|Clonidine|clonidine|mesh-list
56247182|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56247183|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56247184|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56247185|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
56247186|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247187|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247223|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56247224|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56247225|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
56247226|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
56247227|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247228|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56247229|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56247230|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247231|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247232|NCT01840800|Ropivacaine|ropivacaine|mesh-list
56247233|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
56247234|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
56247235|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247236|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247237|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
56247238|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247239|NCT01840813|Misoprostol|misoprostol|mesh-list
56247240|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56247241|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
56247242|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56247243|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247244|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56247245|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247246|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
56247248|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56247249|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
56247250|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247251|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56247268|NCT01841125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56247269|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56247270|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247271|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247272|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247273|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
56247274|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746806|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56247276|NCT01841125|Antidepressive Agents|antidepressive agents|mesh-ancestor
56247277|NCT01841125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56247278|NCT01841164|Montelukast|montelukast|mesh-list
56247279|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56247280|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
56247281|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56247282|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
56247283|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247284|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247285|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56247286|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56247287|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247289|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
56247290|NCT01841242|Povidone|povidone|mesh-list
56247291|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56247312|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56247313|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56247314|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
56247315|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56247316|NCT01841320|Methadone|methadone|mesh-list
56247317|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56247318|NCT01841320|Narcotics|narcotics|mesh-ancestor
56247319|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247320|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247321|NCT01841320|Analgesics|analgesics|mesh-ancestor
56247322|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
56247323|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247324|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
56247326|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
56247327|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247328|NCT01841411|Metronidazole|metronidazole|mesh-list
56247329|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
56247330|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56247331|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247332|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56247333|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56247334|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56247335|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
56247336|NCT01841411|Expectorants|expectorants|mesh-ancestor
56247337|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
56247338|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56247339|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
56247340|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247341|NCT01841411|Protective Agents|protective agents|mesh-ancestor
56247342|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247343|NCT01841411|Antidotes|antidotes|mesh-ancestor
56247344|NCT01841424|Benzocaine|benzocaine|mesh-list
56247345|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
56247346|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
55870086|NCT04358770|Fluocortolone|fluocortolone|mesh-list
55870087|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
55870088|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870089|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
55870090|NCT04358770|Hormones|hormones|mesh-ancestor
55870091|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870092|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870093|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
55870094|NCT03516981|Lenvatinib|lenvatinib|mesh-list
56247347|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247348|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247349|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
56247350|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247351|NCT01841463|Vemurafenib|vemurafenib|mesh-list
56247352|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247353|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56247354|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247355|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247357|NCT01841502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56247358|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56247359|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247360|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247361|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247362|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
56247363|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247364|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56247365|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
56247366|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56247367|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56247405|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56247406|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
56247407|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56247408|NCT01841827|Protective Agents|protective agents|mesh-ancestor
56247409|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56247410|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56247411|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247412|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56247413|NCT01842074|Bortezomib|bortezomib|mesh-list
56247414|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247415|NCT01842087|Iproplatin|iproplatin|mesh-list
56247416|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247417|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56247418|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247419|NCT01842113|Rifaximin|rifaximin|mesh-list
56247420|NCT01842113|Lactulose|lactulose|mesh-list
56247421|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56247422|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247423|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247424|NCT01842139|Poly I-C|poly i-c|mesh-list
56247425|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56247426|NCT01842139|Poly ICLC|poly iclc|mesh-list
55870126|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247427|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56247428|NCT01842139|Basiliximab|basiliximab|mesh-list
56247429|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
56247430|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
56247431|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247432|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56247433|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56247434|NCT01842139|Laxatives|laxatives|mesh-ancestor
56247435|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247436|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
56247437|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247438|NCT01842230|Niacin|niacin|mesh-list
56247450|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56247451|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247452|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56247453|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247454|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
56247455|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56247456|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56247457|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
56247458|NCT01842230|Vitamins|vitamins|mesh-ancestor
56247459|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
55870168|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
56247460|NCT01842256|Amlodipine|amlodipine|mesh-list
56247461|NCT01842256|Telmisartan|telmisartan|mesh-list
56247462|NCT01842256|Atorvastatin|atorvastatin|mesh-list
56247463|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56247464|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56247465|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
56247466|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247467|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56247468|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56247469|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870169|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870170|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870171|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55870172|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
56247470|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56247471|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56247472|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247473|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56247474|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247495|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56247497|NCT01842373|Tetracaine|tetracaine|mesh-list
56247498|NCT01842373|Benzocaine|benzocaine|mesh-list
56247499|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
56247500|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
56247501|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247502|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247503|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
56247504|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247505|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56247506|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56247507|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56247508|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247509|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247510|NCT01842516|Delpazolid|delpazolid|mesh-list
56247511|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
56247512|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56247513|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247514|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56247515|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247516|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247517|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
56247518|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56247519|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247520|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247521|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
56247522|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870207|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
55870208|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
55870209|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
55870232|NCT03032458|Analgesics|analgesics|mesh-ancestor
56247523|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247525|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56247526|NCT01842893|Narcotics|narcotics|mesh-ancestor
56247527|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247528|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247533|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56247534|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
56247535|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
56247536|NCT01842932|Bromides|bromides|mesh-list
56247537|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56247538|NCT01842932|Cimetropium|cimetropium|mesh-list
56247539|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
56247540|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
56247541|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247542|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247543|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247544|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
56247545|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
56247546|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247547|NCT01843010|Parecoxib|parecoxib|mesh-list
56247548|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56247549|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56247550|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247551|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247552|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56247553|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56247554|NCT01843010|Analgesics|analgesics|mesh-ancestor
56247555|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
56247556|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247557|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247558|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56247559|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56247561|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56247562|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247563|NCT01843075|Incretins|incretins|mesh-ancestor
56247564|NCT01843075|Hormones|hormones|mesh-ancestor
56247565|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247566|NCT01843088|Mannitol|mannitol|mesh-list
56247567|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56247574|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870265|NCT02245438|Hormones|hormones|mesh-ancestor
56247575|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56247576|NCT01843127|Incretins|incretins|mesh-ancestor
56247577|NCT01843127|Hormones|hormones|mesh-ancestor
56247578|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247579|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56247580|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247581|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247582|NCT01843153|Ropivacaine|ropivacaine|mesh-list
56247583|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
56247584|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
56247585|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247586|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247587|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
56247588|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247589|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56247590|NCT01843166|Estrogens|estrogens|mesh-ancestor
56247591|NCT01843166|Hormones|hormones|mesh-ancestor
56247593|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247628|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56247630|NCT01843296|Analgesics|analgesics|mesh-ancestor
56247631|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56247632|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56247633|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
56247634|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56247635|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
56247636|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56247637|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247638|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247639|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56247641|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56247642|NCT01843309|Spironolactone|spironolactone|mesh-list
56247643|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56247644|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
56247645|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56247646|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247647|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56247648|NCT01843309|Diuretics|diuretics|mesh-ancestor
56247649|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
56247650|NCT01843439|Pyridoxine|pyridoxine|mesh-list
56247651|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
56247652|NCT01843439|Vitamins|vitamins|mesh-ancestor
56247653|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
56247654|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247655|NCT01843452|Capecitabine|capecitabine|mesh-list
56247656|NCT01843452|Mitomycins|mitomycins|mesh-list
55870307|NCT03456687|Exenatide|exenatide|mesh-list
55870308|NCT03456687|Glucagon|glucagon|mesh-list
55870309|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55870310|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55870311|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870312|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56247657|NCT01843452|Mitomycin|mitomycin|mesh-list
56247658|NCT01843452|Panitumumab|panitumumab|mesh-list
56247659|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56247660|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
56247662|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247670|NCT01843556|Donepezil|donepezil|mesh-list
56247671|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56247672|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247673|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247674|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
56247675|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247676|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247677|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
56247678|NCT01843647|Cisplatin|cisplatin|mesh-list
56247679|NCT01843647|Vinorelbine|vinorelbine|mesh-list
56247680|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247681|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56247682|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
56247683|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
56247684|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
56247685|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247686|NCT01843699|Topiramate|topiramate|mesh-list
55747148|NCT03337087|Irinotecan|irinotecan|mesh-list
56247688|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56247689|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247690|NCT01843725|Capecitabine|capecitabine|mesh-list
56247691|NCT01843725|Aflibercept|aflibercept|mesh-list
56247692|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56247693|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
56247694|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247695|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247696|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56247697|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56247698|NCT01843725|Growth Substances|growth substances|mesh-ancestor
56247716|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56247717|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
56247718|NCT01843868|Prednisolone|prednisolone|mesh-list
56247719|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
56247720|NCT01843868|Doxorubicin|doxorubicin|mesh-list
56247721|NCT01843868|Vincristine|vincristine|mesh-list
56247722|NCT01843868|Lorazepam|lorazepam|mesh-list
56247723|NCT01843868|Ondansetron|ondansetron|mesh-list
56247724|NCT01843868|Aprepitant|aprepitant|mesh-list
56247725|NCT01843868|Metoclopramide|metoclopramide|mesh-list
56247726|NCT01843868|Palonosetron|palonosetron|mesh-list
56247727|NCT01843868|Granisetron|granisetron|mesh-list
56247728|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
56247729|NCT01843868|Tropisetron|tropisetron|mesh-list
56247730|NCT01843868|Antiemetics|antiemetics|mesh-list
56247731|NCT01843868|Emetics|emetics|mesh-list
56247732|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56247733|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
56247734|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247735|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56247736|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56247737|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
56247738|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247739|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247740|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56247741|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56247742|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56247743|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56247744|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247764|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55870344|NCT00944710|Atropine|atropine|mesh-list
56247765|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56247766|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56247767|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56247768|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56247769|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56247770|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
56247771|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56247772|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
56247773|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56247774|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
56247775|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
56247777|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56247778|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247779|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56247780|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247781|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
56247782|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56247783|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
56247784|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247785|NCT01844024|Misoprostol|misoprostol|mesh-list
56247786|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56247787|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
56247816|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
56247818|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56247819|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56247820|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56247821|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56247822|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
56247823|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247824|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247825|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
56247826|NCT01844427|Memantine|memantine|mesh-list
56247827|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56247828|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56247829|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
56247830|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247831|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247832|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247833|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56247834|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55747246|NCT02973997|Lenvatinib|lenvatinib|mesh-list
56247835|NCT01844622|Domperidone|domperidone|mesh-list
56247836|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
56247837|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
56247838|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247839|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247840|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247841|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56247842|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
55870357|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
55870358|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870360|NCT00949078|Omalizumab|omalizumab|mesh-list
56247843|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247844|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247845|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
56247846|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
56247849|NCT01844648|Tropicamide|tropicamide|mesh-list
56247858|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247860|NCT01844674|Tizanidine|tizanidine|mesh-list
56247861|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247862|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56247863|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247864|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247865|NCT01844674|Analgesics|analgesics|mesh-ancestor
56247866|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
56247867|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247868|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247869|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
56247870|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56247871|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56247872|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
56247873|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
56247874|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55747253|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
56247877|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
56247878|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247879|NCT01844791|Gemcitabine|gemcitabine|mesh-list
56247880|NCT01844791|Pentamidine|pentamidine|mesh-list
56247881|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56247882|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
56247883|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247884|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247886|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247887|NCT01844791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247888|NCT01844791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56247889|NCT01844791|Immunologic Factors|immunologic factors|mesh-ancestor
56247890|NCT01844791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247891|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
56247892|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56247893|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56247894|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56247896|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
56247897|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56247898|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56247900|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56247901|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247902|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56247903|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247904|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247905|NCT01844947|Sorafenib|sorafenib|mesh-list
56247906|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56247907|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56247908|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56247909|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247910|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
56247911|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56247912|NCT01845038|Timolol|timolol|mesh-list
56247913|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247914|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56247915|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56247916|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
56247917|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247918|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247919|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56247920|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56247944|NCT01845194|Midazolam|midazolam|mesh-list
56247945|NCT01845194|Codeine|codeine|mesh-list
56247946|NCT01845194|Caffeine|caffeine|mesh-list
56247947|NCT01845194|Pravastatin|pravastatin|mesh-list
56247948|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56247949|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56247950|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56247951|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247952|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55870431|NCT03490864|Melatonin|melatonin|mesh-list
55870432|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
55870433|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870434|NCT03490864|Protective Agents|protective agents|mesh-ancestor
55870435|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870436|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55870438|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
55870439|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870440|NCT05100862|Rituximab|rituximab|mesh-list
55870441|NCT05100862|Obinutuzumab|obinutuzumab|mesh-list
55870442|NCT05100862|Lenalidomide|lenalidomide|mesh-list
56247953|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56247954|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56247955|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56247956|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
56247957|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
56247958|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
56247959|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
56247960|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56247961|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56247962|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56247963|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56247965|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56247966|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56247967|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
56247968|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56247969|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56247970|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
56247971|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
56247972|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56247973|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56247974|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56247975|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56247985|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
56247986|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
56247987|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
56247988|NCT01845194|Diuretics|diuretics|mesh-ancestor
56247989|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
56247990|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56247991|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56247992|NCT01845246|Colistin|colistin|mesh-list
56247993|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56247994|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56247995|NCT01845259|Liraglutide|liraglutide|mesh-list
56247996|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56247997|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56247998|NCT01845259|Incretins|incretins|mesh-ancestor
56247999|NCT01845259|Hormones|hormones|mesh-ancestor
56248000|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248001|NCT01845272|Amlodipine|amlodipine|mesh-list
56248002|NCT01845272|Candesartan|candesartan|mesh-list
56248003|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
56248004|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56248005|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55747383|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
56248006|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56248013|NCT01845298|Rifampin|rifampin|mesh-list
56248036|NCT01845363|Cefazolin|cefazolin|mesh-list
56248037|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56248038|NCT01845376|Anesthetics|anesthetics|mesh-list
56248039|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56248040|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248041|NCT01845428|Pravastatin|pravastatin|mesh-list
56248042|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56248043|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56248044|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
56248045|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248046|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56248047|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56248048|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248049|NCT01845493|Sulforaphane|sulforaphane|mesh-list
56248050|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56248051|NCT01845493|Protective Agents|protective agents|mesh-ancestor
56248052|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248053|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248054|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55789194|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
56248055|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
56248056|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
56248057|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56248058|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248059|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
56248060|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248061|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56248062|NCT01845558|Wobenzym|wobenzym|mesh-list
56248063|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56248064|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
56248065|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248066|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
56248067|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56248079|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56248080|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
56248081|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248082|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248083|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56248084|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56248085|NCT01845675|Growth Substances|growth substances|mesh-ancestor
56248086|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248087|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
56248089|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56248090|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56248091|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56248092|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56248093|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870452|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
55870453|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55870454|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870455|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870456|NCT03455829|Osimertinib|osimertinib|mesh-list
55870457|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870458|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56248094|NCT01845701|Artesunate|artesunate|mesh-list
56248095|NCT01845701|Lumefantrine|lumefantrine|mesh-list
56248096|NCT01845701|Artemether|artemether|mesh-list
56248100|NCT01845701|Artenimol|artenimol|mesh-list
56248137|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56248138|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
56248139|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56248140|NCT01846117|Estrogens|estrogens|mesh-ancestor
56248141|NCT01846117|Hormones|hormones|mesh-ancestor
56248142|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248143|NCT01846143|Poly ICLC|poly iclc|mesh-list
56248144|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
56248145|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248146|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
56248147|NCT01846273|Ranibizumab|ranibizumab|mesh-list
56248148|NCT01846273|Verteporfin|verteporfin|mesh-list
56248149|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56248150|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56248151|NCT01846273|Growth Substances|growth substances|mesh-ancestor
56248152|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248153|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
56248154|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248155|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56248156|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
56248157|NCT01846325|Vitamin E|vitamin e|mesh-list
56248158|NCT01846325|Vitamins|vitamins|mesh-ancestor
56248159|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
56248190|NCT01846390|Immunologic Factors|immunologic factors|mesh-ancestor
56248191|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56248192|NCT01846559|Clopidogrel|clopidogrel|mesh-list
56248193|NCT01846559|Ticagrelor|ticagrelor|mesh-list
56248194|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56248195|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56248196|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56248197|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56248198|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
56248199|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248200|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248201|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248202|NCT01846650|Capecitabine|capecitabine|mesh-list
56248203|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56248204|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
55747454|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56248205|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248206|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248207|NCT01846806|Rifaximin|rifaximin|mesh-list
56248208|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56248209|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248210|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56248211|NCT01846832|Interferons|interferons|mesh-list
56248212|NCT01846832|Ribavirin|ribavirin|mesh-list
56248213|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
55870542|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55870543|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248214|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
56248215|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56248239|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248240|NCT01846975|Abatacept|abatacept|mesh-list
56248241|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56248242|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248243|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248244|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56248245|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
56248246|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248247|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56248248|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56248249|NCT01847144|Gliclazide|gliclazide|mesh-list
56248250|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56248251|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56248252|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248253|NCT01847144|Incretins|incretins|mesh-ancestor
56248254|NCT01847144|Hormones|hormones|mesh-ancestor
56248295|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
56248296|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248297|NCT01847404|Pantoprazole|pantoprazole|mesh-list
56248298|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248299|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248300|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56248301|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56248302|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56248303|NCT01847417|Pantoprazole|pantoprazole|mesh-list
56248304|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56248305|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56248306|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56248307|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248308|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248309|NCT01847456|Insulin|insulin|mesh-list
56248310|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56248311|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56248312|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248313|NCT01847495|Irinotecan|irinotecan|mesh-list
56248314|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55870579|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870580|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870581|NCT03035578|Morphine|morphine|mesh-list
55870582|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55870583|NCT03035578|Narcotics|narcotics|mesh-ancestor
55870584|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55870585|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870586|NCT03035578|Analgesics|analgesics|mesh-ancestor
55870587|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
55870588|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870589|NCT04933942|Lomustine|lomustine|mesh-list
55870590|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55870591|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
55870593|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248315|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56248316|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248317|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248318|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248319|NCT01847521|Quercetin|quercetin|mesh-list
56248320|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
56248321|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248322|NCT01847521|Protective Agents|protective agents|mesh-ancestor
56248343|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56248344|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248345|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
56248346|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
56248347|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
56248348|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248349|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56248350|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56248351|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56248352|NCT01847677|Growth Substances|growth substances|mesh-ancestor
56248353|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248354|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
56248355|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
56248356|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56248357|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
56248358|NCT01847768|Dimercaprol|dimercaprol|mesh-list
56248359|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
56248360|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
56248361|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248362|NCT01847768|Miotics|miotics|mesh-ancestor
56248363|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
56248364|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248365|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248366|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56248367|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56248368|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
56248369|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56248370|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56248371|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
56248372|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248373|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56248374|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
56248382|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
56248383|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56248384|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56248385|NCT01848106|Bivalirudin|bivalirudin|mesh-list
56248386|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
55870602|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55870603|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
55870604|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248387|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56248388|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
56248389|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248390|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248391|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
56248392|NCT01848119|Gabapentin|gabapentin|mesh-list
56248393|NCT01848119|Analgesics|analgesics|mesh-ancestor
56248394|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
56248395|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747573|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
56248396|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248398|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56248399|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56248400|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56248401|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56248402|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56248403|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56248404|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248405|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248406|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
56248407|NCT01848132|Prednisone|prednisone|mesh-list
56248408|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
56248409|NCT01848132|Rituximab|rituximab|mesh-list
56248410|NCT01848132|Doxorubicin|doxorubicin|mesh-list
56248411|NCT01848132|Vincristine|vincristine|mesh-list
56248428|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
55870640|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870643|NCT03017248|Narcotics|narcotics|mesh-ancestor
56248430|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248431|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56248432|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56248433|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
56248434|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
56248435|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
56248436|NCT01848197|Paclitaxel|paclitaxel|mesh-list
56248437|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56248438|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248439|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
56248440|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
56248441|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
56248442|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248443|NCT01848236|Vitamin D|vitamin d|mesh-list
56248444|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
56248445|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
56248446|NCT01848236|Vitamins|vitamins|mesh-list
56248447|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
56248448|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248449|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56248450|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56248451|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56248453|NCT01848301|Acetylcholine|acetylcholine|mesh-list
55747610|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56248477|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248478|NCT01848652|Doxorubicin|doxorubicin|mesh-list
56248479|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56248480|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248481|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56248482|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56248483|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248484|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248485|NCT01848665|Indomethacin|indomethacin|mesh-list
56248486|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56248487|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56248488|NCT01848665|Analgesics|analgesics|mesh-ancestor
56248489|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
56248490|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248491|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248492|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56248493|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56248494|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
56248495|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
56248496|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56248497|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56248498|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248499|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248500|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
56248501|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
56248502|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248503|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
56248504|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248505|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248507|NCT01848743|Lamivudine|lamivudine|mesh-list
56248508|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
56248509|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248518|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56248519|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
56248520|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248521|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747644|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
56248523|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
56248524|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56248525|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55870757|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248526|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56248527|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
56248528|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248529|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248530|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56248531|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
56248532|NCT01848769|Hormones|hormones|mesh-ancestor
56248533|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248534|NCT01848808|Wobenzym|wobenzym|mesh-list
56248535|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56248536|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
56248537|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248538|NCT01848873|Amlodipine|amlodipine|mesh-list
56248570|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248571|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
56248573|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56248574|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56248575|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
56248576|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56248577|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56248578|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248579|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248580|NCT01849094|Protective Agents|protective agents|mesh-ancestor
56248581|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248582|NCT01849211|Rocuronium|rocuronium|mesh-list
56248583|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56248584|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56248585|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56248586|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248587|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248588|NCT01849406|Budesonide|budesonide|mesh-list
55870764|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55870765|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
55870774|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
55870775|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870776|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870777|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870778|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55870779|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870780|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55870781|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
55870782|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
56248589|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56248590|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56248591|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
56248592|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248593|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248594|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56248595|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
56248596|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
56248597|NCT01849406|Hormones|hormones|mesh-ancestor
56248619|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
56248620|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
56248621|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248622|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248623|NCT01849926|Amdinocillin|amdinocillin|mesh-list
56248624|NCT01849926|Ibuprofen|ibuprofen|mesh-list
56248625|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56248626|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56248627|NCT01849926|Analgesics|analgesics|mesh-ancestor
56248628|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
56248629|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248630|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248631|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56248632|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56248633|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56248634|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248635|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248636|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56248637|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248673|NCT01850147|Growth Substances|growth substances|mesh-ancestor
55870809|NCT00084747|Bortezomib|bortezomib|mesh-list
56248674|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248675|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
56248676|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56248677|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248678|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248679|NCT01850160|Valsartan|valsartan|mesh-list
56248680|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
56248681|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
56248682|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
56248683|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56248684|NCT01850160|Diuretics|diuretics|mesh-list
56248685|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56248686|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56248687|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248688|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
56248689|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823997|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
56248696|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56248697|NCT01850277|Amiodarone|amiodarone|mesh-list
56248698|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248699|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56248700|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
56248701|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56248702|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56248703|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56248704|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56248705|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56248706|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248707|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56248708|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56248709|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56248710|NCT01850511|Phenylephrine|phenylephrine|mesh-list
56248711|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
56248712|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56248713|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56248714|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
56248715|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248716|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248725|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
55870963|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55870964|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55870974|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
56248736|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248737|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56248738|NCT01850680|Folic Acid|folic acid|mesh-list
56248739|NCT01850680|Methotrexate|methotrexate|mesh-list
56248740|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56248741|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
56248742|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56248743|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248744|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56248745|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
56248746|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248747|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248748|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
56248749|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248750|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55871066|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248751|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56248752|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
56248753|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56248754|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56248755|NCT01850680|Hematinics|hematinics|mesh-ancestor
56248756|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
56248757|NCT01850680|Vitamins|vitamins|mesh-ancestor
56248758|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
56248759|NCT01850940|Tolvaptan|tolvaptan|mesh-list
56248760|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56248761|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248762|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
56248763|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248764|NCT01850953|Varenicline|varenicline|mesh-list
56248765|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56248766|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56248776|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248777|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248778|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
56248779|NCT01851005|Remifentanil|remifentanil|mesh-list
56248780|NCT01851005|Anesthetics|anesthetics|mesh-list
56248781|NCT01851005|Propofol|propofol|mesh-list
56248782|NCT01851005|Sevoflurane|sevoflurane|mesh-list
56248783|NCT01851005|Rocuronium|rocuronium|mesh-list
56248784|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56248785|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248786|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56248787|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56248788|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
56248789|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56248791|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
56248792|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248793|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56248794|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55871161|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55871162|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871163|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55871164|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
55871165|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
55871166|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248795|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56248796|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
56248797|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248798|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248799|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56248800|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56248801|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56248802|NCT01851005|Narcotics|narcotics|mesh-ancestor
56248808|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
56248823|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56248824|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56248825|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
56248827|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56248828|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248829|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56248830|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
56248831|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248832|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248833|NCT01851408|Sirolimus|sirolimus|mesh-list
56248834|NCT01851408|Sorafenib|sorafenib|mesh-list
56248835|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248836|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56248837|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248838|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248839|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56248880|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56248881|NCT01851486|Analgesics|analgesics|mesh-ancestor
56248882|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56248883|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
56248884|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
56248885|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56248886|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56248887|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56248888|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
56248889|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56248890|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248891|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56248892|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56248893|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248895|NCT01851551|Vincristine|vincristine|mesh-list
56248896|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56248897|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248898|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
56248899|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248900|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56248901|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56248902|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
56248903|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
56248904|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
56248905|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248906|NCT01851681|Amoxicillin|amoxicillin|mesh-list
56248907|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56248926|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56248927|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56248928|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248929|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56248930|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56248932|NCT01851941|Folic Acid|folic acid|mesh-list
56248933|NCT01851941|Fluorouracil|fluorouracil|mesh-list
56248934|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
56248935|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
56248936|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
56248937|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56248938|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56248939|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56248940|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56248941|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
56248942|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56248943|NCT01851941|Antidotes|antidotes|mesh-ancestor
56248944|NCT01851941|Protective Agents|protective agents|mesh-ancestor
56248945|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
56248947|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
56248948|NCT01851941|Hematinics|hematinics|mesh-ancestor
56248949|NCT01851954|Clarithromycin|clarithromycin|mesh-list
56248957|NCT01851980|Furosemide|furosemide|mesh-list
56248979|NCT01851993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56248980|NCT01851993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56248981|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
56248982|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56248983|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56248984|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56248985|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
56248986|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
56248987|NCT01852266|Vaccines|vaccines|mesh-list
56249046|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249047|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56249048|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249049|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
56249050|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56249051|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249052|NCT01852604|Interferons|interferons|mesh-list
56249053|NCT01852604|Ritonavir|ritonavir|mesh-list
56249054|NCT01852604|Ribavirin|ribavirin|mesh-list
56249055|NCT01852604|Simeprevir|simeprevir|mesh-list
56249056|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249057|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
56249058|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249059|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56249108|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249110|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56249111|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
56249112|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249113|NCT01853306|Veliparib|veliparib|mesh-list
56249114|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56249115|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249116|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249117|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249118|NCT01853423|Sirolimus|sirolimus|mesh-list
56249119|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56249120|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249121|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56249122|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249123|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
56249124|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249125|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
55871413|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871414|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
55871415|NCT01884922|Vinblastine|vinblastine|mesh-list
55871416|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55871417|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871418|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
55871419|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
55871420|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
55871421|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871422|NCT05687409|Entecavir|entecavir|mesh-list
55871424|NCT05687409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55871425|NCT05687409|Antiviral Agents|antiviral agents|mesh-ancestor
56249126|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249127|NCT01853449|Fentanyl|fentanyl|mesh-list
56249129|NCT01853449|Narcotics|narcotics|mesh-ancestor
56249130|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249131|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249132|NCT01853449|Analgesics|analgesics|mesh-ancestor
56249133|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
56249134|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249135|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56249136|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56249137|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
56249138|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
56249139|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
56249140|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
56249141|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56249142|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56249143|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824433|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56249144|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249145|NCT01853540|Urological Agents|urological agents|mesh-ancestor
56249146|NCT01853566|Hormones|hormones|mesh-list
56249147|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249148|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249149|NCT01853709|Bisacodyl|bisacodyl|mesh-list
56249150|NCT01853709|Cathartics|cathartics|mesh-ancestor
56249151|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249152|NCT01853709|Laxatives|laxatives|mesh-ancestor
56249153|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
56249154|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56249155|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56249156|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
56249157|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249158|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249159|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56249160|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
56249161|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56249162|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56249163|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56249164|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
56249165|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249166|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249167|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
56249168|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56249169|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
56249170|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56249171|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
56249172|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249173|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249174|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
56249175|NCT01853813|Bevacizumab|bevacizumab|mesh-list
55824470|NCT04553770|Anastrozole|anastrozole|mesh-list
56249176|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56249177|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789235|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55789236|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55720817|NCT01745588|Pomalidomide|pomalidomide|mesh-list
55720818|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720819|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
55720820|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
55720821|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720822|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720823|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55720824|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
55720825|NCT01745588|Hormones|hormones|mesh-ancestor
55720826|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720827|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55720828|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828268|NCT04104646|Morphine|morphine|mesh-list
55720829|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55720830|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720831|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55720832|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249178|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56249179|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56249180|NCT01853813|Growth Substances|growth substances|mesh-ancestor
56249181|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249182|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
56249183|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
56249184|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
56249185|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249186|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249187|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249188|NCT01853956|Alprazolam|alprazolam|mesh-list
56249189|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56249190|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249191|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249192|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56249195|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
56249233|NCT01854203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249235|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
56249236|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
56249237|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789238|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789239|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55789243|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
55789244|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789245|NCT05030857|Midazolam|midazolam|mesh-list
55789246|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55789247|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55789248|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789249|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720909|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
55720911|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55720912|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
55720913|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720914|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55720915|NCT05526989|Niraparib|niraparib|mesh-list
55720916|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55720917|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720918|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720919|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720920|NCT02743949|Esomeprazole|esomeprazole|mesh-list
55720921|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55720922|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55720923|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55720924|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720925|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720926|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
55720927|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55720928|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720929|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55720930|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55720931|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720932|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720933|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720935|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55720936|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55720938|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720939|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720940|NCT02289898|Antiviral Agents|antiviral agents|mesh-ancestor
55720941|NCT02289898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720942|NCT02289898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720943|NCT02289898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720944|NCT02289898|Immunologic Factors|immunologic factors|mesh-ancestor
56249238|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249239|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249240|NCT01854411|Analgesics|analgesics|mesh-list
56249241|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
56249242|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249243|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249245|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
56249246|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
56249247|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249248|NCT01854463|Vitamin D|vitamin d|mesh-list
56249249|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
56249250|NCT01854463|Vitamins|vitamins|mesh-ancestor
56249251|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
56249252|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249253|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56249254|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56249255|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
56249256|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56249257|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56249258|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249259|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
56249260|NCT01854476|Coagulants|coagulants|mesh-ancestor
56249261|NCT01854489|Rifampin|rifampin|mesh-list
56249262|NCT01854489|Buprenorphine|buprenorphine|mesh-list
56249263|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56249264|NCT01854489|Narcotics|narcotics|mesh-ancestor
56249265|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249266|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249267|NCT01854489|Analgesics|analgesics|mesh-ancestor
56249268|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
56249274|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249275|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
56249276|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56249277|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249278|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249279|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56249280|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55779158|NCT04494503|Rituximab|rituximab|mesh-list
56249281|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56249282|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56249283|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56249284|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56249285|NCT01854502|Fluorides|fluorides|mesh-list
55789250|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55789252|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55789253|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55789254|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
55789255|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
55789256|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
55789257|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
55789258|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789259|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789260|NCT03319459|Trastuzumab|trastuzumab|mesh-list
55789261|NCT03319459|Cetuximab|cetuximab|mesh-list
55789262|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55789264|NCT04916951|Amoxicillin|amoxicillin|mesh-list
56249286|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
56249287|NCT01854502|Protective Agents|protective agents|mesh-ancestor
56249288|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249289|NCT01854515|Dexamethasone|dexamethasone|mesh-list
56249290|NCT01854515|Budesonide|budesonide|mesh-list
55748096|NCT03282643|Heparin|heparin|mesh-list
56249291|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
56249292|NCT01854515|BB 1101|bb 1101|mesh-list
56249293|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56249294|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
56249295|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
56249296|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249297|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249298|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249324|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249325|NCT01854749|Cisplatin|cisplatin|mesh-list
56249326|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249327|NCT01854762|Ritonavir|ritonavir|mesh-list
56249328|NCT01854762|Lopinavir|lopinavir|mesh-list
56249329|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
56249330|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55789266|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789267|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789269|NCT04430933|Docetaxel|docetaxel|mesh-list
55789270|NCT04430933|Carboplatin|carboplatin|mesh-list
55789271|NCT04430933|Pemetrexed|pemetrexed|mesh-list
55789272|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55789273|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789274|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
55789275|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
55789276|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
55789277|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789280|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55789281|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
55789282|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55789283|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55789284|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55789285|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
55789286|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789287|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789288|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789290|NCT03055091|Cathartics|cathartics|mesh-ancestor
55789291|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789292|NCT02648581|Ustekinumab|ustekinumab|mesh-list
56249331|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56249332|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
56249333|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249334|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249335|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56249336|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56249337|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
56249338|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249339|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56249340|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56249382|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249383|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249384|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
56249385|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
55789293|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
55789295|NCT02609815|Glimepiride|glimepiride|mesh-list
55789296|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55789297|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789299|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789300|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
55789301|NCT05132023|Metformin|metformin|mesh-list
55789302|NCT05132023|Empagliflozin|empagliflozin|mesh-list
55789303|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55789304|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789305|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55789306|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789307|NCT02619617|Pasireotide|pasireotide|mesh-list
55789308|NCT02619617|Hormones|hormones|mesh-ancestor
55789309|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789310|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789311|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
55789313|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
55789314|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55789315|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55789317|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
55789318|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55789319|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
55789320|NCT05125627|Progesterone|progesterone|mesh-list
56249386|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56249387|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
56249388|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56249389|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
56249390|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249391|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249392|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
56249393|NCT01855256|Oxybutynin|oxybutynin|mesh-list
56249394|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
56249395|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
56249396|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249397|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249398|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56249399|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56249400|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
56249401|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249404|NCT01855321|Vitamin D|vitamin d|mesh-list
56249437|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249438|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
56249439|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249440|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
56249441|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56249442|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56249443|NCT01855555|Propofol|propofol|mesh-list
56249444|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56249445|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249446|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789333|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249447|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56249448|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
56249449|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
56249450|NCT01855568|Methotrexate|methotrexate|mesh-list
56249451|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56249452|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
56249453|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56249495|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249496|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249497|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249499|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56249500|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
56249501|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249502|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249503|NCT01855724|Antiviral Agents|antiviral agents|mesh-ancestor
56249504|NCT01855724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789386|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249505|NCT01855724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249506|NCT01855724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249507|NCT01855724|Immunologic Factors|immunologic factors|mesh-ancestor
56249508|NCT01855724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249509|NCT01855737|Warfarin|warfarin|mesh-list
56249510|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
56249511|NCT01855763|Insulin|insulin|mesh-list
56249512|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56249513|NCT01855763|Metformin|metformin|mesh-list
56249514|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56249515|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249516|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56249517|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
56249518|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249519|NCT01855971|Protective Agents|protective agents|mesh-ancestor
56249520|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249521|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56249522|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56249523|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249524|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56249525|NCT01855984|Tocotrienols|tocotrienols|mesh-list
56249540|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56249541|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249542|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56249543|NCT01856023|Analgesics|analgesics|mesh-ancestor
56249544|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
56249545|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249546|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789450|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55789451|NCT05134519|Trastuzumab|trastuzumab|mesh-list
56249547|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56249548|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56249549|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
56249550|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249551|NCT01856062|Dexamethasone|dexamethasone|mesh-list
56249552|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56249553|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
56249554|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
56249555|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249556|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249557|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249558|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
56249559|NCT01856062|Hormones|hormones|mesh-ancestor
56249560|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249561|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56249562|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249563|NCT01856101|Dactolisib|dactolisib|mesh-list
56249564|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249565|NCT01856127|Sertraline|sertraline|mesh-list
56249566|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56249569|NCT01856127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56249570|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56249571|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56249572|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249573|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249574|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
56249575|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790042|NCT04870073|Mannitol|mannitol|mesh-list
55790043|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55790044|NCT04870073|Diuretics|diuretics|mesh-ancestor
55748338|NCT03359057|Hematinics|hematinics|mesh-ancestor
56249582|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249583|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249584|NCT01856166|Analgesics|analgesics|mesh-ancestor
56249585|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
56249586|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249587|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56249588|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56249589|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
56249590|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
56249591|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
56249592|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
56249593|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56249594|NCT01856205|Antibodies|antibodies|mesh-list
56249595|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
56249596|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56249597|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
56249598|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249599|NCT01856348|Vitamin D|vitamin d|mesh-list
56249600|NCT01856348|Vitamins|vitamins|mesh-ancestor
56249601|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
56249602|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249603|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56249604|NCT01856374|Sirolimus|sirolimus|mesh-list
56249605|NCT01856374|Everolimus|everolimus|mesh-list
56249606|NCT01856374|Atorvastatin|atorvastatin|mesh-list
56249607|NCT01856374|Pravastatin|pravastatin|mesh-list
55748408|NCT04521491|Vitamins|vitamins|mesh-ancestor
56249610|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
56249611|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249612|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56249613|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56249614|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249615|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249616|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249617|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
56249618|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871685|NCT05613153|Peppermint oil|peppermint oil|mesh-list
56249619|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56249620|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249621|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56249622|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
56249623|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
56249624|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
56249625|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249626|NCT01856517|Clonidine|clonidine|mesh-list
56249627|NCT01856517|Analgesics|analgesics|mesh-ancestor
56249628|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
56249629|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249630|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249631|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56249632|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
55790097|NCT04876313|Paclitaxel|paclitaxel|mesh-list
56249633|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
56249634|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56249635|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56249636|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56249637|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
56249638|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249639|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249640|NCT01856556|Glycine|glycine|mesh-list
56249646|NCT01856621|Charcoal|charcoal|mesh-list
56249647|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56249648|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
56249649|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249650|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249651|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56249652|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
56249653|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
56249654|NCT01856621|Hormones|hormones|mesh-ancestor
56249655|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249656|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
56249657|NCT01856621|Antidotes|antidotes|mesh-ancestor
56249658|NCT01856621|Protective Agents|protective agents|mesh-ancestor
56249659|NCT01856738|Rivastigmine|rivastigmine|mesh-list
56249660|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56249661|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249662|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249663|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
56249664|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249665|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249666|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56249667|NCT01856738|Protective Agents|protective agents|mesh-ancestor
56249668|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
56249669|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56249670|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
56249671|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249672|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249673|NCT01856946|Vitamin D|vitamin d|mesh-list
56249674|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
56249675|NCT01856946|Vitamins|vitamins|mesh-ancestor
56249676|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
56249677|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249678|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56249689|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
56249690|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56249691|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56249692|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249693|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56249694|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
56249695|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56249696|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56249697|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
56249698|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56249699|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
56249700|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56249701|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56249702|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56249703|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
56249704|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249705|NCT01856985|Misoprostol|misoprostol|mesh-list
56249706|NCT01856985|Mifepristone|mifepristone|mesh-list
56249707|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56249708|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
56249726|NCT01856998|Propofol|propofol|mesh-list
56249743|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
56249744|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249745|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
56249746|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56249747|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249748|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249749|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56249750|NCT01857141|Analgesics|analgesics|mesh-ancestor
55779335|NCT02669407|Anesthetics|anesthetics|mesh-list
56249751|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
56249752|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249753|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56249754|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56249755|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56249756|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
56249757|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249758|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249760|NCT01857154|Vitamin D|vitamin d|mesh-list
56249761|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
56249762|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
56249763|NCT01857154|Calcium|calcium|mesh-list
56249764|NCT01857154|Vitamins|vitamins|mesh-ancestor
56249765|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
56249766|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249767|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55790146|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790147|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790148|NCT04868903|Vitamin D|vitamin d|mesh-list
56249768|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56249769|NCT01857154|Antacids|antacids|mesh-ancestor
55871830|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249770|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249772|NCT01857193|Everolimus|everolimus|mesh-list
56249773|NCT01857193|Exemestane|exemestane|mesh-list
56249774|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249785|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56249786|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56249787|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56249788|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56249790|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249791|NCT01857349|Ethanol|ethanol|mesh-list
56249792|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
56249793|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56249794|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56249795|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249796|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249797|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249798|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
56249799|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
55790194|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790195|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790196|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790197|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55790198|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55790238|NCT04722601|Cc-486|cc-486|mesh-list
56249800|NCT01857375|Insulin|insulin|mesh-list
56249801|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56249802|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249803|NCT01857453|Etoposide|etoposide|mesh-list
56249804|NCT01857453|Carboplatin|carboplatin|mesh-list
56249805|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56249806|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249807|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56249808|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56249809|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249810|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249811|NCT01857479|Amphotericin B|amphotericin b|mesh-list
56249812|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56249813|NCT01857479|Budesonide|budesonide|mesh-list
56249814|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56249815|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56249816|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
56249829|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
56249830|NCT01857544|Aflibercept|aflibercept|mesh-list
56249831|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56249832|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56249833|NCT01857544|Growth Substances|growth substances|mesh-ancestor
56249834|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249835|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
56249836|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249837|NCT01857596|Trazodone|trazodone|mesh-list
56249838|NCT01857596|Bupropion|bupropion|mesh-list
55790251|NCT04383743|Vinblastine|vinblastine|mesh-list
55790252|NCT04383743|Lenograstim|lenograstim|mesh-list
55790253|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249839|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56249840|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
56249841|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56249842|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56249843|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56249844|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56249845|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249847|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56249848|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249849|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56249883|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56249884|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56249886|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
56249887|NCT01857817|Etodolac|etodolac|mesh-list
56249888|NCT01857817|Propranolol|propranolol|mesh-list
56249889|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56249890|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56249891|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
56249892|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790258|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249893|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249894|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249895|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55748722|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
56249896|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56249897|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
56249898|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56249899|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56249900|NCT01857817|Analgesics|analgesics|mesh-ancestor
56249901|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
56249902|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56249903|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56249904|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56249905|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56249906|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56249907|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56249909|NCT01857843|Simvastatin|simvastatin|mesh-list
56249910|NCT01857843|Ezetimibe|ezetimibe|mesh-list
56249911|NCT01857843|Pravastatin|pravastatin|mesh-list
56249912|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249913|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249914|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
56249926|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249927|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249928|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56249929|NCT01857856|Diuretics|diuretics|mesh-ancestor
56249930|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
56249931|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56249932|NCT01857895|Exenatide|exenatide|mesh-list
56249933|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56249934|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790259|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790260|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55790261|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
55790262|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55790263|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790264|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790265|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
56249935|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56249936|NCT01857895|Incretins|incretins|mesh-ancestor
56249937|NCT01857895|Hormones|hormones|mesh-ancestor
56249938|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56249939|NCT01857921|Trimetazidine|trimetazidine|mesh-list
56249940|NCT01857921|Atorvastatin|atorvastatin|mesh-list
56249941|NCT01857921|Pravastatin|pravastatin|mesh-list
56249942|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56249943|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56249944|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
56249945|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56249946|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56249947|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56249978|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56249979|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56249980|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
55790266|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
56249981|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249982|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
56249984|NCT01858090|Diclofenac|diclofenac|mesh-list
56249985|NCT01858090|Atropine|atropine|mesh-list
56249986|NCT01858090|Ephedrine|ephedrine|mesh-list
56249987|NCT01858090|Fentanyl|fentanyl|mesh-list
56249988|NCT01858090|Sufentanil|sufentanil|mesh-list
56249989|NCT01858090|Meperidine|meperidine|mesh-list
56249990|NCT01858090|Metoclopramide|metoclopramide|mesh-list
56249991|NCT01858090|Propofol|propofol|mesh-list
56249992|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
56249993|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56249994|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56249995|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56249996|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56249997|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
56249998|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
56249999|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56250000|NCT01858090|Narcotics|narcotics|mesh-ancestor
56250001|NCT01858090|Analgesics|analgesics|mesh-ancestor
56250002|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
56250003|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250004|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56250005|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56250006|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56250007|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250008|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250009|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56250011|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250012|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56250013|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56250014|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
56250015|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56250016|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
56250017|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
56250018|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
56250019|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56250020|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56250021|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
56250022|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250023|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56250024|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
56250025|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
56250026|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56250027|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56250028|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
56250029|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
56250030|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56250031|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
56250032|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
56250033|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56250034|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56250035|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
56250036|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56250037|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
56250038|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56250039|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
55790267|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56250040|NCT01858155|Melatonin|melatonin|mesh-list
56250041|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
55790268|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790269|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
55790270|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790271|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55790272|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55790273|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55790274|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
55790275|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
55790276|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790277|NCT03126643|Nivolumab|nivolumab|mesh-list
55790278|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790279|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790280|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55790281|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790282|NCT04617067|Gemcitabine|gemcitabine|mesh-list
55790283|NCT04617067|Paclitaxel|paclitaxel|mesh-list
56250042|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250043|NCT01858155|Protective Agents|protective agents|mesh-ancestor
56250044|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250045|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250046|NCT01858168|Irinotecan|irinotecan|mesh-list
56250047|NCT01858168|Temozolomide|temozolomide|mesh-list
56250048|NCT01858168|Olaparib|olaparib|mesh-list
56250049|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56250050|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250051|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250059|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250060|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56250061|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250062|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250063|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250064|NCT01858311|Tocotrienols|tocotrienols|mesh-list
56250065|NCT01858311|Vitamin E|vitamin e|mesh-list
56250066|NCT01858311|Tocopherols|tocopherols|mesh-list
55790284|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55790285|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250067|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
55748918|NCT02456701|Vemurafenib|vemurafenib|mesh-list
56250099|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250100|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250101|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56250102|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
56250103|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250104|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250105|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56250106|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56250107|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56250108|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250109|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250110|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56250111|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56250112|NCT01858571|Analgesics|analgesics|mesh-ancestor
56250113|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
56250114|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250115|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250116|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56250117|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56250118|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
56250119|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56250120|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250121|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56250122|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55790286|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
56250123|NCT01858571|Growth Substances|growth substances|mesh-ancestor
56250124|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
56250125|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56250127|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56250128|NCT01858610|Diuretics|diuretics|mesh-ancestor
56250129|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
56250136|NCT01858623|Losartan|losartan|mesh-list
56250137|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56250138|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56250139|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56250140|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56250141|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55790287|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
56250142|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250143|NCT01858623|Diuretics|diuretics|mesh-ancestor
56250144|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
56250145|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250146|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56250147|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250148|NCT01858649|Bevacizumab|bevacizumab|mesh-list
56250149|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
56250150|NCT01858649|Irinotecan|irinotecan|mesh-list
56250151|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56250152|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250153|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56250154|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55790288|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790289|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250155|NCT01858649|Growth Substances|growth substances|mesh-ancestor
56250156|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250157|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
56250158|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56250159|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250160|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250161|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250162|NCT01858662|Leucovorin|leucovorin|mesh-list
56250163|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
56250164|NCT01858662|Irinotecan|irinotecan|mesh-list
56250165|NCT01858662|Cetuximab|cetuximab|mesh-list
56250166|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250180|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
56250181|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250183|NCT01858831|Proguanil|proguanil|mesh-list
56250184|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56250185|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250186|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
56250187|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56250188|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56250189|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250190|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250191|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
56250192|NCT01858870|Lacosamide|lacosamide|mesh-list
56250193|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
56250194|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56250195|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56250196|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250197|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250198|NCT01858909|Melatonin|melatonin|mesh-list
56250199|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
56250200|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250201|NCT01858909|Protective Agents|protective agents|mesh-ancestor
55790290|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56250202|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250203|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250204|NCT01858961|Interferons|interferons|mesh-list
56250205|NCT01858961|Ribavirin|ribavirin|mesh-list
56250206|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250207|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
56250208|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250209|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
56250210|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250211|NCT01859234|Bevacizumab|bevacizumab|mesh-list
56250223|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56250224|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56250225|NCT01859377|Analgesics|analgesics|mesh-ancestor
56250226|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
56250227|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250228|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250229|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250230|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250231|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56250232|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250233|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250234|NCT01859455|Atorvastatin|atorvastatin|mesh-list
56250235|NCT01859455|Simvastatin|simvastatin|mesh-list
55790292|NCT04617067|Antiviral Agents|antiviral agents|mesh-ancestor
55790293|NCT04617067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250236|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56250237|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56250238|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
56250239|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250240|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56250241|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56250242|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250243|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
56250244|NCT01859468|Calcium|calcium|mesh-list
55749186|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
56250245|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56250246|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790294|NCT04617067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790295|NCT04617067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790296|NCT04617067|Immunologic Factors|immunologic factors|mesh-ancestor
55790297|NCT04617067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250247|NCT01859468|Antacids|antacids|mesh-ancestor
56250248|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250269|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56250271|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56250272|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
56250273|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250274|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250275|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56250276|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
56250277|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
56250278|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55749206|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
56250279|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56250280|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56250281|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56250282|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
56250283|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250284|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250285|NCT01859728|Gemcitabine|gemcitabine|mesh-list
56250326|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56250327|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250328|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56250329|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
56250330|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250331|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250332|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56250333|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
56250334|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
55790300|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
56250335|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56250336|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56250337|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56250338|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56250339|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
56250340|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250341|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250342|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
56250343|NCT01860066|Hormones|hormones|mesh-ancestor
56250344|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56250345|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
56250346|NCT01860105|Clopidogrel|clopidogrel|mesh-list
56250347|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56250348|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55721104|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
55721105|NCT05350124|Vitamin E|vitamin e|mesh-list
55721106|NCT05350124|Tocopherols|tocopherols|mesh-list
55721107|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
55721108|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721109|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
55721110|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721111|NCT05350124|Protective Agents|protective agents|mesh-ancestor
55721112|NCT04940637|Niraparib|niraparib|mesh-list
55721113|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55721114|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721115|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721116|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721117|NCT04925427|Naloxone|naloxone|mesh-list
55721118|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55721119|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721120|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
55721121|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721122|NCT00494234|Olaparib|olaparib|mesh-list
55721123|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55721124|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721125|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721126|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721127|NCT05556746|Rifampin|rifampin|mesh-list
55721128|NCT05556746|Clofazimine|clofazimine|mesh-list
55721129|NCT05556746|Isoniazid|isoniazid|mesh-list
55721130|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
55721131|NCT05556746|Ethambutol|ethambutol|mesh-list
55721132|NCT05556746|Bedaquiline|bedaquiline|mesh-list
55721133|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55721134|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
55721135|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55721136|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721137|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
55721138|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55721139|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721140|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721141|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55721142|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55721143|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55721144|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55721145|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55721146|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55721147|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55721148|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55721149|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
55721150|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55721151|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55721152|NCT05554406|Cytarabine|cytarabine|mesh-list
55721153|NCT05554406|Azacitidine|azacitidine|mesh-list
55721154|NCT05554406|Daunorubicin|daunorubicin|mesh-list
55721155|NCT05554406|Venetoclax|venetoclax|mesh-list
55721156|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55721158|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721159|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828340|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721160|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
55721161|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721162|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790301|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55790302|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55790303|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250349|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56250350|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56250351|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
56250352|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250353|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250354|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250355|NCT01860144|Bevacizumab|bevacizumab|mesh-list
56250356|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56250357|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250358|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56250359|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56250362|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
56250363|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
56250364|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56250365|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250366|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56250367|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
55872456|NCT03681639|Cobalt|cobalt|mesh-list
56250368|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56250369|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250371|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250372|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56250373|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56250374|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250375|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250376|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56250377|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250378|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250379|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
56250418|NCT01860508|Pemetrexed|pemetrexed|mesh-list
56250419|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790305|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
55790306|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
55790307|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55790308|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
55790309|NCT03045185|Metronidazole|metronidazole|mesh-list
55790310|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
55790311|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790312|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55790313|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55790314|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55790315|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55790316|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55790317|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790318|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790319|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790320|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55790321|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55790323|NCT04969237|Vitamins|vitamins|mesh-ancestor
55790324|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
55790325|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790326|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55790327|NCT01669915|Vitamin D|vitamin d|mesh-list
56250420|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250421|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250422|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56250423|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56250424|NCT01860625|Donepezil|donepezil|mesh-list
56250425|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56250426|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749297|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250427|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250428|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
56250429|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250430|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250431|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
56250432|NCT01860638|Bevacizumab|bevacizumab|mesh-list
56250433|NCT01860638|Temozolomide|temozolomide|mesh-list
55790329|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
55790330|NCT01669915|Vitamins|vitamins|mesh-list
55790331|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
55790332|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250434|NCT01860638|Lomustine|lomustine|mesh-list
56250435|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56250436|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250470|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56250471|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56250472|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
56250473|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250474|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56250475|NCT01860742|Interferons|interferons|mesh-list
56250476|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
56250477|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
56250478|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56250479|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250480|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
56250481|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250482|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
56250483|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250484|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55790333|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55790334|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55721163|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
55721164|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721165|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721166|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55721167|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55721168|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55721169|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
55721170|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55721171|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55721172|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721173|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
55721174|NCT04803591|Coagulants|coagulants|mesh-ancestor
55721175|NCT05536856|Fluorouracil|fluorouracil|mesh-list
55721176|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
55721177|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721178|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55721179|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721180|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721181|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
55721182|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721183|NCT04735263|Atorvastatin|atorvastatin|mesh-list
55721184|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55721185|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55721186|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
55721187|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721188|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55721189|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55721190|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721191|NCT00493298|Natalizumab|natalizumab|mesh-list
55721192|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
55721193|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721194|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55721195|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55721197|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
55721198|NCT04662723|Empagliflozin|empagliflozin|mesh-list
55721199|NCT04662723|Canagliflozin|canagliflozin|mesh-list
55721200|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55721201|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
55721202|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55721203|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55721204|NCT04662723|Prednisolone|prednisolone|mesh-list
55721205|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
55721206|NCT04662723|Losartan|losartan|mesh-list
55721207|NCT04662723|Ramipril|ramipril|mesh-list
55721208|NCT04662723|Lisinopril|lisinopril|mesh-list
55721209|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55721210|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
55721211|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55721212|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
55721213|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
55721214|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721215|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250485|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250486|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56250487|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56250488|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56250489|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250490|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250491|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56250492|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56250493|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55790337|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
56250494|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
56250495|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250496|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250497|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56250514|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56250515|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56250516|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250517|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250518|NCT01861015|Vasopressins|vasopressins|mesh-list
56250519|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
56250520|NCT01861015|Epinephrine|epinephrine|mesh-list
56250521|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56250522|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56250523|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
55749405|NCT03245671|Hormones|hormones|mesh-ancestor
56250524|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790339|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721757|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721758|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721759|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55721760|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55721761|NCT05387187|Protective Agents|protective agents|mesh-ancestor
55721762|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721763|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
55721764|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55721765|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
55721766|NCT03199755|Lumefantrine|lumefantrine|mesh-list
55721768|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55721769|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
55721770|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55721771|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55721772|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721773|NCT05318066|Norepinephrine|norepinephrine|mesh-list
55721774|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55721775|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55721776|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
55721777|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721778|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721779|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721780|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
55721781|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
55721782|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721783|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55721784|NCT02327793|Labetalol|labetalol|mesh-list
55721785|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
55721786|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
55721787|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55721788|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55721789|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
55721790|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828477|NCT01580488|Vitamins|vitamins|mesh-ancestor
55721792|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721793|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55721794|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
55721795|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
55721796|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721797|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55721798|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55721799|NCT02327715|Emtricitabine|emtricitabine|mesh-list
55721800|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
55721801|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721802|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55721803|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55721804|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721805|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721807|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55721808|NCT02951013|Chrysarobin|chrysarobin|mesh-list
55721809|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55721810|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55721811|NCT02951013|Analgesics|analgesics|mesh-ancestor
55721812|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
55721813|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250525|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250526|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250527|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56250528|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56250530|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250531|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56250532|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
56250533|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
56250534|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
56250535|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56250536|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
56250537|NCT01861015|Coagulants|coagulants|mesh-ancestor
56250538|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56250539|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
56250540|NCT01861041|Bupivacaine|bupivacaine|mesh-list
56250541|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
56250542|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
56250543|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250544|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790340|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790341|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790342|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55790343|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55790344|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790345|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55790346|NCT04341467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55790347|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55790348|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250545|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
56250546|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250547|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
56250548|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250549|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
56250554|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56250555|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250556|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250557|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56250558|NCT01861340|Dexamethasone|dexamethasone|mesh-list
56250559|NCT01861340|Lenalidomide|lenalidomide|mesh-list
56250560|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250561|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
56250562|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
56250563|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250564|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250565|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56250566|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
56250567|NCT01861340|Hormones|hormones|mesh-ancestor
56250568|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56250569|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56250570|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250571|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
56250572|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56250573|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56250574|NCT01861340|Growth Substances|growth substances|mesh-ancestor
56250575|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
56250576|NCT01861535|Imiquimod|imiquimod|mesh-list
56250577|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56250578|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
56250579|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250580|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250581|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
56250582|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
56250583|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56250584|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
56250585|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250586|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250587|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55790349|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790350|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250588|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
56250593|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
56250594|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
56250595|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
56250596|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250597|NCT01861951|Doxorubicin|doxorubicin|mesh-list
56250598|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56250599|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250600|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56250601|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250602|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250603|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250604|NCT01861990|Valproic Acid|valproic acid|mesh-list
56250605|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
56250606|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250607|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250609|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250610|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250611|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
56250612|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56250613|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250614|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56250616|NCT01862003|Folic Acid|folic acid|mesh-list
56250617|NCT01862003|Fluorouracil|fluorouracil|mesh-list
56250618|NCT01862003|Irinotecan|irinotecan|mesh-list
56250619|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
56250620|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
56250621|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250622|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790351|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
55790352|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55790353|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
56250623|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250624|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56250625|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
56250626|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250627|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56250628|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250629|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250632|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
56250633|NCT01862003|Vitamins|vitamins|mesh-ancestor
56250634|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
56250635|NCT01862003|Hematinics|hematinics|mesh-ancestor
56250636|NCT01862081|Paclitaxel|paclitaxel|mesh-list
56250637|NCT01862081|Docetaxel|docetaxel|mesh-list
56250638|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56250639|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250640|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
56250641|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
56250642|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
56250643|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250644|NCT01862120|Interleukin-2|interleukin-2|mesh-list
56250645|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250646|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56250647|NCT01862120|Analgesics|analgesics|mesh-ancestor
56250648|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
56250649|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721886|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
55721887|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55721888|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721889|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55721890|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
55721891|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721892|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721894|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721895|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55721896|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721897|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
55721898|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55721899|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55721900|NCT05482334|Molgramostim|molgramostim|mesh-list
55721901|NCT05482334|Sargramostim|sargramostim|mesh-list
55721902|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
55721903|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721904|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721905|NCT05253794|Colchicine|colchicine|mesh-list
55721906|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
55721907|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55721908|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
55721909|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
55721910|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
55721911|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721912|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721913|NCT03140943|Thalidomide|thalidomide|mesh-list
55721914|NCT03140943|Dexamethasone|dexamethasone|mesh-list
55721915|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55721916|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
55721917|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
55721918|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721919|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721920|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721921|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
55721922|NCT03140943|Hormones|hormones|mesh-ancestor
55721923|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721924|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55721925|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55766180|NCT02416427|Atorvastatin|atorvastatin|mesh-list
55721926|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721927|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
55721928|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
55721929|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55721930|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721932|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55721933|NCT03140943|Growth Substances|growth substances|mesh-ancestor
55721934|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
55721936|NCT02038257|Emollients|emollients|mesh-ancestor
55721937|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
55721938|NCT05311436|Iron|iron|mesh-list
56250650|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250651|NCT01862263|Vildagliptin|vildagliptin|mesh-list
56250652|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56250653|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250654|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56250655|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
56250656|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250657|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250659|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
56250660|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
56250661|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
56250662|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250663|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250664|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56250665|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56250666|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55872731|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56250671|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250672|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250673|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55790354|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55790355|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
55790357|NCT04872881|Propofol|propofol|mesh-list
55790358|NCT04872881|Rocuronium|rocuronium|mesh-list
55790359|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55790360|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790361|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790362|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55790363|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
55790364|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
55790365|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55790366|NCT04872881|Narcotics|narcotics|mesh-ancestor
56250675|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250676|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250677|NCT01862497|Carvedilol|carvedilol|mesh-list
56250678|NCT01862497|Prazosin|prazosin|mesh-list
56250679|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55749564|NCT03345797|Testosterone|testosterone|mesh-list
56250680|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56250681|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
56250682|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250683|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250684|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250685|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56250686|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
56250687|NCT01862497|Protective Agents|protective agents|mesh-ancestor
56250688|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56250689|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250690|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56250691|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
56250692|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56250693|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56250694|NCT01862523|Capsaicin|capsaicin|mesh-list
56250695|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
56250719|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56250720|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749621|NCT04088591|Vitamins|vitamins|mesh-ancestor
56250721|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250722|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790367|NCT04872881|Analgesics|analgesics|mesh-ancestor
55790368|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
56250723|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
56250724|NCT01862926|Rituximab|rituximab|mesh-list
56250725|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56250726|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
56250727|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250728|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250729|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56250730|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
56250731|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250732|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250733|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56250734|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56250735|NCT01862978|Heparin|heparin|mesh-list
56250736|NCT01862978|Nadroparin|nadroparin|mesh-list
56250737|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
56250738|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56250739|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56250740|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250741|NCT01863004|Bortezomib|bortezomib|mesh-list
56250742|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250743|NCT01863069|Interferons|interferons|mesh-list
56250744|NCT01863069|Interferon-beta|interferon-beta|mesh-list
55790369|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790370|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56250745|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
56250746|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250767|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
56250768|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
56250769|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250770|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250771|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56250772|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56250773|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56250774|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
56250775|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250776|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250777|NCT01863199|Ranibizumab|ranibizumab|mesh-list
56250778|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56250780|NCT01863199|Growth Substances|growth substances|mesh-ancestor
56250781|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250782|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
56250783|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250784|NCT01863225|Atorvastatin|atorvastatin|mesh-list
56250785|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56250786|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56250787|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56250788|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
56250790|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56250818|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250819|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56250820|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56250821|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
56250822|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
56250823|NCT01863407|Metronidazole|metronidazole|mesh-list
56250824|NCT01863407|Dexamethasone|dexamethasone|mesh-list
56250825|NCT01863407|Allantoin|allantoin|mesh-list
56250826|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250827|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
56250828|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
56250829|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250830|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250831|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56250832|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
56250833|NCT01863407|Hormones|hormones|mesh-ancestor
56250834|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56250835|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56250836|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56250837|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250838|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56250839|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56250840|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56250841|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
56250842|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56250843|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56250844|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250845|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56250846|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56250847|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250848|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250849|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
56250850|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250851|NCT01863485|Vorolanib|vorolanib|mesh-list
56250852|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56250856|NCT01863511|Diuretics|diuretics|mesh-list
56250857|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56250858|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
56250859|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250860|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56250861|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250862|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250863|NCT01863589|Adefovir|adefovir|mesh-list
56250864|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
56250865|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250866|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56250867|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56250868|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250869|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250870|NCT01863602|Lamotrigine|lamotrigine|mesh-list
56250871|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
56250872|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56250873|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250874|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250875|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56250876|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250877|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56250878|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56250879|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250880|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56250881|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56250882|NCT01863615|Isotretinoin|isotretinoin|mesh-list
56250883|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
56250884|NCT01863641|Calcitriol|calcitriol|mesh-list
56250885|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56250886|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250887|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56250893|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56250894|NCT01863654|Montelukast|montelukast|mesh-list
56250895|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56250896|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
56250897|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56250898|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
56250899|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56250900|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250901|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56250902|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56250903|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250904|NCT01863706|Misoprostol|misoprostol|mesh-list
56250906|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
56250907|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56250908|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250909|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56250910|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
56250911|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56250912|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56250913|NCT01863719|Colistin|colistin|mesh-list
56250914|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56250915|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56250916|NCT01863810|Pregabalin|pregabalin|mesh-list
56250917|NCT01863810|Analgesics|analgesics|mesh-ancestor
56250918|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
56250919|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250920|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250921|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
56250922|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56250923|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56250924|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250926|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56250932|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56250933|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790379|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790380|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56250934|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56250935|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56250936|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250937|NCT01863888|Teriflunomide|teriflunomide|mesh-list
56250938|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
56250939|NCT01863888|Charcoal|charcoal|mesh-list
56250940|NCT01863888|Antidotes|antidotes|mesh-ancestor
56250941|NCT01863888|Protective Agents|protective agents|mesh-ancestor
56250942|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250943|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56250944|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56250945|NCT01863888|Analgesics|analgesics|mesh-ancestor
56250946|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
56250947|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250948|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56250949|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56250950|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56250951|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
56250952|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56250953|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56250954|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
56250955|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56250960|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
56250984|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
56250985|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250986|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
56250987|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56250988|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56250989|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56250990|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56250991|NCT01864187|Analgesics|analgesics|mesh-ancestor
56250992|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
56250993|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56250994|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56250995|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56250997|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
56250998|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56250999|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251000|NCT01864213|Tetracaine|tetracaine|mesh-list
56251001|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
56251002|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
56251003|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251004|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251005|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
56251006|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251007|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
56251008|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
56251009|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
56251010|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56251011|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
56251012|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251013|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56251014|NCT01864551|Lamotrigine|lamotrigine|mesh-list
56251015|NCT01864551|Olanzapine|olanzapine|mesh-list
56251016|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
56251026|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56251027|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56251028|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251029|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251030|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
56251031|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
56251032|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56251033|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56251034|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56251035|NCT01864616|Vitamin D|vitamin d|mesh-list
56251036|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
56251037|NCT01864616|Vitamins|vitamins|mesh-ancestor
55873105|NCT01892189|Ketamine|ketamine|mesh-list
56251038|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
56251039|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251040|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56251041|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56251042|NCT01864655|Saracatinib|saracatinib|mesh-list
56251043|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251044|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251045|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251047|NCT01864681|Gefitinib|gefitinib|mesh-list
56251048|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749874|NCT03243331|Gedatolisib|gedatolisib|mesh-list
56251050|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251051|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56251052|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251053|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251055|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55750259|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56251056|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251057|NCT01864824|Vitamins|vitamins|mesh-list
56251058|NCT01864824|Folic Acid|folic acid|mesh-list
56251059|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
56251060|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
56251061|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
56251062|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
56251063|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251064|NCT01864824|Hematinics|hematinics|mesh-ancestor
56251065|NCT01864863|Bosentan|bosentan|mesh-list
56251066|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56251067|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56251068|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251069|NCT01864915|Prucalopride|prucalopride|mesh-list
56251070|NCT01864915|Laxatives|laxatives|mesh-ancestor
56251071|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251072|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56251073|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56251074|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
56251075|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251076|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251077|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251078|NCT01865175|Iron|iron|mesh-list
56251079|NCT01865175|Trace Elements|trace elements|mesh-ancestor
56251095|NCT01865201|Diuretics|diuretics|mesh-ancestor
56251096|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
55721939|NCT05311436|Folic Acid|folic acid|mesh-list
55721940|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721941|NCT05311436|Trace Elements|trace elements|mesh-ancestor
55721942|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
55721943|NCT05311436|Hematinics|hematinics|mesh-ancestor
55721944|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
55721945|NCT05311436|Vitamins|vitamins|mesh-ancestor
55721946|NCT05199753|Antibodies|antibodies|mesh-list
55721947|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
55721948|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721950|NCT01352741|Tapentadol|tapentadol|mesh-list
55721951|NCT01352741|Analgesics|analgesics|mesh-ancestor
55721952|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
55721953|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721954|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721955|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
55721956|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55721957|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55721958|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721959|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55721960|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55721961|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55721962|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55721963|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55721964|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55721965|NCT01352741|Narcotics|narcotics|mesh-ancestor
55721966|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55721967|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56251097|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251098|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56251099|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
56251100|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251101|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56251102|NCT01865201|Protective Agents|protective agents|mesh-ancestor
56251103|NCT01865279|Insulin|insulin|mesh-list
56251104|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56251105|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
56251106|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
56251107|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
56251108|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
56251109|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251110|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251111|NCT01865292|Insulin|insulin|mesh-list
56251112|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56251113|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
56251114|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251115|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251116|NCT01865305|Insulin|insulin|mesh-list
56251117|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56251118|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
56251119|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
56251147|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56251148|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
56251149|NCT01865630|Etanercept|etanercept|mesh-list
56251150|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56251151|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56251152|NCT01865630|Analgesics|analgesics|mesh-ancestor
56251153|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
55750412|NCT02507843|Vitamin D|vitamin d|mesh-list
56251154|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251155|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251156|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56251157|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56251158|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251159|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56251160|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
56251161|NCT01865669|Oxytocin|oxytocin|mesh-list
56251162|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
56251163|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56251164|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251165|NCT01865721|Entonox|entonox|mesh-list
56251166|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56251167|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
56251168|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251169|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251170|NCT01865760|Octreotide|octreotide|mesh-list
56251171|NCT01865760|Somatostatin|somatostatin|mesh-list
56251172|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251173|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56251174|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251175|NCT01865760|Hormones|hormones|mesh-ancestor
56251176|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750438|NCT05504057|Amantadine|amantadine|mesh-list
56251177|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251178|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
56251179|NCT01865916|Bisacodyl|bisacodyl|mesh-list
56251180|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
56251181|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251182|NCT01865916|Protective Agents|protective agents|mesh-ancestor
56251186|NCT01865916|Cathartics|cathartics|mesh-ancestor
55750636|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
56251187|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790381|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55790382|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790383|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
56251189|NCT01865968|Vaccines|vaccines|mesh-list
56251190|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
56251192|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56251193|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
56251194|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251195|NCT01866059|Methamphetamine|methamphetamine|mesh-list
56251196|NCT01866059|Calcium|calcium|mesh-list
56251197|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56251198|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251199|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56251200|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
56251201|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
56251202|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251203|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
56251204|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750862|NCT05042271|Meropenem|meropenem|mesh-list
56251205|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251206|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
56251207|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56251208|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56251209|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56251210|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56251211|NCT01866241|Misoprostol|misoprostol|mesh-list
56251212|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56251213|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
56251214|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56251215|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251216|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56251227|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251229|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56251230|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55750992|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56251231|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251232|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56251233|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56251234|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
56251235|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251236|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56251237|NCT01866397|Cidofovir|cidofovir|mesh-list
56251238|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
56251239|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251240|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251241|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251242|NCT01866488|Misoprostol|misoprostol|mesh-list
55751130|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
56251243|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56251244|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
56251245|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56251246|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251247|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56251248|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251249|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
56251250|NCT01866514|Lidocaine|lidocaine|mesh-list
56251251|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
56251252|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
56251253|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251254|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251255|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
56251256|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251257|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56251258|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56251259|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56251260|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56251265|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56251267|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
56251268|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251269|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
55790384|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55790385|NCT03044795|Veliparib|veliparib|mesh-list
56251270|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251271|NCT01866605|Midazolam|midazolam|mesh-list
56251272|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56251273|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56251274|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251275|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251276|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56251277|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56251278|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251279|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56251280|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
56251281|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
56251282|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
56251283|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
56251284|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251285|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251286|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
56251319|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
56251320|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251321|NCT01867281|Aspirin|aspirin|mesh-list
56251322|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56251323|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56251324|NCT01867281|Analgesics|analgesics|mesh-ancestor
56251325|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
56251326|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251327|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251328|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56251329|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56251330|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56251331|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56251332|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251333|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56251334|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56251335|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251336|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
56251337|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56251338|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56251339|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
55873399|NCT02287311|Fludarabine|fludarabine|mesh-list
56251340|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251341|NCT01867463|Antacids|antacids|mesh-ancestor
56251342|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251343|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251344|NCT01867502|Metformin|metformin|mesh-list
56251345|NCT01867502|Vildagliptin|vildagliptin|mesh-list
56251346|NCT01867502|Glyburide|glyburide|mesh-list
56251347|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251348|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251349|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55751519|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
56251350|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
56251351|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251358|NCT01867645|Antibodies|antibodies|mesh-list
56251359|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
56251360|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56251361|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
56251362|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251363|NCT01867697|Leucovorin|leucovorin|mesh-list
56251364|NCT01867697|Folic Acid|folic acid|mesh-list
56251365|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
56251366|NCT01867697|Irinotecan|irinotecan|mesh-list
56251367|NCT01867697|Cetuximab|cetuximab|mesh-list
56251368|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
56251369|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
56251370|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251371|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251372|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56251373|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56251374|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251375|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251376|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56251377|NCT01867697|Antidotes|antidotes|mesh-ancestor
56251378|NCT01867697|Protective Agents|protective agents|mesh-ancestor
56251379|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
56251380|NCT01867697|Vitamins|vitamins|mesh-ancestor
56251381|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
56251382|NCT01867697|Hematinics|hematinics|mesh-ancestor
56251383|NCT01867697|Antacids|antacids|mesh-ancestor
55790386|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56251384|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251385|NCT01867775|Mirtazapine|mirtazapine|mesh-list
56251386|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
56251387|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251388|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56251389|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
56251390|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
56251391|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251392|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751632|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
55790387|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790388|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790389|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251393|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251401|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56251402|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56251404|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56251405|NCT01867866|Trifluridine|trifluridine|mesh-list
56251406|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
55751696|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56251407|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251408|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
56251409|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251410|NCT01867892|Leucovorin|leucovorin|mesh-list
56251411|NCT01867892|Gemcitabine|gemcitabine|mesh-list
56251412|NCT01867892|Fluorouracil|fluorouracil|mesh-list
56251413|NCT01867892|Irinotecan|irinotecan|mesh-list
56251414|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
56251415|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56251416|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
56251417|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251418|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251419|NCT01867892|Antiviral Agents|antiviral agents|mesh-ancestor
56251420|NCT01867892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251421|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251422|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56251423|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
56251424|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251425|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56251426|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56251427|NCT01867892|Antidotes|antidotes|mesh-ancestor
56251428|NCT01867892|Protective Agents|protective agents|mesh-ancestor
56251429|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
56251430|NCT01867892|Vitamins|vitamins|mesh-ancestor
56251431|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
56251432|NCT01868048|Nabiximols|nabiximols|mesh-list
56251448|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56251449|NCT01868126|Latanoprost|latanoprost|mesh-list
56251450|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56251451|NCT01868191|Thiamine|thiamine|mesh-list
56251452|NCT01868191|Benphothiamine|benphothiamine|mesh-list
56251453|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56251454|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
56251455|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251456|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
56251457|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
56251458|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251459|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
56251460|NCT01868191|Vitamins|vitamins|mesh-ancestor
56251461|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
56251462|NCT01868360|Aflibercept|aflibercept|mesh-list
56251463|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55751916|NCT03320447|Lidocaine|lidocaine|mesh-list
56251464|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56251465|NCT01868360|Growth Substances|growth substances|mesh-ancestor
56251466|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251467|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
56251468|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251469|NCT01868438|Artesunate|artesunate|mesh-list
56251470|NCT01868438|Pyronaridine|pyronaridine|mesh-list
56251471|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
56251472|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56251473|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56251474|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251475|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251476|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
56251477|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
56251478|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56251479|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
56251480|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
56251481|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56251484|NCT01868529|Insulin|insulin|mesh-list
56251493|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56251494|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55751959|NCT03227419|Abatacept|abatacept|mesh-list
56251496|NCT01868568|Insulin|insulin|mesh-list
56251497|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56251499|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
56251500|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56251501|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
56251502|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
56251503|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251504|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251505|NCT01868581|Insulin|insulin|mesh-list
56251506|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56251507|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
56251508|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
56251509|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55752009|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56251510|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251512|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56251513|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251514|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56251515|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56251516|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251517|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56251518|NCT01868750|Vitamins|vitamins|mesh-ancestor
56251540|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251541|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251542|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56251543|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
56251544|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
56251545|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251546|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56251547|NCT01868906|Temozolomide|temozolomide|mesh-list
56251548|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56251549|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
56251550|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251551|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251552|NCT01868945|Vitamin D|vitamin d|mesh-list
56251553|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
56251554|NCT01868945|Calcifediol|calcifediol|mesh-list
56251555|NCT01868945|Vitamins|vitamins|mesh-ancestor
56251556|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
55752141|NCT03078231|Mydriatics|mydriatics|mesh-list
56251560|NCT01868984|Paclitaxel|paclitaxel|mesh-list
56251561|NCT01868984|Heparin|heparin|mesh-list
56251562|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56251563|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251564|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
56251565|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
56251566|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
56251567|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251568|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
56251569|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56251570|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56251571|NCT01869010|Tenofovir|tenofovir|mesh-list
56251572|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
56251573|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251574|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56251575|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56251576|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251577|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251578|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56251579|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56251580|NCT01869023|Gemcitabine|gemcitabine|mesh-list
56251581|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251582|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56251583|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
56251584|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251585|NCT01869023|Antiviral Agents|antiviral agents|mesh-ancestor
56251586|NCT01869023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790390|NCT04341155|Dexamethasone|dexamethasone|mesh-list
55790391|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
55790392|NCT04341155|BB 1101|bb 1101|mesh-list
55790393|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56251587|NCT01869023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251588|NCT01869023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56251589|NCT01869023|Immunologic Factors|immunologic factors|mesh-ancestor
56251590|NCT01869023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251591|NCT01869036|Morphine|morphine|mesh-list
55752205|NCT03319043|Hormones|hormones|mesh-ancestor
56251592|NCT01869036|Anesthetics|anesthetics|mesh-list
56251593|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251594|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251595|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56251596|NCT01869036|Narcotics|narcotics|mesh-ancestor
56251597|NCT01869036|Analgesics|analgesics|mesh-ancestor
56251598|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
56251599|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251600|NCT01869205|Ivermectin|ivermectin|mesh-list
56251601|NCT01869205|Abamectin|abamectin|mesh-list
56251602|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56251603|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251604|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
56251605|NCT01869257|Triclosan|triclosan|mesh-list
56251606|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56251607|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251609|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56251617|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56251618|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56251619|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
56251620|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251621|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251622|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251623|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
56251624|NCT01869491|Antacids|antacids|mesh-ancestor
56251625|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790394|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
55790395|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
56251626|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251628|NCT01869556|Carboprost|carboprost|mesh-list
56251629|NCT01869556|Ergonovine|ergonovine|mesh-list
56251630|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
56251631|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56251632|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251633|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56251634|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
56251635|NCT01869569|Pregabalin|pregabalin|mesh-list
56251636|NCT01869569|Analgesics|analgesics|mesh-ancestor
56251637|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
56251638|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251639|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251640|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
56251641|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56251642|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56251643|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251644|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56251645|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55790396|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790397|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790398|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790399|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
55790400|NCT04341155|Hormones|hormones|mesh-ancestor
55790401|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790402|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55790403|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790404|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
55790405|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790406|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790407|NCT04865705|Paclitaxel|paclitaxel|mesh-list
55790408|NCT04865705|Cisplatin|cisplatin|mesh-list
55790409|NCT04865705|Carboplatin|carboplatin|mesh-list
55790410|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55790411|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251646|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56251658|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56251659|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56251660|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
56251661|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251662|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251663|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251664|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
56251665|NCT01869803|Calicheamicins|calicheamicins|mesh-list
56251666|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56251667|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251668|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56251669|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
56251670|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56251671|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56251672|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251673|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56251674|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56251675|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
56251676|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752425|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251677|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251679|NCT01869907|Amitriptyline|amitriptyline|mesh-list
56251680|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56251681|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56251682|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56251683|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
56251684|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251685|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56251702|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251703|NCT01870011|Anesthetics|anesthetics|mesh-list
56251704|NCT01870011|Propofol|propofol|mesh-list
56251705|NCT01870011|Desflurane|desflurane|mesh-list
56251706|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251707|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251708|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56251709|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56251710|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
55790412|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
55790413|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
55721968|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
55721969|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721970|NCT04422392|Paclitaxel|paclitaxel|mesh-list
55721971|NCT04422392|Carboplatin|carboplatin|mesh-list
55721972|NCT04422392|Pemetrexed|pemetrexed|mesh-list
55721973|NCT04422392|Antibodies|antibodies|mesh-list
55721974|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55721975|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721976|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
55721977|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
55721978|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
55721979|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721980|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
55721981|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721982|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721983|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55721984|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55721985|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
55721986|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55721987|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721989|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55721990|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
55721991|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721992|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
55721993|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721994|NCT01657292|Octenidine|octenidine|mesh-list
55721995|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721996|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55721997|NCT04167033|Hormones|hormones|mesh-list
55721998|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721999|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722000|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
56251711|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56251712|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
56251713|NCT01870024|Lorazepam|lorazepam|mesh-list
56251714|NCT01870024|Clonazepam|clonazepam|mesh-list
56251715|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
56251716|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
56251717|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
56251718|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251719|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251720|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251721|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56251722|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251723|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56251724|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56251725|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251726|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
56251727|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
56251728|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251729|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251732|NCT01870050|Dapsone|dapsone|mesh-list
56251751|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
55752530|NCT03318029|Vitamin D|vitamin d|mesh-list
56251752|NCT01870115|Protective Agents|protective agents|mesh-ancestor
56251753|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251754|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
56251755|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
56251756|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
56251757|NCT01870128|Methotrexate|methotrexate|mesh-list
56251758|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56251759|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
56251760|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56251761|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251762|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56251763|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
56251764|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251765|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251766|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
56251767|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790414|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790415|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251768|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56251769|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56251770|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
56251771|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56251772|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55752589|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
56251773|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56251774|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
56251775|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
56251776|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251777|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251778|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
56251779|NCT01870128|Hormones|hormones|mesh-ancestor
56251780|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56251782|NCT01870128|Protective Agents|protective agents|mesh-ancestor
56251794|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56251795|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251796|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251797|NCT01870219|Ketamine|ketamine|mesh-list
55790416|NCT04858997|Palbociclib|palbociclib|mesh-list
56251798|NCT01870219|Anesthetics|anesthetics|mesh-list
55790417|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790418|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55790419|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251799|NCT01870219|Sevoflurane|sevoflurane|mesh-list
56251800|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
56251801|NCT01870219|Analgesics|analgesics|mesh-ancestor
56251802|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
56251803|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251804|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251805|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56251806|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
56251807|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251808|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56251809|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56251810|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251811|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251812|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56251813|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56251815|NCT01870284|Ixekizumab|ixekizumab|mesh-list
56251816|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56251817|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56251818|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
56251819|NCT01870427|Aflibercept|aflibercept|mesh-list
56251842|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251843|NCT01870466|Cilostazol|cilostazol|mesh-list
56251844|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56251845|NCT01870466|Simvastatin|simvastatin|mesh-list
56251846|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56251847|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56251848|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
56251849|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251850|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56251851|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56251852|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251853|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56251854|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
56251855|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251856|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251857|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56251858|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
56251859|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56251860|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56251861|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56251862|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
56251863|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56251864|NCT01870466|Protective Agents|protective agents|mesh-ancestor
56251865|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56251866|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56251867|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56251868|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56251869|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56251870|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251871|NCT01870635|Ondansetron|ondansetron|mesh-list
56251873|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
56251874|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251875|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251882|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251883|NCT01870635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56251884|NCT01870635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56251885|NCT01870635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251886|NCT01870635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251887|NCT01870635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56251888|NCT01870648|Ondansetron|ondansetron|mesh-list
56251889|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
56251890|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
56251891|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251892|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251893|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251894|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
56251895|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
56251896|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56251898|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251899|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251900|NCT01870648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56251901|NCT01870648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56251902|NCT01870648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251903|NCT01870648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56251904|NCT01870648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56251905|NCT01870674|Prucalopride|prucalopride|mesh-list
55790420|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251906|NCT01870674|YH12852|yh12852|mesh-list
56251907|NCT01870674|Laxatives|laxatives|mesh-ancestor
56251908|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251909|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56251910|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56251911|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
56251912|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251913|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251915|NCT01870804|Atorvastatin|atorvastatin|mesh-list
56251923|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251924|NCT01870895|Ramosetron|ramosetron|mesh-list
56251925|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
56251926|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
56251927|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251928|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251929|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56251930|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56251931|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
56251932|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251933|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251934|NCT01870908|Tacrolimus|tacrolimus|mesh-list
56251935|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56251936|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
56251937|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251938|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56251939|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251940|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251941|NCT01870986|Adalimumab|adalimumab|mesh-list
56251942|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56251943|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56251944|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
56251945|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56251946|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56251947|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251948|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56251949|NCT01871129|Analgesics|analgesics|mesh-ancestor
56251950|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
56251951|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56251952|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56251953|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56251954|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56251955|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
56251956|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56251957|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251962|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752844|NCT02485145|Diclofenac|diclofenac|mesh-list
56251965|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251966|NCT01871376|Aflibercept|aflibercept|mesh-list
56251967|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56251968|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56251969|NCT01871376|Growth Substances|growth substances|mesh-ancestor
56251970|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251971|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
56251972|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251973|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
56251974|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56251975|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251976|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251977|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56251978|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56251979|NCT01871454|Protective Agents|protective agents|mesh-ancestor
56251980|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251981|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
56251982|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56251983|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
56251984|NCT01871467|Sargramostim|sargramostim|mesh-list
56251985|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
56251986|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251987|NCT01871480|Gefitinib|gefitinib|mesh-list
56251988|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56251989|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56251990|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56251991|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56251992|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
56251993|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56251994|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56251995|NCT01871649|Golimumab|golimumab|mesh-list
56251996|NCT01871649|Methotrexate|methotrexate|mesh-list
55827266|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
56251997|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56251998|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
56251999|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56252000|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752889|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56252001|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56252002|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
56252003|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252004|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252005|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
56252006|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252007|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56252008|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252009|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
56252010|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252011|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56252012|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56252013|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252015|NCT01871662|Ribavirin|ribavirin|mesh-list
56252016|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
56252017|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
56252018|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56252019|NCT01871662|Silybin|silybin|mesh-list
56252020|NCT01871662|Silymarin|silymarin|mesh-list
55752924|NCT02480387|Ledipasvir|ledipasvir|mesh-list
55752927|NCT04999293|Clopidogrel|clopidogrel|mesh-list
56252021|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252022|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
56252023|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252024|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
56252026|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
56252042|NCT01871701|Dexetimide|dexetimide|mesh-list
56252043|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56252044|NCT01871701|Citalopram|citalopram|mesh-list
56252045|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56252046|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252047|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252048|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56252049|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56252050|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252051|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252052|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252053|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56252054|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
56252055|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56252056|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252057|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56252058|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56252059|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56252060|NCT01871701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56252061|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56252062|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56252063|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252064|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
56252065|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55790421|NCT05135143|Antioxidants|antioxidants|mesh-list
55790422|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252066|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
56252067|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56252068|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56252069|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56252070|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
56252071|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
56252072|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252073|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56252074|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56252075|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
56252080|NCT01871740|Enalapril|enalapril|mesh-list
56252081|NCT01871740|Enalaprilat|enalaprilat|mesh-list
56252082|NCT01871740|Maleic acid|maleic acid|mesh-list
56252083|NCT01871740|Hematinics|hematinics|mesh-ancestor
56252084|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
55790423|NCT05135143|Protective Agents|protective agents|mesh-ancestor
55790424|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252085|NCT01871740|Vitamins|vitamins|mesh-ancestor
56252086|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
56252087|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252088|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252089|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252090|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56252091|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
56252092|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56252093|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
56252094|NCT01871792|Pitavastatin|pitavastatin|mesh-list
56252095|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56252096|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56252097|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56252098|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
56252099|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252100|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252101|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56252102|NCT01871844|Octreotide|octreotide|mesh-list
56252103|NCT01871844|Somatostatin|somatostatin|mesh-list
56252104|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56252105|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55753034|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
56252106|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252108|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56252109|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252110|NCT01871857|Epinephrine|epinephrine|mesh-list
56252111|NCT01871857|Racepinephrine|racepinephrine|mesh-list
56252112|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
56252113|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56252114|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56252120|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56252121|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
56252122|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252123|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56252124|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
56252125|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
56252126|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
56252127|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56252128|NCT01871922|Atropine|atropine|mesh-list
56252129|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55790428|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
55790429|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55790430|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
55790431|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790432|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55790433|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55790434|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
55790435|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790436|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252130|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56252131|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56252132|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
56252133|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252134|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252135|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56252136|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
56252137|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
56252138|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
56252177|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56252178|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252179|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252180|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56252181|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
56252182|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56252183|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56252184|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56252185|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790437|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55790438|NCT05305183|Alendronate|alendronate|mesh-list
55790439|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56252186|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252188|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56252189|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
56252190|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56252191|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252193|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56252194|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
56252195|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56252196|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252197|NCT01872039|Nicardipine|nicardipine|mesh-list
56252198|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56252199|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56252200|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56252201|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252202|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56252224|NCT01872416|Doxorubicin|doxorubicin|mesh-list
56252225|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56252226|NCT01872416|Ifosfamide|ifosfamide|mesh-list
56252227|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56252228|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252229|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56252230|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56252231|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252232|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252233|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56252234|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
56252235|NCT01872442|Interferons|interferons|mesh-list
56252236|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
56252237|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
56252238|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56252239|NCT01872442|Dasatinib|dasatinib|mesh-list
56252240|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252241|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
56252242|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252243|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
56252244|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252245|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56252246|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874288|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
56252247|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252274|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56252275|NCT01872494|Narcotics|narcotics|mesh-ancestor
56252276|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56252277|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56252278|NCT01872546|Adalimumab|adalimumab|mesh-list
56252279|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252280|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252281|NCT01872702|Primaquine|primaquine|mesh-list
55753107|NCT03200197|Menthol|menthol|mesh-list
56252282|NCT01872702|Piperaquine|piperaquine|mesh-list
56252283|NCT01872702|Artenimol|artenimol|mesh-list
56252284|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
56252285|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56252286|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56252287|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252288|NCT01872728|Anesthetics|anesthetics|mesh-list
56252289|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790440|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252290|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252291|NCT01872754|Remifentanil|remifentanil|mesh-list
56252292|NCT01872754|Propofol|propofol|mesh-list
56252293|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56252294|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252295|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252296|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56252329|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56252330|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56252331|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252332|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56252333|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56252334|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252335|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
56252336|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56252337|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
56252338|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56252339|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
56252340|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
56252341|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56252342|NCT01872858|Protective Agents|protective agents|mesh-ancestor
56252343|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56252344|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56252345|NCT01872871|Acetaminophen|acetaminophen|mesh-list
56252346|NCT01872871|Anesthetics|anesthetics|mesh-list
56252347|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
56252348|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56252349|NCT01872871|Analgesics|analgesics|mesh-ancestor
56252350|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
56252351|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252352|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252353|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
55753138|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
56252354|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252355|NCT01872884|Remifentanil|remifentanil|mesh-list
56252356|NCT01872884|Sevoflurane|sevoflurane|mesh-list
56252357|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56252358|NCT01872884|Narcotics|narcotics|mesh-ancestor
56252359|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252360|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252361|NCT01872884|Analgesics|analgesics|mesh-ancestor
56252362|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
56252363|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252368|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
56252370|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252371|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56252372|NCT01872923|Bleomycin|bleomycin|mesh-list
56252373|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56252374|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252375|NCT01872936|Ribavirin|ribavirin|mesh-list
56252376|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
56252377|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252378|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
56252379|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252380|NCT01872962|Gemcitabine|gemcitabine|mesh-list
56252381|NCT01872962|Cisplatin|cisplatin|mesh-list
56252382|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252383|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56252384|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
56252385|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252386|NCT01872962|Antiviral Agents|antiviral agents|mesh-ancestor
56252387|NCT01872962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252388|NCT01872962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252389|NCT01872962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252390|NCT01872962|Immunologic Factors|immunologic factors|mesh-ancestor
56252391|NCT01872962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252392|NCT01872988|Tenofovir|tenofovir|mesh-list
56252393|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
56252394|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252395|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56252411|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56252412|NCT01873027|Sirolimus|sirolimus|mesh-list
56252413|NCT01873027|Umirolimus|umirolimus|mesh-list
56252414|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252415|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252416|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
56252417|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252418|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252419|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252420|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56252421|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252422|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
56252423|NCT01873079|Esomeprazole|esomeprazole|mesh-list
56252424|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56252425|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56252426|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56252427|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252428|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252429|NCT01873144|Epinephrine|epinephrine|mesh-list
56252430|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56252431|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56252432|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56252433|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
56252434|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890372|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56252435|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252436|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252437|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56252438|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56252457|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252458|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
56252459|NCT01873313|Ropivacaine|ropivacaine|mesh-list
56252460|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
56252461|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
56252462|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252463|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252464|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
56252465|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252466|NCT01873339|Midazolam|midazolam|mesh-list
56252467|NCT01873339|Darapladib|darapladib|mesh-list
56252468|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56252469|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56252470|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252471|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252472|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56252473|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56252474|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56252475|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56252476|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
56252477|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
56252478|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
56252479|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
56252480|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252481|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252482|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56252483|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252484|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56252485|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
56252486|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56252487|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
56252501|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56252502|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252503|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
56252504|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252505|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252506|NCT01873443|Hematinics|hematinics|mesh-ancestor
56252507|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
56252508|NCT01873443|Vitamins|vitamins|mesh-ancestor
56252509|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
56252510|NCT01873573|Triamcinolone|triamcinolone|mesh-list
56252511|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252512|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
56252513|NCT01873573|Hormones|hormones|mesh-ancestor
56252514|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790441|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
55790442|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
55790443|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790444|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790445|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790446|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
55790447|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
56252516|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
56252563|NCT01873833|Lapatinib|lapatinib|mesh-list
56252564|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56252565|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
56252566|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252567|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252568|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56252569|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
56252570|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252571|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790450|NCT05304559|Analgesics|analgesics|mesh-ancestor
55790451|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
56252572|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56252573|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56252574|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
56252575|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56252576|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56252577|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252578|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
56252579|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
56252580|NCT01874002|Sirolimus|sirolimus|mesh-list
56252581|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252582|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252583|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56252584|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252616|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252617|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
56252618|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252619|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
56252620|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252621|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252622|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56252623|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56252624|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252625|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252626|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252627|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
56252629|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
56252630|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252631|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
56252632|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252633|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252634|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55753437|NCT02447809|Aspirin|aspirin|mesh-list
55790452|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790453|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790454|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55790455|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55790456|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
56252636|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252637|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252638|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252639|NCT01874574|Triamcinolone|triamcinolone|mesh-list
56252640|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56252641|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56252642|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56252644|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252645|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
56252646|NCT01874574|Hormones|hormones|mesh-ancestor
56252662|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252663|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252665|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56252666|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55790458|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252667|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56252668|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
56252669|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
56252670|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
56252671|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
56252672|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252673|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252674|NCT01874730|Anesthetics|anesthetics|mesh-list
56252675|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252676|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252677|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56252678|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56252679|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56252680|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
56252681|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252682|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55790459|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56252683|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56252684|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252685|NCT01874847|Melatonin|melatonin|mesh-list
56252686|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
56252687|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252688|NCT01874847|Protective Agents|protective agents|mesh-ancestor
56252689|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252690|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252691|NCT01874964|Methadone|methadone|mesh-list
56252692|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56252704|NCT01875172|Bupropion|bupropion|mesh-list
56252705|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56252706|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
56252707|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56252708|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56252709|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56252710|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56252711|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252712|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
56252713|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252714|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252715|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56252716|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56252717|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252718|NCT01875185|Aspirin|aspirin|mesh-list
56252719|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56252720|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56252721|NCT01875185|Analgesics|analgesics|mesh-ancestor
56252722|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
56252723|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252724|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252725|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252726|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252727|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56252730|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56252731|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56252732|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252733|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
56252757|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56252758|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56252759|NCT01875653|Molgramostim|molgramostim|mesh-list
56252760|NCT01875653|Sargramostim|sargramostim|mesh-list
56252761|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
56252762|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252763|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252764|NCT01875666|Trastuzumab|trastuzumab|mesh-list
56252765|NCT01875666|Pertuzumab|pertuzumab|mesh-list
56252766|NCT01875666|Lapatinib|lapatinib|mesh-list
56252797|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
56252798|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252800|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
56252801|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252802|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252803|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56252804|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56252805|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
56252806|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252807|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56252808|NCT01876004|Methotrexate|methotrexate|mesh-list
55828098|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56252815|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252824|NCT01876108|Amoxicillin|amoxicillin|mesh-list
56252825|NCT01876108|Azithromycin|azithromycin|mesh-list
56252826|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56252827|NCT01876108|Omeprazole|omeprazole|mesh-list
56252828|NCT01876108|Bismuth|bismuth|mesh-list
56252829|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252832|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56252833|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56252835|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252836|NCT01876108|Antacids|antacids|mesh-ancestor
56252837|NCT01876121|Celecoxib|celecoxib|mesh-list
56252838|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56252839|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56252840|NCT01876121|Analgesics|analgesics|mesh-ancestor
55790460|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56252841|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
56252842|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252843|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252844|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252845|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252846|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56252847|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56252848|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252849|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252850|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
56252851|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56252852|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56252853|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
56252882|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
56252883|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252884|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252885|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56252886|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56252887|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252888|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252889|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56252890|NCT01876433|Mirabegron|mirabegron|mesh-list
56252891|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56252892|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56252893|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56252894|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
56252895|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252896|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252897|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252898|NCT01876433|Urological Agents|urological agents|mesh-ancestor
56252899|NCT01876550|Mupirocin|mupirocin|mesh-list
56252900|NCT01876550|Calcium|calcium|mesh-list
56252901|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56252902|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252903|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56252904|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252905|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56252906|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252907|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252908|NCT01876563|Vitamin D|vitamin d|mesh-list
56252909|NCT01876563|Vitamins|vitamins|mesh-ancestor
56252910|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
56252911|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252912|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56252913|NCT01876615|Diclofenac|diclofenac|mesh-list
56252914|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56252915|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56252920|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252921|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252922|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56252923|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252924|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252925|NCT01876641|Decitabine|decitabine|mesh-list
56252926|NCT01876641|Vemurafenib|vemurafenib|mesh-list
55754854|NCT02467673|Progestins|progestins|mesh-ancestor
56252939|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
56252940|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56252941|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252942|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252955|NCT01876966|Lumefantrine|lumefantrine|mesh-list
56252956|NCT01876966|Artemether|artemether|mesh-list
56252957|NCT01876966|Etravirine|etravirine|mesh-list
56252958|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56252959|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56252960|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56252961|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
56252962|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252963|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252964|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55755273|NCT04880577|Tenofovir|tenofovir|mesh-list
56252966|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
56252967|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56252968|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56252969|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56252970|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
55828256|NCT02321501|Everolimus|everolimus|mesh-list
55755327|NCT04504175|Analgesics|analgesics|mesh-ancestor
56252972|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56252973|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56252974|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56252975|NCT01877122|Ibuprofen|ibuprofen|mesh-list
56252976|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56252977|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56252978|NCT01877122|Analgesics|analgesics|mesh-ancestor
56252979|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
56252980|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252981|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252982|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56252983|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56252984|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56252985|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56252986|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252987|NCT01877226|Tapentadol|tapentadol|mesh-list
56252989|NCT01877226|Narcotics|narcotics|mesh-ancestor
56252990|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56252991|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56252992|NCT01877226|Analgesics|analgesics|mesh-ancestor
56252993|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
56252994|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56252995|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56252996|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56252997|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56252998|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56252999|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
56253000|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253001|NCT01877356|Anesthetics|anesthetics|mesh-list
56253002|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755576|NCT02462915|Cisatracurium|cisatracurium|mesh-list
56253003|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828276|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
56253006|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253008|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
56253009|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
56253010|NCT01877577|Vitamins|vitamins|mesh-list
56253011|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
56253012|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253013|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56253014|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56253015|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
56253016|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
56253017|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253018|NCT01877590|Protective Agents|protective agents|mesh-ancestor
56253019|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253020|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
56253021|NCT01877590|Vitamins|vitamins|mesh-ancestor
55790461|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253032|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
56052418|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
55790462|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253033|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253034|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253035|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253036|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
56253037|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253038|NCT01877811|Agerafenib|agerafenib|mesh-list
56253039|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56253040|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253041|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253042|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
56253043|NCT01877889|Canagliflozin|canagliflozin|mesh-list
56253044|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55755968|NCT03837899|Tremelimumab|tremelimumab|mesh-list
56253045|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253046|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56253047|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253048|NCT01877954|Fluticasone|fluticasone|mesh-list
55790463|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
55790464|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55790465|NCT02613221|Panitumumab|panitumumab|mesh-list
56253049|NCT01877954|Xhance|xhance|mesh-list
56253050|NCT01877954|Beclomethasone|beclomethasone|mesh-list
56253051|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253052|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56253053|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
56253069|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56253070|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
56253071|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253073|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56253074|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56253075|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56253076|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253077|NCT01878227|Fenofibrate|fenofibrate|mesh-list
56253078|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56253079|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
56253080|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253081|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56253082|NCT01878318|Methotrexate|methotrexate|mesh-list
56253083|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56253084|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
56253085|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56253086|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253087|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253088|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
56253089|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253090|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253091|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
56253092|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253093|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55756018|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253118|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253119|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253120|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253121|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
56253122|NCT01878422|Antidotes|antidotes|mesh-ancestor
56253123|NCT01878422|Protective Agents|protective agents|mesh-ancestor
56253124|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
56253126|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
56253127|NCT01878513|Risperidone|risperidone|mesh-list
56253128|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56253129|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
56253130|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790466|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790467|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790468|NCT05304169|Leuprolide|leuprolide|mesh-list
55722530|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
55722531|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722532|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55722533|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55722534|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722535|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722536|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55722537|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
55722538|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55722539|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722540|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55722541|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55722542|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55722543|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722544|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55722545|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
55722546|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
55722547|NCT05088057|Docetaxel|docetaxel|mesh-list
55722548|NCT05088057|Doxorubicin|doxorubicin|mesh-list
55722549|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55722550|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
55722551|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722552|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722553|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55722555|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722556|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722557|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55722558|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
55722559|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
55722560|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
55722561|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55722562|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55722563|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55722564|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722565|NCT03132025|Capecitabine|capecitabine|mesh-list
55722566|NCT03132025|Apatinib|apatinib|mesh-list
55722567|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55722568|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
55722569|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722570|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722571|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55722572|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722573|NCT00857285|Losartan|losartan|mesh-list
55722574|NCT00857285|Olmesartan|olmesartan|mesh-list
55722575|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56253131|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253132|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253133|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56253134|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56253135|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253136|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56253137|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56253138|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
56253139|NCT01878539|Anticoagulants|anticoagulants|mesh-list
56253140|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56253141|NCT01878578|Phenytoin|phenytoin|mesh-list
56253142|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
55756128|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253163|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
56253164|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253165|NCT01878695|Protective Agents|protective agents|mesh-ancestor
56253166|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253167|NCT01878695|Antidotes|antidotes|mesh-ancestor
56253168|NCT01878708|Dexamethasone|dexamethasone|mesh-list
56253169|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
56253170|NCT01878708|Asparaginase|asparaginase|mesh-list
55790469|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56253171|NCT01878708|Pegaspargase|pegaspargase|mesh-list
56253172|NCT01878708|BB 1101|bb 1101|mesh-list
56253173|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253174|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
56253175|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
56253176|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253177|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253178|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56253179|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
56253180|NCT01878708|Hormones|hormones|mesh-ancestor
56253181|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253182|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56253183|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253184|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
55756420|NCT03293927|Narcotics|narcotics|mesh-ancestor
56253186|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253187|NCT01878734|Micronutrients|micronutrients|mesh-list
56253188|NCT01878734|Trace Elements|trace elements|mesh-list
56253189|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253190|NCT01878864|Lidocaine|lidocaine|mesh-list
56253191|NCT01878864|Bupivacaine|bupivacaine|mesh-list
56253192|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
56253193|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
55756667|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
56253194|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253195|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253196|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
56253197|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253198|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56253199|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56253200|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56253201|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56253202|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253203|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
56253204|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
55756736|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
55790471|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55790472|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790473|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55790474|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790475|NCT04732195|Pilocarpine|pilocarpine|mesh-list
55790476|NCT04732195|Miotics|miotics|mesh-ancestor
55790477|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
56253205|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253206|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56253207|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56253208|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
56253209|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253210|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253211|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56253212|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
56253213|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56253214|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253215|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56253216|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56253217|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253220|NCT01879033|Insulin|insulin|mesh-list
56253224|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56253225|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253232|NCT01879293|Metformin|metformin|mesh-list
56253233|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56253234|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253235|NCT01879358|Sirolimus|sirolimus|mesh-list
56253236|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56253237|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253238|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56253239|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253240|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
56253241|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253242|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
56253243|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253244|NCT01879423|Lamotrigine|lamotrigine|mesh-list
56253245|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
56253246|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56253247|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56253248|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253249|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56253250|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253251|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56253252|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56253253|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253254|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56253255|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56253268|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253269|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
56253270|NCT01879514|Hormones|hormones|mesh-ancestor
56253271|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253272|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253273|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56253274|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253278|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56253280|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
56253281|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253282|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56253283|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828566|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
56253287|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56253288|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55757981|NCT04423731|Vitamins|vitamins|mesh-ancestor
56253308|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56253309|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253310|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
56253311|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56253312|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56253313|NCT01880112|Cefazolin|cefazolin|mesh-list
56253314|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56253315|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253316|NCT01880125|Acetaminophen|acetaminophen|mesh-list
56253317|NCT01880125|Tramadol|tramadol|mesh-list
56253318|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56253319|NCT01880125|Analgesics|analgesics|mesh-ancestor
56253320|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
56253321|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253322|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253323|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
56253324|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56253325|NCT01880125|Narcotics|narcotics|mesh-ancestor
56253326|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253327|NCT01880138|Anesthetics|anesthetics|mesh-list
56253328|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828615|NCT01576042|Amiodarone|amiodarone|mesh-list
56253329|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253330|NCT01880216|Enoxaparin|enoxaparin|mesh-list
56253331|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
56253332|NCT01880216|Bemiparin|bemiparin|mesh-list
56253333|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
56253334|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56253335|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55758570|NCT04926753|Fluorouracil|fluorouracil|mesh-list
56253336|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253338|NCT01880307|Azathioprine|azathioprine|mesh-list
56253339|NCT01880307|Infliximab|infliximab|mesh-list
56253340|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253341|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
56253342|NCT01880307|Hormones|hormones|mesh-ancestor
56253343|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253344|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253345|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56253346|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253347|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56253362|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56253365|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253366|NCT01880372|Protective Agents|protective agents|mesh-ancestor
55759055|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56253377|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253378|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
56253379|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253380|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253381|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55871476|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
56253384|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253385|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56253386|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56253387|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56253388|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56253389|NCT01880385|Growth Substances|growth substances|mesh-ancestor
56253390|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
56253391|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
56253392|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
56253393|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
56253394|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
56253395|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253396|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56253397|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56253398|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56253399|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253400|NCT01880463|Vitamin D|vitamin d|mesh-list
56253401|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
56253402|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
56253403|NCT01880463|Vitamins|vitamins|mesh-list
56253404|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
56253405|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759379|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
55759380|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
55759381|NCT04885803|Vitamins|vitamins|mesh-list
55759382|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
56253411|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56253412|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56253413|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
56253414|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253415|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790478|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759487|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
56253424|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253428|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253429|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
56253430|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253431|NCT01880775|Bupivacaine|bupivacaine|mesh-list
56253432|NCT01880775|Prilocaine|prilocaine|mesh-list
56253433|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
56253434|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
56253435|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253436|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253437|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
56253438|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253439|NCT01879241|Rasagiline|rasagiline|mesh-list
56253440|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56253441|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253442|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253443|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56253444|NCT01879241|Protective Agents|protective agents|mesh-ancestor
56253447|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56253448|NCT01880931|Narcotics|narcotics|mesh-ancestor
56253449|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253450|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760492|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253458|NCT01881074|Protective Agents|protective agents|mesh-ancestor
56253459|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253460|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56253461|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760986|NCT04836819|Lidocaine|lidocaine|mesh-list
56253462|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56253463|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55761049|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
56253465|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253466|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56253467|NCT01881100|Listerine|listerine|mesh-list
56253468|NCT01881100|Fluorides|fluorides|mesh-list
56253470|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
56253471|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
56253472|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
56253473|NCT01881100|Protective Agents|protective agents|mesh-ancestor
56253474|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253475|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56253476|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253484|NCT01881464|Adalimumab|adalimumab|mesh-list
56253485|NCT01881464|Infliximab|infliximab|mesh-list
56253486|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253487|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253488|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
56253489|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56253490|NCT01881503|HBOC 201|hboc 201|mesh-list
56253495|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253496|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
56253500|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253501|NCT01881919|Protective Agents|protective agents|mesh-ancestor
56253502|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253504|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56253505|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253506|NCT01881997|Fentanyl|fentanyl|mesh-list
56253507|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56253508|NCT01881997|Narcotics|narcotics|mesh-ancestor
56253509|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253510|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253511|NCT01881997|Analgesics|analgesics|mesh-ancestor
56253512|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
56253513|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253516|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
56253517|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
56253518|NCT01882010|Sargramostim|sargramostim|mesh-list
56253522|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
56253523|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
56253524|NCT01882127|Dexamethasone|dexamethasone|mesh-list
56253525|NCT01882127|Tretinoin|tretinoin|mesh-list
56253526|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253527|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
56253528|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
56253529|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253530|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253531|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56253532|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
56253533|NCT01882127|Hormones|hormones|mesh-ancestor
55790479|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790480|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55790481|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56253534|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253535|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56253536|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253537|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
56253538|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
56253539|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
56253540|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56253541|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
56253542|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
56253543|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56253544|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253545|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56253546|NCT01882179|Diuretics|diuretics|mesh-ancestor
56253547|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
56253548|NCT01882179|Hormones|hormones|mesh-ancestor
56253552|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56253554|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253555|NCT01882322|Tacrolimus|tacrolimus|mesh-list
55761825|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
56253560|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253563|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56253564|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56253565|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253566|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
56253567|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253568|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56253569|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56253570|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
56253571|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
56253572|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55828843|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56253581|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253582|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56253583|NCT01882530|Acetaminophen|acetaminophen|mesh-list
56253585|NCT01882530|Morphine|morphine|mesh-list
56253586|NCT01882530|Nefopam|nefopam|mesh-list
56253587|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56253588|NCT01882530|Narcotics|narcotics|mesh-ancestor
56253589|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762315|NCT04789941|Irinotecan|irinotecan|mesh-list
55762380|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56253594|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56253595|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
56253596|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56253597|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56253598|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253599|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56253600|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253601|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253602|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
56253603|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56253604|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55762717|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
56253606|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56253607|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253608|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
56253609|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253610|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253612|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253643|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56253644|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56253645|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56253646|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253647|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56253648|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56253649|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
56253650|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253651|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56253652|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56253653|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
56253654|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56253663|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253664|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
56253665|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253666|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253667|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56253668|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
56253669|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253696|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
55828961|NCT02217332|Pramipexole|pramipexole|mesh-list
55765014|NCT02428751|Prednisone|prednisone|mesh-list
56253699|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56253700|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253701|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
56253702|NCT01883869|Ticagrelor|ticagrelor|mesh-list
56253703|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56253704|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56253705|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56253706|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56253707|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
56253708|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56253709|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253710|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253711|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
56253712|NCT01883882|Narcotics|narcotics|mesh-ancestor
56253713|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56253714|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253715|NCT01883882|Analgesics|analgesics|mesh-ancestor
56253716|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
55790482|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
56253717|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253718|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
55765533|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
56253852|NCT01884558|Isavuconazole|isavuconazole|mesh-list
56253853|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56253854|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253855|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
56253856|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253857|NCT01884623|Methotrexate|methotrexate|mesh-list
56253858|NCT01884623|Cetuximab|cetuximab|mesh-list
56253859|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56253860|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
56253861|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56253862|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253863|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253864|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
56253865|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253866|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253867|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
56253868|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253869|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56253870|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253871|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
56253872|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253873|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56253874|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56253875|NCT01884636|Isavuconazole|isavuconazole|mesh-list
56253876|NCT01884636|Methotrexate|methotrexate|mesh-list
56253877|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56253878|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
56253879|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55829123|NCT04418180|Fenofibrate|fenofibrate|mesh-list
56253880|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253881|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56253882|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
56253883|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56253884|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56253885|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
56253886|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56253887|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56253888|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56253889|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
56253890|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56253891|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56253892|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
56253893|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56253895|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56253896|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56253897|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
56253898|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
56253899|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56253900|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56253901|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56254017|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254047|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254048|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254050|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56254051|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
56254052|NCT01886001|Povidone|povidone|mesh-list
56254053|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56254054|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254055|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
56254056|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
56254057|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
56254058|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
56254059|NCT01886014|Oxytocin|oxytocin|mesh-list
56254060|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
56254061|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56254062|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254063|NCT01886053|Ertapenem|ertapenem|mesh-list
56254064|NCT01886053|beta-Lactams|beta-lactams|mesh-list
56254065|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56254066|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254067|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
56254068|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56254069|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254070|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254071|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56254072|NCT01886079|Analgesics|analgesics|mesh-ancestor
56254073|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
56254074|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722653|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
55722654|NCT00850577|Paclitaxel|paclitaxel|mesh-list
55722655|NCT00850577|Bevacizumab|bevacizumab|mesh-list
55722656|NCT00850577|Carboplatin|carboplatin|mesh-list
55722657|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55722658|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55722659|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722660|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
55722661|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
55722662|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
55722663|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828571|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55722664|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55722665|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55722666|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55722667|NCT00850577|Growth Substances|growth substances|mesh-ancestor
55722668|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722670|NCT00838981|Methadone|methadone|mesh-list
55722671|NCT00838981|Modafinil|modafinil|mesh-list
55722672|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55722673|NCT00838981|Narcotics|narcotics|mesh-ancestor
55722674|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722675|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722676|NCT00838981|Analgesics|analgesics|mesh-ancestor
55722677|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
55722678|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722679|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
55722680|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
55722681|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55722682|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55722683|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55722684|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55722685|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722687|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
55722688|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55722689|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55722690|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722691|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254075|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56254076|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56254077|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56254078|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
56254079|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254080|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254082|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56254083|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56254084|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56254085|NCT01886196|Analgesics|analgesics|mesh-ancestor
56254086|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
56254087|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254088|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254089|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56254090|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56254091|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254092|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254093|NCT01886209|Prednisone|prednisone|mesh-list
56254094|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
56254095|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56254142|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56254143|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56254144|NCT01886443|Tocopherols|tocopherols|mesh-list
56254145|NCT01886443|Vitamin E|vitamin e|mesh-list
56254146|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
56254147|NCT01886443|Infliximab|infliximab|mesh-list
56254148|NCT01886443|Epoprostenol|epoprostenol|mesh-list
56254149|NCT01886443|Tezosentan|tezosentan|mesh-list
56254150|NCT01886443|Melatonin|melatonin|mesh-list
56254151|NCT01886443|Antithrombins|antithrombins|mesh-list
56254152|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
56254153|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
56254154|NCT01886443|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56254155|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
56254156|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829405|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
56254188|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56254189|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
55790483|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254190|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254191|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254192|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254193|NCT01886599|Asunaprevir|asunaprevir|mesh-list
56254194|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
55829445|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
56254195|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254196|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254198|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56254199|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56254200|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254201|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254202|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
56254203|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829464|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254253|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56254255|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
56254256|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254257|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254258|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254259|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56254260|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56254261|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55829516|NCT01512160|Ibuprofen|ibuprofen|mesh-list
56254262|NCT01887249|Metronidazole|metronidazole|mesh-list
56254263|NCT01887249|Clarithromycin|clarithromycin|mesh-list
56254264|NCT01887249|Esomeprazole|esomeprazole|mesh-list
56254265|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254266|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56254267|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56254268|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56254269|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56254270|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56254271|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56254272|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254273|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254274|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56254275|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55838336|NCT01410448|Everolimus|everolimus|mesh-list
56254309|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56254310|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
56254311|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
56254312|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
56254313|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56254314|NCT01887457|Voriconazole|voriconazole|mesh-list
56254315|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
56254316|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254317|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56254318|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56254319|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254320|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254321|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56254322|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
56254323|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56254324|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254325|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56254326|NCT01887561|Dasatinib|dasatinib|mesh-list
56254327|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254328|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56254331|NCT01887613|Gabapentin|gabapentin|mesh-list
56254332|NCT01887613|Analgesics|analgesics|mesh-ancestor
56254333|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
56254334|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254335|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254336|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
56254337|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56254338|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56254339|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56254340|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254359|NCT01887704|Aspirin|aspirin|mesh-list
56254360|NCT01887704|Sirolimus|sirolimus|mesh-list
56254361|NCT01887704|Paclitaxel|paclitaxel|mesh-list
56254362|NCT01887704|Everolimus|everolimus|mesh-list
56254363|NCT01887704|Clopidogrel|clopidogrel|mesh-list
56254364|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56254365|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56254366|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
56254367|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
56254369|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254370|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56254371|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56254372|NCT01887704|Analgesics|analgesics|mesh-ancestor
56254373|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
56254374|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254375|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254376|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56254377|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56254378|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56254379|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56254380|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56254502|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254503|NCT01888302|Antiviral Agents|antiviral agents|mesh-ancestor
56254504|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254505|NCT01888302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254506|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56254507|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
56254508|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254555|NCT01888575|Analgesics|analgesics|mesh-ancestor
56254556|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
56254557|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254558|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254559|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56254560|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56254561|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56254562|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55829813|NCT01897233|Ivacaftor|ivacaftor|mesh-list
55790484|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790485|NCT04858841|Levetiracetam|levetiracetam|mesh-list
56254563|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254564|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56254565|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56254566|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254567|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
56254568|NCT01888718|Fexofenadine|fexofenadine|mesh-list
56254569|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56254570|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56254571|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56254572|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
56254573|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
56254574|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254575|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254576|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254621|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
56254622|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254623|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254624|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
56254625|NCT01888822|Ampicillin|ampicillin|mesh-list
56254626|NCT01888822|Sulbactam|sulbactam|mesh-list
56254627|NCT01888822|Sultamicillin|sultamicillin|mesh-list
56254628|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55829862|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254629|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254630|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56254631|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56254697|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254698|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56254699|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
56254701|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56254702|NCT01889004|Analgesics|analgesics|mesh-ancestor
56254703|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
56254704|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254705|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56254706|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56254707|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56254708|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
56254709|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254710|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254711|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
56254712|NCT01889056|Hematinics|hematinics|mesh-ancestor
55863828|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56254731|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56254732|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254733|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254734|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
56254735|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56254850|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254851|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56254852|NCT01890538|Protective Agents|protective agents|mesh-ancestor
56254853|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
56254854|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
56254856|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56254857|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
56254858|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254859|NCT01891292|Expectorants|expectorants|mesh-ancestor
56254860|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
56254861|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56254862|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
56254863|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254864|NCT01891292|Protective Agents|protective agents|mesh-ancestor
56254865|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254866|NCT01891292|Antidotes|antidotes|mesh-ancestor
56254867|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56254905|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56254906|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
56254907|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56254908|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56254909|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56254910|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56254911|NCT01894269|Lamivudine|lamivudine|mesh-list
56254912|NCT01894269|Entecavir|entecavir|mesh-list
56254913|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56254914|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56254915|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56254916|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254917|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
56254918|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56254919|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56254920|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56254921|NCT01894789|Clopidogrel|clopidogrel|mesh-list
56254922|NCT01894789|Ticagrelor|ticagrelor|mesh-list
56254923|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56254924|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56254925|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56254926|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56254927|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
56254928|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56254929|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254930|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254931|NCT01894815|Dexetimide|dexetimide|mesh-list
56254932|NCT01894815|Citalopram|citalopram|mesh-list
56254933|NCT01894815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56254934|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56254935|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56254936|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56254937|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830165|NCT02129192|Amlodipine|amlodipine|mesh-list
56254938|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
56254939|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56254940|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56254941|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
56254942|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56254943|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56254944|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56254945|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
56254946|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
56254947|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56254948|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56254949|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56254950|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
56254951|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
56254952|NCT01895049|Prednisone|prednisone|mesh-list
56254953|NCT01895049|Everolimus|everolimus|mesh-list
56255007|NCT01897740|Urological Agents|urological agents|mesh-ancestor
56255008|NCT01897753|Hormones|hormones|mesh-list
56255009|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56255010|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255011|NCT01898065|Misonidazole|misonidazole|mesh-list
56255012|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255013|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56255014|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56255015|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255016|NCT01898221|Ethanol|ethanol|mesh-list
56255017|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56255018|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255019|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255020|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255021|NCT01898338|Daptomycin|daptomycin|mesh-list
56255022|NCT01898338|Fosfomycin|fosfomycin|mesh-list
56255032|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56255034|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255035|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
56255036|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255037|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55830259|NCT02144012|Docetaxel|docetaxel|mesh-list
56255038|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56255039|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56255040|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56255041|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56255042|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56255043|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56255044|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56255045|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56255046|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56255047|NCT01900028|Itraconazole|itraconazole|mesh-list
56255048|NCT01900028|Olaparib|olaparib|mesh-list
56255049|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56255050|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255051|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255052|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255053|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
56255054|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255055|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56255056|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56255057|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56255058|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
56255059|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56255060|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255061|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56255062|NCT01900041|Minoxidil|minoxidil|mesh-list
56255063|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56255064|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
56255065|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56255066|NCT01900093|Hormones|hormones|mesh-ancestor
56255118|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56255119|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
56255120|NCT01900327|Gemcitabine|gemcitabine|mesh-list
56255121|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56255122|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
56255123|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255124|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255125|NCT01900327|Antiviral Agents|antiviral agents|mesh-ancestor
56255126|NCT01900327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255127|NCT01900327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255128|NCT01900327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255129|NCT01900327|Immunologic Factors|immunologic factors|mesh-ancestor
56255130|NCT01900327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255131|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
56255132|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56255133|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255134|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255135|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55830370|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830373|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56255150|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255152|NCT01900509|Dexamethasone|dexamethasone|mesh-list
56255153|NCT01900509|Etoposide|etoposide|mesh-list
56255154|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
56255155|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56255156|NCT01900509|Clofarabine|clofarabine|mesh-list
56255157|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56255158|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
56255159|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
56255160|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255161|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255162|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56255163|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
56255164|NCT01900509|Hormones|hormones|mesh-ancestor
56255165|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56255166|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56255167|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255168|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56255169|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56255175|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56255176|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
56255177|NCT01900587|Tapentadol|tapentadol|mesh-list
56255178|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56255179|NCT01900587|Narcotics|narcotics|mesh-ancestor
56255180|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255181|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255182|NCT01900587|Analgesics|analgesics|mesh-ancestor
56255183|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
56255184|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255185|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56255186|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56255187|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56255188|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255189|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255190|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255191|NCT01900639|Aspirin|aspirin|mesh-list
56255192|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56255193|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56255194|NCT01900639|Analgesics|analgesics|mesh-ancestor
56255195|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
56255204|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56255205|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255206|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
56255207|NCT01900717|Leucovorin|leucovorin|mesh-list
56255208|NCT01900717|Bevacizumab|bevacizumab|mesh-list
56255209|NCT01900717|Fluorouracil|fluorouracil|mesh-list
56255210|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
56255211|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56255212|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255334|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255335|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
56255336|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255337|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
56255338|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255339|NCT01901276|Omeprazole|omeprazole|mesh-list
56255340|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56255341|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56255342|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56255343|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255344|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255345|NCT01901380|Caseins|caseins|mesh-list
56255346|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
56255347|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
56255348|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255349|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
56255350|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56255351|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255376|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255377|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56255378|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56255379|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56255380|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255381|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255382|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255383|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56255384|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
56255385|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255386|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56255387|NCT01901549|Protective Agents|protective agents|mesh-ancestor
56255388|NCT01901601|Anesthetics|anesthetics|mesh-list
56255389|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255390|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255391|NCT01901640|Udenafil|udenafil|mesh-list
56255392|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56255393|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56255394|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255395|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255396|NCT01901666|Hormones|hormones|mesh-list
56255397|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56255398|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255399|NCT01901692|Sorafenib|sorafenib|mesh-list
56255400|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255401|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56255402|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255403|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255404|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56255405|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56255406|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255407|NCT01901861|Incretins|incretins|mesh-ancestor
56255409|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56255410|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55877441|NCT01253980|Amoxicillin|amoxicillin|mesh-list
56255411|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
56255412|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255413|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255415|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
56255416|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
56255417|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56255418|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
56255419|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
56255420|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255421|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255422|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255423|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56255424|NCT01902108|Clonidine|clonidine|mesh-list
56255425|NCT01902108|Bupivacaine|bupivacaine|mesh-list
56255426|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
56255427|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
56255428|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255429|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255430|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
56255431|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255432|NCT01902108|Analgesics|analgesics|mesh-ancestor
56255433|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56255434|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
56255435|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
56255436|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56255464|NCT01902186|Emtricitabine|emtricitabine|mesh-list
56255465|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
56255466|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56255467|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56255468|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
56255469|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830694|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255470|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255471|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56255472|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56255473|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
56255474|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255477|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56255478|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56255480|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56255481|NCT01902225|Doxorubicin|doxorubicin|mesh-list
56255482|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56255483|NCT01902225|Romidepsin|romidepsin|mesh-list
56255484|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56255485|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255486|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55877559|NCT03427086|Biotin|biotin|mesh-list
56255487|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56255488|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255489|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255490|NCT01902238|Ethanol|ethanol|mesh-list
56255491|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
56255492|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56255493|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255494|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255495|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255496|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255497|NCT01902342|Oseltamivir|oseltamivir|mesh-list
55830732|NCT01896531|Leucovorin|leucovorin|mesh-list
56255498|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
56255499|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255500|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255501|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255502|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
56255503|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56255504|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56255505|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255506|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
56255507|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
56255508|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
56255509|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56255510|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255511|NCT01902498|Aspirin|aspirin|mesh-list
56255512|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56255513|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56255514|NCT01902498|Analgesics|analgesics|mesh-ancestor
56255515|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
56255516|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790486|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
55790487|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
55790488|NCT04858529|Carboplatin|carboplatin|mesh-list
56255517|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255518|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56255519|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56255520|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56255521|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56255522|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255523|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56255524|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56255525|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255526|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
56255527|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
56255528|NCT01902511|Lenograstim|lenograstim|mesh-list
56255529|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56255530|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
56255531|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255548|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
56255549|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56255550|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
56255551|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255552|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255553|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255554|NCT01902550|Metoprolol|metoprolol|mesh-list
56255555|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56255556|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56255557|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
56255558|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
56255559|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255560|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255561|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56255562|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56255563|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56255564|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255565|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255566|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255567|NCT01902641|Rocuronium|rocuronium|mesh-list
56255568|NCT01902641|Succinylcholine|succinylcholine|mesh-list
56255569|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56255571|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56255572|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255573|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255574|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56255575|NCT01902771|Imiquimod|imiquimod|mesh-list
56255576|NCT01902771|Vaccines|vaccines|mesh-list
56255577|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
56255578|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255579|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56255580|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255581|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
56255582|NCT01902810|Propranolol|propranolol|mesh-list
56255583|NCT01902810|Metoprolol|metoprolol|mesh-list
56255584|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56255603|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56255604|NCT01902875|Paclitaxel|paclitaxel|mesh-list
56255605|NCT01902875|Cisplatin|cisplatin|mesh-list
56255606|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56255607|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255608|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
56255609|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
56255610|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
56255611|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255612|NCT01903018|Cisplatin|cisplatin|mesh-list
56255613|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255614|NCT01903057|Azithromycin|azithromycin|mesh-list
56255615|NCT01903057|Ivermectin|ivermectin|mesh-list
56255616|NCT01903057|Albendazole|albendazole|mesh-list
56255633|NCT01903070|Hormones|hormones|mesh-ancestor
56255634|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56255635|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56255636|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
56255637|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255638|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255639|NCT01903083|Gemcitabine|gemcitabine|mesh-list
56255640|NCT01903083|Tadalafil|tadalafil|mesh-list
56255641|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56255642|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
56255643|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255644|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255665|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830896|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
56255679|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56255680|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55790490|NCT04858529|Trastuzumab|trastuzumab|mesh-list
56255681|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56255682|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255683|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255684|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56255685|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
56255686|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255687|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56255688|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
56255689|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255690|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
56255691|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255692|NCT01903681|Melatonin|melatonin|mesh-list
56255693|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
56255694|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255695|NCT01903681|Protective Agents|protective agents|mesh-ancestor
55749129|NCT03255811|Apatinib|apatinib|mesh-list
56255696|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255697|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255698|NCT01903694|Sorafenib|sorafenib|mesh-list
56255699|NCT01903694|Pravastatin|pravastatin|mesh-list
56255700|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255701|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56255702|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255703|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255704|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56255705|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56255706|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
56255707|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56255708|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56255709|NCT01903785|Albuterol|albuterol|mesh-list
56255710|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56255711|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
56255736|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56255737|NCT01904045|Tacrolimus|tacrolimus|mesh-list
56255738|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255739|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
56255740|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255741|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56255742|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255743|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255744|NCT01904097|Pregabalin|pregabalin|mesh-list
56255745|NCT01904097|Analgesics|analgesics|mesh-ancestor
56255746|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
56255747|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255748|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255749|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
56255750|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56255751|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56255778|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255779|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863888|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56255793|NCT01904357|Cefazolin|cefazolin|mesh-list
56255794|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56255795|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255796|NCT01904487|Tiagabine|tiagabine|mesh-list
56255797|NCT01904487|Flumazenil|flumazenil|mesh-list
56255798|NCT01904487|Antidotes|antidotes|mesh-ancestor
56255799|NCT01904487|Protective Agents|protective agents|mesh-ancestor
56255800|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255801|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
56255802|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
56255803|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255804|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255805|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
56255806|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
56255807|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56255808|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56255809|NCT01904500|Cefazolin|cefazolin|mesh-list
56255828|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
56255829|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56255830|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255831|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56255832|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56255833|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255834|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255835|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56255836|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
56255837|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
56255838|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255839|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255840|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
56255841|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255842|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56255843|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56255844|NCT01904643|Growth Substances|growth substances|mesh-ancestor
56255845|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
56255846|NCT01904643|Analgesics|analgesics|mesh-ancestor
56255847|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
56255848|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255849|NCT01904682|ON 01910|on 01910|mesh-list
56255850|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255851|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56255852|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255854|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
55831124|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
56255875|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56255877|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255878|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56255879|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255880|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255881|NCT01904786|Melatonin|melatonin|mesh-list
56255882|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
56255883|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255884|NCT01904786|Protective Agents|protective agents|mesh-ancestor
56255885|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255886|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56255887|NCT01904981|Atenolol|atenolol|mesh-list
56255888|NCT01904981|Valsartan|valsartan|mesh-list
56255889|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56255890|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56255891|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56255892|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56255893|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255894|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56255895|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
56255896|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255897|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255898|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56255899|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
56255900|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
56255901|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255902|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56255903|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56255904|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
56255905|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255906|NCT01905059|Lamivudine|lamivudine|mesh-list
56255907|NCT01905059|Lopinavir|lopinavir|mesh-list
56255908|NCT01905059|Darunavir|darunavir|mesh-list
56255909|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56255910|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
56255911|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56255912|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56255913|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255914|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255915|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
56255916|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255917|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56255918|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56255919|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56255920|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56255921|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56255922|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
56255923|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56255924|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56255925|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56255926|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56255927|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255928|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
56255929|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56255930|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790492|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790493|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
56255931|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56255932|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56255933|NCT01905150|Leucovorin|leucovorin|mesh-list
56255934|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
56255935|NCT01905150|Gemcitabine|gemcitabine|mesh-list
56255936|NCT01905150|Fluorouracil|fluorouracil|mesh-list
56255937|NCT01905150|Docetaxel|docetaxel|mesh-list
55877966|NCT01297348|Hormones|hormones|mesh-ancestor
56255938|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
56255939|NCT01905150|Irinotecan|irinotecan|mesh-list
56255940|NCT01905150|Mitomycins|mitomycins|mesh-list
56255941|NCT01905150|Mitomycin|mitomycin|mesh-list
56255942|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
56255943|NCT01905150|Vitamins|vitamins|mesh-ancestor
56255944|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
56255945|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56255946|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56255947|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
56255948|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56255949|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56255950|NCT01905150|Antiviral Agents|antiviral agents|mesh-ancestor
56255951|NCT01905150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56255952|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56255953|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56255954|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
56255955|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
56256014|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56256015|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
56256016|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256017|NCT01905696|Protective Agents|protective agents|mesh-ancestor
56256018|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256019|NCT01905696|Antidotes|antidotes|mesh-ancestor
56256020|NCT01905774|Deferasirox|deferasirox|mesh-list
56256021|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56256022|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
56256023|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
56256024|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256025|NCT01905904|Sevoflurane|sevoflurane|mesh-list
56256026|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56256027|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56256028|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
56256029|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
56256030|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256031|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256032|NCT01906073|Fentanyl|fentanyl|mesh-list
56256033|NCT01906073|Morphine|morphine|mesh-list
56256034|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56256035|NCT01906073|Narcotics|narcotics|mesh-ancestor
56256036|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256037|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256038|NCT01906073|Analgesics|analgesics|mesh-ancestor
56256039|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
56256078|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256080|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56256081|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56256082|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56256083|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256084|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256085|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56256086|NCT01906580|Entecavir|entecavir|mesh-list
56256087|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
56256088|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256089|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
56256090|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
56256091|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256092|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56256093|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256094|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256096|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256097|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56256098|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256099|NCT01906749|Colchicine|colchicine|mesh-list
56256100|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
56256101|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256102|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
56256103|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
56256104|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
56256105|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256106|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256107|NCT01906762|Acetaminophen|acetaminophen|mesh-list
56256108|NCT01906762|Morphine|morphine|mesh-list
56256109|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56256110|NCT01906762|Narcotics|narcotics|mesh-ancestor
56256111|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256120|NCT01906788|Primaquine|primaquine|mesh-list
56256121|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56256122|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
56256123|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56256124|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56256125|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256126|NCT01906801|Diacetylrhein|diacetylrhein|mesh-list
56256127|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256128|NCT01906814|Carboplatin|carboplatin|mesh-list
56256129|NCT01906814|Etoposide|etoposide|mesh-list
56256130|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
56256131|NCT01906814|Vincristine|vincristine|mesh-list
56256132|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256133|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56256134|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56256135|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56256136|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256137|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256138|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
56256139|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
56256140|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
56256141|NCT01906879|Bismuth|bismuth|mesh-list
56256142|NCT01906879|Antacids|antacids|mesh-ancestor
56256143|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256144|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256145|NCT01906944|Triamcinolone|triamcinolone|mesh-list
56256146|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56256147|NCT01906944|Bupivacaine|bupivacaine|mesh-list
56256148|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
56256149|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
55831369|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56256150|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256151|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256152|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
56256153|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256154|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256156|NCT01906944|Hormones|hormones|mesh-ancestor
56256157|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256158|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256159|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
56256160|NCT01907009|Melphalan|melphalan|mesh-list
56256161|NCT01907009|Lenograstim|lenograstim|mesh-list
56256162|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56256163|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
56256164|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256165|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256166|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56256167|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256168|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
56256169|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256170|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55831398|NCT02199509|Levetiracetam|levetiracetam|mesh-list
56256239|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256240|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56256241|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56256273|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56256274|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56256301|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256302|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256303|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256304|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56256305|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
56256306|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256307|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256309|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256310|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
56256311|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
56256312|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
56256313|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256314|NCT01907724|Simeprevir|simeprevir|mesh-list
56256315|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
55831548|NCT02222207|Ranibizumab|ranibizumab|mesh-list
56256385|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
56256387|NCT01908075|Hormones|hormones|mesh-ancestor
56256388|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256389|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
56256390|NCT01908114|Vaccines|vaccines|mesh-list
56256391|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
56256392|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256393|NCT01908257|Lesinurad|lesinurad|mesh-list
56256394|NCT01908257|Ranitidine|ranitidine|mesh-list
55790495|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790496|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256395|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56256396|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56256405|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256406|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
56256418|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256419|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56256420|NCT01908296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56256421|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56256422|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56256423|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256424|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256425|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
56256426|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56256427|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56256428|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56256429|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256430|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56256431|NCT01908322|Sorafenib|sorafenib|mesh-list
56256432|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256433|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56256434|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256435|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256436|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56256437|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
56256438|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
56256439|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256440|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
56256441|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256442|NCT01908348|Erythritol|erythritol|mesh-list
56256443|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
56256444|NCT01908387|Azacitidine|azacitidine|mesh-list
56256445|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56256446|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
56256447|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256448|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256449|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256450|NCT01908452|Pyridoxine|pyridoxine|mesh-list
56256451|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
56256452|NCT01908452|Vitamins|vitamins|mesh-ancestor
56256453|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
56256454|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256455|NCT01908478|Gemcitabine|gemcitabine|mesh-list
56256456|NCT01908478|Veliparib|veliparib|mesh-list
56256457|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56256458|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
56256459|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256460|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256461|NCT01908478|Antiviral Agents|antiviral agents|mesh-ancestor
56256462|NCT01908478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256463|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256464|NCT01908478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256495|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256496|NCT01909037|Curcumin|curcumin|mesh-list
56256497|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55831723|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256502|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256503|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256504|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256505|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256506|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256507|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256508|NCT01909063|Vitamin D|vitamin d|mesh-list
56256509|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
56256510|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
56256511|NCT01909063|Vitamins|vitamins|mesh-list
56256512|NCT01909063|Vitamin E|vitamin e|mesh-list
56256513|NCT01909063|Vitamin A|vitamin a|mesh-list
56256514|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
56256515|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256516|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56256517|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56256518|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
56256519|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256520|NCT01909063|Protective Agents|protective agents|mesh-ancestor
56256530|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
56256531|NCT01909219|Cathartics|cathartics|mesh-ancestor
56256532|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256533|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
56256534|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
56256535|NCT01909557|Vitamins|vitamins|mesh-ancestor
56256536|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
56256537|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256538|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
56256539|NCT01909622|Vitamin D|vitamin d|mesh-list
56256540|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
56256541|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
56256542|NCT01909622|Vitamins|vitamins|mesh-list
56256548|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
56256549|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
56256550|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256551|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
56256552|NCT01909752|Imiquimod|imiquimod|mesh-list
56256553|NCT01909752|Vaccines|vaccines|mesh-list
56256554|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
56256555|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256556|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56256557|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256558|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56256559|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
56256560|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256561|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256562|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56256563|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56256564|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
56256565|NCT01909830|Gemcitabine|gemcitabine|mesh-list
56256566|NCT01909830|Pemetrexed|pemetrexed|mesh-list
56256567|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56256568|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
56256569|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256570|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256571|NCT01909830|Antiviral Agents|antiviral agents|mesh-ancestor
56256572|NCT01909830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256588|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256589|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256597|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56256598|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
56256599|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256600|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256612|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56256613|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
56256614|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
56256615|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256625|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56256627|NCT01910142|Vitamin K|vitamin k|mesh-list
56256628|NCT01910142|Calcium|calcium|mesh-list
56256629|NCT01910142|Vitamins|vitamins|mesh-ancestor
55831852|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
55831854|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56256638|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
56256639|NCT01910155|Dexamethasone|dexamethasone|mesh-list
56256640|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256641|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
56256642|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
56256643|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256644|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256645|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256646|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
56256647|NCT01910155|Hormones|hormones|mesh-ancestor
56256648|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256671|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256672|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256673|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
56256674|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256675|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56256676|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
56256677|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56256678|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56256679|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56256680|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256681|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
56256682|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56256683|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56256684|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56256685|NCT01910259|Protective Agents|protective agents|mesh-ancestor
56256686|NCT01910259|Diuretics|diuretics|mesh-ancestor
56256687|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
56256688|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56256691|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56256693|NCT01910285|Dsuvia|dsuvia|mesh-list
56256694|NCT01910285|Remifentanil|remifentanil|mesh-list
56256695|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56256696|NCT01910285|Narcotics|narcotics|mesh-ancestor
56256697|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256698|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256699|NCT01910285|Analgesics|analgesics|mesh-ancestor
55831919|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
55869891|NCT04355026|Bromhexine|bromhexine|mesh-list
56256709|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56256710|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831928|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55831930|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
56256714|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256715|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56256716|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256717|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
56256718|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56256720|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56256721|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256722|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56256723|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56256724|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790497|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56256725|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256737|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256738|NCT01910480|Ketoconazole|ketoconazole|mesh-list
56256742|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56256743|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256744|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256745|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56256746|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
56256747|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256748|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256749|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56256750|NCT01910506|Verinurad|verinurad|mesh-list
56256751|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
56256752|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56256753|NCT01910532|Clevidipine|clevidipine|mesh-list
56256754|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56256755|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56256756|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256757|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56256758|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256760|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56256761|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256762|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256763|NCT01910610|Bevacizumab|bevacizumab|mesh-list
56256764|NCT01910610|Cetuximab|cetuximab|mesh-list
56256765|NCT01910610|Panitumumab|panitumumab|mesh-list
56256766|NCT01910610|Irinotecan|irinotecan|mesh-list
56256767|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56256768|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256769|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56256770|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56256771|NCT01910610|Growth Substances|growth substances|mesh-ancestor
56256772|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256773|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
56256774|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56256775|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56256776|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256777|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256779|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
56256780|NCT01910766|Clomiphene|clomiphene|mesh-list
56256781|NCT01910766|Enclomiphene|enclomiphene|mesh-list
56256782|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
56256783|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56256784|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
56256785|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256786|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256787|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56256816|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56256817|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56256818|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56256819|NCT01910883|Renal Agents|renal agents|mesh-ancestor
56256820|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56256821|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56256822|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56256823|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256824|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256825|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256826|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56256827|NCT01910987|Dexamethasone|dexamethasone|mesh-list
56256828|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
56256829|NCT01910987|Bortezomib|bortezomib|mesh-list
56256830|NCT01910987|BB 1101|bb 1101|mesh-list
56256831|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56256832|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
56256833|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
56256834|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256835|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256836|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256837|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
56256838|NCT01910987|Hormones|hormones|mesh-ancestor
56256839|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56256840|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56256841|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256842|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
56256843|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790498|NCT05302999|Gabapentin|gabapentin|mesh-list
55790499|NCT05302999|Analgesics|analgesics|mesh-ancestor
55870672|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
56256844|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256863|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256864|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256865|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56256866|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
56256867|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56256868|NCT01911299|Protective Agents|protective agents|mesh-ancestor
56256869|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256870|NCT01911325|Docetaxel|docetaxel|mesh-list
56256871|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256872|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
56256873|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
56256874|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790500|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
55790501|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722838|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
55722839|NCT00835991|Metformin|metformin|mesh-list
55722840|NCT00835991|Glyburide|glyburide|mesh-list
55722841|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722842|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722843|NCT05200052|Colchicine|colchicine|mesh-list
55722844|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
55722845|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722846|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
55722847|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
55722848|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
55722849|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722850|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722852|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55722853|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722854|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55722855|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
55722856|NCT02276872|Treprostinil|treprostinil|mesh-list
55722857|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55722859|NCT00835367|Benazepril|benazepril|mesh-list
55722860|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55722861|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55722862|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722863|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722864|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55722865|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722866|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
55722867|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55722868|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
55722869|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722870|NCT02276560|Gemcitabine|gemcitabine|mesh-list
55722871|NCT02276560|Paclitaxel|paclitaxel|mesh-list
55722872|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55722873|NCT02276560|Cisplatin|cisplatin|mesh-list
55722874|NCT02276560|Pemetrexed|pemetrexed|mesh-list
55722875|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55722876|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722877|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
55722878|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
55722879|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
55722880|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722881|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55722882|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
55722883|NCT02276560|Antiviral Agents|antiviral agents|mesh-ancestor
55722884|NCT02276560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766329|NCT02414945|Analgesics|analgesics|mesh-ancestor
55722885|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722886|NCT02276560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55722887|NCT02276560|Immunologic Factors|immunologic factors|mesh-ancestor
55722888|NCT02276560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722889|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55722890|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55722891|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55722892|NCT02276482|Metronidazole|metronidazole|mesh-list
55722893|NCT02276482|Vancomycin|vancomycin|mesh-list
55722894|NCT02276482|Clindamycin|clindamycin|mesh-list
56256875|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256876|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
56256877|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56256878|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
56256879|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256880|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256881|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56256882|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
56256883|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
56256884|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56256885|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
56256886|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256887|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256888|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
56256901|NCT01911468|Metformin|metformin|mesh-list
56256910|NCT01911494|Methyldopa|methyldopa|mesh-list
56256911|NCT01911494|Analgesics|analgesics|mesh-ancestor
56256912|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
56256913|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256914|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256915|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
56256916|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256917|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56256918|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
56256919|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56256920|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56256921|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256922|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56256923|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
56256924|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56256925|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56256926|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
56256927|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
56256928|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56256929|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56256930|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56256931|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
56256932|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256933|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56256934|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56256935|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56256959|NCT01911624|Coagulants|coagulants|mesh-ancestor
56256960|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56256961|NCT01911728|Pioglitazone|pioglitazone|mesh-list
56256962|NCT01911728|Midazolam|midazolam|mesh-list
56256963|NCT01911728|Omeprazole|omeprazole|mesh-list
56256964|NCT01911728|Warfarin|warfarin|mesh-list
56256965|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56256966|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56256967|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256968|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256969|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56256970|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56256971|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56256972|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56256973|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
56256974|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
56256975|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
56256976|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
56256977|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56256978|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56256979|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56256980|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
56256981|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56256982|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56256983|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56256984|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56256985|NCT01911949|Epinephrine|epinephrine|mesh-list
56256986|NCT01911949|Bupivacaine|bupivacaine|mesh-list
56256987|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
56256988|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
56256989|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56256990|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56256991|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
56256992|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56256993|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56257001|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56257002|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
56257004|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
56257005|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56257006|NCT01911975|Lacosamide|lacosamide|mesh-list
56257007|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
56257008|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56257009|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56257010|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257011|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257012|NCT01912053|Gemcitabine|gemcitabine|mesh-list
56257013|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257014|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56257015|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
56257016|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257017|NCT01912053|Antiviral Agents|antiviral agents|mesh-ancestor
56257018|NCT01912053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257019|NCT01912053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257020|NCT01912053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257021|NCT01912053|Immunologic Factors|immunologic factors|mesh-ancestor
56257022|NCT01912053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257023|NCT01912066|Aceclofenac|aceclofenac|mesh-list
56257024|NCT01912066|Misoprostol|misoprostol|mesh-list
56257025|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56257026|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
56257027|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56257028|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257029|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56257030|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56257031|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
56257032|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56257033|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56257034|NCT01912066|Analgesics|analgesics|mesh-ancestor
56257035|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
56257042|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257043|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257044|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56257045|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
56257046|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
56257047|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56257048|NCT01912118|Narcotics|narcotics|mesh-ancestor
56257049|NCT01912118|Analgesics|analgesics|mesh-ancestor
56257050|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
56257051|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257053|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
56257054|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56257055|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257056|NCT01912391|Selegiline|selegiline|mesh-list
56257057|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
56257058|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56257064|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56257065|NCT01912391|Protective Agents|protective agents|mesh-ancestor
56257066|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257067|NCT01912443|Bevacizumab|bevacizumab|mesh-list
56257068|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56257069|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257070|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56257071|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55790502|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257072|NCT01912443|Growth Substances|growth substances|mesh-ancestor
56257073|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257074|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
56257075|NCT01912534|Valsartan|valsartan|mesh-list
55832271|NCT01856907|Metformin|metformin|mesh-list
56257076|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56257077|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56257078|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56257079|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257080|NCT01912573|Naloxone|naloxone|mesh-list
56257081|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55871370|NCT03083457|Anesthetics|anesthetics|mesh-list
55790503|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
55790504|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56257082|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257083|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
56257084|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257085|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
56257086|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
56257087|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56257088|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56257089|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257090|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257091|NCT01912586|Urological Agents|urological agents|mesh-ancestor
56257092|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
56257093|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56257094|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
55871423|NCT05687409|Lactulose|lactulose|mesh-list
56257099|NCT01912677|Methyldopa|methyldopa|mesh-list
56257100|NCT01912677|Nifedipine|nifedipine|mesh-list
56257101|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56257102|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257103|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257104|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56257105|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257106|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
56257107|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
56257108|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55832297|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56257109|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56257110|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56257111|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
56257112|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257113|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56257114|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
56257115|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
56257116|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257117|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56257118|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56257119|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
56257120|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56257121|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56257122|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56257123|NCT01912755|Lidocaine|lidocaine|mesh-list
56257124|NCT01912755|Epinephrine|epinephrine|mesh-list
56257125|NCT01912755|Racepinephrine|racepinephrine|mesh-list
56257126|NCT01912755|Carticaine|carticaine|mesh-list
56257127|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
56257128|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
56257129|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
56257130|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257131|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257132|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
56257133|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257134|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56257135|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56257136|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56257137|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257138|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257139|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56257140|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56257141|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
56257142|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257143|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56257144|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56257146|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55722895|NCT02276482|Cefazolin|cefazolin|mesh-list
55722896|NCT02276482|Linezolid|linezolid|mesh-list
55722897|NCT02276482|Cephalexin|cephalexin|mesh-list
55722898|NCT02276482|Aztreonam|aztreonam|mesh-list
55722899|NCT02276482|Tedizolid|tedizolid|mesh-list
55722900|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722901|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55722902|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55722903|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55722904|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722905|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722906|NCT05196932|Antibodies|antibodies|mesh-list
55722907|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
55722908|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257147|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
56257148|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
56257149|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
56257150|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55879177|NCT03411330|Lidocaine|lidocaine|mesh-list
56257151|NCT01912820|Quercetin|quercetin|mesh-list
56257152|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
56257153|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257154|NCT01912820|Protective Agents|protective agents|mesh-ancestor
56257155|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257156|NCT01912898|Vitamin D|vitamin d|mesh-list
56257157|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
56257158|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
56257159|NCT01912898|Vitamins|vitamins|mesh-list
56257160|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
56257161|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257162|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56257163|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56257164|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56257165|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56257166|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
56257168|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
56257194|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56257195|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
56257197|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56257198|NCT01913054|Narcotics|narcotics|mesh-ancestor
56257199|NCT01913054|Analgesics|analgesics|mesh-ancestor
56257200|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
56257201|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257202|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56257203|NCT01913106|Valacyclovir|valacyclovir|mesh-list
56257204|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
56257205|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257206|NCT01913119|Romidepsin|romidepsin|mesh-list
56257207|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56257208|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257209|NCT01913379|Itraconazole|itraconazole|mesh-list
56257210|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
56257211|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
56257212|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257213|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56257214|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56257215|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257216|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257217|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56257218|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
56257219|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257220|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257221|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56257222|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55879260|NCT03403842|Sufentanil|sufentanil|mesh-list
56257224|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56257225|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56257226|NCT01913431|Entecavir|entecavir|mesh-list
56257237|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56257238|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257239|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56257240|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257241|NCT01913808|Iron|iron|mesh-list
56257242|NCT01913808|Glycine|glycine|mesh-list
56257243|NCT01913808|Trace Elements|trace elements|mesh-ancestor
56257251|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257252|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56257296|NCT01914042|Milnacipran|milnacipran|mesh-list
56257297|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
56257298|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56257299|NCT01914042|Narcotics|narcotics|mesh-ancestor
56257300|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257301|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257302|NCT01914042|Analgesics|analgesics|mesh-ancestor
56257303|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
56257304|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257305|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56257306|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56257307|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257308|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257309|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257310|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56257355|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
56257356|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56257357|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257358|NCT01914432|Telmisartan|telmisartan|mesh-list
56257359|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56257360|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56257361|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56257362|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
56257363|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257364|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56257365|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56257366|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257367|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56257368|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56257369|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56257370|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
56257371|NCT01914562|Cathartics|cathartics|mesh-ancestor
56257372|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56257373|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
56257374|NCT01914627|Salicylates|salicylates|mesh-list
56257375|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257376|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
56257377|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
56257378|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
56257379|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56257380|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56257381|NCT01914627|Analgesics|analgesics|mesh-ancestor
56257382|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
55832583|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
55832584|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
55832585|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55832586|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832590|NCT02159807|Narcotics|narcotics|mesh-ancestor
56257383|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257384|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257385|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56257386|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56257387|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56257388|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257389|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257390|NCT01914692|Somatostatin|somatostatin|mesh-list
56257391|NCT01914692|Hormones|hormones|mesh-ancestor
56257404|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257405|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257407|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790505|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55790506|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790507|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56257408|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56257409|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56257410|NCT01914770|Belimumab|belimumab|mesh-list
56257411|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257412|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
56257413|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257414|NCT01914822|Methylphenidate|methylphenidate|mesh-list
56257415|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56257416|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257417|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56257418|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56257419|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257420|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257421|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
56257422|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257423|NCT01914900|Docetaxel|docetaxel|mesh-list
56257424|NCT01914900|Fluorouracil|fluorouracil|mesh-list
56257425|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257426|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
56257427|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
56257428|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
56257429|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257430|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
56257431|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56257432|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257433|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
55832644|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257443|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56257444|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56257445|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257446|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257447|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
56257448|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257449|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257450|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56257451|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56257452|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257453|NCT01915069|Cilostazol|cilostazol|mesh-list
56257454|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56257455|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
56257456|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257457|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257458|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56257459|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
56257460|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56257461|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56257462|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257463|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56257464|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
56257470|NCT01915082|Azithromycin|azithromycin|mesh-list
56257475|NCT01915134|Endostatins|endostatins|mesh-list
56257476|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257477|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56257478|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
56257479|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257480|NCT01915134|Antiviral Agents|antiviral agents|mesh-ancestor
56257481|NCT01915134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257482|NCT01915134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257483|NCT01915134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257484|NCT01915134|Immunologic Factors|immunologic factors|mesh-ancestor
56257485|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257486|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56257487|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56257488|NCT01915134|Growth Substances|growth substances|mesh-ancestor
56257489|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
56257490|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56257491|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56257492|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
56257493|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257495|NCT01915264|Acarbose|acarbose|mesh-list
56257496|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56257497|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257498|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56257499|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257500|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257501|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
56257502|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56257503|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257504|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871518|NCT05657613|Antifungal Agents|antifungal agents|mesh-ancestor
55871519|NCT05657613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871520|NCT05657613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55871521|NCT05657613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55871522|NCT05657613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871523|NCT05657613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871524|NCT05657613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55871525|NCT05657613|Hormone Antagonists|hormone antagonists|mesh-ancestor
55871526|NCT05657613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871527|NCT05657613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871528|NCT05657613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55871529|NCT05657613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55871530|NCT05657613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55871531|NCT05657613|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55871532|NCT01021618|Dipyridamole|dipyridamole|mesh-list
55871533|NCT01021618|Regadenoson|regadenoson|mesh-list
55871534|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55871535|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55871536|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
55871537|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
55871538|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871539|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871540|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871541|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55871542|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871543|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55871544|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
55871545|NCT03082053|Capecitabine|capecitabine|mesh-list
55871546|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55871549|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871550|NCT03358563|Docetaxel|docetaxel|mesh-list
55871551|NCT03358563|Bicalutamide|bicalutamide|mesh-list
55871552|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55871553|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257505|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56257506|NCT01915277|Analgesics|analgesics|mesh-ancestor
56257507|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
56257508|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257509|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56257510|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56257511|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56257512|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
56257513|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257514|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257515|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
56257516|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56257517|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56257518|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55871554|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
55871555|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
55871556|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
55749459|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55871557|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871558|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
55871559|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
55871560|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871561|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871562|NCT03358563|Hematinics|hematinics|mesh-ancestor
55871563|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55871564|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55871565|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
55871566|NCT01018420|Colchicine|colchicine|mesh-list
55871567|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55871568|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871569|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55871570|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55871571|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871572|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871573|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871574|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
55871575|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871576|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
55871577|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
55871578|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
55871579|NCT00974350|Bupivacaine|bupivacaine|mesh-list
55871580|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
55871581|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
55871582|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871583|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871584|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
55871585|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871586|NCT05395702|Interferons|interferons|mesh-list
55871587|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
55871588|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871589|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
55871590|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871591|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55871592|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55790508|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55790509|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55790510|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871593|NCT01023178|Estradiol|estradiol|mesh-list
55871594|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55871595|NCT01023178|Estrogens|estrogens|mesh-list
55871596|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55871597|NCT01023178|Progesterone|progesterone|mesh-list
55871598|NCT01023178|Hormones|hormones|mesh-ancestor
55871599|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257519|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257520|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257521|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
56257522|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257523|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257525|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257527|NCT01915472|Labetuzumab|labetuzumab|mesh-list
56257528|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
56257529|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
56257530|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257531|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56257532|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56257533|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257534|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257535|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257536|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56257537|NCT01915537|Infliximab|infliximab|mesh-list
56257538|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
56257539|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56257540|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871600|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871601|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55871602|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
55871603|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55871604|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55871605|NCT01023178|Progestins|progestins|mesh-ancestor
55871608|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55871609|NCT03373851|Narcotics|narcotics|mesh-ancestor
55871610|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871611|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871612|NCT03373851|Analgesics|analgesics|mesh-ancestor
55871613|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
55871614|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871615|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55871616|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55871617|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
55871618|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
55871619|NCT05623995|Evolocumab|evolocumab|mesh-list
55871620|NCT05623995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55871624|NCT05623995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871625|NCT05623995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55871626|NCT05623995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871628|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55871629|NCT01023724|Bromfenac|bromfenac|mesh-list
55871630|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55871631|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55871632|NCT01023724|Analgesics|analgesics|mesh-ancestor
55871633|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
55871634|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871635|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871636|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56257541|NCT01915550|Insulin|insulin|mesh-list
56257542|NCT01915550|Metformin|metformin|mesh-list
56257543|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56257544|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
56257545|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56257546|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257547|NCT01915602|Sorafenib|sorafenib|mesh-list
56257548|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257549|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56257550|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257551|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257552|NCT01915758|Clindamycin|clindamycin|mesh-list
56257553|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
56257554|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
56257555|NCT01915758|Tretinoin|tretinoin|mesh-list
56257556|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56257557|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257558|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56257559|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257560|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257561|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257562|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
56257563|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
56257564|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56257565|NCT01915901|Bismuth|bismuth|mesh-list
56257566|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56257567|NCT01915901|Antacids|antacids|mesh-ancestor
56257568|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257569|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56257570|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56257571|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257572|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
56257584|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56257585|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
56257586|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56257587|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56257588|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257589|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56257590|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56257591|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257592|NCT01916174|Insulin|insulin|mesh-list
56257593|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56257594|NCT01916174|Liraglutide|liraglutide|mesh-list
56257595|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
56257596|NCT01916174|Xultophy|xultophy|mesh-list
55871637|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871638|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55871639|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871640|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871641|NCT00974818|Mitomycins|mitomycins|mesh-list
55871642|NCT00974818|Mitomycin|mitomycin|mesh-list
55871643|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
55871644|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55871645|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871646|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
55871647|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871648|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55871649|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871650|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55871651|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
55871652|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871653|NCT03371667|Methotrexate|methotrexate|mesh-list
55871654|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55871655|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
55871656|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55871657|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871658|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55871659|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
55871660|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871661|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871663|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871664|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55871665|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871666|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
55871667|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871668|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55871669|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
55871670|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55871672|NCT01024738|Fluorides|fluorides|mesh-list
55871673|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
55871674|NCT01024738|Protective Agents|protective agents|mesh-ancestor
55871675|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871676|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55871677|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871678|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
55871679|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
55871680|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55871681|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55871682|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
55871683|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871684|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55871686|NCT05613153|Antiemetics|antiemetics|mesh-ancestor
56257597|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56257598|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257600|NCT01916174|Hormones|hormones|mesh-ancestor
56257601|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257602|NCT01916187|Imetelstat|imetelstat|mesh-list
56257603|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
56257604|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257605|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257606|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56257607|NCT01916200|Paroxetine|paroxetine|mesh-list
56257608|NCT01916200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56257609|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56257610|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257611|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257612|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257613|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
56257614|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257615|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56257616|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
56257617|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56257618|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56257619|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56257620|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257621|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
56257622|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56257623|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
56257624|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257625|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
56257626|NCT01916213|Protective Agents|protective agents|mesh-ancestor
56257627|NCT01916252|Dexamethasone|dexamethasone|mesh-list
56257628|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
56257629|NCT01916252|Lenalidomide|lenalidomide|mesh-list
55871687|NCT05613153|Autonomic Agents|autonomic agents|mesh-ancestor
55871688|NCT05613153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749487|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55871689|NCT05613153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871690|NCT05613153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55871691|NCT05613153|Parasympatholytics|parasympatholytics|mesh-ancestor
56257630|NCT01916252|Bortezomib|bortezomib|mesh-list
56257631|NCT01916252|Melphalan|melphalan|mesh-list
56257632|NCT01916252|Busulfan|busulfan|mesh-list
56257633|NCT01916252|BB 1101|bb 1101|mesh-list
56257634|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56257635|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
56257636|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
56257637|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257638|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257639|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56257640|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
56257641|NCT01916252|Hormones|hormones|mesh-ancestor
56257642|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257643|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56257644|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257645|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
56257646|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56257647|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56257648|NCT01916252|Growth Substances|growth substances|mesh-ancestor
56257649|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
56257650|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56257651|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
56257652|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257653|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55832857|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
55871693|NCT01024972|Dantrolene|dantrolene|mesh-list
55871695|NCT01024972|Diuretics|diuretics|mesh-ancestor
55871696|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
55871697|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871698|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55871699|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55871700|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871701|NCT05686395|Bupivacaine|bupivacaine|mesh-list
55871702|NCT05686395|Anesthetics, Local|anesthetics, local|mesh-ancestor
55871703|NCT05686395|Anesthetics|anesthetics|mesh-ancestor
55871704|NCT05686395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871705|NCT05686395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871706|NCT05686395|Sensory System Agents|sensory system agents|mesh-ancestor
55871707|NCT05686395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871709|NCT01025830|Nevirapine|nevirapine|mesh-list
55871710|NCT01025830|Stavudine|stavudine|mesh-list
55871711|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
55871712|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55871713|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55871714|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871715|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871716|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
55871717|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871718|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55871719|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56257654|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257655|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
56257656|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257657|NCT01916265|Glucagon|glucagon|mesh-list
56257658|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56257659|NCT01916265|Hormones|hormones|mesh-ancestor
56257660|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257661|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257662|NCT01916382|Nitisinone|nitisinone|mesh-list
56257663|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257664|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257665|NCT01916395|Sumatriptan|sumatriptan|mesh-list
56257666|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56257667|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56257668|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56257669|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
56257670|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832878|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
55871720|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55871721|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55871722|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
55871724|NCT03081039|Carboplatin|carboplatin|mesh-list
55871725|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871726|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55871727|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
55871728|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871729|NCT03081039|Antiviral Agents|antiviral agents|mesh-ancestor
55871730|NCT03081039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871731|NCT03081039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871732|NCT03081039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871733|NCT03081039|Immunologic Factors|immunologic factors|mesh-ancestor
55871734|NCT03081039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871735|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
55871736|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55871737|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871738|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55871739|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871740|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871741|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
55871742|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55871743|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55871744|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871745|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871746|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
55871747|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55871748|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871749|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
55871750|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871751|NCT00979732|Protective Agents|protective agents|mesh-ancestor
55871752|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871753|NCT03348969|Mitomycins|mitomycins|mesh-list
55871754|NCT03348969|Mitomycin|mitomycin|mesh-list
55871755|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55871756|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871757|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
56257671|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257672|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257673|NCT01916408|Wobenzym|wobenzym|mesh-list
56257674|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56257675|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
56257676|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257677|NCT01916447|Bevacizumab|bevacizumab|mesh-list
56257678|NCT01916447|Irinotecan|irinotecan|mesh-list
56257679|NCT01916447|Camptothecin|camptothecin|mesh-list
56257680|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56257681|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257682|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55832895|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55871758|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871759|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55871760|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871761|NCT05686005|Tranexamic Acid|tranexamic acid|mesh-list
55871762|NCT05686005|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55871763|NCT05686005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56052419|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55871764|NCT05686005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871765|NCT05686005|Hemostatics|hemostatics|mesh-ancestor
55871766|NCT05686005|Coagulants|coagulants|mesh-ancestor
55789268|NCT04430933|Paclitaxel|paclitaxel|mesh-list
55871775|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55871776|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871777|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871778|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
55871779|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871780|NCT03321981|Trastuzumab|trastuzumab|mesh-list
55871781|NCT03321981|Letrozole|letrozole|mesh-list
55871782|NCT03321981|Vinorelbine|vinorelbine|mesh-list
55871783|NCT03321981|Fulvestrant|fulvestrant|mesh-list
55871784|NCT03321981|Exemestane|exemestane|mesh-list
55871785|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55871786|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871787|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55871788|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55871789|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871790|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871791|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55871792|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
55871793|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871794|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871795|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55871796|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
55871797|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
55871798|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
55871799|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55871800|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55871801|NCT01027000|Sirolimus|sirolimus|mesh-list
55871802|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
55871803|NCT01027000|Busulfan|busulfan|mesh-list
55871804|NCT01027000|Rituximab|rituximab|mesh-list
55871805|NCT01027000|Methotrexate|methotrexate|mesh-list
55871806|NCT01027000|Fludarabine|fludarabine|mesh-list
55871807|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
55871808|NCT01027000|Tacrolimus|tacrolimus|mesh-list
55871809|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871810|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
55871811|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871812|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871813|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55871814|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
56257683|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56257684|NCT01916447|Growth Substances|growth substances|mesh-ancestor
56257685|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257686|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
56257687|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56257688|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56257689|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257690|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257691|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56257692|NCT01916577|Plerixafor|plerixafor|mesh-list
56257693|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56257694|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56257695|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
56257696|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257697|NCT01916642|Lidocaine|lidocaine|mesh-list
56257698|NCT01916642|Etomidate|etomidate|mesh-list
56257699|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
56257700|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
56257701|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257702|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871815|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871816|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871817|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55871818|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55871819|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55871820|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
55871821|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55871822|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55871823|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
55871824|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
55871825|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871826|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55871827|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55871828|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55871829|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55871834|NCT05685615|Polymyxin B|polymyxin b|mesh-list
55871835|NCT05685615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55871836|NCT05685615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871837|NCT01027468|Bevacizumab|bevacizumab|mesh-list
55871838|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55871839|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871840|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55871841|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55871842|NCT01027468|Growth Substances|growth substances|mesh-ancestor
55871843|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871844|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
55871845|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
55871846|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871847|NCT04278807|Anesthetics|anesthetics|mesh-list
55871848|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871849|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871850|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55871851|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871852|NCT03274401|Anticoagulants|anticoagulants|mesh-list
56257703|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
56257704|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257705|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56257706|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56257707|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56257708|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56257709|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257710|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56257711|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56257712|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
56257713|NCT01916707|Enoxaparin|enoxaparin|mesh-list
56257714|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
56257715|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56257716|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56257717|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257718|NCT01916733|Insulin|insulin|mesh-list
56257719|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56257720|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257721|NCT01916785|Dasatinib|dasatinib|mesh-list
56257722|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257723|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56257724|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257725|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257726|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56257727|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56257728|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56257729|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56257730|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55832925|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55871853|NCT05086107|Rifabutin|rifabutin|mesh-list
55871854|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55871855|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871856|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55871857|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
55871858|NCT01029730|Rituximab|rituximab|mesh-list
55871859|NCT01029730|Bortezomib|bortezomib|mesh-list
55871860|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55871861|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55871862|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871863|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
55871864|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257731|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56257732|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257733|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55789279|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56257734|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257736|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56257737|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56257738|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257739|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56257740|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257741|NCT01916902|Ticagrelor|ticagrelor|mesh-list
56257742|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56257743|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56257744|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56257745|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56257746|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
56257747|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257748|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257749|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257750|NCT01916915|Tramadol|tramadol|mesh-list
56257751|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
56257752|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56257778|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257780|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
56257781|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257782|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
56257783|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
56257784|NCT01917045|Sufentanil|sufentanil|mesh-list
56257785|NCT01917045|Morphine|morphine|mesh-list
56257787|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56257788|NCT01917045|Narcotics|narcotics|mesh-ancestor
56052420|NCT03632109|Gentamicins|gentamicins|mesh-list
56257789|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257790|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257791|NCT01917045|Analgesics|analgesics|mesh-ancestor
56257792|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
56257793|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257794|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56257795|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56257796|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
56257797|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
56257798|NCT01917058|Abatacept|abatacept|mesh-list
56257799|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56257800|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257801|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257802|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257803|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
56257804|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257805|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56257806|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
56257807|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56257808|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871865|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871866|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55871867|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
55871868|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871869|NCT03317535|Anesthetics|anesthetics|mesh-list
55871870|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871871|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871872|NCT05066997|Dexamethasone|dexamethasone|mesh-list
55871873|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
55871874|NCT05066997|BB 1101|bb 1101|mesh-list
55871875|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55871876|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
55871877|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
55871878|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871879|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871880|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55871881|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
56257809|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257810|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56257811|NCT01917097|Analgesics|analgesics|mesh-ancestor
56257812|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
56257813|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257814|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56257815|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56257816|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56257817|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
56257818|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871882|NCT05066997|Hormones|hormones|mesh-ancestor
55871883|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871884|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55871885|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871886|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
55871887|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871888|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871889|NCT05025033|Paclitaxel|paclitaxel|mesh-list
55871890|NCT05025033|Irinotecan|irinotecan|mesh-list
55871891|NCT05025033|Apatinib|apatinib|mesh-list
55871892|NCT05025033|Antibodies|antibodies|mesh-list
55871893|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
55871894|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55871895|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871896|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
55871897|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
55871898|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
55871899|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871900|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
55871901|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871902|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55871903|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55871905|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55871906|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55871908|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55871909|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55871910|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55871911|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871912|NCT00981214|Pancrelipase|pancrelipase|mesh-list
55871913|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55871914|NCT05415657|Denosumab|denosumab|mesh-list
55871915|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55871916|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871917|NCT03016234|Propofol|propofol|mesh-list
55871918|NCT03016234|Desflurane|desflurane|mesh-list
55871919|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55871920|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871921|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871922|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55871923|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
55871924|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
55871925|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55871926|NCT02167204|Alovudine|alovudine|mesh-list
55871927|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
55871928|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871929|NCT00982072|Prednisolone|prednisolone|mesh-list
55871930|NCT00982072|Tacrolimus|tacrolimus|mesh-list
55871931|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871932|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
55871933|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871934|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55871935|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257819|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257821|NCT01917149|Valsartan|valsartan|mesh-list
56257822|NCT01917149|Benazepril|benazepril|mesh-list
56257823|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56257824|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56257825|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56257826|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257827|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56257828|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
56257829|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
56257830|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257831|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257832|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56257833|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56257834|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56257835|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
56257836|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257837|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56257838|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
56257839|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257840|NCT01917279|Docetaxel|docetaxel|mesh-list
56257841|NCT01917279|Capecitabine|capecitabine|mesh-list
55833045|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55871936|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871937|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55871938|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
55871939|NCT00982072|Hormones|hormones|mesh-ancestor
55871940|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871941|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55871942|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871943|NCT01899053|Serabelisib|serabelisib|mesh-list
55871944|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871945|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871946|NCT01032694|Azithromycin|azithromycin|mesh-list
55871947|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55871948|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871949|NCT04957095|Levodopa|levodopa|mesh-list
55871950|NCT04957095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55871951|NCT04957095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55871952|NCT04957095|Dopamine Agents|dopamine agents|mesh-ancestor
55871953|NCT04957095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871954|NCT04957095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871955|NCT04957095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871956|NCT01032850|Capecitabine|capecitabine|mesh-list
55871957|NCT01032850|Sorafenib|sorafenib|mesh-list
55871958|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55871959|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
55871960|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257842|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257843|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
56257844|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
56257845|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
56257846|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257847|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56257848|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
56257849|NCT01917318|Iloperidone|iloperidone|mesh-list
56257850|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56257851|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55722909|NCT00924833|Carvedilol|carvedilol|mesh-list
55722910|NCT00924833|Nebivolol|nebivolol|mesh-list
55722911|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55722912|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55722913|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
55722914|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722915|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845503|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55722916|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722917|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55722918|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
55722919|NCT00924833|Protective Agents|protective agents|mesh-ancestor
55722920|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55722921|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55726696|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
56257852|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257853|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257854|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56257855|NCT01917331|Beclomethasone|beclomethasone|mesh-list
56257856|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
56257857|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
56257858|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56257859|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
56257860|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257861|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257862|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56257863|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
56257864|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56257865|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56257866|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56257867|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
56257868|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56257869|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257870|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56257871|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55833068|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
55871961|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871962|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55871963|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871964|NCT05500599|Fentanyl|fentanyl|mesh-list
55871965|NCT05500599|Midazolam|midazolam|mesh-list
55871966|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55871967|NCT05500599|Narcotics|narcotics|mesh-ancestor
55871968|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871969|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871970|NCT05500599|Analgesics|analgesics|mesh-ancestor
55871971|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
55871972|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257872|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56257873|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
56257874|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56257875|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
56257876|NCT01917331|Hormones|hormones|mesh-ancestor
56257877|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56257878|NCT01917448|Morphine|morphine|mesh-list
56257879|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56257880|NCT01917448|Narcotics|narcotics|mesh-ancestor
56257881|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257882|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257883|NCT01917448|Analgesics|analgesics|mesh-ancestor
56257884|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
56257885|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257886|NCT01917578|Paclitaxel|paclitaxel|mesh-list
55871973|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55871974|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55871975|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
55871976|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
55871977|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55871978|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55871982|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
55871983|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871984|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871985|NCT00983242|Colchicine|colchicine|mesh-list
55871986|NCT00983242|Verapamil|verapamil|mesh-list
55871987|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
55871988|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871989|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
55871990|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
55871991|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
55871992|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871993|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871994|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55871995|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55871996|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55871997|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55871998|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871999|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
55872000|NCT00984334|Naloxone|naloxone|mesh-list
55872001|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55872002|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872003|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
55872004|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872005|NCT02168062|Leuprolide|leuprolide|mesh-list
55872006|NCT02168062|Goserelin|goserelin|mesh-list
55872007|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55872008|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55872009|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
55872010|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55872011|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872012|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55872013|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872014|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
55872015|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55872016|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
55872017|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55872018|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55872019|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872020|NCT05343117|Palbociclib|palbociclib|mesh-list
55872021|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257887|NCT01917578|Docetaxel|docetaxel|mesh-list
56257888|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56257889|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
56257890|NCT01917578|Carboplatin|carboplatin|mesh-list
56257891|NCT01917578|Doxorubicin|doxorubicin|mesh-list
56257892|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56257893|NCT01917578|Fluorouracil|fluorouracil|mesh-list
56257894|NCT01917578|Trastuzumab|trastuzumab|mesh-list
56257895|NCT01917578|Epirubicin|epirubicin|mesh-list
56257896|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56257897|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257898|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
56257899|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
56257900|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56257901|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257902|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257903|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
56257904|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257905|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56257906|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56257907|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
56257908|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56257909|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56257910|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56257911|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55833122|NCT01622569|Xhance|xhance|mesh-list
55872023|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872024|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872025|NCT01898195|Varenicline|varenicline|mesh-list
55872026|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55872027|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55872028|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
55872029|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872030|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872031|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872032|NCT01897727|Spironolactone|spironolactone|mesh-list
55723368|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
55723369|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
55723370|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723373|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55723374|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723375|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723376|NCT04224740|Cisplatin|cisplatin|mesh-list
55723377|NCT04224740|Carboplatin|carboplatin|mesh-list
55723378|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
55723379|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723380|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723381|NCT05037500|Decitabine|decitabine|mesh-list
55723382|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55872033|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55872034|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
55872035|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872036|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872037|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55872038|NCT01897727|Diuretics|diuretics|mesh-ancestor
55872039|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
55872040|NCT01897493|Digoxin|digoxin|mesh-list
55872041|NCT01897493|Evacetrapib|evacetrapib|mesh-list
55872042|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55872043|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55872044|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872045|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872046|NCT01897493|Protective Agents|protective agents|mesh-ancestor
56257912|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257913|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
56257914|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56257915|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56257916|NCT01917617|Gemcitabine|gemcitabine|mesh-list
56257917|NCT01917617|Cisplatin|cisplatin|mesh-list
56257918|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56257919|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257920|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56257921|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
56257922|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257923|NCT01917617|Antiviral Agents|antiviral agents|mesh-ancestor
56257924|NCT01917617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257925|NCT01917617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257926|NCT01917617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257927|NCT01917617|Immunologic Factors|immunologic factors|mesh-ancestor
56257928|NCT01917617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257929|NCT01917708|Abatacept|abatacept|mesh-list
56257930|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55872047|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872048|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55872049|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55872050|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
55872051|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55872055|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872056|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872057|NCT01887353|Ranolazine|ranolazine|mesh-list
55872058|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55872059|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55872060|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872061|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55872062|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
55872063|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55872064|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55872065|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55872066|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872067|NCT03331341|Doxorubicin|doxorubicin|mesh-list
55872068|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55872069|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
55872070|NCT03331341|Dacarbazine|dacarbazine|mesh-list
55872071|NCT03331341|Vinblastine|vinblastine|mesh-list
55872072|NCT03331341|Imidazole|imidazole|mesh-list
55790511|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790512|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
55872073|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55872074|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872075|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55872076|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55872077|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872078|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872079|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872080|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55872081|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
55872082|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55872083|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
55872084|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
55872085|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
56257931|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257932|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257933|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56257934|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
56257935|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257936|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56257938|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56257939|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56257940|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
56257941|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56257942|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56257943|NCT01917799|Aspirin|aspirin|mesh-list
56257944|NCT01917799|Heparin|heparin|mesh-list
56257945|NCT01917799|Enoxaparin|enoxaparin|mesh-list
56257946|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56257947|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56257948|NCT01917799|Analgesics|analgesics|mesh-ancestor
56257949|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
56257950|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56257986|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257987|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56257988|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56257989|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56257990|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56257991|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56257992|NCT01918098|Oxycodone|oxycodone|mesh-list
56257993|NCT01918098|Naloxone|naloxone|mesh-list
56257994|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56257995|NCT01918098|Narcotics|narcotics|mesh-ancestor
56257996|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56257997|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56257998|NCT01918098|Analgesics|analgesics|mesh-ancestor
56257999|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
56258000|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258001|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56258002|NCT01918111|Adenosine|adenosine|mesh-list
56258003|NCT01918111|Analgesics|analgesics|mesh-ancestor
56258004|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
56258005|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258006|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258007|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56258008|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
56258009|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56258010|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
56258011|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
56258012|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258013|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258032|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56258033|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56258034|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56258035|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258037|NCT01918150|Chromium|chromium|mesh-list
56258038|NCT01918150|Trace Elements|trace elements|mesh-ancestor
56258039|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
56258040|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258041|NCT01918176|Palbociclib|palbociclib|mesh-list
56258042|NCT01918176|Rabeprazole|rabeprazole|mesh-list
56258043|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880084|NCT02520180|Everolimus|everolimus|mesh-list
56258044|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56258045|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258046|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258047|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56258049|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56258050|NCT01918241|Lenograstim|lenograstim|mesh-list
56258051|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56258052|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
56258053|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258054|NCT01918254|Paclitaxel|paclitaxel|mesh-list
56258055|NCT01918254|Pertuzumab|pertuzumab|mesh-list
56258056|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56258057|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258058|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
56258059|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
56258060|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
56258061|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258062|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872086|NCT02160730|Roscovitine|roscovitine|mesh-list
55872087|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872088|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
55872089|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872090|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55872091|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872092|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872093|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
55872094|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55872095|NCT01896869|Ipilimumab|ipilimumab|mesh-list
55872096|NCT01896869|Folfirinox|folfirinox|mesh-list
55872097|NCT01896869|Vaccines|vaccines|mesh-list
55872098|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
55872099|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872100|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56258063|NCT01918358|Valsartan|valsartan|mesh-list
56258064|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56258065|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56258066|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56258067|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
56258068|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258069|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56258070|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56258071|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258072|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56258073|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56258074|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56258075|NCT01918384|Arbekacin|arbekacin|mesh-list
56258076|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258077|NCT01918475|Carbetocin|carbetocin|mesh-list
56258078|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
56258079|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56258080|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258081|NCT01918488|Amiloride|amiloride|mesh-list
56258082|NCT01918488|Triamterene|triamterene|mesh-list
56258083|NCT01918488|Diuretics|diuretics|mesh-ancestor
56258084|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
56258085|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258086|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56258087|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56258088|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56258089|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258090|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56258092|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
56258093|NCT01918514|Analgesics|analgesics|mesh-ancestor
56258094|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
56258095|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872101|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872102|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55872103|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872104|NCT03329001|Niraparib|niraparib|mesh-list
55872105|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55872106|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258096|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258097|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
56258098|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258099|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56258100|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
56258101|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56258102|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56258103|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258104|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56258105|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
56258106|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56258107|NCT01918631|Tenofovir|tenofovir|mesh-list
56258108|NCT01918631|Entecavir|entecavir|mesh-list
56258109|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
56258110|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258111|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56258112|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56258113|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258114|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258115|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56258116|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56258117|NCT01918709|Valsartan|valsartan|mesh-list
56258118|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56258119|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56258120|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56258121|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
56258122|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258124|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56258125|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258126|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55872107|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872108|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872109|NCT01896557|Omeprazole|omeprazole|mesh-list
55872110|NCT01896557|Ranitidine|ranitidine|mesh-list
55872111|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
55872112|NCT01896557|Clopidogrel|clopidogrel|mesh-list
55872113|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
55872114|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55872115|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55872116|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55872117|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
55872118|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258127|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56258128|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56258129|NCT01918813|Vancomycin|vancomycin|mesh-list
56258130|NCT01918813|Mupirocin|mupirocin|mesh-list
56258131|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56258132|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258133|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56258134|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258135|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258136|NCT01918852|Bevacizumab|bevacizumab|mesh-list
56258137|NCT01918852|Capecitabine|capecitabine|mesh-list
56258138|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56258139|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258140|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56258141|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56258142|NCT01918852|Growth Substances|growth substances|mesh-ancestor
55789289|NCT03055091|Sorbitol|sorbitol|mesh-list
56258144|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
56258145|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56258146|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
56258147|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258148|NCT01918865|Metformin|metformin|mesh-list
56258149|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56258151|NCT01918878|Aflibercept|aflibercept|mesh-list
56258178|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258179|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56258180|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56258181|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56258182|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
56258183|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258184|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258185|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56258186|NCT01918917|Narcotics|narcotics|mesh-ancestor
56258187|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
56258188|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
56258189|NCT01918995|Regadenoson|regadenoson|mesh-list
56258190|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55872119|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872120|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872121|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55872124|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872125|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55872126|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
55872127|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
55872128|NCT02160808|Secretin|secretin|mesh-list
55872129|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55872130|NCT02160808|Hormones|hormones|mesh-ancestor
55872131|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872132|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872133|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
55872134|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55872135|NCT01886105|Analgesics|analgesics|mesh-ancestor
55872136|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
55872137|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872138|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872139|NCT03262779|Nivolumab|nivolumab|mesh-list
55872140|NCT03262779|Ipilimumab|ipilimumab|mesh-list
55872141|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872142|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872143|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55872144|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872145|NCT03245541|Durvalumab|durvalumab|mesh-list
55872146|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872147|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872148|NCT04612725|Benralizumab|benralizumab|mesh-list
55872149|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55872150|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
55872151|NCT05022394|Nivolumab|nivolumab|mesh-list
55872152|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872153|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872154|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55872155|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872156|NCT01895777|Dabigatran|dabigatran|mesh-list
55872157|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
55872158|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55872159|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
55872160|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872161|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872162|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
55872163|NCT00992602|Cytarabine|cytarabine|mesh-list
55872164|NCT00992602|Methotrexate|methotrexate|mesh-list
55872165|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55872166|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
55872167|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55872168|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258191|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56258192|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
56258193|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
56258194|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880229|NCT01451632|Irinotecan|irinotecan|mesh-list
56258195|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258196|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258197|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56258198|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
56258199|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56258200|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56258201|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56258202|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258203|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258204|NCT01919047|Mirabegron|mirabegron|mesh-list
56258205|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56258206|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56258207|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56258208|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
56258209|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258210|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258211|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258212|NCT01919047|Urological Agents|urological agents|mesh-ancestor
56258213|NCT01919203|Remifentanil|remifentanil|mesh-list
56258214|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56258215|NCT01919203|Narcotics|narcotics|mesh-ancestor
56258216|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258217|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258218|NCT01919203|Analgesics|analgesics|mesh-ancestor
56258219|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
56258220|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258221|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
56258222|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
56258223|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
56258224|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
55790513|NCT03919435|Trimethoprim|trimethoprim|mesh-list
55790514|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55790515|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
55790516|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55790517|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790518|NCT03919435|Renal Agents|renal agents|mesh-ancestor
55790519|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
56258225|NCT01919255|Citric Acid|citric acid|mesh-list
56258226|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
55872169|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56258227|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56258228|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
56258229|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
56258230|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258231|NCT01919255|Cathartics|cathartics|mesh-ancestor
56258232|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56258233|NCT01919255|Antacids|antacids|mesh-ancestor
56258234|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
56258235|NCT01919294|Testosterone|testosterone|mesh-list
56258236|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
56258237|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
56258238|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56258239|NCT01919294|Androgens|androgens|mesh-ancestor
56258240|NCT01919294|Hormones|hormones|mesh-ancestor
56258241|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56258242|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258243|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56258285|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
56258286|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56258287|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258288|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258289|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
56258290|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56258291|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258292|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258293|NCT01919905|Vitamin D|vitamin d|mesh-list
56258294|NCT01919905|Vitamins|vitamins|mesh-ancestor
56258295|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
56258296|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258297|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56258298|NCT01919918|Adenosine|adenosine|mesh-list
56258299|NCT01919918|Analgesics|analgesics|mesh-ancestor
56258300|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
56258301|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258302|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258303|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56258304|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
56258305|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56258306|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
56258307|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
56258308|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258309|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258310|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
56258311|NCT01920022|Mifepristone|mifepristone|mesh-list
56258312|NCT01920022|Etonogestrel|etonogestrel|mesh-list
56258313|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56258314|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258315|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56258316|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
56258317|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56258318|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56258324|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
56258325|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56258326|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56258327|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
55790520|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55790521|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55790522|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55790523|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258328|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
56258329|NCT01920516|Melphalan|melphalan|mesh-list
56258330|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56258331|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
56258332|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258333|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258334|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56258335|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56258336|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
56258337|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258338|NCT01920984|Bevacizumab|bevacizumab|mesh-list
56258339|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56258340|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258341|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56258342|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56258343|NCT01920984|Growth Substances|growth substances|mesh-ancestor
56258344|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258345|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
56258346|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
56258347|NCT01921374|Interferons|interferons|mesh-list
56258348|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
56258349|NCT01921374|Interleukin-2|interleukin-2|mesh-list
56258350|NCT01921374|Interleukin-4|interleukin-4|mesh-list
56258351|NCT01921374|Dinoprostone|dinoprostone|mesh-list
56258352|NCT01921374|Hormones|hormones|mesh-list
56258353|NCT01921374|Estradiol|estradiol|mesh-list
56258354|NCT01921374|Testosterone|testosterone|mesh-list
56258355|NCT01921374|Progesterone|progesterone|mesh-list
56258356|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56258357|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56258358|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56258359|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
55833555|NCT02058368|Tamsulosin|tamsulosin|mesh-list
55872170|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
55872171|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872172|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258360|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56258361|NCT01921374|Antibodies|antibodies|mesh-list
56258362|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
56258363|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
56258364|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
56258365|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
56258366|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
56258367|NCT01921374|Uric Acid|uric acid|mesh-list
56258368|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258369|NCT01921374|Vitamins|vitamins|mesh-ancestor
56258370|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
56258371|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258372|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
56258373|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258374|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56258375|NCT01921374|Estrogens|estrogens|mesh-ancestor
56258376|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56258377|NCT01921374|Androgens|androgens|mesh-ancestor
56258378|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
56258379|NCT01921374|Progestins|progestins|mesh-ancestor
56258380|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56258381|NCT01921374|Analgesics|analgesics|mesh-ancestor
56258382|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
56258383|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258384|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
56258385|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052421|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56258386|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258387|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
56258388|NCT01921374|Protective Agents|protective agents|mesh-ancestor
56258389|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
56258390|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56258391|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56258392|NCT01921972|Memantine|memantine|mesh-list
56258393|NCT01921972|Galantamine|galantamine|mesh-list
56258394|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56258395|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55833600|NCT02106884|Paclitaxel|paclitaxel|mesh-list
55872173|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
55872174|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872175|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55872176|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872177|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
55872178|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56258396|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
56258397|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258398|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258399|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258400|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56258401|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56258402|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56258403|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258404|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
56258405|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56258406|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
56258407|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258408|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
56258409|NCT01923454|Acetazolamide|acetazolamide|mesh-list
56258410|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
56258411|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56258412|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258413|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258414|NCT01923454|Diuretics|diuretics|mesh-ancestor
56258415|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
56258416|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258417|NCT01923935|Melphalan|melphalan|mesh-list
56258418|NCT01923935|Busulfan|busulfan|mesh-list
55880449|NCT02981212|Hormones|hormones|mesh-ancestor
56258419|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56258420|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
56258421|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258422|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258423|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56258424|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56258425|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
56258426|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258427|NCT01923974|Melatonin|melatonin|mesh-list
56258428|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
56258435|NCT01924013|Vitamins|vitamins|mesh-ancestor
56258436|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
56258437|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258438|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56258439|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56258440|NCT01924676|Oxycodone|oxycodone|mesh-list
56258441|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56258442|NCT01924676|Narcotics|narcotics|mesh-ancestor
56258443|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258444|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258445|NCT01924676|Analgesics|analgesics|mesh-ancestor
56258446|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
56258447|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258448|NCT01925066|Vancomycin|vancomycin|mesh-list
56258449|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56258450|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258451|NCT01927640|Cocaine|cocaine|mesh-list
56258452|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
56258453|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56258454|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258455|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258456|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56258457|NCT01927640|Analgesics|analgesics|mesh-ancestor
56258458|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
56258459|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258473|NCT01927679|Vitamin E|vitamin e|mesh-list
56258484|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258485|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56258486|NCT01928407|Darunavir|darunavir|mesh-list
56258487|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56258488|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56258489|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
56258491|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258492|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56258493|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56258494|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
56258495|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258496|NCT01928875|Anesthetics|anesthetics|mesh-list
56258497|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258498|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258500|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258501|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56258502|NCT01929590|Laxatives|laxatives|mesh-ancestor
56258503|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55872179|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55872180|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
55872181|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872182|NCT00993226|Bupivacaine|bupivacaine|mesh-list
55872183|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
55872184|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
55872185|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55872186|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872187|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
55872188|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872189|NCT01885559|Telmisartan|telmisartan|mesh-list
55872190|NCT01885559|Lisinopril|lisinopril|mesh-list
55872191|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55872192|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55872193|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55872194|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55872196|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
55872197|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872198|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55872199|NCT01885559|Protective Agents|protective agents|mesh-ancestor
55872200|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872202|NCT00994318|Hematinics|hematinics|mesh-ancestor
55872203|NCT00995722|Prednisone|prednisone|mesh-list
55872204|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790524|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872205|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
55872206|NCT00995722|Hormones|hormones|mesh-ancestor
55872207|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872208|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872209|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55872210|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872211|NCT04434040|Atezolizumab|atezolizumab|mesh-list
55872212|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872213|NCT00996346|Sirolimus|sirolimus|mesh-list
55872214|NCT00996346|Irinotecan|irinotecan|mesh-list
55872215|NCT00996346|Complement Factor H|complement factor h|mesh-list
55872216|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55872217|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56258505|NCT01930019|Etomidate|etomidate|mesh-list
56258506|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
56258507|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258508|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258509|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56258510|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56258511|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
56258512|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
56258513|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
56258514|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
56258515|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258516|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258517|NCT01930201|Anesthetics|anesthetics|mesh-list
56258518|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258519|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258520|NCT01930292|Paclitaxel|paclitaxel|mesh-list
56258521|NCT01930292|Carboplatin|carboplatin|mesh-list
56258522|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56258528|NCT01930318|Parecoxib|parecoxib|mesh-list
56258562|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258563|NCT01930552|Leucovorin|leucovorin|mesh-list
56258564|NCT01930552|Fluorouracil|fluorouracil|mesh-list
56258565|NCT01930552|Irinotecan|irinotecan|mesh-list
56258566|NCT01930552|Aflibercept|aflibercept|mesh-list
56258567|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
56258568|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258569|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56258570|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258571|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56258572|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
55880596|NCT03613506|Captopril|captopril|mesh-list
56258573|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258574|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56258575|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56258576|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258577|NCT01930552|Antidotes|antidotes|mesh-ancestor
56258578|NCT01930552|Protective Agents|protective agents|mesh-ancestor
56258579|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
56258580|NCT01930552|Vitamins|vitamins|mesh-ancestor
56258581|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
56258582|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56258583|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56258613|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
56258614|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56258615|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
56258616|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258618|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56258619|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
56258620|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
56258621|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258622|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258623|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56258624|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56258625|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56258626|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
56258627|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258628|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258629|NCT01930734|Protective Agents|protective agents|mesh-ancestor
56258630|NCT01930773|Clopidogrel|clopidogrel|mesh-list
56258631|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56258632|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56258633|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56258634|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56258635|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
56258636|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833828|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55833830|NCT01621568|Growth Substances|growth substances|mesh-ancestor
55872218|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872219|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872220|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790526|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55790527|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55790528|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55872221|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55872222|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872223|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55872224|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
55872225|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872226|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
55872227|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872228|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55872229|NCT03016468|Treprostinil|treprostinil|mesh-list
55872230|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55872231|NCT00997204|Icatibant|icatibant|mesh-list
55872232|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55872233|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55872234|NCT00997204|Analgesics|analgesics|mesh-ancestor
55872235|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
55872236|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872237|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872238|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55872239|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56258637|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258638|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258640|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56258641|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56258642|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56258643|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56258644|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258645|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
56258646|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258647|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880670|NCT01566526|Hormones|hormones|mesh-ancestor
55872240|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55872241|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55872242|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872243|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55872244|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872245|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
55872246|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55872247|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
55872248|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872249|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
55872250|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872251|NCT04225390|Dacarbazine|dacarbazine|mesh-list
55872252|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55872253|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
55872254|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872255|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872256|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
55872257|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
55872258|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55872259|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872260|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872261|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
55872262|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55872263|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55872264|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872266|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
55872276|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872277|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872278|NCT02164240|Sunitinib|sunitinib|mesh-list
55872279|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872280|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55872281|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55872282|NCT02164240|Growth Substances|growth substances|mesh-ancestor
55872283|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872284|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
55872285|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55872286|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872287|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872288|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
55872289|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872290|NCT02169466|Opicapone|opicapone|mesh-list
55872291|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
55872292|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55872293|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872294|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872295|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56258648|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56258649|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258651|NCT01930812|Fluorides|fluorides|mesh-list
56258652|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
56258653|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
56258654|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
56258655|NCT01930812|Protective Agents|protective agents|mesh-ancestor
56258656|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258657|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56258658|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258659|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56258660|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258661|NCT01930864|Metformin|metformin|mesh-list
56258662|NCT01930864|Irinotecan|irinotecan|mesh-list
56258663|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56258664|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258665|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56258666|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56258667|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258668|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258669|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258670|NCT01930877|Lidocaine|lidocaine|mesh-list
56258671|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
56258672|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
56258673|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258674|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258675|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
56258676|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258677|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56258682|NCT01930916|Anticoagulants|anticoagulants|mesh-list
56258692|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56258693|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
56258694|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56258695|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258696|NCT01931098|Topotecan|topotecan|mesh-list
56258697|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56258698|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56258699|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258700|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258701|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258702|NCT01931137|Insulin|insulin|mesh-list
56258703|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56258704|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258705|NCT01931189|Infliximab|infliximab|mesh-list
56258706|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
56258707|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56258708|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56258709|NCT01931215|Clonidine|clonidine|mesh-list
56258710|NCT01931215|Morphine|morphine|mesh-list
56258711|NCT01931215|Ropivacaine|ropivacaine|mesh-list
56258712|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
56258713|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258716|NCT01931215|Narcotics|narcotics|mesh-ancestor
56258748|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
56258749|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258750|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258751|NCT01931332|Heroin|heroin|mesh-list
56258752|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56258753|NCT01931332|Narcotics|narcotics|mesh-ancestor
56258754|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258755|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258756|NCT01931332|Analgesics|analgesics|mesh-ancestor
56258757|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
56258758|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258759|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56258760|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56258761|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258762|NCT01931410|Misoprostol|misoprostol|mesh-list
56258763|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56258764|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
56258765|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56258766|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258767|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56258768|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56258800|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56258801|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
56258802|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56258803|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258804|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56258805|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56258806|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56258807|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
56258808|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56258809|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56258810|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
56258811|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872296|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55872297|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
55872298|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872299|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872300|NCT03259503|Gemcitabine|gemcitabine|mesh-list
55872301|NCT03259503|Rituximab|rituximab|mesh-list
55872302|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55872303|NCT03259503|Melphalan|melphalan|mesh-list
55872304|NCT03259503|Busulfan|busulfan|mesh-list
55872305|NCT03259503|Olaparib|olaparib|mesh-list
55872306|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
55872307|NCT03259503|Vorinostat|vorinostat|mesh-list
55872308|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55872309|NCT03259503|Antibodies|antibodies|mesh-list
55872310|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
55872311|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55872312|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
55872313|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872314|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872315|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55872316|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55872317|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
55872318|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872319|NCT03259503|Antiviral Agents|antiviral agents|mesh-ancestor
55872320|NCT03259503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872321|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872322|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872323|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55872324|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
55872325|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55872326|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55872327|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55872328|NCT01001806|Ketorolac|ketorolac|mesh-list
55872329|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55872330|NCT01001806|Nepafenac|nepafenac|mesh-list
55872331|NCT01001806|Bromfenac|bromfenac|mesh-list
55872332|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55749577|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55872342|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872343|NCT03290391|Naltrexone|naltrexone|mesh-list
55872344|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55872345|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55872346|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872347|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
55872348|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872349|NCT04021264|Sufentanil|sufentanil|mesh-list
55872350|NCT04021264|Ropivacaine|ropivacaine|mesh-list
55872351|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
55872352|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
55872353|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258812|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
56258813|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56258814|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56258815|NCT01931683|Remifentanil|remifentanil|mesh-list
56258816|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56258817|NCT01931683|Narcotics|narcotics|mesh-ancestor
56258818|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258819|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258820|NCT01931683|Analgesics|analgesics|mesh-ancestor
56258821|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
56258822|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56258823|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
56258824|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
56258825|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258826|NCT01931787|Protective Agents|protective agents|mesh-ancestor
56258827|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258828|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
56258829|NCT01931787|Vitamins|vitamins|mesh-ancestor
56258830|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
56258831|NCT01931982|Liraglutide|liraglutide|mesh-list
56258832|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56258833|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258834|NCT01931982|Incretins|incretins|mesh-ancestor
56258835|NCT01931982|Hormones|hormones|mesh-ancestor
56258836|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56258837|NCT01932151|Terlipressin|terlipressin|mesh-list
56258838|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56258839|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56258840|NCT01932177|Everolimus|everolimus|mesh-list
56258861|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258862|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56258863|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56258864|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258865|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
56258866|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56258867|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
56258868|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56258869|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
56258870|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
56258871|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56258872|NCT01932203|Protective Agents|protective agents|mesh-ancestor
56258873|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56258874|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56258875|NCT01932229|Afatinib|afatinib|mesh-list
56258876|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258877|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56258878|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258879|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258880|NCT01932268|Rifampin|rifampin|mesh-list
56258881|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56258882|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
56258883|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56258884|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258885|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
56258886|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55872354|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872355|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
55872356|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872357|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55872358|NCT04021264|Narcotics|narcotics|mesh-ancestor
55872359|NCT04021264|Analgesics|analgesics|mesh-ancestor
55872360|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55872361|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55872362|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
55872363|NCT03233139|Gemcitabine|gemcitabine|mesh-list
55872365|NCT03233139|Pemetrexed|pemetrexed|mesh-list
55872366|NCT03233139|Ipilimumab|ipilimumab|mesh-list
55872367|NCT03233139|Cemiplimab|cemiplimab|mesh-list
55872368|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55872369|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872370|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
55872371|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
55872372|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
55872373|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872374|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56258887|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258888|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258889|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56258890|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56258891|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56258892|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56258893|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56258894|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56258896|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
56258897|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56258898|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56258899|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56258900|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56258901|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258902|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56258903|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
56258904|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56258905|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258906|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56258936|NCT01932502|Clobazam|clobazam|mesh-list
56258937|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
56258938|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56258939|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56258940|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258941|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258942|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56258943|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56258944|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
56258945|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
56258946|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56258947|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258948|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56258949|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56258950|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56258951|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56258952|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56258953|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56258954|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56258955|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56258991|NCT01932580|Docetaxel|docetaxel|mesh-list
56258992|NCT01932580|Fluorouracil|fluorouracil|mesh-list
56258993|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
56258994|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56258995|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
56258996|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
56258997|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
56258998|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56258999|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
56259000|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56259001|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56259002|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
56259003|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259004|NCT01932918|Ketorolac|ketorolac|mesh-list
56259005|NCT01932918|Morphine|morphine|mesh-list
56259006|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56259007|NCT01932918|Narcotics|narcotics|mesh-ancestor
56259008|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259009|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259010|NCT01932918|Analgesics|analgesics|mesh-ancestor
56259011|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
56259012|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259013|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56259014|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56259015|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56259016|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56259017|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56259018|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259019|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259020|NCT01932931|Vitamin D|vitamin d|mesh-list
56259021|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
56259022|NCT01932931|Vitamins|vitamins|mesh-ancestor
56259023|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
56259024|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259033|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259034|NCT01933061|Paclitaxel|paclitaxel|mesh-list
56259035|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56259036|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56259037|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259038|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
56259039|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
56259040|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
56259041|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259042|NCT01933152|Ranibizumab|ranibizumab|mesh-list
56259043|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55790529|NCT05302921|Nivolumab|nivolumab|mesh-list
55790530|NCT05302921|Ipilimumab|ipilimumab|mesh-list
55790531|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790532|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790535|NCT04682743|Acetaminophen|acetaminophen|mesh-list
56259044|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56259045|NCT01933152|Growth Substances|growth substances|mesh-ancestor
56259046|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259047|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
56259048|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259049|NCT01933347|Gefitinib|gefitinib|mesh-list
56259050|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259051|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56259052|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259053|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259054|NCT01933360|Misoprostol|misoprostol|mesh-list
56259055|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56259056|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
56259057|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56259058|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259059|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56259060|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259061|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
56259062|NCT01933412|Vaccines|vaccines|mesh-list
56259063|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
56259064|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259065|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
56259075|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259076|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56259077|NCT01933542|Morphine|morphine|mesh-list
56259078|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
56259079|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56259080|NCT01933542|Narcotics|narcotics|mesh-ancestor
56259081|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259082|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259083|NCT01933542|Analgesics|analgesics|mesh-ancestor
56259084|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
56259085|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259086|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56259087|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56259088|NCT01933568|Cisplatin|cisplatin|mesh-list
56259089|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259090|NCT01933698|Amoxicillin|amoxicillin|mesh-list
56259091|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56259092|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259093|NCT01933711|Rituximab|rituximab|mesh-list
56259094|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56259095|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259096|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
56259097|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259098|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56259099|NCT01933906|Interferons|interferons|mesh-list
56259100|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
56259101|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
56259102|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56259103|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259104|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
56259105|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259106|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
56259107|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259108|NCT01933945|Sorafenib|sorafenib|mesh-list
55790544|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
56259109|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259110|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56259111|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834294|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
55872375|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
55872376|NCT03233139|Antiviral Agents|antiviral agents|mesh-ancestor
56259112|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259113|NCT01933971|Lenograstim|lenograstim|mesh-list
56259114|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56259115|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
56259116|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259117|NCT01933997|Pyridoxine|pyridoxine|mesh-list
56259118|NCT01933997|Metadoxine|metadoxine|mesh-list
56259119|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56259120|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
56259121|NCT01933997|Vitamins|vitamins|mesh-ancestor
56259122|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
56259123|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259178|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259179|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56259180|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56259181|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56259182|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56259183|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
56259184|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
56259185|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
56259186|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
56259187|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259188|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259189|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56259190|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56259191|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56259239|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56259240|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
56259241|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259242|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56259243|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
56259244|NCT01934816|Liraglutide|liraglutide|mesh-list
56259245|NCT01934816|Exenatide|exenatide|mesh-list
56259246|NCT01934816|Glucagon|glucagon|mesh-list
56259247|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56259248|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56259249|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259250|NCT01934816|Incretins|incretins|mesh-ancestor
56259251|NCT01934816|Hormones|hormones|mesh-ancestor
56259252|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56259253|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55881262|NCT03124680|Narcotics|narcotics|mesh-ancestor
56259254|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259255|NCT01934829|Sorafenib|sorafenib|mesh-list
56259256|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259257|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56259258|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259259|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259260|NCT01934933|Celecoxib|celecoxib|mesh-list
56259261|NCT01934933|Etanercept|etanercept|mesh-list
56259263|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56259291|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
56259292|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56259293|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259294|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
56259295|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259296|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
56259297|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259298|NCT01935115|Ketamine|ketamine|mesh-list
56259299|NCT01935115|Propofol|propofol|mesh-list
56259300|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56259301|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259302|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259303|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56259304|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
56259305|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
56259306|NCT01935115|Analgesics|analgesics|mesh-ancestor
56259307|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
56259308|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259309|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56259310|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56259311|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56259312|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259313|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259314|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
56259315|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56259316|NCT01935141|Growth Substances|growth substances|mesh-ancestor
56259317|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259318|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
56259319|NCT01935193|Analgesics|analgesics|mesh-ancestor
56259320|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
56259321|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259322|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259323|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56259324|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55872377|NCT03233139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872378|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872379|NCT03233139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872380|NCT03233139|Immunologic Factors|immunologic factors|mesh-ancestor
56259325|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56259326|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56259327|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56259328|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56259330|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259331|NCT01935206|Naloxone|naloxone|mesh-list
56259332|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56259333|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259334|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
56259335|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259336|NCT01935310|Imiquimod|imiquimod|mesh-list
56259337|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56259338|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
56259339|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259340|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259341|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
56259342|NCT01935492|Paclitaxel|paclitaxel|mesh-list
56259343|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56259344|NCT01935492|Bevacizumab|bevacizumab|mesh-list
56259345|NCT01935492|Doxorubicin|doxorubicin|mesh-list
56259346|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56259380|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56259381|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56259382|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56259383|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56259384|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
56259385|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56259386|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56259387|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259388|NCT01935518|Fasudil|fasudil|mesh-list
56259389|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56259390|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56259391|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259392|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56259393|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259394|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
56259395|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56259396|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259397|NCT01935531|Diclofenac|diclofenac|mesh-list
56259398|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
56259399|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55872381|NCT03233139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872382|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55872383|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55872384|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872385|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55872386|NCT04763343|Ketamine|ketamine|mesh-list
55872387|NCT04763343|Analgesics|analgesics|mesh-ancestor
55872388|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
55872389|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872390|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872391|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55872392|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55872393|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
55872394|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
55872395|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55872396|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55872397|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55872398|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872407|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872408|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55872410|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55872411|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55872412|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55872413|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872414|NCT03232593|Atezolizumab|atezolizumab|mesh-list
55872415|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872416|NCT04746183|Ritonavir|ritonavir|mesh-list
55872417|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
55872418|NCT04746183|Favipiravir|favipiravir|mesh-list
55872419|NCT04746183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55872420|NCT04746183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55872421|NCT04746183|Protease Inhibitors|protease inhibitors|mesh-ancestor
56259400|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56259401|NCT01935531|Analgesics|analgesics|mesh-ancestor
56259402|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
56259403|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259404|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259406|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56259407|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56259408|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259409|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259410|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56259411|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
56259412|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
56259413|NCT01935531|Protective Agents|protective agents|mesh-ancestor
56259414|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
56259415|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56259416|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56259417|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259418|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
56259456|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56259457|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
56259458|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56259459|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56259460|NCT01935713|Nicotine|nicotine|mesh-list
56259461|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56259462|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
56259463|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259464|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259465|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56259466|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56259467|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
55790545|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790546|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
56259468|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259469|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259470|NCT01935804|Metformin|metformin|mesh-list
56259471|NCT01935804|Pioglitazone|pioglitazone|mesh-list
56259472|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56259473|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259513|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56259514|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259515|NCT01935908|Levetiracetam|levetiracetam|mesh-list
56259516|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
56259517|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
56259518|NCT01935973|Trametinib|trametinib|mesh-list
56259519|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259520|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56259521|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259522|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259523|NCT01936012|Lisinopril|lisinopril|mesh-list
56259524|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56259525|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
56259526|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259527|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259528|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56259529|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56259530|NCT01936012|Protective Agents|protective agents|mesh-ancestor
56259531|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259532|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56259533|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
56259534|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56259535|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259536|NCT01936025|Incretins|incretins|mesh-ancestor
56259537|NCT01936025|Hormones|hormones|mesh-ancestor
56259538|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56259539|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56259540|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
56259541|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259542|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259543|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
55872422|NCT04746183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872423|NCT04746183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872424|NCT04746183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55872425|NCT04746183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55872426|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
55872427|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872428|NCT04746183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55872429|NCT04746183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55872430|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55872431|NCT01895309|Etanercept|etanercept|mesh-list
55872432|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56259544|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
56259545|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56259546|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56259547|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259548|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
56259549|NCT01936064|Epirubicin|epirubicin|mesh-list
56259550|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56259551|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
55881565|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
56259552|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259554|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56259555|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
56259556|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259557|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259558|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56259559|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56259560|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56259561|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56259562|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259563|NCT01936090|Bortezomib|bortezomib|mesh-list
56259564|NCT01936090|Melphalan|melphalan|mesh-list
56259565|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259566|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56259567|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
56259568|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259569|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56259570|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56259590|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259591|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259592|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56259593|NCT01936233|Aspirin|aspirin|mesh-list
56259594|NCT01936233|Lamivudine|lamivudine|mesh-list
56259595|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56259596|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56259597|NCT01936233|Analgesics|analgesics|mesh-ancestor
56259598|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
56259599|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259600|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259601|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56259602|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56259603|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56259604|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56259605|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259606|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56259607|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56259608|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259609|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
56259610|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56259611|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56259612|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
56259613|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259614|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56259615|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56259616|NCT01936285|Colchicine|colchicine|mesh-list
56259617|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
55872433|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55872434|NCT01895309|Analgesics|analgesics|mesh-ancestor
55872435|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
55872436|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872437|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872438|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55872439|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55872440|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55872441|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872442|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
55872443|NCT04614311|Triamcinolone|triamcinolone|mesh-list
55872444|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55872445|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55872446|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55872447|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55872448|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
55872449|NCT04614311|Hormones|hormones|mesh-ancestor
55872450|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56259619|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
56259620|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
56259621|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
56259622|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259623|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259624|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
56259625|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
56259626|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56259627|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56259628|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259629|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259630|NCT01936350|Urological Agents|urological agents|mesh-ancestor
56259631|NCT01936532|Dexamethasone|dexamethasone|mesh-list
56259632|NCT01936532|Lenalidomide|lenalidomide|mesh-list
56259633|NCT01936532|Ixazomib|ixazomib|mesh-list
56259634|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56259635|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
56259636|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
56259637|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259638|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259639|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259640|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
56259641|NCT01936532|Hormones|hormones|mesh-ancestor
56259642|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56259643|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56259644|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259645|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
56259646|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56259647|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55872451|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872452|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872453|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
55872454|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872455|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872457|NCT03681639|Chromium|chromium|mesh-list
55872458|NCT03681639|Trace Elements|trace elements|mesh-ancestor
55872459|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
55872460|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872461|NCT03285321|Nivolumab|nivolumab|mesh-list
55872462|NCT03285321|Ipilimumab|ipilimumab|mesh-list
55872463|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872466|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259648|NCT01936532|Growth Substances|growth substances|mesh-ancestor
56259649|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
56259650|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
56259651|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259652|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259653|NCT01936545|Propofol|propofol|mesh-list
56259654|NCT01936545|Desflurane|desflurane|mesh-list
56259655|NCT01936545|Liver Extracts|liver extracts|mesh-list
56259656|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56259657|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259658|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259659|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56259660|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
56259661|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
56259662|NCT01936545|Hematinics|hematinics|mesh-ancestor
56259663|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56259664|NCT01936636|Fentanyl|fentanyl|mesh-list
55872468|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749600|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
55723383|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
55723384|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723385|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723386|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723387|NCT05036798|Lenvatinib|lenvatinib|mesh-list
55723388|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723389|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55723390|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723391|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723392|NCT04982354|Fludarabine|fludarabine|mesh-list
55723393|NCT04982354|Melphalan|melphalan|mesh-list
55723394|NCT04982354|Busulfan|busulfan|mesh-list
55723395|NCT04982354|Midostaurin|midostaurin|mesh-list
55723396|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723397|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723398|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55723399|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
55723400|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723401|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55723402|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
55723403|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55723404|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55723405|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723406|NCT04209218|Dexamethasone|dexamethasone|mesh-list
55872469|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872470|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55872471|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55872472|NCT03284307|Midazolam|midazolam|mesh-list
55872473|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
55872474|NCT03284307|Ketamine|ketamine|mesh-list
55872475|NCT03284307|Propofol|propofol|mesh-list
55872476|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55872477|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55872478|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872479|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55872480|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
55872481|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
55872482|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55872483|NCT03284307|Analgesics|analgesics|mesh-ancestor
55872484|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
55872485|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872486|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55872487|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55872488|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55872489|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
55872490|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872491|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872492|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55872493|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55872494|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55872495|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55872496|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55872497|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55872498|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55872499|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
55872500|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
55872501|NCT04323748|Rituximab|rituximab|mesh-list
55872502|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872503|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872504|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
55872505|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872506|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55872507|NCT03283917|Dexamethasone|dexamethasone|mesh-list
55872508|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
55872509|NCT03283917|Daratumumab|daratumumab|mesh-list
55872510|NCT03283917|Ixazomib|ixazomib|mesh-list
55872511|NCT03283917|Ichthammol|ichthammol|mesh-list
56259666|NCT01936636|Narcotics|narcotics|mesh-ancestor
56259667|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259668|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259669|NCT01936636|Analgesics|analgesics|mesh-ancestor
56259670|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
56259671|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259672|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56259673|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56259674|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
56259675|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
56259676|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56259677|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56259678|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56259679|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
56259680|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259681|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56259682|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56259683|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259684|NCT01936961|Antibodies|antibodies|mesh-list
56259685|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
55872512|NCT03283917|BB 1101|bb 1101|mesh-list
55872513|NCT03283917|Glycine|glycine|mesh-list
55872514|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55872515|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
55872516|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
55872517|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872518|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872519|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55872520|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
55872521|NCT03283917|Hormones|hormones|mesh-ancestor
55872522|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872523|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55872524|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872525|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
55872526|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872527|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872528|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
55872529|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
55872530|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872531|NCT04704999|Chloroquine|chloroquine|mesh-list
55872532|NCT04704999|Lumefantrine|lumefantrine|mesh-list
55872533|NCT04704999|Artemether|artemether|mesh-list
55872534|NCT04704999|Tafenoquine|tafenoquine|mesh-list
55872535|NCT04704999|Amebicides|amebicides|mesh-ancestor
55872536|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55872537|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55872538|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872543|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872544|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55749605|NCT04486651|Irinotecan|irinotecan|mesh-list
55872545|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872546|NCT05320731|Lidocaine|lidocaine|mesh-list
55872547|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
55872548|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
56259686|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259687|NCT01937013|Oxytocin|oxytocin|mesh-list
56259688|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
56259689|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56259690|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259691|NCT01937078|Famotidine|famotidine|mesh-list
56259692|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56259693|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259694|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56259695|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
56259696|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
56259697|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259698|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259699|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259700|NCT01937104|Remifentanil|remifentanil|mesh-list
56259701|NCT01937104|Desflurane|desflurane|mesh-list
55872549|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55872550|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872551|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
55872552|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872553|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55872554|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55872555|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55872556|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55872557|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872558|NCT02808364|Vaccines|vaccines|mesh-list
55872559|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
55872560|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872561|NCT02709616|Vaccines|vaccines|mesh-list
55872562|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
55872563|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872564|NCT04534881|Progesterone|progesterone|mesh-list
55872565|NCT04534881|Progestins|progestins|mesh-ancestor
55872566|NCT04534881|Hormones|hormones|mesh-ancestor
55872567|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872568|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872569|NCT04817956|Trastuzumab|trastuzumab|mesh-list
55872570|NCT04817956|Pertuzumab|pertuzumab|mesh-list
55872571|NCT04817956|Atezolizumab|atezolizumab|mesh-list
55872572|NCT04817956|Vemurafenib|vemurafenib|mesh-list
55872573|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55872574|NCT04817956|Entrectinib|entrectinib|mesh-list
55872575|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872576|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872577|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872578|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
55872579|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55872580|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872581|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872582|NCT01894919|Vaccines|vaccines|mesh-list
55872583|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
55872584|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872585|NCT04130698|Nicotine|nicotine|mesh-list
55872586|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55872587|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
55872588|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872589|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872590|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55872591|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56259702|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56259703|NCT01937104|Narcotics|narcotics|mesh-ancestor
56259704|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259705|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259706|NCT01937104|Analgesics|analgesics|mesh-ancestor
56259707|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
56259708|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259709|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56259710|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
56259711|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
56259712|NCT01937156|Granisetron|granisetron|mesh-list
56259713|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
56259714|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
56259715|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259716|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259717|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259718|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56259719|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
56259720|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259721|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259722|NCT01937169|Levodopa|levodopa|mesh-list
56259723|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55872592|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
55872593|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872594|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872595|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55872596|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55872597|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872598|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872599|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
55872600|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872601|NCT05306223|Levofloxacin|levofloxacin|mesh-list
55872602|NCT05306223|Ofloxacin|ofloxacin|mesh-list
55872603|NCT05306223|Cycloserine|cycloserine|mesh-list
55872604|NCT05306223|Linezolid|linezolid|mesh-list
55872605|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
55872606|NCT05306223|Bedaquiline|bedaquiline|mesh-list
55872607|NCT05306223|Clofazimine|clofazimine|mesh-list
55872608|NCT05306223|Prothionamide|prothionamide|mesh-list
55872611|NCT05306223|Renal Agents|renal agents|mesh-ancestor
55872612|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55872613|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55872614|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55872615|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872616|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872617|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872618|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55872619|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55872620|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55872621|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55872622|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
55872624|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56259724|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56259725|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
56259726|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259727|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259728|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259729|NCT01937182|Citalopram|citalopram|mesh-list
56259730|NCT01937182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56259731|NCT01937182|Serotonin|serotonin|mesh-list
56259732|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56259733|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56259734|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259735|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259736|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
56259737|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259738|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56259739|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
56259740|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56259741|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56259742|NCT01937234|Metoclopramide|metoclopramide|mesh-list
56259743|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
56259744|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
56259745|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259746|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259747|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259748|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56259749|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56259750|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
55834943|NCT02013817|Rituximab|rituximab|mesh-list
55872625|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
55872626|NCT03016000|Thalidomide|thalidomide|mesh-list
55872627|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872628|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
55872629|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872630|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
55872631|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55872632|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872633|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55872634|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55872635|NCT03016000|Growth Substances|growth substances|mesh-ancestor
55872636|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
55872637|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872638|NCT04130152|Letrozole|letrozole|mesh-list
55872639|NCT04130152|Palbociclib|palbociclib|mesh-list
55872640|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872641|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55872642|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56259751|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259752|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259753|NCT01937325|Ivacaftor|ivacaftor|mesh-list
56259754|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56259755|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56259756|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259757|NCT01937338|AZD7624|azd7624|mesh-list
56259758|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56259759|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259760|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259761|NCT01937442|Thalidomide|thalidomide|mesh-list
56259762|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56259763|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
56259764|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259765|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
56259766|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56259767|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259768|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56259769|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56259770|NCT01937442|Growth Substances|growth substances|mesh-ancestor
56259771|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
56259772|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259773|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
56259774|NCT01937494|Histamine|histamine|mesh-list
56259775|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
56259776|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
56259777|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259778|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259779|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259780|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
56259794|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56259795|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56259796|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56259797|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
56259798|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259799|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259800|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56259801|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56259802|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56259803|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56259804|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56259805|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
56259807|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
56259808|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
56259809|NCT01937650|Metronidazole|metronidazole|mesh-list
56259810|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259811|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56259812|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56259813|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56259814|NCT01937728|Interferons|interferons|mesh-list
56259815|NCT01937728|Ribavirin|ribavirin|mesh-list
56259816|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
56259817|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
56259818|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56259819|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259820|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
56259821|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259822|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
56259824|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
56259842|NCT01937767|Remifentanil|remifentanil|mesh-list
56259843|NCT01937767|Propofol|propofol|mesh-list
56259844|NCT01937767|Sevoflurane|sevoflurane|mesh-list
55872643|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872644|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872645|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55872646|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
55872647|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872648|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872649|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55872650|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
55872651|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872652|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872653|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872654|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55872655|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
55872656|NCT03254589|Methotrexate|methotrexate|mesh-list
55872657|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55872658|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
55872659|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55872660|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872661|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55872662|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
55872663|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872664|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872665|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
55872666|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872667|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55872668|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872669|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
55872670|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55872671|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55872672|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872673|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55872674|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55872675|NCT03254589|Analgesics|analgesics|mesh-ancestor
55872676|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
55872677|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872678|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55872679|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55872682|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55872683|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55872684|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872685|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
55872686|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872687|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55872688|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
55872689|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55872690|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55872691|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55872692|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55872693|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872694|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
55872695|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872696|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55872697|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55872698|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872699|NCT03250377|Brivaracetam|brivaracetam|mesh-list
55872700|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
55872701|NCT04613453|Midazolam|midazolam|mesh-list
55872702|NCT04613453|Ketamine|ketamine|mesh-list
55872703|NCT04613453|Analgesics|analgesics|mesh-ancestor
55872704|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
55872705|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872706|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872707|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55872708|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55872709|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
55872710|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
55872711|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55872712|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56259845|NCT01937767|Rocuronium|rocuronium|mesh-list
56259846|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56259847|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259848|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259849|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56259850|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
56259851|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
56259852|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56259853|NCT01937767|Narcotics|narcotics|mesh-ancestor
56259854|NCT01937767|Analgesics|analgesics|mesh-ancestor
56259855|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
56259856|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259857|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56259858|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56259859|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56259860|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56259861|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56259862|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56259863|NCT01937806|Tenofovir|tenofovir|mesh-list
56259864|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
56259865|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259866|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56259867|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56259868|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259869|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259870|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56259871|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56259872|NCT01937832|Ertapenem|ertapenem|mesh-list
56259893|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
56259894|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
56259895|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259896|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259897|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
56259898|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56259899|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259900|NCT01938144|Acetaminophen|acetaminophen|mesh-list
56259901|NCT01938144|Ibuprofen|ibuprofen|mesh-list
56259902|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56259903|NCT01938144|Analgesics|analgesics|mesh-ancestor
56259904|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
56259905|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259906|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259907|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
56259908|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56259911|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56259912|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790548|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56259913|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259914|NCT01938183|Metronidazole|metronidazole|mesh-list
56259919|NCT01938235|Exenatide|exenatide|mesh-list
56259946|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56259947|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259948|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259949|NCT01938456|Docetaxel|docetaxel|mesh-list
56259950|NCT01938456|Trametinib|trametinib|mesh-list
56259951|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259952|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
56259953|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
56259954|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
56259955|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259956|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56259957|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835148|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
55872713|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55872714|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872715|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872716|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55872717|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55872718|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55872719|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55872720|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55872721|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
55872722|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
55872723|NCT02000596|Trastuzumab|trastuzumab|mesh-list
55872724|NCT02000596|Pertuzumab|pertuzumab|mesh-list
55872725|NCT02000596|Fulvestrant|fulvestrant|mesh-list
55872726|NCT02000596|Anastrozole|anastrozole|mesh-list
55872727|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872728|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872729|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55872730|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55872732|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
55872733|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872734|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872735|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55872736|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55872737|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872738|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872739|NCT03223779|Trifluridine|trifluridine|mesh-list
55872740|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
55872741|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872742|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
55872743|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872744|NCT05168865|Letrozole|letrozole|mesh-list
55872745|NCT05168865|Estradiol|estradiol|mesh-list
55872746|NCT05168865|Progesterone|progesterone|mesh-list
55872747|NCT05168865|Estrogens|estrogens|mesh-ancestor
55872748|NCT05168865|Hormones|hormones|mesh-ancestor
55872749|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872750|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872751|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872752|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55872753|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55872755|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872756|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55872757|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
55872758|NCT05168865|Progestins|progestins|mesh-ancestor
55872759|NCT01882985|Lycopene|lycopene|mesh-list
55872760|NCT01882985|Docetaxel|docetaxel|mesh-list
55872761|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872762|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
56259958|NCT01938508|Minocycline|minocycline|mesh-list
56259959|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56259960|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259961|NCT01938612|Durvalumab|durvalumab|mesh-list
56259962|NCT01938612|Tremelimumab|tremelimumab|mesh-list
56259963|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56259964|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259965|NCT01938729|Gemcitabine|gemcitabine|mesh-list
56259966|NCT01938729|Dexamethasone|dexamethasone|mesh-list
56259967|NCT01938729|Floxuridine|floxuridine|mesh-list
56259968|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56259969|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
56259970|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
56259971|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259972|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259973|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56259974|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
56259975|NCT01938729|Hormones|hormones|mesh-ancestor
56259976|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56259977|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55790550|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56259978|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56259979|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56259980|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
56259981|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56259982|NCT01938729|Antiviral Agents|antiviral agents|mesh-ancestor
56259983|NCT01938729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259984|NCT01938729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56259985|NCT01938729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56259986|NCT01938729|Immunologic Factors|immunologic factors|mesh-ancestor
56259987|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
56259988|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
56259989|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
55872763|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
55872764|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
55872765|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872766|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55872767|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
55872768|NCT01882985|Protective Agents|protective agents|mesh-ancestor
55872769|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872770|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55872771|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55872772|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
55872773|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55872774|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56259990|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56259991|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56259992|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
56259993|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56259994|NCT01938781|Entecavir|entecavir|mesh-list
56259995|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
56259996|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56259997|NCT01938820|Entecavir|entecavir|mesh-list
56259998|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
56259999|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260000|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56260001|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
56260002|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56260003|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56260004|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56260005|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260006|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260007|NCT01938872|Paclitaxel|paclitaxel|mesh-list
56260008|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56260009|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260010|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
56260011|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
56260012|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
56260013|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260014|NCT01938911|Oxytocin|oxytocin|mesh-list
56260015|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
55790551|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790552|NCT04682743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55872775|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872776|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55872777|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
55872778|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872779|NCT03015922|Lenalidomide|lenalidomide|mesh-list
55872780|NCT03015922|Pomalidomide|pomalidomide|mesh-list
55872781|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
55872782|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872783|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55872784|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55872785|NCT03015922|Growth Substances|growth substances|mesh-ancestor
55872786|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
55872787|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790553|NCT04682743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55790554|NCT04682743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55872788|NCT01893827|Naltrexone|naltrexone|mesh-list
55872789|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55872790|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55872791|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872792|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
55872793|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872794|NCT01882907|Pioglitazone|pioglitazone|mesh-list
55872795|NCT01882907|Vildagliptin|vildagliptin|mesh-list
55872796|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55872797|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260016|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56260017|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260019|NCT01939054|Capecitabine|capecitabine|mesh-list
56260020|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
56260021|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260022|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
56260023|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
56260024|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
56260025|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260026|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56260027|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
56260028|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260029|NCT01939093|Thiamine|thiamine|mesh-list
56260030|NCT01939093|Cinnarizine|cinnarizine|mesh-list
56260031|NCT01939093|Diazepam|diazepam|mesh-list
56260032|NCT01939093|Vitamins|vitamins|mesh-ancestor
56260033|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
56260076|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
56260078|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56260079|NCT01939379|Morphine|morphine|mesh-list
56260080|NCT01939379|Oxycodone|oxycodone|mesh-list
56260081|NCT01939379|Analgesics|analgesics|mesh-list
55882086|NCT03003832|Analgesics|analgesics|mesh-list
56260082|NCT01939379|Ropivacaine|ropivacaine|mesh-list
56260083|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56260084|NCT01939379|Narcotics|narcotics|mesh-ancestor
56260085|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260087|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
56260088|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260089|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
56260090|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
56260091|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56260092|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56260093|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56260094|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56260095|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
56260096|NCT01939418|Gemcitabine|gemcitabine|mesh-list
56260097|NCT01939418|Everolimus|everolimus|mesh-list
56260098|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260099|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56260100|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
56260108|NCT01939444|Naloxone|naloxone|mesh-list
56260129|NCT01939509|Atenolol|atenolol|mesh-list
56260130|NCT01939509|Bisoprolol|bisoprolol|mesh-list
56260131|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56260132|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56260133|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
56260134|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
56260135|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260136|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260137|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56260138|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56260139|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56260140|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
56260141|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260142|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260143|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55872798|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55872799|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
55872800|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872801|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872802|NCT01051570|Prednisone|prednisone|mesh-list
55872803|NCT01051570|Carboplatin|carboplatin|mesh-list
55872804|NCT01051570|Everolimus|everolimus|mesh-list
55872805|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872806|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55872807|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
55872808|NCT01051570|Hormones|hormones|mesh-ancestor
55872809|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872810|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872811|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55872812|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872813|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
55872814|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
55872815|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55872816|NCT01893281|Testosterone|testosterone|mesh-list
55790555|NCT04682743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55790556|NCT04682743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55790557|NCT03472573|Dexamethasone|dexamethasone|mesh-list
55790558|NCT03472573|Palbociclib|palbociclib|mesh-list
55790559|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55872817|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
55872818|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
55872819|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55872820|NCT01893281|Androgens|androgens|mesh-ancestor
55872822|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872823|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872824|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55872825|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872826|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
55872827|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55872828|NCT02981446|Latanoprost|latanoprost|mesh-list
55872829|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55872831|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55872832|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
55872833|NCT05263947|Bevacizumab|bevacizumab|mesh-list
55872834|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872835|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872836|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55872837|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55872838|NCT05263947|Growth Substances|growth substances|mesh-ancestor
55872839|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872840|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
55872842|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260144|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
56260145|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260146|NCT01939561|Lamotrigine|lamotrigine|mesh-list
56260147|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
56260148|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56260149|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260150|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260151|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56260152|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260153|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56260154|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56260155|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260156|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56260157|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56260158|NCT01939574|Bevacizumab|bevacizumab|mesh-list
56260159|NCT01939574|Temozolomide|temozolomide|mesh-list
56260160|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260161|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260162|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56260163|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56260164|NCT01939574|Growth Substances|growth substances|mesh-ancestor
56260165|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260166|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
56260167|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56260168|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
56260169|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260170|NCT01939639|Oxytocin|oxytocin|mesh-list
56260171|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
56260172|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55835343|NCT01986062|Amphetamine|amphetamine|mesh-list
55872843|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55872844|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872845|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872846|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
55872847|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55872848|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872849|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55872850|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
55872851|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55872852|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872853|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872854|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260174|NCT01939691|Prednisolone|prednisolone|mesh-list
56260175|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56260176|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
56260177|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56260178|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
56260179|NCT01939691|Nepafenac|nepafenac|mesh-list
56260180|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56260181|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
56260182|NCT01939691|Difluprednate|difluprednate|mesh-list
56260183|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56260184|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
56260185|NCT01939691|Hormones|hormones|mesh-ancestor
56260186|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56260187|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260188|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56260189|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260190|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
56260191|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
56260192|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260193|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56260194|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56260195|NCT01939691|Protective Agents|protective agents|mesh-ancestor
56260196|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56260197|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56260198|NCT01939691|Analgesics|analgesics|mesh-ancestor
56260199|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
56260200|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56260201|NCT01939730|Rituximab|rituximab|mesh-list
56260202|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260218|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260219|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260220|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55872855|NCT03280251|Methylphenidate|methylphenidate|mesh-list
55872856|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55872857|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872858|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55872859|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55872860|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55872861|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872862|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
55872863|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872864|NCT01882829|Quinidine|quinidine|mesh-list
55872865|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
55872866|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
55872867|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
55872868|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55872869|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55872870|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872871|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872872|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872873|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55872874|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55872875|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
55872876|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55872877|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
55872878|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55872879|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55872880|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872881|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872882|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55872883|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55872884|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
55872885|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55872886|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55872887|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55872888|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55872889|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55872890|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
55872891|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55872892|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55872894|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
55872895|NCT04760301|Coagulants|coagulants|mesh-ancestor
55872896|NCT04392375|Nifedipine|nifedipine|mesh-list
55872897|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55872898|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55872899|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872909|NCT01054768|Protective Agents|protective agents|mesh-ancestor
55872910|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872911|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
55872912|NCT01054768|Vitamins|vitamins|mesh-ancestor
55872913|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
55872914|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
55872915|NCT04387617|Cannabidiol|cannabidiol|mesh-list
55872916|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
55872917|NCT01055704|Naltrexone|naltrexone|mesh-list
55872918|NCT01055704|Codeine|codeine|mesh-list
55872919|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
55872920|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55872921|NCT01055704|Narcotics|narcotics|mesh-ancestor
55872922|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55872923|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872924|NCT01055704|Analgesics|analgesics|mesh-ancestor
55872925|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
55872926|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872927|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
55872928|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
55872929|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56260221|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56260223|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56260224|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56260225|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56260226|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260227|NCT01939834|Insulin|insulin|mesh-list
56260228|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56260229|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260230|NCT01939886|Artesunate|artesunate|mesh-list
55882247|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
56260231|NCT01939886|Lumefantrine|lumefantrine|mesh-list
56260232|NCT01939886|Artemether|artemether|mesh-list
55872930|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55872931|NCT03280017|Ketamine|ketamine|mesh-list
55872932|NCT03280017|Analgesics|analgesics|mesh-ancestor
55872933|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
55872934|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872935|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872936|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55872937|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55872938|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
55872939|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
55872940|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55872941|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55872942|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55872943|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872944|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872945|NCT01882439|Tofacitinib|tofacitinib|mesh-list
55872946|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55790560|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
55790561|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
55790562|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790563|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790564|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790565|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
55790567|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790568|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55790569|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790570|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55872947|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872948|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872949|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
55872950|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
55872951|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55872952|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55872953|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872954|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872955|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872956|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55872957|NCT05225805|Lefamulin|lefamulin|mesh-list
55872958|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55872959|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872960|NCT03915405|Avelumab|avelumab|mesh-list
55872961|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872962|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872963|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55872964|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
55872965|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872969|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872970|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872971|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872972|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
55872973|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872974|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55872976|NCT01109056|Cyclosporins|cyclosporins|mesh-list
55872977|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872978|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872979|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55872980|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
55872981|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260233|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56260235|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
56260236|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56260237|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56260238|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260239|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260240|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
56260241|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
56260242|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56260243|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
56260244|NCT01939912|Adenosine|adenosine|mesh-list
56260245|NCT01939912|Analgesics|analgesics|mesh-ancestor
56260246|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
56260247|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260248|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260249|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56260250|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
56260251|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56260252|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
55872982|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
55872983|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872984|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
55872985|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55872986|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55872987|NCT03870399|Tamoxifen|tamoxifen|mesh-list
55872988|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55872989|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
55872990|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55872991|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872992|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55872993|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55872994|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55790571|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723407|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
55723408|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723409|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
55723410|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
55723411|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723412|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723413|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723414|NCT04209218|Hormones|hormones|mesh-ancestor
55723415|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723416|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55723417|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723418|NCT04218968|Carvedilol|carvedilol|mesh-list
55723419|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55723420|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55723421|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
55723422|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723423|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723424|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723425|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55723426|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
55723427|NCT04218968|Protective Agents|protective agents|mesh-ancestor
55723428|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55723429|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55723430|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55723431|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
55723432|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55723433|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55723434|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
55723435|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55723436|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723437|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55723438|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723439|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55723440|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
55723441|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55723442|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55723443|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
55723444|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723446|NCT04421300|Protective Agents|protective agents|mesh-ancestor
55723447|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55723448|NCT05026736|Antibodies|antibodies|mesh-list
55723449|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
55723450|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55723451|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
55723452|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723453|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723454|NCT02268058|Acetaminophen|acetaminophen|mesh-list
55723455|NCT02268058|Ibuprofen|ibuprofen|mesh-list
55723456|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55723457|NCT02268058|Analgesics|analgesics|mesh-ancestor
55723458|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
55723459|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723460|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723461|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
55723462|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55872995|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55872996|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55872997|NCT03867201|Erenumab|erenumab|mesh-list
55872998|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55872999|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873000|NCT03867201|Analgesics|analgesics|mesh-ancestor
55873001|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
55873002|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873003|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873004|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55873005|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55873006|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873007|NCT04333407|Aspirin|aspirin|mesh-list
55873008|NCT04333407|Omeprazole|omeprazole|mesh-list
55873009|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
55873010|NCT04333407|Clopidogrel|clopidogrel|mesh-list
55873011|NCT04333407|Atorvastatin|atorvastatin|mesh-list
55873012|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55873013|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873014|NCT04333407|Analgesics|analgesics|mesh-ancestor
55873015|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
55873016|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260253|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
56260254|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260255|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260256|NCT01939990|Nebivolol|nebivolol|mesh-list
56260257|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56260258|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
56260259|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56260260|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56260261|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56260262|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
56260263|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260264|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260265|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260266|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56260267|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873017|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873018|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873019|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873020|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55873021|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55873022|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873023|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55873025|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873026|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
55873027|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55873028|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55873029|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
55873030|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55873031|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55873032|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55873033|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55873034|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55873037|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55873038|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
55873039|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55873040|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
55873041|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
55873042|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55873043|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55873044|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55873045|NCT04398927|Folfirinox|folfirinox|mesh-list
55873046|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873047|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
55873048|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55873049|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55873050|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
55873051|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873052|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55873053|NCT04399083|Caffeine|caffeine|mesh-list
55873054|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55873055|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873056|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55873057|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873058|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873059|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56260268|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260269|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260270|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56260271|NCT01940172|Conatumumab|conatumumab|mesh-list
56260272|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260273|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260274|NCT01940224|Pregabalin|pregabalin|mesh-list
56260275|NCT01940224|Morphine|morphine|mesh-list
56260276|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56260277|NCT01940224|Narcotics|narcotics|mesh-ancestor
56260278|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260279|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260280|NCT01940224|Analgesics|analgesics|mesh-ancestor
56260281|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
56260282|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260283|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
56260284|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56260285|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260286|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260287|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56260288|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56260289|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56260290|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56260291|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
56260292|NCT01940250|Analgesics|analgesics|mesh-ancestor
56260293|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
56260294|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260295|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260296|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
56260297|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260298|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55873060|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55873061|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
55873062|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873063|NCT01892345|Eculizumab|eculizumab|mesh-list
55873064|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55873065|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55873066|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
55873067|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873068|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
55873069|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
55873070|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55873071|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56260299|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
56260300|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56260301|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260302|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723541|NCT04215146|Avelumab|avelumab|mesh-list
55723542|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55723543|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723544|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
55723545|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
55723546|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
55723547|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723548|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723549|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55723550|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55723551|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
55723552|NCT04214678|Hormones|hormones|mesh-ancestor
55723553|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723554|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723556|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723558|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
55723559|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
55723560|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723561|NCT04959266|Itraconazole|itraconazole|mesh-list
55723562|NCT04959266|Rifampin|rifampin|mesh-list
55723563|NCT04959266|Omeprazole|omeprazole|mesh-list
55723564|NCT04959266|Adavosertib|adavosertib|mesh-list
55723565|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55723566|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723567|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55723568|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723569|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723570|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
55723571|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723572|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55723573|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55723574|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55828651|NCT04102618|Atezolizumab|atezolizumab|mesh-list
55828652|NCT04102618|Letrozole|letrozole|mesh-list
55828653|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260303|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56260304|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
56260305|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56260306|NCT01940393|Cetirizine|cetirizine|mesh-list
56260307|NCT01940393|Fexofenadine|fexofenadine|mesh-list
56260308|NCT01940393|Desloratadine|desloratadine|mesh-list
56260309|NCT01940393|Ebastine|ebastine|mesh-list
55882305|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
56260310|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56260311|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56260312|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56260313|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
56260314|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
56260315|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260316|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260317|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260318|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56260319|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
56260320|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
56260321|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56260322|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56260323|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260324|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
56260325|NCT01940419|Coagulants|coagulants|mesh-ancestor
56260326|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
56260327|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56260328|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56260329|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260330|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
55873072|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723650|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
55723651|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723652|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723653|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55723654|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55723655|NCT05003570|Fentanyl|fentanyl|mesh-list
55723656|NCT05003570|Remifentanil|remifentanil|mesh-list
55723657|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55723658|NCT05003570|Narcotics|narcotics|mesh-ancestor
55723659|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55723660|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723661|NCT05003570|Analgesics|analgesics|mesh-ancestor
55723662|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
55723663|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723664|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55723665|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55723666|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
55723667|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
55723668|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55723669|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723670|NCT02483078|Leronlimab|leronlimab|mesh-list
55723671|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55723672|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55723673|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723674|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55723675|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55723676|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
55723678|NCT02452190|Reslizumab|reslizumab|mesh-list
55723679|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55723680|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
55723681|NCT02514122|Ketamine|ketamine|mesh-list
55723682|NCT02514122|Analgesics|analgesics|mesh-ancestor
55723683|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
55723684|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723685|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723687|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55723688|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
55723690|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55723691|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55723692|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55723693|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723694|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723696|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723697|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873073|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873074|NCT01059994|Urological Agents|urological agents|mesh-ancestor
55873075|NCT03819465|Gemcitabine|gemcitabine|mesh-list
55873076|NCT03819465|Paclitaxel|paclitaxel|mesh-list
55873077|NCT03819465|Carboplatin|carboplatin|mesh-list
55873078|NCT03819465|Pemetrexed|pemetrexed|mesh-list
55873079|NCT03819465|Durvalumab|durvalumab|mesh-list
55873080|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56260331|NCT01940536|Coagulants|coagulants|mesh-ancestor
56260332|NCT01940601|Lenograstim|lenograstim|mesh-list
56260333|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56260334|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
56260335|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260336|NCT01940627|Ubiquinone|ubiquinone|mesh-list
56260337|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
56260338|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
56260339|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260340|NCT01940627|Vitamins|vitamins|mesh-ancestor
56260341|NCT01940653|Estradiol|estradiol|mesh-list
56260342|NCT01940653|Progesterone|progesterone|mesh-list
56260343|NCT01940653|Estrogens|estrogens|mesh-ancestor
56260344|NCT01940653|Hormones|hormones|mesh-ancestor
56260345|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56260346|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260347|NCT01940653|Progestins|progestins|mesh-ancestor
56260348|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
55835531|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55835545|NCT01802385|Sertraline|sertraline|mesh-list
55873081|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873082|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
55873083|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
55873084|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
55873085|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873086|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55873087|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
55873088|NCT03819465|Antiviral Agents|antiviral agents|mesh-ancestor
55873089|NCT03819465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55873090|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873091|NCT03819465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55873092|NCT03819465|Immunologic Factors|immunologic factors|mesh-ancestor
55873093|NCT03819465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873094|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55873095|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55873096|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873097|NCT01111318|Empagliflozin|empagliflozin|mesh-list
55873098|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55873099|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873100|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55873101|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873102|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
55873103|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873104|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873106|NCT01892189|Analgesics|analgesics|mesh-ancestor
55873107|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
55873108|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873113|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
55873114|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873115|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55873116|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55873117|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873118|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873119|NCT01062568|Dexamethasone|dexamethasone|mesh-list
55873120|NCT01062568|Cosyntropin|cosyntropin|mesh-list
55873121|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55873122|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56260350|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56260351|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260352|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
56260353|NCT01940692|Coagulants|coagulants|mesh-ancestor
56260354|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
56260355|NCT01940718|Testosterone|testosterone|mesh-list
56260356|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
56260357|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
56260358|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56260359|NCT01940718|Androgens|androgens|mesh-ancestor
56260360|NCT01940718|Hormones|hormones|mesh-ancestor
56260361|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56260362|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260363|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56260364|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260365|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
56260366|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56260367|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260368|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260369|NCT01940952|Donepezil|donepezil|mesh-list
56260370|NCT01940952|Udenafil|udenafil|mesh-list
56260371|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56260372|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260374|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
56260399|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
56260400|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56260401|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
56260402|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56260403|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56260404|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56260405|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260407|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
56260408|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260409|NCT01941056|Vaccines|vaccines|mesh-list
56260410|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
56260411|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260412|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
56260413|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56260414|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56260415|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
56260416|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
56260417|NCT01941134|Estradiol|estradiol|mesh-list
56260418|NCT01941134|Estrogens|estrogens|mesh-ancestor
56260419|NCT01941134|Hormones|hormones|mesh-ancestor
56260420|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56260421|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260422|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56260423|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56260424|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56260425|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56260426|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56260427|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56260428|NCT01941173|Leucovorin|leucovorin|mesh-list
56260429|NCT01941173|Fluorouracil|fluorouracil|mesh-list
56260430|NCT01941173|Irinotecan|irinotecan|mesh-list
56260431|NCT01941173|Aflibercept|aflibercept|mesh-list
56260432|NCT01941173|Calcium|calcium|mesh-list
56260433|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
56260434|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
55873123|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
56260437|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
56260438|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260439|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56260440|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260441|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56260442|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
56260443|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56260444|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56260445|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260446|NCT01941173|Antidotes|antidotes|mesh-ancestor
56260447|NCT01941173|Protective Agents|protective agents|mesh-ancestor
56260448|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
56260449|NCT01941173|Vitamins|vitamins|mesh-ancestor
56260450|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
56260451|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56260452|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56260453|NCT01941173|Growth Substances|growth substances|mesh-ancestor
56260454|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
56260455|NCT01941199|Metformin|metformin|mesh-list
56260456|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56260457|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260458|NCT01941225|Iloprost|iloprost|mesh-list
56260459|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56260460|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
56260461|NCT01941264|Lumefantrine|lumefantrine|mesh-list
55882454|NCT03357900|Propofol|propofol|mesh-list
56260463|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56260464|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
55873124|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873125|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
55873126|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
55873127|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873128|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873129|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55873130|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
55873131|NCT01062568|Hormones|hormones|mesh-ancestor
55873132|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873133|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55873134|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873135|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873136|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873137|NCT05155137|Amlodipine|amlodipine|mesh-list
55873138|NCT05155137|Valsartan|valsartan|mesh-list
55873139|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55873141|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55873142|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873143|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260465|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56260466|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56260467|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260469|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56260470|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56260471|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260472|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260473|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260474|NCT01941329|Ranibizumab|ranibizumab|mesh-list
56260475|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56260476|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56260477|NCT01941329|Growth Substances|growth substances|mesh-ancestor
56260478|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260479|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
56260480|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260481|NCT01941407|Bevacizumab|bevacizumab|mesh-list
56260482|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260483|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260484|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56260485|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55790572|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260486|NCT01941407|Growth Substances|growth substances|mesh-ancestor
56260487|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260488|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
56260489|NCT01941524|Poractant alfa|poractant alfa|mesh-list
56260490|NCT01941524|Beractant|beractant|mesh-list
56260491|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56260492|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
56260493|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56260494|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
56260495|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260496|NCT01941602|Enoxaparin|enoxaparin|mesh-list
56260497|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
56260498|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56260499|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56260500|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260501|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
55873144|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55873145|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260502|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
56260503|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56260504|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56260505|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260506|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260507|NCT01941732|Urological Agents|urological agents|mesh-ancestor
56260508|NCT01941758|Vaccines|vaccines|mesh-list
56260509|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
56260510|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260511|NCT01941771|Capecitabine|capecitabine|mesh-list
56260512|NCT01941771|Vinorelbine|vinorelbine|mesh-list
56260513|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56260514|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
56260515|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790573|NCT04636333|Vaccines|vaccines|mesh-list
55790574|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
56260516|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260517|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56260518|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
56260519|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
56260520|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
56260521|NCT01941810|Lactoferrin|lactoferrin|mesh-list
56260522|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260523|NCT01941888|Midazolam|midazolam|mesh-list
56260524|NCT01941888|Propofol|propofol|mesh-list
56260525|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56260526|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873146|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
55873147|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55873148|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55873149|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
55873150|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55873151|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55790575|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790577|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55873152|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873153|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55873154|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55873155|NCT01064284|Factor VIII|factor viii|mesh-list
55873156|NCT01064284|Coagulants|coagulants|mesh-ancestor
55873157|NCT04156347|Topotecan|topotecan|mesh-list
55749655|NCT04501367|Hormones|hormones|mesh-ancestor
55873158|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55873159|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55873160|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873161|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873162|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873164|NCT05145309|Cathartics|cathartics|mesh-ancestor
55873165|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55873166|NCT01064362|Heparin|heparin|mesh-list
55873167|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55873168|NCT01064362|Tinzaparin|tinzaparin|mesh-list
55873169|NCT01064362|Dalteparin|dalteparin|mesh-list
55873170|NCT01064362|PENTA|penta|mesh-list
55873171|NCT01064362|Fondaparinux|fondaparinux|mesh-list
55873172|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
55835720|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260527|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260528|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56260529|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
56260530|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
56260531|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56260532|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56260533|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56260534|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56260535|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
56260536|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
56260537|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835721|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
55873173|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55873174|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55873175|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873176|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55873177|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
55873178|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55873179|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
55873183|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873184|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873185|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55873186|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873188|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
55873189|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
55873190|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55873191|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873192|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873193|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
55873194|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55873195|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873196|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873197|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
55873198|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55873199|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873200|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55873201|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55873202|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55873203|NCT01064830|Cyclosporine|cyclosporine|mesh-list
55873204|NCT01064830|Cyclosporins|cyclosporins|mesh-list
55873205|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873206|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873207|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55873208|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
55873209|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873210|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
55873211|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55873212|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
55873213|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873214|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55873215|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55873216|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55873217|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873218|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55873219|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55873220|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873221|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873223|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873224|NCT04616963|Tenofovir|tenofovir|mesh-list
55873225|NCT04616963|Emtricitabine|emtricitabine|mesh-list
56260538|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260540|NCT01941901|Bleomycin|bleomycin|mesh-list
55873226|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55873227|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
55873228|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790578|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790579|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873229|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55873230|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55873231|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873232|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873233|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55873234|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55873235|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55873236|NCT01066624|Calcium|calcium|mesh-list
55873237|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55873238|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873239|NCT04398771|Valsartan|valsartan|mesh-list
55873240|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55873241|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55873242|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55873243|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
55873244|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873245|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55873246|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55873247|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873248|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55873254|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55873255|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55873256|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55873257|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55873258|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55873259|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
55873260|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873261|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873262|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873263|NCT01068964|Timolol|timolol|mesh-list
55873264|NCT01068964|Bimatoprost|bimatoprost|mesh-list
55873265|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55873266|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55873267|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55873268|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55873269|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
55873270|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873271|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873272|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873273|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55873274|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55873275|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55873276|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
55873277|NCT05111145|Ivacaftor|ivacaftor|mesh-list
55873278|NCT05111145|Elexacaftor|elexacaftor|mesh-list
55873279|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55873280|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873281|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873282|NCT02984475|Metformin|metformin|mesh-list
55873283|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55873284|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873285|NCT01069354|Lidocaine|lidocaine|mesh-list
55873286|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
55873287|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
55873288|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873289|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873290|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
55749662|NCT03347357|Tacrolimus|tacrolimus|mesh-list
55873291|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873292|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55873293|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55873294|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55873295|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260541|NCT01941901|Calcium|calcium|mesh-list
55790580|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790581|NCT03103009|Pasireotide|pasireotide|mesh-list
56260542|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56260543|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260544|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56260545|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56260546|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260547|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
56260548|NCT01941914|Calcium|calcium|mesh-list
56260549|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56260550|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873296|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873297|NCT03080974|Nivolumab|nivolumab|mesh-list
55873298|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873299|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873300|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55873301|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873302|NCT01069510|Spironolactone|spironolactone|mesh-list
55873303|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55873304|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
55873305|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873306|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873307|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55873308|NCT01069510|Diuretics|diuretics|mesh-ancestor
55873309|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
55873310|NCT04278495|Losartan|losartan|mesh-list
55873311|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55873312|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55873313|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55873314|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55873315|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873316|NCT04276545|Midazolam|midazolam|mesh-list
55873320|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873321|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55873322|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55873323|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55873324|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55873325|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
55873326|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
55873327|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
55873328|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
55873329|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873330|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873332|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55873333|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873334|NCT01117948|Analgesics|analgesics|mesh-ancestor
55873335|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
55873336|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873337|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873338|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873339|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873340|NCT03602157|Fludarabine|fludarabine|mesh-list
55873341|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55873342|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723851|NCT03488485|Ledipasvir|ledipasvir|mesh-list
55723852|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723853|NCT00821249|Dexamethasone|dexamethasone|mesh-list
55723854|NCT00821249|Filanesib|filanesib|mesh-list
55723855|NCT00821249|Lenograstim|lenograstim|mesh-list
55723856|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723857|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
55723858|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
55723859|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723860|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723861|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723862|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
55723863|NCT00821249|Hormones|hormones|mesh-ancestor
55723864|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723865|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55723866|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723867|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55723868|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
55723869|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
55723870|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
55723871|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723872|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
55723873|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
55723874|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55723875|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
55723876|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723877|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55723878|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55723879|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
55766444|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
55723880|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723881|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723882|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55723883|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723885|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55723886|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723888|NCT03496519|Trabectedin|trabectedin|mesh-list
55723889|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55723890|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723891|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723892|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
55723893|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723894|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55723895|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
55723896|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723897|NCT00813605|Conatumumab|conatumumab|mesh-list
55723898|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723899|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723900|NCT00724841|Temozolomide|temozolomide|mesh-list
55723901|NCT00724841|Obatoclax|obatoclax|mesh-list
55873343|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873344|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55873345|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
55873346|NCT03014440|Cannabidiol|cannabidiol|mesh-list
55873347|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
55873348|NCT03013036|Fentanyl|fentanyl|mesh-list
55873349|NCT03013036|Midazolam|midazolam|mesh-list
55873350|NCT03013036|Propofol|propofol|mesh-list
55873351|NCT03013036|Sevoflurane|sevoflurane|mesh-list
55873352|NCT03013036|Rocuronium|rocuronium|mesh-list
55873353|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56260551|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56260552|NCT01941953|Metformin|metformin|mesh-list
56260553|NCT01941953|Fluorouracil|fluorouracil|mesh-list
56260554|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56260555|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260556|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
56260557|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260558|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56260559|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260560|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56260561|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
56260563|NCT01941966|Mitomycins|mitomycins|mesh-list
56260564|NCT01941966|Mitomycin|mitomycin|mesh-list
56260565|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56260566|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
56260567|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260568|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260569|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56260570|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
56260571|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56260573|NCT01941979|Leucovorin|leucovorin|mesh-list
55835801|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260605|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260606|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56260607|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
56260608|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260609|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260610|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
56260611|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260612|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55835802|NCT02073929|Incretins|incretins|mesh-ancestor
55873354|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873355|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873356|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55873357|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
55873358|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
55873359|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55873360|NCT03013036|Narcotics|narcotics|mesh-ancestor
55873361|NCT03013036|Analgesics|analgesics|mesh-ancestor
55873362|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
55873363|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873364|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55873365|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55873366|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55790583|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873367|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55873368|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
55873369|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
55873370|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873371|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873372|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55873373|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55873374|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55873375|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55873376|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55873377|NCT01071538|Buprenorphine|buprenorphine|mesh-list
55873378|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55873379|NCT01071538|Narcotics|narcotics|mesh-ancestor
55873380|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873381|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873382|NCT01071538|Analgesics|analgesics|mesh-ancestor
55873383|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
55873384|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790584|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873385|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55873386|NCT04352686|Buspirone|buspirone|mesh-list
55873387|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55873388|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55873389|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873394|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873395|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873396|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55790586|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55790587|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790588|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724054|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55724055|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55724056|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55724057|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724058|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724059|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
55724060|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
55724061|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724062|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724063|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55724064|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55724065|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
55724066|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55724067|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55724068|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55724069|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55724070|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
55724071|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55724072|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
55724073|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724074|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724075|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55724076|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
55724077|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724078|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724079|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55724080|NCT03495739|Dabigatran|dabigatran|mesh-list
55724081|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
55724082|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55724083|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
55724084|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724085|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724086|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
55724087|NCT03298061|Prednisolone|prednisolone|mesh-list
55724088|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724089|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
55724091|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724092|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724093|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55724094|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724095|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55724097|NCT04071613|Tenecteplase|tenecteplase|mesh-list
55724098|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55724099|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55724100|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724101|NCT00678119|Sunitinib|sunitinib|mesh-list
55724102|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724103|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55724104|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55724105|NCT00678119|Growth Substances|growth substances|mesh-ancestor
55724106|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724107|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
55724108|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55724109|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724110|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873397|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55873398|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
55873400|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55873401|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
55873402|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873403|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873404|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55873405|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
55873406|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873407|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873408|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55873409|NCT02172742|Digoxin|digoxin|mesh-list
55873410|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55873411|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56260613|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56260614|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
56260615|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56260616|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56260618|NCT01942187|Bupropion|bupropion|mesh-list
56260619|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56260620|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
56260621|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56260622|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56260623|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56260624|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260625|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260626|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
56260627|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260628|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260629|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56260630|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56260631|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260668|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56260669|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56260670|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
56260671|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260672|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260673|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56260674|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
56260675|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56260676|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
56260677|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56260678|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260679|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56260680|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56260681|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260682|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56260683|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56260684|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56260685|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873412|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55873413|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873414|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873415|NCT02172742|Protective Agents|protective agents|mesh-ancestor
55790589|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873416|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873417|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
55873418|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55873419|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55873420|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873421|NCT01075204|Clarithromycin|clarithromycin|mesh-list
55873422|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55873423|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55873424|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55873425|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873426|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873427|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55873428|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55873429|NCT01120834|Azacitidine|azacitidine|mesh-list
55873430|NCT01120834|Vorinostat|vorinostat|mesh-list
55873431|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55873432|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
55873433|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873434|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873435|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873436|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55873437|NCT01122160|Omeprazole|omeprazole|mesh-list
55873438|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55873439|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55873440|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55873441|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873442|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873443|NCT02623816|Omeprazole|omeprazole|mesh-list
55873444|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55873445|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55873446|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56260686|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260688|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56260689|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56260690|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
56260691|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260692|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260693|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56260694|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56260695|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
56260696|NCT01942447|Vancomycin|vancomycin|mesh-list
56260697|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56260698|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260699|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56260700|NCT01942460|Hematinics|hematinics|mesh-ancestor
56260701|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56260702|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56260703|NCT01942551|Tadalafil|tadalafil|mesh-list
55873447|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873448|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873449|NCT01122238|Nicotine|nicotine|mesh-list
55873450|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55873451|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
55873452|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873453|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873454|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55873455|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55873456|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
55873457|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873458|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873459|NCT01122316|Metformin|metformin|mesh-list
55873461|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873463|NCT03049449|Fludarabine|fludarabine|mesh-list
55873464|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55873465|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
55873466|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873467|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873468|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55873469|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
55873470|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873471|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873472|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55873473|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55873474|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55873475|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873476|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55873477|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55873478|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873479|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873480|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
55873481|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873482|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
55873483|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55873484|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873485|NCT02393625|Nivolumab|nivolumab|mesh-list
56260704|NCT01942551|Dutasteride|dutasteride|mesh-list
56260705|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
56260706|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56260707|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56260708|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260709|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260710|NCT01942551|Urological Agents|urological agents|mesh-ancestor
56260711|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56260712|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56260713|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
56260714|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56260715|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260716|NCT01942577|Protective Agents|protective agents|mesh-list
56260717|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260718|NCT01942681|Propiverine|propiverine|mesh-list
56260719|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
56260720|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
56260721|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260722|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260724|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56260725|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
55835903|NCT02028338|Dapivirine|dapivirine|mesh-list
55873486|NCT02393625|Ceritinib|ceritinib|mesh-list
55873487|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873488|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873489|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55873490|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873491|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55873492|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873493|NCT02399943|Panitumumab|panitumumab|mesh-list
55873494|NCT02399943|Trametinib|trametinib|mesh-list
55873495|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873496|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873497|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55873498|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873499|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873500|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
55873501|NCT03186027|Ubiquinone|ubiquinone|mesh-list
55873502|NCT03186027|Vitamins|vitamins|mesh-ancestor
55873503|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
55749684|NCT03952091|Hormones|hormones|mesh-ancestor
55873504|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873505|NCT02595892|Gemcitabine|gemcitabine|mesh-list
55873506|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55873507|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
55873508|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873509|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873510|NCT02595892|Antiviral Agents|antiviral agents|mesh-ancestor
55873511|NCT02595892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55873512|NCT02595892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260726|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260727|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260728|NCT01942681|Urological Agents|urological agents|mesh-ancestor
56260729|NCT01942889|Antioxidants|antioxidants|mesh-list
56260730|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260731|NCT01942889|Protective Agents|protective agents|mesh-ancestor
56260732|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260733|NCT01943019|Linagliptin|linagliptin|mesh-list
56260734|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56260735|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260736|NCT01943019|Incretins|incretins|mesh-ancestor
56260737|NCT01943019|Hormones|hormones|mesh-ancestor
56260738|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56260739|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56260740|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
56260741|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835926|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
55873513|NCT02595892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55873514|NCT02595892|Immunologic Factors|immunologic factors|mesh-ancestor
55873515|NCT02595892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873516|NCT04397913|Acetaminophen|acetaminophen|mesh-list
55873517|NCT04397913|Ibuprofen|ibuprofen|mesh-list
55873518|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873519|NCT04397913|Analgesics|analgesics|mesh-ancestor
55873520|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
55873521|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873522|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873523|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
55873524|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55873525|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790593|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
55873526|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873527|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55873528|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873529|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873530|NCT02176486|Ixazomib|ixazomib|mesh-list
55873531|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873536|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55873537|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55873538|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873539|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873541|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873542|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55873543|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
55873544|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55873545|NCT03013114|Bortezomib|bortezomib|mesh-list
55873546|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873547|NCT01077310|Naltrexone|naltrexone|mesh-list
55873548|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55873549|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55873550|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873551|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
55873552|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873553|NCT02989857|Ivosidenib|ivosidenib|mesh-list
55873554|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873555|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260742|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260744|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
56260745|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
56260746|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56260747|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
56260748|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56260749|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260750|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56260751|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56260752|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56260753|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56260754|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56260755|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260756|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
55835942|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790594|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55790597|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
55873556|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873557|NCT02393937|Metronidazole|metronidazole|mesh-list
55873558|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55873559|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55873560|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55873561|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55873562|NCT00632853|Carboplatin|carboplatin|mesh-list
55873563|NCT00632853|Etoposide|etoposide|mesh-list
55873564|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873565|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55873566|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55873567|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55873568|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873569|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873570|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
55873571|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55873572|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
55873573|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55873574|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
55873575|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873576|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873577|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
55873578|NCT04397601|Bevacizumab|bevacizumab|mesh-list
55873579|NCT04397601|Aflibercept|aflibercept|mesh-list
55873580|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873581|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873582|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55873583|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55873584|NCT04397601|Growth Substances|growth substances|mesh-ancestor
55873585|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873586|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
55873587|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
55873588|NCT02870829|Vitamin K|vitamin k|mesh-list
55873589|NCT02870829|Vitamin MK 7|vitamin mk 7|mesh-list
55790598|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790599|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790601|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
55873590|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55873591|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55873592|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873593|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
55873594|NCT02870829|Coagulants|coagulants|mesh-ancestor
55873595|NCT02870829|Vitamins|vitamins|mesh-ancestor
55873596|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
55873597|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873598|NCT01876823|Memantine|memantine|mesh-list
56260757|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56260758|NCT01943136|Mupirocin|mupirocin|mesh-list
55873599|NCT01876823|Citalopram|citalopram|mesh-list
55873600|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55873601|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55873602|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
55873603|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873606|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55873607|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55873608|NCT01876823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55790603|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790604|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
55873609|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55873610|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873611|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
55873612|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55873613|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
55873614|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55873615|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
55873616|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873617|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873618|NCT01993719|Vidarabine|vidarabine|mesh-list
55873619|NCT01993719|Aldesleukin|aldesleukin|mesh-list
55873620|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
55873621|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
55873622|NCT01993719|Fludarabine|fludarabine|mesh-list
55873623|NCT01993719|Fludarabine phosphate|fludarabine phosphate|mesh-list
55873624|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55873625|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
55873626|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873627|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873628|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55873629|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
55873630|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873631|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873632|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55873633|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873634|NCT01993719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55873635|NCT01993719|Antimetabolites|antimetabolites|mesh-ancestor
55873636|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
55873637|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55873638|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55873639|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55873640|NCT02758665|Venetoclax|venetoclax|mesh-list
55873641|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
55873642|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873643|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873644|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55873645|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873646|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873647|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873648|NCT02650401|Entrectinib|entrectinib|mesh-list
55873649|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55873650|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873651|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873652|NCT02647203|Fluorides|fluorides|mesh-list
55873653|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
55873654|NCT02647203|Protective Agents|protective agents|mesh-ancestor
55873655|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873656|NCT00638157|Gentamicins|gentamicins|mesh-list
55873657|NCT00638157|Daptomycin|daptomycin|mesh-list
55873658|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55873659|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790606|NCT03020875|Acetaminophen|acetaminophen|mesh-list
55790607|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55790608|NCT03020875|Analgesics|analgesics|mesh-ancestor
55873660|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55873661|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873662|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873663|NCT02530437|Paclitaxel|paclitaxel|mesh-list
55873664|NCT02530437|Carboplatin|carboplatin|mesh-list
55873665|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55873666|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55790609|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
55790610|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790611|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873667|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873668|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
55873669|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
55873670|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
55873671|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873672|NCT00637377|Ranibizumab|ranibizumab|mesh-list
56260759|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56260760|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260761|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56260762|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260763|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260764|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
56260765|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56260766|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
56260767|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260768|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56260769|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56260770|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
56260771|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790614|NCT02996305|Analgesics|analgesics|mesh-ancestor
56260772|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260773|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56260774|NCT01943240|Ropivacaine|ropivacaine|mesh-list
56260775|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
56260776|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
56260777|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260778|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260779|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
56260780|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260781|NCT01943305|Vaccines|vaccines|mesh-list
56260782|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
56260783|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260784|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56260785|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55873673|NCT00637377|Aflibercept|aflibercept|mesh-list
55873674|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55873675|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55873677|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873678|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
55873679|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873680|NCT01787409|Vitamin D|vitamin d|mesh-list
55873681|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
55873682|NCT01787409|Vitamins|vitamins|mesh-ancestor
55873683|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
55873684|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724806|NCT00309985|Hormones|hormones|mesh-ancestor
55724807|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724808|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724809|NCT02356588|Sufentanil|sufentanil|mesh-list
55724810|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55724811|NCT02356588|Narcotics|narcotics|mesh-ancestor
55724812|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724813|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724814|NCT02356588|Analgesics|analgesics|mesh-ancestor
55724815|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
55724816|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724817|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55724818|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55724819|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
55724820|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
55724822|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
55724823|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724824|NCT02355028|Ranibizumab|ranibizumab|mesh-list
55724825|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55724826|NCT02355028|Acrizanib|acrizanib|mesh-list
55724827|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55724828|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55724829|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55724830|NCT02355028|Growth Substances|growth substances|mesh-ancestor
55724831|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724832|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
55724833|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724834|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55724835|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724836|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724837|NCT05647330|Gemcitabine|gemcitabine|mesh-list
55724838|NCT05647330|Hydroxychloroquine|hydroxychloroquine|mesh-list
55724839|NCT05647330|Chloroquine|chloroquine|mesh-list
55724840|NCT05647330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55724841|NCT05647330|Antimetabolites|antimetabolites|mesh-ancestor
55724842|NCT05647330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724843|NCT05647330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724844|NCT05647330|Antiviral Agents|antiviral agents|mesh-ancestor
55724845|NCT05647330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724846|NCT05647330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724847|NCT05647330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55724848|NCT05647330|Immunologic Factors|immunologic factors|mesh-ancestor
55724849|NCT05647330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724850|NCT05647330|Antimalarials|antimalarials|mesh-ancestor
55724851|NCT05647330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55724852|NCT05647330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55724853|NCT05647330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724854|NCT05647330|Amebicides|amebicides|mesh-ancestor
55724855|NCT01643668|Busulfan|busulfan|mesh-list
55724856|NCT01643668|Clofarabine|clofarabine|mesh-list
55724857|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
55724858|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724859|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55724861|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724862|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55724863|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724864|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55724865|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55724866|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
55873685|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55873686|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55873687|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
55873688|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873689|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55873690|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260786|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56260787|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56260788|NCT01943422|Interferons|interferons|mesh-list
56260789|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
55873691|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873692|NCT05307718|Anticoagulants|anticoagulants|mesh-list
55873693|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
55873694|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55873695|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55873696|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
55873697|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55873698|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55873699|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
55873700|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873701|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873702|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55873703|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55873704|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55873705|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
55873706|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873707|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873708|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
55790615|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
55790616|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790617|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873709|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55873710|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
55873711|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
55873712|NCT01033864|Prednisone|prednisone|mesh-list
55873713|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873714|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
55873715|NCT01033864|Hormones|hormones|mesh-ancestor
55873716|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873717|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873718|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55873719|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873720|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55873721|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55873722|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
55873723|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55873724|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55873725|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873726|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873728|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873729|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55873730|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873731|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873732|NCT01083706|Azacitidine|azacitidine|mesh-list
55873733|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55873734|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
55790618|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
55790619|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
55873735|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873736|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873737|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873738|NCT01035346|Ibuprofen|ibuprofen|mesh-list
55873739|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55873740|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873741|NCT01035346|Analgesics|analgesics|mesh-ancestor
55873742|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
55873743|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873744|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873745|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873746|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873747|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55873748|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873752|NCT01035658|Doxorubicin|doxorubicin|mesh-list
55873753|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55873754|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55873755|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873756|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55873757|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55873758|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835990|NCT04684238|Midazolam|midazolam|mesh-list
55835991|NCT04684238|Isoflurane|isoflurane|mesh-list
55835992|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56260790|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
56260791|NCT01943422|Vemurafenib|vemurafenib|mesh-list
56260792|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260793|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
56260794|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260795|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
56260796|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260797|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56260798|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260799|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260800|NCT01943487|Verapamil|verapamil|mesh-list
56260801|NCT01943487|Tamsulosin|tamsulosin|mesh-list
56260802|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
56260803|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56260804|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56260805|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56260806|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
56260807|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260808|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260809|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260810|NCT01943487|Urological Agents|urological agents|mesh-ancestor
56260811|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55873759|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873760|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
55873761|NCT01037452|Lansoprazole|lansoprazole|mesh-list
55873762|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
55873763|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
55873764|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55873765|NCT01037452|Calcium|calcium|mesh-list
55873766|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55873767|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873768|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55873770|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55873771|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55873772|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873773|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873774|NCT01037452|Antacids|antacids|mesh-ancestor
55873775|NCT03012646|Treprostinil|treprostinil|mesh-list
55873776|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55873777|NCT05289856|Avelumab|avelumab|mesh-list
55873778|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873779|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873780|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
55873781|NCT00636441|Docetaxel|docetaxel|mesh-list
55873782|NCT00636441|Doxorubicin|doxorubicin|mesh-list
55873783|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55873784|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56260812|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56260813|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
56260814|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56260815|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56260816|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56260817|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56260818|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
56260819|NCT01943526|Natalizumab|natalizumab|mesh-list
56260820|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
56260821|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260822|NCT01943617|Entecavir|entecavir|mesh-list
56260823|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
56260824|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260825|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
56260826|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56260827|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
56260828|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260829|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260830|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56260831|NCT01943630|Protective Agents|protective agents|mesh-ancestor
56260832|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56260833|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55836001|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
55836002|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
55836003|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
55836004|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836007|NCT02006576|Ibuprofen|ibuprofen|mesh-list
55873785|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
55873786|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790621|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790622|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873787|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873788|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55873789|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
55873790|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873791|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873792|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55873793|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
55873795|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
55873796|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55873797|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55873798|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55873799|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873800|NCT03543189|Nivolumab|nivolumab|mesh-list
55873801|NCT03543189|Androgens|androgens|mesh-list
56260835|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260836|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
56260837|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790623|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
56260839|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56260840|NCT01943760|Narcotics|narcotics|mesh-ancestor
56260841|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260842|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260843|NCT01943760|Analgesics|analgesics|mesh-ancestor
56260844|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
56260845|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836012|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836013|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836014|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873802|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873803|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873804|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55873805|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873806|NCT03543189|Hormones|hormones|mesh-ancestor
55873807|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873808|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873809|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55873810|NCT02984397|Ketotifen|ketotifen|mesh-list
55873811|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
55873812|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
55873813|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55873814|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
55873815|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
55873816|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873817|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873818|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873819|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55873820|NCT01922427|RNS60|rns60|mesh-list
55873821|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55873825|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873826|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873827|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873828|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790624|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873829|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55873830|NCT01088464|Necitumumab|necitumumab|mesh-list
55873831|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55873832|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873833|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873834|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
55873835|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873836|NCT01090180|Dexamethasone|dexamethasone|mesh-list
55873837|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873838|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
55873839|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
55790625|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790626|NCT02888041|Dinoprostone|dinoprostone|mesh-list
55790627|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
55790628|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55790629|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725166|NCT02190721|Lenograstim|lenograstim|mesh-list
55725167|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55725168|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
55725169|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725171|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55725172|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55725173|NCT03134339|Nicotine|nicotine|mesh-list
55725174|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55725175|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
55725176|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725177|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725178|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55725179|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55725180|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
55725181|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725182|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725183|NCT02282267|Gefitinib|gefitinib|mesh-list
55725184|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725185|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55725186|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725187|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725188|NCT02283905|Voriconazole|voriconazole|mesh-list
55725189|NCT02283905|Amphotericin B|amphotericin b|mesh-list
55725190|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55725191|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
55725192|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725193|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55725194|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55725195|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725196|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725197|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55725198|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
55725199|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725200|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725201|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55725202|NCT02283905|Amebicides|amebicides|mesh-ancestor
55725203|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55725204|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55725205|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55725206|NCT03480997|Bromides|bromides|mesh-list
55725207|NCT03480997|Albuterol|albuterol|mesh-list
55725208|NCT03480997|Ipratropium|ipratropium|mesh-list
55725209|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
55725210|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55725211|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
55725212|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725213|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725214|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55725215|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
55725216|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
55725217|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55725218|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55726697|NCT01601626|Rifampin|rifampin|mesh-list
55873840|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873841|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873842|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55873843|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
55873845|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873846|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55873847|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873848|NCT00636207|Montelukast|montelukast|mesh-list
56260846|NCT01943786|Cetuximab|cetuximab|mesh-list
56260847|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260848|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260849|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56260850|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56260851|NCT01943812|Estradiol|estradiol|mesh-list
56260852|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56260853|NCT01943812|Progesterone|progesterone|mesh-list
56260854|NCT01943812|Estrogens|estrogens|mesh-ancestor
56260855|NCT01943812|Hormones|hormones|mesh-ancestor
56260856|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873849|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55873850|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
55873851|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55873852|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
55790631|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873853|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873854|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873855|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55873856|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55873857|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873858|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
55873859|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55749691|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
55873860|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55790633|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873861|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873862|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55873863|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55873864|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
55873865|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873866|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
55873867|NCT03169881|Hematinics|hematinics|mesh-ancestor
55873868|NCT01092676|Ibuprofen|ibuprofen|mesh-list
55873869|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55873870|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873871|NCT01092676|Analgesics|analgesics|mesh-ancestor
55873872|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
55873873|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873874|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873875|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873876|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873877|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55873878|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873879|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873880|NCT05273320|Dronabinol|dronabinol|mesh-list
55873881|NCT05273320|Nabilone|nabilone|mesh-list
55873882|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
55873883|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
55873884|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873885|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873886|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55873887|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55873888|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55873897|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873898|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873899|NCT05273320|Hormones|hormones|mesh-ancestor
55873900|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873901|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
55873902|NCT01039792|Vitamins|vitamins|mesh-ancestor
55873903|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
55873904|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260857|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260858|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56260859|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
56260860|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56260861|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56260862|NCT01943812|Progestins|progestins|mesh-ancestor
56260863|NCT01943877|Propolis|propolis|mesh-list
56260864|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260865|NCT01943942|Montelukast|montelukast|mesh-list
56260866|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56260867|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
56260868|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56260869|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
56260870|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56260871|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836036|NCT02005562|Cyclosporine|cyclosporine|mesh-list
55873905|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
55873906|NCT01041274|Citalopram|citalopram|mesh-list
55873907|NCT01041274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55873908|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55873909|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55873910|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790634|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55790635|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55790637|NCT00136435|Cytarabine|cytarabine|mesh-list
55790638|NCT00136435|Dexamethasone|dexamethasone|mesh-list
55790639|NCT00136435|Prednisone|prednisone|mesh-list
55790640|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
55790641|NCT00136435|Doxorubicin|doxorubicin|mesh-list
55873911|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873912|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
55873913|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873914|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55873915|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
55873916|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55873917|NCT00635349|Acetaminophen|acetaminophen|mesh-list
55873918|NCT00635349|Meloxicam|meloxicam|mesh-list
55873919|NCT00635349|Aceclofenac|aceclofenac|mesh-list
55873920|NCT00635349|Tramadol|tramadol|mesh-list
55790642|NCT00136435|Methotrexate|methotrexate|mesh-list
55790643|NCT00136435|Vincristine|vincristine|mesh-list
55790644|NCT00136435|Asparaginase|asparaginase|mesh-list
55873921|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873922|NCT00635349|Analgesics|analgesics|mesh-ancestor
55873923|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
55873924|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873925|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873926|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
55873927|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55873928|NCT00635349|Narcotics|narcotics|mesh-ancestor
55873929|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873930|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55873931|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873932|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873933|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55873934|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55790646|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790647|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
55790648|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
55790649|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725299|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
55725301|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725302|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55725303|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725304|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55725305|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725306|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55725307|NCT03480607|Analgesics|analgesics|mesh-ancestor
55725308|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
55725309|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55725310|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55725311|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55725312|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
55725313|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725314|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725315|NCT00489203|Beclomethasone|beclomethasone|mesh-list
55725316|NCT00489203|Methotrexate|methotrexate|mesh-list
55725317|NCT00489203|Tacrolimus|tacrolimus|mesh-list
55725318|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55725319|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
55725320|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55725321|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725322|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55725323|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
55725324|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725325|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725326|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
55725327|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725328|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55725329|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725330|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
55725331|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725332|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55725333|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55725334|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725335|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
55725337|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725338|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55725339|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
55725341|NCT05646394|Vitamins|vitamins|mesh-list
55725342|NCT05646394|Vitamin K|vitamin k|mesh-list
55725343|NCT05646394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55725344|NCT05646394|Micronutrients|micronutrients|mesh-ancestor
55725345|NCT05646394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725346|NCT05646394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55725347|NCT05646394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55725348|NCT05646394|Analgesics|analgesics|mesh-ancestor
55725349|NCT05646394|Sensory System Agents|sensory system agents|mesh-ancestor
55725350|NCT05646394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725351|NCT05646394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873936|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873937|NCT00634803|Buprenorphine|buprenorphine|mesh-list
55873938|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55873939|NCT00634803|Narcotics|narcotics|mesh-ancestor
55873940|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873941|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873942|NCT00634803|Analgesics|analgesics|mesh-ancestor
55873943|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
55790650|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873944|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873945|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55873946|NCT01042288|Carboplatin|carboplatin|mesh-list
55873947|NCT01042288|Pemetrexed|pemetrexed|mesh-list
56260872|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56260873|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56260874|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260875|NCT01944033|Terbutaline|terbutaline|mesh-list
56260876|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56260877|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
56260878|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790651|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56260879|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260880|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55790652|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
56260881|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
56260882|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
56260883|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
56260884|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55873948|NCT01042288|Panitumumab|panitumumab|mesh-list
55873949|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55873950|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052422|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790654|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790655|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55790656|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790657|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55790658|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55864008|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873951|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873952|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55873953|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55873954|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55873955|NCT01043926|Suvorexant|suvorexant|mesh-list
55873961|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873962|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873963|NCT01044706|Bicalutamide|bicalutamide|mesh-list
55873964|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
55873965|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
55873966|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873967|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873968|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790659|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55790660|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864831|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864832|NCT00832390|Incretins|incretins|mesh-ancestor
55864833|NCT00832390|Hormones|hormones|mesh-ancestor
55864836|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
55873969|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
55873970|NCT04447534|Chloroquine|chloroquine|mesh-list
55873971|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
55873972|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
55873973|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55873974|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55873975|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55873976|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873977|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873978|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55873979|NCT04447534|Amebicides|amebicides|mesh-ancestor
55873980|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55873981|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873982|NCT04447534|Analgesics|analgesics|mesh-ancestor
55873983|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
55873984|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55873985|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873986|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55873987|NCT04447534|Filaricides|filaricides|mesh-ancestor
55873988|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
55873989|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
55873990|NCT01044862|Letrozole|letrozole|mesh-list
55873991|NCT01044862|Clomiphene|clomiphene|mesh-list
55873992|NCT01044862|Enclomiphene|enclomiphene|mesh-list
55873993|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
55873994|NCT01044862|Hormones|hormones|mesh-list
55873995|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55873996|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55873997|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873998|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55873999|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260885|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56260887|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56260888|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
56260889|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260890|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260891|NCT01944085|Acetaminophen|acetaminophen|mesh-list
56260892|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
56260893|NCT01944085|Ibuprofen|ibuprofen|mesh-list
56260894|NCT01944085|Vitamins|vitamins|mesh-ancestor
56260895|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
56260896|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260897|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56260898|NCT01944085|Analgesics|analgesics|mesh-ancestor
55874000|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874001|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55874002|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874003|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55874004|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
55874005|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55874006|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
55874007|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55874008|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55874009|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55874011|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55874012|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55874013|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874014|NCT01047358|Exemestane|exemestane|mesh-list
55874015|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874016|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55874017|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55874018|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874019|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874020|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55874021|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
55874022|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55868511|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55790661|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869926|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55790662|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55790664|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55874023|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874024|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
55874033|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874034|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870162|NCT03422523|Gemcitabine|gemcitabine|mesh-list
55874035|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
55874036|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874037|NCT01772004|Avelumab|avelumab|mesh-list
55874038|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55874039|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874040|NCT02930044|Insulin|insulin|mesh-list
55874041|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55874042|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
55874043|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55874044|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874045|NCT03683524|Dolutegravir|dolutegravir|mesh-list
55871221|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55874046|NCT03683524|Darunavir|darunavir|mesh-list
55874047|NCT03683524|Cobicistat|cobicistat|mesh-list
55874048|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
55874049|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55874050|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55874051|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874052|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874053|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55874054|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55874055|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
56260899|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
56260900|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260902|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56260903|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56260904|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56260905|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56260906|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790665|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790667|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
55790668|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55790669|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790670|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
55790671|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790672|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55790673|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
55790674|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790675|NCT00136435|Antidotes|antidotes|mesh-ancestor
55790676|NCT00136435|Protective Agents|protective agents|mesh-ancestor
55790677|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
55882978|NCT02230696|Xhance|xhance|mesh-list
56260907|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260908|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
56260909|NCT01944085|Protective Agents|protective agents|mesh-ancestor
56260910|NCT01944176|Simvastatin|simvastatin|mesh-list
56260911|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56260912|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56260913|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
56052423|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55790678|NCT00136435|Vitamins|vitamins|mesh-ancestor
55790679|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
55790680|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55790681|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
55790682|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
55790683|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790684|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55790685|NCT04864379|Molgramostim|molgramostim|mesh-list
56260914|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260915|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56260916|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55874056|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874057|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55874058|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55874059|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
55874060|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55874061|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55874062|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
55874063|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55874064|NCT02246842|Antibodies|antibodies|mesh-list
55874065|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55874066|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
55874067|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
55874068|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874069|NCT02623426|Dexamethasone|dexamethasone|mesh-list
55874070|NCT02623426|Methotrexate|methotrexate|mesh-list
55874071|NCT02623426|Ranibizumab|ranibizumab|mesh-list
55874072|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874073|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
55874074|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
55874075|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874076|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874077|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55874078|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
55874079|NCT02623426|Hormones|hormones|mesh-ancestor
55874080|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874081|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55874082|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874083|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55874084|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
55874085|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55874086|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55874087|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
55874088|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874089|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
55874090|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874091|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56260918|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55790687|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844832|NCT01841762|Macitentan|macitentan|mesh-list
56260919|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
56260920|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56260921|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56260922|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260923|NCT01944215|Caffeine|caffeine|mesh-list
56260924|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56260925|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260926|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56260927|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260928|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260929|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56260930|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56260931|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
56260932|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260933|NCT01944384|Spironolactone|spironolactone|mesh-list
56260934|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56260935|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
56260936|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56260937|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260938|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56260939|NCT01944384|Diuretics|diuretics|mesh-ancestor
55790690|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790691|NCT04336241|Nivolumab|nivolumab|mesh-list
56260940|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
55836091|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55836094|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55874092|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874098|NCT02623426|Growth Substances|growth substances|mesh-ancestor
55874099|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
55874101|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
55874102|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55874103|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874104|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55874105|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874106|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052424|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790693|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790694|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55790695|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874107|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55874108|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55874109|NCT02182492|Hormones|hormones|mesh-ancestor
55874110|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874111|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874113|NCT01163656|Trace Elements|trace elements|mesh-ancestor
55874114|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
55874115|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874116|NCT01165840|Dapsone|dapsone|mesh-list
55874117|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56260941|NCT01944410|Mitogens|mitogens|mesh-list
55790696|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
55790697|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260942|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
56260943|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260944|NCT01944436|Rivastigmine|rivastigmine|mesh-list
56260945|NCT01944436|Donepezil|donepezil|mesh-list
56260946|NCT01944436|Galantamine|galantamine|mesh-list
56260947|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
56260948|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260949|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260950|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
56260951|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260952|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260953|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
56260954|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56260955|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
55779623|NCT03718559|Edoxaban|edoxaban|mesh-list
55790698|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
55790699|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55790700|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55790701|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790702|NCT03044561|Urological Agents|urological agents|mesh-ancestor
55790703|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
55790704|NCT02455141|Carboplatin|carboplatin|mesh-list
55790705|NCT02455141|Epirubicin|epirubicin|mesh-list
55725352|NCT05646394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725353|NCT05646394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55725354|NCT05646394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55726699|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
56260956|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874118|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
55874119|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55874120|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55874121|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55874122|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874123|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874124|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
55874125|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55874126|NCT00952692|Lapatinib|lapatinib|mesh-list
55874127|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874128|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55874129|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790707|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790708|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
55790709|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790710|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725425|NCT00542633|Insulin|insulin|mesh-list
55725426|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55725427|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55725428|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865048|NCT00841828|Docetaxel|docetaxel|mesh-list
55725429|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
55725430|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
55725431|NCT05005897|Vitamins|vitamins|mesh-ancestor
55725432|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
55725433|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725434|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
55725435|NCT05005897|Hematinics|hematinics|mesh-ancestor
55725436|NCT02523547|Entecavir|entecavir|mesh-list
55725437|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
55725438|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725439|NCT00483977|Oxycodone|oxycodone|mesh-list
55725440|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55725441|NCT00483977|Narcotics|narcotics|mesh-ancestor
55725442|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725443|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725444|NCT00483977|Analgesics|analgesics|mesh-ancestor
55725445|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
55725446|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725447|NCT00481325|Citalopram|citalopram|mesh-list
55725448|NCT00481325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55725449|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55725450|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55725451|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725452|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725453|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
55725454|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725455|NCT00481325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55725456|NCT00481325|Antidepressive Agents|antidepressive agents|mesh-ancestor
55725457|NCT00481325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55725458|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
55725459|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
55865202|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55725460|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55725461|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725462|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725463|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725464|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
55725465|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55725466|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
55725467|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725468|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
55725469|NCT03480295|Protective Agents|protective agents|mesh-ancestor
55725471|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725472|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55725473|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725474|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725475|NCT03472963|Darunavir|darunavir|mesh-list
55726437|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790711|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55790712|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
55790713|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790714|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874130|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874131|NCT03535506|Palbociclib|palbociclib|mesh-list
55874132|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874133|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55874134|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874135|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874136|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55874137|NCT01170754|Laxatives|laxatives|mesh-ancestor
55874138|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55874139|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55874140|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
55874141|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
55749704|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
55874142|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874143|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
55874144|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874145|NCT01131052|Insulin|insulin|mesh-list
55874146|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55874147|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
55874148|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
55874149|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55874150|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874151|NCT01379274|Lenalidomide|lenalidomide|mesh-list
55874152|NCT01379274|Azacitidine|azacitidine|mesh-list
55874153|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
55874154|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874155|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55874156|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55874157|NCT01379274|Growth Substances|growth substances|mesh-ancestor
55874158|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
55874159|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874160|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55874161|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
56260957|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56260958|NCT01944436|Protective Agents|protective agents|mesh-ancestor
56260959|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
56260960|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56260961|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260962|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56260963|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260964|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
56260965|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56260966|NCT01944683|Midazolam|midazolam|mesh-list
56260967|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56260968|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56260969|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56260970|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260971|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56260972|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56260973|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55790725|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56260974|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56260975|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
56260976|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
56260977|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
56260978|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
56260979|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56260980|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260981|NCT01944735|Mannitol|mannitol|mesh-list
56260982|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56260983|NCT01944735|Diuretics|diuretics|mesh-ancestor
56260984|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
56260985|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56260986|NCT01944852|Icodextrin|icodextrin|mesh-list
55874173|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874174|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
55874175|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874177|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55790726|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790727|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55874178|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55874179|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55874180|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
55874181|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874182|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874183|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874184|NCT01132846|Dopamine|dopamine|mesh-list
55874185|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55874186|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55874187|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
56260988|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56260989|NCT01945021|Crizotinib|crizotinib|mesh-list
56260990|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56260991|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56260992|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56260993|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56260994|NCT01945047|Midazolam|midazolam|mesh-list
56260995|NCT01945047|Ketamine|ketamine|mesh-list
56260996|NCT01945047|Analgesics|analgesics|mesh-ancestor
55790728|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55790730|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790731|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
55790732|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55790733|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55790734|NCT02439385|Analgesics|analgesics|mesh-ancestor
55790735|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
55790736|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260997|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
56260998|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56260999|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261000|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56261001|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56261002|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
56261003|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
56261004|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261005|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56261006|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56261007|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890417|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790737|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790738|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890593|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052542|NCT01823510|Clopidogrel|clopidogrel|mesh-list
56052543|NCT01823510|Ticagrelor|ticagrelor|mesh-list
56052544|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56052545|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56052546|NCT01823510|Analgesics|analgesics|mesh-ancestor
56052547|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
56052548|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052549|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052550|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56052551|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790739|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790740|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261008|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261041|NCT01945450|Gentamicins|gentamicins|mesh-list
56261042|NCT01945450|Ampicillin|ampicillin|mesh-list
56261043|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261044|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56261045|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261046|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261047|NCT01945476|Midazolam|midazolam|mesh-list
56261048|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56261049|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56261050|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261051|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261052|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55790741|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
55790742|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55790743|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
55790744|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845286|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
56261053|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56261055|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56261056|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
56261057|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
56261058|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
56261059|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
56261060|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261061|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261062|NCT01945528|Lidocaine|lidocaine|mesh-list
56261063|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
56261064|NCT01945528|Anesthetics|anesthetics|mesh-list
56261065|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261066|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261067|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
56261068|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261069|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56261070|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56261071|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56261072|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261073|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261074|NCT01945554|Bupivacaine|bupivacaine|mesh-list
56261080|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790746|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
56261081|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
56261082|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56261083|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56261084|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56261085|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261086|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261087|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
56261088|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261089|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261090|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56261091|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261092|NCT01945736|Methadone|methadone|mesh-list
56261093|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56261094|NCT01945736|Narcotics|narcotics|mesh-ancestor
56261095|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261096|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261097|NCT01945736|Analgesics|analgesics|mesh-ancestor
56261098|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
56261099|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261100|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
56261101|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
56261102|NCT01945788|Teriparatide|teriparatide|mesh-list
56261103|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56261104|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261105|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56261106|NCT01945801|Furosemide|furosemide|mesh-list
56261107|NCT01945801|Spironolactone|spironolactone|mesh-list
56261108|NCT01945801|Diuretics|diuretics|mesh-ancestor
56261109|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
55836259|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
55874188|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
55874189|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874190|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874191|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
55874192|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874193|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874194|NCT01132846|Protective Agents|protective agents|mesh-ancestor
55874195|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
55874196|NCT01133158|Dexamethasone|dexamethasone|mesh-list
55874197|NCT01133158|Rituximab|rituximab|mesh-list
56261110|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052552|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56261111|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56261112|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261113|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261114|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56261115|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
56261116|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261117|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56261118|NCT05410782|Vitamins|vitamins|mesh-list
56261119|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
56261120|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261121|NCT05410626|Methylphenidate|methylphenidate|mesh-list
56261122|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56261123|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261124|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56261125|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56261126|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261127|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261128|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
56261129|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790747|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55790748|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
56261130|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56261131|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55874198|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55874199|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
55874200|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55874201|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874202|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
55874203|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874204|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874205|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874206|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
55874207|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
55874208|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874209|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55874210|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
55874211|NCT01133158|Hormones|hormones|mesh-ancestor
55874212|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790749|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874213|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55790750|NCT03104959|Protective Agents|protective agents|mesh-ancestor
55790751|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790752|NCT03104959|Antidotes|antidotes|mesh-ancestor
55790753|NCT03044171|Listerine|listerine|mesh-list
55790754|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55790755|NCT03044171|Fluorides|fluorides|mesh-list
55790756|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
55790757|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
55790758|NCT03044171|Protective Agents|protective agents|mesh-ancestor
55790759|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790771|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790772|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55790773|NCT03998839|Renal Agents|renal agents|mesh-ancestor
55790774|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
55790775|NCT04856969|Olmesartan|olmesartan|mesh-list
55790776|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55790777|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790778|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55790779|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790780|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55790781|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55790782|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55790783|NCT04108039|Cetrorelix|cetrorelix|mesh-list
55790784|NCT04108039|Progesterone|progesterone|mesh-list
55790785|NCT04108039|Ganirelix|ganirelix|mesh-list
55790786|NCT04108039|Progestins|progestins|mesh-ancestor
55790787|NCT04108039|Hormones|hormones|mesh-ancestor
55790789|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790790|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
55790791|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55874214|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55874215|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
55874216|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874217|NCT01133158|Analgesics|analgesics|mesh-ancestor
55874218|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
55874219|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56261132|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56261134|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261135|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
55790793|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55790794|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
56261136|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
56261137|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
56261138|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261139|NCT05410314|Inositol|inositol|mesh-list
56261140|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
56261141|NCT05410314|Vitamins|vitamins|mesh-ancestor
56261142|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
56261143|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261144|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
56261145|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56261146|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
56261147|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56261148|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
55790795|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
55790796|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790797|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
55790798|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55790799|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56261149|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261150|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261151|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
56261152|NCT05410093|Vitamin E|vitamin e|mesh-list
56261153|NCT05410093|Tocopherols|tocopherols|mesh-list
56261154|NCT05410093|Resveratrol|resveratrol|mesh-list
56261155|NCT05410093|Vitamins|vitamins|mesh-ancestor
56261156|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
56261157|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261158|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
55836313|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55874220|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55874221|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874222|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55874223|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56052553|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55790800|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790801|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
55874224|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874225|NCT04099836|Bevacizumab|bevacizumab|mesh-list
55874226|NCT04099836|Atezolizumab|atezolizumab|mesh-list
55874227|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55874228|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874235|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55874236|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55874237|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874238|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874239|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55874240|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790802|NCT04089865|Coagulants|coagulants|mesh-ancestor
55790803|NCT04856111|Pirfenidone|pirfenidone|mesh-list
55790804|NCT04856111|Nintedanib|nintedanib|mesh-list
55725776|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55725777|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55725778|NCT00375791|Dexamethasone|dexamethasone|mesh-list
55725779|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725780|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
55725781|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
55725782|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725783|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725784|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55725785|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
55725786|NCT00375791|Hormones|hormones|mesh-ancestor
55725787|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725788|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55725789|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725790|NCT00431873|Mocetinostat|mocetinostat|mesh-list
55725791|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55766663|NCT04871529|Antiviral Agents|antiviral agents|mesh-ancestor
55725792|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725793|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725794|NCT02287181|Remifentanil|remifentanil|mesh-list
55725795|NCT02287181|Propofol|propofol|mesh-list
55725796|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55725797|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866960|NCT05384691|Luspatercept|luspatercept|mesh-list
55725798|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725799|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55725800|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
55725801|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
55725802|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55725803|NCT02287181|Narcotics|narcotics|mesh-ancestor
55725804|NCT02287181|Analgesics|analgesics|mesh-ancestor
55725805|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
55725806|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725807|NCT02287259|Olanzapine|olanzapine|mesh-list
55725808|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
55725809|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
55725810|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725811|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725812|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55725813|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55725814|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55725815|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725816|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55725817|NCT02287259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55725818|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55725819|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55725820|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725821|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725822|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
55725823|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
55828873|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828874|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
55828875|NCT01572844|Antidotes|antidotes|mesh-ancestor
55828876|NCT01572844|Protective Agents|protective agents|mesh-ancestor
55828877|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828878|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
55725824|NCT00429923|Difluprednate|difluprednate|mesh-list
55725825|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
55790805|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790806|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55790807|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790808|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790809|NCT04856111|Analgesics|analgesics|mesh-ancestor
55790810|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
55890688|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890689|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890690|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890691|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890692|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
55890693|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55890694|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55890781|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55790811|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790812|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790813|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55874241|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874242|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
55874244|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55874245|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874246|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55874247|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
55874248|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56261159|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261160|NCT05410093|Protective Agents|protective agents|mesh-ancestor
56261161|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261162|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56261163|NCT05409820|Anesthetics|anesthetics|mesh-list
56261164|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261165|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261166|NCT05409339|Mannitol|mannitol|mesh-list
56261167|NCT05409339|Caffeine|caffeine|mesh-list
56261168|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55790815|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790816|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790818|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55790819|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261169|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261170|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56261171|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261172|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261173|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56261174|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56261175|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
56261176|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261177|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56261178|NCT05409339|Diuretics|diuretics|mesh-ancestor
56261179|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
56261180|NCT05273567|Guanfacine|guanfacine|mesh-list
56261181|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55890782|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
56261182|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56261183|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56261184|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56261185|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
56261186|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261205|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261206|NCT05068063|Bupivacaine|bupivacaine|mesh-list
56261207|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
56261208|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
56261209|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890783|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
55790833|NCT03841201|Lenvatinib|lenvatinib|mesh-list
56261210|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261211|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
56261212|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261213|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
56261214|NCT05049707|Analgesics|analgesics|mesh-ancestor
56261215|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
56261216|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261217|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261218|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
56261219|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261220|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56261221|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
56261222|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56261223|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55836384|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55874249|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874250|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874251|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874252|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
55874253|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874254|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
55874255|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874259|NCT01175902|Timolol|timolol|mesh-list
55874260|NCT01175902|Dorzolamide|dorzolamide|mesh-list
55874261|NCT01175902|Latanoprost|latanoprost|mesh-list
55874262|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55790834|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790835|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874263|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55874264|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
55874265|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874266|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874267|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874268|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55874269|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55874270|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55874271|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55874272|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55874273|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874274|NCT01135186|Verapamil|verapamil|mesh-list
55874275|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55874276|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55874277|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55874278|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874279|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55874280|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874281|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
56261224|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836404|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55874282|NCT01216683|Rituximab|rituximab|mesh-list
55874283|NCT01216683|Lenalidomide|lenalidomide|mesh-list
55874284|NCT01216683|Bortezomib|bortezomib|mesh-list
55874285|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55749715|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
55874286|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55874287|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874289|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874290|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874291|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55874292|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55874293|NCT01216683|Growth Substances|growth substances|mesh-ancestor
55790836|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55790837|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790838|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55874294|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
55874295|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55874296|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
55874297|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874298|NCT05376228|Vancomycin|vancomycin|mesh-list
55874299|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55874303|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55874304|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874305|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874306|NCT05164770|Prednisone|prednisone|mesh-list
55874307|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
55874308|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
55874309|NCT05164770|Vincristine|vincristine|mesh-list
55874310|NCT05164770|Rituximab|rituximab|mesh-list
55874311|NCT05164770|Doxorubicin|doxorubicin|mesh-list
55874312|NCT05164770|Etoposide|etoposide|mesh-list
55874313|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874314|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55874315|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790839|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790840|NCT01371981|Cytarabine|cytarabine|mesh-list
55790841|NCT01371981|Etoposide|etoposide|mesh-list
55790842|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
55790843|NCT01371981|Daunorubicin|daunorubicin|mesh-list
55790844|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
55790845|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
55790846|NCT01371981|Bortezomib|bortezomib|mesh-list
55874316|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874317|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874318|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
55874319|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874320|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874321|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55874322|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
55790847|NCT01371981|Sorafenib|sorafenib|mesh-list
55790848|NCT01371981|Asparaginase|asparaginase|mesh-list
55790849|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55790850|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874323|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55874324|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874325|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
55874326|NCT05164770|Hormones|hormones|mesh-ancestor
55874327|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874328|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55874329|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55874330|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
55874331|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
55790851|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55790852|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55790853|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874332|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
55874333|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55874334|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55874335|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55874336|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55874338|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55874339|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55874340|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
55874341|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874342|NCT01175980|Vorinostat|vorinostat|mesh-list
55874343|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874344|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55874345|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874346|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874347|NCT04246554|Acetaminophen|acetaminophen|mesh-list
55790854|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790855|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55874348|NCT04246554|Ketorolac|ketorolac|mesh-list
55874349|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55874350|NCT04246554|Oxycodone|oxycodone|mesh-list
55874351|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55874352|NCT04246554|Analgesics|analgesics|mesh-ancestor
55874353|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
55874354|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874355|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261225|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56261226|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
56261227|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56261228|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
56261229|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
56261230|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56261231|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261232|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261233|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56261234|NCT04946396|Analgesics|analgesics|mesh-ancestor
56261235|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
56261236|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052575|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790857|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
55790858|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261237|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56261238|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56261239|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56261240|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
56261241|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261242|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261243|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
56261244|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
56261245|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56261246|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55790859|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790860|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
56261247|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874356|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
55874357|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55874358|NCT04246554|Narcotics|narcotics|mesh-ancestor
55874359|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874360|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55874361|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874362|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874363|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55874364|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874365|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874366|NCT01922817|Saxagliptin|saxagliptin|mesh-list
55874367|NCT01922817|Incretins|incretins|mesh-ancestor
55874369|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790861|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790862|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55790863|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55874370|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874371|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55874372|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
55874375|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55874377|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
55874378|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
55874379|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55874380|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55874381|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874382|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55874383|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
55874384|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55874385|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
56261248|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261249|NCT04908657|Urological Agents|urological agents|mesh-ancestor
56261250|NCT04887389|Listerine|listerine|mesh-list
56261251|NCT04887389|Fluorides|fluorides|mesh-list
56261252|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
56261254|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
56261255|NCT04887389|Protective Agents|protective agents|mesh-ancestor
56261256|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261257|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56261258|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261259|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
56261260|NCT04812028|Analgesics|analgesics|mesh-ancestor
55790864|NCT01371981|Analgesics|analgesics|mesh-ancestor
55790865|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
55790866|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790867|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
56261261|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
56261262|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261263|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261264|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
56261265|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261266|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56261267|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
55874386|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874387|NCT00634179|Prednisone|prednisone|mesh-list
55790868|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
55874388|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
55874389|NCT00634179|Rituximab|rituximab|mesh-list
55874390|NCT00634179|Doxorubicin|doxorubicin|mesh-list
55874391|NCT00634179|Vincristine|vincristine|mesh-list
55874392|NCT00634179|Bortezomib|bortezomib|mesh-list
55874393|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874394|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
55874395|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874396|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874397|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55874398|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
55874399|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874400|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874401|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55874402|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55874403|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55874404|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55790869|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
55790870|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
55790871|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790872|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55790873|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
55790874|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55790875|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55790876|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55874405|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55874406|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874407|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874408|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
55874409|NCT00634179|Hormones|hormones|mesh-ancestor
55874410|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874411|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55874412|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55874413|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
55874414|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
55874415|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
55874417|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
55874418|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874419|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55874420|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874421|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874422|NCT01179490|Prednisolone|prednisolone|mesh-list
56261268|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56261269|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261270|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261271|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56261272|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
56261273|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56261274|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
56261275|NCT04773392|Prednisone|prednisone|mesh-list
56261276|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
56261277|NCT04773392|Azathioprine|azathioprine|mesh-list
56261278|NCT04773392|Tacrolimus|tacrolimus|mesh-list
56261279|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
55883295|NCT05584878|Hemostatics|hemostatics|mesh-ancestor
56261280|NCT04773392|Basiliximab|basiliximab|mesh-list
56261281|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56261282|NCT04773392|Antimetabolites|antimetabolites|mesh-list
56261283|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56261284|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
56261285|NCT04773392|Hormones|hormones|mesh-ancestor
56261286|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261287|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261288|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56261289|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874423|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874424|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
55874425|NCT01179490|Hormones|hormones|mesh-ancestor
55874426|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874427|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874428|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55874429|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874430|NCT01179568|Citalopram|citalopram|mesh-list
55874431|NCT01179568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55874432|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55874433|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55874434|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874435|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874436|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
55874437|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874438|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55874439|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
55874440|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55874442|NCT01180036|Rituximab|rituximab|mesh-list
55874443|NCT01180036|Cyclosporins|cyclosporins|mesh-list
55874444|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55874445|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874449|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874450|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874451|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874452|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
55874453|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874454|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
56261290|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56261291|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
56261292|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56261293|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261294|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261295|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56261296|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56261297|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
56261298|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56261299|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261300|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
56261301|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
56261302|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790877|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790878|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790880|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56261303|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56261304|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56261305|NCT04773392|Protective Agents|protective agents|mesh-ancestor
56261306|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56261307|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56261308|NCT04724655|Mineral Oil|mineral oil|mesh-list
56261309|NCT04724655|Emollients|emollients|mesh-ancestor
56261310|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
56261311|NCT04722835|Albuterol|albuterol|mesh-list
55790882|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790883|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55790884|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55790885|NCT03044093|Misoprostol|misoprostol|mesh-list
56261312|NCT04722835|Dimercaprol|dimercaprol|mesh-list
56261313|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56261314|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
56261315|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261316|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261317|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56261318|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
56261319|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
56261320|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56261335|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56261336|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261337|NCT04487990|Heparin|heparin|mesh-list
56261338|NCT04487990|Calcium heparin|calcium heparin|mesh-list
56261339|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
56261340|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56261341|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56261342|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261343|NCT04476979|Dexamethasone|dexamethasone|mesh-list
56261344|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56261345|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
56261346|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
56261347|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874455|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55874456|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55874457|NCT01180894|Hematinics|hematinics|mesh-ancestor
55874458|NCT01181674|Insulin|insulin|mesh-list
55874459|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55874460|NCT01181674|Metformin|metformin|mesh-list
55874461|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
55874462|NCT01181674|Acarbose|acarbose|mesh-list
55874463|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55874464|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874465|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55874466|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874467|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874468|NCT01182376|Dronedarone|dronedarone|mesh-list
55874469|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55790887|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55790888|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
55874470|NCT01183312|Flumazenil|flumazenil|mesh-list
55874471|NCT01183312|Antidotes|antidotes|mesh-ancestor
55874472|NCT01183312|Protective Agents|protective agents|mesh-ancestor
55874473|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874474|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
55874475|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
55874476|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874477|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874478|NCT03188172|Dexamethasone|dexamethasone|mesh-list
55874479|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
55874480|NCT03188172|Melphalan|melphalan|mesh-list
55874481|NCT03188172|Lenalidomide|lenalidomide|mesh-list
55790889|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55874482|NCT03188172|Bortezomib|bortezomib|mesh-list
55874483|NCT03188172|Daratumumab|daratumumab|mesh-list
55874484|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874485|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
55874486|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874487|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874488|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55874489|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
55874490|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874491|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874492|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55790890|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790891|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55790892|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790893|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
55790894|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55874493|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874494|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
55874495|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
55874496|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874497|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55874498|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
55874499|NCT03188172|Hormones|hormones|mesh-ancestor
55874500|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874501|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55874502|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55790895|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55790896|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55874503|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55874504|NCT03188172|Growth Substances|growth substances|mesh-ancestor
55874505|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
55874506|NCT01184014|Insulin|insulin|mesh-list
55874507|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56261348|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261349|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56261350|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
56261351|NCT04476979|Hormones|hormones|mesh-ancestor
56000887|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55874508|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
55874509|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
55874510|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
55874511|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
55790897|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55790898|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
55790899|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55874512|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
55874513|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55874514|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874515|NCT05672550|Enoxaparin|enoxaparin|mesh-list
55874516|NCT05672550|Enoxaparin sodium|enoxaparin sodium|mesh-list
55874517|NCT05672550|Anticoagulants|anticoagulants|mesh-ancestor
55874518|NCT05672550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55874519|NCT05672550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55874520|NCT05672550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874525|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
55874526|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874527|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
55874528|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874529|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55874530|NCT05282706|Peppermint oil|peppermint oil|mesh-list
55874531|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
55874532|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
55874533|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874534|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874535|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790900|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55790901|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
55790902|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874536|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
55874537|NCT02187016|Listerine|listerine|mesh-list
55874538|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55874539|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874541|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
55874542|NCT05439798|Ondansetron|ondansetron|mesh-list
55874543|NCT05439798|Palonosetron|palonosetron|mesh-list
55874544|NCT05439798|BB 1101|bb 1101|mesh-list
55874545|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874546|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
55874547|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
55874548|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874549|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874550|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55874551|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
55874552|NCT05439798|Hormones|hormones|mesh-ancestor
55874553|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874554|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55874555|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874556|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
55874557|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874558|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874559|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
55874560|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
55874561|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55874562|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
55874563|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874564|NCT05439798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55874565|NCT05439798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55874566|NCT05439798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874567|NCT05439798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55874568|NCT05439798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55874569|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55874570|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
55874571|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55874572|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55874573|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874574|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
55874575|NCT02188576|Coagulants|coagulants|mesh-ancestor
55874576|NCT02189122|Aspirin|aspirin|mesh-list
55874577|NCT02189122|Bradykinin|bradykinin|mesh-list
55874578|NCT02189122|Kininogens|kininogens|mesh-list
55874579|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56261352|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261353|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56261354|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261355|NCT04411953|Haloperidol|haloperidol|mesh-list
56261356|NCT04411953|Benztropine|benztropine|mesh-list
56261357|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
56261358|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
56261359|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
56261360|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261361|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261362|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56261363|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56261364|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56052576|NCT02271698|Dexamethasone|dexamethasone|mesh-list
55790903|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
55790904|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55874580|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55874581|NCT02189122|Analgesics|analgesics|mesh-ancestor
55874582|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
55874583|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874584|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874585|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874586|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874587|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55874588|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55874589|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790905|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55790906|NCT01553071|Fenretinide|fenretinide|mesh-list
55790908|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790909|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55790910|NCT01553071|Protective Agents|protective agents|mesh-ancestor
55874590|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55874591|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55874592|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874593|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
55874594|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
55874596|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
55874597|NCT05309460|Labetalol|labetalol|mesh-list
55874598|NCT05309460|Nifedipine|nifedipine|mesh-list
55874599|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55874600|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55874601|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874602|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55874603|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874604|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
55874605|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
55874606|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55874607|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55874608|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55874609|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
55874610|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874611|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55874612|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
55874613|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
55790911|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790912|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790913|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790914|NCT01506973|Gemcitabine|gemcitabine|mesh-list
55790915|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
55790916|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55790917|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790918|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
55790919|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874614|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874615|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55874616|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55874617|NCT01093690|Metoclopramide|metoclopramide|mesh-list
55874618|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
55874619|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
55874620|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874621|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874622|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55874623|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55874624|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55874625|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
55836543|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56261365|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261366|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56261367|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56261368|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
56261369|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261370|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261371|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56261372|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56261373|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
56261374|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55874626|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874627|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874628|NCT01143688|Albuterol|albuterol|mesh-list
55874629|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55874630|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
55874631|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874632|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874633|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55874634|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
55874635|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
55874636|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55874637|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55874638|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55874639|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55874640|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
55874641|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874642|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874643|NCT04455594|Carboplatin|carboplatin|mesh-list
55874644|NCT04455594|Pemetrexed|pemetrexed|mesh-list
55874645|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55874646|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874647|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874648|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874649|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55874650|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55874651|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55874652|NCT01143766|Gabapentin|gabapentin|mesh-list
55874653|NCT01143766|Analgesics|analgesics|mesh-ancestor
55874654|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
55874655|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874656|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874657|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
55874658|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55874659|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55874660|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874661|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55874662|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55874663|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55874665|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874669|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55874670|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890769|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874671|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874672|NCT03011476|Donepezil|donepezil|mesh-list
55874673|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55874674|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874675|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874676|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
55874677|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874678|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790920|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790921|NCT01506973|Antiviral Agents|antiviral agents|mesh-ancestor
55790922|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790923|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790924|NCT01506973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56261376|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
56261377|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56261378|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56261379|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261380|NCT04411940|Haloperidol|haloperidol|mesh-list
56261381|NCT04411940|Benztropine|benztropine|mesh-list
56261382|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
56261383|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
56261384|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
56052577|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
55790925|NCT01506973|Immunologic Factors|immunologic factors|mesh-ancestor
55790926|NCT01506973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790928|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55790929|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55790930|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790931|NCT04380545|Interferons|interferons|mesh-list
55790932|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
55790933|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
55790934|NCT04380545|Fluorouracil|fluorouracil|mesh-list
55790935|NCT04380545|Nivolumab|nivolumab|mesh-list
55790936|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
55790937|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790938|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790939|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261385|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261386|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261387|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56261388|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56261389|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55836561|NCT01443130|Renal Agents|renal agents|mesh-ancestor
55874679|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
55874680|NCT02522754|Vaccines|vaccines|mesh-list
55874681|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
55790940|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874682|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874683|NCT01188694|Methylene Blue|methylene blue|mesh-list
55874684|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874685|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874686|NCT01188928|Betamethasone|betamethasone|mesh-list
55874687|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
55874688|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55874689|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
55874690|NCT01188928|Calcipotriene|calcipotriene|mesh-list
55874691|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55874692|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874693|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
55790941|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
55874694|NCT01188928|Hormones|hormones|mesh-ancestor
55874695|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874696|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874697|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55874698|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
55874699|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
55874700|NCT05438706|Carboplatin|carboplatin|mesh-list
55874701|NCT05438706|Capecitabine|capecitabine|mesh-list
55874702|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874703|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55874704|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
55874705|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874706|NCT01189240|Bevacizumab|bevacizumab|mesh-list
55874707|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55874708|NCT01189240|Antibodies|antibodies|mesh-list
55874709|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
55874710|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55874711|NCT01189240|R04929097|r04929097|mesh-list
55874712|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874713|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55874714|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55874715|NCT01189240|Growth Substances|growth substances|mesh-ancestor
55874716|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874717|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
55874718|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
55874719|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874720|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874721|NCT03467334|Simethicone|simethicone|mesh-list
55790942|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790943|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790944|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55790946|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790947|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55790948|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790949|NCT03101995|Gemcitabine|gemcitabine|mesh-list
55790950|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790951|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
55874722|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
55836569|NCT01959139|Leucovorin|leucovorin|mesh-list
55836570|NCT01959139|Fluorouracil|fluorouracil|mesh-list
55836571|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
55836572|NCT01959139|Irinotecan|irinotecan|mesh-list
55836573|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
55836574|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836575|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
55836576|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836577|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55836578|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261390|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261391|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56261392|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56261393|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
56261394|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261395|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261396|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56261397|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56261398|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
56261399|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56261400|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56261401|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
55836579|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56261402|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56261403|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56261404|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261405|NCT04294160|Trametinib|trametinib|mesh-list
56261406|NCT04294160|Dabrafenib|dabrafenib|mesh-list
56261407|NCT04294160|Spartalizumab|spartalizumab|mesh-list
56261408|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261409|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56261410|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000888|NCT05471544|Amodiaquine|amodiaquine|mesh-list
55874723|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874724|NCT03467334|Emollients|emollients|mesh-ancestor
55874725|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
55874726|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
55874727|NCT02874144|Fluticasone|fluticasone|mesh-list
55874728|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874729|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
55874730|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55874731|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55874732|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
55874733|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790952|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790953|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790954|NCT03101995|Antiviral Agents|antiviral agents|mesh-ancestor
56261411|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261413|NCT04150614|Dexamethasone|dexamethasone|mesh-list
56261414|NCT04150614|Ondansetron|ondansetron|mesh-list
56261415|NCT04150614|Granisetron|granisetron|mesh-list
56261416|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56261417|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
56261418|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
56261419|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261420|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261421|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56261422|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
56261423|NCT04150614|Hormones|hormones|mesh-ancestor
55790955|NCT03101995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790956|NCT03101995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261424|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261425|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56261426|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261427|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
56261428|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
56261429|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56261430|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
56261431|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261432|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261433|NCT04150614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55883440|NCT02064036|Leuprolide|leuprolide|mesh-list
56261434|NCT04150614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56261435|NCT04150614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261436|NCT04150614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56261437|NCT04150614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56261438|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56261439|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56261440|NCT04030429|Crizotinib|crizotinib|mesh-list
56261441|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261442|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56261443|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000889|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
55874734|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874735|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55874736|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
55874737|NCT03467178|Gemcitabine|gemcitabine|mesh-list
55874738|NCT03467178|Paclitaxel|paclitaxel|mesh-list
56261444|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261445|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
56261446|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
56261447|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261448|NCT03970694|Capecitabine|capecitabine|mesh-list
56261449|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
56261450|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56261451|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
56261452|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261453|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261454|NCT03941132|Ustekinumab|ustekinumab|mesh-list
56261455|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
56261456|NCT03920007|Trimethoprim|trimethoprim|mesh-list
56261457|NCT03920007|Polymyxins|polymyxins|mesh-list
56261458|NCT03920007|Polymyxin B|polymyxin b|mesh-list
56261459|NCT03920007|Prednisone|prednisone|mesh-list
56261460|NCT03920007|Prednisolone|prednisolone|mesh-list
56261461|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56261462|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
56261463|NCT03920007|Hormones|hormones|mesh-ancestor
56261464|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261465|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261466|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56261467|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261468|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55836609|NCT01619852|Lidocaine|lidocaine|mesh-list
55874744|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874745|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
55874746|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
55874747|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
55874748|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874749|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55874750|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
55874751|NCT03467178|Antiviral Agents|antiviral agents|mesh-ancestor
55752951|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55790957|NCT03101995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790958|NCT03101995|Immunologic Factors|immunologic factors|mesh-ancestor
55790959|NCT03101995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874752|NCT03467178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874753|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874754|NCT03467178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874755|NCT03467178|Immunologic Factors|immunologic factors|mesh-ancestor
55874756|NCT03467178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874757|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55874758|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55874759|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55874761|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
55874762|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874763|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55790961|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
55874764|NCT02835534|Plasminogen|plasminogen|mesh-list
55874765|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55874766|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55874767|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874768|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
56261469|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261470|NCT03920007|Renal Agents|renal agents|mesh-ancestor
56261471|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
56261472|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56261473|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56261474|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56261475|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752952|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
55790962|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261476|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261477|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56261478|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56261479|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56261480|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56261481|NCT03873246|Varenicline|varenicline|mesh-list
56261482|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56261483|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56261484|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
56261485|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261486|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261487|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261488|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
56261489|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56261490|NCT03866577|Antibodies|antibodies|mesh-list
56261491|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
56261492|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56261493|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
56261494|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261495|NCT03714880|Mifepristone|mifepristone|mesh-list
56261496|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55874769|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874770|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
55874771|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874772|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
55874773|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874774|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874775|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55874776|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
55874777|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874778|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874779|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55874780|NCT02611830|Vedolizumab|vedolizumab|mesh-list
55874781|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55874782|NCT03461718|Fentanyl|fentanyl|mesh-list
55874783|NCT03461718|Midazolam|midazolam|mesh-list
55790964|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790965|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55874784|NCT03461718|Ketamine|ketamine|mesh-list
55874785|NCT03461718|Analgesics|analgesics|mesh-ancestor
55874786|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
55874787|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261497|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
56261498|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56261499|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261500|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56261501|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56261502|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56261503|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
56261504|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55883510|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56261505|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56261506|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
56261507|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261508|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
55790966|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790967|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261509|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56261510|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56261511|NCT03623633|Denosumab|denosumab|mesh-list
56261512|NCT03623633|Alendronate|alendronate|mesh-list
56261513|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55836660|NCT04666129|Hormones|hormones|mesh-ancestor
55836664|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
55874788|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790968|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55790969|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55874789|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55874790|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55874791|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
55874792|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
55874793|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874794|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55874795|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55874796|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874797|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874798|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55874799|NCT03461718|Narcotics|narcotics|mesh-ancestor
55874800|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55874801|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55874802|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55874803|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55874804|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55874805|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
55874806|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
55790970|NCT00484471|Valproic Acid|valproic acid|mesh-list
55790971|NCT00484471|Aripiprazole|aripiprazole|mesh-list
55790972|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
55874807|NCT05431920|Vitamin D|vitamin d|mesh-list
55874808|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
55874809|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
55874810|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55874816|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55874817|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
55874818|NCT03467022|Vitamins|vitamins|mesh-ancestor
55874819|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
55874820|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874821|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
55874822|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874823|NCT03467022|Protective Agents|protective agents|mesh-ancestor
55874824|NCT03129594|Glucagon|glucagon|mesh-list
55874825|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55874826|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790973|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55874827|NCT03129594|Hormones|hormones|mesh-ancestor
56261515|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261516|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56261517|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
56261518|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261519|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56261520|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56261521|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56261522|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56261523|NCT03619850|Hematinics|hematinics|mesh-ancestor
56261524|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56261525|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56261526|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
56261527|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56261528|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
56261529|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261530|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56261531|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
56261532|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56261533|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
56261534|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261535|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56261536|NCT03532516|Brivaracetam|brivaracetam|mesh-list
56261537|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
56261538|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
56261539|NCT03333005|Clotrimazole|clotrimazole|mesh-list
56261540|NCT03333005|Miconazole|miconazole|mesh-list
56261541|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261542|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56261543|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55874828|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874829|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874830|NCT03129594|Incretins|incretins|mesh-ancestor
55874831|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
55874832|NCT03466632|Propofol|propofol|mesh-list
55874833|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55874834|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874835|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874836|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55874837|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
55874838|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
55874839|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55874840|NCT03466632|Analgesics|analgesics|mesh-ancestor
55874841|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
56261544|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56261545|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261546|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874842|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874843|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55874844|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55874845|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55874846|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
55874847|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874848|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874849|NCT05339334|Ritonavir|ritonavir|mesh-list
55874850|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55874851|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55874852|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
55874853|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874854|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874855|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55790974|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55790975|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55874856|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55874857|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
55874858|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874859|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55874860|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55874861|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
55874862|NCT03461328|Analgesics|analgesics|mesh-ancestor
55874863|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
55874864|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874865|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874866|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
55753118|NCT04997967|Ketamine|ketamine|mesh-list
55790976|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790977|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790978|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
55874867|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874868|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55874869|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
55874870|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55874871|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55874872|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874873|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55874874|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
55874875|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55874877|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55874878|NCT01145638|Trace Elements|trace elements|mesh-ancestor
55874879|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
55749787|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
55874884|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55874885|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
55874886|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874887|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874888|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55874889|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
55874890|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874891|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874892|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55874893|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
55874895|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55874896|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874897|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874898|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55874899|NCT03466242|Analgesics|analgesics|mesh-ancestor
55874900|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
55874901|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874902|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55874903|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55874904|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55790980|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790981|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874905|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
55874906|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55874907|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874908|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55874909|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55874910|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
56261547|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56261548|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
56261549|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261550|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790982|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55790983|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56261551|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56261552|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55874911|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
55874912|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55874913|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55874914|NCT01190878|Bromfenac|bromfenac|mesh-list
55874915|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55874916|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55874917|NCT01190878|Analgesics|analgesics|mesh-ancestor
55874918|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
55874919|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874920|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874921|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874922|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874923|NCT01146808|Adefovir|adefovir|mesh-list
55790984|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
55790985|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55874924|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
55874925|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
55874926|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55874927|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55874928|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55874929|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874930|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874931|NCT02522130|Naproxen|naproxen|mesh-list
55874932|NCT02522130|Lidocaine|lidocaine|mesh-list
55874933|NCT02522130|Misoprostol|misoprostol|mesh-list
55874934|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
55874935|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
55874936|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874937|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874938|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
55874939|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874940|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55874941|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55874942|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55874943|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55874944|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874945|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55874946|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
55874947|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55874948|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55874951|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55874952|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55874954|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55874955|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874956|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
55874957|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55874958|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874959|NCT01148524|Vaccines|vaccines|mesh-list
55874960|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
55790986|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55790987|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55790988|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55790989|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
55874961|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874962|NCT03460860|Tocopherols|tocopherols|mesh-list
55874963|NCT03460860|Vitamin E|vitamin e|mesh-list
55874964|NCT03460860|Tocotrienols|tocotrienols|mesh-list
55874965|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
55874966|NCT03460860|Lycopene|lycopene|mesh-list
55874967|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
55874968|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874969|NCT03460860|Protective Agents|protective agents|mesh-ancestor
55874970|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874971|NCT03460860|Vitamins|vitamins|mesh-ancestor
55874972|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
55874973|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56261553|NCT03148366|Levofloxacin|levofloxacin|mesh-list
56261554|NCT03148366|Ofloxacin|ofloxacin|mesh-list
56261555|NCT03148366|Bismuth|bismuth|mesh-list
56261556|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55790990|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790992|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
56261557|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261558|NCT03148366|Renal Agents|renal agents|mesh-ancestor
56261559|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56261560|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56261561|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56261562|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261563|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261564|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261565|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56261566|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56261567|NCT03148366|Antacids|antacids|mesh-ancestor
56261568|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56261569|NCT03122496|Durvalumab|durvalumab|mesh-list
56261570|NCT03122496|Tremelimumab|tremelimumab|mesh-list
56261571|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56261572|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261573|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
56261574|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56261575|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
56261576|NCT03118232|Povidone|povidone|mesh-list
55836723|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
55874974|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55874975|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55874976|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874977|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
55874978|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55874979|NCT05215236|Narcotics|narcotics|mesh-ancestor
55874980|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55874981|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874982|NCT05215236|Analgesics|analgesics|mesh-ancestor
55874983|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
55790993|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55790994|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55790995|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874984|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55874985|NCT03460782|Ipilimumab|ipilimumab|mesh-list
55874986|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55874987|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874988|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55874989|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874990|NCT01099618|Metformin|metformin|mesh-list
55874991|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55874992|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55874993|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874994|NCT01099618|Incretins|incretins|mesh-ancestor
55874995|NCT01099618|Hormones|hormones|mesh-ancestor
55874996|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874997|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55874998|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
55790996|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
55790997|NCT01746849|Thiotepa|thiotepa|mesh-list
55790998|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790999|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
55874999|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875000|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261577|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56261578|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261579|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
56261580|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
56261581|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
56261582|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
56261583|NCT03073694|Melphalan|melphalan|mesh-list
56261584|NCT03073694|Mitomycins|mitomycins|mesh-list
56261585|NCT03073694|Mitomycin|mitomycin|mesh-list
56261586|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56261587|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
56261588|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261589|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791000|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791001|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56261590|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56261591|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56261592|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
56261593|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261594|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56261595|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56261596|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261597|NCT03069703|Rituximab|rituximab|mesh-list
56261598|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56261599|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261600|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
56261601|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261602|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56261603|NCT03043313|Trastuzumab|trastuzumab|mesh-list
56261604|NCT03043313|Tucatinib|tucatinib|mesh-list
56261605|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56261606|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261607|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56261608|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000890|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55875001|NCT01099774|Bimatoprost|bimatoprost|mesh-list
55875002|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55875003|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55875004|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55875005|NCT05678244|Acetaminophen|acetaminophen|mesh-list
55875006|NCT05678244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55875007|NCT05678244|Analgesics|analgesics|mesh-ancestor
55875008|NCT05678244|Sensory System Agents|sensory system agents|mesh-ancestor
55875009|NCT05678244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875010|NCT05678244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261609|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261610|NCT02955082|Carboplatin|carboplatin|mesh-list
55791002|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56261611|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261612|NCT02944617|Micronutrients|micronutrients|mesh-list
56261613|NCT02944617|Trace Elements|trace elements|mesh-list
56261614|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261615|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
56261616|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261617|NCT02818738|Levamisole|levamisole|mesh-list
56261618|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56261619|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
55791003|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
56261620|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261621|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
56261622|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
56261623|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56261624|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261625|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56261626|NCT02335099|Ticagrelor|ticagrelor|mesh-list
56261627|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56261628|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56261629|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56261630|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56261631|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
56261632|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791004|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791005|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261633|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261634|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261635|NCT02330562|Bevacizumab|bevacizumab|mesh-list
56261643|NCT02138617|Leucovorin|leucovorin|mesh-list
56261656|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261657|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56261658|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883658|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261659|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
56261660|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56261661|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56261662|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261664|NCT02138617|Protective Agents|protective agents|mesh-ancestor
56261665|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
56261667|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
56261668|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
56261669|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56261670|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56261671|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261672|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
56261673|NCT02053363|Coagulants|coagulants|mesh-ancestor
56261674|NCT01100775|Galantamine|galantamine|mesh-list
56261675|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56261676|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261677|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261678|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
56261679|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791006|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55791007|NCT04847921|Dalbavancin|dalbavancin|mesh-list
55791008|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56261680|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261681|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56261682|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
56261683|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261684|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
56261685|NCT00504712|Testosterone|testosterone|mesh-list
56261686|NCT00504712|Androgens|androgens|mesh-ancestor
55875011|NCT05678244|Antipyretics|antipyretics|mesh-ancestor
55875012|NCT01100242|Bortezomib|bortezomib|mesh-list
55875013|NCT01100242|Sorafenib|sorafenib|mesh-list
55875014|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875015|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55875016|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875017|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875018|NCT01148836|Ubiquinone|ubiquinone|mesh-list
55875019|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
55875020|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
55875021|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875022|NCT01148836|Vitamins|vitamins|mesh-ancestor
55875023|NCT01149616|Dexamethasone|dexamethasone|mesh-list
55875024|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875029|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56261687|NCT00504712|Hormones|hormones|mesh-ancestor
56261688|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261689|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261690|NCT05413200|Isotretinoin|isotretinoin|mesh-list
56261691|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
56261692|NCT05413096|Propolis|propolis|mesh-list
56261693|NCT05413096|Diclofenac|diclofenac|mesh-list
56261694|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56261695|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56261696|NCT05413096|Analgesics|analgesics|mesh-ancestor
56261697|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
56261698|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261699|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261700|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836856|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836857|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753119|NCT04997967|Propofol|propofol|mesh-list
55836858|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836859|NCT01441414|Axitinib|axitinib|mesh-list
55836860|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836861|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55836862|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836863|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836864|NCT01954927|Gabapentin|gabapentin|mesh-list
55836865|NCT01954927|Analgesics|analgesics|mesh-ancestor
55875030|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
55875031|NCT01149616|Hormones|hormones|mesh-ancestor
55875032|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875033|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55875034|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875035|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
55875036|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
55875037|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55753202|NCT03201913|Hormones|hormones|mesh-ancestor
55791009|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791010|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
55875038|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55875039|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875040|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875041|NCT03460470|Urological Agents|urological agents|mesh-ancestor
55875042|NCT01101100|Brodalumab|brodalumab|mesh-list
55875043|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
55875044|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55875045|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875046|NCT01101880|Cytarabine|cytarabine|mesh-list
55875047|NCT01101880|Clofarabine|clofarabine|mesh-list
55875048|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55875049|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
55875050|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875051|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875052|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
55875053|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875054|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55875055|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
55791012|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56261701|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56261702|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56261703|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261704|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261705|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261706|NCT05412914|Propofol|propofol|mesh-list
56261707|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56261708|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261709|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261710|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56261711|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
56261712|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
56261713|NCT05412589|Apatinib|apatinib|mesh-list
55875056|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875057|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55875058|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
55875059|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875060|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
55875061|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875062|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
55875063|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55875064|NCT01102270|Eszopiclone|eszopiclone|mesh-list
55875065|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55875066|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875067|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875068|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
55875069|NCT01103440|Tirofiban|tirofiban|mesh-list
55875070|NCT01103440|Ticlopidine|ticlopidine|mesh-list
55875071|NCT01103440|Abciximab|abciximab|mesh-list
55875072|NCT01103440|Clopidogrel|clopidogrel|mesh-list
55875073|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55875074|NCT01103440|Cangrelor|cangrelor|mesh-list
55875075|NCT01103440|Eptifibatide|eptifibatide|mesh-list
55875076|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55875077|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55875078|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55875079|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55875080|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
55875081|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875082|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875083|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875084|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
55875085|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55875086|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55875087|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55875088|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
55875089|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55875090|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875091|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
55875092|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875093|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
55875094|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55875095|NCT01103440|Protective Agents|protective agents|mesh-ancestor
55875096|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55875098|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875099|NCT01105312|Letrozole|letrozole|mesh-list
55875102|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55875103|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55875104|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875105|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875106|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56261715|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55791014|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
55791015|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56261716|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261717|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261718|NCT05412576|Lidocaine|lidocaine|mesh-list
56261719|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
56261720|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
56261721|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261722|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261723|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
56261724|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261725|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56261726|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56261727|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56261728|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261729|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261730|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
56261731|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
56261732|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883734|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56261733|NCT05412472|Protective Agents|protective agents|mesh-ancestor
55791017|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791018|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
55791019|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
56261734|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261735|NCT05412394|Prednisolone|prednisolone|mesh-list
56261736|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56261737|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
56261738|NCT05412394|Hormones|hormones|mesh-ancestor
56261739|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261740|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261741|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56261742|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261743|NCT05412147|Vitamins|vitamins|mesh-list
55875107|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
55791020|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791021|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875108|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875109|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875110|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55875111|NCT04488978|Amlodipine|amlodipine|mesh-list
55875112|NCT04488978|Irbesartan|irbesartan|mesh-list
55875113|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55875114|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55875115|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261745|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261746|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56261747|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55791022|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791023|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
56261748|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261749|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261750|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56261751|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261752|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875116|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875117|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55875118|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875119|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
55875120|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55875121|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55875122|NCT03460002|Vaccines|vaccines|mesh-list
55791025|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875123|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
55875124|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875125|NCT01105702|Bevacizumab|bevacizumab|mesh-list
55875126|NCT01105702|Temozolomide|temozolomide|mesh-list
55875127|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
55875128|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55875129|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875130|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55838338|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875131|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55791026|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55791027|NCT04847687|Protective Agents|protective agents|mesh-ancestor
55791028|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791029|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791031|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791032|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
55791033|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791035|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55791036|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791037|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55791038|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
55791039|NCT04737343|Azathioprine|azathioprine|mesh-list
55791040|NCT04737343|Leflunomide|leflunomide|mesh-list
55791041|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
55875132|NCT01105702|Growth Substances|growth substances|mesh-ancestor
55875133|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875134|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
55875135|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55875136|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
55875137|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875138|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
55875139|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55875140|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875141|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
55875142|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55875143|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875144|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55875145|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55875146|NCT04453332|Hormones|hormones|mesh-list
55875147|NCT04453332|Estradiol|estradiol|mesh-list
55875148|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55875149|NCT04453332|Progesterone|progesterone|mesh-list
55875150|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875151|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875152|NCT04453332|Estrogens|estrogens|mesh-ancestor
55875153|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55875154|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
55791042|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875155|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55875156|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55875157|NCT04453332|Progestins|progestins|mesh-ancestor
55875158|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
55875159|NCT03456570|Progestins|progestins|mesh-ancestor
55875160|NCT03456570|Hormones|hormones|mesh-ancestor
55875161|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875162|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875163|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55875164|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55875165|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55875166|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261753|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
56261754|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791043|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56261756|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56261757|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56261758|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56261759|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56261760|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
56261761|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261762|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56261763|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56261764|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261765|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56261766|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56261767|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56261768|NCT05411757|Bevacizumab|bevacizumab|mesh-list
56261769|NCT05411757|Lenvatinib|lenvatinib|mesh-list
56261770|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56261771|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261772|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56261773|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56261774|NCT05411757|Growth Substances|growth substances|mesh-ancestor
56261775|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261776|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
56261777|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56261815|NCT05411679|Olaparib|olaparib|mesh-list
56261816|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56261817|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261818|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261819|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261820|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55791044|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791045|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791046|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
55791047|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791048|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55791049|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791050|NCT05579769|Cyclosporine|cyclosporine|mesh-list
55791051|NCT05579769|Cyclophosphamide|cyclophosphamide|mesh-list
55791053|NCT05579769|Thiotepa|thiotepa|mesh-list
56261821|NCT05411276|Maleic acid|maleic acid|mesh-list
56261822|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261823|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261824|NCT05396781|Proflavine|proflavine|mesh-list
56261825|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56261826|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261827|NCT05384951|Vitamin D|vitamin d|mesh-list
55875169|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875171|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
55875172|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875173|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
55875174|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55791054|NCT05579769|Methotrexate|methotrexate|mesh-list
55791055|NCT05579769|Fludarabine|fludarabine|mesh-list
55791056|NCT05579769|Cyclosporins|cyclosporins|mesh-list
55791057|NCT05579769|Thymoglobulin|thymoglobulin|mesh-list
55875175|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
55875176|NCT03464682|Atorvastatin|atorvastatin|mesh-list
55875177|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55875178|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55875179|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
55875180|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875181|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55875182|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55875183|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875184|NCT03464058|Rabeprazole|rabeprazole|mesh-list
55875185|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55875186|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55875187|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55875188|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875189|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875190|NCT03451734|Metformin|metformin|mesh-list
55875191|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
55875192|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55791058|NCT05579769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55791059|NCT05579769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791060|NCT05579769|Immunologic Factors|immunologic factors|mesh-ancestor
55875193|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875194|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55875195|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875196|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55875197|NCT03130218|Peppermint oil|peppermint oil|mesh-list
55875198|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
55875199|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
55875200|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875201|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875202|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55875203|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
55875204|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
55875205|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261828|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
56261829|NCT05384951|Vitamins|vitamins|mesh-ancestor
56261830|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
56261831|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261832|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56261833|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55791061|NCT05579769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791062|NCT05579769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55791063|NCT05579769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55791064|NCT05579769|Alkylating Agents|alkylating agents|mesh-ancestor
56261834|NCT05320406|Leuprolide|leuprolide|mesh-list
56261835|NCT05320406|Relugolix|relugolix|mesh-list
56261836|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56261837|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
56261838|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56261839|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261840|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56261841|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261842|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
56261843|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
55753518|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
55791065|NCT05579769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261844|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261845|NCT05303038|Bevacizumab|bevacizumab|mesh-list
56261846|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56261847|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261848|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56261849|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56261850|NCT05303038|Growth Substances|growth substances|mesh-ancestor
56261851|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261852|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
56261853|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56261854|NCT05275894|Metronidazole|metronidazole|mesh-list
56261855|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56261856|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56261857|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56261858|NCT05167760|Apraclonidine|apraclonidine|mesh-list
56261859|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56261870|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56261871|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261872|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
56261873|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56261874|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56261875|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261876|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
56261877|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261878|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261879|NCT05042674|Ergothioneine|ergothioneine|mesh-list
56261880|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
56261881|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261882|NCT05042674|Protective Agents|protective agents|mesh-ancestor
56261883|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261885|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
56261886|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261887|NCT04917055|Dexamethasone|dexamethasone|mesh-list
56261888|NCT04917055|Epinephrine|epinephrine|mesh-list
56261889|NCT04917055|Ropivacaine|ropivacaine|mesh-list
56261890|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56261891|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
56261892|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
56261893|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261894|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261895|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56261896|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
56261897|NCT04917055|Hormones|hormones|mesh-ancestor
56261898|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261899|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56261900|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261901|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
56261902|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
55875206|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55875207|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875208|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875209|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
55875210|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875211|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261903|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261904|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
55753596|NCT05651399|Propofol|propofol|mesh-list
55791067|NCT05579769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55791068|NCT05579769|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56261905|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56261906|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56261907|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
56261908|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261909|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261910|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56261911|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56261912|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56261913|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
56261914|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
56261915|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
56261916|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56261917|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
56261918|NCT04898478|Narcotics|narcotics|mesh-ancestor
55791069|NCT05579769|Abortifacient Agents|abortifacient agents|mesh-ancestor
55791070|NCT05579769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56261919|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56261920|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261921|NCT04898478|Analgesics|analgesics|mesh-ancestor
56261922|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
56261923|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261924|NCT04792385|Drospirenone|drospirenone|mesh-list
56261925|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
56261926|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
56261927|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56261928|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56261929|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261930|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56261931|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56261932|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
56261933|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56261943|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261944|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261945|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
56261946|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753679|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791072|NCT05579769|Antimetabolites|antimetabolites|mesh-ancestor
55791073|NCT05579769|Dermatologic Agents|dermatologic agents|mesh-ancestor
55791074|NCT05579769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791075|NCT05579769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55791076|NCT05579769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55791077|NCT05579769|Antifungal Agents|antifungal agents|mesh-ancestor
55791078|NCT05579769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791079|NCT05579769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55791080|NCT02609399|Oseltamivir|oseltamivir|mesh-list
55791081|NCT02609399|Peramivir|peramivir|mesh-list
55791082|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
56261947|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56261948|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56261949|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56261950|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56261951|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261952|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56261953|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56261954|NCT04777006|Analgesics|analgesics|mesh-ancestor
56261955|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
56261956|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56261957|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56261958|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
56261960|NCT04755244|Venetoclax|venetoclax|mesh-list
56261961|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56261962|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
56261963|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261964|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261965|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261966|NCT04733534|Dasatinib|dasatinib|mesh-list
56261967|NCT04733534|Quercetin|quercetin|mesh-list
56261968|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56261969|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55791083|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791084|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791085|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791086|NCT05430217|Buspirone|buspirone|mesh-list
55791087|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55791088|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55791089|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791090|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791091|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55791092|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55791094|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791095|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791096|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
55791097|NCT03103555|Bortezomib|bortezomib|mesh-list
55791098|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56261970|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261971|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261972|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
56261973|NCT04733534|Protective Agents|protective agents|mesh-ancestor
56261974|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261975|NCT04725864|Progesterone|progesterone|mesh-list
56261976|NCT04725864|Progestins|progestins|mesh-ancestor
56261977|NCT04725864|Hormones|hormones|mesh-ancestor
56261979|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261981|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56261982|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56261983|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261984|NCT04721353|Prazosin|prazosin|mesh-list
56261985|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56261986|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55791099|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
55791100|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791101|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55791102|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55791103|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
55791104|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791105|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791106|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56261987|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56261988|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56261989|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
56261990|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56261991|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56261992|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56261993|NCT04655391|Decitabine|decitabine|mesh-list
56261994|NCT04655391|Venetoclax|venetoclax|mesh-list
56261995|NCT04655391|Ivosidenib|ivosidenib|mesh-list
56261996|NCT04655391|Maleic acid|maleic acid|mesh-list
56261997|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55875212|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55875213|NCT05322252|Misoprostol|misoprostol|mesh-list
55875214|NCT05322252|Mifepristone|mifepristone|mesh-list
55875215|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55875216|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
55875217|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55875218|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875219|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55875220|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55875221|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
55875222|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55875223|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55875224|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55875225|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55875226|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
55875227|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55875228|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55791107|NCT02720185|Dasatinib|dasatinib|mesh-list
55791108|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791109|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55875229|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
55875230|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749804|NCT03297593|Nivolumab|nivolumab|mesh-list
55875231|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
55875232|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55875233|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55875234|NCT01199926|Vitamin D|vitamin d|mesh-list
55875235|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
55875236|NCT01199926|Vitamins|vitamins|mesh-ancestor
55875237|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
55875241|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
55875242|NCT01106950|Fludarabine|fludarabine|mesh-list
55875243|NCT01106950|Interleukin-2|interleukin-2|mesh-list
55875244|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
55875245|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55875246|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
55875247|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875248|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55875249|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55875250|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
55890770|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791110|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791111|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875251|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875252|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875253|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56261998|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
56261999|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262000|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262001|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262002|NCT04609098|Piperaquine|piperaquine|mesh-list
56262003|NCT04609098|Artenimol|artenimol|mesh-list
56262004|NCT04609098|Tafenoquine|tafenoquine|mesh-list
55791112|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
55791113|NCT04846673|Pregabalin|pregabalin|mesh-list
55791114|NCT04846673|Analgesics|analgesics|mesh-ancestor
55791115|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
55791116|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791117|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791118|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
55791119|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55791120|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55791121|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791122|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56262005|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
56262006|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56262007|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56262008|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262009|NCT04605614|Copper|copper|mesh-list
56262010|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
56262011|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262012|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262013|NCT04605614|Trace Elements|trace elements|mesh-ancestor
55791123|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55791124|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55791125|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262014|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
56262015|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262016|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
56262017|NCT04493333|Psyllium|psyllium|mesh-list
56262018|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56262019|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56262020|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
56262021|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262022|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
56262023|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262024|NCT04493333|Cathartics|cathartics|mesh-ancestor
56262025|NCT04475016|Paclitaxel|paclitaxel|mesh-list
56262026|NCT04475016|Ifosfamide|ifosfamide|mesh-list
55791127|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
55791128|NCT04846673|Protective Agents|protective agents|mesh-ancestor
55791129|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
55791130|NCT04846673|Vitamins|vitamins|mesh-ancestor
55791131|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
55791132|NCT04498273|Aspirin|aspirin|mesh-list
55791133|NCT04498273|Apixaban|apixaban|mesh-list
55791134|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55791135|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55791136|NCT04498273|Analgesics|analgesics|mesh-ancestor
55791137|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
55791138|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791139|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262027|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56262028|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
56262029|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56262030|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875254|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55875255|NCT01106950|Analgesics|analgesics|mesh-ancestor
55875256|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
55875257|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875258|NCT03463044|Nangibotide|nangibotide|mesh-list
55875259|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875260|NCT02522208|Hydralazine|hydralazine|mesh-list
55875261|NCT02522208|Isosorbide|isosorbide|mesh-list
55875262|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55875263|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55875264|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55875265|NCT02522208|Diuretics|diuretics|mesh-ancestor
55875266|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
55875267|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791140|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791141|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55791142|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55791143|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55791144|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262031|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
56262032|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
56262033|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
56262034|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262035|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56262036|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
56262037|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262050|NCT04321551|Letrozole|letrozole|mesh-list
56262051|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
56262052|NCT04321551|Testosterone|testosterone|mesh-list
56262053|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
56262054|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
55837207|NCT04678895|Naltrexone|naltrexone|mesh-list
55875268|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
55875269|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55875270|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875271|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55875272|NCT05684172|Tenecteplase|tenecteplase|mesh-list
55875273|NCT05684172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55875274|NCT05684172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55875275|NCT05684172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875277|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55875278|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
55875279|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875280|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55875281|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
55875282|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
55875283|NCT01200160|Vitamins|vitamins|mesh-ancestor
55875284|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
55875285|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875286|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
55875287|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55875288|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875289|NCT01153672|Letrozole|letrozole|mesh-list
55875290|NCT01153672|Anastrozole|anastrozole|mesh-list
55875291|NCT01153672|Vorinostat|vorinostat|mesh-list
55875292|NCT01153672|Exemestane|exemestane|mesh-list
55875293|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875294|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56262055|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56262056|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262057|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56262058|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56262059|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262060|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262061|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56262062|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
56262063|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262064|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262065|NCT04321551|Androgens|androgens|mesh-ancestor
56262066|NCT04321551|Hormones|hormones|mesh-ancestor
56262067|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791145|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55791146|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55791147|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791148|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
55791149|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55791150|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
55791151|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55791152|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
56262068|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
55875295|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55875296|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875297|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875298|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55875299|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
55875300|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875301|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875302|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55875303|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55875304|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
55875305|NCT03010072|Hematinics|hematinics|mesh-ancestor
55875306|NCT03462810|Cabotegravir|cabotegravir|mesh-list
55875307|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55875308|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55875313|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
55875314|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875316|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875317|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55875318|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
55791153|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
55791154|NCT01660971|Gemcitabine|gemcitabine|mesh-list
55791155|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55875319|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875320|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875321|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55875322|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
55875323|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
55875324|NCT01219738|Hormones|hormones|mesh-ancestor
55875325|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875326|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
55875327|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55875328|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875329|NCT01155154|Clindamycin|clindamycin|mesh-list
55875330|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
55875331|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
55875332|NCT01155154|Cephalexin|cephalexin|mesh-list
55875333|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55875334|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875335|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55875336|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875337|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875338|NCT04614714|Niacinamide|niacinamide|mesh-list
55875340|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
55875341|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
55875342|NCT04614714|Vitamins|vitamins|mesh-ancestor
55875343|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
55875344|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262069|NCT04302324|Clarithromycin|clarithromycin|mesh-list
55791156|NCT01660971|Dasatinib|dasatinib|mesh-list
55791157|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55791158|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
55791159|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262070|NCT04302324|Dexamethasone|dexamethasone|mesh-list
56262071|NCT04302324|Daratumumab|daratumumab|mesh-list
56262072|NCT04302324|Pomalidomide|pomalidomide|mesh-list
56262073|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262074|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
56262075|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
56262076|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262077|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262078|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262079|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
56262080|NCT04302324|Hormones|hormones|mesh-ancestor
56262081|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262082|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56262083|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262084|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56262085|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262086|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56262087|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262088|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262089|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56262090|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56262091|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
56262092|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56262093|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56262094|NCT04302324|Growth Substances|growth substances|mesh-ancestor
55875345|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55875346|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
55875347|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875348|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55875349|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
55875350|NCT01221298|Ritonavir|ritonavir|mesh-list
55875351|NCT01221298|Ribavirin|ribavirin|mesh-list
55875352|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55875353|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55875354|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
55875355|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875356|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875357|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55875358|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55875359|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
55875360|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890771|NCT01893723|Analgesics|analgesics|mesh-ancestor
55875361|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55875362|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55875363|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
55875364|NCT01222234|Vitamin D|vitamin d|mesh-list
55875365|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
55875366|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
55875367|NCT01222234|Calcitriol|calcitriol|mesh-list
56262096|NCT04074460|Propofol|propofol|mesh-list
56262097|NCT04074460|Sevoflurane|sevoflurane|mesh-list
56262098|NCT04074460|Desflurane|desflurane|mesh-list
56262099|NCT04074460|Isoflurane|isoflurane|mesh-list
56262100|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56262101|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262102|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262103|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56262104|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
56262105|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
56262106|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56262107|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56262108|NCT03993327|Iodine|iodine|mesh-list
56262109|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55837265|NCT02013791|Cyclosporins|cyclosporins|mesh-list
55875368|NCT01222234|Vitamins|vitamins|mesh-list
55875369|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
55875370|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875371|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55875372|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55875373|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55875374|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55875375|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875376|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55875377|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55875378|NCT01203046|Ertapenem|ertapenem|mesh-list
55875379|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875380|NCT02460588|Prednisolone|prednisolone|mesh-list
55875381|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
55875386|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55875387|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
55875388|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875389|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875390|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55875391|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875392|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
55875394|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875395|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55875396|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55875397|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
55875398|NCT03449082|Coagulants|coagulants|mesh-ancestor
55875399|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
55875400|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55875401|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875402|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
55875403|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55875404|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55875405|NCT03413202|Protective Agents|protective agents|mesh-ancestor
55875406|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875407|NCT04169100|Prednisone|prednisone|mesh-list
55875408|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875409|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
55875410|NCT04169100|Hormones|hormones|mesh-ancestor
55875411|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875412|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875413|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55875414|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875415|NCT04155840|Rituximab|rituximab|mesh-list
55875416|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56262111|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
56262112|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56262113|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
56262114|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262115|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262116|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56262117|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262118|NCT03993327|Trace Elements|trace elements|mesh-ancestor
56262119|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
56262120|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56262121|NCT03817125|Vancomycin|vancomycin|mesh-list
56262122|NCT03817125|Nivolumab|nivolumab|mesh-list
56262123|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262124|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262125|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56262126|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262127|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262128|NCT03747042|Letrozole|letrozole|mesh-list
56262129|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875417|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55875418|NCT04155840|Antibodies|antibodies|mesh-list
55875419|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
55875420|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55875421|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
55875422|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875423|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875424|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55875425|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55875426|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
55875427|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875428|NCT03448770|Lactulose|lactulose|mesh-list
55875429|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55875430|NCT03443778|Dexamethasone|dexamethasone|mesh-list
55875431|NCT03443778|Bupivacaine|bupivacaine|mesh-list
55875432|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875433|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
55875434|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
55875435|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875436|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875437|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55875438|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
55875439|NCT03443778|Hormones|hormones|mesh-ancestor
55749830|NCT03234517|Clindamycin|clindamycin|mesh-list
55875440|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875441|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791160|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791162|NCT01660971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875442|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875443|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
55875444|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
55875445|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875446|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
55875447|NCT03011008|Liraglutide|liraglutide|mesh-list
55875448|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55875449|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875450|NCT03011008|Incretins|incretins|mesh-ancestor
55875451|NCT03011008|Hormones|hormones|mesh-ancestor
55791163|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791164|NCT01660971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791165|NCT01660971|Immunologic Factors|immunologic factors|mesh-ancestor
55875457|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56262130|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56262131|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56262132|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262133|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262134|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56262135|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
56262136|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262137|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262138|NCT03703102|KHK4083|khk4083|mesh-list
56262139|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
56262140|NCT03637764|Atezolizumab|atezolizumab|mesh-list
56262141|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262142|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56262143|NCT03581370|Cephalosporins|cephalosporins|mesh-list
56262144|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
56262145|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55791166|NCT01660971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791167|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55791169|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55791170|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791171|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55791172|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791173|NCT05573607|Chromium|chromium|mesh-list
56262146|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262147|NCT03581370|Renal Agents|renal agents|mesh-ancestor
56262148|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56262149|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56262150|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262151|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262152|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55837299|NCT01951417|Analgesics|analgesics|mesh-ancestor
55875458|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
55875459|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55875460|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
55875461|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875462|NCT01206478|Megestrol|megestrol|mesh-list
55875463|NCT01206478|Amitriptyline|amitriptyline|mesh-list
55875464|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55875465|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
55875466|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55875467|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55875468|NCT01206478|Analgesics|analgesics|mesh-ancestor
55875469|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
55875470|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875471|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875472|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55875473|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55875474|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55753838|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791175|NCT05573607|Micronutrients|micronutrients|mesh-ancestor
55791176|NCT05573607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791177|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
55875475|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875476|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
55875477|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875478|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55875479|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55875480|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55875481|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
55875482|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56262153|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55791178|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791179|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55791180|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
56262154|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
56262155|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262157|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
56262158|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56262159|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
56262160|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262161|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262162|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
56262163|NCT03485534|Tenofovir|tenofovir|mesh-list
56262164|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
56262165|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875483|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55875484|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55875485|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55875486|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875487|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
55875488|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
55875489|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55875490|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875491|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875492|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
55791181|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875493|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55875494|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875495|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875496|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
55875497|NCT01158820|Fentanyl|fentanyl|mesh-list
55875498|NCT01158820|Midazolam|midazolam|mesh-list
55875499|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
55875500|NCT01158820|Ketamine|ketamine|mesh-list
55875501|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55875502|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875503|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875504|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55875505|NCT01158820|Analgesics|analgesics|mesh-ancestor
55875506|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
55753840|NCT03192943|Linrodostat|linrodostat|mesh-list
55791182|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791183|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791184|NCT03040817|Esomeprazole|esomeprazole|mesh-list
55875507|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875508|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55875509|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55875510|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55875511|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
55875512|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875513|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875514|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55875515|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55875516|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
55875517|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
55875518|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55875528|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55875529|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
55875530|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
55875531|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
55875532|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55875533|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55875534|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
55875535|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
55875536|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55875538|NCT03707028|Apatinib|apatinib|mesh-list
55875539|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55875540|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262166|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56262167|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56262169|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262170|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56262171|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56262172|NCT03427736|Ketorolac|ketorolac|mesh-list
56262173|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56262174|NCT03427736|Ketamine|ketamine|mesh-list
56262175|NCT03427736|Morphine|morphine|mesh-list
56262176|NCT03427736|Oxycodone|oxycodone|mesh-list
56262177|NCT03427736|Hydromorphone|hydromorphone|mesh-list
56262178|NCT03427736|Analgesics|analgesics|mesh-ancestor
56262179|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
56262180|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262181|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262182|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56262183|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56262184|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
56262185|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
56262186|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262187|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56262188|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56262189|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262190|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262191|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56262192|NCT03427736|Narcotics|narcotics|mesh-ancestor
56262193|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55791186|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791187|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56262194|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56262195|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262196|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55875541|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
55875542|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
55875543|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
55875544|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875545|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55875546|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875547|NCT04956042|Cytarabine|cytarabine|mesh-list
55875548|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55875549|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
55875550|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875551|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262197|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55791188|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262199|NCT03395704|Hepcidins|hepcidins|mesh-list
56262200|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262201|NCT03246503|Bilirubin|bilirubin|mesh-list
56262202|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
56262203|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262204|NCT03246503|Protective Agents|protective agents|mesh-ancestor
56262205|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262206|NCT03115567|Triamcinolone|triamcinolone|mesh-list
55791189|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55791190|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791191|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56262207|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262208|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
56262209|NCT03115567|Hormones|hormones|mesh-ancestor
56262210|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262211|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262212|NCT03091881|Granisetron|granisetron|mesh-list
56262213|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
56262214|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
56262215|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791192|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
55791193|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262216|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262217|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262218|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56262219|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
56262220|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262221|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262222|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
55791194|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791196|NCT04853069|Estrogens|estrogens|mesh-ancestor
55791197|NCT04853069|Hormones|hormones|mesh-ancestor
55791198|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791199|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791200|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56262223|NCT03032406|Everolimus|everolimus|mesh-list
56262224|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262225|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56262226|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
56262227|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262228|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
56262229|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56262230|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56262231|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791201|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55791202|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791203|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55837356|NCT01910402|Ritonavir|ritonavir|mesh-list
55875552|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
55875553|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875554|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55875555|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
56262232|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262233|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262234|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56262235|NCT02897063|Midodrine|midodrine|mesh-list
56262236|NCT02897063|Droxidopa|droxidopa|mesh-list
56262237|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
56262238|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
56262239|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262240|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262241|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56262242|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56262243|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56262244|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55875556|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875557|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
55875558|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55875559|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875560|NCT01225354|Calcium|calcium|mesh-list
55875561|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55875562|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875563|NCT02521662|Nicotine|nicotine|mesh-list
55875564|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55875565|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
55875566|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791204|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55875567|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875568|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55875569|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55875570|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
55875571|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875572|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875573|NCT03499704|Metformin|metformin|mesh-list
55875574|NCT03499704|Pioglitazone|pioglitazone|mesh-list
55875575|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
55791205|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55791206|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875576|NCT03499704|Alogliptin|alogliptin|mesh-list
55875577|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55875578|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875579|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55875580|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875581|NCT03499704|Incretins|incretins|mesh-ancestor
55875582|NCT03499704|Hormones|hormones|mesh-ancestor
55875583|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875584|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55875585|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
55875587|NCT05183880|Vitamins|vitamins|mesh-list
55875588|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
55875589|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
55875590|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875591|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
55875592|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875593|NCT05183880|Protective Agents|protective agents|mesh-ancestor
55875594|NCT01159054|Niacin|niacin|mesh-list
55875595|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
55875596|NCT01159054|Niacinamide|niacinamide|mesh-list
55875597|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55875598|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
55875599|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875600|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55875601|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
55875602|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
55875603|NCT01159054|Vitamins|vitamins|mesh-ancestor
55875604|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
55875605|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262245|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
56262246|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262247|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262248|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56262249|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56262250|NCT02864368|Temozolomide|temozolomide|mesh-list
56262251|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56262252|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
56262253|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262254|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262255|NCT02856698|Midazolam|midazolam|mesh-list
56262256|NCT02856698|Morphine|morphine|mesh-list
56262257|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56262258|NCT02856698|Narcotics|narcotics|mesh-ancestor
55791208|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791209|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
56262259|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837399|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55875606|NCT01209442|Bevacizumab|bevacizumab|mesh-list
55875607|NCT01209442|Temozolomide|temozolomide|mesh-list
55875608|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55875609|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875610|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55875611|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55875612|NCT01209442|Growth Substances|growth substances|mesh-ancestor
55875613|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875614|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
55875615|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55875616|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
55875617|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875618|NCT01160380|Modafinil|modafinil|mesh-list
55875619|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55875620|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875621|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55875622|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55875623|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55875624|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875625|NCT01228084|Sulforaphane|sulforaphane|mesh-list
55875626|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55875627|NCT01228084|Protective Agents|protective agents|mesh-ancestor
55875628|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875629|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875630|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55875631|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55753918|NCT03074097|Bupivacaine|bupivacaine|mesh-list
55791210|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
55791211|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55875632|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55875633|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55875634|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55875635|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
55875636|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875637|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875639|NCT04901208|Nicotine|nicotine|mesh-list
55875640|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55875641|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
55875642|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875643|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875644|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55875645|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55875646|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
56262260|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262261|NCT02856698|Analgesics|analgesics|mesh-ancestor
56262262|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
56262263|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262264|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56262265|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56262266|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56262267|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56262268|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56262269|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56262270|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
56262271|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
56262272|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
56262273|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
56262274|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262275|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262276|NCT02793375|Montelukast|montelukast|mesh-list
56262277|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56262278|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
56262279|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56262280|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
56262281|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262282|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262283|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56262284|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56262285|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262286|NCT02625610|Leucovorin|leucovorin|mesh-list
55875647|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875648|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875649|NCT01212484|Carbidopa|carbidopa|mesh-list
55875650|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55875651|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55875652|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
55875653|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875654|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875655|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753919|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
55791213|NCT05244811|Estradiol|estradiol|mesh-list
55791214|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55875656|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55875657|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875658|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55875659|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
55875664|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55875665|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55875666|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55875667|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
55791215|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875668|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791216|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55791217|NCT05244811|Hormones|hormones|mesh-ancestor
55791218|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791219|NCT05244811|Estrogens|estrogens|mesh-ancestor
56262288|NCT02625610|Capecitabine|capecitabine|mesh-list
56262289|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
56262290|NCT02625610|Avelumab|avelumab|mesh-list
56262291|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
56262292|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
56262293|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262294|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55837439|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875669|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875670|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875671|NCT01859741|Carboplatin|carboplatin|mesh-list
55875672|NCT01859741|Etoposide|etoposide|mesh-list
55875673|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875674|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55875675|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55875676|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55875677|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875678|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875679|NCT01212952|Dexamethasone|dexamethasone|mesh-list
55875680|NCT01212952|Bortezomib|bortezomib|mesh-list
55875681|NCT01212952|Pomalidomide|pomalidomide|mesh-list
55875682|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875683|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
55875684|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
55875685|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875686|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875687|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791220|NCT05564403|Calcium, Dietary|calcium, dietary|mesh-list
55791221|NCT05564403|Leucovorin|leucovorin|mesh-list
55875688|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
55875689|NCT01212952|Hormones|hormones|mesh-ancestor
55875690|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875691|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55875692|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875693|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
55875694|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55875695|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55875696|NCT01212952|Growth Substances|growth substances|mesh-ancestor
55875697|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
55875698|NCT04609865|Lidocaine|lidocaine|mesh-list
55875699|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
55875700|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
55875701|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875702|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875703|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
55875704|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875705|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55875706|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55875707|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55875708|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55875709|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875710|NCT01873859|Metformin|metformin|mesh-list
55875711|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55875712|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791222|NCT05564403|Folic Acid|folic acid|mesh-list
55791223|NCT05564403|Fluorouracil|fluorouracil|mesh-list
55875713|NCT00493896|Enoxaparin|enoxaparin|mesh-list
55875714|NCT00493896|PENTA|penta|mesh-list
55875715|NCT00493896|Fondaparinux|fondaparinux|mesh-list
55875716|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
55875717|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55875718|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55875719|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875720|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55875721|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
55791224|NCT05564403|Oxaliplatin|oxaliplatin|mesh-list
55791225|NCT05564403|Calcium|calcium|mesh-list
55791226|NCT05564403|Levoleucovorin|levoleucovorin|mesh-list
55791227|NCT05564403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55875722|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55875723|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
55875724|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875725|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
56262295|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262296|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56262297|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
56262298|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262299|NCT02625610|Antidotes|antidotes|mesh-ancestor
56262300|NCT02625610|Protective Agents|protective agents|mesh-ancestor
56262301|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
56262302|NCT02625610|Vitamins|vitamins|mesh-ancestor
55791228|NCT05564403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791229|NCT05564403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55791230|NCT05564403|Antimetabolites|antimetabolites|mesh-ancestor
55791231|NCT05564403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791232|NCT05564403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55791233|NCT05564403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791234|NCT05564403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791235|NCT05564403|Immunologic Factors|immunologic factors|mesh-ancestor
55791236|NCT05564403|Antidotes|antidotes|mesh-ancestor
55791238|NCT05564403|Vitamin B Complex|vitamin b complex|mesh-ancestor
55791239|NCT05564403|Vitamins|vitamins|mesh-ancestor
55791240|NCT05564403|Micronutrients|micronutrients|mesh-ancestor
55791241|NCT05564403|Hematinics|hematinics|mesh-ancestor
55791242|NCT05395065|Listerine|listerine|mesh-list
55791243|NCT05395065|Fluorides|fluorides|mesh-list
55791244|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
55791245|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
55791246|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
55791247|NCT05395065|Protective Agents|protective agents|mesh-ancestor
55791248|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791249|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55791250|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791251|NCT02710669|Propafenone|propafenone|mesh-list
56262303|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
56262304|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262305|NCT02515591|Dimercaprol|dimercaprol|mesh-list
56262306|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
56262307|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
56262308|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262309|NCT02514447|Topotecan|topotecan|mesh-list
56262310|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56262311|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56262312|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262313|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262314|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262315|NCT02352883|Hormones|hormones|mesh-list
56262316|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262317|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262318|NCT02257346|Lidocaine|lidocaine|mesh-list
56262319|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
56262320|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
55753920|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
55791253|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55791254|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55791255|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55791256|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262321|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262322|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262323|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
55875726|NCT04597619|Analgesics|analgesics|mesh-ancestor
55875727|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
55875728|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875729|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875733|NCT03449940|Lidocaine|lidocaine|mesh-list
55875734|NCT03449940|Analgesics|analgesics|mesh-list
55875735|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
55875736|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
55875737|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875738|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875739|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
55875740|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875741|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55875742|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55875743|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55791257|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
55791258|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56262324|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262325|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56262326|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56262327|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56262328|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56262329|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262330|NCT02192359|Irinotecan|irinotecan|mesh-list
56262331|NCT02192359|Camptothecin|camptothecin|mesh-list
56262332|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56262333|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56262334|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262335|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753997|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
55791259|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791260|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55791261|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791262|NCT04851977|Vaccines|vaccines|mesh-list
55791263|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
55791264|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791265|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55791266|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55791267|NCT05370417|Fluorides|fluorides|mesh-list
55791268|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
55791269|NCT05370417|Protective Agents|protective agents|mesh-ancestor
56262336|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262337|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56262338|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
56262339|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
56262340|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
56262341|NCT01618357|Veliparib|veliparib|mesh-list
56262342|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56262343|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262344|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262345|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262346|NCT01530373|Clonidine|clonidine|mesh-list
56262347|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
55875744|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55875745|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875746|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875747|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55875748|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55875749|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875750|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55875751|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55875752|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875753|NCT01230424|Triamcinolone|triamcinolone|mesh-list
55875754|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55875755|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55875756|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55875757|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875758|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
55875759|NCT01230424|Hormones|hormones|mesh-ancestor
55875760|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875761|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875762|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55875763|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
55791270|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791271|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
55791272|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
55791273|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791274|NCT05369793|Protective Agents|protective agents|mesh-ancestor
55875764|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875765|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875766|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
56262348|NCT01530373|Analgesics|analgesics|mesh-ancestor
56262349|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
56262350|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262351|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262352|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55791275|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791276|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
56262353|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
56262354|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
56262355|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56262356|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56262357|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56262358|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
56262359|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262360|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262361|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56262362|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56262363|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
56262364|NCT01530373|Urological Agents|urological agents|mesh-ancestor
56262365|NCT01442246|Leuprolide|leuprolide|mesh-list
56262366|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55875767|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55875768|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875769|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55875770|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
55875771|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55749935|NCT02512523|Incretins|incretins|mesh-ancestor
55875772|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875773|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875774|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875775|NCT03438240|Fentanyl|fentanyl|mesh-list
55875776|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
55875777|NCT03438240|Bupivacaine|bupivacaine|mesh-list
55791277|NCT05369793|Vitamins|vitamins|mesh-ancestor
55791278|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
55791279|NCT04844333|Anesthetics|anesthetics|mesh-list
55791280|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791281|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875778|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
55875779|NCT03438240|Anesthetics|anesthetics|mesh-list
55875780|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
55875781|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875782|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875783|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
55875784|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875785|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55875786|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55875787|NCT03438240|Analgesics|analgesics|mesh-ancestor
55875788|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55875789|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55875790|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55875791|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
55875792|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875793|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875794|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55875795|NCT03438240|Narcotics|narcotics|mesh-ancestor
55875796|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55875797|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55875798|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
55791282|NCT04423185|Atezolizumab|atezolizumab|mesh-list
55791283|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
55875799|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
55875801|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55875802|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875803|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262368|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56262369|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262370|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791284|NCT04423185|Palbociclib|palbociclib|mesh-list
55791285|NCT04423185|Niraparib|niraparib|mesh-list
55791286|NCT04423185|Vemurafenib|vemurafenib|mesh-list
55791287|NCT04423185|Crizotinib|crizotinib|mesh-list
56262371|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262372|NCT00712322|Darifenacin|darifenacin|mesh-list
56262373|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56262374|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56262375|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
56262376|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262377|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262378|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262379|NCT00712322|Urological Agents|urological agents|mesh-ancestor
56262380|NCT00572169|Thalidomide|thalidomide|mesh-list
56262381|NCT00572169|Dexamethasone|dexamethasone|mesh-list
56262382|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
56262383|NCT00572169|Cisplatin|cisplatin|mesh-list
56262384|NCT00572169|Doxorubicin|doxorubicin|mesh-list
56262385|NCT00572169|Etoposide|etoposide|mesh-list
56262386|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56262387|NCT00572169|Bortezomib|bortezomib|mesh-list
56262388|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791288|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791289|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55791290|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262389|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
56262390|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262391|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56262392|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56262393|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
56262394|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262395|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262398|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
55791291|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791292|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56262419|NCT00323856|Coagulants|coagulants|mesh-ancestor
56262420|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56262421|NCT05415150|Eptifibatide|eptifibatide|mesh-list
56262422|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56262423|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56262424|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262425|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
56262426|NCT05414942|Narcotics|narcotics|mesh-ancestor
56262427|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262428|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262429|NCT05414942|Analgesics|analgesics|mesh-ancestor
56262430|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
56262431|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262432|NCT05414721|Anesthetics|anesthetics|mesh-list
56262433|NCT05414721|Desflurane|desflurane|mesh-list
55791293|NCT05414877|Phenylephrine|phenylephrine|mesh-list
55791294|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
55791295|NCT05414877|Norepinephrine|norepinephrine|mesh-list
55791296|NCT05414877|Ephedrine|ephedrine|mesh-list
56262434|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262435|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262436|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56262437|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
56262438|NCT05414669|Allopurinol|allopurinol|mesh-list
56262439|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
56262440|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262441|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262442|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
56262443|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56262444|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56262445|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
56262446|NCT05414669|Protective Agents|protective agents|mesh-ancestor
56262447|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262448|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
56262449|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
56262450|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262451|NCT05414474|Protective Agents|protective agents|mesh-ancestor
56262452|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875804|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875806|NCT01213576|Albendazole|albendazole|mesh-list
55875807|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55875808|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875809|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
55875810|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
56262453|NCT05414474|Vitamins|vitamins|mesh-ancestor
56262454|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
56262455|NCT05414292|Sirolimus|sirolimus|mesh-list
56262456|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56262457|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262458|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56262459|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262460|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
56262461|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56262462|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
56262463|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262464|NCT05414149|Ranibizumab|ranibizumab|mesh-list
55791297|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55791298|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
55791299|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
55875811|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55875812|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55875813|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
55875814|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
55875815|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
55875816|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875817|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875818|NCT01161862|Glucagon|glucagon|mesh-list
55875819|NCT01161862|Pancrelipase|pancrelipase|mesh-list
55875821|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55875822|NCT01161862|Hormones|hormones|mesh-ancestor
55875823|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875824|NCT01214356|Vitamin D|vitamin d|mesh-list
55875825|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
55875826|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
55875827|NCT01214356|Vitamins|vitamins|mesh-list
55875828|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
55875829|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749942|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
55875830|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55875831|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55875832|NCT04560660|Midazolam|midazolam|mesh-list
55875833|NCT04560660|Ketamine|ketamine|mesh-list
55875834|NCT04560660|Analgesics|analgesics|mesh-ancestor
55875835|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
55875836|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875837|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875838|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55875839|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55875840|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
55875841|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
55875842|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875843|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55875844|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55875845|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875846|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791300|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875847|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55875848|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55875849|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55875850|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55875851|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55875852|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
55875853|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
55875854|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
55875855|NCT01232920|Methotrexate|methotrexate|mesh-list
55875856|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55875857|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
55875858|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55875859|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875860|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55875861|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
55791301|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791303|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55791304|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
55791305|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
55791306|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55791307|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55791308|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56262465|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56262466|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56262467|NCT05414149|Growth Substances|growth substances|mesh-ancestor
56262468|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262469|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
56262470|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262476|NCT05413902|Acetaminophen|acetaminophen|mesh-list
56262477|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
56262478|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56262479|NCT05413902|Lidocaine|lidocaine|mesh-list
56262480|NCT05413902|Epinephrine|epinephrine|mesh-list
56262481|NCT05413902|Morphine|morphine|mesh-list
56262482|NCT05413902|Narcotics|narcotics|mesh-list
56262483|NCT05413902|Gabapentin|gabapentin|mesh-list
56262484|NCT05413902|Orphenadrine|orphenadrine|mesh-list
55884492|NCT01665508|Nebivolol|nebivolol|mesh-list
56262485|NCT05413902|Bupivacaine|bupivacaine|mesh-list
56262486|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
56262487|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
56262488|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262489|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262490|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
55837611|NCT02008877|Sirolimus|sirolimus|mesh-list
55875862|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875863|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875864|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
55875865|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875866|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55875867|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55875868|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
55875869|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55875870|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55875871|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55875872|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55875873|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
55875874|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55875875|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875876|NCT03445182|Anesthetics|anesthetics|mesh-list
55875880|NCT03010540|Morphine|morphine|mesh-list
55875881|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55875882|NCT03010540|Narcotics|narcotics|mesh-ancestor
55875883|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875884|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875885|NCT03010540|Analgesics|analgesics|mesh-ancestor
55875886|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
55875887|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875888|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55753998|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
55791309|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
55791310|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791311|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791312|NCT05414877|Protective Agents|protective agents|mesh-ancestor
55791313|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55791314|NCT04850885|Dexamethasone|dexamethasone|mesh-list
55791315|NCT04850885|Lidocaine|lidocaine|mesh-list
55791316|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791318|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
55791319|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791320|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791321|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791322|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
55791323|NCT04850885|Hormones|hormones|mesh-ancestor
55791324|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791325|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791326|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875889|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55875890|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
55875891|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
55875892|NCT03445104|Huperzine A|huperzine a|mesh-list
55875893|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55875894|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875895|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875896|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
55875897|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262491|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262492|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56262493|NCT05413902|Analgesics|analgesics|mesh-ancestor
56262494|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56262495|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
56262496|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262497|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
56262498|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
56262499|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791332|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55791333|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55791334|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55791335|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791337|NCT04850417|Clopidogrel|clopidogrel|mesh-list
55791338|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55791339|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55791340|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55791341|NCT04850417|Analgesics|analgesics|mesh-ancestor
55791342|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
55791343|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262500|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
56262501|NCT05413902|Hormones|hormones|mesh-ancestor
56262502|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262503|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56262504|NCT05413902|Protective Agents|protective agents|mesh-ancestor
56262505|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56262506|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56262507|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
55791345|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791346|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55791347|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55791348|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55791349|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791350|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55791352|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262508|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262509|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262510|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56262511|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56262512|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56262513|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
56262514|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
56262515|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
56262516|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56262517|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
56262518|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56262519|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56262520|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56262521|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56262522|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56262523|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
55791354|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55791355|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56262524|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55837669|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
56262532|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56262533|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56262534|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56262535|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56262536|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
56262537|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56262538|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56262539|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
56262540|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
56262541|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56262542|NCT05413863|Insulin|insulin|mesh-list
56262543|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56262544|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56262545|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262546|NCT05413746|Antioxidants|antioxidants|mesh-list
56262547|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262548|NCT05413746|Protective Agents|protective agents|mesh-ancestor
56262549|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262550|NCT05409365|Antibodies|antibodies|mesh-list
56262551|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
56262552|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56262553|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
56262554|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262555|NCT05397587|Vaccines|vaccines|mesh-list
55875898|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875899|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55875900|NCT03445104|Protective Agents|protective agents|mesh-ancestor
55875901|NCT01234714|Liver Extracts|liver extracts|mesh-list
55875902|NCT01234714|Hematinics|hematinics|mesh-ancestor
55875903|NCT03440502|Anesthetics|anesthetics|mesh-list
55875904|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875905|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875906|NCT01234870|Adenosine|adenosine|mesh-list
55875907|NCT01234870|Analgesics|analgesics|mesh-ancestor
55753999|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
55791356|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55791357|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
55791358|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791359|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55791360|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
55791362|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55875908|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
55875909|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875910|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875911|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55875912|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
55875913|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55875914|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
55875915|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
55875916|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875917|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875918|NCT00861705|Paclitaxel|paclitaxel|mesh-list
55875919|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
55875920|NCT00861705|Bevacizumab|bevacizumab|mesh-list
55875921|NCT00861705|Carboplatin|carboplatin|mesh-list
55875922|NCT00861705|Doxorubicin|doxorubicin|mesh-list
55875923|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55875924|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56262556|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
56262557|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262558|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56262559|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262560|NCT05356936|Vitamin D|vitamin d|mesh-list
56262561|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
56262562|NCT05356936|Vitamins|vitamins|mesh-list
55884556|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
56262564|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
56262565|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
56262566|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262567|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56000892|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875925|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55875926|NCT00861705|Antibodies|antibodies|mesh-list
55875927|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
55875928|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55875929|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
55875930|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
55875931|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55875932|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875933|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
55875934|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
55875935|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
55875936|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875937|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55875938|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
55875939|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875940|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55875941|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55875942|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
55875943|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55875944|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55875945|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55875946|NCT00861705|Growth Substances|growth substances|mesh-ancestor
55875947|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
55875948|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55791363|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791364|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55791365|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55875949|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55875951|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875952|NCT03437460|Ibuprofen|ibuprofen|mesh-list
55875953|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875954|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55875955|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55875956|NCT03437460|Analgesics|analgesics|mesh-ancestor
55875957|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
55875958|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875959|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55875960|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55875961|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55875962|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875963|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875964|NCT03444636|Fentanyl|fentanyl|mesh-list
55875965|NCT03444636|Bupivacaine|bupivacaine|mesh-list
55875966|NCT03444636|Ropivacaine|ropivacaine|mesh-list
55791367|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875967|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
55875968|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
55875969|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875970|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875971|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
55875972|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875973|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55875974|NCT03444636|Narcotics|narcotics|mesh-ancestor
55875975|NCT03444636|Analgesics|analgesics|mesh-ancestor
55791368|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
55791369|NCT04850261|Nafarelin|nafarelin|mesh-list
55791370|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56262568|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56262569|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56262570|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56262571|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262572|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
56262573|NCT05356936|Coagulants|coagulants|mesh-ancestor
56262574|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
56262575|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
56262576|NCT05352178|Androgens|androgens|mesh-list
56262577|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56262578|NCT05352178|Hormones|hormones|mesh-ancestor
56262579|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262580|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262581|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
56262582|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262583|NCT05352178|Protective Agents|protective agents|mesh-ancestor
56262584|NCT05352178|Vitamins|vitamins|mesh-ancestor
56262585|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
56262586|NCT05352178|Estrogens|estrogens|mesh-ancestor
56262587|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56262588|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262589|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
56262590|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
56262591|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
55791371|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
55791372|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56262592|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262593|NCT05328141|Protective Agents|protective agents|mesh-ancestor
56262594|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262595|NCT05328141|Vitamins|vitamins|mesh-ancestor
56262596|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
56262597|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
55875976|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55750041|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
55875977|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55875978|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
55875979|NCT01215292|Ketoconazole|ketoconazole|mesh-list
55875980|NCT01215292|Anastrozole|anastrozole|mesh-list
55875981|NCT01215292|Testosterone|testosterone|mesh-list
55875982|NCT01215292|Dutasteride|dutasteride|mesh-list
55791373|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791375|NCT04843553|Niacin|niacin|mesh-list
55791376|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
55875984|NCT01215292|Androgens|androgens|mesh-ancestor
55875985|NCT01215292|Hormones|hormones|mesh-ancestor
55875986|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875987|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875988|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55875989|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55875990|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55875991|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55875992|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262598|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56262599|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56262600|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262601|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262602|NCT05259137|Enalaprilat|enalaprilat|mesh-list
56262603|NCT05259137|Enalapril|enalapril|mesh-list
56262604|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56262605|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
55791378|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
55791379|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791380|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
56262606|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262607|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838587|NCT02092961|Adalimumab|adalimumab|mesh-list
56262608|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56262610|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56262611|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
56262612|NCT05251493|Trace Elements|trace elements|mesh-ancestor
56262613|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
55754000|NCT03073863|Atorvastatin|atorvastatin|mesh-list
55791381|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55791382|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
55791383|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262614|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262615|NCT05251493|Hematinics|hematinics|mesh-ancestor
56262616|NCT05233709|Fesoterodine|fesoterodine|mesh-list
56262617|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56262618|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56262619|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
56262620|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262621|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791385|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
55791387|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
55791388|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55791389|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791390|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
55791391|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
55791392|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
55791393|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791394|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55791395|NCT03040193|Lidocaine|lidocaine|mesh-list
55791396|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
55791397|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
55791398|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791399|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791400|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
55791401|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791402|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56262622|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875993|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875994|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55875995|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
55875996|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
55875997|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875998|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55875999|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55876000|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55876001|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55876002|NCT04796454|Gemcitabine|gemcitabine|mesh-list
55791403|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55791404|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55876003|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
55876004|NCT04796454|Temozolomide|temozolomide|mesh-list
55876005|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876006|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55876007|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
55876008|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876009|NCT04796454|Antiviral Agents|antiviral agents|mesh-ancestor
55876010|NCT04796454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876011|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876012|NCT04796454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55876013|NCT04796454|Immunologic Factors|immunologic factors|mesh-ancestor
55876014|NCT04796454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876015|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56262623|NCT05233709|Urological Agents|urological agents|mesh-ancestor
56262624|NCT05216952|Misoprostol|misoprostol|mesh-list
56262625|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
56262626|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56262627|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
55791405|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56262628|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56262629|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262630|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56262631|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262632|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
56262633|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56262634|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
56262635|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55791406|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791407|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
56262636|NCT05173896|Tadalafil|tadalafil|mesh-list
56262637|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
56262638|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55876016|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
55876017|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55876018|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55876019|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876020|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55791408|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55791409|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791410|NCT03039101|Montelukast|montelukast|mesh-list
55791411|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55791412|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
55791413|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55876021|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876022|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876023|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
55876026|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55876028|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55876029|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876030|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876031|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876032|NCT03437226|Simendan|simendan|mesh-list
55876033|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55876034|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
55876035|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55876036|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55876037|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876038|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876039|NCT03437226|Protective Agents|protective agents|mesh-ancestor
55876040|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876041|NCT04788420|Sorafenib|sorafenib|mesh-list
55876042|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876043|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55876044|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791414|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
55791415|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791416|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791417|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55791418|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55791419|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791420|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55876045|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876046|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55876047|NCT01282138|Dextrans|dextrans|mesh-list
55876048|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55876049|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55876050|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
55876051|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
55876052|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
55876053|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55876054|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55876055|NCT01282138|Analgesics|analgesics|mesh-ancestor
55876056|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
55876057|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876058|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876059|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876060|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56262639|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56262640|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262641|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262642|NCT05173896|Urological Agents|urological agents|mesh-ancestor
56262643|NCT05150236|Nivolumab|nivolumab|mesh-list
56262644|NCT05150236|Ipilimumab|ipilimumab|mesh-list
55876061|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55876062|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55791422|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55791423|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55791424|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876063|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55876064|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
55876065|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
55876066|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876067|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876068|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
55876069|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55876070|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876071|NCT03444402|Esomeprazole|esomeprazole|mesh-list
55876072|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55876073|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876074|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55876075|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876076|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876077|NCT01238536|Dexamethasone|dexamethasone|mesh-list
55876078|NCT01238536|Betamethasone|betamethasone|mesh-list
55876079|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55876080|NCT01238536|Lidocaine|lidocaine|mesh-list
55876081|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
55876082|NCT01238536|Anesthetics|anesthetics|mesh-list
55876083|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876084|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
55876085|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
55876086|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876087|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876088|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876089|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
55876090|NCT01238536|Hormones|hormones|mesh-ancestor
55876091|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876092|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55754480|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55876093|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876094|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876099|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55876100|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55876101|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55876102|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
55876103|NCT03437070|Doxorubicin|doxorubicin|mesh-list
55876104|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55876105|NCT03437070|Trabectedin|trabectedin|mesh-list
55876107|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55876108|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876109|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55876110|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55876111|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876112|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876113|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55876114|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
55876115|NCT03128736|Esomeprazole|esomeprazole|mesh-list
55876116|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
55876117|NCT03128736|Lansoprazole|lansoprazole|mesh-list
55876118|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55791425|NCT03103399|Levodopa|levodopa|mesh-list
55876119|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876120|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55876121|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876122|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876124|NCT05054868|Oxycodone|oxycodone|mesh-list
55876125|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55876126|NCT05054868|Narcotics|narcotics|mesh-ancestor
55876127|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876128|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262645|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
56262646|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262647|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262648|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55754562|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
55791427|NCT03103399|Entacapone|entacapone|mesh-list
55791428|NCT03103399|Benserazide|benserazide|mesh-list
55791429|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
56262649|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262650|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56262651|NCT05111821|Deferiprone|deferiprone|mesh-list
56262652|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56262653|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
56262654|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
56262655|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262656|NCT05105282|Anesthetics|anesthetics|mesh-list
56262657|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
56262658|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262659|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262660|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
56262661|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262662|NCT05067387|Dronabinol|dronabinol|mesh-list
56262663|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
56262664|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262665|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56262666|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56262667|NCT05067387|Analgesics|analgesics|mesh-ancestor
56262668|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
56262669|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754563|NCT03303677|Hormones|hormones|mesh-ancestor
56262670|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56262671|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56262672|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262673|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262674|NCT05067387|Hormones|hormones|mesh-ancestor
56262675|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262676|NCT05005455|Bevacizumab|bevacizumab|mesh-list
55791430|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
55791431|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56262677|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262678|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837789|NCT04069156|Aspirin|aspirin|mesh-list
55876129|NCT05054868|Analgesics|analgesics|mesh-ancestor
55876130|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
56262679|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56262680|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55837814|NCT01466062|Palivizumab|palivizumab|mesh-list
55876131|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791433|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
55876132|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55876133|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55876134|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876135|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876136|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55876137|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876138|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876139|NCT01218958|Naltrexone|naltrexone|mesh-list
55876140|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55876141|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55876142|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876143|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
55876144|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876145|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
55876146|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55876147|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
55876148|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876149|NCT03440268|Expectorants|expectorants|mesh-ancestor
55876150|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
55876151|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55876152|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
55876153|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876154|NCT03440268|Protective Agents|protective agents|mesh-ancestor
55876155|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876156|NCT03440268|Antidotes|antidotes|mesh-ancestor
55791435|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791436|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791438|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55876157|NCT03444246|Iodine|iodine|mesh-list
55876158|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
55876159|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55876160|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876161|NCT03444246|Trace Elements|trace elements|mesh-ancestor
55876162|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
55876163|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876164|NCT04369014|Anesthetics|anesthetics|mesh-list
55876165|NCT04369014|Propofol|propofol|mesh-list
55876166|NCT04369014|Etomidate|etomidate|mesh-list
55876169|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55876170|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55876171|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
55791439|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55791440|NCT05357833|Hematinics|hematinics|mesh-ancestor
55791441|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55791442|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55791443|NCT03043157|Rocuronium|rocuronium|mesh-list
55876172|NCT03436836|Lidocaine|lidocaine|mesh-list
55876173|NCT03436836|Nalbuphine|nalbuphine|mesh-list
55876174|NCT03436836|Bupivacaine|bupivacaine|mesh-list
55876175|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
55876176|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
55876177|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876178|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876179|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
55876180|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876181|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55876182|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55876183|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55876184|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55876185|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876186|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55876187|NCT03436836|Narcotics|narcotics|mesh-ancestor
55876188|NCT03436836|Analgesics|analgesics|mesh-ancestor
55876189|NCT03444012|Ticagrelor|ticagrelor|mesh-list
55876190|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55876191|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55876192|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55755142|NCT05546411|Protective Agents|protective agents|mesh-ancestor
55791444|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55791445|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55791446|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55791447|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791448|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791449|NCT05339113|FAPI-46|fapi-46|mesh-list
55791450|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55876193|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55876194|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
55876195|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876196|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876197|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876198|NCT03440034|Pioglitazone|pioglitazone|mesh-list
55876199|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55876200|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876201|NCT03433326|Grazoprevir|grazoprevir|mesh-list
55876202|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56262681|NCT05005455|Growth Substances|growth substances|mesh-ancestor
56262682|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262683|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
56262685|NCT04910386|Cisplatin|cisplatin|mesh-list
56262686|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262687|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56262688|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
56262689|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262690|NCT04910386|Antiviral Agents|antiviral agents|mesh-ancestor
56262691|NCT04910386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262692|NCT04910386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262693|NCT04910386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56262694|NCT04910386|Immunologic Factors|immunologic factors|mesh-ancestor
55791451|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791452|NCT05332795|Metformin|metformin|mesh-list
55791453|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55791454|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262695|NCT04910386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262696|NCT04875715|Hydroquinone|hydroquinone|mesh-list
56262697|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
56262698|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262699|NCT04875715|Protective Agents|protective agents|mesh-ancestor
56262700|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262701|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56262702|NCT04757662|Tadalafil|tadalafil|mesh-list
56262703|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
56262704|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55791455|NCT04370483|Leflunomide|leflunomide|mesh-list
55791456|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791457|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791458|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791459|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
55791460|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791462|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
55791463|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55791464|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55791465|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791467|NCT03042923|Lactulose|lactulose|mesh-list
55791468|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55791469|NCT03042923|Diuretics|diuretics|mesh-ancestor
55791470|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
55791471|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791472|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791473|NCT04429295|Vaccines|vaccines|mesh-list
56262705|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56262706|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262707|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262708|NCT04757662|Urological Agents|urological agents|mesh-ancestor
56262709|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
56262710|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56262711|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262712|NCT04641234|Aflibercept|aflibercept|mesh-list
55837817|NCT04504864|Aspirin|aspirin|mesh-list
55876203|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
55876204|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876205|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55876206|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
55876207|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55876208|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55876209|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55876210|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876211|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262713|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56262714|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56262715|NCT04641234|Growth Substances|growth substances|mesh-ancestor
56262716|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262717|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
56262718|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262719|NCT04636034|Anesthetics|anesthetics|mesh-list
56262720|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
56262721|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837848|NCT04060342|Immunologic Factors|immunologic factors|mesh-ancestor
55876212|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55876213|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55876214|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876215|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
55791474|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
55876216|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876218|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55876219|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55876220|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876221|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
55876222|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
55876223|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
55876224|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876225|NCT03128619|Letrozole|letrozole|mesh-list
55876226|NCT03128619|Palbociclib|palbociclib|mesh-list
55876227|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791475|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791476|NCT05258851|Ceftazidime|ceftazidime|mesh-list
55876228|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55876229|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55876230|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876231|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876232|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55876233|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
55876234|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876235|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876236|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55876237|NCT03433092|Carotenoids|carotenoids|mesh-list
55876240|NCT03433092|Protective Agents|protective agents|mesh-ancestor
55876241|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876242|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
55876243|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
55876244|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
55876245|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876246|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876247|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
55876248|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876249|NCT01872689|Pirfenidone|pirfenidone|mesh-list
55876250|NCT01872689|Analgesics|analgesics|mesh-ancestor
55876251|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
55876252|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791478|NCT05258851|Avibactam|avibactam|mesh-list
55791479|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55791480|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55791481|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876253|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876254|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55876255|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55876256|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876257|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876258|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876259|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55876261|NCT03435900|Fosfomycin|fosfomycin|mesh-list
55876262|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55876263|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876264|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
55876265|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55876266|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55876267|NCT00632931|Vorinostat|vorinostat|mesh-list
55876268|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262722|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262723|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
56262724|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876269|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55876270|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876271|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876272|NCT01857323|Albuterol|albuterol|mesh-list
55876273|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55876274|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
55876275|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876276|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876277|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55876278|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
55876279|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
55876280|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55876281|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55876282|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55876283|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55876284|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
55876285|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876286|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876287|NCT03104439|Nivolumab|nivolumab|mesh-list
55876288|NCT03104439|Ipilimumab|ipilimumab|mesh-list
55876289|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55876290|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876291|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55876292|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876293|NCT03432780|Docetaxel|docetaxel|mesh-list
55876294|NCT03432780|Hormones|hormones|mesh-list
55876295|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876296|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
55876297|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
55876298|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
55876299|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876300|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876301|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876302|NCT00055731|Aspirin|aspirin|mesh-list
55876303|NCT00055731|Docetaxel|docetaxel|mesh-list
55876304|NCT00055731|Goserelin|goserelin|mesh-list
55876305|NCT00055731|Bicalutamide|bicalutamide|mesh-list
55876306|NCT00055731|Estramustine|estramustine|mesh-list
55876307|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876308|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
55876309|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
55876310|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
55876311|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791482|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55791483|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876322|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55876323|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55876324|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876325|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
55876326|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55876327|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
55876328|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
55876329|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876330|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55876331|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
55876332|NCT03435744|Simvastatin|simvastatin|mesh-list
55876333|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55876334|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55876335|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
55876336|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876337|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55876338|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55876339|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876340|NCT03435666|Capecitabine|capecitabine|mesh-list
55876341|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55876342|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
55876343|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876344|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876345|NCT00632541|Bevacizumab|bevacizumab|mesh-list
56262730|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791484|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262732|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
56262733|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262734|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262735|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56262736|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56262742|NCT04435795|Ciclesonide|ciclesonide|mesh-list
56262743|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
56262744|NCT04435795|Hormones|hormones|mesh-ancestor
56262745|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791485|NCT03043001|Memantine|memantine|mesh-list
55791486|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56262746|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262747|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56262748|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
56262749|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56262750|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262751|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56262752|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262753|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
56262754|NCT04233866|Leucovorin|leucovorin|mesh-list
56262755|NCT04233866|Folic Acid|folic acid|mesh-list
56262756|NCT04233866|Gemcitabine|gemcitabine|mesh-list
56262757|NCT04233866|Paclitaxel|paclitaxel|mesh-list
55791487|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55791488|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
56262758|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56262759|NCT04233866|Fluorouracil|fluorouracil|mesh-list
56262760|NCT04233866|Irinotecan|irinotecan|mesh-list
56262761|NCT04233866|Calcium|calcium|mesh-list
56262762|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
55876347|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262763|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56262765|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
56262766|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
56262767|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
56262768|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262769|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55791489|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791490|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791491|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262770|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
56262771|NCT04233866|Antiviral Agents|antiviral agents|mesh-ancestor
56262772|NCT04233866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262773|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262774|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56262775|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
56262776|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262777|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56262778|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56262779|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56262780|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56262781|NCT04233866|Antidotes|antidotes|mesh-ancestor
56262782|NCT04233866|Protective Agents|protective agents|mesh-ancestor
56262783|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
56262784|NCT04233866|Vitamins|vitamins|mesh-ancestor
56262785|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
56262786|NCT04233866|Hematinics|hematinics|mesh-ancestor
56262787|NCT04222283|Emtricitabine|emtricitabine|mesh-list
55837898|NCT01417156|Nintedanib|nintedanib|mesh-list
55876348|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876349|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55876350|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55876351|NCT00632541|Growth Substances|growth substances|mesh-ancestor
55876352|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876353|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
55791492|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55791493|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55791494|NCT04843007|Pemetrexed|pemetrexed|mesh-list
55876354|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55876355|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876356|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876357|NCT01872611|Prednisolone|prednisolone|mesh-list
55876358|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55876359|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
55876360|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55876361|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
55876362|NCT01872611|Nepafenac|nepafenac|mesh-list
55876363|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55876364|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
55755143|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
55791495|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876365|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876366|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
55876367|NCT01872611|Hormones|hormones|mesh-ancestor
55876368|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876369|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838687|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55876370|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56262788|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
56262789|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262791|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56262792|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262793|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262794|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56262795|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56262796|NCT04131504|Adalimumab|adalimumab|mesh-list
56262797|NCT04131504|Infliximab|infliximab|mesh-list
56262798|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262799|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56262800|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
56262801|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262802|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
56262803|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56262804|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876371|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791496|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791497|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791498|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55791499|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55791500|NCT04840745|Leuprolide|leuprolide|mesh-list
55876372|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
55876373|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
55876374|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876383|NCT03432468|Valsartan|valsartan|mesh-list
55876384|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55876385|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55876386|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55876387|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876388|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
55791501|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55791502|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
55791503|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55791504|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791505|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55876389|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876390|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
55876391|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55876392|NCT03432312|Nicotine|nicotine|mesh-list
55876393|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55876394|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
55876395|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876396|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876397|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55791506|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791507|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
55791508|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55876398|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55876399|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
55876400|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876401|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876402|NCT03438942|Folic Acid|folic acid|mesh-list
55876403|NCT03438942|Hematinics|hematinics|mesh-ancestor
55876404|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
55876405|NCT03438942|Vitamins|vitamins|mesh-ancestor
55876406|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
55876407|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876408|NCT04450680|Lactams|lactams|mesh-list
55876409|NCT04450680|beta-Lactams|beta-lactams|mesh-list
55876410|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55876411|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876412|NCT03438708|Axitinib|axitinib|mesh-list
55876413|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876414|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55876415|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876416|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876417|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
55876418|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
55876419|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876420|NCT01923597|Protective Agents|protective agents|mesh-ancestor
56262805|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56262806|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262807|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262808|NCT03962998|Lactulose|lactulose|mesh-list
56262809|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262810|NCT03926143|Maytansine|maytansine|mesh-list
56262811|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
56262812|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56262813|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262814|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
56262815|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
56262816|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262817|NCT03891667|Disulfiram|disulfiram|mesh-list
56262818|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56262819|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56262820|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262821|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262822|NCT03859635|Bupivacaine|bupivacaine|mesh-list
56262823|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
56262824|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
55876421|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876422|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55876423|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55876424|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876425|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55876426|NCT05666310|Zoledronic Acid|zoledronic acid|mesh-list
55876427|NCT05666310|Denosumab|denosumab|mesh-list
55876428|NCT05666310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55876429|NCT05666310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876430|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55876431|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55876432|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55876433|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876434|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876435|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55876436|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55876437|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55876438|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
55876439|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876442|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55876443|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
55876444|NCT00631137|Testosterone|testosterone|mesh-list
55876445|NCT00631137|Androgens|androgens|mesh-ancestor
55876446|NCT00631137|Hormones|hormones|mesh-ancestor
55876447|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876448|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876449|NCT03428880|Morphine|morphine|mesh-list
55876450|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55876451|NCT03428880|Narcotics|narcotics|mesh-ancestor
55876452|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876453|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876454|NCT03428880|Analgesics|analgesics|mesh-ancestor
55876455|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
55876456|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876457|NCT01923831|Dexamethasone|dexamethasone|mesh-list
55876458|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
56262825|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262826|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262827|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
56262828|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791509|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
56262830|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262831|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
56262832|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262833|NCT03783013|Protective Agents|protective agents|mesh-ancestor
56262834|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262835|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56262836|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56262837|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262838|NCT03762473|Tacrolimus|tacrolimus|mesh-list
56262839|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56262840|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
56262841|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791510|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791511|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
56262842|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56262843|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262844|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262845|NCT03726229|Cholic Acids|cholic acids|mesh-list
56262846|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262847|NCT03712228|Antibodies|antibodies|mesh-list
56262848|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56262849|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
56262850|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262851|NCT03626922|Folic Acid|folic acid|mesh-list
56262852|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
56262853|NCT03626922|Dexamethasone|dexamethasone|mesh-list
56262854|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
56262855|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
56262856|NCT03626922|Pemetrexed|pemetrexed|mesh-list
56262870|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262871|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262872|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262873|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56262874|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56262876|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
56262877|NCT03600818|Prednisone|prednisone|mesh-list
56262878|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262879|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
56262880|NCT03600818|Hormones|hormones|mesh-ancestor
55791512|NCT05072899|Protective Agents|protective agents|mesh-ancestor
55791513|NCT04839653|Vancomycin|vancomycin|mesh-list
55791514|NCT04839653|Gentamicins|gentamicins|mesh-list
55791515|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
55791516|NCT04839653|Polymyxins|polymyxins|mesh-list
55791517|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55791518|NCT04839653|Cefotaxime|cefotaxime|mesh-list
56262881|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262882|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262883|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56262884|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262885|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
56262886|NCT03578276|Prednisolone|prednisolone|mesh-list
56262887|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56262888|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
56262889|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56262890|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
56262891|NCT03578276|Bromfenac|bromfenac|mesh-list
55791519|NCT04839653|Cefoxitin|cefoxitin|mesh-list
55876459|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876460|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
55876461|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
55876462|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876463|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876464|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876465|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
55876466|NCT01923831|Hormones|hormones|mesh-ancestor
55876467|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876468|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55876469|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876470|NCT01923831|Analgesics|analgesics|mesh-ancestor
55791520|NCT04839653|Polymyxin B|polymyxin b|mesh-list
55791521|NCT04839653|Amphotericin B|amphotericin b|mesh-list
55791522|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55791523|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876471|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
55876472|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
55750060|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
55876473|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876474|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55876475|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
55876476|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55876477|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55876478|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876479|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55876480|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
55876481|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55876482|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55876483|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876484|NCT03086343|Abatacept|abatacept|mesh-list
55876485|NCT03086343|Upadacitinib|upadacitinib|mesh-list
55876486|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56262892|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56262893|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
56262894|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56262895|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
56262896|NCT03578276|Hormones|hormones|mesh-ancestor
55755144|NCT05546411|Vitamins|vitamins|mesh-ancestor
55791524|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55791525|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262897|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56262898|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262899|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56262900|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262901|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
56262902|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
56262903|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262904|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56262905|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56262906|NCT03578276|Protective Agents|protective agents|mesh-ancestor
55838024|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876487|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876488|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876489|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55876490|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
55876491|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876492|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876493|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
55876494|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55876495|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876496|NCT04892940|Analgesics|analgesics|mesh-list
55876497|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
55876498|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876499|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876500|NCT03085563|Midazolam|midazolam|mesh-list
55876501|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
55791526|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791528|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55876502|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55876503|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55876504|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876505|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876506|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55876507|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55876508|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55876509|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55876510|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
55876523|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876525|NCT04450446|Heparin|heparin|mesh-list
55791529|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55791530|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
55876526|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55876527|NCT04450446|Tinzaparin|tinzaparin|mesh-list
55876528|NCT04450446|Dalteparin|dalteparin|mesh-list
55876529|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
55876530|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55876531|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55876532|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876533|NCT03274752|Paroxetine|paroxetine|mesh-list
55876534|NCT03274752|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55876535|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55876536|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55876537|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876538|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876539|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
55876540|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262907|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56262908|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56262909|NCT03578276|Analgesics|analgesics|mesh-ancestor
56262910|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
56262911|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56262912|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56262913|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262914|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56262915|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56262916|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56262917|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56262918|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262919|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262920|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
56262921|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262922|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262923|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56262924|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56262925|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55755145|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
56262926|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56262927|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262928|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56262929|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876541|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55876542|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
55876543|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55876544|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55876545|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55876546|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876547|NCT03242382|Palbociclib|palbociclib|mesh-list
55755635|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
55791532|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
55876548|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876549|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55876551|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876552|NCT03902418|Tenofovir|tenofovir|mesh-list
55876553|NCT03902418|Emtricitabine|emtricitabine|mesh-list
55876554|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
55876555|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876556|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55755636|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
55791533|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
55791534|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876557|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55876558|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876559|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876560|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55876561|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55876562|NCT03428568|Clarithromycin|clarithromycin|mesh-list
55876563|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55876564|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262930|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56262931|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
56262932|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56262933|NCT03491267|Tretinoin|tretinoin|mesh-list
55791535|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791536|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791537|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
55791538|NCT04884139|Tenofovir|tenofovir|mesh-list
55791539|NCT04884139|Lamivudine|lamivudine|mesh-list
55791540|NCT04884139|Emtricitabine|emtricitabine|mesh-list
55791541|NCT04884139|Dolutegravir|dolutegravir|mesh-list
55791542|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
55791543|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791544|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55791545|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55791546|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791547|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791548|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56262934|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262935|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
56262936|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
56262937|NCT03174184|Amoxicillin|amoxicillin|mesh-list
56262938|NCT03174184|Rifampin|rifampin|mesh-list
56262939|NCT03174184|Meropenem|meropenem|mesh-list
55884934|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56262940|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
56262941|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
56262942|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56262943|NCT03174184|Rifamycins|rifamycins|mesh-list
56262944|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56262945|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56262946|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56262947|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
56262948|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
56262949|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56262950|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262951|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262952|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56262953|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56262954|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56262955|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56262956|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56262975|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
56262976|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56262977|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56262978|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
56262979|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56262980|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56262981|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56262982|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56262983|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55791549|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55791550|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55791551|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55791552|NCT04860167|Diclofenac|diclofenac|mesh-list
55791553|NCT04860167|Lidocaine|lidocaine|mesh-list
55791554|NCT04860167|Propofol|propofol|mesh-list
55791555|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56262984|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262985|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
56262986|NCT02900560|Azacitidine|azacitidine|mesh-list
56262987|NCT02900560|Cc-486|cc-486|mesh-list
56262988|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262989|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262990|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56262991|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
56262992|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56262993|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56262994|NCT02877550|Venetoclax|venetoclax|mesh-list
56262995|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
56262996|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56262997|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56262998|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
56262999|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263000|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56263001|NCT02679170|Crizotinib|crizotinib|mesh-list
56263002|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263003|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55791556|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791557|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263004|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263005|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263006|NCT02640534|Metformin|metformin|mesh-list
56263007|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56263008|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263009|NCT02518009|Estrogens|estrogens|mesh-list
56263013|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263014|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56263015|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55791558|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55791559|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
55791560|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
55791561|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55791562|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55791563|NCT04860167|Analgesics|analgesics|mesh-ancestor
55791564|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
55791565|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791566|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263016|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56263017|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56263019|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56263020|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263021|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56263022|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263023|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
56263024|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56263025|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
56263026|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263027|NCT02220426|Xenon|xenon|mesh-list
56263028|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56263029|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
56263030|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
56263031|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263032|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263033|NCT02034110|Trametinib|trametinib|mesh-list
56263034|NCT02034110|Dabrafenib|dabrafenib|mesh-list
56263035|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263036|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56263037|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263038|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263039|NCT01968213|Rucaparib|rucaparib|mesh-list
56263040|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55791567|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55791568|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55791569|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791570|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791571|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
55791572|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55791573|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55791574|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55791575|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55791576|NCT04880785|Lamivudine|lamivudine|mesh-list
56263041|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263042|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263043|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263057|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263058|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263059|NCT01427712|Pancrelipase|pancrelipase|mesh-list
56263060|NCT01427712|Pancreatin|pancreatin|mesh-list
56263061|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263064|NCT01369147|Clevidipine|clevidipine|mesh-list
56263065|NCT01369147|Propofol|propofol|mesh-list
56263066|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56263067|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263068|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791608|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55791609|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791610|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
56263069|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56263070|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
56263071|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
56263072|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56263073|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56263074|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263075|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56263076|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
56263077|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55791611|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55791612|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56263078|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
56263079|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263080|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263081|NCT01079780|Irinotecan|irinotecan|mesh-list
56263082|NCT01079780|Cetuximab|cetuximab|mesh-list
56263083|NCT01079780|Ramucirumab|ramucirumab|mesh-list
56263084|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56263085|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56263086|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885079|NCT03120468|Topiramate|topiramate|mesh-list
56263087|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263088|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263089|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56263090|NCT00075946|Rituximab|rituximab|mesh-list
56263091|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55791614|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
55791615|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56263092|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876565|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56263093|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
56263094|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263095|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263096|NCT00003641|Interferons|interferons|mesh-list
56263097|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
56263098|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
56263099|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263100|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
56263101|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263102|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
56263103|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263104|NCT01945840|Hormones|hormones|mesh-list
56263105|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263106|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263107|NCT01945879|Heparin|heparin|mesh-list
56263108|NCT01945879|Enoxaparin|enoxaparin|mesh-list
56263109|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56263110|NCT01945879|Tinzaparin|tinzaparin|mesh-list
56263111|NCT01945879|Dalteparin|dalteparin|mesh-list
56263112|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
56263113|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56263114|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56263115|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263116|NCT01945892|Dexamethasone|dexamethasone|mesh-list
56263117|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263118|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
56263119|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
56263120|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263121|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263122|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263123|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
56263138|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263139|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
56263140|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
56263141|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263142|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56263143|NCT01946009|Cidofovir|cidofovir|mesh-list
56263144|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
56263145|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263146|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263147|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263148|NCT01946035|Doxazosin|doxazosin|mesh-list
56263149|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56263150|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56263151|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56263152|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56263153|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
56263154|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263155|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263156|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263157|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
56263158|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263159|NCT01946256|Amoxicillin|amoxicillin|mesh-list
56263160|NCT01946256|Erythromycin|erythromycin|mesh-list
56263161|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
56263162|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55791616|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
55876566|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876567|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876568|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55876569|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55876570|NCT00630825|Dulaglutide|dulaglutide|mesh-list
55876571|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55876572|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876575|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876576|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
55876577|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
55876578|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876579|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876580|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876581|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
55876582|NCT03434340|Hormones|hormones|mesh-ancestor
55876583|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876584|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55876585|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876586|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55876587|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
55876588|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876589|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876590|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55876591|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56263163|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
56263164|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56263165|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263166|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263167|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56263168|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263169|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263171|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56263172|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263173|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56263174|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
56263175|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
55791617|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791618|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
55791619|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
56263176|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263177|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263178|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263179|NCT01946386|Betamethasone|betamethasone|mesh-list
56263180|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
56263181|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56263182|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
56263183|NCT01946386|Clobetasol|clobetasol|mesh-list
56263184|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56263185|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263186|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
56263187|NCT01946386|Hormones|hormones|mesh-ancestor
56263188|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263189|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263190|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56263191|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
56263192|NCT01946399|Dexamethasone|dexamethasone|mesh-list
56263193|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263194|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
56263195|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
55876592|NCT01923987|Cetuximab|cetuximab|mesh-list
55876593|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55876594|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876595|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
55876596|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55876597|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
55876598|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876599|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
55876600|NCT03101163|Protective Agents|protective agents|mesh-ancestor
55876601|NCT01924065|Anticoagulants|anticoagulants|mesh-list
56263196|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263197|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263198|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263199|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
55791620|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791621|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791622|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791624|NCT04622917|Hormones|hormones|mesh-ancestor
56263200|NCT01946399|Hormones|hormones|mesh-ancestor
56263201|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263202|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56263203|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263204|NCT01946555|Fentanyl|fentanyl|mesh-list
56263205|NCT01946555|Morphine|morphine|mesh-list
56263206|NCT01946555|Oxycodone|oxycodone|mesh-list
56263207|NCT01946555|Buprenorphine|buprenorphine|mesh-list
56263208|NCT01946555|Methadone|methadone|mesh-list
56263259|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56263260|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56263261|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56263262|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
56263263|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263264|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263265|NCT01946815|Atorvastatin|atorvastatin|mesh-list
56263266|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56263267|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56263268|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
56263269|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263270|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55789341|NCT04903847|Lamivudine|lamivudine|mesh-list
56263271|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56263272|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263273|NCT01946906|Rifaximin|rifaximin|mesh-list
56263274|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56263275|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263276|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263277|NCT01946971|Lansoprazole|lansoprazole|mesh-list
56263278|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
56263279|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56263280|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263281|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56263282|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263283|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263284|NCT01946984|Diclofenac|diclofenac|mesh-list
56263285|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
56263301|NCT01947062|Cisplatin|cisplatin|mesh-list
56263304|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56263305|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
55791625|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791626|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56263306|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263307|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263308|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56263309|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
56263310|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263311|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263312|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56263313|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56263314|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56263316|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263317|NCT01947114|Ketamine|ketamine|mesh-list
56263318|NCT01947114|Remifentanil|remifentanil|mesh-list
56263319|NCT01947114|Propofol|propofol|mesh-list
56263320|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56263321|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263322|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263323|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56263324|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
56263325|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
56263326|NCT01947114|Analgesics|analgesics|mesh-ancestor
56263327|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
56263328|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263329|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56263330|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56263331|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56263332|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263333|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263334|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56263335|NCT01947114|Narcotics|narcotics|mesh-ancestor
55876602|NCT03434106|Dextrans|dextrans|mesh-list
56263347|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
56263348|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56263349|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263350|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263351|NCT01947309|Lenalidomide|lenalidomide|mesh-list
56263352|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
56263353|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263354|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56263355|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56263356|NCT01947309|Growth Substances|growth substances|mesh-ancestor
56263357|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
56263358|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263359|NCT01947465|Vaccines|vaccines|mesh-list
56263360|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
56263361|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263362|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
56263363|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56263364|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263365|NCT01947608|Ceritinib|ceritinib|mesh-list
56263366|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263367|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56263368|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789347|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263369|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263370|NCT01947660|Anesthetics|anesthetics|mesh-list
56263371|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263372|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263373|NCT01947699|Glyburide|glyburide|mesh-list
56263376|NCT01947777|Rifampin|rifampin|mesh-list
56263394|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263395|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56263396|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56263397|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56263398|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263399|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263400|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56263401|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56263402|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56263403|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
56263404|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263405|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263406|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56263407|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56263408|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
56263409|NCT01947920|Tramadol|tramadol|mesh-list
56263410|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56263411|NCT01947920|Narcotics|narcotics|mesh-ancestor
55791627|NCT04622917|Protective Agents|protective agents|mesh-ancestor
55791628|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791629|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263412|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263413|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263414|NCT01947920|Analgesics|analgesics|mesh-ancestor
56263415|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
56263416|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263417|NCT01947933|Mirikizumab|mirikizumab|mesh-list
56263418|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56263419|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56263420|NCT01947933|Analgesics|analgesics|mesh-ancestor
56263421|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
56263422|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263423|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263424|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263425|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263426|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56263427|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876603|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
55876604|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
55876605|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
55876606|NCT03179904|Paclitaxel|paclitaxel|mesh-list
55876607|NCT03179904|Trastuzumab|trastuzumab|mesh-list
55876608|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56263428|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
56263429|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56263430|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
55755715|NCT04083963|Carboplatin|carboplatin|mesh-list
56263431|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56263432|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
56263433|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263434|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263435|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
56263436|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
56263437|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56263438|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
55791630|NCT03038477|Durvalumab|durvalumab|mesh-list
55791631|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55791632|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791633|NCT03038243|Vaccines|vaccines|mesh-list
56263439|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56263440|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
56263441|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263442|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263443|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
56263444|NCT01947998|Warfarin|warfarin|mesh-list
56263445|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
56263446|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56263447|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
56263448|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55791634|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
55791635|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791637|NCT03038321|Lornoxicam|lornoxicam|mesh-list
56263449|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
56263450|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56263451|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
56263452|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263453|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263454|NCT01948011|Racecadotril|racecadotril|mesh-list
56263455|NCT01948011|Thiorphan|thiorphan|mesh-list
56263456|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
56263457|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56263458|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
56263459|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791638|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56263460|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263461|NCT01948024|Asenapine|asenapine|mesh-list
55885453|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
56263462|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56263467|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
56263468|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56263469|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
56263471|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263472|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263473|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56263474|NCT01948115|Analgesics|analgesics|mesh-ancestor
56263475|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
56263476|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263477|NCT01948128|Vitamin D|vitamin d|mesh-list
56263478|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
56263479|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
56263480|NCT01948128|Vitamins|vitamins|mesh-list
56263481|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
56263482|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263483|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56263484|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56263485|NCT01948232|Perindopril|perindopril|mesh-list
56263486|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56263487|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
56263488|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263489|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263490|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56263491|NCT01948245|Taurolidine|taurolidine|mesh-list
56263492|NCT01948245|Heparin|heparin|mesh-list
56263493|NCT01948245|Calcium heparin|calcium heparin|mesh-list
56263494|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
55791639|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263495|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791640|NCT03038321|Renal Agents|renal agents|mesh-ancestor
55791641|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55791642|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56263496|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56263497|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56263514|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56263515|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56263516|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56263517|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
56263518|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263519|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263520|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56263521|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55791643|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55791644|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791645|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263522|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56263523|NCT01948362|Sulforaphane|sulforaphane|mesh-list
56263524|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56263525|NCT01948362|Protective Agents|protective agents|mesh-ancestor
56263526|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263527|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263528|NCT01948401|Prednisolone|prednisolone|mesh-list
56263529|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791646|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791647|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56263530|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
56263531|NCT01948401|Hormones|hormones|mesh-ancestor
56263532|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263533|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263534|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56263535|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263536|NCT01948505|Acetaminophen|acetaminophen|mesh-list
56263537|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56263538|NCT01948505|Analgesics|analgesics|mesh-ancestor
56263539|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
56263540|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263541|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263542|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
56263543|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
56263544|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56263545|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
56263546|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263547|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
56263548|NCT01948583|Protective Agents|protective agents|mesh-ancestor
55838649|NCT01975285|Hormones|hormones|mesh-ancestor
55876609|NCT03179904|Letrozole|letrozole|mesh-list
55876610|NCT03179904|Fulvestrant|fulvestrant|mesh-list
55791648|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55791649|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56263549|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56263550|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56263551|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56263552|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
56263553|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263554|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56263555|NCT01948765|Propofol|propofol|mesh-list
56263556|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56263557|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263558|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263559|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56263560|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
56263561|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
56263562|NCT01948804|Letrozole|letrozole|mesh-list
56263563|NCT01948804|Clomiphene|clomiphene|mesh-list
56263564|NCT01948804|Cetrorelix|cetrorelix|mesh-list
56263565|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56263566|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263567|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56263568|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56263569|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263570|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263571|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56263572|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
56263573|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263574|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263575|NCT01948804|Hormones|hormones|mesh-ancestor
56263576|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56263577|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
56263578|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56263579|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56263580|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56263581|NCT01948817|Deferasirox|deferasirox|mesh-list
56263582|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56263583|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
55890772|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
56263587|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56263588|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56263589|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56263590|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263591|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263592|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791650|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55791651|NCT03038321|Analgesics|analgesics|mesh-ancestor
55791652|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
56263593|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
56263594|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56263595|NCT01948921|Meperidine|meperidine|mesh-list
56263596|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56263597|NCT01948921|Narcotics|narcotics|mesh-ancestor
56263598|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263599|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263600|NCT01948921|Analgesics|analgesics|mesh-ancestor
56263601|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
56263602|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263603|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56263604|NCT01948960|Everolimus|everolimus|mesh-list
56263605|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263606|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56263607|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
56263608|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263609|NCT01948999|Anesthetics|anesthetics|mesh-list
56263610|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56263638|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
55791653|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791654|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263639|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263640|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263641|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56263642|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
56263643|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263644|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263645|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56263646|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56263647|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56263648|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56263649|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263651|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56263652|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
56263653|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263654|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
56263655|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263656|NCT01949233|Doxycycline|doxycycline|mesh-list
56263657|NCT01949233|Irbesartan|irbesartan|mesh-list
56263658|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56263659|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263660|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
56263661|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56263662|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55791655|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791656|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263663|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56263664|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56263665|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56263666|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263667|NCT01949363|Cefixime|cefixime|mesh-list
56263668|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56263669|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791657|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56263670|NCT01949454|Fluorometholone|fluorometholone|mesh-list
56263671|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56263676|NCT01949454|Hormones|hormones|mesh-ancestor
56263677|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263678|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263679|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56263680|NCT01949519|Lycopene|lycopene|mesh-list
56263681|NCT01949519|Docetaxel|docetaxel|mesh-list
56263682|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263683|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
55791659|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791660|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
55791661|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56263684|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
56263685|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
56263686|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263687|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263688|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
56263689|NCT01949519|Protective Agents|protective agents|mesh-ancestor
56263693|NCT01949571|Mirtazapine|mirtazapine|mesh-list
56263739|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263740|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56263741|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56263742|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
56263743|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263744|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263745|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56263746|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56263747|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56263748|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56263749|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263750|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263751|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
56263753|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263754|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56263755|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56263756|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
56263757|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
56263758|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
56263759|NCT01949857|Vaccines|vaccines|mesh-list
56263760|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
55791662|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55791664|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55791665|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263761|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263762|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
56263763|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56263764|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
56263765|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263766|NCT01949935|Mupirocin|mupirocin|mesh-list
56263767|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56263768|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263769|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56263781|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263783|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
56263784|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263785|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56263786|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56263787|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
56263788|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
56263789|NCT01950182|Tamoxifen|tamoxifen|mesh-list
56263790|NCT01950182|Gemcitabine|gemcitabine|mesh-list
56263791|NCT01950182|Capecitabine|capecitabine|mesh-list
56263792|NCT01950182|Trastuzumab|trastuzumab|mesh-list
56263793|NCT01950182|Vinorelbine|vinorelbine|mesh-list
56263794|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56263795|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56263796|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
56263797|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263798|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263799|NCT01950182|Antiviral Agents|antiviral agents|mesh-ancestor
56263800|NCT01950182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263835|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56263836|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263837|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263838|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
56263839|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56263840|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263841|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
56263842|NCT01950507|Fluconazole|fluconazole|mesh-list
56263843|NCT01950507|Voriconazole|voriconazole|mesh-list
56263844|NCT01950507|Micafungin|micafungin|mesh-list
56263845|NCT01950507|Budesonide|budesonide|mesh-list
56263846|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263847|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56263848|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
56263849|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56263850|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263851|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56263852|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
56263853|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
56263854|NCT01950507|Hormones|hormones|mesh-ancestor
56263855|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263856|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
56263857|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263858|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56263859|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56263860|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263861|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263862|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56263863|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
56263864|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56263865|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56263866|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56263867|NCT01950546|Fluorides|fluorides|mesh-list
56263868|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
55791666|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55791667|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791668|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
56263869|NCT01950546|Protective Agents|protective agents|mesh-ancestor
56263870|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263871|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
56263872|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263873|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
56263874|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263875|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263876|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56263878|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56263879|NCT01950689|Nimorazole|nimorazole|mesh-list
56263880|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56263881|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56263882|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56263883|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56263884|NCT01950793|Triamcinolone|triamcinolone|mesh-list
56263885|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55791669|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
55791670|NCT04860011|Metolazone|metolazone|mesh-list
55791671|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56263886|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56263887|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
56263888|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56263889|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56263890|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
56263891|NCT01950793|Hormones|hormones|mesh-ancestor
56263895|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
56263925|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56263926|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55791672|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791673|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55791674|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791675|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56263927|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263928|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56263929|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
56263930|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263931|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56263932|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
56263933|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56263934|NCT01951079|Digoxin|digoxin|mesh-list
56263935|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56263936|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56263937|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56263938|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263939|NCT01951079|Protective Agents|protective agents|mesh-ancestor
56263940|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263941|NCT01951144|Lorazepam|lorazepam|mesh-list
56263942|NCT01951144|PF-06372865|pf-06372865|mesh-list
56263958|NCT01951209|Rifaximin|rifaximin|mesh-list
56263982|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56263983|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56263985|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56263986|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56263987|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
55890773|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791678|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55791679|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56263988|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56263989|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56263990|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56263991|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56263992|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56263993|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56263994|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56263995|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56263996|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56263997|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56263998|NCT01951430|Renal Agents|renal agents|mesh-ancestor
55791681|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55791682|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791683|NCT05562609|Tranexamic Acid|tranexamic acid|mesh-list
55791684|NCT05562609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55791685|NCT05562609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55791686|NCT05562609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791687|NCT05562609|Hemostatics|hemostatics|mesh-ancestor
55791688|NCT05562609|Coagulants|coagulants|mesh-ancestor
55791689|NCT05071339|Ganirelix|ganirelix|mesh-list
55791690|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
55791691|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791692|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791693|NCT02606279|Valsartan|valsartan|mesh-list
56263999|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
56264000|NCT01951482|Bevacizumab|bevacizumab|mesh-list
56264001|NCT01951482|Cisplatin|cisplatin|mesh-list
56264002|NCT01951482|Pemetrexed|pemetrexed|mesh-list
56264003|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56264004|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264005|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56264006|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56264027|NCT01951560|Valproic Acid|valproic acid|mesh-list
56264028|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
56264029|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264030|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791694|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55791695|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55791696|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55791697|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791708|NCT04859621|Vitamins|vitamins|mesh-list
55791709|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55791710|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
55791711|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791712|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55791713|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55791714|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55791715|NCT03039491|Vaccines|vaccines|mesh-list
55791716|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55791717|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
56264031|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
56264032|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264033|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264034|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
56264035|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56264036|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264037|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56264038|NCT01951599|Osimertinib|osimertinib|mesh-list
56264039|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264040|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56264041|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264042|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264043|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56264044|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
55791718|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791720|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55791721|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
55791722|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791723|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791724|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55791725|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55791726|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
55791727|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791728|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791731|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
55791732|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791733|NCT03038009|Pantoprazole|pantoprazole|mesh-list
55791734|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55791735|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791736|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55791737|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791738|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791739|NCT03466801|Prednisone|prednisone|mesh-list
55791740|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
55791741|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55791742|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791743|NCT03466801|Hormones|hormones|mesh-ancestor
56264045|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264046|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56264048|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264049|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56264050|NCT01951729|Atropine|atropine|mesh-list
56264051|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56264052|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56264053|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56264055|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264056|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264071|NCT01951872|Caffeine|caffeine|mesh-list
56264072|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56264073|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264074|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56264075|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264076|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791744|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791745|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264077|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56264078|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56264079|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
56264080|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264081|NCT01951898|Montelukast|montelukast|mesh-list
56264082|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56264083|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
56264084|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56264085|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
56264087|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791746|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791747|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264126|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
56264127|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264128|NCT01952626|Ondansetron|ondansetron|mesh-list
56264129|NCT01952626|Palonosetron|palonosetron|mesh-list
56264130|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
56264131|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
56264132|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264133|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264134|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56264135|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
56264136|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
56264137|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55791748|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
55791750|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55791751|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
55791752|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
55791753|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
55791754|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791755|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791756|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791757|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55791758|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791759|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55791760|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55791761|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55791762|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55791763|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55791764|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55791765|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
55791766|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
55791767|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
55791768|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
55791769|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791770|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264138|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
56264139|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264140|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264141|NCT01952626|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56264142|NCT01952626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56264143|NCT01952626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264144|NCT01952626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56264145|NCT01952626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56264146|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56264147|NCT01952652|Naproxen|naproxen|mesh-list
56264148|NCT01952652|Codeine|codeine|mesh-list
56264149|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56264150|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56264151|NCT01952652|Analgesics|analgesics|mesh-ancestor
56264152|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
56264153|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264154|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264155|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56264156|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56264157|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
56264158|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56264162|NCT01952652|Narcotics|narcotics|mesh-ancestor
56264168|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
55890774|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
56264169|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264170|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264171|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56264172|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
56264173|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56264174|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56264175|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264176|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56264177|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
56264178|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56264179|NCT01952756|Protective Agents|protective agents|mesh-ancestor
56264180|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56264181|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56264182|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264183|NCT01952769|Pidilizumab|pidilizumab|mesh-list
56264227|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56264228|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264229|NCT01953406|Fluorouracil|fluorouracil|mesh-list
56264230|NCT01953406|Mitomycins|mitomycins|mesh-list
55764583|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
56264231|NCT01953406|Mitomycin|mitomycin|mesh-list
56264232|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
56264233|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264234|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56264235|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264236|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56264237|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
56264238|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264239|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56264240|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
56264241|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56264242|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264243|NCT01953419|Pemetrexed|pemetrexed|mesh-list
56264244|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264245|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264246|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264247|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56264248|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56264249|NCT01953445|Paclitaxel|paclitaxel|mesh-list
56264250|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56264278|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744392|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55744393|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
56264279|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56264280|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264281|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264282|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56264283|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
56264284|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56264285|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818584|NCT01843348|Cyclosporins|cyclosporins|mesh-list
55818585|NCT01843348|Basiliximab|basiliximab|mesh-list
55818586|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818587|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
55818588|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818589|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55818590|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818611|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818612|NCT05370599|Losartan|losartan|mesh-list
55818613|NCT05370599|Amlodipine|amlodipine|mesh-list
55818614|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
55818615|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
55818616|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55818617|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818618|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818619|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55818620|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818637|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818638|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55818639|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818640|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818641|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
55818642|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
56264286|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
56264287|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56264288|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56264289|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56264290|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56264291|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56264292|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56264334|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
56264335|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264336|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
55818814|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818911|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
55818912|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
55818913|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845393|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
56264337|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264338|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56264339|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56264340|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
56264341|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56264342|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56264343|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
56264344|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264345|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56264346|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56264347|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56264348|NCT01953796|Clomiphene|clomiphene|mesh-list
56264349|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56264350|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
56264351|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56264352|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264353|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56264354|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
56264355|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56264356|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56264357|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56264358|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56264359|NCT01953835|Simvastatin|simvastatin|mesh-list
56264360|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56264380|NCT01953887|Tamsulosin|tamsulosin|mesh-list
56264381|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
56264382|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56264383|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56264384|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56264385|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264386|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264387|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264388|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264389|NCT01953887|Urological Agents|urological agents|mesh-ancestor
56264390|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56264391|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56264392|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
56264393|NCT01953952|Cisplatin|cisplatin|mesh-list
56264394|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264395|NCT01953978|Acetaminophen|acetaminophen|mesh-list
56264396|NCT01953978|Dexamethasone|dexamethasone|mesh-list
56264397|NCT01953978|Ibuprofen|ibuprofen|mesh-list
56264398|NCT01953978|Morphine|morphine|mesh-list
56264399|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56264400|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
56264401|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
56264402|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264403|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264404|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56264405|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
56264406|NCT01953978|Hormones|hormones|mesh-ancestor
56264407|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56264426|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56264427|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56264428|NCT01954030|Growth Substances|growth substances|mesh-ancestor
56264429|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264430|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
56264431|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56264432|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264433|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264434|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56264435|NCT01954043|Rifampin|rifampin|mesh-list
56264436|NCT01954043|Dabrafenib|dabrafenib|mesh-list
56264437|NCT01954043|Rabeprazole|rabeprazole|mesh-list
56264438|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56264439|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56264440|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56264441|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264442|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264443|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56264444|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
56264445|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56264446|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264447|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
56264448|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56264449|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56264450|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56264451|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56264452|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56264453|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56264454|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56264455|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264456|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56264457|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
56264465|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56264466|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264467|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
56264468|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56264469|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
56264470|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56264471|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
56264472|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264473|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264474|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
56264475|NCT01954290|Mannitol|mannitol|mesh-list
56264476|NCT01954290|Conivaptan|conivaptan|mesh-list
56264477|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56264478|NCT01954290|Diuretics|diuretics|mesh-ancestor
56264479|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
56264480|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818938|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818940|NCT01816594|Paclitaxel|paclitaxel|mesh-list
55818953|NCT02453711|Hormones|hormones|mesh-ancestor
55819013|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55819014|NCT01610206|Gemcitabine|gemcitabine|mesh-list
55819015|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55819016|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
55819017|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819018|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819019|NCT01610206|Antiviral Agents|antiviral agents|mesh-ancestor
55819020|NCT01610206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819021|NCT01610206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819022|NCT01610206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819023|NCT01610206|Immunologic Factors|immunologic factors|mesh-ancestor
55819024|NCT01610206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819025|NCT01816048|Listerine|listerine|mesh-list
55819081|NCT01652573|Katacalcin|katacalcin|mesh-list
56264481|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56264482|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264483|NCT01954355|Paclitaxel|paclitaxel|mesh-list
56264484|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56264485|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264486|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
56264487|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
56264488|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
56264489|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264490|NCT01954368|Sufentanil|sufentanil|mesh-list
56264491|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56264516|NCT01954784|Cyclosporins|cyclosporins|mesh-list
56264517|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264518|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55819202|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819203|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
55819204|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55819205|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819206|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
55819207|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55819208|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55819209|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55819211|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819212|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
55819213|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819214|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819215|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55819216|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819217|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
55819231|NCT01810432|Evacetrapib|evacetrapib|mesh-list
55819232|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55819233|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55819234|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
55819235|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819237|NCT04908449|Bupivacaine|bupivacaine|mesh-list
56264519|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
56264520|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264521|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56264522|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
56264523|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264524|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264525|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
56264526|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819284|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819285|NCT02404493|Decanoic acid|decanoic acid|mesh-list
55819286|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
55819287|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819288|NCT02379221|Lidocaine|lidocaine|mesh-list
55819289|NCT02379221|Epinephrine|epinephrine|mesh-list
55819290|NCT02379221|Benzocaine|benzocaine|mesh-list
55819291|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
55819292|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
55819293|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819294|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819295|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
55819296|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819300|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55819301|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819302|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55819303|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55819304|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
55819368|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
55819369|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819394|NCT01867294|Protective Agents|protective agents|mesh-ancestor
55819395|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
55819396|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55819397|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55819398|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819399|NCT02401529|Acetaminophen|acetaminophen|mesh-list
56264527|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
56264528|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56264529|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56264530|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56264531|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56264532|NCT01954784|Growth Substances|growth substances|mesh-ancestor
56264533|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
56264534|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56264535|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56264536|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
56264537|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56264538|NCT01954914|Plerixafor|plerixafor|mesh-list
56264539|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56264540|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56264541|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
56264542|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264543|NCT01954992|Fluorouracil|fluorouracil|mesh-list
56264544|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
56264545|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264546|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56264547|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264548|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56264556|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819510|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819511|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55819512|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
55819517|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
55819567|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819568|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55819569|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55819570|NCT02016183|Candesartan|candesartan|mesh-list
55819688|NCT02420327|Nicotine|nicotine|mesh-list
56264557|NCT01955070|Ketamine|ketamine|mesh-list
56264558|NCT01955070|Analgesics|analgesics|mesh-ancestor
56264559|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
56264560|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264561|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264562|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56264563|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56264564|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
56264565|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
56264566|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264567|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56264568|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56264569|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264570|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264571|NCT01955135|Ketamine|ketamine|mesh-list
56264572|NCT01955135|Propofol|propofol|mesh-list
56264573|NCT01955135|Sevoflurane|sevoflurane|mesh-list
56264574|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56264575|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264576|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264577|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56264578|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
56264579|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
56264580|NCT01955135|Analgesics|analgesics|mesh-ancestor
56264581|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
56264582|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264583|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56264584|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56264585|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56264598|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56264599|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56264601|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
56264602|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
56264603|NCT01955187|Rituximab|rituximab|mesh-list
56264604|NCT01955187|Tacrolimus|tacrolimus|mesh-list
56264605|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55819863|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764690|NCT05192889|Etoposide|etoposide|mesh-list
55819864|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
55819865|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
55819866|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819867|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819868|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819869|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
55819870|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
55819871|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
55819872|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
55819873|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819874|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819875|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819876|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
55819877|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
56264606|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
56264607|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56264608|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
56264609|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264610|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56264611|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56264612|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
56264613|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264614|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264615|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56264616|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56264617|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56264618|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264619|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56264620|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
56264621|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
56264622|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264623|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56264624|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
56264625|NCT01955187|Hormones|hormones|mesh-ancestor
56264626|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56264627|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56264628|NCT01955187|Protective Agents|protective agents|mesh-ancestor
56264641|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56264642|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
56264643|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264644|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56264645|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
56264646|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56264647|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56264648|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
56264649|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56264650|NCT01955200|Protective Agents|protective agents|mesh-ancestor
56264651|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56264652|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56264653|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264654|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
56264655|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56264656|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264657|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
56264658|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264659|NCT01955252|Azithromycin|azithromycin|mesh-list
56264660|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819921|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819922|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55819923|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55819924|NCT02079519|Growth Substances|growth substances|mesh-ancestor
55819984|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819985|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819986|NCT01806064|Axitinib|axitinib|mesh-list
55820094|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820095|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56264661|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264662|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
56264663|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56264664|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56264665|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
56264667|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
56264690|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264691|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56264692|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56264693|NCT01955642|Clopidogrel|clopidogrel|mesh-list
56264694|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56264695|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56264696|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56264697|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56264698|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
56264699|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820096|NCT01734850|Busulfan|busulfan|mesh-list
55820097|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
55820098|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820099|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820100|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
55820246|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
55820247|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55820248|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820249|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55820250|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820251|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
55820252|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55820253|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55820254|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55820255|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55820256|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
55820289|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55820290|NCT01765582|Growth Substances|growth substances|mesh-ancestor
55764769|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
56264700|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264701|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264702|NCT01955655|Baclofen|baclofen|mesh-list
56264703|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56264704|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264705|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56264706|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264707|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56264708|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
56264709|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
56264710|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264711|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264712|NCT01955694|Eplerenone|eplerenone|mesh-list
56264713|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56264714|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
55838688|NCT01937299|Brinzolamide|brinzolamide|mesh-list
56264715|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56264716|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264717|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56264718|NCT01955694|Diuretics|diuretics|mesh-ancestor
56264719|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
56264720|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56264721|NCT01955759|Amiodarone|amiodarone|mesh-list
55820291|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820294|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820295|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55820296|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820297|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
55820298|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55820299|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55820300|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820301|NCT01765582|Antidotes|antidotes|mesh-ancestor
55820302|NCT01765582|Protective Agents|protective agents|mesh-ancestor
56264722|NCT01955759|Bisoprolol|bisoprolol|mesh-list
55839818|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
55876611|NCT03179904|Anastrozole|anastrozole|mesh-list
55876612|NCT03179904|Exemestane|exemestane|mesh-list
55876613|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
55876614|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56264723|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56264724|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56264725|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56264726|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56264727|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
56264728|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264729|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56264730|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56264731|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820585|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
55820586|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820587|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820588|NCT02332889|Decitabine|decitabine|mesh-list
55820589|NCT02332889|Poly ICLC|poly iclc|mesh-list
55820590|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55820591|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
55820592|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820593|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820617|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820619|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55820620|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
55820621|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820677|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820678|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264732|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55886729|NCT04945824|Hormones|hormones|mesh-ancestor
56264733|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264734|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264735|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264736|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56264737|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
56264738|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56264739|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264740|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56264741|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56264742|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56264743|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56264744|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56264745|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56264746|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56264767|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264768|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
55820679|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55820680|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820681|NCT04673175|Tazobactam|tazobactam|mesh-list
55820682|NCT04673175|Ceftolozane|ceftolozane|mesh-list
55820683|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55820684|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55820685|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820686|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55820687|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820688|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820689|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55820690|NCT04673175|Renal Agents|renal agents|mesh-ancestor
55820727|NCT02312063|Hormones|hormones|mesh-ancestor
55820728|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820729|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55820730|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
55820731|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820732|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820733|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55820734|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820735|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
55820736|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
55820737|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55820752|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264769|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264770|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56264771|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56264772|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56264773|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264774|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264775|NCT01956006|Milrinone|milrinone|mesh-list
55820810|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820811|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
55820812|NCT01642615|Lansoprazole|lansoprazole|mesh-list
55820813|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55820814|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820815|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55820816|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820817|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820950|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820951|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820952|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
55820953|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
55820984|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55820986|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820987|NCT04672005|Leucovorin|leucovorin|mesh-list
55821091|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55821092|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55821093|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55821094|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
55821095|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821096|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821099|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821100|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55821144|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821145|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55821146|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
56264776|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56264777|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56264778|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
56264779|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56264780|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56264781|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264782|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264783|NCT01956006|Protective Agents|protective agents|mesh-ancestor
56264784|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264785|NCT01956201|Atorvastatin|atorvastatin|mesh-list
56264786|NCT01956201|Fenofibrate|fenofibrate|mesh-list
56264787|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56264788|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55764812|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
55821148|NCT02254681|Antiviral Agents|antiviral agents|mesh-ancestor
55821149|NCT02254681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821154|NCT01965327|Interferons|interferons|mesh-list
56264789|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
56264790|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264815|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56264817|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
56264818|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264819|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264820|NCT01956591|Urological Agents|urological agents|mesh-ancestor
56264821|NCT01956604|Clonidine|clonidine|mesh-list
56264822|NCT01956604|Analgesics|analgesics|mesh-ancestor
56264823|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
56264824|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264825|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264826|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56264827|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
56264828|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
56264829|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56264830|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56264831|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56264832|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264833|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264834|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264835|NCT01956695|Rituximab|rituximab|mesh-list
56264836|NCT01956695|Lenalidomide|lenalidomide|mesh-list
56264846|NCT01956734|Temozolomide|temozolomide|mesh-list
56264867|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264868|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56264869|NCT01956955|Heparin|heparin|mesh-list
56264870|NCT01956955|Enoxaparin|enoxaparin|mesh-list
56264871|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56264872|NCT01956955|Calcium heparin|calcium heparin|mesh-list
56264873|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
56264874|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55821280|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821281|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55821282|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821283|NCT01732588|Artefenomel|artefenomel|mesh-list
55821284|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
55821285|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55821286|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55821287|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821292|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55821352|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821353|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55821354|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55821355|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
55821356|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821357|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55821358|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55821359|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
56264875|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56264876|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264877|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
56264878|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
56264879|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56264880|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56264881|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264882|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56264883|NCT01956981|Analgesics|analgesics|mesh-ancestor
56264884|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
56264885|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264886|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56264887|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56264888|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56264889|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264890|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264891|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264892|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
56264893|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56264894|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
56264895|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56264896|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56264897|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56264900|NCT01957007|Docetaxel|docetaxel|mesh-list
56264910|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56264911|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56264912|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56264913|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264914|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264915|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264916|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264917|NCT01957189|Urological Agents|urological agents|mesh-ancestor
56264918|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55821429|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
55821430|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821431|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821432|NCT04419493|Heparin|heparin|mesh-list
55821433|NCT04419493|Calcium heparin|calcium heparin|mesh-list
55821434|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55821532|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821533|NCT01998399|Ticagrelor|ticagrelor|mesh-list
55821534|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55821535|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55821536|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55821537|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55821581|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
55821591|NCT01781026|Vemurafenib|vemurafenib|mesh-list
55821642|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
55821643|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821644|NCT01637623|Allopurinol|allopurinol|mesh-list
56264919|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56264920|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56264921|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
56264922|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56264923|NCT01957293|Albuterol|albuterol|mesh-list
56264924|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56264925|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
56264926|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56264927|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264928|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56264929|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
56264930|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
56264931|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56264932|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56264933|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56264934|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56264935|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
56264936|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56264937|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56264938|NCT01957319|Vitamin E|vitamin e|mesh-list
56264939|NCT01957319|Silybin|silybin|mesh-list
56264940|NCT01957319|Vitamins|vitamins|mesh-ancestor
56264941|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
56264942|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56264943|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
56264945|NCT01957319|Protective Agents|protective agents|mesh-ancestor
56264947|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264948|NCT01957436|Docetaxel|docetaxel|mesh-list
56264949|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
56264950|NCT01957436|Androgens|androgens|mesh-list
56264951|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56264952|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
56264953|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
55821645|NCT01637623|Losartan|losartan|mesh-list
55821646|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55821647|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55821648|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55821649|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55821650|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821651|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
55821652|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821653|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
55821654|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821655|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55821656|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
55821657|NCT01637623|Protective Agents|protective agents|mesh-ancestor
55821658|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821659|NCT01995825|Lamotrigine|lamotrigine|mesh-list
56264954|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
56264964|NCT01957449|Metoprolol|metoprolol|mesh-list
56265015|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56265016|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
56265017|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
56265018|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265019|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265020|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265021|NCT01957852|Thrombin|thrombin|mesh-list
56265022|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
56265023|NCT01957852|Coagulants|coagulants|mesh-ancestor
56265024|NCT01957943|SMOFlipid|smoflipid|mesh-list
56265025|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56265026|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55821674|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55821675|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55821676|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55821677|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821678|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821679|NCT04267081|Venetoclax|venetoclax|mesh-list
55821680|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821681|NCT05406583|Dolutegravir|dolutegravir|mesh-list
55821682|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55821683|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55821684|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821686|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55821729|NCT04196413|Fludarabine|fludarabine|mesh-list
55821730|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821731|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
55821732|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821733|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821734|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55821735|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
55821736|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821737|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821738|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55821739|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55821740|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
55821741|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821742|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55821743|NCT01756456|Mitogens|mitogens|mesh-list
55821744|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
55821746|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
56265027|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56265028|NCT01957995|Docetaxel|docetaxel|mesh-list
56265029|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265030|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
56265031|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
56265032|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
56265033|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265034|NCT01958138|Propofol|propofol|mesh-list
56265035|NCT01958138|Isoflurane|isoflurane|mesh-list
56265036|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56265037|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265068|NCT01958580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265069|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
56265070|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
56265071|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
56265072|NCT01958684|Copper|copper|mesh-list
56265073|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
55789404|NCT02370589|Vaccines|vaccines|mesh-list
56265074|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56265075|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
56265076|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56265077|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265078|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56265079|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56265080|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56265081|NCT01958684|Trace Elements|trace elements|mesh-ancestor
56265082|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
56265083|NCT01958775|Glucagon|glucagon|mesh-list
56265084|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56265085|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821759|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821760|NCT04745299|Riluzole|riluzole|mesh-list
55821761|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
55821762|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56265086|NCT01958775|Hormones|hormones|mesh-ancestor
56265087|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265088|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265089|NCT01958775|Incretins|incretins|mesh-ancestor
56265090|NCT01958814|Albuterol|albuterol|mesh-list
56265122|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265123|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265124|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56265125|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
56265126|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56265128|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265129|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821766|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821767|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55821768|NCT04745299|Protective Agents|protective agents|mesh-ancestor
55821769|NCT05221021|Mirabegron|mirabegron|mesh-list
55821783|NCT03167437|Ustekinumab|ustekinumab|mesh-list
55821784|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821785|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55821786|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821787|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821788|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
55821789|NCT03164473|Rituximab|rituximab|mesh-list
55821790|NCT03164473|Azathioprine|azathioprine|mesh-list
55821791|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55821792|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821793|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
55821794|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821840|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55821841|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821842|NCT04544293|Molgramostim|molgramostim|mesh-list
55821843|NCT04544293|Sargramostim|sargramostim|mesh-list
55821844|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
55821845|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265130|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56265131|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
56265132|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
56265133|NCT01958944|Protective Agents|protective agents|mesh-ancestor
56265134|NCT01958996|Idarubicin|idarubicin|mesh-list
56265135|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56265136|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265137|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56265138|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55764838|NCT04299867|Metronidazole|metronidazole|mesh-list
55822056|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
55822057|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55822058|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55822059|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822060|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744394|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822160|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
55822161|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55822162|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
55822163|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55822164|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822165|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55822166|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55822168|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822180|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55822181|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55822182|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55822183|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822184|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822185|NCT01939977|Calcifediol|calcifediol|mesh-list
55822186|NCT01939977|Vitamins|vitamins|mesh-ancestor
55822187|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
55822188|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822189|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56265139|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265140|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265141|NCT01959022|Doxazosin|doxazosin|mesh-list
56265142|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56265143|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56265144|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56265145|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56265146|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265147|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755716|NCT04083963|Doxorubicin|doxorubicin|mesh-list
55822277|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55822278|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
55822279|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822280|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822281|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55822283|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
55822328|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822329|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55822330|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55822331|NCT01969851|Lacosamide|lacosamide|mesh-list
55822332|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
55822333|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55822334|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55822335|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55822350|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55822352|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
56265148|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265149|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265150|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
56265151|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
56265152|NCT01959061|Raltitrexed|raltitrexed|mesh-list
56265153|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265159|NCT01959074|Aceclofenac|aceclofenac|mesh-list
56265162|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56265164|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
56265165|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265166|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265167|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56265168|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56265169|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55822472|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822473|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
55822474|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822476|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
55822477|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55822478|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
55822479|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822480|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822493|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55764882|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265170|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56265171|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265172|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265173|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265174|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56265175|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56265176|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56265177|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56265178|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56265179|NCT01959100|Azithromycin|azithromycin|mesh-list
56265180|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56265181|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56265182|NCT01959152|Imidacloprid|imidacloprid|mesh-list
56265183|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
56265184|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265185|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265186|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265187|NCT01959191|Aspirin|aspirin|mesh-list
56265208|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265209|NCT01959386|Trastuzumab|trastuzumab|mesh-list
56265210|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56265211|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265212|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56265213|NCT01959399|Peficitinib|peficitinib|mesh-list
56265214|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56265215|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56265216|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
56265217|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265218|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56265219|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55822602|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822603|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55822604|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55822605|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
55822606|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
55822607|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822608|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55822609|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
56265220|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265221|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265222|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
56265223|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265224|NCT01959438|Selenious Acid|selenious acid|mesh-list
56265225|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
56265226|NCT01959438|Trace Elements|trace elements|mesh-ancestor
56265227|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
56265228|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265229|NCT01959451|Clopidogrel|clopidogrel|mesh-list
56265230|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56265231|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56265232|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56265233|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56265234|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56265254|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56265255|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265256|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
56265257|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56265258|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
56265259|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265260|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265261|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56265262|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
56265263|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56265264|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
56265265|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265266|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265267|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56265268|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
56265313|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265314|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
56265315|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265316|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56265317|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265318|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
56265319|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56265320|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56265321|NCT01960426|Adalimumab|adalimumab|mesh-list
56265322|NCT01960426|Infliximab|infliximab|mesh-list
56265323|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56265324|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56265325|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
56265326|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56265327|NCT01960543|Fentanyl|fentanyl|mesh-list
56265328|NCT01960543|Bupivacaine|bupivacaine|mesh-list
56265329|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
56265330|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265331|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
56265332|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265333|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265334|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
56265335|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265336|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56265337|NCT01960543|Narcotics|narcotics|mesh-ancestor
56265338|NCT01960543|Analgesics|analgesics|mesh-ancestor
56265339|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56265340|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56265341|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
56265363|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56265364|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
56265366|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56265367|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265368|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
56265369|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
56265370|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
56265371|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265372|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56265373|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56265374|NCT01960829|Everolimus|everolimus|mesh-list
56265375|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265376|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265377|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
56265378|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265379|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56265380|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56265381|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56265382|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
56265383|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56265384|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
56265385|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265386|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265387|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
56265388|NCT01961154|Hormones|hormones|mesh-ancestor
56265389|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265390|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
56265391|NCT01961180|Citalopram|citalopram|mesh-list
56265392|NCT01961180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56265393|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56265394|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56265403|NCT01961193|Trace Elements|trace elements|mesh-ancestor
56265404|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
56265405|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755872|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
55822745|NCT01929135|Atorvastatin|atorvastatin|mesh-list
55822746|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55822747|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55822748|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
55822749|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822750|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55822751|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55822752|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822753|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55822754|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55822755|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55822756|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822757|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822758|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56265407|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265408|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265409|NCT01961336|Testosterone|testosterone|mesh-list
56265410|NCT01961336|Androgens|androgens|mesh-ancestor
56265411|NCT01961336|Hormones|hormones|mesh-ancestor
56265412|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265413|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265414|NCT01961388|Metformin|metformin|mesh-list
56265415|NCT01961388|Acarbose|acarbose|mesh-list
56265416|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56265417|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265418|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56265419|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265420|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265421|NCT01961414|Aflibercept|aflibercept|mesh-list
56265422|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56265423|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56265424|NCT01961414|Growth Substances|growth substances|mesh-ancestor
56265425|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265426|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
56265427|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265428|NCT01961453|Isosorbide|isosorbide|mesh-list
56265429|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56265430|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56265431|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56265432|NCT01961453|Diuretics|diuretics|mesh-ancestor
56265433|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
56265434|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265435|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
56265436|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56265437|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265438|NCT01961635|Cimetidine|cimetidine|mesh-list
56265439|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56265440|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876615|NCT03179904|Antibodies|antibodies|mesh-list
56265441|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56265442|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
56265443|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
56265444|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265445|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265446|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265447|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56265448|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56265449|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265451|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265452|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
56265453|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265454|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265455|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
56265456|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755873|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55822786|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55822787|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
55822788|NCT01910181|Vemurafenib|vemurafenib|mesh-list
55822789|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822790|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55822791|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822793|NCT04885907|Vaccines|vaccines|mesh-list
56265457|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56265458|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56265459|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56265460|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56265461|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265462|NCT01961752|Triamcinolone|triamcinolone|mesh-list
56265463|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56265464|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56265465|NCT01961752|Bupivacaine|bupivacaine|mesh-list
56265466|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56265485|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56265486|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
56265487|NCT01961843|Hormones|hormones|mesh-ancestor
56265488|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265489|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265490|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56265491|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265492|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56265493|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265494|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265495|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
56265496|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56265497|NCT01961856|Clopidogrel|clopidogrel|mesh-list
56265498|NCT01961856|Ticagrelor|ticagrelor|mesh-list
56265499|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56265500|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56265501|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56265502|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56265503|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
56265504|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265505|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265506|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265507|NCT01961947|Vaccines|vaccines|mesh-list
56265508|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
56265509|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265510|NCT01962116|Heparin|heparin|mesh-list
56265511|NCT01962116|Calcium heparin|calcium heparin|mesh-list
56265512|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
56265513|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265514|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56265515|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56265524|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265525|NCT01962285|Propofol|propofol|mesh-list
56265526|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56265527|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265528|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265529|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56265530|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
56265531|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
56265532|NCT01962363|Tocotrienols|tocotrienols|mesh-list
56265533|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
56265534|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
56265535|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265536|NCT01962363|Protective Agents|protective agents|mesh-ancestor
56265537|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265538|NCT01962363|Vitamins|vitamins|mesh-ancestor
56265539|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
56265540|NCT01962376|Bevacizumab|bevacizumab|mesh-list
56265541|NCT01962376|Capecitabine|capecitabine|mesh-list
56265542|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
56265543|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56265544|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265545|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56265546|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56265547|NCT01962376|Growth Substances|growth substances|mesh-ancestor
56265548|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265549|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
56265550|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56265551|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
56265573|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56265574|NCT01963039|Protective Agents|protective agents|mesh-ancestor
56265575|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265576|NCT01963182|Irinotecan|irinotecan|mesh-list
56265577|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56265578|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56265579|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265640|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265641|NCT01963559|Lidocaine|lidocaine|mesh-list
56265642|NCT01963559|Prilocaine|prilocaine|mesh-list
56265643|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56265644|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265645|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
56265646|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265647|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265648|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
56265649|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265650|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56265651|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56265652|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56265701|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56265702|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56265703|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265704|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265706|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265707|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56265708|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
56265709|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56265710|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55755874|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
56265711|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56265712|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265713|NCT01963910|Mannitol|mannitol|mesh-list
56265714|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56265715|NCT01963910|Diuretics|diuretics|mesh-ancestor
56265716|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
56265717|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265761|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265762|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265763|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265765|NCT01964079|Amlodipine|amlodipine|mesh-list
56265766|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56265767|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56265768|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56265769|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265770|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56265771|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265772|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
56265773|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56265774|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55887773|NCT03311022|Nefopam|nefopam|mesh-list
56265775|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56265776|NCT01964157|Ceritinib|ceritinib|mesh-list
56265777|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265779|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265815|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
56265816|NCT01964287|Irinotecan|irinotecan|mesh-list
56265817|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56265818|NCT01964287|Folfirinox|folfirinox|mesh-list
56265819|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56265820|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56265821|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
56265822|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
56265823|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
56265824|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265825|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56265826|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
56265827|NCT01964287|Antiviral Agents|antiviral agents|mesh-ancestor
56265828|NCT01964287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56265829|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265830|NCT01964287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56265831|NCT01964287|Immunologic Factors|immunologic factors|mesh-ancestor
56265832|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265833|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56265834|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56265835|NCT01964287|Antidotes|antidotes|mesh-ancestor
56265836|NCT01964287|Protective Agents|protective agents|mesh-ancestor
56265837|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
56265838|NCT01964287|Vitamins|vitamins|mesh-ancestor
56265839|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
56265840|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
56265867|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56265868|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55822895|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55822897|NCT02252965|Metformin|metformin|mesh-list
56265869|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56265870|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56265872|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
56265873|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265874|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56265875|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56265876|NCT01964404|Analgesics|analgesics|mesh-ancestor
56265877|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
56265878|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265879|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56265880|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56265881|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265882|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265883|NCT01964404|Hormones|hormones|mesh-ancestor
56265884|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56265885|NCT01964534|Gemcitabine|gemcitabine|mesh-list
56265886|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56265887|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56265888|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
56265889|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265917|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56265918|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265919|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56265920|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56265921|NCT01964586|Analgesics|analgesics|mesh-ancestor
56265922|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56265923|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56265924|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56265925|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
56265926|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56265927|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56265928|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56265929|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
56265930|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56265931|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
56265932|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
56265933|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
56265934|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56265935|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
56265936|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755875|NCT03719313|Lonafarnib|lonafarnib|mesh-list
55822901|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55822903|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
55822904|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822905|NCT02242201|Ketorolac|ketorolac|mesh-list
56265937|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56265938|NCT01964781|Epinephrine|epinephrine|mesh-list
56265939|NCT01964781|Racepinephrine|racepinephrine|mesh-list
56265940|NCT01964781|Bupivacaine|bupivacaine|mesh-list
56265941|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
56265942|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
56265943|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
56265944|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
56265945|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56265947|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
56265963|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
56265964|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
56265965|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56265967|NCT01964846|Resveratrol|resveratrol|mesh-list
56265968|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56265969|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56265970|NCT01964846|Analgesics|analgesics|mesh-ancestor
56265971|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
56265972|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56265973|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56265974|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56265975|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56265976|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266026|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
56266027|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
56266028|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266029|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266030|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56266031|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
56266032|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
56266033|NCT01965353|Dexamethasone|dexamethasone|mesh-list
56266034|NCT01965353|Lenalidomide|lenalidomide|mesh-list
56266035|NCT01965353|Bortezomib|bortezomib|mesh-list
56266036|NCT01965353|Panobinostat|panobinostat|mesh-list
56266037|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56266038|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
56266039|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
56266040|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266041|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266042|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56266043|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
56266044|NCT01965353|Hormones|hormones|mesh-ancestor
56266045|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266046|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56266047|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266048|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
56266049|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56266050|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56266051|NCT01965353|Growth Substances|growth substances|mesh-ancestor
56266075|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
56266076|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266077|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56266078|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56266079|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
56266080|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266081|NCT01965522|Protective Agents|protective agents|mesh-ancestor
55822975|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
55822976|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822980|NCT02238379|Oxytocin|oxytocin|mesh-list
56266082|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266083|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
56266084|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56266085|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
56266086|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56266087|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266088|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56266089|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56266090|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56266091|NCT01965626|Oseltamivir|oseltamivir|mesh-list
56266092|NCT01965626|Dexamethasone|dexamethasone|mesh-list
56266093|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56266094|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
56266095|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
56266096|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266097|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266098|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56266099|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
56266100|NCT01965626|Hormones|hormones|mesh-ancestor
56266101|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266102|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56266103|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266104|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
56266105|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266115|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56266116|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266117|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56266118|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56266119|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56266120|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266122|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266123|NCT01966055|Solithromycin|solithromycin|mesh-list
56266124|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56266125|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266126|NCT01966133|Doxorubicin|doxorubicin|mesh-list
56266127|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56266128|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
56266129|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56266130|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266131|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56266132|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56266133|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266134|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266135|NCT01966172|Acetaminophen|acetaminophen|mesh-list
56266136|NCT01966172|Ibuprofen|ibuprofen|mesh-list
56266137|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56266138|NCT01966172|Morphine|morphine|mesh-list
56266139|NCT01966172|Gabapentin|gabapentin|mesh-list
56266140|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56266141|NCT01966172|Narcotics|narcotics|mesh-ancestor
56266142|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266143|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266144|NCT01966172|Analgesics|analgesics|mesh-ancestor
56266145|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
56266146|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266157|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56266158|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56266159|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56266160|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266161|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
56266162|NCT01966276|Methylphenidate|methylphenidate|mesh-list
56266163|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56266164|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266165|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56266166|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56266167|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56266168|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266169|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
56266170|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266171|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
56266172|NCT01966289|Guadecitabine|guadecitabine|mesh-list
56266173|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
56266174|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266175|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56266176|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266177|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56266178|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
56266179|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266180|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266181|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56266182|NCT01966302|Beraprost|beraprost|mesh-list
56266183|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56266184|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
56266185|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56266186|NCT01966341|Laxatives|laxatives|mesh-list
56266187|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
56266188|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266197|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56266198|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266199|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266200|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56266201|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56266202|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
56266203|NCT01966575|Progestins|progestins|mesh-list
56266204|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56266205|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56266206|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56266207|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
56266208|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56266209|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266210|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56266211|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56266212|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56266213|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56266214|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266215|NCT01966575|Hormones|hormones|mesh-ancestor
56266216|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266217|NCT01966627|Liver Extracts|liver extracts|mesh-list
56266248|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56266249|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56266251|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
56266252|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56266253|NCT01966822|Ritonavir|ritonavir|mesh-list
56266315|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
56266316|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266317|NCT01967381|Methamphetamine|methamphetamine|mesh-list
56266318|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56266320|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
56266385|NCT01967758|Renal Agents|renal agents|mesh-ancestor
56266386|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
56266387|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56266388|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56266389|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56266390|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266391|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266392|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56266393|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56266396|NCT01967823|Aldesleukin|aldesleukin|mesh-list
56266446|NCT01968005|Etodolac|etodolac|mesh-list
56266447|NCT01968005|Lidocaine|lidocaine|mesh-list
56266448|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
55888444|NCT05327556|Racepinephrine|racepinephrine|mesh-list
56266449|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
56266450|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266451|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266452|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
56266453|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266454|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56266455|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56266456|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56266457|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56266458|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266459|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56266460|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56266502|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56266504|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56266505|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56266506|NCT01968239|Growth Substances|growth substances|mesh-ancestor
56266507|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266508|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
56266509|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266510|NCT01968395|Caspofungin|caspofungin|mesh-list
56266511|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
56266512|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266513|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266514|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266515|NCT01968460|Pramipexole|pramipexole|mesh-list
56266516|NCT01968460|Rasagiline|rasagiline|mesh-list
56266517|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
55756040|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
56266518|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266519|NCT01968460|Protective Agents|protective agents|mesh-ancestor
56266520|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266521|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56266522|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56266524|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
56266556|NCT01968616|Ranibizumab|ranibizumab|mesh-list
56266557|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55838791|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
56266558|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56266559|NCT01968616|Growth Substances|growth substances|mesh-ancestor
56266560|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266561|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
56266562|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266563|NCT01968655|Factor VIII|factor viii|mesh-list
56266564|NCT01968655|Coagulants|coagulants|mesh-ancestor
56266565|NCT01968759|Ramipril|ramipril|mesh-list
56266566|NCT01968759|Irbesartan|irbesartan|mesh-list
56266567|NCT01968759|Sevelamer|sevelamer|mesh-list
56266568|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56266569|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
56266570|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266577|NCT01968798|Aspirin|aspirin|mesh-list
56266618|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
56266619|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56266620|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
56266621|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56266622|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
56266623|NCT01969019|Hormones|hormones|mesh-ancestor
56266624|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266625|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266626|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56266627|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266628|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
56266629|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
56266630|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266631|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56266632|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56266633|NCT01969019|Protective Agents|protective agents|mesh-ancestor
56266634|NCT01969032|Paclitaxel|paclitaxel|mesh-list
56266635|NCT01969032|Doxorubicin|doxorubicin|mesh-list
56266636|NCT01969032|Capecitabine|capecitabine|mesh-list
56266637|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
56266638|NCT01969032|Carboplatin|carboplatin|mesh-list
56266639|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56266640|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266641|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
56266642|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
56266643|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
56266644|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266645|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56266646|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56266647|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56266648|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266649|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56266658|NCT01969071|Simendan|simendan|mesh-list
56266661|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
56266662|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56266663|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56266664|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266665|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266666|NCT01969071|Protective Agents|protective agents|mesh-ancestor
56266667|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266668|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
56266669|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
56266670|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266671|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56266672|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56266673|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55888670|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
56266674|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
56266675|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266676|NCT01969149|Insulin|insulin|mesh-list
56266677|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56266678|NCT01969149|Exenatide|exenatide|mesh-list
56266679|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
56266680|NCT01969149|Incretins|incretins|mesh-list
56266681|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56266682|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266712|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56266713|NCT01969656|Vitamins|vitamins|mesh-ancestor
56266714|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
56266715|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56266716|NCT01969669|Ketoconazole|ketoconazole|mesh-list
56266717|NCT01969669|Venetoclax|venetoclax|mesh-list
56266718|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266719|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
56266720|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266721|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56266722|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56266723|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266724|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266725|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56266726|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
56266727|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266728|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266729|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56266731|NCT01969682|Venetoclax|venetoclax|mesh-list
56266732|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266733|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56266734|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
56266735|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56266736|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266737|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
56266738|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56266739|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266740|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266741|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56266742|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56266743|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56266744|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56266745|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56266747|NCT01969695|Venetoclax|venetoclax|mesh-list
56266749|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
56266750|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56266751|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56266752|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56266753|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56266754|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266755|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
56266756|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266757|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266758|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56266759|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266760|NCT01969877|Cetuximab|cetuximab|mesh-list
56266761|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266762|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56266763|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
56266764|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56266765|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56266766|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266767|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56266768|NCT01969903|Analgesics|analgesics|mesh-ancestor
56266769|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
56266770|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266771|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56266772|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56266773|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56266774|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
56266775|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266794|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266796|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56266797|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266798|NCT01970059|Metoprolol|metoprolol|mesh-list
56266799|NCT01970059|Carvedilol|carvedilol|mesh-list
55823067|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55823068|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
56266800|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56266801|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56266802|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
56266803|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
56266804|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56266805|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266806|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56266807|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56266808|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56266809|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
56266810|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266811|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266812|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
56266813|NCT01970059|Protective Agents|protective agents|mesh-ancestor
56266814|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56266815|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56266846|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266848|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56266849|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266850|NCT01970280|Enoxaparin|enoxaparin|mesh-list
56266851|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
56266852|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56266853|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56266854|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266855|NCT01970358|Poly ICLC|poly iclc|mesh-list
56266856|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
56266857|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
56266858|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266859|NCT01970449|Vaccines|vaccines|mesh-list
56266860|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
56266861|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266862|NCT01970553|Gemcitabine|gemcitabine|mesh-list
56266863|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56266864|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
56266865|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266866|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266867|NCT01970553|Antiviral Agents|antiviral agents|mesh-ancestor
56266868|NCT01970553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266869|NCT01970553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266870|NCT01970553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56266871|NCT01970553|Immunologic Factors|immunologic factors|mesh-ancestor
56266872|NCT01970553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266873|NCT01970579|Paclitaxel|paclitaxel|mesh-list
56266874|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56266875|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266889|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
56266890|NCT01970800|Hormones|hormones|mesh-list
56266891|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56266892|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266893|NCT01970904|Ribavirin|ribavirin|mesh-list
56266894|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56266895|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
56266896|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266897|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
56266898|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56266899|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56266900|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56266901|NCT01971034|Metformin|metformin|mesh-list
56266902|NCT01971034|Paclitaxel|paclitaxel|mesh-list
56266903|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56266904|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56266905|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
56266906|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
56266907|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
56266908|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266909|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56266910|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266911|NCT01971047|Insulin|insulin|mesh-list
56266912|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
56266913|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56266914|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56266915|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266916|NCT01971190|Aflibercept|aflibercept|mesh-list
56266917|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56266918|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56266919|NCT01971190|Growth Substances|growth substances|mesh-ancestor
56266934|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
56266935|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
56266936|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56266937|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56266938|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56266939|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56266940|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56266941|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56266942|NCT01971281|Gemcitabine|gemcitabine|mesh-list
56266943|NCT01971281|Paclitaxel|paclitaxel|mesh-list
56266951|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
56266998|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56266999|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56267000|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56267001|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56267002|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
56267003|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267004|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56267005|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56267006|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267008|NCT01971632|Naloxone|naloxone|mesh-list
56267009|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56267010|NCT01971632|Narcotics|narcotics|mesh-ancestor
56267011|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823147|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823148|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55823149|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55823150|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
55823151|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267012|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267013|NCT01971632|Analgesics|analgesics|mesh-ancestor
56267014|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
56267016|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56267055|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56267056|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267057|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267058|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267059|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
56267060|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56267061|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
56267062|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56267063|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56267064|NCT01971801|Vitamin D|vitamin d|mesh-list
56267065|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
56267066|NCT01971801|Vitamins|vitamins|mesh-ancestor
56267067|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
56267068|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267069|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56267070|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56267071|NCT01971814|Infliximab|infliximab|mesh-list
56267072|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
56267073|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56267074|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56267075|NCT01971918|Antibodies|antibodies|mesh-list
56267076|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
56267077|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267078|NCT01972113|Vitamins|vitamins|mesh-list
56267079|NCT01972113|Vitamin K|vitamin k|mesh-list
56267080|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
56267081|NCT01972113|Vitamin MK 7|vitamin mk 7|mesh-list
56267082|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
56267083|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267084|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56267085|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56267102|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267103|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56267104|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56267105|NCT01972269|Lidocaine|lidocaine|mesh-list
56267106|NCT01972269|Fentanyl|fentanyl|mesh-list
56267107|NCT01972269|Bupivacaine|bupivacaine|mesh-list
56267108|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
56267109|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
56267110|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267111|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267112|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
56267113|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267114|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56267115|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56267116|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56267117|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267118|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267119|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56267120|NCT01972269|Narcotics|narcotics|mesh-ancestor
56267121|NCT01972269|Analgesics|analgesics|mesh-ancestor
56267122|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56267123|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56267124|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
56267125|NCT01972373|Bevacizumab|bevacizumab|mesh-list
56267126|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56267127|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267128|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56267129|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56267130|NCT01972373|Growth Substances|growth substances|mesh-ancestor
56267131|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267132|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
56267133|NCT01972490|Bevacizumab|bevacizumab|mesh-list
56267134|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56267141|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
56267142|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267143|NCT01972620|Bupivacaine|bupivacaine|mesh-list
56267144|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
56267145|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
56267146|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267147|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267148|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
56267149|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267150|NCT01972711|Amisulpride|amisulpride|mesh-list
56267151|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56267152|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56267153|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267154|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267155|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56267156|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56267157|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
56267158|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267159|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267160|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56267161|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
56267195|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267196|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56267197|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
56267198|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267199|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267200|NCT01973010|Ibuprofen|ibuprofen|mesh-list
55889195|NCT01932112|Adenosine|adenosine|mesh-list
56267201|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56267203|NCT01973010|Analgesics|analgesics|mesh-ancestor
56267204|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
56267205|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267206|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267207|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267208|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56267209|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56267210|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267211|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267212|NCT01973101|Gemcitabine|gemcitabine|mesh-list
56267213|NCT01973101|Cisplatin|cisplatin|mesh-list
56267214|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267215|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56267216|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
56267217|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267218|NCT01973101|Antiviral Agents|antiviral agents|mesh-ancestor
56267219|NCT01973101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267227|NCT01973140|Tolvaptan|tolvaptan|mesh-list
56267242|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267243|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56267244|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56267246|NCT01973400|Vitamin E|vitamin e|mesh-list
56267247|NCT01973400|Tocopherols|tocopherols|mesh-list
56267248|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
55764948|NCT02432807|Vancomycin|vancomycin|mesh-list
56267249|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267250|NCT01973400|Protective Agents|protective agents|mesh-ancestor
56267251|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267252|NCT01973400|Vitamins|vitamins|mesh-ancestor
56267253|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
56267254|NCT01973504|Chrysarobin|chrysarobin|mesh-list
56267255|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56267256|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56267257|NCT01973504|Analgesics|analgesics|mesh-ancestor
56267258|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
56267259|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838792|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
56267260|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267261|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267262|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56267263|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56267264|NCT01973517|Hematinics|hematinics|mesh-ancestor
56267265|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56267266|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56267267|NCT01973660|Tamoxifen|tamoxifen|mesh-list
56267268|NCT01973660|Paclitaxel|paclitaxel|mesh-list
56267269|NCT01973660|Trastuzumab|trastuzumab|mesh-list
56267270|NCT01973660|Letrozole|letrozole|mesh-list
56267271|NCT01973660|Lapatinib|lapatinib|mesh-list
56267272|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56267274|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
56267288|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56267289|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56267290|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56267291|NCT01973751|Budesonide|budesonide|mesh-list
56267292|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267293|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56267294|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
56267295|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267296|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267297|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56267298|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
56267299|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
56267300|NCT01973751|Hormones|hormones|mesh-ancestor
56267301|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267302|NCT01973790|Z 338|z 338|mesh-list
56267303|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56267304|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267305|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267306|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
56267307|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267308|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267309|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56267310|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
56267311|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56267312|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55823221|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
55823222|NCT02203591|Ethanol|ethanol|mesh-list
55823223|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
55823224|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55823225|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55823226|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823227|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823228|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823229|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
56267313|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56267314|NCT01973816|Estradiol|estradiol|mesh-list
56267315|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56267316|NCT01973816|Cyproterone|cyproterone|mesh-list
56267317|NCT01973816|Estrogens|estrogens|mesh-ancestor
56267318|NCT01973816|Hormones|hormones|mesh-ancestor
56267319|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267330|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267331|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56267332|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
56267333|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56267334|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
56267335|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56267336|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267337|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56267338|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56267339|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267341|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
56267342|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267343|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
56267344|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267345|NCT01973868|Cetuximab|cetuximab|mesh-list
56267389|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
56267390|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
56267391|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56267392|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267393|NCT01974167|Vitamins|vitamins|mesh-ancestor
56267394|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
56267395|NCT01974258|Vemurafenib|vemurafenib|mesh-list
56267396|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267397|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56267398|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267399|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267400|NCT01974297|Atorvastatin|atorvastatin|mesh-list
56267401|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
56267402|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56267403|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56267404|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
56267405|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267406|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55823230|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
55823231|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
56267407|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56267408|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267409|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56267410|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56267411|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56267413|NCT01974375|Micafungin|micafungin|mesh-list
56267414|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
56267426|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
56267436|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56267437|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
56267438|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267439|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267440|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56267441|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56267442|NCT01974622|Verteporfin|verteporfin|mesh-list
56267443|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56267444|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
56267445|NCT01974648|Remifentanil|remifentanil|mesh-list
56267446|NCT01974648|Propofol|propofol|mesh-list
56267447|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56267448|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267449|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267450|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56267451|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
56267452|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
56267453|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56267454|NCT01974648|Narcotics|narcotics|mesh-ancestor
56267455|NCT01974648|Analgesics|analgesics|mesh-ancestor
56267456|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
56267457|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267458|NCT01974843|Bupivacaine|bupivacaine|mesh-list
56267459|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
56267460|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
56267461|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
56267462|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267463|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267464|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
56267465|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267466|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56267467|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56267468|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56267469|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267470|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876616|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
55876617|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56267471|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267472|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267473|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
56267474|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56267475|NCT01975012|Rilpivirine|rilpivirine|mesh-list
56267476|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56267477|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56267478|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267479|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267480|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
56267481|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267482|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56267483|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56267484|NCT01975051|Miltefosine|miltefosine|mesh-list
56267485|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
56267486|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267487|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267488|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56267489|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56267490|NCT01975129|Oxytocin|oxytocin|mesh-list
56267491|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
56267492|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56267493|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267494|NCT01975142|Trastuzumab|trastuzumab|mesh-list
56267495|NCT01975142|Maytansine|maytansine|mesh-list
56267496|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56267497|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267520|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56267521|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267522|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267523|NCT01975363|Curcumin|curcumin|mesh-list
56267524|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56267525|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56267526|NCT01975363|Analgesics|analgesics|mesh-ancestor
56267527|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
56267528|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267529|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267530|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267531|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56267532|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267533|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267534|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267535|NCT01975441|Ivermectin|ivermectin|mesh-list
56267536|NCT01975441|Albendazole|albendazole|mesh-list
56267537|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
56267538|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56267539|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267540|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
56267541|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
56267542|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56267543|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56267544|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
56267545|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
56267546|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
56267547|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267548|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267564|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267565|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267566|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
56267567|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56267568|NCT01975662|Vancomycin|vancomycin|mesh-list
56267569|NCT01975662|Daptomycin|daptomycin|mesh-list
56267570|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56267571|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267572|NCT01975688|Nabiximols|nabiximols|mesh-list
56267573|NCT01975688|Analgesics|analgesics|mesh-ancestor
56267574|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
56267575|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267576|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267577|NCT01975714|Bimatoprost|bimatoprost|mesh-list
56267578|NCT01975714|Latanoprost|latanoprost|mesh-list
56267628|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56267629|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56267631|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56267632|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56267633|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56267634|NCT01976078|Midazolam|midazolam|mesh-list
56267635|NCT01976078|Esomeprazole|esomeprazole|mesh-list
56267636|NCT01976078|Ranitidine|ranitidine|mesh-list
56267637|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56267638|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56267639|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56267640|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267641|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267642|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56267643|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56267644|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56267645|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56267646|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
56267647|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
56267648|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
56267682|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267683|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56267684|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56267685|NCT01976195|Growth Substances|growth substances|mesh-ancestor
56267686|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
56267687|NCT01976208|Omalizumab|omalizumab|mesh-list
56267688|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56267689|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56267690|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
56267691|NCT01976520|Vaccines|vaccines|mesh-list
56267692|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
56267693|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267694|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
56267695|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56267696|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56267697|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56267698|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267699|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267700|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
56267705|NCT01976676|Folic Acid|folic acid|mesh-list
56267740|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56267741|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56267742|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267743|NCT01977118|Streptokinase|streptokinase|mesh-list
56267744|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56267745|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56267746|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267748|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56267749|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
56267750|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56267751|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267752|NCT01977235|Irinotecan|irinotecan|mesh-list
56267753|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56267754|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56267755|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56267756|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267757|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267758|NCT01977300|Valproic Acid|valproic acid|mesh-list
56267759|NCT01977300|Olanzapine|olanzapine|mesh-list
56267760|NCT01977300|Risperidone|risperidone|mesh-list
56267761|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
56267762|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56267763|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
56267772|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
56267791|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267792|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56267793|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56267794|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56267795|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56267796|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267797|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267798|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267799|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267800|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56267801|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
56267802|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56267803|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56267804|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56267805|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56267807|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
56267808|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267809|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267810|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56267811|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56267812|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56267813|NCT01977430|Furosemide|furosemide|mesh-list
56267814|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56267815|NCT01977430|Diuretics|diuretics|mesh-ancestor
56267816|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
56267817|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267818|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56267819|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267822|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56267831|NCT01978015|Bimatoprost|bimatoprost|mesh-list
56267832|NCT01978015|Travoprost|travoprost|mesh-list
56267833|NCT01978015|Dextrans|dextrans|mesh-list
56267834|NCT01978015|Latanoprost|latanoprost|mesh-list
56267835|NCT01978015|Maleic acid|maleic acid|mesh-list
56267836|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267837|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267838|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56267839|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56267840|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
56267841|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267842|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267843|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56267844|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56267845|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56267846|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56267847|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
56267892|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56267893|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56267894|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
56267895|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267896|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267897|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267898|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56267899|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56267900|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
56267901|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
56267903|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56267904|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
56267905|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267906|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56267907|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56267908|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56267910|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
56267946|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
56267947|NCT01978782|Citalopram|citalopram|mesh-list
56267948|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56267949|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56267950|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
56267951|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56267952|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56267953|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56267954|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56267955|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56267956|NCT01978782|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56267957|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56267958|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56267959|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56267961|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267962|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56267963|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
56267964|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56267965|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
56267966|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
56267967|NCT01978873|Androgens|androgens|mesh-list
56267968|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56267969|NCT01978873|Hormones|hormones|mesh-ancestor
56267970|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56267971|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267972|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
56267975|NCT01978873|Vitamins|vitamins|mesh-ancestor
56267995|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56267996|NCT01979354|Analgesics|analgesics|mesh-ancestor
56267997|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
56267998|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56267999|NCT01979406|Vaccines|vaccines|mesh-list
56268000|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
56268001|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268002|NCT01979510|Acetaminophen|acetaminophen|mesh-list
56268003|NCT01979510|Etoricoxib|etoricoxib|mesh-list
56268004|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56268005|NCT01979510|Analgesics|analgesics|mesh-ancestor
56268006|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
56268007|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268008|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268009|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
56268010|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56268011|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56268012|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268013|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56268014|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56268015|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268016|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268017|NCT01979653|Midazolam|midazolam|mesh-list
56268018|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
56268019|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56268020|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268021|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268022|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56268023|NCT01979653|Analgesics|analgesics|mesh-ancestor
56268024|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
56268028|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55843183|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
55843184|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
55843185|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843186|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843206|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843207|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843208|NCT01695135|Prednisone|prednisone|mesh-list
55843209|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
55843210|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55843211|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
55843212|NCT01695135|Hormones|hormones|mesh-ancestor
55843213|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55843214|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843215|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55843218|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268038|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
56268078|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268080|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56268081|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268082|NCT01980277|Paclitaxel|paclitaxel|mesh-list
56268083|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56268084|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268085|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
56268086|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
56268087|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
56268088|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268089|NCT01980303|Esketamine|esketamine|mesh-list
56268090|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
56268091|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55823405|NCT01605370|Nebivolol|nebivolol|mesh-list
55823406|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55823407|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56268092|NCT01980316|Heparin|heparin|mesh-list
56268093|NCT01980316|Calcium heparin|calcium heparin|mesh-list
56268094|NCT01980316|Argatroban|argatroban|mesh-list
56268095|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
56268096|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56268097|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56268098|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268099|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
56268100|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56268101|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
56268102|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268103|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56268104|NCT01980329|Maraviroc|maraviroc|mesh-list
56268105|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56268106|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56268107|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268109|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56268110|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
56268111|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268112|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56268113|NCT01980407|Leucovorin|leucovorin|mesh-list
56268114|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56268115|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
56268118|NCT01980407|Protective Agents|protective agents|mesh-ancestor
56268119|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268120|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
56268121|NCT01980407|Vitamins|vitamins|mesh-ancestor
56268122|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
56268123|NCT01980472|Paclitaxel|paclitaxel|mesh-list
56268124|NCT01980472|Bevacizumab|bevacizumab|mesh-list
56268125|NCT01980472|Carboplatin|carboplatin|mesh-list
56268126|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56268127|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268128|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
56268129|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
56268130|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
56268131|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268132|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56268133|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56268134|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56268135|NCT01980472|Growth Substances|growth substances|mesh-ancestor
56268136|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268137|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
56268138|NCT01980498|Fentanyl|fentanyl|mesh-list
56268139|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56268140|NCT01980498|Narcotics|narcotics|mesh-ancestor
56268141|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823466|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823467|NCT01749826|Morphine|morphine|mesh-list
56268142|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268143|NCT01980498|Analgesics|analgesics|mesh-ancestor
56268144|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
56268145|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268146|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56268149|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
56268164|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268165|NCT01980680|Estradiol|estradiol|mesh-list
56268166|NCT01980680|Progesterone|progesterone|mesh-list
56268167|NCT01980680|Estrogens|estrogens|mesh-ancestor
56268168|NCT01980680|Hormones|hormones|mesh-ancestor
56268169|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268170|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268171|NCT01980680|Progestins|progestins|mesh-ancestor
56268172|NCT01980745|Chloroquine|chloroquine|mesh-list
56268173|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56268174|NCT01980745|Amebicides|amebicides|mesh-ancestor
56268175|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56268176|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56268177|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268178|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
56268179|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268180|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56268181|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56268182|NCT01980745|Analgesics|analgesics|mesh-ancestor
56268183|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
56268184|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268185|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268186|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56268187|NCT01980745|Filaricides|filaricides|mesh-ancestor
56268188|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
56268189|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
56268190|NCT01980810|Paclitaxel|paclitaxel|mesh-list
55843358|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55843359|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843360|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
55843361|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55843362|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55843364|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
55843365|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268215|NCT01981278|Narcotics|narcotics|mesh-ancestor
56268216|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268217|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268218|NCT01981278|Analgesics|analgesics|mesh-ancestor
56268227|NCT01981291|Anesthetics|anesthetics|mesh-list
56268266|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268267|NCT01981499|Cetirizine|cetirizine|mesh-list
56268268|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55823468|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55823469|NCT01749826|Narcotics|narcotics|mesh-ancestor
55823470|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823471|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823472|NCT01749826|Analgesics|analgesics|mesh-ancestor
55823473|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
55823474|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268269|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56268270|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56268271|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
56268272|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
56268273|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268274|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268275|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268276|NCT01981525|Metformin|metformin|mesh-list
56268277|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56268278|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268279|NCT01981707|Choline|choline|mesh-list
56268280|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
56268281|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56268282|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
56268283|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268284|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268285|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56268286|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
56268287|NCT01981746|Ropivacaine|ropivacaine|mesh-list
56268288|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
56268289|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
56268294|NCT01981811|Aripiprazole|aripiprazole|mesh-list
56268316|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268317|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268318|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56268319|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268320|NCT01981941|Gabapentin|gabapentin|mesh-list
56268321|NCT01981941|Analgesics|analgesics|mesh-ancestor
56268322|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
56268323|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268324|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268325|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
56268326|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56268327|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56268328|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268329|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55890332|NCT04840641|Losartan|losartan|mesh-list
56268330|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56268331|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56268332|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268333|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268335|NCT01982019|Hormones|hormones|mesh-list
56268336|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268337|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268338|NCT01982071|Micafungin|micafungin|mesh-list
56268339|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
56268340|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268341|NCT01982097|Sorafenib|sorafenib|mesh-list
56268342|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268343|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56268344|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268345|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268346|NCT01982201|Lesinurad|lesinurad|mesh-list
56268347|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
56268348|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268355|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268356|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
56268357|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268358|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56268359|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56268360|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56268361|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56268362|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56268363|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
56268364|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268365|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56268366|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56268367|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268368|NCT01982578|Genistein|genistein|mesh-list
56268369|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56268370|NCT01982578|Protective Agents|protective agents|mesh-ancestor
56268371|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268372|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268373|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56268374|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268375|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268376|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
56268377|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56268378|NCT01982578|Estrogens|estrogens|mesh-ancestor
56268379|NCT01982578|Hormones|hormones|mesh-ancestor
56268380|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268381|NCT01982734|Curcumin|curcumin|mesh-list
55756041|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
55764974|NCT02429687|Paclitaxel|paclitaxel|mesh-list
56268382|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56268383|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56268384|NCT01982734|Analgesics|analgesics|mesh-ancestor
56268398|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268399|NCT01982799|Acetaminophen|acetaminophen|mesh-list
56268400|NCT01982799|Ibuprofen|ibuprofen|mesh-list
56268401|NCT01982799|Naproxen|naproxen|mesh-list
56268402|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56268403|NCT01982799|Hydrocodone|hydrocodone|mesh-list
56268404|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56268405|NCT01982799|Analgesics|analgesics|mesh-ancestor
56268406|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
56268407|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268408|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268409|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
56268410|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56268411|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56268412|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268413|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56268414|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268415|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268416|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
56268417|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56268418|NCT01982799|Narcotics|narcotics|mesh-ancestor
56268419|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268420|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
56268421|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
56268422|NCT01982864|Gentamicins|gentamicins|mesh-list
56268423|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56268424|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268425|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56268426|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268427|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268428|NCT01982929|Epinephrine|epinephrine|mesh-list
56268429|NCT01982929|Bupivacaine|bupivacaine|mesh-list
56268430|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
56268431|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
56268439|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268440|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268441|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56268442|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56268443|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
56268444|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56268445|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
56268446|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
56268447|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
56268448|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56268449|NCT01983124|Vemurafenib|vemurafenib|mesh-list
56268450|NCT01983124|Fotemustine|fotemustine|mesh-list
56268451|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268452|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56268453|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268454|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268455|NCT01983137|Oxycodone|oxycodone|mesh-list
56268456|NCT01983137|Naloxone|naloxone|mesh-list
56268457|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56268458|NCT01983137|Narcotics|narcotics|mesh-ancestor
56268459|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268460|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268462|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
56268463|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268464|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56268465|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56268466|NCT01983371|Hematinics|hematinics|mesh-ancestor
56268467|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56268468|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56268469|NCT01983384|Anesthetics|anesthetics|mesh-list
56268470|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268471|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268472|NCT01983449|Dexamethasone|dexamethasone|mesh-list
56268473|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
56268475|NCT01983449|BB 1101|bb 1101|mesh-list
56268480|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268481|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268482|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
56268484|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268485|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56268486|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268487|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
56268488|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268489|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268490|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56268491|NCT01983462|Clonidine|clonidine|mesh-list
56268492|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56268493|NCT01983462|Diuretics|diuretics|mesh-ancestor
56268494|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
56268495|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268496|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56268497|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56268498|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268499|NCT01983462|Analgesics|analgesics|mesh-ancestor
56268500|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
56268501|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268502|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
56268503|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
56268504|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56268506|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56268528|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56268529|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
56268530|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
56268531|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268532|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268533|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268534|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
56268535|NCT01983527|Hormones|hormones|mesh-ancestor
56268536|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268537|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56268538|NCT01983527|Protective Agents|protective agents|mesh-ancestor
56268539|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56268540|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268541|NCT01983540|Vaccines|vaccines|mesh-list
56268542|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56268543|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
56268544|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268545|NCT01983657|Molgramostim|molgramostim|mesh-list
56268546|NCT01983657|Sargramostim|sargramostim|mesh-list
56268547|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
56268548|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268584|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56268585|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268586|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56268587|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56268588|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
56268589|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56268590|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56268591|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
56268592|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56268593|NCT01983800|Midazolam|midazolam|mesh-list
56268594|NCT01983800|Propofol|propofol|mesh-list
56268595|NCT01983800|Isoflurane|isoflurane|mesh-list
55789503|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
56268596|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56268597|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268598|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268599|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56268600|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
56268601|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
56268602|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56268603|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56268604|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56268605|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56268606|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
56268607|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
56268608|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268609|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268610|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56268611|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
56268612|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268613|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
56268614|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268630|NCT01984073|Niacin|niacin|mesh-list
56268631|NCT01984073|Niacinamide|niacinamide|mesh-list
56268632|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
56268633|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56268634|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
56268635|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268636|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56268637|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
56268638|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
56268639|NCT01984073|Vitamins|vitamins|mesh-ancestor
56268640|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
56268641|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268642|NCT01984086|Albuterol|albuterol|mesh-list
56268643|NCT01984086|Charcoal|charcoal|mesh-list
56268644|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56268645|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
56268646|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268647|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268648|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56268649|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
56268650|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
56268651|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56268652|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56268653|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56268654|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56268655|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
56268656|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268657|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268658|NCT01984086|Antidotes|antidotes|mesh-ancestor
56268659|NCT01984086|Protective Agents|protective agents|mesh-ancestor
56268660|NCT01984099|Folic Acid|folic acid|mesh-list
56268661|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
56268662|NCT01984099|Methotrexate|methotrexate|mesh-list
56268663|NCT01984099|Vitamins|vitamins|mesh-ancestor
56268664|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
56268671|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268672|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268674|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268675|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56268676|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56268677|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
56268678|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268679|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56268680|NCT01984099|Hematinics|hematinics|mesh-ancestor
56268681|NCT01984177|Hormones|hormones|mesh-list
56268682|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56268683|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
56268684|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268685|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268686|NCT01984255|Ipilimumab|ipilimumab|mesh-list
56268687|NCT01984255|Bavituximab|bavituximab|mesh-list
56268688|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56268689|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268690|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56268691|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268692|NCT01984372|Insulin|insulin|mesh-list
56268693|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55839672|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56268694|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268695|NCT01984463|Fentanyl|fentanyl|mesh-list
56268696|NCT01984463|Morphine|morphine|mesh-list
56268697|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56268698|NCT01984463|Narcotics|narcotics|mesh-ancestor
56268699|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268700|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268701|NCT01984463|Analgesics|analgesics|mesh-ancestor
56268702|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
56268703|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268713|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
56268714|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268716|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
56268717|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56268718|NCT01984606|Empagliflozin|empagliflozin|mesh-list
56268719|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56268720|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268721|NCT01984606|Incretins|incretins|mesh-ancestor
56268722|NCT01984606|Hormones|hormones|mesh-ancestor
56268723|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268724|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56268725|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
56268726|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268727|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268728|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56268729|NCT01984749|Febuxostat|febuxostat|mesh-list
56268730|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
56268731|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268732|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
56268733|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56268734|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268735|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56268736|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56268737|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268738|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268739|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268740|NCT01984931|Medazepam|medazepam|mesh-list
56268741|NCT01984931|Metoclopramide|metoclopramide|mesh-list
56268742|NCT01984931|Bromazepam|bromazepam|mesh-list
56268743|NCT01984931|Simethicone|simethicone|mesh-list
56268744|NCT01984931|Trimebutine|trimebutine|mesh-list
56268745|NCT01984931|Mosapride|mosapride|mesh-list
56268746|NCT01984931|Maleic acid|maleic acid|mesh-list
56268747|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268756|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
56268757|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268758|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
55765003|NCT02429219|Ethanol|ethanol|mesh-list
56268759|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56268760|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
56268761|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
56268762|NCT01984931|Emollients|emollients|mesh-ancestor
56268763|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
56268764|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56268765|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56268766|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268767|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56268768|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
56268769|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
56268770|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
56268771|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56268772|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56268773|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56268774|NCT01985061|Busulfan|busulfan|mesh-list
56268775|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
56268776|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268777|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56268778|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
56268779|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268780|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56268781|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268782|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56268783|NCT01985087|Temozolomide|temozolomide|mesh-list
56268784|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56268785|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
56268786|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268787|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268788|NCT01985152|Choline|choline|mesh-list
56268789|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56268790|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56268796|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268797|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56268799|NCT01985256|Flucytosine|flucytosine|mesh-list
56268800|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
56268801|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56268802|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
56268803|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268804|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
56268805|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56268806|NCT01985373|Antibodies|antibodies|mesh-list
56268807|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
56268808|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56268809|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
56268810|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268811|NCT01985451|Temozolomide|temozolomide|mesh-list
56268812|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56268813|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
56268814|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268815|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268816|NCT01985477|Dexamethasone|dexamethasone|mesh-list
56268817|NCT01985477|Lenalidomide|lenalidomide|mesh-list
56268818|NCT01985477|Tretinoin|tretinoin|mesh-list
56268819|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56268820|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
56268821|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
56268822|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268823|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268824|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268825|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
56268826|NCT01985477|Hormones|hormones|mesh-ancestor
56268827|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268828|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56268829|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268838|NCT01985594|Progesterone|progesterone|mesh-list
56268839|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56268840|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56268841|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268842|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56268843|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268844|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
56268845|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
56268846|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56268847|NCT01985594|Progestins|progestins|mesh-ancestor
56268848|NCT01985594|Hormones|hormones|mesh-ancestor
56268849|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56268850|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
56268851|NCT01985724|Docetaxel|docetaxel|mesh-list
56268852|NCT01985724|Epirubicin|epirubicin|mesh-list
56268853|NCT01985724|Fluorouracil|fluorouracil|mesh-list
56268854|NCT01985724|Lenograstim|lenograstim|mesh-list
56268855|NCT01985724|Mitogens|mitogens|mesh-list
56268856|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56268857|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
56268858|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268859|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56268860|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56268861|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
56268862|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268863|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268864|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56268885|NCT01985789|Promethazine|promethazine|mesh-list
56268886|NCT01985789|Cetirizine|cetirizine|mesh-list
56268887|NCT01985789|Desloratadine|desloratadine|mesh-list
56268888|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56268889|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56268890|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268891|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268892|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
56268893|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
56268894|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
56268895|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268897|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
56268898|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56268899|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56268900|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
56268901|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
56268902|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56268903|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268904|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56268905|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
56268906|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
56268907|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56268908|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56268909|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
56268910|NCT01985828|Androgens|androgens|mesh-list
56268935|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268936|NCT01985854|Propofol|propofol|mesh-list
56268937|NCT01985854|Desflurane|desflurane|mesh-list
56268938|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56268939|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268940|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268941|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56268942|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
56268943|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
56268944|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56268945|NCT01985893|Trastuzumab|trastuzumab|mesh-list
56268946|NCT01985893|Lapatinib|lapatinib|mesh-list
56268947|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56268948|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56268949|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56268950|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56268951|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56268952|NCT01986036|Calcium|calcium|mesh-list
56268953|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56268954|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268955|NCT01986049|Bupivacaine|bupivacaine|mesh-list
56268956|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
56268957|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
56268958|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56268959|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56268960|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
56268961|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56268962|NCT01986088|Sumatriptan|sumatriptan|mesh-list
56268963|NCT01986088|Eletriptan|eletriptan|mesh-list
56268967|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
56269057|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
56269058|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55756042|NCT03296657|Protective Agents|protective agents|mesh-ancestor
55823802|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823803|NCT02294474|Insulin|insulin|mesh-list
55823804|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55823805|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
55823806|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
55823807|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55823808|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823809|NCT02168101|Ixazomib|ixazomib|mesh-list
56269059|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
56269060|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56269061|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
56269062|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56269063|NCT01986582|Protective Agents|protective agents|mesh-ancestor
56269064|NCT01986608|Lacosamide|lacosamide|mesh-list
56269065|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
56269066|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56269067|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56269068|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269069|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269070|NCT01986660|Ibuprofen|ibuprofen|mesh-list
56269071|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56269072|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56269073|NCT01986660|Analgesics|analgesics|mesh-ancestor
56269074|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
56269075|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269076|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269077|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269078|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56269079|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56269080|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269081|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269082|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
56269083|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
55790040|NCT04870541|Analgesics|analgesics|mesh-ancestor
56269084|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56269085|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56269086|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269087|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269088|NCT01986673|Urological Agents|urological agents|mesh-ancestor
56269089|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56269094|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269095|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56269096|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56269097|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56269098|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269099|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269100|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
56269101|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269102|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56269103|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56269104|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269105|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56269106|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56269107|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269108|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269109|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
56269110|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269111|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
56269112|NCT01986894|Thalidomide|thalidomide|mesh-list
56269113|NCT01986894|Pomalidomide|pomalidomide|mesh-list
56269114|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56269115|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269116|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56269117|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56269118|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269119|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269120|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269121|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269136|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269137|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
56269138|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
56269139|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269140|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269141|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56269142|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
56269143|NCT01986998|Hormones|hormones|mesh-ancestor
56269144|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269145|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56269146|NCT01986998|Protective Agents|protective agents|mesh-ancestor
56269147|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56269148|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269149|NCT01987076|Prednisone|prednisone|mesh-list
56269198|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56269199|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56269200|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269202|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56269203|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56269204|NCT01987375|Cetuximab|cetuximab|mesh-list
56269205|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56269206|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269207|NCT01987570|Allopurinol|allopurinol|mesh-list
56269208|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
56269209|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269210|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269211|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
56269212|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56269213|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56269214|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
56269215|NCT01987570|Protective Agents|protective agents|mesh-ancestor
56269216|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269217|NCT01987739|Zolpidem|zolpidem|mesh-list
56269218|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56269219|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56269220|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823820|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55823821|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
55823822|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765011|NCT02429453|Thrombin|thrombin|mesh-list
56269249|NCT01988298|Analgesics|analgesics|mesh-ancestor
56269250|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
56269251|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269252|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269253|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
56269254|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56269255|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269256|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56269257|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56269258|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269259|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269260|NCT01988311|Psilocybin|psilocybin|mesh-list
56269261|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
56269262|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269263|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56269264|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
56269265|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56269266|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269267|NCT01988506|Interleukin-2|interleukin-2|mesh-list
56269268|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269269|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56269270|NCT01988506|Analgesics|analgesics|mesh-ancestor
56269271|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
56269272|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269273|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269274|NCT01988545|Exenatide|exenatide|mesh-list
56269275|NCT01988545|Glucagon|glucagon|mesh-list
56269276|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56269277|NCT01988545|Incretins|incretins|mesh-ancestor
56269278|NCT01988545|Hormones|hormones|mesh-ancestor
56269279|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269293|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56269294|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56269295|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
56269296|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269297|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
56269298|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56269299|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56269301|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
56269302|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56269303|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269304|NCT01988831|Propranolol|propranolol|mesh-list
56269305|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56269306|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56269307|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
56269308|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269309|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269310|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269311|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56269312|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56269313|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
56269314|NCT01988896|Atezolizumab|atezolizumab|mesh-list
55765042|NCT05155293|Aflibercept|aflibercept|mesh-list
55823905|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55823906|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55823907|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
55823908|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823909|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823910|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55823911|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55823912|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
55823913|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823914|NCT05648591|Iloperidone|iloperidone|mesh-list
56269315|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269317|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56269318|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269319|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56269320|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
56269321|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269322|NCT01989000|Gemcitabine|gemcitabine|mesh-list
56269323|NCT01989000|Imidazole|imidazole|mesh-list
56269324|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56269325|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
56269326|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269327|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269328|NCT01989000|Antiviral Agents|antiviral agents|mesh-ancestor
56269329|NCT01989000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876618|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56269331|NCT01989000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823945|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823946|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55823947|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
55823948|NCT01925703|Hematinics|hematinics|mesh-ancestor
55823949|NCT01617681|Valsartan|valsartan|mesh-list
56269332|NCT01989000|Immunologic Factors|immunologic factors|mesh-ancestor
56269333|NCT01989000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269334|NCT01989052|Lomustine|lomustine|mesh-list
56269335|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
56269336|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56269337|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
56269338|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269339|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269340|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56269341|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269342|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56269343|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269344|NCT01989078|Losartan|losartan|mesh-list
56269345|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56269346|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56269347|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56269348|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56269349|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269350|NCT01989091|Heparin|heparin|mesh-list
56269351|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
56269352|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56269353|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56269354|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269355|NCT01989312|Lidocaine|lidocaine|mesh-list
56269356|NCT01989312|Epinephrine|epinephrine|mesh-list
56269357|NCT01989312|Midazolam|midazolam|mesh-list
56269358|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
56269359|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
56269360|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
56269361|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269362|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269369|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269371|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56269372|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56269373|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56269374|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56269375|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56269376|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
56269377|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
56269378|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
56269379|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269380|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56269381|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56269382|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
56269383|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56269384|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56269385|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
56269386|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55891399|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
55756119|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
55714986|NCT04520607|Lorecivivint|lorecivivint|mesh-list
55714987|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55714988|NCT04416451|Rituximab|rituximab|mesh-list
56269387|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
56269388|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
56269389|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
56269390|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56269391|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
56269392|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56269393|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56269394|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269395|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
56269396|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
56269397|NCT01989507|Nicotine|nicotine|mesh-list
56269398|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56269399|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
56269400|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269401|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269402|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56269403|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56269404|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
56269405|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269406|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269407|NCT01989559|Vaccines|vaccines|mesh-list
56269408|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
56269409|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269410|NCT01989611|Tenofovir|tenofovir|mesh-list
56269411|NCT01989611|Emtricitabine|emtricitabine|mesh-list
56269412|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
56269413|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269414|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56269415|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56269416|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269417|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269418|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56269419|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56269420|NCT01989663|Tenofovir|tenofovir|mesh-list
56269421|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
56269422|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269423|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56269424|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56269425|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890775|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269426|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269427|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56269428|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56269429|NCT01989676|Paclitaxel|paclitaxel|mesh-list
56269457|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269458|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
56269459|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56269460|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56269461|NCT01989923|Nicotine|nicotine|mesh-list
56269462|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56269463|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
56269464|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269465|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269466|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56269467|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56269468|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
56269469|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269470|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269471|NCT01989936|Eletriptan|eletriptan|mesh-list
56269472|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56269473|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
56269474|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269475|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269476|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269477|NCT01990079|Bupropion|bupropion|mesh-list
56269478|NCT01990079|Nicotine|nicotine|mesh-list
56269479|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56269480|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
56269481|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269482|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269483|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56269484|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56269485|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
56269486|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269487|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269497|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269498|NCT01990118|Cyclosporine|cyclosporine|mesh-list
56269499|NCT01990118|Cyclosporins|cyclosporins|mesh-list
56269500|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269501|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269502|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56269503|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
56269504|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269505|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
56269506|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269507|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
56269508|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56269509|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56269510|NCT01990144|Rituximab|rituximab|mesh-list
56269511|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56269512|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56269513|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269514|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
56269515|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269516|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56269517|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56269518|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
56269519|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269520|NCT01990378|Rabeprazole|rabeprazole|mesh-list
56269521|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56269522|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56269546|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269547|NCT01990690|Protective Agents|protective agents|mesh-ancestor
56269548|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269549|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
55715028|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
56269550|NCT01990755|Olanzapine|olanzapine|mesh-list
56269551|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
56269552|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
56269553|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269554|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269555|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56269556|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56269557|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56269558|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269559|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56269560|NCT01990755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56269561|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56269562|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269563|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269564|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269565|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
56269566|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
56269567|NCT01990781|Dexamethasone|dexamethasone|mesh-list
56269568|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
56269569|NCT01990781|Lidocaine|lidocaine|mesh-list
56269570|NCT01990781|BB 1101|bb 1101|mesh-list
56269571|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269572|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
56269573|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
56269574|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269575|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269577|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
56269588|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
56269589|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56269590|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56269591|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56269592|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269593|NCT01990807|Idarubicin|idarubicin|mesh-list
56269594|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56269595|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269596|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56269597|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56269598|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269599|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269600|NCT01990872|Vitamin D|vitamin d|mesh-list
56269601|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
56269602|NCT01990872|Vitamins|vitamins|mesh-ancestor
56269603|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
56269604|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269605|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56269606|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56269607|NCT01990937|Midazolam|midazolam|mesh-list
56269608|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56269609|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56269610|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269611|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269612|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56269613|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56269614|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56269615|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56269616|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
56269617|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
56269618|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
56269632|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56269633|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56269634|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56269635|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269636|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269637|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
56269638|NCT01991145|Hematinics|hematinics|mesh-ancestor
56269639|NCT01991158|Gemcitabine|gemcitabine|mesh-list
56269640|NCT01991158|Dexamethasone|dexamethasone|mesh-list
56269641|NCT01991158|Methotrexate|methotrexate|mesh-list
56269642|NCT01991158|Pegaspargase|pegaspargase|mesh-list
56269643|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56269644|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
56269645|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
56269646|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269647|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269648|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56269649|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
56269650|NCT01991158|Hormones|hormones|mesh-ancestor
56269651|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269652|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56269653|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269654|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56269655|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
56269656|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269657|NCT01991158|Antiviral Agents|antiviral agents|mesh-ancestor
56269658|NCT01991158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269659|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269660|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56269661|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
56269662|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56269663|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
56269664|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56269665|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
56269666|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56269671|NCT01991275|Narcotics|narcotics|mesh-ancestor
56269672|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269673|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269674|NCT01991275|Analgesics|analgesics|mesh-ancestor
56269675|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
56269676|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269677|NCT01991288|Epinephrine|epinephrine|mesh-list
56269678|NCT01991288|Racepinephrine|racepinephrine|mesh-list
56269679|NCT01991288|Bupivacaine|bupivacaine|mesh-list
56269680|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
56269681|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
56269682|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
56269683|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
56269684|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269685|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269686|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
56269687|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269688|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56269689|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56269690|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
56269691|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269692|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269693|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56269694|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56269695|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
56269696|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56269698|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
56269720|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56269721|NCT01991574|Calcium|calcium|mesh-list
56269722|NCT01991574|Calcium acetate|calcium acetate|mesh-list
56269723|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56269724|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269725|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
56269726|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
56269727|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269728|NCT01991587|Vaccines|vaccines|mesh-list
56269729|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
56269730|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269731|NCT01991626|Iron|iron|mesh-list
56269732|NCT01991626|Trace Elements|trace elements|mesh-list
56269733|NCT01991626|Micronutrients|micronutrients|mesh-list
56269734|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269735|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
56269736|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269737|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56269738|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56269739|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269740|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269741|NCT01991834|Cefazolin|cefazolin|mesh-list
56269776|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
56269777|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269778|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
56269779|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56269780|NCT01992198|Metronidazole|metronidazole|mesh-list
56269781|NCT01992198|Meropenem|meropenem|mesh-list
56269782|NCT01992198|Cefoperazone|cefoperazone|mesh-list
56269783|NCT01992198|Sulperazone|sulperazone|mesh-list
56269784|NCT01992198|Somatostatin|somatostatin|mesh-list
56269785|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56269786|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269787|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
56269788|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
56269789|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56269790|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56269791|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56269792|NCT01992198|Hormones|hormones|mesh-ancestor
56269793|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269794|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269795|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56269796|NCT01992198|Renal Agents|renal agents|mesh-ancestor
56269797|NCT01992211|Metformin|metformin|mesh-list
56269798|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56269799|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56269800|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269827|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269828|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
56269829|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
56269830|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
56269831|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269832|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56269833|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56269834|NCT01992341|Growth Substances|growth substances|mesh-ancestor
56269835|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269836|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
56269837|NCT01992562|Ziconotide|ziconotide|mesh-list
56269838|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56269839|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56269840|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269841|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56269842|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269843|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56269844|NCT01992562|Protective Agents|protective agents|mesh-ancestor
56269845|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56269846|NCT01992562|Analgesics|analgesics|mesh-ancestor
56269847|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
56269848|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269850|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56269851|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
56269852|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
56269853|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56269854|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56269855|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269856|NCT01992601|Telmisartan|telmisartan|mesh-list
56269857|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56269859|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56269869|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
56269870|NCT01992705|Irinotecan|irinotecan|mesh-list
56269871|NCT01992705|Folfirinox|folfirinox|mesh-list
56269872|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
56269873|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269874|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56269875|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56269876|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56269877|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
55715165|NCT03532763|Tocotrienols|tocotrienols|mesh-list
56269878|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269879|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56269880|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56269881|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269882|NCT01992796|Telmisartan|telmisartan|mesh-list
56269883|NCT01992796|Candesartan|candesartan|mesh-list
56269884|NCT01992796|Olmesartan|olmesartan|mesh-list
56269885|NCT01992796|Irbesartan|irbesartan|mesh-list
56269886|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56269887|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56269888|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56269889|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269890|NCT01992900|Piperaquine|piperaquine|mesh-list
56269891|NCT01992900|Artenimol|artenimol|mesh-list
56269892|NCT01992900|Artemisinins|artemisinins|mesh-list
56269893|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
56269894|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56269895|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56269896|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269897|NCT01993134|Cefazolin|cefazolin|mesh-list
56269898|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56269918|NCT01993225|Androgens|androgens|mesh-ancestor
56269919|NCT01993225|Hormones|hormones|mesh-ancestor
56269920|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56269921|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269922|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56269923|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
56269924|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56269925|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
56269926|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56269927|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56269928|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56269930|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
56269931|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269932|NCT01993251|Protective Agents|protective agents|mesh-ancestor
56269933|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269934|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269935|NCT01993290|Ropivacaine|ropivacaine|mesh-list
56269936|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
56269937|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
56269938|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56269939|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269940|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
56269941|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269969|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56269970|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269971|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56269972|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56269973|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56269974|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56269976|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56269977|NCT01993537|Vitamin D|vitamin d|mesh-list
56269978|NCT01993537|Vitamins|vitamins|mesh-ancestor
56269979|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
56269980|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269981|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56269982|NCT01993589|Acetaminophen|acetaminophen|mesh-list
56269983|NCT01993589|Analgesics|analgesics|mesh-list
56269984|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56269985|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
56269986|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715207|NCT02324842|Incretins|incretins|mesh-ancestor
56269987|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269988|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
56269989|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
56269990|NCT01993680|Bromides|bromides|mesh-list
56269991|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56269992|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
56269993|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56269994|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56269995|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56269996|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
55891985|NCT04756726|Dexamethasone|dexamethasone|mesh-list
56269997|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56269998|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56269999|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270000|NCT01993771|Anesthetics|anesthetics|mesh-list
56270001|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270012|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270013|NCT01993979|Antiviral Agents|antiviral agents|mesh-ancestor
56270014|NCT01993979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270015|NCT01993979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270016|NCT01993979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270017|NCT01993979|Immunologic Factors|immunologic factors|mesh-ancestor
56270018|NCT01993979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270019|NCT01994031|Paclitaxel|paclitaxel|mesh-list
56270020|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56270021|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56270022|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270023|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
56270024|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
56270025|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
56270026|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270027|NCT01994070|Procainamide|procainamide|mesh-list
56270028|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56270029|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56270033|NCT01994096|Caspofungin|caspofungin|mesh-list
56270066|NCT01994642|BB 1101|bb 1101|mesh-list
56270067|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270068|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
56270069|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
56270070|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270071|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270072|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55892061|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270074|NCT01994642|Hormones|hormones|mesh-ancestor
56270075|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56270076|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56270077|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270078|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
56270079|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270080|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270081|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56270082|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270087|NCT01994668|Lorazepam|lorazepam|mesh-list
56270122|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55715220|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
56270123|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56270124|NCT01994759|Protective Agents|protective agents|mesh-ancestor
56270125|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
56270126|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56270127|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
56270128|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270129|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270130|NCT01994941|Clopidogrel|clopidogrel|mesh-list
56270131|NCT01994941|Ticagrelor|ticagrelor|mesh-list
56270132|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56270133|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56270134|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56270135|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56270136|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
56270137|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270138|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270139|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270140|NCT01994967|Bupivacaine|bupivacaine|mesh-list
56270141|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
56270142|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
56270143|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
56270144|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270145|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270146|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
56270147|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270149|NCT01995006|Naproxen|naproxen|mesh-list
56270169|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
56270170|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270171|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
56270172|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
56270173|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270174|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270175|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270176|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
56270177|NCT01995019|Hormones|hormones|mesh-ancestor
56270178|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56270179|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56270180|NCT01995019|Protective Agents|protective agents|mesh-ancestor
56270181|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56270182|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270183|NCT01995032|Metformin|metformin|mesh-list
56270184|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56270185|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270186|NCT01995058|Prednisone|prednisone|mesh-list
56270187|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
56270188|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270189|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
56270190|NCT01995058|Hormones|hormones|mesh-ancestor
55890776|NCT02675829|Trastuzumab|trastuzumab|mesh-list
56270191|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56270192|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270193|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56270194|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270195|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56270196|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270197|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270198|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
56270199|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56270200|NCT01995084|Imidazole|imidazole|mesh-list
56270201|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270209|NCT01995188|Growth Substances|growth substances|mesh-ancestor
56270210|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270211|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
56270212|NCT01995214|Propofol|propofol|mesh-list
56270213|NCT01995214|Sevoflurane|sevoflurane|mesh-list
56270214|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56270215|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270216|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270217|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56270218|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
56270219|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
56270220|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56270221|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56270223|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
56270224|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270225|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270226|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
56270227|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270228|NCT01995331|Cyclosporine|cyclosporine|mesh-list
56270229|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
56270230|NCT01995331|Cyclosporins|cyclosporins|mesh-list
56270231|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270232|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
56270233|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270234|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56270235|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56270236|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
56270237|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270238|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270239|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56270240|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270241|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
56270242|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270243|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
56270251|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56270252|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56270253|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
56270254|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270255|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270256|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56270257|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56270259|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
56270260|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270261|NCT01995370|Aspirin|aspirin|mesh-list
56270262|NCT01995370|Cilostazol|cilostazol|mesh-list
56270263|NCT01995370|Clopidogrel|clopidogrel|mesh-list
56270264|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56270265|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56270266|NCT01995370|Analgesics|analgesics|mesh-ancestor
56270267|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
56270268|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270269|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270270|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270271|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56270272|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56270302|NCT01995799|Hematinics|hematinics|mesh-ancestor
56270303|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56270304|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56270305|NCT01995890|Nepafenac|nepafenac|mesh-list
56270306|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56270307|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56270308|NCT01995890|Analgesics|analgesics|mesh-ancestor
56270309|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
56270310|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270311|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270312|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270313|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56270314|NCT01996085|Amlodipine|amlodipine|mesh-list
56270315|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56270316|NCT01996085|Telmisartan|telmisartan|mesh-list
56270317|NCT01996085|Lisinopril|lisinopril|mesh-list
56270318|NCT01996085|Nebivolol|nebivolol|mesh-list
56270319|NCT01996085|Indapamide|indapamide|mesh-list
56270320|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56270321|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56270322|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56270323|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270324|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56270325|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270326|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
56270327|NCT01996085|Diuretics|diuretics|mesh-ancestor
56270328|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
56270329|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56270330|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56270331|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56270332|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56270333|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
56270334|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270335|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56270336|NCT01996085|Protective Agents|protective agents|mesh-ancestor
56270337|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56270339|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56270340|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
56270341|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270342|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56270343|NCT01996150|Eusol|eusol|mesh-list
56270344|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
56270345|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270346|NCT01996189|Insulin|insulin|mesh-list
56270347|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56270348|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270349|NCT01996306|Leucovorin|leucovorin|mesh-list
56270350|NCT01996306|Bevacizumab|bevacizumab|mesh-list
56270351|NCT01996306|Fluorouracil|fluorouracil|mesh-list
56270352|NCT01996306|Capecitabine|capecitabine|mesh-list
56270353|NCT01996306|Irinotecan|irinotecan|mesh-list
56270354|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56270355|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270356|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56270357|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56270358|NCT01996306|Growth Substances|growth substances|mesh-ancestor
56270359|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270360|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
56270361|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
56270362|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270363|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56270364|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270365|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
56270366|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56270367|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56270368|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270388|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270389|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56270390|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56270391|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56270392|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56270393|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270394|NCT01996423|Vitamin D|vitamin d|mesh-list
56270395|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
56270396|NCT01996423|Vitamins|vitamins|mesh-ancestor
56270397|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
56270398|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270399|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56270400|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56270401|NCT01996462|Dexetimide|dexetimide|mesh-list
56270402|NCT01996462|Citalopram|citalopram|mesh-list
56270403|NCT01996462|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56270404|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56270405|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56270406|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270407|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270408|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
56270409|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270410|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56270411|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
55790052|NCT04878497|Warfarin|warfarin|mesh-list
56270412|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56270413|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56270414|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56270415|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
56270416|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
56270417|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270427|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270428|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
56270429|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270430|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56270431|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
56270432|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56270433|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56270434|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56270435|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
56270436|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
56270437|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270438|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56270439|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56270440|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
56270442|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
56270443|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
56270444|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270445|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270446|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270447|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56270448|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56270449|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270450|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56270451|NCT01996488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56270452|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56270453|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56270473|NCT01996579|Lactoferrin|lactoferrin|mesh-list
56270474|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270476|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56270477|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55756120|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
56270478|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270479|NCT01996683|Deferiprone|deferiprone|mesh-list
56270480|NCT01996683|Deferoxamine|deferoxamine|mesh-list
56270481|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56270482|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
56270483|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
56270484|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270485|NCT01996683|Siderophores|siderophores|mesh-ancestor
56270486|NCT01996696|Metformin|metformin|mesh-list
56270487|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56270488|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270489|NCT01996735|Ticagrelor|ticagrelor|mesh-list
56270490|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56270491|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56270492|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56270493|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56270494|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
56270495|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270496|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270497|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270498|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
56270499|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56270500|NCT01996761|Protective Agents|protective agents|mesh-ancestor
56270501|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270502|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
56270503|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56270504|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
56270505|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56270506|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270507|NCT01997099|Diazepam|diazepam|mesh-list
56270508|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56270510|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
56270512|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270513|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270515|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56270516|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270517|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56270518|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56270519|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55892516|NCT01878669|Antidotes|antidotes|mesh-ancestor
56270520|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56270521|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56270522|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56270523|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
56270525|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
56270526|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
56270527|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270528|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270529|NCT01997112|Acetaminophen|acetaminophen|mesh-list
56270530|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56270531|NCT01997112|Analgesics|analgesics|mesh-ancestor
56270532|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
56270533|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270534|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270535|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
56270536|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56270537|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56270538|NCT01997164|Aflibercept|aflibercept|mesh-list
56270539|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56270540|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56270541|NCT01997164|Growth Substances|growth substances|mesh-ancestor
55715326|NCT02208791|Sirolimus|sirolimus|mesh-list
56270542|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270543|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
56270544|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270545|NCT01997190|Valacyclovir|valacyclovir|mesh-list
56270554|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56270555|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270556|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
56270557|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270558|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
56270559|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270560|NCT01997255|Everolimus|everolimus|mesh-list
56270561|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270562|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270563|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
56270564|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270565|NCT01997294|Atorvastatin|atorvastatin|mesh-list
56270566|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56270567|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56270568|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
56270569|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270570|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56270571|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56270572|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270573|NCT01997580|Citalopram|citalopram|mesh-list
56270574|NCT01997580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56270575|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56270576|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56270577|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270578|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270579|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
56270580|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270581|NCT01997580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56270582|NCT01997580|Antidepressive Agents|antidepressive agents|mesh-ancestor
56270583|NCT01997580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56270584|NCT01997593|Ropivacaine|ropivacaine|mesh-list
56270585|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
56270586|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
56270591|NCT01997632|Vaccines|vaccines|mesh-list
56270593|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270594|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
56270595|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56270596|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56270597|NCT01997658|Prednisolone|prednisolone|mesh-list
56270598|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
56270599|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56270600|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
56270601|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270602|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
56270603|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
56270604|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270605|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790054|NCT04878497|Dabigatran|dabigatran|mesh-list
56270607|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
56270609|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56270610|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56270611|NCT01997658|Protective Agents|protective agents|mesh-ancestor
56270612|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56270613|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270614|NCT01997762|Resveratrol|resveratrol|mesh-list
56270615|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
56270616|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270617|NCT01997762|Protective Agents|protective agents|mesh-ancestor
55715329|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56270618|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270619|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270620|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56270621|NCT01997775|Metformin|metformin|mesh-list
56270639|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
56270640|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
56270641|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270642|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56270643|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56270644|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270645|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270646|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
56270647|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
56270648|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270649|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56270650|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56270651|NCT01997944|Interferons|interferons|mesh-list
56270652|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
56270653|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
56270654|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56270655|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270656|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
56270657|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270658|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
56270659|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270660|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
56270661|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56270662|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56270663|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270664|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
56270665|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270666|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270667|NCT01998113|Insulin|insulin|mesh-list
56270668|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56270669|NCT01998113|Metformin|metformin|mesh-list
56270670|NCT01998113|Glyburide|glyburide|mesh-list
56270671|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56270672|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270674|NCT01998126|Ipilimumab|ipilimumab|mesh-list
56270675|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56270676|NCT01998126|Crizotinib|crizotinib|mesh-list
56270677|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56270678|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270679|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56270680|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270681|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56270682|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270683|NCT01998165|Remifentanil|remifentanil|mesh-list
56270684|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56270685|NCT01998165|Narcotics|narcotics|mesh-ancestor
56270686|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270687|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270688|NCT01998165|Analgesics|analgesics|mesh-ancestor
56270689|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
56270690|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270691|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
56270692|NCT01998217|Remifentanil|remifentanil|mesh-list
56270693|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56270694|NCT01998217|Narcotics|narcotics|mesh-ancestor
56270695|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270696|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270697|NCT01998217|Analgesics|analgesics|mesh-ancestor
55715340|NCT02852057|Timolol|timolol|mesh-list
55839673|NCT01863680|Hormones|hormones|mesh-list
56270699|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270700|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56270701|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56270702|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270703|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56270704|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55845854|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845855|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270723|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270724|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
56270725|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
56270726|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
56270727|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270728|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
56270729|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56270730|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270731|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
56270732|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270733|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56270734|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56270735|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270736|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56270737|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
56270738|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270739|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56270740|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270741|NCT01998503|Dexamethasone|dexamethasone|mesh-list
56270742|NCT01998503|Bortezomib|bortezomib|mesh-list
56270743|NCT01998503|Melphalan|melphalan|mesh-list
56270744|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270745|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
56270746|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
56270747|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892742|NCT00469755|Adapalene|adapalene|mesh-list
56270767|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270768|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270769|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56270770|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
56270771|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
56270772|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56270773|NCT01998685|Narcotics|narcotics|mesh-ancestor
56270774|NCT01998685|Analgesics|analgesics|mesh-ancestor
56270775|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
56270776|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270777|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56270778|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56270779|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56270780|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56270781|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
56270782|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
56270783|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270784|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270785|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56270786|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56270787|NCT01998698|Lidocaine|lidocaine|mesh-list
56270788|NCT01998698|Dipivefrin|dipivefrin|mesh-list
56270789|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
56270790|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56270791|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
56270792|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56270796|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
56270816|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56270817|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
56270818|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56270819|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270820|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55892821|NCT01371201|Sunitinib|sunitinib|mesh-list
56270821|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56270822|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
56270823|NCT01998789|Everolimus|everolimus|mesh-list
56270824|NCT01998789|Tacrolimus|tacrolimus|mesh-list
56270825|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270826|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
56270827|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270828|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56270829|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270830|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270831|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270832|NCT01999153|Ropivacaine|ropivacaine|mesh-list
56270833|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
56270834|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
56270835|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56270836|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270837|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
56270838|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270839|NCT01999270|Bevacizumab|bevacizumab|mesh-list
56270840|NCT01999270|Irinotecan|irinotecan|mesh-list
56270841|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56270842|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270843|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56270844|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56270845|NCT01999270|Growth Substances|growth substances|mesh-ancestor
56270846|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270857|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56270858|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56270859|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270861|NCT01999413|Daunorubicin|daunorubicin|mesh-list
56270862|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56270863|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
56270864|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270865|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270866|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
56270867|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56270868|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56270869|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
56270870|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270871|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56270872|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56270917|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
56270918|NCT01999907|Vitamins|vitamins|mesh-list
56270919|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
56270920|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270921|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56270922|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56270923|NCT01999933|Cisplatin|cisplatin|mesh-list
56270924|NCT01999933|Docetaxel|docetaxel|mesh-list
56270925|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270926|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
56270927|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
56270928|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
56270929|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270930|NCT02000102|Aflibercept|aflibercept|mesh-list
56270931|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56270932|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56270933|NCT02000102|Growth Substances|growth substances|mesh-ancestor
56270934|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270935|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
56270936|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270937|NCT02000193|Fulvestrant|fulvestrant|mesh-list
56270938|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55715373|NCT02220647|Hormones|hormones|mesh-ancestor
56270939|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270940|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56270941|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56270942|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
56270943|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56270944|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270945|NCT02000206|Ketamine|ketamine|mesh-list
56270946|NCT02000206|Alfentanil|alfentanil|mesh-list
56270947|NCT02000206|Propofol|propofol|mesh-list
56270961|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270962|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56270963|NCT02000206|Narcotics|narcotics|mesh-ancestor
56270964|NCT02000336|Prednisolone|prednisolone|mesh-list
56270965|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270966|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
56270968|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56270969|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270970|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56270971|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56270972|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56270973|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56270974|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
56270975|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270977|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56270978|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56270979|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56270981|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
56270982|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56270983|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56270984|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56270985|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56270986|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56270987|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56270988|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56270989|NCT02000401|Ketorolac|ketorolac|mesh-list
56270990|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56270991|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56270992|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56271003|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56271004|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271005|NCT02000674|Rocuronium|rocuronium|mesh-list
56271006|NCT02000674|Succinylcholine|succinylcholine|mesh-list
56271007|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56271008|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56271009|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56271010|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271011|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271012|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56271013|NCT02000700|Canagliflozin|canagliflozin|mesh-list
56271014|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56271015|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271016|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56271017|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271018|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
56271019|NCT02000726|Citalopram|citalopram|mesh-list
56271020|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56271021|NCT02000726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56271022|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56271023|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56271024|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271025|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271026|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
56271027|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271028|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56271029|NCT02000804|Darapladib|darapladib|mesh-list
56271030|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
56271036|NCT02000947|Durvalumab|durvalumab|mesh-list
56271046|NCT02001012|Artemether|artemether|mesh-list
56271047|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56271049|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56271050|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56271051|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271052|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
56271053|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56271054|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56271055|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56271056|NCT02001012|Analgesics|analgesics|mesh-ancestor
56271057|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
56271058|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271059|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271060|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271061|NCT02001012|Filaricides|filaricides|mesh-ancestor
56271062|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
56271063|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
56271064|NCT02001103|Memantine|memantine|mesh-list
56271065|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56271066|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56271067|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
56271068|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271069|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271100|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56271101|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56271102|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56271103|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271105|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56271106|NCT02001272|Carboplatin|carboplatin|mesh-list
56271107|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56271108|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271109|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271110|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
56271111|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
56271112|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271113|NCT02001285|Remifentanil|remifentanil|mesh-list
56271114|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56271115|NCT02001285|Narcotics|narcotics|mesh-ancestor
56271116|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271117|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271118|NCT02001285|Analgesics|analgesics|mesh-ancestor
56271119|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
56271120|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271121|NCT02001298|Nitroprusside|nitroprusside|mesh-list
56271122|NCT02001298|Remifentanil|remifentanil|mesh-list
55893119|NCT02006836|Metformin|metformin|mesh-list
56271123|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56271124|NCT02001298|Narcotics|narcotics|mesh-ancestor
55715383|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
55715384|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715385|NCT05426395|Hematinics|hematinics|mesh-ancestor
55715386|NCT03544567|Paclitaxel|paclitaxel|mesh-list
55715387|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56271125|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271126|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271127|NCT02001298|Analgesics|analgesics|mesh-ancestor
56271128|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
56271129|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271130|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56271131|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
56271141|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56271142|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271143|NCT02001363|Incretins|incretins|mesh-ancestor
56271145|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271146|NCT02001428|Piperaquine|piperaquine|mesh-list
56271147|NCT02001428|Artenimol|artenimol|mesh-list
56271148|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
56271149|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56271150|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56271151|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271152|NCT02001506|Docetaxel|docetaxel|mesh-list
56271153|NCT02001506|Epirubicin|epirubicin|mesh-list
56271154|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271155|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271156|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
56271157|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
56271158|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271159|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56271160|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56271161|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56271162|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271163|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
56271164|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271165|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56271166|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271167|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271168|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
56271169|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271170|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271171|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56271172|NCT02001584|Memantine|memantine|mesh-list
56271173|NCT02001584|Baclofen|baclofen|mesh-list
56271183|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56271184|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271185|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56271187|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
56271188|NCT02001740|Lidocaine|lidocaine|mesh-list
56271189|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
56271190|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
56271191|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271192|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271193|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
56271194|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271195|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56271196|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56271197|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56271198|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56271199|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271200|NCT02001818|Interferons|interferons|mesh-list
56271201|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
56271202|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
55715401|NCT02220803|Acetazolamide|acetazolamide|mesh-list
56271203|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56271204|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
56271205|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271206|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
56271207|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271232|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
56271233|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271234|NCT02001896|Antiviral Agents|antiviral agents|mesh-ancestor
56271235|NCT02001896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271236|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271237|NCT02001896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271238|NCT02001896|Immunologic Factors|immunologic factors|mesh-ancestor
56271239|NCT02001896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271240|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56271241|NCT02001909|Neomycin|neomycin|mesh-list
56271242|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56271243|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271244|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56271245|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271246|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271247|NCT02001935|Theophylline|theophylline|mesh-list
56271248|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56271249|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
56271289|NCT02002065|Vaccines|vaccines|mesh-list
56271290|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
56271291|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271292|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56271293|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
56271294|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56271295|NCT02002078|Prednisolone|prednisolone|mesh-list
56271296|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
56271297|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56271298|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
56271299|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271300|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
56271301|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
56271302|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271303|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271304|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56271305|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
56271306|NCT02002078|Hormones|hormones|mesh-ancestor
56271307|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271308|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56271309|NCT02002078|Protective Agents|protective agents|mesh-ancestor
56271310|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56271311|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271312|NCT02002156|Vaccines|vaccines|mesh-list
56271313|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56271314|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
56271315|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
56271316|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271317|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56271318|NCT02002195|Leucovorin|leucovorin|mesh-list
56271319|NCT02002195|Fluorouracil|fluorouracil|mesh-list
56271320|NCT02002195|Capecitabine|capecitabine|mesh-list
56271335|NCT02002247|Selenious Acid|selenious acid|mesh-list
56271336|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
56271337|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
56271338|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271339|NCT02002247|Protective Agents|protective agents|mesh-ancestor
56271340|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271341|NCT02002247|Trace Elements|trace elements|mesh-ancestor
56271342|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
56271343|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
56271344|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56271345|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
56271346|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
56271347|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56271348|NCT02002260|Estradiol|estradiol|mesh-list
56271349|NCT02002260|Estrogens|estrogens|mesh-ancestor
56271350|NCT02002260|Hormones|hormones|mesh-ancestor
56271351|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271352|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271353|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56271354|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56271355|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56271356|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56271357|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56271358|NCT02002286|Triptolide|triptolide|mesh-list
56271359|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56271360|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271361|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56271362|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
56271363|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56271364|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271365|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
56271366|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56271367|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
56271376|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56271377|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56271378|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271379|NCT02002377|Aflibercept|aflibercept|mesh-list
56271380|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56271381|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56271382|NCT02002377|Growth Substances|growth substances|mesh-ancestor
56271383|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271384|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
56271385|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271386|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56271387|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56271388|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271389|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271390|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
56271391|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271392|NCT02002403|Danazol|danazol|mesh-list
56271393|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56271394|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
56271395|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271396|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271397|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
56271398|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
56271399|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56271422|NCT02002611|Warfarin|warfarin|mesh-list
56271423|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
56271424|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
56271425|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56271426|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56271427|NCT02002663|Prednisolone|prednisolone|mesh-list
56271428|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
56271429|NCT02002663|Morphine|morphine|mesh-list
56271430|NCT02002663|Ropivacaine|ropivacaine|mesh-list
56271431|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56271432|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
56271433|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56271434|NCT02002663|Narcotics|narcotics|mesh-ancestor
56271435|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271436|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271437|NCT02002663|Analgesics|analgesics|mesh-ancestor
56271438|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
56271439|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271440|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
56271441|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
56271442|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271443|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
56271444|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
56271445|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56271446|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
56271447|NCT02002663|Hormones|hormones|mesh-ancestor
56271448|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271449|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56271450|NCT02002663|Protective Agents|protective agents|mesh-ancestor
56271451|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56271452|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271453|NCT02002715|Budesonide|budesonide|mesh-list
56271454|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271455|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56271456|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
56271457|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271462|NCT02002715|Hormones|hormones|mesh-ancestor
56271463|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271465|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56271466|NCT02002741|Analgesics|analgesics|mesh-ancestor
56271467|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
56271468|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271469|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271470|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
56271471|NCT02002754|Bambuterol|bambuterol|mesh-list
56271472|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56271473|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
56271474|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271475|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271476|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56271477|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
56271478|NCT02002806|Ethanol|ethanol|mesh-list
56271479|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56271480|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271481|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271482|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271483|NCT02002858|Nicotine|nicotine|mesh-list
56271484|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56271485|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
56271486|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893503|NCT03282006|Renal Agents|renal agents|mesh-ancestor
56271510|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271518|NCT02003209|Carboplatin|carboplatin|mesh-list
56271586|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271587|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271588|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271589|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
56271590|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271591|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
56271592|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271593|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
56271594|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56271595|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56271597|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56271598|NCT02004171|Nicotine|nicotine|mesh-list
56271599|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56271600|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
56271601|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271602|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271603|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56271604|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56271605|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
56271606|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56271607|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271608|NCT02004184|Pemetrexed|pemetrexed|mesh-list
56271609|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271610|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271611|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271612|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56271613|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56271614|NCT02004197|Amoxicillin|amoxicillin|mesh-list
56271615|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56271616|NCT02004197|Bismuth|bismuth|mesh-list
55715433|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
56271629|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271631|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56271632|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56271633|NCT02004301|Analgesics|analgesics|mesh-ancestor
56271634|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
56271635|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271636|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271637|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271638|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56271639|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56271640|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271641|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271642|NCT02004314|Chloroquine|chloroquine|mesh-list
56271643|NCT02004314|Amebicides|amebicides|mesh-ancestor
56271644|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56271645|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56271646|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271647|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
56271648|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56271649|NCT02004418|Choline|choline|mesh-list
56271650|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
56271684|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271685|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
56271686|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
56271687|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
56271688|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271689|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56271690|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
56271691|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56271692|NCT02004782|Prednisolone|prednisolone|mesh-list
56271693|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271694|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
56271695|NCT02004782|Hormones|hormones|mesh-ancestor
56271696|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56271697|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271698|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56271699|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271700|NCT02004860|Ciclopirox|ciclopirox|mesh-list
56271701|NCT02004860|Tacrolimus|tacrolimus|mesh-list
56271702|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271703|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
56271704|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271705|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56271736|NCT02005120|Bevacizumab|bevacizumab|mesh-list
56271737|NCT02005120|Endostatins|endostatins|mesh-list
56271738|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56271739|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271740|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56271741|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56271742|NCT02005120|Growth Substances|growth substances|mesh-ancestor
56271743|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271744|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
56271745|NCT02005289|Lenalidomide|lenalidomide|mesh-list
56271746|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
56271747|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271748|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56271749|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56271750|NCT02005289|Growth Substances|growth substances|mesh-ancestor
56271751|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
56271752|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271753|NCT02005302|Vitamin D|vitamin d|mesh-list
56271754|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
56271755|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
56271756|NCT02005302|Vitamins|vitamins|mesh-list
56271757|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
56271758|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271759|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56271761|NCT02005315|Gemcitabine|gemcitabine|mesh-list
56271786|NCT02005419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271787|NCT02005419|Immunologic Factors|immunologic factors|mesh-ancestor
56271788|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271789|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56271790|NCT02005523|RNS60|rns60|mesh-list
56271791|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56271792|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56271793|NCT02005523|Analgesics|analgesics|mesh-ancestor
56271794|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
56271795|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271796|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271797|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271798|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56271799|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56271850|NCT02005718|Vitamins|vitamins|mesh-ancestor
56271851|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
56271852|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56271853|NCT02005757|Mizoribine|mizoribine|mesh-list
56271854|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56271855|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56271856|NCT02005757|Analgesics|analgesics|mesh-ancestor
56271857|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
56271858|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271859|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271860|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56271861|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56271862|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56271863|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271864|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56271865|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271866|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
56271867|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56271868|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56271869|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271870|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271871|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56271872|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
56271873|NCT02005770|Propofol|propofol|mesh-list
56271874|NCT02005770|Sevoflurane|sevoflurane|mesh-list
56271875|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56271876|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271877|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271878|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56271897|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
55715480|NCT03172975|Albendazole|albendazole|mesh-list
55715481|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55715482|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
55715483|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55715484|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715485|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
55715486|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56271898|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56271899|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56271900|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56271901|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271903|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
56271904|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56271905|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
56271906|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56271907|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
56271908|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271909|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271910|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56271911|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56271912|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56271913|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271914|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56271915|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56271916|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271917|NCT02006173|Lidocaine|lidocaine|mesh-list
56271918|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
56271919|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
56271920|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271921|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271922|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
56271923|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271924|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56271925|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56271926|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56271940|NCT02006355|Ropivacaine|ropivacaine|mesh-list
56271941|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
56271942|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
56271943|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271944|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271945|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
56271946|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271947|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56271948|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56271949|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56271950|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
56271951|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271952|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56271953|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
56271954|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271955|NCT02006498|Silymarin|silymarin|mesh-list
56271956|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
56271957|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271958|NCT02006498|Protective Agents|protective agents|mesh-ancestor
56271959|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271960|NCT02006589|Candesartan|candesartan|mesh-list
56271961|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
56271962|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56271963|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56271964|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56271965|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271966|NCT02006602|Candesartan|candesartan|mesh-list
56271967|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
56271968|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56271969|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55756291|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55824489|NCT01644500|Dulaglutide|dulaglutide|mesh-list
56271970|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56271980|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271981|NCT02006914|Chromium|chromium|mesh-list
56271982|NCT02006914|Picolinic acid|picolinic acid|mesh-list
56271983|NCT02006914|Trace Elements|trace elements|mesh-ancestor
56271984|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
56271985|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271986|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56271987|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
56271988|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
56271989|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56271990|NCT02006966|Lidocaine|lidocaine|mesh-list
56271991|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
56271992|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
56271993|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56271994|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56271995|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
56271996|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56271997|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56271998|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56271999|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56272000|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272001|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272002|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
56272003|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272004|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56272005|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56272006|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
56272007|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272008|NCT02007148|Docetaxel|docetaxel|mesh-list
56272009|NCT02007148|Capecitabine|capecitabine|mesh-list
56272010|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272011|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
56272012|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
55824496|NCT04877834|Lansoprazole|lansoprazole|mesh-list
56272013|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
56272016|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
56272020|NCT02007161|Analgesics|analgesics|mesh-ancestor
56272021|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
56272022|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272023|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272024|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56272025|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56272026|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56272027|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272028|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272029|NCT02007174|Bevacizumab|bevacizumab|mesh-list
56272030|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272031|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272032|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56272033|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56272034|NCT02007174|Growth Substances|growth substances|mesh-ancestor
56272035|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272036|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
56272037|NCT02007330|Lidocaine|lidocaine|mesh-list
56272038|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
56272039|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
56272040|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272041|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272042|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
56272043|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272044|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56272045|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56272046|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56272047|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272048|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272049|NCT02007408|Lidocaine|lidocaine|mesh-list
56272050|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
56272051|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
56272059|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272060|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272061|NCT02007447|Oxytocin|oxytocin|mesh-list
56272062|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
56272063|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56272064|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272065|NCT02007603|Amoxicillin|amoxicillin|mesh-list
56272066|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
56272067|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
56272068|NCT02007603|Ampicillin|ampicillin|mesh-list
56272069|NCT02007603|Sulbactam|sulbactam|mesh-list
56272070|NCT02007603|Sultamicillin|sultamicillin|mesh-list
56272071|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56272072|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272073|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272074|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272075|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56272076|NCT02007629|Riociguat|riociguat|mesh-list
56272077|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
56272078|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272079|NCT02007746|Liver Extracts|liver extracts|mesh-list
56272080|NCT02007746|Hematinics|hematinics|mesh-ancestor
56272113|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
56272114|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272115|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272116|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
56272117|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272118|NCT02007915|Pamidronate|pamidronate|mesh-list
56272119|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56272120|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272121|NCT02007928|Olanzapine|olanzapine|mesh-list
56272122|NCT02007928|Risperidone|risperidone|mesh-list
56272123|NCT02007928|Aripiprazole|aripiprazole|mesh-list
56272124|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56272125|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
56272126|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272127|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272128|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272129|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56272130|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56272131|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272132|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56272133|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56272134|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
56272135|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
56272136|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
56272137|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272138|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56272139|NCT02007928|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56272140|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56272141|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272142|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
56272143|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
56272144|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56272145|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56272146|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56272152|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56272153|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272154|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56272155|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56272156|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272157|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272158|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56272160|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
56272161|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272162|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56272163|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
56272164|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272165|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56272166|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
56272167|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56272169|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715574|NCT04467931|Triamterene|triamterene|mesh-list
56272170|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56272171|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
56272172|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272173|NCT02008123|Primidone|primidone|mesh-list
56272174|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
56272175|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
56272176|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
56272177|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272178|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272179|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272180|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
56272181|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56272182|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272183|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272184|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
56272185|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272186|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272190|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
56272191|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
56272192|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272193|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272194|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56272195|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
56272196|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
56272197|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56272198|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
56272199|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272200|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272201|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
56272202|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
56272203|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56272204|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56272205|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56272206|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56272207|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
56272208|NCT02008201|Vitamin D|vitamin d|mesh-list
56272209|NCT02008201|Vitamins|vitamins|mesh-ancestor
56272210|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
56272243|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272244|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
56272245|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272246|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272247|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
56272248|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55894245|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56272249|NCT02008578|Antibodies|antibodies|mesh-list
56272250|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
56272251|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272252|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
56272253|NCT02008721|Protective Agents|protective agents|mesh-ancestor
56272254|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272255|NCT02008734|Palbociclib|palbociclib|mesh-list
56272256|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272257|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56272258|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272259|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272260|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
56272261|NCT02008747|Analgesics|analgesics|mesh-ancestor
56272262|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
56272263|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272264|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272265|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
56272292|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56272293|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56272294|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
56272295|NCT02008968|Protective Agents|protective agents|mesh-ancestor
56272296|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272297|NCT02008981|Aspirin|aspirin|mesh-list
56272298|NCT02008981|Turmeric extract|turmeric extract|mesh-list
56272299|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56272300|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56272301|NCT02008981|Analgesics|analgesics|mesh-ancestor
56272302|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
56272303|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272304|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272305|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56272306|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56272307|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56272308|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56272309|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272310|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56272311|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56272312|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272313|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
56272314|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
56272315|NCT02008981|Protective Agents|protective agents|mesh-ancestor
56272316|NCT02009007|Phenylephrine|phenylephrine|mesh-list
56272317|NCT02009007|Dopamine|dopamine|mesh-list
56272318|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
56272319|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56272338|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56272339|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272340|NCT02009189|Taurolidine|taurolidine|mesh-list
56272341|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272342|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56272343|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272344|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
56272345|NCT02009202|Cathartics|cathartics|mesh-ancestor
56272346|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56272347|NCT02009215|Piperaquine|piperaquine|mesh-list
56272349|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
56272350|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56272351|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56272352|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272353|NCT05778838|Midodrine|midodrine|mesh-list
56272354|NCT05778838|Sympathomimetics|sympathomimetics|mesh-ancestor
56272355|NCT05778838|Autonomic Agents|autonomic agents|mesh-ancestor
56272356|NCT05778838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272357|NCT05778838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272358|NCT05778838|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56272359|NCT05778838|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56272360|NCT05778838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56272361|NCT05778838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56272362|NCT05778838|Adrenergic Agents|adrenergic agents|mesh-ancestor
56272390|NCT05778305|Dexmedetomidine|dexmedetomidine|mesh-list
56272391|NCT05778305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56272392|NCT05778305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272393|NCT05778305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272394|NCT05778305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56272395|NCT05778305|Analgesics|analgesics|mesh-ancestor
56272396|NCT05778305|Sensory System Agents|sensory system agents|mesh-ancestor
56272397|NCT05778305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272398|NCT05778305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56272399|NCT05778305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56272400|NCT05778305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56272401|NCT05778305|Adrenergic Agents|adrenergic agents|mesh-ancestor
56272402|NCT05778305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272403|NCT05778305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272404|NCT05778227|Etidronic Acid|etidronic acid|mesh-list
56272405|NCT05778227|Acetic Acid|acetic acid|mesh-list
56272406|NCT05778227|Sodium Hypochlorite|sodium hypochlorite|mesh-list
56272408|NCT05778227|Retinol acetate|retinol acetate|mesh-list
56272409|NCT05778227|Ethylene|ethylene|mesh-list
56272410|NCT05778227|Maleic acid|maleic acid|mesh-list
56272411|NCT05778227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56272412|NCT05778227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272413|NCT05778227|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56272414|NCT05778227|Immunologic Factors|immunologic factors|mesh-ancestor
56272415|NCT05778227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272416|NCT05778227|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56272417|NCT05778227|Protective Agents|protective agents|mesh-ancestor
56272418|NCT05778227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272419|NCT05778227|Disinfectants|disinfectants|mesh-ancestor
56272420|NCT05778227|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56272421|NCT05778227|Growth Substances|growth substances|mesh-ancestor
56272422|NCT05778227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272423|NCT05778227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272424|NCT05778227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56272430|NCT05778084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56272431|NCT05778084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272432|NCT05778084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56272433|NCT05778084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272434|NCT05777902|Ozanimod|ozanimod|mesh-list
56272435|NCT05777902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56272436|NCT05777902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272437|NCT05777902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56272438|NCT05777902|Immunologic Factors|immunologic factors|mesh-ancestor
56272439|NCT05777902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272440|NCT05777824|Antibodies|antibodies|mesh-list
56272441|NCT05777824|Immunologic Factors|immunologic factors|mesh-ancestor
56272442|NCT05777824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272443|NCT05777733|Acetylcysteine|acetylcysteine|mesh-list
56272444|NCT05777733|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56272445|NCT05777733|Antidotes|antidotes|mesh-ancestor
56272446|NCT05777733|Protective Agents|protective agents|mesh-ancestor
56272447|NCT05777733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272448|NCT05777733|Antioxidants|antioxidants|mesh-ancestor
56272449|NCT05777733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272450|NCT05777733|Antiviral Agents|antiviral agents|mesh-ancestor
56272451|NCT05777733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272452|NCT05777733|Expectorants|expectorants|mesh-ancestor
56272453|NCT05777733|Respiratory System Agents|respiratory system agents|mesh-ancestor
56272454|NCT05777733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56272455|NCT05777707|Paclitaxel|paclitaxel|mesh-list
56272456|NCT05777707|Carboplatin|carboplatin|mesh-list
56272457|NCT05777707|Nedaplatin|nedaplatin|mesh-list
56272458|NCT05777707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56272459|NCT05777707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272460|NCT05777707|Tubulin Modulators|tubulin modulators|mesh-ancestor
56272461|NCT05777707|Antimitotic Agents|antimitotic agents|mesh-ancestor
56272462|NCT05777707|Mitosis Modulators|mitosis modulators|mesh-ancestor
56272472|NCT05777369|Vindesine|vindesine|mesh-list
56272473|NCT05777369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56272474|NCT05777369|Immunologic Factors|immunologic factors|mesh-ancestor
56272475|NCT05777369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272476|NCT05777369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894493|NCT04346277|Antibodies|antibodies|mesh-list
56272477|NCT05777369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56272478|NCT05777369|Alkylating Agents|alkylating agents|mesh-ancestor
56272479|NCT05777369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272480|NCT05777369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272481|NCT05777369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56272482|NCT05777369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272483|NCT05777369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56272484|NCT05777369|Glucocorticoids|glucocorticoids|mesh-ancestor
56272486|NCT05777369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56272487|NCT05777369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56272488|NCT05777369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56272489|NCT05777369|Tubulin Modulators|tubulin modulators|mesh-ancestor
56272490|NCT05777369|Antimitotic Agents|antimitotic agents|mesh-ancestor
56272491|NCT05777369|Mitosis Modulators|mitosis modulators|mesh-ancestor
56272525|NCT05753306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272527|NCT05750745|Cariostatic Agents|cariostatic agents|mesh-ancestor
56272528|NCT05750745|Protective Agents|protective agents|mesh-ancestor
56272529|NCT05750745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272530|NCT05741086|Atorvastatin|atorvastatin|mesh-list
56272531|NCT05741086|Evolocumab|evolocumab|mesh-list
56272532|NCT05741086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56272533|NCT05741086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56272534|NCT05741086|Antimetabolites|antimetabolites|mesh-ancestor
55840214|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272535|NCT05741086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272536|NCT05741086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56272537|NCT05741086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56272538|NCT05741086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272539|NCT05721937|Abrocitinib|abrocitinib|mesh-list
56272540|NCT05721937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56272541|NCT05721937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272542|NCT05721937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272543|NCT05718843|BI 425809|bi 425809|mesh-list
56272544|NCT05718843|Nootropic Agents|nootropic agents|mesh-ancestor
56272545|NCT05717140|Nivolumab|nivolumab|mesh-list
56272546|NCT05717140|Sargramostim|sargramostim|mesh-list
56272547|NCT05717140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272548|NCT05717140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272549|NCT05717140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56272574|NCT05706259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56272575|NCT05701917|Heparin|heparin|mesh-list
56272576|NCT05701917|Calcium heparin|calcium heparin|mesh-list
56272577|NCT05701917|Rivaroxaban|rivaroxaban|mesh-list
56272578|NCT05701917|Apixaban|apixaban|mesh-list
56272579|NCT05701917|Warfarin|warfarin|mesh-list
56272580|NCT05701917|Anticoagulants|anticoagulants|mesh-ancestor
56272581|NCT05701917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56272582|NCT05701917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56272583|NCT05701917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272584|NCT05701917|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56272585|NCT05701917|Antithrombins|antithrombins|mesh-ancestor
56272586|NCT05701917|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56272587|NCT05701917|Protease Inhibitors|protease inhibitors|mesh-ancestor
56272588|NCT05701917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272589|NCT05680129|Metformin|metformin|mesh-list
56272590|NCT05680129|Dulaglutide|dulaglutide|mesh-list
56272591|NCT05680129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56272592|NCT05680129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272593|NCT05657990|Tamsulosin|tamsulosin|mesh-list
56272594|NCT05657990|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55715613|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
56272595|NCT05657990|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56272596|NCT05657990|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56272597|NCT05657990|Adrenergic Agents|adrenergic agents|mesh-ancestor
56272598|NCT05657990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272599|NCT05657990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272600|NCT05657990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272601|NCT05657990|Urological Agents|urological agents|mesh-ancestor
56272621|NCT05624151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56272622|NCT05624151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56272623|NCT05624151|Adrenergic Agents|adrenergic agents|mesh-ancestor
56272624|NCT05624151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272625|NCT05624151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272626|NCT05624151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56272628|NCT05624151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56272629|NCT05624151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272630|NCT05624151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56272631|NCT05624151|Tocolytic Agents|tocolytic agents|mesh-ancestor
56272632|NCT05624151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56272633|NCT05616390|Bevacizumab|bevacizumab|mesh-list
56272634|NCT05616390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272635|NCT05616390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272636|NCT05616390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56272637|NCT05616390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56272638|NCT05616390|Growth Substances|growth substances|mesh-ancestor
56272639|NCT05616390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272640|NCT05616390|Growth Inhibitors|growth inhibitors|mesh-ancestor
56272641|NCT05613413|Pembrolizumab|pembrolizumab|mesh-list
56272642|NCT05613413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272643|NCT05613413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272644|NCT05597150|Magnesium citrate|magnesium citrate|mesh-list
56272645|NCT05597150|Cathartics|cathartics|mesh-ancestor
56272664|NCT05590468|Niacin|niacin|mesh-list
56272671|NCT05590468|Antimetabolites|antimetabolites|mesh-ancestor
56272672|NCT05590468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272673|NCT05590468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55790084|NCT02614859|Bicalutamide|bicalutamide|mesh-list
56272675|NCT05587894|Ritonavir|ritonavir|mesh-list
56272676|NCT05587894|Remdesivir|remdesivir|mesh-list
56272677|NCT05587894|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56272678|NCT05587894|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56272679|NCT05587894|Protease Inhibitors|protease inhibitors|mesh-ancestor
56272680|NCT05587894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272681|NCT05587894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272682|NCT05587894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56272683|NCT05587894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56272684|NCT05587894|Antiviral Agents|antiviral agents|mesh-ancestor
56272685|NCT05587894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272686|NCT05587894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56272687|NCT05587894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56272688|NCT05587894|Antimetabolites|antimetabolites|mesh-ancestor
56272689|NCT05582798|Protease Inhibitors|protease inhibitors|mesh-list
56272690|NCT05582798|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56272691|NCT05582798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272692|NCT05582798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272693|NCT05582798|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56272694|NCT05582798|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55894699|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56272723|NCT05548270|Scopolamine|scopolamine|mesh-list
56272724|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55715661|NCT03522649|Vitamins|vitamins|mesh-ancestor
56272725|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
56272726|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
56272727|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272728|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272729|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56272730|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
56272731|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56272732|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
56272733|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272734|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272735|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56272736|NCT05543629|Paclitaxel|paclitaxel|mesh-list
56272737|NCT05543629|Docetaxel|docetaxel|mesh-list
56272738|NCT05543629|Carboplatin|carboplatin|mesh-list
56272739|NCT05543629|Nivolumab|nivolumab|mesh-list
56272740|NCT05543629|Taxane|taxane|mesh-list
56272741|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56272742|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272743|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
56272744|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
56272745|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
56272746|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272747|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272748|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56272749|NCT05534620|Fludarabine|fludarabine|mesh-list
56272750|NCT05534620|Treosulfan|treosulfan|mesh-list
56272751|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272752|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272753|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56272754|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
56272763|NCT05499052|Hormones|hormones|mesh-ancestor
56272764|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56272765|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272766|NCT05493735|Lidocaine|lidocaine|mesh-list
56272767|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
56272768|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
56272769|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272770|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272771|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
56272772|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272773|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56272774|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56272775|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56272776|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272777|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272778|NCT05459571|Dexamethasone|dexamethasone|mesh-list
56272779|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
56272780|NCT05459571|Fludarabine|fludarabine|mesh-list
56272781|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56272782|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
55840350|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
56272797|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56272798|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56272800|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56272801|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272802|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272803|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272804|NCT05447286|Oxycodone|oxycodone|mesh-list
56272805|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56272806|NCT05447286|Narcotics|narcotics|mesh-ancestor
56272807|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272808|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272809|NCT05447286|Analgesics|analgesics|mesh-ancestor
56272810|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
56272811|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272812|NCT05439616|Cariprazine|cariprazine|mesh-list
56272813|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56272814|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56272815|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272816|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272817|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56272818|NCT05410158|Ketamine|ketamine|mesh-list
56272819|NCT05410158|Analgesics|analgesics|mesh-ancestor
56272820|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
56272821|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272822|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930086|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930087|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55930088|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55876621|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
56272831|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272833|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56272834|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56272835|NCT05291403|Erythromycin|erythromycin|mesh-list
56272836|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
56272837|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56272838|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
56272839|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56272840|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272841|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56272842|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56272843|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272844|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272866|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272867|NCT05279690|Colchicine|colchicine|mesh-list
56272868|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
56272869|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56272870|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
56272871|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
56272872|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
56272873|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272874|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272875|NCT05261139|Ritonavir|ritonavir|mesh-list
56272876|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56272877|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56272878|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
56272879|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272880|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272881|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56272882|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56272883|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
56272884|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56272885|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56272886|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56272887|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
56272888|NCT05255302|Pemetrexed|pemetrexed|mesh-list
56272889|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272890|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272891|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715685|NCT02373735|Mannitol|mannitol|mesh-list
55715687|NCT02373735|Diuretics|diuretics|mesh-ancestor
56272892|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272893|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56272894|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56272895|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
56272896|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272897|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272908|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56272909|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56272910|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
56272911|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272912|NCT05185947|Paclitaxel|paclitaxel|mesh-list
56272913|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56272914|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56272915|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
56272916|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
56272917|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
56272918|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272919|NCT05182840|Empagliflozin|empagliflozin|mesh-list
56272920|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56272921|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272922|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56272923|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272924|NCT05153915|Tacrolimus|tacrolimus|mesh-list
56272925|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56272926|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
55894927|NCT00354562|Docetaxel|docetaxel|mesh-list
56272927|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272928|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56272929|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56272930|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272931|NCT05139238|Labetalol|labetalol|mesh-list
56272932|NCT05139238|Nifedipine|nifedipine|mesh-list
56272933|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56272934|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272935|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272936|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56272937|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272947|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
56272948|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272949|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56272950|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56272951|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56272952|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
56272953|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272954|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56272955|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
56272956|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56272957|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56272958|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56272959|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56272960|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56272961|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
56272962|NCT05121168|Bupivacaine|bupivacaine|mesh-list
55715698|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272963|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
56272964|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
56272965|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56272966|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272967|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
56272968|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56272969|NCT05103332|Amlodipine|amlodipine|mesh-list
56272970|NCT05103332|Olmesartan|olmesartan|mesh-list
56272995|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56272996|NCT05087992|Growth Substances|growth substances|mesh-ancestor
56272997|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56272998|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
55895003|NCT04773717|Vitamins|vitamins|mesh-ancestor
56272999|NCT05085873|Midazolam|midazolam|mesh-list
56273000|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
56273001|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56273002|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56273003|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56273004|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273005|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56273006|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56273007|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56273008|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56273009|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
56273010|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
56273011|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
56273012|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
56273013|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273014|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273015|NCT05083169|Dexamethasone|dexamethasone|mesh-list
56273016|NCT05083169|Bortezomib|bortezomib|mesh-list
56273049|NCT04975334|Hormones|hormones|mesh-ancestor
56273050|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56273051|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273052|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56273053|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
56273054|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273055|NCT04961580|Ceftazidime|ceftazidime|mesh-list
56273056|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56273057|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273058|NCT04929041|Paclitaxel|paclitaxel|mesh-list
56273059|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56273060|NCT04929041|Carboplatin|carboplatin|mesh-list
56273061|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
56273062|NCT04929041|Nivolumab|nivolumab|mesh-list
56273063|NCT04929041|Pemetrexed|pemetrexed|mesh-list
56273064|NCT04929041|Ipilimumab|ipilimumab|mesh-list
56273065|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56273066|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273067|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
56273068|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
56273069|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
56273070|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273071|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273072|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56273073|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273074|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55790087|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
56273075|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56273077|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
56273078|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273079|NCT04861922|Heparin|heparin|mesh-list
56273080|NCT04861922|Calcium heparin|calcium heparin|mesh-list
56273081|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
56273082|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56273083|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56273085|NCT04840472|Panitumumab|panitumumab|mesh-list
56273090|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273091|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56273092|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273093|NCT04790370|Heparin|heparin|mesh-list
56273094|NCT04790370|Calcium heparin|calcium heparin|mesh-list
56273095|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
56273096|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56273097|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56273098|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273099|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
56273100|NCT04789408|Fludarabine|fludarabine|mesh-list
56273101|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273102|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
56273103|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273104|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273105|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56273106|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
56273107|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273108|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273109|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56273110|NCT04782830|Midodrine|midodrine|mesh-list
56273111|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56273112|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56273113|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56273114|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56273115|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273116|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
56273117|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273118|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273119|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
56273120|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
56273121|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273122|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56273123|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56273124|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56273127|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56273128|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56273129|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56273130|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273131|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56273132|NCT04771000|Ambrisentan|ambrisentan|mesh-list
56273133|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56273134|NCT04760288|Pralsetinib|pralsetinib|mesh-list
56273135|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273136|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56273137|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
56273138|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56273139|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273141|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56273142|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273143|NCT04704934|Paclitaxel|paclitaxel|mesh-list
56273144|NCT04704934|Trastuzumab|trastuzumab|mesh-list
56273145|NCT04704934|Ramucirumab|ramucirumab|mesh-list
56273146|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56273147|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273148|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
56273149|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
56273150|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
56273151|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273152|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273153|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
56273154|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273155|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273156|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
56273157|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273158|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273159|NCT04686786|PF-06372865|pf-06372865|mesh-list
56273210|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56273211|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
56273212|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273213|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273214|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56273215|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273216|NCT04567420|Fulvestrant|fulvestrant|mesh-list
56273217|NCT04567420|Palbociclib|palbociclib|mesh-list
56273218|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56273219|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273220|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56273221|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56273222|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
56273223|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56273224|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273329|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273330|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56273331|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56273332|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273333|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273334|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273335|NCT04449549|Paclitaxel|paclitaxel|mesh-list
56273336|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56273337|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273338|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
56273339|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
56273340|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56273341|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273342|NCT04371107|Azithromycin|azithromycin|mesh-list
56273343|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56273344|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273345|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
56273346|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56273347|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56273348|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273349|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
56273350|NCT04298567|Aspirin|aspirin|mesh-list
56273351|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
56273352|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56273353|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
56273377|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
56273378|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273379|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273380|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56273381|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
56273382|NCT04278833|Hormones|hormones|mesh-ancestor
56273383|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56273384|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56273385|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273386|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56273387|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
56273388|NCT04240002|Cytarabine|cytarabine|mesh-list
56273389|NCT04240002|Fludarabine|fludarabine|mesh-list
56273390|NCT04240002|Lenograstim|lenograstim|mesh-list
56273391|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273392|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56273393|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
56273394|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273395|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273396|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
56273397|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273398|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
56273399|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273400|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56273401|NCT04229004|Gemcitabine|gemcitabine|mesh-list
56273402|NCT04229004|Paclitaxel|paclitaxel|mesh-list
56273403|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56273404|NCT04229004|Spartalizumab|spartalizumab|mesh-list
56273405|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56273406|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273422|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273423|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56273424|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56273425|NCT04226690|Analgesics|analgesics|mesh-ancestor
56273426|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
56273427|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273428|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56273429|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56273430|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273431|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273432|NCT04226690|Hormones|hormones|mesh-ancestor
56273433|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56273434|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
56273435|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
56273436|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56273437|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273438|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
56273439|NCT04221087|Dexamethasone|dexamethasone|mesh-list
56273440|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273441|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
56273442|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
56273443|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273444|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273445|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56273446|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
56273447|NCT04221087|Hormones|hormones|mesh-ancestor
56273448|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56273449|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56273450|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895449|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
56273452|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56273453|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273464|NCT04170348|Trientine|trientine|mesh-list
56273465|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
56273466|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273467|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56273468|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56273469|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
56273470|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
56273471|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273472|NCT04166409|Carboplatin|carboplatin|mesh-list
56273473|NCT04166409|Vincristine|vincristine|mesh-list
56273474|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273475|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56273476|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
56273477|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
56273478|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
56273479|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273480|NCT04125472|Lumasiran|lumasiran|mesh-list
56273481|NCT04125472|Renal Agents|renal agents|mesh-ancestor
56273482|NCT04112641|Niacinamide|niacinamide|mesh-list
56273483|NCT04112641|Niacin|niacin|mesh-list
56273484|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
56273485|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
56273486|NCT04112641|Vitamins|vitamins|mesh-ancestor
56273487|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
56273488|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273489|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56273490|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
56273491|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273492|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56273493|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
56273510|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273511|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56273513|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
56273514|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273515|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56273516|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56273517|NCT04059770|Amebicides|amebicides|mesh-ancestor
56273518|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56273519|NCT04057898|Ibudilast|ibudilast|mesh-list
56273520|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56273521|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
56273522|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273523|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273524|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55756292|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56273525|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
56273526|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56273527|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273528|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273529|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56273530|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
56273531|NCT04050280|Cytarabine|cytarabine|mesh-list
56273532|NCT04050280|Cladribine|cladribine|mesh-list
56273533|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
56273534|NCT04050280|Lenograstim|lenograstim|mesh-list
56273535|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56273536|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
56273537|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273538|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273539|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
56273540|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273541|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273542|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
56273543|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273544|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56273547|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273549|NCT03994731|Folic Acid|folic acid|mesh-list
56273550|NCT03994731|Fexofenadine|fexofenadine|mesh-list
56273551|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
56273552|NCT03994731|Methotrexate|methotrexate|mesh-list
56273553|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56273554|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
56273555|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56273556|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273557|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56273558|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
56273559|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273560|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273561|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
56273562|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273563|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56273564|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273565|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
56273566|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273567|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56273568|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56273569|NCT03994731|Analgesics|analgesics|mesh-ancestor
56273570|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
56273571|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273572|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
56273573|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56273574|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
56273575|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
56273576|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56273598|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56273599|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
56273600|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273601|NCT03984357|Antiviral Agents|antiviral agents|mesh-ancestor
56273602|NCT03984357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273603|NCT03984357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273604|NCT03984357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273606|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273607|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273608|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
56273609|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273610|NCT03853707|Paclitaxel|paclitaxel|mesh-list
56273611|NCT03853707|Carboplatin|carboplatin|mesh-list
56273612|NCT03853707|Capecitabine|capecitabine|mesh-list
56273613|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56273614|NCT03853707|Atezolizumab|atezolizumab|mesh-list
56273615|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56273616|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56273617|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273618|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
56273619|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
56273620|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
56273621|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273622|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56273623|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
56273624|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
56273647|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273648|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
56273649|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273651|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56273652|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56273653|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273654|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273655|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273659|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
56273660|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56273661|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
56273662|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273663|NCT03652753|Expectorants|expectorants|mesh-ancestor
56273671|NCT03617458|Metformin|metformin|mesh-list
56273694|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273695|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273696|NCT03461120|Anesthetics|anesthetics|mesh-list
56273697|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
56273698|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56273699|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273700|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
56273701|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273702|NCT03459846|Durvalumab|durvalumab|mesh-list
56273703|NCT03459846|Olaparib|olaparib|mesh-list
56273704|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273705|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273706|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56273707|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273708|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273709|NCT03452137|Atezolizumab|atezolizumab|mesh-list
56273710|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273721|NCT03429543|Empagliflozin|empagliflozin|mesh-list
56273722|NCT03429543|Linagliptin|linagliptin|mesh-list
56273723|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56273724|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273725|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56273731|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
56273732|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273733|NCT03396588|Clonidine|clonidine|mesh-list
56273734|NCT03396588|Morphine|morphine|mesh-list
56273735|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56273736|NCT03396588|Narcotics|narcotics|mesh-ancestor
56273737|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56273738|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273739|NCT03396588|Analgesics|analgesics|mesh-ancestor
56273740|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
56273741|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273742|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56273743|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
56273744|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
56273745|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56273746|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56273747|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56273748|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
56273749|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840351|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
56273750|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273751|NCT03361852|Rituximab|rituximab|mesh-list
56273752|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
56273753|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273754|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273755|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
56273756|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273757|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273758|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
56273759|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
56273760|NCT03350516|Calcium|calcium|mesh-list
56273761|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56273762|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273764|NCT03350516|Antacids|antacids|mesh-ancestor
56273776|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56273777|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
56273778|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
56273779|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273780|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56273781|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273782|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56273783|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
56273784|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56273785|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56273786|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273787|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56273788|NCT03325972|Analgesics|analgesics|mesh-ancestor
56273789|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
56273790|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273791|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56273792|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56273793|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55824820|NCT04419662|Phenylephrine|phenylephrine|mesh-list
56273794|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
56273795|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273796|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273797|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
56273798|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273799|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273800|NCT03289039|Fulvestrant|fulvestrant|mesh-list
56273801|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56273802|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273803|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56273828|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56273829|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273830|NCT03145272|Analgesics|analgesics|mesh-ancestor
56273831|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
56273832|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273833|NCT03127007|Atezolizumab|atezolizumab|mesh-list
56273834|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273835|NCT03109093|Blinatumomab|blinatumomab|mesh-list
56273836|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273840|NCT03047993|Azacitidine|azacitidine|mesh-list
56273841|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56273842|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
56273843|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273844|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273845|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56273867|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
56273868|NCT02858310|Fludarabine|fludarabine|mesh-list
56273869|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273870|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
56273871|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273872|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56273873|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56273874|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
56273875|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273876|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273877|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56273878|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56273879|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56273880|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
56273881|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273888|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
56273889|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273890|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273891|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
56273892|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
56273893|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56273897|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56273898|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
56273899|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273900|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273901|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56273902|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273903|NCT02726711|Trimethaphan|trimethaphan|mesh-list
56273904|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
56273905|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56273906|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56273907|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56273908|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
56273909|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273910|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273911|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56273912|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56273913|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
56273914|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56273915|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273916|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
56273917|NCT02725060|Phenylephrine|phenylephrine|mesh-list
56273918|NCT02725060|Isoproterenol|isoproterenol|mesh-list
56273919|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
56273920|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56273921|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
56273922|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
56273923|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56273925|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
56273943|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56273944|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56273945|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
56273946|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56273947|NCT02649998|Furosemide|furosemide|mesh-list
56273948|NCT02649998|Isosorbide|isosorbide|mesh-list
56273949|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56273950|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56273951|NCT02649998|Diuretics|diuretics|mesh-ancestor
56273952|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
56273953|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56273954|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56273955|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56273956|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273957|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56273958|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
56273959|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56273960|NCT02595944|Nivolumab|nivolumab|mesh-list
56273961|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56273962|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273963|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56273964|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56273965|NCT02562235|Riociguat|riociguat|mesh-list
55715897|NCT02361645|Analgesics|analgesics|mesh-ancestor
55715898|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
56273966|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
56273993|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56273994|NCT02336087|Metformin|metformin|mesh-list
56273995|NCT02336087|Gemcitabine|gemcitabine|mesh-list
56273996|NCT02336087|Paclitaxel|paclitaxel|mesh-list
56273997|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56273998|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56273999|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274000|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
56274001|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
56274002|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
56274003|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274004|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56274005|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
56274006|NCT02336087|Antiviral Agents|antiviral agents|mesh-ancestor
56274007|NCT02336087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274008|NCT02336087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274009|NCT02336087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274010|NCT02336087|Immunologic Factors|immunologic factors|mesh-ancestor
56274011|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274012|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56274013|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
56274014|NCT02332980|Idelalisib|idelalisib|mesh-list
56274015|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56274016|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274017|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274018|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274019|NCT02197234|Osimertinib|osimertinib|mesh-list
56274020|NCT02197234|Simvastatin|simvastatin|mesh-list
56274021|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56274022|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56274023|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
56274025|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56274039|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
56274113|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56274114|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274115|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56274116|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56274117|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274118|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274119|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56274120|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
56274121|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
55715914|NCT02373033|Folic Acid|folic acid|mesh-list
56274122|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274123|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274124|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
56274125|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274126|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56274127|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
56274128|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56274129|NCT01332097|Prednisone|prednisone|mesh-list
56274130|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56274131|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
56274132|NCT01332097|Hormones|hormones|mesh-ancestor
56274133|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274134|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274135|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56274136|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274138|NCT01163357|Fludarabine|fludarabine|mesh-list
56274139|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
56274140|NCT01163357|Bortezomib|bortezomib|mesh-list
56274141|NCT01163357|Melphalan|melphalan|mesh-list
56274142|NCT01163357|Tacrolimus|tacrolimus|mesh-list
56274143|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274144|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56274157|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
56274158|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56274159|NCT00978458|Temozolomide|temozolomide|mesh-list
56274160|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56274161|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
56274162|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274163|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274164|NCT00976963|Fosfomycin|fosfomycin|mesh-list
56274165|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56274166|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274167|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
56274168|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56274169|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
56274170|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274171|NCT00967005|Expectorants|expectorants|mesh-ancestor
56274172|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
56274173|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56274174|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
56274175|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274176|NCT00967005|Protective Agents|protective agents|mesh-ancestor
56274177|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274178|NCT00967005|Antidotes|antidotes|mesh-ancestor
56274179|NCT00863369|Gemcitabine|gemcitabine|mesh-list
56274180|NCT00863369|Rituximab|rituximab|mesh-list
56274181|NCT00863369|Bortezomib|bortezomib|mesh-list
56274183|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274209|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
56274210|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
56274211|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
56274212|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274213|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55715945|NCT05172167|Antibodies|antibodies|mesh-list
56274214|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274215|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56274216|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274217|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56274218|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
56274219|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274220|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
56274221|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274222|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56274223|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
56274224|NCT00538031|Celecoxib|celecoxib|mesh-list
56274225|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
56274226|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274227|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
56274228|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274229|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56274230|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56274231|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
56274232|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274233|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274234|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56274235|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56274236|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56274237|NCT00538031|Analgesics|analgesics|mesh-ancestor
56274238|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
56274253|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56274254|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274255|NCT00203996|Hormones|hormones|mesh-ancestor
56274256|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274257|NCT00099437|Fulvestrant|fulvestrant|mesh-list
56274258|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56274259|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274260|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56274261|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56274262|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
56274263|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274264|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274265|NCT00092222|Interferons|interferons|mesh-list
56274266|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
56274267|NCT00092222|Zidovudine|zidovudine|mesh-list
56274268|NCT00092222|Valganciclovir|valganciclovir|mesh-list
56274269|NCT00092222|Sirolimus|sirolimus|mesh-list
56274270|NCT00092222|Prednisone|prednisone|mesh-list
56274271|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
56274272|NCT00092222|Rituximab|rituximab|mesh-list
56274273|NCT00092222|Doxorubicin|doxorubicin|mesh-list
56274274|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56274275|NCT00092222|Etoposide|etoposide|mesh-list
56274276|NCT00092222|Vincristine|vincristine|mesh-list
55715970|NCT03500731|Rituximab|rituximab|mesh-list
56274307|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56274308|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56274309|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56274319|NCT00001337|Rituximab|rituximab|mesh-list
56274320|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56274321|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274322|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
56274323|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274324|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56274325|NCT02009280|Anesthetics|anesthetics|mesh-list
56274326|NCT02009280|Propofol|propofol|mesh-list
56274327|NCT02009280|Sevoflurane|sevoflurane|mesh-list
56274328|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274329|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274330|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56274331|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56274332|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
56274333|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56274357|NCT02009410|Pancreatin|pancreatin|mesh-list
56274358|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274359|NCT02009436|Azacitidine|azacitidine|mesh-list
56274360|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56274361|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
56274362|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274363|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274364|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274365|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56274366|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
56274367|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56274368|NCT02009462|Protective Agents|protective agents|mesh-ancestor
56274369|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274370|NCT02009488|Canagliflozin|canagliflozin|mesh-list
56274371|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56274372|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274373|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56274374|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274375|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
56274376|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
56274377|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56274378|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
56274379|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56274380|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56274381|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56274382|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56274404|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56274405|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
56274406|NCT02009709|Vitamins|vitamins|mesh-ancestor
56274407|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
56274408|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274409|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56274410|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
56274411|NCT02009748|Vitamin D|vitamin d|mesh-list
55715987|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56274412|NCT02009748|Vitamins|vitamins|mesh-ancestor
56274413|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
56274414|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274415|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56274416|NCT02009787|Vitamin D|vitamin d|mesh-list
56274417|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
56274418|NCT02009787|Vitamins|vitamins|mesh-ancestor
56274419|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
56274420|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274421|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56274422|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56274423|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56274425|NCT02010164|Ubiquinone|ubiquinone|mesh-list
56274426|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
56274427|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
56274428|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274429|NCT02010164|Vitamins|vitamins|mesh-ancestor
56274430|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56274431|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56274432|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56274433|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
56274434|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274435|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274436|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
56274437|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56274438|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56274439|NCT02010723|Polidocanol|polidocanol|mesh-list
56274440|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56274442|NCT02010762|Vitamin D|vitamin d|mesh-list
56274446|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56274447|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
56274448|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56274449|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56274450|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56274451|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56274452|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274453|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
56274454|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274455|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274456|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56274457|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274458|NCT02010827|Glucagon|glucagon|mesh-list
56274459|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274460|NCT02010827|Hormones|hormones|mesh-ancestor
56274461|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274462|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274463|NCT02010905|Losartan|losartan|mesh-list
56274464|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56274465|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56274466|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56274470|NCT02010944|Mirabegron|mirabegron|mesh-list
56274497|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274498|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56274499|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56274500|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56274501|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56274502|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
56274503|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
56274504|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
56274505|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
56274506|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274507|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274508|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
56274509|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274510|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56274511|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56274512|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274513|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56274514|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
56274515|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274516|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56274517|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56274518|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56274519|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
56274521|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
56274522|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274523|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274524|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56274541|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56274542|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274543|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274544|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
56274545|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56274546|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274548|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
56274549|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
56274550|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56274551|NCT02011620|Diuretics|diuretics|mesh-ancestor
56274552|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
56274553|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274554|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
56274555|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56274556|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274557|NCT02011633|Metformin|metformin|mesh-list
56274558|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56274559|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56274560|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274561|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56274562|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56274563|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
56274564|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274565|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56274566|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56274567|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274568|NCT02011659|Ramosetron|ramosetron|mesh-list
56274569|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
56274570|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
56274571|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274572|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274583|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274584|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274585|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56274586|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56274587|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56274588|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56274589|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56274590|NCT02011750|Valproic Acid|valproic acid|mesh-list
56274591|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
56274592|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274593|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274595|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274596|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274597|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
56274598|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56274599|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274600|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56274601|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
56274602|NCT02011828|Vitamin D|vitamin d|mesh-list
56274603|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56274604|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274605|NCT02011828|Vitamins|vitamins|mesh-ancestor
56274606|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
56274607|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56274608|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
56274609|NCT02011841|Rifaximin|rifaximin|mesh-list
56274610|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56274611|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274612|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56274613|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56274614|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274615|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274616|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274622|NCT02011880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274623|NCT02011880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274624|NCT02011880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56274625|NCT02011880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56274626|NCT02011880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274627|NCT02011906|Vitamins|vitamins|mesh-list
56274628|NCT02011906|Vitamin E|vitamin e|mesh-list
56274629|NCT02011906|Tocopherols|tocopherols|mesh-list
56274630|NCT02011906|Tocotrienols|tocotrienols|mesh-list
56274631|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
56274632|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
56274633|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274634|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
56274635|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274636|NCT02011906|Protective Agents|protective agents|mesh-ancestor
56274637|NCT02011958|Amphotericin B|amphotericin b|mesh-list
56274638|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56274639|NCT02011958|Miltefosine|miltefosine|mesh-list
56274640|NCT02011958|Amebicides|amebicides|mesh-ancestor
56274641|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56274642|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56274643|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274644|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56274645|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
56274646|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274647|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56274648|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56274649|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
56274650|NCT02012049|Risperidone|risperidone|mesh-list
56274651|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56274652|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
56274653|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890777|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55716089|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716090|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
55716091|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
55716092|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55716094|NCT02212535|Plerixafor|plerixafor|mesh-list
55716095|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55716096|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55716097|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
55716098|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716099|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
55716101|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
56274654|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274655|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274656|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56274664|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56274665|NCT02012075|Metoprolol|metoprolol|mesh-list
56274666|NCT02012075|Carvedilol|carvedilol|mesh-list
56274667|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56274668|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55896660|NCT02450994|Hormones|hormones|mesh-ancestor
56274670|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
56274671|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274672|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274673|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56274674|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56274675|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56274676|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
56274677|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274678|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274679|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
56274680|NCT02012075|Protective Agents|protective agents|mesh-ancestor
56274681|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56274682|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56274683|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56274684|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
56274685|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56274686|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56274687|NCT02012088|Prednisone|prednisone|mesh-list
56274688|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
56274689|NCT02012088|Rituximab|rituximab|mesh-list
56274711|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56274712|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
56274713|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
56274714|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56274715|NCT02012140|Ticagrelor|ticagrelor|mesh-list
56274716|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56274717|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56274718|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56274719|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56274720|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
56274721|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716129|NCT05055713|Hormones|hormones|mesh-ancestor
55716131|NCT02360709|Sirolimus|sirolimus|mesh-list
56274722|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274723|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274724|NCT02012166|Insulin|insulin|mesh-list
56274725|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56274726|NCT02012166|Octreotide|octreotide|mesh-list
56274727|NCT02012166|Glucagon|glucagon|mesh-list
56274728|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56274729|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274730|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56274731|NCT02012166|Hormones|hormones|mesh-ancestor
56274732|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56274733|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56274734|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274735|NCT02012244|Fentanyl|fentanyl|mesh-list
56274736|NCT02012244|Anesthetics|anesthetics|mesh-list
56274737|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
56274738|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56274739|NCT02012244|Narcotics|narcotics|mesh-ancestor
56274740|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274759|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274760|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274761|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56274762|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56274763|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
56274764|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
56274765|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274766|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56274767|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56274768|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274769|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274770|NCT02012387|Omalizumab|omalizumab|mesh-list
56274771|NCT02012387|Vaccines|vaccines|mesh-list
56274772|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56274773|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
56274774|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274775|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56274776|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56274777|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
56274778|NCT02012465|Insulin|insulin|mesh-list
56274779|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
56274780|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56274781|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274782|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56274783|NCT02012517|Cefazolin|cefazolin|mesh-list
56274784|NCT02012517|Cephalexin|cephalexin|mesh-list
56274785|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56274786|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56274787|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
56274788|NCT02012556|Tesamorelin|tesamorelin|mesh-list
56274789|NCT02012556|Growth Substances|growth substances|mesh-ancestor
56274802|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274803|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
55890778|NCT02675829|Maytansine|maytansine|mesh-list
56274804|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274805|NCT02012777|Propranolol|propranolol|mesh-list
56274806|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56274807|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56274808|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
56274809|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274810|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274811|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274812|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56274813|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56274814|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
56274815|NCT02012920|Seviteronel|seviteronel|mesh-list
56274816|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274817|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56274818|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274819|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274820|NCT02012933|Amifampridine|amifampridine|mesh-list
56274821|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56274822|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56274823|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274824|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56274825|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56274826|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274827|NCT02012946|Simendan|simendan|mesh-list
56274828|NCT02012946|Dobutamine|dobutamine|mesh-list
56274829|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56274830|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
56274831|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56274832|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56274833|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274835|NCT02012946|Protective Agents|protective agents|mesh-ancestor
56274841|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56274842|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56274843|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
56274844|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274845|NCT02012998|Vaccines|vaccines|mesh-list
56274846|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
56274847|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274848|NCT02013089|Everolimus|everolimus|mesh-list
56274849|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56274850|NCT02013089|Sorafenib|sorafenib|mesh-list
56274851|NCT02013089|Sunitinib|sunitinib|mesh-list
56274852|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
56274853|NCT02013089|Gefitinib|gefitinib|mesh-list
56274854|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274855|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274856|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
56274857|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274858|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56274859|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274861|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56274897|NCT02013232|Aripiprazole|aripiprazole|mesh-list
56274898|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
56274899|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56274900|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56274901|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56274902|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56274903|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274904|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
56274905|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
56274906|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56274907|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274908|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56274909|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56274910|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
56274911|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56274912|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56274913|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56274914|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56274915|NCT02013258|Oxytocin|oxytocin|mesh-list
56274916|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
56274917|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56274918|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274919|NCT02013271|Paclitaxel|paclitaxel|mesh-list
56274920|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56274921|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274922|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
56274923|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
56274924|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
56274925|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274926|NCT02013362|Folic Acid|folic acid|mesh-list
56274927|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
56274928|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
56274929|NCT02013362|Vitamins|vitamins|mesh-ancestor
56274932|NCT02013362|Hematinics|hematinics|mesh-ancestor
56274940|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56274941|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
56274942|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
56274943|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
56274944|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56274945|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
56274946|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790140|NCT05256719|Abatacept|abatacept|mesh-list
56274947|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56274948|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
56274949|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56274950|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56274951|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56274952|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56274953|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56274998|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
56274999|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56275000|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56275001|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56275002|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56275003|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
56275004|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
56275005|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275006|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275007|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56275008|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56275009|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56275010|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275011|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275012|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
56275013|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275014|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275015|NCT02014103|Tacrolimus|tacrolimus|mesh-list
56275016|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275017|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
56275018|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275019|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56275020|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275021|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275022|NCT02014337|Mifepristone|mifepristone|mesh-list
56275023|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56275024|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
56275025|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56275026|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275027|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56275028|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56275029|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56275030|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
56275036|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56275037|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56275038|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
56275039|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56275040|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
56275041|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275043|NCT02014428|Protective Agents|protective agents|mesh-ancestor
56275044|NCT02014454|Propranolol|propranolol|mesh-list
56275045|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56275046|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56275047|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56275048|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56275049|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56275050|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275051|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275052|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275053|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56275054|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56275055|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
56275056|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
56275057|NCT02014506|Fludarabine|fludarabine|mesh-list
56275058|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56275059|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275060|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
56275061|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275062|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56275063|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56275064|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
56275065|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275066|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275067|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56275068|NCT02014532|Montelukast|montelukast|mesh-list
56275069|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
56275070|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56275071|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
56275074|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275075|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56275076|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56275077|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275079|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
56275080|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56275081|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
56275082|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56275083|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275084|NCT02014558|Voriconazole|voriconazole|mesh-list
56275085|NCT02014558|Cephalexin|cephalexin|mesh-list
56275086|NCT02014558|Midazolam|midazolam|mesh-list
56275087|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56275088|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56275089|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275090|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275091|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56275092|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56275093|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56275094|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56275095|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
56275096|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
56275097|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
56275098|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
56275099|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275123|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275124|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275126|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
56275127|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275128|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56275129|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56275130|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
56275131|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
56275132|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56275133|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56275134|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
56275135|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275136|NCT02014727|Antacids|antacids|mesh-ancestor
56275137|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275138|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56275140|NCT02014753|Chromium|chromium|mesh-list
56275141|NCT02014753|Everolimus|everolimus|mesh-list
56275142|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275143|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275144|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
56275145|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275146|NCT02014753|Trace Elements|trace elements|mesh-ancestor
56275147|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
56275148|NCT02014831|Cetuximab|cetuximab|mesh-list
56275149|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56275150|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275151|NCT02014922|Vitamin E|vitamin e|mesh-list
56275152|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
56275153|NCT02014922|Tocopherols|tocopherols|mesh-list
56275154|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56275155|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56275156|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
56275157|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56275158|NCT02014922|Laxatives|laxatives|mesh-ancestor
56275159|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756375|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56275163|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275164|NCT02014922|Vitamins|vitamins|mesh-ancestor
56275165|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
56275166|NCT02015156|Trastuzumab|trastuzumab|mesh-list
56275167|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56275168|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275169|NCT02015169|Lapatinib|lapatinib|mesh-list
56275170|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275171|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56275172|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275173|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275174|NCT02015182|Bupivacaine|bupivacaine|mesh-list
56275175|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
56275176|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
56275177|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275178|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275179|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
56275180|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275181|NCT02015260|Citric Acid|citric acid|mesh-list
56275182|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
56275183|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56275184|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
56275185|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
56275186|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275187|NCT02015299|Linagliptin|linagliptin|mesh-list
56275188|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56275189|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56275190|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275191|NCT02015299|Incretins|incretins|mesh-ancestor
56275192|NCT02015299|Hormones|hormones|mesh-ancestor
56275193|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56275194|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
56275195|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275196|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275197|NCT02015312|Silicon|silicon|mesh-list
56275198|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56275202|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
56275203|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275204|NCT02015312|Trace Elements|trace elements|mesh-ancestor
56275205|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
56275206|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
56275207|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275208|NCT02015312|Protective Agents|protective agents|mesh-ancestor
56275209|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56275210|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56275211|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275212|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56275213|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
56275214|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56275215|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
56275216|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275217|NCT02015403|Expectorants|expectorants|mesh-ancestor
56275218|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
56275219|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56275220|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
56275221|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275222|NCT02015403|Protective Agents|protective agents|mesh-ancestor
56275224|NCT02015403|Antidotes|antidotes|mesh-ancestor
56275256|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275257|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275258|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
56275259|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275260|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56275261|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56275262|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
56275263|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56275264|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275265|NCT02015728|Etoposide|etoposide|mesh-list
56275266|NCT02015728|Everolimus|everolimus|mesh-list
56275267|NCT02015728|Temozolomide|temozolomide|mesh-list
56275268|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56275269|NCT02015728|Sorafenib|sorafenib|mesh-list
56275270|NCT02015728|Dasatinib|dasatinib|mesh-list
56275271|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56275272|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275273|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56275274|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56275275|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275276|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275277|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275278|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
56275279|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275305|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275306|NCT02016001|Fluorides|fluorides|mesh-list
56275307|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
56275308|NCT02016001|Protective Agents|protective agents|mesh-ancestor
56275309|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275310|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
56275311|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56275312|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275313|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55840352|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
56275314|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56275316|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275317|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275318|NCT02016196|Rifaximin|rifaximin|mesh-list
56275319|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56275320|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275321|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56275322|NCT02016209|Paclitaxel|paclitaxel|mesh-list
56275323|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56275324|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56275325|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275326|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
56275327|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
56275328|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
56275329|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275330|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
56275331|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55716332|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275332|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56275333|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275334|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275350|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55716333|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
56275351|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275352|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
56275353|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
56275354|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
56275355|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275356|NCT02016287|Paclitaxel|paclitaxel|mesh-list
56275357|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56275358|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275359|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
56275360|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
56275361|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
56275362|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275363|NCT02016365|Doxycycline|doxycycline|mesh-list
56275364|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56275365|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56275366|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275367|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
56275368|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56275369|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56275370|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56275371|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56275372|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
56275377|NCT02016391|Analgesics|analgesics|mesh-ancestor
56275401|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
56275402|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
56275404|NCT02016443|Analgesics|analgesics|mesh-ancestor
56275405|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
56275406|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275407|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275408|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
56275409|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56275410|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56275411|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
56275412|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
56275413|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56275414|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56275415|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56275416|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
56275417|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275418|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275419|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
56275420|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
56275421|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275422|NCT02016495|Protective Agents|protective agents|mesh-ancestor
56275423|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275424|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
56275425|NCT02016495|Vitamins|vitamins|mesh-ancestor
56275426|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
56275427|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56275448|NCT02016703|Erythritol|erythritol|mesh-list
55716369|NCT03521245|Trastuzumab|trastuzumab|mesh-list
56275449|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
56275450|NCT02016729|Trametinib|trametinib|mesh-list
56275451|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275452|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56275453|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275454|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275455|NCT02016807|Sucralfate|sucralfate|mesh-list
56275456|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56275457|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56275458|NCT02016820|Omeprazole|omeprazole|mesh-list
56275459|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56275460|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56275461|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56275462|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275463|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275464|NCT02016846|Liraglutide|liraglutide|mesh-list
56275465|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56275466|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275467|NCT02016846|Incretins|incretins|mesh-ancestor
56275468|NCT02016846|Hormones|hormones|mesh-ancestor
56275469|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56275470|NCT02016976|Midazolam|midazolam|mesh-list
56275471|NCT02016976|Meperidine|meperidine|mesh-list
56275472|NCT02016976|Analgesics|analgesics|mesh-list
56275473|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
56275474|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275475|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275498|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275499|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275500|NCT02017314|Analgesics|analgesics|mesh-ancestor
56275501|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
56275502|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275503|NCT02017340|Nilvadipine|nilvadipine|mesh-list
56275504|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56275505|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56275506|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275507|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275508|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56275509|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275510|NCT02017392|Lidocaine|lidocaine|mesh-list
56275511|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
56275512|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
56275513|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275514|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275515|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
56275516|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275517|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56275518|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56275519|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56275520|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275521|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275522|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
56275523|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56275524|NCT02017405|Antibodies|antibodies|mesh-list
56275525|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
56275526|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275527|NCT02017457|Azacitidine|azacitidine|mesh-list
56275528|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56275529|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
56275530|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275531|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275535|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275537|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275538|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
56275539|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275540|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56275541|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275542|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
56275543|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275544|NCT02017613|Tenalisib|tenalisib|mesh-list
56275545|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
56275546|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275547|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275548|NCT02017639|Simvastatin|simvastatin|mesh-list
56275549|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56275550|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56275551|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
56275553|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56275591|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275592|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275593|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56275594|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56275596|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
56275597|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
56275598|NCT02018094|Metronidazole|metronidazole|mesh-list
56275599|NCT02018094|Clindamycin|clindamycin|mesh-list
56275600|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56275601|NCT02018094|Teicoplanin|teicoplanin|mesh-list
56275602|NCT02018094|Povidone|povidone|mesh-list
56275603|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56275604|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275605|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
56275606|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56275651|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275652|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56275653|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56275654|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
56275655|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275656|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56275657|NCT02018328|Curcumin|curcumin|mesh-list
56275658|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56275659|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56275660|NCT02018328|Analgesics|analgesics|mesh-ancestor
56275661|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
56275662|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275663|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275664|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56275665|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56275666|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275667|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275668|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275669|NCT02018367|Proflavine|proflavine|mesh-list
56275670|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56275671|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275672|NCT02018419|Vaccines|vaccines|mesh-list
56275673|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
56275674|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275675|NCT02018523|Lenalidomide|lenalidomide|mesh-list
56275683|NCT02018536|Simeprevir|simeprevir|mesh-list
56275700|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
56275701|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56275702|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56275703|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56275704|NCT02018731|Metformin|metformin|mesh-list
56275705|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56275706|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275707|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
56275708|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
56275709|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56275710|NCT02018757|Estrogens|estrogens|mesh-ancestor
56275711|NCT02018757|Hormones|hormones|mesh-ancestor
56275712|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56275713|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275714|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56275715|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275716|NCT02018783|Listerine|listerine|mesh-list
56275717|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
56275718|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
56275719|NCT02018783|Protective Agents|protective agents|mesh-ancestor
56275720|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275721|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56275722|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275723|NCT02018796|Misoprostol|misoprostol|mesh-list
56275724|NCT02018796|Mifepristone|mifepristone|mesh-list
56275726|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
56275749|NCT02018874|Antiviral Agents|antiviral agents|mesh-ancestor
55716434|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
56275827|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
56275828|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275829|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275830|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275831|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56275832|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56275833|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275834|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56275835|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56275836|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
56275837|NCT02019355|Fluorouracil|fluorouracil|mesh-list
56275838|NCT02019355|Calcipotriene|calcipotriene|mesh-list
56275839|NCT02019355|Petrolatum|petrolatum|mesh-list
56275840|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
56275841|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275842|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56275843|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275844|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56275845|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
56275846|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275847|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
56275848|NCT02019355|Emollients|emollients|mesh-ancestor
56275849|NCT02019381|Vitamin D|vitamin d|mesh-list
56275850|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
56275851|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
56275852|NCT02019381|Vitamins|vitamins|mesh-list
56275853|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
56275854|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275857|NCT02019446|Terbinafine|terbinafine|mesh-list
56275875|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275876|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275877|NCT02019485|Analgesics|analgesics|mesh-ancestor
56275878|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
56275879|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275880|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56275881|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56275882|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275883|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275884|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
56275885|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275886|NCT02019524|Folic Acid|folic acid|mesh-list
56275887|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
56275888|NCT02019524|Molgramostim|molgramostim|mesh-list
56275889|NCT02019524|Vaccines|vaccines|mesh-list
56275890|NCT02019524|Sargramostim|sargramostim|mesh-list
56275891|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
56275892|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275893|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56275894|NCT02019524|Hematinics|hematinics|mesh-ancestor
56275895|NCT02019524|Vitamins|vitamins|mesh-ancestor
56275896|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
56275897|NCT02019784|Rifaximin|rifaximin|mesh-list
56275898|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56275899|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275900|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56275901|NCT02019797|Desflurane|desflurane|mesh-list
56275902|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56275903|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
56275904|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
56275905|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56275906|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275907|NCT02019810|Dobutamine|dobutamine|mesh-list
56275908|NCT02019810|Norepinephrine|norepinephrine|mesh-list
56275909|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56275910|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56275911|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
56275912|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56275915|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
56275916|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
56275917|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275918|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56275919|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56275920|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56275921|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56275922|NCT02019810|Protective Agents|protective agents|mesh-ancestor
56275923|NCT02019836|Vitamin D|vitamin d|mesh-list
56275924|NCT02019836|Vitamins|vitamins|mesh-ancestor
56275925|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
56275926|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275927|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56275928|NCT02019875|Clarithromycin|clarithromycin|mesh-list
56275929|NCT02019875|Rifampin|rifampin|mesh-list
56275930|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56275931|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56275932|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56275933|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56275934|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275935|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56275936|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56275937|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56275938|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
56275939|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
56275940|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56275941|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56275942|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56275943|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56275947|NCT02020005|Nicotine|nicotine|mesh-list
56275956|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275957|NCT02020122|Pregabalin|pregabalin|mesh-list
56275958|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56275959|NCT02020122|Analgesics|analgesics|mesh-ancestor
56275960|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
56275961|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56275962|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56275963|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
56275964|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56275965|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56275966|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56275967|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56275968|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56275969|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56275977|NCT02020161|Methotrexate|methotrexate|mesh-list
56276013|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56276015|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276016|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56276017|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
56276018|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276019|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276020|NCT02020330|Lumefantrine|lumefantrine|mesh-list
56276021|NCT02020330|Artemether|artemether|mesh-list
56276022|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56276023|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
56276024|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56276025|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56276026|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276027|NCT02020499|Lanreotide|lanreotide|mesh-list
56276028|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276029|NCT02020551|Lidocaine|lidocaine|mesh-list
56276030|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
56276031|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
56276032|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276033|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276034|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
56276065|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
56276066|NCT02020681|Protective Agents|protective agents|mesh-ancestor
56276067|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276069|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
56276070|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
56276136|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
56276137|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276138|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276139|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56276140|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
56276141|NCT02021240|Hormones|hormones|mesh-ancestor
56276142|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276143|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56276144|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276145|NCT02021240|Analgesics|analgesics|mesh-ancestor
56276146|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
56276147|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56276148|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56276149|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
56276150|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
56276195|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
56276196|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276198|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56276199|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
56276200|NCT02021851|Hormones|hormones|mesh-ancestor
56276201|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276202|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56276203|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276204|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
56276205|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716507|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276206|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276207|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
56276208|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
56276209|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56276210|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
56276211|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276212|NCT02021851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56276213|NCT02021851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56276214|NCT02021851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276215|NCT02021851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56276216|NCT02021851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56276217|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56276218|NCT02021864|Vitamin D|vitamin d|mesh-list
56276219|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
56276220|NCT02021864|Vitamins|vitamins|mesh-ancestor
56276221|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
56276226|NCT02022163|Vaccines|vaccines|mesh-list
56276242|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276243|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56276244|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
56276245|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56276246|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
56276247|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56276248|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276249|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56276250|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56276251|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276252|NCT02022254|Metformin|metformin|mesh-list
56276253|NCT02022254|Warfarin|warfarin|mesh-list
56276254|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56276255|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276256|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
56276257|NCT02022293|Atorvastatin|atorvastatin|mesh-list
56276258|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56276302|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276303|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276304|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56276305|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56276306|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
56276307|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
56276308|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276309|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56276310|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56276311|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276312|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276313|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56276314|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56276315|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56276316|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56276317|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56276318|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
56276319|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
56276320|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56276321|NCT02022488|Narcotics|narcotics|mesh-ancestor
56276322|NCT02022527|Aspirin|aspirin|mesh-list
56276323|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
56276324|NCT02022527|Salicylates|salicylates|mesh-list
56276325|NCT02022527|Warfarin|warfarin|mesh-list
56276326|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56276327|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56276328|NCT02022527|Analgesics|analgesics|mesh-ancestor
56276329|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
56276330|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276331|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276348|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56276349|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56276350|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55716519|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
56276351|NCT02022540|Growth Substances|growth substances|mesh-ancestor
56276352|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276353|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
56276354|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276355|NCT02022722|Triamcinolone|triamcinolone|mesh-list
56276356|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56276357|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56276358|NCT02022722|Bupivacaine|bupivacaine|mesh-list
56276359|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56276360|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
56276361|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
56276362|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276363|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276364|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
56276365|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276366|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56276367|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
56276368|NCT02022722|Hormones|hormones|mesh-ancestor
56276369|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276370|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276371|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
56276372|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276373|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276374|NCT02022761|Laninamivir|laninamivir|mesh-list
56276375|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
56276376|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276377|NCT02022852|Capecitabine|capecitabine|mesh-list
56276378|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276379|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
56276380|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276381|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276387|NCT02022917|Growth Substances|growth substances|mesh-ancestor
56276388|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276389|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
56276390|NCT02022930|Triamcinolone|triamcinolone|mesh-list
56276391|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56276392|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56276393|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56276394|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56276395|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
56276396|NCT02022930|Hormones|hormones|mesh-ancestor
56276397|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276398|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276399|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276400|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
56276401|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276402|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276404|NCT02023021|Paclitaxel|paclitaxel|mesh-list
56276405|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56276406|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276407|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
56276408|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
56276409|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
56276410|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276411|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276412|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
56276413|NCT02023021|Antiviral Agents|antiviral agents|mesh-ancestor
55825219|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276414|NCT02023021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276415|NCT02023021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276416|NCT02023021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276417|NCT02023021|Immunologic Factors|immunologic factors|mesh-ancestor
56276431|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276432|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276433|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56276434|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56276435|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
56276436|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276437|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276438|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
56276439|NCT02023164|Promethazine|promethazine|mesh-list
56276440|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56276441|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56276442|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276443|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276444|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
56276445|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
56276446|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
56276447|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276448|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
56276449|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
56276450|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56276451|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56276452|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
56276453|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
56276454|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276456|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56276480|NCT02023450|Saquinavir|saquinavir|mesh-list
56276481|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56276482|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56276483|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
56276484|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276485|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276486|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56276487|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56276488|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
56276489|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276490|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56276491|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56276492|NCT02023554|Azithromycin|azithromycin|mesh-list
56276493|NCT02023554|Theophylline|theophylline|mesh-list
56276494|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56276495|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276496|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56276497|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
56276498|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276499|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276500|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56276501|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
56276502|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56276503|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276504|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276505|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
56276506|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56276507|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56276524|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276525|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
56276526|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276527|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56276528|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56276529|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56276530|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276531|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276532|NCT02023710|Paclitaxel|paclitaxel|mesh-list
56276533|NCT02023710|Bevacizumab|bevacizumab|mesh-list
56276534|NCT02023710|Carboplatin|carboplatin|mesh-list
56276535|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56276536|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276537|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
56276538|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
56276539|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
56276540|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276541|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56276542|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56276543|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56276544|NCT02023710|Growth Substances|growth substances|mesh-ancestor
56276545|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276546|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
56276547|NCT02023840|Metronidazole|metronidazole|mesh-list
55898522|NCT03193710|Propofol|propofol|mesh-list
56276548|NCT02023840|Erythritol|erythritol|mesh-list
56276549|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276550|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56276551|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56276554|NCT02023853|Metronidazole|metronidazole|mesh-list
56276567|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56276568|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276569|NCT02023931|Sulforaphane|sulforaphane|mesh-list
56276570|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56276571|NCT02023931|Protective Agents|protective agents|mesh-ancestor
56276572|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276573|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276574|NCT02024009|Gemcitabine|gemcitabine|mesh-list
56276576|NCT02024009|Paclitaxel|paclitaxel|mesh-list
56276577|NCT02024009|Capecitabine|capecitabine|mesh-list
56276578|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56276579|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276580|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
56276581|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
56276582|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
56276583|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276584|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276585|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
56276586|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
56276587|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276588|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276589|NCT02024009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276590|NCT02024009|Immunologic Factors|immunologic factors|mesh-ancestor
56276591|NCT02024009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276592|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56276593|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56276615|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276617|NCT02024256|Analgesics|analgesics|mesh-ancestor
56276618|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
56276619|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276620|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276621|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
56276622|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276623|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56276624|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
56276625|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56276626|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276627|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276628|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56276630|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56276631|NCT02024295|Choline|choline|mesh-list
56276633|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
56276672|NCT02024555|Rifampin|rifampin|mesh-list
56276673|NCT02024555|Ethambutol|ethambutol|mesh-list
56276674|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56276675|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276676|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56276677|NCT02024555|Renal Agents|renal agents|mesh-ancestor
56276678|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56276679|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56276680|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276681|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276682|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276683|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56276684|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56276685|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56276686|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
56276687|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
56276688|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56276689|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56276690|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56276691|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56276692|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56276693|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56276694|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56276695|NCT02024568|Pregabalin|pregabalin|mesh-list
56276696|NCT02024568|Analgesics|analgesics|mesh-ancestor
56276697|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
56276698|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276699|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276701|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56276715|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56276716|NCT02024594|Analgesics|analgesics|mesh-ancestor
56276717|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
56276718|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276719|NCT02024633|Gemcitabine|gemcitabine|mesh-list
56276720|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276721|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
56276722|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276723|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716567|NCT02223611|Vinorelbine|vinorelbine|mesh-list
56276724|NCT02024633|Antiviral Agents|antiviral agents|mesh-ancestor
56276725|NCT02024633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276726|NCT02024633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276727|NCT02024633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276728|NCT02024633|Immunologic Factors|immunologic factors|mesh-ancestor
56276729|NCT02024633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276730|NCT02024659|Budesonide|budesonide|mesh-list
56276731|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56276732|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56276733|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
56276734|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276735|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276736|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56276737|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
56276738|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
56276739|NCT02024659|Hormones|hormones|mesh-ancestor
56276740|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276741|NCT02024841|Docetaxel|docetaxel|mesh-list
56276742|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276743|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
56276744|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
56276745|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
56276746|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276747|NCT02024906|Caseins|caseins|mesh-list
56276748|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
56276749|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
56276750|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276751|NCT02024919|Diltiazem|diltiazem|mesh-list
56276752|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56276753|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56276754|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276755|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276756|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56276757|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276758|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
56276759|NCT02024945|Propiverine|propiverine|mesh-list
56276760|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
56276761|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
56276762|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276763|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276764|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56276765|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56276766|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
56276767|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276768|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276769|NCT02024945|Urological Agents|urological agents|mesh-ancestor
56276806|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56276807|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276808|NCT02025140|Anesthetics|anesthetics|mesh-list
56276809|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276810|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276811|NCT02025166|Acetaminophen|acetaminophen|mesh-list
55716578|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56276812|NCT02025166|Lornoxicam|lornoxicam|mesh-list
56276813|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56276814|NCT02025166|Analgesics|analgesics|mesh-ancestor
56276815|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
56276816|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276817|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276818|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
56276819|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56276820|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56276821|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56276822|NCT02025192|Capecitabine|capecitabine|mesh-list
56276823|NCT02025192|Trastuzumab|trastuzumab|mesh-list
56276824|NCT02025192|Tucatinib|tucatinib|mesh-list
56276825|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56276826|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
56276827|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276828|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276829|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56276830|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56276831|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56276832|NCT02025218|Gefitinib|gefitinib|mesh-list
56276833|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276851|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
56276852|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
56276853|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276854|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276855|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
56276856|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276857|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56276858|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56276859|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56276860|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56276861|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276862|NCT02025374|Bupivacaine|bupivacaine|mesh-list
56276863|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
56276864|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
56276865|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
56276866|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56276867|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276868|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
56276869|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276870|NCT02025465|Metoprolol|metoprolol|mesh-list
56276871|NCT02025465|Diltiazem|diltiazem|mesh-list
56276872|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56276873|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56276874|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
56276875|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
56276876|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56276877|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276878|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55716605|NCT03520543|Clonidine|clonidine|mesh-list
56276879|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56276880|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56276881|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
56276882|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276883|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276889|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56276890|NCT02025491|Amebicides|amebicides|mesh-ancestor
56276891|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56276892|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56276893|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56276894|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56276895|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
56276896|NCT02025608|Pramipexole|pramipexole|mesh-list
56276897|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
56276898|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56276899|NCT02025608|Protective Agents|protective agents|mesh-ancestor
56276900|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276901|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56276902|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56276903|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
56276904|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
56276905|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56276906|NCT02025712|Everolimus|everolimus|mesh-list
56276907|NCT02025712|Exemestane|exemestane|mesh-list
56276908|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56276909|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56276910|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
56276911|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56276944|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56277018|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277019|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277020|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
56277021|NCT02026479|Hormones|hormones|mesh-ancestor
56277022|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277023|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56277024|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277025|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
56277026|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277027|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277028|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
56277029|NCT02026492|Miotics|miotics|mesh-ancestor
56277030|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
56277031|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277032|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277033|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56277034|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56277035|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
56277036|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56277037|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56277038|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
56277039|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277040|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277041|NCT02026505|Bortezomib|bortezomib|mesh-list
56277042|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277067|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277068|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899053|NCT05716906|Protective Agents|protective agents|mesh-ancestor
56277070|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
56277071|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
56277072|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56277073|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
56277074|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277075|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277076|NCT02026778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56277077|NCT02026778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56277078|NCT02026778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277079|NCT02026778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56277080|NCT02026778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56277081|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
56277082|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
56277083|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
56277085|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56277086|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277087|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277088|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56277089|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56277090|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
56277091|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277092|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56277093|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56277094|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277095|NCT02026856|Selenious Acid|selenious acid|mesh-list
56277096|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
56277097|NCT02026856|Trace Elements|trace elements|mesh-ancestor
56277098|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
56277100|NCT02026869|Metformin|metformin|mesh-list
56277111|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
56277112|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277113|NCT02026973|Fulvestrant|fulvestrant|mesh-list
56277114|NCT02026973|Anastrozole|anastrozole|mesh-list
56277115|NCT02026973|Somatostatin|somatostatin|mesh-list
56277116|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56277117|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277118|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56277119|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56277120|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
56277121|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277122|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277123|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56277124|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56277125|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277126|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277127|NCT02026973|Hormones|hormones|mesh-ancestor
56277128|NCT02027064|Interferons|interferons|mesh-list
56277129|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
56277130|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716634|NCT02355639|Hormones|hormones|mesh-ancestor
56277131|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
56277132|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277133|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
56277134|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277135|NCT02027103|Metformin|metformin|mesh-list
56277161|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56277162|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277163|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277164|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277165|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
56277166|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277167|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56277168|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
56277169|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
56277170|NCT02027324|Povidone|povidone|mesh-list
56277171|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56277172|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277173|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
56277174|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
56277175|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
56277176|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
56277177|NCT02027337|Drospirenone|drospirenone|mesh-list
56277178|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56277179|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
56277180|NCT02027337|Cyproterone|cyproterone|mesh-list
56277181|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
56277182|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56277183|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56277184|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56277185|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
56277186|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56277187|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277188|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56277189|NCT02027337|Estrogens|estrogens|mesh-ancestor
56277190|NCT02027337|Hormones|hormones|mesh-ancestor
56277193|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
56277202|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
56277203|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277204|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716670|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56277205|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
56277206|NCT02027454|Cabotegravir|cabotegravir|mesh-list
56277207|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56277208|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277209|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56277210|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56277211|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277212|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277213|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277214|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56277215|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56277216|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56277217|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56277218|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
56277219|NCT02027493|Interferons|interferons|mesh-list
56277220|NCT02027493|Ribavirin|ribavirin|mesh-list
56277222|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
56277223|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56277224|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277225|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
56277226|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277227|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
56277255|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56277256|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277257|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277259|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56277260|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277261|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56277262|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277263|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
56277264|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277265|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
56277266|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277267|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
56277268|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
56277269|NCT02027922|Protective Agents|protective agents|mesh-ancestor
56277314|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756461|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55716713|NCT02227823|Bromides|bromides|mesh-list
56277316|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56277317|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277318|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56277319|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56277320|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56277321|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277322|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56277323|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56277324|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
56277373|NCT02028598|Clomipramine|clomipramine|mesh-list
56277374|NCT02028598|Citric Acid|citric acid|mesh-list
56277375|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
56277376|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
56277377|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56277378|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
56277379|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
56277380|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277381|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
56277382|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56277383|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56277384|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277385|NCT02028598|Urological Agents|urological agents|mesh-ancestor
56277386|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56277387|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
56277388|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56277389|NCT02028598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56277390|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56277391|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56277392|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277393|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
56277394|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277395|NCT02028663|Esomeprazole|esomeprazole|mesh-list
56277396|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56277397|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277423|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
56277424|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277425|NCT02028910|Ondansetron|ondansetron|mesh-list
56277426|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
56277427|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
56277428|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277429|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277430|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277431|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
56277432|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56277433|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56277434|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
56277435|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277436|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277437|NCT02028910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56277438|NCT02028910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56277439|NCT02028910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277440|NCT02028910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56277441|NCT02028910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56277442|NCT02028923|Morphine|morphine|mesh-list
56277443|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56277444|NCT02028923|Narcotics|narcotics|mesh-ancestor
56277445|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899425|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
56277446|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277448|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
56277449|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277450|NCT02028949|Idarubicin|idarubicin|mesh-list
56277451|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56277452|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277453|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56277454|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55930089|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55930090|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930206|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930208|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55930210|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
55930211|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930212|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55930213|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55930214|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144592|NCT00801138|Ropivacaine|ropivacaine|mesh-list
56277455|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277456|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277457|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
56277458|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56277459|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
56277460|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277461|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
56277462|NCT02029105|Protective Agents|protective agents|mesh-ancestor
56277463|NCT02029118|Aspirin|aspirin|mesh-list
56277464|NCT02029118|Metoprolol|metoprolol|mesh-list
56277465|NCT02029118|Ramipril|ramipril|mesh-list
56277466|NCT02029118|Atorvastatin|atorvastatin|mesh-list
56277467|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56277468|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56277469|NCT02029118|Analgesics|analgesics|mesh-ancestor
56277470|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
56277471|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277472|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277473|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56277474|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56277475|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56277476|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56277477|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277478|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56277479|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56277480|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277503|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277504|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277505|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56277506|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56277507|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277508|NCT02029378|Eculizumab|eculizumab|mesh-list
56277517|NCT02029482|Ponesimod|ponesimod|mesh-list
56277566|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56277567|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56277569|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
56277570|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277571|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
56277572|NCT02029612|Nicotine|nicotine|mesh-list
56277573|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56277574|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
56277575|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277576|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277577|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56277578|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56277579|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
56277580|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277581|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277582|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56277583|NCT02029625|Ezetimibe|ezetimibe|mesh-list
56277584|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56277585|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56277586|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
56277587|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277588|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56277589|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56277590|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277616|NCT02029950|Etoposide|etoposide|mesh-list
56277617|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
56277618|NCT02029950|Daunorubicin|daunorubicin|mesh-list
56277619|NCT02029950|Idarubicin|idarubicin|mesh-list
56277620|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
56277621|NCT02029950|Pomalidomide|pomalidomide|mesh-list
56277622|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56277623|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277624|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56277625|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56277626|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56277627|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277628|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56277629|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
56277630|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
56277631|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277632|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56277633|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
56277634|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277635|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56277636|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56277637|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56277638|NCT02029950|Growth Substances|growth substances|mesh-ancestor
56277639|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
56277640|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
56277641|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
56277645|NCT02030561|Trastuzumab|trastuzumab|mesh-list
56277665|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56277668|NCT02031692|Vitamins|vitamins|mesh-ancestor
56277737|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56277738|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56277739|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
56277740|NCT02035020|Interferons|interferons|mesh-list
56277741|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
56277742|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277743|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
56277744|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277745|NCT02035709|Hydromorphone|hydromorphone|mesh-list
56277746|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56277747|NCT02035709|Narcotics|narcotics|mesh-ancestor
56277748|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277749|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277750|NCT02035709|Analgesics|analgesics|mesh-ancestor
56277751|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
56277752|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277754|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
56277755|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56277756|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
56277757|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
56277758|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
56277759|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277760|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277761|NCT02035956|Vaccines|vaccines|mesh-list
56277762|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
56277763|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277764|NCT02036151|Fluorides|fluorides|mesh-list
56277765|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
56277766|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
56277767|NCT02036151|Protective Agents|protective agents|mesh-ancestor
56277768|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277769|NCT02036255|Taurolidine|taurolidine|mesh-list
56277770|NCT02036255|Heparin|heparin|mesh-list
56277782|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
56277783|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277784|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277785|NCT02039453|Fentanyl|fentanyl|mesh-list
56277786|NCT02039453|Meperidine|meperidine|mesh-list
56277787|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56277788|NCT02039453|Narcotics|narcotics|mesh-ancestor
56277789|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277790|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277791|NCT02039453|Analgesics|analgesics|mesh-ancestor
56277792|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
56277793|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277794|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56277795|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56277796|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
56277797|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
56277798|NCT02039492|Spironolactone|spironolactone|mesh-list
56277799|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56277800|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
56277801|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277802|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277803|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56277804|NCT02039492|Diuretics|diuretics|mesh-ancestor
56277805|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
56277806|NCT02039869|Omeprazole|omeprazole|mesh-list
56277807|NCT02039869|Sucralfate|sucralfate|mesh-list
56277808|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56277809|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56277829|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56277830|NCT02040220|Growth Substances|growth substances|mesh-ancestor
56277831|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277832|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
56277833|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277834|NCT02040246|Metformin|metformin|mesh-list
56277835|NCT02040246|Repaglinide|repaglinide|mesh-list
56277836|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277837|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277838|NCT02040285|Metoclopramide|metoclopramide|mesh-list
56277840|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
56277841|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
56277842|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277843|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277844|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277845|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56277846|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56277847|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
56277848|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277849|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277850|NCT02040285|Cathartics|cathartics|mesh-ancestor
56277851|NCT02040285|Laxatives|laxatives|mesh-ancestor
56277852|NCT02040311|Topiramate|topiramate|mesh-list
56277882|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56277883|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
56277884|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56277885|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277886|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56277887|NCT02040441|Diuretics|diuretics|mesh-ancestor
56277888|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
56277889|NCT02040454|Paclitaxel|paclitaxel|mesh-list
56277890|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56277891|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56277892|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
56277893|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
56277894|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
56277895|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277896|NCT02040571|Insulin|insulin|mesh-list
56277897|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56277898|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277899|NCT02040597|Beclomethasone|beclomethasone|mesh-list
56277900|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
56277901|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
56277902|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56277903|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
56277904|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277905|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277906|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56277907|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
56277908|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56277928|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277929|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277930|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56277931|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
56277932|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
56277933|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56277934|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56277935|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56277936|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56277937|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
56277938|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
56277939|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277940|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277942|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56277943|NCT02040662|Narcotics|narcotics|mesh-ancestor
56277944|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277945|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277946|NCT02040662|Analgesics|analgesics|mesh-ancestor
56277947|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
56277948|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277949|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
56277950|NCT02040818|Tigecycline|tigecycline|mesh-list
56277951|NCT02040818|Heparin|heparin|mesh-list
56277952|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56277953|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
56277954|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56277955|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56277956|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277957|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
56277958|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56277959|NCT02040818|Expectorants|expectorants|mesh-ancestor
56277974|NCT02040883|Aripiprazole|aripiprazole|mesh-list
56277975|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56277976|NCT02040883|Ziprasidone|ziprasidone|mesh-list
56277977|NCT02040883|Tandospirone|tandospirone|mesh-list
56277978|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56277979|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
56277980|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56277981|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56277982|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56277983|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56277984|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56277985|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56277986|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56277987|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56277988|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
56277989|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
56277990|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
56277991|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56277992|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56277993|NCT02040883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56278028|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278029|NCT02041143|Caseins|caseins|mesh-list
56278030|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
56278031|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
56278032|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278033|NCT02041273|Palbociclib|palbociclib|mesh-list
56278034|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278035|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56278036|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278037|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278038|NCT02041338|Paclitaxel|paclitaxel|mesh-list
56278039|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56278040|NCT02041338|Carboplatin|carboplatin|mesh-list
56278041|NCT02041338|Epirubicin|epirubicin|mesh-list
56278042|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56278043|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278044|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
56278045|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
56278046|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
56278047|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278048|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56278049|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56278050|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56278051|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278052|NCT02041351|Docetaxel|docetaxel|mesh-list
56278053|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278077|NCT02041481|Leucovorin|leucovorin|mesh-list
56278078|NCT02041481|Fluorouracil|fluorouracil|mesh-list
56278079|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
56278080|NCT02041481|Calcium|calcium|mesh-list
56278081|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
56278082|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56278083|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278084|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
56278085|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278086|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278087|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278088|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278089|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
56278090|NCT02041481|Antidotes|antidotes|mesh-ancestor
56278091|NCT02041481|Protective Agents|protective agents|mesh-ancestor
56278092|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
56278093|NCT02041481|Vitamins|vitamins|mesh-ancestor
56278094|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
56278095|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56278096|NCT02041546|Poractant alfa|poractant alfa|mesh-list
56278097|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
56278098|NCT02041650|Ticagrelor|ticagrelor|mesh-list
56278099|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56278100|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56278101|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56278102|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56278103|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
56278104|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278105|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278106|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278107|NCT02041767|Ertapenem|ertapenem|mesh-list
56278116|NCT02042170|Hormones|hormones|mesh-list
56278122|NCT02042196|Hormones|hormones|mesh-ancestor
56278123|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278124|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278125|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278126|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56278127|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
56278128|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
56278129|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
56278130|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278131|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
56278132|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278133|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278134|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56278135|NCT02042482|Ubiquinone|ubiquinone|mesh-list
56278136|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
56278137|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
56278138|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278139|NCT02042482|Vitamins|vitamins|mesh-ancestor
56278180|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278181|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278182|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56278183|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
56278184|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278185|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278186|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56278187|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56278188|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
56278189|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
56278190|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278191|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56278192|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
56278193|NCT02042690|Hormones|hormones|mesh-ancestor
56278194|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278195|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56278196|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278197|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56278198|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
56278199|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278200|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278201|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
56278202|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
55900186|NCT00702546|Progestins|progestins|mesh-ancestor
56278228|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56278229|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
56278230|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278231|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278232|NCT02043171|Vitamin D|vitamin d|mesh-list
56278233|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
56278234|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
56278235|NCT02043171|Vitamins|vitamins|mesh-list
56278236|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
56278237|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278238|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56278239|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56278240|NCT02043223|Vitamins|vitamins|mesh-list
56278241|NCT02043223|Vitamin A|vitamin a|mesh-list
56278242|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
56278243|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
56278244|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278245|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
56278246|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278247|NCT02043223|Protective Agents|protective agents|mesh-ancestor
56278248|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56278249|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278250|NCT02043288|Gemcitabine|gemcitabine|mesh-list
56278251|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278252|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
56278253|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278254|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278255|NCT02043288|Antiviral Agents|antiviral agents|mesh-ancestor
56278256|NCT02043288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278257|NCT02043288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278258|NCT02043288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278259|NCT02043288|Immunologic Factors|immunologic factors|mesh-ancestor
56278260|NCT02043288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278271|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
56278272|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
56278273|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56278274|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278275|NCT02043717|Vitamin D|vitamin d|mesh-list
56278276|NCT02043717|Vitamins|vitamins|mesh-ancestor
56278277|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
56278278|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717002|NCT02232347|Ketamine|ketamine|mesh-list
56278279|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56278280|NCT02043730|Gemcitabine|gemcitabine|mesh-list
56278281|NCT02043730|Paclitaxel|paclitaxel|mesh-list
56278282|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56278283|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278284|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
56278285|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
56278286|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
56278287|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278288|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278289|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
56278290|NCT02043730|Antiviral Agents|antiviral agents|mesh-ancestor
56278291|NCT02043730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278292|NCT02043730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278293|NCT02043730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278294|NCT02043730|Immunologic Factors|immunologic factors|mesh-ancestor
56278295|NCT02043730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278296|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
56278297|NCT02043756|Analgesics|analgesics|mesh-ancestor
56278298|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
56278306|NCT02043821|Capecitabine|capecitabine|mesh-list
56278316|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278317|NCT02043912|Haloperidol|haloperidol|mesh-list
56278318|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
56278319|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
56278320|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
56278321|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278322|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278323|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56278324|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56278325|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56278326|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278327|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56278328|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56278329|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
56278330|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278331|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278332|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56278334|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56278335|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278336|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278337|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56278338|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
56278339|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
56278340|NCT02044120|Irinotecan|irinotecan|mesh-list
56278341|NCT02044120|Temozolomide|temozolomide|mesh-list
56278342|NCT02044120|Niraparib|niraparib|mesh-list
56278343|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56278344|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56278345|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278361|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56278362|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56278363|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
56278364|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278365|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278366|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278367|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
56278368|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56278369|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278370|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278371|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56278372|NCT02044224|Analgesics|analgesics|mesh-ancestor
56278373|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
56278374|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278375|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56278376|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56278377|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56278378|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
56278379|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278380|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278381|NCT02044250|Aspirin|aspirin|mesh-list
56278382|NCT02044250|Clopidogrel|clopidogrel|mesh-list
56278383|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56278384|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56278385|NCT02044250|Analgesics|analgesics|mesh-ancestor
56278386|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
56278387|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278388|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278404|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278405|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
56278406|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
56278407|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
56278408|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278409|NCT02044549|Oxytocin|oxytocin|mesh-list
56278410|NCT02044549|Carbetocin|carbetocin|mesh-list
56278411|NCT02044549|Methylergonovine|methylergonovine|mesh-list
56278412|NCT02044549|Syntometrine|syntometrine|mesh-list
56278413|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
56278414|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278415|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278416|NCT02044601|Paclitaxel|paclitaxel|mesh-list
56278417|NCT02044601|Carboplatin|carboplatin|mesh-list
56278418|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56278419|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56278420|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278421|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
56278422|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
56278423|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
56278424|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278425|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56278426|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278427|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56278428|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56278429|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
56278430|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278431|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56278432|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278433|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56278434|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278435|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
56278436|NCT02044653|Hematinics|hematinics|mesh-ancestor
56278437|NCT02044809|Cannabidiol|cannabidiol|mesh-list
56278438|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
56278439|NCT02044952|Mesalamine|mesalamine|mesh-list
56278440|NCT02044952|Triptolide|triptolide|mesh-list
55853534|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55876622|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
56278441|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56278442|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56278443|NCT02044952|Analgesics|analgesics|mesh-ancestor
56278444|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
56278445|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278446|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278447|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56278448|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278449|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717034|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278450|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56278451|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56278452|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
56278453|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278454|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278455|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
56278456|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56278457|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
56278458|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278459|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56278460|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56278461|NCT02044965|Trimethoprim|trimethoprim|mesh-list
56278462|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
56278463|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278464|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56278465|NCT02044965|Renal Agents|renal agents|mesh-ancestor
56278466|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
56278488|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278489|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56278490|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278491|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
56278492|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56278493|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56278494|NCT02045017|Growth Substances|growth substances|mesh-ancestor
56278495|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
56278496|NCT02045030|Aflibercept|aflibercept|mesh-list
56278497|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56278498|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56278499|NCT02045030|Growth Substances|growth substances|mesh-ancestor
56278500|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900486|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
56278502|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278503|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
56278504|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56278505|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
56278506|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278507|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56278508|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56278509|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56278510|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278512|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56278513|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278514|NCT02045290|Metformin|metformin|mesh-list
56278515|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56278533|NCT02045589|Gemcitabine|gemcitabine|mesh-list
56278534|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56278535|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278536|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
56278537|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278538|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278539|NCT02045589|Antiviral Agents|antiviral agents|mesh-ancestor
56278540|NCT02045589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278541|NCT02045589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278542|NCT02045589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278543|NCT02045589|Immunologic Factors|immunologic factors|mesh-ancestor
56278544|NCT02045589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278545|NCT02045602|Gemcitabine|gemcitabine|mesh-list
56278546|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56278547|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278548|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
56278549|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278550|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278551|NCT02045602|Antiviral Agents|antiviral agents|mesh-ancestor
56278552|NCT02045602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278553|NCT02045602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717053|NCT02296411|Bromides|bromides|mesh-list
56278554|NCT02045602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278555|NCT02045602|Immunologic Factors|immunologic factors|mesh-ancestor
56278584|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
56278585|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278586|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56278587|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56278588|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278589|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278590|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56278591|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
56278592|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278593|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278594|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56278595|NCT02045914|Calcium|calcium|mesh-list
56278596|NCT02045914|Ionophores|ionophores|mesh-list
56278597|NCT02045914|Ionomycin|ionomycin|mesh-list
56278598|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
56278599|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56278600|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278601|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56278602|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278603|NCT02045940|GSK2881078|gsk2881078|mesh-list
56278604|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
56278605|NCT02045940|Hormones|hormones|mesh-ancestor
55790163|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278606|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278607|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278608|NCT02045953|Albuterol|albuterol|mesh-list
56278609|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56278610|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
56278611|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278612|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278613|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56278614|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
56278624|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56278625|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278626|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56278628|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278629|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56278630|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55825810|NCT04786964|Hormones|hormones|mesh-ancestor
56278631|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
56278632|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278633|NCT02046044|Digoxin|digoxin|mesh-list
56278634|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56278635|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56278636|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278637|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278638|NCT02046044|Protective Agents|protective agents|mesh-ancestor
56278639|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278640|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
56278641|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56278642|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278643|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
56278644|NCT02046187|Temozolomide|temozolomide|mesh-list
56278645|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56278646|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
55900636|NCT03182322|Insulin|insulin|mesh-list
56278647|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278648|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278649|NCT02046304|Gemcitabine|gemcitabine|mesh-list
56278650|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278667|NCT02046421|Antiviral Agents|antiviral agents|mesh-ancestor
56278668|NCT02046421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278669|NCT02046421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278670|NCT02046421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278671|NCT02046421|Immunologic Factors|immunologic factors|mesh-ancestor
56278672|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278673|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56278674|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
56278675|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278676|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56278677|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56278678|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56278679|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
56278680|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56278681|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56278682|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
56278683|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278684|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
56278685|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56278722|NCT02046486|Ticagrelor|ticagrelor|mesh-list
56278723|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56278724|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56278725|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56278726|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56278727|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
56278728|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278729|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278730|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278731|NCT02046499|Oxytocin|oxytocin|mesh-list
56278732|NCT02046499|Ergonovine|ergonovine|mesh-list
56278733|NCT02046499|Syntometrine|syntometrine|mesh-list
56278734|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
56278735|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56278736|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278737|NCT02046538|Leucovorin|leucovorin|mesh-list
56278738|NCT02046538|Fluorouracil|fluorouracil|mesh-list
56278739|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
56278740|NCT02046538|Irinotecan|irinotecan|mesh-list
56278741|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
56278742|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278743|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278744|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278745|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278746|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
56278747|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278748|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56278749|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56278750|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278751|NCT02046538|Antidotes|antidotes|mesh-ancestor
56278752|NCT02046538|Protective Agents|protective agents|mesh-ancestor
56278753|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
56278754|NCT02046538|Vitamins|vitamins|mesh-ancestor
56278755|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
56278756|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56278757|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56278758|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56278760|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278762|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278763|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278764|NCT02046577|Vitamin D|vitamin d|mesh-list
56278765|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
56278766|NCT02046577|Vitamins|vitamins|mesh-ancestor
56278767|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
56278768|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278769|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56278770|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56278771|NCT02046629|Teriflunomide|teriflunomide|mesh-list
56278772|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
56278773|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56278774|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56278775|NCT02046629|Analgesics|analgesics|mesh-ancestor
56278776|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
56278777|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825846|NCT04216784|Furosemide|furosemide|mesh-list
56278778|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278779|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56278780|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278781|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278782|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
56278783|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56278784|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56278785|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
56278786|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278787|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56278788|NCT02046668|Spironolactone|spironolactone|mesh-list
56278789|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56278790|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
56278791|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278792|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278793|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56278794|NCT02046668|Diuretics|diuretics|mesh-ancestor
56278795|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
56278798|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56278799|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278800|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56278801|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
56278802|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
56278803|NCT02046733|Nivolumab|nivolumab|mesh-list
56278804|NCT02046733|Ipilimumab|ipilimumab|mesh-list
56278805|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56278806|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278807|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56278808|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717133|NCT02289937|Ropivacaine|ropivacaine|mesh-list
56278809|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56278810|NCT02046850|Rifampin|rifampin|mesh-list
56278811|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56278812|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
56278813|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56278814|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278815|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
56278816|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56278817|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278818|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278819|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56278820|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56278821|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56278822|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56278823|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56278824|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56278825|NCT02046915|Dexamethasone|dexamethasone|mesh-list
56278826|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
56278827|NCT02046915|Pomalidomide|pomalidomide|mesh-list
56278828|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278829|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
56278830|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278836|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56278837|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56278838|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
56278839|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
56278840|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278841|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56278842|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
56278843|NCT02046915|Hormones|hormones|mesh-ancestor
56278844|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278845|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56278846|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56278847|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56278848|NCT02046915|Growth Substances|growth substances|mesh-ancestor
56278849|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
56278850|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
56278851|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56278852|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
56278853|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56278854|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
56278855|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278856|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278857|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
56278858|NCT02047019|Candesartan|candesartan|mesh-list
56278859|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
56278860|NCT02047019|Nifedipine|nifedipine|mesh-list
56278861|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56278862|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56278863|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56278865|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56278881|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278882|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55717177|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55717178|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55717179|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717180|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278883|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278884|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278885|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56278886|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56278887|NCT02047149|Analgesics|analgesics|mesh-ancestor
56278888|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
56278889|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278890|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278891|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56278892|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56278893|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56278894|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56278895|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
56278896|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56278897|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
56278898|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56278899|NCT02047162|Bismuth|bismuth|mesh-list
56278900|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56278901|NCT02047162|Antacids|antacids|mesh-ancestor
56278902|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278903|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56278904|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
56278905|NCT02047175|Niacin|niacin|mesh-list
56278906|NCT02047175|Amlodipine|amlodipine|mesh-list
56278907|NCT02047175|Telmisartan|telmisartan|mesh-list
56278908|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56278909|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56278910|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56278911|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56278912|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278921|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278922|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56278923|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56278924|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
56278926|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
56278927|NCT02047201|Docetaxel|docetaxel|mesh-list
56278928|NCT02047201|Fluorouracil|fluorouracil|mesh-list
56278929|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278930|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
56278931|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
56278932|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
55717194|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
56278933|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278934|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
56278935|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278936|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278937|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
56278938|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278939|NCT02047292|Tacrine|tacrine|mesh-list
56278940|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56278941|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278942|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278943|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
56278944|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56278945|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278946|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56278947|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
56278948|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278949|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
56278950|NCT00005823|Cytarabine|cytarabine|mesh-list
56278951|NCT00005823|Etoposide|etoposide|mesh-list
56278952|NCT00005823|Daunorubicin|daunorubicin|mesh-list
56278953|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
56278954|NCT00005823|Idarubicin|idarubicin|mesh-list
56278955|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
56278956|NCT00005823|Tretinoin|tretinoin|mesh-list
56278963|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278964|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278966|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
56278967|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278968|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56278969|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
56278970|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56278971|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56278972|NCT00005823|Analgesics|analgesics|mesh-ancestor
56278973|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
56278974|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56278975|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
56278976|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56278977|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
56278978|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
56278979|NCT00005826|Rubitecan|rubitecan|mesh-list
56278980|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278981|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56278982|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56278983|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278984|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278985|NCT00005829|Gemcitabine|gemcitabine|mesh-list
56278986|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56278987|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
56278988|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278989|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56278990|NCT00005829|Antiviral Agents|antiviral agents|mesh-ancestor
56278991|NCT00005829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56278992|NCT00005829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56278993|NCT00005829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717229|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56278996|NCT00005832|Tipifarnib|tipifarnib|mesh-list
56279004|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279005|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279006|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279007|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279008|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
56279009|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279010|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279011|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56279012|NCT00005835|Protective Agents|protective agents|mesh-ancestor
56279013|NCT00005838|Paclitaxel|paclitaxel|mesh-list
56279014|NCT00005838|Vinorelbine|vinorelbine|mesh-list
56279015|NCT00005838|Carboplatin|carboplatin|mesh-list
56279016|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279017|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279018|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279019|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279020|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279021|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279023|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56279024|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
56279025|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279026|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
56279027|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279028|NCT00005847|Interferons|interferons|mesh-list
56279029|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
56279030|NCT00005847|Paclitaxel|paclitaxel|mesh-list
56279031|NCT00005847|Vinorelbine|vinorelbine|mesh-list
56279032|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
56279033|NCT00005847|Estramustine|estramustine|mesh-list
56279034|NCT00005847|Isotretinoin|isotretinoin|mesh-list
56279035|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279036|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279037|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279038|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279039|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279040|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279046|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
56279047|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279048|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56279049|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279050|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279051|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
56279052|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279053|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
56279054|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56279055|NCT00005850|Gemcitabine|gemcitabine|mesh-list
56279056|NCT00005850|Fluoxetine|fluoxetine|mesh-list
56279057|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279058|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279059|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
56279060|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279061|NCT00005850|Antiviral Agents|antiviral agents|mesh-ancestor
56279062|NCT00005850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279063|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279064|NCT00005850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279065|NCT00005850|Immunologic Factors|immunologic factors|mesh-ancestor
56279066|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279067|NCT00005850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56279068|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56279097|NCT00005862|Growth Substances|growth substances|mesh-ancestor
56279098|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279099|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
56279100|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279101|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56279102|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279103|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279104|NCT00005865|Vinorelbine|vinorelbine|mesh-list
56279105|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279106|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279107|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279108|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279109|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279110|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279111|NCT00005868|Docetaxel|docetaxel|mesh-list
56279112|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279113|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279114|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279115|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279116|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279117|NCT00005871|Fluorouracil|fluorouracil|mesh-list
56279118|NCT00005871|Rubitecan|rubitecan|mesh-list
56279119|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
56279120|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279121|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279122|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279123|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279124|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
56279125|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279126|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56279127|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279128|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279129|NCT00005874|Rubitecan|rubitecan|mesh-list
56279130|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279131|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56279135|NCT00005877|Rubitecan|rubitecan|mesh-list
56279136|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279137|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56279138|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279139|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279140|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279141|NCT00005880|Budesonide|budesonide|mesh-list
56279142|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279143|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56279144|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
56279145|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279146|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279147|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56279148|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
56279149|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
56279150|NCT00005880|Hormones|hormones|mesh-ancestor
56279151|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279152|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
56279153|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279154|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279155|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56279156|NCT00005883|Protective Agents|protective agents|mesh-ancestor
56279157|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279158|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279159|NCT00005886|Tamoxifen|tamoxifen|mesh-list
56279182|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279183|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
56279184|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279185|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279186|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279187|NCT00005898|Cyclosporine|cyclosporine|mesh-list
56279188|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
56279189|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
56279190|NCT00005898|Fludarabine|fludarabine|mesh-list
56279191|NCT00005898|Cyclosporins|cyclosporins|mesh-list
56279192|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56279193|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279194|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
56279195|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717256|NCT03146247|Analgesics|analgesics|mesh-ancestor
56279196|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279197|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279198|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
56279199|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279200|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279201|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279202|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279203|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
56279204|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279205|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
56279206|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56279207|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279208|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
56279209|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
56279210|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279211|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56279212|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
56279213|NCT00005898|Hormones|hormones|mesh-ancestor
56279225|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279226|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279227|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279228|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279229|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56279230|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56279231|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279232|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56279233|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56279234|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279235|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
56279236|NCT00005922|Triamcinolone|triamcinolone|mesh-list
56279237|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56279238|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56279239|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56279240|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279241|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
56279242|NCT00005922|Hormones|hormones|mesh-ancestor
56279243|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279244|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279245|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279246|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
56279247|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279248|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279250|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56279251|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
56279252|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
56279253|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56279254|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279255|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279256|NCT00005928|Ramipril|ramipril|mesh-list
56279257|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56279258|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
56279264|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56279265|NCT00005931|Growth Substances|growth substances|mesh-ancestor
56279266|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279267|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
56279268|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279269|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56279270|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279271|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279272|NCT00005934|Azacitidine|azacitidine|mesh-list
56279273|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279274|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
56279275|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279276|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279277|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279278|NCT00005940|Iodine|iodine|mesh-list
56279279|NCT00005940|Cyclosporine|cyclosporine|mesh-list
56279280|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
56279281|NCT00005940|Busulfan|busulfan|mesh-list
56279282|NCT00005940|Methotrexate|methotrexate|mesh-list
56279283|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56279284|NCT00005940|Cyclosporins|cyclosporins|mesh-list
56279285|NCT00005940|Antibodies|antibodies|mesh-list
56279286|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
56279287|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56279288|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279289|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
56279290|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279291|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279292|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279310|NCT00005940|Trace Elements|trace elements|mesh-ancestor
56279311|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
56279312|NCT00005943|Aldesleukin|aldesleukin|mesh-list
56279313|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279314|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56279315|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55826003|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279316|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
56279317|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279318|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
56279320|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279321|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
56279322|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279323|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279324|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279325|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
56279326|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279327|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279328|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279329|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279330|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56279331|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279332|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279335|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279336|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56279337|NCT00005949|Analgesics|analgesics|mesh-ancestor
56279338|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
56279339|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279340|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279341|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56279342|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56279355|NCT00005958|Gemcitabine|gemcitabine|mesh-list
56279356|NCT00005958|Docetaxel|docetaxel|mesh-list
56279357|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279358|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
56279359|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279360|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279361|NCT00005958|Antiviral Agents|antiviral agents|mesh-ancestor
56279362|NCT00005958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279363|NCT00005958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279364|NCT00005958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279365|NCT00005958|Immunologic Factors|immunologic factors|mesh-ancestor
56279366|NCT00005958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279367|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279368|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279369|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279370|NCT00005961|Carmustine|carmustine|mesh-list
56279371|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56279372|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279373|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
56279374|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279375|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854543|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56279407|NCT00005970|Tamoxifen|tamoxifen|mesh-list
56279408|NCT00005970|Paclitaxel|paclitaxel|mesh-list
56279409|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
56279410|NCT00005970|Doxorubicin|doxorubicin|mesh-list
56279411|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56279412|NCT00005970|Trastuzumab|trastuzumab|mesh-list
56279413|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56279414|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56279415|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56279416|NCT00005970|Antibodies|antibodies|mesh-list
56279417|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
56279418|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56279419|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56279420|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279421|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279422|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279423|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279424|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279425|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279426|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279427|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
56279428|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279429|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279430|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279431|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
56279432|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279433|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56279434|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56279435|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279436|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279449|NCT00005979|Fluorouracil|fluorouracil|mesh-list
56279450|NCT00005979|Irinotecan|irinotecan|mesh-list
56279451|NCT00005979|Calcium|calcium|mesh-list
56279452|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
56279453|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56279454|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279455|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
56279456|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279457|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279458|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279459|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279460|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
56279461|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56279462|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279463|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279464|NCT00005979|Antidotes|antidotes|mesh-ancestor
56279465|NCT00005979|Protective Agents|protective agents|mesh-ancestor
56279466|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
56279467|NCT00005979|Vitamins|vitamins|mesh-ancestor
56279468|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
56279469|NCT00005985|Cytarabine|cytarabine|mesh-list
56279470|NCT00005985|Dexamethasone|dexamethasone|mesh-list
56279471|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
55901460|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
56279472|NCT00005985|Carmustine|carmustine|mesh-list
56279474|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
56279475|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279476|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
56279477|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279498|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
56279499|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
56279500|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279501|NCT00005985|Analgesics|analgesics|mesh-ancestor
56279502|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
56279503|NCT00005988|Leucovorin|leucovorin|mesh-list
56279504|NCT00005988|Cyclosporine|cyclosporine|mesh-list
56279505|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
56279506|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
56279507|NCT00005988|Methotrexate|methotrexate|mesh-list
56279508|NCT00005988|Cyclosporins|cyclosporins|mesh-list
56279509|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
56279510|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279511|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
56279512|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279513|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279514|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279515|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
56279516|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279517|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279518|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56279519|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56279520|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
56279521|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56279522|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279523|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
56279524|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
56279525|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279526|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56279527|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56279528|NCT00005988|Antidotes|antidotes|mesh-ancestor
56279529|NCT00005988|Protective Agents|protective agents|mesh-ancestor
55717322|NCT02293447|Lidocaine|lidocaine|mesh-list
56279530|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
56279531|NCT00005988|Vitamins|vitamins|mesh-ancestor
56279532|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
56279533|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
56279537|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
56279538|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
56279539|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279540|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56279541|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
56279542|NCT00005988|Hormones|hormones|mesh-ancestor
56279543|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279544|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56279545|NCT00005991|Gemcitabine|gemcitabine|mesh-list
56279546|NCT00005991|Doxorubicin|doxorubicin|mesh-list
56279547|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56279548|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279549|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
56279550|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279551|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279552|NCT00005991|Antiviral Agents|antiviral agents|mesh-ancestor
56279553|NCT00005991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790178|NCT04868513|Fluorides|fluorides|mesh-list
56279554|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279555|NCT00005991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279556|NCT00005991|Immunologic Factors|immunologic factors|mesh-ancestor
56279557|NCT00005991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279558|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56279559|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56279560|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279561|NCT00005994|Ondansetron|ondansetron|mesh-list
56279562|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
56279563|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
56279564|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279565|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279566|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56279567|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
56279568|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
56279569|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56279570|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
56279571|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56279572|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854665|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
56279573|NCT00005994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56279574|NCT00005994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56279575|NCT00005994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56279576|NCT00005994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56279577|NCT00005994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56279578|NCT00006000|Irinotecan|irinotecan|mesh-list
56279579|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279580|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56279581|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279582|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279583|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279584|NCT00006003|Semaxinib|semaxinib|mesh-list
56279585|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56279586|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56279587|NCT00006003|Growth Substances|growth substances|mesh-ancestor
56279588|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279589|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
56279590|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279591|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56279592|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279593|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279594|NCT00006006|Interferons|interferons|mesh-list
56279595|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
56279596|NCT00006006|Thalidomide|thalidomide|mesh-list
56279597|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279598|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
56279599|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279600|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
56279601|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279602|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279603|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
56279618|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279619|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279620|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279621|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279622|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56279623|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56279624|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279625|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279626|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56279627|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56279628|NCT00006012|Protective Agents|protective agents|mesh-ancestor
56279630|NCT00006015|Fluorouracil|fluorouracil|mesh-list
56279631|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
56279632|NCT00006015|Trastuzumab|trastuzumab|mesh-list
56279633|NCT00006015|Calcium|calcium|mesh-list
56279634|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
56279635|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56279636|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279637|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
56279638|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279639|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279640|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279641|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279642|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
56279643|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56279644|NCT00006015|Antidotes|antidotes|mesh-ancestor
56279647|NCT00006015|Vitamins|vitamins|mesh-ancestor
56279668|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
56279669|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279670|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279672|NCT00006027|Cisplatin|cisplatin|mesh-list
56279673|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279674|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279675|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279676|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279677|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279678|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279679|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56279680|NCT00386646|Laxatives|laxatives|mesh-ancestor
56279681|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56279682|NCT00386685|Trastuzumab|trastuzumab|mesh-list
56279683|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56279684|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279685|NCT00006030|Tamoxifen|tamoxifen|mesh-list
56279686|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56279687|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
56279688|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279689|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279690|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56279691|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279692|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56279693|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56279694|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56279695|NCT00006033|Methotrexate|methotrexate|mesh-list
56279696|NCT00006033|Interleukin-2|interleukin-2|mesh-list
56279697|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56279698|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
56279699|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56279707|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56279708|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279709|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
56279710|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279711|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56279712|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56279713|NCT00006033|Analgesics|analgesics|mesh-ancestor
56279714|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
56279715|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279717|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279718|NCT00006039|Interferons|interferons|mesh-list
56279719|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
56279720|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279721|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
56279722|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279723|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
56279724|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279725|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
56279726|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
56279766|NCT05680662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279767|NCT05680662|Antioxidants|antioxidants|mesh-ancestor
56279768|NCT05680662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279769|NCT05680662|Protective Agents|protective agents|mesh-ancestor
56279770|NCT05680545|Sevoflurane|sevoflurane|mesh-list
56279771|NCT05680545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56279772|NCT05680545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56279773|NCT05680545|Anesthetics, General|anesthetics, general|mesh-ancestor
56279774|NCT05680545|Anesthetics|anesthetics|mesh-ancestor
56279775|NCT05680545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56279776|NCT05680545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279777|NCT05680389|Minocycline|minocycline|mesh-list
56279778|NCT05680389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56279779|NCT05680389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279780|NCT05680194|Diphosphonates|diphosphonates|mesh-list
56279781|NCT05680194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56279782|NCT05680194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279783|NCT05679921|Pembrolizumab|pembrolizumab|mesh-list
56279784|NCT05679921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56279785|NCT05679921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279786|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
56279787|NCT00386802|Clotrimazole|clotrimazole|mesh-list
56279788|NCT00386802|Miconazole|miconazole|mesh-list
56279790|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56279791|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56279792|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56279793|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279794|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279795|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56279796|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
56279797|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56279798|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279801|NCT00386841|Citalopram|citalopram|mesh-list
56279804|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56279805|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279806|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56279807|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
56279808|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279809|NCT00386841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56279810|NCT00386841|Antidepressive Agents|antidepressive agents|mesh-ancestor
56279811|NCT00386841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56279812|NCT05679453|Etodolac|etodolac|mesh-list
56279813|NCT05679453|Lornoxicam|lornoxicam|mesh-list
56279814|NCT05679453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56279815|NCT05679453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56279816|NCT05679453|Analgesics|analgesics|mesh-ancestor
56279817|NCT05679453|Sensory System Agents|sensory system agents|mesh-ancestor
56279818|NCT05679453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279819|NCT05679453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279820|NCT05679453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279821|NCT05679453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279822|NCT05679453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56279823|NCT05679453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56279824|NCT05679453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56279825|NCT05679453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279826|NCT05679375|Ketamine|ketamine|mesh-list
56279827|NCT05679375|Analgesics|analgesics|mesh-ancestor
56279828|NCT05679375|Sensory System Agents|sensory system agents|mesh-ancestor
56279829|NCT05679375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279830|NCT05679375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279831|NCT05679375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56279832|NCT05679375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56279833|NCT05679375|Anesthetics, General|anesthetics, general|mesh-ancestor
56279834|NCT05679375|Anesthetics|anesthetics|mesh-ancestor
56279845|NCT05679336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56279846|NCT05679336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56279847|NCT05679336|Alkylating Agents|alkylating agents|mesh-ancestor
56279848|NCT05679336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279849|NCT05679336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279850|NCT05679336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55756859|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
56279851|NCT05679336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56279852|NCT05677152|Zoledronic Acid|zoledronic acid|mesh-list
56279853|NCT05677152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56279854|NCT05677152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279855|NCT05675943|Antibodies|antibodies|mesh-list
56279856|NCT05675943|Immunologic Factors|immunologic factors|mesh-ancestor
56279857|NCT05675943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279858|NCT05675163|Vitamin K|vitamin k|mesh-list
56279859|NCT05675163|Vitamin K 2|vitamin k 2|mesh-list
56279860|NCT05675163|Vitamins|vitamins|mesh-ancestor
56279861|NCT05675163|Micronutrients|micronutrients|mesh-ancestor
56279862|NCT05675163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279863|NCT05675163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56279864|NCT05675163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56279865|NCT05675163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279866|NCT05675163|Hemostatics|hemostatics|mesh-ancestor
56279867|NCT05675163|Coagulants|coagulants|mesh-ancestor
56279868|NCT05626725|Insulin|insulin|mesh-list
56279869|NCT05626725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56279870|NCT05626725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279871|NCT05605509|Gemcitabine|gemcitabine|mesh-list
56279872|NCT05605509|Trastuzumab|trastuzumab|mesh-list
56279873|NCT05605509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56279874|NCT05605509|Antimetabolites|antimetabolites|mesh-ancestor
56279875|NCT05605509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279876|NCT05605509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279884|NCT05597163|Atropine|atropine|mesh-list
56279887|NCT05597163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56279888|NCT05597163|Autonomic Agents|autonomic agents|mesh-ancestor
56279889|NCT05597163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279890|NCT05597163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279891|NCT05597163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56279892|NCT05597163|Respiratory System Agents|respiratory system agents|mesh-ancestor
56279893|NCT05597163|Mydriatics|mydriatics|mesh-ancestor
56279894|NCT05597163|Parasympatholytics|parasympatholytics|mesh-ancestor
56279895|NCT05597163|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56279896|NCT05597163|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56279897|NCT05597163|Cholinergic Agents|cholinergic agents|mesh-ancestor
56279898|NCT05597163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56279899|NCT05597163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279900|NCT05550129|Metformin|metformin|mesh-list
56279901|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56279902|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279903|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
56279904|NCT00386958|Povidone|povidone|mesh-list
56279905|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
56279906|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
56279907|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56279908|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279909|NCT00386997|Amphotericin B|amphotericin b|mesh-list
56279910|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56279911|NCT00386997|Amebicides|amebicides|mesh-ancestor
56279912|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56279913|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56279914|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279915|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56279916|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
56279932|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55717341|NCT02293525|Morphine|morphine|mesh-list
56279933|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56279934|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
56279935|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56279936|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279937|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
56279938|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279939|NCT04921722|Sirolimus|sirolimus|mesh-list
56279940|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56279941|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279942|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56279943|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279944|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
56279945|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56279946|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
56279947|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279948|NCT04910568|Dexamethasone|dexamethasone|mesh-list
56279949|NCT04910568|Daratumumab|daratumumab|mesh-list
56279950|NCT04910568|Pomalidomide|pomalidomide|mesh-list
56279951|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56279952|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
56279953|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
56279954|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56279955|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279958|NCT04910568|Hormones|hormones|mesh-ancestor
56279983|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56279984|NCT04787991|Gemcitabine|gemcitabine|mesh-list
56279985|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
56279986|NCT04787991|Paclitaxel|paclitaxel|mesh-list
56279987|NCT04787991|Nivolumab|nivolumab|mesh-list
56279988|NCT04787991|Ipilimumab|ipilimumab|mesh-list
56279989|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56279990|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56279991|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
56279992|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
56279993|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
56279994|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56279996|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
56279997|NCT04787991|Antiviral Agents|antiviral agents|mesh-ancestor
56279998|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56279999|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280000|NCT04787991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56280001|NCT04787991|Immunologic Factors|immunologic factors|mesh-ancestor
56280002|NCT04787991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280003|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55901985|NCT02416752|Remifentanil|remifentanil|mesh-list
56280004|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56280005|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
56280006|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56280007|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56280008|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56280009|NCT04552080|Amoxicillin|amoxicillin|mesh-list
56280010|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56280029|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
56280030|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280031|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56280032|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56280033|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
56280034|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56280035|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56280036|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56280095|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280096|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56280097|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280098|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55717362|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280099|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280100|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56280101|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56280102|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
56280103|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56280104|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
56280105|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56280106|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
56280107|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
56280108|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56280109|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280110|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56280111|NCT03869736|Analgesics|analgesics|mesh-ancestor
56280112|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
56280113|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280114|NCT03786081|Bevacizumab|bevacizumab|mesh-list
56280115|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
56280116|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
56280117|NCT03786081|Carboplatin|carboplatin|mesh-list
56280118|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280119|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280142|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280143|NCT03628209|Nivolumab|nivolumab|mesh-list
56280144|NCT03628209|Azacitidine|azacitidine|mesh-list
56280145|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280146|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280147|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56280148|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280149|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56280150|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
56280151|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280152|NCT03601923|Niraparib|niraparib|mesh-list
56280153|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56280154|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280155|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280156|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280157|NCT03568656|Atezolizumab|atezolizumab|mesh-list
56280158|NCT03568656|Olaparib|olaparib|mesh-list
56280159|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
56280160|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280161|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56280162|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280163|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280171|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
56280172|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717374|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56280173|NCT03084939|Capecitabine|capecitabine|mesh-list
56280180|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56280181|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280182|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56280183|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56280184|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56280185|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56280186|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
56280187|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
56280188|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
56280189|NCT03002259|Dexamethasone|dexamethasone|mesh-list
56280190|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56280191|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
56280192|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
56280193|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280194|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56280195|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56280196|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
56280197|NCT03002259|Hormones|hormones|mesh-ancestor
56280198|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56280199|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56280200|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56280201|NCT03000387|Nicotine|nicotine|mesh-list
56280202|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56280203|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
56280204|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56280205|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991210|NCT03019081|Protective Agents|protective agents|mesh-ancestor
55991212|NCT00986401|Trospium chloride|trospium chloride|mesh-list
55991213|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55991214|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991215|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
55991216|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
55991217|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991218|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55991219|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55991220|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
55991221|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991222|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991223|NCT00986401|Urological Agents|urological agents|mesh-ancestor
55991224|NCT00375076|Enoxaparin|enoxaparin|mesh-list
55991225|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
55991226|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55717404|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55991227|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55991228|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991230|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
55991232|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55991234|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991235|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55991236|NCT03078946|Analgesics|analgesics|mesh-ancestor
55991243|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991244|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991245|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55991246|NCT03078946|Narcotics|narcotics|mesh-ancestor
55991282|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55991283|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991284|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991285|NCT04707118|Paclitaxel|paclitaxel|mesh-list
55991286|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55991287|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55991288|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991289|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
55991290|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
55991291|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
55991294|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
55991295|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55991296|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
55991297|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991298|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991299|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
55991334|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991335|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55991336|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55991337|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55991338|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991339|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991340|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55991341|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55991342|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
55991357|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991358|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
55991359|NCT00987727|Protective Agents|protective agents|mesh-ancestor
55991360|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55991361|NCT00987727|Laxatives|laxatives|mesh-ancestor
55991362|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55991363|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55991365|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55991366|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991367|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991368|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55991369|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991370|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991371|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
55991372|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991373|NCT04557189|Ondansetron|ondansetron|mesh-list
55991374|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
55991375|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
55991376|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991377|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991378|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55991379|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
55991381|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55991382|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
55991383|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991385|NCT04557189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55756950|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
55991394|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991396|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991397|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991398|NCT05386459|Interferons|interferons|mesh-list
55991399|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
55991400|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991401|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
55991402|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991403|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
55991404|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55991405|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55991406|NCT03018535|Prednisolone|prednisolone|mesh-list
55991407|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
55991408|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
55991409|NCT03018535|Rituximab|rituximab|mesh-list
55991410|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55991411|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
55991412|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991413|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
55991414|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991415|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55991416|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55991417|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
55991418|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991419|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991420|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55991421|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991422|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55991423|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
55991424|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
55991427|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
55991438|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
55991439|NCT04889547|BB 1101|bb 1101|mesh-list
55991440|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55991441|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
55991442|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
55991443|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991444|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991445|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55991446|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
55991447|NCT04889547|Hormones|hormones|mesh-ancestor
55717450|NCT03912233|Ivacaftor|ivacaftor|mesh-list
55991448|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55991449|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55991450|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991451|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
55991452|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991453|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991454|NCT00989911|Bosentan|bosentan|mesh-list
55991455|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55991456|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55991457|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991458|NCT04045665|Anticoagulants|anticoagulants|mesh-list
55991459|NCT05250895|Misonidazole|misonidazole|mesh-list
55991464|NCT02977065|Atorvastatin|atorvastatin|mesh-list
55991490|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55991491|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
55991492|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
55991493|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991494|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991495|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55991496|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
55991497|NCT03439293|Hormones|hormones|mesh-ancestor
55991498|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55991499|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55991500|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991501|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
55991502|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991503|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991504|NCT04706806|Acetic Acid|acetic acid|mesh-list
55991506|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991507|NCT03424005|Gemcitabine|gemcitabine|mesh-list
55991508|NCT03424005|Paclitaxel|paclitaxel|mesh-list
55991509|NCT03424005|Bevacizumab|bevacizumab|mesh-list
55991510|NCT03424005|Carboplatin|carboplatin|mesh-list
55991511|NCT03424005|Capecitabine|capecitabine|mesh-list
55717472|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991512|NCT03424005|Atezolizumab|atezolizumab|mesh-list
55991513|NCT03424005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55991514|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991515|NCT03424005|Tubulin Modulators|tubulin modulators|mesh-ancestor
55991516|NCT03424005|Antimitotic Agents|antimitotic agents|mesh-ancestor
55991517|NCT03424005|Mitosis Modulators|mitosis modulators|mesh-ancestor
55991518|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991519|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991520|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55991521|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55991534|NCT03953235|Nivolumab|nivolumab|mesh-list
55991535|NCT03953235|Ipilimumab|ipilimumab|mesh-list
55991536|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991537|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991538|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55991539|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991540|NCT03402945|Vancomycin|vancomycin|mesh-list
55991541|NCT03402945|Cefazolin|cefazolin|mesh-list
55991542|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55991543|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991544|NCT03095638|Dolutegravir|dolutegravir|mesh-list
55991545|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55991546|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55991547|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991548|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991549|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55991550|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55991551|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
55991552|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991553|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
55991554|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
55991555|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991556|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
55991557|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55991558|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
55991559|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991560|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991561|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55991562|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
55991563|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55991564|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
55991565|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991566|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991567|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55991575|NCT04341831|Teicoplanin|teicoplanin|mesh-list
55991576|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55717507|NCT03896009|Meloxicam|meloxicam|mesh-list
55717508|NCT03896009|Rizatriptan|rizatriptan|mesh-list
55991577|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991578|NCT00361959|Fluticasone|fluticasone|mesh-list
55991579|NCT00361959|Xhance|xhance|mesh-list
55991580|NCT00361959|Bromides|bromides|mesh-list
55991581|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
55991582|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55991583|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55991584|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55991585|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
55991586|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991587|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991588|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55991589|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
55991590|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
55991591|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55991592|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
55991593|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55991594|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
55991595|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991596|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991597|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55991598|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55991599|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55991600|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
55991601|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
55991603|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55991604|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991605|NCT03096730|Sufentanil|sufentanil|mesh-list
55991606|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
55991607|NCT03096730|Remifentanil|remifentanil|mesh-list
55991608|NCT03096730|Dsuvia|dsuvia|mesh-list
55991609|NCT03096730|Nalmefene|nalmefene|mesh-list
55991610|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55991619|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55718950|NCT01959633|Interferons|interferons|mesh-list
55991620|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
55991621|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991622|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991623|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55991624|NCT03096730|Narcotics|narcotics|mesh-ancestor
55991625|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55991626|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55991627|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
55991628|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
55991629|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55991630|NCT00362037|Irbesartan|irbesartan|mesh-list
55991631|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55991632|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55991633|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55991634|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991635|NCT03161158|Diuretics|diuretics|mesh-list
55991636|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
55991637|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991638|NCT03161938|Dexamethasone|dexamethasone|mesh-list
55991639|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55991640|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
55991641|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
55991642|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991643|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991644|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55991645|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
55991646|NCT03161938|Hormones|hormones|mesh-ancestor
55991647|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55991663|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991665|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55991666|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
55991667|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991668|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991669|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55991670|NCT03018301|Ketamine|ketamine|mesh-list
55991671|NCT03018301|Analgesics|analgesics|mesh-ancestor
55991672|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
55991673|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991674|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991675|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55991676|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55991677|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
55991678|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
55991679|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991680|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55991681|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55991682|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991683|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991684|NCT00990769|Anesthetics|anesthetics|mesh-list
55991685|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991686|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991687|NCT00991081|Bupropion|bupropion|mesh-list
55991688|NCT00991081|Nicotine|nicotine|mesh-list
55991689|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55991709|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
55991710|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55991711|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
55991712|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55991713|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55991714|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991715|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55991716|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991717|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55991718|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55991719|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55991720|NCT03168022|Analgesics|analgesics|mesh-ancestor
55991721|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
55991722|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55991723|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55991724|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991725|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991726|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
55991727|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991728|NCT03102190|Verapamil|verapamil|mesh-list
55991729|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55991730|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55991731|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991732|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991733|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55991734|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991735|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
55991736|NCT03254667|Brodalumab|brodalumab|mesh-list
55991737|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
55991738|NCT03102736|Nitroprusside|nitroprusside|mesh-list
55991739|NCT03102736|Ketamine|ketamine|mesh-list
55991740|NCT03102736|Analgesics|analgesics|mesh-ancestor
55991749|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55991750|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55991751|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717540|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
55991752|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991753|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55991754|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
55991755|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55991756|NCT03743103|Nitroprusside|nitroprusside|mesh-list
55991757|NCT03743103|Esmolol|esmolol|mesh-list
55991758|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55991759|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
55991760|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55991761|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991762|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55991763|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55991764|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55991765|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
55991766|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991767|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991768|NCT04049266|Aflibercept|aflibercept|mesh-list
55991769|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55991770|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55991771|NCT04049266|Growth Substances|growth substances|mesh-ancestor
55991772|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991773|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
55991774|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991775|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
55991776|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991777|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991778|NCT01502917|Antibodies|antibodies|mesh-list
55991779|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55991780|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
55991782|NCT00362505|Clevudine|clevudine|mesh-list
55991791|NCT00993187|Hormones|hormones|mesh-ancestor
55991792|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55991793|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55991794|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
55991795|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991796|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991797|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55991798|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991799|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
55991800|NCT03173170|Itraconazole|itraconazole|mesh-list
55991801|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
55991802|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991803|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55991804|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55991805|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991806|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991807|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55991808|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
55991809|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55991810|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991811|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55991812|NCT03106870|Insulin|insulin|mesh-list
55991813|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55991814|NCT03106870|Metformin|metformin|mesh-list
55991815|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
55991816|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55991817|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991818|NCT03792490|Fasudil|fasudil|mesh-list
55991819|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55991820|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991821|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717548|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991822|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55991823|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991824|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
55930215|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991825|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55991826|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991827|NCT00375310|Gemcitabine|gemcitabine|mesh-list
55991828|NCT00375310|Sorafenib|sorafenib|mesh-list
55991829|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55991830|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
55991831|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991832|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991833|NCT00375310|Antiviral Agents|antiviral agents|mesh-ancestor
55991834|NCT00375310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991835|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991836|NCT00375310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991837|NCT00375310|Immunologic Factors|immunologic factors|mesh-ancestor
55991838|NCT00375310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991839|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55719175|NCT04463875|Analgesics|analgesics|mesh-ancestor
55991840|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55991841|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55991842|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
55991843|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991844|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55991845|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55991846|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
55991847|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
55991848|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991850|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
55991873|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
55991874|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
55991875|NCT00657241|Valsartan|valsartan|mesh-list
55991876|NCT00657241|Carvedilol|carvedilol|mesh-list
55991877|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55991878|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55991879|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55991880|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991881|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55991882|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55991883|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
55991884|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55991885|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991886|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
55991887|NCT00657241|Protective Agents|protective agents|mesh-ancestor
55991888|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55991889|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55991890|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55991891|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
55991892|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55991893|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55991894|NCT04342065|Celecoxib|celecoxib|mesh-list
55991895|NCT04342065|Pregabalin|pregabalin|mesh-list
55991897|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
55991898|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55991899|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991900|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
55991918|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991919|NCT03178149|Tacrolimus|tacrolimus|mesh-list
55991920|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991921|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
55991922|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991923|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55991924|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991925|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991926|NCT00478465|Valganciclovir|valganciclovir|mesh-list
55991927|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
55991928|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991929|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
55991930|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55991931|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
55991932|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991933|NCT00421785|Expectorants|expectorants|mesh-ancestor
55991934|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
55991935|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55991936|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
55717603|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
55991937|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991938|NCT00421785|Protective Agents|protective agents|mesh-ancestor
55991939|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991940|NCT00421785|Antidotes|antidotes|mesh-ancestor
55991941|NCT02519348|Bevacizumab|bevacizumab|mesh-list
55991942|NCT02519348|Durvalumab|durvalumab|mesh-list
55991943|NCT02519348|Tremelimumab|tremelimumab|mesh-list
55991944|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55991945|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991946|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55991947|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55991948|NCT02519348|Growth Substances|growth substances|mesh-ancestor
55991949|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55991961|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991962|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55991963|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55991964|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
55991965|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55991966|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
55991967|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55991968|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55991969|NCT03113500|Prednisone|prednisone|mesh-list
55991970|NCT03113500|Cortisone|cortisone|mesh-list
55991971|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
55991972|NCT03113500|Doxorubicin|doxorubicin|mesh-list
55991973|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55991974|NCT03113500|Etoposide|etoposide|mesh-list
55991975|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
55991976|NCT03113500|Daunorubicin|daunorubicin|mesh-list
55991977|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55991978|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
55991979|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55991980|NCT03113500|Antibodies|antibodies|mesh-list
55991981|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
55991982|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55991983|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
55991984|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717635|NCT03761225|Prednisone|prednisone|mesh-list
55991985|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
55991986|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719331|NCT02324413|Clonidine|clonidine|mesh-list
55991987|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55991988|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55991989|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
55991990|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991991|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55991992|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55991993|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55991994|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55991996|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930216|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
55930218|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55930219|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55991999|NCT03113500|Hormones|hormones|mesh-ancestor
55992000|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992001|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55992002|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55992003|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
55992004|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
55992005|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992006|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992009|NCT00421863|Telmisartan|telmisartan|mesh-list
55992063|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992064|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
55719433|NCT03132103|Vitamin D|vitamin d|mesh-list
55992065|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992066|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55992067|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55992068|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55992069|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55992070|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992071|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992072|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
55992073|NCT03127137|Hormones|hormones|mesh-ancestor
55992074|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992075|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992076|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
55992077|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992078|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
55992079|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55992080|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55992081|NCT03122847|Prednisolone|prednisolone|mesh-list
55992082|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
55992083|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55992084|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
55992085|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992086|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
55992087|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
55992088|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992089|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992090|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55992091|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
55992092|NCT03122847|Hormones|hormones|mesh-ancestor
55992104|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992105|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992106|NCT03525028|Metformin|metformin|mesh-list
55992107|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55992108|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992109|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55992110|NCT00754312|Entinostat|entinostat|mesh-list
55992111|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992112|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55992113|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992114|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992115|NCT03523312|Capecitabine|capecitabine|mesh-list
55992116|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55992117|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
55992118|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992119|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992120|NCT03623373|Cytarabine|cytarabine|mesh-list
55992121|NCT03623373|Rituximab|rituximab|mesh-list
55992122|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55992123|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
55992124|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55992125|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992126|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
55992127|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992128|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717720|NCT02349399|Estrogens|estrogens|mesh-ancestor
55992129|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55992130|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
55992131|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992132|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
55992133|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992134|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992135|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55992136|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
55992137|NCT03505762|Prednisone|prednisone|mesh-list
55992138|NCT03505762|Cortisone|cortisone|mesh-list
55930290|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930291|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930292|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55930293|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
55992139|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
55992140|NCT03505762|Rituximab|rituximab|mesh-list
55992141|NCT03505762|Doxorubicin|doxorubicin|mesh-list
55992142|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55992143|NCT03505762|Vincristine|vincristine|mesh-list
55992144|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55992145|NCT03505762|Antibodies|antibodies|mesh-list
55992146|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
55992147|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55992148|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992149|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
55992150|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992151|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992152|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55992153|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
55992154|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992155|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992156|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55992157|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55992158|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55992159|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55992160|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992161|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992162|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
55992163|NCT03505762|Hormones|hormones|mesh-ancestor
55717752|NCT02344095|Cisplatin|cisplatin|mesh-list
55992164|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992165|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55992186|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55992187|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992188|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
55992189|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992190|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992192|NCT03410446|Analgesics|analgesics|mesh-ancestor
55992193|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
55992194|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992195|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992196|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55992197|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55992198|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
55992199|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
55992200|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992201|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55992202|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55992203|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992204|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992205|NCT03617445|Vancomycin|vancomycin|mesh-list
55992206|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55992207|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992208|NCT00375388|Metformin|metformin|mesh-list
55992209|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55992210|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992211|NCT00375778|Memantine|memantine|mesh-list
55992212|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55930294|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930295|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930296|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55930297|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
55930298|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55930299|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930300|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
55930341|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930342|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55930343|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55930344|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
55930345|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55930346|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55930347|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55930348|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
55930397|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930399|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55930400|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55930401|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
55930402|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55992213|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55992215|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992216|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992217|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992218|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55992219|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55992220|NCT04652440|Antibodies|antibodies|mesh-list
55992221|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55992222|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
55992223|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992224|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55992225|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992226|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55992227|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992228|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992229|NCT03001726|Docetaxel|docetaxel|mesh-list
55992230|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
55992231|NCT03001726|Tegafur|tegafur|mesh-list
55992232|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992233|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992234|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992235|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992236|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992237|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55992238|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
55992239|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
55992258|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992259|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55992260|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
55992261|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992262|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992263|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55992264|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
55992265|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55992266|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992267|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55992268|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
55992269|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55992270|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992271|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992272|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992273|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
55992274|NCT04598074|Narcotics|narcotics|mesh-ancestor
55756951|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
55717816|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992275|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992276|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992277|NCT04598074|Analgesics|analgesics|mesh-ancestor
55992278|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
55992279|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992280|NCT04593940|Remdesivir|remdesivir|mesh-list
55992281|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
55992282|NCT04593940|Abatacept|abatacept|mesh-list
55992283|NCT04593940|Infliximab|infliximab|mesh-list
55992284|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
55992285|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55992286|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992287|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55992288|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992289|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719629|NCT02234921|Imiquimod|imiquimod|mesh-list
55992290|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992291|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
55992293|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
55992296|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55992297|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55992298|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55992299|NCT04353193|Octreotide|octreotide|mesh-list
55992300|NCT04353193|Terlipressin|terlipressin|mesh-list
55992301|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55992302|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55992303|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992304|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55992305|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55992306|NCT01023841|Bimatoprost|bimatoprost|mesh-list
55992307|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55992308|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55992309|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55992310|NCT00635648|Caspofungin|caspofungin|mesh-list
55992311|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
55992312|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992313|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992314|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992315|NCT03056001|Doxorubicin|doxorubicin|mesh-list
55992316|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
55992317|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55992318|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992319|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55992320|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55992321|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992322|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992323|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55992324|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
55992325|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
55992326|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
55992327|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
55992340|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55992341|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992342|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992343|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992344|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992345|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992346|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55992347|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55992348|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55992349|NCT03574779|Growth Substances|growth substances|mesh-ancestor
55992350|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992351|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
55992352|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55992353|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992354|NCT04341883|Paclitaxel|paclitaxel|mesh-list
55992355|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55992356|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55992357|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992358|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992359|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992360|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992361|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719700|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55992362|NCT00995761|Cisplatin|cisplatin|mesh-list
55992363|NCT00995761|Docetaxel|docetaxel|mesh-list
55992364|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992365|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992366|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992367|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992368|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992369|NCT00362271|Aripiprazole|aripiprazole|mesh-list
55992370|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55992371|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
55992378|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
55992379|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992380|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992381|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55992382|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55992384|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55992385|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55992386|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55992387|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55756952|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
55992388|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55992389|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55992390|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55992391|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55992438|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992439|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
55992440|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
55992441|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992442|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992443|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55992444|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
55992445|NCT03544281|Hormones|hormones|mesh-ancestor
55992446|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992447|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55992448|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992449|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
55992450|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55992451|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55992452|NCT03544281|Growth Substances|growth substances|mesh-ancestor
55992453|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
55992454|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55992455|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55992456|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992457|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
55992458|NCT03182920|Lasmiditan|lasmiditan|mesh-list
55992459|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55992460|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
55992461|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992462|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992463|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992464|NCT05406388|Fentanyl|fentanyl|mesh-list
55992465|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55992466|NCT05406388|Narcotics|narcotics|mesh-ancestor
55992467|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992481|NCT03485547|Venetoclax|venetoclax|mesh-list
55992482|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992483|NCT03456063|Gemcitabine|gemcitabine|mesh-list
55992484|NCT03456063|Paclitaxel|paclitaxel|mesh-list
55992485|NCT03456063|Carboplatin|carboplatin|mesh-list
55992486|NCT03456063|Pemetrexed|pemetrexed|mesh-list
55992487|NCT03456063|Atezolizumab|atezolizumab|mesh-list
55992488|NCT03456063|Antibodies|antibodies|mesh-list
55992489|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55992490|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992491|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992492|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992493|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992494|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992495|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
55992496|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992497|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55992498|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
55992499|NCT03456063|Antiviral Agents|antiviral agents|mesh-ancestor
55992500|NCT03456063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992501|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992502|NCT03456063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992503|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55992504|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55992505|NCT02947347|Rituximab|rituximab|mesh-list
55992506|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55992507|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992508|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
55992509|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992510|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992511|NCT03187678|Selexipag|selexipag|mesh-list
55992512|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55992513|NCT02942355|Palbociclib|palbociclib|mesh-list
55719855|NCT02262143|Fenofibrate|fenofibrate|mesh-list
55992514|NCT02942355|Anastrozole|anastrozole|mesh-list
55992517|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992522|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55992523|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
55992524|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992525|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992526|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55992527|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
55992529|NCT03192826|Brinzolamide|brinzolamide|mesh-list
55992530|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55992531|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55992532|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55992533|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55992534|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
55992535|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992536|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992537|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992538|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55992539|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55992540|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55992541|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992577|NCT00634244|Topotecan|topotecan|mesh-list
55992578|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
55992579|NCT00634244|Alvocidib|alvocidib|mesh-list
55992580|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992581|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55992582|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55992583|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55992584|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992585|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992586|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55992587|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
55992588|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
55992589|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992590|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992591|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
55992592|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992593|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55992594|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55992595|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
55992596|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55992597|NCT00634244|Analgesics|analgesics|mesh-ancestor
55992598|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
55992599|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992600|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
55992601|NCT00634244|Growth Substances|growth substances|mesh-ancestor
55992602|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55992603|NCT01922804|Vitamins|vitamins|mesh-list
55992604|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
55992605|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992606|NCT03289858|Bupivacaine|bupivacaine|mesh-list
55992607|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
55992608|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
55992621|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55992622|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
55992623|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992624|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992625|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55992626|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55992627|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
55717904|NCT02299765|Antiviral Agents|antiviral agents|mesh-ancestor
55992628|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992629|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992630|NCT03294850|Cholic Acids|cholic acids|mesh-list
55992631|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55992632|NCT00996931|Lenalidomide|lenalidomide|mesh-list
55992633|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
55992634|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992635|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55992636|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55992637|NCT00996931|Growth Substances|growth substances|mesh-ancestor
55992638|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
55992639|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992640|NCT00634088|Capecitabine|capecitabine|mesh-list
55992641|NCT00634088|Lapatinib|lapatinib|mesh-list
55992642|NCT00634088|Epothilones|epothilones|mesh-list
55992643|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55992644|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
55992645|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992646|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992647|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55992648|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992649|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992650|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992651|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992652|NCT03428230|Acetaminophen|acetaminophen|mesh-list
55992653|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
55992654|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55992655|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55992660|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
55992661|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
55992662|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
55992663|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992664|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
55992666|NCT03296800|Probenecid|probenecid|mesh-list
55720069|NCT01516073|Xhance|xhance|mesh-list
55992667|NCT03296800|Verapamil|verapamil|mesh-list
55992668|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55992669|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
55992670|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55992671|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992672|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
55992673|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55992674|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992675|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992676|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55992677|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55992678|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55992679|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55992680|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55992681|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55992682|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55992683|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55992684|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55992685|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55992686|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992687|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
55992704|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
55992705|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992706|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
55992707|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
55992708|NCT00633932|Esomeprazole|esomeprazole|mesh-list
55992709|NCT00633932|Omeprazole|omeprazole|mesh-list
55992710|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55992711|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55992712|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55992713|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992714|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992715|NCT01028677|Oxytocin|oxytocin|mesh-list
55992716|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
55992717|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55717963|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55992718|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992719|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
55992720|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992721|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
55992722|NCT01000285|Prednisone|prednisone|mesh-list
55992723|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
55992724|NCT01000285|Doxorubicin|doxorubicin|mesh-list
55992725|NCT01000285|Etoposide|etoposide|mesh-list
55992726|NCT01000285|Vincristine|vincristine|mesh-list
55992727|NCT01000285|Bortezomib|bortezomib|mesh-list
55992728|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992730|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992731|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992732|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55992733|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
55992734|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930403|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55930404|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
55930405|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
55930406|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930407|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55930408|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55930409|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55930410|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55930411|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55930446|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930447|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55930448|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931444|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931445|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
55992735|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992736|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55992737|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55992738|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55992739|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55992740|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992741|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992742|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
55720075|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55992744|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992745|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55992746|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55992747|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992748|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992749|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992750|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55992751|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55992752|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
55992753|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992754|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55992755|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55992756|NCT01000987|Varenicline|varenicline|mesh-list
55992757|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55992758|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55992759|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
55992760|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992761|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992762|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992763|NCT00633464|Cetuximab|cetuximab|mesh-list
55992764|NCT00633464|Epothilones|epothilones|mesh-list
55992765|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55992766|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992767|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992768|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992769|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992773|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55992774|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55992775|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55992777|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
55992778|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992779|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992780|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992781|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55992782|NCT01923194|Hormones|hormones|mesh-ancestor
55992783|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992784|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992785|NCT03303196|Pancrelipase|pancrelipase|mesh-list
55992786|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55992788|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55992789|NCT00633152|Cephalosporins|cephalosporins|mesh-list
55992790|NCT00633152|Aztreonam|aztreonam|mesh-list
55992791|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55992792|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55992793|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55992794|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992795|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992796|NCT01030783|Sorafenib|sorafenib|mesh-list
55992797|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992798|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55992799|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992800|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992801|NCT00633074|Vaccines|vaccines|mesh-list
55720149|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55992818|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992819|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992820|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992821|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
55992822|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
55992824|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55992825|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992826|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718009|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55992827|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
55992828|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992829|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992830|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55992831|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
55992878|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992879|NCT03933397|Morphine|morphine|mesh-list
55992880|NCT03933397|Hydromorphone|hydromorphone|mesh-list
55992881|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55992882|NCT03933397|Narcotics|narcotics|mesh-ancestor
55992883|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992884|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992885|NCT03933397|Analgesics|analgesics|mesh-ancestor
55992886|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
55992887|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992888|NCT03506048|Lenvatinib|lenvatinib|mesh-list
55992889|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992890|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55992891|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992892|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992893|NCT02161705|Ropivacaine|ropivacaine|mesh-list
55992894|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
55992895|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
55992896|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992897|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992898|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
55992899|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992900|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
55992901|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55992902|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
55992903|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992904|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992905|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55992906|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
55992907|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55992908|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
55992909|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992910|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992911|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55992912|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
55992913|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
55992914|NCT01929824|Protective Agents|protective agents|mesh-ancestor
55992918|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
55992919|NCT01031953|Aprepitant|aprepitant|mesh-list
55992920|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
55992921|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
55992922|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992923|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992924|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55992925|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55992926|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718035|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718036|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55718037|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55718038|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718039|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55718040|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55718041|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
55718042|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
55718043|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
55718044|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992927|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992929|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
55992930|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992931|NCT00630344|Everolimus|everolimus|mesh-list
55992932|NCT00630344|Bicalutamide|bicalutamide|mesh-list
55992933|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55992934|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55992935|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
55992936|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992937|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
55992938|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
55992939|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55992940|NCT01923818|Aspirin|aspirin|mesh-list
55992941|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
55992942|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55992943|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55992944|NCT01923818|Analgesics|analgesics|mesh-ancestor
55992945|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
55992946|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992947|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992948|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992949|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55992955|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992956|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
55992957|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55992958|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
55992959|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55992960|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
55992961|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
55992962|NCT02169115|Omalizumab|omalizumab|mesh-list
55992963|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55992964|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55992965|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55992966|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
55992967|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
55992968|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992969|NCT00376792|Docetaxel|docetaxel|mesh-list
55992970|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931446|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931447|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55931448|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
55931449|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931450|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55932449|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932450|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
55932451|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932452|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55932453|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
55932454|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55932455|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55932456|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932457|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55932850|NCT04361409|Rituximab|rituximab|mesh-list
55932851|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55932852|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932853|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
55932854|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932855|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932856|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55932857|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
55932858|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932859|NCT04361409|Antiviral Agents|antiviral agents|mesh-ancestor
55932860|NCT04361409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932861|NCT04361409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932862|NCT04361409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55932863|NCT04368273|Antibodies|antibodies|mesh-list
55932864|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
55932865|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932866|NCT04995354|Mitogens|mitogens|mesh-list
55932867|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
55932868|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932869|NCT04368351|Azithromycin|azithromycin|mesh-list
55932871|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55932872|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932873|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
55932874|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55932875|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55932876|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55992971|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
55992972|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
55992973|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
55992974|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992975|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
55992976|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
55992977|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55992978|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
55992979|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992980|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992981|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55992982|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
55992983|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55992984|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55992985|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55992986|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
55992987|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55992988|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55992989|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55992990|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
55992991|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55992992|NCT03316378|Ropivacaine|ropivacaine|mesh-list
55992993|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
55992994|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
55992995|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55992996|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55992997|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
55992998|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55992999|NCT00637130|Travoprost|travoprost|mesh-list
55993006|NCT02847559|Antibodies|antibodies|mesh-list
55993013|NCT02847559|Growth Substances|growth substances|mesh-ancestor
55993014|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993015|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
55993016|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
55993017|NCT00637052|Filanesib|filanesib|mesh-list
55993018|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
55993019|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
55993020|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993021|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993022|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
55993023|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
55993024|NCT01921868|Vitamins|vitamins|mesh-ancestor
55993025|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
55993026|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993027|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
55993028|NCT02150785|Streptokinase|streptokinase|mesh-list
55993029|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55993030|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55993031|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993032|NCT01926158|Denosumab|denosumab|mesh-list
55993033|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55993034|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993035|NCT02393859|Dexamethasone|dexamethasone|mesh-list
55993036|NCT02393859|Methotrexate|methotrexate|mesh-list
55993067|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55993068|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55993069|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55993070|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
55993072|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993073|NCT03445390|Analgesics|analgesics|mesh-ancestor
55993074|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
55993075|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993076|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993077|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
55993078|NCT00981890|Sunitinib|sunitinib|mesh-list
55993079|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993080|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55993081|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55993082|NCT00981890|Growth Substances|growth substances|mesh-ancestor
55993085|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55993086|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993087|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993088|NCT03221764|Amiodarone|amiodarone|mesh-list
55993089|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55993090|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
55993091|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55993092|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55993093|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993094|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55993095|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55993096|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55993097|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993098|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55993099|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55993100|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55993106|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55993107|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55993108|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993109|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
55993110|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993111|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993112|NCT05593627|Lithium Carbonate|lithium carbonate|mesh-list
55993113|NCT05593627|Calcium Carbonate|calcium carbonate|mesh-list
55993114|NCT05593627|Calcium|calcium|mesh-list
55993115|NCT05593627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55993116|NCT05593627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993117|NCT05593627|Antidepressive Agents|antidepressive agents|mesh-ancestor
55993118|NCT05593627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55993119|NCT05593627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993120|NCT05593627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993121|NCT05593627|Antimanic Agents|antimanic agents|mesh-ancestor
55993122|NCT05593627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55993123|NCT05593627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993125|NCT05593627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55993126|NCT02169427|Opicapone|opicapone|mesh-list
55993127|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55993128|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993129|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993130|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55993131|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55993132|NCT02376699|Gemcitabine|gemcitabine|mesh-list
55993133|NCT02376699|Paclitaxel|paclitaxel|mesh-list
55993134|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
55993135|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55993136|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993137|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
55932877|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932878|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932879|NCT05620641|Gabapentin|gabapentin|mesh-list
55932880|NCT05620641|Ondansetron|ondansetron|mesh-list
55932881|NCT05620641|Analgesics|analgesics|mesh-ancestor
55932882|NCT05620641|Sensory System Agents|sensory system agents|mesh-ancestor
55993138|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
55993139|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
55993140|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993141|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55993142|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
55993143|NCT02376699|Antiviral Agents|antiviral agents|mesh-ancestor
55993144|NCT02376699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993145|NCT02376699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993146|NCT02376699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993147|NCT02376699|Immunologic Factors|immunologic factors|mesh-ancestor
55993148|NCT02376699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993149|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55993150|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
55993151|NCT03454048|Piperaquine|piperaquine|mesh-list
55993152|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
55993153|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55993154|NCT03454048|Atovaquone|atovaquone|mesh-list
55993155|NCT03454048|Proguanil|proguanil|mesh-list
55993156|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
55993157|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
55993158|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55993159|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55993160|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993161|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55993162|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993163|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993164|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55993165|NCT03454048|Renal Agents|renal agents|mesh-ancestor
55993166|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
55993167|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55993169|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
55993182|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993183|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55993184|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
55993185|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55993186|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
55993187|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993188|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993189|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55993190|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
55993191|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
55993192|NCT03455218|Protective Agents|protective agents|mesh-ancestor
55993193|NCT01050907|Miltefosine|miltefosine|mesh-list
55993194|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
55993195|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993196|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993206|NCT04433845|Psilocybin|psilocybin|mesh-list
55993242|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
55993243|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993244|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993245|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
55993246|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55993247|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55993248|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
55993249|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993250|NCT01052701|Ribavirin|ribavirin|mesh-list
55993251|NCT01052701|Abacavir|abacavir|mesh-list
55993252|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
55993253|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993254|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
55993255|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993256|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55993257|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55993258|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993259|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55993260|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55993261|NCT01921010|Niacin|niacin|mesh-list
55993262|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
55993263|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55993293|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993294|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55993295|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993296|NCT00986258|Tapentadol|tapentadol|mesh-list
55993297|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55993298|NCT00986258|Narcotics|narcotics|mesh-ancestor
55993299|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993300|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993301|NCT00986258|Analgesics|analgesics|mesh-ancestor
55993302|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
55993303|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993304|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55993305|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55993306|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55993307|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993308|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
55993309|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993310|NCT00986180|Oxycodone|oxycodone|mesh-list
55993311|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55993312|NCT00986180|Narcotics|narcotics|mesh-ancestor
55993313|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993314|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993315|NCT00986180|Analgesics|analgesics|mesh-ancestor
55993316|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
55993317|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993318|NCT05510089|Cytarabine|cytarabine|mesh-list
55993319|NCT05510089|Etoposide|etoposide|mesh-list
55993320|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55993321|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993322|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55993323|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55993324|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993325|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993333|NCT01056601|Bortezomib|bortezomib|mesh-list
55993334|NCT01056601|Panobinostat|panobinostat|mesh-list
55993335|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993336|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55993337|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993338|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993339|NCT03014947|Adalimumab|adalimumab|mesh-list
55993340|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993341|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993342|NCT04238767|Dolutegravir|dolutegravir|mesh-list
55993343|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55993344|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55993345|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993346|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993347|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55993348|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55993349|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
55993350|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993351|NCT01057225|Thalidomide|thalidomide|mesh-list
55993352|NCT01057225|Dexamethasone|dexamethasone|mesh-list
55993353|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
55993354|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993355|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
55993356|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993357|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993358|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55993359|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
55993382|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993383|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993384|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993385|NCT01057381|Analgesics|analgesics|mesh-ancestor
55993386|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
55993387|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993388|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55993389|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55993390|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55993391|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
55993392|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993393|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993394|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55993395|NCT01057381|Narcotics|narcotics|mesh-ancestor
55993396|NCT00986102|Doripenem|doripenem|mesh-list
55993397|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55993398|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993399|NCT01058239|Rituximab|rituximab|mesh-list
55993400|NCT01058239|Bortezomib|bortezomib|mesh-list
55993401|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55993402|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993403|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
55993404|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993405|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993406|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
55993407|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
55993408|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993409|NCT01058941|Protective Agents|protective agents|mesh-ancestor
55993410|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993411|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
55993412|NCT01058941|Vitamins|vitamins|mesh-ancestor
55993413|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
55993414|NCT00985946|Panobinostat|panobinostat|mesh-list
55932940|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932942|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
55932943|NCT02245191|Ephedrine|ephedrine|mesh-list
55932944|NCT02245191|Metaraminol|metaraminol|mesh-list
55932945|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55932946|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
55932947|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
55993415|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993416|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55993417|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993418|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993419|NCT02170519|Iloprost|iloprost|mesh-list
55720754|NCT05401916|Acetaminophen|acetaminophen|mesh-list
55993420|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55993421|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
55993422|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
55993423|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55993424|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756953|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
55718197|NCT03147963|Docetaxel|docetaxel|mesh-list
55993425|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55993426|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
55993427|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993428|NCT01924910|Vitamin D|vitamin d|mesh-list
55993429|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
55993430|NCT01924910|Vitamins|vitamins|mesh-ancestor
55993431|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
55993432|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993433|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55993434|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55993435|NCT04395638|Vitamin D|vitamin d|mesh-list
55993436|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
55993437|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
55993438|NCT04395638|Vitamins|vitamins|mesh-list
55932970|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
55932971|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932972|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
55932973|NCT04145687|Metformin|metformin|mesh-list
55932974|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55932975|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932976|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
55932977|NCT04359615|Favipiravir|favipiravir|mesh-list
55932978|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
55932979|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55932980|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55932981|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932982|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932983|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932984|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932985|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
55933020|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55933021|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55933022|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933023|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55933024|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55933049|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
55933050|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
55933051|NCT04355949|Vitamins|vitamins|mesh-list
55933052|NCT04355949|Folic Acid|folic acid|mesh-list
55933053|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
55993439|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
55993440|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993441|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55993442|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55993444|NCT01921790|Dexamethasone|dexamethasone|mesh-list
55993445|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
55993446|NCT01921790|Bevacizumab|bevacizumab|mesh-list
55993447|NCT01921790|Pegaspargase|pegaspargase|mesh-list
55993448|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993449|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
55993450|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
55993451|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993452|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993453|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55993454|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
55993455|NCT01921790|Hormones|hormones|mesh-ancestor
55993456|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993457|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55993458|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993459|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55993460|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
55993461|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993462|NCT01921790|Antiviral Agents|antiviral agents|mesh-ancestor
55993463|NCT01921790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993464|NCT01921790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993473|NCT04347980|Dexamethasone|dexamethasone|mesh-list
55993486|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55993487|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55993488|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993489|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993490|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993491|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993492|NCT01925300|Bisoprolol|bisoprolol|mesh-list
55993493|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55993494|NCT01925300|Calcium|calcium|mesh-list
55993495|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55993496|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993497|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55993498|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55993499|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
55993500|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993501|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55993502|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55993503|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993504|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55993505|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
55993506|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
55993507|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993508|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55993509|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55993510|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55993511|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
55993512|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993513|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55993514|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55993515|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55993517|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993518|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55993519|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55993520|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993521|NCT01925378|Nelfinavir|nelfinavir|mesh-list
55993524|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
55993525|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993526|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993527|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55993528|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55993529|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
55993530|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993531|NCT01925456|Fesoterodine|fesoterodine|mesh-list
55993532|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55993533|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55993534|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
55993535|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993536|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993537|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993538|NCT01925456|Urological Agents|urological agents|mesh-ancestor
55993539|NCT02259621|Paclitaxel|paclitaxel|mesh-list
55993540|NCT02259621|Carboplatin|carboplatin|mesh-list
55993541|NCT02259621|Nivolumab|nivolumab|mesh-list
55993542|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55993543|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993544|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
55993545|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
55993546|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
55993547|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993548|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55993549|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55993550|NCT02255799|Donepezil|donepezil|mesh-list
55993551|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55993552|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993570|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993571|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55993572|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993573|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
55993574|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993578|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993579|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
55993580|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55756954|NCT03988205|Cytarabine|cytarabine|mesh-list
55826937|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
55826938|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826939|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826940|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
55826941|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55826942|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55826943|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55718231|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
55718233|NCT02300935|Paclitaxel|paclitaxel|mesh-list
55993581|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55993582|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55993583|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55993584|NCT03241030|Acetaminophen|acetaminophen|mesh-list
55993586|NCT03241030|Sucralfate|sucralfate|mesh-list
55993587|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993588|NCT03241030|Analgesics|analgesics|mesh-ancestor
55993589|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
55993590|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993591|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993592|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
55993593|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55993594|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993595|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993596|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55993597|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993601|NCT02184195|Olaparib|olaparib|mesh-list
55993616|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993617|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55993618|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993620|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993621|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993622|NCT03241810|Fulvestrant|fulvestrant|mesh-list
55993623|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55993624|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993625|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55993626|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55993627|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
55993628|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993629|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993630|NCT02129751|Bupropion|bupropion|mesh-list
55993631|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55993632|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
55993633|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55993634|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55993635|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55993636|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55993638|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
55993664|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
55993665|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55993666|NCT03242590|Testosterone|testosterone|mesh-list
55993667|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
55993668|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
55993669|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55993670|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993671|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
55993672|NCT03242590|Hormones|hormones|mesh-ancestor
55993673|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993674|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993675|NCT03242590|Androgens|androgens|mesh-ancestor
55993676|NCT03247738|Cangrelor|cangrelor|mesh-list
55993677|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55993678|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55993679|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55993680|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55993681|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
55993682|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993683|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993684|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993685|NCT01567605|Lidocaine|lidocaine|mesh-list
55993686|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
55993687|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
55993688|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993689|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993690|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
55718264|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
55993691|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993692|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55993693|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55993704|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993705|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993707|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55993708|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993709|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993710|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
55993711|NCT02604537|Hormones|hormones|mesh-ancestor
55993712|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993713|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55993714|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
55993715|NCT02568267|Entrectinib|entrectinib|mesh-list
55993716|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55993717|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993718|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993719|NCT01384773|Riboflavin|riboflavin|mesh-list
55721050|NCT02318602|Cannabidiol|cannabidiol|mesh-list
55993720|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55993721|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55993722|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
55993723|NCT01384773|Vitamins|vitamins|mesh-ancestor
55993724|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
55993725|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993726|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55993727|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
55993728|NCT01063075|Carboplatin|carboplatin|mesh-list
55993729|NCT01063075|Cetuximab|cetuximab|mesh-list
55993730|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993731|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55993732|NCT01341405|Celecoxib|celecoxib|mesh-list
55993733|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55993734|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993735|NCT01341405|Analgesics|analgesics|mesh-ancestor
55993736|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
55993739|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993743|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993744|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993745|NCT05136157|Insulin|insulin|mesh-list
55993746|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55993747|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
55993748|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55993749|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993750|NCT03487276|Vilobelimab|vilobelimab|mesh-list
55993751|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55993752|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55993753|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
55993754|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993755|NCT03489850|Ibudilast|ibudilast|mesh-list
55993756|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55993757|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
55993758|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993759|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993760|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55993761|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
55993762|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55993763|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993764|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993765|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55993766|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
55993767|NCT03490942|Glucagon|glucagon|mesh-list
55993768|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55993769|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55993770|NCT03490942|Hormones|hormones|mesh-ancestor
55993790|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55993791|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55993792|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993793|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993794|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55993795|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55993796|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55993797|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55993798|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55993799|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
55993800|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
55993801|NCT03493828|Bupivacaine|bupivacaine|mesh-list
55993802|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
55993803|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
55993804|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993805|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993806|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
55993807|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993808|NCT03496324|Ibuprofen|ibuprofen|mesh-list
55993809|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55993810|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993811|NCT03496324|Analgesics|analgesics|mesh-ancestor
55993812|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
55993813|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993814|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993815|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993816|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993837|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55993838|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993839|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993840|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55993841|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55993842|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
55993843|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993844|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993845|NCT01072669|Ambrisentan|ambrisentan|mesh-list
55993846|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55993847|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
55993848|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
55993849|NCT03014713|Dezocine|dezocine|mesh-list
55993850|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55993851|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993852|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993853|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993854|NCT03014713|Analgesics|analgesics|mesh-ancestor
55993855|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
55993856|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993857|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55993858|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55993859|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55993860|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
55993861|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55993862|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993863|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55993864|NCT03014713|Narcotics|narcotics|mesh-ancestor
55757036|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
55993865|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55993866|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993881|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
55993883|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55993884|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993885|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
55993886|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993887|NCT01075399|Imidazole|imidazole|mesh-list
55993888|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993889|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993890|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
55993891|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55993892|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993893|NCT03358576|Amoxicillin|amoxicillin|mesh-list
55993894|NCT03358576|Metronidazole|metronidazole|mesh-list
55993895|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
55993896|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
55993897|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
55993898|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55993899|NCT03358576|Ertapenem|ertapenem|mesh-list
55993900|NCT03358576|Lactams|lactams|mesh-list
55993901|NCT03358576|Probenecid|probenecid|mesh-list
55993902|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55993903|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993904|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55993905|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55993906|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55993907|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55993908|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993909|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858091|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
55933054|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
55933055|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
55933056|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
55933057|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933058|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55933059|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55933070|NCT05580887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933072|NCT05580887|Immunologic Factors|immunologic factors|mesh-ancestor
55718291|NCT02335281|Mesalamine|mesalamine|mesh-list
55933196|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
55933197|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55933198|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933199|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933200|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55933201|NCT04358367|Analgesics|analgesics|mesh-ancestor
55933202|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
55993910|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993911|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55993912|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55993913|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55993914|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
55993915|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
55993916|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993917|NCT03358576|Renal Agents|renal agents|mesh-ancestor
55993918|NCT03822013|Miglustat|miglustat|mesh-list
55993919|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993920|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993921|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55993922|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55993923|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
55993924|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993925|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55993926|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55993927|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993928|NCT00376324|Tigecycline|tigecycline|mesh-list
55993929|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55993930|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55993931|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55993932|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993933|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993934|NCT04735510|Cyclosporine|cyclosporine|mesh-list
55993935|NCT04735510|Cyclosporins|cyclosporins|mesh-list
55993959|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
55993960|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
55993961|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993962|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55993963|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
55993964|NCT00376480|Hormones|hormones|mesh-ancestor
55993965|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55993966|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55993967|NCT00376480|Protective Agents|protective agents|mesh-ancestor
55993968|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55993969|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
55993970|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55993971|NCT03016039|Curcumin|curcumin|mesh-list
55993972|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55993973|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55993974|NCT03016039|Analgesics|analgesics|mesh-ancestor
55993975|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
55993976|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55993977|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55993978|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55993979|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55993980|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993981|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55993982|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55993983|NCT03753919|Durvalumab|durvalumab|mesh-list
55993984|NCT03753919|Tremelimumab|tremelimumab|mesh-list
55993985|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55993986|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55993987|NCT03498196|Avelumab|avelumab|mesh-list
55993988|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55994003|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994004|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994005|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55994006|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55994007|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
55994008|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
55994009|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994010|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55994011|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55994012|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994013|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994014|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55994015|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55994016|NCT03270514|Bupivacaine|bupivacaine|mesh-list
55994017|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
55994018|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
55994019|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994020|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994021|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
55994022|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994023|NCT02178241|Gemcitabine|gemcitabine|mesh-list
55994024|NCT02178241|Halichondrin B|halichondrin b|mesh-list
55994025|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55994026|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
55994027|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994028|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994029|NCT02178241|Antiviral Agents|antiviral agents|mesh-ancestor
55994030|NCT02178241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994031|NCT02178241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994032|NCT02178241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994033|NCT02178241|Immunologic Factors|immunologic factors|mesh-ancestor
55994038|NCT03015727|Docetaxel|docetaxel|mesh-list
55994044|NCT03539731|Piperazine|piperazine|mesh-list
55994045|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
55994046|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
55994047|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55994048|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994049|NCT01077973|Ibuprofen|ibuprofen|mesh-list
55994050|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55994051|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55994052|NCT01077973|Analgesics|analgesics|mesh-ancestor
55994053|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
55994054|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718351|NCT02303587|Hormones|hormones|mesh-ancestor
55994055|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994056|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994057|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994058|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55994059|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994060|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994061|NCT02973646|Tenofovir|tenofovir|mesh-list
55994062|NCT02973646|Entecavir|entecavir|mesh-list
55994063|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55994064|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
55994065|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994066|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55994067|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55994068|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994069|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994070|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55994071|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55994072|NCT01078363|Ramipril|ramipril|mesh-list
55994073|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55994078|NCT03371836|Clobazam|clobazam|mesh-list
55994088|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994089|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994090|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55994091|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
55994092|NCT01078753|Coagulants|coagulants|mesh-ancestor
55994093|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55994094|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
55994095|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994096|NCT03372382|Acetaminophen|acetaminophen|mesh-list
55994097|NCT03372382|Ibuprofen|ibuprofen|mesh-list
55994098|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55994099|NCT03372382|Analgesics|analgesics|mesh-ancestor
55994100|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
55994101|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994102|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994103|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
55994104|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55994105|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994106|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994107|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55994108|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994109|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994110|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55994111|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55994112|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55994113|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994114|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994115|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55994116|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55994117|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994118|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
55994119|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994120|NCT03374176|Amoxicillin|amoxicillin|mesh-list
55994121|NCT03374176|Metronidazole|metronidazole|mesh-list
55994122|NCT03374176|Clindamycin|clindamycin|mesh-list
55994127|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55994128|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55994129|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55994130|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994131|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994133|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
55994134|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
55994135|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994136|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994138|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55994139|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55994141|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55994142|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994143|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
55994144|NCT03378076|Hormones|hormones|mesh-ancestor
55994145|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994146|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994147|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994148|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
55994149|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994150|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994151|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
55994152|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
55994153|NCT03520348|Vitamins|vitamins|mesh-ancestor
55994154|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
55994155|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994156|NCT03380026|Triamcinolone|triamcinolone|mesh-list
55994157|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55994158|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55994159|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
55994160|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55994161|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994162|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
55994163|NCT03380026|Hormones|hormones|mesh-ancestor
55994167|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
55994168|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994169|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994170|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
55994171|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55994172|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721517|NCT02328183|Polymyxins|polymyxins|mesh-list
55994174|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
55994175|NCT01079143|Everolimus|everolimus|mesh-list
55994176|NCT01079143|Cyclosporins|cyclosporins|mesh-list
55994177|NCT01079143|Basiliximab|basiliximab|mesh-list
55994178|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994179|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790245|NCT04383743|Cisplatin|cisplatin|mesh-list
55994180|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994181|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
55994182|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994183|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
55994184|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994185|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
55994186|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994187|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55994188|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994189|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55994190|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55994191|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
55994192|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994193|NCT03381742|Clopidogrel|clopidogrel|mesh-list
55994194|NCT03381742|Ticagrelor|ticagrelor|mesh-list
55994195|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55994196|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55994197|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55994198|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55994199|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
55994208|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994209|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55994210|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994211|NCT04735042|Incretins|incretins|mesh-ancestor
55994212|NCT04735042|Hormones|hormones|mesh-ancestor
55994213|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994214|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55994215|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
55994216|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994217|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55994218|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55994219|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994220|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
55994221|NCT00376012|Rifampin|rifampin|mesh-list
55994222|NCT00376012|Isoniazid|isoniazid|mesh-list
55994223|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
55994224|NCT00376012|Ethambutol|ethambutol|mesh-list
55994225|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55994226|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
55994227|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994228|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994229|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
55994230|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55994231|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994232|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994233|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55994234|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55994235|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55994236|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55994237|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55994238|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55994239|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55994240|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55994241|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
55994242|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55933203|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994243|NCT02171611|Dabigatran|dabigatran|mesh-list
55994244|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
55994245|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55994246|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
55994247|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994248|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994249|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
55994250|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
55994251|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
55994252|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55994253|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55994254|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994255|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55994256|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994257|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994258|NCT00942305|Brincidofovir|brincidofovir|mesh-list
55994259|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
55994260|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994261|NCT01084759|Etoposide|etoposide|mesh-list
55994262|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
55718477|NCT02304055|Oxytocin|oxytocin|mesh-list
55994263|NCT01084759|Testosterone|testosterone|mesh-list
55994264|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
55994265|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
55994266|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55994267|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55994268|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994269|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55994270|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55994271|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994272|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994273|NCT01084759|Androgens|androgens|mesh-ancestor
55994288|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
55994289|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
55994290|NCT01110421|Cefepime|cefepime|mesh-list
55994291|NCT01110421|Doripenem|doripenem|mesh-list
55994292|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55994293|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994294|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994295|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55994296|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994297|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994298|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
55994299|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55994300|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994301|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994302|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55994303|NCT04358627|Analgesics|analgesics|mesh-ancestor
55994304|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
55994305|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994306|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55994307|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55994308|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55994309|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
55994310|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994311|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994312|NCT04356677|Ribavirin|ribavirin|mesh-list
55994313|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
55994315|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
55994336|NCT04579523|Fludarabine|fludarabine|mesh-list
55994337|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
55994338|NCT04579523|Daratumumab|daratumumab|mesh-list
55994339|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55994340|NCT04579523|Antibodies|antibodies|mesh-list
55994341|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
55994342|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55994343|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55718479|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
55994344|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
55994345|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994346|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994347|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55994348|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
55994349|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994350|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994351|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55994352|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55994353|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
55994354|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
55994355|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
55994356|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55994357|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55994358|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
55994359|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994360|NCT02174419|Nalbuphine|nalbuphine|mesh-list
55994361|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55994387|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994388|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
55994389|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994390|NCT01112683|Memantine|memantine|mesh-list
55994391|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55994392|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55994393|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
55994394|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994395|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994396|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840507|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55994397|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55994398|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55994399|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
55994400|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55994401|NCT04355273|Heparin|heparin|mesh-list
55994402|NCT04355273|Calcium heparin|calcium heparin|mesh-list
55994403|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
55994404|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55994405|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55994406|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994407|NCT04355429|Captopril|captopril|mesh-list
55994408|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55994409|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
55994410|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994411|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994412|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55994413|NCT01114555|Bevacizumab|bevacizumab|mesh-list
55994414|NCT01114555|Irinotecan|irinotecan|mesh-list
55994415|NCT01114555|Temozolomide|temozolomide|mesh-list
55994416|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55994417|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994418|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55994419|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55994420|NCT01114555|Growth Substances|growth substances|mesh-ancestor
55994421|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994422|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
55933204|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55933232|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55933233|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994423|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55994424|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55994425|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994426|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994427|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55994428|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
55994429|NCT02673931|Exenatide|exenatide|mesh-list
55994430|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55994431|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994432|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55994433|NCT02673931|Incretins|incretins|mesh-ancestor
55994434|NCT02673931|Hormones|hormones|mesh-ancestor
55994435|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994436|NCT02579473|Rotigotine|rotigotine|mesh-list
55994437|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
55994438|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
55994439|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994440|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994441|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994442|NCT01115101|Pirinitramide|pirinitramide|mesh-list
55994443|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55994444|NCT01115101|Narcotics|narcotics|mesh-ancestor
55994445|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994446|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994447|NCT01115101|Analgesics|analgesics|mesh-ancestor
55994448|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
55994449|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994450|NCT02245529|Tamsulosin|tamsulosin|mesh-list
55994451|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55994452|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55718547|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718548|NCT02321800|Imipenem|imipenem|mesh-list
55994465|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994466|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55994467|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55994468|NCT00947765|Prednisolone|prednisolone|mesh-list
55994469|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55994470|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
55994471|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55994472|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
55994473|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55994474|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
55721806|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55994475|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994476|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
55994477|NCT00947765|Hormones|hormones|mesh-ancestor
55994478|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994479|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994480|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55994481|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994482|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
55994483|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
55994484|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994485|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994486|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55994487|NCT00947765|Protective Agents|protective agents|mesh-ancestor
55994488|NCT01089517|Ranibizumab|ranibizumab|mesh-list
55994489|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55994513|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
55994514|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994515|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994516|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55994517|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55994518|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
55994519|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994520|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994521|NCT01089751|Urological Agents|urological agents|mesh-ancestor
55994523|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55994524|NCT03032315|Telmisartan|telmisartan|mesh-list
55994525|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
55994526|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55994527|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55994528|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55994529|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757115|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
55994530|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55994531|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994567|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55994568|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
55994569|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
55994570|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994571|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55994572|NCT04355039|Dexamethasone|dexamethasone|mesh-list
55994573|NCT04355039|Pomalidomide|pomalidomide|mesh-list
55994574|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994575|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
55994576|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
55994577|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994578|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994579|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994580|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
55994581|NCT04355039|Hormones|hormones|mesh-ancestor
55994582|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994583|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55994584|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994585|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
55994586|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55994587|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55994588|NCT04355039|Growth Substances|growth substances|mesh-ancestor
55994589|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
55994590|NCT02524405|Corticosterone|corticosterone|mesh-list
55994618|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
55994619|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
55994620|NCT01092559|Protective Agents|protective agents|mesh-ancestor
55994622|NCT03587428|Trace Elements|trace elements|mesh-ancestor
55994623|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
55994624|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994626|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55994628|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994629|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994630|NCT03398278|Analgesics|analgesics|mesh-ancestor
55994631|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
55994632|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994633|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
55994634|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55994635|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55994681|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55994682|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
55994683|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
55994684|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
55994685|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994686|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994687|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994688|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55994689|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55994690|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994691|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55994692|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55994693|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
55994694|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994695|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994696|NCT02516241|Gemcitabine|gemcitabine|mesh-list
55994697|NCT02516241|Carboplatin|carboplatin|mesh-list
55994698|NCT02516241|Durvalumab|durvalumab|mesh-list
55994699|NCT02516241|Tremelimumab|tremelimumab|mesh-list
55994700|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994701|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55994711|NCT03944681|Droperidol|droperidol|mesh-list
55994732|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
55994733|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994734|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
55994735|NCT01093183|Lenalidomide|lenalidomide|mesh-list
55994736|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994737|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
55994738|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994739|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994740|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55994741|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
55994742|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994743|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994744|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55994745|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55994746|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55994747|NCT01093183|Growth Substances|growth substances|mesh-ancestor
55994748|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
55994749|NCT02430103|Goserelin|goserelin|mesh-list
55994750|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55994751|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994752|NCT03031535|Octreotide|octreotide|mesh-list
55994753|NCT03031535|Hormones|hormones|mesh-list
55994754|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
55994755|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994756|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994757|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994758|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55994759|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994760|NCT01093417|Vitamin D|vitamin d|mesh-list
55994777|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55994778|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55994779|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994780|NCT01093651|Incretins|incretins|mesh-ancestor
55994781|NCT01093651|Hormones|hormones|mesh-ancestor
55994782|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994783|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55994784|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
55994785|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994786|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994787|NCT00362895|Tobramycin|tobramycin|mesh-list
55994788|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
55994789|NCT00362895|Dexamethasone|dexamethasone|mesh-list
55994790|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
55994791|NCT00362895|BB 1101|bb 1101|mesh-list
55994792|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994793|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
55994794|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
55994795|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994796|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994797|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994798|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
55994799|NCT00362895|Hormones|hormones|mesh-ancestor
55994802|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994829|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55994830|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
55994831|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55994832|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994833|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55994834|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
55994835|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994836|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994837|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994838|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994839|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55994840|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
55994842|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55994843|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994844|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55994845|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
55994846|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
55994847|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994848|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994849|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55994850|NCT04744623|Protective Agents|protective agents|mesh-ancestor
55994851|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994852|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
55994853|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
55994854|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55994855|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55994877|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55994878|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55994879|NCT03729245|Growth Substances|growth substances|mesh-ancestor
55994880|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994881|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
55994882|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55994883|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994885|NCT03609047|Docetaxel|docetaxel|mesh-list
55994886|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
55994887|NCT03609047|Doxorubicin|doxorubicin|mesh-list
55994888|NCT03609047|Epirubicin|epirubicin|mesh-list
55994889|NCT03609047|Palbociclib|palbociclib|mesh-list
55994890|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55994891|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994892|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
55718655|NCT02310997|Melphalan|melphalan|mesh-list
55994893|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
55994894|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
55994895|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994896|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55994897|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
55994898|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994899|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994900|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55994901|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
55994902|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55994903|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55994904|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55994905|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55994906|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55994907|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55994908|NCT01118845|Rituximab|rituximab|mesh-list
55994909|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55994910|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55994911|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994912|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
55933234|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55933235|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55933236|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994913|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994914|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55994915|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55994916|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
55994917|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994918|NCT01130077|Poly ICLC|poly iclc|mesh-list
55994919|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
55994920|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
55994921|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994922|NCT03162731|Nivolumab|nivolumab|mesh-list
55994923|NCT03162731|Ipilimumab|ipilimumab|mesh-list
55994924|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55994925|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994926|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55994927|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994929|NCT03030911|Midazolam|midazolam|mesh-list
55994930|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
55994931|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55994932|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994933|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994934|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55994935|NCT03030911|Analgesics|analgesics|mesh-ancestor
55994936|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
55994937|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55994938|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55994939|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55994940|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55994941|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
55994942|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55994943|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994956|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55994957|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55994958|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
55994959|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
55994960|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55994961|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55994962|NCT03013387|Octreotide|octreotide|mesh-list
55994963|NCT03013387|Edotreotide|edotreotide|mesh-list
55994964|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55994965|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55994966|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994967|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55994968|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994969|NCT01782989|Doxycycline|doxycycline|mesh-list
55994970|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55994971|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55994972|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
55994973|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55994974|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55994975|NCT01120639|Temozolomide|temozolomide|mesh-list
55994976|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55718690|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994977|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
55994978|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55994979|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55994980|NCT01095757|Plerixafor|plerixafor|mesh-list
55994981|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55994982|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55994983|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
55994984|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995002|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55995004|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995005|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995006|NCT02245451|Analgesics|analgesics|mesh-ancestor
55995007|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
55995008|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995009|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
55995010|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
55995011|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55995013|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55995014|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55995015|NCT00951899|Metformin|metformin|mesh-list
55995016|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
55995017|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55995018|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995019|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55995020|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55995021|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
55995022|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995023|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55995024|NCT01097395|Ribavirin|ribavirin|mesh-list
55995025|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
55995026|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995027|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
55995028|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995029|NCT00467987|Testosterone|testosterone|mesh-list
55995030|NCT00467987|Androgens|androgens|mesh-ancestor
55995031|NCT00467987|Hormones|hormones|mesh-ancestor
55995032|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995033|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995034|NCT00433589|Tamoxifen|tamoxifen|mesh-list
55859242|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55995046|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55995047|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995048|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55995049|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
55995050|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995051|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995052|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55995053|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55995054|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55995055|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55995056|NCT03013075|Morphine|morphine|mesh-list
55995057|NCT03013075|Bupivacaine|bupivacaine|mesh-list
55995058|NCT03013075|Anesthetics|anesthetics|mesh-list
55995059|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
55718724|NCT02333799|Linezolid|linezolid|mesh-list
55995060|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
55995061|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995062|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995063|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
55995064|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995065|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55995066|NCT03013075|Narcotics|narcotics|mesh-ancestor
55995068|NCT00268385|Temozolomide|temozolomide|mesh-list
55995069|NCT00268385|Vorinostat|vorinostat|mesh-list
55995070|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55995071|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
55995076|NCT03030677|Lidocaine|lidocaine|mesh-list
55995093|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55995094|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
55995095|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995096|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55995097|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55995098|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995099|NCT03030287|Paclitaxel|paclitaxel|mesh-list
55995100|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55995101|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55995102|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995103|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
55995104|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
55995105|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
55995106|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995107|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
55995108|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995109|NCT03035357|Daratumumab|daratumumab|mesh-list
55995110|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995111|NCT00940589|Melatonin|melatonin|mesh-list
55995112|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
55890779|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55718764|NCT02304445|Estrogens|estrogens|mesh-ancestor
55995113|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995114|NCT00940589|Protective Agents|protective agents|mesh-ancestor
55995115|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995116|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995117|NCT02574078|Gemcitabine|gemcitabine|mesh-list
55995118|NCT02574078|Paclitaxel|paclitaxel|mesh-list
55995138|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55995140|NCT02574078|Antiviral Agents|antiviral agents|mesh-ancestor
55995141|NCT02574078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995142|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995143|NCT02574078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55995144|NCT02574078|Immunologic Factors|immunologic factors|mesh-ancestor
55995145|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55995146|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55995147|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55995148|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55995150|NCT03605914|Diclofenac|diclofenac|mesh-list
55995151|NCT03605914|Hydrocodone|hydrocodone|mesh-list
55995152|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55995153|NCT03605914|Analgesics|analgesics|mesh-ancestor
55995154|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
55995155|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995156|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995157|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
55995158|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55995159|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995160|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995161|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55995162|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995163|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995164|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55995165|NCT03605914|Narcotics|narcotics|mesh-ancestor
55995166|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995167|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
55995168|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
55995169|NCT04353479|Decitabine|decitabine|mesh-list
55995170|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55995182|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
55995183|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55995184|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
55995185|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995186|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995187|NCT03035045|Acetaminophen|acetaminophen|mesh-list
55995189|NCT03035045|Analgesics|analgesics|mesh-ancestor
55995190|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
55995191|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995192|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995193|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
55995194|NCT03034733|Dexamethasone|dexamethasone|mesh-list
55995195|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995196|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
55995197|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
55995198|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995199|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995200|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55995201|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
55995202|NCT03034733|Hormones|hormones|mesh-ancestor
55995203|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995204|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55995205|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995206|NCT05512416|Letrozole|letrozole|mesh-list
55995207|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995208|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55995209|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55995210|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995211|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995212|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55995213|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
55995214|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995215|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995216|NCT04290624|Listerine|listerine|mesh-list
55995217|NCT04290624|Fluorides|fluorides|mesh-list
55933237|NCT05583149|Cyclophosphamide|cyclophosphamide|mesh-list
55933238|NCT05583149|Fludarabine|fludarabine|mesh-list
55933239|NCT05583149|Acalabrutinib|acalabrutinib|mesh-list
55933240|NCT05583149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55995218|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
55995220|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
55995221|NCT04290624|Protective Agents|protective agents|mesh-ancestor
55995222|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995223|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55995224|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995225|NCT03403504|Oxycodone|oxycodone|mesh-list
55995226|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55995227|NCT03403504|Narcotics|narcotics|mesh-ancestor
55995228|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995229|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995230|NCT03403504|Analgesics|analgesics|mesh-ancestor
55995231|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
55995232|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995233|NCT05512728|Midazolam|midazolam|mesh-list
55995234|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55995235|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55995236|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995237|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995238|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55995239|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55995240|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55995241|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55995242|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
55995243|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
55995244|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
55995245|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
55995246|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995247|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995265|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995266|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995267|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
55995268|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995269|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55995270|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55995271|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55995272|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55995274|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55995276|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
55995277|NCT03565666|Pancrelipase|pancrelipase|mesh-list
55995278|NCT03565666|Pancreatin|pancreatin|mesh-list
55995279|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55995280|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995281|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55995282|NCT03620890|Protamines|protamines|mesh-list
55995283|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
55890780|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995284|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995285|NCT03620890|Coagulants|coagulants|mesh-ancestor
55995286|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
55995287|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55995288|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995289|NCT05507112|Capecitabine|capecitabine|mesh-list
55995290|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55995291|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55995292|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
55995293|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995294|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995295|NCT05511948|Hydroquinone|hydroquinone|mesh-list
55995296|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
55995297|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995298|NCT05511948|Protective Agents|protective agents|mesh-ancestor
55995299|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995300|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55995301|NCT00952133|Dexamethasone|dexamethasone|mesh-list
55995305|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995306|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
55995307|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
55995308|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995309|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995310|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55995311|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
55995313|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995314|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55995315|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995317|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995318|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995319|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55995320|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55995321|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
55995322|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995324|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55995325|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995326|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55995327|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55995328|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995329|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
55995330|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55995331|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55995332|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995333|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
55995334|NCT03023189|Coagulants|coagulants|mesh-ancestor
55995335|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
55995336|NCT02561832|Carboplatin|carboplatin|mesh-list
55995337|NCT02561832|Olaparib|olaparib|mesh-list
55995338|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55995339|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
55995340|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933271|NCT05583071|Dermatologic Agents|dermatologic agents|mesh-ancestor
55933272|NCT05583071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933273|NCT05583071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55995341|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995342|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55995344|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995345|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995346|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55995347|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55995348|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995349|NCT02982161|Celecoxib|celecoxib|mesh-list
55995350|NCT02982161|Tramadol|tramadol|mesh-list
55995351|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55995352|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55995353|NCT02982161|Analgesics|analgesics|mesh-ancestor
55995354|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
55995355|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995356|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995357|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995358|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995359|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55995360|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55995361|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995362|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995363|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55995364|NCT02982161|Narcotics|narcotics|mesh-ancestor
55995365|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995366|NCT05506488|Dasatinib|dasatinib|mesh-list
55995367|NCT05506488|Quercetin|quercetin|mesh-list
55995368|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995369|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55995370|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995371|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995372|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
55995373|NCT05506488|Protective Agents|protective agents|mesh-ancestor
55995374|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995380|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55995381|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
55995382|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995383|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995384|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55995385|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995386|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55995387|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55995388|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55995390|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
55995392|NCT03023111|Sargramostim|sargramostim|mesh-list
55995393|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
55995394|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995395|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995396|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
55995397|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995398|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55995399|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55995400|NCT03022253|Acetaminophen|acetaminophen|mesh-list
55995401|NCT03022253|Ibuprofen|ibuprofen|mesh-list
55995402|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55995403|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55995404|NCT03022253|Analgesics|analgesics|mesh-ancestor
55995405|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
55718840|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55995406|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995407|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995408|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995409|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995410|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55995411|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995413|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
55995421|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995422|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55995423|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
55995424|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55995425|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
55995426|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55995427|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995428|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995429|NCT03017807|Antibodies|antibodies|mesh-list
55995430|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
55995431|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995432|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
55995433|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55995434|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55995435|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55995436|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55995437|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995438|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
55995439|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995440|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995441|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55995442|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995444|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55995445|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55995447|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995471|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55995472|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55995473|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55995474|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995475|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995476|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995477|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55995478|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55995479|NCT01125163|Iron|iron|mesh-list
55995480|NCT01125163|Trace Elements|trace elements|mesh-ancestor
55995481|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
55995482|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995483|NCT03019991|Ritonavir|ritonavir|mesh-list
55995484|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55995485|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55995486|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
55995487|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995488|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995489|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55995524|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995525|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55995526|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55995527|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
55995528|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
55995529|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995530|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55722851|NCT00925535|Rifabutin|rifabutin|mesh-list
55995531|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55995532|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995533|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995534|NCT01005407|Vaccines|vaccines|mesh-list
55995535|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
55995536|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995537|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
55995538|NCT03633448|Guaifenesin|guaifenesin|mesh-list
55995539|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
55995540|NCT03633448|Expectorants|expectorants|mesh-ancestor
55995541|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
55995542|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55995543|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55995544|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
55995555|NCT05313958|Cytarabine|cytarabine|mesh-list
55995575|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55995576|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55995578|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995580|NCT01006655|Hormones|hormones|mesh-ancestor
55995581|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995582|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995583|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55995584|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
55995585|NCT03633526|Ivacaftor|ivacaftor|mesh-list
55995586|NCT03633526|VX-659|vx-659|mesh-list
55995587|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55995588|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55995589|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995590|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
55995591|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718920|NCT03501433|Niacin|niacin|mesh-list
55995592|NCT03019523|Caffeine|caffeine|mesh-list
55995593|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55995594|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995595|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55995596|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995597|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995598|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55995599|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55995600|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
55995604|NCT01008059|Narcotics|narcotics|mesh-ancestor
55995618|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995620|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995621|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995622|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55995623|NCT04467424|Lidocaine|lidocaine|mesh-list
55995624|NCT04467424|Ketamine|ketamine|mesh-list
55995625|NCT04467424|Propofol|propofol|mesh-list
55995626|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
55995627|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
55995628|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995629|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995630|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
55995631|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995632|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55995633|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55995634|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55995635|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55995636|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995637|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55995638|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55995639|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
55995640|NCT04467424|Analgesics|analgesics|mesh-ancestor
55995641|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55757349|NCT03262727|Norethindrone|norethindrone|mesh-list
55995642|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55995643|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55995644|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995645|NCT03016715|Sirolimus|sirolimus|mesh-list
55995646|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55995647|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995648|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55995649|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995654|NCT00377104|Alvocidib|alvocidib|mesh-list
55995658|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995659|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55995660|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995661|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995662|NCT03016793|Puerarin|puerarin|mesh-list
55995663|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
55995664|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55995665|NCT03928522|Vancomycin|vancomycin|mesh-list
55995666|NCT03928522|Tobramycin|tobramycin|mesh-list
55995667|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995668|NCT01010399|Ritonavir|ritonavir|mesh-list
55995669|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
55995670|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55995671|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55995672|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
55995673|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995674|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995675|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55995676|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55995677|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
55995678|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995679|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55995680|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55995681|NCT03638908|Fluoxetine|fluoxetine|mesh-list
55995682|NCT03638908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55995683|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55995684|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55995685|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995686|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995687|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
55995688|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995689|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55995690|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
55995691|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55933274|NCT05583071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55995694|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995696|NCT01041781|Celecoxib|celecoxib|mesh-list
55995697|NCT01041781|Carboplatin|carboplatin|mesh-list
55995698|NCT01041781|Pemetrexed|pemetrexed|mesh-list
55995699|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995700|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55995701|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
55995702|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995703|NCT01041781|Antiviral Agents|antiviral agents|mesh-ancestor
55995704|NCT01041781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995705|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995706|NCT01041781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55995707|NCT01041781|Immunologic Factors|immunologic factors|mesh-ancestor
55995708|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995709|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55995754|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
55995755|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55995756|NCT04425850|Ivermectin|ivermectin|mesh-list
55995757|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55995758|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995760|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55995761|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55995762|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55995763|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995764|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
55995765|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995766|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995767|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55995768|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995769|NCT01042795|Sunitinib|sunitinib|mesh-list
55995770|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995771|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55995772|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55995773|NCT01042795|Growth Substances|growth substances|mesh-ancestor
55995775|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
55995776|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55995777|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995778|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995780|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
55995781|NCT03644212|Vitamins|vitamins|mesh-list
55995782|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
55995799|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55995800|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55995801|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55995802|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55995803|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55995804|NCT03889444|Dexamethasone|dexamethasone|mesh-list
55995805|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995806|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
55995807|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
55995808|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995809|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995810|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55995811|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
55995813|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995814|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55995815|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995817|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
55995818|NCT01104025|Methotrexate|methotrexate|mesh-list
55995819|NCT01104025|Etoposide|etoposide|mesh-list
55995820|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
55995821|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995828|NCT01104025|Hormones|hormones|mesh-ancestor
55995850|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
55995852|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55995853|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995854|NCT01105117|Epoprostenol|epoprostenol|mesh-list
55995855|NCT01105117|Tezosentan|tezosentan|mesh-list
55995856|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55995857|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55995858|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
55995859|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
55995860|NCT03885154|Valproic Acid|valproic acid|mesh-list
55995861|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
55995862|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995863|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995864|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
55995865|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933275|NCT05583071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55933276|NCT05583071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55933277|NCT05583071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55933278|NCT05583071|Growth Substances|growth substances|mesh-ancestor
55933279|NCT05583071|Growth Inhibitors|growth inhibitors|mesh-ancestor
55933280|NCT04989348|Hormones|hormones|mesh-list
55933313|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933315|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933316|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55933317|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933318|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933319|NCT04143191|Sorafenib|sorafenib|mesh-list
55933320|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933321|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55933322|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933398|NCT04140461|Amebicides|amebicides|mesh-ancestor
55933399|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55933400|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55933401|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55933402|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
55933403|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
55933404|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933405|NCT03021629|Vitamin D|vitamin d|mesh-list
55933406|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
55933407|NCT03021629|Vitamins|vitamins|mesh-ancestor
55933408|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
55933409|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933469|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
55933470|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933874|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55933875|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
55933876|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55933877|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55933878|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
55933879|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
55933880|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
55933881|NCT03067896|Bupivacaine|bupivacaine|mesh-list
55933882|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
55933883|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
55933884|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933885|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933886|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
55933887|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933888|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55933889|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55933890|NCT03067896|Analgesics|analgesics|mesh-ancestor
55995866|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995867|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
55995868|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55995869|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995871|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55995872|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
55995873|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
55995874|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55995875|NCT03885154|Analgesics|analgesics|mesh-ancestor
55995876|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
55995877|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995878|NCT01106833|Sirolimus|sirolimus|mesh-list
55995879|NCT01106833|Prednisone|prednisone|mesh-list
55995880|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55995881|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995882|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
55995883|NCT01106833|Hormones|hormones|mesh-ancestor
55995884|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995885|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995886|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55995887|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55995888|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55995889|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55995890|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55995891|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
55995893|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
55995894|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55995896|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55995910|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
55995912|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
55995913|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995914|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
55995915|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55995916|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55995917|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
55995918|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55995919|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55995920|NCT00957593|Oxytocin|oxytocin|mesh-list
55995921|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
55995922|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55995923|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995924|NCT00957671|Hormones|hormones|mesh-list
55995925|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55995926|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995927|NCT04322968|Ketorolac|ketorolac|mesh-list
55995928|NCT04322968|Ketamine|ketamine|mesh-list
55995929|NCT04322968|Analgesics|analgesics|mesh-ancestor
55995930|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
55995931|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995932|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55995933|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55995934|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55995935|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
55995936|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
55995937|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55995958|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55995959|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
55995960|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55995961|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55995962|NCT04323592|Prednisolone|prednisolone|mesh-list
55995963|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
55995964|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55995965|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
55995966|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55995967|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
55995968|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
55995969|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55995972|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
55996019|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
55996020|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996021|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55996022|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55996023|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996024|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996025|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55996026|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55996029|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55996030|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996031|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55996032|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996033|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996034|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55996035|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55996036|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55996037|NCT00962039|Citalopram|citalopram|mesh-list
55996038|NCT00962039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55996039|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55996040|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55996041|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996042|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996043|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
55996044|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996045|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55996046|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
55996047|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55996048|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
55996049|NCT03375385|Propofol|propofol|mesh-list
55996050|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55996051|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996052|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996056|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996057|NCT03375385|Analgesics|analgesics|mesh-ancestor
55996058|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
55996059|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996060|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55996061|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55996062|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55996063|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
55996064|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996065|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996066|NCT03018665|Metformin|metformin|mesh-list
55996067|NCT03018665|Exenatide|exenatide|mesh-list
55996068|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55996069|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996070|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55996071|NCT03018665|Incretins|incretins|mesh-ancestor
55996072|NCT03018665|Hormones|hormones|mesh-ancestor
55996073|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996075|NCT03012763|Fexofenadine|fexofenadine|mesh-list
55996076|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
55996077|NCT03012763|Valsartan|valsartan|mesh-list
55996078|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996079|NCT03012763|Analgesics|analgesics|mesh-ancestor
55996080|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
55996081|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996082|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996083|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
55996084|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55996085|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55996086|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55996088|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55996099|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55996101|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55996102|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996103|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996104|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
55996105|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996106|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55996107|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55996108|NCT01048879|Oseltamivir|oseltamivir|mesh-list
55996109|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
55996110|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55996111|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
55996112|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996113|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790328|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
55996114|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996116|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
55996117|NCT04290676|BB 1101|bb 1101|mesh-list
55996152|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
55996153|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996154|NCT03859960|Insulin|insulin|mesh-list
55996155|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55996156|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55996157|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996158|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55996159|NCT03857230|Hormones|hormones|mesh-ancestor
55996160|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996161|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996162|NCT02181127|Glucagon|glucagon|mesh-list
55996163|NCT02181127|Pancrelipase|pancrelipase|mesh-list
55996164|NCT02181127|Pancreatin|pancreatin|mesh-list
55996165|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996166|NCT02181127|Hormones|hormones|mesh-ancestor
55996167|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996168|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996169|NCT04332094|Azithromycin|azithromycin|mesh-list
55996170|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
55996171|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55996172|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996173|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
55996174|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55790336|NCT04341467|Amisulpride|amisulpride|mesh-list
55996177|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996178|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55996201|NCT04974151|Folic Acid|folic acid|mesh-list
55996202|NCT04974151|Amlodipine|amlodipine|mesh-list
55719126|NCT02440009|Hormones|hormones|mesh-ancestor
55996203|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55996204|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55996205|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55996206|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996207|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55996208|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996209|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
55996211|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
55996212|NCT04974151|Vitamins|vitamins|mesh-ancestor
55996213|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
55996214|NCT01924819|Leucovorin|leucovorin|mesh-list
55996215|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
55996216|NCT01924819|Cisplatin|cisplatin|mesh-list
55996217|NCT01924819|Docetaxel|docetaxel|mesh-list
55996218|NCT01924819|Fluorouracil|fluorouracil|mesh-list
55996219|NCT01924819|Capecitabine|capecitabine|mesh-list
55996220|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
55996221|NCT01924819|Epirubicin|epirubicin|mesh-list
55996261|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996262|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55996263|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996264|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
55996265|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55996266|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996267|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996268|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996270|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
55996271|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996272|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55996275|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
55996276|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996277|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996279|NCT04822363|Clopidogrel|clopidogrel|mesh-list
55996280|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55719163|NCT04463875|Riboflavin|riboflavin|mesh-list
55996281|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996309|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996310|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55996311|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55996312|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996313|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996315|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55996316|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55996317|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55996318|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55996319|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
55996320|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996321|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996322|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996323|NCT01170715|Etanercept|etanercept|mesh-list
55996324|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55996325|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996326|NCT01170715|Analgesics|analgesics|mesh-ancestor
55996327|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
55996328|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996360|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996361|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55996362|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55996364|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
55996365|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
55996366|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55996367|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55996368|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996369|NCT03802864|Bupivacaine|bupivacaine|mesh-list
55996370|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
55996371|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
55996372|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996373|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996374|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
55996375|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996376|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
55996377|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
55996378|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55996379|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55996380|NCT03797872|Prednisolone|prednisolone|mesh-list
55996381|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
55996382|NCT03797872|Triamcinolone|triamcinolone|mesh-list
55996383|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55996384|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55996385|NCT03797872|Methotrexate|methotrexate|mesh-list
55719186|NCT04462939|Micronutrients|micronutrients|mesh-list
55996386|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55996387|NCT03797872|Leflunomide|leflunomide|mesh-list
55996388|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55996389|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
55996390|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55996391|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
55996392|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55996393|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996402|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
55996403|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55996404|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55996405|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996407|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
55996408|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996409|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996410|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
55996411|NCT03797872|Hormones|hormones|mesh-ancestor
55996412|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996413|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55996414|NCT03797872|Protective Agents|protective agents|mesh-ancestor
55996415|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55996416|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996417|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55996418|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55996420|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
55996421|NCT01127581|Dinoprostone|dinoprostone|mesh-list
55996422|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
55996423|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55996424|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996425|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
55996426|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55996427|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55996428|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996429|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996430|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
55723731|NCT04462003|Enoxaparin|enoxaparin|mesh-list
55996432|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55996433|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860590|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
55933891|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55933892|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55933893|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55933894|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
55996434|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996436|NCT04498351|Analgesics|analgesics|mesh-ancestor
55996437|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
55996438|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996439|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55996440|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55996441|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55996442|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
55996443|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996444|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996445|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
55996446|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55996447|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
55996448|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55996449|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55996450|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55996451|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
55996452|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55996453|NCT02186665|Calcitriol|calcitriol|mesh-list
55996454|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55996455|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996456|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55996457|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55996458|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996459|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55996486|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996487|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996488|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996489|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
55996490|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55996491|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996492|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55996493|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55996494|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55996495|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996496|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
55996497|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996499|NCT03746002|Furosemide|furosemide|mesh-list
55996500|NCT03746002|Diuretics|diuretics|mesh-ancestor
55996501|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
55933895|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933896|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933897|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55933898|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
55933899|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55933900|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55933901|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55933902|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
55933903|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55933907|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
55933908|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933909|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
55933911|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
55933912|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
55933913|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933914|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933915|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
55933916|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933917|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55933918|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55933919|NCT03067740|Analgesics|analgesics|mesh-ancestor
55933920|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55933921|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55933923|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
55933924|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933925|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933926|NCT05730114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55933927|NCT05634174|Mirabegron|mirabegron|mesh-list
55933928|NCT05634174|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55996502|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996503|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55996504|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55996505|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996506|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55996507|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55996508|NCT04089982|Varenicline|varenicline|mesh-list
55996509|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55996510|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55996511|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
55996512|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996513|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996514|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719274|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
55719275|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55719276|NCT03502135|Protective Agents|protective agents|mesh-ancestor
55719277|NCT02315287|Pioglitazone|pioglitazone|mesh-list
55719278|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55719279|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719280|NCT02319577|Vinorelbine|vinorelbine|mesh-list
55719281|NCT02319577|Gefitinib|gefitinib|mesh-list
55719282|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55719283|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719284|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
55719285|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
55996515|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55996516|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
55996517|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55996518|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
55996519|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996555|NCT01926236|Fluorouracil|fluorouracil|mesh-list
55996556|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
55996557|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
55996558|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
55996559|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996560|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55996561|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996562|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996563|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
55996564|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996565|NCT01926236|Antidotes|antidotes|mesh-ancestor
55996566|NCT01926236|Protective Agents|protective agents|mesh-ancestor
55996567|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
55996568|NCT01926236|Vitamins|vitamins|mesh-ancestor
55996569|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
55996570|NCT01926236|Hematinics|hematinics|mesh-ancestor
55996590|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
55996591|NCT00983528|Clofarabine|clofarabine|mesh-list
55996592|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55996593|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996594|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55996595|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
55996596|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996609|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55996610|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996611|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
55996612|NCT01173211|Vaccines|vaccines|mesh-list
55996613|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
55996614|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996615|NCT00983294|Azithromycin|azithromycin|mesh-list
55996616|NCT00983294|Colchicine|colchicine|mesh-list
55996617|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55719286|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
55996618|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996619|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
55996620|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55996621|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
55996622|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
55996623|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
55996624|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996625|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996626|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
55996627|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
55996628|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55860803|NCT02995096|Sirolimus|sirolimus|mesh-list
55933929|NCT05634174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55933930|NCT05634174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55933931|NCT05634174|Adrenergic Agents|adrenergic agents|mesh-ancestor
55933932|NCT05634174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933933|NCT05634174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933934|NCT05634174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933935|NCT05634174|Urological Agents|urological agents|mesh-ancestor
55933936|NCT05730036|Dexamethasone|dexamethasone|mesh-list
55933956|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933957|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933959|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55933960|NCT03068832|Poly ICLC|poly iclc|mesh-list
55933961|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
55933962|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
55933963|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933964|NCT03068832|Laxatives|laxatives|mesh-ancestor
55933965|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55933966|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
55933967|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933968|NCT04573920|Atrasentan|atrasentan|mesh-list
55933969|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933970|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55933971|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55933972|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933973|NCT04801797|Cytarabine|cytarabine|mesh-list
55933974|NCT04801797|Azacitidine|azacitidine|mesh-list
55933975|NCT04801797|Daunorubicin|daunorubicin|mesh-list
55933976|NCT04801797|Venetoclax|venetoclax|mesh-list
55933977|NCT04801797|Idarubicin|idarubicin|mesh-list
55933978|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55933979|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
55933980|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933981|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933982|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
55933983|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996629|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996630|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55996631|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55996632|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
55996633|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55996634|NCT05601830|Cytarabine|cytarabine|mesh-list
55996635|NCT05601830|Cyclophosphamide|cyclophosphamide|mesh-list
55996636|NCT05601830|Fludarabine|fludarabine|mesh-list
55996637|NCT05601830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996638|NCT05601830|Immunologic Factors|immunologic factors|mesh-ancestor
55996639|NCT05601830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996640|NCT05601830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55933984|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55719309|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55933985|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
55933986|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933987|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933988|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55933989|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55933990|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55933991|NCT03033537|Verapamil|verapamil|mesh-list
55933992|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
55933993|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55933994|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933996|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55933997|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933998|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
55933999|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
55934000|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934001|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934002|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55934003|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55934004|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934005|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934006|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934007|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55934008|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55934009|NCT03069144|Calcitriol|calcitriol|mesh-list
55934010|NCT03069144|Calcipotriene|calcipotriene|mesh-list
55934011|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
55934012|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55934013|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934014|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55934015|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55934016|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934018|NCT03069144|Vitamins|vitamins|mesh-ancestor
55934019|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
55934020|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55934021|NCT03017703|Eplerenone|eplerenone|mesh-list
55934022|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55934023|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
55934024|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55934025|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934026|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55934027|NCT03017703|Diuretics|diuretics|mesh-ancestor
55934028|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
55934029|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55934030|NCT01670669|Prucalopride|prucalopride|mesh-list
55934031|NCT01670669|Laxatives|laxatives|mesh-ancestor
55934032|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55934034|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55934035|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
55996641|NCT05601830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55996642|NCT05601830|Alkylating Agents|alkylating agents|mesh-ancestor
55996643|NCT05601830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996644|NCT05601830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996645|NCT05601830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55996646|NCT05601830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55996647|NCT05601830|Antimetabolites|antimetabolites|mesh-ancestor
55996648|NCT05601830|Antiviral Agents|antiviral agents|mesh-ancestor
55996649|NCT05601830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996650|NCT00982280|Tapentadol|tapentadol|mesh-list
55996651|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55996652|NCT00982280|Narcotics|narcotics|mesh-ancestor
55996653|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996654|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996656|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
55996657|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996658|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55996659|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55996660|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55996661|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996662|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
55996663|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996665|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996666|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
55996667|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996668|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
55996669|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55996670|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996671|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55934036|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934037|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934038|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934040|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
55934041|NCT00946023|Rituximab|rituximab|mesh-list
55719378|NCT02320045|Exenatide|exenatide|mesh-list
55719379|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55934042|NCT00946023|Fludarabine|fludarabine|mesh-list
55934043|NCT00946023|Tacrolimus|tacrolimus|mesh-list
55934044|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55934045|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
55934046|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996672|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55996673|NCT03069326|Growth Substances|growth substances|mesh-ancestor
55996675|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996676|NCT01175395|Triamcinolone|triamcinolone|mesh-list
55996677|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55996678|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55996679|NCT01175395|Ranibizumab|ranibizumab|mesh-list
55996680|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55996681|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996682|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
55996683|NCT01175395|Hormones|hormones|mesh-ancestor
55996684|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996685|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996686|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996687|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
55996688|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996689|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996690|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55996691|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55996692|NCT01175395|Growth Substances|growth substances|mesh-ancestor
55996693|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
55996694|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996695|NCT03011905|Acetaminophen|acetaminophen|mesh-list
55934047|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934048|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55934049|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
55934050|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934051|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934053|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55934054|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55934055|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934056|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55934057|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55934058|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
55934059|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934060|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934061|NCT01672151|Sirolimus|sirolimus|mesh-list
55934062|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934063|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934064|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55934065|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934066|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
55934099|NCT05629494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934100|NCT05629494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55934101|NCT05629494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934102|NCT05629494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934103|NCT05629494|Gout Suppressants|gout suppressants|mesh-ancestor
55996696|NCT03011905|Dexamethasone|dexamethasone|mesh-list
55996697|NCT03011905|Etoricoxib|etoricoxib|mesh-list
55996698|NCT03011905|Oxycodone|oxycodone|mesh-list
55996699|NCT03011905|Ropivacaine|ropivacaine|mesh-list
55996700|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55996701|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
55996702|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
55996703|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996704|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996705|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996706|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
55996707|NCT03011905|Hormones|hormones|mesh-ancestor
55996708|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55996709|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55996710|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996711|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
55996712|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
55996713|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996714|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
55996715|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719411|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
55996716|NCT03011905|Analgesics|analgesics|mesh-ancestor
55996718|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55934104|NCT00952653|Midazolam|midazolam|mesh-list
55934105|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55934106|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55934107|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55934108|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934117|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
55934118|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934119|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934120|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55934121|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55934122|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55934123|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
55934125|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55934127|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
55934128|NCT01673087|Metyrapone|metyrapone|mesh-list
55934129|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55934130|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
55934131|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
55934132|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934133|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934134|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55934135|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
55934136|NCT01673087|Hormones|hormones|mesh-ancestor
55934137|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55934138|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55934139|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934140|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
55934141|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934142|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996720|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55996721|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55996722|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55996723|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55996724|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996725|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996726|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
55996727|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996728|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55996729|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996730|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996731|NCT04769713|Ropivacaine|ropivacaine|mesh-list
55996732|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
55996733|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
55996734|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996735|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996736|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
55996737|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996738|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55996739|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
55934143|NCT02299505|Ceritinib|ceritinib|mesh-list
55934144|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934145|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55934146|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934147|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934148|NCT01673399|Atosiban|atosiban|mesh-list
55934149|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
55934150|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55934151|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934152|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
55934153|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55934154|NCT04781855|Nivolumab|nivolumab|mesh-list
55934155|NCT04781855|Ipilimumab|ipilimumab|mesh-list
55934156|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55934157|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934158|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55934159|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934160|NCT02235701|Ifosfamide|ifosfamide|mesh-list
55934161|NCT02235701|Doxorubicin|doxorubicin|mesh-list
55934163|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
55934164|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934165|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743376|NCT02511613|Growth Substances|growth substances|mesh-ancestor
55934166|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55934167|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55934168|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55934169|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934170|NCT04404881|Bevacizumab|bevacizumab|mesh-list
55934171|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55996740|NCT00980798|Hydromorphone|hydromorphone|mesh-list
55996741|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55996742|NCT00980798|Narcotics|narcotics|mesh-ancestor
55996743|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55996744|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996745|NCT00980798|Analgesics|analgesics|mesh-ancestor
55996746|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
55996747|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996748|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
55996749|NCT01177189|Vitamins|vitamins|mesh-ancestor
55996750|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
55996751|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996752|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
55996753|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996754|NCT01177189|Protective Agents|protective agents|mesh-ancestor
55996755|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
55996756|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55996757|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
55996758|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996759|NCT01177735|Pomalidomide|pomalidomide|mesh-list
55996760|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
55996761|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996762|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55996763|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55996764|NCT01177735|Growth Substances|growth substances|mesh-ancestor
55996765|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
55996766|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996767|NCT01135069|Tretinoin|tretinoin|mesh-list
55996768|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996769|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
55996770|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
55996771|NCT01178281|Thalidomide|thalidomide|mesh-list
55934172|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934173|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55934176|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934177|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
55934178|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55934180|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
55934181|NCT01674257|Protective Agents|protective agents|mesh-ancestor
55934182|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934184|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55934185|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55996773|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
55996774|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996775|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55996776|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55996777|NCT01178281|Growth Substances|growth substances|mesh-ancestor
55996778|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
55996779|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996780|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996781|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
55996782|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55996783|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996785|NCT01178827|Oxybutynin|oxybutynin|mesh-list
55996786|NCT01178827|Trospium chloride|trospium chloride|mesh-list
55996787|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
55996788|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
55996789|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55996790|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996791|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55996832|NCT03872947|Ramucirumab|ramucirumab|mesh-list
55996833|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996834|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996835|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55996836|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55996837|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55996838|NCT03872947|Growth Substances|growth substances|mesh-ancestor
55996839|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996840|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
55996841|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55996842|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
55996843|NCT03872947|Antiviral Agents|antiviral agents|mesh-ancestor
55996844|NCT03872947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996845|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996846|NCT03872947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996847|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
55996851|NCT03872947|Antidotes|antidotes|mesh-ancestor
55996892|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996893|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
55996894|NCT01138969|Esomeprazole|esomeprazole|mesh-list
55996895|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55996896|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55996897|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55996898|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996899|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996900|NCT01139515|Eletriptan|eletriptan|mesh-list
55996901|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55996902|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
55996903|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757350|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
55719441|NCT04635943|Ivermectin|ivermectin|mesh-list
55996904|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996905|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996906|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55996907|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55996952|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55996953|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
55996954|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996955|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55996956|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55996957|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
55996958|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996959|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55996960|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
55996961|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55996962|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55996963|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
55996964|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55996965|NCT04395170|Antibodies|antibodies|mesh-list
55996966|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
55996967|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996968|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55996969|NCT01927328|Hematinics|hematinics|mesh-ancestor
55996970|NCT04552808|Yimitasvir|yimitasvir|mesh-list
55996971|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
55996972|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55996973|NCT01927406|Timolol|timolol|mesh-list
55996974|NCT01927406|Bimatoprost|bimatoprost|mesh-list
55996975|NCT01927406|Travoprost|travoprost|mesh-list
55996976|NCT01927406|Latanoprost|latanoprost|mesh-list
55996977|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55996978|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55996979|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55996980|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
55996981|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55996982|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55996995|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55996996|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
55996997|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997001|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55997002|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55997003|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
55997004|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55997005|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55997007|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
55997008|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
55997009|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997010|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997011|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
55997012|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997014|NCT05607446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55997015|NCT05607446|Respiratory System Agents|respiratory system agents|mesh-ancestor
55997016|NCT05607446|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55997017|NCT05607446|Hormone Antagonists|hormone antagonists|mesh-ancestor
55997018|NCT05607446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997019|NCT05607446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997020|NCT05607446|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55997021|NCT05607446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55997022|NCT05607446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997023|NCT02185339|Rocuronium|rocuronium|mesh-list
55757825|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997024|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55997025|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55861172|NCT04345276|Ritonavir|ritonavir|mesh-list
55934186|NCT01674413|Adalimumab|adalimumab|mesh-list
55934187|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55934188|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934189|NCT00953121|Bevacizumab|bevacizumab|mesh-list
55934190|NCT00953121|Carboplatin|carboplatin|mesh-list
55934191|NCT00953121|Irinotecan|irinotecan|mesh-list
55934192|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55934193|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997026|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55997027|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997028|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997029|NCT03831464|Metformin|metformin|mesh-list
55997030|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55997031|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997032|NCT01928498|Paclitaxel|paclitaxel|mesh-list
55997033|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55997034|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997035|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
55997036|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
55997037|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
55997038|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997040|NCT04558502|Clarithromycin|clarithromycin|mesh-list
55997041|NCT04558502|Minocycline|minocycline|mesh-list
55997042|NCT04558502|Esomeprazole|esomeprazole|mesh-list
55997043|NCT04558502|Bismuth|bismuth|mesh-list
55997044|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55997045|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997046|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55997047|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55997048|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55997049|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997050|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997051|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55997052|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55997053|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55997054|NCT04558502|Antacids|antacids|mesh-ancestor
55934194|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55934195|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55934196|NCT00953121|Growth Substances|growth substances|mesh-ancestor
55934197|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934198|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
55934199|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55934200|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55934201|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934202|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934203|NCT03017391|Dexamethasone|dexamethasone|mesh-list
55934204|NCT03017391|Metoclopramide|metoclopramide|mesh-list
55934205|NCT03017391|Granisetron|granisetron|mesh-list
55934206|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55934207|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
55934208|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
55934209|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934210|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934211|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55934212|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
55997055|NCT01218997|Naltrexone|naltrexone|mesh-list
55997056|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55997057|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55997058|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997059|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
55997060|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997061|NCT01219777|Paclitaxel|paclitaxel|mesh-list
55997062|NCT01219777|Bevacizumab|bevacizumab|mesh-list
55997063|NCT01219777|Carboplatin|carboplatin|mesh-list
55997064|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55997065|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997066|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
55997067|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
55997068|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
55997069|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997070|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997071|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55997072|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55997073|NCT01219777|Growth Substances|growth substances|mesh-ancestor
55997074|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997075|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
55997076|NCT05603156|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55997077|NCT05603156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997078|NCT05603156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997079|NCT05603156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55997080|NCT04759742|Ropivacaine|ropivacaine|mesh-list
55997081|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
55997082|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
55997083|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997084|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997085|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
55997086|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997087|NCT01928888|Famotidine|famotidine|mesh-list
55997088|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
55997095|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997096|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997097|NCT01928888|Antacids|antacids|mesh-ancestor
55997098|NCT04556084|Blinatumomab|blinatumomab|mesh-list
55997099|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997100|NCT04394234|Warfarin|warfarin|mesh-list
55997101|NCT04394234|Anticoagulants|anticoagulants|mesh-list
55997102|NCT02569710|Simeprevir|simeprevir|mesh-list
55997103|NCT02569710|Odalasvir|odalasvir|mesh-list
55997104|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
55997105|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997106|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
55997107|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997108|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997109|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
55997110|NCT04550624|Lenvatinib|lenvatinib|mesh-list
55997111|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997112|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997113|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55997114|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997115|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997117|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55997118|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997119|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
55997121|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55997122|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997123|NCT02984072|Menthol|menthol|mesh-list
55997124|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
55997125|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
55997126|NCT04589832|Entrectinib|entrectinib|mesh-list
55997127|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55997141|NCT05506410|Hormones|hormones|mesh-ancestor
55997142|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997143|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55997144|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55997145|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
55997146|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997147|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
55997148|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997149|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55997150|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55997151|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
55997152|NCT05506332|Venetoclax|venetoclax|mesh-list
55997153|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
55997154|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997155|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
55997156|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997157|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55997158|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55997159|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
55997160|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997161|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55997162|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997164|NCT05609942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55997165|NCT05609942|Antimetabolites|antimetabolites|mesh-ancestor
55997166|NCT05609942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934213|NCT03017391|Hormones|hormones|mesh-ancestor
55934214|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55934215|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55934216|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934217|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55934218|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55934219|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
55934220|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934221|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934222|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55934223|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
55934224|NCT00953199|Lidocaine|lidocaine|mesh-list
55934225|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
55934226|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
55934227|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934228|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934229|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
55934230|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934231|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55997167|NCT05609942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997168|NCT05609942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997169|NCT05604638|Tenecteplase|tenecteplase|mesh-list
55997171|NCT05604638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55997172|NCT05604638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55997173|NCT05604638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997174|NCT05604638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55997175|NCT05609630|Upadacitinib|upadacitinib|mesh-list
55997176|NCT05609630|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
55997177|NCT05609630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55997178|NCT05609630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997179|NCT05609630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997180|NCT05609630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55997181|NCT03033758|Budesonide|budesonide|mesh-list
55997182|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
55997183|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724457|NCT02266888|Rituximab|rituximab|mesh-list
55997184|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55997186|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997190|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
55997220|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55997221|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55997222|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
55997223|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997224|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997225|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997226|NCT04394390|Vitamin D|vitamin d|mesh-list
55997227|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
55997228|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
55997229|NCT04394390|Vitamins|vitamins|mesh-list
55997230|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
55997231|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997232|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55997233|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55997234|NCT05604794|Ketamine|ketamine|mesh-list
55997235|NCT05604794|Analgesics|analgesics|mesh-ancestor
55997236|NCT05604794|Sensory System Agents|sensory system agents|mesh-ancestor
55997237|NCT05604794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997238|NCT05604794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997239|NCT05604794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55997240|NCT05604794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55997241|NCT05604794|Anesthetics, General|anesthetics, general|mesh-ancestor
55997242|NCT05604794|Anesthetics|anesthetics|mesh-ancestor
55997243|NCT05604794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997244|NCT05604794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55997245|NCT05604794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55997246|NCT05604794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997249|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
55997267|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55997268|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55997269|NCT00966641|Analgesics|analgesics|mesh-ancestor
55997270|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
55997271|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997272|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997273|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55997274|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55997275|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
55997276|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55997277|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997278|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997280|NCT00970073|Tacrolimus|tacrolimus|mesh-list
55997281|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
55997282|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55997283|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55997284|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
55997285|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997286|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55997287|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997288|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997289|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55997290|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997291|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55997292|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
55997293|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55997294|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997295|NCT00971633|Ondansetron|ondansetron|mesh-list
55997296|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
55997297|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
55997298|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934232|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55934233|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55934234|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55934235|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934236|NCT03033147|Amoxicillin|amoxicillin|mesh-list
55934237|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
55934238|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
55934239|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55934240|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55997299|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997300|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55997301|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
55997302|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
55997303|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55997304|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
55997305|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997306|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997307|NCT00971633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55997308|NCT00971633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55997309|NCT00971633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997310|NCT00971633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55997311|NCT00971633|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55997312|NCT05511246|Ethanol|ethanol|mesh-list
55997313|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55997314|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997315|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997316|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997318|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55997319|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55997320|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997321|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55997322|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997323|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
55997324|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55997325|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
55997326|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997327|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55997329|NCT05510778|Charcoal|charcoal|mesh-list
55997345|NCT02337530|Pemetrexed|pemetrexed|mesh-list
55997346|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997347|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997348|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997349|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55997350|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55997351|NCT03341156|Thrombin|thrombin|mesh-list
55997352|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
55997353|NCT03341156|Coagulants|coagulants|mesh-ancestor
55997354|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
55997355|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
55997356|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55997357|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997358|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997359|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
55997360|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55997361|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997362|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997363|NCT04122560|Fluconazole|fluconazole|mesh-list
55997364|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
55997365|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997366|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55997367|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55997368|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997369|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997370|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55997371|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
55997372|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997373|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997374|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55997375|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55997377|NCT02569242|Docetaxel|docetaxel|mesh-list
55997378|NCT02569242|Nivolumab|nivolumab|mesh-list
55997379|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55861523|NCT05582109|Lenvatinib|lenvatinib|mesh-list
55997381|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
55997382|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
55997383|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
55997384|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997385|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997386|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55997387|NCT04124588|Hemostatics|hemostatics|mesh-list
55997388|NCT04124588|Coagulants|coagulants|mesh-ancestor
55997389|NCT05501340|Molgramostim|molgramostim|mesh-list
55997390|NCT05501340|Sargramostim|sargramostim|mesh-list
55997391|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997392|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
55997393|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997394|NCT05608070|Oxytocin|oxytocin|mesh-list
55997395|NCT05608070|Oxytocics|oxytocics|mesh-ancestor
55997396|NCT05608070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55997398|NCT00972725|Chloroquine|chloroquine|mesh-list
55997440|NCT05609240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55997441|NCT05609240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997442|NCT00973739|Lapatinib|lapatinib|mesh-list
55997443|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997444|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55997445|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997446|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997447|NCT00974051|Insulin|insulin|mesh-list
55997448|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55997449|NCT00974051|Terbutaline|terbutaline|mesh-list
55997450|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
55997451|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55997453|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55997454|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
55997455|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997456|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55997498|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
55997499|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
55997500|NCT00955487|Protective Agents|protective agents|mesh-ancestor
55997501|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
55997502|NCT04120922|Calcium|calcium|mesh-list
55997503|NCT04120922|Sevelamer|sevelamer|mesh-list
55997504|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55997505|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997506|NCT04120922|Antacids|antacids|mesh-ancestor
55861666|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
55934241|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934242|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55934243|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934244|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934245|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
55934246|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55934253|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934254|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
55934255|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934256|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55934257|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55934258|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55934259|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55934260|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934262|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55934263|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55934264|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934265|NCT04764851|Ecopipam|ecopipam|mesh-list
55934266|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55934267|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55934268|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934269|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934270|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55934271|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55934272|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
55934273|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934274|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934276|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55934277|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55934278|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
55934279|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934280|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934281|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934282|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55934283|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55934284|NCT01005459|Bupivacaine|bupivacaine|mesh-list
55934285|NCT01005459|Tetracaine|tetracaine|mesh-list
55934286|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
55934287|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
55934288|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934289|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934290|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
55934291|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934292|NCT01676285|Metoprolol|metoprolol|mesh-list
55934293|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55934294|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55934295|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
55934296|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
55934297|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934298|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934299|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55934300|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55934301|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55934302|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
55997507|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997508|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55997509|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
55997510|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
55997511|NCT01663740|Valganciclovir|valganciclovir|mesh-list
55997512|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
55997513|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997514|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
55997515|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55997516|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
55997517|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997518|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
55997519|NCT02984228|Protective Agents|protective agents|mesh-ancestor
55997520|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55997521|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55997522|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55997523|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
55997524|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997525|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55997526|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55997527|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997528|NCT03828032|Mannitol|mannitol|mesh-list
55719506|NCT02321371|Rifaximin|rifaximin|mesh-list
55719507|NCT02321371|Lactulose|lactulose|mesh-list
55719508|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55719509|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719510|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55719511|NCT04002037|Dexamethasone|dexamethasone|mesh-list
55719512|NCT04002037|Triamcinolone|triamcinolone|mesh-list
55719513|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55719514|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55719515|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55827934|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55827935|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997529|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55997530|NCT03828032|Diuretics|diuretics|mesh-ancestor
55861676|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861691|NCT03588273|Amoxicillin|amoxicillin|mesh-list
55934303|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934304|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934305|NCT01676363|Diflunisal|diflunisal|mesh-list
55934306|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55934307|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55934308|NCT01676363|Analgesics|analgesics|mesh-ancestor
55934309|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
55934310|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934311|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934312|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55934314|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55934320|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
55934321|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934322|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934323|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
55934324|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934325|NCT00957333|Ketamine|ketamine|mesh-list
55934326|NCT00957333|Analgesics|analgesics|mesh-ancestor
55934327|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
55934328|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934329|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997531|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
55997532|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997533|NCT03827876|Calcitriol|calcitriol|mesh-list
55997534|NCT03827876|Betamethasone|betamethasone|mesh-list
55997535|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55997536|NCT03827876|Calcipotriene|calcipotriene|mesh-list
55997537|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55997538|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
55997539|NCT03827876|Hormones|hormones|mesh-ancestor
55997540|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997541|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997542|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55997543|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
55997544|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55997545|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55997546|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55997547|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997548|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55997550|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
55997551|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55997552|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
55997553|NCT03898934|Vitamin D|vitamin d|mesh-list
55997554|NCT03898934|Vitamins|vitamins|mesh-ancestor
55997558|NCT04128800|Apatinib|apatinib|mesh-list
55997583|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997584|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
55997585|NCT01608893|Protective Agents|protective agents|mesh-ancestor
55997587|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55997588|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55997589|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
55997590|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55997591|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55997592|NCT04128878|Sotalol|sotalol|mesh-list
55997593|NCT04128878|Dofetilide|dofetilide|mesh-list
55997594|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55997595|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55997596|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
55997597|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757904|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
55719521|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55997598|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997599|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997600|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55997601|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
55997602|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
55997603|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997604|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55997605|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55997606|NCT00979745|Afamelanotide|afamelanotide|mesh-list
55997607|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
55997608|NCT00042341|Clofarabine|clofarabine|mesh-list
55997609|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55997610|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
55997611|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997612|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997613|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
55997614|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
55997615|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
55934330|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55934331|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55934332|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
55934333|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
55934334|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997616|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997618|NCT04759196|Levetiracetam|levetiracetam|mesh-list
55997619|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
55997620|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55997621|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997624|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55997625|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
55997626|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55997627|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
55997628|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997629|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997630|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
55997631|NCT04128020|Nivolumab|nivolumab|mesh-list
55997632|NCT04128020|Azacitidine|azacitidine|mesh-list
55997633|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55997634|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997635|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55724904|NCT02260492|Fluticasone|fluticasone|mesh-list
55997637|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55997669|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
55997670|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997671|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997672|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55997673|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55997674|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997675|NCT04127396|Sorafenib|sorafenib|mesh-list
55997676|NCT04127396|Lenvatinib|lenvatinib|mesh-list
55997677|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
55997678|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997679|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55997680|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997681|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997682|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55997683|NCT04127396|Estrogens|estrogens|mesh-ancestor
55997684|NCT04127396|Hormones|hormones|mesh-ancestor
55997685|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997686|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997687|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55997688|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
55997689|NCT04120064|Vitamin D|vitamin d|mesh-list
55997690|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55997691|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997692|NCT04120064|Vitamins|vitamins|mesh-ancestor
55997720|NCT02979548|Ondansetron|ondansetron|mesh-list
55997722|NCT02979548|Metoclopramide|metoclopramide|mesh-list
55997723|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
55997724|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
55997725|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997726|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997727|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55997728|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
55997729|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
55997730|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55997731|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
55997732|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997733|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997735|NCT02979548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55997736|NCT02979548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997737|NCT02979548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55997738|NCT02979548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55997739|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55997740|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55997741|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55997742|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
55997743|NCT03821246|Atezolizumab|atezolizumab|mesh-list
55997744|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55997745|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997746|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
55997747|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997748|NCT03826316|Nalbuphine|nalbuphine|mesh-list
55997749|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55997750|NCT03826316|Narcotics|narcotics|mesh-ancestor
55997751|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997752|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997753|NCT03826316|Analgesics|analgesics|mesh-ancestor
55997754|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
55997755|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997762|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997763|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
55997764|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997765|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55997766|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55997767|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55997768|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55997769|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997770|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55997772|NCT04393610|Analgesics|analgesics|mesh-ancestor
55997773|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55997774|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55997775|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
55997776|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
55997777|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55997778|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55997779|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
55997780|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55997781|NCT03820466|Aspirin|aspirin|mesh-list
55997782|NCT03820466|Atorvastatin|atorvastatin|mesh-list
55997783|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55997784|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55997785|NCT03820466|Analgesics|analgesics|mesh-ancestor
55997797|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
55997811|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997812|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55997813|NCT02338076|Petrolatum|petrolatum|mesh-list
55997814|NCT02338076|Emollients|emollients|mesh-ancestor
55997815|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
55997816|NCT03822962|Acetaminophen|acetaminophen|mesh-list
55997817|NCT03822962|Ibuprofen|ibuprofen|mesh-list
55997818|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56003768|NCT00000730|Trimethoprim|trimethoprim|mesh-list
55997821|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
55997822|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997823|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997824|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55997825|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55997826|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55997827|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997828|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997829|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
55997830|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55997831|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
55997832|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55997833|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55997834|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55997835|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997836|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997837|NCT01222117|Plasminogen|plasminogen|mesh-list
55997838|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55934335|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55934336|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55934337|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934338|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934339|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55934340|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55934341|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55934342|NCT02159547|Analgesics|analgesics|mesh-ancestor
55934343|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
55934344|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934345|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934346|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55934347|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934348|NCT00958035|Bimatoprost|bimatoprost|mesh-list
55934349|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55934350|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55997839|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
55997840|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55997841|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55997842|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997844|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55997845|NCT01222195|Lenalidomide|lenalidomide|mesh-list
55997846|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
55997847|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
55997848|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997849|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55997850|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55997851|NCT01222195|Growth Substances|growth substances|mesh-ancestor
55997852|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
55997853|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997854|NCT01222195|Hematinics|hematinics|mesh-ancestor
55997855|NCT01222273|Vitamin D|vitamin d|mesh-list
55997856|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
55997857|NCT01222273|Vitamins|vitamins|mesh-ancestor
55997858|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
55997859|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997861|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55997862|NCT03161912|Aflibercept|aflibercept|mesh-list
55997863|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55997864|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55997865|NCT03161912|Growth Substances|growth substances|mesh-ancestor
55997866|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997867|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
55997868|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997869|NCT01222585|Metronidazole|metronidazole|mesh-list
55997870|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55997871|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934351|NCT01011075|Paclitaxel|paclitaxel|mesh-list
55934352|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
55934353|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55934354|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934355|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934356|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
55934357|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934358|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934359|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55934360|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934361|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
55997872|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55997873|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55997874|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55997875|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
55997876|NCT03829592|Misoprostol|misoprostol|mesh-list
55997877|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55997878|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
55997879|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55997880|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997881|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55997883|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
55997884|NCT01142323|Fenofibrate|fenofibrate|mesh-list
55997885|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55997886|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
55997887|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997888|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55997889|NCT01142947|Beclomethasone|beclomethasone|mesh-list
55997890|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55997891|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
55997892|NCT01142947|Hormones|hormones|mesh-ancestor
55997893|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997894|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997895|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55997896|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
55997898|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
55997899|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55997900|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
55997901|NCT02972294|Trace Elements|trace elements|mesh-ancestor
55934362|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
55934363|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55934364|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55934365|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934366|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
55934367|NCT00958581|Coagulants|coagulants|mesh-ancestor
55934368|NCT01012089|Daptomycin|daptomycin|mesh-list
55934369|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934370|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934371|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
55934372|NCT04422431|Choline|choline|mesh-list
55934373|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
55934374|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55934375|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
55934376|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934377|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55997902|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
55997903|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997904|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55997905|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55997906|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997907|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
55997908|NCT02972294|Coagulants|coagulants|mesh-ancestor
55997909|NCT02972294|Hematinics|hematinics|mesh-ancestor
55997910|NCT02969798|Metformin|metformin|mesh-list
55997911|NCT02969798|Pioglitazone|pioglitazone|mesh-list
55997912|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
55997913|NCT02969798|Saxagliptin|saxagliptin|mesh-list
55997914|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55997915|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719546|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719550|NCT05118685|Estrogens|estrogens|mesh-list
55997916|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55997917|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997918|NCT02969798|Incretins|incretins|mesh-ancestor
55997919|NCT02969798|Hormones|hormones|mesh-ancestor
55997920|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55997921|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55997922|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
55997923|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55997924|NCT02983214|Cilostazol|cilostazol|mesh-list
55997925|NCT02983214|Clopidogrel|clopidogrel|mesh-list
55997926|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55997954|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997955|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997956|NCT03824834|Analgesics|analgesics|mesh-ancestor
55997957|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
55997958|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997959|NCT03829124|Ketamine|ketamine|mesh-list
55997960|NCT03829124|Propofol|propofol|mesh-list
55997961|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55997962|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55997963|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997964|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55997965|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
55997966|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
55997967|NCT03829124|Analgesics|analgesics|mesh-ancestor
55997968|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
55997969|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997970|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55997971|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55997972|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55997973|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997974|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997975|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
55997976|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55997977|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55997978|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55862118|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
55934378|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55934379|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
55934380|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
55934381|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
55934382|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934383|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55934384|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55934397|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934398|NCT03975647|Tucatinib|tucatinib|mesh-list
55934399|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934400|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934401|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55934402|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934403|NCT03871361|Abatacept|abatacept|mesh-list
55934404|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55934405|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934406|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934407|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55934408|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
55934409|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997979|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55997980|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55997981|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55997982|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
55997983|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55997984|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997985|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55997986|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55997987|NCT03047330|Leuprolide|leuprolide|mesh-list
55997988|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55997989|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
55997990|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55997991|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55997992|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55997993|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997996|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55997997|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55997998|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
55997999|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998000|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55998001|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55998002|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998003|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998008|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
55998023|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55998024|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55998026|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998027|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
55998028|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55998029|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998030|NCT01025453|Sirolimus|sirolimus|mesh-list
55998031|NCT01025453|Sorafenib|sorafenib|mesh-list
55998032|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998033|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55998034|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998035|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998036|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55998037|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998038|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55998039|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
55998079|NCT02939300|Ipilimumab|ipilimumab|mesh-list
55998080|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998081|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998082|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55998083|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998084|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
55998085|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998086|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998087|NCT04392128|Azithromycin|azithromycin|mesh-list
55725358|NCT05646394|Antipyretics|antipyretics|mesh-ancestor
55998088|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
55998089|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55998090|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998091|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
55998092|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55998138|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998139|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998140|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55998141|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55998142|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55998143|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55998144|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55998145|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55998146|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55998147|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55998148|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
55998149|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55998150|NCT04274816|Tremelimumab|tremelimumab|mesh-list
55998151|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998152|NCT03252938|Avelumab|avelumab|mesh-list
55998153|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998154|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998155|NCT05509374|Dexamethasone|dexamethasone|mesh-list
55998156|NCT05509374|Pomalidomide|pomalidomide|mesh-list
55998157|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998158|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
55998159|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
55998160|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998161|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998162|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998163|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
55998166|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55998167|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934410|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934411|NCT04764227|Paclitaxel|paclitaxel|mesh-list
55934412|NCT04764227|Carboplatin|carboplatin|mesh-list
55934413|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55934414|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934415|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934416|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
55934417|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934418|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934420|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55934421|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998168|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
55998169|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55998170|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55998171|NCT05509374|Growth Substances|growth substances|mesh-ancestor
55998172|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
55998173|NCT04124822|Prednisolone|prednisolone|mesh-list
55998174|NCT04124822|Piroxicam|piroxicam|mesh-list
55998175|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998176|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
55998177|NCT04124822|Hormones|hormones|mesh-ancestor
55998178|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998179|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998180|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55998181|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998182|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998183|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55998184|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55998185|NCT04124822|Analgesics|analgesics|mesh-ancestor
55998186|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
55998187|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998188|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55998189|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757905|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
55998190|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998218|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998219|NCT03519308|Gemcitabine|gemcitabine|mesh-list
55998220|NCT03519308|Paclitaxel|paclitaxel|mesh-list
55998221|NCT03519308|Nivolumab|nivolumab|mesh-list
55998222|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55998223|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998224|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
55998225|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
55998226|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
55998227|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998229|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
55998230|NCT03519308|Antiviral Agents|antiviral agents|mesh-ancestor
55998231|NCT03519308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998232|NCT03519308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998233|NCT03519308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998234|NCT03519308|Immunologic Factors|immunologic factors|mesh-ancestor
55998235|NCT03519308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998236|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998237|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55862394|NCT01275352|Eplerenone|eplerenone|mesh-list
55934422|NCT03497975|Nalbuphine|nalbuphine|mesh-list
55934423|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55934424|NCT03497975|Narcotics|narcotics|mesh-ancestor
55934425|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934426|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934427|NCT03497975|Analgesics|analgesics|mesh-ancestor
55934428|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
55934429|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934430|NCT04764383|Histamine|histamine|mesh-list
55934431|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
55934432|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
55934433|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934434|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934435|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934436|NCT03016611|Ticagrelor|ticagrelor|mesh-list
55934437|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55934438|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55934439|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55934440|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55934441|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55934442|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
55934443|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934444|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934445|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934446|NCT00961233|Budesonide|budesonide|mesh-list
55934447|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55934452|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55934453|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
55934455|NCT00961233|Hormones|hormones|mesh-ancestor
55934456|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55934458|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55934459|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
55934460|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998239|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
55998240|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55998241|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55998242|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55998243|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
55998244|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
55998245|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998246|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998247|NCT03821714|Hormones|hormones|mesh-ancestor
56032496|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998248|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998249|NCT02565108|Cannabidiol|cannabidiol|mesh-list
55998250|NCT02565108|Clobazam|clobazam|mesh-list
55998251|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
55998252|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55998253|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55998254|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998255|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998256|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55998257|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55998258|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
55998259|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
55998260|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998261|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998291|NCT01454180|Protective Agents|protective agents|mesh-ancestor
55998292|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
55998293|NCT01454180|Vitamins|vitamins|mesh-ancestor
55998294|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
55998295|NCT02564952|Cannabidiol|cannabidiol|mesh-list
55998296|NCT02564952|Clobazam|clobazam|mesh-list
55998297|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
55998298|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55998299|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55998300|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998301|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998302|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55998303|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55998304|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
55998305|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
55998306|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998307|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998308|NCT05564286|Dexamethasone|dexamethasone|mesh-list
55998309|NCT05564286|Fosaprepitant|fosaprepitant|mesh-list
55998310|NCT05564286|Aprepitant|aprepitant|mesh-list
55998311|NCT05564286|Tropisetron|tropisetron|mesh-list
55998312|NCT05564286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998313|NCT05564286|Antiemetics|antiemetics|mesh-ancestor
55998347|NCT05504382|Analgesics|analgesics|mesh-ancestor
55998348|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
55998349|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998350|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998351|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998352|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998353|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
55998354|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55998355|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998356|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998357|NCT03823040|Oxiconazole|oxiconazole|mesh-list
55998358|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
55998359|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998360|NCT02566902|Albuterol|albuterol|mesh-list
55998361|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55998362|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
55998363|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998364|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998365|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55998366|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
55998367|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
55998368|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55998369|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55998370|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55998371|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55998372|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
55998390|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55998391|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998392|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998393|NCT01455506|Fludarabine|fludarabine|mesh-list
55998395|NCT01455506|Decitabine|decitabine|mesh-list
55998396|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998397|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55998398|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
55998399|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998400|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998402|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998403|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
55998404|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55998405|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55998406|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998407|NCT02564796|Iron|iron|mesh-list
55998408|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
55998409|NCT02564796|Trace Elements|trace elements|mesh-ancestor
55998410|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
55998411|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998412|NCT02564796|Hematinics|hematinics|mesh-ancestor
55998413|NCT03829436|Nivolumab|nivolumab|mesh-list
55998414|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998415|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998416|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55998417|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998418|NCT05563350|Midazolam|midazolam|mesh-list
55998419|NCT05563350|Omeprazole|omeprazole|mesh-list
55934461|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55934462|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55934463|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934464|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934465|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55934466|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55934467|NCT01014351|Paclitaxel|paclitaxel|mesh-list
55934468|NCT01014351|Carboplatin|carboplatin|mesh-list
55934469|NCT01014351|Everolimus|everolimus|mesh-list
55934470|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55934471|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934472|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934473|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
55934474|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934475|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934476|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998420|NCT05563350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55998421|NCT05563350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55998422|NCT05563350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998423|NCT05563350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998424|NCT05563350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55998425|NCT05563350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55998426|NCT05563350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55998427|NCT05563350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55998428|NCT05563350|Anesthetics, General|anesthetics, general|mesh-ancestor
55998429|NCT05563350|Anesthetics|anesthetics|mesh-ancestor
55998430|NCT05563350|GABA Modulators|gaba modulators|mesh-ancestor
55998431|NCT05563350|GABA Agents|gaba agents|mesh-ancestor
55998432|NCT05563350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998433|NCT05563350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998434|NCT05563350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55998435|NCT05563350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998436|NCT05563350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55998437|NCT05563350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998438|NCT04273100|Lenvatinib|lenvatinib|mesh-list
55998439|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998440|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55998441|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998443|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
55998473|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998474|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
55998475|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
55998476|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998478|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998480|NCT05560542|Hormones|hormones|mesh-ancestor
55998481|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998482|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55998483|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998484|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55998485|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55998486|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55998487|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55998488|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
55998489|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
55998490|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
55998491|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55998492|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55998493|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
55998494|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998495|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998496|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
55998497|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55998498|NCT05560308|Trastuzumab|trastuzumab|mesh-list
55998499|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55998500|NCT05560308|Maytansine|maytansine|mesh-list
55998501|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998502|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998503|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998504|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55998505|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
55998506|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
55998508|NCT04775082|Liraglutide|liraglutide|mesh-list
55998511|NCT04775082|Incretins|incretins|mesh-ancestor
55998512|NCT04775082|Hormones|hormones|mesh-ancestor
55998513|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998514|NCT04843046|Pioglitazone|pioglitazone|mesh-list
55998515|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55998516|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998517|NCT01456208|Norepinephrine|norepinephrine|mesh-list
55998518|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
55998519|NCT01456208|Giapreza|giapreza|mesh-list
55998520|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
55998521|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55998522|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55998523|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
55998524|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998525|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998526|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998527|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
55998528|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
55998529|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998530|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55998531|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55998532|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
55998533|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998534|NCT05436522|Propofol|propofol|mesh-list
55998535|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55998536|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998537|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998538|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55998539|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
55998540|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
55998541|NCT03780010|Paclitaxel|paclitaxel|mesh-list
55934477|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
55934478|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934479|NCT01014741|Ibutilide|ibutilide|mesh-list
55934480|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55934481|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
55934482|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55934483|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
55934484|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934485|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934486|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55934487|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
55998543|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55998544|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998545|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
55998546|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
55998547|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
55998548|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998550|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55998551|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55998552|NCT03826550|Analgesics|analgesics|mesh-ancestor
55998553|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
55998554|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998555|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998556|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998557|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998558|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55998559|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998560|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998561|NCT03827018|Prednisone|prednisone|mesh-list
55998562|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
55998563|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998564|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
55998595|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
55998596|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55998597|NCT05498064|Ensartinib|ensartinib|mesh-list
55998598|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998599|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55998600|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998601|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998602|NCT03767062|Topiramate|topiramate|mesh-list
55998603|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
55998604|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55998605|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998606|NCT01456364|Ticagrelor|ticagrelor|mesh-list
55998607|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55998608|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55998609|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55998610|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55998611|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55998612|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
55998613|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998614|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998615|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998617|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55998618|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
55998620|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55998621|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
55998622|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
55998623|NCT04281420|Vitamins|vitamins|mesh-ancestor
55998624|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
55998625|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998626|NCT03765502|Glucagon|glucagon|mesh-list
55998627|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55998628|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998629|NCT03765502|Hormones|hormones|mesh-ancestor
55998630|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998631|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998632|NCT03765502|Incretins|incretins|mesh-ancestor
55998633|NCT04447716|Rituximab|rituximab|mesh-list
55998634|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55998635|NCT04447716|Lenalidomide|lenalidomide|mesh-list
55998636|NCT04447716|Venetoclax|venetoclax|mesh-list
55998637|NCT04447716|Piperidine|piperidine|mesh-list
55998638|NCT04447716|Antibodies|antibodies|mesh-list
55998639|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
55719643|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55719644|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55998640|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55998641|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
55998642|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998643|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998644|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998645|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55998646|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55998647|NCT04447716|Growth Substances|growth substances|mesh-ancestor
55998648|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
55998649|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998650|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55998651|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55998652|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55998653|NCT05285124|Melatonin|melatonin|mesh-list
55998654|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
55998655|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998656|NCT05285124|Protective Agents|protective agents|mesh-ancestor
55998657|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998658|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998659|NCT01450046|Vitamin E|vitamin e|mesh-list
55998660|NCT01450046|Tocopherols|tocopherols|mesh-list
55998661|NCT01450046|Tocotrienols|tocotrienols|mesh-list
55998662|NCT01450046|Vitamins|vitamins|mesh-ancestor
55998663|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
55934488|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934489|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934490|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55934491|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
55934492|NCT00962949|Giapreza|giapreza|mesh-list
55934493|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
55934494|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55934495|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55934496|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
55934497|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934498|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934499|NCT01711541|Paclitaxel|paclitaxel|mesh-list
55934500|NCT01711541|Cisplatin|cisplatin|mesh-list
55934501|NCT01711541|Carboplatin|carboplatin|mesh-list
55998664|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998665|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
55998666|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998667|NCT01450046|Protective Agents|protective agents|mesh-ancestor
55998668|NCT05497596|Vitamin D|vitamin d|mesh-list
55998669|NCT05497596|Vitamins|vitamins|mesh-ancestor
55998670|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
55998671|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998672|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55998673|NCT01450124|Boswellic acid|boswellic acid|mesh-list
55998674|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55998675|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55998676|NCT01450124|Analgesics|analgesics|mesh-ancestor
55998677|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
55998678|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998679|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998680|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998681|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998682|NCT05243862|Atezolizumab|atezolizumab|mesh-list
55998683|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998684|NCT03751124|Norethindrone|norethindrone|mesh-list
55998685|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
55998686|NCT03751124|Estradiol|estradiol|mesh-list
55998687|NCT03751124|Relugolix|relugolix|mesh-list
55998688|NCT03751124|Estrogens|estrogens|mesh-ancestor
55998689|NCT03751124|Hormones|hormones|mesh-ancestor
55998690|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998691|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934502|NCT01711541|Fluorouracil|fluorouracil|mesh-list
55934503|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55934504|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
55934505|NCT01711541|Veliparib|veliparib|mesh-list
55934506|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55934507|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934508|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934509|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
55934510|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934511|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934512|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
55934513|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55934514|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55934515|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
55934516|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934517|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
55934518|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934527|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
55934528|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998692|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55998693|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
55998694|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55998695|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55998697|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55998698|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55998699|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
55998700|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
55998702|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55998703|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
55998704|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998705|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998706|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
55998707|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55998708|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998709|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55998710|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998711|NCT04081324|Lasmiditan|lasmiditan|mesh-list
55998712|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55998713|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
55998714|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998715|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998716|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998717|NCT04042324|Heparin|heparin|mesh-list
55998718|NCT04042324|Calcium heparin|calcium heparin|mesh-list
55998719|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
55998720|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998721|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55998722|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55998723|NCT04391660|Ethanol|ethanol|mesh-list
55998724|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
55998725|NCT04391660|Eusol|eusol|mesh-list
55998726|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55998735|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998736|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998737|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
55998738|NCT04066426|Acetaminophen|acetaminophen|mesh-list
55998739|NCT04066426|Dexamethasone|dexamethasone|mesh-list
55998740|NCT04066426|Naproxen|naproxen|mesh-list
55998741|NCT04066426|Codeine|codeine|mesh-list
55998742|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998743|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
55998744|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
55998745|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998746|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998747|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998748|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
55998749|NCT04066426|Hormones|hormones|mesh-ancestor
55998750|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998751|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55998752|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998753|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55998754|NCT04066426|Analgesics|analgesics|mesh-ancestor
55998755|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
55998756|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
55998757|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55998758|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998759|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
55998760|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55998761|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998762|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998763|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55998764|NCT04066426|Narcotics|narcotics|mesh-ancestor
55998765|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998766|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
55998767|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
55998768|NCT01450514|Pipamperone|pipamperone|mesh-list
55934529|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934530|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934531|NCT01244789|Paclitaxel|paclitaxel|mesh-list
55934532|NCT01244789|Carboplatin|carboplatin|mesh-list
55934533|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55934534|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934535|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934536|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
55998769|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55998770|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
55998771|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998772|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998773|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998774|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55998775|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55998776|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998777|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55998778|NCT05095116|Fluticasone|fluticasone|mesh-list
55998779|NCT05095116|Xhance|xhance|mesh-list
55998780|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998781|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55998782|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
55998783|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998784|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998785|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55998786|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
55998787|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
55998788|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55998789|NCT02899052|Dexamethasone|dexamethasone|mesh-list
55998790|NCT02899052|Venetoclax|venetoclax|mesh-list
55998791|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55998792|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
55998793|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
55934537|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934538|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934540|NCT02631876|Maytansine|maytansine|mesh-list
55934541|NCT02631876|Doxorubicin|doxorubicin|mesh-list
55934542|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55934543|NCT02631876|Topotecan|topotecan|mesh-list
55934544|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55934545|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934546|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934547|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
55934548|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934549|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934550|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55934551|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55934552|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55934553|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934554|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55934555|NCT03156179|Calcium|calcium|mesh-list
55934556|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55934557|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934558|NCT03881345|Anticoagulants|anticoagulants|mesh-list
55934559|NCT03878069|Elapegademase|elapegademase|mesh-list
55934560|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
55934561|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934562|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934563|NCT04436796|Pancrelipase|pancrelipase|mesh-list
55998794|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998795|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998796|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998797|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
55998799|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55998800|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55998801|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998802|NCT04758728|Epinephrine|epinephrine|mesh-list
55998803|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55998804|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55998805|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
55998806|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998807|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998808|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998809|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55998810|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55998811|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
55998812|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998813|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55998814|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
55998815|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
55998817|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55998818|NCT02559570|Linaclotide|linaclotide|mesh-list
55998845|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998846|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998848|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998849|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55998850|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55998851|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55998852|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55998853|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998854|NCT04272788|Infliximab|infliximab|mesh-list
55998855|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
55998856|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998857|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55998858|NCT01457690|Tocopherols|tocopherols|mesh-list
55998859|NCT01457690|Vitamin E|vitamin e|mesh-list
55998860|NCT01457690|Tocotrienols|tocotrienols|mesh-list
55998861|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
55998862|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
55998863|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998864|NCT01457690|Protective Agents|protective agents|mesh-ancestor
55998865|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998866|NCT01457690|Vitamins|vitamins|mesh-ancestor
55998867|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
55998868|NCT05497206|Metronidazole|metronidazole|mesh-list
55998873|NCT01451060|Ephedrine|ephedrine|mesh-list
55998896|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
55998897|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998898|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55998899|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
55998900|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998901|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55998902|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
55998903|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55998904|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998905|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55998906|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55998907|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55998908|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
55998909|NCT04846478|Talazoparib|talazoparib|mesh-list
55998910|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55998911|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032497|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55998912|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998913|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998915|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
55998916|NCT01451294|Ephedrine|ephedrine|mesh-list
55998917|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55998918|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
55998919|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
55998946|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
55998947|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
55998948|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
55998949|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998950|NCT01224145|Bupivacaine|bupivacaine|mesh-list
55998951|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
55998952|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
55998953|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998954|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998955|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
55998956|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998957|NCT01451840|Lidocaine|lidocaine|mesh-list
55998958|NCT01451840|Remifentanil|remifentanil|mesh-list
55998959|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
55998960|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
55998961|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55998962|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998963|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
55998964|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55998965|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55998966|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55998967|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55998968|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55998969|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998970|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55998971|NCT01451840|Narcotics|narcotics|mesh-ancestor
55998972|NCT01451840|Analgesics|analgesics|mesh-ancestor
55719686|NCT01329263|Menthol|menthol|mesh-list
55998973|NCT01451918|Resveratrol|resveratrol|mesh-list
55998974|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
55998975|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998976|NCT01451918|Protective Agents|protective agents|mesh-ancestor
55998977|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998978|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998979|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55998980|NCT00378196|Ranibizumab|ranibizumab|mesh-list
55863108|NCT05743270|Nivolumab|nivolumab|mesh-list
55934564|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55934565|NCT02081963|Amikacin|amikacin|mesh-list
55934566|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55998981|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55998983|NCT00378196|Growth Substances|growth substances|mesh-ancestor
55998984|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55998985|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
55998986|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998987|NCT01188109|Gemcitabine|gemcitabine|mesh-list
55998988|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55998989|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55998990|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
55998991|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55998992|NCT01188109|Antiviral Agents|antiviral agents|mesh-ancestor
55998993|NCT01188109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55998994|NCT01188109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55998995|NCT01188109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55998996|NCT01188109|Immunologic Factors|immunologic factors|mesh-ancestor
55998997|NCT01188109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726251|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55998999|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55999000|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
55999002|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55999003|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55999004|NCT01146457|Narcotics|narcotics|mesh-ancestor
55999005|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999006|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999007|NCT01146457|Analgesics|analgesics|mesh-ancestor
55999008|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
55999009|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999010|NCT04031430|Antihypertensive Agents|antihypertensive agents|mesh-list
55999011|NCT05490888|Terlipressin|terlipressin|mesh-list
55999013|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55999014|NCT02886962|Vitamin K|vitamin k|mesh-list
55999015|NCT02886962|Vitamins|vitamins|mesh-ancestor
55999018|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55999019|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55999020|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999021|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
55999022|NCT02886962|Coagulants|coagulants|mesh-ancestor
55999023|NCT05495958|Vitamin D|vitamin d|mesh-list
55999024|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55999025|NCT05495958|Vitamins|vitamins|mesh-ancestor
55999026|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
55999027|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999028|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55999029|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55999030|NCT04011592|Ketamine|ketamine|mesh-list
55999031|NCT04011592|Analgesics|analgesics|mesh-ancestor
55999032|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
55999033|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999034|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999035|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55999036|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55999037|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
55999038|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
55999039|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999040|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55999041|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55999042|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999043|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999044|NCT01458470|Memantine|memantine|mesh-list
55999045|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55999046|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55999053|NCT05028062|Naltrexone|naltrexone|mesh-list
55999061|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
55999062|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999064|NCT05025488|Poly ICLC|poly iclc|mesh-list
55999065|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
55999066|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
55999067|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999068|NCT01452542|Eliglustat|eliglustat|mesh-list
55999069|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999070|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999071|NCT01458548|Rituximab|rituximab|mesh-list
55999072|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55999073|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999074|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
55999075|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999076|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999077|NCT05027204|Docetaxel|docetaxel|mesh-list
55999078|NCT05027204|Nivolumab|nivolumab|mesh-list
55999079|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999080|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
55999081|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
55999082|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
55999083|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999084|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55999085|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55999086|NCT01458626|Mirtazapine|mirtazapine|mesh-list
55999087|NCT01458626|Paroxetine|paroxetine|mesh-list
55999088|NCT01458626|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55999089|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55999090|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55999091|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999092|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999093|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
55934567|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934568|NCT04765085|Aripiprazole|aripiprazole|mesh-list
55934569|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
55934570|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55934571|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55934573|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999095|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55999096|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
55999097|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55999098|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55999099|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55999100|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999101|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55999102|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
55999103|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
55999104|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55999105|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55999106|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999107|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55999108|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55999109|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55999110|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
55999149|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999150|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55999151|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55999152|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999153|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55999154|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55999155|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55999157|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55999158|NCT04713904|Estrogens|estrogens|mesh-ancestor
55999159|NCT04713904|Hormones|hormones|mesh-ancestor
55999160|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999161|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999162|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55999163|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
55999164|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55999165|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55999166|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55999167|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55999168|NCT03995680|Mebendazole|mebendazole|mesh-list
55999169|NCT03995680|Piperazine|piperazine|mesh-list
55999170|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
55999171|NCT03995680|DMP 777|dmp 777|mesh-list
55999172|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
55999173|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
55999174|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55999175|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999176|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
55999177|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
55999178|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
55999179|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999180|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999182|NCT01452698|Lansoprazole|lansoprazole|mesh-list
55999188|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999189|NCT05029856|Vaccines|vaccines|mesh-list
55999190|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
55999191|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999192|NCT05490342|Antibodies|antibodies|mesh-list
55999193|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
55999194|NCT05490342|Paraproteins|paraproteins|mesh-list
55999195|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
55999196|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999197|NCT05495100|Azacitidine|azacitidine|mesh-list
55999198|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
55999199|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55999200|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
55999201|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999202|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999203|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999204|NCT05495100|Analgesics|analgesics|mesh-ancestor
55999205|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
55999206|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999207|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999208|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55999209|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55999210|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
55999211|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55999212|NCT03325114|Diuretics|diuretics|mesh-ancestor
55999213|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
55999214|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999215|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55999216|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55999217|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999218|NCT01453400|Aspirin|aspirin|mesh-list
55934574|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934575|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
55934576|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
55934577|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934578|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934579|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55934580|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55934581|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
55934582|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55934583|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55934584|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55999220|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55999221|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55999222|NCT01453400|Analgesics|analgesics|mesh-ancestor
55999223|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
55999224|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999225|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999226|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999227|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999228|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55999229|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55999231|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55999282|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999283|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999284|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
55999285|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999286|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55999287|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55999288|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55999289|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55999290|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55999291|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55999292|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55999293|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55999294|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55999295|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
55999296|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
55999297|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999298|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999299|NCT02880020|Nivolumab|nivolumab|mesh-list
55999300|NCT02880020|Ipilimumab|ipilimumab|mesh-list
55999301|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55999302|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999303|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55999304|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999305|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55999306|NCT03150160|Travoprost|travoprost|mesh-list
55999307|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55999308|NCT03150160|Brinzolamide|brinzolamide|mesh-list
55999309|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55999310|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55999311|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55999312|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55999313|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55999319|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999321|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999322|NCT05489952|Iron|iron|mesh-list
55999323|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55999324|NCT05489952|Trace Elements|trace elements|mesh-ancestor
55999325|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
55999326|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999327|NCT05489952|Hematinics|hematinics|mesh-ancestor
55999328|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
55999329|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55999330|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
55999331|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999332|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
55999333|NCT01459640|Protective Agents|protective agents|mesh-ancestor
55999334|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
55999335|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55719756|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55999336|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999337|NCT01500772|Ribavirin|ribavirin|mesh-list
55999338|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55934585|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55934586|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55934587|NCT02633046|Hormones|hormones|mesh-ancestor
55934588|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55934612|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55934613|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
55934614|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934616|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
55934617|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
55934618|NCT04364802|Povidone|povidone|mesh-list
55934619|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55934620|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934621|NCT04364802|Trace Elements|trace elements|mesh-ancestor
55934622|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
55934623|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934624|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
55934625|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
55934626|NCT03155087|Metformin|metformin|mesh-list
55934627|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55934628|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934629|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55934630|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
55934631|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934632|NCT05491278|Remifentanil|remifentanil|mesh-list
55934633|NCT05491278|Propofol|propofol|mesh-list
55934634|NCT05491278|Fospropofol|fospropofol|mesh-list
55934635|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55934636|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934637|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934638|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55934639|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
55934640|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
55934641|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55934646|NCT00963105|Lenalidomide|lenalidomide|mesh-list
55934647|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
55934648|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934649|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55934650|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55934651|NCT00963105|Growth Substances|growth substances|mesh-ancestor
55934652|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
55999339|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
55999340|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999341|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
55999342|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999343|NCT04272476|Fluoxetine|fluoxetine|mesh-list
55999344|NCT04272476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55999345|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55999346|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55999347|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999348|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55999349|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
55999350|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999351|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55999352|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
55999353|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55999354|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55999355|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55999356|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999357|NCT03984838|Dolutegravir|dolutegravir|mesh-list
55999358|NCT03984838|Rilpivirine|rilpivirine|mesh-list
56032498|NCT04955574|Metronidazole|metronidazole|mesh-list
55999359|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
55999360|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55999361|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55999362|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999363|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999364|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55999365|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55934653|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934654|NCT04879992|Amoxicillin|amoxicillin|mesh-list
55934655|NCT04879992|Metronidazole|metronidazole|mesh-list
55934656|NCT04879992|Tetracycline|tetracycline|mesh-list
55934657|NCT04879992|Rifabutin|rifabutin|mesh-list
55934658|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
55934659|NCT04879992|Esomeprazole|esomeprazole|mesh-list
55934660|NCT04879992|Bismuth|bismuth|mesh-list
55934661|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934662|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934663|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934664|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55934665|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55934666|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55934667|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55934668|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55934669|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934670|NCT04879992|Antacids|antacids|mesh-ancestor
55934671|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55999366|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
55999367|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999368|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55999369|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55999371|NCT05489796|Fentanyl|fentanyl|mesh-list
55999372|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55999374|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55999375|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999376|NCT05489796|Analgesics|analgesics|mesh-ancestor
55999377|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
55999378|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999379|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55999380|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55999381|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
55999382|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
55999383|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55999384|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55999385|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999386|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999387|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55999388|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863529|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55719781|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55719782|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
55719783|NCT03736265|Protective Agents|protective agents|mesh-ancestor
55719784|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55719785|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55719786|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55719787|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
55934672|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55934673|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
55934674|NCT04879992|Diuretics|diuretics|mesh-ancestor
55934675|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
55934676|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934677|NCT04879992|Expectorants|expectorants|mesh-ancestor
55934678|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
55934679|NCT03864419|Prednisone|prednisone|mesh-list
55934680|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
55934681|NCT03864419|Rituximab|rituximab|mesh-list
55934682|NCT03864419|Doxorubicin|doxorubicin|mesh-list
55934683|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55934684|NCT03864419|Methotrexate|methotrexate|mesh-list
55934686|NCT03864419|Vincristine|vincristine|mesh-list
55934687|NCT03864419|Daunorubicin|daunorubicin|mesh-list
55934688|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
55934689|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55934690|NCT03864419|Antibodies|antibodies|mesh-list
55934691|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
55934692|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55934693|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55934694|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
55934695|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934696|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934697|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55934698|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
55934699|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934700|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934701|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55934702|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55934703|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55999389|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999391|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999392|NCT01890902|Ketoprofen|ketoprofen|mesh-list
55999393|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55999394|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55999395|NCT01890902|Analgesics|analgesics|mesh-ancestor
55999396|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
55999397|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999398|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999399|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999400|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999401|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55999402|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999403|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999404|NCT04423926|Prednisolone|prednisolone|mesh-list
55999405|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
55999406|NCT04423926|Doxorubicin|doxorubicin|mesh-list
55999407|NCT04423926|Vincristine|vincristine|mesh-list
55999408|NCT04423926|Lenalidomide|lenalidomide|mesh-list
55999409|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55999410|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
55999411|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999412|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999413|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55999414|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
55999415|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999416|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999417|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55999418|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55719802|NCT02934529|Leucovorin|leucovorin|mesh-list
55999421|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999433|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999434|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55999435|NCT03979066|Atezolizumab|atezolizumab|mesh-list
55999436|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999437|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
55999438|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999439|NCT05489406|Dolutegravir|dolutegravir|mesh-list
55999440|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55999441|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55999445|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55999446|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
55999447|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999448|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55999449|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999450|NCT01472692|Febuxostat|febuxostat|mesh-list
55999451|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
55999452|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999453|NCT05020028|Cannabidiol|cannabidiol|mesh-list
55999454|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
55999455|NCT00378820|Caseins|caseins|mesh-list
55999456|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
55999457|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
55999458|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999463|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55999464|NCT02558400|Latanoprost|latanoprost|mesh-list
55999465|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55999466|NCT00950430|Corticosterone|corticosterone|mesh-list
55999467|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999468|NCT04758260|Antioxidants|antioxidants|mesh-list
55999469|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999470|NCT04758260|Protective Agents|protective agents|mesh-ancestor
55999471|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999472|NCT01446250|Ribavirin|ribavirin|mesh-list
55999473|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55999474|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
55999479|NCT05024552|Daunorubicin|daunorubicin|mesh-list
55999480|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55999481|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
55999482|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999483|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999484|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
55999485|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999486|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55999487|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
55999488|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999489|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55999490|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55999491|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55999492|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999493|NCT05493618|Dexamethasone|dexamethasone|mesh-list
55999494|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
55999495|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999496|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
55999497|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
55934704|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55934705|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934707|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
55934709|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55934710|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55934711|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55934712|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
55934713|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55934714|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55934715|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
55934716|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
55934717|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55934720|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934721|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
55934722|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934723|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
55934724|NCT01016691|Bimatoprost|bimatoprost|mesh-list
55934725|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55934726|NCT04181736|Guanfacine|guanfacine|mesh-list
55934727|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55934728|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55934729|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55934730|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55934731|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
55934732|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55934733|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934734|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934735|NCT04404491|Capecitabine|capecitabine|mesh-list
55934736|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55934737|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
55934738|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934739|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934740|NCT03861299|Anesthetics|anesthetics|mesh-list
55934741|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934742|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999498|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55999499|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999500|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55999501|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
55999503|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999504|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55999505|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999506|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55999507|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
55999508|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55999509|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999511|NCT04139304|Cortisone|cortisone|mesh-list
55999512|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
55999513|NCT04139304|Doxorubicin|doxorubicin|mesh-list
55999514|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55999515|NCT04139304|Etoposide|etoposide|mesh-list
55999516|NCT04139304|Vincristine|vincristine|mesh-list
55999517|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
55999518|NCT04139304|Daunorubicin|daunorubicin|mesh-list
55999519|NCT04139304|Daratumumab|daratumumab|mesh-list
55999520|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
55999521|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55999522|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
55999523|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999524|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55999525|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55999526|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
55999527|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55999528|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999529|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55999530|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55999531|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55999532|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55999533|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55999534|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55999538|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55999539|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55999540|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
55999541|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
55999542|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
55999543|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
55999544|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
55999545|NCT05020574|Cephalexin|cephalexin|mesh-list
55999546|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55999547|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55999548|NCT02936206|Tamoxifen|tamoxifen|mesh-list
55999549|NCT02936206|Fulvestrant|fulvestrant|mesh-list
55999550|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55999551|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
55999552|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55999553|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55999554|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55999555|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999556|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55999557|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55999558|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55999559|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55999560|NCT01891526|Tretinoin|tretinoin|mesh-list
55999561|NCT01891526|Alitretinoin|alitretinoin|mesh-list
55999562|NCT01891526|Isotretinoin|isotretinoin|mesh-list
55999563|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55999564|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
55999565|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
55999566|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
55999567|NCT01406860|Promethazine|promethazine|mesh-list
55999568|NCT01406860|Droperidol|droperidol|mesh-list
55999569|NCT01406860|Metoclopramide|metoclopramide|mesh-list
55999570|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55999575|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
56005850|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56005851|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56005852|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
56005853|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
56005854|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005855|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005856|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
56005857|NCT00002548|Hormones|hormones|mesh-ancestor
56005858|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005859|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56005860|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56005861|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56005862|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56005863|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005864|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
56005865|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005866|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56005867|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
56005868|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
56005869|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
56005870|NCT02087306|Brincidofovir|brincidofovir|mesh-list
56005871|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
56005872|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005873|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
56005874|NCT00002554|Busulfan|busulfan|mesh-list
56005875|NCT00002554|Methotrexate|methotrexate|mesh-list
56005876|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005877|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
56005878|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005879|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005880|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56005894|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
56005895|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56005896|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56005897|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005898|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56005899|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56005900|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
56005901|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56005902|NCT00002560|Antibodies|antibodies|mesh-list
56005903|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56005904|NCT00002560|Sargramostim|sargramostim|mesh-list
56005905|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
56005906|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005907|NCT00254384|Cisplatin|cisplatin|mesh-list
56005908|NCT00254384|Docetaxel|docetaxel|mesh-list
56005909|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56005910|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005911|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
56005912|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
56005913|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
56005914|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005915|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56005916|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005917|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
56005918|NCT00002566|Ifosfamide|ifosfamide|mesh-list
56005919|NCT00002566|Carboplatin|carboplatin|mesh-list
56005920|NCT00002566|Etoposide|etoposide|mesh-list
56005921|NCT00002566|Vinblastine|vinblastine|mesh-list
56005922|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005923|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
56005924|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005925|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005926|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56005927|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
56005928|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005936|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
56005937|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
56005938|NCT00002572|Aldesleukin|aldesleukin|mesh-list
56005939|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
56005940|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005941|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56005942|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56005943|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
56005944|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005945|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
56005946|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005947|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005948|NCT00002578|Leucovorin|leucovorin|mesh-list
56005949|NCT00002578|Cytarabine|cytarabine|mesh-list
56005950|NCT00002578|Methotrexate|methotrexate|mesh-list
56005952|NCT00002578|Calcium|calcium|mesh-list
56005953|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
56005954|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56005955|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005956|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56005957|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
56005958|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56005959|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56005960|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
56005961|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005962|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005963|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
56005964|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005965|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56005966|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005967|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
56005972|NCT00002578|Antidotes|antidotes|mesh-ancestor
56005998|NCT00002590|Cytarabine|cytarabine|mesh-list
56005999|NCT00002590|Prednisone|prednisone|mesh-list
56006000|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
56006001|NCT00002590|Doxorubicin|doxorubicin|mesh-list
56006002|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56006003|NCT00002590|Methotrexate|methotrexate|mesh-list
56006004|NCT00002590|Etoposide|etoposide|mesh-list
56006005|NCT00002590|Vincristine|vincristine|mesh-list
56006006|NCT00002590|Daunorubicin|daunorubicin|mesh-list
56006007|NCT00002590|Asparaginase|asparaginase|mesh-list
56006008|NCT00002590|Pegaspargase|pegaspargase|mesh-list
56006009|NCT00002590|Thioguanine|thioguanine|mesh-list
56006010|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
56006011|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006012|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
56006013|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006014|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006015|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006016|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
56006017|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006018|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006019|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56006020|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56006021|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006023|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006024|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006025|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
56006026|NCT00002590|Hormones|hormones|mesh-ancestor
56006027|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006028|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006029|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56006030|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
56006031|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56006032|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006033|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
56006034|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
56006035|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56006036|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56006037|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006038|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
56006039|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006040|NCT00002590|Antidotes|antidotes|mesh-ancestor
56006041|NCT00002590|Protective Agents|protective agents|mesh-ancestor
56006042|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
56006043|NCT00002590|Vitamins|vitamins|mesh-ancestor
56006044|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
56006045|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
56006046|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
56006047|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
56006048|NCT01273610|Trastuzumab|trastuzumab|mesh-list
56006049|NCT01273610|Lapatinib|lapatinib|mesh-list
56006050|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56006051|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006052|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56006053|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006054|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006055|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
56006056|NCT00002596|Carboplatin|carboplatin|mesh-list
56006057|NCT00002596|Etoposide|etoposide|mesh-list
56006058|NCT00002596|Bleomycin|bleomycin|mesh-list
56006059|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006060|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
56006061|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006062|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006063|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006064|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
56006065|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006066|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006067|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56006068|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006069|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006070|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006071|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006072|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56006074|NCT00199082|Dexamethasone|dexamethasone|mesh-list
56006075|NCT00199082|Prednisolone|prednisolone|mesh-list
56006076|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
56006077|NCT00199082|Ifosfamide|ifosfamide|mesh-list
56006078|NCT00199082|Rituximab|rituximab|mesh-list
56006079|NCT00199082|Methotrexate|methotrexate|mesh-list
56006080|NCT00199082|Vincristine|vincristine|mesh-list
56006081|NCT00199082|Doxorubicin|doxorubicin|mesh-list
56006082|NCT00199082|Vindesine|vindesine|mesh-list
56006083|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006084|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
56006085|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006086|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006087|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006088|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
56006089|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006090|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006091|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56006092|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56006093|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006110|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56006111|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
56006112|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006113|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006114|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
56006115|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
56006116|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
56006117|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56006118|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006119|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006120|NCT00194090|Celecoxib|celecoxib|mesh-list
56006121|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56006122|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56006123|NCT00194090|Analgesics|analgesics|mesh-ancestor
56006124|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
56006125|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006126|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006127|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006128|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006129|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56006130|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56006131|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006132|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006133|NCT04194554|Leuprolide|leuprolide|mesh-list
56006158|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56006159|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
56006160|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006161|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006162|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006163|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56006164|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56006165|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56006167|NCT00002620|Carmustine|carmustine|mesh-list
56006168|NCT00002620|Mitolactol|mitolactol|mesh-list
56006169|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006170|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
56006171|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006172|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006173|NCT00002620|Trace Elements|trace elements|mesh-ancestor
56006174|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
56006214|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006215|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
56006216|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006217|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56006218|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006219|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
56006220|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006221|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56006222|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56006223|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56006224|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006225|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006226|NCT01896440|Ondansetron|ondansetron|mesh-list
56006227|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
56006228|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
56006229|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006230|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006231|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56006232|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
56006233|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
56006234|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56006235|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
56006236|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56006237|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006238|NCT01896440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56006239|NCT01896440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56006240|NCT01896440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56006262|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006263|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56006264|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56006265|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006266|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
56006267|NCT00002662|Paclitaxel|paclitaxel|mesh-list
56006268|NCT00002662|Docetaxel|docetaxel|mesh-list
56006269|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006270|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006271|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
56006272|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
56006273|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
56006274|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006275|NCT00054314|IDN 5109|idn 5109|mesh-list
56006276|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006277|NCT01743950|Bevacizumab|bevacizumab|mesh-list
56006278|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56006279|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006280|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56006281|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56006282|NCT01743950|Growth Substances|growth substances|mesh-ancestor
56006283|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006284|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
56006285|NCT00002674|Cytarabine|cytarabine|mesh-list
56006286|NCT00002674|Etoposide|etoposide|mesh-list
56006287|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
56006288|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
56006289|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006290|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006291|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006306|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56006307|NCT01743872|Dextrans|dextrans|mesh-list
56006308|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
56006309|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
56006310|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
56006311|NCT00002680|Tamoxifen|tamoxifen|mesh-list
56006312|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
56006313|NCT00002680|Melphalan|melphalan|mesh-list
56006314|NCT00002680|Thiotepa|thiotepa|mesh-list
56006315|NCT00002680|Megestrol|megestrol|mesh-list
56006316|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
56006317|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006318|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
56006319|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006320|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006321|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006322|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
56006323|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006324|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006325|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56006326|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56006327|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
56006328|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006329|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006330|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56006331|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56006332|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56006333|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56006334|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56006335|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56006336|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
56006337|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56006338|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56006339|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56006343|NCT00002692|Fluorouracil|fluorouracil|mesh-list
56006346|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56006347|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006348|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
56006349|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006350|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006351|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006352|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006353|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
56006354|NCT00002692|Antidotes|antidotes|mesh-ancestor
56006355|NCT00002692|Protective Agents|protective agents|mesh-ancestor
56006356|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
56006358|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
56006359|NCT05293210|Dexamethasone|dexamethasone|mesh-list
56006360|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006361|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
56006362|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
56006363|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006364|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006365|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56006366|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
56006367|NCT05293210|Hormones|hormones|mesh-ancestor
56006368|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006369|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006370|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006371|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
56006372|NCT01895348|Remifentanil|remifentanil|mesh-list
56006373|NCT01895348|Propofol|propofol|mesh-list
56006374|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56006375|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56006376|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006377|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56006378|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
56006379|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
56006380|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56006381|NCT01895348|Analgesics|analgesics|mesh-ancestor
56006385|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56006386|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56006387|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
56006388|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56006389|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006390|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56006392|NCT04784000|Carbamazepine|carbamazepine|mesh-list
56006393|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
56006394|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
56006395|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56006396|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56006397|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006399|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56006400|NCT04784000|Analgesics|analgesics|mesh-ancestor
56006401|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
56006402|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719883|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
56006403|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56006404|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56006405|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006406|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56006407|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56006408|NCT05271292|Chiauranib|chiauranib|mesh-list
56006409|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006410|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56006411|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006412|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006413|NCT01121588|Crizotinib|crizotinib|mesh-list
56006414|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006415|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56006416|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006417|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006418|NCT05266846|Bevacizumab|bevacizumab|mesh-list
56006425|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006426|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
56006427|NCT01113476|Gemcitabine|gemcitabine|mesh-list
56006428|NCT01113476|Paclitaxel|paclitaxel|mesh-list
56006429|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56006430|NCT01113476|Bevacizumab|bevacizumab|mesh-list
56006431|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006432|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006433|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
56006434|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
56006435|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
56006436|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006437|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56006438|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56006439|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56006440|NCT01113476|Growth Substances|growth substances|mesh-ancestor
56006441|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006442|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
56006443|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006444|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
56006445|NCT01113476|Antiviral Agents|antiviral agents|mesh-ancestor
56006446|NCT01113476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006447|NCT01113476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006448|NCT01113476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006449|NCT01113476|Immunologic Factors|immunologic factors|mesh-ancestor
56006450|NCT05260684|Trametinib|trametinib|mesh-list
56006451|NCT05260684|Vemurafenib|vemurafenib|mesh-list
56006452|NCT05260684|Dabrafenib|dabrafenib|mesh-list
56006453|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006454|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56006470|NCT00002704|Leucovorin|leucovorin|mesh-list
56006471|NCT00002704|Cytarabine|cytarabine|mesh-list
56006472|NCT00002704|Dexamethasone|dexamethasone|mesh-list
56006473|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
56006474|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56006475|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56006476|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56006477|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
56006478|NCT00002704|Thiotepa|thiotepa|mesh-list
56006479|NCT00002704|Methotrexate|methotrexate|mesh-list
56006480|NCT00002704|Etoposide|etoposide|mesh-list
56006481|NCT00002704|Vincristine|vincristine|mesh-list
56006482|NCT00002704|Daunorubicin|daunorubicin|mesh-list
56006483|NCT00002704|Asparaginase|asparaginase|mesh-list
56006484|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
56006485|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
56006486|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006487|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
56006488|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006489|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006490|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006491|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
56006492|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006493|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006494|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55733673|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
56006495|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006496|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
56006497|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
56006498|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006499|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56006500|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
56006501|NCT00002704|Hormones|hormones|mesh-ancestor
56006502|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006503|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006508|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
56006512|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56006513|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006514|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006515|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006517|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006518|NCT00002704|Antidotes|antidotes|mesh-ancestor
56006519|NCT00002704|Protective Agents|protective agents|mesh-ancestor
56006520|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
56006521|NCT00002704|Vitamins|vitamins|mesh-ancestor
56006522|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
56006523|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
56006524|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
56006525|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
56006526|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56006527|NCT00002716|Leucovorin|leucovorin|mesh-list
56006528|NCT00002716|Dexamethasone|dexamethasone|mesh-list
56006529|NCT00002716|Fluorouracil|fluorouracil|mesh-list
56006530|NCT00002716|Floxuridine|floxuridine|mesh-list
56006531|NCT00002716|Calcium|calcium|mesh-list
56006532|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
56006533|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006534|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
56006535|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
56006536|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006537|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006538|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56006539|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
56006540|NCT00002716|Hormones|hormones|mesh-ancestor
56006541|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006542|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006543|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006559|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006560|NCT02533674|Antiviral Agents|antiviral agents|mesh-ancestor
56006561|NCT02533674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006562|NCT02533674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006563|NCT02533674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006564|NCT02533674|Immunologic Factors|immunologic factors|mesh-ancestor
56006565|NCT02533674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006566|NCT00002722|Leucovorin|leucovorin|mesh-list
56006567|NCT00002722|Fluorouracil|fluorouracil|mesh-list
55733756|NCT05604131|Deferiprone|deferiprone|mesh-list
56006568|NCT00002722|Calcium|calcium|mesh-list
56006569|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
56006570|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006571|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56006572|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006574|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006575|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006576|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006577|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
56006578|NCT00002722|Antidotes|antidotes|mesh-ancestor
56006579|NCT00002722|Protective Agents|protective agents|mesh-ancestor
56006580|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
56006581|NCT00002722|Vitamins|vitamins|mesh-ancestor
56006582|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
56006583|NCT00002734|Interferons|interferons|mesh-list
56006584|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
56006585|NCT00002734|Paclitaxel|paclitaxel|mesh-list
56006586|NCT00002734|Topotecan|topotecan|mesh-list
56006587|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56006588|NCT00002734|Antibodies|antibodies|mesh-list
56006589|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
56006590|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56006591|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006599|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
56006605|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56006606|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006607|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56006608|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006609|NCT00002740|Cobalt|cobalt|mesh-list
56006610|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
56006611|NCT00002740|Carboplatin|carboplatin|mesh-list
56006612|NCT00002740|Doxorubicin|doxorubicin|mesh-list
56006613|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56006614|NCT00002740|Etoposide|etoposide|mesh-list
56006615|NCT00002740|Vincristine|vincristine|mesh-list
56006616|NCT00002740|Lenograstim|lenograstim|mesh-list
56006617|NCT00002740|Mesna|mesna|mesh-list
56006618|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006619|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
56006620|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006621|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006622|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006623|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
56006624|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006625|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006626|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56006627|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56006628|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006629|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006630|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006656|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006657|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006659|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
56006660|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56006661|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56006662|NCT01049945|Growth Substances|growth substances|mesh-ancestor
56006663|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
56006664|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006665|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
56006666|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006667|NCT00002752|Antibodies|antibodies|mesh-list
56006668|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56006669|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
56006670|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006671|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
56006672|NCT05465226|Narcotics|narcotics|mesh-ancestor
56006673|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56006674|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006676|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
56006677|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006678|NCT05070754|Cantharidin|cantharidin|mesh-list
56006679|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006680|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006681|NCT01050647|Castor Oil|castor oil|mesh-list
56006682|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
56006683|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
56006684|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56006685|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
56006686|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006687|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006688|NCT01050647|Progestins|progestins|mesh-ancestor
56006694|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006695|NCT04825678|Analgesics|analgesics|mesh-ancestor
56006696|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
56006697|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006698|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006699|NCT03968393|Anticoagulants|anticoagulants|mesh-list
56006700|NCT00002764|Doxorubicin|doxorubicin|mesh-list
56006701|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56006702|NCT00002764|Ifosfamide|ifosfamide|mesh-list
56006703|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56006704|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006705|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006706|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006707|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006708|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006709|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006710|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
56006711|NCT01688492|Ipilimumab|ipilimumab|mesh-list
56006712|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56006713|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006714|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56006715|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006716|NCT05167175|Prednisone|prednisone|mesh-list
56006717|NCT05167175|Olaparib|olaparib|mesh-list
56006718|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
56006719|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006720|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
56006721|NCT05167175|Hormones|hormones|mesh-ancestor
56006722|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006723|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006724|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006725|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006726|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56006732|NCT00002788|Dexamethasone|dexamethasone|mesh-list
56006733|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
56006734|NCT00002788|Etoposide|etoposide|mesh-list
56006735|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006736|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
56006737|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006738|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006739|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006740|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
56006741|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006742|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006743|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56006744|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006745|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
56006746|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
56006747|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006748|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56006749|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
56006750|NCT00002788|Hormones|hormones|mesh-ancestor
56006751|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006752|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56006753|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56006754|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56006755|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56006756|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006757|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
56006758|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
56006759|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56006760|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56006761|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006777|NCT01052831|Naltrexone|naltrexone|mesh-list
56006778|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56006779|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56006780|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006781|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
56006782|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006783|NCT04330300|Losartan|losartan|mesh-list
56006784|NCT04330300|Verapamil|verapamil|mesh-list
56006785|NCT04330300|Felodipine|felodipine|mesh-list
56006786|NCT04330300|Amlodipine|amlodipine|mesh-list
56006787|NCT04330300|Valsartan|valsartan|mesh-list
56006788|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56006789|NCT04330300|Telmisartan|telmisartan|mesh-list
56006790|NCT04330300|Candesartan|candesartan|mesh-list
56006791|NCT04330300|Ramipril|ramipril|mesh-list
56006792|NCT04330300|Olmesartan|olmesartan|mesh-list
56006793|NCT04330300|Enalapril|enalapril|mesh-list
56006794|NCT04330300|Lisinopril|lisinopril|mesh-list
56006795|NCT04330300|Irbesartan|irbesartan|mesh-list
56006796|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
56006797|NCT04330300|Perindopril|perindopril|mesh-list
56006798|NCT04330300|Diltiazem|diltiazem|mesh-list
56006799|NCT04330300|Benazepril|benazepril|mesh-list
56006800|NCT04330300|Captopril|captopril|mesh-list
55733976|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
56006801|NCT04330300|Indapamide|indapamide|mesh-list
56006802|NCT04330300|Nicardipine|nicardipine|mesh-list
56006803|NCT04330300|Nimodipine|nimodipine|mesh-list
56006804|NCT04330300|Quinapril|quinapril|mesh-list
56006806|NCT04330300|Trandolapril|trandolapril|mesh-list
56006807|NCT04330300|Fosinopril|fosinopril|mesh-list
56006808|NCT04330300|Eprosartan|eprosartan|mesh-list
56006809|NCT04330300|Nitrendipine|nitrendipine|mesh-list
56006810|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
56006811|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
56006812|NCT04330300|Nifedipine|nifedipine|mesh-list
56006813|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
56006814|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56006815|NCT04330300|Diuretics|diuretics|mesh-list
56006816|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56006817|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56006818|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006822|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
56006823|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56006824|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56006825|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
56006826|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56006827|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
56006828|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006829|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
56006830|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56006831|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56006832|NCT04330300|Protective Agents|protective agents|mesh-ancestor
56006833|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
56006834|NCT04352855|Tazobactam|tazobactam|mesh-list
56006835|NCT04352855|Ceftolozane|ceftolozane|mesh-list
56006836|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56006837|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56006838|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006839|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56006840|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006841|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006842|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56006843|NCT04352855|Renal Agents|renal agents|mesh-ancestor
56006844|NCT04757584|Propranolol|propranolol|mesh-list
56006845|NCT04757584|Metoprolol|metoprolol|mesh-list
56006846|NCT04757584|Atenolol|atenolol|mesh-list
56006847|NCT04757584|Sotalol|sotalol|mesh-list
56006848|NCT04757584|Nadolol|nadolol|mesh-list
56006849|NCT04757584|Acebutolol|acebutolol|mesh-list
56006850|NCT04757584|Carvedilol|carvedilol|mesh-list
56006872|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56006873|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56006874|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56006878|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56006880|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
56006881|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56006882|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
56006884|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56006885|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56006886|NCT04782128|Growth Substances|growth substances|mesh-ancestor
56006887|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006888|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
56006889|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006890|NCT04354012|Gentian Violet|gentian violet|mesh-list
56006891|NCT04354012|Methylene Blue|methylene blue|mesh-list
56006892|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006893|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006894|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56006895|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006896|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
56006897|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56006898|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
56006899|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56006900|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006901|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56006902|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56006903|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56006912|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56006913|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
56006914|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56006915|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006916|NCT00382642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56006917|NCT00382642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56006918|NCT00382642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56006919|NCT00382642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56006920|NCT00382642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56006921|NCT01054079|Cinacalcet|cinacalcet|mesh-list
56006922|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56006923|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006924|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56006925|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
55738936|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
56006926|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56006927|NCT04338022|Teriflunomide|teriflunomide|mesh-list
56006928|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56006929|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56006930|NCT04338022|Analgesics|analgesics|mesh-ancestor
56006931|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
56006932|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006933|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006934|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56006935|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006936|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006937|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
56006938|NCT01054625|Zalutumumab|zalutumumab|mesh-list
56006939|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56006940|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006942|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
56006943|NCT01662050|Cytarabine|cytarabine|mesh-list
56006944|NCT01662050|Rituximab|rituximab|mesh-list
56006945|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56006946|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56006947|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006948|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
56006949|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006950|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56006951|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006952|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
56006953|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006954|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
56006955|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56006956|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56006957|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56006958|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
56006959|NCT04748848|Azacitidine|azacitidine|mesh-list
56006960|NCT04748848|Venetoclax|venetoclax|mesh-list
56006961|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
56006962|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56006963|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
56006964|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006965|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006966|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56006967|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56006968|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
56006988|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
56006989|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
56006990|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56006991|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56006992|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
56006993|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56006994|NCT04294264|Trifluridine|trifluridine|mesh-list
56006995|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
56006996|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56006997|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
56006998|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56006999|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
56007000|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007001|NCT05081375|Enoxaparin|enoxaparin|mesh-list
56007002|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
56007003|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56007004|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56007005|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007006|NCT03913559|Acetaminophen|acetaminophen|mesh-list
56007007|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
56007008|NCT03913559|Promethazine|promethazine|mesh-list
56007009|NCT03913559|Cytarabine|cytarabine|mesh-list
56007010|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
56007011|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56007012|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
56007013|NCT03913559|Methotrexate|methotrexate|mesh-list
56007014|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56007016|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
56007037|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007039|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
56007040|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007041|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
56007042|NCT03913559|Hormones|hormones|mesh-ancestor
56007043|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007044|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56007045|NCT03913559|Protective Agents|protective agents|mesh-ancestor
56007046|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56007047|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56007048|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56007049|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007050|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
56007051|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
56007052|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56007053|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
56007054|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
55719946|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
56007055|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007056|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56007057|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
55757907|NCT02455115|Protective Agents|protective agents|mesh-ancestor
56007058|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007059|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56007060|NCT04755062|Micronutrients|micronutrients|mesh-list
56007061|NCT04755062|Trace Elements|trace elements|mesh-list
56007062|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007063|NCT03852797|Ketamine|ketamine|mesh-list
56007064|NCT03852797|Propofol|propofol|mesh-list
56007065|NCT03852797|Etomidate|etomidate|mesh-list
56007066|NCT03852797|Oxytocin|oxytocin|mesh-list
56007067|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56007068|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007069|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007070|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56007071|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
56007072|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
56007078|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56007079|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007080|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007081|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
56007082|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56007083|NCT01055171|Propranolol|propranolol|mesh-list
56007084|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56007085|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56007086|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
56007087|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007088|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007089|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007090|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56007091|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56007092|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
56007094|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007095|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007096|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
56007097|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007098|NCT00866840|Riluzole|riluzole|mesh-list
56007099|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
56007100|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56007101|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56007102|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007103|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007104|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007105|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56007106|NCT00866840|Protective Agents|protective agents|mesh-ancestor
55734280|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
56007107|NCT04349722|Scopolamine|scopolamine|mesh-list
56007108|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56007109|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56007110|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
56007111|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
56007112|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007113|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007114|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007116|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56007117|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
56007118|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007119|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007120|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56007121|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
56007122|NCT01058993|Plerixafor|plerixafor|mesh-list
56007123|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56007124|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56007125|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
56007126|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007127|NCT04652518|Pirfenidone|pirfenidone|mesh-list
56007128|NCT04652518|Analgesics|analgesics|mesh-ancestor
56007129|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
56007130|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007131|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007132|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56007133|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56007134|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007135|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007136|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007137|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56007138|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007139|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56007140|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007141|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007162|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56007163|NCT03014687|Renal Agents|renal agents|mesh-ancestor
56007164|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
56007165|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56007166|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56007167|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56007168|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007169|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007170|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56007171|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56007172|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56007174|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007175|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007176|NCT04199572|Acetaminophen|acetaminophen|mesh-list
56007177|NCT04199572|Diclofenac|diclofenac|mesh-list
56007178|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56007179|NCT04199572|Analgesics|analgesics|mesh-ancestor
56007180|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
56007181|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007182|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007183|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
56007184|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56007185|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007186|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007187|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56007188|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007189|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007190|NCT00383032|Mifepristone|mifepristone|mesh-list
56007191|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56007204|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56007205|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56007206|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56007207|NCT02169479|Opicapone|opicapone|mesh-list
56007208|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56007209|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
56007210|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007211|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56007212|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56007213|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
56007214|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
56007215|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007216|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007217|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56007218|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007219|NCT04302454|Leuprolide|leuprolide|mesh-list
56007220|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56007222|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56007223|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007224|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56007225|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007226|NCT01059851|Suvorexant|suvorexant|mesh-list
56007227|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56007228|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56007229|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007230|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007252|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56007254|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
56007255|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007256|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56007257|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56007258|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56007259|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
56007260|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007261|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007262|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56007264|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56007265|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56007266|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56007267|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56007268|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
56007269|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
56007270|NCT04828031|Vitamin D|vitamin d|mesh-list
56007271|NCT04828031|Vitamins|vitamins|mesh-ancestor
56007272|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
56007273|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007274|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56007275|NCT04162522|Citalopram|citalopram|mesh-list
56007276|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
56007277|NCT04162522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56007278|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56007279|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56007280|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007281|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007282|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
56007283|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007284|NCT04162522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56007285|NCT04162522|Antidepressive Agents|antidepressive agents|mesh-ancestor
56007286|NCT04162522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56007289|NCT04896658|Dexamethasone|dexamethasone|mesh-list
56007293|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007294|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007295|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56007296|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
56007297|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007298|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007299|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56007300|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007302|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
56007303|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007304|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007305|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
56007306|NCT04896658|Hormones|hormones|mesh-ancestor
56007307|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007308|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56007309|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
56007310|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56007311|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56007312|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
56007313|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007314|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56007315|NCT04156828|Gemcitabine|gemcitabine|mesh-list
56007316|NCT04156828|Dexamethasone|dexamethasone|mesh-list
56007317|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
56007318|NCT04156828|Rituximab|rituximab|mesh-list
56007341|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007342|NCT04156828|Antiviral Agents|antiviral agents|mesh-ancestor
56007343|NCT04156828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007344|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007345|NCT04156828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007346|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56007347|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
56007349|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56007350|NCT01063049|Cathartics|cathartics|mesh-ancestor
56007351|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007352|NCT01063049|Laxatives|laxatives|mesh-ancestor
56007353|NCT04883242|Dexamethasone|dexamethasone|mesh-list
56007354|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
56007355|NCT04883242|Pomalidomide|pomalidomide|mesh-list
56007356|NCT04883242|Ichthammol|ichthammol|mesh-list
56007357|NCT04883242|BB 1101|bb 1101|mesh-list
56007358|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56007359|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007360|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
56007361|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
56007362|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007363|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007364|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007365|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
55719956|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56007366|NCT04883242|Hormones|hormones|mesh-ancestor
56007367|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007368|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56007369|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007370|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
56007371|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007372|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007373|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
56007374|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56007375|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56007376|NCT04883242|Growth Substances|growth substances|mesh-ancestor
56007377|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56007378|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
56007380|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
56007381|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
56007382|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56007383|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007384|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56007385|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007386|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007388|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
56007389|NCT03661138|Upadacitinib|upadacitinib|mesh-list
56007390|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56007391|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56007392|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007393|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007394|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007395|NCT04588792|Furosemide|furosemide|mesh-list
56007396|NCT04588792|Diuretics|diuretics|mesh-ancestor
56007397|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
56007398|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007399|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56007400|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56007401|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007402|NCT04579510|Vaccines|vaccines|mesh-list
56007403|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
56007404|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007405|NCT04565236|Factor VIII|factor viii|mesh-list
56007406|NCT04565236|Coagulants|coagulants|mesh-ancestor
55734586|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007407|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56007408|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007409|NCT04075396|Lazertinib|lazertinib|mesh-list
56007410|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56007411|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007412|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007413|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
56007414|NCT04038970|Methotrexate|methotrexate|mesh-list
56007415|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56007416|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
56007417|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56007418|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007419|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56007420|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
56007421|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007422|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007423|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
56007424|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007426|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007427|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
56007428|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007429|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56007430|NCT02181738|Doxorubicin|doxorubicin|mesh-list
56007431|NCT02181738|Nivolumab|nivolumab|mesh-list
56007432|NCT02181738|Dacarbazine|dacarbazine|mesh-list
56007433|NCT02181738|Vinblastine|vinblastine|mesh-list
56007434|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56007435|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007436|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56007437|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56007438|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007439|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007440|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007441|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56007442|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56007443|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
56007444|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56007445|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
56007446|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
56007447|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
56007458|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007459|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007460|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56007461|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
56007462|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56007463|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56007464|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56007465|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007466|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007467|NCT02091960|Trastuzumab|trastuzumab|mesh-list
56007468|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007469|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007470|NCT04494958|Palbociclib|palbociclib|mesh-list
56007471|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007472|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56007473|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007474|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007475|NCT04487080|Osimertinib|osimertinib|mesh-list
56007476|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56007477|NCT04487080|Lazertinib|lazertinib|mesh-list
56007478|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007479|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56007480|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007481|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007482|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007483|NCT00382954|Bortezomib|bortezomib|mesh-list
55734657|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
56007484|NCT00382954|Idarubicin|idarubicin|mesh-list
56007485|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007486|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56007487|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55719978|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
56007488|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56007489|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007490|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007497|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
56007498|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007499|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56007500|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
56007501|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56007502|NCT03274492|Prednisone|prednisone|mesh-list
56007503|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
56007504|NCT03274492|Rituximab|rituximab|mesh-list
56007505|NCT03274492|Doxorubicin|doxorubicin|mesh-list
56007506|NCT03274492|Vincristine|vincristine|mesh-list
56007507|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56007508|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
56007509|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007510|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
56007511|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007512|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007513|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56007514|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
56007515|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007516|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007517|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56007518|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007519|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56007520|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56007521|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56007522|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007523|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007524|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
56007525|NCT03274492|Hormones|hormones|mesh-ancestor
56007527|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56007543|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007544|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56007545|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007546|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56007547|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56007548|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56007549|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007550|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007551|NCT03218488|Ustekinumab|ustekinumab|mesh-list
56007552|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
56007553|NCT03836014|Dexamethasone|dexamethasone|mesh-list
56007554|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
56007555|NCT03836014|Lenalidomide|lenalidomide|mesh-list
56007556|NCT03836014|Daratumumab|daratumumab|mesh-list
56007557|NCT03836014|BB 1101|bb 1101|mesh-list
56007558|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56007559|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007560|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
56007561|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
56007562|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007563|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007564|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007565|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
56007566|NCT03836014|Hormones|hormones|mesh-ancestor
56007567|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007568|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56007569|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007570|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
56007588|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56007589|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56007590|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56007591|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55719999|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007592|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007593|NCT03187834|Amoxicillin|amoxicillin|mesh-list
56007594|NCT03187834|Azithromycin|azithromycin|mesh-list
56007595|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56007596|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56007597|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007598|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56007599|NCT03187834|Renal Agents|renal agents|mesh-ancestor
56007600|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
56007601|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56007602|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56007603|NCT01206595|Bupivacaine|bupivacaine|mesh-list
56007604|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
56007605|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
56007606|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007607|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007608|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
56007609|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007610|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56007611|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56007612|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007613|NCT01158703|Aspirin|aspirin|mesh-list
56007614|NCT01158703|Clopidogrel|clopidogrel|mesh-list
56007615|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56007616|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56007617|NCT01158703|Analgesics|analgesics|mesh-ancestor
56007618|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
56007619|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007620|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007621|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56007622|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007623|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56007626|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56007627|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56007628|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007629|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
56007630|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56007631|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56007632|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56007633|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
56007634|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007635|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
56007636|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56007637|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
56007638|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007639|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007640|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56007641|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
56007642|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56007643|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
56007644|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007645|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007646|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56007647|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
56007648|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
56007649|NCT03009643|Protective Agents|protective agents|mesh-ancestor
56007650|NCT04275232|Plasminogen|plasminogen|mesh-list
56007651|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56007652|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56007654|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56007672|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
56007673|NCT03779854|Busulfan|busulfan|mesh-list
56007674|NCT03779854|Thiotepa|thiotepa|mesh-list
56007675|NCT03779854|Methotrexate|methotrexate|mesh-list
56007676|NCT03779854|Fludarabine|fludarabine|mesh-list
55720012|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720016|NCT01590719|Vitamins|vitamins|mesh-ancestor
56007677|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
56007678|NCT03779854|Tacrolimus|tacrolimus|mesh-list
56007679|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007680|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
56007681|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007682|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007683|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56007684|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
56007685|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007686|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007687|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56007688|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56007689|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
56007690|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56007691|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56007692|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
56007693|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
56007694|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007695|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56007696|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56007697|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56007698|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
56007699|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007721|NCT00002896|Calcium|calcium|mesh-list
56007722|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
56007723|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56007724|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007725|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
56007726|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007727|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56007728|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007729|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007730|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
56007731|NCT00002896|Antidotes|antidotes|mesh-ancestor
56007732|NCT00002896|Protective Agents|protective agents|mesh-ancestor
56007733|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
56007734|NCT00002896|Vitamins|vitamins|mesh-ancestor
56007735|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
56007736|NCT00002896|Trace Elements|trace elements|mesh-ancestor
56007737|NCT03077542|Sirolimus|sirolimus|mesh-list
56007738|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
56007739|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
56007740|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
56007741|NCT03077542|Pentostatin|pentostatin|mesh-list
56007742|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007743|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
56007744|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007745|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56007746|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56007747|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
56007748|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007749|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007750|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56007768|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56007769|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56007770|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56007771|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
56007772|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
56007773|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
56007774|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
55720025|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007775|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007776|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007777|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
56007778|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56007779|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56007780|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007781|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56007782|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56007783|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
56007784|NCT01249027|Everolimus|everolimus|mesh-list
55720039|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734960|NCT02951377|Hormones|hormones|mesh-ancestor
56007785|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007786|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007787|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
56007788|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007790|NCT00002902|Raltitrexed|raltitrexed|mesh-list
56007791|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56007792|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56007793|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007794|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007795|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007796|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56007797|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
56007798|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56007799|NCT02992756|Mitogens|mitogens|mesh-list
56007800|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
56007802|NCT01250899|Vitamin D|vitamin d|mesh-list
56007803|NCT01250899|Vitamins|vitamins|mesh-ancestor
56007810|NCT00002908|Vincristine|vincristine|mesh-list
56007811|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
56007812|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56007813|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007814|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
56007815|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
56007816|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
56007817|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007818|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56007819|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
56007820|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007822|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007823|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56007824|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007825|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007827|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56007828|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
56007829|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56007830|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
56007831|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007832|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007833|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56007835|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56007836|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56007837|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56007838|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56007839|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56007852|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007853|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
56007854|NCT01161121|Adenosine|adenosine|mesh-list
56007855|NCT01161121|Regadenoson|regadenoson|mesh-list
56007856|NCT01161121|Analgesics|analgesics|mesh-ancestor
56007857|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
56007858|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007859|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007860|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56007861|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
56007862|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56007863|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
56007864|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
55720101|NCT02264171|Ketoconazole|ketoconazole|mesh-list
56007865|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007866|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007867|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56007868|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
56007869|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
56007870|NCT03010579|Hematinics|hematinics|mesh-list
56007871|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
56007872|NCT01214083|Naltrexone|naltrexone|mesh-list
56007873|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56007874|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56007875|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56007876|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007877|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
56007878|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007879|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
56007880|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007881|NCT01214083|Expectorants|expectorants|mesh-ancestor
56007882|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
56007883|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56007884|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
56007885|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007886|NCT01214083|Protective Agents|protective agents|mesh-ancestor
56007887|NCT01214083|Antidotes|antidotes|mesh-ancestor
56007888|NCT01254877|Ondansetron|ondansetron|mesh-list
56007889|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
56007892|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007893|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56007894|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
56007895|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
56007896|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56007897|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
56007898|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56007899|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007900|NCT01254877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56007901|NCT01254877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56007902|NCT01254877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007903|NCT01254877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56007904|NCT01254877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56007905|NCT02189317|Bupivacaine|bupivacaine|mesh-list
56007906|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
56007907|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
56007908|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56007909|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007910|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
56007911|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007912|NCT03713944|Bevacizumab|bevacizumab|mesh-list
56007913|NCT03713944|Carboplatin|carboplatin|mesh-list
56007914|NCT03713944|Pemetrexed|pemetrexed|mesh-list
56007915|NCT03713944|Atezolizumab|atezolizumab|mesh-list
56007916|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56007917|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007918|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56007919|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56007920|NCT03713944|Growth Substances|growth substances|mesh-ancestor
56007937|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56007938|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007939|NCT02945800|Gemcitabine|gemcitabine|mesh-list
56007941|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55720105|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56007942|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007943|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
56007944|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
56007945|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
56007946|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007947|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56007948|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
56007949|NCT02945800|Antiviral Agents|antiviral agents|mesh-ancestor
56007950|NCT02945800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007951|NCT02945800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007952|NCT02945800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007953|NCT02945800|Immunologic Factors|immunologic factors|mesh-ancestor
56007954|NCT02945800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007955|NCT02981329|Metformin|metformin|mesh-list
56007956|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56007957|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007958|NCT00383656|Hormones|hormones|mesh-list
56007959|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56007960|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007961|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
56007962|NCT01214317|Analgesics|analgesics|mesh-ancestor
56007963|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
56007964|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56007965|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007966|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007967|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56007968|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56007971|NCT00383812|Bevacizumab|bevacizumab|mesh-list
56007977|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007978|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
56007979|NCT02189629|Trifarotene|trifarotene|mesh-list
56007980|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
56007981|NCT00002926|Cytarabine|cytarabine|mesh-list
56007982|NCT00002926|Etoposide|etoposide|mesh-list
56007983|NCT00002926|Idarubicin|idarubicin|mesh-list
56007984|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56007985|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56007986|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56007987|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56007988|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56007989|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56007990|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56007991|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
56007992|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
56007993|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56007994|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56007995|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
56007996|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56007997|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56007998|NCT01281007|Acyclovir|acyclovir|mesh-list
56007999|NCT01281007|Famciclovir|famciclovir|mesh-list
56008000|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
56008001|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008002|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56008003|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008004|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008005|NCT02898610|Colchicine|colchicine|mesh-list
56008024|NCT01572662|Fludarabine|fludarabine|mesh-list
56008025|NCT01572662|Busulfan|busulfan|mesh-list
56008026|NCT01572662|Tacrolimus|tacrolimus|mesh-list
56008027|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56008028|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
56008029|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56008030|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008031|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008032|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
56008033|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008034|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008035|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
56008036|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008037|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56008038|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720121|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56008039|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
56008040|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008041|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56008042|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56008043|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
56008044|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008045|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56008046|NCT02822092|Risperidone|risperidone|mesh-list
56008047|NCT02822092|Aripiprazole|aripiprazole|mesh-list
56008048|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56008049|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
56008050|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008051|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008052|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008053|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56008054|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56008067|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56008068|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
56008069|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008070|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008071|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56008072|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
56008073|NCT01555268|Cytarabine|cytarabine|mesh-list
56008074|NCT01555268|Trebananib|trebananib|mesh-list
56008075|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008076|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
56008077|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008078|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008079|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
56008080|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008081|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008083|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008084|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56008085|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56008086|NCT01555268|Growth Substances|growth substances|mesh-ancestor
56008087|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
56008088|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56008089|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008090|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
56008091|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56008092|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
56008093|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56008094|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56008095|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56008096|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008097|NCT04781270|Bevacizumab|bevacizumab|mesh-list
56008098|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56008099|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008100|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56008101|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56008102|NCT04781270|Growth Substances|growth substances|mesh-ancestor
56008103|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008105|NCT00003388|Cytarabine|cytarabine|mesh-list
56008106|NCT00003388|Prednisone|prednisone|mesh-list
56008107|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
56008108|NCT00003388|Doxorubicin|doxorubicin|mesh-list
56008109|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56008111|NCT00003388|Vincristine|vincristine|mesh-list
56008112|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008113|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
56008114|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720126|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008115|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008116|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008117|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
56008118|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008119|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008120|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56008121|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56008122|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56008123|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008124|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008125|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56008126|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
56008127|NCT00003388|Hormones|hormones|mesh-ancestor
56008128|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56008129|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56008130|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56008131|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
56008134|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
56008151|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008152|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008153|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008154|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008155|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56008156|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
56008157|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56008158|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008159|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56008160|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008161|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
56008162|NCT00003400|Melphalan|melphalan|mesh-list
56008163|NCT00003400|Vinorelbine|vinorelbine|mesh-list
56008164|NCT00003400|Carmustine|carmustine|mesh-list
56008165|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008166|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
56008167|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008168|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008169|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
56008170|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008171|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56008172|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008173|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008174|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008175|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008176|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008177|NCT04348370|Vaccines|vaccines|mesh-list
56008178|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
56008179|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
56008180|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008181|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56008182|NCT00002944|Carboplatin|carboplatin|mesh-list
56008183|NCT00002944|Vincristine|vincristine|mesh-list
56008193|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008194|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
56008195|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008196|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
56008197|NCT04778072|Iron|iron|mesh-list
56008198|NCT04778072|Trace Elements|trace elements|mesh-ancestor
56008199|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
56008200|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008201|NCT00002950|Topotecan|topotecan|mesh-list
56008202|NCT00002950|Sargramostim|sargramostim|mesh-list
56008203|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56008204|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008205|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008206|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008207|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008208|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
56008209|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008210|NCT00777140|Deferoxamine|deferoxamine|mesh-list
56008211|NCT00777140|Siderophores|siderophores|mesh-ancestor
56008212|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56008213|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
55720142|NCT02264561|Caffeine|caffeine|mesh-list
56008214|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
56008215|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008216|NCT00003406|Carboplatin|carboplatin|mesh-list
56008217|NCT00003406|Docetaxel|docetaxel|mesh-list
56008218|NCT00003406|Ifosfamide|ifosfamide|mesh-list
56008244|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56008245|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720143|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56008246|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008247|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
56008248|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56008249|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56008250|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56008251|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56008252|NCT04780958|Vitamin A|vitamin a|mesh-list
56008253|NCT04780958|Vitamins|vitamins|mesh-ancestor
56008254|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
56008255|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008256|NCT00002968|Edrecolomab|edrecolomab|mesh-list
56008257|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56008258|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
56008259|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008260|NCT04780412|Alprostadil|alprostadil|mesh-list
56008261|NCT04780412|Misoprostol|misoprostol|mesh-list
56008262|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56008263|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
56008264|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56008265|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008266|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56008267|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56008268|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
56008269|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56008270|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
56008271|NCT04780412|Urological Agents|urological agents|mesh-ancestor
56008272|NCT00002974|Carboplatin|carboplatin|mesh-list
56008274|NCT00002974|Ifosfamide|ifosfamide|mesh-list
56008283|NCT00754364|Gemcitabine|gemcitabine|mesh-list
56008289|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008290|NCT00754364|Antiviral Agents|antiviral agents|mesh-ancestor
56008291|NCT00754364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008292|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008293|NCT00754364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008294|NCT00754364|Immunologic Factors|immunologic factors|mesh-ancestor
56008295|NCT00754364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008296|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56008297|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56008298|NCT02612896|Praziquantel|praziquantel|mesh-list
56008299|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
56008300|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56008301|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008302|NCT00002980|Decitabine|decitabine|mesh-list
56008303|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008304|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
56008305|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008306|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008307|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008308|NCT00002986|Topotecan|topotecan|mesh-list
56008309|NCT00002986|Carmustine|carmustine|mesh-list
56008310|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56008311|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008312|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008313|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758321|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55720223|NCT02265731|Rituximab|rituximab|mesh-list
56008314|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008315|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008316|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
56008317|NCT00003418|Tamoxifen|tamoxifen|mesh-list
56008319|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008320|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56008321|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
56008330|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56008331|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008332|NCT02609776|Carboplatin|carboplatin|mesh-list
56008333|NCT02609776|Pemetrexed|pemetrexed|mesh-list
56008335|NCT02609776|Lazertinib|lazertinib|mesh-list
56008336|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56008337|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008338|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008339|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008340|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56008341|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56008342|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56008343|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56008344|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
56008345|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008346|NCT04777838|Amitriptyline|amitriptyline|mesh-list
56008347|NCT04777838|Citalopram|citalopram|mesh-list
56008348|NCT04777838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56008349|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56008350|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56008351|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008352|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008353|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
56008354|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008356|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
56008379|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008380|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008381|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008383|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008384|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008385|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
56008386|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720233|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56008387|NCT00002998|Antiviral Agents|antiviral agents|mesh-ancestor
56008388|NCT00002998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008389|NCT00002998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008390|NCT00002998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008391|NCT00002998|Immunologic Factors|immunologic factors|mesh-ancestor
56008392|NCT00002998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008393|NCT00003004|Paclitaxel|paclitaxel|mesh-list
56008394|NCT00003004|Alvocidib|alvocidib|mesh-list
56008395|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008396|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008397|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008398|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008399|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008400|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008401|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
56008402|NCT00003004|Growth Substances|growth substances|mesh-ancestor
56008403|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008404|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56008405|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008407|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
56008408|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
56008411|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
56008423|NCT00003436|Daunorubicin|daunorubicin|mesh-list
56008424|NCT00003436|Asparaginase|asparaginase|mesh-list
56008425|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
56008426|NCT00003436|Amsacrine|amsacrine|mesh-list
56008427|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56008428|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
56008429|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56008430|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008431|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008432|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
56008433|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008434|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008435|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
56008436|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008437|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56008438|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008439|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
56008440|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008441|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56008442|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008443|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56008444|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008445|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
56008446|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008447|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56008472|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008473|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008474|NCT00003478|Antibodies|antibodies|mesh-list
56008475|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56008476|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
56008477|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008478|NCT00003016|Tamoxifen|tamoxifen|mesh-list
56008479|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56008480|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
56008481|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56008482|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008483|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56008484|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008485|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56008486|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56008487|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56008488|NCT00003022|Antibodies|antibodies|mesh-list
56008489|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56008490|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
56008491|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008492|NCT01258387|Mitogens|mitogens|mesh-list
56008493|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008494|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008495|NCT00003484|Irinotecan|irinotecan|mesh-list
56008496|NCT00003484|Carmustine|carmustine|mesh-list
56008497|NCT00003484|Antibodies|antibodies|mesh-list
56008498|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56008499|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
56008500|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008534|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008535|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56008536|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008537|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008538|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008539|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56008541|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
56008542|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56008543|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56008564|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008565|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56008566|NCT00383890|Analgesics|analgesics|mesh-ancestor
56008567|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
56008568|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008569|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56008570|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56008571|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56008572|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
56008573|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008574|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008575|NCT00003046|Interleukin-12|interleukin-12|mesh-list
56008576|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56008577|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
56008578|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008579|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56008580|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56008593|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008594|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008595|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008596|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
56008598|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56008599|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008600|NCT04775732|Infliximab|infliximab|mesh-list
56008601|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
56008602|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56008603|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008604|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56008605|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56008606|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56008607|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56008608|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008609|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56008610|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56008611|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56008626|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008627|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
55720289|NCT01355393|Sargramostim|sargramostim|mesh-list
56008628|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008629|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008630|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56008631|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008632|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008633|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
56008634|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008635|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56008636|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008637|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
56008638|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56008639|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008640|NCT00003544|Irinotecan|irinotecan|mesh-list
56008641|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56008642|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008643|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008644|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008645|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008646|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
56008647|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56008648|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008649|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
56008650|NCT01269424|Temozolomide|temozolomide|mesh-list
56008651|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56008652|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008653|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
56008654|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008655|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008656|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008657|NCT03395912|Anesthetics|anesthetics|mesh-list
56008658|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
56008659|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56008660|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008664|NCT00384436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56008665|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56008666|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56008667|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008668|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008670|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008671|NCT00384436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56008672|NCT00384436|Antidepressive Agents|antidepressive agents|mesh-ancestor
56008673|NCT00384436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56008675|NCT00003562|Docetaxel|docetaxel|mesh-list
56008676|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008677|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008678|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008679|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008680|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008681|NCT04775576|Anesthetics|anesthetics|mesh-list
56008682|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56008683|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008684|NCT00003568|Aldesleukin|aldesleukin|mesh-list
56008685|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
56008686|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008687|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56008688|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55735856|NCT04962893|Vaccines|vaccines|mesh-list
56008689|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
56008691|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56008692|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
56008693|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008694|NCT00003070|Enalapril|enalapril|mesh-list
56008695|NCT00003070|Enalaprilat|enalaprilat|mesh-list
56008696|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008697|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008698|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56008699|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
56008704|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56008705|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56008706|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008707|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56008708|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008709|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008711|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56008712|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
56008713|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56008714|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008715|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56008716|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56008717|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
56008718|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008719|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008720|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56008721|NCT00003082|Antibodies|antibodies|mesh-list
56008722|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
56008723|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56008724|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
56008725|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739011|NCT03394105|Docetaxel|docetaxel|mesh-list
56008726|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008727|NCT00003088|Paclitaxel|paclitaxel|mesh-list
56008728|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
56008729|NCT00003088|Doxorubicin|doxorubicin|mesh-list
56008730|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56008731|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008732|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008733|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008734|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008735|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008736|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008737|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008738|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
56008739|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008740|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008741|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008742|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
56008743|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56008744|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56008745|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56008746|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008747|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008749|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008750|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
56008751|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
56008752|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
56008753|NCT05423210|Atezolizumab|atezolizumab|mesh-list
56008754|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008755|NCT00755560|Albendazole|albendazole|mesh-list
56008756|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
56008757|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56008758|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008759|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
56008760|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56008761|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56008762|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008763|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
55735941|NCT03442283|Vitamins|vitamins|mesh-list
56008764|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008765|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008766|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008767|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
56008768|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56008769|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008770|NCT00003118|Fluorouracil|fluorouracil|mesh-list
56008784|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008785|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008786|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008787|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008788|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
55720307|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
56008789|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008790|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56008791|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008792|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008793|NCT05358704|Antidotes|antidotes|mesh-ancestor
56008794|NCT05358704|Protective Agents|protective agents|mesh-ancestor
56008795|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
56008796|NCT05358704|Vitamins|vitamins|mesh-ancestor
56008797|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
56008798|NCT00003124|Leuprolide|leuprolide|mesh-list
56008799|NCT00003124|Flutamide|flutamide|mesh-list
56008800|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56008801|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
56008802|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56008803|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008804|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56008805|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008806|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
56008807|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
56008808|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56008809|NCT00003580|Amifostine|amifostine|mesh-list
56008810|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56008811|NCT00003580|Protective Agents|protective agents|mesh-ancestor
56008812|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008813|NCT00056498|Risperidone|risperidone|mesh-list
56008814|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56008815|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
56008816|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008826|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
56008827|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56008828|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008829|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
56008830|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
56008831|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56008832|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56008833|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56008834|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008835|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008836|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008837|NCT00003130|Paclitaxel|paclitaxel|mesh-list
56008838|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008839|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008840|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008841|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008842|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008843|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008844|NCT00058370|Vincristine|vincristine|mesh-list
56008845|NCT00058370|Lomustine|lomustine|mesh-list
56008846|NCT00058370|Antibodies|antibodies|mesh-list
56008847|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56008848|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
56008849|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008850|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008851|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008852|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008853|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008854|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
56008855|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008856|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008857|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
56008858|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56008859|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56008866|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56008867|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
56008868|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56008869|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56008870|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56008871|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56008872|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008874|NCT00062738|Nortriptyline|nortriptyline|mesh-list
56008875|NCT00062738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56008876|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56008877|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56008878|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008879|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008880|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
56008881|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008882|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56008883|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
56008884|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56008885|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56008886|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56008887|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008888|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56008889|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56008890|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
56008891|NCT00063362|Lamotrigine|lamotrigine|mesh-list
56008892|NCT00063362|Valproic Acid|valproic acid|mesh-list
56008893|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
56008894|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
56008895|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56008907|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56008908|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
56008909|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56008910|NCT00064844|Nicotine|nicotine|mesh-list
56008911|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56008939|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
56008940|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008941|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56008942|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56008943|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56008944|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008945|NCT00067808|Decitabine|decitabine|mesh-list
56008946|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56008947|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
56008948|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008949|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008950|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56008951|NCT05174312|Diuretics|diuretics|mesh-list
56008952|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
56008953|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008954|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
56008977|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
56008978|NCT03287336|Coagulants|coagulants|mesh-ancestor
56008979|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
56008980|NCT00003136|Carboplatin|carboplatin|mesh-list
56008981|NCT00003136|Amifostine|amifostine|mesh-list
56008982|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56008983|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
56008984|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56008985|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56008986|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56008987|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
56008988|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56008989|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008990|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56008991|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56008992|NCT00003136|Protective Agents|protective agents|mesh-ancestor
56008993|NCT00003592|Paclitaxel|paclitaxel|mesh-list
56008994|NCT00003592|Methotrexate|methotrexate|mesh-list
56008995|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56008996|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56008997|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
56008998|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
56008999|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009000|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009001|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56009002|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
56009003|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56009004|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009005|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009006|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
56009007|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
56009008|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009009|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56009020|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56009021|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56009022|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
56009023|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009024|NCT00002794|Carboplatin|carboplatin|mesh-list
56009025|NCT00002794|Vincristine|vincristine|mesh-list
56009026|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009027|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009028|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009029|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009030|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009031|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009032|NCT00003610|Capsaicin|capsaicin|mesh-list
56009033|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
56009034|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
56009035|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
56009036|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009037|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009038|NCT00003616|Irinotecan|irinotecan|mesh-list
56009039|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56009040|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009074|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009075|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009076|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009077|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009078|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009079|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009080|NCT00003148|Aldesleukin|aldesleukin|mesh-list
56009081|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009082|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56009083|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56009084|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
56009085|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009086|NCT00384046|Testosterone|testosterone|mesh-list
56009087|NCT00384046|Androgens|androgens|mesh-ancestor
56009088|NCT00384046|Hormones|hormones|mesh-ancestor
56009089|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56009090|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009091|NCT00002800|Cytarabine|cytarabine|mesh-list
56009092|NCT00002800|Etoposide|etoposide|mesh-list
56009093|NCT00002800|Idarubicin|idarubicin|mesh-list
56009094|NCT00002800|Lintuzumab|lintuzumab|mesh-list
56009095|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009096|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009097|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009098|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009099|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009100|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009101|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009102|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
56009120|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758322|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
56009121|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009122|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
56009123|NCT00003160|Paclitaxel|paclitaxel|mesh-list
56009124|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009125|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009126|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009127|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009128|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009129|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009130|NCT00002812|Cytarabine|cytarabine|mesh-list
56009131|NCT00002812|Dexamethasone|dexamethasone|mesh-list
56009132|NCT00002812|Prednisone|prednisone|mesh-list
56009133|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
56009134|NCT00002812|Doxorubicin|doxorubicin|mesh-list
56009135|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56009136|NCT00002812|Methotrexate|methotrexate|mesh-list
56009137|NCT00002812|Vincristine|vincristine|mesh-list
56009138|NCT00002812|Daunorubicin|daunorubicin|mesh-list
56009139|NCT00002812|Asparaginase|asparaginase|mesh-list
56009140|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
56009141|NCT00002812|Idarubicin|idarubicin|mesh-list
56009142|NCT00002812|Pegaspargase|pegaspargase|mesh-list
56009143|NCT00002812|Thioguanine|thioguanine|mesh-list
56009144|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009145|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
56009146|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009147|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009148|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009149|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
56009150|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009151|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009152|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56009153|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56009154|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
56009155|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
56009162|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009163|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009164|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009166|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56009167|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
56009169|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009170|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
56009171|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
56009172|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56009173|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009174|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
56009175|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009176|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009177|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009178|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009179|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009180|NCT01258855|Aldesleukin|aldesleukin|mesh-list
56009181|NCT01258855|Aflibercept|aflibercept|mesh-list
56009182|NCT01258855|Interleukin-2|interleukin-2|mesh-list
56009183|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
56009184|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56009185|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56009186|NCT01258855|Growth Substances|growth substances|mesh-ancestor
56009187|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009188|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
56009189|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009190|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56009191|NCT01258855|Analgesics|analgesics|mesh-ancestor
56009192|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
56009193|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009194|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56009196|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
56009197|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009198|NCT00003166|Vincristine|vincristine|mesh-list
56009199|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
56009200|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009201|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009202|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009203|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009204|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009205|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758398|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55720340|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56009206|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56009207|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
56009208|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009209|NCT00003172|Interferons|interferons|mesh-list
56009210|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
56009212|NCT00003172|Doxorubicin|doxorubicin|mesh-list
56009213|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56009214|NCT00003172|Fluorouracil|fluorouracil|mesh-list
56009215|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
56009216|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009217|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009218|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009219|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009220|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009221|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009222|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009223|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009224|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009225|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
56009226|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009228|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
56009229|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009230|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
56009231|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009232|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
56009233|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009235|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56009236|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009241|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009242|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56009243|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56009244|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
56009245|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56009246|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009247|NCT00002818|Cytarabine|cytarabine|mesh-list
56009248|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009249|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
56009250|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009251|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009252|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
56009253|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009254|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009255|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
56009256|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009257|NCT00003640|Doxorubicin|doxorubicin|mesh-list
56009258|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56009259|NCT00003640|Methotrexate|methotrexate|mesh-list
56009260|NCT00003640|Vinblastine|vinblastine|mesh-list
56009261|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009262|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009263|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009264|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009265|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009266|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009267|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56009285|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
56009286|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009287|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009288|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009289|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009290|NCT00003178|Idarubicin|idarubicin|mesh-list
56009291|NCT00003178|Cladribine|cladribine|mesh-list
56009292|NCT00003178|Lenograstim|lenograstim|mesh-list
56009293|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56009294|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
56009295|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009296|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009297|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009298|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009299|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009300|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009315|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56009316|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009317|NCT01260883|Ketorolac|ketorolac|mesh-list
56009318|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56009323|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009324|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009325|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56009326|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009327|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56009328|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009329|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009330|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
56009331|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56009332|NCT00423202|Ambrisentan|ambrisentan|mesh-list
56009333|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56009334|NCT00003184|Vaccines|vaccines|mesh-list
56009335|NCT00003184|Sargramostim|sargramostim|mesh-list
56009336|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
56009337|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
56009338|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009339|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56009340|NCT00003190|Cytarabine|cytarabine|mesh-list
56009341|NCT00003190|Etoposide|etoposide|mesh-list
56009342|NCT00003190|Daunorubicin|daunorubicin|mesh-list
56009343|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
56009344|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009345|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009346|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009348|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009349|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009350|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009351|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
56009352|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
56009353|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009354|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009355|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
56009356|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009357|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009358|NCT00003652|Fluorouracil|fluorouracil|mesh-list
56009359|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009360|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
56009361|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009362|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009363|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009364|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
56009365|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009366|NCT04773236|Lidocaine|lidocaine|mesh-list
56009367|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
56009368|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
56009369|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56009370|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009371|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
56009372|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009373|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56009374|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55720343|NCT02267057|Buprenorphine|buprenorphine|mesh-list
56009406|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56009407|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009408|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009409|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009410|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009412|NCT00003664|Interferons|interferons|mesh-list
56009413|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
56009414|NCT00003664|Aldesleukin|aldesleukin|mesh-list
56009415|NCT00003664|Fluorouracil|fluorouracil|mesh-list
56009416|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009417|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
56009418|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009419|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009420|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
56009421|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009422|NCT00003664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009423|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009424|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
56009425|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009426|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56009427|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56009428|NCT00003196|Cyclosporine|cyclosporine|mesh-list
56009429|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
56009430|NCT00003196|Cyclosporins|cyclosporins|mesh-list
56009431|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009432|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009433|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009434|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
56009435|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009436|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
56009452|NCT00003202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009453|NCT00003202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009454|NCT00003202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009455|NCT00003202|Immunologic Factors|immunologic factors|mesh-ancestor
56009456|NCT00003202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009458|NCT00002854|Etoposide|etoposide|mesh-list
56009459|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
56009460|NCT00002854|Carboplatin|carboplatin|mesh-list
56009461|NCT00002854|Ifosfamide|ifosfamide|mesh-list
56009462|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009463|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009464|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009465|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009466|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009467|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009468|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009469|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
56009470|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009471|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009472|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009473|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
56009474|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56009475|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009476|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009477|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009478|NCT02308202|Perindopril|perindopril|mesh-list
56009479|NCT02308202|Doxazosin|doxazosin|mesh-list
56009480|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56009481|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
56009482|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009483|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009484|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56009485|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56009494|NCT00003214|Doxorubicin|doxorubicin|mesh-list
56009495|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56009496|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009498|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009499|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009500|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009501|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009502|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009503|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
56009504|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009505|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009506|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009507|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
56009508|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56009509|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009510|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009511|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009512|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009513|NCT03233204|Olaparib|olaparib|mesh-list
56009514|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56009515|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009516|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009517|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009518|NCT00384592|Esomeprazole|esomeprazole|mesh-list
56009520|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56009521|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56009522|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009523|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009525|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56009529|NCT00002866|Docetaxel|docetaxel|mesh-list
56009536|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009537|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009538|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009539|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009540|NCT00002872|Doxycycline|doxycycline|mesh-list
56009541|NCT00002872|Bleomycin|bleomycin|mesh-list
56009542|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56009543|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009544|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
56009545|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56009546|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56009547|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009548|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009549|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
56009550|NCT00003232|Prednisone|prednisone|mesh-list
56009551|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
56009552|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56009553|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
56009554|NCT00003232|Hormones|hormones|mesh-ancestor
56009555|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56009556|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009557|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56009558|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009559|NCT00003232|Analgesics|analgesics|mesh-ancestor
56009560|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
56009561|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009562|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009563|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009564|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009565|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009566|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56009567|NCT00002878|Dexamethasone|dexamethasone|mesh-list
56009568|NCT00002878|Doxorubicin|doxorubicin|mesh-list
56009569|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56009570|NCT00002878|Vincristine|vincristine|mesh-list
56009572|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
56009576|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56009577|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
56009578|NCT00002878|Hormones|hormones|mesh-ancestor
56009579|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56009580|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56009581|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009582|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55720366|NCT01262261|Analgesics|analgesics|mesh-ancestor
55720367|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
56009583|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009584|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009585|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009586|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009587|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009588|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009589|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009590|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009591|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
56009592|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009593|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009594|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009595|NCT00002884|Fluorouracil|fluorouracil|mesh-list
56009596|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009597|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
56009598|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009599|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009600|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009601|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
56009602|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009603|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
56009604|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56009618|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56009619|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
56009620|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
56009621|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56009622|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009623|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56009624|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
56009625|NCT00003682|Hormones|hormones|mesh-ancestor
56009626|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56009627|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56009628|NCT00003682|Protective Agents|protective agents|mesh-ancestor
56009629|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56009630|NCT00003688|Dactinomycin|dactinomycin|mesh-list
56009631|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56009632|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009633|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009634|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009635|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56009636|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009637|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009638|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009639|NCT00083174|Exemestane|exemestane|mesh-list
56009640|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009641|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56009642|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56009643|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739085|NCT03612921|Analgesics|analgesics|mesh-ancestor
56009646|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
56009664|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009665|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56009666|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009667|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
56009668|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009669|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009670|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
56009671|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009672|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009673|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009674|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009675|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
56009678|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009679|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
56009680|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009681|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009682|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
56009683|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009684|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009685|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
56009686|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009687|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009688|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56009717|NCT00003262|Vincristine|vincristine|mesh-list
56009718|NCT00003262|Vinblastine|vinblastine|mesh-list
56009720|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009721|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009722|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009723|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009724|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009725|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009726|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56009727|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
56009728|NCT00003262|Hormones|hormones|mesh-ancestor
56009729|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56009730|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009731|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56009732|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009733|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009734|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009735|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009736|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
56009737|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009738|NCT00003700|Leucovorin|leucovorin|mesh-list
56009739|NCT00003700|Cytarabine|cytarabine|mesh-list
56009740|NCT00003700|Prednisone|prednisone|mesh-list
56009741|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
56009742|NCT00003700|Methotrexate|methotrexate|mesh-list
56009743|NCT00003700|Vincristine|vincristine|mesh-list
56009744|NCT00003700|Daunorubicin|daunorubicin|mesh-list
56009763|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56009764|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
56009765|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56009766|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009767|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
56009768|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
56009769|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009770|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56009771|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009772|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
56009773|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009774|NCT00003700|Antidotes|antidotes|mesh-ancestor
56009775|NCT00003700|Protective Agents|protective agents|mesh-ancestor
56009776|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
56009777|NCT00003700|Vitamins|vitamins|mesh-ancestor
56009778|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
56009779|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009780|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009781|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009782|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009783|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009784|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56009785|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009786|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
56009787|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56009788|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
56009789|NCT00003706|Pemetrexed|pemetrexed|mesh-list
56009790|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009792|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009793|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56009795|NCT00003958|Dactinomycin|dactinomycin|mesh-list
56009807|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009808|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009809|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56009810|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009811|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009812|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009813|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009814|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56009815|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009816|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009817|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56009818|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009819|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009820|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56009821|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009823|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56009824|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009825|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009826|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009827|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
56009828|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009829|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
56009858|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56009859|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009860|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
56009861|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009862|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56009863|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
56009865|NCT02106572|Mitomycin|mitomycin|mesh-list
56009866|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56009867|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009868|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
56009869|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009870|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56009871|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009872|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56009874|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
56009875|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009876|NCT00384124|Imiquimod|imiquimod|mesh-list
56009877|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56009878|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
56009879|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009880|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009881|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
56009882|NCT00003718|Temozolomide|temozolomide|mesh-list
56009883|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009884|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
56009885|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009886|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009887|NCT00003970|Irinotecan|irinotecan|mesh-list
56009888|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56009889|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56009890|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009893|NCT00085436|Interferons|interferons|mesh-list
56009901|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
56009902|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56009903|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56009904|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56009905|NCT00384202|Tacrolimus|tacrolimus|mesh-list
56009906|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009907|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
56009908|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009909|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56009910|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56009911|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009912|NCT00086138|Sertraline|sertraline|mesh-list
56009913|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
56009914|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56009915|NCT00086138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56009916|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56009917|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56009918|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009919|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56009920|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
56009921|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009922|NCT04329130|Lenalidomide|lenalidomide|mesh-list
56009923|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
56009924|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009925|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55758399|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
56009926|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56009927|NCT04329130|Growth Substances|growth substances|mesh-ancestor
56009930|NCT00384280|Rifampin|rifampin|mesh-list
56009945|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
56009946|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009947|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56009949|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009950|NCT00003730|Fluorouracil|fluorouracil|mesh-list
56009951|NCT00003730|Vinorelbine|vinorelbine|mesh-list
56009952|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
56009953|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009954|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56009955|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009956|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56009957|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
56009958|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009959|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56009960|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
56009961|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
56009962|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
56009963|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
56009964|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
56009965|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56009966|NCT00003292|Ifosfamide|ifosfamide|mesh-list
56009967|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56009968|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
56009969|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009970|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009971|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55737131|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009972|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56009973|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56009974|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56009975|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56009982|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56009983|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56009984|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56009985|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
56009986|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56009987|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56009988|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
56009989|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
56009990|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009991|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56009992|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
56009993|NCT00003994|Carboplatin|carboplatin|mesh-list
56009994|NCT00003994|Fluorouracil|fluorouracil|mesh-list
56009995|NCT00003994|Vincristine|vincristine|mesh-list
56009996|NCT00003994|Amifostine|amifostine|mesh-list
56009997|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56009998|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
56009999|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010000|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010038|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720397|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
56010039|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010040|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010041|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010042|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010043|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010044|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010045|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010046|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56010048|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010049|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
56010050|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010052|NCT00003316|Antiviral Agents|antiviral agents|mesh-ancestor
56010053|NCT00003316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010054|NCT00003316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010055|NCT00003316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010056|NCT00003316|Immunologic Factors|immunologic factors|mesh-ancestor
56010057|NCT00003316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010058|NCT00089024|Leucovorin|leucovorin|mesh-list
56010059|NCT00089024|Gemcitabine|gemcitabine|mesh-list
56010060|NCT00089024|Fluorouracil|fluorouracil|mesh-list
56010061|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
56010062|NCT00089024|Calcium|calcium|mesh-list
56010063|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
56010064|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010065|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
56010066|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010067|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010068|NCT00089024|Antiviral Agents|antiviral agents|mesh-ancestor
56010069|NCT00089024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010070|NCT00089024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010078|NCT00089024|Vitamins|vitamins|mesh-ancestor
56010080|NCT00003322|Paclitaxel|paclitaxel|mesh-list
56010081|NCT00003322|Cisplatin|cisplatin|mesh-list
56010082|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010083|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010084|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010085|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010086|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010087|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010088|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
56010089|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56010090|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56010091|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56010092|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56010093|NCT00003748|Irinotecan|irinotecan|mesh-list
55758400|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
56010094|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56010095|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010096|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010097|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010098|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010099|NCT00089102|Gemcitabine|gemcitabine|mesh-list
56010100|NCT00089102|Irinotecan|irinotecan|mesh-list
56010101|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010102|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
56010103|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010104|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010105|NCT00089102|Antiviral Agents|antiviral agents|mesh-ancestor
56010106|NCT00089102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010107|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010108|NCT00089102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010109|NCT00089102|Immunologic Factors|immunologic factors|mesh-ancestor
56010124|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010125|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
56010126|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010127|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010128|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010129|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
56010130|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56010131|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010132|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56010133|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56010134|NCT00003754|Growth Substances|growth substances|mesh-ancestor
56010135|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
56010136|NCT00003328|Porfiromycin|porfiromycin|mesh-list
55720449|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56010137|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010138|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010139|NCT00004024|Aldesleukin|aldesleukin|mesh-list
56010165|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010166|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010167|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010168|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
56010169|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010170|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
56010171|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010184|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
56010185|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010186|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56010187|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010188|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010189|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010190|NCT00004030|Doxorubicin|doxorubicin|mesh-list
56010191|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010192|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010193|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010194|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010195|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010196|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737353|NCT03430297|Dacarbazine|dacarbazine|mesh-list
56010197|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010198|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
56010199|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
56010200|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56010201|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56010202|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010203|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010204|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010205|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010206|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
56010208|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010209|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
56010210|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010211|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010212|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010213|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
56010215|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010228|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010229|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
56010230|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010231|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010232|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010233|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56010234|NCT00004036|Protective Agents|protective agents|mesh-ancestor
56010235|NCT00003346|Acetaminophen|acetaminophen|mesh-list
56010236|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
56010237|NCT00003346|Carmustine|carmustine|mesh-list
56010238|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56010239|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56010240|NCT00003346|Analgesics|analgesics|mesh-ancestor
56010241|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
56010242|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56010243|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010244|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
56010245|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
55720497|NCT01234025|Prednisone|prednisone|mesh-list
56010246|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010247|NCT00003346|Expectorants|expectorants|mesh-ancestor
56010248|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
56010249|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56010250|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
56010251|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010252|NCT00003346|Protective Agents|protective agents|mesh-ancestor
56010253|NCT00003346|Antidotes|antidotes|mesh-ancestor
56010254|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010255|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
56010256|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010257|NCT00096122|Cytarabine|cytarabine|mesh-list
56010258|NCT00096122|Idarubicin|idarubicin|mesh-list
56010259|NCT00096122|Tipifarnib|tipifarnib|mesh-list
56010272|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010273|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
56010274|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010275|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010276|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010277|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010278|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010279|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56010280|NCT00004042|Antibodies|antibodies|mesh-list
56010281|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
56010282|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56010283|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
56010284|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010285|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010286|NCT00003784|Prednisone|prednisone|mesh-list
56010287|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
56010288|NCT00003784|Doxorubicin|doxorubicin|mesh-list
56010289|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010290|NCT00003784|Vincristine|vincristine|mesh-list
56010291|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
56010292|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010293|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
56010294|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010295|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010296|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010297|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
56010298|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010299|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010300|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010301|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010302|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010307|NCT00003784|Hormones|hormones|mesh-ancestor
56010308|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56010309|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56010310|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010311|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010312|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010313|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010314|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
56010315|NCT00003352|Docetaxel|docetaxel|mesh-list
56010316|NCT00003352|Doxorubicin|doxorubicin|mesh-list
56010317|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010318|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010319|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
56010320|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010321|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010322|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010323|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
56010324|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010325|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010326|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010327|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010328|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010329|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010330|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010335|NCT00004048|Doxorubicin|doxorubicin|mesh-list
56010336|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010337|NCT00004048|Antibodies|antibodies|mesh-list
56010338|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
56010339|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56010340|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
56010341|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010342|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010343|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010346|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010347|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010348|NCT00003358|Gemcitabine|gemcitabine|mesh-list
56010349|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010350|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010351|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
56010352|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010353|NCT00003358|Antiviral Agents|antiviral agents|mesh-ancestor
56010354|NCT00003358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010355|NCT00003358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010356|NCT00003358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010357|NCT00003358|Immunologic Factors|immunologic factors|mesh-ancestor
56010358|NCT00003358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010359|NCT00004060|Exatecan|exatecan|mesh-list
56010360|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56010361|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010362|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010363|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010364|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010365|NCT00384826|Paclitaxel|paclitaxel|mesh-list
56010366|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56010367|NCT00384826|Carboplatin|carboplatin|mesh-list
56010368|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010369|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010370|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010371|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010372|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010373|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010374|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56010375|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010379|NCT00003364|Etoposide|etoposide|mesh-list
56010389|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010390|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010391|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010392|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010393|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010394|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010395|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010396|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010397|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010399|NCT00004066|Docetaxel|docetaxel|mesh-list
56010400|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010401|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
56010402|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010403|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010404|NCT00004066|Antiviral Agents|antiviral agents|mesh-ancestor
56010405|NCT00004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010406|NCT00004066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010407|NCT00004066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010408|NCT00004066|Immunologic Factors|immunologic factors|mesh-ancestor
56010436|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56010437|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010438|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010439|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
56010452|NCT00003382|Antiviral Agents|antiviral agents|mesh-ancestor
56010453|NCT00003382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010454|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010455|NCT00003382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010456|NCT00003382|Immunologic Factors|immunologic factors|mesh-ancestor
56010457|NCT00003382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010458|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56010459|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010460|NCT00004834|Imipramine|imipramine|mesh-list
56010461|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56010462|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
56010463|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56010464|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56010465|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56010466|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56010467|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010468|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
56010469|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56010470|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010471|NCT00004840|Hormones|hormones|mesh-list
56010472|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
56010473|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56010474|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010475|NCT00004852|Lamivudine|lamivudine|mesh-list
56010476|NCT00004852|Zidovudine|zidovudine|mesh-list
56010477|NCT00004852|Efavirenz|efavirenz|mesh-list
56010478|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56010479|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56010480|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010481|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010482|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
56010483|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010484|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56010491|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56010492|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56010493|NCT00004858|Genistein|genistein|mesh-list
56010494|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
56010495|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56010496|NCT00004858|Protective Agents|protective agents|mesh-ancestor
56010497|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010498|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010499|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56010500|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010501|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010503|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56010504|NCT00004858|Estrogens|estrogens|mesh-ancestor
56010505|NCT00004858|Hormones|hormones|mesh-ancestor
56010506|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56010507|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
56010508|NCT00004864|Docetaxel|docetaxel|mesh-list
56010509|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010510|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010511|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010512|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010513|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010514|NCT00003796|Irofulven|irofulven|mesh-list
56010515|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010516|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
56010517|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010518|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010521|NCT02972866|Budesonide|budesonide|mesh-list
56010522|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56010523|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56010524|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
56010533|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56010534|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
56010535|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56010536|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010538|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
56010539|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56010540|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010541|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010542|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
56010543|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56010544|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56010545|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
56010546|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56010547|NCT00003814|Eflornithine|eflornithine|mesh-list
56010548|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010549|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56010550|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56010551|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56010552|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010553|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
56010554|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010555|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010556|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
56010557|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
56010558|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
56010559|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010560|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56010561|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010562|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
56010563|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010564|NCT00003850|Thalidomide|thalidomide|mesh-list
56010565|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010566|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
56010567|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010572|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56010573|NCT00003850|Growth Substances|growth substances|mesh-ancestor
56010574|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
56010575|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010577|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56010578|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010579|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
56010580|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010581|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010582|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010583|NCT00004078|Irinotecan|irinotecan|mesh-list
56010584|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56010585|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010586|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010587|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010588|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010589|NCT00003856|Temoporfin|temoporfin|mesh-list
56010590|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010591|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56010592|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
56010593|NCT00014222|Paclitaxel|paclitaxel|mesh-list
56010594|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
56010595|NCT00014222|Doxorubicin|doxorubicin|mesh-list
56010596|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010597|NCT00014222|Fluorouracil|fluorouracil|mesh-list
56010598|NCT00014222|Epirubicin|epirubicin|mesh-list
56010599|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
56010600|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010622|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56010623|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010624|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010625|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010626|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010627|NCT00004084|Epratuzumab|epratuzumab|mesh-list
56010628|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56010629|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010630|NCT00004876|Thalidomide|thalidomide|mesh-list
56010631|NCT00004876|Carboplatin|carboplatin|mesh-list
56010632|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010633|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010634|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
56010635|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010636|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
56010637|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56010638|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010639|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56010640|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56010641|NCT00004876|Growth Substances|growth substances|mesh-ancestor
56010642|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
56010643|NCT00003862|Leucovorin|leucovorin|mesh-list
56010644|NCT00003862|Paclitaxel|paclitaxel|mesh-list
56010645|NCT00003862|Fluorouracil|fluorouracil|mesh-list
56010646|NCT00003862|Calcium|calcium|mesh-list
56010647|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
56010648|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010649|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010650|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010660|NCT00003862|Antidotes|antidotes|mesh-ancestor
56010671|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010672|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010673|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010674|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
56010675|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010676|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010677|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010678|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56010679|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
56010680|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56010688|NCT00003874|Antibodies|antibodies|mesh-list
56010735|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010736|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010737|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
56010738|NCT00004900|Thiotepa|thiotepa|mesh-list
56010739|NCT00004900|Carboplatin|carboplatin|mesh-list
56010740|NCT00004900|Etoposide|etoposide|mesh-list
56010741|NCT00004900|Anastrozole|anastrozole|mesh-list
56010742|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010743|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
56010744|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010745|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010746|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010747|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
56010748|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010749|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010750|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010751|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55720673|NCT05628389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56010761|NCT00004114|Cytarabine|cytarabine|mesh-list
56010791|NCT00004906|Doxorubicin|doxorubicin|mesh-list
56010792|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56010794|NCT00004906|Anastrozole|anastrozole|mesh-list
56010795|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010796|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
56010797|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010798|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010799|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010800|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
56010801|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010802|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010803|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010804|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
56010805|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
56010806|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
56010807|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56010808|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010809|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010810|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010811|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010812|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56010813|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56010814|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56010815|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56010816|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
56010817|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56010818|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56010819|NCT00004918|Sargramostim|sargramostim|mesh-list
56010820|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56010821|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
56010822|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010823|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55720716|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56010824|NCT00003892|ISIS 5132|isis 5132|mesh-list
56010831|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56010832|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
56010833|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010834|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010835|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56010836|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
55739101|NCT01936857|Analgesics|analgesics|mesh-ancestor
56010837|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010838|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010839|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010840|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010841|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010842|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010843|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010844|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56010845|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56010846|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010847|NCT05776979|Lenalidomide|lenalidomide|mesh-list
56010848|NCT05776979|Immunologic Factors|immunologic factors|mesh-ancestor
56010850|NCT05776979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56010851|NCT05776979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56010852|NCT05776979|Growth Substances|growth substances|mesh-ancestor
56010853|NCT05776979|Growth Inhibitors|growth inhibitors|mesh-ancestor
56010854|NCT05776979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010855|NCT05776953|Ketorolac|ketorolac|mesh-list
56010856|NCT05776953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56010857|NCT05776953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56010858|NCT05776953|Analgesics|analgesics|mesh-ancestor
56010875|NCT05776940|Autonomic Agents|autonomic agents|mesh-ancestor
56010876|NCT05776940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56010877|NCT05776940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010878|NCT05776940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56010879|NCT05776940|Glucocorticoids|glucocorticoids|mesh-ancestor
56010880|NCT05776940|Hormones|hormones|mesh-ancestor
55738031|NCT02735707|Apremilast|apremilast|mesh-list
56010881|NCT05776940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56010882|NCT05776940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56010883|NCT05776940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010884|NCT05776940|Protease Inhibitors|protease inhibitors|mesh-ancestor
56010885|NCT05776940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010886|NCT05776940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010887|NCT05776940|Immunologic Factors|immunologic factors|mesh-ancestor
56010888|NCT05776927|Fluticasone|fluticasone|mesh-list
56010889|NCT05776927|Xhance|xhance|mesh-list
56010890|NCT05776927|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56010891|NCT05776927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56010892|NCT05776927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56010893|NCT05776927|Autonomic Agents|autonomic agents|mesh-ancestor
56010894|NCT05776927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56010895|NCT05776927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010896|NCT05776927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56010897|NCT05776927|Respiratory System Agents|respiratory system agents|mesh-ancestor
56010898|NCT05776927|Dermatologic Agents|dermatologic agents|mesh-ancestor
56010899|NCT05776927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56010900|NCT05776927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56010901|NCT05776927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56010902|NCT05776927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56010903|NCT05776927|Adrenergic Agents|adrenergic agents|mesh-ancestor
56010904|NCT05776927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56010905|NCT05776927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010906|NCT05776888|Ofatumumab|ofatumumab|mesh-list
56010916|NCT05776875|Growth Inhibitors|growth inhibitors|mesh-ancestor
56010917|NCT05776862|Ursolic acid|ursolic acid|mesh-list
56010918|NCT05776862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56010919|NCT05776862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010920|NCT05776862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010921|NCT05776862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56010922|NCT05776862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010923|NCT05776862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010924|NCT05776862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56010925|NCT05776862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56010926|NCT05776862|Analgesics|analgesics|mesh-ancestor
56010927|NCT05776862|Sensory System Agents|sensory system agents|mesh-ancestor
56010928|NCT05776862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56010929|NCT05776862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010930|NCT05776862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56010931|NCT05776862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56010932|NCT05776758|Cisplatin|cisplatin|mesh-list
56010933|NCT05776758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010934|NCT05776524|Gemcitabine|gemcitabine|mesh-list
56010935|NCT05776524|Paclitaxel|paclitaxel|mesh-list
56010936|NCT05776524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55720805|NCT02532374|Nicotine|nicotine|mesh-list
56010937|NCT05776524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010967|NCT05776407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010968|NCT05776407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56010969|NCT05776407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56010970|NCT05776407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56010971|NCT05776407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56010972|NCT05776407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56010973|NCT05776407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010975|NCT05776290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56010976|NCT05776290|Immunologic Factors|immunologic factors|mesh-ancestor
56010977|NCT05776290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010978|NCT05776290|Viscosupplements|viscosupplements|mesh-ancestor
56010979|NCT05776290|Protective Agents|protective agents|mesh-ancestor
56010980|NCT05776212|Fluorides|fluorides|mesh-list
56010981|NCT05776212|Cariostatic Agents|cariostatic agents|mesh-ancestor
56010982|NCT05776212|Protective Agents|protective agents|mesh-ancestor
56010983|NCT05776212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010984|NCT05776186|Bupivacaine|bupivacaine|mesh-list
56010985|NCT05776186|Anesthetics, Local|anesthetics, local|mesh-ancestor
56010986|NCT05776186|Anesthetics|anesthetics|mesh-ancestor
56010987|NCT05776186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56010988|NCT05776186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56010989|NCT05776186|Sensory System Agents|sensory system agents|mesh-ancestor
56010990|NCT05776186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56010991|NCT05776108|Cabotegravir|cabotegravir|mesh-list
56010992|NCT05776108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56010993|NCT05776108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56010994|NCT05776108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56010995|NCT05776108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56010996|NCT05776108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56010997|NCT05776108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56010998|NCT05776108|Antiviral Agents|antiviral agents|mesh-ancestor
56010999|NCT05776108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011000|NCT05776056|Methylphenidate|methylphenidate|mesh-list
56011001|NCT05776056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56011002|NCT05776056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011004|NCT05776056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56011005|NCT05776056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56011006|NCT05776056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011007|NCT05776056|Dopamine Agents|dopamine agents|mesh-ancestor
56011008|NCT05776056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011009|NCT05776043|Dapagliflozin|dapagliflozin|mesh-list
56011010|NCT05776043|Empagliflozin|empagliflozin|mesh-list
56011011|NCT05776043|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56011012|NCT05776043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011013|NCT05776043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56011014|NCT05776043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011015|NCT05776030|Methamphetamine|methamphetamine|mesh-list
56011016|NCT05776030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56011017|NCT05776030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011018|NCT05776030|Sympathomimetics|sympathomimetics|mesh-ancestor
56011019|NCT05776030|Autonomic Agents|autonomic agents|mesh-ancestor
56011020|NCT05776030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011021|NCT05776030|Dopamine Agents|dopamine agents|mesh-ancestor
56011022|NCT05776030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011023|NCT05776030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011024|NCT05776030|Adrenergic Agents|adrenergic agents|mesh-ancestor
56011025|NCT05776030|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56011026|NCT05776030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56011027|NCT05776030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55738205|NCT03415763|Leucovorin|leucovorin|mesh-list
56011033|NCT05776017|Antacids|antacids|mesh-ancestor
56011048|NCT05775965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011049|NCT05775965|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56011050|NCT05775965|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56011051|NCT05775965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011052|NCT05775965|Antipyretics|antipyretics|mesh-ancestor
56011053|NCT05775965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56011054|NCT05775965|Antithrombins|antithrombins|mesh-ancestor
56011055|NCT05775965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56011056|NCT05775965|Protease Inhibitors|protease inhibitors|mesh-ancestor
56011057|NCT05775965|Anticoagulants|anticoagulants|mesh-ancestor
56011058|NCT05775939|Deoxyglucose|deoxyglucose|mesh-list
56011059|NCT05775939|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56011060|NCT05775939|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56011061|NCT05775939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011062|NCT05775939|Antimetabolites|antimetabolites|mesh-ancestor
56011063|NCT05775939|Antiviral Agents|antiviral agents|mesh-ancestor
56011064|NCT05775939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011065|NCT05775900|Capecitabine|capecitabine|mesh-list
56011066|NCT05775900|Cetuximab|cetuximab|mesh-list
56011067|NCT05775900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56011068|NCT05775900|Antimetabolites|antimetabolites|mesh-ancestor
56011069|NCT05775900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011070|NCT05775900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011071|NCT05775900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011072|NCT05775887|Vaccines|vaccines|mesh-list
56011073|NCT05775887|Immunologic Factors|immunologic factors|mesh-ancestor
56011074|NCT05775887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011075|NCT05775874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56011076|NCT05775874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011078|NCT05775861|Dexmedetomidine|dexmedetomidine|mesh-list
56011092|NCT05775861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011093|NCT05775861|Anesthetics, Local|anesthetics, local|mesh-ancestor
56011094|NCT05775861|Anesthetics|anesthetics|mesh-ancestor
56011095|NCT05775809|Serotonin|serotonin|mesh-list
55720844|NCT05398874|Analgesics|analgesics|mesh-ancestor
56011096|NCT05775809|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56011097|NCT05775809|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56011098|NCT05775809|Serotonin Agents|serotonin agents|mesh-ancestor
56011099|NCT05775809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011100|NCT05775809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011101|NCT05775809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738261|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
56011102|NCT05775809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56011103|NCT05775809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56011104|NCT05775770|Insulin|insulin|mesh-list
56011105|NCT05775770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56011106|NCT05775770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011107|NCT05775731|Hemostatics|hemostatics|mesh-list
56011108|NCT05775731|Coagulants|coagulants|mesh-ancestor
56011109|NCT05775705|Antibodies|antibodies|mesh-list
56011110|NCT05775705|Immunologic Factors|immunologic factors|mesh-ancestor
56011111|NCT05775705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011112|NCT05775692|Fluconazole|fluconazole|mesh-list
56011113|NCT05775692|Antifungal Agents|antifungal agents|mesh-ancestor
56011114|NCT05775692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011115|NCT05775692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56011116|NCT05775692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56011117|NCT05775692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011118|NCT05775692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011119|NCT05775692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56011120|NCT05775692|Hormone Antagonists|hormone antagonists|mesh-ancestor
56011121|NCT05775692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011132|NCT05775536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011133|NCT05775536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56011134|NCT05775536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56011135|NCT05775536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56011136|NCT05775536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011137|NCT05775536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56011138|NCT05775536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56011139|NCT05775536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011140|NCT05775536|Antipyretics|antipyretics|mesh-ancestor
56011141|NCT05775471|Pembrolizumab|pembrolizumab|mesh-list
56011142|NCT05775471|Immunoconjugates|immunoconjugates|mesh-list
56011143|NCT05775471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011144|NCT05775471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011145|NCT05775471|Immunologic Factors|immunologic factors|mesh-ancestor
56011146|NCT05775471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011148|NCT05775289|Carboplatin|carboplatin|mesh-list
56011149|NCT05775289|Pembrolizumab|pembrolizumab|mesh-list
56011150|NCT05775289|Pemetrexed|pemetrexed|mesh-list
56011151|NCT05775289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56011152|NCT05775289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011153|NCT05775289|Tubulin Modulators|tubulin modulators|mesh-ancestor
56011154|NCT05775289|Antimitotic Agents|antimitotic agents|mesh-ancestor
56011155|NCT05775289|Mitosis Modulators|mitosis modulators|mesh-ancestor
56011156|NCT05775289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011157|NCT05775289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011158|NCT05775289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011159|NCT05775289|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56011160|NCT05775289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56011161|NCT05775159|Bevacizumab|bevacizumab|mesh-list
56011162|NCT05775159|Lenvatinib|lenvatinib|mesh-list
56011163|NCT05775159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011164|NCT05775159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011165|NCT05775159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56011166|NCT05775159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56011171|NCT05775159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011172|NCT05775159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011174|NCT05774964|Vitamin A|vitamin a|mesh-list
56011175|NCT05774964|Metronidazole|metronidazole|mesh-list
55738339|NCT02344004|Amikacin|amikacin|mesh-list
56011176|NCT05774964|Oxaliplatin|oxaliplatin|mesh-list
56011178|NCT05774964|Tegafur|tegafur|mesh-list
56011181|NCT05774964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011182|NCT05774964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011183|NCT05774964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011184|NCT05774964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011185|NCT05774964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56011186|NCT05774964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56011187|NCT05774964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56011188|NCT05774964|Hematinics|hematinics|mesh-ancestor
56011189|NCT05774964|Vitamin B Complex|vitamin b complex|mesh-ancestor
56011190|NCT05774964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011191|NCT05774964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56011192|NCT05774964|Antimetabolites|antimetabolites|mesh-ancestor
56011193|NCT05774951|Tamoxifen|tamoxifen|mesh-list
56011194|NCT05774951|Letrozole|letrozole|mesh-list
56011195|NCT05774951|Anastrozole|anastrozole|mesh-list
56011196|NCT05774951|Exemestane|exemestane|mesh-list
56011197|NCT05774951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011198|NCT05774951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56011199|NCT05774951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56011200|NCT05774951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011201|NCT05774951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011205|NCT05774951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011206|NCT05774951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56011207|NCT05774951|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56011208|NCT05774951|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56011209|NCT05774951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56011215|NCT05774899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011216|NCT05774717|Tranexamic Acid|tranexamic acid|mesh-list
56011217|NCT05774717|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56011218|NCT05774717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56011219|NCT05774717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011220|NCT05774717|Hemostatics|hemostatics|mesh-ancestor
56011221|NCT05774717|Coagulants|coagulants|mesh-ancestor
56011222|NCT05774704|Curcumin|curcumin|mesh-list
56011223|NCT05774704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56011224|NCT05774704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56011225|NCT05774704|Analgesics|analgesics|mesh-ancestor
56011226|NCT05774704|Sensory System Agents|sensory system agents|mesh-ancestor
56011227|NCT05774704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011228|NCT05774704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011229|NCT05774704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011230|NCT05774704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56011231|NCT05774704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011232|NCT05774704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011233|NCT05774704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011234|NCT05774691|Heparin|heparin|mesh-list
56011235|NCT05774691|Calcium heparin|calcium heparin|mesh-list
56011236|NCT05774691|Protamines|protamines|mesh-list
56011237|NCT05774691|Anticoagulants|anticoagulants|mesh-ancestor
56011238|NCT05774691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56011239|NCT05774691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56011240|NCT05774691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011241|NCT05774691|Heparin Antagonists|heparin antagonists|mesh-ancestor
56011242|NCT05774691|Coagulants|coagulants|mesh-ancestor
55720889|NCT01106807|Analgesics|analgesics|mesh-ancestor
56011243|NCT05773976|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56011244|NCT05773976|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56011245|NCT05773963|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56011246|NCT05773963|Lubricant Eye Drops|lubricant eye drops|mesh-list
56011247|NCT05773963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56011248|NCT05773950|Fosaprepitant|fosaprepitant|mesh-list
56011249|NCT05773950|Aprepitant|aprepitant|mesh-list
56011250|NCT05773950|Antiemetics|antiemetics|mesh-ancestor
56011251|NCT05773950|Autonomic Agents|autonomic agents|mesh-ancestor
56011303|NCT05682443|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56011305|NCT05682443|Sequestering Agents|sequestering agents|mesh-ancestor
56011306|NCT05682443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011307|NCT05659329|Gentamicins|gentamicins|mesh-list
56011308|NCT05659329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56011309|NCT05659329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011310|NCT05659329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56011312|NCT05659329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011313|NCT05645692|Atezolizumab|atezolizumab|mesh-list
56011314|NCT05645692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011316|NCT05638594|Carboplatin|carboplatin|mesh-list
56011317|NCT05638594|Docetaxel|docetaxel|mesh-list
56011318|NCT05638594|Trastuzumab|trastuzumab|mesh-list
56011319|NCT05638594|Letrozole|letrozole|mesh-list
56011320|NCT05638594|Pertuzumab|pertuzumab|mesh-list
56011321|NCT05638594|Hormones|hormones|mesh-list
56011322|NCT05638594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011323|NCT05638594|Tubulin Modulators|tubulin modulators|mesh-ancestor
56011324|NCT05638594|Antimitotic Agents|antimitotic agents|mesh-ancestor
56011325|NCT05638594|Mitosis Modulators|mitosis modulators|mesh-ancestor
56011326|NCT05638594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011327|NCT05638594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011328|NCT05638594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011329|NCT05638594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011330|NCT05638594|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56011331|NCT05638594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56011332|NCT05638594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011333|NCT05638594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56011338|NCT05635227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011339|NCT05635227|Antiemetics|antiemetics|mesh-ancestor
56011340|NCT05635227|Autonomic Agents|autonomic agents|mesh-ancestor
56011341|NCT05635227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011342|NCT05635227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011343|NCT05635227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56011344|NCT05635227|Glucocorticoids|glucocorticoids|mesh-ancestor
56011345|NCT05635227|Hormones|hormones|mesh-ancestor
56011346|NCT05635227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011347|NCT05635227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56011348|NCT05635227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011350|NCT05635227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56011351|NCT05635227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56011352|NCT05635227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56011353|NCT05635227|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56011354|NCT05635227|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56011355|NCT05635227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56011356|NCT05635227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011357|NCT05635227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011358|NCT05635227|Serotonin Agents|serotonin agents|mesh-ancestor
56011359|NCT05624554|Cyclophosphamide|cyclophosphamide|mesh-list
56011360|NCT05624554|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56011361|NCT05624554|Rituximab|rituximab|mesh-list
56011362|NCT05624554|Fludarabine|fludarabine|mesh-list
56011363|NCT05624554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56011364|NCT05624554|Immunologic Factors|immunologic factors|mesh-ancestor
56011365|NCT05624554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011366|NCT05624554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56011367|NCT05624554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56011368|NCT05624554|Alkylating Agents|alkylating agents|mesh-ancestor
56011369|NCT05624554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011370|NCT05624554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011371|NCT05624554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56011372|NCT05624554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011373|NCT05607147|Antibodies|antibodies|mesh-list
56011374|NCT05607147|Immunologic Factors|immunologic factors|mesh-ancestor
56011375|NCT05607147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011376|NCT05599451|Pyrithione zinc|pyrithione zinc|mesh-list
56011377|NCT05599451|Keratolytic Agents|keratolytic agents|mesh-ancestor
56011378|NCT05599451|Dermatologic Agents|dermatologic agents|mesh-ancestor
56011379|NCT05595642|Astegolimab|astegolimab|mesh-list
56011380|NCT05595642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56011381|NCT05595642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011382|NCT05595642|Antiviral Agents|antiviral agents|mesh-ancestor
56011383|NCT05595642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011386|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011387|NCT05512819|Vaccines|vaccines|mesh-list
56011427|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56011428|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011429|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56011430|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
56011432|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56011433|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56011434|NCT05429970|Analgesics|analgesics|mesh-ancestor
56011435|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
56011436|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011437|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011438|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56011461|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56011462|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011463|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56011464|NCT05383495|Analgesics|analgesics|mesh-ancestor
56011465|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
56011466|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011467|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56011468|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56011469|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56011470|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
56011471|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011472|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011473|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56011474|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56011475|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56011476|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56011477|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56011478|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
56011479|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
56011480|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
56011481|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
56011482|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56011483|NCT05376904|Ropivacaine|ropivacaine|mesh-list
56011484|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
56011485|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
55739121|NCT03399955|Amphotericin B|amphotericin b|mesh-list
56011486|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56011487|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011488|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
56011489|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011491|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011492|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011494|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011495|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011496|NCT05345171|Prednisolone|prednisolone|mesh-list
56011497|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011498|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
56011499|NCT05345171|Hormones|hormones|mesh-ancestor
56011500|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011546|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
56011547|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011548|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011549|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56011550|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56011551|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
56011552|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011553|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011554|NCT05304767|Urological Agents|urological agents|mesh-ancestor
56011555|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55760429|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
56011558|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56011560|NCT05304585|Cactinomycin|cactinomycin|mesh-list
56011561|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
56011562|NCT05304585|Vincristine|vincristine|mesh-list
56011563|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720937|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
56011564|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
56011565|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011566|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56011567|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56011568|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
56011569|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011570|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011571|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56011572|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56011573|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
56011574|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
56011575|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
56011576|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56011577|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011578|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56011579|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56011580|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011581|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56011582|NCT05298670|Metformin|metformin|mesh-list
56011583|NCT05298670|Interferons|interferons|mesh-list
56011584|NCT05298670|Interferon-beta|interferon-beta|mesh-list
56011585|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
56011586|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56011587|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011588|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011589|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
56011598|NCT05297851|Riboflavin|riboflavin|mesh-list
56011599|NCT05297851|Niacinamide|niacinamide|mesh-list
56011600|NCT05297851|Niacin|niacin|mesh-list
56011601|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
56011602|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
56011603|NCT05297851|Vitamins|vitamins|mesh-ancestor
56011604|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
56011605|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011606|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56011607|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
56011608|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56011609|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
56011610|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011611|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56011612|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
56011613|NCT05295589|Paclitaxel|paclitaxel|mesh-list
56011614|NCT05295589|Doxorubicin|doxorubicin|mesh-list
56011615|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56011616|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56011617|NCT05295589|Topotecan|topotecan|mesh-list
56011618|NCT05295589|Olaparib|olaparib|mesh-list
56011619|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56011620|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56011621|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011622|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
56011623|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
56011624|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
56011625|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738793|NCT03127319|Docetaxel|docetaxel|mesh-list
56011626|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56011627|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56011628|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56011629|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011630|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56011631|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
56011632|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011653|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011654|NCT05223829|Brexanolone|brexanolone|mesh-list
56011655|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
56011656|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011657|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011658|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720984|NCT01054196|Growth Substances|growth substances|mesh-ancestor
56011659|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
56011660|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
56011661|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
56011662|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011663|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011664|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
56011665|NCT05217446|Cetuximab|cetuximab|mesh-list
56011666|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011668|NCT05180006|Bevacizumab|bevacizumab|mesh-list
56011688|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56011689|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56011690|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
56011691|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011692|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011693|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011694|NCT05145413|Xanomeline|xanomeline|mesh-list
56011695|NCT05145413|Trospium chloride|trospium chloride|mesh-list
56011696|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
56011697|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
56011698|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011699|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011700|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56011701|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55738857|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
56011702|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
56011703|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011704|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011705|NCT05145413|Urological Agents|urological agents|mesh-ancestor
56011706|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56011707|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56011708|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56011709|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56011710|NCT05144854|Capecitabine|capecitabine|mesh-list
56011711|NCT05144854|Tegafur|tegafur|mesh-list
56011712|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
56011713|NCT05144854|Nivolumab|nivolumab|mesh-list
56011714|NCT05144854|Ipilimumab|ipilimumab|mesh-list
56011715|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56011716|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
56011717|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011718|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011721|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
56011729|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011731|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011732|NCT05099666|Doxorubicin|doxorubicin|mesh-list
56011733|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56011734|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011735|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56011745|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011747|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
56011748|NCT05090566|Hormones|hormones|mesh-ancestor
56011749|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011750|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56011751|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011752|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
56011753|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56011754|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56011755|NCT05090566|Growth Substances|growth substances|mesh-ancestor
56011756|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
56011757|NCT05080946|Aspirin|aspirin|mesh-list
56011758|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56011759|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56011760|NCT05080946|Analgesics|analgesics|mesh-ancestor
56011761|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
56011762|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011763|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011764|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56011765|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56011766|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56011767|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56011768|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011769|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56011770|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56011771|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011772|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
56011773|NCT05042817|Sufentanil|sufentanil|mesh-list
56011776|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56011777|NCT05042817|Narcotics|narcotics|mesh-ancestor
56011778|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56011779|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011780|NCT05042817|Analgesics|analgesics|mesh-ancestor
56011781|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
56011782|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011783|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56011784|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56011785|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
56011786|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
56011810|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56011811|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
56011812|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011813|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011814|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011815|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56011816|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56011817|NCT04933227|Capecitabine|capecitabine|mesh-list
56011818|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
56011819|NCT04933227|Atezolizumab|atezolizumab|mesh-list
56011820|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56011821|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
56011822|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011823|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011824|NCT04929392|Paclitaxel|paclitaxel|mesh-list
56011825|NCT04929392|Carboplatin|carboplatin|mesh-list
56011826|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
56011827|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56011828|NCT04929392|Lenvatinib|lenvatinib|mesh-list
56011829|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56011830|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011831|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
56011832|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
56011833|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
56011834|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011835|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56011836|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56011837|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011838|NCT04914234|Metoprolol|metoprolol|mesh-list
56011862|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011863|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011864|NCT04882085|Ceftazidime|ceftazidime|mesh-list
56011865|NCT04882085|Avibactam|avibactam|mesh-list
56011866|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
56011867|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56011868|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011869|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56011870|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011871|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011872|NCT04832854|Gemcitabine|gemcitabine|mesh-list
56011873|NCT04832854|Paclitaxel|paclitaxel|mesh-list
56011874|NCT04832854|Carboplatin|carboplatin|mesh-list
56011875|NCT04832854|Pemetrexed|pemetrexed|mesh-list
56011876|NCT04832854|Atezolizumab|atezolizumab|mesh-list
56011877|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56011878|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011879|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
56011880|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
56011881|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
56011882|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011883|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56011884|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
56011885|NCT04832854|Antiviral Agents|antiviral agents|mesh-ancestor
56011886|NCT04832854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56011887|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011888|NCT04832854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56011889|NCT04832854|Immunologic Factors|immunologic factors|mesh-ancestor
56011890|NCT04832854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011893|NCT04820309|Xanomeline|xanomeline|mesh-list
56011908|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56011909|NCT04818086|Buprenorphine|buprenorphine|mesh-list
56011910|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56011911|NCT04818086|Lemborexant|lemborexant|mesh-list
56011912|NCT04818086|Naloxone|naloxone|mesh-list
56011913|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56011914|NCT04818086|Narcotics|narcotics|mesh-ancestor
56011915|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56011916|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011917|NCT04818086|Analgesics|analgesics|mesh-ancestor
56011918|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
56011919|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56011920|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56011921|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56011922|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56011923|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011924|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56011925|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56011926|NCT04808843|Dienogest|dienogest|mesh-list
56011927|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56011928|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
56011929|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55739132|NCT03397199|Apatinib|apatinib|mesh-list
56011930|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011931|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56011933|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56011934|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56011935|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
56011936|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011939|NCT04802161|Cytarabine|cytarabine|mesh-list
56011951|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56011952|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56011953|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56011954|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011955|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56011956|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56011957|NCT04802161|Growth Substances|growth substances|mesh-ancestor
56011958|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
56011960|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56011961|NCT04779307|Vedolizumab|vedolizumab|mesh-list
56011962|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56011963|NCT04762979|Fulvestrant|fulvestrant|mesh-list
56011964|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56011965|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56011966|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56011967|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56011968|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56011969|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
56011970|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56011971|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56011972|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56011973|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56011974|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56011975|NCT04762199|Osimertinib|osimertinib|mesh-list
56011980|NCT04739800|Paclitaxel|paclitaxel|mesh-list
56012007|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012010|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012011|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012012|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56012013|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56012014|NCT04737187|Growth Substances|growth substances|mesh-ancestor
56012015|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012016|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
56012017|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
56012018|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012019|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
56012020|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012021|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
56012022|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56012023|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56012024|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012025|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
56012026|NCT04733157|Coagulants|coagulants|mesh-ancestor
56012027|NCT04723147|Levodopa|levodopa|mesh-list
56012028|NCT04723147|Carbidopa|carbidopa|mesh-list
56012029|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56012030|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56012031|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56012032|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
56012033|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56012034|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012035|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012036|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56012037|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012038|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56012039|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
56012053|NCT04676477|Osimertinib|osimertinib|mesh-list
56012054|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
56012055|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56012056|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012057|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012058|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012059|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012060|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
56012061|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012062|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739238|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
56012081|NCT04662710|Leucovorin|leucovorin|mesh-list
56012082|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
56012083|NCT04662710|Capecitabine|capecitabine|mesh-list
56012084|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
56012085|NCT04662710|Lenvatinib|lenvatinib|mesh-list
56012086|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
56012087|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012088|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012089|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012090|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
56012091|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012092|NCT04662710|Antidotes|antidotes|mesh-ancestor
56012093|NCT04662710|Protective Agents|protective agents|mesh-ancestor
56012094|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012095|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
56012096|NCT04662710|Vitamins|vitamins|mesh-ancestor
56012097|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
56012098|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012099|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012100|NCT04659174|Xanomeline|xanomeline|mesh-list
56012101|NCT04659174|Trospium chloride|trospium chloride|mesh-list
56012102|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
56012103|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
56012106|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56012110|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012111|NCT04659174|Urological Agents|urological agents|mesh-ancestor
56012112|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56012113|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56012114|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56012115|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56012116|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
56012117|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56012118|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012119|NCT04643405|Gemcitabine|gemcitabine|mesh-list
56012120|NCT04643405|Paclitaxel|paclitaxel|mesh-list
56012121|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012122|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012123|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012124|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012125|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012126|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012127|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012128|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
56012129|NCT04643405|Antiviral Agents|antiviral agents|mesh-ancestor
56012130|NCT04643405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012131|NCT04643405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012132|NCT04643405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012133|NCT04643405|Immunologic Factors|immunologic factors|mesh-ancestor
56012134|NCT04643405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012135|NCT04633122|Sunitinib|sunitinib|mesh-list
56012136|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012137|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56012138|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56012139|NCT04633122|Growth Substances|growth substances|mesh-ancestor
56012140|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012141|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
56012145|NCT04628026|Venetoclax|venetoclax|mesh-list
56012154|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012155|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55739312|NCT02520479|Pegaspargase|pegaspargase|mesh-list
56012166|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56012167|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56012168|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012169|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012170|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56012171|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
56012172|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012173|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012174|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56012175|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56012176|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56012177|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56012178|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56012179|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
56012180|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56012197|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56012198|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56012199|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012201|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012202|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
56032499|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55721100|NCT02317510|Anesthetics|anesthetics|mesh-list
56012203|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012204|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012205|NCT04439318|Trametinib|trametinib|mesh-list
56012206|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56012207|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012208|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012209|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012210|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012211|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56012212|NCT04439318|Protective Agents|protective agents|mesh-ancestor
56012213|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012214|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56012215|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
56012216|NCT04439279|Trametinib|trametinib|mesh-list
56012217|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
56012218|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012219|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012220|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012221|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012222|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56012223|NCT04439279|Protective Agents|protective agents|mesh-ancestor
56012224|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012226|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
56012227|NCT04439227|Adavosertib|adavosertib|mesh-list
56012228|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012229|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739383|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56012230|NCT04439201|Palbociclib|palbociclib|mesh-list
56012231|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012232|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012233|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012234|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012235|NCT04439188|GSK2636771|gsk2636771|mesh-list
56012236|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012237|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012238|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012239|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012240|NCT04401761|Aspirin|aspirin|mesh-list
56012241|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
56012242|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56012243|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56012244|NCT04401761|Analgesics|analgesics|mesh-ancestor
56012245|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
56012246|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012247|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012248|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56012249|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56012250|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56012251|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56012252|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012253|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56012254|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56012255|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012256|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
56012257|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56012258|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
56012262|NCT04385277|Vitamin A|vitamin a|mesh-list
56012279|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012280|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
56012281|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
56012282|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
56012283|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
56012284|NCT04385277|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56012285|NCT04340843|Decitabine|decitabine|mesh-list
56012286|NCT04340843|Azacitidine|azacitidine|mesh-list
56012287|NCT04340843|Belinostat|belinostat|mesh-list
56012288|NCT04340843|Guadecitabine|guadecitabine|mesh-list
56012289|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012290|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
55739147|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56012291|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012292|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012293|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012294|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56012295|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
55721157|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
56012296|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56012297|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012298|NCT04273165|Etravirine|etravirine|mesh-list
56012299|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56012300|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56012301|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012302|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012303|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
56012326|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012327|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012328|NCT04041128|Olaparib|olaparib|mesh-list
56012329|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56012330|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012331|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012332|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012333|NCT04030962|Lifitegrast|lifitegrast|mesh-list
56012334|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56012335|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56012336|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
56012337|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012338|NCT03951753|Tirzepatide|tirzepatide|mesh-list
56012339|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55721196|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012340|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012341|NCT03951753|Incretins|incretins|mesh-ancestor
56012342|NCT03951753|Hormones|hormones|mesh-ancestor
56012343|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012344|NCT03947671|Acetaminophen|acetaminophen|mesh-list
56012345|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56012346|NCT03947671|Analgesics|analgesics|mesh-ancestor
56012347|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
56012348|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012349|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012350|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
56012351|NCT03941964|Azacitidine|azacitidine|mesh-list
56012352|NCT03941964|Decitabine|decitabine|mesh-list
56012376|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012377|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56012378|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56012379|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012380|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56012381|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012382|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
56012383|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
56012384|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56012385|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
56012386|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56012387|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
56012388|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012389|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012390|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
56012391|NCT03859024|Acetaminophen|acetaminophen|mesh-list
56012392|NCT03859024|Dexamethasone|dexamethasone|mesh-list
56012393|NCT03859024|Ibuprofen|ibuprofen|mesh-list
56012394|NCT03859024|Celecoxib|celecoxib|mesh-list
56012395|NCT03859024|Oxycodone|oxycodone|mesh-list
56012396|NCT03859024|Gabapentin|gabapentin|mesh-list
56012397|NCT03859024|Bupivacaine|bupivacaine|mesh-list
56012398|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56012399|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
56012400|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
56012401|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012402|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012403|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56012404|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
56012405|NCT03859024|Hormones|hormones|mesh-ancestor
56012406|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012407|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56012408|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012419|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012420|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012421|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56012422|NCT03859024|Narcotics|narcotics|mesh-ancestor
55758643|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
56012423|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56012424|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
56012425|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56012426|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56012427|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56012428|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56012429|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56012430|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56012431|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
56012432|NCT03837509|Daratumumab|daratumumab|mesh-list
56012433|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012434|NCT03836261|Venetoclax|venetoclax|mesh-list
56012435|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
56012436|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
56012437|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012438|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012439|NCT03816163|Gemcitabine|gemcitabine|mesh-list
56012440|NCT03816163|Paclitaxel|paclitaxel|mesh-list
56012441|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012442|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012443|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012444|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012445|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012469|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012470|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012471|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012472|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012473|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
56012474|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012475|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012476|NCT03586999|Nivolumab|nivolumab|mesh-list
56012477|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012478|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012479|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56012480|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012481|NCT03507452|BAY 2287411|bay 2287411|mesh-list
56012482|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56012483|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012484|NCT03493490|Diclofenac|diclofenac|mesh-list
56012485|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56012486|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56012487|NCT03493490|Analgesics|analgesics|mesh-ancestor
56012488|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
56012489|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012490|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012491|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56012492|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56012493|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56012494|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012495|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012496|NCT03414658|Trastuzumab|trastuzumab|mesh-list
56012497|NCT03414658|Avelumab|avelumab|mesh-list
56012498|NCT03414658|Vinorelbine|vinorelbine|mesh-list
56012499|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012500|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012501|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012502|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012503|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012505|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012506|NCT03377491|Gemcitabine|gemcitabine|mesh-list
56012507|NCT03377491|Paclitaxel|paclitaxel|mesh-list
56012508|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012509|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012510|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012511|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012512|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
55758724|NCT02185534|Clopidogrel|clopidogrel|mesh-list
56012513|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012514|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012515|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
56012516|NCT03377491|Antiviral Agents|antiviral agents|mesh-ancestor
56012517|NCT03377491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012518|NCT03377491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012519|NCT03377491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012520|NCT03377491|Immunologic Factors|immunologic factors|mesh-ancestor
56012521|NCT03377491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012543|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012545|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012546|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
56012547|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012548|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
56012549|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012550|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012551|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
56012552|NCT03126630|Maytansine|maytansine|mesh-list
56012553|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012554|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012555|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012556|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012557|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012558|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012559|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012560|NCT03036930|Vaccines|vaccines|mesh-list
56012561|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
56012562|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012563|NCT02941783|Factor VIII|factor viii|mesh-list
56012564|NCT02941783|Coagulants|coagulants|mesh-ancestor
56012565|NCT02889081|Vitamin D|vitamin d|mesh-list
56012566|NCT02889081|Vitamins|vitamins|mesh-ancestor
56012567|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
55760442|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
56012568|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012569|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56012570|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
56012571|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56012572|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56012573|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012574|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56012576|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
56012577|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012578|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56012579|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56012580|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56012581|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
56012582|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739154|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56012583|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012584|NCT02840539|Cytarabine|cytarabine|mesh-list
56012585|NCT02840539|Dexamethasone|dexamethasone|mesh-list
56012586|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
56012587|NCT02840539|Bortezomib|bortezomib|mesh-list
56012588|NCT02840539|BB 1101|bb 1101|mesh-list
56012589|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56012590|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
56012591|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
56012592|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012593|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012615|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012616|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56012617|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012618|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012619|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
56012620|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
56012621|NCT02612311|Chlorambucil|chlorambucil|mesh-list
56012622|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012623|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012624|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012625|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
56012626|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012627|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
56012628|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012629|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012631|NCT02342782|Etoposide|etoposide|mesh-list
56012632|NCT02342782|Melphalan|melphalan|mesh-list
56012633|NCT02342782|Carmustine|carmustine|mesh-list
56012634|NCT02342782|Basiliximab|basiliximab|mesh-list
56012635|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012636|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012637|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012638|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012639|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012640|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721338|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55828394|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56012641|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012642|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
56012643|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
56012644|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012645|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012658|NCT02112864|Dexamethasone|dexamethasone|mesh-list
56012659|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56012660|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
56012661|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
56012662|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012663|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012683|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012684|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55739832|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012685|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012686|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012687|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012688|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012689|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012690|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012691|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012692|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
56012693|NCT02091141|Trastuzumab|trastuzumab|mesh-list
56012694|NCT02091141|Pertuzumab|pertuzumab|mesh-list
56012695|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56012696|NCT02091141|Atezolizumab|atezolizumab|mesh-list
56012697|NCT02091141|Vemurafenib|vemurafenib|mesh-list
56012698|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012699|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012700|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012701|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012702|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012703|NCT01970865|Crizotinib|crizotinib|mesh-list
56012704|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012705|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56012706|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012707|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012708|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56012709|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56012710|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012723|NCT00684073|Buprenorphine|buprenorphine|mesh-list
56012724|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56012725|NCT00684073|Naloxone|naloxone|mesh-list
56012726|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56012727|NCT00684073|Narcotics|narcotics|mesh-ancestor
56012728|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739160|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56012729|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012730|NCT00684073|Analgesics|analgesics|mesh-ancestor
56012731|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
56012732|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012733|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56012735|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56012736|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56012737|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56012738|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56012739|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012740|NCT00603109|Hormones|hormones|mesh-ancestor
56012741|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012742|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012743|NCT00199095|Cytarabine|cytarabine|mesh-list
56012744|NCT00199095|Dexamethasone|dexamethasone|mesh-list
56012745|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
56012746|NCT00199095|Ifosfamide|ifosfamide|mesh-list
56012747|NCT00199095|Methotrexate|methotrexate|mesh-list
56012748|NCT00199095|Vincristine|vincristine|mesh-list
56012749|NCT00199095|Doxorubicin|doxorubicin|mesh-list
56012750|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
56012751|NCT00199095|Idarubicin|idarubicin|mesh-list
56012752|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012753|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
56012754|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012755|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56012756|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012757|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
56012758|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012759|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012760|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56012761|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56012762|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
56012763|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
56012764|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012766|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
56012767|NCT00199095|Hormones|hormones|mesh-ancestor
56012768|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012769|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56012770|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56012771|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
56012772|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56012773|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012774|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
56012775|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
56012776|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012777|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56012778|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56012779|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
56012780|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012781|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012782|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012783|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012784|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012785|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56012786|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012787|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012789|NCT00199056|Dexamethasone|dexamethasone|mesh-list
56012790|NCT00199056|Prednisolone|prednisolone|mesh-list
56012791|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
56012792|NCT00199056|Ifosfamide|ifosfamide|mesh-list
56012793|NCT00199056|Methotrexate|methotrexate|mesh-list
56012794|NCT00199056|Fludarabine|fludarabine|mesh-list
56012795|NCT00199056|Vincristine|vincristine|mesh-list
56012796|NCT00199056|Doxorubicin|doxorubicin|mesh-list
56012797|NCT00199056|Daunorubicin|daunorubicin|mesh-list
56012798|NCT00199056|Asparaginase|asparaginase|mesh-list
56012799|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
56012800|NCT00199056|Idarubicin|idarubicin|mesh-list
56012801|NCT00199056|Thioguanine|thioguanine|mesh-list
56012802|NCT00199056|Vindesine|vindesine|mesh-list
56012803|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012804|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
56012805|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012806|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56012807|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56012808|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
56012809|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012810|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012811|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56012812|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56012813|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
56012814|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
56012815|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012816|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56012817|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
56012818|NCT00199056|Hormones|hormones|mesh-ancestor
56012819|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012820|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56012821|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56012822|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
56012823|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56012824|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012825|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
56012826|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
56012827|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012828|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56012829|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56012830|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
56012831|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012832|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012833|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012834|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012835|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012836|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56012837|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012838|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012839|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
56012840|NCT00199030|Cladribine|cladribine|mesh-list
56012841|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012842|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012843|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012844|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
56012845|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012846|NCT00198978|Cytarabine|cytarabine|mesh-list
56012847|NCT00198978|Dexamethasone|dexamethasone|mesh-list
56012848|NCT00198978|Prednisolone|prednisolone|mesh-list
56012850|NCT00198978|Rituximab|rituximab|mesh-list
56012864|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012865|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56012866|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56012867|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56012869|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
56012870|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012871|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56012872|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
56012873|NCT00198978|Hormones|hormones|mesh-ancestor
56012874|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56012875|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56012876|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56012877|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
56012878|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56012879|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012880|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
56012881|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56012882|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012883|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56012884|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56012885|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
56012886|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012887|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56012888|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
56012889|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
56012890|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
56012891|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56012892|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56012893|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012894|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012895|NCT00109395|Midazolam|midazolam|mesh-list
56012896|NCT00109395|Lorazepam|lorazepam|mesh-list
56012897|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56012904|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56012905|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
56012906|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
56012907|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
56012908|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
56012909|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56012910|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012911|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
56012912|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
56012913|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
56012914|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56012934|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
56012935|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012936|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
56012937|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012938|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012939|NCT00004144|Antiviral Agents|antiviral agents|mesh-ancestor
56012940|NCT00004144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012941|NCT00004144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012942|NCT00004144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012943|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
56012944|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012945|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56012946|NCT00004150|Leucovorin|leucovorin|mesh-list
56012947|NCT00004150|Fluorouracil|fluorouracil|mesh-list
56012948|NCT00004150|Calcium|calcium|mesh-list
56012949|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
56012950|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56012951|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012952|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
56012953|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012954|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012955|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012956|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012957|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
56012958|NCT00004150|Antidotes|antidotes|mesh-ancestor
56012959|NCT00004150|Protective Agents|protective agents|mesh-ancestor
56012960|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
56012961|NCT00004150|Vitamins|vitamins|mesh-ancestor
56012962|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
56012963|NCT00004930|Doxorubicin|doxorubicin|mesh-list
56012964|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56012965|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56012966|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012967|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012968|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012971|NCT00003928|Gemcitabine|gemcitabine|mesh-list
56012972|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012973|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012974|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
56012975|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56012976|NCT00003928|Antiviral Agents|antiviral agents|mesh-ancestor
56012977|NCT00003928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56012978|NCT00003928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012979|NCT00003928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56012980|NCT00003928|Immunologic Factors|immunologic factors|mesh-ancestor
55758801|NCT04902885|Carboplatin|carboplatin|mesh-list
55721443|NCT05303792|Hormones|hormones|mesh-ancestor
56012981|NCT00003928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012982|NCT00004162|Doxorubicin|doxorubicin|mesh-list
56012983|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56012984|NCT00004162|Methotrexate|methotrexate|mesh-list
56012985|NCT00004162|Vincristine|vincristine|mesh-list
56012986|NCT00004162|Sargramostim|sargramostim|mesh-list
56012987|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56012988|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56012989|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56012990|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56012991|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56012992|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740129|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56012993|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56012994|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
56012995|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56012996|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56012997|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56012998|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
56012999|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
56013000|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56013014|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
56013015|NCT00004174|Thiotepa|thiotepa|mesh-list
56013016|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56013017|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013018|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
56013019|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013020|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
56013021|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013022|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013023|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
56013024|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013025|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56013026|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56013027|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
56013028|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56013029|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56013030|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56013031|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56013032|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56013033|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013034|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56013035|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56013036|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56013037|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56013038|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
56013039|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721470|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013040|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013041|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56013042|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56013043|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
56013044|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56013055|NCT00004990|Hormones|hormones|mesh-ancestor
56013056|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013057|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56013058|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013059|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
56013060|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56013061|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013062|NCT01216735|Fluticasone|fluticasone|mesh-list
56013063|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013064|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56013065|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
56013066|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013067|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013068|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56013069|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
56013070|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
56013071|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56013073|NCT00004186|Etoposide|etoposide|mesh-list
56013074|NCT00004186|Topotecan|topotecan|mesh-list
56013075|NCT00004186|Ifosfamide|ifosfamide|mesh-list
56013076|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013078|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56013110|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013111|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56013112|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
56013114|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013115|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56013116|NCT00004192|Protective Agents|protective agents|mesh-ancestor
56013117|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56013118|NCT00005002|Lamivudine|lamivudine|mesh-list
56013119|NCT00005002|Zidovudine|zidovudine|mesh-list
56013120|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56013121|NCT00005002|Nelfinavir|nelfinavir|mesh-list
56013122|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56013123|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56013124|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013125|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013126|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
56013127|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013128|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56013129|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56013130|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
56013131|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56013132|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56013133|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
56013134|NCT00004198|Sargramostim|sargramostim|mesh-list
56013135|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56013163|NCT00005014|Risperidone|risperidone|mesh-list
56013164|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56013165|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
56013166|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013167|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013168|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013169|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56013170|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56013171|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56013172|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56013173|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56013174|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
56013175|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56013176|NCT03009799|Laxatives|laxatives|mesh-ancestor
56013177|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56013178|NCT00005026|Paclitaxel|paclitaxel|mesh-list
56013179|NCT00005026|Carboplatin|carboplatin|mesh-list
56013180|NCT00005026|Topotecan|topotecan|mesh-list
56013181|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56013182|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013183|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
56013184|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013185|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
56013186|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013187|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56013205|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56013206|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56013207|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
56013208|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
56013209|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
56013210|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56013211|NCT00004216|Cefixime|cefixime|mesh-list
56013212|NCT00004216|Trimethoprim|trimethoprim|mesh-list
56013213|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
56013214|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56013215|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013216|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55740359|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
56013217|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013218|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013219|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013220|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013221|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56013262|NCT00005050|Fluorouracil|fluorouracil|mesh-list
56013263|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
56013264|NCT00005050|Eniluracil|eniluracil|mesh-list
56013265|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
56013275|NCT00005578|Doxorubicin|doxorubicin|mesh-list
56013276|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56013278|NCT00005578|Vincristine|vincristine|mesh-list
56013279|NCT00005578|Bleomycin|bleomycin|mesh-list
56013280|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
56013281|NCT00005578|Razoxane|razoxane|mesh-list
56013282|NCT00005578|Lenograstim|lenograstim|mesh-list
56013283|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013284|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
56013285|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013286|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56013287|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56013288|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
56013289|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013290|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013291|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55740435|NCT03383315|Analgesics|analgesics|mesh-ancestor
56013292|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56013293|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56013294|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013295|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013310|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013311|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
56013312|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013313|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013314|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
56013315|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013316|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013317|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
56013318|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013319|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56013320|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013322|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
56013323|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013324|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56013325|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56013326|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013327|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
56013328|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013329|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56013330|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56013331|NCT00097448|Prednisone|prednisone|mesh-list
56013332|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
56013333|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56013334|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56013335|NCT00097448|Prednisolone|prednisolone|mesh-list
56013336|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
56013337|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56013338|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
56013339|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013340|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
56013354|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013355|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013356|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
56013357|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013358|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013359|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
56013360|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013362|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56013363|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013364|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
56013365|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56013366|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
56013367|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013368|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013369|NCT00004252|Leucovorin|leucovorin|mesh-list
56013371|NCT00004252|Calcium|calcium|mesh-list
56013372|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
56013373|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56013374|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013375|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
56013376|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013377|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013378|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013379|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013380|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
56013381|NCT00004252|Antidotes|antidotes|mesh-ancestor
56013382|NCT00004252|Protective Agents|protective agents|mesh-ancestor
56013383|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
56013384|NCT00004252|Vitamins|vitamins|mesh-ancestor
56013385|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
56013386|NCT00005590|Levofloxacin|levofloxacin|mesh-list
56013387|NCT00005590|Ofloxacin|ofloxacin|mesh-list
56013388|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56013389|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013390|NCT00005590|Renal Agents|renal agents|mesh-ancestor
56013391|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56013392|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56013393|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013394|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013395|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013396|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013397|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56013398|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56013399|NCT00005596|Leucovorin|leucovorin|mesh-list
56013400|NCT00005596|Cytarabine|cytarabine|mesh-list
55721521|NCT01646398|Vaccines|vaccines|mesh-list
56013401|NCT00005596|Dexamethasone|dexamethasone|mesh-list
56013426|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013427|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56013428|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56013429|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
56013430|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56013431|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013448|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56013449|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56013450|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013452|NCT00005068|Fluorouracil|fluorouracil|mesh-list
56013453|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
56013454|NCT00005068|Irinotecan|irinotecan|mesh-list
56013455|NCT00005068|Calcium|calcium|mesh-list
56013456|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
56013457|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56013458|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013459|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
56013460|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013461|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013462|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013463|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013464|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
56013465|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56013466|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013467|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013468|NCT00005068|Antidotes|antidotes|mesh-ancestor
56013469|NCT00005068|Protective Agents|protective agents|mesh-ancestor
56013470|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
56013471|NCT00005068|Vitamins|vitamins|mesh-ancestor
56013472|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
56013473|NCT00004264|Docetaxel|docetaxel|mesh-list
56013474|NCT00004264|Amifostine|amifostine|mesh-list
56013475|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013476|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
55721535|NCT01646320|Incretins|incretins|mesh-ancestor
56013477|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013483|NCT00005074|Alvocidib|alvocidib|mesh-list
56013496|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013497|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
56013498|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56013499|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013500|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56013501|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56013502|NCT00004276|Growth Substances|growth substances|mesh-ancestor
56013503|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
56013504|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013505|NCT00004288|Olsalazine|olsalazine|mesh-list
56013506|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56013507|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56013508|NCT00004288|Analgesics|analgesics|mesh-ancestor
56013509|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
56013510|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013511|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013512|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013513|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56013514|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56013515|NCT00005086|Gemcitabine|gemcitabine|mesh-list
56013516|NCT00005086|Docetaxel|docetaxel|mesh-list
56013517|NCT00005086|Methotrexate|methotrexate|mesh-list
56013518|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013519|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013520|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
56013521|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013522|NCT00005086|Antiviral Agents|antiviral agents|mesh-ancestor
56013523|NCT00005086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013524|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013525|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013526|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
56013527|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013528|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
56013529|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013530|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
56013531|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56013532|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
56013534|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
56013535|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56013536|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56013537|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56013539|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013540|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
56013541|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013542|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013543|NCT00005614|Antiviral Agents|antiviral agents|mesh-ancestor
56013544|NCT00005614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013545|NCT00005614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013546|NCT00005614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013547|NCT00005614|Immunologic Factors|immunologic factors|mesh-ancestor
56013548|NCT00005614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013549|NCT00101036|Lapatinib|lapatinib|mesh-list
56013550|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013551|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56013552|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013553|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013554|NCT00004300|Bromocriptine|bromocriptine|mesh-list
56013555|NCT00004300|Sertraline|sertraline|mesh-list
56013556|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
56013557|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56013558|NCT00004300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56013559|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56013560|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56013581|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013582|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
56013583|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013584|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56013585|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56013586|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
56013587|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013588|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013589|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56013590|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56013591|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
56013592|NCT00005638|Irinotecan|irinotecan|mesh-list
56013593|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013594|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56013595|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013596|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013597|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013598|NCT00005104|Metformin|metformin|mesh-list
56013599|NCT00005104|Clomiphene|clomiphene|mesh-list
56013600|NCT00005104|Enclomiphene|enclomiphene|mesh-list
56013601|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
56013602|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56013603|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013604|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56013605|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
56013606|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013607|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56013608|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
56013609|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56013610|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56013611|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56013612|NCT00005110|Albuterol|albuterol|mesh-list
56013613|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56013614|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56013615|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
56013616|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013619|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56013620|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56013621|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56013623|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
56013624|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013625|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013626|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
56013627|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56013628|NCT00004330|Hormones|hormones|mesh-list
55758802|NCT04902885|Etoposide|etoposide|mesh-list
56013629|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013630|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013631|NCT00005644|Gemcitabine|gemcitabine|mesh-list
56013632|NCT00005644|Paclitaxel|paclitaxel|mesh-list
56013633|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56013634|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013635|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
56013636|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
56013637|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
56013638|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013639|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56013640|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
56013641|NCT00005644|Antiviral Agents|antiviral agents|mesh-ancestor
56013642|NCT00005644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013643|NCT00005644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013644|NCT00005644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013645|NCT00005644|Immunologic Factors|immunologic factors|mesh-ancestor
56013646|NCT00005644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013647|NCT00005668|Itraconazole|itraconazole|mesh-list
56013648|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
56013649|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013659|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
56013661|NCT00030992|Ranitidine|ranitidine|mesh-list
56013662|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
56013663|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56013664|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56013665|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56013666|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013667|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
56013668|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
56013669|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
56013670|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013671|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
56013672|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
56013673|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56013674|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56013675|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
56013676|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
56013677|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013678|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013679|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56013680|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
56013681|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
56013682|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56013683|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56013711|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
56013712|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013713|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
56013714|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
56013715|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56013716|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
56013717|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56013718|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56013719|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56013720|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56013721|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013722|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
56013723|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013724|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013725|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56013726|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758803|NCT04902885|Topotecan|topotecan|mesh-list
56013727|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013728|NCT00004402|Calcitriol|calcitriol|mesh-list
56013729|NCT00004402|Interferons|interferons|mesh-list
56013730|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
56013731|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013732|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
56013733|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013734|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56013735|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013736|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56013737|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56013738|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013739|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56013740|NCT00004402|Vitamins|vitamins|mesh-ancestor
56013751|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56013752|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56013753|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
56013754|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013755|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56013756|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
56013758|NCT00004426|Hormones|hormones|mesh-list
56013759|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739192|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
56013760|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013761|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56013762|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
56013763|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56013764|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56013765|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013766|NCT00004438|Leuprolide|leuprolide|mesh-list
56013767|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56013768|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
56013769|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56013770|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013771|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56013772|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013773|NCT01217749|Ofatumumab|ofatumumab|mesh-list
56013801|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56013802|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
56013803|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
56013804|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
56013805|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56013806|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013807|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
56013808|NCT02197273|Hormones|hormones|mesh-ancestor
56013809|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56013810|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55721634|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013811|NCT02197273|Protective Agents|protective agents|mesh-ancestor
56013812|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56013813|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013814|NCT00004444|Paromomycin|paromomycin|mesh-list
56013815|NCT00004444|Streptomycin|streptomycin|mesh-list
56013816|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56013817|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013818|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56013819|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56013820|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56013821|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013822|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013823|NCT00004450|Interferons|interferons|mesh-list
56013824|NCT00004450|Interferon-beta|interferon-beta|mesh-list
56013825|NCT00004450|Thalidomide|thalidomide|mesh-list
56013827|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
56013828|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013829|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013830|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
56013846|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
56013847|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56013848|NCT01288807|Milnacipran|milnacipran|mesh-list
56013849|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56013850|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56013851|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56013852|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013853|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013854|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013855|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56013856|NCT01288807|Analgesics|analgesics|mesh-ancestor
56013857|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
56013858|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013859|NCT00005764|Lamivudine|lamivudine|mesh-list
56013860|NCT00005764|Zidovudine|zidovudine|mesh-list
56013861|NCT00005764|Abacavir|abacavir|mesh-list
56013862|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56013863|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56013864|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56013865|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013866|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013867|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
56013868|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56013869|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56013870|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56013871|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
56013872|NCT01289275|Nicotine|nicotine|mesh-list
56013873|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56013874|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
56013875|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56013876|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013877|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56013878|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56013879|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
56013880|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013882|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
56013883|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56013884|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56013885|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
56013886|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013887|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56013888|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56013889|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
56013890|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013891|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56013892|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56013893|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
56013894|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56013941|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013942|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56013943|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
56013944|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56013945|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
56013946|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013947|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013948|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56013949|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
56013950|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
56013951|NCT00005776|Protective Agents|protective agents|mesh-ancestor
56013952|NCT01290445|Varenicline|varenicline|mesh-list
56013953|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56013954|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56013955|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
56013956|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56013957|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013958|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013959|NCT00005782|Lenograstim|lenograstim|mesh-list
56013960|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56013961|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
56013962|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56013963|NCT01290913|Omalizumab|omalizumab|mesh-list
56013964|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56013965|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56013966|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
56013967|NCT00004552|Acamprosate|acamprosate|mesh-list
56013968|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56013969|NCT00101660|Dasatinib|dasatinib|mesh-list
56013970|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741111|NCT03125473|Vaccines|vaccines|mesh-list
56013984|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013986|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56013987|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56013988|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013989|NCT00004564|Clopidogrel|clopidogrel|mesh-list
56013990|NCT00004564|Atorvastatin|atorvastatin|mesh-list
56013991|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56013992|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56013993|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
56013994|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56013995|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56013996|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56013997|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56013998|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55721679|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56013999|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55760009|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
56014000|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56014002|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
56014003|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014004|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014005|NCT01268527|Calcipotriene|calcipotriene|mesh-list
56014006|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
56014007|NCT00005806|Paclitaxel|paclitaxel|mesh-list
56014008|NCT00005806|Carboplatin|carboplatin|mesh-list
56014009|NCT00005806|Gefitinib|gefitinib|mesh-list
56014010|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56014011|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014012|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
56014013|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
56014014|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
56014015|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014016|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56014017|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014018|NCT00005812|Temozolomide|temozolomide|mesh-list
56014021|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014022|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014023|NCT01270555|Bupropion|bupropion|mesh-list
56014024|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56014025|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
56014026|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56014027|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56014028|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56014029|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56014030|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014031|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
56014032|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014033|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014034|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56014035|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56014036|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014037|NCT00004582|Ritonavir|ritonavir|mesh-list
56014038|NCT00004582|Lopinavir|lopinavir|mesh-list
56014039|NCT00004582|Efavirenz|efavirenz|mesh-list
56014040|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56014041|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56014042|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
56014043|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014044|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014045|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56014046|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56014047|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
56014048|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014058|NCT00004690|Monolaurin|monolaurin|mesh-list
56014064|NCT00004696|Narcotics|narcotics|mesh-ancestor
56014065|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014066|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014067|NCT00004696|Analgesics|analgesics|mesh-ancestor
56014068|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
56014069|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014070|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
56014071|NCT00004744|Antibodies|antibodies|mesh-list
56014072|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
56014073|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56014074|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56014075|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
56014076|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014077|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
56014078|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56014079|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014080|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014081|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56014082|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56014083|NCT01292005|Protective Agents|protective agents|mesh-ancestor
56014084|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014085|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
56014117|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014119|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
56014120|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56014121|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014139|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014148|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014149|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014150|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
56014151|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014152|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
56014153|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014154|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
56014155|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014156|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56014157|NCT01342549|Naltrexone|naltrexone|mesh-list
56014158|NCT01342549|Valproic Acid|valproic acid|mesh-list
56014159|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56014160|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56014161|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014162|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
56014164|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
56014193|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56014194|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014195|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741340|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
56014197|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
56014198|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014199|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014200|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56014201|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56014202|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
56014203|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56014204|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56014205|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56014206|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56014207|NCT00103376|Bortezomib|bortezomib|mesh-list
56014252|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014253|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014254|NCT01402375|Acetaminophen|acetaminophen|mesh-list
56014255|NCT01402375|Oxycodone|oxycodone|mesh-list
56014256|NCT01402375|Hydrocodone|hydrocodone|mesh-list
56014257|NCT01402375|Codeine|codeine|mesh-list
56014258|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56014259|NCT01402375|Analgesics|analgesics|mesh-ancestor
56014260|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
56014261|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014262|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014263|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
56014264|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56014265|NCT01402375|Narcotics|narcotics|mesh-ancestor
56014266|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014267|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
56014268|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
56014269|NCT01302379|Metformin|metformin|mesh-list
56014270|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741411|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56014272|NCT01351753|Metformin|metformin|mesh-list
56014311|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
56014312|NCT00047060|Cyclosporine|cyclosporine|mesh-list
56014313|NCT00047060|Fludarabine|fludarabine|mesh-list
56014314|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
56014315|NCT00047060|Cyclosporins|cyclosporins|mesh-list
56014316|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014317|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014318|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014319|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
56014320|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014321|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014322|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
56014323|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014324|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
55721741|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56014325|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014326|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56014327|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56014328|NCT01304407|Calcium|calcium|mesh-list
56014329|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56014330|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014331|NCT00106106|Acamprosate|acamprosate|mesh-list
56014332|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56014333|NCT01304641|Atorvastatin|atorvastatin|mesh-list
56014360|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56014361|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
56014362|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014363|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56014364|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014365|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144662|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144663|NCT00804648|Timolol|timolol|mesh-list
56144664|NCT00804648|Maleic acid|maleic acid|mesh-list
56144665|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144666|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144667|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56144668|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56144669|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
56144670|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144671|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144672|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56144673|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56144674|NCT00806598|Cyclosporine|cyclosporine|mesh-list
56144675|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
56144676|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56144677|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56144678|NCT00806598|Prednisolone|prednisolone|mesh-list
56144679|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
56144680|NCT00806598|Cyclosporins|cyclosporins|mesh-list
56144681|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
56144682|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56144683|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56144684|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
56144685|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144699|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56144700|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
56144701|NCT00806598|Hormones|hormones|mesh-ancestor
56144702|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144703|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56144704|NCT00806598|Protective Agents|protective agents|mesh-ancestor
56144705|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56144706|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144707|NCT00807768|Paclitaxel|paclitaxel|mesh-list
56144708|NCT00807768|Carboplatin|carboplatin|mesh-list
56144709|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56144710|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56144711|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144712|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
56144713|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
56144714|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
56144715|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144716|NCT00808470|Beta Carotene|beta carotene|mesh-list
56144717|NCT00808470|Carotenoids|carotenoids|mesh-list
56144718|NCT00808470|Vitamins|vitamins|mesh-ancestor
56144719|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
56144720|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014367|NCT01410409|Pantoprazole|pantoprazole|mesh-list
56014368|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56014369|NCT01410409|Analgesics|analgesics|mesh-ancestor
56014370|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
56014371|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014372|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014373|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
56014374|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56014391|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014393|NCT01411501|Citric Acid|citric acid|mesh-list
56014394|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
56014395|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
56014396|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56014397|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
56014398|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
56014399|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014400|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56014401|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56014402|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
56014403|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014404|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014405|NCT01310179|Fludarabine|fludarabine|mesh-list
56014406|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
56014407|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014408|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56014409|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
56014410|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014411|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014412|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
56014413|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014414|NCT01412281|Vaccines|vaccines|mesh-list
56014415|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
56014416|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014417|NCT01359007|Leucovorin|leucovorin|mesh-list
56014418|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
56014419|NCT01359007|Irinotecan|irinotecan|mesh-list
56014420|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014421|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56014422|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56014423|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014424|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014425|NCT01359007|Antidotes|antidotes|mesh-ancestor
56014432|NCT01414153|Ranibizumab|ranibizumab|mesh-list
56014433|NCT01414153|Aflibercept|aflibercept|mesh-list
56014434|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56014435|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56014436|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014437|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56014438|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56014439|NCT01414153|Growth Substances|growth substances|mesh-ancestor
56014440|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014441|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
56014442|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
56014444|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56014445|NCT01311895|Narcotics|narcotics|mesh-ancestor
56014446|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014447|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014448|NCT01311895|Analgesics|analgesics|mesh-ancestor
56014494|NCT01363843|Antidotes|antidotes|mesh-ancestor
56014495|NCT01363843|Protective Agents|protective agents|mesh-ancestor
56014496|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014497|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
56014498|NCT01363843|Vitamins|vitamins|mesh-ancestor
56014499|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
56014500|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
56014501|NCT02092298|Cisplatin|cisplatin|mesh-list
56014502|NCT02092298|Mitomycins|mitomycins|mesh-list
56014503|NCT02092298|Mitomycin|mitomycin|mesh-list
56014504|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721791|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014505|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56014506|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
56014507|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014508|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56014509|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014510|NCT02092298|Antidotes|antidotes|mesh-ancestor
56014511|NCT02092298|Protective Agents|protective agents|mesh-ancestor
56014512|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014514|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
56014515|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56014516|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741713|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
56014517|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
56014518|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
56014544|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56014545|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
56014546|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014547|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56014548|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56014549|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014550|NCT00257894|Baclofen|baclofen|mesh-list
56014551|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014552|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56014553|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56014554|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014555|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56014556|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
56014557|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
56014558|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014559|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014560|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56014561|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56014562|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56014563|NCT00258128|Analgesics|analgesics|mesh-ancestor
56014564|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
56014565|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014566|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014567|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56014568|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014569|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
56014570|NCT01364623|Testosterone|testosterone|mesh-list
56014571|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
56014589|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014590|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014591|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56014592|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56014593|NCT01063907|Bortezomib|bortezomib|mesh-list
56014594|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014595|NCT01316263|Olaratumab|olaratumab|mesh-list
56014596|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014597|NCT03015857|Phenylephrine|phenylephrine|mesh-list
56014598|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
56014599|NCT03015857|Norepinephrine|norepinephrine|mesh-list
56014600|NCT03015857|Fentanyl|fentanyl|mesh-list
56014601|NCT03015857|Bupivacaine|bupivacaine|mesh-list
56014602|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
56014603|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
56014604|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014605|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014606|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
55760010|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
56014626|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014627|NCT03015857|Protective Agents|protective agents|mesh-ancestor
56014628|NCT03295487|Estrogens|estrogens|mesh-list
56014629|NCT03295487|Hormones|hormones|mesh-ancestor
56014630|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56014631|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014632|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
56014633|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56014634|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014635|NCT03015701|Mifepristone|mifepristone|mesh-list
56014636|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56014637|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
56014638|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56014639|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014640|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56014641|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56014642|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56014643|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
56014644|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56014657|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
56014658|NCT04780061|Vitamins|vitamins|mesh-list
56014659|NCT04780061|Vitamin K|vitamin k|mesh-list
56014660|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
56014661|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
56014662|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014663|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56014664|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56014665|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014666|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56014667|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56014668|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
56014669|NCT04780061|Coagulants|coagulants|mesh-ancestor
56014670|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56014671|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
56014672|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56014673|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56014674|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56014675|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014676|NCT02973737|Capecitabine|capecitabine|mesh-list
56014677|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56014678|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
56014679|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014680|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014681|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
56014682|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56014683|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014684|NCT02762669|Oxytocin|oxytocin|mesh-list
56014685|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
56014686|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56014687|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014688|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
56014689|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55760011|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
56014690|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56014691|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014692|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56014694|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
56014695|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56014696|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56014697|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56014698|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56014699|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
56014700|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014701|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014702|NCT01076231|Etoposide|etoposide|mesh-list
56014703|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
56014704|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
56014705|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014706|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56014707|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56014708|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56014709|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014710|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014711|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
56014750|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014751|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56014752|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56014753|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014754|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014755|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56014756|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
56014757|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56014758|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014759|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56014760|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56014761|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56014762|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
56014763|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56014764|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56014765|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
56014766|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56014767|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56014768|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
56014769|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56014770|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56014771|NCT00118352|Cyclosporine|cyclosporine|mesh-list
56014800|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
56014801|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56014802|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014803|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56014804|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014805|NCT00167102|Alefacept|alefacept|mesh-list
56014806|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
56014807|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
56014808|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014809|NCT01859819|Cytarabine|cytarabine|mesh-list
56014810|NCT01859819|Rituximab|rituximab|mesh-list
56014811|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56014812|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014813|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
56014814|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014815|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014816|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56014817|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
56014818|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014819|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
56014820|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014821|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014822|NCT01795313|Imiquimod|imiquimod|mesh-list
56014823|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56014824|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
56014825|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014826|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014827|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
56014846|NCT02176031|Protective Agents|protective agents|mesh-ancestor
56014847|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56014848|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014849|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
56014850|NCT03013361|Bupivacaine|bupivacaine|mesh-list
56014851|NCT03013361|Ropivacaine|ropivacaine|mesh-list
56014852|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
56014853|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
56014914|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56014915|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
56014916|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014917|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56014918|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014919|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014920|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
56014921|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56014922|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
56014980|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
56014981|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
56014982|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
56014983|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014984|NCT00258830|Vaccines|vaccines|mesh-list
56014985|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
56014986|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56014987|NCT02539368|Infliximab|infliximab|mesh-list
56014988|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
56014989|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56014990|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56014991|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
56014992|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56014993|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
56014994|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56014995|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56014996|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56014997|NCT01035749|Vaccines|vaccines|mesh-list
56014998|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
56014999|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015000|NCT00123110|Metformin|metformin|mesh-list
56015001|NCT00123110|Leuprolide|leuprolide|mesh-list
56015005|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
56015033|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015034|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56015035|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015036|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
56015037|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56015038|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56015039|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56015040|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56015041|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015042|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
56015043|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015044|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015045|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56015046|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015047|NCT01427881|Cyclosporine|cyclosporine|mesh-list
56015048|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
56015050|NCT01427881|Fludarabine|fludarabine|mesh-list
56015051|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
56015052|NCT01427881|Cyclosporins|cyclosporins|mesh-list
56015053|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015054|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
56015055|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015056|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015057|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56015058|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
56015059|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015060|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015061|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56015062|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56015063|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
56015064|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015065|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
56015066|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015069|NCT02112734|Vitamin D|vitamin d|mesh-list
56015073|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
56015074|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015075|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56015076|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56015077|NCT01319773|Cyclosporine|cyclosporine|mesh-list
56015078|NCT01319773|Cyclosporins|cyclosporins|mesh-list
56015079|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015080|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015081|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015082|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
56015083|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015084|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
56015085|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015086|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015087|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015088|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56015089|NCT01319851|Alefacept|alefacept|mesh-list
56015090|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015091|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
56015092|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015093|NCT04351867|Docetaxel|docetaxel|mesh-list
56015094|NCT04351867|Capecitabine|capecitabine|mesh-list
56015095|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
56015096|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015097|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
56015098|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
56015099|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
56015100|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015101|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56015102|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
56015103|NCT00262730|Temozolomide|temozolomide|mesh-list
56015104|NCT00262730|Poly ICLC|poly iclc|mesh-list
56015105|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56015106|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
56015107|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015108|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015109|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
56015110|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
56015111|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015112|NCT04262934|Vitamin D|vitamin d|mesh-list
56015113|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
56015114|NCT04262934|Vitamins|vitamins|mesh-ancestor
56015115|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
56015116|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015117|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56015118|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56015119|NCT00262964|Niacin|niacin|mesh-list
56015120|NCT00262964|Fenofibrate|fenofibrate|mesh-list
56015121|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56015122|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
56015123|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015124|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56015125|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
56015126|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
56015127|NCT00262964|Vitamins|vitamins|mesh-ancestor
56015128|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
56015129|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015130|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
56015131|NCT05449392|Petrolatum|petrolatum|mesh-list
56015132|NCT05449392|Emollients|emollients|mesh-ancestor
56015133|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015134|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55721893|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015135|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015136|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56015137|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56015138|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
56015139|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56015140|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
56015151|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
56015152|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56015153|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015154|NCT01322815|Leucovorin|leucovorin|mesh-list
56015155|NCT01322815|Fluorouracil|fluorouracil|mesh-list
56015156|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
56015157|NCT01322815|Irinotecan|irinotecan|mesh-list
56015158|NCT01322815|Bevacizumab|bevacizumab|mesh-list
56015159|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
56015160|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
56015161|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015162|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56015163|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015164|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015165|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
56015166|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015167|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56015168|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56015169|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015170|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56015171|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56015172|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56015173|NCT01322815|Growth Substances|growth substances|mesh-ancestor
56015174|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
56015175|NCT01322815|Antidotes|antidotes|mesh-ancestor
56015176|NCT01322815|Protective Agents|protective agents|mesh-ancestor
56015177|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
56015178|NCT01322815|Vitamins|vitamins|mesh-ancestor
56015200|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015201|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015202|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015203|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56015204|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56015205|NCT01429987|Plecanatide|plecanatide|mesh-list
56015206|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56015207|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
56015208|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015209|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56015210|NCT00265616|Pentobarbital|pentobarbital|mesh-list
56015211|NCT00265616|Thiopental|thiopental|mesh-list
56015212|NCT00265616|Propofol|propofol|mesh-list
56015213|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56015214|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56015215|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015216|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55721931|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56015217|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
56015218|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
56015219|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
56015220|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
56015221|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
56015222|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015223|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015224|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56015225|NCT00176852|Vidarabine|vidarabine|mesh-list
56015226|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
56015227|NCT00176852|Busulfan|busulfan|mesh-list
56015228|NCT00176852|Fludarabine|fludarabine|mesh-list
56015229|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
56015230|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
56015231|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56015232|NCT00176852|Lenograstim|lenograstim|mesh-list
56015233|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015234|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
56015235|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015236|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015237|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56015238|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
56015239|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015240|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015241|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56015242|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56015243|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
56015244|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
56015245|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015246|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56015247|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56015248|NCT01323517|Dactinomycin|dactinomycin|mesh-list
56015249|NCT01323517|Ipilimumab|ipilimumab|mesh-list
56015250|NCT01323517|Melphalan|melphalan|mesh-list
56015251|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56015252|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015253|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56015254|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015255|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56015256|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
56015257|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56015258|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015259|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
56015260|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015262|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015263|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56015264|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56015267|NCT01323595|Celecoxib|celecoxib|mesh-list
56015280|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56015281|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56015282|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015283|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56015284|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015285|NCT01431391|Leuprolide|leuprolide|mesh-list
56015286|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56015287|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
56015288|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56015289|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015290|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015291|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015292|NCT03009097|Atorvastatin|atorvastatin|mesh-list
56015293|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56015294|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56015295|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
56015296|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015297|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56015298|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56015299|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015300|NCT01325311|Vitamin D|vitamin d|mesh-list
56015301|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
56015302|NCT01325311|Genistein|genistein|mesh-list
56015303|NCT01325311|Vitamins|vitamins|mesh-ancestor
56015304|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
56015305|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015306|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56015307|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56015308|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56015309|NCT01325311|Protective Agents|protective agents|mesh-ancestor
56015310|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015319|NCT01432015|Aprepitant|aprepitant|mesh-list
56015320|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
56015321|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
56015322|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
56015323|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015324|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015325|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56015326|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56015327|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015328|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015329|NCT01080677|Propranolol|propranolol|mesh-list
56015330|NCT01080677|Caffeine|caffeine|mesh-list
56015331|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56015332|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015333|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56015347|NCT01378273|Hematinics|hematinics|mesh-ancestor
56015380|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015381|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
56015382|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015383|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015384|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56015385|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
55721988|NCT00911963|Ribavirin|ribavirin|mesh-list
56015386|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015387|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015388|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56015389|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56015390|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56015391|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
56015392|NCT01381471|Fluticasone|fluticasone|mesh-list
56015393|NCT01381471|Xhance|xhance|mesh-list
56015394|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56015395|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015396|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56015397|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
56015398|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015399|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015400|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56015401|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
56015402|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015403|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56015404|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56015405|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56015406|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56015408|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015409|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015410|NCT02941926|Letrozole|letrozole|mesh-list
56015411|NCT02941926|Leuprolide|leuprolide|mesh-list
56015412|NCT02941926|Goserelin|goserelin|mesh-list
56015420|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015421|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015422|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56015423|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
56015424|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56015425|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015426|NCT05422092|Pioglitazone|pioglitazone|mesh-list
56015427|NCT05422092|Canagliflozin|canagliflozin|mesh-list
56015428|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56015429|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015430|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56015431|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015432|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
56015433|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56015434|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56015435|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015436|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
56015437|NCT05448456|Coagulants|coagulants|mesh-ancestor
56015438|NCT05448378|Inositol|inositol|mesh-list
56015439|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
56015473|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015474|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
56015475|NCT01118273|Promethazine|promethazine|mesh-list
56015476|NCT01118273|Ibuprofen|ibuprofen|mesh-list
56015477|NCT01118273|Naproxen|naproxen|mesh-list
56015478|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015479|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56015480|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56015481|NCT01118273|Analgesics|analgesics|mesh-ancestor
56015482|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
56015483|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015484|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015485|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015486|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015487|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56015488|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015489|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
56015490|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56015491|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56015529|NCT01439815|Xhance|xhance|mesh-list
56015530|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015531|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56015532|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
56015533|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015534|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015535|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56015536|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
56015537|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56015538|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56015539|NCT01332253|Ibuprofen|ibuprofen|mesh-list
56015540|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56015541|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56015542|NCT01332253|Analgesics|analgesics|mesh-ancestor
56015543|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
56015544|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015545|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015546|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015547|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015548|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56015549|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015550|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015551|NCT01332721|Bevacizumab|bevacizumab|mesh-list
56015552|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56015553|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015554|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56015555|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56015556|NCT01332721|Growth Substances|growth substances|mesh-ancestor
56015557|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015558|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
56015559|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
56015571|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56015573|NCT01384591|Protective Agents|protective agents|mesh-ancestor
56015574|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015575|NCT01384591|Antidotes|antidotes|mesh-ancestor
56015576|NCT01086605|Pixantrone|pixantrone|mesh-list
56015577|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56015578|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56015579|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015580|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015581|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015583|NCT00265850|Folic Acid|folic acid|mesh-list
56015584|NCT00265850|Bevacizumab|bevacizumab|mesh-list
56015585|NCT00265850|Cetuximab|cetuximab|mesh-list
56015586|NCT00265850|Fluorouracil|fluorouracil|mesh-list
56015587|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
56015588|NCT00265850|Irinotecan|irinotecan|mesh-list
56015589|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
56015590|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56015591|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015592|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56015593|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56015594|NCT00265850|Growth Substances|growth substances|mesh-ancestor
56015595|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015596|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
56015597|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
56015598|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015599|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56015600|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015601|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
56015602|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56015603|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56015604|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015605|NCT00265850|Antidotes|antidotes|mesh-ancestor
56015606|NCT00265850|Protective Agents|protective agents|mesh-ancestor
56015607|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
56015608|NCT00265850|Vitamins|vitamins|mesh-ancestor
56015609|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
56015611|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56015612|NCT00125372|Bexarotene|bexarotene|mesh-list
56015613|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015614|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56015615|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015616|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015617|NCT00125528|Cycloserine|cycloserine|mesh-list
56015618|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56015619|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015620|NCT00125528|Renal Agents|renal agents|mesh-ancestor
56015621|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56015622|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
56015623|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56015624|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
56015625|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015626|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
56015627|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
56015628|NCT01390909|Lactitol|lactitol|mesh-list
56015629|NCT01390909|Cathartics|cathartics|mesh-ancestor
56015630|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56015631|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015632|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56015633|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56015634|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56015635|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56015636|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56015657|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
56015658|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
56015659|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56015660|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015661|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
56015662|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015663|NCT01336933|Prednisone|prednisone|mesh-list
56015664|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
56015665|NCT01336933|Etoposide|etoposide|mesh-list
56015666|NCT01336933|Vincristine|vincristine|mesh-list
56015667|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
56015668|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015669|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
56015670|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015671|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015672|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56015673|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
56015674|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015675|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015676|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56015677|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015678|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
56015679|NCT01336933|Hormones|hormones|mesh-ancestor
56015680|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56015681|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015682|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56015683|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56015684|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56015685|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015686|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
56015687|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
56015688|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
56015689|NCT03009409|Ketamine|ketamine|mesh-list
56015690|NCT03009409|Analgesics|analgesics|mesh-ancestor
56015698|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56015699|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56015700|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56015701|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015702|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015703|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
56015704|NCT00176930|Busulfan|busulfan|mesh-list
56015705|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56015706|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
56015707|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015708|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56015709|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56015710|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
56015711|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015712|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015713|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56015714|NCT01473745|Daminozide|daminozide|mesh-list
56015715|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
56015716|NCT01473745|Growth Substances|growth substances|mesh-ancestor
56015717|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015718|NCT00178178|Bupivacaine|bupivacaine|mesh-list
56015719|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
56015720|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
56015721|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56015722|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015723|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
56015724|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015725|NCT01441843|Lorazepam|lorazepam|mesh-list
56015726|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
56015727|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
56015728|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
56015729|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015730|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015731|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56015737|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
56015738|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
56015739|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015740|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015741|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
56015742|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56015743|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56015744|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56015745|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56015746|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015747|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
56015748|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015749|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015750|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56015751|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015752|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
56015753|NCT01089569|Exenatide|exenatide|mesh-list
56015754|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56015755|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015756|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56015757|NCT01089569|Incretins|incretins|mesh-ancestor
56015789|NCT00128180|Protective Agents|protective agents|mesh-ancestor
56015790|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015791|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015792|NCT01121939|Bevacizumab|bevacizumab|mesh-list
56015793|NCT01121939|Pertuzumab|pertuzumab|mesh-list
56015794|NCT01121939|Octreotide|octreotide|mesh-list
56015795|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56015796|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015797|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56015798|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56015799|NCT01121939|Growth Substances|growth substances|mesh-ancestor
56015800|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015801|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
56015802|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742989|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
56015803|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56015804|NCT03013751|Udenafil|udenafil|mesh-list
56015805|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56015806|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56015807|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015808|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015842|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56015843|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015844|NCT00182000|Renal Agents|renal agents|mesh-ancestor
56015845|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56015846|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
56015847|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56015848|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
56015849|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015850|NCT01092923|Sevoflurane|sevoflurane|mesh-list
56015851|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55739220|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015903|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56015904|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56015905|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
56015906|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
56015907|NCT00183092|Quinacrine|quinacrine|mesh-list
56015908|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
56015909|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56015910|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
56015911|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56015912|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015913|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
56015914|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56015915|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
56015916|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015917|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015918|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015920|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722423|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56015921|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56015922|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56015923|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015924|NCT00183794|Gemcitabine|gemcitabine|mesh-list
56015925|NCT00183794|Docetaxel|docetaxel|mesh-list
55739222|NCT05161429|Insulin|insulin|mesh-list
56015955|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56015956|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56015957|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56015958|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
56015959|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56015960|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56015962|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56015963|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
56015964|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56015965|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56015966|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56015967|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56015968|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
56015969|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56015970|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56015971|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
56015972|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56015973|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56015974|NCT01048697|Ethambutol|ethambutol|mesh-list
56015975|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
56015976|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56015977|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56015978|NCT01049243|Fluocinonide|fluocinonide|mesh-list
56015979|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56015980|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
56015981|NCT01049243|Hormones|hormones|mesh-ancestor
56015983|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016000|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
56016001|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016002|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
56016003|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016004|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56016005|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56016006|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56016007|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016009|NCT01094717|Acitretin|acitretin|mesh-list
56016010|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
56016011|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
55722461|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
56016012|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56016013|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56016014|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016015|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
56016016|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016017|NCT01095887|Eculizumab|eculizumab|mesh-list
56016018|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56016019|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016020|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
56016021|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016022|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56016023|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56016024|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016025|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016026|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
55743216|NCT03083067|Budesonide|budesonide|mesh-list
56016044|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016045|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56016046|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56016047|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
56016048|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
56016049|NCT01100255|Ketamine|ketamine|mesh-list
56016050|NCT01100255|Analgesics|analgesics|mesh-ancestor
56016051|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
56016052|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016053|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016054|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56016055|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56016056|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
56016057|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
56016058|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016059|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56016060|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56016061|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016062|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016063|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
56016064|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56016065|NCT03012347|Protective Agents|protective agents|mesh-ancestor
56016066|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016067|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
56016068|NCT01100723|Vitamin D|vitamin d|mesh-list
56016069|NCT01100723|Calcitriol|calcitriol|mesh-list
55739225|NCT03984045|Lidocaine|lidocaine|mesh-list
56016070|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56016071|NCT01100723|Cinacalcet|cinacalcet|mesh-list
56016089|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016090|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56016091|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56016092|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
56016093|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56016094|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56016095|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
56016096|NCT04352621|Ketamine|ketamine|mesh-list
56016097|NCT04352621|Analgesics|analgesics|mesh-ancestor
55722516|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56016098|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
56016099|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016100|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016101|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56016102|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56016103|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
56016104|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
56016105|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016106|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56016146|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56016147|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56016148|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56016149|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
56016150|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56016151|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56016152|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
56016153|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016154|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
56016155|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56016156|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56016157|NCT00186446|Bupropion|bupropion|mesh-list
56016158|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56016159|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
56016160|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56016161|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56016162|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56016163|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016164|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016165|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
56016166|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016167|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016168|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56016192|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56016193|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56016194|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56016195|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016196|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016197|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56016198|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56016199|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56016200|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56016202|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
56016203|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016204|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
56016205|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
56016206|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
56016207|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016208|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56016209|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56016210|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56016211|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55760012|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
55722591|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
56016212|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016213|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016214|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016215|NCT04751318|Analgesics|analgesics|mesh-ancestor
56016216|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
56016217|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016218|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
56016221|NCT01107665|Paclitaxel|paclitaxel|mesh-list
56016235|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56016236|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
56016237|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016238|NCT01447225|Antiviral Agents|antiviral agents|mesh-ancestor
56016239|NCT01447225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016240|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016241|NCT01447225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016242|NCT01447225|Immunologic Factors|immunologic factors|mesh-ancestor
56016243|NCT01447225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016244|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56016245|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56016247|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56016248|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016249|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016250|NCT00277394|Heparin|heparin|mesh-list
56016251|NCT00277394|Tinzaparin|tinzaparin|mesh-list
56016252|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
56016253|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56016254|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56016255|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016256|NCT01450189|Tenofovir|tenofovir|mesh-list
56016257|NCT01450189|Emtricitabine|emtricitabine|mesh-list
56016258|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
56016259|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56016260|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
56016261|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016266|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56016280|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56016281|NCT01474213|Analgesics|analgesics|mesh-ancestor
56016282|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
56016283|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016284|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56016285|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56016286|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56016287|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
56016288|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016289|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016290|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56016292|NCT00147212|Trabectedin|trabectedin|mesh-list
56016293|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56016294|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
56016295|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016296|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016297|NCT01474915|Promethazine|promethazine|mesh-list
56016298|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
56016299|NCT01474915|Dexamethasone|dexamethasone|mesh-list
56016300|NCT01474915|Ondansetron|ondansetron|mesh-list
56016301|NCT01474915|Aprepitant|aprepitant|mesh-list
56016302|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56016303|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
56016304|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
56016305|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016306|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016307|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56016308|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
56016309|NCT01474915|Hormones|hormones|mesh-ancestor
56016326|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
56016327|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
56016328|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56016329|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56016330|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55722650|NCT00851045|Protective Agents|protective agents|mesh-ancestor
56016331|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
56016332|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
56016333|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
56016334|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
56016335|NCT01899794|Oxybutynin|oxybutynin|mesh-list
56016336|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
56016337|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
56016338|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016339|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016340|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56016341|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56016342|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
56016343|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016344|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016345|NCT01899794|Urological Agents|urological agents|mesh-ancestor
56016346|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56016347|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016348|NCT01899794|Renal Agents|renal agents|mesh-ancestor
56016377|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56016378|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56016379|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56016380|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
56016381|NCT00201734|Paclitaxel|paclitaxel|mesh-list
56016382|NCT00201734|Carboplatin|carboplatin|mesh-list
56016383|NCT00201734|Capecitabine|capecitabine|mesh-list
56016384|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56016385|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016386|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
56016387|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
56016388|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
56016389|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016390|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56016391|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
56016392|NCT00203216|Levetiracetam|levetiracetam|mesh-list
56016394|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
56016396|NCT05156060|Gabapentin|gabapentin|mesh-list
56016397|NCT05156060|Analgesics|analgesics|mesh-ancestor
56016398|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
56016399|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016400|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016401|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56016402|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56016403|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
56016404|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
56016405|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016406|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56016407|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56016408|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016409|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016410|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
56016411|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56016420|NCT00210470|Indomethacin|indomethacin|mesh-list
56016421|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
56016422|NCT00210470|Omeprazole|omeprazole|mesh-list
56016423|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016424|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
56016425|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016426|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56016427|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56016428|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
56016429|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722686|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
56016430|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016431|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56016432|NCT00210470|Trace Elements|trace elements|mesh-ancestor
56016433|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
56016434|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56016435|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56016436|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56016437|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016438|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56016439|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56016440|NCT00210470|Analgesics|analgesics|mesh-ancestor
56016441|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
56016442|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016443|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56016444|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
56016445|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
56016446|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56016447|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56016467|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56016468|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56016469|NCT04352153|Febuxostat|febuxostat|mesh-list
56016470|NCT04352153|Citric Acid|citric acid|mesh-list
56016471|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
55722714|NCT03140397|Hormones|hormones|mesh-ancestor
56016472|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56016473|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
56016474|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
56016475|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016476|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
56016477|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56016478|NCT05215067|Docetaxel|docetaxel|mesh-list
55722762|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
56016479|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016530|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016531|NCT04087460|Vaccines|vaccines|mesh-list
56016532|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56016533|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
56016534|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016536|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56016537|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56016538|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56016598|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016599|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016600|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56016601|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016602|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56016603|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56016604|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016605|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56016606|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56016607|NCT00290654|Tamoxifen|tamoxifen|mesh-list
56016608|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56016609|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
56016610|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016611|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016612|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56016613|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016614|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56016615|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56016616|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56016617|NCT00290810|Bevacizumab|bevacizumab|mesh-list
56016618|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56016619|NCT00290810|Antibodies|antibodies|mesh-list
55743817|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56016620|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
56016621|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56016622|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016623|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56016624|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56016631|NCT04042142|Hormones|hormones|mesh-ancestor
56016640|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56016641|NCT00293540|Tamoxifen|tamoxifen|mesh-list
56016642|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56016643|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
56016644|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016645|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016646|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56016647|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016648|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56016649|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56016650|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56016651|NCT03012113|Mirabegron|mirabegron|mesh-list
56016652|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56016653|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56016654|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56016655|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
56016656|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016657|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016658|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016659|NCT03012113|Urological Agents|urological agents|mesh-ancestor
56016661|NCT01139801|Oxytocin|oxytocin|mesh-list
56016662|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
56016663|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56016664|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016689|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56016690|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56016691|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
56016692|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016701|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722946|NCT00834977|Amlodipine|amlodipine|mesh-list
56016702|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016703|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56016704|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56016712|NCT01141049|Gabapentin|gabapentin|mesh-list
56016713|NCT01141049|Analgesics|analgesics|mesh-ancestor
56016714|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
56016715|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56016716|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016717|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
56016718|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56016719|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56016720|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016721|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56016722|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56016723|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56016724|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016726|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
56016727|NCT01141595|Verapamil|verapamil|mesh-list
56016728|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56016729|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56016730|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016731|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016732|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56016733|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016734|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
56016735|NCT04391309|Remdesivir|remdesivir|mesh-list
56016736|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
56016737|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016738|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
56016739|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016740|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
56016741|NCT01167569|Vitamins|vitamins|mesh-ancestor
56016742|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
56016743|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016744|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
56016745|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016781|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016783|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56016784|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56016785|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
56016786|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016787|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016788|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56016789|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56016790|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56016791|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
56016792|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56016793|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56016794|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016795|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56016796|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56016797|NCT01144949|Silodosin|silodosin|mesh-list
56016798|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56016799|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56016800|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56016801|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
56016802|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016803|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016804|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016805|NCT01144949|Urological Agents|urological agents|mesh-ancestor
56016806|NCT00215930|Gemcitabine|gemcitabine|mesh-list
56016807|NCT00215930|Carboplatin|carboplatin|mesh-list
56016808|NCT00215930|Docetaxel|docetaxel|mesh-list
56016809|NCT00215930|Vinorelbine|vinorelbine|mesh-list
56016810|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760093|NCT03043677|Vedolizumab|vedolizumab|mesh-list
56016811|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56016812|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
56016814|NCT00215930|Antiviral Agents|antiviral agents|mesh-ancestor
56016820|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
56016821|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
56016822|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
56016823|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56016824|NCT01145183|Doxazosin|doxazosin|mesh-list
56016825|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56016826|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56016827|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56016828|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56016829|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
56016830|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016831|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016832|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016833|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56016834|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016835|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56016836|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016837|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016838|NCT04128722|Sirolimus|sirolimus|mesh-list
56016839|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56016840|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56016841|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56016842|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016843|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
56016844|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56016868|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56016869|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016870|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016871|NCT01147601|Timolol|timolol|mesh-list
56016872|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56016873|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56016874|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
56016875|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016876|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016877|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016878|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56016879|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56016880|NCT03011645|Ziprasidone|ziprasidone|mesh-list
56016881|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56016882|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
56016883|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016884|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016885|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016886|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56016887|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56016888|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56016919|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56016920|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56016921|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016922|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016923|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
56016924|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
56016926|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56016927|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56016928|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56016929|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56016930|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56016931|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016932|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
56016933|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016934|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
56016935|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016936|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56016937|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
56016938|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016939|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56016940|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
56016941|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56016942|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56016943|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56016945|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56016946|NCT01151813|Varenicline|varenicline|mesh-list
56016947|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56016948|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56016949|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
56016950|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016951|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016952|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016953|NCT03877991|Cannabidiol|cannabidiol|mesh-list
56016959|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56016960|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56016961|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56016962|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016963|NCT03660683|Incretins|incretins|mesh-ancestor
56016964|NCT03660683|Hormones|hormones|mesh-ancestor
56016965|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56016966|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56016967|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
56016968|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56016969|NCT01177709|Metformin|metformin|mesh-list
56016970|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56016971|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56016972|NCT01179113|Esmolol|esmolol|mesh-list
56016973|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56016974|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56016975|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56016976|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
56016977|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56016978|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017007|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56017008|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017009|NCT03418805|Analgesics|analgesics|mesh-ancestor
56017010|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
56017011|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017012|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017013|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017014|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017015|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56017016|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017017|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017018|NCT01156571|Clopidogrel|clopidogrel|mesh-list
56017019|NCT01156571|Cangrelor|cangrelor|mesh-list
56017028|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
56017066|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56017067|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56017068|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
56017069|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
56017070|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017071|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56017072|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56017073|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017074|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017075|NCT01602666|Carboplatin|carboplatin|mesh-list
56017076|NCT01602666|Etoposide|etoposide|mesh-list
56017077|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
56017078|NCT01602666|Ifosfamide|ifosfamide|mesh-list
56017079|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
56017080|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
56017081|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017082|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56017083|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55760263|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
56017084|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56017085|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017086|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017087|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56017088|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
56017089|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
56017090|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
56017091|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
56017092|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
56017093|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
56017094|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56017095|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017096|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56017097|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017098|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017099|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
56017100|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56017101|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56017103|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
56017104|NCT05441592|Coagulants|coagulants|mesh-ancestor
56017106|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
56017107|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017108|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56017109|NCT00300482|Calcium|calcium|mesh-list
56017110|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56017111|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017112|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56017113|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56017114|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
56017165|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017167|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56017168|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56017169|NCT01896284|Growth Substances|growth substances|mesh-ancestor
56017170|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017171|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
56017172|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017173|NCT05438160|Coal Tar|coal tar|mesh-list
56017174|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
56017175|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
56017176|NCT03954990|Metronidazole|metronidazole|mesh-list
56017177|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017178|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56017179|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56017180|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56017181|NCT01478581|Dexamethasone|dexamethasone|mesh-list
56017182|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017183|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
56017184|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
56017185|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017186|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017187|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56017188|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
56017189|NCT01478581|Hormones|hormones|mesh-ancestor
56017190|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56017191|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56017192|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017193|NCT00239642|Iron|iron|mesh-list
56017194|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56017195|NCT00239642|Trace Elements|trace elements|mesh-ancestor
56017230|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017232|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56017233|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56017234|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
56017235|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
56017236|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
56017237|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017256|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017258|NCT01479127|Levodopa|levodopa|mesh-list
56017259|NCT01479127|Carbidopa|carbidopa|mesh-list
56017260|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56017261|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56017262|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
56017263|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017264|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017265|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017266|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56017267|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017268|NCT01479127|Trace Elements|trace elements|mesh-ancestor
56017269|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
56017270|NCT03917966|Docetaxel|docetaxel|mesh-list
56017271|NCT03917966|Apatinib|apatinib|mesh-list
56017272|NCT03917966|Nedaplatin|nedaplatin|mesh-list
56017273|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017274|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
56017275|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
56017276|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
56017277|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017278|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56017279|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017280|NCT00243152|Lamotrigine|lamotrigine|mesh-list
56017281|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
56017282|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56017283|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56017284|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017285|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56017286|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017287|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56017288|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56017289|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017290|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56017291|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56017292|NCT01453075|Valacyclovir|valacyclovir|mesh-list
56017305|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017307|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017308|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
56017309|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017310|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017311|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
56017312|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56017313|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56017314|NCT00248534|Prednisolone|prednisolone|mesh-list
56017315|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
56017316|NCT00248534|Rituximab|rituximab|mesh-list
56017317|NCT00248534|Temozolomide|temozolomide|mesh-list
56017318|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56017319|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
56017320|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56017321|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017322|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
56017323|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017324|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55723173|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
56017325|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56017326|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
56017327|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017328|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017329|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
56017330|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
56017331|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017332|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56017333|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
56017335|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56017336|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56017337|NCT00248534|Protective Agents|protective agents|mesh-ancestor
56017338|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56017339|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56017340|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56017341|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56017342|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56017392|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56017393|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017394|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017395|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
56017396|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56017397|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56017398|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56017399|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
56017400|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56017401|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56017402|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56017403|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
56017404|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
56017406|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017454|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
56017455|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017456|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017457|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
56017458|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017459|NCT01480219|Voriconazole|voriconazole|mesh-list
56017516|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
56017517|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56017518|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
56017519|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
56017526|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017527|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
56017528|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017529|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
56017530|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017531|NCT01481545|Leucovorin|leucovorin|mesh-list
56017532|NCT01481545|Bevacizumab|bevacizumab|mesh-list
56017533|NCT01481545|Fluorouracil|fluorouracil|mesh-list
56017534|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
56017535|NCT01481545|Raltitrexed|raltitrexed|mesh-list
56017536|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
56017537|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56017538|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017539|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56017540|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56017541|NCT01481545|Growth Substances|growth substances|mesh-ancestor
56017542|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017543|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
56017544|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
56017545|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017546|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56017547|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56017548|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
56017549|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55723189|NCT02273752|Everolimus|everolimus|mesh-list
56017550|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017551|NCT01481545|Antidotes|antidotes|mesh-ancestor
56017552|NCT01481545|Protective Agents|protective agents|mesh-ancestor
56017553|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
56017554|NCT01481545|Vitamins|vitamins|mesh-ancestor
56017555|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
56017556|NCT01482091|Fentanyl|fentanyl|mesh-list
56017561|NCT01482091|Analgesics|analgesics|mesh-ancestor
56017562|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
56017563|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017564|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56017565|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56017566|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
56017567|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
56017568|NCT00327392|Fospropofol|fospropofol|mesh-list
56017569|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56017570|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017571|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017572|NCT03007238|Aldesleukin|aldesleukin|mesh-list
56017573|NCT03007238|Interleukin-2|interleukin-2|mesh-list
56017574|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017575|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017576|NCT03007238|Analgesics|analgesics|mesh-ancestor
56017577|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
56017578|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017579|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017580|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56017581|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56017582|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
56017583|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017584|NCT01791608|Zinc|zinc|mesh-list
56017585|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
56017587|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
56017588|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017589|NCT01791608|Astringents|astringents|mesh-ancestor
56017590|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
56017591|NCT04346030|Triamcinolone|triamcinolone|mesh-list
56017592|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56017593|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56017594|NCT04346030|Lidocaine|lidocaine|mesh-list
56017595|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56017596|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
56017597|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
55828613|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56017598|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017599|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017602|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56017603|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56017604|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56017605|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56017606|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017607|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017608|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
56017609|NCT04346030|Hormones|hormones|mesh-ancestor
56017610|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56017611|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56017612|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
56017613|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017626|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
56017648|NCT02106494|Dexamethasone|dexamethasone|mesh-list
56017649|NCT02106494|Ondansetron|ondansetron|mesh-list
56017650|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
56017651|NCT02106494|Aprepitant|aprepitant|mesh-list
56017652|NCT02106494|Granisetron|granisetron|mesh-list
56017653|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017654|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
56017655|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
56017656|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017657|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017658|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56017659|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
56017660|NCT02106494|Hormones|hormones|mesh-ancestor
56017661|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56017662|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56017663|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017664|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
56017665|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
56017666|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56017668|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017669|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017670|NCT02106494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56017671|NCT02106494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56017672|NCT02106494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017673|NCT02106494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56017674|NCT02106494|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56017675|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56017676|NCT00335504|Sulindac|sulindac|mesh-list
56017677|NCT00335504|Atorvastatin|atorvastatin|mesh-list
56017678|NCT00335504|Calcium|calcium|mesh-list
56017679|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56017680|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017681|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56017682|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56017683|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
56017684|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017685|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56017686|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56017687|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017688|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56017689|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56017691|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
56017692|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017693|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017694|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017695|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017696|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56017697|NCT01183169|Ribavirin|ribavirin|mesh-list
56017698|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56017699|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
56017700|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017701|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
56017702|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017703|NCT01183481|Aprepitant|aprepitant|mesh-list
56017704|NCT01183481|Granisetron|granisetron|mesh-list
56017705|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
56017706|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
56017707|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017708|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017709|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56017710|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56017711|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017712|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017730|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
56017731|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56017732|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017733|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017734|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56017735|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56017736|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017737|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017738|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
56017739|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
56017740|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56017741|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56017742|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56017744|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56017745|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
56017746|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
56017747|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017748|NCT02352948|Gemcitabine|gemcitabine|mesh-list
56017749|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56017751|NCT02352948|Vinorelbine|vinorelbine|mesh-list
56017752|NCT02352948|Tremelimumab|tremelimumab|mesh-list
56017753|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56017754|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56017755|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
56017756|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017757|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017758|NCT02352948|Antiviral Agents|antiviral agents|mesh-ancestor
56017759|NCT02352948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017760|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017761|NCT02352948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56017762|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
56017763|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017764|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56017771|NCT01222091|Remifentanil|remifentanil|mesh-list
56017772|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56017773|NCT01222091|Narcotics|narcotics|mesh-ancestor
56017774|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56017775|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017776|NCT01222091|Analgesics|analgesics|mesh-ancestor
56017777|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
56017778|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017779|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56017780|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56017781|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
56017782|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017783|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017784|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56017785|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56017786|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
56017787|NCT01225055|Teriparatide|teriparatide|mesh-list
56017788|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56017789|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017790|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56017791|NCT01336140|Aminophylline|aminophylline|mesh-list
56017792|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56017793|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
56017794|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017795|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017796|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56017817|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017818|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017819|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56017820|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
56017821|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56017822|NCT01187381|Trastuzumab|trastuzumab|mesh-list
56017823|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56017824|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017825|NCT01225289|Vitamin A|vitamin a|mesh-list
56017826|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
56017827|NCT01225289|Vitamins|vitamins|mesh-ancestor
56017828|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
56017829|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017830|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
56017831|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017832|NCT01225289|Protective Agents|protective agents|mesh-ancestor
56017833|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56017834|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017835|NCT01161563|Leuprolide|leuprolide|mesh-list
56017836|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56017837|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56017838|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
56017839|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56017840|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017841|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56017842|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723262|NCT05648734|Gout Suppressants|gout suppressants|mesh-ancestor
56017843|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
56017847|NCT01189409|Sennosides|sennosides|mesh-list
56017865|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017866|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56017867|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017868|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017869|NCT04352465|Methotrexate|methotrexate|mesh-list
56017870|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56017871|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
56017872|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56017873|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017874|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56017875|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
56017876|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017877|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017878|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
56017879|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017880|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56017881|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56017882|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
56017883|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56017884|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56017885|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
56017886|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56017887|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56017888|NCT00343460|Dexamethasone|dexamethasone|mesh-list
56017889|NCT00343460|Palonosetron|palonosetron|mesh-list
56017890|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56017891|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
56017892|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
56017893|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017909|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017910|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56017912|NCT01192139|Saxagliptin|saxagliptin|mesh-list
56017913|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56017914|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017915|NCT01192139|Incretins|incretins|mesh-ancestor
56017916|NCT01192139|Hormones|hormones|mesh-ancestor
56017917|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56017918|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56017919|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
56017920|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56017921|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017922|NCT04892186|Inositol|inositol|mesh-list
56017923|NCT04892186|Metformin|metformin|mesh-list
56017924|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56017925|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017926|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
56017927|NCT04892186|Vitamins|vitamins|mesh-ancestor
56017928|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
56017929|NCT01229423|Bimatoprost|bimatoprost|mesh-list
55723328|NCT04993352|Antibodies|antibodies|mesh-list
56017930|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56017931|NCT01229891|Vitamin D|vitamin d|mesh-list
56017932|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
56017933|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
56017934|NCT01229891|Vitamins|vitamins|mesh-list
56017935|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
55790533|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56017936|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017937|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56017938|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56017939|NCT01283555|Tenofovir|tenofovir|mesh-list
56017940|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
56017941|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56017942|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56017948|NCT01194089|Nicotine|nicotine|mesh-list
56017951|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017952|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017955|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
56017956|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56017957|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56017958|NCT01650350|Naltrexone|naltrexone|mesh-list
56017959|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56017960|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56017961|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56017962|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
56017963|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56017964|NCT00349388|Mesalamine|mesalamine|mesh-list
56017965|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56018011|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56018012|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
56018013|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018014|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56018015|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018016|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018017|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56018018|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
56018019|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56018020|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018021|NCT00305942|Carboplatin|carboplatin|mesh-list
56018022|NCT00305942|Topotecan|topotecan|mesh-list
56018023|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018024|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56018025|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56018026|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018027|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018028|NCT02527200|Liraglutide|liraglutide|mesh-list
56018029|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56018030|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018031|NCT02527200|Incretins|incretins|mesh-ancestor
56018032|NCT02527200|Hormones|hormones|mesh-ancestor
56018033|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56018034|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
56018035|NCT00352976|Sirolimus|sirolimus|mesh-list
56018036|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
56018037|NCT00352976|Fludarabine|fludarabine|mesh-list
55723371|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018038|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018039|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
56018040|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018041|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56018052|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018053|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
56018054|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56018055|NCT00306488|Antioxidants|antioxidants|mesh-list
56018056|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56018057|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018058|NCT00306488|Protective Agents|protective agents|mesh-ancestor
56018059|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018060|NCT01793636|Everolimus|everolimus|mesh-list
56018061|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018062|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018063|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
56018064|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018065|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
56018066|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56018067|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56018068|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
56018069|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018070|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56018083|NCT00353834|Insulin|insulin|mesh-list
56018109|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018110|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745324|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
56018112|NCT01792388|Vitamins|vitamins|mesh-ancestor
56018113|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
56018114|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018115|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56018116|NCT05395104|Midazolam|midazolam|mesh-list
56018117|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56018118|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56018119|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56018120|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018121|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56018122|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56018123|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56018124|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56018125|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
56018126|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
56018127|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
56018128|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
56018129|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018130|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018131|NCT01793870|Carvedilol|carvedilol|mesh-list
56018132|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56018133|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56018134|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
56018135|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018136|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018137|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018138|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56018139|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
56018140|NCT01793870|Protective Agents|protective agents|mesh-ancestor
56018141|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56018142|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56018147|NCT01793948|Metformin|metformin|mesh-list
56018148|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56018149|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018150|NCT00355394|Metoclopramide|metoclopramide|mesh-list
56018151|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
56018152|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
56018153|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723501|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56018154|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018155|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56018156|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56018157|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56018158|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
56018159|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018160|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018161|NCT00311246|Adalimumab|adalimumab|mesh-list
56018162|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56018163|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56018164|NCT02105324|Pancrelipase|pancrelipase|mesh-list
56018165|NCT02105324|Pancreatin|pancreatin|mesh-list
56018166|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56018167|NCT02105558|Anesthetics|anesthetics|mesh-list
56018168|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56018169|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018170|NCT02106962|Bacitracin|bacitracin|mesh-list
56018171|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
56018172|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55739286|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56018173|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56018174|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018175|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
56018176|NCT02106962|Coagulants|coagulants|mesh-ancestor
56018177|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56018178|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018179|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56018180|NCT00315146|Pioglitazone|pioglitazone|mesh-list
56018181|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56018188|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56018189|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018190|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56018191|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56018192|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018193|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018194|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018195|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56018196|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56018197|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56018198|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56018199|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56018200|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56018202|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56018203|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56018204|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56018205|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
56018255|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
55723557|NCT05010200|Poly ICLC|poly iclc|mesh-list
56018256|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018263|NCT00980460|Sirolimus|sirolimus|mesh-list
56018264|NCT00980460|Cisplatin|cisplatin|mesh-list
56018265|NCT00980460|Doxorubicin|doxorubicin|mesh-list
56018266|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56018267|NCT00980460|Fluorouracil|fluorouracil|mesh-list
56018268|NCT00980460|Irinotecan|irinotecan|mesh-list
56018269|NCT00980460|Vincristine|vincristine|mesh-list
56018270|NCT00980460|Camptothecin|camptothecin|mesh-list
56018271|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
56018272|NCT00980460|Razoxane|razoxane|mesh-list
56018300|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
56018301|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
56018302|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
56018303|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018304|NCT01792934|Bevacizumab|bevacizumab|mesh-list
56018305|NCT01792934|Irinotecan|irinotecan|mesh-list
56018306|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56018307|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018308|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56018309|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56018310|NCT01792934|Growth Substances|growth substances|mesh-ancestor
56018311|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018312|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
56018313|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56018314|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56018315|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018316|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018317|NCT00365144|Bevacizumab|bevacizumab|mesh-list
56018318|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56018319|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56018320|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018321|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56018322|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56018323|NCT00365144|Growth Substances|growth substances|mesh-ancestor
56018324|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018325|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
56018326|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56018327|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018328|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018330|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
56018331|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
56018333|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56018334|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56018335|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018339|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56018340|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56018341|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
55723590|NCT05008484|Vitamin D|vitamin d|mesh-list
56018342|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
56018343|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018344|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56018345|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018346|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018347|NCT03809000|Leuprolide|leuprolide|mesh-list
56018348|NCT03809000|Goserelin|goserelin|mesh-list
56018349|NCT03809000|Bicalutamide|bicalutamide|mesh-list
56018350|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56018351|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018352|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56018353|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
56018354|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56018355|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56018356|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018357|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
56018358|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
56018359|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56018360|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
56018361|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018362|NCT05334654|Enoxaparin|enoxaparin|mesh-list
56018363|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
56018364|NCT05334654|Bivalirudin|bivalirudin|mesh-list
56018365|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
56018366|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56018367|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56018368|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018383|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56018384|NCT00389610|Pancrelipase|pancrelipase|mesh-list
56018385|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56018386|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56018387|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018388|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56018389|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018390|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018391|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56018392|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
56018393|NCT00324272|Coagulants|coagulants|mesh-ancestor
56018394|NCT05367492|Varenicline|varenicline|mesh-list
56018395|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56018396|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56018397|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
56018398|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018399|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018400|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018401|NCT00369590|Aflibercept|aflibercept|mesh-list
56018402|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
56018403|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56018404|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56018435|NCT05366868|Vildagliptin|vildagliptin|mesh-list
56018436|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56018437|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018438|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56018439|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
56018440|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018441|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018443|NCT00369746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56018444|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56018445|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56018446|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018447|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018448|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
56018494|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018495|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56018496|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56018497|NCT00392444|Growth Substances|growth substances|mesh-ancestor
56018498|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018499|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
56018500|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56018501|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018502|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018504|NCT02528214|Prednisolone|prednisolone|mesh-list
56018505|NCT02528214|Albuterol|albuterol|mesh-list
56018506|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56018507|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
56018508|NCT02528214|Hormones|hormones|mesh-ancestor
56018509|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56018510|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018511|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56018512|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018513|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
56018514|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018515|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56018516|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56018517|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
56018518|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
56018519|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56018520|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56018521|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56018522|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56018523|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
56018524|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018538|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018539|NCT00392834|Leucovorin|leucovorin|mesh-list
56018540|NCT00392834|Cytarabine|cytarabine|mesh-list
56018541|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
56018542|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56018543|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56018544|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56018545|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
56018546|NCT00392834|Ifosfamide|ifosfamide|mesh-list
56018547|NCT00392834|Rituximab|rituximab|mesh-list
56018548|NCT00392834|Doxorubicin|doxorubicin|mesh-list
56018549|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56018550|NCT00392834|Methotrexate|methotrexate|mesh-list
56018551|NCT00392834|Etoposide|etoposide|mesh-list
56018552|NCT00392834|Vincristine|vincristine|mesh-list
56018553|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
56018554|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018555|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
56018556|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018557|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56018559|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
56018596|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56018597|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56018598|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56018600|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
56018601|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018602|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018603|NCT00393380|Teriparatide|teriparatide|mesh-list
56018604|NCT00393380|Hormones|hormones|mesh-list
56018605|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
56018606|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56018607|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018608|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56018609|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56018610|NCT05361642|Lidocaine|lidocaine|mesh-list
56018611|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
56018612|NCT05361642|Bupivacaine|bupivacaine|mesh-list
56018613|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
56018614|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
56018615|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56018617|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
56018647|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56018648|NCT05287256|Analgesics|analgesics|mesh-ancestor
56018649|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
56018650|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018651|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56018652|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56018653|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018654|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018655|NCT05287256|Hormones|hormones|mesh-ancestor
56018713|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56018714|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018716|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56018717|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018718|NCT05514990|Dexamethasone|dexamethasone|mesh-list
56018719|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
56018720|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
56018721|NCT05514990|Bortezomib|bortezomib|mesh-list
56018722|NCT05514990|Ichthammol|ichthammol|mesh-list
56018723|NCT05514990|BB 1101|bb 1101|mesh-list
56018724|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56018725|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
56018726|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
56018727|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018728|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018729|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56018730|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
56018731|NCT05514990|Hormones|hormones|mesh-ancestor
56018732|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56018771|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56018772|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56018773|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018774|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56018775|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018776|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56018778|NCT00397904|Irinotecan|irinotecan|mesh-list
56018779|NCT00397904|Cetuximab|cetuximab|mesh-list
56018780|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018781|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56018782|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56018783|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018784|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018785|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56018786|NCT05352516|Denosumab|denosumab|mesh-list
56018787|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56018788|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018789|NCT00398918|Zonisamide|zonisamide|mesh-list
56018790|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
56018791|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56018792|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56018793|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018794|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56018795|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018796|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
55760264|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
56018797|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56018798|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018799|NCT00401414|Warfarin|warfarin|mesh-list
56018800|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
56018801|NCT05314998|Leucovorin|leucovorin|mesh-list
56018802|NCT05314998|Folic Acid|folic acid|mesh-list
56018803|NCT05314998|Gemcitabine|gemcitabine|mesh-list
56018804|NCT05314998|Fluorouracil|fluorouracil|mesh-list
56018805|NCT05314998|Capecitabine|capecitabine|mesh-list
56018806|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
56018813|NCT05314998|Antiviral Agents|antiviral agents|mesh-ancestor
56018814|NCT05314998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018815|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018816|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018817|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
56018818|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018819|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56018820|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56018821|NCT05314998|Antidotes|antidotes|mesh-ancestor
56018822|NCT05314998|Protective Agents|protective agents|mesh-ancestor
56018823|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
56018824|NCT05314998|Vitamins|vitamins|mesh-ancestor
56018825|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
56018826|NCT05314998|Hematinics|hematinics|mesh-ancestor
56018827|NCT00370838|Clonidine|clonidine|mesh-list
56018828|NCT00370838|Levetiracetam|levetiracetam|mesh-list
56018829|NCT00370838|Analgesics|analgesics|mesh-ancestor
56018830|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
56018831|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56018832|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018833|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56018834|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
56018835|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
56018836|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56018837|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56018838|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56018839|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
56018840|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018841|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018842|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
56018843|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
56018844|NCT01795430|Etoposide|etoposide|mesh-list
56018856|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56018857|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
56018858|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56018859|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018860|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
56018861|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018862|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56018864|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018865|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56018871|NCT04750382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56018872|NCT04750382|Immunologic Factors|immunologic factors|mesh-ancestor
56018873|NCT04750382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018874|NCT05347212|Nivolumab|nivolumab|mesh-list
56018875|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56018876|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018877|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56018878|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018879|NCT00401882|Metoprolol|metoprolol|mesh-list
56018880|NCT00401882|Epinephrine|epinephrine|mesh-list
56018881|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56018882|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56018883|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
56018884|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018885|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018889|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
56018899|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56018900|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56018901|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56018902|NCT00373334|Nizatidine|nizatidine|mesh-list
56018903|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56018904|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56018905|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56018906|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
56018907|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
56018908|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018909|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018910|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018911|NCT04749914|Dabigatran|dabigatran|mesh-list
56018912|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56018913|NCT04749914|Lasmiditan|lasmiditan|mesh-list
56018914|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56018915|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56018916|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
56018917|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018918|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56018919|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56018920|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018921|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
56018922|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56018923|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
56018924|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
56018925|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56018926|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
56018927|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56018945|NCT05305404|Hormones|hormones|mesh-ancestor
56018946|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56018947|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56018948|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56018949|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
56018950|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018951|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018952|NCT00402896|Mitogens|mitogens|mesh-list
56018953|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
56018954|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
56018955|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018956|NCT00402896|Growth Substances|growth substances|mesh-ancestor
56018957|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56018958|NCT05268120|Doxycycline|doxycycline|mesh-list
56018959|NCT05268120|Rifampin|rifampin|mesh-list
56018960|NCT05268120|Trimethoprim|trimethoprim|mesh-list
56018961|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56018962|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018963|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
56018964|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56018987|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56018988|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56018989|NCT00405704|Renal Agents|renal agents|mesh-ancestor
56018990|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
56018991|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56018992|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56018993|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56018994|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56018995|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56018996|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56018997|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56018998|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56018999|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56019000|NCT01657266|Nepafenac|nepafenac|mesh-list
56019001|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56019002|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56019003|NCT01657266|Analgesics|analgesics|mesh-ancestor
56019004|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
56019045|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
56019046|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019047|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019048|NCT05302284|Gemcitabine|gemcitabine|mesh-list
56019049|NCT05302284|Carboplatin|carboplatin|mesh-list
56019050|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019051|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56019052|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
56019053|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019054|NCT05302284|Antiviral Agents|antiviral agents|mesh-ancestor
56019055|NCT05302284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019056|NCT05302284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019057|NCT05302284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019058|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
56019059|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019060|NCT05263284|Venetoclax|venetoclax|mesh-list
56019061|NCT05263284|Adenosine|adenosine|mesh-list
56019062|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019063|NCT05263284|Analgesics|analgesics|mesh-ancestor
56019064|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
56019065|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019066|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019067|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56019068|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
56019069|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56019070|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
56019071|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
56019072|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019073|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019074|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
56019075|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56019076|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019087|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019088|NCT05299476|Bevacizumab|bevacizumab|mesh-list
56019090|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019091|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56019092|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56019093|NCT05299476|Growth Substances|growth substances|mesh-ancestor
56019094|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019095|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
56019097|NCT00405938|Fulvestrant|fulvestrant|mesh-list
56019098|NCT00405938|Anastrozole|anastrozole|mesh-list
56019099|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56019100|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019101|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56019102|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56019103|NCT00405938|Growth Substances|growth substances|mesh-ancestor
56019104|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019105|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
56019106|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56019107|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56019108|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56019134|NCT01793480|Analgesics|analgesics|mesh-ancestor
56019135|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
56019136|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723677|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019137|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
56019138|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
56019139|NCT05299086|Fluticasone|fluticasone|mesh-list
56019140|NCT05299086|Xhance|xhance|mesh-list
56019141|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56019142|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56019143|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
56019144|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019145|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019146|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56019147|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
56019148|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
56019149|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56019150|NCT05299008|Bethanechol|bethanechol|mesh-list
56019151|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56019152|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
55723686|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55723689|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
56019153|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019154|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019155|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56019156|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56019157|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
56019158|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019159|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019160|NCT05258292|Insulin|insulin|mesh-list
56019161|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56019162|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019163|NCT00378326|Tacrolimus|tacrolimus|mesh-list
56019164|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56019165|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
56019166|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019167|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56019176|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56019177|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
56019178|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
56019179|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019180|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56019181|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56019182|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019183|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019184|NCT00379574|Prednisolone|prednisolone|mesh-list
56019185|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
56019186|NCT00379574|Doxorubicin|doxorubicin|mesh-list
56019187|NCT00379574|Vincristine|vincristine|mesh-list
56019188|NCT00379574|Bortezomib|bortezomib|mesh-list
56019191|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
56019192|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019193|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56019194|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56019195|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
56019196|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019197|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019198|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56019199|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56019200|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56019201|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56019202|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019203|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56019204|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
56019205|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
56019206|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
56019207|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56019208|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
56019210|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56019211|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56019212|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56019213|NCT05256108|Oxycodone|oxycodone|mesh-list
56019214|NCT05256108|Tramadol|tramadol|mesh-list
56019215|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56019216|NCT05256108|Narcotics|narcotics|mesh-ancestor
56019217|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019218|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019219|NCT05256108|Analgesics|analgesics|mesh-ancestor
56019220|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
56019221|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723745|NCT03344341|Acarbose|acarbose|mesh-list
56019222|NCT00407654|Aflibercept|aflibercept|mesh-list
56019223|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
56019224|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56019225|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55723756|NCT03260881|Hormones|hormones|mesh-ancestor
56019230|NCT05484492|Calcium|calcium|mesh-list
56019274|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019275|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
56019276|NCT00407966|Growth Substances|growth substances|mesh-ancestor
56019277|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56019278|NCT00408200|Sotalol|sotalol|mesh-list
56019279|NCT00408200|Flecainide|flecainide|mesh-list
56019280|NCT00408200|Propafenone|propafenone|mesh-list
56019281|NCT00408200|Dofetilide|dofetilide|mesh-list
56019282|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56019283|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56019284|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
56019285|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019286|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019287|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019288|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56019289|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
56019290|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
56019291|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019292|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56019293|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56019294|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56019295|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56019296|NCT05255406|Aflutinib|aflutinib|mesh-list
56019297|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56019298|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019299|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019300|NCT05250050|Amoxicillin|amoxicillin|mesh-list
56019322|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56019323|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56019324|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019325|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56019326|NCT05250050|Antacids|antacids|mesh-ancestor
56019327|NCT05250050|Diuretics|diuretics|mesh-ancestor
56019328|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
56019329|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019330|NCT05250050|Expectorants|expectorants|mesh-ancestor
56019331|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56019332|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
56019333|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56019334|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019335|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56019336|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56019337|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56019338|NCT05294328|Aceclidine|aceclidine|mesh-list
56019339|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56019342|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56019379|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019380|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
56019381|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56019382|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56019383|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019384|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56019385|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56019386|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56019387|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019388|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019389|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56019390|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56019391|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019392|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
56019393|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
56019394|NCT04270994|Misoprostol|misoprostol|mesh-list
56019395|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56019396|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
56019397|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56019398|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019399|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56019400|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56019401|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
56019402|NCT05189756|Aprepitant|aprepitant|mesh-list
56019403|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
56019404|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
56019405|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
56019406|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019407|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019408|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56019412|NCT02111798|Bupropion|bupropion|mesh-list
56019421|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019422|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019423|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56019424|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56019425|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019426|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
56019427|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56019428|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
56019429|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019430|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
56019482|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56019483|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
56019484|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
56019485|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56019486|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
56019487|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019488|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019489|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
56019490|NCT00383942|Misoprostol|misoprostol|mesh-list
56019491|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56019492|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
56019493|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56019494|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019495|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56019496|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56019497|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
56019498|NCT05245968|Sunitinib|sunitinib|mesh-list
56019499|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
56019500|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019501|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56019502|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56019503|NCT05245968|Growth Substances|growth substances|mesh-ancestor
56019504|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019505|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
56019506|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56019507|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019510|NCT05288400|Bisoprolol|bisoprolol|mesh-list
56019530|NCT05193318|Ketamine|ketamine|mesh-list
56019531|NCT05193318|Analgesics|analgesics|mesh-ancestor
56019532|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
56019533|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019534|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019535|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55760265|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
56019536|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56019537|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
56019538|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
56019539|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019540|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56019541|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56019542|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019543|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019544|NCT05474040|Morphine|morphine|mesh-list
56019545|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56019546|NCT05474040|Narcotics|narcotics|mesh-ancestor
56019547|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019548|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019549|NCT05474040|Analgesics|analgesics|mesh-ancestor
56019550|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
56019584|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56019585|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56019586|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019587|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56019588|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019589|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019590|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
56019591|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
56019592|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
56019593|NCT00411086|Rituximab|rituximab|mesh-list
56019594|NCT00411086|Molgramostim|molgramostim|mesh-list
56019595|NCT00411086|Sargramostim|sargramostim|mesh-list
56019596|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56019597|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019598|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
56019599|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019600|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56019601|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
56019602|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56019603|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019604|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56019605|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56019606|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56019607|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019633|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
56019634|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
56019635|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019636|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019637|NCT00385580|Dasatinib|dasatinib|mesh-list
56019638|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019639|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56019640|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019641|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019642|NCT05236530|Metformin|metformin|mesh-list
56019643|NCT05236530|Repaglinide|repaglinide|mesh-list
56019644|NCT05236530|Dolutegravir|dolutegravir|mesh-list
56019645|NCT05236530|Lumefantrine|lumefantrine|mesh-list
56019646|NCT05236530|Midazolam|midazolam|mesh-list
56019647|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
56019648|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56019650|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019651|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56019652|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56019653|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019654|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56019655|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56019656|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019657|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56019659|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
56019660|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
56019661|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
56019662|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019663|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019664|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56019665|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56019666|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
56019667|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56019669|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019675|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019676|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
56019677|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56019678|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56019679|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
56019680|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
56019681|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56019682|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56019683|NCT00455702|Cycloserine|cycloserine|mesh-list
56019684|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56019685|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019686|NCT00455702|Renal Agents|renal agents|mesh-ancestor
56019687|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56019732|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
56019733|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019734|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
56019735|NCT00458822|Dexamethasone|dexamethasone|mesh-list
56019736|NCT00458822|Bortezomib|bortezomib|mesh-list
56019737|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56019738|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
56019739|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
56019740|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019741|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019742|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56019743|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
56019744|NCT00458822|Hormones|hormones|mesh-ancestor
56019745|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56019746|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56019747|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56019748|NCT00389168|Atenolol|atenolol|mesh-list
56019749|NCT00389168|Irbesartan|irbesartan|mesh-list
56019750|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56019751|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56019752|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56019753|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019754|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56019755|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
56019756|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
56019757|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019758|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019780|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56019781|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019782|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019783|NCT05177718|Natalizumab|natalizumab|mesh-list
56019784|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
56019785|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019786|NCT00414206|Mecamylamine|mecamylamine|mesh-list
56019787|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56019788|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56019789|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
56019790|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019791|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019792|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56019793|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56019794|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
56019841|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56019842|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
56019843|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
56019844|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56019845|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56019846|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56019847|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019848|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
56019849|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
56019850|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019851|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019852|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56019853|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56019854|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56019855|NCT00462722|Ibuprofen|ibuprofen|mesh-list
56019856|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56019857|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56019858|NCT00462722|Analgesics|analgesics|mesh-ancestor
56019859|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
56019860|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56019861|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019862|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56019863|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56019864|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56019865|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019866|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019867|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
56019868|NCT05272254|Povidone|povidone|mesh-list
56019869|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
56019870|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
56019871|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56019872|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019873|NCT00528398|Cytarabine|cytarabine|mesh-list
56019874|NCT00528398|Idarubicin|idarubicin|mesh-list
56019883|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019884|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56019885|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56019886|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56019887|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019888|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
56019889|NCT00528788|Vitamins|vitamins|mesh-ancestor
56019890|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
56019891|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019892|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56019893|NCT00414518|Ritonavir|ritonavir|mesh-list
56019894|NCT00414518|Lopinavir|lopinavir|mesh-list
56019895|NCT00414518|Tenofovir|tenofovir|mesh-list
56019896|NCT00414518|Emtricitabine|emtricitabine|mesh-list
56019897|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56019898|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56019899|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
56019900|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019901|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019902|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56019903|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56019904|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
56019905|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56019906|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56019907|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56019908|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56019909|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56019910|NCT01795664|Fluticasone|fluticasone|mesh-list
56019911|NCT01795664|Xhance|xhance|mesh-list
56019912|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56019913|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56019914|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56019924|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56019925|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56019926|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
56019927|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019928|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019929|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
56019930|NCT01795664|Hormones|hormones|mesh-ancestor
56019931|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56019932|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
56019933|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
56019934|NCT05271084|Dexetimide|dexetimide|mesh-list
56019935|NCT05271084|Citalopram|citalopram|mesh-list
56019936|NCT05271084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56019937|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56019938|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56019939|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019940|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019941|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
56019942|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019943|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56019944|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
56019945|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56019946|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56019947|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56019948|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
56019949|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
56019962|NCT00531518|Lamotrigine|lamotrigine|mesh-list
56019972|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56019973|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56019975|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56019976|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56019977|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56019978|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56019979|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56019980|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56019981|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56019982|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56019983|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
56019984|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56019985|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56019986|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
56019987|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56019988|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56019989|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56019990|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56019991|NCT00531518|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56019992|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
56019993|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56019994|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56019995|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56019996|NCT05221554|Tacrine|tacrine|mesh-list
56019997|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56020017|NCT00534794|Analgesics|analgesics|mesh-ancestor
56020018|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
56020019|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723887|NCT03496519|Durvalumab|durvalumab|mesh-list
55739391|NCT03126695|Ticagrelor|ticagrelor|mesh-list
56020020|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020021|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56020023|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56020024|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56020025|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56020026|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
56020027|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
56020028|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020029|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020030|NCT01658436|Dactolisib|dactolisib|mesh-list
56020031|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020032|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
56020033|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56020034|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020035|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020036|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020037|NCT05168280|Analgesics|analgesics|mesh-ancestor
56020038|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
56020039|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020040|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56020041|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56020042|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56020043|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
56020044|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020045|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020046|NCT05169684|Docetaxel|docetaxel|mesh-list
56020047|NCT05169684|Nivolumab|nivolumab|mesh-list
56020048|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020049|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
56020050|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
56020055|NCT05053854|Talazoparib|talazoparib|mesh-list
56020056|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56020057|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020058|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020059|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020060|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56020061|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
55723979|NCT03382925|Lidocaine|lidocaine|mesh-list
56020062|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
56020063|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
56020064|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
56020065|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56020066|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56020067|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020068|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56020069|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56020070|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020071|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020072|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020073|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56020074|NCT00465530|Gentamicins|gentamicins|mesh-list
55724040|NCT04460521|Expectorants|expectorants|mesh-ancestor
56020075|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56020076|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020077|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56020078|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020079|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020080|NCT00466310|Risperidone|risperidone|mesh-list
56020081|NCT00466310|Aripiprazole|aripiprazole|mesh-list
56020082|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56020083|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
56020084|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020085|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020086|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020087|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56020088|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56020096|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56020097|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56020098|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56020100|NCT03463460|Sunitinib|sunitinib|mesh-list
56020101|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56020102|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020103|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56020104|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56020105|NCT03463460|Growth Substances|growth substances|mesh-ancestor
56020106|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020107|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
56020108|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56020112|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56020113|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020115|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56020116|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
56020117|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020118|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020119|NCT00537290|Rituximab|rituximab|mesh-list
56020120|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56020121|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020122|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
56020123|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020124|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020125|NCT00537680|Ubiquinone|ubiquinone|mesh-list
56020126|NCT00537680|Idebenone|idebenone|mesh-list
56020127|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
56020128|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020129|NCT00537680|Protective Agents|protective agents|mesh-ancestor
56020130|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020132|NCT00538304|Bimatoprost|bimatoprost|mesh-list
56020133|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56020134|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56020135|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56020136|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
56020138|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56020139|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020140|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020141|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56020142|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
56020143|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
56020144|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020146|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
56020196|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
56020197|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020198|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020199|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56020200|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020201|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56020202|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739431|NCT04446715|Sufentanil|sufentanil|mesh-list
56020203|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020205|NCT00471068|Travoprost|travoprost|mesh-list
56020206|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56020207|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56020208|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
56020209|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020210|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020211|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020212|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56020213|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56020214|NCT00471380|Timolol|timolol|mesh-list
56020215|NCT00471380|Travoprost|travoprost|mesh-list
56020216|NCT00471380|Dorzolamide|dorzolamide|mesh-list
56020217|NCT00471380|Brinzolamide|brinzolamide|mesh-list
55747451|NCT03370835|Metoprolol|metoprolol|mesh-list
56020218|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56020219|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56020220|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
56020221|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020222|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020223|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020224|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56020225|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56020226|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56020227|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020228|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
56020236|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020237|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020238|NCT00538850|Analgesics|analgesics|mesh-ancestor
56020239|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
56020240|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020241|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56020242|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56020243|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
56020244|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
56020245|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56020246|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56020247|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56020248|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56020249|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020250|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
56020251|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020252|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020253|NCT00418574|Abagovomab|abagovomab|mesh-list
56020254|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56020255|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020256|NCT00473642|Ranibizumab|ranibizumab|mesh-list
56020257|NCT00473642|Verteporfin|verteporfin|mesh-list
56020258|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56020259|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56020260|NCT00473642|Growth Substances|growth substances|mesh-ancestor
56020261|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020277|NCT00419666|Calcitriol|calcitriol|mesh-list
56020278|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56020279|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020280|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56020281|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56020282|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020283|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56020284|NCT00419666|Vitamins|vitamins|mesh-ancestor
56020285|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
56020286|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56020287|NCT00540722|Acetic Acid|acetic acid|mesh-list
56020288|NCT00540722|Retinol acetate|retinol acetate|mesh-list
56020289|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
56020290|NCT00540722|Gossypol|gossypol|mesh-list
55747523|NCT03700541|Analgesics|analgesics|mesh-ancestor
56020291|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56020292|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020293|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56020294|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
56020295|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020296|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56020297|NCT00540722|Protective Agents|protective agents|mesh-ancestor
56020298|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020299|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56020300|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
56020301|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56020302|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56020303|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56020304|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56020305|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56020306|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
56020307|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56020308|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
56020319|NCT00475904|Analgesics|analgesics|mesh-ancestor
56020320|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
56020321|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020322|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020323|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
56020324|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56020325|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56020326|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020327|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56020328|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56020329|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56020330|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020331|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020332|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
56020334|NCT00420992|Morphine|morphine|mesh-list
56020335|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56020336|NCT00420992|Narcotics|narcotics|mesh-ancestor
56020337|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020338|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020339|NCT00420992|Analgesics|analgesics|mesh-ancestor
56020340|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
56020341|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020342|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56020343|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56020369|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56020370|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56020371|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56020372|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
56020373|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56020374|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020375|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020376|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020377|NCT00480740|Analgesics|analgesics|mesh-ancestor
56020378|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
56020379|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020380|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56020381|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56020382|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56020383|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56020384|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020385|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020386|NCT02918864|Oxytocin|oxytocin|mesh-list
56020387|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
56020388|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56020389|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020390|NCT00424502|Rituximab|rituximab|mesh-list
56020391|NCT00424502|Methotrexate|methotrexate|mesh-list
56020392|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56020393|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020394|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
56020395|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020396|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020397|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56020408|NCT00425672|Interleukin-2|interleukin-2|mesh-list
56020412|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020413|NCT00425672|Analgesics|analgesics|mesh-ancestor
56020414|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
56020415|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020416|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020417|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
56020418|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
56020419|NCT00544076|Alprostadil|alprostadil|mesh-list
56020420|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020421|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
56020422|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56020423|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56020424|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020425|NCT00544076|Urological Agents|urological agents|mesh-ancestor
56020426|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56020427|NCT00544778|Doxorubicin|doxorubicin|mesh-list
56020428|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56020429|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
56020430|NCT00544778|Irinotecan|irinotecan|mesh-list
56020432|NCT00544778|Razoxane|razoxane|mesh-list
55760345|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
56020433|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56020434|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020435|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56020436|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56020437|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020438|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020439|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56020440|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020457|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
56020458|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56020459|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56020460|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56020461|NCT00486824|Analgesics|analgesics|mesh-ancestor
56020462|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
56020463|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020464|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56020465|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020466|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
56020467|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56020468|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020469|NCT00489086|Tazarotene|tazarotene|mesh-list
56020470|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
56020519|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56020520|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020521|NCT00550394|Topiramate|topiramate|mesh-list
56020522|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55760504|NCT03040635|Risdiplam|risdiplam|mesh-list
56020523|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
56020524|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56020525|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56020526|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56020527|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020528|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020529|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
56020530|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56020531|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56020532|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56020533|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56020534|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
56020535|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56020536|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020537|NCT00492206|Cetuximab|cetuximab|mesh-list
56020538|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56020539|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020540|NCT00431132|Estradiol|estradiol|mesh-list
56020541|NCT00431132|Estrogens|estrogens|mesh-ancestor
56020542|NCT00431132|Hormones|hormones|mesh-ancestor
56020543|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020544|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020557|NCT00493064|Hormones|hormones|mesh-ancestor
56020569|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
56020570|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020571|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56020572|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
56020573|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
56020574|NCT00493064|Vitamins|vitamins|mesh-ancestor
56020575|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
56020576|NCT00552422|Domperidone|domperidone|mesh-list
56020577|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
56020578|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
56020579|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020580|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020581|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56020582|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56020583|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
56020584|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020585|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020586|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
56020587|NCT00432458|Thalidomide|thalidomide|mesh-list
56020588|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56020589|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
56020590|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020625|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56020626|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
56020627|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020628|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020629|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56020630|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56020631|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
56020632|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56020633|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56020634|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
56020635|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
56020636|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020637|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56020638|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56020639|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55760505|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56020640|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56020641|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56020642|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
56020643|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56020644|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56020645|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56020646|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56020647|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56020648|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56020649|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
56020650|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56020651|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
56020652|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56020653|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
56020654|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020668|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56020671|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020672|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56020673|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020674|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
56020675|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
56020676|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020677|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
56020678|NCT05041842|Trastuzumab|trastuzumab|mesh-list
56020680|NCT05041842|Tucatinib|tucatinib|mesh-list
56020681|NCT05041842|Hormones|hormones|mesh-list
56020682|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56020683|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020684|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020685|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020686|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56020687|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020688|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020689|NCT05150496|Vaccines|vaccines|mesh-list
56020690|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
56020691|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020692|NCT00496340|Rituximab|rituximab|mesh-list
55724231|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724232|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724234|NCT01352507|Tadalafil|tadalafil|mesh-list
55724235|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
56020693|NCT00496340|Busulfan|busulfan|mesh-list
56020694|NCT00496340|Pentostatin|pentostatin|mesh-list
56020716|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55739447|NCT03398473|Hematinics|hematinics|mesh-ancestor
56020717|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020718|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56020720|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56020721|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020722|NCT05148078|Anesthetics|anesthetics|mesh-list
56020723|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020724|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020726|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56020727|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56020728|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56020729|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56020730|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
56020731|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020732|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020733|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020734|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
56020735|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
56020736|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56020737|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56020763|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56020764|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
56020765|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56020766|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
56020767|NCT00555464|Hormones|hormones|mesh-ancestor
56020768|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56020769|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020770|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56020771|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020772|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56020773|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
56020826|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56020827|NCT01464229|Iloperidone|iloperidone|mesh-list
56020828|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56020829|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56020830|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020831|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020832|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56020833|NCT00556478|Lidocaine|lidocaine|mesh-list
56020834|NCT00556478|Prilocaine|prilocaine|mesh-list
56020835|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56020836|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
56020837|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
56020838|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020839|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020840|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
56020841|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56020842|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56020843|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56020844|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56020845|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56020846|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020847|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56020848|NCT00500240|Insulin|insulin|mesh-list
56020849|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56020850|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
56020877|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56020878|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56020879|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56020880|NCT03246620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56020881|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56020882|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56020883|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020884|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020885|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
56020886|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56020887|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
56020888|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56020889|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56020890|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
56020891|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56020892|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56020893|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56020894|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56020895|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55724301|NCT00774761|Xhance|xhance|mesh-list
56020896|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
56020897|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
56020898|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
56020899|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
56020900|NCT05080218|Adalimumab|adalimumab|mesh-list
56020929|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56020930|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56020931|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56020932|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
56020933|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56020934|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56020935|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020936|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56020937|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56020938|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
56020939|NCT01470859|Protective Agents|protective agents|mesh-ancestor
56020940|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
56020941|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56020991|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
56020992|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56020993|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020994|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
56020995|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56020996|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56020997|NCT00438854|Dasatinib|dasatinib|mesh-list
56020998|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56020999|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56021000|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021001|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021002|NCT01485055|Infliximab|infliximab|mesh-list
56021003|NCT01485055|Basiliximab|basiliximab|mesh-list
56021004|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
56021005|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021006|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021007|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56021008|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
56021009|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021010|NCT05028348|Dexamethasone|dexamethasone|mesh-list
56021011|NCT05028348|Pomalidomide|pomalidomide|mesh-list
56021012|NCT05028348|Elotuzumab|elotuzumab|mesh-list
56021013|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021014|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
56021015|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
56021016|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021017|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021018|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021019|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
56021020|NCT05028348|Hormones|hormones|mesh-ancestor
56021021|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021022|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56021035|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021036|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021037|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56021038|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56021039|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56021040|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56021041|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
56021042|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
55748234|NCT02730377|Hormones|hormones|mesh-ancestor
56021043|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021044|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56021045|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56021046|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
56021047|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56021048|NCT00503750|Vinorelbine|vinorelbine|mesh-list
56021049|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021050|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56021051|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
56021052|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
56021053|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
56021054|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021056|NCT05077332|Famotidine|famotidine|mesh-list
56021057|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55724361|NCT02273843|Vitamin D|vitamin d|mesh-list
56021058|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56021059|NCT05077332|Analgesics|analgesics|mesh-ancestor
56021060|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
56021085|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021086|NCT00508118|Nicardipine|nicardipine|mesh-list
56021087|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56021088|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56021089|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56021090|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021091|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56021092|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021093|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
56021094|NCT05139030|Bupivacaine|bupivacaine|mesh-list
56021095|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
56021096|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
56021097|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021098|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021099|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
56021100|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021140|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56021142|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56021143|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021144|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56021145|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56021146|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56021147|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021148|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
56021149|NCT04421742|Beclomethasone|beclomethasone|mesh-list
56021150|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
56021151|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56021152|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
56021153|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021154|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021155|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56021156|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
56021157|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56021158|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56021159|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56021160|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
56021161|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021193|NCT01364922|Acetaminophen|acetaminophen|mesh-list
56021194|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56021195|NCT01364922|Hydrocodone|hydrocodone|mesh-list
56021196|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56021197|NCT01364922|Analgesics|analgesics|mesh-ancestor
56021198|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
56021199|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021200|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021201|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
56021202|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56021203|NCT01364922|Narcotics|narcotics|mesh-ancestor
56021204|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021205|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
56021206|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
56021207|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56021208|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021209|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021212|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
56021213|NCT04216524|Prednisone|prednisone|mesh-list
56021214|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
56021215|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56021216|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56021217|NCT04216524|Prednisolone|prednisolone|mesh-list
56021218|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
56021219|NCT04216524|Cortisone|cortisone|mesh-list
56021220|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
56021221|NCT04216524|Rituximab|rituximab|mesh-list
56021227|NCT04216524|Venetoclax|venetoclax|mesh-list
56021243|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021244|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56021245|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021246|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
56021247|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
56021248|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021249|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021250|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
56021252|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021253|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56021254|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
56021255|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021256|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56021257|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56021258|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56021259|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56021260|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
56021261|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56021262|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56021263|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
56021264|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
56021265|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56021266|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56021267|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
56021268|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021269|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56021270|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
56021271|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
56021272|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
56021273|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56021286|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021288|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56021289|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
56021290|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021291|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021292|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56021293|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56021294|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56021295|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
56021296|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021297|NCT00442364|Polidocanol|polidocanol|mesh-list
56021298|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56021299|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56021301|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021302|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56021303|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021304|NCT05135910|Terbinafine|terbinafine|mesh-list
56021305|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
56021306|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021307|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021308|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021309|NCT05070156|Vaccines|vaccines|mesh-list
56021310|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
56021311|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021312|NCT00511706|Dexamethasone|dexamethasone|mesh-list
56021313|NCT00511706|Ranibizumab|ranibizumab|mesh-list
56021314|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021315|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
56021316|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
56021317|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021318|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021319|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021320|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
56021321|NCT00511706|Hormones|hormones|mesh-ancestor
56021325|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56021326|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56021327|NCT00511706|Growth Substances|growth substances|mesh-ancestor
56021328|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
56021329|NCT05067894|Vaccines|vaccines|mesh-list
56021330|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
56021331|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021332|NCT01493947|Metronidazole|metronidazole|mesh-list
56021333|NCT01493947|Ivermectin|ivermectin|mesh-list
56021334|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021335|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56021336|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56021389|NCT05011266|Narcotics|narcotics|mesh-ancestor
56021390|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021391|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021392|NCT05011266|Analgesics|analgesics|mesh-ancestor
56021393|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
56021394|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021395|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56021396|NCT00512876|Bevacizumab|bevacizumab|mesh-list
56021397|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56021398|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021399|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56021400|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56021401|NCT00512876|Growth Substances|growth substances|mesh-ancestor
56021402|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021403|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
56021404|NCT05062980|Docetaxel|docetaxel|mesh-list
56021405|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
56021406|NCT05062980|Ramucirumab|ramucirumab|mesh-list
56021407|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021408|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
56021409|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
56021410|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
56021411|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021412|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56021414|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
56021415|NCT05127876|Ondansetron|ondansetron|mesh-list
56021416|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
56021417|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
56021418|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021419|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021420|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021421|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
56021422|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
56021423|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56021430|NCT05127876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56021431|NCT05127876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56021432|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56021433|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
56021434|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56021435|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
56021436|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56021437|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56021438|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
56021439|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
56021441|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
56021442|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56021443|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56021444|NCT05009862|Analgesics|analgesics|mesh-ancestor
56021445|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
56021446|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021447|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021448|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021449|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021450|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56021451|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56021452|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021453|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56021454|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56021455|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021456|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
56021457|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56021458|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
56021459|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56021460|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
56021461|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
56021462|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
56021463|NCT01496131|Goserelin|goserelin|mesh-list
56021472|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56021473|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56021474|NCT02520726|Sertraline|sertraline|mesh-list
56021475|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
56021476|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56021477|NCT02520726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56021478|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56021479|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56021480|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021481|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021482|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
56021483|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021484|NCT00450242|Lidocaine|lidocaine|mesh-list
56021485|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
56021486|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
56021487|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021488|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021490|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021491|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56021492|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56021493|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56021494|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56021495|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021496|NCT05617742|FAPI-46|fapi-46|mesh-list
56021497|NCT05617742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56021498|NCT05617742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021507|NCT00517010|Ranibizumab|ranibizumab|mesh-list
56021508|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56021509|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56021510|NCT00517010|Growth Substances|growth substances|mesh-ancestor
56021511|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021512|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
56021513|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021517|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021518|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56021519|NCT00519584|Bupivacaine|bupivacaine|mesh-list
56021520|NCT00519584|Ropivacaine|ropivacaine|mesh-list
56021521|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
56021522|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
56021523|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021524|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021525|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
56021526|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021527|NCT05122884|Milrinone|milrinone|mesh-list
56021528|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56021529|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56021530|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
56021531|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56021532|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56021533|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021534|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021535|NCT05122884|Protective Agents|protective agents|mesh-ancestor
56021536|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021537|NCT00520286|Modafinil|modafinil|mesh-list
56021538|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56021539|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021540|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56021541|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56021542|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56021543|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021544|NCT05590676|Metformin|metformin|mesh-list
56021545|NCT05590676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56021546|NCT05590676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021559|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021560|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56021561|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56021562|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
56021563|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021564|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021565|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56021566|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56021567|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
56021568|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56021569|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
56021570|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
56021571|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
56021572|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56021574|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56021575|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56021576|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56021577|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56021578|NCT00521456|Analgesics|analgesics|mesh-ancestor
56021579|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
56021580|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021581|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021582|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021583|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021584|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56021585|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021586|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021588|NCT03813108|Artemether|artemether|mesh-list
56021589|NCT03813108|Mefloquine|mefloquine|mesh-list
56021590|NCT03813108|Atovaquone|atovaquone|mesh-list
56021591|NCT03813108|Proguanil|proguanil|mesh-list
56021603|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
56021604|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56021605|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021606|NCT03326180|Bupivacaine|bupivacaine|mesh-list
56021607|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
56021608|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
56021609|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021610|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021611|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
56021612|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021613|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56021614|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56021615|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56021616|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56021617|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021618|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
56021619|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021620|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021621|NCT05119920|Pilocarpine|pilocarpine|mesh-list
56021622|NCT05119920|Miotics|miotics|mesh-ancestor
56021623|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
56021624|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021625|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021626|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56021627|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56021628|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
56021629|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021630|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021631|NCT01796444|Hormones|hormones|mesh-list
56021645|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021646|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021647|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56021648|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021649|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021652|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021653|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021654|NCT00452426|Analgesics|analgesics|mesh-ancestor
56021655|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
56021656|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021657|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
56021658|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021659|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56021660|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021661|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021662|NCT00524342|Oprelvekin|oprelvekin|mesh-list
56021663|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021664|NCT00524576|Vaccines|vaccines|mesh-list
56021665|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
56021666|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021667|NCT04950660|Caffeine|caffeine|mesh-list
56021668|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56021669|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021670|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56021671|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021672|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021673|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56021674|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56021675|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
56021676|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021677|NCT02516202|Estradiol|estradiol|mesh-list
56021678|NCT02516202|Estrogens|estrogens|mesh-ancestor
56021679|NCT02516202|Hormones|hormones|mesh-ancestor
56021682|NCT00526058|Clotrimazole|clotrimazole|mesh-list
56021685|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021686|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
56021687|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55760584|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
56021688|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56021689|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021690|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021691|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56021692|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
56021693|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56021694|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021695|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56021696|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56021697|NCT05116254|AZD7648|azd7648|mesh-list
56021698|NCT05116254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56021699|NCT05116254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021700|NCT05116254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021701|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
56021702|NCT00526292|Fludarabine|fludarabine|mesh-list
56021703|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56021704|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
56021705|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021706|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021707|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56021732|NCT04521140|Protective Agents|protective agents|mesh-ancestor
56021733|NCT02124044|Asunaprevir|asunaprevir|mesh-list
56021734|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
56021735|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021736|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021737|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
56021738|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56021739|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
56021740|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56021741|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
56021742|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021743|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021744|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
56021745|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
56021746|NCT01502761|Analgesics|analgesics|mesh-ancestor
56021747|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
56021748|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021749|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021750|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
56021751|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021752|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56021753|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
56021754|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56021755|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56021756|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021757|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56021758|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
56021759|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56021760|NCT01504477|Bortezomib|bortezomib|mesh-list
56021761|NCT01504477|Panitumumab|panitumumab|mesh-list
55760755|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021762|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021763|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56021764|NCT02124512|Rifaximin|rifaximin|mesh-list
56021765|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56021766|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021772|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021773|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021774|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56021775|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56021776|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021777|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748986|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
56021795|NCT02209519|Metronidazole|metronidazole|mesh-list
56021796|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021797|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56021798|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56021799|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56021800|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
56021801|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56021802|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56021803|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56021804|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
56021805|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021806|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021807|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021809|NCT04946370|Androgens|androgens|mesh-list
56021810|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56021811|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56021812|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021813|NCT04946370|Hormones|hormones|mesh-ancestor
56021820|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56021821|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021822|NCT01797848|Ribavirin|ribavirin|mesh-list
56021823|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56021824|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
56021825|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021826|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
56021827|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56021828|NCT01398943|Antioxidants|antioxidants|mesh-list
56021829|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021830|NCT01398943|Protective Agents|protective agents|mesh-ancestor
56021831|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021832|NCT01550341|Buprenorphine|buprenorphine|mesh-list
56021833|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56021834|NCT01550341|Naloxone|naloxone|mesh-list
56021835|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56021836|NCT01550341|Narcotics|narcotics|mesh-ancestor
56021837|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021838|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021839|NCT01550341|Analgesics|analgesics|mesh-ancestor
56021840|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
56021841|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021842|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56021843|NCT03946358|Atezolizumab|atezolizumab|mesh-list
56021844|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021845|NCT02125292|Mesalamine|mesalamine|mesh-list
56021846|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56021847|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56021848|NCT02125292|Analgesics|analgesics|mesh-ancestor
56021849|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
56021850|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021851|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021852|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021853|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021854|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
56021855|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55930019|NCT01720485|Desloratadine|desloratadine|mesh-list
56021856|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021857|NCT01653912|Paclitaxel|paclitaxel|mesh-list
56021858|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56021859|NCT01653912|Carboplatin|carboplatin|mesh-list
56021860|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56021861|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021862|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
56021863|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
56021864|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
56021865|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021866|NCT04132388|Adalimumab|adalimumab|mesh-list
56021867|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021868|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021869|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
56021870|NCT03693014|Nivolumab|nivolumab|mesh-list
56021871|NCT03693014|Ipilimumab|ipilimumab|mesh-list
56021872|NCT03693014|Atezolizumab|atezolizumab|mesh-list
55724770|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
56021873|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56021874|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021875|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56021876|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021877|NCT04081688|Atezolizumab|atezolizumab|mesh-list
56021878|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56021879|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
56021880|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
56021881|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021882|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
56021883|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021885|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021886|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56021887|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021888|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021899|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
56021900|NCT01508455|Morphine|morphine|mesh-list
56021901|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56021902|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56021903|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021904|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56021905|NCT01508455|Analgesics|analgesics|mesh-ancestor
56021906|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
56021907|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021908|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55724821|NCT04445389|Vaccines|vaccines|mesh-list
56021909|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56021910|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56021911|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
56021912|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021913|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021914|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56021915|NCT01508455|Narcotics|narcotics|mesh-ancestor
56021916|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56021917|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56021918|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
56021919|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
56021920|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56021921|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56021922|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56021923|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
56021924|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
56021925|NCT03095612|Docetaxel|docetaxel|mesh-list
56021926|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021927|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
56021928|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
56021929|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
56021930|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021931|NCT01509625|Fulvestrant|fulvestrant|mesh-list
56021932|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56021933|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021939|NCT02482428|Imiquimod|imiquimod|mesh-list
56021940|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55724868|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
56021941|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
56021942|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021943|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021944|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
56021945|NCT01510327|Aspirin|aspirin|mesh-list
56021946|NCT01510327|Everolimus|everolimus|mesh-list
56021947|NCT01510327|Ticlopidine|ticlopidine|mesh-list
56021948|NCT01510327|Clopidogrel|clopidogrel|mesh-list
56021949|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56021950|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56021951|NCT01510327|Analgesics|analgesics|mesh-ancestor
56021952|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
56021953|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56021954|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56021955|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56021956|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56021957|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56021958|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56021959|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56021960|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56021961|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56021962|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56021963|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
56021964|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56021965|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56021966|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
56021967|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56021971|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56021972|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56021973|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56021994|NCT01401595|Dexetimide|dexetimide|mesh-list
56021995|NCT01401595|Citalopram|citalopram|mesh-list
56021996|NCT01401595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56021997|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56021998|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56021999|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022000|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022001|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
55828768|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022002|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022003|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56022004|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
56022005|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56022006|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56022007|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56022008|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
56022009|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
56022010|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022011|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56022012|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56022013|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
56022014|NCT02949284|Prednisone|prednisone|mesh-list
56022015|NCT02949284|Cortisone|cortisone|mesh-list
56022016|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
56022017|NCT02949284|Hormones|hormones|mesh-list
56022018|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56022019|NCT02949284|Androgens|androgens|mesh-list
56022020|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
56022021|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56022022|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
56022023|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56022024|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022039|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022040|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56022041|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56022042|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
56022043|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022044|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56022045|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56022046|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
56022047|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56022048|NCT02480712|Velpatasvir|velpatasvir|mesh-list
56022049|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
56022050|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022051|NCT03916094|Trastuzumab|trastuzumab|mesh-list
56022052|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022053|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022054|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
56022055|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022056|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022057|NCT00115700|Prednisolone|prednisolone|mesh-list
56022058|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
56022059|NCT00115700|Rituximab|rituximab|mesh-list
56022060|NCT00115700|Vincristine|vincristine|mesh-list
56022061|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022062|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
56022063|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022064|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022065|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56022066|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
56022086|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
56022087|NCT03385304|Povidone|povidone|mesh-list
56022088|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56022089|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022090|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
56022091|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
56022092|NCT03385304|Trace Elements|trace elements|mesh-ancestor
56022093|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
56022094|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022095|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
56022096|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
56022098|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
56022099|NCT03243890|Vitamin K|vitamin k|mesh-list
56022100|NCT03243890|Vitamin MK 7|vitamin mk 7|mesh-list
56022101|NCT03243890|Vitamins|vitamins|mesh-ancestor
56022102|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
56022103|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022104|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56022105|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56022106|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56022107|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022108|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
56022109|NCT03243890|Coagulants|coagulants|mesh-ancestor
56022110|NCT00560612|Paroxetine|paroxetine|mesh-list
56022111|NCT00560612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56022112|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56022113|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56022137|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022138|NCT03236792|Dexamethasone|dexamethasone|mesh-list
56022139|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
56022140|NCT03236792|Ixazomib|ixazomib|mesh-list
56022141|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022142|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
56022143|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022144|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022145|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56022146|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
56022147|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022148|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022149|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56022150|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56022151|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
56022152|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
56022153|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022154|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56022155|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
56022156|NCT03236792|Hormones|hormones|mesh-ancestor
56022157|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56022158|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56022159|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
56022160|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022161|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
56022162|NCT03725384|Iron|iron|mesh-list
56022163|NCT03725384|Vitamins|vitamins|mesh-ancestor
56022164|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
56022165|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022166|NCT03725384|Trace Elements|trace elements|mesh-ancestor
56022167|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
56022168|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022169|NCT03725384|Protective Agents|protective agents|mesh-ancestor
56022170|NCT03214562|Cytarabine|cytarabine|mesh-list
56022171|NCT03214562|Fludarabine|fludarabine|mesh-list
56022172|NCT03214562|Venetoclax|venetoclax|mesh-list
56022179|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022180|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
56022181|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724945|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724949|NCT02353468|Dexamethasone|dexamethasone|mesh-list
56022182|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
56022183|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022184|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56022185|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56022186|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56022187|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56022188|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022190|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56022191|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56022192|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022193|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
56022194|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022195|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
56022196|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022197|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56022198|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022199|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022200|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
56022201|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56022202|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022203|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56022225|NCT05566093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022226|NCT05566093|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56022227|NCT05566093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56022228|NCT01558063|Ketamine|ketamine|mesh-list
56022229|NCT01558063|Analgesics|analgesics|mesh-ancestor
56022230|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
56022231|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022232|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022233|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56022234|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56022235|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
56022236|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
56022237|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56022238|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56022239|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56022240|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022241|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022242|NCT03641846|Tadalafil|tadalafil|mesh-list
56022243|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
56022244|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56022245|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56022246|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749449|NCT03248791|Phenylephrine|phenylephrine|mesh-list
56022247|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022248|NCT03641846|Urological Agents|urological agents|mesh-ancestor
56022249|NCT03474458|Doxycycline|doxycycline|mesh-list
56022250|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56022251|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022252|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
56022253|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56022254|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56022255|NCT01516957|Brodalumab|brodalumab|mesh-list
56022256|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56022257|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
56022258|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
56022259|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022260|NCT01519063|Naltrexone|naltrexone|mesh-list
56022263|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56022264|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022265|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
56022266|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022267|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56022268|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55724984|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56022269|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
56022270|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022271|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022272|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56022273|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56022274|NCT01559857|Pioglitazone|pioglitazone|mesh-list
56022275|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56022276|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022277|NCT05565625|Sunscreening Agents|sunscreening agents|mesh-list
56022278|NCT05565625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56022279|NCT05565625|Protective Agents|protective agents|mesh-ancestor
56022280|NCT05565625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022281|NCT05565625|Dermatologic Agents|dermatologic agents|mesh-ancestor
56022282|NCT00754208|Methylphenidate|methylphenidate|mesh-list
56022283|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56022284|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022285|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56022286|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56022287|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56022288|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022289|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
56022291|NCT01562041|Ranolazine|ranolazine|mesh-list
56022308|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56022309|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022310|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022311|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56022312|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
56022313|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56022314|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022315|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56022316|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56022317|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56022318|NCT00565370|Capecitabine|capecitabine|mesh-list
56022320|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022321|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56022322|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
56022323|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022324|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56022325|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022326|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
56022327|NCT03303950|Busulfan|busulfan|mesh-list
56022328|NCT03303950|Fludarabine|fludarabine|mesh-list
56022329|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022330|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
56022331|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022332|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022333|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56022334|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
56022335|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022336|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022337|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56022338|NCT01563055|Ofatumumab|ofatumumab|mesh-list
56022339|NCT01563055|Chlorambucil|chlorambucil|mesh-list
56022348|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56022349|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022350|NCT00565916|Progestins|progestins|mesh-ancestor
56022351|NCT03258320|Docetaxel|docetaxel|mesh-list
56022352|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
56022353|NCT03258320|Satraplatin|satraplatin|mesh-list
56022354|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022355|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
56022356|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
56022357|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
56022358|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022359|NCT03258320|Analgesics|analgesics|mesh-ancestor
56022360|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
56022361|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022362|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022363|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56022364|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56022365|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022366|NCT01797926|Losartan|losartan|mesh-list
56022367|NCT01797926|Amlodipine|amlodipine|mesh-list
56022368|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56022369|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56022370|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56022371|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022372|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56022373|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022374|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
55744400|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022395|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56022396|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749585|NCT04279847|INCB057643|incb057643|mesh-list
56022397|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
56022398|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
56022399|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
56022400|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022401|NCT00567008|Varenicline|varenicline|mesh-list
56022402|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56022403|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56022404|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
56022405|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022406|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022407|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022408|NCT00567320|Varenicline|varenicline|mesh-list
56022409|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56022410|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56022411|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
56022412|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725027|NCT05153785|Lidocaine|lidocaine|mesh-list
56022413|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022414|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022415|NCT01522417|Tirofiban|tirofiban|mesh-list
56022416|NCT01522417|Eptifibatide|eptifibatide|mesh-list
56022417|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56022418|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56022419|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022420|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56022421|NCT00568022|Capecitabine|capecitabine|mesh-list
56022422|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56022423|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
56022424|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022434|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022435|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022436|NCT03094286|Durvalumab|durvalumab|mesh-list
56022437|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022438|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022439|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
55725038|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022440|NCT03071666|Vitamins|vitamins|mesh-ancestor
56022441|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
56022442|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022443|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
56022444|NCT05533580|Sufentanil|sufentanil|mesh-list
56022445|NCT05533580|Dsuvia|dsuvia|mesh-list
56022446|NCT05533580|Propofol|propofol|mesh-list
56022447|NCT05533580|Cisatracurium|cisatracurium|mesh-list
56022448|NCT05533580|Atracurium|atracurium|mesh-list
56022449|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56022450|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56022451|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022452|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56022453|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
56022454|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
56022455|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56022456|NCT05533580|Narcotics|narcotics|mesh-ancestor
56022457|NCT05533580|Analgesics|analgesics|mesh-ancestor
56022458|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
56022459|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022460|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56022461|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56022462|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56022463|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56022483|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022484|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022485|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56022486|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56022487|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
56022488|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
56022489|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56022490|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56022491|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56022492|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56022493|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56022494|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56022495|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
56022496|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
56022497|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
56022498|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56022499|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022500|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022501|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56022502|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56022503|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
56022504|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56022505|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56022506|NCT02429570|Analgesics|analgesics|mesh-ancestor
56022507|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
56022508|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022509|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022510|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56022515|NCT05409716|Hemostatics|hemostatics|mesh-list
56022516|NCT05409716|Coagulants|coagulants|mesh-ancestor
56022517|NCT05395910|Paclitaxel|paclitaxel|mesh-list
56022518|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56022519|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022520|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
56022521|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
56022522|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
56022523|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022524|NCT05389046|Dexetimide|dexetimide|mesh-list
56022525|NCT05389046|Aripiprazole|aripiprazole|mesh-list
56022526|NCT05389046|Citalopram|citalopram|mesh-list
56022527|NCT05389046|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56022528|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56022529|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56022530|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022531|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022532|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
56022533|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022534|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56022535|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
56022536|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56022537|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56022538|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56022539|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
56022540|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
56022541|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022542|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56022543|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56022544|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
56022545|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56022566|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022567|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022573|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56022574|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
56022575|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022576|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022577|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56022578|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56022579|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
56022580|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022581|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022582|NCT01569451|Rituximab|rituximab|mesh-list
56022583|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
56022584|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
56022585|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022586|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022587|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
56022588|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022589|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022590|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56022591|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022592|NCT02132936|Calcipotriene|calcipotriene|mesh-list
56022593|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
56022594|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
56022612|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56022613|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022615|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022616|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022617|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56022618|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022619|NCT01667120|Ketorolac|ketorolac|mesh-list
56022620|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56022621|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56022622|NCT01667120|Analgesics|analgesics|mesh-ancestor
56022623|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
56022624|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022625|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022626|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56022627|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022628|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56022629|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022630|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022631|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
56022632|NCT01529827|Methotrexate|methotrexate|mesh-list
56022633|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
56022634|NCT01529827|Fludarabine|fludarabine|mesh-list
56022635|NCT01529827|Melphalan|melphalan|mesh-list
56022636|NCT01529827|Tacrolimus|tacrolimus|mesh-list
56022637|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56022638|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
56022639|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56022640|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022641|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56022642|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
56022643|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022652|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56022653|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56022654|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56022655|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
56022656|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56022657|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022658|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56022659|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
56022660|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56022661|NCT01571557|Dexamethasone|dexamethasone|mesh-list
56022662|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56022663|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
56022664|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
56022665|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022666|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022667|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56022668|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
56022670|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56022671|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56022672|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022673|NCT00569660|Azacitidine|azacitidine|mesh-list
56022674|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56022675|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
56022676|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022677|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022678|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022679|NCT01573273|Oxytocin|oxytocin|mesh-list
56022680|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
56022681|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56022694|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56022695|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56022696|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022697|NCT00572468|Simvastatin|simvastatin|mesh-list
56022698|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56022699|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56022700|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
56022701|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022702|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56022703|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56022704|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022705|NCT02339246|Tacrolimus|tacrolimus|mesh-list
56022706|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022707|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
56022708|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022709|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56022710|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022711|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022712|NCT00572936|Timolol|timolol|mesh-list
56022713|NCT00572936|Dorzolamide|dorzolamide|mesh-list
56022714|NCT00572936|Latanoprost|latanoprost|mesh-list
56022715|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56022716|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56022717|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
56022718|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022719|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022720|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022721|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56022722|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56022723|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56022724|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56022734|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
56022735|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022736|NCT05092412|Carboplatin|carboplatin|mesh-list
56022737|NCT05092412|Etoposide|etoposide|mesh-list
56022738|NCT05092412|Durvalumab|durvalumab|mesh-list
56022739|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022740|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56022741|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56022742|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56022743|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022744|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022745|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022746|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56022747|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022748|NCT05004896|Midazolam|midazolam|mesh-list
56022749|NCT05004896|Ketamine|ketamine|mesh-list
56022750|NCT05004896|Analgesics|analgesics|mesh-ancestor
56022751|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
56022752|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022753|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022754|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56022755|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56022756|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
56022757|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
56022758|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56022759|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56022760|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56022761|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022762|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022763|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56022764|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56022765|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56022766|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56022767|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56022768|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
56022774|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022775|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022776|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022777|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
56022778|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022779|NCT04866602|Atovaquone|atovaquone|mesh-list
56022780|NCT04866602|Proguanil|proguanil|mesh-list
56022781|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
56022782|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022783|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
56022784|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56022785|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56022786|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022787|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022788|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
56022789|NCT00578552|Gabapentin|gabapentin|mesh-list
56022790|NCT00578552|Analgesics|analgesics|mesh-ancestor
56022791|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
56022792|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022793|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022794|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
56022795|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56022796|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56022797|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56022798|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56022799|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56022800|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56022801|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56022802|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022803|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
56022805|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56022806|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56022807|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
56022814|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56022815|NCT01532089|Growth Substances|growth substances|mesh-ancestor
56022816|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022817|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
56022818|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
56022819|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56022820|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022821|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022822|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
56022823|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
56022824|NCT00579878|Methotrexate|methotrexate|mesh-list
56022825|NCT00579878|Leflunomide|leflunomide|mesh-list
56022826|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56022827|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
56022828|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56022829|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022830|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56022831|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
56022832|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022833|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022834|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
56022835|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022836|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56022837|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022838|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
56022839|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022840|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56022841|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
56022842|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56022843|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56022844|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022845|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56022846|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56022848|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
56022854|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56022855|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
56022856|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022857|NCT04925648|Dasatinib|dasatinib|mesh-list
56022858|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022859|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56022860|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022861|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022862|NCT05246072|Ivermectin|ivermectin|mesh-list
56022863|NCT05246072|Colchicine|colchicine|mesh-list
55766609|NCT05520645|Propofol|propofol|mesh-list
56022864|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
56022865|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022866|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
56022867|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
56022868|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
56022869|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022870|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022871|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56022872|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022873|NCT02135432|Ivacaftor|ivacaftor|mesh-list
56022874|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56022875|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56022876|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022877|NCT05245994|Carboplatin|carboplatin|mesh-list
56022878|NCT05245994|Etoposide|etoposide|mesh-list
56022879|NCT05245994|Durvalumab|durvalumab|mesh-list
56022880|NCT05245994|Olaparib|olaparib|mesh-list
56022881|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022882|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56022883|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56022884|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56022885|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022886|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022887|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56022888|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56022889|NCT05245604|Cyclosporine|cyclosporine|mesh-list
56022892|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022893|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022894|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022895|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
56022896|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022897|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
56022898|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022899|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
56022900|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56022901|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56022902|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56022903|NCT05245448|Tetrandrine|tetrandrine|mesh-list
56022904|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
56022905|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56022907|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022908|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56022909|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022910|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
56022911|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56022912|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56022913|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022914|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56022915|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022916|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022917|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
56022918|NCT00581048|Vitamin E|vitamin e|mesh-list
56022919|NCT00581048|Tocopherols|tocopherols|mesh-list
56022920|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
56022938|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022939|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56022940|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56022941|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022942|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
56022943|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55760756|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55725233|NCT02348008|Growth Substances|growth substances|mesh-ancestor
56022944|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56022945|NCT01579513|Prednisolone|prednisolone|mesh-list
56022946|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
56022947|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56022948|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
56022949|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
56022950|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56022951|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
56022952|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
56022953|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56022954|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022955|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56022956|NCT01579513|Hormones|hormones|mesh-ancestor
56022957|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56022958|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56022959|NCT01579513|Protective Agents|protective agents|mesh-ancestor
56022960|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56022961|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022962|NCT01534897|Dabrafenib|dabrafenib|mesh-list
56022963|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56022964|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56022965|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022966|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022983|NCT00583622|Growth Substances|growth substances|mesh-ancestor
56022984|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56022985|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
56022986|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56022987|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
56022988|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56022989|NCT00583622|Antiviral Agents|antiviral agents|mesh-ancestor
56022990|NCT00583622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56022991|NCT00583622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56022992|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56022993|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
56022994|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
56022995|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
56022996|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
56022997|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56022998|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
56022999|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56023002|NCT00583700|Vitamins|vitamins|mesh-ancestor
56023003|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
56023004|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023005|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
56023006|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023007|NCT00583700|Protective Agents|protective agents|mesh-ancestor
56023008|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56023009|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023010|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56023011|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56023012|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
56023013|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56023014|NCT05540743|Adalimumab|adalimumab|mesh-list
56023015|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023016|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023017|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
56023018|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
56023019|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56023023|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023024|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023025|NCT04257188|Anesthetics|anesthetics|mesh-list
56023026|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023027|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023028|NCT04224428|Fexofenadine|fexofenadine|mesh-list
56023029|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56023030|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56023031|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56023032|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
56023033|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
56023034|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032500|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023035|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023036|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023037|NCT04224194|Adalimumab|adalimumab|mesh-list
56023038|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023039|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023040|NCT00584948|Memantine|memantine|mesh-list
56023041|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56023042|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56023043|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
56023044|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023045|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023046|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023047|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56023048|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56023049|NCT00605072|Metoprolol|metoprolol|mesh-list
56023050|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56023051|NCT00605072|Candesartan|candesartan|mesh-list
56023052|NCT00605072|Lisinopril|lisinopril|mesh-list
56023053|NCT00605072|Nifedipine|nifedipine|mesh-list
56023054|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56023065|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56023066|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56023067|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56023068|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
56023069|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023070|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56023071|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56023072|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56023073|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56023074|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
56023075|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
56023076|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56023077|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56023078|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
56023079|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023080|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56023081|NCT00605072|Protective Agents|protective agents|mesh-ancestor
56023082|NCT00585104|Simendan|simendan|mesh-list
56023083|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56023084|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
56023085|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56023086|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56023087|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023088|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023089|NCT00585104|Protective Agents|protective agents|mesh-ancestor
56023090|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023091|NCT00585182|Enoxaparin|enoxaparin|mesh-list
56023092|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
56023093|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55725340|NCT05646394|Aspirin|aspirin|mesh-list
56023094|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56023095|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023096|NCT00585650|Etanercept|etanercept|mesh-list
56023097|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56023098|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56023103|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023104|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023105|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023106|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56023107|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
56023109|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
56023110|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
56023111|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023112|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023113|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
56023114|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023115|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56023116|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56023117|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56023118|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023119|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023120|NCT00605384|Tenofovir|tenofovir|mesh-list
56023121|NCT00605384|Lamivudine|lamivudine|mesh-list
56023122|NCT00605384|Entecavir|entecavir|mesh-list
56023123|NCT00605384|Adefovir|adefovir|mesh-list
56023124|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
56023125|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023126|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56023127|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56023128|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023129|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023130|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56023131|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56023133|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56023134|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023135|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023136|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
56023137|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023138|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023142|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023144|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023145|NCT00587132|Hormones|hormones|mesh-ancestor
56023146|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023147|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023148|NCT00587678|Simvastatin|simvastatin|mesh-list
56023149|NCT00587678|Ezetimibe|ezetimibe|mesh-list
56023150|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56023151|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56023152|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
56023153|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023154|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56023155|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56023156|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023157|NCT02138006|Insulin|insulin|mesh-list
56023158|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56023159|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56023160|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023161|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
56023162|NCT04545008|Famotidine|famotidine|mesh-list
56023163|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56023164|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
56023165|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023166|NCT04545008|Expectorants|expectorants|mesh-ancestor
56023167|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
56023168|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56023169|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
56023170|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023171|NCT04545008|Protective Agents|protective agents|mesh-ancestor
56023172|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023173|NCT04545008|Antidotes|antidotes|mesh-ancestor
56023174|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56023175|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023176|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56023177|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
56023183|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
56023184|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
56023185|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023186|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023187|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023188|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
56023189|NCT04527770|Hormones|hormones|mesh-ancestor
56023190|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023191|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56023192|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023193|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56023194|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56023195|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023196|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56023197|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56023198|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56023199|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56023200|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
56023201|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
56023202|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
56023203|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
56023204|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023205|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023206|NCT01798940|Pioglitazone|pioglitazone|mesh-list
56023212|NCT00609128|Analgesics|analgesics|mesh-ancestor
56023231|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725392|NCT00561743|Hormones|hormones|mesh-ancestor
56023232|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56023233|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
56023234|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023235|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023236|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56023237|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56023238|NCT00610688|Vitamin D|vitamin d|mesh-list
56023239|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
56023240|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
56023241|NCT00610688|Vitamins|vitamins|mesh-list
56023242|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
56023243|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023244|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56023245|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56023246|NCT00669578|Pomalidomide|pomalidomide|mesh-list
56023247|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
56023248|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023249|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56023250|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56023251|NCT00669578|Growth Substances|growth substances|mesh-ancestor
56023252|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
56023253|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023254|NCT02137382|Pancrelipase|pancrelipase|mesh-list
56023255|NCT02137382|Pancreatin|pancreatin|mesh-list
56023256|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023257|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56023258|NCT00611468|Topotecan|topotecan|mesh-list
56023259|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023260|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56023276|NCT00670982|Vinorelbine|vinorelbine|mesh-list
56023277|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56023278|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023279|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56023280|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56023281|NCT00670982|Growth Substances|growth substances|mesh-ancestor
56023282|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023283|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
56023284|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56023285|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
56023286|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
56023287|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
56023288|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023289|NCT00612560|Anastrozole|anastrozole|mesh-list
56023290|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56023291|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023292|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56023293|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56023294|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023295|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023296|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56023297|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
56023298|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023300|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
56023301|NCT00612716|Busulfan|busulfan|mesh-list
56023302|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56023303|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
56023304|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023305|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023306|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56023307|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
56023308|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023309|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023315|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
56023316|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023317|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56023318|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
56023319|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023320|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
56023321|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023322|NCT00613028|Bevacizumab|bevacizumab|mesh-list
56023323|NCT00613028|Etoposide|etoposide|mesh-list
56023324|NCT00613028|Temozolomide|temozolomide|mesh-list
56023325|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56023326|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023327|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56023328|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56023329|NCT00613028|Growth Substances|growth substances|mesh-ancestor
56023330|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023331|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
56023332|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56023333|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56023334|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56023335|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023336|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023337|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56023338|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
56023339|NCT01799798|Denosumab|denosumab|mesh-list
56023340|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56023341|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023342|NCT00614198|Caseins|caseins|mesh-list
56023343|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
56023344|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
56023345|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023346|NCT00616772|Choline|choline|mesh-list
56023347|NCT00616772|Atorvastatin|atorvastatin|mesh-list
56023348|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
56023349|NCT00616772|Fenofibrate|fenofibrate|mesh-list
56023350|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56023351|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56023352|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
56023353|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023379|NCT00673712|Analgesics|analgesics|mesh-ancestor
56023380|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
56023381|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023382|NCT04062032|Aspirin|aspirin|mesh-list
56023383|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56023384|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56023385|NCT04062032|Analgesics|analgesics|mesh-ancestor
56023386|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
56023387|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023388|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023389|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023390|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023391|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56023392|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56023393|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023394|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56023395|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56023396|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023398|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56023399|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
56023400|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56023401|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56023402|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56023403|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023404|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023405|NCT03722966|Nicotine|nicotine|mesh-list
56023406|NCT03722966|Varenicline|varenicline|mesh-list
56023410|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023411|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56023412|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56023413|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
56023414|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023415|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023416|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
56023417|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023418|NCT01582477|Bupivacaine|bupivacaine|mesh-list
56023419|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
56023420|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
56023421|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023422|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023423|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
56023424|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023425|NCT03001687|Vitamin D|vitamin d|mesh-list
56023426|NCT03001687|Vitamins|vitamins|mesh-ancestor
56023427|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
56023428|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023429|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56023430|NCT03001609|Abivertinib|abivertinib|mesh-list
56023431|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56023432|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023433|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023434|NCT03007381|Ketorolac|ketorolac|mesh-list
56023435|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56023436|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56023437|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56023438|NCT03007381|Analgesics|analgesics|mesh-ancestor
56023439|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
56023440|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023441|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023449|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023450|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
56023451|NCT01585207|Vigabatrin|vigabatrin|mesh-list
56023452|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
56023453|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023454|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023455|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
56023456|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023457|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023458|NCT03007303|Olanzapine|olanzapine|mesh-list
56023459|NCT03007303|Risperidone|risperidone|mesh-list
56023460|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56023461|NCT03007303|Ziprasidone|ziprasidone|mesh-list
56023462|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
56023463|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56023464|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
56023465|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023466|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023467|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023468|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56023469|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023470|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56023471|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56023472|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
56023473|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
56023474|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
56023475|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023498|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023499|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56023500|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
56023501|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023502|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
56023503|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56023504|NCT01588561|Nicotine|nicotine|mesh-list
56023505|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56023507|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023508|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023509|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56023510|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56023511|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
56023512|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023513|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023514|NCT00619190|Aripiprazole|aripiprazole|mesh-list
56023515|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
56023516|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56023517|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56023518|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56023519|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023520|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023521|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
56023523|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023524|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023532|NCT01589263|Tamsulosin|tamsulosin|mesh-list
56023546|NCT00619970|Lactulose|lactulose|mesh-list
56023547|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56023548|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56023549|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023550|NCT01591837|Vaccines|vaccines|mesh-list
56023551|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
56023552|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023553|NCT01592851|Fluorides|fluorides|mesh-list
56023554|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
56023555|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
56023556|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
56023557|NCT01592851|Protective Agents|protective agents|mesh-ancestor
56023558|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023559|NCT00675584|Budesonide|budesonide|mesh-list
56023560|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023561|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56023562|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
56023563|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023564|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023565|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56023566|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
56023567|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
56023568|NCT00675584|Hormones|hormones|mesh-ancestor
56023569|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023570|NCT03376646|Paclitaxel|paclitaxel|mesh-list
56023571|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56023572|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023573|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
56023574|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
56023575|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
56023576|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023577|NCT00676364|Lidocaine|lidocaine|mesh-list
56023578|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
56023579|NCT00676364|Anesthetics|anesthetics|mesh-list
56023580|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023581|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023586|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56023587|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023588|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023590|NCT00676676|Androgens|androgens|mesh-ancestor
56023591|NCT00676676|Hormones|hormones|mesh-ancestor
56023592|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023593|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023594|NCT00677924|Zalutumumab|zalutumumab|mesh-list
56023595|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56023596|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023597|NCT03177122|Inositol|inositol|mesh-list
56023598|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
56023599|NCT03177122|Vitamins|vitamins|mesh-ancestor
56023600|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
56023601|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023602|NCT00621530|Ketorolac|ketorolac|mesh-list
56023603|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56023604|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56023605|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56023606|NCT00621530|Analgesics|analgesics|mesh-ancestor
56023607|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
56023608|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023609|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023610|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023611|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023612|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56023613|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023614|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023615|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
56023616|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56023617|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023618|NCT00621686|Bevacizumab|bevacizumab|mesh-list
56023619|NCT00621686|Sorafenib|sorafenib|mesh-list
56023620|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56023625|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023626|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
56023627|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56023628|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023629|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023630|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
56023631|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023632|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56023633|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023634|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023635|NCT00678470|Alefacept|alefacept|mesh-list
56023636|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
56023637|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
56023638|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023639|NCT00623012|Sirolimus|sirolimus|mesh-list
56023640|NCT00623012|Tacrolimus|tacrolimus|mesh-list
56023641|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56023642|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
56023643|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023644|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56023645|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023646|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023647|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56023648|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023649|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56023650|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023651|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
56023652|NCT02592356|Lenvatinib|lenvatinib|mesh-list
56023653|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023654|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56023655|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023656|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023666|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56023667|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
56023668|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023669|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023670|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55761142|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023671|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56023672|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
56023673|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56023674|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023675|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56023676|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56023677|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
56023678|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56023687|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
56023688|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023689|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023690|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56023691|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
56023692|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
56023693|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56023694|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56023695|NCT02174822|Paroxetine|paroxetine|mesh-list
56023696|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56023697|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56023698|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023699|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023700|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023701|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023702|NCT02174822|Analgesics|analgesics|mesh-ancestor
56023703|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
56023704|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023705|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
56023706|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56023707|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
56023708|NCT02174822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56023709|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
56023710|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56023711|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56023712|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56023713|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023714|NCT00624416|Prednisolone|prednisolone|mesh-list
56023715|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56023716|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
56023717|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56023718|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
56023719|NCT00624416|Cortisone|cortisone|mesh-list
56023720|NCT00624416|Isoproterenol|isoproterenol|mesh-list
56023721|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56023722|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
56023723|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56023724|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
56023725|NCT00624416|Hormones|hormones|mesh-ancestor
56023726|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023727|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023728|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56023742|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56023743|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
56023744|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56023745|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
56023746|NCT01872260|Letrozole|letrozole|mesh-list
56023747|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023748|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56023749|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56023750|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023751|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023752|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56023753|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
56023754|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023755|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023756|NCT00626210|Modafinil|modafinil|mesh-list
56023757|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56023758|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023759|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56023760|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56023761|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56023762|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023763|NCT00653276|Cyclosporine|cyclosporine|mesh-list
56023764|NCT00653276|Ezetimibe|ezetimibe|mesh-list
56023765|NCT00653276|Cyclosporins|cyclosporins|mesh-list
56023766|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023767|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023768|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56023769|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
56023770|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023771|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
56023772|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023773|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
56023780|NCT00683852|Aripiprazole|aripiprazole|mesh-list
56023782|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56023783|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56023784|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56023785|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023786|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023787|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
56023788|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
56023789|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023790|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023791|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56023792|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56023793|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
56023794|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56023795|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56023796|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56023797|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56023798|NCT03006835|Clopidogrel|clopidogrel|mesh-list
56023799|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56023800|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56023801|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56023802|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56023803|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
56023804|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023805|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023806|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023807|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
56023808|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
56023809|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56023810|NCT03006757|Protective Agents|protective agents|mesh-ancestor
56023811|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023822|NCT03000127|Hormones|hormones|mesh-ancestor
56023823|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56023824|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023825|NCT03000205|Lidocaine|lidocaine|mesh-list
56023826|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
56023827|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
56023828|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023829|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023830|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
56023831|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023832|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56023833|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56023834|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56023835|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023836|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023837|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
56023838|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56023840|NCT02999815|Antitoxins|antitoxins|mesh-list
56023841|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
56023842|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023843|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
56023844|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56023845|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023846|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023847|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56023848|NCT05134363|Analgesics|analgesics|mesh-ancestor
56023849|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
56023850|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023851|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56023852|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56023853|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56023854|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
56023855|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023856|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023859|NCT03006679|Piperacillin|piperacillin|mesh-list
56023860|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56023861|NCT03006679|Vaborbactam|vaborbactam|mesh-list
56023862|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56023863|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023864|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56023865|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023866|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023867|NCT03006445|Dotinurad|dotinurad|mesh-list
56023868|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
56023869|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
56023870|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56023872|NCT05011123|Vaccines|vaccines|mesh-list
56023873|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
56023874|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023875|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
56023876|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
56023877|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56023878|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
56023879|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
56023880|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023881|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023882|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56023883|NCT03006211|Analgesics|analgesics|mesh-ancestor
56023884|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
56023885|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023886|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56023887|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
56023900|NCT02247505|Tadalafil|tadalafil|mesh-list
56023908|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56023909|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56023910|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56023911|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
56023912|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56023913|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023914|NCT04707625|Aflibercept|aflibercept|mesh-list
56023915|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56023916|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56023917|NCT04707625|Growth Substances|growth substances|mesh-ancestor
56023918|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023919|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
56023920|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023921|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56023922|NCT02248129|Telmisartan|telmisartan|mesh-list
56023923|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56023924|NCT02248129|Diuretics|diuretics|mesh-ancestor
56023925|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
56023926|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023927|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56023928|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56023929|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023930|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56023931|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56023932|NCT02248207|Pramipexole|pramipexole|mesh-list
56023933|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
56023934|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023935|NCT02248207|Protective Agents|protective agents|mesh-ancestor
56023936|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023937|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56023948|NCT05672095|Selenium|selenium|mesh-list
56023950|NCT05672095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56023951|NCT05672095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023952|NCT05672095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023953|NCT05672095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023954|NCT05672095|Antioxidants|antioxidants|mesh-ancestor
56023955|NCT05672095|Protective Agents|protective agents|mesh-ancestor
56023956|NCT05672095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023957|NCT05672095|Trace Elements|trace elements|mesh-ancestor
56023958|NCT05672095|Micronutrients|micronutrients|mesh-ancestor
56023959|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
56023960|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56023961|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023962|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56023963|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
56023964|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56023965|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56023966|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751172|NCT04968951|Metronidazole|metronidazole|mesh-list
56023967|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023968|NCT00684242|Lenalidomide|lenalidomide|mesh-list
56023969|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
56023970|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023971|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56023972|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56023973|NCT00684242|Growth Substances|growth substances|mesh-ancestor
56023974|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56023975|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56023976|NCT00651560|Simvastatin|simvastatin|mesh-list
56023978|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56023979|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56023980|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
56023981|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56023982|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56023983|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56023984|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56023985|NCT00684554|Buprenorphine|buprenorphine|mesh-list
56023986|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56023987|NCT00684554|Narcotics|narcotics|mesh-ancestor
56023988|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56023989|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56023990|NCT00684554|Analgesics|analgesics|mesh-ancestor
56023991|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
56023992|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56023993|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56023994|NCT00551876|Simvastatin|simvastatin|mesh-list
56023995|NCT00551876|Ezetimibe|ezetimibe|mesh-list
56023996|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56023997|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56023998|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
56023999|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024000|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56024001|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56024002|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024003|NCT04451863|Caryophyllene|caryophyllene|mesh-list
56024004|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024005|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56024006|NCT04451863|Analgesics|analgesics|mesh-ancestor
56024007|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
56024008|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024009|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56024010|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024011|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024012|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56024013|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56024014|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56024015|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56024016|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024017|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
56024018|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024020|NCT00251576|Heparin|heparin|mesh-list
56024022|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56024023|NCT00251576|Tinzaparin|tinzaparin|mesh-list
56024024|NCT00251576|Dalteparin|dalteparin|mesh-list
56024025|NCT00251576|Tirofiban|tirofiban|mesh-list
56024026|NCT00251576|Simvastatin|simvastatin|mesh-list
56024027|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
56024028|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56024029|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56024030|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024031|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56024032|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56024033|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
56024034|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56024035|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56024036|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024037|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56024038|NCT04387604|Ranibizumab|ranibizumab|mesh-list
56024039|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56024040|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56024041|NCT04387604|Growth Substances|growth substances|mesh-ancestor
56024042|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024043|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
56024044|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024045|NCT03005665|Acetazolamide|acetazolamide|mesh-list
56024046|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
56024047|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56024048|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024049|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024050|NCT03005665|Diuretics|diuretics|mesh-ancestor
56024051|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
56024052|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024053|NCT00628628|Rasburicase|rasburicase|mesh-list
56024054|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
56024055|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024056|NCT04386811|Calcitriol|calcitriol|mesh-list
56024057|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56024058|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024059|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56024060|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56024061|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024062|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56024064|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
56024065|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56024066|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
56024067|NCT04357873|Vorinostat|vorinostat|mesh-list
56024068|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56024069|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024070|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56024071|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024072|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024073|NCT05671315|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56024074|NCT05671315|Antiviral Agents|antiviral agents|mesh-ancestor
56024075|NCT05671315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024076|NCT05671081|Magnesium Sulfate|magnesium sulfate|mesh-list
56024077|NCT05671081|Dexmedetomidine|dexmedetomidine|mesh-list
56024078|NCT05671081|Analgesics|analgesics|mesh-list
56024079|NCT05671081|Narcotics|narcotics|mesh-list
56024080|NCT05671081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56024081|NCT05671081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024082|NCT05671081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024083|NCT05671081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56024084|NCT05671081|Sensory System Agents|sensory system agents|mesh-ancestor
56024085|NCT05671081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024086|NCT05671081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56024087|NCT05671081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56024102|NCT00630734|Pravastatin|pravastatin|mesh-list
56024103|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56024104|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56024105|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
56024106|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024107|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024108|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56024109|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56024110|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
56024111|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024112|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56024113|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56024114|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55725726|NCT04470479|Miotics|miotics|mesh-ancestor
56024115|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55751324|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56024116|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
56024117|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56024118|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56024119|NCT05644249|Doxorubicin|doxorubicin|mesh-list
56024120|NCT05644249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024121|NCT05644249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56024122|NCT05644249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56024123|NCT05644249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56024124|NCT05644249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024125|NCT05644249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024129|NCT00631358|Dexamethasone|dexamethasone|mesh-list
56024130|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024131|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
56024138|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024139|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56024140|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024141|NCT02248753|Metoprolol|metoprolol|mesh-list
56024142|NCT02248753|Digoxin|digoxin|mesh-list
56024143|NCT02248753|Amiodarone|amiodarone|mesh-list
56024144|NCT02248753|Verapamil|verapamil|mesh-list
56024145|NCT02248753|Flecainide|flecainide|mesh-list
56024146|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56024147|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56024148|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
56024149|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
56024150|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024151|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024152|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56024153|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56024154|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56024155|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
56024156|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024157|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024158|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56024159|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024160|NCT02248753|Protective Agents|protective agents|mesh-ancestor
56024161|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
56024162|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55739515|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56024163|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56024164|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56024165|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56024166|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56024167|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56024168|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56024177|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
56024178|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
56024179|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024180|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024181|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56024182|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
56024183|NCT00687674|Hormones|hormones|mesh-ancestor
56024184|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024185|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56024186|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024187|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
56024188|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56024189|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56024190|NCT00687674|Growth Substances|growth substances|mesh-ancestor
56024191|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
56024192|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56024193|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024194|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024195|NCT04143061|Vaccines|vaccines|mesh-list
56024196|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
56024197|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024198|NCT00687908|Adapalene|adapalene|mesh-list
56024199|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56024200|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
56024201|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56024202|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56024203|NCT00687908|Analgesics|analgesics|mesh-ancestor
56024204|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
56024205|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024206|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024207|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024208|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024209|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56024210|NCT00689078|Prednisolone|prednisolone|mesh-list
56024211|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56024212|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
56024215|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
56024216|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56024217|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
56024218|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024219|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
56024220|NCT00689078|Hormones|hormones|mesh-ancestor
56024221|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024222|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024223|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56024224|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024225|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
56024226|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
56024227|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024228|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56024229|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56024230|NCT00689078|Protective Agents|protective agents|mesh-ancestor
56024231|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56024232|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56024233|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56024234|NCT05568979|Vaccines|vaccines|mesh-list
56024235|NCT05568979|Immunologic Factors|immunologic factors|mesh-ancestor
56024236|NCT05568979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024237|NCT03005353|Clotrimazole|clotrimazole|mesh-list
56024238|NCT03005353|Miconazole|miconazole|mesh-list
56024239|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56024240|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024241|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
56024242|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56024243|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56024244|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024245|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024246|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56024247|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
56024248|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024249|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024252|NCT00588536|Leucovorin|leucovorin|mesh-list
56024253|NCT00588536|Methotrexate|methotrexate|mesh-list
56024254|NCT00588536|Thioguanine|thioguanine|mesh-list
56024255|NCT00588536|Calcium|calcium|mesh-list
56024256|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
56024257|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56024258|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024259|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56024260|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
56024261|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56024262|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56024263|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
56024264|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024265|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024266|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56024267|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024268|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56024269|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024270|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
56024271|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024272|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56024273|NCT00588536|Antidotes|antidotes|mesh-ancestor
56024274|NCT00588536|Protective Agents|protective agents|mesh-ancestor
56024275|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
56024276|NCT00588536|Vitamins|vitamins|mesh-ancestor
56024277|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
56024278|NCT03977233|Leucovorin|leucovorin|mesh-list
56024279|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
56024280|NCT03977233|Irinotecan|irinotecan|mesh-list
56024281|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024282|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56024283|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56024284|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024285|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024286|NCT03977233|Antidotes|antidotes|mesh-ancestor
56024287|NCT03977233|Protective Agents|protective agents|mesh-ancestor
56024288|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024289|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
56024290|NCT03977233|Vitamins|vitamins|mesh-ancestor
56024291|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
56024292|NCT03951649|Acetaminophen|acetaminophen|mesh-list
56024293|NCT03951649|Caffeine|caffeine|mesh-list
56024294|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56024295|NCT03951649|Analgesics|analgesics|mesh-ancestor
56024296|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
56024297|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024298|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024299|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
56024300|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56024301|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56024302|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024303|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024304|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56024305|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56024306|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
56024307|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024308|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
56024309|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024310|NCT02219503|Ritonavir|ritonavir|mesh-list
56024311|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56024312|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56024313|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
56024314|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024315|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024316|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56024317|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56024318|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
56024319|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024320|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56024321|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56024322|NCT00592124|Tenofovir|tenofovir|mesh-list
56024323|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
56024324|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024325|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56024326|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56024328|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024330|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56024331|NCT02221219|Indomethacin|indomethacin|mesh-list
56024332|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56024333|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56024334|NCT02221219|Analgesics|analgesics|mesh-ancestor
56024335|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
56024336|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024337|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024338|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024339|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024340|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
56024341|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
56024342|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56024343|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56024344|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024345|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024346|NCT03875287|Decitabine|decitabine|mesh-list
56024347|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56024348|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
56024349|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024350|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024351|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024352|NCT00593450|Bevacizumab|bevacizumab|mesh-list
56024353|NCT00593450|Ranibizumab|ranibizumab|mesh-list
56024354|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56024355|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024356|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56024357|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56024358|NCT00593450|Growth Substances|growth substances|mesh-ancestor
56024359|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024360|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
56024367|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024368|NCT00594230|Panobinostat|panobinostat|mesh-list
56024369|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024370|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56024371|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024372|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024373|NCT00594308|Cyclosporine|cyclosporine|mesh-list
56024374|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
56024375|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
56024376|NCT00594308|Fludarabine|fludarabine|mesh-list
56024377|NCT00594308|Cyclosporins|cyclosporins|mesh-list
56024378|NCT00594308|Basiliximab|basiliximab|mesh-list
56024379|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024380|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
56024381|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024382|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024383|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56024384|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
56024385|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024386|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024387|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56024388|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024389|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
56024390|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024391|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
56024392|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56024393|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56024394|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56024395|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
56024396|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56024398|NCT02137538|Anastrozole|anastrozole|mesh-list
56024399|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024400|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56024402|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024407|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024408|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56024409|NCT00595556|Zonisamide|zonisamide|mesh-list
56024410|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
56024411|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56024412|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56024413|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024415|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024417|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
56024418|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024419|NCT00595946|Lubiprostone|lubiprostone|mesh-list
56024420|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56024421|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56024422|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024423|NCT00597038|Dasatinib|dasatinib|mesh-list
56024424|NCT00597038|Dacarbazine|dacarbazine|mesh-list
56024425|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024426|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56024427|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024428|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024429|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56024430|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
56032501|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
56024457|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024458|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024460|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
56024461|NCT01798004|Melphalan|melphalan|mesh-list
56024462|NCT01798004|Busulfan|busulfan|mesh-list
56024463|NCT01798004|Doxorubicin|doxorubicin|mesh-list
56024464|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56024465|NCT01798004|Etoposide|etoposide|mesh-list
56024466|NCT01798004|Vincristine|vincristine|mesh-list
56024467|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
56024468|NCT01798004|Topotecan|topotecan|mesh-list
56024469|NCT01798004|Mesna|mesna|mesh-list
56024470|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024471|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
56024472|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024473|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024474|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56024475|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
56024519|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024520|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024521|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56024522|NCT00692978|Fluticasone|fluticasone|mesh-list
56024523|NCT00692978|Xhance|xhance|mesh-list
56024524|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024525|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56024526|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
56024527|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024528|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024529|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56024530|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
56024531|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
56024532|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56024533|NCT00601718|Rituximab|rituximab|mesh-list
56024534|NCT00601718|Carboplatin|carboplatin|mesh-list
56024535|NCT00601718|Etoposide|etoposide|mesh-list
56024536|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
56024537|NCT00601718|Ifosfamide|ifosfamide|mesh-list
56024538|NCT00601718|Vorinostat|vorinostat|mesh-list
56024539|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56024540|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024541|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
56024542|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024543|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024544|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56024545|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56024546|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56024547|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024548|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024549|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56024550|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
56024551|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56024552|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
56024561|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024562|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024563|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56024564|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
56024565|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
56024566|NCT00693992|Sunitinib|sunitinib|mesh-list
56024567|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751774|NCT03324815|Morphine|morphine|mesh-list
56024568|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56024569|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56024570|NCT00693992|Growth Substances|growth substances|mesh-ancestor
56024571|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024572|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
56024573|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56024574|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024575|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024576|NCT00645710|Gemcitabine|gemcitabine|mesh-list
56024577|NCT00645710|Floxuridine|floxuridine|mesh-list
56024578|NCT00645710|Antibodies|antibodies|mesh-list
56024579|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56024580|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
56024581|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024582|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56024583|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
56024584|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024585|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024586|NCT00645710|Antiviral Agents|antiviral agents|mesh-ancestor
56024587|NCT00645710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024607|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56024608|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
56024609|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
56024610|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56024611|NCT00646646|Analgesics|analgesics|mesh-ancestor
56024613|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024614|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56024615|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56024616|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56024617|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
56024618|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024619|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024620|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56024621|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56024622|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56024623|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56024624|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
56024625|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
56024626|NCT02998424|Propofol|propofol|mesh-list
56024627|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56024628|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024629|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024630|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56024631|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
56024632|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
56024633|NCT00696488|Fluorouracil|fluorouracil|mesh-list
56024634|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
56024635|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024636|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56024637|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024638|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024639|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
56024645|NCT00650078|Prednisone|prednisone|mesh-list
56024650|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024651|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56024652|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024654|NCT01799486|Telbivudine|telbivudine|mesh-list
56024655|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
56024656|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024657|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56024658|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56024659|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024660|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024661|NCT00650546|Exenatide|exenatide|mesh-list
56024662|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56024663|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024664|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56024665|NCT00650546|Incretins|incretins|mesh-ancestor
56024666|NCT00650546|Hormones|hormones|mesh-ancestor
56024667|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024668|NCT01386710|Bevacizumab|bevacizumab|mesh-list
56024669|NCT01386710|Carboplatin|carboplatin|mesh-list
56024670|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56024671|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024672|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56024673|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56024674|NCT01386710|Growth Substances|growth substances|mesh-ancestor
56024675|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024676|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
56024677|NCT00650858|Plasminogen|plasminogen|mesh-list
56024678|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56024679|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
56024680|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56024681|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024682|NCT00651482|Bevacizumab|bevacizumab|mesh-list
56024683|NCT00651482|Everolimus|everolimus|mesh-list
56024684|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56024685|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024686|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56024687|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56024688|NCT00651482|Growth Substances|growth substances|mesh-ancestor
56024689|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024690|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
56024691|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024692|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
56024693|NCT00654836|Bevacizumab|bevacizumab|mesh-list
56024694|NCT00654836|Carboplatin|carboplatin|mesh-list
56024695|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56024696|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56024697|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024698|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56024699|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56024700|NCT00654836|Growth Substances|growth substances|mesh-ancestor
56024701|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024702|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
56024703|NCT02997800|Labetalol|labetalol|mesh-list
56024704|NCT02997800|Fentanyl|fentanyl|mesh-list
56024705|NCT02997800|Esmolol|esmolol|mesh-list
56024706|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56024707|NCT02997800|Narcotics|narcotics|mesh-ancestor
56024708|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024709|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024710|NCT02997800|Analgesics|analgesics|mesh-ancestor
56024711|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
56024712|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024713|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56024714|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56024735|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56024736|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
56024737|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024738|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56024739|NCT00656630|Naltrexone|naltrexone|mesh-list
56024740|NCT00656630|Acamprosate|acamprosate|mesh-list
56024741|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56024742|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56024743|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024744|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
56024745|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024746|NCT01362998|Fentanyl|fentanyl|mesh-list
56024747|NCT01362998|Morphine|morphine|mesh-list
56024748|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56024749|NCT01362998|Narcotics|narcotics|mesh-ancestor
56024750|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024751|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024752|NCT01362998|Analgesics|analgesics|mesh-ancestor
56024753|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
56024754|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024755|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56024756|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56024757|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
56024758|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
56024759|NCT02998268|Paclitaxel|paclitaxel|mesh-list
56024760|NCT02998268|Carboplatin|carboplatin|mesh-list
56024761|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
56024762|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56024763|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024764|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
56024765|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
56024782|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
56024783|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56024784|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024785|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
56024786|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024787|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56024788|NCT04345094|Hydroquinone|hydroquinone|mesh-list
56024789|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
56024790|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024791|NCT04345094|Protective Agents|protective agents|mesh-ancestor
56024792|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024793|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56024794|NCT00702884|Sunitinib|sunitinib|mesh-list
56024795|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024796|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56024797|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56024798|NCT00702884|Growth Substances|growth substances|mesh-ancestor
56024799|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024800|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
56024801|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56024802|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024803|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024804|NCT00703508|Metformin|metformin|mesh-list
56024805|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56024806|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024807|NCT01284335|Gemcitabine|gemcitabine|mesh-list
56024808|NCT01284335|Docetaxel|docetaxel|mesh-list
56024809|NCT01284335|Temozolomide|temozolomide|mesh-list
56024810|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56024811|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024812|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56024813|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
56024814|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024815|NCT01284335|Antiviral Agents|antiviral agents|mesh-ancestor
56024821|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
56024822|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
56024823|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
56024824|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56024825|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
56024826|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56024827|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
56024828|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56024829|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
56024830|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024831|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024832|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56024833|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
56024834|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56024835|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56024836|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56024837|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
56024838|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024839|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024840|NCT01230593|Tobramycin|tobramycin|mesh-list
56024841|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
56024842|NCT01230593|Dexamethasone|dexamethasone|mesh-list
56024843|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
56024844|NCT01230593|BB 1101|bb 1101|mesh-list
56024845|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024846|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
56024847|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
56024848|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024849|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024850|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56024865|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56024866|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56024867|NCT01195025|Analgesics|analgesics|mesh-ancestor
56024868|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
56024869|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024870|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024871|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024872|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024873|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
56024875|NCT01231841|Cyclosporine|cyclosporine|mesh-list
56024876|NCT01231841|Cyclosporins|cyclosporins|mesh-list
56024877|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
56024878|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56024879|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
56024880|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024881|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024882|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56024883|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
56024884|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024885|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
55725933|NCT00407303|Bortezomib|bortezomib|mesh-list
56024886|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56024887|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
56024888|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024889|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56024890|NCT00703664|Bortezomib|bortezomib|mesh-list
56024891|NCT00703664|Vorinostat|vorinostat|mesh-list
56024892|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024893|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56024894|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024895|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024896|NCT00658736|Triamcinolone|triamcinolone|mesh-list
56024897|NCT00658736|Bupivacaine|bupivacaine|mesh-list
56024898|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
56024899|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
56024905|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
56024907|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56024908|NCT00659360|Saracatinib|saracatinib|mesh-list
56024909|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024910|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024911|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024912|NCT01197833|Polidocanol|polidocanol|mesh-list
56024913|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56024914|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56024915|NCT01287377|Nicotine|nicotine|mesh-list
56024916|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56024917|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
56024918|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024919|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024920|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56024921|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56024922|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
56024923|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024924|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024925|NCT04270370|Atorvastatin|atorvastatin|mesh-list
56024926|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56024927|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56024928|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
56024929|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024930|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56024931|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56024932|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024933|NCT01288781|Acetazolamide|acetazolamide|mesh-list
56024934|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
56024935|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56024936|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024937|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024938|NCT01288781|Diuretics|diuretics|mesh-ancestor
56024939|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
56024940|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024945|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56024946|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024947|NCT02990078|Urological Agents|urological agents|mesh-ancestor
56024948|NCT01288859|Curcumin|curcumin|mesh-list
56024949|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56024950|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56024951|NCT01288859|Analgesics|analgesics|mesh-ancestor
56024952|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
56024953|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024954|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024955|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56024956|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56024957|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56024958|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024959|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024960|NCT01235195|Sertraline|sertraline|mesh-list
56024961|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
56024962|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56024963|NCT01235195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56024964|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56024965|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56024966|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024967|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024968|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
56024969|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56024970|NCT02996942|Factor VIII|factor viii|mesh-list
56024971|NCT02996942|Coagulants|coagulants|mesh-ancestor
56024972|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
56024973|NCT01199237|Sevoflurane|sevoflurane|mesh-list
56024974|NCT01199237|Desflurane|desflurane|mesh-list
56024975|NCT01199237|Rocuronium|rocuronium|mesh-list
56024976|NCT01199237|Neostigmine|neostigmine|mesh-list
56024977|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56024978|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56024979|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
56024980|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
56024981|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56024983|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56024984|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56024985|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56024986|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56024987|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56024988|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56024989|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56024990|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
56024991|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56024992|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56024993|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
56024994|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56024995|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56024996|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56024997|NCT01235897|Paclitaxel|paclitaxel|mesh-list
56024998|NCT01235897|Trastuzumab|trastuzumab|mesh-list
56024999|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56025000|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025001|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
56025002|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
56025003|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
56025004|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025005|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56025006|NCT01236053|Gabapentin|gabapentin|mesh-list
56025007|NCT01236053|Analgesics|analgesics|mesh-ancestor
56025008|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
56025009|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025010|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025011|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
56025027|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56025028|NCT00703976|Growth Substances|growth substances|mesh-ancestor
56025029|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025030|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
56025031|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025032|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025033|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56025034|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56025035|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
56025036|NCT00661544|Melphalan|melphalan|mesh-list
56025038|NCT00661544|Vitamins|vitamins|mesh-ancestor
56025092|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56025093|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56025094|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025095|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56025096|NCT00664430|Vitamins|vitamins|mesh-ancestor
56025097|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
56025098|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56025099|NCT01292447|Lidocaine|lidocaine|mesh-list
56025100|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
56025101|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
56025102|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025103|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025104|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
56025105|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025106|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56025107|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56025108|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56025109|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56025110|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025111|NCT00704912|Orlistat|orlistat|mesh-list
56025112|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
56025113|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
56025114|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
56025115|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56025116|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025117|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56025118|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025133|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
56025134|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025135|NCT02189213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56025136|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56025137|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56025138|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025139|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025140|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
56025141|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025142|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56025143|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56025144|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56025145|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
56025146|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025147|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56025148|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56025149|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025150|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56025151|NCT00666848|Enalapril|enalapril|mesh-list
56025152|NCT00666848|Enalaprilat|enalaprilat|mesh-list
56025153|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56025154|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025155|NCT00666848|Incretins|incretins|mesh-ancestor
56025156|NCT00666848|Hormones|hormones|mesh-ancestor
56025157|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56025159|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
56025179|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025181|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56025182|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
56025183|NCT04386122|Loxoprofen|loxoprofen|mesh-list
56025184|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56025185|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56025186|NCT04386122|Analgesics|analgesics|mesh-ancestor
56025187|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
56025188|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025189|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025190|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56025191|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56025192|NCT03009461|Sorafenib|sorafenib|mesh-list
56025193|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025194|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56025195|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025196|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025197|NCT02990702|Bupivacaine|bupivacaine|mesh-list
56025198|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
56025199|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
56025200|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025201|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025202|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
56025203|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025204|NCT02995304|Midazolam|midazolam|mesh-list
56025205|NCT02995304|Morphine|morphine|mesh-list
56025228|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025229|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56025230|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56025231|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
56025232|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025233|NCT00725504|Lidocaine|lidocaine|mesh-list
56025234|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
56025235|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
56025236|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025237|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025238|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
56025239|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025240|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56025241|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56025242|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56025243|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55752450|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
56025244|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025245|NCT03830684|Baicalein|baicalein|mesh-list
56025246|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
56025247|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025248|NCT03830684|Protective Agents|protective agents|mesh-ancestor
56025249|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025250|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025251|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
56025252|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
56025253|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56025254|NCT02990546|Midodrine|midodrine|mesh-list
56025255|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
56025256|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
56025257|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025258|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025259|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56025261|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56025265|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025266|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56025267|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56025268|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56025269|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56025270|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56025271|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025272|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025273|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025274|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56025275|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
56025276|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025277|NCT01294163|Propofol|propofol|mesh-list
56025278|NCT01294163|Sevoflurane|sevoflurane|mesh-list
56025279|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56025280|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025281|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025282|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56025283|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
56025284|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
56025285|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56025286|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56025287|NCT01294319|Dexamethasone|dexamethasone|mesh-list
56025288|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
56025289|NCT01294319|Spironolactone|spironolactone|mesh-list
56025290|NCT01294319|Mifepristone|mifepristone|mesh-list
56025291|NCT01294319|BB 1101|bb 1101|mesh-list
56025292|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56025293|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
56025294|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
56025297|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56025306|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56025307|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
56025308|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56025309|NCT01294319|Diuretics|diuretics|mesh-ancestor
56025310|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
56025311|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56025312|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
56025313|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56025314|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56025315|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56025316|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56025317|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
56025318|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56025319|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56025320|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
56025321|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56025322|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56025324|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
56025325|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56025326|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56025327|NCT02990312|Sirolimus|sirolimus|mesh-list
56025328|NCT02990312|Maraviroc|maraviroc|mesh-list
56025329|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56025330|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025331|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56025332|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025333|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
56025334|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56025335|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
56025336|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025337|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56025338|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56025339|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025340|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56025346|NCT01295879|Vitamins|vitamins|mesh-ancestor
56025347|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
56025348|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025349|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56025350|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56025351|NCT01244633|Ecopipam|ecopipam|mesh-list
56025352|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56025353|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56025354|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025355|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025356|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025357|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56025358|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
56025359|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025360|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025361|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
56025362|NCT01296191|Besifloxacin|besifloxacin|mesh-list
56025363|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56025364|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025365|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56025366|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56025367|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025368|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025369|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025370|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56025371|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
56025372|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025373|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56025374|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56025375|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025376|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025377|NCT01210079|Gabapentin|gabapentin|mesh-list
56025379|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
56025380|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025383|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56025384|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56025385|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025386|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025387|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56025388|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56025389|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025390|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025392|NCT01245647|Naltrexone|naltrexone|mesh-list
56025393|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56025394|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56025395|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025396|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
56025397|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025399|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56025400|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56025401|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025402|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025403|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56025404|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56025405|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
56025406|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025407|NCT01296815|Bevacizumab|bevacizumab|mesh-list
56025408|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56025409|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025410|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56025411|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56025412|NCT01296815|Growth Substances|growth substances|mesh-ancestor
56025414|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
56025425|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56025426|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56025427|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56025428|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56025429|NCT01276496|Paclitaxel|paclitaxel|mesh-list
56025430|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56025431|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56025432|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025433|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
56025434|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
56025435|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
56025436|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025437|NCT01297595|Crizotinib|crizotinib|mesh-list
56025438|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025439|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56025440|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025441|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025442|NCT02992418|Vaccines|vaccines|mesh-list
56025443|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
56025444|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025445|NCT01276730|Interferons|interferons|mesh-list
56025446|NCT01276730|Tretinoin|tretinoin|mesh-list
56025447|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025448|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
56025449|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025450|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
56025451|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
56025452|NCT01298063|Afatinib|afatinib|mesh-list
56025453|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025454|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56025455|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025456|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025457|NCT02999594|Tramadol|tramadol|mesh-list
56025458|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56025459|NCT02999594|Narcotics|narcotics|mesh-ancestor
56025460|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025462|NCT02999594|Analgesics|analgesics|mesh-ancestor
56025463|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
56025464|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025465|NCT01298219|Lubiprostone|lubiprostone|mesh-list
56025466|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56025467|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56025468|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025469|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56025470|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025471|NCT02322242|Dexamethasone|dexamethasone|mesh-list
56025472|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
56025473|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56025475|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56025476|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
56025477|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
56025478|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025479|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025480|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56025481|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
56025482|NCT02322242|Hormones|hormones|mesh-ancestor
56025483|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56025484|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56025485|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025486|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
56025487|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025488|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025489|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56025504|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
56025505|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025506|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56025507|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
56025508|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025509|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
56025510|NCT01270412|Protective Agents|protective agents|mesh-ancestor
56025511|NCT02992496|Midazolam|midazolam|mesh-list
56025512|NCT02992496|Ketamine|ketamine|mesh-list
56025513|NCT02992496|Analgesics|analgesics|mesh-ancestor
56025514|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
56025515|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025516|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025517|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56025518|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56025519|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
56025520|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
56025521|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025522|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56025523|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56025524|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025525|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025526|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56025527|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56025528|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56025529|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56025530|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025531|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
56025532|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
56025533|NCT00729482|Everolimus|everolimus|mesh-list
56025534|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025535|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56025536|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
56025537|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025538|NCT01270490|Interferons|interferons|mesh-list
56025544|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56025545|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
56025546|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
56025547|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025549|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
56025550|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025551|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025552|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
56025553|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56025554|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56025555|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
56025556|NCT02992652|Protective Agents|protective agents|mesh-ancestor
56025557|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025558|NCT01270724|Gemcitabine|gemcitabine|mesh-list
56025559|NCT01270724|Paclitaxel|paclitaxel|mesh-list
56025560|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
56025561|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56025562|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025563|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
56025564|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
56025565|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
56025566|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025567|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56025568|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
56025569|NCT01270724|Antiviral Agents|antiviral agents|mesh-ancestor
56025593|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025594|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025595|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025596|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
56025597|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
56025598|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025599|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56025600|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56025601|NCT02992340|Gemcitabine|gemcitabine|mesh-list
56025602|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025603|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56025604|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
56025605|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025606|NCT02992340|Antiviral Agents|antiviral agents|mesh-ancestor
56025607|NCT02992340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025608|NCT02992340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025609|NCT02992340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56025610|NCT02992340|Immunologic Factors|immunologic factors|mesh-ancestor
56025611|NCT02992340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025612|NCT00711464|Modafinil|modafinil|mesh-list
56025613|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56025614|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752837|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
56025615|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56025616|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56025617|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56025618|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025619|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56025620|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56025621|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
56025622|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56025623|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
56025624|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56025628|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025630|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56025631|NCT01278446|Caseins|caseins|mesh-list
56025632|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
56025633|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
56025634|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025635|NCT02339558|Nivolumab|nivolumab|mesh-list
56025636|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56025637|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025638|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56025639|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025640|NCT00731198|Drotaverin|drotaverin|mesh-list
56025641|NCT00731198|Scopolamine|scopolamine|mesh-list
56025642|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56025643|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56025644|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
56025645|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
56025646|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025647|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025648|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56025649|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
56025650|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56025651|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
56025652|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025653|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025654|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56025655|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
56025656|NCT00731198|Analgesics|analgesics|mesh-ancestor
56025677|NCT01271582|Irinotecan|irinotecan|mesh-list
56025678|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56025679|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56025680|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025681|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025682|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025683|NCT01271582|Antidotes|antidotes|mesh-ancestor
56025684|NCT01271582|Protective Agents|protective agents|mesh-ancestor
56025685|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025686|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
56025687|NCT01271582|Vitamins|vitamins|mesh-ancestor
56025688|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
55752901|NCT02485067|Urological Agents|urological agents|mesh-ancestor
56025689|NCT01271660|Pregabalin|pregabalin|mesh-list
56025690|NCT01271660|Analgesics|analgesics|mesh-ancestor
56025691|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
56025692|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025693|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025694|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
56025695|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56025696|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56025697|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025698|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56025699|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56025700|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56025701|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025702|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025704|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
56025705|NCT00731588|Vitamins|vitamins|mesh-ancestor
56025706|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
56025707|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025708|NCT01271894|Efavirenz|efavirenz|mesh-list
56025709|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56025717|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56025718|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56025719|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56025720|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56025721|NCT01278758|Vadimezan|vadimezan|mesh-list
56025722|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025723|NCT00717626|Factor VIII|factor viii|mesh-list
56025724|NCT00717626|Coagulants|coagulants|mesh-ancestor
56025725|NCT01272128|Interferons|interferons|mesh-list
56025726|NCT01272128|Interferon-beta|interferon-beta|mesh-list
56025727|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
56025728|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025729|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
56025730|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025731|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
56025732|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025733|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56025734|NCT00719186|Letrozole|letrozole|mesh-list
56025735|NCT00719186|Clomiphene|clomiphene|mesh-list
56025736|NCT00719186|Enclomiphene|enclomiphene|mesh-list
56025737|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
56025738|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025739|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025740|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55876631|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876632|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55876633|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55876634|NCT01241344|Brincidofovir|brincidofovir|mesh-list
55876635|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
55876636|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876637|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55876638|NCT03009682|Olaparib|olaparib|mesh-list
55876639|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55876640|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876641|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876642|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876643|NCT03431142|Aspirin|aspirin|mesh-list
55876644|NCT03431142|Clopidogrel|clopidogrel|mesh-list
55876645|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55876646|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55876647|NCT03431142|Analgesics|analgesics|mesh-ancestor
55876648|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
55876649|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876650|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876651|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876652|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876653|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55876654|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55876655|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876656|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55876657|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55876658|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025741|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56025742|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025743|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56025744|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
56025745|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56025746|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025747|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56025748|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
56025749|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56025750|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56025751|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56025752|NCT00721136|Heparin|heparin|mesh-list
56025753|NCT00721136|Warfarin|warfarin|mesh-list
56025754|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
56025755|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56025756|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56025757|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025758|NCT00737204|Modafinil|modafinil|mesh-list
56025759|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56025760|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025761|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56025762|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56025763|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56025764|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025765|NCT00722072|Sorafenib|sorafenib|mesh-list
56025766|NCT00722072|Fulvestrant|fulvestrant|mesh-list
56025767|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025768|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56025769|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025770|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025771|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56025772|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56025773|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56025774|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
55876660|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56025776|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025777|NCT01275170|Imipenem|imipenem|mesh-list
56025778|NCT01275170|Relebactam|relebactam|mesh-list
56025779|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
56025780|NCT01275170|Midazolam|midazolam|mesh-list
56025781|NCT01275170|Caffeine|caffeine|mesh-list
56025782|NCT01275170|Omeprazole|omeprazole|mesh-list
56025783|NCT01275170|Cilastatin|cilastatin|mesh-list
56025784|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56025785|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56025786|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025787|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025788|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56025789|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56025790|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025791|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56025792|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
56025793|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
56025794|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
56025795|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
56025796|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025797|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025798|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56025799|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56025800|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025801|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56025802|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56025803|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
56025804|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56025805|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56025806|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56025822|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025823|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
56025824|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
56025825|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025826|NCT01272908|Rituximab|rituximab|mesh-list
56025827|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56025828|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025829|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
56025830|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025831|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56025832|NCT01271504|Sorafenib|sorafenib|mesh-list
56025833|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025834|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56025835|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025836|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753047|NCT04991181|Zamicastat|zamicastat|mesh-list
56025837|NCT02144714|Adalimumab|adalimumab|mesh-list
56025838|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56025839|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56025840|NCT00741026|Olanzapine|olanzapine|mesh-list
56025841|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
56025842|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
56025843|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025844|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025845|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56025846|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56025847|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56025848|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025849|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025850|NCT00741026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56025851|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56025852|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56025853|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025854|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025855|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
56025860|NCT01273298|Bisoprolol|bisoprolol|mesh-list
56025861|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56025862|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
56025863|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
56025864|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025865|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025866|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56025867|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56025868|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56025869|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
56025870|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025871|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025872|NCT01270802|Tenofovir|tenofovir|mesh-list
56025873|NCT01270802|Emtricitabine|emtricitabine|mesh-list
56025874|NCT01270802|Efavirenz|efavirenz|mesh-list
56025875|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
56025876|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
56025877|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56025878|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56025879|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56025880|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025881|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025882|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56025883|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56025884|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56025885|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56025886|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56025887|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56025888|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56025889|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56025890|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56025891|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56025892|NCT01273454|Hydromorphone|hydromorphone|mesh-list
56025893|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56025898|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
56025899|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025901|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56025902|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56025903|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
56025904|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025905|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025906|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56025907|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
56025908|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
56025909|NCT01270256|Hormones|hormones|mesh-ancestor
56025910|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56025911|NCT01279694|Prednisone|prednisone|mesh-list
56025912|NCT01279694|Melphalan|melphalan|mesh-list
56025913|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56025914|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
56025915|NCT01279694|Hormones|hormones|mesh-ancestor
56025916|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56025917|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025918|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56025919|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025920|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55726179|NCT02479412|Albuterol|albuterol|mesh-list
56025921|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
56025922|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025923|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56025924|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56025943|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025944|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025945|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56025946|NCT00744380|Analgesics|analgesics|mesh-ancestor
56025947|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
56025948|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025949|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56025950|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56025951|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56025952|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
56025953|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025954|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025955|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56025956|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56025957|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56025958|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56025959|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56025960|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
56025961|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
56025962|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
56025963|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
56025964|NCT00744692|Fludarabine|fludarabine|mesh-list
56025965|NCT00744692|Melphalan|melphalan|mesh-list
56025966|NCT00744692|Thiotepa|thiotepa|mesh-list
56025967|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
56025968|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56025969|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025970|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56025971|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
56025972|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025973|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56025974|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
56025975|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56025976|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
56025977|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56025983|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56025984|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56025985|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
56025986|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56025987|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55753201|NCT03201913|Estrogens|estrogens|mesh-list
56025988|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56025989|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
56025990|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56025991|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56025992|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56025993|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56025994|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
56025995|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56025996|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
56025997|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
56025998|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
56025999|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56026000|NCT03830606|Paclitaxel|paclitaxel|mesh-list
56026001|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56026002|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026003|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
56026004|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
56026005|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
56026006|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026007|NCT01278134|Ritonavir|ritonavir|mesh-list
56026008|NCT01278134|Ribavirin|ribavirin|mesh-list
56026009|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56026010|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56026011|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56026012|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
56026013|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026015|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56026023|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026024|NCT01271348|Etoricoxib|etoricoxib|mesh-list
56026025|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56026026|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56026027|NCT01271348|Analgesics|analgesics|mesh-ancestor
56026028|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
56026029|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026030|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026031|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56026032|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026033|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56026034|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56026035|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026036|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026037|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
56026038|NCT04385264|Mannitol|mannitol|mesh-list
56026039|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
56026040|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56026041|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56026042|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026043|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026044|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026045|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026046|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56026047|NCT04385264|Diuretics|diuretics|mesh-ancestor
56026048|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
56026049|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026050|NCT00746954|Acetazolamide|acetazolamide|mesh-list
56026051|NCT00746954|Buspirone|buspirone|mesh-list
56026052|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
56026053|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56026054|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026056|NCT00746954|Diuretics|diuretics|mesh-ancestor
56026066|NCT00752102|Calcitriol|calcitriol|mesh-list
56026067|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56026068|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026069|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56026070|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56026071|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026072|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56026073|NCT00752102|Vitamins|vitamins|mesh-ancestor
56026074|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
56026075|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56026076|NCT00723632|Ribavirin|ribavirin|mesh-list
56026077|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56026078|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
56026079|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026080|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
56026081|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026082|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
56026083|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
56026084|NCT01279616|Busulfan|busulfan|mesh-list
56026085|NCT01279616|Rituximab|rituximab|mesh-list
56026086|NCT01279616|Fludarabine|fludarabine|mesh-list
56026087|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
56026088|NCT01279616|Tacrolimus|tacrolimus|mesh-list
56026089|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
56026090|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56026091|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
56026092|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026093|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026094|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56026095|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
56026096|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026097|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026110|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56026111|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
56026112|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56026113|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
56026114|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56026115|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
56026116|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56026117|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
56026118|NCT01275638|Hormones|hormones|mesh-ancestor
56026119|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026120|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026121|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56026122|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026123|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
56026124|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
56026125|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026126|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56026127|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56026128|NCT01275638|Protective Agents|protective agents|mesh-ancestor
56026129|NCT00724568|Dexamethasone|dexamethasone|mesh-list
56026130|NCT00724568|Lenalidomide|lenalidomide|mesh-list
56026131|NCT00724568|Bortezomib|bortezomib|mesh-list
56026132|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56026133|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
56026134|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
56026135|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026136|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026137|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56026138|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
56026139|NCT00724568|Hormones|hormones|mesh-ancestor
56026140|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026141|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56026142|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026143|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
56026144|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56026151|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026152|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026153|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56026154|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56026155|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
56026156|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026157|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026158|NCT04274426|Gemcitabine|gemcitabine|mesh-list
56026159|NCT04274426|Paclitaxel|paclitaxel|mesh-list
56026160|NCT04274426|Maytansine|maytansine|mesh-list
56026161|NCT04274426|Carboplatin|carboplatin|mesh-list
56026162|NCT04274426|Doxorubicin|doxorubicin|mesh-list
56026163|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56026164|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56026165|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026166|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
56026167|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
56026168|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
56026169|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026170|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56026171|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
56026172|NCT04274426|Antiviral Agents|antiviral agents|mesh-ancestor
56026173|NCT04274426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026174|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026175|NCT04274426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56026176|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
56026177|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026178|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56026179|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56026180|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56026181|NCT04272320|Bupivacaine|bupivacaine|mesh-list
56026182|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
56026183|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
56026184|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56026185|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026192|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56026193|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56026194|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56026195|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026196|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56026197|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026198|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
56026199|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56026200|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56026201|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56026202|NCT00249002|Paclitaxel|paclitaxel|mesh-list
56026203|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56026204|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56026205|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026206|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
56026207|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
56026208|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
56026209|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026210|NCT00748826|Infliximab|infliximab|mesh-list
56026211|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
56026212|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56026213|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753424|NCT05712941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56026214|NCT00246740|Doxycycline|doxycycline|mesh-list
56026215|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56026216|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026238|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026239|NCT01274624|Antidotes|antidotes|mesh-ancestor
56026240|NCT01274624|Protective Agents|protective agents|mesh-ancestor
56026241|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
56026243|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
56026244|NCT00761930|Listerine|listerine|mesh-list
56026245|NCT00761930|Triclosan|triclosan|mesh-list
56026246|NCT00761930|Fluorides|fluorides|mesh-list
56026247|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
56026248|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
55726416|NCT05156749|Calpastatin|calpastatin|mesh-list
55726486|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726493|NCT03478033|Rifampin|rifampin|mesh-list
56026249|NCT00761930|Protective Agents|protective agents|mesh-ancestor
56026250|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026253|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56026254|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56026255|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
56026256|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026257|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56026258|NCT00245102|Sorafenib|sorafenib|mesh-list
55726565|NCT04351243|Gimsilumab|gimsilumab|mesh-list
55726731|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55726732|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
55726979|NCT05708573|Antimetabolites|antimetabolites|mesh-ancestor
55727037|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
55727498|NCT04221035|Vindesine|vindesine|mesh-list
55727728|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
55728258|NCT05651464|Vancomycin|vancomycin|mesh-list
55728410|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
55728411|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728412|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728413|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728414|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55728415|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55728416|NCT00434434|Omalizumab|omalizumab|mesh-list
55728417|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55728418|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55728419|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55728421|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
55728503|NCT01633060|Fulvestrant|fulvestrant|mesh-list
55728504|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55728505|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728506|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55728508|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
55728509|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728510|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728511|NCT03878459|Pioglitazone|pioglitazone|mesh-list
55728512|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55728513|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728514|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
55728515|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55728516|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728517|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728646|NCT00159783|Olanzapine|olanzapine|mesh-list
55728723|NCT04551261|Ritonavir|ritonavir|mesh-list
55729180|NCT02296073|Narcotics|narcotics|mesh-ancestor
55729248|NCT02298335|Prednisone|prednisone|mesh-list
55729837|NCT03135795|Narcotics|narcotics|mesh-ancestor
55730085|NCT02305823|Aripiprazole|aripiprazole|mesh-list
55730515|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55829267|NCT01571362|Analgesics|analgesics|mesh-ancestor
55730666|NCT02312375|Amlodipine|amlodipine|mesh-list
55730739|NCT01680861|Everolimus|everolimus|mesh-list
55730816|NCT02312609|Minocycline|minocycline|mesh-list
55730963|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
55731120|NCT02310347|Analgesics|analgesics|mesh-ancestor
55731265|NCT02311205|Sorafenib|sorafenib|mesh-list
55731494|NCT02315495|Hormones|hormones|mesh-ancestor
55731561|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731640|NCT03353233|Ropivacaine|ropivacaine|mesh-list
55731709|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55731862|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731863|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55731864|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55731865|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55829520|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
55731874|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
55731875|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55731879|NCT04691362|Coagulants|coagulants|mesh-ancestor
55732158|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
55732383|NCT04527289|Amantadine|amantadine|mesh-list
55732537|NCT02252536|Gabapentin|gabapentin|mesh-list
55732965|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
55733040|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
55733110|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733410|NCT03477929|Cetrorelix|cetrorelix|mesh-list
55733411|NCT03477929|Ganirelix|ganirelix|mesh-list
55733485|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
55733811|NCT05162417|Coagulants|coagulants|mesh-ancestor
55733812|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
55733889|NCT04508803|Niraparib|niraparib|mesh-list
55734563|NCT05398679|Amoxicillin|amoxicillin|mesh-list
55734863|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734864|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734865|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734866|NCT03443869|Valganciclovir|valganciclovir|mesh-list
55734868|NCT03443869|Letermovir|letermovir|mesh-list
55734869|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
55734870|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734871|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55735097|NCT03268083|Vaccines|vaccines|mesh-list
55735167|NCT03463733|Temozolomide|temozolomide|mesh-list
55736263|NCT03342417|Nivolumab|nivolumab|mesh-list
55736337|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55736572|NCT02424734|Ampicillin|ampicillin|mesh-list
55736655|NCT03861611|Ketorolac|ketorolac|mesh-list
55736940|NCT03424889|Xylometazoline|xylometazoline|mesh-list
55737172|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
55737237|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737238|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737239|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55737622|NCT01912651|Cephalexin|cephalexin|mesh-list
55737691|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737916|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737993|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
55738073|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
55738149|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55841208|NCT04028518|Plasminogen|plasminogen|mesh-list
55739061|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
55739062|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739063|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739140|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
55739141|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
55739142|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739143|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739144|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
55844820|NCT01931059|Risperidone|risperidone|mesh-list
55739145|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739153|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
55739210|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739211|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55739212|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
55739213|NCT01602224|Hormones|hormones|mesh-ancestor
55845589|NCT01770392|Nintedanib|nintedanib|mesh-list
55739215|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55739282|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
55739283|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739284|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55739285|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55739287|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
55739355|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739356|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55739357|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
55739358|NCT03396107|Dexamethasone|dexamethasone|mesh-list
55847023|NCT01903837|ALKS-33|alks-33|mesh-list
55739427|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
55739428|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55739429|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847476|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847477|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55739491|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55739492|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55739493|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55739494|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55739495|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739496|NCT03126097|Drospirenone|drospirenone|mesh-list
55739497|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55744403|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
55739627|NCT03395093|Narcotics|narcotics|mesh-ancestor
55739701|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739702|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739703|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
55739704|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55739705|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55849733|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739706|NCT03398837|Analgesics|analgesics|mesh-ancestor
55739768|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739769|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55739770|NCT03394001|Ketorolac|ketorolac|mesh-list
55739771|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55739772|NCT03394001|Lidocaine|lidocaine|mesh-list
55739773|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
55739774|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
55739775|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739836|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55739837|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55739838|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
55744406|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739839|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739897|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55739898|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55739899|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739900|NCT00380705|Montelukast|montelukast|mesh-list
55739901|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55739902|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739903|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55744414|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
55739966|NCT03390595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739967|NCT03390595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739968|NCT03390595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55739969|NCT03390595|Immunologic Factors|immunologic factors|mesh-ancestor
55739970|NCT03390595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739971|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739973|NCT00271817|Niacinamide|niacinamide|mesh-list
55739974|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
55740030|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55740031|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
55740032|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
55740033|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55740034|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55740035|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55740036|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55740037|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
55740038|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
55740089|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740090|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
55740091|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
55740092|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55850534|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
55740093|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
55740094|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740095|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
55740155|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
55740156|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
55740157|NCT02732015|Dexamethasone|dexamethasone|mesh-list
55740158|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
55740159|NCT02732015|Doxorubicin|doxorubicin|mesh-list
55740160|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55740161|NCT02732015|Vincristine|vincristine|mesh-list
55740162|NCT02732015|Daunorubicin|daunorubicin|mesh-list
55740163|NCT02732015|Ifosfamide|ifosfamide|mesh-list
55740165|NCT02732015|Ondansetron|ondansetron|mesh-list
55740225|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55740226|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55740227|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55740228|NCT03439085|Growth Substances|growth substances|mesh-ancestor
55740229|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
55740230|NCT01964807|Nicotine|nicotine|mesh-list
55740231|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55740232|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
55740284|NCT05174195|Desogestrel|desogestrel|mesh-list
55740285|NCT05174195|Etonogestrel|etonogestrel|mesh-list
55740286|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55740287|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55740288|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55740289|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
55740290|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55740294|NCT05174195|Progestins|progestins|mesh-ancestor
55740345|NCT02520817|Vitamins|vitamins|mesh-list
55740346|NCT02520817|Vitamin E|vitamin e|mesh-list
55740347|NCT02520817|Vitamin A|vitamin a|mesh-list
55740348|NCT02520817|Lactulose|lactulose|mesh-list
55740349|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
55740350|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740351|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
55740355|NCT03387943|Cisplatin|cisplatin|mesh-list
55740419|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740420|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740496|NCT03383003|Esomeprazole|esomeprazole|mesh-list
55740497|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55740498|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740499|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55740500|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55740501|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55740502|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55740503|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55740510|NCT03378713|Testosterone|testosterone|mesh-list
55740562|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740564|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740565|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740566|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
55740567|NCT05237791|Analgesics|analgesics|mesh-ancestor
55740568|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
55740569|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740633|NCT03436433|Levetiracetam|levetiracetam|mesh-list
55740634|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
55740635|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
55740636|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55740637|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55740638|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55740641|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55740701|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55740702|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
55740703|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55740704|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55740705|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55740773|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55740774|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740775|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740776|NCT04436965|Cisplatin|cisplatin|mesh-list
56026259|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026260|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56026261|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026262|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026263|NCT01275014|Dexamethasone|dexamethasone|mesh-list
56026264|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55740917|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55740993|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55740994|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
55740995|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55851383|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55851433|NCT01474239|Bevacizumab|bevacizumab|mesh-list
55741062|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55741063|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
55741064|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741067|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55741068|NCT04445857|Katacalcin|katacalcin|mesh-list
55741069|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55741070|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851534|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741132|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741133|NCT03700411|Analgesics|analgesics|mesh-ancestor
55741134|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
55741136|NCT03691051|Capecitabine|capecitabine|mesh-list
55741204|NCT02520115|Valproic Acid|valproic acid|mesh-list
55741205|NCT02520115|Ichthammol|ichthammol|mesh-list
55741206|NCT02520115|BB 1101|bb 1101|mesh-list
55741207|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55741208|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
55741209|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
55741210|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741211|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741276|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741277|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741278|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55741279|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
55851607|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
55741348|NCT03370159|Protective Agents|protective agents|mesh-ancestor
55741349|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741350|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
55741352|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
55741353|NCT04522297|Octreotide|octreotide|mesh-list
55741355|NCT04522297|Midodrine|midodrine|mesh-list
55741356|NCT04522297|Norepinephrine|norepinephrine|mesh-list
55741358|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55741418|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55741419|NCT02518789|Fentanyl|fentanyl|mesh-list
55741421|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
55741422|NCT02518789|Remifentanil|remifentanil|mesh-list
55741423|NCT02518789|Propofol|propofol|mesh-list
55741491|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741492|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741493|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55741494|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55741495|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55741496|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741497|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741552|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741553|NCT02267343|Nivolumab|nivolumab|mesh-list
55741554|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55741555|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741558|NCT03123445|Gemcitabine|gemcitabine|mesh-list
55741632|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
55741633|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741634|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55741635|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55741636|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55741637|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55741638|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741695|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55741696|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741697|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
55741698|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
55741700|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741701|NCT05123781|Metformin|metformin|mesh-list
55741702|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741704|NCT04523233|Vitamins|vitamins|mesh-list
55741764|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55741765|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55741766|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741767|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
55741768|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741769|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741770|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55741836|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55741837|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741838|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55851894|NCT01524627|Varenicline|varenicline|mesh-list
55741911|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741912|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741913|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55741915|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55741916|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55741917|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772088|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741971|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55741972|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55741973|NCT04443517|Propofol|propofol|mesh-list
55741974|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
55741975|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741976|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741978|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55741979|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
55742038|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742039|NCT03568929|Idelalisib|idelalisib|mesh-list
55742040|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742041|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742042|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742044|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55742045|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742048|NCT04841499|Niacinamide|niacinamide|mesh-list
55742112|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742113|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
55742114|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55742115|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55742116|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
55742117|NCT03349177|Docetaxel|docetaxel|mesh-list
55742118|NCT03349177|Fluorouracil|fluorouracil|mesh-list
55742119|NCT03349177|Epirubicin|epirubicin|mesh-list
55742120|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55742177|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
55742178|NCT03353857|Desogestrel|desogestrel|mesh-list
55742179|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55742180|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55742182|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742183|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55742184|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55742185|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55742245|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55742246|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742247|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742249|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55742250|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55772412|NCT03111797|Analgesics|analgesics|mesh-ancestor
55742251|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742313|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55742315|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
55742316|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55742317|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
55742318|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55742319|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55772483|NCT03189901|Simendan|simendan|mesh-list
56144860|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
56144932|NCT00824460|Sevelamer|sevelamer|mesh-list
56144933|NCT00824460|Trace Elements|trace elements|mesh-ancestor
56144934|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
56144935|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144936|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
56144937|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
56144938|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144939|NCT00824538|Sunitinib|sunitinib|mesh-list
56144940|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144941|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55742397|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56144942|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56144943|NCT00824538|Growth Substances|growth substances|mesh-ancestor
56144944|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144945|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
56144950|NCT00825786|Mepivacaine|mepivacaine|mesh-list
55791805|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55791806|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55791807|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55791808|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
55791809|NCT03036605|Dexamethasone|dexamethasone|mesh-list
55791810|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
55791811|NCT03036605|Bupivacaine|bupivacaine|mesh-list
55791813|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791834|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55791835|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791836|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791837|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55791838|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
55791839|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
55791840|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55791841|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55791842|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55791843|NCT03098875|Narcotics|narcotics|mesh-ancestor
55791844|NCT03098875|Analgesics|analgesics|mesh-ancestor
55791845|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
55791846|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791847|NCT03099031|Tinzaparin|tinzaparin|mesh-list
55847966|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791848|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55791850|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
55791851|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55791852|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55791853|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791854|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55791856|NCT04785287|Antibodies|antibodies|mesh-list
55791857|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
55791858|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55791859|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
55791860|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791861|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791864|NCT03101137|Dexamethasone|dexamethasone|mesh-list
55791879|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791880|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
55791881|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55791882|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55791883|NCT04833101|Vaccines|vaccines|mesh-list
55791884|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
55791885|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791886|NCT00794599|Cetirizine|cetirizine|mesh-list
55791887|NCT00794599|Desloratadine|desloratadine|mesh-list
55791888|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55791890|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55791905|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55791906|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55791907|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
55791908|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
55791909|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55791910|NCT03098407|Buprenorphine|buprenorphine|mesh-list
55791911|NCT03098407|Methadone|methadone|mesh-list
55791912|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55791948|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55791973|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55791974|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55791975|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
55791976|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791977|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55791978|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55791979|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791987|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791988|NCT00396175|Urological Agents|urological agents|mesh-ancestor
55791990|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
55791991|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55791992|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791993|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55791994|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
55792007|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55792008|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55792009|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
55792010|NCT04832945|Ivermectin|ivermectin|mesh-list
55792011|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55792012|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792013|NCT02642653|Lovastatin|lovastatin|mesh-list
55792014|NCT02642653|L 647318|l 647318|mesh-list
55792015|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
55792016|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55792018|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
55792030|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792031|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
55792032|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792033|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
55792034|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792036|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
55792037|NCT05363631|Axitinib|axitinib|mesh-list
55792038|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55792039|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792040|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55792041|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792042|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792043|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
55792044|NCT05363631|Protective Agents|protective agents|mesh-ancestor
55792045|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792056|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55792057|NCT03036995|Analgesics|analgesics|mesh-ancestor
55792058|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
55792059|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792060|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792061|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792062|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55792063|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55792064|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55792065|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792067|NCT05066035|Neostigmine|neostigmine|mesh-list
55792078|NCT04822649|Analgesics|analgesics|mesh-ancestor
55792079|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
55792080|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792081|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792082|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55792083|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
55792084|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55792085|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
55792086|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
55792087|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792088|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792090|NCT04822415|Carticaine|carticaine|mesh-list
55792091|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
55792092|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
55792093|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792094|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792095|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
55792096|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792097|NCT05065177|Vaccines|vaccines|mesh-list
55792098|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
55792099|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792100|NCT04821947|Bupivacaine|bupivacaine|mesh-list
55792101|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
55792102|NCT04821947|Anesthetics|anesthetics|mesh-list
55792103|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792104|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792114|NCT03037073|Analgesics|analgesics|mesh-ancestor
55792119|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
55792120|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55792121|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55792122|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792123|NCT04470973|Amikacin|amikacin|mesh-list
55792124|NCT04470973|Cefuroxime|cefuroxime|mesh-list
55792125|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
55792126|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55792127|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792128|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
55792129|NCT05046457|Provitamins|provitamins|mesh-ancestor
55792147|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
55792148|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55792149|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
55792150|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792151|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
55792152|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
55792153|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792154|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792155|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792156|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
55792165|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792166|NCT05045443|Curcumin|curcumin|mesh-list
55792167|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55792168|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55792169|NCT05045443|Analgesics|analgesics|mesh-ancestor
55792170|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
55792171|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792172|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792173|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792174|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55792175|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792206|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55792207|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55792208|NCT03097003|Analgesics|analgesics|mesh-ancestor
55792209|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
55792210|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792211|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792212|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792213|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55792214|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55792241|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
55792242|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792243|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792244|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55792245|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55792246|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
55792247|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
55792248|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792249|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55792250|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55792251|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792252|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792253|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
55792254|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55792255|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55792256|NCT05035849|Acarbose|acarbose|mesh-list
55792257|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55792258|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792259|NCT05035849|Incretins|incretins|mesh-ancestor
55792260|NCT05035849|Hormones|hormones|mesh-ancestor
55792261|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792262|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55792263|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
55792264|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792265|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792266|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55792268|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792269|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55792270|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792271|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792273|NCT05035381|Bevacizumab|bevacizumab|mesh-list
55792274|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
55792275|NCT05035381|Fluorouracil|fluorouracil|mesh-list
55792276|NCT05035381|Irinotecan|irinotecan|mesh-list
55792277|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55792278|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55792279|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792280|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55792281|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55792282|NCT05035381|Growth Substances|growth substances|mesh-ancestor
55792283|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792284|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
55792285|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
55792286|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792287|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55792288|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55792289|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
55827543|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792317|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792318|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792319|NCT05035069|Propofol|propofol|mesh-list
55792320|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55792321|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792322|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792323|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55792324|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
55792325|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
55792326|NCT05035147|Gemcitabine|gemcitabine|mesh-list
55792327|NCT05035147|Paclitaxel|paclitaxel|mesh-list
55792328|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55792329|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55792330|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792331|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
55792334|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792335|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55792336|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
55792337|NCT05035147|Antiviral Agents|antiviral agents|mesh-ancestor
55792338|NCT05035147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792339|NCT05035147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792340|NCT05035147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55792341|NCT05035147|Immunologic Factors|immunologic factors|mesh-ancestor
55792342|NCT05035147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792343|NCT04834115|Ivermectin|ivermectin|mesh-list
55792344|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55792345|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792346|NCT01505465|Melatonin|melatonin|mesh-list
55792347|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
55792348|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792349|NCT01505465|Protective Agents|protective agents|mesh-ancestor
55827544|NCT04854551|Naltrexone|naltrexone|mesh-list
55792350|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792351|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792352|NCT04820933|Tenofovir|tenofovir|mesh-list
55792353|NCT04820933|Emtricitabine|emtricitabine|mesh-list
55792354|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
55792355|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792356|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55792357|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55792358|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792359|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792360|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55792361|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55792362|NCT04831229|Menthol|menthol|mesh-list
55792369|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
55792370|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55792371|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
55792372|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
55792373|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792374|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
55792375|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
55792376|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792377|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792378|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792379|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
55792380|NCT04816253|Hormones|hormones|mesh-ancestor
55792408|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
55792409|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55792411|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
55792412|NCT04815395|Oxytocin|oxytocin|mesh-list
55792413|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
55792414|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55792415|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792416|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
55792417|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792418|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
55792419|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
55792420|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
55792421|NCT05034055|Atezolizumab|atezolizumab|mesh-list
55792422|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792423|NCT05042245|Silymarin|silymarin|mesh-list
55792424|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
55792425|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
55792426|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792427|NCT05042245|Protective Agents|protective agents|mesh-ancestor
55792428|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792429|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
55792430|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55792431|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792432|NCT03095209|Paclitaxel|paclitaxel|mesh-list
55792433|NCT03095209|Carboplatin|carboplatin|mesh-list
55792434|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55792435|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792436|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
55792437|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
55792438|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
55792439|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792440|NCT05034133|Cisplatin|cisplatin|mesh-list
55792441|NCT05034133|Etoposide|etoposide|mesh-list
55792442|NCT05034133|Durvalumab|durvalumab|mesh-list
55827545|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55792443|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792444|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55792445|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55792446|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55792447|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792448|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792449|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55792451|NCT03096457|Pentamidine|pentamidine|mesh-list
55792452|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55792453|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827546|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55792457|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55792458|NCT03096223|KHK4083|khk4083|mesh-list
55792459|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
55792460|NCT04814303|Morphine|morphine|mesh-list
55792461|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55792462|NCT04814303|Narcotics|narcotics|mesh-ancestor
55792463|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792464|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792465|NCT04814303|Analgesics|analgesics|mesh-ancestor
55792466|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
55792467|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792468|NCT05053009|Ibuprofen|ibuprofen|mesh-list
55792469|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55792470|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55792471|NCT05053009|Analgesics|analgesics|mesh-ancestor
55792479|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792480|NCT04813913|Bevacizumab|bevacizumab|mesh-list
55792481|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55792482|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792483|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55792484|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55792485|NCT04813913|Growth Substances|growth substances|mesh-ancestor
55792486|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792487|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
55792488|NCT03094663|Cefazolin|cefazolin|mesh-list
55792489|NCT03094663|Dexamethasone|dexamethasone|mesh-list
55792490|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
55792491|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
55792492|NCT03094663|Epinephrine|epinephrine|mesh-list
55792494|NCT03094663|BB 1101|bb 1101|mesh-list
55792497|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
55792498|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792499|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792500|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792501|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
55792503|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792504|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55792505|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792506|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
55792507|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792509|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
55792510|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
55792511|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792512|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
55792513|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55792514|NCT03094663|Protective Agents|protective agents|mesh-ancestor
55792515|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55792516|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55792517|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
55792518|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792519|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55792520|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55792521|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55792522|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
55792523|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
55792524|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
55792525|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55792526|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55792527|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792529|NCT04814381|Ketamine|ketamine|mesh-list
55792538|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792539|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55792540|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55792541|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792542|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792543|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55792544|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
55792545|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55792573|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792574|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792575|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
55792576|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
55792577|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792647|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55792648|NCT05029297|Capsaicin|capsaicin|mesh-list
55792649|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
55792650|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
55792651|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
55792652|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792653|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792654|NCT05028907|Tocopherols|tocopherols|mesh-list
55792657|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
55792658|NCT05028907|Dexamethasone|dexamethasone|mesh-list
55792659|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
55792662|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
55792664|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792665|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
55792667|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792668|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792669|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792672|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792673|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55792680|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792681|NCT05028907|Vitamins|vitamins|mesh-ancestor
55792682|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
55792683|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
55792684|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792685|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55792686|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792687|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55792688|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55792690|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
55792691|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
55792692|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55792693|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
55792694|NCT05050357|Norethindrone|norethindrone|mesh-list
55792695|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
55792696|NCT05050357|Progestins|progestins|mesh-list
55792697|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55792698|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55792699|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55792700|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
55792702|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792703|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55792705|NCT05050357|Hormones|hormones|mesh-ancestor
55792706|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792707|NCT05028049|Sufentanil|sufentanil|mesh-list
55792708|NCT05028049|Remifentanil|remifentanil|mesh-list
55792709|NCT05028049|Dsuvia|dsuvia|mesh-list
55792710|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55792711|NCT05028049|Narcotics|narcotics|mesh-ancestor
55792712|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792713|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792714|NCT05028049|Analgesics|analgesics|mesh-ancestor
55792715|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
55792716|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792717|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55792718|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55792720|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
55792731|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792732|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55792733|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849146|NCT02559778|Dasatinib|dasatinib|mesh-list
55792734|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
55792735|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55792736|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
55792737|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792738|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
55792739|NCT05027581|Protective Agents|protective agents|mesh-ancestor
55792741|NCT05027191|Desflurane|desflurane|mesh-list
55792742|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55792743|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55792744|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
55792745|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
55792746|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792747|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792748|NCT03094507|Dolutegravir|dolutegravir|mesh-list
55792749|NCT03094507|Darunavir|darunavir|mesh-list
55792750|NCT03094507|Cobicistat|cobicistat|mesh-list
55827547|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792751|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55827548|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
55792754|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792755|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55792756|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55792757|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
55792758|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849147|NCT02559778|Vorinostat|vorinostat|mesh-list
55792759|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55792760|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55792761|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
55792762|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55792763|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55792765|NCT02528253|Tanezumab|tanezumab|mesh-list
55792766|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55792767|NCT02528253|Narcotics|narcotics|mesh-ancestor
55792768|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827550|NCT04536467|Goserelin|goserelin|mesh-list
55792791|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55792792|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792793|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55792794|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
55792795|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55792796|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792797|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792798|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792799|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
55792800|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792801|NCT05047393|Vitamin D|vitamin d|mesh-list
55792802|NCT05047393|Vitamins|vitamins|mesh-ancestor
55792803|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
55792804|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792805|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55792806|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55792812|NCT05021887|Xhance|xhance|mesh-list
55849148|NCT02559778|Ceritinib|ceritinib|mesh-list
55792821|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55792823|NCT05021731|Rifapentine|rifapentine|mesh-list
55792824|NCT05021731|Isoniazid|isoniazid|mesh-list
55792825|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55792826|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
55792827|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55792828|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792829|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
55792830|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55792831|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792832|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792833|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55792834|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55792835|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55792836|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55827551|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55792837|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55792838|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55792839|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55792840|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55792841|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
55827554|NCT05341349|Nivolumab|nivolumab|mesh-list
55792842|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55792843|NCT05009953|Leucovorin|leucovorin|mesh-list
55792844|NCT05009953|Fluorouracil|fluorouracil|mesh-list
55792845|NCT05009953|Irinotecan|irinotecan|mesh-list
55792846|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
55792847|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792848|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55792849|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792851|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
55792852|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792853|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55849499|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
55792854|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55792855|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792856|NCT05009953|Antidotes|antidotes|mesh-ancestor
55792857|NCT05009953|Protective Agents|protective agents|mesh-ancestor
55792859|NCT05009953|Vitamins|vitamins|mesh-ancestor
55792860|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
55792861|NCT03079453|Dexamethasone|dexamethasone|mesh-list
55792862|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792863|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
55792864|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
55792865|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792866|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792867|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792868|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
55792869|NCT03079453|Hormones|hormones|mesh-ancestor
55792870|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849500|NCT02363374|Hematinics|hematinics|mesh-ancestor
55792872|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792874|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
55792876|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
55792877|NCT04294459|Ranitidine|ranitidine|mesh-list
55792878|NCT04294459|Montelukast|montelukast|mesh-list
55792879|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55792880|NCT04294459|Analgesics|analgesics|mesh-ancestor
55792881|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
55792882|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792883|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849501|NCT01511445|Silicon|silicon|mesh-list
55792885|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792887|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
55792888|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792889|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
55792890|NCT04294459|Hormones|hormones|mesh-ancestor
55792891|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792892|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55792893|NCT04294459|Protective Agents|protective agents|mesh-ancestor
55792894|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55849502|NCT01511445|Trace Elements|trace elements|mesh-ancestor
55792895|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
55792896|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55792897|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
55792898|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55792899|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55792900|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792901|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55792902|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55792903|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792904|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
55792905|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
55792906|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55792907|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
55792909|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792910|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55792911|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
55792912|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
55792913|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55792914|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55792916|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55792917|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792918|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55792920|NCT05009017|Growth Substances|growth substances|mesh-ancestor
55827580|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792921|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792922|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
55792923|NCT05008939|Sevoflurane|sevoflurane|mesh-list
55792924|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55792925|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55792926|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
55792927|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
55792928|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55849503|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
55792929|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792931|NCT05008861|Nivolumab|nivolumab|mesh-list
55792932|NCT05008861|Durvalumab|durvalumab|mesh-list
55792933|NCT05008861|Antibodies|antibodies|mesh-list
55792934|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55792935|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
55792936|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792937|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849633|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827581|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55827582|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792938|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792939|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55792940|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792941|NCT05360277|Capecitabine|capecitabine|mesh-list
55792942|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55792943|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
55792944|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792945|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792946|NCT03091699|Nicotine|nicotine|mesh-list
55792947|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55792948|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
55792949|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792950|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792951|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55792952|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55792953|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
55792954|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792955|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792956|NCT05344209|Sargramostim|sargramostim|mesh-list
55792957|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
55792958|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792959|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
55792960|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792961|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792962|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
55792963|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792964|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849736|NCT02223208|Hormones|hormones|mesh-ancestor
55792965|NCT04253457|Triamcinolone|triamcinolone|mesh-list
55792966|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792967|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
55792968|NCT04253457|Hormones|hormones|mesh-ancestor
55792969|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792970|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792972|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55792973|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792974|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55792975|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792976|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792977|NCT02525133|Bupivacaine|bupivacaine|mesh-list
55792978|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
55792979|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
55792980|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792981|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792982|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
55792983|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792984|NCT05602311|Anesthetics|anesthetics|mesh-list
55792985|NCT05602311|Anesthetics, General|anesthetics, general|mesh-list
55792986|NCT05602311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792987|NCT05602311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792988|NCT05016349|Tamoxifen|tamoxifen|mesh-list
55792989|NCT05016349|Tocopherols|tocopherols|mesh-list
55792990|NCT05016349|Tretinoin|tretinoin|mesh-list
55792992|NCT05016349|Cannabidiol|cannabidiol|mesh-list
55850316|NCT01125436|Vitamins|vitamins|mesh-ancestor
55792993|NCT05016349|Isotretinoin|isotretinoin|mesh-list
55792994|NCT05016349|Mifepristone|mifepristone|mesh-list
55792995|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55792996|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
55792997|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792998|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792999|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55793000|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793001|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55793002|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55793003|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55793004|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
55793005|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
55793006|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
55793007|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55793008|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
55793009|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55793010|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55793012|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55793013|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
55793014|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55793015|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55793016|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
55793017|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55793018|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55850317|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
55793020|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793021|NCT05016349|Protective Agents|protective agents|mesh-ancestor
55793022|NCT05016349|Vitamins|vitamins|mesh-ancestor
55793023|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
55793024|NCT05380635|Hypericin|hypericin|mesh-list
55793026|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55793027|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793028|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
55793029|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793030|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793031|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793032|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55793033|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
55793034|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793036|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55793037|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55793038|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793039|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55793040|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
55793041|NCT03079219|Dexamethasone|dexamethasone|mesh-list
55793042|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
55793043|NCT03079219|Ondansetron|ondansetron|mesh-list
55793044|NCT03079219|Olanzapine|olanzapine|mesh-list
55793045|NCT03079219|Aprepitant|aprepitant|mesh-list
55793046|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
55793047|NCT03079219|BB 1101|bb 1101|mesh-list
55793049|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
55793050|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
55793051|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793052|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793053|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55793054|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
55793055|NCT03079219|Hormones|hormones|mesh-ancestor
55793056|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55793057|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55793058|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793059|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
55793060|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793061|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793063|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
55793064|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55793065|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
55793066|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793067|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55793068|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55793069|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793070|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55793071|NCT03079219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55793072|NCT03079219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55793073|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55793074|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55793075|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55793076|NCT03078829|Leuprolide|leuprolide|mesh-list
55793077|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55793078|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
55793079|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55793080|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793081|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55793083|NCT05008237|Docetaxel|docetaxel|mesh-list
55793084|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793085|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
55793087|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
55793088|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793089|NCT05014711|Fentanyl|fentanyl|mesh-list
55793090|NCT05014711|Remifentanil|remifentanil|mesh-list
55793091|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55793096|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
55793097|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793098|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55793099|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55793100|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
55793101|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
55793102|NCT05018923|Metronidazole|metronidazole|mesh-list
55793103|NCT05018923|Doxycycline|doxycycline|mesh-list
55793105|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
55793106|NCT05018923|Rabeprazole|rabeprazole|mesh-list
55793108|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850454|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55793109|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793110|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55793111|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55793112|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55793113|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
55793114|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55793115|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55793116|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55793117|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793119|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55793120|NCT05018923|Diuretics|diuretics|mesh-ancestor
55793121|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
55793122|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793123|NCT05018923|Expectorants|expectorants|mesh-ancestor
55793124|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
55793125|NCT03086473|Caffeine|caffeine|mesh-list
55793126|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
55793127|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793128|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55793129|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793130|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55793131|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850455|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55793132|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55793133|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55793134|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
55793135|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793137|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55793138|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793139|NCT03079141|Eplerenone|eplerenone|mesh-list
55793140|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55793141|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
55793161|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55793162|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55793163|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
55793164|NCT05531955|Pirfenidone|pirfenidone|mesh-list
55793165|NCT05531955|Analgesics|analgesics|mesh-ancestor
55793166|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
55793167|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793168|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793169|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55793177|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793178|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793179|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793181|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
55793182|NCT05006911|Bromfenac|bromfenac|mesh-list
55793183|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55793184|NCT05006911|Phenylephrine|phenylephrine|mesh-list
55793185|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
55793186|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
55793187|NCT05006911|Pilocarpine|pilocarpine|mesh-list
55793188|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55793189|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
55793190|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793191|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
55793192|NCT05006911|Protective Agents|protective agents|mesh-ancestor
55793193|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55793194|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55793195|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55793196|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55793197|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
55793198|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793199|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793200|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
55793201|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
55793202|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793203|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
55793204|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55793205|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
55793206|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55793207|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
55793208|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55793209|NCT05006911|Miotics|miotics|mesh-ancestor
55793210|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55793211|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55793212|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
55793213|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55793214|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793216|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
55793217|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793218|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55793219|NCT05339295|Levofloxacin|levofloxacin|mesh-list
55793221|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55793223|NCT05339295|Renal Agents|renal agents|mesh-ancestor
55793224|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55793225|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55793226|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55793227|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793228|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793229|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793230|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55793231|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55793233|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
55793234|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55793235|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793236|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55793237|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793238|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
55793239|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55793240|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55793241|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
55793242|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851897|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
55793243|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
55793244|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
55793245|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
55793246|NCT02637895|Vortioxetine|vortioxetine|mesh-list
55793247|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
55793248|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55793249|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55793250|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55793251|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793252|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793253|NCT02637895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55793254|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55793255|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55793256|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793257|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793258|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
55793259|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55793260|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55793261|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55793262|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55793263|NCT05305989|Belumosudil|belumosudil|mesh-list
55793278|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
55793279|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55793280|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55793281|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793282|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
55793283|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55793284|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793285|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55793286|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793287|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55793288|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793289|NCT05007223|Doxycycline|doxycycline|mesh-list
55793291|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793292|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
55793293|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55793294|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55793295|NCT05000281|Ibuprofen|ibuprofen|mesh-list
55793296|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55793297|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793298|NCT05000281|Analgesics|analgesics|mesh-ancestor
55793299|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
55793300|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793301|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793302|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793303|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55793304|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55793305|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793306|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793307|NCT03081949|Selenium|selenium|mesh-list
55793308|NCT03081949|Selenious Acid|selenious acid|mesh-list
55793309|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
55793310|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
55793311|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793312|NCT03081949|Protective Agents|protective agents|mesh-ancestor
55793313|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793314|NCT03081949|Trace Elements|trace elements|mesh-ancestor
55793316|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
55793317|NCT05347173|Nalbuphine|nalbuphine|mesh-list
55793318|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55793319|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793320|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852036|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
55793321|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793322|NCT05347173|Analgesics|analgesics|mesh-ancestor
55793323|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
55793324|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793325|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55793326|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55793327|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55793328|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
55793329|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793330|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793331|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55793332|NCT05347173|Narcotics|narcotics|mesh-ancestor
55793333|NCT05006287|Warfarin|warfarin|mesh-list
55793334|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
55793335|NCT05006287|Dabigatran|dabigatran|mesh-list
55793336|NCT05006287|Apixaban|apixaban|mesh-list
55793337|NCT05006287|Anticoagulants|anticoagulants|mesh-list
55793338|NCT05006287|Edoxaban|edoxaban|mesh-list
55793339|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55793340|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
55793341|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55793342|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
55793344|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793345|NCT05013151|Castor Oil|castor oil|mesh-list
55793346|NCT05013151|Cathartics|cathartics|mesh-ancestor
55793347|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55793348|NCT05006209|Calcium|calcium|mesh-list
55793349|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55793350|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793351|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
55793352|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55793353|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793354|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55793355|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793356|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
55793357|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55793358|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793359|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793360|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793361|NCT03076099|Analgesics|analgesics|mesh-ancestor
55793362|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
55793363|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793364|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55793365|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55793366|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55793367|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
55793368|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793369|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793371|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55793372|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793373|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793374|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55793375|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
55793377|NCT05554419|Cytarabine|cytarabine|mesh-list
55793378|NCT05554419|Azacitidine|azacitidine|mesh-list
55793379|NCT05554419|Daunorubicin|daunorubicin|mesh-list
55793380|NCT05554419|Venetoclax|venetoclax|mesh-list
55793381|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55793382|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
55793383|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793384|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793385|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
55793386|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793387|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55793388|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
55793389|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793390|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793391|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55793392|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55793393|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55793394|NCT05554341|Paclitaxel|paclitaxel|mesh-list
55793395|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55793396|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55793397|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793398|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
55793399|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
55793400|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
55793401|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793402|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
55793404|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793405|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55793406|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793407|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793408|NCT05268003|Venetoclax|venetoclax|mesh-list
55793409|NCT05268003|Ponatinib|ponatinib|mesh-list
55793410|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793411|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55793412|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793413|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793416|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793417|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
55793418|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793419|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55793420|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
55793421|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
55793422|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793423|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793424|NCT05262855|FAPI-46|fapi-46|mesh-list
55793425|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55793426|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793427|NCT05262777|Lidocaine|lidocaine|mesh-list
55793428|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
55793429|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
55793434|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55793435|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55793436|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55793437|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55793438|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793440|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
55793441|NCT05260359|Petrolatum|petrolatum|mesh-list
55793488|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55793489|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55793490|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793492|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793493|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55793494|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
55793495|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
55793496|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793497|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793498|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793499|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
55793506|NCT05012137|Ropivacaine|ropivacaine|mesh-list
55793507|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
55793508|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
55793509|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793510|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793511|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
55793512|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793513|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
55793514|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
55793515|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793516|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793517|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793518|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
55793519|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
55793520|NCT04925167|Heparin|heparin|mesh-list
55793521|NCT04925167|Calcium heparin|calcium heparin|mesh-list
55793522|NCT04925167|Argatroban|argatroban|mesh-list
55793523|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
55793524|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55793525|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55793526|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793527|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
55793528|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55793529|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
55793530|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793531|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55793532|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55793533|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55793534|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55793535|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793536|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793537|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55793538|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55793539|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55793540|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55793541|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
55793542|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793543|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793544|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55793545|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55793547|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55793548|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55793549|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
55793550|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
55793551|NCT02524665|Salicylates|salicylates|mesh-list
55793552|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55793553|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793554|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
55793555|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
55793556|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
55793557|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55793558|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793560|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
55793561|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793562|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793563|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793564|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55793565|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55793566|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793567|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793568|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55793569|NCT04998253|Propofol|propofol|mesh-list
55793570|NCT04998253|Sevoflurane|sevoflurane|mesh-list
55793571|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55793572|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793573|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793574|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55793575|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
55793576|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
55793577|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55793578|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55793579|NCT05616923|Trametinib|trametinib|mesh-list
55793580|NCT05616923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793581|NCT05616923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55793585|NCT02638129|Bupropion|bupropion|mesh-list
55793599|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793600|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55793601|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55793602|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793603|NCT02524275|Docetaxel|docetaxel|mesh-list
55793604|NCT02524275|Capecitabine|capecitabine|mesh-list
55793605|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793606|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
55793607|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
55793608|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
55793609|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793610|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55793611|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
55793613|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55793614|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793615|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793616|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793619|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55793620|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793621|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793623|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
55793624|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
55793625|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55793626|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55793627|NCT05010499|Bupivacaine|bupivacaine|mesh-list
55793628|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
55793629|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
55793630|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
55793631|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793632|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793633|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
55793634|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793635|NCT03075241|Zolpidem|zolpidem|mesh-list
55793636|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55793637|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55793638|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793639|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793640|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55793641|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
55793642|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
55793643|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793644|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793645|NCT04994119|Warfarin|warfarin|mesh-list
55793646|NCT04994119|Zamicastat|zamicastat|mesh-list
55793647|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
55793648|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793649|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793650|NCT01658943|Fluorouracil|fluorouracil|mesh-list
55793653|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793654|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55793655|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793656|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55793657|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
55793661|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55793663|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793664|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55793665|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55793666|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55793667|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
55793668|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793669|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55793670|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55793671|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793672|NCT03074773|Dexamethasone|dexamethasone|mesh-list
55793673|NCT03074773|Bupivacaine|bupivacaine|mesh-list
55793674|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793675|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
55793676|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
55793677|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793678|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793680|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
55793681|NCT03074773|Hormones|hormones|mesh-ancestor
55793682|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55793683|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55793684|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793685|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
55793687|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793688|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
55793689|NCT03077581|Anesthetics|anesthetics|mesh-list
55793690|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793691|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793692|NCT03077503|Fentanyl|fentanyl|mesh-list
55793693|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
55793694|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55793695|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793696|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793697|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793698|NCT03077503|Analgesics|analgesics|mesh-ancestor
55793699|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
55793700|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793701|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55793702|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55793703|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55793704|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
55793705|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793706|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793707|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55793708|NCT03077503|Narcotics|narcotics|mesh-ancestor
55793709|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55793710|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55793711|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
55793729|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
55793730|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55793731|NCT03073057|Charcoal|charcoal|mesh-list
55793732|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793733|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55793734|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
55793735|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793736|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793737|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55793738|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
55793739|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
55793740|NCT03073057|Hormones|hormones|mesh-ancestor
55793741|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55793742|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55793743|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55793748|NCT03073057|Antidotes|antidotes|mesh-ancestor
55793756|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55793757|NCT04433611|Lidocaine|lidocaine|mesh-list
55793758|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
55793759|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
55793760|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793761|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793762|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
55793763|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793764|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55793765|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55793766|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55793767|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55793768|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793770|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
55793771|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
55793772|NCT04992481|Protective Agents|protective agents|mesh-ancestor
55793773|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793774|NCT02597933|Nintedanib|nintedanib|mesh-list
55793775|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793795|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793796|NCT04360889|Protective Agents|protective agents|mesh-ancestor
55793797|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793798|NCT04360889|Vitamins|vitamins|mesh-ancestor
55793799|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
55793800|NCT03072589|Regadenoson|regadenoson|mesh-list
55793801|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55793802|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55793803|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
55793804|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
55793805|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793806|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793807|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793809|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793810|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55793811|NCT04807829|Nabilone|nabilone|mesh-list
55793812|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
55793813|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
55793816|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55793817|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55793818|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55793819|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793820|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55793821|NCT04811573|Thalidomide|thalidomide|mesh-list
55793822|NCT04811573|Apremilast|apremilast|mesh-list
55793823|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55793824|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793825|NCT04811573|Analgesics|analgesics|mesh-ancestor
55793826|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
55793827|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793828|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793829|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793830|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55793831|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55793833|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793834|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793835|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55793836|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
55793837|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
55793838|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55793839|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793840|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55793841|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55793842|NCT04811573|Growth Substances|growth substances|mesh-ancestor
55793843|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
55793844|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793845|NCT03072511|Nicotine|nicotine|mesh-list
55793846|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55793847|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
55793848|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793849|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793850|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55793851|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55793861|NCT03072121|Aspirin|aspirin|mesh-list
55793862|NCT03072121|Metoprolol|metoprolol|mesh-list
55793863|NCT03072121|Isosorbide|isosorbide|mesh-list
55793864|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55793865|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55793866|NCT03072121|Trimetazidine|trimetazidine|mesh-list
55793867|NCT03072121|Clopidogrel|clopidogrel|mesh-list
55793868|NCT03072121|Atorvastatin|atorvastatin|mesh-list
55793869|NCT03072121|Calcium|calcium|mesh-list
55793870|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55793871|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793872|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55793873|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793874|NCT03072121|Analgesics|analgesics|mesh-ancestor
55793875|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
55793876|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793877|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793878|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55793879|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55793880|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55793881|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793882|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55793884|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793886|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55793887|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55793888|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
55793889|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55793890|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55793891|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55793892|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55793893|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55793894|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
55793895|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793896|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55793897|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55793898|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
55793899|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
55793900|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55793901|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55793902|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55793904|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55793906|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
55793907|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
55793908|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55793909|NCT02597855|Aflibercept|aflibercept|mesh-list
55793910|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55793911|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55793912|NCT02597855|Growth Substances|growth substances|mesh-ancestor
55793951|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55793952|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55793953|NCT03071731|Bromides|bromides|mesh-list
55793954|NCT03071731|Ipratropium|ipratropium|mesh-list
55793955|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
55793956|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
55793957|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
55793958|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793959|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793960|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55793961|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
55793962|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793963|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793965|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
55793966|NCT04809935|Ethanol|ethanol|mesh-list
55793967|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55793968|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793969|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793970|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793971|NCT04255927|Triclosan|triclosan|mesh-list
55793972|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55793973|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793974|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55793975|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55793976|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
55793977|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793978|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55794001|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
55794002|NCT04798391|Hormones|hormones|mesh-ancestor
55794003|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794004|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55794005|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794006|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
55794007|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
55794008|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55794009|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
55794010|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794011|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794012|NCT05616455|Nitroglycerin|nitroglycerin|mesh-list
55794013|NCT05616455|Vasodilator Agents|vasodilator agents|mesh-ancestor
55794014|NCT04986319|Vitamin D|vitamin d|mesh-list
55794015|NCT04986319|Vitamins|vitamins|mesh-ancestor
55794016|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
55794017|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794018|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55794020|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55794021|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794029|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794030|NCT01657461|Plasminogen|plasminogen|mesh-list
55794031|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55794032|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55794033|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55794034|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794035|NCT05001919|Mitogens|mitogens|mesh-list
55794036|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
55794037|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794038|NCT05001763|Prucalopride|prucalopride|mesh-list
55794039|NCT05001763|Laxatives|laxatives|mesh-ancestor
55794040|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794041|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55794042|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55794043|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
55794044|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794045|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794046|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794048|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794059|NCT02592551|Durvalumab|durvalumab|mesh-list
55794060|NCT02592551|Tremelimumab|tremelimumab|mesh-list
55794061|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55794062|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794063|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55794064|NCT04989127|Penicillins|penicillins|mesh-list
55794066|NCT04989127|Analgesics|analgesics|mesh-list
55794067|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794068|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
55794069|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
55794070|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794071|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794073|NCT04982809|Prednisolone|prednisolone|mesh-list
55794074|NCT04982809|Betamethasone|betamethasone|mesh-list
55794075|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55794076|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
55794077|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
55794078|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794079|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794080|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794081|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
55794083|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794084|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55794085|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794086|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55794087|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
55794088|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
55794089|NCT03068533|Calcium|calcium|mesh-list
55794090|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55794091|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794092|NCT03068533|Antacids|antacids|mesh-ancestor
55794093|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794096|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794097|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794111|NCT04808687|Paclitaxel|paclitaxel|mesh-list
55794112|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55794113|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794114|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
55794115|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
55794116|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
55794117|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794118|NCT05279703|Epinephrine|epinephrine|mesh-list
55794119|NCT05279703|Racepinephrine|racepinephrine|mesh-list
55794120|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
55794121|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55794122|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55794123|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
55794124|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794125|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794126|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794128|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55794130|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794131|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55794132|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
55794133|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
55794134|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
55794135|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55794137|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
55794138|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
55794139|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55794140|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794141|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
55794142|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794143|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55794144|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55794145|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55794146|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55794147|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794150|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55794151|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
55794152|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794153|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55794154|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55794155|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
55794156|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794157|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794158|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55794159|NCT05635357|Letrozole|letrozole|mesh-list
55794160|NCT05635357|Anastrozole|anastrozole|mesh-list
55794161|NCT05635357|Exemestane|exemestane|mesh-list
55794162|NCT05635357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794163|NCT05635357|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55794164|NCT05635357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55794165|NCT05635357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794166|NCT05635357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794167|NCT05635357|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55794168|NCT05635357|Hormone Antagonists|hormone antagonists|mesh-ancestor
55794169|NCT05635357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794173|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
55794174|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55794175|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55794176|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794177|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794178|NCT05275725|Urological Agents|urological agents|mesh-ancestor
55794179|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
55794180|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55794198|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55794200|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
55794201|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794202|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55794203|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
55794204|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
55794205|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794206|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55794207|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55794208|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55794209|NCT04785755|Protective Agents|protective agents|mesh-ancestor
55794210|NCT05272605|Vaccines|vaccines|mesh-list
55794211|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
55794212|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794213|NCT04785911|Antiemetics|antiemetics|mesh-list
55794214|NCT04785911|Histamine|histamine|mesh-list
55794215|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
55794216|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
55794217|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794218|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794221|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794222|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794223|NCT04240821|Theophylline|theophylline|mesh-list
55794224|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55794225|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
55794226|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794227|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794234|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55794235|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55794236|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
55794237|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794238|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55794239|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55794240|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794241|NCT05314101|Bevacizumab|bevacizumab|mesh-list
55794242|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55794243|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794244|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55794245|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55794246|NCT05314101|Growth Substances|growth substances|mesh-ancestor
55794247|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794248|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
55794249|NCT02595749|Oxytocin|oxytocin|mesh-list
55794250|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
55794286|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794287|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
55794288|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55794289|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55794290|NCT05214573|Glucagon|glucagon|mesh-list
55794291|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55794292|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794293|NCT05214573|Hormones|hormones|mesh-ancestor
55794296|NCT05214573|Incretins|incretins|mesh-ancestor
55794321|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
55794322|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794323|NCT03070405|Tenofovir|tenofovir|mesh-list
55794324|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
55794325|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
55794326|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794327|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55794328|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55794330|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794331|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55794332|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55794333|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
55794334|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55794335|NCT03068065|Metformin|metformin|mesh-list
55794336|NCT03068065|Liraglutide|liraglutide|mesh-list
55794337|NCT03068065|Gliclazide|gliclazide|mesh-list
55794338|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55794339|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794340|NCT03068065|Incretins|incretins|mesh-ancestor
55794342|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794343|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
55794344|NCT05161611|Astringents|astringents|mesh-ancestor
55794345|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794346|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
55794347|NCT03660475|Naltrexone|naltrexone|mesh-list
55794348|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55794349|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55794350|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794351|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
55794352|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794353|NCT05211609|Methyldopa|methyldopa|mesh-list
55794354|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55794363|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794364|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794365|NCT05615987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55794366|NCT05615987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55794367|NCT05615987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55794368|NCT05615987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794369|NCT05615987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794370|NCT05615987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55794371|NCT05615987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55794372|NCT05615987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794402|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55794403|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55794404|NCT04793399|Atezolizumab|atezolizumab|mesh-list
55794405|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794406|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
55794407|NCT05157711|Phenylephrine|phenylephrine|mesh-list
55794408|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
55794409|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
55794410|NCT05157711|Bismuth|bismuth|mesh-list
55794411|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55794412|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
55794414|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794415|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794416|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
55794417|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55794418|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
55794419|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
55794420|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55794421|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55794422|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55794423|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
55794424|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794425|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794426|NCT05157711|Protective Agents|protective agents|mesh-ancestor
55794427|NCT05157711|Antacids|antacids|mesh-ancestor
55794428|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794429|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
55794430|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
55794431|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55794432|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794433|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
55794434|NCT05157711|Coagulants|coagulants|mesh-ancestor
55794435|NCT05105997|Dexamethasone|dexamethasone|mesh-list
55794436|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55794437|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
55794438|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
55794439|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794440|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794441|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794442|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
55794443|NCT05105997|Hormones|hormones|mesh-ancestor
55794444|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794445|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55794446|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794447|NCT03424525|Trimethoprim|trimethoprim|mesh-list
55794448|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55794449|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794450|NCT03424525|Renal Agents|renal agents|mesh-ancestor
55794452|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55794453|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55794454|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55794455|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794456|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794457|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55794458|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55794460|NCT05104983|Sirolimus|sirolimus|mesh-list
55794474|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794475|NCT04801511|Protective Agents|protective agents|mesh-ancestor
55794476|NCT04230759|Fluorouracil|fluorouracil|mesh-list
55794477|NCT04230759|Durvalumab|durvalumab|mesh-list
55794478|NCT04230759|Mitomycins|mitomycins|mesh-list
55794479|NCT04230759|Mitomycin|mitomycin|mesh-list
55794480|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55794481|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
55794482|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794496|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794497|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794498|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55794499|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
55794500|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55794501|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
55794502|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
55794503|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794505|NCT05471609|Levodopa|levodopa|mesh-list
55794511|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794512|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794513|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55794515|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
55794516|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55794517|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
55794518|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794519|NCT05370729|Expectorants|expectorants|mesh-ancestor
55794541|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55794542|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55794543|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55794544|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55794545|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794546|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55794547|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55794548|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794549|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55794550|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55794551|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55794552|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55794553|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794554|NCT04801199|Incretins|incretins|mesh-ancestor
55794564|NCT04340141|Irinotecan|irinotecan|mesh-list
55794565|NCT04340141|Calcium|calcium|mesh-list
55794587|NCT05201547|Carboplatin|carboplatin|mesh-list
55794588|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55794589|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794590|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
55794591|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
55794592|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
55794593|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794594|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55794595|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
55794596|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55794597|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55794600|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794601|NCT05226455|Azacitidine|azacitidine|mesh-list
55794602|NCT05226455|Venetoclax|venetoclax|mesh-list
55794603|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55794604|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
55794605|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794606|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794607|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794609|NCT05201313|Mepivacaine|mepivacaine|mesh-list
55794610|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
55794611|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
55794612|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55794613|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794614|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
55794615|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026265|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
56026266|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
56026267|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026268|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026269|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56026270|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
56026271|NCT01275014|Hormones|hormones|mesh-ancestor
56026272|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026273|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56026274|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026278|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026279|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026280|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56026281|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
56026282|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
56026283|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56026284|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
56026285|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026286|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026287|NCT01275248|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56026288|NCT01275248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56026289|NCT01275248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56026290|NCT01275248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56026291|NCT01275248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56026293|NCT00756236|Esmolol|esmolol|mesh-list
56026294|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56026295|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56026296|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
56026297|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
56026298|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794616|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55794617|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55794618|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55794619|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55794620|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794621|NCT05201001|Carboplatin|carboplatin|mesh-list
55794622|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794623|NCT04799639|Paclitaxel|paclitaxel|mesh-list
55794624|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55794643|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794644|NCT04798703|Paclitaxel|paclitaxel|mesh-list
55794645|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
55794646|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55794647|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794648|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
55794649|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
55794650|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
55794651|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794652|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55794653|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
55794654|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794655|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
55794656|NCT04798703|Protective Agents|protective agents|mesh-ancestor
55794658|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55794660|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
55794665|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
55794666|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794667|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55827583|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794676|NCT05624359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55794677|NCT05624359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794678|NCT05624359|Sensory System Agents|sensory system agents|mesh-ancestor
55794679|NCT05624359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794680|NCT05194293|Durvalumab|durvalumab|mesh-list
55794681|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
55794682|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55794683|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
55794684|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55794686|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
55794687|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794689|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
55794690|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55794691|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
55794692|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
55794693|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
55794694|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794695|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794696|NCT04338659|Antibodies|antibodies|mesh-list
55794697|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55794698|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
55794699|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794700|NCT03901001|Sirolimus|sirolimus|mesh-list
55794701|NCT03901001|Oseltamivir|oseltamivir|mesh-list
55794702|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55794717|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
55794718|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
55794719|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
55794720|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794721|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55794722|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794723|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55794724|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55794725|NCT05189535|Protective Agents|protective agents|mesh-ancestor
55794726|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794727|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
55794728|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55794729|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
55794731|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
55794733|NCT02633059|Ichthammol|ichthammol|mesh-list
55794734|NCT02633059|BB 1101|bb 1101|mesh-list
55794735|NCT02633059|Glycine|glycine|mesh-list
55794739|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794740|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794741|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794742|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
55794743|NCT02633059|Hormones|hormones|mesh-ancestor
55794744|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794745|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55794746|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794747|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794748|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
55794750|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
55794751|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
55794753|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
55794754|NCT05089461|Analgesics|analgesics|mesh-ancestor
55794755|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
55794756|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794757|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794758|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794759|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55794760|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55794761|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794762|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794763|NCT05730439|Lobeline|lobeline|mesh-list
55794764|NCT05730439|Nicotine|nicotine|mesh-list
55794765|NCT05730439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55794766|NCT05730439|Autonomic Agents|autonomic agents|mesh-ancestor
55794767|NCT05730439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794768|NCT05730439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794769|NCT05730439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55794770|NCT05730439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55794771|NCT05730439|Cholinergic Agents|cholinergic agents|mesh-ancestor
55794772|NCT05730439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794773|NCT05730439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794774|NCT05730439|Respiratory System Agents|respiratory system agents|mesh-ancestor
55794775|NCT04224987|Azithromycin|azithromycin|mesh-list
55794776|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55794777|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794778|NCT04583969|Remdesivir|remdesivir|mesh-list
55794783|NCT04805515|Nicotine|nicotine|mesh-list
55794784|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55794785|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
55794786|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794787|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794788|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55794789|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55794790|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
55794791|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794793|NCT05195177|Anesthetics|anesthetics|mesh-list
55794811|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794812|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794813|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55794814|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55794815|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55794816|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55794817|NCT05170919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55794818|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55794819|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55794820|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794823|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
55794824|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55794825|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
55794826|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
55827584|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55795091|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55795092|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55795093|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55795094|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
55795095|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795096|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795097|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795100|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55795101|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795102|NCT04733963|Bevacizumab|bevacizumab|mesh-list
55795103|NCT04733963|Capecitabine|capecitabine|mesh-list
55795160|NCT05728333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795161|NCT05728333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55795162|NCT01364727|Amrubicin|amrubicin|mesh-list
55795163|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795164|NCT04990869|Niacinamide|niacinamide|mesh-list
55795165|NCT04990869|Niacin|niacin|mesh-list
55795232|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
55795233|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795234|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
55795235|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795236|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795237|NCT04426487|Progesterone|progesterone|mesh-list
55795238|NCT04426487|Progestins|progestins|mesh-ancestor
55795239|NCT04426487|Hormones|hormones|mesh-ancestor
55795242|NCT04988217|Interferons|interferons|mesh-list
55795302|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55795303|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795304|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55795305|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
55795306|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795307|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
55795308|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795309|NCT05034627|Asparaginase|asparaginase|mesh-list
55795310|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795358|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
55795359|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795360|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55795361|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55795362|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55795363|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795364|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795381|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795382|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795384|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55795385|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
55795388|NCT04421547|Letrozole|letrozole|mesh-list
55795409|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
55795410|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
55795412|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795413|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
55795414|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795415|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55795416|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55795417|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55795475|NCT03775629|Narcotics|narcotics|mesh-ancestor
55795476|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795477|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795478|NCT03775629|Analgesics|analgesics|mesh-ancestor
55795479|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
55795560|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55795561|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
55795562|NCT01670539|Hormones|hormones|mesh-ancestor
55795563|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795564|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795565|NCT02252887|Gemcitabine|gemcitabine|mesh-list
55795566|NCT02252887|Trastuzumab|trastuzumab|mesh-list
55795567|NCT02252887|Pertuzumab|pertuzumab|mesh-list
55795568|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55795616|NCT04950465|Protective Agents|protective agents|mesh-ancestor
55795617|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795618|NCT04877821|Paclitaxel|paclitaxel|mesh-list
55795619|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
55795620|NCT04877821|Carboplatin|carboplatin|mesh-list
55795621|NCT04877821|Epirubicin|epirubicin|mesh-list
55795622|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55795623|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795624|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
55795625|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
55795626|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
55795627|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795628|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795629|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
55795630|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795631|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795632|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55795633|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
55795634|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55795635|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55795674|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795675|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55795676|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55795677|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
55795678|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55795680|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
55795681|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795682|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55795717|NCT05008809|Irinotecan|irinotecan|mesh-list
55795718|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
55795719|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
55795720|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795721|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55795722|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795723|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795724|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
55795725|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795726|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55795760|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
55795761|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795762|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795763|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55795764|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55795765|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
55795766|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
55795767|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795768|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55795769|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55795770|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795803|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55795804|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795806|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795807|NCT00660673|Levodopa|levodopa|mesh-list
55795808|NCT00660673|Carbidopa|carbidopa|mesh-list
55795809|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55795810|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55795863|NCT05701007|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55795864|NCT05701007|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55795865|NCT05701007|Fertility Agents|fertility agents|mesh-ancestor
55795866|NCT04426955|Paclitaxel|paclitaxel|mesh-list
55795867|NCT04426955|Cisplatin|cisplatin|mesh-list
55795868|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55795869|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795870|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
55795871|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
55795872|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
55795911|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
55795912|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795913|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795914|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
55795915|NCT02521415|Acetaminophen|acetaminophen|mesh-list
55795917|NCT02521415|Fentanyl|fentanyl|mesh-list
55795918|NCT02521415|Ketamine|ketamine|mesh-list
55795919|NCT02521415|Analgesics|analgesics|mesh-list
55795984|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795985|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55795986|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
55795987|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795988|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795990|NCT05554133|Proflavine|proflavine|mesh-list
55795992|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796044|NCT05553665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55796045|NCT05553665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55796046|NCT05553665|GABA Modulators|gaba modulators|mesh-ancestor
55796047|NCT05553665|GABA Agents|gaba agents|mesh-ancestor
55796048|NCT05553665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796049|NCT05553665|Immunologic Factors|immunologic factors|mesh-ancestor
55796050|NCT02629159|Adalimumab|adalimumab|mesh-list
55796051|NCT02629159|Upadacitinib|upadacitinib|mesh-list
55796052|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796053|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55796054|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
55796055|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55796056|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796057|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796058|NCT05548985|Midodrine|midodrine|mesh-list
55796059|NCT05548985|Metoclopramide|metoclopramide|mesh-list
55796103|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55796104|NCT05548283|Lactams|lactams|mesh-list
55796105|NCT05548283|beta-Lactams|beta-lactams|mesh-list
55796106|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796107|NCT02628769|Solithromycin|solithromycin|mesh-list
55796108|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55796109|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796111|NCT05552807|Docetaxel|docetaxel|mesh-list
55796112|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55796162|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
55796163|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
55796164|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796166|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55796167|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
55796168|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55796170|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796171|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796172|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
55796173|NCT05547659|Acetaminophen|acetaminophen|mesh-list
55796174|NCT05547659|Celecoxib|celecoxib|mesh-list
55796175|NCT05547659|Pregabalin|pregabalin|mesh-list
55796176|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55796177|NCT05547659|Analgesics|analgesics|mesh-ancestor
55796178|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
55796179|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796180|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796181|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
55796182|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
55796183|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55796197|NCT05541419|Budesonide|budesonide|mesh-list
55796220|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
55796221|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796222|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796223|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
55796224|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796225|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55796226|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55796227|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55796266|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796267|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55796268|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55796269|NCT05540951|Growth Substances|growth substances|mesh-ancestor
55796270|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796271|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
55796273|NCT04964505|Venetoclax|venetoclax|mesh-list
55796274|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55796275|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
55796276|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796277|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796278|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796279|NCT04981093|Dexamethasone|dexamethasone|mesh-list
55796280|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
55796281|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796282|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
55796283|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
55796284|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796285|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796286|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796287|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
55796306|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55796307|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796308|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55796309|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
55796310|NCT02513823|Vitamin D|vitamin d|mesh-list
55796311|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
55796312|NCT02513823|Vitamins|vitamins|mesh-ancestor
55796313|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
55796314|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796315|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55796316|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55796317|NCT05545475|Heparin|heparin|mesh-list
55796319|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55796320|NCT05545475|Tinzaparin|tinzaparin|mesh-list
55796321|NCT05545475|Dalteparin|dalteparin|mesh-list
55796322|NCT05545475|Nadroparin|nadroparin|mesh-list
55796323|NCT05545475|Warfarin|warfarin|mesh-list
55796369|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
55796370|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796371|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796372|NCT04620733|Seladelpar|seladelpar|mesh-list
55796373|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55796374|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
55796375|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796377|NCT02476617|Ritonavir|ritonavir|mesh-list
55796378|NCT02476617|Ribavirin|ribavirin|mesh-list
55796379|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55796380|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55796381|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
55796382|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796383|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796384|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55796385|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55796386|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
55796387|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796388|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55796389|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55796390|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
55796391|NCT04428307|Artemisinins|artemisinins|mesh-list
55796397|NCT05535725|Vancomycin|vancomycin|mesh-list
55796423|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796424|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796425|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
55796426|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796427|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55796429|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
55796430|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796431|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796432|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55796433|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55796434|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
55796435|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55796436|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
55796438|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
55796439|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55796461|NCT05699135|Avelumab|avelumab|mesh-list
55796474|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796475|NCT03765619|Aspirin|aspirin|mesh-list
55796476|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55796477|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55796478|NCT03765619|Analgesics|analgesics|mesh-ancestor
55796479|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
55796480|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796481|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796482|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796483|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55796484|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55796485|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55796486|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796490|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
55796494|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
55796495|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55796497|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796499|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
55796500|NCT04979923|Lidocaine|lidocaine|mesh-list
55796501|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
55796502|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
55796503|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796534|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55796535|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
55796536|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
55796537|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796538|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796539|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796540|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55796541|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
55796542|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55796543|NCT05697809|Dexamethasone|dexamethasone|mesh-list
55796544|NCT05697809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796545|NCT05697809|Antiemetics|antiemetics|mesh-ancestor
55796546|NCT05697809|Autonomic Agents|autonomic agents|mesh-ancestor
55796547|NCT05697809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796548|NCT05697809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796549|NCT05697809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796550|NCT05697809|Glucocorticoids|glucocorticoids|mesh-ancestor
55796567|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55796570|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55796571|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55796572|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55796573|NCT03611881|Nicotine|nicotine|mesh-list
55796574|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55796575|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
55796576|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796577|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796578|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55796579|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55796580|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
55796598|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55796599|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55796602|NCT04978597|Opicapone|opicapone|mesh-list
55796603|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55796604|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796605|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796606|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55796607|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55796608|NCT03491683|Temozolomide|temozolomide|mesh-list
55796609|NCT03491683|Cemiplimab|cemiplimab|mesh-list
55796610|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55796656|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
55796657|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796658|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
55796659|NCT04977427|Hormones|hormones|mesh-ancestor
55796660|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796661|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796662|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55796663|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796664|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
55796667|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796668|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55796669|NCT04977427|Protective Agents|protective agents|mesh-ancestor
55796670|NCT03327805|Choline|choline|mesh-list
55796671|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
55796672|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55796673|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
55796674|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796675|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796677|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
55796693|NCT03061981|Metformin|metformin|mesh-list
55796694|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55796695|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796696|NCT02510001|Crizotinib|crizotinib|mesh-list
55796697|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796698|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55796699|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796703|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
55796705|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55796706|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796707|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
55796708|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796709|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796710|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55796711|NCT04925505|Anesthetics|anesthetics|mesh-list
55796727|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55796728|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796729|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796730|NCT02474199|Acetaminophen|acetaminophen|mesh-list
55796731|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
55796732|NCT02474199|Promethazine|promethazine|mesh-list
55796733|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55796734|NCT02474199|Analgesics|analgesics|mesh-ancestor
55796735|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
55796736|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796737|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796738|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
55796740|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55796741|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796743|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
55796744|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
55796745|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
55796747|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55796748|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
55796749|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
55796750|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796751|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796753|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
55796756|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55796757|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55796758|NCT02450487|Analgesics|analgesics|mesh-ancestor
55796759|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
55796779|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796780|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796781|NCT04213885|Riboflavin|riboflavin|mesh-list
55796784|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
55796785|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796786|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55796787|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
55796788|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
55796789|NCT02448771|Palbociclib|palbociclib|mesh-list
55796790|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796791|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55796792|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796793|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796794|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55796795|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55796796|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
55796797|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796798|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796799|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55796835|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796836|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
55796837|NCT03117751|Hormones|hormones|mesh-ancestor
55796838|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796839|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55796840|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55796841|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55796842|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55796843|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796844|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55796846|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55796855|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
55796856|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
55796857|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
55796858|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55796859|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55796860|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
55796861|NCT02504541|Testosterone|testosterone|mesh-list
55796862|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
55796863|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
55796864|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55796865|NCT02504541|Androgens|androgens|mesh-ancestor
55796866|NCT02504541|Hormones|hormones|mesh-ancestor
55796868|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796914|NCT02426281|Paclitaxel|paclitaxel|mesh-list
55796915|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55796916|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796917|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
55796918|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
55796919|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
55796920|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796921|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55796922|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
55796923|NCT02426281|Antiviral Agents|antiviral agents|mesh-ancestor
55796924|NCT02426281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796925|NCT02426281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796926|NCT02426281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55796927|NCT02426281|Immunologic Factors|immunologic factors|mesh-ancestor
55796955|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796956|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796957|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
55796958|NCT02504151|Cannabidiol|cannabidiol|mesh-list
55796959|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
55796960|NCT02448381|Hypericin|hypericin|mesh-list
55796961|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
55796962|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55796963|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796964|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
55796965|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796966|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796967|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796968|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797013|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55797014|NCT05536271|Bisoprolol|bisoprolol|mesh-list
55797015|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55797016|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
55797017|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
55797018|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797019|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797020|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55797021|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55797022|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55797023|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
55797024|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797025|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797074|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
55797075|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797076|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55797077|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55797078|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
55797079|NCT05591417|Dexamethasone|dexamethasone|mesh-list
55797080|NCT05591417|Dexamethasone acetate|dexamethasone acetate|mesh-list
55797081|NCT05591417|Dexmedetomidine|dexmedetomidine|mesh-list
55797082|NCT05591417|Morphine|morphine|mesh-list
55797083|NCT05591417|BB 1101|bb 1101|mesh-list
55797085|NCT05591417|Antiemetics|antiemetics|mesh-ancestor
55797132|NCT05678933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797134|NCT05678933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55797135|NCT05678933|Alkylating Agents|alkylating agents|mesh-ancestor
55797136|NCT05678933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797137|NCT05678933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797138|NCT05678933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55797140|NCT05678933|Glucocorticoids|glucocorticoids|mesh-ancestor
55797188|NCT05697029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797190|NCT05697029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55797191|NCT05697029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55797192|NCT05697029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797193|NCT05697029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55797194|NCT05697029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797195|NCT05697029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797196|NCT05697029|Immunologic Factors|immunologic factors|mesh-ancestor
55797249|NCT05696951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55797250|NCT05696951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55797251|NCT05696951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797252|NCT05696951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797254|NCT05677373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797255|NCT05677373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55797256|NCT05677373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797316|NCT02500641|Omeprazole|omeprazole|mesh-list
55797317|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55797318|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55797319|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55797320|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797321|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797322|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55797323|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797368|NCT05653271|Obinutuzumab|obinutuzumab|mesh-list
55797369|NCT05653271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797370|NCT05653271|Immunologic Factors|immunologic factors|mesh-ancestor
55797371|NCT05653271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797372|NCT05653271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797373|NCT05653271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55797374|NCT05653271|Alkylating Agents|alkylating agents|mesh-ancestor
55797439|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797440|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55797520|NCT05595083|Dexmedetomidine|dexmedetomidine|mesh-list
55797521|NCT05595083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55797600|NCT05645705|Sodium Fluoride|sodium fluoride|mesh-list
55797601|NCT05645705|Cariostatic Agents|cariostatic agents|mesh-ancestor
55797602|NCT05645705|Protective Agents|protective agents|mesh-ancestor
55797603|NCT05645705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797604|NCT05645705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797605|NCT02445339|Naltrexone|naltrexone|mesh-list
55797606|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55797672|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797673|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797674|NCT04445519|Latanoprost|latanoprost|mesh-list
55797675|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55797676|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55797677|NCT04291079|Antibodies|antibodies|mesh-list
55797679|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797681|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55797682|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55797730|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55797731|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797763|NCT04958473|Axitinib|axitinib|mesh-list
55797808|NCT05587673|Prednisolone acetate|prednisolone acetate|mesh-list
55797809|NCT05587673|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55797810|NCT05587673|Prednisolone phosphate|prednisolone phosphate|mesh-list
55797811|NCT05587673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797840|NCT04948957|Esmolol|esmolol|mesh-list
55797884|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55797885|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
55797886|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797888|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797962|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55797963|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55797964|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55797965|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797966|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
55797967|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797968|NCT02577029|Interferons|interferons|mesh-list
55852503|NCT00130780|Bevacizumab|bevacizumab|mesh-list
55852887|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
55852888|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55853068|NCT02102932|Metformin|metformin|mesh-list
55853171|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55853180|NCT04339426|Atovaquone|atovaquone|mesh-list
55853815|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853928|NCT01462695|Sunitinib|sunitinib|mesh-list
55854602|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854702|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026299|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026300|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56026301|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56026302|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56026303|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
56026304|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876661|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55876662|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55876663|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
55876664|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876665|NCT03831321|Diclofenac|diclofenac|mesh-list
55876666|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55876667|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55876668|NCT03831321|Analgesics|analgesics|mesh-ancestor
55876669|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
55876670|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876671|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876672|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855030|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876673|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876674|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55876675|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026305|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026307|NCT00762320|Lopinavir|lopinavir|mesh-list
56026308|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56026309|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56026310|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
56026311|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026312|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026313|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56026314|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56026315|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
55855164|NCT00381550|Fludarabine|fludarabine|mesh-list
56026316|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026317|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56026318|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56026319|NCT00244712|Tenofovir|tenofovir|mesh-list
56026320|NCT00244712|Lamivudine|lamivudine|mesh-list
56026321|NCT00244712|Emtricitabine|emtricitabine|mesh-list
56026322|NCT00244712|Abacavir|abacavir|mesh-list
56026323|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
56026324|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026325|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56026326|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56026327|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026328|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026329|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56026330|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56026331|NCT00725270|Mifepristone|mifepristone|mesh-list
56026332|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56026333|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
56026334|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56026335|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026336|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56026337|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56026338|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56032502|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56026345|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56026346|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56026347|NCT00243932|Ubiquinone|ubiquinone|mesh-list
56026348|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
56026349|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
56026350|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026351|NCT00243932|Vitamins|vitamins|mesh-ancestor
56026352|NCT00243386|Factor VIII|factor viii|mesh-list
56026353|NCT00243386|Coagulants|coagulants|mesh-ancestor
56026354|NCT03807362|CC-11050|cc-11050|mesh-list
56026355|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56026356|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56026357|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026358|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026359|NCT01275560|Metronidazole|metronidazole|mesh-list
56026360|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026361|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56026362|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56026363|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56026364|NCT00762710|Prazosin|prazosin|mesh-list
56026365|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56026366|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56026367|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56026368|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56026369|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
56026370|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026371|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026372|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026373|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56026375|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56026376|NCT00243074|Cediranib|cediranib|mesh-list
56026377|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026378|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026388|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026389|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56026390|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56026391|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56032503|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56026392|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026393|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
56026394|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026395|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
56026396|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56026397|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026398|NCT01247285|Fluoxetine|fluoxetine|mesh-list
56026399|NCT01247285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56026400|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56026401|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56026402|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026403|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026404|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
56026405|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026406|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56026407|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
56026408|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56026409|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56026410|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56026411|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026412|NCT03806582|Norepinephrine|norepinephrine|mesh-list
56026413|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56026414|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56026415|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
56026416|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026417|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026418|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026419|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
56026420|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
56026421|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026422|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56026423|NCT00779558|Heparin|heparin|mesh-list
56026424|NCT00779558|Calcium heparin|calcium heparin|mesh-list
56026425|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
56026426|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56026427|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56026428|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026429|NCT00758342|Travoprost|travoprost|mesh-list
56026430|NCT00758342|Brinzolamide|brinzolamide|mesh-list
56026431|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56026432|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56026433|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026434|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026435|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56026436|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56026437|NCT01301183|Estradiol|estradiol|mesh-list
56026438|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56026439|NCT01301183|Mecasermin|mecasermin|mesh-list
56026440|NCT01301183|Estrogens|estrogens|mesh-ancestor
56026441|NCT01301183|Hormones|hormones|mesh-ancestor
56026442|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026443|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026444|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56026445|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
56026446|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56026447|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56026448|NCT01301183|Growth Substances|growth substances|mesh-ancestor
56026449|NCT00758420|Polidocanol|polidocanol|mesh-list
56026450|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56026451|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56026452|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
56026453|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56026458|NCT01213199|Adapalene|adapalene|mesh-list
56026463|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026464|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026465|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56026466|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026467|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
56026469|NCT03809702|Analgesics|analgesics|mesh-ancestor
56026470|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
56032504|NCT04716335|Harmine|harmine|mesh-list
56026471|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026472|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026473|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
56026474|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56026475|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56026476|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026477|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56026478|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56026479|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56026480|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56026481|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56026482|NCT03806036|Vitamin D|vitamin d|mesh-list
56026483|NCT03806036|Clomiphene|clomiphene|mesh-list
56026484|NCT03806036|Enclomiphene|enclomiphene|mesh-list
56026485|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
56026486|NCT03806036|Vitamins|vitamins|mesh-ancestor
56026487|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
56026488|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026489|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56026490|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56026491|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
56026492|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026493|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56026494|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
56026495|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56026498|NCT00780026|Insulin|insulin|mesh-list
56026505|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56026506|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026507|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56026510|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56026511|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56026512|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56026513|NCT01214057|Narcotics|narcotics|mesh-ancestor
56026514|NCT01214057|Analgesics|analgesics|mesh-ancestor
56026515|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
56026516|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026517|NCT03809546|Dronabinol|dronabinol|mesh-list
56026518|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
56026519|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026520|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56026521|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56026522|NCT03809546|Analgesics|analgesics|mesh-ancestor
56026523|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
56026524|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026525|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56026526|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56026527|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026528|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026529|NCT03809546|Hormones|hormones|mesh-ancestor
56026530|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026531|NCT03809312|Amoxicillin|amoxicillin|mesh-list
56026532|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
56026533|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
56026534|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56026535|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026536|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026537|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026539|NCT01247363|Globalagliatin|globalagliatin|mesh-list
56026540|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
56026544|NCT00780494|Capecitabine|capecitabine|mesh-list
56026545|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56026546|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026547|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56026548|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56026549|NCT00780494|Growth Substances|growth substances|mesh-ancestor
56026550|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026551|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
56026552|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56026553|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
56026554|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026555|NCT00763412|Repaglinide|repaglinide|mesh-list
56026556|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56026557|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026558|NCT01302743|Metformin|metformin|mesh-list
56026559|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56026560|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026561|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
56026562|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56026563|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026564|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56026565|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
56026566|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56026567|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026568|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026569|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026570|NCT01214759|Tenofovir|tenofovir|mesh-list
56026571|NCT01214759|Emtricitabine|emtricitabine|mesh-list
56026572|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
56026573|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56026574|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
56026580|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56026587|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026588|NCT00780962|Expectorants|expectorants|mesh-ancestor
56026589|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
56026590|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55856695|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
56026591|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
56026592|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026593|NCT00780962|Protective Agents|protective agents|mesh-ancestor
56026594|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026595|NCT00780962|Antidotes|antidotes|mesh-ancestor
56026596|NCT00764738|Ranibizumab|ranibizumab|mesh-list
56026597|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56026598|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56026599|NCT00764738|Growth Substances|growth substances|mesh-ancestor
56026600|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026601|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
56026602|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026603|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
56026604|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
56026605|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56026606|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56026607|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026608|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026609|NCT00781508|Urological Agents|urological agents|mesh-ancestor
56026610|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
56026611|NCT03805568|Remifentanil|remifentanil|mesh-list
56026612|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56026613|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56026614|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026615|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56026616|NCT03805568|Analgesics|analgesics|mesh-ancestor
55856971|NCT01880593|Ketamine|ketamine|mesh-list
56026617|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
56026618|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026619|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55876676|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876677|NCT04450134|Fexofenadine|fexofenadine|mesh-list
55876678|NCT04450134|Famotidine|famotidine|mesh-list
55876679|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56026620|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56026621|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56026622|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
56026623|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026624|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026625|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56026626|NCT03805568|Narcotics|narcotics|mesh-ancestor
56026627|NCT00781898|Naltrexone|naltrexone|mesh-list
56026628|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56026629|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56026630|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026631|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
56026632|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026633|NCT00765128|Ketorolac|ketorolac|mesh-list
56026634|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56026635|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56026636|NCT00765128|Analgesics|analgesics|mesh-ancestor
56026637|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
56026638|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026639|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026640|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56026641|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026642|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56026643|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026644|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026645|NCT00765206|Omeprazole|omeprazole|mesh-list
56026646|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56026647|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56026648|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56026649|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56026663|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
56026664|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56026665|NCT03809078|Bombesin|bombesin|mesh-list
56026666|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56026667|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026668|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026669|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026670|NCT05316428|Ethanol|ethanol|mesh-list
56026671|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56026672|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026673|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56026674|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026675|NCT05310968|Aspirin|aspirin|mesh-list
56026676|NCT05310968|Tirofiban|tirofiban|mesh-list
56026677|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56026678|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56026679|NCT05310968|Analgesics|analgesics|mesh-ancestor
56026680|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
56026681|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026682|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026683|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56026684|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026685|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56026686|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56026687|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026688|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56026689|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56026690|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026691|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
56026692|NCT03805178|Abatacept|abatacept|mesh-list
56026693|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56026694|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026695|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026696|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56026697|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
56026703|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026704|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
56026705|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026707|NCT01250717|Goserelin|goserelin|mesh-list
56026708|NCT01250717|Estramustine|estramustine|mesh-list
56026709|NCT01250717|Docetaxel|docetaxel|mesh-list
56026710|NCT01250717|Bicalutamide|bicalutamide|mesh-list
56026711|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56026712|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
56026713|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
56026714|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026715|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026716|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56026717|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
56026718|NCT01250717|Hormones|hormones|mesh-ancestor
56026719|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026720|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56026721|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026722|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
56026723|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
56026724|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
56026725|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026726|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
56026727|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
55739723|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857649|NCT00217971|Analgesics|analgesics|mesh-ancestor
56026728|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56026730|NCT03804866|Doxorubicin|doxorubicin|mesh-list
56026731|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56026732|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56026733|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026734|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56026735|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56026736|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026737|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026738|NCT01251575|Cyclosporine|cyclosporine|mesh-list
56026740|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
56026741|NCT01251575|Fludarabine|fludarabine|mesh-list
56026742|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
56026743|NCT01251575|Cyclosporins|cyclosporins|mesh-list
56026744|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026745|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56026746|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
56026747|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026748|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56026749|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
56026750|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857721|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
56026751|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026752|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
56026753|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026754|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
56026755|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026756|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56026757|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56026758|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55857823|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
55858052|NCT03598725|Hormones|hormones|mesh-ancestor
56026759|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
56026760|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56026761|NCT00782756|Bevacizumab|bevacizumab|mesh-list
56026762|NCT00782756|Temozolomide|temozolomide|mesh-list
56026763|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56026764|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026765|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56026766|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56026767|NCT00782756|Growth Substances|growth substances|mesh-ancestor
56026768|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026769|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
56026770|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56026771|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
56026772|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026781|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026782|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026783|NCT01306175|Protective Agents|protective agents|mesh-ancestor
56026784|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032505|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
55858359|NCT03950427|Bupropion|bupropion|mesh-list
56026785|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56026786|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56026787|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
55739736|NCT04446923|Propranolol|propranolol|mesh-list
56026788|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56026789|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026790|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56026791|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56026792|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56026793|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026794|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
56026795|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026796|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
56026797|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56026799|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56026800|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026801|NCT01216397|Metformin|metformin|mesh-list
56026802|NCT01216397|Linagliptin|linagliptin|mesh-list
56026803|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56026804|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026805|NCT01216397|Incretins|incretins|mesh-ancestor
56026806|NCT01216397|Hormones|hormones|mesh-ancestor
56026807|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026809|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
56026826|NCT05621174|Dextroamphetamine|dextroamphetamine|mesh-list
56026827|NCT05621174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56026828|NCT05621174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026829|NCT05621174|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56026830|NCT05621174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56026831|NCT05621174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56026832|NCT05621174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026833|NCT05621174|Dopamine Agents|dopamine agents|mesh-ancestor
56026834|NCT05621174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026835|NCT01216943|Timolol|timolol|mesh-list
56026836|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56026837|NCT01216943|Bimatoprost|bimatoprost|mesh-list
56026838|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56026839|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56026840|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56026841|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56026842|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
56026882|NCT04278872|SJX-653|sjx-653|mesh-list
56026883|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
56026884|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56026885|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026886|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
56026887|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56026888|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
55754091|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026889|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026890|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
56026891|NCT03807596|Protective Agents|protective agents|mesh-ancestor
56026892|NCT01217411|R04929097|r04929097|mesh-list
56026893|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026894|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026895|NCT01253525|Paclitaxel|paclitaxel|mesh-list
56026896|NCT01253525|Ramucirumab|ramucirumab|mesh-list
56026897|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56026898|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56026899|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
56026900|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
56026901|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
56026902|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026903|NCT00768716|Acetaminophen|acetaminophen|mesh-list
56026904|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56026905|NCT00768716|Analgesics|analgesics|mesh-ancestor
55858692|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
56026906|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
56026909|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
56026930|NCT05583188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56026931|NCT05583188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56026932|NCT05583188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026933|NCT05583188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56026934|NCT05583188|Antimetabolites|antimetabolites|mesh-ancestor
56026935|NCT05583188|Antiviral Agents|antiviral agents|mesh-ancestor
56026936|NCT05583188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026937|NCT05583188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026938|NCT05583188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56026939|NCT05583188|Immunologic Factors|immunologic factors|mesh-ancestor
56026940|NCT05583188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762041|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
56026941|NCT05583188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56026942|NCT05583188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56026943|NCT05583188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56026944|NCT05583188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56026945|NCT01218971|Naltrexone|naltrexone|mesh-list
56026946|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56026947|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56026948|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026949|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
56026950|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56026951|NCT05743244|Abrocitinib|abrocitinib|mesh-list
56026952|NCT05743244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56026953|NCT05743244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026954|NCT05743244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026955|NCT03837626|Amiloride|amiloride|mesh-list
56026956|NCT03837626|Diuretics|diuretics|mesh-ancestor
56026957|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
56026958|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026959|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56026960|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56026961|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56032506|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56026962|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026963|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56026965|NCT01337687|Oxytocin|oxytocin|mesh-list
56026969|NCT04351919|Azithromycin|azithromycin|mesh-list
56026970|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
56026971|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56026972|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56026973|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
56026974|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56026975|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56026976|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56026977|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026978|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56026979|NCT00769886|Ketotifen|ketotifen|mesh-list
56026980|NCT00769886|Naphazoline|naphazoline|mesh-list
56026981|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
56026982|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
56026983|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56026984|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
56026985|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
56026986|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56026987|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56026988|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859082|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56026989|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56026990|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56026991|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56026992|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
56026993|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
56026994|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56026995|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
56026996|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56026997|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56026998|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56027011|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027012|NCT01309451|Dexamethasone|dexamethasone|mesh-list
56027013|NCT01309451|Bevacizumab|bevacizumab|mesh-list
56027014|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56027015|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027016|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56027017|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56027018|NCT01309451|Growth Substances|growth substances|mesh-ancestor
56027019|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027020|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
56027021|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027022|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
56027023|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
56027024|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027025|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56027026|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
56027027|NCT01309451|Hormones|hormones|mesh-ancestor
56027028|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56027029|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55859141|NCT03031210|Amoxicillin|amoxicillin|mesh-list
56027030|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
56027031|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56027032|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027033|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
56027034|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
56027035|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56027036|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56027037|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027038|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027039|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027040|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027041|NCT00795002|Cytarabine|cytarabine|mesh-list
56027042|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
56027043|NCT00795002|Alvocidib|alvocidib|mesh-list
56027044|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56027045|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
56027051|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
56027052|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027053|NCT00795002|Analgesics|analgesics|mesh-ancestor
56027054|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
56027055|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027056|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56027057|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56027058|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027059|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
56027060|NCT00795002|Growth Substances|growth substances|mesh-ancestor
56027061|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56027063|NCT05742698|Antiemetics|antiemetics|mesh-ancestor
56027064|NCT05742698|Autonomic Agents|autonomic agents|mesh-ancestor
56027065|NCT05742698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027066|NCT05742698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859212|NCT02454322|Analgesics|analgesics|mesh-ancestor
56027067|NCT05742698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56027068|NCT05742698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56027069|NCT05742698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56027070|NCT05742698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56027071|NCT05742698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56027072|NCT03802838|Amisulpride|amisulpride|mesh-list
56027073|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56027074|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56027075|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56027076|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027077|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56027078|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56027079|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
56027080|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027081|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027083|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
56027084|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56027085|NCT00772304|Azelastine|azelastine|mesh-list
55859269|NCT04497298|Vaccines|vaccines|mesh-list
56027086|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56027089|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
56027090|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027091|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027092|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027093|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027094|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56027095|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56027096|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56027097|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
56027098|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
56027099|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027100|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027101|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56027102|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
56027103|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56027104|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
56027105|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56027106|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027107|NCT01310231|Metformin|metformin|mesh-list
56027108|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56027109|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027110|NCT00789074|Varenicline|varenicline|mesh-list
55859423|NCT01866319|Ipilimumab|ipilimumab|mesh-list
56027111|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56027112|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56027113|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
56027114|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027115|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027116|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027118|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027119|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56027120|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027133|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027134|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56027135|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
56027136|NCT03834506|Hormones|hormones|mesh-ancestor
56027137|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56027138|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56027139|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027140|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
56027141|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
56027142|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
56027143|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027144|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56027145|NCT01339091|Vancomycin|vancomycin|mesh-list
56027146|NCT01339091|Linezolid|linezolid|mesh-list
56027147|NCT01339091|Dalbavancin|dalbavancin|mesh-list
56027148|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56027149|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027150|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56027151|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027152|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027153|NCT03832010|Triamcinolone|triamcinolone|mesh-list
56027154|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
56027155|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027156|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
56027157|NCT03832010|Hormones|hormones|mesh-ancestor
56027158|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56027179|NCT00772772|Vitamin D|vitamin d|mesh-list
56027180|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
56027181|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
56027182|NCT00772772|Vitamins|vitamins|mesh-list
56027184|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027185|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56027186|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56027187|NCT00773474|Lonafarnib|lonafarnib|mesh-list
55754396|NCT03312413|Analgesics|analgesics|mesh-ancestor
56027188|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027189|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027190|NCT01310855|Gefitinib|gefitinib|mesh-list
56027191|NCT01310855|Cediranib|cediranib|mesh-list
56027192|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027193|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027194|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027195|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56027196|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
56027197|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56027198|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
56027199|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027200|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027201|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56027202|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
56027203|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56027204|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56027205|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56027206|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
56027207|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027223|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56027224|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56027225|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
56027226|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027227|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027228|NCT05477108|Antidotes|antidotes|mesh-ancestor
56027229|NCT05477108|Protective Agents|protective agents|mesh-ancestor
56027230|NCT01258049|Artemether|artemether|mesh-list
56027231|NCT01258049|Quinine|quinine|mesh-list
56027232|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
56027233|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56027234|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56027235|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027236|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56027237|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027238|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56027239|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027240|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56027241|NCT01258049|Analgesics|analgesics|mesh-ancestor
56027242|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
56027243|NCT03802214|Vedolizumab|vedolizumab|mesh-list
56027244|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56027245|NCT03801746|Cyclosporine|cyclosporine|mesh-list
56027246|NCT03801746|Rifampin|rifampin|mesh-list
56027247|NCT03801746|Probenecid|probenecid|mesh-list
56027248|NCT03801746|Cyclosporins|cyclosporins|mesh-list
56027249|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027250|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027251|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56027252|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
56027254|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
56027269|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56027271|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
56027272|NCT03801746|Renal Agents|renal agents|mesh-ancestor
56027273|NCT03801668|Paclitaxel|paclitaxel|mesh-list
56027274|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
56027275|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56027276|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56027277|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027278|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
56027279|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
56027282|NCT05414006|Ketamine|ketamine|mesh-list
56027283|NCT05414006|Esketamine|esketamine|mesh-list
56027284|NCT05414006|Analgesics|analgesics|mesh-ancestor
56027285|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
56032507|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55859618|NCT00652444|Simvastatin|simvastatin|mesh-list
56027286|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027287|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027288|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56027289|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56027290|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
56027291|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
56027292|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56027293|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56027294|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56027295|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876680|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876681|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55876682|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
55876683|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
55876684|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876685|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876686|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876687|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55876688|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55876689|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55876690|NCT03162627|Olaparib|olaparib|mesh-list
55876691|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55876692|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876693|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876694|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876695|NCT01286818|Leucovorin|leucovorin|mesh-list
55876696|NCT01286818|Fluorouracil|fluorouracil|mesh-list
55876697|NCT01286818|Irinotecan|irinotecan|mesh-list
55876698|NCT01286818|Ramucirumab|ramucirumab|mesh-list
55876699|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55876700|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
55876701|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
56027296|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027298|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56027299|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
56027300|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
56027301|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56027302|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56027303|NCT02199041|Prednisolone|prednisolone|mesh-list
56027304|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
56027305|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
56027306|NCT02199041|Melphalan|melphalan|mesh-list
56027307|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
56027308|NCT02199041|Thiotepa|thiotepa|mesh-list
56027309|NCT02199041|Fludarabine|fludarabine|mesh-list
56027310|NCT02199041|Tacrolimus|tacrolimus|mesh-list
56027311|NCT02199041|Lenograstim|lenograstim|mesh-list
56027312|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56027313|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
56027314|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56027315|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
56027316|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027317|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027318|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56027319|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
56027320|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027321|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027322|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56027324|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027325|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56027326|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56027341|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56027342|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
56027343|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
56027345|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
56027347|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56027348|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
56027349|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027350|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027351|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56027352|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
56027353|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027354|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027355|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56027356|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56027357|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
56027358|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56027359|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027360|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55859856|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
56027361|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56027362|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
56027363|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56027364|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027365|NCT05380388|Vaccines|vaccines|mesh-list
56027366|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
56027367|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027368|NCT03801590|Riboflavin|riboflavin|mesh-list
56027369|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
56027370|NCT03801590|Vitamins|vitamins|mesh-ancestor
56027371|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
56027372|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027373|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56027384|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56027385|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56027386|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56027387|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
56027388|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
56027389|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027390|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027391|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56027392|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027393|NCT00799604|Clevidipine|clevidipine|mesh-list
56027394|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56027395|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56027396|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027397|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56027398|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027399|NCT01259063|Gemcitabine|gemcitabine|mesh-list
56027400|NCT01259063|Everolimus|everolimus|mesh-list
56027401|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56027402|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
56027403|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027404|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027405|NCT01259063|Antiviral Agents|antiviral agents|mesh-ancestor
56027406|NCT01259063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027407|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027408|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56027409|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
56027410|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027411|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
56027412|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56027413|NCT04383548|Antibodies|antibodies|mesh-list
56027414|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
56027415|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027416|NCT01313897|Bortezomib|bortezomib|mesh-list
56027417|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027418|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56027419|NCT04351763|Amiodarone|amiodarone|mesh-list
56027420|NCT04351763|Verapamil|verapamil|mesh-list
56027421|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56027422|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
56027423|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56027424|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56027425|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027426|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56027427|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56027428|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56027429|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027430|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56027431|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56027432|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56027433|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56027434|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56027435|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860147|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56027436|NCT00801398|Oxymorphone|oxymorphone|mesh-list
56027437|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56027438|NCT00801398|Narcotics|narcotics|mesh-ancestor
56027439|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56027440|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027441|NCT00801398|Analgesics|analgesics|mesh-ancestor
56027442|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
55876702|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876703|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55876704|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876705|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55876706|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
55860251|NCT01840579|Ipilimumab|ipilimumab|mesh-list
55876707|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876708|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55876709|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55876710|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876711|NCT01286818|Antidotes|antidotes|mesh-ancestor
55876712|NCT01286818|Protective Agents|protective agents|mesh-ancestor
55876713|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
55876714|NCT01286818|Vitamins|vitamins|mesh-ancestor
55876715|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
55876716|NCT03428256|Anesthetics|anesthetics|mesh-list
55876717|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876718|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876719|NCT00635505|Albuterol|albuterol|mesh-list
55876720|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55876721|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
55876722|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876723|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876725|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
55876727|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55876728|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55876729|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55876730|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56027443|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027444|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56027445|NCT01342523|Nicotine|nicotine|mesh-list
56027446|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56027447|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
56027448|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027449|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027450|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56027451|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56027452|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
56027453|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027454|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027455|NCT01342757|Temozolomide|temozolomide|mesh-list
56027456|NCT01342757|Vorinostat|vorinostat|mesh-list
56027457|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56027458|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
56027459|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027460|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027461|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56027462|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027463|NCT02199743|Haloperidol|haloperidol|mesh-list
56027464|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
56027465|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56027466|NCT02199743|Perphenazine|perphenazine|mesh-list
56027467|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
56027468|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
56027469|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027470|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027471|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56027472|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56027473|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56027474|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56027475|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55860604|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56027476|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56027482|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56027483|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56027485|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56027486|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55754692|NCT03302039|Phenylephrine|phenylephrine|mesh-list
56027487|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
56027488|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56027489|NCT00776594|Bevacizumab|bevacizumab|mesh-list
56027490|NCT00776594|Bicalutamide|bicalutamide|mesh-list
56027491|NCT00776594|Androgens|androgens|mesh-list
56027492|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860684|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860692|NCT02995330|Hormones|hormones|mesh-ancestor
56027493|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027494|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56027495|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56027496|NCT00776594|Growth Substances|growth substances|mesh-ancestor
56027497|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027498|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
56027499|NCT00776594|Hormones|hormones|mesh-ancestor
56027500|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56027501|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
56027502|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
56027503|NCT00777062|Naltrexone|naltrexone|mesh-list
56027504|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56027505|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56027506|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027507|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
56027508|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027509|NCT02193347|Temozolomide|temozolomide|mesh-list
55762284|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
56027510|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56027511|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
56027512|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027513|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027514|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55876731|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
55876732|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876733|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876734|NCT01243450|Tretinoin|tretinoin|mesh-list
55876735|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876736|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
56027516|NCT01318967|Diuretics|diuretics|mesh-ancestor
56027517|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
56027518|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027519|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56027520|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56027521|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027522|NCT01319045|Iloprost|iloprost|mesh-list
56027523|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56027524|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
56027525|NCT01348607|Methylphenidate|methylphenidate|mesh-list
56027526|NCT01348607|Modafinil|modafinil|mesh-list
56027527|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56027528|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027529|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56027530|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56027531|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56027532|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027533|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
56027534|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027535|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56027536|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56027537|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56027564|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027565|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861132|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56027566|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56027567|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
56027568|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027569|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027570|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56027571|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56027572|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027573|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56027574|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56027575|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
56027576|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56027577|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027578|NCT01321151|Resveratrol|resveratrol|mesh-list
56027579|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
56027580|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027581|NCT01321151|Protective Agents|protective agents|mesh-ancestor
56027582|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027583|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027584|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56027585|NCT01350947|Azacitidine|azacitidine|mesh-list
56027586|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56027587|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
56027588|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027589|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027590|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027592|NCT01269047|Pramlintide|pramlintide|mesh-list
56027593|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56027594|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027595|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56027596|NCT01269047|Incretins|incretins|mesh-ancestor
56027606|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027607|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56027608|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56027609|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56027610|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
56027611|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027612|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027613|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
56027614|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56027615|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
56027616|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027617|NCT05287724|Expectorants|expectorants|mesh-ancestor
56027618|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
56027619|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56027621|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027622|NCT05287724|Protective Agents|protective agents|mesh-ancestor
56027623|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027625|NCT01321541|Gemcitabine|gemcitabine|mesh-list
56027627|NCT01321541|Pixantrone|pixantrone|mesh-list
56027628|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56027629|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027630|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
56027631|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027632|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027633|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56027634|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
56027635|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027636|NCT01321541|Antiviral Agents|antiviral agents|mesh-ancestor
56027638|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027639|NCT01321541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55876737|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
55876738|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
55876739|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
55876740|NCT05249751|Coagulants|coagulants|mesh-ancestor
55876741|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55876742|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55876743|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
55876744|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876745|NCT00635193|Doxorubicin|doxorubicin|mesh-list
56027640|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56027641|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56027642|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56027643|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56027644|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027645|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027646|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
56027647|NCT05201612|Olaparib|olaparib|mesh-list
56027648|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56027649|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027650|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56027651|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027652|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027653|NCT01271855|Glycerol|glycerol|mesh-list
56027654|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027655|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56027656|NCT01271855|Protective Agents|protective agents|mesh-ancestor
56027657|NCT04865978|Warfarin|warfarin|mesh-list
56027658|NCT04865978|Apixaban|apixaban|mesh-list
56027659|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
56027660|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56027661|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
56027662|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56027663|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
56027664|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027665|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027666|NCT01354145|Celecoxib|celecoxib|mesh-list
56027667|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56027668|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56027669|NCT01354145|Analgesics|analgesics|mesh-ancestor
56027684|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027685|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027686|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
56027687|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
56027688|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027689|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56027690|NCT02196857|Azacitidine|azacitidine|mesh-list
56027691|NCT02196857|Sorafenib|sorafenib|mesh-list
56027692|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56027693|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
56032508|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56027694|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027695|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027696|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027697|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56027698|NCT01272245|Cytarabine|cytarabine|mesh-list
56027699|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
56027700|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56027701|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
55861568|NCT03945513|Estrogens|estrogens|mesh-ancestor
56027702|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027703|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027704|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
56027705|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027706|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56027707|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
55754920|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
56027735|NCT00802100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56027736|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56027737|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56027738|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861716|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
55861717|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
56027739|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
56027740|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
56027741|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
56027742|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
56027743|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56027744|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56027745|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56027746|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55861839|NCT04765527|Turmeric extract|turmeric extract|mesh-list
56027747|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56027748|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56027749|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56027750|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56027751|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
56027752|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56027753|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56027754|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
56027755|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56027756|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
56027757|NCT00809276|Busulfan|busulfan|mesh-list
56027758|NCT00809276|Fludarabine|fludarabine|mesh-list
56027759|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56027760|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
56027761|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027762|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027763|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56027764|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
56027765|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027766|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027776|NCT01355705|Amrubicin|amrubicin|mesh-list
56027777|NCT01355705|BB 1101|bb 1101|mesh-list
56027778|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027779|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
56027780|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
56027781|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027782|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027783|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56027784|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
56027785|NCT01355705|Hormones|hormones|mesh-ancestor
56027786|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56027787|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56027789|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
56027790|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027791|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862021|NCT00724984|Abexinostat|abexinostat|mesh-list
56027792|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56027793|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56027794|NCT01355705|Analgesics|analgesics|mesh-ancestor
56027795|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
56027796|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027797|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56027798|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56027799|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56027800|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56027801|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
56027802|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
56027824|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56027825|NCT03839888|Atropine|atropine|mesh-list
56027826|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56027827|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56027828|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56027829|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
56027830|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027831|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027832|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56027833|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
56027834|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
56027835|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
56027836|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56027837|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56027838|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
56027839|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027840|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027841|NCT05116202|Nivolumab|nivolumab|mesh-list
55862193|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
55862194|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55862195|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55862196|NCT01274260|Prednisolone|prednisolone|mesh-list
55862197|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
55862198|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55862199|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
55862200|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862201|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
56027842|NCT05116202|Ipilimumab|ipilimumab|mesh-list
56027843|NCT05116202|Atezolizumab|atezolizumab|mesh-list
56027844|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56027845|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027846|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56027847|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027848|NCT05089526|Lidocaine|lidocaine|mesh-list
56027849|NCT05089526|Fentanyl|fentanyl|mesh-list
56027850|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
56027851|NCT05089526|Ketamine|ketamine|mesh-list
56027852|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
56027853|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
56027854|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56027868|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56027869|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
56027870|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027871|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56027872|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56027873|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
56027874|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56027875|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56027876|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56027877|NCT05089526|Narcotics|narcotics|mesh-ancestor
56027878|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56027879|NCT03984188|Theophylline|theophylline|mesh-list
56027880|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55862343|NCT03153813|Capsaicin|capsaicin|mesh-list
56027881|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
56027882|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027883|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027884|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56027885|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
56027886|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56027887|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027888|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027889|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
56027890|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56027891|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56027892|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
56027893|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56027896|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56027897|NCT04645550|Tinzaparin|tinzaparin|mesh-list
56027898|NCT04645550|Dalteparin|dalteparin|mesh-list
56027899|NCT04645550|Dipyridamole|dipyridamole|mesh-list
56027900|NCT04645550|Warfarin|warfarin|mesh-list
56027901|NCT04645550|Apixaban|apixaban|mesh-list
56027912|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027913|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56027914|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56027915|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027916|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
56027917|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
56027918|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56027919|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
56027920|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56027921|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
56027922|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56027923|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
56027924|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
56027925|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56027926|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56027927|NCT05032820|Lenalidomide|lenalidomide|mesh-list
56027928|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
56027929|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027930|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56027931|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56027932|NCT05032820|Growth Substances|growth substances|mesh-ancestor
56027933|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
56027934|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027935|NCT04699838|Carboplatin|carboplatin|mesh-list
56027937|NCT04699838|Durvalumab|durvalumab|mesh-list
56027938|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56027939|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56027940|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56027941|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56027942|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027957|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
56027958|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56027959|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56027960|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027961|NCT04382768|Ibuprofen|ibuprofen|mesh-list
56027962|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56027963|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56027964|NCT04382768|Analgesics|analgesics|mesh-ancestor
56027965|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
56027966|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56027967|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027968|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56027969|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56027970|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56027971|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56027972|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027973|NCT03932162|Insulin|insulin|mesh-list
56027974|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56027975|NCT03932162|Mitogens|mitogens|mesh-list
56027976|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56027977|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56027978|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
56027979|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56027980|NCT04501718|Etoposide|etoposide|mesh-list
56027981|NCT04501718|Temozolomide|temozolomide|mesh-list
56027982|NCT04501718|Apatinib|apatinib|mesh-list
56027983|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56028006|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
56028007|NCT00806234|Metformin|metformin|mesh-list
56028008|NCT00806234|Olanzapine|olanzapine|mesh-list
56028009|NCT00806234|Risperidone|risperidone|mesh-list
56028010|NCT00806234|Aripiprazole|aripiprazole|mesh-list
56028011|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56028014|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56028015|NCT00806234|Asenapine|asenapine|mesh-list
56028016|NCT00806234|Iloperidone|iloperidone|mesh-list
56028017|NCT00806234|Perphenazine|perphenazine|mesh-list
56028018|NCT00806234|Fluoxetine|fluoxetine|mesh-list
56028019|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56028020|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028021|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56028022|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
56028023|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028024|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028025|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56028026|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56028027|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028028|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56028029|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56028030|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
56028031|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
56028032|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
56028033|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028034|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56028035|NCT00806234|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56028036|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56028037|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56028038|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
56028039|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
56028040|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55739751|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56028044|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56028045|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56028046|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56028047|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028048|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56028049|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56028050|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56028051|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
56028052|NCT04493138|Azacitidine|azacitidine|mesh-list
56028053|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56028054|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
56028055|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028056|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028057|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028058|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
56028059|NCT01275365|Testosterone|testosterone|mesh-list
56028060|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
56028061|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
56028062|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56028063|NCT01275365|Androgens|androgens|mesh-ancestor
56028064|NCT01275365|Hormones|hormones|mesh-ancestor
56028065|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028066|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028067|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56028068|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028069|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
56028070|NCT00811850|Timolol|timolol|mesh-list
56028071|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56028072|NCT00811850|Dorzolamide|dorzolamide|mesh-list
56028074|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56028085|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56028086|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56028087|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56028088|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56028089|NCT03678506|Apixaban|apixaban|mesh-list
56028090|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56028091|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
56028092|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56028093|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
56028094|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028095|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028096|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
56028097|NCT00844298|Cytarabine|cytarabine|mesh-list
56028098|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56028099|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
56028100|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028101|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028102|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
56028103|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028104|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56028105|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
56028106|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028107|NCT01329185|Valganciclovir|valganciclovir|mesh-list
56028108|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
56028109|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028110|NCT01276301|Empagliflozin|empagliflozin|mesh-list
56028111|NCT01276301|Verapamil|verapamil|mesh-list
56032509|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862806|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56028112|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56028113|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028114|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56028115|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028116|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56028117|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56028118|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56028120|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
56028124|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56028125|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
56028126|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028127|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028128|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028129|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56028130|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028131|NCT01330043|Bupropion|bupropion|mesh-list
56028132|NCT01330043|Nicotine|nicotine|mesh-list
56028133|NCT01330043|Varenicline|varenicline|mesh-list
56028134|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56028135|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
56028136|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028137|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028138|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56028139|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56028140|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
55762285|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56028141|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028142|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028143|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56028144|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
56028145|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56028146|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56028147|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56028148|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56028149|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
56028150|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56028151|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56028152|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028167|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56028168|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028169|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028170|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
56028171|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56028172|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028173|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56028174|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56028175|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56028176|NCT02193815|Vitamins|vitamins|mesh-ancestor
56028177|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
56028178|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56028179|NCT01277081|Acetaminophen|acetaminophen|mesh-list
56028180|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56028181|NCT01277081|Analgesics|analgesics|mesh-ancestor
56028182|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
56028183|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028184|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028185|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
56028186|NCT01361633|Cycloserine|cycloserine|mesh-list
56028187|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56028188|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028189|NCT01361633|Renal Agents|renal agents|mesh-ancestor
55739761|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
56028190|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55862974|NCT03809884|Diuretics|diuretics|mesh-ancestor
56028191|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
56028192|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56028193|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
56028194|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028195|NCT01331213|Pregabalin|pregabalin|mesh-list
56028196|NCT01331213|Analgesics|analgesics|mesh-ancestor
56028208|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56028209|NCT01332071|Metformin|metformin|mesh-list
56028210|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
56028211|NCT01332071|Maleic acid|maleic acid|mesh-list
56028212|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56028213|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028214|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028215|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028216|NCT01277159|Dexamethasone|dexamethasone|mesh-list
56028217|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
56028218|NCT01277159|Buprenorphine|buprenorphine|mesh-list
56028219|NCT01277159|BB 1101|bb 1101|mesh-list
56028220|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56028221|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
56028222|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
56028223|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028224|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028225|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56028226|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
56028227|NCT01277159|Hormones|hormones|mesh-ancestor
56028228|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028229|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56028230|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028231|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
56028232|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028233|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028234|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56028235|NCT01277159|Narcotics|narcotics|mesh-ancestor
56028236|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755451|NCT02465645|Carvedilol|carvedilol|mesh-list
56028237|NCT01277159|Analgesics|analgesics|mesh-ancestor
56028238|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
56028253|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56028254|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56028255|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
56028256|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028257|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028258|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56028259|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
56028260|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
56028261|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56028262|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56028263|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56028264|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56028265|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
56028266|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028267|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762286|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56028269|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56028270|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028271|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56028272|NCT01280123|Pioglitazone|pioglitazone|mesh-list
56028273|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56028274|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028275|NCT03608696|Buprenorphine|buprenorphine|mesh-list
56028276|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56028277|NCT03608696|Narcotics|narcotics|mesh-ancestor
56028278|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028279|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028280|NCT03608696|Analgesics|analgesics|mesh-ancestor
56028281|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
56028282|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028283|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55863337|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
56028284|NCT01334723|Finasteride|finasteride|mesh-list
56028285|NCT01334723|Dutasteride|dutasteride|mesh-list
56028286|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
56028287|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56028288|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028289|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028290|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
56028291|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028292|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028293|NCT01334723|Urological Agents|urological agents|mesh-ancestor
56028294|NCT04311710|Nivolumab|nivolumab|mesh-list
56028295|NCT04311710|Ipilimumab|ipilimumab|mesh-list
56028296|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56028297|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028298|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56028299|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028300|NCT01334957|Ibuprofen|ibuprofen|mesh-list
56028301|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56028302|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56028303|NCT01334957|Analgesics|analgesics|mesh-ancestor
56028304|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
56028305|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028306|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028307|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56028308|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56028309|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56028310|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028311|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028312|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
56028313|NCT03410030|Gemcitabine|gemcitabine|mesh-list
56028314|NCT03410030|Paclitaxel|paclitaxel|mesh-list
56028315|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56028316|NCT03410030|Cisplatin|cisplatin|mesh-list
56028317|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56028324|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
56028336|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56028337|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56028338|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55739763|NCT03126461|Nivolumab|nivolumab|mesh-list
56028339|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028340|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56028342|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
56028343|NCT03637400|Doxycycline|doxycycline|mesh-list
56028344|NCT03637400|Trimethoprim|trimethoprim|mesh-list
56028345|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
56028346|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56028347|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028348|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
56028349|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56028350|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56028351|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56028352|NCT03637400|Renal Agents|renal agents|mesh-ancestor
56028353|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56028354|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028355|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028356|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56028357|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56028358|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56028359|NCT03386240|Triclosan|triclosan|mesh-list
56028360|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56028361|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028362|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56028363|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56028380|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56028381|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56028382|NCT01365611|Analgesics|analgesics|mesh-ancestor
56028383|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
56028384|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56028385|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56028386|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028387|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755597|NCT02462837|Mirabegron|mirabegron|mesh-list
56028388|NCT01472549|Ethanol|ethanol|mesh-list
56028389|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
55762287|NCT04344717|Apixaban|apixaban|mesh-list
56028390|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56028391|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028392|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028393|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028394|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
56028395|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56028396|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56028397|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028398|NCT01404923|Mebeverine|mebeverine|mesh-list
56028399|NCT01404923|Alverine|alverine|mesh-list
56028400|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
56028401|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
56028402|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028403|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028404|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
56028405|NCT01368263|Letrozole|letrozole|mesh-list
56028406|NCT01368263|Anastrozole|anastrozole|mesh-list
56028407|NCT01368263|Goserelin|goserelin|mesh-list
56028408|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028409|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56028410|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56028418|NCT00815360|Triamcinolone|triamcinolone|mesh-list
56028423|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56028424|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56028425|NCT00815360|Growth Substances|growth substances|mesh-ancestor
56028426|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028427|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
56028428|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028429|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56028430|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
56028431|NCT00815360|Hormones|hormones|mesh-ancestor
56028432|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028433|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56028434|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
56028435|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028436|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028438|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56028439|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56028440|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028441|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56028442|NCT01405937|Ribavirin|ribavirin|mesh-list
56028443|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
56028444|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028445|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
56028446|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028447|NCT01368653|Nicotine|nicotine|mesh-list
56028448|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56028449|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
56028450|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028451|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028452|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56028453|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56028454|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
56028457|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
56028463|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028464|NCT01368809|Analgesics|analgesics|mesh-ancestor
56028465|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
56028466|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863667|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
55863668|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
55863669|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863670|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863671|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55863672|NCT04753294|Diazepam|diazepam|mesh-list
55863673|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55863674|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
55863675|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
55863676|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
55863677|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863678|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863679|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55863680|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55863681|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55863682|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55863683|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55863684|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55863685|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55863690|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
55863691|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
55863692|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863694|NCT01719380|Cetuximab|cetuximab|mesh-list
56028467|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56028468|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56028469|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
56028470|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
56028471|NCT01369745|Prednisone|prednisone|mesh-list
56028472|NCT01369745|Prednisolone|prednisolone|mesh-list
56028473|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56028474|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
56028475|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56028476|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
56028477|NCT01369745|Dipyridamole|dipyridamole|mesh-list
56028478|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56028479|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
56028480|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56028481|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
56028482|NCT01369745|Hormones|hormones|mesh-ancestor
56028483|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028484|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028485|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56028486|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028487|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
56028488|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
56028489|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028490|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56028491|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56028492|NCT01369745|Protective Agents|protective agents|mesh-ancestor
56028493|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56028494|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028495|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028496|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56028497|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
56028498|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
56028502|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56028503|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56028504|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028505|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028506|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028507|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56028508|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
56028509|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56028510|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028511|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56028512|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56028513|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56028514|NCT01407575|Buprenorphine|buprenorphine|mesh-list
55822235|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028515|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56028516|NCT01407575|Narcotics|narcotics|mesh-ancestor
56028517|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028518|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028519|NCT01407575|Analgesics|analgesics|mesh-ancestor
56028520|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
56028521|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028522|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56028523|NCT01476449|Ranibizumab|ranibizumab|mesh-list
56028524|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56028525|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56028526|NCT01476449|Growth Substances|growth substances|mesh-ancestor
56028527|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028528|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
56028529|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028530|NCT01370369|Testosterone|testosterone|mesh-list
56028531|NCT01370369|Androgens|androgens|mesh-ancestor
56028532|NCT01370369|Hormones|hormones|mesh-ancestor
56028533|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028534|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028535|NCT01477463|Vitamin D|vitamin d|mesh-list
56028536|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
56028537|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
56028538|NCT01477463|Vitamins|vitamins|mesh-list
56028540|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028541|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56028542|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56028545|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56028546|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
56028547|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028548|NCT01375127|Tofacitinib|tofacitinib|mesh-list
56028549|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56028550|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028551|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028552|NCT00857714|Lapatinib|lapatinib|mesh-list
56028553|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028554|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56028555|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028556|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028557|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
56028597|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028598|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56028599|NCT02669186|Narcotics|narcotics|mesh-ancestor
56028600|NCT02669186|Analgesics|analgesics|mesh-ancestor
56028601|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56028602|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56028603|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
56028604|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56028605|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56028606|NCT00859508|Estradiol|estradiol|mesh-list
56028607|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56028608|NCT00859508|Estrogens|estrogens|mesh-ancestor
56028609|NCT00859508|Hormones|hormones|mesh-ancestor
56028610|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028611|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028612|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56028613|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
55755816|NCT02629965|Olodaterol|olodaterol|mesh-list
56028614|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56028615|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56028616|NCT01377467|Denosumab|denosumab|mesh-list
56028617|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56028618|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028619|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
56028620|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56028622|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
56028623|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028624|NCT02348762|Expectorants|expectorants|mesh-ancestor
56028625|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
56028626|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56028627|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
56028628|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028629|NCT02348762|Protective Agents|protective agents|mesh-ancestor
56028630|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028639|NCT01377623|Analgesics|analgesics|mesh-ancestor
56028640|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
56028641|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028642|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56028643|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56028644|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56028645|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
56028646|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028647|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028648|NCT01486043|Metformin|metformin|mesh-list
56028649|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56028650|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028651|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
56028652|NCT01490723|Rituximab|rituximab|mesh-list
56028653|NCT01490723|Methotrexate|methotrexate|mesh-list
56028654|NCT01490723|Fludarabine|fludarabine|mesh-list
56028655|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
56028656|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56028657|NCT01490723|Tacrolimus|tacrolimus|mesh-list
56028658|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
56028659|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56028660|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56028661|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56028662|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028663|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
56028664|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028665|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56028666|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56028686|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
56028687|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
56028688|NCT03839498|Axitinib|axitinib|mesh-list
56028689|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028690|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56028691|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028692|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028694|NCT02252432|Methadone|methadone|mesh-list
56028695|NCT02252432|Analgesics|analgesics|mesh-ancestor
56028696|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
56028697|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028698|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028699|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56028700|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56028701|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
56028703|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028704|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56028705|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56028706|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028707|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028708|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56028709|NCT02252432|Narcotics|narcotics|mesh-ancestor
56028710|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
56028711|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
56028712|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
56028713|NCT01492673|Bevacizumab|bevacizumab|mesh-list
56028714|NCT01492673|Topotecan|topotecan|mesh-list
56028715|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56028718|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56028731|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028733|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56028734|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56028735|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
56028736|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028737|NCT00818324|Protective Agents|protective agents|mesh-ancestor
56028738|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028739|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028740|NCT02187224|Progesterone|progesterone|mesh-list
56028741|NCT02187224|Progestins|progestins|mesh-ancestor
56028742|NCT02187224|Hormones|hormones|mesh-ancestor
56028743|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028744|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028745|NCT01419275|Xenon|xenon|mesh-list
56028746|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56028747|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
56028748|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
56028749|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028750|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028751|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
56028752|NCT02155010|Bupivacaine|bupivacaine|mesh-list
56028753|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
56028754|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
56028755|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028756|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028757|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
56028758|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028759|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56028760|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56028761|NCT02155010|Analgesics|analgesics|mesh-ancestor
56028770|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56028771|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028772|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028773|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56028774|NCT01495481|Analgesics|analgesics|mesh-ancestor
56028775|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
56028776|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028777|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56028778|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56028779|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56028780|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
56028781|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028782|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028783|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56028784|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
56028785|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56028786|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
56028787|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
56028788|NCT01379183|Erythromycin|erythromycin|mesh-list
56028789|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
55822558|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56028790|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56028791|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
56028792|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56028793|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028794|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56028795|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56028796|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028797|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028798|NCT01380197|Morphine|morphine|mesh-list
56028800|NCT01380197|Narcotics|narcotics|mesh-ancestor
56028815|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028816|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56028817|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56028818|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
56028819|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028820|NCT00862784|Antidotes|antidotes|mesh-ancestor
56028821|NCT00862784|Protective Agents|protective agents|mesh-ancestor
56028822|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
56028823|NCT00862784|Vitamins|vitamins|mesh-ancestor
56028824|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
56028825|NCT00862784|Hematinics|hematinics|mesh-ancestor
56028826|NCT00864032|Sorafenib|sorafenib|mesh-list
56028827|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028828|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56028829|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028830|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028831|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56028832|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56028833|NCT00820664|Estradiol|estradiol|mesh-list
56028834|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56028835|NCT00820664|Estrogens|estrogens|mesh-ancestor
56028836|NCT00820664|Hormones|hormones|mesh-ancestor
56028837|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028838|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028839|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56028840|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
56028841|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56028843|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
56028844|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
56028845|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028846|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028848|NCT01419977|Dalteparin|dalteparin|mesh-list
56028861|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56028862|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56028863|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
56028864|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028865|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56028866|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
56028867|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028868|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
56028869|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028870|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56028871|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
56028872|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56028873|NCT00823082|Antithrombins|antithrombins|mesh-list
56028874|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
56028875|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56028876|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
56028877|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028878|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028879|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
56028880|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
56028881|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56028882|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028883|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028884|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56028885|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56028886|NCT01382303|Protective Agents|protective agents|mesh-ancestor
56028887|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028888|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
56028889|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56028890|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
56028891|NCT05236634|Tadalafil|tadalafil|mesh-list
56028892|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56028893|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
56028900|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
56028901|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028902|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028903|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
56028904|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56028906|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56028907|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028908|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
56028909|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028910|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028911|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56028912|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028913|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
56028914|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56028915|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
56028916|NCT00865202|Tryptophan|tryptophan|mesh-list
56028917|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56028918|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
56028919|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56028920|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
56028921|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56028922|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
56028923|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56028924|NCT01424033|Expectorants|expectorants|mesh-ancestor
56028925|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
56028926|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56028927|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
56028928|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028929|NCT01424033|Protective Agents|protective agents|mesh-ancestor
56028930|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028931|NCT01424033|Antidotes|antidotes|mesh-ancestor
56028932|NCT01503749|Lenograstim|lenograstim|mesh-list
56028933|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56028936|NCT00867932|Eculizumab|eculizumab|mesh-list
56028940|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028942|NCT00825266|Bosentan|bosentan|mesh-list
56028943|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56028944|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028945|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56028946|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56028947|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028948|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56028949|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56028950|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
56028951|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028952|NCT01385189|Antacids|antacids|mesh-ancestor
56028953|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028954|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56028955|NCT01386983|Finasteride|finasteride|mesh-list
56028956|NCT01386983|Dutasteride|dutasteride|mesh-list
56028957|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56028958|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56028959|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56028960|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822826|NCT02322281|Gemcitabine|gemcitabine|mesh-list
56028961|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
56028962|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56028963|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028964|NCT01386983|Urological Agents|urological agents|mesh-ancestor
56028965|NCT01387139|Ketamine|ketamine|mesh-list
56028966|NCT01387139|Propofol|propofol|mesh-list
56028967|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56028968|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56028969|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56028970|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56028971|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
56028980|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028981|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
56028982|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56028983|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
56028984|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028986|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56028987|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
56028988|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
56028989|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56028990|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
56028991|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56028992|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56028993|NCT00825344|Etanercept|etanercept|mesh-list
56028994|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56028995|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56028996|NCT00825344|Analgesics|analgesics|mesh-ancestor
56028997|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
56028998|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56028999|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029000|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56029001|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029002|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029003|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029004|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
56029005|NCT01426763|Complement C1s|complement c1s|mesh-list
56029006|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56029007|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
55876746|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55876747|NCT00635193|Volociximab|volociximab|mesh-list
55876748|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55876749|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55876750|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876751|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55876752|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55876753|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876754|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876755|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55876756|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55876757|NCT00635193|Growth Substances|growth substances|mesh-ancestor
55822884|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
55876758|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876759|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
56029008|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
56029009|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029010|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56029011|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029012|NCT00825500|Loxapine|loxapine|mesh-list
56029013|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56029014|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56029015|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029016|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029017|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56029018|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56029019|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
56029020|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029021|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029022|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
56029023|NCT01505933|Propofol|propofol|mesh-list
56029024|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56029025|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029026|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029027|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56029028|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
56029029|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
56029030|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56029031|NCT01505933|Analgesics|analgesics|mesh-ancestor
56029032|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
56029033|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029056|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56029057|NCT00872534|Analgesics|analgesics|mesh-ancestor
56029058|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
56029059|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029060|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029061|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56029062|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029063|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56029064|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55756274|NCT03290417|Analgesics|analgesics|mesh-ancestor
56029065|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029066|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56029067|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56029068|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029070|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
56029071|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56029072|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029073|NCT02513160|Beclomethasone|beclomethasone|mesh-list
56029075|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56029076|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
56029077|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029078|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029079|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56029080|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
56029081|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
56029082|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56029084|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56029102|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56029103|NCT02480010|Pertuzumab|pertuzumab|mesh-list
56029104|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56029105|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029106|NCT00876200|Minoxidil|minoxidil|mesh-list
56029107|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56029108|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
56029109|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
56029110|NCT02512302|Bromides|bromides|mesh-list
56029111|NCT02512302|Charcoal|charcoal|mesh-list
56029112|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
56029113|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56029114|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56029115|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56029116|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
56029117|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029118|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029119|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029120|NCT02512302|Antidotes|antidotes|mesh-ancestor
56029121|NCT02512302|Protective Agents|protective agents|mesh-ancestor
56029122|NCT01507181|Midazolam|midazolam|mesh-list
56029123|NCT01507181|Ketamine|ketamine|mesh-list
56029124|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
56029125|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
56029155|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029157|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56029158|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029159|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
56029160|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029161|NCT01508117|Axitinib|axitinib|mesh-list
56029162|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029163|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56029164|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029165|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029166|NCT00878228|Ondansetron|ondansetron|mesh-list
56029167|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
56029168|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
56029169|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029170|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029171|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029172|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
56029173|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56029174|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56029175|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
56029176|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029177|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029178|NCT00878228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56029179|NCT00878228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56029180|NCT00878228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029181|NCT00878228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56029182|NCT00878228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56029183|NCT01391273|Bimatoprost|bimatoprost|mesh-list
56029184|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56029185|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56029186|NCT01429259|Meropenem|meropenem|mesh-list
56029187|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56029188|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029189|NCT05177198|Clindamycin|clindamycin|mesh-list
56029196|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029197|NCT01392989|Cyclosporine|cyclosporine|mesh-list
56029198|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
56029199|NCT01392989|Cyclosporins|cyclosporins|mesh-list
56029200|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
56029201|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56029202|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029203|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029204|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029205|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
56029206|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029207|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
56029208|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029209|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
56029210|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029211|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56029212|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56029213|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029214|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56029215|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
56029216|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56029217|NCT01393457|Levodopa|levodopa|mesh-list
56029218|NCT01393457|Carbidopa|carbidopa|mesh-list
56029219|NCT01393457|Ropinirole|ropinirole|mesh-list
56029220|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56029221|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56029223|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029224|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029225|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029226|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56029227|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029228|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
56029229|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56029230|NCT04985760|Vaccines|vaccines|mesh-list
56029231|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
56029232|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
55876760|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
55876761|NCT00630201|Buprenorphine|buprenorphine|mesh-list
55876762|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56029233|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029234|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56029235|NCT04985760|Antacids|antacids|mesh-ancestor
56029236|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029237|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029238|NCT02518464|Ticagrelor|ticagrelor|mesh-list
56029239|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56029240|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56029241|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55762288|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56029242|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56029243|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
56029244|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029245|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029246|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029247|NCT02479230|Gemcitabine|gemcitabine|mesh-list
56029248|NCT02479230|Vaccines|vaccines|mesh-list
56029249|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
56029250|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029251|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56029252|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
56029253|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029254|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029255|NCT02479230|Antiviral Agents|antiviral agents|mesh-ancestor
56029256|NCT02479230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029257|NCT02479230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029258|NCT02479230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029259|NCT04985136|Sorafenib|sorafenib|mesh-list
56029260|NCT04985136|Apatinib|apatinib|mesh-list
56029261|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029262|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56029263|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029264|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029265|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
56029266|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56029267|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55876763|NCT00630201|Narcotics|narcotics|mesh-ancestor
55876764|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029268|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029269|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
56029270|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029271|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029273|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
56029274|NCT04411446|Vitamins|vitamins|mesh-ancestor
56029275|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
56029276|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029277|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56029278|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56029279|NCT01510379|Promethazine|promethazine|mesh-list
56029280|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
56029281|NCT01510379|Ondansetron|ondansetron|mesh-list
56029282|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
56029283|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
56029284|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029285|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029286|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029287|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
56029288|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
56029289|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56029290|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
56029291|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029292|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029293|NCT01510379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56029294|NCT01510379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56029295|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029296|NCT01510379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56029297|NCT01510379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56029298|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56029299|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
56029311|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
56029312|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56029313|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56029314|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56029315|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029316|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029317|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029318|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56029319|NCT01510457|Analgesics|analgesics|mesh-ancestor
56029320|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
56029321|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029322|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
56029323|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56029324|NCT04983966|Desflurane|desflurane|mesh-list
55762289|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
56029325|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56029326|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
56029327|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
56029328|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029329|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029330|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
56029331|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56029332|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029333|NCT02478372|Bupivacaine|bupivacaine|mesh-list
56029334|NCT02478372|Ropivacaine|ropivacaine|mesh-list
56029335|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
56029336|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
56029337|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
56029338|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029339|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029340|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
56029341|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029342|NCT01511315|Ustekinumab|ustekinumab|mesh-list
56029343|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
56029344|NCT01654536|Ciclesonide|ciclesonide|mesh-list
56029351|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56029352|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029353|NCT02509026|Etanercept|etanercept|mesh-list
55762764|NCT05610969|GABA Agents|gaba agents|mesh-ancestor
55823313|NCT05649020|Prilocaine|prilocaine|mesh-list
56029354|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56029355|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56029356|NCT02509026|Analgesics|analgesics|mesh-ancestor
56029357|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
56029358|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029359|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029360|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56029361|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029362|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029363|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029364|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
56029365|NCT03439280|Dexamethasone|dexamethasone|mesh-list
56029366|NCT03439280|Pomalidomide|pomalidomide|mesh-list
56029410|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
56029411|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56029412|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029413|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56029414|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56029415|NCT04382300|Growth Substances|growth substances|mesh-ancestor
56029416|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
56029417|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029418|NCT01430819|Vaccines|vaccines|mesh-list
56029419|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
56029420|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029421|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56029422|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
56029423|NCT00828542|Desogestrel|desogestrel|mesh-list
56029424|NCT00828542|Etonogestrel|etonogestrel|mesh-list
56029425|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56029426|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56029427|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56029428|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
56029429|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56029430|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029431|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56029432|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56029433|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56029434|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56029435|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029436|NCT00828542|Progestins|progestins|mesh-ancestor
56029437|NCT00828542|Hormones|hormones|mesh-ancestor
56029438|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56029439|NCT01395329|Metoprolol|metoprolol|mesh-list
56029456|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029457|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
56029458|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56029459|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56029460|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56029461|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56029462|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56029463|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
56029464|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56029465|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56029467|NCT00882206|Prednisone|prednisone|mesh-list
56029468|NCT00882206|Doxorubicin|doxorubicin|mesh-list
55823460|NCT02269163|Antibodies|antibodies|mesh-list
56029469|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56029470|NCT00882206|Methotrexate|methotrexate|mesh-list
56029471|NCT00882206|Vincristine|vincristine|mesh-list
56029472|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
56029473|NCT00882206|Decitabine|decitabine|mesh-list
56029474|NCT00882206|Asparaginase|asparaginase|mesh-list
56029475|NCT00882206|Vorinostat|vorinostat|mesh-list
56029476|NCT00882206|Pegaspargase|pegaspargase|mesh-list
56029477|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56029478|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029479|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56029480|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56029481|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029482|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029483|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56029484|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
56029485|NCT00882206|Hormones|hormones|mesh-ancestor
56029486|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56029487|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029488|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56029489|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56029497|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
56029498|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029499|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56029500|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
56029501|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029502|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56029503|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56029504|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56029505|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56029506|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56029507|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56029508|NCT00831272|Naltrexone|naltrexone|mesh-list
56029509|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56029510|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56029511|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029512|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
56029513|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029514|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56029515|NCT01512251|Vemurafenib|vemurafenib|mesh-list
56029516|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029517|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56029518|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756718|NCT03285503|Aripiprazole|aripiprazole|mesh-list
56029519|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029520|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56029521|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56029522|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029525|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56029526|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56029527|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
56029528|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823579|NCT01723072|Omalizumab|omalizumab|mesh-list
56029529|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029533|NCT01512797|Incretins|incretins|mesh-ancestor
56029537|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
56029538|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029539|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029540|NCT05620940|Naltrexone|naltrexone|mesh-list
56029541|NCT05620940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56029542|NCT05620940|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56029543|NCT05620940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029544|NCT05620940|Sensory System Agents|sensory system agents|mesh-ancestor
56029545|NCT05620940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029546|NCT01395797|Pioglitazone|pioglitazone|mesh-list
56029547|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56029548|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029549|NCT05124704|Ropivacaine|ropivacaine|mesh-list
55823635|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029550|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
56029551|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
56029552|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029553|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029554|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
56029555|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029556|NCT02203019|Fentanyl|fentanyl|mesh-list
56029557|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
56029558|NCT02203019|Propofol|propofol|mesh-list
56029559|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55762847|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56029560|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56029561|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029588|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56029589|NCT00886262|Vasopressins|vasopressins|mesh-list
56029590|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
56029591|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
56029592|NCT00886262|Coagulants|coagulants|mesh-ancestor
56029593|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56029594|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56029595|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
56029596|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029597|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56029598|NCT00887510|Trandolapril|trandolapril|mesh-list
56029599|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56029601|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
56029602|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029603|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56029604|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56029605|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029606|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56029607|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
56029608|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029610|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56029611|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029612|NCT01431989|Amoxicillin|amoxicillin|mesh-list
56029613|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56029638|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029639|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56029640|NCT01397591|Bortezomib|bortezomib|mesh-list
56029641|NCT01397591|Ofatumumab|ofatumumab|mesh-list
56029642|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029643|NCT04067726|Vitamin D|vitamin d|mesh-list
56029644|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
56029645|NCT04067726|Denosumab|denosumab|mesh-list
56029646|NCT04067726|Calcium|calcium|mesh-list
56029647|NCT04067726|Vitamins|vitamins|mesh-ancestor
56029648|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
56029649|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029650|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56029651|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56029652|NCT03855332|Cilostazol|cilostazol|mesh-list
56029653|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
56029654|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
56029655|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56029656|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56029657|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029658|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029659|NCT03855332|Urological Agents|urological agents|mesh-ancestor
56029660|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56029661|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
56029662|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029663|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029664|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56029665|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
56029666|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56029667|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56029668|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56029669|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56029670|NCT03855332|Protective Agents|protective agents|mesh-ancestor
56029671|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56029672|NCT02335580|Somatostatin|somatostatin|mesh-list
56029673|NCT02335580|Hormones|hormones|mesh-ancestor
56029674|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876765|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876766|NCT00630201|Analgesics|analgesics|mesh-ancestor
56029675|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029677|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56029678|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029679|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029680|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029681|NCT03808610|Cytarabine|cytarabine|mesh-list
56029682|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
56029683|NCT03808610|Dexamethasone|dexamethasone|mesh-list
56029684|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
56029685|NCT03808610|Prednisone|prednisone|mesh-list
56029686|NCT03808610|Cortisone|cortisone|mesh-list
56029687|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
56029688|NCT03808610|Rituximab|rituximab|mesh-list
56029689|NCT03808610|Methotrexate|methotrexate|mesh-list
56029690|NCT03808610|Vincristine|vincristine|mesh-list
56029691|NCT03808610|Asparaginase|asparaginase|mesh-list
56029692|NCT03808610|Venetoclax|venetoclax|mesh-list
56029693|NCT03808610|Pegaspargase|pegaspargase|mesh-list
56029694|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56029695|NCT03808610|Antibodies|antibodies|mesh-list
56029696|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
56029697|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56029698|NCT03808610|BB 1101|bb 1101|mesh-list
56029699|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56029700|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
56029701|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029702|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56029727|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
56029728|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029729|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56029730|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
56029731|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
56029732|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
56029733|NCT01514513|Permethrin|permethrin|mesh-list
56029734|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029735|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029736|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
56029737|NCT04981860|Povidone|povidone|mesh-list
56029738|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
56029739|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
55823823|NCT02298179|Antacids|antacids|mesh-ancestor
56029740|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56029741|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029742|NCT01432145|Methotrexate|methotrexate|mesh-list
56029743|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
56029744|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56029745|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
56029746|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56029770|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56029771|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029811|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
56029812|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56029813|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56029814|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029815|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56029816|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
56029817|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56029818|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
56029819|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029820|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
56029821|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757018|NCT03277391|Droperidol|droperidol|mesh-list
56029822|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029823|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56029824|NCT01401023|Tigecycline|tigecycline|mesh-list
56029826|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029827|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56029828|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029829|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029830|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
56029831|NCT01515995|Analgesics|analgesics|mesh-ancestor
56029832|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
56029833|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029834|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029858|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56029859|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
56029860|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56029861|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029862|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56029863|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56029864|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56029865|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
56029866|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56029867|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56029868|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
56029869|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823863|NCT02196259|Ketamine|ketamine|mesh-list
56029870|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
56029871|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56029872|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56029873|NCT02210195|Aprepitant|aprepitant|mesh-list
56029874|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
56029875|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
56029876|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029877|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029878|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029879|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56029880|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029881|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029882|NCT01437449|Carboplatin|carboplatin|mesh-list
56029883|NCT01437449|Docetaxel|docetaxel|mesh-list
56029884|NCT01437449|Cetuximab|cetuximab|mesh-list
56029885|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029886|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
56029887|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
56029888|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
56029897|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029898|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029899|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029900|NCT00889226|Atorvastatin|atorvastatin|mesh-list
56029901|NCT00889226|Pitavastatin|pitavastatin|mesh-list
56029902|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56029903|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56029904|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
56029905|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029906|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56029907|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56029908|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029909|NCT00837200|Doxorubicin|doxorubicin|mesh-list
56029910|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56029911|NCT00837200|Asparaginase|asparaginase|mesh-list
56029912|NCT00837200|Pegaspargase|pegaspargase|mesh-list
56029913|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56029914|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56029915|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56029916|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56029917|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029918|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029919|NCT00837512|Insulin|insulin|mesh-list
56029920|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56029921|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56029922|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029923|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56029924|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
56029925|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56029926|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56029927|NCT00837590|Analgesics|analgesics|mesh-ancestor
56029928|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
56029939|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
56029940|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
56029941|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029942|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029943|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56029944|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56029945|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56029946|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
56029947|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56029948|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029949|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56029950|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
56029951|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029952|NCT00839540|Caspofungin|caspofungin|mesh-list
56029953|NCT00839540|Micafungin|micafungin|mesh-list
56029954|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
56029955|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56029956|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029957|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029958|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
56029959|NCT02966912|Antacids|antacids|mesh-ancestor
56029960|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029961|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029962|NCT02964182|Nicotine|nicotine|mesh-list
56029963|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56029964|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
56029965|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56029966|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029967|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56029984|NCT02684006|Growth Substances|growth substances|mesh-ancestor
55824105|NCT02266706|Tazobactam|tazobactam|mesh-list
56029985|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56029986|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
56029987|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56029988|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029989|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56029990|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56029992|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56029993|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56029994|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56029995|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56029996|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824116|NCT02266706|Renal Agents|renal agents|mesh-ancestor
56029997|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56029998|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56029999|NCT01520207|Mannitol|mannitol|mesh-list
56030000|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56030001|NCT01520207|Diuretics|diuretics|mesh-ancestor
56030002|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
56030003|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030004|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
56030005|NCT01203722|Sirolimus|sirolimus|mesh-list
56030006|NCT01203722|Fludarabine|fludarabine|mesh-list
56030007|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
56030008|NCT01203722|Tacrolimus|tacrolimus|mesh-list
56030009|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030010|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030011|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030012|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
56030013|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030014|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56030026|NCT01520519|Rituximab|rituximab|mesh-list
56030027|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56030028|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030029|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
56030030|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030031|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030032|NCT03008057|Vitamin D|vitamin d|mesh-list
56030033|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
56030034|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
56030035|NCT03008057|Vitamins|vitamins|mesh-list
56030036|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
56030037|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030038|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56030039|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56030040|NCT01542125|Lidocaine|lidocaine|mesh-list
56030041|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
56030042|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
56030043|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030044|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824152|NCT02289833|Maytansine|maytansine|mesh-list
56030045|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
56030046|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030047|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56030048|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56030049|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56030050|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030051|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030052|NCT03216668|Silymarin|silymarin|mesh-list
56030053|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
56030054|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030055|NCT03216668|Protective Agents|protective agents|mesh-ancestor
56030056|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030057|NCT02548832|Bezafibrate|bezafibrate|mesh-list
56030058|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56030059|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
56030062|NCT03216278|Metformin|metformin|mesh-list
56030067|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030068|NCT04381910|Irinotecan|irinotecan|mesh-list
56030069|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56030070|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56030071|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030072|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030073|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824255|NCT01632241|Belimumab|belimumab|mesh-list
56030074|NCT05310344|Paclitaxel|paclitaxel|mesh-list
56030075|NCT05310344|Bevacizumab|bevacizumab|mesh-list
56030076|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56030077|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56030078|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030079|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
56030080|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
56030081|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
56030082|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030083|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56030084|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56030085|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55824265|NCT02289950|Farletuzumab|farletuzumab|mesh-list
56030086|NCT05310344|Growth Substances|growth substances|mesh-ancestor
56030087|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030088|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
56030089|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
56030090|NCT04382144|Bupivacaine|bupivacaine|mesh-list
56030091|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
56030092|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
56030093|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030094|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030095|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
56030096|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030097|NCT03215966|Tadalafil|tadalafil|mesh-list
55876767|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
55876768|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876769|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55876770|NCT01925547|Curcumin|curcumin|mesh-list
55876771|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55876772|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55876773|NCT01925547|Analgesics|analgesics|mesh-ancestor
55876774|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
55876775|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876776|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030098|NCT03215966|Macitentan|macitentan|mesh-list
56030099|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
56030100|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56030101|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56030102|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030103|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030104|NCT03215966|Urological Agents|urological agents|mesh-ancestor
56030105|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56030106|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56030107|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56030109|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56030110|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
56030111|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
56030112|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56030113|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56030114|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030115|NCT01441037|Danazol|danazol|mesh-list
56030116|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56030117|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
56030118|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56030119|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030120|NCT00891878|Capecitabine|capecitabine|mesh-list
56030121|NCT00891878|Sunitinib|sunitinib|mesh-list
56030122|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56030123|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
56030124|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030125|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030126|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56030127|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56030128|NCT00891878|Growth Substances|growth substances|mesh-ancestor
56030139|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030140|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
56030141|NCT03838328|Coagulants|coagulants|mesh-ancestor
56030142|NCT01526213|Fexofenadine|fexofenadine|mesh-list
56030143|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56030144|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56030145|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56030146|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
56030147|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
56030148|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030149|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030150|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030151|NCT01549223|Misoprostol|misoprostol|mesh-list
56030152|NCT01549223|Oxytocin|oxytocin|mesh-list
56030153|NCT01549223|Methylergonovine|methylergonovine|mesh-list
56030154|NCT01549223|Carboprost|carboprost|mesh-list
56030155|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
56030156|NCT01549223|Maleic acid|maleic acid|mesh-list
56030157|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
56030158|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56030159|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030160|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56030161|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
56030162|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56030163|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56030164|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030165|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030166|NCT00895934|Azacitidine|azacitidine|mesh-list
56030167|NCT00895934|Vorinostat|vorinostat|mesh-list
56030168|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
56030169|NCT00895934|Calicheamicins|calicheamicins|mesh-list
56030170|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56030171|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
56030172|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030173|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030174|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030179|NCT01550471|Beclomethasone|beclomethasone|mesh-list
56030180|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56030181|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
56030182|NCT01550471|Hormones|hormones|mesh-ancestor
55889859|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030183|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56030184|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030185|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56030186|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
56030187|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56030188|NCT00896012|Sirolimus|sirolimus|mesh-list
56030189|NCT00896012|Tacrolimus|tacrolimus|mesh-list
56030190|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030191|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
56030192|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030193|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55757391|NCT03062163|Vitamins|vitamins|mesh-ancestor
56030194|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030195|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824562|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
56030196|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56030197|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030198|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56030199|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030200|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
56030201|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
56030203|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
56030204|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56030205|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56030206|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030207|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030208|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030209|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030210|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030211|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56030212|NCT01447511|Rifampin|rifampin|mesh-list
56030213|NCT01447511|Fluconazole|fluconazole|mesh-list
56030214|NCT01447511|Warfarin|warfarin|mesh-list
55876777|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824585|NCT05642702|Antioxidants|antioxidants|mesh-ancestor
55876778|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876779|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030215|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
56030216|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56030217|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
56030218|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56030219|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030220|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
56030221|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56030222|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030223|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030224|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56030225|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56030226|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56030227|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56030228|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56030229|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56030230|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
55827636|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824601|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
56030231|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56030232|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56030233|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56030234|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
56030235|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56030236|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030237|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56030238|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56030239|NCT01831622|Methylphenidate|methylphenidate|mesh-list
56030240|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56030241|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030242|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56030256|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56030257|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56030258|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
56030259|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030260|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030261|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56030262|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56030263|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
56030264|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889860|NCT02915523|Avelumab|avelumab|mesh-list
56030265|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56030266|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56030268|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56030269|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56030270|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56030271|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
56030272|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56030273|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56030274|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030275|NCT05312294|Vaccines|vaccines|mesh-list
56030276|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
56030277|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030278|NCT01550705|Isoniazid|isoniazid|mesh-list
56030279|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
56030280|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56030281|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030282|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56030283|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56030284|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
56030285|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030286|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56030287|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56030297|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56030298|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
56030299|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030300|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56030301|NCT01831700|Protective Agents|protective agents|mesh-ancestor
56030302|NCT01531439|Naloxone|naloxone|mesh-list
56030303|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56030304|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030305|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
56030306|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030307|NCT03214874|Torsemide|torsemide|mesh-list
56030308|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56030309|NCT03214874|Diuretics|diuretics|mesh-ancestor
56030310|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
56030311|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030312|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56030313|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030314|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030315|NCT02504268|Methotrexate|methotrexate|mesh-list
56030316|NCT02504268|Abatacept|abatacept|mesh-list
56030317|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56030318|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
56030319|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56030320|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824767|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030321|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56030322|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
56030323|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030324|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030325|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
56030326|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030327|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56030328|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030338|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56030340|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030341|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56030342|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56030343|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56030345|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56030346|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030347|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
56030348|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030349|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56030350|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56030352|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56030353|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56030354|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56030355|NCT01654302|Lidocaine|lidocaine|mesh-list
56030356|NCT01654302|Tetracaine|tetracaine|mesh-list
56030357|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
56030358|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
56030359|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030360|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030361|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
56030362|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030363|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55824890|NCT02164513|Xhance|xhance|mesh-list
56030364|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56030365|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56030366|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030367|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030368|NCT01832558|Eplerenone|eplerenone|mesh-list
56030369|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56030382|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
56030383|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030384|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030385|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56030386|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030387|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55824901|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
56030388|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030389|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030390|NCT01450319|Cetuximab|cetuximab|mesh-list
56030391|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56030392|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030393|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56030394|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
56030395|NCT01552343|Coagulants|coagulants|mesh-ancestor
56030396|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56030397|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
56030398|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030399|NCT02475564|Resveratrol|resveratrol|mesh-list
56030400|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
56030401|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030402|NCT02475564|Protective Agents|protective agents|mesh-ancestor
56030403|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030404|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030405|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56030406|NCT00893984|Nebivolol|nebivolol|mesh-list
55824916|NCT04831736|Ketamine|ketamine|mesh-list
56030407|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56030408|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
56030409|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56030410|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56030411|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56030412|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
56030413|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030423|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030424|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030425|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
56030426|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030427|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030429|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56030430|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
56030431|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56030432|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
56030433|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030434|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030435|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
56030436|NCT01832948|Leucovorin|leucovorin|mesh-list
56030437|NCT01832948|Folic Acid|folic acid|mesh-list
56030438|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
56030439|NCT01832948|Endostar protein|endostar protein|mesh-list
56030440|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
56030441|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030442|NCT01832948|Antidotes|antidotes|mesh-ancestor
56030443|NCT01832948|Protective Agents|protective agents|mesh-ancestor
56030444|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030445|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
56030446|NCT01832948|Vitamins|vitamins|mesh-ancestor
56030447|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
56030448|NCT01832948|Hematinics|hematinics|mesh-ancestor
56030449|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56030450|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56030451|NCT01832948|Growth Substances|growth substances|mesh-ancestor
56030452|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
56030453|NCT01533077|Levodopa|levodopa|mesh-list
56030454|NCT01533077|Carbidopa|carbidopa|mesh-list
56030455|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56030456|NCT01533077|Opicapone|opicapone|mesh-list
56030457|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56030458|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56030459|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
55876780|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876781|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824988|NCT01713946|Everolimus|everolimus|mesh-list
55876782|NCT03122301|Bupivacaine|bupivacaine|mesh-list
55876783|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
55876784|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
56030460|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030461|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030462|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030463|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56030465|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56030466|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
56030467|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
56030468|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56030469|NCT01534013|Insulin|insulin|mesh-list
56030470|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56030471|NCT01534013|Pancrelipase|pancrelipase|mesh-list
56030472|NCT01534013|Pancreatin|pancreatin|mesh-list
56030473|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56030474|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030475|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56030476|NCT03211988|Entinostat|entinostat|mesh-list
56030477|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030478|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56030479|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030480|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030481|NCT01833572|Gefitinib|gefitinib|mesh-list
56030482|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030483|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56030484|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739796|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
56030486|NCT01833728|Acetaminophen|acetaminophen|mesh-list
56030506|NCT03219788|Analgesics|analgesics|mesh-ancestor
56030507|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
56030508|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030509|NCT03219710|Dexamethasone|dexamethasone|mesh-list
56030510|NCT03219710|Ondansetron|ondansetron|mesh-list
56030511|NCT03219710|Olanzapine|olanzapine|mesh-list
56030512|NCT03219710|Aprepitant|aprepitant|mesh-list
56030513|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56030514|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
56030515|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
56030516|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030517|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030518|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56030519|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
56030520|NCT03219710|Hormones|hormones|mesh-ancestor
56030521|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56030522|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56030523|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030524|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
56030525|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56030526|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56030527|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
56030528|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030529|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030530|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56030531|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56030532|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030533|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56030534|NCT03219710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56030535|NCT03219710|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56030536|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56030537|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030538|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56030539|NCT00899600|Ketamine|ketamine|mesh-list
56030547|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
56030548|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030549|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56030550|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56030551|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825114|NCT04327934|Hormones|hormones|mesh-ancestor
56030552|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030553|NCT03219554|Palbociclib|palbociclib|mesh-list
56030554|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030555|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56030556|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739799|NCT03389321|Riociguat|riociguat|mesh-list
56030557|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030558|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
56030559|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030560|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
56030561|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030562|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030563|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56030564|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
56030565|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030566|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030567|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56030568|NCT01451411|Conivaptan|conivaptan|mesh-list
56030569|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56030570|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030571|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
56030572|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030573|NCT03837938|Dipropizine|dipropizine|mesh-list
56030574|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
56030575|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
56030576|NCT01554683|Levetiracetam|levetiracetam|mesh-list
56030577|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
56030578|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
56030585|NCT01535573|Citalopram|citalopram|mesh-list
56030586|NCT01535573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56030587|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56030588|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030589|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030590|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030591|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
56030592|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030593|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56030594|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
56030595|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56030596|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56030597|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56030598|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
56030599|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
56030600|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030601|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56030602|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56030603|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
56030604|NCT01834508|Entecavir|entecavir|mesh-list
56030605|NCT01834508|Adefovir|adefovir|mesh-list
56030606|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
56030607|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030608|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56030609|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56030610|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030611|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030612|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
56030613|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56030614|NCT03213002|Capecitabine|capecitabine|mesh-list
56030615|NCT03213002|Temozolomide|temozolomide|mesh-list
56030616|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55739805|NCT03393377|Valsartan|valsartan|mesh-list
56030617|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
56030618|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030622|NCT01556633|Oseltamivir|oseltamivir|mesh-list
56030623|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
56030624|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030625|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889861|NCT02915523|Entinostat|entinostat|mesh-list
55825267|NCT04836962|Dexamethasone|dexamethasone|mesh-list
56030626|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030627|NCT03218852|Prednisone|prednisone|mesh-list
56030628|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
56030629|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030630|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
56030631|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030632|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030633|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56030634|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
56030635|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030636|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030637|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56030638|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56030639|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
56030640|NCT03218852|Hormones|hormones|mesh-ancestor
56030641|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56030642|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56030644|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56030645|NCT01834898|Narcotics|narcotics|mesh-ancestor
56030646|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030647|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030648|NCT01834898|Analgesics|analgesics|mesh-ancestor
56030651|NCT01557959|Docetaxel|docetaxel|mesh-list
56030670|NCT03217838|Azacitidine|azacitidine|mesh-list
56030671|NCT03217838|Venetoclax|venetoclax|mesh-list
56030672|NCT03217838|Pyrazole|pyrazole|mesh-list
56030673|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56030674|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
56030675|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030676|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030677|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030678|NCT01558661|Axitinib|axitinib|mesh-list
56030679|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030680|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56030681|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030682|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825323|NCT04816682|Silymarin|silymarin|mesh-list
56030683|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
56030684|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030685|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
56030686|NCT02502864|Docetaxel|docetaxel|mesh-list
56030687|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030688|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
56030689|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030690|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030691|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56030692|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
56030693|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030694|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030695|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56030696|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
56030697|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
56030698|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
56030699|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
56030700|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56030701|NCT03217292|Tramadol|tramadol|mesh-list
56030702|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56030703|NCT03217292|Narcotics|narcotics|mesh-ancestor
56030704|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030705|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030706|NCT03217292|Analgesics|analgesics|mesh-ancestor
56030708|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030709|NCT03217448|Warfarin|warfarin|mesh-list
56030710|NCT03217448|Dabigatran|dabigatran|mesh-list
56030711|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
56030712|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
56030713|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56030714|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
56030715|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030716|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030717|NCT01457573|Tamsulosin|tamsulosin|mesh-list
56030719|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56030720|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56030721|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56030722|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
56030723|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56030724|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030725|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030726|NCT01457573|Urological Agents|urological agents|mesh-ancestor
56030727|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56030728|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56030729|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
56030730|NCT01560143|Tigecycline|tigecycline|mesh-list
56030731|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56030732|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030733|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56030734|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030735|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030736|NCT01836224|Terlipressin|terlipressin|mesh-list
56030737|NCT01836224|Norepinephrine|norepinephrine|mesh-list
56030738|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56030739|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56030740|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56030750|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56030751|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030752|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56030753|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56030754|NCT01836536|Growth Substances|growth substances|mesh-ancestor
56030755|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030756|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
56030757|NCT03216980|Antioxidants|antioxidants|mesh-list
56030758|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030759|NCT03216980|Protective Agents|protective agents|mesh-ancestor
56030760|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030761|NCT00895232|Iron|iron|mesh-list
56030762|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56030763|NCT00895232|Trace Elements|trace elements|mesh-ancestor
56030764|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
56030765|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825416|NCT03740204|Hormones|hormones|mesh-ancestor
56030766|NCT00895232|Hematinics|hematinics|mesh-ancestor
56030767|NCT03211052|Leuprolide|leuprolide|mesh-list
56030768|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56030769|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
56030770|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56030771|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030772|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56030773|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030774|NCT01560923|Tryptophan|tryptophan|mesh-list
56030775|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56030776|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
56030777|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56030778|NCT01839032|Vinorelbine|vinorelbine|mesh-list
56030779|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030781|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
56030794|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56030795|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56030796|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
56030797|NCT01460225|Lubiprostone|lubiprostone|mesh-list
56030798|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56030799|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030800|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030801|NCT01561469|Vancomycin|vancomycin|mesh-list
56030802|NCT01561469|Linezolid|linezolid|mesh-list
56030803|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56030804|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030805|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56030806|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030807|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030808|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56030809|NCT01561703|Amoxicillin|amoxicillin|mesh-list
56030810|NCT01561703|Azithromycin|azithromycin|mesh-list
56030811|NCT01561703|Clindamycin|clindamycin|mesh-list
56030812|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
56030813|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56030814|NCT01561703|Cephalexin|cephalexin|mesh-list
56030815|NCT01561703|Cefdinir|cefdinir|mesh-list
56030816|NCT01561703|Cefaclor|cefaclor|mesh-list
56030817|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56030818|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56030819|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030820|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030821|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56030822|NCT01839500|Trastuzumab|trastuzumab|mesh-list
56030823|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56030824|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030825|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
56030826|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56030827|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030835|NCT02501928|Urological Agents|urological agents|mesh-ancestor
56030837|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56030838|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030839|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030840|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
56030841|NCT01462253|Clofarabine|clofarabine|mesh-list
56030842|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030843|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
56030844|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030845|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030846|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56030847|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
55762848|NCT04425993|Diuretics|diuretics|mesh-ancestor
56030848|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030850|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56030851|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56030852|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
56030853|NCT01837394|Acetaminophen|acetaminophen|mesh-list
56030854|NCT01837394|Morphine|morphine|mesh-list
56030855|NCT01837394|Ondansetron|ondansetron|mesh-list
56030856|NCT01837394|Metoclopramide|metoclopramide|mesh-list
56030857|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56030858|NCT01837394|Narcotics|narcotics|mesh-ancestor
56030859|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030860|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030861|NCT01837394|Analgesics|analgesics|mesh-ancestor
56030862|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
56030863|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030864|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56030881|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
56030882|NCT01462565|Epoprostenol|epoprostenol|mesh-list
56030883|NCT01462565|Tezosentan|tezosentan|mesh-list
56030884|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56030885|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56030886|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
56030887|NCT01837628|Lidocaine|lidocaine|mesh-list
56030888|NCT01837628|Mineral Oil|mineral oil|mesh-list
56030889|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
56030890|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
56030891|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030892|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030893|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
56030894|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030895|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56030896|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56030897|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56030898|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030899|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030900|NCT01837628|Emollients|emollients|mesh-ancestor
56030901|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
56030902|NCT01462877|Fenofibrate|fenofibrate|mesh-list
56030903|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56030904|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
56030905|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030906|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56030907|NCT04972656|Ambrisentan|ambrisentan|mesh-list
56030910|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
56030929|NCT04939272|Venetoclax|venetoclax|mesh-list
56030930|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030931|NCT01839890|Paclitaxel|paclitaxel|mesh-list
56030932|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56030933|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030934|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56030935|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
56030936|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
56030937|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030938|NCT02205983|Acetaminophen|acetaminophen|mesh-list
56030939|NCT02205983|Hydromorphone|hydromorphone|mesh-list
56030940|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56030941|NCT02205983|Analgesics|analgesics|mesh-ancestor
56030942|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
56030943|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030944|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030945|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
56030946|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56030947|NCT02205983|Narcotics|narcotics|mesh-ancestor
56030948|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030949|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56030950|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56030951|NCT03210038|Lidocaine|lidocaine|mesh-list
56030952|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
56030953|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
56030954|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56030955|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030956|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
56030957|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030958|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56030959|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56030960|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56030961|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56030962|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030963|NCT02472756|Rituximab|rituximab|mesh-list
55876785|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876786|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030964|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56030965|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030967|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030968|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030969|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
56030970|NCT01464359|Busulfan|busulfan|mesh-list
56030971|NCT01464359|Fludarabine|fludarabine|mesh-list
56030972|NCT01464359|Interleukin-2|interleukin-2|mesh-list
56030973|NCT01464359|Allopurinol|allopurinol|mesh-list
56030974|NCT01464359|Levetiracetam|levetiracetam|mesh-list
56030975|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56030976|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
56030977|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56030978|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56030979|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56030980|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
56030981|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56030982|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56030983|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56030984|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
56030985|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56030986|NCT01464359|Analgesics|analgesics|mesh-ancestor
56030987|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
56030988|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56030989|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
56030990|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
56030991|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56030992|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
56030993|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56030994|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
56030995|NCT01464359|Protective Agents|protective agents|mesh-ancestor
56030996|NCT04969224|Ivacaftor|ivacaftor|mesh-list
56030997|NCT04969224|Elexacaftor|elexacaftor|mesh-list
56031008|NCT01838330|Cathartics|cathartics|mesh-ancestor
56031009|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56031010|NCT02498652|Allopurinol|allopurinol|mesh-list
56031011|NCT02498652|Verinurad|verinurad|mesh-list
56031012|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
56031013|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031014|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031015|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
56031016|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031017|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56031018|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
56031019|NCT02498652|Protective Agents|protective agents|mesh-ancestor
56031020|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031021|NCT03213158|Ixazomib|ixazomib|mesh-list
56031022|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031023|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
56031024|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031025|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031027|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56031028|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031029|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56031030|NCT03219476|Tamoxifen|tamoxifen|mesh-list
56031031|NCT03219476|Letrozole|letrozole|mesh-list
55825737|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56031032|NCT03219476|Anastrozole|anastrozole|mesh-list
56031033|NCT03219476|Exemestane|exemestane|mesh-list
56031034|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031035|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56031036|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56031037|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031038|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031039|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56031040|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
56031041|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762849|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
55825836|NCT02213263|Rituximab|rituximab|mesh-list
56031042|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031043|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56031044|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56031048|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56031049|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
56031050|NCT02472366|Hormones|hormones|mesh-ancestor
56031051|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56031052|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031053|NCT01724606|Sorafenib|sorafenib|mesh-list
56031054|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031055|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56031056|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031057|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031058|NCT03217136|Metronidazole|metronidazole|mesh-list
56031059|NCT03217136|Meropenem|meropenem|mesh-list
56031060|NCT03217136|Tazobactam|tazobactam|mesh-list
56031061|NCT03217136|Ceftolozane|ceftolozane|mesh-list
56031062|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56031063|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031064|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56031065|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56031066|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56031067|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56031068|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031069|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031070|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56031071|NCT03217136|Renal Agents|renal agents|mesh-ancestor
56031072|NCT03219164|Aztreonam|aztreonam|mesh-list
56031073|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56031074|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031075|NCT01720238|Lamivudine|lamivudine|mesh-list
56031076|NCT01720238|Adefovir|adefovir|mesh-list
56031077|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
55827637|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031094|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031095|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
55758293|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
56031096|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56031097|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
56031098|NCT01830218|Anesthetics|anesthetics|mesh-list
56031099|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031100|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031101|NCT00910208|Morphine|morphine|mesh-list
56031102|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56031103|NCT00910208|Narcotics|narcotics|mesh-ancestor
56031104|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031105|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031106|NCT00910208|Analgesics|analgesics|mesh-ancestor
56031107|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
56031108|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031109|NCT01566539|Vasopressins|vasopressins|mesh-list
56031110|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
56031111|NCT01566539|Lorazepam|lorazepam|mesh-list
56031112|NCT01566539|Oxytocin|oxytocin|mesh-list
56031113|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
56031114|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56031115|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031116|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
56031117|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
56031118|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
56031119|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031120|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56031121|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56031122|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031123|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56031124|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56031125|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56031126|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
55827638|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56031127|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
56031128|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031129|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031130|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
56031131|NCT01566539|Coagulants|coagulants|mesh-ancestor
56031132|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56031133|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56031134|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
56031135|NCT04967664|Capsaicin|capsaicin|mesh-list
56031136|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
56031137|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
56031138|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
56031139|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031140|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031141|NCT01725776|Milrinone|milrinone|mesh-list
56031142|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56031143|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56031144|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
56031145|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56031146|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56031147|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031148|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031149|NCT01725776|Protective Agents|protective agents|mesh-ancestor
56031150|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031151|NCT01830296|Morphine|morphine|mesh-list
56031152|NCT01830296|Remifentanil|remifentanil|mesh-list
56031153|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56031154|NCT01830296|Narcotics|narcotics|mesh-ancestor
56031155|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031156|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031157|NCT01830296|Analgesics|analgesics|mesh-ancestor
56031158|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
56031159|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031160|NCT05564819|Acetaminophen|acetaminophen|mesh-list
56031161|NCT05564819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56031162|NCT05564819|Analgesics|analgesics|mesh-ancestor
56031163|NCT05564819|Sensory System Agents|sensory system agents|mesh-ancestor
56031164|NCT05564819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031165|NCT05564819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031166|NCT05564819|Antipyretics|antipyretics|mesh-ancestor
56031173|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56031174|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56031175|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
56031176|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031177|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
56031178|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56031179|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56031180|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56031181|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56031182|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031183|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
56031184|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031185|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031186|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56031187|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031188|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
56031190|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56031191|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031192|NCT01568255|Vitamins|vitamins|mesh-ancestor
56031193|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
56031194|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56031195|NCT01720628|Angiogenin|angiogenin|mesh-list
55825965|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
56031196|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56031197|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56031198|NCT01720628|Growth Substances|growth substances|mesh-ancestor
56031199|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031200|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
56031201|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56031202|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
56031203|NCT01569191|Epinastine|epinastine|mesh-list
56031204|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56031205|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56031206|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
56031214|NCT03409874|Analgesics|analgesics|mesh-ancestor
56031215|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
56031216|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031217|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031218|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56031219|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031220|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56031221|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031222|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031223|NCT01726088|Modafinil|modafinil|mesh-list
56031224|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56031225|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031226|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56031227|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56031228|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56031229|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031230|NCT01468337|Interferons|interferons|mesh-list
56031231|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
56031232|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031233|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
56031234|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031235|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56031236|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56031237|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56031238|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
56031239|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031240|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56031241|NCT05562089|Paclitaxel|paclitaxel|mesh-list
56031243|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031256|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031257|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031258|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031259|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031260|NCT03409250|Ranibizumab|ranibizumab|mesh-list
56031261|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56031262|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56031263|NCT03409250|Growth Substances|growth substances|mesh-ancestor
56031264|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031265|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
56031266|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031267|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56031268|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56031269|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031270|NCT01469585|Doxycycline|doxycycline|mesh-list
56031271|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56031272|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031273|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
56031274|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56031275|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56031276|NCT01720940|Vancomycin|vancomycin|mesh-list
56031277|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56031278|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031279|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56031280|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031281|NCT01721798|Copper|copper|mesh-list
56031303|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031304|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56031305|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
56031306|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56031307|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55826082|NCT02135107|Rabeprazole|rabeprazole|mesh-list
56031309|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
56031310|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56031311|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56031312|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031313|NCT04205994|Tolcapone|tolcapone|mesh-list
56031314|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56031315|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56031316|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56031317|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031318|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031319|NCT02218307|Mupirocin|mupirocin|mesh-list
56031320|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55758521|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031321|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031322|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56031323|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031324|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031325|NCT01722110|Indomethacin|indomethacin|mesh-list
56031326|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56031327|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56031328|NCT01722110|Analgesics|analgesics|mesh-ancestor
56031329|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
56031330|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031331|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031332|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56031333|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031334|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
55827639|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56031342|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031343|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56031344|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
56031345|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56031346|NCT01574183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56031347|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56031348|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56031349|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031350|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031352|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031353|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56031354|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56031355|NCT01574807|Lidocaine|lidocaine|mesh-list
56031356|NCT01574807|Mepivacaine|mepivacaine|mesh-list
56031357|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
56031358|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
56031359|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031360|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031361|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
56031362|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031363|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56031364|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56031365|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56031366|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56031367|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031368|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56031369|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56031370|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
55826152|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56031371|NCT01728272|Metoprolol|metoprolol|mesh-list
56031372|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56031373|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56031374|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
56031380|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56031381|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
56031382|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031383|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031384|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
56031385|NCT03835286|Vitamins|vitamins|mesh-ancestor
56031386|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
56031387|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031388|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
56031389|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031390|NCT03835286|Protective Agents|protective agents|mesh-ancestor
56031391|NCT04377386|Vitamin D|vitamin d|mesh-list
56031392|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
56031393|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
56031394|NCT04377386|Vitamins|vitamins|mesh-list
56031396|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031397|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56031398|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56031399|NCT01728740|Metformin|metformin|mesh-list
56031400|NCT01728740|Acarbose|acarbose|mesh-list
56031401|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56031402|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031403|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56031404|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031405|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031406|NCT01728818|Gemcitabine|gemcitabine|mesh-list
56031407|NCT01728818|Afatinib|afatinib|mesh-list
56031408|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56031409|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
56031410|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031411|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031412|NCT01728818|Antiviral Agents|antiviral agents|mesh-ancestor
56031413|NCT01728818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031422|NCT03407300|Docetaxel|docetaxel|mesh-list
56031423|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031424|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
56031425|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
56031426|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
56031427|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031428|NCT01722968|Paclitaxel|paclitaxel|mesh-list
56031429|NCT01722968|Bevacizumab|bevacizumab|mesh-list
56031430|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56031431|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031432|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
56031433|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
56031434|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
56031435|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031436|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56031437|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56031438|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56031439|NCT01722968|Growth Substances|growth substances|mesh-ancestor
56031440|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031441|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
56031442|NCT04379180|Bosentan|bosentan|mesh-list
56031443|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
56031444|NCT04379180|Tadalafil|tadalafil|mesh-list
56031445|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
56031446|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56031447|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56031448|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031449|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031450|NCT04379180|Urological Agents|urological agents|mesh-ancestor
56031451|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56031452|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56031453|NCT01576523|Complement C1s|complement c1s|mesh-list
56031454|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56031455|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
55826226|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031456|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
56031457|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031461|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031462|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031463|NCT03001739|Urapidil|urapidil|mesh-list
56031464|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56031465|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
56031466|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56031467|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
56031468|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031469|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031470|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031471|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56031472|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56031473|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56031474|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
56031475|NCT03001661|Dinoprostone|dinoprostone|mesh-list
56031476|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
56031477|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56031478|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031479|NCT03006965|Factor VIII|factor viii|mesh-list
56031480|NCT03006965|BAX 855|bax 855|mesh-list
56031481|NCT03006965|Coagulants|coagulants|mesh-ancestor
56031482|NCT04379102|Anesthetics|anesthetics|mesh-list
56031483|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
56031484|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031485|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031486|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
56031487|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031488|NCT02469246|Lamivudine|lamivudine|mesh-list
56031489|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56031490|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56031491|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031492|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031501|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031502|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031503|NCT01578317|Vaccines|vaccines|mesh-list
56031504|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
56031505|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031506|NCT03830216|Insulin|insulin|mesh-list
56031507|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56031508|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56031509|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031510|NCT01726946|Ribavirin|ribavirin|mesh-list
56031511|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
56031512|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031513|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
56031514|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031515|NCT01723670|Flurbiprofen|flurbiprofen|mesh-list
56031517|NCT01723670|Sensory System Agents|sensory system agents|mesh-ancestor
56031518|NCT01723670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031519|NCT01723670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031520|NCT01723670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56031521|NCT01723670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56031522|NCT01723670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56031523|NCT01723670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031524|NCT01723670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56031525|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031526|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031527|NCT01723748|Hormones|hormones|mesh-list
56031528|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762850|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
56031529|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031530|NCT02469090|Apomorphine|apomorphine|mesh-list
56031531|NCT02469090|Emetics|emetics|mesh-ancestor
56031532|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031533|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
56031534|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031535|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56031536|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
56031539|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031540|NCT02496000|Insulin|insulin|mesh-list
56031541|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56031542|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758750|NCT02157376|Esomeprazole|esomeprazole|mesh-list
56031543|NCT02517528|Ritonavir|ritonavir|mesh-list
56031545|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56031546|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56031547|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
56031548|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031549|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031550|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56031551|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56031552|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
56031553|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031554|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56031555|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56031556|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
56031557|NCT01727336|Axitinib|axitinib|mesh-list
56031558|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031559|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55826427|NCT02181673|Golimumab|golimumab|mesh-list
56031560|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031561|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031562|NCT01578707|Ofatumumab|ofatumumab|mesh-list
56031563|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031564|NCT03835442|Baclofen|baclofen|mesh-list
56031565|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56031567|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56031585|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
56031587|NCT03405584|Bismuth|bismuth|mesh-list
56031588|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031589|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56031590|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031591|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56031592|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56031593|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56031594|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031596|NCT03405584|Diuretics|diuretics|mesh-ancestor
56031597|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
56031598|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031599|NCT03405584|Expectorants|expectorants|mesh-ancestor
56031600|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
56031601|NCT03007121|Sufentanil|sufentanil|mesh-list
56031602|NCT03007121|Morphine|morphine|mesh-list
56031603|NCT03007121|Dsuvia|dsuvia|mesh-list
56031604|NCT03007121|Bupivacaine|bupivacaine|mesh-list
56031605|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
56031606|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
56031607|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031608|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031609|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
56031610|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031611|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56031612|NCT03007121|Narcotics|narcotics|mesh-ancestor
56031613|NCT03007121|Analgesics|analgesics|mesh-ancestor
55826477|NCT02241512|Analgesics|analgesics|mesh-ancestor
56031614|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56031615|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56031616|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
56031617|NCT01725152|Ganaxolone|ganaxolone|mesh-list
56031618|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
56031619|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031620|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031621|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031622|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
56031623|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
56031627|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56031629|NCT02981459|Mirabegron|mirabegron|mesh-list
56031630|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55826504|NCT01590082|Ipilimumab|ipilimumab|mesh-list
56031631|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56031632|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56031633|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
56031634|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031635|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031636|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031637|NCT02981459|Urological Agents|urological agents|mesh-ancestor
56031638|NCT01724138|Deferasirox|deferasirox|mesh-list
56031639|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56031640|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
56031641|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
56031642|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031643|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56031644|NCT03006809|Metronidazole|metronidazole|mesh-list
56031646|NCT03006809|Neomycin|neomycin|mesh-list
56031647|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031648|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56031649|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56031651|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031678|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56031679|NCT03001193|Oxytocin|oxytocin|mesh-list
56031680|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
56031681|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56031682|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031683|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
56031684|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56031685|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
56031686|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031687|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031688|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56031689|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
56031690|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56031691|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56031692|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56031693|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
56031694|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031695|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031696|NCT02494596|Capecitabine|capecitabine|mesh-list
56031697|NCT02494596|Pertuzumab|pertuzumab|mesh-list
56031698|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56031699|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
56031700|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031701|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031702|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56031703|NCT01048502|Fenofibrate|fenofibrate|mesh-list
56031704|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56031705|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
56031706|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031707|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56031708|NCT01583543|Olaparib|olaparib|mesh-list
56031710|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031720|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031721|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
56031722|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
56031723|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031724|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031725|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56031726|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56031727|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
56031728|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56031729|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56031730|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56031731|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56031732|NCT01724372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56031733|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56031734|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56031735|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55739828|NCT01889303|Docetaxel|docetaxel|mesh-list
56031736|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56031737|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56031738|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031739|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
56031740|NCT02464410|Narcotics|narcotics|mesh-ancestor
56031741|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031742|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031743|NCT02464410|Analgesics|analgesics|mesh-ancestor
56031744|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
56031745|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031746|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
56031747|NCT03006419|Basiliximab|basiliximab|mesh-list
56031748|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
56031749|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031750|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56031751|NCT03405272|Antibodies|antibodies|mesh-list
56031758|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56031759|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56031760|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031761|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031762|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
56031763|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56031764|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56031765|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56031766|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56031767|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56031768|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56031769|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56031770|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56031772|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56031773|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56031774|NCT03006107|Piroxicam|piroxicam|mesh-list
55762851|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56031775|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56031776|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56031777|NCT03006107|Analgesics|analgesics|mesh-ancestor
56031778|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
56031779|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031780|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031781|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56031782|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031783|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56031784|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031785|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031786|NCT01046396|Adapalene|adapalene|mesh-list
56031787|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56031788|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56031789|NCT01046396|Analgesics|analgesics|mesh-ancestor
56031790|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
56031791|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031792|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031794|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031795|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
56031796|NCT01046084|Lansoprazole|lansoprazole|mesh-list
56031797|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
56031798|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55826687|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
56031799|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56031800|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56031801|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031802|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031803|NCT01045694|Triamcinolone|triamcinolone|mesh-list
56031804|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56031805|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56031806|NCT01045694|Lidocaine|lidocaine|mesh-list
56031807|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
56031808|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56031809|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56031810|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56031811|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
56031813|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031814|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031815|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
56031816|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031817|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56031818|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56031819|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56031820|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56031821|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762852|NCT03971643|Vilobelimab|vilobelimab|mesh-list
55826720|NCT02148445|Nicotine|nicotine|mesh-list
56031822|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56031823|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
56031824|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031825|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56031826|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56031827|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
56031829|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762934|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031830|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56031832|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031833|NCT01586975|Aspirin|aspirin|mesh-list
56031834|NCT01586975|Clopidogrel|clopidogrel|mesh-list
56031835|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56031836|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56031837|NCT01586975|Analgesics|analgesics|mesh-ancestor
56031838|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
56031839|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031840|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031841|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56031842|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56031843|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56031844|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55889862|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56031845|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031846|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56031847|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56031848|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031849|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
56031850|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56031851|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56031852|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56031853|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
56031854|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031855|NCT03000413|Fentanyl|fentanyl|mesh-list
56031856|NCT03000413|Ketamine|ketamine|mesh-list
56031857|NCT03000413|Analgesics|analgesics|mesh-ancestor
56031858|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
56031859|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031860|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031861|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56031862|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56031873|NCT01724918|Lacosamide|lacosamide|mesh-list
56031875|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56031876|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56031877|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56031878|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031879|NCT01588457|Lamotrigine|lamotrigine|mesh-list
56031880|NCT01588457|Valproic Acid|valproic acid|mesh-list
56031881|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56031882|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
56031883|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
56031884|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55826802|NCT01587274|Acetaminophen|acetaminophen|mesh-list
56031885|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56031886|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56031887|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031888|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031889|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031890|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031891|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
56031892|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
56031893|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56031894|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56031895|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56031896|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56031897|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
56031898|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031899|NCT03005639|Vemurafenib|vemurafenib|mesh-list
56031900|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031901|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56031902|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031903|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031904|NCT01590875|Adenosine|adenosine|mesh-list
56031905|NCT01590875|Analgesics|analgesics|mesh-ancestor
56031906|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
56031915|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031916|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56031917|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56031918|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031919|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56031921|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56031922|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56031923|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
56031924|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031925|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56031926|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56031927|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031928|NCT01591733|Capecitabine|capecitabine|mesh-list
56031929|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
56031930|NCT01591733|Irinotecan|irinotecan|mesh-list
56031931|NCT01591733|Folfirinox|folfirinox|mesh-list
56031932|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56031933|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
56031934|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031935|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56031936|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56031937|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56031938|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56031939|NCT03005405|Methamphetamine|methamphetamine|mesh-list
56031940|NCT03005405|Fluorides|fluorides|mesh-list
56031941|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
56031942|NCT03005405|Protective Agents|protective agents|mesh-ancestor
56031943|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031944|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56031945|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
56031946|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
56031947|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031948|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
56031957|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56031959|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031960|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031961|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56031962|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
56031963|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56031964|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56031965|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56031966|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
56031967|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826881|NCT02236988|Analgesics|analgesics|mesh-ancestor
56031968|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031969|NCT03005483|Gabapentin|gabapentin|mesh-list
56031970|NCT03005483|Analgesics|analgesics|mesh-ancestor
56031971|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
56031972|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031973|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031974|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
56031975|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56031977|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56031978|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56031979|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56031980|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56031981|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031982|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031983|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
56031984|NCT01593215|Yohimbine|yohimbine|mesh-list
56031985|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
56031986|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
56031987|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031988|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56031989|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56031990|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55876787|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
55876788|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56031991|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55759195|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
56031992|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
56031993|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56031994|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56031995|NCT01593215|Urological Agents|urological agents|mesh-ancestor
56031996|NCT05404919|Tenofovir|tenofovir|mesh-list
56031997|NCT05404919|Entecavir|entecavir|mesh-list
56031998|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
56031999|NCT05404919|Antibodies|antibodies|mesh-list
56032000|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
56032001|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56032002|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56032003|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
56032004|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032005|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56032006|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56032007|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032008|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032009|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56032010|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55826948|NCT02236130|Acetaminophen|acetaminophen|mesh-list
56032011|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
56032012|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032013|NCT03005015|Doxorubicin|doxorubicin|mesh-list
56032014|NCT03005015|Lenvatinib|lenvatinib|mesh-list
56032015|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56032016|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032017|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56032018|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56032019|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032020|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032021|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56032022|NCT03005171|Lidocaine|lidocaine|mesh-list
56032032|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56032033|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56032034|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032036|NCT01041638|Aldesleukin|aldesleukin|mesh-list
56032037|NCT01041638|Interleukin-2|interleukin-2|mesh-list
56032038|NCT01041638|Tretinoin|tretinoin|mesh-list
56032039|NCT01041638|Dinutuximab|dinutuximab|mesh-list
56032040|NCT01041638|Isotretinoin|isotretinoin|mesh-list
56032041|NCT01041638|Sargramostim|sargramostim|mesh-list
56032042|NCT01041638|Vitamins|vitamins|mesh-ancestor
56032043|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
56032044|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032045|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032046|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56032047|NCT01041638|Analgesics|analgesics|mesh-ancestor
56032048|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
56032049|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032050|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
56032051|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56032052|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56032053|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
56032054|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032055|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
56032056|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827034|NCT05650151|Vitamin D|vitamin d|mesh-list
56032057|NCT03004625|Ribavirin|ribavirin|mesh-list
56032058|NCT03004625|Asunaprevir|asunaprevir|mesh-list
56032059|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
56032060|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032061|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
56032062|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032063|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
56032079|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032080|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032081|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
56032082|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032083|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032084|NCT01725542|Ribavirin|ribavirin|mesh-list
56032085|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56032086|NCT01725542|Asunaprevir|asunaprevir|mesh-list
56032087|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
56032088|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032089|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
56032090|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032091|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
56032092|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032093|NCT01725620|Etanercept|etanercept|mesh-list
56032094|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56032095|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56032096|NCT01725620|Analgesics|analgesics|mesh-ancestor
56